<SEC-DOCUMENT>0001628280-24-008024.txt : 20240229
<SEC-HEADER>0001628280-24-008024.hdr.sgml : 20240229
<ACCEPTANCE-DATETIME>20240229165050
ACCESSION NUMBER:		0001628280-24-008024
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		195
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240229
DATE AS OF CHANGE:		20240229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Astrana Health, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		24704697

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 282-0288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Apollo Medical Holdings, Inc.
		DATE OF NAME CHANGE:	20080715

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>asth-20231231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:asth="http://www.apollomed.net/20231231" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>asth-20231231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-33">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-34">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-35">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-36">0001083446</ix:nonNumeric><ix:nonNumeric contextRef="c-95" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-642">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-100" name="asth:RevenuePaymentTerms" id="f-665">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="c-203" name="us-gaap:WarrantsAndRightsOutstandingTerm" id="f-980">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" id="f-1895">http://fasb.org/us-gaap/2023#GeneralAndAdministrativeExpense</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="asth-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>asth:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="unit"><xbrli:measure>asth:unit</xbrli:measure></xbrli:unit><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayerDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:PerMemberPerMonthManagedCareContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:CMSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:RiskPoolSettlementsAndIncentivesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">asth:AccountsPayableAndAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:UniversalCareIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ForYourBenefitIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ValleyOaksMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:JadeHealthCareMedicalGroupIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:OrmaHealthIncAndProviderGrowthSolutionsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntangibleAssetsAmortizationPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:MediPortalLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:MediPortalLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:AchievaMedInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:AchievaMedInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:AchievaMedInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:ThirdWayHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:ThirdWayHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:SeenHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:Pacific6EnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:Pacific6EnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-27</xbrli:startDate><xbrli:endDate>2023-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:LmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcLsmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:ConstructionLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:ConstructionLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-03</xbrli:startDate><xbrli:endDate>2023-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">asth:NewTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-16</xbrli:startDate><xbrli:endDate>2021-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AstranaMedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">asth:NewTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="loan"><xbrli:measure>asth:loan</xbrli:measure></xbrli:unit><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:A120HellmanLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:A120HellmanLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-25</xbrli:startDate><xbrli:endDate>2022-01-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:A120HellmanLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:A120HellmanLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ConstructionLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ConstructionLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ConstructionLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:SubordinatedLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:SubordinatedLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ApcBusinessLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:PreferredBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ApcBusinessLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-10-01</xbrli:startDate><xbrli:endDate>2015-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-01</xbrli:startDate><xbrli:endDate>2016-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:APAMHMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:APAMHMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:APAMHMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:ApolloMedicalHoldingsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:ApolloMedicalHoldingsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AstranaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AstranaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-14</xbrli:startDate><xbrli:endDate>2023-11-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CompanyAndAPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CompanyAndAPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-11-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">asth:ApcStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">asth:ApcStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:LmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:LmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:LmaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PmiocMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SongPCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:SongPCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:SpinOffTransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FulgentGeneticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FulgentGeneticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FulgentGeneticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:CallCenterServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:Tag2PromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:Tag2PromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApolloMedOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApolloMedOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ConsultingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-23</xbrli:startDate><xbrli:endDate>2023-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="physician"><xbrli:measure>asth:physician</xbrli:measure></xbrli:unit><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:DmgMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:CollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:DMGAndSunLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2023MetricMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024MetricMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RevolverLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-31</xbrli:startDate><xbrli:endDate>2024-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-29</xbrli:startDate><xbrli:endDate>2024-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-117 f-83 f-116 f-82" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:91.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-3">December 31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:91.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF<br/>1934 </span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">for the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___&#160;to ___</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number:&#160; <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-37392</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><img src="asth-20231231_g1.jpg" alt="Astrana_LogoLockup_RGB_Plum_with 1_2  height of the wordmark (002).jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:470px"/></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">Astrana Health, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:47.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.071%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">95-4472349</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">1668 S. Garfield Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-11">2nd Floor</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-12">Alhambra</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-13">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-14">91801</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code:&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-15">626</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-16">282-0288</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.751%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">ASTH</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(g)&#160;of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Title of class)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-20">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section 15(d)&#160;of the Exchange Act. Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-21">No</ix:nonNumeric>&#160;&#9746;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-22">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-23">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-24">Large accelerated filer</ix:nonNumeric>&#160;&#160; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer&#160;&#160; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-26">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-27">&#9746;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-28">&#9744;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive o&#64259;cers during the relevant recovery period pursuant to &#167;240.10D-1(b).</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-29">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;Yes&#160;&#9746; No</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of common stock held by non-affiliates of the registrant, as of June 30, 2023, the last day of the registrant&#8217;s most recently completed second fiscal quarter, was approximately $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="f-30">1.3</ix:nonFraction>&#160;billion (based on the closing price for shares of the registrant&#8217;s common stock as reported by the Nasdaq Stock Market on June 30, 2023). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of February&#160;22, 2024, there were <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-31">55,423,408</ix:nonFraction> shares of common stock of the registrant, $0.001 par value per share, issued and outstanding, which includes 7,132,698 treasury shares that are owned by Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (&#8220;APC&#8221;), a consolidated affiliate of Astrana Health, Inc. These shares are legally issued and outstanding but treated as treasury shares for accounting purposes.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-32" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s definitive Proxy Statement for the 2024 annual meeting of the stockholders of the registrant are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. Such Proxy Statement will be filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) within 120 days of the registrant&#8217;s fiscal year ended December&#160;31, 2023.</span></div></ix:nonNumeric><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Table of Contents</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Astrana Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year Ended December&#160;31, 2023</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:80.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.782%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_16">Introductory Note</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_19">Note About Forward-Looking Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_19">5</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_22">PART I</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_22">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_25">ITEM 1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_25">Business</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_25">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_28">ITEM 1A</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_28">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_28">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_34">ITEM 1B</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_34">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_34">47</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_549755816203">I</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_549755816203">TEM 1C</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_549755816203">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_549755816203">yber</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_549755816203">security</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_549755816203">47</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_37">ITEM 2</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_37">Properties</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_37">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_40">ITEM 3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_40">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_40">48</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_43">ITEM 4</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_43">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_43">48</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_46">PART II</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_46">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_49">ITEM 5</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_49">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_49">49</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_58">ITEM 6</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_58">[Reserved]</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_55">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_61">ITEM 7</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_61">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_61">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_103">ITEM 7A</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_103">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_103">72</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_106">ITEM 8</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_106">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_106">73</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_247">ITEM 9</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_247">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_247">135</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_250">ITEM 9A</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_250">Controls and Procedures</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_250">135</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_253">ITEM 9B</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_253">Other Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_253">138</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_256">ITEM 9C</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_256">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_256">138</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_259">PART III</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_259">139</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_262">ITEM 10</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_262">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_262">139</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_265">ITEM 11</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_265">Executive Compensation</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_265">139</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_268">ITEM 12</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_268">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_268">139</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_271">ITEM 13</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_271">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_271">139</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_274">ITEM 14</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_274">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_274">139</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_277">PART IV</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_277">140</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_280">ITEM 15</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_280">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_280">140</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_283">ITEM 16</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_283">Form 10-K Summary</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_283">147</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glossary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following abbreviations or acronyms that may be used in this document shall have the adjacent meanings set forth below:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:28.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:69.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAMG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All-American Medical Group</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACO REACH</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACO Realizing Equity, Access, and Community Health</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHMC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHMC Healthcare Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AHM</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana Health Management, Inc. (f/k/a Network Medical Management Inc.)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AIPBP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All-Inclusive Population-Based Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAACO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APA ACO, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allied Physicians of California, a Professional Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APC-LSMA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APC-LSMA Designated Shareholder Medical Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana Medical</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana Care Partners Medical</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana Care Partners Medical Corporation (f/k/a AP - AMH 2 Medical Corporation)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers for Medicare &amp; Medicaid Services</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMHC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California Department of Managed Health Care</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Medical Group of Southern California </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GPDC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global and Professional Direct Contracting </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HSMSO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Source MSO Inc., a California corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Practice Association</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jade</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jade Health Care Medical Group, Inc. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LMA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LaSalle Medical Associates</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NGACO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Next Generation Accountable Care Organization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PMIOC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific Medical Imaging and Oncology Center, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun Labs</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun Clinical Labs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VIE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable Interest Entity</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTRODUCTORY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context dictates otherwise, references in this Annual Report on Form 10-K to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar words are references to Astrana Health, Inc., a Delaware corporation (&#8220;Astrana&#8221;), and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of our results of operations and financial performance. This discussion should be read in conjunction with the consolidated financial statements and notes thereto appearing elsewhere herein, and with our prior filings with the Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) have not reviewed any statements contained in this Report, including statements describing the participation of APA ACO, Inc. (&#8220;APAACO&#8221;) in the Global and Professional Direct Contracting Model (&#8220;GPDC Model&#8221;) or the ACO Realizing Equity, Access, and Community Health Model (&#8220;ACO REACH Model&#8221;). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names and trademarks of Astrana and its subsidiaries referred to herein, and their respective logos, are our property. This Annual Report on Form 10-K may contain additional trade names and/or trademarks of other companies, which are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names and/or trademarks, if any, to imply an endorsement or sponsorship of us by such companies, or any relationship with any of these companies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE ABOUT FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Annual Report on Form 10-K contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section&#160;27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All statements other than statements of historical fact are &#8220;forward-looking statements&#8221; for purposes of federal and state securities laws, including, but not limited to, any statements about our business, financial condition, operating results, plans, objectives, expectations, and intentions; any projections of earnings, revenue, earnings before interest, taxes, depreciation, and amortization (&#8220;EBITDA&#8221;), Adjusted EBITDA, or other financial items, such as our projected capitation from CMS, our forward-looking guidance&#160;and our future liquidity; any statements of any plans, strategies, and objectives of management for future operations,&#160;such as the material opportunities that we believe exist for our Company; any statements concerning proposed services, developments, mergers, or acquisitions;&#160; any statements with respect to dividends or stock repurchases and timing, methods, and payment of same; any statements regarding the outlook of the GPDC Model, ACO REACH Model, or strategic transactions; any statements regarding management&#8217;s view of future expectations and prospects for us; any statements about prospective adoption of new accounting standards or effects of changes in accounting standards; our ability to maintain effective internal control over financial reporting and disclosure controls and procedures; any statements regarding potential changes to our tax structure; any statements regarding future economic conditions or performance; any statements of belief; any statements of assumptions underlying any of the foregoing; and other statements that are not historical facts. Forward-looking statements may be identified by the use of forward-looking terms, such as &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;should,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;think,&#8221; &#8220;plan,&#8221; &#8220;envision,&#8221; &#8220;intend,&#8221; &#8220;continue,&#8221; &#8220;target,&#8221; &#8220;seek,&#8221; &#8220;contemplate,&#8221; &#8220;budgeted,&#8221; &#8220;will,&#8221; or &#8220;would,&#8221; and the negative of such terms, other variations on such terms or other similar or comparable words, phrases, or terminology.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements involve risks and uncertainties, many of which are difficult to predict and are outside of our control, and are based on the current beliefs, expectations, and certain assumptions of management. Some or all of such beliefs, expectations, and assumptions may not materialize or may vary significantly from actual results. Such statements are qualified by important economic, competitive, governmental, and technological factors that could cause our business, strategy, or actual results or events to differ materially from those in our forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in this Annual Report on Form 10-K, including the risk factors discussed under the heading &#8220;Risk Factors&#8221; in Part I, Item 1A below. Although we believe that the expectations reflected in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and significant risks and uncertainties that could cause actual conditions, outcomes, and results to differ materially from those indicated by such statements. Any forward-looking statement made by the Company in this Form 10-K speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_25"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Business</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2024, Apollo Medical Holdings, Inc. rebranded as Astrana Health, Inc. Astrana is a leading provider-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. We, together with our affiliated physician groups and consolidated entities, provide coordinated outcomes-based medical care serving patients in California, Nevada, and Texas, the majority of whom are covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (&#8220;HMOs&#8221;), with a small portion of our revenue coming from non-insured patients. We provide care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Our physician network consists of primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists. Astrana&#8217;s common stock is listed on The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) and trades under the symbol &#8220;ASTH&#8221;.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Led by a management team with several decades of experience, we have built a company and culture that is focused on physicians providing high-quality medical care, population health management, and care coordination for patients. Through our integrated health network, with more than 10,000 contracted physicians, we are responsible for coordinating value-based care for approximately 0.9 million patients as of December&#160;31, 2023. As a result, we believe we are well-positioned to take advantage of the shift in the U.S. healthcare industry toward providing value-based and results-oriented healthcare with a focus on patient satisfaction, high-quality care, and cost efficiency. We implement and operate different innovative healthcare models, primarily including the following three reportable segments:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Delivery; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Enablement.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Partners</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners aligned on a shared vision for coordinated care delivery. Astrana meets providers where they are and enables independent providers to remain independent while succeeding in value-based care. Astrana acts as &#8220;single payer&#8221; for our network of providers, enabling value-based care arrangements including hospital shared-risk contracts. By leveraging our unique care enablement platform and ability to recruit, empower, and incentivize physicians to effectively manage total cost of care, we are able to organize partnered providers into successful multi-payer risk-bearing organizations that take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare fee for service (&#8220;FFS&#8221;), Medicare Advantage, Medicaid, Commercial, and Exchange. Through our network of &#8220;independent practice associations&#8221; (&#8220;IPAs&#8221;), &#8220;accountable care organizations&#8221; (&#8220;ACOs&#8221;), and Restricted Knox-Keene (&#8220;RKK&#8221;) licensed health plan, our healthcare delivery entities are responsible for coordinating and delivering high-quality care to our patients and ensuring continuity of care in Astrana&#8217;s ecosystem across age, stage of life, or life circumstance.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An IPA is an association of independent physicians, or other organization that contracts with independent physicians, and provides services to HMOs, which are medical insurance groups that provide health services generally for a fixed annual fee, on a negotiated per capita rate, flat retainer fee, or negotiated FFS basis. Our affiliated IPAs comprise a network of independent primary care physicians and specialists who collectively care for patients. Our IPAs contract with various HMOs and other licensed healthcare service plans, as defined in the California Knox-Keene Health Care Service Plan Act of 1975, to provide physician services to their enrollees typically under capitated arrangements. Each HMO negotiates a fixed amount per member per month (&#8220;PMPM&#8221;) that is to be paid to our IPAs. In return, the IPAs arrange for the delivery of healthcare services by contracting with physicians or professional medical corporations for primary care and specialty care services. Our IPAs assume the financial risk of the cost of delivering healthcare services in excess of the fixed amounts received. Some of the risk is transferred to the contracted physicians or professional corporations. The risk is subject to stop-loss provisions in contracts with HMOs. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An ACO participates in in one or more payment and delivery models sponsored by Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) that provides high-quality and affordable care to Medicare FFS patients. The CMS programs allow provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participation in the respective program&#8217;s attribution-based risk-sharing model. For the year ended December&#160;31, 2023, one of the Company&#8217;s ACO participated in the ACO REACH Model. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2024, in addition to participating in the ACO REACH Model, our other ACO began participating in the Medicare Shared Savings Program (&#8220;MSSP&#8221;). The MSSP was created to promote accountability and improve coordination of care for Medicare beneficiaries. The MSSP has multiple risk tracks, and we are currently participating in the ENHANCED risk track. Much like the ACO REACH Model, under the MSSP Model, we recruit a group of Participant and Preferred (in-network) Providers. Based on the Participant Providers that join our ACO, CMS grants us a pool of Traditional Medicare patients (beneficiaries) to manage (the &#8220;MSSP Aligned Beneficiaries&#8221;). Our MSSP Aligned Beneficiaries will receive services from physicians and other medical service providers that are both in-network and out-of-network. Unlike the ACO REACH Program, CMS continues to pay participant and preferred providers on a FFS basis for Medicare-covered services provided to MSSP Aligned Beneficiaries. However, we continue to bear risk on all Medicare expenditures (both in-network and out-of-network), excluding drug expenditures covered by Medicare Part D, based on a budgetary benchmark established with CMS. Our shared savings or losses in managing our beneficiaries are generally determined on an annual basis after reconciliation with CMS. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With our Restricted Knox-Keene licensed health plan, we can assume full financial responsibility, including both professional and institutional risk, for the medical costs of our members under the plans, which allows our Care Partners to manage a full spectrum of care.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Delivery</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients that sees over 800,000 patients annually. As medical care has increasingly been delivered in clinic settings, many integrated health networks also operate healthcare facilities primarily focused on the diagnosis and/or care of outpatients, including those with chronic conditions such as heart disease and diabetes, to cover the primary healthcare needs of local communities. Our Care Delivery organization spans approximately 60 locations across 3 states and includes:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Primary care clinics, including post-acute care services; </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Multi-specialty care clinics and medical groups, including hospitalist, intensivist, and physician advisory services, cardiac care and diagnostic testing, and specialized care for women&#8217;s health; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ancillary service providers, such as urgent care centers, outpatient imaging centers, ambulatory surgery centers, and full-service labs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We analyze our Care Partners networks by specialty and geography and then build or acquire practices and provider groups to fulfill network gaps in access to ensure patients have high-quality access to care. Our ability to build Care Delivery clinics tailor-made for specific markets helps us scale as we enter de novo into new markets.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Enablement</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Enablement segment is an integrated, end-to-end clinical, operational, financial, and administrative platform powered by our proprietary technology suite and underpinned by 35+ years of real-world data, that enhances delivery of high-quality, value-based care to our patients and leading to superior clinical and financial outcomes. Our Care Enablement tools are leveraged across our Care Partners and Care Delivery lines of business as well as 3rd party providers outside of our Astrana ecosystem. Care Enablement provides solutions to providers, including independent physicians, provider and medical groups, ACOs, and payers, including health plans and other risk-bearing organizations. Our platform meets providers and payers where they are, with a wide spectrum of solutions across the total cost of care risk spectrum, ranging from solutions for FFS entities to full risk-bearing entities, and across patient types, including Medicare, Medicaid, Commercial, and Exchange-insured patients. By leveraging our care enablement platform, we believe that providers and payers can improve their ability to deliver high-quality care to their patients and achieve better patient outcomes. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Population health management (&#8220;PHM&#8221;) is a central trend within healthcare delivery, which includes the aggregation of patient data across multiple health information technology resources, the analysis of that data into a single, actionable patient record, and the actions through which care providers can improve both clinical and financial outcomes. PHM seeks to improve health outcomes by monitoring and identifying individual patients, aggregating data, and providing a comprehensive clinical picture of each patient. Using that data, providers can track, and hopefully improve, clinical outcomes while lowering costs. A successful PHM platform requires a robust care and risk management infrastructure, a cohesive delivery system, and a well-managed partnership network.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Care Enablement segment includes management service organizations (&#8220;MSOs&#8221;) that provide non-medical services, under management service agreements (&#8220;MSAs&#8221;) to IPAs, ACOs, or clinics. Under these arrangements, the MSOs have authority over various non-medical decision-making related to ongoing business operations. These services include but are not limited to:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Physician recruiting;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Physician and health plan contracting;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care management, including utilization management, medical management, and quality management;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provider relations;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Member services, including annual wellness evaluations;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims processing;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pre-negotiating contracts with specialists, labs, imaging centers, nursing homes, and other vendors; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue cycle management.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Integrated Health Network</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An integrated health network that is able to pool a large number of patients, such as the Company and its affiliated physician groups, is positioned to take advantage of industry trends, meet patient and government demands, and benefit from cost advantages resulting from their scale of operation and integrated approach of care delivery. In addition, an integrated health network with years of managed care experience can leverage their expertise and sizeable medical data to identify specific treatment strategies and interventions, improve the quality of medical care and lower costs. Many integrated health networks, including the Company and its affiliated physician groups, have also established physician performance metrics that allow them to monitor quality and service outcomes achieved by participating physicians in order to reward efficient, high-quality care delivered to members and initiate improvement efforts for physicians whose performance can be enhanced.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our ACOs, network of IPAs and Restricted-Knox-Keene licensed health plan with approximately 10,000 contracted healthcare providers, which have agreements with various health plans, hospitals, and other HMOs, we are responsible for coordinating the care of approximately 0.9&#160;million patients, as of December&#160;31, 2023. These patients are comprised of managed care members whose health coverage is provided through their employers, or who have acquired health coverage directly from a health plan or as a result of their eligibility for Medicaid or Medicare benefits. Our managed patients benefit from an integrated approach that places physicians at the center of patient care and utilizes sophisticated risk management techniques and clinical protocols to provide high-quality, cost-effective care. To implement a patient-centered, physician-centric experience, we also have other integrated and synergistic operations, including (i) MSOs that provide management and other services to our affiliated IPAs, (ii) primary care clinics, (iii) multi-specialty care clinics and medical groups, and (iv) ancillary service providers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Human Capital </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, Astrana, its subsidiaries, and consolidated VIEs had approximately 1,800 employees. None of our employees are members of a labor union, and we have not experienced any work stoppage. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to supporting the professional development of our employees, providing competitive compensation and benefits and a safe and inclusive workplace. We measure employee engagement on an ongoing basis to create a more innovative, productive, and profitable company. The results from engagement surveys are used to implement programs and processes designed to support employee retention and satisfaction. The Company believes a diverse workforce fosters innovation and cultivates an environment filled with unique perspectives and growth. Respect for human rights is fundamental to the Company&#8217;s business and its commitment to ethical business conduct. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our dedication to employee growth is reflected in the various learning and development programs offered at Astrana. We organize leadership programs, including a bi-annual summit, the Becoming Leaders program, individual coaching, and ad hoc training sessions, to support our employees in their professional advancement. Our professional development reimbursement program empowers employees to attend classes, seminars, or obtain certifications, enhancing their skill sets and opening up new opportunities for advancement within the Company.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We actively promote and support employees seeking to make a positive impact on their communities and charitable causes through the donation of time, talents, and resources. In 2023, Astrana contributed to several charitable organizations, including the Children's Hospital of Los Angeles, American Heart Association, American Red Cross, and a blanket drive dedicated to supporting residents in our nursing homes.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Organization</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate through our wholly owned subsidiaries and their consolidated entities, including consolidated VIEs. Our wholly owned subsidiaries are MSOs and ACOs. Our MSOs operate within our Care Enablement segment and are in the business of providing management services. Our ACOs operate within our Care Partners segment and participate in CMS programs. The consolidated IPAs operate within our Care Partners segment and the clinics and ancillary service providers operate within our Care Delivery segment. Our IPAs, clinics and ancillary service businesses are consolidated by the Company as VIEs. We consolidate a VIE if we have both power and benefits &#8211; that is, (i) we have the power to direct the activities of a VIE that most significantly influence the VIE&#8217;s economic performance, and (ii) we have the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states have laws that prohibit business entities with non-physician owners, such as Astrana and its subsidiaries, from practicing medicine, employing physicians to practice medicine, or exercising control over medical decisions by physicians. These laws are generally referred to as corporate practice of medicine laws. States that have corporate practice of medicine laws permit only physicians to practice medicine, exercise control over medical decisions, or engage in certain arrangements, such as fee-splitting, with physicians. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to these laws, we operate by maintaining long-term MSAs with our affiliated IPAs and medical groups, each of which is owned and operated by physicians only, and employs or contracts with additional physicians to provide medical services. Astrana Health Management, Inc. (&#8220;AHM&#8221;), formerly known as Network Medical Management Inc., is a wholly owned subsidiary of the Company and has entered into MSAs with several affiliated IPAs, including Allied Physicians of California IPA, a Professional Medical Corporation, d.b.a. Allied Pacific of California IPA (&#8220;APC&#8221;). APC contracts with various HMOs or licensed healthcare service plans, each of which pays a fixed payment (&#8220;capitation&#8221;). In return, APC arranges for the delivery of healthcare services by contracting with physicians or professional medical corporations for primary care and specialty care services. APC assumes the financial risk of the cost of delivering healthcare services in excess of the fixed amounts received. The risk is subject to stop-loss provisions in contracts with HMOs. Some risk is transferred to the contracted physicians or professional corporations. The physicians in the IPA are exclusively in control of, and responsible for, all aspects of the practice of medicine for enrolled patients. In accordance with relevant accounting guidance, APC has been determined to be a VIE of AHM, as AHM is its primary beneficiary with the ability, through majority representation on the APC Joint Planning Board and otherwise, to direct the activities (excluding clinical decisions) that most significantly affect APC&#8217;s economic performance. Therefore, APC and its wholly owned subsidiaries and VIEs are consolidated in the accompanying financial statements.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to laws prohibiting a California professional corporation that has more than one shareholder, such as Astrana and APC, from being a shareholder in another California professional corporation, the Company cannot directly own shares in other professional corporations. However, an exception to this regulation permits a professional corporation that has only one shareholder to own shares in another professional corporation. In reliance on this exception, the Company will designate certain key personnel as a nominee shareholder of the professional corporation which holds controlling and non-controlling ownership interests in several medical corporations. Via a Physician Shareholder Agreement with the nominee shareholder, the Company has the ability to designate another person to be the equity holder of each professional corporation. In addition, these entities are managed by our wholly owned MSOs via MSAs. Under the MSAs, we provide and perform non-medical management and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">administrative services. In accordance with relevant accounting guidance, the professional corporations and their consolidated medical corporations are consolidated by the Company in the accompanying financial statements.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; to our consolidated financial statements for information on our entities that qualify as consolidated VIEs. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invested in several entities in the healthcare industry. Astrana holds a 30% interest in CAIPA MSO, LLC (&#8220;CAIPA MSO&#8221;). CAIPA MSO is a New York-based management services organization affiliated with Chinese-American IPA d.b.a. Coalition of Asian-American IPA (&#8220;CAIPA&#8221;), a leading independent practice association serving the greater New York City area. APC-LSMA, a consolidated VIE of APC, holds a 25% interest in the IPA line of business of LaSalle Medical Associates (&#8220;LMA&#8221;) and a 40% interest in Pacific Medical Imaging and Oncology Center, Inc. (&#8220;PMIOC&#8221;). PMIOC provides comprehensive diagnostic imaging services using state-of-the-art technology. PMIOC offers high-quality diagnostic services, such as MRI/MRA, PET/CT, CT, nuclear medicine, ultrasound, digital X-rays, bone densitometry, and digital mammography, at its facilities. These investments are accounted for under the equity method as the Company has the ability to exercise significant influence, but not control over operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">APC holds 2.8% membership interests of MediPortal LLC, a New York limited liability company, and AHM holds a 10% interest in AchievaMed, Inc., a California corporation. The Company also holds equity securities in Nutex Health Inc. (&#8220;Nutex&#8221;). As of December&#160;31, 2023, the value of the equity securities was $0.3 million. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a Simple Agreement for Future Equity (&#8220;SAFE&#8221;) with Third Way Health, Inc. (&#8220;Third Way Health&#8221;) and Seen Health, Inc. (&#8220;Seen Health&#8221;). Based on certain triggering events defined in each SAFE agreement, the Company has rights to Third Way Health and Seen Health shares. The number of shares to be acquired will be calculated when the triggering event occurs. As of December&#160;31, 2023, the related investment balance for Third Way Health SAFE and Seen Health SAFE was $3.5 million and $2.0 million, respectively.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Excluded Assets</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company completed the following series of transactions with its affiliates, Astrana Health Medical Corporation (&#8220;Astrana Medical&#8221;), formerly known as AP-AMH Medical Corporation, a consolidated VIE of Astrana, and APC, a consolidated VIE of AHM:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">A $545.0&#160;million loan from the Company to Astrana Medical, pursuant to a 10-year secured loan agreement (the &#8220;Astrana Medical Loan&#8221;). The loan bears interest at a rate of 10% per annum simple interest, is not prepayable (except in certain limited circumstances), requires quarterly payments of interest only in arrears, and is secured by a first-priority security interest in all of Astrana Medical&#8217;s assets. To the extent that Astrana Medical is unable to make any interest payment when due because it has received dividends on the APC Series A Preferred Stock insufficient to pay in full such interest payment, then the outstanding principal amount of the loan will be increased by the amount of any such accrued but unpaid interest, and any such increased principal amounts will bear interest at the rate of 10.75% per annum simple interest.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">A $545.0 million private placement, where Astrana Medical purchased 1,000,000 shares of APC Series A Preferred Stock which entitles Astrana Medical to receive preferential, cumulative dividends that accrue on a daily basis. During the years ended December&#160;31, 2023 and 2022, APC declared $58.0 million and $58.3 million, respectively, as preferred returns.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">A $300.0&#160;million private placement, where APC purchased 15,015,015 shares of the Company&#8217;s common stock and in connection therewith, the Company granted APC certain registration rights with respect to the purchased shares.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Astrana licensed to Astrana Medical the right to use certain tradenames for specified purposes for a fee equal to a percentage of the aggregate gross revenues of Astrana Medical. The license fee is payable out of any Series A Preferred Stock dividends received by Astrana Medical from APC.</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Through its subsidiary, AHM, the Company agreed to provide certain administrative services to Astrana Medical for a fee equal to a percentage of the aggregate gross revenues of Astrana Medical. The </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">administrative fee is also payable out of any APC Series A Preferred Stock dividends received by Astrana Medical from APC.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the series of transactions, in September 2019, APC and Astrana Medical entered into a Second Amendment to the Series A Preferred Stock Purchase Agreement, clarifying the term excluded assets (&#8220;Excluded Assets&#8221;). Excluded Assets means (i) assets received from the sale of shares of the Series A Preferred equal to the Series A purchase price, (ii) the assets of APC that are not Healthcare Services Assets (as defined in the purchase agreement), including APC&#8217;s equity interests in Astrana Health, Inc., and any entity that is primarily engaged in the business of owning, leasing, developing, or otherwise operating real estate, (iii) any assets acquired with the proceeds of the sale, assignment, or other disposition of any of the assets described in clauses (i) or (ii), and (iv) any proceeds of the assets described in clauses (i), (ii), and (iii). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 26, 2023, APC completed a restructuring transaction to spin-off its real estate business and investments, a component of Excluded Assets (&#8220;the Spin-Off&#8221;). To effect the restructuring, APC contributed its real estate investments to a wholly owned subsidiary in exchange for 100% of the subsidiary&#8217;s membership interest units, which membership interests were then distributed to holders of APC&#8217;s outstanding common stock as a dividend, with each such stockholder receiving one membership interest unit for each share of outstanding APC common stock held. As a result of the distribution, the real estate investments are no longer included within our consolidated financial statements after December 26, 2023.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, APC also held a 13.22% ownership interest in Astrana. APC&#8217;s ownership interest in Astrana is eliminated upon consolidation. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Industry</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industry Overview</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. healthcare spending has increased steadily over the past two decades. CMS estimates that total U.S. healthcare expenditures are expected to grow at an average annual rate of 5.4% from 2022 to 2031 and will reach $7.2 trillion by 2031. Health spending is projected to grow 0.8% faster than the U.S. gross domestic product per year on average over 2022-2031, and as a result, the healthcare share of gross domestic product is expected to grow from 18.3% in 2021 to 19.6% in 2031. Medicare spending increased by 5.9% to $944.3 billion and Medicaid spending increased by 9.6% to $805.7 billion in 2022, which accounted for 21% and 18% of total health expenditures, respectively. Private health insurance spending increased by 5.9% to $1.3 trillion in 2022, accounting for 29% of total health expenditures. Medicare spending is expected to have the fastest growth (7.5% per year for 2022-2031) primarily due to the projected enrollment growth. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed care health plans were developed in the U.S., primarily during the 1980s, in an attempt to mitigate the rising cost of providing healthcare to populations covered by health insurance. These managed care health plans enroll members through their employers in connection with federal Medicare benefits or state Medicaid programs. As a result of the prevalence of these health plans, many seniors now becoming eligible for Medicare have been interacting with managed care companies through their employers for the last 30 years. Individuals now turning 65 are likely more familiar with the managed care setting than previous Medicare populations. The healthcare industry, however, is highly regulated by various government agencies and heavily relies on reimbursement and payments from government-sponsored programs such as Medicare and Medicaid. Companies in the healthcare industry, therefore, have to organize, operate around, and face challenges from idiosyncratic laws and regulations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many health plans recognize both the opportunity for growth from adding members, as well as the potential risks and costs associated with managing additional members. In California, many health plans subcontract a significant portion of the responsibility for managing patient care to an integrated health network such as Astrana and our affiliated physician groups. These integrated healthcare systems offer a comprehensive medical delivery system, sophisticated care management know-how, and infrastructure to more efficiently provide for the healthcare needs of the population enrolled with that health plan. While reimbursement models for these arrangements vary around the U.S., health plans often prospectively pay the integrated healthcare system a fixed capitation payment, which is frequently based on a percentage of the amount received by the health plan. Capitation payments to integrated healthcare systems, in the aggregate, represent a prospective budget from which the system manages care-related expenses on behalf of the population enrolled with that system. To the extent that these systems manage such expenses under the capitated levels, the system realizes an operating profit. On the other hand, if the expenses exceed projected levels, the system will realize an operating deficit. Since premiums paid represent a substantial amount per person, there is a significant revenue opportunity for an integrated health network that is able to effectively manage healthcare costs for the capitated arrangements entered into by its affiliated physician groups.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industry Trends and Demand Drivers</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the healthcare industry is undergoing a significant transformation and the demand for our offerings is driven by the confluence of a number of fundamental healthcare industry trends, including:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shift to Value-Based and Results-Oriented Models.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> According to the 2022 National Health Expenditure Historical Data prepared by CMS, healthcare spending in the U.S. increased by 4.1% to $4.5 trillion in 2022, representing 17.3% of the U.S. Gross Domestic Product. CMS projects healthcare spending in the U.S. to increase at an average rate of 5.4% for 2022-2031 and to reach approximately $7.2 trillion by 2031. To address this expected significant rise in healthcare costs, the U.S. healthcare market is seeking more efficient and effective methods of delivering care. The FFS reimbursement model has arguably played a major role in increasing the level and growth rate of healthcare spending. In response, both the public and private sectors are shifting away from the FFS reimbursement model toward value-based, capitated payment models that are designed to incentivize value and quality at an individual patient level. The number of Americans covered by capitated payment programs continues to increase, which drives more coordinated and outcomes-based patient care.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Increasingly Patient-Centered</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. More patients are becoming actively involved and taking an informed role in how their own healthcare is delivered, resulting in the healthcare marketplace becoming increasingly patient-centered, and thus requiring providers to deliver team-based, coordinated, and accessible care to stay competitive.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Added Complexity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the healthcare space, more sophisticated technology has been employed, new diagnostics and treatments have been introduced, research and development have expanded, and regulations have multiplied. This expanding complexity drives a growing and continuous need for integrated care delivery systems.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Integration of Healthcare Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Across the healthcare landscape, a significant amount of data is being created every day, driven by patient care, payment systems, regulatory compliance, and record keeping. As the amount of healthcare data continues to grow, it becomes increasingly important to connect disparate data and apply insights in a targeted manner in order to better achieve the goals of higher quality and more efficient care.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Revenue Streams</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue reflected in the accompanying consolidated financial statements includes revenue generated by our subsidiaries and consolidated entities. Our revenue streams are diversified among our various operations and multi-year renewable contractual arrangements as follows:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Capitation revenue;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk pool settlements and incentives;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ACO REACH capitation revenue;</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management fee income; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FFS revenue.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitation Revenue</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our capitation revenue consists primarily of capitated fees for medical services we provide under capitated arrangements made directly with various managed care providers, including HMOs. Under the capitated model, an HMO pays the IPA a capitation payment and assigns it the responsibility for providing physician services required by patients. The IPA physicians are exclusively in control of, and responsible for, all aspects of the practice of medicine for enrolled patients. Capitation revenue for our Restricted Knox-Keene licensed health plan consists of &#8220;global&#8221; capitation arrangements whereby the Restricted Knox-Keene licensed health plan accepts financial risk for hospital and other institutional services in addition to professional medical services (whereas IPA capitation contracts are typically limited to accepting financial risk for professional medical services). Most of the HMO agreements have an initial term of two years, renewing automatically for successive one-year terms. The HMO agreements generally allow either party to terminate the HMO agreements without cause, typically with a four to six months advance notice and provide for a termination for cause by the HMO at any time.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation revenue is typically prepaid monthly to us based on the number of enrollees selecting us as their healthcare provider. Capitation is a fixed payment amount per patient per unit of time paid in advance for the delivery of healthcare </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services, whereby the service providers are generally liable for excess medical costs. The actual amount paid is determined by the ranges of services provided, the number of patients enrolled, and the period of time during which the services are provided. Capitation rates are generally based on local costs and average utilization of services. Because Medicare pays capitation using a &#8220;Risk Adjustment&#8221; model, which compensates managed care providers based on the health status (acuity) of each individual enrollee, managed care providers with higher acuity enrollees receive more, and those with lower acuity enrollees receive less, capitation that can be allocated to service providers. Under the Risk Adjustment model, capitation is paid on an interim basis based on enrollee data submitted for the preceding year and is adjusted in subsequent periods after the final data is compiled.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PMPM managed care contracts generally have a term of one year or longer. All managed care contracts have a single performance obligation that constitutes a series for the provision of managed healthcare services for a population of enrolled members for the duration of the contract. The transaction price for PMPM contracts is variable, as it primarily includes PMPM fees associated with unspecified membership that fluctuates throughout the term of the contract. In certain contracts, PMPM fees also include adjustments for items such as performance incentives, performance guarantees, and risk shares. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Pool Settlements and Incentives</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation arrangements are supplemented by risk-sharing arrangements. Our affiliated IPAs have two different types of capitation risk-sharing arrangements: hospital shared-risk and health plan shared-risk arrangements.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our affiliated IPAs may enter into hospital shared-risk capitation arrangements with certain health plans and local hospitals, where the hospital is responsible for providing, arranging, and paying for institutional risk, and the IPA is responsible for providing, arranging, and paying for professional risk. Under a hospital shared-risk pool-sharing agreement, we generally receive a percentage of the net surplus from the affiliated hospital&#8217;s risk pools with HMOs after deductions for the affiliated hospital&#8217;s costs, whereas deficits, if any, are not payable until and unless (and only to the extent) risk-sharing surpluses are generated. At the termination of the hospital shared-risk pool-sharing agreement, any accumulated deficit will be extinguished. Advance settlement payments are typically made quarterly in arrears if there is a surplus. Risk pool settlements under arrangements with health plans and hospitals are recognized using the most likely amount methodology and amounts are only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. Assumptions for medical loss ratios (&#8220;MLR&#8221;), incurred but not reported (&#8220;IBNR&#8221;) completion factors and constraint percentages were used by management in applying the most likely amount methodology.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with certain HMOs, our affiliated IPAs may participate in one or more health plan shared-risk arrangements relating to the provision of institutional services to enrollees (health plan shared-risk arrangements) and thus can earn additional revenue or incur losses based upon the enrollee utilization of institutional services. Health plan shared-risk capitation arrangements are entered into with certain health plans, which are administered by the health plan, where we are responsible for rendering professional services, but the health plan does not enter into a capitation arrangement with a hospital and therefore, the health plan retains the institutional risk. Health plan shared-risk deficits, if any, are not payable until and unless (and only to the extent of any) risk-sharing surpluses are generated. At the termination of the HMO contract, any accumulated deficit will be extinguished.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to risk-sharing revenues, we also receive incentives under &#8220;pay-for-performance&#8221; programs for quality medical care, based on various criteria. As an incentive to promote quality care, certain HMOs have designed quality incentive programs and commercial generic pharmacy incentive programs to compensate us for our efforts to improve the quality of services and to promote the efficient and effective use of pharmacy supplemental benefits provided to HMO members. The incentive programs track specific performance measures and calculate payments to us based on the performance measures. Generally, for the foregoing arrangements, the final settlement is dependent on each distinct day&#8217;s performance within the annual measurement period, but cannot be determined until the full measurement period has occurred and performance can be assessed.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACO REACH Capitation Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through one of our ACOs, we participate in the Global Risk track with Total Care Capitation (&#8220;TCC&#8221;) in the Accountable Care Organization Realizing Equity, Access, and Community Health (&#8220;ACO REACH&#8221;) Model sponsored by CMS. Under the ACO REACH Model, we recruit a group of Participant and Preferred (in-network) Providers. Based on the Participant Providers that join our ACO, CMS grants us a pool of Traditional Medicare patients (beneficiaries) to manage (the &#8220;Aligned Beneficiaries&#8221;). Our Aligned Beneficiaries will receive services from physicians and other medical service providers that are both in-network and out-of-network. Under TCC, CMS estimates an average of in-network monthly expenditures for our ACO&#8217;s Aligned Beneficiaries and pays that projected amount to us in monthly installments. We are then responsible for paying our in-network providers for all Medicare-covered services provided to our Aligned Beneficiaries by those providers. In </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">addition, we bear risk on all Medicare expenditures (both in-network and out-of-network), excluding drug expenditures covered by Medicare Part D, based on a budgetary benchmark established with CMS. Claims from out-of-network providers are processed and paid by CMS. Our shared savings or losses in managing our beneficiaries are generally determined on an annual basis after reconciliation with CMS. Pursuant to our risk-share agreement with CMS, we are eligible to receive the surplus (shared savings) or are liable for the deficit (shared losses) according to the budgetary benchmark established by CMS based on our efficiency, or lack thereof, in managing the expenditures associated with our Aligned Beneficiaries. Using the most recent data from CMS, the Company estimates the potential</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">savings or deficit for the performance year. We also recognize the budgetary benchmark established by CMS, net of any ACO REACH program discounts and adjustments, as revenue. Our maximum shared savings or losses are determined by the risk track we elect with CMS. Under the Global Risk track, we are responsible for 100% of shared savings or losses up to 25% of the total budgetary benchmark established by CMS, with adjusted risk corridors taking effect for any proportion of shared savings / losses exceeding 25% of the benchmark&#8212;for savings/losses of 25-35% of the benchmark, we assume 50% risk responsibility, for savings/losses 35%-50% of the benchmark we assume 25% of the risk responsibility, and for savings/losses exceeding 50% of the benchmark, we assume only 10% of the risk responsibility.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management Fee Income</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management fee income encompasses fees paid for management, physician advisory, healthcare staffing, administrative, and other non-medical services provided by us to IPAs, hospitals, and other healthcare providers. Our MSOs enter into management service agreements with terms generally ranging from one to ten years, although they may be terminated earlier under the terms of the applicable contracts. Management fees may be in the form of billings at agreed-upon hourly rates, percentages of revenue, or fee collections, or amounts fixed on a monthly, quarterly, or annual basis. The revenue may include variable arrangements measuring factors such as hours staffed, patient visits, or collections per visit against benchmarks, and, in certain cases, may be subject to achieving quality metrics or fee collections.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fee For Service (&#8220;FFS&#8221;) Revenue</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FFS revenue represents revenue earned under contracts in which we bill and collect the professional component of charges for medical services rendered by our contracted physicians and employed physicians. Under the FFS arrangements, we bill, and receive payments from, the hospitals and third-party payers for physician staffing and further bill patients or their third-party payers for patient care services provided.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Key Payers</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of payers represent a significant portion of our net revenue. For the years ended December 31, 2023, 2022 and 2021, four payers accounted for an aggregate of 61.7%, 59.0%, and 49.6% of our total net revenue, respectively.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strengths and Advantages</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are some of the material opportunities that we believe exist for our company:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Combination of Clinical, Administrative and Technology Capabilities</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our key strength lies in our combined clinical, administrative, and technology capabilities. While many companies separately provide clinical, MSO, or technology support services, to our knowledge, there are currently very few organizations like ours that provide all three types of services to approximately 0.9 million patients as of December&#160;31, 2023.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversification</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our subsidiaries, consolidated affiliates, and invested entities, we have been able to reduce our business risk and increase revenue opportunities by diversifying our service offerings and expanding our ability to manage patient care across a horizontally integrated care network. Our revenue is spread across our operations. Additionally, with our ability to monitor and manage care within our wide network, we believe we are an attractive business partner to health plans, hospitals, IPAs, and other medical groups seeking to provide better care at lower costs.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strong Management Team</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management team has, collectively, several decades of experience managing physician practices, risk-based organizations, health plans, hospitals, and health systems, a deep understanding of the healthcare marketplace and emerging trends, and a vision for the future of healthcare delivery led by physician-driven healthcare networks.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A Robust Physician Network</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, our physician network consisted of approximately 10,000 contracted physicians, including primary care physicians, specialist physicians, and hospitalists, through our affiliated physician groups and ACOs.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cultural Affinities with Patients</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to delivering premium healthcare, we believe in the importance of providing services that are sensitive to the needs of local communities, including their cultural affinities. This value is shared by physicians within our affiliated IPAs and medical groups, and promotes patient comfort in communicating with care providers.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Standing Relationships with Partners</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed long-standing relationships with multiple health plans, hospitals, IPAs, and other medical groups that have helped to generate recurring contractual revenue for us.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive and Effective Healthcare Management Programs</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer comprehensive and effective healthcare management programs to patients. We have developed expertise in population health management and care coordination, and in proper medical coding, which results in improved Risk Adjustment Factor (&#8220;RAF&#8221;) scores and higher payments from health plans, and in improved quality metrics in both inpatient and outpatient settings and thus patient satisfaction and CMS scores. Using our own proprietary risk assessment scoring tool, we have also developed our own protocol for identifying high-risk patients.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is highly competitive and fragmented. We compete for customers across all of our services with other healthcare management companies, including MSOs and healthcare providers, such as local, regional, and national networks of physicians, medical groups, and hospitals, many of which are substantially larger than us and have significantly greater financial and other resources, including personnel, than we have.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IPAs</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our affiliated IPAs compete with other IPAs, medical groups, and hospitals, many of which have greater financial, personnel, and other resources available to them. In the greater Los Angeles area, such competitors include Regal Medical Group and Lakeside Medical Group, which are part of Heritage Provider Network (&#8220;Heritage&#8221;), as well as Optum (f/k/a HealthCare Partners), a subsidiary of UnitedHealth Group.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ACOs</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ACOs competes with other sophisticated provider groups in the creation, administration, and management of ACOs, many of which have greater financial, personnel, and other resources available to them. Major competitors of APAACO include Privia Health and Aledade.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Outpatient Clinics</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outpatient clinics compete with large ambulatory surgery centers and/or diagnostic centers such as RadNet and Envision Healthcare, many of which have greater financial, personnel, and other resources available to them, as well as smaller </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clinics that have ties to local communities. Optum (f/k/a HealthCare Partners) also has its own urgent care centers, clinics, and diagnostic centers.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MSOs</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MSOs compete with other MSOs in providing management, administrative and other support services. Such competitors include Prospect Medical Systems and Conifer Health Solutions. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a healthcare company, our operations and relationships with healthcare providers, such as hospitals, other healthcare facilities, and healthcare professionals, are subject to extensive and increasing regulation by numerous federal, state, and local government agencies, including the Office of Inspector General, the Department of Justice, CMS, and various state authorities. These laws and regulations often are interpreted broadly and enforced aggressively. Imposition of liabilities associated with a violation of any of these healthcare laws and regulations could have a material adverse effect on our business, financial condition, or results of operations. We cannot guarantee that our practices will not be subject to government scrutiny or be found to violate certain healthcare laws. Government investigations and prosecutions, even if we are ultimately found to be without fault, can be costly and disruptive to our business. Moreover, changes in healthcare legislation or government regulation may restrict our existing operations, limit our expansion, or impose additional compliance requirements and costs, any of which could have a material adverse effect on our business, financial condition, or results of operations. Below are brief descriptions of some, but not all, of such laws and regulations that affect our business operations. There are many other laws and regulations that impact us; for instance, California has enacted new laws requiring additional disclosure with respect to certain climate-related risks and greenhouse gas emissions reduction claims. Non-compliance with these new laws may result in the imposition of substantial fines or penalties.   </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Practice of Medicine</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements include our subsidiaries and VIEs. Some states have laws that prohibit business entities with non-physician owners, such as Astrana and its subsidiaries, from practicing medicine, employing physicians to practice medicine, or exercising control over medical decisions by physicians. These laws are generally referred to as corporate practice of medicine laws. States that have corporate practice of medicine laws permit only physicians to practice medicine, exercise control over medical decisions, or engage in certain arrangements, such as fee-splitting, with physicians. In these states, a violation of the corporate practice of medicine prohibition constitutes the unlawful practice of medicine, which is a public offense punishable by fines and other criminal penalties. In addition, any physician who participates in a scheme that violates the state&#8217;s corporate practice of medicine prohibition may be punished for aiding and abetting a lay entity in the unlawful practice of medicine.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California, Nevada and Texas are corporate practice of medicine states, and we operate by maintaining long-term MSAs with our affiliated IPAs and medical groups, each of which is owned and operated by physicians only, and employs or contracts with additional physicians to provide medical services. Under such MSAs, our wholly owned MSOs are contracted to provide non-medical management and administrative services, such as financial and risk management, as well as information systems, marketing, and administrative support to the IPAs and medical groups. The MSAs typically have an initial term of one to thirty years and are generally not terminable by our affiliated IPAs and medical groups except in the case of bankruptcy, gross negligence, fraud, or other illegal acts by the contracting MSO.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the MSAs and the relationship with the physician owners of our medical affiliates, we have exclusive authority over all non-medical decisions related to the ongoing business operations of those affiliates. Consequently, Astrana consolidates the revenue and expenses of such affiliates as their primary beneficiary from the date of execution of the applicable MSA. When necessary, our Vice Chairman of the Board, Dr. Thomas Lam, or a locally-licensed physician (where State laws require a physician licensed in that State) serves as nominee shareholder of affiliated medical practices on Astrana&#8217;s behalf, in order to comply with corporate practice of medicine laws and certain accounting rules applicable to consolidated financial reporting by our affiliates as VIEs. In Texas, a nonprofit health organization meeting certain criteria and approved by the Texas Medical Board is an alternative structure for compliance with corporate practice of medicine laws. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these arrangements, our MSOs perform only non-medical functions, do not represent to offer medical services, and do not exercise influence or control over the practice of medicine by physicians. The California Medical Board, as well as other states&#8217; regulatory bodies, has taken the position that MSAs that confer too much control over a physician practice to MSOs may violate the prohibition against corporate practice of medicine. Some of the relevant laws, regulations, and agency interpretations in California and other states that have corporate practice prohibitions have been subject to limited judicial and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory interpretation. Moreover, state laws and regulatory interpretations are subject to change. Other parties, including our affiliated physicians, may assert that, despite these arrangements, Astrana and its subsidiaries are engaged in the prohibited corporate practice of medicine or that such arrangements constitute unlawful fee-splitting between physicians and non-physicians. If this occurred, we could be subject to civil or criminal penalties, our MSAs could be found legally invalid and unenforceable in whole or in part, and we could be required to restructure arrangements with our affiliated IPAs and medical groups. If we were required to change our operating structures due to determination that a corporate practice of medicine violation existed, such a restructuring might require revising our MSOs&#8217; management fees.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">False Claims Acts</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The False Claims Act imposes civil liability on individuals or entities that submit false or fraudulent claims for payment to the federal government. The False Claims Act provides, in part, that the federal government may bring a lawsuit against any person whom it believes has knowingly or recklessly presented, or caused to be presented, a false or fraudulent request for payment from the federal government, or who has made a false statement or used a false record to get a claim for payment approved. Private parties may initiate qui tam whistleblower lawsuits against any person or entity under the False Claims Act in the name of the federal government and may share in the proceeds of a successful suit. The federal government has used the False Claims Act to prosecute a wide variety of alleged false claims and fraud allegedly perpetrated against Medicare and state healthcare programs. By way of illustration, these prosecutions may be based upon alleged coding errors, billing for services not rendered, billing services at a higher payment rate than appropriate, and billing for care that is not considered medically necessary. The federal government and a number of courts have taken the position that claims presented in violation of certain other statutes, including the federal Anti-Kickback Statute or the Stark Law, can also be considered a violation of the False Claims Act based on the theory that a provider impliedly certifies compliance with all applicable laws, regulations, and other rules when submitting claims for reimbursement.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Penalties for False Claims Act violations include substantial fines for each false claim, plus up to three times the amount of damages sustained by the government. A False Claims Act violation may provide the basis for the imposition of administrative penalties as well as exclusion from participation in governmental healthcare programs, including Medicare and Medicaid. In addition to the provisions of the False Claims Act, which provide for civil enforcement, the federal government can also use several criminal statutes to prosecute persons who are alleged to have submitted false or fraudulent claims to the government for payments.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of states, including California, have enacted laws that are similar to the federal False Claims Act. Under Section 6031 of the Deficit Reduction Act of 2005 (&#8220;DRA&#8221;), as amended, if a state enacts a false claims act that is at least as stringent as the federal statute and that also meets certain other requirements, the state will be eligible to receive a greater share of any monetary recovery obtained pursuant to certain actions brought under the state&#8217;s false claims act. As a result, a number of states have adopted, and more states are expected to enact laws that are similar to the federal False Claims Act, along with an expected corresponding increase in state false claims enforcement efforts. In addition, Section 6032 of the DRA requires entities that make or receive annual Medicaid payments of $5.0 million or more from any one state to provide their employees, contractors, and agents with written policies and employee handbook materials on federal and state false claims acts and related statues. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-Kickback Statutes</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Anti-Kickback Statute is a provision of the Social Security Act of 1972 that prohibits as a felony offense the knowing and willful offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, (1) the referral of a patient for items or services for which payment may be made in whole or part under Medicare, Medicaid, or other federal healthcare programs, (2) the furnishing or arranging for the furnishing of items or services reimbursable under Medicare, Medicaid, or other federal healthcare programs or (3) the purchase, lease, or order or arranging or recommending the purchasing, leasing, or ordering of any item or service reimbursable under Medicare, Medicaid, or other federal healthcare programs. The Patient Protection and Affordable Care Act (&#8220;ACA&#8221;) amended section 1128B of the Social Security Act to make it clear that a person need not have actual knowledge of the statute, or specific intent to violate the statute, as a predicate for a violation. The Office of Inspector General (&#8220;OIG&#8221;), which has the authority to impose administrative sanctions for violation of the statute, has adopted as its standard for review a judicial interpretation, which concludes that the statute prohibits any arrangement where even one purpose of the remuneration is to induce or reward referrals. A violation of the Anti-Kickback Statute is a felony punishable by imprisonment, criminal fines, civil fines, and three times the amount of the unlawful remuneration. A violation also can result in exclusion from Medicare, Medicaid, or other federal healthcare programs. In addition, pursuant to the changes of the ACA, a claim that includes items or services resulting from a violation of the Anti-Kickback Statute is a false claim for purposes of the False Claims Act.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the breadth of the Anti-Kickback Statute&#8217;s broad prohibitions, statutory exceptions exist that protect certain arrangements from prosecution. In addition, the OIG has published safe harbor regulations that specify arrangements that are deemed protected from prosecution under the Anti-Kickback Statute, provided all applicable criteria are met. The failure of an activity to meet all of the applicable safe harbor criteria does not necessarily mean that the particular arrangement violates the Anti-Kickback Statute, but these arrangements may be subject to scrutiny and prosecution by enforcement agencies. We may be less willing than some competitors to take action or enter into arrangements that do not clearly satisfy the OIG safe harbors and suffer a competitive disadvantage.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2020, in conjunction with the U.S. Department of Health and Human Services&#8217; (&#8220;HHS&#8221;) Regulatory Sprint to Coordinated Care, the OIG finalized modifications to existing safe harbors to the Anti-Kickback Statute and added new safe harbors and a new exception to the civil monetary penalty provision prohibiting inducements to beneficiaries, the purpose of which was to remove potential barriers to more effective coordination and management of patient care and delivery of value-based care. The changes implemented by the final rules went into effect on January 19, 2021. These or other changes implemented by OIG in the future may impact our business, results of operations and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states have enacted statutes and regulations similar to the Anti-Kickback Statute, but which may be applicable regardless of the payer source for the patient. These state laws may contain exceptions and safe harbors that are different from and/or more limited than those of the federal law and that may vary from state to state. For example, California has adopted the Physician Ownership and Referral Act of 1993 (&#8220;PORA&#8221;). PORA makes it unlawful for physicians, surgeons, and other licensed professionals to refer a person for certain healthcare services if they have a financial interest with the person or entity that receives the referral. While PORA also provides certain exemptions from this prohibition, failure to fit within an exemption in violation of PORA can lead to a misdemeanor offense that may subject a physician to civil penalties and disciplinary action by the Medical Board of California.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, Section 445 of the California Health and Safety Code provides that &#8220;no person, firm, partnership, association or corporation, or agent or employee thereof, shall for profit refer or recommend a person to a physician, hospital, health-related facility, or dispensary for any form of medical care or treatment of any ailment or physical condition. The imposition of a fee or charge of any such referral or recommendation creates a presumption that the referral or recommendation is for profit.&#8221; A violation of Section 445 is a misdemeanor and may subject the offender to imprisonment and/or monetary fines. Further, a violation of Section 445 may be enjoined by the California Attorney General. Section 650 of the California Business and Professions Code contains prohibitions against self-referral and kickbacks. Business &amp; Professions Code Section 650 makes it unlawful for a &#8220;licensee,&#8221; including a physician, to pay or receive any compensation or inducement for referring patients, clients, or customers to any person or entity, irrespective of any membership or proprietary interest in or with the person or entity receiving the referral. Violation of the statute is a public offense punishable by imprisonment and/or monetary fines. Section 650 further provides that it is not unlawful for a physician to refer a patient to a healthcare facility solely because the physician has a proprietary interest or co-ownership in a healthcare facility, provided that (1) the physician&#8217;s return on investment for that proprietary interest or co-ownership is based upon the amount of capital investment or proportional ownership of the physician; and (2) the ownership interest is not based on the number or value of any patients referred. A violation of Section 650 is a misdemeanor and may subject the offender to imprisonment and/or monetary fines.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure that the applicable regulatory authorities will not determine that some of our arrangements with physicians violate the federal Anti-Kickback Statute or other applicable laws. An adverse determination could subject us to different liabilities, including criminal penalties, civil monetary penalties, and exclusion from participation in Medicare, Medicaid, or other healthcare programs, any of which could have a material adverse effect on our business, financial condition, or results of operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Antitrust Laws</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government and most states have enacted antitrust laws that prohibit certain types of conduct deemed to be anti-competitive. These laws prohibit price fixing, market allocation, concerted refusal to deal, market monopolization, price discrimination, tying arrangements, acquisitions of competitors and other practices that have, or may have, an adverse effect on competition. Violations of federal or state antitrust laws can result in various sanctions, including criminal and civil penalties. Antitrust enforcement in the health care industry is currently a priority of the Federal Trade Commission and the U.S. Department of Justice. A review or action by regulatory authorities or the courts that is negative in nature as to the relationship between us and the physician groups or IPAs that we manage or contract with, could force us to terminate those contractual relationships. We believe we are in compliance with such federal and state laws, but courts or regulatory authorities may reach a determination in the future that could adversely affect our operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stark Laws</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Stark Law, also known as the physician self-referral law, generally prohibits a physician from referring Medicare and Medicaid patients to an entity (including hospitals) providing &#8220;designated health services&#8221; if the physician or a member of the physician&#8217;s immediate family has a &#8220;financial relationship&#8221; with the entity, unless a specific exception applies. Designated health services include, among other services, inpatient hospital services, outpatient prescription drug services, clinical laboratory services, certain imaging services (e.g., MRI, CT, ultrasound), and other services that our affiliated physicians may order for their patients. The prohibition applies regardless of the reasons for the financial relationship and the referral, and therefore, unlike the federal Anti-Kickback Statute, intent to violate the law is not required. Like the Anti-Kickback Statute, the Stark Law contains statutory and regulatory exceptions intended to protect certain types of transactions and arrangements. Unlike safe harbors under the Anti-Kickback Statute, with which compliance is voluntary, an arrangement must comply with every requirement of a Stark Law exception or the arrangement is in violation of the Stark Law.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the Stark Law and implementing regulations continue to evolve and are detailed and complex, while we attempt to structure our relationships to meet an exception to the Stark Law, there can be no assurance that the arrangements entered into by us with affiliated physicians and facilities will be found to be in compliance with the Stark Law, as it ultimately may be implemented or interpreted. The penalties for violating the Stark Law can include the denial of payment for services ordered in violation of the statute, mandatory refunds of any sums paid for such services, and civil penalties for each violation, double damages, and possible exclusion from future participation in the governmental healthcare programs. A person who engages in a scheme to circumvent the Stark Law&#8217;s prohibitions may face substantial fines for each applicable arrangement or scheme. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2020, in conjunction with HHS&#8217;s Regulatory Sprint to Coordinated Care, CMS issued a final rule intended to address the regulatory impact and burden of the Stark Law that impeded the healthcare system&#8217;s move toward value-based reimbursement. CMS added new exceptions to attempt to address potential barriers to coordinated care and value-based care. The changes implemented by the final rules went into effect on January 19, 2021. These or other changes implemented by CMS in the future may impact our business, results of operations, and financial condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states have enacted statutes and regulations against self-referral arrangements similar to the federal Stark Law, but which may be applicable to the referral of patients regardless of their payer source and which may apply to different types of services. These state laws may contain statutory and regulatory exceptions that are different from those of the federal law and that may vary from state to state. For example, California has adopted PORA, which makes it unlawful for physicians, surgeons, and other licensed professionals to refer a person for certain healthcare services if they have a financial interest with the person or entity that receives the referral. While PORA also provides certain exemptions from this prohibition, failure to fit within an exemption in violation of PORA can lead to a misdemeanor offense that may subject a physician to civil penalties and disciplinary action by the Medical Board of California.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An adverse determination under these state laws and/or the federal Stark Law could subject us to different liabilities, including criminal penalties, civil monetary penalties, and exclusion from participation in Medicare, Medicaid, or other healthcare programs, any of which could have a material adverse effect on our business, financial condition, or results of operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Information Privacy and Security Standards</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The privacy regulations promulgated under the Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), as amended, contain detailed requirements concerning the use and disclosure of individually identifiable patient health information (&#8220;PHI&#8221;) by entities like our MSOs and affiliated IPAs and medical groups. HIPAA-covered entities must implement certain administrative, physical, and technical security standards to protect the integrity, confidentiality, and availability of certain electronic health information received, maintained, or transmitted. HIPAA also implemented standard transaction code sets and standard identifiers that covered entities must use when submitting or receiving certain electronic healthcare transactions, including billing and claim collection activities. New health information standards could have a significant effect on the manner in which we do business, and the cost of complying with new standards could be significant.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the HIPAA privacy and security rules may result in civil and criminal penalties, including a tiered system of civil money penalties. A HIPAA-covered entity must also promptly notify affected individuals where a breach affects more than 500 individuals and report annually any breaches affecting fewer than 500 individuals.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State attorneys general may bring civil actions on behalf of state residents for violations of the HIPAA privacy and security rules, obtain damages on behalf of state residents, and enjoin further violations. Many states also have laws that protect </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the privacy and security of confidential, personal information, which may be similar to or even more stringent than HIPAA. Where applicable state laws are more protective than HIPAA, we are required to comply with the stricter provisions. Some of these state laws may impose fines and penalties on violators and may afford private rights of action to individuals who believe their personal information has been misused. California&#8217;s patient privacy laws, for example, provide for monetary penalties and permit injured parties to sue for damages. Both state and federal laws are subject to modification or enhancement of privacy protection at any time.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with HIPAA or similar state laws, we could incur substantial civil monetary or criminal penalties. We expect increased federal and state privacy and security enforcement efforts.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Knox-Keene Act and State Insurance Laws</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Knox-Keene Health Care Service Plan Act of 1975, as amended (the &#8220;Knox-Keene Act&#8221;), is the California law that regulates managed care plans. Neither our MSOs nor their managed medical groups and IPAs hold a Knox-Keene license. Some of the medical groups and IPAs that have entered into MSAs with our MSOs have historically contracted with health plans and other payers to receive capitation payments and assumed the financial responsibility for professional services. In many of these cases, the health plans or other payers separately enter into contracts with hospitals that receive payments and assume some type of contractual financial responsibility for their institutional services. In some instances, our affiliated medical groups and IPAs have been paid by their contracting payers or hospitals for the financial outcome of managing the care costs associated with both the professional and institutional services received by patients, and have recognized a percentage of the surplus of institutional revenues less institutional expense as the medical groups&#8217; and IPAs&#8217; net revenues; and, under certain circumstances, may be responsible for a percentage of any shortfall in the event that institutional expenses exceed institutional revenues. While our MSOs and their managed medical groups and IPAs are not contractually obligated to pay claims to hospitals or other institutions under these arrangements, if it is determined that our MSOs or the medical groups and IPAs have been inappropriately taking financial risk for institutional and professional services without a Knox-Keene license or regulatory exemption as a result of their hospital and physician arrangements, we may be required to obtain a restricted Knox-Keene license to resolve such violations and we could be subject to civil and criminal liability, any of which could have a material adverse effect on our business, financial condition, or results of operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some states require ACOs to be registered or otherwise comply with state insurance laws. Our ACOs are not registered with any state insurance agency. If it is determined that we have been inappropriately operating an ACO without state registration or licensure, we may be required to obtain such registration or licensure to resolve such violations and we could be subject to liability, which could have a material adverse effect on our business,&#160;financial condition, or results of operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental and Occupational Safety and Health Administration Regulations</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to federal, state, and local regulations governing the storage, use, and disposal of waste materials and products. Although we believe that our safety procedures for storing, handling, and disposing of these materials and products comply with the standards prescribed by law and regulation, we cannot eliminate the risk of accidental contamination or injury from those hazardous materials. In the event of an accident, we could be held liable for any damages that result and any liability could exceed the limits or fall outside the coverage of our insurance policies, which we may not be able to maintain on acceptable terms, or at all. We could incur significant costs and the attention of our management could be diverted to comply with current or future environmental laws and regulations. Federal regulations promulgated by the Occupational Safety and Health Administration impose additional requirements on us, including those protecting employees from exposure to elements such as blood-borne pathogens. We cannot predict the frequency of compliance, monitoring, or enforcement actions to which we may be subject as those regulations are being implemented, which could adversely affect our operations.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Federal and State Healthcare Laws</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to other federal and state healthcare laws that could have a material adverse effect on our business, financial condition, or results of operations. The Health Care Fraud Statute prohibits any person from knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, which can be either a government or private payer plan. Violation of this statute, even in the absence of actual knowledge of or specific intent to violate the statute, may be charged as a felony offense and may result in fines, imprisonment, or both. The Health Care False Statement Statute prohibits, in any matter involving a federal healthcare program, anyone from knowingly and willfully falsifying, concealing, or covering up, by any trick, scheme, or device, a material fact, or making any materially false, fictitious, or fraudulent statement or representation, or making or using any materially false writing or document knowing that it contains a materially false or fraudulent statement. A violation of this statute may be charged as a felony offense and may result in fines, imprisonment, or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">both. Under the Civil Monetary Penalties Law of the Social Security Act, a person (including an organization) is prohibited from knowingly presenting or causing to be presented to any United States officer, employee, agent, or department, or any state agency a claim for payment for medical or other items or services where the person knows or should know (a) the items or services were not provided as described in the coding of the claim, (b) the claim is a false or fraudulent claim, (c) the claim is for a service furnished by an unlicensed physician, (d) the claim is for medical or other items or service furnished by a person or an entity that is in a period of exclusion from the program, or (e) the items or services are medically unnecessary items or services. Violations of the law may result in substantial penalties, treble damages, and exclusion from federal healthcare programs. In addition, the OIG may impose civil monetary penalties against any physician who knowingly accepts payment from a hospital (as well as against the hospital making the payment) as an inducement to reduce or limit medically necessary services provided to Medicare or Medicaid program beneficiaries. Further, except as permitted under the Civil Monetary Penalties Law, a person who offers or transfers to a Medicare or Medicaid beneficiary any remuneration that the person knows or should know is likely to influence the beneficiary&#8217;s selection of a particular provider of Medicare or Medicaid payable items or services may be liable for civil money penalties for each wrongful act.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the state laws previously described, we may also be subject to other state fraud and abuse statutes and regulations as we expand our operations beyond California, including into Nevada and Texas. Many states, such as California, Nevada and Texas, have adopted a form of anti-kickback law, self-referral prohibition, and false claims and insurance fraud prohibition. Many states have adopted a form of anti-kickback law, self-referral prohibition, and false claims and insurance fraud prohibition. The scope and interpretations of these laws vary from state to state and are enforced by state courts and regulatory authorities, each with broad discretion. Generally, state laws reach all healthcare services and not just those covered under a governmental healthcare program. A determination of liability under any of these laws could result in fines, penalties, and restrictions on our ability to operate in these states. We cannot assure that our arrangements or business practices will not be subject to government scrutiny or be found to violate applicable fraud and abuse laws.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensure, Certification, Accreditation, and Related Laws and Guidelines</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our clinical personnel are subject to numerous federal, state, and local licensing laws and regulations relating to, among other things, professional credentialing and professional ethics. Clinical professionals are also subject to state and federal regulations regarding prescribing medication and controlled substances. Our affiliated physicians and hospitalists must satisfy and maintain their individual professional licensing in each state where they practice medicine, including California, and many states require that nurse practitioners and physician assistants work in collaboration with or under the supervision of a physician. Each state defines the scope of practice of clinical professionals through legislation and through the respective Boards of Medicine and Nursing. Activities that qualify as professional misconduct under state law may subject our clinical personnel to sanctions, or to even lose their license and could potentially subject us to sanctions as well. Some state boards of medicine impose reciprocal discipline&#8212;that is, if a physician is disciplined for having committed professional misconduct in one state where they are licensed, another state where they are also licensed may impose the same discipline even though the conduct occurred in another state. Since we and our affiliated medical groups perform services at hospitals and other healthcare facilities, we may indirectly be subject to laws, ethical guidelines, and operating standards of professional trade associations and private accreditation commissions (such as the American Medical Association and The Joint Commission) applicable to those entities. Penalties for non-compliance with these laws and standards include loss of professional license, civil or criminal fines and penalties, loss of hospital admitting privileges, and exclusion from participation in various governmental and other third-party healthcare programs. In addition, our affiliated facilities are subject to state and local licensing regulations ranging from the adequacy of medical care to compliance with building codes and environmental protection laws. Our ability to operate profitably will depend, in part, upon our ability, and the ability of our affiliated physicians and facilities, to obtain and maintain all necessary licenses and other approvals and operate in compliance with applicable healthcare and other laws and regulations that evolve rapidly. We provide home health, hospice, and palliative care, which require compliance with additional regulatory requirements. Reimbursement for palliative care and house call services is generally conditioned on clinical professionals providing the correct procedure and diagnosis codes and properly documenting both the service and the medical necessity for the service. Incorrect or incomplete documentation and billing information, or the incorrect selection of codes for the level and type of service provided, could result in non-payment for services rendered or lead to allegations of billing fraud. We must also comply with laws relating to hospice care eligibility, development, and maintenance of care plans and coordination with nursing homes or assisted living facilities where patients live.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Professional Liability and Other Insurance Coverage</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business has an inherent and significant risk of claims of medical malpractice against us and our affiliated physicians. We and our affiliated physician groups pay premiums for third-party professional liability insurance that provides indemnification on a claims-made basis for losses incurred related to medical malpractice litigation in order to carry out our operations. Our physicians are required to carry first-dollar coverage with limits of liability equal to not less than $1.0&#160;million </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for claims based on occurrence up to an aggregate of $3.0&#160;million per year. Our IPAs purchase stop-loss insurance, which will reimburse them for claims from service providers on a per-enrollee basis. The specific retention amount per enrollee per policy period is $45,000 to $90,000 for professional coverage. We also maintain workers&#8217; compensation, director and officer, and other third-party insurance coverage subject to deductibles and other restrictions that we believe are in accordance with industry standards. While we believe that our insurance coverage is adequate based upon claims experience and the nature and risks of our business, we cannot be certain that our insurance coverage will be adequate to cover liabilities arising out of pending or future claims asserted against us or our affiliated physician groups in the future where the outcomes of such claims are unfavorable. The ultimate resolution of pending and future claims in excess of our insurance coverage may have a material adverse effect on our business, financial position, results of operations, or cash flows.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a website at www.astranahealth.com and make available there, free of charge, our periodic reports filed with the SEC, and any amendments to such reports, as soon as is reasonably practicable after filing. Information contained on or accessible through, including any reports available on, our website is not a part of, and is not incorporated by reference into, this Annual Report on Form 10-K or any other report or document we file with the SEC. Any reference to our website in this Annual Report on Form 10-K is intended to be an inactive textual reference only. The SEC maintains a website at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers such as us that file electronically with the SEC.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_28"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A.&#160;&#160;&#160;&#160;Risk Factors </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Annual Report on Form 10-K, including the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7, and our consolidated financial statements and related notes, before making a decision to invest in our common stock. Disclosures of risks should not be interpreted to imply that the risks have not already materialized, and the risks and uncertainties described below may not be the only ones we face. If any of the risks actually occur, our business, financial condition, operating results, and prospects could be materially and adversely affected. In that event, the market price of our common stock could decline, and you could lose part or all of your investment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Summary of Risk Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties, discussed in more detail in the following section. These include, among others, the following key risks:</span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may need to raise additional capital to grow, which might not be available.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We could be negatively impacted by uncertain or adverse economic conditions and/or public health crises. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential changes in laws, accounting principles, and regulations related to VIEs could impact our consolidation of total revenues derived from our affiliated physician groups.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The arrangements we have with our VIEs are not as secure as direct ownership of such entities.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We currently derive a substantial portion of our revenues in California and are vulnerable to changes in that state.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business strategy involves acquisitions and strategic partnerships, which can be costly, risky, and complex. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s complex legal structure may cause tax authorities to question our tax filing status. The Company can be adversely impacted if a tax authority does not agree with our position.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may encounter difficulties in managing our growth, and the nature of our business and rapid changes in the healthcare industry make it difficult to reliably predict future growth and operating results.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We could experience significant losses under capitation contracts if our expenses exceed revenues.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our agreements with affiliated physician groups are deemed invalid or are terminated under applicable law, our results of operations and financial condition will be materially impaired.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our revenues and operations are dependent on a limited number of key payers.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be impacted by a shift in payer mix, including eligibility changes to government and private insurance programs.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Many of our agreements with hospitals and medical groups have limited durations, may be terminated without cause by them, and prohibit us from acquiring physicians or patients from or competing with them.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes to federal, state, and local healthcare law, including the ACA and/or the adoption of a primarily publicly funded healthcare system, may negatively impact our business. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The success of our emphasis on the ACO REACH Model is not guaranteed, due to political risks, uncertainties of ACO REACH administration, program economics, the requirement of the Company to maintain significant capital reserves, and the possibility that the ACO REACH Program will not be expanded beyond 2025. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Laws regulating the corporate practice of medicine could restrict the manner in which we are permitted to conduct our business and the failure to comply with such laws could subject us to penalties and restructuring.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The healthcare industry is intensely regulated at the federal, state, and local levels, and government authorities may determine that we fail to comply with applicable laws or regulations and take action against us.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Controls imposed by Medicare, Medicaid, and private payers designed to reduce inpatient services and associated costs may reduce our revenues.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our affiliated physician groups are not able to satisfy California regulations related to financial solvency and operational performance, they could become subject to sanctions and their ability to do business in California could be limited or terminated.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our current principal stockholders, executive officers, and directors have significant influence over our operations and strategic direction, and they could cause us to take actions with which other stockholders might not agree and could delay, deter, or prevent a change of control or a business combination with respect to us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to Our General Business and Operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;In 2019, the Company, Astrana Medical, and APC consummated a series of interrelated transactions that may expose the Company and its subsidiaries and VIEs to additional risks, including the inability to repay a significant loan made in connection with such transactions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 11, 2019, the Company, Astrana Medical, and APC concurrently consummated a series of interrelated transactions (collectively, the &#8220;APC Transactions&#8221;), which included a $545.0 million ten-year secured loan made by the Company to Astrana Medical, which Astrana Medical used to purchase 1,000,000 shares of Series A Preferred Stock of APC. The Company obtained the funds to make the loan to Astrana Medical (i) by entering into a credit agreement with Truist Bank, in its capacity as administrative agent for various lenders, and the lenders from time to time party thereto, for a $290.0 million senior secured credit facility (the &#8220;Credit Agreement&#8221; and the credit facility thereunder, the &#8220;Credit Facility&#8221;), and then immediately drawing down $250.0 million in cash, and (ii) by selling $300.0 million of shares of the Company&#8217;s common stock to APC, the purchase price of which was offset against $300.0 million of Astrana Medical&#8217;s purchase price for its APC Series A Preferred Stock.</span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AHM guaranteed the obligations of the Company under the Credit Facility, and both the Company and AHM have granted the lenders a security interest in all of their assets, including, without limitation, in all stock and other equity issued by their subsidiaries (including the shares of AHM) and all rights with respect to the loan to Astrana Medical. The Credit Agreement was amended and restated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on June 16, 2021 and was most recently amended on November 3, 2023 to, among other things, provide a new term loan to the Company in an aggregate amount of up to $300.0 million (as amended, the &#8220;Amended Credit Agreement&#8221; and the credit facility thereunder, the &#8220;Amended Credit Facility&#8221;). </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The APC Transactions may expose the Company, its subsidiaries and its VIEs to additional risks, including without limitation, the following: Astrana Medical may never be able to repay the loan from the Company; even if Astrana Medical does not, or cannot repay the loan, the Company will be obligated to pay principal and interest on the Amended Credit Facility; in connection with the Credit Facility, the lenders were granted a first priority perfected security interest over all of the assets of the Company and its subsidiaries, and such lenders have the right to foreclose on those assets if the Company defaults on its obligations under the Amended Credit Facility; a disconnect could arise between APC achieving net income, declaring and paying dividends to Astrana Medical, and Astrana Medical making its required payments to the Company, which disconnect could materially negatively impact the Company&#8217;s financial results and its ability to make its required payments under the Amended Credit Facility; APC may be prohibited from paying, or may otherwise be unable to pay, the dividends on its Series A Preferred Stock, including under the California Corporations Code; regulators could determine that the current, post-APC Transactions consolidated structure amounts to the Company violating California&#8217;s corporate practice of medicine doctrine; and the Company may be deemed an investment company, which could impose burdensome compliance requirements on the Company and restrict its future activities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to raise additional capital or generate cash flows necessary to expand our operations and invest in new technologies in the future could reduce our ability to compete successfully and harm our results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, in the future, require additional capital to grow our business and may have to raise additional funds by selling equity, issuing debt, borrowing, refinancing our existing debt, or selling assets or subsidiaries. We may not be able to obtain additional debt or equity financing on favorable terms, in a timely manner, or at all. If we raise additional equity financing, our security holders may experience significant dilution of their ownership interests. If we engage in additional debt financing, we may be required to accept terms that restrict our ability to incur additional indebtedness, force us to maintain specified liquidity or other ratios or restrict our ability to pay dividends or make acquisitions. In addition, the covenants in our Amended Credit Agreement may limit our ability to obtain additional debt or issue additional equity securities, and any failure to adhere to these covenants could result in penalties or defaults that could further restrict our liquidity or limit our ability to obtain financing. In addition, our ability to obtain additional capital may be adversely impacted by factors beyond our control, such as the market demand for our securities, the state of financial markets generally and other relevant factors, including potential worsening global economic conditions resulting from increasing inflation and interest rates, ongoing supply chain disruptions and shortages, labor shortages and geopolitical conditions, and any disruptions to, or volatility in, the credit and financial markets in the United States and worldwide that arise from any economic downturn or recession. If we need additional capital and cannot raise it on acceptable terms, or at all, we may not be able to, among other things, develop and enhance our patient services; continue to expand our organization; hire, train and retain employees; respond to competitive pressures or unanticipated working capital requirements; or pursue acquisition opportunities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company has a complex legal structure, and tax regulatory authorities may disagree with our positions and conclusions regarding certain tax positions, resulting in unanticipated costs or non-realization of expected benefits.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a complex legal structure, and a tax authority may disagree with tax positions that we have taken. For example, the Internal Revenue Service or another tax authority could challenge our allocation of income by tax jurisdiction and the amounts paid between our affiliated companies pursuant to our intercompany arrangements and transfer pricing policies, including amounts paid with respect to our legal structure. A tax authority may take the position that material income tax liabilities, interest, and penalties are payable by us, in which case, we expect that we might contest such assessment. Contesting such an assessment may be lengthy and costly, and if we were unsuccessful in disputing the assessment, the implications could be materially adverse to us and affect our anticipated effective tax rate or operating income, and we could be required to pay substantial penalties and interest where applicable. The Company is currently under examination by the Internal Revenue Service for our 2019-2021 tax returns. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our&#160;net operating loss carryforwards and certain other tax attributes will be subject to limitations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a corporation undergoes an &#8220;ownership change&#8221; within the meaning of Section&#160;382 of the Internal Revenue Code of 1986, as amended, its net operating loss carryforwards and certain other tax attributes arising from before the ownership change are subject to limitations on use after the ownership change. In general, an ownership change occurs if there is a cumulative change in the corporation&#8217;s equity ownership by certain stockholders that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under state tax laws. Ownership changes in the future could result in additional limitations on our net operating loss carryforwards. Consequently, we may not be able to utilize a material portion of our net operating loss carryforwards and other tax attributes to offset our tax liabilities, which could have a material adverse effect on our cash flows and results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncertain or adverse economic conditions could adversely impact us.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. and global economy, as well as our business and results of operations, may be negatively impacted by a variety of factors, including inflation, interest rate increases, supply chain and labor disruptions, decreased consumer spending, unemployment rates, banking instability, geopolitical events and uncertainty, such as the Ukraine-Russia conflict and Israel-Hamas war, any U.S. government shutdown, any downgrades in the U.S. government&#8217;s sovereign credit rating, public health crises and an economic downturn or recession. A downturn in economic conditions could have a material adverse effect on our results of operations, financial condition, business prospects, and stock price. Historically, government budget limitations have resulted in reduced spending. Given that Medicaid is a significant component of state budgets, an economic downturn would put continued cost containment pressures on Medicaid outlays for healthcare services, including in California and other states in which we operate. The existing federal deficit and continued deficit spending by the federal government could lead to reduced government expenditures, including for government-funded programs in which we participate, such as Medicare. An economic downturn and sustained unemployment may also impact the number of enrollees in managed care programs and the profitability of managed care companies, which could result in reduced reimbursement rates. Although we attempt to stay informed, any sustained failure to identify and respond to these trends could have a material adverse effect on our results of operations, financial condition, business, and prospects.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be required to take write-downs or write-offs, restructuring, and impairment or other charges that could have a significant negative effect on our financial condition, results of operations, and stock price.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be forced to write-down or write-off assets in the future, restructure its operations, or incur impairment or other charges that could result in losses. Even though these charges may not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute to negative market perceptions about us or our securities and may make our future financing difficult to obtain on favorable terms or at all.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, our intangible assets are subject to impairment testing. Under current accounting standards, our goodwill, including acquired goodwill, is tested for impairment on an annual basis and may be subject to impairment losses as circumstances change (e.g., after an acquisition). If we record an impairment loss, it could have a material adverse effect on our results of operations for the year in which the impairment is recorded.&#160;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A prolonged disruption of or any actual or perceived difficulties in the capital and credit markets may adversely affect our future access to capital, our cost of capital, and our ability to continue operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance depend primarily on California and U.S. economic conditions and their impact on purchases of, or capitated rates for, our healthcare services, and our business is significantly exposed to risks associated with government spending and private payer reimbursement rates. A number of factors have negatively impacted the economy in recent years, including inflation, increased interest rates, supply chain and labor disruptions, geopolitical events and uncertainty, and declines in consumer and business confidence, as well as private and government spending, together with significant reductions in the availability of and increases in the cost of credit and volatility in the capital and credit markets. Such factors have adversely affected the business and economic environment in which we operate and our profitability and could, in the future, adversely affect our patients&#8217; spending habits, private payers&#8217; access to capital, and governmental budgetary processes, which, in turn, could result in reduced revenue for us. The continuation or recurrence of any of these conditions may adversely affect our cash flows, results of operations, and financial condition. As economic uncertainty may continue in future periods, our patients, private payers, and government payers may alter their purchasing activities of healthcare services. Our patients may scale back healthcare spending, and private and government payers may reduce reimbursement rates, which may also cause delay or cancellation of consumer spending for discretionary and non-reimbursed healthcare. This uncertainty may also affect our ability to prepare accurate financial forecasts or meet specific forecasted results, and we may be unable to adequately respond to or forecast further changes in demand for healthcare services. Volatility and disruption of capital and credit markets may adversely affect our access to capital and increase our cost of capital. Should current economic and market conditions deteriorate, our ability to finance ongoing operations and our expansion may be adversely affected, we may be unable to raise necessary funds, our cost of debt or equity capital may increase significantly, and future access to capital markets may be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If there is a change in accounting principles or the interpretation thereof affecting consolidation of VIEs, it could impact our consolidation of total revenues derived from our affiliated physician groups.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial statements are consolidated and include the accounts of our majority-owned subsidiaries and various non-owned affiliated physician groups that are VIEs, whose consolidation is effectuated in accordance with applicable accounting rules promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;). Such accounting rules require that, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under some circumstances, the VIE consolidation model be applied when a reporting enterprise holds a variable interest (e.g., equity interests, debt obligations, certain management, and service contracts) in a legal entity. Under this model, an enterprise must assess the entity in which it holds a variable interest to determine whether it meets the criteria to be consolidated as a VIE. If the entity is a VIE, the consolidation framework next identifies the party, if one exists, that possesses a controlling financial interest in the VIE, and then requires that party to consolidate the VIE as it is the primary beneficiary. An enterprise&#8217;s determination of whether it has a controlling financial interest in a VIE requires that a qualitative determination be made, and is not solely based on voting rights. If an enterprise determines the entity in which it holds a variable interest is not subject to the VIE consolidation model, the enterprise should apply the traditional voting control model, which focuses on voting rights.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our case, the VIE consolidation model applies to our controlled, but not owned, physician-affiliated entities. Our determination regarding the consolidation of our affiliates, however, could be challenged, which could have a material adverse effect on our operations. In addition, in the event of a change in accounting rules or FASB&#8217;s interpretations thereof, or if there were an adverse determination by a regulatory agency or a court or a change in state or federal law relating to the ability to maintain present agreements or arrangements with our affiliated physician groups, we may not be permitted to continue to consolidate the revenues of our VIEs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Breaches or compromises of our information security systems or our information technology systems or infrastructure could result in exposure of private information, disruption of our business, and damage to our reputation, which could harm our business, results of operation, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we create, receive, maintain, transmit, collect, store, use, disclose, share and process sensitive data, including PHI and other types of personal data or personally identifiable information (collectively, &#8220;PII&#8221; and, together with PHI, &#8220;PHI/PII&#8221;) relating to our patients, employees, vendors, and others. We also contract with third-party service providers to process sensitive information, including PHI/PII, confidential information and other proprietary business information. We are highly dependent on information technology networks and systems, including the internet, to securely process PHI/PII and other sensitive data and information. Security breaches of this infrastructure, whether ours or of our third-party service providers, including physical or electronic break-ins, employee or service provider error, third-party action, including actions of foreign actors, insider attacks, phishing or denial-of-service attacks, computer viruses, ransomware or other malware, social engineering, malfeasance, other unauthorized physical or electronic access, or other vulnerabilities, could create system disruptions, shutdowns or unauthorized access, acquisition, use, disclosure or modifications of such data or information, and could cause PHI/PII to be accessed, acquired, used, disclosed or modified without authorization, to be made publicly available, or to be further accessed, acquired, used or disclosed. To our knowledge, we have not experienced any material breach of our cybersecurity systems.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use third-party service providers for important aspects of the processing of employee and patient PHI/PII and other confidential and sensitive data and information, and therefore rely on third parties to manage functions that have material cybersecurity risks. Because of the sensitivity of the PHI/PII and other sensitive data and information that we and our service providers process, the security of our technology platform and other aspects of our services, including those provided or facilitated by our third-party service providers, are important to our operations and business strategy. We have implemented certain administrative, physical and technological safeguards to address these risks; however, such policies and procedures may not address certain HIPAA requirements or address situations that could lead to increased privacy or security risks. We may be required to expend significant capital and other resources to protect against security breaches, to safeguard the privacy, security, and confidentiality of PHI/PII and other sensitive data and information, to investigate, contain, remediate, and mitigate actual or potential security breaches, and/or to report security breaches to patients, employees, regulators, media, credit bureaus, and other third parties in accordance with applicable law and to offer complimentary credit monitoring, identity theft protection, and similar services to patients and/or employees where required by law or otherwise appropriate. Cyber-attacks are becoming more sophisticated and frequent, and we or our third-party service providers may be unable to anticipate these techniques or implement adequate protective measures against them or to prevent future attacks, and future cyber-attacks could go undetected and persist for an extended period of time. Furthermore, to the extent artificial intelligence capabilities improve and are increasingly adopted, they may be used to identify vulnerabilities and craft increasingly sophisticated cybersecurity attacks, and vulnerabilities may be introduced from the use of artificial intelligence by us and our third-party service providers. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our third-party service providers and others to whom we entrust confidential data, and on whom we rely to provide products and services, face similar threats and growing requirements. We depend on such parties to implement adequate controls and safeguards to protect against and report cyber incidents. If such parties fail to deter, detect or report cyber incidents in a timely manner, we may suffer from financial and other harm, including to our information, operations, performance, employees and reputation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A security breach, security incident, or privacy violation that leads to unauthorized use, disclosure, access, acquisition, loss or modification of, or that prevents access to or otherwise impacts the confidentiality, security, or integrity of, patient or employee information, including PHI/PII that we or our third-party service providers process, or other confidential information could harm our reputation and business, compel us to comply with breach notification laws, cause us to incur significant costs for investigation, containment, remediation, mitigation, fines, penalties, settlements, notification to individuals, regulators, media, credit bureaus, and other third parties, complimentary credit monitoring, identity theft protection, training and similar services to participants and/or employees where required by law or otherwise appropriate, for measures intended to repair or replace systems or technology and to prevent future occurrences. We may also be subject to potential increases in insurance premiums, resulting in increased costs or loss of revenue.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or our third-party service providers are unable to prevent or mitigate security breaches, security incidents or privacy violations in the future, or if we or our third-party service providers are unable to implement satisfactory remedial measures with respect to known or future security incidents, or if it is perceived that we have been unable to do so, our operations could be disrupted, we may be unable to provide access to our systems, and we could suffer a loss of patients, loss of reputation, adverse impacts on patient and investor confidence, financial loss, litigation, governmental investigations or other actions, regulatory or contractual penalties, and other claims and liability. In addition, security breaches and incidents and other compromises or inappropriate access to, or acquisition or processing of, PHI/PII or other sensitive data or information can be difficult to detect, and any delay in identifying such breaches or incidents or in providing timely notification of such incidents may lead to increased harm and increased penalties. While we carry cyber insurance, we cannot be certain that our coverage will be adequate for liabilities actually incurred, that insurance will continue to be available to us on economically reasonable terms, or at all, or that any insurer will not deny coverage as to any future claim.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on complex software systems and hosted applications to operate our business, and our business may be disrupted if we are unable to successfully or efficiently update these systems or convert to new systems.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are increasingly dependent on technology systems to operate our business, reduce costs, and enhance customer service. These systems include complex software systems and hosted applications that are provided by third parties. Software systems need to be updated on a regular basis with patches, bug fixes, and other modifications. Hosted applications are subject to service availability and reliability of hosting environments. We also migrate from legacy systems to new systems from time to time. Maintaining existing software systems, implementing upgrades, and converting to new systems are costly and require personnel and other resources. The implementation of these systems upgrades and conversions is a complex and time-consuming project involving substantial expenditures for implementation activities, consultants, system hardware and software, so it often requires transforming our current business and processes to conform to new systems, and therefore, may take longer, be more disruptive, and cost more than forecast and may not be successful. If the implementation is delayed or otherwise is not successful, it may hinder our business operations and negatively affect our financial condition and results of operations. There are many factors that may materially and adversely affect the schedule, cost, and execution of the implementation process, including, without limitation, problems in the design and testing of new systems; system delays and malfunctions; the deviation by suppliers and contractors from the required performance under their contracts with us; the diversion of management attention from our daily operations to the implementation project; reworks due to unanticipated changes in business processes; difficulty in training employees in the operation of new systems and maintaining internal control while converting from legacy systems to new systems; and integration with our existing systems. Some of such factors may not be reasonably anticipated or may be beyond our control.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our internal control over financial reporting is not considered effective, our business and stock price could be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 404 of the Sarbanes-Oxley Act of 2002 requires us to evaluate the effectiveness of our internal control over financial reporting as of the end of each fiscal year, and to include a management report assessing the effectiveness of our internal control over financial reporting in our Annual Report on Form 10-K for that fiscal year. Section 404 also requires our independent registered public accounting firm to attest to, and report on, management&#8217;s assessment of our internal control over financial reporting. Our management, including our principal executive officer and principal financial officer, does not expect that our internal control over financial reporting will prevent all errors and fraud. A control system, no matter how well-designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud involving a company have been, or will be, detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become ineffective because of changes in conditions or deterioration in the degree of compliance with policies or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected, such as those that resulted in the restatement of certain of our previously issued consolidated financial statements and related material weakness in August 2023. We identified a material weakness in our internal control over financial reporting in connection with the restatement, and we cannot assure you that we or our independent registered public accounting firm will not identify a material weakness in our internal controls in the future. A material weakness in our internal control over financial reporting would require management and our independent registered public accounting firm to consider our internal controls as ineffective. While we continue to take meaningful steps to enhance our disclosure controls and procedures and our internal control over financial reporting by strengthening our financial reporting and accounting functions, we cannot provide any assurance that we will be able to maintain adequate controls over our financial processes and reporting in the future or that we will not identify additional significant deficiencies and material weaknesses in our internal control over financial reporting in the future. Any failure of our internal controls could result in material misstatements in our consolidated financial statements, significant deficiencies, material weaknesses, costs, failure to timely meet our periodic reporting obligations and erosion of investor confidence. Such failure could also negatively affect the market price and trading liquidity of our common stock, subject us to civil and criminal investigations and penalties and could have a material adverse effect on our business, financial condition, results of operations or cash flow.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to renew our leases on favorable terms or at all as our leases expire, which could adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate several leased premises. There is no assurance that we will be able to continue to occupy such premises in the future. For example, we currently rent our corporate headquarters on a month-to-month basis. We could thus spend substantial resources to meet the current landlords&#8217; demands or look for other premises. We may be unable to timely renew such leases or renew them on favorable terms, if at all. If any current lease is terminated or not renewed, we may be required to relocate our operations at substantial costs or incur increased rental expenses, which could adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently derive a substantial portion of our revenues in California and are vulnerable to changes in that state.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily operate in California. Any material changes with respect to consumer preferences, taxation, reimbursements, financial requirements, or other aspects of healthcare delivery in California or the state&#8217;s economic conditions could have an adverse effect on our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends, to a significant degree, upon our ability to adapt to the ever-changing healthcare industry and continued development of additional services.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we expect to provide a broad and competitive range of services, there can be no assurance of acceptance of current services by the marketplace. Our ability to procure new contracts&#160;may be dependent upon the continuing results achieved at the current facilities, upon pricing and operational considerations, and the potential need for continuing improvement to our existing services. Moreover, the markets for our new services may not develop as expected nor can there be any assurance that we will be successful in marketing any such services.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reputation could be adversely impacted by environmental, social and governance (&#8220;ESG&#8221;), policies and practices.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increasing focus by stakeholders on our ESG policies and practices, including corporate citizenship and sustainability, could result in additional costs, and could adversely impact our reputation, consumer perception, employee retention, and willingness of third parties to do business with us. Additionally, public interest and legislative pressure related to public companies&#8217; ESG practices continues to grow. If our ESG policies and practices fail to meet regulatory requirements or stakeholders&#8217; evolving expectations and standards for responsible corporate citizenship, our reputation and employee retention may be negatively impacted. We could also incur additional costs and require additional resources to monitor, report and comply with various ESG practices, laws and regulations, as well as any initiatives or goals we may establish or announce. If we do establish such initiatives or goals, there can be no assurance that our stakeholders will agree with our strategy or that we will be successful in achieving such initiatives or goals. Moreover, we may determine that it is in the best interest of our Company and our stockholders to prioritize other business, social, governance or sustainability investments over the achievement of any such initiatives or goals based on economic, regulatory and social factors, business strategy or pressure from investors, activist groups or other stakeholders. Inconsistency of legislation and regulations among jurisdictions, including anti-ESG policies or legislation, and expected additional regulations may also affect the costs of compliance with such laws and regulations. If we fail to adopt ESG standards or practices as quickly as stakeholders desire, fail, or are perceived to fail, in our achievement of any initiatives or goals, or fail in fully and accurately reporting our progress on any such initiatives and goals, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our reputation, business, financial performance and growth may be adversely impacted. Any such matters, or related corporate citizenship and sustainability matters, could have a material adverse effect on our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Risks Relating to Our Growth Strategy and Business Model.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our growth strategy may not prove viable and we may not realize expected results.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business strategy is to grow rapidly by building a network of medical groups and integrated physician networks and is significantly dependent on locating and acquiring, partnering or contracting with medical practices to provide healthcare delivery services. We seek growth opportunities both organically and through acquisitions of or alliances with other medical service providers. As part of our growth strategy, we regularly review potential strategic opportunities, including acquisitions, partnerships, investments and divestitures. Identifying and establishing suitable strategic relationships is time-consuming and costly. There can be no assurance that we will be successful. We cannot guarantee that we will be successful in pursuing such strategic opportunities or assure the consequences of any strategic transactions. If we fail to evaluate and execute strategic transactions properly, we may not achieve anticipated benefits and may incur increased costs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategic transactions involve a number of risks and uncertainties, including:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to successfully identify suitable strategic opportunities, complete desired strategic transactions, or realize their expected benefits. In addition, we compete for strategic transactions with other potential players, some of whom may have greater resources than we do. This competition may intensify due to the ongoing consolidation in the healthcare industry, which may increase our costs to pursue such opportunities.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to establish suitable strategic relationships and may fail to integrate them into our business. We cannot be certain of the extent of any unknown, undisclosed or contingent liabilities of any acquired business, including liabilities for failure to comply with applicable laws. We may incur material liabilities for past activities from strategic relationships. Also, depending on the location of the strategic transactions, we may be required to comply with laws and regulations that may differ from those of California, the state in which we currently operate.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may form strategic relationships with medical practices that operate with lower profit margins as compared with ours or that have a different payer mix than our other practice groups, which would reduce our overall profit margin. Depending upon the nature of the local market, we may not be able to implement our business model in every local market that we enter, which could negatively impact our revenues and financial condition.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may incur substantial costs to complete strategic transactions, integrate strategic relationships into our business, or expand our operations, including hiring more employees and engaging other personnel, to provide services to additional patients that we are responsible for managing pursuant to the new relationships. If such relationships terminate or diminish before we can realize their expected benefits, any costs that we have already incurred may not be recovered.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we finance strategic transactions by issuing our equity securities or securities convertible thereto, our existing stockholders could be diluted. If we finance strategic transactions with debt, it could result in higher leverage and interest costs for us.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not successful in our efforts to identify and execute strategic transactions on beneficial terms, our ability to implement our business plan and achieve our targets could be adversely affected.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of integrating strategic relationships also involves significant risks, including:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in coping with demands on management related to the increased size of our business;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties resulting from the diversion of management&#8217;s attention from our daily operations;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in assimilating different corporate cultures and business practices;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in converting other entities&#8217; books and records and conforming their practices to ours;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in integrating operating, accounting, and information technology systems of other entities with ours and in maintaining uniform procedures, policies, and standards such as internal accounting controls;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in retaining employees who may be vital to the integration of the acquired entities; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in maintaining contracts and relationships with payers of other entities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to make certain contingent payments in connection with strategic transactions from time to time. The fair value of such payments is reevaluated periodically based on changes in our estimate of future operating results and changes in market discount rates. Any changes in our estimated fair value are recognized in our results of operations. The actual payments, however, may exceed our estimated fair value. Increases in actual contingent payments compared to the amounts recognized may have an adverse effect on our financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that we will be able to effectively integrate strategic relationships into our business, which may negatively impact our business model, revenues, results of operations, and financial condition. In addition, strategic transactions are time-intensive, requiring significant commitment of our management&#8217;s focus. If our management spends too much time assessing potential opportunities, completing strategic transactions, and integrating strategic relationships, our management may not have sufficient time to focus on our existing operations. This diversion of attention could have material and adverse consequences on our operations and profitability.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obligations in our credit or loan documents could restrict our operations, particularly our ability to respond to changes in our business or to take specified actions. An event of default could harm our business, and creditors having security interests over our assets would be able to foreclose on our assets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of our Amended Credit Agreement and other indebtedness we may incur from time to time require us to comply with a number of financial and other obligations, which may include maintaining debt service coverage and leverage ratios and maintaining insurance coverage, that impose significant operating and financial restrictions on us, including restrictions on our ability to take actions that may be in our interests. These obligations may limit our flexibility in our operations, and breaches of these obligations could result in defaults under the agreements or instruments governing the indebtedness, even if we had satisfied our payment obligations. Moreover, if we defaulted on these obligations, creditors having security interests over our assets could exercise various remedies, including foreclosing on and selling our assets. Unless waived by creditors, for which no assurance can be given, defaulting on these obligations could result in a material adverse effect on our financial condition and ability to continue our operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may encounter difficulties in managing our growth, and the nature of our business and rapid changes in the healthcare industry make it difficult to reliably predict future growth and operating results.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to successfully grow and expand. Successful implementation of our business plan will require management of growth, including potentially rapid and substantial growth, which could result in an increase in the level of responsibility for management personnel and strain on our human and capital resources. To manage growth effectively, we will be required, among other things, to continue to implement and improve our operating and financial systems, procedures, and controls and to expand, train, and manage our employee base. If we are unable to implement and scale improvements to our existing systems and controls in an efficient and timely manner or if we encounter deficiencies, we will not be able to successfully execute our business plans. Failure to attract and retain sufficient numbers of qualified personnel could also impede our growth. If we are unable to manage our growth effectively, it will have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The evolving nature of our business and rapid changes in the healthcare industry make it difficult to anticipate the nature and amount of medical reimbursements, third-party private payments, and participation in certain government programs and thus to reliably predict our future growth and operating results.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could experience significant losses under capitation contracts if our expenses exceed revenues.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under a capitation contract, a health plan typically prospectively pays an IPA periodic capitation payments based on a percentage of the amount received by the health plan. Capitation payments, in the aggregate, represent a prospective budget from which an IPA manages care-related expenses on behalf of the population enrolled with that IPA. If our affiliated IPAs are able to manage care-related expenses under the capitated levels, we realize operating profits from capitation contracts. However, if care-related expenses exceed projected levels, our affiliated IPAs may realize substantial operating deficits, which are not capped and could lead to substantial losses. For example, the State of California&#8217;s Budget Act of 2023 (AB 118) mandated a &#8220;targeted rate increase&#8221; in reimbursement rates under the Medi-Cal program for providers of primary care and obstetric care services commencing January 1, 2024, including where applicable, an equivalent adjustment to capitation rates for those providers reimbursed on a capitated basis. If the required capitation rate adjustments payable to such primary care and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obstetric care providers exceed the corresponding capitation rate increase received by us from our contracted Medi-Cal health plans, substantial losses could result.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, factors beyond our control, such as natural disasters, the potential effects of climate change, and major epidemics, pandemics, or newly emergent viruses (such as COVID-19), could reduce our ability to effectively manage the costs of providing healthcare.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the acquisition of our Restricted Knox-Keene licensed health plan (For Your Benefit Inc., &#8220;FYB&#8221;), we may expand the use of &#8220;global&#8221; capitation arrangements whereby FYB accepts financial risk for hospital and other institutional services in addition to professional medical services (whereas IPA capitation contracts are typically limited to accepting financial risk for professional medical services). However, if care-related expenses under these global capitation arrangements exceed projected levels, our Restricted Knox-Keene licensed health plan may realize substantial operating deficits, which are not capped and could lead to substantial losses. Expansion of global capitation arrangements may also require the funding of additional capital to our Restricted Knox-Keene licensed health plan in order to comply with DMHC regulations relating to tangible net equity which could result in having less cash available for other parts of our operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our agreements with affiliated physician groups are deemed invalid or are terminated under applicable law, our results of operations and financial condition will be materially impaired.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are various state laws, including laws in California and other states in which we operate, regulating the corporate practice of medicine, which prohibit us from directly owning medical professional entities. These prohibitions are intended to prevent unlicensed persons from interfering with or inappropriately influencing a physician&#8217;s professional judgment. These and other laws may also prevent fee-splitting, which is the sharing of professional service income with non-professional or business interests. The interpretation and enforcement of these laws vary significantly from state to state. We currently derive revenues from MSAs or similar arrangements with our affiliated IPAs, whereby we provide management and administrative services to them. If these agreements and arrangements are held to be invalid under laws prohibiting the corporate practice of medicine and other laws or new laws are adopted that prohibit such agreements or arrangements, a significant portion of our revenues would be lost, resulting in a material adverse effect on our results of operations and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The arrangements we have with our VIEs are not as secure as direct ownership of such entities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of corporate practice of medicine laws, we have entered into contractual arrangements to manage certain affiliated physician practice groups, which allow us to consolidate those groups for financial reporting purposes. We do not have direct ownership interests in any of our VIEs and are not able to exercise rights as an equity holder to directly change the members of the boards of directors of these entities so as to affect changes at the management and operational level. Under our arrangements with our VIEs, we must rely on their equity holders to exercise our control over the entities. If our affiliated entities or their equity holders fail to perform as expected, we may have to incur substantial costs and expend additional resources to enforce such arrangements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure by our affiliated entities or their owners to perform their obligations under their agreements with us would have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our affiliated physician practice groups are owned by individual physicians who could die, become incapacitated, or become no longer affiliated with us. Although our MSAs with these affiliates provide that they will be binding on successors of current owners, as the successors are not parties to the MSAs, it is uncertain in case of the death, bankruptcy, or divorce of a current owner whether their successors would be subject to such MSAs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our revenues and operations are dependent on a limited number of key payers.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are dependent on a concentrated number of payers. Four payers accounted for an aggregate of 61.7% and 59.0% of our total net revenue for the years ended December&#160;31, 2023 and 2022, respectively. We believe that a majority of our revenues will continue to be derived from a limited number of key payers, which may terminate their contracts with us, or our physicians credentialed by them, upon the occurrence of certain events. They may also amend the material terms of the contracts under certain circumstances. Failure to maintain such contracts on favorable terms, or at all, would materially and adversely affect our results of operations and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An exodus of our patients could have a material adverse effect on our results of operations. We may also be impacted by a shift in payer mix, including eligibility changes to government and private insurance programs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material decline in the number of patients that we and our affiliated physician groups serve, whether a government or a private entity is paying for their healthcare, could have a material adverse effect on our results of operations and financial condition, which could result from increased competition, new developments in the healthcare industry, or regulatory overhauls. In light of the repeal of the individual mandate requirement under the ACA via the Tax Cuts and Jobs Act of 2017, some people are expected to lose their health insurance and thus may not continue to afford services by our managed medical groups. In addition, due to potential decreased availability of healthcare through private employers, the number of patients who are uninsured or participate in governmental programs may increase. A shift in payer mix from managed care and other private payers to government payers or the uninsured may result in a reduction in our rates of reimbursement or an increase in our uncollectible receivables or uncompensated care, with a corresponding decrease in our net revenue. Changes in the eligibility requirements for governmental programs could also change the number of patients who participate in such programs or the number of uninsured patients. For those patients who remain with private insurance, changes in those programs could increase patient responsibility amounts, resulting in a greater risk for uncollectible receivables. Such events could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future growth could be harmed if we lose the services of our key management personnel.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends to a significant extent on the continued contributions of our key management personnel, particularly our Chief Executive Officer and President Brandon K. Sim, M.S. for the management of our business and implementation of our business strategy. The loss of his services, or services of other key members of management, could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If having our key personnel serving as nominee equity holders of our VIEs is deemed invalid under applicable laws, or if we lose the services of key personnel for any reason, it could have a material adverse impact on our results of operations and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are various state laws, including laws in California and other states in which we operate, regulating the corporate practice of medicine, which prohibit us from owning various healthcare entities. These corporate practice of medicine prohibitions are intended to prevent unlicensed persons from interfering with or inappropriately influencing a physician&#8217;s professional judgment. The interpretation and enforcement of these laws vary significantly from state to state. As a result, many of our affiliated physician practice groups are either wholly owned or primarily owned by key personnel as the nominee shareholder for our benefit. If these arrangements were held to be invalid under applicable laws, which may change from time to time, a significant portion of our consolidated revenues would be affected, which may result in a material adverse effect on our results of operations and financial condition. Similarly, if such key personnel die, become incapacitated, or otherwise are no longer affiliated with us, our relationships and arrangements with those VIEs could be in jeopardy, and our business could be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent in part on referrals from third parties and preferred provider status with payers.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business relies in part on referrals from third parties for our services. We receive referrals from community medical providers, emergency departments, payers, and hospitals in the same manner as other medical professionals receive patient referrals. We do not provide compensation or other remuneration to referral sources for referring patients to us. A decrease in these referrals due to competition, concerns about our services and other factors could result in a significant decrease in our revenues and adversely impact our financial condition. Similarly, we cannot assure that we will be able to obtain or maintain preferred provider status with significant third-party payers in the communities where we operate. If we are unable to maintain our referral base or our preferred provider status with significant third-party payers, it may negatively impact our revenues and financial performance.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Partner facilities may terminate agreements with our affiliated physician groups or reduce their fees.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our hospitalist physician services net revenue is derived from contracts directly with hospitals and other inpatient and post-acute care facilities. Our current partner facilities may decide not to renew contracts with, impose unfavorable terms on, or reduce fees paid to our affiliated physician groups. Any of these events may impact the ability of our affiliated physician groups to operate at such facilities, which would negatively impact our revenues, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Many of our agreements with hospitals and medical groups have limited durations, may be terminated without cause by them, and prohibit us from acquiring physicians or patients from or competing with them.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our agreements with hospitals and medical groups are limited in their terms or may be terminated without cause by providing advance notice. If such agreements are not renewed or terminated, we would lose the revenue generated by them. Any such events could have a material adverse effect on our results of operations, financial condition, and future business plans. Because many of such agreements with hospitals and medical groups prohibit us from acquiring physicians or patients from or competing with them, our ability to hire physicians, attract patients, or conduct business in certain areas may be limited in some cases.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business model depends on numerous complex management information systems, and any failure to successfully maintain these systems or implement new systems could undermine our ability to receive payments and otherwise materially harm our operations and may result in violations of healthcare laws and regulations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on a complex, specialized, integrated management information system and standardized procedures for operational and financial information, as well as for our billing operations. We may be unable to enhance existing management information systems or implement new management information systems when necessary. We may experience unanticipated delays, complications, or expenses in implementing, integrating, and operating our systems. Our management information systems may require modifications, improvements, or replacements that may require both substantial expenditures, as well as interruptions in operations. Our ability to create and implement these systems depends on the availability of technology and skilled personnel. Our failure to successfully implement and maintain all of our systems could undermine our ability to receive payments and otherwise have a material adverse effect on our business, results of operations, and financial condition. Our failure to successfully operate our billing systems could also lead to potential violations of healthcare laws and regulations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently, and may in the future, have assets held at financial institutions that exceed the insurance coverage offered by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;); the loss of such assets would have a severe negative affect on our operations and liquidity. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain our cash assets at certain financial institutions in the U.S. in amounts that are significantly in excess of the FDIC insurance limit of $250,000. As of December&#160;31, 2023, our deposit accounts with banks exceeded the FDIC&#8217;s insured limit by approximately $318.9 million. In the event of a failure of any financial institutions where we maintain our deposits or other assets, we may incur a significant loss to the extent such loss exceeds the FDIC insurance limitation, which could have a material adverse effect on our liquidity, financial condition and our results of operations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to the Healthcare Industry.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The healthcare industry is highly competitive.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete directly with national, regional, and local providers of inpatient healthcare for patients and physicians. There are many other companies and individuals currently providing healthcare services, many of which have been in business longer and/or have substantially more resources. Since there are virtually no substantial capital expenditures required for providing healthcare services, there are few financial barriers to entry into the healthcare industry. Other companies could enter the healthcare industry in the future and divert some or all of our business. On a national basis, our competitors include, but are not limited to, Optum, Heritage, Privia Health, and Aledade, each of which has greater financial and other resources available to them. We also compete with physician groups and privately-owned healthcare companies in local markets. In addition, our relationships with governmental and private third-party payers are not exclusive and our competitors have established or could seek to establish relationships with such payers to serve their covered patients. Competitors may also seek to compete with us for acquisitions, which could have the effect of increasing the price and reducing the number of suitable acquisitions, which would have an adverse impact on our growth strategy. Individual physicians, physician groups, and companies in other healthcare industry segments, including those with which we have contracts, and some of which have greater financial, marketing, and staffing resources, may become competitors in providing healthcare services, and this competition may have a material adverse effect on our business operations and financial position. We therefore may be unable to compete successfully and even after we expend significant resources.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hospitals where our affiliated physicians provide services may deny privileges to our physicians.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, our affiliated physicians may only provide services in a hospital where they have maintained certain credentials, also known as privileges, which are granted by the medical staff according to the bylaws of the hospital. The medical staff could decide that our affiliated physicians can no longer receive privileges to practice there. Such a decision would limit our ability to furnish services at the hospital, decrease the number of our affiliated physicians, or preclude us from entering new hospitals. In addition, hospitals may attempt to enter into exclusive contracts for certain physician services, which would reduce our access to patient populations within the hospital.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes associated with reimbursements by third-party payers or decreases in payer rates may adversely affect our operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical services industry is undergoing significant changes with government and other third-party payers that are taking measures to reduce reimbursement rates or, in some cases, denying reimbursement altogether. There is no assurance that government or other third-party payers will continue to pay for the services provided by our affiliated medical groups. Furthermore, there has been, and continues to be, a great deal of discussion and debate about the repeal and replacement of existing government reimbursement programs, such as the ACA. As a result, the future of healthcare reimbursement programs is uncertain, making long-term business planning difficult and imprecise. In addition, decreases in payer rates, either prospectively or retroactively, could have a significant adverse effect on our revenues, cash flows, and results of operations. The failure of government or other third-party payers to adequately cover the medical services provided by us could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business may be significantly and adversely affected by legislative initiatives aimed at or having the effect of reducing healthcare costs associated with Medicare and other government healthcare programs and changes in reimbursement policies. In order to participate in the Medicare program, our affiliated provider groups must comply with stringent and often complex enrollment and reimbursement requirements; failure to do so could result in the provider group&#8217;s participation in the federal health care programs being terminated, or civil and/or criminal penalties being imposed. These programs generally provide for reimbursement on a fee-schedule basis rather than on a charge-related basis. As a result, we cannot increase our revenue by increasing the amount that we and our affiliates charge for services. To the extent that our costs increase, we may not be able to recover the increased costs from these programs. In addition, cost containment measures in non-governmental insurance plans have generally restricted our ability to recover, or shift to non-governmental payers, these increased costs. In attempts to limit federal and state spending, there have been, and we expect that there will continue to be, a number of proposals to limit or reduce Medicare reimbursement for various services. For example, the Medicare Access and CHIP Reauthorization Act of 2015 made numerous changes to Medicare, Medicaid, and other healthcare-related programs, including new systems for establishing annual updates to Medicare rates for physicians&#8217; services.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may have difficulty collecting payments from third-party payers in a timely manner.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive significant revenue from third-party payers, and delays in payment or refunds to payers may adversely impact our net revenue. We assume the financial risks relating to uncollectible and delayed payments. In particular, we rely on some key governmental payers. Governmental payers typically pay on a more extended payment cycle, which could require us to incur substantial expenses prior to receiving corresponding payments. In the current healthcare environment, as payers continue to control expenditures for healthcare services, including through revising their coverage and reimbursement policies, we may continue to experience difficulties in collecting payments from payers who may seek to reduce or delay such payments. If we are not timely paid in full or if we need to refund some payments, our revenues, cash flows, and financial condition could be adversely affected.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and state laws may limit our ability to collect monies owed by patients.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use third-party collection agencies whom we do not control to collect from patients any co-payments and other payments for services that our physicians provide. The federal Fair Debt Collection Practices Act of 1977 (the &#8220;FDCPA&#8221;) restricts the methods that third-party collection companies may use to contact and seek payment from consumer debtors regarding past-due accounts. State laws vary with respect to debt collection practices, although most state requirements are similar to those under the FDCPA. Therefore, such agencies may not be successful in collecting payments owed to us and our affiliated physician groups. If the practices of collection agencies utilized by us are inconsistent with these standards, we may be subject to actual damages and penalties. These factors and events could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have established reserves for our potential medical claim losses, which are subject to inherent uncertainties, and a deficiency in the established reserves may lead to a reduction in our assets or net income.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We establish reserves for estimated IBNR claims. IBNR estimates are developed using actuarial methods and are based on many variables, including the utilization of healthcare services, historical payment patterns, cost trends, product mix, seasonality, changes in membership, and other factors. The estimation methods and the resulting reserves are periodically reviewed and updated.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of various services. Such interpretations may not come to light until a substantial period of time has passed. The inherent difficulty in interpreting contracts and estimating necessary reserves could result in significant fluctuations in our estimates from period to period. Our actual losses and related expenses therefore may differ, even substantially, from the reserve estimates reflected in our financial statements. If actual claims exceed our estimated reserves, we may be required to increase reserves, which would lead to a reduction in our assets or net income.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competition for qualified physicians, employees, and management personnel is intense in the healthcare industry, and we may not be able to hire and retain or contract with qualified physicians and other personnel.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on our affiliated physicians to provide services and generate revenue. We compete with many types of healthcare providers, including teaching, research and government institutions, hospitals, and other practice groups, for the services of clinicians and management personnel. The limited number of residents and other licensed providers on the job market with the expertise necessary to provide services within our business makes it challenging to meet our hiring needs and may require us to train new employees, contract temporary physicians, or offer more attractive wage and benefit packages to experienced professionals, which could decrease our profit margins. The limited number of available residents and other licensed providers also impacts our ability to renew contracts with existing physicians on acceptable terms or replace physicians as they retire from practice. As a result, our ability to provide services could be adversely affected. In some markets, the lack of availability of clinical personnel, such as physicians and allied health professionals, has become a significant operating issue facing all healthcare providers. This shortage has required us to enhance wages and benefits to recruit and retain qualified personnel or to contract for more expensive temporary personnel. In addition, our labor costs have increased due to higher wage rates associated with the increased competitive labor market. Because the majority of our revenue consists of prospective monthly capitated, or fixed, payments per patient, our ability to pass along increased labor costs is limited. In particular, if labor costs rise at an annual rate greater than our net annual consumer price index basket update from Medicare, our results of operations and cash flows will likely be adversely affected. Any failure to recruit and retain or contract with qualified management and medical personnel, or to control our labor costs, could have a material adverse effect on our business, prospects, results of operations and financial condition. Even though our physician turnover rate has remained stable over the last three years, if the turnover rate were to increase significantly, our growth could be adversely affected. Moreover, unlike some of our competitors who sometimes pay additional compensation to physicians who agree to provide services exclusively to that competitor, our affiliated IPAs have historically not entered into such exclusivity agreements and have allowed our affiliated physicians to affiliate with multiple IPAs. This practice may place us at a competitive disadvantage regarding the hiring and retention of physicians relative to those competitors who do enter into such exclusivity agreements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to effectively adapt to changes in the healthcare industry, including changes to laws and regulations regarding or affecting U.S. healthcare reform, our business may be harmed.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the importance of the healthcare industry in the lives of all Americans, federal, state, and local legislative bodies frequently pass legislation and promulgate regulations relating to healthcare reform or that affect the healthcare industry. As has been the trend in recent years, it is reasonable to assume that there will continue to be increased government oversight and regulation of the healthcare industry in the future. We cannot assure our stockholders as to the ultimate content, timing, or effect of any new healthcare legislation or regulations, nor is it possible at this time to estimate the impact of potential new legislation or regulations on our business. It is possible that future legislation enacted by Congress or state legislatures, or regulations promulgated by regulatory authorities at the federal or state level, could adversely affect our business or could change the operating environment of the hospitals and other facilities where our affiliated physicians provide services. It is possible that the changes to Medicare, Medicaid, or other governmental healthcare program reimbursements may serve as precedent to possible changes in other payers&#8217; reimbursement policies in a manner adverse to us. Similarly, changes in private payer reimbursements could lead to adverse changes in Medicare, Medicaid, and other governmental healthcare programs, which could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we do not anticipate that a single-payer national health insurance system will be enacted by the current Congress, several legislative initiatives have been proposed by members of Congress and presidential candidates that would establish some form of a single public or quasi-public agency that organizes healthcare financing, but under which healthcare delivery would remain private. If enacted, such a system could adversely affect our business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidation in the healthcare industry could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many healthcare industry participants and payers are consolidating to create larger and more integrated healthcare delivery systems with greater market power. We expect regulatory and economic conditions to result in additional consolidation in the healthcare industry in the future. As consolidation accelerates, the economies of scale of our partners&#8217; organizations may grow. If a partner experiences sizable growth following consolidation, it may determine that it no longer needs to rely on us and may reduce its demand for our products and services. In addition, as healthcare providers consolidate to create larger and more integrated healthcare delivery systems with greater market power, these providers may try to use their market power to negotiate fee reductions for our products and services. Finally, consolidation may also result in the acquisition or future development by our partners of products and services that compete with our products and services. Any of these potential results of consolidation could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to ACO REACH.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There are uncertainties regarding the design and administration of the ACO REACH Model and CMS&#8217; financial reports to ACO REACH participants, which could negatively impact our results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the novelty of the ACO REACH</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Model, we are subject to program challenges, including, but not limited to, process design, data, and other related aspects. We rely on CMS for the design, oversight, and governance of the ACO REACH Model. If CMS cannot provide accurate data, guidance on claims processing, claims benchmarking and calculations, make timely payments, and conduct periodic process reviews, our results of operations and financial condition could be materially and adversely affected. CMS relies on various third parties to effect the ACO REACH program, including other departments of the U.S. government, such as Centers for Medicare &amp; Medicaid Services Innovation Center (&#8220;CMMI&#8221;). CMS also relies on multiple third-party contractors to manage the ACO REACH Model program, including claims and auditing. As a result, there is the potential for errors, delays, and poor communication among the differing entities involved, which are beyond our control. As CMS is implementing extensive reporting protocols for the ACO REACH Model, CMS has indicated that because of inherent biases in reporting the results, its initial financial reports under the ACO REACH Model may not be indicative of final results of actual risk sharing and revenues that we receive. Were that to be the case, we might not report accurately our revenues for relevant periods, which could result in adjustments in a later period when we receive final results from CMS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:line-through"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We chose to participate in the TCC mechanism and Global risk tracks of ACO REACH, which entails certain special risks.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the TCC mechanism, CMS estimates the total annual Part A and Part B Medicare expenditures of our assigned Medicare beneficiaries and pays us that projected amount in per beneficiary per month payments. We chose the Global risk track, under which we assume 100% risk for Part A and Part B Medicare expenditures where shared savings and losses are less than 25% of the benchmark, with adjusted risk corridors taking effect for any portion of shared savings/losses equaling or exceeding 25% of the benchmark&#8212;for savings/losses of 25-35%, we assume 50% risk, for savings/losses 35%-50% we assume 25% of the risk, and for savings/losses exceeding 50% of the benchmark, we assume only 10% of the risk. Under the Global risk track of the TCC mechanism, we could have profits or be liable for losses of up to 100% of the first 25% of such benchmarked expenditures, with adjusted risk corridors taking effect afterward. While performance can be monitored throughout the year, end results for any given performance year will not be known until the third quarter of the subsequent year. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shared savings retained by our ACO are impacted by the amount of the Quality Withhold earned back.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the ACO REACH programs, a substantial portion of our ACO&#8217;s spending benchmark is held at-risk by CMS, subject to our ACO meeting certain quality measures as determined by CMS. In the ACO REACH program, the portion of the benchmark held at-risk by CMS for quality is 2% of the benchmark. Failing to earn back all or part of the portion of our ACO&#8217;s spending benchmark held at-risk by CMS for quality metrics could materially affect our financial performance in the ACO REACH programs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may suffer losses and may not generate savings through our participation in the ACO REACH</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Model.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the ACO REACH Model, CMS provides an opportunity to provider groups that are willing to assume higher levels of financial risk and reward to participate in this relatively new attribution-based risk-sharing model. The ACO REACH Model uses a prospectively set preliminary benchmark that is retrospectively adjusted throughout and at the end of the performance year. The preliminary benchmark is based on baseline historical expenditures by Participant Providers in the benchmark years trended forward using the US Per Capita Cost (&#8220;USPCC&#8221;) growth trend, and subsequently blended with regional expenditure rates, which are contained in the ACO REACH / Kidney Care Choices (&#8220;KCC&#8221;) Rate Book. The benchmark years are set at CY2017-2019 for the duration of the model. In PY2024, historical baseline expenditures are weighted at 55%, regional expenditures are weighted at 45%, and historical expenditures will be weighted less in future performance years. Throughout the performance year and after the performance year concludes, the preliminary benchmark is adjusted for numerous factors, such as the ACO&#8217;s developing risk and quality scores and beneficiaries who became ineligible for the program over the course of the performance year. If necessary, a Retrospective Trend Adjustment (&#8220;RTA&#8221;) may be applied as well. An RTA is applied if the USPCC trend differs by at least 1% from the observed expenditure trend in the National Reference Population. It adjusts the benchmark by the difference between the observed expenditure trend and the predicted USPCC trend. Once all adjustments are made to the benchmark, our ACO&#8217;s expenditures will be compared to a final benchmark to calculate shared savings or shared losses. Under the ACO REACH Model, we are responsible for savings and losses related to care received by assigned patients by covering claims from physicians, nurses, and other medical professionals. If claim costs exceed the benchmarked expenditures, or the baseline years used in benchmark calculations are statistical anomalies, we could experience losses, which could be significant. Among other things, this could result from factors beyond our control, such as inflation, natural disasters, the potential effects of climate change, and major epidemics, pandemics, or newly emergent viruses (such as COVID-19). As we are providing care coordination through our ACO, but do not provide direct patient care, our influence could be limited. Because of our limited influence, it is possible that we may not be able to control care providers&#8217; behavior, utilization, and costs. As a result, we may not be able to generate savings through our participation in the ACO REACH Model to cover our administrative and care coordination operating costs, and any savings generated, if at all, will be earned in arrears and uncertain in both timing and amount. Furthermore, the process by which the final benchmark is calculated from the preliminary benchmark is complex, and we may have limited ability to understand what the final benchmark may be before the value is reported to us by CMS. Due to this dynamic, we may have limited ability to predict our final performance and shared savings/losses amount prior to receiving a final report from CMS in the third quarter of the year following any given performance year.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not control, but are responsible for savings and losses related to, care received by assigned patients at out-of-network providers, which could negatively impact our ability to control claim costs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare beneficiaries in the ACO REACH Model are not required to receive care from a specified network of contracted providers and facilities, which could make it difficult for us to control the financial risks of those beneficiaries. While we are not responsible for directly paying claims for out-of-network providers, we may have difficulty managing patient care and costs in relation to such out-of-network providers as compared to contracted, in-network providers, which could adversely impact our financial results as we are responsible for savings and losses of assigned beneficiaries, irrespective of whether they are using in-network or out-of-network providers. In addition, even if we are successful in encouraging more assigned patients to receive care from our contracted, in-network providers, there is the possibility that the monthly TCC from CMS will be insufficient to cover our expenditures, since the TCC is generally based on historical in-network/out-of-network ratios. If CMS fails to monitor the in-network/out-of-network provider ratio for our assigned patients on a frequent basis, or CMS&#8217;s reconciliation payments to us are not timely made, this could result in negative cash flows for us, especially if increased payments will need to be made to our contracted, in-network providers.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our continued participation in other CMS Advanced Alternative Payment Models, such as the ACO REACH, cannot be guaranteed.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ACO participated in the GPDC Model in 2022, the ACO Reach Model in 2023 and has an active participation agreement with CMS for 2024. However, the Participation Agreement for the ACO REACH Model may be terminated sooner by CMS as specified therein and CMS has the flexibility to alter or change the program over time. Among many requirements to be eligible to participate in the ACO REACH Model, we must have at least 5,000 aligned Medicare beneficiaries and must maintain that number throughout each performance year. If that number were not maintained, we would become ineligible for the ACO REACH Model. In addition, we are required to comply with all applicable laws and regulations regarding provider-based risk-bearing entities. We could be terminated from the ACO REACH Model at any time if we do not continue to comply with the ACO REACH participation requirements. If future compliance or performance issues arise, we may lose our current eligibility and may be subject to CMS&#8217;s enforcement or contract actions, including our potential inability to participate in the TCC mechanism (where the payment mechanism would default to traditional FFS) or dismissal from the ACO REACH Model, which would have a material adverse effect on our revenues and cash flows. In addition, the payments from CMS to us will </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decrease if the number of beneficiaries assigned to our ACO declines or if the contracted providers terminate their relationships with us, which could have a material adverse effect on our results of operations on a consolidated basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to MSSP Participation Beginning in 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to generate revenue under the MSSP or continue to participate in the MSSP. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MSSP is consistently being updated by CMS. Beginning in 2024, the calculation of the benchmark is being adjusted to address prior performance, to incorporate a prospective administrative growth factor, and to attempt to reduce the cap on negative regional adjustments. These changes will impact how savings under the model are calculated and may impact our ability to generate revenue under the model.  In addition, our participation in the MSSP requires our participant providers maintain at least 5,000 MSSP Aligned Beneficiaries.  If we fail to meet the threshold, we will not be eligible to participate for the applicable year.   </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may suffer losses and may not generate savings through our participation in the MSSP.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are participating in the MSSP Level ENHANCED, pursuant to which we may be responsible for 1st dollar losses at a rate determined using a sliding scale based on the ACO&#8217;s health equity adjusted quality performance score, if an applicable quality performance standard established by CMS is met with a minimum shared loss rate of 40% and a maximum of 75%. If an applicable quality performance standard is not met, we are responsible for 1st dollar losses at a rate of 75%. Total losses for which we are responsible are not to exceed 15% of the updated benchmark. We are responsible for savings and losses related to care received by patients by covering claims from physicians, nurses, and other medical professionals. If claim costs exceed the benchmarked expenditures, we could experience losses, which could be significant. Among other things, this could result from factors beyond our control, such as inflation, natural disasters, the potential effects of climate change, and major epidemics, pandemics, or newly emergent viruses (such as COVID-19). As we are providing care coordination through our ACO, but do not provide direct patient care, our influence could be limited. Because of our limited influence, it is possible that we may not be able to control care providers&#8217; behavior, utilization, and costs. As a result, we may not be able to generate savings through our participation in the MSSP to cover our administrative and care coordination operating costs, and any savings generated, if at all, will be earned in arrears and uncertain in both timing and amount. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not control, but are responsible for savings and losses related to, care received by assigned patients at out-of-network providers, which could negatively impact our ability to control claim costs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare beneficiaries in the MSSP Model are not required to receive care from a specified network of contracted providers and facilities, which could make it difficult for us to control the financial risks of those beneficiaries. While we are not responsible for directly paying claims for out-of-network providers, we may have difficulty managing patient care and costs in relation to such out-of-network providers as compared to contracted, in-network providers, which could adversely impact our financial results as we are responsible for savings and losses of assigned beneficiaries, irrespective of whether they are using in-network or out-of-network providers. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to Regulatory Compliance.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws regulating the corporate practice of medicine could restrict the manner in which we are permitted to conduct our business and the failure to comply with such laws could subject us to penalties and restructuring.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states have laws that prohibit business entities from practicing medicine, employing physicians to practice medicine, exercising control over medical decisions by physicians (also known collectively as the corporate practice of medicine) or engaging in some arrangements, such as fee-splitting, with physicians. In some states, these prohibitions are expressly stated in a statute or regulation, while in other states, the prohibition is a matter of judicial or regulatory interpretation. California, where a substantial amount of our operations are located, is one of the states that prohibit the corporate practice of medicine.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In California, Nevada, and Texas, we operate by maintaining contracts with our affiliated physician groups, which are each owned and operated by physicians, and which employ or contract with additional physicians to provide physician services. Under these arrangements, we or our subsidiaries provide management services, receive a management fee for providing management services, do not represent to offer medical services, and do not exercise influence or control over the practice of medicine by the physicians or the affiliated physician groups.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above management arrangements, in certain instances, we have contractual rights relating to the transfer of equity interests in our affiliated physician groups under physician shareholder agreements that we entered into with the controlling equity holder of such affiliated physician groups. However, even in such instances, such equity interests cannot be transferred to or held by us or by any non-professional organization. Accordingly, we do not directly own any equity interests in any affiliated physician groups in California, Nevada, and Texas. In the event that any of these affiliated physician groups or their equity holders fail to comply with these management or ownership transfer arrangements, these arrangements are terminated, we are unable to enforce such arrangements, or these arrangements are invalidated under applicable laws, there could be a material adverse effect on our business, results of operations, and financial condition and we may have to restructure our organization and change our arrangements with our affiliated physician groups, which may not be successful.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The healthcare industry is intensely regulated at the federal, state, and local levels, and government authorities may determine that we fail to comply with applicable laws or regulations and take action against us.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a company involved in providing healthcare services, we are subject to numerous federal, state, and local laws and regulations. There are significant costs involved in complying with these laws and regulations. If we are found to have violated any applicable laws or regulations, we could be subject to civil and/or criminal damages, fines, sanctions, or penalties, including exclusion from participation in governmental healthcare programs, such as Medicare and Medicaid, and we may be required to change our method of operations and business strategy. These consequences could be the result of our current conduct or even conduct that occurred a number of years ago. We could incur significant costs to defend ourselves if we become the subject of an investigation or legal proceeding alleging a violation of these laws and regulations. We cannot predict whether a federal, state, or local government will determine that we are not operating in accordance with the law, or whether, when or how the laws will change in the future and impact our business. The following is a non-exhaustive list of some of the more significant healthcare laws and regulations that could affect us:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The False Claims Act, which provides for penalties against entities and individuals who knowingly or recklessly make claims to Medicare, Medicaid, and other governmental healthcare programs, as well as third-party payers, that contain or are based upon false or fraudulent information;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">A provision of the Social Security Act, commonly referred to as the &#8220;Anti-Kickback Statute,&#8221; that prohibits the knowing and willful offering, payment, solicitation, or receipt of any bribe, kickback, rebate, or other remuneration, in cash or in kind, in return for the referral or recommendation of patients for items and services covered, in or in part, by federal healthcare programs such as Medicare and Medicaid;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">A provision of the Social Security Act, commonly referred to as the Stark Law or physician self-referral law (subject to limited exceptions), prohibits physicians from referring Medicare patients to an entity for the provision of specific &#8220;designated health services&#8221; if the physician or a member of such physician&#8217;s immediate family has a direct or indirect financial relationship with the entity, and prohibits the entity from billing for services arising out of such prohibited referrals;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">A provision of the Social Security Act that provides for criminal penalties on healthcare providers who fail to disclose known overpayments;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">A provision of the Social Security Act that provides for civil monetary penalties on healthcare providers who fail to repay known overpayments within 60 days of identification or the date any corresponding cost report was due, if applicable, and also allows improper retention of known overpayments to serve as a basis for False Claims Act violations;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Provisions of the Social Security Act (emanating from the DRA) require entities that make or receive annual Medicaid payments of $5 million or more from a single Medicaid program to provide its employees, contractors, and agents with written policies and employee handbook materials on federal and state false claims acts and related statutes, that establish a Medicaid Integrity Program designed to enhance federal and state efforts to detect Medicaid fraud, waste, and abuse, and that increase financial incentives for both states and individuals to bring fraud and abuse claims against healthcare companies;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">State law provisions pertaining to anti-kickback, self-referral, and false claims issues;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Provisions of, and regulations relating to, HIPAA that provide penalties for knowingly and willfully executing a scheme or artifice to defraud a healthcare benefit program or falsifying, concealing, or covering up a material fact or making any materially false, fictitious, or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items, or services;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Provisions of HIPAA and the Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;) limiting how covered entities, business associates, and business associate sub-contractors may use and disclose PHI and the security measures that must be taken in connection with protecting that information and related systems, as well as similar or more stringent state laws;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Federal and state laws provide penalties for providers for billing and receiving payments from a governmental healthcare program for services unless the services are medically necessary and reasonable, adequately and accurately documented, and billed using codes that accurately reflect the type and level of services rendered;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">State laws that provide for financial solvency requirements relating to risk-bearing organizations (&#8220;RBOs&#8221;), plan operations, plan-affiliate operations and transactions, plan-provider contractual relationships, and provider-affiliate operations and transactions, such as California Business &amp; Professions Code Section 1375.4;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Federal laws that provide for administrative sanctions, including civil monetary penalties for, among other violations, inappropriate billing of services to federal healthcare programs, payments by hospitals to physicians for reducing or limiting services to Medicare or Medicaid patients, or employing or contracting with individuals or entities who/which are excluded from participation in federal healthcare programs;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Federal and state laws and policies require healthcare providers to enroll in the Medicare and Medicaid programs before submitting any claims for services, to promptly report certain changes in their operations to the agencies that administer these programs, and to re-enroll in these programs when changes in direct or indirect ownership occur or in response to revalidation requests from Medicare and Medicaid;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">State laws that prohibit general business entities from practicing medicine, controlling physicians&#8217; medical decisions or engaging in certain practices, such as splitting fees with physicians;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">State laws that require timely payment of claims, including &#167;1371.38, et al., of the California Health &amp; Safety Code, which imposes time limits for the payment of uncontested covered claims and requires healthcare service plans to pay interest on uncontested claims not paid promptly within the required time period;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Laws in some states that prohibit non-domiciled entities from owning and operating medical practices in such states;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Federal and state laws and regulations restricting the techniques that may be used to collect past due accounts from consumers, such as our patients, for services provided to the consumer; and</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">State laws that require healthcare providers that assume professional and institutional risk (i.e., full risk) to either obtain a license under the Knox-Keene Health Care Service Plan Act of 1975 or receive an exemption from the California Department of Managed Healthcare (&#8220;DMHC&#8221;) for the contract(s) under which the entity assumes full risk.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any violation or alleged violation of any of these laws or regulations by us or our affiliates could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in healthcare laws could create an uncertain environment and materially impact us. We cannot predict the effect that the ACA (also known as Obamacare) and its implementation, amendment, or repeal and replacement, may have on our business, results of operations, or financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any changes in healthcare laws or regulations that reduce, curtail, or eliminate payments, government-subsidized programs, government-sponsored programs, and/or the expansion of Medicare or Medicaid, among other actions, could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the ACA dramatically changed how healthcare services are covered, delivered, and reimbursed. The ACA requires insurers to accept all applicants, regardless of pre-existing conditions, cover an extensive list of conditions and treatments, and charge the same rates, regardless of pre-existing conditions or gender. The ACA and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;Health Care Reform Acts&#8221;) also mandated changes specific to home health and hospice benefits under Medicare. In 2012, the U.S. Supreme Court upheld the constitutionality of the ACA, including the &#8220;individual mandate&#8221; provisions of the ACA that generally require all individuals to obtain healthcare insurance or pay a penalty. However, the U.S. Supreme Court also held that the provision of the ACA that authorized the Secretary of the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) to penalize states that choose not to participate in the expansion of the Medicaid program by removing all of its existing Medicaid funding was unconstitutional. In response to the ruling, a number of state governors opposed their state&#8217;s participation in the expanded Medicaid program, which resulted in the ACA not providing coverage to some low-income persons in those states. In addition, several bills have been, and are continuing to be, introduced in U.S. Congress to amend all or significant provisions of the ACA, or repeal and replace the ACA with another law. In December 2017, the individual mandate was repealed via the Tax Cuts and Jobs Act of 2017. Afterward, legal and political challenges as to the constitutionality of the remaining provisions of the ACA resumed. Just as the fate of the ACA is uncertain, so is the future of care organizations established under the ACA, such as ACOs and ACO REACH. Under its ACO REACH Participation Agreement with CMS, our operations are always subject to the nation&#8217;s healthcare laws, as amended, repealed, or replaced from time to time.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net effect of the ACA on our business is subject to numerous variables, including the law&#8217;s complexity, lack of complete implementing regulations and interpretive guidance, gradual and potentially delayed implementation, or possible amendment, as well as the uncertainty as to the extent to which states will choose to participate in the expanded Medicaid program. The continued implementation of provisions of the ACA, the adoption of new regulations thereunder and ongoing challenges thereto, also add uncertainty about the current state of U.S. healthcare laws and could negatively impact our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare providers could be subject to federal and state investigations and payer audits.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to our and our affiliates&#8217; participation in government and private healthcare programs, we are from time to time involved in inquiries, reviews, audits, and investigations by governmental agencies and private payers of our business practices, including assessments of our compliance with coding, billing, and documentation requirements. Federal and state government agencies have active civil and criminal enforcement efforts against healthcare companies and their executives and managers. The DRA, provides a financial incentive to states to enact their own false claims acts, and similar laws encourage investigations against healthcare companies by different agencies. These investigations could also be initiated by private whistleblowers. Responding to audit and investigative activities are costly and disruptive to our business operations, even when the allegations are without merit. If we are subject to an audit or investigation, a finding could be made that we or our affiliates erroneously billed or were incorrectly reimbursed, and we may be required to repay such agencies or payers, may be subjected to pre-payment reviews, which can be time-consuming and result in non-payment or delayed payments for the services we or our affiliates provide, and may be subject to financial sanctions or required to modify our operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Controls imposed by Medicare, Medicaid, and private payers designed to reduce inpatient services and associated costs may reduce our revenues.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Controls imposed by Medicare, Medicaid, and private payers designed to reduce admissions and lengths of stay, commonly referred to as &#8220;utilization review,&#8221; have affected and are expected to continue to affect our operations. Federal law contains numerous provisions designed to ensure that services rendered by hospitals and other care providers to Medicare and Medicaid patients meet professionally recognized standards and are medically necessary and that claims for reimbursement are properly filed. These provisions include a requirement that a sampling of admissions of Medicare and Medicaid patients must be reviewed by quality improvement organizations, which review the appropriateness of Medicare and Medicaid patient admissions and discharges, the quality of care provided, and the appropriateness of cases of extraordinary length of stay or cost on a post-discharge basis. Quality improvement organizations may deny payment for services or assess fines and also have the authority to recommend to the HHS that a provider is in substantial non-compliance with the standards of the quality improvement organization and should be excluded from participation in the Medicare program. The ACA potentially expands the use of prepayment review by Medicare contractors by eliminating statutory restrictions on its use, and, as a result, efforts to impose more stringent cost controls are expected to continue. Utilization review is also a requirement of most non-governmental managed care organizations and other third-party payers. Inpatient utilization, average lengths of stay and occupancy rates continue to be negatively affected by payer-required pre-admission authorization and utilization review and by third-party payer pressure to maximize outpatient and alternative healthcare delivery services for less acutely ill patients. Although we are unable to predict the effect these controls and any changes thereto may have on our operations, significant </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limits on the scope of our services reimbursed and on reimbursement rates and fees could have a material, adverse effect on our business, financial position, and results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not have a Knox-Keene license covering all of our lines of business.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Knox-Keene Health Care Service Plan Act of 1975 was passed by the California State Legislature to regulate California managed care plans and is currently administered by the DMHC. A Knox-Keene Act license is required to operate a healthcare service plan, e.g., an HMO, or an organization that accepts full risk, i.e., accepts full risk for a patient population, including risk related to institutional services, e.g., hospital and professional services. Applying for and obtaining such a license is a time-consuming and detail-oriented undertaking. Although FYB is licensed by the DMHC as a full-service Restricted Knox-Keene licensed health plan, its license is limited to its Medicare Advantage line of business in designated California counties only and does not extend to all of our lines of business, such as Medi-Cal and commercial lines of business.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As such, for those lines of business not covered by our Restricted Knox-Keene license, if the DMHC were to determine that we have been inappropriately taking risk for institutional and professional services as a result of our various hospital and physician arrangements without having any Knox-Keene license or applicable regulatory exemption, we may be required to obtain a Knox-Keene license and could be subject to civil and criminal liability, any of which could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our affiliated physician groups and Restricted Knox-Keene licensed health plan are not able to satisfy California regulations related to financial solvency and operational performance, they could become subject to sanctions and their ability to do business in California could be limited or terminated.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DMHC has instituted regulations that are intended to provide a formal mechanism for monitoring the financial solvency and operational performance of RBOs (including capitated physician groups) and Restricted Knox-Keene licensed health plans in California. Under current DMHC regulations, our affiliated physician groups, as applicable, are required to, among other things:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Maintain, at all times, a minimum &#8220;cash-to-claims ratio&#8221; (which means the organization&#8217;s cash, marketable securities, and certain qualified receivables, divided by the organization&#8217;s total unpaid claims liability) of 0.75; and</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Submit periodic reports to the DMHC containing various data and attestations regarding their performance and financial solvency, including IBNR calculations, documentation, and attestations as to whether or not the organization (i) was in compliance with the &#8220;Knox-Keene Act&#8221; requirements related to claims payment timeliness, and (ii) had maintained compliance with minimum &#8220;cash-to-claims ratio&#8221;, tangible net equity, and positive working capital requirements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that a physician group is not in compliance with any of the above criteria, it would be required to describe in a report submitted to the DMHC the reasons for non-compliance and actions to be taken to bring it into compliance. Under such regulations, the DMHC can also make some of the information contained in the reports public, including, but not limited to, whether or not a particular physician organization met each of the criteria. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that a physician group is not in compliance with any of the above criteria, it would be required to describe in a report submitted to the DMHC the reasons for non-compliance and actions to be taken to bring it into compliance. Under such regulations, the DMHC can also make some of the information contained in the reports public, including, but not limited to, whether or not a particular physician organization met each of the criteria. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our revenue will be negatively impacted if our physicians fail to appropriately document their services.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely upon our affiliated physicians to appropriately and accurately complete necessary medical record documentation and assign appropriate reimbursement codes for their services. Reimbursement is conditioned upon, in part, our affiliated physicians providing the correct procedure and diagnosis codes and properly documenting the services themselves, including the level of service provided and the medical necessity for the services. If our affiliated physicians have provided incorrect or incomplete documentation or selected inaccurate reimbursement codes, this could result in non-payment for services rendered or lead to allegations of billing fraud. This could subsequently lead to civil and criminal penalties, including exclusion from government healthcare programs, such as Medicare and Medicaid. In addition, third-party payers may disallow, in whole or in part, requests for reimbursement based on determinations that certain amounts are not covered, services provided </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were not medically necessary, or supporting documentation was not adequate. Retroactive adjustments may change amounts realized from third-party payers and result in recoupments or refund demands, affecting revenue already received.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Primary care physicians may seek to affiliate with our competitors&#8217; IPAs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is common in the medical services industry for primary care physicians to be affiliated with multiple IPAs. Our affiliated IPAs, therefore, may enter into agreements with physicians who are also affiliated with our competitors. However, some of our competitors at times have agreements with physicians that require the physician to provide exclusive services. Our affiliated IPAs often have no knowledge, and no way of knowing, whether a physician is subject to an exclusivity agreement without being informed by the physician. Competitors have, in the past, initiated lawsuits against us alleging in part interference with such exclusivity arrangements, and may do so again in the future. An adverse outcome from any such lawsuit could adversely affect our business, cash flows, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we inadvertently employ or contract with an excluded person, we may face government sanctions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individuals and entities can be excluded from participating in the Medicare and Medicaid programs for violating certain laws and regulations, or for other reasons such as the loss of a license in any state, even if the person retains other licensure. This means that the excluded person and others are prohibited from receiving payments for such person&#8217;s services rendered to Medicare or Medicaid beneficiaries, and if the excluded person is a physician, all services ordered (not just provided) by such physician are also non-covered and non-payable. Entities that employ or contract with excluded individuals are prohibited from billing the Medicare or Medicaid programs for the excluded individual&#8217;s services, and are subject to civil penalties if they do. The HHS Office of the Inspector General maintains a list of excluded persons. Although we have instituted policies and procedures to minimize such risks, there can be no assurance that we will not inadvertently hire or contract with an excluded person, or that our employees or contracts will not become excluded in the future without our knowledge. If this occurs, we may be subject to substantial repayments and civil penalties, and the hospitals at which we furnish services may also be subject to repayments and sanctions, for which they may seek recovery from us, which could adversely affect our business, cash flows, and financial condition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with federal and state privacy and data security laws is expensive, and we may be subject to government or private actions due to privacy and security breaches.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must comply with various federal and state laws and regulations governing the collection, dissemination, access, use, security, and confidentiality of PHI, including HIPAA and HITECH. As part of our medical record keeping, third-party billing, and other services, we collect and maintain PHI in paper and electronic format. Privacy and data security laws and regulations thus could have a significant effect on the manner in which we handle healthcare-related data and communicate with payers. In addition, compliance with these standards could limit our ability to offer services, thereby negatively impacting the business opportunities available to us. Despite our efforts to prevent privacy and security breaches, they may still occur. If any non-compliance with such laws and regulations results in privacy or security breaches, we could be subject to monetary fines, suits, penalties, or sanctions. As a result of the expanded scope of HIPAA through HITECH, we may incur significant costs in order to minimize the amount of &#8220;unsecured PHI&#8221; that we handle and retain, and/or to implement improved administrative, technical, or physical safeguards to protect PHI. We may have to demonstrate and document our compliance efforts, even if there is a low probability that PHI has been compromised, in order to overcome the presumption that an impermissible use or disclosure of PHI results in a reportable breach. We may incur significant costs to notify the relevant individuals, government entities and, in some cases, the media, in the event of a breach and to provide appropriate remediation and monitoring to mitigate any potential damage.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to liability for failure to fully comply with applicable corporate and securities laws.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various corporate and securities laws. Any failure to comply with such laws could cause government agencies to take action against us, which could restrict our ability to issue securities and result in fines or penalties. Any claim brought by such an agency could also cause us to expend resources to defend ourselves, divert the attention of our management from our business and could significantly harm our business, operating results, and financial condition, even if the claim is resolved in our favor.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face lawsuits not covered by insurance and related expenses may be material. Our failure to avoid, defend, and accrue for claims and litigation could negatively impact our results of operations or cash flows.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to and become involved in various litigation matters arising out of our business, including from time to time, actual or threatened lawsuits. Malpractice lawsuits are common in the healthcare industry. The medical malpractice legal environment varies greatly by state. The status of tort reform, availability of non-economic damages, or the presence or absence of other statutes, such as elder abuse or vulnerable adult statutes, influence the incidence and severity of malpractice litigation. We may also be subject to other types of lawsuits, such as those initiated by our competitors, stockholders, employees, service providers, contractors, or by government agencies, including when we terminate relationships with them, which may involve large claims and significant defense costs. Many states have joint and several liabilities for providers who deliver care to a patient and are at least partially liable. As a result, if one provider is found liable for medical malpractice for the provision of care to a particular patient, all other providers who furnished care to that same patient, which could potentially include us and our affiliated physicians, may also share in the liability, which could be substantial individually or in aggregate.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The defense of litigation, including fees of legal counsel, expert witnesses, and related costs, is expensive and difficult to forecast accurately. Such costs may be unrecoverable even if we ultimately prevail in litigation and could consume a significant portion of our limited capital resources. To defend lawsuits, it may also be necessary for us to divert officers and other employees from our normal business functions to gather evidence, give testimony, and otherwise support litigation efforts. If we lose any material litigation, we could face material judgments or awards against them. An unfavorable resolution of one or more of the proceedings in which we are involved now or in the future could have a material adverse effect on our business, cash flows, and financial condition. We may also in the future find it necessary to file lawsuits to recover damages or protect our interests. The cost of such litigation could also be significant and unrecoverable, which may also deter us from aggressively pursuing even legitimate claims.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently maintain malpractice liability insurance coverage to cover professional liability and other claims for certain hospitalists and clinic physicians. All of our affiliated physicians are required to carry first-dollar coverage with limits of coverage equal to $1.0 million for all claims based on occurrence up to an aggregate of $3.0 million per year. We cannot be certain that our insurance coverage will be adequate to cover liabilities arising out of claims asserted against us, our affiliated professional organizations, or our affiliated physicians. Liabilities incurred by us or our affiliates in excess of our insurance coverage, including coverage for professional liability and other claims, could have a material adverse effect on our business, financial condition, and results of operations. Our professional liability insurance coverage generally must be renewed annually and may not continue to be available to us in future years at acceptable costs and on favorable terms, which could increase our exposure to litigation.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may also be subject to laws and regulations not specifically targeting the healthcare industry.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain regulations not specifically targeting the healthcare industry could also have material effects on our operations. For example, the California Finance Lenders Law (the &#8220;CFLL&#8221;) could be applied to us as a result of our various affiliate and subsidiary loans and similar arrangements. If a regulator were to take the position that such loans were covered by the CFLL, we could be subject to regulatory action that could impair our ability to continue to operate and may have a material adverse effect on our profitability and business as we currently do not hold a CFLL licensure. Pursuant to an exemption under the CFLL, a person may make five or fewer commercial loans in a 12-month period without a CFLL licensure if the loans are &#8220;incidental&#8221; to the business of the person. This exemption, however, creates some uncertainty as to which loans could be deemed as incidental to our business. In addition, a person without a CFLL licensure may also make a single commercial loan in a 12-month period without the loan being &#8220;incidental&#8221; to such person&#8217;s business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to the Ownership of Astrana&#8217;s Common Stock.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have to meet certain requirements in order to remain as a Nasdaq-listed public company.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, Astrana is required to comply with various regulatory and reporting requirements, including those required by the SEC. Astrana is also subject to Nasdaq listing rules. Complying with these requirements is time-consuming and expensive. No assurance can be given that Astrana can continue to meet the SEC reporting and Nasdaq listing requirements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Astrana&#8217;s common stock may be thinly traded and its market price may be subject to fluctuations and volatility. Stockholders may be unable to sell their shares at a profit and might incur losses.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of Astrana&#8217;s common stock has been volatile in the past and may continue to be so from time to time in the future. The price at which Astrana&#8217;s common stock trades could be subject to significant fluctuation and may be affected by a variety of factors, including the trading volume, our results of operations, the announcement and consummation of certain transactions, and our ability or inability to raise additional capital and the terms thereof, and therefore could fluctuate, and potentially decline, significantly. Other factors that may cause the market price of Astrana&#8217;s common stock to fluctuate include:</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Variations in our operating results, such as actual or anticipated quarterly and annual increases or decreases in revenue, gross margin or earnings;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Changes in our business, operations, or prospects, including announcements relating to strategic relationships, mergers, acquisitions, partnerships, collaborations, joint ventures, dispositions, other corporate transactions, financings, capital commitments, or other events by us or our competitors;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Developments, conditions, or trends in the healthcare industry;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Changes in the economic performance or market valuations of other healthcare-related companies;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">General market conditions or domestic or international macroeconomic and geopolitical factors unrelated to our performance or financial condition, including economic or political instability, inflation, wars, civil unrest, terrorism, public health crises, and natural disasters;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Sales of stock by Astrana&#8217;s stockholders generally and Astrana&#8217;s larger stockholders, including insiders, in particular, including sale or distributions of large blocks of common stock by our executives and directors or large stockholders;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Volatility and limitations in trading volumes of Astrana&#8217;s common stock and the stock market;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Approval, maintenance, and withdrawal of our and our affiliates&#8217; certificates, permits, registration, licensure, certification, and accreditation by the applicable regulatory or other oversight bodies;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our financing activities, including our ability to obtain financings and prices at which we sell our equity securities, including securities convertible to or exercisable for shares of Astrana&#8217;s common stock;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Failures to meet external expectations or management guidance;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Changes in our capital structure and cash position;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Analyst research reports on Astrana&#8217;s common stock, including analysts&#8217; recommendations and changes in recommendations, price targets, and withdrawals of coverage;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Departures and additions of our key personnel, including our officers or directors;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Disputes and litigations related to intellectual properties, proprietary rights, and contractual obligations;</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Changes in applicable laws, rules, regulations, or accounting practices and other dynamics; and</span></div><div style="margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Other events or factors, many of which may be out of our control.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There may be a limited trading market for Astrana&#8217;s common stock. A lack of an active market may contribute to stock price volatility or supply/demand imbalances, make an investment in Astrana&#8217;s common stock less attractive to certain investors, and/or impair the ability of Astrana&#8217;s stockholders to sell shares at the time they desire or at a price that they consider favorable. The lack of an active market may also reduce the fair market value of Astrana&#8217;s common stock, impair our ability to raise capital by selling shares of Astrana&#8217;s common stock, or use such stock as consideration to attract and retain talent or engage in business transactions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If analysts do not report about us, or negatively evaluate us, Astrana&#8217;s stock price could decline.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for Astrana&#8217;s common stock will rely in part on the availability of research and reports that third-party analysts publish about us. There are many large companies active in the healthcare industry, which makes it more difficult for us to receive widespread coverage. Furthermore, if one or more of the analysts who do cover us downgrade Astrana&#8217;s common stock, its price would likely decline. If one or more of these analysts cease coverage of us, we could lose market visibility, which in turn could cause Astrana&#8217;s stock price to decline.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we have no current plans to pay regular cash dividends on our common stock, you may not receive any return on investment unless you sell your common stock for a price greater than that which you paid for it.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not anticipate paying any regular cash dividends on our common stock. Any decision to declare and pay dividends in the future will be made at the discretion of our board of directors and will depend on, among other things, our results of operations, financial condition, cash requirements, contractual restrictions and other factors that our board of directors may deem relevant. In addition, our ability to pay dividends is, and may be, limited by covenants of existing and any future outstanding indebtedness we or our subsidiaries incur. Similarly, we may not repurchase any shares through our public repurchase program or otherwise return capital to our stockholders. Therefore, any return on investment in our common stock is dependent upon the appreciation of the price of our common stock on the open market, which may not occur.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our current principal stockholders, executive officers, and directors have significant influence over our operations and strategic direction and they could cause us to take actions with which other stockholders might not agree and could delay, deter, or prevent a change of control or a business combination with respect to us.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, our executive officers, directors, five percent or greater stockholders, and their respective affiliated entities in the aggregate own approximately 44.1% of our outstanding common stock (including restricted stock awards held by them, but excluding stock options). As a result, these stockholders, who are entitled to vote their shares in their own interests, acting together, exert a significant degree of influence over our management and affairs and over matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions. This concentration of ownership may have the effect of delaying or preventing a change of control, merger, consolidation, sale of all or substantially all of our assets or other corporate transactions that other stockholders may view as beneficial, or conversely, this concentrated control could result in the consummation of a transaction that other stockholders may not support. This may harm the value of our shares and discourage investors from investing in us.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions under Delaware law and Astrana&#8217;s charter and bylaws could deter takeover attempts or attempts to remove its board members or management that might otherwise be beneficial to its stockholders.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana is subject to Section 203 of the Delaware General Corporation Law, which generally provides that a corporation may not engage in any business combination with any interested stockholder during the three-year period following the time that such stockholder becomes an interested stockholder unless certain approval requirements are met. This provision, and others that could be adopted in the future, could make the acquisition of Astrana and the removal of its incumbent officers and directors more difficult for potential acquirers, deter unsolicited takeovers or delay or prevent changes in Astrana&#8217;s control or management, including transactions in which Astrana&#8217;s stockholders might otherwise receive a premium for their shares over then current market prices. These provisions may also limit the ability of Astrana&#8217;s stockholders to approve transactions that they may deem to be in their best interests.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, Astrana&#8217;s charter and bylaws contain additional provisions, such as the authorization for its board of directors to issue one or more classes of preferred stock and determine the rights, preferences, and privileges of the preferred stock, which could cause substantial dilution to a person or group that attempts to acquire Astrana on terms not approved by the board, and the ownership requirement for Astrana&#8217;s stockholders to call special meetings, that could deter, discourage, or make it more difficult for a change in control of Astrana or for a third party to acquire Astrana, even if such a change in control could be deemed in the interest of Astrana&#8217;s stockholders, or if such an acquisition would provide Astrana&#8217;s stockholders with a substantial premium for their shares over the market price of Astrana&#8217;s common stock.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As such, these provisions could discourage a potential acquirer from acquiring us or otherwise attempting to obtain  control of us and increase the likelihood that our incumbent directors and officers will retain their positions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may issue additional equity securities in the future, which may result in dilution to existing investors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Astrana issues additional equity securities, its existing stockholders may experience substantial dilution. Astrana may sell equity securities and may issue securities convertible into or exercisable for common stock in one or more transactions at prices and manners as we may determine from time to time, including at prices (or conversion or exercise prices) below the market price of Astrana&#8217;s common stock, for capital-raising purposes, including in any debt financing, registered offering, or private placement, and new investors could have superior rights such as liquidation and other preferences. To attract and retain the right talent, Astrana also issues equity awards under its equity compensation plans to its officers, other employees, directors, and consultants from time to time. Astrana may also issue additional shares of its common stock or other securities that are convertible into or exercisable for common stock in connection with future acquisitions or for other business purposes. In addition, the exercise or conversion of outstanding options or warrants to purchase shares of Astrana&#8217;s stock may result in dilution to its existing stockholders upon any such exercise or conversion. </span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_34"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1B.&#160;&#160;&#160;&#160;Unresolved Staff Comments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_549755816203"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1C.&#160;&#160;&#160;&#160;Cybersecurity</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana, like the rest of the healthcare industry, continues to innovate and rely on digital technology, further increasing the importance of cybersecurity to the business. The world is seeing an increase in cyberattacks by nation-states, hacktivists, organized cybercriminal groups, and insider threat actors, all of which may, among other avenues of attack, be using artificial intelligence (&#8220;AI&#8221;) and distributed hosted environments across different geographies to attack their victims. These threat actors may be individuals or part of a cyber organized crime group that leverages large-scale Cybercrime-as-a-Service (&#8220;CaaS&#8221;) subscriptions to quickly scale the impact of attacks and avoid disruption to their operations. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s digital systems are distributed across various architectures, including on-premises, hosted, Software-as-a-Service (&#8220;SaaS&#8221;), and other architectures operated by third-party service providers. If these architectures and third-party environments fail to operate as contracted, Astrana&#8217;s systems could stop functioning for some time, placing Astrana&#8217;s strategy, data, clients, and users at risk. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted in Item 1 and Item 1A of Part I of this report, a breach of Astrana&#8217;s network, hosted service providers, or vendor systems may expose Astrana to a risk of loss or misuse of information, litigation, and potential liability. Therefore, the Company has a team of experienced professionals with expertise in cybersecurity leadership, risk management, incident response, and security operations overseeing Astrana&#8217;s program. This team is responsible for developing and implementing our cybersecurity strategy, identifying and mitigating risks, and responding to incidents. Astrana utilizes external resources from reputable cybersecurity firms to supplement certain Chief Information Security Officer (&#8220;CISO&#8221;) functions, including risk assessments, strategy, and security, while integrating these activities with Astrana&#8217;s risk management processes. Astrana assesses third-party cybersecurity controls through cybersecurity questionnaires and includes security and privacy addendums to our contracts, where applicable. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To address cybersecurity, privacy, and overall business risk adequately, Astrana employs a consistent risk management process that assigns risks to functional owners. Risks can be strategic (e.g., loss of market share, technology shifts), reputational (e.g., loss of trust, revenue decline), regulatory (e.g., regulatory fines, business restrictions), or operational (e.g., operational downtime, productivity loss) in nature.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cybersecurity team collaborates with leaders in management to assess materiality, align on a remediation roadmap, and comply with disclosure requirements. On an ongoing basis, the board of directors and the audit committee oversee Astrana&#8217;s cybersecurity risks and remediation strategies to prevent and mitigate cyberattacks.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, the Company is not aware of any risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect the Company, including its business strategy, results of operations, or financial condition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.&#160;&#160;&#160;&#160;Properties</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located in Alhambra, California, where we lease approximately 35,000 square feet of office space in two adjacent buildings from a related party. We also lease approximately 47,500 square feet of office space in Monterey Park, California, from a related party. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease other offices and medical spaces located in Los Angeles, Riverside, and San Mateo County in California. We also maintain offices and medical spaces in Nevada, Texas and New York. Monthly rental payments range from approximately $1,000 to $42,000 and have terms that expire between January 2024 and, subject to options to extend provided thereunder, January 2041.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our existing facilities are in good condition and are suitable and adequate for our current requirements. Based on current information and subject to future events and circumstances, we anticipate that we may extend leases on our various facilities as necessary, as they expire, and lease additional facilities to accommodate possible future growth.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_40"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are, from time to time, party to lawsuits, threatened lawsuits, disputes and other claims arising in the normal course of business. We assess our liabilities and contingencies in connection with outstanding legal proceedings utilizing the latest information available. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our consolidated financial statements. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the pending or threatened legal proceedings or claims in which we are involved are discussed under Note 14 - &#8220;Commitments and Contingencies,&#8221; to our consolidated financial statements in this Annual Report on Form 10-K, which disclosure is incorporated by reference herein.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_43"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4.&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_49"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.&#160;&#160;&#160;&#160;Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana&#8217;s common stock is listed on Nasdaq under the symbol &#8220;ASTH.&#8221; Prior to the Company&#8217;s rebranding in February 2024, the Company&#8217;s common stock was listed on Nasdaq under the symbol &#8220;AMEH.&#8221;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Record Holders</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;22, 2024, there were approximately 599 holders of record of Astrana&#8217;s common stock based on our transfer agent&#8217;s report. Because many shares of Astrana&#8217;s common stock are held by brokers and other nominees on behalf of stockholders, including in trust, we are unable to estimate the total number of stockholders represented by these record-holders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not paid any cash dividends on Astrana&#8217;s common stock, and we do not contemplate the payment of cash dividends thereon in the foreseeable future. Our future dividend policy will depend on our earnings, capital requirements, financial condition, and other factors relevant to our ability to pay dividends, including any contractual restrictions contained in our Amended Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December&#160;31, 2023, no shares were repurchased under the Company&#8217;s share repurchase plan. In December 2022, Astrana&#8217;s Board of Directors approved a share repurchase plan authorizing the Company to repurchase up to $50.0&#160;million of its shares of common stock on the open market and through privately negotiated transactions. This share repurchase plan does not have an expiration date. The Board may suspend or discontinue the repurchase program at any time. This repurchase program does not obligate the Company to make additional repurchases at any specific time or in any specific situation. As of December&#160;31, 2023, $40.5&#160;million remained available for repurchase under the repurchase plan.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about purchases made by the Company of shares of the Company's common stock during the three months ended December&#160;31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.770%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.061%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.218%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.061%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.521%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.066%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet be Purchased Under the Program (in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1- October 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1 - November 30</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,170,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1 - December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,188,138&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,461&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes shares repurchased to satisfy tax withholding obligations due upon the vesting of restricted stock held by certain employees. We did not pay cash to repurchase these shares, nor were these repurchases part of a publicly announced plan or program. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes 3,166,561 shares of common stock repurchased from APC on November 14, 2023, pursuant to a stock repurchase agreement with APC entered into on November 6, 2023. The Company&#8217;s Board of Directors and the Audit Committee of the Board of Directors approved the repurchase.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes 15,000 shares of common stock repurchased from two members of the Board of Directors on December 6, 2023. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Measurement Comparison</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following chart compares the cumulative total return of our common stock with the cumulative total return of the Russell 3000 Index and the S&amp;P 500 Healthcare Index from December 31, 2018 to December&#160;31, 2023. The annual changes for the five-year period shown in the graph are based on the assumption that $100 was invested in our common stock and each index on December 31, 2018, and that all dividends were reinvested. The stock price performance included in the line graph below is not necessarily indicative of future stock price performance.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the Russell 3000 Index is an appropriate independent broad market index because it measures the performance of similar-sized companies in numerous sectors. In addition, we believe the S&amp;P 500 Health Care Index is an appropriate third-party published industry index because it measures the performance of healthcare companies.</span></div><div style="margin-top:12pt;text-align:center"><img src="asth-20231231_g2.jpg" alt="1791" style="height:480px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.559%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indexed Returns for the Years Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company/Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Period</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/2018</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.07&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.95&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Russell 3000 Index</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Healthcare</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6.&#160;&#160;&#160;&#160;[Reserved]</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_61"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following management&#8217;s discussion and analysis should be read in conjunction with the audited consolidated financial statements and the notes thereto included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221; of this Annual Report on Form 10-K. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In this section, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; and &#8220;us&#8221; refer to Astrana Health, Inc. (&#8220;Astrana&#8221;) and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VIEs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">).</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_64"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana Health, Inc. is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, Astrana operates an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. We, together with our affiliated physician groups and consolidated entities, provide coordinated outcomes-based medical care in a cost-effective manner.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our accountable care organization and our network of IPAs we were responsible for coordinating the care for approximately 0.9 million patients, primarily in California, as of December&#160;31, 2023. These covered patients are comprised of managed care members whose health coverage is provided either through their employers, acquired directly from a health plan, or as a result of their eligibility for Medicaid or Medicare benefits. Our managed patients benefit from an integrated approach that places physicians at the center of patient care and utilizes sophisticated risk management techniques and clinical protocols to provide high-quality, cost-effective care. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Highlights</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company&#8217;s Credit Facility Increased to $700.0 million</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2023, the Company entered into a Third Amendment to the Amended Credit Agreement (as amended, the &#8220;Amended Credit Agreement&#8221;) with the banks and other financial institutions party thereto and Truist Bank, as administrative agent, which provided a term loan to the Company in an aggregate amount of up to $300.0 million. This increased the Company&#8217;s facility (the &#8220;Amended Credit Facility&#8221;) to $700.0 million with our existing $400.0 million revolver. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distribution of APC Excluded Assets</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 26, 2023, APC completed a restructuring transaction to spin-off its real estate investments, a component of Excluded Assets (&#8220;the Spin-Off&#8221;). To effect the restructuring, APC contributed its real estate investments to a wholly owned subsidiary in exchange for 100% of the subsidiary&#8217;s membership interest units, which membership interests were then distributed to holders of APC&#8217;s outstanding common stock as a dividend, with each such stockholder receiving one membership interest unit for each share of outstanding APC common stock held. As a result of the distribution, the real estate investments are no longer included within our consolidated financial statements after December 26, 2023.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the restructuring, APC amended certain provisions of the Certificate of Determination of Preferences of Series A Preferred Stock relating to dividend restrictions and liquidation rights. Astrana Medical, a consolidated VIE of Astrana holds all of APC&#8217;s outstanding Series A Preferred Stock. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 6, 2023, the Company entered into a stock repurchase agreement with APC to repurchase approximately $100.0 million, or 3,166,561 shares, of the Company&#8217;s common stock from APC. The Company repurchased the shares on November 14, 2023. The Company financed the share repurchase with borrowings under its Amended and Restated Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business and Asset Acquisitions and Partnerships</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Texas Independent Providers, LLC</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;1, 2023, the Company acquired certain assets relating to Texas Independent Providers, LLC (&#8220;TIP&#8221;). The acquired assets allow the Company to provide high-quality care services to Medicare Advantage patients in Texas. The purchase price consisted of cash funded on September 1, 2023.</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IntraCare</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July&#160;27, 2023, the Company announced an agreement to partner with IntraCare, an operator of a value-based primary care provider network and primary care clinics located predominantly in Texas with a growing presence in Oklahoma. On July 27, 2023, the Company entered into a 5-year convertible promissory note with IntraCare as the borrower. The principal on the note is $25.0 million with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to 8.81%, compounded annually.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FYB</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;1, 2023, the Company acquired 100% of the equity interest in FYB. FYB is licensed by the California Department of Managed Health Care as a full-service Restricted Knox-Keene licensed health plan, which enables FYB to assume full financial responsibility, including both professional and institutional risk, for the medical costs of its members under the Knox-Keene Health Care Service Plan Act of 1975.</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chinese Community Health Care Association (&#8220;CCHCA&#8221;)</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;1, 2023, the Company acquired certain healthcare assets from CCHCA. The acquired assets allow the Company to provide high-quality care to more patients in the San Francisco Community. The purchase price consisted of cash funded on May&#160;1, 2023. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Name Change</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective February 26, 2024, the Company changed its name to Astrana Health, Inc.. Alongside the corporate name change, the Company's common stock is trading under the new symbol "ASTH" on Nasdaq.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Closing of Acquiring Community Family Care Medical Group IPA, Inc. Assets</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Company entered into an Asset and Equity Purchase Agreement (the &#8220;Purchase Agreement&#8221;) to acquire the partnership interests of Advanced Health Management Systems, L.P. (&#8220;AHMS&#8221;) and certain assets of Community Family Care Medical Group IPA, Inc. (&#8220;CFC&#8221;), which acquisitions the Company expected would occur in two separate closings. In November 2023, AHM also entered into a Stock Purchase Agreement (the &#8220;I Health Purchase Agreement&#8221;) to purchase 25% of the outstanding shares of common stock of I Health, Inc. (&#8220;I Health&#8221;). On January 31, 2024, the first closing under the Purchase Agreement occurred, and the Company completed its acquisition of CFC&#8217;s assets. CFC IPA manages the healthcare of over 200,000 members in the Los Angeles, California area, serving patients across Medicare, Medicaid, and Commercial payers. The Company expects to complete the second closing under the Purchase Agreement and acquire the outstanding general and limited partnership interests of AHMS during the first quarter of 2024, subject to obtaining required regulatory approvals. It is currently expected that the I Health Purchase Agreement closing will occur during the first quarter of 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BASS Medical Group</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2024, the Company announced its strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. Together, the two organizations will aim to bring high-quality care via value-based arrangements to patients of all insurance types, including Medicare, Medicaid, ACA Marketplace, and Commercial. Astrana has provided BASS Medical Group with a $20 million senior secured promissory note (&#8220;BASS secured promissory note&#8221;), which is intended to be used, in partnership with Astrana, to continue to grow their footprint and invest in high-quality, high-value, and accessible primary and multi-specialty care for communities across California. The BASS secured promissory note matures on January 11, 2031 and has an interest rate per annum equal to 2.9% plus the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator) compounded annually.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leadership Transitions</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 24, 2024, the Company announced the following executive appointments effective January 19, 2024:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Thomas S. Lam, M.D., M.P.H., previously Co-Chief Executive Officer and President and a director, was appointed Vice Chairman of the Board;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Brandon K. Sim, M.S., previously Co-Chief Executive Officer, was appointed Chief Executive Officer and President; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Chandan Basho, previously Chief Financial Officer and Chief Strategy Officer, was appointed Chief Financial Officer and Chief Operating Officer.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Dinesh Kumar, M.D., was appointed Chief Medical Officer effective January 23, 2024.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2024, the Company&#8217;s ESPP came into effect. The Company&#8217;s ESPP allows eligible employees to contribute a portion of their eligible earnings toward the semi-annual purchase of the Company&#8217;s common stock at a discounted price, subject to an annual maximum dollar amount. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Shared Savings Program (&#8220;MSSP&#8221;)</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2024, in addition to participating in the ACO REACH Model, one of our other ACOs will participate in the Medicare Shared Savings Program (&#8220;MSSP&#8221;). The MSSP was created to promote accountability and improve coordination of care for Medicare beneficiaries. Unlike the ACO REACH Program, CMS continues to pay participant and preferred providers on a fee-for-service basis for Medicare-covered services provided to MSSP Aligned Beneficiaries. Our shared savings or losses in managing our beneficiaries are generally determined on an annual basis after reconciliation with CMS.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_70"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Financial Measures and Indicators</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating Revenues</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue, which is recorded in the period in which services are rendered and earned, primarily consists of capitation revenue, risk pool settlements and incentives, ACO REACH capitation revenue, management fee income, and fee-for-services (&#8220;FFS&#8221;) revenue. The form of billing and related risk of collection for such services may vary by type of revenue and the customer.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our largest expenses consist of the cost of: (i) patient care paid to contracted providers; (ii) information technology equipment and software; and (iii) hiring staff to provide management and administrative support services to our affiliated physician groups, as further described in the following sections. These services include claims processing, utilization management, contracting, accounting, credentialing, and administrative oversight.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA and Adjusted EBITDA Margin</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Adjusted EBITDA and Adjusted EBITDA margin are supplemental performance measures of our operations for financial and operational decision-making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation, and amortization, excluding income or loss from equity method investments, non-recurring and non-cash transactions, stock-based compensation, and APC excluded assets costs. The Company defines Adjusted EBITDA margin as Adjusted EBITDA over total revenue.</span></div><div><span><br/></span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_73"></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Compared to 2022</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated operating results for the year ended December&#160;31, 2023, as compared to the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Astrana Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income (in thousands)</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,215,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">930,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">285,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk pool settlements and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53,786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,386,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,144,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">242,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,302,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,039,898&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">262,150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19,652)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other income (expense)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from equity method investments</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,920)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,581)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,944&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense), net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,649)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(130)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,741&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net (loss) income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income attributable to Astrana Health, Inc.</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,717&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,171&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,546&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:17pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> *  Percentage change of over 500%</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Groups and Patients</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the total number of affiliated physician groups we managed were 15 groups and 14 groups, respectively, and the total number of patients for whom we managed the delivery of healthcare services was approximately 0.9 million and 1.3 million, respectively. The decrease in membership is primarily due to an IPA ending its MSA with the Company. This was partially offset by managing 2 new physician groups in 2023.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total revenue in 2023 was $1,386.7 million, as compared to $1,144.2 million in 2022, an increase of $242.5 million or 21%. The increase in total revenue was primarily attributable to the following:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) An overall increase of $285.5 million in capitation revenue primarily driven by membership growth in our ACO  participating in a value-based Medicare FFS model and our acquisition of a Restricted Knox-Keene licensed health plan in 2023. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) An overall decrease of $53.8 million in risk pool settlements and incentive revenue due to the Company recognizing the shared savings from the NGACO program in 2022 for the 2021 performance year. With the end of the NGACO program ending on December 31, 2021, the Company began participating in the ACO REACH model.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) An increase of $10.1 million in FFS revenue attributable to fees generated from Astrana primary, multi-specialty, and ancillary care delivery entities and expanding our locations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services, Excluding Depreciation and Amortization</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses related to the cost of services, excluding depreciation and amortization, in 2023 were $1,171.7 million, as compared to $944.7 million in 2022, an increase of $227.0 million or 24%. The overall increase was primarily due to increased participation in a value-based Medicare FFS model, medical costs associated with both professional and institutional risk of our Restricted Knox-Keene licensed health plan, and increased patient visits, which were commensurate to our increase in revenue.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses in 2023 were $112.6 million, as compared to $77.7 million in 2022, an increase of $34.9 million or 45%. This increase was primarily due to an increase in headcount and personnel-related costs to support the continued growth in the depth and breadth of our operations and nonrecurring costs related to acquisitions, tax restructuring fees, and an excise tax related to the repurchase of the Company&#8217;s stock from APC.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense were $17.7 million and $17.5 million for the years ended December&#160;31, 2023 and 2022, respectively. This amount includes depreciation of property and equipment and the amortization of intangible assets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income From Equity Method Investments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from equity method investments in 2023 was $5.6 million, as compared to income of $5.6 million in 2022. This amount includes the Company&#8217;s portion of the equity method investment&#8217;s net earnings or losses. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense in 2023 was $16.1 million, as compared to $7.9 million in 2022, an increase of $8.2 million. The increase in interest expense for the year was primarily due to higher interest rates and an increase in amounts borrowed under the Amended Credit Facility. On December&#160;31, 2023, the outstanding principal and interest rate on the Amended Credit Agreement was $280.0 million and 7.69% compared to $180.0 million and 5.92% on December 31, 2022.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income in 2023 was $14.2 million, as compared to $2.0 million in 2022, an increase of $12.2 million. The increase in interest income was due to more bank accounts becoming interest-bearing and interest income from the IntraCare convertible promissory note. On July&#160;27, 2023, the Company entered into a 5-year convertible promissory note with IntraCare as the borrower. The principal on the note is $25.0 million with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to 8.81%, compounded annually.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrealized Loss on Investments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on investments in 2023 was $4.6 million, as compared to an unrealized loss on investments of $21.3 million in 2022, a decrease of $16.7 million. The decrease in unrealized loss on investments was primarily driven by a $21.2 million decrease as a result of APC selling all of its equity securities in a payer partner and the change in the share price of our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">remaining equity securities held. This was offset by a $4.3 million increase in unrealized loss as a result of the change in the fair value of our interest rate swaps and collar arrangements. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income in 2023 was $6.1 million, as compared to other income of $3.9 million in 2022, an increase of $2.2 million primarily due to an increase in rental income. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes was $32.0 million in 2023, as compared to $40.9 million in 2022, a decrease of $8.9 million or 22%. This was primarily attributable to changes to our tax structure resulting in a decreased tax rate. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net (Loss) Income Attributable to Noncontrolling Interests</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to non-controlling interests was $2.9 million in 2023, as compared to net income of $0.6 million in 2022, a decrease of $3.4 million. The decrease was primarily attributable to more expenses incurred by APC&#8217;s Excluded Assets. Operations from Excluded Assets are for the benefit of APC and its common shareholders. As such, any income pertaining to APC&#8217;s interests in Excluded Assets do not affect net income attributable to Astrana.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Astrana Health, Inc.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Astrana Health, Inc. was $60.7 million in 2023, as compared to net income of $45.2 million in 2022, an increase of $15.5 million. The increase was primarily due to a decrease in the provision for income taxes and an increase in interest income. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Compared to 2021</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated operating results for the year ended December&#160;31, 2022, as compared to the year ended December&#160;31, 2021, were as follows:</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Astrana Health, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Income (in thousands)</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">930,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">593,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">336,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk pool settlements and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management fee income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fee-for-service, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(374)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,144,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">773,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">370,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">596,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">348,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,039,898&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">675,736&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">364,162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,086&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other income (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) from equity method investments</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,920)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,649)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20,431)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77,748&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,741&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,055&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(314)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to noncontrolling interests</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income attributable to Astrana Health, Inc.</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,171&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23,752)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Groups and Patients</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022 and 2021, the total number of affiliated physician groups we managed were 14 groups and 12 groups, respectively, and the total number of patients for whom we managed the delivery of healthcare services was approximately 1.3 million and 1.2 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total revenue in 2022 was $1,144.2 million, as compared to $773.9 million in 2021, an increase of $370.2 million or 48%. The increase in total revenue was primarily attributable to the following:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) An overall increase of $336.9 million in capitation revenue primarily driven by organic membership growth in our core IPAs and participation in a value-based Medicare FFS model.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) An increase of $23.0 million in FFS revenue attributable to fees generated from Astrana primary, multi-specialty, and ancillary care delivery entities.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services, Excluding Depreciation and Amortization</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses related to the cost of services, excluding depreciation and amortization, in 2022 were $944.7 million, as compared to $596.1 million in 2021, an increase of $348.5 million or 58%. The overall increase was primarily due to the expected return to pre-COVID-19 medical expense run rates, participation in a value-based Medicare FFS model and growth in membership, which was commensurate to our increase in revenue.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses in 2022 were $77.7 million, as compared to $62.1 million in 2021, an increase of $15.6 million or 25%. This increase was primarily due to a $14.8 million increase in personnel-related costs to support the continued growth in the depth and breadth of our operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense were $17.5 million and $17.5 million for the years ended December 31, 2022 and 2021, respectively. These amounts included depreciation of property and equipment and the amortization of intangible assets.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income (Loss) From Equity Method Investments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from equity method investments in 2022 was $5.6 million, as compared to a loss of $4.3 million in 2021, an increase of $9.9 million. The increase in income from equity method investments was primarily due to our investment partner having a favorable contract change, including rate and division of financial responsibility on certain claims.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on Sale of Equity Method Investment</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain on sale of equity method investment in 2022 was $0, as compared to $2.2 million in 2021, a decrease of $2.2 million. The decrease in gain on the sale of equity method investment is due to APC selling 21.25% of its interest in one if its equity method investments back to Dr. Arteaga for the year ended December 31, 2021. There was no sale of our equity method investment for the year ended December 31, 2022.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense in 2022 was $7.9 million, as compared to $5.4 million in 2021, an increase of $2.5 million. The increase in interest expense for the year was primarily due to higher interest rates. On December 31, 2022, the interest rate on the Amended Credit Agreement was 5.92% compared to 1.71% on December 31, 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income in 2022 was $2.0 million, as compared to $1.6 million in 2021, an increase of $0.4 million. Interest income reflects interest earned on cash held in money market and certificate of deposit accounts and the interest from notes receivable.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unrealized Loss on Investments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on investments in 2022 was $21.3 million, as compared to an unrealized loss on investments of $10.7 million in 2021, an increase of $10.5 million. The increase in unrealized loss on investments was primarily driven by a decrease in the stock price of a payer partner in which we hold shares and Nutex.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income in 2022 was $3.9 million, as compared to other expenses of $3.8 million in 2021, an increase of $7.7 million. The increase was primarily due to the write-off of certain beneficial interest related to the disposition of ownership </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest in one of APC&#8217;s equity method investments totaling $15.7 million for the year ended December 31, 2021. The beneficial interest was an Excluded Assets that was deemed solely for the benefit of APC and its common shareholders. As such, the write-off did not result in any impact on net income attributable to Astrana Health, Inc. This was partially offset by non-recurring income recognized for the year ended December 31, 2021 relating to $2.8 million income from consolidating an equity method investment, $5.3 million income from the stock purchase agreement with Nutex, and $1.7 million income in stimulus checks. In addition, the Company recognized a $2.3 million gain on sale of equity securities for the year ended December 31, 2022.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes was $40.9 million in 2022, as compared to $31.7 million in 2021, an increase of $9.2 million or 29%. This was primarily attributable to an increase in pre-tax income in 2022, as compared to 2021, due to the factors described above.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Attributable to Noncontrolling Interests</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to non-controlling interests was $0.6 million in 2022, as compared to a net loss of $22.9 million in 2021, an increase of $23.4 million. The increase in net income attributable to noncontrolling interest was primarily due to non-recurring write-offs recognized for the year ended December 31, 2021 related to certain beneficial interest totaling $15.7 million.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_76"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Financial Performance </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the first quarter of 2023, the Company began providing reporting for three reportable segments consisting of Care Partners, Care Delivery and Care Enablement. The Company evaluates the performance of its operating segments based on segment revenue growth as well as operating income. Management uses revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors. For more information about our segments, refer to Note 1 &#8212; &#8220;Description of Business&#8221; and Note 20 - &#8220;Segments&#8221; to our consolidated financial statements under Item 8 in this Annual Report on Form 10-K for additional information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Segments Compared to 2022 Segments</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our revenue and operating income by segment for the year ended December&#160;31, 2023, as compared to the year ended December&#160;31, 2022:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.893%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Revenue (in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Delivery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Enablement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.893%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income (in thousands)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Delivery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Enablement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,964)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Care Partners Segment</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was $1,300.1 million in 2023, as compared to $1,051.5 million in 2022, an increase of $248.6 million. Operating income was $91.7 million in 2023, as compared to $85.2 million in 2022, an increase of $6.5 million. The increase in revenue and operating income was primarily driven by membership growth in our ACO participating in a value-based Medicare FFS model and our acquisition of a Restricted Knox-Keene licensed health plan in 2023. The increase in revenue was partially </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offset by a decrease in incentive revenue due to the Company recognizing the shared savings from the NGACO program in 2022 for the 2021 performance year.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Care Delivery Segment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/><br/>&#160;&#160;&#160;&#160;Revenue was $119.9 million in 2023, as compared to $96.1 million in 2022, an increase of $23.8 million. Operating income was $5.9 million in 2023, as compared to income of $9.0 million in 2022, a decrease in operating income of $3.1 million. The increase in revenue was primarily due to more clinic locations opening during 2023 from our primary, multi-specialty, and ancillary care delivery entities. The decrease in operating income was due to more costs incurred for expanding to new locations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Care Enablement Segment</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue was $135.8 million in 2023, as compared to $120.2 million in 2022, an increase of $15.6 million. Operating income was $19.1 million in 2023, as compared to $27.0 million in 2022, a decrease of $8.0 million. The increase in revenue was due to more managed independent physician groups. As of December&#160;31, 2023 and 2022, the total number of affiliated physician groups we managed were 15 groups and 14 groups, respectively. The decrease in operating income was due to an increase in personnel-related costs to support the increase in our managed independent physician groups. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Segments Compared to 2021 Segments </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our revenue and operating income by segment for the year ended December&#160;31, 2022, as compared to the year ended December&#160;31, 2021:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.893%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Revenue (in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709,714&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Delivery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Enablement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.893%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Operating Income (Loss) (in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Delivery</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Enablement</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:17pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">* Percentage change of over 500%</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Care Partners Segment</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was $1,051.5 million in 2022, as compared to $709.7 million in 2021, an increase of $341.8 million. Operating income was $85.2 million in 2022, as compared to $72.6 million in 2021, an increase of $12.6 million. The increase in revenue and operating income was primarily driven by organic membership growth in our core IPAs and participation in a value-based Medicare FFS model.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Care Delivery Segment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/><br/>&#160;&#160;&#160;&#160;Revenue was $96.1 million in 2022, as compared to $46.7 million in 2021, an increase of $49.4 million. Operating income was $9.0 million in 2022, as compared to a loss of $0.5 million in 2021, an increase of $9.5 million. The increase in revenue and operating income was primarily due to increased visits from our primary, multi-specialty, and ancillary care delivery entities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Care Enablement Segment</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue was $120.2 million in 2022, as compared to $107.7 million in 2021, an increase of $12.5 million. Operating income was $27.0 million in 2022, as compared to $37.5 million in 2021, a decrease of $10.5 million. The increase in revenue was due to more managed independent physician groups. As of December 31, 2022 and 2021, the total number of affiliated physician groups we managed were 14 groups and 12 groups, respectively. The decrease in operating income was due to an increase in personnel-related costs to support the increase in our managed independent physician groups. </span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_79"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Guidance</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana is providing the following guidance for total revenue, net income attributable to Astrana, Adjusted EBITDA, and EPS &#8212; diluted. These guidance assumptions are based on the Company's existing business, current view of existing market conditions and assumptions for the year ending December&#160;31, 2024.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.955%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.957%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($ in millions, except per share amounts)</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 Guidance Range</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,650.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,850.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Astrana Health, Inc.</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS &#8211; diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See &#8220;Guidance Reconciliation of Net Income to EBITDA and Adjusted EBITDA&#8221; and &#8220;Use of Non-GAAP Financial Measures&#8221; below for additional information. There can be no assurance that actual amounts will not be materially higher or lower than these expectations. See &#8220;Note About Forward-Looking Statements&#8221; above for additional information.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.353%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Guidance Reconciliation of Net Income to EBITDA and Adjusted EBITDA</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 Guidance Range</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Low</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">High</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (income) from equity method investments</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below are reconciliations of Net Income to EBITDA and Adjusted EBITDA for the years ended December&#160;31, 2023 and 2022:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.636%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.431%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.583%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Reconciliation of Net Income to EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>&#160;December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,976)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,680)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APC excluded assets costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,587&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA margin</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The Company defines Adjusted EBITDA margin as Adjusted EBITDA over total revenue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain APC minority interests where APC owns the asset but not the right to the dividends are reclassified from APC excluded asset costs to income from equity method investments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other, net for the year ended December 31, 2023 consists of nonrecurring transaction costs and tax restructuring fees incurred, non-cash gains and losses related to the changes in the fair value of our financing obligation to purchase the remaining equity interests, contingent liabilities, and the Company's collar agreement relating to interest on the Revolver Loan, and excise tax related to a nonrecurring buyback of the Company&#8217;s stock from APC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other, net for the year ended December 31, 2022 consists of one-time transaction costs incurred and non-cash gains and losses related to the changes in the fair value of our financing obligation to purchase the remaining equity interests and contingent considerations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Non-GAAP Financial Measures&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains the non-GAAP financial measures EBITDA, Adjusted EBITDA, and Adjusted EBITDA margin, of which the most directly comparable financial measure presented in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) is net income. These measures are not in accordance with, or alternatives to GAAP, and may be calculated differently from similar non-GAAP financial measures used by other companies. The Company uses Adjusted EBITDA as a supplemental performance measure of our operations for financial and operational decision-making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation, and amortization, excluding income or loss from equity method investments, non-recurring and non-cash transactions, stock-based compensation, and APC excluded assets costs. The Company defines Adjusted EBITDA margin as Adjusted EBITDA over total revenue.</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the presentation of these non-GAAP financial measures provides investors with relevant and useful information, as it allows investors to evaluate the operating performance of the business activities without having to account for differences recognized because of non-core or non-recurring financial information. When GAAP financial measures are viewed in conjunction with non-GAAP financial measures, investors are provided with a more meaningful understanding of the Company&#8217;s ongoing operating performance. In addition, these non-GAAP financial measures are among those indicators </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company uses as a basis for evaluating operational performance, allocating resources, and planning and forecasting future periods. Non-GAAP financial measures are not intended to be considered in isolation, or as a substitute for, GAAP financial measures. Other companies may calculate both EBITDA and Adjusted EBITDA differently, limiting the usefulness of these measures for comparative purposes. To the extent this Form 10-K contains historical or future non-GAAP financial measures, the Company has provided corresponding GAAP financial measures for comparative purposes. The reconciliation between certain GAAP and non-GAAP measures is provided above.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_88"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and investments in marketable securities at December&#160;31, 2023 totaled $296.3 million. Working capital totaled $242.8 million at December&#160;31, 2023, compared to $279.5 million at December&#160;31, 2022, a decrease of $36.7 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically financed our operations primarily through internally generated funds. We generate cash primarily from capitation contracts, risk pool settlements and incentives, fees for medical management services provided to our affiliated physician groups, and FFS reimbursements. We generally invest cash in money market accounts, which are classified as cash and cash equivalents. We also have the Amended Credit Agreement, which provides for a five-year revolving credit facility of $400.0 million and a term loan of up to $300.0 million and expires in June 2026 and November 2028, respectively. In addition, we have a current shelf registration statement filed with the SEC under which we may issue common stock, preferred stock, debt securities and other securities that may be offered in one or more offerings on terms to be determined at the time of the offering. We believe we have sufficient liquidity to fund our operations through at least the next 12 months and the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows for the years ended December&#160;31, 2023 and 2022 are summarized as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.753%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.893%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by (used in) financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase in cash, cash equivalents, and restricted cash</span></div></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,125&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,930&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,805)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Percentage change of over 500%</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents, and restricted cash increased by $6.1 million from $288.0 million at December&#160;31, 2022, to $294.2 million at December&#160;31, 2023. Cash provided by operating activities during the year ended December&#160;31, 2023 was $68.2 million, as compared to $82.1 million during the year ended December&#160;31, 2022. The decrease in cash provided by operating activities was primarily driven by changes in net income and working capital. For the year ended December&#160;31, 2023, net income exclusive of depreciation and amortization, amortization of debt issuance costs, share-based compensation, non-cash lease expense, income from equity method investments, gains or losses on investments and contingent liabilities, deferred tax, and gains or losses from distribution or consolidation of investments was $91.6 million compared to $84.1 million for the year ended December&#160;31, 2022. Working capital for the year ended December&#160;31, 2023, decreased operating cash flow by $23.4 million, compared to a $2.0 million increase in operating cash flow at December&#160;31, 2022. The change in working capital for the year ended December&#160;31, 2023, was mainly driven by an increase in our receivable, net, other receivable, prepaid and other current assets, and income tax receivable. These are due to the timing of when our receivables are collected and the timing of paying our income taxes. The decrease in working capital was partially offset by a decrease in our receivable, net &#8212; related parties and increase in our medical liabilities. The decrease in our receivable, net &#8212; related parties was attributable to cash received from our risk pool arrangements and the increase in our medical liabilities was attributable to the timing of claims paid and the Company&#8217;s participation in the value-based Medicare FFS model. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities during the year ended December&#160;31, 2023, was $65.5 million, primarily due to purchases of property and equipment of $28.5 million, issuance of loans of $26.5 million, business acquisition, net of cash, of $6.5 million, purchase of investments in privately held entities for payments for $4.0 million, contributions to an equity method </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment of $0.7 million, and purchase of marketable securities of $2.2 million. The cash used in investing activities was partially offset by proceeds from repayment of a loan receivable of $2.7 million and proceeds from the sale of marketable securities of $0.5 million. Cash used in investing activities during the year ended December&#160;31, 2022, was $7.1 million, primarily due to purchases of property and equipment of $22.9 million, payments for business acquisition, net of cash, of $16.4 million, purchase of marketable securities of $1.9 million, and funding for equity method investments of $2.1 million. The cash used in investing activities was partially offset by proceeds from the sale of marketable securities of $31.7 million, repayment of a loan receivable of $4.1 million, and distributions from an equity method investment of $0.4 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities during the year ended December&#160;31, 2023 was $3.4 million, as compared to cash used in financing activities of $20.1 million for the year ended December&#160;31, 2022. Cash provided by financing activities during the year ended December&#160;31, 2023 was primarily attributable to borrowings on our debt of $284.5 million and proceeds from the exercise of stock options of $1.5 million. This was partially offset by repayment of debt for $204.7 million, dividends payments of $62.1 million, repurchase of common shares of $10.2 million, debt issuance costs of $3.9 million for our Amended Credit Agreement, payments related to our contingent liabilities of $1.0 million, and repayment of finance lease obligations of $0.7 million. Cash used in financing activities for the year ended December&#160;31, 2022 was $20.1 million, which was attributable to dividend payments of $14.0 million, repurchase of common shares of $9.3 million, purchase of non-controlling interest of $5.0 million, repayment of debt of $3.9 million, and repayment of finance lease obligations of $0.6 million. This was partially offset by proceeds from the exercise of options and warrants of $8.6 million, borrowings from the Construction Loan of $3.6 million and proceeds from the sale of non-controlling interest of $0.4 million.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_2336"></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Excluded Assets </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, APC and Astrana Medical entered into the Second Amendment to Series A Preferred Stock Purchase Agreement, clarifying the term Excluded Assets. &#8220;Excluded Assets&#8221; means (i) assets received from the sale of shares of the Series A Preferred equal to the Series A purchase price, (ii) the assets of APC that are not Healthcare Services Assets, including the APC&#8217;s equity interests in Astrana Health, Inc., and any entity that is primarily engaged in the business of owning, leasing, developing, or otherwise operating real estate, (iii) any assets acquired with the proceeds of the sale, assignment, or other disposition of any of the assets described in clauses (i) or (ii), and (iv) any proceeds of the assets described in clauses (i), (ii), and (iii). </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 26, 2023, APC completed a restructuring transaction to spin-off its real estate investments, a component of Excluded Assets (&#8220;the Spin-Off&#8221;). To effect the restructuring, APC contributed its real estate investments to a wholly owned subsidiary in exchange for 100% of the subsidiary&#8217;s membership interest units, which membership interests were then distributed to holders of APC&#8217;s outstanding common stock as a dividend, with each such stockholder receiving one membership interest unit for each share of outstanding APC common stock held. As a result of the distribution, the real estate investments are no longer included within our consolidated financial statements after December 26, 2023. Net loss from Excluded Assets for the year ended December 26, 2023 and years ended December 31, 2022 and 2021 consisted of the following (in thousands):</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 26,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excluded Assets net loss</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_94"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Facilities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt balance consisted of the following (in thousands):</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:82.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.883%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note Payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Long-term debt </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the future commitments of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:82.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.883%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amended Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2021, the Company entered into an amended and restated credit agreement (as subsequently amended as described below, the &#8220;Amended Credit Agreement&#8221;) with Truist Bank, in its capacity as administrative agent for the lenders, issuing bank, swingline lender and lender, and the banks and other financial institutions from time to time party thereto, to, among other things, amend and restate that certain credit agreement, dated September 11, 2019, by and among the Company, Truist Bank, and certain lenders thereto, in its entirety. The Amended Credit Agreement provides for a five-year revolving credit facility to the Company of $400.0 million (&#8220;Revolver Loan&#8221;), which includes a letter of credit sub-facility of up to $25.0 million and a swingline loan sub-facility of $25.0 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2022, an amendment was made to the Amended Credit Facility, in which all amounts borrowed under the Amended Credit Agreement as of the effective date were automatically converted from LIBOR Loans to SOFR Loans with an initial interest period of one month on and as of the amendment effective date. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 8, 2023, a Second Amendment to the Amended Credit Agreement was entered into which, among other things, increased the letter of credit sub-facility from $25.0&#160;million to $50.0&#160;million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;3, 2023, the Company entered into a Third Amendment to the Amended Credit Agreement (&#8220;Third Amendment&#8221;) with Truist Bank and the other financial institutions party thereto. The Third Amendment provided a new term loan to the Company in an aggregate amount of up to $300.0&#160;million, with $180.0&#160;million funded at the closing of the Third Amendment, and $120.0&#160;million available to be drawn by the Company as delayed draw loans during the six months subsequent to the closing of the Third Amendment (collectively, the &#8220;Term Loan&#8221;). The Term Loan matures on November&#160;3, 2028 (or such earlier date on which it is terminated in accordance with the provisions of the Amended Credit Agreement) and amortizes quarterly at 5% per annum for each of the first two years, 7.5% per annum for years three and four, and 10% per annum for year five.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 10 &#8211; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our consolidated financial statements under Item 8 in this Annual Report on Form 10-K for additional information on the Amended Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Promissory Note Payable</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, FYB entered into a promissory note agreement with CCHCA. The principal on the promissory note is $2.0&#160;million with a maturity date of May&#160;9, 2024. Refer to Note 10 &#8211; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our consolidated financial statements under Item 8 in this Annual Report on Form 10-K for additional information on the Promissory Note Payable.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Financing Costs</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Amended Credit Agreement had unamortized deferred financing costs of $6.1 million. $2.6 million of unamortized deferred financing costs was related to unborrowed amounts available on the Term Loan and the unamortized deferred financing costs for the Revolver Loan. $3.6 million of unamortized deferred financing costs were netted against amounts borrowed on the Term Loan.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effective Interest Rate</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s average effective interest rate on its total debt during the years ended December&#160;31, 2023, 2022, and 2021 was 6.19%, 3.22%, and 2.06%, respectively. Interest expense in the consolidated statements of income included amortization of deferred debt issuance costs for the years ended December&#160;31, 2023, 2022, and 2021 of $1.1 million, $0.9 million, and $1.2 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Real Estate Loans and Construction Loan (Excluded Assets for the benefit of APC and its subsidiaries)</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate - East West Bank</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, APC&#8217;s Excluded Assets entered into three real estate loans with East West Bank. As of December 31, 2022, the principal on each loan was $5.9 million, $0.6 million, and $0.6 million, respectively, and had a variable interest rate of 0.50%, 0.50%, and 0.30% less than the independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate&#8221;, respectively. The maturity date of each loan was August 5, 2030. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate - MUFG Union Bank N.A.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, a subsidiary of APC, which was included in Excluded Assets, entered into a loan agreement with MUFG Union Bank N.A. with a maturity date of March&#160;1, 2032. The variable interest rate was 2.0% in excess of Daily Simple SOFR (as defined in the loan agreement). As of December 31, 2022 the principal on the loan was $16.0 million. On December 14, 2023, APC paid off the outstanding loan balance of $15.6 million.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Construction Loan</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, an entity included in Excluded Assets entered into a construction loan agreement with MUFG Union Bank N.A. (&#8220;Construction Loan&#8221;). The Construction Loan had a borrowing capacity of $10.7&#160;million with a maturity date of March&#160;1, 2024 or, upon completion of the construction and certain other requirements defined in the loan agreement, March&#160;1, 2034. The loan balance as of December 31, 2022 was $4.2 million. On December 14, 2023, APC paid off the outstanding loan balance of $8.5 million.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Real Estate Loans and the Construction Loan are deemed Excluded Assets and were spun-off on December 26, 2023 as part of the Spin-Off. Refer to Note 10 &#8211; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our consolidated financial statements under Item 8 in this Annual Report on Form 10-K for additional information on the Real Estate Loans and the Construction Loan.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lines of Credit </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;10, 2019, APC amended its promissory note agreement with Preferred Bank (&#8220;APC Business Loan Agreement&#8221;), which is affiliated with one of the Company&#8217;s board members, to modify loan availability to $4.1 million. This decrease further limited the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and added as a permitted lien the security interest in all of its assets granted by APC in favor of AHM under a Security Agreement dated on or about September 11, 2019 securing APC&#8217;s obligations to AHM under, and as required pursuant to, that certain Management Services Agreement dated as of July 1, 1999, as amended.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Letters of Credit</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the Company established irrevocable standby letters of credit with Truist Bank for a total of $36.5 million for the benefit of CMS and certain health plans as of December&#160;31, 2023. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional one-year periods from the present, or any future expiration date.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain IPAs consolidated by the Company established irrevocable standby letters of credit with a financial institution for a total of $3.9 million for the benefit of certain health plans as of December&#160;31, 2023. The standby letters of credit are automatically extended without amendment for additional one-year periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_97"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;), which require management to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and to the reported amounts of revenues and expenses during the period. The Company bases its estimates on historical experience and on various other assumptions that the Company believes are reasonable under the circumstances. Changes in estimates are recorded if and when better information becomes available. Actual results could differ from those estimates under different assumptions and conditions. The Company believes that the accounting policies discussed below are those that are most important to the presentation of its financial condition and results of operations and that require its management&#8217;s most difficult, subjective, and complex judgments. Our significant accounting policies are described in Note 2 &#8211; &#8220;Basis of Presentation and Summary of Significant Accounting Policies&#8221; to our consolidated financial statements under Item 8 in this Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets as of December&#160;31, 2023 and 2022 and consolidated statements of income for the years ended December&#160;31, 2023, 2022 and 2021 include Astrana&#8217;s wholly owned subsidiaries and consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including constraints, completion factors and historical margins), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Receivables and Receivables &#8211; Related Parties</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivables are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation and claims receivables relate to each health plan&#8217;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s hospital shared-risk pool receivable that is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately 18 months after the risk pool performance year is completed. Other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivables consist of receivables from FFS reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables, and our expectation is that the historical credit loss experienced across our receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments include cash and cash equivalents, restricted cash, investment in marketable securities, receivables, loans receivable &#8211; related parties, accounts payable, certain accrued expenses, capital lease obligations, bank loan, line of credit &#8211; related party, and long-term debt. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amount of the loan receivables &#8211; related parties, net of current portion, bank loan, capital lease obligations line of credit - related party, and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality. The FASB&#8217;s Accounting Standards Codification 820, Fair Value Measurement (&#8220;ASC 820&#8221;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosures of the inputs to valuations used to measure fair value.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This hierarchy prioritizes the inputs into three broad levels as follows:</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#8217;s own data.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets and Long-Lived Assets</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives include network-payer relationships, management contracts, and member relationships and are stated at cost, less accumulated amortization and impairment losses. These intangible assets are amortized on the accelerated method using the discounted cash flow rate. Intangible assets with finite lives also include a patient management platform, as well as trade names and trademarks, whose valuations were determined using the cost to recreate method and the relief from royalty method, respectively. These assets are stated at cost, less accumulated amortization and impairment losses, and are amortized using the straight-line method.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangibles and long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If the expected future cash flows from the use of such assets (undiscounted and without interest charges) are less than the carrying value, a write-down would be recorded to reduce the carrying value of the asset to its estimated fair value. Fair value is determined based on appropriate valuation techniques.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> goodwill and indefinite-lived intangible assets are reviewed at least annually for impairment under a two step process. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Step 1&#8212;  Under a qualitative assessment, determine if there are indicators of impairment. If so, proceed to Step 2. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Step 2 &#8212; Under a quantitative assessment, if the fair value of each reporting unit is less than its carrying value, there is an impairment. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also elect to skip the qualitative testing and proceed directly to quantitative testing. The Company&#8217;s four reporting units consist of the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners &#8211; IPA;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners &#8211; ACO;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Delivery; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Enablement. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An impairment loss is recognized if the carrying value of a reporting unit exceeds its fair value. If this event arises, the impairment loss recorded is equal to the excess of the carrying value of the reporting unit over its fair value.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At least annually, indefinite-lived intangible assets are tested for impairment. Impairment for intangible assets with indefinite lives exists if the carrying value of the intangible asset exceeds its fair value. The fair values of indefinite-lived intangible assets are determined using valuation techniques based on estimates, judgments, and assumptions management believes are appropriate in the circumstances.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrual of Medical Liabilities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Partners segment is responsible for integrated care that the associated physicians and contracted hospitals provide to their enrollees. The Company&#8217;s Care Partners segment provides integrated care to HMOs, Medicare, and Medi-Cal enrollees through a network of contracted providers under sub-capitation and direct patient service arrangements. Medical costs for professional and institutional services rendered by contracted providers are recorded as cost of services, excluding depreciation and amortization, in the accompanying consolidated statements of income.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An estimate of amounts due to contracted physicians, hospitals, and other professional providers is included in medical liabilities in the accompanying consolidated balance sheets. Medical liabilities include claims reported as of the balance sheet date and estimated IBNR claims. Such estimates are developed using actuarial methods and are based on numerous variables, including the utilization of healthcare services, historical payment patterns, cost trends, product mix, seasonality, changes in membership, and other factors. The estimation methods and the resulting reserves are periodically reviewed and updated. Many of the medical contracts are complex in nature and may&#160;be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations may&#160;not come to light until a substantial period of time has passed following the contract implementation. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Pool Settlements and Incentives</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain IPAs enter into hospital shared-risk capitation arrangements with certain health plans and local hospitals, where the hospital is responsible for providing, arranging and paying for institutional risk and the IPA is responsible for providing, arranging, and paying for professional risk. Under a hospital shared-risk pool-sharing agreement, the IPA generally receives a percentage of the net surplus from the affiliated hospital&#8217;s risk pools with HMOs after deductions for the affiliated hospital&#8217;s costs. Advance settlement payments are typically made quarterly in arrears if there is a surplus. The Company&#8217;s risk pool settlements under arrangements with health plans and hospitals are recognized using the most likely amount methodology and amounts are only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The assumptions for historical margin, IBNR completion factors, and constraint percentages were used by management in applying the most likely amount methodology.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitated arrangements with certain HMOs, certain IPAs participate in one or more health plan shared-risk arrangements relating to the provision of institutional services to enrollees and thus can earn additional revenue or incur losses based upon the enrollee utilization of institutional services. Health plan shared-risk arrangements are entered into with certain health plans, which are administered by the health plan, where the IPA is responsible for rendering professional services, but the health plan does not enter into a capitation arrangement with a hospital and therefore the health plan retains the institutional risk. Health plan shared-risk deficits, if any, are not payable until and unless (and only to the extent) risk-sharing surpluses are generated. At the termination of the HMO contract, any accumulated deficit will be extinguished.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's risk pool settlements under arrangements with HMOs are recognized, using the most likely methodology, and only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur. Given the lack of access to the health plans&#8217; data and control over the members assigned to the IPA, the adjustments and/or the withheld amounts are unpredictable and as such the IPAs risk-share revenues are deemed to be fully constrained until they are notified of the amount by the health plan. Final settlement of risk pools for prior contract years generally occurs in the third or fourth quarter of the following year.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to risk-sharing revenues, the Company also receives incentives under &#8220;pay-for-performance&#8221; programs for quality medical care, based on various criteria. As an incentive to promote quality care, certain HMOs have designed quality incentive programs and commercial generic pharmacy incentive programs to compensate the Company for its efforts to improve the quality of services and efficient and effective use of pharmacy supplemental benefits provided to HMO members. The incentive programs track specific performance measures and calculate payments to the Company based on the performance measures. The Company&#8217;s incentives under &#8220;pay-for-performance&#8221; programs are recognized using the most likely methodology. However, as the Company does not have sufficient insight from the health plans on the amount and timing of the health plan shared-risk pool and incentive payments, these amounts are considered to be fully constrained and only recorded when such payments are known and/or received.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, for the foregoing arrangements, the final settlement is dependent on each distinct day&#8217;s performance within the annual measurement period, but cannot be allocated to specific days until the full measurement period has occurred and performance can be assessed. As such, this is a form of variable consideration estimated at contract inception and updated through the measurement period (i.e., the contract year), to the extent the risk of reversal does not exist and the consideration is not constrained.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a stock-based compensation program for employees, non-employees, directors, and consultants. From time to time, the Company issues shares of its common stock to its employees, directors, and consultants, which shares may be subject to the Company&#8217;s repurchase right (but not obligation), that vests based on time-based and/or performance-based vesting schedules. The value of share-based awards is recognized as compensation expense and adjusted for forfeitures as they occur. Compensation expenses for time-based awards are recognized on a cumulative straight-line basis over the vesting period of the awards. Share-based awards with performance conditions are recognized to the extent the performance conditions are probable of being achieved. Compensation expenses for performance-based awards are recognized on an accelerated attribution method. The grant date fair value of the restricted stock awards is the grant date&#8217;s closing market price of the Company&#8217;s common stock. The fair value of options granted is determined using the Black-Scholes option pricing model and include several assumptions, including expected term, expected volatility, expected dividends, and risk-free rates. The expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. The expected stock price volatility is determined based on an average of historical volatility. The expected dividend yield is based on the Company&#8217;s expected dividend payouts. The risk-free interest rate is based on the U.S. Constant Maturity curve over the expected term of the option at the time of grant.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at its inception. The expected term of the lease used for computing the lease liability and right-of-use asset and determining the classification of the lease as operating or financing may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company elected practical expedients for ongoing accounting that were provided by the new standard comprised of the following: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The election for classes of underlying assets to not separate non-lease components from lease components, and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The election for short-term lease recognition exemption for all leases with an under twelve-month terms.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The present value of the lease payments is calculated using a rate implicit in the lease, when readily determinable. However, as most of the Company&#8217;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to determine the present value of the lease payments for the majority of its leases.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Model</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company &#8211; that is, the Company has:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power to direct the activities of a VIE that most significantly influence the VIE&#8217;s economic performance (power), and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Other Entities - Equity Method</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for certain investments using the equity method of accounting when it is determined that the investment provides the Company with the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee&#8217;s board of directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize the Company&#8217;s share of net earnings or losses of the investee and is recognized in the accompanying consolidated statements of income under &#8220;Income (loss) from equity method investments&#8221; and also is adjusted by contributions to and distributions from the investee. During the year ended December&#160;31, 2023, the Company recognized no impairment loss. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-controlling Interests</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates entities in which the Company has a controlling financial interest. The Company consolidates subsidiaries in which the Company holds, directly or indirectly, more than 50% of the voting rights, and VIEs in which the Company is the primary beneficiary. Non-controlling interests represent third-party equity ownership interests (including equity ownership interests held by certain VIEs) in the Company&#8217;s consolidated entities. Net income attributable to non-controlling interests is disclosed in the consolidated statements of income.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mezzanine Equity</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to APC&#8217;s shareholder agreements, in the event of a disqualifying event, as defined in the agreements, APC could be required to repurchase its shares from the respective shareholders based on certain triggers outlined in the shareholder agreements. As the redemption feature of the shares is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as mezzanine or temporary equity. Accordingly, the Company recognizes non-controlling interests in APC as mezzanine equity in the consolidated financial statements. APC&#8217;s shares were not redeemable, and it was not probable that the shares would become redeemable as of December&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted both for items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in recognition of tax positions, and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the consolidated financial statements. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effect of New Accounting Standards</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Refer to &#8220;Recent Accounting Pronouncements Not Yet Adopted&#8221; under Note 2 &#8212; &#8220;Basis of Presentation and Summary of Significant Accounting Policies&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our consolidated financial statements under Item 8 in this Annual Report on Form 10-K for additional information.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_103"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;7A.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:12pt;padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings under the Term Loan provided for under our Amended Credit Agreement, as of December&#160;31, 2023, were $280.0 million. The Term Loan bears interest at an annual rate equal to either, at the Company&#8217;s option, (a) the Term SOFR Reference Rate (as defined in the Amended Credit Agreement), adjusted for any Term SOFR Adjustment (as defined in the Amended Credit Agreement ), plus a spread from 1.50% to 2.75%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio, or (b) a base rate, plus a spread of 0.50% to 1.75%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio. As of December&#160;31, 2023, there were no borrowings under the Revolver Loan. The Revolver Loan bears interest at an annual rate equal to either, at the Company&#8217;s option, (a) the Term SOFR Reference Rate (as defined in the Amended Credit Agreement ), adjusted for any Term SOFR Adjustment (as defined in the Amended Credit Agreement) plus a spread ranging from 1.25% to 2.50%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio (as defined in the Amended Credit Agreement), or (b) a base rate, plus a spread ranging from 0.25% to 1.50%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio. Borrowings under the Promissory Note Payable, as of December&#160;31, 2023, was $2.0 million. The interest rate is defined as the prime rate plus 1.0%. The prime rate is updated annually on the effective date of the note and published by the Wall Street Journal. The Company has entered into a collar agreement for its Revolver Loan to effectively convert its floating-rate debt to a fixed-rate basis. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. A hypothetical 1% change in our interest rates for our outstanding borrowings under our Credit Agreement would have increased or decreased our interest expense for the year ended December&#160;31, 2023, by $2.8 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.&#160;&#160;&#160;&#160;Financial Statements and Supplementary Data</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:90.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Index to the Consolidated Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_109">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (PCAOB ID No. <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-37">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_109">74</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_118">Consolidated Balance Sheets as of December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_118">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_118"> and 2022</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_118">77</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_121">Consolidated Statements of Income for the Years Ended December 31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_121">80</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_124">Consolidated Statements of Mezzanine and Stockholders&#8217; Equity </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_124">(Deficit) </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_124">for the Years Ended December 31, 2023, 2022, and 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_124">81</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_127">Consolidated Statements of Cash Flows for the Years Ended December 31, 2023, 2022, and 2021</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_127">83</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_133">Notes to the Consolidated Financial Statements</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib8ab676c07c14f5e97ea961ccac78e95_139">86</a></span></div></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of Astrana Health, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Astrana Health, Inc. (formerly known as Apollo Medical Holdings, Inc.) (the Company) as of December 31, 2023 and 2022, the related consolidated statements of income, mezzanine and stockholders' equity (deficit) and cash flows for each of the three years in the period ended December 31, 2023, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February 29, 2024 expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Critical Audit Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div><span><br/></span></div><div style="padding-left:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Risk Pool Settlements and Related Receivables</span></div><div style="padding-left:108pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As described in Note 2 of the consolidated financial statements, the Company enters into hospital shared-risk capitation arrangements with certain health plans and local hospitals, where the hospital is responsible for providing, arranging and paying for institutional risk and the Company is responsible for providing, arranging and paying for professional risk. Under a hospital shared-risk pool-sharing agreement, the Company generally receives a percentage of the net surplus from the affiliated hospitals&#8217; risk pools with health plans after deductions for the affiliated hospitals&#8217; costs. The Company recognizes risk pool settlements relating to such arrangements using the most likely amount methodology and amounts are only included in revenues to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The amount of such risk pool settlements recorded is calculated by the Company using historical margin, incurred but not reported (IBNR) completion factors and constraint percentages and various data and information provided by the affiliated hospitals.  <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing management&#8217;s estimate of the risk pool settlements and related receivables involved a high degree of subjectivity used by management and the nature of the significant assumptions, which include a margin factor based on historical trends and other available information. The Company relies on data provided by other parties in its estimation model. Additionally, judgment is used to develop the margin factor used to account for the expected performance of the risk pools for each settlement year and is derived based on an evaluation of historical data provided by the affiliated hospitals and communications between the Company and the affiliated hospitals.</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.286%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We <br/>Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of internal controls over the Company&#8217;s process for estimating risk pool settlements and related receivable amounts. For example, we tested controls over management&#8217;s review controls of the reasonableness of the data (including capitation revenue and related claims and other administrative expenses) underlying the risk pool calculations provided by the affiliated hospitals and management&#8217;s review controls analyzing the historical trends and appropriateness of the method used in determining the estimated risk pool surplus. We also reviewed relevant Service Organization Control (SOC) 1 reports to evaluate that such affiliated hospitals and administrator have effective controls over the completeness and accuracy of the data they process and provide to the Company. We also assessed and tested complementary user entity controls relevant to the SOC 1 reports.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the Company&#8217;s estimates of risk pool settlements and related receivables, our audit procedures included, among others, confirming the external data used in the calculations of risk pools directly with the affiliated hospitals, testing the receivables amount by comparing it to subsequent cash receipts, and testing the margin factor used by the Company in its estimate. In order to test the margin factor, we evaluated historical margin trends within the risk pools, and reviewed the Company&#8217;s own volumes and margins to identify any trends which may provide contrary evidence. Additionally, we assessed the precision of the Company&#8217;s prior year estimates by comparing the Company&#8217;s prior year estimates to the final settled amounts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="padding-left:108pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Valuation of Incurred but not Reported (IBNR) Claims Liability </span></div><div style="padding-left:108pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">At December 31, 2023, the Company&#8217;s medical liabilities totaled $106.7 million. As described in Note 2 of the consolidated financial statements, medical liabilities include reserves for incurred but not reported claims. The IBNR liability is an estimate that management developed using actuarial methods and is based on numerous variables, including the utilization of healthcare services, historical payment patterns, cost trends, product mix, seasonality, changes in membership, and other factors. <br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing management&#8217;s estimate of the IBNR claims liability involved a high degree of subjectivity due to the complexity of the models used by management and the nature of the significant assumptions used in the estimation of the liability. These assumptions have a significant effect on the valuation of the IBNR liability.<br/></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of the Company&#8217;s internal controls over the process for estimating the IBNR claims liability. For example, we tested controls over management&#8217;s review controls of the completion factor and per member per month trend factor assumptions, and management&#8217;s review controls of the actuarial methods used to calculate the IBNR claims liability, including the completeness and accuracy of data inputs and outputs of those models. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the Company&#8217;s estimate of the IBNR claims liability, our audit procedures included, among others, testing the completeness and accuracy of data used in the Company&#8217;s models by testing reconciliations of underlying claims and membership data recorded in source systems to the actuarial reserve models, and comparing claims to source documentation. We involved our actuarial specialists to assist with the testing due to the highly judgmental nature of assumptions used in the valuation process, including completion factors and per member per month trend factors. With the assistance of our actuarial specialists, we used the Company&#8217;s underlying claims and membership data to develop an independent range of IBNR estimates and compared management&#8217;s recorded IBNR claims liability to our range. Additionally, we performed a hindsight review of prior period estimates by comparing to subsequent claims development, and we evaluated the Company&#8217;s disclosures surrounding IBNR claims liability in the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:55.561%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-38">Ernst &amp; Young LLP</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We have served as the Company&#8217;s auditor since 2020.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-39">Los Angeles, California</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> February&#160;29, 2024</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;CONSOLIDATED BALANCE SHEETS</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-40">293,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-41">288,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-42">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-43">5,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-44">76,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-45">49,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net &#8211; related parties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">58,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">65,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-48">10,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:fixed-zero" scale="3" id="f-49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">1,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">1,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">17,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">14,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:fixed-zero" scale="3" id="f-54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="f-55">996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable &#8211; related party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:fixed-zero" scale="3" id="f-56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">2,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">461,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-59">428,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-60">7,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-61">108,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-62">71,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-63">76,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-64">278,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-65">269,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">15,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">15,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">26,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" format="ixt:fixed-zero" scale="3" id="f-69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other entities &#8211; equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-70">25,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-71">40,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in privately held entities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-72">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" format="ixt:num-dot-decimal" scale="3" id="f-73">2,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-74">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="3" id="f-75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-76">37,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-77">20,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-78">1,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-79">4,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-80">471,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">538,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-82">933,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-83">966,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED BALANCE SHEETS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Continued)</span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands, except share data)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities, Mezzanine Equity (Deficit), and Stockholders&#8217; Equity</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">59,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">49,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="asth:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-86">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="asth:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-87">8,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-88">106,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-89">81,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:fixed-zero" scale="3" id="f-90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-91">4,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DividendsPayableCurrent" scale="3" id="f-92">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DividendsPayableCurrent" scale="3" id="f-93">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-94">646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-95">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-96">4,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-97">3,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-98">19,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="f-99">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-100">18,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:fixed-zero" scale="3" id="f-101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-102">218,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-103">148,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-104">4,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-105">14,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-106">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-107">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-108">36,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-109">19,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion and deferred financing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-110">258,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-111">203,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-112">3,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-113">20,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-114">303,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-115">259,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-116">522,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-117">407,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Note 14)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-118"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-119"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mezzanine (deficit) equity </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (&#8220;APC&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="asth:TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-120">205,883</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="asth:TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-121">14,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-122"><ix:nonFraction unitRef="usdPerShare" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-123">0.001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-124"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-125">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized (inclusive of Series B Preferred stock); <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-126"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-127">1,111,111</ix:nonFraction></ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="c-11" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-128"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-129">zero</ix:nonFraction></ix:nonFraction> outstanding</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-131">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-132"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-133">0.001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-134"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-135">5,000,000</ix:nonFraction></ix:nonFraction> shares authorized (inclusive of Series A Preferred stock); <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-136"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-137">555,555</ix:nonFraction></ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-138"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-139">zero</ix:nonFraction></ix:nonFraction> outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-140">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-141">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-142"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-143">0.001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-144"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-145">100,000,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-146">46,843,743</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-147">46,575,699</ix:nonFraction> shares outstanding, excluding <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-148">10,584,340</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-149">10,299,259</ix:nonFraction> treasury shares, at December&#160;31, 2023 and 2022, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-150">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-151">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-152">371,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-153">360,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-154">243,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-155">182,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-156">614,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-157">542,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-158">2,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-159">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-160">616,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-161">544,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities, mezzanine equity (deficit), and stockholders&#8217; equity</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-162">933,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-163">966,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote">The Company&#8217;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-164">540.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-165">579.8</ix:nonFraction>&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-166">146.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-167">149.6</ix:nonFraction>&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively. These VIE balances do not include $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-168">273.2</ix:nonFraction>&#160;million of investment in affiliates and $<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-169">107.3</ix:nonFraction>&#160;million of amounts due to affiliates as of December&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="f-170">304.8</ix:nonFraction>&#160;million of investment in affiliates and $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="f-171">11.6</ix:nonFraction>&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; for further detail.</ix:footnote></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</span></div></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENTS OF INCOME</span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-172">1,215,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-173">930,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-174">593,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk pool settlements and incentives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-175">63,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-176">117,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-177">111,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-178">38,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-179">41,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-180">35,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-181">59,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-182">49,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-183">26,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-184">9,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-185">6,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-186">6,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-187">1,386,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-188">1,144,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-189">773,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services, excluding depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-190">1,171,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-191">944,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-192">596,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-193">112,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-194">77,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-195">62,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-196">17,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-197">17,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-198">17,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-199">1,302,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-200">1,039,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-201">675,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-202">84,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">104,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-204">98,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from equity method investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-205">5,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-206">5,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-207">4,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="f-208">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="f-209">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="3" id="f-210">2,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-211">16,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-212">7,920</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-213">5,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-214">14,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-215">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-216">1,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-217">4,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-218">21,271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-219">10,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-220">6,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-221">3,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-222">3,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-223">5,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-224">17,649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-225">20,431</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-226">89,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-227">86,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-228">77,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-229">31,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-230">40,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-231">31,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-232">57,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-233">45,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-234">46,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-235">2,868</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-236">570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-237">22,868</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Astrana Health, Inc.</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-238">60,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-239">45,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-240">68,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share &#8211; basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-241">1.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-242"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-243">1.00</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-32" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-244">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-245">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-246"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-247">0.99</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-32" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-248">1.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.617%"/><td style="width:0.1%"/></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</span></div></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands, except share data)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity (Deficit)&#160;&#8211;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest&#160;in&#160;APC</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional<br/>Paid-in&#160;Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common&#160;Stock&#160;Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-249">113,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-250">42,249,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-251">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-252">261,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-253">68,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-254">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-255">329,463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" sign="-" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-256">25,635</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-257">68,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-258">2,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-259">71,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="f-260">1,546</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-261">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-262">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="f-263">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of shares by non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="asth:StockIssuedDuringPeriodSharesNoncontrollingInterest" format="ixt:num-dot-decimal" scale="0" id="f-264">1,638,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="asth:StockIssuedDuringPeriodValueNoncontrollingInterest" scale="3" id="f-265">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="asth:StockIssuedDuringPeriodValueNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-266">40,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:StockIssuedDuringPeriodValueNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-267">40,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-268">29,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for exercise of options and warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="asth:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-269">898,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" scale="3" id="f-270">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-271">9,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-272">9,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-273">174,158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-274">5,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-275">5,738</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-276">6,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-277">6,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" format="ixt:num-dot-decimal" scale="3" id="f-278">3,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" format="ixt:num-dot-decimal" scale="3" id="f-279">3,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="3" id="f-280">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="3" id="f-281">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" format="ixt:num-dot-decimal" scale="0" id="f-282">10,707</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="f-283">334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="f-284">334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interest capital change</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="asth:NoncontrollingInterestIncreaseFromCapitalCharge" scale="3" id="f-285">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:NoncontrollingInterestIncreaseFromCapitalCharge" scale="3" id="f-286">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-287">30,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" sign="-" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-288">1,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-289">1,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-290">56,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-45" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-291">44,630,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-292">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-293">310,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-294">137,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-295">5,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-296">454,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-297">3,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-298">45,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-299">3,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-300">48,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="f-301">4,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="f-302">4,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span id="i0318391050a74c42b0cbee4f04eeba1e_22-7-1-1-245372"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="f-303">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="f-304">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buy back</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="f-305">708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-306">342,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-307">321</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-308">321</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for cash and exercise of options and warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="asth:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-309">860,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" scale="3" id="f-310">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-311">8,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-312">8,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-313">250,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-314">9,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-315">9,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-316">16,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-317">16,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.614%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.617%"/><td style="width:0.1%"/></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</span></div></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div></td></tr><tr><td colspan="42" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands, except share data)</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity (Deficit)&#160;&#8211;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest&#160;in&#160;APC</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional<br/>Paid-in&#160;Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common&#160;Stock&#160;Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares for business acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-318">18,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-319">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-320">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="f-321">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="f-322">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" format="ixt:num-dot-decimal" scale="0" id="f-323">11,084</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="f-324">457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" scale="3" id="f-325">457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact of acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="asth:TemporaryEquityTaxImpactOnAcquisition" scale="3" id="f-326">448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAMG stock contingent consideration (see Note 21)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="asth:AAMGEquityContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="f-327">5,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:AAMGEquityContingentConsideration" format="ixt:num-dot-decimal" scale="3" id="f-328">5,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-329">37,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="0" id="f-330">984,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" scale="3" id="f-331">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-332">27,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-333">4,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-334">23,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-335">14,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-56" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-336">46,575,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-337">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-338">360,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-339">182,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-340">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-341">544,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="f-342">7,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-343">60,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-344">4,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-345">65,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-346">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-347">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of non-controlling interest </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="f-348">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="f-349">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-350">390,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-351">933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="3" id="f-352">933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued for cash and exercise of options and warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="INF" name="asth:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-353">140,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-354">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" format="ixt:num-dot-decimal" scale="3" id="f-355">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="3" id="f-356">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-63" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-357">285,081</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-358">10,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" format="ixt:num-dot-decimal" scale="3" id="f-359">10,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-360">22,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-361">22,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of shares for business acquisition </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-63" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="f-362">22,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="f-363">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="f-364">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-365">210,873</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" sign="-" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-366">3,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" format="ixt:num-dot-decimal" scale="3" id="f-367">3,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer of common control entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="asth:TemporaryEquityTransferOfCommonControlEntities" format="ixt:num-dot-decimal" scale="3" id="f-368">1,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="asth:StockholdersEquityTransferOfCommonControlEntities" format="ixt:num-dot-decimal" scale="3" id="f-369">2,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:StockholdersEquityTransferOfCommonControlEntities" format="ixt:num-dot-decimal" scale="3" id="f-370">2,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact from dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="asth:TaxImpactFromDividends" format="ixt:num-dot-decimal" scale="3" id="f-371">3,076</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact from investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="asth:TaxImpactFromInvestments" scale="3" id="f-372">361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" sign="-" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-373">205,883</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-66" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-374">46,843,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-375">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-376">371,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-377">243,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-378">2,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-379">616,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</span></div></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-380">57,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-381">45,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-382">46,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-383">17,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-384">17,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-385">17,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-386">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-387">939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-388">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-389">22,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-390">16,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-391">6,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-392">7,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-393">3,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-394">3,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) loss from equity method investments, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-395">5,579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-396">5,622</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-397">4,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="asth:UnrealizedGainLossFromInvestmentInEquitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-398">4,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="asth:UnrealizedGainLossFromInvestmentInEquitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-399">25,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="asth:UnrealizedGainLossFromInvestmentInEquitySecurities" format="ixt:num-dot-decimal" scale="3" id="f-400">10,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (gain) loss on interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="f-401">201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-402">4,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="f-403">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale or distribution of investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="3" id="f-404">1,246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:GainOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="3" id="f-405">2,272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:GainOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="3" id="f-406">2,193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-407">12,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-408">14,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="f-409">7,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on consolidation of equity method investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:GainLossOnConsolidationOfEquityMethodInvestment" format="ixt:fixed-zero" scale="3" id="f-410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="asth:GainLossOnConsolidationOfEquityMethodInvestment" scale="3" id="f-411">901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:GainLossOnConsolidationOfEquityMethodInvestment" format="ixt:num-dot-decimal" scale="3" id="f-412">2,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on contingent equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:GainLossOnEquityReceivable" format="ixt:fixed-zero" scale="3" id="f-413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:GainLossOnEquityReceivable" format="ixt:fixed-zero" scale="3" id="f-414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:GainLossOnEquityReceivable" format="ixt:num-dot-decimal" scale="3" id="f-415">4,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain from investment in warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:fixed-zero" scale="3" id="f-416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:fixed-zero" scale="3" id="f-417">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-418">1,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of beneficial interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherAssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OtherAssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:OtherAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="f-421">15,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromOtherOperatingActivities" scale="3" id="f-422">422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProceedsFromOtherOperatingActivities" format="ixt:fixed-zero" scale="3" id="f-423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromOtherOperatingActivities" scale="3" id="f-424">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of acquisition amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-425">26,735</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-426">38,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-427">1,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable, net &#8211; related parties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-428">6,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-429">4,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-430">20,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" id="f-431">311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-432">8,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-433">5,351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-434">2,956</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" scale="3" id="f-435">818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-436">2,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-437">2,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="f-438">243</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-439">1,529</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="f-440">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="f-441">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-442">3,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" scale="3" id="f-443">328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-444">2,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" scale="3" id="f-445">892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:IncreaseDecreaseInMedicalLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-446">18,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:IncreaseDecreaseInMedicalLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-447">22,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:IncreaseDecreaseInMedicalLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-448">5,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable/receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="f-449">14,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="f-450">6,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="f-451">14,005</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-452">6,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-453">3,945</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-454">3,215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-455">68,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-456">82,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-457">70,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for business and asset acquisition, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="f-458">6,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="f-459">16,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="f-460">2,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from repayment of loans receivable - related parties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-461">2,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-462">4,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties" scale="3" id="f-463">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-464">2,151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-465">1,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-466">28,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="f-467">491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-468">31,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="f-469">67,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of loans receivable </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="3" id="f-470">26,473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:fixed-zero" scale="3" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:fixed-zero" scale="3" id="f-472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments &#8211;privately held</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-473">4,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" format="ixt:fixed-zero" scale="3" id="f-474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment" format="ixt:fixed-zero" scale="3" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-476">28,529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-477">22,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-478">19,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments &#8211; equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="f-479">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-481">13,622</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of equity method investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromSaleOfEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-484">6,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution from investment - equity method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:fixed-zero" scale="3" id="f-485">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="f-486">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:fixed-zero" scale="3" id="f-487">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</span></div></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution to investment - equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:PaymentsToEquityMethodInvestments" scale="3" id="f-488">700</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:PaymentsToEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-489">2,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:PaymentsToEquityMethodInvestments" format="ixt:fixed-zero" scale="0" id="f-490">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash recorded from consolidation of VIE</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" format="ixt:fixed-zero" scale="3" id="f-491">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" format="ixt:fixed-zero" scale="3" id="f-492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" format="ixt:num-dot-decimal" scale="3" id="f-493">5,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-494">65,523</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-495">7,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-496">16,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-497">62,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-498">14,030</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-499">31,089</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments on long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-500">204,681</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RepaymentsOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-501">3,865</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:RepaymentsOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-502">238,326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings on long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-503">284,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-504">3,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-505">180,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of finance lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="f-506">675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="f-507">561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" scale="3" id="f-508">208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options and warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-509">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-510">8,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-511">9,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-512">10,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-513">9,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-514">5,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-515">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-517">40,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="3" id="f-518">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsOfDividendsMinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-519">5,046</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsOfDividendsMinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-520">1,471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of noncontrolling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="f-521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" scale="3" id="f-522">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" scale="3" id="f-523">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of debt issuances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-524">3,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-525">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentOfFinancingAndStockIssuanceCosts" scale="3" id="f-526">727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of contingent consideration liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-527">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-528">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-529">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-530">3,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-531">20,085</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-532">47,748</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-533">6,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-534">54,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-535">39,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents, and restricted cash, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-536">288,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-537">233,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-538">193,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-539">294,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-540">288,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-541">233,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-542">56,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-543">47,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-544">37,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-545">14,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-546">6,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-547">4,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosures of non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-548">25,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact from APC dividends to APC Shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:TemporaryEquityDividendsImpact" format="ixt:num-dot-decimal" scale="3" id="f-551">3,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:TemporaryEquityDividendsImpact" format="ixt:fixed-zero" scale="3" id="f-552">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:TemporaryEquityDividendsImpact" format="ixt:fixed-zero" scale="3" id="f-553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of real estate investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForProceedsFromRealEstatePartnershipInvestmentNet" format="ixt:num-dot-decimal" scale="3" id="f-554">152,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsForProceedsFromRealEstatePartnershipInvestmentNet" format="ixt:fixed-zero" scale="3" id="f-555">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:PaymentsForProceedsFromRealEstatePartnershipInvestmentNet" format="ixt:fixed-zero" scale="3" id="f-556">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend declared included in dividend payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="f-557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="f-558">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="3" id="f-559">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of financing obligation for business combinations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:IssuanceOfFinancingObligationForBusinessCombination" format="ixt:fixed-zero" scale="3" id="f-560">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:IssuanceOfFinancingObligationForBusinessCombination" format="ixt:fixed-zero" scale="3" id="f-561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:IssuanceOfFinancingObligationForBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="f-562">12,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cashless exercise of warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:CashlessExerciseOfStockOptions" format="ixt:fixed-zero" scale="3" id="f-563">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:CashlessExerciseOfStockOptions" scale="3" id="f-564">694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:CashlessExerciseOfStockOptions" format="ixt:fixed-zero" scale="3" id="f-565">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed asset obtained in exchange for finance lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" scale="3" id="f-566">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" scale="3" id="f-567">971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="f-568">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued in business combination</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssued1" scale="3" id="f-569">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="3" id="f-570">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssued1" format="ixt:fixed-zero" scale="3" id="f-571">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:fixed-zero" scale="3" id="f-572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:num-dot-decimal" scale="3" id="f-573">16,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:fixed-zero" scale="3" id="f-574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation of Restricted Stock Awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:CancellationOfRestrictedStockAwards" format="ixt:fixed-zero" scale="3" id="f-575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:CancellationOfRestrictedStockAwards" format="ixt:fixed-zero" scale="3" id="f-576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:CancellationOfRestrictedStockAwards" scale="3" id="f-577">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total amounts of cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows (in thousands).</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:58.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.072%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-578">293,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-579">288,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-580">233,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashEquivalentsNoncurrent" scale="3" id="f-581">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RestrictedCashEquivalentsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-582">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:RestrictedCashEquivalentsNoncurrent" format="ixt:fixed-zero" scale="3" id="f-583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-584">294,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-585">288,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-586">233,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_139"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:NatureOfOperations" id="f-587" continuedAt="f-587-1" escape="true">Description of Business</ix:nonNumeric></span></div><ix:continuation id="f-587-1" continuedAt="f-587-2"><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2024, Apollo Medical Holdings, Inc. rebranded as Astrana Health, Inc (&#8220;Astrana&#8221;). Unless the context dictates otherwise, references in these notes to the financial statements, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar words are references to Astrana and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headquartered in Alhambra, California, Astrana is a leading provider-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. Together with Astrana&#8217;s affiliated physician groups and consolidated subsidiaries and VIEs, the Company provides value-based care enablement services and care delivery with its consolidated care partners to serve patients in California, Nevada, and Texas, the majority of whom are covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (&#8220;HMOs&#8221;), with a small portion of our revenue coming from non-insured patients. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company&#8217;s physician network consists of primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments changed from <ix:nonFraction unitRef="segment" contextRef="c-31" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-588">one</ix:nonFraction> to <ix:nonFraction unitRef="segment" contextRef="c-70" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-589">three</ix:nonFraction> in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#8217;s chief operating decision maker when reviewing the Company&#8217;s performance as well as an effort to provide additional transparency to investors and other financial statement users. The <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-590">three</ix:nonFraction> segments identified by the Company are Care Partners, Care Delivery and Care Enablement, which are described as follows:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Partners</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners aligned on a shared vision for coordinated care delivery. By leveraging the Company&#8217;s unique care enablement platform and ability to recruit, empower, and incentivize physicians to effectively manage total cost of care, the Company is able to organize partnered providers into successful multi-payer risk-bearing organizations that take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare fee for service (&#8220;FFS&#8221;), Medicare Advantage, Medicaid, Commercial, and Exchange. Through the Company&#8217;s network of &#8220;independent practice associations&#8221; (&#8220;IPAs&#8221;), &#8220;accountable care organizations&#8221; (&#8220;ACOs&#8221;), and Restricted Knox-Keene licensed health plan, the Company&#8217;s healthcare delivery entities are responsible for coordinating and delivering high-quality care to the Company&#8217;s patients and ensuring continuity of care in Astrana&#8217;s ecosystem across age, stage of life, or life circumstance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the Company&#8217;s Accountable Care Organizations (&#8220;ACO&#8221;) began participating in the Next Generation Accountable Care Organization (&#8220;NGACO&#8221;) Model of CMS in January 2017. The NGACO Model was a Center for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) program that allowed provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participating in this new attribution-based risk-sharing model. With the termination of the NGACO Model on December 31, 2021, the Company&#8217;s ACO participated as a Direct Contracting Entity (&#8220;DCE&#8221;) in the standard track of CMS&#8217;s Global and Professional Direct Contracting (&#8220;GPDC&#8221;) Model for Performance Year 2022 (&#8220;PY22&#8221;), beginning January 1, 2022. CMS has since redesigned the GPDC Model in response to the current Administration&#8217;s health care priorities, including their commitment to advancing health equity, stakeholder feedback, and participant experience, and renamed the GPDC Model to ACO Realizing Equity, Access, and Community Health (&#8220;ACO REACH&#8221;) Model. The Company began participation in the ACO REACH Model on January 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Delivery</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. The Company&#8217;s care delivery organization includes primary care, multi-specialty care, and ancillary care services. This segment includes the following:</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-587-2" continuedAt="f-587-3"><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Primary care clinics, including post-acute care services; </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Multi-specialty care clinics and medical groups, including hospitalist, intensivist, and physician advisory services, cardiac care and diagnostic testing, and specialized care for women&#8217;s health; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ancillary service providers, such as urgent care centers, outpatient imaging centers, ambulatory surgery centers, and full-service labs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Enablement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Enablement segment is an integrated, end-to-end clinical, operational, financial, and administrative platform, powered by the Company&#8217;s proprietary technology suite, that enhances delivery of high-quality, value-based care to patients and leading to superior clinical and financial outcomes. The Company provides solutions to providers, including independent physicians, provider and medical groups, accountable care organizations, and payers, including health plans and other risk-bearing organizations. The Company&#8217;s platform meets providers and payers where they are, with a wide spectrum of solutions across the total cost of care risk spectrum, ranging from solutions for fee-for-service entities to full risk-bearing entities, and across patient types, including Medicare, Medicaid, Commercial, and Exchange patients. This segment includes the Company&#8217;s wholly owned subsidiaries which operate as management services organizations (&#8220;MSOs&#8221;), which enter into long-term management and/or administrative services agreements with Independent Practice Associations (&#8220;IPAs&#8221;), ACOs, or clinics. By leveraging the Company&#8217;s care enablement platform, providers and payers can improve their ability to deliver high-quality care to their patients and achieve better patient outcomes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Affiliates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other affiliates are not included as a reportable segment and primarily consist of the real estate operations and other entities that are individually immaterial. The real estate operations are deemed Excluded Assets that are solely for the benefit of Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (&#8220;APC&#8221;) and its shareholders. Excluded Assets means (i) assets received from the sale of shares of APC&#8217;s Series A Preferred equal to the Series A purchase price, (ii) the assets of APC that are not Healthcare Services Assets (as defined in the Series A Preferred purchase agreement), including APC&#8217;s equity interests in Astrana Health, Inc., and any entity that is primarily engaged in the business of owning, leasing, developing, or otherwise operating real estate, (iii) any assets acquired with the proceeds of the sale, assignment, or other disposition of any of the assets described in clauses (i) or (ii), and (iv) any proceeds of the assets described in clauses (i), (ii), and (iii). As such, any income pertaining to Excluded Assets have no impact on the Series A Preferred dividend payable by APC to Astrana Health Medical Corporation (&#8220;Astrana Medical&#8221;), formerly known as AP-AMH Medical Corporation, and consequently will not affect net income attributable to Astrana. APC and Astrana Medical are consolidated variable interest entities of the Company. See Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; to the consolidated financial statements for information on the Company&#8217;s entities that qualify as consolidated VIEs. </span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-587-3">On December 26, 2023, APC completed a restructuring transaction to spin-off its real estate investments, a component of Excluded Assets (&#8220;the Spin-Off&#8221;). To effect the restructuring, APC contributed its real estate investments to a wholly owned subsidiary in exchange for <ix:nonFraction unitRef="number" contextRef="c-71" decimals="INF" name="asth:RestructuringSpinoffTransactionPercentage" scale="-2" id="f-591">100</ix:nonFraction>% of the subsidiary&#8217;s membership interest units, which membership interests were then distributed to holders of APC&#8217;s outstanding common stock as a dividend, with each such stockholder receiving <ix:nonFraction unitRef="unit" contextRef="c-71" decimals="INF" name="asth:RestructuringSpinoffTransactionNumberOfMembershipUnits" format="ixt-sec:numwordsen" scale="0" id="f-592">one</ix:nonFraction> membership interest unit for each share of outstanding APC common stock held. Dr. Thomas Lam, the Company&#8217;s Vice Chairman, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder of APC; Dr. Kenneth Sim, the Company&#8217;s Executive Chairman, is Chairman and a director and stockholder of APC; and Dr. Albert Young, the Company&#8217;s Chief Administrative Officer, is Senor Executive Vice President and a director and stockholder of APC. The Company leases certain properties that were spun-off and will continue to lease from these properties. After the distribution, the real estate investments became related parties since the chief executive officer of the real estate investments is also a board member of the Company. See Note 15 &#8211; &#8220;Related-Party Transactions&#8221; to the consolidated financial statements for information on related party transactions. The dividend was $<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-5" name="asth:RestructuringSpinoffTransactionDividendRealEstateOperations" format="ixt:num-dot-decimal" scale="6" id="f-593">190.3</ix:nonFraction>&#160;million and recorded at fair value of the investments&#8217; net assets on the date of distribution, December 26, 2023. The fair value of the dividend was measured using Level 3 inputs by applying market data of similar real estate comparables. The gain, representing the difference between the fair value and the carrying value of the net assets, was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FairValueNetAssetLiability" format="ixt:num-dot-decimal" scale="6" id="f-594">5.3</ix:nonFraction>&#160;million and is presented within other income in the accompanying consolidated statement of income. As a result of the distribution, the real estate investments are no longer included within the consolidated financial statements after December 26, 2023.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_145"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="f-595" continuedAt="f-595-1" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-595-1" continuedAt="f-595-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-596" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared by management in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-597" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets as of December&#160;31, 2023 and 2022 and consolidated statements of income for the years ended December&#160;31, 2023, 2022 and 2021 include Astrana&#8217;s wholly owned subsidiaries and consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="f-598" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts disclosed in prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications were made between other assets and investments in privately held entities on the accompanying consolidated balance sheet as of December 31, 2022. The reclassification had no effect on net income, earnings per share, retained earnings, cash flows or total assets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-599" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combinations and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including constraints, completion factors, and historical margins), income tax valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="f-600" continuedAt="f-600-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#8217;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#8217;s net assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A legal entity is determined to be a VIE if it has any of the following three characteristics:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity does not have sufficient equity to finance its activities without additional subordinated financial support;</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-595-2" continuedAt="f-595-3"><ix:continuation id="f-600-1"><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:</span></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#8217;s economic performance, as evidenced by:</span></div><div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Substantive participating rights in day-to-day management of the entity&#8217;s activities; or</span></div><div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Substantive kick-out rights over the party responsible for significant decisions;</span></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb the entity&#8217;s expected losses; or</span></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The right to receive the entity&#8217;s expected residual returns.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company determines that any of the three characteristics of a VIE are met, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable interest model</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company &#8211; that is, the Company has:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power to direct the activities of a VIE that most significantly influence the VIE&#8217;s economic performance (power), and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; to the consolidated financial statements for information on the Company&#8217;s consolidated VIEs. If there are variable interests in a VIE but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting, refer to Note 6 &#8211; &#8220;Investments in Other Entities&#8221; for entities that qualify as VIEs but the Company is not the primary beneficiary.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationsPolicy" id="f-601" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-602" continuedAt="f-602-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-603"><ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-604">three</ix:nonFraction></ix:nonFraction> reportable segments: </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-595-3" continuedAt="f-595-4"><ix:continuation id="f-602-1"><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Delivery; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Enablement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 1 &#8212; &#8220;Description of Business&#8221; and Note 20 &#8212; &#8220;Segments&#8221; to the consolidated financial statements for information on the Company&#8217;s segments.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-605" continuedAt="f-605-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-605-1">The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company believes it is not exposed to any significant credit risk with respect to its cash, cash equivalents, and restricted cash.</ix:continuation> As of December&#160;31, 2023 and 2022, the Company&#8217;s deposit accounts with banks exceeded the FDIC&#8217;s insured limit by approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashUninsuredAmount" format="ixt:num-dot-decimal" scale="6" id="f-606">318.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashUninsuredAmount" format="ixt:num-dot-decimal" scale="6" id="f-607">324.7</ix:nonFraction> million, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#8217;s concentration of risk exposure.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-608" continuedAt="f-608-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-608-1">Restricted cash consists of cash held as collateral in the event of default as required by certain health plan contracts</ix:continuation>.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesPolicy" id="f-609" continuedAt="f-609-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase and such designation is reevaluated at each balance sheet date. Certificates of deposit in investments in marketable securities are reported at par value, plus accrued interest, with maturity dates greater than <ix:nonNumeric contextRef="c-72" name="asth:MarketableSecuritiesCurrentMaturityPeriod" format="ixt-sec:durwordsen" id="f-610">ninety days</ix:nonNumeric>. Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, the Company classifies such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted-average share prices from observable market data.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="asth:ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock" id="f-611" continuedAt="f-611-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables, Receivables &#8211; Related Parties, Other Receivables, Loan Receivable, and Loan Receivable - Related Party</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivables are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s loan receivable and loan receivable - related party consists of promissory notes that accrue interest per annum. As of December&#160;31, 2023, promissory notes are expected to be collected by their maturity date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation receivables relate to each health plan&#8217;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s hospital shared-risk pool receivable that is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately <ix:nonNumeric contextRef="c-1" name="asth:RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" format="ixt-sec:durmonth" id="f-612">18</ix:nonNumeric> months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#8220;FFS&#8221;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-595-4" continuedAt="f-595-5"><ix:continuation id="f-611-1" continuedAt="f-611-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-611-2">Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables, and the Company&#8217;s expectation is that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-613" continuedAt="f-613-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-613-1">The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts.</ix:continuation> The consolidated statements of income present disaggregated revenue by service type. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-614" continuedAt="f-614-1" escape="true">The following table presents disaggregated revenue generated by each payer type (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-614-1"><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.144%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-615">167,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-616">171,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-617">138,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-618">901,322</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-619">633,463</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-620">307,286</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-621">266,093</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-622">280,083</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-623">283,311</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third parties</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-624">52,198</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-625">58,894</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-626">44,985</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-627">1,386,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-628">1,144,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-629">773,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="f-630" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-85" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-631">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-86" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-632">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-87" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-633">34.2</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-88" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-634">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-635">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-90" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-636">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Less than 10% of total net revenues</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payers that contributed to the following percentages of net receivables and receivables - related parties:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.826%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.778%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-91" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-637">36.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-92" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-638">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer E</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-639">41.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-94" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-640">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-641" continuedAt="f-641-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Land, Property, and Equipment, Net</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land is carried at cost and is not depreciated as it is considered to have an indefinite useful life.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-595-5" continuedAt="f-595-6"><ix:continuation id="f-641-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, including leasehold improvements, are carried at cost less accumulated depreciation and amortization. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets ranging from <span style="-sec-ix-hidden:f-642">three</span> to <ix:nonNumeric contextRef="c-96" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-643">thirty-nine years</ix:nonNumeric>. Leasehold improvements are amortized on a straight-line basis over the shorter of the terms of the respective leases or the expected useful lives of those improvements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maintenance and repairs are charged to expense as incurred. Upon sale or retirement, the asset cost and related accumulated depreciation and amortization are removed from the accounts, and any related gain or loss is included in the determination of consolidated net income.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-644" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, long-term debt, and certain other liabilities. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 820&#8221;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This hierarchy prioritizes the inputs into three broad levels as follows:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#8217;s own data.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for these assets and liabilities for the years ended December&#160;31, 2023 and 2022.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-645" continuedAt="f-645-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Long-Lived Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives include network-payer relationships, management contracts, member relationships, subscriber relationships, and developed technology and are stated at cost, less accumulated amortization, and impairment losses. These intangible assets are amortized using the accelerated method based on the discounted cash flow rate or using the straight-line method.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives also include a patient management platform, as well as trade names and trademarks, whose valuations were determined using the cost to recreate method and the relief from royalty method, respectively. These assets are stated at cost, less accumulated amortization, and impairment losses, and are amortized using the straight-line method.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-645-1">Finite-lived intangibles and other long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may&#160;not be recoverable. If the expected future cash flows from the use of such assets (undiscounted and without interest charges) are less than the carrying value, a write-down would be recorded to reduce the carrying value of the asset to its estimated fair value. Fair value is determined based on appropriate valuation techniques.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="f-646" continuedAt="f-646-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Indefinite-Lived Intangible Assets</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-595-6" continuedAt="f-595-7"><ix:continuation id="f-646-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> goodwill and indefinite-lived intangible assets are reviewed at least annually for impairment under a two step process. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Step 1&#8212;  Under a qualitative assessment, determine if there are indicators of impairment. If so, proceed to Step 2. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Step 2 &#8212; Under a quantitative assessment, if the fair value of each reporting unit is less than its carrying value, there is an impairment. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also elect to skip the qualitative testing and proceed directly to quantitative testing. The Company&#8217;s <ix:nonFraction unitRef="unit" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="f-647">four</ix:nonFraction> reporting units consist of the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners &#8211; IPA;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners &#8211; ACO;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Delivery; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Enablement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An impairment loss is recognized if the carrying value of a reporting unit exceeds its fair value. If this event arises, the impairment loss recorded is equal to the excess of the carrying value of the reporting unit over its fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At least annually, indefinite-lived intangible assets are tested for impairment. Impairment for intangible assets with indefinite lives exists if the carrying value of the intangible asset exceeds its fair value. The fair values of indefinite-lived intangible assets are determined using valuation techniques based on estimates, judgments, and assumptions management believes are appropriate in the circumstances.</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="usd" contextRef="c-32" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-648"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-649"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-650"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-651"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-652"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-653">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment of its goodwill or indefinite-lived intangible assets during the years ended December&#160;31, 2023, 2022 and 2021.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="f-654" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Other Entities &#8211; Equity Method</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for certain investments using the equity method of accounting when it is determined that the investment provides the Company with the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee&#8217;s board of directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize the Company&#8217;s share of net earnings or losses of the investee and is recognized in the accompanying consolidated statements of income under &#8220;Income (loss) from equity method investments&#8221; and also is adjusted by contributions to and distributions from the investee. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Privately Held Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for certain investments using the cost method of accounting when it is determined that the investment provides the Company with little or no influence over the investee. Under the cost method of accounting, the investment is measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. The investments in privately held entities that do not report net asset value are subject to qualitative assessment for indicators of impairments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:HealthCareCostsPolicyPolicyTextBlock" id="f-655" continuedAt="f-655-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Liabilities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Partners segment is responsible for integrated care that the associated physicians and contracted hospitals provide to their enrollees. The Company&#8217;s Care Partners segment provides integrated care to HMOs, Medicare, and Medi-Cal enrollees through a network of contracted providers under sub-capitation and direct patient service arrangements. Medical costs for professional and institutional services rendered by contracted providers are recorded as cost of services, excluding depreciation and amortization, in the accompanying consolidated statements of income.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-595-7" continuedAt="f-595-8"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-655-1">An estimate of amounts due to contracted physicians, hospitals, and other professional providers is included in medical liabilities in the accompanying consolidated balance sheets. Medical liabilities include claims reported as of the balance sheet date and estimated IBNR claims. Such estimates are developed using actuarial methods and are based on numerous variables, including the utilization of healthcare services, historical payment patterns, cost trends, product mix, seasonality, changes in membership, and other factors. The estimation methods and the resulting reserves are periodically reviewed and updated. Many of the medical contracts are complex in nature and may&#160;be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations may&#160;not come to light until a substantial period of time has passed following the contract implementation.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="asth:FiduciaryCashAndPayablePolicyTextBlock" id="f-656" continuedAt="f-656-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiduciary Cash and Payable</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-656-1">The Company&#8217;s Care Partner segment collects cash from health plans on behalf of their sub-IPAs and providers and passes the money through to them.</ix:continuation> The fiduciary cash balance of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="asth:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-657">7.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="asth:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-658">8.1</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively, is presented within prepaid expenses and other current assets and the related payable is presented as fiduciary payable in the accompanying consolidated balance sheets.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-659" continuedAt="f-659-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives payments from the following sources for services rendered: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Commercial insurers;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal government under the Medicare program administered by CMS;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">State governments under Medicaid and other programs;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other third-party payers (e.g., hospitals and IPAs); and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Individual patients and clients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Capitation revenue;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk pool settlements and incentives;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">GPDC/ACO REACH capitation revenue;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management fee income; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FFS revenue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nature of Services and Revenue Streams</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH capitation revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. The following is a summary of the principal forms of the Company&#8217;s billing arrangements and how revenue is recognized for each.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitation, Net</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed care revenues of the Company consist primarily of capitated fees for medical services provided by the Company under a capitated arrangement directly made with various managed care providers, including HMOs. Capitation revenue is </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-659-1" continuedAt="f-659-2"><ix:continuation id="f-595-8" continuedAt="f-595-9"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">typically prepaid monthly to the Company based on the number of enrollees selecting the Company as their healthcare provider. Capitation revenue is recognized in the month in which the Company is obligated to provide services to plan enrollees under contracts with various health plans. Minor ongoing adjustments to prior months&#8217; capitation, primarily arising from contracted HMOs finalizing their monthly patient eligibility data for additions or subtractions of enrollees, are recognized in the month they are communicated to the Company. Additionally, Medicare pays capitation using a &#8220;Risk Adjustment&#8221; model, which compensates managed care organizations and providers based on the health status (acuity) of each individual enrollee. Health plans and providers with higher acuity enrollees will receive more and those with lower acuity enrollees will receive less. Under Risk Adjustment, capitation is determined based on health severity, measured using patient encounter data. Capitation is paid on a monthly basis based on data submitted for the enrollee for the preceding year and is adjusted in subsequent periods after the final data is compiled. Positive or negative capitation adjustments are made for Medicare enrollees with conditions requiring more or fewer healthcare services than assumed in the interim payments. Since the Company cannot reliably predict these adjustments, periodic changes in capitation amounts earned as a result of Risk Adjustment are recognized when those changes are communicated by the health plans to the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Per member per month (&#8220;PMPM&#8221;) managed care contracts generally have a term of <ix:nonNumeric contextRef="c-97" name="us-gaap:RevenuePerformanceObligationDescriptionOfTiming" id="f-660">one year</ix:nonNumeric> or longer. The Company assesses the profitability of its managed care contracts to identify contracts where current operating results or forecasts indicate probable future losses. If anticipated future variable costs exceed anticipated future revenues, a premium deficiency reserve is recognized. No premium deficiency reserves were recorded as of December&#160;31, 2023. All managed care contracts have a single performance obligation that constitutes a series for the provision of managed healthcare services for a population of enrolled members for the duration of the contract. The transaction price for PMPM contracts is variable as it primarily includes PMPM fees associated with unspecified membership that fluctuates throughout the contract. In certain contracts, PMPM fees also include adjustments for items such as performance incentives, performance guarantees, and risk sharing. The Company generally estimates the transaction price using the most likely amount methodology and amounts are only included in the net transaction price to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The majority of the Company&#8217;s net PMPM transaction price relates specifically to the Company&#8217;s efforts to transfer the service for a distinct increment of the series (e.g., day or month) and is recognized as revenue in the month in which members are entitled to service.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GPDC/ACO REACH Capitation Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS contracts with ACOs, which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC/ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, ACOs and providers. By entering into a contract with CMS, an ACO voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each ACO bears the economic costs, and reaps the economic rewards, of fulfilling its responsibilities and managing its risks as an ACO. APAACO has participated in ACO REACH, and its predecessor model, Global and Professional Direct Contracting Model (&#8220;GPDC Model&#8221;), since January 1, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the ACO&#8217;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#8217;s performance. ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties. ACO REACH capitation revenue is recognized in the accompanying consolidated statements of income under capitation, net.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Pool Settlements and Incentives</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-659-2" continuedAt="f-659-3"><ix:continuation id="f-595-9" continuedAt="f-595-10"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain IPAs enter into hospital shared-risk capitation arrangements with certain health plans and local hospitals, where the hospital is responsible for providing, arranging and paying for institutional risk and the IPA is responsible for providing, arranging, and paying for professional risk. Under a hospital shared-risk pool-sharing agreement, the IPA generally receives a percentage of the net surplus from the affiliated hospital&#8217;s risk pools with HMOs after deductions for the affiliated hospital&#8217;s costs. Advance settlement payments are typically made quarterly in arrears if there is a surplus. The Company&#8217;s risk pool settlements under arrangements with health plans and hospitals are recognized using the most likely amount methodology and amounts are only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The assumptions for historical margin, IBNR completion factors, and constraint percentages were used by management in applying the most likely amount methodology.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitated arrangements with certain HMOs, certain IPAs participate in one or more health plan shared-risk arrangements relating to the provision of institutional services to enrollees and thus can earn additional revenue or incur losses based upon the enrollee utilization of institutional services. Health plan shared-risk arrangements are entered into with certain health plans, which are administered by the health plan, where the IPA is responsible for rendering professional services, but the health plan does not enter into a capitation arrangement with a hospital and therefore the health plan retains the institutional risk. Health plan shared-risk deficits, if any, are not payable until and unless (and only to the extent) risk-sharing surpluses are generated. At the termination of the HMO contract, any accumulated deficit will be extinguished.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's risk pool settlements under arrangements with HMOs are recognized, using the most likely methodology, and only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur. Given the lack of access to the health plans&#8217; data and control over the members assigned to the IPA, the adjustments and/or the withheld amounts are unpredictable and as such, the IPA&#8217;s risk-share revenues are deemed to be fully constrained until they are notified of the amount by the health plan. Final settlement of risk pools for prior contract years generally occur in the third or fourth quarter of the following year.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to risk-sharing revenues, the Company also receives incentives under &#8220;pay-for-performance&#8221; programs for quality medical care, based on various criteria. As an incentive to promote quality care, certain HMOs have designed quality incentive programs and commercial generic pharmacy incentive programs to compensate the Company for its efforts to improve the quality of services and efficient and effective use of pharmacy supplemental benefits provided to HMO members. The incentive programs track specific performance measures and calculate payments to the Company based on the performance measures. The Company&#8217;s incentives under &#8220;pay-for-performance&#8221; programs are recognized using the most likely methodology. However, as the Company does not have sufficient insight from the health plans on the amount and timing of the health plan shared-risk pool and incentive payments, these amounts are considered to be fully constrained and only recorded when such payments are known and/or received.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, for the foregoing arrangements, the final settlement is dependent on each distinct day&#8217;s performance within the annual measurement period but cannot be allocated to specific days until the full measurement period has occurred and performance can be assessed. As such, this is a form of variable consideration estimated at contract inception and updated through the measurement period (i.e., the contract year), to the extent the risk of reversal does not exist and the consideration is not constrained.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NGACO AIPBP Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the NGACO Model, CMS aligned beneficiaries to the Company to manage direct care and pay providers based on a budgetary benchmark established with CMS. The Company was responsible for managing medical costs for these beneficiaries. The beneficiaries received services from physicians and other medical service providers that were both in-network and out-of-network. The Company received capitation-like All Inclusive Population Based Payment (&#8220;AIPBP&#8221;) payments from CMS on a monthly basis to pay claims from in-network providers. The Company recorded such AIPBPs received from CMS as revenue as the Company was primarily responsible and liable for managing the patient care and for satisfying provider obligations, was assuming the credit risk for the services provided by in-network providers through its arrangement with CMS, and had control of the funds, the services provided and the process by which the providers were ultimately paid. Claims from out-of-network providers were processed and paid by CMS, while claims from APAACO&#8217;s in-network contracted providers were paid by APAACO. The Company&#8217;s shared savings or losses in managing the services provided by out-of-network providers were generally determined on an annual basis after reconciliation with CMS. Pursuant to the Company&#8217;s risk share agreement with CMS, the Company was eligible to receive the savings or was liable for the deficit according to the budget established by CMS based on the Company&#8217;s efficiency in managing how the beneficiaries aligned to the Company by CMS were served by in-network and out-of-network providers. The Company&#8217;s savings or losses on providing such services were both capped by CMS, </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-659-3" continuedAt="f-659-4"><ix:continuation id="f-595-10" continuedAt="f-595-11"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and were subject to significant estimation risk, whereby payments would vary significantly depending upon certain patient characteristics and other variable factors. Accordingly, the Company recognized such surplus or deficit upon substantial completion of reconciliation and determination of the amounts. The Company recorded NGACO AIPBP revenues monthly. Excess AIPBPs over claims paid, plus an estimate for the related IBNR claims were deferred and recorded as a liability until actual claims were paid or incurred. CMS determined if there were any excess AIPBPs for the performance year and the excess was refunded to CMS. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each performance year, CMS paid the Company in accordance with the alternative payment mechanism, if any, for which CMS had approved the Company; the risk arrangement for which the Company has been approved by CMS, and was otherwise provided in an NGACO Participation Agreement between APAACO and CMS (the &#8220;Participation Agreement&#8221;). Following the end of each performance year and at such other times as would be required under the Participation Agreement, CMS would issue a settlement report to the Company setting forth the amount of any shared savings or shared losses and the amount of other monies. If CMS owed the Company shared savings or other monies, CMS would pay the Company in full within <ix:nonNumeric contextRef="c-98" name="asth:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" format="ixt-sec:durday" id="f-661">30</ix:nonNumeric> days after the date on which the relevant settlement report was deemed final, except as provided in the Participation Agreement. If the Company owed CMS shared losses or other monies owed as a result of a final settlement, the Company would pay CMS in full within <ix:nonNumeric contextRef="c-98" name="asth:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" format="ixt-sec:durday" id="f-662">30</ix:nonNumeric> days after the relevant settlement report was deemed final. If the Company failed to pay the amounts due to CMS in full within <ix:nonNumeric contextRef="c-98" name="asth:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" format="ixt-sec:durday" id="f-663">30</ix:nonNumeric> days after the date of a demand letter or settlement report, CMS would assess simple interest on the unpaid balance at the rate applicable to other Medicare debts under current provisions of law and applicable regulations. In addition, CMS and the U.S. Department of the Treasury would use any applicable debt collection tools available to collect any amounts owed by the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participated in the AIPBP track of the NGACO Model. Under the AIPBP track, CMS estimated the total annual expenditures for APAACO&#8217;s assigned patients and paid that projected amount to the Company in monthly installments, and the Company was responsible for all Part A and Part B costs for in-network participating providers and preferred providers contracted by the Company to provide services to the assigned patients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As APAACO did not have sufficient insight into the financial performance of the shared risk pool with CMS because of unknown factors related to IBNR claims, risk adjustment factors, and stop-loss provisions, among other factors, an estimate couldn&#8217;t be developed. Due to these limitations, APAACO could not determine the amount of surplus or deficit that would likely be recognized in the future and therefore this shared risk pool revenue was considered fully constrained. With the ending of the NGACO Model on December 31, 2021, the Company no longer received AIPBPs but remained eligible to recognize any shared savings or loss for performance year 2021 upon issuance of the settlement report from CMS. Pursuant to the Participation Agreement, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-664">48.8</ix:nonFraction> million related to savings from the 2021 performance year as revenue in risk pool settlements and incentives in the accompanying consolidated statements of income for the year ended December 31, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Fee Income</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management fee income encompasses fees paid for management, physician advisory, healthcare staffing, administrative, and other non-medical services provided by the Company to IPAs, hospitals, and other healthcare providers. Such fees may be in the form of billings at agreed-upon hourly rates, percentages of gross revenue or fee collections, or amounts fixed on a monthly, quarterly, or annual basis. The revenue may include variable arrangements measuring factors, such as hours staffed, patient visits, or collections per visit, against benchmarks, and, in certain cases, may be subject to achieving quality metrics or fee collections. The Company recognizes such variable supplemental revenues in the period when such amounts are determined to be fixed and therefore contractually obligated as payable by the customer under the terms of the applicable agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a significant service of integrating the services selected by the Company&#8217;s clients into one overall output for which the client has contracted. Therefore, such management contracts generally contain a single performance obligation. The nature of the Company&#8217;s performance obligation is to stand ready to provide services over the contractual period. Also, the Company&#8217;s performance obligation forms a series of distinct periods of time over which the Company stands ready to perform. The Company&#8217;s performance obligation is satisfied as the Company completes each period&#8217;s obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration from management contracts is variable in nature because the majority of the fees are generally based on revenue or collections, which can vary from period to period. The Company has control over pricing. Contractual fees are invoiced to the Company&#8217;s clients generally monthly and payment terms are typically due within 30 days. The variable consideration in the Company&#8217;s management contracts meets the criteria to be allocated to the distinct period of time to which it relates because (i) </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-659-4" continuedAt="f-659-5"><ix:continuation id="f-595-11" continuedAt="f-595-12"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">it is due to the activities performed to satisfy the performance obligation during that period and (ii) it represents the consideration to which the Company expects to be entitled.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management contracts generally have terms ranging from <span style="-sec-ix-hidden:f-665">one</span> to <ix:nonNumeric contextRef="c-101" name="asth:RevenuePaymentTerms" format="ixt-sec:durwordsen" id="f-666">thirty years</ix:nonNumeric>, although they may be terminated earlier under the terms of the applicable contracts. Since the remaining variable consideration will be allocated to a wholly unsatisfied promise that forms part of a single performance obligation recognized under the series guidance, the Company has applied the optional exemption to exclude disclosure of the allocation of the transaction price to remaining performance obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fee-for-Service Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FFS revenue represents revenue earned under contracts in which the professional component of charges for medical services rendered by the Company&#8217;s affiliated physician-owned medical groups are billed and collected from third-party payers, hospitals, and patients. FFS revenue related to patient care services is reported net of contractual allowances and policy discounts and is recognized in the period in which the services are rendered to specific patients. All services provided are expected to result in cash flows and are therefore reflected as net revenue in the consolidated financial statements. The recognition of net revenue (gross charges, less contractual allowances) from such services is dependent on such factors as proper completion of medical charts following a patient visit, the forwarding of such charts to the Company&#8217;s billing center for medical coding and entering into the Company&#8217;s billing system and the verification of each patient&#8217;s submission or representation at the time services are rendered as to the payer(s) responsible for payment of such services. Revenue is recorded based on the information known at the time of entering such information into the Company&#8217;s billing systems, as well as an estimate of the revenue associated with medical services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is responsible for confirming member eligibility, performing program utilization review, potentially directing payment to the provider and accepting the financial risk of loss associated with services rendered, as specified within the Company&#8217;s client contracts. The Company has the ability to adjust contractual fees with clients and possesses the financial risk of loss in certain contractual obligations. These factors indicate the Company is the principal and, as such, the Company records gross fees contracted with clients in revenues.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration from FFS arrangements is variable in nature because fees are based on patient encounters, credits due to clients, and reimbursement of provider costs, all of which can vary from period to period.&#160;Patient encounters and related episodes of care and procedures qualify as distinct goods and services, provided simultaneously together with other readily available resources, in a single instance of service, and thereby constitute a single performance obligation for each patient encounter and, in most instances, occur at readily determinable transaction prices. As a practical expedient, the Company adopted a portfolio approach for the FFS revenue stream to group together contracts with similar characteristics and analyze historical cash collection trends. The contracts within the portfolio share the characteristics conducive to ensuring that the results do not materially differ under the new standard if it were to be applied to individual patient contracts related to each patient encounter. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating net FFS revenue is a complex process, largely due to the volume of transactions, the number and complexity of contracts with payers, the limited availability at times of certain patient and payer information at the time services are provided, and the length of time it takes for collections to fully mature. These expected collections are based on fees and negotiated payment rates in the case of third-party payers, the specific benefits provided for under each patient&#8217;s healthcare plans, mandated payment rates in the case of Medicare and Medicaid programs, and historical cash collections (net of recoveries) in combination with expected collections from third-party payers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The relationship between gross charges and the transaction price recognized is significantly influenced by payer mix, as collections on gross charges may vary significantly, depending on whether the patients, to whom services are provided, in the period are insured and the contractual relationships with those payers. Payer mix is subject to change as additional patient and payer information is obtained after the period services are provided. The Company periodically assesses the estimates of unbilled revenue, contractual adjustments and discounts, and payer mix by analyzing actual results, including cash collections, against estimates. Changes in these estimates are charged or credited to the consolidated statements of income in the period that the assessment is made. Significant changes in payer mix, contractual arrangements with payers, specialty mix, acuity, general economic conditions, and healthcare coverage provided by federal or state governments or private insurers may have a significant impact on estimates and significantly affect the results of operations and cash flows.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-595-12" continuedAt="f-595-13"><ix:continuation id="f-659-5" continuedAt="f-659-6"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues and receivables are recognized once the Company has satisfied its performance obligation. Accordingly, contract assets are comprised of receivables and receivables - related parties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#211d1e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billing and accounting systems provide historical trends of cash collections and contractual write-offs, accounts receivable aging, and established fee adjustments from third-party payers. These estimates are recorded and monitored monthly as revenues are recognized.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The principal exposure for uncollectible fees for service visits is from self-pay patients and, to a lesser extent, for co-payments and deductibles from patients with insurance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities (Deferred Revenue)</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-659-6">Contract liabilities are recorded when cash payments are received in advance of the Company&#8217;s performance.</ix:continuation> As of December&#160;31, 2023, the Company&#8217;s contract liability balance was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-667">0.7</ix:nonFraction> million. The Company&#8217;s contract liability was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-668">0.5</ix:nonFraction>&#160;million as of December&#160;31, 2022. Approximately $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="f-669">0.5</ix:nonFraction> million of the Company&#8217;s contract liability accrued in 2022 has been recognized as revenue during the year ended December&#160;31, 2023. Contract liability is presented within accounts payable and accrued expenses in the accompanying consolidated balance sheets.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-670" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period of enactment. The Company records a valuation allowance to reduce deferred tax assets to an amount for which realization is more likely than not. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained upon examination by the tax authorities, based on the merits of the position. The Company&#8217;s policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. To date, there have been no interest or penalties incurred in relation to the unrecognized tax benefits.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-671" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a stock-based compensation program for employees, non-employees, directors, and consultants. From time to time, the Company issues shares of its common stock to its employees, directors, and consultants, which shares may be subject to the Company&#8217;s repurchase right (but not obligation), that vests based on time-based and/or performance-based vesting schedules. The value of share-based awards is recognized as compensation expense and adjusted for forfeitures as they occur. Compensation expenses for time-based awards are recognized on a cumulative straight-line basis over the vesting period of the awards. Share-based awards with performance conditions are recognized to the extent the performance conditions are probable of being achieved. Compensation expenses for performance-based awards are recognized on an accelerated attribution method. The grant date fair value of the restricted stock awards is the grant date&#8217;s closing market price of the Company&#8217;s common stock. The fair value of options granted is determined using the Black-Scholes option pricing model and includes several assumptions, including expected term, expected volatility, expected dividends, and risk-free rates. The expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. The expected stock price volatility is determined based on an average of historical volatility. The expected dividend yield is based on the Company&#8217;s expected dividend payouts. The risk-free interest rate is based on the U.S. Constant Maturity curve over the expected term of the option at the time of grant.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-672" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basic and Diluted Earnings Per Share</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) is computed by dividing net income attributable to holders of the Company&#8217;s common stock by the weighted-average number of shares of common stock outstanding during the periods presented. Diluted earnings per share is computed using the weighted-average number of shares of common stock outstanding, plus the effect of dilutive securities outstanding during the periods presented, using the treasury stock method. Refer to Note 17 &#8212; &#8220;Earnings Per Share&#8221; for a discussion of shares treated as treasury shares for accounting purposes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="asth:MinorityInterestPolicyPolicyTextBlock" id="f-673" continuedAt="f-673-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-controlling Interests</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-595-13"><ix:continuation id="f-673-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates entities in which the Company has a controlling financial interest. The Company consolidates subsidiaries in which the Company holds, directly or indirectly, more than <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="f-674">50</ix:nonFraction>% of the voting rights, and VIEs in which the Company is the primary beneficiary. Non-controlling interests represent third-party equity ownership interests (including equity ownership interests held by certain VIEs) in the Company&#8217;s consolidated entities. Net income attributable to non-controlling interests is disclosed in the consolidated statements of income.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="asth:TemporaryEquityPolicyPolicyTextBlock" id="f-675" continuedAt="f-675-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mezzanine Equity</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-675-1">Pursuant to APC&#8217;s shareholder agreements, in the event of a disqualifying event, as defined in the agreements, APC could be required to repurchase its shares from the respective shareholders based on certain triggers outlined in the shareholder agreements. As the redemption feature of the shares is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as mezzanine or temporary equity. Accordingly, the Company recognizes non-controlling interests in APC as mezzanine equity in the consolidated financial statements.</ix:continuation> As of December&#160;31, 2023 and 2022, APC&#8217;s shares were not redeemable nor was it probable the shares would become redeemable.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-676" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at its inception. The expected term of the lease used for computing the lease liability and right-of-use asset and determining the classification of the lease as operating or financing may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company elected practical expedients for ongoing accounting that is provided by the standard comprised of the following: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The election for classes of underlying assets to not separate non-lease components from lease components, and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The election for short-term lease recognition exemption for all leases under twelve-month terms.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The present value of the lease payments is calculated using a rate implicit in the lease, when readily determinable. However, as most of the Company&#8217;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to determine the present value of the lease payments for the majority of its leases.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="asth:BeneficialInterestPolicyTextBlock" id="f-677" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Interest</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, APC received a beneficial interest as a result of selling one of its equity method investments, pursuant to the terms of the stock purchase agreement. The estimated fair value of such interest in April 2020 was&#160;$<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="asth:AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" format="ixt:num-dot-decimal" scale="6" id="f-678">15.7</ix:nonFraction>&#160;million. In 2021, the beneficial interest was determined to not be collectible and the $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="asth:AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" format="ixt:num-dot-decimal" scale="6" id="f-679">15.7</ix:nonFraction>&#160;million was written off and expensed in other income (expense) in the accompanying consolidated statements of income for the year ended December 31, 2021.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-680" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Standards Accounting Board (FASB) issued Accounting Standards Update (ASU) 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for the Company&#8217;s annual periods beginning January 1, 2024, and for interim periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09 "Income Taxes (Topics 740): Improvements to Income Tax Disclosures" to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#8217;s annual periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-681" continuedAt="f-681-1" escape="true">Business Combinations, Asset Acquisitions, and Goodwill</ix:nonNumeric></span></div><ix:continuation id="f-681-1" continuedAt="f-681-2"><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Texas Independent Providers, LLC (&#8220;TIP&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;1, 2023, the Company acquired certain assets relating to TIP. The acquired assets allow the Company to provide high-quality care services to Medicare Advantage patients in Texas. The purchase price consisted of cash funded on September 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For Your Benefit, Inc. (&#8220;FYB&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;1, 2023, the Company acquired <ix:nonFraction unitRef="number" contextRef="c-104" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-682">100</ix:nonFraction>% of the equity interest in FYB. FYB is licensed by the California Department of Managed Health Care as a full-service Restricted Knox-Keene licensed health plan to serve Medicare Advantage members only in designated California counties. As a Restricted Knox-Keene licensed health plan, FYB is not permitted to market directly to Medicare beneficiaries, but rather, contracts with &#8220;upstream&#8221; Medicare Advantage payer plans on a &#8220;global capitation&#8221; basis, which enables FYB to assume full financial responsibility, including both professional and institutional risk, for the medical costs of its Medicare Advantage members under the Knox-Keene Health Care Service Plan Act of 1975.</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Chinese Community Health Care Association (&#8220;CCHCA&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;1, 2023, the Company acquired certain healthcare assets from CCHCA. The acquired assets allow the Company to provide high-quality care to more patients in the San Francisco Community. The purchase price consisted of cash funded on May&#160;1, 2023. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">All American Medical Group (&#8220;AAMG&#8221;) </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, Astrana Care Partners Medical Corporation (&#8220;Astrana Care Partners Medical&#8221;), formerly known as AP-AMH 2 Medical Corporation, a consolidated VIE of the Company, acquired <ix:nonFraction unitRef="number" contextRef="c-105" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-683">100</ix:nonFraction>% of the equity interest in AAMG. AAMG is an IPA operating in Northern California. The purchase price consisted of cash funded upon close of the transaction and additional consideration (&#8220;AAMG contingent consideration&#8221;) and stock consideration (&#8220;AAMG stock contingent consideration&#8221;) contingent on AAMG meeting revenue and capitated member metrics for fiscal year 2023 and 2024. The fair value of the AAMG contingent consideration and AAMG stock contingent consideration on the date of acquisition was $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-684">5.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="asth:BusinessCombinationStockContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-685">5.6</ix:nonFraction> million, respectively. Refer to Note 21 - &#8220;Fair Value Measurements of Financial Instruments&#8221; for additional information on contingent considerations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valley Oaks Medical Group (&#8220;VOMG&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 14, 2022, one of the Company&#8217;s key personnel acquired <ix:nonFraction unitRef="number" contextRef="c-106" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-686">100</ix:nonFraction>% of the equity interest in VOMG, resulting in the Company consolidating VOMG as a VIE. VOMG owns primary care clinics in Nevada and Texas. The purchase price consists of cash funded upon the close of transaction and additional cash consideration (&#8220;VOMG contingent consideration&#8221;) contingent on VOMG meeting financial metrics for fiscal years 2023 and 2024. Refer to Note 21 - &#8220;Fair Value Measurements of Financial Instruments&#8221; for additional information on contingent considerations. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jade Health Care Medical Group, Inc. (&#8220;Jade&#8221;)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 19, 2022, the Company acquired <ix:nonFraction unitRef="number" contextRef="c-107" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-687">100</ix:nonFraction>% of the capital stock of Jade. The purchase was paid in cash. Jade is a primary and specialty care physicians&#8217; group focused on providing high-quality care to its patients in the San Francisco Bay Area in Northern California.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Orma Health, Inc., and Provider Growth Solutions LLC (together, &#8220;Orma Health&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 27, 2022, the Company acquired <ix:nonFraction unitRef="number" contextRef="c-108" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-688">100</ix:nonFraction>% of the capital stock of Orma Health, Inc., and Provider Growth Solutions, LLC (together, &#8220;Orma Health&#8221;). The purchase was paid in cash and in the Company&#8217;s capital stock. Orma Health&#8217;s real-time Clinical AI platform ingests data from multiple sources and utilizes advanced risk-stratification models to identify patients for various clinical programs, including remote patient monitoring (&#8220;RPM&#8221;), mental health support, chronic care management, and more. Its clinical platform is also deeply integrated with Orma Health&#8217;s proprietary RPM ecosystem, which consists of smart health devices and a suite of technology tools to manage patient health.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisitions were accounted for under the acquisition method of accounting. The fair value of the consideration for the acquired companies were allocated to acquired tangible and intangible assets and liabilities based upon their fair values. The </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-681-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excess of the purchase consideration over the fair value of the net tangible and identifiable intangible assets acquired was recorded as goodwill. The determination of the fair value of assets and liabilities acquired requires the Company to make estimates and use valuation techniques when market value is not readily available. The results of operations of the acquisitions have been included in the Company&#8217;s consolidated financial statements from the date of acquisition. Transaction costs associated with business acquisitions are expensed as they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of acquisition, the Company estimates the amount of the identifiable intangible assets based on a valuation and the facts and circumstances available at the time. The Company determines the final value of the identifiable intangible assets as soon as information is available, but not more than one year from the date of acquisition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not deductible for tax purposes.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-689" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying value of goodwill for the years ended December&#160;31, 2023 and 2022 was as follows (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-690">246,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-691">21,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="f-692">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-693">269,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-694">7,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="f-695">1,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-696">278,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_160"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="asth:PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock" id="f-697" continuedAt="f-697-1" escape="true">Land, Property, and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="f-697-1" continuedAt="f-697-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-698" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land, property, and equipment, net consisted of (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life (Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="f-699">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-700">32,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-111" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-701">5</ix:nonNumeric> - <ix:nonNumeric contextRef="c-112" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-702">39</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:fixed-zero" scale="3" id="f-703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-704">58,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-115" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-705">3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-116" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-706">5</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-707">4,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-708">4,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-119" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-709">3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-120" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-710">7</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-711">18,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-712">17,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="f-713">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-714">12,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-125" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-715">3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-126" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-716">39</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-717">5,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-718">7,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-719">30,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-720">132,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-721">22,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-722">24,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-723">7,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-724">108,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Certain land, property, and equipment, net that were deemed Excluded Assets that are solely for the benefit of APC and its common shareholders were spun-off as part of the Spin-Off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the Company had finance leases totaling $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-725">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-726">1.8</ix:nonFraction> million, respectively, included in land, property, and equipment, net in the accompanying consolidated balance sheets.</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><ix:continuation id="f-697-2" continuedAt="f-697-3"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-727">5.1</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-697-3"> $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-728">3.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-729">2.1</ix:nonFraction> million for the years ended December&#160;31, 2023, 2022 and 2021, respectively, which is included in depreciation and amortization in the accompanying consolidated statements of income.</ix:continuation> </span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_163"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-730" continuedAt="f-730-1" escape="true">Intangible Assets, Net</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-732" continuedAt="f-732-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="f-731" continuedAt="f-731-1" escape="true"><ix:continuation id="f-730-1" continuedAt="f-730-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful<br/>Life<br/>(Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>January 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment/<br/>Disposal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-733">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" format="ixt:fixed-zero" scale="3" id="f-734">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-736">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-737">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-132" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-738">11</ix:nonNumeric>-<ix:nonNumeric contextRef="c-133" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-739">21</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-740">150,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-743">150,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-744">104,859</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-745">45,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-137" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-746">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-747">22,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-750">22,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-751">16,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-752">6,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-140" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-753">10</ix:nonNumeric>-<ix:nonNumeric contextRef="c-141" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-754">14</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-755">16,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="f-756">7,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-758">24,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-759">7,345</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-760">16,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-145" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-761">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-762">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-764">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-765">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-766">2,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="f-767">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-148" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-768">20</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-769">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-772">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-773">308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-774">703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-151" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-775">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-776">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-777">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-779">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-780">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-781">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-782">195,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:FiniteAndIndefiniteLivedIntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="f-783">7,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-784">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-785">202,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-786">131,268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-787">71,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-730-2"><ix:continuation id="f-732-1"><ix:continuation id="f-731-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.388%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.244%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.819%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.963%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful<br/>Life<br/>(Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross January 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment/<br/>Disposal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite Lived Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-788">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" format="ixt:fixed-zero" scale="3" id="f-789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-790">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-791">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-792">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-156" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-793">11</ix:nonNumeric>-<ix:nonNumeric contextRef="c-157" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-794">21</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-795">150,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-797">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-798">150,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-799">95,451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-800">55,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-138" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-801">15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-802">22,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-803">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-805">22,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-806">15,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-807">7,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-142" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-808">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-809">8,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="3" id="f-810">7,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-811">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-812">16,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-813">5,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-814">11,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-146" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-815">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-816">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-817">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-818">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-819">2,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-820">2,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="f-821">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename/trademarks</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-149" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-822">20</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-823">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:fixed-zero" scale="3" id="f-824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-826">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-827">257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-828">754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-152" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-829">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:fixed-zero" scale="3" id="f-830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" scale="3" id="f-831">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:fixed-zero" scale="3" id="f-832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-833">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-834">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-835">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-836">187,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:FiniteAndIndefiniteLivedIntangibleAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="f-837">7,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-839">195,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-840">118,611</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-841">76,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, network relationships, management contracts, member relationships, tradename/trademarks, and developed technology had weighted-average remaining useful lives of <ix:nonNumeric contextRef="c-135" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-842">9.4</ix:nonNumeric> years, <ix:nonNumeric contextRef="c-139" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-843">6.5</ix:nonNumeric> years, <ix:nonNumeric contextRef="c-143" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-844">11.1</ix:nonNumeric> years, <ix:nonNumeric contextRef="c-150" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-845">13.9</ix:nonNumeric> years, and <ix:nonNumeric contextRef="c-170" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-846">4.1</ix:nonNumeric> years respectively. Total weighted-average remaining useful lives for all amortized intangible assets as of December&#160;31, 2023 was <ix:nonNumeric contextRef="c-171" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-847">9.6</ix:nonNumeric> years. Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-848">12.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-849">13.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-850">15.4</ix:nonFraction> million for the years ended December&#160;31, 2023, 2022, and 2021, respectively, which is included in depreciation and amortization in the accompanying consolidated statements of income. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment loss recorded related to intangibles for the years ended December&#160;31, 2023, 2022 and 2021.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-851" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):</span></div><div style="margin-top:17pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-852">12,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-853">11,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="f-854">10,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="f-855">8,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="f-856">7,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-857">18,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-858">69,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_166"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="f-859" continuedAt="f-859-1" escape="true">Investments in Other Entities</ix:nonNumeric></span></div><ix:continuation id="f-859-1" continuedAt="f-859-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsTextBlock" id="f-860" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2023 and 2022, the Company&#8217;s equity method investment balance consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.876%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Initial Investment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustment of Fair Value*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-172" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-861">25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-862">5,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="asth:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-863">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-864">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-865">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="asth:EquityMethodInvestmentAdjustmentToFairValue" format="ixt:fixed-zero" scale="3" id="f-866">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-867">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-868">9,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-175" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-869">40</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-870">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="asth:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-872">187</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="asth:EquityMethodInvestmentAdjustmentToFairValue" format="ixt:fixed-zero" scale="3" id="f-874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-875">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-876">1,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-877">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-878">17,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="asth:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-880">508</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="asth:EquityMethodInvestmentsContribution" scale="3" id="f-881">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="asth:EquityMethodInvestmentAdjustmentToFairValue" scale="3" id="f-882">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-883">17,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-181" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-885">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-886">2,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="asth:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-887">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-888">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-889">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="asth:EquityMethodInvestmentAdjustmentToFairValue" format="ixt:num-dot-decimal" scale="3" id="f-890">3,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-891">6,916</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-184" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-893">30</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-894">12,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="asth:EquityMethodInvestmentAdditionalInvestment" format="ixt:fixed-zero" scale="3" id="f-895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-896">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="asth:EquityMethodInvestmentAdjustmentToFairValue" format="ixt:fixed-zero" scale="3" id="f-898">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-900">13,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other **</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-187" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-901">25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-902">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="asth:EquityMethodInvestmentAdditionalInvestment" scale="3" id="f-903">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-904">232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="asth:EquityMethodInvestmentAdjustmentToFairValue" format="ixt:fixed-zero" scale="3" id="f-906">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-907">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="f-908">557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-909">40,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:EquityMethodInvestmentAdditionalInvestment" scale="3" id="f-910">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-911">5,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:EquityMethodInvestmentsContribution" scale="3" id="f-912">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:EquityMethodInvestmentAdjustmentToFairValue" format="ixt:num-dot-decimal" scale="3" id="f-913">3,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-914">24,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-915">25,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-Off. On the date of distribution, the investments were recorded at fair value. The gain, representing the difference between the fair value and the carrying value of the investment, was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="asth:EquityMethodInvestmentAdjustmentToFairValue" scale="6" id="f-916">3.4</ix:nonFraction> million and is presented within other income in the accompanying consolidated statement of net income. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Other consists of smaller equity method investments. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.040%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.876%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funding Reclassified to Loan Receivable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Entity Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-173" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-917">25</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-918">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-919">4,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:num-dot-decimal" scale="3" id="f-920">2,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="asth:EquityMethodInvestmentsConsolidated" format="ixt:fixed-zero" scale="3" id="f-922">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-923">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-924">5,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-925">40</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-926">1,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-927">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-928">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-929">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="asth:EquityMethodInvestmentsConsolidated" format="ixt:fixed-zero" scale="3" id="f-930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-931">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-932">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-933">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-934">17,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-935">619</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-936">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="asth:EquityMethodInvestmentsContribution" scale="3" id="f-937">670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="asth:EquityMethodInvestmentsConsolidated" format="ixt:fixed-zero" scale="3" id="f-938">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-939">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-940">17,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-182" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-941">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-942">2,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-943">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="asth:EquityMethodInvestmentsConsolidated" format="ixt:fixed-zero" scale="3" id="f-946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" scale="3" id="f-947">600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-948">2,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tag-6 Medical Investment Group, LLC*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-198" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-949">100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-950">4,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-951">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:num-dot-decimal" scale="3" id="f-953">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="asth:EquityMethodInvestmentsConsolidated" format="ixt:num-dot-decimal" scale="3" id="f-954">6,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-955">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="f-956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-185" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-957">30</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-958">11,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-959">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:fixed-zero" scale="3" id="f-960">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:fixed-zero" scale="3" id="f-961">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="asth:EquityMethodInvestmentsConsolidated" format="ixt:fixed-zero" scale="3" id="f-962">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-963">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-964">12,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-965">41,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-966">5,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable" format="ixt:num-dot-decimal" scale="3" id="f-967">2,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:EquityMethodInvestmentsContribution" format="ixt:num-dot-decimal" scale="3" id="f-968">2,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:EquityMethodInvestmentsConsolidated" format="ixt:num-dot-decimal" scale="3" id="f-969">6,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" scale="3" id="f-970">600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-971">40,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method investments are subject to impairment evaluation. There was no impairment loss recorded related to equity method investments for the years ended December&#160;31, 2023, 2022, and 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in privately held entities that do not report net asset value</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MediPortal, LLC</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, APC purchased <ix:nonFraction unitRef="shares" contextRef="c-203" decimals="INF" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares" format="ixt:num-dot-decimal" scale="0" id="f-972">270,000</ix:nonFraction> membership interests of MediPortal LLC, a New York limited liability company, for $<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-5" name="asth:PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments" format="ixt:num-dot-decimal" scale="6" id="f-973">0.4</ix:nonFraction> million or $<ix:nonFraction unitRef="usdPerShare" contextRef="c-203" decimals="INF" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest" scale="0" id="f-974">1.50</ix:nonFraction> per membership interest, which represented approximately <ix:nonFraction unitRef="number" contextRef="c-203" decimals="3" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="f-975">2.8</ix:nonFraction>% ownership interest. In connection with </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-859-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the initial purchase, APC received a <ix:nonNumeric contextRef="c-203" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-976">five-year</ix:nonNumeric> warrant to purchase an additional <ix:nonFraction unitRef="shares" contextRef="c-203" decimals="-3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-977">270,000</ix:nonFraction> membership interests. A <ix:nonNumeric contextRef="c-204" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption" format="ixt-sec:durwordsen" id="f-978">five-year</ix:nonNumeric> option to purchase an additional <ix:nonFraction unitRef="shares" contextRef="c-204" decimals="-3" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests" format="ixt:num-dot-decimal" scale="0" id="f-979">380,000</ix:nonFraction> membership interests and a <span style="-sec-ix-hidden:f-980">five</span>-year warrant to purchase <ix:nonFraction unitRef="shares" contextRef="c-203" decimals="0" name="asth:EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet" format="ixt:num-dot-decimal" scale="0" id="f-981">480,000</ix:nonFraction> membership interests were contingent upon the portal completion date. These warrants and options were not exercised and are expired as of December&#160;31, 2023. As APC does not have the ability to exercise significant influence, and lacks control over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the years ended December&#160;31, 2023 and 2022, there were no observable price changes to APC&#8217;s investment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AchievaMed</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, Astrana Health Management, Inc. (&#8220;AHM&#8221;), formerly known as Network Medical Management Inc., and AchievaMed, Inc., a California corporation (&#8220;AchievaMed&#8221;), entered into an agreement in which AHM would purchase <ix:nonFraction unitRef="number" contextRef="c-205" decimals="INF" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears" scale="-2" id="f-982">50</ix:nonFraction>% of the aggregate shares of capital stock of AchievaMed over a period of time not to exceed <ix:nonNumeric contextRef="c-206" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment" format="ixt-sec:durwordsen" id="f-983">five years</ix:nonNumeric>. As a result of this transaction, AHM invested $<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" format="ixt:num-dot-decimal" scale="6" id="f-984">0.5</ix:nonFraction> million for a <ix:nonFraction unitRef="number" contextRef="c-205" decimals="2" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="f-985">10</ix:nonFraction>% interest. The related investment balance of $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" format="ixt:num-dot-decimal" scale="6" id="f-986">0.5</ix:nonFraction>&#160;million is included in investments in privately held entities in the accompanying consolidated balance sheets as of December&#160;31, 2023. As AHM does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the years ended December&#160;31, 2023 and 2022, there were no observable price changes to AHM&#8217;s investment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third Way Health, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into a Simple Agreement for Future Equity (&#8220;SAFE&#8221;) with Third Way Health, Inc. (&#8220;Third Way Health&#8221;). Based on certain triggering events defined in the SAFE, the Company has rights to Third Way Health&#8217;s shares. The number of shares to be acquired will be calculated when the triggered event occurs.  As of December&#160;31, 2023 and 2022, the related investment balance of $<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" format="ixt:num-dot-decimal" scale="6" id="f-987">3.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" format="ixt:num-dot-decimal" scale="6" id="f-988">1.5</ix:nonFraction>&#160;million, respectively, is included in investments in privately held entities in the accompanying consolidated balance sheets. As the Company does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the years ended December&#160;31, 2023 and 2022, there were no observable price changes to the Third Way Health investment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Seen Health, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2023, the Company entered into a SAFE with Seen Health, Inc. (&#8220;Seen Health&#8221;). Based on certain triggering events defined in the SAFE, the Company has rights to Seen Health&#8217;s shares. The number of shares to be acquired will be calculated when the triggering event occurs. As of December&#160;31, 2023, the related investment balance of $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" format="ixt:num-dot-decimal" scale="6" id="f-989">2.0</ix:nonFraction>&#160;million is included in investments in privately held entities in the accompanying consolidated balance sheets. As the Company does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the year ended December&#160;31, 2023, there were no observable price changes to the Seen Health investment.</span></div></ix:continuation><div id="ib8ab676c07c14f5e97ea961ccac78e95_172"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="asth:LoanReceivableTextBlock" id="f-990" continuedAt="f-990-1" escape="true">Loan Receivable and Loan Receivable &#8211; Related Parties</ix:nonNumeric></span></div><ix:continuation id="f-990-1" continuedAt="f-990-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loans receivable</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pacific6</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, AHM received a promissory note from 6 Founder LLC, a California limited liability company doing business as Pacific6 Enterprises totaling $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="6" id="f-991">0.5</ix:nonFraction>&#160;million as a result of the sale of the Company&#8217;s interest in MWN. Interest accrues at a rate of <ix:nonFraction unitRef="number" contextRef="c-212" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-992">5</ix:nonFraction>% per annum and is payable monthly through the maturity date of December 1, 2023. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IntraCare </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-990-2" continuedAt="f-990-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;27, 2023, the Company entered into a <ix:nonNumeric contextRef="c-213" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-993">five-year</ix:nonNumeric> convertible promissory note with IntraCare as the borrower. The principal on the note is $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-994">25.0</ix:nonFraction> million, with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to <ix:nonFraction unitRef="number" contextRef="c-214" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-995">8.81</ix:nonFraction>%, compounded annually. In the event that the convertible promissory note remains outstanding on or after the maturity date of July&#160;27, 2028, the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into IntraCare preferred shares. As of December&#160;31, 2023, the related note balance of $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-996">26.0</ix:nonFraction> million is included in loan receivable, non-current in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the outstanding loan receivable under the CECL model by assessing the party&#8217;s ability to pay by reviewing their interest payment history quarterly, financial history annually, and reassessing any identified insolvency risk.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan receivable &#8212; related party</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LaSalle Medical Associates Loan (&#8220;LMA Loan&#8221;)</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-990-3">LaSalle Medical Associates (&#8220;LMA&#8221;) issued a promissory note to APC-LSMA for a principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:NotesReceivableNet" format="ixt:num-dot-decimal" scale="6" id="f-997">2.1</ix:nonFraction>&#160;million with an August 2023 maturity date. The contractual interest rate on the LMA Loan is <ix:nonFraction unitRef="number" contextRef="c-216" decimals="3" name="asth:FinanceReceivableInterestRateStatedPercentage" scale="-2" id="f-998">1.0</ix:nonFraction>% above the prime rate of interest for commercial customers. In March 2023, LMA paid off the full balance of the promissory note and all interest. APC&#8217;s investment in LMA is accounted for under the equity method based on the <ix:nonFraction unitRef="number" contextRef="c-217" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-999">25</ix:nonFraction>% equity ownership interest held by APC-LSMA in LMA&#8217;s IPA line of business (see Note 6 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;).</ix:continuation> </span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_178"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-1000" continuedAt="f-1000-1" escape="true">Accounts Payable and Accrued Expenses</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-1001" escape="true"><ix:continuation id="f-1000-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts payable and accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1002">9,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1003">10,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="asth:SpecialtyCapitationPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1004">4,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="asth:SpecialtyCapitationPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1005">4,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor IPA payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="asth:SubcontractorIpaRiskPoolPayable" format="ixt:num-dot-decimal" scale="3" id="f-1006">2,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="asth:SubcontractorIpaRiskPoolPayable" format="ixt:num-dot-decimal" scale="3" id="f-1007">2,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1008">4,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1009">2,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to related parties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RelatedPartyDepositLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1010">9,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RelatedPartyDepositLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1011">3,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="f-1012">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="f-1013">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1014">20,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1015">15,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other provider payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1016">9,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1017">10,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued expenses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1018">59,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1019">49,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_181"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" id="f-1020" continuedAt="f-1020-1" escape="true">Medical Liabilities</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="f-1021" continuedAt="f-1021-1" escape="true"><ix:continuation id="f-1020-1" continuedAt="f-1020-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s medical liabilities consisted of the following (in thousands):</span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1021-1"><ix:continuation id="f-1020-2"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1022">81,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1023">55,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired (see Note 3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-1024">6,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:num-dot-decimal" scale="3" id="f-1025">2,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1026">866,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1027">646,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1028">13,566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1029">5,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="3" id="f-1030">852,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="3" id="f-1031">651,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="3" id="f-1032">759,354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="3" id="f-1033">559,751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="3" id="f-1034">76,696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="3" id="f-1035">67,149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1036">836,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1037">626,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1038">2,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1039">2,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1040">106,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1041">81,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_184"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-1042" continuedAt="f-1042-1" escape="true">Credit Facility, Bank Loans, and Lines of Credit</ix:nonNumeric></span></div><ix:continuation id="f-1042-1" continuedAt="f-1042-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="f-1043" continuedAt="f-1043-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt balance consists of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-1044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1045">180,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1046">280,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-1047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Loans*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-1048">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1049">23,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction Loan *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-1050">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1051">4,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note Payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1052">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-1053">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1054">282,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1055">207,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1056">19,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="f-1057">619</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1058">3,561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1059">3,319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Long-term debt </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1060">258,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1061">203,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1043-1">*These loans are a component of Excluded Assets that are solely for the benefit of APC and its common shareholders.</ix:continuation> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using Level 2 inputs primarily related to comparable market prices. As of December&#160;31, 2023 and 2022, the carrying value was not materially different from fair value, as the interest rates on the Company&#8217;s debt approximated rates currently available to the Company.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-1062" continuedAt="f-1062-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the future commitments of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1042-2" continuedAt="f-1042-3"><ix:continuation id="f-1062-1"><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.181%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1063">19,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1064">15,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1065">21,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1066">22,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1067">203,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:fixed-zero" scale="3" id="f-1068">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-1069">282,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amended Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2021, the Company entered into an amended and restated credit agreement (as subsequently amended as described below, the &#8220;Amended Credit Agreement&#8221;) with Truist Bank, in its capacity as administrative agent for the lenders, issuing bank, swingline lender and lender, and the banks and other financial institutions from time to time party thereto, to, among other things, amend and restate that certain credit agreement, dated September 11, 2019, by and among the Company, Truist Bank, and certain lenders thereto, in its entirety. The Amended Credit Agreement provides for a <ix:nonNumeric contextRef="c-228" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1070">five-year</ix:nonNumeric> revolving credit facility to the Company of $<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1071">400.0</ix:nonFraction> million (&#8220;Revolver Loan&#8221;), which includes a letter of credit sub-facility of up to $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1072">25.0</ix:nonFraction> million and a swingline loan sub-facility of $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1073">25.0</ix:nonFraction> million. As of December&#160;31, 2023, the Company did not have any outstanding borrowings under the Revolver Loan. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2022, the Company entered into the First Amendment to the Amended Credit Agreement in which all amounts borrowed under the Amended Credit Agreement as of the effective date were automatically converted from LIBOR Loans to SOFR Loans with an initial interest period of one month on and as of the amendment effective date. Amounts borrowed under the Revolver Loan bear interest at an annual rate equal to either, at the Company&#8217;s option, (a) the Term SOFR Reference Rate (as defined in the Amended Credit Agreement), adjusted for any Term SOFR Adjustment (as defined in the Amended Credit Agreement) plus a spread ranging from  <ix:nonFraction unitRef="number" contextRef="c-231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1074">1.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-232" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1075">2.50</ix:nonFraction>%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio (as defined in the Amended Credit Agreement), or (b) a base rate, plus a spread ranging from <ix:nonFraction unitRef="number" contextRef="c-233" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1076">0.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-234" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1077">1.50</ix:nonFraction>%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 8, 2023, a Second Amendment to the Amended Credit Agreement was entered into which, among other things, (i) increased the letter of credit sub-facility from $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1078">25.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1079">50.0</ix:nonFraction> million; (ii) revised the form of compliance certificate required to be submitted by the Company to the lenders on a quarterly basis; and (iii) waived the Specified Events of Default (as defined in the amendment) that occurred under the Amended Credit Agreement, relating to the Company&#8217;s calculation of Consolidated Total Net Leverage Ratio  and payment of certain interest and letter of credit fees, in each case, for the periods from the quarter ended September 30, 2021 through the quarter ended March 31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;3, 2023, the Company entered into a Third Amendment to the Amended Credit Agreement (&#8220;Third Amendment&#8221;) with Truist Bank and the other financial institutions party thereto. The Third Amendment provided a new term loan to the Company in an aggregate amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="INF" name="asth:LineOfCreditFacilityAmountFundedAtClosing" format="ixt:num-dot-decimal" scale="6" id="f-1080">300.0</ix:nonFraction>&#160;million, with $<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1081">180.0</ix:nonFraction>&#160;million funded at the closing of the Third Amendment, and $<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfBankOverdrafts" format="ixt:num-dot-decimal" scale="6" id="f-1082">120.0</ix:nonFraction>&#160;million available to be drawn by the Company as delayed draw loans during the six months subsequent to the closing of the Third Amendment (collectively, the &#8220;Term Loan&#8221;).  The Term Loan matures on November&#160;3, 2028 (or such earlier date on which it is terminated in accordance with the provisions of the Amended Credit Agreement) and amortizes quarterly at <ix:nonFraction unitRef="number" contextRef="c-239" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1083">5</ix:nonFraction>% per annum for each of the first two years, <ix:nonFraction unitRef="number" contextRef="c-240" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1084">7.5</ix:nonFraction>% per annum for years three and four, and <ix:nonFraction unitRef="number" contextRef="c-241" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1085">10</ix:nonFraction>% per annum for year five. As of December&#160;31, 2023, the Company made total drawdowns under the Term Loan of $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1086">280.0</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="f-1087">180.0</ix:nonFraction>&#160;million was used to pay down outstanding amounts borrowed on the Revolver Loan as of the Third Amendment closing date.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay a quarterly ticking fee on the delayed draw portion of the Term Loan, during the draw period, in an amount equal to <ix:nonFraction unitRef="number" contextRef="c-243" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1088">0.375</ix:nonFraction>% per annum multiplied by the average daily unused portion of the delayed draw maximum amount. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1042-3" continuedAt="f-1042-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan will be secured by substantially all assets of the Company and subsidiaries of the Company that are not designated as excluded subsidiaries pursuant to the terms of the Amended Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan bears interest at an annual rate equal to either, at the Company&#8217;s option, (a) the Term SOFR Reference Rate, adjusted for any Term SOFR Adjustment, plus a spread from <ix:nonFraction unitRef="number" contextRef="c-244" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1089">1.50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-245" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1090">2.75</ix:nonFraction>%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio, or (b) a base rate, plus a spread of <ix:nonFraction unitRef="number" contextRef="c-246" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1091">0.50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-247" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1092">1.75</ix:nonFraction>%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio. As of December&#160;31, 2023, the interest rate on the Term Loan was <ix:nonFraction unitRef="number" contextRef="c-248" decimals="4" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="f-1093">7.69</ix:nonFraction>%. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the Company is required to pay an annual agent fee of $<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="0" id="f-1094">50,000</ix:nonFraction> and an annual facility fee of <ix:nonFraction unitRef="number" contextRef="c-250" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1095">0.175</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-251" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1096">0.35</ix:nonFraction>% on the available commitments under the Amended Credit Agreement, regardless of usage, with the applicable fee determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio. The Company will pay fees for standby letters of credit at an annual rate equal to <ix:nonFraction unitRef="number" contextRef="c-252" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1097">1.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-253" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="f-1098">2.50</ix:nonFraction>%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio, plus fronting fees and standard fees payable to the issuing bank on the respective letter of credit. The Company is also required to pay customary fees between the Company and Truist Bank, the lead arranger of the Amended Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement requires the Company to comply with two key financial ratios, each calculated on a consolidated basis. The Company must maintain a maximum consolidated total net leverage ratio of not greater than <ix:nonFraction unitRef="number" contextRef="c-254" decimals="INF" name="asth:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="f-1099">3.75</ix:nonFraction> to 1.00 as of the last day of each fiscal quarter, provided that for any fiscal quarter during which the Company or certain subsidiaries consummate a permitted acquisition or investment, the aggregate purchase price is greater than $<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="asth:DebtCovenantAggregatePurchasePriceMaximum" format="ixt:num-dot-decimal" scale="6" id="f-1100">75.0</ix:nonFraction>&#160;million, the maximum consolidated total net leverage ratio may temporarily increase by <ix:nonFraction unitRef="number" contextRef="c-254" decimals="INF" name="asth:DebtInstrumentCovenantLeverageRatioIncrementalChange" scale="0" id="f-1101">0.25</ix:nonFraction> to 1.00 to <ix:nonFraction unitRef="number" contextRef="c-254" decimals="INF" name="asth:DebtInstrumentCovenantLeverageRatioAdjustedMaximum" scale="0" id="f-1102">4.00</ix:nonFraction> to 1.00. The Company must maintain a minimum consolidated interest coverage ratio of not less than <ix:nonFraction unitRef="number" contextRef="c-255" decimals="INF" name="asth:DebtInstrumentCovenantInterestCoverageRatioMinimum" scale="0" id="f-1103">3.25</ix:nonFraction> to 1.00 as of the last day of each fiscal quarter. The Third Amendment also revised certain negative covenants in the Credit Agreement, providing the Company with additional baskets and increased flexibility with respect to restrictions on indebtedness, liens, investments, acquisitions and restricted payments. The Third Amendment also updates the definition of Consolidated EBITDA to include additional addbacks and to clarify certain components of the calculation thereof. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the terms and conditions of the Guaranty and Security Agreement (the &#8220;Guaranty and Security Agreement&#8221;) between the Company, AHM and Truist Bank remain in effect. Pursuant to the Guaranty and Security Agreement, the Company and AHM have granted the lenders under the Amended Credit Agreement a security interest in substantially all of their assets to secure obligations under the Amended Credit Agreement, including, without limitation, all stock and other equity issued by their subsidiaries (including AHM) and all rights with respect to the $<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1104">545.0</ix:nonFraction>&#160;million loan from the Company to Astrana Medical. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, certain of the lenders under the Amended Credit Agreement and their affiliates have provided to the Company and its subsidiaries and the associated practices, and may in the future provide, (i) investment banking, commercial banking, cash management, foreign exchange or other financial services, and (ii) services as a bond trustee and other trust and fiduciary services, for which they have received compensation and may receive compensation in the future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Financing Costs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, unamortized deferred financing costs were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="asth:UnamortizedDeferredFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="f-1105">6.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="asth:UnamortizedDeferredFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="f-1106">3.3</ix:nonFraction> million, respectively. During the year ended December 31, 2023, the Company recorded additional deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-5" name="us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet" format="ixt:num-dot-decimal" scale="6" id="f-1107">3.9</ix:nonFraction> million related to the Third Amendment. As of December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="f-1108">2.6</ix:nonFraction> million of unamortized deferred financing costs was recognized in prepaid expenses and other current assets in the accompanying consolidated balance sheets and consisted of unamortized deferred financing costs related to unborrowed amounts available on the Term Loan and the unamortized deferred financing costs for the Revolver Loan. As of December&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="f-1109">3.6</ix:nonFraction> million of unamortized deferred financing costs was recorded as a direct reduction against the amounts borrowed on the Term Loan. The remaining unamortized deferred financing costs related to the Revolver Loan are amortized over the life of the Revolver Loan using the straight-line method. The remaining unamortized deferred financing costs related to the Term Loan are amortized over the life of the Term Loan using the effective interest rate method. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Real Estate Loans (Excluded Assets for the benefit of APC and its subsidiaries)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate - East West Bank</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1042-4" continuedAt="f-1042-5"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, APC purchased <ix:nonFraction unitRef="loan" contextRef="c-1" decimals="INF" name="asth:NumberOfRealEstateLoans" format="ixt-sec:numwordsen" scale="0" id="f-1110">three</ix:nonFraction> entities, each of which was included in Excluded Assets and had entered into real estate loan with East West Bank. As of December 31, 2022, the principal on each loan was $<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1111">5.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1112">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1113">0.6</ix:nonFraction> million, respectively,  and had a variable interest rate of <ix:nonFraction unitRef="number" contextRef="c-262" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1114">0.50</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-263" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1115">0.50</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-264" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1116">0.30</ix:nonFraction>% less than the independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate&#8221;, respectively. The maturity date of each loan was August 5, 2030. These loans are a component of Excluded Assets that are solely for the benefit of APC and its shareholders. These loans were spun off on December 26, 2023 as part of the Spin-Off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate - MUFG Union Bank N.A.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, a subsidiary of APC, which was included in Excluded Assets, entered into a loan agreement with MUFG Union Bank N.A. with the principal on the loan of $<ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1117">16.3</ix:nonFraction> million and a maturity date of March&#160;1, 2032. The loan was used to purchase property in Monterey Park, California. The variable interest rate was <ix:nonFraction unitRef="number" contextRef="c-266" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1118">2.0</ix:nonFraction>% in excess of Daily Simple SOFR (as defined in the loan agreement). As of December 31, 2022, the principal on the loan was $<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1119">16.0</ix:nonFraction> million. On December 14, 2023, APC paid off the outstanding loan balance of $<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1120">15.6</ix:nonFraction> million. This loan was a component of Excluded Assets that are solely for the benefit of APC and its shareholders. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction Loan (Excluded Assets for the benefit of APC and its subsidiaries)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, an entity included in Excluded Assets entered into a construction loan agreement with MUFG Union Bank N.A. (&#8220;Construction Loan&#8221;). The Construction Loan has a borrowing capacity of $<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1121">10.7</ix:nonFraction>&#160;million with a maturity date of March&#160;1, 2024 or, upon completion of the construction and certain other requirements defined in the loan agreement, March&#160;1, 2034. The loan balance as of December 31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1122">4.2</ix:nonFraction> million. On December 14, 2023, APC paid off the outstanding loan balance of $<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1123">8.5</ix:nonFraction> million. This loan was a component of Excluded Assets that are solely for the benefit of APC and its shareholders. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Promissory Note Payable</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FYB Promissory Note Agreement with CCHCA</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, FYB entered into a promissory note agreement with CCHCA. The principal on the promissory note is $<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1124">2.0</ix:nonFraction>&#160;million, with a maturity date of May&#160;9, 2024. The interest rate is the prime rate plus <ix:nonFraction unitRef="number" contextRef="c-273" decimals="3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1125">1.0</ix:nonFraction>%. The prime rate is updated annually on the effective date of the note and published by the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s average effective interest rate on its total debt during the years ended December&#160;31, 2023, 2022 and 2021, was <ix:nonFraction unitRef="number" contextRef="c-255" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-1126">6.19</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-274" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-1127">3.22</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-275" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="f-1128">2.06</ix:nonFraction>%, respectively. Interest expense in the consolidated statements of income included amortization of deferred debt issuance costs for the years ended December&#160;31, 2023, 2022 and 2021, of $<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1129">1.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1130">0.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-5" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1131">1.2</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lines of Credit </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">APC Business Loan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the APC Business Loan Agreement with Preferred Bank (the &#8220;APC Business Loan Agreement&#8221;) was amended to, among other things, decrease loan availability to $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1132">4.1</ix:nonFraction> million, limit the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and include as a permitted lien, the security interest in all of its assets that APC granted to AHM under a Security Agreement dated on or about September 11, 2019, securing APC&#8217;s obligations to AHM under their management services agreement dated as of July 1, 1999, as amended.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Letters of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established irrevocable standby letters of credit with Truist Bank under the Amended Credit Agreement for a total of $<ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1133">36.5</ix:nonFraction> million for the benefit of CMS and certain health plans as of December&#160;31, 2023. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional <ix:nonNumeric contextRef="c-278" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen" id="f-1134">one-year</ix:nonNumeric> periods from the present, or any future expiration date.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1042-5"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of $<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1135">3.9</ix:nonFraction> million for the benefit of certain health plans as of December&#160;31, 2023. The standby letters of credit are automatically extended without amendment for additional <ix:nonNumeric contextRef="c-280" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen" id="f-1136">one-year</ix:nonNumeric> periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.</span></div></ix:continuation><div id="ib8ab676c07c14f5e97ea961ccac78e95_190"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1137" continuedAt="f-1137-1" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="f-1137-1" continuedAt="f-1137-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1138" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.184%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1139">35,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1140">35,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1141">15,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1142">8,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1143">19,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1144">8,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1145">44,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1146">55,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1147">24,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1148">3,638</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1149">11,552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1150">3,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1151">8,806</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1152">2,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1153">3,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1154">12,444</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1155">14,278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1156">7,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1157">31,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1158">40,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1159">31,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1160" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes differs from the amount computed by applying the federal income tax rate as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:57.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at U.S. federal statutory rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1161">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1162">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1163">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1164">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1165">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1166">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible permanent items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" scale="-2" id="f-1167">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" scale="-2" id="f-1168">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" scale="-2" id="f-1169">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable interest entities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="f-1170">2.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="f-1171">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" scale="-2" id="f-1172">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-1173">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-1174">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="f-1175">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-1176">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="f-1177">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:fixed-zero" scale="-2" id="f-1178">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of investment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" scale="-2" id="f-1179">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" scale="-2" id="f-1180">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" sign="-" name="asth:EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" scale="-2" id="f-1181">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOL adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" scale="-2" id="f-1182">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" scale="-2" id="f-1183">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" sign="-" name="asth:EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" scale="-2" id="f-1184">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undistributed dividend</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="asth:EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" scale="-2" id="f-1185">11.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" scale="-2" id="f-1186">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" scale="-2" id="f-1187">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off transaction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" scale="-2" id="f-1188">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" format="ixt:fixed-zero" scale="-2" id="f-1189">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" name="asth:EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" format="ixt:fixed-zero" scale="-2" id="f-1190">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1191">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1192">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1193">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="f-1194">35.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-31" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="f-1195">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-32" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="f-1196">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate differs from the Federal statutory rate of <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1197">21</ix:nonFraction>% due to increases from state taxes, non-deductible permanent items, stock-based compensation, gain on sale of investment, and a one-time gain in connection with the December 26, 2023 Spin-Off transaction. This is offset by variable interest entities, change in valuation allowance, and a benefit related to the reversal on deferred taxes on undistributed dividends. The Company had previously recorded deferred tax liabilities related to undistributed dividends for taxpaying groups that could not consolidate under US federal tax law. As a result of the spinoff transaction that occurred on December 26, 2023, the separate taxpaying groups now have the ability to consolidate under US federal tax law, resulting in tax benefits on the future payment of the dividends. </span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1198" continuedAt="f-1198-1" escape="true"></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1137-2"><ix:continuation id="f-1198-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the Company&#8217;s deferred tax assets (liabilities) as of December&#160;31, 2023 and 2022, are shown below (in thousands).</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsStateTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1199">2,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsStateTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1200">2,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1201">1,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" id="f-1202">670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for bad debts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-1203">1,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="f-1204">853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in other entities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="asth:DeferredTaxAssetsInvestment" format="ixt:num-dot-decimal" scale="3" id="f-1205">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="asth:DeferredTaxAssetsInvestment" format="ixt:num-dot-decimal" scale="3" id="f-1206">2,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1207">7,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1208">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="asth:DeferredTaxAssetsLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1209">10,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="asth:DeferredTaxAssetsLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1210">6,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" format="ixt:num-dot-decimal" scale="3" id="f-1211">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" format="ixt:num-dot-decimal" scale="3" id="f-1212">8,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="f-1213">663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1214">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:fixed-zero" scale="3" id="f-1215">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-1216">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1217">28,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1218">31,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1219">5,904</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1220">8,292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1221">22,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1222">23,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="f-1223">329</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1224">1,840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1225">15,301</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1226">21,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1227">9,936</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1228">5,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" scale="3" id="f-1229">648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" scale="3" id="f-1230">725</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undistributed dividend</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="asth:DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" format="ixt:fixed-zero" scale="3" id="f-1231">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="asth:DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" format="ixt:num-dot-decimal" scale="3" id="f-1232">8,454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1233">26,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1234">37,919</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1235">4,072</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1236">14,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-1237">5.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="f-1238">8.3</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively, has been established against the Company&#8217;s deferred tax assets related to loss entities the Company cannot consolidate under the federal consolidation rules, as realization of these assets is uncertain. Valuation allowance decreased by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1239">2.4</ix:nonFraction> million in 2023 and increased by $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1240">4.3</ix:nonFraction>&#160;million in 2022.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had federal and California net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1241">21.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1242">44.8</ix:nonFraction> million, respectively. The federal and California net operating loss carryforwards will expire at various dates from 2027 through 2043; however, $<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-5" name="asth:OperatingLossCarryforwardsNotSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="f-1243">5.3</ix:nonFraction> million of the federal net operating loss carryforwards do not expire and can be carried forward indefinitely. The Company has determined certain NOLs are limited pursuant to Internal Revenue Code Sections 382 and 383, but does not anticipate these NOLs will expire before utilization. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the Company does not have any unrecognized tax benefits related to various federal and state income tax matters. The Company will recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to U.S. federal income tax, as well as income tax in California. The Company&#8217;s and its subsidiaries&#8217; state&#160;and federal income tax returns are open to audit under the statute of limitations for the years ended December&#160;31, 2019 through December&#160;31, 2022 and for the years ended December&#160;31, 2020 through December&#160;31, 2022, respectively. The Company is currently under audit for federal and California amended tax years ended December&#160;31, 2019, 2020 and 2021. The Company does not anticipate any significant changes to unrecognized tax benefits over the next 12 months.</span></div></ix:continuation><div id="ib8ab676c07c14f5e97ea961ccac78e95_196"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-1244" continuedAt="f-1244-1" escape="true">Mezzanine and Stockholders&#8217; Equity (Deficit)</ix:nonNumeric></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1244-1" continuedAt="f-1244-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Mezzanine Equity (Deficit)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">APC</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the redemption feature (see Note 2 &#8212; &#8220;Basis of Presentation and Summary of Significant Accounting Policies&#8221;) of APC&#8217;s shares of common stock is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as non-controlling interests in mezzanine or temporary equity. APC&#8217;s shares were not redeemable, and it was not probable that the shares would become redeemable as of December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Stockholders&#8217; Equity</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock &#8211; Series A</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2015, Astrana entered into an agreement with AHM, a wholly owned subsidiary of Astrana, pursuant to which Astrana sold to AHM, and AHM purchased from Astrana, in a private offering of securities, <ix:nonFraction unitRef="shares" contextRef="c-283" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-1245">1,111,111</ix:nonFraction> units, each unit consisting of <ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="f-1246">one</ix:nonFraction> share of Astrana&#8217;s Series A Preferred Stock and a common stock warrant to purchase <ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="f-1247">one</ix:nonFraction> share of Astrana&#8217;s common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-284" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-1248">9.00</ix:nonFraction> per share. AHM paid Astrana an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-1249">10.0</ix:nonFraction> million for the units. Holders of the Company&#8217;s shares of Series A preferred stock are entitled to receive dividends out of legally available assets, on parity with the holders of the Company&#8217;s shares of common stock. The Series A preferred stock has a liquidation preference in the amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-285" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-1250">9.00</ix:nonFraction> per share plus any declared and unpaid dividends, and is convertible into common stock, at the option of the holder thereof, at any time after issuance, at an initial conversion rate of <ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="f-1251">one</ix:nonFraction>-for-one, in each case, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock &#8211; Series B</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2016, Astrana entered into an agreement with AHM pursuant to which Astrana sold to AHM, and AHM purchased from Astrana, in a private offering of securities, <ix:nonFraction unitRef="shares" contextRef="c-286" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-1252">555,555</ix:nonFraction> units, each unit consisting of <ix:nonFraction unitRef="shares" contextRef="c-287" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="f-1253">one</ix:nonFraction> share of Astrana&#8217;s Series B Preferred Stock and a common stock warrant to purchase <ix:nonFraction unitRef="shares" contextRef="c-287" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="f-1254">one</ix:nonFraction> share of Astrana&#8217;s common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-287" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-1255">10.00</ix:nonFraction> per share. AHM paid Astrana an aggregate $<ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="6" id="f-1256">5.0</ix:nonFraction> million for the units. Holders of the Company&#8217;s shares of Series B preferred stock are entitled to receive dividends out of legally available assets, on parity with the holders of the Company&#8217;s shares of common stock. The Series B preferred stock has a liquidation preference in the amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-287" decimals="INF" name="us-gaap:PreferredStockLiquidationPreference" scale="0" id="f-1257">9.00</ix:nonFraction> per share plus any declared and unpaid dividends, and is convertible into common stock, at the option of the holder thereof, at any time after issuance, at an initial conversion rate of <ix:nonFraction unitRef="shares" contextRef="c-287" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" format="ixt-sec:numwordsen" scale="0" id="f-1258">one</ix:nonFraction>-for-one, in each case, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the rights of preferred stockholders, if any, holders of the Company&#8217;s common stock are entitled to receive such dividends, if any, as may be declared from time to time by the Company&#8217;s board of directors, at its discretion, from legally available funds. In the event of a liquidation, dissolution or winding up, the holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of the Company&#8217;s known debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Share Issuances and Repurchases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, Astrana completed its business combination with AHM following the satisfaction or waiver of the conditions set forth in the Agreement and Plan of Merger, dated December 21, 2016, as amended, pursuant to which the merger subsidiary of Astrana merged with and into AHM, with AHM surviving as a wholly owned subsidiary of Astrana (&#8220;2017 Merger&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2017 Merger, former AHM shareholders received Astrana common stock subject to a 10% holdback. As of December&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="asth:StockIssuedDuringPeriodSharesMerger" format="ixt:num-dot-decimal" scale="0" id="f-1259">41,048</ix:nonFraction> holdback shares have not been issued to certain former AHM shareholders who were AHM shareholders at the time of closing of the 2017 Merger, as they have yet to submit properly completed letters of transmittal to Astrana in order to receive their pro rata portion of Astrana common stock as contemplated under the Merger Agreement. Pending such receipt, such former AHM shareholders have the right to receive, without interest, their pro rata share of dividends or distributions with a record date after the effectiveness of the 2017 Merger. The consolidated financial statements </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1244-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered perfunctory and the Company is legally obligated to issue these shares in connection with the 2017 Merger.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC declared dividends of $<ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="6" id="f-1260">58.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="6" id="f-1261">58.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="6" id="f-1262">57.9</ix:nonFraction> million, respectively, to their Series A Preferred shareholders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC declared dividends of $<ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1263">210.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1264">37.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1265">29.9</ix:nonFraction> million, respectively, to their common shareholders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, certain consolidated subsidiaries of the Company paid distributions of $<ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1266">3.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1267">4.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-5" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1268">1.2</ix:nonFraction> million, respectively, to the shareholders who own the non-controlling interests in the entities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, APC owned <ix:nonFraction unitRef="shares" contextRef="c-297" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1269">7,132,698</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-298" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1270">10,299,259</ix:nonFraction> shares of Astrana&#8217;s common stock, respectively. While such shares of Astrana&#8217;s common stock are legally issued and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the consolidated financial statements. APC's ownership in Astrana was <ix:nonFraction unitRef="number" contextRef="c-299" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1271">13.22</ix:nonFraction>% and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-300" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1272">18.12</ix:nonFraction>%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of December&#160;31, 2023 and 2022, respectively.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, Astrana bought back <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-1273">3,451,642</ix:nonFraction> shares of its common stock, which included <ix:nonFraction unitRef="shares" contextRef="c-301" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1274">3,166,561</ix:nonFraction> shares of common stock purchased from APC for $<ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1275">100.0</ix:nonFraction> million on November 14, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the total treasury stock, including the Company&#8217;s stock held by APC, was <ix:nonFraction unitRef="shares" contextRef="c-303" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1276">10,584,340</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-304" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1277">10,299,259</ix:nonFraction>, respectively.</span></div></ix:continuation><div id="ib8ab676c07c14f5e97ea961ccac78e95_202"></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-1278" continuedAt="f-1278-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-1278-1" continuedAt="f-1278-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2017 Merger, the Company assumed the 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;), pursuant to which <ix:nonFraction unitRef="shares" contextRef="c-305" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1279">500,000</ix:nonFraction> shares of the Company&#8217;s common stock were reserved for issuance thereunder. The Company issued new shares to satisfy stock options and warrant exercises under the 2013 Plan. As of December&#160;31, 2023, there were <ix:nonFraction unitRef="shares" contextRef="c-306" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:fixed-zero" scale="0" id="f-1280">no</ix:nonFraction> shares available for future grants under the 2013 Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2017 Merger, the Company assumed the 2015 Equity Incentive Plan (as amended, the &#8220;2015 Plan&#8221;), pursuant to which <ix:nonFraction unitRef="shares" contextRef="c-307" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1281">1,500,000</ix:nonFraction> shares of the Company&#8217;s common stock were reserved for issuance thereunder. The Company&#8217;s stockholders approved an amendment to the 2015 Plan at the 2021 annual meeting of stockholders to increase the maximum number of shares authorized for issuance thereunder by <ix:nonFraction unitRef="shares" contextRef="c-308" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1282">2,000,000</ix:nonFraction> shares, from <ix:nonFraction unitRef="shares" contextRef="c-307" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1283">1,500,000</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="c-309" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-1284">3,500,000</ix:nonFraction> shares. In addition, shares that are subject to outstanding grants under the Company&#8217;s 2013 Plan, but that ordinarily would have been restored to such plans reserve due to award forfeitures and terminations, were rolled into and became available for awards under the 2015 Plan. The 2015 Plan provides for awards, including incentive stock options, non-qualified options, restricted common stock, and stock appreciation rights. The 2015 Plan was approved by Astrana&#8217;s stockholders at Astrana&#8217;s 2016 annual meeting of stockholders that was held in September 2016. As of December&#160;31, 2023, 2022 and 2021, there were approximately <ix:nonFraction unitRef="shares" contextRef="c-310" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="f-1285">0.4</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="c-311" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="f-1286">1.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-309" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="f-1287">1.7</ix:nonFraction> million shares available for future grants under the 2015 Plan, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2023, the Company adopted the Employment Inducement Award Plan (the &#8220;Inducement Plan&#8221;), pursuant to which the Company may from time to time grant equity-based awards to new employees as a material inducement to their employment. Awards granted under the Inducement Plan may be in the form of non-qualified stock options, stock appreciation rights, restricted stock awards, restricted stock units, and other stock-based awards. A total of <ix:nonFraction unitRef="shares" contextRef="c-312" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1288">500,000</ix:nonFraction> shares of the Company&#8217;s common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-312" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-1289">0.001</ix:nonFraction> per share, have been reserved for issuance pursuant to awards granted under the Inducement Plan (subject to adjustment as provided in the Inducement Plan). As of December&#160;31, 2023, there were approximately <ix:nonFraction unitRef="shares" contextRef="c-313" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="f-1290">0.5</ix:nonFraction> million shares available for future grants in the Inducement Plan.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1278-2" continuedAt="f-1278-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-1291" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock-based compensation expense recognized under all of the Company&#8217;s stock plans in 2023, 2022 and 2021, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income recognized (in thousands): </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1292">1,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1293">3,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1294">2,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1295">20,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1296">12,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1297">4,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1298">22,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1299">16,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1300">6,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized compensation expense related to total share-based payments outstanding as of December&#160;31, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1301">32.2</ix:nonFraction>&#160;million and is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="c-320" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1302">2.1</ix:nonNumeric> years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-1303" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding stock options consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at January 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1304">859,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1305">25.88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-31" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1306">2.19</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-1307">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-1308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="f-1309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1310">140,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1311">10.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="f-1312">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options canceled, forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1313">215,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1314">16.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1315">504,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1316">34.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1317">2.10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="f-1318">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-1319">466,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-1320">28.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-1321">1.87</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="f-1322">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023 and 2022, stock options were exercised for <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1323">140,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1324">41,603</ix:nonFraction> shares, respectively, of the Company&#8217;s common stock, which resulted in proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="f-1325">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="f-1326">0.7</ix:nonFraction> million, respectively. The exercise prices ranged from $<ix:nonFraction unitRef="usdPerShare" contextRef="c-95" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1327">10.00</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-96" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1328">18.11</ix:nonFraction> per share for the exercises during the year ended December&#160;31, 2023 and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-323" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1329">15.35</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-324" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1330">23.24</ix:nonFraction> per share for the exercises during the year ended December&#160;31, 2022. The total intrinsic value of stock options exercised was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-1331">3.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-1332">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-1333">2.8</ix:nonFraction> million during the years ended December&#160;31, 2023, 2022 and 2021, respectively. The intrinsic value of stock options is defined as the difference between the Company&#8217;s stock price on the exercise date and the grant date exercise price. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, no options were granted. The weighted-average grant-date fair value of options granted during the years ended December&#160;31, 2022 and 2021 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1334">22.32</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-32" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1335">32.63</ix:nonFraction>, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="f-1336" continuedAt="f-1336-1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unvested restricted stock award activity for the year ended December&#160;31, 2023 consisted of the following:</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1278-3" continuedAt="f-1278-4"><ix:continuation id="f-1336-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.278%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Based Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average <br/>Grant-Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average <br/>Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-325" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1337">539,632</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-325" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1338">72.58</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-326" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1339">289,635</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-326" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1340">41.14</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-327" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1341">480,228</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1342">33.90</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-328" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1343">561,386</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1344">33.61</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-327" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1345">260,637</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1346">39.39</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-328" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1347">158,421</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1348">37.94</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-327" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1349">45,939</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-327" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1350">36.57</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-328" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1351">65,267</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-328" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1352">42.66</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-329" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1353">713,284</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-329" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1354">60.98</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-330" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1355">627,333</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-330" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1356">35.05</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants restricted stock awards to employees and executives, which are earned based on service conditions. The awards will vest over a period of <ix:nonNumeric contextRef="c-331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1357">one month</ix:nonNumeric> to <ix:nonNumeric contextRef="c-332" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1358">four years</ix:nonNumeric> in accordance with the terms of those plans. The grant date fair value of the restricted stock awards is the grant date&#8217;s closing market price of the Company&#8217;s common stock. During the year ended December&#160;31, 2023, the Company granted <ix:nonFraction unitRef="shares" contextRef="c-333" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1359">561,386</ix:nonFraction> shares of restricted stock awards with performance based conditions and <ix:nonFraction unitRef="shares" contextRef="c-333" decimals="0" name="asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" format="ixt:num-dot-decimal" scale="0" id="f-1360">480,228</ix:nonFraction> shares of restricted stock without performance conditions. During the year ended December&#160;31, 2023, the weighted average grant date fair value of restricted stock with and without performance based conditions was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-334" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1361">33.61</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-333" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1362">33.90</ix:nonFraction>, respectively. Shares of restricted stock with performance conditions are recognized to the extent the performance conditions are probable of being achieved. The total fair value of restricted stock awards, as of their respective vesting dates during the years ended December&#160;31, 2023, 2022 and 2021, was $<ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1363">14.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1364">10.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1365">1.1</ix:nonFraction> million, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1278-4">All warrants issued by the Company expired as of December 31, 2022. As a result, there were <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:fixed-zero" scale="0" id="f-1366"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:fixed-zero" scale="0" id="f-1367">no</ix:nonFraction></ix:nonFraction> outstanding warrants as of December&#160;31, 2023 and December&#160;31, 2022. During the twelve months ended December&#160;31, 2022, common stock warrants were exercised for <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-5" name="asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1368">0.9</ix:nonFraction> million shares of the Company&#8217;s common stock, which resulted in proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="asth:WarrantIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="f-1369">9.0</ix:nonFraction> million. The exercise price ranged from $<ix:nonFraction unitRef="usdPerShare" contextRef="c-337" decimals="2" name="asth:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" scale="0" id="f-1370">10.00</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-338" decimals="2" name="asth:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" scale="0" id="f-1371">11.00</ix:nonFraction> per share for the exercises during the twelve months ended December&#160;31, 2022. Of the <ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-5" name="asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1372">0.9</ix:nonFraction> million warrants exercised during the year ended December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="c-291" decimals="-5" name="asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" format="ixt:num-dot-decimal" scale="6" id="f-1373">0.1</ix:nonFraction> million of the common stock warrants were exercised by APC and are treated as treasury shares (see Note 12 &#8212; &#8220;Mezzanine and Stockholders&#8217; Equity&#8221;).</ix:continuation> </span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_208"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1374" continuedAt="f-1374-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-1374-1" continuedAt="f-1374-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws and regulations governing the Medicare program and healthcare generally are complex and subject to interpretation. The Company believes it complies with all applicable laws and regulations and is unaware of any pending or threatened investigations involving allegations of potential wrongdoing. While no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medi-Cal programs.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1374-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a risk-bearing organization, the Company is required to follow regulations of the Department of Managed Health Care (&#8220;DMHC&#8221;). The Company must comply with a minimum working capital requirement, tangible net equity (&#8220;TNE&#8221;) requirement, cash-to-claims ratio, and claims payment requirements prescribed by the DMHC. TNE is defined as net assets less intangibles, less non-allowable assets (which include amounts due from affiliates), plus subordinated obligations.  At December&#160;31, 2023 and 2022, the consolidated IPAs were in compliance with these regulations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the Company&#8217;s payer and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services. Such differing interpretations may not come to light until a substantial period of time has passed following contract implementation. Liabilities for claims disputes are recorded when the loss is probable and can be estimated. Any adjustments to reserves are reflected in current operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Letters of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established irrevocable standby letters of credit with Truist Bank for a total of $<ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1375">36.5</ix:nonFraction> million for the benefit of CMS and certain health plans as of December&#160;31, 2023 (see Note 10 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank for a total of $<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="f-1376">3.9</ix:nonFraction> million, for the benefit of certain health plans as of December&#160;31, 2023 (see Note 10 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of its business. The resolution of any claim or litigation is subject to inherent uncertainty and could have a material adverse effect on the Company&#8217;s financial condition, cash flows, or results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability Insurance</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its insurance coverage is appropriate based upon the Company&#8217;s claims experience and the nature and risks of the Company&#8217;s business. In addition to the known incidents that have resulted in the assertion of claims, the Company cannot be certain that its insurance coverage will be adequate to cover liabilities arising out of claims asserted against the Company, the Company&#8217;s affiliated professional organizations or the Company&#8217;s affiliated hospitalists in the future where the outcomes of such claims are unfavorable. The Company believes that the ultimate resolution of all pending claims, including liabilities in excess of the Company&#8217;s insurance coverage, will not have a material adverse effect on the Company&#8217;s financial position, results of operations, or cash flows; however, there can be no assurance that future claims will not have such a material adverse effect on the Company&#8217;s business. Contracted physicians are required to obtain their own insurance coverage.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contracted physicians are required to carry first-dollar coverage with limits of liability equal to not less than $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1377">1.0</ix:nonFraction>&#160;million for claims based on occurrence up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="asth:ClaimsBasedOnOccurrenceAnAggregateAmount" format="ixt:num-dot-decimal" scale="6" id="f-1378">3.0</ix:nonFraction>&#160;million per year. The Company&#8217;s IPAs purchase stop-loss insurance, which will reimburse them for claims from service providers on a per enrollee basis. The specific retention amount per enrollee per policy period is $<ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="0" id="f-1379">45,000</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="c-340" decimals="-3" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="0" id="f-1380">90,000</ix:nonFraction> for professional coverage.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company currently maintains liability insurance policies on a claims-made basis, which are intended to cover malpractice liability and certain other claims, the coverage must be renewed annually, and may&#160;not continue to be available to the Company in future years at acceptable costs, and on favorable terms.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_214"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-1381" continuedAt="f-1381-1" escape="true">Related-Party Transactions</ix:nonNumeric></span></div><ix:continuation id="f-1381-1" continuedAt="f-1381-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022, and 2021, AHM recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-341" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1382">16.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-342" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1383">21.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-343" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1384">18.7</ix:nonFraction> million, respectively, in management fee income, from LMA. On August 31, 2023, the management service agreement between LMA&#8217;s IPA and AHM was terminated. LMA is accounted for under the equity method based on <ix:nonFraction unitRef="number" contextRef="c-344" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1385">25</ix:nonFraction>% equity ownership interest held by APC (see Note 6 &#8212; &#8220;Investments in Other Entities&#8221;). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1386">2.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-346" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1387">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1388">2.4</ix:nonFraction> million, respectively, to Pacific Medical Imaging and Oncology Center, Inc. (&#8220;PMIOC&#8221;) for provider services. APC and PMIOC have an Ancillary Service Contract together whereby PMIOC provides covered services on behalf of APC to enrollees of the plans of APC. PMIOC is accounted for under the equity method based on <ix:nonFraction unitRef="number" contextRef="c-348" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1389">40</ix:nonFraction>% equity ownership interest held by APC (see Note 6 &#8212; &#8220;Investments in Other Entities&#8221;).</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-349" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1390">1.1</ix:nonFraction> million, to James Song, M.D., a Professional Corporation (&#8220;Song PC&#8221;) for provider services. Song PC is accounted for under the equity method accounting based on <ix:nonFraction unitRef="number" contextRef="c-350" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-1391">25</ix:nonFraction>% equity ownership interest held by a subsidiary of the Company (see Note 6 &#8212; &#8220;Investments in Other Entities&#8221;).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Astrana Board Members and Officers</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, AHM recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-351" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1392">2.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1393">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-353" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1394">1.6</ix:nonFraction> million, respectively, in management fee income from Arroyo Vista Family Health Center (&#8220;Arroyo Vista&#8221;). Arroyo Vista&#8217;s chief executive officer is a member of the Company&#8217;s board of directors. The Company has a managed service agreement with Arroyo Vista. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023 2022 and 2021, the Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1395">0.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-355" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1396">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1397">0.4</ix:nonFraction>&#160;million respectively, to Arroyo Vista for services as a provider. The Company has provider contracts with Arroyo Vista. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-1398">14.1</ix:nonFraction> million in operating lease right-of-use assets and $<ix:nonFraction unitRef="usd" contextRef="c-357" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="f-1399">14.5</ix:nonFraction> million in operating lease liabilities from certain lease agreements with properties that were spun-off as part of the Spin-Off. The chief executive officer of the real estate business managing these properties is also a member of the Company&#8217;s board of directors. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1400">0.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-359" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1401">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1402">0.7</ix:nonFraction> million, respectively, to Advanced Diagnostic Surgery Center for services as a provider. Advanced Diagnostic Surgery Center shares common ownership with certain board members of Astrana. The Company has provider contracts with Advanced Diagnostic Surgery Center.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-361" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1403">0.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1404">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-363" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1405">0.6</ix:nonFraction> million respectively, in rental income from Advanced Diagnostic Surgery Center. Advanced Diagnostic Surgery Center is leasing from a property that is a component of Excluded Assets. The property was spun-off on December 26, 2023, as part of the Spin-Off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="0" id="f-1406">10,000</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-365" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1407">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1408">2.0</ix:nonFraction> million respectively, to Fulgent Genetics, Inc. for services as a provider. One of the Company&#8217;s board members is a board member of Fulgent Genetics, Inc. The Company has provider contracts with Fulgent Genetics, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company incurred approximately $<ix:nonFraction unitRef="usd" contextRef="c-367" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1409">1.3</ix:nonFraction> million in expenses payable to Third Way Health for call center services. One of Astrana&#8217;s officers is a board member of Third Way Health in 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, the Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1410">2.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-369" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1411">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1412">1.3</ix:nonFraction> million, respectively, to Sunny Village Care Center for services as a provider. Sunny Village Care Center shares common ownership with certain Astrana board members and officers. The Company has provider contracts with Sunny Village Care Center. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1381-2" continuedAt="f-1381-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023 and 2022, APC recognized approximately $<ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1413">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1414">0.3</ix:nonFraction> million, respectively, in rental income from Sunny Village Care Center. Sunny Village Care Center is leasing from a property that is a component of Excluded Assets. The property was spun-off on December 26, 2023 as part of the Spin-Off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Company entered into a <ix:nonNumeric contextRef="c-373" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-1415">three-year</ix:nonNumeric> promissory note with Sunny Village Care Center as the borrower for a principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-1416">0.5</ix:nonFraction> million. The loan balance is presented within long-term debt, net of current portion and deferred financing costs in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company incurred rent expense of approximately $<ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="6" id="f-1417">0.1</ix:nonFraction> million from First Commonwealth Property, LLC for office leases. First Commonwealth Property, LLC shares common ownership with certain board members of Astrana. The Company has lease arrangements with First Commonwealth Property, LLC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, Astrana paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-5" name="asth:PaymentMadeToRelatedParty" format="ixt:num-dot-decimal" scale="6" id="f-1418">9.8</ix:nonFraction> million, to purchase Astrana&#8217;s stock from certain board members. During the year ended December&#160;31, 2022, APC paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-377" decimals="-5" name="asth:PaymentMadeToRelatedParty" format="ixt:num-dot-decimal" scale="6" id="f-1419">9.3</ix:nonFraction> million to purchase Astrana&#8217;s stock from a board member. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, AHM paid approximately $<ix:nonFraction unitRef="usd" contextRef="c-378" decimals="-3" name="asth:PaymentMadeToRelatedParty" format="ixt:num-dot-decimal" scale="0" id="f-1420">44,000</ix:nonFraction> to an Astrana board member for consulting services. The Company did not incur any similar expenses for the years ended December&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with Health Source MSO Inc., a California corporation (&#8220;HSMSO&#8221;), Aurion Corporation (&#8220;Aurion&#8221;), and AHMC for services provided to the Company. One of the Company&#8217;s board members is an officer of AHMC, HSMSO, and Aurion. Aurion is also partially owned by one of the Company&#8217;s board members. Revenue with AHMC and HSMSO consists of capitation, risk pool, and miscellaneous fees and expenses consist of claims expense, management fees, and consulting fees. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="f-1421" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth fees incurred and income received related to AHMC, HSMSO, and Aurion (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.042%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.042%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.042%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.042%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.042%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AHMC</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HSMSO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AURION</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AHMC</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HSMSO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AURION</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-379" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1422">49,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-380" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1423">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-381" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:fixed-zero" scale="3" id="f-1424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-382" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1425">56,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-383" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1426">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-384" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:fixed-zero" scale="3" id="f-1427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-385" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1428">20,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1429">822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-387" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1430">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-388" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1431">21,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-389" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1432">1,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-390" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1433">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1434">29,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1435">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-3" sign="-" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1436">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" format="ixt:num-dot-decimal" scale="3" id="f-1437">34,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-3" sign="-" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1438">465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-3" sign="-" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="f-1439">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. Under this agreement, during the years ended December&#160;31, 2023, 2022 and 2021, the Company has recognized risk pool revenue of $<ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-5" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1440">43.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-5" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1441">50.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-5" name="us-gaap:InsuranceServicesRevenue" format="ixt:num-dot-decimal" scale="6" id="f-1442">60.1</ix:nonFraction> million, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-5" name="us-gaap:DeferredCreditsAndOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1443">54.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-5" name="us-gaap:DeferredCreditsAndOtherLiabilities" format="ixt:num-dot-decimal" scale="6" id="f-1444">58.7</ix:nonFraction> million, remained outstanding as of December&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">APC Board Members</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022, and 2021, the Company paid an aggregate of approximately $<ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-5" name="asth:PaymentMadeToRelatedParty" format="ixt:num-dot-decimal" scale="6" id="f-1445">23.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-5" name="asth:PaymentMadeToRelatedParty" format="ixt:num-dot-decimal" scale="6" id="f-1446">34.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-5" name="asth:PaymentMadeToRelatedParty" format="ixt:num-dot-decimal" scale="6" id="f-1447">32.5</ix:nonFraction> million, respectively, to board members for provider services which included approximately $<ix:nonFraction unitRef="usd" contextRef="c-405" decimals="-5" name="asth:PaymentMadeToRelatedParty" format="ixt:num-dot-decimal" scale="6" id="f-1448">4.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-406" decimals="-5" name="asth:PaymentMadeToRelatedParty" format="ixt:num-dot-decimal" scale="6" id="f-1449">3.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-5" name="asth:PaymentMadeToRelatedParty" format="ixt:num-dot-decimal" scale="6" id="f-1450">3.4</ix:nonFraction> million, respectively, to Astrana board members and officers who are also board members and officers of APC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 6, 2023, the Company entered into a stock repurchase agreement with APC, pursuant to which the Company agreed to repurchase approximately $<ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1451">100.0</ix:nonFraction> million, or <ix:nonFraction unitRef="shares" contextRef="c-301" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-1452">3,166,561</ix:nonFraction> shares, of the Company&#8217;s common stock from APC. APC is a consolidated affiliate of the Company of which Dr. Thomas Lam, the Company&#8217;s Co-Chief Executive Officer and President and a director, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder; Dr. Kenneth Sim, the Company&#8217;s Executive Chairman, is Chairman and a director and stockholder; and Dr. Albert Young, the Company&#8217;s Chief Administrative Officer, is Senor Executive Vice President and a stockholder. The Company&#8217;s Board of Directors and the Audit Committee of the Board of Directors approved the proposed repurchase.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1381-3"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, affiliates wholly owned by the Company&#8217;s key personnel, are reported in the accompanying consolidated statements of income on a consolidated basis, together with the Company&#8217;s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company&#8217;s subsidiaries as related-party transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intercompany Transactions</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of corporate practice of medicine laws, the Company uses designated shareholder professional corporations, of which the sole shareholder is a member of the Company&#8217;s key personnel, to engage in certain transactions and make intercompany loans from time to time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For equity method investments, loans receivable and line of credits from related parties, see Note 6 &#8212; &#8220;Investments in Other Entities,&#8221; and Note 7 &#8212; &#8220;Loans Receivable and Loan Receivable &#8212; Related Parties,&#8221; respectively.</span></div></ix:continuation><div id="ib8ab676c07c14f5e97ea961ccac78e95_220"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="f-1453" continuedAt="f-1453-1" escape="true">Employee Benefit Plan</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1453-1">AHM has a qualified 401(k) plan that covers substantially all employees who have completed at least <ix:nonNumeric contextRef="c-1" name="asth:DefinedContributionPlanServicePeriod" format="ixt-sec:durwordsen" id="f-1454">six months</ix:nonNumeric> of service and meet minimum age requirements. Participants may&#160;contribute a portion of their compensation to the plan, up to the maximum amount permitted under Section 401(k) of the Internal Revenue Code. Participants become fully vested after <ix:nonNumeric contextRef="c-1" name="asth:DefinedContributionPlanVestingPeriod" format="ixt-sec:durwordsen" id="f-1455">six years</ix:nonNumeric> of service. AHM matches a portion of the participants&#8217; contributions. AHM&#8217;s matching contributions for the years ended December&#160;31, 2023, 2022, and 2021 were approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="f-1456">0.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="f-1457">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="f-1458">0.4</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_223"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1459" continuedAt="f-1459-1" escape="true">Earnings Per Share</ix:nonNumeric></span></div><ix:continuation id="f-1459-1" continuedAt="f-1459-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to Astrana by the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants. The non-controlling interests in APC are allocated their share of Astrana&#8217;s income from APC&#8217;s ownership of Astrana common stock and this is included in the net income attributable to non-controlling interests on the consolidated statements of income. Therefore, none of the shares of Astrana held by APC are considered outstanding for the purposes of basic or diluted earnings per share computation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, 2022 and 2021, APC held <ix:nonFraction unitRef="shares" contextRef="c-291" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1460">7,132,698</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="c-292" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1461">10,299,259</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-293" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1462">10,925,702</ix:nonFraction> shares of Astrana's common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, restricted stock of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-408" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1463">186,290</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="c-409" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1464">133,480</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and <ix:nonFraction unitRef="shares" contextRef="c-410" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1465">9,137</ix:nonFraction>, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being anti-dilutive. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022, restricted stock with performance conditions of <ix:nonFraction unitRef="shares" contextRef="c-411" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1466">782,484</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-412" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1467">245,478</ix:nonFraction>, respectively, were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of December&#160;31, 2023 or 2022, as applicable.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1468" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the earnings per share computations:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:65.029%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share &#8211; basic</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1469">1.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1470">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-32" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1471">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share &#8211; diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1472">1.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-31" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1473">0.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-32" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1474">1.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1475">46,553,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1476">44,971,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1477">43,828,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1478">46,943,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1479">45,602,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1480">45,403,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="f-1481" escape="true"><ix:continuation id="f-1459-2"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the shares included in the diluted earnings per share computations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:64.589%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1482">46,553,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1483">44,971,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1484">43,828,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-413" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1485">169,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-414" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1486">439,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-415" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1487">495,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-416" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="0" id="f-1488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-417" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="0" id="f-1489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-418" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1490">819,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-408" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1491">51,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-409" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1492">161,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-410" decimals="0" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="0" id="f-1493">259,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" format="ixt:num-dot-decimal" scale="0" id="f-1494">169,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" format="ixt:num-dot-decimal" scale="0" id="f-1495">30,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" format="ixt:fixed-zero" scale="0" id="f-1496">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1497">46,943,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1498">45,602,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-32" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1499">45,403,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div><span><br/></span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_226"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="f-1500" continuedAt="f-1500-1" escape="true">Variable Interest Entities (VIEs)</ix:nonNumeric></span></div><ix:continuation id="f-1500-1" continuedAt="f-1500-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated financial statements include its subsidiaries and consolidated VIEs. A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity&#8217;s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states have laws that prohibit business entities with non-physician owners, such as Astrana and its subsidiaries, from practicing medicine, employing physicians to practice medicine, or exercising control over medical decisions by physicians. These laws are generally referred to as corporate practice of medicine laws. States that have corporate practice of medicine laws permit only physicians to practice medicine, exercise control over medical decisions, or engage in certain arrangements, such as fee-splitting, with physicians. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to these laws, the Company operates by maintaining long-term MSAs with its affiliated IPAs and medical groups, each of which is owned and operated by physicians only, and employs or contracts with additional physicians to provide medical services. AHM  is a wholly owned subsidiary of the Company and has entered into MSAs with several affiliated IPAs, including APC. APC contracts with various HMOs or licensed healthcare service plans, each of which pays a fixed payment (&#8220;capitation&#8221;). In return, APC arranges for the delivery of healthcare services by contracting with physicians or professional medical corporations for primary care and specialty care services. APC assumes the financial risk of the cost of delivering healthcare services in excess of the fixed amounts received. The risk is subject to stop-loss provisions in contracts with HMOs. Some risk is transferred to the contracted physicians or professional corporations. The physicians in the IPA are exclusively in control of, and responsible for, all aspects of the practice of medicine for enrolled patients. In accordance with relevant accounting guidance, APC has been determined to be a VIE of AHM, as AHM is its primary beneficiary with the ability, through majority representation on the APC Joint Planning Board and otherwise, to direct the activities (excluding clinical decisions) that most significantly affect APC&#8217;s economic performance. Therefore, APC and its wholly owned subsidiaries and VIEs are consolidated in the accompanying financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain state laws prohibit a professional corporation that has more than one shareholder from being a shareholder in another professional corporation. As a result, the Company cannot directly own shares in other professional corporations. However, an exception to this regulation permits a professional corporation that has only one shareholder to own shares in another professional corporation. In reliance on this exception, the Company designated certain key personnel as the nominee shareholder of professional corporations which hold controlling and non-controlling ownership interests in several medical corporations. Via a Physician Shareholder Agreement with the nominee shareholder. the Company has the ability to designate another person to be the equity holder of the professional corporation. In addition these entities are managed by the Company&#8217;s wholly owned MSOs via MSA. In accordance with relevant accounting guidance, the professional corporations, and their consolidated medical corporations are consolidated by the Company in the accompanying financial statements. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana Medical and Astrana Health Care Partners were formed in May 2019 and July 2021, respectively, as a designated shareholder professional corporation. The Company&#8217;s Vice Chairman is the sole shareholder of Astrana Medical and Astrana Health Care Partners via a Physician Shareholder Agreement, Astrana makes all the decisions on behalf of Astrana Medical and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1500-2" continuedAt="f-1500-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana Health Care Partners. Astrana has the obligation to absorb losses of, or the right to receive benefits from, Astrana Medical and Astrana Health Care Partners. Therefore, Astrana Medical and Astrana Health Care Partners are controlled by and consolidated by Astrana as the primary beneficiary of the VIEs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2023, Astrana Health Care Partners purchased <ix:nonFraction unitRef="number" contextRef="c-419" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="f-1501">100</ix:nonFraction>% of certain Care Delivery companies (AMG, a Professional Medical Corporation, 1 World Medicine Urgent Care Corporation, and Eleanor Leung M.D., a Professional Medical Corporation) from APC. As a result, these entities are now consolidated by Astrana Health Care Partners instead of APC. On May 1, 2023, Astrana Health Care Partners sold <ix:nonFraction unitRef="number" contextRef="c-420" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="f-1502">25</ix:nonFraction>% of Eleanor Leung M.D. to <ix:nonFraction unitRef="physician" contextRef="c-421" decimals="INF" name="asth:VariableInterestEntityNumberOfPhysicians" format="ixt-sec:numwordsen" scale="0" id="f-1503">two</ix:nonFraction> of its physicians. As a result, Astrana Health Care Partners now owns <ix:nonFraction unitRef="number" contextRef="c-422" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="f-1504">75</ix:nonFraction>% of Eleanor Leung M.D.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="f-1505" continuedAt="f-1505-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes assets that can only be used to settle the liabilities of the Company&#8217;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#8217;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to, or from, affiliates, which are eliminated upon consolidation, are included in the accompanying consolidated balance sheets (in thousands). </span></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><ix:continuation id="f-1505-1" continuedAt="f-1505-2"><ix:continuation id="f-1500-3" continuedAt="f-1500-4"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1506">184,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-1507">113,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:fixed-zero" scale="3" id="f-1508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1509">4,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1510">21,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1511">14,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net &#8211; related party</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1512">58,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1513">62,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-1514">1,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-1515">8,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="f-1516">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1517">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1518">9,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1519">9,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:fixed-zero" scale="3" id="f-1520">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="f-1521">516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable &#8212; related parties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:fixed-zero" scale="3" id="f-1522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-3" name="us-gaap:NotesAndLoansReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1523">2,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts due from affiliates*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:fixed-zero" scale="3" id="f-1524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1525">11,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1526">275,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1527">228,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1528">5,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-1529">106,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1530">60,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1531">62,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1532">140,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1533">133,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable, non-current </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1534">15,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:IncomeTaxesReceivableNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1535">15,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other entities &#8211; equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1536">12,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1537">27,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in a privately held entity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" scale="3" id="f-1538">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" scale="3" id="f-1539">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1540">273,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:OtherLongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1541">304,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="f-1542">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:fixed-zero" scale="3" id="f-1543">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1544">28,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1545">11,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1546">1,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1547">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1548">537,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1549">667,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1550">813,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-1551">896,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1552">32,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1553">27,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="asth:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1554">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="asth:FiduciaryAccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1555">8,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1556">55,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-1557">55,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:DividendsPayableCurrent" scale="3" id="f-1558">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:DividendsPayableCurrent" scale="3" id="f-1559">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-1560">646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-1561">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1562">3,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1563">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1564">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:LongTermDebtCurrent" scale="3" id="f-1565">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount due to affiliates*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1566">107,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:fixed-zero" scale="3" id="f-1567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1568">216,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1569">94,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-1570">7,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-1571">6,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1572">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1573">1,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1505-2"><ix:continuation id="f-1500-4"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1574">28,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1575">12,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1577">26,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="f-1578">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1579">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1580">37,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1581">55,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-423" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1582">253,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-1583">149,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> *</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investment in affiliates represents APC&#8217;s investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#8217;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#8217;s consolidated balance sheets as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2023 and 2022.</span></div></ix:continuation></ix:continuation><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_229"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-1585" continuedAt="f-1585-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-1584" continuedAt="f-1584-1" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="f-1585-1" continuedAt="f-1585-2"><ix:continuation id="f-1584-1" continuedAt="f-1584-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for corporate offices, physicians&#8217; offices, and certain equipment. This includes leases with properties that were spun-off as part of the Spin-Off. These leases have remaining lease terms ranging from <ix:nonNumeric contextRef="c-95" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-1586"><ix:nonNumeric contextRef="c-95" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:durwordsen" id="f-1587">one month</ix:nonNumeric></ix:nonNumeric> to <ix:nonNumeric contextRef="c-96" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:durwordsen" id="f-1588"><ix:nonNumeric contextRef="c-96" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-1589">seventeen years</ix:nonNumeric></ix:nonNumeric>, some of which may include options to extend the leases for up to <ix:nonNumeric contextRef="c-4" name="us-gaap:LesseeFinanceLeaseRenewalTerm1" format="ixt-sec:durwordsen" id="f-1590"><ix:nonNumeric contextRef="c-4" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-1591">ten years</ix:nonNumeric></ix:nonNumeric>, and some of which may include options to terminate the leases within <ix:nonNumeric contextRef="c-1" name="asth:LesseeFinanceLeaseTerminationPeriodIfApplicable" format="ixt-sec:durwordsen" id="f-1592"><ix:nonNumeric contextRef="c-1" name="asth:LesseeOperatingLeaseTerminationPeriodIfApplicable" format="ixt-sec:durwordsen" id="f-1593">one year</ix:nonNumeric></ix:nonNumeric>. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as Consumer Price Index.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, assets recorded under finance leases were $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-1594">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-1595">1.8</ix:nonFraction> million, respectively, and accumulated depreciation associated with finance leases was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1596">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="f-1597">1.0</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company has entered into a lease arrangement for <ix:nonNumeric contextRef="c-4" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-1598">seven years</ix:nonNumeric> with an option to extend an additional <ix:nonNumeric contextRef="c-1" name="asth:LesseeOperatingLeaseOptionToExtendPeriod" format="ixt-sec:durwordsen" id="f-1599">five years</ix:nonNumeric>. The tentative move date is March 2024, once the unit is made available. Base rent during the initial <ix:nonNumeric contextRef="c-4" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-1600">seven-year</ix:nonNumeric> term of the 2024 lease agreement will total $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForLeasingCosts" format="ixt:num-dot-decimal" scale="6" id="f-1601">2.3</ix:nonFraction> million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheets.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-1602" continuedAt="f-1602-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1603">7,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1604">6,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1605">675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1606">564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1607">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1608">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1609">1,025</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="f-1610">649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1611">7,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1612">6,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1585-2"><ix:continuation id="f-1584-2"><ix:continuation id="f-1602-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/>Other information related to leases was as follows (dollars in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flows Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1613">7,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1614">6,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1615">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1616">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-1617">675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-1618">564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1619">25,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-1620">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="f-1621">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="f-1622">971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1623">8.73</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1624">6.66</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-4" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1625">3.00</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1626">3.41</ix:nonNumeric> years</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1627">6.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1628">5.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1629">5.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1630">4.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-1632" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-1631" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.223%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.225%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1633">6,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="f-1634">719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1635">6,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="f-1636">556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1637">6,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="f-1638">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1639">6,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="f-1640">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1641">5,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="f-1642">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1643">21,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:fixed-zero" scale="3" id="f-1644">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1645">53,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1646">1,826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-1647">12,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="f-1648">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1649">40,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1650">1,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1651">4,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="f-1652">646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1653">36,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1654">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_235"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1655" continuedAt="f-1655-1" escape="true">Segments</ix:nonNumeric></span></div><ix:continuation id="f-1655-1" continuedAt="f-1655-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its operating segments in accordance with ASC 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;). The Company currently has <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1656">three</ix:nonFraction> reportable segments consisting of: 1) Care Partners; 2) Care Delivery; and 3) Care Enablement (See Note 1 &#8211; Description of Business). The Company&#8217;s reportable segments changed from <ix:nonFraction unitRef="segment" contextRef="c-31" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1657">one</ix:nonFraction> to <ix:nonFraction unitRef="segment" contextRef="c-70" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1658">three</ix:nonFraction> in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#8217;s chief operating decision maker when reviewing the Company&#8217;s performance as well as an effort to provide additional transparency to investors and other financial statement users which the Company believes will assist in the evaluation of changes in the operating results of the Company&#8217;s segments separate from non-operational factors that affect net income, thus providing insight into both operations and other factors impacting reported results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the performance of its operating segments based on segment revenue growth as well as operating income. Management uses revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors. The Company&#8217;s operations are based in the United States. All revenues of the Company are derived from the United States. The Company&#8217;s segments are not evaluated using asset information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners with a shared vision for coordinated care delivery. Under relevant accounting guidance, while the Company&#8217;s Care Partners &#8211; IPAs and Care Partners &#8211; ACO are <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="asth:NumberOfOperatingSegmentsThatShareSimilarCharacteristics" format="ixt-sec:numwordsen" scale="0" id="f-1659">two</ix:nonFraction> operating segments, they share similar economic characteristics and meet other criteria, which permits the Company to aggregate them into a single reportable segment, which the Company has done. Revenue for this segment is primarily comprised of capitation and risk pool settlements and incentives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. The care delivery organization includes primary care, multi-specialty care, and ancillary care services. Revenue is primarily earned based on fee-for-service reimbursements, capitation, and performance-based incentives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Enablement segment is an integrated, end-to-end clinical and administrative platform powered by the Company&#8217;s proprietary technology suite, which provides operational, clinical, financial, technology, management, and strategic services to enable success in the delivering of high-quality, value-based care for providers and payers. Revenue for this segment is primarily comprised of management and software fees, charged as a percentage of gross revenue or on a per-member-per-month basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other is not a reportable segment and primarily consists of real estate operations and other entities that are individually immaterial. Revenue is primarily comprised of equipment sales and real estate revenue is presented in other income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company&#8217;s reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate costs are unallocated and primarily include corporate initiatives, corporate infrastructure costs and corporate shared costs, such as finance, human resources, legal, and executives.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-1660" continuedAt="f-1660-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1660-1" continuedAt="f-1660-2"><ix:continuation id="f-1655-2" continuedAt="f-1655-3"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1661">1,284,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1662">61,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1663">40,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1664">753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1665">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-434" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1666">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1667">1,386,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-436" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1668">16,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-437" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1669">58,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-438" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1670">95,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-439" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1671">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-440" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1672">170,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-441" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1673">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-442" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1675">1,300,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1676">119,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1677">135,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1678">937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1679">170,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1680">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1681">1,386,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1682">1,182,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1683">96,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1684">59,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="f-1685">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-3" sign="-" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1686">166,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1687">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1688">1,171,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1689">25,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1690">17,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1691">57,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1692">3,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-3" sign="-" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1693">7,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1694">33,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1695">130,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1696">1,208,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1697">114,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1698">116,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1699">4,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-3" sign="-" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1700">174,340</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1701">33,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1702">1,302,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-443" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1703">91,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-444" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1704">5,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1705">19,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1706">3,111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1707">4,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1708">33,171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1709">84,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-449" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1710">1,051,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-450" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1711">49,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1712">42,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1713">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1714">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1715">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1716">1,144,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-456" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1717">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1718">46,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1719">78,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1720">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-460" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1721">124,675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1723">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1724">1,051,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1725">96,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1726">120,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1727">985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1728">124,675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1730">1,144,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1731">944,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1732">73,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1733">51,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="f-1734">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" sign="-" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1735">125,823</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1736">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1737">944,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1738">21,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1739">13,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1740">41,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1741">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" sign="-" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1742">3,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1743">19,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1744">95,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1745">966,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1746">87,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1747">93,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1748">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" sign="-" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1749">128,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1750">19,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1751">1,039,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1752">85,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1753">8,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1754">27,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1755">1,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1756">4,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1757">19,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1758">104,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-469" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1759">709,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1760">28,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1761">35,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1762">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-474" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1764">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1765">773,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-476" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1766">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-477" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1767">18,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1768">71,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1769">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1770">90,543</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1771">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-482" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1772">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1773">709,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1774">46,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1775">107,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-1776">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1777">90,543</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-1778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-1779">773,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1780">607,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1781">37,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1782">41,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" sign="-" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" scale="3" id="f-1783">242</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" sign="-" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1784">89,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="3" id="f-1785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1786">596,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1787">30,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1788">9,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1789">28,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1790">1,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" sign="-" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1791">3,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1792">12,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1793">79,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1794">637,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1795">47,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1796">70,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1797">1,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" sign="-" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1798">92,888</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1799">12,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1800">675,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1801">72,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-1802">540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1803">37,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1804">1,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1805">2,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1806">12,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-1807">98,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance includes general and administrative expenses and depreciation and amortization. </span></div></ix:continuation></ix:continuation><div style="margin-top:12pt;text-align:justify"><ix:continuation id="f-1660-2" continuedAt="f-1660-3"><ix:continuation id="f-1655-3" continuedAt="f-1655-4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1660-3"><ix:continuation id="f-1655-4"> Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.</ix:continuation></ix:continuation> </span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_2019"></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-1808" continuedAt="f-1808-1" escape="true">Fair Value Measurements of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="f-1808-1" continuedAt="f-1808-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="f-1809" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of December&#160;31, 2023 are presented below (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.556%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1810">4,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-1811">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-1812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1813">4,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-1814">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-1815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="f-1816">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-1817">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="f-1818">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-1819">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-1820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="f-1821">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1822">7,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-1823">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-1824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1825">7,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAMG contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-492" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1826">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-493" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1827">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-494" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-1828">5,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-495" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-1829">5,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VOMG contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-496" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-497" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1831">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-498" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="f-1832">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="f-1833">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DMG remaining equity interest purchase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1834">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1835">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1836">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1837">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sun Labs remaining equity interest purchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-505" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-506" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1840">7,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-507" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1841">7,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate collar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-508" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-1842">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-509" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="f-1843">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-510" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-1844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-511" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="f-1845">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-1846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="3" id="f-1847">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1848">21,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1849">22,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Included in cash and cash equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of December&#160;31, 2022 are presented below (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1850">135,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-1851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-1852">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1853">135,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-1854">5,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-1855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="f-1856">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="f-1857">5,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-515" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-1858">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-516" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-1859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-517" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-1860">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-518" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-1861">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-1862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-1863">3,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-1864">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="f-1865">3,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1866">140,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1867">3,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1868">1,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1869">145,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1870">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-525" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-1872">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-526" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-1873">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAMG contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-527" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-528" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1875">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-529" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-1876">5,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-1877">5,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOMG contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1878">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="f-1879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="f-1880">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="f-1881">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG remaining equity interest purchase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1883">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1884">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-538" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1885">8,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun Labs remaining equity interest purchase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:fixed-zero" scale="3" id="f-1887">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-3" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1888">5,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="f-1889">5,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-1890">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-1891">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1892">21,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-1893">21,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Included in cash and cash equivalents</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-1894" continuedAt="f-1894-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of existing Level 3 liabilities is recognized in <span style="-sec-ix-hidden:f-1895">unrealized loss on investments and general and administrative expenses</span> in the accompanying consolidated statements of income. As of December&#160;31, 2023, the reconciliation of our Level 3 liabilities was as follows (in thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1808-2" continuedAt="f-1808-3"><ix:continuation id="f-1894-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-1896">21,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of existing Level 3 liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:num-dot-decimal" scale="3" id="f-1897">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="asth:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid" format="ixt:num-dot-decimal" scale="3" id="f-1898">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="f-1899">21,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:continuation id="f-609-1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, certificates of deposit amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-1900">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-1901">0</ix:nonFraction>, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, equity securities held by the Company are primarily comprised of common stock of Nutex Health, Inc. (formerly known as Clinigence Holdings, Inc.) (&#8220;Nutex&#8221;). In September 2021, Astrana and Nutex entered into a stock purchase agreement in which Astrana purchased shares of common stock, warrants, and potentially additional shares of common stock if certain metrics were not met (such additional shares &#8220;contingent equity securities&#8221;) for $<ix:nonFraction unitRef="usd" contextRef="c-545" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="f-1902">3.0</ix:nonFraction> million. The common stock is included in investments in marketable securities in the accompanying consolidated balance sheets. In May 2022, the Company exercised the warrants and subsequently recognized the shares within investments in marketable securities in the accompanying consolidated balance sheet. In March 2023, the contingent equity securities were settled and the Company received additional Nutex common stock. The additional common stock received from the contingent equity securities is included in investments in marketable securities in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the equity securities were approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-1903">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="f-1904">5.6</ix:nonFraction> million, respectively, in the accompanying consolidated balance sheets. In December 2023, APC sold all of its common stock in a payer partner. <ix:nonNumeric contextRef="c-1" name="us-gaap:GainLossOnInvestmentsTextBlock" id="f-1905" continuedAt="f-1905-1" escape="true">The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:</ix:nonNumeric></span></div><ix:continuation id="f-1905-1"><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total losses recognized on equity securities  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1906">6,629</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1907">19,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less (loss) gains recognized on equity securities sold  </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1908">4,052</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1909">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized losses recognized on equity securities held at end of period  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1910">2,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-1911">21,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-1912" continuedAt="f-1912-1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Swap Agreements and Collar Agreements</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1912-1">The Company is exposed to interest rate risk on its floating-rate debt. APC&#8217;s Excluded Assets entered into interest rate swap agreements to effectively convert its floating-rate debt to a fixed-rate basis. The principal objective of these contracts was to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 10 - &#8220;Credit Facility, Bank Loans, and Lines of Credit,&#8221; for further information on the Company&#8217;s debt. Interest rate swap agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps. The estimated fair value of the interest rate swap agreements was determined using Level 2 inputs. On December 1, 2023, APC&#8217;s Excluded Assets ended the interest rate swap agreements. As of December&#160;31, 2022, the fair value was $<ix:nonFraction unitRef="usd" contextRef="c-546" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="f-1913">3.2</ix:nonFraction> million and was presented within other long-term assets in the accompanying consolidated balance sheets.</ix:continuation> For the years ended December&#160;31, 2023 and 2022, APC recognized unrealized gains of $<ix:nonFraction unitRef="usd" contextRef="c-547" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="f-1914">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-548" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="6" id="f-1915">4.2</ix:nonFraction>&#160;million, respectively. The interest rate swaps were deemed Excluded Assets that were solely for the benefit of APC and its common shareholders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s collar agreement is designed to limit the interest rate risk associated with the Company&#8217;s Revolver Loan. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 10 - &#8220;Credit Facility, Bank Loans, and Lines of Credit,&#8221; for further information on the Company&#8217;s </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1808-3" continuedAt="f-1808-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt. Under the terms of the agreement, the ceiling is <ix:nonFraction unitRef="number" contextRef="c-549" decimals="3" name="asth:DerivativeCeilingInterestRate" scale="-2" id="f-1916">5.0</ix:nonFraction>% and the floor is <ix:nonFraction unitRef="number" contextRef="c-549" decimals="4" name="us-gaap:DerivativeFloorInterestRate" scale="-2" id="f-1917">2.34</ix:nonFraction>%. The collar agreement is not designated as a hedging instrument. Changes in the fair value on this contract is recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized loss on investments. The estimated fair value of the collar was determined using Level 2 inputs. As of December&#160;31, 2023 the fair value of the collar was $<ix:nonFraction unitRef="usd" contextRef="c-549" decimals="-5" name="us-gaap:FairValueHedgeLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1918">0.3</ix:nonFraction>&#160;million and was presented within other long-term liabilities in the accompanying consolidated balance sheets. For the year ended December&#160;31, 2023, the Company recognized an unrealized loss of $<ix:nonFraction unitRef="usd" contextRef="c-550" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="f-1919">0.3</ix:nonFraction>&#160;million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Equity Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana was entitled to additional common stock if Nutex did not pay AHM management fees exceeding a threshold by the end of December 31, 2022. The contingent equity securities are considered to be derivatives but are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and accompanying consolidated statements of cash flows. The Company determined the fair value of the contingent equity security using a probability-weighted model, which includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of recognizing management fees and assigned probabilities to each such scenario in determining fair value. During the year ended December 31, 2023, the metric was not achieved. Subsequently, the common stock received from the contingent equity securities were accounted for as investments in marketable securities (refer to the subsection above on investments in marketable securities and Note 2 - &#8220;Basis of Presentation and Summary of Significant Accounting Policies&#8221; for further information on the Company&#8217;s investments in marketable securities). As of December&#160;31, 2022, the contingent equity securities were valued at $<ix:nonFraction unitRef="usd" contextRef="c-518" decimals="-5" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="6" id="f-1920">1.9</ix:nonFraction> million and were presented within prepaid and other current assets in the accompanying consolidated balance sheets. For the year ended December&#160;31, 2022, when the equity securities were still contingent, the Company recognized unrealized losses of $<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedLoss" format="ixt:num-dot-decimal" scale="6" id="f-1921">2.4</ix:nonFraction>&#160;million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining equity interest purchase</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company entered into a financing obligation to purchase the remaining equity interest in Diagnostic Medical Group of Southern California (&#8220;DMG&#8221;) and Sun Clinical Laboratories (&#8220;Sun Labs&#8221;) within <ix:nonNumeric contextRef="c-551" name="asth:BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" format="ixt-sec:durwordsen" id="f-1922">three years</ix:nonNumeric> from the date the Company consolidated DMG and Sun Labs. The purchase of the remaining DMG equity value is considered a financing obligation with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="c-538" decimals="-5" name="us-gaap:EquityMethodInvestments" scale="6" id="f-1923">8.5</ix:nonFraction> million as of both December&#160;31, 2023 and December&#160;31, 2022. Changes in the fair value of the remaining equity purchase are presented in unrealized loss on investments in the accompanying consolidated statements of income. The purchase of the remaining Sun Labs equity value is considered a financing obligation with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="c-507" decimals="-5" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" scale="6" id="f-1924">7.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-5" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-1925">5.8</ix:nonFraction> million as of December&#160;31, 2023 and December&#160;31, 2022, respectively. For the years ended December&#160;31, 2023 and 2022, the change in the fair value of Sun Labs equity value obligation was $<ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-5" sign="-" name="asth:BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" format="ixt:num-dot-decimal" scale="6" id="f-1926">2.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-554" decimals="-5" sign="-" name="asth:BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" format="ixt:num-dot-decimal" scale="6" id="f-1927">1.7</ix:nonFraction>&#160;million, respectively, and is presented in unrealized loss on investments in the accompanying consolidated statements of income. As the financing obligations are embedded in the non-controlling interest, the non-controlling interests are recognized in other liabilities as of December&#160;31, 2023 and other long-term liabilities as of December&#160;31, 2022 in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent considerations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VOMG</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon consolidating VOMG as a VIE, the purchase price consisted of cash funded upon the close of transaction and additional cash consideration (&#8220;VOMG contingent consideration&#8221;) contingent on VOMG meeting financial metrics for fiscal years 2023 and 2024. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). The contingent consideration is included within other long-term liabilities in the accompanying consolidated balance sheets. The contingent consideration was valued at $<ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="0" id="f-1928">17,000</ix:nonFraction> as of both December&#160;31, 2023 and December&#160;31, 2022. Changes in the VOMG contingent consideration are presented in general and administrative expenses in the accompanying consolidated statements of income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AAMG </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon acquiring <ix:nonFraction unitRef="number" contextRef="c-495" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-1929">100</ix:nonFraction>% of the equity interest in AAMG, the purchase price consisted of cash funded upon close of the transaction and additional consideration (&#8220;AAMG contingent consideration&#8221;) and stock consideration (&#8220;AAMG stock contingent consideration&#8221;) contingent on AAMG meeting revenue and capitated member metrics for fiscal years 2023 (&#8220;2023 metric&#8221;) and 2024 (&#8220;2024 metric&#8221;). If the contingent considerations are met, the settlement will be paid in the Company&#8217;s common stock. The total amount of stock that can be issued for the 2023 and 2024 metrics is <ix:nonFraction unitRef="usd" contextRef="c-495" decimals="INF" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="0" id="f-1930">157,048</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="c-542" decimals="INF" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="0" id="f-1931">184,361</ix:nonFraction>, respectively. The Company determined the fair value of the contingent considerations using a probability-weighted model that includes significant </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1808-4"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AAMG contingent consideration for the 2023 metric was valued at $<ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1932">2.6</ix:nonFraction>&#160;million and presented within other liabilities in the accompanying consolidated balance sheets as of December&#160;31, 2023. The AAMG contingent consideration for the 2024 metric was valued at $<ix:nonFraction unitRef="usd" contextRef="c-556" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1933">2.9</ix:nonFraction>&#160;million and presented within other long-term liabilities in the accompanying consolidated balance sheets as of December&#160;31, 2023. As of December&#160;31, 2022, for capitated member metrics for fiscal years 2023 and 2024, the AAMG contingent consideration was valued at $<ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="f-1934">5.9</ix:nonFraction> million and was presented within other long-term liabilities in the accompanying consolidated balance sheets. Changes in the AAMG contingent consideration are presented in general and administrative expenses in the accompanying consolidated statements of income. The AAMG stock contingent consideration was valued at $<ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-5" name="asth:BusinessCombinationStockContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1935"><ix:nonFraction unitRef="usd" contextRef="c-495" decimals="-5" name="asth:BusinessCombinationStockContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1936">5.6</ix:nonFraction></ix:nonFraction>&#160;million as of December&#160;31, 2023 and 2022 and is included in additional paid-in capital in the accompanying consolidated balance sheets.</span></div></ix:continuation><div id="ib8ab676c07c14f5e97ea961ccac78e95_241"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1937" continuedAt="f-1937-1" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="f-1937-1" continuedAt="f-1937-2"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drawdown on Term Loan and Revolver Loan</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2023, the Company drew down $<ix:nonFraction unitRef="usd" contextRef="c-557" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1938">20</ix:nonFraction>&#160;million on its Term Loan and $<ix:nonFraction unitRef="usd" contextRef="c-558" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-1939">90</ix:nonFraction>&#160;million on its Revolver Loan. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Closing of Acquiring Community Family Care Medical Group IPA, Inc. (&#8220;CFC&#8221;) Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Company entered into an Asset and Equity Purchase Agreement (the &#8220;Purchase Agreement&#8221;) to acquire the partnership interests of Advanced Health Management Systems, L.P. (&#8220;AHMS&#8221;) and certain assets of Community Family Care Medical Group IPA, Inc. (&#8220;CFC&#8221;), which acquisitions the Company expected would occur in two separate closings. In November 2023, AHM also entered into a Stock Purchase Agreement (the &#8220;I Health Purchase Agreement&#8221;) to purchase <ix:nonFraction unitRef="number" contextRef="c-559" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-1940">25</ix:nonFraction>% of the outstanding shares of common stock of I Health, Inc. (&#8220;I Health&#8221;). On January 31, 2024, the first closing under the Purchase Agreement occurred, and the Company completed its acquisition of CFC&#8217;s assets. The Company expects to complete the second closing under the Purchase Agreement and acquire the outstanding general and limited partnership interests of AHMS during the first quarter of 2024, subject to obtaining required regulatory approvals. It is currently expected that the I Health Purchase Agreement closing will occur during the first quarter of 2024. The purchase price consisted of $<ix:nonFraction unitRef="usd" contextRef="c-560" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-1941">93.8</ix:nonFraction>&#160;million cash and <ix:nonFraction unitRef="shares" contextRef="c-560" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1942">631,712</ix:nonFraction> shares of common stock of the Company. In addition, the Purchase Agreement contains earnout payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-561" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="f-1943">15.0</ix:nonFraction>&#160;million cash. The Company is in the process of finalizing its purchase price allocation of CFC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bass Medical Group</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2024, the Company announced its strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. Together, the two organizations will aim to bring high-quality care via value-based arrangements to patients of all insurance types, including Medicare, Medicaid, ACA Marketplace, and Commercial. Astrana has provided BASS Medical Group with a $<ix:nonFraction unitRef="usd" contextRef="c-562" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="f-1944">20</ix:nonFraction>&#160;million senior secured promissory note (&#8220;BASS secured promissory note&#8221;),which is intended to be used, in partnership with Astrana, to continue to grow their footprint and invest in high-quality, high-value, and accessible primary and multi-specialty care for communities across California. The BASS secured promissory note matures on January 11, 2031 and has an interest rate per annum equal to <ix:nonFraction unitRef="number" contextRef="c-563" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1945">2.9</ix:nonFraction>% plus the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator) compounded annually.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advanced Diagnostic and Surgical Center, Inc.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 18, 2023, the Company acquired <ix:nonFraction unitRef="number" contextRef="c-564" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-1946">95</ix:nonFraction>% of the equity interest of Advanced Diagnostic and Surgical Center, Inc. (&#8220;ADSC&#8221;). ADSC is a diagnostic and surgical center that also provides ambulatory surgery services. Certain Astrana board members previously owned ADSC. The transaction was funded with cash. In addition, the arrangement contains earnout payments. The Company is in the process of finalizing its purchase price allocation.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2024, the Company&#8217;s ESPP came into effect. The Company&#8217;s ESPP allows eligible employees to contribute a portion of their eligible earnings toward the semi-annual purchase of the Company&#8217;s common stock at a discounted price, subject to an annual maximum dollar amount. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span><br/></span></div></div><ix:continuation id="f-1937-2"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Shared Savings Program (&#8220;MSSP&#8221;)</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2024, in addition to participating in the ACO REACH Model, one of the Company&#8217;s ACOs will participate in the Medicare Shared Savings Program (&#8220;MSSP&#8221;). The MSSP was created to promote accountability and improve coordination of care for Medicare beneficiaries. The MSSP has multiple risk tracks, and the Company is currently participating in the ENHANCED risk track. Much like the ACO REACH Model, under the MSSP Model, the Company recruits a group of Participant and Preferred (in-network) Providers. Based on the Participant Providers that join the Company&#8217;s ACO, CMS grants the Company a pool of Traditional Medicare patients (beneficiaries) to manage (the &#8220;MSSP Aligned Beneficiaries&#8221;). MSSP Aligned Beneficiaries will receive services from physicians and other medical service providers that are both in-network and out-of-network. Unlike the ACO REACH Program, CMS continues to pay participant and preferred providers on a fee-for-service basis for Medicare covered services provided to MSSP Aligned Beneficiaries. However, the Company continues to bear risk on all Medicare expenditures (both in-network and out-of-network), excluding drug expenditures covered by Medicare Part D, based on a budgetary benchmark established with CMS. The Company&#8217;s shared savings or losses in managing its beneficiaries are generally determined on an annual basis after reconciliation with CMS.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_247"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_250"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.&#160;&#160;&#160;&#160;Controls and Procedures </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, designed to ensure that information required to be disclosed by a company in the reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial and Operating Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial and Operating Officer, concluded that our disclosure controls and procedures were effective as of December&#160;31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate &#8220;internal control over financial reporting,&#8221; as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). A company&#8217;s internal control over financial reporting is a process designed by, or under the supervision of, its principal executive officer and principal financial officer, and effected by such company&#8217;s board of directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and the receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.19pt">Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial and Operating Officer, assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2023, the end of our fiscal year. Our management based its assessment on criteria established in Internal Control&#8212;Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Our management&#8217;s assessment included evaluation and testing of the design and operating effectiveness of key financial reporting controls, process documentation, accounting policies, and our overall control environment.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our management&#8217;s assessment, our management has concluded that our internal control over financial reporting was effective as of December&#160;31, 2023. Our management communicated the results of its assessment to the Audit Committee of our Board of Directors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm, Ernst &amp; Young, LLP, audited our consolidated financial statements for the fiscal year ended December&#160;31, 2023 included in this Annual Report on Form 10-K, and has issued an audit report with respect to the effectiveness of the Company&#8217;s internal control over financial reporting, a copy of which is included below in this Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remediation of Previously Reported Material Weakness</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material weakness in our internal control over financial reporting related to the inadequate design of controls associated with the accounting for income taxes, as disclosed in the Company&#8217;s Annual Report on Form 10-K/A for the year ended December 31, 2022, has been remediated as of December 31, 2023. Specifically, as of December 31, 2022, the Company did not sufficiently design controls to properly analyze, document, and review the completeness and accuracy of the Company&#8217;s assessment of the tax implications of intercompany dividends and the rationale for conclusions with respect to which entities were (or should have been) included in consolidated tax returns.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s remediation actions included, but were not limited to, the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">We implemented controls to ensure the completeness and accuracy of the Company&#8217;s tax filing structure.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">We designed and implemented relevant controls to enable an effective and timely review of the income tax consequences of intercompany transactions and consolidated tax group determinations. This includes the identification of relevant supporting documentation and the retention of sufficient detailed evidence of review procedures performed.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except with respect to the remediation of the material weakness, as described above, there were no changes in our internal control over financial reporting during the quarter ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of Astrana Health, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting<br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Astrana Health, Inc.&#8217;s (formerly known as Apollo Medical Holdings, Inc.) internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Astrana Health, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on the COSO criteria.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2023 and 2022, the related consolidated statements of income, mezzanine and stockholders' equity (deficit) and cash flows for each of the three years in the period ended December 31, 2023, and the related notes and our report dated February 29, 2024 expressed an unqualified opinion thereon.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Definition and Limitations of Internal Control Over Financial Reporting<br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.164%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ernst &amp; Young LLP</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Los Angeles, California<br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;29, 2024</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_253"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.&#160;&#160;&#160;&#160;Other Information</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rule 10b5-1 Trading Plans</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December&#160;31, 2023, none of the Company&#8217;s directors or executive officers <ix:nonNumeric contextRef="c-565" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1947"><ix:nonNumeric contextRef="c-565" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1948">adopted</ix:nonNumeric></ix:nonNumeric>, modified or <ix:nonNumeric contextRef="c-565" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1949"><ix:nonNumeric contextRef="c-565" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1950">terminated</ix:nonNumeric></ix:nonNumeric> any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement&#8221; (as defined in Item 408(c) of Regulation S-K).</span></div><div style="margin-top:12pt;text-indent:36pt"><span><br/></span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_256"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C.&#160;&#160;&#160;&#160;Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_259"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_262"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.&#160;&#160;&#160;&#160;Directors, Executive Officers, and Corporate Governance</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item will be contained in the Company&#8217;s Proxy Statement for the 2024 Annual Meeting to be filed with the SEC not later than 120 days following the end of the Company&#8217;s fiscal year ended December&#160;31, 2023, which information is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted a Code of Ethics that applies to all of its officers, directors and employees. The Code of Ethics is available on the &#8220;Investors&#8221; section of its website, www.astranahealth.com, under the &#8220;Governance&#8212;Governance Documents&#8221; heading. The Company intends to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding an amendment to, or waiver from, a provision of its Code of Ethics by posting such information on its website at the web address and location specified above within four business days following the date of the amendment or waiver. </span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_265"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11.&#160;&#160;&#160;&#160;Executive Compensation</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item will be contained in the Company&#8217;s Proxy Statement for the 2024 Annual Meeting to be filed with the SEC not later than 120 days following the end of the Company&#8217;s fiscal year ended December&#160;31, 2023, which information is incorporated herein by reference.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_268"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12.&#160;&#160;&#160;&#160;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item will be contained in the Company&#8217;s Proxy Statement for the 2024 Annual Meeting to be filed with the SEC not later than 120 days following the end of the Company&#8217;s fiscal year ended December&#160;31, 2023, which information is incorporated herein by reference.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_271"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.&#160;&#160;&#160;&#160;Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item will be contained in the Company&#8217;s Proxy Statement for the 2024 Annual Meeting to be filed with the SEC not later than 120 days following the end of the Company&#8217;s fiscal year ended December&#160;31, 2023, which information is incorporated herein by reference.</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_274"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.&#160;&#160;&#160;&#160;Principal Accounting Fees and Services</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item will be contained in the Company&#8217;s Proxy Statement for the 2024 Annual Meeting to be filed with the SEC not later than 120 days following the end of the Company&#8217;s fiscal year ended December&#160;31, 2023, which information is incorporated herein by reference.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_277"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_280"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.&#160;&#160;&#160;&#160;Exhibits and Financial Statement Schedules</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The following documents are filed as part of this Annual Report on Form 10-K:</span></div><div style="margin-top:12pt;padding-left:76.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Consolidated financial statements</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and notes thereto contained herein are as listed on the &#8220;Index to Consolidated Financial Statements&#8221; in Part II, Item&#160;8 of this Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;padding-left:76.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Financial Statement Schedules</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All financial statement schedules have been omitted, since the required information is not applicable or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the consolidated financial statements and notes thereto included in this Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;padding-left:76.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Exhibits required by Item 601 of Regulation S-K.</span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#8224;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">Agreement and Plan of Merger, dated December&#160;21, 2016, among </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">Astrana Health</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm"> Inc. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">f/k/a </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">Apollo Medical Holdings, Inc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">., </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">Astrana Health Management, Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm"> (f/k/a </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">Network Medical Management, Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">, Apollo Acquisition Corp. and Kenneth Sim, M.D. (incorporated herein by reference to Annex&#160;A to the joint proxy statement/prospectus filed pursuant to Rule&#160;424(b)(3) on November&#160;15, 2017 that is a part of a Registration Statement on Form&#160;S-4).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm#a_annexa">Amendment to the Agreement and Plan of Merger, dated March&#160;30, 2017, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">among Astrana Health</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm"> Inc. (f/k/a Apollo Medical Holdings, Inc)., Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.), Apollo Acquisition Corp. and Kenneth Sim, M.D. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm#a_annexa">(incorporated herein by reference to Annex&#160;A to the joint proxy statement/prospectus filed pursuant to Rule&#160;424(b)(3) on November&#160;15, 2017 that is a part of a Registration Statement on Form&#160;S-4).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417053488/tv477411_ex10-1.htm#:~:text=2%20TO%20AGREEMENT%20AND%20PLAN%20OF%20MERGER%20.,%E2%80%9CCompany%E2%80%9D),%20and%20Kenneth%20Sim,%20M.D.%20(the%20%E2%80%9CShareholders%E2%80%99%20Representative%E2%80%9D).">Amendment No.&#160;2 to the Agreement and Plan of Merger, dated October&#160;17, 2017, </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm#a_annexa">mong Astrana Health</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm#a_annexa">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm#a_annexa"> Inc. (f/k/a Apollo Medical Holdings, Inc)., Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.), Apollo Acquisition Corp. and Kenneth Sim, M.D. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417053488/tv477411_ex10-1.htm#:~:text=2%20TO%20AGREEMENT%20AND%20PLAN%20OF%20MERGER%20.,%E2%80%9CCompany%E2%80%9D),%20and%20Kenneth%20Sim,%20M.D.%20(the%20%E2%80%9CShareholders%E2%80%99%20Representative%E2%80%9D).">(incorporated herein by reference to Annex&#160;A to the joint proxy statement/prospectus filed pursuant to Rule&#160;424(b)(3) on November&#160;15, 2017 that is a part of a Registration Statement on Form&#160;S-4).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025049/tv520199_ex2-4.htm">Stock Purchase Agreement, dated March 15, 2019, by and between Allied Physicians of California, APC-LSMA Designated Shareholder Medical Corporation, and Dr. Kevin Tyson (incorporated herein by reference to Exhibit 2.4 to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 10, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465920057432/tm2018794d1_ex2-1.htm">Stock Purchase Agreement, dated as of December 31, 2019, among Bright Health Company of California, Inc., the sellers party thereto, Universal Care, Inc., the seller representatives set forth therein, and Bright Health, Inc. (solely for purposes of Section 13.22 thereto) (incorporated herein by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on May 6, 2020).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420415002897/v398912_ex3-1.htm">Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on January 21, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420415025170/v408340_ex3-1.htm">Certificate of Amendment of Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on April 27, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417063540/tv481301_ex3-1.htm">Certificate of Amendment of Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on December 13, 2017).</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420418035195/tv496923_ex3-1.htm">Certificate of Amendment of Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420418035195/tv496923_ex3-1.htm">on </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420418035195/tv496923_ex3-1.htm">June 21, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465924006988/tm244161d1_ex3-1.htm">Certificate of Amendment of Restated Certificate of Incorporation (effective February 26, 2024) (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on January 26, 2024).</a></span></div><div><span><br/></span></div><div><span><br/></span></div></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465924028972/tm247268d2_ex3-1.htm">Amended and Restated By-laws (effective February 28, 2024) (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on February 29, 2024).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420415059991/v422440_ex3-1.htm">Certificate of Designation of Series A Convertible Preferred Stock (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on October 19, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex3-1.htm">Amended and Restated Certificate of Designation of Astrana Health, Inc (f/k/a Apollo Medical Holdings, Inc.) (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on April 4, 2016).</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit41-descriptionofsec.htm">Description of Registered Securities.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-2015equityincen.htm">2015 Equity Incentive Plan of the Company (as amended and restated February 26, 2024). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit102-formofrestricte.htm">Form of Restricted Stock Agreement (2015 Equity Incentive Plan). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit103-formofrestricte.htm">Form of Restricted Stock Unit Agreement (2015 Equity Incentive Plan). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit104-formofincentive.htm">Form of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit104-formofincentive.htm">Incentive Stock Option Agreement (2015 Equity Incentive Plan).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit105-formofnonqualif.htm">Form of Nonqualified Stock Option Agreement (2015 Equity Incentive Plan). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-14.htm">Board of Directors Agreement dated May&#160;22, 2013 by and between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-14.htm">Astrana Health, Inc (f/k/a </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-14.htm">Apollo Medical Holdings, Inc.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-14.htm">)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-14.htm">, and David Schmidt (incorporated herein by reference to Exhibit 10.14 to the Company&#8217;s Annual Report on Form&#160;10-K filed on May&#160;8, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420416076130/v429126_ex10-2.htm">Board of Directors Agreement between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-14.htm">Astrana Health, Inc (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420416076130/v429126_ex10-2.htm"> and Thomas S. Lam, M.D. dated January&#160;19, 2016 (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K filed on January&#160;19, 2016.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417063540/tv481301_ex10-1.htm">Form of Board of Directors Agreement (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on December&#160;13, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417063540/tv481301_ex10-2.htm">Form of Director Proprietary Information Agreement (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K filed on December&#160;13, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420417063540/tv481301_ex10-3.htm">Form of Indemnification Agreement (incorporated herein by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form&#160;8-K filed on December&#160;13, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1011-physiciansha.htm">Physician Shareholder Agreement, effective as of July 14, 2021, as amended by Amendment No. 1, dated October 19, 2023, granted and delivered by Thomas Lam, M.D., in favor of Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.) and Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.), for the benefit of Astrana Care Partners Medical Corporation (f/k/a AP-AMH 2 Medical Corporation), a California professional medical corporation.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  </span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414068523/v393189_ex10-5.htm">Second Amendment to Lease Agreement dated October&#160;14, 2014 by and between Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.) and EOP-700 North Brand,&#160;LLC (incorporated herein by reference to Exhibit 10.5 on Quarterly Report on Form&#160;10-Q filed on November&#160;14, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414072756/v395966_ex10-01.htm">Lease Agreement, dated July&#160;22, 2014, by and between Numen,&#160;LLC and Astrana Health</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414072756/v395966_ex10-01.htm"> Medical Management</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420414072756/v395966_ex10-01.htm"> (f/k/a Apollo Medical Management, Inc.) (incorporated herein by reference to Exhibit 10.01 to the Company&#8217;s Current Report on Form&#160;8-K/A filed on December&#160;8, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420418018690/tv489499_ex10-27.htm">Lease Agreement, dated August 1, 2002, by and between Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.) and Medical Property Partner. (incorporated herein by reference to Exhibit 10.27 to the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420418018690/tv489499_ex10-28.htm">Lease Agreement, dated August 1, 2002, by and between Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.) and Medical Property Partner. (incorporated herein by reference to Exhibit 10.28 to the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420418018690/tv489499_ex10-29.htm">Lease Agreement Addendum, dated February 1, 2013, by and between Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.) and Medical Property Partner. (incorporated herein by reference to Exhibit 10.29 to the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420415059991/v422440_ex10-1.htm">Securities Purchase Agreement, dated October 14, 2015, between Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.) and Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.) (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on October 19, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex10-1.htm">Securities Purchase Agreement, dated March 30, 2016, between Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.) and Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.) (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 4, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Board of Directors Agreement, dated January 11, 2019, between Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.) and Linda Marsh. (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 17, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z2.htm">Board of Directors Agreement, dated January 11, 2019, between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z2.htm"> and John Chiang. (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on January 17, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-1.htm">Loan Agreement, dated May 10, 2019, by and between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-1.htm">, a Delaware corporation and Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation), a California professional medical corporation (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 13, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419042604/tv528615_ex10-3.htm">First Amendment to Loan Agreement, dated August 26, 2019, by and between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419042604/tv528615_ex10-3.htm"> and</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-1.htm">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419042604/tv528615_ex10-3.htm">, a Professional Medical Corporation (incorporated herein by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed on August 29, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-10.htm">Second Amendment to Loan Agreement, dated September 11, 2019, by and between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-10.htm">, a Delaware corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-1.htm">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-10.htm">, a California professional medical corporation (incorporated herein by reference to Exhibit 10.10 to the Company's Current Report on Form 8-K filed on September 12, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-3.htm">Tradename Licensing Agreement, dated May 10, 2019, by and between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-3.htm">, a Delaware corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-1.htm">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-3.htm">, a California professional medical corporation (incorporated herein by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on May 13, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-5.htm">First Amendment to Tradename Licensing Agreement, dated as of September 10, 2019, by and between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-5.htm">, a Delaware corporation, and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-1.htm">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-5.htm">, a California professional medical corporation (incorporated herein by reference to Exhibit 10.5 to the Company's Current Report on Form 8-K filed on September 12, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-5.htm">Physician Shareholder Agreement, dated May 10, 2019, granted by Thomas Lam, M.D., in favor of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-5.htm">, a Delaware corporation, and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-4.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-5.htm">, a California corporation, for the benefit of AP-AMH Medical Corporation, a California professional medical corporation (incorporated herein by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on May 13, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-6.htm">Series A Preferred Stock Purchase Agreement, dated May 10, 2019, by and between Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation), a California professional medical corporation and Allied Physicians of California, a Professional Medical Corporation, a California professional medical corporation (incorporated herein by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K filed on May 13, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420419042604/tv528615_ex10-2.htm">First Amendment to the Series A Preferred Stock Purchase Agreement dated August 26, 2019, by and between Allied Physicians of California, a California Professional Medical Corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-6.htm">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000114420419042604/tv528615_ex10-2.htm">, a Professional Medical Corporation (incorporated herein by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on August 29, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-3.htm">Second Amendment to Series A Preferred Stock Purchase Agreement, dated as of September 9, 2019, by and between Allied Physicians of California, a Professional Medical Corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-6.htm">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-3.htm">, a California professional medical corporation (incorporated herein by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on September 12, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-7.htm">Special Purpose Shareholder Agreement of Allied Physicians of California, dated May 10, 2019, by and between Allied Physicians of California, a Professional Medical Corporation, a California professional medical corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-6.htm">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-7.htm">, a California professional medical corporation (incorporated herein by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed on May 13, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-4.htm">First Amendment to Special Purpose Shareholder Agreement of Allied Physicians of California, dated as of September 11, 2019, by and between Allied Physicians of California, a Professional Medical Corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-6.htm">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-4.htm">, a California professional medical corporation (incorporated herein by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on September 12, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-8.htm">Stock Purchase Agreement, dated May 10, 2019, by and between Allied Physicians of California, a Professional Medical Corporation, a California professional medical corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-8.htm">, a Delaware corporation (incorporated herein by reference to Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K filed on May 13, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419042604/tv528615_ex10-1.htm">First Amendment to Stock Purchase Agreement, dated August 26, 2019, by and between Allied Physicians of California, a California Professional Medical Corporation and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419042604/tv528615_ex10-1.htm"> (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on August 29, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-7.htm">Security Agreement, dated as of September 11, 2019, in favor of Apollo Medical Holdings, Inc., a Delaware corporation, by </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-6.htm">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-7.htm">, a California professional medical corporation (incorporated herein by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed on September 12, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465924000337/tm2333902d1_ex10-1.htm">Amended Certificate of Determination of Preferences of Series A Preferred Stock of Allied Physicians of California, a Professional Medical Corporation (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 2, 2024).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-9.htm">Voting and Registration Rights Agreement, dated as of September 11, 2019, by and between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-9.htm">, a Delaware corporation, and Allied Physicians of California, a Professional Medical Corporation (incorporated herein by reference to Exhibit 10.9 to the Company&#8217;s Current Report on Form 8-K filed on September 12, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419046557/tv530294_ex10-1.htm">Board of Directors Agreement, dated September 29, 2019, with Matthew Mazdyasni (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on September 30, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1012020063010-qngksim.htm">Employment Agreement, dated June 8, 2020, between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-4.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1012020063010-qngksim.htm"> and Kenneth Sim, M.D. (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 10, 2020).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1022020063010qngtlam.htm">Employment Agreement, dated June 8, 2020, between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-4.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1022020063010qngtlam.htm"> and Thomas Lam, M.D. (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 10, 2020).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1052020063010qngayou.htm">Employment Agreement, dated June 8, 2020, between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-4.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1052020063010qngayou.htm"> and Albert Young, M.D. (incorporated herein by reference to Exhibit 10.5 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 10, 2020).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1062020063010qngbsim.htm">Employment Agreement, dated June 8, 2020, between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-4.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1062020063010qngbsim.htm"> and Brandon </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1062020063010qngbsim.htm">K. </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1062020063010qngbsim.htm">Sim</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1062020063010qngbsim.htm">, M.S.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828020012247/ex1062020063010qngbsim.htm"> (incorporated herein by reference to Exhibit 10.6 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 10, 2020).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828022021959/ex1012022063010qngcbasho.htm">Employment Agreement, dated April 12, 2022, between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-4.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828022021959/ex1012022063010qngcbasho.htm"> and Chandan Basho (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 9, 2022).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001083446/000162828021016083/ex102021063010-q.htm">Amended and Restated Credit Agreement dated as of June 16,2021, by and among </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001083446/000162828021016083/ex102021063010-q.htm">, as Borrower, the Lenders from time to time party thereto, and Truist Bank, in its capacity as administrative agent for the Lenders, as issuing bank and as swingline lender. (incorporated herein by reference to Exhibit 10 to the Company&#8217;s Quarterly Report on Form 10-Q filed on August 6,2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828023005871/exh1055-firstamendmentto.htm">First Amendment to Amended and Restated Credit Agreement dated as of December 20,2022, by and among </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000162828023005871/exh1055-firstamendmentto.htm">, as Borrower, the Lenders from time to time party thereto, and Truist Bank, in its capacity as administrative agent for the Lenders, as issuing bank and as swingline lender (incorporated herein by reference to Exhibit 10.55 to the Company&#8217;s Annual Report on Form 10-K filed on March 1, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923099360/tm2325794d1_ex10-1.htm">Second Amendment to Amended and Restated Credit Agreement and Waiver, dated as of September 8, 2023, by and among </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923099360/tm2325794d1_ex10-1.htm">, as borrower, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-4.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923099360/tm2325794d1_ex10-1.htm">, as guarantor, the lenders party thereto, and Truist Bank, as administrative agent, issuing bank and swingline lender (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on September 8, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/tm2329882d1_ex10-1.htm">Third Amendment to Amended and Restated Credit Agreement and Incremental Agreement, dated as of November 3, 2023, by and among </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/tm2329882d1_ex10-1.htm">, as borrower, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-4.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115255/tm2329882d1_ex10-1.htm">, as guarantor, the lenders party thereto, and Truist Bank, as administrative agent, issuing bank and swingline lender (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 7, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-2.htm">Guaranty and Security Agreement dated as of September 11, 2019, by and among </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-2.htm">, as Borrower, and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025470/tv521268_ex10-4.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419044449/tv529206_ex10-2.htm">, as Guarantor, in favor of SunTrust Bank, as administrative agent for the Secured Parties (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on September 12, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1048-astranaemploye.htm">Employee Stock Purchase Plan of the Company (amended and restated effective February 26, 2024). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1049-astrananonqual.htm">Nonqualified Deferred Compensation Plan (amended and restated effective February 26, 2024).  </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115249/tm2330057d3_ex10-1.htm">Stock Repurchase Agreement, dated November 6, 2023, between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1083446/000155335019000061/ameh_ex10z1.htm">Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115249/tm2330057d3_ex10-1.htm"> and Allied Physicians of California, a Professional Medical Corporation (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 7, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115243/tm2330057d1_ex10-1.htm">Asset and Equity Purchase Agreement, dated as of November 7, 2023, by and among Metropolitan IPA, a California professional corporation, Astrana Health Enablement of CA LLC (f/k/a ApolloCare Enablement of CA, LLC), Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.), Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.), Community Family Care Medical Group IPA, Inc., Advanced Health Management Systems, L.P., Accie M. Mitchell and Gloria C. Mitchell, as Co-Trustees of the Mitchell Family Trust dated July 2, 2003, CFC Management, LLC, the other parties thereto and Marc Mitchell, as the Equityholder Representative (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 7, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465924009754/tm244783d1_ex10-1.htm">Amendment No. 1 to Asset and Equity Purchase Agreement, dated as of January 31, 2024, by and among Metropolitan IPA, a California professional corporation, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115243/tm2330057d1_ex10-1.htm">Astrana Health Enablement of CA LLC (f/k/a ApolloCare Enablement of CA, LLC), Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.), Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465924009754/tm244783d1_ex10-1.htm">, Community Family Care Medical Group IPA, Inc., Advanced Health Management Systems, L.P., Accie M. Mitchell and Gloria C. Mitchell, as Co-Trustees of the Mitchell Family Trust dated July 2, 2003, CFC Management, LLC, the other parties thereto and Marc Mitchell, as the Equityholder Representative (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 2, 2024).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115243/tm2330057d1_ex10-2.htm">Stock Purchase Agreement, dated as of November 7, 2023, by and among </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115243/tm2330057d1_ex10-1.htm">Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923115243/tm2330057d1_ex10-2.htm">, I Health, Inc., Ronald Brandt and Allison Brandt (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on November 7, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.54+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1054-astranaxemploy.htm">Employment Inducement Award Plan of the Company (amended and restated effective February 26, 2024).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.55+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923119527/tm2330755d1_ex10-2.htm">Form of Stock Option Agreement (Employment Inducement Award Plan) (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on November 17, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56+</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1083446/000110465923119527/tm2330755d1_ex10-3.htm">Form of Restricted Stock Agreement (Employment Inducement Award Plan) (incorporated herein by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on November 17, 2023).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.57+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1057-formofstockopt.htm">Form of Stock Option Agreement (Employment Inducement Award Plan) (2024).</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:9.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.292%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.705%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.58+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1058-formofrestrict.htm">Form of Restricted Stock Agreement (Employment Inducement Award Plan) (2024).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.59+*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1059-formofrestrict.htm">Form of Restricted Stock Unit Agreement (Employment Inducement Award Plan) (2024).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.60+&#8224;*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1060-kumaremploym.htm">Employment Agreement, dated January 23, 2024, by and between ApolloCare Enablement of Nevada and Dinesh Kumar, MD.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.61*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1061-loanandsecur.htm">Loan and Security Agreement, dated January 31, 2024, by and between AP-AMH 2 Medical Corporation, a California professional corporation, and Apollo Medical Holdings, Inc. </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.62*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1062-securedpromi.htm">Secured Promissory Note, dated January 31, 2024, between AP-AMH 2 Medical Corporation, a California professional corporation, as the Borrower, and Apollo Medical Holdings, Inc., as the Lender.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit191-insidertradingp.htm">Astrana Health, Inc. Insider Trading Policy (last revised</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit191-insidertradingp.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit191-insidertradingp.htm">February 26, 2024).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1*  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="asth-20231231xexx211.htm">Subsidiaries of Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="asth-20231231xexx231.htm">Consent of Ernst &amp; Young LLP, Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Power of Attorney (included on the signatures page of this Annual Report on Form 10-K).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="asth-20231231xexx311.htm">Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="asth-20231231xexx312.htm">Certification of Principal </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="asth-20231231xexx312.htm">F</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="asth-20231231xexx312.htm">i</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="asth-20231231xexx312.htm">nancial</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="asth-20231231xexx312.htm"> Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="asth-20231231xexx32.htm">Certification of Principal Executive Officers and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.1*</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit971-asthxcompensati.htm">Astrana Health, Inc. Compensation Recovery Policy (last revised February 26, 2024). </a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;Management contract or compensatory plan, contract or arrangement</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request. </span></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_283"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.&#160;&#160;&#160;&#160;Form 10-K Summary</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_286"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:41.275%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.949%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.476%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 29, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brandon K. Sim, M.S.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brandon K. Sim, M.S.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><div id="ib8ab676c07c14f5e97ea961ccac78e95_289"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints, jointly and severally,  Brandon K. Sim, M.S., as their true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place, and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934 this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.204%"><tr><td style="width:1.0%"/><td style="width:4.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.582%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.107%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNATURE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TITLE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DATE</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Brandon K. Sim, M.S.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive&#160;Officer and President (Principal Executive Officer)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brandon K. Sim, M.S.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Chandan Basho </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial and Operating Officer (Principal Financial Officer)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chandan Basho</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John Vong</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Accounting Officer (Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Vong</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kenneth Sim</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Chairman, Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kenneth Sim, M.D</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas Lam</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice Chairman, Director</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas Lam, M.D., M.P.H.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John Chiang</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John Chiang</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Weili Dai</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weili Dai</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ J. Lorraine Estradas</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. Lorraine Estradas</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mitchell Kitayama</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mitchell Kitayama</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Linda Marsh</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda Marsh</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew Mazdyasni</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Mazdyasni</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David Schmidt</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Schmidt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>exhibit41-descriptionofsec.htm
<DESCRIPTION>EX-4.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i1d60408351af408eba9bab74e888745e_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 4.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESCRIPTION OF ASTRANA HEALTH, INC. REGISTERED SECURITIES</font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">The following summarizes the terms and provisions of the common stock of Astrana Health, Inc., a Delaware corporation (the &#8220;Company&#8221;), which common stock is registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). The summary does not purport to be complete and is qualified in its entirety by reference to the Company&#8217;s Restated Certificate of Incorporation (as amended, the &#8220;Certificate of Incorporation&#8221;) and Amended and Restated By-Laws (the &#8220;Bylaws&#8221;), which the Company has previously filed with the Securities and Exchange Commission, and applicable Delaware law.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Authorized Capital</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company has 100,000,000 shares of common stock, par value $0.001 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share, authorized for issuance, of which 1,111,111 preferred shares are designated as Series&#160;A convertible preferred stock (&#8220;Series&#160;A preferred stock&#8221;) and 555,555 preferred shares are designated as Series&#160;B convertible preferred stock (&#8220;Series&#160;B preferred stock&#8221;).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Voting</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Holders of the Company&#8217;s common stock are entitled to one vote for each share for the election of directors and on all other matters submitted to a stockholder vote. Holders of the Company&#8217;s common stock do not have cumulative voting rights.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Dividends</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the rights of preferred stockholders, if any, holders of the Company&#8217;s common stock are entitled to receive such dividends, if any, as may be declared from time to time by the board of directors, in its discretion, from legally available funds.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Liquidation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of a liquidation, dissolution or winding up, the holders of the Company&#8217;s common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of the Company&#8217;s known debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Rights and Preferences</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding shares of common stock are duly authorized, fully paid and non-assessable. Holders of common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences, and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that the Company has designated or may designate in the future.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Stock Exchange Listing</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The common stock is listed on The Nasdaq Stock Market LLC under the trading symbol &#8220;ASTH.&#8221;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Registration Rights</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain of the Company&#8217;s outstanding shares of common stock have registration rights.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Transfer Agent</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The transfer agent for the Company&#8217;s common stock is Pacific Stock Transfer, a Securitize company. &#8195;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Preferred Stock</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under the terms of the Certificate of Incorporation, the Company&#8217;s board of directors is authorized to provide for the issuance of up to 5,000,000 shares of preferred stock in one or more series, to establish the number of shares to be included in each series, and to fix the designation, powers, including voting rights, if any, preferences, and relative, participating, optional and other rights and the qualifications, limitations and restrictions thereof. The issuance of preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. In addition, the issuance of preferred stock </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">could have the effect of delaying, deferring or preventing a change of control of the Company or other corporate action.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company has 1,666,666 shares of preferred stock designated and issued, consisting of 1,111,111 shares of Series&#160;A preferred stock and 555,555 shares of Series&#160;B preferred stock, all of which are held by Astrana Health Management, Inc., a wholly-owned subsidiary of the Company (&#8220;AHM&#8221;). As AHM is a wholly-owned subsidiary of the Company, pursuant to the Delaware General Corporation Law, the shares held by AMH are not entitled to vote or to be counted for quorum purposes with respect to the Company&#8217;s stockholder actions. Holders of the Company&#8217;s shares of Series&#160;A preferred stock and Series&#160;B preferred stock are entitled to receive dividends, out of legally available assets, on parity with the holders of the Company&#8217;s shares of common stock. The Series&#160;A preferred stock and Series&#160;B preferred stock have an initial liquidation preference in the amount of $9.00 per share, plus any declared and unpaid dividends, and are convertible into common stock, at the option of the holder thereof, at any time after issuance, at an initial conversion rate of one-for-one, in each case, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-Takeover Provisions</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following provisions of the Certificate of Incorporation and Bylaws could have the effect of delaying or discouraging another party from acquiring control of the Company and could encourage persons seeking to acquire control of the Company to first negotiate with the Company&#8217;s board of directors&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the Bylaws require holders of not less than one-tenth of all shares entitled to vote at a meeting to call a special meeting of stockholders&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the Certificate of Incorporation and Bylaws provide that the board of directors will establish the authorized number of directors from time to time&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the Certificate of Incorporation does not permit cumulative voting in the election of directors&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">the Certificate of Incorporation permits the board of directors to determine the rights, privileges and preferences of any new series of preferred stock, some of which could impede the ability of a person to acquire control of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company is subject to Section&#160;203 of the Delaware General Corporation Law (&#8220;Section&#160;203&#8221;), which generally prohibits a public Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder unless&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned by (i) persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#59; or</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In general, Section&#160;203 defines &#8220;business combination&#8221; to include the following&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any merger or consolidation involving the corporation and the interested stockholder&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of transactions), except proportionately as a stockholder of such corporation, to or with the interested stockholder, of assets of the corporation, which assets have an aggregate market value equal to 10% or more of either the aggregate market value of all the assets of the corporation determined on a consolidated basis or the aggregate market value of all the outstanding stock of the corporation&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder&#59;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">subject to certain exceptions, any transaction involving the corporation that has the effect, directly or indirectly, of increasing the interested stockholder&#8217;s proportionate share of the stock of any class or series, or securities convertible into the stock of any class or series, of the corporation&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">any receipt by the interested stockholder of the benefit, directly or indirectly (except proportionately as a stockholder of such corporation), of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In general, Section&#160;203 defines an &#8220;interested stockholder&#8221; as an entity or person that, together with the person&#8217;s affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.</font></div><div><font style="font-family:'Tahoma',sans-serif;font-size:10pt;font-weight:400;line-height:100%"></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Authorized and Unissued Shares</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Company&#8217;s authorized and unissued shares of common stock are available for future issuance without stockholder approval except as may otherwise be required by applicable regulations or Delaware law.  The Company may issue additional shares for a variety of purposes, including future offerings to raise additional capital, to fund acquisitions and as employee, director and consultant compensation. The existence of authorized but unissued shares of common stock could render more difficult, or discourage an attempt, to obtain control of the Company by means of a proxy contest, tender offer, merger or otherwise.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The issuance of shares of preferred stock by the Company could have certain anti-takeover effects under certain circumstances, and could enable the Company&#8217;s board of directors to render more difficult or discourage an attempt to obtain control of the Company by means of a merger, tender offer or other business combination transaction directed at the Company by, among other things, placing shares of preferred stock with investors who might align themselves with the board of directors.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>exhibit101-2015equityincen.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ia0b6bdc2c30644eebc29ef4d681921b4_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2015 EQUITY INCENTIVE PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(Amended and Restated Effective February 26, 2024)</font></div><div style="padding-left:0.5pt;padding-right:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purpose, History and Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Astrana Health, Inc. 2015 Equity Incentive Plan has two complementary purposes&#58; (i) to attract and retain outstanding individuals to serve as officers, employees, directors or consultants and (ii) to increase stockholder value. The Plan will provide participants incentives to increase stockholder value by offering the opportunity to acquire shares of the Company&#8217;s common stock or receive monetary payments based on the value of such common stock on the potentially favorable terms that this Plan provides.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">History</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Prior to the effective date of this Plan, the Company had in effect the 2010 Plan and the 2013 Plan, which were originally effective March 4, 2010 and April 30, 2013, respectively. Upon adoption of this Plan by the Board, no new awards will be granted under the 2013 Plan. No awards have been granted under the 2010 Plan since the effectiveness of the 2013 Plan.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Plan became effective, and Awards may be granted under this Plan, on and after the Effective Date&#59; provided, however, that prior to approval of this Plan by the Company&#8217;s stockholders, but after adoption by the Board, Incentive Stock Options may be granted under this Plan subject to obtaining the stockholders&#8217; approval of this Plan&#59; and provided, further, that such stockholder approval must occur no later than 12 months after the date of adoption of this Plan by the Board. This Plan will terminate as provided in Section 14. The Plan is amended and restated as set forth herein, effective February 26, 2024.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Capitalized terms used in this Plan have the following meanings&#58;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) &#8220;2010&#8221; Plan means the Company&#8217;s 2010 Equity Incentive Plan.</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) &#8220;2013 Plan&#8221; means the Company&#8217;s 2013 Equity Incentive Plan.</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) &#8220;Affiliate&#8221; has the meaning ascribed to such term in Rule 12b-2 promulgated under the Exchange Act or any successor rule or regulation thereto.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) &#8220;Award&#8221; means a grant of Options, Stock Appreciation Rights, Performance Shares, Performance Units, Restricted Stock, Restricted Stock Units or Dividend Equivalent Units.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) &#8220;Award Agreement&#8221; means a written agreement, contract, or other instrument or document evidencing the grant of an Award in such form as the Committee determines.</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f) &#8220;Board&#8221; means the Board of Directors of the Company.</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g) &#8220;Change of Control&#8221; means the occurrence of any one of the following events&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) the consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if more than fifty percent (50%) of the combined voting power of the continuing or surviving entity&#8217;s securities outstanding immediately after such merger, consolidation or other reorganization is owned by Persons who were not stockholders of the Company immediately prior to such merger, consolidation or other reorganization&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) the sale, transfer or other disposition of all or substantially all of the Company&#8217;s assets&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) a change in the composition of the Board, as a result of which fewer than fifty percent (50%) of the incumbent directors are directors who either (A) had been directors of the Company on the date twenty-four (24) months prior to the date of the event that may constitute a Change of Control (the &#8220;original directors&#8221;) or (B) were elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the aggregate of the original directors who were still in office at the time of the election or nomination and the directors whose election or nomination was previously so approved&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv) any transaction as a result of which any Person is the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing at least fifty percent (50%) of the total voting power represented by the Company&#8217;s then outstanding voting securities. For purposes of this paragraph (iv), the term &#8220;Person&#8221; shall exclude (A) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or a Subsidiary and (B) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A transaction shall not constitute a Change of Control if its sole purpose is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything herein contained to the contrary, with respect to an Award that is or may be considered deferred compensation subject to Code Section 409A, the definition of &#8220;Change of Control&#8221; herein shall be amended and interpreted in a manner that allows the definition to satisfy the requirements of a change of control under Code Section 409A solely for purposes of complying with the requirements of Code Section 409A.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h) &#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended. Any reference to a specific provision of the Code includes any successor provision and the regulations promulgated under such provision.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) &#8220;Committee&#8221; means the Compensation Committee of the Board (or a successor committee with the same or similar authority), except as otherwise provided in Section 3(b).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(j) &#8220;Company&#8221; means Astrana Health, Inc., a Delaware corporation (formerly known as Apollo Medical Holdings, Inc.), or any successor thereto.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(k) &#8220;Director&#8221; means a member of the Board, and &#8220;Non-Employee Director&#8221; means a Director who is not also an employee of the Company or its Subsidiaries.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(l) &#8220;Disability&#8221; has the meaning ascribed to the term in Code Section 22(e)(3), as determined by the Committee.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(m) &#8220;Disinterested Persons&#8221; means the &#8220;non-employee directors&#8221; of the Company as such term is defined in Rule 16b-3.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(n) &#8220;Dividend Equivalent Unit&#8221; means the right to receive a payment equal to the cash dividends paid with respect to a Share.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(o) &#8220;Effective Date&#8221; means the earlier to occur of the date this Plan is (i) adopted by the Board or (ii) approved by the Company&#8217;s stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(p) &#8220;Exchange Act&#8221; means the Securities Exchange Act of 1934, as amended. Any reference to a specific provision of the Exchange Act includes any successor provision and the regulations and rules promulgated under such provision.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(q) &#8220;Fair Market Value&#8221; means, per Share on a particular date, (i) if the Stock is listed for trading on the Nasdaq Stock Market, the last reported sales price on the date in question as reported in The Wall Street Journal, or if no sales of Stock occur on the date in question, on the last preceding date on which there was a sale on such exchange&#59; or (ii) if the Stock is not listed or admitted to trading on the Nasdaq Stock Market, the last reported sales price on the date in question on the principal national securities exchange on which the Stock is listed or admitted to trading, or if no sales of Stock occur on the date in question, on the last preceding date on which there was a sale on such exchange&#59; or (iii) if the Stock is not listed or admitted to trading on any national securities exchange, the last sales price on the date in question in the over-the-counter market reported by such reporting system as is then in use, or if no sales of Stock occur on the date in question, on the last preceding date on which there was a sale&#59; or (iv) if on any such date the Stock is not reported on any such system, the last sales price on the date in question as furnished by a professional market making a market in the Stock selected by the Board for the date in question, or if no sales of Stock occur on the date in question, on the last preceding date on which there was a sale&#59; or (v) if on any such date no market maker is making a market in the Stock, the price as determined in good faith by the Committee.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(r) &#8220;Incentive Stock Option&#8221; means an Option that meets the requirements of Code Section 422.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(s) &#8220;Option&#8221; means the right to purchase Shares at a specified price during a specified period of time.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(t) &#8220;Participant&#8221; means an individual (or a wholly-owned entity of such individual) selected by the Committee to receive an Award, and includes any individual who holds an Award after the death of the original recipient.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(u) &#8220;Performance Goals&#8221; means any goals the Committee establishes that relate to one or more of the following for such period as the Committee specifies&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) Revenue&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) &#160;Earnings before interest, taxes, depreciation and amortization, as adjusted (EBITDA as adjusted)&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) Income before income taxes and minority interests&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv) Operating income&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v) &#160;Pre- or after-tax income&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi) Average accounts receivable&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii) &#160;Cash flow&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(viii) Cash flow per share&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ix) &#160;Net earnings&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(x) Basic or diluted earnings per share&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xi) &#160;Return on equity&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xii) Return on assets&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xiii) &#160;Return on capital&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xiv) Growth in assets&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xv) &#160;Economic value added&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xvi) Share price performance&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xvii) &#160;Total stockholder return&#59;</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xviii) Improvement or attainment of expense levels&#59;</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xix) &#160;Market share or market penetration&#59; or</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(xx) Business expansion, and&#47;or acquisitions or divestitures.</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee may specify at the time an Award is made that the Performance Goals are to be measured for an individual, the Company, for the Company on a consolidated basis, for any one or more Affiliates or divisions of the Company and&#47;or for any other business unit or units of the Company, and&#47;or that the Performance Goals are to be measured either in absolute terms or relative to the performance of one or more comparable companies or an index covering multiple companies. In the case of Awards that the Committee determines will not be considered &#8220;performance based compensation&#8221; under Code Section 162(m), the Committee may establish other Performance Goals not listed in this Plan.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v) &#8220;Performance Shares&#8221; means the right to receive Shares to the extent Performance Goals are achieved.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(w) &#8220;Performance Units&#8221; means the right to receive a payment, based on a number of units with a specified value, to the extent Performance Goals are achieved.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(x) &#8220;Person&#8221; has the meaning given in Section 3(a)(9) of the Exchange Act, as modified and used in Sections 14(d) and 15(d) thereof.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(y) &#8220;Plan&#8221; means this Astrana Health, Inc. 2015 Equity Incentive Plan, as may be amended from time to time.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(z) &#8220;Restricted Stock&#8221; means Shares that are subject to a risk of forfeiture and&#47;or restrictions on transfer, which may lapse upon the achievement or partial achievement of Performance Goals and&#47;or upon the completion of a period of service.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(aa) &#8220;Restricted Stock Unit&#8221; means the right to receive a payment which right may vest upon the achievement or partial achievement of Performance Goals and&#47;or upon the completion of a period of service, with each unit having a value equal to the Fair Market Value of one or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">more Shares, or the average of the Fair Market Value of one or more Shares over such period as the Committee specifies.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(bb) &#8220;Retirement&#8221; means, unless the Committee determines otherwise in an Award Agreement, termination of employment from the Company and its Affiliates on or after age 65 with five (5) years of continuous service with the Company and its Affiliates.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(cc) &#8220;Rule 16b-3&#8221; means Rule 16b-3 as promulgated by the United States Securities and Exchange Commission under the Exchange Act.&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(dd) &#8220;Section 16 Participants&#8221; means Participants who are subject to the provisions of Section 16 of the Exchange Act.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ee) &#8220;Share&#8221; means a share of Stock.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ff) &#8220;Stock&#8221; means the common stock of the Company.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(gg) &#8220;Stock Appreciation Right&#8221; or &#8220;SAR&#8221; means the right to receive a payment equal to the appreciation of the Fair Market Value of a Share during a specified period of time.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(hh) &#8220;Subsidiary&#8221; means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if each such corporation owns stock possessing fifty percent (50%) or more of the total combined voting power in one of the other corporations in the chain.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Committee Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to the authority specifically granted to the Committee in this Plan, the Committee has full discretionary authority to administer this Plan, including but not limited to the authority to (i) interpret the provisions of this Plan, (ii) prescribe, amend and rescind rules and regulations relating to this Plan, (iii) correct any defect, supply any omission, or reconcile any inconsistency in the Plan, any Award or Award Agreement in the manner and to the extent it deems desirable to carry this Plan, such Award or such Award Agreement into effect and (iv) make all other determinations necessary or advisable for the administration of this Plan. All decisions, interpretations and other actions of the Committee shall be final and binding on all Participants and any other individual with a right under the Plan or under any Award.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delegation to Other Committees or CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent applicable law permits, the Board may delegate to another committee of the Board, or the Committee may delegate to a subcommittee or to the Chief Executive Officer of the Company, any or all of the authority and responsibility of the Committee&#59; provided, however, that no such delegation shall be permitted with respect to Awards made to Section 16 Participants. The Board may retain any or all of the authority and responsibility of the Committee, or may delegate to another committee or subcommittee of the Board consisting solely of two or more Disinterested Persons any or all of the authority and responsibility of the Committee, with respect to Section 16 Participants. If the Board or Committee has retained such authority or made such a delegation, then all references to the Committee in this Plan include the Board, such other committee, subcommittee or the Chief Executive Officer to the extent of such retained authority or delegation.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to such other rights of indemnification as they may have as members of the Board or the Committee, the members of the Board and the Committee shall be indemnified by the Company against all costs and expenses reasonably incurred by them in connection with any action, suit or proceeding to which they or any of them may be party by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">reason of any action taken or failure to act under or in connection with the Plan or any Award, and against all amounts paid by them in settlement thereof (provided such settlement is approved by independent legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such action, suit or proceeding, except a judgment based upon a finding of bad faith&#59; provided that upon the institution of any such action, suit or proceeding a Committee or Board member shall, in writing, give the Company notice thereof and an opportunity, at its own expense, to handle and defend the same before such Committee or Board member undertakes to handle and defend it on such member&#8217;s own behalf.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee may designate any of the following as a Participant from time to time&#58; (i) any officer or other employee of the Company or any of its Affiliates&#59; (ii) an individual that the Company or an Affiliate has engaged to become an officer or other employee&#59; (iii) a Non-Employee Director&#8217; or (iv) a consultant or advisor who provides bona fide services that are not in connection with the offer or sale of securities in a capital raising transaction, and does not directly or indirectly promote or maintain a market for the Company&#8217;s securities to the Company or an Affiliate as an independent contractor. The Committee&#8217;s designation of a Participant in any year will not require the Committee to designate such person to receive an Award in any other year. Notwithstanding the foregoing, each Non-Employee Director automatically will be a Participant with respect to elections to receive Options in lieu of directors&#8217; fees pursuant to Section 12.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Types of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms of this Plan, the Committee may grant any type of Award to any Participant it selects, but only employees of the Company or a Subsidiary may receive grants of Incentive Stock Options. Awards may be granted alone or in addition to, in tandem with, or in substitution for any other Award (or any other award granted under another plan of the Company or any Affiliate). Awards granted under the Plan shall be evidenced by an Award Agreement except to the extent the Committee provides otherwise.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Shares Reserved under this Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to adjustment as provided in Section 16, an aggregate of 3,500,000 Shares, plus the number of Shares described in Section 6(c), are reserved for issuance under this Plan. The number of Shares reserved for issuance under this Plan shall be reduced only by the number of Shares delivered in payment or settlement of Awards. Notwithstanding the foregoing, the Company may issue only 3,500,000 Shares upon the exercise of Incentive Stock Options.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Replenishment of Shares Under this Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If an Award lapses, expires, terminates or is cancelled without the issuance of Shares under the Award, or if Shares are forfeited under an Award, then the Shares subject to such Award may again be used for new Awards under this Plan under Section 6(a), including issuance upon the exercise of Incentive Stock Options. If Shares are issued under any Award and the Company subsequently reacquires them pursuant to rights reserved upon the issuance of the Shares, or if previously owned Shares are delivered to the Company in payment of the exercise price of an Award or the withholding taxes due as a result of the issuance or receipt of a payment or Shares under an Award, then such Shares may again be used for new Awards under this Plan under Section 6(a), but such Shares may not be issued upon the exercise of Incentive Stock Options.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Addition of Shares from Predecessor Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. After the Effective Date, if any Shares subject to awards granted under the 2010 Plan or 2013 Plan would again become available for new grants under the terms of such plan, then those Shares will be available for the purpose of granting Awards under this Plan, thereby increasing the number of Shares available for issuance under this Plan as determined under the first sentence of Section 6(a), including with respect to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the exercise of Incentive Stock Options. Any such Shares will not be available for future awards under the respective terms of the 2010 Plan and 2013 Plan after the Effective Date.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to adjustment as provided in Section 16, with respect to Awards that are intended to qualify as &#8220;performance-based compensation&#8221; under Code Section 162(m), no Participant may be granted Awards that could result in such Participant&#58;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) receiving in any calendar year Options for, and&#47;or Stock Appreciation Rights with respect to, more than 500,000 Shares (reduced, in the initial calendar year in which this Plan is effective, by the number of options granted to a Participant under the 2010 Plan and&#47;or 2013 Plan in such year, if any), except that Options and&#47;or Stock Appreciation Rights granted to a new employee in the calendar year in which his or her employment commences may not relate to more than 1,000,000 Shares&#59;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) &#160;receiving in any calendar year Awards of Restricted Stock and&#47;or Restricted Stock Units relating to more than 500,000 Shares&#59;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) receiving in any calendar year Awards of Performance Shares, and&#47;or Awards of Performance Units (the value of which is based on the Fair Market Value of a Share), for more than 500,000 Shares&#59; or</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv) receiving in any calendar year Awards of Performance Units (the value of which is not based on the Fair Market Value of a Share) that could result in a payment of more than $500,000.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to Awards that are not intended to meet the requirements of performance- based compensation under Code Section 162(m), the Committee may grant Awards in excess of the limits described in this subsection (d), but only if such discretion would not cause Awards that are intended to be performance-based compensation under Code Section 162(m) from being treated as such.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms of this Plan, the Committee shall determine all terms and conditions of each Option, including but not limited to&#58;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) Whether the Option is an Incentive Stock Option, or a &#8220;nonqualified stock option&#8221; which does not meet the requirements of Code Section 422&#59; provided that Incentive Stock Options may only be granted to individuals and that in the case of an Incentive Stock Option, if the aggregate Fair Market Value (determined at the time of grant) of the Shares with respect to which all Incentive Stock Options are first exercisable by the Participant during any calendar year (under this Plan and under all other incentive stock option plans of the Company or any Affiliate that is required to be included under Code Section 422) exceeds $100,000, such Option automatically shall be treated as a nonqualified stock option to the extent this limit is exceeded.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) The number of Shares subject to the Option.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) The exercise price per Share, which may not be less than the Fair Market Value of a Share as determined on the date of grant&#59; provided that (i) no Incentive Stock Option shall be granted to any employee who, at the time the Option is granted, owns (directly or indirectly, within the meaning of Code Section 424(d)) more than ten percent of the total combined voting power of all classes of stock of the Company or of any Subsidiary unless the exercise price is at least 110 percent of the Fair Market Value of a Share on the date of grant&#59; and (ii) the exercise price may vary during the term of the Option if the Committee determines that there should be adjustments to the exercise price relating to achievement of Performance Goals and&#47;or to changes in an index or indices that the Committee determines is appropriate (but in no event may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the exercise price per Share be less than the Fair Market Value of a Share as determined on the date of grant).</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) The terms and conditions of exercise, which may include a requirement that exercise of the Option is conditioned upon achievement of one or more Performance Goals or may provide for an acceleration of the exercisability upon the Participant&#8217;s death, Disability or Retirement.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) The termination date, except that each Option must terminate no later than the tenth (10th) anniversary of the date of grant, and each Incentive Stock Option granted to any employee who, at the time the Option is granted, owns (directly or indirectly, within the meaning of Code Section 424(d)) more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any Subsidiary must terminate no later than the fifth (5th) anniversary of the date of grant. Notwithstanding the foregoing, the Committee may extend the term of an Option for up to six (6) months beyond the tenth (10th) anniversary of the date of grant in the event a Participant dies prior to the Option&#8217;s termination date.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f) The exercise period following a Participant&#8217;s termination of employment or service. In all other respects, the terms of any Incentive Stock Option should comply with the provisions of Code Section 422 except to the extent the Committee determines otherwise.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g) Notwithstanding anything contained in this Plan to the contrary, the Board as a whole shall pre-approve each option grant to Non-Employee Directors.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms of this Plan, the Committee shall determine all terms and conditions of each SAR, including but not limited to&#58;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) Whether the SAR is granted independently of an Option or relates to an Option&#59; provided that if an SAR is granted in relation to an Option, then unless otherwise determined by the Committee, the SAR shall be exercisable or shall mature at the same time or times, on the same conditions and to the extent and in the proportion, that the related Option is exercisable and may be exercised or mature for all or part of the Shares subject to the related Option. Upon exercise of any number of SARs, the number of Shares subject to the related Option shall be reduced accordingly and such Option may not be exercised with respect to that number of Shares. The exercise of any number of Options that relate to an SAR shall likewise result in an equivalent reduction in the number of Shares covered by the related SAR.</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) The number of Shares to which the SAR relates.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) The grant price, provided that the grant price shall not be less than the Fair Market Value of the Shares subject to the SAR as determined on the date of grant.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) The terms and conditions of exercise or maturity, which may include a provision that accelerates the exercisability of the SAR upon the Participant&#8217;s death, Disability or Retirement. Notwithstanding the foregoing, unless the Committee determines otherwise in the Award Agreement, if on the date when the SAR expires or otherwise terminates, the grant price for the SAR is less than the Fair Market Value of a Share, then the unexercised portion of the SAR that was exercisable immediately prior to such date shall automatically be deemed exercised.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) The term, provided that an SAR must terminate no later than 10 years after the date of grant. Notwithstanding the foregoing, the Committee may extend the term of an SAR for up to six (6) months beyond the tenth (10th) anniversary of the date of grant in the event a Participant dies prior to the SAR&#8217;s termination date.</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f) Whether the SAR will be settled in cash, Shares or a combination thereof.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g) Notwithstanding anything contained in this Plan to the contrary, the Board as a whole shall pre-approve each SAR grant to Non-Employee Directors.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Performance Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms of this Plan, the Committee shall determine all terms and conditions of each award of Performance Shares or Performance Units, including but not limited to&#58;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) The number of Shares and&#47;or units to which such Award relates, and with respect to Performance Units, whether the value of each unit will be based on the Fair Market Value of one or more Shares, the average of the Fair Market Value of one or more Shares over such period as the Committee specifies, or such other value as the Committee specifies in the Award Agreement.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) One or more Performance Goals that must be achieved during such period as the Committee specifies in order for the Participant to realize the benefit of such Award.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) Whether all or a portion of the Performance Goals subject to an Award are deemed achieved upon a Participant&#8217;s death, Disability or Retirement.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) With respect to Performance Units, whether to settle such Award in cash, Shares, or a combination of cash and Shares.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) Notwithstanding anything contained in this Plan to the contrary, the Board as a whole shall pre-approve each Award grant under this Section 9 to Non-Employee Directors.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Unless otherwise provided by the Committee, a Participant shall not be entitled to and shall agree to waive or otherwise surrender any rights to receive dividends or dividend equivalents paid with respect to Performance Shares or Performance Units valued in Shares until after the Performance Shares or Performance Units have been earned.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock and Restricted Stock Unit Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Subject to the terms of this Plan, the Committee shall determine all terms and conditions of each award of Restricted Stock or Restricted Stock Units, including but not limited to&#58;</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a) The number of Shares and&#47;or units to which such Award relates.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b) The period of time over which the restrictions imposed on Restricted Stock will lapse and the vesting of Restricted Stock Units will occur, and whether, as a condition for the Participant to realize all or a portion of the benefit provided under the Award, one or more Performance Goals must be achieved during such period as the Committee specifies&#59; provided that, subject to the provisions of Section 10(c), an Award that is subject to the achievement of Performance Goals must have a restriction or vesting period of at least one year, and an Award that is not subject to Performance Goals must have a restriction or vesting period of at least three years. Notwithstanding the foregoing, if the Committee determines in its sole discretion that an Award of Restricted Stock or Restricted Stock Units is granted to a Participant in lieu of cash compensation (including without limitation bonus cash compensation), the Committee may impose such restriction or vesting period on such Award as it determines.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c) Whether all or any portion of the restrictions or vesting schedule imposed on the Award will lapse or be accelerated upon a Participant&#8217;s death, Disability or Retirement.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d) With respect to Restricted Stock Units, whether to settle such Awards in cash, Shares, or a combination of cash and Shares.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e) With respect to Restricted Stock, the manner of registration of certificates for such Shares, and whether to hold such Shares in escrow pending lapse of the restrictions or to issue such Shares with an appropriate legend referring to such restrictions.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f) Whether dividends paid with respect to an Award of Restricted Stock will be immediately paid or held in escrow or otherwise deferred and whether such dividends shall be subject to the same terms and conditions as the Award to which they relate.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g) Notwithstanding anything contained in this Plan to the contrary, the Board as a whole shall pre-approve each grant under this Section 10 to Non-Employee Directors.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11. &#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Equivalent Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms and conditions of this Plan, the Committee shall determine all terms and conditions of each award of Dividend Equivalent Units, including but not limited to whether such Award will be granted in tandem with another Award, and the form, timing and conditions of payment.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12. &#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Directors&#8217; Fees in Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to such restrictions as may be imposed by the Board, a Non-Employee Director may elect to receive all or any portion of his or her annual cash retainer payment from the Company in the form of Options. The number of Options granted as a result of such election shall be determined by multiplying the amount of foregone cash compensation by four (4), and dividing such product by the Fair Market Value of a Share on the date the cash compensation would have otherwise been paid to the Non-Employee Director.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Such Options shall be issued under and subject to the terms of this Plan. An election under this Section 12 shall be filed with the Company on such form and in such manner as the Board determines. The Board as a whole shall pre-approve each option grant under this Section 12.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13. &#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Awards are not transferable other than by will or the laws of descent and distribution, unless and to the extent the Committee allows a Participant to&#58; (a) designate in writing a beneficiary to exercise the Award after the Participant&#8217;s death&#59; or (b) transfer an Award.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14. &#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination and Amendment of Plan&#59; Amendment, Modification or Cancellation of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Plan will terminate on the tenth anniversary of the Effective Date unless the Board or Committee earlier terminates this Plan pursuant to Section 14(b).</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination and Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Board or the Committee may amend, suspend or terminate this Plan at any time, subject to the following limitations&#58;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) the Board must approve any amendment, suspension or termination of this Plan to the extent the Company determines such approval is required by&#58; (A) action of the Board, (B) applicable corporate law, (C) the listing requirements of any principal securities exchange or market on which the Shares are then traded, or (D) any other applicable law&#59;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) &#160;stockholders must approve any amendment of this Plan to the extent the Company determines such approval is required by&#58; (A) Section 16 of the Exchange Act, (B) the Code, (C) the listing requirements of any principal securities exchange or market on which the Shares are then traded, or (D) any other applicable law&#59; and</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) stockholders must approve any of the following Plan amendments&#58; (A) an amendment to materially increase any number of Shares specified in Section 6(a) or 6(d) (except as permitted by Section 16)&#59; or (B) an amendment to the provisions of Section 14(e).</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment, Modification or Cancellation of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as provided in Section 14(e) and subject to the requirements of this Plan, the Committee may modify or amend any Award or waive any restrictions or conditions applicable to any Award or the exercise of the Award, and the terms and conditions applicable to any Awards may at any time be amended, modified or canceled by mutual agreement between the Committee and the Participant, so long as any amendment or modification does not increase the number of Shares issuable under this Plan (except as permitted by Section 16), but the Committee need not obtain Participant (or other interested party) consent for the cancellation of an Award pursuant to the provisions of Section 16(a) or the modification of an Award to the extent deemed necessary to comply with any applicable law or the listing requirements of any principal securities exchange or market on which the Shares are then traded, or to preserve favorable accounting treatment of any Award for the Company.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Survival of Authority and Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding the foregoing, the authority of the Board and the Committee under this Section 14 will extend beyond the date of this Plan&#8217;s termination. In addition, termination of this Plan will not affect the rights of Participants with respect to Awards previously granted to them, and all unexpired Awards will continue in force and effect after termination of this Plan except as they may lapse or be terminated by their own terms and conditions.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Repricing and Backdating Prohibited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in this Plan to the contrary, and except for the adjustments provided in Section 16, neither the Committee nor any other person may decrease the exercise or grant price for any outstanding Option or SAR after the date of grant, cancel an outstanding Option or SAR in exchange for cash or other Awards (other than cash or other Awards with a value equal to the excess of the Fair Market Value of the Shares subject to such Option or SAR at the time of cancellation over the exercise or grant price for such Shares) or allow a Participant to surrender an outstanding Option or SAR to the Company as consideration for the grant of a new Option or SAR with a lower exercise price. In addition, the Committee may not make a grant of an Option or SAR with a grant date that is effective prior to the date the Committee takes action to approve such Award.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To assure the viability of Awards granted to Participants employed in foreign countries, the Committee may provide for such special terms as it may consider necessary or appropriate to accommodate differences in local law, tax policy or custom. Moreover, the Committee may approve such supplements to, or amendments, restatements or alternative versions of, this Plan as it determines is necessary or appropriate for such purposes. Any such amendment, restatement or alternative versions that the Committee approves for purposes of using this Plan in a foreign country will not affect the terms of this Plan for any other country. In addition, all such supplements, amendments, restatements or alternative versions must comply with the provisions of Section 14(b)(ii).</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Recoupment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any Awards granted pursuant to the Plan, and any Stock issued or cash paid pursuant to an Award, shall be subject to (A) any recoupment, clawback, equity holding, stock ownership or similar policies adopted by the Company from time to time and (B) any recoupment, clawback, equity holding, stock ownership or similar requirements made applicable by law, regulation or listing standards to the Company from time to time.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company is entitled to withhold the amount of any tax attributable to any amount payable or Shares deliverable under this Plan after giving the person entitled to receive such amount or Shares notice as far in advance as practicable, and the Company may defer making payment or delivery if any such tax may be pending unless and until indemnified to its satisfaction.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of Shares to Satisfy Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. A Participant shall have the right to satisfy all or a portion of the federal, state and local withholding tax obligations arising in connection with an Award by electing to (i) have the Company withhold Shares otherwise issuable under the Award, (ii) tender back Shares received in connection with such Award or (iii) deliver other previously owned Shares, in each case having a Fair Market Value equal to the amount to be withheld. However, the amount to be withheld may not exceed the total minimum federal, state and local tax withholding obligations associated with the transaction to the extent required to avoid an expense on the Company&#8217;s financial statements. The election must be made on or before the date as of which the amount of tax to be withheld is determined and otherwise as the Committee requires.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Guarantee of Tax Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any provision of the Plan to the contrary, the Company does not guarantee to any Participant or any other person with an interest in an Award that (i) any Award intended to be exempt from Code Section 409A shall be so exempt, (ii) any Award intended to comply with Code Section 409A or Code Section 422 shall so comply, or (iii) any Award shall otherwise receive a specific tax treatment under any other applicable tax law, nor in any such case will the Company or any Affiliate be obligated to indemnify, defend or hold harmless any individual with respect to the tax consequences of any Award.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant Responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If a Participant shall dispose of Stock acquired through exercise of an Incentive Stock Option within either (i) two years after the date the Option is granted or (ii) one year after the date the Option is exercised (i.e., in a disqualifying disposition), such Participant shall notify the Company within seven days of the date of such disqualifying disposition.</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment Provisions&#59; Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the Committee determines that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Shares or other securities of the Company, issuance of warrants or other rights to purchase Shares or other securities of the Company, or other similar corporate transaction or event affects the Shares such that the Committee determines an adjustment to be appropriate to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this Plan, then, subject to Participants&#8217; rights under Section 16(c), the Committee shall, in such manner as it may deem equitable, adjust any or all of (i) the number and type of Shares subject to this Plan (including the number and type of Shares described in Sections 6(a) and 6(d)), and which may after the event be made the subject of Awards under this Plan, (ii) the number and type of Shares subject to outstanding Awards, and (iii) the grant, purchase, or exercise price with respect to any Award. In any such case, the Committee may also (or in lieu of the foregoing) make provision for a cash payment to the holder of an outstanding Award in exchange for the cancellation of all or a portion of the Award (without the consent of the holder of an Award) in an amount determined by the Committee effective at such time as the Committee specifies (which may be the time such transaction or event is effective), but if such transaction or event constitutes a Change of Control, then (A) such payment shall be at least as favorable to the holder as the amount the holder could have received in respect of such Award under Section 16(c) and (b) from and after the Change of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Control, the Committee may make such a provision only if the Committee determines that doing so is necessary to substitute, for each Share then subject to an Award, the number and kind of shares of stock, other securities, cash or other property to which holders of Stock are or will be entitled in respect of each Share pursuant to the transaction or event in accordance with the last sentence of this subsection (a). However, in each case, with respect to Awards of Incentive Stock Options, no such adjustment may be authorized to the extent that such authority would cause this Plan to violate Code Section 422(b). Further, the number of Shares subject to any Award payable or denominated in Shares must always be a whole number. Without limitation, subject to Participants&#8217; rights under Section 16(c), in the event of any reorganization, merger, consolidation, combination or other similar corporate transaction or event, whether or not constituting a Change of Control (other than any such transaction in which the Company is the continuing corporation and in which the outstanding Stock is not being converted into or exchanged for different securities, cash or other property, or any combination thereof), the Committee may substitute, on an equitable basis as the Committee determines, for each Share then subject to an Award, the number and kind of shares of stock, other securities, cash or other property to which holders of Stock are or will be entitled in respect of each Share pursuant to the transaction.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Issuance or Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of this Plan, and without affecting the number of Shares otherwise reserved or available under this Plan, in connection with any merger, consolidation, acquisition of property or stock, or reorganization, the Committee may authorize the issuance of substitute awards or assumption of awards under this Plan by another party to any such merger, consolidation, acquisition or reorganization upon such terms and conditions as it may deem appropriate.</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) The Committee may specify, either in an Award Agreement or at the time of a Change of Control, whether an outstanding Award shall become vested and&#47;or payable, in whole or in part, as a result of a Change of Control.</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:37pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) &#160;If, in connection with the Change of Control, the Options and SARs issued under the Plan are not assumed, or if substitute Options and SARs are not issued by the successor or Affiliate thereof in the Change of Control transaction, or if the assumed or substituted awards fail to contain similar terms and conditions as the Award prior to the Change of Control or fail to preserve, to the extent applicable, the benefit to be provided to the Participant as of the date of the Change of Control, including but not limited to the right of the Participant to receive shares upon exercise of the Option or SAR that are registered for sale to the public pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission, then (1) each holder of an Option or SAR that is outstanding as of the date of the Change of Control who is an employee of the Company or any Subsidiary shall have the right, and (2) the Committee, in its sole discretion, may grant to a holder of an Option or SAR that is outstanding as of the date of the Change of Control who is not an employee of the Company or any Subsidiary the right, exercisable by written notice to the Company (or its successor in the Change of Control transaction) within 30 days after the Change of Control (but not beyond the Option&#8217;s or SAR&#8217;s expiration date), to receive, in exchange for the surrender of the Option or SAR, an amount of cash equal to the excess of the greater of the Fair Market Value of the Shares determined on the Change of Control date or the Fair Market Value of the Shares on the date of surrender covered by the Option or SAR (to the extent vested and not yet exercised) that is so surrendered over the purchase or grant price of such Shares under the Award. If the Committee so determines prior to the Change of Control, any such Option or SAR that is not exercised or surrendered prior to the end of such 30- day period will be cancelled.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) If, in connection with the Change of Control, the Shares issued to a Participant as a result of the accelerated vesting or payment of a Restricted Stock Award, Performance Share Award, Restricted Stock Unit Award, Performance Unit Award or Dividend Equivalent Award under this subsection (c) are not registered for sale to the public pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission, then each holder of such Shares shall have the right, exercisable by written notice to the Company (or its successor in the Change of Control transaction) within 30 days after the Change of Control, to receive, in exchange for the surrender of such Shares an amount of cash equal to the greater of the Fair Market Value of a Share on the Change of Control date or the Fair Market Value of such Share on the date of surrender.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provisions of Sections 16(c)(ii) and (iii) shall govern the treatment of awards made under the 2010 Plan and 2013 Plan in the event of a Change of Control, and the 2010 Plan and 2013 Plan are each deemed amended accordingly.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Parachute Payment Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:73pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Scope of Limitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Section 16(d) shall apply to an Award only if&#58;</font></div><div style="padding-left:73pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:73pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(A) &#160;the independent auditors most recently selected by the Board (the &#8220;Auditors&#8221;) determine that the after-tax value of such Award to the Participant, taking into account the effect of all federal, state and local income taxes, employment taxes and excise taxes applicable to the Participant (including the excise tax under Code Section 4999), will be greater after the application of this Section 16(d) than it was before the application of this Section 16(d)&#59; or</font></div><div style="padding-left:73pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:73pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(B) &#160;the Committee, at the time of making an Award under the Plan or at any time thereafter, specifies in writing that such Award shall be subject to this Section 16(d) (regardless of the after-tax value of such Award to the Participant).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If this Section 16(d) applies to an Award, it shall supersede any contrary provision of the Plan or of any Award granted under the Plan.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) &#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Basic Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as may be set forth in a written agreement by and between the Company and the holder of an Award, in the event that the Auditors determine that any payment or transfer by the Company under the Plan to or for the benefit of a Participant (a &#8220;Payment&#8221;) would be nondeductible by the Company for federal income tax purposes because of the provisions concerning &#8220;excess parachute payments&#8221; in Code Section 280G, then the aggregate present value of all Payments shall be reduced (but not below zero) to the Reduced Amount. For purposes of this Section 16(d), the &#8220;Reduced Amount&#8221; shall be the amount, expressed as a present value, which maximizes the aggregate present value of the Payments without causing any Payment to be nondeductible by the Company because of Code Section 280G.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Reduction of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the Auditors determine that any Payment would be nondeductible by the Company because of Code Section 280G, then the Company shall promptly give the Participant notice to that effect and a copy of the detailed calculation thereof and of the Reduced Amount, and the Participant may then elect, in his or her sole discretion, which and how much of the Payments shall be eliminated or reduced (as long as after such election the aggregate present value of the Payments equals the Reduced Amount) and shall advise the Company in writing of his or her election within ten (10) days of receipt of notice. If no such election is made by the Participant within such ten </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(10) day period, then the Company may elect which and how much of the Payments shall be eliminated or reduced (as long as after such election the aggregate present value of the Payments equals the Reduced Amount) and shall notify the Participant promptly of such election. For purposes of this Section 16(d), present value shall be determined in accordance with Code Section 280G(d)(4). All determinations made by the Auditors under this Section 16(d) shall be binding upon the Company and the Participant and shall be made within sixty (60) days of the date when a Payment becomes payable or transferable. As promptly as practicable following such determination and the elections hereunder, the Company shall pay or transfer to or for the benefit of the Participant such amounts as are then due to him or her under the Plan and shall promptly pay or transfer to or for the benefit of the Participant in the future such amounts as become due to him or her under the Plan.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Overpayments and Underpayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As a result of uncertainty in the application of Code Section 280G at the time of an initial determination by the Auditors hereunder, it is possible that Payments will have been made by the Company that should not have been made (an &#8220;Overpayment&#8221;) or that additional Payments that will not have been made by the Company could have been made (an &#8220;Underpayment&#8221;), consistent in each case with the calculation of the Reduced Amount hereunder. In the event that the Auditors, based upon the assertion of a deficiency by the Internal Revenue Service against the Company or the Participant that the Auditors believe has a high probability of success, determine that an Overpayment has been made, such Overpayment shall be treated for all purposes as a loan to the Participant which he or she shall repay to the Company, together with interest at the applicable federal rate provided in Code Section 7872(f)(2)&#59; provided, however, that no amount shall be payable by the Participant to the Company if and to the extent that such payment would not reduce the amount subject to taxation under Code Section 4999. In the event that the Auditors determine that an Underpayment has occurred, such Underpayment shall promptly be paid or transferred by the Company to or for the benefit of the Participant, together with interest at the applicable federal rate provided in Code Section 7872(f)(2).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Related Corporations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of this Section 16(d), the term &#8220;Company&#8221; shall include affiliated corporations to the extent determined by the Auditors in accordance with Code Section 280G(d)(5).</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Other Terms and Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The grant of any Award may also be subject to other provisions (whether or not applicable to the Award granted to any other Participant) as the Committee determines appropriate, including, without limitation, provisions for&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) one or more means to enable Participants to defer the delivery of Shares or recognition of taxable income relating to Awards or cash payments derived from the Awards on such terms and conditions as the Committee determines, including, by way of example, the form and manner of the deferral election, the treatment of dividends paid on the Shares during the deferral period or a means for providing a return to a Participant on amounts deferred, and the permitted distribution dates or events (provided that if Shares would have otherwise been issued under an Award but for the deferral described in this paragraph, then such Shares shall be treated as if they were issued for purposes of Sections 6(a))&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) &#160;the payment of the purchase price of Options by delivery of cash or other Shares or other securities of the Company (including by attestation) having a then Fair Market Value equal to the purchase price of such Shares, or by delivery (including by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">fax) to the Company or its designated agent of an executed irrevocable option exercise form together with irrevocable instructions to a broker dealer to sell or margin a sufficient portion of the Shares and deliver the sale or margin loan proceeds directly to the Company to pay for the exercise price&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) conditioning the grant or benefit of an Award on the Participant&#8217;s agreement to comply with covenants not to compete, not to solicit employees and customers and not to disclose confidential information that may be effective during or after the Participant&#8217;s employment or service, and&#47;or provisions requiring the Participant to disgorge any profit, gain or other benefit received in connection with an Award as a result of the breach of such covenant&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv) the automatic grant of a new Option (the &#8220;replenishment Option&#8221;) to a Participant who pays the exercise price of an existing Option in Shares&#59; provided that the replenishment Option shall cover only that number of Shares that is used to pay the exercise price and shall expire at the same time as the original Option to which it relates&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v) &#160;restrictions on resale or other disposition of Shares, including imposition of a retention period&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi) compliance with federal or state securities laws and stock exchange requirements.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment or Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The issuance of an Award shall not confer upon a Participant any right with respect to continued employment or service with the Company or any Affiliate, or the right to continue as a Director. Unless determined otherwise by the Committee, for purposes of the Plan and all Awards, the following rules shall apply&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i) a Participant who transfers employment between the Corporation and any Affiliate of the Company, or between the Company&#8217;s Affiliates, will not be considered to have terminated employment&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii) &#160;a Participant who ceases to be a Non-Employee Director because he or she becomes an employee of the Company or an Affiliate shall not be considered to have ceased service as a Director with respect to any Award until such Participant&#8217;s termination of employment with the Company and its Affiliates&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii) a Participant who ceases to be employed by the Company or an Affiliate of the Company and immediately thereafter becomes a Non-Employee Director, a non- employee director of any Affiliate, or a consultant to the Company or any Affiliate shall not be considered to have terminated employment until such Participant&#8217;s service as a director of, or consultant to, the Company and its Affiliates has ceased&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv) a Participant employed by an Affiliate of the Company will be considered to have terminated employment when such entity ceases to be an Affiliate of the Company.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything herein contained to the contrary, for purposes of an Award that is subject to Code Section 409A, if a Participant&#8217;s termination of employment or service triggers the payment of compensation under such Award, then the Participant will be deemed to have terminated employment or service upon his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A. Notwithstanding any other provision in this Plan or an Award to the contrary, if any Participant is a &#8220;specified employee&#8221; within the meaning of Code Section 409A as of the date of his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A, then, to the extent required by Code Section 409A, any payment made to the Participant on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">account of such separation from service shall not be made before a date that is six months after the date of the separation from service.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No fractional Shares or other securities may be issued or delivered pursuant to this Plan, and the Committee may determine whether cash, other securities or other property will be paid or transferred in lieu of any fractional Shares or other securities, or whether such fractional Shares or other securities or any rights to fractional Shares or other securities will be canceled, terminated or otherwise eliminated.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Unfunded Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Plan is unfunded and does not create, and should not be construed to create, a trust or separate fund with respect to this Plan&#8217;s benefits. This Plan does not establish any fiduciary relationship between the Company and any Participant or other person. To the extent any person holds any rights by virtue of an Award granted under this Plan, such rights are no greater than the rights of the Company&#8217;s general unsecured creditors.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Requirements of Law and Securities Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The granting of Awards and the issuance of Shares in connection with an Award are subject to all applicable laws, rules and regulations and to such approvals by any governmental agencies or national securities exchanges as may be required. Notwithstanding any other provision of this Plan or any Award Agreement, the Company has no liability to deliver any Shares under this Plan or make any payment unless such delivery or payment would comply with all applicable laws and the applicable requirements of any securities exchange or similar entity, and unless and until the Participant has taken all actions required by the Company in connection therewith. The Company may impose such restrictions on any Shares issued under the Plan as the Company determines necessary or desirable to comply with all applicable laws, rules and regulations or the requirements of any national securities exchanges.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Plan, and all agreements under this Plan, will be construed in accordance with and governed by the laws of the State of Delaware, without reference to any conflict of law principles. The parties agree that the exclusive venue for any legal action or proceeding with respect to this Plan, any Award or any Award Agreement, or for recognition and enforcement of any judgment in respect of this Plan, any Award or any Award Agreement, shall be a court sitting in the County of Los Angeles, or the Federal District Court for the Central District of California sitting in the County of Los Angeles, in the State of California, and further agree that any such action may be heard only in a &#8220;bench&#8221; trial, and any party to such action or proceeding shall agree to waive its right to assert a jury trial.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(g)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Limitations on Actions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any legal action or proceeding with respect to this Plan, any Award or any Award Agreement, must be brought within one year (365 days) after the day the complaining party first knew or should have known of the events giving rise to the complaint.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(h)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Whenever any words are used herein in the masculine, they shall be construed as though they were used in the feminine in all cases where they would so apply&#59; and wherever any words are used in the singular or plural, they shall be construed as though they were used in the plural or singular, as the case may be, in all cases where they would so apply. Titles of sections are for general information only, and this Plan is not to be construed with reference to such titles.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If any provision of this Plan or any Award Agreement or any Award (i) is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction, or as to any person or Award, or (ii) would disqualify this Plan, any Award Agreement or any Award under any law the Committee deems applicable, then such provision should be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Committee, materially altering the intent of this Plan, Award </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="padding-left:1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Agreement or Award, then such provision should be stricken as to such jurisdiction, person or Award, and the remainder of this Plan, such Award Agreement and such Award will remain in full force and effect.</font></div><div style="padding-left:1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:0.5pt;padding-right:0.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;END OF DOCUMENT&#93;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>exhibit102-formofrestricte.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="id541eddc4c034b32b44221738ac7cc3a_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2015 EQUITY INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTED STOCK GRANT NOTICE</font></div><div style="margin-top:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Astrana Health, Inc., a Delaware corporation (together with any successor thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), pursuant to its 2015 Equity Incentive Plan, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the holder listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the number of shares of the Company&#8217;s common stock, par value $0.001, set forth below (individually and collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Restricted Shares are subject to all of the terms and conditions set forth herein and in the Restricted Stock Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Restricted Stock Agreement. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:76.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.589%"><tr><td style="width:1.0%"></td><td style="width:52.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.669%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.738%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Participant&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Grant Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Total&#160;Number&#160;of&#160;Restricted&#160;Shares&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Vesting Schedule&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Restricted Shares shall vest as follows&#58;</font></div></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Date</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Number of Shares</font></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Restricted Stock Agreement and this Grant Notice. Participant has reviewed the Restricted Stock Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Restricted Stock Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Company and the Committee (as defined in the Plan) upon any questions arising under the Plan, this Grant Notice or the Restricted Stock Agreement. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">IMPORTANT NOTICE&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">THIS AGREEMENT SHALL BE VOID, AND THE RESTRICTED SHARES SHALL BE FORFEITED AUTOMATICALLY, IF THE AGREEMENT HAS NOT BEEN SIGNED BY PARTICIPANT AND RETURNED TO THE COMPANY WITHIN 30 DAYS AFTER THE GRANT DATE. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the undersigned have executed this Grant Notice effective as of the Grant Date. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.992%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.764%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.589%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">ASTRANA HEALTH, INC.</font></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">PARTICIPANT</font></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="30" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="24" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="27" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="27" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Brandon Sim</font></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Executive Officer &#38; President</font></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="66" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TO RESTRICTED STOCK GRANT NOTICE </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTED STOCK AGREEMENT </font></div><div style="margin-top:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to the Restricted Stock Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to which this Restricted Stock Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is attached, Astrana Health, Inc., a Delaware corporation (together with any successor thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), has granted to Participant restricted shares of the Company&#8217;s common stock, par value $0.001 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) under the Company&#8217;s 2015 Equity Incentive Plan, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) as indicated in the Grant Notice. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice, unless the context clearly indicates otherwise. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation of Terms of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Restricted Shares are subject to the terms and conditions of the Plan which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of Participant&#8217;s employment with or service to the Company or a Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Company grants to Participant the Restricted Shares, upon the terms and conditions set forth in the Plan and this Agreement, subject to adjustments as provided in Article 13 of the Plan. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consideration to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of the grant of the Restricted Shares by the Company, Participant agrees to render faithful and efficient services to the Company or a Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Vesting, Delivery, Restrictions and Etc.</font></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms and conditions of the Plan, the Restricted Shares shall vest at such times as are set forth in the Grant Notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, none of the Restricted Shares that has not become vested at the date of Participant&#8217;s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), shall thereafter become vested, except as may be otherwise provided by the Committee or as set forth in a written agreement between the Company and Participant. </font></div><div style="padding-left:24.5pt;text-align:justify;text-indent:24.5pt"><font><br></font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless and until the Restricted Shares vest as set forth in the Grant Notice, Participant shall have no right to sell, assign, transfer, pledge or otherwise encumber Restricted Shares in any manner. Any purported attempt to sell, assign, transfer, pledge or otherwise encumber any Restricted Shares under this Agreement shall be void and shall result in the forfeiture and cancellation of such Restricted Shares. Upon Participant&#8217;s termination of employment or service for any reason, with or without cause (including, but not limited to, death, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Disability or Retirement), any Restricted Shares that are unvested as of the date of such termination of employment or service (and whose vesting is not accelerated pursuant to this Agreement or the Plan) shall be forfeited, and Participant shall have no further rights with respect to such Restricted Shares under this Agreement or otherwise. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Restricted Shares shall be registered in book entry in the name of Participant and shall not be transferred to Participant until the Restricted Shares have vested in accordance with this Agreement. Participant acknowledges that prior to the vesting of the Restricted Shares, the certificates representing Restricted Shares may be stamped with a legend indicating the possibility of cancellation and the restrictions on transfer. Upon vesting of any of the Restricted Shares, such Restricted Shares shall be transferred or delivered to Participant as soon as practicable thereafter. Upon such transfer or delivery to Participant, the vested Restricted Shares will not be subject to any restrictions other than those that may arise under the securities laws or the Company&#8217;s policies. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to Section 3.5 below, the vesting of the Restricted Shares under this Agreement will result in Participant&#8217;s recognition of income for U.S. federal income tax purposes.  The parties agree that to the extent the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes in connection with the vesting or the grant of the Restricted Shares, then such tax withholding shall be satisfied by the forfeiture of a number of Restricted Shares having a value equal to the required tax withholding (based on the Fair Market Value per Share on the applicable date), provided that in no event shall the value of the Restricted Shares forfeited to satisfy applicable tax withholding exceed the minimum amount of taxes required to be withheld or such other amount that will not result in a negative accounting impact, as determined by the Company. Notwithstanding the foregoing, to the extent authorized by the Committee, the Participant may be permitted to elect, in accordance with procedures adopted by the Company from time to time, to&#160;pay or provide for payment of any required tax withholding. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;83(b) Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If Participant makes an election under Section&#160;83(b) of the Code to be taxed with respect to the Restricted Shares as of the date of transfer of the Restricted Shares rather than as of the date or dates upon which Participant would otherwise be taxable under Section&#160;83 of the Code, Participant shall be required to deliver a copy of such election to the Company promptly after filing such election with the Internal Revenue Service. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Upon issuance of the Restricted Shares and until the forfeiture or cancellation of the Restricted Shares, Participant shall have, unless otherwise provided by the Committee, all the rights of a stockholder with respect to the Restricted Shares, subject to the transferability and other restrictions set forth in this Agreement, including the right to receive all dividends and other distributions paid or made with respect to the Restricted Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that, in the sole discretion of the Committee, the Committee may provide that any extraordinary distributions with respect to the Company&#8217;s common stock received by Participant in the form of shares of such common stock shall be subject to the same vesting and other restrictions as the Restricted Shares to which they relate. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Recovery Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Restricted Shares are subject to forfeiture or repayment as may be provided pursuant to the Company&#8217;s Compensation Recovery Policy (or any successor compensation recovery policy), as in effect from time to time.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Other Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">taken and all interpretations and determinations made by the Committee in good faith shall be final, binding and conclusive upon Participant, the Company and all other interested persons. No member of the Committee or the Board, or any employee or officer of the Company, shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the Restricted Shares. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments Upon Specified Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee may accelerate the vesting of the Restricted Shares in such circumstances as it, in its sole discretion, may determine. In addition, upon the occurrence of certain events relating to the Company&#8217;s common stock contemplated by the Plan (including, without limitation, an extraordinary cash dividend on such Shares), the Committee shall make such adjustments as the Committee deems appropriate to the Restricted Shares in order to preserve the benefits intended to be made available to Participant under this Agreement. Participant acknowledges that the Restricted Shares are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company (or any other person or entity as designated by the Committee) at the Company&#8217;s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant&#8217;s last address reflected on the Company&#8217;s records. By a notice given pursuant to this Section&#160;4.3, either party may hereafter designate a different address for notices to be given to that party. A notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Titles and Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The laws of the State of Delaware, without reference to any conflict of law principles thereof, shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conformity to Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act of 1933, as amended, the Exchange Act and the Code, and any and all regulations and rules promulgated thereunder, state securities laws and regulations and all other applicable law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Restricted Shares are granted and shall be administered only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Restricted Shares in any material way without the prior written consent of Participant. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.8 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section&#160;3.2 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries. </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relation to Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any economic or other benefit to Participant under this Agreement or the Plan shall not be taken into account in determining any benefits to which Participant may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company or an Affiliate, except as expressly provided in writing in such other plan&#8217;s governing instrument.   </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to administer the Plan, the Company may process personal data about Participant.  Such data includes, but is not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about Participant such as home address and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan.  Participant hereby gives explicit consent to the Company to process any such personal data.  Participant also gives explicit consent to the Company to transfer any such personal data outside the country in which Participant works or is employed, including, if Participant is not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver, including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual and quarterly reports, and all other forms of communications (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in connection with this and any other Award made or offered under the Plan. Participant has the right at any time to request that the Company deliver written copies of any and all Prospectus Information at no charge. Participant also hereby consents to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that the Company may elect to deliver and agrees that Participant&#8217;s electronic response or signature is the same as, and shall have the same force and effect as, Participant&#8217;s manual signature.</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.13 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan, the Grant Notice and this Agreement (including all Exhibits thereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;END OF DOCUMENT&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.300%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>exhibit103-formofrestricte.htm
<DESCRIPTION>EX-10.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i3ca6e2ce083e4cb18c95a727b0934917_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2015 EQUITY INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="margin-top:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Astrana Health, Inc., a Delaware corporation (together with any successor thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), pursuant to its 2015 Equity Incentive Plan, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the holder listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) the number of restricted stock units set forth below (individually and collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The RSUs are subject to all of the terms and conditions set forth herein and in the Restricted Stock Unit Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSU Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which is incorporated herein by reference. Capitalized terms not specifically defined in this Grant Notice shall have the meanings specified in the Plan and&#47;or RSU Agreement, unless the context clearly indicates otherwise. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:76.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.429%"><tr><td style="width:1.0%"></td><td style="width:46.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.740%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Participant&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Grant Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Total&#160;Number&#160;of&#160;RSUs&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Vesting Schedule&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The RSUs shall vest as follows, subject to Participant&#8217;s continuous employment or other service from the Grant Date until the applicable Vesting Date&#58;</font></div></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Vesting Date</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Number of RSUs Vesting</font></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">IMPORTANT NOTICE&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">THE RSU AGREEMENT AND THIS GRANT NOTICE SHALL BE VOID, AND THE RSUS SHALL BE FORFEITED AUTOMATICALLY, IF THIS GRANT NOTICE HAS NOT BEEN SIGNED BY PARTICIPANT AND RETURNED TO THE COMPANY WITHIN 30 DAYS AFTER THE GRANT DATE PROVIDED ABOVE. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the RSU Agreement and this Grant Notice. Participant has reviewed the RSU Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the RSU Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Company and the Committee (as defined in the Plan) upon any questions arising under the Plan, this Grant Notice or the RSU Agreement. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the undersigned have executed this Grant Notice effective as of the Grant Date set forth above. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.992%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.764%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.589%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">ASTRANA HEALTH, INC.</font></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">PARTICIPANT</font></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="30" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="24" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="27" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="27" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Brandon Sim</font></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Executive Officer &#38; President</font></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="66" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i3ca6e2ce083e4cb18c95a727b0934917_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">EXHIBIT A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TO RESTRICTED STOCK UNIT GRANT NOTICE </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTED STOCK UNIT AGREEMENT </font></div><div style="margin-top:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to the Restricted Stock Unit Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to which this Restricted Stock Unit Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is attached, Astrana Health, Inc., a Delaware corporation (together with any successor thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), has granted  certain restricted stock units (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to Participant under the Company&#8217;s 2015 Equity Incentive Plan, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) as indicated in the Grant Notice. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and&#47;or the Grant Notice, unless the context clearly indicates otherwise. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation of Terms of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The RSUs are subject to the terms and conditions of the Plan, which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement or the Grant Notice, the terms of the Plan shall control. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of Participant&#8217;s employment with or service to the Company or a Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Company grants to Participant the RSUs, upon the terms and conditions set forth in the Plan, the Grant Notice and this Agreement, subject to adjustments as provided in Article 16 of the Plan. Each RSU represents the contingent right to receive one Share and shall at all times be equal to the value of one Share.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consideration to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of the grant of the RSUs by the Company, Participant agrees to render faithful and efficient services to the Company or a Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Vesting, Restrictions, Settlement and Etc.</font></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms and conditions of the Plan, the RSUs shall vest at such times and subject to such conditions as are set forth in the Grant Notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no RSUs that are unvested as of the date of Participant&#8217;s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), shall thereafter become vested, except as may be otherwise provided by the Committee or as set forth in a written agreement between the Company and Participant. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant shall have no right to sell, assign, transfer, pledge or otherwise encumber RSUs in any manner. Any purported attempt to sell, assign, transfer, pledge or otherwise encumber any RSUs under this Agreement shall be void and shall result in the forfeiture and cancellation of such RSUs. Upon Participant&#8217;s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), any RSUs that are unvested as of the date of such termination of employment or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">service (and whose vesting is not accelerated pursuant to this Agreement or the Plan) shall be forfeited, and Participant shall have no further rights with respect to such RSUs under this Agreement or otherwise. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The RSUs shall be registered in book entry in the name of Participant until they have vested in accordance with this Agreement. Upon vesting of any of the RSUs, the Company shall deliver the corresponding number of Shares to Participant within 30 days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">following the date on which such RSUs vested.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon such delivery to Participant, such Shares will not be subject to any restrictions other than those that may arise under the securities laws or the Company&#8217;s policies. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes in connection with the delivery of Shares under this Agreement, then the Company or Subsidiary (as applicable) shall retain a number of Shares otherwise deliverable hereunder with a value equal to the required withholding (based on the Fair Market Value per Share on the applicable date)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in no event shall the value of the Shares retained exceed the minimum amount of taxes required to be withheld or such other amount that will not result in a negative accounting impact to the Company, as determined by the Company. Notwithstanding the foregoing, to the extent authorized by the Committee, the Participant may be permitted to elect, in accordance with procedures adopted by the Company from time to time, to&#160;pay or provide for payment of any required tax withholding.  To the extent that the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes at any time other than upon delivery of Shares under this Agreement, the Company, in its discretion may (a) require Participant to&#160;pay or provide for payment of the required tax withholding, or (b)&#160;satisfy the required tax withholding by deduction from any amount of compensation otherwise payable in cash to Grantee (including any cash dividend equivalent payments pursuant to Section 3.6 of this Agreement).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant shall not possess any incidents of ownership (including, without limitation, dividend and voting rights) in the Shares underlying the RSUs unless and until such Shares have been delivered to Participant in accordance with Section 3.3. The obligations of the Company pursuant to this Agreement are merely that of an unfunded and unsecured promise of the Company to deliver Shares (and cash dividend equivalents, if any, pursuant to Section 3.6 hereof) in the future and subject to the terms and conditions of this Agreement, and the rights of Participant hereunder are no greater than those of an unsecured general creditor. No Company assets shall be held or set aside as security for the Company&#8217;s obligations pursuant to this Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  From and after the Grant Date and until the earlier of (a) the time when the Shares underlying the vested RSUs (if any) are delivered to Participant in accordance with this Agreement, or (b) the time that the RSUs are forfeited in accordance with this Agreement, on each date, if any, that the Company pays a cash dividend to holders of its Shares generally, the Company will credit Participant&#8217;s account hereunder with the right to receive a cash amount equal to the product of (x) the dollar amount of the cash dividend paid per Share to stockholders on such date multiplied by (y) the total number of unpaid RSUs credited to Participant&#8217;s account under this Agreement as of such date. Subject to and conditioned upon the vesting of the underlying RSUs, the aggregate amount of any such dividend equivalents credited to Participant&#8217;s account hereunder shall be paid to Participant in cash (without interest), at the same time and in the same proportion that the Shares underlying any vested RSUs are delivered to Participant, and the Participant&#8217;s right to receive any such dividend equivalents shall be automatically and correspondingly forfeited to the extent that the RSUs are forfeited pursuant to the terms of this Agreement and the Plan.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Recovery Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The RSUs and any Shares that may be delivered pursuant to this Agreement are subject to forfeiture or repayment as may be provided pursuant to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company&#8217;s Compensation Recovery Policy (or any successor compensation recovery policy), as in effect from time to time.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Other Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee shall have the power to interpret the Plan, the Grant Notice and this Agreement, and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee in good faith shall be final, binding and conclusive upon Participant, the Company and all other interested persons. No member of the Committee or the Board, or any employee or officer of the Company or any Affiliate, shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, the Grant Notice, this Agreement or the RSUs. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments Upon Specified Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee may accelerate the vesting of all or a portion the RSUs in such circumstances as it, in its sole discretion, may determine. Participant acknowledges that the RSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company (or any other person or entity as designated by the Committee) at the Company&#8217;s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant&#8217;s last address reflected on the Company&#8217;s records. By a notice given pursuant to this Section&#160;4.3, either party may hereafter designate a different address for notices to be given to that party. A notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Titles and Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. </font></div><div style="text-align:justify;text-indent:24.5pt"><font><br></font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The laws of the State of Delaware, without reference to any conflict of law principles thereof, shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conformity to Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant acknowledges that the Plan, the Grant Notice and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act of 1933, as amended, the Exchange Act and the Code, and any and all regulations and rules promulgated thereunder, state securities laws and regulations and all other applicable law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted and shall be administered, only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan, the Grant Notice and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A of the Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award of RSUs evidenced by this Agreement is intended to be exempt from, or to comply with, the requirements of Section&#160;409A of the Code, and this Agreement shall be interpreted and administered in accordance with such intent.  Accordingly, solely to the extent necessary to comply with the requirements of Section 409A of the Code&#58; (a) the termination of Participant&#8217;s employment or other service shall be interpreted to mean the Participant&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A of the Code&#59; (b) if Participant is a &#8220;specified employee&#8221; (as determined by the Company in accordance with Section 409A of the Code), settlement of any vested RSUs (and payment of any related </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">dividend equivalents) as a result of Participant&#8217;s separation from service shall be delayed until the first business day that is at least six months after the date of Participant&#8217;s separation from service or, if earlier, the date of Participant&#8217;s death&#59; and (c) a Change of Control shall be interpreted to mean an event that qualifies as both a &#8220;Change of Control&#8221; as defined in the Plan and a &#8220;change in control event&#8221; within the meaning of Section 409A of the Code and Treasury Regulation &#167;1.409A-3(i)(5). Notwithstanding the foregoing, the tax treatment of the RSUs is not warranted or guaranteed. Neither the Company and its Affiliates, nor their respective directors, officers, employees and advisers shall be held liable for any taxes, interest, penalties or other monetary amounts that may owed by the Participant or other taxpayer as a result of the Award of RSUs or this Agreement.  </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> Amendments, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent permitted by the Plan, the Grant Notice and this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that except as may otherwise be provided by the Plan or Section 4.6 of this Agreement, no amendment, modification, suspension or termination of this Agreement shall adversely affect the RSUs in any material way without the prior written consent of Participant. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in Section&#160;3.2 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing in this Agreement, the Grant Notice or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Affiliates. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relation to Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any economic or other benefit to Participant under this Agreement or the Plan shall not be taken into account in determining any benefits to which Participant may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company or an Affiliate, except as expressly provided in writing in such other plan&#8217;s governing instrument.   </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to administer the Plan, the Company may process personal data about Participant.  Such data includes, but is not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about Participant such as home address and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan.  Participant hereby gives explicit consent to the Company to process any such personal data.  Participant also gives explicit consent to the Company to transfer any such personal data outside the country in which Participant works or is employed, including, if Participant is not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.13 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver, including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual and quarterly reports, and all other forms of communications (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in connection with this and any other Award made or offered under the Plan. Participant has the right at any time to request that the Company deliver written copies of any and all Prospectus Information at no charge. Participant also hereby consents to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that the Company may elect to deliver and agrees </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that Participant&#8217;s electronic response or signature is the same as, and shall have the same force and effect as, Participant&#8217;s manual signature.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.14 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan, the Grant Notice and this Agreement (including any Exhibits to any of the foregoing) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;END OF DOCUMENT&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>6
<FILENAME>exhibit104-formofincentive.htm
<DESCRIPTION>EX-10.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i7fff2c19c7e8490e9b08fbc5ac7fa87c_1"></div><div style="min-height:40.32pt;width:100%"><div style="margin-bottom:10pt;text-align:right"><font><br></font></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">OPTION CERTIFICATE<br>(Incentive Stock Option)</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THIS IS TO CERTIFY that Astrana Health, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), has granted to the individual named below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) an incentive stock option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to purchase shares of the Company&#8217;s Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) under its 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and upon the terms and conditions set forth below and in the attached Stock Option Agreement&#58;</font></div><div style="margin-bottom:10pt;padding-left:42.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.051%"><tr><td style="width:1.0%"></td><td style="width:37.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Name of Optionee&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Address of Optionee&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Number of Shares&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Option Exercise Price&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">$    per share</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Date of Grant&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Option Expiration Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exercise Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#58;  The Option shall become exercisable (&#8220;vest&#8221;) as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:42.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.025%"><tr><td style="width:1.0%"></td><td style="width:65.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Date</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Number of Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Commencing on &#8230;.</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">-----  Shares per month</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">IMPORTANT NOTICE&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">THIS AGREEMENT SHALL BE VOID, AND THE OPTION SHALL BE FORFEITED AUTOMATICALLY, IF THE AGREEMENT HAS NOT BEEN SIGNED BY OPTIONEE AND RETURNED TO THE COMPANY WITHIN 30 DAYS AFTER THE GRANT DATE.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:68.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;padding-left:342.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.320%"><tr><td style="width:1.0%"></td><td style="width:33.077%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">Grant #</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">########</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.32pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the Company has granted to Optionee the Option as of the Date of Grant set forth above.</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.593%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ASTRANA HEALTH, INC. </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Its&#160;&#160;&#160;&#160;Chief Executive Officer</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Optionee acknowledges that he or she has received a copy of the 2015 Equity Incentive Plan and the Stock Option Agreement related to this grant.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_____________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Address&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________________  </font></div><div style="height:68.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;padding-left:342.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.320%"><tr><td style="width:1.0%"></td><td style="width:33.077%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:133%">Grant #</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">########</font></td></tr></table></div><div><font><br></font></div></div></div><div id="i7fff2c19c7e8490e9b08fbc5ac7fa87c_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STOCK OPTION AGREEMENT<br>(Incentive Stock Option)</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This STOCK OPTION AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is made and entered into as of the Date of Grant set forth in the Option Certificate to which this Agreement is attached (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) by and between Astrana Health, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and the optionee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) named in the Certificate. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to the 2015 Equity Incentive Plan of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Administrator (which term includes, for the purposes hereof, the Board, the Committee or any other Person that has authority to administer the Plan) has determined that Optionee is to be granted, on the terms and conditions set forth in this Agreement and in the Plan, an option to purchase shares of the Company&#8217;s common stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  It is intended that the option qualify as an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Capitalized terms not otherwise defined in this Agreement shall have the meanings ascribed to them in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company and Optionee agree as follows&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Grant of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company hereby grants to Optionee, upon the terms and subject to the conditions set forth in this Agreement, an Option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to purchase all or any portion of that number of shares of Common Stock set forth in the Certificate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), at the exercise price set forth in the Certificate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Vesting</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;The Option shall &#8220;vest&#8221; (that is, become exercisable) in installments upon and after the dates set forth under the caption &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; in the Certificate.  The installments shall be cumulative&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Option may be exercised, as to any or all Option Shares covered by an installment, at any time or times after the installment first becomes exercisable and until expiration or termination of the Option.  In addition, the Option shall vest as to all Option Shares immediately preceding, and conditioned upon the closing of, a Change of Control.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;No vesting shall occur after the Employment Termination Date (as defined in Section 4.2 of this Agreement).  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in this Option Agreement, the Option may not be exercised, in whole or in part, unless and until any then-applicable requirements of all state and federal laws and regulatory agencies shall have been fully complied with to the satisfaction of the Company and its counsel.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise of the Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1&#160;&#160;&#160;&#160;The Option may be exercised, in whole or in part, only by delivery to the Company of&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1.1&#160;&#160;&#160;&#160;written notice of the exercise of the Option in form identical to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit &#8220;A&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached to this Agreement, the terms of which are incorporated herein by this reference, stating the number of Option Shares being purchased (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchased Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1.2.&#160;&#160;&#160;&#160;payment of the Exercise Price by any combination of (i) cash or cash equivalent&#59; (ii) delivery of other Shares or other securities of the Company (including by </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Option Certificate and Agreement (ISO)-2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">attestation) valued at their then Fair Market Value, (iii) delivery (including by fax) to the Company or its designated agent of an executed irrevocable option exercise form together with irrevocable instructions to a broker dealer to sell or margin a sufficient portion of the Purchased Shares and deliver the sale or margin loan proceeds directly to the Company to pay for the Exercise Price, (iv) the surrender of Shares then issuable upon exercise of the Option, valued at their then Fair Market Value, and (v) with the approval of the Administrator, by delivery to the Company of such other consideration (such as a promissory note) acceptable to the Administrator.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2&#160;&#160;&#160;&#160;Following receipt of the exercise notice, any other applicable documents and the payment referred to above, the Company shall, within 30 days, cause certificates representing the Purchased Shares to be delivered to Optionee either at Optionee&#8217;s address set forth in the records of the Company or at such other address as Optionee may designate in writing to the Company (or, if no certificate is issued, by entry on the Company&#8217;s books and records of the foregoing)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Company shall not be obligated to issue a fraction or fractions of a share otherwise issuable upon exercise of the Option, and may pay to Optionee, in cash or cash equivalent, the fair market value of any such fraction or fractions of a share as of the date of exercise.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3&#160;&#160;&#160;&#160;If requested by the Administrator, Optionee shall also deliver this Agreement to the Secretary of the Company, who shall endorse hereon a notation of the exercise and return this Agreement to Optionee.  The date of exercise of an Option that is validly exercised shall be deemed to be the date on which there shall have been delivered to the Administrator the instruments referred to in this Section 3.  Optionee shall not be deemed to be a holder of any Option Shares pursuant to exercise of the Option until the date of issuance of a stock certificate to him or her for such shares following payment in full for the Option Shares purchased.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4&#160;&#160;&#160;&#160;Optionee acknowledges and agrees that any income or other taxes due from Optionee with respect to the Option (upon exercise of the Option, the sale of Shares issued pursuant to the Option or otherwise) shall be Optionee&#8217;s responsibility. Without limiting the foregoing, the parties agree that to the extent the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes in connection with the exercise of the Option, then the Company or Subsidiary (as applicable) shall retain a number of Shares otherwise deliverable hereunder with a value equal to the required withholding (based on the fair market value of the Shares on the applicable date)&#59; provided that in no event shall the value of the Shares retained exceed the minimum amount of taxes required to be withheld or such other amount that will not result in a negative accounting impact. Notwithstanding the foregoing, (a) to the extent permitted by the Administrator, Optionee may elect, in accordance with procedures adopted by the Company from time to time, to&#160;pay or provide for payment of any required tax withholding, and (b) in the event that the Company or any Subsidiary is required to withhold taxes at any time other than upon exercise of the Option, the Company may withhold applicable taxes from other compensation payable to Optionee or require Optionee to make arrangements satisfactory to the Company to provide for such tax withholding.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5&#160;&#160;&#160;&#160;The Option and any Shares that may be delivered pursuant to this Agreement are subject to forfeiture or repayment as may be provided pursuant to the Company&#8217;s Compensation Recovery Policy (or any successor compensation recovery policy), as in effect from time to time.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Option Certificate and Agreement (ISO)-2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt;text-decoration:underline">Termination of Option</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1&#160;&#160;&#160;&#160;The Option shall terminate and expire upon the earliest to occur of&#58; (i) the Option Expiration Date set forth in the Option Certificate&#59; (ii) the Termination Date&#59; and (iii) any action taken by the Administrator in connection with a Change of Control or other transaction as provided in Section 16 of the Plan.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2&#160;&#160;&#160;&#160;For purposes of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2.1&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the first day Optionee is not an employee of the Company or any of its Affiliates.  Optionee&#8217;s employment shall not be deemed to terminate by reason of a transfer to or from the Company or an Affiliate or among such entities, or sick leave, military leave or other leave of absence approved by the Administrator, if the period of any such leave does not exceed 90 days or, if longer, if Optionee&#8217;s right to reemployment by the Company or any Affiliate is guaranteed either contractually or by statute. </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2.2&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall be&#58; (a) the date 90 days following the Employment Termination Date unless Optionee&#8217;s employment is terminated For Cause or as a result of the death, Disability or Retirement of Optionee&#59; (b) upon the Employment Termination Date if Optionee&#8217;s employment is terminated For Cause&#59; or (c)&#160;the date one year following the Employment Termination Date as a result of the death, Disability or Retirement of Optionee.  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2.3&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">For Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean Optionee&#8217;s loss of employment by the Company or any of its Affiliates due to Optionee&#8217;s (a) willful breach or habitual neglect or continued incapacity to perform Optionee&#8217;s required duties, (b) commission of acts of dishonesty, fraud, misrepresentation or other acts of moral turpitude in connection with Optionee&#8217;s services to the Company or its Affiliates or which in the determination of the Administrator would prevent the effective performance of Optionee&#8217;s duties or (c) termination For Cause under any employment agreement between the Company and Optionee (as &#8220;cause&#8221; is defined therein).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The number of shares and Exercise Price of this Option shall be subject to adjustment under the circumstances contemplated by the Plan and the Option Expiration Date may be accelerated by the Administrator upon the circumstances set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the occurrence of a Change of Control or other transaction contemplated by Section 16 of the Plan, the Option shall be subject to adjustment and to any other actions of the Administrator as contemplated in the Plan.  This Agreement shall not in any way affect the right of the Company to adjust, reclassify, reorganize or otherwise change its capital structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions and within the limitations of the Plan, the Administrator may modify, extend or renew the Option or accept the surrender of, and authorize the grant of a new option in substitution for, the Option (to the extent not previously exercised).  No modification of the Option shall be made which, without the consent of Optionee, would cause the Option to fail to continue to qualify as an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">incentive stock option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; within the meaning of Section 422 of the Code or would alter or impair any rights of Optionee under the Option.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Disqualifying Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee agrees that, should he or she make a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; (as defined in Section 424(c) of the Code) of all or any of the Purchased Shares </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Option Certificate and Agreement (ISO)-2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">within two years from the date of the grant of the Option or within one year after the issuance of such Purchased Shares, he or she shall immediately advise the Company in writing as to the occurrence of the sale and the price realized upon the sale of such Purchased Shares.  Optionee agrees that he or she shall maintain all Purchased Shares in his or her name so long as he or she maintains beneficial ownership of such Purchased Shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement is made pursuant to the Plan, and it is intended, and shall be interpreted in a manner, to comply with the Plan.  Any provision of this Agreement inconsistent with the Plan shall be superseded and governed by the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictions on Sale of Purchased Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee understands that&#58; (a) unless the issuance of the Purchased Shares to Optionee upon exercise of the Option is registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Purchased Shares will be &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">restricted securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; within the meaning of Rule 144 under such Act&#59; (b) the Purchased Shares may not be sold, transferred or assigned by the Optionee except pursuant to an effective registration statement under the Securities Act or an exemption from registration under the Securities Act&#59; and (c) the Company is under no obligation to register or qualify the Purchased Shares or the Option Shares with the Securities and Exchange Commission, any state securities commission or any stock exchange to effect such compliance.  Optionee agrees that any certificates evidencing Purchased Shares may bear a legend indicating that their transferability is restricted in accordance with applicable state and federal securities laws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">General Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All notices, requests, demands and other communications (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) given pursuant to this Agreement shall be in writing, and shall be delivered by personal service, courier, or by United States first class, registered or certified mail, postage prepaid, addressed to the party at the address set forth on the signature page of this Agreement.  Any Notice, other than a Notice sent by registered or certified mail, shall be effective when received&#59; a Notice sent by registered or certified mail, postage prepaid return receipt requested, shall be effective on the earlier of when received or the third day following deposit in the United States mails.  Any party may from time to time change its address for further Notices hereunder by giving notice to the other party in the manner prescribed in this Section.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Failure to Enforce Not a Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The failure of the Company to enforce at any time any provision of this Agreement shall in no way be construed to be a waiver of such provision or of any other provision hereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed in accordance with the law of the State of Delaware applicable to contracts made in, and to be performed within, that State.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer of Rights under this Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company may at any time transfer and assign its rights and delegate its obligations under this Agreement to any other person, corporation, firm or entity, with or without consideration.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option Non-transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee may not sell, transfer, assign or otherwise dispose of the Option except by will or the laws of descent and distribution, and only Optionee or his or her legal representative or guardian may exercise the Option during Optionee&#8217;s lifetime.</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Option Certificate and Agreement (ISO)-2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Right to Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Nothing in this Option shall interfere with or limit in any way the right of the Company or of any of its Affiliates to terminate Optionee&#8217;s employment, consulting or advising at any time, nor confer upon Optionee any right to continue in the employ of, consult with or advise the Company or any of its Affiliates.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except to the extent specifically limited by the terms and provision of this Agreement, this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors, assigns, heirs and personal representatives.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Titles and captions contained in this Agreement are inserted for convenience of reference only and do not constitute a part of this Agreement for any other purpose.   Except as specifically provided herein, neither this Agreement nor any right pursuant hereto or interest herein shall be assignable by any of the parties hereto without the prior written consent of the other party hereto.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee acknowledges that the tax treatment of the Option, the Option Shares or any events or transactions with respect thereto may be dependent upon various factors or events that are not determined by the Plan or this Agreement.  The Company makes no representations with respect to and hereby disclaims all responsibility as to such tax treatment.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delivery of Plan to Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee acknowledges that a copy of the Plan has been delivered to Optionee. The Optionee has read and understands the terms of the Plan and this Agreement, and agrees to be bound by their terms and conditions. The Optionee acknowledges that there may be adverse tax consequences upon the exercise of the Option or disposition of the Purchased Shares, and that the Optionee has been advised to consult a tax adviser prior to such time.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee shall promptly take all actions and execute all documents requested by the Company that the Company deems to be reasonably necessary to effectuate the term and intent of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Laws and Exchange Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The issuance and transfer of any Purchased Shares shall be subject to compliance by the Company and the Optionee with all applicable requirements of securities laws and with all applicable requirements of any stock exchange on which the shares may be listed at the time of such issuance or transfer.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;11.13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Optionee shall have no rights as a stockholder of the Company with respect to any Option Shares until the Optionee exercises the Option in accordance with the terms of this Agreement and pursuant to the Plan.</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.14.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relation to Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any economic or other benefit to Participant under this Agreement or the Plan shall not be taken into account in determining any benefits to which Participant may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company or any of its Subsidiaries or affiliates, except as expressly provided in writing in such other plan&#8217;s governing instrument.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to administer the Plan, the Company may process personal data about Optionee.  Such data includes, but is not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about Optionee such as home address and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the </font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Option Certificate and Agreement (ISO)-2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">administration of the Plan.  Optionee hereby gives explicit consent to the Company to process any such personal data.  Optionee also gives explicit consent to the Company to transfer any such personal data outside the country in which Optionee works or is employed, including, if Optionee is not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.16  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver, including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual and quarterly reports, and all other forms of communications (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in connection with this and any other Award made or offered under the Plan. Optionee has the right at any time to request that the Company deliver written copies of any and all Prospectus Information at no charge. Optionee also hereby consents to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that the Company may elect to deliver and agrees that Optionee&#8217;s electronic response or signature is the same as, and shall have the same force and effect as, Optionee&#8217;s manual signature.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The Certificate is the signature page of this Agreement.</font></div><div style="height:74.16pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Option Certificate and Agreement (ISO)-2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div><div id="i7fff2c19c7e8490e9b08fbc5ac7fa87c_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EXHIBIT &#8220;A&#8221;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOTICE OF EXERCISE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(To be completed and signed only upon exercise of the Option)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;Astrana Health, Inc. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The undersigned, the holder of the enclosed Stock Option Agreement (Incentive Stock Option), hereby irrevocably elects to exercise the purchase right represented by the Option and to purchase thereunder _____________* shares (the &#8220;Purchased Shares&#8221;) of Common Stock of Astrana Health, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and delivers herewith payment of the full Exercise Price of the Purchased Shares equal to $_________ as follows&#58; &#91;initial and complete applicable payment method&#93;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______  in cash or check.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______ delivery of the following Shares or other securities of the Company (including by attestation) having a Fair Market Value on the date hereof equal to the Exercise Price&#58; &#91;describe the securities tendered&#93; __________________________________________________________,</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______ delivery to the Company or its designated agent of an executed irrevocable option exercise form together with irrevocable instructions to a broker-dealer to sell or margin a sufficient portion of the Purchased Shares and deliver the sale or margin loan proceeds directly to the Company to pay for the Exercise Price.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______ the surrender of __________ Purchased Shares having a Fair Market Value on the date hereof equal to the Exercise Price.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______ with the approval of the Administrator, by delivery to the Company of such other consideration (such as a promissory note) acceptable to the Administrator described as follows&#58; ____________________________________________________________________________.</font></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Signature must conform in all respects to name of holder as specified on the face of the Option)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:4pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:12.35pt;padding-right:12.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Address)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:12.35pt;padding-right:12.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Social Security Number</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*Insert here the number of shares being exercised making all adjustments for stock splits, stock dividends or other additional Common Stock of the Company, other securities or property which, pursuant to the adjustment provisions of Section 5 of the Option, may be deliverable upon exercise.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:97.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>7
<FILENAME>exhibit105-formofnonqualif.htm
<DESCRIPTION>EX-10.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ieb332f13eb8344adafbbbcf5524bf246_1"></div><div style="min-height:49.68pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">OPTION CERTIFICATE<br>(Non-Qualified Stock Option)</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THIS IS TO CERTIFY that Astrana Health, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), has granted to the individual named below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) a non-qualified stock option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to purchase shares of the Company&#8217;s Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) under its 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and upon the terms and conditions set forth below and in the attached Stock Option Agreement&#58;</font></div><div style="padding-left:42.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.051%"><tr><td style="width:1.0%"></td><td style="width:37.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name of Optionee&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Number of Shares&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Option Exercise Price&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$     per Share</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date of Grant&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Option Expiration Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exercise Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;  The Option shall become exercisable (&#8220;vest&#8221;) as follows&#58;</font></div><div style="padding-left:86.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.006%"><tr><td style="width:1.0%"></td><td style="width:60.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Date</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Number of Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Commencing on &#8230;.</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">IMPORTANT NOTICE&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">THIS AGREEMENT SHALL BE VOID, AND THE OPTION SHALL BE FORFEITED AUTOMATICALLY, IF THE AGREEMENT HAS NOT BEEN SIGNED BY OPTIONEE AND RETURNED TO THE COMPANY WITHIN 30 DAYS AFTER THE GRANT DATE.</font></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div><font><br></font></div><div style="height:83.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:342.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.320%"><tr><td style="width:1.0%"></td><td style="width:33.077%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Grant #</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">########</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In Witness Whereof, the Company has granted to Optionee the Option as of the Date of Grant set forth above.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ASTRANA HEALTH, INC. </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:3pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Its&#160;&#160;&#160;&#160;Chief Executive Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Optionee acknowledges that he or she has received a copy of the 2015 Equity Incentive Plan and the Stock Option Agreement related to this grant.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">_____________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Address&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">______________________________________  </font></div><div style="height:83.52pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:342.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.320%"><tr><td style="width:1.0%"></td><td style="width:33.077%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Grant #</font></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">########</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><div id="ieb332f13eb8344adafbbbcf5524bf246_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STOCK OPTION AGREEMENT<br>(Non-Qualified Stock Option)</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This STOCK OPTION AGREEMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is made and entered into as of the Date of Grant set forth in the Option Certificate to which this Agreement is attached (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) by and between Astrana Health, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and the optionee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) named in the Certificate. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to the 2015 Equity Incentive Plan of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Administrator (which term includes, for the purposes hereof, the Board, the Committee  or any other Person that has authority to administer the Plan) has determined that Optionee is to be granted, on the terms and conditions set forth in this Agreement and in the Plan, an option to purchase shares of the Company&#8217;s Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  It is intended that the option </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> qualify as an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Capitalized terms not otherwise defined in this Agreement shall have the meanings ascribed to them in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company and Optionee agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Grant of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company hereby grants to Optionee, upon the terms and subject to the conditions set forth in this Agreement, an Option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to purchase all or any portion of that number of shares of Common Stock set forth in the Certificate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), at the exercise price set forth in the Certificate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Vesting</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1&#160;&#160;&#160;&#160;The Option shall &#8220;vest&#8221; and become exercisable in installments upon and after the dates set forth under the caption &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; in the Certificate.  The installments shall be cumulative&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the Option may be exercised, as to any or all Option Shares covered by an installment, at any time or times after the installment first becomes exercisable and until expiration or termination of the Option. In addition, the Option shall vest as to all Option Shares immediately preceding, and conditioned upon the closing of, a Change of Control. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2&#160;&#160;&#160;&#160;No vesting shall occur after the Employment Termination Date (as defined in Section 4.2 of this Agreement).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in this Option Agreement, the Option may not be exercised, in whole or in part, unless and until any then-applicable requirements of all state and federal laws and regulatory agencies shall have been fully complied with to the satisfaction of the Company and its counsel.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Exercise of the Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1&#160;&#160;&#160;&#160;The Option may be exercised, in whole or in part, only by delivery to the Company of&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1.1&#160;&#160;&#160;&#160;written notice of the exercise of the Option in form identical to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit &#8220;A&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> attached to this Agreement, the terms of which are incorporated herein by this reference, stating the number of Option Shares being purchased (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Purchased Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1.2&#160;&#160;&#160;&#160;payment of the Exercise Price by any combination of (i) cash or cash equivalent&#59; (ii) delivery of other Shares or other securities of the Company (including by attestation) valued at their then Fair Market Value, (iii) delivery (including by fax) to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Options Certificate &#38; Agreement-NQSO under 2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Company or its designated agent of an executed irrevocable option exercise form together with irrevocable instructions to a broker dealer to sell or margin a sufficient portion of the Purchased Shares and deliver the sale or margin loan proceeds directly to the Company to pay for the Exercise Price, (iv) the surrender of Shares then issuable upon exercise of the Option, valued at their then Fair Market Value, and (v) with the approval of the Administrator, by delivery to the Company of such other consideration (such as a promissory note) acceptable to the Administrator.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2&#160;&#160;&#160;&#160;Following receipt of the exercise notice, any other applicable documents and the payment referred to above, the Company shall, within 30 days, cause certificates representing the Purchased Shares to be delivered to Optionee either at Optionee&#8217;s address set forth in the records of the Company or at such other address as Optionee may designate in writing to the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that the Company shall not be obligated to issue a fraction or fractions of a share otherwise issuable upon exercise of the Option, and may pay to Optionee, in cash or cash equivalent, the fair market value of any such fraction or fractions of a share as of the date of exercise.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3&#160;&#160;&#160;&#160;If requested by the Administrator, Optionee shall also deliver this Agreement to the Secretary of the Company, who shall endorse hereon a notation of the exercise and return this Agreement to Optionee.  The date of exercise of an Option that is validly exercised shall be deemed to be the date on which there shall have been delivered to the Administrator the instruments referred to in this Section 3.  Optionee shall not be deemed to be a holder of any Option Shares pursuant to exercise of the Option until the date of issuance of a stock certificate to him or her for such shares following payment in full for the Option Shares purchased.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4&#160;&#160;&#160;&#160;Optionee acknowledges and agrees that any income or other taxes due from Optionee with respect to the Option (upon exercise of the Option, the sale of Shares issued pursuant to the Option or otherwise) shall be Optionee&#8217;s responsibility. Without limiting the foregoing, the parties agree that to the extent the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes in connection with the exercise of the Option, then the Company or Subsidiary (as applicable) shall retain a number of Shares otherwise deliverable hereunder with a value equal to the required withholding (based on the fair market value of the Shares on the applicable date)&#59; provided that in no event shall the value of the Shares retained exceed the minimum amount of taxes required to be withheld or such other amount that will not result in a negative accounting impact. Notwithstanding the foregoing, (a) to the extent permitted by the Administrator, Optionee may elect, in accordance with procedures adopted by the Company from time to time, to&#160;pay or provide for payment of any required tax withholding, and (b) in the event that the Company or any Subsidiary is required to withhold taxes at any time other than upon exercise of the Option, the Company may withhold applicable taxes from other compensation payable to Optionee or require Optionee to make arrangements satisfactory to the Company to provide for such tax withholding.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5&#160;&#160;&#160;&#160;The Option and any Shares that may be delivered pursuant to this Agreement are subject to forfeiture or repayment as may be provided pursuant to the Company&#8217;s Compensation Recovery Policy (or any successor compensation recovery policy), as in effect from time to time.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Termination of Option</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1&#160;&#160;&#160;&#160;The Option shall terminate and expire upon the earliest to occur of&#58; (i) the Option Expiration Date set forth in the Option Certificate&#59; (ii) the Termination Date&#59; and (iii) any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Options Certificate &#38; Agreement-NQSO under 2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">action taken by the Administrator in connection with a Change of Control or other transaction as provided in Section 16 of the Plan.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2&#160;&#160;&#160;&#160;For purposes of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2.1&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Employment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the first day Optionee is not a director, employee or consultant to the Company and its Affiliates.  As long as Optionee is at least one of employee, director or consultant, the Employment Termination Date shall not be deemed to have occurred.  For example, if Optionee is an employee and a director, the termination of employment as an employee while remaining a director shall not establish an Employment Termination Date (which would only be established if and when Optionee ceases to be a director).  Optionee&#8217;s employment shall not be deemed to terminate by reason of a transfer to or from the Company or an Affiliate or among such entities, or sick leave, military leave or other leave of absence approved by the Administrator, if the period of any such leave does not exceed 90 days or, if longer, if Optionee&#8217;s right to reemployment by the Company or any Affiliate is guaranteed either contractually or by statute.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2.2&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall be&#58; (a) the date 90 days following the Employment Termination Date unless Optionee&#8217;s employment is terminated For Cause or as a result of the death, Disability or Retirement of Optionee&#59; (b) upon the Employment Termination Date if Optionee&#8217;s employment is terminated For Cause&#59; or (c) one year following the Employment Termination Date as a result of the death, Disability or Retirement of Optionee.  </font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2.3&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">For Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean Optionee&#8217;s loss of employment, directorship or consulting engagement by the Company or any of its Affiliates due to Optionee&#8217;s (a) willful breach or habitual neglect or continued incapacity to perform Optionee&#8217;s required duties, (b) commission of acts of dishonesty, fraud, misrepresentation or other acts of moral turpitude in connection with Optionee&#8217;s services to the Company or its Affiliates or which in the determination of the Administrator would prevent the effective performance of Optionee&#8217;s duties or (c) termination For Cause under any employment or consulting agreement between the Company and Optionee (as &#8220;cause&#8221; is defined therein).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The number of shares and Exercise Price of this Option shall be subject to adjustment under the circumstances contemplated by the Plan and the Option Expiration Date may be accelerated by the Administrator upon the circumstances set forth in the Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Upon the occurrence of a Change of Control or other transaction contemplated by Section 16 of the Plan, the Option shall be subject to adjustment and to any other actions of the Administrator as contemplated in the Plan. This Agreement shall not in any way affect the right of the Company to adjust, reclassify, reorganize or otherwise change its capital structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions and within the limitations of the Plan, the Administrator may modify, extend or renew the Option or accept the surrender of, and authorize the grant of a new option in substitution for, the Option (to the extent not previously exercised).  No modification of the Option shall be made which, without the consent of Optionee, would alter or impair any rights of Optionee under the Option.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement is made pursuant to the Plan, and it is intended, and shall be interpreted in a manner, to comply with the Plan.  Any provision of this Agreement inconsistent with the Plan shall be superseded and governed by the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Options Certificate &#38; Agreement-NQSO under 2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictions on Sale of Purchased Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee understands that&#58; (a) unless the issuance of the Purchased Shares to Optionee upon exercise of the Option is registered under the Securities Act of 1933, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Purchased Shares will be &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">restricted securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; within the meaning of Rule 144 under such Act&#59; (b) the Purchased Shares may not be sold, transferred or assigned by the Optionee except pursuant to an effective registration statement under the Securities Act or an exemption from registration under the Securities Act&#59; and (c) the Company is under no obligation to register or qualify the Purchased Shares or the Option Shares with the Securities and Exchange Commission, any state securities commission or any stock exchange to effect such compliance.  Optionee agrees that any certificates evidencing Purchased Shares may bear a legend indicating that their transferability is restricted in accordance with applicable state and federal securities laws.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">General Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All notices, requests, demands and other communications (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) given pursuant to this Agreement shall be in writing, and shall be delivered by personal service, courier, or by United States first class, registered or certified mail, postage prepaid, addressed to the party at the address set forth on the signature page of this Agreement.  Any Notice, other than a Notice sent by registered or certified mail, shall be effective when received&#59; a Notice sent by registered or certified mail, postage prepaid return receipt requested, shall be effective on the earlier of when received or the third day following deposit in the United States mails.  Any party may from time to time change its address for further Notices hereunder by giving notice to the other party in the manner prescribed in this Section.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Failure to Enforce Not a Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The failure of the Company to enforce at any time any provision of this Agreement shall in no way be construed to be a waiver of such provision or of any other provision hereof.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and construed in accordance with the law of the State of Delaware applicable to contracts made in, and to be performed within, that State.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Transfer of Rights under this Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company may at any time transfer and assign its rights and delegate its obligations under this Agreement to any other person, corporation, firm or entity, with or without consideration.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option Non-transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee may not sell, transfer, assign or otherwise dispose of the Option except by will or the laws of descent and distribution, and only Optionee or his or her legal representative or guardian may exercise the Option during Optionee&#8217;s lifetime.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Right to Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Nothing in this Option shall interfere with or limit in any way the right of the Company or of any of its Affiliates to terminate Optionee&#8217;s employment, consulting or advising at any time, nor confer upon Optionee any right to continue in the employ of, consult with or advise the Company or any of its Affiliates.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except to the extent specifically limited by the terms and provision of this Agreement, this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors, assigns, heirs and personal representatives.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Titles and captions contained in this Agreement are inserted for convenience of reference only and do not constitute a part of this Agreement for any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Options Certificate &#38; Agreement-NQSO under 2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">other purpose.   Except as specifically provided herein, neither this Agreement nor any right pursuant hereto or interest herein shall be assignable by any of the parties hereto without the prior written consent of the other party hereto.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Treatment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee acknowledges that the tax treatment of the Option, the Option Shares or any events or transactions with respect thereto may be dependent upon various factors or events that are not determined by the Plan or this Agreement.  The Company makes no representations with respect to and hereby disclaims all responsibility as to such tax treatment.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delivery of Plan to Optionee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee acknowledges that a copy of the Plan has been delivered to Optionee. The Optionee has read and understands the terms of the Plan and this Agreement, and agrees to be bound by their terms and conditions. The Optionee acknowledges that there may be adverse tax consequences upon the exercise of the Option or disposition of the Purchased Shares, and that the Optionee has been advised to consult a tax adviser prior to such time.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee shall promptly take all actions and execute all documents requested by the Company that the Company deems to be reasonably necessary to effectuate the term and intent of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Laws and Exchange Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The issuance and transfer of any Purchased Shares shall be subject to compliance by the Company and the Optionee with all applicable requirements of securities laws and with all applicable requirements of any stock exchange on which the shares may be listed at the time of such issuance or transfer.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Optionee shall have no rights as a stockholder of the Company with respect to any Option Shares until the Optionee exercises the Option in accordance with the terms of this Agreement and pursuant to the Plan.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.14&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relation to Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any economic or other benefit to Participant under this Agreement or the Plan shall not be taken into account in determining any benefits to which Participant may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company or any of its Subsidiaries or affiliates, except as expressly provided in writing in such other plan&#8217;s governing instrument.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to administer the Plan, the Company may process personal data about Optionee.  Such data includes, but is not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about Optionee such as home address and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan.  Optionee hereby gives explicit consent to the Company to process any such personal data.  Optionee also gives explicit consent to the Company to transfer any such personal data outside the country in which Optionee works or is employed, including, if Optionee is not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Optionee hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver, including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual and quarterly reports, and all other forms of communications (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in connection with this and any other Award made or offered under the Plan. Optionee has the right at any time to request that the Company deliver written copies of any and all Prospectus Information at no charge. Optionee also hereby consents to any and all procedures </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Options Certificate &#38; Agreement-NQSO under 2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that the Company may elect to deliver and agrees that Optionee&#8217;s electronic response or signature is the same as, and shall have the same force and effect as, Optionee&#8217;s manual signature.</font></div><div style="margin-bottom:6pt;text-indent:72pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">The Certificate is the signature page of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.740%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Options Certificate &#38; Agreement-NQSO under 2015 EIP-template rev 02-28-24.docx</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><div id="ieb332f13eb8344adafbbbcf5524bf246_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.5</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">EXHIBIT &#8220;A&#8221;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTICE OF EXERCISE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(To be completed and signed only upon exercise of the Option)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">TO&#58;&#160;&#160;&#160;&#160;Astrana Health, Inc. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The undersigned, the holder of the enclosed Stock Option Agreement (Non-Qualified Stock Option), hereby irrevocably elects to exercise the purchase right represented by the Option and to purchase thereunder ____________* shares (the &#8220;Purchased Shares&#8221;) of Common Stock of Astrana Health, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and delivers herewith payment of the full Exercise Price of the Purchased Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">equal to $_________  as follows&#58; &#91;initial and complete applicable payment method&#93;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> ______  in cash or check.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">______ delivery of the following Shares or other securities of the Company (including by attestation) having a Fair Market Value on the date hereof equal to the Exercise Price&#58; &#91;describe the securities tendered&#93; __________________________________________________________,</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">______ delivery to the Company or its designated agent of an executed irrevocable option exercise form together with irrevocable instructions to a broker-dealer to sell or margin a sufficient portion of the Purchased Shares and deliver the sale or margin loan proceeds directly to the Company to pay for the Exercise Price.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">______ the surrender of __________ Purchased Shares having a Fair Market Value on the date hereof equal to the Exercise Price.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">______ with the approval of the Administrator, by delivery to the Company of such other consideration (such as a promissory note) acceptable to the Administrator described as follows&#58; ____________________________________________________________________________.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Signature must conform in all respects to name of holder as specified on the face of the Option)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:4pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:12.35pt;padding-right:12.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(Address)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:12.35pt;padding-right:12.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Social Security Number</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*Insert here the number of shares being exercised making all adjustments for stock splits, stock dividends or other additional Common Stock of the Company, other securities or property which, pursuant to the adjustment provisions of Section 5 of the Option, may be deliverable upon exercise.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>8
<FILENAME>exhibit1011-physiciansha.htm
<DESCRIPTION>EX-10.11
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit1011-physiciansha</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit1011-physiciansha001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">PHYSICIAN SHAREHOLDER AGREEMENT  This PHYSICIAN SHAREHOLDER AGREEMENT (this &quot;Agreement&quot;), dated as of August  31, 2023, is granted and delivered by Thomas Lam, M.D. (&quot;Shareholder&quot;), a physician licensed under  the laws of the State of California (the &quot;State&quot;), in favor of Network Medical Management, Inc. a  California corporation (&quot;Manager&quot;), and Apollo Medical Holdings, Inc., a Delaware corporation  (&quot;Apollo&quot;), and for the benefit of AP-AMH 2 Medical Corporation, a California professional medical  corporation (&quot;Practice&quot; or &quot;AP-AMH 2&quot;). Capitalized terms used herein and not otherwise defined shall  have the meanings given such terms in the Management Agreement (as defined below). The parties  acknowledge and agree that this Agreement shall be effective as of July 14, 2021, i.e., the date on which  Practice's Articles of Incorporation were filed with the California Secretary of State (the &quot;Effective  Date&quot;).  BACKGROUND STATEMENT  A. Practice is a professional entity organized under the laws of the State to provide  professional medical services. Shareholder is the legal and beneficial owner of one hundred percent  (100%) of the issued and outstanding stock in Practice (the &quot;Shares&quot;). Practice has entered into that  certain Administrative Services Agreement dated as of the date hereof by and between Practice and  Manager (as amended or restated from time to time, the &quot;Management Agreement&quot;), pursuant to which  Manager provides exclusive management and administrative services to Practice.  B. As the majority shareholder of Practice, Shareholder will substantially benefit from  Manager's performance under the Management Agreement, including Manager's or Apollo's ability to  extend credit to the Practice, and has the ability to impact Practice's compliance with certain terms of the  Management Agreement. The purpose of this Agreement is to memorialize the agreement of Shareholder  to act in accordance with the Management Agreement, and to the extent of Shareholder's personal  authority, refrain from any action or inaction that would result in a breach by Practice of its obligations  under the Management Agreement.  C. Pursuant to the Management Agreement, Manager has the exclusive right to provide  management and administrative services to Practice. Manager has expended, and will continue to expend,  significant resources, and has undertaken significant obligations, and will continue to incur significant  obligations, to be in a position to perform its obligations under the Management Agreement. In  consideration of such services, Practice has entered into certain covenants under the Management  Agreement that assure Manager the exclusive right to provide management and administrative services to  Practice.  D. Apollo, as the sole shareholder of Manager, has the authority to cause Manager to enter  into the Management Agreement. In light of the substantial benefits flowing directly to Practice and  indirectly to Shareholder from Manager's performance of the Management Agreement, it is a condition  to Apollo's causing Manager to enter into the Management Agreement that Shareholder execute and  deliver this Agreement. Apollo and Manager are relying on this Agreement in their decision for Manager  to enter into the Management Agreement and Manager would not enter into the Management Agreement  without this Agreement.  Physician Shareholder Agreement-Dr Lam-AP-AMH 2 - 1 -  Exhibit 10.11 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  E. Apollo is loaning money to Practice pursuant to (i) a Loan Agreement between Apollo and  Practice, dated on or about the date hereof (as amended or restated from time to time, the &quot;Loan  Agreement&quot;), (ii) a Security Agreement made by Practice in favor of Apollo, dated on or about the date  hereof (as amended or restated from time to time, the &quot;Security Agreement&quot;), and (iii) a Secured  Promissory Note made by Practice in favor of Apollo, dated on or about the date hereof (as amended or  restated from time to time, the &quot;Note&quot; and, collectively with the Loan Agreement and Security Agreement,  the &quot;Loan Documents&quot;). Apollo has required this Agreement to be executed as a condition to entering  into the Loan Documents. The proceeds of Apollo's loans to Practice will provide substantial benefits and  assistance to Practice and to Manager in the performance of Manager's obligations under the Management  Agreement, including Manager's obligation to extend credit to the Practice; consequently, Shareholder  will receive substantial benefits from Apollo's loans to Practice.  F. The parties are entering into this Agreement to memorialize the arrangement between the  parties regarding the subject matter set forth herein that has been in effect since the Effective Date, and to  set forth their respective rights and responsibilities during the term of this Agreement.  AGREEMENT  NOW, THEREFORE, in consideration of the foregoing recitals, which are incorporated herein,  and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,  and to induce Apollo to cause Manager to enter into the Management Agreement with Practice and Apollo  to make loans to Practice, Shareholder hereby agrees as follows:  ARTICLE I  SHAREHOLDER COVENANTS  1.1 Compliance with Management Agreement and Loan Documents.  1.1.1 Without limiting any other obligation of Shareholder hereunder or of Practice under  the Management Agreement, during the term of the Management Agreement, Shareholder shall not take  any action, or fail to take any action, in his or her capacity as a shareholder, director or officer of Practice,  that would cause Practice to breach the Management Agreement or any of the Loan Documents to which  Practice is a party.  1.1.2 Whenever the Management Agreement requires Manager and Practice to agree on  the amount of the management fees payable by Practice under the Management Agreement, Shareholder  shall use his or her best efforts to cause Practice to negotiate in good faith and to reach an agreement on  the amount of such management fees.  1.1.3 Shareholder agrees to be responsible for all damages suffered by Manager due to  the affirmative actions or intentional omissions by Shareholder that result in a breach by Practice of its  obligations under the Management Agreement or any Loan Document (such that the breach would not  have occurred but for Shareholder's affirmative action or intentional omission in connection therewith).  1.2 Issuance, Transfer of Shares. Except as otherwise provided herein or in the Loan  Documents, neither the Shareholder nor his estate, heirs or devisees shall sell, assign, transfer, gift, pledge,  hypothecate, encumber or otherwise dispose of, whether voluntarily, involuntarily, by operation of law or  otherwise, any or all of the Shares which the Shareholder now owns or may hereafter acquire. In addition,  Physician Shareholder Agreement-Dr Lam-AP-AMH 2 - 2 -  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">the Shareholder shall not cause Practice to authorize, approve or declare any dividend or other distribution  with respect to the Shares. In furtherance of the foregoing, concurrently with the execution hereof,  Shareholder agrees to place a restrictive legend on any certificates representing Shares that reads  substantially as follows:  &quot;THE SHARES REPRESENTED BY THIS CERTIFICATE, AND THE  TRANSFER THEREOF, ARE SUBJECT TO THE PROVISIONS OF A  PHYSICIAN SHAREHOLDER AGREEMENT IN FAVOR OF APOLLO  MEDICAL HOLDINGS, INC. AND NETWORK MEDICAL MANAGEMENT,  INC., DATED AS OF AUGUST 31, 2023 (A COPY OF WHICH IS ON FILE IN,  AND MAY BE EXAMINED AT, THE PRINCIPAL OFFICE OF THE  CORPORATION), AND NO TRANSFER OF THE SHARES REPRESENTED  HEREBY OR OF SHARES ISSUED IN EXCHANGE THEREFOR SHALL BE  VALID OR EFFECTIVE UNLESS AND UNTIL THE TERMS AND  CONDITIONS OF SUCH AGREEMENT SHALL HAVE BEEN FULFILLED.&quot;  1.3 Obligations Concerning Certain Actions.  1.3.1 The Shareholder and Practice shall provide written notice (the &quot;Notice&quot;) to Apollo  of any vote or action (an &quot;Action&quot;) to be taken at any time or from time-to-time by the Shareholder in his  capacity as Practice's sole shareholder or as its sole director with respect to any of the matters set forth  below:  (a) The lease, sale, exchange, transfer, mortgage or other assignment or disposal of all  or substantially all of Practice's assets;  (b) The merger, consolidation, or reorganization of Practice;  (c) The issuance of any shares of Practice's stock or any warrant, option, right or other  security convertible into or exchangeable for capital stock of Practice, or the creation of any new class or  series of stock;  (d) The sale, exchange, transfer, mortgage or other assignment or disposal of any of  the Shares;  (e) The adoption, amendment, restatement, repeal or modification of this Agreement,  the Articles of Incorporation and/or the Bylaws of Practice;  (f) The formation of any subsidiaries, joint ventures, or other entities by Practice or in  which Practice has an equity or debt interest;  (g) Any action related to the amendment, modification or termination of any  agreements with Apollo and/or Manager (or any successor);  (h) Any action concerning legal matters or the management of financial affairs or  resources of Practice;  Physician Shareholder Agreement-Dr Lam-AP-AMH 2 - 3 -  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">(i) The delegation of any authority with respect to the affairs of Practice by the  Shareholder to any other person or entity;  a)  Board of Directors;  The nomination or election of any person other than the Shareholder to Practice's  (k) Except in connection with the Loan Documents, incurrence of extraordinary  indebtedness (other than indebtedness incurred with respect to normal accounts payable or otherwise in  the ordinary course of business) by Practice in excess of Five Thousand Dollars ($5,000), whether as a  demand or term loan, a line of credit, or other form of short-term or long-term debt;  (I) Except in connection with the Loan Documents, entry into any material agreement  pertaining to the business of Practice;  (m) Liquidation or dissolution of Practice; and/or  (n) Entry into any agreement with any other person or entity to do any of the foregoing.  1.3.2 No Action Permitted During the Notice Period. The Notice shall be given by the  Shareholder at least thirty (30) days prior to taking any Action; provided that, if the Shareholder is required  by law to act prior to the expiration of such 30-day period, the Shareholder shall give such written notice  to Apollo as early as possible prior to the time that the Shareholder is required to act (such 30-day period,  or less if required by law, is referred to as the &quot;Notice Period&quot;). During the Notice Period, the Shareholder  shall not take or ratify the Action described in the Notice.  1.3.3 Notice Requirements. The Notice shall include a description of the contemplated  Action and copies of all relevant documents and materials. Within ten (10) days after Apollo's receipt of  the Notice, Apollo may reasonably request additional documentation and materials related to the  contemplated vote or action, and the Shareholder shall promptly provide the same to the requesting party;  provided that, unless otherwise required by law, the Notice Period shall be extended by the number of  days between the date of any request for additional documentation and the date such additional  documentation is delivered to the requesting party.  1.3.4 Action Taken in Contravention is Null and Void. Any Action taken by the  Shareholder or Practice in contravention of the Shareholder's obligations to provide the Notice or to  refrain from taking an Action within the Notice Period, shall be null and void and of no force or effect to  the extent permitted by applicable law.  1.4 General. 1.4.1 Shareholder agrees that his obligations hereunder are absolute and unconditional,  and such obligations shall not be discharged, limited or otherwise affected by (i) any amendment,  modification, supplement to, discharge or waiver of any provisions of the Management Agreement or  Loan Documents or (ii) any other circumstance that might otherwise constitute a legal or equitable  discharge or defense available to Practice or Shareholder.  1.4.2 No obligation of Shareholder hereunder shall be discharged other than by complete  performance of such obligation.  Physician Shareholder Agreement-Dr Lam-AP-AMH 2 - 4 -  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  1.4.3 Shareholder agrees that, pursuant to this Agreement, Shareholder shall deliver to  Apollo, for Apollo to hold for the term of this Agreement, (i) an undated and signed irrevocable stock  power with regard to its stock in Practice, (ii) an undated and signed resignation of Shareholder's position  as officer and/or director, as applicable, of Practice, and (iii) Shareholder's stock certificate in Practice.  1.4.4 Shareholder shall maintain Shareholder's license to practice medicine in the State,  and Shareholder shall notify Apollo immediately upon the loss of such licensure or the commencement of  any proceeding or action that may result in the loss of such licensure.  ARTICLE II  APOLLO'S ACQUISITION RIGHT  2.1 Apollo's Acquisition Right.  (a) In support and furtherance of Shareholder's obligations under this Agreement and  for the consideration received herewith, Shareholder agrees that at any time or from time to time during  the term of this Agreement, Apollo may designate a third party who is permitted under California law to  be a shareholder of Practice (a &quot;Permitted Transferee&quot;) with the right (the &quot;Acquisition Right&quot;) (a) to  acquire Shareholder's Shares for a purchase price of $100.00, or (b) to acquire from Practice, for a  purchase price of $100.00, a number of equity interests in Practice that, if issued to the Permitted  Transferee, would result in such Permitted Transferee's holding a 51% ownership interest in Practice (the  &quot;Share Transfer&quot;).  (b) The Acquisition Right shall be exercisable by Apollo by delivering written notice  of such exercise and payment to Shareholder or Practice, as applicable, and upon exercise, Shareholder  shall be obligated to assign and transfer the Shares or to cause Practice to issue new equity interests (as  applicable), free and clear of all liens, encumbrances, claims of third parties, security interests, mortgages,  pledges, agreements, options and rights of others of any kind whatsoever, whether or not filed, recorded  or perfected. In furtherance of, but without limiting, the foregoing, at any time an &quot;Event of Default&quot; is  in existence under the Loan Documents, Apollo shall have the right to exercise its Acquisition Right in  favor of a Permitted Transferee approved by Apollo. On or before the Share Transfer, the Shareholder  shall execute all such documentation, if any, required or convenient to transfer and convey all of the  Shareholder's right, title and interest in and to the Shares.  ARTICLE III  GENERAL  3.1 Term. This Agreement shall remain in full force and effect until such time as Shareholder  no longer holds an ownership interest in any capital stock or other equity interests of Practice.  3.2 Representations. Each of the parties acknowledge, agree and represent and warrant to each  other as follows:  (a) This Agreement is substantially similar to the Physician Shareholder Agreement  dated May 10, 2019, entered into among Shareholder, Manager, Apollo and AP-AMH Medical  Corporation, a California professional medical corporation (&quot;AP-AMH&quot;).  Physician Shareholder Agreement-Dr Lam-AP-AMH 2 - 5 -  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  (b) This Agreement reflects the intention of Shareholder and Apollo, at the time of the  formation of Practice, to execute this Agreement on the date Practice was formed.  (c) Until August 2023, the parties were not aware that this Agreement had not been  properly executed.  (d) Prior to the date that Practice was formed, consideration was given by Apollo,  Shareholder, and legal counsel as to whether AP-AMH could be used to fulfil the functions of AP-AMH  2 or whether a new, &quot;clean&quot; entity (i.e., AP-AMH 2) was a better option. It was decided that a &quot;clean&quot;  entity was more desirable due to the complicated organizational structure of AP-AMH. Similarly, at such  time, Shareholder was aware that his legal ownership of AP-AMH 2 would be subject to substantially  similar restrictions as his ownership of AP-AMH and had explicitly agreed to such restrictions.  Notwithstanding such understanding, Apollo and Shareholder inadvertently neglected to execute this  Agreement at the time AP-AMH 2 was formed.  (e) Between the date AP-AMH 2 was formed through the date this Agreement will be  executed, Shareholder and Apollo acted in a manner consistent with the terms of this Agreement, and both  parties were legally bound during such period by their mutual belief that the terms of this Agreement  already were in effect.  3.3 Arbitration. Any dispute hereunder shall be settled exclusively by binding arbitration  before a single arbitrator in accordance with the Rules of Procedure for Arbitration of the American Health  Lawyers Association (AHLA) Alternative Dispute Resolution Service, and judgment upon the award  rendered by the arbitrator may be entered in any court having jurisdiction thereof. Such arbitration shall  occur in the city where Practice is located within sixty (60) days after a party gives notice to the other  party of its election to trigger this arbitration clause. The arbitrator shall be chosen in accordance with the  rules of the AHLA Alternative Dispute Resolution Service then in effect. If the AHLA Alternative Dispute  Resolution Service is no longer in effect, then the arbitration shall be conducted as set out above by the  American Arbitration Association in accordance with the Commercial Rules of the American Arbitration  Association then in effect. The arbitrator may award attorneys' fees and costs to the prevailing party. The  arbitrator shall prepare in writing and provide to the parties an award including factual findings and the  reasons on which their decision is based. The arbitrator shall not have the power to commit errors of law  or legal reasoning, and the award may be vacated or corrected on appeal to a court of competent  jurisdiction for any such error. The parties shall share the costs of the arbitrator equally between them.  Each party shall bear its own expenses of preparation for and participation in arbitration. The statute of  limitations applicable to any claim shall be determined as if such claim were being asserted in the State  where Practice is located, and such statute of limitations shall apply to preclude arbitration of any claim  hereunder not brought within the applicable limitation period. Notwithstanding anything herein to the  contrary, the parties reserve the right to proceed at any time in any court having jurisdiction or by self- help to exercise or prosecute the following remedies, as applicable: (i) all rights of self-help, including  peaceful occupation of real property and collection of rents, set off, and peaceful possession of personal  property, (ii) pre judgment garnishment or attachment of property, (iii) a preliminary injunction or  temporary restraining order to preserve the status quo or to enforce a party's rights under any provision  set forth herein, and (iv) when applicable, a judgment by confession of judgment. Preservation of these  remedies does not limit the power of the arbitrator to grant similar remedies that may be requested by a  party in a dispute. The agreement to arbitrate set forth in this Section may only be enforced by the parties  to this Agreement and their permitted successors and assigns, shall survive the termination or breach of  Physician Shareholder Agreement-Dr Lam-AP-AMH 2 - 6 -  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">this Agreement, and shall be construed pursuant to and governed by the provisions of the Federal  Arbitration Act, 9 U.S.C. &sect;1, et seq.  3.4 Waiver of Jury Trial. To the fullest extent permitted by law, the parties hereby waive the  right to trial by jury.  3.5 Entire Agreement. This Agreement expresses the entire agreement between the parties  hereto regarding the subject matter hereof and supersedes any prior or contemporaneous written or oral  understanding or agreement.  3.6 Legal Events. If any law is adopted or amended or any rule or regulation is published for  public comment, promulgated or modified, any administrative ruling, advisory opinion or judicial  interpretation in any jurisdiction is issued or modified or any court or administrative tribunal in any  jurisdiction issues any decision, judgment, order or interpretation, which, in the reasonable judgment of  one party draws into question the terms of this Agreement in a manner that may materially and adversely  affect a party's or any party's affiliate's licensure, accreditation, certification, or ability to bill, to claim,  to present a bill or claim, or to receive payment or reimbursement from any payor or that may subject such  party to a substantial risk of prosecution or civil monetary penalty, then the parties shall modify this  Agreement to the minimum extent necessary to eliminate the illegal or unenforceable aspects hereof, while  remaining consistent with the intent of this Agreement in its original form.  3.7 Amendments: Waivers. No amendment, modification, or waiver of any provision of this  Agreement shall be binding unless in writing and signed by the party against whom the operation of such  amendment, modification, or waiver is sought to the enforced. No delay in the exercise of any right shall  be deemed a waiver thereof, and no waiver of a right or remedy in a particular instance shall constitute a  waiver of such right or remedy generally. In addition, this Agreement shall not be amended, terminated,  supplemented or superseded without the prior written consent of Apollo's Board of Directors.  3.8 Waiver. A waiver of any breach on any one occasion shall not constitute a waiver of any  other or subsequent breach whether of like or different nature. No delay or failure by any party to insist  upon the strict performance of any term of this Agreement, or to exercise any right or remedy available  upon any breach of this Agreement, shall operate as a waiver thereof, and no single or partial exercise of  any right or remedy under this Agreement shall preclude other or further exercise thereof or the exercise  of any other right, power or privilege. No course of dealing between the parties shall be effective to change,  modify or discharge any provision of this Agreement or to constitute a waiver of any default hereunder.  3.9 Assignment. Neither Practice nor Shareholder shall assign this Agreement or any of its  rights or obligations under this Agreement without the prior written consent of Apollo. Each of Apollo  and Manager shall have a right to assign this Agreement in connection with a transfer of all or substantially  all of such party's business, whether by sale, merger or otherwise. Shareholder specifically agrees that  Manager shall have the right to perform its obligations hereunder through any affiliate without  Shareholder's consent.  3.10 Successors and Assigns. All of the provisions herein contained shall be binding upon and  inure to the benefit of the heirs, successors and permitted assigns of the parties hereto to the same extent  as if such heirs, successors and permitted assigns were in each case named as a party to this Agreement.  Physician Shareholder Agreement-Dr Lam-AP-AMH 2 - 7 -  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3.11 Severabi I itv. If any provision contained in this Agreement shall for any reason be held  invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not  affect any other provision of this Agreement, but this Agreement shall be construed as if such invalid,  illegal or unenforceable provision had never been contained therein, except as otherwise expressly  provided in this Agreement. The parties hereto agree that if a court determines that any of the covenants  contained herein is unreasonable, void or invalid for any reason whatsoever, then such covenant shall be  modified as the court, or jury if applicable, shall determine to be fair and reasonable, IT BEING THE  INTENT OF THE PARTIES HERETO TO BE SUBJECT TO AN AGREEMENT FOR THE  NECESSARY PROTECTION OF THE LEGITIMATE INTERESTS OF APOLLO AND MANAGER,  WHICH IS NOT UNDULY HARSH IN CURTAILING THE LEGITIMATE RIGHTS OF  SHAREHOLDER. Shareholder acknowledges and agrees that the provisions herein do not deprive  him/her of the ability to find employment and maintain a reasonable personal income.  3.12 Covenants Independent. The covenants contained herein shall be construed as independent  agreements and the existence of any claim which Shareholder may have against Apollo and/or Manager  will not constitute a defense to the enforcement by Apollo and/or Manager by injunctive relief or  otherwise, of the provisions contained herein.  3.13 Notices. Any notices required or permitted to be given under this Agreement shall be given  in writing to each other party and shall be deemed to be given (i) if deposited in the United States mail,  postage prepaid, certified mail, return receipt requested, on the third (3rd) day following mailing or (ii) if  deposited with a commercial overnight delivery service, on the day following deposit. Notice shall be  addressed to the recipient at the address set forth below, or such other address or addresses as Party may  designate from time to time by notice satisfactory under this section:  To Shareholder: To Practice: Thomas Lam, M.D.  1668 S. Garfield Ave., 2nd Floor  Alhambra, CA 91801  AP-AMH 2 Medical Corporation  1668 S. Garfield Ave., rd Floor  Alhambra, CA 91801  To Apollo: To Manager:  Apollo Medical Holdings, Inc.  1668 S. Garfield Ave., 2 nd Floor  Alhambra, CA 91801  Network Medical Management, Inc.  1668 S. Garfield Ave., 2nd Floor  Alhambra, CA 91801  3.14 Further Assurances. At any time and from time to time, each party agrees, without further  consideration, to take such actions and to execute and deliver such documents as may be necessary to  effectuate the purposes of this Agreement.  3.15 Captions. The paragraph captions contained in this Agreement are inserted only as a matter  of convenience of reference and in no way define, limit or describe the scope of this Agreement, nor the  intent of any provision thereof.  3.16 Counterparts. This Agreement may be executed simultaneously in two or more  counterparts each of which shall be deemed an original, and all of which, when taken together, constitute  Physician Shareholder Agreement-Dr Lam-AP-AMH 2 - 8 -  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">one and the same document. The signature of any party to any counterpart shall be deemed a signature to,  and may be appended to, any other counterpart. Signatures transmitted by facsimile transmission or  electronically shall be deemed originals for this purpose.  3.17 Governing Law. This Agreement shall be governed by and construed in accordance with  the internal laws of the State.  3.18 Construction. Notwithstanding the general rules of construction, both parties were given  an equal opportunity to negotiate the terms and conditions of this Agreement and agree that the identity  of the drafter of this Agreement is not relevant to any interpretation of the terms and conditions of this  Agreement.  3.19 Number and Gender. In this Agreement, the masculine, feminine or neuter gender, and the  singular or plural number, shall each be deemed to include the other, whenever the context so requires.  3.20 Spousal Consent. Shareholder shall cause his or her spouse to execute an Adoption,  Ratification and Consent of Spouse, substantially in the form of Exhibit A attached hereto, signifying such  spouse's consent to this Agreement and such spouse's agreement that any rights that such spouse may  have, as a result of a community property or other interest in the Shares, shall be subject to the provisions  of this Agreement. It is intended by this Agreement that Shareholder shall subject his or her entire interest  in the Shares to the terms of this Agreement, irrespective of any community property or other interest of  his or her spouse. The provisions of this Section shall survive the termination of this Agreement.  [Signatures continued on next page]  Physician Shareholder Agreement-Dr Lam-AP-AMH 2 - 9 -  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">IN WITNESS WHEREOF, Shareholder has executed this Physician Shareholder Agreement as  of the date and year first above written.  &quot;Shareholder&quot;: Thomas Lam, M.D.  ACCEPTED AND AGREED  as of the date first above written:  &quot;Apollo&quot;: APOLLO MEDICAL HOLDINGS, INC.  DocuSigned by: E aelAtA, 15640  By:   chanTAIME3 , DD451...  Chief Strategy Officer and Chief  Financial Officer  &quot;Practice&quot;: AP-AMH 2 MEDICAL CORPORATION  By:  Thomas Lam, M.D.  Chief Executive Officer  Physician Shareholder Agreement-Dr Lam-AP-AMH 2  &quot;Manager&quot;:  NETWORK MEDICAL MANAGEMENT,  INC. DocuSigned by: C By:  66A, 15611,6  Chandan  C3A  Ba aFA s B293DD451...  ho,  Chief Strategy Officer and Chief  Financial Officer  - 10 -  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit A  ADOPTION, RATIFICATION AND CONSENT  OF SPOUSE  1. I am the spouse of Thomas Lam, M.D., and do hereby certify that I have carefully read the foregoing  Physician Shareholder Agreement attached hereto (the &quot;Agreement&quot;) relating to the shares of capital  stock of AP-AMH 2 Medical Corporation, a California professional corporation, owned by my spouse  (the &quot;Shares&quot;).  2. I am aware that, under to the terms of the Agreement, my spouse agrees to sell and have fixed the  value and terms of any sale of all of his shares of AP-AMH 2 Medical Corporation, including any  community property interest I may have therein.  3. I understand the meaning and effect of the Agreement, and I fully and freely consent to, approve, and  join in the purpose of such Agreement. I do hereby subject, to the terms of the Agreement, any  community property interest I may have in the Shares, and I promise and agree to execute any and all  instruments and to do any and all things necessary or proper to accomplish the purposes set forth in  the Agreement. In consideration of the benefits to me, I hereby agree to be bound by the terms and  conditions of the Agreement, as surviving spouse, heir, devisee, or legatee in the event that I survive  my spouse.  4. I hereby agree that my spouse is the manager of the Shares subject to the Agreement.  5. I acknowledge that my execution of this Adoption, Ratification and Consent of Spouse will affect  (i) my ability to dispose of any community interest I may have in the Shares at my death, and (ii) my  succession to said interest in the Shares. I direct that the residuary clause of each of my wills shall not  be deemed to apply to my community property interest, if any, in the Shares.  6. I HAVE BEEN ADVISED TO SEEK INDEPENDENT LEGAL REPRESENTATION TO  ADVISE ME OF MY INTERESTS AND RIGHTS, IF ANY, IN SUCH SHARES AND  ACKNOWLEDGE THAT I HAVE HAD THE OPPORTUNITY TO SEEK SUCH  INDEPENDENT LEGAL COUNSEL.  Executed at Los Angeles County, California.  Spouse of Thomas Lam, M.D.:  Sign Name:  Print Name:  Date:  dtt, ic-,  J-aN,A1 5-TTE ZA-0  coqae /  Physician Shareholder Agreement-Dr Lam-AP-AMH 2  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">EXECUTION VERSION  AMENDMENT NO. 1  TO  PHYSICIAN SHAREHOLDER AGREEMENT     This AMENDMENT NO. 1 (this &#8220;Amendment&#8221;) to that certain Physician Shareholder  Agreement, dated as of August 31, 2023 (as amended or otherwise modified, the &#8220;Agreement&#8221;),  granted and delivered by Thomas Lam, M.D., a physician licensed under the laws of the State of  California (&#8220;Shareholder&#8221;), in favor of Network Medical Management, Inc., a California  corporation (&#8220;Manager&#8221;), and Apollo Medical Holdings, Inc., a Delaware corporation  (&#8220;Apollo&#8221;), and for the benefit of AP-AMH 2 Medical Corporation, a California professional  medical corporation (&#8220;Practice&#8221;), is made and entered into by Shareholder, Manager, Apollo, and  Practice as of October 19, 2023.  Capitalized terms used herein and not otherwise defined shall  have the meanings ascribed to them in the Agreement.  WHEREAS, the Agreement was originally entered into as of August 31, 2023; and  WHEREAS, the undersigned seek to amend the Agreement to clarify the extent of  certain obligations of and restrictions on the Shareholder with respect to the Practice and its  subsidiaries.  NOW, THEREFORE, BE IT RESOLVED, that in consideration of the mutual  promises and covenants contained in this Amendment, the undersigned agree as follows:  1. Subsidiaries.  A new Section 1.3.5 is hereby added to the Agreement to read as  follows:  &#8220;1.3.5 Subsidiaries.  Notwithstanding anything to the contrary in this  Agreement, for the avoidance of doubt, the obligations of and restrictions  on Shareholder for any Action with respect to the Practice shall also, out  of an abundance of caution, apply to any Action with respect to the  Practice&#8217;s subsidiaries.&#8221;  2. Continuing Effect.  Except as specifically amended above, all of the terms and  conditions of the Agreement shall remain in full force and effect.  3. Counterparts.  This Amendment may be executed and delivered by electronic  signature and in two or more counterparts, each of which will be deemed an original, but all of  which together will constitute one and the same instrument.  [Signature Page Follows]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1011-physiciansha013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1011-physiciansha013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">[Signature Page to Amendment No. 1 to Physician Shareholder Agreement]  IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the date  first written above.  SHAREHOLDER:  THOMAS LAM, M.D.  __________________________________  Thomas Lam, M.D.  MANAGER:  NETWORK MEDICAL MANAGEMENT, INC.  By:__________________________________  Name: Chandan Basho  Title:   Chief Strategy Officer and Chief Financial  Officer  APOLLO:  APOLLO MEDICAL HOLDINGS, INC.  By:__________________________________  Name: Chandan Basho  Title:   Chief Strategy Officer and Chief Financial  Officer  PRACTICE:  AP-AMH 2 MEDICAL CORPORATION  By:__________________________________  Name: Thomas Lam, M.D.  Title:   Chief Executive Officer  &#15;&#26;&#20;&#28;&#19;&#23;&#22;&#25;&#1;&#16;&#25;&#29;&#21;&#24;&#26;&#27;&#21;&#1;&#18;&#15;&#11;&#1;&#3;&#9;&#12; &#16;&#5;&#14;&#17;&#2; &#17;&#3;&#5;&#2;&#7;&#15;&#15;&#15;&#2; &#8; &#3;&#2;&#7;&#4; &#7;&#15; &#14;&#7;&#17;&#6;&#9;&#14; </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.48
<SEQUENCE>9
<FILENAME>exhibit1048-astranaemploye.htm
<DESCRIPTION>EX-10.48
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic2377ada0c104947bc24d5e35ca9ffb1_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.48</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">EMPLOYEE STOCK PURCHASE PLAN</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">(Amended and Restated Effective February 26, 2024)</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">1.&#160;&#160;&#160;&#160;Establishment and Purpose of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.  This Astrana Health, Inc. Employee Stock Purchase Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;) was adopted by the Board effective April 21, 2023 and approved by the stockholders of the Company at the 2023 Annual Meeting of Stockholders.  The purpose of the Plan is to provide to eligible service providers of the Company and its Designated Subsidiaries opportunities to purchase shares of the Company&#8217;s Common Stock. The Plan includes two components&#58; a Code Section&#160;423 Component (the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">423 Component</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">and a&#160;non-Code&#160;Section&#160;423 Component (the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Non-423&#160;Component</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;).  It is intended for the 423 Component to constitute an &#8220;employee stock purchase plan&#8221; within the meaning of Section&#160;423(b) of the Code, pursuant to which Purchase Rights may be granted to Eligible Employees, and the 423 Component shall be interpreted in accordance with that intent. Under the&#160;Non-423&#160;Component, which is not intended to qualify as an &#8220;employee stock purchase plan&#8221; within the meaning of Section&#160;423(b) of the Code, Purchase Rights may be granted to Eligible Employees and Consultants pursuant to rules, procedures or&#160;sub-plans&#160;adopted by the Administrator and designed to achieve tax, securities laws or other objectives. Except as otherwise provided herein, the&#160;Non-423&#160;Component shall operate and be administered in the same manner as the 423 Component.  Unless otherwise defined herein, capitalized terms used in this Plan shall have the meanings ascribed to them in&#160;Section&#160;2.  The Plan is amended and restated as set forth herein, effective February 26, 2024.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">2.&#160;&#160;&#160;&#160;Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.  </font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">423 Component</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">has the meaning set forth in Section 1.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means the Committee (or a delegate appointed in accordance with&#160;Section&#160;4(b)).</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(c)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;&#160;means the Board of Directors of the Company.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(d)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto.  A reference to any specific section of the Code shall also be deemed to be a reference to the provisions of any section of the final treasury regulations issued by the U.S. Department of the Treasury under the Code, as amended from time to time, under that Code section.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(e)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means the Compensation Committee of the Board (or any other committee or subcommittee of the Board which the Board may appoint to administer the Plan). Subject to the discretion of the Board, the Committee shall be composed entirely of individuals who meet the qualifications of (i)&#160;a&#160;&#8220;non-employee&#160;director&#8221; within the meaning of Rule&#160;16b-3&#160;under the Securities Exchange Act of 1934, as amended, and (ii)&#160;any other qualifications required by the applicable exchange on which the Common Stock is traded. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.108%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div><div><font><br></font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(f)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221; means the Company&#8217;s common stock, par value $0.001 per share.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(g)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;&#160;means Astrana Health, Inc., a Delaware corporation (formerly known as Apollo Medical Holdings, Inc.), or any successor corporation.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(h)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means, except as otherwise determined by the Administrator, an Eligible Employee&#8217;s (or, with respect to the Non-423 Component, a Consultant&#8217;s) base pay and cash incentive bonus otherwise payable during an Offering, prior to salary reduction (such as pursuant to Sections 125, 132(f) or 401(k) of the Code), as determined by the Administrator. The Administrator shall have the discretion to determine the application of this definition to Participants, including those outside working outside the United States.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(i)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Consultant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221; means an individual who performs services for the Company or a Subsidiary as an independent contractor and in a capacity other than as an employee or a member of a board of directors.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(j)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Designated Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means any present or future Subsidiary that has been designated by the Administrator to participate in the Plan. The Administrator may so designate any Subsidiary, or revoke any such designation, at any time and from time to time, either before or after the Plan is approved by the stockholders, and may further designate such Designated Subsidiaries as participating in the 423 Component or the&#160;Non-423&#160;Component. The Administrator may also determine which Subsidiaries may be excluded from participation in the Plan, to the extent consistent with Section&#160;423 of the Code or as implemented under the&#160;Non-423&#160;Component, and which Designated Subsidiaries shall participate in separate Offerings. For purposes of clarity, under the 423 Component, only those Subsidiaries that qualify as &#8220;subsidiary corporations&#8221; to the Company within the meaning of Section 424(f) of the Code may be Designated Subsidiaries with respect to any Offering under the 423 Component.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(k)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Eligible Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">has the meaning set forth in&#160;Section&#160;6.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(l)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Enrollment Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means an agreement, which may be electronic, pursuant to which an Eligible Employee (or, with respect to the Non-423 Component, a Consultant) may elect to enroll in the Plan, to authorize a new level of payroll deductions, or to stop payroll deductions and withdraw from an Offering.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(m)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Exercise Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means the last Trading Day of a Purchase Period.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(n)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">on any given date means the closing price of the Common Stock on the applicable Trading Day, as reported on the NASDAQ Stock Market&#160;or such other national securities exchange upon which the Common Stock may be listed at the time.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(o)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Non-423&#160;Component</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">has the meaning set forth in&#160;Section&#160;1.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(p)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Offering</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means an offering to Eligible Employees (or, with respect to the Non-423 Component, Consultants) to purchase Common Stock under the Plan. Unless otherwise determined by the Administrator, each Offering under the 423 Component in which Eligible Employees of one or more Designated Subsidiaries may participate may be deemed a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">separate offering for purposes of Section&#160;423 of the Code, even if the dates of the applicable Offering are identical, and the provisions of the Plan will separately apply to each Offering. With respect to Offerings under the 423 Component, the terms of separate Offerings need not be identical, provided that all Eligible Employees granted a Purchase Right in a particular Offering under the 423 Component will have the same rights and privileges, except as otherwise may be permitted by Code Section&#160;423&#59; Offerings under the&#160;Non-423&#160;Component need not satisfy such requirements.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(q)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Offering Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means the first Trading Day of an Offering.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(r)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means a &#8220;parent corporation&#8221; with respect to the Company, as defined in Section&#160;424(e) of the Code.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(s)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#8221;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means&#58; (i) with respect to the 423 Component, an Eligible Employee as provided in&#160;Section&#160;6&#160;who has enrolled in the Plan in compliance with the provisions of&#160;Section&#160;7&#59; and (ii) with respect to the Non-423 Component, an Eligible Employee or Consultant whom the Administrator has determined to be eligible to participate in the Non-423 Component pursuant to Section 6 and who has enrolled in the Plan in compliance with the provisions of&#160;Section&#160;7.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(t)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means the Astrana Health, Inc. Employee Stock Purchase Plan, as set forth in this document and as it may be amended from time to time.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(u)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Purchase Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means the period of time specified within an Offering beginning on the Offering Date and ending on the Exercise Date.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(v)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">has the meaning set forth in&#160;Section&#160;11.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(w)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Purchase Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">has the meaning set forth in&#160;Section&#160;11.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(x)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Reorganization Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means&#58; (i)&#160;the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity&#59; (ii)&#160;a merger, reorganization or consolidation pursuant to which the holders of the Company&#8217;s aggregate outstanding voting power and outstanding stock immediately prior to such transaction do not own a majority of the aggregate outstanding voting power and outstanding stock or other equity interests of the resulting or successor entity (or its ultimate parent, if applicable) immediately upon completion of such transaction&#59; (iii)&#160;the sale of all of the Common Stock to an unrelated person, entity or group thereof acting in concert&#59; or (iv)&#160;any other transaction in which the owners of the Company&#8217;s outstanding voting power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any successor entity immediately upon completion of the transaction other than as a result of the acquisition of securities directly from the Company.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(y)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;&#160;means the United States Securities and Exchange Commission.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(z)&#160;&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">means (i) with respect to the 423 Component, a &#8220;subsidiary corporation&#8221; of the Company within the meaning Section&#160;424(f) of the Code, and (ii) with respect to the Non-423 Component, any entity that, directly or indirectly through one or more </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">intermediaries, controls, is controlled by or is under the common control with, the Company, whether or not such entity is a &#8220;subsidiary corporation&#8221; of the Company within the meaning of Section&#160;424(f) of the Code.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(aa)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Trading Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221; means a day on which the NASDAQ Capital Market&#160;(or such other national securities exchange upon which the Common Stock may be listed at the time) is open for trading.</font></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">3.&#160;&#160;&#160;&#160;Share Reserve</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.  Subject to adjustment as provided in Section&#160;15, the maximum aggregate number of shares of Common Stock that may be issued under the Plan shall be 5,000,000 shares, which shall consist of authorized but unissued shares, treasury shares, shares acquired on the open market, or any combination thereof.  If an outstanding Purchase Right for any reason expires or is terminated or canceled without the issuance of shares of Common Stock thereunder, the shares of Common Stock allocable to the unexercised portion of that Purchase Right shall again be available for issuance under the Plan.  For the avoidance of doubt, up to the maximum number of shares of Common Stock reserved under this Section&#160;3 may be used to satisfy purchases of Common Stock under the 423 Component, and any remaining portion of such maximum number of shares may be used to satisfy purchases of Common Stock under the Non-423 Component.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">4.&#160;&#160;&#160;&#160;Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. </font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.  The Plan shall be administered by the Administrator. The Administrator has full authority at any time to&#58; (i)&#160;adopt, alter and repeal such rules, guidelines and practices for the administration of the Plan and for its own acts and proceedings as it shall deem advisable and appoint such agents as it deems appropriate for the proper administration of the Plan&#59; (ii)&#160;interpret and construe, reconcile any inconsistency in, correct any default in and supply any omission in, and apply the terms of the Plan and any Enrollment Form or other instrument or agreement relating to the Plan&#59; (iii)&#160;determine the terms and conditions of any right to purchase shares of Common Stock under the Plan&#59; (iv)&#160;make all determinations and take all actions it deems advisable for the administration of the Plan, including to accommodate the specific requirements of local laws, regulations and procedures for jurisdictions outside the United States, such as adopting rules and procedures regarding payment of interest (if any), conversion of local currency, payroll tax, withholding procedures and handling of stock certificates that vary with local requirements outside of the United States, and adopting&#160;sub-plans&#160;applicable to particular Designated Subsidiaries or locations, which&#160;sub-plans&#160;may be necessary or appropriate to permit the participation in the Plan by employees who are foreign nationals or employed outside the United States, as further set forth in&#160;Section&#160;17&#160;below&#59; (v)&#160;determine eligibility and decide all disputes arising in connection with the Plan, including whether Eligible Employees will participate in the 423 Component, whether Eligible Employees or Consultants will participate in the&#160;Non-423&#160;Component, and which Subsidiaries will be Designated Subsidiaries under the 423 Component or the&#160;Non-423&#160;Component&#59; (vi)&#160;amend an outstanding right to purchase shares of Common Stock, including any amendments to a right that may be necessary for purposes of effecting a transaction contemplated under Section 15 or Section 16 (including, but not limited to, an amendment to the class or type of stock that may be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">issued pursuant to the exercise of a right or the Purchase Price applicable to a right), provided that the amended right otherwise conforms to the terms of the Plan&#59; and (vii)&#160;otherwise supervise and take any other actions necessary or desirable for the administration of the Plan. All interpretations and decisions of the Administrator shall be binding on all persons, including the Company and the Participants.  Neither the Administrator nor any member of the Board, the Committee or any other individual exercising administrative authority with respect to the Plan shall be liable for any action or determination made in good faith with respect to the Plan or any Purchase Right granted hereunder.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Delegation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.  Subject to applicable laws, the Administrator may delegate administrative authority hereunder to one or more officers of the Company or to such other individual or group as the Administrator may determine in its discretion. </font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Authority of the Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.  The Board may reserve to itself any or all of the authority or responsibility of the Administrator under the Plan or may act as the Administrator of the Plan for any or all purposes.  To the extent the Board has reserved any such authority or responsibility or during any time that the Board is acting as Administrator of the Plan, the Board shall have all the powers of the Administrator hereunder, and any reference in the Plan to the Administrator (other than in this Section 4(c)) shall include the Board.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">5.&#160;&#160;&#160;&#160;&#160;Offerings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The Company will make one or more Offerings to Eligible Employees to purchase Common Stock under the 423 Component and may make one or more Offerings to Eligible Employees and&#47;or Consultants under the Non-423 Component. The Administrator shall, in its discretion, designate the period of any Offering, provided that no Offering shall exceed 27 months in duration. Unless and until the Administrator determines otherwise, each Offering shall be for a Purchase Period of 6 months beginning on the first day of a calendar quarter and ending on the last day of the next succeeding calendar quarter. Subject to applicable law, the Administrator, or its delegate, retains the discretion to impose trading restrictions or holding requirements on Common Stock purchased with respect to a particular Offering. If the Administrator elects to impose such restrictions or requirements, the restrictions or requirements will be described in the enrollment materials for the applicable Offering.  </font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">6.&#160;&#160;&#160;&#160;&#160;Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. </font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;Except as otherwise provided in this Section 6 (including, but not limited to, the provisions of Section 6(d) regarding the Non-423 Component), all individuals classified as employees on the payroll records of the Company and each Designated Subsidiary shall be eligible to participate in any one or more of the Offerings under the Plan (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Eligible Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;). Notwithstanding the foregoing, no Participant may be granted a Purchase Right under the 423 Component if such Participant, immediately after the Purchase Right was granted, would be treated as owning stock possessing 5% or more of the total combined voting power or value of all classes of stock of the Company or any Parent or Subsidiary.  For purposes of the preceding sentence, the attribution rules of Section&#160;424(d) of the Code shall apply in determining the stock ownership of a Participant, and all stock which the Participant has a contractual right to purchase shall be treated as stock owned by the Participant. Further notwithstanding the foregoing, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Administrator may determine, prior to the beginning of an Offering, that one or more of the following categories of Eligible Employees shall not be eligible to participate in the Plan with respect to such Offering (provided that any such determination shall be applied in a consistent manner to all employees of the applicable corporation(s))&#58;  </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(i)&#160;&#160;&#160;&#160;Employees who have been employed by the Company or a Designated Subsidiary for fewer than two years (or such shorter period of time as may be specified by the Administrator)&#59; </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(ii) &#160;&#160;&#160;&#160;Employees who customarily work not more than twenty (20) hours per week (or such shorter period of time as may be specified by the Administrator)&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(iii)&#160;&#160;&#160;&#160;Employees who customarily work not more than five (5) months per calendar year (or such shorter period of time as may be specified by the Administrator)&#59;</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(iv)&#160;&#160;&#160;&#160;&#8220;Highly compensated employees&#8221; (as defined in Section 414(q) of the Code), or a subset of highly compensated employees specified by the Administrator who (A) are officers of the Company and subject to the disclosure requirements of Section 16(a) of the Securities Exchange Act of 1934 as amended, and&#47;or (B) have compensation (within the meaning of Section 415(c)(3) of the Code) exceeding an amount specified by the Administrator that is higher than the amount provided in Section 414(q)(1)(B)(i) of the Code for the applicable calendar year&#59; or </font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(v) &#160;&#160;&#160;&#160;Employees who are citizens or residents of a non-U.S. jurisdiction, if the grant of a purchase right under the Plan to such an employee would be prohibited under the laws of such jurisdiction, or if compliance with the laws of such jurisdiction would cause the Plan to violate the requirements of Section 423 of the Code.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"> (b)&#160;&#160;&#160;&#160; Notwithstanding any other provision herein, individuals who are not classified as employees of the Company or a Designated Subsidiary for purposes of the Company&#8217;s or applicable Designated Subsidiary&#8217;s payroll system on the Offering Date are not considered to be &#8220;Eligible Employees&#8221; of the Company or any Designated Subsidiary and shall not be eligible to participate in the 423 Component with respect to such Offering. In the event any such individuals are reclassified as employees of the Company or a Designated Subsidiary for any purpose, including, without limitation, common law or statutory employees, by any action of any third party, including, without limitation, any government agency, or as a result of any private lawsuit, action or administrative proceeding, such individuals shall, notwithstanding such reclassification, remain ineligible for participation in the 423 Component. Notwithstanding the foregoing, the exclusive means for individuals who are not classified as of an Offering Date as employees of the Company or a Designated Subsidiary on the Company&#8217;s or Designated Subsidiary&#8217;s payroll system to become eligible to participate in an Offering under the 423 Component is through an amendment to this Plan, duly executed by the Company, which specifically renders such individuals eligible to participate herein.  For purposes of the Plan, in accordance with Treas. Reg. &#167;&#160;1.421-1(h)(2),&#160;the employment relationship shall be treated as continuing intact while the individual is on military leave, sick leave or other leave of absence </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">approved by the Company or a Designated Subsidiary that does not exceed three months and during any period longer than three months if the individual&#8217;s right to reemployment is guaranteed by statute or contract.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(c)&#160;&#160;&#160;&#160;The Administrator retains the discretion to determine which Eligible Employees may participate in the 423 Component pursuant to and consistent with Treasury Regulation &#167;&#167;&#160;1.423-2(e)&#160;and (f), and which Eligible Employees and Consultants may participate in the Non-423 Component.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(d)&#160;&#160;&#160;&#160;Notwithstanding anything in this Section&#160;6 to the contrary, in the case of an Offering under the Non-423 Component, (i) an Eligible Employee (or group of Eligible Employees) may be excluded from, or included in, participation in the Non-423 Component or an Offering as the Administrator may determine, in its sole discretion&#59; and (ii) a Consultant (or group of Consultants) may be included in, or excluded from, participation in the Non-423 Component or an Offering as the Administrator may determine, in its sole discretion.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">7.&#160;&#160;&#160;&#160;&#160;Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Participants on Offering Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. An Eligible Employee (or, with respect to the Non-423 Component, a Consultant) may elect to participate in the Plan by properly completing and submitting an Enrollment Form (in the manner described in&#160;Section&#160;7(b)) by such deadline as shall be established by the Administrator for the Offering and in accordance with enrollment procedures established by the Administrator. Participation in the Plan is entirely voluntary.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Enrollment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The Enrollment Form shall (i)&#160;state a whole percentage or, to the extent permitted by the Administrator, a fixed dollar amount, to be deducted from an Eligible Employee&#8217;s (or, with respect to the Non-423 Component, a Consultant&#8217;s) Compensation per pay period during an Offering, (ii)&#160;authorize the purchase of Common Stock in each Offering in accordance with the terms of the Plan and (iii)&#160;specify the exact name or names in which shares of Common Stock purchased for such individual are to be issued pursuant to&#160;Section&#160;13. An eligible individual who does not enroll in an Offering in accordance with these procedures shall be deemed to have waived participation in such Offering.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(c)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Automatic&#160;Re-Enrollment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Except as otherwise determined by the Administrator prior to an Offering Date, the deduction rate selected in the Enrollment Form shall remain in effect for subsequent Offerings unless the Participant (i)&#160;submits a new Enrollment Form authorizing a new level of payroll deductions in accordance with&#160;Section&#160;9, (ii) withdraws from the Plan in accordance with&#160;Section&#160;10, or (iii)&#160;terminates employment or other service or otherwise becomes ineligible to participate in the Plan.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;(d)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Electronic Submission of Enrollment Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The Administrator may specify that Enrollment Forms to be submitted to the Company pursuant to this Section 7 or Section 10 below are to be submitted electronically via the Company&#8217;s intranet or the internet site of a third party or via email or any other means of electronic delivery specified by the Administrator.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(e) &#160;&#160;&#160;&#160;Notwithstanding the foregoing, participation in the 423 Component shall neither be permitted nor denied contrary to the requirements of the Code.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">8.&#160;&#160;&#160;&#160;&#160;Participant Contributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Subject to the annual dollar amount limitation set forth in Section 11(b), each Eligible Employee (or, with respect to the Non-423 Component, each eligible Consultant) may, by submitting an Enrollment Form as described in&#160;Section&#160;7(b), authorize payroll deductions, in whole percentages, at a minimum of 1% up to a maximum of 25% of such individual&#8217;s Compensation (or such other maximum percentage deduction as may be determined by the Administrator), or, to the extent permitted by the Administrator, in a fixed dollar amount, such individual&#8217;s Compensation (between such minimum and maximum dollar amount as specified by the Administrator prior to the applicable Offering), to be deducted on a pro rata basis for each pay period during an Offering. Payroll deductions shall commence on the first payroll date following the Offering Date and end on the last payroll date on or before the last day of the Offering. Payroll deductions shall be made in accordance with the Eligible Employee&#8217;s (or, with respect to the Non-423 Component, the Consultant&#8217;s) election&#59; however, if the Eligible Employee (or, with respect to the Non-423 Component, the Consultant) elects to contribute in whole percentages, due to rounding or other administrative reasons, the actual percentage contributed may be less than the elected percentage. The Company shall maintain notional book accounts showing the amount of payroll deductions made by each Participant for each Purchase Period, but the Company will not hold payroll deductions in a trust or in any segregated account, unless otherwise determined by the Administrator or required by applicable law. No interest shall accrue or be paid on payroll deductions, except as may be required by applicable law. If required under applicable law or if specifically provided in the Offering, in either case as and to the extent determined by the Administrator, in addition to or instead of making contributions by payroll deduction, a Participant may make contributions through a payment by cash, check, or wire transfer prior to an Exercise Date, in such manner as may be directed by the Administrator. Any reference to &#8220;payroll deductions&#8221; in this&#160;Section&#160;8&#160;(or in any other section of the Plan) shall similarly cover contributions by other means made pursuant to this&#160;Section&#160;8.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">9.&#160;&#160;&#160;&#160;&#160;Deduction Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Except as may be determined by the Administrator in advance of an Offering, a Participant may not increase or decrease his or her payroll deduction during any Offering, but may increase or decrease his or her payroll deduction with respect to the next Offering (subject to the limitations of&#160;Section&#160;10) by filing a new Enrollment Form by such deadline as shall be established by the Administrator for the Offering. The Administrator may, in advance of any Offering, establish rules permitting a Participant to increase, decrease or terminate his or her payroll deduction during an Offering.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">10.&#160;&#160;&#160;&#160;&#160;Withdrawal</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. A Participant may withdraw from participation in the Plan by submitting to the Company a revised Enrollment Form indicating his or her election to withdraw (in accordance with such procedures as may be established by the Administrator). The Participant&#8217;s withdrawal shall be effective as of the next business day, or as soon as practicable thereafter. Following a Participant&#8217;s withdrawal, the Company shall promptly refund such individual&#8217;s entire account balance under the Plan to him or her (after payment for any Common </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Stock purchased before the effective date of withdrawal). Partial withdrawals are not permitted. Such an individual may not begin participation again during the remainder of the Offering, but may enroll in a subsequent Offering in accordance with&#160;Section&#160;7.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">11.&#160;&#160;&#160;&#160;&#160;Grant of Purchase Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. </font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;On each Offering Date, the Company shall grant to each Participant in the Plan the right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">to purchase (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Purchase Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;), on the Exercise Date and at the Purchase Price hereinafter provided for, the lowest of (i)&#160;a number of shares of Common Stock determined by dividing such Participant&#8217;s accumulated payroll deductions on such Exercise Date by the Purchase Price (as defined herein)&#59; (ii) 920 shares of Common Stock&#59; or (iii)&#160;such other lesser maximum number of shares as shall have been established by the Administrator in advance of the Offering (in each case subject to adjustment pursuant to&#160;Section&#160;15&#160;or&#160;Section&#160;16)&#59; provided, however, that such Purchase Right shall be subject to the limitations set forth below. Each Participant&#8217;s Purchase Right shall be exercisable only to the extent of such Participant&#8217;s accumulated payroll deductions on the Exercise Date. The purchase price for each share purchased under each Purchase Right shall be as determined by the Administrator in advance of the applicable Offering (the&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Purchase Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8221;),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">provided that in no event shall the Purchase Price be less than the lesser of 85% of the Fair Market Value of the Common Stock on the Offering Date or 85% of the Fair Market Value of the Common Stock on the Exercise Date.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, no Participant may be granted a Purchase Right which permits the Participant&#8217;s rights to purchase stock under the 423 Component, and any other employee stock purchase plan (described in Section&#160;423 of the Code) of the Company and its Parents and Subsidiaries, to accrue at a rate which exceeds $25,000 of the fair market value of such stock (determined on the Offering Date) for each calendar year in which the Purchase Right is outstanding at any time. The purpose of the limitation in the preceding sentence is to comply with Section&#160;423(b)(8) of the Code and shall be applied taking Purchase Rights into account in the order in which they were granted.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">12.&#160;&#160;&#160;&#160;&#160;Exercise of Purchase Right and Purchase of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Each individual who continues to be a Participant in the Plan on the Exercise Date shall be deemed to have exercised his or her Purchase Right on such date and shall acquire from the Company such number of whole shares (and&#47;or fractional shares, as determined by the Administrator) of Common Stock reserved for the purpose of the Plan as the Participant&#8217;s accumulated payroll deductions on such date shall purchase at the Purchase Price, subject to any other limitations contained in the Plan. Unless otherwise determined by the Administrator in advance of an Offering, any amount remaining in a Participant&#8217;s account after the purchase of shares on an Exercise Date of an Offering solely by reason of any inability to purchase a fractional share shall be carried forward to the next Offering&#59; any other balance remaining in a Participant&#8217;s account at the end of an Offering shall be refunded to the Participant promptly.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">13.&#160;&#160;&#160;&#160;&#160;Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Shares of Common Stock may be issued under the Plan, and certificates (if any) representing shares of Common Stock purchased under the Plan may be issued only in the name of the Participant, or, to the extent permitted by the Administrator in its </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">discretion in the name of the Participant and another person of legal age as joint tenants with rights of survivorship, or in the name of a broker authorized by the Participant to be his, her or their, nominee for such purpose. Participants will not have any voting, dividend, or other rights of a stockholder with respect to the shares of Common Stock until such shares have been delivered pursuant to this&#160;Section&#160;13.  All transactions under this Plan are subject to the Company&#8217;s insider trading policy as may be in effect from time to time. This includes any blackout period prohibition or requirement to obtain mandatory&#160;pre-clearance&#160;of transactions such as enrollment, withdrawal, or trading. If the standard enrollment period is scheduled to occur during a blackout period, arrangements will be made to allow for restricted insiders to update their elections during the preceding open trading window.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">14.&#160;&#160;&#160;&#160;&#160;Rights on Termination or Transfer of Employment or Other Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. If a Participant&#8217;s employment or other service terminates for any reason, or if the Participant&#8217;s status changes such that the Participant is no longer an Eligible Employee (or, in the case of the Non-423 Component, an eligible Consultant), before the Exercise Date for any Purchase Period, no payroll deduction shall be taken from any Compensation due and owing to the Participant and the balance in the Participant&#8217;s notional account shall be paid&#8212;as if such Participant had withdrawn from the Plan under&#160;Section&#160;10&#8212;to such Participant or, in the case of such Participant&#8217;s death, (a) to the participant&#8217;s designated beneficiary, if any, to the extent that the Administrator, in its discretion, has permitted the designation of a beneficiary, or (b)&#160;otherwise, to the Participant&#8217;s estate. A Participant shall be deemed to have terminated employment or other service, for this purpose, if the entity by which the Participant is employed or with which the Participant has a service relationship, ceases to be a Designated Subsidiary, or if the Participant&#8217;s employment or other service is transferred to any entity other than the Company or a Designated Subsidiary. Unless otherwise determined by the Administrator, a Participant whose employment transfers between, or whose employment or other service terminates with an immediate rehire (with no break in service) by, a Designated Subsidiary or the Company shall not be treated as having terminated employment or other service for purposes of participating in the Plan or an Offering&#59; provided, however, that if a Participant transfers from an Offering under the 423 Component to an Offering under the&#160;Non-423&#160;Component, the exercise of the Participant&#8217;s Purchase Right shall be qualified under the 423 Component only to the extent that such exercise complies with Section&#160;423 of the Code. If a Participant transfers from an Offering under the&#160;Non-423&#160;Component to an Offering under the 423 Component, the exercise of the Participant&#8217;s Purchase Right shall remain&#160;non-qualified&#160;under the&#160;Non-423&#160;Component.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">15.&#160;&#160;&#160;&#160;&#160;Adjustment in Case of Changes Affecting Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Subject to any required action by the stockholders of the Company, in the event of any change in the Common Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock&#160;split,&#160;split-up,&#160;split-off,&#160;spin-off,&#160;combination&#160;of shares, exchange of shares, or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Common Stock (excepting normal cash dividends) that has a material effect on the Fair Market Value of shares of Common Stock, appropriate adjustments shall be made in the number and class of shares </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">subject to the Plan, the limit on the shares which may be purchased by any Participant during an Offering (as described in Section 11(a)) and the number of shares of Common Stock subject to, and the Purchase Price of, each outstanding Purchase Right, in order to prevent dilution or enlargement of Participants&#8217; rights under the Plan.  Any fractional share resulting from an adjustment pursuant to this Section&#160;15 shall be rounded down to the nearest whole number, and in no event may the Purchase Price of any Purchase Right be decreased to an amount less than the par value, if any, of the stock subject to the Purchase Right. The adjustments determined by the Administrator pursuant to this Section&#160;15 shall be final, binding and conclusive.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">16.&#160;&#160;&#160;&#160;&#160;Reorganization Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. In connection with a Reorganization Event, the Administrator may take such actions with respect to outstanding Purchase Rights as the Administrator deems appropriate, consistent with applicable law and the treatment of the 423 Component as an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423(b) of the Code, including, any one or more of the following&#58;</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(a) &#160;&#160;&#160;&#160;provide that Purchase Rights shall be assumed, or substantially equivalent Purchase Rights shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof)&#59;</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(b) &#160;&#160;&#160;&#160;upon written notice to Participants, provide that all outstanding Purchase Rights will be terminated as of the effective date of the Reorganization Event and that all such outstanding Purchase Rights will become exercisable to the extent of accumulated payroll deductions as of a date specified by the Administrator in such notice, which date shall not be less than ten (10)&#160;days preceding the effective date of the Reorganization Event&#59;</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(c) &#160;&#160;&#160;&#160;upon written notice to Participants, provide that all outstanding Purchase Rights will be cancelled as of a date prior to the effective date of the Reorganization Event and that all accumulated payroll deductions will be returned to the Participant on such date&#59;</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(d) &#160;&#160;&#160;&#160;in the event of a Reorganization Event under the terms of which holders of Common Stock will receive, upon consummation thereof, a cash payment for each share surrendered in the Reorganization Event, make or provide for a cash payment to a Participant equal to the excess, if any, of (1) the amount of cash payable for a Common Share pursuant to the Reorganization Event times the number of shares of Common Stock subject to the Participant&#8217;s Purchase Right over (2)&#160;the aggregate Purchase Price of the Common Stock subject to such Purchase Right, in exchange for the termination of such Purchase Right&#59;</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(e) &#160;&#160;&#160;&#160;provide that, in connection with a liquidation or dissolution of the Company, Purchase Rights shall convert into the right to receive liquidation proceeds (net of the Purchase Price thereof)&#59; or</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(f) &#160;&#160;&#160;&#160;any combination of the foregoing.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">For purposes of clause&#160;(a) above, a Purchase Right shall be considered assumed if, following consummation of the Reorganization Event, the Purchase Right confers the right to purchase, for each share of Common Stock subject to the Purchase Right immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities, or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock)&#59; provided, however, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise of Purchase Rights to consist solely of common stock of the acquiring or succeeding corporation (or an affiliate thereof) equivalent in value (as determined by the Administrator) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">In addition, with respect to any outstanding Purchase Right under the 423 Component of the Plan, any action taken under this&#160;Section&#160;16&#160;shall be consistent with the intent that such Purchase Rights comply with Section&#160;423 of the Code, unless otherwise expressly determined by the Administrator. The Plan shall in no event be construed to restrict in any way the Company&#8217;s right to undertake a dissolution, liquidation, merger, consolidation or other Reorganization Event.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">17.&#160;&#160;&#160;&#160;&#160;Special Rules and&#160;Sub-Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Notwithstanding anything herein to the contrary, the Administrator may adopt special rules or&#160;sub-plans&#160;applicable to Participants who are employees of or Consultants to a particular Designated Subsidiary, whenever the Administrator determines that such rules are necessary or appropriate for the implementation of the Plan in a jurisdiction where such Designated Subsidiary has employees or Consultants, regarding, without limitation, eligibility to participate in the Plan, handling and making of payroll deductions or contribution by other means, establishment of bank or trust accounts to hold payroll deductions, payment of interest, conversion of local currency, obligations to pay payroll tax, withholding procedures and handling of share issuances, any of which may vary according to applicable requirements&#59; provided that if such special rules or&#160;sub-plans&#160;are inconsistent with the requirements of Section&#160;423 of the Code, any employees subject to such special rules or&#160;sub-plans&#160;shall participate in the&#160;Non-423&#160;Component, and Purchase Rights granted thereunder will not be required by the terms of the Plan to comply with Section&#160;423 of the Code.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">18.&#160;&#160;&#160;&#160;&#160;Amendment, Suspension and Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. </font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Amendment of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.  The Board may at any time and from time to time amend the Plan in any respect, except that, without the approval by the stockholders of the Company within 12 months of such Board action, no amendment shall be made increasing the number of shares approved for the Plan or making any other change that would require stockholder approval under the requirements of any stock exchange upon which the shares may then be listed or in order for the 423 Component of the Plan, as amended, to qualify as an &#8220;employee stock purchase plan&#8221; under Section&#160;423(b) of the Code. In no event may any amendment be made which would cause the 423 Component of the Plan to fail to comply with Section&#160;423 of the Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Suspension of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The Administrator may, at any time, suspend the Plan&#59; provided that the Company shall provide notice to the Participants prior to the effectiveness of such suspension. The Administrator may resume the operation of the Plan following any such suspension&#59; provided that the Company shall provide notice to the Participants prior to the date of termination of the suspension period. A Participant shall remain a Participant in the Plan during any suspension period (unless the Participant withdraws pursuant to&#160;Section&#160;10). However, no Purchase Rights shall be granted or exercised, and no payroll deductions shall be made in respect of any Participant, during the suspension period.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(c)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Termination of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The Board reserves the right to terminate the Plan, in whole or in part, at any time.  The Plan shall terminate upon the date when all shares of Common Stock reserved under Section 3 of the Plan have been purchased, or upon such earlier date as may be determined by the Board. Upon termination of the Plan, all amounts in the accounts of Participants shall be promptly refunded.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">19.&#160;&#160;&#160;&#160;&#160;Insufficient Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. If the total number of shares of Common Stock that would otherwise be purchased on any Exercise Date plus the number of shares of Common Stock purchased under previous Offerings under the Plan exceeds the maximum number of shares issuable under the Plan, the shares then available shall be apportioned in a manner consistent with the requirements of Section&#160;423(b)(4) and (5)&#160;of the Code and the regulations thereunder among Participants in proportion to the amount of payroll deductions accumulated on behalf of each Participant that would otherwise be used to purchase Common Stock on such Exercise Date.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">20.&#160;&#160;&#160;&#160;&#160;Notification Upon Sale of Shares Under 423 Component</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Each Participant shall agree, by enrolling in the 423 Component of the Plan, to give the Company prompt notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date of grant of the Purchase Right pursuant to which such shares were purchased or within one year after the date such shares were purchased.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">21.&#160;&#160;&#160;&#160;&#160;Equal Rights and Privileges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Notwithstanding any provision of the Plan to the contrary and in accordance with Section&#160;423 of the Code, all Eligible Employees participating in the 423 Component shall have the same rights and privileges.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">22.&#160;&#160;&#160;&#160;&#160;General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(a)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">No Right to Purchase Rights&#59; No Stockholder Rights&#59; No Right to Employment or other service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. No person shall have any right to be granted any Purchase Right under the Plan. No person shall have any rights as a stockholder with respect to any Common Stock to be issued under the Plan prior to the issuance thereof. The Plan is not a contract of employment or service, and the terms of employment or service of any Participant shall not be affected in any way by the Plan except as specifically provided in the Plan.  The establishment of, enrollment in, or grant of a Purchase Right under the Plan shall not be construed as giving any person the right to be retained in the employ or other service of the Company or any Subsidiary. Further, the Company and each Subsidiary expressly reserves the right at any time to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">dismiss an employee or Consultant, free from any liability or any claim under the Plan, except as expressly provided herein.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(b)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Purchase Rights Not Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">.  Except as provided herein, or to the extent otherwise required by applicable law, no Participant may alienate, commute, anticipate, assign, pledge, encumber, transfer, or dispose of any Purchase Rights hereunder, which Purchase Rights and the right to receive them are expressly declared to be nonassignable and nontransferable.  Further, notwithstanding any other provision of the Plan to the contrary, Purchase Rights under the 423 Component are not transferable by a Participant other than by will or the laws of descent and distribution and are exercisable during the Participant&#8217;s lifetime only by the Participant.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(c)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Application of Funds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. All funds received or held by the Company under the Plan may be combined with other corporate funds and may be used for any corporate purpose, unless otherwise required under applicable law.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(d)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Governmental Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The Company&#8217;s obligation to sell and deliver Common Stock under the Plan is subject to the completion of any registration or qualification of the Common Stock under any U.S. or&#160;non-U.S.&#160;local, state or federal securities or exchange control law, or under rulings or regulations of the SEC or of any other governmental regulatory body, and to obtaining any approval or other clearance from any U.S. and&#160;non-U.S.&#160;local, state or federal governmental agency, which registration, qualification or approval the Company may, in its absolute discretion, deem necessary or advisable. The Company is under no obligation to register or qualify the Common Stock with the SEC or any other U.S. or&#160;non-U.S.&#160;securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of such stock. If, pursuant to this&#160;Section&#160;22, the Administrator determines that the shares of Common Stock will not be issued to any Participant, all accumulated payroll deductions will be promptly refunded, without interest (unless otherwise required pursuant to applicable law), to the Participant, without any liability to the Company or any of its Subsidiaries.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(e)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The Plan shall be binding on the Company and its successors and assigns.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(f)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Entire Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. This Plan constitutes the entire plan with respect to the subject matter hereof and supersedes all prior plans with respect to the subject matter hereof.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(g)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Compliance with Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The obligations of the Company with respect to payments under the Plan are subject to compliance with all applicable laws and regulations. Common Stock shall not be issued with respect to a right to purchase unless the issuance and delivery of the shares of Common Stock pursuant thereto shall comply with all applicable provisions of law, including, without limitation, the Securities Act of 1933 and the Securities Exchange Act of 1934 (each as amended) and the requirements of any stock exchange upon which the shares may then be listed.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(h)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Severability of Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. If any provision of the Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provision hereof, and the Plan shall be construed and enforced as if such provision had not been included.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(i)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. This Plan and all Purchase Rights and actions taken thereunder shall be governed by, and construed in accordance with, applicable federal law and, to the extent not preempted by applicable federal law, the laws of the State of Delaware, applied without regard to conflict of law principles.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(j)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Participation in the Plan is subject to any applicable U.S. and&#160;non-U.S.&#160;federal, state or local tax withholding requirements on income the Participant realizes in connection with the Plan. Each Participant agrees, by entering the Plan, that the Company or any Subsidiary may, but shall not be obligated to, withhold from a Participant&#8217;s wages, salary or other compensation at any time the amount necessary for the Company or any Subsidiary to meet applicable withholding obligations, including any withholding required to make available to the Company or any Subsidiary any tax deductions or benefits attributable to the sale or disposition of Common Stock by such Participant. In addition, the Company or any Subsidiary may, but shall not be obligated to, withhold from the proceeds of the sale of Common Stock or any other method of withholding that the Company or any Subsidiary deems appropriate to the extent permitted by U.S. Treasury Regulation&#160;Section&#160;1.423-2(f)&#160;with respect to the 423 Component. The Company shall not be required to issue any Common Stock under the Plan until any such obligations are satisfied.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(k)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Section&#160;409A of the Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The 423 Component of the Plan is intended to be exempt from the provisions of Section&#160;409A of the Code, and any ambiguities herein shall be interpreted to so be exempt from Section&#160;409A of the Code. The&#160;Non-423&#160;Component is intended to be exempt from, or to comply with, the provisions of Section&#160;409A of the Code, any ambiguities herein shall be interpreted in accordance with such intent. Notwithstanding the foregoing, neither the Company, the Board, the Committee nor the Administrator shall have any liability to a Participant or any other party if a Purchase Right to purchase Common Stock under the Plan that is intended to be exempt from or compliant with Section&#160;409A of the Code is not so exempt or compliant, or for any action taken by the Administrator with respect thereto. The Company makes no guaranty or warranty of the tax treatment of Purchase Rights under the Plan, under Section 409A or otherwise.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(l)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Incapacity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. Any benefit payable to or for the benefit of a minor, an incompetent person, or other person incapable of accepting receipt shall be deemed paid when paid to such person&#8217;s guardian, agent or attorney-in-fact under a power of attorney, or to the party providing or reasonably appearing to provide for the care of such person, and such payment shall fully discharge any liability or obligation of the Board, the Administrator, the Company and any Designated Subsidiary, and all other parties with respect thereto.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(m)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Headings and Captions&#59; Rules of Construction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The headings and captions herein are provided for reference and convenience only, shall not be considered part of the Plan, and shall not be employed in the construction of the Plan. Whenever used in the Plan, words in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">the masculine gender shall be deemed to refer to females as well as to males&#59; words in the singular shall be deemed to refer also to the plural&#59; and references to a statute or statutory provision shall be construed as if they referred also to that provision (or to a successor provision of similar import) as currently in effect, as amended, or as reenacted, and to any regulations and other formal guidance of general applicability issued thereunder. Except where otherwise indicated, references to Sections are references to sections of this Plan.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(n)&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Unfunded Status of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">. The Plan is unfunded and shall not create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between any Participant (or beneficiary thereof), on the one hand, and the Company, any Designated Subsidiary, the Board, the Administrator, or any other person, on the other hand.</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#91;END OF DOCUMENT&#93;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.49
<SEQUENCE>10
<FILENAME>exhibit1049-astrananonqual.htm
<DESCRIPTION>EX-10.49
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i2bb4736ab63549d682f63230c6bde04d_1"></div><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-right:0.5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.49</font></div><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center"><font><br></font></div><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12.5pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">NONQUALIFIED DEFERRED COMPENSATION PLAN</font></div><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center"><font><br></font></div><div style="padding-left:0.25pt;padding-right:0.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(Amended and Restated Effective February 26, 2024)</font></div><div style="margin-top:15.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-top:11.7pt;padding-left:32.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">This Nonqualified Deferred Compensation Plan (the &#8220;Plan&#8221;) is adopted by Astrana Health, Inc. (the &#8220;Company&#8221;), a Delaware corporation, for the benefit of its Eligible Individuals. The purpose of the Plan is to offer selected Eligible Individuals who contribute significantly to the future business success of the Company an opportunity to elect to defer a portion of their Base Salary, Bonus Compensation, and&#47;or Independent Contractor Compensation, and to provide a deferred compensation vehicle to which the Company may credit Company Contribution amounts pursuant to the terms of the Plan.</font></div><div style="margin-top:13.15pt;padding-left:32.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">The Plan is an unfunded plan maintained primarily for the purpose of providing deferred compensation for a select group of management or highly-compensated Employees, and as such, is intended to be exempt from the provisions of Parts 2, 3, and 4 of Title I of the Employee Retirement Income Security Act of 1974 by operation of Sections 201(2), 301(a)(3) and 401(a)(1) thereof. The Plan will be administered, operated and construed in accordance with this intention.</font></div><div style="margin-top:13.35pt;padding-left:32.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">The Plan is intended to comply in form and operation with all applicable law, including, to the extent applicable, the requirements of Internal Revenue Code Section 409A and will be administered, operated and construed in accordance with this intention.</font></div><div style="margin-top:12.35pt;padding-left:36pt;text-indent:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Accordingly, the Plan, as adopted and made effective as of July 1, 2023, is amended and restated as set forth herein, effective February 26, 2024.</font></div><div style="margin-top:12.65pt;padding-left:252pt;text-indent:10.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:126%">ARTICLE 1 <br>DEFINITIONS</font></div><div style="margin-top:13.65pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The words and phrases defined in this Article shall have the meaning set out in the definition, unless the</font></div><div style="margin-top:0.15pt;padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">context in which the word or phrase appears reasonably requires a broader, narrower or different meaning.</font></div><div style="margin-top:11.9pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Account&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean all bookkeeping accounts pertaining to a Participant which are maintained by</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">the Plan Administrator or Plan recordkeeper to reflect the Company&#8217;s obligation to the Participant under the Plan, including a Deferral Account, a Company Contribution Account (if any), and Scheduled Withdrawal Account(s) (if any). The Plan Administrator or Plan recordkeeper shall establish additional subaccounts that the Plan Administrator considers necessary to reflect the entire interest of the Participant under the Plan.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Affiliate&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean any business entity other than the Company that is a member of a controlled</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">group of corporations, within the meaning of Section 414(b) of the Code, of which such Company is a member&#59; any other trade or business (whether or not incorporated) under common control, within the meaning of Section 414(c) of the Internal Revenue Code.</font></div><div style="margin-top:13.85pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Base Salary&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean a Participant&#8217;s base annual salary excluding incentive and discretionary</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">bonuses and other non-regular forms of compensation, before reductions for contributions to or deferrals under any pension, deferred compensation or benefit plans sponsored by the Company.</font></div><div style="margin-top:11.9pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Beneficiary&#8221; or &#8220;Beneficiaries&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean one or more persons, trusts, estates or other entities,</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">designated by a Participant in accordance with the Plan, that are entitled to receive benefits under the Plan upon the death of a Participant.</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_4"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:30.3pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Beneficiary Designation Form&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean the form established from time to time by the Plan</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Administrator that a Participant completes, signs, and returns to the Plan Administrator to designate one or more Beneficiaries.</font></div><div style="margin-top:13.8pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Bonus Compensation&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean amounts paid to a Participant by the Company in the form of</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">incentive compensation or any other bonus designated by the Company before reductions for contributions to or deferrals under any pension, deferred compensation or benefit plans sponsored by the Company.</font></div><div style="margin-top:11.9pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Cause&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean conduct by a Participant determined by the Company to be&#58; (a) gross negligence</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">or willful malfeasance in the performance of his or her duties&#59; (b) actions or omissions that harm the Company and are undertaken or omitted knowingly or are criminal or fraudulent or involve material dishonesty or moral turpitude&#59; (c) being indicted in a court of law for any felony or for a crime involving misuse or misappropriation of Company funds&#59; or (d) breach of fiduciary duty to the Company.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Change in Control&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean and shall include a change in ownership of the Company, a change</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">in effective control of the Company, or a change in the ownership of a substantial portion of the assets of the Company, within the meaning of Internal Revenue Code Section 409A and as described in Treasury Regulation &#167;&#167;1.409A-3(i)(5)(v), (vi) and (vii).</font></div><div style="margin-top:12.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Claimant&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean a Participant or a Beneficiary who believes that he or she is entitled to a</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">benefit under this Plan or being denied a benefit to which he or she is entitled hereunder.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Code&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean the U.S. Internal Revenue Code of 1986, as amended, or any successor statue,</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">and the Treasury Regulations and other authoritative guidance issued thereunder.</font></div><div style="margin-top:13.6pt;padding-left:31.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Company&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean Astrana Health, Inc., and its successors and assigns, unless otherwise provided in this Plan, or any other corporation or business organization which, with the consent Astrana Health, Inc., or its successors or assigns, assumes the Company&#8217;s obligations under this Plan, or any Affiliate which agrees, with the consent of Astrana Health, Inc., or its successors or assigns, to become a party to the Plan.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Company Contribution&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean the deferred compensation amount credited on behalf of a</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Participant by the Company to the Company Contribution Account, as described in Section 5.2.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Company Contribution Account&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean a subaccount of a Participant&#8217;s Account consisting</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">of&#58; (a) the sum of the Company Contribution amounts (if any) for any Plan Year, plus (b) Deemed Investment gains or losses credited or debited thereon, less (c) any distributions made to the Participant or his or her Beneficiary that relate to the Participant&#8217;s Company Contribution Account, and tax withholding amounts deducted (if any) from said Account.</font></div><div style="margin-top:11.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Deemed Investment&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean the notional conversion of the balance held in a Participant&#8217;s</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">Account(s) into shares or units of the Deemed Investment Options that are used as measuring devices for determining the value of a Participant&#8217;s Account(s).</font></div><div style="margin-top:13.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Deemed Investment Options&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean the hypothetical securities or other investments</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">described under Section 6.1 from which the Plan Administrator may select to be used as measuring devices to determine the Deemed Investment gains or losses of a Participant&#8217;s Account(s). A Participant shall have no real or beneficial ownership in the security or other investment represented by the Deemed Investment Options.</font></div><div style="margin-top:13.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Deferral Account&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean a subaccount of a Participant&#8217;s Account consisting of&#58; (a) the sum of</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">a Participant&#8217;s Deferral Amounts for any Plan Year or Performance Period that may be allocated, in whole or in part,</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_7"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:30.05pt;padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">by a Participant pursuant to his or her Deferral Election to the Deferral Account, plus (b) Deemed Investment gains or losses credited or debited thereon, less (c) any distributions made to the Participant or his or her Beneficiary that relate to the Participant&#8217;s Deferral Account, and tax withholding amounts deducted (if any) from said Account.</font></div><div style="margin-top:13.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Deferral Amount&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean that portion of a Participant&#8217;s Base Salary, Bonus Compensation,</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">and&#47;or Independent Contractor Compensation that a Participant elects to defer for any Plan Year or Performance Period.</font></div><div style="margin-top:11.05pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Deferral Election&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean an election by an Eligible Individual on an Election Form approved</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">by the Plan Administrator (in a paper or electronic format) to defer a portion of his or her Base Salary, Bonus</font></div><div style="margin-top:0.15pt;padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Compensation, and&#47;or Independent Contractor Compensation in accordance with the provisions of Article 3.</font></div><div style="margin-top:13.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Disability&#8221; or &#8220;Disabled&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall be defined as a condition of a Participant whereby he or she has</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">been deemed disabled by the Social Security Administration or has been determined to be disabled in accordance with a disability insurance program of the Company, provided that the disability insurance program covers the Participant and the definition of disability applied under such program complies with Code Section 409A. Upon the request of the Plan Administrator, the Participant must submit proof to the Plan Administrator of the Social Security Administration&#8217;s or disability insurance provider&#8217;s determination.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Effective Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean July 1, 2023.</font></div><div style="margin-top:10.8pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.21&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Election Form&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean the form or forms established from time to time by the Plan</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Administrator (in a paper or electronic format) on which the Participant makes certain designations as required under the terms of this Plan.</font></div><div style="margin-top:12.25pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.22&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Eligibility Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean the date designated by the Plan Administrator on which an Eligible</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Individual shall become eligible to participate in the Plan.</font></div><div style="margin-top:11.95pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.23&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Eligible Individual&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean an Employee or Independent Contractor who is selected by the</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">Company to participate in the Plan. Participation in the Plan is limited to a select group of the Company&#8217;s key management or highly compensated employees and independent contractors.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.24&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Employee&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean an individual who provides services to the Company in the capacity of a</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">common law employee of the Company.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.25&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;ERISA&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean the Employee Retirement Income Security Act of 1974, as amended from time</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">to time.</font></div><div style="margin-top:11.3pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.26&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Independent Contractor&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean an individual providing services to the Company who has</font></div><div style="margin-top:0.05pt;padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">been designated by the Company as an independent contractor, as reflected by the fact that the individual receives 1099 income from the Company.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.27&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Independent Contractor Compensation&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean the total amount of cash remuneration that is</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">paid by the Company to an Independent Contractor with respect to his or her service for the Company.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.28&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Participant&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean an Eligible Individual of the Company who is designated as eligible to</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">participate in this Plan in accordance with the provisions of Article 2.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.29&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Performance Period&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean, with respect to any Bonus Compensation, the period of time over</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">which such Bonus Compensation is earned.</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_10"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:30.3pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.30&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Plan&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean this Nonqualified Deferred Compensation Plan, as evidenced by this written</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">instrument, Participation Agreements, Election Forms, and any other forms as may be required by the Plan Administrator, as amended from time to time. For purposes of Section 409A, the portion of the amounts deferred by a Participant and Deemed Investment gains or losses credited or debited thereon, shall be considered an elective account balance plan as defined in Treasury Regulations &#167;1.409A-1(c)(2)(i)(A), or as otherwise provided by the Code&#59; the portion of the amounts deferred as Company Contributions together with Deemed Investment gains or losses credited or debited thereon, shall be considered a nonelective account balance plan as defined in Treasury Regulations &#167;1.409A-1(c)(2)(i)(B), or as otherwise provided in the Code.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.31&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Plan Administrator&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean the Company or its designee. The Plan Administrator shall</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">appoint delegates and service providers as it, in its sole discretion, deems necessary to properly administer the Plan, and may from time to time consult with legal counsel. No person who is a Plan Administrator shall participate in an action on a matter which applies solely to that person.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.32&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Plan Year&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean for the first Plan Year, the period beginning on the Effective Date and ending</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">December 31 of the same calendar year&#59; and thereafter shall mean a twelve (12) month period beginning January 1 of each calendar year and continuing through December 31 of such calendar year during which the Plan is in effect.</font></div><div style="margin-top:13.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.33&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Scheduled Withdrawal Account&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean a subaccount of a Participant&#8217;s Account consisting of&#58;</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%;padding-left:28.51pt">the sum of a Participant&#8217;s Deferral Amounts for any Plan Year or Performance Period that may be allocated, in whole or in part, by the Participant pursuant to his or her Deferral Election to a Scheduled Withdrawal Account, plus</font></div><div style="margin-top:0.35pt;padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%;padding-left:27.94pt">Deemed Investment gains or losses credited or debited thereon less (c) any distributions made to the Participant or his or her Beneficiary, and tax withholding amounts that relate to the Participant&#8217;s Scheduled Withdrawal Account, and tax withholding amounts deducted (if any) from said Account.</font></div><div style="margin-top:10.95pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.34&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Section 409A&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean Code Section 409A and the Treasury Regulations or other authoritative</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">guidance issued thereunder.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.35&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Separation from Service&#8221; or &#8220;Separates from Service&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean a Participant has experienced a</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">termination of employment or service with the Company. Whether a termination of employment or service has occurred is determined based on whether the facts and circumstances indicate that the Company and the Participant reasonably anticipated that no further services would be performed after a certain date or that the level of bona fide services the Participant would perform after such date (whether as an Employee or as an Independent Contractor) would permanently decrease to no more than twenty percent (20%) of the average level of bona fide services performed (whether as an Employee or an Independent Contractor) over the immediately preceding thirty-six (36) month period (or the full period during which the Participant performed services for the Company, if that is less than thirty-six (36) months).</font></div><div style="margin-top:13.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;1.36&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">&#8220;Specified Time&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">shall mean, with respect to a Participant&#8217;s Scheduled Withdrawal Account, the</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">date on which the Scheduled Withdrawal Account shall be paid to the Participant.</font></div><div style="margin-top:11.95pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;1.37&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">&#8220;Treasury Regulation&#8221; or &#8220;Treasury Regulations&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">shall mean regulations promulgated by the</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Internal Revenue Service for the U.S. Department of the Treasury, as they may be amended from time to time.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.38&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Unforeseeable Emergency&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean&#58; (a) a severe financial hardship to a Participant resulting</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">from an illness or accident of the Participant, the Participant&#8217;s spouse, the Participant&#8217;s Beneficiary, or the Participant&#8217;s dependents (as defined in Code Section 152 (without regard to Code Sections 152(b)(1), (b)(2), and (d)(1)(B))&#59; (b) loss of the Participant&#8217;s property due to casualty&#59; or (c) other similar extraordinary and unforeseeable circumstances arising as a result of events beyond the control of the Participant. The Plan Administrator will determine whether a Participant incurs an Unforeseeable Emergency based on the relevant facts and circumstances and in accordance with Treasury Regulations &#167;1.409A-3(i)(3).</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_13"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:30.45pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;1.39&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">&#8220;Valuation Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall mean the date a Participant&#8217;s Account is to be valued for purposes of</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">providing benefits under the terms of the Plan. The Valuation Date shall be interpreted as each day at the close of business of the New York Stock Exchange (currently 4&#58;00 p.m. Eastern Time), on days that the New York Stock Exchange is open for trading or any other day on which there is sufficient trading in securities of the applicable fund to materially affect the unit value of the fund and the corresponding unit value of the Participant's Deemed Investment Option(s).</font></div><div style="margin-top:12.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:127%">ARTICLE 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:126%">ELIGIBILITY AND PARTICIPATION</font></div><div style="margin-top:13.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Requirements for Participation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Every Eligible Individual selected by the Company on the Effective</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">Date shall be eligible to become a Participant on the Effective Date. Before the beginning of each Plan Year, or such other times as determined by the Company, the Company shall select those Employees and Independent Contractors who shall be Eligible Individuals for such Plan Year.</font></div><div style="margin-top:12.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Election to Participate&#59; Benefits of Participation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Each Eligible Individual may become a Participant</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">in the Plan by executing and submitting to the Plan Administrator, a Participation Agreement, a Deferral Election, and any other Election Form within the time period specified by the Plan Administrator and Section 409A. If an Eligible Individual fails to meet all requirements contained in this Section 2.2 within the period required, that Eligible Individual shall not be entitled to participate in the Plan during such Plan Year. In addition, the Plan Administrator may establish from time to time such other enrollment requirements permitted by Section 409A as it determines in its sole discretion are necessary or desirable.</font></div><div style="margin-top:12.55pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Re-employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The re-employment of a former Participant or re-engagement of a former</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">Independent Contractor by the Company shall not entitle such individual to become a Participant hereunder. Such individual shall not become a Participant until the individual is again designated as an Eligible Individual in accordance with Section 2.1. If a Participant who has experienced a Separation from Service is receiving installment distributions and is re-employed or re-engaged by the Company, distributions due to the Participant shall not be suspended.</font></div><div style="margin-top:12.3pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Ceasing to be an Eligible Individual. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Plan Administrator may remove an Eligible Individual</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">from further active participation in the Plan at its discretion. If this occurs, the Participant shall not have additional amounts credited to the Company Contribution Account and shall be prevented from making Participant Deferral Elections for subsequent Plan Years or Performance Periods. Any existing Deferral Election shall continue in effect for the remainder of the Plan Year or Performance Period and may only be cancelled in accordance with Section 3.4(b) hereof.</font></div><div style="margin-top:12.4pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Termination of Participation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">A Participant will cease to be a Participant as of the date on which his</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">or her entire Account balance has been distributed or forfeited.</font></div><div style="margin-top:12.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:127%">ARTICLE 3</font></div><div style="margin-top:0.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:127%">DEFERRAL ELECTIONS</font></div><div style="margin-top:13.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Minimum and Maximum Deferral Limits. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">For each Plan Year and&#47;or Performance Period (as</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">applicable), a Participant shall specify the percentage of Base Salary, Bonus Compensation, and&#47;or Independent Contractor Compensation to be deferred subject to the minimums or maximums established by the Plan Administrator and communicated to the Participant on the Election Form.</font></div><div style="margin-top:11.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Deferral Elections &#8211; First Year of Eligibility.</font></div><div style="margin-top:10.65pt;padding-left:67.5pt;text-indent:36pt"><font><br></font></div><div style="margin-top:10.65pt;padding-left:67.5pt;text-indent:36pt"><font><br></font></div><div style="margin-top:10.65pt;padding-left:67.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Application. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">This Section 3.2 applies to each Eligible Individual who first becomes eligible to participate in the Plan. The Plan Administrator shall determine (in accordance with Treasury Regulation </font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10.65pt;padding-left:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#167;1.409A-2(a)(7)(ii)) the date upon which a Participant who ceased being eligible to participate in the Plan, can again become eligible to participate in the Plan.</font></div><div style="margin-top:10.85pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Deferral Election. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">An Eligible Individual described in Section 3.2(a) may elect to defer receipt of Base Salary or Independent Contractor Compensation earned during such Plan Year or his or her Bonus Compensation earned during a Performance Period by filing a Deferral Election with the Plan Administrator in accordance with the following rules&#58;</font></div><div style="margin-top:10.7pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:29.71pt">Timing&#59; Irrevocability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Deferral Election must be filed with the Plan Administrator by, and shall become irrevocable as of, the thirtieth (30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:132%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">) day following the Participant&#8217;s Eligibility Date (or such earlier date as specified by the Plan Administrator).</font></div><div style="margin-top:10.5pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:26.8pt">Base Salary and Independent Contractor Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Deferral Election shall only apply to Base Salary and Independent Contractor Compensation earned during such calendar year beginning with the first payroll period that begins immediately after the date the Deferral Election becomes irrevocable. Base Salary and Independent Contractor Compensation payable after the last day of a calendar year solely for services performed during the final payroll period, described in Section 3401(b) of the Code, containing December 31 of such year shall be treated as earned during the subsequent calendar year.</font></div><div style="margin-top:10.65pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:23.89pt">Bonus Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Where a Deferral Election is filed in the first year of eligibility but after the commencement of the Performance Period, then, except as otherwise provided in Section 3.3 below, the Deferral Election shall only apply to that portion of Bonus Compensation earned for such Performance Period equal to the total amount of the Bonus Compensation earned during such Performance Period multiplied by a fraction, the numerator of which is the number of days beginning on the day immediately after the date that the Deferral Election becomes irrevocable and ending on the last day of the Performance Period, and the denominator of which is the total number of days in the Performance Period.</font></div><div style="margin-top:10.65pt;padding-left:32.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Annual Deferral Elections. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Unless Section 3.2 applies, each Eligible Individual may elect to defer receipt of Base Salary and Independent Contractor Compensation for a Plan Year or his or her Bonus Compensation for a Performance Period, by filing a Deferral Election with the Plan Administrator in accordance with the following rules&#58;</font></div><div style="margin-top:10.75pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.37pt">Base Salary and Independent Contractor Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Deferral Election with respect to Base Salary and Independent Contractor Compensation must be filed with the Plan Administrator by, and shall become irrevocable following, December 31 (or such earlier date as specified by the Plan Administrator on the Deferral Election ) of the calendar year next preceding the calendar year for which such amounts would otherwise be earned.</font></div><div style="margin-top:10.35pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:26.79pt">Bonus Compensation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Deferral Election with respect to Bonus Compensation must be filed with the Plan Administrator by, and shall become irrevocable following, December 31 (or such earlier date as specified by the Plan Administrator on the Deferral Election) of the calendar year next preceding the first day of the Performance Period for which such Bonus Compensation would otherwise be earned. If the Company has a fiscal year other than the calendar year, Bonus Compensation relating to services in the fiscal year of the Company, of which no amount is paid or payable during the fiscal year, may be deferred at the Participant&#8217;s election if the Deferral Election is made not later than the close of the Company&#8217;s fiscal year next preceding the first fiscal year in which the Participant performs any services for which such Bonus Compensation is payable. Any Deferral Election with respect to Bonus Compensation that constitutes &#8220;performance-based compensation&#8221; under Treasury Regulation &#167;1.409A-1(e)(1), must be filed with the Plan Administrator by, and </font></div><div style="margin-top:10.35pt;text-align:justify"><font><br></font></div><div style="margin-top:10.35pt;padding-left:31.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">shall become irrevocable as of, the date that is six (6) months before the end of the applicable Performance Period (or such earlier date as specified by the Plan Administrator on the Deferral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:132%">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">lection), provided that in no event may such Deferral Election be filed after such Bonus Compensation has become &#8220;readily ascertainable&#8221; within the meaning of Section 409A.</font></div><div style="margin-top:11.4pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Duration and Cancellation of Deferral Elections.</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10.4pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.37pt">Duration. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Once irrevocable, a Deferral Election shall only be effective for the Plan Year or Performance Period with respect to which such election was timely filed with the Plan Administrator. Except as provided in Section 3.4(b), a Deferral Election, once irrevocable, cannot be cancelled or altered during a Plan Year or Performance Period.</font></div><div style="margin-top:12.3pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%;padding-left:26.79pt">Cancellation.</font></div><div style="margin-top:10.6pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:169%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:169%;padding-left:30.17pt">The Plan Administrator may cancel a Participant&#8217;s Deferral Election where such cancellation occurs by the later of&#58; (A) the end of the Participant&#8217;s taxable year, or (B) the fifteenth (15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:169%">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:169%">) day of the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:169%">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:169%">) month following the date the Participant incurs a &#8220;disability,&#8221; in accordance with Treasury Regulation &#167;1.409A-3(j)(4)(xii). For purposes of this Section 3.4(b)(i), a disability refers to any medically determinable physical or mental impairment resulting in the Participant&#8217;s inability to perform duties of his or her position or any substantially similar position, where such impairment can be expected to result in death or can be expected to last for a continuous period of not less than six (6) months, in accordance with Treasury Regulation &#167;1.409A-3(i)(3).</font></div><div style="margin-top:11.05pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:27.4pt">The Plan Administrator must cancel a Participant's Deferral Election due to an Unforeseeable Emergency distribution. If a Participant&#8217;s Deferral Election is cancelled with respect to a particular calendar year or Performance Period, the Participant may complete a new Deferral Election for a subsequent Plan Year or Performance Period, only in accordance with Section 3.3.</font></div><div style="margin-top:11.4pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Withholding and Crediting of Deferral Amounts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">For each Plan Year, the Base Salary and</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">Independent Contractor Compensation portions of the Deferral Amount shall be withheld from each regularly scheduled payroll in approximately equal amounts (or as otherwise specified by the Plan Administrator), as adjusted from time to time for increases and decreases in Base Salary or Independent Contractor Compensation (if the Participant&#8217;s Deferral Election is expressed as a percentage). The Bonus Compensation portion of the Deferral Amount shall be withheld as soon as administratively feasible following the time the Bonus Compensation otherwise would be paid to the Participant, whether or not this occurs during the Plan Year or Performance Period as the case may be. Deferral Amounts shall be credited to the Participant&#8217;s Deferral Account and&#47;or to a Scheduled Withdrawal Account as soon as administratively feasible following the time such amounts would otherwise have been paid to a Participant.</font></div><div style="margin-top:14.95pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE 4</font></div><div style="margin-top:0.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ACCOUNT ALLOCATION AND DISTRIBUTION ELECTIONS</font></div><div style="margin-top:13.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Establishment of Account(s). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Plan Administrator shall establish and maintain a Deferral</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">Account, a Company Contribution Account, and Scheduled Withdrawal Accounts for each Plan Year, as applicable, in the name of each Participant.</font></div><div style="margin-top:11.4pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Account Allocation. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Concurrent with any Deferral Election, a Participant may make an irrevocable</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">election to allocate all or a portion of his or her elected Deferral Amount to the Plan Year Deferral Account and&#47;or a Plan Year Scheduled Withdrawal Account. To the extent that a Participant does not designate the Account to which Deferral Amounts will be allocated for a Plan Year, or such designation is ambiguous or does not comply with the terms of the Plan, such Deferral Amounts shall be allocated and credited to the Participant&#8217;s Deferral Account. </font></div><div style="padding-left:32.4pt;text-align:justify"><font><br></font></div><div style="padding-left:32.4pt;text-align:justify"><font><br></font></div><div style="padding-left:32.4pt;text-align:justify"><font><br></font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">Company Contributions shall not be allocated to a Scheduled Withdrawal Account, and instead shall be allocated to a Plan Year Company Contribution Account.</font></div><div style="padding-left:32.4pt;text-align:justify"><font><br></font></div><div style="padding-left:67.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:131%">Scheduled Withdrawal Account Elections. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">If a Participant elects to allocate Deferral Amounts for a</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">Plan Year into a Scheduled Withdrawal Account in accordance with Section 4.2, the Participant shall make an election as to the year in which payment will commence to be paid from that Scheduled Withdrawal Account (the &#8220;Specified Time&#8221;). A </font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">Participant may elect to receive a distribution of a Scheduled Withdrawal Account no sooner than January 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:168%">th </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">of the fifth (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:168%">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">) Plan Year following the Plan Year of the deferral unless otherwise stated in the Election Form. (For example&#58; If a Participant elects to allocate 2023 Deferral Amounts into a Scheduled Withdrawal Account, the earliest date these Deferral Amounts could be distributed would be January 15, 2028). A Participant must also elect whether a Scheduled Withdrawal Account will be paid in a lump sum or in annual installments of up to four (4) years. To the extent that the designations are ambiguous or do not comply with the terms of this Section, then that Scheduled Withdrawal Account shall be paid at the earliest permissible date in accordance with this Section and&#47;or in a lump sum.</font></div><div style="margin-top:11.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Other Distribution Elections. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Within thirty (30) days following a Participant&#8217;s Eligibility Date, and</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">during each subsequent annual enrollment thereafter, a Participant must elect whether to be paid in a lump sum or in five (5), ten (10), fifteen (15), or twenty (20) installments for a Separation from Service&#59; and shall make a one-time election within thirty (30) days following the initial Eligibility Date to be paid in a lump sum or five (5) annual installments for Disability and death. To the extent that a Participant does not designate the form of payment or such designation is ambiguous or does not comply with the terms of the Plan, the Participant shall be deemed to have elected to be paid in a lump sum.</font></div><div style="margin-top:12.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:128%">ARTICLE 5</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:128%">COMPANY CONTRIBUTIONS</font></div><div style="margin-top:13.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Company Contributions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Each Plan Year, the Company may make Company Contributions to the</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">Plan on behalf of a Participant in such amount as the Company shall determine in its sole discretion. The Company is under no obligation to make a Company Contribution for a Plan Year, and Company Contributions, if made, need not be uniform among Participants. Any Company Contribution shall be credited to the Participant's Company Contribution Account on such date as determined by the Company.</font></div><div style="margin-top:12.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:128%">ARTICLE 6</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:128%">DEEMED INVESTMENT GAINS OR LOSSES</font></div><div style="margin-top:11.95pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Deemed Investment Options. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Plan Administrator will determine the available Deemed</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">Investment Options for purposes of crediting or debiting the Deemed Investment gains or losses to the Account. The Plan Administrator may discontinue, substitute, or add Deemed Investment Options in its sole discretion on a prospective basis. Any discontinuance, substitution, or addition of a Deemed Investment Option will take effect as soon as administratively practicable. The Deemed Investment Options are to be used for measurement purposes only, and the Plan Administrator&#8217;s selection of any such Deemed Investment Option, the allocation of such Deemed Investment Options to the Account, the calculation of additional amounts, and the crediting or debiting of such amounts to the Account </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;text-decoration:underline">shall not</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%"> be considered or construed in any manner as an actual investment of the Account. The Plan Administrator will not be responsible in any manner to any Participant, Beneficiary or other person for any damages, losses, liabilities, costs or expenses of any kind arising in connection with any designation or elimination of a Deemed Investment Option. Without limiting the foregoing, the Account shall at all times be a bookkeeping entry only and shall not represent any investment made on his or her behalf by the Plan Administrator. A Participant (or Beneficiary) shall at all times remain an unsecured creditor of the Company. Any liability or obligation of the Company to any Participant, former Participant, or Beneficiary with respect to a right to payment shall be based solely upon contractual obligations created by this Plan.</font></div><div style="margin-top:11.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Participant&#8217;s Allocation of Deemed Investment Options. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Each Participant shall have the right to</font></div><div style="padding-left:32.4pt;text-align:justify"><font><br></font></div><div style="padding-left:32.4pt;text-align:justify"><font><br></font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">direct the Plan Administrator as to how the Participant&#8217;s Deferral Amounts and Company Contributions shall be deemed to be invested among the Deemed Investment Options offered under the Plan, subject to any rule, policy, practice or procedure adopted by the Plan Administrator. As of each Valuation Date, the Participant&#8217;s Account(s) will be credited or debited to reflect the performance of the Deemed Investment Options elected by the Participant. If a Deemed Investment Option selected by a Participant sustains a loss, the Participant&#8217;s Account(s) shall be reduced to reflect such loss. If the Participant fails to elect a Deemed Investment Option the Deemed Investment shall be based on an investment as may be established by the Plan Administrator.</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:11.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Participant Responsibilities. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Each Participant is solely responsible for any and all consequences of</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">his or her investment directions made pursuant to this Article 6. Neither the Company, any of its directors, officers or employees, nor the Plan Administrator has any responsibility to any Participant or other person for any damages, losses, liabilities, costs or expenses of any kind arising in connection with any investment direction made by a Participant pursuant to this Article 6.</font></div><div style="margin-top:11.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">No Required Investment of Company Assets. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Notwithstanding anything contained herein to the</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">contrary, the Company reserves the right to invest its assets, including any assets that may have been set aside for the purpose of funding the benefits to be provided under the Plan, at its own discretion, and such assets shall remain the property of the Company, or may be held in a trust, as the case may be, subject to the claims of the general creditors of the Company, and no Participant shall have any right to any portion of such assets other than as an unsecured general creditor of the Company.</font></div><div style="margin-top:14.7pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE 7</font></div><div style="margin-top:0.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">VESTING &#47; FORFEITURES &#47; TAXES</font></div><div style="margin-top:13.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Participant Accounts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">A Participant shall at all times be one hundred percent (100%) vested in his or</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">her Deferral Account and Scheduled Withdrawal Account(s).</font></div><div style="margin-top:11.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Company Contribution Account. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Unless otherwise described in a Participant&#8217;s Participation</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">Agreement, Company Contributions shall be tracked separately for each Plan Year and shall become one hundred percent (100%) vested on December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:168%">st </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">of the fifth (5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:168%">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">) Plan Year following the year the contribution is credited to the Participant&#8217;s Account. For example&#58; Company Contributions credited in 2023 will 100% vest on December 31, 2028&#59; contributions credited in 2024 will 100% vest on December 31, 2029&#59; contributions credited in 2025 will 100% vest on December 31, 2030&#59; and so on.</font></div><div style="margin-top:13.95pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Accelerated Vesting. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Notwithstanding the foregoing vesting schedule, a Participant&#8217;s Company</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">Contribution Account shall become one hundred percent (100%) vested upon the earliest of the following events to occur while employed by the Company&#58; (a) Disability&#59; (b) death&#59; (c) a Change in Control&#59; or (d) at the discretion of the Company.</font></div><div style="margin-top:13.75pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;7.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Forfeiture. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Notwithstanding any other provision to the contrary herein, in the event a Participant&#8217;s</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">employment is terminated for Cause, no benefits of any kind will be due or payable by the Company under the terms of this Plan from the Participant&#8217;s Company Contribution Account and all rights of the Participant, his or her designated Beneficiary, executors, or administrators, or any other person, to receive payments thereof shall be forfeited. Additionally, a Participant will forfeit any portion of an Account that is not vested upon Separation from Service.</font></div><div style="margin-top:12.3pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;7.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Taxes and Withholding. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Deferral Amounts, Company Contributions, and Deemed Investment gains</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">and&#47;or losses on each are subject to the Federal Insurance Contribution Act (FICA), the Federal Unemployment Tax Act (FUTA), and the Self-Employment Contributions Act (SECA) for Independent Contractors, to the extent provided under applicable Code provisions, and benefits payable under the Plan are subject to all applicable federal, state, city, income, employment or other taxes as may be required to be withheld or paid. A Participant is solely responsible for the payment of all individual tax liabilities relating to any such benefits.</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_16"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:44.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE 8</font></div><div style="margin-top:1.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">PAYMENT OF ACCOUNT(S)</font></div><div style="margin-top:13.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">Payments in General.</font></div><div style="margin-top:11.75pt;padding-left:104.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">Payment Events.</font></div><div style="margin-top:11.75pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:30.17pt">A Participant (or, in the event of the death of the Participant, the Participant&#8217;s Beneficiary) shall be entitled to a benefit equal to the Participant&#8217;s vested Account(s) balance upon the earliest to occur of Separation from Service, Disability, or death.</font></div><div style="margin-top:12.25pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:27.4pt">Unless the vested balance of a Participant&#8217;s Scheduled Withdrawal Account has been paid earlier in accordance with this Section 8.1(a)(i), the Participant shall be entitled to a benefit equal to such vested balance at the Specified Time.</font></div><div style="margin-top:10.95pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Source of Payments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Company will pay, from its general assets, the portion of any benefit payable pursuant to this Article 8 that is attributable to a Participant&#8217;s Account, and all costs, charges and expenses relating thereto.</font></div><div style="margin-top:10.8pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Minimum Threshold for Installment Payments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">If the vested Account balance at the due date of the first installment is fifty thousand dollars ($50,000) or less, payment of the vested Account shall be made instead in a lump sum and no installments shall be available hereunder. This lump sum minimum threshold does not apply to Scheduled Withdrawal Accounts.</font></div><div style="margin-top:10.7pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Subsequent Deferral Elections. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Upon the Company&#8217;s approval, a Participant may delay the time of a payment or change the form of payment as expressly provided under this Section 8.1(d) and Section 409A (hereinafter, a &#8220;Subsequent Deferral Election&#8221;). Notwithstanding the foregoing, a Subsequent Deferral Election cannot accelerate any payment. A Subsequent Deferral Election which delays payment or changes the form of payment is permitted only if all of the following requirements are met&#58;</font></div><div style="margin-top:10.7pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%;padding-left:30.17pt">The Subsequent Deferral Election does not take effect until at least twelve (12) months after the date on which the Subsequent Deferral Election is made and approved by the Plan Administrator&#59;</font></div><div style="margin-top:11.25pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:27.4pt">If the Subsequent Deferral Election relates to a payment based on Separation from Service or at a Specified Time, the Subsequent Deferral Election must result in payment being deferred for a period of not less than five (5) years from the date the first amount was scheduled to be paid&#59;</font></div><div style="margin-top:10.95pt;padding-left:104.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%;padding-left:24.63pt">If the Subsequent Deferral Election relates to a payment at a Specified Time, the Participant must make the Subsequent Deferral Election not less than twelve (12) months before the date the first amount was scheduled to be paid.</font></div><div style="margin-top:10.8pt;padding-left:32.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">For purposes of applying this Section 8.1(d), installment payments shall be treated as a &#8220;single payment.&#8221; Any election made pursuant to this Section shall be made on such Election Forms or electronic media as is required by the Plan Administrator, in accordance with the rules established by the Plan Administrator and shall comply with all requirements of Section 409A.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Separation from Service. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">In the event of a Participant&#8217;s Separation from Service (other than for</font></div><div style="padding-left:32.4pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">death), the Company shall pay the Participant in the form of payment elected in accordance with Section 4.4. Payment shall be made or commence on January 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:134%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%"> of the calendar year following the date of Separation from</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_19"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:30.05pt;padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:169%">Service and each January 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:169%">th </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:169%">thereafter in the case of installment payments. The amount of each payment shall be determined by dividing the value of the Participant&#8217;s vested Account balance(s) as of December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:169%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:169%"> prior to the January 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:169%">th </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:169%">payment date by the number of payments remaining to be paid.</font></div><div style="margin-top:13.25pt;padding-left:32.4pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Required Delay for Specified Employee of a Public Company. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">If a Participant is considered a &#8220;specified employee&#8221; of a public company, pursuant to Code Section 409A(a)(2)(B)(i), then solely to the extent necessary to avoid penalties under Section 409A, payments to be made as a result of a Separation from Service under this Article may not commence earlier than six (6) months after the Participant&#8217;s Separation from Service. In the event a distribution is delayed pursuant to this paragraph, any amounts otherwise payable during the six months shall be accumulated and paid in a lump sum on the first day of the seventh month following Separation from Service.</font></div><div style="margin-top:13.5pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Disability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">In the event a Participant becomes Disabled while employed by the Company, the</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">Company shall pay to the Participant his or her Account balance in the form of payment elected by the Participant in accordance with Section 4.4. Payment shall be made or commence within ninety (90) days following the date of Disability. The amount of each payment shall be determined by dividing the value of the Participant&#8217;s Account balance as of the Disability (and each anniversary of Disability for subsequent installment payments) by the number of payments remaining to be paid.</font></div><div style="margin-top:13.75pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Death.</font></div><div style="margin-top:12.85pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.37pt">While Employed. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">In the event of a Participant&#8217;s death while employed by the Company, the Company shall pay the Participant&#8217;s vested Account balance in the form of payment elected by the Participant in accordance with Section 4.4. Payment shall be made or commence within ninety (90) days following the date of the Participant&#8217;s death. The amount of each payment shall be determined by dividing the value of the Participant&#8217;s Account balance as of the date of death (and each anniversary of the date of death for subsequent installment payments) by the number of payments remaining to be paid.</font></div><div style="margin-top:13.25pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:26.79pt">During Installments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">In the event of a Participant&#8217;s death after installments have commenced, as applicable, but before receiving all installments owed, the Company shall continue to pay any remaining installments to the Participant&#8217;s Beneficiary in accordance with the schedule the installments would have otherwise been paid to the Participant.</font></div><div style="margin-top:13.25pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.96pt">During a Delay. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">In the event of a Participant&#8217;s death after becoming entitled to a benefit but before payment is made or commences, as applicable, the Company shall pay the Participant&#8217;s Beneficiary the same benefit the Participant would have received in accordance with the schedule the payment would have otherwise been paid to the Participant.</font></div><div style="margin-top:13.75pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Payment at a Specified Time. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">A Participant shall be paid a Scheduled Withdrawal Account on</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">January 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:168%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%"> (and each January 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:168%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%"> thereafter in the case of installment payments) of the year elected and in the form of payment elected by the Participant in accordance with Section 4.3. The amount of each payment shall be determined by dividing the value of the Participant&#8217;s Scheduled Withdrawal Account balance as of December 31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:168%">st </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">prior to the January 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:168%">th </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:168%">payment date by the number of payments remaining to be paid. Notwithstanding anything contained herein to the contrary, should an event occur that triggers a payment under Separation from Service, Disability, or death, any Account balances subject to a Participant&#8217;s Scheduled Withdrawal Account(s) that have not yet begun to be paid shall not be paid under the election as to time and form of the Participant&#8217;s Scheduled Withdrawal Account, but instead shall be paid, in time and form, in accordance with the event that triggers the distribution and as permitted under Section 409A. Any Scheduled Withdrawal Accounts already in payout will continue to be paid in accordance with the Participant&#8217;s Deferral Election for that Scheduled Withdrawal Account.</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:30.5pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;8.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Payment due to an Unforeseeable Emergency. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">A Participant shall have the right to request, on a</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">form provided by the Plan Administrator, a payment of all or a portion of his or her vested Account balance, in a lump sum payment due to an Unforeseeable Emergency. The Plan Administrator shall have the sole discretion to determine, in accordance with the standards under Section 409A, whether to grant such a request and the amount to be paid pursuant to such request.</font></div><div style="margin-top:11pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.37pt">Determination of Unforeseeable Emergency. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Whether a Participant is faced with an Unforeseeable Emergency permitting a lump sum payment is to be determined based on the relevant facts and circumstances of each case, but, in any case, a payment on account of an Unforeseeable Emergency may not be made to the extent that such emergency is or may be relieved through reimbursement or compensation from insurance or otherwise, by liquidation of the Participant&#8217;s assets, to the extent the liquidation of such assets would not cause severe financial hardship, or by cessation of deferrals under the Plan. Payments because of an Unforeseeable Emergency must be limited to the amount reasonably necessary to satisfy the emergency need (which may include amounts necessary to pay any federal, state, local, or foreign income taxes or penalties reasonably anticipated to result from the payment).</font></div><div style="margin-top:11.15pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:26.79pt">Payment of Account. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Payment shall be made within thirty (30) days following the determination by the Plan Administrator that a payment will be permitted under this Section 8.6.</font></div><div style="margin-top:11.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;8.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Permissible Payment Accelerations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Except as specifically permitted herein or in other sections of</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">this Plan, no acceleration of the time or schedule of any payment may be made hereunder. Notwithstanding the foregoing, payments may be accelerated hereunder by the Company (without any direct or indirect election on the part of any Participant), in accordance with the provisions of Treasury Regulation &#167;1.409A-3(j)(4) and any subsequent guidance issued by the United States Treasury Department. Accordingly, payments may be accelerated, in accordance with the provisions of Treasury Regulation &#167;1.409A-3(j)(4) in the following circumstances&#58; (a) in limited cashouts (but not in excess of the limit under Code Section 402(g)(1)(B))&#59; (b) to pay employment-related taxes&#59; or (c) to pay any taxes that may become due at any time that the Plan fails to meet the requirements of Section 409A (but in no case shall such payments exceed the amount to be included in income as a result of the failure to comply with the requirements of Section 409A).</font></div><div style="margin-top:11.4pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;8.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Rights of Participant and Beneficiary.</font></div><div style="margin-top:11.45pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.37pt">Creditor Status of Participant and Beneficiary. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Plan constitutes the unfunded, unsecured promise of the Company to make payments to a Participant or Beneficiary in the future and shall be a liability solely against the general assets of the Company. The Company shall not be required to segregate, set aside or escrow any amounts for the benefit of a Participant or Beneficiary. A Participant and Beneficiary shall have the status of a general unsecured creditor of the Company and may look only to the Company and its general assets for payment of benefits under the Plan.</font></div><div style="margin-top:13.5pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:26.79pt">Investments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">In its sole discretion, the Company may acquire insurance policies, annuities or other financial vehicles for the purpose of providing future assets of the Company to meet its anticipated liabilities under the Plan. Such policies, annuities or other investments shall at all times be and remain unrestricted general property and assets of the Company. A Participant and his or her designated Beneficiary shall have no rights, other than as general creditors, with respect to such policies, annuities or other acquired assets. In the event that the Company purchases an insurance policy or policies insuring the life of a Participant or Employee, to allow the Company to recover or meet the cost of providing benefits, in whole or in part, hereunder, no Participant or Beneficiary shall have any rights whatsoever in said policy or the proceeds therefrom. The Company shall be the sole owner and beneficiary of any such insurance policy or property and shall possess and may exercise all incidents of ownership therein. No insurance policy with regard to any director, &#8220;highly compensated employee,&#8221; or &#8220;highly compensated individual,&#8221; as defined in</font></div><div><font><br></font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:13.5pt;text-align:justify"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:30.15pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">Code Section 101(j) shall be acquired before satisfying the Code Section 101(j) &#8220;Notice and Consent&#8221; requirements.</font></div><div style="margin-top:13.35pt;padding-left:68.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;8.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">Discharge of Obligations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The payment to a Participant or his or her Beneficiary of the Account</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">balance in full shall discharge all obligations of the Company to such Participant or Beneficiary under the Plan.</font></div><div style="margin-top:12.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:130%">ARTICLE 9</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:130%">BENEFICIARY DESIGNATION</font></div><div style="margin-top:13.25pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">Designation of Beneficiaries.</font></div><div style="margin-top:11.3pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%;padding-left:28.51pt">Each Participant may designate any person or persons (who may be named contingently or successively) to receive any benefits payable under the Plan upon the Participant&#8217;s death, and the designation may be changed from time to time by the Participant by filing a new designation. Each designation will revoke all prior designations by the same Participant, shall be in the form prescribed by the Company, and shall be effective only when signed by the Participant and filed with the Company during the Participant&#8217;s lifetime.</font></div><div style="margin-top:11.5pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%;padding-left:27.94pt">In the absence of a valid Beneficiary designation, or if, at the time any benefit payment is due to a Beneficiary, there is no living Beneficiary validly named by the Participant, the Company shall pay the benefit payment to the Participant&#8217;s spouse, if then living, and if the spouse is not then living to the Participant&#8217;s then living descendants, if any, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:136%">per stirpes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">, and if there are no living descendants, to the Participant&#8217;s estate. In determining the existence or identity of anyone entitled to a benefit payment, the Company may rely conclusively upon information supplied by the Participant&#8217;s personal representative, executor, or administrator.</font></div><div style="margin-top:12pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%;padding-left:28.51pt">A Participant&#8217;s designation of a Beneficiary will not be revoked or changed automatically by any future marriage or divorce. Should the Participant wish to change the designated Beneficiary in the event of a future marriage or divorce, the Participant will have to do so by means of filing a new designation.</font></div><div style="margin-top:11.8pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%;padding-left:27.94pt">If a question arises as to the existence or identity of anyone entitled to receive a death benefit payment under the Plan, or if a dispute arises with respect to any death benefit payment under the Plan, the Company may distribute the payment to the Participant&#8217;s estate without liability for any tax or other consequences, or may take any other action which the Company deems to be appropriate.</font></div><div style="margin-top:11.95pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">Information to be furnished by Participants and Beneficiaries&#59; Inability to Locate Participants or</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:131%">Beneficiaries. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">Any communication, statement or notice addressed to a Participant or to a Beneficiary at his or her last post office address as shown on the Company&#8217;s records shall be binding on the Participant or Beneficiary for all purposes of the Plan. The Company shall not be obliged to search for any Participant or Beneficiary beyond the sending of a registered letter to such last known address.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;9.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Facility of Payment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">If the Plan Administrator determines in its discretion that a benefit is to be paid</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">to a minor, to a person legally declared incompetent, or to a person legally deemed incapable of handling the disposition of that person&#8217;s property, the Plan Administrator may direct payment of such benefit to the guardian, legal representative or person having care or custody of such minor, incompetent person or incapable person. The Plan Administrator may require proof of incompetence, minority or guardianship as it may deem appropriate prior to payment of the benefit. Any distribution of a benefit shall be a distribution for the account of the Participant and the Beneficiary, as the case may be, and shall be a complete discharge of any liability under the Plan for such distribution amount.</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_22"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:30.55pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:128%">ARTICLE 10</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:128%">PLAN AMENDMENT</font></div><div style="margin-top:13.35pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Right to Amend. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Subject to Section 409A, the Company, by action of its board of directors or similar</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">governing body, shall have the right to amend the Plan, at any time and with respect to any provisions hereof, and all parties hereto or claiming any interest hereunder shall be bound by such amendment&#59; provided, however, that no such amendment shall deprive a Participant or a Beneficiary of a benefit amount accrued hereunder prior to the date of the amendment without written consent of the Participant or Beneficiary.</font></div><div style="margin-top:11.4pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Amendments Required By Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Notwithstanding the provisions of Section 10.1, the Plan may be</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">amended by the Company at any time, retroactively if required, if found necessary, in the opinion of the Company, in order to ensure that the Plan is characterized as a &#8220;top-hat&#8221; plan of deferred compensation maintained for a select group of management or highly compensated employees as described under ERISA sections 201(2), 301(a)(3), and 401(a)(1), to conform the Plan to the provisions of Section 409A, and to conform the Plan to the requirements of any other applicable law (including but not limited to ERISA and the Code). No such amendment shall be considered prejudicial to any interest of a Participant or a Beneficiary hereunder.</font></div><div style="margin-top:12.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:128%">ARTICLE 11</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:128%">PLAN TERMINATION</font></div><div style="margin-top:13.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Company&#8217;s Right to Suspend Plan. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Company reserves the right to suspend the operation of the</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">Plan for a fixed or indeterminate period of time, in its sole discretion. In the event of a suspension of the Plan, during the period of the suspension, the Company shall continue all aspects of the Plan other than crediting of Company Contributions, and Deferral Amounts shall be suspended effective with the first day of the Plan Year following the date the Plan is suspended. Payments of distributions will continue to be made during the period of the suspension in accordance with Article 8.</font></div><div style="margin-top:12.6pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Plan Termination and Liquidation under Section 409A. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Notwithstanding anything to the contrary</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">in Section 11.1, any acceleration of the payment of benefits due to Plan termination and liquidation shall comply with the following subparagraphs, but only as permitted in accordance with Section 409A and Treasury Regulation &#167;1.409A-3(j)(4)(ix). The Company may distribute all Participants&#8217; vested Account balances, determined as of the date of the termination of the Plan, subject to the terms below&#58;</font></div><div style="margin-top:10.8pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:28.51pt">Upon the Company&#8217;s termination of this and all other arrangements that would be aggregated with this Plan pursuant to Treasury Regulation &#167;1.409A-1(c) if a Participant participated in such arrangements (&#8220;Similar Arrangements&#8221;), provided that&#58; (i) the termination does not occur proximate to a downturn in the financial health of the Company&#59; (ii) all termination distributions are made no earlier than twelve (12) months and no later than twenty-four (24) months following such termination&#59; and (iii) the Company does not adopt any new arrangement that would be a Similar Arrangement for a minimum of three (3) years following the date the Company takes all necessary action to irrevocably terminate and liquidate the Plan.</font></div><div style="margin-top:11pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:27.94pt">Upon the Company&#8217;s dissolution taxed under Code Section 331, or with approval of a bankruptcy court, provided that the amounts deferred under the Plan are included in the Participant&#8217;s gross income in the latest of&#58; (i) the calendar year in which the Plan terminates&#59; (ii) the calendar year in which the amount is no longer subject to a substantial risk of forfeiture&#59; or (iii) the first calendar year in which the payment is administratively practicable&#59; or</font></div><div style="margin-top:10.85pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:28.51pt">Within thirty (30) days before or twelve (12) months after a Change in Control, provided that all distributions are made no later than twelve (12) months following such termination of the Plan and further provided that all the Company&#8217;s Similar Arrangements are terminated so the Participant and all</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_25"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:29.95pt;padding-left:68.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:137%">participants in the Similar Arrangements are required to receive all amounts of compensation deferred under the terminated arrangements within twelve (12) months of the termination of the Plan.</font></div><div style="margin-top:12.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE 12</font></div><div style="margin-top:0.6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">PLAN ADMINISTRATION</font></div><div style="margin-top:13.4pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;12.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">Plan Administrator Duties. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">The Plan Administrator shall be responsible for the management,</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">operation, and administration of the Plan. When making a determination or calculation, the Plan Administrator shall be entitled to rely on information furnished by the Company, the Participants, or Beneficiaries. No provision of this Plan shall be construed as imposing on the Plan Administrator any fiduciary duty under ERISA or other law, or any duty similar to any fiduciary duty under ERISA or other law.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;12.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Plan Administrator Authority. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Plan Administrator shall enforce this Plan in accordance with</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">its terms, shall be charged with the general administration of this Plan, and shall have all powers necessary to accomplish its purposes, including, but not by way of limitation, the following&#58;</font></div><div style="margin-top:11.75pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:137%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:137%;padding-left:28.51pt">To construe and interpret the terms and provisions of this Plan and to reconcile any inconsistency, in its sole and absolute discretion&#59;</font></div><div style="margin-top:12.1pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%;padding-left:27.94pt">To compute and certify the amount payable to a Participant and his or her Beneficiaries&#59; to determine the time and manner in which such benefits are paid&#59; and to determine the amount of any withholding taxes to be deducted&#59;</font></div><div style="margin-top:12.15pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:28.51pt">To maintain all records that may be necessary for the administration of this Plan&#59;</font></div><div style="margin-top:12.2pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:27.94pt">To provide for the disclosure of all information and the filing or provision of all reports and statements to a Participant, Beneficiaries, and governmental agencies as shall be required by law&#59;</font></div><div style="margin-top:12pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:28.51pt">To make and publish such rules for the regulation of this Plan and procedures for the administration of this Plan so long as such rules or procedures are not inconsistent with the terms hereof&#59;</font></div><div style="margin-top:12.15pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:29.61pt">To administer this Plan&#8217;s claims procedures&#59;</font></div><div style="margin-top:12.4pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:27.94pt">To approve the forms and procedures for use under this Plan&#59; and</font></div><div style="margin-top:12pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:27.94pt">To employ such persons or organizations, including without limitation, actuaries, attorneys, accountants, independent fiduciaries, recordkeepers and administrative consultants, to render advice or perform services with respect to the responsibilities of the Plan Administrator under the Plan.</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;12.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">Binding Effect of Decision. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The decision or action of the Plan Administrator with respect to any</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">question arising out of or in connection with the administration, interpretation, and application of this Plan and the rules and regulations promulgated hereunder shall be final and conclusive and binding upon all persons having any interest in this Plan.</font></div><div style="margin-top:12.45pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;12.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:133%">Compensation and Expenses. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">The Plan Administrator shall serve without compensation for services</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">rendered hereunder. The Plan Administrator is authorized at the expense of the Company to employ such legal counsel and&#47;or Plan recordkeeper as it may deem advisable to assist in the performance of its duties hereunder. Expense and fees in connection with the administration of this Plan shall be paid by the Company.</font></div><div style="margin-bottom:32.9pt;margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">&#160;&#160;&#160;&#160;12.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:134%">Compliance with Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">.</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_28"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:30.25pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:28.51pt">Notwithstanding anything contained herein to the contrary, the interpretation and distribution of Participants&#8217; benefits under the Plan shall be made in a manner and at such times as to comply with all applicable provisions of Section 409A and the regulations and guidance promulgated thereunder, or an exception or exclusion therefrom to avoid the imposition of any accelerated or additional taxes. Any defined terms shall be construed consistent with Section 409A and any terms not specifically defined shall have the meaning set forth in Section 409A.</font></div><div style="margin-top:11.8pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:27.94pt">The intent of this Section is to ensure that the Participants are not subject to any tax liability or interest penalty, by reason of the application of Code Section 409A(a)(1) as a result of any failure to comply with all the requirements of Section 409A, and this Section shall be interpreted in light of, and consistent with, such requirements. This Section shall apply to distributions under the Plan, but only to the extent required in order to avoid taxation of, or interest penalties on, a Participant under Section 409A. These rules shall also be deemed modified or supplemented by such other rules as may be necessary, from time to time, to comply with Section 409A.</font></div><div style="margin-top:13.3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE 13</font></div><div style="margin-top:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">CLAIMS PROCEDURES</font></div><div style="margin-top:13pt;padding-left:32.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">13.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Claims Procedure. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">This Article is based on Department of Labor Regulation Section 2560.503-1. If any provision of this Article conflicts with the requirements of those regulations, the requirements of those regulations will prevail. A Claimant who has not received benefits under the Plan that he or she believes should be paid shall make a claim for such benefits as follows&#58;</font></div><div style="margin-top:13.3pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.37pt">Initiation - Written Claim. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Claimant initiates a claim by submitting a written request for the benefits to the Plan Administrator. The Plan Administrator will, upon written request of a Claimant, make available copies of all forms and instructions necessary to file a claim for benefits or advise the Claimant where such forms and instructions may be obtained. If the claim relates to Disability benefits, then the Plan Administrator shall designate a sub-committee to conduct the initial review of the claim (and applicable references below to the Plan Administrator shall mean such sub-committee).</font></div><div style="margin-top:13.65pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:26.79pt">Timing of Company Response. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Plan Administrator shall respond to such Claimant within ninety (90) days after receiving the claim. If the Plan Administrator determines that special circumstances require additional time for processing the claim, the Plan Administrator can extend the response period by an additional ninety (90) days by notifying the Claimant in writing prior to the end of the initial 90-day period that an additional period is required. In the event that the claim for benefits pertains to Disability, the Plan Administrator shall provide written response within forty-five (45) days, but can extend this response period by an additional thirty (30) days, if necessary, due to circumstances beyond the Plan Administrator&#8217;s control. Any notice of extension must set forth the special circumstances requiring an extension of time and the date by which the Plan Administrator expects to render its decision.</font></div><div style="margin-top:13.5pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.96pt">Notice of Decision. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">If the Plan Administrator denies the claim, in whole or in part, the Plan Administrator shall notify the Claimant in writing of such denial. The Plan Administrator shall write the notification in a manner calculated to be understood by the Claimant. The notification shall set forth&#58;</font></div><div style="margin-top:13.6pt;padding-left:176.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:26.57pt">The specific reasons for the denial&#59;</font></div><div style="padding-left:176.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:23.8pt">A reference to the specific provisions of the Plan on which the denial is based&#59;</font></div><div style="padding-left:176.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%;padding-left:21.03pt">A description of any additional information or material necessary for the Claimant to perfect the claim and an explanation of why it is needed&#59;</font></div><div style="margin-top:0.15pt;padding-left:176.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:21.57pt">An explanation of the Plan's review procedures and the time limits applicable to such procedures&#59; and</font></div><div style="margin-top:0.15pt;text-align:justify"><font><br></font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.15pt;padding-left:176.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%;padding-left:24.34pt">A  statement of the Claimant&#8217;s right to bring a civil action under ERISA Section 502(a) following an adverse benefit determination on review.</font></div><div style="margin-top:13.7pt;padding-left:32.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">13.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:131%">Review Procedure. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">If the Plan Administrator denies the claim, in whole or in part, the Claimant shall have the opportunity for a full and fair review by the Plan Administrator of the denial, as follows&#58;</font></div><div style="margin-top:13pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.37pt">Initiation - Written Request. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">To initiate the review, the Claimant, within sixty (60) days after receiving the Plan Administrator&#8217;s notice of denial, must file with the Plan Administrator a written request for review.</font></div><div style="margin-top:13.7pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:26.79pt">Review of a Disability Benefit Claim. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">If the Claimant&#8217;s initial claim is for Disability benefits, any review of a denied claim shall be made by members of the Plan Administrator other than the original decision maker(s) and such person(s) shall not be a subordinate of the original decision maker(s).</font></div><div style="margin-top:13.35pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.96pt">Additional Submissions - Information Access. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Claimant shall then have the opportunity to submit written comments, documents, records and other information relating to the claim. The Plan Administrator shall also provide the Claimant, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant (as defined in applicable ERISA regulations) to the Claimant&#8217;s claim for benefits.</font></div><div style="margin-top:13.45pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:26.79pt">Considerations on Review. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">In considering the review, the Plan Administrator shall take into account all comments, documents, records and other information submitted by the Claimant relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination. Additional considerations shall be required in the case of a claim for Disability benefits. For example, the claim will be reviewed without deference to the initial adverse benefits determination and, if the initial adverse benefit determination was based in whole or in part on a medical judgment, the Plan Administrator will consult with a health care professional with appropriate training and experience in the field of medicine involving the medical judgment. The health care professional who is consulted on appeal will not be the same individual who was consulted during the initial determination or the subordinate of such individual. If the Plan Administrator obtained the advice of medical or vocational experts in making the initial adverse benefits determination (regardless of whether the advice was relied upon), the Plan Administrator will identify such experts.</font></div><div style="margin-top:13.55pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%;padding-left:27.96pt">Timing of Company Response. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Plan Administrator shall respond in writing to such Claimant within sixty (60) days after receiving the request for review. If the Plan Administrator determines that special circumstances require additional time for processing the claim, the Plan Administrator can extend the response period by an additional sixty (60) days by notifying the Claimant in writing, prior to the end of the initial 60-day period that an additional period is required. The notice of extension must set forth the special circumstances and the date by which the Plan Administrator expects to render its decision.</font></div><div style="margin-top:13.4pt;padding-left:68.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:131%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:131%;padding-left:29.13pt">Notice of Decision. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:131%">The Plan Administrator shall notify the Claimant in writing of its decision on review. The Plan Administrator shall write the notification in a manner calculated to be understood by the Claimant. The notification shall set forth&#58;</font></div><div style="margin-top:13.85pt;padding-left:176.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:26.57pt">The specific reasons for the denial&#59;</font></div><div style="margin-top:0.15pt;padding-left:176.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:23.8pt">A reference to the specific provisions of the Plan on which the denial is based&#59;</font></div><div style="padding-left:176.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%;padding-left:21.03pt">A statement that the Claimant is entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant (as defined in applicable ERISA regulations) to the Claimant's claim for benefits&#59; and</font></div><div style="margin-top:0.75pt;padding-left:176.4pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%;padding-left:21.57pt">A statement of the Claimant's right to bring a civil action under ERISA Section</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_31"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:29.85pt;padding-left:172.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:136%">502(a).</font></div><div style="margin-top:14.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;13.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Calculation of Time Periods. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">For purposes of the time periods specified in this Article, the period</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">of time during which a benefit determination is required to be made begins at the time a claim is filed in accordance with the Plan procedures without regard to whether all the information necessary to make a decision accompanies the claim. If a period of time is extended due to a Claimant's failure to submit all information necessary, the period for making the determination shall be tolled from the date the notification is sent to the Claimant until the date the Claimant responds.</font></div><div style="margin-top:13.8pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;13.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Exhaustion of Remedies. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">A Claimant must follow the claims review procedures under this Plan</font></div><div style="padding-left:32.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">and exhaust his or her administrative remedies before taking any further action with respect to a claim for benefits.</font></div><div style="margin-top:13.8pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;13.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Failure of Plan to Follow Procedures. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">If the Plan fails to establish or follow the claims procedures</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">required by this Article, a Claimant shall be deemed to have exhausted the administrative remedies available under the Plan and shall be entitled to immediately pursue any available remedy under ERISA Section 502(a) on the basis that the Plan has failed to provide a reasonable claims procedure that would yield a decision on the merits of the claim. The Claimant may request a written explanation of the violation from the Plan, and the Plan must provide such explanation within ten (10) days, including a specific description of its bases, if any, for asserting that the violation should not cause the administrative remedies to be deemed exhausted. If a court rejects the Claimant&#8217;s request for immediate review on the basis that the Plan met the standards for the exception, the claim shall be considered as re-filed on appeal upon the Plan&#8217;s receipt of the decision of the court. Within a reasonable time after the receipt of the decision, the Plan shall provide the claimant with notice of the resubmission.</font></div><div style="margin-top:13.8pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;13.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Arbitration. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">If a Claimant continues to dispute the benefit denial based upon completed</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">performance of the Plan or the meaning and effect of the terms and conditions thereof, then the Claimant must submit the dispute to an arbitrator for final arbitration. The arbitrator shall be selected by mutual agreement of the Company and the Claimant. The arbitrator shall operate under any generally recognized set of arbitration rules. The parties hereto agree that they and their heirs, personal representatives, successors and assigns shall be bound by the decision of such arbitrator with respect to any controversy properly submitted to it for determination. Where a dispute arises as to the Company&#8217;s discharge of a Participant for Cause, such dispute shall likewise be submitted to arbitration as above described and the parties hereto agree to be bound by the decision thereunder.</font></div><div style="margin-top:17.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">ARTICLE 14</font></div><div style="margin-top:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">MISCELLANEOUS</font></div><div style="margin-top:13.1pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;14.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Validity. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">In case any provision of this Plan shall be illegal or invalid for any reason, said illegality or</font></div><div style="margin-top:0.25pt;padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">invalidity shall not affect the remaining parts hereof, but this Plan shall be construed and enforced as if such illegal or invalid provision had never been inserted herein.</font></div><div style="margin-top:11.4pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;14.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Nonassignability. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Neither any Participant nor any other person shall have any right to commute,</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">sell, assign, transfer, pledge, anticipate, mortgage, or otherwise encumber, transfer, hypothecate, alienate, or convey in advance of actual receipt, the amounts, if any, payable hereunder, or any part hereof, which are, and all rights to which are expressly declared to be, unassignable and non-transferable. No part of the amounts payable shall, prior to actual payment, be subject to seizure, attachment, garnishment or sequestration for the payment of any debts, judgments, alimony, or separate maintenance owed by a Participant or any other person, be transferable by operation of law in the event of a Participant&#8217;s or any other person&#8217;s bankruptcy or insolvency, or be transferable to a spouse as a result of a property settlement or otherwise. If any Participant, Beneficiary, or successor in interest is adjudicated bankrupt or purports to commute, sell, assign, transfer, pledge, anticipate, mortgage or otherwise encumber transfer, hypothecate, alienate, or convey in advance of actual receipt, the amount, if any, payable hereunder, or any part thereof, the Plan Administrator, in its discretion, may cancel such distribution or payment (or any part thereof) to or</font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div><div><font><br></font></div></div></div><div id="i2bb4736ab63549d682f63230c6bde04d_34"></div><hr style="page-break-after:always"><div style="min-height:10.08pt;width:100%"><div><font><br></font></div></div><div style="margin-top:29.75pt;padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:137%">for the benefit of such Participant, Beneficiary, or successor in interest in such manner as the Plan Administrator shall direct.</font></div><div style="margin-top:11.4pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;14.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Not a Contract of Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The terms and conditions of this Plan shall not be deemed to</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">constitute a contract of employment between the Company and the Employee. Nothing in this Plan shall be deemed to give the Employee the right to be retained in the service of the Company as an Employee or otherwise or to interfere with the right of the Company to discipline or discharge the Employee at any time.</font></div><div style="margin-top:10.95pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;14.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Governing Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The Plan shall be administered, construed and governed in all respects under and</font></div><div style="margin-top:0.05pt;padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">by the laws of State of Delaware, without reference to the principles of conflicts of law (except and to the extent preempted by applicable federal law).</font></div><div style="margin-top:12.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;14.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Notice. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">Any notice, consent or demand required or permitted to be given under the provisions of</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:134%">this Plan shall be in writing and shall be signed by the party giving or making the same. If such notice, consent or demand is mailed, it shall be sent by United States certified mail, postage prepaid, addressed to the addressee&#8217;s last known address as shown on the records of the Company. The date of such mailing shall be deemed the date of notice consent or demand. Any person may change the address to which notice is to be sent by giving notice of the change of address in the manner aforesaid.</font></div><div style="margin-top:11.15pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;14.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Coordination with Other Benefits. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">The benefits provided for a Participant or a Participant&#8217;s</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">Beneficiary under this Plan are in addition to any other benefits available to such Participant under any other plan or program for employees of the Company. This Plan shall supplement and shall not supersede, modify, or amend any other such plan or program except as may otherwise be expressly provided herein.</font></div><div style="margin-top:11.2pt;padding-left:68.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">&#160;&#160;&#160;&#160;14.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:132%">Unclaimed Benefits. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">In the case of a benefit payable on behalf of such Participant, if the Plan</font></div><div style="padding-left:32.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:135%">Administrator is unable to locate the Participant or Beneficiary to whom such benefit is payable after reasonable efforts have been undertaken by the Plan Administrator to locate such party(ies), such Plan benefit may be forfeited to the Company upon the Plan Administrator&#8217;s determination. Notwithstanding the foregoing, if, subsequent to any such forfeiture, the Participant or Beneficiary to whom such Plan benefit is payable makes a valid claim for such Plan benefit, such forfeited Plan benefit shall be paid by the Plan Administrator to the Participant or Beneficiary, without interest, from the date it would have otherwise been paid.</font></div><div style="margin-top:12.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#91;END OF DOCUMENT&#93;</font></div><div style="margin-top:0.55pt;padding-left:320.4pt"><font><br></font></div><div style="margin-top:10.9pt"><font><br></font></div><div style="height:60.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.54
<SEQUENCE>11
<FILENAME>exhibit1054-astranaxemploy.htm
<DESCRIPTION>EX-10.54
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic3b678acea54483a925153554d457ff4_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.54</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EMPLOYMENT INDUCEMENT AWARD PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">(Amended and Restated Effective February 26, 2024)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.13pt"><br>PURPOSE </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Plan was established effective as of November 15, 2023, the date of approval of the Plan by the Board. The Plan&#8217;s purpose is to enhance the Company&#8217;s ability to attract and motivate individuals who are expected to make important contributions to the Company and its Subsidiaries by providing such individuals with equity-based incentive awards as inducements to enter into employment with the Company or a Subsidiary. The Plan is intended to be exempt from stockholder approval pursuant to Nasdaq Stock Market Rule 5635(c)(4) as a plan providing exclusively for &#8220;employment inducement&#8221; awards (within the meaning of Nasdaq Stock Market Rule 5635(c)(4)).  Capitalized terms used in the Plan are defined in Article&#160;XI.  The Plan is amended and restated as set forth herein, effective February 26, 2024.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:7.85pt"><br>ELIGIBILITY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Eligible Individuals are eligible to be granted Awards under the Plan, subject to the limitations described herein.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:3.57pt"><br>ADMINISTRATION AND DELEGATION </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Plan is administered by the Committee. The Board may reserve to itself any of the authority of the Committee or may act as the Administrator of the Plan for any or all purposes&#59; provided, however, that any action taken by the Board in connection with the administration of the Plan shall not be deemed approved by the Board unless such actions are approved by a majority of the Independent Directors.  Awards under the Plan will be approved by (a) the Committee, which shall be comprised entirely of Independent Directors, or (b) a majority of the Company&#8217;s Independent Directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Powers of the Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator has authority to determine which Eligible Individuals receive Awards, grant Awards and establish the terms and conditions of Awards, subject to the conditions and limitations in the Plan.  The Administrator also has the authority to take all actions and make all determinations under the Plan, to interpret the Plan and Award Agreements and to adopt, amend and repeal Plan administrative rules, guidelines and practices as it deems advisable, including, but not limited to, the adoption of procedures from time to time intended to ensure that an individual is an Eligible Individual prior to the granting of any Awards to such individual under the Plan (including, without limitation, a requirement, if any, that such individual certify to the Company prior to the receipt of an Award under the Plan that he or she has not previously been employed by the Company or any Subsidiary, or if previously employed, has had a bona fide period of non-employment, and that the grant of Awards under the Plan is an inducement material to his or her agreement to enter into employment with the Company or any Subsidiary).  The Administrator may correct defects and ambiguities, supply omissions and reconcile inconsistencies in the Plan or any Award Agreement as it deems necessary or appropriate to administer the Plan and any Awards.  The Administrator&#8217;s determinations under the Plan are in its sole discretion and will be final and binding on all persons having or claiming any interest in the Plan or any Award. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.19pt"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">STOCK AVAILABLE FOR AWARDS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Number of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to adjustment under Article&#160;VIII and the terms of this Article&#160;IV, the maximum number of Shares that may be delivered pursuant to Awards under the Plan shall be 500,000 Shares.  Shares issued under the Plan may consist of authorized but unissued Shares, Shares purchased on the open market or treasury Shares.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Share Recycling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If all or any part of an Award expires, lapses or is forfeited, canceled, surrendered, reacquired, settled in cash or terminated without the issuance of Shares, the unused Shares covered by the Award will, as applicable, become or again be available for Awards under the Plan. In addition, Shares delivered (either by actual delivery or attestation) to the Company by a Participant to satisfy the applicable exercise or purchase price of an Award and&#47;or to satisfy any applicable tax withholding obligation with respect to an Award (including Shares retained by the Company from the Award) will, as applicable, become or again be available for Awards under the Plan.  The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards shall not count against the Share limit set forth in Section 4.1.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.47pt"><br>STOCK OPTIONS AND STOCK APPRECIATION RIGHTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator may grant Options or Stock Appreciation Rights to Eligible Individuals subject to the limitations in the Plan.  The Administrator will determine the number of Shares covered by each Option and Stock Appreciation Right and the conditions and limitations applicable to the exercise of each Option and Stock Appreciation Right.  A Stock Appreciation Right will entitle the Participant (or other person entitled to exercise the Stock Appreciation Right) to receive from the Company upon exercise of the exercisable portion of the Stock Appreciation Right an amount determined by multiplying the excess, if any, of the Fair Market Value of one Share on the date of exercise over the exercise price per Share of the Stock Appreciation Right by the number of Shares with respect to which the Stock Appreciation Right is exercised, subject to any limitations of the Plan or that the Administrator may impose, and payable in cash, Shares or a combination of the two as the Administrator may determine or provide in the Award Agreement.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator will establish the exercise price of each Option and Stock Appreciation Right, which exercise price will not be less than 100% of the Fair Market Value on the Grant Date of the Option or Stock Appreciation Right.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Duration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Option or Stock Appreciation Right will be exercisable at such times and as specified in the Award Agreement, provided that the term of an Option or Stock Appreciation Right will not exceed ten years.  Notwithstanding the foregoing and unless determined otherwise by the Company, in the event that on the last business day of the term of an Option or Stock Appreciation Right (a) the exercise of the Option or Stock Appreciation Right is prohibited by Applicable Law, as determined by the Company, or (b) Shares may not be purchased or sold by the applicable Participant due to any Company insider trading policy (including blackout periods) or a &#8220;lock-up&#8221; agreement undertaken in connection with an issuance of securities by the Company, the term of the Option or Stock Appreciation Right shall be automatically extended until the date that is 30 days after the end of the legal prohibition, black-out period or lock-up agreement, as determined by the Company&#59; provided, however, in no event shall the extension last beyond the ten year term (or any shorter maximum, if applicable) of the applicable Option or Stock Appreciation Right. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Options and Stock Appreciation Rights may be exercised by delivering to the Company (or its Agent) a written notice of exercise, in a form the Administrator approves (which may be electronic and provided through an online platform maintained by an Agent), signed by the person authorized to exercise the Option or Stock Appreciation Right, together with, as applicable, payment in full of the exercise price for the number of Shares for which an Option is exercised.  Unless the Administrator otherwise determines, an Option or Stock Appreciation Right may not be exercised for a fraction of a Share. The exercise price of an Option may be paid, in the discretion of the Administrator and as set forth in the applicable Award Agreement&#58; (a) in cash or its equivalent&#59; (b) by tendering (either by actual delivery or attestation) previously acquired Shares having an aggregate Fair Market Value at the time of exercise equal to the aggregate exercise price&#59; (c) by a cashless exercise (including by withholding Shares deliverable upon exercise or through a broker-assisted arrangement to the extent permitted by Applicable Laws)&#59; (d) by a combination of the methods described in the foregoing clauses (a), (b) and&#47;or (c)&#59; or (e) through any other method approved by the Administrator in its discretion. As soon as practicable after receipt of the notification of exercise and full payment of the exercise price, the Company shall cause the appropriate number of Shares to be issued to the Participant. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:4.19pt"><br>RESTRICTED STOCK&#59; RESTRICTED STOCK UNITS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator may grant Restricted Stock, or the right to purchase Restricted Stock, to any Eligible Individual, subject to the Company&#8217;s right to repurchase all or part of such Shares at their issue price or other stated or formula price from the Participant (or to require forfeiture of such Shares) if conditions the Administrator specifies in the Award Agreement are not satisfied before the end of the applicable restriction period or periods that the Administrator establishes for such Award.  In addition, the Administrator may grant Restricted Stock Units to any Eligible Individual, which may be subject to vesting and forfeiture conditions during the applicable restriction period or periods, as set forth in an Award Agreement.  The Administrator will determine and set forth in the Award Agreement the terms and conditions for each Restricted Stock and Restricted Stock Unit Award, subject to the conditions and limitations contained in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Dividends</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Participants holding Shares of Restricted Stock will be entitled to all ordinary cash dividends paid with respect to such Shares, provided, however, that the Administrator may provide in the Award Agreement that payment of any such ordinary cash dividends may deferred and contingent upon the vesting of the Restricted Stock.  In addition, unless the Administrator provides otherwise, if any dividends or distributions are paid in Shares or other property, other than an ordinary cash dividend, the Shares or other property will be subject to the same restrictions on transferability and forfeitability as the Shares of Restricted Stock with respect to which they were paid.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Stock Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Company may require that the Participant deposit in escrow with the Company (or its designee) any stock certificates issued in respect of Shares of Restricted Stock, together with a stock power endorsed in blank.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Restricted Stock Units.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator may provide that settlement of Restricted Stock Units will occur upon or as soon as reasonably practicable after the Restricted Stock Units vest or will instead be deferred, on a mandatory basis or at the Participant&#8217;s election, in a manner intended to comply with Section&#160;409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A Participant will have no rights of a stockholder with respect to Shares subject to any Restricted Stock Unit unless and until the Shares are delivered in settlement of the Restricted Stock Unit.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:35.91pt"><br>OTHER STOCK-BASED AWARDS&#59; DIVIDEND EQUIVALENTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Stock-Based Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Other Stock-Based Awards may be granted to Participants, which may include fully vested Shares or Awards that are valued in whole or in part by reference to, or otherwise based on the Fair Market Value of, Shares, in each case subject to any conditions and limitations in the Plan. Other Stock-Based Awards may be paid in Shares, cash or other property, or any combination of the foregoing, as the Administrator determines.  Subject to the provisions of the Plan, the Administrator will determine the terms and conditions of each Other Stock-Based Award, including any purchase price, performance goal(s) (which may be based on the Performance Criteria), transfer restrictions, and vesting conditions, which will be set forth in the applicable Award Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  A grant of Restricted Stock Units or Other Stock-Based Award may provide a Participant with the right to receive Dividend Equivalents, and no dividends or Dividend Equivalents shall be payable with respect to Options or Stock Appreciation Rights.  Dividend Equivalents may be paid currently or credited to an account for the Participant, settled in cash or Shares and subject to the same restrictions on transferability and forfeitability as the Award with respect to which the Dividend Equivalents are paid and subject to other terms and conditions as set forth in the Award Agreement.  Except as otherwise determined by the Administrator and set forth in the applicable Award Agreement, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dividend Equivalents with respect to an Award shall only be paid out to the Participant to the extent that the vesting conditions applicable to the underlying Award are satisfied.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:31.63pt"><br>ADJUSTMENTS&#59; CHANGE OF CONTROL</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Equity Restructurings and Other Corporate Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event of any equity restructuring (within the meaning of Financial Accounting Standards Board Accounting Standards Codification Topic 718, or any successor thereto), such as a stock dividend, stock split, reverse stock split, spinoff, rights offering, or recapitalization through a large, nonrecurring cash dividend, the Committee shall cause there to be an equitable adjustment in the number and kind of Shares specified in Section&#160;4.1 of the Plan and, with respect to outstanding Awards, in the number and kind of Shares subject to outstanding Awards and the exercise price or other price of Shares subject to outstanding Awards, in each case to prevent dilution or enlargement of the rights of Participants. In the event of any other change in corporate capitalization, or in the event of a merger, consolidation, liquidation, or similar transaction, the Committee may, in its sole discretion, cause there to be an equitable adjustment as described in the foregoing sentence, to prevent dilution or enlargement of rights&#59; provided, however, that, unless otherwise determined by the Committee, the number of Shares subject to any Award shall always be rounded down to a whole number. Moreover, in the event of any such transaction or event, the Committee, in its discretion, may provide in substitution for any or all outstanding Awards such alternative consideration (including cash) as it, in good faith, may determine to be equitable in the circumstances, and may require in connection therewith the surrender of all Awards so replaced. Notwithstanding the foregoing, the Committee shall not make any adjustment pursuant to this Section 8.1 that would (a) cause an Award that is otherwise exempt from Section 409A to become subject to Section 409A, or (b)&#160;cause an Award that is subject to Section 409A to fail to satisfy the requirements of Section 409A. The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and binding on all Participants and any other persons claiming under or through any Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator may specify, either in an Award Agreement or at the time of a Change of Control, whether an outstanding Award shall become vested and&#47;or payable, in whole or in part, as a result of a Change of Control.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Options and Stock Appreciation Rights Not Assumed</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If, in connection with a Change of Control, any Options and Stock Appreciation Rights issued under the Plan are not assumed, or if substitute Options and Stock Appreciation Rights are not issued by the successor or affiliate thereof in the Change of Control transaction, or if the assumed or substituted awards fail to contain similar terms and conditions as the Award prior to the Change of Control or fail to preserve, to the extent applicable, the benefit to be provided to the Participant as of the date of the Change of Control, including but not limited to the right of the Participant to receive shares upon exercise of the Option or Stock Appreciation Right that are registered for sale to the public pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission, then (i) each holder of an Option or Stock Appreciation Right that is outstanding as of the date of the Change of Control who is an employee of the Company or any Subsidiary shall have the right, and (ii) the Administrator, in its sole discretion, may grant to a holder of an Option or Stock Appreciation Right that is outstanding as of the date of the Change of Control who is not an employee of the Company or any Subsidiary the right, exercisable by written notice to the Company (or its successor in the Change of Control transaction) within 30 days after the Change of Control (but not beyond the Option&#8217;s or Stock Appreciation Right&#8217;s expiration date), to receive, in exchange for the surrender of the Option or Stock Appreciation Right, an amount of cash equal to the excess of the greater of the Fair Market Value of the Shares determined on the Change of Control date or the Fair Market Value of the Shares on the date of surrender of the Option or Stock Appreciation Right (to the extent vested and not yet exercised) that is so surrendered over the exercise price of the Award. If the Committee so determines prior to the Change of Control, any such Option or Stock Appreciation Right that is not exercised or surrendered prior to the end of such 30-day period will be cancelled. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If, in connection with the Change of Control, the Shares issued to a Participant as a result of the accelerated vesting or payment of  Restricted Stock Restricted Stock Units, Other Stock-Based Awards or Dividend Equivalents under this subsection (c) are not registered for sale to the public pursuant to an effective registration statement filed with the U.S. Securities and Exchange Commission, then each holder of such Shares shall have the right, exercisable by written notice to the Company (or its successor in the Change of Control transaction) within 30 days after the Change of Control, to receive, in exchange for the surrender of such Shares an amount of cash equal to the greater of the Fair Market Value of a Share on the Change of Control date or the Fair Market Value of such Share on the date of surrender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cancellation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator may, in its discretion and without the consent of Participants, either by the terms of the Award Agreement applicable to any Award or by resolution adopted prior to the occurrence of the Change of Control, provide that any outstanding Award (or a portion thereof) shall, upon the occurrence of such Change of Control, be cancelled in exchange for a payment in cash or other property (including shares of the resulting entity in connection with a Change of Control) in an amount equal to the excess, if any, of the Fair Market Value of the Shares subject to the Award, over any exercise price related to the Award, which amount may be zero if the Fair Market Value of a Share on the date of the Change of Control does not exceed the exercise price per Share of the applicable Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as expressly provided in the Plan or the Administrator&#8217;s action under the Plan, no Participant will have any rights due to any subdivision or consolidation of Shares of any class, dividend payment, increase or decrease in the number of Shares of any class or dissolution, liquidation, merger, or consolidation of the Company or other corporation.  Except as expressly provided with respect to an equity restructuring under Section 8.1 or the Administrator&#8217;s action under the Plan, no issuance by the Company of Shares of any class, or securities convertible into Shares of any class, will affect, and no adjustment will be made regarding, the number of Shares subject to an Award or the Award&#8217;s grant or exercise price.  The existence of the Plan, any Award Agreements and the Awards granted hereunder will not affect or restrict in any way the Company&#8217;s right or power to make or authorize (i) any adjustment, recapitalization, reorganization or other change in the Company&#8217;s capital structure or its business, (ii) any merger, consolidation dissolution or liquidation of the Company or sale of Company assets or (iii) any sale or issuance of securities, including securities with rights superior to those of the Shares or securities convertible into or exchangeable for Shares.  The Administrator may treat Participants and Awards (or portions thereof) differently under this Article&#160;VIII.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE IX.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:4.19pt"><br>GENERAL PROVISIONS APPLICABLE TO AWARDS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as the Administrator may determine or provide in an Award Agreement or otherwise, Awards may not be sold, assigned, transferred, pledged or otherwise encumbered, either voluntarily or by operation of law, except for certain beneficiary designations, by will or the laws of descent and distribution, or, subject to the Administrator&#8217;s consent, pursuant to a domestic relations order, and, during the life of the Participant, will be exercisable only by the Participant.  Any permitted transfer of an Award hereunder shall be without consideration, except as required by Applicable Law.  References to a Participant, to the extent relevant in the context, will include references to a Participant&#8217;s authorized transferee that the Administrator specifically approves.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Documentation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Award will be evidenced in an Award Agreement, which may be written or electronic, as the Administrator determines.  The Award Agreement will contain the terms and conditions applicable to an Award.  Each Award may contain terms and conditions in addition to those set forth in the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Discretion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as the Plan otherwise provides, each Award may be made alone or in addition or in relation to any other Award.  The terms of each Award to a Participant need not be identical, and the Administrator need not treat Participants or Awards (or portions thereof) uniformly. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Termination of Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator will determine how a Participant&#8217;s Disability, death, Retirement or authorized leave of absence or any other change or purported change in a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Participant&#8217;s employment or other service affects an Award (including whether and when a termination of employment or other service has occurred) and the extent to which, and the period during which the Participant, the Participant&#8217;s legal representative, conservator, guardian or Designated Beneficiary may exercise rights under the Award, if applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent required by Applicable Laws, a Participant shall be required to satisfy, in a manner satisfactory to the Company or Subsidiary, as applicable, any withholding tax obligations that arise by reason of the exercise of a Stock Option or Stock Appreciation Right, the vesting of or settlement of Shares under an Award, the payment of cash in settlement of an Award, an election pursuant to Section&#160;83(b) of the Code or otherwise with respect to an Award. The Company and its Subsidiaries shall not be required to issue or deliver Shares, make any payment, or recognize the transfer or disposition of any Shares, until such withholding tax obligations are satisfied. The Committee may permit or require these obligations to be satisfied by having the Company withhold a portion of the Shares that otherwise would be issued or delivered to a Participant upon exercise of a Stock Option or Stock Appreciation Right or upon the vesting or settlement of an Award, or by tendering Shares previously acquired, in each case having a value (as determined by the Company) equal to the amount required to be withheld. Any such elections are subject to such conditions or procedures as may be established by the Committee and may be subject to disapproval by the Committee. In no event will the value of the Shares to be withheld or tendered pursuant to this Section 9.5 to satisfy applicable withholding taxes exceed the amount of taxes required to be withheld based on the maximum statutory tax rates in the applicable taxing jurisdictions.. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline"> Amendment of Award&#59; Repricing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator may amend, modify or terminate any outstanding Award, including by substituting another Award of the same or a different type and changing the exercise or settlement date.  The Participant&#8217;s consent to such action will be required unless (a) the action, taking into account any related action, does not materially and adversely affect the Participant&#8217;s rights under the Award, or (b) the change is permitted under Article&#160;VIII or pursuant to Section&#160;10.6.  Notwithstanding the foregoing or anything in the Plan to the contrary, the Administrator may, without the approval of the stockholders of the Company, (x) reduce the exercise price per share of outstanding Options or Stock Appreciation Rights or (y) cancel outstanding Options or Stock Appreciation Rights in exchange for cash, other Awards or Options or Stock Appreciation Rights with an exercise price per share that is less than the exercise price per share of the original Options or Stock Appreciation Rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Conditions on Delivery of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Company will not be obligated to deliver any Shares under the Plan or remove restrictions from Shares previously delivered under the Plan until (a)&#160;all Award conditions have been met or removed to the Company&#8217;s satisfaction, (b)&#160;as determined by the Company, all other legal matters regarding the issuance and delivery of such Shares have been satisfied, including any applicable securities laws and stock exchange or stock market rules and regulations, and (c)&#160;the Participant has executed and delivered to the Company such representations or agreements as the Administrator deems necessary or appropriate to satisfy any Applicable Laws.  The Company&#8217;s inability to obtain authority from any regulatory body having jurisdiction, which the Administrator determines is necessary to the lawful issuance and sale of any securities, will relieve the Company of any liability for failing to issue or sell such Shares as to which such requisite authority has not been obtained.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Acceleration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator may at any time provide that any Award will become immediately vested and fully or partially exercisable, free of some or all restrictions or conditions, or otherwise fully or partially realizable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt;text-decoration:underline">Cash Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Without limiting the generality of any other provision of the Plan, the Administrator may provide, in an Award Agreement or subsequent to the grant of an Award, in its discretion, that any Award may be settled in cash, Shares or a combination thereof.</font></div><div id="ic3b678acea54483a925153554d457ff4_32"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE X.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.47pt"><br>MISCELLANEOUS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Right to Employment or Other Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No person will have any claim or right to be granted an Award, and the grant of an Award will not be construed as giving a Participant the right to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">continued employment or any other relationship with the Company or any of its Subsidiaries.  The Company and its Subsidiaries expressly reserve the right at any time to dismiss or otherwise terminate their respective relationships with a Participant free from any liability or claim under the Plan or any Award, except as expressly provided in an Award Agreement or in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">No Rights as Stockholder&#59; Certificates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to the Award Agreement, no Participant or Designated Beneficiary will have any rights as a stockholder with respect to any Shares to be distributed under an Award until becoming the record holder of such Shares.  Notwithstanding any other provision of the Plan, unless the Administrator otherwise determines or Applicable Laws require, the Company will not be required to deliver to any Participant certificates evidencing Shares issued in connection with any Award and instead such Shares may be recorded in the books of the Company (or, as applicable, its transfer agent or stock plan administrator).  The Company may place legends on stock certificates issued under the Plan that the Administrator deems necessary or appropriate to comply with Applicable Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date and Term of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Plan is effective on the date on which it is adopted by the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and will remain in effect until terminated by the Administrator.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator may amend, suspend or terminate the Plan at any time&#59; provided that no amendment, other than (a) as permitted by the applicable Award Agreement, (b) as provided under Sections 10.6 and 10.15, or (c) an amendment to increase the Share limit set forth in Section 4.1, may materially and adversely affect any Award outstanding at the time of such amendment without the affected Participant&#8217;s consent.  No Awards may be granted under the Plan during any suspension period or after the Plan&#8217;s termination.  Awards outstanding at the time of any Plan suspension or termination will continue to be governed by the Plan and the Award Agreement, as in effect before such suspension or termination.  The Administrator will obtain stockholder approval of any Plan amendment to the extent necessary to comply with Applicable Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Provisions for Foreign Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Administrator may modify Awards granted to Participants who are foreign nationals or employed outside the United States or establish subplans or procedures under the Plan to address differences in laws, rules, regulations or customs of such foreign jurisdictions with respect to tax, securities, currency, employee benefit or other matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent that the Administrator determines that any Award granted under the Plan is subject to Section 409A, the Award Agreement evidencing such Award shall incorporate the terms and conditions required by Section 409A.  To the extent applicable, the Plan and the Award Agreements shall be interpreted in accordance with Section 409A, such that no adverse tax consequences, interest, or penalties under Section&#160;409A apply.  Notwithstanding anything in the Plan or any Award Agreement to the contrary, the Administrator may, without a Participant&#8217;s consent, amend this Plan or Awards, adopt policies and procedures, or take any other actions (including amendments, policies, procedures and retroactive actions) as are necessary or appropriate to preserve the intended tax treatment of Awards, including any such actions intended to (A)&#160;exempt this Plan or any Award from Section&#160;409A, or (B)&#160;comply with Section&#160;409A, including regulations, guidance, compliance programs and other interpretative authority that may be issued after an Award&#8217;s Grant Date.  The Company makes no representations or warranties as to an Award&#8217;s tax treatment under Section&#160;409A or otherwise.  The Company will have no obligation under this Section&#160;10.6 or otherwise to avoid the taxes, penalties or interest under Section&#160;409A with respect to any Award and will have no liability to any Participant or any other person if any Award, compensation or other benefits under the Plan are determined to constitute noncompliant &#8220;nonqualified deferred compensation&#8221; subject to taxes, penalties or interest under Section&#160;409A.  Notwithstanding any contrary provision of the Plan or any Award Agreement, any payment of &#8220;nonqualified deferred compensation&#8221; under the Plan that may be made in installments shall be treated as a right to receive a series of separate and distinct payments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If an Award is subject to and constitutes &#8220;nonqualified deferred compensation&#8221; under Section&#160;409A, any payment or settlement of such Award upon a termination of a Participant&#8217;s employment or other service relationship will, to the extent necessary to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">avoid taxes under Section&#160;409A, be made only upon the Participant&#8217;s &#8220;separation from service&#8221; (within the meaning of Section&#160;409A).  For purposes of this Plan or any Award Agreement relating to any such payments or benefits, references to a &#8220;termination,&#8221; &#8220;termination of employment&#8221; or like terms means a &#8220;separation from service.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Payments to Specified Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding any contrary provision in the Plan or any Award Agreement, any payment(s) of &#8220;nonqualified deferred compensation&#8221; required to be made under an Award subject to Section 409A to a &#8220;specified employee&#8221; (as defined under Section&#160;409A and as the Administrator determines) due to his or her &#8220;separation from service&#8221; will, to the extent necessary to avoid taxes under Section&#160;409A(a)(2)(B)(i) of the Code, be delayed for the six-month period immediately following such &#8220;separation from service&#8221; (or, if earlier, until the specified employee&#8217;s death) and will instead be paid (as set forth in the Award Agreement) on the day immediately following such six-month period or as soon as administratively practicable thereafter (without interest).  Any payments of &#8220;nonqualified deferred compensation&#8221; under such Award payable more than six months following the Participant&#8217;s &#8220;separation from service&#8221; will be paid at the time or times the payments are otherwise scheduled to be made.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Limitations on Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding any other provisions of the Plan, no individual acting as a director, officer, other employee or agent of the Company or any Subsidiary will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability, or expense incurred in connection with the Plan or any Award, and such individual will not be personally liable with respect to the Plan because of any contract or other instrument executed in his or her capacity as an Administrator, director, officer, other employee or agent of the Company or any Subsidiary.  The Company will indemnify and hold harmless each director, officer, other employee and agent of the Company or any Subsidiary that has been or will be granted or delegated any duty or power relating to the Plan&#8217;s administration or interpretation, against any cost or expense (including attorneys&#8217; fees) or liability (including any sum paid in settlement of a claim with the Administrator&#8217;s approval) arising from any act or omission concerning this Plan unless arising from such person&#8217;s own fraud or bad faith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Actions Required Upon Grant of Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Following the issuance of any Award under the Plan, the Company shall, in accordance with the listing requirements of the applicable securities exchange, (a) promptly issue a press release disclosing the material terms of the grant, including the recipient(s) of the grant and the number of shares involved (and if the disclosure relates to an award to executive officers, or if the award was individually negotiated, then the disclosure must include the identity of the recipient), and (b) notify the applicable securities exchange of such grant no later than the earlier to occur of (i) five calendar days after entering into the agreement to issue the Award or (ii) the date of the public announcement of the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  As a condition for receiving any Award, each Participant explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of personal data as described in this section by and among the Company and its Subsidiaries and affiliates exclusively for implementing, administering and managing the Participant&#8217;s participation in the Plan.  The Company and its Subsidiaries and affiliates may hold certain personal information about a Participant, including the Participant&#8217;s name, address and telephone number&#59; birthdate&#59; social security number, insurance number or other identification number&#59; salary&#59; nationality&#59; job title(s)&#59; any Shares held in the Company or its Subsidiaries and affiliates&#59; and Award details, to implement, manage and administer the Plan and Awards (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Data</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The Company and its Subsidiaries and affiliates may transfer the Data amongst themselves as necessary to implement, administer and manage a Participant&#8217;s participation in the Plan, and the Company and its Subsidiaries and affiliates may transfer the Data to third parties assisting the Company with Plan implementation, administration and management.  These recipients may be located in the Participant&#8217;s country, or elsewhere, and the Participant&#8217;s country may have different data privacy laws and protections than the recipients&#8217; country.  By accepting an Award, each Participant authorizes such recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, to implement, administer and manage the Participant&#8217;s participation in the Plan, including any required Data transfer to a broker or other third party with whom the Company or the Participant may elect to deposit any Shares.  The Data related to a Participant will be held only as long as necessary to implement, administer, and manage the Participant&#8217;s participation in the Plan.  A Participant may, at any time, view the Data that the Company and its Subsidiaries hold regarding such Participant, request additional information about the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">storage and processing of the Data regarding such Participant, recommend any necessary corrections to the Data regarding the Participant or refuse or withdraw the consents in this Section 10.9 in writing, without cost, by contacting the local human resources representative.  If the Participant refuses or withdraws the consents in this Section 10.9, the Company may cancel Participant&#8217;s ability to participate in the Plan and, in the Administrator&#8217;s discretion, the Participant may forfeit any outstanding Awards.  For more information on the consequences of refusing or withdrawing consent, Participants may contact their local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any portion of the Plan or any action taken under it is held illegal or invalid for any reason, the illegality or invalidity will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provisions had been excluded, and the illegal or invalid action will be null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any contradiction occurs between the Plan and any Award Agreement or other written agreement between a Participant and the Company (or any Subsidiary) that the Administrator has approved, the Plan will govern, unless it is expressly specified in such Award Agreement or other written document that the specific provision of the Plan will not apply.  For clarity, the foregoing sentence shall not limit the applicability of any additive language contained in an Award Agreement or other written agreement which provides supplemental or additional terms not inconsistent with the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Plan and all Awards will be governed by and interpreted in accordance with the laws of the State of Delaware, disregarding any state&#8217;s choice-of-law principles requiring the application of a jurisdiction&#8217;s laws other than the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Clawback Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All Awards (including, without limitation, any proceeds, gains or other economic benefit actually or constructively received by a Participant upon any receipt or exercise of any Award or upon the receipt or resale of any Shares underlying the Award) shall be subject to the provisions of any compensation recovery or clawback policy implemented by the Company, including, without limitation, any clawback policy adopted to comply with Applicable Laws (including the Dodd-Frank Wall Street Reform and Consumer Protection Act and the rules or regulations promulgated thereunder) as and to the extent set forth in such clawback policy or the Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Titles and Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The titles and headings in the Plan are for convenience of reference only and, if any conflict, the Plan&#8217;s text, rather than such titles or headings, will control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conformity to Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Participant acknowledges that the Plan is intended to conform to the extent necessary with Applicable Laws.  Notwithstanding anything herein to the contrary, the Plan and all Awards will be administered only in conformance with Applicable Laws.  To the extent Applicable Laws permit, the Plan and all Award Agreements will be deemed amended as necessary to conform to Applicable Laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unfunded Status of Awards.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  The Plan is intended to be an &#8220;unfunded&#8221; plan for incentive compensation.  With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award Agreement shall give the Participant any rights that are greater than those of a general creditor of the Company or any Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Relationship to Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No payment under the Plan will be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare or other benefit plan of the Company or any Subsidiary except as expressly provided in writing in such other plan or an agreement thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Stockholder Approval Not Required</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  It is expressly intended that approval of the Company&#8217;s stockholders not be required as a condition of the effectiveness of the Plan, and the Plan&#8217;s provisions shall be interpreted in a manner consistent with such intent for all purposes.  Specifically, Nasdaq Stock Market Rule 5635(c) generally requires stockholder approval for stock option plans or other equity compensation arrangements adopted by companies whose securities are listed on the Nasdaq Stock Market pursuant to which stock awards or stock may be acquired by officers, directors, employees </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or consultants of such companies.  Nasdaq Stock Market Rule 5635(c)(4) provides an exemption in certain circumstances for &#8220;employment inducement&#8221; awards (within the meaning of Nasdaq Stock Market Rule 5635(c)(4)).  Notwithstanding anything to the contrary herein, Awards under the Plan may only be made to employees who have not previously been an employee or director of the Company or a parent or Subsidiary, or following a bona fide period of non-employment by the Company or a parent or Subsidiary, in each case as an inducement material to the employee&#8217;s entering into employment with the Company or a Subsidiary.  Awards under the Plan will be approved by (y) the Committee, which shall be comprised solely of Independent Directors, or (z) a majority of the Company&#8217;s Independent Directors.  Accordingly, pursuant to Nasdaq Stock Market Rule 5635(c)(4), the issuance of Awards and the Shares issuable upon exercise or vesting of such Awards pursuant to the Plan are not subject to the approval of the Company&#8217;s stockholders.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ARTICLE XI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:4.19pt"><br>DEFINITIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As used in the Plan, the following words and phrases will have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Committee, except to the extent that the Board has assumed the authority for administration of the Plan in accordance with Section 3.1 of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the brokerage firm, bank or other financial institution, entity or person(s), if any, engaged, retained, appointed or authorized to act as the agent of the Company or a Participant with regard to the Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Applicable Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the requirements relating to the administration of equity incentive plans under U.S. federal and state securities, tax and other applicable laws, rules and regulations, the applicable rules of any stock exchange or quotation system on which Shares are listed or quoted and the applicable laws and rules of any foreign country or other jurisdiction where Awards are granted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Dividend Equivalents, or Other Stock-Based Awards.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a written notice or agreement evidencing an Award, which may be electronic, that contains such terms and conditions as the Administrator determines, consistent with and subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the occurrence of any one of the following events&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if more than fifty percent (50%) of the combined voting power of the continuing or surviving entity&#8217;s securities outstanding immediately after such merger, consolidation or other reorganization is owned by Persons who were not stockholders of the Company immediately prior to such merger, consolidation or other reorganization&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The sale, transfer or other disposition of all or substantially all of the Company&#8217;s assets&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">A change in the composition of the Board, as a result of which fewer than fifty percent (50%) of the incumbent Directors are Directors who either (i) had been Directors of the Company on the date twenty-four (24) months prior to the date of the event that may constitute a Change of Control (the &#8220;original directors&#8221;) or (B) were elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the aggregate of the original directors who were still in office at the time of the election or nomination and the Directors whose election or nomination was previously so approved&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Any transaction as a result of which any Person is the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing at least fifty percent (50%) of the total voting power represented by the Company&#8217;s then outstanding voting securities. For purposes of this paragraph (iv), the term &#8220;Person&#8221; shall exclude (A) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or a Subsidiary and (B) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">A transaction shall not constitute a Change of Control if its sole purpose is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything herein contained to the contrary, with respect to an Award that is or may be considered deferred compensation subject to Section 409A, the definition of &#8220;Change of Control&#8221; herein shall be amended and interpreted in a manner that allows the definition to satisfy the requirements of a change in control event under Section 409A solely for purposes of complying with the requirements of Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Compensation Committee of the Board comprised of two or more Directors, each of whom is intended to qualify as a Non-Employee Director and Independent Director.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Astrana Health, Inc., a Delaware corporation (formerly known as Apollo Medical Holdings, Inc.), or any successor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Designated Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the beneficiary or beneficiaries the Participant designates, in a manner the Administrator determines, to receive amounts due or exercise the Participant&#8217;s rights if the Participant dies or becomes incapacitated.  Without a Participant&#8217;s effective designation, &#8220;Designated Beneficiary&#8221; will mean the Participant&#8217;s estate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a member of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning ascribed to the term in Code Section 22(e)(3), as determined by the Administrator. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a right granted to a Participant under the Plan to receive the equivalent value (in cash or Shares) of dividends paid on Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Eligible Individual</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any prospective Employee who has not previously been an Employee or Director of the Company or any Subsidiary, or who is commencing employment with the Company or any Subsidiary following a bona fide period of non-employment by the Company or any Subsidiary, if he or she is granted an Award in connection with his or her commencement of employment with the Company or any Subsidiary and such grant is an inducement material to his or her entering into employment with the Company or any Subsidiary (within the meaning of Nasdaq Stock Market Rule IM-5636-1 or any successor rule, if the Company&#8217;s securities are traded on the Nasdaq Stock Market, and&#47;or the applicable requirements of any other established stock exchange on which the Company&#8217;s securities are traded, as applicable, as such rules and requirements may be amended from time to time).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any employee of the Company or its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the value of one Share on any relevant date, determined under the following rules&#58; (i) the closing sale price per Share on that date as reported on the Nasdaq Stock </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Market or such other principal exchange on which Shares are then trading, if any, or if there are no sales on that date, on the next preceding trading day during which a sale occurred&#59; (ii) if the Shares are not reported on a principal exchange or national market system, the average of the closing bid and asked prices last quoted on that date by an established quotation service for over-the-counter securities&#59; or (iii) if neither (i) nor (ii) applies, the value as determined by the Administrator through the reasonable application of a reasonable valuation method, taking into account all information material to the value of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the date specified by the Administrator on which the grant of an Award is to be effective. The Date of Grant shall not be earlier than the date of the resolution and action therein by the Administrator to grant such Award. In no event shall the Date of Grant be earlier than the Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Director of the Company who is not an Employee and who qualifies as &#8220;independent&#8221; within the meaning of Nasdaq Stock Market Rule 5605(a)(2), or any successor rule, if the Company&#8217;s securities are traded on the Nasdaq Stock Market, and&#47;or the applicable requirements of any other established stock exchange on which the Company&#8217;s securities are traded, as applicable, as such rules and requirements may be amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Non-Employee Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Director who qualifies as a &#8220;Non-Employee Director&#8221; as defined in Rule 16b-3(b)(3) of the Exchange Act, or any successor definition.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Non-Qualified Stock Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an Option that does not qualify as and is not an &#8220;incentive stock option&#8221; as defined in Section&#160;422 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an option to purchase Shares.  All Options granted under the Plan will be Non-Qualified Stock Options.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Other Stock-Based Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means cash awards, awards of Shares, and other awards valued wholly or partially by referring to, or are otherwise based on, Shares or other property awarded to a Participant under Article&#160;VII.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an Eligible Individual who has been granted an Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Performance Criteria</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the criteria (and adjustments) that the Administrator may select for an Award to establish performance goals for a performance period, which may include (but shall not be limited to) the following&#58; (a) revenue&#59; (b) earnings before interest, taxes, depreciation and amortization, as adjusted (EBITDA as adjusted)&#59; (c) income before income taxes and minority interests&#59; (d) operating income&#59; (e) pre- or after-tax income&#59; (f) average accounts receivable&#59; (g) cash flow&#59; (h) cash flow per share&#59; (i) net earnings&#59; (j) basic or diluted earnings per share&#59; (k) return on equity&#59; (l) return on assets&#59; (m) return on capital&#59; (n) growth in assets&#59; (o) economic value added&#59; (p) share price performance&#59; (q) total stockholder return&#59; (r) improvement or attainment of expense levels&#59; (s) market share or market penetration&#59; or (t) business expansion, and&#47;or acquisitions or divestitures.  Such performance goals may be based solely by reference to the Company&#8217;s performance or the performance of a Subsidiary, division, business segment or business unit of the Company or a Subsidiary, or based upon performance relative to performance of other companies or upon comparisons of any of the indicators of performance relative to performance of other companies. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means this Astrana, Inc. Employment Inducement Award Plan, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Shares awarded to a Participant under Article&#160;VI subject to certain vesting conditions and other restrictions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.29</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Unit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means an unfunded, unsecured right to receive, on the applicable settlement date, one Share or an amount in cash or other consideration determined by the Administrator to be of equal value as of such settlement date awarded to a Participant under Article&#160;VI subject to certain vesting conditions and other restrictions.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, unless the Administrator determines otherwise in an Award Agreement, termination of employment from the Company and its Subsidiaries on or after age 65 with five (5) years of continuous service with the Company and its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Rule 16b-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Rule 16b-3 promulgated under the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.32</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means Section&#160;409A of the Code and all regulations, guidance, compliance programs and other interpretative authority thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.33</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Securities Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.34</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means shares of the Company&#8217;s common stock, $0.001 par value per share.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.35</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Stock Appreciation Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a stock appreciation right granted under Article&#160;V.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.36</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:100%">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any corporation or other entity in which the Company owns, directly or indirectly, a proprietary interest of more than fifty percent (50%) by reason of stock ownership or otherwise.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;END OF DOCUMENT&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.57
<SEQUENCE>12
<FILENAME>exhibit1057-formofstockopt.htm
<DESCRIPTION>EX-10.57
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i22d5260fa4a4407c921884e1b7bfde42_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 10.57</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EMPLOYMENT INDUCEMENT AWARD PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCK OPTION GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Astrana Health, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), pursuant to its Employment Inducement Award Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the individual listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as an inducement to Participant&#8217;s commencement of employment with the Company or a Subsidiary, an option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to purchase the number of shares of the Company&#8217;s common stock, par value $0.001 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), set forth below for the exercise price per Share set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Option subject to all of the terms and conditions set forth herein and in the Stock Option Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Option Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which are incorporated herein by reference. Capitalized terms used but not defined in this Grant Notice and the Option Agreement shall have the meanings given to such terms in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant&#58;&#160;&#160;&#160;&#160;_________________________</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grant Date&#58;&#160;&#160;&#160;&#160;_________________________</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Total Number of Option Shares&#58;&#160;&#160;&#160;&#160;_________________________</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exercise Price&#58;&#160;&#160;&#160;&#160;_________________________</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vesting Schedule&#58;&#160;&#160;&#160;&#160;_________________________</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Expiration Date&#58;&#160;&#160;&#160;&#160;the tenth anniversary of the Grant Date</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">IMPORTANT NOTICE&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">THIS AGREEMENT SHALL BE VOID, AND THE OPTION SHALL BE FORFEITED AUTOMATICALLY, IF THE AGREEMENT HAS NOT BEEN SIGNED BY PARTICIPANT AND RETURNED TO THE COMPANY WITHIN 30 DAYS AFTER THE GRANT DATE.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Option Agreement and this Grant Notice.  Participant has reviewed the Option Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Option Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Company and the Committee (as defined in the Plan) upon any questions arising under the Plan, this Grant Notice or the Option Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the undersigned have executed this Grant Notice effective as of the Grant Date.</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">ASTRANA HEALTH, INC.</font></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">PARTICIPANT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">_______________________________________</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="i22d5260fa4a4407c921884e1b7bfde42_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TO STOCK OPTION GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCK OPTION AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.&#160;&#160;&#160;&#160;General.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice, unless the context clearly indicates otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation of Terms of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Option subject to the terms and conditions of the Plan which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.&#160;&#160;&#160;&#160;Grant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of Participant&#8217;s employment with the Company or a Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Company grants to Participant the Option, upon the terms and conditions set forth in the Plan and this Agreement, subject to adjustments as provided in Article VIII of the Plan.  The Option is a nonqualified stock option, and shall not be treated as an &#8220;incentive stock option&#8221; (within the meaning of Section 422 of the Code).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consideration to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of the grant of the Option by the Company, Participant agrees to render faithful and efficient services to the Company or a Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The exercise price of the Option shall be the amount per Share set forth in the Stock Option Grant Notice, subject to adjustment as provided in Article VIII of the Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). Payment of the Exercise Price shall be made in accordance with Section 3.2 of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Term of Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Option shall terminate on the Expiration Date as specified in the Stock Option Grant Notice, but shall be subject to earlier termination as provided herein or in the Plan.  Upon termination of Participant&#8217;s employment or service for any reason, any vested portion of the Option shall remain exercisable for 90 days thereafter, and any unvested portion of the Option shall be forfeited.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.&#160;&#160;&#160;&#160;Vesting, Exercise, Restrictions, Etc.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms and conditions of the Plan, the Option shall vest and become exercisable at such times as are set forth in the Grant Notice&#59; provided, however, no portion of the Option that has not become vested at the date of Participant&#8217;s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), shall thereafter become vested, except as may be otherwise provided by the Committee or as set forth in a written agreement between the Company and Participant.  Notwithstanding any provision of this Agreement to the contrary, in the event of a Change of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Control, the treatment of the Option will be governed by any applicable provisions of Section 8.2 of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions of this Agreement, the Option, to the extent vested and exercisable, may be exercised, in whole or in part, by written notice to the Company or its designee, in substantially the form of&#160;attached hereto (or in such other form acceptable to the Company, which may include electronic notice). Such notice shall state the number of Shares with respect to which the Option is being exercised and shall be signed by the person exercising the Option (which signature may be provided electronically in a form acceptable to the Company). Payment of the Exercise Price for such Shares shall be made in cash or its equivalent, or in such other manner as may be approved by the Committee pursuant to the Plan. The Company shall deliver such Shares as soon as practicable after the notice shall be received, provided, however, that (a) no fractional Shares shall be issued pursuant to this Option, and (b) the Company may delay issuance of such Shares until completion of any action or obtaining of any consent, which the Company deems necessary under any Applicable Laws (including, without limitation, state securities or &#8220;blue sky&#8221; laws). The Shares as to which the Option shall have been so exercised shall be registered in the Company&#8217;s share register in the name of the person so exercising the Option and shall be delivered as provided above to or upon the written order of the person exercising the Option. In the event the Option shall be exercised, by any person other than Participant, such notice shall be accompanied by appropriate proof of the right of such person to exercise the Option. All Shares that shall be purchased upon the exercise of the Option as provided herein shall be fully paid and nonassessable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Option shall not be transferable by Participant otherwise than by will or by the laws of descent and distribution, provided that the Company may permit Participant to designate a beneficiary to exercise any vested portion of the Option in the event of Participant&#8217;s death. Except as provided above in this paragraph, the Option shall be exercisable, during Participant&#8217;s lifetime, only by Participant and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process.  Any attempted transfer, assignment, pledge, hypothecation or other disposition of the Option or of any rights granted hereunder contrary to the provisions of this Section&#160;3.3, or the levy of any attachment or similar process upon the Option shall be null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant acknowledges and agrees that any income or other taxes due from Participant with respect to the Option (upon exercise of the Option, the sale of Shares issued pursuant to the Option or otherwise) shall be Participant&#8217;s responsibility. Without limiting the foregoing, the parties agree that to the extent the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes in connection with the exercise of the Option, then the Company or Subsidiary (as applicable) shall retain a number of Shares otherwise deliverable hereunder with a value equal to the required withholding (based on the fair market value of the Shares on the applicable date)&#59; provided that in no event shall the value of the Shares retained exceed the minimum amount of taxes required to be withheld or such other amount that will not result in a negative accounting impact. Notwithstanding the foregoing, (a) to the extent permitted by the Committee, Participant may elect, in accordance with procedures adopted by the Company from time to time, to&#160;pay or provide for payment of the required tax withholding, and (b) in the event that the Company or any Subsidiary is required to withhold taxes at any time other than upon exercise of the Option, the Company may withhold applicable taxes from other compensation payable to Participant or require Participant to make arrangements satisfactory to the Company to provide for such tax withholding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant shall have no rights as a stockholder with respect to Shares subject to this Agreement until exercise of the Option and registration of the Shares in the Company&#8217;s share register in the name of Participant.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Recovery Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Option and any Shares that may be delivered pursuant to this Agreement are subject to forfeiture or repayment as may be provided pursuant to the Company&#8217;s Compensation Recovery Policy (or any successor compensation recovery policy), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.&#160;&#160;&#160;&#160;Other Provisions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee in good faith shall be final, binding and conclusive upon Participant, the Company and all other interested persons. No member of the Committee or the Board, or any employee or officer of the Company, shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments Upon Specified Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee may accelerate the vesting and exercisability of the Option in such circumstances as it, in its sole discretion, may determine. In addition, upon the occurrence of certain events relating to the Company&#8217;s common stock contemplated by the Plan (including, without limitation, an extraordinary cash dividend on such Shares), the Committee shall make such adjustments as the Committee deems appropriate to the Option in order to preserve the benefits intended to be made available to Participant under this Agreement. Participant acknowledges that the Option is subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company (or any other person or entity as designated by the Committee) at the Company&#8217;s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant&#8217;s last address reflected on the Company&#8217;s records. By a notice given pursuant to this Section 4.3, either party may hereafter designate a different address for notices to be given to that party. A notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.4 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Titles and Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.5 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The laws of the State of Delaware, without reference to any conflict of law principles thereof, shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.6 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conformity to Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act of 1933, as amended, the Exchange Act and the Code, and any and all regulations and rules promulgated thereunder, state securities laws and regulations and all other applicable law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Option is granted and shall be administered only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.7 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Option in any material way without the prior written consent of Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.8 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section 3.3 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.9 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.10 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan, the Grant Notice and this Agreement (including all Exhibits thereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relation to Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any economic or other benefit to Participant under this Agreement or the Plan shall not be taken into account in determining any benefits to which Participant may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company or any of its Subsidiaries or affiliates, except as expressly provided in writing in such other plan&#8217;s governing instrument.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to administer the Plan, the Company may process personal data about Participant.  Such data includes, but is not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about Participant such as home address and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan.  Participant hereby gives explicit consent to the Company to process any such personal data.  Participant also gives explicit consent to the Company to transfer any such personal data outside the country in which Participant works or is employed, including, if Participant is not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Participant hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver, including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual and quarterly reports, and all other forms of communications (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in connection with this and any other Award made or offered under the Plan. Participant has the right at any time to request that the Company deliver written copies of any and all Prospectus Information at no charge. Participant also hereby consents to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that the Company may elect to deliver and agrees that Participant&#8217;s electronic response or signature is the same as, and shall have the same force and effect as, Participant&#8217;s manual signature.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><div id="i22d5260fa4a4407c921884e1b7bfde42_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">NOTICE OF EXERCISE OF STOCK OPTION</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.740%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">To&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Astrana Health, Inc.</font></td></tr></table></div><div style="margin-top:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I hereby exercise my Stock Option to purchase _________ shares (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Shares</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of the common stock, $0.001 par value, of Astrana Health, Inc. (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), at the Exercise Price of $____&#160;per Share, pursuant to and subject to the terms of that Stock Option Grant Notice dated ______________, 20__ and the Astrana Health, Inc. Employment Inducement Award Plan.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I understand the nature of the investment I am making and the financial risks thereof. I am aware that it is my responsibility to have consulted with competent tax and legal advisors about the relevant national, state and local income tax and securities laws affecting the exercise of the Option and the purchase and subsequent sale of the Shares.</font></div><div style="margin-top:12pt;text-indent:24.5pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I am paying the Exercise Price for the Shares as follows&#58;</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td></tr></table></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="margin-bottom:8pt;padding-left:280.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.384%"><tr><td style="width:1.0%"></td><td style="width:48.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.710%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Very truly yours,</font></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Participant (signature)</font></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Print Name</font></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td></tr></table></div><div style="text-indent:279pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.58
<SEQUENCE>13
<FILENAME>exhibit1058-formofrestrict.htm
<DESCRIPTION>EX-10.58
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="iccb738fbf2f24790b84d73bfffb2ca83_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 10.58</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EMPLOYMENT INDUCEMENT AWARD PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTED STOCK GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Astrana Health, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), pursuant to its Employment Inducement Award Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the individual listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), as an inducement to the Participant&#8217;s commencement of employment with the Company or a Subsidiary, the number of shares of the Company&#8217;s common stock, par value $0.001, set forth below (individually and collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The Restricted Shares are subject to all of the terms and conditions set forth herein and in the Restricted Stock Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which are incorporated herein by reference. Capitalized terms used but not defined in this Grant Notice and the Restricted Stock Agreement shall have the meanings given to such terms in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Participant&#58;&#160;&#160;&#160;&#160;_________________________</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grant Date&#58;&#160;&#160;&#160;&#160;_________________________</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Total Number of Restricted Shares&#58;&#160;&#160;&#160;&#160;_________________________</font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vesting Schedule&#58;&#160;&#160;&#160;&#160;_________________________</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the Restricted Stock Agreement and this Grant Notice.  Participant has reviewed the Restricted Stock Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Restricted Stock Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Company and the Committee (as defined in the Plan) upon any questions arising under the Plan, this Grant Notice or the Restricted Stock Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">IMPORTANT NOTICE&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">THIS AGREEMENT SHALL BE VOID, AND THE RESTRICTED SHARES SHALL BE FORFEITED AUTOMATICALLY, IF THE AGREEMENT HAS NOT BEEN SIGNED BY PARTICIPANT AND RETURNED TO THE COMPANY WITHIN 30 DAYS AFTER THE GRANT DATE. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 10.58</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, the undersigned have executed this Grant Notice effective as of the Grant Date.</font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">ASTRANA HEALTH, INC.</font></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">PARTICIPANT</font></td></tr><tr style="height:25pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">_______________________________________</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:3.1pt;padding-right:3.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Name&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><div id="iccb738fbf2f24790b84d73bfffb2ca83_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 10.58</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TO RESTRICTED STOCK GRANT NOTICE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTED STOCK AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.&#160;&#160;&#160;&#160;General.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice, unless the context clearly indicates otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation of Terms of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Restricted Shares are subject to the terms and conditions of the Plan which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.&#160;&#160;&#160;&#160;Grant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of Participant&#8217;s employment with the Company or a Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Company grants to Participant the Restricted Shares, upon the terms and conditions set forth in the Plan and this Agreement, subject to adjustments as provided in Article VIII of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consideration to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of the grant of the Restricted Shares by the Company, Participant agrees to render faithful and efficient services to the Company or a Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.&#160;&#160;&#160;&#160;Vesting, Delivery, Restrictions, Etc.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms and conditions of the Plan, the Restricted Shares shall vest at such times as are set forth in the Grant Notice&#59; provided, however, none of the Restricted Shares that have not become vested at the date of Participant&#8217;s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), shall thereafter become vested, except as may be otherwise provided by the Committee or as set forth in a written agreement between the Company and Participant.  Notwithstanding any provision of this Agreement to the contrary, in the event of a Change of Control, the treatment of the Restricted Shares will be governed by any applicable provisions of Section 8.2 of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless and until the Restricted Shares vest as set forth in the Grant Notice, Participant shall have no right to sell, assign, transfer, pledge or otherwise encumber the Restricted Shares in any manner. Any purported attempt to sell, assign, transfer, pledge or otherwise encumber any Restricted Shares under this Agreement shall be void and shall result in the forfeiture and cancellation of such Restricted Shares. Upon Participant&#8217;s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), any Restricted Shares that are unvested as of the date of such termination of employment or service (and whose vesting is not accelerated pursuant to this Agreement or the Plan) shall be forfeited, and Participant shall have no further rights with respect to such Restricted Shares under this Agreement or otherwise. The Restricted Shares shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 10.58</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">be registered in book entry in the name of Participant and shall include a legend indicating the possibility of cancellation and the restrictions on transfer of the Restricted Shares.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to Section 3.4 below, the vesting of the Restricted Shares under this Agreement will result in Participant&#8217;s recognition of income for U.S. federal income tax purposes.  The parties agree that to the extent the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes in connection with the vesting or the grant of the Restricted Shares, then such tax withholding shall be satisfied by the forfeiture of a number of Restricted Shares having a value equal to the required tax withholding (based on the Fair Market Value per Share on the applicable date), provided that in no event shall the value of the Shares retained exceed maximum statutory tax rates in the applicable taxing jurisdictions. Notwithstanding the foregoing, to the extent authorized by the Committee, the Participant may be permitted to elect, in accordance with procedures adopted by the Company from time to time, to&#160;pay or provide for payment of any required tax withholding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 83(b) Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If Participant makes an election under Section 83(b) of the Code to be taxed with respect to the Restricted Shares as of the date of transfer of the Restricted Shares rather than as of the date or dates upon which Participant would otherwise be taxable under Section 83 of the Code, Participant shall be required to deliver a copy of such election to the Company promptly after filing such election with the Internal Revenue Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Rights as Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Upon issuance of the Restricted Shares and until the forfeiture or cancellation of the Restricted Shares, Participant shall have, unless otherwise provided by the Committee, all the rights of a stockholder with respect to the Restricted Shares, subject to the transferability and other restrictions set forth in this Agreement, including the right to receive all dividends and other distributions paid or made with respect to the Restricted Shares&#59; provided, however, that any extraordinary distributions with respect to the Company&#8217;s common stock received by Participant in the form of shares of such common stock shall be subject to the same vesting and other restrictions as the Restricted Shares to which they relate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Recovery Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Restricted Shares are subject to forfeiture or repayment as may be provided pursuant to the Company&#8217;s Compensation Recovery Policy (or any successor compensation recovery policy), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.&#160;&#160;&#160;&#160;Other Provisions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.1 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Committee in good faith shall be final, binding and conclusive upon Participant, the Company and all other interested persons. No member of the Committee or the Board, or any employee or officer of the Company, shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the Restricted Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments Upon Specified Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Committee may accelerate the vesting of the Restricted Shares in such circumstances as it, in its sole discretion, may determine. In addition, upon the occurrence of certain events relating to the Company&#8217;s common stock contemplated by the Plan (including, without limitation, an extraordinary cash dividend on such Shares), the Committee shall make such adjustments as the Committee deems appropriate to the Restricted Shares in order to preserve the benefits intended to be made available to Participant under this Agreement. Participant acknowledges that the Restricted Shares are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 10.58</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.3 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company (or any other person or entity as designated by the Committee) at the Company&#8217;s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant&#8217;s last address reflected on the Company&#8217;s records. By a notice given pursuant to this Section 4.3, either party may hereafter designate a different address for notices to be given to that party. A notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.4 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Titles and Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.5 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The laws of the State of Delaware, without reference to any conflict of law principles thereof, shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.6 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conformity to Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act of 1933, as amended, the Exchange Act and the Code, and any and all regulations and rules promulgated thereunder, state securities laws and regulations and all other applicable law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Restricted Shares are granted and shall be administered only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.7 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendments, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Restricted Shares in any material way without the prior written consent of Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.8 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section 3.2 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.9 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.10 &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan, the Grant Notice and this Agreement (including all Exhibits thereto) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relation to Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any economic or other benefit to Participant under this Agreement or the Plan shall not be taken into account in determining any benefits to which Participant may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company or any of its Subsidiaries or affiliates, except as expressly provided in writing in such other plan&#8217;s governing instrument.   </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 10.58</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to administer the Plan, the Company may process personal data about Participant.  Such data includes, but is not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about Participant such as home address and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan.  Participant hereby gives explicit consent to the Company to process any such personal data.  Participant also gives explicit consent to the Company to transfer any such personal data outside the country in which Participant works or is employed, including, if Participant is not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Participant hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver, including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual and quarterly reports, and all other forms of communications (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in connection with this and any other Award made or offered under the Plan. Participant has the right at any time to request that the Company deliver written copies of any and all Prospectus Information at no charge. Participant also hereby consents to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that the Company may elect to deliver and agrees that Participant&#8217;s electronic response or signature is the same as, and shall have the same force and effect as, Participant&#8217;s manual signature.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;END OF DOCUMENT&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.59
<SEQUENCE>14
<FILENAME>exhibit1059-formofrestrict.htm
<DESCRIPTION>EX-10.59
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i8ad44fe8b8364bac871afbb2c28a2029_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.59</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EMPLOYMENT INDUCEMENT AWARD PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTED STOCK UNIT GRANT NOTICE</font></div><div style="margin-top:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Astrana Health, Inc., a Delaware corporation (together with any successor thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), pursuant to its Employment Inducement Award Plan, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), hereby grants to the holder listed below (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) the number of restricted stock units set forth below (individually and collectively referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). The RSUs are subject to all of the terms and conditions set forth herein and in the Restricted Stock Unit Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSU Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Plan, each of which is incorporated herein by reference. Capitalized terms not specifically defined in this Grant Notice shall have the meanings specified in the Plan and&#47;or RSU Agreement, unless the context clearly indicates otherwise. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="padding-left:76.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.429%"><tr><td style="width:1.0%"></td><td style="width:46.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.376%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.129%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.740%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Participant&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Grant Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Total&#160;Number&#160;of&#160;RSUs&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Vesting Schedule&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The RSUs shall vest as follows, subject to Participant&#8217;s continuous employment or other service from the Grant Date until the applicable Vesting Date&#58;</font></div></td></tr><tr><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Vesting Date</font></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Number of RSUs Vesting</font></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">IMPORTANT NOTICE&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">THE RSU AGREEMENT AND THIS GRANT NOTICE SHALL BE VOID, AND THE RSUS SHALL BE FORFEITED AUTOMATICALLY, IF THIS GRANT NOTICE HAS NOT BEEN SIGNED BY PARTICIPANT AND RETURNED TO THE COMPANY WITHIN 30 DAYS AFTER THE GRANT DATE PROVIDED ABOVE. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the RSU Agreement and this Grant Notice. Participant has reviewed the RSU Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the RSU Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Company and the Administrator (as defined in the Plan) upon any questions arising under the Plan, this Grant Notice or the RSU Agreement. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the undersigned have executed this Grant Notice effective as of the Grant Date set forth above. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.269%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.992%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.764%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.571%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.850%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.417%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.589%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">ASTRANA HEALTH, INC.</font></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">PARTICIPANT</font></td></tr><tr style="height:12pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="30" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="24" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="27" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="27" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Brandon Sim</font></td><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="24" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Executive Officer &#38; President</font></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="66" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i8ad44fe8b8364bac871afbb2c28a2029_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">EXHIBIT A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TO RESTRICTED STOCK UNIT GRANT NOTICE </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RESTRICTED STOCK UNIT AGREEMENT </font></div><div style="margin-top:9pt;text-align:justify;text-indent:48.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Pursuant to the Restricted Stock Unit Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to which this Restricted Stock Unit Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is attached, Astrana Health, Inc., a Delaware corporation (together with any successor thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), has granted certain restricted stock units (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) to Participant under the Company&#8217;s Employment Inducement Plan, as amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) as indicated in the Grant Notice. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and&#47;or the Grant Notice, unless the context clearly indicates otherwise. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation of Terms of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The RSUs are subject to the terms and conditions of the Plan, which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement or the Grant Notice, the terms of the Plan shall control. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of Participant&#8217;s employment with or service to the Company or a Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Company grants to Participant the RSUs, upon the terms and conditions set forth in the Plan, the Grant Notice and this Agreement, subject to adjustments as provided in Article 8 of the Plan. Each RSU represents the contingent right to receive one Share and shall at all times be equal to the value of one Share.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Consideration to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In consideration of the grant of the RSUs by the Company, Participant agrees to render faithful and efficient services to the Company or a Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Vesting, Restrictions, Settlement and Etc.</font></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to the terms and conditions of the Plan, the RSUs shall vest at such times and subject to such conditions as are set forth in the Grant Notice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that no RSUs that are unvested as of the date of Participant&#8217;s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), shall thereafter become vested, except as may be otherwise provided by the Administrator or as set forth in a written agreement between the Company and Participant.  Notwithstanding any provision of this Agreement to the contrary, in the event of a Change of Control, the treatment of the RSUs will be governed by any applicable provisions of Section 8.2 of the Plan.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant shall have no right to sell, assign, transfer, pledge or otherwise encumber RSUs in any manner. Any purported attempt to sell, assign, transfer, pledge or otherwise encumber any RSUs under this Agreement shall be void and shall result in the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">forfeiture and cancellation of such RSUs. Upon Participant&#8217;s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), any RSUs that are unvested as of the date of such termination of employment or service (and whose vesting is not accelerated pursuant to this Agreement or the Plan) shall be forfeited, and Participant shall have no further rights with respect to such RSUs under this Agreement or otherwise. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The RSUs shall be registered in book entry in the name of Participant until they have vested in accordance with this Agreement. Upon vesting of any of the RSUs, the Company shall deliver the corresponding number of Shares to Participant within 30 days</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">following the date on which such RSUs vested.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Upon such delivery to Participant, such Shares will not be subject to any restrictions other than those that may arise under the securities laws or the Company&#8217;s policies. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes in connection with the delivery of Shares under this Agreement, then the Company or Subsidiary (as applicable) shall retain a number of Shares otherwise deliverable hereunder with a value equal to the required withholding (based on the Fair Market Value per Share on the applicable date)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that in no event shall the value of the Shares retained exceed maximum statutory tax rates in the applicable taxing jurisdictions. Notwithstanding the foregoing, to the extent authorized by the Committee, the Participant may be permitted to elect, in accordance with procedures adopted by the Company from time to time, to&#160;pay or provide for payment of any required tax withholding.  To the extent that the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes at any time other than upon delivery of Shares under this Agreement, the Company, in its discretion may (a) require Participant to&#160;pay or provide for payment of the required tax withholding, or (b)&#160;satisfy the required tax withholding by deduction from any amount of compensation otherwise payable in cash to Grantee (including any cash dividend equivalent payments pursuant to Section 3.6 of this Agreement).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant shall not possess any incidents of ownership (including, without limitation, dividend and voting rights) in the Shares underlying the RSUs unless and until such Shares have been delivered to Participant in accordance with Section 3.3. The obligations of the Company pursuant to this Agreement are merely that of an unfunded and unsecured promise of the Company to deliver Shares (and cash dividend equivalents, if any, pursuant to Section 3.6 hereof) in the future and subject to the terms and conditions of this Agreement, and the rights of Participant hereunder are no greater than those of an unsecured general creditor. No Company assets shall be held or set aside as security for the Company&#8217;s obligations pursuant to this Agreement.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  From and after the Grant Date and until the earlier of (a) the time when the Shares underlying the vested RSUs (if any) are delivered to Participant in accordance with this Agreement, or (b) the time that the RSUs are forfeited in accordance with this Agreement, on each date, if any, that the Company pays a cash dividend to holders of its Shares generally, the Company will credit Participant&#8217;s account hereunder with the right to receive a cash amount equal to the product of (x) the dollar amount of the cash dividend paid per Share to stockholders on such date multiplied by (y) the total number of unpaid RSUs credited to Participant&#8217;s account under this Agreement as of such date. Subject to and conditioned upon the vesting of the underlying RSUs, the aggregate amount of any such dividend equivalents credited to Participant&#8217;s account hereunder shall be paid to Participant in cash (without interest), at the same time and in the same proportion that the Shares underlying any vested RSUs are delivered to Participant, and the Participant&#8217;s right to receive any such dividend equivalents shall be automatically and correspondingly forfeited to the extent that the RSUs are forfeited pursuant to the terms of this Agreement and the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compensation Recovery Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The RSUs and any Shares that may be delivered pursuant to this Agreement are subject to forfeiture or repayment as may be provided pursuant to the Company&#8217;s Compensation Recovery Policy (or any successor compensation recovery policy), as in effect from time to time.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Other Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div></td></tr></table></div><div style="margin-top:4.5pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator has the authority to take all actions and make all determinations under the Plan, to interpret the Plan, the Grant Notice, and this Agreement, and to adopt, amend and repeal Plan administrative rules, guidelines and practices as it deems advisable. The Administrator may correct defects and ambiguities, supply omissions and reconcile inconsistencies in the Plan, the Grant Notice or this Agreement as it deems necessary or appropriate to administer the Plan, the Grant Notice and this Agreement.  The Administrator&#8217;s determinations under the Plan are in its sole discretion and will be final and binding on all persons having or claiming any interest in the Plan or any Award.  </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.2 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustments Upon Specified Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may accelerate the vesting of all or a portion the RSUs in such circumstances as it, in its sole discretion, may determine. Participant acknowledges that the RSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company (or any other person or entity as designated by the Administrator) at the Company&#8217;s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant&#8217;s last address reflected on the Company&#8217;s records. By a notice given pursuant to this Section&#160;4.3, either party may hereafter designate a different address for notices to be given to that party. A notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.4 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Titles and Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. </font></div><div style="text-align:justify;text-indent:24.5pt"><font><br></font></div><div style="text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.5 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The laws of the State of Delaware, without reference to any conflict of law principles thereof, shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.6 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Conformity to Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant acknowledges that the Plan, the Grant Notice and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act of 1933, as amended, the Exchange Act and the Code, and any and all regulations and rules promulgated thereunder, state securities laws and regulations and all other applicable law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted and shall be administered, only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan, the Grant Notice and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.7 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A of the Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Award of RSUs evidenced by this Agreement is intended to be exempt from, or to comply with, the requirements of Section&#160;409A of the Code, and this Agreement shall be interpreted and administered in accordance with such intent.  Accordingly, solely to the extent necessary to comply with the requirements of Section 409A of the Code&#58; (a) the termination of Participant&#8217;s employment or other service shall be interpreted to mean the Participant&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A of the Code&#59; (b) if Participant is a &#8220;specified employee&#8221; (as determined by the Company in accordance </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">with Section 409A of the Code), settlement of any vested RSUs (and payment of any related dividend equivalents) as a result of Participant&#8217;s separation from service shall be delayed until the first business day that is at least six months after the date of Participant&#8217;s separation from service or, if earlier, the date of Participant&#8217;s death&#59; and (c) a Change of Control shall be interpreted to mean an event that qualifies as both a &#8220;Change of Control&#8221; as defined in the Plan and a &#8220;change in control event&#8221; within the meaning of Section 409A of the Code and Treasury Regulation &#167;1.409A-3(i)(5). Notwithstanding the foregoing, the tax treatment of the RSUs is not warranted or guaranteed. Neither the Company and its Subsidiaries, nor their respective affiliates, directors, officers, employees and advisers shall be held liable for any taxes, interest, penalties or other monetary amounts that may owed by the Participant or other taxpayer as a result of the Award of RSUs or this Agreement.  </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"> Amendments, Suspension and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent permitted by the Plan, the Grant Notice and this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, that except as may otherwise be provided by the Plan or Section 4.6 of this Agreement, no amendment, modification, suspension or termination of this Agreement shall adversely affect the RSUs in any material way without the prior written consent of Participant. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.9 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in Section&#160;3.2 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Not a Contract of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing in this Agreement, the Grant Notice or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries or affiliates. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.11 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Relation to Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any economic or other benefit to Participant under this Agreement or the Plan shall not be taken into account in determining any benefits to which Participant may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company or any of its Subsidiaries or affiliates, except as expressly provided in writing in such other plan&#8217;s governing instrument.   </font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.12 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In order to administer the Plan, the Company may process personal data about Participant.  Such data includes, but is not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about Participant such as home address and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan.  Participant hereby gives explicit consent to the Company to process any such personal data.  Participant also gives explicit consent to the Company to transfer any such personal data outside the country in which Participant works or is employed, including, if Participant is not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.13 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Electronic Delivery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Participant hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver, including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual and quarterly reports, and all other forms of communications (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Prospectus Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in connection with this and any other Award made or offered under the Plan. Participant has the right at any time to request that the Company deliver written copies of any and all Prospectus Information at no charge. Participant also hereby consents to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that the Company may elect to deliver and agrees </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">that Participant&#8217;s electronic response or signature is the same as, and shall have the same force and effect as, Participant&#8217;s manual signature.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.14 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan, the Grant Notice and this Agreement (including any Exhibits to any of the foregoing) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;END OF DOCUMENT&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.60
<SEQUENCE>15
<FILENAME>exhibit1060-kumaremploym.htm
<DESCRIPTION>EX-10.60
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit1060-kumaremploym</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit1060-kumaremploym001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 1 -  EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this &#8220;Agreement&#8221; including Exhibits and Schedules) is made and entered into as of January 23, 2024, by and between ApolloCare Enablement of Nevada, a Nevada corporation (the  &#8220;Employer&#8221;), and Dinesh Kumar, MD (the &#8220;Employee,&#8221; and together with Employer, collectively referred to as the &#8220;Parties&#8221;) with effect from and after the &#8220;Effective Date&#8221; as set forth in Section 22 below.  WHEREAS, the Employer desires to employ the Employee from and after the Effective Date on the terms  and conditions set forth below, and the Employee is willing to serve the Employer on such terms and conditions.  NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein and other  good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as  follows:  1. Employment.  (a) Engagement and Duties. Employer hereby employs Employee as Chief Medical Officer  during the term of this Agreement to perform the duties outlined in Exhibit A to this Agreement and such other duties  as may be assigned to the Employee from time to time by Employer&#8217;s CEO. Employee hereby accepts such  employment by Employer upon the terms and subject to conditions set forth in this Agreement. Employee shall report  to Brandon Sim, CEO. Employee shall devote best efforts, skills and abilities, on a full-time basis, exclusively to the  Employer&#8217;s business. Employee covenants and agrees to faithfully adhere to and fulfill such policies as are established from time to time by the Board of Directors of Apollo Medical Holdings, Inc. (the &#8220;Board&#8221;) or the Employer (&#8220;Policies&#8221;). (b) Performance of Services for Affiliates. In addition to the performance of services for  Employer, Employee shall, to the extent so required by Employer, also perform services for its &#8220;Affiliates&#8221; (as defined in Section 6 below), provided that such services are consistent with the kind of services Employee performs or may  be required to perform for Employer under this Agreement. If Employee performs any services for any Affiliate,  Employee shall not be entitled to receive any compensation or remuneration in addition to or in lieu of the  compensation and remuneration provided under this Agreement on account of such services for the Affiliate. The  Policies will govern Employee&#8217;s employment by Employer and its Affiliates for which Employee is asked to provide services. In addition, Employee covenants and agrees that Employee will faithfully adhere to and fulfill such additional  policies as may be established from time to time by the board of directors of any Affiliate for which Employee  performs services, to the extent that such policies and procedures differ from or are in addition to the Policies adopted  by Employer.  (c) Standards of Performance.  Employee shall provide the Services consistent with the  following standards of performance:  (i) Accepted standards of Chief Medical Officer;  (ii) Applicable laws, rules and regulations, including, without limitation, Medicare  and Medicaid statutes and regulations and the statutes, rules and regulations relating to the licensure of physicians and  surgeons and the practice of medicine and the patient privacy and security requirements set forth in the  Health  Insurance Portability and Accountability Act of 1996, and  attendant  regulations at 45 C.F.R. Parts 160 and 164 (the  &#8220;Privacy and Security Standards&#8221;), as amended by the federal Health Information Technology for Economic and  Clinical Health Act (&#8220;HITECH Act&#8221;) and its implementing regulations, as may be modified or amended, including future issuance of regulations and guidance by the United States Department of Health and Human Services  (collectively &#8220;HIPAA&#8221;), and any applicable state patient privacy and security laws. Employee shall notify Company within 24 hours of any Privacy Breach of which he or she becomes aware. &#8220;Privacy Breach&#8221; means the unlawful or unauthorized access to, viewing, acquisition, use, or disclosure of protected health information, as defined by HIPAA  (&#8220;PHI&#8221;). Exhibit 10.60 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 2 -  (iii) Company guidelines, policies and protocols as may be established by Company  from time to time.  (iv) The terms and conditions of this Agreement.  (d) Professional Requirements.  Employee covenants, warrants, and represents that  Employee shall at all times during the Term:  (i) Comply with all applicable laws, rules, and standards, including, without  limitation, those of the California Medical Board or other applicable state authority;   (ii) Have a valid drug enforcement agency number with which to prescribe controlled  substances; and be certified (or agree to be certified) as a Medicare/Medicaid provider without having been excluded  from any such programs;  (iii) Maintain Employee&#8217;s professional competence and skills commensurate with the standards of the medical community; and  (iv) Notify Company within twenty four (24) hours of any: (i) modification,  restriction, suspension or revocation of Employee&#8217;s license to practice; (ii) modification, restriction, suspension, or revocation of Employee&#8217;s authorization to prescribe or to administer controlled substances; (iii) imposition of  sanctions against Employee under the Medicaid or Medicare program, or any other governmental program; or  (iv) other professional disciplinary action or criminal or professional liability action of any kind against Employee  which is either initiated, in progress, or completed as of the Effective Date of this Agreement and at any other time  during the Term of this Agreement.  (v) Records and Reports.  Employee shall timely (within 24 hours) and properly  complete, in accordance with Company policies, all medical records and reports for patients for whom Employee has  provided Services.  Employee shall be liable for all damages or losses that Company may incur as a result of such  failure.  (vi) Continuing Education.  Employee shall participate in continuing education as  necessary to maintain licensure, professional competence and skills commensurate with the standards of the  medical/clinical community, as otherwise required by Employee&#8217;s profession and as required to effectively perform  Employee&#8217;s obligations under this Agreement;  (vii) The Employer agrees to five (5) days per year of CME time and reimbursement  up to $5,000 per year to cover the reasonable and necessary expenses associated with the Employee participation in  Continuing Medical Education (CME) activities;  (viii) Eligible expenses include, but are not limited to, registration fees, conferences,  journals, board certification, society memberships and other related costs directly associated with approved CME  activities.  (ix) Quality Initiatives. Employee shall comply and cooperate with all utilization  management, quality assurance, risk management, peer review and credentialing programs and audits, and other  policies and procedures, as adopted or amended by Company or otherwise applicable to Employee.   (e) No Conflicting Obligations. Employee represents and warrants to Employer that  Employee is under no obligations or commitments, whether contractual or otherwise, that are inconsistent with  Employee&#8217;s obligations under this Agreement or that would prohibit Employee, contractually or otherwise, from  performing Employee&#8217;s duties as under this Agreement and the Policies. </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 3 -  (f) No Unauthorized Use of Third-Party Intellectual Property. Employee represents  and warrants to Employer that Employee will not use or disclose, in connection with Employee&#8217;s employment by Employer or any Affiliate, any patents, trade secrets, confidential information, or other proprietary information or  intellectual property as to which any other person has any right, title or interest, except to the extent that Employer or  its Affiliate holds a valid license or other written permission for such use from the owner(s) thereof. Employee  represents and warrants to Employer that Employee has returned all property and confidential information belonging  to any prior employer.  2. Start Date. January 23, 2024 will be the tentative start date, unless other mutually acceptable  arrangements are made.  3. Term. The Parties mutually agree that Employee&#8217;s employment pursuant to this Agreement may be terminated at any time as long as the terminating Party gives the other written notice of intent to terminate at least  sixty (60) days prior to such date.  The time during which Employee is employed by Employer pursuant to this  Agreement is referred to herein as the &#8220;Term&#8221;. 4. Compensation and Related Matters. Employer shall provide Employee with the compensation and  benefits set forth in this Section 4 during the Term.  (a) Base Salary. The Employer shall pay the Employee, as an exempt employee, for all services  rendered a base salary of $700,000.00 per year (the &#8220;Base Salary&#8221;), payable, bi-weekly, and in accordance with the  Employer&#8217;s payroll procedures, subject to customary withholdings and employment taxes. (b) Initial Stock Award. As soon as practicable following the Effective Date, Employee shall  be granted a restricted stock award (the &#8220;Initial Stock Award&#8221;) of common shares issued by Apollo Medical Holdings, Inc. in the amount of 85,130 shares, which is to be time vested in annual increments of 33.3% of the shares per year  on each anniversary of the Start Date over three (3) full years of Employee&#8217;s active and continuous full-time  employment (28,376 shares after 1 year, 28,376 shares after 2 years, and 28,376 after 3 years of service). This Initial  Stock Award is offered as an inducement for Employee to accept employment with Employer on the terms of this  Agreement and is subject to approval by the Compensation Committee of Employer&#8217;s Board of Directors. The definition of Fair Market Value, and other applicable terms and provisions are set forth in the APOLLO MEDICAL  HOLDINGS, INC. EMPLOYMENT INDUCEMENT AWARD PLAN (&#8220;Inducement Plan&#8221;). The terms and  provisions of the Inducement Plan are hereby incorporated into this Agreement and are made applicable to the Initial  Stock Award.  Additionally, should both Dr. Kenneth Sim, Executive Chairman, and Brandon Sim, CEO, no longer be employed by  the Company (and / or its successor) or sit on the Company&#8217;s Board, all unvested shares of the Initial Stock Award  will immediately vest.  (c) Performance Equity Award. Additionally, the Employee will be granted a performance- based restricted stock award (the &#8220;Performance Equity Award&#8221;) of 65,265 shares. This Performance Equity Award is  offered as an inducement for Employee to accept employment with Employer on the terms of this Agreement and is  subject to approval by the Compensation Committee of Employer&#8217;s Board of Directors. The definition of Fair Market  Value, and other applicable terms and provisions are set forth in the Inducement Plan. The terms and provisions of the  Inducement Plan are hereby incorporated into this Agreement and are made applicable to the Performance Equity  Award. All performance-based equity grants will have both a performance based and a time-based component, both  of which must be met in order for the shares to vest to the Employee. Both the time-based vesting schedule and  performance targets as defined in Exhibit B must be fulfilled for the shares to vest to Employee. For avoidance of  doubt, for the Employee to vest the shares granted in this Addendum, both the appropriate amount of time must have  passed as well as the performance targets having been accomplished for the shares to vest to Employee.    For each of the Performance Targets listed in Exhibit B, Employer, in its sole discretion, shall make a calculation and  determine (&#8220;Determination&#8221;), in good faith, whether such triggers were successfully achieved. Employee will not have  any right to audit the Determination by Employer, and Employer is under no obligation to share the Determination  with Employee.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  - 4 -  The Performance Targets, if earned, subject to Determination, will be payable in accordance with the Employer&#8217;s payroll procedures, subject to customary withholdings and employment taxes.  Similar to the Initial Stock Award, should both Dr. Kenneth Sim, Executive Chairman, and Brandon Sim, CEO, no  longer be employed by the Company (and / or its successor) or sit on the Company&#8217;s Board, all earned but unvested  shares of the Performance Equity Award will immediately vest.  (d) Annual Bonus. In the Employer&#8217;s sole discretion, your annualized target bonus will be $700,000.00. At the discretion of Company leadership, bonuses granted to individuals are based primarily upon  exceptional performance and contributions. You will be subject to the Company&#8217;s annual bonus program in effect at the time, with no minimum payment, and a requirement to be employed continuously during the year and at the time  of payment. The Company&#8217;s annual bonus program provides a discretionary pool of dollars to be allocated across the  Company&#8217;s employees. Based upon the Company achieving certain fiscal year financial metrics related to profitability, among other metrics, an additional pool of bonus dollars may be generated with the intent of those dollars being shared  more uniformly across our employees in the Company who are significantly exceeding the Company&#8217;s performance expectations. The Company reserves the right to alter, revise or eliminate the annual bonus program at its sole  discretion.  (e) Long Term Incentive Awards. In the Employer&#8217;s sole discretion, the Employee may be eligible to participate in any long term incentive plan that may be available to similarly positioned Employees. The  Board may determine to grant long-term incentive awards in cash or in equity awards settled in shares of the  Employer&#8217;s or its Affiliates&#8217; stock, including but not limited to stock options, restricted stock and performance shares. Any equity or options will be granted according to the latest Equity Incentive Plan approved by the Board.    (f) Paid Time Off. During the Term, the Employee will be eligible for paid time off in  accordance with and subject to all of the terms and conditions of the Employer&#8217;s Paid Time Off policy (which such policy is compliant with CA&#8217;s Paid Sick Leave requirements), as such policy may be amended from time to time in the Employer&#8217;s sole discretion.  Employee will also be eligible for paid holidays, in accordance with and subject to  all of the terms and conditions of the Employer&#8217;s policies, as such policies may be amended from time to time or  terminated in the Employer&#8217;s sole discretion. (g) Expenses. The Employee shall be entitled to prompt reimbursement of reasonable and  usual business expenses incurred on behalf of Employer in accordance with the Employer&#8217;s expense reimbursement policy;  (h) The Employer shall cover up to $5,000.00 per year in expenses on the Employee behalf for  but not limited to medical licensure, DEA fees, hospital dues, or related expenses upon invoices being sent to Apollo  Medical Holdings Inc.  (i) Benefits. The Employee shall be entitled to continue to participate in or receive benefits  under any employee benefit plan or arrangement which is or may, in the future, be made available by the Employer to  its employees, subject to and on a basis consistent with the terms, conditions and overall administration of such plan  or arrangement.  (j) Professional Liability Insurance.   (1) If Employee has engaged in the practice of medicine prior to  commencing services under this Agreement, Employee represents and warrants that Employee has  adequate &#8220;tail&#8221; (i.e., extended reporting) coverage in connection with any cancellation of  Employee&#8217;s current professional liability policy. (2) The Company shall add Employee as an additional insured on the  Company&#8217;s professional liability insurance, for services solely related to or arising from services provided by Employee under the terms of this Agreement or, at Company&#8217;s election, if Company has established a professional liability self-insurance program, Company may include Employee  within such self-insurance program.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 5 -  (3) Tail Insurance. Upon termination of this Agreement for any reason,  Company will indemnify Employee for professional liability claims, for services; (i) solely related  to or arising from services provided by Employee under the terms of this Agreement, (ii) occurring  during the period of employment, and (iii) reported either during the Term or after termination of  employment, up to amounts provided for other physicians then employed by the Company in the  area. Company agrees that if, for any reason, Company shall require Employee to obtain &#8216;tail insurance&#8217; at the termination of his/her employment hereunder, Company shall pay the entire cost of such insurance.  (k) Tax Withholding. The Employer shall undertake to make deductions, withholdings and tax  reports with respect to payments and benefits under this Agreement, to the extent it reasonably and in good faith  believes it is required to make such deductions, withholdings and tax reports. Payments with respect to compensation  and benefits referred to under this Agreement shall be in amounts net of any such deductions or withholdings. Nothing  in this Agreement shall be construed to require the Employer to make any payments to compensate the Employee for  any adverse tax effect associated with any payments or benefits, or for any deduction or withholding from any payment  or benefit.   Employee will be solely responsible for and will satisfy all of Employee&#8217;s tax obligations associated with all compensation paid or provided to Employee under this Employment Agreement.  Employee acknowledges and  agrees that Employee is not relying on any advice from the Employer or any Employer affiliate, officer, director,  employee, agent or attorney with respect to any tax issue relating to this Employment Agreement.  (l) Other Notable Considerations  (1) If Employee succeeds in CMO role, both Employee and Employer  (and/or its successors) will utilize best efforts to add Employee to the Company&#8217;s Board (2) If the Employee moves to the Company&#8217;s Board of Directors after  working 24 months (or another mutually agreed upon timeframe) as full-time CMO and helps  Employer successfully recruit and onboard a mutually agreed upon CMO successor, the time-based  Initial Stock Award will continue to vest.  (3) The Employee acknowledges and declares that, as of January 22nd, 2024,  he currently serves as a member of the board of advisors for two companies, namely Stellar Health  and Ounce of Care. The individual expresses the intention to continue providing advisory services  to these two companies while concurrently expressing interest to serve on the board of advisors for  an additional two companies. The individual agrees to manage their commitments responsibly,  ensuring that their advisory roles do not conflict with their obligations to Apollo Medical Holdings  Inc. This commitment includes dedicating an appropriate amount of time and attention to fulfill the  duties and responsibilities associated with each advisory position. The individual agrees to promptly  notify Apollo Medical Holdings Inc. of any potential conflicts of interest and will work  collaboratively to address such situations in a transparent and ethical manner.     5. Termination. The Employee&#8217;s employment hereunder may be terminated during the Term without any breach of this Agreement under the following circumstances:  (a) Death. The Employee&#8217;s employment hereunder shall terminate upon the Employee&#8217;s death. (b) Disability. The Employer may terminate the Employee&#8217;s employment if the Employee is disabled for 90 or more consecutive days and, because of the disability, is unable to perform the essential functions of  the Employee&#8217;s then existing position or positions under this Agreement with or without reasonable accommodation. This provision is not intended to reduce any rights the Employee may have pursuant to any law, including without  limitation the California Family Rights Act, the Family and Medical Leave Act, the California Fair Employment and  Housing Act, and the Americans with Disabilities Act.  (c) Termination by the Employer for Cause. At any time during the Term, the Employer may  terminate the Employee&#8217;s employment hereunder for Cause. For purposes of this Agreement, &#8220;Cause&#8221; shall mean: (i) </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 6 -  conduct by the Employee constituting a material act of willful misconduct, in the sole discretion of Employer, in  connection with the performance of the Employee&#8217;s duties that results in loss, damage or injury that is material to the Employer; (ii) the commission by the Employee of any felony; (iii) continued non-performance, or failure to achieve  growth, operational, and strategic goals, in the sole discretion of Employer, by the Employee of the Employee&#8217;s duties hereunder (other than by reason of the Employee&#8217;s physical or mental illness, incapacity or disability); (iv) a material breach, according to the standard of the Employer, by the Employee of any of the provisions of any agreement with  the Employer or its successor that results in loss, damage or injury that is material to the Employer; (v) willful failure  to cooperate with a bona fide, in the sole discretion of Employer, internal investigation or an investigation by  regulatory or law enforcement authorities, after being instructed by the Employer to cooperate, or the willful  destruction or failure to preserve documents or other materials known to be relevant to such investigation or the willful  inducement of others to fail to cooperate or to produce documents or other materials in connection with such  investigations; (vi) fraud, embezzlement or theft against the Employer or any of its Affiliates (as defined in Section  6(a) below); (vii) any damage of a material nature to any property of Employer or any of its affiliates caused by  Employee's willful or grossly negligent conduct; (viii) the repeated nonprescription use of any controlled substance  or the repeated use of alcohol, (vii), the Employer reasonably determines or renders the Employee unfit to serve as an  officer or employee of Employer or its affiliates; or (ix) conduct by Employee that in the good faith determination of  the Employer demonstrates unfitness to serve as an officer or employee of Employer or its affiliates, including, without  limitation, a finding by the Employer or any regulatory authority that Employee committed acts of employee  harassment or violated a material law or regulation applicable to the business of Employer or any of its Affiliates.   With respect to the events in (i), (iii) and (iv) herein, the Employer shall have delivered written notice to the Employee  of its intention to terminate the Employee&#8217;s employment for Cause, which notice specifies in reasonable detail the circumstances claimed to give rise to the Employer&#8217;s right to terminate the Employee&#8217;s employment for Cause and  the Employee shall not have cured such circumstances to the extent such circumstances are reasonably susceptible to  cure as determined by the Board in good faith within sixty (60) days following the Employer&#8217;s delivery of such notice. For avoidance of doubt, &#8220;Cause&#8221; shall not include (1) expense reimbursement disputes in which the Employee acts in reasonable good faith; (2) occasional, customary and de minimis use of the Employer&#8217;s property for personal purposes; and (3) acting in good faith upon advice of Employer&#8217;s legal counsel. (d) Termination by Employer without Cause. At any time during the Term, the Employer may  terminate the Employee&#8217;s employment hereunder without Cause by providing the Employee with thirty (30) days  advance written notice. Any termination by the Employer of the Employee&#8217;s employment under this Agreement that does not constitute a termination for Cause under Section 4(c) and does not result from the death or Disability of the  Employee under Sections 4(a) or 4(b) shall be deemed a termination without Cause under this Section 4(d). Any  suspension of the Employee&#8217;s employment with pay or benefits by the Board in good faith pending an investigation of alleged improper activities by the Employee that, if determined to be accurate, would be grounds for a Cause  termination, shall not be considered a termination of the Employee&#8217;s employment without Cause or provide with Good Reason to terminate employment.  (e) Termination by the Employee. At any time during the Term, the Employee may terminate  his employment hereunder for any reason, including, but not limited to, Good Reason. For purposes of this Agreement,  &#8220;Good Reason&#8221; shall mean that the Employee has complied with the Good Reason Process (hereinafter defined) following the occurrence of any of the following events: (i) a material diminution in the Employee&#8217;s title, responsibilities, authority or duties; or (ii) the material breach of this Agreement by the Employer, including but not  limited to a failure to pay Base Salary, Annual Bonus, as provided for under this Agreement. &#8220;Good Reason Process&#8221; shall mean (i) the Employee reasonably determines in good faith that a &#8220;Good Reason&#8221; condition has occurred; (ii) the Employee notifies the Employer in writing of the occurrence of the Good Reason condition within (60) days of  the occurrence of such condition; (iii) the Employee cooperates in good faith with the Employer&#8217;s efforts, for a period of sixty (60) days following such notice (the &#8220;Cure Period&#8221;), to remedy the condition; (iv) notwithstanding such efforts, the Good Reason condition continues to exist; and (v) the Employee terminates his employment within thirty  (30) days after the end of the Cure Period. If the Employer cures the Good Reason condition during the Cure Period,  Good Reason shall be deemed not to have occurred.  (f) Notice of Termination. Except for termination as specified in Section 4(a), any termination  of the Employee&#8217;s employment shall be communicated by written Notice of Termination by the terminating Party to the other Party hereto. For purposes of this Agreement, a &#8220;Notice of Termination&#8221; shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 7 -  (g) Date of Termination. &#8220;Date of Termination&#8221; shall mean the earliest of the following: (i) if the Employee&#8217;s employment is terminated by the Employee&#8217;s death, the date of the Employee&#8217;s death; (ii) if the Employee&#8217;s employment is terminated on account of Disability under Section 4(b) or by the Employer for Cause  under Section 4(c), the date on which Notice of Termination is given that follows any applicable required cure period;  (iii) if the Employee&#8217;s employment is terminated by the Employer under Section 4(d), sixty (60) days after the date  on which a Notice of Termination is given; (iv) if the Employee&#8217;s employment is terminated by the Employee under Section 4(e) without Good Reason, sixty (60) days after the date of which a Notice of Termination is given or  such shorter period agreed to by the Employer; or (v) if the Employee&#8217;s employment is terminated by the Employee under Section 4(e) with Good Reason, the date on which Notice of Termination is given after the end of the Cure  Period. Notwithstanding the foregoing, in the event that the Employee gives a Notice of Termination to the Employer,  the Employer may unilaterally accelerate the Date of Termination but such acceleration shall nevertheless be deemed  a termination without cause by the Employer, on the accelerated date for purposes of this Agreement. For purposes of  determining the time when the lump sum portion of the Severance Amount, if any, is to be paid under Section 5(b)(i) of  this Agreement, &#8220;Date of Termination&#8221; means the Employee&#8217;s separation from service as defined under Section 409A.  6. Compensation upon Termination.  (a) Accrued Benefits. If the Employee&#8217;s employment with the Employer is terminated for any reason during the Term, the Employer shall pay or provide the Employee (or the Employee&#8217;s authorized representative or estate) any earned but unpaid Base Salary or Annual Bonus for services rendered through the Date of Termination,  unpaid expense reimbursements, and accrued but unused paid time off (the &#8220;Accrued Benefits&#8221;) within the time prescribed by California law. With respect to vested compensation or benefits the Employee may have under any  employee benefit or compensation plan, program or arrangement of the Employer, payment will be made to the  Employee under the terms of the applicable plan, program or arrangement.  (b) Termination by the Employer without Cause or by the Employee with Good Reason. If the  Employee&#8217;s employment is terminated by the Employer without Cause as provided in Section 4(d), or the Employee  terminates his employment for Good Reason as provided in Section 4(e), then (i) the Employer shall, through the Date  of Termination, pay the Employee his or her Accrued Benefits, and (ii) if the Employee signs a general release of  claims (the &#8220;Release&#8221;) within twenty-one (21) days of the receipt of the form of the Release (extended to forty-five  (45) days in the event of a group termination or exit incentive program) and does not revoke such Release during the  seven-day revocation period:  (i) the Employer shall pay the Employee at a minimum an amount equal to one- twelfth (1/12) of the Employee&#8217;s most recent Base Salary times the number of full years of service completed, not to exceed twelve (12) years of service (but determined prior to any action involving Base Salary that  would constitute Good Reason) (the &#8220;Severance Amount&#8221;). For the avoidance of doubt, the maximum Severance Amount payable to Employee pursuant to the terms of this Agreement shall equal one (1) year of  the Employee&#8217;s most recent Base Salary, subject to such payroll deductions and withholdings as are required  by law. To the extent that such Severance Amount exceeds the 409A Separation Pay Limit (as defined below),  such amount shall be paid in a single lump sum on the regular payroll date of the Employer, pertaining to  then current salaried employees of the Employer, (&#8220;payroll date&#8221;) next following the first anniversary date of the Employee&#8217;s Date of Termination. The portion of the Severance Amount that does not exceed the 409A Separation Pay Limit shall be paid in substantially equal amounts on each payroll date over a one-year period;  and  (ii) Employer shall pay Employee an amount in cash equal to Employer&#8217;s premium amounts paid by Employee for coverage of Employee under Employer&#8217;s group medical, dental and vision programs for a period of six (6) months after the time of Employee&#8217;s termination of coverage, to be paid directly to Employee at the same times such payments would be paid on behalf of a current employee for  such coverage; provided, however:  (A)  No payments shall be made under this paragraph (ii) unless and until the  Employee timely elects continued coverage under such plan(s) pursuant to the Consolidated  Omnibus Budget Reconciliation Act of 1985 as amended (&#8220;COBRA&#8221;).  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 8 -  (B) This paragraph (ii) shall not be read or construed as placing any  restrictions upon amounts paid under this paragraph (ii) as to their use.  (C)  Payments under this paragraph (ii) shall cease as of the earliest to occur  of the following: (1) the Employee is no longer eligible for and continuing to receive the COBRA  coverage elected in subparagraph (A); (2) the time period set forth in the first sentence of this  paragraph (ii); (3) the date on which the Employee first becomes eligible to enroll in a group health  plan in which eligibility is based on employment with an employer; and (4) if the Employer in good  faith determines that payments under this paragraph (ii) would result in a discriminatory health plan  pursuant to the Patient Protection and Affordable Care Act of 2010, as amended.  (iii) Each individual payment of Severance Amount under Section 5(b)(i), and each  payment under Section 5(b)(ii) of this Agreement, shall be deemed to be a separate &#8220;payment&#8221; for purposes and within the meaning of Treasury Regulation Section 1.409A-2(b)(2)(iii).  (iv) For each individual payment of the Severance Amount under Section 5(b)(i), and  each payment under Section 5(b)(ii), of this Agreement, if considered &#8220;non-qualified deferred compensation&#8221; (&#8220;NQDC&#8221;) under Section 409A, then the Employer shall make any such payment not earlier than the earlier  of: (x) the first payroll date which is six (6) months following the Employee&#8217;s separation from service (as defined under Section 409A) with the Employer, or (y) the date of Employee&#8217;s death. The Employer may in its sole discretion accelerate or defer (but not beyond the time limit set forth below) any severance payments  which do not constitute NQDC in order to allow for the payment of taxes due, but not beyond the time limit  specified for such payment such that the payment would be treated as NQDC.  (v) For purposes of this Section 5, (A) &#8220;Section 409A&#8221; means Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations thereunder, and (B) &#8220;409A Separation Pay  Limit&#8221; means two times the lesser of (x) the Employee&#8217;s annual compensation during the calendar year preceding the year of the termination of employment; and (y) the adjusted compensation limit under Code  Section 401(a)(17) in effect for the year of the termination.  7. Confidential Information/Competitive Activities/Intellectual Property/ Cooperation.  (a) Definitions. As used in this Agreement:  (i) &#8220;Affiliate&#8221; means, as to any Person, (A) any other Person which directly, or indirectly through one or more intermediaries, controls such Person or is consolidated with such Person in  accordance with GAAP, (ii) any other Person which directly, or indirectly through one or more  intermediaries, is controlled by or is under common control with such Person, or (B) any other Person of  which such Person owns, directly or indirectly, fifty percent (50%) or more of the common stock or  equivalent equity interests. As used herein, the term &#8220;control&#8221; means possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the  ownership of voting securities or otherwise.  (ii) &#8220;Person&#8221; means an individual, a corporation, a partnership, a limited liability company, an association, a trust or any other entity or organization.  (iii) &#8220;Confidential Information&#8221; means information belonging to the Employer or its Affiliates which is of value to the Employer or any of its Affiliates in the course of conducting its business  (whether having existed, now existing, or to be developed or created during Employee&#8217;s employment by  Employer) and the disclosure of which could result in a competitive or other disadvantage to the Employer  or its Affiliates. Confidential Information includes, without limitation, contract terms and rates; negotiating  and contracting strategies; financial information, reports, and forecasts; inventions, improvements and other  intellectual property; product plans or proposed product plans; trade secrets; designs, processes or formulae;  software; employee, customer, patient, provider and supplier information; information from patient medical  records; financial data; insurance reimbursement methodologies, strategies and practices; product and service  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 9 -  pricing methodologies, strategies and practices; contracts with physicians, providers, provider networks,  payors, physician databases and contracts with hospitals; regulatory and clinical manuals; and business plans,  prospects and opportunities (such as possible acquisitions or dispositions of businesses or facilities) that have  been discussed or considered by the Employer or its Affiliates, including, without limitation, the management  of the Employer or its Affiliates. Confidential Information includes information developed by the Employee  in the course of the Employee&#8217;s employment by the Employer, as well as other information to which the Employee may have access in connection with the Employee&#8217;s employment. Confidential Information also includes the confidential information of others with which the Employer or its Affiliates has a business  relationship. Notwithstanding the foregoing, Confidential Information does not include information in the  public domain, unless due to breach of the Employee&#8217;s duties under Section 6(b), unless otherwise due to  Employee&#8217;s breach of the obligations in this Agreement, or unless due to violation of another Person&#8217;s obligations to the Employer or its Affiliates that Employee should have taken reasonable measures to prevent  but that Employee did not take.  (b) Confidentiality. The Employee understands and agrees that the Employee&#8217;s employment creates a relationship of confidence and trust between the Employer and the Employee with respect to all Confidential  Information. At all times, both during the Employee&#8217;s employment with the Employer and after the Employee&#8217;s termination from employment for any reason, the Employee shall keep in confidence and trust all such Confidential  Information, and shall not use, disclose, or transfer any such Confidential Information without the written consent of  the Employer, except as may be necessary within the scope of Employee&#8217;s duties with Employer and in the ordinary course of performing the Employee&#8217;s duties to the Employer or as otherwise provided in Section 6(c). Employee  understands and agrees not to sell, license or otherwise exploit any products or services which embody or otherwise  exploit in whole or in part any Confidential Information or materials. Employee acknowledges and agrees that the  sale, misappropriation, or unauthorized use or disclosure in writing, orally or by electronic means, at any time of  Confidential Information obtained by Employee during or in connection with the course of Employee&#8217;s employment constitutes unfair competition. Employee agrees and promises not to engage in unfair competition with Employer or  its Affiliates, either during employment, or at any time thereafter.  Employee further agrees (unless required by the  Employer in connection with employment or with the Employer's express written consent) not to copy, take, or remove  any of the Employer's books, records, customer lists, or any other documents or materials from the Employer's  premises, including Human Resources manuals, materials, and forms. The Employee shall not, at any time whatsoever,  either during the term of this Agreement or after its termination, disclose to others, either directly or indirectly, or take  or use for the Employee&#8217;s own competitive purposes or the competitive purposes of others, either directly or indirectly, any confidential information, knowledge or data of the Employer. Upon (a) the voluntary or involuntary termination  of employment with the Employer for whatever reason; or (b) at any time the Employer demands, Employee shall  promptly deliver to the Employer at his or her sole cost any and all of the Employer's books, records, confidential  information, and/or any other documents or materials which are in Employee&#8217;s possession or under Employee&#8217;s control or any copies thereof.  (c) Protected Rights. Notwithstanding anything to the contrary in this Section 6, this  Agreement is not intended to, and shall not, in any way prohibit, limit or otherwise interfere with the Employee&#8217;s protected rights under federal, state or local law to, without notice to the Employer, (i) communicate or file a charge  with a government regulator; (ii) participate in an investigation or proceeding conducted by a government regulator;  or (iii) receive an award paid by a government regulator for providing information.  (d) Documents, Records, etc. All documents, records, data, apparatus, equipment and other  physical property, whether or not pertaining to Confidential Information, that are furnished to the Employee by the  Employer or its Affiliates or are produced by the Employee in connection with the Employee&#8217;s employment will be and remain the sole property of the Employer and its Affiliates. The Employee shall return to the Employer all such  materials and property as and when requested by the Employer. In any event, the Employee shall return all such  materials and property immediately upon termination of the Employee&#8217;s employment for any reason. The Employee shall not retain any such material or property or any copies thereof after such termination. It is specifically agreed that  any documents, card files, notebooks, programs, or similar items containing customer or patient information are the  property of the Employer and its Affiliates regardless of by whom they were compiled.  (e) Disclosure Prevention. The Employee will take all reasonable precautions to prevent the  inadvertent or accidental exposure of Confidential Information.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 10 -  (f) Removal of Material. The Employee will not remove any Confidential Information from  the Employer&#8217;s or its Affiliate&#8217;s premises except for use in the Employer&#8217;s business, and only consistent with the Employee&#8217;s duties with the Employer. (g) Copying. The Employee agrees that copying or transferring Confidential Information (by  any means) shall be done only as needed in furtherance of and for use in the Employer&#8217;s and its Affiliate&#8217;s business, and consistent with the Employee&#8217;s duties with the Employer. The Employee further agrees that copies of Confidential  Information shall be treated with the same degree of confidentiality as the original information and shall be subject to  all restrictions herein.  (h) Computer Security. The Employee agrees to comply with the Employer&#8217;s policies and procedures concerning computer security.  (i) E-Mail. The Employee acknowledges that the Employer retains the right to review any and  all electronic mail communications made with employer provided email accounts, hardware, software, or networks,  with or without notice, at any time.  (j) Assignment. The Employee acknowledges that any and all inventions, discoveries, designs,  developments, methods, modifications, trade secrets, processes, software, formulae, data, &#8220;know-how,&#8221; databases, algorithms, techniques and works of authorship whether or not patentable or protectable by copyright or trade secret,  made or conceived, first reduced to practice, or learned by the Employee, either alone or jointly with others, during  the Term that (i) relate to or are useful in the business of the Employer or its Affiliates, or (ii) are conceived, made or  worked on at the expense of or during the Employee&#8217;s work time for the Employer, or using any resources or materials of the Employer or its Affiliates, or (iii) arise out of tasks assigned to the Employee by the Employer (together  &#8220;Proprietary Inventions&#8221;) will be the sole property of the Employer or its Affiliates. The Employee acknowledges that all work performed by the Employee is on a &#8220;work for hire&#8221; basis and the Employee hereby assigns or agrees to assign  to the Employer the Employee&#8217;s entire right, title and interest in and to any and all Proprietary Inventions and related intellectual property rights. The Employee agrees to assist the Employer to obtain, maintain and enforce intellectual  property rights for Proprietary Inventions in any and all countries during the Term, and thereafter for as long as such  intellectual property rights exist.  NOTICE TO CALIFORNIA EMPLOYEES Pursuant to California Labor Code &sect;2870, an agreement requiring the employee to assign or offer to assign any of his  or her rights in any invention to his or her employer does not apply to an invention which qualifies fully under the  provisions of California Labor Code &sect; 2870, which provides as follows:  &#8220;(a) Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not  apply to an invention that the employee developed entirely on his or her own time without using the  employer&#8217;s equipment, supplies, facilities, or trade secret information except for those inventions that either:  &#8220;(1) Relate at the time of conception or reduction to practice of the invention to the employer&#8217;s business, or actual or demonstrably anticipated research or development of the employer; or  &#8220;(2) Result from any work performed by the employee for the employer. &#8220;(b) To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a),  the provision is against the public policy of this state and is unenforceable.&#8221; (k) Competitive Activities. Employee agrees and covenants that, at any time during  Employee&#8217;s employment with the Employer and for a period of twelve (12) months immediately following the </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 11 -  termination of Employee&#8217;s relationship with the Employer for any reason, whether with or without cause, Employee shall not, either on Employee&#8217;s own behalf or on behalf of any other Person: (i) solicit the services of the Employer&#8217;s employees or entice away, directly or indirectly, any Person employed or engaged by or otherwise providing services  to the Employer or its Affiliates, whether in an employment capacity or otherwise (this provision does not prohibit the  Employee&#8217;s post- termination acceptance of unsolicited applications for employment); or (ii) take any action or engage  in any unfair business practice, including, without limitation, any misappropriation of confidential, proprietary or trade  secret information of the Employer or its Affiliates, as a result of which relations between the Employer or its  Affiliates, and any of their customers, clients, suppliers, distributors or others, may be impaired or which might  otherwise be detrimental to the business interests or reputation of the Employer or its Affiliates. During the term of  Employee&#8217;s employment, Employee shall not, directly or indirectly as an employee, contractor, officer, director, member, partner, agent, or equity owner, engage in any activity or business that competes or could reasonably be  expected to compete with the business of Employer or any Affiliate. Employee acknowledges that there is a substantial  likelihood that the activities described in this Section would (a) involve the unauthorized use or disclosure of  Employer&#8217;s or an Affiliate&#8217;s Confidential Information and that use or disclosure would be extremely difficult to detect, and (b) result in substantial competitive harm to the business of Employer or an Affiliate. Employee has accepted the  limitations of this Section as a reasonably practicable and unrestrictive means of preventing such use or disclosure of  Confidential Information and preventing such competitive harm.    (l) Third-Party Agreements and Rights. The Employee hereby confirms that the Employee is  not bound by the terms of any agreement with any previous employer or other party which restricts in any way the  Employee&#8217;s use or disclosure of information or the Employee&#8217;s engagement in any business except as Employee has  previously provided written notice to Employer and has attached to this Agreement. The Employee represents to the  Employer that the Employee&#8217;s execution of this Agreement, the Employee&#8217;s employment with the Employer and the  performance of the Employee&#8217;s proposed duties for the Employer will not violate any obligations the Employee may have to any previous employer or other party. In Employee&#8217;s work for Employer, Employee will not disclose or use any information in violation of any agreements with or rights of any such previous employer or other party, and  Employee will not bring into (by any means) the premises of Employer any copies or other tangible embodiments of  non-public information belonging to or obtained from any such previous employment or other Person.  (m) Litigation and Regulatory Cooperation. During and after the Employee&#8217;s employment, the Employee shall cooperate fully with the Employer in the defense or prosecution of any claims or actions now in  existence or that may be brought in the future against or on behalf of the Employer that relate to events or occurrences  that transpired while the Employee was employed by the Employer. The Employee&#8217;s full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for  discovery or trial and to act as a witness on behalf of the Employer at mutually convenient times. During and after the  Employee&#8217;s employment, the Employee also shall cooperate fully with the Employer in connection with any  investigation or review of any federal, state, or local regulatory authority as any such investigation or review relates  to events or occurrences that transpired while the Employee was employed by the Employer. The Employer shall  reimburse the Employee for any reasonable out-of-pocket expenses, including, but not limited to, actual missed wages,  incurred in connection with the Employee&#8217;s performance of obligations pursuant to this Section. &#8220;Full cooperation&#8221; shall not be construed to in any way require any violation of law or any testimony that is false or misleading.  (n) Enforcement; Injunction. The Employee acknowledges and agrees that the restrictions  contained in this Agreement are reasonable and necessary to protect the business and interests of the Employer and its  Affiliates, do not create any undue hardship for the Employee, and that any violation of the restrictions in this  Agreement would cause the Employer and its Affiliates substantial irreparable injury. Accordingly, the Employee  agrees that a remedy at law for any breach or threatened breach of the covenants or other obligations in Section 6 of  this Agreement would be inadequate and that the Employer, in addition to any other remedies available, shall be  entitled to obtain preliminary and permanent injunctive relief to secure specific performance of such covenants and to  prevent a breach or contemplated or threatened breach of this Agreement without the necessity of proving actual  damage and without the necessity of posting bond or security, which the Employee expressly waives. Moreover, the  Employee will provide the Employer a full accounting of all proceeds and profits received by the Employee as a result  of or in connection with a breach of Section 6 of this Agreement. Unless prohibited by law, the Employer shall have  the right to retain any amounts otherwise payable by the Employer to the Employee to satisfy any of the Employee&#8217;s obligations as a result of any breach of Section 6 of this Agreement. The Employee hereby agrees to indemnify and  hold harmless the Employer and its Affiliates from and against any damages incurred by the Employer or its Affiliates  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 12 -  as assessed by a court of competent jurisdiction as a result of any breach of Section 6 of this Agreement by the  Employee.  Likewise, the Employer hereby agrees to indemnify and hold harmless the Employee from and against  any damages incurred by the Employee as assessed by a court of competent jurisdiction as a result of any breach  of Section 6 of this Agreement by the Employer. The prevailing party shall be entitled to recover its reasonable  attorneys&#8217; fees and costs if it prevails in any action to enforce Section 6 of this Agreement. It is the express intention  of the parties that the obligations of Section 6 of this Agreement shall survive the termination of the Employee&#8217;s employment. The Employee agrees that each obligation specified in Section 6 of this Agreement is a separate and  independent covenant that shall survive any termination of this Agreement and that the unenforceability of any of  them shall not preclude the enforcement of any other covenants in Section 6 of this Agreement. No change in the  Employee&#8217;s duties or compensation shall be construed to affect, alter or otherwise release the Employee from the covenants herein.  8. Successors. This Agreement shall be binding upon and inure to the benefit of both parties and their  respective successors and permitted assigns, except it shall not be binding to Employee where any corporation or  entity with which or into which the Employer may be merged or which may succeed to its assets or business wherein  there has been a change in ownership of more than 50% (&#8220;CIO&#8221;), Where succession is permissible, Employee&#8217;s obligations are personal and shall not be assigned by Employee. The Employee consents to be bound by the provisions  of this Agreement, except in circumstances of CIO, for the benefit of the Employer or its Affiliates to whose employ  the Employee may be transferred without the necessity that this Agreement be resigned at the time of such transfer.  In the event of the Employee&#8217;s death after the Date of Termination but prior to the completion by the Employer of all payments due to the Employee under this Agreement, the Employer shall continue such payments to the Employee&#8217;s beneficiary designated in writing to the Employer prior to the Employee&#8217;s death (or to the Employee&#8217;s estate, if the Employee fails to make such designation).  9. Enforceability. If any portion or provision of this Agreement shall to any extent be declared illegal  or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such  portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not  be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest  extent permitted by law.  10. Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by  the waiving party. The failure of any party to require the performance of any term or obligation of this Agreement, or  the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term  or obligation or be deemed a waiver of any subsequent breach.  11. Notices. Any notices, requests, demands and other communications provided for by this Agreement  shall be sufficient if in writing and delivered in person or sent by registered or certified mail, postage prepaid, to the  Employee at the last address for which the Employee has provided written notice to the Employer, or to the Employer  at its main office, to the attention of Chief Executive Officer. 12. Publicity. The Employee hereby grants to the Employer the right to use the Employee&#8217;s name and likeness, without additional consideration, on, in and in connection with technical, marketing, regulatory filings and/or  disclosure materials published by or for the Employer for the duration of Employee&#8217;s employment with Employer. 13. Conflicting Obligations and Rights. The Employee agrees to inform the Employer in writing of any  apparent conflicts between the Employee&#8217;s work for the Employer and (a) any obligations the Employee may have to preserve the confidentiality of another&#8217;s proprietary information or materials or (b) any rights the Employee claims to  any inventions or ideas before using the same on the Employer&#8217;s behalf. Otherwise, the Employer may conclude that no such conflict exists and the Employee agrees thereafter to make no such claim against the Employer. The Employer  shall receive such disclosures in confidence and consistent with the objectives of avoiding any conflict of obligations  and rights or the appearance of any conflict of interest.  14. Notification of New Employer. In the event that the Employee leaves the employment of the  Employer, voluntarily or involuntarily, the Employee agrees to inform any subsequent employer of the Employee&#8217;s </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 13 -  obligations under Section 6 of this Agreement. The Employee further hereby authorizes the Employer to notify the  Employee&#8217;s new employer about the Employee&#8217;s obligations under Section 6 of this Agreement.  15. Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect  to the subject matter hereof and supersedes any previous oral or written communications, negotiations, representations,  understandings, or agreements between them. Any modification of this Agreement shall be effective only if set forth  in a written document signed by the Employee and a duly authorized officer of the Employer.  16. Amendment. This Agreement may be amended or modified only by a written instrument signed by  the Employee and by a duly authorized representative of the Employer.  17. Governing Law. This is a California contract and shall be construed under and be governed in all  respects by the laws of the State of California, without giving effect to the conflict of laws principles of such State.  18. Obligations of Successors. The Employer shall require any successor (whether direct or indirect, by  purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Employer to  expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Employer  would be required to perform if no such succession had taken place.  19. Limitation on Payments in Certain Events.  (a) Limitation on Payments. Notwithstanding anything to the contrary in Section  3 and Section 5 of this Agreement, if any payment or distribution that the Employee would receive pursuant to this  Agreement or otherwise (&#8220;Payment&#8221;) would (a) constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Code), and (b) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the  &#8220;Excise Tax&#8221;), then the Employer shall cause to be determined, before any amounts of the Payment are paid to the Employee, which of the following alternative forms of payment would maximize the Employee&#8217;s after-tax proceeds:  (i) payment in full of the entire amount of the Payment (a &#8220;Full Payment&#8221;), or (ii) payment of only a part of the Payment so that the Employee receives that largest Payment possible without being subject to the Excise Tax (a  &#8220;Reduced Payment&#8221;), whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax (all computed at the highest marginal rate, net of the maximum reduction in federal  income taxes which could be obtained from a deduction of such state and local taxes), results in the Employee&#8217;s receipt, on an after-tax basis, of the greater amount of the Payment, notwithstanding that all or some portion the  Payment may be subject to the Excise Tax.  (b) The independent registered public accounting firm engaged by the Employer for general  audit purposes as of the day prior to the date the first Payment is due shall make all determinations required to be  made under this Section 18. If the independent registered public accounting firm so engaged by the Employer is  serving as accountant or auditor for the individual, group or entity effecting the transaction, the Employer shall appoint  a nationally recognized independent registered public accounting firm to make the determinations required hereunder.  The Employer shall bear all expenses with respect to the determinations by such independent registered public  accounting firm required to be made hereunder.  (c) The independent registered public accounting firm engaged to make the determinations  hereunder shall provide its calculations, together with detailed supporting documentation, to the Employer and the  Employee at such time as requested by the Employer or the Employee. If the independent registered public accounting  firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the  Reduced Payment, it shall furnish the Employer and the Employee with an opinion reasonably acceptable to the  Employee that no Excise Tax will be imposed with respect to such Payment. Any good faith determinations of the  accounting firm made hereunder shall be final, binding and conclusive upon the Parties.  20. Consent to Jurisdiction; Forum Selection. At all times the Employee and Employer: (a) irrevocably  submit to the exclusive jurisdiction of the Los Angeles Superior Court and United States District Court for the Central  District of California, whichever may have competent subject matter jurisdiction, in any action or proceeding arising  out of or relating to this Agreement, and irrevocably agree that all claims in respect of any such action or proceeding  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  brot,htA, Sivx  01/23/2024 01/23/2024  - 14 -  may be heard and determined in such court; (b) to the extent permitted by law, irrevocably consent to the service of  any and all process in any such action or proceeding by the mailing of copies of such process to such party at the  address set forth in this Agreement (or otherwise on record with the Employer); (c) to the extent permitted by law,  irrevocably confirm that service of process out of such courts in such manner shall be deemed due service upon such  party for the purposes of such action or proceeding; (d) to the extent permitted by law, irrevocably waives (i) any  objection the Employee or Employer may have to the laying of venue of any such action or proceeding in any of such  courts, or (ii) any claim that the Employee or Employer may have that any such action or proceeding has been brought  in an inconvenient forum; and (e) to the extent permitted by law, irrevocably agrees that a final nonappealable  judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on  the judgment or in any other manner provided by law. Nothing in this Section shall affect the right of any party hereto  to serve legal process in any manner permitted by law.  21. Counterparts. This Agreement may be executed in any number of counterparts, each of which when  so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and the  same document.  22. Effective Date. The effective date of this Agreement (the &#8220;Effective Date&#8221;) will be January 23,  2024, or as otherwise mutually agreed up on by the Parties.  IN WITNESS WHEREOF, this Agreement has been executed as a sealed instrument by the Employer by  its duly authorized officer, and by the Employee, as of the date first above written.  EMPLOYER: APOLLO MEDICAL HOLDINGS, INC.  By: _________________________  Brandon Sim  Chief Executive Officer  EMPLOYEE: Dinesh Kumar, MD  Signed:  ________________________   Date: Date: </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1060-kumaremploym015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1060-kumaremploym015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 15 -  EXHIBIT A DUTIES  Employee&#8217;s duties shall include but not be limited to the following under the direction of the CEO: &#149; Provide clinical leadership and expertise to guide the organization's healthcare practices and policies.  &#149; Ensure that the organization's clinical services meet high-quality standards and comply with regulations and  best practices.  &#149; Oversee and manage the medical staff, including physicians, nurses, and other healthcare professionals.  &#149; Develop and implement quality improvement initiatives to enhance patient care and safety.  &#149; Develop and implement strategies to enhance healthcare quality for Medicaid and Commercial (exchange)  populations.  &#149; Drive improvements in encounter PMPMs through cost-effective care delivery without compromising  quality.  &#149; Collaborate with other executives to develop and execute the organization's strategic goals and objectives,  including expanding services, improving patient outcomes, and managing resources effectively.  &#149; Being a physician leader, playing a key role in maintaining positive relations with the medical staff.  &#149; Responsible for presenting to external entities and conveying the unity and commitment of the medical  staff to the organization's mission and values.  &#149; Establish and maintain clinical governance structures to promote transparency and accountability in clinical  decision-making and patient care.  &#149; Manage and mitigate clinical and legal risks, including malpractice claims, by implementing appropriate  risk management strategies.  &#149; Develop and update clinical policies and protocols to ensure they reflect the latest evidence-based practices  and align with the organization's goals.  &#149; Work with the financial team to manage the budget for clinical services, ensuring cost-effectiveness while  maintaining high-quality care.  &#149; Develop and implement strategies to improve the health of the population served by the organization,  including preventive care and chronic disease management.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.61
<SEQUENCE>16
<FILENAME>exhibit1061-loanandsecur.htm
<DESCRIPTION>EX-10.61
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit1061-loanandsecur</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit1061-loanandsecur001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">- 1 -  LOAN AND SECURITY AGREEMENT  This Loan and Security Agreement (this &#8220;Agreement&#8221;) is entered into on January 31, 2024, by and  between AP-AMH 2 Medical Corporation, a California professional corporation (&#8220;Borrower&#8221;) and Apollo  Medical Holdings, Inc., a Delaware corporation (&#8220;Lender&#8221;).  Lender and Borrower are collectively referred  to herein as the &#8220;Parties&#8221;.  RECITALS  A. Contemporaneously with the execution of this Agreement, Borrower is entering into that  certain Subscription Agreement (the &#8220;Subscription Agreement&#8221;), pursuant to which Borrower is  subscribing for one thousand (1,000) shares of Series A Preferred Stock (the &#8220;Preferred Shares&#8221;) of  Metropolitan IPA, a California professional medical corporation and wholly owned subsidiary of Borrower  (&#8220;Metropolitan&#8221;), which shares constitute all of the authorized, issued and outstanding preferred shares of  Metropolitan. The rights and preferences of the Preferred Shares are governed by a Certificate of  Determination of Preference of Series A Preferred Stock in substantially the form attached as Exhibit C  hereto (the &#8220;Certificate of Determination&#8221;), to be filed on or before the date on which the first Advance  (as defined below) is funded by Lender with the Secretary of State of the State of California.   B. Lender has entered into that certain Asset and Equity Purchase Agreement (the &#8220;CFC  Purchase Agreement&#8221;), pursuant to which (i) Lender will be acquiring 100% of the issued and outstanding  general partnership interest of Advanced Health Management Systems, L.P., a California limited  partnership (&#8220;AHMS&#8221;) and limited partnership interests of AHMS; and (ii) Metropolitan will be acquiring  substantially all of the assets from Community Family Care Medical Group IPA, Inc., a California  corporation (&#8220;CFC&#8221;, and the transactions described in this clause (ii), the &#8220;CFC Acquisition&#8221;), all as more  specifically provided in the CFC Purchase Agreement.  C. Lender has agreed to (i) provide loans to Borrower from time to time, on a secured basis,  to advance to Borrower (a) Ninety-Three Million Eight Hundred Thousand Dollars ($93,800,000), as the  closing cash purchase with respect to the CFC Acquisition, as more fully described in Article 1 of the CFC  Purchase Agreement, plus (b) any purchase price adjustment payable by the Company with respect to the  CFC Acquisition as more fully described in Article 2 of the CFC Purchase Agreement, plus (c) earnout  payments of up to Fifteen Million Dollars ($15,000,000) with respect to the CFC Acquisition as more fully  described in Section 1.3 of the CFC Purchase Agreement; and (ii) issue 631,712 shares of common stock  in Lender, as a portion of the purchase price payable to CFC IPA for the CFC Acquisition at the direction  of the Company, having a value of $20,000,000 as more fully described in Article 1 of the CFC Purchase  Agreement (collectively, the consideration described in clauses (i) and (ii), the &#8220;Purchase  Consideration&#8221;), all on the terms and conditions set forth in this Agreement.  AGREEMENT  In consideration of the premises and the mutual covenants and agreements contained herein, and  for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,  the Parties, intending to be legally bound, hereby agree as follows:  1. Certain Definitions.  Unless otherwise defined herein, or the context hereof otherwise  requires, each term defined in the CFC Purchase Agreement or in the UCC (as defined below) is used in  this Agreement with the same meaning; provided that, if the definition given to such term in the CFC  Purchase Agreement conflicts with the definition given to such term in the UCC, the UCC definition shall  control to the extent legally allowable; and if any definition given to such term in Article 9 of the UCC  conflicts with the definition given to such term in any other chapter of the UCC, the Article 9  definition shall prevail. As used herein, the following terms have the meanings indicated. The meaning  of defined terms shall be equally applicable to both the singular and plural forms of the terms defined.  Exhibit 10.61 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 2 -   &#8220;Collateral&#8221; means, collectively and severally, all of Borrower&#8217;s right, title and interest in and to  the assets of Borrower, whether now owned or hereafter acquired, including, without limitation, (i) all of  Borrower&#8217;s right, title and interest in and to the Preferred Shares and Common Stock (and any other  securities) of Metropolitan, now or hereafter owned by Borrower, together in each case with all certificates  representing the same, (ii) all shares, securities, moneys or other property representing a dividend on or a  distribution or return of capital on or in respect of the Pledged Shares, or resulting from a split-up, revision,  reclassification or other like change of the Pledged Shares or otherwise received in exchange therefor, and  any warrants, rights or options issued to the holders of, or otherwise in respect of, the Pledged Shares, (iii)  all shares of any successor entity of any such merger or consolidation (collectively, the &#8220;Pledged Shares&#8221;),  and (iv) (a) all Accounts, (b) all Equipment, Goods, Inventory and Fixtures, (c) all Documents, Instruments  and Chattel Paper, (d) all Letters of Credit and Letter-of-Credit Rights, (e) all Securities Collateral, (f) all  Investment Property, (g) all Intellectual Property Collateral, (h) all Commercial Tort Claims, (i) all General  Intangibles, (j) all Money and Deposit Accounts, (k) all Supporting Obligations, (l) all books and records,  customer lists, credit files, computer files, programs, printouts and other computer materials and records  relating to the Collateral and any General Intangibles at any time evidencing or relating to any of the  foregoing and (m) to the extent covered by clauses (a) through (l) of this sentence all Proceeds and products  of each of the foregoing and all accessions to, substitutions and replacements for, and rents, profits and  products of, each of the foregoing, and any and all Proceeds of any insurance, indemnity, warranty or  guaranty payable to Borrower from time to time with respect to any of the foregoing; provided, however,  that the Collateral shall not include any property of Borrower the disclosure, transfer, assignment, pledge  or encumbrance of which is prohibited by applicable law (including applicable anti-assignment rules of the  Medicare, Medicaid and other Federal Health Care Programs, as that term is defined in 42 USC Section  1320a-7b(f)).  &#8220;Common Stock&#8221; has the meaning set forth in the Certificate of Determination.  &#8220;Documents&#8221; means this Agreement, the CFC Purchase Agreement, the Subscription Agreement,  the Shareholder Agreement, any promissory notes and all other certificates, documents, agreements and  instruments delivered by Borrower to Lender hereunder or in connection therewith.  &#8220;Event of Default&#8221; has the meaning set forth in Section 5 hereof.  &#8220;Federal  Health  Care  Program&#8221; means any &#8220;federal health care program&#8221; as defined in 42  U.S.C. &sect; 1320a-7b(f), including Medicare, state Medicaid programs, state CHIP programs, TRICARE and  similar or successor programs with or for the benefit of any government authority.  &#8220;Lender&#8221; means on any date of determination, Lender and its successors and assigns.  &#8220;Obligations&#8221; means the indebtedness, liabilities and other obligations of Borrower to Lender at  any time under or in connection with this Agreement and the other Documents, whether now existing or  hereafter arising, whether due or to become due, absolute or contingent, liquidated or unliquidated,  determined or undetermined, whether or not from time to time decreased or extinguished and later  increased, created or incurred and whether arising or liquidated before or after a termination of this  Agreement.  &#8220;Person&#8221; means any natural individual, corporation, partnership, limited liability company, joint  venture, association, bank, trust company, trust or other entity, whether or not legal entities, or any  government entity, agency or political subdivision.  &#8220;Security Interest&#8221; means the security interest granted and the pledge and assignment made under  Section 3 hereof.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 3 -   &#8220;UCC&#8221; means the Uniform Commercial Code, including each such provision as it may  subsequently be renumbered, as enacted in California or other applicable jurisdiction, as amended at the  time in question.  2. Amounts and Terms of Loans.  (a) Advances.  If, from time to time during the Term, Borrower has insufficient funds  to pay in full the Purchase Consideration then Lender shall provide financing to Borrower for such purposes  by advancing funds to or on behalf of Borrower (collectively, &#8220;Advances&#8221;).  Borrower will use any such  Advances solely for such purposes approved in connection with any Advance. Lender will record on Exhibit  A the amount of each Advance made by Lender to Borrower under this Agreement and all payments made  by Borrower to Lender; provided, however, that Lender's failure to make an entry shall not limit or  otherwise affect the obligations of Borrower or any endorser or guarantor. As Lender may request from  time to time, Borrower will execute a secured promissory note evidencing the amount of then-outstanding  Advances, in the form attached hereto as Exhibit B.  (b) Interest.  Each Advance will bear interest from the date of disbursement to the  date of repayment at a rate equal to twelve percent (12%) per annum, not to exceed the maximum rate  allowed by applicable law; provided, however, that the portion of outstanding principal that is the result of  any increase in outstanding principal pursuant to Section 2(c) shall bear simple interest at the rate of ten  and 75/100 percent (10.75%) per annum.  (c) Repayment. The sum of all Advances made by Lender to Borrower and not  previously repaid, plus all accrued but unpaid interest thereon (such sum, the &#8220;Outstanding Balance&#8221;) will  be due and payable in full, without offset or deduction, by Borrower to Lender on the Maturity Date.   Interest shall be payable quarterly in arrears within three (3) business days after each Series A Dividend  Payment Date (as defined in the Certificate of Determination) (each, an &#8220;Interest Payment Date&#8221;). To the  extent that Borrower is unable to make any interest payment due hereunder on the Interest Payment Date  corresponding to any Series A Dividend Payment Date because it has received Series A Dividends with  respect to such Series A Dividend Payment Date in an amount insufficient (or because it has not received  any Series A Dividends on the Series A Dividend Payment Date) and does not otherwise have sufficient  cash as reasonably determined by the Board (as defined in the Certificate of Determination) to pay in full  such interest payment, the then outstanding principal amount of all Advances made by Lender to Borrower  and not previously repaid shall be increased by the amount of any such accrued but unpaid interest.  Borrower may not prepay any principal amount of any Advances prior to the Maturity Date without the  written consent of Lender; provided, however, that Borrower shall apply any Series A Dividends that are  received after any Interest Payment Date corresponding to the immediately preceding Series A Dividend  Payment Date to prepay the Outstanding Balance in the amount equal to the portion of any such scheduled  interest payment that was not paid as scheduled and was added to the principal amount. Notwithstanding  the foregoing, the Outstanding Balance shall be immediately due and payable by Borrower to Lender upon  termination or expiration of this Agreement or as provided in Section 5 hereof.  Upon termination or  expiration of this Agreement or other acceleration of any Advances hereunder, Lender may pursue any  remedy available at law or in equity to enforce or compel Borrower&#8217;s performance of their obligations  under this Agreement and pursue any remedies set forth in this Agreement. Any other payments made by  Borrower under this Agreement will be applied first to accrued and unpaid interest and then to the  repayment of the outstanding principal amount of the Outstanding Balance.  3. Security Interest.    (a) In order to secure the full and complete payment and performance when due of the  Obligations, except as otherwise prohibited by applicable law (including applicable anti-assignment rules  of the Medicare, Medicaid and other Federal Health Care Programs, as that term is defined in 42 USC  Section 1320a-7b(f)), Borrower hereby grants to Lender a first-priority security interest in the Collateral  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 4 -   and all of Borrower&#8217;s rights, titles and interests in and to the Collateral, and Borrower hereby pledges and  collaterally transfers and assigns the Collateral to Lender, all upon and subject to the terms and conditions  of this Agreement.  Such security interest is granted and collateral pledge and assignment are made as  security only and shall not subject Lender to, or transfer or in any way affect or modify, any obligation of  Borrower with respect to any of the Collateral or any transaction involving or giving rise thereto. If the  grant, pledge, or collateral transfer or assignment of any specific item of the Collateral is expressly  prohibited by any contract, then the security interest created hereby nonetheless remains effective to the  extent allowed by the UCC or other applicable law, but is otherwise limited by that prohibition.    (b) Borrower authorizes Lender to prepare and file any and all documents Lender  deems appropriate to perfect its security interest hereunder, and Borrower agrees to cooperate with Lender  and execute all documents requested by Lender to enable Lender to perfect its security interest hereunder.  (c) Borrower hereby irrevocably appoints Lender, effective on the occurrence and  during the continuance of an Event of Default, as its attorney-in-fact to do (but Lender shall not be obligated  to do and shall incur no liability to Borrower or any third party for failure to do) any act which Borrower is  obligated by this Agreement to do, and to (i) exercise such rights and powers as Borrower might exercise  with respect to the Collateral, including, without limitation, the right to collect by legal proceedings or  otherwise and endorse, receive and receipt for all dividends, interest, payments, proceeds and other sums  and property now or hereafter payable on or account of Collateral; (ii) exercise such privileges or options  pertaining to, or deposit, surrender, accept, hold or apply other property in exchange for, Collateral; (iii)  insure, process and preserve the Collateral; (iv) transfer the Collateral to Lender&#8217;s own name or the name  of a nominee of Lender; and (v) make any compromise or settlement, and take any action it deems advisable,  with respect to the Collateral. Borrower agrees to reimburse Lender on demand for any costs and expenses,  including, without limitation, attorneys&#8217; fees, Lender may incur while acting a Borrower&#8217;s attorney-in-fact  hereunder, all of which costs and expenses are included in the Obligations. It is further agreed that such  case as Lender gives to the safekeeping of its own property of like kind shall constitute reasonable care of  the Collateral when in Lender&#8217;s possession; provided, however, that Lender shall not be required to make  any presentment, demand or protest, or give any notice and need not take any action to preserve any rights  against any prior party or any other person in connection with the Obligations or with respect to the  Collateral.   4. Covenants.  For so long as this Agreement is in effect or any amounts remain outstanding  under this Agreement, Borrower shall:  (a) Promptly furnish to Lender, upon request, financial or other information  concerning the assets, liabilities, operations and transactions of Borrower as Lender may from time to time  reasonably request;  (b) Maintain, or cause or arrange to be maintained, on its properties and assets,  insurance from reputable companies in such amounts and covering such risks as is prudent and  commercially reasonable;  (c) Furnish to Lender, promptly upon becoming aware of the existence of any  condition or event constituting an Event of Default hereunder, written notice specifying the nature and  period of existence thereof and any action which Borrower is taking or proposes to take with respect thereto;  (d) Promptly notify Lender of (i) any material adverse change in its financial condition  or business; (ii) any default under any material agreement, contract or other instrument to which Borrower  is a party or by which any of its properties are bound, or any acceleration of any maturity of any  indebtedness owed by Borrower, (iii) any material adverse claim against or affecting Borrower or any of  its properties, or any claim, action, or proceeding affecting title to all or any of the Collateral or the Security  Interest and, at the request of Lender, appear in and defend, at Borrower&#8217;s expense, any such action or  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 5 -   proceeding; and (iv) any litigation, or any claim or controversy which might become the subject of  litigation, against Borrower or affecting any of Borrower&#8217;s property, if such litigation or potential litigation  would reasonably be expected to, in the event of an unfavorable outcome, have an adverse effect on  Borrower&#8217;s financial condition or business or cause an Event of Default;   (e) Not, without the prior written consent of Lender, except as provided for under the  Documents, either in a single or series of related transactions, (i) pledge, mortgage or otherwise encumber  any of the Collateral, (ii) pledge, mortgage or otherwise encumber any of its other property, (iii) sell, assign,  transfer or convey all or substantially all of its assets, including its goodwill, (iv) merge or consolidate with  any other entity or person, (v) allow the transfer, issuance or redemption of any of its capital stock or equity  interests nor any security convertible into or exercisable for such capital stock or equity interests, (vi) take  or allow any act that would materially impair the ability of Borrower to carry on its business or to fulfill its  obligations under this Agreement or the Documents, (vii) liquidate, dissolve or reorganize, nor (viii) agree  to do any of the foregoing;  (f) Do all acts that may be necessary to maintain, preserve and protect the Collateral;   (g) Not use any Collateral or permit any Collateral to be used unlawfully or in  violation of any provision of this Agreement, any other Document or any applicable statute, regulation or  ordinance or any policy of insurance covering the Collateral;   (h) Pay promptly when due all taxes, assessments, charges, encumbrances and liens  now or hereafter imposed on or affecting any Collateral;   (i) Notify Lender promptly after any change in Borrower&#8217;s name or place of business,  or if, Borrower has more than one place of business, Borrower&#8217;s primary place of business;  (j) Keep the Collateral at the location(s) set forth in Section 9(s) and not to remove  the Collateral from such location(s) without the prior written consent of Lender;  (k) Following an Event of Default, account fully for and promptly deliver to Lender,  in the form received, all proceeds of the Collateral received, endorsed to Lender as appropriate, and until  so delivered all proceeds shall be held by Borrower in trust for lender, separate from all other property of  Borrower and identified as the property of Lender;   (l) If any of the Pledged Shares are received by Borrower, to forthwith (i) deliver to  Lender the certificates or instruments representing or evidencing the same, duly endorsed in blank or  accompanied by such instruments of assignment and transfer in such form and substance as Lender may  reasonably request, all of which thereafter shall be held by Lender, pursuant to the terms of this Agreement,  as part of the Collateral and (ii) take such other action as Lender may reasonably deem necessary or  appropriate to duly record or otherwise perfect the security interest created hereunder in such Collateral;  and   (m) At the reasonable request of Lender, insure the Collateral, with Lender named as  loss payee, in form and amounts, with companies, and against risks and liabilities, reasonably required by  Lender to protect the value of its security interest hereunder, and following an Event of Default: (i) to assign  the policies to Lender, (ii) to deliver them to Lender at its request, and (iii) to cooperate with and assist  Lender in making any claim thereunder, or in canceling the insurance, or in collecting and receiving  payment of, and endorse any instrument in payment of loss or return premium or other refund or return,  and apply such amounts received, at Lender&#8217;s election, to replacement of Collateral or to the Obligations;  provided that in no event shall Lender be deemed to have a security interest in insurance proceeds except  to the extent solely arising from the Collateral, and if Lender receives any other insurance proceeds, it will  deliver such proceeds to Borrower.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 6 -   5. Default; Remedies.  (a) Event of Default.  For purposes of this Agreement, an &#8220;Event of Default&#8221; shall  exist if any one or more of the following events shall occur:  (i) Borrower fails to make any payment on the Outstanding Balance when  due and such failure continues without cure by Borrower for a period of ten (10) days after such due date;   (ii) Any shareholder of Borrower sells, assigns, pledges or otherwise transfers,  with or without consideration, any shares of capital stock of Borrower unless such sale, assignment, pledge  or transfer was approved in writing by Lender;  (iii) Except as otherwise provided herein, Borrower breaches or defaults in the  performance of any of its Obligations or covenants or agreements contained in this Agreement and such  breach or default continues without cure by Borrower for a period of thirty (30) days after Borrower&#8217;s  receipt of written notice of such breach from Lender;  (iv) Borrower applies for or consents to the appointment of a receiver, trustee  or liquidator of all or substantially all of its assets, files a voluntary petition in bankruptcy or makes a  general assignment for the benefit of its creditors, or an involuntary petition in bankruptcy is filed with  respect to Borrower and is not dismissed within sixty (60) days thereafter, or any order, judgment or decree  is entered by any court of competent jurisdiction on the application of a creditor or otherwise adjudicating  Borrower bankrupt or approving appointment of a receiver, trustee or liquidator of Borrower of all or  substantially all of its assets and such order, judgment or decree continues unstayed and in effect for sixty  (60) calendar days after its entry; and/or  (v) Borrower is excluded, debarred or suspended from participating in any  Federal Health Care Program.  (b) Rights and Remedies.    (i) On the occurrence of any Event of Default, Lender may, at its option, upon  contemporaneous notice to Borrower, and in addition to all rights and remedies available to Lender and its  affiliates under this Agreement or any other Document, do any one or more of the following: (A) declare  all obligations, whether evidenced by this Agreement or by any of the other Documents, immediately due  and payable, (B) foreclose or otherwise enforce Lender&#8217;s security interest in any manner permitted by law  or provided in this Agreement, subject to the rights of senior lienholders; (C) sell, lease or otherwise dispose  of any Collateral at one or more public or private sales, whether or not such Collateral is present at the place  of sale, for cash or credit or future delivery, on such terms and in such manner as Lender may determine;  (D) recover from Borrower all costs and expenses, including, without limitation, reasonable attorneys&#8217; fees,  incurred or paid by Lender in exercising any right, power or remedy provided by this Agreement or by law;  (E) require Borrower to assemble the Collateral and make it available to Lender at a place to be designated  by Lender; (F) enter onto property where any Collateral is located and take possession thereof with or  without judicial process; (G) require Borrower to cause the Pledged Shares to be transferred of record into  the name of Lender or its nominee; and (H) prior to the disposition of the Collateral, store, process, repair  or recondition it or otherwise prepare it for disposition in any manner and to the extent Lender deems  appropriate and in connection with such preparation and disposition, without charge, use any trademark,  service mark, trade name, copyright, patent or technical process used by Borrower.  (ii) Borrower recognizes that Lender may be compelled, at any time after the  occurrence and during the continuance of an Event of Default, to conduct any sale of all or any part of the  Pledged Shares without registering or qualifying such Pledged Shares under the Securities Act of 1933, as  amended (the &#8220;Securities Act&#8221;), and/or any applicable state securities laws in effect at such time. Borrower  acknowledges that any such private sales may, to the extent permitted by applicable law, be made in such  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 7 -   manner and under such circumstances as Lender may deem necessary or advisable in its sole and absolute  discretion, including at prices and on terms that might be less favorable than those obtainable through a  public sale without such restrictions (including, without limitation, a public offering made pursuant to a  registration statement under the Securities Act), and, notwithstanding such circumstances, agrees that any  such sale shall not be deemed not to have been made in a commercially reasonable manner solely because  it was conducted as a private sale, and agrees that Lender shall have no obligation to conduct any public  sales and no obligation to delay the sale of any Pledged Shares for the period of time necessary to permit  its registration for public sale under the Securities Act and applicable state securities laws, and shall not  have any responsibility or liability as a result of its election so not to conduct any such public sales or delay  the sale of any Pledged Shares, notwithstanding the possibility that a substantially higher price might be  realized if the sale were deferred until after such registration. To the extent permitted by applicable law,  Borrower hereby waives any claims against Lender arising by reason of the fact that the price at which any  Pledged Shares may have been sold at any private sale was less than the price that might have been obtained  at a public sale or was less than the aggregate amount of the Obligations, even if Lender accepts the first  offer received and does not offer such Pledged Shares to more than one offeree. Borrower agrees that a  breach of any of the covenants contained in this Section 5(b) will cause irreparable injury to Lender, that  Lender has no adequate remedy at law in respect of such breach and, as a consequence, that each and every  covenant contained in this Section 5(b) shall be specifically enforceable against Borrower.  (c) Notice.  Reasonable notification of the time and place of any public sale of the  Collateral, or reasonable notification of the time after which any private sale or other intended disposition  of the Collateral is to be made, shall be sent to Borrower and to any other Person entitled to notice under  the UCC; provided that, if any of the Collateral threatens to decline speedily in value or is of the type  customarily sold on a recognized market, Lender may sell or otherwise dispose of the Collateral without  notification, advertisement, or other notice of any kind. It is agreed that notice sent or given not less than  five (5) business days prior to the taking of the action to which the notice relates is reasonable notification  and notice for the purposes of this subsection.  (d) Compliance with Other Laws.  Lender may comply with any applicable state or  federal law requirements in connection with a disposition of the Collateral and compliance will not be  considered to adversely affect the commercial reasonableness of any sale of the Collateral.  (e) Application of Proceeds.  Lender shall apply the proceeds of any sale or other  disposition of the Collateral under this Section 5 in the following order: first, to the payment of all expenses  incurred by Lender in retaking, holding and preparing any of the Collateral for sale(s) or other disposition,  in arranging for such sale(s) or other disposition, and in actually selling or disposing of the same (all of  which are part of the Obligations); second, toward repayment of amounts expended by Lender under  Section 5; and third, toward payment of the balance of the Obligations in the order and manner determined  in Lender&#8217;s sole discretion. Any surplus remaining shall be delivered to Borrower or as a court of competent  jurisdiction may direct. If the proceeds are insufficient to pay the Obligations in full, Borrower shall remain  liable for any deficiency.  (f) Set-Off.  The Obligations shall be paid by Borrower without regard to any equities  between Borrower and Lender or any right of set-off or cross-claim. Lender may set-off and apply any  indebtedness owing by it to Borrower against any Obligations before or after maturity, and without any  demand upon or notice to Borrower or any other Person.  (g) No Recourse.  All amounts due and owing under this Agreement are repayable  solely from the assets of Borrower, and Lender will have no recourse against any equity holder, director,  manager, officer or employee of Borrower for any such amounts.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 8 -   6. Regulatory.  (a) No amount advanced under this Agreement is intended to be or will be interpreted  to be an inducement or payment for, or recommendation of, referral of patients by (i) any Borrower or any  member of Borrower&#8217;s professional staff to Lender or any of Lender&#8217;s affiliates, or (ii) Lender or any of  Lender&#8217;s affiliates to Borrower or any member of Borrower&#8217;s professional staff.  (b) Nothing in this Agreement will be interpreted as authorizing or requiring Lender  or any of Lender&#8217;s affiliates to practice any licensed profession, invest in or own Borrower or exercise any  control or direction over any aspect of Borrower. Borrower and Borrower&#8217;s professional staff remain free  to exercise their professional judgment, in their sole discretion, in the diagnosis and treatment of patients.  (c) To the extent, but only to the extent that, a court of competent jurisdiction holds  any act or service required or permitted of a Party under this Agreement to impermissibly constitute  Lender&#8217;s practice of any licensed profession or operation of a health care facility or service requiring  licensure under applicable law, then such provision of this Agreement will be void ab initio and each Party  will be deemed to have waived the performance of such act or service by the other Party.  7. Representations and Warranties of Borrower; Representations, Warranties and  Agreements of Lender.    (a) Borrower represents and warrants to Lender that:   (i) Borrower: (A) has been duly organized and is validly existing as a  corporation in good standing under the laws of California with full power and authority (corporate and  other) to own, lease and operate its properties and conduct its business as currently conducted; and (B) is  duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which  the ownership or leasing of its respective properties or the conduct of its respective business requires such  qualification.  (ii) Borrower is a professional corporation as defined in Section 13401 of the  General Corporation Law of the State of California and the ownership and operation of Borrower are in  compliance with the requirements of Sections 13400-13410 of the General Corporation law of the State of  California (the &#8220;California PC Law&#8221;). Borrower has entered into a Physician Shareholder Agreement with  its sole shareholder and Lender (the &#8220;Shareholder Agreement&#8221;) pursuant to which, among other things,  such shareholder has agreed not to sell, assign, pledge, or otherwise transfer, with or without consideration,  any shares of Borrower&#8217;s stock to any Person whose ownership of the shares would violate the California  PC Law. The Shareholder Agreement is valid and binding on the sole shareholder and is enforceable by  Borrower against the sole shareholder. Lender is a third-party beneficiary of the Shareholder Agreement  for so long as the Outstanding Balance remains outstanding.  (iii) Borrower has full legal right, power and authority to enter into this  Agreement and the other Documents to which it is a party and to perform the transactions contemplated  hereby and thereby. All corporate action on the part of Borrower and its directors and shareholders for the  authorization, execution and delivery of, and the performance of all obligations of Borrower under the  Documents has been duly taken. Each of this Agreement and the other Documents to which Borrower is a  party has been duly authorized, executed and delivered by Borrower and is a valid and binding agreement  on the part of Borrower, enforceable in accordance with its terms. The performance of each Document and  the consummation of the transactions contemplated by any such Document will not result in a breach or  violation of any of the terms and provisions of, or constitute a default under, (a) any contract, (b) the  organizational documents of Borrower, or (c) any applicable law. No consent, approval, authorization or  order of, or qualification with, any governmental authority having jurisdiction over Borrower or over its  properties or assets is required for the execution and delivery of this Agreement and the consummation by  Borrower of the transactions herein contemplated.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 9 -   (iv) All of the outstanding shares of Borrower are owned of record by Thomas  Lam, M.D.  (v) Borrower has all permits, licenses, certificates, approvals, consents  notices, waivers, franchise, registrations, filings, accreditations, or other similar authorizations, as  applicable, required by any applicable law, governmental authority or contract.   (vi) Borrower is in compliance with all applicable laws and is not in violation  of any applicable law.   (b) Lender represents and warrants, and agrees with, Borrower as follows:   (i) Lender is acquiring the promissory note(s) for Lender&#8217;s own account, for  investment purposes only.   (ii) Lender is an &#8220;accredited investor&#8221; as the term is defined in Rule 501(a)  under Regulation D promulgated pursuant to the Securities Act.   (iii) Lender understands that the issuance and sale of the promissory note(s)  has not been registered under the Securities Act or under any state securities laws.   (iv) Lender has received all the information Lender considers necessary or  appropriate for deciding whether to enter into this Agreement, and Lender has had an opportunity to ask  questions and receive answers from Borrower and its members regarding the business, prospects and  financial condition of Borrower.   8. Pledged Shares.    (a) All Pledged Shares in which Borrower shall hereafter grant a security interest  pursuant to this Agreement will be, duly authorized, validly existing, fully paid and nonassessable, and  none of such Pledged Shares are or will be subject to any contractual restriction, or any restriction under  the charter, by-laws, shareholders agreement or other organizational instrument of Metropolitan or any  other issuer thereof, upon the transfer of such Pledged Shares (except for any such restriction contained  herein or under such organizational documents).   (b) All certificates, agreements or instruments representing or evidencing the Pledged  Shares in existence on the date hereof will have been delivered to Lender in a suitable form for transfer by  delivery or accompanied by duly executed instruments of transfer or assignment in blank and (assuming  continuing possession by Lender of all such Pledged Shares) Lender has a perfected first priority security  interest therein.   (c) So long as no Event of Default shall have occurred and be continuing, Borrower  shall have the right to exercise all voting, consensual and other powers of ownership pertaining to the  Pledged Shares for all purposes not inconsistent with the terms of this Agreement, the other Documents, or  any other instrument or agreement referred to herein or therein, provided that Borrower agrees that it will  not vote the Pledged Shares in any manner that is inconsistent with the terms of this Agreement, the other  Documents or any such other instrument or agreement; and Lender shall execute and deliver to Borrower  or cause to be executed and delivered to Borrower all such proxies, powers of attorney, dividend and other  orders, and all such instruments, without recourse, as Borrower may reasonably request for the purpose of  enabling Borrower to exercise the rights and powers that they are entitled to exercise pursuant to this Section  8(c).  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 10 -   (d) Unless and until an Event of Default shall have occurred and be continuing,  Borrower shall be entitled to receive and retain any dividends, distributions or proceeds on the Pledged  Shares paid in cash out of earned surplus.   (e) If an Event of Default shall have occurred and be continuing, whether or not  Lender exercises any available right to declare any Obligations due and payable or seek or pursue any other  relief or remedy available to them under applicable law or under this Agreement, the other Documents or  any other agreement relating to such Obligation, all dividends and other distributions on the Pledged Shares  shall be paid directly to Lender and retained by it as part of the Collateral, subject to the terms of this  Agreement, and, if Lender shall so request in writing, Borrower agrees to execute and deliver to Lender  appropriate additional dividend, distribution and other orders and documents to that end, provided that if  such Event of Default is cured, any such dividend or distribution theretofore paid to Lender shall, upon  request of Borrower (except to the extent theretofore applied to the Obligations), be returned by Lender to  Borrower.  (f) Borrower hereby expressly authorizes and instructs each issuer of any Pledged  Shares pledged hereunder to (i) comply with any instruction received by it from Lender in writing that (A)  states that an Event of Default has occurred and is continuing and (B) is otherwise in accordance with the  terms of this Agreement, without any other or further instructions from Borrower, and Borrower agrees that  such issuer shall be fully protected in so complying and (ii) unless otherwise expressly permitted hereby,  pay any dividend or other payment with respect to the Pledged Shares directly to Lender for the benefit of  Lender.  (g) Notwithstanding anything to the contrary in this Agreement, Lender shall take no  action with respect to the Pledged Shares that would result in Borrower having an ineligible shareholder  under the laws relating to the corporate practice of medicine in the State of California.  9. Miscellaneous.  (a) Confidentiality.  The existence and the terms and conditions of this Agreement  are confidential and may not be disclosed to any third party without Lender&#8217;s prior written consent;  provided, however, that Borrower may disclose the terms and conditions of this Agreement on a confidential  basis to its financial advisors and attorneys or as otherwise may be required by applicable Law.  Borrower&#8217;s  obligations under this Section 9(a) will survive the termination of this Agreement indefinitely for a period  of five (5) years following its expiration or termination.  (b) Payment of Expenses.  Borrower will pay and indemnify Lender against all out- of-pocket expenses incurred by Lender in connection with the execution, delivery or administration  (including Lender&#8217;s payment of any insurance premiums on Borrower&#8217;s behalf, any modification of or  consent or waiver under this Agreement, and any enforcement or preservation of rights under this  Agreement) of the transactions contemplated by this Agreement.  Borrower&#8217;s obligations under this Section  9(b) will survive the termination of this Agreement indefinitely.  (c) Notices.  All notices and other communications required or permitted under this  Agreement (i) must be in writing, (ii) will be duly given (A) when delivered personally to the recipient or  (B) one (1) Business Day after being sent to the recipient by nationally recognized overnight private carrier  (charges prepaid) and (iii) addressed as follows (as applicable):  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 11 -   If to Borrower:   AP-AMH 2 Medical Corporation  1668 S. Garfield Ave. 2nd Fl  Alhambra, CA 91801  Attn: Chief Executive Officer    If to Lender:  Apollo Medical Holdings, Inc.  1668 S. Garfield Ave. 2nd Fl  Alhambra, CA 91801  Attn: Chief Executive Officer  or to such other respective address as each Party may designate by notice given in accordance with this  Section 9(c).  (d) Entire Agreement.  This Agreement constitutes the complete agreement and  understanding among the Parties regarding the subject matter of this Agreement and supersedes any prior  understandings, agreements or representations regarding the subject matter of this Agreement.  (e) Amendments.  Except as otherwise set forth in Section 2(a), the Parties may  amend this Agreement only pursuant to a written agreement executed by the Parties.  (f) Non-Waiver.  The Parties&#8217; respective rights and remedies under this Agreement  are cumulative and not alternative.  Neither the failure nor any delay by any Party in exercising any right,  power or privilege under this Agreement will operate as a waiver of such right, power or privilege, and no  single or partial exercise of any such right, power or privilege will preclude any other or further exercise of  such right, power or privilege or the exercise of any other right, power or privilege.  No waiver will be  effective unless it is in writing and signed by an authorized representative of the waiving Party.  No waiver  given will be applicable except in the specific instance for which it was given.  No notice to or demand on  a Party will constitute a waiver of any obligation of such Party or the right of the Party giving such notice  or demand to take further action without notice or demand as provided in this Agreement.  (g) Waiver of Defenses.  BORROWER HEREBY WAIVES PRESENTMENT,  PROTEST AND DEMAND, NOTICE OF PROTEST, DEMAND AND DISHONOR AND  NONPAYMENT OF ANY AMOUNT OWING UNDER THIS AGREEMENT OR ANY INSTRUMENT  OR DOCUMENT DELIVERED PURSUANT TO THIS AGREEMENT.  (h) Waiver or Set-Off.  BORROWER HEREBY WAIVES THE RIGHT TO  INTERPOSE ANY SET-OFF, COUNTER-CLAIM AND/OR CROSS-CLAIM AGAINST LENDER IN  CONNECTION WITH ANY SUIT, ACTION OR PROCEEDING IN CONNECTION WITH ANY  MATTER RELATING TO THIS AGREEMENT OR ANY INSTRUMENT OR DOCUMENT  DELIVERED PURSUANT TO THIS AGREEMENT.  (i) Excessive Charges.  Interest may not accrue under this Agreement in excess of  the maximum interest rate allowed by applicable law.  If Lender receives interest payments at an interest  rate in excess of the maximum interest rate allowed by applicable law, then the excess amount will be  treated as being received on account of, and will automatically reduce, the principal amount then- outstanding under this Agreement and if such excess amount exceeds the principal amount then-outstanding  under this Agreement, then Lender will refund to Borrower the amount by which such excess exceeds the  principal amount then-outstanding under this Agreement.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 12 -   (j) Assignment.  Borrower may not assign or transfer any of its rights or obligations  under this Agreement without obtaining the prior written consent of the Lender. Lender may assign its rights  hereunder without the consent of Borrower. In addition to the foregoing, Lender may collaterally assign its  rights and benefits hereunder to one or more lenders or one or more agent for any lenders for security purposes  or as collateral.  (k) Binding Effect; Benefit.  This Agreement will inure to the benefit of and bind the  Parties and their respective successors and permitted assigns.  Nothing in this Agreement, express or  implied, may be construed to give any Person other than the Parties and their respective successors and  permitted assigns any right, remedy, claim, obligation or liability arising from or related to this Agreement.   This Agreement and all of its provisions and conditions are for the sole and exclusive benefit of the Parties  and their respective successors and permitted assigns.  (l) Severability.  If any court of competent jurisdiction holds any provision of this  Agreement invalid or unenforceable, then the other provisions of this Agreement will remain in full force  and effect.  Any provision of this Agreement held invalid or unenforceable only in part or degree will  remain in full force and effect to the extent not held invalid or unenforceable.  (m) References.  The headings of Sections are provided for convenience only and will  not affect the construction or interpretation of this Agreement.  Unless otherwise provided, references to  &#8220;Section(s)&#8221; and &#8220;Exhibit(s)&#8221; refer to the corresponding section(s) and exhibit(s) of this Agreement.   Reference to a statute refers to the statute, any amendments or successor legislation and all rules and  regulations promulgated under or implementing the statute, as in effect at the relevant time.  Reference to  a contract, instrument or other document as of a given date means the contract, instrument or other  document as amended, supplemented and modified from time to time through such date.  (n) Construction.  Each Party participated in the negotiation and drafting of this  Agreement, assisted by such legal and tax counsel as it desired, and contributed to its revisions.  Any  ambiguities with respect to any provision of this Agreement will be construed fairly as to all Parties and  not in favor of or against any Party.  All pronouns and any variation thereof will be construed to refer to  such gender and number as the identity of the subject may require.  The terms &#8220;include&#8221; and &#8220;including&#8221;  indicate examples of a predicate word or clause and not a limitation on that word or clause.  The term  &#8220;Business Day&#8221; means a day that is not a Saturday, Sunday or legal holiday on which banks are authorized  or required to be closed in New York, New York.  The term &#8220;Person&#8221; means any natural individual,  corporation, partnership, limited liability company, joint venture, association, bank, trust company, trust or  other entity, whether or not legal entities, or any governmental entity, agency or political subdivision.  (o) Applicable Law; Venue. This Agreement and all disputes or controversies arising  out of or relating thereto shall be governed by, and construed in accordance with, the internal laws of the  State of Delaware, without regard to the laws of any other jurisdiction that might be applied because of the  conflicts of laws principles of any state. The parties agree that any action brought by either party to interpret  or enforce any provision of this Agreement shall be brought in, and each party agrees to, and does hereby,  submit to the jurisdiction and venue of, the appropriate state court or federal district court in the County of  Los Angeles.  (p) WAIVER OF JURY TRIAL. EACH OF BORROWER AND LENDER  AGREES THAT NEITHER OF THEM NOR ANY OF THEIR ASSIGNEES OR SUCCESSORS WILL  (A) SEEK A JURY TRIAL IN ANY LAWSUIT, PROCEEDING, COUNTERCLAIM OR ANY OTHER  ACTION BASED UPON OR ARISING OUT OF, THIS AGREEMENT OR ANY AGREEMENT  EXECUTED IN CONNECTION HEREWITH, ANY COLLATERAL SECURING ALL OR ANY PART  OF THE OBLIGATIONS OR THE DEALINGS OR THE RELATIONSHIP BETWEEN THEM, OR (B)  SEEK TO CONSOLIDATE ANY SUCH ACTION WITH ANY OTHER ACTION IN WHICH A JURY  TRIAL CANNOT BE OR HAS NOT BEEN WAIVED.  THE PROVISIONS OF THIS SECTION HAVE  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> - 13 -   BEEN FULLY DISCUSSED BY EACH OF LENDER AND COMPANY WITH THEIR RESPECTIVE  COUNSEL, AND THESE PROVISIONS WILL BE SUBJECT TO NO EXCEPTIONS.  NEITHER  LENDER NOR BORROWER HAS AGREED WITH OR REPRESENTED TO THE OTHER THAT THE  PROVISIONS OF THIS PARAGRAPH WILL NOT BE FULLY ENFORCED IN ALL INSTANCES.  (q) Attorneys&#8217; Fees.  In any suit, action or proceeding brought by either Party in  connection with any matter relating to this Agreement, the prevailing Party will be entitled to recover from  the losing Party all reasonable costs and expenses (including reasonable attorneys&#8217; fees and expenses)  incurred in such suit, action or proceeding (including any appeals).  (r) Counterparts.  The Parties may execute this Agreement in multiple counterparts,  each of which will constitute an original and all of which, when taken together, will constitute one and the  same agreement.  The Parties may deliver executed signature pages to this Agreement by facsimile or e- mail transmission.  No Party may raise as a defense to the formation or enforceability of this Agreement,  and each Party forever waives any such defense, either (i) the use of a facsimile or email transmission to  deliver a signature or (ii) the fact that any signature was signed and subsequently transmitted by facsimile  or email transmission.  (s) Location(s) of Collateral.  Borrower represents that as of the date hereof, the  Collateral is located at Lender&#8217;s offices at 1668 S. Garfield Ave., 2nd Floor, Alhambra, CA 91801, and that  Borrower&#8217;s records regarding the Collateral are kept at 1668 S. Garfield Ave., 2nd Floor, Alhambra, CA  91801.  (t) Termination of the Agreement.  This Agreement may be terminated at any time  upon mutual written agreement of the Parties. Upon termination of this Agreement, the Outstanding  Balance, if any, will automatically become immediately due and payable.    [SIGNATURE PAGE IMMEDIATELY FOLLOWS]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">[Signature Page to Loan and Security Agreement]  IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the day and year  first written above.  LENDER: APOLLO MEDICAL HOLDINGS, INC.,  a Delaware corporation   By:      _____________________________________  Name: _____________________________________  Title:   _____________________________________  BORROWER AP-AMH 2 MEDICAL CORPORATION,  a California professional corporation   By:      _____________________________________  Name: _____________________________________  Title:   _____________________________________  Brandon Sim Co-Chief Executive Officer Thomas S. Lam Chief Executive Officer </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">[Exhibit A]  EXHIBIT A  SCHEDULE OF LOANS  Amount Date Borrowed  $_______________________ ____/____/____  $_______________________ ____/____/____  $_______________________ ____/____/____  $_______________________ ____/____/____  113,800,000 1 31 24 </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur016.jpg" title="slide16" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  [Exhibit B]  EXHIBIT B  FORM OF PROMISSORY NOTE    [See attached.]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur017.jpg" title="slide17" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">[FORM OF]  THIS NOTE HAS NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S.  SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), OR WITH ANY  SECURITIES REGULATORY AUTHORITY OR ANY STATE OR OTHER JURISDICTION OF  THE UNITED STATES. THIS NOTE IS SUBJECT TO RESTRICTIONS ON  TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED, RESOLD,  PLEDGED, ASSIGNED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN  EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION  REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE STATE LAW.  SECURED PROMISSORY NOTE    $[113,800,000] [___], 202[___]  FOR VALUE RECEIVED, AP-AMH 2 Medical Corporation, a California professional corporation  (&#8220;Borrower&#8221;), promises to pay to the order of Apollo Medical Holdings, Inc., a Delaware corporation  (&#8220;Lender&#8221;), the principal amount of [One Hundred Thirteen Million Eight Hundred Thousand Dollars  ($113,800,000)] (the &#8220;Principal Amount&#8221;) delivered by Lender to Borrower as set forth below, together  with accrued and unpaid interest thereon, each due and payable in the manner set forth below.  This Note  is entered into concurrently with the Loan and Security Agreement (the &#8220;Loan and Security Agreement&#8221;),  dated as of January 31, 2024, entered into by and between Borrower and Lender, and is subject to the terms  of the Loan and Security Agreement.  1. Delivery of Principal Amount.  The Principal Amount shall be delivered by Lender to Borrower on  the date hereof.   2. Interest. Interest shall accrue as set forth in the Loan and Security Agreement.    3. Maturity Date.  This Note will mature on [___]1 (the &#8220;Maturity Date&#8221;).    4. Security. This Note is secured pursuant to the Loan and Security Agreement. Subject to the terms  of the Loan and Security Agreement, Lender is entitled to enforce the provisions of the Loan and Security  Agreement and to enjoy the benefits thereof.   5. Payments. All cash payments of principal and interest in respect of this Note shall be made in lawful  money of the United States of America in same day funds at such place as shall be designated in writing  for such purpose in accordance with the terms of the Loan and Security Agreement. This Note may not be  prepaid without the prior consent of Lender, as provided in the Loan and Security Agreement.   6. Collateral Assignment. Borrower and Lender acknowledge that Lender may incur indebtedness  secured by the assets of Lender and, in connection therewith, may assign, as collateral security for such  obligations, all of its right, title and interest in, to and under the Loan and Security Agreement and this Note  to the agent or any secured creditors of such indebtedness. Borrower hereby acknowledges that a collateral  assignment may occur and consents to any such collateral assignment for the benefit of any such agent or  secured creditors and consents to any subsequent actions taken by such agent or secured creditors in  connection with any collateral assignment, including, without limitation, in connection with the  enforcement of such collateral assignment.   7. Usury. Notwithstanding any other provision of this Note, Lender does not intend to charge and  Borrower shall not be required to pay any interest or other fees or charges in excess of the maximum    1 NTD: To be the date that is 10 years from the date of this Note.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur018.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur018.jpg" title="slide18" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   2  permitted by applicable law; any payments in excess of such maximum shall be refunded to Borrower or  credited to reduce principal hereunder.    8. Miscellaneous. This Note, and the obligations and rights of the parties hereunder, shall be binding  upon and inure to the benefit of Borrower, Lender, and their respective heirs, successors and permitted  assigns.  The titles and subtitles used in this Note are used for convenience only and shall not be considered  in construing or interpreting this Note. Borrower and Lender shall each bear its respective expenses and  legal fees incurred with respect to the negotiation, execution and delivery of this Note and the transactions  contemplated herein. This Note may only be assigned, delegated or transferred only in the manner provided  in the Loan and Security Agreement. Any term of this Note may only be amended or waived only in the  manner provided in the Loan and Security Agreement. This Note may be executed in two or more  counterparts, each of which shall be deemed an original, but all of which together shall constitute one and  the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any  electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions  Act or other applicable law) or other transmission method and any counterpart so delivered shall be deemed  to have been duly and validly delivered and be valid and effective for all purposes.  9. Applicable Law; Venue. This Note and all disputes or controversies arising out of or relating thereto  shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without  regard to the laws of any other jurisdiction that might be applied because of the conflicts of laws principles  of any state. The parties agree that any action brought by either party to interpret or enforce any provision  of this Note shall be brought in, and each party agrees to, and does hereby, submit to the jurisdiction and  venue of, the appropriate state court or federal district court in the County of Los Angeles.  10. WAIVER OF JURY TRIAL. EACH OF BORROWER AND LENDER AGREES THAT  NEITHER OF THEM NOR ANY OF THEIR ASSIGNEES OR SUCCESSORS WILL (A) SEEK A JURY  TRIAL IN ANY LAWSUIT, PROCEEDING, COUNTERCLAIM OR ANY OTHER ACTION BASED  UPON OR ARISING OUT OF, THIS NOTE OR ANY AGREEMENT EXECUTED IN CONNECTION  HEREWITH, ANY COLLATERAL SECURING ALL OR ANY PART OF THE OBLIGATIONS OR  THE DEALINGS OR THE RELATIONSHIP BETWEEN THEM, OR (B) SEEK TO CONSOLIDATE  ANY SUCH ACTION WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR  HAS NOT BEEN WAIVED.  THE PROVISIONS OF THIS SECTION HAVE BEEN FULLY  DISCUSSED BY EACH OF LENDER AND COMPANY WITH THEIR RESPECTIVE COUNSEL, AND  THESE PROVISIONS WILL BE SUBJECT TO NO EXCEPTIONS.  NEITHER LENDER NOR  BORROWER HAS AGREED WITH OR REPRESENTED TO THE OTHER THAT THE PROVISIONS  OF THIS PARAGRAPH WILL NOT BE FULLY ENFORCED IN ALL INSTANCES.  11. Entire Agreement.  This Note, together with the Loan and Security Agreement, constitutes the full  and entire understanding and agreement between the parties with regard to the subjects hereof, and no party  shall be liable or bound to any other party in any manner by any representations, warranties, covenants and  agreements except as specifically set forth herein.  [Signature Page Follows] </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur019.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur019.jpg" title="slide19" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  [Signature Page to Secured Promissory Note]  IN WITNESS WHEREOF, the parties have executed this Secured Promissory Note as of the date  first written above.     BORROWER:           AP-AMH 2 MEDICAL CORPORATION      By:         Name:     Title:        E-mail:       Address:                </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur020.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur020.jpg" title="slide20" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  [Signature Page to Secured Promissory Note]  IN WITNESS WHEREOF, the parties have executed this Secured Promissory Note as of the date  first written above.     LENDER:           APOLLO MEDICAL HOLDINGS, INC.      By:         Name:     Title:        E-mail:       Address:               </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur021.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur021.jpg" title="slide21" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  [Exhibit C]  EXHIBIT C  FORM OF CERTIFICATE OF DETERMINATION    [See attached.]    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur022.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur022.jpg" title="slide22" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur023.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur023.jpg" title="slide23" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur024.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur024.jpg" title="slide24" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur025.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur025.jpg" title="slide25" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur026.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur026.jpg" title="slide26" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1061-loanandsecur027.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1061-loanandsecur027.jpg" title="slide27" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.62
<SEQUENCE>17
<FILENAME>exhibit1062-securedpromi.htm
<DESCRIPTION>EX-10.62
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit1062-securedpromi</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit1062-securedpromi001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1062-securedpromi001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">                     Exhibit 10.62  THIS NOTE HAS NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S.  SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), OR WITH ANY  SECURITIES REGULATORY AUTHORITY OR ANY STATE OR OTHER JURISDICTION OF  THE UNITED STATES. THIS NOTE IS SUBJECT TO RESTRICTIONS ON  TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED, RESOLD,  PLEDGED, ASSIGNED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN  EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION  REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE STATE LAW.  SECURED PROMISSORY NOTE    $113,800,000 January 31, 2024  FOR VALUE RECEIVED, AP-AMH 2 Medical Corporation, a California professional corporation  (&#8220;Borrower&#8221;), promises to pay to the order of Apollo Medical Holdings, Inc., a Delaware corporation  (&#8220;Lender&#8221;), the principal amount of One Hundred Thirteen Million Eight Hundred Thousand Dollars  ($113,800,000) (the &#8220;Principal Amount&#8221;) delivered by Lender to Borrower as set forth below, together  with accrued and unpaid interest thereon, each due and payable in the manner set forth below.  This Note  is entered into concurrently with the Loan and Security Agreement (the &#8220;Loan and Security Agreement&#8221;),  dated as of January 31, 2024, entered into by and between Borrower and Lender, and is subject to the terms  of the Loan and Security Agreement.  1. Delivery of Principal Amount.  The Principal Amount shall be delivered by Lender to Borrower on  the date hereof.   2. Interest. Interest shall accrue as set forth in the Loan and Security Agreement.    3. Maturity Date.  This Note will mature on January 31, 2034 (the &#8220;Maturity Date&#8221;).    4. Security. This Note is secured pursuant to the Loan and Security Agreement. Subject to the terms  of the Loan and Security Agreement, Lender is entitled to enforce the provisions of the Loan and Security  Agreement and to enjoy the benefits thereof.   5. Payments. All cash payments of principal and interest in respect of this Note shall be made in lawful  money of the United States of America in same day funds at such place as shall be designated in writing  for such purpose in accordance with the terms of the Loan and Security Agreement. This Note may not be  prepaid without the prior consent of Lender, as provided in the Loan and Security Agreement.   6. Collateral Assignment. Borrower and Lender acknowledge that Lender may incur indebtedness  secured by the assets of Lender and, in connection therewith, may assign, as collateral security for such  obligations, all of its right, title and interest in, to and under the Loan and Security Agreement and this Note  to the agent or any secured creditors of such indebtedness. Borrower hereby acknowledges that a collateral  assignment may occur and consents to any such collateral assignment for the benefit of any such agent or  secured creditors and consents to any subsequent actions taken by such agent or secured creditors in  connection with any collateral assignment, including, without limitation, in connection with the  enforcement of such collateral assignment.   7. Usury. Notwithstanding any other provision of this Note, Lender does not intend to charge and  Borrower shall not be required to pay any interest or other fees or charges in excess of the maximum  permitted by applicable law; any payments in excess of such maximum shall be refunded to Borrower or  credited to reduce principal hereunder.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1062-securedpromi002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1062-securedpromi002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">   2  8. Miscellaneous. This Note, and the obligations and rights of the parties hereunder, shall be binding  upon and inure to the benefit of Borrower, Lender, and their respective heirs, successors and permitted  assigns.  The titles and subtitles used in this Note are used for convenience only and shall not be considered  in construing or interpreting this Note. Borrower and Lender shall each bear its respective expenses and  legal fees incurred with respect to the negotiation, execution and delivery of this Note and the transactions  contemplated herein. This Note may only be assigned, delegated or transferred only in the manner provided  in the Loan and Security Agreement. Any term of this Note may only be amended or waived only in the  manner provided in the Loan and Security Agreement. This Note may be executed in two or more  counterparts, each of which shall be deemed an original, but all of which together shall constitute one and  the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any  electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions  Act or other applicable law) or other transmission method and any counterpart so delivered shall be deemed  to have been duly and validly delivered and be valid and effective for all purposes.  9. Applicable Law; Venue. This Note and all disputes or controversies arising out of or relating thereto  shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without  regard to the laws of any other jurisdiction that might be applied because of the conflicts of laws principles  of any state. The parties agree that any action brought by either party to interpret or enforce any provision  of this Note shall be brought in, and each party agrees to, and does hereby, submit to the jurisdiction and  venue of, the appropriate state court or federal district court in the County of Los Angeles.  10. WAIVER OF JURY TRIAL. EACH OF BORROWER AND LENDER AGREES THAT  NEITHER OF THEM NOR ANY OF THEIR ASSIGNEES OR SUCCESSORS WILL (A) SEEK A JURY  TRIAL IN ANY LAWSUIT, PROCEEDING, COUNTERCLAIM OR ANY OTHER ACTION BASED  UPON OR ARISING OUT OF, THIS NOTE OR ANY AGREEMENT EXECUTED IN CONNECTION  HEREWITH, ANY COLLATERAL SECURING ALL OR ANY PART OF THE OBLIGATIONS OR  THE DEALINGS OR THE RELATIONSHIP BETWEEN THEM, OR (B) SEEK TO CONSOLIDATE  ANY SUCH ACTION WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR  HAS NOT BEEN WAIVED.  THE PROVISIONS OF THIS SECTION HAVE BEEN FULLY  DISCUSSED BY EACH OF LENDER AND COMPANY WITH THEIR RESPECTIVE COUNSEL, AND  THESE PROVISIONS WILL BE SUBJECT TO NO EXCEPTIONS.  NEITHER LENDER NOR  BORROWER HAS AGREED WITH OR REPRESENTED TO THE OTHER THAT THE PROVISIONS  OF THIS PARAGRAPH WILL NOT BE FULLY ENFORCED IN ALL INSTANCES.  11. Entire Agreement.  This Note, together with the Loan and Security Agreement, constitutes the full  and entire understanding and agreement between the parties with regard to the subjects hereof, and no party  shall be liable or bound to any other party in any manner by any representations, warranties, covenants and  agreements except as specifically set forth herein.  [Signature Page Follows] </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1062-securedpromi003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1062-securedpromi003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">[Signature Page to Secured Promissory Note]  IN WITNESS WHEREOF, the parties have executed this Secured Promissory Note as of the date  first written above.  BORROWER:  AP-AMH 2 MEDICAL CORPORATION  By:  Name:  Title:  E-mail: Address:  Thomas S. Lam Chief Executive Officer 1668 S. Garfield Ave., 2nd Floor Alhambra, CA 91801 [*]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1062-securedpromi004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1062-securedpromi004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">[Signature Page to Secured Promissory Note]  IN WITNESS WHEREOF, the parties have executed this Secured Promissory Note as of the date  first written above.  LENDER:  APOLLO MEDICAL HOLDINGS, INC.  By:  Name:  Title:  E-mail: Address:  Brandon Sim Co-Chief Executive Officer 1668 S. Garfield Ave., 2nd Floor Alhambra, CA 91801 [*]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>18
<FILENAME>exhibit191-insidertradingp.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i3a36677e53884e51b1d9800a201ba276_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 19.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INSIDER TRADING POLICY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Astrana Health, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) has adopted this Insider Trading Policy, which is designed to provide guidelines to all directors, officers and other personnel, whether employees, consultants or contractors, to the Company and its subsidiaries and affiliated entities, as appropriate, including variable interest entities (collectively, the &#8220;Company&#8217;s Affiliated Entities&#8221;), for transactions in the Company&#8217;s securities and the handling of confidential information about the Company and the companies with which it engages in transactions or does business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Insider Trading Policy, the Company&#8217;s securities include common stock, options to purchase common stock and any other securities the Company may issue from time to time, such as preferred stock, warrants and convertible notes, as well as derivative securities that are not issued by the Company, such as exchange-traded put or call options or swaps relating to Company securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Insider Trading Policy applies to transactions in the Company&#8217;s securities, including (but not limited to) purchases and sales, gifts, and purchases, sales and other transactions in shares of the Company&#8217;s common stock through the self-directed option of the Company&#8217;s 401(k) plan (if any). However, transactions in mutual funds that are invested in Company securities are not transactions subject to this Insider Trading Policy. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">POLICY </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is the policy of the Company to comply with all insider trading laws and regulations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">RESPONSIBILITY </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Directors, officers, and other personnel, whether employees, consultants, or contractors, to the Company and the Company&#8217;s Affiliated Entities, may create, use or have access to material information about the Company that is not generally available to the investing public (such information is referred to in this Insider Trading Policy as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">material non-public information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; as explained in more detail below). Each individual has an important ethical and legal obligation to maintain the confidentiality of such information and not to engage in any transactions in the Company&#8217;s securities while in possession of material non-public information. Each individual and the Company may be subject to severe civil and criminal penalties as a result of unauthorized disclosure of material non-public information or engaging in transactions in the Company&#8217;s securities while in possession of material non-public information. In addition, an individual&#8217;s failure to comply with this Insider Trading Policy may subject the individual to Company-imposed sanctions, including dismissal for cause, whether or not the individual&#8217;s failure to comply results in a violation of law. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company&#8217;s Compliance Officer is the Company&#8217;s Chief Financial Officer, who is responsible for the administration of this Insider Trading Policy.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">GUIDELINES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Prohibition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Directors, officers, and other personnel, whether employees, consultants, or contractors, to the Company and the Company&#8217;s Affiliated Entities are prohibited from&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">engaging in transactions in the Company&#8217;s securities while in possession of material non-public information&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">communicating such information to third parties other than those who need to know such information in connection with doing business with or for the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">recommending engaging in transactions in the Company&#8217;s securities while in the possession of material non-public information&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">assisting anyone engaged in any of the above activities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This prohibition also applies to information about, and transaction in the securities of, other companies with which the Company has a relationship, such as distributors, vendors, customers, and suppliers, companies in which the Company or the Company&#8217;s Affiliated Entities have significant investments, or companies involved in a potential transaction or business relationship with the Company or its Affiliated Entities. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The prohibitions in this Insider Trading Policy also apply to certain family members, members of a person&#8217;s household and entities controlled or influenced by a person covered by this Insider Trading Policy, as described below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">There are no exceptions to this Insider Trading Policy other than those described in Section 10 and Section 11 below. Engaging in transactions in the Company&#8217;s securities that are otherwise necessary for personal reasons, such as personal financial commitments, are still prohibited if you possess material non-public information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Transactions By Family Members&#59; Entities Controlled by You</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Insider Trading Policy applies to your family members who reside with you (including a spouse, a child, a child away at college, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws, as well as adoptive relationships), anyone else who lives in your household, and any family members who do not live in your household but whose transactions in Company securities are directed by you or are subject to your influence or control, such as parents or children who consult with you before they engage in transactions in Company securities (collectively referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Covered Family Members</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). You are responsible for the transactions of these other persons and therefore should make them aware of the need to confer with you before they engage in transactions in Company securities, and you should treat all such transactions for the purposes of this Insider Trading Policy and applicable securities laws as if the transactions were for your own account. This Insider Trading Policy does not, however, apply to personal securities transactions of Covered Family Members where the decision to engage in transactions in Company securities is made by a third party not controlled by, influenced by or related to you or your Covered Family Members.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This Insider Trading Policy also applies to any entities that you influence or control, including any corporations, partnerships or trusts (collectively referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Controlled Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and transactions by these Controlled Entities should be treated for the purposes of this Insider Trading Policy and applicable securities laws as if they were for your own account.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Tipping Information to Others</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> You may not disclose any material non-public information to others, including your family members, friends or social acquaintances. This prohibition applies whether or not you receive any benefit from the other person&#8217;s use of that information. The Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) has imposed large penalties even when the disclosing person did not profit from the trading.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:27.75pt;text-decoration:underline">Material Non-Public Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Material Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Information is considered &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">material</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; if a reasonable investor would consider it important in making a decision to purchase, hold or sell the Company&#8217;s securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">e.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, information regarding a possible merger or acquisition involving the Company, the introduction of important products or major marketing changes, etc.). In addition, any information that could affect the market for the Company&#8217;s securities (whether positive or negative) is material.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Non-public Information. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-public information is any information that has not been disclosed generally to the investing public. Disclosure by press release or in the Company&#8217;s periodic reports filed with the SEC is necessary to make the information public. However, even after the Company has released information to the public, you should generally allow at least two full business days (that is, days on which securities markets are open for trading) for the investing public to absorb and evaluate the information before you trade in the Company&#8217;s securities. Depending on the particular circumstances, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company may determine that a longer or shorter period should apply to the release of specific material non-public information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Although it is not possible to list all types of material information, the following are a few examples of information that is particularly sensitive and should be treated as material&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">financial results</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">projections of future earnings or revenues or other earnings guidance, or changes to previously announced earnings guidance or the decision to suspend earnings guidance&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">stock splits and repurchase programs for Company securities&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">securities offerings or incurring debt&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">possible mergers, acquisitions, joint ventures or dispositions&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">a Company restructuring&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">significant related party transactions&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">significant contract wins or losses&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">changes in management&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">the introduction of important new services&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">unusual gains or losses in operations&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">notification that the auditor&#8217;s reports may no longer be relied upon&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">significant litigation exposure due to actual or threatened litigation, or the resolution of such litigation&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">financial liquidity or bankruptcy problems&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">the imposition of a ban on trading in Company securities or the securities of another company or the extension or termination of such restriction&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">the effects of any natural disaster, terrorist event or other catastrophic event on the Company&#8217;s business, including any public health crisis&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#183;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:32.01pt">a significant cybersecurity event, such as a data breach, or any other significant disruption in the Company&#8217;s operations or loss, potential loss, breach or unauthorized access of its property or assets, whether at its facilities or through its information technology infrastructure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If you have any question as to whether particular information is material or non-public, you should not trade or communicate the information to anyone without prior approval by the Compliance Officer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Inadvertent Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If material non-public information is inadvertently disclosed by any of the directors, officers or other personnel, whether an employee, consultant or contractor, to the Company and the Company&#8217;s Affiliated Entities to a person outside the Company who is not obligated to keep the information confidential, you should immediately report all the facts to the Compliance Officer </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">so that the Company may take appropriate remedial action. Under SEC rules, the Company generally has only 24 hours after learning of an inadvertent disclosure of material non-public information to publicly disclose such information.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Short-term, Speculative Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company has determined that there is a substantial likelihood for the appearance of improper conduct by personnel of the Company and the Company&#8217;s Affiliated Entities when they engage in short-term or speculative securities transactions. Therefore, such personnel are prohibited from engaging in any of the following activities involving the Company&#8217;s securities, except with the prior written consent of the Compliance Officer&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">purchasing the Company&#8217;s securities on margin&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">pledging Company securities&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">short sales (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the sale of a security that the seller does not own)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">hedging or monetization transactions, including through the use of financial instruments such as prepaid variable forwards, equity swaps, collars and exchange funds&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">buying or selling puts or calls&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">engaging in options transactions (other than where the options were granted by the Company).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Short sales are prohibited for any Section 16 Person (as defined below). In addition, any Section 16 Person who purchases Company securities in the open market may not sell any Company securities of the same class during the six months following the purchase (or vice versa). All personnel are encouraged to adhere to the same restriction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Further Prohibition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">From time to time, effective immediately upon notice or as otherwise provided by the Company, the Company may determine that other types of transactions, or all transactions, by personnel of the Company and the Company&#8217;s Affiliated Entities in the Company&#8217;s securities shall be prohibited or shall be permitted only with the prior written consent of the Compliance Officer. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Blackout Period Trading Prohibition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The following guidelines are applicable to (i) all members of the Company&#8217;s Board of Directors, (ii) all executive officers (including the Chief Executive Officer(s) and the Chief Financial Officer and Principal Financial Officer and Principal Accounting Officer), (iii) other senior personnel, whether employees, consultants or contractors, and (iv) any additional persons that the Compliance Officer may designate (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Covered Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">These guidelines are also applicable to the Covered Family Members and Controlled Entities of Covered Persons.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> The persons to whom such guidelines are applicable may be changed by the Company from time to time as circumstances require.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The release of earnings is a particularly sensitive period of time for transactions in the Company&#8217;s stock, given that officers, directors and other personnel may possess material non-public information about the expected financial results for the quarter. Accordingly, no Covered Person (even if such person&#8217;s services terminate during a blackout period) may engage in transactions in the Company&#8217;s securities during a blackout period for the quarter. The blackout period with respect to each fiscal quarter of the Company begins on the close of business on the 15th day of the third month of the quarter and ends on the opening of the third business day following the Company&#8217;s filing with the SEC of the Company&#8217;s quarterly or annual financial reports or public release of quarterly or annual financial information. The Company will inform you of the anticipated date of public disclosure of each quarter&#8217;s financial results upon request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">From time to time, the Company may also determine that certain persons designated by the Compliance Officer should not engage in transactions in the Company&#8217;s securities because of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">developments known to the Company and not yet disclosed to the public. In such event, such persons may not engage in any transactions in the Company&#8217;s securities during such period and should not disclose to others the fact of such suspension of transactions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It should be noted that, even outside of the prohibition on engaging in transactions, any person possessing material non-public information concerning the Company should not engage in any transactions in the Company&#8217;s securities until such information has been known publicly for at least two trading days, whether or not the Company has recommended a suspension of transactions to that person. Engaging in transactions in the Company&#8217;s securities outside of the blackout period should </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">not </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">be considered a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">safe harbor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; and all Covered Persons should use good judgment at all times.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Pre-Clearance Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Officers and directors of the Company who are required to file Section 16 reports (Forms 3, 4 and 5) with the SEC (such persons, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Section 16 Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) are subject to pre-clearance procedures. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Only Section 16 Persons, as well as their Covered Family Members and Controlled Entities, are subject to the pre-clearance procedures discussed below. However, all Company personnel are required to notify, and obtain pre-approval from, the Compliance Officer prior to entering into, modifying or terminating a Rule 10b5-1 Plan (as defined below) (providing a copy of such plan and any supporting documentation).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Section 16 Persons, as well as the Covered Family Members and Controlled Entities of such persons, may not engage in any transaction in Company securities without first obtaining pre-clearance of the transaction from the Compliance Officer. The Compliance Officer is under no obligation to approve a transaction submitted for pre-clearance and may determine not to permit the transaction. If a person seeks pre-clearance and permission to engage in the transaction is denied, then such person should refrain from initiating any transaction in Company securities and should not inform any other person of the restriction. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;When a request for pre-clearance is made, the requestor should carefully consider whether such requestor may be aware of any material non-public information about the Company and should describe fully those circumstances to the Compliance Officer. The requestor should also indicate whether the requestor has effected any non-exempt &#8220;opposite-way&#8221; transactions within the past six months and should be prepared to report the proposed transaction on an appropriate Form 4 or Form 5. The requestor should also be prepared to comply with SEC Rule 144 and file a Form 144, if necessary, at the time of any sale.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Approved Pre-Planned Trading Programs Pursuant to Rule 10b5-l</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any other guidelines contained herein, it shall not be a violation of this Insider Trading Policy for personnel of the Company and the Company&#8217;s Affiliated Entities to engage in transactions in securities of the Company under certain pre-planned trading programs adopted to purchase or sell securities in the future which are in compliance with SEC Rule 10b5-l (a &#8220;Rule 10b5-1 Plan&#8221;). Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, provides a defense from insider trading liability under Rule 10b-5. In order to be eligible to rely on this defense, a person subject to this Insider Trading Policy must enter into a Rule 10b5-1 Plan for transactions in Company securities that meets certain conditions specified in the rule.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To comply with the Insider Trading Policy, a Rule 10b5-1 Plan must be approved by the Compliance Officer, comply with this Insider Trading Policy, and meet the requirements of Rule 10b5-1. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In general, a Rule 10b5-1 Plan must be entered into at a time when the person entering into the plan is not aware of material non-public information, and the person who enters into such Rule 10b5-1 Plan must act in good faith with respect to such plan. Directors and officers must include a representation in their Rule 10b5-1 Plan certifying that&#58; (i) they are not aware of any material non-public information&#59; and (ii) they are adopting the plan in good faith and not as part of a plan or scheme to evade the prohibitions in Rule 10b-5. Once the Rule 10b5-1 Plan is adopted, the person must not exercise any influence over the amount of securities to be traded, the price(s) at which they are to be traded or the date(s) of the trade(s). The Rule 10b5-1 Plan must either specify the amount, pricing and timing of transactions in advance or delegate discretion on these matters to an independent third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Any Rule 10b5-1 Plan must be submitted for approval prior to the entry into the Rule 10b5-1 Plan and any subsequent modification or termination. No further pre-approval of transactions conducted pursuant to the Rule 10b5-1 Plan will be required. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">After a Rule 10b5-1 Plan is approved, you must wait for a cooling-off period before the first trade is made under the plan. Pursuant to the SEC&#8217;s rules, a Rule 10b5-1 Plan must include a cooling-off period before trading can commence that, (1) for directors or officers, ends on the later of 90 days after the adoption of the Rule 10b5-1 Plan or two business days following the disclosure of the Company&#8217;s financial results in an SEC periodic report for the fiscal quarter in which the Rule 10b5-1 Plan was adopted (but in any event, the required cooling-off period is subject to a maximum of 120 days after adoption of the plan), and (2) for persons other than directors or officers, ends 30 days following the adoption or modification of the Rule 10b5-1 Plan. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Only one Rule 10b5-1 Plan should be in effect at any one time. Any Rule 10b5-1 Plans that would call for execution of a single trade are limited to one such plan in a consecutive 12-month period. Any modification of a Rule 10b5-1 Plan is the equivalent of entering into a new trading plan and cancelling the old trading plan. Company personnel seeking to establish, modify or cancel a Rule 10b5-1 Plan must contact the Compliance Officer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Section 16 Person understands that the approval or adoption of a Rule 10b5-1 Plan in no way reduces or eliminates such person&#8217;s obligations under Section 16 of the Securities Exchange Act of 1934, as amended, including such person&#8217;s disclosure and short-swing trading liabilities thereunder. If any questions arise, such person should consult with their own counsel in designing a Rule 10b5-1 Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Transactions under Company Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> This Insider Trading Policy does not apply in the case of the following transactions, except as specifically noted&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:32.15pt">Stock Option Exercises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Insider Policy does not apply to the exercise of an employee stock option acquired pursuant to the Company&#8217;s plans, or to the exercise of a tax withholding right pursuant to which a person has elected to have the Company withhold shares subject to an option to satisfy tax withholding requirements. This Insider Trading Policy does apply, however, to any sale of stock as part of a broker-assisted cashless exercise of an option, or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:32.15pt">Restricted Stock Awards and Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Insider Trading Policy does not apply to the vesting of restricted stock or restricted stock units, or the exercise of a tax withholding right pursuant to which you elect to have the Company withhold shares of stock to satisfy tax withholding requirements upon the vesting of any restricted stock or restricted stock units. The Insider Trading Policy does apply, however, to any market sale of restricted stock.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Confidentiality Guidelines</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To provide more effective protection against the inadvertent disclosure of material non-public information about the Company and its Affiliated Entities or the companies with which it does business, the Company has adopted the following guidelines in addition to the prohibition in Section 1 above. These guidelines are not intended to be exhaustive. Additional measures to secure the confidentiality of information should be undertaken as deemed necessary under the circumstances. If you have any doubt as to your responsibilities with respect to confidential information, please seek clarification and guidance from the Compliance Officer before you act. Do not try to resolve any uncertainties on your own.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The following guidelines establish procedures with which every employee, officer and director of the Company and the Company&#8217;s Affiliated Entities should comply in order to maximize the security of confidential information&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Do not discuss any matter regarding the Company and the Company&#8217;s Affiliated Entities in public places, such as elevators, hallways, restrooms or eating facilities, where conversations might be overheard.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Use passwords to restrict access to the information on computers.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Limit access to particular physical areas where material non-public information is likely to be documented or discussed.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Authorized Disclosure of Material Non-Public Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Under certain circumstances, the Compliance Officer may authorize the immediate release of material non-public information. If disclosure is authorized, the form and content of all public disclosures shall be approved by the Compliance Officer. All requests for information, comments, or interviews (other than routine product inquiries) made to any personnel should be directed to the Compliance Officer, who will clear all proposed responses. It is anticipated that most questions raised can be answered by the Compliance Officer or another company representative to whom the Compliance Officer refers the request. All personnel should not respond to such requests directly, unless expressly instructed otherwise by the Compliance Officer. In particular, great care should be taken not to comment on the Company&#8217;s expected future financial results. All communications with representatives of the media and securities analysts shall be directed to the Compliance Officer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Post-Termination Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Insider Trading Policy continues to apply to transactions in Company securities even after termination of service to the Company or any of the Company&#8217;s Affiliated Entities. If an individual is in possession of material non-public information when such individual&#8217;s service terminates, that individual may not engage in transactions in Company securities until that information has become public or is no longer material. In addition, after termination of service to the Company or the Company&#8217;s Affiliated Entities, Section 16 Persons remain subject to Section 16 &#8220;short swing&#8221; profit-disgorgement rules for up to six months after termination and are required to file Forms 4 to report any non-exempt transactions in Company securities (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, purchases and sales) occurring within six months after an &#8220;opposite-way&#8221; non-exempt transaction that occurred while they were still serving at the Company or the Company&#8217;s Affiliated Entities. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Company Assistance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If you have any questions about specific information or proposed transactions, or as to the applicability or interpretation of this Insider Trading Policy or the propriety of any desired action, you are encouraged to contact the Compliance Officer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Last revised February 26, 2024</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">FORM OF PRE-TRANSACTION CERTIFICATION</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Proposed Transaction Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Type of Security&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Type of Transaction(s) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">e.g.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Purchase &#47; Sale &#47; Entry into, Modification or Termination of Rule 10b5-1 Plan (if Plan, please attach) &#47; Gift &#47; Other (please specify))&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Number of Shares Involved (if applicable)&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;I hereby certify that I am not aware of any material non-public information about </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Astrana Health, Inc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(the &#8220;Company&#8221;) and &#47; or its subsidiaries. I understand that material non-public information is information concerning the Company that (a) is not generally known to the public&#59; and (b) if publicly known, would be likely to affect either the market price of Company securities or a person&#8217;s decision to buy, sell or hold Company securities. I understand that if I engage in transactions in Company securities while aware of material non-public information, I may be subject to severe civil or criminal penalties and may be subject to discipline by the Company up to and including termination for cause. The undersigned agrees to advise the Company promptly if, as a result of future developments, any of the foregoing information becomes inaccurate or incomplete in any respect. The undersigned understands that the Company may require additional information about the transaction and agrees to provide such information upon request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If seeking approval for the entry or modification of Rule 10b-5 Plan, I certify that I am adopting the plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b-5, that I shall act in good faith with respect to such plan, that I shall comply with the requirements of Rule 10b5-1 and this policy relating to such plans, and that I shall include, or cause to be included, requisite certifications in the Rule 10b5-1 Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Signature&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br>Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>19
<FILENAME>asth-20231231xexx211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i8db7443773cf4384bd9d03eb0c9d1f56_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 21.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Subsidiaries</font></div><div style="margin-bottom:7pt"><font><br></font></div><div style="margin-bottom:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The entity names below are as of February&#160;29, 2024&#58;</font></div><div style="margin-top:5pt;padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:58.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.287%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.320%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana Health Management, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana Health Technologies, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAACO, Inc.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana Health Medical Corporation*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Astrana Care Partners Medical Corporation*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allied Physicians of California, a Professional Medical Corporation*</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.25pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr></table></div><div style="margin-bottom:7pt;margin-top:3pt"><font><br></font></div><div style="margin-top:5pt;padding-left:2.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable Interest Entity</font></div></td></tr></table></div><div style="margin-top:4pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>20
<FILENAME>asth-20231231xexx231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="idac4cf531bb742d7bfdd7d4dbf26084f_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 23.1</font></div><div style="text-align:center"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><br>Consent of Independent Registered Public Accounting Firm</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We consent to the incorporation by reference in the following Registration Statements&#58;           </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Registration Statement (Form S-3 No. 333-229895) of Astrana Health, Inc. (formerly known as Apollo Medical Holdings, Inc.),</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Registration Statement (Form S-3 No. 333-228432) of Astrana Health, Inc., </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-153138) pertaining to the 2008 Professional&#47;Consultant Stock Compensation Plan of Astrana Health, Inc.,</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-217719) pertaining to the 2010 Equity Incentive Plan and 2015 Equity Incentive Plan of Astrana Health, Inc.,</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-221900) pertaining to the 2013 Equity Incentive Plan of Astrana Health, Inc., </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-221915) pertaining to Written Compensation Contracts Between the Registrant and Certain Directors, Employees and Consultants of Astrana Health, Inc.,</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Registration Statement (Form S-3 No. 333-274013) of Astrana Health, Inc., </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Registration Statement (Form S-3 No. 333-274021) pertaining to the Employee Stock Purchase Plan of Astrana Health, Inc., </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-275289) pertaining to the 2015 Equity Incentive Plan (as amended) of Astrana Health, Inc., and </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Registration Statement (Form S-8 No. 333-275642) pertaining to the Employment Inducement Award Plan of Astrana Health Inc.&#59; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated February 29, 2024, with respect to the consolidated financial statements of Astrana Health, Inc. and the effectiveness of internal control over financial reporting of Astrana Health, Inc. included in this Annual Report (Form 10-K) of Astrana Health, Inc. for the year ended December 31, 2023.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP   </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Los Angeles, California</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 29, 2024</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>21
<FILENAME>asth-20231231xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ia3f69c5dfe3d4cb7a451c410da6e9348_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">PURSUANT TO</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brandon K. Sim, M.S., certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this annual report on Form 10-K of Astrana Health, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DATE&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brandon K. Sim, M.S.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brandon K. Sim, M.S.</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>22
<FILENAME>asth-20231231xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ibeb69d01e3094786aa61add81797c8ab_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">PURSUANT TO</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Chandan Basho, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this annual report on Form 10-K of Astrana Health, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DATE&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Chandan Basho</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chandan Basho</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Chief Operating Officer</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>23
<FILENAME>asth-20231231xexx32.htm
<DESCRIPTION>EX-32
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ifa38c528c9dc4bd68457b3d8723aab1a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brandon K. Sim, M.S., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of Astrana Health, Inc. for the year ended December&#160;31, 2023, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Astrana Health, Inc.</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DATE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Brandon K. Sim, M.S.</font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brandon K. Sim, M.S.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Chandan Basho, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report on Form 10-K of Astrana Health, Inc. for the year ended December&#160;31, 2023, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Astrana Health, Inc.</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DATE&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 29, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Chandan Basho </font></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chandan Basho</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer and Chief Operating Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>24
<FILENAME>exhibit971-asthxcompensati.htm
<DESCRIPTION>EX-97.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="id34645a3daec48a0a81cb69a17ba91ce_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 97.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COMPENSATION RECOVERY POLICY</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(Last revised February 26, 2024)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Introduction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) of Astrana Health, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) has adopted this Compensation Recovery Policy (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which provides for the recovery of certain executive compensation in the event of an accounting restatement resulting from material noncompliance with financial reporting requirements under the federal securities laws. This Policy is intended to comply with Section 10D of the Securities Exchange Act of 1934 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the rules of the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commission</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) promulgated thereunder and the listing requirements of the Nasdaq Stock Market, or such other national securities exchange on which the Company&#8217;s securities may be listed from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Covered Executive Officers </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy applies to the Company&#8217;s current and former executive officers, as determined by the Board in accordance with Section 10D of the Exchange Act (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Recovery in General&#59; Applicable Restatements</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.&#160;&#160;&#160;&#160;In the event the Company is required to prepare an accounting restatement of its financial statements due to the Company&#8217;s material noncompliance with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that (i) is material to the previously issued financial statements, or (ii) would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Restatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Compensation Committee of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall cause the Company to promptly recover, to the fullest extent permitted under applicable law (and subject to the exceptions set forth below), any erroneously awarded Incentive Compensation (as defined below) received by each Executive Officer during the three completed fiscal years immediately preceding the date on which the Company is required to prepare such a Restatement (including, where required under Section 10D of the Exchange Act, any transition period resulting from a change in the Company&#8217;s fiscal year).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.&#160;&#160;&#160;&#160;For purposes of clarity, a &#8220;Restatement&#8221; shall not be deemed to include changes to the Company&#8217;s financial restatements that do not involve the correction of an error resulting from material non-compliance with financial reporting requirements, as determined in accordance with applicable accounting standards and guidance.  By way of example, based on current accounting standards and guidance, a &#8220;Restatement&#8221; would not include changes to the Company&#8217;s financial statements resulting solely from&#58; (i) retrospective application of a change in accounting principles&#59; (ii) retrospective revision to reportable segment information due to a change in the structure of the Company&#8217;s internal organization&#59; (iii) retrospective reclassification due to a discontinued operation&#59; (iv) retrospective application of a change in reporting entity, such as from a reorganization of entities under common control&#59; or (v) retrospective revision for stock splits, stock dividends, reverse stock splits or other changes in capital structure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.&#160;&#160;&#160;&#160;For purposes of this Policy, the date that the Company is required to prepare a Restatement shall be the earlier of (i) the date that the Board (or the officer or officers of the Company authorized to take such action if Board action is not required) concludes, or reasonably should have concluded, that the Company is required to prepare a Restatement&#59; or (ii) the date a court, regulator or other legally authorized body directs the Company to prepare a Restatement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d.&#160;&#160;&#160;&#160;For purposes of this Policy, Incentive Compensation shall be deemed to be received by an Executive Officer in the Company&#8217;s fiscal period during which the applicable Financial Reporting Measure (as defined below) specified in the Incentive Compensation award is attained, even if the payment or grant of the Incentive Compensation occurs after the end of that period.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%;text-decoration:underline">Incentive Compensation</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Policy, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Incentive Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any compensation that is granted, earned or vested based wholly or in part on the attainment of a Financial Reporting Measure (as defined below).  For purposes of this Policy, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Reporting Measures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; are measures that are determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measures that are derived wholly or in part from such measures, regardless of whether such measures are presented within the Company&#8217;s financial statements or included in a filing with the Commission.  Financial Reporting Measures include stock price and total shareholder return.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Erroneously Awarded Compensation&#58; Amount Subject to Recovery </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.&#160;&#160;&#160;&#160;The amount to be recovered from an Executive Officer pursuant to this Policy in the event of a Restatement shall equal the amount of Incentive Compensation received by the Executive Officer that exceeds the amount of Incentive Compensation that otherwise would have been received had it been determined based on the restated amounts, computed without regard to any taxes paid, plus, as and to the extent determined by the Committee in its discretion, interest or earnings thereon.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.&#160;&#160;&#160;&#160;Where the amount of erroneously awarded Incentive Compensation is not subject to mathematical recalculation directly from the information in the Restatement (as in the case of Incentive Compensation based on stock price or total shareholder return), the Committee shall determine such amount based on a reasonable estimate of the effect of the Restatement on the applicable Financial Reporting Measure, and the Committee shall maintain documentation of any such estimate and provide such documentation to the Exchange.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.&#160;&#160;&#160;&#160;To the extent that this Policy otherwise would provide for recovery of Incentive Compensation that the Company has recovered from an Executive Officer pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (or pursuant to any other recovery obligation), the amount already so recovered from such Executive Officer may be credited against the recovery otherwise required under this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exceptions to Recovery</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything herein to the contrary, the Company need not recover erroneously awarded Incentive Compensation from an Executive Officer to the extent that the Committee determines that such recovery would be impracticable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> either&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.&#160;&#160;&#160;&#160;The direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered (determined by the Committee after making and documenting a reasonable attempt to recover such erroneously awarded compensation, and providing documentation to the Exchange of such reasonable attempt to recover the compensation)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.&#160;&#160;&#160;&#160;Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code and regulations thereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c.&#160;&#160;&#160;&#160;Recovery would violate home country law where that law was adopted prior to November 28, 2022 (determined by the Committee after the Company has obtained an opinion of home country counsel acceptable to the Exchange, that recovery would result in such a violation, and such opinion is provided to the Exchange).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Methods of Recovery</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.&#160;&#160;&#160;&#160;The Committee will determine, in its absolute discretion and taking into account the applicable facts and circumstances, the method or methods for recovering any erroneously awarded Incentive Compensation hereunder, which method(s) need not be applied on a consistent basis&#59; provided in any case that any such method provides for reasonably prompt recovery and otherwise complies with any requirements of the Exchange and applicable law. By way of example and not in limitation of the foregoing, methods of recovery that the Committee, in its discretion, may determine to use under the Policy may include, to the extent permitted by applicable law (including, without limitation, Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)), one or more of the following methods (which rights shall be cumulative and not exclusive)&#58; (i) repayment by the Executive Officer in immediately available funds, (ii) the forfeiture or repayment of Incentive Compensation, (iii) the forfeiture or repayment of time-based equity or cash incentive compensation awards, (iv) the surrender of shares of Company common stock held by the Executive Officer pursuant to any applicable Company guidelines or policies regarding stock ownership or retention, (v) the forfeiture of, or offset against, benefits under a deferred compensation plan, and&#47;or (vi) the offset of all or a portion of the amount of the erroneously awarded Incentive Compensation against other compensation payable to the Executive Officer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.&#160;&#160;&#160;&#160;To the fullest extent permitted by applicable law (including, without limitation, Section 409A), the Committee may, in its sole discretion, delay the vesting or payment of any compensation otherwise payable to an Executive Officer to provide a reasonable period of time to conduct or complete an investigation into whether this Policy is applicable, and if so, how it should be enforced, under the circumstances.    </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">No Indemnification</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the terms of any agreement, policy or governing document of the Company to the contrary, the Company shall not indemnify any Executive Officer against (a) the loss of any erroneously awarded Incentive Compensation, or (b) any claim relating to the Company&#8217;s enforcement of its rights under this Policy.  By signing the Acknowledgement Form (defined below), each Executive Officer irrevocably agrees never to institute any claim against the Company or any subsidiary, knowingly and voluntarily waives his or her ability, if any, to bring any such claim, and releases the Company and any subsidiary from any such claim, for indemnification with respect to any expenses (including attorneys&#8217; fees), judgments or amounts of compensation paid or forfeited by the Executive Officer in connection with the application or enforcement of this Policy&#59; and if, notwithstanding the foregoing, any such claim for indemnification is allowed by a court of competent jurisdiction, then, the Executive Officer shall be deemed irrevocably to have agreed not to pursue such claim and hereby agrees to execute any and all documents necessary to request dismissal or withdrawal of such claim.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Administration</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy shall be administered by the Committee.  The Committee shall have full and final authority to make all determinations under this Policy.  In this regard, the Committee shall have </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">no obligation to treat any Executive Officer uniformly and the Committee may make determinations selectively among Executive Officers in its business judgment. All determinations and decisions made by the Committee pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the Company, its subsidiaries, its stockholders and its employees.  It is intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act and any applicable rules or standards adopted by the Commission or the Exchange.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Policy Not Exclusive</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The remedies specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the Company.  The repayment or forfeiture of Incentive Compensation or other amounts pursuant to the Policy shall not in any way limit or affect the Company&#8217;s right to pursue disciplinary action or dismissal, take legal action or pursue any other remedies available to the Company (including, without limitation, the exercise of any rights of recovery, recoupment, forfeiture or offset that may be available to the Company pursuant to the terms of any other applicable Company policy, employment agreement, equity plan or award agreement).  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Effective Date</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy shall be effective as of October 2, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and shall apply to any Incentive Compensation that is received by an Executive Officer on or after the Effective Date.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment&#59; Termination</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Board may amend this Policy from time to time in its discretion and shall amend this Policy as it may deem necessary to comply with the rules of the Commission and the listing standards of the Exchange under Section 10D of the Exchange Act (in any event without the consent of an Executive Officer or any other individual). The Board may terminate this Policy at any time.  Notwithstanding the foregoing, no amendment or termination of this Policy shall be effective to the extent that such amendment or termination would (after taking into account any actions taken by the Company contemporaneously with such amendment or termination) cause the Company to violate any federal securities law, any rule of the Commission, or any listing standards of the Exchange.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Governing Law&#59; Exclusive Forum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">To the extent not preempted by federal law, this Policy shall be governed, construed, interpreted and enforced in accordance with the substantive laws of the State of Delaware, without regard to conflicts of law principles. Notwithstanding any dispute resolution policy maintained by the Corporation or any subsidiary to the contrary, any action directly or indirectly arising out of or related to this Policy may be brought only in the Court of Chancery of the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Court of Chancery</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or, to the extent the Court of Chancery does not have subject matter jurisdiction, the United States District Court for the District of Delaware and the appellate courts having jurisdiction of appeals in such courts (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Delaware Federal Court</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) or, to the extent neither the Court of Chancery nor the Delaware Federal Court has subject matter jurisdiction, the Superior Court of the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Chosen Courts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Solely with respect to any such action, the Corporation and each Officer (a) irrevocably submits to the exclusive jurisdiction of the Chosen Courts, (b) waives any objection to laying venue in any such action in the Chosen Courts, and (c) waives any objection that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any party hereto.  Notwithstanding the existence of any other dispute between the Corporation and an Officer, the governing law and choice of forum for any action directly or indirectly arising out of or related to this Policy shall be governed exclusively by the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">terms of this Policy, and to the extent necessary to comply with this Policy, any action directly or indirectly arising out of or related to this Policy shall be severed from any other dispute between the Corporation and an Officer.  For avoidance of doubt, no action directly or indirectly arising out of or related to this Policy may be brought in any forum other than the Chosen Courts.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Severability&#59; Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If any provision of this Policy is determined to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted by applicable law and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law.  The waiver by the Company or the Committee with respect to compliance of any provision of this Policy by an Executive Officer shall not operate or be construed as a waiver of any other provision of this Policy, or of any subsequent acts or omissions by an Executive Officer under this Policy.&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Filings</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee shall cause the Company to make any filings with, or submissions to, the Commission and the Exchange that may be required pursuant to rules or standards adopted by the Commission or the Exchange pursuant to Section 10D of the Exchange Act. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Acknowledgement by Executive Officers</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a.&#160;&#160;&#160;&#160;The Committee shall require each Executive Officer serving as such on or after the Effective Date to sign and return to the Company an acknowledgement in the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (or in such other form as may be prescribed by the Committee from time to time) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), pursuant to which the Executive Officer will affirmatively agree to be bound by, and to comply with, the terms and conditions of this Policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b.&#160;&#160;&#160;&#160;Moreover, any award agreement or other document setting forth the terms and conditions of Incentive Compensation (collectively, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) may include a provision incorporating the terms and conditions of the Policy&#59; provided that the Company&#8217;s failure to incorporate the Policy into any Covered Agreement shall not waive the Company&#8217;s right to enforce the Policy. In the event of any inconsistency between the provisions of the Policy and the applicable Covered Agreement, the terms of the Policy shall govern, notwithstanding any provision in the Covered Agreement to the contrary.    </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">* * * * *</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div><div><font><br></font></div></div></div><div id="id34645a3daec48a0a81cb69a17ba91ce_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ACKNOWLEDGEMENT FORM</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ASTRANA HEALTH, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COMPENSATION RECOVERY POLICY</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">As an Executive Officer of Astrana Health, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), I hereby acknowledge the receipt of a copy of the Company&#8217;s Compensation Recovery Policy (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), affirm that I have read and understand the Policy, and agree to be bound by, and to comply with, the terms and conditions of the Policy as in effect from time to time (which are fully incorporated herein), in each case during my service as an Executive Officer of the Company and thereafter for as long as required under the Policy.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I agree to fully cooperate with the Company in the event it is required to enforce the Policy. In this regard, I agree to repay to the Company fully and promptly, upon demand (in immediately available funds denominated in U.S. dollars or otherwise as specified by the Company pursuant to the Policy), all amounts of erroneously awarded Incentive Compensation, as may be determined by the Committee in its discretion and set out in the Company&#8217;s demand for repayment, plus such interest or earnings as may be determined by the Committee in its discretion and set out in the Company&#8217;s demand for repayment.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I also agree that my obligation to repay the erroneously awarded Incentive Compensation shall be absolute and unconditional, irrespective of any defense or any rights of set-off, recoupment or counterclaim I might otherwise have against the Company. In this regard, I voluntarily, irrevocably and unconditionally waive any objection to, or any claim for damages or loss related to, the Company pursuing any other method of recovery of erroneously awarded Incentive Compensation that is deemed appropriate by the Committee in its sole discretion (including, without limitation, the methods of recovery set forth in the Policy).   </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I further acknowledge and agree that in no event shall any of the terms of the Policy, or any action taken the Company to enforce its rights under the Policy, be deemed to constitute &#8220;good reason&#8221; for purposes of determining any right I may otherwise have to receive any severance or other benefits under any Company plan, policy, agreement or arrangement in connection with the termination of my employment.  Further, I acknowledge and agree that the Company&#8217;s rights under the Policy are in addition to, and not in lieu of, any other legal remedies or rights of recovery, recoupment, forfeiture or offset that may be available to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">My execution of this Acknowledgement Form is in consideration of, and is a condition to, my opportunity to participate in, and receive future awards under, the Company&#8217;s Incentive Compensation programs&#59; provided, however, that nothing in this Acknowledgement Form or the Policy shall be deemed to obligate the Company to make any specific Incentive Compensation awards in the future.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;SIGNATURE PAGE FOLLOWS&#93;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AGREED TO AND ACCEPTED BY&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Print Name</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>25
<FILENAME>asth-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:04cda4cf-3e82-4310-bba4-80cea29b7bde,g:59735ae4-b6da-4fb6-9f6d-2f4a46b99a61-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:asth="http://www.apollomed.net/20231231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.apollomed.net/20231231">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="asth-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="asth-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="asth-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="asth-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.apollomed.net/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.apollomed.net/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusiness" roleURI="http://www.apollomed.net/role/DescriptionofBusiness">
        <link:definition>0000008 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetAcquisitionsandGoodwill" roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill">
        <link:definition>0000010 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LandPropertyandEquipmentNet" roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNet">
        <link:definition>0000011 - Disclosure - Land, Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNet" roleURI="http://www.apollomed.net/role/IntangibleAssetsNet">
        <link:definition>0000012 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinOtherEntities" roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntities">
        <link:definition>0000013 - Disclosure - Investments in Other Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoanReceivableandLoanReceivableRelatedParties" roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties">
        <link:definition>0000014 - Disclosure - Loan Receivable and Loan Receivable &#8211; Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableandAccruedExpenses" roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpenses">
        <link:definition>0000015 - Disclosure - Accounts Payable and Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalLiabilities" roleURI="http://www.apollomed.net/role/MedicalLiabilities">
        <link:definition>0000016 - Disclosure - Medical Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCredit" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit">
        <link:definition>0000017 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.apollomed.net/role/IncomeTaxes">
        <link:definition>0000018 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MezzanineandStockholdersEquityDeficit" roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficit">
        <link:definition>0000019 - Disclosure - Mezzanine and Stockholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.apollomed.net/role/StockBasedCompensation">
        <link:definition>0000020 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.apollomed.net/role/CommitmentsandContingencies">
        <link:definition>0000021 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.apollomed.net/role/RelatedPartyTransactions">
        <link:definition>0000022 - Disclosure - Related-Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlan" roleURI="http://www.apollomed.net/role/EmployeeBenefitPlan">
        <link:definition>0000023 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.apollomed.net/role/EarningsPerShare">
        <link:definition>0000024 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesVIEs" roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEs">
        <link:definition>0000025 - Disclosure - Variable Interest Entities (VIEs)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.apollomed.net/role/Leases">
        <link:definition>0000026 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segments" roleURI="http://www.apollomed.net/role/Segments">
        <link:definition>0000027 - Disclosure - Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsofFinancialInstruments" roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstruments">
        <link:definition>0000028 - Disclosure - Fair Value Measurements of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.apollomed.net/role/SubsequentEvents">
        <link:definition>0000029 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954472 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetAcquisitionsandGoodwillTables" roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables">
        <link:definition>9954473 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LandPropertyandEquipmentNetTables" roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNetTables">
        <link:definition>9954474 - Disclosure - Land, Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetTables" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetTables">
        <link:definition>9954475 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinOtherEntitiesTables" roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables">
        <link:definition>9954476 - Disclosure - Investments in Other Entities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableandAccruedExpensesTables" roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables">
        <link:definition>9954477 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalLiabilitiesTables" roleURI="http://www.apollomed.net/role/MedicalLiabilitiesTables">
        <link:definition>9954478 - Disclosure - Medical Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCreditTables" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables">
        <link:definition>9954479 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.apollomed.net/role/IncomeTaxesTables">
        <link:definition>9954480 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.apollomed.net/role/StockBasedCompensationTables">
        <link:definition>9954481 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsTables" roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsTables">
        <link:definition>9954482 - Disclosure - Related-Party Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.apollomed.net/role/EarningsPerShareTables">
        <link:definition>9954483 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesVIEsTables" roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables">
        <link:definition>9954484 - Disclosure - Variable Interest Entities (VIEs) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.apollomed.net/role/LeasesTables">
        <link:definition>9954485 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsTables" roleURI="http://www.apollomed.net/role/SegmentsTables">
        <link:definition>9954486 - Disclosure - Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsofFinancialInstrumentsTables" roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsTables">
        <link:definition>9954487 - Disclosure - Fair Value Measurements of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessDetails" roleURI="http://www.apollomed.net/role/DescriptionofBusinessDetails">
        <link:definition>9954488 - Disclosure - Description of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>9954489 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails">
        <link:definition>9954490 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Disaggregation of Revenue by Payor Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails" roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails">
        <link:definition>9954491 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Contributions to Revenue and Receivables by Payor (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails">
        <link:definition>9954492 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails" roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails">
        <link:definition>9954493 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Goodwill Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails" roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails">
        <link:definition>9954494 - Disclosure - Land, Property and Equipment, Net - Schedule of Land, Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LandPropertyandEquipmentNetAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNetAdditionalInformationDetails">
        <link:definition>9954495 - Disclosure - Land, Property and Equipment, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetScheduleofIntangibleAssetsDetails" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails">
        <link:definition>9954496 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1">
        <link:definition>9954496 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails">
        <link:definition>9954497 - Disclosure - Intangible Assets, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails">
        <link:definition>9954498 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails">
        <link:definition>9954499 - Disclosure - Investments in Other Entities - Schedule of Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinOtherEntitiesNarrativeDetails" roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails">
        <link:definition>9954500 - Disclosure - Investments in Other Entities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoanReceivableandLoanReceivableRelatedPartiesDetails" roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails">
        <link:definition>9954501 - Disclosure - Loan Receivable and Loan Receivable &#8211; Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsPayableandAccruedExpensesDetails" roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails">
        <link:definition>9954502 - Disclosure - Accounts Payable and Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MedicalLiabilitiesDetails" roleURI="http://www.apollomed.net/role/MedicalLiabilitiesDetails">
        <link:definition>9954503 - Disclosure - Medical Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails">
        <link:definition>9954504 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails">
        <link:definition>9954505 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails">
        <link:definition>9954506 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Credit Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails" roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails">
        <link:definition>9954507 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Lines of Credit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionBenefitDetails" roleURI="http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails">
        <link:definition>9954508 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesProvisionforIncomeTaxesDetails" roleURI="http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails">
        <link:definition>9954509 - Disclosure - Income Taxes - Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>9954510 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsLiabilitiesDetails" roleURI="http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails">
        <link:definition>9954511 - Disclosure - Income Taxes - Deferred Tax Assets (Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MezzanineandStockholdersEquityDeficitAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails">
        <link:definition>9954512 - Disclosure - Mezzanine and Stockholders&#8217; Equity (Deficit) - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails">
        <link:definition>9954513 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationShareBasedCompensationExpenseDetails" roleURI="http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails">
        <link:definition>9954514 - Disclosure - Stock-Based Compensation - Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationSummaryofStockOptionActivityDetails" roleURI="http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails">
        <link:definition>9954515 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationSummaryofRestrictedStockActivityDetails" roleURI="http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails">
        <link:definition>9954516 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails">
        <link:definition>9954517 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>9954518 - Disclosure - Related-Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails">
        <link:definition>9954519 - Disclosure - Related-Party Transactions - Schedule of Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/EmployeeBenefitPlanAdditionalInformationDetails">
        <link:definition>9954520 - Disclosure - Employee Benefit Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails">
        <link:definition>9954521 - Disclosure - Earnings Per Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails" roleURI="http://www.apollomed.net/role/EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails">
        <link:definition>9954522 - Disclosure - Earnings Per Share - Basic Net Income (loss) Per Share is Calculated Using Weighted Average Number of Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails" roleURI="http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails">
        <link:definition>9954523 - Disclosure - Earnings Per Share - Summary of Shares Included in Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails" roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails">
        <link:definition>9954524 - Disclosure - Variable Interest Entities (VIEs) - Eliminated Upon Consolidation Included In Accompanying Consolidated Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalinformationDetails" roleURI="http://www.apollomed.net/role/LeasesAdditionalinformationDetails">
        <link:definition>9954525 - Disclosure - Leases - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofLeaseExpenseDetails" roleURI="http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails">
        <link:definition>9954526 - Disclosure - Leases - Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOtherInformationRelatedtoLeasesDetails" roleURI="http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails">
        <link:definition>9954527 - Disclosure - Leases - Other Information Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details" roleURI="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details">
        <link:definition>9954528 - Disclosure - Leases - Future Minimum Payments Under Non-cancelable Leases After Adoption of 842 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1" roleURI="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1">
        <link:definition>9954528 - Disclosure - Leases - Future Minimum Payments Under Non-cancelable Leases After Adoption of 842 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsNarrativeDetails" roleURI="http://www.apollomed.net/role/SegmentsNarrativeDetails">
        <link:definition>9954529 - Disclosure - Segments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsScheduleofInformationaboutourSegmentsDetails" roleURI="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails">
        <link:definition>9954530 - Disclosure - Segments - Schedule of Information about our Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails" roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails">
        <link:definition>9954531 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails" roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails">
        <link:definition>9954532 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails" roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails">
        <link:definition>9954533 - Disclosure - Fair Value Measurements of Financial Instruments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails" roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails">
        <link:definition>9954534 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Gain (Loss) on Equity Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.apollomed.net/role/SubsequentEventsDetails">
        <link:definition>9954535 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="asth_LoanReceivableTextBlock" abstract="false" name="LoanReceivableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" abstract="false" name="RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" abstract="false" name="AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_IntersegmentMember" abstract="true" name="IntersegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="asth_MemberRelationshipsMember" abstract="true" name="MemberRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_ApcStockOptionMember" abstract="true" name="ApcStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_OperatingLossCarryforwardsNotSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_LoanReceivableAbstract" abstract="true" name="LoanReceivableAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_PaymentsForMedicalCareCostsAbstract" abstract="true" name="PaymentsForMedicalCareCostsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_IssuanceOfFinancingObligationForBusinessCombination" abstract="false" name="IssuanceOfFinancingObligationForBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_AmendedAndRestatedCreditAgreementMember" abstract="true" name="AmendedAndRestatedCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_OtherThirdPartiesMember" abstract="true" name="OtherThirdPartiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" abstract="false" name="NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="asth_RealEstateLoanTwoMember" abstract="true" name="RealEstateLoanTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" abstract="false" name="EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired" abstract="false" name="FiniteAndIndefiniteLivedIntangibleAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_PreferredBankMember" abstract="true" name="PreferredBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_ManagementContractsMember" abstract="true" name="ManagementContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_RestructuringSpinoffTransactionPercentage" abstract="false" name="RestructuringSpinoffTransactionPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="asth_AstranaMedicalMember" abstract="true" name="AstranaMedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" abstract="true" name="ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_TaxImpactFromDividends" abstract="false" name="TaxImpactFromDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_DeferredTaxAssetsInvestment" abstract="false" name="DeferredTaxAssetsInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" abstract="false" name="GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_EquityMethodInvestmentsContribution" abstract="false" name="EquityMethodInvestmentsContribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_APCMGMember" abstract="true" name="APCMGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" abstract="false" name="NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_DefinedContributionPlanServicePeriod" abstract="false" name="DefinedContributionPlanServicePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="asth_UnrealizedGainLossFromInvestmentInEquitySecurities" abstract="false" name="UnrealizedGainLossFromInvestmentInEquitySecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_RelatedPartyTransactionRevenueExpenseNetMember" abstract="true" name="RelatedPartyTransactionRevenueExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_RevenuePaymentTerms" abstract="false" name="RevenuePaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" abstract="false" name="FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_MedicaidMember" abstract="true" name="MedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_LesseeFinanceLeaseTerminationPeriodIfApplicable" abstract="false" name="LesseeFinanceLeaseTerminationPeriodIfApplicable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_RiskPoolSettlementsAndIncentivesMember" abstract="true" name="RiskPoolSettlementsAndIncentivesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_PayerDMember" abstract="true" name="PayerDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_CallCenterServicesMember" abstract="true" name="CallCenterServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_ContingentEquitySecuritiesMember" abstract="true" name="ContingentEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_AstranaMember" abstract="true" name="AstranaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_CareEnablementMember" abstract="true" name="CareEnablementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="asth_EquityMethodInvestmentsConsolidated" abstract="false" name="EquityMethodInvestmentsConsolidated" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_ProviderServicesMember" abstract="true" name="ProviderServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_A2024MetricMember" abstract="true" name="A2024MetricMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" abstract="false" name="BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_ForYourBenefitIncMember" abstract="true" name="ForYourBenefitIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_AAMGMember" abstract="true" name="AAMGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioAdjustedMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="asth_LmaMember" abstract="true" name="LmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" abstract="false" name="EquityMethodInvestmentFundingReclassifiedToLoanReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_ValleyOaksMedicalGroupMember" abstract="true" name="ValleyOaksMedicalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_TruistBankMember" abstract="true" name="TruistBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EquityMethodInvestmentAdditionalInvestment" abstract="false" name="EquityMethodInvestmentAdditionalInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_SpecialtyCapitationPayableCurrent" abstract="false" name="SpecialtyCapitationPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_CAIPAMSOMember" abstract="true" name="CAIPAMSOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_FinanceReceivableInterestRateStatedPercentage" abstract="false" name="FinanceReceivableInterestRateStatedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="asth_RevolverLoanMember" abstract="true" name="RevolverLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_ApolloSunLabsManagementLLCMember" abstract="true" name="ApolloSunLabsManagementLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_Tag8MedicalInvestmentGroupLLCMember" abstract="true" name="Tag8MedicalInvestmentGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EquityIncentivePlanTwentyThirteenMember" abstract="true" name="EquityIncentivePlanTwentyThirteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EquityMethodInvestmentAdjustmentToFairValue" abstract="false" name="EquityMethodInvestmentAdjustmentToFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_BusinessCombinationStockContingentConsiderationLiability" abstract="false" name="BusinessCombinationStockContingentConsiderationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_OfficeLeaseMember" abstract="true" name="OfficeLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_CarePartnersMember" abstract="true" name="CarePartnersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_MinorityInterestPolicyPolicyTextBlock" abstract="false" name="MinorityInterestPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="asth_MedicalCareCostsAbstract" abstract="true" name="MedicalCareCostsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_PerformanceBasedRestrictedStockMember" abstract="true" name="PerformanceBasedRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_LasalleMedicalAssociatesIpaMember" abstract="true" name="LasalleMedicalAssociatesIpaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock" abstract="false" name="PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="asth_MezzanineMember" abstract="true" name="MezzanineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" abstract="false" name="TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_IncreaseDecreaseInMedicalLiabilities" abstract="false" name="IncreaseDecreaseInMedicalLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_OneMSOLLCMember" abstract="true" name="OneMSOLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_DmgMember" abstract="true" name="DmgMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_ApcShareholdersMember" abstract="true" name="ApcShareholdersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_PayorBMember" abstract="true" name="PayorBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_VOMGMember" abstract="true" name="VOMGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_NetworkMedicalManagementIncMember" abstract="true" name="NetworkMedicalManagementIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_NewTermLoanMember" abstract="true" name="NewTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" abstract="false" name="InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_TemporaryEquityTaxImpactOnAcquisition" abstract="false" name="TemporaryEquityTaxImpactOnAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_LesseeOperatingLeaseTerminationPeriodIfApplicable" abstract="false" name="LesseeOperatingLeaseTerminationPeriodIfApplicable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_CollarMember" abstract="true" name="CollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_DerivativeCeilingInterestRate" abstract="false" name="DerivativeCeilingInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="asth_PerformanceBasedRestrictedStockUnitsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="asth_CMSMember" abstract="true" name="CMSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_DefinedContributionPlanVestingPeriod" abstract="false" name="DefinedContributionPlanVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_EquityMethodInvestmentsRollForward" abstract="true" name="EquityMethodInvestmentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_TemporaryEquityDividendsImpact" abstract="false" name="TemporaryEquityDividendsImpact" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_PayorCMember" abstract="true" name="PayorCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_NoncontrollingInterestIncreaseFromCapitalCharge" abstract="false" name="NoncontrollingInterestIncreaseFromCapitalCharge" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_MezzanineEquityAbstract" abstract="true" name="MezzanineEquityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_DeferredTaxAssetsLeaseLiability" abstract="false" name="DeferredTaxAssetsLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_AchievaMedInc.Member" abstract="true" name="AchievaMedInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_SeenHealthIncMember" abstract="true" name="SeenHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_Tag2PromissoryNoteMember" abstract="true" name="Tag2PromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_SubcontractorIpaRiskPoolPayable" abstract="false" name="SubcontractorIpaRiskPoolPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_NumberOfRealEstateLoans" abstract="false" name="NumberOfRealEstateLoans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="asth_A2023MetricMember" abstract="true" name="A2023MetricMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_ApolloMedicalHoldingsIncMember" abstract="true" name="ApolloMedicalHoldingsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_LeaseWeightedAverageRemainingLeaseTermAbstract" abstract="true" name="LeaseWeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_MedicalPropertyPartnersLLCMember" abstract="true" name="MedicalPropertyPartnersLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments" abstract="false" name="PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_NetworkRelationshipsMember" abstract="true" name="NetworkRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_FiduciaryAccountsPayableCurrent" abstract="false" name="FiduciaryAccountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_PayorAMember" abstract="true" name="PayorAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" abstract="false" name="DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_ProfessionalMedicalCorporationMember" abstract="true" name="ProfessionalMedicalCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_TaxImpactFromInvestments" abstract="false" name="TaxImpactFromInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_AdvanceDiagnosticSurgeryCenterMember" abstract="true" name="AdvanceDiagnosticSurgeryCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_SunnyVillageCareCenterMember" abstract="true" name="SunnyVillageCareCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_StockIssuedDuringPeriodSharesNoncontrollingInterest" abstract="false" name="StockIssuedDuringPeriodSharesNoncontrollingInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="asth_ApolloMedOfficerMember" abstract="true" name="ApolloMedOfficerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_LineOfCreditFacilityAmountFundedAtClosing" abstract="false" name="LineOfCreditFacilityAmountFundedAtClosing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_StockIssuedDuringPeriodSharesMerger" abstract="false" name="StockIssuedDuringPeriodSharesMerger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" abstract="false" name="StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="asth_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" abstract="false" name="StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="asth_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_ThirdPartyMember" abstract="true" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_VariableInterestEntityNumberOfPhysicians" abstract="false" name="VariableInterestEntityNumberOfPhysicians" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="asth_Pacific6EnterprisesMember" abstract="true" name="Pacific6EnterprisesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_LeaseWeightedAverageDiscountRateAbstract" abstract="true" name="LeaseWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_GainLossOnEquityReceivable" abstract="false" name="GainLossOnEquityReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_LesseeOperatingLeaseOptionToExtendPeriod" abstract="false" name="LesseeOperatingLeaseOptionToExtendPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_PayorEMember" abstract="true" name="PayorEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_PmiocMember" abstract="true" name="PmiocMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_UniversalCareIncMember" abstract="true" name="UniversalCareIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="asth_RelatedPartyTransactionRevenueRecognizedMember" abstract="true" name="RelatedPartyTransactionRevenueRecognizedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_RestructuringSpinoffTransactionDividendRealEstateOperations" abstract="false" name="RestructuringSpinoffTransactionDividendRealEstateOperations" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" abstract="true" name="LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet" abstract="false" name="EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="asth_CompanyAndAPCMember" abstract="true" name="CompanyAndAPCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="asth_MarketableSecuritiesCurrentMaturityPeriod" abstract="false" name="MarketableSecuritiesCurrentMaturityPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" abstract="false" name="NumberOfOperatingSegmentsThatShareSimilarCharacteristics" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock" abstract="false" name="ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="asth_ApcLsmaMember" abstract="true" name="ApcLsmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" abstract="true" name="OrmaHealthIncAndProviderGrowthSolutionsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_ThirdWayHealthIncMember" abstract="true" name="ThirdWayHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_UnamortizedDeferredFinancingCosts" abstract="false" name="UnamortizedDeferredFinancingCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_SubordinatedLoanAgreementMember" abstract="true" name="SubordinatedLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_RelatedPartyTransactionExpensesIncurredMember" abstract="true" name="RelatedPartyTransactionExpensesIncurredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_ConsultingServicesMember" abstract="true" name="ConsultingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_RentPaymentMember" abstract="true" name="RentPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_CDSCMember" abstract="true" name="CDSCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_AdvancedDiagnosticAndSurgicalCenterMember" abstract="true" name="AdvancedDiagnosticAndSurgicalCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" abstract="false" name="RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_AmendedCreditAgreementMember" abstract="true" name="AmendedCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_RealEstateLoanThreeMember" abstract="true" name="RealEstateLoanThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_AccountsPayableAndAccruedExpensesMember" abstract="true" name="AccountsPayableAndAccruedExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_FiveThreeOneW.CollegeLLCMember" abstract="true" name="FiveThreeOneW.CollegeLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" abstract="false" name="RestructuringSpinoffTransactionNumberOfMembershipUnits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="asth_PatientManagementPlatformMember" abstract="true" name="PatientManagementPlatformMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_RealEstateLoanOneMember" abstract="true" name="RealEstateLoanOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_SpinOffTransactionMember" abstract="true" name="SpinOffTransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" abstract="false" name="DebtInstrumentCovenantLeverageRatioIncrementalChange" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="asth_CashPaidForLeaseLiabilitiesAbstractAbstract" abstract="true" name="CashPaidForLeaseLiabilitiesAbstractAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" abstract="false" name="ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_InterestRateCollarMember" abstract="true" name="InterestRateCollarMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_ArroyoVistaMember" abstract="true" name="ArroyoVistaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_SongPCMember" abstract="true" name="SongPCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_PaymentsToEquityMethodInvestments" abstract="false" name="PaymentsToEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_A120HellmanLLCMember" abstract="true" name="A120HellmanLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_FulgentGeneticsIncMember" abstract="true" name="FulgentGeneticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_WarrantIssuedDuringPeriodValueStockOptionsExercised" abstract="false" name="WarrantIssuedDuringPeriodValueStockOptionsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_StockAwardsAndUnitsMember" abstract="true" name="StockAwardsAndUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_StockholdersEquityTransferOfCommonControlEntities" abstract="false" name="StockholdersEquityTransferOfCommonControlEntities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_MediPortalLLCMember" abstract="true" name="MediPortalLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_DebtCovenantAggregatePurchasePriceMaximum" abstract="false" name="DebtCovenantAggregatePurchasePriceMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_Tag6MedicalInvestmentGroupLLCMember" abstract="true" name="Tag6MedicalInvestmentGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_PerMemberPerMonthManagedCareContractMember" abstract="true" name="PerMemberPerMonthManagedCareContractMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_AHMCMember" abstract="true" name="AHMCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_ConstructionLoanMember" abstract="true" name="ConstructionLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="asth_PacificMedicalImagingAndOncologyCenterIncMember" abstract="true" name="PacificMedicalImagingAndOncologyCenterIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_DMGAndSunLabsMember" abstract="true" name="DMGAndSunLabsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="asth_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_CommunityFamilyCareMedicalGroupMember" abstract="true" name="CommunityFamilyCareMedicalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_ClaimsBasedOnOccurrenceAnAggregateAmount" abstract="false" name="ClaimsBasedOnOccurrenceAnAggregateAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_GainLossOnConsolidationOfEquityMethodInvestment" abstract="false" name="GainLossOnConsolidationOfEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" abstract="false" name="BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="asth_CashlessExerciseOfStockOptions" abstract="false" name="CashlessExerciseOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_CommercialMember" abstract="true" name="CommercialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_StockIssuedDuringPeriodValueNoncontrollingInterest" abstract="false" name="StockIssuedDuringPeriodValueNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_IntraCareConvertiblePromissoryNoteReceivableMember" abstract="true" name="IntraCareConvertiblePromissoryNoteReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_TemporaryEquityPolicyPolicyTextBlock" abstract="false" name="TemporaryEquityPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="asth_AurionMember" abstract="true" name="AurionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_BeneficialInterestPolicyTextBlock" abstract="false" name="BeneficialInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="asth_SecuredOvernightFinancingRateMember" abstract="true" name="SecuredOvernightFinancingRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_PaymentMadeToRelatedParty" abstract="false" name="PaymentMadeToRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_CancellationOfRestrictedStockAwards" abstract="false" name="CancellationOfRestrictedStockAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_TemporaryEquityTransferOfCommonControlEntities" abstract="false" name="TemporaryEquityTransferOfCommonControlEntities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_AlliedPacificOfCaliforniaIPAMember" abstract="true" name="AlliedPacificOfCaliforniaIPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_NetworkMedicalManagementMember" abstract="true" name="NetworkMedicalManagementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" abstract="false" name="NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" abstract="false" name="DebtInstrumentCovenantInterestCoverageRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="asth_HSMSOMember" abstract="true" name="HSMSOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" abstract="false" name="IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_AAMGEquityContingentConsideration" abstract="false" name="AAMGEquityContingentConsideration" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" abstract="false" name="BusinessCombinationEquityInterestPurchaseObligationNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="asth_FirstCommonwealthPropertyLLCMember" abstract="true" name="FirstCommonwealthPropertyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="asth_APCMember" abstract="true" name="APCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="asth_JadeHealthCareMedicalGroupIncMember" abstract="true" name="JadeHealthCareMedicalGroupIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_APAMHMedicalCorporationMember" abstract="true" name="APAMHMedicalCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_CareDeliveryMember" abstract="true" name="CareDeliveryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_HealthCareCapitationRevenueMember" abstract="true" name="HealthCareCapitationRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_ApcBusinessLoanAgreementMember" abstract="true" name="ApcBusinessLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="asth_FiduciaryCashAndPayablePolicyTextBlock" abstract="false" name="FiduciaryCashAndPayablePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="asth_EquityIncentivePlanTwentyFifteenMember" abstract="true" name="EquityIncentivePlanTwentyFifteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>26
<FILENAME>asth-20231231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:04cda4cf-3e82-4310-bba4-80cea29b7bde,g:59735ae4-b6da-4fb6-9f6d-2f4a46b99a61-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_abb43959-b2a0-47d4-b052-070165d671c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b8314cfc-6873-4630-bbea-9cf5cf07cb1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_abb43959-b2a0-47d4-b052-070165d671c5" xlink:to="loc_us-gaap_Liabilities_b8314cfc-6873-4630-bbea-9cf5cf07cb1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a338dc3f-e979-4dd4-b2f5-f8df536aa101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_abb43959-b2a0-47d4-b052-070165d671c5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a338dc3f-e979-4dd4-b2f5-f8df536aa101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_889bc81a-433b-4e54-8233-85d15d316122" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_abb43959-b2a0-47d4-b052-070165d671c5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_889bc81a-433b-4e54-8233-85d15d316122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_15b79879-bc5c-4e36-9afd-2703daa5b6f5" xlink:href="asth-20231231.xsd#asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_abb43959-b2a0-47d4-b052-070165d671c5" xlink:to="loc_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_15b79879-bc5c-4e36-9afd-2703daa5b6f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_12906a1d-329b-4e68-b50e-707b3e254756" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9b4bae2e-74c9-45a8-8075-68df8b26f5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_12906a1d-329b-4e68-b50e-707b3e254756" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9b4bae2e-74c9-45a8-8075-68df8b26f5bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c72fe013-0c86-44af-96a4-7e3a74c23bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_12906a1d-329b-4e68-b50e-707b3e254756" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c72fe013-0c86-44af-96a4-7e3a74c23bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_be141b44-bd9d-404e-9586-0f0f61b39009" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_12906a1d-329b-4e68-b50e-707b3e254756" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_be141b44-bd9d-404e-9586-0f0f61b39009" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_441a9bb1-88ee-41e4-8a84-051f4ea90dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_12906a1d-329b-4e68-b50e-707b3e254756" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_441a9bb1-88ee-41e4-8a84-051f4ea90dbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bb64ed0c-eaad-4e3c-a8c7-bd91c1cc4991" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_12906a1d-329b-4e68-b50e-707b3e254756" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bb64ed0c-eaad-4e3c-a8c7-bd91c1cc4991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_c0bb04ed-4f5f-43d8-a055-5c953d2b9ec4" xlink:href="asth-20231231.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_c0bb04ed-4f5f-43d8-a055-5c953d2b9ec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e86cf1ed-f6ac-4f2c-9d0a-3bc0d0cbcde8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_us-gaap_Goodwill_e86cf1ed-f6ac-4f2c-9d0a-3bc0d0cbcde8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_3ed97b72-c7ac-4e6d-a7f4-b9937e2d83f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_3ed97b72-c7ac-4e6d-a7f4-b9937e2d83f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_60704701-bdff-4ed3-9514-426f33243a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_60704701-bdff-4ed3-9514-426f33243a1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_042dd1c4-25a1-4028-bfea-8f577a785068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_042dd1c4-25a1-4028-bfea-8f577a785068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_136fd50a-75d3-4256-9bac-4436b1e99d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_136fd50a-75d3-4256-9bac-4436b1e99d5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_e4b878cf-ad43-42a1-8980-43b44878c894" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_e4b878cf-ad43-42a1-8980-43b44878c894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_29f75747-5eaa-4e0d-900b-c32f5b04f4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_us-gaap_EquityMethodInvestments_29f75747-5eaa-4e0d-900b-c32f5b04f4b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b9e1d61b-a5a7-4d36-8d90-a954d39a9281" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b9e1d61b-a5a7-4d36-8d90-a954d39a9281" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5b4a7b18-4e80-4750-9fc3-0350f0965af8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_071dbfe3-3062-4061-9b36-bd7184a7fc3d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5b4a7b18-4e80-4750-9fc3-0350f0965af8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_70a0f586-8680-4481-be7d-0647021e6f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b5edf240-d54b-47c1-a52a-a4b5658e76a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_70a0f586-8680-4481-be7d-0647021e6f6c" xlink:to="loc_us-gaap_LiabilitiesCurrent_b5edf240-d54b-47c1-a52a-a4b5658e76a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_6cf9bd3b-1015-4982-906c-0e296f5907e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_70a0f586-8680-4481-be7d-0647021e6f6c" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_6cf9bd3b-1015-4982-906c-0e296f5907e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1c5bf90b-2f1f-455e-a47c-ad5628110ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_26e049f3-b965-43c4-91f3-18cc2876980b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1c5bf90b-2f1f-455e-a47c-ad5628110ce3" xlink:to="loc_us-gaap_PreferredStockValue_26e049f3-b965-43c4-91f3-18cc2876980b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8f9ab92c-3f3c-4c9f-8319-6c0f603edd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1c5bf90b-2f1f-455e-a47c-ad5628110ce3" xlink:to="loc_us-gaap_CommonStockValue_8f9ab92c-3f3c-4c9f-8319-6c0f603edd2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_620814f4-c475-42d3-8bfb-782535d03b46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1c5bf90b-2f1f-455e-a47c-ad5628110ce3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_620814f4-c475-42d3-8bfb-782535d03b46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_69e2ea6b-e547-4292-9d1c-f2e539c46800" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1c5bf90b-2f1f-455e-a47c-ad5628110ce3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_69e2ea6b-e547-4292-9d1c-f2e539c46800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bf863c61-7108-4e76-b864-c0272bc6fc51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fb9a3eeb-cfe3-4025-a779-417b108209fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bf863c61-7108-4e76-b864-c0272bc6fc51" xlink:to="loc_us-gaap_StockholdersEquity_fb9a3eeb-cfe3-4025-a779-417b108209fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_281027a5-3b17-43aa-bb82-170066fb045c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_bf863c61-7108-4e76-b864-c0272bc6fc51" xlink:to="loc_us-gaap_MinorityInterest_281027a5-3b17-43aa-bb82-170066fb045c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f5144c15-7a29-405a-a162-163141ca1020" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_038cf7e8-9b7d-4541-9886-cef7afdb6427" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f5144c15-7a29-405a-a162-163141ca1020" xlink:to="loc_us-gaap_AssetsCurrent_038cf7e8-9b7d-4541-9886-cef7afdb6427" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_864653c8-6008-438f-8d6e-f1637af62af7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f5144c15-7a29-405a-a162-163141ca1020" xlink:to="loc_us-gaap_AssetsNoncurrent_864653c8-6008-438f-8d6e-f1637af62af7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_c246c704-8072-47f3-84e2-d1a7770b8481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_c246c704-8072-47f3-84e2-d1a7770b8481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryAccountsPayableCurrent_b922648e-dcc8-46b2-a9d9-df2120dee29f" xlink:href="asth-20231231.xsd#asth_FiduciaryAccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:to="loc_asth_FiduciaryAccountsPayableCurrent_b922648e-dcc8-46b2-a9d9-df2120dee29f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_991ea42d-801e-47c1-809f-f354a0630b42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_991ea42d-801e-47c1-809f-f354a0630b42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_c62a7d65-72b9-4654-9a92-3bd4a9827ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_c62a7d65-72b9-4654-9a92-3bd4a9827ce7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_dcdb5938-58b6-43b2-b661-de4aba7be7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:to="loc_us-gaap_DividendsPayableCurrent_dcdb5938-58b6-43b2-b661-de4aba7be7a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0c7bd9f5-b6fd-4c87-b816-a7820fd8f727" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0c7bd9f5-b6fd-4c87-b816-a7820fd8f727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb35a84e-3330-4f96-aaca-e6e8021b29fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb35a84e-3330-4f96-aaca-e6e8021b29fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0bbe1e00-530b-4bca-9ea7-2d227c95da64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:to="loc_us-gaap_LongTermDebtCurrent_0bbe1e00-530b-4bca-9ea7-2d227c95da64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_b981b1c9-92d8-4190-a122-cc2f8b2ba206" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f3979cf-11a4-40d7-8fca-99be346b887a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_b981b1c9-92d8-4190-a122-cc2f8b2ba206" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_90a11782-2d56-4861-a3b6-73565188f048" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_9eef352c-f663-4924-8dee-f004c147766c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_90a11782-2d56-4861-a3b6-73565188f048" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_9eef352c-f663-4924-8dee-f004c147766c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_b483318c-ca0d-42f9-8005-b24f03b17a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_90a11782-2d56-4861-a3b6-73565188f048" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_b483318c-ca0d-42f9-8005-b24f03b17a3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_ce62718b-db3e-47a2-b60d-abbae597ad69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_90a11782-2d56-4861-a3b6-73565188f048" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_ce62718b-db3e-47a2-b60d-abbae597ad69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aee1ef8a-16b0-4aba-b0e1-270fc2b4c6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cd4ef40e-f7f5-4dd3-a9c6-c97e006c5fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aee1ef8a-16b0-4aba-b0e1-270fc2b4c6aa" xlink:to="loc_us-gaap_OperatingIncomeLoss_cd4ef40e-f7f5-4dd3-a9c6-c97e006c5fd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ec828afc-8334-422c-aeab-29a79923bb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aee1ef8a-16b0-4aba-b0e1-270fc2b4c6aa" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ec828afc-8334-422c-aeab-29a79923bb2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c33b19a5-6b78-44dc-a72a-5f3ae8d0c69c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f6505720-8751-49ce-a77f-d9f4b349283e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c33b19a5-6b78-44dc-a72a-5f3ae8d0c69c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_f6505720-8751-49ce-a77f-d9f4b349283e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_01684773-1615-4a0a-809f-af6db3a5af1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c33b19a5-6b78-44dc-a72a-5f3ae8d0c69c" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_01684773-1615-4a0a-809f-af6db3a5af1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0d6771f5-01e4-4465-8bad-1c39fc045e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c33b19a5-6b78-44dc-a72a-5f3ae8d0c69c" xlink:to="loc_us-gaap_InterestExpense_0d6771f5-01e4-4465-8bad-1c39fc045e1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_672f814a-3b7e-4383-8e92-856f8aaf8999" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c33b19a5-6b78-44dc-a72a-5f3ae8d0c69c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_672f814a-3b7e-4383-8e92-856f8aaf8999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_91589751-2bfb-4042-81db-7eea78a77baa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c33b19a5-6b78-44dc-a72a-5f3ae8d0c69c" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_91589751-2bfb-4042-81db-7eea78a77baa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_95d26a8f-233a-4743-9a58-cfe5fec5e390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c33b19a5-6b78-44dc-a72a-5f3ae8d0c69c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_95d26a8f-233a-4743-9a58-cfe5fec5e390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1667f1a2-af6a-4f25-8035-318090f01ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_640a4d03-ddaa-495e-8d06-13bc9bb52f19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1667f1a2-af6a-4f25-8035-318090f01ca7" xlink:to="loc_us-gaap_ProfitLoss_640a4d03-ddaa-495e-8d06-13bc9bb52f19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a50b45ef-e7f4-42ac-953f-a20ac333a5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1667f1a2-af6a-4f25-8035-318090f01ca7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a50b45ef-e7f4-42ac-953f-a20ac333a5cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b20bd7c1-6773-4581-a270-f56a1ecf8b12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e6820429-284b-40b8-83bb-5298d2d0aefc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b20bd7c1-6773-4581-a270-f56a1ecf8b12" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e6820429-284b-40b8-83bb-5298d2d0aefc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6773500f-e44a-4a4a-88bb-9893f2b55f47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b20bd7c1-6773-4581-a270-f56a1ecf8b12" xlink:to="loc_us-gaap_CostsAndExpenses_6773500f-e44a-4a4a-88bb-9893f2b55f47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6c94742f-d01a-42f3-b638-d241954cd52d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_507c568b-2ac4-4673-b359-a1ec88b59abc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6c94742f-d01a-42f3-b638-d241954cd52d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_507c568b-2ac4-4673-b359-a1ec88b59abc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e2e2195f-6808-47da-b0fb-5535b4aedf4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6c94742f-d01a-42f3-b638-d241954cd52d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e2e2195f-6808-47da-b0fb-5535b4aedf4c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3f61328-52bb-4619-bbc5-41f630a1f2af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1d21ffea-8399-4237-9380-d62f2f494751" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3f61328-52bb-4619-bbc5-41f630a1f2af" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1d21ffea-8399-4237-9380-d62f2f494751" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_3a02a2b5-6ad0-4799-b4ca-1016ae8d2133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3f61328-52bb-4619-bbc5-41f630a1f2af" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_3a02a2b5-6ad0-4799-b4ca-1016ae8d2133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_194a54d8-5592-40f6-a2f5-6db462c0d969" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_194a54d8-5592-40f6-a2f5-6db462c0d969" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_84040158-4199-4a3e-b7c9-3598d2ba9843" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_84040158-4199-4a3e-b7c9-3598d2ba9843" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherOperatingActivities_a7c5c444-d9e5-492c-b5de-f89c3013154f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromOtherOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_ProceedsFromOtherOperatingActivities_a7c5c444-d9e5-492c-b5de-f89c3013154f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_GainLossOnEquityReceivable_80b3d6bd-2584-4d8c-af17-852c7bf30de2" xlink:href="asth-20231231.xsd#asth_GainLossOnEquityReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_asth_GainLossOnEquityReceivable_80b3d6bd-2584-4d8c-af17-852c7bf30de2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ceac3af0-9a22-47b5-99d8-3cc526b00d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ceac3af0-9a22-47b5-99d8-3cc526b00d5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_21329d05-cac5-44d5-aad9-1b295e2f7494" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_21329d05-cac5-44d5-aad9-1b295e2f7494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_97f8e999-b260-45b0-8314-9ffb5d94258a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_97f8e999-b260-45b0-8314-9ffb5d94258a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_24e35430-fc13-4aa2-ac8d-715f5ee2c36f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_24e35430-fc13-4aa2-ac8d-715f5ee2c36f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_50a71cae-8a6c-4cc6-8ed2-47aec8fbc7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_ShareBasedCompensation_50a71cae-8a6c-4cc6-8ed2-47aec8fbc7ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_2bcadab1-f0df-4980-812d-0542711d87c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_2bcadab1-f0df-4980-812d-0542711d87c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_GainLossOnConsolidationOfEquityMethodInvestment_f3897694-79e3-4e79-84ba-57d4c1208444" xlink:href="asth-20231231.xsd#asth_GainLossOnConsolidationOfEquityMethodInvestment"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_asth_GainLossOnConsolidationOfEquityMethodInvestment_f3897694-79e3-4e79-84ba-57d4c1208444" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_164b1127-9cc2-451f-9fc5-4dfc4f210583" xlink:href="asth-20231231.xsd#asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_164b1127-9cc2-451f-9fc5-4dfc4f210583" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_949ccfd1-57b1-45e0-86c4-f81f5daa66f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_949ccfd1-57b1-45e0-86c4-f81f5daa66f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_802af1e8-df84-4ce0-8fd2-7c893671d486" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_802af1e8-df84-4ce0-8fd2-7c893671d486" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a0433ce0-467b-4ae7-9282-1cccf26bbeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a0433ce0-467b-4ae7-9282-1cccf26bbeb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties_0f7b31c4-b320-4043-97ab-a61f50eac014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties_0f7b31c4-b320-4043-97ab-a61f50eac014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_2b9e39de-2368-47ac-bb80-8250be81135e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_2b9e39de-2368-47ac-bb80-8250be81135e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_f64ff621-68b4-437a-ba9d-b99ec67b5b98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_f64ff621-68b4-437a-ba9d-b99ec67b5b98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_40be21da-0586-42c2-a727-19d2defa8442" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_40be21da-0586-42c2-a727-19d2defa8442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9444743a-d0ec-4be8-ab9e-9cbe943eef0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_ProfitLoss_9444743a-d0ec-4be8-ab9e-9cbe943eef0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_UnrealizedGainLossFromInvestmentInEquitySecurities_d79b9046-3495-496e-be46-c1eb90c08690" xlink:href="asth-20231231.xsd#asth_UnrealizedGainLossFromInvestmentInEquitySecurities"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_asth_UnrealizedGainLossFromInvestmentInEquitySecurities_d79b9046-3495-496e-be46-c1eb90c08690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3be659cb-2c53-497e-9b56-4fd3239f99f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="22" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3be659cb-2c53-497e-9b56-4fd3239f99f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IncreaseDecreaseInMedicalLiabilities_1c20f115-1d46-4ec4-8649-bead04be9a95" xlink:href="asth-20231231.xsd#asth_IncreaseDecreaseInMedicalLiabilities"/>
    <link:calculationArc order="23" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_asth_IncreaseDecreaseInMedicalLiabilities_1c20f115-1d46-4ec4-8649-bead04be9a95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_82ac5bdf-60de-4607-8c05-348f9d37ad1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="24" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_82ac5bdf-60de-4607-8c05-348f9d37ad1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncashLeaseExpense_31a3b105-e938-4014-9d10-f76fce748c4b" xlink:href="asth-20231231.xsd#asth_NoncashLeaseExpense"/>
    <link:calculationArc order="25" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98ad14ae-198b-4f73-a8d6-87fa4a86b5c3" xlink:to="loc_asth_NoncashLeaseExpense_31a3b105-e938-4014-9d10-f76fce748c4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cd49693b-7b7d-4fe6-af3d-178aeb46edbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_cd49693b-7b7d-4fe6-af3d-178aeb46edbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_1b78351a-e031-4e49-9246-4620f294ef7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_1b78351a-e031-4e49-9246-4620f294ef7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_3e683f0e-1a6c-44d4-8060-9f9755b8c064" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_3e683f0e-1a6c-44d4-8060-9f9755b8c064" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_702383bc-0c19-4efd-9f0a-694b2e01f818" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_702383bc-0c19-4efd-9f0a-694b2e01f818" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_72f4f09d-b698-432f-9e10-13c5a575d620" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_72f4f09d-b698-432f-9e10-13c5a575d620" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_05776ac6-75af-4c50-863d-575d232fd75c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_05776ac6-75af-4c50-863d-575d232fd75c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_12fe79a2-c985-4a8c-858a-014a5d5e115f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_12fe79a2-c985-4a8c-858a-014a5d5e115f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_56ede3c5-668c-419f-97b3-2d9be1388039" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_56ede3c5-668c-419f-97b3-2d9be1388039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity_fb0d12a5-3e5d-443b-a098-06dd3c9fcb1b" xlink:href="asth-20231231.xsd#asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity_fb0d12a5-3e5d-443b-a098-06dd3c9fcb1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_7b228ebc-f798-4cb1-b7a3-1706f1ccd970" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_7b228ebc-f798-4cb1-b7a3-1706f1ccd970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentsToEquityMethodInvestments_43fa62c1-16a5-4941-81c3-f1ff56c431ab" xlink:href="asth-20231231.xsd#asth_PaymentsToEquityMethodInvestments"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_asth_PaymentsToEquityMethodInvestments_43fa62c1-16a5-4941-81c3-f1ff56c431ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_c8e845a2-dfe8-4ecf-b360-c65dd7f94eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_599d1920-2f13-4bd0-9939-1389282f9f8c" xlink:to="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_c8e845a2-dfe8-4ecf-b360-c65dd7f94eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d0d7ca03-8378-4015-8148-c69bf17a6130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d0d7ca03-8378-4015-8148-c69bf17a6130" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_6ed4439d-f5c3-400d-b1cd-ffcf63b1c51d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_6ed4439d-f5c3-400d-b1cd-ffcf63b1c51d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_bdf6ca23-9a78-41c7-9346-82d550c8ea8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_bdf6ca23-9a78-41c7-9346-82d550c8ea8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_56ea12f0-d815-4ba0-a0c5-71d9ee3087fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_56ea12f0-d815-4ba0-a0c5-71d9ee3087fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_098286ae-d477-4dae-ad88-9d332f9745f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_098286ae-d477-4dae-ad88-9d332f9745f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_ae15d7f8-9b5d-4d23-ba46-82f550ad3e48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_ae15d7f8-9b5d-4d23-ba46-82f550ad3e48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ce05fcb8-8aa6-4afd-b8d2-279bd5c2f17f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ce05fcb8-8aa6-4afd-b8d2-279bd5c2f17f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_77d1de1c-fc0e-4fde-9704-7777150cd767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_77d1de1c-fc0e-4fde-9704-7777150cd767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_f7a5709d-b357-4c55-a37c-ef32e3ef488b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_f7a5709d-b357-4c55-a37c-ef32e3ef488b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_af833dab-3b9c-4b01-a28b-2e09102a8759" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_af833dab-3b9c-4b01-a28b-2e09102a8759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9352f2ab-7348-4f9a-ae55-233bbb0d5a86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4c929dc7-c94e-41a2-868d-f6903e162a43" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9352f2ab-7348-4f9a-ae55-233bbb0d5a86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4e240d42-9d63-4693-9dae-6734dc8e3dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_49617392-6906-42b9-8d65-b9d43bd1985f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4e240d42-9d63-4693-9dae-6734dc8e3dfb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_49617392-6906-42b9-8d65-b9d43bd1985f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_61294523-4a0b-41b2-bcc5-8fefe71a0213" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4e240d42-9d63-4693-9dae-6734dc8e3dfb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_61294523-4a0b-41b2-bcc5-8fefe71a0213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3ac30a3-661d-46dd-8ba5-c3eeb8b117b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4e240d42-9d63-4693-9dae-6734dc8e3dfb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e3ac30a3-661d-46dd-8ba5-c3eeb8b117b6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b169d6cf-04b4-462d-8d98-d10b65f3525f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_368d566f-53a4-41bb-86fa-d6ef17cee4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b169d6cf-04b4-462d-8d98-d10b65f3525f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_368d566f-53a4-41bb-86fa-d6ef17cee4f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_9a44b2d3-3f77-48a2-b96c-58a683eacdf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b169d6cf-04b4-462d-8d98-d10b65f3525f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_9a44b2d3-3f77-48a2-b96c-58a683eacdf5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_34960df6-4987-4d1b-9322-2e2dd0ac019f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_e874ba7c-77c7-4a02-811c-e12557b37d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_34960df6-4987-4d1b-9322-2e2dd0ac019f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_e874ba7c-77c7-4a02-811c-e12557b37d7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_580ba2bd-da71-4b25-a536-2076f5f019b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_34960df6-4987-4d1b-9322-2e2dd0ac019f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_580ba2bd-da71-4b25-a536-2076f5f019b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d35b99a3-f8df-4fc6-b6cb-21a0a234390f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3df76161-40cc-49c0-881b-541432138a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d35b99a3-f8df-4fc6-b6cb-21a0a234390f" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3df76161-40cc-49c0-881b-541432138a74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8404561f-4470-482d-bfbe-c88368f8e50d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d35b99a3-f8df-4fc6-b6cb-21a0a234390f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8404561f-4470-482d-bfbe-c88368f8e50d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c720f441-8783-49f0-b08b-4e7409103969" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5bb5518a-74c6-45e4-9121-18aab21c3566" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c720f441-8783-49f0-b08b-4e7409103969" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5bb5518a-74c6-45e4-9121-18aab21c3566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_24b090a7-a94b-4087-b061-5232f9bad57d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c720f441-8783-49f0-b08b-4e7409103969" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_24b090a7-a94b-4087-b061-5232f9bad57d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_91a211bc-d5c4-42e5-ad86-3e0474f089a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_fab15f48-f0e2-4db8-91e4-73c6c0ffcc39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_91a211bc-d5c4-42e5-ad86-3e0474f089a5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_fab15f48-f0e2-4db8-91e4-73c6c0ffcc39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_82748f26-fe3b-45f1-91b3-52de81d46bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_91a211bc-d5c4-42e5-ad86-3e0474f089a5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_82748f26-fe3b-45f1-91b3-52de81d46bc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_d6df6ce2-a344-4d52-8f5e-340d6dec8e31" xlink:href="asth-20231231.xsd#asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_e88008fc-9c22-43e5-b361-396e85ca3d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_d6df6ce2-a344-4d52-8f5e-340d6dec8e31" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_e88008fc-9c22-43e5-b361-396e85ca3d3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_83b5f0df-e763-448b-8dcc-ea74e6f82afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_d6df6ce2-a344-4d52-8f5e-340d6dec8e31" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_83b5f0df-e763-448b-8dcc-ea74e6f82afc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1f6e8710-5a91-4768-92ce-e102fa3b7819" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_eaa5ee3c-4d09-41f9-ab85-f86f9a34f31d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1f6e8710-5a91-4768-92ce-e102fa3b7819" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_eaa5ee3c-4d09-41f9-ab85-f86f9a34f31d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_31a82835-67dd-4eaa-8bc9-a97e92397e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1f6e8710-5a91-4768-92ce-e102fa3b7819" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_31a82835-67dd-4eaa-8bc9-a97e92397e2a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f48ec020-6574-4b64-a30f-86dba56451a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_910da5b0-df92-41ef-9421-524d480b1b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f48ec020-6574-4b64-a30f-86dba56451a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_910da5b0-df92-41ef-9421-524d480b1b3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_67f9b82a-943f-4742-b601-84141c0a0425" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f48ec020-6574-4b64-a30f-86dba56451a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_67f9b82a-943f-4742-b601-84141c0a0425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d51bf51f-23ad-44db-8314-5c4353639c98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f48ec020-6574-4b64-a30f-86dba56451a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d51bf51f-23ad-44db-8314-5c4353639c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9b9486b9-33b8-4f0e-9483-c0c83cc03f95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f48ec020-6574-4b64-a30f-86dba56451a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9b9486b9-33b8-4f0e-9483-c0c83cc03f95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d88a5672-1f21-498d-815a-3e87cc47fb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f48ec020-6574-4b64-a30f-86dba56451a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d88a5672-1f21-498d-815a-3e87cc47fb8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f749ddc2-978a-44e1-b030-9bf608130b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f48ec020-6574-4b64-a30f-86dba56451a1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f749ddc2-978a-44e1-b030-9bf608130b1a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#AccountsPayableandAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d502c08c-c6f3-4f49-8c79-b68c09da34ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a3af69f4-515a-431f-9ae5-9604bc2985a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d502c08c-c6f3-4f49-8c79-b68c09da34ae" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a3af69f4-515a-431f-9ae5-9604bc2985a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDepositLiabilities_e89ae51a-42e1-4356-893f-fd8d83b9be81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDepositLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d502c08c-c6f3-4f49-8c79-b68c09da34ae" xlink:to="loc_us-gaap_RelatedPartyDepositLiabilities_e89ae51a-42e1-4356-893f-fd8d83b9be81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SpecialtyCapitationPayableCurrent_4bd50c06-db81-4f52-b214-d2b30030646f" xlink:href="asth-20231231.xsd#asth_SpecialtyCapitationPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d502c08c-c6f3-4f49-8c79-b68c09da34ae" xlink:to="loc_asth_SpecialtyCapitationPayableCurrent_4bd50c06-db81-4f52-b214-d2b30030646f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SubcontractorIpaRiskPoolPayable_d102441d-ffe2-4626-83b4-cbae39b8aad7" xlink:href="asth-20231231.xsd#asth_SubcontractorIpaRiskPoolPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d502c08c-c6f3-4f49-8c79-b68c09da34ae" xlink:to="loc_asth_SubcontractorIpaRiskPoolPayable_d102441d-ffe2-4626-83b4-cbae39b8aad7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_5be7bcc5-d4a0-438f-a1a2-ef0f2b1f2e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d502c08c-c6f3-4f49-8c79-b68c09da34ae" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_5be7bcc5-d4a0-438f-a1a2-ef0f2b1f2e5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3ec1c891-5e48-49fb-99f6-8e662428894d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d502c08c-c6f3-4f49-8c79-b68c09da34ae" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3ec1c891-5e48-49fb-99f6-8e662428894d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_b190c2b5-c140-4469-b31a-7b19238ee7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d502c08c-c6f3-4f49-8c79-b68c09da34ae" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_b190c2b5-c140-4469-b31a-7b19238ee7ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a568891d-6442-43ca-87d9-b5f1531870ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d502c08c-c6f3-4f49-8c79-b68c09da34ae" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a568891d-6442-43ca-87d9-b5f1531870ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MedicalLiabilitiesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#MedicalLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/MedicalLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_9451f62f-1a2f-4616-b70a-a701ccba1aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_241e2e67-cc40-436c-bdc5-3b04f3556827" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_9451f62f-1a2f-4616-b70a-a701ccba1aeb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_241e2e67-cc40-436c-bdc5-3b04f3556827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_94f8f51e-5b5a-4bf7-ac7f-58a443687852" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_9451f62f-1a2f-4616-b70a-a701ccba1aeb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_94f8f51e-5b5a-4bf7-ac7f-58a443687852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_327aec26-6502-4f0e-aeef-123077701f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_90fceb59-a798-493a-9d2f-d820a265f2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_327aec26-6502-4f0e-aeef-123077701f8c" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_90fceb59-a798-493a-9d2f-d820a265f2ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_807de095-c6b7-4c31-9aa4-5b0a2c92162d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_327aec26-6502-4f0e-aeef-123077701f8c" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_807de095-c6b7-4c31-9aa4-5b0a2c92162d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_8eab3b74-d9ce-40a8-b22a-c2e0c97372a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0f94454c-3ff6-44cd-befe-f317642cd9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_8eab3b74-d9ce-40a8-b22a-c2e0c97372a1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0f94454c-3ff6-44cd-befe-f317642cd9a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6fd935cc-bde1-46c9-873f-d376f5500371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_8eab3b74-d9ce-40a8-b22a-c2e0c97372a1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6fd935cc-bde1-46c9-873f-d376f5500371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5273b061-398e-43e5-8908-2fa0232db919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_8eab3b74-d9ce-40a8-b22a-c2e0c97372a1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5273b061-398e-43e5-8908-2fa0232db919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7931653e-397c-4826-ae6c-bfea79288235" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_8eab3b74-d9ce-40a8-b22a-c2e0c97372a1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7931653e-397c-4826-ae6c-bfea79288235" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_d8d996ae-3fe9-4ecf-b419-f1ae2d1bde4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_8eab3b74-d9ce-40a8-b22a-c2e0c97372a1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_d8d996ae-3fe9-4ecf-b419-f1ae2d1bde4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_bd914597-3546-464f-a763-466d8ef6f059" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LineOfCredit_8eab3b74-d9ce-40a8-b22a-c2e0c97372a1" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_bd914597-3546-464f-a763-466d8ef6f059" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxesIncomeTaxProvisionBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a5a61166-3c16-4616-b8a4-e3ddbc4154eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0bc6dc1b-0bb7-4516-b407-9dacdf77c432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a5a61166-3c16-4616-b8a4-e3ddbc4154eb" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0bc6dc1b-0bb7-4516-b407-9dacdf77c432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4af99363-dc3e-4741-83f3-8ca882fe0c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a5a61166-3c16-4616-b8a4-e3ddbc4154eb" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4af99363-dc3e-4741-83f3-8ca882fe0c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9a35c7eb-1860-43ff-bca5-a1d537b47f66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cee9b631-5003-44fd-95f4-fef897c80345" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_9a35c7eb-1860-43ff-bca5-a1d537b47f66" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cee9b631-5003-44fd-95f4-fef897c80345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_49e1ed8b-7ae5-4f7e-98f5-4d32504b0e50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_9a35c7eb-1860-43ff-bca5-a1d537b47f66" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_49e1ed8b-7ae5-4f7e-98f5-4d32504b0e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cad94f27-fb99-4705-8774-2329ac8a69fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_6659415d-92b9-47b7-ac64-5fd74ffd3e78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cad94f27-fb99-4705-8774-2329ac8a69fd" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_6659415d-92b9-47b7-ac64-5fd74ffd3e78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9d0c10d7-2eb8-4d61-9076-523c92487499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cad94f27-fb99-4705-8774-2329ac8a69fd" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9d0c10d7-2eb8-4d61-9076-523c92487499" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxesProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_8ee33617-bcf5-4809-981b-ce6d19003ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_8ee33617-bcf5-4809-981b-ce6d19003ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent_5a6e67a4-3de8-419a-8748-c94eb2b13fb8" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent_5a6e67a4-3de8-419a-8748-c94eb2b13fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_5fd706f5-f1a0-44be-9753-c43fc859a2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_5fd706f5-f1a0-44be-9753-c43fc859a2d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_8910aeb2-8073-411b-aa34-b07cefef6c82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_8910aeb2-8073-411b-aa34-b07cefef6c82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent_fe537316-59e8-4040-8088-2a93438f0de2" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent_fe537316-59e8-4040-8088-2a93438f0de2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent_f8b1e2c8-3a1d-4886-b72c-4817556ea256" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent_f8b1e2c8-3a1d-4886-b72c-4817556ea256" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d43b7184-00fc-49d4-8536-5b5d1a237641" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d43b7184-00fc-49d4-8536-5b5d1a237641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent_828f43d2-3649-4ec0-9a37-a551a1b68795" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent_828f43d2-3649-4ec0-9a37-a551a1b68795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment_0cc17316-a660-4f8d-849c-996aff9a165a" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment_0cc17316-a660-4f8d-849c-996aff9a165a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_ff8a29a5-0df8-417c-a163-36d76459d536" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_ff8a29a5-0df8-417c-a163-36d76459d536" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_37a0b2b6-ceec-47ec-9894-fd51d242dda3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_14a1810f-2ab8-4728-ac29-b7dc66120546" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_37a0b2b6-ceec-47ec-9894-fd51d242dda3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_308fd1cf-eab8-4207-886e-6221d4c5da3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_bb2e1823-c9a6-4126-9021-e4046026a3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_308fd1cf-eab8-4207-886e-6221d4c5da3b" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_bb2e1823-c9a6-4126-9021-e4046026a3ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a241a95d-f621-45e2-8086-577593df0765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_308fd1cf-eab8-4207-886e-6221d4c5da3b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a241a95d-f621-45e2-8086-577593df0765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_eb1ad0ab-3ab0-4011-8066-994a3867f63f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_eb1ad0ab-3ab0-4011-8066-994a3867f63f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_5852cc78-427d-4697-be3f-0b6afc385e52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_5852cc78-427d-4697-be3f-0b6afc385e52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_f16c9a72-7648-486c-9710-7c67c84ddac3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_f16c9a72-7648-486c-9710-7c67c84ddac3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_9e007491-496e-4820-a2d9-5479e4b81b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_9e007491-496e-4820-a2d9-5479e4b81b2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DeferredTaxAssetsInvestment_40533c18-9ff1-4217-98c5-a5b28ba80dc0" xlink:href="asth-20231231.xsd#asth_DeferredTaxAssetsInvestment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:to="loc_asth_DeferredTaxAssetsInvestment_40533c18-9ff1-4217-98c5-a5b28ba80dc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d9a1963c-a627-4fc3-8abe-c9d86781b1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_d9a1963c-a627-4fc3-8abe-c9d86781b1cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DeferredTaxAssetsLeaseLiability_4f3afbde-3b0b-4a02-b014-5cfc25074548" xlink:href="asth-20231231.xsd#asth_DeferredTaxAssetsLeaseLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:to="loc_asth_DeferredTaxAssetsLeaseLiability_4f3afbde-3b0b-4a02-b014-5cfc25074548" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_f3a2f4ab-4d79-4058-9fba-705c0b3623ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_f3a2f4ab-4d79-4058-9fba-705c0b3623ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_8aa7f7ce-f6d5-406a-bd18-017f1868e282" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_44f440e4-08c2-46d5-b94c-f606f9ac71a8" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_8aa7f7ce-f6d5-406a-bd18-017f1868e282" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_ae0ca45b-ac61-40a3-ab0d-a6e756ab0604" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8735bc32-4fcd-4fac-9035-01549eda59d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_ae0ca45b-ac61-40a3-ab0d-a6e756ab0604" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_8735bc32-4fcd-4fac-9035-01549eda59d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c0e96c08-b1c5-4ed1-a474-1b52defdfb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_ae0ca45b-ac61-40a3-ab0d-a6e756ab0604" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c0e96c08-b1c5-4ed1-a474-1b52defdfb0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b0dd444b-9e31-4ada-84b1-f874898ae6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d7a64100-43e9-416a-8be6-f51bbb06b037" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_b0dd444b-9e31-4ada-84b1-f874898ae6d7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d7a64100-43e9-416a-8be6-f51bbb06b037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_54d98213-abd7-460b-b00a-8b03516873d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_b0dd444b-9e31-4ada-84b1-f874898ae6d7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_54d98213-abd7-460b-b00a-8b03516873d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_60b13b59-1bec-4d72-91d4-f0b08aec8be3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_b0dd444b-9e31-4ada-84b1-f874898ae6d7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_60b13b59-1bec-4d72-91d4-f0b08aec8be3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_929ec31c-aef6-4123-862b-2b799fd2b9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_b0dd444b-9e31-4ada-84b1-f874898ae6d7" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_929ec31c-aef6-4123-862b-2b799fd2b9ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend_f4d5ebc4-f57c-4e0b-86e8-59f04c241e8f" xlink:href="asth-20231231.xsd#asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_b0dd444b-9e31-4ada-84b1-f874898ae6d7" xlink:to="loc_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend_f4d5ebc4-f57c-4e0b-86e8-59f04c241e8f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01a7f5ca-2221-4c2f-9b43-e7f912dce100" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d37328a6-239c-4725-946d-30de16eb6e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01a7f5ca-2221-4c2f-9b43-e7f912dce100" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d37328a6-239c-4725-946d-30de16eb6e1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d3b3628b-1c09-4b5b-9919-8757be3c88c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01a7f5ca-2221-4c2f-9b43-e7f912dce100" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d3b3628b-1c09-4b5b-9919-8757be3c88c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f1b45612-1297-46a6-962e-a8ec618bb4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_f3a7d94a-08e7-4818-8515-aa23de3b7e37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f1b45612-1297-46a6-962e-a8ec618bb4e4" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_f3a7d94a-08e7-4818-8515-aa23de3b7e37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7b7cb690-8125-44e7-beb3-526329ff9d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f1b45612-1297-46a6-962e-a8ec618bb4e4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7b7cb690-8125-44e7-beb3-526329ff9d6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b1ca9422-c805-49b6-8ed0-24033c3d51e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f1b45612-1297-46a6-962e-a8ec618bb4e4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b1ca9422-c805-49b6-8ed0-24033c3d51e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1be14316-f0d5-4013-b07b-a56a3b8ebc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f1b45612-1297-46a6-962e-a8ec618bb4e4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1be14316-f0d5-4013-b07b-a56a3b8ebc0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_6b3a3ee8-519e-4c52-aecb-e854df42bcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f1b45612-1297-46a6-962e-a8ec618bb4e4" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_6b3a3ee8-519e-4c52-aecb-e854df42bcfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_957dc365-c3cc-419d-b167-e1166955fef0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f1b45612-1297-46a6-962e-a8ec618bb4e4" xlink:to="loc_us-gaap_IncomeTaxesReceivable_957dc365-c3cc-419d-b167-e1166955fef0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_a01fabc4-b370-4027-86c7-e65d8fbba381" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f1b45612-1297-46a6-962e-a8ec618bb4e4" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_a01fabc4-b370-4027-86c7-e65d8fbba381" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_c7fa3f14-a22b-4c9f-8c7e-28d4187f7c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_005a847e-3d01-49d1-84b5-79aba08a395f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_c7fa3f14-a22b-4c9f-8c7e-28d4187f7c57" xlink:to="loc_us-gaap_OperatingLeaseCost_005a847e-3d01-49d1-84b5-79aba08a395f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_65c3da58-212a-4ccc-8903-8f55660175e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_c7fa3f14-a22b-4c9f-8c7e-28d4187f7c57" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_65c3da58-212a-4ccc-8903-8f55660175e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_ef816198-aaaf-46ca-b0e0-729afcc3cb57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_c7fa3f14-a22b-4c9f-8c7e-28d4187f7c57" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_ef816198-aaaf-46ca-b0e0-729afcc3cb57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_188d1bdd-18ec-4ceb-b847-78e2337292ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_c7fa3f14-a22b-4c9f-8c7e-28d4187f7c57" xlink:to="loc_us-gaap_SubleaseIncome_188d1bdd-18ec-4ceb-b847-78e2337292ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f2e90619-b3eb-4b5b-8cf6-ce15db95b631" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ef657d93-dc44-4708-adb4-1eb4282924d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f2e90619-b3eb-4b5b-8cf6-ce15db95b631" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_ef657d93-dc44-4708-adb4-1eb4282924d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2ac7c37f-7476-44fd-80d5-930f43bf10d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f2e90619-b3eb-4b5b-8cf6-ce15db95b631" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2ac7c37f-7476-44fd-80d5-930f43bf10d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_5dc9c373-2f26-48f9-9431-551cabc8b6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f2e90619-b3eb-4b5b-8cf6-ce15db95b631" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_5dc9c373-2f26-48f9-9431-551cabc8b6fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_13d65241-760e-41db-8b1c-691119ff4945" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f2e90619-b3eb-4b5b-8cf6-ce15db95b631" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_13d65241-760e-41db-8b1c-691119ff4945" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_9d750644-8778-4ecf-89c7-65e2b0c58674" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f2e90619-b3eb-4b5b-8cf6-ce15db95b631" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_9d750644-8778-4ecf-89c7-65e2b0c58674" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_e17ce8c9-84e0-4911-88bd-ab99bc0cf48d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_f2e90619-b3eb-4b5b-8cf6-ce15db95b631" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_e17ce8c9-84e0-4911-88bd-ab99bc0cf48d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_8aafb062-2b05-465f-9a57-fa2f0e013058" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_6274398a-ff1a-4dcc-afaa-9da1198f667d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_8aafb062-2b05-465f-9a57-fa2f0e013058" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_6274398a-ff1a-4dcc-afaa-9da1198f667d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_649624b4-95dc-4b82-9573-2f5367675073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_8aafb062-2b05-465f-9a57-fa2f0e013058" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_649624b4-95dc-4b82-9573-2f5367675073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ede751ea-02f1-480d-b207-d45ca84e0da4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bced6e96-1f76-4332-8f6f-4152b9cf3bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ede751ea-02f1-480d-b207-d45ca84e0da4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bced6e96-1f76-4332-8f6f-4152b9cf3bbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ae03671e-37aa-42a0-80ab-df8bc4e8c5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ede751ea-02f1-480d-b207-d45ca84e0da4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ae03671e-37aa-42a0-80ab-df8bc4e8c5ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e2bb5b67-5c54-4a52-8841-256c59086941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ede751ea-02f1-480d-b207-d45ca84e0da4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e2bb5b67-5c54-4a52-8841-256c59086941" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ffe70d30-20e8-4aaa-98da-5df0d0640999" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ede751ea-02f1-480d-b207-d45ca84e0da4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ffe70d30-20e8-4aaa-98da-5df0d0640999" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e1b9b0d6-aa2c-490e-971a-3359d80e48be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ede751ea-02f1-480d-b207-d45ca84e0da4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e1b9b0d6-aa2c-490e-971a-3359d80e48be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0170608f-53f7-451e-9b72-2d2ffda1719a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ede751ea-02f1-480d-b207-d45ca84e0da4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0170608f-53f7-451e-9b72-2d2ffda1719a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ca1e9608-d10c-4a4d-b14e-8bf0a0cb58ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_eee62db4-30f5-4cfd-b974-325ef3a303ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_ca1e9608-d10c-4a4d-b14e-8bf0a0cb58ee" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_eee62db4-30f5-4cfd-b974-325ef3a303ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5d6d8a5e-ec1d-4519-abd6-7198bac6e2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_ca1e9608-d10c-4a4d-b14e-8bf0a0cb58ee" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5d6d8a5e-ec1d-4519-abd6-7198bac6e2a2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1"/>
  <link:calculationLink xlink:role="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_569b6134-7938-4457-aced-b6580f84121e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_0e35b00d-a2f7-4e7d-8aba-3442405fd0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_569b6134-7938-4457-aced-b6580f84121e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_0e35b00d-a2f7-4e7d-8aba-3442405fd0a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d9b52ee3-f0f0-4ec5-9e79-88d3a916b50a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_569b6134-7938-4457-aced-b6580f84121e" xlink:to="loc_us-gaap_FinanceLeaseLiability_d9b52ee3-f0f0-4ec5-9e79-88d3a916b50a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dded687e-97c2-4e98-b271-8efee36db429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1c93788b-fb3d-49af-8237-4975fcc884c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dded687e-97c2-4e98-b271-8efee36db429" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1c93788b-fb3d-49af-8237-4975fcc884c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_41989349-e097-4f6a-a4ce-7c884dc7d477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dded687e-97c2-4e98-b271-8efee36db429" xlink:to="loc_us-gaap_OperatingLeaseLiability_41989349-e097-4f6a-a4ce-7c884dc7d477" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>27
<FILENAME>asth-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:04cda4cf-3e82-4310-bba4-80cea29b7bde,g:59735ae4-b6da-4fb6-9f6d-2f4a46b99a61-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_89ca6d4b-7033-4c61-8737-d132484103c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_096da139-453d-4ddb-b001-35129b024552" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_89ca6d4b-7033-4c61-8737-d132484103c5" xlink:to="loc_us-gaap_StatementTable_096da139-453d-4ddb-b001-35129b024552" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c7576a66-3c65-4bd2-90d1-bd270c7b1514" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_096da139-453d-4ddb-b001-35129b024552" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c7576a66-3c65-4bd2-90d1-bd270c7b1514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c7576a66-3c65-4bd2-90d1-bd270c7b1514_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c7576a66-3c65-4bd2-90d1-bd270c7b1514" xlink:to="loc_us-gaap_RelatedPartyDomain_c7576a66-3c65-4bd2-90d1-bd270c7b1514_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c06dc3b8-8de2-479b-a57d-b13a5fd4bb83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c7576a66-3c65-4bd2-90d1-bd270c7b1514" xlink:to="loc_us-gaap_RelatedPartyDomain_c06dc3b8-8de2-479b-a57d-b13a5fd4bb83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_170b9819-9016-4d24-90cb-64da9d98835c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c06dc3b8-8de2-479b-a57d-b13a5fd4bb83" xlink:to="loc_us-gaap_NonrelatedPartyMember_170b9819-9016-4d24-90cb-64da9d98835c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_791a3b1e-f9db-407b-9530-3c89754b3b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c06dc3b8-8de2-479b-a57d-b13a5fd4bb83" xlink:to="loc_us-gaap_RelatedPartyMember_791a3b1e-f9db-407b-9530-3c89754b3b1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fa36a6ee-1a99-4fda-9b2e-c0a70d37c63c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_096da139-453d-4ddb-b001-35129b024552" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fa36a6ee-1a99-4fda-9b2e-c0a70d37c63c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fa36a6ee-1a99-4fda-9b2e-c0a70d37c63c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fa36a6ee-1a99-4fda-9b2e-c0a70d37c63c" xlink:to="loc_us-gaap_ClassOfStockDomain_fa36a6ee-1a99-4fda-9b2e-c0a70d37c63c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5521d7df-442e-41f5-aa2b-ca21f8cd2c35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fa36a6ee-1a99-4fda-9b2e-c0a70d37c63c" xlink:to="loc_us-gaap_ClassOfStockDomain_5521d7df-442e-41f5-aa2b-ca21f8cd2c35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_f08c9371-fd5c-424f-983c-4e83b6dc691c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5521d7df-442e-41f5-aa2b-ca21f8cd2c35" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_f08c9371-fd5c-424f-983c-4e83b6dc691c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_edb8a0fb-6812-4036-b40c-cc7124b01b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_5521d7df-442e-41f5-aa2b-ca21f8cd2c35" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_edb8a0fb-6812-4036-b40c-cc7124b01b6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89ca6d4b-7033-4c61-8737-d132484103c5" xlink:to="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1b32f858-34e4-4938-85d5-3b22ff3385a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1b32f858-34e4-4938-85d5-3b22ff3385a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_03baa069-4cbf-4338-8b36-b3d33943d086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_03baa069-4cbf-4338-8b36-b3d33943d086" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4b27f247-46e5-4e63-901f-4cc7d497a229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4b27f247-46e5-4e63-901f-4cc7d497a229" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_9e033f8f-4db5-4f10-8e92-dd532491dc17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_IncomeTaxesReceivable_9e033f8f-4db5-4f10-8e92-dd532491dc17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_6017a919-996c-4576-a8bd-1d0a9d2a67f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_6017a919-996c-4576-a8bd-1d0a9d2a67f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34ca3319-2c38-4524-9dbb-4a632f60449f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34ca3319-2c38-4524-9dbb-4a632f60449f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_0e95ec59-cc27-4314-9751-b34a1047b3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_0e95ec59-cc27-4314-9751-b34a1047b3c9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3080a554-5401-4927-bd02-6c3c04b7cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_AssetsCurrent_3080a554-5401-4927-bd02-6c3c04b7cb5b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2220c2b4-810a-4ab4-b33d-9f2c17ef20aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2220c2b4-810a-4ab4-b33d-9f2c17ef20aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58ec6617-53b5-49f8-8075-e491f60b138f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58ec6617-53b5-49f8-8075-e491f60b138f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4e160b1f-0485-44fc-b3f4-9733635225d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_Goodwill_4e160b1f-0485-44fc-b3f4-9733635225d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_36e771b6-4901-474a-93fa-4412da13e933" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_36e771b6-4901-474a-93fa-4412da13e933" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_cc5e2f61-2d4c-487e-be31-b4c1b49ac9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_cc5e2f61-2d4c-487e-be31-b4c1b49ac9bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ebc58579-2908-4280-8883-13bf67bd8832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_EquityMethodInvestments_ebc58579-2908-4280-8883-13bf67bd8832" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_422c02b8-ec28-4927-ba3f-d4bee2fa5d5e" xlink:href="asth-20231231.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_422c02b8-ec28-4927-ba3f-d4bee2fa5d5e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6e2bba59-4e79-4546-bb97-cae1d55c221e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6e2bba59-4e79-4546-bb97-cae1d55c221e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b71a4cbf-2e63-472f-b98b-574562a84d64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b71a4cbf-2e63-472f-b98b-574562a84d64" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9d9e2e66-a1f7-4f44-8e94-32eae627add6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9d9e2e66-a1f7-4f44-8e94-32eae627add6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_9bebf3a9-788b-4236-a290-5be97860a85f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_AssetsNoncurrent_9bebf3a9-788b-4236-a290-5be97860a85f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a82fc9e2-0490-4eda-8116-52614e989370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:to="loc_us-gaap_Assets_a82fc9e2-0490-4eda-8116-52614e989370" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89ca6d4b-7033-4c61-8737-d132484103c5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3bc623be-78bb-4ddf-b370-d46560672c07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3bc623be-78bb-4ddf-b370-d46560672c07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryAccountsPayableCurrent_e80298f9-c8e6-487b-be6d-f3ca65cc3e06" xlink:href="asth-20231231.xsd#asth_FiduciaryAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_asth_FiduciaryAccountsPayableCurrent_e80298f9-c8e6-487b-be6d-f3ca65cc3e06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_774a6e25-9f30-47dd-bc7d-c26aa63867df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_774a6e25-9f30-47dd-bc7d-c26aa63867df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_954d3574-0f7c-4f99-967a-e446a3a559b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_954d3574-0f7c-4f99-967a-e446a3a559b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_ec8340bc-678d-49ee-901f-a0964a5f243b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_DividendsPayableCurrent_ec8340bc-678d-49ee-901f-a0964a5f243b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d3f50ccc-2156-4837-a5da-224836c25183" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d3f50ccc-2156-4837-a5da-224836c25183" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1df36b06-f5ad-423c-896f-78a6a450ab47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1df36b06-f5ad-423c-896f-78a6a450ab47" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6885fd31-e332-45b4-a574-f9bc9316f3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_LongTermDebtCurrent_6885fd31-e332-45b4-a574-f9bc9316f3e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c6dfb2b5-367e-4fef-800b-4ccb4f18b9da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c6dfb2b5-367e-4fef-800b-4ccb4f18b9da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_da767227-dac7-4b2f-883d-8edec82626fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_LiabilitiesCurrent_da767227-dac7-4b2f-883d-8edec82626fd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_119aab9d-223d-4a93-96d0-f9d61acaef22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_119aab9d-223d-4a93-96d0-f9d61acaef22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_18692427-4889-44ae-b2b3-02a6dfff7cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_18692427-4889-44ae-b2b3-02a6dfff7cfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e0288f0c-ebc8-4102-b4e1-f2bcc3b222cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e0288f0c-ebc8-4102-b4e1-f2bcc3b222cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ca7dc834-afb4-41c3-9104-9ee0446cc1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ca7dc834-afb4-41c3-9104-9ee0446cc1c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_93873afc-69f8-460e-802d-8f8b0d9aec81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_93873afc-69f8-460e-802d-8f8b0d9aec81" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_017aecd7-47f5-4fe5-a200-6b7c8f60cdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_017aecd7-47f5-4fe5-a200-6b7c8f60cdd9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9d4f7a71-51ce-439b-831e-7b34e7ce63e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_Liabilities_9d4f7a71-51ce-439b-831e-7b34e7ce63e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e3ff5a13-8225-445f-bab9-bad312603f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e3ff5a13-8225-445f-bab9-bad312603f5e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MezzanineEquityAbstract_8fbcce1e-dfe1-4383-ae41-90b80f0facee" xlink:href="asth-20231231.xsd#asth_MezzanineEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_asth_MezzanineEquityAbstract_8fbcce1e-dfe1-4383-ae41-90b80f0facee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_e5025257-b760-4a39-8f19-3494916d2fb4" xlink:href="asth-20231231.xsd#asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_MezzanineEquityAbstract_8fbcce1e-dfe1-4383-ae41-90b80f0facee" xlink:to="loc_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_e5025257-b760-4a39-8f19-3494916d2fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_566ea6cd-f235-447e-b26a-af6c0a092c97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_PreferredStockValue_566ea6cd-f235-447e-b26a-af6c0a092c97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7a487d20-9d95-492b-b7c5-eb710ba35a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_CommonStockValue_7a487d20-9d95-492b-b7c5-eb710ba35a3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cfc8c5e7-567c-4e4c-b3b0-267cb3918ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cfc8c5e7-567c-4e4c-b3b0-267cb3918ff1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01f9d020-34a5-4264-9a77-259931d9c81a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01f9d020-34a5-4264-9a77-259931d9c81a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3df7c6b4-d480-4c2d-a72c-6842522f9868" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_StockholdersEquity_3df7c6b4-d480-4c2d-a72c-6842522f9868" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_349dd0d6-c407-4dce-9d0c-6e84bdd729db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_MinorityInterest_349dd0d6-c407-4dce-9d0c-6e84bdd729db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1beb8c73-904c-49d3-8b48-40d68365c52d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1beb8c73-904c-49d3-8b48-40d68365c52d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5ff4def-15b4-4220-a324-ee7cbb68966d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5ff4def-15b4-4220-a324-ee7cbb68966d" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5d587e57-0013-4761-911b-3202e48e1477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_StatementTable_5d587e57-0013-4761-911b-3202e48e1477" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1d6c12c6-8877-48d8-853f-a5ac5013c21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5d587e57-0013-4761-911b-3202e48e1477" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1d6c12c6-8877-48d8-853f-a5ac5013c21e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1d6c12c6-8877-48d8-853f-a5ac5013c21e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1d6c12c6-8877-48d8-853f-a5ac5013c21e" xlink:to="loc_us-gaap_ClassOfStockDomain_1d6c12c6-8877-48d8-853f-a5ac5013c21e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_682a9d2b-4912-4e62-9628-e347f711460e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1d6c12c6-8877-48d8-853f-a5ac5013c21e" xlink:to="loc_us-gaap_ClassOfStockDomain_682a9d2b-4912-4e62-9628-e347f711460e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_876205bb-c673-4e9a-8442-10e77c96438f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_682a9d2b-4912-4e62-9628-e347f711460e" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_876205bb-c673-4e9a-8442-10e77c96438f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_616ad4d7-919e-4837-ac17-1200b98af988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_682a9d2b-4912-4e62-9628-e347f711460e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_616ad4d7-919e-4837-ac17-1200b98af988" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_60300d7e-fcef-4fbb-9ae9-2d249b18d4ad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5d587e57-0013-4761-911b-3202e48e1477" xlink:to="loc_srt_ConsolidatedEntitiesAxis_60300d7e-fcef-4fbb-9ae9-2d249b18d4ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_60300d7e-fcef-4fbb-9ae9-2d249b18d4ad_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_60300d7e-fcef-4fbb-9ae9-2d249b18d4ad" xlink:to="loc_srt_ConsolidatedEntitiesDomain_60300d7e-fcef-4fbb-9ae9-2d249b18d4ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7ea55aae-ed9b-4f38-8e61-f8a33a93e56b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_60300d7e-fcef-4fbb-9ae9-2d249b18d4ad" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7ea55aae-ed9b-4f38-8e61-f8a33a93e56b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0d03aa8a-a2c5-4cf7-8458-bdc88a5691a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7ea55aae-ed9b-4f38-8e61-f8a33a93e56b" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0d03aa8a-a2c5-4cf7-8458-bdc88a5691a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_82c05e48-fd45-431f-ae21-c0e1cc3a59b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_82c05e48-fd45-431f-ae21-c0e1cc3a59b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f060ccfc-b8c0-46c5-8239-3a348e47455a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f060ccfc-b8c0-46c5-8239-3a348e47455a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_358fefe9-69f4-4739-a816-e0d75c446478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_PreferredStockSharesIssued_358fefe9-69f4-4739-a816-e0d75c446478" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dca5108d-5222-42e2-bf80-7d714322536b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_dca5108d-5222-42e2-bf80-7d714322536b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_35c492ab-18ac-43d8-9745-f88e62fcf840" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_35c492ab-18ac-43d8-9745-f88e62fcf840" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_fc47ba87-88e4-485e-ad81-ec2afdbe322e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_fc47ba87-88e4-485e-ad81-ec2afdbe322e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1bd1323f-5fab-4b5d-ae73-57071f937c12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_SharesOutstanding_1bd1323f-5fab-4b5d-ae73-57071f937c12" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_bf014055-d6c9-4fd6-8dde-f511fb568fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_TreasuryStockCommonShares_bf014055-d6c9-4fd6-8dde-f511fb568fdf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a789439a-a893-4262-9ee3-c2204e53f20b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_Assets_a789439a-a893-4262-9ee3-c2204e53f20b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5fc464c3-fbd7-4d43-8e5c-55cf3a59c7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_Liabilities_5fc464c3-fbd7-4d43-8e5c-55cf3a59c7c4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_de91beca-0a38-429f-a0fc-5ddaa6e1f387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_de91beca-0a38-429f-a0fc-5ddaa6e1f387" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_636569f9-8877-497e-a726-0ac59e8141b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_OtherLiabilities_636569f9-8877-497e-a726-0ac59e8141b8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_45721189-b72b-4f74-a97d-ff87a3bda30a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_OtherReceivables_45721189-b72b-4f74-a97d-ff87a3bda30a" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_aaa2a832-9281-41bd-b8fe-8056a27798e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_StatementTable_aaa2a832-9281-41bd-b8fe-8056a27798e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_10629ca3-c811-480c-a6e2-dcaf0f5c234f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_aaa2a832-9281-41bd-b8fe-8056a27798e9" xlink:to="loc_srt_ProductOrServiceAxis_10629ca3-c811-480c-a6e2-dcaf0f5c234f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_10629ca3-c811-480c-a6e2-dcaf0f5c234f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_10629ca3-c811-480c-a6e2-dcaf0f5c234f" xlink:to="loc_srt_ProductsAndServicesDomain_10629ca3-c811-480c-a6e2-dcaf0f5c234f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_10629ca3-c811-480c-a6e2-dcaf0f5c234f" xlink:to="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_HealthCareCapitationRevenueMember_829100cb-e24b-4591-a6bb-3e0dd0cdf8f0" xlink:href="asth-20231231.xsd#asth_HealthCareCapitationRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_asth_HealthCareCapitationRevenueMember_829100cb-e24b-4591-a6bb-3e0dd0cdf8f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_64d4b08b-0710-49d7-b4f7-02e0f95c0330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_us-gaap_HealthCareOtherMember_64d4b08b-0710-49d7-b4f7-02e0f95c0330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceMember_55705122-76c5-4685-8ac1-6c1fe25213bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_us-gaap_ManagementServiceMember_55705122-76c5-4685-8ac1-6c1fe25213bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_003825fa-d044-42a1-97af-18610b494b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_003825fa-d044-42a1-97af-18610b494b0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_8e5e7383-676c-4981-a8be-8df7aaf9f527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_8e5e7383-676c-4981-a8be-8df7aaf9f527" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6337f61e-fda3-4a19-8736-00536d68b069" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_RevenuesAbstract_6337f61e-fda3-4a19-8736-00536d68b069" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7975004a-d178-457a-91c4-5bba0bb84e12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_6337f61e-fda3-4a19-8736-00536d68b069" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7975004a-d178-457a-91c4-5bba0bb84e12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_88017d73-5e11-47fd-816f-426877a7393a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_88017d73-5e11-47fd-816f-426877a7393a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5d2545ea-6614-4cd3-af10-1b5fe9eff2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5d2545ea-6614-4cd3-af10-1b5fe9eff2fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_20681da9-4d44-4c0b-8fe8-347499bd7e47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_20681da9-4d44-4c0b-8fe8-347499bd7e47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ac54fb55-7b82-4d88-acf6-4c5da891b388" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:to="loc_us-gaap_CostsAndExpenses_ac54fb55-7b82-4d88-acf6-4c5da891b388" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5a959d15-c939-40ee-a12d-b526601d0318" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_OperatingIncomeLoss_5a959d15-c939-40ee-a12d-b526601d0318" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_aff2c3ba-51ca-4819-a1ef-be456fcfdb53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_aff2c3ba-51ca-4819-a1ef-be456fcfdb53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_08bb1f37-89e0-414d-bd9a-1220647fcd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_08bb1f37-89e0-414d-bd9a-1220647fcd3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6f58a5bc-56a4-406b-90a1-156aa6b98185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_InterestExpense_6f58a5bc-56a4-406b-90a1-156aa6b98185" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3b24d088-bdc1-4263-8e96-465c6cb5f949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3b24d088-bdc1-4263-8e96-465c6cb5f949" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_c61a40b9-4431-4c1d-b4a2-db8738a2cb24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_c61a40b9-4431-4c1d-b4a2-db8738a2cb24" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0c10bd4c-2056-4696-be9a-ffed58a3bb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0c10bd4c-2056-4696-be9a-ffed58a3bb0a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_67c1e296-9270-4bd5-94b5-4e8a07f4ca39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_67c1e296-9270-4bd5-94b5-4e8a07f4ca39" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13c175b2-b914-4d90-9b3a-558c3be1245d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13c175b2-b914-4d90-9b3a-558c3be1245d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_455b42b2-49b3-428b-8e4b-530895558bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_455b42b2-49b3-428b-8e4b-530895558bf6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e7abc263-64f9-406d-85c4-ce97ec762a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_ProfitLoss_e7abc263-64f9-406d-85c4-ce97ec762a6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6a9b640d-e4fa-45c6-9eb3-6080220ba39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6a9b640d-e4fa-45c6-9eb3-6080220ba39c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_791e7fbc-e6f8-42cb-b02b-f3e9676242d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_NetIncomeLoss_791e7fbc-e6f8-42cb-b02b-f3e9676242d9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f53a0778-07ea-4f3e-9fe7-0f5d1532f56a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_EarningsPerShareBasic_f53a0778-07ea-4f3e-9fe7-0f5d1532f56a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_316ad45a-b1f2-4a66-aee3-4b22d72d6019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_316ad45a-b1f2-4a66-aee3-4b22d72d6019" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_97027d89-bd09-407f-bfed-eedcb5ccd40b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f938bb4e-d3cd-4ea2-8460-f72cae09a54c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_97027d89-bd09-407f-bfed-eedcb5ccd40b" xlink:to="loc_us-gaap_StatementTable_f938bb4e-d3cd-4ea2-8460-f72cae09a54c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b40d4666-6dda-4ba0-90fd-b4ade821eca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f938bb4e-d3cd-4ea2-8460-f72cae09a54c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b40d4666-6dda-4ba0-90fd-b4ade821eca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b40d4666-6dda-4ba0-90fd-b4ade821eca7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b40d4666-6dda-4ba0-90fd-b4ade821eca7" xlink:to="loc_us-gaap_EquityComponentDomain_b40d4666-6dda-4ba0-90fd-b4ade821eca7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b40d4666-6dda-4ba0-90fd-b4ade821eca7" xlink:to="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_07831bf0-611e-4fda-96a0-4ef00fccb748" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:to="loc_us-gaap_CommonStockMember_07831bf0-611e-4fda-96a0-4ef00fccb748" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_75c0228e-7f54-4a7e-b9e2-5a61d1e674ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_75c0228e-7f54-4a7e-b9e2-5a61d1e674ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d644432e-dd7c-452c-8c2c-8f0a27e8e034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:to="loc_us-gaap_RetainedEarningsMember_d644432e-dd7c-452c-8c2c-8f0a27e8e034" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_2edb9ca8-ec8e-4e89-9caa-f29592c83550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:to="loc_us-gaap_NoncontrollingInterestMember_2edb9ca8-ec8e-4e89-9caa-f29592c83550" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7509e522-bfea-4365-bc9c-e3251ff4311e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f938bb4e-d3cd-4ea2-8460-f72cae09a54c" xlink:to="loc_dei_LegalEntityAxis_7509e522-bfea-4365-bc9c-e3251ff4311e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7509e522-bfea-4365-bc9c-e3251ff4311e_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_7509e522-bfea-4365-bc9c-e3251ff4311e" xlink:to="loc_dei_EntityDomain_7509e522-bfea-4365-bc9c-e3251ff4311e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_19e13e6a-2fcf-4765-adcc-6f649c96b23a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_7509e522-bfea-4365-bc9c-e3251ff4311e" xlink:to="loc_dei_EntityDomain_19e13e6a-2fcf-4765-adcc-6f649c96b23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MezzanineMember_2da8017e-9428-433f-bd99-ee38e2b9421c" xlink:href="asth-20231231.xsd#asth_MezzanineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_19e13e6a-2fcf-4765-adcc-6f649c96b23a" xlink:to="loc_asth_MezzanineMember_2da8017e-9428-433f-bd99-ee38e2b9421c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97027d89-bd09-407f-bfed-eedcb5ccd40b" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6a7c8d6b-425d-41f0-b386-26f160edad5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6a7c8d6b-425d-41f0-b386-26f160edad5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_1684bfae-fedd-492c-a5c2-95c96349935d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_1684bfae-fedd-492c-a5c2-95c96349935d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_d3c733d8-2a9d-4993-be27-5764c234cbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_d3c733d8-2a9d-4993-be27-5764c234cbfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_737f7984-d4a7-49d6-ba4e-15d1a0c4d6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_737f7984-d4a7-49d6-ba4e-15d1a0c4d6cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_abfee95b-67f9-4635-be8d-493e2bf8c0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_abfee95b-67f9-4635-be8d-493e2bf8c0a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityTaxImpactOnAcquisition_d9617f8e-4da6-4c4f-865e-f2cb393130fe" xlink:href="asth-20231231.xsd#asth_TemporaryEquityTaxImpactOnAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_asth_TemporaryEquityTaxImpactOnAcquisition_d9617f8e-4da6-4c4f-865e-f2cb393130fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e1c0ee7b-e543-42c9-97a6-698f78bf3823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e1c0ee7b-e543-42c9-97a6-698f78bf3823" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends_3adef0b9-72ea-4c2d-9687-4c5ddbc3d83d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_TemporaryEquityAccretionOfDividends_3adef0b9-72ea-4c2d-9687-4c5ddbc3d83d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityTransferOfCommonControlEntities_10f726c3-40a6-4fac-9039-8386d33331d0" xlink:href="asth-20231231.xsd#asth_TemporaryEquityTransferOfCommonControlEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_asth_TemporaryEquityTransferOfCommonControlEntities_10f726c3-40a6-4fac-9039-8386d33331d0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TaxImpactFromDividends_28d19577-f952-4148-a247-7438495c59d0" xlink:href="asth-20231231.xsd#asth_TaxImpactFromDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_asth_TaxImpactFromDividends_28d19577-f952-4148-a247-7438495c59d0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TaxImpactFromInvestments_8b8e066e-7171-4851-886a-46974676879d" xlink:href="asth-20231231.xsd#asth_TaxImpactFromInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_asth_TaxImpactFromInvestments_8b8e066e-7171-4851-886a-46974676879d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d05fd6d8-9da8-4d51-8adc-aef5749d510c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_97027d89-bd09-407f-bfed-eedcb5ccd40b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_bc574c97-7b53-4a49-8ec5-da95d915ed24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_SharesOutstanding_bc574c97-7b53-4a49-8ec5-da95d915ed24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_61d8fc14-0283-4a0d-ae6a-2ea6830cc04f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_61d8fc14-0283-4a0d-ae6a-2ea6830cc04f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_5613391a-590d-412e-90a7-8a2a2cd2cdb6" xlink:href="asth-20231231.xsd#asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_5613391a-590d-412e-90a7-8a2a2cd2cdb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_8024b2f6-11d9-4771-b659-b3ee8c9ba8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_cbd3bbdf-d4bc-48cc-9693-5f75e1fca15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest_500fbc0f-bdbb-4691-b6a3-f6ef82ef8855" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringPeriodSharesNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest_500fbc0f-bdbb-4691-b6a3-f6ef82ef8855" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringPeriodValueNoncontrollingInterest_84169c79-0cff-48ea-80ea-7d4508344f96" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringPeriodValueNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockIssuedDuringPeriodValueNoncontrollingInterest_84169c79-0cff-48ea-80ea-7d4508344f96" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_ea594cef-e603-4b36-b4a7-f62e332dce58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_ea594cef-e603-4b36-b4a7-f62e332dce58" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1dc0de7c-51d4-4bf3-93b7-0c17a1450791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1dc0de7c-51d4-4bf3-93b7-0c17a1450791" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_d26d6930-bc42-465c-8541-eafc73afa860" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_d26d6930-bc42-465c-8541-eafc73afa860" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_a57ba7f8-4ba1-4522-b51d-e8d8d6b154a1" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_a57ba7f8-4ba1-4522-b51d-e8d8d6b154a1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_60882320-d4f0-4472-89b0-e8aceac34f28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_60882320-d4f0-4472-89b0-e8aceac34f28" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_ccfe9391-3474-44d4-9a53-f9b830d23e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2650ad84-b361-48d7-ba7e-7161703e8c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2650ad84-b361-48d7-ba7e-7161703e8c57" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1c7e9271-b2fa-4374-bd23-72fc7dd659a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1c7e9271-b2fa-4374-bd23-72fc7dd659a9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c67424a9-5fcd-4d85-936c-3c0cbde49232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c67424a9-5fcd-4d85-936c-3c0cbde49232" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_c8c37fea-46dc-4abf-8eb6-da667aa1b49a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_c8c37fea-46dc-4abf-8eb6-da667aa1b49a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_cde52751-3b42-4f96-b9fd-c27d8b90543a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_cde52751-3b42-4f96-b9fd-c27d8b90543a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_9fc79afa-7d49-4601-9816-4ae217eae5db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_9fc79afa-7d49-4601-9816-4ae217eae5db" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_61f8d969-0842-44ae-b8ac-954ce2bd32e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_61f8d969-0842-44ae-b8ac-954ce2bd32e6" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncontrollingInterestIncreaseFromCapitalCharge_30c0f9bb-35a2-4253-a203-fe40f5b4ce09" xlink:href="asth-20231231.xsd#asth_NoncontrollingInterestIncreaseFromCapitalCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_NoncontrollingInterestIncreaseFromCapitalCharge_30c0f9bb-35a2-4253-a203-fe40f5b4ce09" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGEquityContingentConsideration_b6795d77-602f-4720-8a66-9fbeda65b088" xlink:href="asth-20231231.xsd#asth_AAMGEquityContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_AAMGEquityContingentConsideration_b6795d77-602f-4720-8a66-9fbeda65b088" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_0addeb8e-43c0-4491-abe6-1eded84b7697" xlink:href="asth-20231231.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_0addeb8e-43c0-4491-abe6-1eded84b7697" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_2bf12fe5-0d44-41a6-aa14-4df70d631cef" xlink:href="asth-20231231.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_2bf12fe5-0d44-41a6-aa14-4df70d631cef" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockholdersEquityTransferOfCommonControlEntities_07d67565-bf11-48af-a979-e183f8998b04" xlink:href="asth-20231231.xsd#asth_StockholdersEquityTransferOfCommonControlEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockholdersEquityTransferOfCommonControlEntities_07d67565-bf11-48af-a979-e183f8998b04" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e5d302df-cf14-46c6-95c0-04e0af0d33f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ce7e15a-94e6-434c-86d0-e41402dd98c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:href="asth-20231231.xsd#asth_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:href="asth-20231231.xsd#asth_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_28f4d368-7508-476a-89d0-40dedaf1ffab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_us-gaap_FinancialInstrumentAxis_28f4d368-7508-476a-89d0-40dedaf1ffab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_28f4d368-7508-476a-89d0-40dedaf1ffab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_28f4d368-7508-476a-89d0-40dedaf1ffab" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_28f4d368-7508-476a-89d0-40dedaf1ffab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e8635576-34f2-4c58-aa3e-e7ba626a52d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_28f4d368-7508-476a-89d0-40dedaf1ffab" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e8635576-34f2-4c58-aa3e-e7ba626a52d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_ce2b8f45-9ea6-461f-85c3-d7036ccb88e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e8635576-34f2-4c58-aa3e-e7ba626a52d6" xlink:to="loc_us-gaap_CertificatesOfDepositMember_ce2b8f45-9ea6-461f-85c3-d7036ccb88e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0ed02c6d-3780-400e-80d1-1278010bd65e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_srt_RangeAxis_0ed02c6d-3780-400e-80d1-1278010bd65e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0ed02c6d-3780-400e-80d1-1278010bd65e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0ed02c6d-3780-400e-80d1-1278010bd65e" xlink:to="loc_srt_RangeMember_0ed02c6d-3780-400e-80d1-1278010bd65e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3047ad38-f93a-49fa-b6b7-d87c7e786fad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0ed02c6d-3780-400e-80d1-1278010bd65e" xlink:to="loc_srt_RangeMember_3047ad38-f93a-49fa-b6b7-d87c7e786fad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_57274299-57c6-4a68-b575-b8968489717d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3047ad38-f93a-49fa-b6b7-d87c7e786fad" xlink:to="loc_srt_MinimumMember_57274299-57c6-4a68-b575-b8968489717d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_531fd9ee-4b08-4be9-aa96-150e37d22b91" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3047ad38-f93a-49fa-b6b7-d87c7e786fad" xlink:to="loc_srt_MaximumMember_531fd9ee-4b08-4be9-aa96-150e37d22b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9897982e-a2ce-4ead-bbea-983f82be9bd5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_srt_ProductOrServiceAxis_9897982e-a2ce-4ead-bbea-983f82be9bd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9897982e-a2ce-4ead-bbea-983f82be9bd5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9897982e-a2ce-4ead-bbea-983f82be9bd5" xlink:to="loc_srt_ProductsAndServicesDomain_9897982e-a2ce-4ead-bbea-983f82be9bd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9897982e-a2ce-4ead-bbea-983f82be9bd5" xlink:to="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerMemberPerMonthManagedCareContractMember_328d0088-e392-43d6-8c30-a666d845c7ff" xlink:href="asth-20231231.xsd#asth_PerMemberPerMonthManagedCareContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:to="loc_asth_PerMemberPerMonthManagedCareContractMember_328d0088-e392-43d6-8c30-a666d845c7ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RiskPoolSettlementsAndIncentivesMember_a5930f2f-d245-478d-b3ef-f818794e8833" xlink:href="asth-20231231.xsd#asth_RiskPoolSettlementsAndIncentivesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:to="loc_asth_RiskPoolSettlementsAndIncentivesMember_a5930f2f-d245-478d-b3ef-f818794e8833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceMember_d96fa8ce-d6dc-45bb-8d8b-b1090b4db33f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:to="loc_us-gaap_ManagementServiceMember_d96fa8ce-d6dc-45bb-8d8b-b1090b4db33f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_581ba204-f872-4c38-8f56-40a1fb682b17" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_srt_CounterpartyNameAxis_581ba204-f872-4c38-8f56-40a1fb682b17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_581ba204-f872-4c38-8f56-40a1fb682b17_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_581ba204-f872-4c38-8f56-40a1fb682b17" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_581ba204-f872-4c38-8f56-40a1fb682b17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d00ad7a-6fad-4a85-ae07-b84720d28c93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_581ba204-f872-4c38-8f56-40a1fb682b17" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d00ad7a-6fad-4a85-ae07-b84720d28c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CMSMember_41a7b35f-1cf6-4968-b55e-a075bf2a4f04" xlink:href="asth-20231231.xsd#asth_CMSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d00ad7a-6fad-4a85-ae07-b84720d28c93" xlink:to="loc_asth_CMSMember_41a7b35f-1cf6-4968-b55e-a075bf2a4f04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b316b0b3-c20c-45a9-95be-f0f3cdfc6106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b316b0b3-c20c-45a9-95be-f0f3cdfc6106" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b316b0b3-c20c-45a9-95be-f0f3cdfc6106_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b316b0b3-c20c-45a9-95be-f0f3cdfc6106" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b316b0b3-c20c-45a9-95be-f0f3cdfc6106_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d966b6bd-e6d7-4abf-a00e-e957d17bdbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b316b0b3-c20c-45a9-95be-f0f3cdfc6106" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d966b6bd-e6d7-4abf-a00e-e957d17bdbeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AccountsPayableAndAccruedExpensesMember_31bd2bec-ac17-45e4-a0f1-92f9d52b2cb5" xlink:href="asth-20231231.xsd#asth_AccountsPayableAndAccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d966b6bd-e6d7-4abf-a00e-e957d17bdbeb" xlink:to="loc_asth_AccountsPayableAndAccruedExpensesMember_31bd2bec-ac17-45e4-a0f1-92f9d52b2cb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c798563e-3345-4654-bc37-682891251b52" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c798563e-3345-4654-bc37-682891251b52" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c798563e-3345-4654-bc37-682891251b52_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c798563e-3345-4654-bc37-682891251b52" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c798563e-3345-4654-bc37-682891251b52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7ef02ba3-a4a5-4e63-9f30-c1a76923cad1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c798563e-3345-4654-bc37-682891251b52" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7ef02ba3-a4a5-4e63-9f30-c1a76923cad1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_UniversalCareIncMember_09219292-24e1-414a-a847-87cda9357f88" xlink:href="asth-20231231.xsd#asth_UniversalCareIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7ef02ba3-a4a5-4e63-9f30-c1a76923cad1" xlink:to="loc_asth_UniversalCareIncMember_09219292-24e1-414a-a847-87cda9357f88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9c7117d8-5134-4086-adb6-5551281875ab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_dei_LegalEntityAxis_9c7117d8-5134-4086-adb6-5551281875ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9c7117d8-5134-4086-adb6-5551281875ab_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_9c7117d8-5134-4086-adb6-5551281875ab" xlink:to="loc_dei_EntityDomain_9c7117d8-5134-4086-adb6-5551281875ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0da008c2-2f05-454c-80b4-0e5cfea89922" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_9c7117d8-5134-4086-adb6-5551281875ab" xlink:to="loc_dei_EntityDomain_0da008c2-2f05-454c-80b4-0e5cfea89922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_780e8384-8f2a-496e-a309-8cd48e1607c2" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0da008c2-2f05-454c-80b4-0e5cfea89922" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_780e8384-8f2a-496e-a309-8cd48e1607c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_d70cfe81-1e9a-4ff5-98f5-f6998d95a18c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_NumberOfReportableSegments_d70cfe81-1e9a-4ff5-98f5-f6998d95a18c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_f485dc3e-0c50-4259-b01f-dcdf99382782" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_NumberOfOperatingSegments_f485dc3e-0c50-4259-b01f-dcdf99382782" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_a895b529-0eaf-4d70-b9da-d2a58364c75b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_CashUninsuredAmount_a895b529-0eaf-4d70-b9da-d2a58364c75b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MarketableSecuritiesCurrentMaturityPeriod_eb8dc9b6-7bec-431e-9310-38f2020ce722" xlink:href="asth-20231231.xsd#asth_MarketableSecuritiesCurrentMaturityPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_MarketableSecuritiesCurrentMaturityPeriod_eb8dc9b6-7bec-431e-9310-38f2020ce722" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_ebd8751e-655d-4950-868b-6c2f5296c85f" xlink:href="asth-20231231.xsd#asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_ebd8751e-655d-4950-868b-6c2f5296c85f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e0e05bb2-fcc7-413a-9bd8-60febaf7f39b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e0e05bb2-fcc7-413a-9bd8-60febaf7f39b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_79cbc9e7-4701-44f5-b055-844a9ec12efc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_NumberOfReportingUnits_79cbc9e7-4701-44f5-b055-844a9ec12efc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a2ee595c-7b61-48ce-b6ff-c314d9625452" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a2ee595c-7b61-48ce-b6ff-c314d9625452" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_86b4e772-019e-41e5-ac5e-af5afdf910b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_86b4e772-019e-41e5-ac5e-af5afdf910b0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryAccountsPayableCurrent_907b5a1f-9331-479b-81a0-2986703588bf" xlink:href="asth-20231231.xsd#asth_FiduciaryAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_FiduciaryAccountsPayableCurrent_907b5a1f-9331-479b-81a0-2986703588bf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_83141e95-192e-42d4-9688-ec86e34a88b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_83141e95-192e-42d4-9688-ec86e34a88b3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport_9f15502a-d384-4a5b-8331-ab4c16058e29" xlink:href="asth-20231231.xsd#asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport_9f15502a-d384-4a5b-8331-ab4c16058e29" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_687f6668-2ad9-4285-a137-c24d47f1eff8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_687f6668-2ad9-4285-a137-c24d47f1eff8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RevenuePaymentTerms_44bc2a6a-6ed0-4e97-b002-8ef680f193ac" xlink:href="asth-20231231.xsd#asth_RevenuePaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_RevenuePaymentTerms_44bc2a6a-6ed0-4e97-b002-8ef680f193ac" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c6f4c0f9-8560-4544-8ecc-6e81ef6834fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c6f4c0f9-8560-4544-8ecc-6e81ef6834fd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3e4e1e0f-84e8-49f5-9202-0ac317370996" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3e4e1e0f-84e8-49f5-9202-0ac317370996" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_93334a79-7e17-4c0a-89d0-4d7cca453d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_93334a79-7e17-4c0a-89d0-4d7cca453d9c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet_af26771f-da68-4789-981c-357a70f5c3a6" xlink:href="asth-20231231.xsd#asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet_af26771f-da68-4789-981c-357a70f5c3a6" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f20605b0-30e4-4161-a270-98b3aaac2053" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b26e3c1a-d861-4b02-9d88-841081e3ae06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f20605b0-30e4-4161-a270-98b3aaac2053" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b26e3c1a-d861-4b02-9d88-841081e3ae06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_b9ecd2ad-b810-4e3b-b81c-a1424c72791c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b26e3c1a-d861-4b02-9d88-841081e3ae06" xlink:to="loc_srt_MajorCustomersAxis_b9ecd2ad-b810-4e3b-b81c-a1424c72791c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b9ecd2ad-b810-4e3b-b81c-a1424c72791c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_b9ecd2ad-b810-4e3b-b81c-a1424c72791c" xlink:to="loc_srt_NameOfMajorCustomerDomain_b9ecd2ad-b810-4e3b-b81c-a1424c72791c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_b9ecd2ad-b810-4e3b-b81c-a1424c72791c" xlink:to="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommercialMember_dc11b952-2a34-4a1f-834d-94ef6b371bfb" xlink:href="asth-20231231.xsd#asth_CommercialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:to="loc_asth_CommercialMember_dc11b952-2a34-4a1f-834d-94ef6b371bfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicareMember_9ca448bc-34e2-4813-9510-a063a2f8014f" xlink:href="asth-20231231.xsd#asth_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:to="loc_asth_MedicareMember_9ca448bc-34e2-4813-9510-a063a2f8014f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicaidMember_7fc31be1-0716-4d1a-a6b5-a095d1d32f67" xlink:href="asth-20231231.xsd#asth_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:to="loc_asth_MedicaidMember_7fc31be1-0716-4d1a-a6b5-a095d1d32f67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OtherThirdPartiesMember_ba8f270f-2e3e-4b0e-bb46-e973d326c6aa" xlink:href="asth-20231231.xsd#asth_OtherThirdPartiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:to="loc_asth_OtherThirdPartiesMember_ba8f270f-2e3e-4b0e-bb46-e973d326c6aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7faa4532-696a-49a3-babe-a332c93f43ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f20605b0-30e4-4161-a270-98b3aaac2053" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7faa4532-696a-49a3-babe-a332c93f43ba" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_2fef5ef7-9e50-4d5e-b9cb-96f92c6a8f78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2fef5ef7-9e50-4d5e-b9cb-96f92c6a8f78" xlink:to="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_81002f35-4c0a-4299-894f-75608811a25a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_81002f35-4c0a-4299-894f-75608811a25a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_81002f35-4c0a-4299-894f-75608811a25a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_81002f35-4c0a-4299-894f-75608811a25a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_81002f35-4c0a-4299-894f-75608811a25a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f2040373-b711-4108-8cb1-b011c612d7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_81002f35-4c0a-4299-894f-75608811a25a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f2040373-b711-4108-8cb1-b011c612d7ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_896aa861-0ec0-4f48-9d57-be5b6a95e65f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f2040373-b711-4108-8cb1-b011c612d7ac" xlink:to="loc_us-gaap_SalesRevenueNetMember_896aa861-0ec0-4f48-9d57-be5b6a95e65f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_96a078c5-64f8-48c7-a7db-171e649a2aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f2040373-b711-4108-8cb1-b011c612d7ac" xlink:to="loc_us-gaap_AccountsReceivableMember_96a078c5-64f8-48c7-a7db-171e649a2aae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_4982c65b-72c0-4943-8314-44086c60e0f6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:to="loc_srt_MajorCustomersAxis_4982c65b-72c0-4943-8314-44086c60e0f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4982c65b-72c0-4943-8314-44086c60e0f6_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_4982c65b-72c0-4943-8314-44086c60e0f6" xlink:to="loc_srt_NameOfMajorCustomerDomain_4982c65b-72c0-4943-8314-44086c60e0f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_4982c65b-72c0-4943-8314-44086c60e0f6" xlink:to="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorAMember_98a7aef3-c10b-453d-960b-60fae6378d2f" xlink:href="asth-20231231.xsd#asth_PayorAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayorAMember_98a7aef3-c10b-453d-960b-60fae6378d2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorBMember_71a58d2d-73d9-4e0f-900e-6b24f960f30b" xlink:href="asth-20231231.xsd#asth_PayorBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayorBMember_71a58d2d-73d9-4e0f-900e-6b24f960f30b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorCMember_86396bf2-1c9e-493e-941d-82a47ac05083" xlink:href="asth-20231231.xsd#asth_PayorCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayorCMember_86396bf2-1c9e-493e-941d-82a47ac05083" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayerDMember_fbe0deb1-5e9c-44a8-ae43-6d6c8e38e4f2" xlink:href="asth-20231231.xsd#asth_PayerDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayerDMember_fbe0deb1-5e9c-44a8-ae43-6d6c8e38e4f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorEMember_677b171f-834c-4f1f-b60f-ba38c168d082" xlink:href="asth-20231231.xsd#asth_PayorEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayorEMember_677b171f-834c-4f1f-b60f-ba38c168d082" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_b9361c86-8f46-437c-ab50-a0fb4cbc86ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_b9361c86-8f46-437c-ab50-a0fb4cbc86ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b9361c86-8f46-437c-ab50-a0fb4cbc86ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_b9361c86-8f46-437c-ab50-a0fb4cbc86ad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b9361c86-8f46-437c-ab50-a0fb4cbc86ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9a47ea6c-184a-4e0b-97b0-012ea00baf18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_b9361c86-8f46-437c-ab50-a0fb4cbc86ad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9a47ea6c-184a-4e0b-97b0-012ea00baf18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c3a33082-96ba-4466-9f6a-abe0ab41f90e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9a47ea6c-184a-4e0b-97b0-012ea00baf18" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c3a33082-96ba-4466-9f6a-abe0ab41f90e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_74214312-a71d-405a-8bfc-02a1b7cb4d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2fef5ef7-9e50-4d5e-b9cb-96f92c6a8f78" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_74214312-a71d-405a-8bfc-02a1b7cb4d7d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d636357f-4ddf-48b8-8505-9850128881a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d636357f-4ddf-48b8-8505-9850128881a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4ec5d3b7-d6af-4f51-a0e5-a4b9d43bb0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d636357f-4ddf-48b8-8505-9850128881a4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4ec5d3b7-d6af-4f51-a0e5-a4b9d43bb0bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ec5d3b7-d6af-4f51-a0e5-a4b9d43bb0bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ec5d3b7-d6af-4f51-a0e5-a4b9d43bb0bc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ec5d3b7-d6af-4f51-a0e5-a4b9d43bb0bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ec5d3b7-d6af-4f51-a0e5-a4b9d43bb0bc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ForYourBenefitIncMember_352f4616-f0f1-4b77-b466-1faddab204ca" xlink:href="asth-20231231.xsd#asth_ForYourBenefitIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_ForYourBenefitIncMember_352f4616-f0f1-4b77-b466-1faddab204ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGMember_05afb6e5-ebaf-4b35-b1b3-d2c901c31f75" xlink:href="asth-20231231.xsd#asth_AAMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_AAMGMember_05afb6e5-ebaf-4b35-b1b3-d2c901c31f75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ValleyOaksMedicalGroupMember_19b5a9c8-c18f-4b4d-b9a0-16424e172b92" xlink:href="asth-20231231.xsd#asth_ValleyOaksMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_ValleyOaksMedicalGroupMember_19b5a9c8-c18f-4b4d-b9a0-16424e172b92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_JadeHealthCareMedicalGroupIncMember_bdd0101c-4850-4686-866f-7e719a61a589" xlink:href="asth-20231231.xsd#asth_JadeHealthCareMedicalGroupIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_JadeHealthCareMedicalGroupIncMember_bdd0101c-4850-4686-866f-7e719a61a589" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_bb2c0c8c-31ef-43a0-a42f-60ef4e4b71c7" xlink:href="asth-20231231.xsd#asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_bb2c0c8c-31ef-43a0-a42f-60ef4e4b71c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_abba5189-d0ef-4981-b5e6-901d9d22ff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_abba5189-d0ef-4981-b5e6-901d9d22ff1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_843d9d7d-f653-437e-b72c-3afcfd9f45d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_843d9d7d-f653-437e-b72c-3afcfd9f45d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationStockContingentConsiderationLiability_7adfb5e7-aa0d-4d47-bc1a-73db75ffd485" xlink:href="asth-20231231.xsd#asth_BusinessCombinationStockContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:to="loc_asth_BusinessCombinationStockContingentConsiderationLiability_7adfb5e7-aa0d-4d47-bc1a-73db75ffd485" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b0d945e-79c7-4df6-9b66-7fac56b1eef8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b0d945e-79c7-4df6-9b66-7fac56b1eef8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eaae8ffa-f64d-4838-a6b6-c147d6a26adb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b0d945e-79c7-4df6-9b66-7fac56b1eef8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eaae8ffa-f64d-4838-a6b6-c147d6a26adb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaae8ffa-f64d-4838-a6b6-c147d6a26adb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eaae8ffa-f64d-4838-a6b6-c147d6a26adb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eaae8ffa-f64d-4838-a6b6-c147d6a26adb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eaae8ffa-f64d-4838-a6b6-c147d6a26adb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_17f07d4c-1d4c-4a23-989d-77c4e3d5f71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_LandMember_17f07d4c-1d4c-4a23-989d-77c4e3d5f71a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_fe1d2bfb-d8c9-49b7-8d47-75267b932cee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_BuildingMember_fe1d2bfb-d8c9-49b7-8d47-75267b932cee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_b52706a4-2b7e-4caa-b5fe-f10e12ebb692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_ComputerEquipmentMember_b52706a4-2b7e-4caa-b5fe-f10e12ebb692" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_36505b2e-870f-4f4c-b52e-13bd6fc3b6db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_36505b2e-870f-4f4c-b52e-13bd6fc3b6db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_08dc4e7d-233a-4909-b5cc-30aea922a8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_ConstructionInProgressMember_08dc4e7d-233a-4909-b5cc-30aea922a8e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_502333b8-679e-4e1d-b57d-b52ce1d0c580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_502333b8-679e-4e1d-b57d-b52ce1d0c580" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f0039d7b-f1b3-4875-b513-cb398e019418" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b0d945e-79c7-4df6-9b66-7fac56b1eef8" xlink:to="loc_srt_RangeAxis_f0039d7b-f1b3-4875-b513-cb398e019418" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0039d7b-f1b3-4875-b513-cb398e019418_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f0039d7b-f1b3-4875-b513-cb398e019418" xlink:to="loc_srt_RangeMember_f0039d7b-f1b3-4875-b513-cb398e019418_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_599ee9b3-2ea6-417c-b582-5629a7f91063" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f0039d7b-f1b3-4875-b513-cb398e019418" xlink:to="loc_srt_RangeMember_599ee9b3-2ea6-417c-b582-5629a7f91063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_913ab549-9c7e-460e-a09f-bfa5c6e8a431" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_599ee9b3-2ea6-417c-b582-5629a7f91063" xlink:to="loc_srt_MinimumMember_913ab549-9c7e-460e-a09f-bfa5c6e8a431" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_309212a2-ab3f-4f4e-8d8d-907ff30ffe11" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_599ee9b3-2ea6-417c-b582-5629a7f91063" xlink:to="loc_srt_MaximumMember_309212a2-ab3f-4f4e-8d8d-907ff30ffe11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d157c25d-a31a-49dc-9b0e-86dd546ffc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d157c25d-a31a-49dc-9b0e-86dd546ffc1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_62042421-7faf-46e5-9977-459087653b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_62042421-7faf-46e5-9977-459087653b14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_f0e84698-6586-43ab-89c5-22c9b5544d03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_f0e84698-6586-43ab-89c5-22c9b5544d03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c7c02564-43cd-4080-b19b-fe77417bc389" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c7c02564-43cd-4080-b19b-fe77417bc389" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_655f8575-39a4-47ed-b034-7074eb8c9607" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_655f8575-39a4-47ed-b034-7074eb8c9607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_655f8575-39a4-47ed-b034-7074eb8c9607_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_655f8575-39a4-47ed-b034-7074eb8c9607" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_655f8575-39a4-47ed-b034-7074eb8c9607_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e03cb310-fb68-45b2-b1b3-1e1b6fc66203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_655f8575-39a4-47ed-b034-7074eb8c9607" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e03cb310-fb68-45b2-b1b3-1e1b6fc66203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4ed4923c-8bfc-458f-b884-f21aa7030961" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e03cb310-fb68-45b2-b1b3-1e1b6fc66203" xlink:to="loc_us-gaap_TrademarksMember_4ed4923c-8bfc-458f-b884-f21aa7030961" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e3086bb-b88f-42e8-989c-cedc882f1854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e3086bb-b88f-42e8-989c-cedc882f1854" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1e3086bb-b88f-42e8-989c-cedc882f1854_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e3086bb-b88f-42e8-989c-cedc882f1854" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1e3086bb-b88f-42e8-989c-cedc882f1854_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e3086bb-b88f-42e8-989c-cedc882f1854" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkRelationshipsMember_3ecd7119-9e3d-4de1-b080-2db06ec382d8" xlink:href="asth-20231231.xsd#asth_NetworkRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_asth_NetworkRelationshipsMember_3ecd7119-9e3d-4de1-b080-2db06ec382d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ManagementContractsMember_e00c5ce3-040f-4cae-8ba1-e0502f1f6f1b" xlink:href="asth-20231231.xsd#asth_ManagementContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_asth_ManagementContractsMember_e00c5ce3-040f-4cae-8ba1-e0502f1f6f1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MemberRelationshipsMember_544fca2e-f94f-4e92-b306-bdbe77a6ec33" xlink:href="asth-20231231.xsd#asth_MemberRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_asth_MemberRelationshipsMember_544fca2e-f94f-4e92-b306-bdbe77a6ec33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PatientManagementPlatformMember_bb922686-cc58-44ba-a188-e522baa07fdb" xlink:href="asth-20231231.xsd#asth_PatientManagementPlatformMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_asth_PatientManagementPlatformMember_bb922686-cc58-44ba-a188-e522baa07fdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_d371eae0-32ed-4bed-9bc3-d8e9c57ca4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_d371eae0-32ed-4bed-9bc3-d8e9c57ca4a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a6ac6b3b-3b6c-4fb2-b166-7a2e25b468aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a6ac6b3b-3b6c-4fb2-b166-7a2e25b468aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_80f8525f-ec33-4df4-86b0-0431b7e252b7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:to="loc_srt_RangeAxis_80f8525f-ec33-4df4-86b0-0431b7e252b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_80f8525f-ec33-4df4-86b0-0431b7e252b7_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_80f8525f-ec33-4df4-86b0-0431b7e252b7" xlink:to="loc_srt_RangeMember_80f8525f-ec33-4df4-86b0-0431b7e252b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2ccdd739-17a4-44d7-aae9-f79005dab81d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_80f8525f-ec33-4df4-86b0-0431b7e252b7" xlink:to="loc_srt_RangeMember_2ccdd739-17a4-44d7-aae9-f79005dab81d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1260948d-8af1-44e0-a598-5897eb9de758" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2ccdd739-17a4-44d7-aae9-f79005dab81d" xlink:to="loc_srt_MinimumMember_1260948d-8af1-44e0-a598-5897eb9de758" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_64a833e6-f072-423a-82de-cb96620fd4ee" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2ccdd739-17a4-44d7-aae9-f79005dab81d" xlink:to="loc_srt_MaximumMember_64a833e6-f072-423a-82de-cb96620fd4ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e613ef67-7847-479e-b52f-a635c3c358f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e613ef67-7847-479e-b52f-a635c3c358f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_91d9c689-dfd3-4a5b-bb3a-1068a5c8c91a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_91d9c689-dfd3-4a5b-bb3a-1068a5c8c91a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_9dcfe069-6ae7-4872-95dd-99ac5dcf482b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_9dcfe069-6ae7-4872-95dd-99ac5dcf482b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ecb8cb65-0a0e-4f0f-9894-9cbc46e4af00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ecb8cb65-0a0e-4f0f-9894-9cbc46e4af00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_16cbbed0-1c1b-47c9-95ca-0b76bfe4db95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_07ff8cd3-f154-4c89-9b7c-d50416c6f42d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_07ff8cd3-f154-4c89-9b7c-d50416c6f42d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_d8ee5f98-280a-49b3-aa5f-93a665372670" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_d8ee5f98-280a-49b3-aa5f-93a665372670" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_ec8ae07b-6eb1-4e65-9367-8954ef9f2a21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_ec8ae07b-6eb1-4e65-9367-8954ef9f2a21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7f816c7d-fb14-4d3f-9085-fe339593a5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7f816c7d-fb14-4d3f-9085-fe339593a5c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b34b6016-aae0-427e-9025-333506ac1f74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_729713fa-8452-46b3-97f7-8d00d1db87b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_729713fa-8452-46b3-97f7-8d00d1db87b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0ceec260-49b2-48af-8874-97768c6c6a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0ceec260-49b2-48af-8874-97768c6c6a7a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_b082f627-50b3-4a2f-9d12-4e58c3f8b05d" xlink:href="asth-20231231.xsd#asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_b082f627-50b3-4a2f-9d12-4e58c3f8b05d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_a325b125-85da-432a-9c17-df80acef9cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_a325b125-85da-432a-9c17-df80acef9cdc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_97a85eeb-4bcc-4355-84f1-544b4ec38951" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_97a85eeb-4bcc-4355-84f1-544b4ec38951" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a2b731e5-10b0-4a2f-8f70-ba1b464a48c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58961dec-76e5-4d3a-b162-41248f5621a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a2b731e5-10b0-4a2f-8f70-ba1b464a48c0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58961dec-76e5-4d3a-b162-41248f5621a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e07697af-8464-4686-b12f-fb1b5c2890f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58961dec-76e5-4d3a-b162-41248f5621a5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e07697af-8464-4686-b12f-fb1b5c2890f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e07697af-8464-4686-b12f-fb1b5c2890f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e07697af-8464-4686-b12f-fb1b5c2890f7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e07697af-8464-4686-b12f-fb1b5c2890f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e07697af-8464-4686-b12f-fb1b5c2890f7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkRelationshipsMember_736f0c3c-5096-4031-9c6a-f44dfdbf7647" xlink:href="asth-20231231.xsd#asth_NetworkRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_asth_NetworkRelationshipsMember_736f0c3c-5096-4031-9c6a-f44dfdbf7647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ManagementContractsMember_acd1df06-2c40-4981-81ca-54e8136f2c9b" xlink:href="asth-20231231.xsd#asth_ManagementContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_asth_ManagementContractsMember_acd1df06-2c40-4981-81ca-54e8136f2c9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MemberRelationshipsMember_c59bcfff-9d83-4f06-b086-d2b1232b3764" xlink:href="asth-20231231.xsd#asth_MemberRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_asth_MemberRelationshipsMember_c59bcfff-9d83-4f06-b086-d2b1232b3764" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_9b786481-4bec-4843-9f64-827bca851985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_9b786481-4bec-4843-9f64-827bca851985" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6e5dd2be-7901-4863-b9da-93f0b11313f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6e5dd2be-7901-4863-b9da-93f0b11313f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsAmortizationPeriodMember_a9b841a1-1e70-4df6-8ae4-b07de6fdc0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsAmortizationPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_us-gaap_IntangibleAssetsAmortizationPeriodMember_a9b841a1-1e70-4df6-8ae4-b07de6fdc0bb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_90ec0795-80f2-4a4e-8fe7-6731ea8dd34d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a2b731e5-10b0-4a2f-8f70-ba1b464a48c0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_90ec0795-80f2-4a4e-8fe7-6731ea8dd34d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_704f98f4-45ae-4159-bd22-c130625cc746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a2b731e5-10b0-4a2f-8f70-ba1b464a48c0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_704f98f4-45ae-4159-bd22-c130625cc746" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_05720c54-d996-43f4-96cc-0009735c3e60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7c549ea0-a410-4c67-b7a7-2b00c60d4826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_05720c54-d996-43f4-96cc-0009735c3e60" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7c549ea0-a410-4c67-b7a7-2b00c60d4826" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7a21465d-31b0-4735-ac8e-6329d72d11d6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7c549ea0-a410-4c67-b7a7-2b00c60d4826" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7a21465d-31b0-4735-ac8e-6329d72d11d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7a21465d-31b0-4735-ac8e-6329d72d11d6_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7a21465d-31b0-4735-ac8e-6329d72d11d6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7a21465d-31b0-4735-ac8e-6329d72d11d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7a21465d-31b0-4735-ac8e-6329d72d11d6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LasalleMedicalAssociatesIpaMember_82c6ebf2-e7c8-4114-8bfd-8de4b4f9feac" xlink:href="asth-20231231.xsd#asth_LasalleMedicalAssociatesIpaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_LasalleMedicalAssociatesIpaMember_82c6ebf2-e7c8-4114-8bfd-8de4b4f9feac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PacificMedicalImagingAndOncologyCenterIncMember_bc108015-a4f9-4cb3-a90b-907109983ddc" xlink:href="asth-20231231.xsd#asth_PacificMedicalImagingAndOncologyCenterIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_PacificMedicalImagingAndOncologyCenterIncMember_bc108015-a4f9-4cb3-a90b-907109983ddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiveThreeOneW.CollegeLLCMember_dc840b1e-ed6b-42b5-b84c-910ad45d03d4" xlink:href="asth-20231231.xsd#asth_FiveThreeOneW.CollegeLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_FiveThreeOneW.CollegeLLCMember_dc840b1e-ed6b-42b5-b84c-910ad45d03d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OneMSOLLCMember_eb1562b7-8462-48f7-be96-04a2ad4713a3" xlink:href="asth-20231231.xsd#asth_OneMSOLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_OneMSOLLCMember_eb1562b7-8462-48f7-be96-04a2ad4713a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CAIPAMSOMember_aed61bde-47d0-4893-b83e-f80cd0a53b00" xlink:href="asth-20231231.xsd#asth_CAIPAMSOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_CAIPAMSOMember_aed61bde-47d0-4893-b83e-f80cd0a53b00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag6MedicalInvestmentGroupLLCMember_a3d4ab0b-db44-4863-b75a-dc66e83c731c" xlink:href="asth-20231231.xsd#asth_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_Tag6MedicalInvestmentGroupLLCMember_a3d4ab0b-db44-4863-b75a-dc66e83c731c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OtherMember_a896e768-dcf5-4bbb-a245-fd82f0bdd351" xlink:href="asth-20231231.xsd#asth_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_OtherMember_a896e768-dcf5-4bbb-a245-fd82f0bdd351" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_97e24462-df89-4a16-b7b0-0648a347229e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_05720c54-d996-43f4-96cc-0009735c3e60" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_97e24462-df89-4a16-b7b0-0648a347229e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_05720c54-d996-43f4-96cc-0009735c3e60" xlink:to="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_77c00998-bf93-4c6f-982c-a7bbe3418a78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_us-gaap_EquityMethodInvestments_77c00998-bf93-4c6f-982c-a7bbe3418a78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentAdditionalInvestment_31c70917-5bf2-472c-a82e-94d54a53e5ba" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentAdditionalInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentAdditionalInvestment_31c70917-5bf2-472c-a82e-94d54a53e5ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5971eb31-7921-4cde-9697-f388a28fba14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5971eb31-7921-4cde-9697-f388a28fba14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_8d8e0790-17b6-4819-a924-230cf2d71326" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_8d8e0790-17b6-4819-a924-230cf2d71326" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentsContribution_5475d7f5-317c-41e4-8213-8af7337f7443" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentsContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentsContribution_5475d7f5-317c-41e4-8213-8af7337f7443" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentAdjustmentToFairValue_700c96b0-9569-48dc-9fc8-2a5bf0a7071b" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentAdjustmentToFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentAdjustmentToFairValue_700c96b0-9569-48dc-9fc8-2a5bf0a7071b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentsConsolidated_22fee068-5802-442f-944a-2bc6648f0898" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentsConsolidated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentsConsolidated_22fee068-5802-442f-944a-2bc6648f0898" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount_186fcf89-b1ff-4534-8549-a3cb87ff2ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentSoldCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount_186fcf89-b1ff-4534-8549-a3cb87ff2ea5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_5b589b00-207b-455d-82be-23c9a4e34e67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#InvestmentsinOtherEntitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d5ee6d8a-7786-4378-8105-81d2a4b88b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d5ee6d8a-7786-4378-8105-81d2a4b88b7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5c18cea6-3770-4307-823e-68695b65777e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d5ee6d8a-7786-4378-8105-81d2a4b88b7f" xlink:to="loc_srt_OwnershipAxis_5c18cea6-3770-4307-823e-68695b65777e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5c18cea6-3770-4307-823e-68695b65777e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_5c18cea6-3770-4307-823e-68695b65777e" xlink:to="loc_srt_OwnershipDomain_5c18cea6-3770-4307-823e-68695b65777e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_5c18cea6-3770-4307-823e-68695b65777e" xlink:to="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MediPortalLLCMember_5a4b8685-e786-46ff-baaa-6bcc426bc063" xlink:href="asth-20231231.xsd#asth_MediPortalLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:to="loc_asth_MediPortalLLCMember_5a4b8685-e786-46ff-baaa-6bcc426bc063" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AchievaMedInc.Member_3e1bfb16-4a3d-4313-992e-934b7f7ee822" xlink:href="asth-20231231.xsd#asth_AchievaMedInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:to="loc_asth_AchievaMedInc.Member_3e1bfb16-4a3d-4313-992e-934b7f7ee822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ThirdWayHealthIncMember_32a10333-55bd-4a89-bd91-1795417af7d2" xlink:href="asth-20231231.xsd#asth_ThirdWayHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:to="loc_asth_ThirdWayHealthIncMember_32a10333-55bd-4a89-bd91-1795417af7d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SeenHealthIncMember_76f78828-3ef7-4dd9-8436-a7eb2cf86b41" xlink:href="asth-20231231.xsd#asth_SeenHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:to="loc_asth_SeenHealthIncMember_76f78828-3ef7-4dd9-8436-a7eb2cf86b41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b566f1b8-fc51-4fb8-af06-2f0c55662e48" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d5ee6d8a-7786-4378-8105-81d2a4b88b7f" xlink:to="loc_dei_LegalEntityAxis_b566f1b8-fc51-4fb8-af06-2f0c55662e48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b566f1b8-fc51-4fb8-af06-2f0c55662e48_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b566f1b8-fc51-4fb8-af06-2f0c55662e48" xlink:to="loc_dei_EntityDomain_b566f1b8-fc51-4fb8-af06-2f0c55662e48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_da63a71a-5676-4d18-8d5b-c99c7d1797a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b566f1b8-fc51-4fb8-af06-2f0c55662e48" xlink:to="loc_dei_EntityDomain_da63a71a-5676-4d18-8d5b-c99c7d1797a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_5612e8ee-dac2-4550-9dfe-99384587368a" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_da63a71a-5676-4d18-8d5b-c99c7d1797a5" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_5612e8ee-dac2-4550-9dfe-99384587368a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkMedicalManagementIncMember_d9272f98-7ea4-45ee-8111-d18f84c8d1ff" xlink:href="asth-20231231.xsd#asth_NetworkMedicalManagementIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_da63a71a-5676-4d18-8d5b-c99c7d1797a5" xlink:to="loc_asth_NetworkMedicalManagementIncMember_d9272f98-7ea4-45ee-8111-d18f84c8d1ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares_4f4e3f6d-a898-4fdf-9cac-f52a308f24a9" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares_4f4e3f6d-a898-4fdf-9cac-f52a308f24a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments_a1d200d4-0044-49f6-bc59-e8a89fac4e7b" xlink:href="asth-20231231.xsd#asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments_a1d200d4-0044-49f6-bc59-e8a89fac4e7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest_bf33d8bd-88c2-4c0d-b74b-0312fa4f5bb1" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest_bf33d8bd-88c2-4c0d-b74b-0312fa4f5bb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_8376d68c-a34e-4f34-9936-edc05b9e2215" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_8376d68c-a34e-4f34-9936-edc05b9e2215" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_903b2f12-4d42-40c1-afc2-a8b590213886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_903b2f12-4d42-40c1-afc2-a8b590213886" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_69ac4311-a2d5-4451-97a5-ffeca3c3b297" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_69ac4311-a2d5-4451-97a5-ffeca3c3b297" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption_dda5090c-01c6-4d09-9c3f-4e46a39f3a2c" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption_dda5090c-01c6-4d09-9c3f-4e46a39f3a2c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests_db56f3a6-b371-409f-b243-19b7ad5136a5" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests_db56f3a6-b371-409f-b243-19b7ad5136a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet_b810319d-dc48-4114-a75f-6baf4c153556" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet_b810319d-dc48-4114-a75f-6baf4c153556" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears_240feeb2-fef3-47a6-aa2e-a6973891dbc6" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears_240feeb2-fef3-47a6-aa2e-a6973891dbc6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment_9ee64d15-1946-4b5e-98ef-a85ad37c25ac" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment_9ee64d15-1946-4b5e-98ef-a85ad37c25ac" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost_89b68fe7-0e6c-472a-a348-ae9844938b1e" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost_89b68fe7-0e6c-472a-a348-ae9844938b1e" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LoanReceivableandLoanReceivableRelatedPartiesDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_381ee7d7-04e6-41bd-ad72-821c6a0e9ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_381ee7d7-04e6-41bd-ad72-821c6a0e9ee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_381ee7d7-04e6-41bd-ad72-821c6a0e9ee6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_381ee7d7-04e6-41bd-ad72-821c6a0e9ee6" xlink:to="loc_us-gaap_ReceivableTypeDomain_381ee7d7-04e6-41bd-ad72-821c6a0e9ee6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_5e4eff94-5946-42bf-b3e7-b6acabf5e432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_381ee7d7-04e6-41bd-ad72-821c6a0e9ee6" xlink:to="loc_us-gaap_ReceivableTypeDomain_5e4eff94-5946-42bf-b3e7-b6acabf5e432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_23a96920-02ae-4cd6-abfa-fa38e83c2c35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_5e4eff94-5946-42bf-b3e7-b6acabf5e432" xlink:to="loc_us-gaap_NotesReceivableMember_23a96920-02ae-4cd6-abfa-fa38e83c2c35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f1f44b9d-a1da-4983-b67e-7b8136779211" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f1f44b9d-a1da-4983-b67e-7b8136779211" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f1f44b9d-a1da-4983-b67e-7b8136779211_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f1f44b9d-a1da-4983-b67e-7b8136779211" xlink:to="loc_us-gaap_RelatedPartyDomain_f1f44b9d-a1da-4983-b67e-7b8136779211_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cda8dcff-0029-4a4e-bfb1-02dd7b33afff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f1f44b9d-a1da-4983-b67e-7b8136779211" xlink:to="loc_us-gaap_RelatedPartyDomain_cda8dcff-0029-4a4e-bfb1-02dd7b33afff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Pacific6EnterprisesMember_be3fb63a-5921-41a9-b46b-89b51d3f8bbf" xlink:href="asth-20231231.xsd#asth_Pacific6EnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_cda8dcff-0029-4a4e-bfb1-02dd7b33afff" xlink:to="loc_asth_Pacific6EnterprisesMember_be3fb63a-5921-41a9-b46b-89b51d3f8bbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcLsmaMember_6205a836-b2b6-488f-82dd-41486c61a594" xlink:href="asth-20231231.xsd#asth_ApcLsmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_cda8dcff-0029-4a4e-bfb1-02dd7b33afff" xlink:to="loc_asth_ApcLsmaMember_6205a836-b2b6-488f-82dd-41486c61a594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3f513f1b-845f-489e-9664-747c30067534" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_dei_LegalEntityAxis_3f513f1b-845f-489e-9664-747c30067534" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3f513f1b-845f-489e-9664-747c30067534_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3f513f1b-845f-489e-9664-747c30067534" xlink:to="loc_dei_EntityDomain_3f513f1b-845f-489e-9664-747c30067534_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_286dae21-6382-4350-8fe9-e3f5798caf05" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3f513f1b-845f-489e-9664-747c30067534" xlink:to="loc_dei_EntityDomain_286dae21-6382-4350-8fe9-e3f5798caf05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkMedicalManagementMember_ef313aff-9f6b-494f-92a0-9f5626f6b645" xlink:href="asth-20231231.xsd#asth_NetworkMedicalManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_286dae21-6382-4350-8fe9-e3f5798caf05" xlink:to="loc_asth_NetworkMedicalManagementMember_ef313aff-9f6b-494f-92a0-9f5626f6b645" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LmaMember_594dc3c7-29f0-489e-85ab-30474f834396" xlink:href="asth-20231231.xsd#asth_LmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_286dae21-6382-4350-8fe9-e3f5798caf05" xlink:to="loc_asth_LmaMember_594dc3c7-29f0-489e-85ab-30474f834396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6b32c47e-9dbe-4bfd-9950-8799422681f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_us-gaap_DebtInstrumentAxis_6b32c47e-9dbe-4bfd-9950-8799422681f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6b32c47e-9dbe-4bfd-9950-8799422681f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6b32c47e-9dbe-4bfd-9950-8799422681f7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6b32c47e-9dbe-4bfd-9950-8799422681f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94c0128b-19cc-43d0-a8bd-89f89e86d5db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6b32c47e-9dbe-4bfd-9950-8799422681f7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94c0128b-19cc-43d0-a8bd-89f89e86d5db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IntraCareConvertiblePromissoryNoteReceivableMember_726cec24-d30c-47ac-8e60-3d9735fb3ac2" xlink:href="asth-20231231.xsd#asth_IntraCareConvertiblePromissoryNoteReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94c0128b-19cc-43d0-a8bd-89f89e86d5db" xlink:to="loc_asth_IntraCareConvertiblePromissoryNoteReceivableMember_726cec24-d30c-47ac-8e60-3d9735fb3ac2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_97b4dc65-96e1-4df2-be42-1cdb34a1a6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_97b4dc65-96e1-4df2-be42-1cdb34a1a6c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_97b4dc65-96e1-4df2-be42-1cdb34a1a6c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_97b4dc65-96e1-4df2-be42-1cdb34a1a6c1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_97b4dc65-96e1-4df2-be42-1cdb34a1a6c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_625bd092-bd8d-4520-ad75-9a0e00425185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_97b4dc65-96e1-4df2-be42-1cdb34a1a6c1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_625bd092-bd8d-4520-ad75-9a0e00425185" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_8eaa0e84-94ae-481f-ba67-8cdc23784854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_625bd092-bd8d-4520-ad75-9a0e00425185" xlink:to="loc_us-gaap_NotesReceivableMember_8eaa0e84-94ae-481f-ba67-8cdc23784854" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6494383f-84ca-43d6-ae7d-1fb33c729f95" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6494383f-84ca-43d6-ae7d-1fb33c729f95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6494383f-84ca-43d6-ae7d-1fb33c729f95_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6494383f-84ca-43d6-ae7d-1fb33c729f95" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6494383f-84ca-43d6-ae7d-1fb33c729f95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_fa0a0ac4-ddc8-4b11-a471-d6f340940e72" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6494383f-84ca-43d6-ae7d-1fb33c729f95" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_fa0a0ac4-ddc8-4b11-a471-d6f340940e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LmaMember_dbeeda66-fa3c-46e1-86c8-c399dd307c0a" xlink:href="asth-20231231.xsd#asth_LmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_fa0a0ac4-ddc8-4b11-a471-d6f340940e72" xlink:to="loc_asth_LmaMember_dbeeda66-fa3c-46e1-86c8-c399dd307c0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_35989c4f-5632-4c56-a2d6-5c48ada8657b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_NotesReceivableNet_35989c4f-5632-4c56-a2d6-5c48ada8657b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4adaf8ef-9065-42f8-8e8d-602afaa27f22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4adaf8ef-9065-42f8-8e8d-602afaa27f22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_06e1951a-791b-4c6b-8903-9c2567e67a99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_DebtInstrumentTerm_06e1951a-791b-4c6b-8903-9c2567e67a99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_39dd2885-192b-4b2b-b5ef-22786d2f779e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_39dd2885-192b-4b2b-b5ef-22786d2f779e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_967f4a19-89b6-440f-b40d-8d6f34151f01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_967f4a19-89b6-440f-b40d-8d6f34151f01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FinanceReceivableInterestRateStatedPercentage_a953870d-531e-4f5f-80ba-2e9e2895d559" xlink:href="asth-20231231.xsd#asth_FinanceReceivableInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_asth_FinanceReceivableInterestRateStatedPercentage_a953870d-531e-4f5f-80ba-2e9e2895d559" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4c0666a4-a37a-49ad-af5f-3514a6eb624c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4c0666a4-a37a-49ad-af5f-3514a6eb624c" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_92eb12db-da80-4fc0-8eca-0abe344aaa97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_92eb12db-da80-4fc0-8eca-0abe344aaa97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c9d991a5-86f3-4e13-be40-ec148c22ffe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_92eb12db-da80-4fc0-8eca-0abe344aaa97" xlink:to="loc_us-gaap_CreditFacilityAxis_c9d991a5-86f3-4e13-be40-ec148c22ffe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c9d991a5-86f3-4e13-be40-ec148c22ffe9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c9d991a5-86f3-4e13-be40-ec148c22ffe9" xlink:to="loc_us-gaap_CreditFacilityDomain_c9d991a5-86f3-4e13-be40-ec148c22ffe9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3cc52a34-411a-44bd-a931-f5791eea2625" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c9d991a5-86f3-4e13-be40-ec148c22ffe9" xlink:to="loc_us-gaap_CreditFacilityDomain_3cc52a34-411a-44bd-a931-f5791eea2625" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f98a8bdd-040c-48de-a720-ed14e05128ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3cc52a34-411a-44bd-a931-f5791eea2625" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f98a8bdd-040c-48de-a720-ed14e05128ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4feed0d2-7051-496b-b8a4-9c3cdd23e9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_92eb12db-da80-4fc0-8eca-0abe344aaa97" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4feed0d2-7051-496b-b8a4-9c3cdd23e9aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4feed0d2-7051-496b-b8a4-9c3cdd23e9aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4feed0d2-7051-496b-b8a4-9c3cdd23e9aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4feed0d2-7051-496b-b8a4-9c3cdd23e9aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4feed0d2-7051-496b-b8a4-9c3cdd23e9aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TermLoanMember_3b39eee1-7376-4058-bac2-53bc362e2151" xlink:href="asth-20231231.xsd#asth_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:to="loc_asth_TermLoanMember_3b39eee1-7376-4058-bac2-53bc362e2151" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember_38fed5b0-9bf8-408e-8753-607f3d89ee70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:to="loc_us-gaap_RealEstateLoanMember_38fed5b0-9bf8-408e-8753-607f3d89ee70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ConstructionLoanMember_86979709-dafb-4dde-8ffa-194f2241e28e" xlink:href="asth-20231231.xsd#asth_ConstructionLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:to="loc_asth_ConstructionLoanMember_86979709-dafb-4dde-8ffa-194f2241e28e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_d63e9706-78d1-4ae2-9dd3-b27703efee81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:to="loc_us-gaap_NotesPayableToBanksMember_d63e9706-78d1-4ae2-9dd3-b27703efee81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_97fb520f-0b40-4635-ae34-14b6a35b68f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_97fb520f-0b40-4635-ae34-14b6a35b68f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e538333e-86f4-419a-a211-84db0dc3997a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:to="loc_us-gaap_LongTermDebtCurrent_e538333e-86f4-419a-a211-84db0dc3997a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a0935373-f3d4-4d76-932d-d64eb55a6f52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a0935373-f3d4-4d76-932d-d64eb55a6f52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_894e910e-1912-46da-8e39-6615bf6617d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_894e910e-1912-46da-8e39-6615bf6617d4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_636f251f-4aa2-448b-a3f2-465517aa7b2e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_srt_RangeAxis_636f251f-4aa2-448b-a3f2-465517aa7b2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_636f251f-4aa2-448b-a3f2-465517aa7b2e_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_636f251f-4aa2-448b-a3f2-465517aa7b2e" xlink:to="loc_srt_RangeMember_636f251f-4aa2-448b-a3f2-465517aa7b2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2f4b39a8-c854-4c78-a55b-6e6b43145df4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_636f251f-4aa2-448b-a3f2-465517aa7b2e" xlink:to="loc_srt_RangeMember_2f4b39a8-c854-4c78-a55b-6e6b43145df4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_66904bdc-a0a6-44b5-92ab-bfd389149080" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2f4b39a8-c854-4c78-a55b-6e6b43145df4" xlink:to="loc_srt_MinimumMember_66904bdc-a0a6-44b5-92ab-bfd389149080" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f1664aa0-a445-45d4-a394-0d3fdc87ec02" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2f4b39a8-c854-4c78-a55b-6e6b43145df4" xlink:to="loc_srt_MaximumMember_f1664aa0-a445-45d4-a394-0d3fdc87ec02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_020be8f3-3d6d-4ed1-806f-49c654547ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_DebtInstrumentAxis_020be8f3-3d6d-4ed1-806f-49c654547ddf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_020be8f3-3d6d-4ed1-806f-49c654547ddf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_020be8f3-3d6d-4ed1-806f-49c654547ddf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_020be8f3-3d6d-4ed1-806f-49c654547ddf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_020be8f3-3d6d-4ed1-806f-49c654547ddf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AmendedCreditAgreementMember_4b76bdef-6536-480e-94bb-90899bb60cae" xlink:href="asth-20231231.xsd#asth_AmendedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:to="loc_asth_AmendedCreditAgreementMember_4b76bdef-6536-480e-94bb-90899bb60cae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CreditAgreementMember_92314c20-c75b-459f-ba5c-7845de357aeb" xlink:href="asth-20231231.xsd#asth_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:to="loc_asth_CreditAgreementMember_92314c20-c75b-459f-ba5c-7845de357aeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AmendedAndRestatedCreditAgreementMember_d4f02b9f-7ee0-465c-b496-5a3cf73fefd2" xlink:href="asth-20231231.xsd#asth_AmendedAndRestatedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:to="loc_asth_AmendedAndRestatedCreditAgreementMember_d4f02b9f-7ee0-465c-b496-5a3cf73fefd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_88b4093a-7b2d-4044-a866-2fb86a233a11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_VariableRateAxis_88b4093a-7b2d-4044-a866-2fb86a233a11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_88b4093a-7b2d-4044-a866-2fb86a233a11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_88b4093a-7b2d-4044-a866-2fb86a233a11" xlink:to="loc_us-gaap_VariableRateDomain_88b4093a-7b2d-4044-a866-2fb86a233a11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_203f52ed-1477-4e79-ad71-91316690797b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_88b4093a-7b2d-4044-a866-2fb86a233a11" xlink:to="loc_us-gaap_VariableRateDomain_203f52ed-1477-4e79-ad71-91316690797b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SecuredOvernightFinancingRateMember_6b5c8091-fa96-476c-89cd-0ec28dd4c6ad" xlink:href="asth-20231231.xsd#asth_SecuredOvernightFinancingRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_203f52ed-1477-4e79-ad71-91316690797b" xlink:to="loc_asth_SecuredOvernightFinancingRateMember_6b5c8091-fa96-476c-89cd-0ec28dd4c6ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_15d13c0e-7585-41ac-b70a-91943ca75538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_203f52ed-1477-4e79-ad71-91316690797b" xlink:to="loc_us-gaap_BaseRateMember_15d13c0e-7585-41ac-b70a-91943ca75538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_879fad45-1033-4511-ba84-87bdeb88c8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_CreditFacilityAxis_879fad45-1033-4511-ba84-87bdeb88c8c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_879fad45-1033-4511-ba84-87bdeb88c8c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_879fad45-1033-4511-ba84-87bdeb88c8c4" xlink:to="loc_us-gaap_CreditFacilityDomain_879fad45-1033-4511-ba84-87bdeb88c8c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_879fad45-1033-4511-ba84-87bdeb88c8c4" xlink:to="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d3fe486f-95d7-4432-86d0-2307f6373cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d3fe486f-95d7-4432-86d0-2307f6373cc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_4c9e0070-ce21-4923-a71a-ffc8729b2cff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_4c9e0070-ce21-4923-a71a-ffc8729b2cff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NewTermLoanMember_6f6a82e3-ff16-41af-9931-42b38afb8249" xlink:href="asth-20231231.xsd#asth_NewTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:to="loc_asth_NewTermLoanMember_6f6a82e3-ff16-41af-9931-42b38afb8249" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_6949715a-f445-4e78-8225-4c10a2ecd4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:to="loc_us-gaap_LetterOfCreditMember_6949715a-f445-4e78-8225-4c10a2ecd4d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b323c302-3262-484b-bca2-6df838f7ec80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b323c302-3262-484b-bca2-6df838f7ec80" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b323c302-3262-484b-bca2-6df838f7ec80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b323c302-3262-484b-bca2-6df838f7ec80" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b323c302-3262-484b-bca2-6df838f7ec80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_22bae62b-f418-495a-97c8-2e3ae07e7e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b323c302-3262-484b-bca2-6df838f7ec80" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_22bae62b-f418-495a-97c8-2e3ae07e7e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_31716be8-983b-42ae-820d-21905fb495f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bae62b-f418-495a-97c8-2e3ae07e7e4a" xlink:to="loc_us-gaap_LineOfCreditMember_31716be8-983b-42ae-820d-21905fb495f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_1104d789-1dd6-42b3-b169-6707bbd5cfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bae62b-f418-495a-97c8-2e3ae07e7e4a" xlink:to="loc_us-gaap_SecuredDebtMember_1104d789-1dd6-42b3-b169-6707bbd5cfa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_96930927-40b0-452b-94de-d3db7e5c71de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_96930927-40b0-452b-94de-d3db7e5c71de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_96930927-40b0-452b-94de-d3db7e5c71de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_96930927-40b0-452b-94de-d3db7e5c71de" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_96930927-40b0-452b-94de-d3db7e5c71de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_f15eef11-f360-4616-aa9d-043128fda6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_96930927-40b0-452b-94de-d3db7e5c71de" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_f15eef11-f360-4616-aa9d-043128fda6d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TruistBankMember_3bca2036-f865-42d9-94ff-a4b962052412" xlink:href="asth-20231231.xsd#asth_TruistBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_f15eef11-f360-4616-aa9d-043128fda6d0" xlink:to="loc_asth_TruistBankMember_3bca2036-f865-42d9-94ff-a4b962052412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_153d2cec-3865-4fca-a206-5fc433a3e13d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_153d2cec-3865-4fca-a206-5fc433a3e13d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_153d2cec-3865-4fca-a206-5fc433a3e13d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_153d2cec-3865-4fca-a206-5fc433a3e13d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_153d2cec-3865-4fca-a206-5fc433a3e13d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_153d2cec-3865-4fca-a206-5fc433a3e13d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_6fec7a44-2c3e-4f16-8f32-b717b29c6fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_6fec7a44-2c3e-4f16-8f32-b717b29c6fa3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e7bbf126-e51a-4b08-b0ab-e72edad93d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e7bbf126-e51a-4b08-b0ab-e72edad93d02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_00b9fd5f-8731-416b-a41a-fc5e95640948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_00b9fd5f-8731-416b-a41a-fc5e95640948" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_04d80cb5-418d-48f1-b2b5-288ad8680930" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_srt_CounterpartyNameAxis_04d80cb5-418d-48f1-b2b5-288ad8680930" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_04d80cb5-418d-48f1-b2b5-288ad8680930_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_04d80cb5-418d-48f1-b2b5-288ad8680930" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_04d80cb5-418d-48f1-b2b5-288ad8680930_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c10688de-83c0-469a-946b-0b64116c0fb6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_04d80cb5-418d-48f1-b2b5-288ad8680930" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c10688de-83c0-469a-946b-0b64116c0fb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AstranaMedicalMember_1d191d49-2ca0-4a43-a0e2-5a37cb4570c6" xlink:href="asth-20231231.xsd#asth_AstranaMedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c10688de-83c0-469a-946b-0b64116c0fb6" xlink:to="loc_asth_AstranaMedicalMember_1d191d49-2ca0-4a43-a0e2-5a37cb4570c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2a01a6ab-013f-4011-b3b3-9d6167f42451" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2a01a6ab-013f-4011-b3b3-9d6167f42451" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_6a21580b-8c83-4042-805d-6f2c60ea9ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_6a21580b-8c83-4042-805d-6f2c60ea9ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_bbe95d02-5029-448c-9505-bf19e675740a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_bbe95d02-5029-448c-9505-bf19e675740a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_bae06451-9ad2-4c76-85bd-6207d42b2965" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_bae06451-9ad2-4c76-85bd-6207d42b2965" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantLeverageRatioMaximum_91d0ec61-636e-4894-b09c-b547a6a66db9" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtInstrumentCovenantLeverageRatioMaximum_91d0ec61-636e-4894-b09c-b547a6a66db9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtCovenantAggregatePurchasePriceMaximum_6efea54d-5c0d-4fec-81f7-e406e9ee653e" xlink:href="asth-20231231.xsd#asth_DebtCovenantAggregatePurchasePriceMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtCovenantAggregatePurchasePriceMaximum_6efea54d-5c0d-4fec-81f7-e406e9ee653e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_01931fb1-016d-4559-b34a-0ff65aa5857c" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantLeverageRatioIncrementalChange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_01931fb1-016d-4559-b34a-0ff65aa5857c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_45219e18-a925-4e16-aed4-4a312651c00e" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_45219e18-a925-4e16-aed4-4a312651c00e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_720b61dc-5887-4ea4-86e9-5a225898fc7f" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_720b61dc-5887-4ea4-86e9-5a225898fc7f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_aa6635a2-d5ab-4560-9b1a-03e526318d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCredit_aa6635a2-d5ab-4560-9b1a-03e526318d6f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_UnamortizedDeferredFinancingCosts_82bb4497-e623-4a5e-b595-d368b5100887" xlink:href="asth-20231231.xsd#asth_UnamortizedDeferredFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_UnamortizedDeferredFinancingCosts_82bb4497-e623-4a5e-b595-d368b5100887" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_9c10b483-8c76-490f-b4a8-a2f039a29f23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_9c10b483-8c76-490f-b4a8-a2f039a29f23" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_17502176-72f1-4621-8c84-c913fc8d94bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_17502176-72f1-4621-8c84-c913fc8d94bd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_91214dd8-e4d8-48b7-b785-0d47f2155fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtInstrumentTerm_91214dd8-e4d8-48b7-b785-0d47f2155fdf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_91622c34-73f0-4a6a-966b-9009f1ceca42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_91622c34-73f0-4a6a-966b-9009f1ceca42" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LineOfCreditFacilityAmountFundedAtClosing_b3e89cf0-e068-4592-a03d-28d73f2ebe2e" xlink:href="asth-20231231.xsd#asth_LineOfCreditFacilityAmountFundedAtClosing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_LineOfCreditFacilityAmountFundedAtClosing_b3e89cf0-e068-4592-a03d-28d73f2ebe2e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_06be22e2-9d82-4789-b614-535eba89743b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_RepaymentsOfDebt_06be22e2-9d82-4789-b614-535eba89743b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts_071077e1-3868-4f84-b402-7aa655451af6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfBankOverdrafts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts_071077e1-3868-4f84-b402-7aa655451af6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8291bd47-85c7-4143-93e9-bd2e43fa3dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8291bd47-85c7-4143-93e9-bd2e43fa3dc4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_7f396d1d-e96e-4df7-9a93-3fec80924426" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_7f396d1d-e96e-4df7-9a93-3fec80924426" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_794213c1-f64a-4614-968a-4d5f1f393d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_DebtInstrumentAxis_794213c1-f64a-4614-968a-4d5f1f393d0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_794213c1-f64a-4614-968a-4d5f1f393d0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_794213c1-f64a-4614-968a-4d5f1f393d0c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_794213c1-f64a-4614-968a-4d5f1f393d0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_794213c1-f64a-4614-968a-4d5f1f393d0c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RealEstateLoanOneMember_b2ead17b-7315-46d9-91a0-03349cceda92" xlink:href="asth-20231231.xsd#asth_RealEstateLoanOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_RealEstateLoanOneMember_b2ead17b-7315-46d9-91a0-03349cceda92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RealEstateLoanTwoMember_468a4abc-15e3-4f4b-b2f4-a27d65602cf0" xlink:href="asth-20231231.xsd#asth_RealEstateLoanTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_RealEstateLoanTwoMember_468a4abc-15e3-4f4b-b2f4-a27d65602cf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RealEstateLoanThreeMember_8698dfb0-be13-411e-b795-0dbf886608c9" xlink:href="asth-20231231.xsd#asth_RealEstateLoanThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_RealEstateLoanThreeMember_8698dfb0-be13-411e-b795-0dbf886608c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ConstructionLoanMember_c06a1c7d-9f5a-466f-9881-c7b3a4837927" xlink:href="asth-20231231.xsd#asth_ConstructionLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_ConstructionLoanMember_c06a1c7d-9f5a-466f-9881-c7b3a4837927" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SubordinatedLoanAgreementMember_ec0904de-8115-499f-b66f-6921d15a4785" xlink:href="asth-20231231.xsd#asth_SubordinatedLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_SubordinatedLoanAgreementMember_ec0904de-8115-499f-b66f-6921d15a4785" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CreditAgreementMember_d83b7787-e11d-48f8-80b5-8f86c816f2f2" xlink:href="asth-20231231.xsd#asth_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_CreditAgreementMember_d83b7787-e11d-48f8-80b5-8f86c816f2f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcBusinessLoanAgreementMember_cc3dd51d-5f1a-4f22-baab-5c66cfffaff4" xlink:href="asth-20231231.xsd#asth_ApcBusinessLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_ApcBusinessLoanAgreementMember_cc3dd51d-5f1a-4f22-baab-5c66cfffaff4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AmendedCreditAgreementMember_a1f35607-c5f4-4b6d-976e-a0a4636cea29" xlink:href="asth-20231231.xsd#asth_AmendedCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_AmendedCreditAgreementMember_a1f35607-c5f4-4b6d-976e-a0a4636cea29" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_704911be-fd82-436c-803c-18d6eadf2332" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_dei_LegalEntityAxis_704911be-fd82-436c-803c-18d6eadf2332" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_704911be-fd82-436c-803c-18d6eadf2332_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_704911be-fd82-436c-803c-18d6eadf2332" xlink:to="loc_dei_EntityDomain_704911be-fd82-436c-803c-18d6eadf2332_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_704911be-fd82-436c-803c-18d6eadf2332" xlink:to="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_d27a5caa-30d3-4789-9ba5-6395a3cffcc1" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_d27a5caa-30d3-4789-9ba5-6395a3cffcc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_A120HellmanLLCMember_6ebd1689-9509-4536-97e2-afa288885d48" xlink:href="asth-20231231.xsd#asth_A120HellmanLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:to="loc_asth_A120HellmanLLCMember_6ebd1689-9509-4536-97e2-afa288885d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag8MedicalInvestmentGroupLLCMember_675880ab-7e87-454e-a70a-948142f7b6e9" xlink:href="asth-20231231.xsd#asth_Tag8MedicalInvestmentGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:to="loc_asth_Tag8MedicalInvestmentGroupLLCMember_675880ab-7e87-454e-a70a-948142f7b6e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4b1eaf3a-802e-4f17-bd74-4484e2515ada" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_VariableRateAxis_4b1eaf3a-802e-4f17-bd74-4484e2515ada" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4b1eaf3a-802e-4f17-bd74-4484e2515ada_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_4b1eaf3a-802e-4f17-bd74-4484e2515ada" xlink:to="loc_us-gaap_VariableRateDomain_4b1eaf3a-802e-4f17-bd74-4484e2515ada_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_47c7dde4-ffd7-41f0-93c9-a05911c49f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_4b1eaf3a-802e-4f17-bd74-4484e2515ada" xlink:to="loc_us-gaap_VariableRateDomain_47c7dde4-ffd7-41f0-93c9-a05911c49f1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_96eac801-c357-4c26-b372-11aedaada253" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_47c7dde4-ffd7-41f0-93c9-a05911c49f1e" xlink:to="loc_us-gaap_PrimeRateMember_96eac801-c357-4c26-b372-11aedaada253" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6f26fadf-8c77-4cff-9ee6-0dd4b2ad0c48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6f26fadf-8c77-4cff-9ee6-0dd4b2ad0c48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6f26fadf-8c77-4cff-9ee6-0dd4b2ad0c48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6f26fadf-8c77-4cff-9ee6-0dd4b2ad0c48" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6f26fadf-8c77-4cff-9ee6-0dd4b2ad0c48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a9bfb077-b11a-41c0-850a-e25d316088fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6f26fadf-8c77-4cff-9ee6-0dd4b2ad0c48" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a9bfb077-b11a-41c0-850a-e25d316088fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedDebtMember_74788f02-cb4e-4488-bbe3-327bfb0c6a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a9bfb077-b11a-41c0-850a-e25d316088fc" xlink:to="loc_us-gaap_SubordinatedDebtMember_74788f02-cb4e-4488-bbe3-327bfb0c6a2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2309cdb8-550a-4986-a27f-99661b25ed5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_CreditFacilityAxis_2309cdb8-550a-4986-a27f-99661b25ed5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2309cdb8-550a-4986-a27f-99661b25ed5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2309cdb8-550a-4986-a27f-99661b25ed5c" xlink:to="loc_us-gaap_CreditFacilityDomain_2309cdb8-550a-4986-a27f-99661b25ed5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2995b6b2-30f1-4e0c-b8d6-7fe899e41931" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2309cdb8-550a-4986-a27f-99661b25ed5c" xlink:to="loc_us-gaap_CreditFacilityDomain_2995b6b2-30f1-4e0c-b8d6-7fe899e41931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_8eab9dc0-3396-4ccb-a4d4-f8526bdf62ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2995b6b2-30f1-4e0c-b8d6-7fe899e41931" xlink:to="loc_us-gaap_LineOfCreditMember_8eab9dc0-3396-4ccb-a4d4-f8526bdf62ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_88d80d3b-225b-45ea-9dcb-0272f437aeee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2995b6b2-30f1-4e0c-b8d6-7fe899e41931" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_88d80d3b-225b-45ea-9dcb-0272f437aeee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_46026ead-d36b-41ef-99a6-d44114cc4de1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_46026ead-d36b-41ef-99a6-d44114cc4de1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_46026ead-d36b-41ef-99a6-d44114cc4de1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_46026ead-d36b-41ef-99a6-d44114cc4de1" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_46026ead-d36b-41ef-99a6-d44114cc4de1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_267a3994-9499-49c4-aa99-3add4d29ab96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_46026ead-d36b-41ef-99a6-d44114cc4de1" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_267a3994-9499-49c4-aa99-3add4d29ab96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PreferredBankMember_d1155fea-ace5-4935-96e5-c7b54b3511f0" xlink:href="asth-20231231.xsd#asth_PreferredBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_267a3994-9499-49c4-aa99-3add4d29ab96" xlink:to="loc_asth_PreferredBankMember_d1155fea-ace5-4935-96e5-c7b54b3511f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TruistBankMember_25e4473d-80c8-426e-b60b-2d7b274767e7" xlink:href="asth-20231231.xsd#asth_TruistBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_267a3994-9499-49c4-aa99-3add4d29ab96" xlink:to="loc_asth_TruistBankMember_25e4473d-80c8-426e-b60b-2d7b274767e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_0e3b6727-45c3-4ca6-b323-b262eb29820f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_0e3b6727-45c3-4ca6-b323-b262eb29820f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_0e3b6727-45c3-4ca6-b323-b262eb29820f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_0e3b6727-45c3-4ca6-b323-b262eb29820f" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_0e3b6727-45c3-4ca6-b323-b262eb29820f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_82df2e37-df5c-4354-ad73-914136d0a3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_0e3b6727-45c3-4ca6-b323-b262eb29820f" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_82df2e37-df5c-4354-ad73-914136d0a3f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_ac44559b-1635-4fa8-b692-8a5daade36d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_82df2e37-df5c-4354-ad73-914136d0a3f2" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_ac44559b-1635-4fa8-b692-8a5daade36d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NumberOfRealEstateLoans_94f6fac5-5a10-43aa-a3cb-d8686ce6b279" xlink:href="asth-20231231.xsd#asth_NumberOfRealEstateLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_asth_NumberOfRealEstateLoans_94f6fac5-5a10-43aa-a3cb-d8686ce6b279" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9bf720a5-c4ec-4d63-970b-6308e5a37a04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_LongTermDebt_9bf720a5-c4ec-4d63-970b-6308e5a37a04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f097542b-c5e5-4d2b-9f85-80ea1a9635b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f097542b-c5e5-4d2b-9f85-80ea1a9635b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a2d0e865-890d-4939-afa7-5297c565f6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a2d0e865-890d-4939-afa7-5297c565f6b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_26ad438f-4b56-4275-a5d9-684a10645847" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_26ad438f-4b56-4275-a5d9-684a10645847" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_17ecc2d7-cec5-4624-895f-bca7665d5608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_InterestExpense_17ecc2d7-cec5-4624-895f-bca7665d5608" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5d8b5d2-fecb-40e8-9eb6-346fe865e774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5d8b5d2-fecb-40e8-9eb6-346fe865e774" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_49659088-2c54-46ab-bb96-27ccce9bd993" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_49659088-2c54-46ab-bb96-27ccce9bd993" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_7f8dbf0a-50ba-49d3-93d8-d98104b956d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_7f8dbf0a-50ba-49d3-93d8-d98104b956d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_1ef8dc33-325e-4e65-9ec6-232be1808cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7f8dbf0a-50ba-49d3-93d8-d98104b956d3" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_1ef8dc33-325e-4e65-9ec6-232be1808cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_1ef8dc33-325e-4e65-9ec6-232be1808cb3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1ef8dc33-325e-4e65-9ec6-232be1808cb3" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_1ef8dc33-325e-4e65-9ec6-232be1808cb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_c5d9c5b7-94c5-4fc5-a6e7-17bf6c3a44e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1ef8dc33-325e-4e65-9ec6-232be1808cb3" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_c5d9c5b7-94c5-4fc5-a6e7-17bf6c3a44e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_4a53a560-75ba-4cc4-9a62-9e4a82e1c127" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_c5d9c5b7-94c5-4fc5-a6e7-17bf6c3a44e0" xlink:to="loc_us-gaap_DomesticCountryMember_4a53a560-75ba-4cc4-9a62-9e4a82e1c127" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_77bc4bdc-aeed-4168-b9b4-afff5be30bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_c5d9c5b7-94c5-4fc5-a6e7-17bf6c3a44e0" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_77bc4bdc-aeed-4168-b9b4-afff5be30bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_154d5727-ba6f-4fc2-8faa-91e6296f28ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_154d5727-ba6f-4fc2-8faa-91e6296f28ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8527aa03-68dc-44f3-ad4b-3ea892803850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8527aa03-68dc-44f3-ad4b-3ea892803850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_20d39084-340a-492d-8a27-44b63536fbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_20d39084-340a-492d-8a27-44b63536fbc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_5525690d-42d3-4959-b66a-6fccc27cf8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_us-gaap_OperatingLossCarryforwards_5525690d-42d3-4959-b66a-6fccc27cf8ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OperatingLossCarryforwardsNotSubjectToExpiration_cd6dc192-3339-48f2-8074-25224df89de8" xlink:href="asth-20231231.xsd#asth_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_asth_OperatingLossCarryforwardsNotSubjectToExpiration_cd6dc192-3339-48f2-8074-25224df89de8" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_86af2f63-eee9-4a9f-98e2-625ece8b269f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_86af2f63-eee9-4a9f-98e2-625ece8b269f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86af2f63-eee9-4a9f-98e2-625ece8b269f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_86af2f63-eee9-4a9f-98e2-625ece8b269f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_86af2f63-eee9-4a9f-98e2-625ece8b269f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef19ce38-c5cc-49ee-857a-cc54c861a088" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_86af2f63-eee9-4a9f-98e2-625ece8b269f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef19ce38-c5cc-49ee-857a-cc54c861a088" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_f23ee653-7435-4715-85dd-9640459c4c36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef19ce38-c5cc-49ee-857a-cc54c861a088" xlink:to="loc_us-gaap_PrivatePlacementMember_f23ee653-7435-4715-85dd-9640459c4c36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3ee722d5-041a-4bdc-9d4f-9c1be28d809c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3ee722d5-041a-4bdc-9d4f-9c1be28d809c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3ee722d5-041a-4bdc-9d4f-9c1be28d809c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3ee722d5-041a-4bdc-9d4f-9c1be28d809c" xlink:to="loc_us-gaap_ClassOfStockDomain_3ee722d5-041a-4bdc-9d4f-9c1be28d809c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b9a0fa1e-206c-45ca-b5ce-593147eb5706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3ee722d5-041a-4bdc-9d4f-9c1be28d809c" xlink:to="loc_us-gaap_ClassOfStockDomain_b9a0fa1e-206c-45ca-b5ce-593147eb5706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_1db05180-0ab3-45a6-95e9-5df7ced6d92d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b9a0fa1e-206c-45ca-b5ce-593147eb5706" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_1db05180-0ab3-45a6-95e9-5df7ced6d92d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_f1610f30-de1e-4292-9a50-f61a5def00c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b9a0fa1e-206c-45ca-b5ce-593147eb5706" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_f1610f30-de1e-4292-9a50-f61a5def00c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_95053f88-1e29-4743-9e7f-32a9997730af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_dei_LegalEntityAxis_95053f88-1e29-4743-9e7f-32a9997730af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_95053f88-1e29-4743-9e7f-32a9997730af_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_95053f88-1e29-4743-9e7f-32a9997730af" xlink:to="loc_dei_EntityDomain_95053f88-1e29-4743-9e7f-32a9997730af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_95053f88-1e29-4743-9e7f-32a9997730af" xlink:to="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_a54cbbe0-7949-4065-b5f7-0835d41f189f" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_a54cbbe0-7949-4065-b5f7-0835d41f189f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CDSCMember_0308b973-19b9-4c82-82f2-ad6927613463" xlink:href="asth-20231231.xsd#asth_CDSCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:to="loc_asth_CDSCMember_0308b973-19b9-4c82-82f2-ad6927613463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CompanyAndAPCMember_2fbd76ce-6a6d-4599-ac8e-aeda496c3746" xlink:href="asth-20231231.xsd#asth_CompanyAndAPCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:to="loc_asth_CompanyAndAPCMember_2fbd76ce-6a6d-4599-ac8e-aeda496c3746" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AstranaMember_427e870f-0810-46bb-96f8-aecbd75c8a5b" xlink:href="asth-20231231.xsd#asth_AstranaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:to="loc_asth_AstranaMember_427e870f-0810-46bb-96f8-aecbd75c8a5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_29a21bb8-53f8-4cab-b759-6d103656a6c5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_29a21bb8-53f8-4cab-b759-6d103656a6c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_29a21bb8-53f8-4cab-b759-6d103656a6c5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_29a21bb8-53f8-4cab-b759-6d103656a6c5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_29a21bb8-53f8-4cab-b759-6d103656a6c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9b3d7392-771f-41e4-ac05-ec4a39b7477a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_29a21bb8-53f8-4cab-b759-6d103656a6c5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9b3d7392-771f-41e4-ac05-ec4a39b7477a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloMedicalHoldingsIncMember_8f8e23cc-6b73-45f3-9f65-5ab7a0b7d694" xlink:href="asth-20231231.xsd#asth_ApolloMedicalHoldingsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9b3d7392-771f-41e4-ac05-ec4a39b7477a" xlink:to="loc_asth_ApolloMedicalHoldingsIncMember_8f8e23cc-6b73-45f3-9f65-5ab7a0b7d694" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_bf46863d-e11c-40a3-a8be-6360c9c218fc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_srt_CounterpartyNameAxis_bf46863d-e11c-40a3-a8be-6360c9c218fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf46863d-e11c-40a3-a8be-6360c9c218fc_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_bf46863d-e11c-40a3-a8be-6360c9c218fc" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bf46863d-e11c-40a3-a8be-6360c9c218fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b083d745-47af-476f-b99d-ea49891f8dc2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_bf46863d-e11c-40a3-a8be-6360c9c218fc" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b083d745-47af-476f-b99d-ea49891f8dc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_APAMHMedicalCorporationMember_e6f5a234-6dee-42fa-b61f-25baf4101678" xlink:href="asth-20231231.xsd#asth_APAMHMedicalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b083d745-47af-476f-b99d-ea49891f8dc2" xlink:to="loc_asth_APAMHMedicalCorporationMember_e6f5a234-6dee-42fa-b61f-25baf4101678" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_829ea42d-d54b-4383-87d7-e4b2033d6970" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_829ea42d-d54b-4383-87d7-e4b2033d6970" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_829ea42d-d54b-4383-87d7-e4b2033d6970_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_829ea42d-d54b-4383-87d7-e4b2033d6970" xlink:to="loc_us-gaap_RelatedPartyDomain_829ea42d-d54b-4383-87d7-e4b2033d6970_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d62d0f8b-0cd7-4d0d-b3a4-8905764aa302" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_829ea42d-d54b-4383-87d7-e4b2033d6970" xlink:to="loc_us-gaap_RelatedPartyDomain_d62d0f8b-0cd7-4d0d-b3a4-8905764aa302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_6b42c4ff-7585-46b1-b525-33234000d053" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_d62d0f8b-0cd7-4d0d-b3a4-8905764aa302" xlink:to="loc_srt_AffiliatedEntityMember_6b42c4ff-7585-46b1-b525-33234000d053" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e6f05fc-5bae-40fc-bcbf-0ee6632defc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e6f05fc-5bae-40fc-bcbf-0ee6632defc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_cb4d8617-d10f-4954-9a0d-45a0d4d61bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_cb4d8617-d10f-4954-9a0d-45a0d4d61bb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b7faed57-1e0d-4f04-ab91-c8e9ceaa78a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b7faed57-1e0d-4f04-ab91-c8e9ceaa78a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d1538aeb-01fb-4ab7-baa1-000408531971" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d1538aeb-01fb-4ab7-baa1-000408531971" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_3ab2005a-24f6-421a-91d8-b2c1090819d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_3ab2005a-24f6-421a-91d8-b2c1090819d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringPeriodSharesMerger_a3f4e009-f5ef-43d5-9102-e152441dc8e1" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringPeriodSharesMerger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_asth_StockIssuedDuringPeriodSharesMerger_a3f4e009-f5ef-43d5-9102-e152441dc8e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dd806689-561b-4b2e-9b70-20bf5251ea12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dd806689-561b-4b2e-9b70-20bf5251ea12" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_3e73b8a8-55eb-43f4-b282-231e14d491db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_3e73b8a8-55eb-43f4-b282-231e14d491db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_0383189c-c059-4b06-8abc-1cdce27c1497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_TreasuryStockCommonShares_0383189c-c059-4b06-8abc-1cdce27c1497" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fd441840-488e-4e59-9c32-14b4bd118c13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fd441840-488e-4e59-9c32-14b4bd118c13" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c103caba-b785-4a42-8862-51f46ded167b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c103caba-b785-4a42-8862-51f46ded167b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_63653f47-5ff0-4c11-a6a1-79e6b2a45d21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_63653f47-5ff0-4c11-a6a1-79e6b2a45d21" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0825a581-20ea-4996-8b84-2309ac80e988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_us-gaap_PlanNameAxis_0825a581-20ea-4996-8b84-2309ac80e988" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_0825a581-20ea-4996-8b84-2309ac80e988_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_0825a581-20ea-4996-8b84-2309ac80e988" xlink:to="loc_us-gaap_PlanNameDomain_0825a581-20ea-4996-8b84-2309ac80e988_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fe4fdcbd-92f6-4812-ba3b-941dac8de94c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_0825a581-20ea-4996-8b84-2309ac80e988" xlink:to="loc_us-gaap_PlanNameDomain_fe4fdcbd-92f6-4812-ba3b-941dac8de94c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityIncentivePlanTwentyThirteenMember_697d42ae-e442-46ae-b110-18de67f1f754" xlink:href="asth-20231231.xsd#asth_EquityIncentivePlanTwentyThirteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fe4fdcbd-92f6-4812-ba3b-941dac8de94c" xlink:to="loc_asth_EquityIncentivePlanTwentyThirteenMember_697d42ae-e442-46ae-b110-18de67f1f754" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityIncentivePlanTwentyFifteenMember_fabca358-9313-4ebe-9fee-c505f046b348" xlink:href="asth-20231231.xsd#asth_EquityIncentivePlanTwentyFifteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fe4fdcbd-92f6-4812-ba3b-941dac8de94c" xlink:to="loc_asth_EquityIncentivePlanTwentyFifteenMember_fabca358-9313-4ebe-9fee-c505f046b348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_04c35536-ae1f-4902-a850-881795e6c697" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_srt_TitleOfIndividualAxis_04c35536-ae1f-4902-a850-881795e6c697" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_04c35536-ae1f-4902-a850-881795e6c697_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_04c35536-ae1f-4902-a850-881795e6c697" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_04c35536-ae1f-4902-a850-881795e6c697_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_425d8cc1-9588-4ccb-b662-28d095339eea" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_04c35536-ae1f-4902-a850-881795e6c697" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_425d8cc1-9588-4ccb-b662-28d095339eea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcStockOptionMember_a118457c-2377-4706-98cc-ddea95bb32be" xlink:href="asth-20231231.xsd#asth_ApcStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_425d8cc1-9588-4ccb-b662-28d095339eea" xlink:to="loc_asth_ApcStockOptionMember_a118457c-2377-4706-98cc-ddea95bb32be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cacdc7e5-e5c9-4a05-a900-a31f123d02b8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_srt_RangeAxis_cacdc7e5-e5c9-4a05-a900-a31f123d02b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cacdc7e5-e5c9-4a05-a900-a31f123d02b8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cacdc7e5-e5c9-4a05-a900-a31f123d02b8" xlink:to="loc_srt_RangeMember_cacdc7e5-e5c9-4a05-a900-a31f123d02b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_595be31b-5ad3-4c58-bd73-f28e57704715" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cacdc7e5-e5c9-4a05-a900-a31f123d02b8" xlink:to="loc_srt_RangeMember_595be31b-5ad3-4c58-bd73-f28e57704715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6a78e8bc-f9cd-4e4f-aaa9-4681e5843e3d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_595be31b-5ad3-4c58-bd73-f28e57704715" xlink:to="loc_srt_MinimumMember_6a78e8bc-f9cd-4e4f-aaa9-4681e5843e3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c17a5cba-721b-4cd6-b06d-b296be1aa613" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_595be31b-5ad3-4c58-bd73-f28e57704715" xlink:to="loc_srt_MaximumMember_c17a5cba-721b-4cd6-b06d-b296be1aa613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0e21d921-0293-488d-a87b-b9c9551d35f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_us-gaap_AwardTypeAxis_0e21d921-0293-488d-a87b-b9c9551d35f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e21d921-0293-488d-a87b-b9c9551d35f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0e21d921-0293-488d-a87b-b9c9551d35f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e21d921-0293-488d-a87b-b9c9551d35f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_367ac941-3b20-490b-bbe5-0778413f506e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0e21d921-0293-488d-a87b-b9c9551d35f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_367ac941-3b20-490b-bbe5-0778413f506e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ac521b82-a48d-4e49-a973-2c5cf5c0a584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_367ac941-3b20-490b-bbe5-0778413f506e" xlink:to="loc_us-gaap_RestrictedStockMember_ac521b82-a48d-4e49-a973-2c5cf5c0a584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockMember_f5761a4a-cdd2-4853-afb9-f02c0e800e26" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_367ac941-3b20-490b-bbe5-0778413f506e" xlink:to="loc_asth_PerformanceBasedRestrictedStockMember_f5761a4a-cdd2-4853-afb9-f02c0e800e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2e37ec75-17f7-4a5b-93e8-af5f570afe2e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_dei_LegalEntityAxis_2e37ec75-17f7-4a5b-93e8-af5f570afe2e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2e37ec75-17f7-4a5b-93e8-af5f570afe2e_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2e37ec75-17f7-4a5b-93e8-af5f570afe2e" xlink:to="loc_dei_EntityDomain_2e37ec75-17f7-4a5b-93e8-af5f570afe2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_958f7063-01f9-47a5-9ba0-11431971103c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2e37ec75-17f7-4a5b-93e8-af5f570afe2e" xlink:to="loc_dei_EntityDomain_958f7063-01f9-47a5-9ba0-11431971103c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_0b1d3343-903b-49a8-b903-c051802c51d2" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_958f7063-01f9-47a5-9ba0-11431971103c" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_0b1d3343-903b-49a8-b903-c051802c51d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_718fffff-fd61-4b1c-a8bd-855303fa881b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_718fffff-fd61-4b1c-a8bd-855303fa881b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_93d6e36c-b8e8-4dec-80bf-ec1b1be223f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_93d6e36c-b8e8-4dec-80bf-ec1b1be223f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1b7c857a-cc02-482e-8583-345204111119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1b7c857a-cc02-482e-8583-345204111119" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5d974e9b-0669-4b2d-ab23-c0a282a8cea0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5d974e9b-0669-4b2d-ab23-c0a282a8cea0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_465ff757-0cff-4f82-95ad-d230f19a8477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_465ff757-0cff-4f82-95ad-d230f19a8477" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6aeb7e83-88d6-4088-8dd1-93623450150f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6aeb7e83-88d6-4088-8dd1-93623450150f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f5ae97e4-fe0e-478a-9cc2-ea922f8e3e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f5ae97e4-fe0e-478a-9cc2-ea922f8e3e92" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5599f8e9-c3e1-4c26-bbe5-8d366614cdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5599f8e9-c3e1-4c26-bbe5-8d366614cdb2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a47b3ec2-591f-4957-bbe4-5ae995d7ca2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a47b3ec2-591f-4957-bbe4-5ae995d7ca2f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_05f9f9eb-fac9-4683-8ffa-3b415ae37e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_05f9f9eb-fac9-4683-8ffa-3b415ae37e0d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8caf9183-e59f-490a-8eb6-4801b192de32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8caf9183-e59f-490a-8eb6-4801b192de32" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26bf3674-e784-432c-a9f4-970927453567" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26bf3674-e784-432c-a9f4-970927453567" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_72915659-4133-4cda-90f6-9f518765ac42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_72915659-4133-4cda-90f6-9f518765ac42" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99d10166-eaaf-458a-b1cb-388e1bd76caf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99d10166-eaaf-458a-b1cb-388e1bd76caf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_4c72bc73-5893-48e9-8c88-25dc1db1ef1d" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_4c72bc73-5893-48e9-8c88-25dc1db1ef1d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2f1a7887-c6ec-4f14-aa83-d09b46ecad99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2f1a7887-c6ec-4f14-aa83-d09b46ecad99" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3a4ba14b-28e9-4ff3-9748-dd8a060a0e24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3a4ba14b-28e9-4ff3-9748-dd8a060a0e24" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_914de359-8f5a-4af3-ac1b-55b40488abed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_914de359-8f5a-4af3-ac1b-55b40488abed" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_a6de9114-cb4e-4686-b5c1-5dfb608d33ec" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_a6de9114-cb4e-4686-b5c1-5dfb608d33ec" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised_d6618f78-2cc2-47b6-b588-6c26fe1c3b55" xlink:href="asth-20231231.xsd#asth_WarrantIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised_d6618f78-2cc2-47b6-b588-6c26fe1c3b55" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_c53ca202-07e6-4028-9e31-ce13955fcefa" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_c53ca202-07e6-4028-9e31-ce13955fcefa" xlink:type="arc" order="20"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#StockBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5f768b1-d341-4376-8173-54b609e703c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_124c74e2-91dc-422a-8867-45ad907bbecb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5f768b1-d341-4376-8173-54b609e703c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_124c74e2-91dc-422a-8867-45ad907bbecb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1496c74f-82e7-4729-9deb-354607ea9261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_124c74e2-91dc-422a-8867-45ad907bbecb" xlink:to="loc_us-gaap_AwardTypeAxis_1496c74f-82e7-4729-9deb-354607ea9261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1496c74f-82e7-4729-9deb-354607ea9261_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1496c74f-82e7-4729-9deb-354607ea9261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1496c74f-82e7-4729-9deb-354607ea9261_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a75321c-b6fd-4ae3-98f9-f93c8d29cd54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1496c74f-82e7-4729-9deb-354607ea9261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a75321c-b6fd-4ae3-98f9-f93c8d29cd54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9d919de3-4110-4b1d-96a5-250921cbe627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a75321c-b6fd-4ae3-98f9-f93c8d29cd54" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9d919de3-4110-4b1d-96a5-250921cbe627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockAwardsAndUnitsMember_28f45e87-5aaa-438b-a90d-713e4c1f2eaa" xlink:href="asth-20231231.xsd#asth_StockAwardsAndUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a75321c-b6fd-4ae3-98f9-f93c8d29cd54" xlink:to="loc_asth_StockAwardsAndUnitsMember_28f45e87-5aaa-438b-a90d-713e4c1f2eaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_97d57d7f-86ff-4d66-bb3b-bb1f18e4287e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5f768b1-d341-4376-8173-54b609e703c5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_97d57d7f-86ff-4d66-bb3b-bb1f18e4287e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#StockBasedCompensationSummaryofRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b50dbb02-90b1-45c4-b011-e1256b16bb78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a11e921d-6e30-4f37-9812-8d439c758a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b50dbb02-90b1-45c4-b011-e1256b16bb78" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a11e921d-6e30-4f37-9812-8d439c758a5e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6c152b9a-e8ee-4375-a63b-6c8faa5695b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a11e921d-6e30-4f37-9812-8d439c758a5e" xlink:to="loc_us-gaap_AwardTypeAxis_6c152b9a-e8ee-4375-a63b-6c8faa5695b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c152b9a-e8ee-4375-a63b-6c8faa5695b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6c152b9a-e8ee-4375-a63b-6c8faa5695b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6c152b9a-e8ee-4375-a63b-6c8faa5695b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3514996a-d0bc-442a-9f5a-48ce52eff538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6c152b9a-e8ee-4375-a63b-6c8faa5695b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3514996a-d0bc-442a-9f5a-48ce52eff538" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_64ff5e08-a521-424f-bc29-446d384d39d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3514996a-d0bc-442a-9f5a-48ce52eff538" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_64ff5e08-a521-424f-bc29-446d384d39d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockUnitsMember_024081fc-b9ea-4bca-85b5-e34ff2b0438d" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3514996a-d0bc-442a-9f5a-48ce52eff538" xlink:to="loc_asth_PerformanceBasedRestrictedStockUnitsMember_024081fc-b9ea-4bca-85b5-e34ff2b0438d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b50dbb02-90b1-45c4-b011-e1256b16bb78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8f4799d-a4dc-489b-ade1-b72500912802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8f4799d-a4dc-489b-ade1-b72500912802" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a395c9e2-b2e0-4d45-830f-955b73ffd115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a395c9e2-b2e0-4d45-830f-955b73ffd115" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ea8ace95-0509-469c-a9b2-ce5295c8c85c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ea8ace95-0509-469c-a9b2-ce5295c8c85c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_aae62b5e-dab8-4da2-a3a4-b7d5755a0cff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_aae62b5e-dab8-4da2-a3a4-b7d5755a0cff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_88fc3124-9a30-4857-b4b0-10ca58274eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b50dbb02-90b1-45c4-b011-e1256b16bb78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1112d3c2-f215-4255-9bcc-0b59310bc4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1112d3c2-f215-4255-9bcc-0b59310bc4c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e5afb38-bc07-4915-9e59-844cd1e8ee1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e5afb38-bc07-4915-9e59-844cd1e8ee1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b4b9f850-ad10-4982-8b51-8bb2d1e887ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b4b9f850-ad10-4982-8b51-8bb2d1e887ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_39ed968b-3a75-455c-87f4-04ce3d22e8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_39ed968b-3a75-455c-87f4-04ce3d22e8c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f1738110-1d9f-412d-835d-6c6545bac306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:href="asth-20231231.xsd#asth_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:href="asth-20231231.xsd#asth_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:to="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f440453a-9e6d-4eb8-a1f0-a69d6f290a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_us-gaap_CreditFacilityAxis_f440453a-9e6d-4eb8-a1f0-a69d6f290a3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f440453a-9e6d-4eb8-a1f0-a69d6f290a3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f440453a-9e6d-4eb8-a1f0-a69d6f290a3a" xlink:to="loc_us-gaap_CreditFacilityDomain_f440453a-9e6d-4eb8-a1f0-a69d6f290a3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fbc7409e-22ae-415e-9747-8883b67b54a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f440453a-9e6d-4eb8-a1f0-a69d6f290a3a" xlink:to="loc_us-gaap_CreditFacilityDomain_fbc7409e-22ae-415e-9747-8883b67b54a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_8782798e-361e-4be5-974f-b6ec667831f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_fbc7409e-22ae-415e-9747-8883b67b54a2" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_8782798e-361e-4be5-974f-b6ec667831f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_3eaeb220-8d98-47b4-8bd1-715b99b42248" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bce4d4b4-f07e-43aa-baae-3d26f0c3961e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_us-gaap_DebtInstrumentAxis_bce4d4b4-f07e-43aa-baae-3d26f0c3961e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bce4d4b4-f07e-43aa-baae-3d26f0c3961e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bce4d4b4-f07e-43aa-baae-3d26f0c3961e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bce4d4b4-f07e-43aa-baae-3d26f0c3961e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_16830f50-a2a6-4168-a4d6-1c40dfbb9dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bce4d4b4-f07e-43aa-baae-3d26f0c3961e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_16830f50-a2a6-4168-a4d6-1c40dfbb9dcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcBusinessLoanAgreementMember_b018cf4e-de4c-4876-8155-5d8b5403baf3" xlink:href="asth-20231231.xsd#asth_ApcBusinessLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_16830f50-a2a6-4168-a4d6-1c40dfbb9dcf" xlink:to="loc_asth_ApcBusinessLoanAgreementMember_b018cf4e-de4c-4876-8155-5d8b5403baf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_8f92ee4d-d2be-42d6-9532-76ef4e81473b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_8f92ee4d-d2be-42d6-9532-76ef4e81473b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_8f92ee4d-d2be-42d6-9532-76ef4e81473b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_8f92ee4d-d2be-42d6-9532-76ef4e81473b" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_8f92ee4d-d2be-42d6-9532-76ef4e81473b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_1c9adaee-a4b3-4149-a225-2eb2abda26e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_8f92ee4d-d2be-42d6-9532-76ef4e81473b" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_1c9adaee-a4b3-4149-a225-2eb2abda26e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TruistBankMember_6e10221c-6ed7-4f9b-8e4b-f28b191b4cf5" xlink:href="asth-20231231.xsd#asth_TruistBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_1c9adaee-a4b3-4149-a225-2eb2abda26e1" xlink:to="loc_asth_TruistBankMember_6e10221c-6ed7-4f9b-8e4b-f28b191b4cf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PreferredBankMember_ed178ceb-0e92-4d02-b7c5-a2e1d41fc24c" xlink:href="asth-20231231.xsd#asth_PreferredBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_1c9adaee-a4b3-4149-a225-2eb2abda26e1" xlink:to="loc_asth_PreferredBankMember_ed178ceb-0e92-4d02-b7c5-a2e1d41fc24c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2e406b87-8a83-4f73-840a-641779c87180" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_dei_LegalEntityAxis_2e406b87-8a83-4f73-840a-641779c87180" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2e406b87-8a83-4f73-840a-641779c87180_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2e406b87-8a83-4f73-840a-641779c87180" xlink:to="loc_dei_EntityDomain_2e406b87-8a83-4f73-840a-641779c87180_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bdf74660-c3bd-4bb4-9116-22ead633b620" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2e406b87-8a83-4f73-840a-641779c87180" xlink:to="loc_dei_EntityDomain_bdf74660-c3bd-4bb4-9116-22ead633b620" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_4a4e9c0f-03ba-45e5-bfb3-8fe572437727" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bdf74660-c3bd-4bb4-9116-22ead633b620" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_4a4e9c0f-03ba-45e5-bfb3-8fe572437727" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_01157254-1247-431f-823c-2dc9b5cde325" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_srt_RangeAxis_01157254-1247-431f-823c-2dc9b5cde325" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_01157254-1247-431f-823c-2dc9b5cde325_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_01157254-1247-431f-823c-2dc9b5cde325" xlink:to="loc_srt_RangeMember_01157254-1247-431f-823c-2dc9b5cde325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8adfdca7-9cc1-469e-a48a-c48460dd68b3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_01157254-1247-431f-823c-2dc9b5cde325" xlink:to="loc_srt_RangeMember_8adfdca7-9cc1-469e-a48a-c48460dd68b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_68127f54-f467-49f2-96ca-37496ceac183" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8adfdca7-9cc1-469e-a48a-c48460dd68b3" xlink:to="loc_srt_MaximumMember_68127f54-f467-49f2-96ca-37496ceac183" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e21735b1-3515-4f52-9615-8df1b479be62" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8adfdca7-9cc1-469e-a48a-c48460dd68b3" xlink:to="loc_srt_MinimumMember_e21735b1-3515-4f52-9615-8df1b479be62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8adb0a13-858c-4ec4-9ace-d04df31f0584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8adb0a13-858c-4ec4-9ace-d04df31f0584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_f490f0bc-1ecc-4957-a553-b42fbe523202" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_f490f0bc-1ecc-4957-a553-b42fbe523202" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ClaimsBasedOnOccurrenceAnAggregateAmount_6f3cd935-57cf-4d7b-9e0c-e72c3dd3bcf4" xlink:href="asth-20231231.xsd#asth_ClaimsBasedOnOccurrenceAnAggregateAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:to="loc_asth_ClaimsBasedOnOccurrenceAnAggregateAmount_6f3cd935-57cf-4d7b-9e0c-e72c3dd3bcf4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_e785d7b9-1f3e-4c1c-8f84-68a469d30089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:to="loc_us-gaap_ProfessionalFees_e785d7b9-1f3e-4c1c-8f84-68a469d30089" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a12a46a0-9372-43d9-8e6f-83a061e4a2c6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_srt_CounterpartyNameAxis_a12a46a0-9372-43d9-8e6f-83a061e4a2c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a12a46a0-9372-43d9-8e6f-83a061e4a2c6_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a12a46a0-9372-43d9-8e6f-83a061e4a2c6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a12a46a0-9372-43d9-8e6f-83a061e4a2c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a12a46a0-9372-43d9-8e6f-83a061e4a2c6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LmaMember_0f8c04d7-a4ca-454b-b313-fd726b998700" xlink:href="asth-20231231.xsd#asth_LmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_LmaMember_0f8c04d7-a4ca-454b-b313-fd726b998700" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PmiocMember_1977be9b-2310-45b0-a6e5-04a9d08bff0e" xlink:href="asth-20231231.xsd#asth_PmiocMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_PmiocMember_1977be9b-2310-45b0-a6e5-04a9d08bff0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SongPCMember_7c196dae-4224-4e64-8a43-a06e4b9645a2" xlink:href="asth-20231231.xsd#asth_SongPCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_SongPCMember_7c196dae-4224-4e64-8a43-a06e4b9645a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ArroyoVistaMember_1235d3bb-0509-41b4-aac5-e202144bbbaa" xlink:href="asth-20231231.xsd#asth_ArroyoVistaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_ArroyoVistaMember_1235d3bb-0509-41b4-aac5-e202144bbbaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AdvanceDiagnosticSurgeryCenterMember_73e1a7e1-d815-4e8a-a285-0ed3257c1145" xlink:href="asth-20231231.xsd#asth_AdvanceDiagnosticSurgeryCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_AdvanceDiagnosticSurgeryCenterMember_73e1a7e1-d815-4e8a-a285-0ed3257c1145" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FulgentGeneticsIncMember_0dd7108a-422c-4bf4-a888-f963a1c13a32" xlink:href="asth-20231231.xsd#asth_FulgentGeneticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_FulgentGeneticsIncMember_0dd7108a-422c-4bf4-a888-f963a1c13a32" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SunnyVillageCareCenterMember_e4866f97-8a9e-4db8-b835-bb20c89cd952" xlink:href="asth-20231231.xsd#asth_SunnyVillageCareCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_SunnyVillageCareCenterMember_e4866f97-8a9e-4db8-b835-bb20c89cd952" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FirstCommonwealthPropertyLLCMember_2e9c885e-f997-4c28-a42c-2aed6e4ee9b4" xlink:href="asth-20231231.xsd#asth_FirstCommonwealthPropertyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_FirstCommonwealthPropertyLLCMember_2e9c885e-f997-4c28-a42c-2aed6e4ee9b4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4d1a9574-dbd7-4780-aa66-faba1029e4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4d1a9574-dbd7-4780-aa66-faba1029e4ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4d1a9574-dbd7-4780-aa66-faba1029e4ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4d1a9574-dbd7-4780-aa66-faba1029e4ef" xlink:to="loc_us-gaap_RelatedPartyDomain_4d1a9574-dbd7-4780-aa66-faba1029e4ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4d1a9574-dbd7-4780-aa66-faba1029e4ef" xlink:to="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_f348cbab-d7de-4449-8cce-bfd47a41190b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:to="loc_us-gaap_RelatedPartyMember_f348cbab-d7de-4449-8cce-bfd47a41190b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloMedOfficerMember_e30c8518-3683-43f5-a732-35483d61b844" xlink:href="asth-20231231.xsd#asth_ApolloMedOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:to="loc_asth_ApolloMedOfficerMember_e30c8518-3683-43f5-a732-35483d61b844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AHMCMember_cc0c410a-23b9-4f06-b3c2-57d333989f04" xlink:href="asth-20231231.xsd#asth_AHMCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:to="loc_asth_AHMCMember_cc0c410a-23b9-4f06-b3c2-57d333989f04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcShareholdersMember_c6a17abf-ea5f-4c1d-8e12-af36cd639f20" xlink:href="asth-20231231.xsd#asth_ApcShareholdersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:to="loc_asth_ApcShareholdersMember_c6a17abf-ea5f-4c1d-8e12-af36cd639f20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_398201f2-28ad-4a47-8c7b-e814bdb2f6f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_dei_LegalEntityAxis_398201f2-28ad-4a47-8c7b-e814bdb2f6f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_398201f2-28ad-4a47-8c7b-e814bdb2f6f4_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_398201f2-28ad-4a47-8c7b-e814bdb2f6f4" xlink:to="loc_dei_EntityDomain_398201f2-28ad-4a47-8c7b-e814bdb2f6f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_398201f2-28ad-4a47-8c7b-e814bdb2f6f4" xlink:to="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AHMCMember_4bb9df81-9c0c-437b-9e17-54675677fa87" xlink:href="asth-20231231.xsd#asth_AHMCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_AHMCMember_4bb9df81-9c0c-437b-9e17-54675677fa87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_88fffd4d-a916-49da-a206-bf7d813ace3b" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_88fffd4d-a916-49da-a206-bf7d813ace3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicalPropertyPartnersLLCMember_ae5f75fb-fd26-45cc-a851-84b18b449aa4" xlink:href="asth-20231231.xsd#asth_MedicalPropertyPartnersLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_MedicalPropertyPartnersLLCMember_ae5f75fb-fd26-45cc-a851-84b18b449aa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag6MedicalInvestmentGroupLLCMember_25209f7f-7e22-4031-9fe4-f072fa309f5a" xlink:href="asth-20231231.xsd#asth_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_Tag6MedicalInvestmentGroupLLCMember_25209f7f-7e22-4031-9fe4-f072fa309f5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ProfessionalMedicalCorporationMember_0f5906a4-7c57-4bff-b9ca-8608ccdf3d1e" xlink:href="asth-20231231.xsd#asth_ProfessionalMedicalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_ProfessionalMedicalCorporationMember_0f5906a4-7c57-4bff-b9ca-8608ccdf3d1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkMedicalManagementMember_beff6663-abe5-49d1-997a-3fec234d1f16" xlink:href="asth-20231231.xsd#asth_NetworkMedicalManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_NetworkMedicalManagementMember_beff6663-abe5-49d1-997a-3fec234d1f16" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AstranaMember_7848c7e6-1e28-481c-b204-ea26335e3932" xlink:href="asth-20231231.xsd#asth_AstranaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_AstranaMember_7848c7e6-1e28-481c-b204-ea26335e3932" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a71ac12f-8e04-4903-a5f8-69e9d58fb0ce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a71ac12f-8e04-4903-a5f8-69e9d58fb0ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a71ac12f-8e04-4903-a5f8-69e9d58fb0ce_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a71ac12f-8e04-4903-a5f8-69e9d58fb0ce" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a71ac12f-8e04-4903-a5f8-69e9d58fb0ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a71ac12f-8e04-4903-a5f8-69e9d58fb0ce" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LasalleMedicalAssociatesIpaMember_6de57649-d79d-47d2-bd90-fb153b2ea969" xlink:href="asth-20231231.xsd#asth_LasalleMedicalAssociatesIpaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:to="loc_asth_LasalleMedicalAssociatesIpaMember_6de57649-d79d-47d2-bd90-fb153b2ea969" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PmiocMember_fbfe3980-e667-44b8-8e89-93f4097790fa" xlink:href="asth-20231231.xsd#asth_PmiocMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:to="loc_asth_PmiocMember_fbfe3980-e667-44b8-8e89-93f4097790fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SongPCMember_060287f0-e7af-4ef0-a49a-aece49038acc" xlink:href="asth-20231231.xsd#asth_SongPCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:to="loc_asth_SongPCMember_060287f0-e7af-4ef0-a49a-aece49038acc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1e1c88a3-cd91-4334-bdae-658efc0e03f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1e1c88a3-cd91-4334-bdae-658efc0e03f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_1e1c88a3-cd91-4334-bdae-658efc0e03f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1e1c88a3-cd91-4334-bdae-658efc0e03f2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_1e1c88a3-cd91-4334-bdae-658efc0e03f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1e1c88a3-cd91-4334-bdae-658efc0e03f2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ProviderServicesMember_fbd57452-2c04-4aec-a899-2a2348ac96cc" xlink:href="asth-20231231.xsd#asth_ProviderServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_ProviderServicesMember_fbd57452-2c04-4aec-a899-2a2348ac96cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RentPaymentMember_89da39df-1cf3-4087-9830-f7adb6700d7b" xlink:href="asth-20231231.xsd#asth_RentPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_RentPaymentMember_89da39df-1cf3-4087-9830-f7adb6700d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OfficeLeaseMember_ef33f0ba-4192-4eff-a3e4-8fdddeac0437" xlink:href="asth-20231231.xsd#asth_OfficeLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_OfficeLeaseMember_ef33f0ba-4192-4eff-a3e4-8fdddeac0437" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ConsultingServicesMember_fef005bb-49c8-4640-abe5-7882f9853e64" xlink:href="asth-20231231.xsd#asth_ConsultingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_ConsultingServicesMember_fef005bb-49c8-4640-abe5-7882f9853e64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SpinOffTransactionMember_0107f1ad-ab84-4765-acbd-f3fb204a456c" xlink:href="asth-20231231.xsd#asth_SpinOffTransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_SpinOffTransactionMember_0107f1ad-ab84-4765-acbd-f3fb204a456c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CallCenterServicesMember_8f26d68b-d22d-4f92-80ec-2e3be49669fc" xlink:href="asth-20231231.xsd#asth_CallCenterServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_CallCenterServicesMember_8f26d68b-d22d-4f92-80ec-2e3be49669fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a6bcb89d-a128-496d-9d53-286c2e1ebf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_a6bcb89d-a128-496d-9d53-286c2e1ebf6d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a6bcb89d-a128-496d-9d53-286c2e1ebf6d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a6bcb89d-a128-496d-9d53-286c2e1ebf6d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a6bcb89d-a128-496d-9d53-286c2e1ebf6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d0ac82fa-6fa2-4bcc-be82-5aca83116197" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a6bcb89d-a128-496d-9d53-286c2e1ebf6d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d0ac82fa-6fa2-4bcc-be82-5aca83116197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag2PromissoryNoteMember_b27956f1-0d0c-4858-b54f-c80dd5142ef4" xlink:href="asth-20231231.xsd#asth_Tag2PromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d0ac82fa-6fa2-4bcc-be82-5aca83116197" xlink:to="loc_asth_Tag2PromissoryNoteMember_b27956f1-0d0c-4858-b54f-c80dd5142ef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9432f7ed-98cc-410e-8842-36933fa21603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9432f7ed-98cc-410e-8842-36933fa21603" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9432f7ed-98cc-410e-8842-36933fa21603_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9432f7ed-98cc-410e-8842-36933fa21603" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9432f7ed-98cc-410e-8842-36933fa21603_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_082504d1-8a9e-4b98-9ecd-6e52eb84aa19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9432f7ed-98cc-410e-8842-36933fa21603" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_082504d1-8a9e-4b98-9ecd-6e52eb84aa19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_3d1d73e6-ba7c-4034-ace2-98515185e2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_082504d1-8a9e-4b98-9ecd-6e52eb84aa19" xlink:to="loc_us-gaap_NotesReceivableMember_3d1d73e6-ba7c-4034-ace2-98515185e2ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_59847302-dbd2-4fc3-9320-cf9815052495" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_srt_TitleOfIndividualAxis_59847302-dbd2-4fc3-9320-cf9815052495" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59847302-dbd2-4fc3-9320-cf9815052495_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_59847302-dbd2-4fc3-9320-cf9815052495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_59847302-dbd2-4fc3-9320-cf9815052495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_59847302-dbd2-4fc3-9320-cf9815052495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_8c4d037d-ac09-4e3d-9e6d-3cf0818d29d2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:to="loc_srt_DirectorMember_8c4d037d-ac09-4e3d-9e6d-3cf0818d29d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_81dfe270-d91a-4676-a6d5-5ced573e87a1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:to="loc_srt_OfficerMember_81dfe270-d91a-4676-a6d5-5ced573e87a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_a9bebebc-ea6c-4584-a863-cc0b95d65568" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:to="loc_srt_ChiefExecutiveOfficerMember_a9bebebc-ea6c-4584-a863-cc0b95d65568" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_681308e3-0900-4f41-9537-97e9fcacb167" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_681308e3-0900-4f41-9537-97e9fcacb167" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d46d639-6a62-4846-b45d-5eb1487929f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d46d639-6a62-4846-b45d-5eb1487929f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_2a11699e-4f7d-4543-8ed2-eb9445d732b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_2a11699e-4f7d-4543-8ed2-eb9445d732b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7a8466df-9ef9-4e28-9ba5-23700e8c71b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7a8466df-9ef9-4e28-9ba5-23700e8c71b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_44385da3-c400-4070-8605-96bf48f01581" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_OperatingLeaseLiability_44385da3-c400-4070-8605-96bf48f01581" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5f7c0631-b742-4dd1-8de8-da4125fed9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5f7c0631-b742-4dd1-8de8-da4125fed9ec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentMadeToRelatedParty_9cdfe0b8-f097-4935-9312-e1ba7ed19fb2" xlink:href="asth-20231231.xsd#asth_PaymentMadeToRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_asth_PaymentMadeToRelatedParty_9cdfe0b8-f097-4935-9312-e1ba7ed19fb2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceServicesRevenue_1e700d41-0926-41d2-bc60-1351df4ab00e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceServicesRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_InsuranceServicesRevenue_1e700d41-0926-41d2-bc60-1351df4ab00e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilities_ce163d78-22c3-41d7-b18a-f2a8b76c554d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCreditsAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilities_ce163d78-22c3-41d7-b18a-f2a8b76c554d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_8749e2af-206d-4819-9585-9d0b0824c0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_DebtInstrumentTerm_8749e2af-206d-4819-9585-9d0b0824c0f9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2b78ceaa-bd8e-43ee-955f-55654c6a8e58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2b78ceaa-bd8e-43ee-955f-55654c6a8e58" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_41da7d13-4116-48cb-acb0-600f33def4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_TreasuryStockCommonShares_41da7d13-4116-48cb-acb0-600f33def4f5" xlink:type="arc" order="11"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_4be3f355-4426-4cde-b6a9-a4e1c87166f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7bb74992-5ad9-4e9e-86d3-950ce4a9546f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4be3f355-4426-4cde-b6a9-a4e1c87166f9" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7bb74992-5ad9-4e9e-86d3-950ce4a9546f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_cd92dd19-20ed-4a39-ad67-08d1fa60919a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7bb74992-5ad9-4e9e-86d3-950ce4a9546f" xlink:to="loc_srt_CounterpartyNameAxis_cd92dd19-20ed-4a39-ad67-08d1fa60919a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cd92dd19-20ed-4a39-ad67-08d1fa60919a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_cd92dd19-20ed-4a39-ad67-08d1fa60919a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cd92dd19-20ed-4a39-ad67-08d1fa60919a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_cd92dd19-20ed-4a39-ad67-08d1fa60919a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AHMCMember_abce3662-d4f7-46e6-95af-a5bbe9a44659" xlink:href="asth-20231231.xsd#asth_AHMCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:to="loc_asth_AHMCMember_abce3662-d4f7-46e6-95af-a5bbe9a44659" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_HSMSOMember_c0067350-78ba-4928-bac3-1574d65ecac6" xlink:href="asth-20231231.xsd#asth_HSMSOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:to="loc_asth_HSMSOMember_c0067350-78ba-4928-bac3-1574d65ecac6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AurionMember_d13068e4-18a3-4933-b639-ad301fe36196" xlink:href="asth-20231231.xsd#asth_AurionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:to="loc_asth_AurionMember_d13068e4-18a3-4933-b639-ad301fe36196" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_d79b1ded-3d21-4fb9-88a1-a7c64217f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7bb74992-5ad9-4e9e-86d3-950ce4a9546f" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_d79b1ded-3d21-4fb9-88a1-a7c64217f9a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d79b1ded-3d21-4fb9-88a1-a7c64217f9a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_d79b1ded-3d21-4fb9-88a1-a7c64217f9a4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d79b1ded-3d21-4fb9-88a1-a7c64217f9a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_d79b1ded-3d21-4fb9-88a1-a7c64217f9a4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RelatedPartyTransactionRevenueRecognizedMember_1363dc66-fa92-4127-831d-6e3ed82d36f2" xlink:href="asth-20231231.xsd#asth_RelatedPartyTransactionRevenueRecognizedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:to="loc_asth_RelatedPartyTransactionRevenueRecognizedMember_1363dc66-fa92-4127-831d-6e3ed82d36f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RelatedPartyTransactionExpensesIncurredMember_f42eaca5-d4ce-411d-a481-7b9292212ce6" xlink:href="asth-20231231.xsd#asth_RelatedPartyTransactionExpensesIncurredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:to="loc_asth_RelatedPartyTransactionExpensesIncurredMember_f42eaca5-d4ce-411d-a481-7b9292212ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RelatedPartyTransactionRevenueExpenseNetMember_622ea6f8-92ff-4d64-b468-446c438f1b67" xlink:href="asth-20231231.xsd#asth_RelatedPartyTransactionRevenueExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:to="loc_asth_RelatedPartyTransactionRevenueExpenseNetMember_622ea6f8-92ff-4d64-b468-446c438f1b67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e60e61cd-fb89-420a-bc05-b7533b254acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4be3f355-4426-4cde-b6a9-a4e1c87166f9" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e60e61cd-fb89-420a-bc05-b7533b254acb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#EarningsPerShareAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_9eba5ff6-2540-4687-999e-c1bebfb289de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_64419d91-5ae7-4e7b-8c45-90ab67db10f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_9eba5ff6-2540-4687-999e-c1bebfb289de" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_64419d91-5ae7-4e7b-8c45-90ab67db10f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a7087abf-ff7f-4d8f-9e96-731c19ccdd45" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_64419d91-5ae7-4e7b-8c45-90ab67db10f2" xlink:to="loc_dei_LegalEntityAxis_a7087abf-ff7f-4d8f-9e96-731c19ccdd45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a7087abf-ff7f-4d8f-9e96-731c19ccdd45_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a7087abf-ff7f-4d8f-9e96-731c19ccdd45" xlink:to="loc_dei_EntityDomain_a7087abf-ff7f-4d8f-9e96-731c19ccdd45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c48299b6-8082-4610-be81-91d9bb1cbc04" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a7087abf-ff7f-4d8f-9e96-731c19ccdd45" xlink:to="loc_dei_EntityDomain_c48299b6-8082-4610-be81-91d9bb1cbc04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_52271195-1673-4315-9d30-503f86c263f5" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c48299b6-8082-4610-be81-91d9bb1cbc04" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_52271195-1673-4315-9d30-503f86c263f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b4c0763-c4b4-42bf-8232-398132007de8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_64419d91-5ae7-4e7b-8c45-90ab67db10f2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b4c0763-c4b4-42bf-8232-398132007de8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b4c0763-c4b4-42bf-8232-398132007de8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b4c0763-c4b4-42bf-8232-398132007de8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b4c0763-c4b4-42bf-8232-398132007de8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a9901f5c-3da2-4471-9511-a734284d5b36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b4c0763-c4b4-42bf-8232-398132007de8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a9901f5c-3da2-4471-9511-a734284d5b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_f4ea0ff0-a73a-469f-8051-6ef6a2ac020f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a9901f5c-3da2-4471-9511-a734284d5b36" xlink:to="loc_us-gaap_RestrictedStockMember_f4ea0ff0-a73a-469f-8051-6ef6a2ac020f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_82cc19d4-b4c1-475e-94d1-ca515dac633b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a9901f5c-3da2-4471-9511-a734284d5b36" xlink:to="loc_us-gaap_PerformanceSharesMember_82cc19d4-b4c1-475e-94d1-ca515dac633b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_170b1b70-97d1-4ace-94e7-d4b347a30470" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_9eba5ff6-2540-4687-999e-c1bebfb289de" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_170b1b70-97d1-4ace-94e7-d4b347a30470" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_39258353-67d5-4eea-b5b9-57a0e0c58bda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_39258353-67d5-4eea-b5b9-57a0e0c58bda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a4ec77ad-88c6-4c89-b9af-6a03d59fa6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_39258353-67d5-4eea-b5b9-57a0e0c58bda" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a4ec77ad-88c6-4c89-b9af-6a03d59fa6b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a4ec77ad-88c6-4c89-b9af-6a03d59fa6b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a4ec77ad-88c6-4c89-b9af-6a03d59fa6b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a4ec77ad-88c6-4c89-b9af-6a03d59fa6b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cfd7f85f-6b5f-4fd4-afa8-e837db23df2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a4ec77ad-88c6-4c89-b9af-6a03d59fa6b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cfd7f85f-6b5f-4fd4-afa8-e837db23df2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e9acb43e-23db-4e24-b84a-b598a0acb42d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cfd7f85f-6b5f-4fd4-afa8-e837db23df2b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e9acb43e-23db-4e24-b84a-b598a0acb42d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_785e28f8-3c19-42b3-b86e-35e21f850147" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cfd7f85f-6b5f-4fd4-afa8-e837db23df2b" xlink:to="loc_us-gaap_RestrictedStockMember_785e28f8-3c19-42b3-b86e-35e21f850147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_667adabf-ec4a-4061-bca7-1f27ebf8f191" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_39258353-67d5-4eea-b5b9-57a0e0c58bda" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_667adabf-ec4a-4061-bca7-1f27ebf8f191" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_667adabf-ec4a-4061-bca7-1f27ebf8f191_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_667adabf-ec4a-4061-bca7-1f27ebf8f191" xlink:to="loc_us-gaap_EquityComponentDomain_667adabf-ec4a-4061-bca7-1f27ebf8f191_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_290154e5-3ced-4847-b875-ceed99570915" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_667adabf-ec4a-4061-bca7-1f27ebf8f191" xlink:to="loc_us-gaap_EquityComponentDomain_290154e5-3ced-4847-b875-ceed99570915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_34d68422-4681-42b2-b27e-6531b860f8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_290154e5-3ced-4847-b875-ceed99570915" xlink:to="loc_us-gaap_WarrantMember_34d68422-4681-42b2-b27e-6531b860f8fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02442e73-80d0-41e9-9156-2ffb58aa5576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02442e73-80d0-41e9-9156-2ffb58aa5576" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a29ea61d-8e2f-4e45-ba3d-29a6d457d41d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a29ea61d-8e2f-4e45-ba3d-29a6d457d41d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_8692c1d1-23df-42f0-a992-1c946a90d7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_8692c1d1-23df-42f0-a992-1c946a90d7f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7ac63b3d-7096-411d-b1bb-3303094b5299" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7ac63b3d-7096-411d-b1bb-3303094b5299" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_5a9a0bba-5b47-4b97-a1cb-adf94a55aded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_5a9a0bba-5b47-4b97-a1cb-adf94a55aded" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_275906cc-2967-424a-8685-767542881fce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_5a9a0bba-5b47-4b97-a1cb-adf94a55aded" xlink:to="loc_srt_ConsolidatedEntitiesAxis_275906cc-2967-424a-8685-767542881fce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_275906cc-2967-424a-8685-767542881fce_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_275906cc-2967-424a-8685-767542881fce" xlink:to="loc_srt_ConsolidatedEntitiesDomain_275906cc-2967-424a-8685-767542881fce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ced2592c-c213-4854-9a43-d9789d08dc64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_275906cc-2967-424a-8685-767542881fce" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ced2592c-c213-4854-9a43-d9789d08dc64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d4104fd4-0e86-4799-b7dc-8db80f633ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ced2592c-c213-4854-9a43-d9789d08dc64" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d4104fd4-0e86-4799-b7dc-8db80f633ab6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_8ddfbd61-c345-473b-bb52-a6b253dcdca2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ced2592c-c213-4854-9a43-d9789d08dc64" xlink:to="loc_srt_AffiliatedEntityMember_8ddfbd61-c345-473b-bb52-a6b253dcdca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba804a7d-3ce2-4a86-98cb-d3d842e669c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_5a9a0bba-5b47-4b97-a1cb-adf94a55aded" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba804a7d-3ce2-4a86-98cb-d3d842e669c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_ba804a7d-3ce2-4a86-98cb-d3d842e669c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba804a7d-3ce2-4a86-98cb-d3d842e669c7" xlink:to="loc_us-gaap_RelatedPartyDomain_ba804a7d-3ce2-4a86-98cb-d3d842e669c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_17c83c1e-8c37-449b-971d-14b0fc5d86fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba804a7d-3ce2-4a86-98cb-d3d842e669c7" xlink:to="loc_us-gaap_RelatedPartyDomain_17c83c1e-8c37-449b-971d-14b0fc5d86fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_39ce299a-3b72-4ab1-8470-5b77eec971fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_17c83c1e-8c37-449b-971d-14b0fc5d86fb" xlink:to="loc_us-gaap_NonrelatedPartyMember_39ce299a-3b72-4ab1-8470-5b77eec971fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_48c3bb48-b1cf-4605-9757-8b453666ca79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_17c83c1e-8c37-449b-971d-14b0fc5d86fb" xlink:to="loc_us-gaap_RelatedPartyMember_48c3bb48-b1cf-4605-9757-8b453666ca79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:to="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b03ed1ae-6c9b-4c56-a7a8-64b82687981d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b03ed1ae-6c9b-4c56-a7a8-64b82687981d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_a6782461-a35f-4fd2-b380-cb5000724c27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_a6782461-a35f-4fd2-b380-cb5000724c27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7007f95c-4b3a-44f0-882d-78890984170c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7007f95c-4b3a-44f0-882d-78890984170c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_f4cd9f55-f8bb-44bd-b051-58c4d474eb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_IncomeTaxesReceivable_f4cd9f55-f8bb-44bd-b051-58c4d474eb8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_bc12cd8b-04f4-406a-a484-733c00e6955e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_bc12cd8b-04f4-406a-a484-733c00e6955e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0ef7c3ee-cb33-4eef-a9ec-d5b17b02281c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0ef7c3ee-cb33-4eef-a9ec-d5b17b02281c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_f00061e5-3421-4372-8752-807d0fbbf584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_f00061e5-3421-4372-8752-807d0fbbf584" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6ca2264b-3519-4b6b-9b9a-9c1826607361" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_OtherAssetsCurrent_6ca2264b-3519-4b6b-9b9a-9c1826607361" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d0432e61-e9de-47e2-8cd1-5e3bf0a7844a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_AssetsCurrent_d0432e61-e9de-47e2-8cd1-5e3bf0a7844a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3889e366-91d8-45db-ad0c-ceb665a19958" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3889e366-91d8-45db-ad0c-ceb665a19958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1fcffb1b-f09d-4e94-a5ed-446cd7872a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1fcffb1b-f09d-4e94-a5ed-446cd7872a42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_070df296-4706-4a00-910d-39ed264283b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_Goodwill_070df296-4706-4a00-910d-39ed264283b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_666133f6-ca65-42d4-a649-8427ab85546c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_666133f6-ca65-42d4-a649-8427ab85546c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ee22fe7b-9c1c-4a0b-922c-aeb7a9a65463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_EquityMethodInvestments_ee22fe7b-9c1c-4a0b-922c-aeb7a9a65463" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_c073c358-70ce-435f-a5bf-1f6126ab6f63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_c073c358-70ce-435f-a5bf-1f6126ab6f63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_8891fa31-8b7a-45cc-ad9f-73e7525f6897" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_OtherLongTermInvestments_8891fa31-8b7a-45cc-ad9f-73e7525f6897" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_99394361-ed09-4c77-bedc-16fc64bef8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_RestrictedCash_99394361-ed09-4c77-bedc-16fc64bef8ea" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a9e47572-5147-45fc-ba77-be026542e3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a9e47572-5147-45fc-ba77-be026542e3ad" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_86deeedc-afd9-42ed-a17f-3c167132c846" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_86deeedc-afd9-42ed-a17f-3c167132c846" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_3d774e78-75de-4aff-a79a-477529c96e34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_AssetsNoncurrent_3d774e78-75de-4aff-a79a-477529c96e34" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b7782c98-f67f-4571-b5fa-dcaf7320292b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:to="loc_us-gaap_Assets_b7782c98-f67f-4571-b5fa-dcaf7320292b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1faa3b98-2753-47d6-a4a8-700778af7710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1faa3b98-2753-47d6-a4a8-700778af7710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryAccountsPayableCurrent_b2ba4f2d-c2f4-4230-b20d-4372918c9b62" xlink:href="asth-20231231.xsd#asth_FiduciaryAccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_asth_FiduciaryAccountsPayableCurrent_b2ba4f2d-c2f4-4230-b20d-4372918c9b62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_39431c22-0797-47e8-b0c6-e60c22a70e63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_39431c22-0797-47e8-b0c6-e60c22a70e63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_45f6e8dc-213c-4fb6-a4db-132246cd66eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_DividendsPayableCurrent_45f6e8dc-213c-4fb6-a4db-132246cd66eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_efa2d452-c585-412a-99cc-8b60c21c4e01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_efa2d452-c585-412a-99cc-8b60c21c4e01" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_290bc88a-f8cb-4c30-a358-7c996fd34917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_290bc88a-f8cb-4c30-a358-7c996fd34917" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ccca4376-0119-4cb8-8815-243fcd599988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_LongTermDebtCurrent_ccca4376-0119-4cb8-8815-243fcd599988" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_2a65998c-9e8c-4e86-90d4-fd25421a3b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_OtherLiabilities_2a65998c-9e8c-4e86-90d4-fd25421a3b4d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9ea17b5b-911b-48cb-a2ed-073540505130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_LiabilitiesCurrent_9ea17b5b-911b-48cb-a2ed-073540505130" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4124e523-248a-45cd-a29f-21dc7733d398" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4124e523-248a-45cd-a29f-21dc7733d398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_1608e608-6647-47af-8eaf-ed8a3772b6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_1608e608-6647-47af-8eaf-ed8a3772b6f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f04274c-8169-4e28-8c76-59036a18cdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f04274c-8169-4e28-8c76-59036a18cdd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9ddc42be-411e-4fbc-b2ca-2b3d0989084e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9ddc42be-411e-4fbc-b2ca-2b3d0989084e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9788f3bf-4263-4486-bcc0-349abd6aac60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9788f3bf-4263-4486-bcc0-349abd6aac60" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_f9f14d84-b632-4792-8a10-1494a9eb52cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_f9f14d84-b632-4792-8a10-1494a9eb52cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_90ba6365-7612-42a7-b431-0a93dec22b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_Liabilities_90ba6365-7612-42a7-b431-0a93dec22b5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_b021be55-8ac5-4c2f-bd88-cf230e338e38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_b021be55-8ac5-4c2f-bd88-cf230e338e38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_VariableInterestEntityNumberOfPhysicians_2dbd8e5d-04bc-4268-9cb2-debeec987304" xlink:href="asth-20231231.xsd#asth_VariableInterestEntityNumberOfPhysicians"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_asth_VariableInterestEntityNumberOfPhysicians_2dbd8e5d-04bc-4268-9cb2-debeec987304" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesAdditionalinformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesAdditionalinformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/LeasesAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ee2d609c-2999-44a8-bb77-83c39133afd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ee2d609c-2999-44a8-bb77-83c39133afd7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_042faf08-1810-4624-a7ab-8bbfa64b8f96" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ee2d609c-2999-44a8-bb77-83c39133afd7" xlink:to="loc_srt_RangeAxis_042faf08-1810-4624-a7ab-8bbfa64b8f96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_042faf08-1810-4624-a7ab-8bbfa64b8f96_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_042faf08-1810-4624-a7ab-8bbfa64b8f96" xlink:to="loc_srt_RangeMember_042faf08-1810-4624-a7ab-8bbfa64b8f96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c4e03b4c-2cd0-41ab-ba15-ede5127008d5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_042faf08-1810-4624-a7ab-8bbfa64b8f96" xlink:to="loc_srt_RangeMember_c4e03b4c-2cd0-41ab-ba15-ede5127008d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_334555b1-81f6-4c49-8dd1-eeef70295bdc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c4e03b4c-2cd0-41ab-ba15-ede5127008d5" xlink:to="loc_srt_MinimumMember_334555b1-81f6-4c49-8dd1-eeef70295bdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d4cca733-537d-4489-9288-99a85e39e3a0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c4e03b4c-2cd0-41ab-ba15-ede5127008d5" xlink:to="loc_srt_MaximumMember_d4cca733-537d-4489-9288-99a85e39e3a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_074cf487-e401-4937-97a9-9fa665df765a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_074cf487-e401-4937-97a9-9fa665df765a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_8b93b5dd-c23c-4921-8968-8564ea074bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_8b93b5dd-c23c-4921-8968-8564ea074bc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_14c04066-c0dd-46ea-9e64-2b4e29281d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_14c04066-c0dd-46ea-9e64-2b4e29281d92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_d1a4d497-18d4-4f13-8b28-b9fe188c2c18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_d1a4d497-18d4-4f13-8b28-b9fe188c2c18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable_5f7f98e8-2fde-4a35-a57a-a23952c11b72" xlink:href="asth-20231231.xsd#asth_LesseeOperatingLeaseTerminationPeriodIfApplicable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable_5f7f98e8-2fde-4a35-a57a-a23952c11b72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable_24f54fc1-d6e5-46cd-be91-89aa1b7ddbe1" xlink:href="asth-20231231.xsd#asth_LesseeFinanceLeaseTerminationPeriodIfApplicable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable_24f54fc1-d6e5-46cd-be91-89aa1b7ddbe1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_f21c1b4e-79cb-4185-affc-174a58b8b7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_f21c1b4e-79cb-4185-affc-174a58b8b7e4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_a1798719-74f8-4208-af8c-b2d8f1993584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_a1798719-74f8-4208-af8c-b2d8f1993584" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LesseeOperatingLeaseOptionToExtendPeriod_10c84e9c-088e-4655-a009-bc3e8a9be9f0" xlink:href="asth-20231231.xsd#asth_LesseeOperatingLeaseOptionToExtendPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_asth_LesseeOperatingLeaseOptionToExtendPeriod_10c84e9c-088e-4655-a009-bc3e8a9be9f0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCosts_11653903-0982-4c71-9381-5a3a1b8be75b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLeasingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_PaymentsForLeasingCosts_11653903-0982-4c71-9381-5a3a1b8be75b" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#SegmentsScheduleofInformationaboutourSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c33f18bb-5b73-4de0-8889-127c260575de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c33f18bb-5b73-4de0-8889-127c260575de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c33f18bb-5b73-4de0-8889-127c260575de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c33f18bb-5b73-4de0-8889-127c260575de" xlink:to="loc_us-gaap_SegmentDomain_c33f18bb-5b73-4de0-8889-127c260575de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c33f18bb-5b73-4de0-8889-127c260575de" xlink:to="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CareEnablementMember_e7b5f697-a0a8-40f5-9246-ee46e1eebfb4" xlink:href="asth-20231231.xsd#asth_CareEnablementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:to="loc_asth_CareEnablementMember_e7b5f697-a0a8-40f5-9246-ee46e1eebfb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CarePartnersMember_61464b8d-af35-4498-b0b3-10b813a8dfad" xlink:href="asth-20231231.xsd#asth_CarePartnersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:to="loc_asth_CarePartnersMember_61464b8d-af35-4498-b0b3-10b813a8dfad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CareDeliveryMember_0bb523b9-b59a-4819-b8af-f1387c0b3eb0" xlink:href="asth-20231231.xsd#asth_CareDeliveryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:to="loc_asth_CareDeliveryMember_0bb523b9-b59a-4819-b8af-f1387c0b3eb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OtherMember_f2cc9b2a-7501-4ad9-b9da-da6662b0bec1" xlink:href="asth-20231231.xsd#asth_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:to="loc_asth_OtherMember_f2cc9b2a-7501-4ad9-b9da-da6662b0bec1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_51667aa7-7e96-46f9-8af6-3fd17ab16382" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:to="loc_srt_ConsolidationItemsAxis_51667aa7-7e96-46f9-8af6-3fd17ab16382" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_51667aa7-7e96-46f9-8af6-3fd17ab16382_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_51667aa7-7e96-46f9-8af6-3fd17ab16382" xlink:to="loc_srt_ConsolidationItemsDomain_51667aa7-7e96-46f9-8af6-3fd17ab16382_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_51667aa7-7e96-46f9-8af6-3fd17ab16382" xlink:to="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6f36afdd-d379-4dbe-b663-562d961fc6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:to="loc_us-gaap_OperatingSegmentsMember_6f36afdd-d379-4dbe-b663-562d961fc6a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_6aee75db-b7f9-47f7-8ccc-bde8ee865d04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_6aee75db-b7f9-47f7-8ccc-bde8ee865d04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_21f65a1c-0937-4a39-9867-d7da9b905556" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_21f65a1c-0937-4a39-9867-d7da9b905556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_340af204-3b38-4d69-a244-2e89250da364" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:to="loc_us-gaap_SubsegmentsAxis_340af204-3b38-4d69-a244-2e89250da364" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_340af204-3b38-4d69-a244-2e89250da364_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_340af204-3b38-4d69-a244-2e89250da364" xlink:to="loc_us-gaap_SubsegmentsDomain_340af204-3b38-4d69-a244-2e89250da364_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_8a240563-87e7-4d8e-b333-c080cdb9d689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_340af204-3b38-4d69-a244-2e89250da364" xlink:to="loc_us-gaap_SubsegmentsDomain_8a240563-87e7-4d8e-b333-c080cdb9d689" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ThirdPartyMember_45083fb6-18f2-442d-aead-1d38f4ffa8f7" xlink:href="asth-20231231.xsd#asth_ThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8a240563-87e7-4d8e-b333-c080cdb9d689" xlink:to="loc_asth_ThirdPartyMember_45083fb6-18f2-442d-aead-1d38f4ffa8f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IntersegmentMember_242ee385-cdfb-4e89-83b9-1736748bea4e" xlink:href="asth-20231231.xsd#asth_IntersegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_8a240563-87e7-4d8e-b333-c080cdb9d689" xlink:to="loc_asth_IntersegmentMember_242ee385-cdfb-4e89-83b9-1736748bea4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_754fcb50-2224-41a1-a06f-554c53ef426b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_754fcb50-2224-41a1-a06f-554c53ef426b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_b0042dce-fd2a-4339-a9f0-ce72bd956242" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_b0042dce-fd2a-4339-a9f0-ce72bd956242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_8193f8bf-9e51-4b85-8e1d-cfd72399ce58" xlink:href="asth-20231231.xsd#asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_8193f8bf-9e51-4b85-8e1d-cfd72399ce58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_58fd0298-0146-4f4b-bf93-a1fd18eeceb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_us-gaap_CostsAndExpenses_58fd0298-0146-4f4b-bf93-a1fd18eeceb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1a37badc-4692-48ee-a8a6-58b3d455deed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_us-gaap_OperatingIncomeLoss_1a37badc-4692-48ee-a8a6-58b3d455deed" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7a5826e-bef5-4e9a-b090-805a5acc99cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7a5826e-bef5-4e9a-b090-805a5acc99cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7a5826e-bef5-4e9a-b090-805a5acc99cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7a5826e-bef5-4e9a-b090-805a5acc99cf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7a5826e-bef5-4e9a-b090-805a5acc99cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7a5826e-bef5-4e9a-b090-805a5acc99cf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8dcad636-76f5-46f5-8c32-48896d19d919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8dcad636-76f5-46f5-8c32-48896d19d919" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_045d71ca-de4f-4881-9146-8ccbedfb3b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_045d71ca-de4f-4881-9146-8ccbedfb3b5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3e3d4325-6595-47ed-9c9e-85032ff22d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3e3d4325-6595-47ed-9c9e-85032ff22d4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b7f1a345-b06d-4f0f-9b6e-866b88f24901" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:to="loc_dei_LegalEntityAxis_b7f1a345-b06d-4f0f-9b6e-866b88f24901" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b7f1a345-b06d-4f0f-9b6e-866b88f24901_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b7f1a345-b06d-4f0f-9b6e-866b88f24901" xlink:to="loc_dei_EntityDomain_b7f1a345-b06d-4f0f-9b6e-866b88f24901_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b7f1a345-b06d-4f0f-9b6e-866b88f24901" xlink:to="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGMember_35a899b1-0701-41c6-82d9-b385cd28541d" xlink:href="asth-20231231.xsd#asth_AAMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_AAMGMember_35a899b1-0701-41c6-82d9-b385cd28541d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_APCMGMember_f062aa28-7f03-46f3-bc87-09e9d91285ec" xlink:href="asth-20231231.xsd#asth_APCMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_APCMGMember_f062aa28-7f03-46f3-bc87-09e9d91285ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_VOMGMember_bdcea9c8-8c85-4ed9-addc-b6355ff7c539" xlink:href="asth-20231231.xsd#asth_VOMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_VOMGMember_bdcea9c8-8c85-4ed9-addc-b6355ff7c539" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DmgMember_03cfd1c2-c776-4c77-bf58-6ffcaf22c24d" xlink:href="asth-20231231.xsd#asth_DmgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_DmgMember_03cfd1c2-c776-4c77-bf58-6ffcaf22c24d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloSunLabsManagementLLCMember_2c6b36d3-58e8-48d8-a9ec-7e98850755bb" xlink:href="asth-20231231.xsd#asth_ApolloSunLabsManagementLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_ApolloSunLabsManagementLLCMember_2c6b36d3-58e8-48d8-a9ec-7e98850755bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c74f8547-843a-4173-af6b-2d026a09d49e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c74f8547-843a-4173-af6b-2d026a09d49e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c74f8547-843a-4173-af6b-2d026a09d49e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c74f8547-843a-4173-af6b-2d026a09d49e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c74f8547-843a-4173-af6b-2d026a09d49e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c74f8547-843a-4173-af6b-2d026a09d49e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_InterestRateCollarMember_2e264aee-f094-4b6e-a3ff-1cece94a574b" xlink:href="asth-20231231.xsd#asth_InterestRateCollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:to="loc_asth_InterestRateCollarMember_2e264aee-f094-4b6e-a3ff-1cece94a574b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CollarMember_8ee1684f-8e1b-4623-b08a-1bf13d0b1de1" xlink:href="asth-20231231.xsd#asth_CollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:to="loc_asth_CollarMember_8ee1684f-8e1b-4623-b08a-1bf13d0b1de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ContingentEquitySecuritiesMember_319bf30d-868f-4650-b480-bbda26c6ff9c" xlink:href="asth-20231231.xsd#asth_ContingentEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:to="loc_asth_ContingentEquitySecuritiesMember_319bf30d-868f-4650-b480-bbda26c6ff9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f00ad605-2c4c-4444-bc87-ef0caf0ac181" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:to="loc_us-gaap_InterestRateSwapMember_f00ad605-2c4c-4444-bc87-ef0caf0ac181" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_InterestRateCollarMember_20f1eeb5-f33a-492f-b0ea-b20e42896d35" xlink:href="asth-20231231.xsd#asth_InterestRateCollarMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1c822d2f-0afb-4127-b261-b21d6f5e31c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1c822d2f-0afb-4127-b261-b21d6f5e31c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c822d2f-0afb-4127-b261-b21d6f5e31c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1c822d2f-0afb-4127-b261-b21d6f5e31c3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1c822d2f-0afb-4127-b261-b21d6f5e31c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ce28c5c-ec99-40ef-9e01-e496d8048429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1c822d2f-0afb-4127-b261-b21d6f5e31c3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ce28c5c-ec99-40ef-9e01-e496d8048429" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_feebfb23-e078-428d-90d0-670d9381a11e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_feebfb23-e078-428d-90d0-670d9381a11e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34ad750a-732e-48e3-ac7f-ebb08b0c817e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34ad750a-732e-48e3-ac7f-ebb08b0c817e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_6fb4023a-f078-4c54-a637-bbc9e7dfb435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_6fb4023a-f078-4c54-a637-bbc9e7dfb435" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f1957b9e-03e9-4f37-a889-2bd933f350d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_DerivativeAssets_f1957b9e-03e9-4f37-a889-2bd933f350d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2a6679dc-1d35-440d-8862-b626d45f800c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2a6679dc-1d35-440d-8862-b626d45f800c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0439345a-b5ee-4423-953f-bd2d7e5e4422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0439345a-b5ee-4423-953f-bd2d7e5e4422" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_da025d78-e666-46b2-b08a-009ba02456ef" xlink:href="asth-20231231.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_da025d78-e666-46b2-b08a-009ba02456ef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_cfc0ba3a-730f-4618-9260-cdaa4f5947d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_DerivativeLiabilities_cfc0ba3a-730f-4618-9260-cdaa4f5947d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_0ed611f0-04f5-4209-bafa-b700b500510b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_0ed611f0-04f5-4209-bafa-b700b500510b" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5d4558a7-ba06-4522-8d74-cad39e569607" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5d4558a7-ba06-4522-8d74-cad39e569607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d4558a7-ba06-4522-8d74-cad39e569607_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5d4558a7-ba06-4522-8d74-cad39e569607" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d4558a7-ba06-4522-8d74-cad39e569607_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c4d06fa-c765-4779-a43e-7a973ae710f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5d4558a7-ba06-4522-8d74-cad39e569607" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c4d06fa-c765-4779-a43e-7a973ae710f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_d444cafd-d547-49ef-98b0-ff7e9d971e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c4d06fa-c765-4779-a43e-7a973ae710f7" xlink:to="loc_us-gaap_CertificatesOfDepositMember_d444cafd-d547-49ef-98b0-ff7e9d971e3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_222f9de0-48c1-449c-bda3-3d6f9636df39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_222f9de0-48c1-449c-bda3-3d6f9636df39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_222f9de0-48c1-449c-bda3-3d6f9636df39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_222f9de0-48c1-449c-bda3-3d6f9636df39" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_222f9de0-48c1-449c-bda3-3d6f9636df39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_222f9de0-48c1-449c-bda3-3d6f9636df39" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ContingentEquitySecuritiesMember_ec2d8fc2-5faf-4b53-bb91-76f6f223dddd" xlink:href="asth-20231231.xsd#asth_ContingentEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:to="loc_asth_ContingentEquitySecuritiesMember_ec2d8fc2-5faf-4b53-bb91-76f6f223dddd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_40cca0a2-2d44-4234-9839-ce20cdbec5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:to="loc_us-gaap_InterestRateSwapMember_40cca0a2-2d44-4234-9839-ce20cdbec5c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CollarMember_8d6bcc61-ac19-410d-8550-12c626a8956d" xlink:href="asth-20231231.xsd#asth_CollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:to="loc_asth_CollarMember_8d6bcc61-ac19-410d-8550-12c626a8956d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_95f20edb-ce07-4246-9c31-050515374e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_95f20edb-ce07-4246-9c31-050515374e9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_95f20edb-ce07-4246-9c31-050515374e9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_95f20edb-ce07-4246-9c31-050515374e9a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_95f20edb-ce07-4246-9c31-050515374e9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_95f20edb-ce07-4246-9c31-050515374e9a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_ff10b5d7-3801-4d49-a81a-f3e17fc1c51c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_ff10b5d7-3801-4d49-a81a-f3e17fc1c51c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7f87b752-584e-4563-be1c-0853e6fababb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7f87b752-584e-4563-be1c-0853e6fababb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_d88e3f66-ccf3-45a9-bdb4-787b13ab2eac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:to="loc_us-gaap_OtherLiabilitiesMember_d88e3f66-ccf3-45a9-bdb4-787b13ab2eac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1036dc1b-7037-43a7-a422-e374693950ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1036dc1b-7037-43a7-a422-e374693950ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1036dc1b-7037-43a7-a422-e374693950ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1036dc1b-7037-43a7-a422-e374693950ae" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1036dc1b-7037-43a7-a422-e374693950ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3b8846f5-1aef-46ed-af89-19133c3ba3df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1036dc1b-7037-43a7-a422-e374693950ae" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3b8846f5-1aef-46ed-af89-19133c3ba3df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_bb8a87fc-d939-45c7-a159-7d31662b3a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3b8846f5-1aef-46ed-af89-19133c3ba3df" xlink:to="loc_us-gaap_CashFlowHedgingMember_bb8a87fc-d939-45c7-a159-7d31662b3a3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_406d003f-524b-467e-be4d-259a00c64312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_HedgingDesignationAxis_406d003f-524b-467e-be4d-259a00c64312" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_406d003f-524b-467e-be4d-259a00c64312_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_406d003f-524b-467e-be4d-259a00c64312" xlink:to="loc_us-gaap_HedgingDesignationDomain_406d003f-524b-467e-be4d-259a00c64312_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0f62303f-1c0b-4ab4-913e-ed3ba3dcef0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_406d003f-524b-467e-be4d-259a00c64312" xlink:to="loc_us-gaap_HedgingDesignationDomain_0f62303f-1c0b-4ab4-913e-ed3ba3dcef0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c559cecf-8871-4be0-bcc1-d06cb63cd77c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0f62303f-1c0b-4ab4-913e-ed3ba3dcef0e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c559cecf-8871-4be0-bcc1-d06cb63cd77c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_51b0c12e-6c13-41ff-9b53-2d1c18df5e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0f62303f-1c0b-4ab4-913e-ed3ba3dcef0e" xlink:to="loc_us-gaap_NondesignatedMember_51b0c12e-6c13-41ff-9b53-2d1c18df5e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_25c626c9-ef19-4b39-b2b0-3757e8ee7420" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_25c626c9-ef19-4b39-b2b0-3757e8ee7420" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_25c626c9-ef19-4b39-b2b0-3757e8ee7420_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_25c626c9-ef19-4b39-b2b0-3757e8ee7420" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_25c626c9-ef19-4b39-b2b0-3757e8ee7420_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a76d160d-3f69-49b9-b99a-ce37a22bafe1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_25c626c9-ef19-4b39-b2b0-3757e8ee7420" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a76d160d-3f69-49b9-b99a-ce37a22bafe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DMGAndSunLabsMember_198e0342-90cc-415c-a951-5855f1b1f6ea" xlink:href="asth-20231231.xsd#asth_DMGAndSunLabsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a76d160d-3f69-49b9-b99a-ce37a22bafe1" xlink:to="loc_asth_DMGAndSunLabsMember_198e0342-90cc-415c-a951-5855f1b1f6ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DmgMember_28bbfa8b-e617-489b-82fa-51897f455baf" xlink:href="asth-20231231.xsd#asth_DmgMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a76d160d-3f69-49b9-b99a-ce37a22bafe1" xlink:to="loc_asth_DmgMember_28bbfa8b-e617-489b-82fa-51897f455baf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ee398131-8179-45bc-bd98-e332a2e1c7e9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_dei_LegalEntityAxis_ee398131-8179-45bc-bd98-e332a2e1c7e9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ee398131-8179-45bc-bd98-e332a2e1c7e9_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ee398131-8179-45bc-bd98-e332a2e1c7e9" xlink:to="loc_dei_EntityDomain_ee398131-8179-45bc-bd98-e332a2e1c7e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ee398131-8179-45bc-bd98-e332a2e1c7e9" xlink:to="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloSunLabsManagementLLCMember_26be599f-b05d-47bb-a203-34fc851bde36" xlink:href="asth-20231231.xsd#asth_ApolloSunLabsManagementLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:to="loc_asth_ApolloSunLabsManagementLLCMember_26be599f-b05d-47bb-a203-34fc851bde36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGMember_fe10ca63-e8d9-42f4-99e3-8753e7277b10" xlink:href="asth-20231231.xsd#asth_AAMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:to="loc_asth_AAMGMember_fe10ca63-e8d9-42f4-99e3-8753e7277b10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_APCMember_f986c222-e312-49f5-be2c-f715ca69e443" xlink:href="asth-20231231.xsd#asth_APCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:to="loc_asth_APCMember_f986c222-e312-49f5-be2c-f715ca69e443" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5509d25a-344b-4fb4-b9ce-8bca1c6b99ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5509d25a-344b-4fb4-b9ce-8bca1c6b99ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5509d25a-344b-4fb4-b9ce-8bca1c6b99ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5509d25a-344b-4fb4-b9ce-8bca1c6b99ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5509d25a-344b-4fb4-b9ce-8bca1c6b99ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60896993-cc07-4711-8134-b06b1bea7702" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5509d25a-344b-4fb4-b9ce-8bca1c6b99ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60896993-cc07-4711-8134-b06b1bea7702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloSunLabsManagementLLCMember_c40826b1-f496-48bf-add8-7fd420ce963f" xlink:href="asth-20231231.xsd#asth_ApolloSunLabsManagementLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60896993-cc07-4711-8134-b06b1bea7702" xlink:to="loc_asth_ApolloSunLabsManagementLLCMember_c40826b1-f496-48bf-add8-7fd420ce963f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGMember_303607d8-636d-49d1-9e68-b440c28254e9" xlink:href="asth-20231231.xsd#asth_AAMGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60896993-cc07-4711-8134-b06b1bea7702" xlink:to="loc_asth_AAMGMember_303607d8-636d-49d1-9e68-b440c28254e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_02f6d61c-d084-42e2-8248-1245acce63f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_02f6d61c-d084-42e2-8248-1245acce63f4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_02f6d61c-d084-42e2-8248-1245acce63f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_02f6d61c-d084-42e2-8248-1245acce63f4" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_02f6d61c-d084-42e2-8248-1245acce63f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e13844bd-1be9-4a8a-8525-6427aa5fa416" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_02f6d61c-d084-42e2-8248-1245acce63f4" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e13844bd-1be9-4a8a-8525-6427aa5fa416" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_A2023MetricMember_4dea0753-4b2d-4a4e-9951-5f872cdc1f3d" xlink:href="asth-20231231.xsd#asth_A2023MetricMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e13844bd-1be9-4a8a-8525-6427aa5fa416" xlink:to="loc_asth_A2023MetricMember_4dea0753-4b2d-4a4e-9951-5f872cdc1f3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_A2024MetricMember_5e0f8ec0-d78e-4ee0-b484-2ac562ea1e9c" xlink:href="asth-20231231.xsd#asth_A2024MetricMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e13844bd-1be9-4a8a-8525-6427aa5fa416" xlink:to="loc_asth_A2024MetricMember_5e0f8ec0-d78e-4ee0-b484-2ac562ea1e9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e5379e23-dcf5-44ca-84b6-7b5260263b59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e5379e23-dcf5-44ca-84b6-7b5260263b59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_21accd7c-b054-426b-a78d-265813bb68c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_DerivativeAssets_21accd7c-b054-426b-a78d-265813bb68c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_6dfed0dd-470d-4f2f-ad47-74bf8eeb9b43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_6dfed0dd-470d-4f2f-ad47-74bf8eeb9b43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_4af5be2a-951a-49dc-b134-e94db0d7b4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_4af5be2a-951a-49dc-b134-e94db0d7b4ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DerivativeCeilingInterestRate_1b0d8ea5-14d7-4a36-bb18-b35f6828f8ae" xlink:href="asth-20231231.xsd#asth_DerivativeCeilingInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_DerivativeCeilingInterestRate_1b0d8ea5-14d7-4a36-bb18-b35f6828f8ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFloorInterestRate_3068e626-2732-497d-a14d-989120a0346f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFloorInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_DerivativeFloorInterestRate_3068e626-2732-497d-a14d-989120a0346f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_9175f787-5a7f-4bcd-820b-67f674f7eaae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_9175f787-5a7f-4bcd-820b-67f674f7eaae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d39f0de1-8d37-4ece-be0f-d83f2e085947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d39f0de1-8d37-4ece-be0f-d83f2e085947" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_b365e062-0525-40bf-aa0c-3248ac64de8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_b365e062-0525-40bf-aa0c-3248ac64de8b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_bfa54933-a438-4f56-b988-9e296b5d375c" xlink:href="asth-20231231.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_bfa54933-a438-4f56-b988-9e296b5d375c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_acd910d1-9633-470e-90f1-eabd6e1b5592" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_EquityMethodInvestments_acd910d1-9633-470e-90f1-eabd6e1b5592" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_c6b250ef-0102-4f0e-ac08-1131901bf681" xlink:href="asth-20231231.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_c6b250ef-0102-4f0e-ac08-1131901bf681" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_89d48a4e-0ddf-4164-b41d-22d1c0db6c38" xlink:href="asth-20231231.xsd#asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_89d48a4e-0ddf-4164-b41d-22d1c0db6c38" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6a0beb32-50a5-481a-b530-15be6e1ebc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6a0beb32-50a5-481a-b530-15be6e1ebc3b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_42a448c5-6b94-4b64-84b6-208c9c9dbbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_CommonStockValue_42a448c5-6b94-4b64-84b6-208c9c9dbbc8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_14a9453e-1a0b-47e2-acc1-59b38da9865c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_14a9453e-1a0b-47e2-acc1-59b38da9865c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationStockContingentConsiderationLiability_2ecd5cc0-1ff0-46ad-9272-1b7778622d21" xlink:href="asth-20231231.xsd#asth_BusinessCombinationStockContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_BusinessCombinationStockContingentConsiderationLiability_2ecd5cc0-1ff0-46ad-9272-1b7778622d21" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_f62eede1-a469-4304-b37b-01ac56b6270e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_f62eede1-a469-4304-b37b-01ac56b6270e" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.apollomed.net/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bc73b423-0201-4c2f-ae7a-d6cec9cf332d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bc73b423-0201-4c2f-ae7a-d6cec9cf332d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bc73b423-0201-4c2f-ae7a-d6cec9cf332d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bc73b423-0201-4c2f-ae7a-d6cec9cf332d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bc73b423-0201-4c2f-ae7a-d6cec9cf332d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_23dba60f-807f-4274-866e-34752cbe6d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bc73b423-0201-4c2f-ae7a-d6cec9cf332d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_23dba60f-807f-4274-866e-34752cbe6d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2dc731bb-35cc-45b9-90bb-995035d1b14a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_23dba60f-807f-4274-866e-34752cbe6d40" xlink:to="loc_us-gaap_SubsequentEventMember_2dc731bb-35cc-45b9-90bb-995035d1b14a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bd167f81-d71b-4c0b-883e-794929879dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bd167f81-d71b-4c0b-883e-794929879dfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bd167f81-d71b-4c0b-883e-794929879dfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bd167f81-d71b-4c0b-883e-794929879dfe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bd167f81-d71b-4c0b-883e-794929879dfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_959b963a-599f-4f89-9be8-3e2e4181ca43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bd167f81-d71b-4c0b-883e-794929879dfe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_959b963a-599f-4f89-9be8-3e2e4181ca43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommunityFamilyCareMedicalGroupMember_896b1c3c-b411-4ed7-9741-e2c4fd9fda47" xlink:href="asth-20231231.xsd#asth_CommunityFamilyCareMedicalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_959b963a-599f-4f89-9be8-3e2e4181ca43" xlink:to="loc_asth_CommunityFamilyCareMedicalGroupMember_896b1c3c-b411-4ed7-9741-e2c4fd9fda47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AdvancedDiagnosticAndSurgicalCenterMember_7f9cd9c0-3ac2-4690-a136-87889ad578ac" xlink:href="asth-20231231.xsd#asth_AdvancedDiagnosticAndSurgicalCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_959b963a-599f-4f89-9be8-3e2e4181ca43" xlink:to="loc_asth_AdvancedDiagnosticAndSurgicalCenterMember_7f9cd9c0-3ac2-4690-a136-87889ad578ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_7765eb9e-237d-4261-8414-c796e0ea41b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:to="loc_us-gaap_VariableRateAxis_7765eb9e-237d-4261-8414-c796e0ea41b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7765eb9e-237d-4261-8414-c796e0ea41b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_7765eb9e-237d-4261-8414-c796e0ea41b7" xlink:to="loc_us-gaap_VariableRateDomain_7765eb9e-237d-4261-8414-c796e0ea41b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c5140cd8-3a7a-4a32-811f-1904f2b92fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_7765eb9e-237d-4261-8414-c796e0ea41b7" xlink:to="loc_us-gaap_VariableRateDomain_c5140cd8-3a7a-4a32-811f-1904f2b92fb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_63dbd3d0-2c09-4a7a-bc80-9b1403c70379" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c5140cd8-3a7a-4a32-811f-1904f2b92fb9" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_63dbd3d0-2c09-4a7a-bc80-9b1403c70379" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0ed98380-4c0c-411e-9ed8-a6399f006596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:to="loc_us-gaap_DebtInstrumentAxis_0ed98380-4c0c-411e-9ed8-a6399f006596" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0ed98380-4c0c-411e-9ed8-a6399f006596_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0ed98380-4c0c-411e-9ed8-a6399f006596" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0ed98380-4c0c-411e-9ed8-a6399f006596_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a694d823-a9de-4bfb-ac1c-c269dfff473d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0ed98380-4c0c-411e-9ed8-a6399f006596" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a694d823-a9de-4bfb-ac1c-c269dfff473d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TermLoanMember_ea382694-f491-4dad-ae01-8f19de1a1b18" xlink:href="asth-20231231.xsd#asth_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a694d823-a9de-4bfb-ac1c-c269dfff473d" xlink:to="loc_asth_TermLoanMember_ea382694-f491-4dad-ae01-8f19de1a1b18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RevolverLoanMember_02b22918-c985-4fa7-8395-ba7d91639a61" xlink:href="asth-20231231.xsd#asth_RevolverLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a694d823-a9de-4bfb-ac1c-c269dfff473d" xlink:to="loc_asth_RevolverLoanMember_02b22918-c985-4fa7-8395-ba7d91639a61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_4f3a18ec-9114-485e-ab2e-bf2776f4f646" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_4f3a18ec-9114-485e-ab2e-bf2776f4f646" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_37477614-7e42-4719-b818-e951718cb69a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_37477614-7e42-4719-b818-e951718cb69a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_322049f9-2cde-4c4d-a653-5ade1f3180a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_322049f9-2cde-4c4d-a653-5ade1f3180a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_9cb508d9-251c-4f3a-a714-e9eecc601253" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_9cb508d9-251c-4f3a-a714-e9eecc601253" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_53f415bf-ae07-43d9-be85-560423a7a00b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_SeniorNotes_53f415bf-ae07-43d9-be85-560423a7a00b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bc6e5a3f-0480-4317-af69-be3a5352a688" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bc6e5a3f-0480-4317-af69-be3a5352a688" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3421500a-b832-4c15-8735-a2d4eda75825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3421500a-b832-4c15-8735-a2d4eda75825" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockAwardsAndUnitsMember_84a4aa1d-0520-4e32-b337-69727bbc3f87" xlink:href="asth-20231231.xsd#asth_StockAwardsAndUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_asth_StockAwardsAndUnitsMember_84a4aa1d-0520-4e32-b337-69727bbc3f87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockUnitsMember_2b046948-73e7-4549-a26f-89c12930712d" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_asth_PerformanceBasedRestrictedStockUnitsMember_2b046948-73e7-4549-a26f-89c12930712d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockMember_03e3ca60-a536-4f5d-8601-b9574a72b382" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_asth_PerformanceBasedRestrictedStockMember_03e3ca60-a536-4f5d-8601-b9574a72b382" xlink:type="arc" order="8"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>28
<FILENAME>asth-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:04cda4cf-3e82-4310-bba4-80cea29b7bde,g:59735ae4-b6da-4fb6-9f6d-2f4a46b99a61-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_APCMGMember_e3d1cf32-f68f-4087-abe4-bd5f55521f2b_terseLabel_en-US" xlink:label="lab_asth_APCMGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APCMG</link:label>
    <link:label id="lab_asth_APCMGMember_label_en-US" xlink:label="lab_asth_APCMGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APCMG [Member]</link:label>
    <link:label id="lab_asth_APCMGMember_documentation_en-US" xlink:label="lab_asth_APCMGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APCMG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_APCMGMember" xlink:href="asth-20231231.xsd#asth_APCMGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_APCMGMember" xlink:to="lab_asth_APCMGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_1e81ec6f-0938-4e2b-9080-429d4a34f9f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_341acb9d-716d-4179-902d-adbc2cae6c43_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum loan availability</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed6bc8e8-ebf5-4912-8c61-e139f0c9beeb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of acquisition amounts:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_23003f96-c604-4c60-adcd-228d21843a4a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0e45ddaa-207e-41e6-b25a-398caf40fb36_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_d56ee8c8-929f-4ce2-b9f3-ad250d518a61_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_effa337c-a789-457f-87cc-e3a772b0271d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_9c0f9b5c-5fd6-4daa-addb-5e60375baff6_totalLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment/ Disposal</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_fde82fc7-5ba0-44cf-87b0-c4b4bf79ff4e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire business</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MedicaidMember_643c764c-03ae-4d51-a424-44596f5af3cf_terseLabel_en-US" xlink:label="lab_asth_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_asth_MedicaidMember_label_en-US" xlink:label="lab_asth_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:label id="lab_asth_MedicaidMember_documentation_en-US" xlink:label="lab_asth_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh:MedicaidMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicaidMember" xlink:href="asth-20231231.xsd#asth_MedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MedicaidMember" xlink:to="lab_asth_MedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_3114e68a-d02d-4a16-984e-9bf8b159e95a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in affiliates</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestments" xlink:to="lab_us-gaap_OtherLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_7a0645e1-9ac0-4bc8-b2ce-6355b31f24f5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease option to extend (up to)</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="lab_us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_6fe38128-9a59-4e34-abdb-5b624216e3f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RealEstateLoanOneMember_a12522ad-8520-4917-802a-d4cdfe5ce193_terseLabel_en-US" xlink:label="lab_asth_RealEstateLoanOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan One</link:label>
    <link:label id="lab_asth_RealEstateLoanOneMember_label_en-US" xlink:label="lab_asth_RealEstateLoanOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan One [Member]</link:label>
    <link:label id="lab_asth_RealEstateLoanOneMember_documentation_en-US" xlink:label="lab_asth_RealEstateLoanOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RealEstateLoanOneMember" xlink:href="asth-20231231.xsd#asth_RealEstateLoanOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RealEstateLoanOneMember" xlink:to="lab_asth_RealEstateLoanOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_cdf2a29b-3070-4b6f-b772-bd479d636c0b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_6f6c7db5-43bb-489f-b2a6-15b2a30c486b_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NetworkMedicalManagementIncMember_b267e879-cfdd-43d0-87b6-647a3d99547e_terseLabel_en-US" xlink:label="lab_asth_NetworkMedicalManagementIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network Medical Management, Inc.</link:label>
    <link:label id="lab_asth_NetworkMedicalManagementIncMember_label_en-US" xlink:label="lab_asth_NetworkMedicalManagementIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network Medical Management, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkMedicalManagementIncMember" xlink:href="asth-20231231.xsd#asth_NetworkMedicalManagementIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NetworkMedicalManagementIncMember" xlink:to="lab_asth_NetworkMedicalManagementIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3565306e-9ecd-4949-bef5-cd972d8c4663_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_ea47be81-72f4-4b5e-b288-09c50713b5d0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_44ff57dc-595b-4418-81d0-7ae6354734e3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_933626f1-c17d-4b2d-a29d-685d4434de05_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine and Stockholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CommercialMember_6baf55e7-f6ee-4dda-8e46-99d837f14b06_terseLabel_en-US" xlink:label="lab_asth_CommercialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial</link:label>
    <link:label id="lab_asth_CommercialMember_label_en-US" xlink:label="lab_asth_CommercialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial [Member]</link:label>
    <link:label id="lab_asth_CommercialMember_documentation_en-US" xlink:label="lab_asth_CommercialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh:CommercialMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommercialMember" xlink:href="asth-20231231.xsd#asth_CommercialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CommercialMember" xlink:to="lab_asth_CommercialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_177b150e-510f-44e7-b0c5-955e32decb38_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_6f727693-2001-4d93-9eac-8f4f6bff0538_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_8ede07bc-bcd2-4b1a-9f8f-069486d4a64f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubordinatedDebtMember_dcc3fdb9-2e2a-4a9a-9604-5dd7e78d69c8_terseLabel_en-US" xlink:label="lab_us-gaap_SubordinatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Debt</link:label>
    <link:label id="lab_us-gaap_SubordinatedDebtMember_label_en-US" xlink:label="lab_us-gaap_SubordinatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubordinatedDebtMember" xlink:to="lab_us-gaap_SubordinatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_1c103992-669c-4921-bc18-0d7cd66e281f_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_d264959c-b997-45d1-8049-f9a276efe7f1_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_f3b26cd0-d8fe-43b1-ade1-d823b8e30610_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CDSCMember_b083fd23-f210-454b-9997-b5c0e3b2aecd_terseLabel_en-US" xlink:label="lab_asth_CDSCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CDSC</link:label>
    <link:label id="lab_asth_CDSCMember_label_en-US" xlink:label="lab_asth_CDSCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CDSC [Member]</link:label>
    <link:label id="lab_asth_CDSCMember_documentation_en-US" xlink:label="lab_asth_CDSCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CDSC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CDSCMember" xlink:href="asth-20231231.xsd#asth_CDSCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CDSCMember" xlink:to="lab_asth_CDSCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_74e6b872-3a30-4e20-bd2f-3059cb2e555b_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_5a0db1ac-e411-46b1-a323-6fbb1baf3aab_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_641a14d1-4842-4393-a5bb-b13b595df8fe_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_0bba6d94-5c1e-4e4e-a34b-fb19573fdc35_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_65950fae-db0c-4ae5-b7bb-99e4af4ccffb_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_IncreaseDecreaseInMedicalLiabilities_f6d5d139-3367-4add-a057-1fb8baadadf8_verboseLabel_en-US" xlink:label="lab_asth_IncreaseDecreaseInMedicalLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical liabilities</link:label>
    <link:label id="lab_asth_IncreaseDecreaseInMedicalLiabilities_label_en-US" xlink:label="lab_asth_IncreaseDecreaseInMedicalLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Medical Liabilities</link:label>
    <link:label id="lab_asth_IncreaseDecreaseInMedicalLiabilities_documentation_en-US" xlink:label="lab_asth_IncreaseDecreaseInMedicalLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in the aggregate amount of medical liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IncreaseDecreaseInMedicalLiabilities" xlink:href="asth-20231231.xsd#asth_IncreaseDecreaseInMedicalLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_IncreaseDecreaseInMedicalLiabilities" xlink:to="lab_asth_IncreaseDecreaseInMedicalLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MinorityInterestPolicyPolicyTextBlock_4dd304bd-8123-4aea-8692-5fa904e926fe_terseLabel_en-US" xlink:label="lab_asth_MinorityInterestPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_asth_MinorityInterestPolicyPolicyTextBlock_label_en-US" xlink:label="lab_asth_MinorityInterestPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority Interest Policy [Policy Text Block]</link:label>
    <link:label id="lab_asth_MinorityInterestPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_asth_MinorityInterestPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority Interest Policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MinorityInterestPolicyPolicyTextBlock" xlink:href="asth-20231231.xsd#asth_MinorityInterestPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MinorityInterestPolicyPolicyTextBlock" xlink:to="lab_asth_MinorityInterestPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementServiceMember_39963ff2-bb26-4db5-b277-2a1f5604f4ec_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee income</link:label>
    <link:label id="lab_us-gaap_ManagementServiceMember_label_en-US" xlink:label="lab_us-gaap_ManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementServiceMember" xlink:to="lab_us-gaap_ManagementServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_08b69ffd-9773-456d-95a8-3ced7c48f452_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_c6c08cc9-b3fc-4259-bd9d-65c351d92880_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_ac1d95c3-b0a5-4f63-abcb-13a3b5fe1944_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_4f0e514d-511a-41ff-9c48-79d523ed60a6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options canceled, forfeited or expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_619724c8-7f4a-42c8-88cc-ef8b5bc1d8ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_0acefa6f-0afa-46d6-9ac5-040f434ce7b4_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of ordinary dividends common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_54f19456-15c6-4bce-9324-6ee21c389063_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share &#8211; diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_2ce922ee-0871-48d1-be0c-8390f507b5d6_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_63bfe60e-989a-4bfe-b6b6-ccce89e389fa_netLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_5ec47b46-92bf-425a-bc7d-7745d91f45f5_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AstranaMedicalMember_02cd2d39-172f-486e-8ddf-3e9a27329468_terseLabel_en-US" xlink:label="lab_asth_AstranaMedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Astrana Medical</link:label>
    <link:label id="lab_asth_AstranaMedicalMember_label_en-US" xlink:label="lab_asth_AstranaMedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Astrana Medical [Member]</link:label>
    <link:label id="lab_asth_AstranaMedicalMember_documentation_en-US" xlink:label="lab_asth_AstranaMedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Astrana Medical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AstranaMedicalMember" xlink:href="asth-20231231.xsd#asth_AstranaMedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AstranaMedicalMember" xlink:to="lab_asth_AstranaMedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_8838d6ae-aa55-446b-a7de-c0aa02ebd0e8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_fec95900-e8ac-47d6-b461-1889b78311d9_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_dce29192-e1fb-4ff7-a0d7-236fc7ed0555_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2f27e234-0969-4513-b75c-e279935b929a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_ce26cbcb-7c73-448a-8232-7831764b0937_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments &#8211; equity method</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b2cda897-58dc-4e6f-b756-69ec4302a30d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_02ffe26f-a9f6-4f17-ac93-b17b19fd4ed7_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_4e893347-bd4c-4203-bc04-0fedf7fb371a_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PaymentMadeToRelatedParty_04a2723f-5bc1-4d19-91f8-cf08354ff764_terseLabel_en-US" xlink:label="lab_asth_PaymentMadeToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to related party</link:label>
    <link:label id="lab_asth_PaymentMadeToRelatedParty_label_en-US" xlink:label="lab_asth_PaymentMadeToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Made To Related Party</link:label>
    <link:label id="lab_asth_PaymentMadeToRelatedParty_documentation_en-US" xlink:label="lab_asth_PaymentMadeToRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount paid to related party in relation to providing services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentMadeToRelatedParty" xlink:href="asth-20231231.xsd#asth_PaymentMadeToRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PaymentMadeToRelatedParty" xlink:to="lab_asth_PaymentMadeToRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_223b1846-16b8-4bc3-8323-a32db3595831_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_bffa9c1e-4c38-489c-8f5b-369a75a6ee20_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquityIncentivePlanTwentyThirteenMember_77cca803-7bd9-4ad9-825c-331e9a5a232b_terseLabel_en-US" xlink:label="lab_asth_EquityIncentivePlanTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Equity Incentive Plan</link:label>
    <link:label id="lab_asth_EquityIncentivePlanTwentyThirteenMember_label_en-US" xlink:label="lab_asth_EquityIncentivePlanTwentyThirteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan Twenty Thirteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityIncentivePlanTwentyThirteenMember" xlink:href="asth-20231231.xsd#asth_EquityIncentivePlanTwentyThirteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquityIncentivePlanTwentyThirteenMember" xlink:to="lab_asth_EquityIncentivePlanTwentyThirteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_eca7ee70-961f-41a0-ae7c-172558132352_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b84f4d99-d991-4576-923e-8361c62b0df2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share Computations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_c9d2fb89-68b7-4f6a-b477-a59c080aae68_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, amount of transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_45a6b754-6682-492a-a567-323201a12967_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Shares Included in the Diluted Earnings Per Share Computations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d201cf03-0dbc-4946-a3ac-7801352270da_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_6ae4899f-29d0-45ca-8bd0-ff95cf12373b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_18a3a10a-da5a-401a-aa43-21a03e183f3d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1861ead2-9847-4918-9034-6085a7f95e32_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquityIncentivePlanTwentyFifteenMember_8261d30e-ccce-47ff-8c95-90b326efb15c_terseLabel_en-US" xlink:label="lab_asth_EquityIncentivePlanTwentyFifteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan Twenty Fifteen</link:label>
    <link:label id="lab_asth_EquityIncentivePlanTwentyFifteenMember_label_en-US" xlink:label="lab_asth_EquityIncentivePlanTwentyFifteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan Twenty Fifteen [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityIncentivePlanTwentyFifteenMember" xlink:href="asth-20231231.xsd#asth_EquityIncentivePlanTwentyFifteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquityIncentivePlanTwentyFifteenMember" xlink:to="lab_asth_EquityIncentivePlanTwentyFifteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_1879ae9d-d561-461e-9a1e-99935f2fa2e8_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_TruistBankMember_351294b8-7d32-46fa-9e50-8fb4193ca1a1_terseLabel_en-US" xlink:label="lab_asth_TruistBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist Bank</link:label>
    <link:label id="lab_asth_TruistBankMember_label_en-US" xlink:label="lab_asth_TruistBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist Bank [Member]</link:label>
    <link:label id="lab_asth_TruistBankMember_documentation_en-US" xlink:label="lab_asth_TruistBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Truist Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TruistBankMember" xlink:href="asth-20231231.xsd#asth_TruistBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_TruistBankMember" xlink:to="lab_asth_TruistBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_25f921be-55d4-4c95-b9fe-7e3855608a62_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_a856813b-6aa4-433f-a101-00734a14bc09_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Land, Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_c5907340-d0fb-44a2-9873-02ea889e3f7c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_6afc934b-f03e-4fa7-87e6-0a47d0724567_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise&#160;Price&#160;Per Share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b3e6804d-9d44-4a5a-a0ec-458637f2eaa7_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_0658be61-ee0b-449e-b5f1-685c0a154851_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_97f1afea-e8c9-41d9-903c-f1aa3af0a12a_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_02296c49-f009-4b98-8290-df19618a5ea5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CancellationOfRestrictedStockAwards_c32b4352-986f-4ab9-9433-d770007a83ad_terseLabel_en-US" xlink:label="lab_asth_CancellationOfRestrictedStockAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of Restricted Stock Awards</link:label>
    <link:label id="lab_asth_CancellationOfRestrictedStockAwards_label_en-US" xlink:label="lab_asth_CancellationOfRestrictedStockAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of Restricted Stock Awards</link:label>
    <link:label id="lab_asth_CancellationOfRestrictedStockAwards_documentation_en-US" xlink:label="lab_asth_CancellationOfRestrictedStockAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of Restricted Stock Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CancellationOfRestrictedStockAwards" xlink:href="asth-20231231.xsd#asth_CancellationOfRestrictedStockAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CancellationOfRestrictedStockAwards" xlink:to="lab_asth_CancellationOfRestrictedStockAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_6f913a82-fe0f-4975-b6c3-301632e1d77e_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c8db5ef2-8bce-470a-824e-49110fe9196e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b811e1dd-87ea-4f42-9aa9-372c7927d365_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_402f14fd-a66b-4de6-ad6b-017dd283fe70_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PayorEMember_edd9da33-26d4-4b91-bbd9-2e9d872f8890_terseLabel_en-US" xlink:label="lab_asth_PayorEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payer E</link:label>
    <link:label id="lab_asth_PayorEMember_label_en-US" xlink:label="lab_asth_PayorEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor E [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorEMember" xlink:href="asth-20231231.xsd#asth_PayorEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PayorEMember" xlink:to="lab_asth_PayorEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_19fa142c-4fae-4148-a092-222788d14e7c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_14b3ffb6-ad0b-433a-90bf-01379079c63b_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_a0191e4d-4622-4024-b45a-750c6d8c5332_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet_5257136f-f648-42ff-aaa7-f4bf5bbae537_terseLabel_en-US" xlink:label="lab_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional proceeds to be received from sale of equity method investments, if circumstances met</link:label>
    <link:label id="lab_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet_label_en-US" xlink:label="lab_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Proceeds To Be Received From Sale Of Equity Method Investments, If Circumstances Met</link:label>
    <link:label id="lab_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet_documentation_en-US" xlink:label="lab_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Proceeds To Be Received From Sale Of Equity Method Investments, If Circumstances Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" xlink:href="asth-20231231.xsd#asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" xlink:to="lab_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RestructuringSpinoffTransactionPercentage_c26ae39e-8ead-4bda-91fd-c5d941c5fe6d_terseLabel_en-US" xlink:label="lab_asth_RestructuringSpinoffTransactionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spinoff transaction, ownership percentage</link:label>
    <link:label id="lab_asth_RestructuringSpinoffTransactionPercentage_label_en-US" xlink:label="lab_asth_RestructuringSpinoffTransactionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Spinoff Transaction, Percentage</link:label>
    <link:label id="lab_asth_RestructuringSpinoffTransactionPercentage_documentation_en-US" xlink:label="lab_asth_RestructuringSpinoffTransactionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Spinoff Transaction, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RestructuringSpinoffTransactionPercentage" xlink:href="asth-20231231.xsd#asth_RestructuringSpinoffTransactionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RestructuringSpinoffTransactionPercentage" xlink:to="lab_asth_RestructuringSpinoffTransactionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_d7306d2e-0931-41dc-b5e1-db560642e21b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CAIPAMSOMember_99cfe87d-1d2f-4fd3-aae1-3ee3b9a256f2_terseLabel_en-US" xlink:label="lab_asth_CAIPAMSOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAIPA MSO, LLC</link:label>
    <link:label id="lab_asth_CAIPAMSOMember_label_en-US" xlink:label="lab_asth_CAIPAMSOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAIPA MSO [Member]</link:label>
    <link:label id="lab_asth_CAIPAMSOMember_documentation_en-US" xlink:label="lab_asth_CAIPAMSOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAIPA MSO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CAIPAMSOMember" xlink:href="asth-20231231.xsd#asth_CAIPAMSOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CAIPAMSOMember" xlink:to="lab_asth_CAIPAMSOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_0c90716f-7291-449c-82fe-5aca4434e160_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_d5fb22d6-102e-4e1a-9e6e-b0ad3ac8788e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MarketableSecuritiesCurrentMaturityPeriod_4d016de3-4f23-47d8-b421-e6d7a51530d2_terseLabel_en-US" xlink:label="lab_asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, current, maturity period (greater than)</link:label>
    <link:label id="lab_asth_MarketableSecuritiesCurrentMaturityPeriod_label_en-US" xlink:label="lab_asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current, Maturity Period</link:label>
    <link:label id="lab_asth_MarketableSecuritiesCurrentMaturityPeriod_documentation_en-US" xlink:label="lab_asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current, Maturity Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:href="asth-20231231.xsd#asth_MarketableSecuritiesCurrentMaturityPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:to="lab_asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_9888418e-b886-41a8-8a10-7aa30caf7eaf_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_7182ed44-4b7f-44ba-81d4-25c67e4bb890_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PmiocMember_c974c6e4-e4e0-428a-95d1-9067606e6563_terseLabel_en-US" xlink:label="lab_asth_PmiocMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PMIOC</link:label>
    <link:label id="lab_asth_PmiocMember_label_en-US" xlink:label="lab_asth_PmiocMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PMIOC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PmiocMember" xlink:href="asth-20231231.xsd#asth_PmiocMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PmiocMember" xlink:to="lab_asth_PmiocMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_d791512e-9541-40d9-a247-2275aca01a1e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_2f75f0e3-5414-43eb-96f0-29697b2381c8_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments, Financial Statement Information</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashUninsuredAmount_eb9c7ac5-2cc1-4138-9d98-512d5439f4ee_terseLabel_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount deposit accounts exceeded FDIC insured limit</link:label>
    <link:label id="lab_us-gaap_CashUninsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Uninsured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashUninsuredAmount" xlink:to="lab_us-gaap_CashUninsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_5f99d01d-1f76-4fd8-b349-c4f8c525a205_verboseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_59969845-5064-4a35-8675-ad59362baf48_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_9803b317-05e7-4f06-82a1-f86cfce1bbb6_terseLabel_en-US" xlink:label="lab_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk pool surplus or deficits, settlement period after performance year</link:label>
    <link:label id="lab_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_label_en-US" xlink:label="lab_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Pool Surplus Or Deficits, Settlement Period After Performance Year</link:label>
    <link:label id="lab_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_documentation_en-US" xlink:label="lab_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Pool Surplus Or Deficits, Settlement Period After Performance Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:href="asth-20231231.xsd#asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:to="lab_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_bee9eda6-7e9c-4fa8-a261-2e846c634903_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock_a51f56d4-60c5-4bcf-bb39-17b05b2a273a_terseLabel_en-US" xlink:label="lab_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Property and Equipment, Net</link:label>
    <link:label id="lab_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock_label_en-US" xlink:label="lab_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant And Equipment Disclosure And Asset Acquisition [Text Block]</link:label>
    <link:label id="lab_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock_documentation_en-US" xlink:label="lab_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant And Equipment And Asset Acquisition Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock" xlink:href="asth-20231231.xsd#asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock" xlink:to="lab_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AmendedCreditAgreementMember_566a16b1-62e6-43b1-80a6-2da6006e2ba5_terseLabel_en-US" xlink:label="lab_asth_AmendedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Agreement</link:label>
    <link:label id="lab_asth_AmendedCreditAgreementMember_label_en-US" xlink:label="lab_asth_AmendedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Agreement [Member]</link:label>
    <link:label id="lab_asth_AmendedCreditAgreementMember_documentation_en-US" xlink:label="lab_asth_AmendedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AmendedCreditAgreementMember" xlink:href="asth-20231231.xsd#asth_AmendedCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AmendedCreditAgreementMember" xlink:to="lab_asth_AmendedCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ac9b9972-606e-47a4-8376-6d8bbca0ec2d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_cb8cba5d-92f9-4bc2-8ecd-4e452967d155_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1c0f5924-f702-41b9-b982-2ef19ddc868f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AlliedPacificOfCaliforniaIPAMember_e8de0486-7e6b-484c-a983-bb2c548943b1_terseLabel_en-US" xlink:label="lab_asth_AlliedPacificOfCaliforniaIPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC</link:label>
    <link:label id="lab_asth_AlliedPacificOfCaliforniaIPAMember_label_en-US" xlink:label="lab_asth_AlliedPacificOfCaliforniaIPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allied Pacific Of California IPA [Member]</link:label>
    <link:label id="lab_asth_AlliedPacificOfCaliforniaIPAMember_documentation_en-US" xlink:label="lab_asth_AlliedPacificOfCaliforniaIPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allied Pacific Of California IPA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AlliedPacificOfCaliforniaIPAMember" xlink:to="lab_asth_AlliedPacificOfCaliforniaIPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3eecbce1-a09d-44e3-bc93-c87e86eb63e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_2b9662a4-d1a4-4ccc-9846-900ce9f4f644_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_592aaaaa-a5d6-447c-ad72-be891708f040_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_b7a3c997-4d34-4d5a-8299-976fea58fb27_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b5b5a6bf-641f-4d7e-a7c4-aed40497fed9_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b035f112-8b6b-4876-8b72-5942c13d545f_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0cc6e782-2ea1-49cb-911a-3e8b6689eb43_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related-Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b2bb53bd-8e37-4ea1-8a5f-8c1e33824d87_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_bc34c6ad-541b-4c22-8214-3194af306dc3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1a3d893f-fb4f-4177-8073-6548ce356605_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_573259ac-8078-4086-8a7f-1355a856c6bf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceServicesRevenue_31234fe0-65df-4f87-9529-eb0efe4572eb_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceServicesRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk pool revenue recognized under agreement</link:label>
    <link:label id="lab_us-gaap_InsuranceServicesRevenue_label_en-US" xlink:label="lab_us-gaap_InsuranceServicesRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Services Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceServicesRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceServicesRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceServicesRevenue" xlink:to="lab_us-gaap_InsuranceServicesRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_d7e49e85-46e2-404b-9e57-8276b1fa7623_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b9db59f0-38df-43ea-8b17-2d083b07f6da_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_4bd1dea8-1761-4f82-b53c-257a27b7a222_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ApcShareholdersMember_5b92d5a1-1ce6-4a95-9a03-1af462aea829_terseLabel_en-US" xlink:label="lab_asth_ApcShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC</link:label>
    <link:label id="lab_asth_ApcShareholdersMember_label_en-US" xlink:label="lab_asth_ApcShareholdersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Shareholders [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcShareholdersMember" xlink:href="asth-20231231.xsd#asth_ApcShareholdersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ApcShareholdersMember" xlink:to="lab_asth_ApcShareholdersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fffe1744-eee4-46b2-8583-8a374bfaed66_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_19a30702-db36-44f6-8faf-29460cdc3742_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_c4c4d9cb-945f-40fe-a444-755e598eb124_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4f71df9d-ed26-49b1-877f-403dc128f3d5_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_TaxImpactFromInvestments_22df9c6c-8d5b-4903-8ccf-d52df295e992_terseLabel_en-US" xlink:label="lab_asth_TaxImpactFromInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact from investments</link:label>
    <link:label id="lab_asth_TaxImpactFromInvestments_label_en-US" xlink:label="lab_asth_TaxImpactFromInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Impact From Investments</link:label>
    <link:label id="lab_asth_TaxImpactFromInvestments_documentation_en-US" xlink:label="lab_asth_TaxImpactFromInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Impact From Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TaxImpactFromInvestments" xlink:href="asth-20231231.xsd#asth_TaxImpactFromInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_TaxImpactFromInvestments" xlink:to="lab_asth_TaxImpactFromInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_f096dab4-ac99-4cb8-8324-49ed4650ceb2_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_cfa3b3b6-0610-4521-a6a5-fd1b43107f43_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_BusinessCombinationStockContingentConsiderationLiability_aef45318-c3c1-47a5-a820-5d928d07ecec_terseLabel_en-US" xlink:label="lab_asth_BusinessCombinationStockContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, stock contingent consideration, liability</link:label>
    <link:label id="lab_asth_BusinessCombinationStockContingentConsiderationLiability_label_en-US" xlink:label="lab_asth_BusinessCombinationStockContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Stock Contingent Consideration, Liability</link:label>
    <link:label id="lab_asth_BusinessCombinationStockContingentConsiderationLiability_documentation_en-US" xlink:label="lab_asth_BusinessCombinationStockContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Stock Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationStockContingentConsiderationLiability" xlink:href="asth-20231231.xsd#asth_BusinessCombinationStockContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_BusinessCombinationStockContingentConsiderationLiability" xlink:to="lab_asth_BusinessCombinationStockContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b66011e5-79e8-4a35-9a19-53a40f5426ef_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PayorAMember_3d30648a-5dbb-4d5f-8838-e6b89d0d2e0b_terseLabel_en-US" xlink:label="lab_asth_PayorAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payer A</link:label>
    <link:label id="lab_asth_PayorAMember_label_en-US" xlink:label="lab_asth_PayorAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor A [Member]</link:label>
    <link:label id="lab_asth_PayorAMember_documentation_en-US" xlink:label="lab_asth_PayorAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorAMember" xlink:href="asth-20231231.xsd#asth_PayorAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PayorAMember" xlink:to="lab_asth_PayorAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_10bdbaa3-37f2-4f4b-9d3f-e58e19ecc03b_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_c4658dfa-ef9e-4907-9850-7895a496829c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized intangible assets:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_18c2a7d9-5c72-4aa8-bcaa-871bf1f2ad63_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_364f8fb8-6e28-4899-92ae-20ff34ac0445_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required annual facility fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_c4bae5a9-1211-4d7e-a6dd-eda28b11d107_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1c69cdf6-152c-44e6-a0af-1356fc44add0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_6212959f-efce-4c32-8d38-bed24a232a23_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_5b6b256a-5374-4791-ba24-c381f8a6654c_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_d2b93889-e3d2-4d21-bcb4-0f5a4b90de37_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_A120HellmanLLCMember_e6b61b87-24f0-4c6b-bd24-d31addbe9f2c_terseLabel_en-US" xlink:label="lab_asth_A120HellmanLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">120 Hellman LLC</link:label>
    <link:label id="lab_asth_A120HellmanLLCMember_label_en-US" xlink:label="lab_asth_A120HellmanLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">120 Hellman LLC [Member]</link:label>
    <link:label id="lab_asth_A120HellmanLLCMember_documentation_en-US" xlink:label="lab_asth_A120HellmanLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">120 Hellman LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_A120HellmanLLCMember" xlink:href="asth-20231231.xsd#asth_A120HellmanLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_A120HellmanLLCMember" xlink:to="lab_asth_A120HellmanLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_99219bc0-ee60-4415-a741-9a183ac50b50_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_db517eb5-582f-4e8a-ab36-3505f210af99_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_9dbc99c8-e233-4961-9b86-3be08adf835c_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_700f634c-78c8-4212-b90e-1b7927ab0051_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_68f78d28-79bb-48c8-9534-1a0649dd17f5_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_c0c9aa9c-da41-4fb7-9400-4c65192fee09_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fees Incurred and Revenue Earned from Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_d4003c92-8f26-4d86-bb0b-d9592315b50d_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_3d0d4497-0d20-4a1d-82ff-33ddf62f45bb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1a61768a-3736-43b6-bdee-63c214f11ca9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services, excluding depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_988a1fbb-74f4-49e2-af92-3aea61829e77_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c600e472-1429-4b0d-85d5-65da41feb32b_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_b1ebd8a5-e353-4138-be66-41f10dbe2b15_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_StockIssuedDuringPeriodSharesMerger_de782c4a-1afa-4501-a38a-bd5bcc9b9e63_terseLabel_en-US" xlink:label="lab_asth_StockIssuedDuringPeriodSharesMerger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback shares not issued to former shareholders (in shares)</link:label>
    <link:label id="lab_asth_StockIssuedDuringPeriodSharesMerger_label_en-US" xlink:label="lab_asth_StockIssuedDuringPeriodSharesMerger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Merger</link:label>
    <link:label id="lab_asth_StockIssuedDuringPeriodSharesMerger_documentation_en-US" xlink:label="lab_asth_StockIssuedDuringPeriodSharesMerger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares of stock issued during the period pursuant to merger.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringPeriodSharesMerger" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringPeriodSharesMerger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_StockIssuedDuringPeriodSharesMerger" xlink:to="lab_asth_StockIssuedDuringPeriodSharesMerger" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_44270a0f-b1ba-4669-b1fb-4c28f9226a59_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ab7f3adc-56dc-4f47-b82a-aa704f24781d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_a4e91889-1075-4fec-92b5-6cd2e0627ecc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4efa4f65-6c73-4da5-847a-5cdc886b6adc_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_243d676f-eca1-4993-9151-942d2c1f9806_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_93160e94-b37c-45b4-bfd0-6a81d9195468_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DeferredTaxAssetsLeaseLiability_9b0307ac-5e50-4998-9271-df2fa4ffc8e0_terseLabel_en-US" xlink:label="lab_asth_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_asth_DeferredTaxAssetsLeaseLiability_label_en-US" xlink:label="lab_asth_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Liability</link:label>
    <link:label id="lab_asth_DeferredTaxAssetsLeaseLiability_documentation_en-US" xlink:label="lab_asth_DeferredTaxAssetsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DeferredTaxAssetsLeaseLiability" xlink:href="asth-20231231.xsd#asth_DeferredTaxAssetsLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DeferredTaxAssetsLeaseLiability" xlink:to="lab_asth_DeferredTaxAssetsLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_060818dd-8d07-4a5f-b48b-ea1dd05fe496_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AccountsPayableAndAccruedExpensesMember_a1d53d84-5772-44c7-a21d-0a7be23ff2a0_terseLabel_en-US" xlink:label="lab_asth_AccountsPayableAndAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_asth_AccountsPayableAndAccruedExpensesMember_label_en-US" xlink:label="lab_asth_AccountsPayableAndAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable And Accrued Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AccountsPayableAndAccruedExpensesMember" xlink:href="asth-20231231.xsd#asth_AccountsPayableAndAccruedExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AccountsPayableAndAccruedExpensesMember" xlink:to="lab_asth_AccountsPayableAndAccruedExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_3d7dc673-87e0-4546-816c-20f728e4929b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, FV-NI, unrealized loss</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LesseeOperatingLeaseOptionToExtendPeriod_b190662c-7a11-4e78-98fe-5e19aea37d91_terseLabel_en-US" xlink:label="lab_asth_LesseeOperatingLeaseOptionToExtendPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend, period</link:label>
    <link:label id="lab_asth_LesseeOperatingLeaseOptionToExtendPeriod_label_en-US" xlink:label="lab_asth_LesseeOperatingLeaseOptionToExtendPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option To Extend, Period</link:label>
    <link:label id="lab_asth_LesseeOperatingLeaseOptionToExtendPeriod_documentation_en-US" xlink:label="lab_asth_LesseeOperatingLeaseOptionToExtendPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option To Extend, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LesseeOperatingLeaseOptionToExtendPeriod" xlink:href="asth-20231231.xsd#asth_LesseeOperatingLeaseOptionToExtendPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LesseeOperatingLeaseOptionToExtendPeriod" xlink:to="lab_asth_LesseeOperatingLeaseOptionToExtendPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_4ca411f2-c2ae-4628-84ce-35c276a7ec7a_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tradename/trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_fcb0c264-e700-49c9-b9cb-e9ac95785b94_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Credit Facility</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PayerDMember_ba0cea64-c5c9-4d00-9f57-302e5c81473a_terseLabel_en-US" xlink:label="lab_asth_PayerDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payer D</link:label>
    <link:label id="lab_asth_PayerDMember_label_en-US" xlink:label="lab_asth_PayerDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payer D [Member]</link:label>
    <link:label id="lab_asth_PayerDMember_documentation_en-US" xlink:label="lab_asth_PayerDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payer D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayerDMember" xlink:href="asth-20231231.xsd#asth_PayerDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PayerDMember" xlink:to="lab_asth_PayerDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_62a9901c-af0e-484b-a7ad-c53cfc3b673c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_ceb5400e-1a06-4bca-99d7-f8399956762d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_d3bd3c50-87b4-48b7-8dff-bf2ad873112c_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_a1be43dd-4dba-45b2-8fd2-567493627c3e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_09383a46-6310-4926-a631-1968fd12a052_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsAmortizationPeriodMember_ebe0027f-a83a-461f-b91c-70d85495b530_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsAmortizationPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsAmortizationPeriodMember_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsAmortizationPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Amortization Period [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsAmortizationPeriodMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsAmortizationPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsAmortizationPeriodMember" xlink:to="lab_us-gaap_IntangibleAssetsAmortizationPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_569bec20-25a6-4dc6-bd5a-f085dc90c14b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent_ecf41383-35da-41fa-b078-4db2fcfae900_terseLabel_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NOL adjustment</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent_label_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Adjustment, Percent</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent_documentation_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Net Operating Loss Adjustment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" xlink:to="lab_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_9e35ad4d-75e0-4a07-bd32-da5c6b5e10a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_4f17b530-689c-4c6e-85d0-e8f0e94ad431_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Asset Acquisitions, and Goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_ea5ee71c-bc3f-4ded-a3b5-623350a38467_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_39163daf-0ef0-482f-b6a7-5e5e3e1388ed_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of warrant, number of securities called by each warrant (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_abd2d3be-e7df-4621-a802-c89d24f3cc57_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_69264f4e-66b6-4b2a-a2b5-dd460aef05d7_periodStartLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3798b8e3-c47f-4086-8878-d364bf95ccfe_periodEndLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_ee2b7aa2-0260-48d2-9ef9-e96270df8549_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="lab_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised_8c163921-d694-4b00-aea1-13911a525d89_terseLabel_en-US" xlink:label="lab_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant issued during period value stock options exercised</link:label>
    <link:label id="lab_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Issued During Period Value Stock Options Exercised</link:label>
    <link:label id="lab_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised_documentation_en-US" xlink:label="lab_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Issued During Period Value Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:href="asth-20231231.xsd#asth_WarrantIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_57921b3c-62fd-4e84-bf24-1b4009e681ca_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_fdaf0276-a6ba-40ed-9a7c-5de6c98078c6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ab0133f1-c3cf-4975-87eb-01f517c16d95_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_07300cec-81b5-4b94-adaa-526e26caaae3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_FulgentGeneticsIncMember_b9e8dd0d-0d11-4e4b-a070-109c5012beb8_terseLabel_en-US" xlink:label="lab_asth_FulgentGeneticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fulgent Genetics, Inc.</link:label>
    <link:label id="lab_asth_FulgentGeneticsIncMember_label_en-US" xlink:label="lab_asth_FulgentGeneticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fulgent Genetics, Inc. [Member]</link:label>
    <link:label id="lab_asth_FulgentGeneticsIncMember_documentation_en-US" xlink:label="lab_asth_FulgentGeneticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fulgent Genetics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FulgentGeneticsIncMember" xlink:href="asth-20231231.xsd#asth_FulgentGeneticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_FulgentGeneticsIncMember" xlink:to="lab_asth_FulgentGeneticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment_5fc3a007-f067-4e08-9ff7-f054a6fde8a6_terseLabel_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Duration of investment</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment_label_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Duration Of Investment</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment_documentation_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Duration Of Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment" xlink:to="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f590ff35-8bda-4e59-b50c-758bf50aacd5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_OtherThirdPartiesMember_0e72cc3d-ffc0-4373-a6c3-bd420473ce69_terseLabel_en-US" xlink:label="lab_asth_OtherThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other third parties</link:label>
    <link:label id="lab_asth_OtherThirdPartiesMember_label_en-US" xlink:label="lab_asth_OtherThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Third Parties [Member]</link:label>
    <link:label id="lab_asth_OtherThirdPartiesMember_documentation_en-US" xlink:label="lab_asth_OtherThirdPartiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh:OtherThirdPartiesMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OtherThirdPartiesMember" xlink:href="asth-20231231.xsd#asth_OtherThirdPartiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_OtherThirdPartiesMember" xlink:to="lab_asth_OtherThirdPartiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_ba2b91bf-b29e-4fcd-bcbc-9210433df790_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_611f3585-1de1-4b6b-bfa7-f8ddf55760e9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the collar</link:label>
    <link:label id="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedge Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:to="lab_us-gaap_FairValueHedgeLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_3856bb62-af42-4f2a-b48f-c5d4c4abe697_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RentPaymentMember_15c6de8d-980e-4608-8d38-ee2f18fefe52_terseLabel_en-US" xlink:label="lab_asth_RentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Payment</link:label>
    <link:label id="lab_asth_RentPaymentMember_label_en-US" xlink:label="lab_asth_RentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Payment [Member]</link:label>
    <link:label id="lab_asth_RentPaymentMember_documentation_en-US" xlink:label="lab_asth_RentPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RentPaymentMember" xlink:href="asth-20231231.xsd#asth_RentPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RentPaymentMember" xlink:to="lab_asth_RentPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_66d997e2-3b71-4bd8-be9f-88f8e8bbc0ef_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_APAMHMedicalCorporationMember_b9360979-9dff-40eb-8cb1-a7dd9d2cfe6b_terseLabel_en-US" xlink:label="lab_asth_APAMHMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AP-AMH</link:label>
    <link:label id="lab_asth_APAMHMedicalCorporationMember_label_en-US" xlink:label="lab_asth_APAMHMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AP-AMH Medical Corporation [Member]</link:label>
    <link:label id="lab_asth_APAMHMedicalCorporationMember_documentation_en-US" xlink:label="lab_asth_APAMHMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AP-AMH Medical Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_APAMHMedicalCorporationMember" xlink:href="asth-20231231.xsd#asth_APAMHMedicalCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_APAMHMedicalCorporationMember" xlink:to="lab_asth_APAMHMedicalCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_a4e86ae6-87ba-4ea4-b038-a7932aec6a67_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_58475649-d4eb-42cc-90b2-1448ce3f13d6_verboseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Other Entities - Equity Method and Investments in Privately Held Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_4266e2be-aef5-4bfa-a2c2-0db4642e5040_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_f01dd8af-4bce-4506-bda5-43235aa4781b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_4b5ae960-cc6b-4b34-91e7-bc9496009228_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLeasingCosts_ca038a0d-ec7d-489c-a374-865d4c5195da_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLeasingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease agreement</link:label>
    <link:label id="lab_us-gaap_PaymentsForLeasingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsForLeasingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Leasing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLeasingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLeasingCosts" xlink:to="lab_us-gaap_PaymentsForLeasingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_e3d5b660-55a9-49f2-8cf6-7463d7f8dbbe_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf427e1c-1702-4942-8c8d-5ea463f32ec4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_853bb131-506c-4e60-9f20-2ef5882be511_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_07fa74e9-3212-4860-85da-8eea7cd12f95_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet_45f8f05c-b108-495e-ad1f-f125e3e068c0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution of real estate investments</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Real Estate Partnership Investment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet" xlink:to="lab_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4fd77d29-f60b-40a4-b6b5-db84a03cb605_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_51470e10-4fe0-4ceb-bc6b-b3942457af57_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other accruals</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_VariableInterestEntityNumberOfPhysicians_f87089c4-6937-45fd-b1c9-8c8a6a729b19_terseLabel_en-US" xlink:label="lab_asth_VariableInterestEntityNumberOfPhysicians" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of physicians</link:label>
    <link:label id="lab_asth_VariableInterestEntityNumberOfPhysicians_label_en-US" xlink:label="lab_asth_VariableInterestEntityNumberOfPhysicians" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Number Of Physicians</link:label>
    <link:label id="lab_asth_VariableInterestEntityNumberOfPhysicians_documentation_en-US" xlink:label="lab_asth_VariableInterestEntityNumberOfPhysicians" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Number Of Physicians</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_VariableInterestEntityNumberOfPhysicians" xlink:href="asth-20231231.xsd#asth_VariableInterestEntityNumberOfPhysicians"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_VariableInterestEntityNumberOfPhysicians" xlink:to="lab_asth_VariableInterestEntityNumberOfPhysicians" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e7347e61-700b-4dd0-bbf1-37630e419896_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Deferred Tax Assets (Liabilities)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_404b0d76-5f25-43bd-b674-abb71eeb6556_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_6a396700-4659-4c30-be05-9f94d9a411ba_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities_d6a41054-09ac-47bd-9807-6cb03a274873_verboseLabel_en-US" xlink:label="lab_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed asset obtained in exchange for finance lease liabilities</link:label>
    <link:label id="lab_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities_label_en-US" xlink:label="lab_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Asset Obtained in Exchange for Finance Lease Liabilities</link:label>
    <link:label id="lab_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities_documentation_en-US" xlink:label="lab_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Asset Obtained in Exchange for Finance Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" xlink:href="asth-20231231.xsd#asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" xlink:to="lab_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_17c01325-d4ae-4936-93ae-3f03a706f743_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State taxes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, State Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:to="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_80e9adb2-f813-4848-81b1-7febd4df90d9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_5d76af0c-4846-4418-969c-5cbb84e0ffc5_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_3acb29b5-5330-4100-a697-04fda95e007c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_89c22764-d1d9-4029-ac4d-517fd3698ddc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CommitmentsAndContingenciesTable_4a4fff00-34fc-4962-bd25-5ade46c35ef7_terseLabel_en-US" xlink:label="lab_asth_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_asth_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_asth_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommitmentsAndContingenciesTable" xlink:href="asth-20231231.xsd#asth_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CommitmentsAndContingenciesTable" xlink:to="lab_asth_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PerMemberPerMonthManagedCareContractMember_b7be2e58-0fa7-4999-9a0b-5097df5b28c2_terseLabel_en-US" xlink:label="lab_asth_PerMemberPerMonthManagedCareContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PMPM</link:label>
    <link:label id="lab_asth_PerMemberPerMonthManagedCareContractMember_label_en-US" xlink:label="lab_asth_PerMemberPerMonthManagedCareContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per-Member-Per-Month Managed Care Contract [Member]</link:label>
    <link:label id="lab_asth_PerMemberPerMonthManagedCareContractMember_documentation_en-US" xlink:label="lab_asth_PerMemberPerMonthManagedCareContractMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per-Member-Per-Month Managed Care Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerMemberPerMonthManagedCareContractMember" xlink:href="asth-20231231.xsd#asth_PerMemberPerMonthManagedCareContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PerMemberPerMonthManagedCareContractMember" xlink:to="lab_asth_PerMemberPerMonthManagedCareContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_ed0cee4d-7df6-49e0-9590-a688e7c53fca_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromOtherOperatingActivities_7988852d-352d-4e00-b6d5-f76451fd8d6f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromOtherOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromOtherOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Other Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromOtherOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromOtherOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromOtherOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_69086efa-c861-4b0e-b76d-185c7798df53_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_6bf53618-e046-4e66-8e09-c127b8454f25_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_2b59a459-3226-4b4c-a2fc-743af3c94a12_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_ab4586ac-5b27-415c-80ae-0cb7d715c125_terseLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_e7889e86-8d30-4839-b0b5-87f6858f9230_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_299a9e4b-72c6-4b41-9f07-f964543d4ec8_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at ending (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_fe3eaedb-2dbc-45bf-a6c1-665a546b5af6_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_a8b42d32-7275-455f-8bf3-02e1b86f99a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d4e55b3d-0f67-4540-8c3b-c2ba6caecdc8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_1c809cb8-bd3e-4819-9bba-679801270f2a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_c446ba6d-1ae1-4218-b113-1209b0cbf168_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears_2a886a7c-593f-45ee-a948-7c886b57d5dd_terseLabel_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of voting common stock, within five years</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears_label_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Proportion of Ownership Interest in Voting Common Stock, Within Five Years</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears_documentation_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Proportion of Ownership Interest in Voting Common Stock, Within Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears" xlink:to="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_65f465e8-808b-473f-a6b3-5f4e50b6150e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_3d94655d-b492-4095-b11c-05b84db72529_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities &#8211; equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_52207d8c-8620-42a7-b932-e16b6c0dcb0c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_5757dfb6-e22e-473e-9993-544f32fee9d7_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional coverage</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_f67411ce-557d-4b1c-882f-e159965038d2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NetworkRelationshipsMember_b618f569-d659-49f4-b2b1-5863022675a0_verboseLabel_en-US" xlink:label="lab_asth_NetworkRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network relationships</link:label>
    <link:label id="lab_asth_NetworkRelationshipsMember_label_en-US" xlink:label="lab_asth_NetworkRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network Relationships [Member]</link:label>
    <link:label id="lab_asth_NetworkRelationshipsMember_documentation_en-US" xlink:label="lab_asth_NetworkRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkRelationshipsMember" xlink:href="asth-20231231.xsd#asth_NetworkRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NetworkRelationshipsMember" xlink:to="lab_asth_NetworkRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MedicalPropertyPartnersLLCMember_5cbf9b8d-5540-4523-8385-3df12ee23333_terseLabel_en-US" xlink:label="lab_asth_MedicalPropertyPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MPP</link:label>
    <link:label id="lab_asth_MedicalPropertyPartnersLLCMember_label_en-US" xlink:label="lab_asth_MedicalPropertyPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Property Partners LLC [Member]</link:label>
    <link:label id="lab_asth_MedicalPropertyPartnersLLCMember_documentation_en-US" xlink:label="lab_asth_MedicalPropertyPartnersLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Property Partners LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicalPropertyPartnersLLCMember" xlink:href="asth-20231231.xsd#asth_MedicalPropertyPartnersLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MedicalPropertyPartnersLLCMember" xlink:to="lab_asth_MedicalPropertyPartnersLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_ec4267d6-8b28-4720-bf74-3bdc857800f7_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_db4842b9-5dd1-4e3e-aecc-ee618ba58a78_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_e74132e8-03e1-4803-b48a-80f71711072c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Commitments of Credit Facility</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_e514bdc5-48ee-4634-8d61-26db04c579c3_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_bc346826-7fa5-460b-a7b6-53acf4b36aad_verboseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_a2b6b2c8-7220-46d7-876f-0ca50319bfa8_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_5b8e448d-1eef-4e65-ad57-59089b3d5a14_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_1fced093-9250-4926-9b05-1eb307ef13b0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entities</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_25e377c5-a6e6-44f9-86b1-8f098bc232a5_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_4b36059c-334a-446c-b343-1d1c582ed829_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_aca4fa27-28dc-4f12-965b-1e85e1a88f45_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CarePartnersMember_71e8fa91-164e-43b1-99e8-dcb19813f109_terseLabel_en-US" xlink:label="lab_asth_CarePartnersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Partners</link:label>
    <link:label id="lab_asth_CarePartnersMember_label_en-US" xlink:label="lab_asth_CarePartnersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Partners [Member]</link:label>
    <link:label id="lab_asth_CarePartnersMember_documentation_en-US" xlink:label="lab_asth_CarePartnersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Partners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CarePartnersMember" xlink:href="asth-20231231.xsd#asth_CarePartnersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CarePartnersMember" xlink:to="lab_asth_CarePartnersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_GainLossOnEquityReceivable_259e513c-e436-4ff5-928c-9af068c73676_negatedTerseLabel_en-US" xlink:label="lab_asth_GainLossOnEquityReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on contingent equity securities</link:label>
    <link:label id="lab_asth_GainLossOnEquityReceivable_label_en-US" xlink:label="lab_asth_GainLossOnEquityReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Equity Receivable</link:label>
    <link:label id="lab_asth_GainLossOnEquityReceivable_documentation_en-US" xlink:label="lab_asth_GainLossOnEquityReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Equity Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_GainLossOnEquityReceivable" xlink:href="asth-20231231.xsd#asth_GainLossOnEquityReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_GainLossOnEquityReceivable" xlink:to="lab_asth_GainLossOnEquityReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_1eb43abe-6996-4f53-9288-75a8270e341f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_c95b933f-153b-4d34-94b8-eb6a4ab78884_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ApolloSunLabsManagementLLCMember_6d35e1a8-46ce-46c4-8cab-e6ef8ebd04d8_terseLabel_en-US" xlink:label="lab_asth_ApolloSunLabsManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo-Sun Labs Management, LLC</link:label>
    <link:label id="lab_asth_ApolloSunLabsManagementLLCMember_label_en-US" xlink:label="lab_asth_ApolloSunLabsManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo-Sun Labs Management, LLC [Member]</link:label>
    <link:label id="lab_asth_ApolloSunLabsManagementLLCMember_documentation_en-US" xlink:label="lab_asth_ApolloSunLabsManagementLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo-Sun Labs Management, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloSunLabsManagementLLCMember" xlink:href="asth-20231231.xsd#asth_ApolloSunLabsManagementLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ApolloSunLabsManagementLLCMember" xlink:to="lab_asth_ApolloSunLabsManagementLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_c5f91f93-ae7e-4204-9a00-f16193b3a97e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_aad0274b-4a11-455f-92c0-79b25ce1e8cc_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_0fbe19e2-3fa3-4e7b-9c9d-09f297c27aae_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_6cb1c62c-c0c8-4654-b2d2-00c3828038f7_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_6ccb26c2-ac14-4f9a-a994-00f6571f09a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments &#8211;privately held</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Acquisition, Trading Security, Held-for-Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:to="lab_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_9f11527c-e151-4647-836e-c0a71e9fc8b3_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_071020cf-26f0-48ea-876a-c711684250ff_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SongPCMember_202bd9f7-9a6b-42b5-a4e2-d904eea56b51_terseLabel_en-US" xlink:label="lab_asth_SongPCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Song PC</link:label>
    <link:label id="lab_asth_SongPCMember_label_en-US" xlink:label="lab_asth_SongPCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Song PC [Member]</link:label>
    <link:label id="lab_asth_SongPCMember_documentation_en-US" xlink:label="lab_asth_SongPCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Song PC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SongPCMember" xlink:href="asth-20231231.xsd#asth_SongPCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SongPCMember" xlink:to="lab_asth_SongPCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments_ecd784fa-64bc-481a-ad24-6361c1fa4b9e_terseLabel_en-US" xlink:label="lab_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to purchase membership interests</link:label>
    <link:label id="lab_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments_label_en-US" xlink:label="lab_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Equity Securities Without Readily Determinable Fair Value Investments</link:label>
    <link:label id="lab_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments_documentation_en-US" xlink:label="lab_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Equity Securities Without Readily Determinable Fair Value Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments" xlink:href="asth-20231231.xsd#asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments" xlink:to="lab_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_d1bceb96-1b2d-4098-bd17-bf9b327e0b7f_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reportable Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ea0a6bfc-e15c-4739-beba-52f1c2dcec4d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AdvanceDiagnosticSurgeryCenterMember_84f92545-ee71-42fa-a40c-b1c2883b92eb_terseLabel_en-US" xlink:label="lab_asth_AdvanceDiagnosticSurgeryCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Diagnostic Surgery Center</link:label>
    <link:label id="lab_asth_AdvanceDiagnosticSurgeryCenterMember_label_en-US" xlink:label="lab_asth_AdvanceDiagnosticSurgeryCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Diagnostic Surgery Center [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AdvanceDiagnosticSurgeryCenterMember" xlink:href="asth-20231231.xsd#asth_AdvanceDiagnosticSurgeryCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AdvanceDiagnosticSurgeryCenterMember" xlink:to="lab_asth_AdvanceDiagnosticSurgeryCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_17ef2560-c93f-4533-8fba-a5568ab7e094_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in affiliates</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_ac69466b-a628-4969-8c62-48aa6dcf1070_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_5ee80242-0852-44bb-b1cf-96b07b5e444c_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_IntersegmentMember_e1020a32-9f63-425d-8e08-bd3c20513f13_terseLabel_en-US" xlink:label="lab_asth_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_asth_IntersegmentMember_label_en-US" xlink:label="lab_asth_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment [Member]</link:label>
    <link:label id="lab_asth_IntersegmentMember_documentation_en-US" xlink:label="lab_asth_IntersegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IntersegmentMember" xlink:href="asth-20231231.xsd#asth_IntersegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_IntersegmentMember" xlink:to="lab_asth_IntersegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_b5c4b639-a96b-44f1-a1f0-4017e2d57735_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, carrying amount, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_327a6e76-8330-4488-852a-3838fa18b4f1_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, carrying amount, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_0cf28360-79df-484c-9ca3-3017c03d8ddc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount due to affiliate</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_60d343b7-7e4d-4a3f-88da-d90886d75ebc_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_fdb6eebf-08eb-4b78-a943-6028450da46a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2e204492-ebf6-4b5a-b107-e142be4a063f_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at January 1, 2023</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_810b1b5b-488d-4cc6-b1d3-27c9599d8e29_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31, 2023</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_589639ba-a17c-41c1-abbb-8a96ffe0a855_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_1a25f301-575d-4109-81ff-82e5214c17ba_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_1e964a4c-30e3-417f-87f0-920a35e4c3eb_terseLabel_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share based payment award, warrant exercised, exercise price</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_label_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_documentation_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:to="lab_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_73c74a21-454b-4aa7-8b1e-cd9c199e0546_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_GainLossOnConsolidationOfEquityMethodInvestment_15825cad-3a54-4a46-a66f-0f955d83a641_negatedLabel_en-US" xlink:label="lab_asth_GainLossOnConsolidationOfEquityMethodInvestment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on consolidation of equity method investment</link:label>
    <link:label id="lab_asth_GainLossOnConsolidationOfEquityMethodInvestment_label_en-US" xlink:label="lab_asth_GainLossOnConsolidationOfEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Consolidation of Equity Method Investment</link:label>
    <link:label id="lab_asth_GainLossOnConsolidationOfEquityMethodInvestment_documentation_en-US" xlink:label="lab_asth_GainLossOnConsolidationOfEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Consolidation of Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_GainLossOnConsolidationOfEquityMethodInvestment" xlink:href="asth-20231231.xsd#asth_GainLossOnConsolidationOfEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_GainLossOnConsolidationOfEquityMethodInvestment" xlink:to="lab_asth_GainLossOnConsolidationOfEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_TemporaryEquityTransferOfCommonControlEntities_df4a88a2-e71b-4148-966c-0558c7c368c9_negatedLabel_en-US" xlink:label="lab_asth_TemporaryEquityTransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of common control entities</link:label>
    <link:label id="lab_asth_TemporaryEquityTransferOfCommonControlEntities_label_en-US" xlink:label="lab_asth_TemporaryEquityTransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Transfer Of Common Control Entities</link:label>
    <link:label id="lab_asth_TemporaryEquityTransferOfCommonControlEntities_documentation_en-US" xlink:label="lab_asth_TemporaryEquityTransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Transfer Of Common Control Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityTransferOfCommonControlEntities" xlink:href="asth-20231231.xsd#asth_TemporaryEquityTransferOfCommonControlEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_TemporaryEquityTransferOfCommonControlEntities" xlink:to="lab_asth_TemporaryEquityTransferOfCommonControlEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_81f01a18-088b-49b0-8879-67db9530b517_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_700faffe-62a1-4c8e-bde9-d0e66996bc8a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_bed5a926-479d-4347-8da4-29623088417f_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_4d6134d4-7708-4b16-a452-183924eef0bc_terseLabel_en-US" xlink:label="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends (in shares)</link:label>
    <link:label id="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_label_en-US" xlink:label="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares</link:label>
    <link:label id="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_documentation_en-US" xlink:label="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:href="asth-20231231.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:to="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_dfefb35d-6baf-4e5d-92aa-f042165c1701_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_844cd6d1-afc1-445b-8f59-cef55f54f3de_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_1d7448d7-24b3-4eb9-a1f1-d997d094a694_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_6b5e4ad9-8a82-4544-bae8-1d4c3ed2fae9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_10a28ced-9491-45f4-be93-092b97b066b7_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of restricted stock awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_abde5067-9177-4b06-95b7-7041885aefaf_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Other Entities</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_c1d4949e-455d-43bf-ac53-367c3ff258b4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_2df7fa76-264f-47d1-a874-350fba4a7768_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_1fbfd103-9e61-4746-a928-5a8ce8eec9f3_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_aed771ef-2fa0-47bb-8921-7987d2802bf4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options and warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_9a0dc96e-7b11-4120-830a-86fd45cb2711_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loan</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_aacaf3a8-a404-426c-9d65-fcff41019d55_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock_4104adbb-0409-483c-8668-c5a7a8babec6_verboseLabel_en-US" xlink:label="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Liabilities</link:label>
    <link:label id="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_05fe2e3a-2465-48b2-8635-26dbcca8596b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_ee06fdad-c7a7-4c0e-a50d-67c265d2cb3c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9eb709dd-b962-4345-9cf9-929287229bc8_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d0860e1d-7ab3-4602-b2b4-858969fddbb7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_d3c230a5-2c1b-44fb-ab3c-31b251f9e728_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_57ae4485-3e67-4608-97c7-0d9580c83a01_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_012bf336-1d8c-4b1f-ab83-d4f7c79d1e69_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_29021cd5-8199-4442-b3f1-6c8edadd8058_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_b621f2fb-dcd2-448b-8c08-6e5056c0ddd8_verboseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities (VIEs)</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_838b9560-6e42-40ce-bd6a-a9654b6ad76a_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9c756b9a-3953-477d-ba24-c2f71c04f828_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_d7970048-ba34-465f-841b-83f6879d1782_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilities_d76268f1-1082-4cfe-945a-028392ecef89_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining outstanding under agreement</link:label>
    <link:label id="lab_us-gaap_DeferredCreditsAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Credits and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCreditsAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:to="lab_us-gaap_DeferredCreditsAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ThirdWayHealthIncMember_cb9e03d7-e1d9-4fd6-b074-a63ef9c5a90d_terseLabel_en-US" xlink:label="lab_asth_ThirdWayHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Way Health, Inc</link:label>
    <link:label id="lab_asth_ThirdWayHealthIncMember_label_en-US" xlink:label="lab_asth_ThirdWayHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Way Health, Inc [Member]</link:label>
    <link:label id="lab_asth_ThirdWayHealthIncMember_documentation_en-US" xlink:label="lab_asth_ThirdWayHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Way Health, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ThirdWayHealthIncMember" xlink:href="asth-20231231.xsd#asth_ThirdWayHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ThirdWayHealthIncMember" xlink:to="lab_asth_ThirdWayHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_5fcfe07d-5005-4029-b8a3-ab2daa943e95_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionOfDividends_626bc05e-11bd-42a1-af43-a45da3affd3e_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionOfDividends_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionOfDividends" xlink:to="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8c6818f9-35ac-439c-8628-71e126bfddc0_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_d10a0ef9-db51-4ff1-850d-90462ac1ae66_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_2c13ba92-c5bc-4fc6-93b3-c9f6c1a3fcef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_949f76ba-8db6-48f9-b4f0-ae59b63d0f00_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets before valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_88be433e-0f3e-486d-a95f-186089ab6f9a_terseLabel_en-US" xlink:label="lab_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in privately held entities</link:label>
    <link:label id="lab_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_label_en-US" xlink:label="lab_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment In Privately Held Entity That Does Not Report Net Asset Value</link:label>
    <link:label id="lab_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_documentation_en-US" xlink:label="lab_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total of Investment in privately held entity that does not report net asset value per share .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:href="asth-20231231.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:to="lab_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1e086c91-8e47-4da8-9f63-89a4083a24a0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b6594079-2810-43fc-a929-0178d04141e8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable_82b0a594-a015-46f2-ac3f-0541c61086d3_terseLabel_en-US" xlink:label="lab_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, termination period, if applicable</link:label>
    <link:label id="lab_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable_label_en-US" xlink:label="lab_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Termination Period, If Applicable</link:label>
    <link:label id="lab_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable_documentation_en-US" xlink:label="lab_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Termination Period, If Applicable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:href="asth-20231231.xsd#asth_LesseeOperatingLeaseTerminationPeriodIfApplicable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:to="lab_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_38941c1e-c9cb-4196-8b03-a053030e697d_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock&#160;Outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_332a5f36-d626-431e-b02c-97e96e9ddb8f_totalLabel_en-US" xlink:label="lab_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite and Indefinite Lived Intangible Assets Acquired</link:label>
    <link:label id="lab_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_documentation_en-US" xlink:label="lab_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite and Indefinite Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired" xlink:href="asth-20231231.xsd#asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired" xlink:to="lab_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_f39ce149-39fa-4685-9598-47ca94e40623_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SummaryOfSignificantAccountingPoliciesLineItems_d7947db7-5a9c-4bbb-a8eb-a04cf51252b9_terseLabel_en-US" xlink:label="lab_asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_asth_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_asth_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="asth-20231231.xsd#asth_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d9a91ea2-7bd1-441d-809f-3dc715c3b22b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_9fa49b7e-76c0-4bdc-bc33-0a92e81a439e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_5e398931-abe5-49c1-9f1c-3976046c2303_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Amounts and Fair Values of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_7996078f-f78f-43d5-9b8e-97170ec9a16e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Fair Value of Level 3 Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_0fa8e422-b887-41bf-b09e-5727c69e6f3c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Support to Nonconsolidated Legal Entity [Domain]</link:label>
    <link:label id="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_label_en-US" xlink:label="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Support to Nonconsolidated Legal Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:to="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts_c68bccd5-9f69-4fc6-8446-5e85dcfd9048_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (repayments of) bank overdrafts</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Bank Overdrafts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfBankOverdrafts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b55fd075-5433-4dad-855e-a5972ab79e66_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a306b232-c202-44fa-8e8d-96f6260bee7f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d960e896-c27e-47d9-999d-30f68143455f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at ending</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7b37ac19-2acd-4804-a756-cfe0a09d613c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions of preferred returns</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ValleyOaksMedicalGroupMember_35a58d94-de50-40f6-967a-0a5b1362fda1_terseLabel_en-US" xlink:label="lab_asth_ValleyOaksMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valley Oaks Medical Group</link:label>
    <link:label id="lab_asth_ValleyOaksMedicalGroupMember_label_en-US" xlink:label="lab_asth_ValleyOaksMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valley Oaks Medical Group [Member]</link:label>
    <link:label id="lab_asth_ValleyOaksMedicalGroupMember_documentation_en-US" xlink:label="lab_asth_ValleyOaksMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valley Oaks Medical Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ValleyOaksMedicalGroupMember" xlink:href="asth-20231231.xsd#asth_ValleyOaksMedicalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ValleyOaksMedicalGroupMember" xlink:to="lab_asth_ValleyOaksMedicalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ForYourBenefitIncMember_e907d70e-5e50-43c8-9829-c3b224c0e242_terseLabel_en-US" xlink:label="lab_asth_ForYourBenefitIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Your Benefit Inc.</link:label>
    <link:label id="lab_asth_ForYourBenefitIncMember_label_en-US" xlink:label="lab_asth_ForYourBenefitIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Your Benefit Inc. [Member]</link:label>
    <link:label id="lab_asth_ForYourBenefitIncMember_documentation_en-US" xlink:label="lab_asth_ForYourBenefitIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For Your Benefit Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ForYourBenefitIncMember" xlink:href="asth-20231231.xsd#asth_ForYourBenefitIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ForYourBenefitIncMember" xlink:to="lab_asth_ForYourBenefitIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DeferredTaxAssetsInvestment_5950d967-4760-4a57-985b-a34e96b8e8b7_verboseLabel_en-US" xlink:label="lab_asth_DeferredTaxAssetsInvestment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in other entities</link:label>
    <link:label id="lab_asth_DeferredTaxAssetsInvestment_label_en-US" xlink:label="lab_asth_DeferredTaxAssetsInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Investment</link:label>
    <link:label id="lab_asth_DeferredTaxAssetsInvestment_documentation_en-US" xlink:label="lab_asth_DeferredTaxAssetsInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DeferredTaxAssetsInvestment" xlink:href="asth-20231231.xsd#asth_DeferredTaxAssetsInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DeferredTaxAssetsInvestment" xlink:to="lab_asth_DeferredTaxAssetsInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent_5597867d-a36d-4e25-b5ff-1c06bb3374cb_terseLabel_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed dividend</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent_label_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Undistributed Dividend, Percent</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent_documentation_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Undistributed Dividend, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" xlink:to="lab_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_12fc560e-3bd1-4d9b-85a1-8f9f5faaeeab_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_3886719b-e1ad-412f-bdc4-ef72521cb811_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5e0806f7-9a78-4ca8-8939-de4460c1e99b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_5df96665-6734-4d3e-86e2-66d7479447c9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_f0d75beb-bde3-46b4-b844-70ef30e34870_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_c748e2cf-f345-47c5-be07-9ca4b3ebc5ae_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total medical care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_e57dfabe-47a6-4b7f-a8cc-3e40c8e1cdde_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_366c9859-33f7-4742-8034-8fb5f582f450_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_c6531242-74a4-466f-b6d2-a5d0f42b7056_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_3ffd00c7-0349-4d73-8021-1f4ad102403b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_56169196-495a-42f9-9b9e-4ed4ac329648_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5e9c2e46-eec2-4399-a7bc-85c0470bd99a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_bb81e2e1-15fa-40b5-b0f6-a39b7c733478_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest acquired (percent)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable_eafc1951-ea7a-448c-8713-0998792f1357_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_a788ded5-79fc-466a-a57f-bd111f744c6c_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_81ddfeb6-71f7-4d60-85ff-38012141b54c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_bf1cc6ca-39a0-48d7-a40e-e9653b5d1efe_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_05cfa187-57ec-47f0-9f82-54e5580621e0_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_2e98ca9b-066f-4f59-bfe5-475108c3b01c_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service, net</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_HealthCareCapitationRevenueMember_36aed47f-c288-478f-9c32-ff65bde9fa87_verboseLabel_en-US" xlink:label="lab_asth_HealthCareCapitationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation, net</link:label>
    <link:label id="lab_asth_HealthCareCapitationRevenueMember_label_en-US" xlink:label="lab_asth_HealthCareCapitationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Capitation Revenue [Member]</link:label>
    <link:label id="lab_asth_HealthCareCapitationRevenueMember_documentation_en-US" xlink:label="lab_asth_HealthCareCapitationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh_HealthCareCapitationRevenueMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_HealthCareCapitationRevenueMember" xlink:href="asth-20231231.xsd#asth_HealthCareCapitationRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_HealthCareCapitationRevenueMember" xlink:to="lab_asth_HealthCareCapitationRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SunnyVillageCareCenterMember_8e5e24f7-85d0-413e-8a6c-087b71ec014b_terseLabel_en-US" xlink:label="lab_asth_SunnyVillageCareCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunny Village Care Center</link:label>
    <link:label id="lab_asth_SunnyVillageCareCenterMember_label_en-US" xlink:label="lab_asth_SunnyVillageCareCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunny Village Care Center [Member]</link:label>
    <link:label id="lab_asth_SunnyVillageCareCenterMember_documentation_en-US" xlink:label="lab_asth_SunnyVillageCareCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sunny Village Care Center</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SunnyVillageCareCenterMember" xlink:href="asth-20231231.xsd#asth_SunnyVillageCareCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SunnyVillageCareCenterMember" xlink:to="lab_asth_SunnyVillageCareCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_c534d05b-c078-4dcb-a719-6ff50bcf3299_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_UniversalCareIncMember_ed8e8a40-7a66-4488-95b4-c645af599891_terseLabel_en-US" xlink:label="lab_asth_UniversalCareIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Universal Care Inc</link:label>
    <link:label id="lab_asth_UniversalCareIncMember_label_en-US" xlink:label="lab_asth_UniversalCareIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Universal Care Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_UniversalCareIncMember" xlink:href="asth-20231231.xsd#asth_UniversalCareIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_UniversalCareIncMember" xlink:to="lab_asth_UniversalCareIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_a9421d38-8198-46a2-83db-c1688bfcd208_terseLabel_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_documentation_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4c8548d4-18d6-4306-ab8e-111952089663_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share &#8211; basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_260ae286-c088-4185-bb6a-72a150d7cda5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_cc05173e-5dd8-46b5-948c-867215f5caf9_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_08bfb8d6-a412-42ed-af68-6a5074b12086_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of warrant</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_27847320-14ed-4068-99fe-bbe1ecf1faa1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivableNoncurrent_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:to="lab_us-gaap_IncomeTaxesReceivableNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_7e880c5c-0c9e-4ded-bdd5-1309cb4dd0c5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_72598e42-c61f-420c-bb74-670bc61656b4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_f645e912-cab7-4678-a25f-42357dc0481c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_30a671bf-e8a8-4a08-a5f5-ba5cbd5cff07_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in business combination</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_8c8a4880-334c-432c-be2e-8b4255acb08f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_22885bd2-eee5-4c0e-8d7f-759b9539f7de_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_7f0a6da2-199f-4af5-bc9b-034a6d9c1173_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_53a6551e-a2f3-45e0-bfaa-6d6bb246e13a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_JadeHealthCareMedicalGroupIncMember_ba2888a0-2984-4709-86be-7e2c0b07c2e4_terseLabel_en-US" xlink:label="lab_asth_JadeHealthCareMedicalGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jade Health Care Medical Group, Inc.</link:label>
    <link:label id="lab_asth_JadeHealthCareMedicalGroupIncMember_label_en-US" xlink:label="lab_asth_JadeHealthCareMedicalGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jade Health Care Medical Group, Inc. [Member]</link:label>
    <link:label id="lab_asth_JadeHealthCareMedicalGroupIncMember_documentation_en-US" xlink:label="lab_asth_JadeHealthCareMedicalGroupIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jade Health Care Medical Group, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_JadeHealthCareMedicalGroupIncMember" xlink:href="asth-20231231.xsd#asth_JadeHealthCareMedicalGroupIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_JadeHealthCareMedicalGroupIncMember" xlink:to="lab_asth_JadeHealthCareMedicalGroupIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_cf78eda8-c6ce-43ee-83aa-033796012625_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_0d77ecd0-979b-429a-ba73-148a5e4783aa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOtherMember_3c42b402-4976-481d-b912-87c7944b943c_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk pool settlements and incentives</link:label>
    <link:label id="lab_us-gaap_HealthCareOtherMember_label_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOtherMember" xlink:to="lab_us-gaap_HealthCareOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PreferredBankMember_f1c57c29-4f47-43ac-bac8-7eb93fc0bdf4_terseLabel_en-US" xlink:label="lab_asth_PreferredBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Bank</link:label>
    <link:label id="lab_asth_PreferredBankMember_label_en-US" xlink:label="lab_asth_PreferredBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Bank [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PreferredBankMember" xlink:href="asth-20231231.xsd#asth_PreferredBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PreferredBankMember" xlink:to="lab_asth_PreferredBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cd35ea11-02aa-4c2a-a4a6-9d920bc70630_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CareEnablementMember_63da6834-b4f3-46d6-a28a-afd8a1a09899_terseLabel_en-US" xlink:label="lab_asth_CareEnablementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Enablement</link:label>
    <link:label id="lab_asth_CareEnablementMember_label_en-US" xlink:label="lab_asth_CareEnablementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Enablement [Member]</link:label>
    <link:label id="lab_asth_CareEnablementMember_documentation_en-US" xlink:label="lab_asth_CareEnablementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Enablement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CareEnablementMember" xlink:href="asth-20231231.xsd#asth_CareEnablementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CareEnablementMember" xlink:to="lab_asth_CareEnablementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_602efea1-16ce-43b0-81fb-36406ed90708_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Support to Nonconsolidated Legal Entity [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_label_en-US" xlink:label="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Support to Nonconsolidated Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:to="lab_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ApolloMedOfficerMember_807a243c-beb3-464e-bbdd-fcab204bd9ec_terseLabel_en-US" xlink:label="lab_asth_ApolloMedOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ApolloMed Officer</link:label>
    <link:label id="lab_asth_ApolloMedOfficerMember_label_en-US" xlink:label="lab_asth_ApolloMedOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ApolloMed Officer [Member]</link:label>
    <link:label id="lab_asth_ApolloMedOfficerMember_documentation_en-US" xlink:label="lab_asth_ApolloMedOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ApolloMed Officer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloMedOfficerMember" xlink:href="asth-20231231.xsd#asth_ApolloMedOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ApolloMedOfficerMember" xlink:to="lab_asth_ApolloMedOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_3d210c47-2d9d-4019-a42d-243cbd459638_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ad481513-fab0-4b7f-acda-c97a8416becf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_1e1a0483-b1e0-46bc-98b3-9e3e99c66b10_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_7d4c00c9-ea96-487d-bdc4-6620f474d50a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_1fac8f10-2848-489b-a82b-d2efd126fb3f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_bb1989a1-5745-43bb-a75d-c5a41c56a496_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, increase (decrease)</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_39cd1223-2a9f-4987-9668-3a257cb2827d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_e338aadf-4650-477e-aca9-8012f5be7e91_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_a9b628ff-97d0-44fa-87d8-8ef6449ca513_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_51bef98b-8468-43ae-93b4-57b1a4194c3c_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MemberRelationshipsMember_b16aa7b5-b28a-4475-9ff2-9b71f4a2669f_verboseLabel_en-US" xlink:label="lab_asth_MemberRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member relationships</link:label>
    <link:label id="lab_asth_MemberRelationshipsMember_label_en-US" xlink:label="lab_asth_MemberRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member Relationships [Member]</link:label>
    <link:label id="lab_asth_MemberRelationshipsMember_documentation_en-US" xlink:label="lab_asth_MemberRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MemberRelationshipsMember" xlink:href="asth-20231231.xsd#asth_MemberRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MemberRelationshipsMember" xlink:to="lab_asth_MemberRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDepositLiabilities_d86a88e2-1ba3-4c3c-8643-20352e38a648_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDepositLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to related parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDepositLiabilities_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDepositLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Deposit Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDepositLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDepositLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDepositLiabilities" xlink:to="lab_us-gaap_RelatedPartyDepositLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DMGAndSunLabsMember_c451a010-9eab-406f-80e3-3c5f5f470d0b_terseLabel_en-US" xlink:label="lab_asth_DMGAndSunLabsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG And Sun Labs</link:label>
    <link:label id="lab_asth_DMGAndSunLabsMember_label_en-US" xlink:label="lab_asth_DMGAndSunLabsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG And Sun Labs [Member]</link:label>
    <link:label id="lab_asth_DMGAndSunLabsMember_documentation_en-US" xlink:label="lab_asth_DMGAndSunLabsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG And Sun Labs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DMGAndSunLabsMember" xlink:href="asth-20231231.xsd#asth_DMGAndSunLabsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DMGAndSunLabsMember" xlink:to="lab_asth_DMGAndSunLabsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_11b96d5f-6987-4358-8d7b-69ccff590659_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fc246d4d-2efe-4040-aae0-d942a2a754c1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_304ffdfa-f1b1-47c9-833c-469f7f318b0e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for vesting of restricted stock awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_cff0a6c8-f15a-4279-a4e8-49ae05b2fefe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4f92f72d-d7f7-4441-868a-0cf6a038e34b_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_119bf39b-3a0e-45b4-9eb8-ee51bd111937_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock_8e93df25-f389-4ee7-881e-312f47c2f2a4_verboseLabel_en-US" xlink:label="lab_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Receivables &#8211; Related Parties, Other Receivables, Loan Receivable, and Loan Receivable - Related Party</link:label>
    <link:label id="lab_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock_label_en-US" xlink:label="lab_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables And Related parties Receivables Policy Text Block [Policy Text Block]</link:label>
    <link:label id="lab_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock_documentation_en-US" xlink:label="lab_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Receivables and receivables from related parties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock" xlink:href="asth-20231231.xsd#asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock" xlink:to="lab_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_d395c9ec-65cd-44e9-8eb4-fe84c835ecfc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_df85e7ae-105f-43c4-92e3-22b78b3e070d_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_4d1b4276-79f1-4f3f-8436-2fe0ff79a2b5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired (see Note 3)</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_da8fc74d-85be-4b7e-9d95-771c764ddd10_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_84b3fcac-96b2-4c2b-bfc7-02b4e3f5c5cf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares of the combined company that would be owned by pre-Merger ApolloMed stockholders</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6998eff9-d9e6-4df9-988d-d41b529ede65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_7829883e-f604-4037-94af-cc036f1db320_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution from investment - equity method</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_3354dd61-e5a6-45f9-a9ee-a0608afb1bca_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4c7ce4cb-9bc8-4ea4-9657-0a5a58e7a7d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_821c730c-7aba-4a10-bdce-e48699446538_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_822a0ccd-1614-4ae1-ae80-35c3a5d5557d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from repayment of loans receivable - related parties</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CompanyAndAPCMember_b8b174bd-0439-41e9-b0eb-1f8b482a6dbb_terseLabel_en-US" xlink:label="lab_asth_CompanyAndAPCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company and APC</link:label>
    <link:label id="lab_asth_CompanyAndAPCMember_label_en-US" xlink:label="lab_asth_CompanyAndAPCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company and APC [Member]</link:label>
    <link:label id="lab_asth_CompanyAndAPCMember_documentation_en-US" xlink:label="lab_asth_CompanyAndAPCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company and APC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CompanyAndAPCMember" xlink:href="asth-20231231.xsd#asth_CompanyAndAPCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CompanyAndAPCMember" xlink:to="lab_asth_CompanyAndAPCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_bd07745c-bdb5-45d5-8006-9f6a101fb8b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses recognized on equity securities held at end of period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_60aef4b6-b9ff-4d6e-9ea4-bcaf0f2f4c8d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares for business acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity_3a37947a-86f5-4651-9c83-13bdc7887468_terseLabel_en-US" xlink:label="lab_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash recorded from consolidation of VIE</link:label>
    <link:label id="lab_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity_label_en-US" xlink:label="lab_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Cash Received from Consolidation of Variable Interest Entity</link:label>
    <link:label id="lab_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity_documentation_en-US" xlink:label="lab_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Cash Received from Consolidation of Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" xlink:href="asth-20231231.xsd#asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" xlink:to="lab_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_ceeeb434-97a2-453e-91d7-f4b72f2861ac_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_fe1d2df6-e825-4df4-8477-9ed542c1a868_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_35cc750e-7b2c-4c5b-a9d5-5b46443add11_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_9c235891-fe15-4fb0-9974-4eb4f653a79c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_542f9890-363c-43d8-950c-26ace351e963_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_3d23e177-b30f-4ffa-b8ac-b6c50ad686cf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CashPaidForLeaseLiabilitiesAbstractAbstract_949d4160-c6c2-4500-9264-4cf312216732_terseLabel_en-US" xlink:label="lab_asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_asth_CashPaidForLeaseLiabilitiesAbstractAbstract_label_en-US" xlink:label="lab_asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Lease Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:href="asth-20231231.xsd#asth_CashPaidForLeaseLiabilitiesAbstractAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:to="lab_asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NetworkMedicalManagementMember_da88ba28-8466-4e83-b5ce-dca8e43ecf4f_terseLabel_en-US" xlink:label="lab_asth_NetworkMedicalManagementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NMM</link:label>
    <link:label id="lab_asth_NetworkMedicalManagementMember_label_en-US" xlink:label="lab_asth_NetworkMedicalManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Network Medical Management [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkMedicalManagementMember" xlink:href="asth-20231231.xsd#asth_NetworkMedicalManagementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NetworkMedicalManagementMember" xlink:to="lab_asth_NetworkMedicalManagementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_a95cba8a-ef34-44ce-8224-ae8b117c5c24_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5225e8b2-5c41-44e5-a4ab-a9ff031cd772_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1644ea7e-8e7e-4831-8637-b8813374aaba_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_c1d99095-f437-4eb1-8ad8-f5d68f1af6bb_negatedTerseLabel_en-US" xlink:label="lab_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding Reclassified to Loan Receivable</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_label_en-US" xlink:label="lab_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Funding Reclassified to Loan Receivable</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_documentation_en-US" xlink:label="lab_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Funding Reclassified to Loan Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:to="lab_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_26806411-a6e0-4098-922b-9e51909a5a29_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ArroyoVistaMember_758c3e4e-b28d-4c47-9ab3-d4ff160d5d3d_terseLabel_en-US" xlink:label="lab_asth_ArroyoVistaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arroyo Vista</link:label>
    <link:label id="lab_asth_ArroyoVistaMember_label_en-US" xlink:label="lab_asth_ArroyoVistaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arroyo Vista [Member]</link:label>
    <link:label id="lab_asth_ArroyoVistaMember_documentation_en-US" xlink:label="lab_asth_ArroyoVistaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arroyo Vista</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ArroyoVistaMember" xlink:href="asth-20231231.xsd#asth_ArroyoVistaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ArroyoVistaMember" xlink:to="lab_asth_ArroyoVistaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_70aaecee-7c64-4ad8-95f5-4e46651e4492_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets recorded under finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NoncashLeaseExpense_60d34a75-9361-4bce-9223-dd84ae59bd22_terseLabel_en-US" xlink:label="lab_asth_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_asth_NoncashLeaseExpense_label_en-US" xlink:label="lab_asth_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_asth_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_asth_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncashLeaseExpense" xlink:href="asth-20231231.xsd#asth_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NoncashLeaseExpense" xlink:to="lab_asth_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_12df8051-8208-4eb3-975b-d6cdc6cd8e2e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_UnrealizedGainLossFromInvestmentInEquitySecurities_e8702eaf-ad16-4198-9bec-70c485bbfc79_negatedTerseLabel_en-US" xlink:label="lab_asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on investments</link:label>
    <link:label id="lab_asth_UnrealizedGainLossFromInvestmentInEquitySecurities_label_en-US" xlink:label="lab_asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (Gain) Loss From Investment In Equity Securities</link:label>
    <link:label id="lab_asth_UnrealizedGainLossFromInvestmentInEquitySecurities_documentation_en-US" xlink:label="lab_asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (Gain) Loss From Investment In Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:href="asth-20231231.xsd#asth_UnrealizedGainLossFromInvestmentInEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:to="lab_asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_281c9fb1-f4c5-4c72-bb4a-24d865578849_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_7d4cca23-5b35-4637-ad60-10f971a378a3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4c14a780-b634-4872-adf4-a3da35a5ca14_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CallCenterServicesMember_c2dd90f0-6782-4913-9270-eac05b394dff_terseLabel_en-US" xlink:label="lab_asth_CallCenterServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Center Services</link:label>
    <link:label id="lab_asth_CallCenterServicesMember_label_en-US" xlink:label="lab_asth_CallCenterServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Center Services [Member]</link:label>
    <link:label id="lab_asth_CallCenterServicesMember_documentation_en-US" xlink:label="lab_asth_CallCenterServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Center Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CallCenterServicesMember" xlink:href="asth-20231231.xsd#asth_CallCenterServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CallCenterServicesMember" xlink:to="lab_asth_CallCenterServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_IssuanceOfFinancingObligationForBusinessCombination_d5d58a37-c960-48b4-a096-62e4d074373e_terseLabel_en-US" xlink:label="lab_asth_IssuanceOfFinancingObligationForBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of financing obligation for business combinations</link:label>
    <link:label id="lab_asth_IssuanceOfFinancingObligationForBusinessCombination_label_en-US" xlink:label="lab_asth_IssuanceOfFinancingObligationForBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Financing Obligation for Business Combination</link:label>
    <link:label id="lab_asth_IssuanceOfFinancingObligationForBusinessCombination_documentation_en-US" xlink:label="lab_asth_IssuanceOfFinancingObligationForBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Financing Obligation for Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IssuanceOfFinancingObligationForBusinessCombination" xlink:href="asth-20231231.xsd#asth_IssuanceOfFinancingObligationForBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_IssuanceOfFinancingObligationForBusinessCombination" xlink:to="lab_asth_IssuanceOfFinancingObligationForBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_f25b7416-75a9-486e-9a28-b4d952594f45_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_c2efa89a-80c4-4564-aa8a-14e6fc4dfd6c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PaymentsForMedicalCareCostsAbstract_742e2771-409a-488e-8629-b4bb0609e2e6_terseLabel_en-US" xlink:label="lab_asth_PaymentsForMedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for medical care costs related to claims incurred:</link:label>
    <link:label id="lab_asth_PaymentsForMedicalCareCostsAbstract_label_en-US" xlink:label="lab_asth_PaymentsForMedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Medical Care Costs [Abstract]</link:label>
    <link:label id="lab_asth_PaymentsForMedicalCareCostsAbstract_documentation_en-US" xlink:label="lab_asth_PaymentsForMedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Medical Care Costs [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentsForMedicalCareCostsAbstract" xlink:href="asth-20231231.xsd#asth_PaymentsForMedicalCareCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PaymentsForMedicalCareCostsAbstract" xlink:to="lab_asth_PaymentsForMedicalCareCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_4c0a7914-2aba-48fd-9db6-55b4be5a1a05_terseLabel_en-US" xlink:label="lab_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated leverage ratio, annual change</link:label>
    <link:label id="lab_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_label_en-US" xlink:label="lab_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Incremental Change</link:label>
    <link:label id="lab_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_documentation_en-US" xlink:label="lab_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Incremental Change</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantLeverageRatioIncrementalChange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:to="lab_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_eab2c4d1-b3b8-4d51-863b-6a5790983a5b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (gain) loss on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f8231c02-b5b7-4903-b01d-73e153a955f1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_597234eb-1f32-4a7d-9dba-646b863d625f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a24e2d3f-07f4-4be6-ae1f-ee504e57ffad_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c4781910-ed65-49d5-9037-f47d338a0782_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for business and asset acquisition, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_f71a4d82-9a7a-445b-9adc-22d0cc7b7038_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract term</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:to="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RevenuePaymentTerms_b6e262de-cbbf-49d8-a15a-af120385bcb5_terseLabel_en-US" xlink:label="lab_asth_RevenuePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, payment terms</link:label>
    <link:label id="lab_asth_RevenuePaymentTerms_label_en-US" xlink:label="lab_asth_RevenuePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Payment Terms</link:label>
    <link:label id="lab_asth_RevenuePaymentTerms_documentation_en-US" xlink:label="lab_asth_RevenuePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RevenuePaymentTerms" xlink:href="asth-20231231.xsd#asth_RevenuePaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RevenuePaymentTerms" xlink:to="lab_asth_RevenuePaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_bce6b3f4-fc90-4094-b36a-e161398fdcf3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_95599a43-f143-47f7-b4b6-686b513895df_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_e7515029-861e-48c3-bef6-7c4ab061f0d5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_487e7c2d-0168-4591-bac3-f8c09fc03421_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_66c1b354-02d8-4efc-bf05-587fa0eb579d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life (Years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_071606d4-9c91-45e5-ba84-6937dc63df95_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_69b9cfdf-01e0-4a0a-8a95-f6667f8a0148_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity method investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest_6ce74d41-5bd3-44f5-a0f4-5206937ac550_terseLabel_en-US" xlink:label="lab_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of shares by noncontrolling interest (in shares)</link:label>
    <link:label id="lab_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest_label_en-US" xlink:label="lab_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Noncontrolling Interest</link:label>
    <link:label id="lab_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest_documentation_en-US" xlink:label="lab_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringPeriodSharesNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest" xlink:to="lab_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable_8a4d78b3-86bc-40d8-ac80-44df9b4e9f3a_terseLabel_en-US" xlink:label="lab_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, termination period, if applicable</link:label>
    <link:label id="lab_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable_label_en-US" xlink:label="lab_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Termination Period, If Applicable</link:label>
    <link:label id="lab_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable_documentation_en-US" xlink:label="lab_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Termination Period, If Applicable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:href="asth-20231231.xsd#asth_LesseeFinanceLeaseTerminationPeriodIfApplicable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:to="lab_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_d43e5e69-2e66-424e-bb0d-ef982ac7f89a_terseLabel_en-US" xlink:label="lab_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining equity interest purchase</link:label>
    <link:label id="lab_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_label_en-US" xlink:label="lab_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Equity Interest Purchase Obligation, Noncurrent</link:label>
    <link:label id="lab_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_documentation_en-US" xlink:label="lab_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Equity Interest Purchase Obligation, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:href="asth-20231231.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:to="lab_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_Pacific6EnterprisesMember_ad22cc2f-685a-4874-9be9-abc945ad9df8_terseLabel_en-US" xlink:label="lab_asth_Pacific6EnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific6</link:label>
    <link:label id="lab_asth_Pacific6EnterprisesMember_label_en-US" xlink:label="lab_asth_Pacific6EnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific6 Enterprises [Member]</link:label>
    <link:label id="lab_asth_Pacific6EnterprisesMember_documentation_en-US" xlink:label="lab_asth_Pacific6EnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific6 Enterprises [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Pacific6EnterprisesMember" xlink:href="asth-20231231.xsd#asth_Pacific6EnterprisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_Pacific6EnterprisesMember" xlink:to="lab_asth_Pacific6EnterprisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3fe89c24-0467-4bca-9a2a-0c239367ccb8_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_89b78d3b-1079-4d2c-9534-0ebad5fe514f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_e5807dac-ac07-4739-ad34-8b0fd6b98a66_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in&#160;Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_297c0649-3cac-4bec-8625-42cfcf24e347_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_4edea1b4-e042-4178-a8a8-f2f53793e701_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for bad debts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_6c887dd3-5b4c-48c6-9b65-3112b38018ff_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less (loss) gains recognized on equity securities sold</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_9a3a55ca-15bb-4c05-b9a6-4b65f5c21027_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_a7adc0a7-56cf-4135-b4bc-092ef871e3fb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from equity method investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_e39d3b39-60cc-499c-b692-7ece1ab108f3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) loss from equity method investments, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_8f2a55e0-714c-493f-aeb1-793b36057669_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation of Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_772dbf6d-b2f3-464a-b0d0-e438a2dfcb16_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_477d6e8f-5750-43ae-be52-b3879bb2effd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_1a4d1091-b4f6-45c6-a5ee-2cf15defaac9_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance cost</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DerivativeCeilingInterestRate_b7905803-a52c-496f-8cca-46ac4b0a1fe3_terseLabel_en-US" xlink:label="lab_asth_DerivativeCeilingInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative ceiling interest rate</link:label>
    <link:label id="lab_asth_DerivativeCeilingInterestRate_label_en-US" xlink:label="lab_asth_DerivativeCeilingInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Ceiling Interest Rate</link:label>
    <link:label id="lab_asth_DerivativeCeilingInterestRate_documentation_en-US" xlink:label="lab_asth_DerivativeCeilingInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Ceiling Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DerivativeCeilingInterestRate" xlink:href="asth-20231231.xsd#asth_DerivativeCeilingInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DerivativeCeilingInterestRate" xlink:to="lab_asth_DerivativeCeilingInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ceb85b56-f0df-426c-a89d-7d37102be9f2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_FirstCommonwealthPropertyLLCMember_a7b7e247-b1d4-4c88-a217-43607fa93cc3_terseLabel_en-US" xlink:label="lab_asth_FirstCommonwealthPropertyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Commonwealth Property, LLC</link:label>
    <link:label id="lab_asth_FirstCommonwealthPropertyLLCMember_label_en-US" xlink:label="lab_asth_FirstCommonwealthPropertyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Commonwealth Property, LLC [Member]</link:label>
    <link:label id="lab_asth_FirstCommonwealthPropertyLLCMember_documentation_en-US" xlink:label="lab_asth_FirstCommonwealthPropertyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Commonwealth Property, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FirstCommonwealthPropertyLLCMember" xlink:href="asth-20231231.xsd#asth_FirstCommonwealthPropertyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_FirstCommonwealthPropertyLLCMember" xlink:to="lab_asth_FirstCommonwealthPropertyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1f5b2a5d-0509-4d30-94a1-d85df4cbaea3_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_bcd2a88d-9319-492a-919a-3bc4a033fc7e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options canceled, forfeited or expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_d11dcc72-da08-40c3-b1f2-7ba331a9782a_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2e5362e7-2ea6-405e-aac6-c7d56a8bf2fa_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of lease expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_ebdc55e6-b139-43e0-a782-bed3f05e0b80_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_f10ea3b2-bac4-4e90-ad43-4fb491dd304b_terseLabel_en-US" xlink:label="lab_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for exercise of options and warrants (in shares)</link:label>
    <link:label id="lab_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_label_en-US" xlink:label="lab_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During the Period Shares of Exercise of Option and Warrants</link:label>
    <link:label id="lab_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_documentation_en-US" xlink:label="lab_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">It represents number of share issued exercise of option and warrants during the period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:to="lab_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_18f82b9f-ff53-440e-94e0-af4245ccfcfc_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_a0fce205-d363-45d4-abce-af9e14a7caac_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_ff530e87-b472-41da-b900-5c68456eca89_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_0b65c9a3-ee07-4eb5-9de8-429da518d30e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease option to extend (up to)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c117e276-4123-4418-bd70-03e08dabb205_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_e97db569-8343-44f9-8e09-b4603c2d26a6_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_c26025e5-3244-474e-ab75-1cfd64e64736_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_7676f8ab-1848-4c96-98f4-36fca520e130_verboseLabel_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_label_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_documentation_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3f0c64cc-c6db-4f7d-88a7-662798f21b4c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_e6d0d40a-6fbc-4775-8b61-4b26faa096e0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_456290c9-d4ef-4871-9013-5a8cc5231cb1_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_82f6a37b-8735-449a-b1f5-372b25977b70_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b2324dea-c7d8-4e16-b27e-413ff6677780_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MedicalCareCostsAbstract_ddd6a7de-ae95-41a4-ab51-65d08e010ea2_terseLabel_en-US" xlink:label="lab_asth_MedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of medical care costs related to claims incurred:</link:label>
    <link:label id="lab_asth_MedicalCareCostsAbstract_label_en-US" xlink:label="lab_asth_MedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Care Costs [Abstract]</link:label>
    <link:label id="lab_asth_MedicalCareCostsAbstract_documentation_en-US" xlink:label="lab_asth_MedicalCareCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Care Costs [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicalCareCostsAbstract" xlink:href="asth-20231231.xsd#asth_MedicalCareCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MedicalCareCostsAbstract" xlink:to="lab_asth_MedicalCareCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_61a3f55d-2016-4bb6-ab97-67521ad15867_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of main reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_0509dc80-884a-4f58-8cdf-6b3a08457dae_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_2d079bcd-abb1-43c1-adb4-67830a40f188_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption_0712ae73-6e7b-47ef-a604-54e4b2c3304e_terseLabel_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of option</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption_label_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investment, Options Issued, Term Of Option</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption_documentation_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Options Issued, Term Of Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption" xlink:to="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_4c612056-9a94-46fb-a2de-2794de982fb1_verboseLabel_en-US" xlink:label="lab_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_label_en-US" xlink:label="lab_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Cash Cash Equivalents And Restricted Cash [Abstract]</link:label>
    <link:label id="lab_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_documentation_en-US" xlink:label="lab_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:href="asth-20231231.xsd#asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:to="lab_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PerformanceBasedRestrictedStockMember_b4d639a4-8906-4919-9ec9-4565e54ae648_terseLabel_en-US" xlink:label="lab_asth_PerformanceBasedRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock</link:label>
    <link:label id="lab_asth_PerformanceBasedRestrictedStockMember_label_en-US" xlink:label="lab_asth_PerformanceBasedRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock [Member]</link:label>
    <link:label id="lab_asth_PerformanceBasedRestrictedStockMember_documentation_en-US" xlink:label="lab_asth_PerformanceBasedRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockMember" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PerformanceBasedRestrictedStockMember" xlink:to="lab_asth_PerformanceBasedRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend_02971e3e-80bf-421d-b647-93a4715e416d_negatedLabel_en-US" xlink:label="lab_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed dividend</link:label>
    <link:label id="lab_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend_label_en-US" xlink:label="lab_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Undistributed Dividend</link:label>
    <link:label id="lab_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend_documentation_en-US" xlink:label="lab_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Undistributed Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" xlink:href="asth-20231231.xsd#asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" xlink:to="lab_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_2171ec2e-fe9e-4cf5-acff-b89bf9811c3e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquityMethodInvestmentsRollForward_f58d16ad-cd7d-4d36-b671-17832f899532_terseLabel_en-US" xlink:label="lab_asth_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentsRollForward_label_en-US" xlink:label="lab_asth_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentsRollForward_documentation_en-US" xlink:label="lab_asth_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentsRollForward" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquityMethodInvestmentsRollForward" xlink:to="lab_asth_EquityMethodInvestmentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFloorInterestRate_2489d0c2-6e12-4bcd-ad18-c09a8ece712f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, floor interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeFloorInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Floor Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFloorInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFloorInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFloorInterestRate" xlink:to="lab_us-gaap_DerivativeFloorInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_ccc8e01d-2c27-4ac8-b6ae-fb7d2293376f_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_b411f875-1a68-4cdd-83e6-87a02289296b_totalLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_c09bbc2b-15f3-4c9f-8890-88a3584979e4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_a02e9ecf-bc93-4759-9329-edb74a6b2604_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_OperatingLossCarryforwardsNotSubjectToExpiration_c14a5345-d441-43ec-b202-8c2e1f0dec9f_terseLabel_en-US" xlink:label="lab_asth_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, not subject to expiration</link:label>
    <link:label id="lab_asth_OperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_asth_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:label id="lab_asth_OperatingLossCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_asth_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="asth-20231231.xsd#asth_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_asth_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquityMethodInvestmentAdditionalInvestment_aaa345b5-c20a-4c20-85dc-403377568d9d_terseLabel_en-US" xlink:label="lab_asth_EquityMethodInvestmentAdditionalInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Investment</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentAdditionalInvestment_label_en-US" xlink:label="lab_asth_EquityMethodInvestmentAdditionalInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Additional Investment</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentAdditionalInvestment_documentation_en-US" xlink:label="lab_asth_EquityMethodInvestmentAdditionalInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Additional Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentAdditionalInvestment" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentAdditionalInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquityMethodInvestmentAdditionalInvestment" xlink:to="lab_asth_EquityMethodInvestmentAdditionalInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_7a357d10-edc7-4ed7-b5e5-9c9349ef666a_terseLabel_en-US" xlink:label="lab_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_label_en-US" xlink:label="lab_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity</link:label>
    <link:label id="lab_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_documentation_en-US" xlink:label="lab_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:href="asth-20231231.xsd#asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:to="lab_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6c34a327-50cd-45aa-be47-71f4c50d4ab6_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CreditAgreementMember_cf9919ec-873a-45c7-8ef1-9a3fb706b08d_terseLabel_en-US" xlink:label="lab_asth_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_asth_CreditAgreementMember_label_en-US" xlink:label="lab_asth_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_asth_CreditAgreementMember_documentation_en-US" xlink:label="lab_asth_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CreditAgreementMember" xlink:href="asth-20231231.xsd#asth_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CreditAgreementMember" xlink:to="lab_asth_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_28de18f0-9c47-4156-81ac-23b38269114b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_eeae0fe1-0b8d-4bd2-8df9-9fac4dbbce0b_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f06bb966-c0c3-42b4-a43c-e957b403109c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of existing Level 3 liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_0c35233f-8a25-407a-bcbd-613d46dce76f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CashlessExerciseOfStockOptions_7897611f-7867-487c-8208-a1a02600b2ec_verboseLabel_en-US" xlink:label="lab_asth_CashlessExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless exercise of warrants</link:label>
    <link:label id="lab_asth_CashlessExerciseOfStockOptions_label_en-US" xlink:label="lab_asth_CashlessExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless Exercise Of Stock Options</link:label>
    <link:label id="lab_asth_CashlessExerciseOfStockOptions_documentation_en-US" xlink:label="lab_asth_CashlessExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless Exercise Of Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CashlessExerciseOfStockOptions" xlink:href="asth-20231231.xsd#asth_CashlessExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CashlessExerciseOfStockOptions" xlink:to="lab_asth_CashlessExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5475cfdf-5a15-4544-9e92-1f886fc13704_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_d0c22f65-e3fa-432f-9a7e-0477505d6496_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_e2fc7f96-56b9-42dd-90d8-07714df05fb7_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquityMethodInvestmentAdjustmentToFairValue_d0bb17b4-b213-4518-909a-7bd4ba6e0d06_terseLabel_en-US" xlink:label="lab_asth_EquityMethodInvestmentAdjustmentToFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to fair value</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentAdjustmentToFairValue_label_en-US" xlink:label="lab_asth_EquityMethodInvestmentAdjustmentToFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Adjustment To Fair Value</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentAdjustmentToFairValue_documentation_en-US" xlink:label="lab_asth_EquityMethodInvestmentAdjustmentToFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Adjustment To Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentAdjustmentToFairValue" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentAdjustmentToFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquityMethodInvestmentAdjustmentToFairValue" xlink:to="lab_asth_EquityMethodInvestmentAdjustmentToFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_c5fab34c-6032-4978-9016-4a41fead7153_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, non-current</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_be32e874-6b5e-41ef-a893-de312e364f84_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Debt Securities, Trading, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_52a601a1-a1b2-45be-9db1-bc2d8090b17d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, liquidation preference (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_PreferredStockLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockLiquidationPreference" xlink:to="lab_us-gaap_PreferredStockLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a6062e1b-5a11-42f2-9b5c-e6e5ed3e8565_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_22788a97-83f1-4e09-8ce5-d543e37c3f85_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_7667c22b-5dc4-4d9d-8e89-d14d20a473cd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility, Bank Loans, and Lines of Credit</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_StockholdersEquityTransferOfCommonControlEntities_dd68f8bf-ce84-4873-9a9a-47d793323038_negatedTerseLabel_en-US" xlink:label="lab_asth_StockholdersEquityTransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer of common control entities</link:label>
    <link:label id="lab_asth_StockholdersEquityTransferOfCommonControlEntities_label_en-US" xlink:label="lab_asth_StockholdersEquityTransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Transfer Of Common Control Entities</link:label>
    <link:label id="lab_asth_StockholdersEquityTransferOfCommonControlEntities_documentation_en-US" xlink:label="lab_asth_StockholdersEquityTransferOfCommonControlEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Transfer Of Common Control Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockholdersEquityTransferOfCommonControlEntities" xlink:href="asth-20231231.xsd#asth_StockholdersEquityTransferOfCommonControlEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_StockholdersEquityTransferOfCommonControlEntities" xlink:to="lab_asth_StockholdersEquityTransferOfCommonControlEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_39705f56-94b4-4517-933f-2f2683dc9c0d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_d5815849-1429-4895-8c58-e119c860d6ff_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer discretionary contribution amount</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_a2bb5a94-ceef-4438-aa58-f259775a7b73_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Loan</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_60b79ebf-6f40-402c-83d3-de3b92648ad8_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment/ Disposal</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_825557f7-5c04-467a-be6b-f6388ba22edc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_7275d864-ee7d-4277-92fe-70d545385284_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_f9b3061f-0ee9-40b1-b649-bd399942ab9e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_19dbc95a-6e39-4862-b002-6f9b05ec1e8c_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a4af3706-8f48-4805-8eb3-412aabfdeda1_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_9e4a677e-7641-4b3b-b7c9-e81cada88841_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1dd3c219-b5bf-47ad-8ea8-7a105e03ea87_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax provision at U.S. federal statutory rates</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_0be156a9-7245-4f6f-8954-d74eded2c49c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal corporate tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_a994ca23-f5cc-49b6-b239-00d383c8cac7_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cf021f5a-5054-44b8-b219-11610dc33145_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_99ee10e7-911e-4d1a-b9e6-ad03e248a2e3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_9f7b24e7-2934-4589-878f-b1feadf91a4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of beneficial interest</link:label>
    <link:label id="lab_us-gaap_OtherAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_OtherAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetImpairmentCharges" xlink:to="lab_us-gaap_OtherAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="lab_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_b9c1bbb4-0043-4175-9d88-1fa36d731051_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_A2024MetricMember_34985024-8b75-45b2-b873-96281e57e01b_terseLabel_en-US" xlink:label="lab_asth_A2024MetricMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Metric</link:label>
    <link:label id="lab_asth_A2024MetricMember_label_en-US" xlink:label="lab_asth_A2024MetricMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Metric [Member]</link:label>
    <link:label id="lab_asth_A2024MetricMember_documentation_en-US" xlink:label="lab_asth_A2024MetricMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Metric</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_A2024MetricMember" xlink:href="asth-20231231.xsd#asth_A2024MetricMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_A2024MetricMember" xlink:to="lab_asth_A2024MetricMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_StockAwardsAndUnitsMember_7003eb78-f010-4871-b837-15a9aaacd3d6_terseLabel_en-US" xlink:label="lab_asth_StockAwardsAndUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards</link:label>
    <link:label id="lab_asth_StockAwardsAndUnitsMember_label_en-US" xlink:label="lab_asth_StockAwardsAndUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards And Units [Member]</link:label>
    <link:label id="lab_asth_StockAwardsAndUnitsMember_documentation_en-US" xlink:label="lab_asth_StockAwardsAndUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Awards And Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockAwardsAndUnitsMember" xlink:href="asth-20231231.xsd#asth_StockAwardsAndUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_StockAwardsAndUnitsMember" xlink:to="lab_asth_StockAwardsAndUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_3b9618dc-d045-45eb-a6f3-bac20386c020_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting rights held (more than)</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_707392e7-d9b0-4e75-a3c9-b122f36956df_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_c57602e9-6e54-4867-bf9e-97c9d32181c6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_62aa6ff0-7388-49a3-b674-470cc56ade88_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical liabilities, beginning of year</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_98c6c899-2baf-4369-a800-0a3f88771aeb_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical liabilities, end of year</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_A2023MetricMember_f8cf3e4b-443c-4b3b-b8df-3799a2c41245_terseLabel_en-US" xlink:label="lab_asth_A2023MetricMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Metric</link:label>
    <link:label id="lab_asth_A2023MetricMember_label_en-US" xlink:label="lab_asth_A2023MetricMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Metric [Member]</link:label>
    <link:label id="lab_asth_A2023MetricMember_documentation_en-US" xlink:label="lab_asth_A2023MetricMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Metric</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_A2023MetricMember" xlink:href="asth-20231231.xsd#asth_A2023MetricMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_A2023MetricMember" xlink:to="lab_asth_A2023MetricMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_6dc91e7d-84d7-48cc-80a7-b99acb32a358_terseLabel_en-US" xlink:label="lab_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orma Health, Inc., and Provider Growth Solutions LLC</link:label>
    <link:label id="lab_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_label_en-US" xlink:label="lab_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orma Health, Inc., and Provider Growth Solutions LLC [Member]</link:label>
    <link:label id="lab_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_documentation_en-US" xlink:label="lab_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orma Health, Inc., and Provider Growth Solutions LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:href="asth-20231231.xsd#asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:to="lab_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_b93300b8-4bff-49ed-8bcb-3fe4af1c06e8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_f38aec12-7380-41f7-bcd2-321eb9da2874_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_8674e635-0148-4094-b393-948fb3fc81a7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquityMethodInvestmentsContribution_4702c0af-86c7-4217-8df4-20ab52e2abfb_verboseLabel_en-US" xlink:label="lab_asth_EquityMethodInvestmentsContribution" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentsContribution_label_en-US" xlink:label="lab_asth_EquityMethodInvestmentsContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Contribution</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentsContribution_documentation_en-US" xlink:label="lab_asth_EquityMethodInvestmentsContribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentsContribution" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentsContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquityMethodInvestmentsContribution" xlink:to="lab_asth_EquityMethodInvestmentsContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_461d87e7-10cf-4074-ae95-d32bb42f0b92_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_18e7b620-b12c-476f-9d7e-2d1a21409a8b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_TemporaryEquityTaxImpactOnAcquisition_d9071d13-47f0-4393-a1ee-e0f7a596afbb_negatedLabel_en-US" xlink:label="lab_asth_TemporaryEquityTaxImpactOnAcquisition" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact of acquisition</link:label>
    <link:label id="lab_asth_TemporaryEquityTaxImpactOnAcquisition_label_en-US" xlink:label="lab_asth_TemporaryEquityTaxImpactOnAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Tax Impact on Acquisition</link:label>
    <link:label id="lab_asth_TemporaryEquityTaxImpactOnAcquisition_documentation_en-US" xlink:label="lab_asth_TemporaryEquityTaxImpactOnAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Tax Impact on Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityTaxImpactOnAcquisition" xlink:href="asth-20231231.xsd#asth_TemporaryEquityTaxImpactOnAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_TemporaryEquityTaxImpactOnAcquisition" xlink:to="lab_asth_TemporaryEquityTaxImpactOnAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_e6e8af5a-5c14-4efb-93cc-795034c2be05_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant-Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ApolloMedicalHoldingsIncMember_e428826e-a647-44ca-bfc6-d7596edd38f0_terseLabel_en-US" xlink:label="lab_asth_ApolloMedicalHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ApolloMed</link:label>
    <link:label id="lab_asth_ApolloMedicalHoldingsIncMember_label_en-US" xlink:label="lab_asth_ApolloMedicalHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Apollo Medical Holdings, Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloMedicalHoldingsIncMember" xlink:href="asth-20231231.xsd#asth_ApolloMedicalHoldingsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ApolloMedicalHoldingsIncMember" xlink:to="lab_asth_ApolloMedicalHoldingsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_c9cf8e86-d208-4a46-8537-234b32a3e7a6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_fb779b93-9d5e-43bd-af87-bab2c99c4ddd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DmgMember_285dbee0-7f52-49e1-bc5b-148aa9b3fbdf_terseLabel_en-US" xlink:label="lab_asth_DmgMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG</link:label>
    <link:label id="lab_asth_DmgMember_label_en-US" xlink:label="lab_asth_DmgMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DMG [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DmgMember" xlink:href="asth-20231231.xsd#asth_DmgMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DmgMember" xlink:to="lab_asth_DmgMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_48c02470-d4e7-4911-8470-cec8df8c8d8e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fadec4dd-756d-40fb-8da6-0800e5b1aa00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_d427420a-f583-4336-8beb-e2084febce15_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_40f4279e-6ab5-4c15-b58a-ec891821ef98_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_998ed8d8-8293-4da9-a2ce-ec12ad40a1ac_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_aafcd343-b3ba-47c1-b097-ab988db82e55_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, common, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_75d03bf2-0547-492e-8670-31fa2f2fe358_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b1913fd9-881f-405d-9fcb-64b309aba871_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest_aff64e28-1348-4598-b835-0b6cf12d3c87_terseLabel_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Membership interests acquired (in dollars per share)</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest_label_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Membership Interest Acquired, Per Interest</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest_documentation_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Membership Interest Acquired, Per Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest" xlink:to="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0c190148-09e5-4652-8881-327fc8a63028_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds for exercise of options and warrants</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RestructuringSpinoffTransactionDividendRealEstateOperations_71aedc51-9720-4c07-826b-2bd28d62025d_terseLabel_en-US" xlink:label="lab_asth_RestructuringSpinoffTransactionDividendRealEstateOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spinoff transaction, dividend, real estate operations portion</link:label>
    <link:label id="lab_asth_RestructuringSpinoffTransactionDividendRealEstateOperations_label_en-US" xlink:label="lab_asth_RestructuringSpinoffTransactionDividendRealEstateOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Spinoff Transaction, Dividend, Real Estate Operations</link:label>
    <link:label id="lab_asth_RestructuringSpinoffTransactionDividendRealEstateOperations_documentation_en-US" xlink:label="lab_asth_RestructuringSpinoffTransactionDividendRealEstateOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Spinoff Transaction, Dividend, Real Estate Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RestructuringSpinoffTransactionDividendRealEstateOperations" xlink:href="asth-20231231.xsd#asth_RestructuringSpinoffTransactionDividendRealEstateOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RestructuringSpinoffTransactionDividendRealEstateOperations" xlink:to="lab_asth_RestructuringSpinoffTransactionDividendRealEstateOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties_5f5110b4-9b18-4948-b9f3-d0accdef2182_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable, net &#8211; related parties</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Due from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:to="lab_us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_333400fe-8187-4c5f-be45-521e69e23c10_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_09bae945-2d59-4000-8f2f-c41bcba66fe9_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Astrana Health, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_b2f18691-36aa-477b-9a30-cef4a604113c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a625f1d0-00a5-4509-bf8d-b994408e3d64_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_b671295d-84bb-4e3d-8ce8-3ccdef78c369_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_96828c54-8747-4c0d-976e-66af34eed9f8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_18036e64-2162-47c8-ad2f-55c6471a55bb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_89819b77-aafc-4086-82c2-03495296e022_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, property, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f7831ed9-7dcd-4988-855a-3b7190e2fc6e_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Mezzanine Equity (Deficit), and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_3b247dfc-1797-4b24-941c-da45825b4777_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_6447e0cf-97b2-4140-8bce-2772d752776d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share buy back</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ProviderServicesMember_fdb54c2b-4959-47c6-a89e-c66596ec2413_terseLabel_en-US" xlink:label="lab_asth_ProviderServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Services</link:label>
    <link:label id="lab_asth_ProviderServicesMember_label_en-US" xlink:label="lab_asth_ProviderServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Services [Member]</link:label>
    <link:label id="lab_asth_ProviderServicesMember_documentation_en-US" xlink:label="lab_asth_ProviderServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ProviderServicesMember" xlink:href="asth-20231231.xsd#asth_ProviderServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ProviderServicesMember" xlink:to="lab_asth_ProviderServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_0f959718-7e71-4469-bd01-66f67eeff27a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MediPortalLLCMember_92243b11-75d2-4d3e-8781-c28e5494a54d_terseLabel_en-US" xlink:label="lab_asth_MediPortalLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MediPortal LLC</link:label>
    <link:label id="lab_asth_MediPortalLLCMember_label_en-US" xlink:label="lab_asth_MediPortalLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MediPortal LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MediPortalLLCMember" xlink:href="asth-20231231.xsd#asth_MediPortalLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MediPortalLLCMember" xlink:to="lab_asth_MediPortalLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_25da5c22-405f-43c6-8550-6f26e8ba8ec8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_72813059-e6fe-46a0-b445-d8bf2bee7c4b_terseLabel_en-US" xlink:label="lab_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, equity interest purchase obligation, period to purchase</link:label>
    <link:label id="lab_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_label_en-US" xlink:label="lab_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Equity Interest Purchase Obligation, Period to Purchase</link:label>
    <link:label id="lab_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_documentation_en-US" xlink:label="lab_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Equity Interest Purchase Obligation, Period to Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:href="asth-20231231.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:to="lab_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d460891-5f18-4f40-8963-8cf41638bf46_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for exercise of options and warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dc7de396-5921-474a-b1e6-6ac906ee0711_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1bdd7dd6-5c38-42be-9312-c3978e1fbf54_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_2d08b7b2-bf50-4bef-9850-39b484ef8990_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_d6a226dc-5906-46fb-9ae9-fa7fde8732b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LineOfCreditFacilityAmountFundedAtClosing_a70c04f2-ccac-47f3-ba32-f423a0583ff7_terseLabel_en-US" xlink:label="lab_asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, amount funded at closing</link:label>
    <link:label id="lab_asth_LineOfCreditFacilityAmountFundedAtClosing_label_en-US" xlink:label="lab_asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Amount Funded At Closing</link:label>
    <link:label id="lab_asth_LineOfCreditFacilityAmountFundedAtClosing_documentation_en-US" xlink:label="lab_asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Amount Funded At Closing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:href="asth-20231231.xsd#asth_LineOfCreditFacilityAmountFundedAtClosing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:to="lab_asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_06be69da-6857-441b-ba95-fe2c380546e2_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_06989cdf-0f10-4840-9452-ebc5c296e950_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_e2608cde-a85a-437b-8439-d6d896c5307f_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_370d5e8b-c73a-40ff-959f-9dd31e9a3609_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ManagementContractsMember_42991cea-1887-40c4-beac-228742c96113_verboseLabel_en-US" xlink:label="lab_asth_ManagementContractsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management contracts</link:label>
    <link:label id="lab_asth_ManagementContractsMember_label_en-US" xlink:label="lab_asth_ManagementContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Contracts [Member]</link:label>
    <link:label id="lab_asth_ManagementContractsMember_documentation_en-US" xlink:label="lab_asth_ManagementContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ManagementContractsMember" xlink:href="asth-20231231.xsd#asth_ManagementContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ManagementContractsMember" xlink:to="lab_asth_ManagementContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LasalleMedicalAssociatesIpaMember_1553b1c9-0faf-4547-a2df-5d37f160138f_terseLabel_en-US" xlink:label="lab_asth_LasalleMedicalAssociatesIpaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LaSalle Medical Associates &#8211; IPA Line of Business</link:label>
    <link:label id="lab_asth_LasalleMedicalAssociatesIpaMember_label_en-US" xlink:label="lab_asth_LasalleMedicalAssociatesIpaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LaSalle Medical Associates IPA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LasalleMedicalAssociatesIpaMember" xlink:href="asth-20231231.xsd#asth_LasalleMedicalAssociatesIpaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LasalleMedicalAssociatesIpaMember" xlink:to="lab_asth_LasalleMedicalAssociatesIpaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_fba6ac2b-496d-4bbc-bb0a-764f2fc6d7cf_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_2f6ff3e3-4bec-4a6c-bf95-2614eb28b9b3_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior periods</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_6f150b3d-5cf7-4b67-84cf-6ff9f887af20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquityMethodInvestmentsConsolidated_5b7290bc-38e9-4ad6-b9d1-34ea5862f691_negatedTerseLabel_en-US" xlink:label="lab_asth_EquityMethodInvestmentsConsolidated" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Consolidated</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentsConsolidated_label_en-US" xlink:label="lab_asth_EquityMethodInvestmentsConsolidated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Consolidated</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentsConsolidated_documentation_en-US" xlink:label="lab_asth_EquityMethodInvestmentsConsolidated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Consolidated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentsConsolidated" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentsConsolidated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquityMethodInvestmentsConsolidated" xlink:to="lab_asth_EquityMethodInvestmentsConsolidated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_bfb8a86a-4414-49c2-ba32-b08fd376e419_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e27100d8-6864-44b3-b295-e30723ea7ed4_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b5f0d55d-0362-4b8f-8ec8-081ad2a2db92_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b8030492-b177-48d2-82aa-50a14e6c022f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_dab0f3d6-5bbf-4a5a-ae3c-cd8b3830bdda_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of loans receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-Term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_0781a32a-19ae-40e3-b881-f7d3c06dcca6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1ea89342-9a50-4cc7-a7cd-09d713b7ff91_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_HSMSOMember_91c4ebae-9957-417e-9663-90c522e1e948_terseLabel_en-US" xlink:label="lab_asth_HSMSOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSMSO</link:label>
    <link:label id="lab_asth_HSMSOMember_label_en-US" xlink:label="lab_asth_HSMSOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSMSO [Member]</link:label>
    <link:label id="lab_asth_HSMSOMember_documentation_en-US" xlink:label="lab_asth_HSMSOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xxx_HSMSO Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_HSMSOMember" xlink:href="asth-20231231.xsd#asth_HSMSOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_HSMSOMember" xlink:to="lab_asth_HSMSOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_ead1d1e0-d8d0-410c-bfd7-f5ba426d98c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance cost</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ClaimsBasedOnOccurrenceAnAggregateAmount_23b71a55-3985-48e7-8f72-8f58b215a646_terseLabel_en-US" xlink:label="lab_asth_ClaimsBasedOnOccurrenceAnAggregateAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims based on occurrence an aggregate amount</link:label>
    <link:label id="lab_asth_ClaimsBasedOnOccurrenceAnAggregateAmount_label_en-US" xlink:label="lab_asth_ClaimsBasedOnOccurrenceAnAggregateAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Based On Occurrence An Aggregate Amount</link:label>
    <link:label id="lab_asth_ClaimsBasedOnOccurrenceAnAggregateAmount_documentation_en-US" xlink:label="lab_asth_ClaimsBasedOnOccurrenceAnAggregateAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Based On Occurrence An Aggregate Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ClaimsBasedOnOccurrenceAnAggregateAmount" xlink:href="asth-20231231.xsd#asth_ClaimsBasedOnOccurrenceAnAggregateAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ClaimsBasedOnOccurrenceAnAggregateAmount" xlink:to="lab_asth_ClaimsBasedOnOccurrenceAnAggregateAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c6e8c43-0c1d-4a25-a3a9-9f64d75a6855_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SummaryOfSignificantAccountingPoliciesTable_d61725e1-8c47-4efd-a94c-f9ade46826e1_terseLabel_en-US" xlink:label="lab_asth_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_asth_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_asth_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_asth_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_asth_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SummaryOfSignificantAccountingPoliciesTable" xlink:href="asth-20231231.xsd#asth_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_asth_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_1d8445a2-7764-4740-b053-113d966f5030_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Unamortized financing costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_e1e8d92d-78ad-478a-905c-351b8f4af104_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DefinedContributionPlanServicePeriod_3bd36b18-c96f-4dcd-91b1-97799680d876_terseLabel_en-US" xlink:label="lab_asth_DefinedContributionPlanServicePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, service period</link:label>
    <link:label id="lab_asth_DefinedContributionPlanServicePeriod_label_en-US" xlink:label="lab_asth_DefinedContributionPlanServicePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Service Period</link:label>
    <link:label id="lab_asth_DefinedContributionPlanServicePeriod_documentation_en-US" xlink:label="lab_asth_DefinedContributionPlanServicePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DefinedContributionPlanServicePeriod" xlink:href="asth-20231231.xsd#asth_DefinedContributionPlanServicePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DefinedContributionPlanServicePeriod" xlink:to="lab_asth_DefinedContributionPlanServicePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AurionMember_24c3e808-6017-4fe5-a09a-dd3dccb22398_terseLabel_en-US" xlink:label="lab_asth_AurionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AURION</link:label>
    <link:label id="lab_asth_AurionMember_label_en-US" xlink:label="lab_asth_AurionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurion [Member]</link:label>
    <link:label id="lab_asth_AurionMember_documentation_en-US" xlink:label="lab_asth_AurionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xxx_Aurion Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AurionMember" xlink:href="asth-20231231.xsd#asth_AurionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AurionMember" xlink:to="lab_asth_AurionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PerformanceBasedRestrictedStockUnitsMember_6c703e1f-cbc9-4238-89c4-34a54c7e2a2c_terseLabel_en-US" xlink:label="lab_asth_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock Awards</link:label>
    <link:label id="lab_asth_PerformanceBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_asth_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_asth_PerformanceBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_asth_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockUnitsMember" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PerformanceBasedRestrictedStockUnitsMember" xlink:to="lab_asth_PerformanceBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ee019efa-c132-455c-be71-843a3629c9d6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leases, Future Minimum Lease Payments After Adoption of 842</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_1e197492-5213-45dc-8a40-1897816a68c9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to weighted average shares of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_e318fd2f-f678-41f4-b435-2aa7af0c0471_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_022ed97b-feb2-46cc-a2f2-8cab9fe7b20d_terseLabel_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_label_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_documentation_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:to="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_7d0143a0-de87-4d9e-90b3-1fcc611901c1_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_6761e21a-f6ab-4ea1-b0c9-3867506e0642_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_f0aa1561-5dbb-4de2-bfc1-1f51814573dc_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_ca049a39-a864-4b65-bdba-46243ef739ca_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Expense and Other Information Related to Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RevolverLoanMember_e960fcea-465a-4187-a53f-a5423c5a9a19_terseLabel_en-US" xlink:label="lab_asth_RevolverLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Loan</link:label>
    <link:label id="lab_asth_RevolverLoanMember_label_en-US" xlink:label="lab_asth_RevolverLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Loan [Member]</link:label>
    <link:label id="lab_asth_RevolverLoanMember_documentation_en-US" xlink:label="lab_asth_RevolverLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RevolverLoanMember" xlink:href="asth-20231231.xsd#asth_RevolverLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RevolverLoanMember" xlink:to="lab_asth_RevolverLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_14b4dba1-b1a6-4025-a186-ca5f81ee9e5e_terseLabel_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit</link:label>
    <link:label id="lab_us-gaap_StandbyLettersOfCreditMember_label_en-US" xlink:label="lab_us-gaap_StandbyLettersOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standby Letters of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandbyLettersOfCreditMember" xlink:to="lab_us-gaap_StandbyLettersOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7e0549da-1605-48a0-8e33-f01634877b64_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_UnamortizedDeferredFinancingCosts_ddc375a0-2e36-4435-95ad-dd6447c58b93_terseLabel_en-US" xlink:label="lab_asth_UnamortizedDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_asth_UnamortizedDeferredFinancingCosts_label_en-US" xlink:label="lab_asth_UnamortizedDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Deferred Financing Costs</link:label>
    <link:label id="lab_asth_UnamortizedDeferredFinancingCosts_documentation_en-US" xlink:label="lab_asth_UnamortizedDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Deferred Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_UnamortizedDeferredFinancingCosts" xlink:href="asth-20231231.xsd#asth_UnamortizedDeferredFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_UnamortizedDeferredFinancingCosts" xlink:to="lab_asth_UnamortizedDeferredFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_926487be-87a1-4d82-b844-852d4ae60e59_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MezzanineEquityAbstract_4ec14d7c-e331-4d7f-9796-63de6db9afe7_verboseLabel_en-US" xlink:label="lab_asth_MezzanineEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine (deficit) equity</link:label>
    <link:label id="lab_asth_MezzanineEquityAbstract_label_en-US" xlink:label="lab_asth_MezzanineEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MEZZANINE EQUITY [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MezzanineEquityAbstract" xlink:href="asth-20231231.xsd#asth_MezzanineEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MezzanineEquityAbstract" xlink:to="lab_asth_MezzanineEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_0e94fc4f-9df1-4816-9c49-a36a2e6d8c6e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NoncontrollingInterestIncreaseFromCapitalCharge_aa2d06bd-cfb9-4b2d-9ab5-265d9ef412ca_terseLabel_en-US" xlink:label="lab_asth_NoncontrollingInterestIncreaseFromCapitalCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest capital change</link:label>
    <link:label id="lab_asth_NoncontrollingInterestIncreaseFromCapitalCharge_label_en-US" xlink:label="lab_asth_NoncontrollingInterestIncreaseFromCapitalCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase From Capital Charge</link:label>
    <link:label id="lab_asth_NoncontrollingInterestIncreaseFromCapitalCharge_documentation_en-US" xlink:label="lab_asth_NoncontrollingInterestIncreaseFromCapitalCharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase From Capital Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncontrollingInterestIncreaseFromCapitalCharge" xlink:href="asth-20231231.xsd#asth_NoncontrollingInterestIncreaseFromCapitalCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NoncontrollingInterestIncreaseFromCapitalCharge" xlink:to="lab_asth_NoncontrollingInterestIncreaseFromCapitalCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_FiduciaryAccountsPayableCurrent_4ea746b0-2030-4159-804b-b722ba5d1a0d_terseLabel_en-US" xlink:label="lab_asth_FiduciaryAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary accounts payable</link:label>
    <link:label id="lab_asth_FiduciaryAccountsPayableCurrent_label_en-US" xlink:label="lab_asth_FiduciaryAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary Accounts Payable Current</link:label>
    <link:label id="lab_asth_FiduciaryAccountsPayableCurrent_documentation_en-US" xlink:label="lab_asth_FiduciaryAccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryAccountsPayableCurrent" xlink:href="asth-20231231.xsd#asth_FiduciaryAccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_FiduciaryAccountsPayableCurrent" xlink:to="lab_asth_FiduciaryAccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_f11d620b-5fd1-4792-ae46-8400c9e9bbfc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_beab7a90-0e97-42c5-9170-fb6ee89eda42_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_989f15c0-7681-47ff-9992-7dfe6c2586ab_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_OfficeLeaseMember_5e5ebebd-ed97-4cd2-ad78-ce438b558065_terseLabel_en-US" xlink:label="lab_asth_OfficeLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Lease</link:label>
    <link:label id="lab_asth_OfficeLeaseMember_label_en-US" xlink:label="lab_asth_OfficeLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Lease [Member]</link:label>
    <link:label id="lab_asth_OfficeLeaseMember_documentation_en-US" xlink:label="lab_asth_OfficeLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OfficeLeaseMember" xlink:href="asth-20231231.xsd#asth_OfficeLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_OfficeLeaseMember" xlink:to="lab_asth_OfficeLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a9dc96ae-430c-46e1-8c86-85c20eb690ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_b236012b-4bba-4d54-8e7a-34a79528e943_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_ae4cf6c1-a06e-416f-a0e9-b322ef299750_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_402067a4-11e4-44ee-954c-f92b2b5ee624_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_4ae02a66-e6e6-47e7-999b-3e9cb3bed624_terseLabel_en-US" xlink:label="lab_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum consolidated interest coverage ratio</link:label>
    <link:label id="lab_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_label_en-US" xlink:label="lab_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</link:label>
    <link:label id="lab_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_documentation_en-US" xlink:label="lab_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:to="lab_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_c73d8cc0-0cdc-4861-9bbb-2210df2c3852_verboseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PayorCMember_f5e417f9-54e8-470e-8e7f-bdb6bdf4c093_terseLabel_en-US" xlink:label="lab_asth_PayorCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payer C</link:label>
    <link:label id="lab_asth_PayorCMember_label_en-US" xlink:label="lab_asth_PayorCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor C [Member]</link:label>
    <link:label id="lab_asth_PayorCMember_documentation_en-US" xlink:label="lab_asth_PayorCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor C [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorCMember" xlink:href="asth-20231231.xsd#asth_PayorCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PayorCMember" xlink:to="lab_asth_PayorCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_9fd6d81c-e618-4ec9-818c-d9d61019ec3d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b43a6174-a788-4124-9684-a98b1e9d7f81_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_2a20a661-c07c-4a17-bd0a-f92386167b5e_terseLabel_en-US" xlink:label="lab_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_label_en-US" xlink:label="lab_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expenses and Depreciation and Amortization</link:label>
    <link:label id="lab_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_documentation_en-US" xlink:label="lab_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expenses and Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:href="asth-20231231.xsd#asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:to="lab_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8fdd3966-43e6-47c7-995a-867ef933c86e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_f53ed6e3-4cbb-4ce9-be13-3b9b4cf3ce3f_verboseLabel_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California</link:label>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_label_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Franchise Tax Board [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:to="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_ff23f031-f723-4be2-ac9b-474efbc85251_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ConsultingServicesMember_67d721f2-2ede-4bf4-80ff-962d998ff7c7_terseLabel_en-US" xlink:label="lab_asth_ConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services</link:label>
    <link:label id="lab_asth_ConsultingServicesMember_label_en-US" xlink:label="lab_asth_ConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services [Member]</link:label>
    <link:label id="lab_asth_ConsultingServicesMember_documentation_en-US" xlink:label="lab_asth_ConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ConsultingServicesMember" xlink:href="asth-20231231.xsd#asth_ConsultingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ConsultingServicesMember" xlink:to="lab_asth_ConsultingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ApcStockOptionMember_dd6a0126-54c2-462c-b65e-f8f80b0d2f10_terseLabel_en-US" xlink:label="lab_asth_ApcStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Stock Option</link:label>
    <link:label id="lab_asth_ApcStockOptionMember_label_en-US" xlink:label="lab_asth_ApcStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcStockOptionMember" xlink:href="asth-20231231.xsd#asth_ApcStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ApcStockOptionMember" xlink:to="lab_asth_ApcStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_bf71158a-2ca9-49c3-ac9a-8f0b86f8e1d7_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_d40c11f2-71fa-4dd0-9266-ed68e6a4791e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_dce3d7b1-d417-4465-91a1-4e712c907f01_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount_0f7ba625-14b2-466c-a847-1a75ef393e51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Amount Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentSoldCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:to="lab_us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SubcontractorIpaRiskPoolPayable_9b01ad61-1f07-4495-be9a-f5a0cf546089_verboseLabel_en-US" xlink:label="lab_asth_SubcontractorIpaRiskPoolPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor IPA payable</link:label>
    <link:label id="lab_asth_SubcontractorIpaRiskPoolPayable_label_en-US" xlink:label="lab_asth_SubcontractorIpaRiskPoolPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor IPA Risk Pool Payable</link:label>
    <link:label id="lab_asth_SubcontractorIpaRiskPoolPayable_documentation_en-US" xlink:label="lab_asth_SubcontractorIpaRiskPoolPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of subcontractor IPA risk pool payable current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SubcontractorIpaRiskPoolPayable" xlink:href="asth-20231231.xsd#asth_SubcontractorIpaRiskPoolPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SubcontractorIpaRiskPoolPayable" xlink:to="lab_asth_SubcontractorIpaRiskPoolPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_ac0793f5-db6f-4600-b356-078307b85eda_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_c6b4273f-2d59-4c9d-b990-2c4c2ef1d02f_terseLabel_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent on performance (in shares)</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_label_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other Than Options, Contingent On Performance</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_documentation_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other Than Options, Contingent On Performance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:to="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3bc27433-7300-4c89-8d2d-797196732e8e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable/receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd024bc1-ba9d-4a42-b649-ee2544519698_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2bb8f852-7c9a-4f80-a1f8-b376a0dc5e8d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_faeb6b93-3028-44a2-b508-f8246987f732_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AHMCMember_29aa8d48-b6fb-47b7-a178-27520329aa66_terseLabel_en-US" xlink:label="lab_asth_AHMCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AHMC</link:label>
    <link:label id="lab_asth_AHMCMember_label_en-US" xlink:label="lab_asth_AHMCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AHMC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AHMCMember" xlink:href="asth-20231231.xsd#asth_AHMCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AHMCMember" xlink:to="lab_asth_AHMCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_d6bf61b5-5e4c-486b-9c51-48a0a5b0c5dd_terseLabel_en-US" xlink:label="lab_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease liabilities:</link:label>
    <link:label id="lab_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_label_en-US" xlink:label="lab_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Right Of Use Assets Obtained In Exchange For Lease Obligations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:href="asth-20231231.xsd#asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:to="lab_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_52685738-d166-4a97-9095-9f6b0f9f0367_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_66f2374a-9a24-49d5-8b62-d2a2960522e8_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9122c019-af73-4c9b-87cb-4ea4b387f83b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_fb98fb6b-1b72-49bb-97c8-dd38a78d816f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_473a61e3-4770-460a-aa6f-1c096c887744_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_1ca3f7a6-7e81-403b-b13e-ff31f0622d98_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_VOMGMember_35a2f075-533f-4626-9a5e-f5d3ccee1ff3_terseLabel_en-US" xlink:label="lab_asth_VOMGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOMG</link:label>
    <link:label id="lab_asth_VOMGMember_label_en-US" xlink:label="lab_asth_VOMGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOMG [Member]</link:label>
    <link:label id="lab_asth_VOMGMember_documentation_en-US" xlink:label="lab_asth_VOMGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOMG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_VOMGMember" xlink:href="asth-20231231.xsd#asth_VOMGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_VOMGMember" xlink:to="lab_asth_VOMGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8790e021-fc29-45e8-92e7-157fd59698eb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense, weighted-average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_Tag2PromissoryNoteMember_9389d782-1f27-40bc-b903-b7f33fb3ee99_terseLabel_en-US" xlink:label="lab_asth_Tag2PromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-2 Promissory Note</link:label>
    <link:label id="lab_asth_Tag2PromissoryNoteMember_label_en-US" xlink:label="lab_asth_Tag2PromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-2 Promissory Note [Member]</link:label>
    <link:label id="lab_asth_Tag2PromissoryNoteMember_documentation_en-US" xlink:label="lab_asth_Tag2PromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-2 Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag2PromissoryNoteMember" xlink:href="asth-20231231.xsd#asth_Tag2PromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_Tag2PromissoryNoteMember" xlink:to="lab_asth_Tag2PromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_ad316d95-a5b9-4055-808d-36352d4ed8d9_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory Note Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableToBanksMember" xlink:to="lab_us-gaap_NotesPayableToBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_c85cc8c1-e204-4d73-9e06-c7428e62800d_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_1987ad81-84b6-4540-aebf-248bf76e2113_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares for business acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0459e037-4ab6-4504-a31e-827da4fee02d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_bac20eb6-73db-422a-ab69-6c8313a7a857_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet_b05260b8-6eaf-4380-9d89-dfdc83c65883_terseLabel_en-US" xlink:label="lab_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants available to purchase, contingent upon the portal completion date (in shares)</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet_label_en-US" xlink:label="lab_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Options Issued, Option To Purchase Additional Interests, If Circumstances Met</link:label>
    <link:label id="lab_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet_documentation_en-US" xlink:label="lab_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Options Issued, Option To Purchase Additional Interests, If Circumstances Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet" xlink:to="lab_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9904f332-0be9-4a53-9e6a-43cd89e3f516_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_f3b51e0b-be8d-40a6-bfbf-585157ebc13c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_b9d19713-edd1-41b2-aa03-cce94ae76a4d_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NumberOfRealEstateLoans_ade5fedc-faed-4899-8539-0659aeb5fc95_terseLabel_en-US" xlink:label="lab_asth_NumberOfRealEstateLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of real estate loans</link:label>
    <link:label id="lab_asth_NumberOfRealEstateLoans_label_en-US" xlink:label="lab_asth_NumberOfRealEstateLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Real Estate Loans</link:label>
    <link:label id="lab_asth_NumberOfRealEstateLoans_documentation_en-US" xlink:label="lab_asth_NumberOfRealEstateLoans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Real Estate Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NumberOfRealEstateLoans" xlink:href="asth-20231231.xsd#asth_NumberOfRealEstateLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NumberOfRealEstateLoans" xlink:to="lab_asth_NumberOfRealEstateLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_75f79412-d7e7-4ae5-a701-84e3d16c81be_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_6f7682cc-ef5e-45b9-819f-f108126621bb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_43575579-9429-4e87-a4ff-912280d652c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_619c2665-1736-4598-b56d-357829957ace_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_35f48713-6b31-4c82-8ae4-1bb90099ad68_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares purchased by related party (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_OneMSOLLCMember_ae7eca14-5151-4818-9310-452086193549_terseLabel_en-US" xlink:label="lab_asth_OneMSOLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One MSO, LLC *</link:label>
    <link:label id="lab_asth_OneMSOLLCMember_label_en-US" xlink:label="lab_asth_OneMSOLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One MSO, LLC [Member]</link:label>
    <link:label id="lab_asth_OneMSOLLCMember_documentation_en-US" xlink:label="lab_asth_OneMSOLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One MSO, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OneMSOLLCMember" xlink:href="asth-20231231.xsd#asth_OneMSOLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_OneMSOLLCMember" xlink:to="lab_asth_OneMSOLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5db256c2-0d4b-4b8c-8b44-fa7f6bc0add3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market accounts</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares_b6631c16-96b8-4fc8-899a-335911f7a0d7_terseLabel_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Membership interests purchased (in shares)</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares_label_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Purchase Of Shares</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares_documentation_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Purchase Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares" xlink:to="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_0e3f3127-0f85-4bd0-912a-f8ea41c803bb_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_024d337d-baca-4a8f-8d28-fdaff2a8ba35_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_ec1e97a0-0e20-40bb-9896-efb7d2f95325_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms, financing</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:to="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LoanReceivableAbstract_f7509930-e58c-46aa-92fd-8359c96f1374_terseLabel_en-US" xlink:label="lab_asth_LoanReceivableAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable [Abstract]</link:label>
    <link:label id="lab_asth_LoanReceivableAbstract_label_en-US" xlink:label="lab_asth_LoanReceivableAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LoanReceivableAbstract" xlink:href="asth-20231231.xsd#asth_LoanReceivableAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LoanReceivableAbstract" xlink:to="lab_asth_LoanReceivableAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_52aad99a-8f10-4420-8457-ef76a5c75484_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts due from affiliates</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4c04b538-9c02-42ce-b4fc-c4caaf76e59f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_e9db55d6-33ff-445d-bd3f-465b951e6932_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_c9223281-46de-4470-9199-15c68c1315f2_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_564ab2f7-4653-48f9-ae3b-0baed0bdeb36_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_34e82e44-111c-4dd3-8090-9348c3bfb0a7_terseLabel_en-US" xlink:label="lab_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum adjusted consolidated leverage ratio</link:label>
    <link:label id="lab_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_label_en-US" xlink:label="lab_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum</link:label>
    <link:label id="lab_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_documentation_en-US" xlink:label="lab_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:to="lab_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_f21c177f-ecce-4830-ad27-05a86e0aaea6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Medical Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LoanReceivableTextBlock_41577a61-ffd2-4890-ba79-d2910d6ec825_terseLabel_en-US" xlink:label="lab_asth_LoanReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable and Loan Receivable &#8211; Related Parties</link:label>
    <link:label id="lab_asth_LoanReceivableTextBlock_label_en-US" xlink:label="lab_asth_LoanReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable [Text Block]</link:label>
    <link:label id="lab_asth_LoanReceivableTextBlock_documentation_en-US" xlink:label="lab_asth_LoanReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LoanReceivableTextBlock" xlink:href="asth-20231231.xsd#asth_LoanReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LoanReceivableTextBlock" xlink:to="lab_asth_LoanReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CollarMember_9e01fd29-c114-4c92-ae79-80c63b210527_terseLabel_en-US" xlink:label="lab_asth_CollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar</link:label>
    <link:label id="lab_asth_CollarMember_label_en-US" xlink:label="lab_asth_CollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar [Member]</link:label>
    <link:label id="lab_asth_CollarMember_documentation_en-US" xlink:label="lab_asth_CollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CollarMember" xlink:href="asth-20231231.xsd#asth_CollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CollarMember" xlink:to="lab_asth_CollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_b6ba7d05-67b0-4cb1-ac1d-405471db250b_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in other entities &#8211; equity method</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_31f52fdf-cb6c-434d-954b-c45b526c7ae5_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_c29e7463-a50e-4dd9-8eb6-75c5245e8804_periodEndLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_6c1d430c-8783-4775-82a9-f89bbca0e395_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in other entities &#8211; equity method</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_c2b587dc-d9e9-4b9e-a0f6-4c0c981069ed_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders_d7cc54b1-5c72-4f67-b81c-e4056ad6660a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments to) Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_ad57e580-ff9b-4877-bd53-a6a0a1dccf95_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RiskPoolSettlementsAndIncentivesMember_0766ef25-8ce7-46ef-8105-b2e3f9b5bcaf_terseLabel_en-US" xlink:label="lab_asth_RiskPoolSettlementsAndIncentivesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Pool Settlements and Incentives</link:label>
    <link:label id="lab_asth_RiskPoolSettlementsAndIncentivesMember_label_en-US" xlink:label="lab_asth_RiskPoolSettlementsAndIncentivesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Pool Settlements and Incentives [Member]</link:label>
    <link:label id="lab_asth_RiskPoolSettlementsAndIncentivesMember_documentation_en-US" xlink:label="lab_asth_RiskPoolSettlementsAndIncentivesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Pool Settlements and Incentives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RiskPoolSettlementsAndIncentivesMember" xlink:href="asth-20231231.xsd#asth_RiskPoolSettlementsAndIncentivesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RiskPoolSettlementsAndIncentivesMember" xlink:to="lab_asth_RiskPoolSettlementsAndIncentivesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CommitmentsAndContingenciesLineItems_075c7bac-2c90-4e5f-b048-0d963205f6ef_terseLabel_en-US" xlink:label="lab_asth_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_asth_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_asth_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommitmentsAndContingenciesLineItems" xlink:href="asth-20231231.xsd#asth_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems" xlink:to="lab_asth_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_a0c97456-38c5-44aa-b8b5-9f03c61c81e1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_971eae1b-e111-4097-bb29-42d8d9099d64_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_988e99f7-60e0-413d-966a-fbff211b684b_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LmaMember_860680b3-0507-46d4-a1cd-0bcbc0255162_terseLabel_en-US" xlink:label="lab_asth_LmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LMA</link:label>
    <link:label id="lab_asth_LmaMember_label_en-US" xlink:label="lab_asth_LmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LMA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LmaMember" xlink:href="asth-20231231.xsd#asth_LmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LmaMember" xlink:to="lab_asth_LmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_b16108b6-8c53-47f7-abd1-957371bb35bf_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid_727806c1-d0d5-403a-80a7-9a990ed774d0_negatedTerseLabel_en-US" xlink:label="lab_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APCMG contingent consideration paid</link:label>
    <link:label id="lab_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid_label_en-US" xlink:label="lab_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration Paid</link:label>
    <link:label id="lab_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid_documentation_en-US" xlink:label="lab_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid" xlink:href="asth-20231231.xsd#asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid" xlink:to="lab_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_23cbe07b-e64e-430f-9cb2-ebdd5ea5a62c_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of non-cash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DefinedContributionPlanVestingPeriod_8a7ce79c-4b29-4baf-888e-725b2b3b0d3e_terseLabel_en-US" xlink:label="lab_asth_DefinedContributionPlanVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefit vested estimated year</link:label>
    <link:label id="lab_asth_DefinedContributionPlanVestingPeriod_label_en-US" xlink:label="lab_asth_DefinedContributionPlanVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Vesting Period</link:label>
    <link:label id="lab_asth_DefinedContributionPlanVestingPeriod_documentation_en-US" xlink:label="lab_asth_DefinedContributionPlanVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DefinedContributionPlanVestingPeriod" xlink:href="asth-20231231.xsd#asth_DefinedContributionPlanVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DefinedContributionPlanVestingPeriod" xlink:to="lab_asth_DefinedContributionPlanVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_bda3ab1a-638b-4ec6-b77f-8afbc431d7ea_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_51f58a52-da0f-4d69-9e9e-43f364b903f7_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_e0d73a3f-4ee0-4a38-8f75-3b9dca95bc72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_25045f17-9e8a-490e-968a-dc9580d03cad_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_bb237e7a-8d59-4f38-a8fa-19919a36f296_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_874a53b3-84dd-408a-8b98-70a17078c1e9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for vesting of restricted stock awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_1a06bd43-77c3-42d5-b897-a06872134d2d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_3520acee-7771-4733-938b-d444303e3c95_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_1fe646e1-05f1-4800-80d0-f63f7360b073_netLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_IntraCareConvertiblePromissoryNoteReceivableMember_9e41e0f6-2eb6-4eef-b5e2-21faea6e8e87_terseLabel_en-US" xlink:label="lab_asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IntraCare Convertible Promissory Note Receivable</link:label>
    <link:label id="lab_asth_IntraCareConvertiblePromissoryNoteReceivableMember_label_en-US" xlink:label="lab_asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IntraCare Convertible Promissory Note Receivable [Member]</link:label>
    <link:label id="lab_asth_IntraCareConvertiblePromissoryNoteReceivableMember_documentation_en-US" xlink:label="lab_asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IntraCare Convertible Promissory Note Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:href="asth-20231231.xsd#asth_IntraCareConvertiblePromissoryNoteReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:to="lab_asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_a8ac485c-df3e-4aaa-8974-565168adff3d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_93191b2e-daca-4344-8044-de2539138351_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior periods</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_62c8d891-8493-4b2c-8527-391f8b99ee69_verboseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_dd0a2b72-b673-4f50-8d3c-9aa2e0ae54ad_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_10cc2902-231d-4a29-8480-27ae19ca6fec_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_23163af4-d922-458d-b7cc-00baabb68d64_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_62c5a011-9553-471b-ad3b-9041a0f47cf9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MedicareMember_592847df-3008-4019-8cfb-8b82b24cad1c_terseLabel_en-US" xlink:label="lab_asth_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_asth_MedicareMember_label_en-US" xlink:label="lab_asth_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_asth_MedicareMember_documentation_en-US" xlink:label="lab_asth_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ameh:MedicareMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicareMember" xlink:href="asth-20231231.xsd#asth_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MedicareMember" xlink:to="lab_asth_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a738b3a6-1877-42e5-8985-000134a0399c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CMSMember_b0d284c3-0c3c-40a6-bc84-7135689ddb66_terseLabel_en-US" xlink:label="lab_asth_CMSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS</link:label>
    <link:label id="lab_asth_CMSMember_label_en-US" xlink:label="lab_asth_CMSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS [Member]</link:label>
    <link:label id="lab_asth_CMSMember_documentation_en-US" xlink:label="lab_asth_CMSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CMSMember" xlink:href="asth-20231231.xsd#asth_CMSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CMSMember" xlink:to="lab_asth_CMSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_060329fa-2259-42e6-9d2f-5c94529f7ff1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AAMGEquityContingentConsideration_cb8f6005-af4f-4acd-8c58-f2c9bbee511c_terseLabel_en-US" xlink:label="lab_asth_AAMGEquityContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAMG stock contingent consideration (see Note 21)</link:label>
    <link:label id="lab_asth_AAMGEquityContingentConsideration_label_en-US" xlink:label="lab_asth_AAMGEquityContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAMG Equity Contingent Consideration</link:label>
    <link:label id="lab_asth_AAMGEquityContingentConsideration_documentation_en-US" xlink:label="lab_asth_AAMGEquityContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAMG Equity Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGEquityContingentConsideration" xlink:href="asth-20231231.xsd#asth_AAMGEquityContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AAMGEquityContingentConsideration" xlink:to="lab_asth_AAMGEquityContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CareDeliveryMember_f4ca91be-b3f5-49a0-b463-cadd4571aa43_terseLabel_en-US" xlink:label="lab_asth_CareDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Delivery</link:label>
    <link:label id="lab_asth_CareDeliveryMember_label_en-US" xlink:label="lab_asth_CareDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Delivery [Member]</link:label>
    <link:label id="lab_asth_CareDeliveryMember_documentation_en-US" xlink:label="lab_asth_CareDeliveryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Care Delivery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CareDeliveryMember" xlink:href="asth-20231231.xsd#asth_CareDeliveryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CareDeliveryMember" xlink:to="lab_asth_CareDeliveryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_7f9359cf-8ce2-4e1d-b58a-7f22ee6dd05b_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_c340b1c4-9b17-40e9-9de0-8e49b8b3f893_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_ca458bd9-d5cc-4a26-aa0d-322635e1b700_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c44b4213-df96-45f1-9cfe-a60e93f54c65_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a7019660-87bd-4a01-bba1-b0b1f9dd5c5b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_0899babd-9033-4511-9de2-6911d8a1dae6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_e7090a6d-312f-4713-8642-d144a2415bff_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AchievaMedInc.Member_ecc5529f-03f9-4f5e-8ea7-367e8d09adfb_terseLabel_en-US" xlink:label="lab_asth_AchievaMedInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AchievaMed, Inc.</link:label>
    <link:label id="lab_asth_AchievaMedInc.Member_label_en-US" xlink:label="lab_asth_AchievaMedInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AchievaMed, Inc. [Member]</link:label>
    <link:label id="lab_asth_AchievaMedInc.Member_documentation_en-US" xlink:label="lab_asth_AchievaMedInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AchievaMed, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AchievaMedInc.Member" xlink:href="asth-20231231.xsd#asth_AchievaMedInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AchievaMedInc.Member" xlink:to="lab_asth_AchievaMedInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AmendedAndRestatedCreditAgreementMember_239b2001-a695-4034-87ae-e380f38d326d_terseLabel_en-US" xlink:label="lab_asth_AmendedAndRestatedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Credit Agreement</link:label>
    <link:label id="lab_asth_AmendedAndRestatedCreditAgreementMember_label_en-US" xlink:label="lab_asth_AmendedAndRestatedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Credit Agreement [Member]</link:label>
    <link:label id="lab_asth_AmendedAndRestatedCreditAgreementMember_documentation_en-US" xlink:label="lab_asth_AmendedAndRestatedCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended and Restated Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AmendedAndRestatedCreditAgreementMember" xlink:href="asth-20231231.xsd#asth_AmendedAndRestatedCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AmendedAndRestatedCreditAgreementMember" xlink:to="lab_asth_AmendedAndRestatedCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e7930f95-29fb-4f0c-998e-b6dee2b6c308_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_a8a780c4-74ab-4bb8-95e8-d6a47c66f2cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_7ec21621-647c-4574-a9d5-d36568040968_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_702072c4-cf2f-483a-91a1-35dd2461c4a7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_fa29f77b-d7d1-42c2-adf1-00d8c3eef9c0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_6a810f26-5499-4193-9cd5-1e048a534e97_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities, Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent_f609b83f-95de-46ec-8868-15d60bb606a3_terseLabel_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-off transaction</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent_label_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Spin-off Transaction, Percent</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent_documentation_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Spin-off Transaction, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" xlink:to="lab_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f411dccc-61f4-4f07-b9f8-6b4edac9631d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.001; 100,000,000 shares authorized, 46,843,743 and 46,575,699 shares outstanding, excluding 10,584,340 and 10,299,259 treasury shares, at December&#160;31, 2023 and 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_TermLoanMember_e30a9a9c-03b8-4f88-8c72-4d03d3132a7f_terseLabel_en-US" xlink:label="lab_asth_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_asth_TermLoanMember_label_en-US" xlink:label="lab_asth_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_asth_TermLoanMember_documentation_en-US" xlink:label="lab_asth_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TermLoanMember" xlink:href="asth-20231231.xsd#asth_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_TermLoanMember" xlink:to="lab_asth_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1caa717b-048b-4725-b0d1-2cc005411960_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_FinanceReceivableInterestRateStatedPercentage_0d89e9d2-3988-4969-8fa8-3e62b9043212_terseLabel_en-US" xlink:label="lab_asth_FinanceReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note receivable, interest rate</link:label>
    <link:label id="lab_asth_FinanceReceivableInterestRateStatedPercentage_label_en-US" xlink:label="lab_asth_FinanceReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Receivable, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_asth_FinanceReceivableInterestRateStatedPercentage_documentation_en-US" xlink:label="lab_asth_FinanceReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Receivable, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FinanceReceivableInterestRateStatedPercentage" xlink:href="asth-20231231.xsd#asth_FinanceReceivableInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_FinanceReceivableInterestRateStatedPercentage" xlink:to="lab_asth_FinanceReceivableInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RealEstateLoanTwoMember_fbcd2dfd-050a-49eb-8654-a87204aec4dd_terseLabel_en-US" xlink:label="lab_asth_RealEstateLoanTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan Two</link:label>
    <link:label id="lab_asth_RealEstateLoanTwoMember_label_en-US" xlink:label="lab_asth_RealEstateLoanTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan Two [Member]</link:label>
    <link:label id="lab_asth_RealEstateLoanTwoMember_documentation_en-US" xlink:label="lab_asth_RealEstateLoanTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RealEstateLoanTwoMember" xlink:href="asth-20231231.xsd#asth_RealEstateLoanTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RealEstateLoanTwoMember" xlink:to="lab_asth_RealEstateLoanTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c1c7f96c-34e4-47dc-b731-dcb70e8a8ff8_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_ad54afcc-a311-4564-81f4-57087f63ac69_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_674e8781-3482-4c80-b813-eb9f4fb3b0da_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finance Lease, Future Minimum Lease Payments After Adoption of 842</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_80e5b963-acf3-4eea-bea1-59c002c679df_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3abf540c-2642-4918-b52a-22bffe6774f6_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_76e666da-5e47-4f63-9399-3f843c4b8415_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1400d8c7-4c5c-49ea-ba94-73aa8ae882b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_add0717c-a695-41bb-a571-5a366d0cdd9f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f764cbca-7147-4d09-b5d4-2c9bacc15f01_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_c7ed0772-1da5-4089-8f1e-ff740ed1e226_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SeenHealthIncMember_d0c41d78-d647-4c6e-a003-818074611e6e_terseLabel_en-US" xlink:label="lab_asth_SeenHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seen Health, Inc</link:label>
    <link:label id="lab_asth_SeenHealthIncMember_label_en-US" xlink:label="lab_asth_SeenHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seen Health, Inc [Member]</link:label>
    <link:label id="lab_asth_SeenHealthIncMember_documentation_en-US" xlink:label="lab_asth_SeenHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seen Health, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SeenHealthIncMember" xlink:href="asth-20231231.xsd#asth_SeenHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SeenHealthIncMember" xlink:to="lab_asth_SeenHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_41a41c24-b776-4dcc-a6e3-428079209c76_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_22040900-c1af-4c53-aaa9-6b24a475a89c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation for Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_76305ab7-fb64-4681-9e58-58357fe4795f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_24539fed-ccdf-4f4a-afe4-65db8054264e_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_Tag6MedicalInvestmentGroupLLCMember_89ca7424-d4b1-458b-a91b-047bc1a50a8d_terseLabel_en-US" xlink:label="lab_asth_Tag6MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-6 Medical Investment Group, LLC*</link:label>
    <link:label id="lab_asth_Tag6MedicalInvestmentGroupLLCMember_label_en-US" xlink:label="lab_asth_Tag6MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-6 Medical Investment Group, LLC [Member]</link:label>
    <link:label id="lab_asth_Tag6MedicalInvestmentGroupLLCMember_documentation_en-US" xlink:label="lab_asth_Tag6MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-6 Medical Investment Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag6MedicalInvestmentGroupLLCMember" xlink:href="asth-20231231.xsd#asth_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_Tag6MedicalInvestmentGroupLLCMember" xlink:to="lab_asth_Tag6MedicalInvestmentGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_d781aa46-5d15-48de-bdf9-460d15f2070b_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_863ac720-87b9-4dc3-8f43-195785059dd9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale or distribution of investments</link:label>
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainOnSaleOfInvestments" xlink:to="lab_us-gaap_GainOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_1f2695ca-5e11-4991-8e1c-629563363dd8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_cb902ce6-3825-45d1-9eea-3fba41a138d1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_9a9a148f-65f3-4824-8857-31c76ea9ccb1_terseLabel_en-US" xlink:label="lab_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, change in fair value of equity interest purchase obligation</link:label>
    <link:label id="lab_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_label_en-US" xlink:label="lab_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation</link:label>
    <link:label id="lab_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_documentation_en-US" xlink:label="lab_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:href="asth-20231231.xsd#asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:to="lab_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_5320abd7-3ea2-4827-a42b-7a4b7bd7f440_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_APCMember_94d3a58e-2c2a-45e9-b74d-b8ba831cb87a_terseLabel_en-US" xlink:label="lab_asth_APCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC</link:label>
    <link:label id="lab_asth_APCMember_label_en-US" xlink:label="lab_asth_APCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC [Member]</link:label>
    <link:label id="lab_asth_APCMember_documentation_en-US" xlink:label="lab_asth_APCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_APCMember" xlink:href="asth-20231231.xsd#asth_APCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_APCMember" xlink:to="lab_asth_APCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_b33b19e5-31d3-484c-b196-178bf14bee96_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other provider payable</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_45d604e7-63fd-4324-89c7-901f695568e5_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Costs</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_a33336b5-3db3-406c-a2d5-d7d49cccef81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from investment in warrants</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_19c1e814-03cd-43c6-854e-f0bb482419a9_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ProfessionalMedicalCorporationMember_fdc2d4cb-c819-4709-a956-c81c3cda9701_terseLabel_en-US" xlink:label="lab_asth_ProfessionalMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Medical Corporation</link:label>
    <link:label id="lab_asth_ProfessionalMedicalCorporationMember_label_en-US" xlink:label="lab_asth_ProfessionalMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Medical Corporation [Member]</link:label>
    <link:label id="lab_asth_ProfessionalMedicalCorporationMember_documentation_en-US" xlink:label="lab_asth_ProfessionalMedicalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Medical Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ProfessionalMedicalCorporationMember" xlink:href="asth-20231231.xsd#asth_ProfessionalMedicalCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ProfessionalMedicalCorporationMember" xlink:to="lab_asth_ProfessionalMedicalCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_64800829-45b8-4721-b271-aa4874de40e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_43ea947d-da93-4923-8cfa-e6bb786273ba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_559a5afc-2589-4c07-88c1-8a0758eccf7b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9b7faee4-165e-4eb2-bbf3-60a3f6445776_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_77fee9b1-c136-4597-9ad5-01c89a0401c0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity attributable to parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_29514a13-6984-49db-b112-98b564aa41ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_aad311e2-7ffe-4c41-bbcd-67acd5923647_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LeaseWeightedAverageDiscountRateAbstract_23a8c663-65a8-455a-babd-3c66ada5b6a3_terseLabel_en-US" xlink:label="lab_asth_LeaseWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Discount Rate</link:label>
    <link:label id="lab_asth_LeaseWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_asth_LeaseWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Weighted Average Discount Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LeaseWeightedAverageDiscountRateAbstract" xlink:href="asth-20231231.xsd#asth_LeaseWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LeaseWeightedAverageDiscountRateAbstract" xlink:to="lab_asth_LeaseWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_5375ffaa-0592-4059-8cf4-c0bf86e17389_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_021668a9-9509-483b-b6c9-591407395de3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, net asset</link:label>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_label_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetAssetLiability" xlink:to="lab_us-gaap_FairValueNetAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_aa7412cc-ea05-4601-826f-6677e8eef29f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization associated with finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_608a04d8-79ec-4d82-aa13-7af69fab8bc4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_0459d2d8-43a8-4a0d-806e-783274e3b7ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_553e2bc2-a0ee-49f4-8992-c58157f69cff_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d627f9d6-2bac-40c4-9399-3873ce4f5ec5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_b0eb75e3-6d73-4178-a307-38bc881352f5_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_OtherMember_79ed019e-ba0a-4401-b4ce-fb493388fb2b_terseLabel_en-US" xlink:label="lab_asth_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_asth_OtherMember_label_en-US" xlink:label="lab_asth_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_asth_OtherMember_documentation_en-US" xlink:label="lab_asth_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OtherMember" xlink:href="asth-20231231.xsd#asth_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_OtherMember" xlink:to="lab_asth_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_0b997a96-56f9-44b9-8ba8-74bb6c85c0fc_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_0e183127-cddb-41af-a9d6-af9a4916c0fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_fa78eab2-ae7d-4a0c-b0ac-6c2de129675a_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current period</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_955a56c5-cf4e-4cd7-a8c1-509583d354b9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_label_en-US" xlink:label="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Line of Credit Arrangements, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:to="lab_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_a84dcf8c-30a4-4910-abcb-344d57bcee9e_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings on long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_93bdaee3-b137-465a-9b65-4c8689a97866_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RelatedPartyTransactionRevenueExpenseNetMember_e42a6c68-f722-4111-acf9-131085e4ec9e_terseLabel_en-US" xlink:label="lab_asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Revenue (Expense), Net</link:label>
    <link:label id="lab_asth_RelatedPartyTransactionRevenueExpenseNetMember_label_en-US" xlink:label="lab_asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Revenue (Expense), Net [Member]</link:label>
    <link:label id="lab_asth_RelatedPartyTransactionRevenueExpenseNetMember_documentation_en-US" xlink:label="lab_asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Revenue (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:href="asth-20231231.xsd#asth_RelatedPartyTransactionRevenueExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:to="lab_asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_7cf08e70-28bc-4fc3-9379-bf3a7131e408_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of debt issuances</link:label>
    <link:label id="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Financing and Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentOfFinancingAndStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AuditInformationAbstract_b1ac494d-acb9-4fbf-9d4e-f25d5d171558_terseLabel_en-US" xlink:label="lab_asth_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_asth_AuditInformationAbstract_label_en-US" xlink:label="lab_asth_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_asth_AuditInformationAbstract_documentation_en-US" xlink:label="lab_asth_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AuditInformationAbstract" xlink:href="asth-20231231.xsd#asth_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AuditInformationAbstract" xlink:to="lab_asth_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e9838873-579f-4e1c-ab43-4c2a5841c1e6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_dd242dff-e7a2-4b20-969a-bdc1b8d48e94_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_3af5640a-49a4-4d27-bb34-7ba07f9fd52f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30729cfc-477b-499c-bab3-8c6a9aaf1f21_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3274d5e1-a445-403b-a01b-a048320794db_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f789b2f1-3530-44da-b789-bba1f0f7fa26_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_InterestRateCollarMember_40163e62-112c-4293-a19a-9129c290d47c_terseLabel_en-US" xlink:label="lab_asth_InterestRateCollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Collar</link:label>
    <link:label id="lab_asth_InterestRateCollarMember_label_en-US" xlink:label="lab_asth_InterestRateCollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Collar [Member]</link:label>
    <link:label id="lab_asth_InterestRateCollarMember_documentation_en-US" xlink:label="lab_asth_InterestRateCollarMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Collar</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_InterestRateCollarMember" xlink:href="asth-20231231.xsd#asth_InterestRateCollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_InterestRateCollarMember" xlink:to="lab_asth_InterestRateCollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RelatedPartyTransactionRevenueRecognizedMember_82d00b9e-fb26-4940-88ed-abb441c881c7_terseLabel_en-US" xlink:label="lab_asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Revenue Recognized</link:label>
    <link:label id="lab_asth_RelatedPartyTransactionRevenueRecognizedMember_label_en-US" xlink:label="lab_asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Revenue Recognized [Member]</link:label>
    <link:label id="lab_asth_RelatedPartyTransactionRevenueRecognizedMember_documentation_en-US" xlink:label="lab_asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:href="asth-20231231.xsd#asth_RelatedPartyTransactionRevenueRecognizedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:to="lab_asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_360ff071-62ae-4936-a57f-cfbfa1402702_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_c81b7ebc-63ad-4682-9b96-59109af95fa5_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_3b0db76b-5313-4d6b-a67a-ab1cdb817f57_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RelatedPartyTransactionExpensesIncurredMember_45d5b533-986a-40ed-a1e5-a5013cc43186_terseLabel_en-US" xlink:label="lab_asth_RelatedPartyTransactionExpensesIncurredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses Incurred</link:label>
    <link:label id="lab_asth_RelatedPartyTransactionExpensesIncurredMember_label_en-US" xlink:label="lab_asth_RelatedPartyTransactionExpensesIncurredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses Incurred [Member]</link:label>
    <link:label id="lab_asth_RelatedPartyTransactionExpensesIncurredMember_documentation_en-US" xlink:label="lab_asth_RelatedPartyTransactionExpensesIncurredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RelatedPartyTransactionExpensesIncurredMember" xlink:href="asth-20231231.xsd#asth_RelatedPartyTransactionExpensesIncurredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RelatedPartyTransactionExpensesIncurredMember" xlink:to="lab_asth_RelatedPartyTransactionExpensesIncurredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_TaxImpactFromDividends_3435b948-5a17-4164-8511-4b4782781245_negatedLabel_en-US" xlink:label="lab_asth_TaxImpactFromDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact from dividends</link:label>
    <link:label id="lab_asth_TaxImpactFromDividends_label_en-US" xlink:label="lab_asth_TaxImpactFromDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Impact From Dividends</link:label>
    <link:label id="lab_asth_TaxImpactFromDividends_documentation_en-US" xlink:label="lab_asth_TaxImpactFromDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Impact From Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TaxImpactFromDividends" xlink:href="asth-20231231.xsd#asth_TaxImpactFromDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_TaxImpactFromDividends" xlink:to="lab_asth_TaxImpactFromDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AstranaMember_0e624299-346e-4f64-a68f-acd33b56dc18_terseLabel_en-US" xlink:label="lab_asth_AstranaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Astrana</link:label>
    <link:label id="lab_asth_AstranaMember_label_en-US" xlink:label="lab_asth_AstranaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Astrana [Member]</link:label>
    <link:label id="lab_asth_AstranaMember_documentation_en-US" xlink:label="lab_asth_AstranaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Astrana</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AstranaMember" xlink:href="asth-20231231.xsd#asth_AstranaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AstranaMember" xlink:to="lab_asth_AstranaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_24640f0f-4062-4fb8-bd92-530419b764cf_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">% of Ownership</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_3a58ea53-3f7e-40ce-b2e7-24e275b14f44_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_6136a75a-aaf3-41d8-81bf-313094c9a484_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease terms, operating</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_LeaseWeightedAverageRemainingLeaseTermAbstract_8d9640e1-1498-4475-8dba-b39a6463591f_terseLabel_en-US" xlink:label="lab_asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Lease Term</link:label>
    <link:label id="lab_asth_LeaseWeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:href="asth-20231231.xsd#asth_LeaseWeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SpinOffTransactionMember_6601f46e-6ead-474d-b2e4-9149dd6c5486_terseLabel_en-US" xlink:label="lab_asth_SpinOffTransactionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-Off Transaction</link:label>
    <link:label id="lab_asth_SpinOffTransactionMember_label_en-US" xlink:label="lab_asth_SpinOffTransactionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-Off Transaction [Member]</link:label>
    <link:label id="lab_asth_SpinOffTransactionMember_documentation_en-US" xlink:label="lab_asth_SpinOffTransactionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-Off Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SpinOffTransactionMember" xlink:href="asth-20231231.xsd#asth_SpinOffTransactionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SpinOffTransactionMember" xlink:to="lab_asth_SpinOffTransactionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ed1972f1-b414-4f1f-b9cc-f62641b6ed17_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Transactions Under Stock Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c14a4e04-69e4-465d-aee7-47711de193ff_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_292efa5f-d13e-402c-9c4b-b0b4c4812f4a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_71b41241-9f1b-4e50-a428-fbfdd3358118_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PayorBMember_bbae4d3b-88e9-4b7b-af71-ad7d40bcda92_terseLabel_en-US" xlink:label="lab_asth_PayorBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payer B</link:label>
    <link:label id="lab_asth_PayorBMember_label_en-US" xlink:label="lab_asth_PayorBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor B [Member]</link:label>
    <link:label id="lab_asth_PayorBMember_documentation_en-US" xlink:label="lab_asth_PayorBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payor B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorBMember" xlink:href="asth-20231231.xsd#asth_PayorBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PayorBMember" xlink:to="lab_asth_PayorBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fced7d39-5632-4b67-8d4a-d45347207e81_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonrelatedPartyMember_7940611c-9c3c-4601-8395-8afe7eedf91d_terseLabel_en-US" xlink:label="lab_us-gaap_NonrelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrelated Party</link:label>
    <link:label id="lab_us-gaap_NonrelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_NonrelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrelated Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonrelatedPartyMember" xlink:to="lab_us-gaap_NonrelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_bc7719eb-9eba-4ba1-b715-f9d9f1b1fdc0_terseLabel_en-US" xlink:label="lab_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued for exercise of options and warrants</link:label>
    <link:label id="lab_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_label_en-US" xlink:label="lab_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During the Period Value of Exercise of Option and Warrants</link:label>
    <link:label id="lab_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_documentation_en-US" xlink:label="lab_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">It represents value of stock issued during the period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:to="lab_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_4806d235-13b9-4233-926d-33389686a361_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_64148c45-a192-42b3-a0d1-ea4e51527aee_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_682a4a27-92dc-487d-a061-2ac5e4031be2_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_TemporaryEquityPolicyPolicyTextBlock_4b255ca2-c91a-4871-8e7a-4de4620e7919_verboseLabel_en-US" xlink:label="lab_asth_TemporaryEquityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine Equity</link:label>
    <link:label id="lab_asth_TemporaryEquityPolicyPolicyTextBlock_label_en-US" xlink:label="lab_asth_TemporaryEquityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Policy [Policy Text Block]</link:label>
    <link:label id="lab_asth_TemporaryEquityPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_asth_TemporaryEquityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityPolicyPolicyTextBlock" xlink:href="asth-20231231.xsd#asth_TemporaryEquityPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_TemporaryEquityPolicyPolicyTextBlock" xlink:to="lab_asth_TemporaryEquityPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_349cf12d-418f-4cc4-86fc-8d8e49c082c2_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_d229e480-1a53-4a8e-8a42-9f9b8f9db5a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_bcdb4798-c409-4cb1-b0e8-63c20c6dfba3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, mezzanine equity (deficit), and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_68dd73db-f692-456c-9316-0d0944ec627e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b400a88a-d4e1-4de5-aa9c-868badd08db5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_71a3b52c-6b7d-4238-a53e-3a30d868cbd1_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_7bb49e8b-0e39-4941-9fb7-916c9e104c1c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_51f4bf4a-4f98-4649-97ab-c6a794e4dd55_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_7f16ba88-e03a-44ef-a42b-9a548c59accd_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in a privately held entity</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:to="lab_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SpecialtyCapitationPayableCurrent_0c86c9b6-e942-4cfb-8028-400eb9edbad9_verboseLabel_en-US" xlink:label="lab_asth_SpecialtyCapitationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation payable</link:label>
    <link:label id="lab_asth_SpecialtyCapitationPayableCurrent_label_en-US" xlink:label="lab_asth_SpecialtyCapitationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Capitation Payable Current</link:label>
    <link:label id="lab_asth_SpecialtyCapitationPayableCurrent_documentation_en-US" xlink:label="lab_asth_SpecialtyCapitationPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of specialty capitation payable current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SpecialtyCapitationPayableCurrent" xlink:href="asth-20231231.xsd#asth_SpecialtyCapitationPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SpecialtyCapitationPayableCurrent" xlink:to="lab_asth_SpecialtyCapitationPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OfficerMember_d835a50a-4c78-4c7c-be0d-c560759ee46d_terseLabel_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer</link:label>
    <link:label id="lab_srt_OfficerMember_label_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficerMember" xlink:to="lab_srt_OfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AAMGMember_b5f386a4-89fb-4a41-96a5-8f017a96b3dc_terseLabel_en-US" xlink:label="lab_asth_AAMGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAMG</link:label>
    <link:label id="lab_asth_AAMGMember_label_en-US" xlink:label="lab_asth_AAMGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAMG [Member]</link:label>
    <link:label id="lab_asth_AAMGMember_documentation_en-US" xlink:label="lab_asth_AAMGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAMG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGMember" xlink:href="asth-20231231.xsd#asth_AAMGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AAMGMember" xlink:to="lab_asth_AAMGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b135f5e0-944d-40b1-9076-da55cb180b4e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0a9158d8-78be-4192-a3da-72f4a6d824ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Information about our Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyMember_c3cfe2b6-4c19-4c5e-a326-395d25e8f527_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyMember_label_en-US" xlink:label="lab_us-gaap_RelatedPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyMember" xlink:to="lab_us-gaap_RelatedPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_FiveThreeOneW.CollegeLLCMember_adab269d-267d-4ab7-b011-d4b68b4182a9_terseLabel_en-US" xlink:label="lab_asth_FiveThreeOneW.CollegeLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">531 W. College, LLC *</link:label>
    <link:label id="lab_asth_FiveThreeOneW.CollegeLLCMember_label_en-US" xlink:label="lab_asth_FiveThreeOneW.CollegeLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Three One W. College LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiveThreeOneW.CollegeLLCMember" xlink:href="asth-20231231.xsd#asth_FiveThreeOneW.CollegeLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_FiveThreeOneW.CollegeLLCMember" xlink:to="lab_asth_FiveThreeOneW.CollegeLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits_f853c440-f37a-4a56-9066-ed9ea9841a85_terseLabel_en-US" xlink:label="lab_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spinoff transaction, number of membership units per common share</link:label>
    <link:label id="lab_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits_label_en-US" xlink:label="lab_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Spinoff Transaction, Number Of Membership Units</link:label>
    <link:label id="lab_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits_documentation_en-US" xlink:label="lab_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Spinoff Transaction, Number Of Membership Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" xlink:href="asth-20231231.xsd#asth_RestructuringSpinoffTransactionNumberOfMembershipUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" xlink:to="lab_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_a1065f59-66e0-4b45-b071-154ff8ad2f04_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_01492b00-db41-4f9f-9bbb-3d2bd43a27d9_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_efa494ed-c35f-488c-80c1-92999a8a619e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ed59a091-fdbf-406b-967a-c129362c399e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28498764-536d-4202-bb06-42e6c67856ab_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities &#8211; certificates of deposit</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLoanMember_9065731a-c883-4e28-a719-1447e56ac3a1_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loans*</link:label>
    <link:label id="lab_us-gaap_RealEstateLoanMember_label_en-US" xlink:label="lab_us-gaap_RealEstateLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLoanMember" xlink:to="lab_us-gaap_RealEstateLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_386faa0f-92bb-467d-8cdf-fd8383d97d21_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_4ab91116-d0aa-4715-ae41-d2d91175a7a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total losses recognized on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SubordinatedLoanAgreementMember_fabc134d-be3e-4026-b043-10a488659879_terseLabel_en-US" xlink:label="lab_asth_SubordinatedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Loan Agreement</link:label>
    <link:label id="lab_asth_SubordinatedLoanAgreementMember_label_en-US" xlink:label="lab_asth_SubordinatedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Loan Agreement [Member]</link:label>
    <link:label id="lab_asth_SubordinatedLoanAgreementMember_documentation_en-US" xlink:label="lab_asth_SubordinatedLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subordinated Loan Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SubordinatedLoanAgreementMember" xlink:href="asth-20231231.xsd#asth_SubordinatedLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SubordinatedLoanAgreementMember" xlink:to="lab_asth_SubordinatedLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_14bd4fdf-7f47-452e-a2dc-10c2c750eb91_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c86ed674-d59d-47a4-91f2-a0180b2cebea_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_aebee88e-75a8-415f-929c-f37179426465_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_e934eb31-64df-4169-b6cd-ce25e50dab25_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_fd58e0b8-933a-43bd-945c-0a160f1a45fc_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend declared included in dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_294003d3-f30d-40c1-a9d4-7f04dc82884a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a5280fbf-56c4-4194-972b-28b47caa6e2c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_19f0e6bf-ec8b-49e4-8410-458f68fde7c4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_582a7b62-365f-498b-b396-0367c34a8eec_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan</link:label>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_label_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Related to Property Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:to="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_StockIssuedDuringPeriodValueNoncontrollingInterest_4fc27458-c218-45a5-9644-45dee23dfde4_terseLabel_en-US" xlink:label="lab_asth_StockIssuedDuringPeriodValueNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of shares by non-controlling interest</link:label>
    <link:label id="lab_asth_StockIssuedDuringPeriodValueNoncontrollingInterest_label_en-US" xlink:label="lab_asth_StockIssuedDuringPeriodValueNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Noncontrolling Interest</link:label>
    <link:label id="lab_asth_StockIssuedDuringPeriodValueNoncontrollingInterest_documentation_en-US" xlink:label="lab_asth_StockIssuedDuringPeriodValueNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringPeriodValueNoncontrollingInterest" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringPeriodValueNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_StockIssuedDuringPeriodValueNoncontrollingInterest" xlink:to="lab_asth_StockIssuedDuringPeriodValueNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ContingentEquitySecuritiesMember_2a74c244-745a-4213-aae6-110690bd9080_terseLabel_en-US" xlink:label="lab_asth_ContingentEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent equity securities</link:label>
    <link:label id="lab_asth_ContingentEquitySecuritiesMember_label_en-US" xlink:label="lab_asth_ContingentEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Equity Securities [Member]</link:label>
    <link:label id="lab_asth_ContingentEquitySecuritiesMember_documentation_en-US" xlink:label="lab_asth_ContingentEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ContingentEquitySecuritiesMember" xlink:href="asth-20231231.xsd#asth_ContingentEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ContingentEquitySecuritiesMember" xlink:to="lab_asth_ContingentEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_f0d59d5c-2a47-4328-9d31-7cda18f3a964_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3f6e90a6-ce64-4c80-8fc7-22a47575a6e3_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_91f0cf5d-65e4-4d6d-ac2d-3d4694ab800c_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ef6b0f9c-004c-40d8-aaf8-9b6df78da05c_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_2fc9f463-6715-458b-ab65-16916ac3d32a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_891b5a87-5e1f-4a92-acb5-1dcaaf3c03b6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_d84f2ba1-fce4-489d-b175-c1c77e4a436d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3721a61e-41b6-4ef2-94c9-874ade969090_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_472395ea-8887-4275-bd5a-39d7d861b849_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_0435fe20-be63-4dc8-a7e0-3267b5f6dd78_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8870c2ca-812a-44c1-8143-71b918517771_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_e04453b2-9827-4cb8-b16a-abe3d8836557_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_dc66dcc3-8f77-42bc-8014-30af5d608722_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PatientManagementPlatformMember_1dbabc38-32a1-4ace-a047-9d68569f2014_verboseLabel_en-US" xlink:label="lab_asth_PatientManagementPlatformMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient management platform</link:label>
    <link:label id="lab_asth_PatientManagementPlatformMember_label_en-US" xlink:label="lab_asth_PatientManagementPlatformMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Management Platform [Member]</link:label>
    <link:label id="lab_asth_PatientManagementPlatformMember_documentation_en-US" xlink:label="lab_asth_PatientManagementPlatformMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Management Platform</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PatientManagementPlatformMember" xlink:href="asth-20231231.xsd#asth_PatientManagementPlatformMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PatientManagementPlatformMember" xlink:to="lab_asth_PatientManagementPlatformMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_c7acef15-3731-4dd0-882c-448f948f6ffb_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_d963424d-7096-46d2-9061-4cae895aa9db_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Draws on lines of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_5761a1d8-97a1-425b-b883-a8edf8a7e41d_terseLabel_en-US" xlink:label="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_label_en-US" xlink:label="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares</link:label>
    <link:label id="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_documentation_en-US" xlink:label="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:href="asth-20231231.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:to="lab_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_3e06d61d-da6c-4bcd-92a0-d18a9b65cebd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_205450c6-a13a-4062-90a5-dc6bf9eb1849_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_BeneficialInterestPolicyTextBlock_5dd046a5-2b23-4731-921d-f57250cea289_terseLabel_en-US" xlink:label="lab_asth_BeneficialInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beneficial Interest</link:label>
    <link:label id="lab_asth_BeneficialInterestPolicyTextBlock_label_en-US" xlink:label="lab_asth_BeneficialInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beneficial Interest [Policy Text Block]</link:label>
    <link:label id="lab_asth_BeneficialInterestPolicyTextBlock_documentation_en-US" xlink:label="lab_asth_BeneficialInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beneficial Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BeneficialInterestPolicyTextBlock" xlink:href="asth-20231231.xsd#asth_BeneficialInterestPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_BeneficialInterestPolicyTextBlock" xlink:to="lab_asth_BeneficialInterestPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_534338df-3c61-4289-b48c-fd1d3126ab17_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_450ad723-353a-476e-9049-bb3931fa14dc_periodStartLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4f796a04-e0f2-4ca9-bd09-166ce0cd6dca_periodEndLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_51f59d48-3779-4d1d-b6b0-c3d59a99daa7_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingently issuable shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics_0aef2dab-eff5-4610-ae3e-5a7b66ff680e_terseLabel_en-US" xlink:label="lab_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments that share similar characteristics</link:label>
    <link:label id="lab_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics_label_en-US" xlink:label="lab_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Operating Segments That Share Similar Characteristics</link:label>
    <link:label id="lab_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics_documentation_en-US" xlink:label="lab_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Operating Segments That Share Similar Characteristics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" xlink:href="asth-20231231.xsd#asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" xlink:to="lab_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_e80f177b-8c2c-46e0-b341-3f47ce0f17c2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport_db09f211-9333-47c3-9486-ac186603e874_terseLabel_en-US" xlink:label="lab_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected period of payment upon termination of agreement</link:label>
    <link:label id="lab_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport_label_en-US" xlink:label="lab_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing Of Satisfaction, Period Of Payment Upon Finalization Of Settlement Report</link:label>
    <link:label id="lab_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport_documentation_en-US" xlink:label="lab_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing Of Satisfaction, Period Of Payment Upon Finalization Of Settlement Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" xlink:href="asth-20231231.xsd#asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" xlink:to="lab_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_MezzanineMember_962df5c8-ecf8-4620-b2ad-b48a34e612ba_terseLabel_en-US" xlink:label="lab_asth_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine</link:label>
    <link:label id="lab_asth_MezzanineMember_label_en-US" xlink:label="lab_asth_MezzanineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MezzanineMember" xlink:href="asth-20231231.xsd#asth_MezzanineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_MezzanineMember" xlink:to="lab_asth_MezzanineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ApcBusinessLoanAgreementMember_3f80ca39-b23e-484c-80b3-e1dbebe70851_terseLabel_en-US" xlink:label="lab_asth_ApcBusinessLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Business Loan Agreement</link:label>
    <link:label id="lab_asth_ApcBusinessLoanAgreementMember_label_en-US" xlink:label="lab_asth_ApcBusinessLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC Business Loan Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcBusinessLoanAgreementMember" xlink:href="asth-20231231.xsd#asth_ApcBusinessLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ApcBusinessLoanAgreementMember" xlink:to="lab_asth_ApcBusinessLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_25a900ad-fc7a-4e33-a4ed-fdd17dd93db7_verboseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_66b81e2f-3c5b-4445-8250-2b0817cf32ad_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregated Revenue by Payor Type</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_f06874c1-c829-4241-b262-601adddb1693_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_38b6f30c-3588-4218-b494-23f5a0e27f09_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e16967d7-52ba-4197-a0e0-e8ac09c872f7_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_3227263e-8f26-4c4f-8e16-3c6420d62042_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_bd57fb17-d47b-4065-a5d9-8588c09f0628_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f21061e3-00fe-4eb6-b4cd-0215bbb70196_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_aa03e0bf-845b-4152-bcc2-c8ac20535c97_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_156860e2-7304-44af-9460-60ab9567fae1_negatedLabel_en-US" xlink:label="lab_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_label_en-US" xlink:label="lab_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Prepaid Expenses And Other Current Assets</link:label>
    <link:label id="lab_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_documentation_en-US" xlink:label="lab_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:href="asth-20231231.xsd#asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:to="lab_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_70160f72-ff07-4be8-b4c0-2a5fd1fa95dd_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_SecuredOvernightFinancingRateMember_7d72b061-6029-47fd-a1d9-0f5a77616549_terseLabel_en-US" xlink:label="lab_asth_SecuredOvernightFinancingRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate</link:label>
    <link:label id="lab_asth_SecuredOvernightFinancingRateMember_label_en-US" xlink:label="lab_asth_SecuredOvernightFinancingRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate [Member]</link:label>
    <link:label id="lab_asth_SecuredOvernightFinancingRateMember_documentation_en-US" xlink:label="lab_asth_SecuredOvernightFinancingRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SecuredOvernightFinancingRateMember" xlink:href="asth-20231231.xsd#asth_SecuredOvernightFinancingRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_SecuredOvernightFinancingRateMember" xlink:to="lab_asth_SecuredOvernightFinancingRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_176f27c8-0633-4a68-b84a-2ea042d5518a_terseLabel_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value (in millions)</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_documentation_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_9898c5fd-d719-4332-9423-75d77cb05cd9_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e159b857-f6ca-4a34-a7f5-505f1a7e6a90_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_4fde89d0-e3c1-4a55-8a0d-0d6de6f649fb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PaymentsToEquityMethodInvestments_5024bd5c-dfae-4e2d-91b8-301e6cba5745_negatedTerseLabel_en-US" xlink:label="lab_asth_PaymentsToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution to investment - equity method</link:label>
    <link:label id="lab_asth_PaymentsToEquityMethodInvestments_label_en-US" xlink:label="lab_asth_PaymentsToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Equity Method Investments</link:label>
    <link:label id="lab_asth_PaymentsToEquityMethodInvestments_documentation_en-US" xlink:label="lab_asth_PaymentsToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentsToEquityMethodInvestments" xlink:href="asth-20231231.xsd#asth_PaymentsToEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PaymentsToEquityMethodInvestments" xlink:to="lab_asth_PaymentsToEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ApcLsmaMember_7650ad3e-8063-4570-8d7f-a6ba70bd47d8_terseLabel_en-US" xlink:label="lab_asth_ApcLsmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC LSMA</link:label>
    <link:label id="lab_asth_ApcLsmaMember_label_en-US" xlink:label="lab_asth_ApcLsmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APC LSMA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcLsmaMember" xlink:href="asth-20231231.xsd#asth_ApcLsmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ApcLsmaMember" xlink:to="lab_asth_ApcLsmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_Tag8MedicalInvestmentGroupLLCMember_e707981f-edf4-4809-866d-320cfa2c315e_terseLabel_en-US" xlink:label="lab_asth_Tag8MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-8 Medical Investment Group, LLC &#8212; related party</link:label>
    <link:label id="lab_asth_Tag8MedicalInvestmentGroupLLCMember_label_en-US" xlink:label="lab_asth_Tag8MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-8 Medical Investment Group, LLC [Member]</link:label>
    <link:label id="lab_asth_Tag8MedicalInvestmentGroupLLCMember_documentation_en-US" xlink:label="lab_asth_Tag8MedicalInvestmentGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tag-8 Medical Investment Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag8MedicalInvestmentGroupLLCMember" xlink:href="asth-20231231.xsd#asth_Tag8MedicalInvestmentGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_Tag8MedicalInvestmentGroupLLCMember" xlink:to="lab_asth_Tag8MedicalInvestmentGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_fe6291d8-4601-493e-b1a1-cc5f0a152487_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Liabilities [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_20970ede-b512-4ad1-b37e-5ef15644e273_terseLabel_en-US" xlink:label="lab_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (&#8220;APC&#8221;)</link:label>
    <link:label id="lab_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity (Deficit), Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:label id="lab_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_documentation_en-US" xlink:label="lab_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity (Deficit), Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="asth-20231231.xsd#asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_c40a458c-5abb-4d8a-b948-983b56d714dd_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_b6362694-e443-4e01-97c0-8a3f7a0182f4_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_54e9e725-b1e7-4468-8043-5c5ca6d1b7f4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion and deferred financing costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_61536b3e-d6e8-4630-a3ac-197b10ef4175_netLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_82b31581-a0a8-4677-b954-97825478710f_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_ae321014-b3ae-4dc3-88d8-77fe748fe7a1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_af89bd9a-0c44-4a08-ba3e-4b21fb748a24_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ThirdPartyMember_8756b4ee-addc-4ad5-abae-a66e977cee27_terseLabel_en-US" xlink:label="lab_asth_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:label id="lab_asth_ThirdPartyMember_label_en-US" xlink:label="lab_asth_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party [Member]</link:label>
    <link:label id="lab_asth_ThirdPartyMember_documentation_en-US" xlink:label="lab_asth_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ThirdPartyMember" xlink:href="asth-20231231.xsd#asth_ThirdPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ThirdPartyMember" xlink:to="lab_asth_ThirdPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_83cf4cee-a4fb-4e74-9201-f9106affd41a_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_448bd24f-8144-42df-a393-3fec453834b1_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Equity Securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_04e9972b-2dba-4186-8365-378848cfde2b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79443ef2-aa62-4c89-96f6-8d90a385e782_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests_2cf81d39-64c1-4c3b-9012-1c54f1945a08_terseLabel_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase additional membership interests (in shares)</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests_label_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Options Issued, Option To Purchase Additional Interests</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests_documentation_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Options Issued, Option To Purchase Additional Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests" xlink:to="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_b039c8a0-82ef-4bc7-8651-425a62ac4290_terseLabel_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercises in period (in shares)</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_label_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period</link:label>
    <link:label id="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_documentation_en-US" xlink:label="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:to="lab_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_ee56b94e-be21-42a3-acb3-d6f17855f74a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_CommunityFamilyCareMedicalGroupMember_833d6b77-be8d-4528-9a2d-9ec10b97a719_terseLabel_en-US" xlink:label="lab_asth_CommunityFamilyCareMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Community Family Care Medical Group</link:label>
    <link:label id="lab_asth_CommunityFamilyCareMedicalGroupMember_label_en-US" xlink:label="lab_asth_CommunityFamilyCareMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Community Family Care Medical Group [Member]</link:label>
    <link:label id="lab_asth_CommunityFamilyCareMedicalGroupMember_documentation_en-US" xlink:label="lab_asth_CommunityFamilyCareMedicalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Community Family Care Medical Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommunityFamilyCareMedicalGroupMember" xlink:href="asth-20231231.xsd#asth_CommunityFamilyCareMedicalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_CommunityFamilyCareMedicalGroupMember" xlink:to="lab_asth_CommunityFamilyCareMedicalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_69e01fb4-43be-42f3-9846-497e062605fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_FiduciaryCashAndPayablePolicyTextBlock_4818baa4-269e-431b-9882-a5c713e1191e_terseLabel_en-US" xlink:label="lab_asth_FiduciaryCashAndPayablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary Cash and Payable</link:label>
    <link:label id="lab_asth_FiduciaryCashAndPayablePolicyTextBlock_label_en-US" xlink:label="lab_asth_FiduciaryCashAndPayablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary Cash and Payable [Policy Text Block]</link:label>
    <link:label id="lab_asth_FiduciaryCashAndPayablePolicyTextBlock_documentation_en-US" xlink:label="lab_asth_FiduciaryCashAndPayablePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiduciary Cash and Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryCashAndPayablePolicyTextBlock" xlink:href="asth-20231231.xsd#asth_FiduciaryCashAndPayablePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_FiduciaryCashAndPayablePolicyTextBlock" xlink:to="lab_asth_FiduciaryCashAndPayablePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9bcd7bca-d14f-46e3-8f1e-ea0c06034cd5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_ddad1dd4-2ebd-4331-8d71-b48c975fb7f1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e8fa2fa3-8994-4f38-b496-f8c5aecfc65b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_NewTermLoanMember_9c6debf4-799f-498e-b16b-c20e1c033bb7_terseLabel_en-US" xlink:label="lab_asth_NewTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan</link:label>
    <link:label id="lab_asth_NewTermLoanMember_label_en-US" xlink:label="lab_asth_NewTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan [Member]</link:label>
    <link:label id="lab_asth_NewTermLoanMember_documentation_en-US" xlink:label="lab_asth_NewTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NewTermLoanMember" xlink:href="asth-20231231.xsd#asth_NewTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_NewTermLoanMember" xlink:to="lab_asth_NewTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_bbac126c-569a-4c09-b990-85e35d268d50_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_545ecda7-cadf-4695-a29f-7f1709c8e9ca_verboseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_8c8c549c-23b3-46b9-8307-0ea0af1ef69b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_ConstructionLoanMember_2603cc97-5b81-4149-8689-e35e526a75e7_terseLabel_en-US" xlink:label="lab_asth_ConstructionLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan *</link:label>
    <link:label id="lab_asth_ConstructionLoanMember_label_en-US" xlink:label="lab_asth_ConstructionLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan [Member]</link:label>
    <link:label id="lab_asth_ConstructionLoanMember_documentation_en-US" xlink:label="lab_asth_ConstructionLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ConstructionLoanMember" xlink:href="asth-20231231.xsd#asth_ConstructionLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_ConstructionLoanMember" xlink:to="lab_asth_ConstructionLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_2262a31b-ffa3-4bb7-a453-87208255847a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_73db4793-6ac7-4055-b4ff-82ed994dcd92_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_TemporaryEquityDividendsImpact_74ef2719-ff98-4a0c-a8d9-a7da67a969da_terseLabel_en-US" xlink:label="lab_asth_TemporaryEquityDividendsImpact" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax impact from APC dividends to APC Shareholders</link:label>
    <link:label id="lab_asth_TemporaryEquityDividendsImpact_label_en-US" xlink:label="lab_asth_TemporaryEquityDividendsImpact" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividends Impact</link:label>
    <link:label id="lab_asth_TemporaryEquityDividendsImpact_documentation_en-US" xlink:label="lab_asth_TemporaryEquityDividendsImpact" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividends Impact</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityDividendsImpact" xlink:href="asth-20231231.xsd#asth_TemporaryEquityDividendsImpact"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_TemporaryEquityDividendsImpact" xlink:to="lab_asth_TemporaryEquityDividendsImpact" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent_81039ff4-a600-4683-a125-aad7180d01ad_terseLabel_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of investment</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent_label_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Change In Investment, Percent</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent_documentation_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Change In Investment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" xlink:to="lab_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_c3198ba7-47c3-4bbf-8237-ec79e8d81778_netLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_edb6acde-ce56-4f7a-8e8a-df305f9f2e83_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_3097381f-4af4-4f59-8338-50d2a1e8dd89_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_1f5173ef-9152-46b0-81b1-e2ac2b96ebdb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_6339dcbd-ed9f-4857-a64a-95409b6650d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_RealEstateLoanThreeMember_acc44436-f374-4485-b783-d4e77d36329d_terseLabel_en-US" xlink:label="lab_asth_RealEstateLoanThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan Three</link:label>
    <link:label id="lab_asth_RealEstateLoanThreeMember_label_en-US" xlink:label="lab_asth_RealEstateLoanThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan Three [Member]</link:label>
    <link:label id="lab_asth_RealEstateLoanThreeMember_documentation_en-US" xlink:label="lab_asth_RealEstateLoanThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Loan Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RealEstateLoanThreeMember" xlink:href="asth-20231231.xsd#asth_RealEstateLoanThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_RealEstateLoanThreeMember" xlink:to="lab_asth_RealEstateLoanThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_6a0746e9-99b1-48ae-99b5-9e20f7d7e12c_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_ea8c7b90-4e79-43da-8d04-2f6c487d6cb7_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1ec3172f-6159-4ef2-83a5-e0621bb6ec19_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost_8b2f391b-8f64-4254-9f41-03ffea38cd0e_terseLabel_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment amount</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost_label_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Aggregate Cost</link:label>
    <link:label id="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost_documentation_en-US" xlink:label="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value Investments, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" xlink:to="lab_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bf616a1a-fe30-4859-ba9e-00086c4e35bd_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding &#8211; basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_cab08270-afb6-4b03-9e70-8316a1076201_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_17f6256f-49b0-4b86-8d67-ccdc4028d259_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0d4ae0c2-f186-4823-98a3-260707534eda_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_3db667dc-e15b-4e20-ac8b-afba0becc35a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_6e9bd1ba-b46b-41f4-a3b0-af45cd787b98_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_e9eecce5-f7fa-4582-bd12-ac26e5088f07_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DebtInstrumentCovenantLeverageRatioMaximum_b45dfec8-df27-443a-92d1-1539f8475fd0_terseLabel_en-US" xlink:label="lab_asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum consolidated leverage ratio</link:label>
    <link:label id="lab_asth_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_asth_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_dc56dcea-635e-47db-8c7d-f60a744e7a69_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of restricted stock awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_AdvancedDiagnosticAndSurgicalCenterMember_cbd146e9-9030-4431-b465-42028f530bc1_terseLabel_en-US" xlink:label="lab_asth_AdvancedDiagnosticAndSurgicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Diagnostic and Surgical Center</link:label>
    <link:label id="lab_asth_AdvancedDiagnosticAndSurgicalCenterMember_label_en-US" xlink:label="lab_asth_AdvancedDiagnosticAndSurgicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Diagnostic and Surgical Center [Member]</link:label>
    <link:label id="lab_asth_AdvancedDiagnosticAndSurgicalCenterMember_documentation_en-US" xlink:label="lab_asth_AdvancedDiagnosticAndSurgicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advanced Diagnostic and Surgical Center</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AdvancedDiagnosticAndSurgicalCenterMember" xlink:href="asth-20231231.xsd#asth_AdvancedDiagnosticAndSurgicalCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_AdvancedDiagnosticAndSurgicalCenterMember" xlink:to="lab_asth_AdvancedDiagnosticAndSurgicalCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_03c57458-3ad8-4e09-ad94-c5b2b606215f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d905a0df-86b9-497a-b6cb-72d55f6ba969_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_PacificMedicalImagingAndOncologyCenterIncMember_4a581f3b-afec-47b2-8067-6dc4270d2929_terseLabel_en-US" xlink:label="lab_asth_PacificMedicalImagingAndOncologyCenterIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific Medical Imaging &amp; Oncology Center, Inc.</link:label>
    <link:label id="lab_asth_PacificMedicalImagingAndOncologyCenterIncMember_label_en-US" xlink:label="lab_asth_PacificMedicalImagingAndOncologyCenterIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pacific Medical Imaging and Oncology Center, Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PacificMedicalImagingAndOncologyCenterIncMember" xlink:href="asth-20231231.xsd#asth_PacificMedicalImagingAndOncologyCenterIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_PacificMedicalImagingAndOncologyCenterIncMember" xlink:to="lab_asth_PacificMedicalImagingAndOncologyCenterIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_b9ad71f7-770d-44aa-be5d-b7f909eb0d6b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_74803939-9766-4f1d-9e73-a26e81c9c2c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_DebtCovenantAggregatePurchasePriceMaximum_b1b98008-eeaa-4a2c-a80c-a59e523f3837_terseLabel_en-US" xlink:label="lab_asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant, aggregate purchase price, maximum</link:label>
    <link:label id="lab_asth_DebtCovenantAggregatePurchasePriceMaximum_label_en-US" xlink:label="lab_asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Aggregate Purchase Price, Maximum</link:label>
    <link:label id="lab_asth_DebtCovenantAggregatePurchasePriceMaximum_documentation_en-US" xlink:label="lab_asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Aggregate Purchase Price, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:href="asth-20231231.xsd#asth_DebtCovenantAggregatePurchasePriceMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:to="lab_asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment_4bff02ed-45a9-4880-be6d-50fc8b263d46_verboseLabel_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible permanent items</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment_label_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Federal Rate Adjustment</link:label>
    <link:label id="lab_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment_documentation_en-US" xlink:label="lab_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the effective income tax rate reconciliation of federal rate adjustment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" xlink:to="lab_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_9aa84c1f-8b12-486a-8f3c-8279f9ef8e6e_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>29
<FILENAME>asth-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:04cda4cf-3e82-4310-bba4-80cea29b7bde,g:59735ae4-b6da-4fb6-9f6d-2f4a46b99a61-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.apollomed.net/role/Cover" xlink:type="simple" xlink:href="asth-20231231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_41ed7d29-df4c-4f01-ba43-092c7ec963ab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_DocumentType_41ed7d29-df4c-4f01-ba43-092c7ec963ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_dca0bddb-3987-4144-8609-5c6a7ec5aa04" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_DocumentAnnualReport_dca0bddb-3987-4144-8609-5c6a7ec5aa04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a8970f27-9df1-46bb-86a1-80f2a1e80b64" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_DocumentPeriodEndDate_a8970f27-9df1-46bb-86a1-80f2a1e80b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c5d494d6-664e-4b43-a1f3-a27ab66ad85e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_CurrentFiscalYearEndDate_c5d494d6-664e-4b43-a1f3-a27ab66ad85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b310abdf-7c7a-4042-acab-bdaf89f2eb0b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_DocumentTransitionReport_b310abdf-7c7a-4042-acab-bdaf89f2eb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f4710132-836e-40c7-a2c8-a4e26e62efdd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityFileNumber_f4710132-836e-40c7-a2c8-a4e26e62efdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ebf16730-9944-4147-a377-94d7683a03e6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityRegistrantName_ebf16730-9944-4147-a377-94d7683a03e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2b0a48aa-2c12-4168-a384-f4e29d9a76a8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2b0a48aa-2c12-4168-a384-f4e29d9a76a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_42860575-96a7-420f-9081-1cc5b7c8e1e6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityTaxIdentificationNumber_42860575-96a7-420f-9081-1cc5b7c8e1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9d2f9db4-5cdd-40fb-989d-785e5c646744" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityAddressAddressLine1_9d2f9db4-5cdd-40fb-989d-785e5c646744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_2c8e43bf-e868-4515-8e08-891b0c46dfc2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityAddressAddressLine2_2c8e43bf-e868-4515-8e08-891b0c46dfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c13a4510-32b5-412a-9a30-e9150abfe284" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityAddressCityOrTown_c13a4510-32b5-412a-9a30-e9150abfe284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_253dfdf9-3f4b-4d06-85fe-b4b17ea64315" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityAddressStateOrProvince_253dfdf9-3f4b-4d06-85fe-b4b17ea64315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3d0ff00f-c53a-4581-80cc-3eaa6b8110a9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityAddressPostalZipCode_3d0ff00f-c53a-4581-80cc-3eaa6b8110a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_dad42a74-8cc2-40ba-a4b9-672a6de83c2e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_CityAreaCode_dad42a74-8cc2-40ba-a4b9-672a6de83c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_caea5891-ccd1-4ba3-a003-f91ceb66f161" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_LocalPhoneNumber_caea5891-ccd1-4ba3-a003-f91ceb66f161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_aead4193-cb6c-430d-9a9d-0f105b4aacbb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_Security12bTitle_aead4193-cb6c-430d-9a9d-0f105b4aacbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_da6e9351-6230-4038-9a5b-d5d20b262aaa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_TradingSymbol_da6e9351-6230-4038-9a5b-d5d20b262aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_508aa070-5962-405e-8c8c-b43bef74230c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_SecurityExchangeName_508aa070-5962-405e-8c8c-b43bef74230c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_b4c19e4d-0f51-48b9-8fc5-1a6881166296" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_b4c19e4d-0f51-48b9-8fc5-1a6881166296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_3a24a820-3100-46df-9073-ddae0d0a0b9a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityVoluntaryFilers_3a24a820-3100-46df-9073-ddae0d0a0b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c29ec7c4-0456-4378-ba85-3a833f564a35" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityCurrentReportingStatus_c29ec7c4-0456-4378-ba85-3a833f564a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b951a4ed-5272-4637-bae2-0bdeab92653f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityInteractiveDataCurrent_b951a4ed-5272-4637-bae2-0bdeab92653f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e7cc6771-ff21-46eb-b94a-d1bfac41dc67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityFilerCategory_e7cc6771-ff21-46eb-b94a-d1bfac41dc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_55e19f12-e5e8-4376-99d0-3e52d75d1ca5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntitySmallBusiness_55e19f12-e5e8-4376-99d0-3e52d75d1ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_64a4ce95-fa3a-4f54-b642-7e5f4c6eeaef" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityEmergingGrowthCompany_64a4ce95-fa3a-4f54-b642-7e5f4c6eeaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_50f08832-2eec-4c25-9725-1123aec038a9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_IcfrAuditorAttestationFlag_50f08832-2eec-4c25-9725-1123aec038a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_4796742f-f869-4417-a442-41fa70baa58b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_4796742f-f869-4417-a442-41fa70baa58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b0be5a0d-6fd6-4e07-9e5c-589a4b5a2c7d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityShellCompany_b0be5a0d-6fd6-4e07-9e5c-589a4b5a2c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_edf60f14-6f7b-497b-8bc9-52a874c08f09" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityPublicFloat_edf60f14-6f7b-497b-8bc9-52a874c08f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0cb618f9-24c7-4cba-8866-8e5f199b9834" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0cb618f9-24c7-4cba-8866-8e5f199b9834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_eafbf3b5-2bfc-480d-834b-723a3e857660" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_eafbf3b5-2bfc-480d-834b-723a3e857660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_3965c9c3-00c7-473f-845b-f3898df8add0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_AmendmentFlag_3965c9c3-00c7-473f-845b-f3898df8add0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_122a4154-42a7-43fa-8b2e-e709554c4b17" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_DocumentFiscalYearFocus_122a4154-42a7-43fa-8b2e-e709554c4b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_ae329a21-cf13-471a-a972-a8e43ff30841" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_DocumentFiscalPeriodFocus_ae329a21-cf13-471a-a972-a8e43ff30841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7049d510-10da-4bf6-8057-7c0432698a65" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ac4ab32b-2e27-4522-82fb-5edf73a35773" xlink:to="loc_dei_EntityCentralIndexKey_7049d510-10da-4bf6-8057-7c0432698a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/AuditInformation" xlink:type="simple" xlink:href="asth-20231231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_asth_AuditInformationAbstract_ae7c3f72-f6f2-4516-833f-2c35ebc8ea23" xlink:href="asth-20231231.xsd#asth_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_e435e98b-e868-45b8-8b8d-9a5ea4c8ff56" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_AuditInformationAbstract_ae7c3f72-f6f2-4516-833f-2c35ebc8ea23" xlink:to="loc_dei_AuditorFirmId_e435e98b-e868-45b8-8b8d-9a5ea4c8ff56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_34fb6c92-fa61-4e31-86bd-c0a6078128f1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_AuditInformationAbstract_ae7c3f72-f6f2-4516-833f-2c35ebc8ea23" xlink:to="loc_dei_AuditorName_34fb6c92-fa61-4e31-86bd-c0a6078128f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_79d38914-d10c-4aaa-8299-9c971f271c8c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_AuditInformationAbstract_ae7c3f72-f6f2-4516-833f-2c35ebc8ea23" xlink:to="loc_dei_AuditorLocation_79d38914-d10c-4aaa-8299-9c971f271c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ba5984d6-9828-4828-ab70-29bd4318981d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_096da139-453d-4ddb-b001-35129b024552" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ba5984d6-9828-4828-ab70-29bd4318981d" xlink:to="loc_us-gaap_StatementTable_096da139-453d-4ddb-b001-35129b024552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c7576a66-3c65-4bd2-90d1-bd270c7b1514" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_096da139-453d-4ddb-b001-35129b024552" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c7576a66-3c65-4bd2-90d1-bd270c7b1514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c06dc3b8-8de2-479b-a57d-b13a5fd4bb83" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c7576a66-3c65-4bd2-90d1-bd270c7b1514" xlink:to="loc_us-gaap_RelatedPartyDomain_c06dc3b8-8de2-479b-a57d-b13a5fd4bb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_170b9819-9016-4d24-90cb-64da9d98835c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c06dc3b8-8de2-479b-a57d-b13a5fd4bb83" xlink:to="loc_us-gaap_NonrelatedPartyMember_170b9819-9016-4d24-90cb-64da9d98835c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_791a3b1e-f9db-407b-9530-3c89754b3b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c06dc3b8-8de2-479b-a57d-b13a5fd4bb83" xlink:to="loc_us-gaap_RelatedPartyMember_791a3b1e-f9db-407b-9530-3c89754b3b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fa36a6ee-1a99-4fda-9b2e-c0a70d37c63c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_096da139-453d-4ddb-b001-35129b024552" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fa36a6ee-1a99-4fda-9b2e-c0a70d37c63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5521d7df-442e-41f5-aa2b-ca21f8cd2c35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fa36a6ee-1a99-4fda-9b2e-c0a70d37c63c" xlink:to="loc_us-gaap_ClassOfStockDomain_5521d7df-442e-41f5-aa2b-ca21f8cd2c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_f08c9371-fd5c-424f-983c-4e83b6dc691c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5521d7df-442e-41f5-aa2b-ca21f8cd2c35" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_f08c9371-fd5c-424f-983c-4e83b6dc691c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_edb8a0fb-6812-4036-b40c-cc7124b01b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_5521d7df-442e-41f5-aa2b-ca21f8cd2c35" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_edb8a0fb-6812-4036-b40c-cc7124b01b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_89ca6d4b-7033-4c61-8737-d132484103c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_096da139-453d-4ddb-b001-35129b024552" xlink:to="loc_us-gaap_StatementLineItems_89ca6d4b-7033-4c61-8737-d132484103c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89ca6d4b-7033-4c61-8737-d132484103c5" xlink:to="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1b32f858-34e4-4938-85d5-3b22ff3385a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1b32f858-34e4-4938-85d5-3b22ff3385a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_03baa069-4cbf-4338-8b36-b3d33943d086" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_03baa069-4cbf-4338-8b36-b3d33943d086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4b27f247-46e5-4e63-901f-4cc7d497a229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4b27f247-46e5-4e63-901f-4cc7d497a229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_9e033f8f-4db5-4f10-8e92-dd532491dc17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_IncomeTaxesReceivable_9e033f8f-4db5-4f10-8e92-dd532491dc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_6017a919-996c-4576-a8bd-1d0a9d2a67f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_6017a919-996c-4576-a8bd-1d0a9d2a67f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34ca3319-2c38-4524-9dbb-4a632f60449f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_34ca3319-2c38-4524-9dbb-4a632f60449f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_0e95ec59-cc27-4314-9751-b34a1047b3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_0e95ec59-cc27-4314-9751-b34a1047b3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3080a554-5401-4927-bd02-6c3c04b7cb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_6d44f0b8-8a15-479e-83e6-5d96f905ffe3" xlink:to="loc_us-gaap_AssetsCurrent_3080a554-5401-4927-bd02-6c3c04b7cb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2220c2b4-810a-4ab4-b33d-9f2c17ef20aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2220c2b4-810a-4ab4-b33d-9f2c17ef20aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58ec6617-53b5-49f8-8075-e491f60b138f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_58ec6617-53b5-49f8-8075-e491f60b138f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4e160b1f-0485-44fc-b3f4-9733635225d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_Goodwill_4e160b1f-0485-44fc-b3f4-9733635225d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_36e771b6-4901-474a-93fa-4412da13e933" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_36e771b6-4901-474a-93fa-4412da13e933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_cc5e2f61-2d4c-487e-be31-b4c1b49ac9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_cc5e2f61-2d4c-487e-be31-b4c1b49ac9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ebc58579-2908-4280-8883-13bf67bd8832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_EquityMethodInvestments_ebc58579-2908-4280-8883-13bf67bd8832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_422c02b8-ec28-4927-ba3f-d4bee2fa5d5e" xlink:href="asth-20231231.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_422c02b8-ec28-4927-ba3f-d4bee2fa5d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6e2bba59-4e79-4546-bb97-cae1d55c221e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6e2bba59-4e79-4546-bb97-cae1d55c221e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b71a4cbf-2e63-472f-b98b-574562a84d64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b71a4cbf-2e63-472f-b98b-574562a84d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9d9e2e66-a1f7-4f44-8e94-32eae627add6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9d9e2e66-a1f7-4f44-8e94-32eae627add6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_9bebf3a9-788b-4236-a290-5be97860a85f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_99046d7f-865c-4cf5-af45-56c8fc99f6fd" xlink:to="loc_us-gaap_AssetsNoncurrent_9bebf3a9-788b-4236-a290-5be97860a85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a82fc9e2-0490-4eda-8116-52614e989370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5e6e7a6d-81e4-4bb9-8b8a-7e178d5edb6b" xlink:to="loc_us-gaap_Assets_a82fc9e2-0490-4eda-8116-52614e989370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89ca6d4b-7033-4c61-8737-d132484103c5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3bc623be-78bb-4ddf-b370-d46560672c07" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3bc623be-78bb-4ddf-b370-d46560672c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryAccountsPayableCurrent_e80298f9-c8e6-487b-be6d-f3ca65cc3e06" xlink:href="asth-20231231.xsd#asth_FiduciaryAccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_asth_FiduciaryAccountsPayableCurrent_e80298f9-c8e6-487b-be6d-f3ca65cc3e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_774a6e25-9f30-47dd-bc7d-c26aa63867df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_774a6e25-9f30-47dd-bc7d-c26aa63867df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_954d3574-0f7c-4f99-967a-e446a3a559b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_954d3574-0f7c-4f99-967a-e446a3a559b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_ec8340bc-678d-49ee-901f-a0964a5f243b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_DividendsPayableCurrent_ec8340bc-678d-49ee-901f-a0964a5f243b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d3f50ccc-2156-4837-a5da-224836c25183" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d3f50ccc-2156-4837-a5da-224836c25183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1df36b06-f5ad-423c-896f-78a6a450ab47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1df36b06-f5ad-423c-896f-78a6a450ab47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6885fd31-e332-45b4-a574-f9bc9316f3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_LongTermDebtCurrent_6885fd31-e332-45b4-a574-f9bc9316f3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c6dfb2b5-367e-4fef-800b-4ccb4f18b9da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c6dfb2b5-367e-4fef-800b-4ccb4f18b9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_da767227-dac7-4b2f-883d-8edec82626fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7777fa0f-1fef-4309-9635-1a94f900215e" xlink:to="loc_us-gaap_LiabilitiesCurrent_da767227-dac7-4b2f-883d-8edec82626fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_119aab9d-223d-4a93-96d0-f9d61acaef22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_119aab9d-223d-4a93-96d0-f9d61acaef22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_18692427-4889-44ae-b2b3-02a6dfff7cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_18692427-4889-44ae-b2b3-02a6dfff7cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e0288f0c-ebc8-4102-b4e1-f2bcc3b222cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e0288f0c-ebc8-4102-b4e1-f2bcc3b222cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ca7dc834-afb4-41c3-9104-9ee0446cc1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ca7dc834-afb4-41c3-9104-9ee0446cc1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_93873afc-69f8-460e-802d-8f8b0d9aec81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_93873afc-69f8-460e-802d-8f8b0d9aec81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_017aecd7-47f5-4fe5-a200-6b7c8f60cdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_57f49575-b663-4f14-addc-484ad3af3689" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_017aecd7-47f5-4fe5-a200-6b7c8f60cdd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9d4f7a71-51ce-439b-831e-7b34e7ce63e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_Liabilities_9d4f7a71-51ce-439b-831e-7b34e7ce63e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e3ff5a13-8225-445f-bab9-bad312603f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e3ff5a13-8225-445f-bab9-bad312603f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MezzanineEquityAbstract_8fbcce1e-dfe1-4383-ae41-90b80f0facee" xlink:href="asth-20231231.xsd#asth_MezzanineEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_asth_MezzanineEquityAbstract_8fbcce1e-dfe1-4383-ae41-90b80f0facee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_e5025257-b760-4a39-8f19-3494916d2fb4" xlink:href="asth-20231231.xsd#asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_MezzanineEquityAbstract_8fbcce1e-dfe1-4383-ae41-90b80f0facee" xlink:to="loc_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_e5025257-b760-4a39-8f19-3494916d2fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_566ea6cd-f235-447e-b26a-af6c0a092c97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_PreferredStockValue_566ea6cd-f235-447e-b26a-af6c0a092c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7a487d20-9d95-492b-b7c5-eb710ba35a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_CommonStockValue_7a487d20-9d95-492b-b7c5-eb710ba35a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_cfc8c5e7-567c-4e4c-b3b0-267cb3918ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_AdditionalPaidInCapital_cfc8c5e7-567c-4e4c-b3b0-267cb3918ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01f9d020-34a5-4264-9a77-259931d9c81a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01f9d020-34a5-4264-9a77-259931d9c81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3df7c6b4-d480-4c2d-a72c-6842522f9868" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_StockholdersEquity_3df7c6b4-d480-4c2d-a72c-6842522f9868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_349dd0d6-c407-4dce-9d0c-6e84bdd729db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_MinorityInterest_349dd0d6-c407-4dce-9d0c-6e84bdd729db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1beb8c73-904c-49d3-8b48-40d68365c52d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0cc4e210-db77-4959-8a14-1e30d0ce5e58" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1beb8c73-904c-49d3-8b48-40d68365c52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5ff4def-15b4-4220-a324-ee7cbb68966d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a322568f-b2b8-445d-bfd6-af0da632d516" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5ff4def-15b4-4220-a324-ee7cbb68966d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_19806a3b-ba24-45bf-9edc-2f7ce3dec7be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5d587e57-0013-4761-911b-3202e48e1477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_19806a3b-ba24-45bf-9edc-2f7ce3dec7be" xlink:to="loc_us-gaap_StatementTable_5d587e57-0013-4761-911b-3202e48e1477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1d6c12c6-8877-48d8-853f-a5ac5013c21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5d587e57-0013-4761-911b-3202e48e1477" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1d6c12c6-8877-48d8-853f-a5ac5013c21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_682a9d2b-4912-4e62-9628-e347f711460e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1d6c12c6-8877-48d8-853f-a5ac5013c21e" xlink:to="loc_us-gaap_ClassOfStockDomain_682a9d2b-4912-4e62-9628-e347f711460e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_876205bb-c673-4e9a-8442-10e77c96438f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_682a9d2b-4912-4e62-9628-e347f711460e" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_876205bb-c673-4e9a-8442-10e77c96438f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_616ad4d7-919e-4837-ac17-1200b98af988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_682a9d2b-4912-4e62-9628-e347f711460e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_616ad4d7-919e-4837-ac17-1200b98af988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_60300d7e-fcef-4fbb-9ae9-2d249b18d4ad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5d587e57-0013-4761-911b-3202e48e1477" xlink:to="loc_srt_ConsolidatedEntitiesAxis_60300d7e-fcef-4fbb-9ae9-2d249b18d4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7ea55aae-ed9b-4f38-8e61-f8a33a93e56b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_60300d7e-fcef-4fbb-9ae9-2d249b18d4ad" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7ea55aae-ed9b-4f38-8e61-f8a33a93e56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0d03aa8a-a2c5-4cf7-8458-bdc88a5691a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7ea55aae-ed9b-4f38-8e61-f8a33a93e56b" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0d03aa8a-a2c5-4cf7-8458-bdc88a5691a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5d587e57-0013-4761-911b-3202e48e1477" xlink:to="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_82c05e48-fd45-431f-ae21-c0e1cc3a59b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_82c05e48-fd45-431f-ae21-c0e1cc3a59b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f060ccfc-b8c0-46c5-8239-3a348e47455a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f060ccfc-b8c0-46c5-8239-3a348e47455a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_358fefe9-69f4-4739-a816-e0d75c446478" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_PreferredStockSharesIssued_358fefe9-69f4-4739-a816-e0d75c446478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_dca5108d-5222-42e2-bf80-7d714322536b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_dca5108d-5222-42e2-bf80-7d714322536b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_35c492ab-18ac-43d8-9745-f88e62fcf840" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_35c492ab-18ac-43d8-9745-f88e62fcf840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_fc47ba87-88e4-485e-ad81-ec2afdbe322e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_fc47ba87-88e4-485e-ad81-ec2afdbe322e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_1bd1323f-5fab-4b5d-ae73-57071f937c12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_SharesOutstanding_1bd1323f-5fab-4b5d-ae73-57071f937c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_bf014055-d6c9-4fd6-8dde-f511fb568fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_TreasuryStockCommonShares_bf014055-d6c9-4fd6-8dde-f511fb568fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a789439a-a893-4262-9ee3-c2204e53f20b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_Assets_a789439a-a893-4262-9ee3-c2204e53f20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5fc464c3-fbd7-4d43-8e5c-55cf3a59c7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_Liabilities_5fc464c3-fbd7-4d43-8e5c-55cf3a59c7c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_de91beca-0a38-429f-a0fc-5ddaa6e1f387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_de91beca-0a38-429f-a0fc-5ddaa6e1f387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_636569f9-8877-497e-a726-0ac59e8141b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_OtherLiabilities_636569f9-8877-497e-a726-0ac59e8141b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_45721189-b72b-4f74-a97d-ff87a3bda30a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d6fbddf-fdf8-4cb3-9615-80764fa311d8" xlink:to="loc_us-gaap_OtherReceivables_45721189-b72b-4f74-a97d-ff87a3bda30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_30031f92-ad08-4ba6-97d8-54023ea1c4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_aaa2a832-9281-41bd-b8fe-8056a27798e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_30031f92-ad08-4ba6-97d8-54023ea1c4eb" xlink:to="loc_us-gaap_StatementTable_aaa2a832-9281-41bd-b8fe-8056a27798e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_10629ca3-c811-480c-a6e2-dcaf0f5c234f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aaa2a832-9281-41bd-b8fe-8056a27798e9" xlink:to="loc_srt_ProductOrServiceAxis_10629ca3-c811-480c-a6e2-dcaf0f5c234f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_10629ca3-c811-480c-a6e2-dcaf0f5c234f" xlink:to="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_HealthCareCapitationRevenueMember_829100cb-e24b-4591-a6bb-3e0dd0cdf8f0" xlink:href="asth-20231231.xsd#asth_HealthCareCapitationRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_asth_HealthCareCapitationRevenueMember_829100cb-e24b-4591-a6bb-3e0dd0cdf8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_64d4b08b-0710-49d7-b4f7-02e0f95c0330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_us-gaap_HealthCareOtherMember_64d4b08b-0710-49d7-b4f7-02e0f95c0330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceMember_55705122-76c5-4685-8ac1-6c1fe25213bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_us-gaap_ManagementServiceMember_55705122-76c5-4685-8ac1-6c1fe25213bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_003825fa-d044-42a1-97af-18610b494b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_003825fa-d044-42a1-97af-18610b494b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_8e5e7383-676c-4981-a8be-8df7aaf9f527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_73f01363-635d-40c1-aef3-16003adadb59" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_8e5e7383-676c-4981-a8be-8df7aaf9f527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aaa2a832-9281-41bd-b8fe-8056a27798e9" xlink:to="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_6337f61e-fda3-4a19-8736-00536d68b069" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_RevenuesAbstract_6337f61e-fda3-4a19-8736-00536d68b069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7975004a-d178-457a-91c4-5bba0bb84e12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_6337f61e-fda3-4a19-8736-00536d68b069" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7975004a-d178-457a-91c4-5bba0bb84e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_88017d73-5e11-47fd-816f-426877a7393a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_88017d73-5e11-47fd-816f-426877a7393a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_5d2545ea-6614-4cd3-af10-1b5fe9eff2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_5d2545ea-6614-4cd3-af10-1b5fe9eff2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_20681da9-4d44-4c0b-8fe8-347499bd7e47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_20681da9-4d44-4c0b-8fe8-347499bd7e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ac54fb55-7b82-4d88-acf6-4c5da891b388" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3aa6d2ef-5606-4c12-b141-ea4e4157ce2a" xlink:to="loc_us-gaap_CostsAndExpenses_ac54fb55-7b82-4d88-acf6-4c5da891b388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5a959d15-c939-40ee-a12d-b526601d0318" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_OperatingIncomeLoss_5a959d15-c939-40ee-a12d-b526601d0318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_aff2c3ba-51ca-4819-a1ef-be456fcfdb53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_aff2c3ba-51ca-4819-a1ef-be456fcfdb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_08bb1f37-89e0-414d-bd9a-1220647fcd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_08bb1f37-89e0-414d-bd9a-1220647fcd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_6f58a5bc-56a4-406b-90a1-156aa6b98185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_InterestExpense_6f58a5bc-56a4-406b-90a1-156aa6b98185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_3b24d088-bdc1-4263-8e96-465c6cb5f949" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_InvestmentIncomeInterest_3b24d088-bdc1-4263-8e96-465c6cb5f949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_c61a40b9-4431-4c1d-b4a2-db8738a2cb24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_c61a40b9-4431-4c1d-b4a2-db8738a2cb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_0c10bd4c-2056-4696-be9a-ffed58a3bb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_0c10bd4c-2056-4696-be9a-ffed58a3bb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_67c1e296-9270-4bd5-94b5-4e8a07f4ca39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_f02d55e9-d6f1-4bcd-b36a-340e2a566c75" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_67c1e296-9270-4bd5-94b5-4e8a07f4ca39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13c175b2-b914-4d90-9b3a-558c3be1245d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_13c175b2-b914-4d90-9b3a-558c3be1245d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_455b42b2-49b3-428b-8e4b-530895558bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_455b42b2-49b3-428b-8e4b-530895558bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e7abc263-64f9-406d-85c4-ce97ec762a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_ProfitLoss_e7abc263-64f9-406d-85c4-ce97ec762a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6a9b640d-e4fa-45c6-9eb3-6080220ba39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6a9b640d-e4fa-45c6-9eb3-6080220ba39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_791e7fbc-e6f8-42cb-b02b-f3e9676242d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_NetIncomeLoss_791e7fbc-e6f8-42cb-b02b-f3e9676242d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f53a0778-07ea-4f3e-9fe7-0f5d1532f56a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_EarningsPerShareBasic_f53a0778-07ea-4f3e-9fe7-0f5d1532f56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_316ad45a-b1f2-4a66-aee3-4b22d72d6019" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5225613d-5c26-4a42-ad5e-f568f65b60a1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_316ad45a-b1f2-4a66-aee3-4b22d72d6019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_fbecbdfe-3dab-465a-a043-8594194359ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f938bb4e-d3cd-4ea2-8460-f72cae09a54c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_fbecbdfe-3dab-465a-a043-8594194359ca" xlink:to="loc_us-gaap_StatementTable_f938bb4e-d3cd-4ea2-8460-f72cae09a54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b40d4666-6dda-4ba0-90fd-b4ade821eca7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f938bb4e-d3cd-4ea2-8460-f72cae09a54c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b40d4666-6dda-4ba0-90fd-b4ade821eca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b40d4666-6dda-4ba0-90fd-b4ade821eca7" xlink:to="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_07831bf0-611e-4fda-96a0-4ef00fccb748" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:to="loc_us-gaap_CommonStockMember_07831bf0-611e-4fda-96a0-4ef00fccb748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_75c0228e-7f54-4a7e-b9e2-5a61d1e674ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_75c0228e-7f54-4a7e-b9e2-5a61d1e674ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d644432e-dd7c-452c-8c2c-8f0a27e8e034" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:to="loc_us-gaap_RetainedEarningsMember_d644432e-dd7c-452c-8c2c-8f0a27e8e034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_2edb9ca8-ec8e-4e89-9caa-f29592c83550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc4faa5d-bb2e-4a4c-a762-f034a0d16a98" xlink:to="loc_us-gaap_NoncontrollingInterestMember_2edb9ca8-ec8e-4e89-9caa-f29592c83550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7509e522-bfea-4365-bc9c-e3251ff4311e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f938bb4e-d3cd-4ea2-8460-f72cae09a54c" xlink:to="loc_dei_LegalEntityAxis_7509e522-bfea-4365-bc9c-e3251ff4311e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_19e13e6a-2fcf-4765-adcc-6f649c96b23a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7509e522-bfea-4365-bc9c-e3251ff4311e" xlink:to="loc_dei_EntityDomain_19e13e6a-2fcf-4765-adcc-6f649c96b23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MezzanineMember_2da8017e-9428-433f-bd99-ee38e2b9421c" xlink:href="asth-20231231.xsd#asth_MezzanineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_19e13e6a-2fcf-4765-adcc-6f649c96b23a" xlink:to="loc_asth_MezzanineMember_2da8017e-9428-433f-bd99-ee38e2b9421c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_97027d89-bd09-407f-bfed-eedcb5ccd40b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f938bb4e-d3cd-4ea2-8460-f72cae09a54c" xlink:to="loc_us-gaap_StatementLineItems_97027d89-bd09-407f-bfed-eedcb5ccd40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97027d89-bd09-407f-bfed-eedcb5ccd40b" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6a7c8d6b-425d-41f0-b386-26f160edad5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6a7c8d6b-425d-41f0-b386-26f160edad5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_1684bfae-fedd-492c-a5c2-95c96349935d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_1684bfae-fedd-492c-a5c2-95c96349935d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_d3c733d8-2a9d-4993-be27-5764c234cbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_d3c733d8-2a9d-4993-be27-5764c234cbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_737f7984-d4a7-49d6-ba4e-15d1a0c4d6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_737f7984-d4a7-49d6-ba4e-15d1a0c4d6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_abfee95b-67f9-4635-be8d-493e2bf8c0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_abfee95b-67f9-4635-be8d-493e2bf8c0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityTaxImpactOnAcquisition_d9617f8e-4da6-4c4f-865e-f2cb393130fe" xlink:href="asth-20231231.xsd#asth_TemporaryEquityTaxImpactOnAcquisition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_asth_TemporaryEquityTaxImpactOnAcquisition_d9617f8e-4da6-4c4f-865e-f2cb393130fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e1c0ee7b-e543-42c9-97a6-698f78bf3823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e1c0ee7b-e543-42c9-97a6-698f78bf3823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends_3adef0b9-72ea-4c2d-9687-4c5ddbc3d83d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_TemporaryEquityAccretionOfDividends_3adef0b9-72ea-4c2d-9687-4c5ddbc3d83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityTransferOfCommonControlEntities_10f726c3-40a6-4fac-9039-8386d33331d0" xlink:href="asth-20231231.xsd#asth_TemporaryEquityTransferOfCommonControlEntities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_asth_TemporaryEquityTransferOfCommonControlEntities_10f726c3-40a6-4fac-9039-8386d33331d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TaxImpactFromDividends_28d19577-f952-4148-a247-7438495c59d0" xlink:href="asth-20231231.xsd#asth_TaxImpactFromDividends"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_asth_TaxImpactFromDividends_28d19577-f952-4148-a247-7438495c59d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TaxImpactFromInvestments_8b8e066e-7171-4851-886a-46974676879d" xlink:href="asth-20231231.xsd#asth_TaxImpactFromInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_asth_TaxImpactFromInvestments_8b8e066e-7171-4851-886a-46974676879d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d05fd6d8-9da8-4d51-8adc-aef5749d510c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_a5b73c15-7558-4ea7-a6f4-66b796ca9cd2" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d05fd6d8-9da8-4d51-8adc-aef5749d510c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_97027d89-bd09-407f-bfed-eedcb5ccd40b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_bc574c97-7b53-4a49-8ec5-da95d915ed24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_SharesOutstanding_bc574c97-7b53-4a49-8ec5-da95d915ed24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_61d8fc14-0283-4a0d-ae6a-2ea6830cc04f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_61d8fc14-0283-4a0d-ae6a-2ea6830cc04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_5613391a-590d-412e-90a7-8a2a2cd2cdb6" xlink:href="asth-20231231.xsd#asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_5613391a-590d-412e-90a7-8a2a2cd2cdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_8024b2f6-11d9-4771-b659-b3ee8c9ba8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_8024b2f6-11d9-4771-b659-b3ee8c9ba8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_cbd3bbdf-d4bc-48cc-9693-5f75e1fca15d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_cbd3bbdf-d4bc-48cc-9693-5f75e1fca15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest_500fbc0f-bdbb-4691-b6a3-f6ef82ef8855" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringPeriodSharesNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest_500fbc0f-bdbb-4691-b6a3-f6ef82ef8855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringPeriodValueNoncontrollingInterest_84169c79-0cff-48ea-80ea-7d4508344f96" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringPeriodValueNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockIssuedDuringPeriodValueNoncontrollingInterest_84169c79-0cff-48ea-80ea-7d4508344f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_ea594cef-e603-4b36-b4a7-f62e332dce58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_ea594cef-e603-4b36-b4a7-f62e332dce58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1dc0de7c-51d4-4bf3-93b7-0c17a1450791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_1dc0de7c-51d4-4bf3-93b7-0c17a1450791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_d26d6930-bc42-465c-8541-eafc73afa860" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants_d26d6930-bc42-465c-8541-eafc73afa860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_a57ba7f8-4ba1-4522-b51d-e8d8d6b154a1" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants_a57ba7f8-4ba1-4522-b51d-e8d8d6b154a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_60882320-d4f0-4472-89b0-e8aceac34f28" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_60882320-d4f0-4472-89b0-e8aceac34f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_ccfe9391-3474-44d4-9a53-f9b830d23e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_ccfe9391-3474-44d4-9a53-f9b830d23e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2650ad84-b361-48d7-ba7e-7161703e8c57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2650ad84-b361-48d7-ba7e-7161703e8c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1c7e9271-b2fa-4374-bd23-72fc7dd659a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_1c7e9271-b2fa-4374-bd23-72fc7dd659a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c67424a9-5fcd-4d85-936c-3c0cbde49232" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_c67424a9-5fcd-4d85-936c-3c0cbde49232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_c8c37fea-46dc-4abf-8eb6-da667aa1b49a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_c8c37fea-46dc-4abf-8eb6-da667aa1b49a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_cde52751-3b42-4f96-b9fd-c27d8b90543a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_cde52751-3b42-4f96-b9fd-c27d8b90543a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_9fc79afa-7d49-4601-9816-4ae217eae5db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_9fc79afa-7d49-4601-9816-4ae217eae5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_61f8d969-0842-44ae-b8ac-954ce2bd32e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures_61f8d969-0842-44ae-b8ac-954ce2bd32e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncontrollingInterestIncreaseFromCapitalCharge_30c0f9bb-35a2-4253-a203-fe40f5b4ce09" xlink:href="asth-20231231.xsd#asth_NoncontrollingInterestIncreaseFromCapitalCharge"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_NoncontrollingInterestIncreaseFromCapitalCharge_30c0f9bb-35a2-4253-a203-fe40f5b4ce09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGEquityContingentConsideration_b6795d77-602f-4720-8a66-9fbeda65b088" xlink:href="asth-20231231.xsd#asth_AAMGEquityContingentConsideration"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_AAMGEquityContingentConsideration_b6795d77-602f-4720-8a66-9fbeda65b088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_0addeb8e-43c0-4491-abe6-1eded84b7697" xlink:href="asth-20231231.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_0addeb8e-43c0-4491-abe6-1eded84b7697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_2bf12fe5-0d44-41a6-aa14-4df70d631cef" xlink:href="asth-20231231.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_2bf12fe5-0d44-41a6-aa14-4df70d631cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockholdersEquityTransferOfCommonControlEntities_07d67565-bf11-48af-a979-e183f8998b04" xlink:href="asth-20231231.xsd#asth_StockholdersEquityTransferOfCommonControlEntities"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_asth_StockholdersEquityTransferOfCommonControlEntities_07d67565-bf11-48af-a979-e183f8998b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e5d302df-cf14-46c6-95c0-04e0af0d33f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_SharesOutstanding_e5d302df-cf14-46c6-95c0-04e0af0d33f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ce7e15a-94e6-434c-86d0-e41402dd98c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_954edf9b-be6e-44c5-a222-e2e776890e05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ce7e15a-94e6-434c-86d0-e41402dd98c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="asth-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_80aeffb8-a354-48fd-82ce-d03ec23684a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_80aeffb8-a354-48fd-82ce-d03ec23684a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4134b9fd-cc10-4ac7-8580-f65c1ac49289" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_80aeffb8-a354-48fd-82ce-d03ec23684a8" xlink:to="loc_us-gaap_ProfitLoss_4134b9fd-cc10-4ac7-8580-f65c1ac49289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_80aeffb8-a354-48fd-82ce-d03ec23684a8" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_982fed04-f08d-4dd6-b440-a09718a23464" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_982fed04-f08d-4dd6-b440-a09718a23464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_5c5e639f-95dc-45e6-89c4-3d5c352f6d91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_5c5e639f-95dc-45e6-89c4-3d5c352f6d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6085e752-1df1-4ba6-b418-0c67b31769a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_ShareBasedCompensation_6085e752-1df1-4ba6-b418-0c67b31769a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NoncashLeaseExpense_1cd277a0-753f-4df2-a562-56c63ac5e9cf" xlink:href="asth-20231231.xsd#asth_NoncashLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_asth_NoncashLeaseExpense_1cd277a0-753f-4df2-a562-56c63ac5e9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c87b0e08-a732-45e0-9f5f-a6b25ce946fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c87b0e08-a732-45e0-9f5f-a6b25ce946fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_UnrealizedGainLossFromInvestmentInEquitySecurities_5d48405d-04c9-4ef7-98a0-632c4e302e2d" xlink:href="asth-20231231.xsd#asth_UnrealizedGainLossFromInvestmentInEquitySecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_asth_UnrealizedGainLossFromInvestmentInEquitySecurities_5d48405d-04c9-4ef7-98a0-632c4e302e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_70af4b84-00dc-4566-b442-53edf0f8c7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_70af4b84-00dc-4566-b442-53edf0f8c7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_6057dbd3-42fa-4c57-9f93-021052670d89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_6057dbd3-42fa-4c57-9f93-021052670d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2e3ecb65-db17-4d5d-ae79-0e51d784237e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_2e3ecb65-db17-4d5d-ae79-0e51d784237e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_GainLossOnConsolidationOfEquityMethodInvestment_c1201c03-7e36-4803-bb67-04681796c3d2" xlink:href="asth-20231231.xsd#asth_GainLossOnConsolidationOfEquityMethodInvestment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_asth_GainLossOnConsolidationOfEquityMethodInvestment_c1201c03-7e36-4803-bb67-04681796c3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_GainLossOnEquityReceivable_eb3ad2f2-a4ab-4083-ad83-824796aab211" xlink:href="asth-20231231.xsd#asth_GainLossOnEquityReceivable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_asth_GainLossOnEquityReceivable_eb3ad2f2-a4ab-4083-ad83-824796aab211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_ba8539cc-7534-46e5-a679-7066164f0379" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_ba8539cc-7534-46e5-a679-7066164f0379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_89c11a4e-70c1-471c-9286-135f375f272b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_89c11a4e-70c1-471c-9286-135f375f272b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherOperatingActivities_ee0661cd-81cd-43f0-922b-2eb58aa0dd32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromOtherOperatingActivities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_ProceedsFromOtherOperatingActivities_ee0661cd-81cd-43f0-922b-2eb58aa0dd32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d17797e0-b1ac-4a0f-8575-3c539c2e12b4" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_87dd7826-8543-4978-95fa-b794f5ab63e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_87dd7826-8543-4978-95fa-b794f5ab63e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties_ddd2a033-4c54-4aeb-8c92-32c3e2ec87e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_us-gaap_IncreaseDecreaseInDueFromRelatedParties_ddd2a033-4c54-4aeb-8c92-32c3e2ec87e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_8565ee8f-f57f-407a-83cd-4b439d09cd50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_8565ee8f-f57f-407a-83cd-4b439d09cd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_5530bd95-2de5-4311-b083-e686ebb5431f" xlink:href="asth-20231231.xsd#asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_5530bd95-2de5-4311-b083-e686ebb5431f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c465d8b2-5eac-43b3-84ef-bd1b5c653107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c465d8b2-5eac-43b3-84ef-bd1b5c653107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f91c6dcb-4934-4dd2-a82c-92983840cf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_f91c6dcb-4934-4dd2-a82c-92983840cf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_2c78eca8-bf8a-4a7b-a2e7-1c4ffb8feca3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayable_2c78eca8-bf8a-4a7b-a2e7-1c4ffb8feca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IncreaseDecreaseInMedicalLiabilities_e693cf88-322e-4a06-92f2-f43fa297fa8a" xlink:href="asth-20231231.xsd#asth_IncreaseDecreaseInMedicalLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_asth_IncreaseDecreaseInMedicalLiabilities_e693cf88-322e-4a06-92f2-f43fa297fa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c63ff9ab-b836-41c7-a76a-c1a8b0771bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c63ff9ab-b836-41c7-a76a-c1a8b0771bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_101c68c9-ca69-44a4-b7eb-e193707732f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c36e05b2-bd43-40fe-b7ae-b0178f460e56" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_101c68c9-ca69-44a4-b7eb-e193707732f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ac6d6f0f-a42c-4598-b0eb-9c3b33657921" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_80aeffb8-a354-48fd-82ce-d03ec23684a8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ac6d6f0f-a42c-4598-b0eb-9c3b33657921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9b6b9984-3218-4cac-9af9-97da44f6ab89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9b6b9984-3218-4cac-9af9-97da44f6ab89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_591b44c6-1203-4b49-a734-e6573b70262b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties_591b44c6-1203-4b49-a734-e6573b70262b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_0825eb25-afef-43b4-b975-0d5273c1a9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_0825eb25-afef-43b4-b975-0d5273c1a9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_68045207-c55f-4a1d-a113-77a3e793d289" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_68045207-c55f-4a1d-a113-77a3e793d289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_4d30e2a0-3fd1-4269-957e-67539802f529" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_4d30e2a0-3fd1-4269-957e-67539802f529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_8fd08841-40be-449b-814c-ebada67db93b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment_8fd08841-40be-449b-814c-ebada67db93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2b737940-7052-4745-89f2-b3ba04619b05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2b737940-7052-4745-89f2-b3ba04619b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_d50d1904-c2ea-4070-9743-ff664600fba8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_d50d1904-c2ea-4070-9743-ff664600fba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_360b763e-95aa-453d-a89a-84c3a205955d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_ProceedsFromSaleOfEquityMethodInvestments_360b763e-95aa-453d-a89a-84c3a205955d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_2bf16951-313e-4268-9bfe-82b11fac3aba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_2bf16951-313e-4268-9bfe-82b11fac3aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentsToEquityMethodInvestments_f654553d-313c-4723-904d-88ad290bfd1a" xlink:href="asth-20231231.xsd#asth_PaymentsToEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_asth_PaymentsToEquityMethodInvestments_f654553d-313c-4723-904d-88ad290bfd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity_48ffd808-9eb1-416c-a28a-69f11a43449f" xlink:href="asth-20231231.xsd#asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity_48ffd808-9eb1-416c-a28a-69f11a43449f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_051bd531-5906-4d1c-acb7-69ea6b8fa29b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_52198f9b-7350-49df-a565-f606c5c63a51" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_051bd531-5906-4d1c-acb7-69ea6b8fa29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_c0ab3377-2534-478a-a906-a2c89aec3721" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_c0ab3377-2534-478a-a906-a2c89aec3721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_09559109-e723-443a-8962-c18cdb8568b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_09559109-e723-443a-8962-c18cdb8568b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_e33a3447-4914-4403-804c-4fb98ce3def9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_e33a3447-4914-4403-804c-4fb98ce3def9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_e4244094-fc18-48ce-b9f0-e23208545045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_e4244094-fc18-48ce-b9f0-e23208545045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_6a9e4d9d-ad6c-43cf-ab66-e710cfb1f129" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_6a9e4d9d-ad6c-43cf-ab66-e710cfb1f129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_82c6e97e-be14-474d-8cb5-8e64a433b0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_82c6e97e-be14-474d-8cb5-8e64a433b0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f35eb228-af3f-4022-af48-50e62f9caf57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f35eb228-af3f-4022-af48-50e62f9caf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_7b7aa1a3-8baf-4c87-a1d0-16fdbad1c918" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_7b7aa1a3-8baf-4c87-a1d0-16fdbad1c918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_983ca348-5b33-4dbd-9890-bb52b4d23130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_ProceedsFromPaymentsToMinorityShareholders_983ca348-5b33-4dbd-9890-bb52b4d23130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_fd04e9de-3443-40e7-a3c0-776bf0ebc535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentOfFinancingAndStockIssuanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_PaymentOfFinancingAndStockIssuanceCosts_fd04e9de-3443-40e7-a3c0-776bf0ebc535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_85d15fdc-baf3-4335-9313-c0fa489410ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_85d15fdc-baf3-4335-9313-c0fa489410ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4b9ef2a8-ea7b-4b6c-9b59-2661d889beb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ea473508-aac0-420f-ba28-a7341014556b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4b9ef2a8-ea7b-4b6c-9b59-2661d889beb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0b7ba538-4bbe-4ae3-9ef0-f3e3e72f37eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0b7ba538-4bbe-4ae3-9ef0-f3e3e72f37eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9816f079-05df-49ac-babd-bd51520cdd33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9816f079-05df-49ac-babd-bd51520cdd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5edd77e0-01e2-4825-bc06-d70cd540c0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5edd77e0-01e2-4825-bc06-d70cd540c0ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_46f3dd0e-e39f-4d52-9738-619d99a36210" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_46f3dd0e-e39f-4d52-9738-619d99a36210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_0570a285-56ed-4ebb-a8bf-732bc288220c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_46f3dd0e-e39f-4d52-9738-619d99a36210" xlink:to="loc_us-gaap_IncomeTaxesPaid_0570a285-56ed-4ebb-a8bf-732bc288220c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_6748c345-07da-457e-a9b9-bbab57d02aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_46f3dd0e-e39f-4d52-9738-619d99a36210" xlink:to="loc_us-gaap_InterestPaidNet_6748c345-07da-457e-a9b9-bbab57d02aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f4e7f9e9-c2df-49f1-9582-87996e815dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f4e7f9e9-c2df-49f1-9582-87996e815dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityDividendsImpact_31e10702-0dcd-460a-b86d-99696cc4ec34" xlink:href="asth-20231231.xsd#asth_TemporaryEquityDividendsImpact"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_asth_TemporaryEquityDividendsImpact_31e10702-0dcd-460a-b86d-99696cc4ec34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet_bdd8b900-d37f-4fb3-b4ca-954d2e65c5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet_bdd8b900-d37f-4fb3-b4ca-954d2e65c5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_d0448389-7703-4be4-8a5e-529d5378ff2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_d0448389-7703-4be4-8a5e-529d5378ff2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IssuanceOfFinancingObligationForBusinessCombination_2165daf8-30c6-4a07-8e54-7268b267cb1b" xlink:href="asth-20231231.xsd#asth_IssuanceOfFinancingObligationForBusinessCombination"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_asth_IssuanceOfFinancingObligationForBusinessCombination_2165daf8-30c6-4a07-8e54-7268b267cb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CashlessExerciseOfStockOptions_32f47c8c-e805-4cae-b599-fd35a68f6ba3" xlink:href="asth-20231231.xsd#asth_CashlessExerciseOfStockOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_asth_CashlessExerciseOfStockOptions_32f47c8c-e805-4cae-b599-fd35a68f6ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities_9b5d2c66-de9c-4acb-a1c0-77c671a1a607" xlink:href="asth-20231231.xsd#asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities_9b5d2c66-de9c-4acb-a1c0-77c671a1a607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_8ed0e2b2-d158-410b-99a2-c84ea968b301" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_us-gaap_StockIssued1_8ed0e2b2-d158-410b-99a2-c84ea968b301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1_635dcfbe-051e-489e-86a6-01087ce612f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_us-gaap_MortgageLoanRelatedToPropertySales1_635dcfbe-051e-489e-86a6-01087ce612f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CancellationOfRestrictedStockAwards_e39f3966-2b42-4c90-abf1-2d8f3a68d991" xlink:href="asth-20231231.xsd#asth_CancellationOfRestrictedStockAwards"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8d180846-4eb4-40da-a909-af0099bda82e" xlink:to="loc_asth_CancellationOfRestrictedStockAwards_e39f3966-2b42-4c90-abf1-2d8f3a68d991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_29cc03a6-240b-449d-8ec4-c001d55803bb" xlink:href="asth-20231231.xsd#asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94af35d9-3d18-4f0e-aecb-fafe0ffb7e9e" xlink:to="loc_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_29cc03a6-240b-449d-8ec4-c001d55803bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_53d601c8-404f-45bc-a541-0b6cff0f3dce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_29cc03a6-240b-449d-8ec4-c001d55803bb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_53d601c8-404f-45bc-a541-0b6cff0f3dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f2a40d87-05d3-4fa1-9548-78cae91ff64e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_29cc03a6-240b-449d-8ec4-c001d55803bb" xlink:to="loc_us-gaap_RestrictedCashEquivalentsNoncurrent_f2a40d87-05d3-4fa1-9548-78cae91ff64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f73123ae-a918-4fa7-a125-96384d955beb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_29cc03a6-240b-449d-8ec4-c001d55803bb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f73123ae-a918-4fa7-a125-96384d955beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/DescriptionofBusiness" xlink:type="simple" xlink:href="asth-20231231.xsd#DescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/DescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8fda8190-ce09-40e3-a85b-0377c6c0a30f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_caea8bf9-6c10-42e4-9b39-d5112877afc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8fda8190-ce09-40e3-a85b-0377c6c0a30f" xlink:to="loc_us-gaap_NatureOfOperations_caea8bf9-6c10-42e4-9b39-d5112877afc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="asth-20231231.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a97a410a-d584-42da-b114-946bfade3907" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_14d066fd-ffa1-42db-bab1-594ad495f315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a97a410a-d584-42da-b114-946bfade3907" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_14d066fd-ffa1-42db-bab1-594ad495f315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill" xlink:type="simple" xlink:href="asth-20231231.xsd#BusinessCombinationsAssetAcquisitionsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0a9820a3-8803-485d-9f38-3fccb68e8c46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_f1e457fc-3bf0-4930-bb65-b16e9639e84f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0a9820a3-8803-485d-9f38-3fccb68e8c46" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_f1e457fc-3bf0-4930-bb65-b16e9639e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNet" xlink:type="simple" xlink:href="asth-20231231.xsd#LandPropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LandPropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2ce34220-3c85-4140-96bb-6140d7c73104" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock_cef1808f-4a7a-4eae-9978-10db1da5dadf" xlink:href="asth-20231231.xsd#asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2ce34220-3c85-4140-96bb-6140d7c73104" xlink:to="loc_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock_cef1808f-4a7a-4eae-9978-10db1da5dadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94dfd771-5aca-42a4-81e8-4b2113cb03b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_8bf97282-b522-405b-9b31-3227678c401a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94dfd771-5aca-42a4-81e8-4b2113cb03b9" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_8bf97282-b522-405b-9b31-3227678c401a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntities" xlink:type="simple" xlink:href="asth-20231231.xsd#InvestmentsinOtherEntities"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_60bcca74-009d-433f-9173-131722c154fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_34a25868-ddb9-4e79-b270-085105808960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_60bcca74-009d-433f-9173-131722c154fb" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_34a25868-ddb9-4e79-b270-085105808960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties" xlink:type="simple" xlink:href="asth-20231231.xsd#LoanReceivableandLoanReceivableRelatedParties"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_asth_LoanReceivableAbstract_e325e86d-6ad2-4e78-90f4-7f22bd6df066" xlink:href="asth-20231231.xsd#asth_LoanReceivableAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LoanReceivableTextBlock_442f7ac9-114e-460a-9744-19f6c2c48ee8" xlink:href="asth-20231231.xsd#asth_LoanReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_LoanReceivableAbstract_e325e86d-6ad2-4e78-90f4-7f22bd6df066" xlink:to="loc_asth_LoanReceivableTextBlock_442f7ac9-114e-460a-9744-19f6c2c48ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpenses" xlink:type="simple" xlink:href="asth-20231231.xsd#AccountsPayableandAccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/AccountsPayableandAccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_b98e8244-b41a-42b3-b1c3-6b99d690ee5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_b4daec5f-a191-4834-998c-1c7b6e7e8940" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b98e8244-b41a-42b3-b1c3-6b99d690ee5d" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_b4daec5f-a191-4834-998c-1c7b6e7e8940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MedicalLiabilities" xlink:type="simple" xlink:href="asth-20231231.xsd#MedicalLiabilities"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MedicalLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_02ffa4ce-4624-4316-8579-a7c5309f1f16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_ce498ef9-845b-4de8-80d6-bbd73ceedfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_02ffa4ce-4624-4316-8579-a7c5309f1f16" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_ce498ef9-845b-4de8-80d6-bbd73ceedfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCredit"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5951622f-8156-4362-a305-3e606f800539" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_df87e5d7-7795-47de-bc71-2f5257513e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5951622f-8156-4362-a305-3e606f800539" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_df87e5d7-7795-47de-bc71-2f5257513e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxes" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_022b823c-8876-4019-ae23-8a578752b624" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_27928596-fa1f-481b-91fd-33a281dd13a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_022b823c-8876-4019-ae23-8a578752b624" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_27928596-fa1f-481b-91fd-33a281dd13a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficit" xlink:type="simple" xlink:href="asth-20231231.xsd#MezzanineandStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_606e5f7c-0e98-4bd6-8ff1-270f6da8cc95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_80e3fc79-ec34-4930-92d9-3218f4609d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_606e5f7c-0e98-4bd6-8ff1-270f6da8cc95" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_80e3fc79-ec34-4930-92d9-3218f4609d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensation" xlink:type="simple" xlink:href="asth-20231231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_05745c69-f66c-4be6-b0c2-1a75cd0a45aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d0c3f48d-3a3f-4fa0-9283-8d470afae57e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_05745c69-f66c-4be6-b0c2-1a75cd0a45aa" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d0c3f48d-3a3f-4fa0-9283-8d470afae57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="asth-20231231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_87e1b1eb-7e20-407e-aecb-a09524e763f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7a7c4e1b-9547-47de-9491-61686193c4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_87e1b1eb-7e20-407e-aecb-a09524e763f0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7a7c4e1b-9547-47de-9491-61686193c4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="asth-20231231.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_07e4ef25-311c-4efa-8229-1bf39cda9361" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_a4a53ff7-d640-4d82-83ec-a8a12562053d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_07e4ef25-311c-4efa-8229-1bf39cda9361" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_a4a53ff7-d640-4d82-83ec-a8a12562053d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="asth-20231231.xsd#EmployeeBenefitPlan"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EmployeeBenefitPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9f2eebec-c7f7-491c-9d6c-5c800301f3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d7c01b1b-6df6-4fb2-bce6-f9bc6d5a3638" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_9f2eebec-c7f7-491c-9d6c-5c800301f3b4" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d7c01b1b-6df6-4fb2-bce6-f9bc6d5a3638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShare" xlink:type="simple" xlink:href="asth-20231231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6836330b-008c-4553-829b-ed3deda86551" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_b5f78424-7325-479f-b541-508b8c6d9fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6836330b-008c-4553-829b-ed3deda86551" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_b5f78424-7325-479f-b541-508b8c6d9fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEs" xlink:type="simple" xlink:href="asth-20231231.xsd#VariableInterestEntitiesVIEs"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEs" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5404f000-e44e-40a5-8649-0fcb23832066" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_ba165ecd-9e85-4f5a-81b9-c7a6f54f8247" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5404f000-e44e-40a5-8649-0fcb23832066" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_ba165ecd-9e85-4f5a-81b9-c7a6f54f8247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/Leases" xlink:type="simple" xlink:href="asth-20231231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7805498d-93d8-4de4-9e30-50e5e482e34d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_75cd7ed0-8447-4db5-8cd4-216ec38424d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7805498d-93d8-4de4-9e30-50e5e482e34d" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_75cd7ed0-8447-4db5-8cd4-216ec38424d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_97d08387-cc67-4a24-b351-418ba8f239ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7805498d-93d8-4de4-9e30-50e5e482e34d" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_97d08387-cc67-4a24-b351-418ba8f239ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/Segments" xlink:type="simple" xlink:href="asth-20231231.xsd#Segments"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/Segments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_79eadea1-c3d0-4065-b96d-20dc7561f58c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0d86fb70-f488-4d70-b065-1ef8821a8d53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_79eadea1-c3d0-4065-b96d-20dc7561f58c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0d86fb70-f488-4d70-b065-1ef8821a8d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstruments" xlink:type="simple" xlink:href="asth-20231231.xsd#FairValueMeasurementsofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ad0ce93d-ad42-4684-a351-b56ba641feed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_31abee36-b627-4657-b2c4-0a39ed6ff939" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ad0ce93d-ad42-4684-a351-b56ba641feed" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_31abee36-b627-4657-b2c4-0a39ed6ff939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SubsequentEvents" xlink:type="simple" xlink:href="asth-20231231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_32518660-2234-48df-83a1-7737941ddf42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_b6e89219-0e16-44fb-89a8-5f0c0bffde2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_32518660-2234-48df-83a1-7737941ddf42" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_b6e89219-0e16-44fb-89a8-5f0c0bffde2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="asth-20231231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b6921cc6-61cd-4e4e-9ff6-802b23cc2774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b6921cc6-61cd-4e4e-9ff6-802b23cc2774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_c9808f9b-96bd-4397-82a2-512512317f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_c9808f9b-96bd-4397-82a2-512512317f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_ff16bb15-0846-4aed-8f00-b41780da83e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_ff16bb15-0846-4aed-8f00-b41780da83e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_29ba0dc6-78ce-4e62-be36-a561c1b7a6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_UseOfEstimates_29ba0dc6-78ce-4e62-be36-a561c1b7a6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_9b2c1d7e-9e74-4854-9304-2524fd2697b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_9b2c1d7e-9e74-4854-9304-2524fd2697b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_26c8f5a0-6bdc-4577-8a25-4440bf8a3a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_26c8f5a0-6bdc-4577-8a25-4440bf8a3a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2f0661f2-257e-4dd2-bfdf-a28cb6f041d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_2f0661f2-257e-4dd2-bfdf-a28cb6f041d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d7bdf97b-1067-4df8-8e70-fc16e9a1e1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d7bdf97b-1067-4df8-8e70-fc16e9a1e1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_f63fbd2a-8b2b-446b-b27a-1b5bdb810dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_f63fbd2a-8b2b-446b-b27a-1b5bdb810dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_178cd6bd-7787-4935-ab5e-a3e1039841e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_178cd6bd-7787-4935-ab5e-a3e1039841e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock_90f18508-654b-4618-aa17-5c89173e7000" xlink:href="asth-20231231.xsd#asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock_90f18508-654b-4618-aa17-5c89173e7000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_43c8c65e-fd44-4299-841b-d76b22b3ce6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_43c8c65e-fd44-4299-841b-d76b22b3ce6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_efeb97b9-d355-4b35-ab2e-040f2b3b9bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_efeb97b9-d355-4b35-ab2e-040f2b3b9bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_c0fa0c4a-7b29-4d15-9c04-0c8aabe29960" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_c0fa0c4a-7b29-4d15-9c04-0c8aabe29960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b7a35d35-906a-4240-a11a-9177baa5180a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b7a35d35-906a-4240-a11a-9177baa5180a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_f9f39b0b-3181-466a-8939-94f054ea67d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_f9f39b0b-3181-466a-8939-94f054ea67d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_6100cb9d-0fb0-44d6-a3ff-56cb0b8c68ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_6100cb9d-0fb0-44d6-a3ff-56cb0b8c68ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock_842513ef-83a2-42a2-86dc-cf443a22c450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock_842513ef-83a2-42a2-86dc-cf443a22c450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryCashAndPayablePolicyTextBlock_4277592d-2a41-4274-8aa1-7c5fc68d9a8e" xlink:href="asth-20231231.xsd#asth_FiduciaryCashAndPayablePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_asth_FiduciaryCashAndPayablePolicyTextBlock_4277592d-2a41-4274-8aa1-7c5fc68d9a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6e407fe0-0aeb-49a7-b199-7f3e85b61dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6e407fe0-0aeb-49a7-b199-7f3e85b61dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_41923741-f2f6-4205-8bcc-c81284384a61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_41923741-f2f6-4205-8bcc-c81284384a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ade4d5eb-6578-4414-a5db-2b7d58b395d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ade4d5eb-6578-4414-a5db-2b7d58b395d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_7177314e-4a6f-461b-98f1-87219dd77cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_7177314e-4a6f-461b-98f1-87219dd77cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MinorityInterestPolicyPolicyTextBlock_58f33144-9783-437c-838f-351c9355b3e4" xlink:href="asth-20231231.xsd#asth_MinorityInterestPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_asth_MinorityInterestPolicyPolicyTextBlock_58f33144-9783-437c-838f-351c9355b3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TemporaryEquityPolicyPolicyTextBlock_6c155865-5395-48d4-b643-d36897231f08" xlink:href="asth-20231231.xsd#asth_TemporaryEquityPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_asth_TemporaryEquityPolicyPolicyTextBlock_6c155865-5395-48d4-b643-d36897231f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_daa19993-ed2d-4831-b273-8cf58865f392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_daa19993-ed2d-4831-b273-8cf58865f392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BeneficialInterestPolicyTextBlock_9ade068c-a159-4fb9-88d1-4227d9f673e5" xlink:href="asth-20231231.xsd#asth_BeneficialInterestPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_asth_BeneficialInterestPolicyTextBlock_9ade068c-a159-4fb9-88d1-4227d9f673e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9b21fde8-add3-4722-9bd8-ccc946c8a21e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9b21fde8-add3-4722-9bd8-ccc946c8a21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_c4d9cd28-af3d-495a-b024-1e896b950e73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_f654a848-46c1-4bcd-9f80-4da26ef80de0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a18568ea-75d9-45a7-b632-01d18c44fcef" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_f654a848-46c1-4bcd-9f80-4da26ef80de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="asth-20231231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3ea924aa-d1fe-4bd1-a6ec-924a1cf86185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_596e3ea4-919a-4ec4-ba40-bad6db7f80e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ea924aa-d1fe-4bd1-a6ec-924a1cf86185" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_596e3ea4-919a-4ec4-ba40-bad6db7f80e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_49f5a889-1d66-440f-85d5-50adb9428f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ea924aa-d1fe-4bd1-a6ec-924a1cf86185" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_49f5a889-1d66-440f-85d5-50adb9428f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables" xlink:type="simple" xlink:href="asth-20231231.xsd#BusinessCombinationsAssetAcquisitionsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3dc42648-f0ab-49f4-a596-1da8ba12d95d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_a7e35cd0-7621-488e-8064-21a34f290029" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3dc42648-f0ab-49f4-a596-1da8ba12d95d" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_a7e35cd0-7621-488e-8064-21a34f290029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNetTables" xlink:type="simple" xlink:href="asth-20231231.xsd#LandPropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LandPropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0fb9e01e-31cb-411e-b7ec-a712a7a943fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_41bcd423-0ed1-489b-9f9a-71ba579c712c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0fb9e01e-31cb-411e-b7ec-a712a7a943fc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_41bcd423-0ed1-489b-9f9a-71ba579c712c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e81ac0a4-b75c-422f-8251-ef770f3cc34c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_deb52690-51e3-4c7b-8f6c-5a78c76007a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e81ac0a4-b75c-422f-8251-ef770f3cc34c" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_deb52690-51e3-4c7b-8f6c-5a78c76007a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_233a9eba-8818-48a7-8bad-e7fdd9a2b689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e81ac0a4-b75c-422f-8251-ef770f3cc34c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_233a9eba-8818-48a7-8bad-e7fdd9a2b689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_482117a3-46a4-417d-a530-cf4609ce2339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e81ac0a4-b75c-422f-8251-ef770f3cc34c" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_482117a3-46a4-417d-a530-cf4609ce2339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables" xlink:type="simple" xlink:href="asth-20231231.xsd#InvestmentsinOtherEntitiesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_97f3f6fa-56b2-4256-b226-874e2a6c183e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_264f93c1-1d81-4cba-a2f8-461f2b6e91e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_97f3f6fa-56b2-4256-b226-874e2a6c183e" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_264f93c1-1d81-4cba-a2f8-461f2b6e91e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables" xlink:type="simple" xlink:href="asth-20231231.xsd#AccountsPayableandAccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_6a7810b1-467c-4313-830b-bf0eb48f42a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_aef89cb4-f4e4-4042-80b4-877a35d33ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6a7810b1-467c-4313-830b-bf0eb48f42a0" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_aef89cb4-f4e4-4042-80b4-877a35d33ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MedicalLiabilitiesTables" xlink:type="simple" xlink:href="asth-20231231.xsd#MedicalLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MedicalLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_93afa3a2-570b-46f6-90cc-b8e91502f8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_bee1b638-fdad-4db5-a862-affae61f2f24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_93afa3a2-570b-46f6-90cc-b8e91502f8f2" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_bee1b638-fdad-4db5-a862-affae61f2f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCreditTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a8fb0d2c-7877-4493-ab19-5b9f4024d695" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_3d0e68c8-1812-4b02-a5f7-55379dc22a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a8fb0d2c-7877-4493-ab19-5b9f4024d695" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_3d0e68c8-1812-4b02-a5f7-55379dc22a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_b677ed6f-f60f-47f8-920c-5a91af24bfd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a8fb0d2c-7877-4493-ab19-5b9f4024d695" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_b677ed6f-f60f-47f8-920c-5a91af24bfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesTables" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a164c315-20ef-4a43-80da-8949d32346a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e46b9141-d453-4796-9c7e-ce703b9c6c53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a164c315-20ef-4a43-80da-8949d32346a2" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e46b9141-d453-4796-9c7e-ce703b9c6c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c181f4ae-3050-4a01-aada-7a0adbd1ef45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a164c315-20ef-4a43-80da-8949d32346a2" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_c181f4ae-3050-4a01-aada-7a0adbd1ef45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_28020df6-47c3-41c3-8417-a70b0709898e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a164c315-20ef-4a43-80da-8949d32346a2" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_28020df6-47c3-41c3-8417-a70b0709898e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="asth-20231231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4124b8e7-fa9a-4647-bbb2-f24a0fcf41fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a7989c6e-7fea-4f5d-9c13-22ffaf106806" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4124b8e7-fa9a-4647-bbb2-f24a0fcf41fe" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_a7989c6e-7fea-4f5d-9c13-22ffaf106806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a64bb4ff-e786-43ea-be2d-d65d337b55cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4124b8e7-fa9a-4647-bbb2-f24a0fcf41fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a64bb4ff-e786-43ea-be2d-d65d337b55cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_b59b10de-0647-4d11-9aa4-edb84495c322" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4124b8e7-fa9a-4647-bbb2-f24a0fcf41fe" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_b59b10de-0647-4d11-9aa4-edb84495c322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsTables" xlink:type="simple" xlink:href="asth-20231231.xsd#RelatedPartyTransactionsTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_d10fdba8-6dcb-4c2a-bb6b-c09d9e30d3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_76c80709-c99b-4e7b-912a-dbf20f768e50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_d10fdba8-6dcb-4c2a-bb6b-c09d9e30d3c0" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_76c80709-c99b-4e7b-912a-dbf20f768e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareTables" xlink:type="simple" xlink:href="asth-20231231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_80fea00a-6927-45e8-b589-29a95d41b12a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_44ec862a-1b50-4a2f-bad5-6874d8625c60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_80fea00a-6927-45e8-b589-29a95d41b12a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_44ec862a-1b50-4a2f-bad5-6874d8625c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_cb3bfe50-b3e4-495d-83fe-b88c0b6b1d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_80fea00a-6927-45e8-b589-29a95d41b12a" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_cb3bfe50-b3e4-495d-83fe-b88c0b6b1d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables" xlink:type="simple" xlink:href="asth-20231231.xsd#VariableInterestEntitiesVIEsTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eddbac0b-384a-4a60-89c0-00f1492ba94d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_8b2acc54-63f3-4039-8e47-4c0b6f32e918" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eddbac0b-384a-4a60-89c0-00f1492ba94d" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_8b2acc54-63f3-4039-8e47-4c0b6f32e918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesTables" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ba87f288-2f32-4102-a47a-883d4dde4c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_ffb62cf1-559e-4d37-bbe4-bfa54b6c4080" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ba87f288-2f32-4102-a47a-883d4dde4c0f" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_ffb62cf1-559e-4d37-bbe4-bfa54b6c4080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e48dda78-be9f-40b6-a3c0-55458dcce9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ba87f288-2f32-4102-a47a-883d4dde4c0f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e48dda78-be9f-40b6-a3c0-55458dcce9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_33f31b93-b997-46e1-9802-5a8c21b65308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ba87f288-2f32-4102-a47a-883d4dde4c0f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_33f31b93-b997-46e1-9802-5a8c21b65308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SegmentsTables" xlink:type="simple" xlink:href="asth-20231231.xsd#SegmentsTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SegmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_47ca192d-0478-498d-96fc-8650e3ffc3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b587ecba-7247-463b-8136-e95b03e28487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_47ca192d-0478-498d-96fc-8650e3ffc3a2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b587ecba-7247-463b-8136-e95b03e28487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsTables" xlink:type="simple" xlink:href="asth-20231231.xsd#FairValueMeasurementsofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0c32da6e-d6ca-408d-9af1-3b08ed544546" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_563b4d11-5d43-455f-bebc-df9588910aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0c32da6e-d6ca-408d-9af1-3b08ed544546" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_563b4d11-5d43-455f-bebc-df9588910aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d0561a73-1bf3-4ca4-bfaf-bb0a40f8afed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0c32da6e-d6ca-408d-9af1-3b08ed544546" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d0561a73-1bf3-4ca4-bfaf-bb0a40f8afed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_630c56a8-e76c-4608-ac09-99667e4c473a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0c32da6e-d6ca-408d-9af1-3b08ed544546" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_630c56a8-e76c-4608-ac09-99667e4c473a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/DescriptionofBusinessDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#DescriptionofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/DescriptionofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f2114a7-2ff2-4f1f-824e-77f2d0c187c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f9483ab0-71be-41ac-9605-133a6e77fcc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f2114a7-2ff2-4f1f-824e-77f2d0c187c0" xlink:to="loc_us-gaap_NumberOfReportableSegments_f9483ab0-71be-41ac-9605-133a6e77fcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RestructuringSpinoffTransactionPercentage_0fb110a8-9059-4aa0-af7a-ee3456e6a0a6" xlink:href="asth-20231231.xsd#asth_RestructuringSpinoffTransactionPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f2114a7-2ff2-4f1f-824e-77f2d0c187c0" xlink:to="loc_asth_RestructuringSpinoffTransactionPercentage_0fb110a8-9059-4aa0-af7a-ee3456e6a0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits_4e9d5521-a334-49c9-95cb-3a001bae30df" xlink:href="asth-20231231.xsd#asth_RestructuringSpinoffTransactionNumberOfMembershipUnits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f2114a7-2ff2-4f1f-824e-77f2d0c187c0" xlink:to="loc_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits_4e9d5521-a334-49c9-95cb-3a001bae30df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RestructuringSpinoffTransactionDividendRealEstateOperations_4ca90d82-9745-4894-bcb3-6ed33ef0cfe9" xlink:href="asth-20231231.xsd#asth_RestructuringSpinoffTransactionDividendRealEstateOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f2114a7-2ff2-4f1f-824e-77f2d0c187c0" xlink:to="loc_asth_RestructuringSpinoffTransactionDividendRealEstateOperations_4ca90d82-9745-4894-bcb3-6ed33ef0cfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_c5a822e1-2d9e-40a6-bef2-e6c569c3d31e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2f2114a7-2ff2-4f1f-824e-77f2d0c187c0" xlink:to="loc_us-gaap_FairValueNetAssetLiability_c5a822e1-2d9e-40a6-bef2-e6c569c3d31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f6fd7fec-0f28-4414-a2d8-15cbaec22d89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:href="asth-20231231.xsd#asth_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f6fd7fec-0f28-4414-a2d8-15cbaec22d89" xlink:to="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_28f4d368-7508-476a-89d0-40dedaf1ffab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_us-gaap_FinancialInstrumentAxis_28f4d368-7508-476a-89d0-40dedaf1ffab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e8635576-34f2-4c58-aa3e-e7ba626a52d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_28f4d368-7508-476a-89d0-40dedaf1ffab" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e8635576-34f2-4c58-aa3e-e7ba626a52d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_ce2b8f45-9ea6-461f-85c3-d7036ccb88e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e8635576-34f2-4c58-aa3e-e7ba626a52d6" xlink:to="loc_us-gaap_CertificatesOfDepositMember_ce2b8f45-9ea6-461f-85c3-d7036ccb88e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0ed02c6d-3780-400e-80d1-1278010bd65e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_srt_RangeAxis_0ed02c6d-3780-400e-80d1-1278010bd65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3047ad38-f93a-49fa-b6b7-d87c7e786fad" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0ed02c6d-3780-400e-80d1-1278010bd65e" xlink:to="loc_srt_RangeMember_3047ad38-f93a-49fa-b6b7-d87c7e786fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_57274299-57c6-4a68-b575-b8968489717d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3047ad38-f93a-49fa-b6b7-d87c7e786fad" xlink:to="loc_srt_MinimumMember_57274299-57c6-4a68-b575-b8968489717d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_531fd9ee-4b08-4be9-aa96-150e37d22b91" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3047ad38-f93a-49fa-b6b7-d87c7e786fad" xlink:to="loc_srt_MaximumMember_531fd9ee-4b08-4be9-aa96-150e37d22b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9897982e-a2ce-4ead-bbea-983f82be9bd5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_srt_ProductOrServiceAxis_9897982e-a2ce-4ead-bbea-983f82be9bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9897982e-a2ce-4ead-bbea-983f82be9bd5" xlink:to="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerMemberPerMonthManagedCareContractMember_328d0088-e392-43d6-8c30-a666d845c7ff" xlink:href="asth-20231231.xsd#asth_PerMemberPerMonthManagedCareContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:to="loc_asth_PerMemberPerMonthManagedCareContractMember_328d0088-e392-43d6-8c30-a666d845c7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RiskPoolSettlementsAndIncentivesMember_a5930f2f-d245-478d-b3ef-f818794e8833" xlink:href="asth-20231231.xsd#asth_RiskPoolSettlementsAndIncentivesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:to="loc_asth_RiskPoolSettlementsAndIncentivesMember_a5930f2f-d245-478d-b3ef-f818794e8833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceMember_d96fa8ce-d6dc-45bb-8d8b-b1090b4db33f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ManagementServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_758aafb1-afee-46e5-9b52-385e9eb988cb" xlink:to="loc_us-gaap_ManagementServiceMember_d96fa8ce-d6dc-45bb-8d8b-b1090b4db33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_581ba204-f872-4c38-8f56-40a1fb682b17" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_srt_CounterpartyNameAxis_581ba204-f872-4c38-8f56-40a1fb682b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d00ad7a-6fad-4a85-ae07-b84720d28c93" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_581ba204-f872-4c38-8f56-40a1fb682b17" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d00ad7a-6fad-4a85-ae07-b84720d28c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CMSMember_41a7b35f-1cf6-4968-b55e-a075bf2a4f04" xlink:href="asth-20231231.xsd#asth_CMSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7d00ad7a-6fad-4a85-ae07-b84720d28c93" xlink:to="loc_asth_CMSMember_41a7b35f-1cf6-4968-b55e-a075bf2a4f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b316b0b3-c20c-45a9-95be-f0f3cdfc6106" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b316b0b3-c20c-45a9-95be-f0f3cdfc6106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d966b6bd-e6d7-4abf-a00e-e957d17bdbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b316b0b3-c20c-45a9-95be-f0f3cdfc6106" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d966b6bd-e6d7-4abf-a00e-e957d17bdbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AccountsPayableAndAccruedExpensesMember_31bd2bec-ac17-45e4-a0f1-92f9d52b2cb5" xlink:href="asth-20231231.xsd#asth_AccountsPayableAndAccruedExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d966b6bd-e6d7-4abf-a00e-e957d17bdbeb" xlink:to="loc_asth_AccountsPayableAndAccruedExpensesMember_31bd2bec-ac17-45e4-a0f1-92f9d52b2cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c798563e-3345-4654-bc37-682891251b52" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c798563e-3345-4654-bc37-682891251b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7ef02ba3-a4a5-4e63-9f30-c1a76923cad1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c798563e-3345-4654-bc37-682891251b52" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7ef02ba3-a4a5-4e63-9f30-c1a76923cad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_UniversalCareIncMember_09219292-24e1-414a-a847-87cda9357f88" xlink:href="asth-20231231.xsd#asth_UniversalCareIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7ef02ba3-a4a5-4e63-9f30-c1a76923cad1" xlink:to="loc_asth_UniversalCareIncMember_09219292-24e1-414a-a847-87cda9357f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9c7117d8-5134-4086-adb6-5551281875ab" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_dei_LegalEntityAxis_9c7117d8-5134-4086-adb6-5551281875ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0da008c2-2f05-454c-80b4-0e5cfea89922" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_9c7117d8-5134-4086-adb6-5551281875ab" xlink:to="loc_dei_EntityDomain_0da008c2-2f05-454c-80b4-0e5cfea89922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_780e8384-8f2a-496e-a309-8cd48e1607c2" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0da008c2-2f05-454c-80b4-0e5cfea89922" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_780e8384-8f2a-496e-a309-8cd48e1607c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:href="asth-20231231.xsd#asth_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesTable_08342db5-5792-40c2-90d2-bdc1fbc5fd84" xlink:to="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_d70cfe81-1e9a-4ff5-98f5-f6998d95a18c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_NumberOfReportableSegments_d70cfe81-1e9a-4ff5-98f5-f6998d95a18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_f485dc3e-0c50-4259-b01f-dcdf99382782" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_NumberOfOperatingSegments_f485dc3e-0c50-4259-b01f-dcdf99382782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_a895b529-0eaf-4d70-b9da-d2a58364c75b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashUninsuredAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_CashUninsuredAmount_a895b529-0eaf-4d70-b9da-d2a58364c75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MarketableSecuritiesCurrentMaturityPeriod_eb8dc9b6-7bec-431e-9310-38f2020ce722" xlink:href="asth-20231231.xsd#asth_MarketableSecuritiesCurrentMaturityPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_MarketableSecuritiesCurrentMaturityPeriod_eb8dc9b6-7bec-431e-9310-38f2020ce722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_ebd8751e-655d-4950-868b-6c2f5296c85f" xlink:href="asth-20231231.xsd#asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_ebd8751e-655d-4950-868b-6c2f5296c85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e0e05bb2-fcc7-413a-9bd8-60febaf7f39b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e0e05bb2-fcc7-413a-9bd8-60febaf7f39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_79cbc9e7-4701-44f5-b055-844a9ec12efc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_NumberOfReportingUnits_79cbc9e7-4701-44f5-b055-844a9ec12efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a2ee595c-7b61-48ce-b6ff-c314d9625452" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a2ee595c-7b61-48ce-b6ff-c314d9625452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_86b4e772-019e-41e5-ac5e-af5afdf910b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_86b4e772-019e-41e5-ac5e-af5afdf910b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryAccountsPayableCurrent_907b5a1f-9331-479b-81a0-2986703588bf" xlink:href="asth-20231231.xsd#asth_FiduciaryAccountsPayableCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_FiduciaryAccountsPayableCurrent_907b5a1f-9331-479b-81a0-2986703588bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_83141e95-192e-42d4-9688-ec86e34a88b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_83141e95-192e-42d4-9688-ec86e34a88b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport_9f15502a-d384-4a5b-8331-ab4c16058e29" xlink:href="asth-20231231.xsd#asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport_9f15502a-d384-4a5b-8331-ab4c16058e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_687f6668-2ad9-4285-a137-c24d47f1eff8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_687f6668-2ad9-4285-a137-c24d47f1eff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RevenuePaymentTerms_44bc2a6a-6ed0-4e97-b002-8ef680f193ac" xlink:href="asth-20231231.xsd#asth_RevenuePaymentTerms"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_RevenuePaymentTerms_44bc2a6a-6ed0-4e97-b002-8ef680f193ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c6f4c0f9-8560-4544-8ecc-6e81ef6834fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c6f4c0f9-8560-4544-8ecc-6e81ef6834fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3e4e1e0f-84e8-49f5-9202-0ac317370996" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3e4e1e0f-84e8-49f5-9202-0ac317370996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_93334a79-7e17-4c0a-89d0-4d7cca453d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_93334a79-7e17-4c0a-89d0-4d7cca453d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet_af26771f-da68-4789-981c-357a70f5c3a6" xlink:href="asth-20231231.xsd#asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_SummaryOfSignificantAccountingPoliciesLineItems_0c998fe0-d59c-4b54-851e-fd127f00a3a9" xlink:to="loc_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet_af26771f-da68-4789-981c-357a70f5c3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e0c5056f-3bfa-4faa-bb92-faf18e07572a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b26e3c1a-d861-4b02-9d88-841081e3ae06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e0c5056f-3bfa-4faa-bb92-faf18e07572a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b26e3c1a-d861-4b02-9d88-841081e3ae06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_b9ecd2ad-b810-4e3b-b81c-a1424c72791c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b26e3c1a-d861-4b02-9d88-841081e3ae06" xlink:to="loc_srt_MajorCustomersAxis_b9ecd2ad-b810-4e3b-b81c-a1424c72791c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_b9ecd2ad-b810-4e3b-b81c-a1424c72791c" xlink:to="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommercialMember_dc11b952-2a34-4a1f-834d-94ef6b371bfb" xlink:href="asth-20231231.xsd#asth_CommercialMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:to="loc_asth_CommercialMember_dc11b952-2a34-4a1f-834d-94ef6b371bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicareMember_9ca448bc-34e2-4813-9510-a063a2f8014f" xlink:href="asth-20231231.xsd#asth_MedicareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:to="loc_asth_MedicareMember_9ca448bc-34e2-4813-9510-a063a2f8014f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicaidMember_7fc31be1-0716-4d1a-a6b5-a095d1d32f67" xlink:href="asth-20231231.xsd#asth_MedicaidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:to="loc_asth_MedicaidMember_7fc31be1-0716-4d1a-a6b5-a095d1d32f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OtherThirdPartiesMember_ba8f270f-2e3e-4b0e-bb46-e973d326c6aa" xlink:href="asth-20231231.xsd#asth_OtherThirdPartiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3f2543f1-3c16-4f98-9106-2a7ec24aed36" xlink:to="loc_asth_OtherThirdPartiesMember_ba8f270f-2e3e-4b0e-bb46-e973d326c6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f20605b0-30e4-4161-a270-98b3aaac2053" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b26e3c1a-d861-4b02-9d88-841081e3ae06" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f20605b0-30e4-4161-a270-98b3aaac2053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7faa4532-696a-49a3-babe-a332c93f43ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f20605b0-30e4-4161-a270-98b3aaac2053" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7faa4532-696a-49a3-babe-a332c93f43ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_868d6adc-3c80-4a94-b836-87d6de8338c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_868d6adc-3c80-4a94-b836-87d6de8338c0" xlink:to="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_81002f35-4c0a-4299-894f-75608811a25a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_81002f35-4c0a-4299-894f-75608811a25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f2040373-b711-4108-8cb1-b011c612d7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_81002f35-4c0a-4299-894f-75608811a25a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f2040373-b711-4108-8cb1-b011c612d7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_896aa861-0ec0-4f48-9d57-be5b6a95e65f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f2040373-b711-4108-8cb1-b011c612d7ac" xlink:to="loc_us-gaap_SalesRevenueNetMember_896aa861-0ec0-4f48-9d57-be5b6a95e65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_96a078c5-64f8-48c7-a7db-171e649a2aae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f2040373-b711-4108-8cb1-b011c612d7ac" xlink:to="loc_us-gaap_AccountsReceivableMember_96a078c5-64f8-48c7-a7db-171e649a2aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_4982c65b-72c0-4943-8314-44086c60e0f6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:to="loc_srt_MajorCustomersAxis_4982c65b-72c0-4943-8314-44086c60e0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_4982c65b-72c0-4943-8314-44086c60e0f6" xlink:to="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorAMember_98a7aef3-c10b-453d-960b-60fae6378d2f" xlink:href="asth-20231231.xsd#asth_PayorAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayorAMember_98a7aef3-c10b-453d-960b-60fae6378d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorBMember_71a58d2d-73d9-4e0f-900e-6b24f960f30b" xlink:href="asth-20231231.xsd#asth_PayorBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayorBMember_71a58d2d-73d9-4e0f-900e-6b24f960f30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorCMember_86396bf2-1c9e-493e-941d-82a47ac05083" xlink:href="asth-20231231.xsd#asth_PayorCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayorCMember_86396bf2-1c9e-493e-941d-82a47ac05083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayerDMember_fbe0deb1-5e9c-44a8-ae43-6d6c8e38e4f2" xlink:href="asth-20231231.xsd#asth_PayerDMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayerDMember_fbe0deb1-5e9c-44a8-ae43-6d6c8e38e4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PayorEMember_677b171f-834c-4f1f-b60f-ba38c168d082" xlink:href="asth-20231231.xsd#asth_PayorEMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_94117a62-1858-455f-a053-ccf9da0cd4e6" xlink:to="loc_asth_PayorEMember_677b171f-834c-4f1f-b60f-ba38c168d082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_b9361c86-8f46-437c-ab50-a0fb4cbc86ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_b9361c86-8f46-437c-ab50-a0fb4cbc86ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9a47ea6c-184a-4e0b-97b0-012ea00baf18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_b9361c86-8f46-437c-ab50-a0fb4cbc86ad" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9a47ea6c-184a-4e0b-97b0-012ea00baf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c3a33082-96ba-4466-9f6a-abe0ab41f90e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9a47ea6c-184a-4e0b-97b0-012ea00baf18" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c3a33082-96ba-4466-9f6a-abe0ab41f90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_2fef5ef7-9e50-4d5e-b9cb-96f92c6a8f78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_e97cea50-3308-4a63-a574-6e03618552bb" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_2fef5ef7-9e50-4d5e-b9cb-96f92c6a8f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_74214312-a71d-405a-8bfc-02a1b7cb4d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2fef5ef7-9e50-4d5e-b9cb-96f92c6a8f78" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_74214312-a71d-405a-8bfc-02a1b7cb4d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1e6cdc44-7e09-48b6-b79c-29cdef863173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d636357f-4ddf-48b8-8505-9850128881a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1e6cdc44-7e09-48b6-b79c-29cdef863173" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d636357f-4ddf-48b8-8505-9850128881a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4ec5d3b7-d6af-4f51-a0e5-a4b9d43bb0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d636357f-4ddf-48b8-8505-9850128881a4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4ec5d3b7-d6af-4f51-a0e5-a4b9d43bb0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ec5d3b7-d6af-4f51-a0e5-a4b9d43bb0bc" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ForYourBenefitIncMember_352f4616-f0f1-4b77-b466-1faddab204ca" xlink:href="asth-20231231.xsd#asth_ForYourBenefitIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_ForYourBenefitIncMember_352f4616-f0f1-4b77-b466-1faddab204ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGMember_05afb6e5-ebaf-4b35-b1b3-d2c901c31f75" xlink:href="asth-20231231.xsd#asth_AAMGMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_AAMGMember_05afb6e5-ebaf-4b35-b1b3-d2c901c31f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ValleyOaksMedicalGroupMember_19b5a9c8-c18f-4b4d-b9a0-16424e172b92" xlink:href="asth-20231231.xsd#asth_ValleyOaksMedicalGroupMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_ValleyOaksMedicalGroupMember_19b5a9c8-c18f-4b4d-b9a0-16424e172b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_JadeHealthCareMedicalGroupIncMember_bdd0101c-4850-4686-866f-7e719a61a589" xlink:href="asth-20231231.xsd#asth_JadeHealthCareMedicalGroupIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_JadeHealthCareMedicalGroupIncMember_bdd0101c-4850-4686-866f-7e719a61a589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_bb2c0c8c-31ef-43a0-a42f-60ef4e4b71c7" xlink:href="asth-20231231.xsd#asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_963cad4b-1f67-417a-8192-8ebb17569337" xlink:to="loc_asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember_bb2c0c8c-31ef-43a0-a42f-60ef4e4b71c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d636357f-4ddf-48b8-8505-9850128881a4" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_abba5189-d0ef-4981-b5e6-901d9d22ff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_abba5189-d0ef-4981-b5e6-901d9d22ff1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_843d9d7d-f653-437e-b72c-3afcfd9f45d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_843d9d7d-f653-437e-b72c-3afcfd9f45d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationStockContingentConsiderationLiability_7adfb5e7-aa0d-4d47-bc1a-73db75ffd485" xlink:href="asth-20231231.xsd#asth_BusinessCombinationStockContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_08c59699-eb7e-4aaa-ba69-a649dae99883" xlink:to="loc_asth_BusinessCombinationStockContingentConsiderationLiability_7adfb5e7-aa0d-4d47-bc1a-73db75ffd485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fd7e1f5b-6c16-4e77-8631-18a26485dd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_9f52638c-b1e4-4c5b-8581-a19c826a8bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fd7e1f5b-6c16-4e77-8631-18a26485dd6d" xlink:to="loc_us-gaap_GoodwillRollForward_9f52638c-b1e4-4c5b-8581-a19c826a8bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1aa6b2c1-9472-4350-b787-5fde98391fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f52638c-b1e4-4c5b-8581-a19c826a8bc1" xlink:to="loc_us-gaap_Goodwill_1aa6b2c1-9472-4350-b787-5fde98391fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_8162bcb8-0f99-479e-8f62-15c3d62ec5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f52638c-b1e4-4c5b-8581-a19c826a8bc1" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_8162bcb8-0f99-479e-8f62-15c3d62ec5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_769e3955-65b6-4c18-8181-d3a5a8dae5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f52638c-b1e4-4c5b-8581-a19c826a8bc1" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_769e3955-65b6-4c18-8181-d3a5a8dae5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8ff27ea0-967c-4a86-8b74-eff6a87bcbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_9f52638c-b1e4-4c5b-8581-a19c826a8bc1" xlink:to="loc_us-gaap_Goodwill_8ff27ea0-967c-4a86-8b74-eff6a87bcbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_81d6dfb0-c69e-4276-b725-31fcbd128305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b0d945e-79c7-4df6-9b66-7fac56b1eef8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_81d6dfb0-c69e-4276-b725-31fcbd128305" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b0d945e-79c7-4df6-9b66-7fac56b1eef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eaae8ffa-f64d-4838-a6b6-c147d6a26adb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b0d945e-79c7-4df6-9b66-7fac56b1eef8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eaae8ffa-f64d-4838-a6b6-c147d6a26adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eaae8ffa-f64d-4838-a6b6-c147d6a26adb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_17f07d4c-1d4c-4a23-989d-77c4e3d5f71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_LandMember_17f07d4c-1d4c-4a23-989d-77c4e3d5f71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_fe1d2bfb-d8c9-49b7-8d47-75267b932cee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_BuildingMember_fe1d2bfb-d8c9-49b7-8d47-75267b932cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_b52706a4-2b7e-4caa-b5fe-f10e12ebb692" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_ComputerEquipmentMember_b52706a4-2b7e-4caa-b5fe-f10e12ebb692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_36505b2e-870f-4f4c-b52e-13bd6fc3b6db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_36505b2e-870f-4f4c-b52e-13bd6fc3b6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_08dc4e7d-233a-4909-b5cc-30aea922a8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_ConstructionInProgressMember_08dc4e7d-233a-4909-b5cc-30aea922a8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_502333b8-679e-4e1d-b57d-b52ce1d0c580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3b3ce8b-d2c2-4024-aa1b-c1243b6d76a0" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_502333b8-679e-4e1d-b57d-b52ce1d0c580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f0039d7b-f1b3-4875-b513-cb398e019418" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b0d945e-79c7-4df6-9b66-7fac56b1eef8" xlink:to="loc_srt_RangeAxis_f0039d7b-f1b3-4875-b513-cb398e019418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_599ee9b3-2ea6-417c-b582-5629a7f91063" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f0039d7b-f1b3-4875-b513-cb398e019418" xlink:to="loc_srt_RangeMember_599ee9b3-2ea6-417c-b582-5629a7f91063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_913ab549-9c7e-460e-a09f-bfa5c6e8a431" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_599ee9b3-2ea6-417c-b582-5629a7f91063" xlink:to="loc_srt_MinimumMember_913ab549-9c7e-460e-a09f-bfa5c6e8a431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_309212a2-ab3f-4f4e-8d8d-907ff30ffe11" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_599ee9b3-2ea6-417c-b582-5629a7f91063" xlink:to="loc_srt_MaximumMember_309212a2-ab3f-4f4e-8d8d-907ff30ffe11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4b0d945e-79c7-4df6-9b66-7fac56b1eef8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d157c25d-a31a-49dc-9b0e-86dd546ffc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d157c25d-a31a-49dc-9b0e-86dd546ffc1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_62042421-7faf-46e5-9977-459087653b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_62042421-7faf-46e5-9977-459087653b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_f0e84698-6586-43ab-89c5-22c9b5544d03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_f0e84698-6586-43ab-89c5-22c9b5544d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c7c02564-43cd-4080-b19b-fe77417bc389" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b9979e6d-5cfd-42aa-be5f-87bf1d6bdb35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c7c02564-43cd-4080-b19b-fe77417bc389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LandPropertyandEquipmentNetAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LandPropertyandEquipmentNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LandPropertyandEquipmentNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8760e88b-64ac-42d2-aa76-5135c8beabe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_e5dcd6b2-4312-46d4-976d-b0080e7c4a66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8760e88b-64ac-42d2-aa76-5135c8beabe2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_e5dcd6b2-4312-46d4-976d-b0080e7c4a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_eb9207a3-6739-4472-99f6-b20de514da90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8760e88b-64ac-42d2-aa76-5135c8beabe2" xlink:to="loc_us-gaap_DepreciationAndAmortization_eb9207a3-6739-4472-99f6-b20de514da90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_472be51a-e4a2-4f01-937d-ab46ca6262ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_472be51a-e4a2-4f01-937d-ab46ca6262ac" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_655f8575-39a4-47ed-b034-7074eb8c9607" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_655f8575-39a4-47ed-b034-7074eb8c9607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e03cb310-fb68-45b2-b1b3-1e1b6fc66203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_655f8575-39a4-47ed-b034-7074eb8c9607" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e03cb310-fb68-45b2-b1b3-1e1b6fc66203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4ed4923c-8bfc-458f-b884-f21aa7030961" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e03cb310-fb68-45b2-b1b3-1e1b6fc66203" xlink:to="loc_us-gaap_TrademarksMember_4ed4923c-8bfc-458f-b884-f21aa7030961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e3086bb-b88f-42e8-989c-cedc882f1854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e3086bb-b88f-42e8-989c-cedc882f1854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1e3086bb-b88f-42e8-989c-cedc882f1854" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkRelationshipsMember_3ecd7119-9e3d-4de1-b080-2db06ec382d8" xlink:href="asth-20231231.xsd#asth_NetworkRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_asth_NetworkRelationshipsMember_3ecd7119-9e3d-4de1-b080-2db06ec382d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ManagementContractsMember_e00c5ce3-040f-4cae-8ba1-e0502f1f6f1b" xlink:href="asth-20231231.xsd#asth_ManagementContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_asth_ManagementContractsMember_e00c5ce3-040f-4cae-8ba1-e0502f1f6f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MemberRelationshipsMember_544fca2e-f94f-4e92-b306-bdbe77a6ec33" xlink:href="asth-20231231.xsd#asth_MemberRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_asth_MemberRelationshipsMember_544fca2e-f94f-4e92-b306-bdbe77a6ec33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PatientManagementPlatformMember_bb922686-cc58-44ba-a188-e522baa07fdb" xlink:href="asth-20231231.xsd#asth_PatientManagementPlatformMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_asth_PatientManagementPlatformMember_bb922686-cc58-44ba-a188-e522baa07fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_d371eae0-32ed-4bed-9bc3-d8e9c57ca4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_d371eae0-32ed-4bed-9bc3-d8e9c57ca4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_a6ac6b3b-3b6c-4fb2-b166-7a2e25b468aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_86fcfdd0-71cb-4917-b3ca-23b866739199" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_a6ac6b3b-3b6c-4fb2-b166-7a2e25b468aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_80f8525f-ec33-4df4-86b0-0431b7e252b7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:to="loc_srt_RangeAxis_80f8525f-ec33-4df4-86b0-0431b7e252b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2ccdd739-17a4-44d7-aae9-f79005dab81d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_80f8525f-ec33-4df4-86b0-0431b7e252b7" xlink:to="loc_srt_RangeMember_2ccdd739-17a4-44d7-aae9-f79005dab81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1260948d-8af1-44e0-a598-5897eb9de758" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2ccdd739-17a4-44d7-aae9-f79005dab81d" xlink:to="loc_srt_MinimumMember_1260948d-8af1-44e0-a598-5897eb9de758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_64a833e6-f072-423a-82de-cb96620fd4ee" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2ccdd739-17a4-44d7-aae9-f79005dab81d" xlink:to="loc_srt_MaximumMember_64a833e6-f072-423a-82de-cb96620fd4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8baa8987-fe59-42f2-94ce-0a78cb13c47b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e613ef67-7847-479e-b52f-a635c3c358f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e613ef67-7847-479e-b52f-a635c3c358f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_91d9c689-dfd3-4a5b-bb3a-1068a5c8c91a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_91d9c689-dfd3-4a5b-bb3a-1068a5c8c91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_9dcfe069-6ae7-4872-95dd-99ac5dcf482b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_9dcfe069-6ae7-4872-95dd-99ac5dcf482b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ecb8cb65-0a0e-4f0f-9894-9cbc46e4af00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_ecb8cb65-0a0e-4f0f-9894-9cbc46e4af00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_16cbbed0-1c1b-47c9-95ca-0b76bfe4db95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsRollForward_e421c42d-26df-49a3-b855-123013cb2b09" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_16cbbed0-1c1b-47c9-95ca-0b76bfe4db95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_07ff8cd3-f154-4c89-9b7c-d50416c6f42d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_07ff8cd3-f154-4c89-9b7c-d50416c6f42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_d8ee5f98-280a-49b3-aa5f-93a665372670" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_d8ee5f98-280a-49b3-aa5f-93a665372670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_ec8ae07b-6eb1-4e65-9367-8954ef9f2a21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_ec8ae07b-6eb1-4e65-9367-8954ef9f2a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7f816c7d-fb14-4d3f-9085-fe339593a5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7f816c7d-fb14-4d3f-9085-fe339593a5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b34b6016-aae0-427e-9025-333506ac1f74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b34b6016-aae0-427e-9025-333506ac1f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_729713fa-8452-46b3-97f7-8d00d1db87b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRollForward_55c0b7e4-5485-46a4-a802-5e785c71a21b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_729713fa-8452-46b3-97f7-8d00d1db87b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0ceec260-49b2-48af-8874-97768c6c6a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_0ceec260-49b2-48af-8874-97768c6c6a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_b082f627-50b3-4a2f-9d12-4e58c3f8b05d" xlink:href="asth-20231231.xsd#asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired_b082f627-50b3-4a2f-9d12-4e58c3f8b05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_a325b125-85da-432a-9c17-df80acef9cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_a325b125-85da-432a-9c17-df80acef9cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_97a85eeb-4bcc-4355-84f1-544b4ec38951" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3c5c6df1-6fc9-40f4-b49a-42d9c9821e12" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_97a85eeb-4bcc-4355-84f1-544b4ec38951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b185d236-1164-4adf-9132-7300db918ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58961dec-76e5-4d3a-b162-41248f5621a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b185d236-1164-4adf-9132-7300db918ff9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58961dec-76e5-4d3a-b162-41248f5621a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e07697af-8464-4686-b12f-fb1b5c2890f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58961dec-76e5-4d3a-b162-41248f5621a5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e07697af-8464-4686-b12f-fb1b5c2890f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e07697af-8464-4686-b12f-fb1b5c2890f7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkRelationshipsMember_736f0c3c-5096-4031-9c6a-f44dfdbf7647" xlink:href="asth-20231231.xsd#asth_NetworkRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_asth_NetworkRelationshipsMember_736f0c3c-5096-4031-9c6a-f44dfdbf7647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ManagementContractsMember_acd1df06-2c40-4981-81ca-54e8136f2c9b" xlink:href="asth-20231231.xsd#asth_ManagementContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_asth_ManagementContractsMember_acd1df06-2c40-4981-81ca-54e8136f2c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MemberRelationshipsMember_c59bcfff-9d83-4f06-b086-d2b1232b3764" xlink:href="asth-20231231.xsd#asth_MemberRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_asth_MemberRelationshipsMember_c59bcfff-9d83-4f06-b086-d2b1232b3764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_9b786481-4bec-4843-9f64-827bca851985" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_9b786481-4bec-4843-9f64-827bca851985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6e5dd2be-7901-4863-b9da-93f0b11313f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6e5dd2be-7901-4863-b9da-93f0b11313f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsAmortizationPeriodMember_a9b841a1-1e70-4df6-8ae4-b07de6fdc0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsAmortizationPeriodMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b128ad00-5627-4c3f-9a62-3167f8af6771" xlink:to="loc_us-gaap_IntangibleAssetsAmortizationPeriodMember_a9b841a1-1e70-4df6-8ae4-b07de6fdc0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a2b731e5-10b0-4a2f-8f70-ba1b464a48c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58961dec-76e5-4d3a-b162-41248f5621a5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a2b731e5-10b0-4a2f-8f70-ba1b464a48c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_90ec0795-80f2-4a4e-8fe7-6731ea8dd34d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a2b731e5-10b0-4a2f-8f70-ba1b464a48c0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_90ec0795-80f2-4a4e-8fe7-6731ea8dd34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_704f98f4-45ae-4159-bd22-c130625cc746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a2b731e5-10b0-4a2f-8f70-ba1b464a48c0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_704f98f4-45ae-4159-bd22-c130625cc746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1f0630b-792a-4bc1-a4ff-5f5141bf3503" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8b69a5ef-d300-416b-8df5-5c15942baaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1f0630b-792a-4bc1-a4ff-5f5141bf3503" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8b69a5ef-d300-416b-8df5-5c15942baaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_78f38526-1838-409d-a87d-8de2a5c8cdd9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1f0630b-792a-4bc1-a4ff-5f5141bf3503" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_78f38526-1838-409d-a87d-8de2a5c8cdd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2708c0c7-c218-4b72-8d89-33cba670d4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1f0630b-792a-4bc1-a4ff-5f5141bf3503" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2708c0c7-c218-4b72-8d89-33cba670d4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4dc23f2a-3176-40dc-a3db-a762777faf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1f0630b-792a-4bc1-a4ff-5f5141bf3503" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4dc23f2a-3176-40dc-a3db-a762777faf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8647f2a7-c76e-4c7b-be73-423fed982575" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1f0630b-792a-4bc1-a4ff-5f5141bf3503" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8647f2a7-c76e-4c7b-be73-423fed982575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fe322a88-47f8-4826-89b1-3fb7ddab6a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1f0630b-792a-4bc1-a4ff-5f5141bf3503" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_fe322a88-47f8-4826-89b1-3fb7ddab6a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_96825e59-1ce2-4885-b75f-48be416dec42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e1f0630b-792a-4bc1-a4ff-5f5141bf3503" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_96825e59-1ce2-4885-b75f-48be416dec42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_10e31289-da48-46ef-9103-bbff9ae125a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7c549ea0-a410-4c67-b7a7-2b00c60d4826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_10e31289-da48-46ef-9103-bbff9ae125a2" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7c549ea0-a410-4c67-b7a7-2b00c60d4826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7a21465d-31b0-4735-ac8e-6329d72d11d6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7c549ea0-a410-4c67-b7a7-2b00c60d4826" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7a21465d-31b0-4735-ac8e-6329d72d11d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7a21465d-31b0-4735-ac8e-6329d72d11d6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LasalleMedicalAssociatesIpaMember_82c6ebf2-e7c8-4114-8bfd-8de4b4f9feac" xlink:href="asth-20231231.xsd#asth_LasalleMedicalAssociatesIpaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_LasalleMedicalAssociatesIpaMember_82c6ebf2-e7c8-4114-8bfd-8de4b4f9feac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PacificMedicalImagingAndOncologyCenterIncMember_bc108015-a4f9-4cb3-a90b-907109983ddc" xlink:href="asth-20231231.xsd#asth_PacificMedicalImagingAndOncologyCenterIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_PacificMedicalImagingAndOncologyCenterIncMember_bc108015-a4f9-4cb3-a90b-907109983ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiveThreeOneW.CollegeLLCMember_dc840b1e-ed6b-42b5-b84c-910ad45d03d4" xlink:href="asth-20231231.xsd#asth_FiveThreeOneW.CollegeLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_FiveThreeOneW.CollegeLLCMember_dc840b1e-ed6b-42b5-b84c-910ad45d03d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OneMSOLLCMember_eb1562b7-8462-48f7-be96-04a2ad4713a3" xlink:href="asth-20231231.xsd#asth_OneMSOLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_OneMSOLLCMember_eb1562b7-8462-48f7-be96-04a2ad4713a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CAIPAMSOMember_aed61bde-47d0-4893-b83e-f80cd0a53b00" xlink:href="asth-20231231.xsd#asth_CAIPAMSOMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_CAIPAMSOMember_aed61bde-47d0-4893-b83e-f80cd0a53b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag6MedicalInvestmentGroupLLCMember_a3d4ab0b-db44-4863-b75a-dc66e83c731c" xlink:href="asth-20231231.xsd#asth_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_Tag6MedicalInvestmentGroupLLCMember_a3d4ab0b-db44-4863-b75a-dc66e83c731c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OtherMember_a896e768-dcf5-4bbb-a245-fd82f0bdd351" xlink:href="asth-20231231.xsd#asth_OtherMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a303a586-3c32-4e99-b0d1-bc50ba203042" xlink:to="loc_asth_OtherMember_a896e768-dcf5-4bbb-a245-fd82f0bdd351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_05720c54-d996-43f4-96cc-0009735c3e60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_7c549ea0-a410-4c67-b7a7-2b00c60d4826" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_05720c54-d996-43f4-96cc-0009735c3e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_97e24462-df89-4a16-b7b0-0648a347229e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_05720c54-d996-43f4-96cc-0009735c3e60" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_97e24462-df89-4a16-b7b0-0648a347229e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_05720c54-d996-43f4-96cc-0009735c3e60" xlink:to="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_77c00998-bf93-4c6f-982c-a7bbe3418a78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_us-gaap_EquityMethodInvestments_77c00998-bf93-4c6f-982c-a7bbe3418a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentAdditionalInvestment_31c70917-5bf2-472c-a82e-94d54a53e5ba" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentAdditionalInvestment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentAdditionalInvestment_31c70917-5bf2-472c-a82e-94d54a53e5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5971eb31-7921-4cde-9697-f388a28fba14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5971eb31-7921-4cde-9697-f388a28fba14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_8d8e0790-17b6-4819-a924-230cf2d71326" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable_8d8e0790-17b6-4819-a924-230cf2d71326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentsContribution_5475d7f5-317c-41e4-8213-8af7337f7443" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentsContribution"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentsContribution_5475d7f5-317c-41e4-8213-8af7337f7443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentAdjustmentToFairValue_700c96b0-9569-48dc-9fc8-2a5bf0a7071b" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentAdjustmentToFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentAdjustmentToFairValue_700c96b0-9569-48dc-9fc8-2a5bf0a7071b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentsConsolidated_22fee068-5802-442f-944a-2bc6648f0898" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentsConsolidated"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_asth_EquityMethodInvestmentsConsolidated_22fee068-5802-442f-944a-2bc6648f0898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount_186fcf89-b1ff-4534-8549-a3cb87ff2ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentSoldCarryingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_us-gaap_EquityMethodInvestmentSoldCarryingAmount_186fcf89-b1ff-4534-8549-a3cb87ff2ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_5b589b00-207b-455d-82be-23c9a4e34e67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_EquityMethodInvestmentsRollForward_6795fdb6-ca26-4155-b030-169cafedc9d2" xlink:to="loc_us-gaap_EquityMethodInvestments_5b589b00-207b-455d-82be-23c9a4e34e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#InvestmentsinOtherEntitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c3e53038-a452-41e1-9b4f-ea2c8f7e421a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d5ee6d8a-7786-4378-8105-81d2a4b88b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c3e53038-a452-41e1-9b4f-ea2c8f7e421a" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d5ee6d8a-7786-4378-8105-81d2a4b88b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5c18cea6-3770-4307-823e-68695b65777e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d5ee6d8a-7786-4378-8105-81d2a4b88b7f" xlink:to="loc_srt_OwnershipAxis_5c18cea6-3770-4307-823e-68695b65777e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_5c18cea6-3770-4307-823e-68695b65777e" xlink:to="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MediPortalLLCMember_5a4b8685-e786-46ff-baaa-6bcc426bc063" xlink:href="asth-20231231.xsd#asth_MediPortalLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:to="loc_asth_MediPortalLLCMember_5a4b8685-e786-46ff-baaa-6bcc426bc063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AchievaMedInc.Member_3e1bfb16-4a3d-4313-992e-934b7f7ee822" xlink:href="asth-20231231.xsd#asth_AchievaMedInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:to="loc_asth_AchievaMedInc.Member_3e1bfb16-4a3d-4313-992e-934b7f7ee822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ThirdWayHealthIncMember_32a10333-55bd-4a89-bd91-1795417af7d2" xlink:href="asth-20231231.xsd#asth_ThirdWayHealthIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:to="loc_asth_ThirdWayHealthIncMember_32a10333-55bd-4a89-bd91-1795417af7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SeenHealthIncMember_76f78828-3ef7-4dd9-8436-a7eb2cf86b41" xlink:href="asth-20231231.xsd#asth_SeenHealthIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_8a51164c-3e60-49d3-ad43-94fa10f38f72" xlink:to="loc_asth_SeenHealthIncMember_76f78828-3ef7-4dd9-8436-a7eb2cf86b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b566f1b8-fc51-4fb8-af06-2f0c55662e48" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d5ee6d8a-7786-4378-8105-81d2a4b88b7f" xlink:to="loc_dei_LegalEntityAxis_b566f1b8-fc51-4fb8-af06-2f0c55662e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_da63a71a-5676-4d18-8d5b-c99c7d1797a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b566f1b8-fc51-4fb8-af06-2f0c55662e48" xlink:to="loc_dei_EntityDomain_da63a71a-5676-4d18-8d5b-c99c7d1797a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_5612e8ee-dac2-4550-9dfe-99384587368a" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_da63a71a-5676-4d18-8d5b-c99c7d1797a5" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_5612e8ee-dac2-4550-9dfe-99384587368a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkMedicalManagementIncMember_d9272f98-7ea4-45ee-8111-d18f84c8d1ff" xlink:href="asth-20231231.xsd#asth_NetworkMedicalManagementIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_da63a71a-5676-4d18-8d5b-c99c7d1797a5" xlink:to="loc_asth_NetworkMedicalManagementIncMember_d9272f98-7ea4-45ee-8111-d18f84c8d1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_d5ee6d8a-7786-4378-8105-81d2a4b88b7f" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares_4f4e3f6d-a898-4fdf-9cac-f52a308f24a9" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares_4f4e3f6d-a898-4fdf-9cac-f52a308f24a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments_a1d200d4-0044-49f6-bc59-e8a89fac4e7b" xlink:href="asth-20231231.xsd#asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments_a1d200d4-0044-49f6-bc59-e8a89fac4e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest_bf33d8bd-88c2-4c0d-b74b-0312fa4f5bb1" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest_bf33d8bd-88c2-4c0d-b74b-0312fa4f5bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_8376d68c-a34e-4f34-9936-edc05b9e2215" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_8376d68c-a34e-4f34-9936-edc05b9e2215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_903b2f12-4d42-40c1-afc2-a8b590213886" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_903b2f12-4d42-40c1-afc2-a8b590213886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_69ac4311-a2d5-4451-97a5-ffeca3c3b297" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_69ac4311-a2d5-4451-97a5-ffeca3c3b297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption_dda5090c-01c6-4d09-9c3f-4e46a39f3a2c" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption_dda5090c-01c6-4d09-9c3f-4e46a39f3a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests_db56f3a6-b371-409f-b243-19b7ad5136a5" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests_db56f3a6-b371-409f-b243-19b7ad5136a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet_b810319d-dc48-4114-a75f-6baf4c153556" xlink:href="asth-20231231.xsd#asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet_b810319d-dc48-4114-a75f-6baf4c153556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears_240feeb2-fef3-47a6-aa2e-a6973891dbc6" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears_240feeb2-fef3-47a6-aa2e-a6973891dbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment_9ee64d15-1946-4b5e-98ef-a85ad37c25ac" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment_9ee64d15-1946-4b5e-98ef-a85ad37c25ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost_89b68fe7-0e6c-472a-a348-ae9844938b1e" xlink:href="asth-20231231.xsd#asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_bd9d01d4-6f4b-44cd-b951-4ca49af09dfd" xlink:to="loc_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost_89b68fe7-0e6c-472a-a348-ae9844938b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LoanReceivableandLoanReceivableRelatedPartiesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_asth_LoanReceivableAbstract_dda70ab6-5585-43a8-b536-8f707de719de" xlink:href="asth-20231231.xsd#asth_LoanReceivableAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_LoanReceivableAbstract_dda70ab6-5585-43a8-b536-8f707de719de" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_381ee7d7-04e6-41bd-ad72-821c6a0e9ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_381ee7d7-04e6-41bd-ad72-821c6a0e9ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_5e4eff94-5946-42bf-b3e7-b6acabf5e432" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_381ee7d7-04e6-41bd-ad72-821c6a0e9ee6" xlink:to="loc_us-gaap_ReceivableTypeDomain_5e4eff94-5946-42bf-b3e7-b6acabf5e432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_23a96920-02ae-4cd6-abfa-fa38e83c2c35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_5e4eff94-5946-42bf-b3e7-b6acabf5e432" xlink:to="loc_us-gaap_NotesReceivableMember_23a96920-02ae-4cd6-abfa-fa38e83c2c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f1f44b9d-a1da-4983-b67e-7b8136779211" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f1f44b9d-a1da-4983-b67e-7b8136779211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cda8dcff-0029-4a4e-bfb1-02dd7b33afff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f1f44b9d-a1da-4983-b67e-7b8136779211" xlink:to="loc_us-gaap_RelatedPartyDomain_cda8dcff-0029-4a4e-bfb1-02dd7b33afff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Pacific6EnterprisesMember_be3fb63a-5921-41a9-b46b-89b51d3f8bbf" xlink:href="asth-20231231.xsd#asth_Pacific6EnterprisesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_cda8dcff-0029-4a4e-bfb1-02dd7b33afff" xlink:to="loc_asth_Pacific6EnterprisesMember_be3fb63a-5921-41a9-b46b-89b51d3f8bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcLsmaMember_6205a836-b2b6-488f-82dd-41486c61a594" xlink:href="asth-20231231.xsd#asth_ApcLsmaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_cda8dcff-0029-4a4e-bfb1-02dd7b33afff" xlink:to="loc_asth_ApcLsmaMember_6205a836-b2b6-488f-82dd-41486c61a594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3f513f1b-845f-489e-9664-747c30067534" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_dei_LegalEntityAxis_3f513f1b-845f-489e-9664-747c30067534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_286dae21-6382-4350-8fe9-e3f5798caf05" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3f513f1b-845f-489e-9664-747c30067534" xlink:to="loc_dei_EntityDomain_286dae21-6382-4350-8fe9-e3f5798caf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkMedicalManagementMember_ef313aff-9f6b-494f-92a0-9f5626f6b645" xlink:href="asth-20231231.xsd#asth_NetworkMedicalManagementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_286dae21-6382-4350-8fe9-e3f5798caf05" xlink:to="loc_asth_NetworkMedicalManagementMember_ef313aff-9f6b-494f-92a0-9f5626f6b645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LmaMember_594dc3c7-29f0-489e-85ab-30474f834396" xlink:href="asth-20231231.xsd#asth_LmaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_286dae21-6382-4350-8fe9-e3f5798caf05" xlink:to="loc_asth_LmaMember_594dc3c7-29f0-489e-85ab-30474f834396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6b32c47e-9dbe-4bfd-9950-8799422681f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_us-gaap_DebtInstrumentAxis_6b32c47e-9dbe-4bfd-9950-8799422681f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94c0128b-19cc-43d0-a8bd-89f89e86d5db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6b32c47e-9dbe-4bfd-9950-8799422681f7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94c0128b-19cc-43d0-a8bd-89f89e86d5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IntraCareConvertiblePromissoryNoteReceivableMember_726cec24-d30c-47ac-8e60-3d9735fb3ac2" xlink:href="asth-20231231.xsd#asth_IntraCareConvertiblePromissoryNoteReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94c0128b-19cc-43d0-a8bd-89f89e86d5db" xlink:to="loc_asth_IntraCareConvertiblePromissoryNoteReceivableMember_726cec24-d30c-47ac-8e60-3d9735fb3ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_97b4dc65-96e1-4df2-be42-1cdb34a1a6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_97b4dc65-96e1-4df2-be42-1cdb34a1a6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_625bd092-bd8d-4520-ad75-9a0e00425185" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_97b4dc65-96e1-4df2-be42-1cdb34a1a6c1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_625bd092-bd8d-4520-ad75-9a0e00425185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_8eaa0e84-94ae-481f-ba67-8cdc23784854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_625bd092-bd8d-4520-ad75-9a0e00425185" xlink:to="loc_us-gaap_NotesReceivableMember_8eaa0e84-94ae-481f-ba67-8cdc23784854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6494383f-84ca-43d6-ae7d-1fb33c729f95" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6494383f-84ca-43d6-ae7d-1fb33c729f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_fa0a0ac4-ddc8-4b11-a471-d6f340940e72" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6494383f-84ca-43d6-ae7d-1fb33c729f95" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_fa0a0ac4-ddc8-4b11-a471-d6f340940e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LmaMember_dbeeda66-fa3c-46e1-86c8-c399dd307c0a" xlink:href="asth-20231231.xsd#asth_LmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_fa0a0ac4-ddc8-4b11-a471-d6f340940e72" xlink:to="loc_asth_LmaMember_dbeeda66-fa3c-46e1-86c8-c399dd307c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_b91e9627-55bd-4862-9244-9fad0ca35b31" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_35989c4f-5632-4c56-a2d6-5c48ada8657b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_NotesReceivableNet_35989c4f-5632-4c56-a2d6-5c48ada8657b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4adaf8ef-9065-42f8-8e8d-602afaa27f22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4adaf8ef-9065-42f8-8e8d-602afaa27f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_06e1951a-791b-4c6b-8903-9c2567e67a99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_DebtInstrumentTerm_06e1951a-791b-4c6b-8903-9c2567e67a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_39dd2885-192b-4b2b-b5ef-22786d2f779e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_39dd2885-192b-4b2b-b5ef-22786d2f779e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_967f4a19-89b6-440f-b40d-8d6f34151f01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_967f4a19-89b6-440f-b40d-8d6f34151f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FinanceReceivableInterestRateStatedPercentage_a953870d-531e-4f5f-80ba-2e9e2895d559" xlink:href="asth-20231231.xsd#asth_FinanceReceivableInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_asth_FinanceReceivableInterestRateStatedPercentage_a953870d-531e-4f5f-80ba-2e9e2895d559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4c0666a4-a37a-49ad-af5f-3514a6eb624c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_8795e807-8a2e-4f3a-9b78-5255b60fe64a" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4c0666a4-a37a-49ad-af5f-3514a6eb624c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#AccountsPayableandAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_28f742e2-d94c-48c0-8836-72e8691c0e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_28f742e2-d94c-48c0-8836-72e8691c0e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SpecialtyCapitationPayableCurrent_f8fb6eeb-9c2f-4b3f-9bbf-1d0986eeb602" xlink:href="asth-20231231.xsd#asth_SpecialtyCapitationPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:to="loc_asth_SpecialtyCapitationPayableCurrent_f8fb6eeb-9c2f-4b3f-9bbf-1d0986eeb602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SubcontractorIpaRiskPoolPayable_7ba615e0-1079-48ab-8598-05e6d37fe03d" xlink:href="asth-20231231.xsd#asth_SubcontractorIpaRiskPoolPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:to="loc_asth_SubcontractorIpaRiskPoolPayable_7ba615e0-1079-48ab-8598-05e6d37fe03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_4d7ac3d2-6c83-474b-95cc-65d96f934c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_4d7ac3d2-6c83-474b-95cc-65d96f934c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDepositLiabilities_fdce404f-0e8b-4597-800f-59768651bee4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDepositLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:to="loc_us-gaap_RelatedPartyDepositLiabilities_fdce404f-0e8b-4597-800f-59768651bee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_120e248d-3000-45bd-84d8-2d33ad0b7acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_120e248d-3000-45bd-84d8-2d33ad0b7acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f3a492b3-8d40-4567-b642-63367e4f7d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f3a492b3-8d40-4567-b642-63367e4f7d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b3879ca2-7953-4cd7-9fed-656470ae1421" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b3879ca2-7953-4cd7-9fed-656470ae1421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2722127f-600a-4c88-822c-e018e1d0fa21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_4f929523-f10a-4bdb-9fb2-1fbc0f7a4339" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2722127f-600a-4c88-822c-e018e1d0fa21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MedicalLiabilitiesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#MedicalLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MedicalLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_7b3d744c-91b2-4be4-9765-adbc90902cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_e6001b12-435e-47bb-afbe-f31458f60b25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_7b3d744c-91b2-4be4-9765-adbc90902cfb" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_e6001b12-435e-47bb-afbe-f31458f60b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_510427da-44b9-4103-bace-48253e0c7fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_e6001b12-435e-47bb-afbe-f31458f60b25" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_510427da-44b9-4103-bace-48253e0c7fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_63fac6be-6e6b-4af0-a61c-a1d9783c57f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_e6001b12-435e-47bb-afbe-f31458f60b25" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_63fac6be-6e6b-4af0-a61c-a1d9783c57f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicalCareCostsAbstract_98414a96-4ead-47ef-b21a-1bf360ecc26a" xlink:href="asth-20231231.xsd#asth_MedicalCareCostsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_e6001b12-435e-47bb-afbe-f31458f60b25" xlink:to="loc_asth_MedicalCareCostsAbstract_98414a96-4ead-47ef-b21a-1bf360ecc26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_73522b19-e735-49b6-b47e-d7a53864204f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_MedicalCareCostsAbstract_98414a96-4ead-47ef-b21a-1bf360ecc26a" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_73522b19-e735-49b6-b47e-d7a53864204f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_27911659-2632-43e4-a36a-71a55243bb82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_MedicalCareCostsAbstract_98414a96-4ead-47ef-b21a-1bf360ecc26a" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_27911659-2632-43e4-a36a-71a55243bb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a1446b2d-6d6a-4369-9dfd-f62a4a3b332a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_MedicalCareCostsAbstract_98414a96-4ead-47ef-b21a-1bf360ecc26a" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_a1446b2d-6d6a-4369-9dfd-f62a4a3b332a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentsForMedicalCareCostsAbstract_700781b2-e761-438a-80ac-a0704a9bb2b8" xlink:href="asth-20231231.xsd#asth_PaymentsForMedicalCareCostsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_e6001b12-435e-47bb-afbe-f31458f60b25" xlink:to="loc_asth_PaymentsForMedicalCareCostsAbstract_700781b2-e761-438a-80ac-a0704a9bb2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_eacbca0b-5788-4dd6-8dd7-cd48faa8bbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_PaymentsForMedicalCareCostsAbstract_700781b2-e761-438a-80ac-a0704a9bb2b8" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_eacbca0b-5788-4dd6-8dd7-cd48faa8bbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_c0784c00-679c-402e-8d11-2e529f149c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_PaymentsForMedicalCareCostsAbstract_700781b2-e761-438a-80ac-a0704a9bb2b8" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_c0784c00-679c-402e-8d11-2e529f149c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_aeed35c7-325a-4859-b5a5-b6b0569558d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_PaymentsForMedicalCareCostsAbstract_700781b2-e761-438a-80ac-a0704a9bb2b8" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_aeed35c7-325a-4859-b5a5-b6b0569558d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_1ac39100-3ede-49cd-8306-d3717ae1ab11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_e6001b12-435e-47bb-afbe-f31458f60b25" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_1ac39100-3ede-49cd-8306-d3717ae1ab11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_e7d313a6-07fe-4506-a832-50cb35ead02c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_e6001b12-435e-47bb-afbe-f31458f60b25" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_e7d313a6-07fe-4506-a832-50cb35ead02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6d7aa15d-303c-4f76-a738-766b3e2bf026" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_92eb12db-da80-4fc0-8eca-0abe344aaa97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6d7aa15d-303c-4f76-a738-766b3e2bf026" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_92eb12db-da80-4fc0-8eca-0abe344aaa97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c9d991a5-86f3-4e13-be40-ec148c22ffe9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_92eb12db-da80-4fc0-8eca-0abe344aaa97" xlink:to="loc_us-gaap_CreditFacilityAxis_c9d991a5-86f3-4e13-be40-ec148c22ffe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3cc52a34-411a-44bd-a931-f5791eea2625" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c9d991a5-86f3-4e13-be40-ec148c22ffe9" xlink:to="loc_us-gaap_CreditFacilityDomain_3cc52a34-411a-44bd-a931-f5791eea2625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f98a8bdd-040c-48de-a720-ed14e05128ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3cc52a34-411a-44bd-a931-f5791eea2625" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f98a8bdd-040c-48de-a720-ed14e05128ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4feed0d2-7051-496b-b8a4-9c3cdd23e9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_92eb12db-da80-4fc0-8eca-0abe344aaa97" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4feed0d2-7051-496b-b8a4-9c3cdd23e9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4feed0d2-7051-496b-b8a4-9c3cdd23e9aa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TermLoanMember_3b39eee1-7376-4058-bac2-53bc362e2151" xlink:href="asth-20231231.xsd#asth_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:to="loc_asth_TermLoanMember_3b39eee1-7376-4058-bac2-53bc362e2151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLoanMember_38fed5b0-9bf8-408e-8753-607f3d89ee70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:to="loc_us-gaap_RealEstateLoanMember_38fed5b0-9bf8-408e-8753-607f3d89ee70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ConstructionLoanMember_86979709-dafb-4dde-8ffa-194f2241e28e" xlink:href="asth-20231231.xsd#asth_ConstructionLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:to="loc_asth_ConstructionLoanMember_86979709-dafb-4dde-8ffa-194f2241e28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_d63e9706-78d1-4ae2-9dd3-b27703efee81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2ef4c782-f929-4c78-9740-3705062c6518" xlink:to="loc_us-gaap_NotesPayableToBanksMember_d63e9706-78d1-4ae2-9dd3-b27703efee81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_92eb12db-da80-4fc0-8eca-0abe344aaa97" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_97fb520f-0b40-4635-ae34-14b6a35b68f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_97fb520f-0b40-4635-ae34-14b6a35b68f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e538333e-86f4-419a-a211-84db0dc3997a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:to="loc_us-gaap_LongTermDebtCurrent_e538333e-86f4-419a-a211-84db0dc3997a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a0935373-f3d4-4d76-932d-d64eb55a6f52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_a0935373-f3d4-4d76-932d-d64eb55a6f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_894e910e-1912-46da-8e39-6615bf6617d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_71c0a809-990f-4d34-b3b2-6e563d1f8d52" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_894e910e-1912-46da-8e39-6615bf6617d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5c2f53e7-577a-4cbd-b5b2-cc4b3792f483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_eacf909e-0c38-4dd1-967a-5b9a2ae73032" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c2f53e7-577a-4cbd-b5b2-cc4b3792f483" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_eacf909e-0c38-4dd1-967a-5b9a2ae73032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f1338d61-1d45-46b2-9df0-36c3e57b3924" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c2f53e7-577a-4cbd-b5b2-cc4b3792f483" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f1338d61-1d45-46b2-9df0-36c3e57b3924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e69fff5f-1501-4e5f-bf8d-d2d04e17de3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c2f53e7-577a-4cbd-b5b2-cc4b3792f483" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e69fff5f-1501-4e5f-bf8d-d2d04e17de3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2b6e52e1-775c-443f-93ca-fd134654c651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c2f53e7-577a-4cbd-b5b2-cc4b3792f483" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2b6e52e1-775c-443f-93ca-fd134654c651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_d7325091-2d22-44b6-aa3f-c77eecac28ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c2f53e7-577a-4cbd-b5b2-cc4b3792f483" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_d7325091-2d22-44b6-aa3f-c77eecac28ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d79a7e40-1027-44e2-b9d2-1ef0f733bedf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c2f53e7-577a-4cbd-b5b2-cc4b3792f483" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d79a7e40-1027-44e2-b9d2-1ef0f733bedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_a5ccca6a-ef9a-4cfc-aa5d-7f66b7e2ccc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5c2f53e7-577a-4cbd-b5b2-cc4b3792f483" xlink:to="loc_us-gaap_LineOfCredit_a5ccca6a-ef9a-4cfc-aa5d-7f66b7e2ccc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8422e888-6fea-4a65-a64d-ed97e932e681" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8422e888-6fea-4a65-a64d-ed97e932e681" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_636f251f-4aa2-448b-a3f2-465517aa7b2e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_srt_RangeAxis_636f251f-4aa2-448b-a3f2-465517aa7b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2f4b39a8-c854-4c78-a55b-6e6b43145df4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_636f251f-4aa2-448b-a3f2-465517aa7b2e" xlink:to="loc_srt_RangeMember_2f4b39a8-c854-4c78-a55b-6e6b43145df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_66904bdc-a0a6-44b5-92ab-bfd389149080" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2f4b39a8-c854-4c78-a55b-6e6b43145df4" xlink:to="loc_srt_MinimumMember_66904bdc-a0a6-44b5-92ab-bfd389149080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f1664aa0-a445-45d4-a394-0d3fdc87ec02" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2f4b39a8-c854-4c78-a55b-6e6b43145df4" xlink:to="loc_srt_MaximumMember_f1664aa0-a445-45d4-a394-0d3fdc87ec02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_020be8f3-3d6d-4ed1-806f-49c654547ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_DebtInstrumentAxis_020be8f3-3d6d-4ed1-806f-49c654547ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_020be8f3-3d6d-4ed1-806f-49c654547ddf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AmendedCreditAgreementMember_4b76bdef-6536-480e-94bb-90899bb60cae" xlink:href="asth-20231231.xsd#asth_AmendedCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:to="loc_asth_AmendedCreditAgreementMember_4b76bdef-6536-480e-94bb-90899bb60cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CreditAgreementMember_92314c20-c75b-459f-ba5c-7845de357aeb" xlink:href="asth-20231231.xsd#asth_CreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:to="loc_asth_CreditAgreementMember_92314c20-c75b-459f-ba5c-7845de357aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AmendedAndRestatedCreditAgreementMember_d4f02b9f-7ee0-465c-b496-5a3cf73fefd2" xlink:href="asth-20231231.xsd#asth_AmendedAndRestatedCreditAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e449a97-df31-4934-87b4-fa9db8648a0e" xlink:to="loc_asth_AmendedAndRestatedCreditAgreementMember_d4f02b9f-7ee0-465c-b496-5a3cf73fefd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_88b4093a-7b2d-4044-a866-2fb86a233a11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_VariableRateAxis_88b4093a-7b2d-4044-a866-2fb86a233a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_203f52ed-1477-4e79-ad71-91316690797b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_88b4093a-7b2d-4044-a866-2fb86a233a11" xlink:to="loc_us-gaap_VariableRateDomain_203f52ed-1477-4e79-ad71-91316690797b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SecuredOvernightFinancingRateMember_6b5c8091-fa96-476c-89cd-0ec28dd4c6ad" xlink:href="asth-20231231.xsd#asth_SecuredOvernightFinancingRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_203f52ed-1477-4e79-ad71-91316690797b" xlink:to="loc_asth_SecuredOvernightFinancingRateMember_6b5c8091-fa96-476c-89cd-0ec28dd4c6ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_15d13c0e-7585-41ac-b70a-91943ca75538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_203f52ed-1477-4e79-ad71-91316690797b" xlink:to="loc_us-gaap_BaseRateMember_15d13c0e-7585-41ac-b70a-91943ca75538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_879fad45-1033-4511-ba84-87bdeb88c8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_CreditFacilityAxis_879fad45-1033-4511-ba84-87bdeb88c8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_879fad45-1033-4511-ba84-87bdeb88c8c4" xlink:to="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d3fe486f-95d7-4432-86d0-2307f6373cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d3fe486f-95d7-4432-86d0-2307f6373cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_4c9e0070-ce21-4923-a71a-ffc8729b2cff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_4c9e0070-ce21-4923-a71a-ffc8729b2cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NewTermLoanMember_6f6a82e3-ff16-41af-9931-42b38afb8249" xlink:href="asth-20231231.xsd#asth_NewTermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:to="loc_asth_NewTermLoanMember_6f6a82e3-ff16-41af-9931-42b38afb8249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_6949715a-f445-4e78-8225-4c10a2ecd4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d78e2ccf-8883-46cf-92be-c4014ab08088" xlink:to="loc_us-gaap_LetterOfCreditMember_6949715a-f445-4e78-8225-4c10a2ecd4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b323c302-3262-484b-bca2-6df838f7ec80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b323c302-3262-484b-bca2-6df838f7ec80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_22bae62b-f418-495a-97c8-2e3ae07e7e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b323c302-3262-484b-bca2-6df838f7ec80" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_22bae62b-f418-495a-97c8-2e3ae07e7e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_31716be8-983b-42ae-820d-21905fb495f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bae62b-f418-495a-97c8-2e3ae07e7e4a" xlink:to="loc_us-gaap_LineOfCreditMember_31716be8-983b-42ae-820d-21905fb495f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_1104d789-1dd6-42b3-b169-6707bbd5cfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_22bae62b-f418-495a-97c8-2e3ae07e7e4a" xlink:to="loc_us-gaap_SecuredDebtMember_1104d789-1dd6-42b3-b169-6707bbd5cfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_96930927-40b0-452b-94de-d3db7e5c71de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_96930927-40b0-452b-94de-d3db7e5c71de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_f15eef11-f360-4616-aa9d-043128fda6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_96930927-40b0-452b-94de-d3db7e5c71de" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_f15eef11-f360-4616-aa9d-043128fda6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TruistBankMember_3bca2036-f865-42d9-94ff-a4b962052412" xlink:href="asth-20231231.xsd#asth_TruistBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_f15eef11-f360-4616-aa9d-043128fda6d0" xlink:to="loc_asth_TruistBankMember_3bca2036-f865-42d9-94ff-a4b962052412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_153d2cec-3865-4fca-a206-5fc433a3e13d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_153d2cec-3865-4fca-a206-5fc433a3e13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_153d2cec-3865-4fca-a206-5fc433a3e13d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_6fec7a44-2c3e-4f16-8f32-b717b29c6fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_6fec7a44-2c3e-4f16-8f32-b717b29c6fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e7bbf126-e51a-4b08-b0ab-e72edad93d02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_e7bbf126-e51a-4b08-b0ab-e72edad93d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_00b9fd5f-8731-416b-a41a-fc5e95640948" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_0cfaece8-9e47-463d-a057-f4a93812d5b1" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_00b9fd5f-8731-416b-a41a-fc5e95640948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_04d80cb5-418d-48f1-b2b5-288ad8680930" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_srt_CounterpartyNameAxis_04d80cb5-418d-48f1-b2b5-288ad8680930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c10688de-83c0-469a-946b-0b64116c0fb6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_04d80cb5-418d-48f1-b2b5-288ad8680930" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c10688de-83c0-469a-946b-0b64116c0fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AstranaMedicalMember_1d191d49-2ca0-4a43-a0e2-5a37cb4570c6" xlink:href="asth-20231231.xsd#asth_AstranaMedicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c10688de-83c0-469a-946b-0b64116c0fb6" xlink:to="loc_asth_AstranaMedicalMember_1d191d49-2ca0-4a43-a0e2-5a37cb4570c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c07d148c-b250-4af2-a8a1-87858372fa0d" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2a01a6ab-013f-4011-b3b3-9d6167f42451" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2a01a6ab-013f-4011-b3b3-9d6167f42451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_6a21580b-8c83-4042-805d-6f2c60ea9ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_6a21580b-8c83-4042-805d-6f2c60ea9ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_bbe95d02-5029-448c-9505-bf19e675740a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_bbe95d02-5029-448c-9505-bf19e675740a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_bae06451-9ad2-4c76-85bd-6207d42b2965" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_bae06451-9ad2-4c76-85bd-6207d42b2965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantLeverageRatioMaximum_91d0ec61-636e-4894-b09c-b547a6a66db9" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtInstrumentCovenantLeverageRatioMaximum_91d0ec61-636e-4894-b09c-b547a6a66db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtCovenantAggregatePurchasePriceMaximum_6efea54d-5c0d-4fec-81f7-e406e9ee653e" xlink:href="asth-20231231.xsd#asth_DebtCovenantAggregatePurchasePriceMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtCovenantAggregatePurchasePriceMaximum_6efea54d-5c0d-4fec-81f7-e406e9ee653e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_01931fb1-016d-4559-b34a-0ff65aa5857c" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantLeverageRatioIncrementalChange"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_01931fb1-016d-4559-b34a-0ff65aa5857c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_45219e18-a925-4e16-aed4-4a312651c00e" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_45219e18-a925-4e16-aed4-4a312651c00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_720b61dc-5887-4ea4-86e9-5a225898fc7f" xlink:href="asth-20231231.xsd#asth_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_720b61dc-5887-4ea4-86e9-5a225898fc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_aa6635a2-d5ab-4560-9b1a-03e526318d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCredit_aa6635a2-d5ab-4560-9b1a-03e526318d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_UnamortizedDeferredFinancingCosts_82bb4497-e623-4a5e-b595-d368b5100887" xlink:href="asth-20231231.xsd#asth_UnamortizedDeferredFinancingCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_UnamortizedDeferredFinancingCosts_82bb4497-e623-4a5e-b595-d368b5100887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_9c10b483-8c76-490f-b4a8-a2f039a29f23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet_9c10b483-8c76-490f-b4a8-a2f039a29f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_17502176-72f1-4621-8c84-c913fc8d94bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_17502176-72f1-4621-8c84-c913fc8d94bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_91214dd8-e4d8-48b7-b785-0d47f2155fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtInstrumentTerm_91214dd8-e4d8-48b7-b785-0d47f2155fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_91622c34-73f0-4a6a-966b-9009f1ceca42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_91622c34-73f0-4a6a-966b-9009f1ceca42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LineOfCreditFacilityAmountFundedAtClosing_b3e89cf0-e068-4592-a03d-28d73f2ebe2e" xlink:href="asth-20231231.xsd#asth_LineOfCreditFacilityAmountFundedAtClosing"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_asth_LineOfCreditFacilityAmountFundedAtClosing_b3e89cf0-e068-4592-a03d-28d73f2ebe2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_06be22e2-9d82-4789-b614-535eba89743b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_RepaymentsOfDebt_06be22e2-9d82-4789-b614-535eba89743b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts_071077e1-3868-4f84-b402-7aa655451af6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfBankOverdrafts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts_071077e1-3868-4f84-b402-7aa655451af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8291bd47-85c7-4143-93e9-bd2e43fa3dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8291bd47-85c7-4143-93e9-bd2e43fa3dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_7f396d1d-e96e-4df7-9a93-3fec80924426" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d9f1864-2b32-4b47-9302-e428761e086e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_7f396d1d-e96e-4df7-9a93-3fec80924426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_41269ddd-f9bf-4211-b0f4-ba779644bab2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_41269ddd-f9bf-4211-b0f4-ba779644bab2" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_794213c1-f64a-4614-968a-4d5f1f393d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_DebtInstrumentAxis_794213c1-f64a-4614-968a-4d5f1f393d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_794213c1-f64a-4614-968a-4d5f1f393d0c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RealEstateLoanOneMember_b2ead17b-7315-46d9-91a0-03349cceda92" xlink:href="asth-20231231.xsd#asth_RealEstateLoanOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_RealEstateLoanOneMember_b2ead17b-7315-46d9-91a0-03349cceda92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RealEstateLoanTwoMember_468a4abc-15e3-4f4b-b2f4-a27d65602cf0" xlink:href="asth-20231231.xsd#asth_RealEstateLoanTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_RealEstateLoanTwoMember_468a4abc-15e3-4f4b-b2f4-a27d65602cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RealEstateLoanThreeMember_8698dfb0-be13-411e-b795-0dbf886608c9" xlink:href="asth-20231231.xsd#asth_RealEstateLoanThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_RealEstateLoanThreeMember_8698dfb0-be13-411e-b795-0dbf886608c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ConstructionLoanMember_c06a1c7d-9f5a-466f-9881-c7b3a4837927" xlink:href="asth-20231231.xsd#asth_ConstructionLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_ConstructionLoanMember_c06a1c7d-9f5a-466f-9881-c7b3a4837927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SubordinatedLoanAgreementMember_ec0904de-8115-499f-b66f-6921d15a4785" xlink:href="asth-20231231.xsd#asth_SubordinatedLoanAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_SubordinatedLoanAgreementMember_ec0904de-8115-499f-b66f-6921d15a4785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CreditAgreementMember_d83b7787-e11d-48f8-80b5-8f86c816f2f2" xlink:href="asth-20231231.xsd#asth_CreditAgreementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_CreditAgreementMember_d83b7787-e11d-48f8-80b5-8f86c816f2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcBusinessLoanAgreementMember_cc3dd51d-5f1a-4f22-baab-5c66cfffaff4" xlink:href="asth-20231231.xsd#asth_ApcBusinessLoanAgreementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_ApcBusinessLoanAgreementMember_cc3dd51d-5f1a-4f22-baab-5c66cfffaff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AmendedCreditAgreementMember_a1f35607-c5f4-4b6d-976e-a0a4636cea29" xlink:href="asth-20231231.xsd#asth_AmendedCreditAgreementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_12311053-3b5d-45bf-ad20-7cb6e21a9549" xlink:to="loc_asth_AmendedCreditAgreementMember_a1f35607-c5f4-4b6d-976e-a0a4636cea29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_704911be-fd82-436c-803c-18d6eadf2332" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_dei_LegalEntityAxis_704911be-fd82-436c-803c-18d6eadf2332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_704911be-fd82-436c-803c-18d6eadf2332" xlink:to="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_d27a5caa-30d3-4789-9ba5-6395a3cffcc1" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_d27a5caa-30d3-4789-9ba5-6395a3cffcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_A120HellmanLLCMember_6ebd1689-9509-4536-97e2-afa288885d48" xlink:href="asth-20231231.xsd#asth_A120HellmanLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:to="loc_asth_A120HellmanLLCMember_6ebd1689-9509-4536-97e2-afa288885d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag8MedicalInvestmentGroupLLCMember_675880ab-7e87-454e-a70a-948142f7b6e9" xlink:href="asth-20231231.xsd#asth_Tag8MedicalInvestmentGroupLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_3113912b-9754-45f7-a1dd-f60015c2efad" xlink:to="loc_asth_Tag8MedicalInvestmentGroupLLCMember_675880ab-7e87-454e-a70a-948142f7b6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_4b1eaf3a-802e-4f17-bd74-4484e2515ada" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_VariableRateAxis_4b1eaf3a-802e-4f17-bd74-4484e2515ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_47c7dde4-ffd7-41f0-93c9-a05911c49f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_4b1eaf3a-802e-4f17-bd74-4484e2515ada" xlink:to="loc_us-gaap_VariableRateDomain_47c7dde4-ffd7-41f0-93c9-a05911c49f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_96eac801-c357-4c26-b372-11aedaada253" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_47c7dde4-ffd7-41f0-93c9-a05911c49f1e" xlink:to="loc_us-gaap_PrimeRateMember_96eac801-c357-4c26-b372-11aedaada253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6f26fadf-8c77-4cff-9ee6-0dd4b2ad0c48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6f26fadf-8c77-4cff-9ee6-0dd4b2ad0c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a9bfb077-b11a-41c0-850a-e25d316088fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6f26fadf-8c77-4cff-9ee6-0dd4b2ad0c48" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a9bfb077-b11a-41c0-850a-e25d316088fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubordinatedDebtMember_74788f02-cb4e-4488-bbe3-327bfb0c6a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubordinatedDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a9bfb077-b11a-41c0-850a-e25d316088fc" xlink:to="loc_us-gaap_SubordinatedDebtMember_74788f02-cb4e-4488-bbe3-327bfb0c6a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2309cdb8-550a-4986-a27f-99661b25ed5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_CreditFacilityAxis_2309cdb8-550a-4986-a27f-99661b25ed5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2995b6b2-30f1-4e0c-b8d6-7fe899e41931" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2309cdb8-550a-4986-a27f-99661b25ed5c" xlink:to="loc_us-gaap_CreditFacilityDomain_2995b6b2-30f1-4e0c-b8d6-7fe899e41931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_8eab9dc0-3396-4ccb-a4d4-f8526bdf62ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2995b6b2-30f1-4e0c-b8d6-7fe899e41931" xlink:to="loc_us-gaap_LineOfCreditMember_8eab9dc0-3396-4ccb-a4d4-f8526bdf62ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_88d80d3b-225b-45ea-9dcb-0272f437aeee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2995b6b2-30f1-4e0c-b8d6-7fe899e41931" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_88d80d3b-225b-45ea-9dcb-0272f437aeee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_46026ead-d36b-41ef-99a6-d44114cc4de1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_46026ead-d36b-41ef-99a6-d44114cc4de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_267a3994-9499-49c4-aa99-3add4d29ab96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_46026ead-d36b-41ef-99a6-d44114cc4de1" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_267a3994-9499-49c4-aa99-3add4d29ab96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PreferredBankMember_d1155fea-ace5-4935-96e5-c7b54b3511f0" xlink:href="asth-20231231.xsd#asth_PreferredBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_267a3994-9499-49c4-aa99-3add4d29ab96" xlink:to="loc_asth_PreferredBankMember_d1155fea-ace5-4935-96e5-c7b54b3511f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TruistBankMember_25e4473d-80c8-426e-b60b-2d7b274767e7" xlink:href="asth-20231231.xsd#asth_TruistBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_267a3994-9499-49c4-aa99-3add4d29ab96" xlink:to="loc_asth_TruistBankMember_25e4473d-80c8-426e-b60b-2d7b274767e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_0e3b6727-45c3-4ca6-b323-b262eb29820f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_0e3b6727-45c3-4ca6-b323-b262eb29820f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_82df2e37-df5c-4354-ad73-914136d0a3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_0e3b6727-45c3-4ca6-b323-b262eb29820f" xlink:to="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_82df2e37-df5c-4354-ad73-914136d0a3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_ac44559b-1635-4fa8-b692-8a5daade36d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_82df2e37-df5c-4354-ad73-914136d0a3f2" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_ac44559b-1635-4fa8-b692-8a5daade36d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_3a9276c4-006d-4e54-90ac-ef9ebf6258b4" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NumberOfRealEstateLoans_94f6fac5-5a10-43aa-a3cb-d8686ce6b279" xlink:href="asth-20231231.xsd#asth_NumberOfRealEstateLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_asth_NumberOfRealEstateLoans_94f6fac5-5a10-43aa-a3cb-d8686ce6b279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9bf720a5-c4ec-4d63-970b-6308e5a37a04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_LongTermDebt_9bf720a5-c4ec-4d63-970b-6308e5a37a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f097542b-c5e5-4d2b-9f85-80ea1a9635b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f097542b-c5e5-4d2b-9f85-80ea1a9635b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a2d0e865-890d-4939-afa7-5297c565f6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a2d0e865-890d-4939-afa7-5297c565f6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_26ad438f-4b56-4275-a5d9-684a10645847" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_26ad438f-4b56-4275-a5d9-684a10645847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_17ecc2d7-cec5-4624-895f-bca7665d5608" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_InterestExpense_17ecc2d7-cec5-4624-895f-bca7665d5608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5d8b5d2-fecb-40e8-9eb6-346fe865e774" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5d8b5d2-fecb-40e8-9eb6-346fe865e774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_49659088-2c54-46ab-bb96-27ccce9bd993" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_528f3800-dab9-4000-afef-d4ffcdb1738f" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_49659088-2c54-46ab-bb96-27ccce9bd993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxesIncomeTaxProvisionBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d3e0a0b1-71d7-43ca-8156-b11808944dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c182ecf4-63ed-4842-b513-ed0221dd39ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3e0a0b1-71d7-43ca-8156-b11808944dc5" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c182ecf4-63ed-4842-b513-ed0221dd39ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4897fcd0-a083-4786-89f8-72f2acb64e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c182ecf4-63ed-4842-b513-ed0221dd39ab" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_4897fcd0-a083-4786-89f8-72f2acb64e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7fcd096c-e38c-4544-998e-f1ff56df403d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c182ecf4-63ed-4842-b513-ed0221dd39ab" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7fcd096c-e38c-4544-998e-f1ff56df403d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_91c7d3fe-3a6c-4012-8777-54d56a5c2bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c182ecf4-63ed-4842-b513-ed0221dd39ab" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_91c7d3fe-3a6c-4012-8777-54d56a5c2bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bda9b3cf-e020-4e80-b0ea-6039ce7c21ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3e0a0b1-71d7-43ca-8156-b11808944dc5" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bda9b3cf-e020-4e80-b0ea-6039ce7c21ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_10c31437-9db2-4fc8-8f6c-d1a5aee3e96a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bda9b3cf-e020-4e80-b0ea-6039ce7c21ee" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_10c31437-9db2-4fc8-8f6c-d1a5aee3e96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_027c7415-83cd-4bb8-95b8-2534368f23c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bda9b3cf-e020-4e80-b0ea-6039ce7c21ee" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_027c7415-83cd-4bb8-95b8-2534368f23c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_19629e47-7cfc-4f55-bb43-bdedcb11d41e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bda9b3cf-e020-4e80-b0ea-6039ce7c21ee" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_19629e47-7cfc-4f55-bb43-bdedcb11d41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b9d75f79-c5fb-43cc-ad26-b60e1e0d2570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3e0a0b1-71d7-43ca-8156-b11808944dc5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b9d75f79-c5fb-43cc-ad26-b60e1e0d2570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxesProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70cf883a-6259-4d98-9522-ac7f7814a8a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70cf883a-6259-4d98-9522-ac7f7814a8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1303f916-9bfb-4c3e-884a-c6d56fdd89fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1303f916-9bfb-4c3e-884a-c6d56fdd89fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment_7e574743-a15b-4b58-ad2a-b9f29cc8be3f" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment_7e574743-a15b-4b58-ad2a-b9f29cc8be3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_5155c67b-1684-4a84-83b6-caad36122a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary_5155c67b-1684-4a84-83b6-caad36122a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_3e893047-dcc3-4b3a-aa33-99efa2f25de0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_3e893047-dcc3-4b3a-aa33-99efa2f25de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ba92b218-272a-4642-91d1-530327fd7177" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_ba92b218-272a-4642-91d1-530327fd7177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent_deac20df-7465-48d2-907a-643a8bc1aaff" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent_deac20df-7465-48d2-907a-643a8bc1aaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent_03a711cb-1f4e-4339-8110-2218a8f1975a" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent_03a711cb-1f4e-4339-8110-2218a8f1975a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent_b1234240-44a2-4503-a4c5-6d5b897c8438" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent_b1234240-44a2-4503-a4c5-6d5b897c8438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent_89231824-77a5-49c7-83fe-fd509cf5566b" xlink:href="asth-20231231.xsd#asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent_89231824-77a5-49c7-83fe-fd509cf5566b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5a78269b-af0d-4209-94a9-060af536af33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_5a78269b-af0d-4209-94a9-060af536af33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_e033cae6-4eee-43d9-a34d-007d03ab9f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_31641410-ada4-47b9-9c4f-c271014154cc" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_e033cae6-4eee-43d9-a34d-007d03ab9f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f745204d-3a4c-49ab-ba25-f769818dd6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_7f8dbf0a-50ba-49d3-93d8-d98104b956d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f745204d-3a4c-49ab-ba25-f769818dd6f3" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_7f8dbf0a-50ba-49d3-93d8-d98104b956d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_1ef8dc33-325e-4e65-9ec6-232be1808cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7f8dbf0a-50ba-49d3-93d8-d98104b956d3" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_1ef8dc33-325e-4e65-9ec6-232be1808cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_c5d9c5b7-94c5-4fc5-a6e7-17bf6c3a44e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_1ef8dc33-325e-4e65-9ec6-232be1808cb3" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_c5d9c5b7-94c5-4fc5-a6e7-17bf6c3a44e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_4a53a560-75ba-4cc4-9a62-9e4a82e1c127" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_c5d9c5b7-94c5-4fc5-a6e7-17bf6c3a44e0" xlink:to="loc_us-gaap_DomesticCountryMember_4a53a560-75ba-4cc4-9a62-9e4a82e1c127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_77bc4bdc-aeed-4168-b9b4-afff5be30bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_c5d9c5b7-94c5-4fc5-a6e7-17bf6c3a44e0" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_77bc4bdc-aeed-4168-b9b4-afff5be30bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_7f8dbf0a-50ba-49d3-93d8-d98104b956d3" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_154d5727-ba6f-4fc2-8faa-91e6296f28ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_154d5727-ba6f-4fc2-8faa-91e6296f28ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8527aa03-68dc-44f3-ad4b-3ea892803850" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8527aa03-68dc-44f3-ad4b-3ea892803850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_20d39084-340a-492d-8a27-44b63536fbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_20d39084-340a-492d-8a27-44b63536fbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_5525690d-42d3-4959-b66a-6fccc27cf8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_us-gaap_OperatingLossCarryforwards_5525690d-42d3-4959-b66a-6fccc27cf8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OperatingLossCarryforwardsNotSubjectToExpiration_cd6dc192-3339-48f2-8074-25224df89de8" xlink:href="asth-20231231.xsd#asth_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_189eb292-ba2c-4eb1-8c19-3268f7f75ce9" xlink:to="loc_asth_OperatingLossCarryforwardsNotSubjectToExpiration_cd6dc192-3339-48f2-8074-25224df89de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c07fc454-0189-430d-b052-b042e267061c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c07fc454-0189-430d-b052-b042e267061c" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_3ab6b2a4-a4d8-4fc4-9702-ca68eb0c44b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_3ab6b2a4-a4d8-4fc4-9702-ca68eb0c44b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_4b56a4ab-f052-4114-95ce-953d9955df5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_4b56a4ab-f052-4114-95ce-953d9955df5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_ba40c292-9657-4604-95c8-58982d28f9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_ba40c292-9657-4604-95c8-58982d28f9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DeferredTaxAssetsInvestment_4d80375b-e7d1-41c0-b329-85a9ae56b4a0" xlink:href="asth-20231231.xsd#asth_DeferredTaxAssetsInvestment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_asth_DeferredTaxAssetsInvestment_4d80375b-e7d1-41c0-b329-85a9ae56b4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1da11f8a-07c7-4463-b247-823745df6f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1da11f8a-07c7-4463-b247-823745df6f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DeferredTaxAssetsLeaseLiability_0fd46a9b-9d0a-4417-941f-fdf9c7003af8" xlink:href="asth-20231231.xsd#asth_DeferredTaxAssetsLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_asth_DeferredTaxAssetsLeaseLiability_0fd46a9b-9d0a-4417-941f-fdf9c7003af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_d397eedc-111f-4a6c-bca5-87297099e0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_d397eedc-111f-4a6c-bca5-87297099e0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_876cddd2-6202-4854-8243-41899ce28c56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_876cddd2-6202-4854-8243-41899ce28c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_ac58c410-edb1-4d18-a168-cbb866ad372f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_ac58c410-edb1-4d18-a168-cbb866ad372f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_61a38a62-434a-4101-9f8f-4de8341d184e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_61a38a62-434a-4101-9f8f-4de8341d184e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ed9da813-db2f-4524-8049-f9298a650dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ed9da813-db2f-4524-8049-f9298a650dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1f0b444f-0c3f-48db-9b4e-d9d75ecdb173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bae01570-2449-4987-af47-de5032d0125d" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1f0b444f-0c3f-48db-9b4e-d9d75ecdb173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_cd9d8ae7-db55-424a-9a73-8ecc2c20f9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c07fc454-0189-430d-b052-b042e267061c" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_cd9d8ae7-db55-424a-9a73-8ecc2c20f9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1c51c6e3-cc3a-484d-9613-f19295ee10d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_cd9d8ae7-db55-424a-9a73-8ecc2c20f9dd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_1c51c6e3-cc3a-484d-9613-f19295ee10d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_cae5045f-41ab-41c9-8dc3-97d7750c33a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_cd9d8ae7-db55-424a-9a73-8ecc2c20f9dd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_cae5045f-41ab-41c9-8dc3-97d7750c33a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_56ef54af-4477-4347-a02f-0a0d00f52879" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_cd9d8ae7-db55-424a-9a73-8ecc2c20f9dd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_56ef54af-4477-4347-a02f-0a0d00f52879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_51fc7af5-9d73-462b-9a6f-7774d819975c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_cd9d8ae7-db55-424a-9a73-8ecc2c20f9dd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts_51fc7af5-9d73-462b-9a6f-7774d819975c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend_36309eca-946a-4c41-ac9b-8114f5d28d60" xlink:href="asth-20231231.xsd#asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_cd9d8ae7-db55-424a-9a73-8ecc2c20f9dd" xlink:to="loc_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend_36309eca-946a-4c41-ac9b-8114f5d28d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_eb4c0791-e784-460b-9d73-77fff6146b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_cd9d8ae7-db55-424a-9a73-8ecc2c20f9dd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_eb4c0791-e784-460b-9d73-77fff6146b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_7995d483-8cc7-4136-a1bc-b02f34d83c60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c07fc454-0189-430d-b052-b042e267061c" xlink:to="loc_us-gaap_DeferredTaxLiabilities_7995d483-8cc7-4136-a1bc-b02f34d83c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_28204b4d-88c8-4698-a019-dc462cbdaff9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_28204b4d-88c8-4698-a019-dc462cbdaff9" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_86af2f63-eee9-4a9f-98e2-625ece8b269f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_86af2f63-eee9-4a9f-98e2-625ece8b269f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef19ce38-c5cc-49ee-857a-cc54c861a088" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_86af2f63-eee9-4a9f-98e2-625ece8b269f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef19ce38-c5cc-49ee-857a-cc54c861a088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_f23ee653-7435-4715-85dd-9640459c4c36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef19ce38-c5cc-49ee-857a-cc54c861a088" xlink:to="loc_us-gaap_PrivatePlacementMember_f23ee653-7435-4715-85dd-9640459c4c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3ee722d5-041a-4bdc-9d4f-9c1be28d809c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3ee722d5-041a-4bdc-9d4f-9c1be28d809c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b9a0fa1e-206c-45ca-b5ce-593147eb5706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3ee722d5-041a-4bdc-9d4f-9c1be28d809c" xlink:to="loc_us-gaap_ClassOfStockDomain_b9a0fa1e-206c-45ca-b5ce-593147eb5706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_1db05180-0ab3-45a6-95e9-5df7ced6d92d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b9a0fa1e-206c-45ca-b5ce-593147eb5706" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_1db05180-0ab3-45a6-95e9-5df7ced6d92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_f1610f30-de1e-4292-9a50-f61a5def00c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b9a0fa1e-206c-45ca-b5ce-593147eb5706" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_f1610f30-de1e-4292-9a50-f61a5def00c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_95053f88-1e29-4743-9e7f-32a9997730af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_dei_LegalEntityAxis_95053f88-1e29-4743-9e7f-32a9997730af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_95053f88-1e29-4743-9e7f-32a9997730af" xlink:to="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_a54cbbe0-7949-4065-b5f7-0835d41f189f" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_a54cbbe0-7949-4065-b5f7-0835d41f189f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CDSCMember_0308b973-19b9-4c82-82f2-ad6927613463" xlink:href="asth-20231231.xsd#asth_CDSCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:to="loc_asth_CDSCMember_0308b973-19b9-4c82-82f2-ad6927613463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CompanyAndAPCMember_2fbd76ce-6a6d-4599-ac8e-aeda496c3746" xlink:href="asth-20231231.xsd#asth_CompanyAndAPCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:to="loc_asth_CompanyAndAPCMember_2fbd76ce-6a6d-4599-ac8e-aeda496c3746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AstranaMember_427e870f-0810-46bb-96f8-aecbd75c8a5b" xlink:href="asth-20231231.xsd#asth_AstranaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_51285a75-f46a-46d1-9b3c-8233544b394b" xlink:to="loc_asth_AstranaMember_427e870f-0810-46bb-96f8-aecbd75c8a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_29a21bb8-53f8-4cab-b759-6d103656a6c5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_29a21bb8-53f8-4cab-b759-6d103656a6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9b3d7392-771f-41e4-ac05-ec4a39b7477a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_29a21bb8-53f8-4cab-b759-6d103656a6c5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9b3d7392-771f-41e4-ac05-ec4a39b7477a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloMedicalHoldingsIncMember_8f8e23cc-6b73-45f3-9f65-5ab7a0b7d694" xlink:href="asth-20231231.xsd#asth_ApolloMedicalHoldingsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9b3d7392-771f-41e4-ac05-ec4a39b7477a" xlink:to="loc_asth_ApolloMedicalHoldingsIncMember_8f8e23cc-6b73-45f3-9f65-5ab7a0b7d694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_bf46863d-e11c-40a3-a8be-6360c9c218fc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_srt_CounterpartyNameAxis_bf46863d-e11c-40a3-a8be-6360c9c218fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b083d745-47af-476f-b99d-ea49891f8dc2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_bf46863d-e11c-40a3-a8be-6360c9c218fc" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b083d745-47af-476f-b99d-ea49891f8dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_APAMHMedicalCorporationMember_e6f5a234-6dee-42fa-b61f-25baf4101678" xlink:href="asth-20231231.xsd#asth_APAMHMedicalCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b083d745-47af-476f-b99d-ea49891f8dc2" xlink:to="loc_asth_APAMHMedicalCorporationMember_e6f5a234-6dee-42fa-b61f-25baf4101678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_829ea42d-d54b-4383-87d7-e4b2033d6970" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_829ea42d-d54b-4383-87d7-e4b2033d6970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_d62d0f8b-0cd7-4d0d-b3a4-8905764aa302" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_829ea42d-d54b-4383-87d7-e4b2033d6970" xlink:to="loc_us-gaap_RelatedPartyDomain_d62d0f8b-0cd7-4d0d-b3a4-8905764aa302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_6b42c4ff-7585-46b1-b525-33234000d053" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_d62d0f8b-0cd7-4d0d-b3a4-8905764aa302" xlink:to="loc_srt_AffiliatedEntityMember_6b42c4ff-7585-46b1-b525-33234000d053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_ac07cd7c-411c-42bf-89e7-ea1970db07ee" xlink:to="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e6f05fc-5bae-40fc-bcbf-0ee6632defc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0e6f05fc-5bae-40fc-bcbf-0ee6632defc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_cb4d8617-d10f-4954-9a0d-45a0d4d61bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_cb4d8617-d10f-4954-9a0d-45a0d4d61bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b7faed57-1e0d-4f04-ab91-c8e9ceaa78a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b7faed57-1e0d-4f04-ab91-c8e9ceaa78a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d1538aeb-01fb-4ab7-baa1-000408531971" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d1538aeb-01fb-4ab7-baa1-000408531971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockLiquidationPreference_3ab2005a-24f6-421a-91d8-b2c1090819d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_PreferredStockLiquidationPreference_3ab2005a-24f6-421a-91d8-b2c1090819d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockIssuedDuringPeriodSharesMerger_a3f4e009-f5ef-43d5-9102-e152441dc8e1" xlink:href="asth-20231231.xsd#asth_StockIssuedDuringPeriodSharesMerger"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_asth_StockIssuedDuringPeriodSharesMerger_a3f4e009-f5ef-43d5-9102-e152441dc8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dd806689-561b-4b2e-9b70-20bf5251ea12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dd806689-561b-4b2e-9b70-20bf5251ea12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_3e73b8a8-55eb-43f4-b282-231e14d491db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_3e73b8a8-55eb-43f4-b282-231e14d491db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_0383189c-c059-4b06-8abc-1cdce27c1497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_TreasuryStockCommonShares_0383189c-c059-4b06-8abc-1cdce27c1497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fd441840-488e-4e59-9c32-14b4bd118c13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fd441840-488e-4e59-9c32-14b4bd118c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c103caba-b785-4a42-8862-51f46ded167b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c103caba-b785-4a42-8862-51f46ded167b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_63653f47-5ff0-4c11-a6a1-79e6b2a45d21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_c042a9bb-f873-4b81-a89e-cb533a1505de" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_63653f47-5ff0-4c11-a6a1-79e6b2a45d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#StockBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d5125cfc-f5be-42a5-bcbe-1a91161b813e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d5125cfc-f5be-42a5-bcbe-1a91161b813e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_0825a581-20ea-4996-8b84-2309ac80e988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_us-gaap_PlanNameAxis_0825a581-20ea-4996-8b84-2309ac80e988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fe4fdcbd-92f6-4812-ba3b-941dac8de94c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_0825a581-20ea-4996-8b84-2309ac80e988" xlink:to="loc_us-gaap_PlanNameDomain_fe4fdcbd-92f6-4812-ba3b-941dac8de94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityIncentivePlanTwentyThirteenMember_697d42ae-e442-46ae-b110-18de67f1f754" xlink:href="asth-20231231.xsd#asth_EquityIncentivePlanTwentyThirteenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fe4fdcbd-92f6-4812-ba3b-941dac8de94c" xlink:to="loc_asth_EquityIncentivePlanTwentyThirteenMember_697d42ae-e442-46ae-b110-18de67f1f754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_EquityIncentivePlanTwentyFifteenMember_fabca358-9313-4ebe-9fee-c505f046b348" xlink:href="asth-20231231.xsd#asth_EquityIncentivePlanTwentyFifteenMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fe4fdcbd-92f6-4812-ba3b-941dac8de94c" xlink:to="loc_asth_EquityIncentivePlanTwentyFifteenMember_fabca358-9313-4ebe-9fee-c505f046b348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_04c35536-ae1f-4902-a850-881795e6c697" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_srt_TitleOfIndividualAxis_04c35536-ae1f-4902-a850-881795e6c697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_425d8cc1-9588-4ccb-b662-28d095339eea" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_04c35536-ae1f-4902-a850-881795e6c697" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_425d8cc1-9588-4ccb-b662-28d095339eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcStockOptionMember_a118457c-2377-4706-98cc-ddea95bb32be" xlink:href="asth-20231231.xsd#asth_ApcStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_425d8cc1-9588-4ccb-b662-28d095339eea" xlink:to="loc_asth_ApcStockOptionMember_a118457c-2377-4706-98cc-ddea95bb32be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cacdc7e5-e5c9-4a05-a900-a31f123d02b8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_srt_RangeAxis_cacdc7e5-e5c9-4a05-a900-a31f123d02b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_595be31b-5ad3-4c58-bd73-f28e57704715" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cacdc7e5-e5c9-4a05-a900-a31f123d02b8" xlink:to="loc_srt_RangeMember_595be31b-5ad3-4c58-bd73-f28e57704715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6a78e8bc-f9cd-4e4f-aaa9-4681e5843e3d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_595be31b-5ad3-4c58-bd73-f28e57704715" xlink:to="loc_srt_MinimumMember_6a78e8bc-f9cd-4e4f-aaa9-4681e5843e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c17a5cba-721b-4cd6-b06d-b296be1aa613" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_595be31b-5ad3-4c58-bd73-f28e57704715" xlink:to="loc_srt_MaximumMember_c17a5cba-721b-4cd6-b06d-b296be1aa613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0e21d921-0293-488d-a87b-b9c9551d35f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_us-gaap_AwardTypeAxis_0e21d921-0293-488d-a87b-b9c9551d35f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_367ac941-3b20-490b-bbe5-0778413f506e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0e21d921-0293-488d-a87b-b9c9551d35f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_367ac941-3b20-490b-bbe5-0778413f506e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ac521b82-a48d-4e49-a973-2c5cf5c0a584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_367ac941-3b20-490b-bbe5-0778413f506e" xlink:to="loc_us-gaap_RestrictedStockMember_ac521b82-a48d-4e49-a973-2c5cf5c0a584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockMember_f5761a4a-cdd2-4853-afb9-f02c0e800e26" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_367ac941-3b20-490b-bbe5-0778413f506e" xlink:to="loc_asth_PerformanceBasedRestrictedStockMember_f5761a4a-cdd2-4853-afb9-f02c0e800e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2e37ec75-17f7-4a5b-93e8-af5f570afe2e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_dei_LegalEntityAxis_2e37ec75-17f7-4a5b-93e8-af5f570afe2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_958f7063-01f9-47a5-9ba0-11431971103c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2e37ec75-17f7-4a5b-93e8-af5f570afe2e" xlink:to="loc_dei_EntityDomain_958f7063-01f9-47a5-9ba0-11431971103c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_0b1d3343-903b-49a8-b903-c051802c51d2" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_958f7063-01f9-47a5-9ba0-11431971103c" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_0b1d3343-903b-49a8-b903-c051802c51d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_91dd82b0-4371-4cb4-8115-6cb9b19ce03e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_718fffff-fd61-4b1c-a8bd-855303fa881b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_718fffff-fd61-4b1c-a8bd-855303fa881b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_93d6e36c-b8e8-4dec-80bf-ec1b1be223f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_93d6e36c-b8e8-4dec-80bf-ec1b1be223f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1b7c857a-cc02-482e-8583-345204111119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1b7c857a-cc02-482e-8583-345204111119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5d974e9b-0669-4b2d-ab23-c0a282a8cea0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5d974e9b-0669-4b2d-ab23-c0a282a8cea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_465ff757-0cff-4f82-95ad-d230f19a8477" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_465ff757-0cff-4f82-95ad-d230f19a8477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6aeb7e83-88d6-4088-8dd1-93623450150f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6aeb7e83-88d6-4088-8dd1-93623450150f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f5ae97e4-fe0e-478a-9cc2-ea922f8e3e92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f5ae97e4-fe0e-478a-9cc2-ea922f8e3e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5599f8e9-c3e1-4c26-bbe5-8d366614cdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5599f8e9-c3e1-4c26-bbe5-8d366614cdb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a47b3ec2-591f-4957-bbe4-5ae995d7ca2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a47b3ec2-591f-4957-bbe4-5ae995d7ca2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_05f9f9eb-fac9-4683-8ffa-3b415ae37e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_05f9f9eb-fac9-4683-8ffa-3b415ae37e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8caf9183-e59f-490a-8eb6-4801b192de32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_8caf9183-e59f-490a-8eb6-4801b192de32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26bf3674-e784-432c-a9f4-970927453567" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_26bf3674-e784-432c-a9f4-970927453567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_72915659-4133-4cda-90f6-9f518765ac42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_72915659-4133-4cda-90f6-9f518765ac42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99d10166-eaaf-458a-b1cb-388e1bd76caf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_99d10166-eaaf-458a-b1cb-388e1bd76caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_4c72bc73-5893-48e9-8c88-25dc1db1ef1d" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_4c72bc73-5893-48e9-8c88-25dc1db1ef1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2f1a7887-c6ec-4f14-aa83-d09b46ecad99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2f1a7887-c6ec-4f14-aa83-d09b46ecad99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3a4ba14b-28e9-4ff3-9748-dd8a060a0e24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_3a4ba14b-28e9-4ff3-9748-dd8a060a0e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_914de359-8f5a-4af3-ac1b-55b40488abed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_914de359-8f5a-4af3-ac1b-55b40488abed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_a6de9114-cb4e-4686-b5c1-5dfb608d33ec" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod_a6de9114-cb4e-4686-b5c1-5dfb608d33ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised_d6618f78-2cc2-47b6-b588-6c26fe1c3b55" xlink:href="asth-20231231.xsd#asth_WarrantIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised_d6618f78-2cc2-47b6-b588-6c26fe1c3b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_c53ca202-07e6-4028-9e31-ce13955fcefa" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4103ce62-9789-417d-8541-109652b87bca" xlink:to="loc_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice_c53ca202-07e6-4028-9e31-ce13955fcefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#StockBasedCompensationShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_95547e7c-1fa7-4145-8ce4-2618d58573bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_124c74e2-91dc-422a-8867-45ad907bbecb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_95547e7c-1fa7-4145-8ce4-2618d58573bf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_124c74e2-91dc-422a-8867-45ad907bbecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1496c74f-82e7-4729-9deb-354607ea9261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_124c74e2-91dc-422a-8867-45ad907bbecb" xlink:to="loc_us-gaap_AwardTypeAxis_1496c74f-82e7-4729-9deb-354607ea9261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a75321c-b6fd-4ae3-98f9-f93c8d29cd54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1496c74f-82e7-4729-9deb-354607ea9261" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a75321c-b6fd-4ae3-98f9-f93c8d29cd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9d919de3-4110-4b1d-96a5-250921cbe627" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a75321c-b6fd-4ae3-98f9-f93c8d29cd54" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9d919de3-4110-4b1d-96a5-250921cbe627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockAwardsAndUnitsMember_28f45e87-5aaa-438b-a90d-713e4c1f2eaa" xlink:href="asth-20231231.xsd#asth_StockAwardsAndUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3a75321c-b6fd-4ae3-98f9-f93c8d29cd54" xlink:to="loc_asth_StockAwardsAndUnitsMember_28f45e87-5aaa-438b-a90d-713e4c1f2eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5f768b1-d341-4376-8173-54b609e703c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_124c74e2-91dc-422a-8867-45ad907bbecb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5f768b1-d341-4376-8173-54b609e703c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_97d57d7f-86ff-4d66-bb3b-bb1f18e4287e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5f768b1-d341-4376-8173-54b609e703c5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_97d57d7f-86ff-4d66-bb3b-bb1f18e4287e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#StockBasedCompensationSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9423460b-67b9-4076-80bf-52e376f0bd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_616660db-e8e8-4039-843d-db9d7ae8889b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9423460b-67b9-4076-80bf-52e376f0bd0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_616660db-e8e8-4039-843d-db9d7ae8889b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e7bb1bf1-5925-47e1-bf64-18f436f5824b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_616660db-e8e8-4039-843d-db9d7ae8889b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e7bb1bf1-5925-47e1-bf64-18f436f5824b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ebc58a07-e640-45b0-8ef1-5dee1c4ea7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_616660db-e8e8-4039-843d-db9d7ae8889b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ebc58a07-e640-45b0-8ef1-5dee1c4ea7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_efaf64c0-097b-4a0c-9161-9535e8ef690c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_616660db-e8e8-4039-843d-db9d7ae8889b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_efaf64c0-097b-4a0c-9161-9535e8ef690c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_16ec7b89-3482-4814-be60-458dee74eb1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_616660db-e8e8-4039-843d-db9d7ae8889b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_16ec7b89-3482-4814-be60-458dee74eb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dce4c6ed-874e-4f48-918d-bd71a527d11e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_616660db-e8e8-4039-843d-db9d7ae8889b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dce4c6ed-874e-4f48-918d-bd71a527d11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5f2943e7-844b-4aaa-9029-eec5f5bd8f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9423460b-67b9-4076-80bf-52e376f0bd0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_5f2943e7-844b-4aaa-9029-eec5f5bd8f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_2af31fe9-2526-41fd-b843-ddff0e2bb807" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9423460b-67b9-4076-80bf-52e376f0bd0d" xlink:to="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_2af31fe9-2526-41fd-b843-ddff0e2bb807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5b69acfd-6fc0-447a-b06f-da9301360d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_2af31fe9-2526-41fd-b843-ddff0e2bb807" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5b69acfd-6fc0-447a-b06f-da9301360d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5f918554-2c1d-4bed-9d33-4ab0ca4aabb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_2af31fe9-2526-41fd-b843-ddff0e2bb807" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5f918554-2c1d-4bed-9d33-4ab0ca4aabb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0d84f8d0-2fa8-4970-9530-3dc8e9df8ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_2af31fe9-2526-41fd-b843-ddff0e2bb807" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0d84f8d0-2fa8-4970-9530-3dc8e9df8ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_96bc91a9-8ded-463a-a068-cbbc8e3ec2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_2af31fe9-2526-41fd-b843-ddff0e2bb807" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_96bc91a9-8ded-463a-a068-cbbc8e3ec2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d44c079b-efdc-4db7-b1c9-f121bb3125e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_2af31fe9-2526-41fd-b843-ddff0e2bb807" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d44c079b-efdc-4db7-b1c9-f121bb3125e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_39b8603e-6725-46df-841f-93e01d0b5aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9423460b-67b9-4076-80bf-52e376f0bd0d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_39b8603e-6725-46df-841f-93e01d0b5aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_d794d9c0-1929-41a2-b733-0fb4136629d1" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9423460b-67b9-4076-80bf-52e376f0bd0d" xlink:to="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_d794d9c0-1929-41a2-b733-0fb4136629d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1f1aca11-93ea-4751-be66-aed5c2542025" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_d794d9c0-1929-41a2-b733-0fb4136629d1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_1f1aca11-93ea-4751-be66-aed5c2542025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_8057c69a-6ae7-4e32-b28b-cdba97672819" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_d794d9c0-1929-41a2-b733-0fb4136629d1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_8057c69a-6ae7-4e32-b28b-cdba97672819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_792b073f-a335-4139-acc5-6a9e537ee512" xlink:href="asth-20231231.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9423460b-67b9-4076-80bf-52e376f0bd0d" xlink:to="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_792b073f-a335-4139-acc5-6a9e537ee512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aa9577ca-844d-49eb-a8a6-6710ebee1507" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_792b073f-a335-4139-acc5-6a9e537ee512" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aa9577ca-844d-49eb-a8a6-6710ebee1507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4b5dbbdc-9068-4d63-bf12-6f5a462c5838" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_792b073f-a335-4139-acc5-6a9e537ee512" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4b5dbbdc-9068-4d63-bf12-6f5a462c5838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d39aa6d8-3fb0-44cf-9da4-86b0128f6af5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_792b073f-a335-4139-acc5-6a9e537ee512" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_d39aa6d8-3fb0-44cf-9da4-86b0128f6af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#StockBasedCompensationSummaryofRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3e9d5cbf-b90c-4ceb-904e-163ec5469d56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a11e921d-6e30-4f37-9812-8d439c758a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3e9d5cbf-b90c-4ceb-904e-163ec5469d56" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a11e921d-6e30-4f37-9812-8d439c758a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6c152b9a-e8ee-4375-a63b-6c8faa5695b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a11e921d-6e30-4f37-9812-8d439c758a5e" xlink:to="loc_us-gaap_AwardTypeAxis_6c152b9a-e8ee-4375-a63b-6c8faa5695b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3514996a-d0bc-442a-9f5a-48ce52eff538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6c152b9a-e8ee-4375-a63b-6c8faa5695b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3514996a-d0bc-442a-9f5a-48ce52eff538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_64ff5e08-a521-424f-bc29-446d384d39d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3514996a-d0bc-442a-9f5a-48ce52eff538" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_64ff5e08-a521-424f-bc29-446d384d39d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockUnitsMember_024081fc-b9ea-4bca-85b5-e34ff2b0438d" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3514996a-d0bc-442a-9f5a-48ce52eff538" xlink:to="loc_asth_PerformanceBasedRestrictedStockUnitsMember_024081fc-b9ea-4bca-85b5-e34ff2b0438d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b50dbb02-90b1-45c4-b011-e1256b16bb78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a11e921d-6e30-4f37-9812-8d439c758a5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b50dbb02-90b1-45c4-b011-e1256b16bb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b50dbb02-90b1-45c4-b011-e1256b16bb78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8f4799d-a4dc-489b-ade1-b72500912802" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8f4799d-a4dc-489b-ade1-b72500912802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a395c9e2-b2e0-4d45-830f-955b73ffd115" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a395c9e2-b2e0-4d45-830f-955b73ffd115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ea8ace95-0509-469c-a9b2-ce5295c8c85c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ea8ace95-0509-469c-a9b2-ce5295c8c85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_aae62b5e-dab8-4da2-a3a4-b7d5755a0cff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_aae62b5e-dab8-4da2-a3a4-b7d5755a0cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_88fc3124-9a30-4857-b4b0-10ca58274eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1b8a2407-07d0-40b7-867c-9b957c0c1a0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_88fc3124-9a30-4857-b4b0-10ca58274eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b50dbb02-90b1-45c4-b011-e1256b16bb78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1112d3c2-f215-4255-9bcc-0b59310bc4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1112d3c2-f215-4255-9bcc-0b59310bc4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e5afb38-bc07-4915-9e59-844cd1e8ee1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e5afb38-bc07-4915-9e59-844cd1e8ee1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b4b9f850-ad10-4982-8b51-8bb2d1e887ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b4b9f850-ad10-4982-8b51-8bb2d1e887ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_39ed968b-3a75-455c-87f4-04ce3d22e8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_39ed968b-3a75-455c-87f4-04ce3d22e8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f1738110-1d9f-412d-835d-6c6545bac306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_81a90e36-ea1a-44b7-8b5c-7f009331c91b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f1738110-1d9f-412d-835d-6c6545bac306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1e7ddf1f-969e-489e-ad9d-e5808cc1e68f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:href="asth-20231231.xsd#asth_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1e7ddf1f-969e-489e-ad9d-e5808cc1e68f" xlink:to="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f440453a-9e6d-4eb8-a1f0-a69d6f290a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_us-gaap_CreditFacilityAxis_f440453a-9e6d-4eb8-a1f0-a69d6f290a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_fbc7409e-22ae-415e-9747-8883b67b54a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f440453a-9e6d-4eb8-a1f0-a69d6f290a3a" xlink:to="loc_us-gaap_CreditFacilityDomain_fbc7409e-22ae-415e-9747-8883b67b54a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_8782798e-361e-4be5-974f-b6ec667831f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_fbc7409e-22ae-415e-9747-8883b67b54a2" xlink:to="loc_us-gaap_StandbyLettersOfCreditMember_8782798e-361e-4be5-974f-b6ec667831f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandbyLettersOfCreditMember_3eaeb220-8d98-47b4-8bd1-715b99b42248" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StandbyLettersOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bce4d4b4-f07e-43aa-baae-3d26f0c3961e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_us-gaap_DebtInstrumentAxis_bce4d4b4-f07e-43aa-baae-3d26f0c3961e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_16830f50-a2a6-4168-a4d6-1c40dfbb9dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bce4d4b4-f07e-43aa-baae-3d26f0c3961e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_16830f50-a2a6-4168-a4d6-1c40dfbb9dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcBusinessLoanAgreementMember_b018cf4e-de4c-4876-8155-5d8b5403baf3" xlink:href="asth-20231231.xsd#asth_ApcBusinessLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_16830f50-a2a6-4168-a4d6-1c40dfbb9dcf" xlink:to="loc_asth_ApcBusinessLoanAgreementMember_b018cf4e-de4c-4876-8155-5d8b5403baf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_8f92ee4d-d2be-42d6-9532-76ef4e81473b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_8f92ee4d-d2be-42d6-9532-76ef4e81473b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_1c9adaee-a4b3-4149-a225-2eb2abda26e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_8f92ee4d-d2be-42d6-9532-76ef4e81473b" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_1c9adaee-a4b3-4149-a225-2eb2abda26e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TruistBankMember_6e10221c-6ed7-4f9b-8e4b-f28b191b4cf5" xlink:href="asth-20231231.xsd#asth_TruistBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_1c9adaee-a4b3-4149-a225-2eb2abda26e1" xlink:to="loc_asth_TruistBankMember_6e10221c-6ed7-4f9b-8e4b-f28b191b4cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PreferredBankMember_ed178ceb-0e92-4d02-b7c5-a2e1d41fc24c" xlink:href="asth-20231231.xsd#asth_PreferredBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_1c9adaee-a4b3-4149-a225-2eb2abda26e1" xlink:to="loc_asth_PreferredBankMember_ed178ceb-0e92-4d02-b7c5-a2e1d41fc24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2e406b87-8a83-4f73-840a-641779c87180" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_dei_LegalEntityAxis_2e406b87-8a83-4f73-840a-641779c87180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bdf74660-c3bd-4bb4-9116-22ead633b620" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2e406b87-8a83-4f73-840a-641779c87180" xlink:to="loc_dei_EntityDomain_bdf74660-c3bd-4bb4-9116-22ead633b620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_4a4e9c0f-03ba-45e5-bfb3-8fe572437727" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bdf74660-c3bd-4bb4-9116-22ead633b620" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_4a4e9c0f-03ba-45e5-bfb3-8fe572437727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_01157254-1247-431f-823c-2dc9b5cde325" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_srt_RangeAxis_01157254-1247-431f-823c-2dc9b5cde325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8adfdca7-9cc1-469e-a48a-c48460dd68b3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_01157254-1247-431f-823c-2dc9b5cde325" xlink:to="loc_srt_RangeMember_8adfdca7-9cc1-469e-a48a-c48460dd68b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_68127f54-f467-49f2-96ca-37496ceac183" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8adfdca7-9cc1-469e-a48a-c48460dd68b3" xlink:to="loc_srt_MaximumMember_68127f54-f467-49f2-96ca-37496ceac183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e21735b1-3515-4f52-9615-8df1b479be62" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8adfdca7-9cc1-469e-a48a-c48460dd68b3" xlink:to="loc_srt_MinimumMember_e21735b1-3515-4f52-9615-8df1b479be62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:href="asth-20231231.xsd#asth_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesTable_06138649-9069-4b0c-9a7e-31a17063f371" xlink:to="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8adb0a13-858c-4ec4-9ace-d04df31f0584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8adb0a13-858c-4ec4-9ace-d04df31f0584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_f490f0bc-1ecc-4957-a553-b42fbe523202" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_f490f0bc-1ecc-4957-a553-b42fbe523202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ClaimsBasedOnOccurrenceAnAggregateAmount_6f3cd935-57cf-4d7b-9e0c-e72c3dd3bcf4" xlink:href="asth-20231231.xsd#asth_ClaimsBasedOnOccurrenceAnAggregateAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:to="loc_asth_ClaimsBasedOnOccurrenceAnAggregateAmount_6f3cd935-57cf-4d7b-9e0c-e72c3dd3bcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_e785d7b9-1f3e-4c1c-8f84-68a469d30089" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CommitmentsAndContingenciesLineItems_3a8b1bb0-475e-4ae9-86cf-4d9a665bcdad" xlink:to="loc_us-gaap_ProfessionalFees_e785d7b9-1f3e-4c1c-8f84-68a469d30089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#RelatedPartyTransactionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_e19698e5-aa28-4dfa-b0e1-89fa5d149831" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_e19698e5-aa28-4dfa-b0e1-89fa5d149831" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a12a46a0-9372-43d9-8e6f-83a061e4a2c6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_srt_CounterpartyNameAxis_a12a46a0-9372-43d9-8e6f-83a061e4a2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a12a46a0-9372-43d9-8e6f-83a061e4a2c6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LmaMember_0f8c04d7-a4ca-454b-b313-fd726b998700" xlink:href="asth-20231231.xsd#asth_LmaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_LmaMember_0f8c04d7-a4ca-454b-b313-fd726b998700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PmiocMember_1977be9b-2310-45b0-a6e5-04a9d08bff0e" xlink:href="asth-20231231.xsd#asth_PmiocMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_PmiocMember_1977be9b-2310-45b0-a6e5-04a9d08bff0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SongPCMember_7c196dae-4224-4e64-8a43-a06e4b9645a2" xlink:href="asth-20231231.xsd#asth_SongPCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_SongPCMember_7c196dae-4224-4e64-8a43-a06e4b9645a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ArroyoVistaMember_1235d3bb-0509-41b4-aac5-e202144bbbaa" xlink:href="asth-20231231.xsd#asth_ArroyoVistaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_ArroyoVistaMember_1235d3bb-0509-41b4-aac5-e202144bbbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AdvanceDiagnosticSurgeryCenterMember_73e1a7e1-d815-4e8a-a285-0ed3257c1145" xlink:href="asth-20231231.xsd#asth_AdvanceDiagnosticSurgeryCenterMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_AdvanceDiagnosticSurgeryCenterMember_73e1a7e1-d815-4e8a-a285-0ed3257c1145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FulgentGeneticsIncMember_0dd7108a-422c-4bf4-a888-f963a1c13a32" xlink:href="asth-20231231.xsd#asth_FulgentGeneticsIncMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_FulgentGeneticsIncMember_0dd7108a-422c-4bf4-a888-f963a1c13a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SunnyVillageCareCenterMember_e4866f97-8a9e-4db8-b835-bb20c89cd952" xlink:href="asth-20231231.xsd#asth_SunnyVillageCareCenterMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_SunnyVillageCareCenterMember_e4866f97-8a9e-4db8-b835-bb20c89cd952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FirstCommonwealthPropertyLLCMember_2e9c885e-f997-4c28-a42c-2aed6e4ee9b4" xlink:href="asth-20231231.xsd#asth_FirstCommonwealthPropertyLLCMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef3011bc-908e-4f35-b74c-6aa6deb40366" xlink:to="loc_asth_FirstCommonwealthPropertyLLCMember_2e9c885e-f997-4c28-a42c-2aed6e4ee9b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4d1a9574-dbd7-4780-aa66-faba1029e4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4d1a9574-dbd7-4780-aa66-faba1029e4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4d1a9574-dbd7-4780-aa66-faba1029e4ef" xlink:to="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_f348cbab-d7de-4449-8cce-bfd47a41190b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:to="loc_us-gaap_RelatedPartyMember_f348cbab-d7de-4449-8cce-bfd47a41190b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloMedOfficerMember_e30c8518-3683-43f5-a732-35483d61b844" xlink:href="asth-20231231.xsd#asth_ApolloMedOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:to="loc_asth_ApolloMedOfficerMember_e30c8518-3683-43f5-a732-35483d61b844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AHMCMember_cc0c410a-23b9-4f06-b3c2-57d333989f04" xlink:href="asth-20231231.xsd#asth_AHMCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:to="loc_asth_AHMCMember_cc0c410a-23b9-4f06-b3c2-57d333989f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApcShareholdersMember_c6a17abf-ea5f-4c1d-8e12-af36cd639f20" xlink:href="asth-20231231.xsd#asth_ApcShareholdersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_fe3ec65c-6cc6-4ace-a03d-90e29cad7a55" xlink:to="loc_asth_ApcShareholdersMember_c6a17abf-ea5f-4c1d-8e12-af36cd639f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_398201f2-28ad-4a47-8c7b-e814bdb2f6f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_dei_LegalEntityAxis_398201f2-28ad-4a47-8c7b-e814bdb2f6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_398201f2-28ad-4a47-8c7b-e814bdb2f6f4" xlink:to="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AHMCMember_4bb9df81-9c0c-437b-9e17-54675677fa87" xlink:href="asth-20231231.xsd#asth_AHMCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_AHMCMember_4bb9df81-9c0c-437b-9e17-54675677fa87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_88fffd4d-a916-49da-a206-bf7d813ace3b" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_88fffd4d-a916-49da-a206-bf7d813ace3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_MedicalPropertyPartnersLLCMember_ae5f75fb-fd26-45cc-a851-84b18b449aa4" xlink:href="asth-20231231.xsd#asth_MedicalPropertyPartnersLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_MedicalPropertyPartnersLLCMember_ae5f75fb-fd26-45cc-a851-84b18b449aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag6MedicalInvestmentGroupLLCMember_25209f7f-7e22-4031-9fe4-f072fa309f5a" xlink:href="asth-20231231.xsd#asth_Tag6MedicalInvestmentGroupLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_Tag6MedicalInvestmentGroupLLCMember_25209f7f-7e22-4031-9fe4-f072fa309f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ProfessionalMedicalCorporationMember_0f5906a4-7c57-4bff-b9ca-8608ccdf3d1e" xlink:href="asth-20231231.xsd#asth_ProfessionalMedicalCorporationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_ProfessionalMedicalCorporationMember_0f5906a4-7c57-4bff-b9ca-8608ccdf3d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NetworkMedicalManagementMember_beff6663-abe5-49d1-997a-3fec234d1f16" xlink:href="asth-20231231.xsd#asth_NetworkMedicalManagementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_NetworkMedicalManagementMember_beff6663-abe5-49d1-997a-3fec234d1f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AstranaMember_7848c7e6-1e28-481c-b204-ea26335e3932" xlink:href="asth-20231231.xsd#asth_AstranaMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8922f2a8-0231-4d1f-81c2-b5e1950ce336" xlink:to="loc_asth_AstranaMember_7848c7e6-1e28-481c-b204-ea26335e3932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a71ac12f-8e04-4903-a5f8-69e9d58fb0ce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a71ac12f-8e04-4903-a5f8-69e9d58fb0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a71ac12f-8e04-4903-a5f8-69e9d58fb0ce" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LasalleMedicalAssociatesIpaMember_6de57649-d79d-47d2-bd90-fb153b2ea969" xlink:href="asth-20231231.xsd#asth_LasalleMedicalAssociatesIpaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:to="loc_asth_LasalleMedicalAssociatesIpaMember_6de57649-d79d-47d2-bd90-fb153b2ea969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PmiocMember_fbfe3980-e667-44b8-8e89-93f4097790fa" xlink:href="asth-20231231.xsd#asth_PmiocMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:to="loc_asth_PmiocMember_fbfe3980-e667-44b8-8e89-93f4097790fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SongPCMember_060287f0-e7af-4ef0-a49a-aece49038acc" xlink:href="asth-20231231.xsd#asth_SongPCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_12811620-3e12-4ca4-a8db-c51f482b8bdc" xlink:to="loc_asth_SongPCMember_060287f0-e7af-4ef0-a49a-aece49038acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_1e1c88a3-cd91-4334-bdae-658efc0e03f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_1e1c88a3-cd91-4334-bdae-658efc0e03f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_1e1c88a3-cd91-4334-bdae-658efc0e03f2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ProviderServicesMember_fbd57452-2c04-4aec-a899-2a2348ac96cc" xlink:href="asth-20231231.xsd#asth_ProviderServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_ProviderServicesMember_fbd57452-2c04-4aec-a899-2a2348ac96cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RentPaymentMember_89da39df-1cf3-4087-9830-f7adb6700d7b" xlink:href="asth-20231231.xsd#asth_RentPaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_RentPaymentMember_89da39df-1cf3-4087-9830-f7adb6700d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OfficeLeaseMember_ef33f0ba-4192-4eff-a3e4-8fdddeac0437" xlink:href="asth-20231231.xsd#asth_OfficeLeaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_OfficeLeaseMember_ef33f0ba-4192-4eff-a3e4-8fdddeac0437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ConsultingServicesMember_fef005bb-49c8-4640-abe5-7882f9853e64" xlink:href="asth-20231231.xsd#asth_ConsultingServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_ConsultingServicesMember_fef005bb-49c8-4640-abe5-7882f9853e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_SpinOffTransactionMember_0107f1ad-ab84-4765-acbd-f3fb204a456c" xlink:href="asth-20231231.xsd#asth_SpinOffTransactionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_SpinOffTransactionMember_0107f1ad-ab84-4765-acbd-f3fb204a456c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CallCenterServicesMember_8f26d68b-d22d-4f92-80ec-2e3be49669fc" xlink:href="asth-20231231.xsd#asth_CallCenterServicesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_d68b56af-a32e-41b2-ad28-fb04716c4c41" xlink:to="loc_asth_CallCenterServicesMember_8f26d68b-d22d-4f92-80ec-2e3be49669fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a6bcb89d-a128-496d-9d53-286c2e1ebf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_a6bcb89d-a128-496d-9d53-286c2e1ebf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d0ac82fa-6fa2-4bcc-be82-5aca83116197" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a6bcb89d-a128-496d-9d53-286c2e1ebf6d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d0ac82fa-6fa2-4bcc-be82-5aca83116197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_Tag2PromissoryNoteMember_b27956f1-0d0c-4858-b54f-c80dd5142ef4" xlink:href="asth-20231231.xsd#asth_Tag2PromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d0ac82fa-6fa2-4bcc-be82-5aca83116197" xlink:to="loc_asth_Tag2PromissoryNoteMember_b27956f1-0d0c-4858-b54f-c80dd5142ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9432f7ed-98cc-410e-8842-36933fa21603" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9432f7ed-98cc-410e-8842-36933fa21603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_082504d1-8a9e-4b98-9ecd-6e52eb84aa19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9432f7ed-98cc-410e-8842-36933fa21603" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_082504d1-8a9e-4b98-9ecd-6e52eb84aa19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_3d1d73e6-ba7c-4034-ace2-98515185e2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_082504d1-8a9e-4b98-9ecd-6e52eb84aa19" xlink:to="loc_us-gaap_NotesReceivableMember_3d1d73e6-ba7c-4034-ace2-98515185e2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_59847302-dbd2-4fc3-9320-cf9815052495" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_srt_TitleOfIndividualAxis_59847302-dbd2-4fc3-9320-cf9815052495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_59847302-dbd2-4fc3-9320-cf9815052495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_8c4d037d-ac09-4e3d-9e6d-3cf0818d29d2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:to="loc_srt_DirectorMember_8c4d037d-ac09-4e3d-9e6d-3cf0818d29d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_81dfe270-d91a-4676-a6d5-5ced573e87a1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:to="loc_srt_OfficerMember_81dfe270-d91a-4676-a6d5-5ced573e87a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_a9bebebc-ea6c-4584-a863-cc0b95d65568" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_da2f1ef0-7257-4a30-84ed-145f34f042df" xlink:to="loc_srt_ChiefExecutiveOfficerMember_a9bebebc-ea6c-4584-a863-cc0b95d65568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_b7838578-a395-48f6-b2d3-d07efd39e8b0" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_681308e3-0900-4f41-9537-97e9fcacb167" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_681308e3-0900-4f41-9537-97e9fcacb167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d46d639-6a62-4846-b45d-5eb1487929f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0d46d639-6a62-4846-b45d-5eb1487929f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_2a11699e-4f7d-4543-8ed2-eb9445d732b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_2a11699e-4f7d-4543-8ed2-eb9445d732b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7a8466df-9ef9-4e28-9ba5-23700e8c71b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7a8466df-9ef9-4e28-9ba5-23700e8c71b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_44385da3-c400-4070-8605-96bf48f01581" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_OperatingLeaseLiability_44385da3-c400-4070-8605-96bf48f01581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_5f7c0631-b742-4dd1-8de8-da4125fed9ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_5f7c0631-b742-4dd1-8de8-da4125fed9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PaymentMadeToRelatedParty_9cdfe0b8-f097-4935-9312-e1ba7ed19fb2" xlink:href="asth-20231231.xsd#asth_PaymentMadeToRelatedParty"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_asth_PaymentMadeToRelatedParty_9cdfe0b8-f097-4935-9312-e1ba7ed19fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceServicesRevenue_1e700d41-0926-41d2-bc60-1351df4ab00e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceServicesRevenue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_InsuranceServicesRevenue_1e700d41-0926-41d2-bc60-1351df4ab00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCreditsAndOtherLiabilities_ce163d78-22c3-41d7-b18a-f2a8b76c554d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCreditsAndOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_DeferredCreditsAndOtherLiabilities_ce163d78-22c3-41d7-b18a-f2a8b76c554d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_8749e2af-206d-4819-9585-9d0b0824c0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_DebtInstrumentTerm_8749e2af-206d-4819-9585-9d0b0824c0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2b78ceaa-bd8e-43ee-955f-55654c6a8e58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2b78ceaa-bd8e-43ee-955f-55654c6a8e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_41da7d13-4116-48cb-acb0-600f33def4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_e015a2d7-d931-4947-8a10-d63c9b306af2" xlink:to="loc_us-gaap_TreasuryStockCommonShares_41da7d13-4116-48cb-acb0-600f33def4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_a9afcd4f-d86c-48e6-9c55-0104cac2ffe7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7bb74992-5ad9-4e9e-86d3-950ce4a9546f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_a9afcd4f-d86c-48e6-9c55-0104cac2ffe7" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7bb74992-5ad9-4e9e-86d3-950ce4a9546f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_cd92dd19-20ed-4a39-ad67-08d1fa60919a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7bb74992-5ad9-4e9e-86d3-950ce4a9546f" xlink:to="loc_srt_CounterpartyNameAxis_cd92dd19-20ed-4a39-ad67-08d1fa60919a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_cd92dd19-20ed-4a39-ad67-08d1fa60919a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AHMCMember_abce3662-d4f7-46e6-95af-a5bbe9a44659" xlink:href="asth-20231231.xsd#asth_AHMCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:to="loc_asth_AHMCMember_abce3662-d4f7-46e6-95af-a5bbe9a44659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_HSMSOMember_c0067350-78ba-4928-bac3-1574d65ecac6" xlink:href="asth-20231231.xsd#asth_HSMSOMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:to="loc_asth_HSMSOMember_c0067350-78ba-4928-bac3-1574d65ecac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AurionMember_d13068e4-18a3-4933-b639-ad301fe36196" xlink:href="asth-20231231.xsd#asth_AurionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_27b102d4-f7d1-4949-b155-be11d2bbb27e" xlink:to="loc_asth_AurionMember_d13068e4-18a3-4933-b639-ad301fe36196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_d79b1ded-3d21-4fb9-88a1-a7c64217f9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7bb74992-5ad9-4e9e-86d3-950ce4a9546f" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_d79b1ded-3d21-4fb9-88a1-a7c64217f9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_d79b1ded-3d21-4fb9-88a1-a7c64217f9a4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RelatedPartyTransactionRevenueRecognizedMember_1363dc66-fa92-4127-831d-6e3ed82d36f2" xlink:href="asth-20231231.xsd#asth_RelatedPartyTransactionRevenueRecognizedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:to="loc_asth_RelatedPartyTransactionRevenueRecognizedMember_1363dc66-fa92-4127-831d-6e3ed82d36f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RelatedPartyTransactionExpensesIncurredMember_f42eaca5-d4ce-411d-a481-7b9292212ce6" xlink:href="asth-20231231.xsd#asth_RelatedPartyTransactionExpensesIncurredMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:to="loc_asth_RelatedPartyTransactionExpensesIncurredMember_f42eaca5-d4ce-411d-a481-7b9292212ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RelatedPartyTransactionRevenueExpenseNetMember_622ea6f8-92ff-4d64-b468-446c438f1b67" xlink:href="asth-20231231.xsd#asth_RelatedPartyTransactionRevenueExpenseNetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_18fd80ec-db48-4f4e-a083-a6ce9b183593" xlink:to="loc_asth_RelatedPartyTransactionRevenueExpenseNetMember_622ea6f8-92ff-4d64-b468-446c438f1b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_4be3f355-4426-4cde-b6a9-a4e1c87166f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_7bb74992-5ad9-4e9e-86d3-950ce4a9546f" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_4be3f355-4426-4cde-b6a9-a4e1c87166f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e60e61cd-fb89-420a-bc05-b7533b254acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_4be3f355-4426-4cde-b6a9-a4e1c87166f9" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_e60e61cd-fb89-420a-bc05-b7533b254acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EmployeeBenefitPlanAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#EmployeeBenefitPlanAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EmployeeBenefitPlanAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1643f918-8b8e-4ab3-800e-58dc7cf1bd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DefinedContributionPlanServicePeriod_611846de-aa51-434d-bcb9-909075f1b2cf" xlink:href="asth-20231231.xsd#asth_DefinedContributionPlanServicePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1643f918-8b8e-4ab3-800e-58dc7cf1bd5f" xlink:to="loc_asth_DefinedContributionPlanServicePeriod_611846de-aa51-434d-bcb9-909075f1b2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DefinedContributionPlanVestingPeriod_9ebc9c0e-a11e-424a-95ce-8cf563bc8e98" xlink:href="asth-20231231.xsd#asth_DefinedContributionPlanVestingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1643f918-8b8e-4ab3-800e-58dc7cf1bd5f" xlink:to="loc_asth_DefinedContributionPlanVestingPeriod_9ebc9c0e-a11e-424a-95ce-8cf563bc8e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_b08a4aae-b07d-44ab-9049-42dbbee1db5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1643f918-8b8e-4ab3-800e-58dc7cf1bd5f" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_b08a4aae-b07d-44ab-9049-42dbbee1db5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#EarningsPerShareAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f4ec38d9-f4fe-451e-b068-4616644af088" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_64419d91-5ae7-4e7b-8c45-90ab67db10f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f4ec38d9-f4fe-451e-b068-4616644af088" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_64419d91-5ae7-4e7b-8c45-90ab67db10f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a7087abf-ff7f-4d8f-9e96-731c19ccdd45" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_64419d91-5ae7-4e7b-8c45-90ab67db10f2" xlink:to="loc_dei_LegalEntityAxis_a7087abf-ff7f-4d8f-9e96-731c19ccdd45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c48299b6-8082-4610-be81-91d9bb1cbc04" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a7087abf-ff7f-4d8f-9e96-731c19ccdd45" xlink:to="loc_dei_EntityDomain_c48299b6-8082-4610-be81-91d9bb1cbc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AlliedPacificOfCaliforniaIPAMember_52271195-1673-4315-9d30-503f86c263f5" xlink:href="asth-20231231.xsd#asth_AlliedPacificOfCaliforniaIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c48299b6-8082-4610-be81-91d9bb1cbc04" xlink:to="loc_asth_AlliedPacificOfCaliforniaIPAMember_52271195-1673-4315-9d30-503f86c263f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b4c0763-c4b4-42bf-8232-398132007de8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_64419d91-5ae7-4e7b-8c45-90ab67db10f2" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b4c0763-c4b4-42bf-8232-398132007de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a9901f5c-3da2-4471-9511-a734284d5b36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b4c0763-c4b4-42bf-8232-398132007de8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a9901f5c-3da2-4471-9511-a734284d5b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_f4ea0ff0-a73a-469f-8051-6ef6a2ac020f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a9901f5c-3da2-4471-9511-a734284d5b36" xlink:to="loc_us-gaap_RestrictedStockMember_f4ea0ff0-a73a-469f-8051-6ef6a2ac020f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_82cc19d4-b4c1-475e-94d1-ca515dac633b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a9901f5c-3da2-4471-9511-a734284d5b36" xlink:to="loc_us-gaap_PerformanceSharesMember_82cc19d4-b4c1-475e-94d1-ca515dac633b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_9eba5ff6-2540-4687-999e-c1bebfb289de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_64419d91-5ae7-4e7b-8c45-90ab67db10f2" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_9eba5ff6-2540-4687-999e-c1bebfb289de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_170b1b70-97d1-4ace-94e7-d4b347a30470" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_9eba5ff6-2540-4687-999e-c1bebfb289de" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_170b1b70-97d1-4ace-94e7-d4b347a30470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0c711606-4830-480b-a421-c70e57f71361" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_33a05096-824e-4f09-b2de-d4186531a98e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c711606-4830-480b-a421-c70e57f71361" xlink:to="loc_us-gaap_EarningsPerShareBasic_33a05096-824e-4f09-b2de-d4186531a98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4d74ff2f-cb57-4d3b-a0b7-bd081a93b980" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c711606-4830-480b-a421-c70e57f71361" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4d74ff2f-cb57-4d3b-a0b7-bd081a93b980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dbd49d05-6290-457f-88be-1f49cdbfb378" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c711606-4830-480b-a421-c70e57f71361" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dbd49d05-6290-457f-88be-1f49cdbfb378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d1153b5c-94b7-434d-ab09-dc9a2675f801" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c711606-4830-480b-a421-c70e57f71361" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d1153b5c-94b7-434d-ab09-dc9a2675f801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0e68529e-7b80-4cbd-b6d8-2f60d98307c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_39258353-67d5-4eea-b5b9-57a0e0c58bda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0e68529e-7b80-4cbd-b6d8-2f60d98307c7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_39258353-67d5-4eea-b5b9-57a0e0c58bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a4ec77ad-88c6-4c89-b9af-6a03d59fa6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_39258353-67d5-4eea-b5b9-57a0e0c58bda" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a4ec77ad-88c6-4c89-b9af-6a03d59fa6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cfd7f85f-6b5f-4fd4-afa8-e837db23df2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a4ec77ad-88c6-4c89-b9af-6a03d59fa6b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cfd7f85f-6b5f-4fd4-afa8-e837db23df2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e9acb43e-23db-4e24-b84a-b598a0acb42d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cfd7f85f-6b5f-4fd4-afa8-e837db23df2b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e9acb43e-23db-4e24-b84a-b598a0acb42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_785e28f8-3c19-42b3-b86e-35e21f850147" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cfd7f85f-6b5f-4fd4-afa8-e837db23df2b" xlink:to="loc_us-gaap_RestrictedStockMember_785e28f8-3c19-42b3-b86e-35e21f850147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_667adabf-ec4a-4061-bca7-1f27ebf8f191" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_39258353-67d5-4eea-b5b9-57a0e0c58bda" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_667adabf-ec4a-4061-bca7-1f27ebf8f191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_290154e5-3ced-4847-b875-ceed99570915" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_667adabf-ec4a-4061-bca7-1f27ebf8f191" xlink:to="loc_us-gaap_EquityComponentDomain_290154e5-3ced-4847-b875-ceed99570915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_34d68422-4681-42b2-b27e-6531b860f8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_290154e5-3ced-4847-b875-ceed99570915" xlink:to="loc_us-gaap_WarrantMember_34d68422-4681-42b2-b27e-6531b860f8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_39258353-67d5-4eea-b5b9-57a0e0c58bda" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02442e73-80d0-41e9-9156-2ffb58aa5576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_02442e73-80d0-41e9-9156-2ffb58aa5576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a29ea61d-8e2f-4e45-ba3d-29a6d457d41d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_a29ea61d-8e2f-4e45-ba3d-29a6d457d41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_8692c1d1-23df-42f0-a992-1c946a90d7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_8692c1d1-23df-42f0-a992-1c946a90d7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7ac63b3d-7096-411d-b1bb-3303094b5299" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_fe0a043c-4051-4ee7-8bf8-81742f54c038" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7ac63b3d-7096-411d-b1bb-3303094b5299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cea7e87e-19cc-4743-be8f-68f7882676a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_5a9a0bba-5b47-4b97-a1cb-adf94a55aded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cea7e87e-19cc-4743-be8f-68f7882676a4" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_5a9a0bba-5b47-4b97-a1cb-adf94a55aded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_275906cc-2967-424a-8685-767542881fce" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_5a9a0bba-5b47-4b97-a1cb-adf94a55aded" xlink:to="loc_srt_ConsolidatedEntitiesAxis_275906cc-2967-424a-8685-767542881fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_ced2592c-c213-4854-9a43-d9789d08dc64" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_275906cc-2967-424a-8685-767542881fce" xlink:to="loc_srt_ConsolidatedEntitiesDomain_ced2592c-c213-4854-9a43-d9789d08dc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d4104fd4-0e86-4799-b7dc-8db80f633ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ced2592c-c213-4854-9a43-d9789d08dc64" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_d4104fd4-0e86-4799-b7dc-8db80f633ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_8ddfbd61-c345-473b-bb52-a6b253dcdca2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_ced2592c-c213-4854-9a43-d9789d08dc64" xlink:to="loc_srt_AffiliatedEntityMember_8ddfbd61-c345-473b-bb52-a6b253dcdca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba804a7d-3ce2-4a86-98cb-d3d842e669c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_5a9a0bba-5b47-4b97-a1cb-adf94a55aded" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba804a7d-3ce2-4a86-98cb-d3d842e669c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_17c83c1e-8c37-449b-971d-14b0fc5d86fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ba804a7d-3ce2-4a86-98cb-d3d842e669c7" xlink:to="loc_us-gaap_RelatedPartyDomain_17c83c1e-8c37-449b-971d-14b0fc5d86fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrelatedPartyMember_39ce299a-3b72-4ab1-8470-5b77eec971fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonrelatedPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_17c83c1e-8c37-449b-971d-14b0fc5d86fb" xlink:to="loc_us-gaap_NonrelatedPartyMember_39ce299a-3b72-4ab1-8470-5b77eec971fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyMember_48c3bb48-b1cf-4605-9757-8b453666ca79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_17c83c1e-8c37-449b-971d-14b0fc5d86fb" xlink:to="loc_us-gaap_RelatedPartyMember_48c3bb48-b1cf-4605-9757-8b453666ca79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_5a9a0bba-5b47-4b97-a1cb-adf94a55aded" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:to="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b03ed1ae-6c9b-4c56-a7a8-64b82687981d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b03ed1ae-6c9b-4c56-a7a8-64b82687981d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_a6782461-a35f-4fd2-b380-cb5000724c27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_a6782461-a35f-4fd2-b380-cb5000724c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7007f95c-4b3a-44f0-882d-78890984170c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7007f95c-4b3a-44f0-882d-78890984170c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_f4cd9f55-f8bb-44bd-b051-58c4d474eb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_IncomeTaxesReceivable_f4cd9f55-f8bb-44bd-b051-58c4d474eb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_bc12cd8b-04f4-406a-a484-733c00e6955e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_bc12cd8b-04f4-406a-a484-733c00e6955e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0ef7c3ee-cb33-4eef-a9ec-d5b17b02281c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0ef7c3ee-cb33-4eef-a9ec-d5b17b02281c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_f00061e5-3421-4372-8752-807d0fbbf584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_f00061e5-3421-4372-8752-807d0fbbf584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6ca2264b-3519-4b6b-9b9a-9c1826607361" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_OtherAssetsCurrent_6ca2264b-3519-4b6b-9b9a-9c1826607361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d0432e61-e9de-47e2-8cd1-5e3bf0a7844a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aafde65f-5ee1-4bce-937e-f893be0167b1" xlink:to="loc_us-gaap_AssetsCurrent_d0432e61-e9de-47e2-8cd1-5e3bf0a7844a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3889e366-91d8-45db-ad0c-ceb665a19958" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3889e366-91d8-45db-ad0c-ceb665a19958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1fcffb1b-f09d-4e94-a5ed-446cd7872a42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1fcffb1b-f09d-4e94-a5ed-446cd7872a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_070df296-4706-4a00-910d-39ed264283b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_Goodwill_070df296-4706-4a00-910d-39ed264283b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivableNoncurrent_666133f6-ca65-42d4-a649-8427ab85546c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesReceivableNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_IncomeTaxesReceivableNoncurrent_666133f6-ca65-42d4-a649-8427ab85546c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ee22fe7b-9c1c-4a0b-922c-aeb7a9a65463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_EquityMethodInvestments_ee22fe7b-9c1c-4a0b-922c-aeb7a9a65463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_c073c358-70ce-435f-a5bf-1f6126ab6f63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_c073c358-70ce-435f-a5bf-1f6126ab6f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_8891fa31-8b7a-45cc-ad9f-73e7525f6897" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_OtherLongTermInvestments_8891fa31-8b7a-45cc-ad9f-73e7525f6897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_99394361-ed09-4c77-bedc-16fc64bef8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_RestrictedCash_99394361-ed09-4c77-bedc-16fc64bef8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a9e47572-5147-45fc-ba77-be026542e3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a9e47572-5147-45fc-ba77-be026542e3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_86deeedc-afd9-42ed-a17f-3c167132c846" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_86deeedc-afd9-42ed-a17f-3c167132c846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_3d774e78-75de-4aff-a79a-477529c96e34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_eb8b6df7-5bf7-4dcb-94b6-f671d46fb252" xlink:to="loc_us-gaap_AssetsNoncurrent_3d774e78-75de-4aff-a79a-477529c96e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b7782c98-f67f-4571-b5fa-dcaf7320292b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6c07b016-d302-4497-93fd-542ce9e62def" xlink:to="loc_us-gaap_Assets_b7782c98-f67f-4571-b5fa-dcaf7320292b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1faa3b98-2753-47d6-a4a8-700778af7710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1faa3b98-2753-47d6-a4a8-700778af7710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FiduciaryAccountsPayableCurrent_b2ba4f2d-c2f4-4230-b20d-4372918c9b62" xlink:href="asth-20231231.xsd#asth_FiduciaryAccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_asth_FiduciaryAccountsPayableCurrent_b2ba4f2d-c2f4-4230-b20d-4372918c9b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_39431c22-0797-47e8-b0c6-e60c22a70e63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_39431c22-0797-47e8-b0c6-e60c22a70e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_45f6e8dc-213c-4fb6-a4db-132246cd66eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_DividendsPayableCurrent_45f6e8dc-213c-4fb6-a4db-132246cd66eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_efa2d452-c585-412a-99cc-8b60c21c4e01" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_efa2d452-c585-412a-99cc-8b60c21c4e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_290bc88a-f8cb-4c30-a358-7c996fd34917" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_290bc88a-f8cb-4c30-a358-7c996fd34917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ccca4376-0119-4cb8-8815-243fcd599988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_LongTermDebtCurrent_ccca4376-0119-4cb8-8815-243fcd599988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_2a65998c-9e8c-4e86-90d4-fd25421a3b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_OtherLiabilities_2a65998c-9e8c-4e86-90d4-fd25421a3b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9ea17b5b-911b-48cb-a2ed-073540505130" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6b4aa8cf-cec3-4e10-8c5e-e71010244493" xlink:to="loc_us-gaap_LiabilitiesCurrent_9ea17b5b-911b-48cb-a2ed-073540505130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4124e523-248a-45cd-a29f-21dc7733d398" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4124e523-248a-45cd-a29f-21dc7733d398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_1608e608-6647-47af-8eaf-ed8a3772b6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_1608e608-6647-47af-8eaf-ed8a3772b6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f04274c-8169-4e28-8c76-59036a18cdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f04274c-8169-4e28-8c76-59036a18cdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9ddc42be-411e-4fbc-b2ca-2b3d0989084e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9ddc42be-411e-4fbc-b2ca-2b3d0989084e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_9788f3bf-4263-4486-bcc0-349abd6aac60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_9788f3bf-4263-4486-bcc0-349abd6aac60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_f9f14d84-b632-4792-8a10-1494a9eb52cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_09d443c6-34bd-49bc-99a6-4b7153181eed" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_f9f14d84-b632-4792-8a10-1494a9eb52cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_90ba6365-7612-42a7-b431-0a93dec22b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_Liabilities_90ba6365-7612-42a7-b431-0a93dec22b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_b021be55-8ac5-4c2f-bd88-cf230e338e38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_b021be55-8ac5-4c2f-bd88-cf230e338e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_VariableInterestEntityNumberOfPhysicians_2dbd8e5d-04bc-4268-9cb2-debeec987304" xlink:href="asth-20231231.xsd#asth_VariableInterestEntityNumberOfPhysicians"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2bb2d43a-0a2f-4dc2-8c73-f633c82edebf" xlink:to="loc_asth_VariableInterestEntityNumberOfPhysicians_2dbd8e5d-04bc-4268-9cb2-debeec987304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesAdditionalinformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3510b983-c9d3-4147-a31d-f3200c12b91f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ee2d609c-2999-44a8-bb77-83c39133afd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3510b983-c9d3-4147-a31d-f3200c12b91f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ee2d609c-2999-44a8-bb77-83c39133afd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_042faf08-1810-4624-a7ab-8bbfa64b8f96" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ee2d609c-2999-44a8-bb77-83c39133afd7" xlink:to="loc_srt_RangeAxis_042faf08-1810-4624-a7ab-8bbfa64b8f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c4e03b4c-2cd0-41ab-ba15-ede5127008d5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_042faf08-1810-4624-a7ab-8bbfa64b8f96" xlink:to="loc_srt_RangeMember_c4e03b4c-2cd0-41ab-ba15-ede5127008d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_334555b1-81f6-4c49-8dd1-eeef70295bdc" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c4e03b4c-2cd0-41ab-ba15-ede5127008d5" xlink:to="loc_srt_MinimumMember_334555b1-81f6-4c49-8dd1-eeef70295bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d4cca733-537d-4489-9288-99a85e39e3a0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c4e03b4c-2cd0-41ab-ba15-ede5127008d5" xlink:to="loc_srt_MaximumMember_d4cca733-537d-4489-9288-99a85e39e3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ee2d609c-2999-44a8-bb77-83c39133afd7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_074cf487-e401-4937-97a9-9fa665df765a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_074cf487-e401-4937-97a9-9fa665df765a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_8b93b5dd-c23c-4921-8968-8564ea074bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_8b93b5dd-c23c-4921-8968-8564ea074bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_14c04066-c0dd-46ea-9e64-2b4e29281d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_14c04066-c0dd-46ea-9e64-2b4e29281d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_d1a4d497-18d4-4f13-8b28-b9fe188c2c18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_LesseeFinanceLeaseRenewalTerm1_d1a4d497-18d4-4f13-8b28-b9fe188c2c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable_5f7f98e8-2fde-4a35-a57a-a23952c11b72" xlink:href="asth-20231231.xsd#asth_LesseeOperatingLeaseTerminationPeriodIfApplicable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable_5f7f98e8-2fde-4a35-a57a-a23952c11b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable_24f54fc1-d6e5-46cd-be91-89aa1b7ddbe1" xlink:href="asth-20231231.xsd#asth_LesseeFinanceLeaseTerminationPeriodIfApplicable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable_24f54fc1-d6e5-46cd-be91-89aa1b7ddbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_f21c1b4e-79cb-4185-affc-174a58b8b7e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_f21c1b4e-79cb-4185-affc-174a58b8b7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_a1798719-74f8-4208-af8c-b2d8f1993584" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_a1798719-74f8-4208-af8c-b2d8f1993584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LesseeOperatingLeaseOptionToExtendPeriod_10c84e9c-088e-4655-a009-bc3e8a9be9f0" xlink:href="asth-20231231.xsd#asth_LesseeOperatingLeaseOptionToExtendPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_asth_LesseeOperatingLeaseOptionToExtendPeriod_10c84e9c-088e-4655-a009-bc3e8a9be9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLeasingCosts_11653903-0982-4c71-9381-5a3a1b8be75b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLeasingCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_05900674-0743-47fd-a7e1-9553939ef921" xlink:to="loc_us-gaap_PaymentsForLeasingCosts_11653903-0982-4c71-9381-5a3a1b8be75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_526df806-e6ab-44d2-9375-876fe1ba5995" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_822fcbc7-5acf-45b3-a091-3de22c0a2b22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_526df806-e6ab-44d2-9375-876fe1ba5995" xlink:to="loc_us-gaap_OperatingLeaseCost_822fcbc7-5acf-45b3-a091-3de22c0a2b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_18f3f1d1-fa99-4af7-8cd4-242579233703" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_526df806-e6ab-44d2-9375-876fe1ba5995" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_18f3f1d1-fa99-4af7-8cd4-242579233703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_187677ef-899f-46f3-90e0-0bdcaf45482f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_18f3f1d1-fa99-4af7-8cd4-242579233703" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_187677ef-899f-46f3-90e0-0bdcaf45482f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_3367b983-19c9-40a3-b43f-f2a90b826987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract_18f3f1d1-fa99-4af7-8cd4-242579233703" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_3367b983-19c9-40a3-b43f-f2a90b826987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_43301387-2e85-4c91-994d-5a82e4371df7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_526df806-e6ab-44d2-9375-876fe1ba5995" xlink:to="loc_us-gaap_SubleaseIncome_43301387-2e85-4c91-994d-5a82e4371df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_4ab8c28e-4067-4ae8-8a28-fd86de21d038" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_526df806-e6ab-44d2-9375-876fe1ba5995" xlink:to="loc_us-gaap_LeaseCost_4ab8c28e-4067-4ae8-8a28-fd86de21d038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesOtherInformationRelatedtoLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c9ceb7d8-ce14-4391-b872-cbaa7ab19f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CashPaidForLeaseLiabilitiesAbstractAbstract_cf1b68e9-78f5-405e-80e0-308d045466b9" xlink:href="asth-20231231.xsd#asth_CashPaidForLeaseLiabilitiesAbstractAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c9ceb7d8-ce14-4391-b872-cbaa7ab19f3e" xlink:to="loc_asth_CashPaidForLeaseLiabilitiesAbstractAbstract_cf1b68e9-78f5-405e-80e0-308d045466b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_d85542e8-cca1-4daa-b5e3-b59d5cc9047c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CashPaidForLeaseLiabilitiesAbstractAbstract_cf1b68e9-78f5-405e-80e0-308d045466b9" xlink:to="loc_us-gaap_OperatingLeasePayments_d85542e8-cca1-4daa-b5e3-b59d5cc9047c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_e4d509bd-f317-4347-882a-ae229871214f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CashPaidForLeaseLiabilitiesAbstractAbstract_cf1b68e9-78f5-405e-80e0-308d045466b9" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_e4d509bd-f317-4347-882a-ae229871214f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_064c526e-c746-47b7-8fd0-7b784e1c2cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_CashPaidForLeaseLiabilitiesAbstractAbstract_cf1b68e9-78f5-405e-80e0-308d045466b9" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_064c526e-c746-47b7-8fd0-7b784e1c2cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_37fe373a-ad0c-4c76-a108-6588a5ea6d7a" xlink:href="asth-20231231.xsd#asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c9ceb7d8-ce14-4391-b872-cbaa7ab19f3e" xlink:to="loc_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_37fe373a-ad0c-4c76-a108-6588a5ea6d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_446a8304-54b6-4125-9076-99eb7c546a52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_37fe373a-ad0c-4c76-a108-6588a5ea6d7a" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_446a8304-54b6-4125-9076-99eb7c546a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_985c5b42-9d6b-46ca-baf7-6552af912466" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract_37fe373a-ad0c-4c76-a108-6588a5ea6d7a" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_985c5b42-9d6b-46ca-baf7-6552af912466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LeaseWeightedAverageRemainingLeaseTermAbstract_fa9a5bb1-630c-41a0-8a93-ce2e96eb6d47" xlink:href="asth-20231231.xsd#asth_LeaseWeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c9ceb7d8-ce14-4391-b872-cbaa7ab19f3e" xlink:to="loc_asth_LeaseWeightedAverageRemainingLeaseTermAbstract_fa9a5bb1-630c-41a0-8a93-ce2e96eb6d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_67bc9992-7b1d-4b76-910b-11acde09be19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_LeaseWeightedAverageRemainingLeaseTermAbstract_fa9a5bb1-630c-41a0-8a93-ce2e96eb6d47" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_67bc9992-7b1d-4b76-910b-11acde09be19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_10e23d00-5b77-4fe8-88ac-9e77725435b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_LeaseWeightedAverageRemainingLeaseTermAbstract_fa9a5bb1-630c-41a0-8a93-ce2e96eb6d47" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_10e23d00-5b77-4fe8-88ac-9e77725435b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_LeaseWeightedAverageDiscountRateAbstract_82900997-7466-44fc-bafd-321852902d5d" xlink:href="asth-20231231.xsd#asth_LeaseWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c9ceb7d8-ce14-4391-b872-cbaa7ab19f3e" xlink:to="loc_asth_LeaseWeightedAverageDiscountRateAbstract_82900997-7466-44fc-bafd-321852902d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2d05200a-a996-4973-bd89-bb502886dd5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_LeaseWeightedAverageDiscountRateAbstract_82900997-7466-44fc-bafd-321852902d5d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2d05200a-a996-4973-bd89-bb502886dd5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_fb464f57-5259-42c8-95c6-eb58f92d95bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_asth_LeaseWeightedAverageDiscountRateAbstract_82900997-7466-44fc-bafd-321852902d5d" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_fb464f57-5259-42c8-95c6-eb58f92d95bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_88690a8b-cfac-4837-9805-4fa225c2d70c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_88690a8b-cfac-4837-9805-4fa225c2d70c" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f94bbb86-6e17-400f-af87-2dc59efc4c52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f94bbb86-6e17-400f-af87-2dc59efc4c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fd7c92b1-880e-4c9a-8062-9ef3c9b54501" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fd7c92b1-880e-4c9a-8062-9ef3c9b54501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a6a643dd-eb43-4f83-b11e-396e18646552" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a6a643dd-eb43-4f83-b11e-396e18646552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ad5783e-f52e-42ef-8a5f-87969f622bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0ad5783e-f52e-42ef-8a5f-87969f622bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8db2fa09-04af-4fc2-8198-253e874c242b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8db2fa09-04af-4fc2-8198-253e874c242b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_707bada7-3aac-4ada-83e1-796422720f50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_707bada7-3aac-4ada-83e1-796422720f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0c401792-469e-441a-9b06-cfb3911d83e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0c401792-469e-441a-9b06-cfb3911d83e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_02c8f2d7-4f46-4293-b1d0-e028677d22ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_02c8f2d7-4f46-4293-b1d0-e028677d22ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_89e1ceba-2750-44e0-9379-4cce12b47d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_OperatingLeaseLiability_89e1ceba-2750-44e0-9379-4cce12b47d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f240c55a-d90b-4f25-a9ec-103160668159" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f240c55a-d90b-4f25-a9ec-103160668159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_820a6fc9-1c04-4e4a-bad1-54b52b7f8938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_ad591249-73b3-4e81-a624-cfa915e05f11" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_820a6fc9-1c04-4e4a-bad1-54b52b7f8938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_88690a8b-cfac-4837-9805-4fa225c2d70c" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_afacf0a9-9de4-4157-b018-d2f4bd083107" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_afacf0a9-9de4-4157-b018-d2f4bd083107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_020b0423-4d14-4c06-85e7-5728a14c70c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_020b0423-4d14-4c06-85e7-5728a14c70c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2079c6e7-358c-4687-a011-55b2e81268c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2079c6e7-358c-4687-a011-55b2e81268c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2ea6c587-41d3-4b16-bfda-3559d8ef54da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2ea6c587-41d3-4b16-bfda-3559d8ef54da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_4d8ae1e7-328c-4247-869a-e4c9c93394e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_4d8ae1e7-328c-4247-869a-e4c9c93394e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_3999f4ab-966c-4d62-b1d2-cb78f1fd66f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_3999f4ab-966c-4d62-b1d2-cb78f1fd66f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_7213e736-d5a8-44c9-8100-0f3fd37a3a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_7213e736-d5a8-44c9-8100-0f3fd37a3a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_96de9aaa-4f2f-424c-9c74-557b69f440fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_96de9aaa-4f2f-424c-9c74-557b69f440fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7b661261-73a3-4f89-9501-6df3a43cf620" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiability_7b661261-73a3-4f89-9501-6df3a43cf620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_65166fee-9584-410d-bd83-1a288c753afb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_65166fee-9584-410d-bd83-1a288c753afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a598bcef-302d-4ba3-b5f1-286a5d7e9823" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f3b6f26f-42ac-4100-8f51-7728795ece5f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_a598bcef-302d-4ba3-b5f1-286a5d7e9823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1" xlink:type="simple" xlink:href="asth-20231231.xsd#LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.apollomed.net/role/SegmentsNarrativeDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#SegmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SegmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c8e1b730-6f82-4cf0-a4da-d4bdacccc3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2e6eb04f-a8dc-46a3-aa9c-370374dd050d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c8e1b730-6f82-4cf0-a4da-d4bdacccc3d6" xlink:to="loc_us-gaap_NumberOfReportableSegments_2e6eb04f-a8dc-46a3-aa9c-370374dd050d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_6bc08e10-6d4d-4263-b627-84089042e23a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c8e1b730-6f82-4cf0-a4da-d4bdacccc3d6" xlink:to="loc_us-gaap_NumberOfOperatingSegments_6bc08e10-6d4d-4263-b627-84089042e23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics_223b29e8-6a71-4b90-b63b-aee83e780348" xlink:href="asth-20231231.xsd#asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c8e1b730-6f82-4cf0-a4da-d4bdacccc3d6" xlink:to="loc_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics_223b29e8-6a71-4b90-b63b-aee83e780348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#SegmentsScheduleofInformationaboutourSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b6b868d7-92e7-413b-9331-6e8daf15bf74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b6b868d7-92e7-413b-9331-6e8daf15bf74" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c33f18bb-5b73-4de0-8889-127c260575de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c33f18bb-5b73-4de0-8889-127c260575de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c33f18bb-5b73-4de0-8889-127c260575de" xlink:to="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CareEnablementMember_e7b5f697-a0a8-40f5-9246-ee46e1eebfb4" xlink:href="asth-20231231.xsd#asth_CareEnablementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:to="loc_asth_CareEnablementMember_e7b5f697-a0a8-40f5-9246-ee46e1eebfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CarePartnersMember_61464b8d-af35-4498-b0b3-10b813a8dfad" xlink:href="asth-20231231.xsd#asth_CarePartnersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:to="loc_asth_CarePartnersMember_61464b8d-af35-4498-b0b3-10b813a8dfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CareDeliveryMember_0bb523b9-b59a-4819-b8af-f1387c0b3eb0" xlink:href="asth-20231231.xsd#asth_CareDeliveryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:to="loc_asth_CareDeliveryMember_0bb523b9-b59a-4819-b8af-f1387c0b3eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_OtherMember_f2cc9b2a-7501-4ad9-b9da-da6662b0bec1" xlink:href="asth-20231231.xsd#asth_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b60ec9b3-cf49-40d5-9139-15ca50ad95d3" xlink:to="loc_asth_OtherMember_f2cc9b2a-7501-4ad9-b9da-da6662b0bec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_51667aa7-7e96-46f9-8af6-3fd17ab16382" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:to="loc_srt_ConsolidationItemsAxis_51667aa7-7e96-46f9-8af6-3fd17ab16382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_51667aa7-7e96-46f9-8af6-3fd17ab16382" xlink:to="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_6f36afdd-d379-4dbe-b663-562d961fc6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:to="loc_us-gaap_OperatingSegmentsMember_6f36afdd-d379-4dbe-b663-562d961fc6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_6aee75db-b7f9-47f7-8ccc-bde8ee865d04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_6aee75db-b7f9-47f7-8ccc-bde8ee865d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_21f65a1c-0937-4a39-9867-d7da9b905556" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c33fa649-a390-4595-b9c4-ac307638bf4e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_21f65a1c-0937-4a39-9867-d7da9b905556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_340af204-3b38-4d69-a244-2e89250da364" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:to="loc_us-gaap_SubsegmentsAxis_340af204-3b38-4d69-a244-2e89250da364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_8a240563-87e7-4d8e-b333-c080cdb9d689" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_340af204-3b38-4d69-a244-2e89250da364" xlink:to="loc_us-gaap_SubsegmentsDomain_8a240563-87e7-4d8e-b333-c080cdb9d689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ThirdPartyMember_45083fb6-18f2-442d-aead-1d38f4ffa8f7" xlink:href="asth-20231231.xsd#asth_ThirdPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8a240563-87e7-4d8e-b333-c080cdb9d689" xlink:to="loc_asth_ThirdPartyMember_45083fb6-18f2-442d-aead-1d38f4ffa8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_IntersegmentMember_242ee385-cdfb-4e89-83b9-1736748bea4e" xlink:href="asth-20231231.xsd#asth_IntersegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_8a240563-87e7-4d8e-b333-c080cdb9d689" xlink:to="loc_asth_IntersegmentMember_242ee385-cdfb-4e89-83b9-1736748bea4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_dfbb5d70-03d1-47fe-af22-caf2c6e37473" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_754fcb50-2224-41a1-a06f-554c53ef426b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_754fcb50-2224-41a1-a06f-554c53ef426b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_b0042dce-fd2a-4339-a9f0-ce72bd956242" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_b0042dce-fd2a-4339-a9f0-ce72bd956242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_8193f8bf-9e51-4b85-8e1d-cfd72399ce58" xlink:href="asth-20231231.xsd#asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_8193f8bf-9e51-4b85-8e1d-cfd72399ce58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_58fd0298-0146-4f4b-bf93-a1fd18eeceb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_us-gaap_CostsAndExpenses_58fd0298-0146-4f4b-bf93-a1fd18eeceb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1a37badc-4692-48ee-a8a6-58b3d455deed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_02610a22-4e3e-4496-8560-1b048695d7f6" xlink:to="loc_us-gaap_OperatingIncomeLoss_1a37badc-4692-48ee-a8a6-58b3d455deed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b4b9b8d0-6ca4-4de9-b28f-7596b8b7c635" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b4b9b8d0-6ca4-4de9-b28f-7596b8b7c635" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7a5826e-bef5-4e9a-b090-805a5acc99cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7a5826e-bef5-4e9a-b090-805a5acc99cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7a5826e-bef5-4e9a-b090-805a5acc99cf" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8dcad636-76f5-46f5-8c32-48896d19d919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8dcad636-76f5-46f5-8c32-48896d19d919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_045d71ca-de4f-4881-9146-8ccbedfb3b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_045d71ca-de4f-4881-9146-8ccbedfb3b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3e3d4325-6595-47ed-9c9e-85032ff22d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1fdc11e1-c657-4b41-8f06-49bc24aebf84" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3e3d4325-6595-47ed-9c9e-85032ff22d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b7f1a345-b06d-4f0f-9b6e-866b88f24901" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:to="loc_dei_LegalEntityAxis_b7f1a345-b06d-4f0f-9b6e-866b88f24901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b7f1a345-b06d-4f0f-9b6e-866b88f24901" xlink:to="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGMember_35a899b1-0701-41c6-82d9-b385cd28541d" xlink:href="asth-20231231.xsd#asth_AAMGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_AAMGMember_35a899b1-0701-41c6-82d9-b385cd28541d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_APCMGMember_f062aa28-7f03-46f3-bc87-09e9d91285ec" xlink:href="asth-20231231.xsd#asth_APCMGMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_APCMGMember_f062aa28-7f03-46f3-bc87-09e9d91285ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_VOMGMember_bdcea9c8-8c85-4ed9-addc-b6355ff7c539" xlink:href="asth-20231231.xsd#asth_VOMGMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_VOMGMember_bdcea9c8-8c85-4ed9-addc-b6355ff7c539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DmgMember_03cfd1c2-c776-4c77-bf58-6ffcaf22c24d" xlink:href="asth-20231231.xsd#asth_DmgMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_DmgMember_03cfd1c2-c776-4c77-bf58-6ffcaf22c24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloSunLabsManagementLLCMember_2c6b36d3-58e8-48d8-a9ec-7e98850755bb" xlink:href="asth-20231231.xsd#asth_ApolloSunLabsManagementLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cb49f81e-17f3-4e77-8b8e-699b11fbe12e" xlink:to="loc_asth_ApolloSunLabsManagementLLCMember_2c6b36d3-58e8-48d8-a9ec-7e98850755bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c74f8547-843a-4173-af6b-2d026a09d49e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c74f8547-843a-4173-af6b-2d026a09d49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c74f8547-843a-4173-af6b-2d026a09d49e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_InterestRateCollarMember_2e264aee-f094-4b6e-a3ff-1cece94a574b" xlink:href="asth-20231231.xsd#asth_InterestRateCollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:to="loc_asth_InterestRateCollarMember_2e264aee-f094-4b6e-a3ff-1cece94a574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CollarMember_8ee1684f-8e1b-4623-b08a-1bf13d0b1de1" xlink:href="asth-20231231.xsd#asth_CollarMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:to="loc_asth_CollarMember_8ee1684f-8e1b-4623-b08a-1bf13d0b1de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ContingentEquitySecuritiesMember_319bf30d-868f-4650-b480-bbda26c6ff9c" xlink:href="asth-20231231.xsd#asth_ContingentEquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:to="loc_asth_ContingentEquitySecuritiesMember_319bf30d-868f-4650-b480-bbda26c6ff9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f00ad605-2c4c-4444-bc87-ef0caf0ac181" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b0468c73-5c49-4820-af79-84dc8b300291" xlink:to="loc_us-gaap_InterestRateSwapMember_f00ad605-2c4c-4444-bc87-ef0caf0ac181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_InterestRateCollarMember_20f1eeb5-f33a-492f-b0ea-b20e42896d35" xlink:href="asth-20231231.xsd#asth_InterestRateCollarMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1c822d2f-0afb-4127-b261-b21d6f5e31c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1c822d2f-0afb-4127-b261-b21d6f5e31c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ce28c5c-ec99-40ef-9e01-e496d8048429" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1c822d2f-0afb-4127-b261-b21d6f5e31c3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6ce28c5c-ec99-40ef-9e01-e496d8048429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7ca2a22-3ead-49e6-93ee-1f17a7b926e5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_feebfb23-e078-428d-90d0-670d9381a11e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_feebfb23-e078-428d-90d0-670d9381a11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34ad750a-732e-48e3-ac7f-ebb08b0c817e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34ad750a-732e-48e3-ac7f-ebb08b0c817e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_6fb4023a-f078-4c54-a637-bbc9e7dfb435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_6fb4023a-f078-4c54-a637-bbc9e7dfb435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f1957b9e-03e9-4f37-a889-2bd933f350d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_DerivativeAssets_f1957b9e-03e9-4f37-a889-2bd933f350d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2a6679dc-1d35-440d-8862-b626d45f800c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2a6679dc-1d35-440d-8862-b626d45f800c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0439345a-b5ee-4423-953f-bd2d7e5e4422" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0439345a-b5ee-4423-953f-bd2d7e5e4422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_da025d78-e666-46b2-b08a-009ba02456ef" xlink:href="asth-20231231.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_da025d78-e666-46b2-b08a-009ba02456ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_cfc0ba3a-730f-4618-9260-cdaa4f5947d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_DerivativeLiabilities_cfc0ba3a-730f-4618-9260-cdaa4f5947d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_0ed611f0-04f5-4209-bafa-b700b500510b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ae9c1eb9-969a-4a7b-9bc1-cdb58306424e" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_0ed611f0-04f5-4209-bafa-b700b500510b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_14ed04fa-bcb8-42f5-859d-4ac13b7dc64b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5bd4bd39-94dc-453d-957b-f7a7b3db468a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_14ed04fa-bcb8-42f5-859d-4ac13b7dc64b" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5bd4bd39-94dc-453d-957b-f7a7b3db468a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6d96f644-a8ca-49a9-8762-e0e5750bd4da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5bd4bd39-94dc-453d-957b-f7a7b3db468a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6d96f644-a8ca-49a9-8762-e0e5750bd4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_692df329-06dd-478c-9f95-31c07e870841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5bd4bd39-94dc-453d-957b-f7a7b3db468a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_692df329-06dd-478c-9f95-31c07e870841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid_6a48d232-eea3-47b0-b9cd-0d501a2e0d1e" xlink:href="asth-20231231.xsd#asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5bd4bd39-94dc-453d-957b-f7a7b3db468a" xlink:to="loc_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid_6a48d232-eea3-47b0-b9cd-0d501a2e0d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_edb26853-00db-46b9-8bdf-3e0efef8f815" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5bd4bd39-94dc-453d-957b-f7a7b3db468a" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_edb26853-00db-46b9-8bdf-3e0efef8f815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7a193dc5-f41a-4061-bdd6-1157df7b34dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7a193dc5-f41a-4061-bdd6-1157df7b34dc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5d4558a7-ba06-4522-8d74-cad39e569607" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5d4558a7-ba06-4522-8d74-cad39e569607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c4d06fa-c765-4779-a43e-7a973ae710f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5d4558a7-ba06-4522-8d74-cad39e569607" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c4d06fa-c765-4779-a43e-7a973ae710f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_d444cafd-d547-49ef-98b0-ff7e9d971e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c4d06fa-c765-4779-a43e-7a973ae710f7" xlink:to="loc_us-gaap_CertificatesOfDepositMember_d444cafd-d547-49ef-98b0-ff7e9d971e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_222f9de0-48c1-449c-bda3-3d6f9636df39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_222f9de0-48c1-449c-bda3-3d6f9636df39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_222f9de0-48c1-449c-bda3-3d6f9636df39" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ContingentEquitySecuritiesMember_ec2d8fc2-5faf-4b53-bb91-76f6f223dddd" xlink:href="asth-20231231.xsd#asth_ContingentEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:to="loc_asth_ContingentEquitySecuritiesMember_ec2d8fc2-5faf-4b53-bb91-76f6f223dddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_40cca0a2-2d44-4234-9839-ce20cdbec5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:to="loc_us-gaap_InterestRateSwapMember_40cca0a2-2d44-4234-9839-ce20cdbec5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CollarMember_8d6bcc61-ac19-410d-8550-12c626a8956d" xlink:href="asth-20231231.xsd#asth_CollarMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_efd7df5b-269c-4ce2-b181-e542e000986c" xlink:to="loc_asth_CollarMember_8d6bcc61-ac19-410d-8550-12c626a8956d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_95f20edb-ce07-4246-9c31-050515374e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_95f20edb-ce07-4246-9c31-050515374e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_95f20edb-ce07-4246-9c31-050515374e9a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_ff10b5d7-3801-4d49-a81a-f3e17fc1c51c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_ff10b5d7-3801-4d49-a81a-f3e17fc1c51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7f87b752-584e-4563-be1c-0853e6fababb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_7f87b752-584e-4563-be1c-0853e6fababb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_d88e3f66-ccf3-45a9-bdb4-787b13ab2eac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_46256b04-4c0c-4b96-b7dc-f0632a69d517" xlink:to="loc_us-gaap_OtherLiabilitiesMember_d88e3f66-ccf3-45a9-bdb4-787b13ab2eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1036dc1b-7037-43a7-a422-e374693950ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1036dc1b-7037-43a7-a422-e374693950ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3b8846f5-1aef-46ed-af89-19133c3ba3df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1036dc1b-7037-43a7-a422-e374693950ae" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3b8846f5-1aef-46ed-af89-19133c3ba3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_bb8a87fc-d939-45c7-a159-7d31662b3a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_3b8846f5-1aef-46ed-af89-19133c3ba3df" xlink:to="loc_us-gaap_CashFlowHedgingMember_bb8a87fc-d939-45c7-a159-7d31662b3a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_406d003f-524b-467e-be4d-259a00c64312" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_HedgingDesignationAxis_406d003f-524b-467e-be4d-259a00c64312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0f62303f-1c0b-4ab4-913e-ed3ba3dcef0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_406d003f-524b-467e-be4d-259a00c64312" xlink:to="loc_us-gaap_HedgingDesignationDomain_0f62303f-1c0b-4ab4-913e-ed3ba3dcef0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c559cecf-8871-4be0-bcc1-d06cb63cd77c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0f62303f-1c0b-4ab4-913e-ed3ba3dcef0e" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c559cecf-8871-4be0-bcc1-d06cb63cd77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_51b0c12e-6c13-41ff-9b53-2d1c18df5e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0f62303f-1c0b-4ab4-913e-ed3ba3dcef0e" xlink:to="loc_us-gaap_NondesignatedMember_51b0c12e-6c13-41ff-9b53-2d1c18df5e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_25c626c9-ef19-4b39-b2b0-3757e8ee7420" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_25c626c9-ef19-4b39-b2b0-3757e8ee7420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a76d160d-3f69-49b9-b99a-ce37a22bafe1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_25c626c9-ef19-4b39-b2b0-3757e8ee7420" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a76d160d-3f69-49b9-b99a-ce37a22bafe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DMGAndSunLabsMember_198e0342-90cc-415c-a951-5855f1b1f6ea" xlink:href="asth-20231231.xsd#asth_DMGAndSunLabsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a76d160d-3f69-49b9-b99a-ce37a22bafe1" xlink:to="loc_asth_DMGAndSunLabsMember_198e0342-90cc-415c-a951-5855f1b1f6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DmgMember_28bbfa8b-e617-489b-82fa-51897f455baf" xlink:href="asth-20231231.xsd#asth_DmgMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a76d160d-3f69-49b9-b99a-ce37a22bafe1" xlink:to="loc_asth_DmgMember_28bbfa8b-e617-489b-82fa-51897f455baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ee398131-8179-45bc-bd98-e332a2e1c7e9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_dei_LegalEntityAxis_ee398131-8179-45bc-bd98-e332a2e1c7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ee398131-8179-45bc-bd98-e332a2e1c7e9" xlink:to="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloSunLabsManagementLLCMember_26be599f-b05d-47bb-a203-34fc851bde36" xlink:href="asth-20231231.xsd#asth_ApolloSunLabsManagementLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:to="loc_asth_ApolloSunLabsManagementLLCMember_26be599f-b05d-47bb-a203-34fc851bde36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGMember_fe10ca63-e8d9-42f4-99e3-8753e7277b10" xlink:href="asth-20231231.xsd#asth_AAMGMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:to="loc_asth_AAMGMember_fe10ca63-e8d9-42f4-99e3-8753e7277b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_APCMember_f986c222-e312-49f5-be2c-f715ca69e443" xlink:href="asth-20231231.xsd#asth_APCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e5241546-736c-4bd6-825f-1cc43540d8e9" xlink:to="loc_asth_APCMember_f986c222-e312-49f5-be2c-f715ca69e443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5509d25a-344b-4fb4-b9ce-8bca1c6b99ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5509d25a-344b-4fb4-b9ce-8bca1c6b99ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60896993-cc07-4711-8134-b06b1bea7702" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5509d25a-344b-4fb4-b9ce-8bca1c6b99ff" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60896993-cc07-4711-8134-b06b1bea7702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_ApolloSunLabsManagementLLCMember_c40826b1-f496-48bf-add8-7fd420ce963f" xlink:href="asth-20231231.xsd#asth_ApolloSunLabsManagementLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60896993-cc07-4711-8134-b06b1bea7702" xlink:to="loc_asth_ApolloSunLabsManagementLLCMember_c40826b1-f496-48bf-add8-7fd420ce963f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AAMGMember_303607d8-636d-49d1-9e68-b440c28254e9" xlink:href="asth-20231231.xsd#asth_AAMGMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60896993-cc07-4711-8134-b06b1bea7702" xlink:to="loc_asth_AAMGMember_303607d8-636d-49d1-9e68-b440c28254e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_02f6d61c-d084-42e2-8248-1245acce63f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_02f6d61c-d084-42e2-8248-1245acce63f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e13844bd-1be9-4a8a-8525-6427aa5fa416" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_02f6d61c-d084-42e2-8248-1245acce63f4" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e13844bd-1be9-4a8a-8525-6427aa5fa416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_A2023MetricMember_4dea0753-4b2d-4a4e-9951-5f872cdc1f3d" xlink:href="asth-20231231.xsd#asth_A2023MetricMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e13844bd-1be9-4a8a-8525-6427aa5fa416" xlink:to="loc_asth_A2023MetricMember_4dea0753-4b2d-4a4e-9951-5f872cdc1f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_A2024MetricMember_5e0f8ec0-d78e-4ee0-b484-2ac562ea1e9c" xlink:href="asth-20231231.xsd#asth_A2024MetricMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e13844bd-1be9-4a8a-8525-6427aa5fa416" xlink:to="loc_asth_A2024MetricMember_5e0f8ec0-d78e-4ee0-b484-2ac562ea1e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7016f919-67b1-4acf-9e1a-67be3c0f9ed6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e5379e23-dcf5-44ca-84b6-7b5260263b59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_e5379e23-dcf5-44ca-84b6-7b5260263b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_21accd7c-b054-426b-a78d-265813bb68c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_DerivativeAssets_21accd7c-b054-426b-a78d-265813bb68c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_6dfed0dd-470d-4f2f-ad47-74bf8eeb9b43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_6dfed0dd-470d-4f2f-ad47-74bf8eeb9b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_4af5be2a-951a-49dc-b134-e94db0d7b4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_4af5be2a-951a-49dc-b134-e94db0d7b4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_DerivativeCeilingInterestRate_1b0d8ea5-14d7-4a36-bb18-b35f6828f8ae" xlink:href="asth-20231231.xsd#asth_DerivativeCeilingInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_DerivativeCeilingInterestRate_1b0d8ea5-14d7-4a36-bb18-b35f6828f8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFloorInterestRate_3068e626-2732-497d-a14d-989120a0346f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFloorInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_DerivativeFloorInterestRate_3068e626-2732-497d-a14d-989120a0346f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_9175f787-5a7f-4bcd-820b-67f674f7eaae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueHedgeLiabilitiesAtFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_FairValueHedgeLiabilitiesAtFairValue_9175f787-5a7f-4bcd-820b-67f674f7eaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d39f0de1-8d37-4ece-be0f-d83f2e085947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_d39f0de1-8d37-4ece-be0f-d83f2e085947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_b365e062-0525-40bf-aa0c-3248ac64de8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedLoss_b365e062-0525-40bf-aa0c-3248ac64de8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_bfa54933-a438-4f56-b988-9e296b5d375c" xlink:href="asth-20231231.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_bfa54933-a438-4f56-b988-9e296b5d375c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_acd910d1-9633-470e-90f1-eabd6e1b5592" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_EquityMethodInvestments_acd910d1-9633-470e-90f1-eabd6e1b5592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_c6b250ef-0102-4f0e-ac08-1131901bf681" xlink:href="asth-20231231.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_c6b250ef-0102-4f0e-ac08-1131901bf681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_89d48a4e-0ddf-4164-b41d-22d1c0db6c38" xlink:href="asth-20231231.xsd#asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation_89d48a4e-0ddf-4164-b41d-22d1c0db6c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6a0beb32-50a5-481a-b530-15be6e1ebc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_6a0beb32-50a5-481a-b530-15be6e1ebc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_42a448c5-6b94-4b64-84b6-208c9c9dbbc8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_CommonStockValue_42a448c5-6b94-4b64-84b6-208c9c9dbbc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_14a9453e-1a0b-47e2-acc1-59b38da9865c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_14a9453e-1a0b-47e2-acc1-59b38da9865c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_BusinessCombinationStockContingentConsiderationLiability_2ecd5cc0-1ff0-46ad-9272-1b7778622d21" xlink:href="asth-20231231.xsd#asth_BusinessCombinationStockContingentConsiderationLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_asth_BusinessCombinationStockContingentConsiderationLiability_2ecd5cc0-1ff0-46ad-9272-1b7778622d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_f62eede1-a469-4304-b37b-01ac56b6270e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a549e425-1bb2-4a9b-b086-07610eab4fa0" xlink:to="loc_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_f62eede1-a469-4304-b37b-01ac56b6270e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3c9374f4-ec16-4f17-afee-d787113a0ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_23094ba7-666e-4b68-ac54-42b993cee7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3c9374f4-ec16-4f17-afee-d787113a0ce0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_23094ba7-666e-4b68-ac54-42b993cee7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_31310095-eddc-40f5-9973-3613d0ad8e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3c9374f4-ec16-4f17-afee-d787113a0ce0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_31310095-eddc-40f5-9973-3613d0ad8e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_7ad928f5-9f3b-4695-a995-149c47812015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3c9374f4-ec16-4f17-afee-d787113a0ce0" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_7ad928f5-9f3b-4695-a995-149c47812015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.apollomed.net/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="asth-20231231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.apollomed.net/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_817ca2a0-f739-4888-bf8d-22ea308d4747" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_817ca2a0-f739-4888-bf8d-22ea308d4747" xlink:to="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_bc73b423-0201-4c2f-ae7a-d6cec9cf332d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_bc73b423-0201-4c2f-ae7a-d6cec9cf332d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_23dba60f-807f-4274-866e-34752cbe6d40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_bc73b423-0201-4c2f-ae7a-d6cec9cf332d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_23dba60f-807f-4274-866e-34752cbe6d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2dc731bb-35cc-45b9-90bb-995035d1b14a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_23dba60f-807f-4274-866e-34752cbe6d40" xlink:to="loc_us-gaap_SubsequentEventMember_2dc731bb-35cc-45b9-90bb-995035d1b14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bd167f81-d71b-4c0b-883e-794929879dfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bd167f81-d71b-4c0b-883e-794929879dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_959b963a-599f-4f89-9be8-3e2e4181ca43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bd167f81-d71b-4c0b-883e-794929879dfe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_959b963a-599f-4f89-9be8-3e2e4181ca43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_CommunityFamilyCareMedicalGroupMember_896b1c3c-b411-4ed7-9741-e2c4fd9fda47" xlink:href="asth-20231231.xsd#asth_CommunityFamilyCareMedicalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_959b963a-599f-4f89-9be8-3e2e4181ca43" xlink:to="loc_asth_CommunityFamilyCareMedicalGroupMember_896b1c3c-b411-4ed7-9741-e2c4fd9fda47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_AdvancedDiagnosticAndSurgicalCenterMember_7f9cd9c0-3ac2-4690-a136-87889ad578ac" xlink:href="asth-20231231.xsd#asth_AdvancedDiagnosticAndSurgicalCenterMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_959b963a-599f-4f89-9be8-3e2e4181ca43" xlink:to="loc_asth_AdvancedDiagnosticAndSurgicalCenterMember_7f9cd9c0-3ac2-4690-a136-87889ad578ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_7765eb9e-237d-4261-8414-c796e0ea41b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:to="loc_us-gaap_VariableRateAxis_7765eb9e-237d-4261-8414-c796e0ea41b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c5140cd8-3a7a-4a32-811f-1904f2b92fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_7765eb9e-237d-4261-8414-c796e0ea41b7" xlink:to="loc_us-gaap_VariableRateDomain_c5140cd8-3a7a-4a32-811f-1904f2b92fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_63dbd3d0-2c09-4a7a-bc80-9b1403c70379" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c5140cd8-3a7a-4a32-811f-1904f2b92fb9" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_63dbd3d0-2c09-4a7a-bc80-9b1403c70379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0ed98380-4c0c-411e-9ed8-a6399f006596" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:to="loc_us-gaap_DebtInstrumentAxis_0ed98380-4c0c-411e-9ed8-a6399f006596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a694d823-a9de-4bfb-ac1c-c269dfff473d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0ed98380-4c0c-411e-9ed8-a6399f006596" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a694d823-a9de-4bfb-ac1c-c269dfff473d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_TermLoanMember_ea382694-f491-4dad-ae01-8f19de1a1b18" xlink:href="asth-20231231.xsd#asth_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a694d823-a9de-4bfb-ac1c-c269dfff473d" xlink:to="loc_asth_TermLoanMember_ea382694-f491-4dad-ae01-8f19de1a1b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_RevolverLoanMember_02b22918-c985-4fa7-8395-ba7d91639a61" xlink:href="asth-20231231.xsd#asth_RevolverLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a694d823-a9de-4bfb-ac1c-c269dfff473d" xlink:to="loc_asth_RevolverLoanMember_02b22918-c985-4fa7-8395-ba7d91639a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_47a8cc92-2071-49ce-b82c-06da16c444c0" xlink:to="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_4f3a18ec-9114-485e-ab2e-bf2776f4f646" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_4f3a18ec-9114-485e-ab2e-bf2776f4f646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_37477614-7e42-4719-b818-e951718cb69a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_37477614-7e42-4719-b818-e951718cb69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_322049f9-2cde-4c4d-a653-5ade1f3180a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_322049f9-2cde-4c4d-a653-5ade1f3180a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_9cb508d9-251c-4f3a-a714-e9eecc601253" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_9cb508d9-251c-4f3a-a714-e9eecc601253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_53f415bf-ae07-43d9-be85-560423a7a00b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_SeniorNotes_53f415bf-ae07-43d9-be85-560423a7a00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bc6e5a3f-0480-4317-af69-be3a5352a688" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bc6e5a3f-0480-4317-af69-be3a5352a688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3421500a-b832-4c15-8735-a2d4eda75825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_3bfaa172-6586-46e7-a391-5f9951684b4e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3421500a-b832-4c15-8735-a2d4eda75825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_StockAwardsAndUnitsMember" xlink:href="asth-20231231.xsd#asth_StockAwardsAndUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_asth_StockAwardsAndUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockUnitsMember" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_asth_PerformanceBasedRestrictedStockUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_asth_PerformanceBasedRestrictedStockMember" xlink:href="asth-20231231.xsd#asth_PerformanceBasedRestrictedStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_asth_PerformanceBasedRestrictedStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>asth-20231231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 asth-20231231_g1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0".17AI9@  34T *@    @  @$2  ,
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H
M# ,!  (1 Q$ /P#ZIHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBL7QEXEL/"7AZZU?5'(@A'"+]Z1S]U%]R?\>@HW'&+D
M[+<VJ*^+_&'QC\6^(KR1H-1FTJSS^[M[%S&5'NXPS'\<>PK-T#XH>,=$NEFM
M]>O;A0<F*\E,Z,/3#$X_#!K;V+L>FLJJN-VU<^XJ*X?X3_$&T\?:&TZ1BVU*
MV(2ZMLYVD]&7U4X./3!'N>XK)IIV9YTX2IR<9+5!1112("BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BO#/VG?&=UHMCI>BZ1>SVE[<L;
MF:2WD,;K&N0HR#G#-G_OBOGK_A,O$_\ T,>M?^!TO_Q5:QI.2N>CA\NG6@IW
MM<^^**^!_P#A,O$__0QZU_X'2_\ Q5=S\%_B)JUA\0-/CUO5[^[T^]/V21;J
MY>14+XVL Q(&&V\^A--T6E<NIE<X1<E*]CZ_HHHK$\L**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %?.O[7%_,%\.:>I(MV,UPX[,PVJOY M_P!]5]%5
MY)^T?X-N?$_A*"^TR)IK_2F:01*,M)$P&\ =R-JG\#WJZ;2DKG7@9QA7BY'R
M)11178?4'JW[,]_-:?%*UMXB?*O+>:*4=B I<?J@_.OL"OF[]EOP9<B^N/%=
M]$T=LL;6]GN&/,8GYW'L -N>^3Z5](URU6G+0^<S*<95_=Z!11161YX4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH?#NH&S\^.9YL1(^[!0+]Y3C'S=/6JC%R=D:T:,JTU".[/<**^*_^%S>/O\
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M$NB!O3[?%G_T*G9E*$GLC?HJE8:OINH?\>&H6=U_UPF5_P"1J[2$TUN%%%%
M@HHHH **** /._VA/^2/^(/I!_Z/CKXMK[2_:$_Y(_X@^D'_ */CKXMKIH_"
M?093_!?K^B"OT.T[_D'VO_7)?Y"OSQK]#M._Y!]K_P!<E_D*5?H8YOM#Y_H6
M****YSQ0KY3_ &J]22Y\=V-E&P/V.R7?[,[$X_[YVG\:^E/%OB/3_"N@W.K:
MM*([>%>%S\TC=D4=R?\ /%?"WBK6[GQ)XBU#6+[_ %]Y*9" <A1T"CV   ^E
M;48ZW/5RNBW4=1[(RJ^MOV6O^2:2_P#80E_]!2ODFOK;]EK_ ))I+_V$)?\
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MJDZP6=LF^1V_D/4D\ =R:XSY9)MV18O[RVT^SEN[Z>*WMH5W22RL%51ZDFO
M_'O[0L,$DEIX,M%N"/E-]=*0GU1."?J<?0UY5\5?B5J7CO4F4L]MHT39M[,'
MC_??U;]!T'<G@:Z(4EO(]S"Y;&*YJVK['2^(O'7B?Q$['5]:O9D;K"LFR/\
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M^>::=F%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK1116)Y05B>-M:'AWPCJ^K\%K2V>1 >A?&%'XL0*VZ\Y_:&+#X0Z[LS_ ,L
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M_"OF_P#9(_Y#_B#_ *]8_P#T,U]-US5?B/"S%OZP_E^14_LRP_Y\;7_ORO\
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MEU:2F)P.AQT(]B,$>QK.KK/I$TU='3?##_DH_A?_ +"=O_Z,6OO"O@_X8?\
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M'\.Z"FA:9*4U/4D/F.IPT4'0GV+'('L&]J^3JZ7XC^))/%GC35-69B8I92L
M/\,2\(/R )]R:YJNR$>5'U.#H*A24>O4*]M^$/P3F\16\.L>*#+::4X#PVR_
M++<+V8G^%3^9[8X)Q_V?? :>+O$SWVIQ;](TTJ\B,.)I#]U/<<9/T [U]@@
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M?/\ 0G=%D1D=0R,,%2,@BJO]F6'_ #XVO_?E?\*MT5SGC7:*G]F6'_/C:_\
M?E?\*^!?$H"^(]5"@ "[E  [?.:_06OS[\3?\C)JW_7W+_Z&:WH[L]C*6W*7
MR,VOJ_\ 9ALK6X^&\KSVT$K_ &^4;GC#'&U/6OE"OK;]EK_DFDO_ &$)?_04
MJZWPG5F?\#YGJO\ 9EA_SXVO_?E?\*/[,L/^?&U_[\K_ (5;HKE/G>9C8HTA
MC"1(J(.BJ, ?A3J**!'QA^T/_P E@U[Z6_\ Z3QUYQ7H_P"T/_R6#7OI;_\
MI/'7G%=L/A1];AOX,/1?D%>M_ _X5'QG,=5UKS(M!A?:%4[6NG'50>RCN?P'
M.2/,_#^ESZYKEAI=I_K[R=($/8%CC)]AUK[XT#2;70M%LM+T]-EK:1+$@]0.
MY]R>3[FHJSY59')F&*=&*C#=C])TRQT>QCLM+M(;2UC&%BA0*H_+O[U<HHKE
M/GFVW=A7F7Q;^%.F>,]/GN["&*T\0(I:.=!M$Y_NR>N?[W4?3BO3:*:;3NBZ
M=65*7-!ZGYW75O+:7,MO<QM%/"YCD1A@JP."#[@U%7K/[3&A)I/Q&:[@0+%J
M<"W)P./,!*M_Z"#_ ,"KR:NV+NKGU=&HJL%-=3Z4_90\2/-8ZKX<N')^SD7=
ML">BL<./H#M/U8U]!5\:?LYW[67Q8TM <)=1S0/[CRRP_P#'E6OLNN6JK2/G
M\RIJ%=M==0HHHK,X HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **R/$7B;1?#=MY^N:G:V28R!*_S-_NKU;\ :\'^('[0C2))9^"
MK9H\_*;^Z49^J1_U;\JJ,'+8Z*.%JUG[B/6/B;\1M)\"::6NG6XU.1<V]DC?
M,_\ M-_=7W_+-?&_BOQ%J/BG7+C5=8G,MS,>@X6->RJ.RC_/-4-0OKK4KV6[
MU"XEN;J9MTDLK%F8^Y-5ZZ8043Z#"8..'5]WW"BBBM#K)[&\N-/O(;NRF>"Y
MA<21RH<,C#H0:^M_@[\7++Q?;Q:9K+QVGB!1MVGY4NO=/1O5?RXZ?(-*C,CJ
MR$JRG((."#43@I+4YL3A88B-I;]S]%:*^5?AW\>M5T5(K+Q1$^JV*X47"G%P
M@]R>'_'!]Z^A/"?COPWXKC4Z+JD$LQ&3;N=DR_\  #S^(R/>N:4''<^?KX.K
M0?O+3N=-1114'*%%%% !1110 4444 %%%% !1110 4444 9'B[7(?#?AG4M8
MN<&.S@:0*3C<W15_%B!^-? ]_=S7]]<7ETYDN+B1I9'/5F8Y)_,U]'_M7>)O
M(T[3?#=N^'N&^UW(!_@4D(#[%MQ_X *^::Z:,;*Y]!E='DI\[W85]A?LX>&_
M["^'<%Y,FVZU5_M39'(CZ1CZ8^;_ (%7ROX*T*7Q-XKTO1X<@W<ZHS#JJ=7;
M\%!/X5]\6L$5K;16]N@CAB01H@Z*H& /RI5I:6(S6M:*IKKJ2455U'4K'3(?
M.U*\MK2+^_/*L:_F37*7GQ3\$6C%9?$EBQ'_ #R)E'YJ#6"3>QXL:<Y_"KG:
MT5PL'Q;\"SMM3Q%:@_[:.@_,J*Z72/$>BZS_ ,@G5K"]/]VWN$<C\ <T--;C
ME2G'646@\5:-#XB\-ZCI%UCRKR!HMQ&=I(X;Z@X/X5\#:A9S:??W-G=H8[BW
ME:&1#_"RG!'YBOT.KY(_::\-?V/X[75($VVNK1^:<#@2KA7'_H+?5C6M&6MC
MTLJK<LW3?4\@KZ8_93\3_:-+U'PU</F2U;[5; G_ )9L<.![!L'_ (&:^9ZZ
M?X:>)&\)^-M+U;)$$<NRX [Q-\K_ %X.1[@5M./-&QZN+H^VI./4^[Z*2-UD
M17C8,C#*L#D$>M+7&?*!7,?$[2'U[X?Z]IT*EYI;5FB4?Q.OS*/Q*BNGHIIV
M=RH2<9*2Z'YTT5ZY\?/AQ/X8UR?6=,@+:%>R%R4'%M(QY0^BD_=/X=N?(Z[8
MM25T?6TJL:L%.)[9\,?CK>>'K*#2_$MO)J.GP@)%<1D>?$HZ YX<#MD@^YKW
M3P_\4_!NNJOV77;6&5O^65VWD,#Z?/@'\":^'Z*SE2B]3DK9=2JOF6C/T3AF
MCGC$D$B21MT9&!!_$4^OSST_4;[3I/,T^\N;63^]!*T9_,&NPTCXM^.-+VB'
MQ!<S(.JW06?/XN"?UJ'1?1G%/*9KX9'VY17S)X=_:.U*%E3Q#H]M=1]#+:.8
MG'OM.03^5>S>"OB=X7\7LD6F7XBO6_Y=+H>7+^ Z-_P$FLY0E'<XJN#K4M9+
M0[6BBBH.4**** /C?]I#_DK6I_\ 7*#_ -%+7F->G?M(?\E:U/\ ZY0?^BEK
MS&NV'PH^LPO\&'HCWO\ 9(_Y#_B#_KUC_P#0S7TW7S)^R1_R'_$'_7K'_P"A
MFOINN:K\1X.9?[P_E^04445F<(5\1?'#_DJWB/\ Z[C_ - 6OMVOB+XX?\E6
M\1_]=Q_Z M;4=SU,I_BOT.&KM_@QX<3Q/\1=*LKA ]I$YN;A2,@HG.#[$[5_
M&N(KWG]DFS63Q'KUZ1\T-JD(/IO?/_M.MYNT6SU\74=.C*2/IVBBBN(^4"BB
MB@#Y^_:VU8QZ7H.D(W$TLEU(/]P!5_\ 0V_*OFJO:/VK+DR_$"P@S\L.G)Q[
MF20G],5XO7735HH^HP$>6A$U/"^DOKOB33-*B)#7ES'!N'\(9@"?P&3^%??M
MG;16=I!:VR"."%%CC0=%4# 'Y"OCG]G6S6[^+&DLXRMNDTV/<1L!^I%?9=95
MGK8\W-IMU(P[(****Q/)"BBB@ HHHH ^9?VL/#ZV^L:3K\"8^UQM;3D#^-.5
M)]RI(_X"*\#KZ]_:=LEN?A?),1S:7<,H/IG*?^SU\A5UTG>)]+ETW.@K]-#I
MOAA_R4?PO_V$[?\ ]&+7WA7P?\,/^2C^%_\ L)V__HQ:^\*RK;HX,V^./H%?
M#?QC_P"2H>)?^OQOZ5]R5\-_&/\ Y*AXE_Z_&_I11W%E/\27H<;7M'[*VEK=
M^/+R_D7(L;-BA]'=@H_\=WUXO7T9^R'"-OBF8CG-L@_\BD_TK:H_=9Z>/ERX
M>31]%4445QGRX4444 %?,O[6\8&O>'Y1]YK:13] P_Q-?35?-'[7'_(7\.?]
M<)O_ $):TI?$=V7?[POG^1X!7IG[.1(^+FD8[QS@_P#?EZ\SKTO]G/\ Y*YH
M_P#N3_\ HEZZ9_"SWL5_!GZ,^RZ\P_:/U8Z7\+;V-&VR7\T=H"/0G<WYJA'X
MUZ?7@7[7%R4T/P]:Y^62YEE(_P!U0/\ V>N6FKR1\Y@X\U>*\SYFHHK9\%6:
MZAXRT*S<92XOX(F'LTB@_P Z[#ZF3Y4V?;7PZT!?#/@G1]*5 LD-NIF]Y6^9
MS_WT371T45P-WU/CY2<I.3ZA11102%%%% !7BW[4OA]=0\$V^LQI_I&F3@,V
M/^64A"D?]];/UKVFN7^*5FM_\./$L##/^@3.H_VE4L/U454':29OAING5C)=
MSX1HHHKM/K#]"])_Y!5E_P!<$_\ 015NJFD_\@JR_P"N"?\ H(JW7 ?&O<**
M**!!1110 5^=DW^N?_>-?HG7YV3?ZY_]XUO0ZGLY1]OY?J,KTSX9?"6^\>Z'
M<:G::G;6B0W+6Q26-F)(56SQ_O?I7F=?5G[)_P#R3[4O^PH__HJ*M:DG&-T=
M^.JRHTN>&YQO_#-NK?\ 0?L?^_+T?\,VZM_T'['_ +\O7TY17/[61XO]I8CO
M^!\Q_P##-NK?]!^Q_P"_+T?\,VZM_P!!^Q_[\O7TY11[60?VEB._X'S'_P ,
MVZM_T'['_OR]'_#-NK?]!^Q_[\O7TY11[60?VEB._P"!\Q_\,VZM_P!!^Q_[
M\O5?4OV=]4L=.NKM]=LG6WB:4J(7R0H)Q^E?4E9GBC_D6=7_ .O.;_T TU5D
M5',:[:5_P/S\HHHKJ/HSZ\_9A_Y)>G_7Y-_[+7K5>2_LP_\ )+T_Z_)O_9:]
M:KBG\3/E,7_'GZGS%^UIJIE\1:)I2M\EO;-<,!_>D;;_ "C_ %KP:O3OVD+D
MS_%G4XR<BWB@C'_?M6_]FKS&NJ"M%'T6#CRT(KR_,]0_9OTI=3^*5G)(NY+&
M&2[(/J!L4_@S@_A7V-7YZZ7JNH:1.TVE7]W8S,NQI+:9HF*YS@E2.,@?E6I_
MPFWBK_H9M<_\#Y?_ (JHG3<G<YL7@9XBISJ5C[VHKX)_X3;Q5_T,VN?^!\O_
M ,51_P )MXJ_Z&;7/_ ^7_XJI]@^YR_V3/\ F1][45\$_P#";>*O^AFUS_P/
ME_\ BJ/^$V\5?]#-KG_@?+_\51[!]P_LF?\ ,C[VKY]_:WTY6T[P]J0&'CEE
MMF/J& 8?EM;\Z\+_ .$V\5?]#-KG_@?+_P#%52U3Q!K.KPK#JNKZC?0HV]4N
M;EY5#8QD!B>>3^=.-)Q=[FV'RZ=&HJG-L9E=?\(M5.C?$KP]=AMJFZ6!SVVR
M?(<_@V?PKD*EM)VMKJ&>/AXG5U^H.:V:NK'J3CSQ<7U/T1KB_C-JQT7X8^(+
MI&VR-;_9T(ZYD(CR/INS^%=FC!T5EY##(KQ_]J:Y,'PU@C!_X^-0BC/N CM_
M-17'!7DD?*X://6C%]SY*HHI\$9FFCB3[SL%'U)KM/K#[5^!>@+H'PSTA-FV
M>\3[;,<<EI.1GZ+M'X5WU16D"6MK#;Q#$<2+&H] !@5+7"W=W/CZDW4FYOJ%
M%%%(@**** "O,OVB/#ZZY\-;V=4S<Z:1>1G'.T<./IM)/X"O3:I:W9KJ.BW]
MDXRMS;R0D>H92/ZTXNSN:49NG-370_/:BBBNX^O/O#X8_P#)./"__8,MO_1:
MUTU<S\,?^2<>%_\ L&6W_HM:Z:N%[GQ]7XWZGG?[0G_)'_$'T@_]'QU\6U]I
M?M"?\D?\0?2#_P!'QU\6UT4?A/=RG^"_7]$%?H=IW_(/M?\ KDO\A7YXU^AV
MG?\ (/M?^N2_R%*OT,<WVA\_T+%%%%<YXH5^??B;_D9-6_Z^Y?\ T,U^@E?G
MWXF_Y&35O^ON7_T,UO0W9[&4?%/Y&;7UM^RU_P DTE_["$O_ *"E?)-?6W[+
M7_)-)?\ L(2_^@I5UOA.O-/X'S/8****Y3YP**** /C#]H?_ )+!KWTM_P#T
MGCKSBO1_VA_^2P:]]+?_ -)XZ\XKMA\*/K<-_!AZ+\CU?]F;3%O_ (H0SNN1
M8VLMR,^IQ&/_ $9^E?7]?,/[),0/B779>ZVB*/Q?/]*^GJYZS]X\+,Y7KV[(
M****R//"BBB@#YR_:\A42^%I@/F87*$^P\HC^9KYVKZ._:\_U7A7_>NO_:5?
M.-==+X4?3Y?_ +O'Y_F=M\%"1\5/#F/^?G'_ (Z:^X*^'_@K_P E4\-_]?7_
M +*:^X*RK;GFYM_%CZ!1116)Y04444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5R_C?PSJ/B*V\O3O$VIZ(=NW%H$VD^IX#Y^C@<=*ZBBFG8
MJ,G%W1\C^-?@?XRL)9KRWD77T)W-)$Y\\^Y1N2?H6->375O-:7$D%U#)#/&=
MKQR*593Z$'D5^B-<OXV\":!XSM#%K5DC3!<1W4?RS1_1O3V.1[5M&L^IZM#-
M9+2JM/(^$:*]$^*7PKU?P+,;CF^T9VPEY&N-F>BR#^$^_0_I7G=;IIJZ/9IU
M(U(\T'=!1113+"BBNI\ >!=9\<:I]ETB'$,9'GW4G$<(]SW/H!R?IS2;MJQ2
MG&"YI.R.6 )( !)/  KTCP=\'/&'B'R[A;,:7:G#+/>DQGZA<;OH< >]?1_P
M\^%7A[P7''-# +[50/FO;A06!_V!T0?3GU)KOZPE6_E/&KYKTI+YLX+X>^!]
M7\,",ZEXPU75548^S2!?)Z=/GW-@>S+T_"N]HHK%N^K/)G.51\T@HHHI$!11
M10 4444 %%%% !1110 4CLJ(S.0JJ,DDX %+7FW[0/B;_A'/AU>)"^V\U(_8
MX<'D!A\Y_P"^01GU(II7=BZ5-U)J"ZGRU\3/$C>+/'&JZL&)@DEV6X/:)?E3
MZ9 R?<FN7HHKM2LK'U\(J$5%;(]1^!VO:!X.NM3\2:_,6N(HOLUE:Q+OED9N
M78#HH  &20/F-7?&?QY\3:TSPZ+LT6S/ \KYYB/=R./^ @?6O(:*7(F[LP>%
MIRJ>TFKLL7U]=:A<M<7]S/=3M]Z2:0NQ^I/-5Z "2 !DGH!6S9^%?$-ZH:ST
M+5;A3T,5G(X_04]C=M16NAC4JL48,A*L#D$'!%;TW@OQ3 NZ;PWK4:^K6,H'
M_H-8MS;3VLACN89(9!U61"I_(T70*49;,[CPG\6O%_AID6#5'O;5?^7>^S,N
M/0$G</P(KM_'WQ'T+XE_#^:UO(CI?B"Q875NDC;HYL<.J/ZE23M(&2 !FO"Z
M*EP5[F$L+3E)32LUV"BBBK.@^R?V>O$__"1?#RU@G?=>:8?L<N3R5 _=G_OG
M ^JFO3:^/_V;_$_]@^/X[&=]MGJR_9FR>!*.8S]<Y7_@=?8%<E2/+(^8Q]'V
M59VV>H4445F<9%>6T%[:RVUW#'/;RJ4DBD4,KJ>H(/45X+X]_9ZMKJ22[\'7
M:VCM\QLKDDQ_\!?DCZ$'ZBO?Z*J,G'8VHXBI1=X,^$O$GP^\5>'&;^U=$O$B
M7K-&GFQ?]]KD#\:Y:OT6K%U?PIX?U@L=4T73KMVZO+;(S?\ ?6,UJJW='IT\
MV?VX_<? =%?9.K? _P #7^3'ILUDYZM:W#C]&)'Z5PFO_LW1E6?P_KSJW\,5
M]$"#]73&/^^:M58LZX9G0EOH?.-*K%6#*2&!R"#@BNJ\:_#_ ,1^#7SK=@RV
MQ.U+J([X6/\ O#H?8X/M7*5HFGL=L9QFKQ=T>^?!KXUW-I<V^B>,K@SV;D1P
M7\AR\)["0_Q+_M'D=\CI]- Y&1R*_.FOKK]FWQ;)XA\%OIU[(9+W266'<3DM
M"0?+)^F&7Z**PJP2]Y'C9EA(Q7M8+U/7****P/'/C?\ :0_Y*UJ?_7*#_P!%
M+7F->G?M(?\ )6M3_P"N4'_HI:\QKMA\*/K,+_!AZ(][_9(_Y#_B#_KUC_\
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M6MITF&/56!_I76]CZ::YHM'Z%T4RWFCN((YH6#Q2*'1AT((R#3ZX3XX****
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MG_LE>2UUP^%'TF%=Z,/1&CHNAZKKDDD>C:;>7[Q ,ZVT+2%0>YP.*UO^%?\
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M'&B^-]-:ZT6=B\>!-;RC;+"3TW#T]",BNGJ6K:,YY1E!\LE9A1112)"BBB@
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M7!PZECG&,J1C!YZUSQCS.R/#H476GR1/8?$WBK0_#%OYVO:G;6:D95';+O\
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M^SG_ ,E<T?\ W)__ $2]=,_A9[V*_@S]&?9=<7\9=$/B#X:ZY9Q+NG2'[1$
M.2T9#X'N0"/QKM*",C!Z5QIV=SY6$W"2DNA^=-%=K\8/"3^#_'-]8I&5L9F^
MT6AQP8F)P/\ @)ROX5Q5=J=U<^OA-3BI1V9]D_L]^*4\1?#VTMY) ;[2P+29
M2>=H'[MOH5P/JIKTVOAGX6^-KKP+XGBU"$-+9R#RKN '_61Y[?[0ZC\NA-?:
MWA_6K#Q!I-OJ6D7*7-G.NY'4]/4$=B.X/2N6I#E=SYW'X9T:CDMF:%%%%9G
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MU4445RGS84444 %%%% !69XH_P"19U?_ *\YO_0#6G69XH_Y%G5_^O.;_P!
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M="DU#5) 9""MO;*?GG?^Z/;U/:OB7Q7K]]XGU^\U?5'WW-R^X@?=1>@5?8#
M%:TH7=ST\MPSG/VLME^9DT445U'T!]X?#'_DG'A?_L&6W_HM:Z:N9^&/_)./
M"_\ V#+;_P!%K735PO<^/J_&_4\[_:$_Y(_X@^D'_H^.OBVOM/\ :"!;X0>(
M .>(#_Y'CKXLKHH_">[E/\%^OZ(*_0[3O^0?:_\ 7)?Y"OSQK]"=#GCNM%L+
MB%@T4MO'(C#N"H(-*OT,LWVA\_T+M%%%<YX@5^?GB<8\2ZL#_P _<W_H9K]
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M %W'_H"U]NU\1?'#_DJWB/\ Z[C_ - 6HH[G+E/\5^APU?17[(77Q7_VZ?\
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MV]!T'YDN4U'1&E?%0HM4X[NWR/D*BBBM#L/T+TG_ )!5E_UP3_T$5;JII/\
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M2?L]>#68E9M70>BW"8_5*]AHJE.2ZF\<36BK*3/'/^&>/!__ #\ZS_X$1_\
MQ%=O\/O >E>!+2[M]&DNY$NG61_M+JQ! P,845UE%#FWHV$\35J+EE*Z"O+?
M%7P1\-^)?$%[K%_>:O'<W;AW6&:,(#@#@&,GMZUZE123:V(IU9TG>#L>,?\
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M/P7E1^ KT>BFFUL:0JSI_ ['CI_9Y\'$\7.LCV%PG_Q%)_PSQX/_ .?G6?\
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>asth-20231231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 asth-20231231_g2.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_
MF_\ 1T5?QA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX
M_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_F_\ 1T5?QA5_9[_P7X_Y0V?M
M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[
M_P"WC_T^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7
MX_Y0V?M"?]D_F_\ 1T5?QA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]_P &
MFW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?$OA'1-/AT\2V"R7DL-SIEO;F-XKK>L=O,)'=-J_-N$P_)O_ (.V_AU^T/\
M#S_@H5X8C_:%_:0M?B/+JG@!K[PQ+:^"(-$_L/2GU;4/)TUA#-)]K:,AC]H;
M:S[N5&*_I(_80^'7[1/PQ_9RTCP_^TU^TE:_%+7YECN;3Q#:>"(- 6WLG@A\
MJT-O!-*KF,ASYI8%]_(&.0#V2ORI_P""OG_!R/9_LB_'B#]@C]@+X2VOQ7^.
M5[J4&E7,=P9)-,TC49V5(;+RX662\NRSJ&B5XUC+ ,Y8-&OW_P#MV_'O4?V6
M?V*OBS^TAHL"2ZAX&^'6L:WID4J@K)=6]G+) K _PF14!]B:_F2_X-6O!<?[
M0?\ P6ZT+XD_%&]DUG5-#T'7_%4MWJ+^;)=:B\7D^?(6Y>3?>-+N/.]0W44
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MJVPF!B242K'&R,3&Q8E$=&^^M+\2?MJ?$/\ X+!^(_@W\/\ ]K744^"GP_\
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M#,^\)'.C-$6X7\1/^#7CP1^VK^TA^VW\5=4_9R_;<'PO\7W7@234?$WB[7O
M$'BR;6%DU*W,B.EW<1;9&E<2&;<S$J01\Q- ']5%%?D__P %UO\ @M[\:O\
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MU_X7B\1>%OAG:0ZKX/T>=K[5ENHT/^C?9H0S+*3A</M4$Y9E&2/S-_X(H_\
M!/G]K#_@I'_P5_LO^"E]W\&M9\(?"NU^+M[\1KSQ-JEH\-K<S'4);Z#3[)V"
MB[8SE$=H\HB*Y8@[%< _J.HKXT_X+@_\%9_#W_!(O]D/_A<-EX:M?$'CCQ-J
M1TCP#X?O9&6WFN_+:22YN-A#&WA0!F"D,[/'&&3?O7XN_:P_:O\ ^"M'["G_
M  2Y^$W_  5UUK]M2Z\8^)/$5UHNI?$/X3:[X0T>'PR-+U:(S06EJ+:TCO+>
M6'?!&\IN'9V9VR  K '[-2RQP1M--(J(BEG=C@*!U)/:O"/V#/\ @H'\(/\
M@H;I'Q,\:? @"Z\,?#_XIWG@JQ\01W8EAUU[6PL+F6]APH"PF6\>).7#I"LH
M8"0*OY__ /!=']K3XR?M:?\ !OY:_M[?LD?M#2^ O OB7P]IEQXP\)VV@^=J
M>LI?W]MI\VF'4EN$^R102RSI,$A<W'E;-Z1LP;PC_@T:^"'[;OCC]D+4OB-\
M$/VZ]/\  GPZTGX^R_\ "6?#6X^$UIJTNOF+3]'ENBNIRW,<EGY]NT=N-D;^
M48_,&XL5 !^^%%?@9_P50_X+.?\ !4;]A3_@LC;_ +$_PX_:@M]3\"7^O>'9
M;:'6? VCM=PVFH-"9;8S1VJ;@I>15? ;;MR2P+'VC_@Y^_X*<?\ !0C_ ()7
M^//A1XI_9+_:,33]%^)5MK*7WAS5_"&EWL6GS:<-/ >"62V,I647A++([X9#
MM(4A5 /V+HKY$\ ?&_\ :-^-_P#P11\+_M3Z;\9Y_#?Q-U+X!V?C";Q/IVA6
M$T<NIC2!>.'M9X7A\F23(9$5&"G",AYK\G_^"0G_  7^_P""R_[=/C'XA?L\
M^&5\._$?XG:CX42;X=PZEH%GI6DZ 4E_TO5=0FMXT9X8T:*-(LDR37$*XVER
M #^ANBOR[_X(^ZO_ ,%[OB'\%?V@]$_X*;^,M<\$Z]8S6O\ PJWQ5=^&]$^U
M6UY&MR]YY,,<#6]S9?):+N9""LDGE2!OG3XH_P""*G_!;3_@N3_P4W_:;\2?
MLR:)\6O =Y<S?#^ZOT\2>(O"-I!;>% EY9QMJ?D6D<<E_*!*8([8NL9DN5DD
M)2)@0#^ANBOP+_X)O_\ !9;_ (*>_!S_ (+D7W_!+[]O#]H"P^*NAW_C74/"
MTVJ#P[9V+6=Y''(]M>6OV:&(JDA2-6A?<JK*2N&7+?OI0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>['A;0&EW75^MK;O<7$JQC)$4<:?-(<(&9%SN=0?BOX+_P#!)_\ X*5?L_\
MA6U^%?PU_P""[_Q!_P"$-L+<6^GZ=XA^$FAZOJ-K N%6--0O3+)A4&U05*J
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M_P"'WB>-K;7/AUX;U?\ LU]3T\ON_LZ[U"!Q)/;<E#B-)=C$>8&)<@'YF_\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?\
M9/YO_1T5?QA5_9[_ ,%^/^4-G[0G_9/YO_1T5?QA4 ?O]_P:;?\ *4S]KO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#Y _X+\?\H;/VA/\ LG\W_HZ*OXPJ_L]_X+\?\H;/VA/^R?S?^CHJ
M_C"H _?[_@TV_P"4IG[7?_;Q_P"GR>OW^K\ ?^#3;_E*9^UW_P!O'_I\GK]_
MJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16/_P@^D?\_-[_ .!;4?\
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
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M^4IG[7?_ &\?^GR>OW^K\ ?^#3;_ )2F?M=_]O'_ *?)Z_?Z@ HHHH ****
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MO_7E%_,UL5CV7_([WO\ UY1?S- &Q1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!F^,?\ D6+W_K@:N:=_R#X/^N*_R%4_&/\ R+%[
M_P!<#5S3O^0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH Q_ __ "")?^OV;_T*MBL?P/\ \@B7_K]F_P#0JV* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q+_R%]'_Z_3_Z
M":V*Q_$O_(7T?_K]/_H)H V**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L?P/_R")?\ K]F_]"K8K'\#_P#((E_Z_9O_ $*@#8HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q[+_D=[W_
M *\HOYFMBL>R_P"1WO?^O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#Y _X+\?\H;/VA/\ LG\W_HZ*OXPJ_L]_X+\?\H;/VA/^R?S?
M^CHJ_C"H _?[_@TV_P"4IG[7?_;Q_P"GR>OW^K\ ?^#3;_E*9^UW_P!O'_I\
MGK]_J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PO\ :P_Y+9\#_P#L
M>Y?_ $F:O=*\+_:P_P"2V? __L>Y?_29J]TH **** "BBB@ HHHH **** "L
M>R_Y'>]_Z\HOYFMBL>R_Y'>]_P"O*+^9H V**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** ,WQC_P BQ>_]<#5S3O\ D'P?]<5_D*I^
M,?\ D6+W_K@:N:=_R#X/^N*_R% $U%%% !1110 4444 %%%% !1110 4444
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MB@ HHHH **** "BBB@ HHHH **** "BBB@#'\#_\@B7_ *_9O_0JV*Q_ _\
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M_P CO>_]>47\S6Q6/9?\CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%%%
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M*_R%4_&/_(L7O_7 U<T[_D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@
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M?1S<HR7JU%._;F7='8T445_*!_704444 %%%% !1110 4444 %%%% !1110
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M\=OA7X7^,.O_ !@O=$L_$]Q.]MHZZ$LD\=JLKK$YF,P7<Z(&QLP PZU]N?\
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M%?''V@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6/X'_Y!$O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8_@?_D$2_\
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M_P"A4 ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M&/9?\CO>_P#7E%_,UL5CV7_([WO_ %Y1?S-;% !1110 4444 %%%% !1110
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M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
M"#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q10!C_ /"#Z1_S\WO_ (%M1_P@^D?\
M_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?
M\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U9GA7PKIVH:=
M)--/<@BYD4!+AE& U=76/X'_ .01+_U^S?\ H5 !_P (/I'_ #\WO_@6U'_"
M#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M6Q10!C_\
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M^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\
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M* "BBB@#-\8_\BQ>_P#7 U<T[_D'P?\ 7%?Y"J?C'_D6+W_K@:N:=_R#X/\
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M10!X7^UA_P EL^!__8]R_P#I,U>Z5X7^UA_R6SX'_P#8]R_^DS5[I0 4444
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MVC'_ +=C9+T)R'+7E&2X?!R=Y0BE)_S2M>4O^WI7;]0K'\2_\A?1_P#K]/\
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M4 %%%% !1110 4444 %%%% !1110 5C^!_\ D$2_]?LW_H5;%8_@?_D$2_\
M7[-_Z%0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 8]E_R.][_UY1?S-;%8]E_R.][_ ->47\S6Q0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'R!_P %^/\ E#9^T)_V3^;_ -'15_&%7]GO_!?C
M_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?\I3/VN_^WC_T^3U^_P!7X _\&FW_
M "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1145]?66F64VI:E>16]O;Q-+<7
M$\@1(D499F8\*  22> !0!+17P+\=_\ @O3X0_9LUG2/B!\9/V%?C3H?P.UK
M6H--LOCG?:+;IIW[YML5Z]GYOVN&T?ADDE1'=""L3$JI^MOVGOVJ/@K^R#\
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M_P#0JV*Q_ __ "")?^OV;_T*MB@ HHHH **** "BBB@ HHHH **** "BBB@
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M% !1110!CV7_ ".][_UY1?S-;%8]E_R.][_UY1?S-;% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?('_!?C_E#9^T)_V3^;_T=%7\85?V>_\
M!?C_ )0V?M"?]D_F_P#1T5?QA4 ?O]_P:;?\I3/VN_\ MX_]/D]?O]7X _\
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
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M_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\
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M?!_UQ7^0JGXQ_P"18O?^N!JYIW_(/@_ZXK_(4 34444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 8_@?_D$2_P#7[-_Z%6Q6/X'_ .01
M+_U^S?\ H5;% !1110 4444 %%%% !1110 4444 %%%% !7S?_P4,9OB.WPU
M_9/M&+-\1O'$!UF%3RVD6&+J[X]L1$=N#7TA7S=X!_XO/_P4A\8^.&_>Z7\*
M?"5KX>TX_P !U&])N+B13_>6,>4WX5]3PG_LV.JYB]L-3E47^/2%+[JLX/T3
M/E.+_P#:<!2RU;XJI&F_\&LZOWTH37JT?2"JJ*$10% P !P!2T45\L?5A111
M0 5C^)?^0OH__7Z?_036Q6/XE_Y"^C_]?I_]!- &Q1110 4444 %%%% %/Q#
MH&D^*] OO"^OV27-AJ5G+:WMO)]V6&1"CH?8J2/QKP+_ ()T:]J_ASP!XE_9
M<\7WKS:U\)O$DVCB27[]QILA::QG]E:,LJC^[&*^B:^:_BY_QC[^WUX(^,L?
M[G0?BGIS>$/$C#A%U*/]YI\K>KO@PCT537U60?\ "A@,7E3WG'VM/_KY23DU
M_P!O4G45NLN7R/D^(?\ A.S#!YLMH2]E4_Z]UG&*;_PU53=^D>?:[/I2BBBO
ME3ZP**** "BBB@ HHHH **** "BBB@ K'\#_ /((E_Z_9O\ T*MBL?P/_P @
MB7_K]F_]"H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?]<5_D*I^,?^18O?^N!JYIW_ "#X/^N*_P A0!-1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!C^!_^01+_P!?LW_H5;%8_@?_ )!$
MO_7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1110!G>+O%&D>"/"FI^--
M?N/*L-(TZ:]O9?[D,4;2.?P537B'_!-?POJ]M^SE_P +9\5V^S6_B5X@OO%>
MJ9Y(^U2GR0"?X?)2-@.@WG%-_P""E'B35A^SU#\'/"UR8]:^)OB2P\+::5Y*
MK<2@S,1_=\I'5CT&_FO<_"WAO2?!OAC3O"&@6XAL=*L(;.RA'\$,2!$7\%4"
MOJ?]PX0_O8JK_P"245^4IU/OIGRG_(PXQ_NX6E_Y4K/\XPI_=4\R_1117RQ]
M6%%%% !6/XE_Y"^C_P#7Z?\ T$UL5C^)?^0OH_\ U^G_ -!- &Q1110 4444
M %%%% !7DO[<7P9O_CC^S1XB\+^'0ZZ]I\*ZOX9FA_UD>H6I\Z+8>S-M,>?2
M0UZU17;EN/KY7F%+&4?CIR4EZIWU\GU\CAS+ 4,URZK@Z_P5(N+])*VGFMT^
MC.%_9F^,MA^T%\!?"WQ@L"@;6M)CDO(H^D-TN8YXQ_NRJZ_A7=5\U?LC_P#%
MBOVF/BC^R1=?NM.GO!XT\$1'@?8;Q@MS$@[)%< *![L:^E:]#B3 4,!F\XX?
M^#.U2G_U[J)3BO6*?*_[R:/.X9Q]?,,FIRQ/\:%Z=3_KY3;A-^DFN:/]UI]0
MHHHKPCWPHHHH **** "BBB@ HHHH *Q_ _\ R")?^OV;_P!"K8K'\#_\@B7_
M *_9O_0J -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#'LO^1WO?^O*+^9K8K'LO^1WO?^O*+^9K8H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#Y _P""_'_*&S]H3_LG\W_HZ*OXPJ_L]_X+\?\
M*&S]H3_LG\W_ *.BK^,*@#]_O^#3;_E*9^UW_P!O'_I\GK]_J_ '_@TV_P"4
MIG[7?_;Q_P"GR>OW^H **** "BBB@ HHHH **** "BBB@ HHHH **** /"_V
ML/\ DMGP/_['N7_TF:O=*\+_ &L/^2V? _\ ['N7_P!)FKW2@ HHHH ****
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M$W_?@CY/#_\ "7Q95H[0Q<?:1_Z^TU&%1>LH>S:7]R;[GN-%%%?*GU@4444
M%%%% !1110 4444 %8_@?_D$2_\ 7[-_Z%6Q6/X'_P"01+_U^S?^A4 ;%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/9?\CO>_\
M7E%_,UL5CV7_ ".][_UY1?S-;% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 ?('_!?C_E#9^T)_P!D_F_]'15_&%7]GO\ P7X_Y0V?M"?]D_F_
M]'15_&%0!^_W_!IM_P I3/VN_P#MX_\ 3Y/7[_5^ /\ P:;?\I3/VN_^WC_T
M^3U^_P!0 4444 %%%% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!_\
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MH **** ,>R_Y'>]_Z\HOYFMBL>R_Y'>]_P"O*+^9K8H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#Y _X+\?\ *&S]H3_LG\W_ *.BK^,*O[/?
M^"_'_*&S]H3_ +)_-_Z.BK^,*@#]_O\ @TV_Y2F?M=_]O'_I\GK]_J_ '_@T
MV_Y2F?M=_P#;Q_Z?)Z_?Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKK5-%M&MK/Q-H5_ MQ8:I% [N89-C>5<1!W5)0"K8D"+]05^8OP!74[[_@[
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M ;%8]E_R.][_ ->47\S1_P )+J__ $*%[_WTM9EKKFHKXINKI?#=RSO;1JT
M9=R@$\F@#JZ*Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_
M^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_
M +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^
M^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**
MQ_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X2
M75_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X
M275_^A0O?^^EH_X275_^A0O?^^EH F\8_P#(L7O_ %P-7-._Y!\'_7%?Y"N?
M\2Z]J=SH-U!-X8NH5:(@RNRX7W-6;+Q'JJ6<2+X2O& B4!@RX/'6@#=HK'_X
M275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H
M4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A
M0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH
M V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^E
MH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8H
MK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275
M_P#H4+W_ +Z6@ \#_P#((E_Z_9O_ $*MBN4\*ZYJ-KITD</ANYG!N9&+HRX!
M+=/PK3_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH
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M4 %%%% !1110 4444 %%%% &/9?\CO>_]>47\S6Q6/9?\CO>_P#7E%_,UL4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\@?\ !?C_ )0V?M"?
M]D_F_P#1T5?QA5_9[_P7X_Y0V?M"?]D_F_\ 1T5?QA4 ?O\ ?\&FW_*4S]KO
M_MX_]/D]?O\ 5^ /_!IM_P I3/VN_P#MX_\ 3Y/7[_4 %%%% !1110 4444
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MJ]TKPO\ :P_Y+9\#_P#L>Y?_ $F:O=* "BBB@ HHHH **** "BBB@ K'LO\
MD=[W_KRB_F:V*Q[+_D=[W_KRB_F: -BBBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#-\8_\BQ>_P#7 U<T[_D'P?\ 7%?Y"J?C'_D6
M+W_K@:N:=_R#X/\ KBO\A0!-1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!C^!_P#D$2_]?LW_ *%6Q6/X'_Y!$O\ U^S?^A5L4 %%
M%% !1110 4444 %%%% 'BO\ P4)^)6H_#7]DSQ3)X>W-K/B"!- T.&,X>6YO
M7%N G^T$>1Q_N5Z'\%?AKIWP<^$7AKX5Z7M,/A_1+:Q\Q!CS6CC"O)]68,Q]
MV->*_M(?\7A_;;^$'P"B_>V'A<7/COQ%%U"F#,%@Q'_7<OU[-7TC7U.9_P"P
M\.8/!_:JN=>7HW[.FGZ*$I+RJ'RF5_[?Q-C<9]FDH4(^J7M*C7JYQB_.F%%%
M%?+'U84444 %%%% !1110 5C^)?^0OH__7Z?_036Q6/XE_Y"^C_]?I_]!- &
MQ1110 4444 %%%% !1110 4444 %%%%  0&!5@"".0:^:_V'F/P5^*GQ-_8S
MO28[7PWK9U_P7&QX.C7Y\SRT]5AF)4G^](:^E*^:OVS/^+'?'KX7_MAVG[JQ
MLM3/A/QO*.!_9=\W[J60]DAG^?ZNM?5<,_[='$92_P#E_"\/^OM.\Z=O.2YJ
M:_Z^'R?%'^P2PV;K_F'G:?\ UYJ6A4OY1?)5?_7L^E:***^5/K HHHH ****
M "L?P/\ \@B7_K]F_P#0JV*Q_ __ "")?^OV;_T*@#8HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH Q[+_ )'>]_Z\HOYFMBL>R_Y'
M>]_Z\HOYFMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D#_@
MOQ_RAL_:$_[)_-_Z.BK^,*O[/?\ @OQ_RAL_:$_[)_-_Z.BK^,*@#]_O^#3;
M_E*9^UW_ -O'_I\GK]_J_ '_ (--O^4IG[7?_;Q_Z?)Z_?Z@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH \+_:P_Y+9\#_\ L>Y?_29J]TKPO]K#_DMG
MP/\ ^Q[E_P#29J]TH **** "BBB@ HHHH **** "L>R_Y'>]_P"O*+^9K8K'
MLO\ D=[W_KRB_F: -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$O\ R%]'_P"OT_\ H)K8K'\2_P#(7T?_ *_3_P"@F@#8HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ^>O^"C/AC6M/^%6C?M'^"[,RZ_\)O$,'B"W1.&G
ML0P2]@)[(T1W-[15[KX3\3Z+XV\+:;XS\-W@N-.U:PAO+"X7I)#*@=&_%6!J
M;7=$TOQ+HEYX<URR2YLM0M9+:\MY!E98I%*NA]BI(_&OG_\ X)U:WJOA3P7X
MI_93\6WKRZQ\)_$LVEPR3'Y[C2YBT]C.?9HRR@=E1:^J7_"GPFU]O"3O_P!P
MJKL_E"JE\ZQ\F_\ A+XN3VIXR%O^XU)77SG2;^5$^BJ***^5/K HHHH *Q_
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M":3C)----7336C36J:T:.N,HSBI1=T]F%%%%:E!1110 4444 %%%% !1110
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MB@#PO]K#_DMGP/\ ^Q[E_P#29J]TKPO]K#_DMGP/_P"Q[E_])FKW2@ HHHH
M**** "BBB@ HHHH *Q[+_D=[W_KRB_F:V*Q[+_D=[W_KRB_F: -BBBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-\8_P#(L7O_ %P-
M7-._Y!\'_7%?Y"J?C'_D6+W_ *X&KFG?\@^#_KBO\A0!-1110 4444 %%%%
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M,[Q>98N5*K&*2BWHGW2ZM]SV&BBBOZ&/J0HHHH **** "BBB@ HHHH ****
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M\#_\@B7_ *_9O_0JV*Q_ _\ R")?^OV;_P!"H V**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH \>_;Y_P"33/%G_;A_Z7V]?FY7Z1_M\_\
M)IGBS_MP_P#2^WK\W*_BCZ2'_)<8?_L&A_Z=K'Y]Q9_R,8?X%^<@HHHK^?CY
M@_2/]@;_ )-,\)_]O_\ Z7W%>PUX]^P-_P FF>$_^W__ -+[BO8:_P!+> _^
M2'RO_L&H?^FHGZWEO_(NH_X(_D@HHHKZL[0HHHH **** "BBB@ HHHH ****
M "BBB@#Y _X+\?\ *&S]H3_LG\W_ *.BK^,*O[/?^"_'_*&S]H3_ +)_-_Z.
MBK^,*@#]_O\ @TV_Y2F?M=_]O'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?)Z_?
MZ@ HHHH **** "BBL7XC^"8?B3X!UCX?W'B76=&CUG3I;.75/#VH&TOK59%*
ML\$Z@M#( 3M=?F4\@@@&@#YV_:,\,V7_  4=\1W/[)ND2F;X0:!KT/\ PN76
MXC^Z\0W%K,LJ^%[5Q]]/.2,W\JG"(GV0$R2S_9OF?_@OYHMA!\3/V)_VI=(N
M[2Y\'_#']K#1;#Q7=V$JO#I<<U[!$TDA0[8Q#+9-$P.-LC*AP3BNRTK_ (-H
M_P#@GSH.F)HNA_$KXZV5G'N\NTM/C-J4<2[B6;"J0!DDD\<DD]Z^I]$_8*_9
M:TK]C&W_ & ;_P"&D6K?"^'PZ-&FT+5[AYGN8=WF&62;(<W!FS/YRE7$O[Q2
MK $ 'QE_P<T^$]7^-/P;_9M_9?\ !<+W'B/Q]^U1X<@T^VB&76WBMK[[1<<=
M$B$D;,W15))P!1_P3^\):A\%O^#BC]M/P1XLA:*?XB>#/"?C'PK)*,&]TV*(
MVT\B9ZK'=2F$D<;HZ^POA?\ L'_"WP#\5]#^./C3QWXS^(OBSPEH\VE>"=:^
M(6M1WLGARSF54G6T6**)!-*B(DEU(LEU(BA7F920=;X\_L>_#+X[_$#PU\:'
MUO7O"7C_ ,'V]S:^'/'G@^[B@U&VM+@#[19N)XIH+FWD*HQAGBD17174*X#4
M ?$_[+GA/5_B'_P=#?M+?&G1(GDT/P!\!] \'ZK=H/W8U&_.GZA'%NZ%A%;2
MY';OBOTOKSS]G#]E[X1?LL>%=3\-?"O2;K[1K^MSZUXIU[5[Y[O4M>U.?'G7
MMY<2$M+*VU5'1$151%1%51Z'0 5Y?\5O"G[6>K^+GO/@_P#%?POI&BF! EEJ
MVA/<3"0#YV+@C@GH*]0HH ^0OB[X8_:BTGXY?!YOB[\3_#6KQR>-"-.72M$:
MW,,@A)<ODG<"N0!ZU]2_8O&__0;LO_ 8_P"->1_M8?\ );/@?_V/<O\ Z3-7
MNE &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_
MXT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;
M%% &/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^-;%% &/]B\;_\ 0;LO_ 8_
MXUF6MKXI/BFZCCU2V%P+:,R2& [2N3@ 5U=8]E_R.][_ ->47\S0 ?8O&_\
MT&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_
M -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!
MC_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/
M^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !
MC_C6Q10!C_8O&_\ T&[+_P !C_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0
M;LO_  &/^-'V+QO_ -!NR_\  8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\
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M ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
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M &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XUL44 8_V+QO\ ]!NR_P#
M8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\
MP&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XUL5S7Q*^,'PV^
M$&D_VS\1/%MIIL; ^3%(^Z:<CM'&N7<_0''>N?%XO"X##RKXFI&$(ZN4FDDO
M-O1$SG"G%RF[)=67?L7C?_H-V7_@,?\ &N;^)/Q0T[X1:1_;?Q$^)&D:;$P/
MDQRPDRS$=HXUR[G_ '0:X\_$/]I+X[_N/A+X2_X07P]+Q_PD_BBV#WTR'^*"
MTZ+Z@N<$'((-='\-OV6_AMX"U?\ X3+6?M?B?Q,Y#3>(_$DWVFXW?],PWRQ
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M#'_&MBB@#'^Q>-_^@W9?^ Q_QK0TV/48K4)JEQ'++N.7B3:,=N*L44 %%%%
M!1110 4444 ?('_!?C_E#9^T)_V3^;_T=%7\85?V>_\ !?C_ )0V?M"?]D_F
M_P#1T5?QA4 ?O]_P:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\
MT^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1110!X7^UA_R6SX'_\
M8]R_^DS5[I7A?[6'_);/@?\ ]CW+_P"DS5[I0 4444 %%%% !1110 4444 %
M8]E_R.][_P!>47\S6Q6/9?\ ([WO_7E%_,T ;%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% &;XQ_Y%B]_ZX&KFG?\@^#_ *XK_(53
M\8_\BQ>_]<#5S3O^0?!_UQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@
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MIP@VKIV;BD[72=MKI=C6EA,)AY<U*G&+[I)?D,G@@NH7MKF%)(Y%*R1R*"K
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M>"N554(R Q"LO[+GWBIP7DF7RQ$,7"M.WNPIR4G)]$^6ZBN[E:WF]#\3X?\
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MN7_TF:O=* "BBB@ HHHH **** "BBB@ K'LO^1WO?^O*+^9K8K'LO^1WO?\
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MC_Z-U\=?^"U/_BZ/^&AO$?\ T;KXZ_\ !:G_ ,77IM%']B\2?]#27_@JE_\
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MHXKZE_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ
M-BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V*Q[+_D
M=[W_ *\HOYFC_A!](_Y^;W_P+:LRU\*Z=)XINK!I[G9';1LI%PV[))ZF@#JZ
M*Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X
M0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\
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M+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\
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M;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
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M%?/?5>+LU_WBM'"4W]FE:I5^=2<5"/FHTI6Z3ZGT/MLDP?\ "INM+O/W8?\
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MGP=_9F^/7Q]UF+1?A/\ "W5]6,KA6NX[1DM8<]Y)WQ'&/]YA[9K]\JQ_ _\
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MBBB@ HHHH **** /"_VL/^2V? __ +'N7_TF:O=*\+_:P_Y+9\#_ /L>Y?\
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MS>_8E^,=SH/Q'NO!7B+4&>W\2R&2.25NEZ,D'ZN,J?5@E?2'COXX?"[X</\
M9?$WBR!;PG":=:YFN68]!Y:989[9P/>OSYBEEMY5G@E9'1@R.C8*D="#V-?<
M/[+&D?"C4?AGIOC3P1X1LK2]FB\K4I@OF3K<+Q(ID<E\$_,!GHPK\O\  OC3
MB',\OGPWAYTU.GS3C.KS2:A)KF4::Y>=J3;NZD;<VS2T^O\ $/(<LPF)CFM2
M,G&5HN,+)<R6C<G?ENE;2+O;H(?B+\>_B-^[^&OPRC\/6#_=UGQ<Q64KZK;)
ME@>X+$@UXO\ 'KP+XNU;]I+X3? [7?BAJ?B._P#$.IW.K^*!,BQ6MMI5G'O:
M-(5XC\YR8MX.[CC;FOKJOF[]GC_B\7[<WQ;^.TG[VP\(06O@7P_+U :(_:+\
M#L")RHX[-7]3<-\$9;BGB<PSV<L:J%*4E&K;V//.U.G:A%*D^64U-<\9RM!W
MD]3\-XEXCQU%87 96EAY5ZL8N5._M.2%ZE3]XVYKFC!P?*XJ\UIL?0NA^']"
M\,Z>FD^'=&M;"U3[EO9P+&@_!0!5RBBNBG2IT::ITXJ,5HDE9)>2.V<YU).4
MG=OJPHHHJR0HHHH **** "BBB@ HHHH **** "BBB@ K'\2_\A?1_P#K]/\
MZ":V*Q_$O_(7T?\ Z_3_ .@F@#8HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *Q_ _P#R")?^OV;_ -"K8K'\#_\ ((E_Z_9O_0J
M-BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'LO\
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MUI9QXQLM;=8QCZ*!5NBO9P&29+E2M@L-3I?X(1C_ .DI'!B<PQ^,=\15E/\
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M44 %8_@?_D$2_P#7[-_Z%6Q6/X'_ .01+_U^S?\ H5 &Q1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!CV7_([WO\ UY1?S-;%8]E_
MR.][_P!>47\S6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R
M!_P7X_Y0V?M"?]D_F_\ 1T5?QA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]
M_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110
M4444 %%%% !1110 4444 %%%% !1110!X7^UA_R6SX'_ /8]R_\ I,U>Z5X7
M^UA_R6SX'_\ 8]R_^DS5[I0 4444 %%%% !1110 4444 %8]E_R.][_UY1?S
M-;%8]E_R.][_ ->47\S0!L4444 %%%% !1110 4444 %%%<9\2OVA/@W\),P
M^.?'EE;77\.G0N9KIR>@$,8+\^I 'O7)CLPP.68=U\75C3@MY2DHK[VTB*E6
MG1CS5))+N]#LZ1W2)#)(X55&69C@ >M>,_\ "[OVA/BE^Z^"/P,?2;&3A/$7
MCV0VR8_O+;)F1AW#9QTR*5/V4=;\?N+W]HWXRZUXJ!.YM#L'_L_3!_LF*(AG
MQV8D'UKYS_6>OC],HPDZW]^7[FE_X%-<\EYTZ<UYG)]<E5_@0<O-^['[WJ_D
MF;'C7]KGX+>$]2_X1S1]:N/$^M$D1Z+X4M3?3NPZC*?("#U!8'VK&_M[]L3X
ML_+X=\,:1\-]*DZ7NLN+_4BO]Y85_=H?57Y'K7IW@KX=^!/AQIO]D>!/".GZ
M3;X&Y+&U6,OCNQ RY]R2:V:/[%S_ #+7,L:X1_Y]X=.FO1U7>J_6#I>@?5\3
M5_BU++M'3\=_NY3R/0_V.?AY/J4?B/XN:[K'CW54.5N/$MXSV\9[B.W4A%7_
M &3N%>J:7I6EZ)81Z7HNFV]G;0KMAMK6%8XT'H%4  ?2K%0:AJ>FZ1;->ZKJ
M$%K"OWI;B544?4D@5ZV79+DN10E+"T8T[_%+[4O.<W>4O63;.FAA:-)VI0U?
MWOY[LGHK@=?_ &G?@=H$WV-O'EO?7!.$M])C>[9SZ Q!AGZFL[_A?7COQ'\O
MPY_9\\1WJM]RYUMH].B/^T#(26'Y5Y];C3A>E5=*&)56:WC24JTEZQI*<E\T
M>Y3R'-YQ4Y4G"+ZSM!??-Q7XGI]17M[::;93:C?W"Q06\3232N<*B*,EB?0
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M0G)_]NU<0X4XKRIR45V1Z5/A;ZO+GQ-2G"7><U*2_P"W8\\EZ<J/3ZY_Q/\
M%?X9^#-R^*/'FE63IUAEO4\S_O@'<?RKD/\ AF>WUWY_B3\6/%?B#/\ K+:3
M4C;VS?\ ;*,#'YUT/ACX"?!KP?M;0/AQI4;I]V:>V$\@^CR[F'YU]']=XSQG
M\'"4J"[U:CG)?]PZ<>7_ ,K'5[#(J'\2M.H^T(J*_P# IN__ )(<^_[5'@C5
M7,/P]\*^)?%#YP&T?19#$#_M/)MP/?!I/^$U_:=\4\>&_A%HWA^)ON7/B/6#
M,Q'KY< RI]C7IR(D:".- JJ,*JC  I:/["X@Q?\ ON9R2_EHTX4H_?/VU1?*
MHGYA_:.6T?X&$3\ZDI3?W1Y(_?%GF'_"I?CCXFY\<?M!7-I$WWK/PQIL=MM^
MDQR_YBI]/_93^#T5RNH>(M.O_$%VO_+WK^J2W#'ZC(4_]\UZ1150X)X:<E/$
MT?;R76M*=;7NO:RFE\DDN@I9_FMN6E4]FNU-1I_^D)-_.YG:!X0\*>%(?L_A
MCPSI^G)C&VQLTB!_[Y S6C117TU&A1PU-4Z45&*V2227R1Y-2I4JS<IMMOJ]
M6%?(?QL^ G[3/Q:^).I>,IOAVP@EE\NPB;5[/]U;IPBX\[@X^8_[3&OKRBOC
MN..!<MX^P%/!8^M5A3A+FM3<5S.UES<T)WM=VM;?6^EO<X?XBQ?#>)E7PU.$
MI25KR3=EN[6E'?2_H?"=Y^R+^T-I]J][=_#[9%&N7;^UK0X'T$M21_L>_M&2
MQK+'\.\JR@J?[7L^0?\ MM7VMXQ_Y%B]_P"N!JYIW_(/@_ZXK_(5^8_\2V<"
M_P#03B?_  .E_P#*3Z[_ (BKQ#_SZI?^ S_^3//?V7='^*7A;X;1^#?BGX>:
MRGTN4QZ?*UY#-YMN>57,;M@H<KSCY=N.AKTBBBOV_),JIY%E%#+Z=252-**B
MI3:<FEHKM**=E9;+1:W>I^?9AC)9CC:F)E%1<W=J-TKO>UVWJ]=PHHHKU3C"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q_ _\ R")?^OV;_P!"
MKQW_ (*1>--7T#]E_4/ ?A23_B>_$#5+3PGHD8/^LEO9-DB\<\PB8?B*]B\#
M_P#((E_Z_9O_ $*O!OBU_P 7F_X*'_#SX7)^]TSX;>';OQ;K"#E&O)R+:T1O
M1T/[T#T8U]-PE3I_VU'%5%>&'4JTK[/V:YHI_P"*:C#_ +>/E^,*M3^PYX6D
M[3Q#C1C;=>U?+*2_P0<I_P#;I[U\/_!>D?#CP)HOP^\/Q[;'0]*M["S7&/W<
M,:QK^.%%:]%%?.5:E2M4E4F[R;;;[M[L^EI4J=&E&G35HQ2279+1(****@L*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q+_R%]'_Z_3_Z":V*Q_$O
M_(7T?_K]/_H)H V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "L?P/_R")?\ K]F_]"K8K'\#_P#((E_Z_9O_ $*@#8HHHH ****
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M!GQ3^./P;@^'OQ,TW5GL/&S27BVDC'RD: HI.0."Q KZ9_X3'PQ_T&H/^^J
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M_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\
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M26S60_\  &<-^E=AHGBGX<^)L?\ "-^(]$U#</E^PWD,N?\ ODFN4US]C_\
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MX@*"?_'*/^%W?\%'/^C'?#G_ (<RW_\ B*^6_P!4\>]J^'_\*:'ZU#ZS_6[
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M\S+I7_QNC_5'-?\ GYA__"O"_P#RX/\ 7'*?^?6(_P#"3%__ "D^A?[.T_\
MY\8?^_0H_L[3_P#GQA_[]"OGK_AI3_@H .6_X)HG'?'QDTH_^TZ/^&H_VX?^
MD;6H_P#AS],_^(H_U1S;I4H?^%6%_P#EP?ZXY/UIXA?]RF*7_N$^A?[.T_\
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MC_Y4>K?'?XM_#G]G?X4:Q\7OB#'''IND6^]HXHE,EQ*Q"QPQ@]7=RJCL,Y)
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M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
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M A_L[3_^?&'_ +]"LCP796<NE2-+:1,?MDHRT8/&ZMVL?P/_ ,@B7_K]F_\
M0J -+^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\
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M"_\ A ?^"@G_ $7_ ,"?^$I)_P#%4?\ " _\%!/^B_\ @3_PE)/_ (JO=**
M/"_^$!_X*"?]%_\  G_A*2?_ !5'_" _\%!/^B_^!/\ PE)/_BJ]THH \+_X
M0'_@H)_T7_P)_P"$I)_\51_P@/\ P4$_Z+_X$_\ "4D_^*KW2B@#PO\ X0'_
M (*"?]%_\"?^$I)_\57 ^'M2_;JU7]HGQ#\)H/C7X02^TG0+2]GNW\,DPR)*
MQ"JJ@[@PQR2<5]95Y!X-\"^+K#]M/QI\0+S09X]%U#P?IUK9:BP'ERS1NQ=!
MSU - &5_P@/_  4$_P"B_P#@3_PE)/\ XJC_ (0'_@H)_P!%_P# G_A*2?\
MQ5>Z44 >%_\ " _\%!/^B_\ @3_PE)/_ (JC_A ?^"@G_1?_  )_X2DG_P 5
M7NE% 'A?_" _\%!/^B_^!/\ PE)/_BJ/^$!_X*"?]%_\"?\ A*2?_%5[I10!
MX7_P@/\ P4$_Z+_X$_\ "4D_^*H_X0'_ (*"?]%_\"?^$I)_\57NE% 'A?\
MP@/_  4$_P"B_P#@3_PE)/\ XJC_ (0'_@H)_P!%_P# G_A*2?\ Q5>Z44 >
M%_\ " _\%!/^B_\ @3_PE)/_ (JC_A ?^"@G_1?_  )_X2DG_P 57NE% 'A?
M_" _\%!/^B_^!/\ PE)/_BJ/^$!_X*"?]%_\"?\ A*2?_%5[I10!X7_P@/\
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M'P18"\N3?ZHDN@RW+M=.B*P\PD;@JHJC  ^7.,DUZ7_P@/\ P4$_Z+_X$_\
M"4D_^*KW2BOY>S/,<9F^85<;BI<U2I)RD_-_DNB71:']5Y7EF#R;+J6!PD>6
MG3BHQ7DOS?5OJ]3PO_A ?^"@G_1?_ G_ (2DG_Q5'_" _P#!03_HO_@3_P )
M23_XJO=**X3O/"_^$!_X*"?]%_\  G_A*2?_ !5'_" _\%!/^B_^!/\ PE)/
M_BJ]THH \+_X0'_@H)_T7_P)_P"$I)_\51_P@/\ P4$_Z+_X$_\ "4D_^*KW
M2B@#PO\ X0'_ (*"?]%_\"?^$I)_\51_P@/_  4$_P"B_P#@3_PE)/\ XJO=
M** /"_\ A ?^"@G_ $7_ ,"?^$I)_P#%4?\ " _\%!/^B_\ @3_PE)/_ (JO
M=** /"_^$!_X*"?]%_\  G_A*2?_ !5'_" _\%!/^B_^!/\ PE)/_BJ]THH
M\+_X0'_@H)_T7_P)_P"$I)_\51_P@/\ P4$_Z+_X$_\ "4D_^*KW2B@#PO\
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M,\3V<NO?'+XB:]IJPZK<0+HUEID4$LT$;XCF\UWD #CG&SC/7O7WE\$_@/\
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M?_ G_A*2?_%5[I10!X7_ ,(#_P %!/\ HO\ X$_\)23_ .*H_P"$!_X*"?\
M1?\ P)_X2DG_ ,57NE% 'A?_  @/_!03_HO_ ($_\)23_P"*H_X0'_@H)_T7
M_P "?^$I)_\ %5[I10!X7_P@/_!03_HO_@3_ ,)23_XJC_A ?^"@G_1?_ G_
M (2DG_Q5>Z44 >%_\(#_ ,%!/^B_^!/_  E)/_BJX'XNZE^W5X#\<^!/#6J?
M&OPA<3>)M?>RLY;;PR52%Q$7W2!B25P,8&#7UE7D'[1_@7Q=XL^+'PDUOPYH
M,]W::'XPDNM6GA *VL)@90[<],\4 97_  @/_!03_HO_ ($_\)23_P"*H_X0
M'_@H)_T7_P "?^$I)_\ %5[I10!X7_P@/_!03_HO_@3_ ,)23_XJC_A ?^"@
MG_1?_ G_ (2DG_Q5>Z44 >%_\(#_ ,%!/^B_^!/_  E)/_BJ/^$!_P""@G_1
M?_ G_A*2?_%5[I10!X7_ ,(#_P %!/\ HO\ X$_\)23_ .*H_P"$!_X*"?\
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M ,"?^$I)_P#%5[I10!X7_P (#_P4$_Z+_P"!/_"4D_\ BJ/^$!_X*"?]%_\
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MRY9HW8N@YZ@&O7Z /"_^$!_X*"?]%_\  G_A*2?_ !5'_" _\%!/^B_^!/\
MPE)/_BJ]THH \+_X0'_@H)_T7_P)_P"$I)_\51_P@/\ P4$_Z+_X$_\ "4D_
M^*KW2B@#PO\ X0'_ (*"?]%_\"?^$I)_\51_P@/_  4$_P"B_P#@3_PE)/\
MXJO=** /"_\ A ?^"@G_ $7_ ,"?^$I)_P#%4?\ " _\%!/^B_\ @3_PE)/_
M (JO=** /"_^$!_X*"?]%_\  G_A*2?_ !5>H?"G3/BCI'A%+/XP>*--U?6A
M.Y>]TFR-O"8R?D4(2>0.I[UTE% !1110 4444 %%%% 'R!_P7X_Y0V?M"?\
M9/YO_1T5?QA5_9[_ ,%^/^4-G[0G_9/YO_1T5?QA4 ?O]_P:;?\ *4S]KO\
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MTB]L;;QQXAFU5O#OBJZ996TVUN9R6(%H6GD0'*K<6GF98J[Q_P#!SKJ'Q?\
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M9EO?A%X'U26S\3?%C5[/P%X>N;9L36LFJ2>1=7D?^U:V/VV][\6AX/2O$/\
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MM\5_A#^T#XT\":KX7T6"YB;P?J45F;T/?6T+QS3"(W"H8I)%Q%+&#O\ FW8
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M-_8]G:3+<:_JELC@H]PMQ>W%NJ."C3Z+ &&T'/QA_P %*?V'_BG_ ,$@=,\
M_P#!03]A3]L?XUZYXHA^)NBZ'XU\&_$7X@7&N6GCFWU"X$)CECD !G:0@<#
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M+XHTRWTSQ-?WVLVKVNI6$)C\NT>U%J(8XU\M0#$L;CDA@68GNOVE/V1?@_\
MM2GPQJ_CZ#4].\1^!M8.J^!O&?AS4#9ZMX?O&0QR26\P!!22,F.2&19(95.V
M2-P!@ ^ /^"?WPD^/7_!&+_@I1X?_P""6VG>-+KQM^SG\:=%U_Q%\'IM556U
M+PCJ&GJEQ?64LB@>9"4E3D@!GFB90C&8/^IU>7?#?]E'P7X)^*S?'OQAXR\1
M>.O':Z*^CV7BOQ?-:F;3].>199+6U@L[>WM;99'2-I'CA624Q1^8[B- OJ-
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M?!/PC\)O$'C3Q5H%U?W6H^/?%;:_X@O-1F1W:X^R6UE'&FU5VPQV]G;QHO)
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MO"6L?';1OVA-5O+^?6_#_A6_T'1[:29/LMM!>W%K/<S*FS/G.;*V7?NP$0J
M-S$^1_MW_P#!,/X _P#!1.]\,7'Q]\;_ !$M+?PC-)<:)I_@_P :SZ5;QW3@
MJ;IEAP7G",R*Y.55F"XWON '_LX? _4=&^+OB3]O;]J**ST?XA^/;&Q\.Z'H
MUY>Q%/!_A\7&;+1$E#%)+N>YF\ZY9&*R7,J11ET@B9NG_:=^-GC;3;J']G/]
MG"6TN?BMXIT]I-.ENH?.M/"U@6,;ZY?J/^6,;!A# 2&NYU$2[46>6'Q3]G?_
M ((3_L2_LV_'7PS^T-X9\1_%#Q#KOA"[EN]!M_&WQ(O=6LK>XD@D@\[[/.2A
MD5)7*MU5L,.0*R_B]_P0$_8S^.'QF\3_ !]\=_%CXW-XG\7W_P!JUR]T[XM7
MUJLI7(CC5(MJI%$AV1Q@;40!5 % 'TI^RA\ /@[^R'\'=#_98^$FH!X_#6FB
MYN_MMZLNHW\MS-*\VI7?\3RW-R+B1I" K2>8%P%P/3:\'_87_P""<_[.G_!/
M30_$ND? =O$UY<>+M1AO->UGQAXDFU6_N3#%Y<,1GF);RT#.53H#*Y_BKWB@
M HHHH **** "BBB@ HHHH *_.W_@V$_Y1I7_ /V63Q=_Z<6K[_\ &/A^]\5>
M&KOP]IWBW4]"FNHPBZKH_D_:8!N!)C,\<B D KDH2 Q(PP##QS]A/_@GQ\&O
M^"=W@.^^%7[/GBWQ>_AB_P!3N-2?0_$FLI?QQ7L[*TUPDC1"96<KRN_9DD[=
MQS0!H_M/_&CQS%>1_LT?LU7=M)\4_$^G-);7T\/G6OA#3G9HWUR^7H50AQ;V
MY(:[G3RQMC2XFAP+.R^!/_!+?]A;5O!7PL@^V6GPH\#3:G'HTUZLVIZQ=RF=
MXY9\89[F_OA,/,( DGD<+T('C_Q5_P"#?S]B_P",OQ@\3_';QO\ %GXX-XE\
M7ZB;W7;ZP^+=]:B=P-J($BVJL<:8CC0#:B*%4 #%>@? #_@D%^R3^S;\.;WX
M9?#^[\9W5GJWQ!T;Q?KU[XC\4R:E>:M=Z5-#/8V]Q/<*SO:QSP1RB($?,#\V
M&8$ ]:_8\^".H?LZ?LR>#/A!X@U%;[6],T=9?%&IITU#6;AVN=1N_K->37$Q
M]Y*_/3_@M[^PS=?L\>._ W_!6/\ 8R^)/C?1OC9HWQ-\.Z%<Z9/XTU#4;7Q5
M8ZCJ4=K_ &6+>ZFD\M"\R_N(=D/E^;^ZSM=?T4_:E_9M\$?M<_ O7/V?_B)X
MB\3:3I.NK#Y^I>#_ !!-I>HV[Q3)-&\-Q"0RD/&I(.589#*02*XCX-?\$^_A
ME\+]4\.>(/'?Q:^)7Q5U+P=(9?"5_P#%?Q@^K-I,QC:+[3'&J1Q/<B-W07,J
M/.JNX610[A@#U+XT?\D=\6?]BS?_ /I.]?''_!L[_P H//@/_P!@W6O_ $^Z
MC7V1\7_AK%\8/AYJ?PWN_&>MZ%:ZO:R6M]>^'IX8KIH)$9)(UDEBD\O<K$;E
M <=593S7F_['7["/PP_86_9[7]EWX!^//&-OX.L[>XCT"QU75(;J71#/)-+*
M]M,T&_)EF:3$ID56 VJ!D$ Q_P!AO_BZ?C+XM?M?7/[R/QWXXET3PK,>WA[0
M6DTVV"GO'+?+JMZAZ%+]2..31_:S?5?VS;G6_P!@CX4:Y<6NBWL*V?QP\9:=
M)M_L;29D#2:+;2#@ZE>P-L('-K;3-.^UY+59O8_AA\$_!_P;^!&A?L\?#FXO
MM-T/PWX6M]!T>XBN ;N"WAMQ!'+YA7!FPH8N5Y?+$'-?%L?_  ;:_L$PW=[?
MP?%;X]1S:C?SWVH2Q?&G4E:YNIG,DT[D-\TCNS,S'EB22230!]S?#W2?A[X2
M\,V_PU^&5OIEGI7A*W@T>#1]*=/+TJ.*WB,-J44_NML#0D(<'8Z'&""?S&_X
M**?L,W7[$W_!0G]G;_@H7^Q1\2/&]CXP^(_QXT'P#\3O#&K>--0U:V\2Z->B
M9IF87LTL@$$%O,VS<8HP%E18VARWUJW_  21_9@L/V*]-_87\$^+/B/X6\,Z
M3XA;7K/Q'X7\>W5GX@.I-<RW#7,E^IWSL7E88D#+A4P 8T*]U\&/V'_AM\)_
M%>D?$;Q5\0?'/Q)\5>'K*:T\/>)OB9XF;4[G2HIE"3&V14C@AED0;'G6(3.G
MR-(R_+0![-1110 4444 %%%% !1110 4444 %%%% 'R!_P %^/\ E#9^T)_V
M3^;_ -'15_&%7]GO_!?C_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?\I3/VN_^
MWC_T^3U^_P!7X _\&FW_ "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?]';_P#DQ>__ != 'WU17P+_ ,.H?VHO^CM__)B]_P#BZ/\ AU#^U%_T=O\
M^3%[_P#%T ??5%? O_#J']J+_H[?_P F+W_XNC_AU#^U%_T=O_Y,7O\ \70!
M]]45\"_\.H?VHO\ H[?_ ,F+W_XNC_AU#^U%_P!';_\ DQ>__%T ??5%? O_
M  ZA_:B_Z.W_ /)B]_\ BZ/^'4/[47_1V_\ Y,7O_P 70!]]45\"_P##J']J
M+_H[?_R8O?\ XNC_ (=0_M1?]';_ /DQ>_\ Q= 'WU17P+_PZA_:B_Z.W_\
M)B]_^+H_X=0_M1?]';_^3%[_ /%T ??5%? O_#J']J+_ *.W_P#)B]_^+H_X
M=0_M1?\ 1V__ ),7O_Q= 'WU17P+_P .H?VHO^CM_P#R8O?_ (NC_AU#^U%_
MT=O_ .3%[_\ %T ??5%? O\ PZA_:B_Z.W_\F+W_ .+H_P"'4/[47_1V_P#Y
M,7O_ ,70!]]45\"_\.H?VHO^CM__ "8O?_BZ/^'4/[47_1V__DQ>_P#Q= 'W
MU17P+_PZA_:B_P"CM_\ R8O?_BZ/^'4/[47_ $=O_P"3%[_\70!]]45\"_\
M#J']J+_H[?\ \F+W_P"+H_X=0_M1?]';_P#DQ>__ != 'WU17P+_ ,.H?VHO
M^CM__)B]_P#BZ/\ AU#^U%_T=O\ ^3%[_P#%T ??5%? O_#J']J+_H[?_P F
M+W_XNC_AU#^U%_T=O_Y,7O\ \70!]]45\"_\.H?VHO\ H[?_ ,F+W_XNC_AU
M#^U%_P!';_\ DQ>__%T ??5%? O_  ZA_:B_Z.W_ /)B]_\ BZ/^'4/[47_1
MV_\ Y,7O_P 70!]]45\"_P##J']J+_H[?_R8O?\ XNC_ (=0_M1?]';_ /DQ
M>_\ Q= 'WU17P+_PZA_:B_Z.W_\ )B]_^+H_X=0_M1?]';_^3%[_ /%T ??5
M%? O_#J']J+_ *.W_P#)B]_^+H_X=0_M1?\ 1V__ ),7O_Q= 'WU17P+_P .
MH?VHO^CM_P#R8O?_ (NC_AU#^U%_T=O_ .3%[_\ %T ??5%? O\ PZA_:B_Z
M.W_\F+W_ .+H_P"'4/[47_1V_P#Y,7O_ ,70!]]45\"_\.H?VHO^CM__ "8O
M?_BZ/^'4/[47_1V__DQ>_P#Q= 'WU17P+_PZA_:B_P"CM_\ R8O?_BZ/^'4/
M[47_ $=O_P"3%[_\70!]]45\"_\ #J']J+_H[?\ \F+W_P"+H_X=0_M1?]';
M_P#DQ>__ != 'WU17P+_ ,.H?VHO^CM__)B]_P#BZ/\ AU#^U%_T=O\ ^3%[
M_P#%T ??5%? O_#J']J+_H[?_P F+W_XNC_AU#^U%_T=O_Y,7O\ \70!]]45
M\"_\.H?VHO\ H[?_ ,F+W_XNC_AU#^U%_P!';_\ DQ>__%T ??5%? O_  ZA
M_:B_Z.W_ /)B]_\ BZ/^'4/[47_1V_\ Y,7O_P 70!]]45\"_P##J']J+_H[
M?_R8O?\ XNC_ (=0_M1?]';_ /DQ>_\ Q= 'WU17P+_PZA_:B_Z.W_\ )B]_
M^+H_X=0_M1?]';_^3%[_ /%T ??5%? O_#J']J+_ *.W_P#)B]_^+H_X=0_M
M1?\ 1V__ ),7O_Q= 'WU17P+_P .H?VHO^CM_P#R8O?_ (NC_AU#^U%_T=O_
M .3%[_\ %T ??5%? O\ PZA_:B_Z.W_\F+W_ .+H_P"'4/[47_1V_P#Y,7O_
M ,70!]]45\"_\.H?VHO^CM__ "8O?_BZ/^'4/[47_1V__DQ>_P#Q= 'WU17P
M+_PZA_:B_P"CM_\ R8O?_BZ/^'4/[47_ $=O_P"3%[_\70!]]45\"_\ #J']
MJ+_H[?\ \F+W_P"+H_X=0_M1?]';_P#DQ>__ != 'WU17P+_ ,.H?VHO^CM_
M_)B]_P#BZ/\ AU#^U%_T=O\ ^3%[_P#%T ??5%? O_#J']J+_H[?_P F+W_X
MNC_AU#^U%_T=O_Y,7O\ \70!]]45\"_\.H?VHO\ H[?_ ,F+W_XNC_AU#^U%
M_P!';_\ DQ>__%T ??5%? O_  ZA_:B_Z.W_ /)B]_\ BZ/^'4/[47_1V_\
MY,7O_P 70!]]45\"_P##J']J+_H[?_R8O?\ XNC_ (=0_M1?]';_ /DQ>_\
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M4-G[0G_9/YO_ $=%7\85 '[_ '_!IM_RE,_:[_[>/_3Y/7[_ %?@#_P:;?\
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MU03_ ,NG_P"Y:/\ A[!_U03_ ,NG_P"Y:^)_XC=X8?\ 0?\ ^4J__P K//\
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M%G\/W\+0^.-/GNXM EU,7C6BQW4T !F$<8<D1;ON#&['.,D ]IHHHH ****
M"BBB@ KR']OC_DSGX@_]@!__ $-*]>KR']OC_DSGX@_]@!__ $-* .!_X)'?
M\F<V7_8?O_\ T-:^G*^8_P#@D=_R9S9?]A^__P#0UKZ<H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ^0/^"_'_*&S]H3_LG\W_HZ*OXP
MJ_L]_P""_'_*&S]H3_LG\W_HZ*OXPJ /W^_X--O^4IG[7?\ V\?^GR>OW^K\
M ?\ @TV_Y2F?M=_]O'_I\GK]_J "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "O@7_ ()0_P#)T7Q<_P"VG_I;)7WU7P+_ ,$H?^3HOBY_
MVT_]+9* /OJL?6OB%X!\.7QTSQ#XXT>PN0H8V][J<43@'H=K,#@UL5YQ\3?V
M0_V:/C+XI?QM\4?@YH^MZM) D+WU[$Q<H@PJ\,.!7;@(Y;*O;&RG&%MX14G?
MTE**MOU^1PYA+,HT+X&,)3OM.4HJW76,9._R^9TO_"X/A+_T5'PY_P"#N#_X
MNC_A<'PE_P"BH^'/_!W!_P#%UYS_ ,.[?V)/^C;_  Y_WX?_ .*H_P"'=O[$
MG_1M_AS_ +\/_P#%5[7LN#/^?V(_\%4__EIXGMN-O^?&'_\ !M3_ .4E_P#:
M0_:M^'7P;^!/BGXF:!XXT'4=1TG2))-,LH=4BE,UTV$A4JK9*^8R9QVS7X=>
M)_$WB#QIXBOO%WBO5Y]0U/4KI[F_O;E]TD\KL69V/<DFOUO_ &NO^"<7[.EW
M^S5XQ;X+_ C1[#Q1;:.UUH]Q80/YYDA993&GS'+.J-&!WWU^05?TQX$X7AV&
M5XNME\I2J.:4G.,8R4>5.*2C*7NMN775K;1'\N^/V*XDGFN#H9C&,::@Y15.
M4I1<G*TFW*,?>24=+.R:UU85ZW^Q%^T7K_[,G[1GA[Q_IVI/%ID]['9>([;>
M0EQ82N%E##N4'[Q?1D7WKR2NK^!OPPUGXT_&'PU\*M!M7FN==UB"UPBD[(V8
M>9(<?PH@9R>P4FOV;.</@,5E&(I8VWL7"7/?;EL[OY+6_3<_$LDQ&883.</6
MP-_;1G'DMOS75E\WI;KL?N__ ,+@^$O_ $5'PY_X.X/_ (NC_A<'PE_Z*CX<
M_P#!W!_\77G/_#NW]B3_ *-O\.?]^'_^*H_X=V_L2?\ 1M_AS_OP_P#\57\
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MFVO-#FDTFZEMO+2UCAGL46\2&-K:X$TY$B$2E Y;R?\ X)??'+_@H_\ "?\
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MMXW""3"*WER[&(D& 2&"@&E^TK^T-^W3X7M?V@_B?\4/CMI7[/?AWP+-+8?
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M#\ ?]#SH_P#X,XO_ (JI;/QMX,U"Z2RT_P 7:7/-(V(X8;^-F8^@ ;)KBO\
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M[V.KZ+?27K/!<-'O2!O)=0R3% QD"J6;BOISL.W_ ."%G["WQ4^%7B#XV_\
M!1SXV>*O#(\0?M5>(X/%6G>'O ^K#4-.T72G>ZNK8"[VA+J9A?'+J&3$:D,2
M[@=I^P!^U)^TY\:?V[?VQ?V-?B[\68]4TKX,W_A:T\">(;3P_:6NH0)JNGWM
MS))-LC,,TJ%(0I,00F,DIABM>7?\$\_ _P"V#_P2%^/7BW]@'Q1\$/'_ ,2?
MV:);U]:^"OQ'\.V/]IS^$[>YD=YM&OX5;SF2.3>5>-6;<=^TK/B%_P .[3]I
MS]@W_@LM^TSX_'[$GQ*^)/A']HZU\(:AX'\4> K2TELK&[TS3Y;2>VU*>YN(
M8[%3),[>8Y^Y&"%;=@ $7[./_!4G]KVV_P"">'[9O[1OQ&L=,\?^,/V=/C#X
MQ\*^$H[+0Q9QWMII,%IY,US# WS!6EEFEV%245@"N 1[/^QW\>?B)^TOX@^&
MGQP_9A_;^TSXV_"C5UNX_B9:SZ#I-M?Z/=-I\LMJ46TBAELHQ<($>UN%EN 7
MB/FL@<GYR_X)M:-_P4+_ &1?@)^V!K6I_L,>)9/%6O?M-^(?'/A"Q$]HUEXI
MMKG4+*":QM!/)'=%9(8)VCN9;:.)HG60,#\M6?!G[!'P]F_X*F?!K]LO_@FO
M^SAX_P#@G^^U-_VB]/U;P=>^&]$N]-DM/W5FUI<(D%W=O<, /L/FP H9F<,B
M.P!T'A?_ (*#?'K]L75_VA_A7^SK^V+I7P__ &@OAGXP\1Z)X#^ VN^'M,,.
MHVVGLZ6=S(+R/[5=O=A/,,]O.L,!F0-$ZKNE]U_:Z_;IU?PO^V-X?_80^'GB
M'Q#X>O[GX>3>-?&7BSPM\-K_ ,4ZA8:>;S[%:6UI:6EK<I%+-,MP[7%S$\4:
M6^P1N\Z-'\E?\%"_V8?#'_!1/X&^-Y?BQ_P3\^)7AK]JWPMKVKV?P9^(7A'P
M9<VK:J]M?S+HMXVM6P%I%:- MN9!?S1-#F5H@&\MFZ']KWX&_P#!3/\ 8J_:
MI^"/_!4;X$_"B?X\Z[I7P,L?AI^T1X)T"Z\N_P!76*073:I9*5)D8W;.V%0L
M!&@V;9)&0 ]M_P"";?[6W[;OCK]K;XL_LI?M-?#CQKX@\%>&K2WUCX7_ !SU
M[X/:EX3BUZUD$/G:=<Q75M!";N%YPH,2)YBP3/LP 1YE_P &ZG_*,SXI?]EK
M\=_^CA7TQ^R7^U!^U%^T5;ZI\?\ XR_LI^+?@WX$TO17@T7P3XHM4O/$FN7;
M.CR7LMI:J\EK'$L9BAA!,DQGF=T4)$6^:_\ @B5X4^-7[,?_  3R^*W@#X]_
MLV_$/PUXE;XA^)]?T[P]=>%9YKC4K34'1K7R#"'1W9FV,FX%-I=]L8WT =7_
M ,&N_P#R@J^!?^YXE_\ 4FU6OO+5I#96<VLVVB2W]U:VLC6]M;>6)YCC/E1M
M*R("Y51\S*N<;B ,CXF_X-U?AA\6_P!GO_@E)\._V9OC]\(O$O@OQIX(FUB+
M6])\0Z2\ *W6LW]Y!)#+S',IBG3.QB4;(8#*[O>_VQ?VL?'7[*%KX5UOPS^Q
M]\3/BOINMZN]GKLGPQTV"^NM!B" I<26KRI),C$D?N\[=C9()17 /B?]G']K
MKPYXT_X.!M>T+]L_]D/QE\)/BKK'PJ_X1?X#/XAO+.[L=6\/6L\^HWKB:T>2
M(WDTGF/^[DDCCBMC%N60MYMG_@DGK>J_%+_@N'_P4,^(_B^5I;_P_K?@_P -
MZ2)#G[/81V^H1A%'\*L+2)\#@L23R<U[EJ/P6\2_MV_MZ?!+]L;7O@MXA\#>
M$?@-IOB"ZT.;QM8)9ZMX@U75[6*T\I+,.TMM:V\222.\_EO),8@D91&<\Y#^
MS]XW_8,_X*N?$K]MGPM\./$7B7X6_M!>#],A\<)X.T2;4[[P]XFTH&*VG>RM
MU:>6UN;9Y09(4D*3D[PJ.'H ^-?VB_C)XY_9_P#^"H'_  4^@^%=]/9B]_9*
ML_$LIM6*BWU:VT2UMH+D8X$BI=RR9ZD@FOK;_@FG\.O"MO\ \&X?@GP)=6D3
M:7JW[.NH2:A"5&UQ>V=S-/D=.6GDS]35K]D;_@G7K?Q>^*_[5O[7_P"UYX#N
M]"NOVI+9/"]AX-O98C?:-X.M]._LZ%;CRV>.*ZNH\320AG\K9$"=^]1P'P8\
M&_MH_LS?\$I==_X)00_L_>*?$7Q9TC0-9\"^ /&%AI;+X:U32[MIX['7)=1)
M,%G';VUPIEMI7%SOMF6.*3>A(!\$_L]_%GQ[\8OV/O\ @D)\)O'&H3W.CWOQ
MYUBYNTG8F.<Z!K8M]-4@\$)!*\0'3"D5]Z?\'*/B+4?AKIW[(?QE\)2-%XB\
M/_M=>&X]-EB/SM#+#=&:'CDI)Y,:LO1@<'K6G^T%_P $<?$WPM_X)\?LV?#[
M]E"&#7_B1^R3XMT?Q;X8M99DM4\5SP3B?5[(/(0L'VQVDD3<0 ZQHS*I9QU?
M[2GP6\;?\%4_VM/V>KUO@[XP\)_"CX(^,#X_\87_ (]\/RZ3<:IKL"*NFZ7:
MVL^))A'(99)YPIMR@"1R2%C@ ^]:_,']F+_E:V_:3_[-UT/_ -"TBOT\ED6&
M)IG#$(I)"(6.!Z <D^PK\P_V<_#7QNT/_@XH^,O[87B']F'XEV'PM\<_"G3?
M"_AKQI=>#KE89[Z#^S23)!M^T01,8)@))(U V9;:#F@#H/AK^T]_P5-^/'_!
M3?\ :6_8"T+XZ_#/P]IOPXT+PU=:!XT@^'<LQTJ+4+4W19+"6\8W5RWF+$7E
MNA"GD&00MO\ +%W]A[_@JU\4O!W['_[3WCS_ (*#ZYIFO:_^RE\1=>\.:[XF
M\-:4M@OBFWLT5K65+8$I!<3NWE! 0@+1YYW&G?L@>'OBMX/_ ."WO[57[1WC
M+X _$#2O 'Q&\+^%K3P9XKN_"%W]GU&72M.6*Z78B&6++!_+\Q%\S9A<ED#>
M)?!S]@KXZ_M4?!3_ (*%?LN>//A)XN^'\OQ]^*>J>)_A=KOBS0)K>RU"#S$E
MM'DD4-Y ,T$.^.0+*(Y20C%6"@'1?\%.!^WG\:/^"#?C[]JWQY\?=,TZ]\8_
M#&/7=>^%%MX7M&T6PT6]$4HLX;HH+XWT$$JL;EIVADEC8"W1&&WUV#]N+4_@
M+^SO^Q_^RE\/[G4+/Q-\4_A-8WEWK^E^"+_Q'<:'HVFZ+9O<3PZ?8Q2R37$D
ML\$,1=3#'NDED#B+RI/G[QU\7_V_/C3_ ,$1_&O_  3K^)G_  3&^,EG\8_#
M_P +%\(7U_;:/;2Z%JBVL<=O'?6MZLY^UM+'&I\FW21O,<XQ$#*NU^T=^SA_
MP49\$?!O]CG_ (*%_LP?LOZI<?%3]G'P4OAOQ_\ !?7-5LOM>OZ1<Z;:VMV+
M>2UGFC+*T,A1<^;^\1S%NB\I@#V7]F3]JW]O*^_X* >(?V.O&VG?$[QE\)/$
MO@1]6\#_ !ZUOX#WWAJY\-:LN]7TR^-SI]O97!VQF2.3R4R7C0ARQ">4Z)_P
M4)_X*0_"#]J'XR_\$T_VB?&D.K_&W6[&SN?V4]9T+P3;VND>([*:20/?W0*2
M"-;4(9+M2WRPV]T(MTBQL_U'^RA^V?\ M>_M67[_ !2\??L,^/?@?X!\*Z3<
MW6J:;XWMXI_$'BB_\HJEG:6$2M+';1 O(9FV232B!(UV^=GYC_;6_9'_ &@_
MVY_V8-9_X*.V/A#XA^!?VE_A]XH_M;X!^$CI$QN_#=O87#K;Z2UNA,5R=2C<
MS75QEH@\T43.8;,A@#]*OA%X;^(GA+X<:3H'Q9^)(\7>)(+4#6/$*:1%81W<
MYY9H[>+*Q1@G"J69@H&YF.2>DKR7]B?X^_%#]HO]GS0?'OQS_9_\1_#'QN;*
M./Q9X0\0V#1?9+X*!(;>7++/;LP+(P8L%(#A6R*]:H **** "J^HZOI.D(LF
MK:I;VJN<(UQ.J!CZ#<1FK%8WC+X>^"OB%:PV7C7PY;:C%;R%X$N5)",1@D8/
MI7+C7C8X:3PD8NIT4VU'?JTI-:=D]3:@J#K)5FU'K9)OY)M+\2;_ (37P;_T
M-NF?^!\?_P 51_PFO@W_ *&W3/\ P/C_ /BJYG_AF?X#?]$OTO\ []M_C1_P
MS/\  ;_HE^E_]^V_QKYWVW'7_/C#?^#:O_RD]3V?#O\ S\J_^ 0_^6'3?\)K
MX-_Z&W3/_ ^/_P"*IEQX]\#VEO)=7'C#2TCB0O(QOX^% R3UKG/^&9_@-_T2
M_2_^_;?XUXK^V5X:^#7PO\,67AGP?X$TVUUG5)/,,\49WP6Z'EAD\%FPH/H'
MKP.*.*.*^%,BKYIC*.'Y*:O95:EVV[1BE[)7;;2W7FTCTLHRC)LYS&G@Z%2K
MS3?\D+);MOWWHD>/?%_XL:M\2/BM>?$.VN98-ETO]DX.&MXHS^ZQZ'C<?]HF
MOLSX1?&WPI\1?AYIOBF^U^PM;R: )?VTMTB&.=>'&"<@$C(]B*^ Z]3_ &3#
M\.-5^) \%_$GPQ97\&KQ^782W2<PW"Y*J#D<.,KC^]MK^5_"KQ#SS+>-*O/*
M,WCY6E[23C'VCDW&5XJ36K<=K>\KV2/V'C'AC+\5D,.5.*PRTY4F^1*S5FU?
M1)[]/,^SO^$U\&_]#;IG_@?'_P#%4?\ ":^#?^AMTS_P/C_^*KF?^&9_@-_T
M2_2_^_;?XT?\,S_ ;_HE^E_]^V_QK^Q_;<=?\^,-_P"#:O\ \I/PSV?#O_/R
MK_X!#_Y8=-_PFO@W_H;=,_\  ^/_ .*JQIVO:'J[M'I.LVETR#+K;W"N5'J=
MI.*Y'_AF?X#?]$OTO_OVW^-;/@WX5?#OX>W,UYX*\)6FG2W$82=[92"Z@Y .
M3ZUU8.KQ;+$Q6+I4%3ZN-2HY?).E%/7NT8UX9*J+=&=1RZ7C%+YM3;_ \6_X
M*K_L)?\ #R+]A7QK^R99>.#X:U76X[6[\/:]M9DL]1M+F.ZMVD"_,8V>((Y&
M6"N64%@*_/CX?_\ !:_]HC]CN;_AWQ_P<5?LSZAX?M?$>FS^'[;XX^'[0W6A
M>)+26(PR27(B!4[HV)>2#++Y@\RVA^8U^C'_  4;U[]JCPK^S=%XI_8S^&]Y
MXP\>Z;XY\-W5GX5L]3CLO[6LDU>U:^MGN)66.&-[03JTCG:H.2#C!^>?^"CG
MQ=F_;P_89\=?L?Z5_P $Z?C%K/C_ ,<^'9M-T3PWXO\ A\]II^@:M(A6WU&?
M679M-5;24K/O@N9&;RL*#NKZ(\L^J?C+^U3^S;^R5^SSI_QH^(?Q#MXO"306
M-GX9FTT-?W&NS3JJV5K810!GO9YQM\M(@Q<'=]T%A^-W_!*_X=>+(/VF?B9_
MP0,_;0U'6_A_\.=3\2W'Q*\&?#S6;&W75O&>B7,D5TFBW-_#<RPQ0(D22W%M
M;!Y)76\C^T(D,B2>S?\ !0/_ ()^_MW?LO?!7]@OQU^S[X O_C?;?LDW%K_P
ML#P/H,A-UJ\D<%B@N[.%_FE$8M[F*(!6DB$L3!"OF8M_\%+OV:/VE_\ @M+I
M_@7X_?L8?LB_$SX#_%CX2F;4_#GQ.^+DD/A?4)1Y;.NBV]M!)/<2L\VUQ/-Y
M$$/SX>3SI%H ^S/V%OCK^W/^T+\:/BKJ7Q2?X8VOPB\%_$'4?"_@:_\ #GA7
M4(M2\3"S9HI[CS9=1DAAC@N ;8E8I/-DMYP/*"J3\B6OQ*C^%?\ P=>?$[Q+
M-X%\2^((W_9*M8)+3PKH[7US$#JFE-YAB0AB@*A25!(+KQC)'LG_  3&_;&_
M;9\7>$O _P"R!XQ_X)*>,/@Q?^"[6VT_QCXGUTHGA2VL;90)'TV4RF>^GN"F
MU$7S%C:8RR32A#YG ?"WP[\;-._X./\ QQ^VOJ/[,/Q,M_A1XA^ \/@K2_&D
MW@NZ6)]16ZT^YW-;[?M,<7^CR1[VB&& ) 4[J +W[$O[''[3GQI_X+A_%#_@
MKK\7/@CJGPJ\#S^!X_"7@3PYXDG@76M?VQVL37]U!!)(+>/%NY5)"'.Z'CY"
M:_1WQQI/B77O!6L:'X,\4KH>L7NEW$&E:T]B+D:?<O&RQ7!A+*)?+<J^PLH;
M;C(SFM2N,_:(^(?Q$^$OP/\ $_Q+^$WP9O?B'XCT329+O2?!.G:E'9W&L2IS
MY$<TH*HQ&2,@DXP 20* /RIUL?\ !5O_ (-U?#'A_P"(7Q&_:$L/VD?V4M+U
M2"Q\:0S^%$TWQ%X.M[JX"F_C,;2-<+YLH+&2602.Y!2(R>:/3/V]?%5Q\3/^
M#C3]A3X87-^+GPOIWA#Q=XIT^-'S%<7CZ7>;)1V8K]D@93V!.,9->M_%'Q]\
M7?\ @K9^RKJ'[*Z_L3_%3X3Z;X^MX-/^(VN?%?2;734T/3O-1[R.SC$[S7UU
M(B/' ZQ+"A<2R.A00R7O^"DO[&'CS4?CO^SK_P % /V:/ \NM^*/V=O$MQ%J
M7A#371+K6?"NH6WV/4(;7S&59+J"$F2&)F429E4-N900#Q__ (+,^(M0^'/_
M  5S_P""=?C_ ,)R-!JUY\2?$>@W,D)PTVGWL.FV\Z-C[RA)7.#P-Q-,_P"#
M=C6M5^)7Q=_;?^-_BR5I-;US]JG5].NFE.7CM;(%;:#)YVQ),8U'8+7I_B7]
MGSQK_P %!O\ @J+\'_VOO$7PU\1^&?A5^SMX?U>?PN?&>BRZ9?>)/$VIK'$[
M1V-P%N(K6UA@B?SIDC+S!1&KH&>J?P#^"WCC_@E[^W!^T)XO@^$7B[Q7\)OC
MWKT'CGP]>^!?#TNJW.C^)661=3T^ZMK<&5%N9'CGAN"H@4!DDD0@$@'G_P#P
M10\1:CIG_!4W_@HI\'M.=AX?T[XPZ-KUI;H?W<6H:C%J!O'QTW2&VBR>I\OG
MM7T=_P %OO\ E$1^T7_V2;5__1#5B?\ !)#]BGXD?LXV7QA_:8_:!T./2?B1
M^T)\4K[QCK_A^.[CN#X?T]I)!IVE/+$6266"*1R[H2F^5E4L%#-M_P#!9[2_
M'/CS_@FW\6_@A\*/A=XF\8>+?'?@B^T;P[HOAK19;EI9YE6/,D@'E0(H?<3(
MZ[@K!=Q&* /(?^"2_P"U7\=?"_\ P3$^ 7AS0_\ @FE\;?$EG8_"70H+77]%
MU[P-'::BBV406>%;OQ)!.L;@;E$L4;X(W(IR*\N_X($>(]8\7?\ !3#_ (*'
M^)O$'@'5O"U[>_%'P]+<^'=>FLY+S3W*ZOF*9K*>XMV<=S%-(GHQKZR_X))W
M/BGX9?\ !,[X5?#'XN?"SQ?X4\2_#GX;Z9I'BC0M9\,W0N$GM;81OY C1Q=A
MO++*(#(V&4$!CMKYK_X(^>"/CK\*?^"E7[9/Q*^,W[,?Q#\*>&?C;\0-.U3X
M>:[K/A>46][;VS:BKF8Q[C:EEN(G7S@@PQ!*L-I %U3_ (*0?M._M<?LL^+?
MVM/V0/B?X[\.7T<^LR_"'P1H?[-FL^(],\16VGW,\$"ZAJ":=*LDM\]LQ!LY
MX4MEG1'\UXW8^J:+^UM_P4A_:._9M_9Q\7^#OV:=5^$>I?$?4;M?CYK'B;1E
MM[SX=6=BDPFEBLM4VE3=2PDP23QS*D3HS1R%U:OFG]A+QQ_P4U_X(N6^K_\
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M^)<T'VK5Y_)DCCTW3K?8)&B\UTF>\=8QLM_+12TVZ, ^O:\A_;X_Y,Y^(/\
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M#_OZ_P#\30!Z]17D/_#?'['7_1P6@?\ ?U__ (FC_AOC]CK_ *."T#_OZ_\
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M_B:^@.H]>HKR'_AOC]CK_HX+0/\ OZ__ ,31_P -\?L=?]'!:!_W]?\ ^)H
M]>HKR'_AOC]CK_HX+0/^_K__ !-'_#?'['7_ $<%H'_?U_\ XF@#UZBO(?\
MAOC]CK_HX+0/^_K_ /Q-'_#?'['7_1P6@?\ ?U__ (F@#UZBO(?^&^/V.O\
MHX+0/^_K_P#Q-'_#?'['7_1P6@?]_7_^)H ]>HKR'_AOC]CK_HX+0/\ OZ__
M ,31_P -\?L=?]'!:!_W]?\ ^)H ]>HKR'_AOC]CK_HX+0/^_K__ !-'_#?'
M['7_ $<%H'_?U_\ XF@#UZBO(?\ AOC]CK_HX+0/^_K_ /Q-'_#?'['7_1P6
M@?\ ?U__ (F@#UZBO(?^&^/V.O\ HX+0/^_K_P#Q-'_#?'['7_1P6@?]_7_^
M)H ]>HKR'_AOC]CK_HX+0/\ OZ__ ,31_P -\?L=?]'!:!_W]?\ ^)H ]>HK
MR'_AOC]CK_HX+0/^_K__ !-'_#?'['7_ $<%H'_?U_\ XF@#UZBO(?\ AOC]
MCK_HX+0/^_K_ /Q-'_#?'['7_1P6@?\ ?U__ (F@#UZBO(?^&^/V.O\ HX+0
M/^_K_P#Q-'_#?'['7_1P6@?]_7_^)H ]>HKR'_AOC]CK_HX+0/\ OZ__ ,31
M_P -\?L=?]'!:!_W]?\ ^)H ]>HKR'_AOC]CK_HX+0/^_K__ !-'_#?'['7_
M $<%H'_?U_\ XF@#UZBO(?\ AOC]CK_HX+0/^_K_ /Q-'_#?'['7_1P6@?\
M?U__ (F@#UZBO(?^&^/V.O\ HX+0/^_K_P#Q-'_#?'['7_1P6@?]_7_^)H ]
M>HKR'_AOC]CK_HX+0/\ OZ__ ,31_P -\?L=?]'!:!_W]?\ ^)H ]>KY#^-G
MP$_:9^+7Q)U+QE-\.V$$LOEV$3:O9_NK=.$7'G<''S'_ &F->O?\-\?L=?\
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M.O\ HX+0/^_K_P#Q-'_#?'['7_1P6@?]_7_^)H ]>HKR'_AOC]CK_HX+0/\
MOZ__ ,31_P -\?L=?]'!:!_W]?\ ^)H ]>HKR'_AOC]CK_HX+0/^_K__ !-'
M_#?'['7_ $<%H'_?U_\ XF@#UZBO(?\ AOC]CK_HX+0/^_K_ /Q-'_#?'['7
M_1P6@?\ ?U__ (F@#UZBO(?^&^/V.O\ HX+0/^_K_P#Q-'_#?'['7_1P6@?]
M_7_^)H ]>HKR'_AOC]CK_HX+0/\ OZ__ ,31_P -\?L=?]'!:!_W]?\ ^)H
M]>HKR'_AOC]CK_HX+0/^_K__ !-'_#?'['7_ $<%H'_?U_\ XF@#UZBO(?\
MAOC]CK_HX+0/^_K_ /Q-'_#?'['7_1P6@?\ ?U__ (F@#UZBO(?^&^/V.O\
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M8LV!C@9)KZ2HH ^8_P#AT=^QU_T!-?\ _!Z_^%'_  Z._8Z_Z FO_P#@]?\
MPKZ<HH ^8_\ AT=^QU_T!-?_ /!Z_P#A1_PZ._8Z_P"@)K__ (/7_P *^G**
M /F/_AT=^QU_T!-?_P#!Z_\ A1_PZ._8Z_Z FO\ _@]?_"OIRB@#YC_X='?L
M=?\ 0$U__P 'K_X4?\.COV.O^@)K_P#X/7_PKZ<HH ^8_P#AT=^QU_T!-?\
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M_AT=^QU_T!-?_P#!Z_\ A1_PZ._8Z_Z FO\ _@]?_"OIRB@#YC_X='?L=?\
M0$U__P 'K_X4?\.COV.O^@)K_P#X/7_PKZ<HH ^8_P#AT=^QU_T!-?\ _!Z_
M^%'_  Z._8Z_Z FO_P#@]?\ PKZ<HH ^8_\ AT=^QU_T!-?_ /!Z_P#A1_PZ
M._8Z_P"@)K__ (/7_P *^G** /F/_AT=^QU_T!-?_P#!Z_\ A1_PZ._8Z_Z
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M_P"@)K__ (/7_P *^G** /F/_AT=^QU_T!-?_P#!Z_\ A1_PZ._8Z_Z FO\
M_@]?_"OIRB@#YC_X='?L=?\ 0$U__P 'K_X4?\.COV.O^@)K_P#X/7_PKZ<H
MH ^8_P#AT=^QU_T!-?\ _!Z_^%'_  Z._8Z_Z FO_P#@]?\ PKZ<HH ^8_\
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M /!Z_P#A1_PZ._8Z_P"@)K__ (/7_P *^G** /F/_AT=^QU_T!-?_P#!Z_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#Y _X+\?\ *&S]H3_LG\W_ *.BK^,*O[/?^"_'_*&S]H3_ +)_
M-_Z.BK^,*@#]_O\ @TV_Y2F?M=_]O'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?
M)Z_?Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWQ _\**Q_P */^(WG]EG_HQ[X@?^%%8_X4 ?M]17X@_\1O/[+/\ T8]\0/\
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MOB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\ HQ[X@?\
MA16/^% '[?45^(/_ !&\_LL_]&/?$#_PHK'_  H_XC>?V6?^C'OB!_X45C_A
M0!^WU%?B#_Q&\_LL_P#1CWQ _P#"BL?\*/\ B-Y_99_Z,>^('_A16/\ A0!^
MWU%?B#_Q&\_LL_\ 1CWQ _\ "BL?\*/^(WG]EG_HQ[X@?^%%8_X4 ?M]17X@
M_P#$;S^RS_T8]\0/_"BL?\*/^(WG]EG_ *,>^('_ (45C_A0!^WU%?B#_P 1
MO/[+/_1CWQ _\**Q_P */^(WG]EG_HQ[X@?^%%8_X4 ?M]17X@_\1O/[+/\
MT8]\0/\ PHK'_"C_ (C>?V6?^C'OB!_X45C_ (4 ?M]17X@_\1O/[+/_ $8]
M\0/_  HK'_"C_B-Y_99_Z,>^('_A16/^% '[?45^(/\ Q&\_LL_]&/?$#_PH
MK'_"C_B-Y_99_P"C'OB!_P"%%8_X4 ?M]17X@_\ $;S^RS_T8]\0/_"BL?\
M"C_B-Y_99_Z,>^('_A16/^% '[?45^(/_$;S^RS_ -&/?$#_ ,**Q_PH_P"(
MWG]EG_HQ[X@?^%%8_P"% '[?45^(/_$;S^RS_P!&/?$#_P **Q_PH_XC>?V6
M?^C'OB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\ HQ[X
M@?\ A16/^% '[?45^(/_ !&\_LL_]&/?$#_PHK'_  H_XC>?V6?^C'OB!_X4
M5C_A0!^WU%?B#_Q&\_LL_P#1CWQ _P#"BL?\*/\ B-Y_99_Z,>^('_A16/\
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M>?V6?^C'OB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\
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F_A;]DCQIH>H>.O#;Z;::MJ&N6DD-J[.C;W5!N(^7H/6OPMH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>exhibit1011-physiciansha001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9 &SMD4E64$_[2D"LSPKKVMZEXCU[3M9MK2W-DML\45NQ<H)58E6<_>(VCD
M#KUH ZVBN1T77]=NO'%]I&JVEI:P)81W<$43%Y%#2,F';H3\N< 8&<9/6NNH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@##\9VL]]X'UZTM8FEN)M/GCCC09+L8V  ]R:X32;#PM96
M-B9OAKJ/VV&./?*-'4GS !ELY]1G->KT4 >;>*M%U;Q)X@&L6>G;%T%$>WAN
M$VG4I-RR-&?]A0HVD_QG/0<[6E075Q\1+S6&LKB"UN-&MD1IH]I#B21F0^C
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MD$;W LY_+1CCAFV8'4=?6NDM;J"^M(KJUE2:"90\<B'(93T(KYS\+^*'\/\
MP@U2U;2WN(=1OIK87+$>5$S0QCYAR>!R..:]J^'FAMX=\$:?8-=QW;;6E,L3
M$H=Y+87/;G\>O>@#II'2*-I'8*B@LS'H *AL;ZWU*Q@O;242VT\8DC<?Q*1D
M&N9\>WUL;"VT.XU!;%-5=HYIRX4I"HRY!/<_*O\ P.N9^"NN&32;_P -7$R/
M/I4S")E;(>(L>GJ V>?1A0!WFJ>)M,TFZ2SE>6>^==ZVEK$TTI7UVJ"0/<X%
M)9^*=*OKJ2TBDG6\C@-Q):R6TBRH@(&2I7/4XP.O;->=_"&0ZAXE\8:K>.TN
MH_:%C8L.53+\8[?= Q_LBNOL/%'A_5_%JPVL=V=:MX&AFB:V9##&Q5CO) '!
M"]">I]: )X_B#X<E:\6*YNY#9,5NMFG7+>01G(?$?R]#U]#6E%XDTBXT;^U[
M:[%Q8<YFMXVEQCKD*"1COD<5X]H'BN3PGXA^(MZNE37T:ZBS.8F $?[V4 MG
MG;D]1TKI?AOI/]F?#/4[]KNWF74DEN@(,A(ALP5YQ@@@@^F* .I'Q$\+&R%Z
M-38VI) G^RS;"1U^;9CC(JW?>,O#^F+;M>Z@($N$5X7>)PKAAD8;&"<=NM>9
M?"F[U"?P]HVDO9)_8]S-=I-/YH;S#L)$93L.2>^<"K_QD,%IX;\."V9&@M]0
M1$^?C"*1@GVQ@T >AV_BG1;K5(M,CO1]ME!*0/&Z,P R<!@.W--MO%FAW>LG
M2(=00ZB,YMF5E<8&3P0.W-9NA?:-9O;N_P!;M?LMWIVJ.MK$75O*0P(@&X=0
MV\M]6'I7GWQ L[O2M:G\:Z?$//TS5PDS8Y:-H( ,^HSN7_@= 'K6L^(M(\/0
MI-J]_#:))G89#]['7 ZFJ%[XY\/:;%;2WM[+;1W(S"TMI,HD^F4Y_P#K@]Z\
MJ^*MS%XB\)'Q(BDVYO8K6Q)/!C".SN.WS/Q_VS%:GQHFE?PIX9N"Q,IN4?<.
M"6V9S[<T >B6'C7P_J>I1Z=::AOO)5+)$T,B%@!DD;E'H:FL?%FA:CJKZ7:Z
MC$U^@):V8%'&.O# 5FZ(9-9OKJ_U>)K:[T_462"!I5;R T*+MR!SN#[OJ1Z"
MO/O%?AC4;K6-=\5Z 6CUC2-3Z)DF:,01'IW(R>.X)% 'J;^+-$BN;NWDO@DM
MFA>X5HW'E*!G)XZ?S[5 /&_AHS1P_P!L6_FRKO2,Y#,/4#&>QKG?"&N:?\1;
M?4;AXG19+6UBNX5)7;(KRL5![J>/J#@]Q6+K #?M):"" ?\ 06//_7.:@#U+
M3M2LM6LUN]/N8[FW8E1)&<@D'!'YU:JM9:?:Z>)Q:Q",3S-/(!T+MC)_'%6:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQL^-1&51=S$8' '<^U==X8\*_P!B:OJ>I>3:V7VX1@V5DY:%2H.7Y5?F)/0
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MMXEC5[6*1MH^\Q0$D^I-<9KG@:_M/A9#X-T:T:\GD*M+=&1(T5@X=B<G/)X
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MD!&TC(/M7EOC+6M6U_X9ZMK%D]FFDRAXE@EB;S7C6389-^[ .0<+MZ=\UZF
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MY<O)*MN,Q6[8\M'Y_>8QDM@X!)X[8)J1+*T_M.2]&6N_+$9)E9@B]<!2<+G
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M@BN=,NH)D#QR1,K*>X(KSG2%TJ/X?>!$U>SGN-]U;BU:)\".9B2A;D9'7L:
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MWOAIXMY&9"6*JAP-H98SNQS\P]QO:SX3NM5U'1]2BUN:SO\ 3D=&FC@5A*'
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ME*'OM-N1YT<!*^1;A=LJL?[K#"8'=AVS7H-1);P12R2QPQI))C>ZJ 6^I[T
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M0_#*Z'?W]W'JE]<F_E\Z:.?RMI? &X;4!'  QG% &CJSW$>C7TEH";E;>0Q
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MHS/IB-#$'$>TPD >7@+T^5>>I]>F.OH \Z\-RWE[\+]3ULW4MM?ZB;J]:6(
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MF+IJ0X;?L#!@<].",8QTK'N?AS/<WFNWWVV**^N[M+NPN8PP>T=1CKW!'!%
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MT18M$4157/ SRH;K[4L/ASQ3=Z1+9ZOXCC,BVLD$$MG$T;,S+M$DAW?,0,X
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MUS)!F-!U<J0VT>YQC\:C\(>(]*N_!FGW'VV"$6]M'%<++(%,+JH4JV>G([T
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MP" Q'O@'FNOTZVUBPU5!?:U'?64\  $L:1R"<<G9M !0KDX.2-O6@#>HHHH
M**YKQ9JE[ILVEK!=1VMK/,R7$@7S)S\N56)-K;B3UX/ H\$ZQ?:SI-VVH<SV
MM]-:[C&$9E0\%E' ;GG% '2.P1&<@D*,X R?R'6N;@\>Z#<P7$\,E\\-M(8I
MY!IUQMC<=0QV<8[^G>NEKAOAG$\-IXEC<89=?N\C_OF@#KM.U.QU>QCO=/NH
MKFVD^[)&V0?\#[59DD6*)Y&#%44L0JEC@>@')/L*\<373X.\5>/WTZ+?:J]L
M88EY07$N ?8<LQ(R/NXXQ7:^'YO%R^(&BU.WN9-)>WSY]V+9)(YAV40NV4//
M7D>I[@&_HFMV?B#3%U"P9VMV=T4NA0DJQ4\'D<@]:T:\V\/W]SIWP\TN2UN(
M;9)M3N$N)FP76,W$N?+4@[W.  ,'Z&HSXD\2W?@[Q)=V-R_VW2+YUB,MJJR2
MPJ%8JZD8#!6/( Z#B@#TVBN!@\9N_C+285OO,T74+-&5C&HV7#J61"WNJDX]
M<>N*?<:WJQTS3+I]1%G:ZA/*_F^4LDXBP3"D<84[V88)^4X_6@#KM2TC3=8A
M6'4K"VO(U.56>(. ?49Z5-:65KI]LMO9VT-O OW8X4"*/P%><0>,?$$O@47\
M,L$E]!JXT]GF@V&=?-" D=(R0<'@X]!6C-JWB:SUNWT"YN$N;J?SKOSM/@C5
MQ K*$0"5@H.2V3\W '7DT =[16)X5N-<N-(;_A(;06][',\8(*_O8Q]U\*2
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MCMBN@;=M.T MCC)XS7+>%_&)U[6-6TBZL19WVG/M(64R),NXJ74E5.-RD=*
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MX0_X1U))(XA<"X$P^^&#<=^R?(/05?UOPL^I:AIM_8:K/IES8J\:&%%=3&P
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MFN9(X21:I(,H9!U4D=L$COBN>TC0[S0+_P #V<UO<W']G6ERES/'"SI$\NS
MW = 0P]@!G%4_%UAJNI3^*K;^P]1<2P*MD;%1'%/A,EY6# R,#P%.>, +UH
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M98E!;IR>..M>6>%4GLO@YXGT6?3K^*^WR,5:V?#%@JJ!QR?E/3THA75-#D\
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ME9I:RG$<[3J$<^S9P>E<+XMU6VU+Q!)X2L+Z&Q6YQ-K-Z9 A6/: (U)/WF4
M?3\:R-:N-$@\6Z3NU>;2_#O]FR6UA<VFSRQ*DI61271AR /F'7 Y.: /5I;^
MS@LOMLMW!':[=WGO( F/7=TQ7.>%_$MSK?B/Q%9M+:S65D\!M)K<9#I(A;).
M2&[<BN,LY=+T&]\*1":Y?PHMQ<^1=ZAC:TY'R/T "9+[3CN3TP:W/ T^G-\0
M/&BV%U;2QSR6TT8A888;#N(QU&YN2.Y]Z .I;Q1I8\4)X?%U$UZ8&F<!Q\F&
M50I_VCN) Z_+[BM$:A9M?&Q%W;F[5=Q@$@\P#UVYSBN+OCIEC\7XI[E[:*>X
MT;9#YS*OF2^>-H7/5OUKE/#,VCZEIMD=4UB]_M^TO\_V;$D$4_VG>=V#L#LI
MW')+8QG)XH ]>.HV2RB(WEN)"YC"F5<[@-Q7&>H!!QZ4L>H6<LB1QW<#O("4
M59 2P!P<#/.#7GGA'PUX>OY_$LUUIMI*UIK=P(5*C9$H1,87H!R<\<X&<X&.
M<LM(TK_A7'@>\-K MU/JMM#+<CY9&1I&5EWCG&.,9H ]I@N[>Z\S[//%+Y;;
M7\MPVUO0XZ&H[?4;&\E>*VO;>>1!EDBE5BOU /%>?Q6NE:-XN\86L)33-/.C
MPO-]F7:(^) 7"CN ?\YJQX2$VF^*H=+OK>QN9ETXK::GIX"B6!67B5!T;.W!
MZ<G% '>_:8!.8/.C\X#<8]PW8]<4S[=:?9GN?M4'V=,[Y?,&U<=<GH*XW7KN
M#3OBKX?N;J6&WAEL+F(S3':I(*MC<>,_Y[US.E-'K^B:U9VNIVMK<#Q5,]H9
M%$D4[#+HCK_=8 X]U&.>* /68;RVN;<7$%Q#+ 1D2(X9<?4<4L%W;W4'G6\\
M4T7/SQN&7CKR*\BO+^2U\.3-=6":2$\1PIK(LPLL(41J=Z@J0%R(R00>>O7%
M6-471]*T?7KS0]8N[V*X:U?4F@,9@CB+JK;?*10&,>[..<<GM0!UTOBR1OB#
MINAV<UE<6-S;2R2O&=SHZ=LAL#Z8J?Q5X@O=#U/P]!:I;M%J.H+:S>:I+!3W
M4@C!^N:Y4SZ$WQB\.RZ3+8;'TV52;8J 1CY <>W0>E:?Q(LTOKWPE%+M,3:S
M&KIOVE@5;.,<]OUH [F*>*=-\4B2)G&Y&!&:2&Y@N Q@FCE"G#%'#8/H<5Y!
MK.[0;CQ_::2H2Q5+&62W@3B%'&V8JH]5&3['VK>TO3?#TNKK<V&L1W4=YISI
M)96$4:120J,;G4=""VT$_3UH ]#66-FVJZDXS@'M44\TCV,[V)BEG"-Y09OD
M+XX!([9Q7BUOI=AIOPHTOQ'$)8KB;RK:]NR6D(M3.-P*9P1A0,#L2.]=5H6E
MZ,-4U1K+7(+^&]TYO/M+&)8[= , ,=A^5R,@="0#Z4 =UI4E^^E6K:JENE^T
M8,ZVY)C#=]N><5;CD25=T;JZGNIR*\@TC2;74--^&D-W&<217 <JQ4LOE,P4
MD<[3W'<$BNI\!V=OIFM>+-.LHUALX-00Q0*?ECW1*3@=@3_GB@#M9)8XE#2.
MJ G&6..:<6 (!(&>![UYCXWFM+KQ)J:1FUGN;+1F\Y-0<>1 K$D-&F,M(2%&
M<@ 8ZYQ6?IT-MK4/PTCN\3F6VN(9F60JQ5;<_(2I!QZC_$T >NI(DB[D964]
MU.16!=:[=0>.--T58X#:7=K-,TG)<,A7CTQ\U<!=2Q>'-'\566GE[?2X=:MX
MIEA<_N('6/S=O]W.2/QK>MK/0++XI:2^CQ6,(ETF;=]EV@, T>PX''3//>@#
MT'- (/2N'\>V4%WKGA)93(OF:D8V:.1D;:8V) 92",X'2N3U.[NO#1^(UCX?
M1K>&T2TFBCB8_NC(H\UU]#CGCTH ]D#*V<$'!P<'H:JV.I6VHFY^ROO6WF,#
ML,$;@ 3CZ9Q]0:XC5=*T[2]5\*W/AZUAC^W7 M9XX@ +FU:-F9G'\6 H.X\^
M_-2_#BTTJW?7OLMM9P7*ZM=Q!8U57$2N %XYVC'3I0!WA8#J<54U#4[;3$@:
MY8CSYT@C51DL[' X_,GT )KD&CMM=^)FJZ3K=I#/;VVGQ-8P3#<KJY(ED /?
M)"YZX'O7*/9V\MMX>AU=(+RWM_$LME:7%R Q:U4.%1B>HW#'/7:* /2+/7KB
M?QGJ&ARVT216UK'<1RHY8N&8CD8&.GO6]FO/CX>TS5_B/JEO=0![.+2;5$MT
M8K'@M)C@$ X X].HZ"N8T[4+JX\->!["^O;>&UNH[@&?48S/&TBMB-64NN<#
M.,DC...!0![1FBO'M1TQ;'3+#3H-<-U$/$ELJM:*8HK82'<8T^=L@'#<GC(K
M9\0Z!8>"I=)\1:>C1V=E>D7RRR-+^YFPA;YB3\I((^IH ](S6;]IU0^(1;"Q
MB_LK[-O^U^=\_F[L;-GICG->;6$ES97>I:#Y/V=?$X6[T\%,^5&[;94.<\K'
MA]O09(XKHTMXK/XKB"!C#"OAT[5W$JF)E4$ \#A1T]* .XS1FO)-$CN]!U*R
MAO\ 38KC4S:7+Z9JUG)E=1^0OB8'G=C!!/X5%X3LX[^U\.^(?^$CTZ"]\U1<
M+;6K&XN7=@'CE;S3NR>^T;>H  H ]@S7.6WB2>;Q_>>''M8EAAL5NTG60EGR
MP7!&,#OZ]/PJIX]ODMK;1[2XE,-E?:E%!=R;R@\K#,5+#H"0H/L2*XS5 GAG
MQQXHFT"VCADA\.>9''  %1]X^8+T&/O8 Y_&@#V#(KDKGQ-K5W_:4GAW2(=0
M73[LV;PR3^5))(%!8J3\H ++UZX/MGG?"&BVL5SI.I#7;"6*^@:#[-8V[+]K
MS'EO-)D8LR[?O$ @Y!ZU+HVE64/AWQM-%#Y4L=]?(DD;LK* HP 0<CI0!W^F
M37D^F6TNHVRVMX\8,T*N'"-W (ZU<KR'2K<WUM\,XY;FZ5;B"X27RYV7<! Q
M['@\D9'.#UZ5'-<2>'M!\3:;8W4EKIT&N06XD=W86L$GEESD'=MY/0YY/.30
M![%6!JOB"YT[Q7H6D+9H]MJ9E5K@R<H40M@+CO@<Y]:XG63<^#+/6M1T_7;9
MC<622)86MNRQP_O(XS.H+N =K>P)&<'!J[=Z)H]EX^\$W6DA?WOVHEUF+^:G
MD$AB23D\]>^: /2*PO$VO3:#'ICQ6R3+>:A!9N6<KY8D;&X#'/Z55\<6U]>Z
M3:V^G/;O.UTI^QW#E4O5"L6B)'J 6]/EYXKB[B6TU3PUI]E;P7FF21>);>&>
MV=P7M9,@D(W(VC(*_P J /6Z;(6$;%%#. =H)P"?KVKS5UA\,ZUXO@CU.[L=
M.72X9S,TCSM%,Y=?,4,22W [\G'X.\,1WMA\36M)(!9VT^B><;9;CS2[K,JB
M5^,!R&.<$_4T ; \;7 \$VWB%M-1GEN_LSVZSGY?WYAR&V\\@'&!UKLJ\>-V
M8/@=I]R0"_\ :8<#L2+UF_I7L- !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 UY$B0O(ZH@ZLQP!2C!&1R*X
MSXL)&WPSUEI(U<HB%=P^Z=ZC(]^:GT;Q3,VJ:=HUYHUU9+=6IDM)Y'5A*$ W
M A2=IP<X)Z8Z'B@#K:CGC:6!XTF>%F4@2( 67W&X$9^H-<G:^.OM%[I8DTR2
M*RU69X+25I1YNY=W+QD#:#M.""?<"I+'QJ)U\0B^L/L,FB?ZY'GW%QM+ C"]
M"!QZYZ4 :_AS0(/#.AP:3:W%Q/;P9$;7!4L 3G&5 &,D]JU:Y+5_',&D30VD
MT-M%?M;+<R075]' $4G 4,WWFX/ &..HXK;T#6K?Q#H=IJUJDL<-PI8)*N&4
M@D$$>Q!H TJ0%22 1D=1Z5R_B#7]3T_Q9H&EVEB9;>]:9I'6107V1L=F#TP2
MK9SVQ7*:=XA/AG5_&T\&E7%['#?^=.MN%001B,%G+,1G/)"C)X)[T >J48KF
M]1\7VMJ;2.VC2>>YMQ=!);A( L1Z$ECU)X 'H<X K0\/:]9^)=$M]6L#)]GG
M!P)%PRD$@@_0@].* -3%%8.O>*(]!U'3;.33KVY:_9TC:W4-\RJ6QC.<\>F.
MY(P:RO\ A8*+:ZBSZ#JGVK3&/VVW14;R5 W;BVX*05Y !)]J .SJCIVE6^E"
M9+3>D$CEQ!D;(V));:.V222.GIBLJ_\ &FEV5MITH<.VH0?:+='E2+,> <DN
M0!]X#'7)]CBI;_$+3+[2+.[L89KBYO+AK2&T!4-YRC)4MG: !SN!(P1C- '7
M45R4GQ TVWT$ZM=6MY%''?&PN(]JLT,H;:<X;!4'N,_2K>F>+[?4M2O-..G:
MC:7EO;BZ$-S&JO+&20&4!CW&,'!Y% '145PVC^)-!\/>#-)GL[74_P"S+FX>
M"+='YDBN96!WC))RV[&,GVK7TOQA9:@^J1W-O<Z=-I@#W$5XH#",@L'^4D8(
M!_*@#HL48KDD\>6_GZ9'+I&I1C5>;%@L;><N-V<!LK\N#SS@U;3Q?;372);V
M-Y/:M>FQ^V1^68UE!P<C?NQGC.V@#HL48HKFM1\;:=IT6H7!MKRXM-.E$-Y<
MP(I2)^,KRP8D;ESM!QF@#I*6N0FU#2I_&NC321ZJNI36<QM8B"L)09+9!.-W
M _-?:K>G>-+#4=&U/4Q:WL$>G2/%/%,BB7>HR5"ACSR ,XSF@#I*,5SVJ^+[
M/2FG1[2\GDMH1/=)"J$P(03\V6 )P"<+D\?2HYO'6CQSV4,7VJZ>^M3=6HMX
M&?SE'9?]KGIV[XH Z7%%97A_Q!:>(]/>[M$FC,4K030SILDBD7[R,.Q%3ZMJ
MMMHNGM>71?RPRHJHN6=V8*J@>I) H O48KF+CQO96%E+=:CI^HV4<-VMI*)H
ME)1F4,K?*QRIR!D9Y-:QUNU376T>021W/V<W*LR_(T8(!(.>Q8#!Q^5 &A2B
MN=MO&.EWE_9686ZC740YLIWCVQW 7KM.<CCD9 R.1VKF/"7C"RTG1[A-3N+Z
M4+JL]NURZ22I%F4J@>0YQVZGT]10!Z324M<Q%XK>7QU/H!L+E(X+82&4QY#E
MFP&&.B<'D]3].0#IL4M8">,-+;4;:S?[1$MVQ2UN)(2L,[#LC=SQQZ]LU1C^
M)7AF:_\ L27-P9@TJNOV63,9C!+!AC(/!XQVH ZVBN57XB^&BUN3>2I!<Q[X
M;E[>18I#C.Q6(P7Q_".<\=>*N67C#1[ZPU&\26:)-.)%U'/ \<D?&1E&&>1T
MXYH WJ.HP:RM*UZWU:YN;9+:\MI[=$=X[J$QDJ^=I&>OW35G5I(8M'O7N)YK
M>$0/OFA!+QC!RRX!.1UZ=J + @A!!$2 CH0HJ2N0LO%6@Z#I.A6=QJMW/]MM
MO,M)[F-V>==N[DA>6P0,=<D#'-;VC:Y8:_9-=Z?,9(TD:*170H\;CJK*P!!&
M1P?6@!EQHZWFM07]W+YL=J-UK;[,+'(1@R$Y^9L<#IC)[G-:01 [,% 9L9('
M)Q6+XM\0+X8\.7>J?9Y;AXUQ''&A8%SPNXCHN<9/]<5SFK^)/LGC#PQ=2WE[
M;6-S#=+<6TD,D8=T5=N(RH9CESC@YXQ0!W]106T%LFRWACB4G.V- H_2LRV\
M4Z->:2^IP7F^U27R&/E.'$F<;-A&[=D@8QFI=(U_3];-PEH\JSVS!)[>>)HI
M8R1D;D8 @$<@]#0!H>7&,X1<DYZ=ZYGP]X=O+/5M6O-5M]-D%W>?;+<Q9=X6
MVA,991V4<C'>M#Q9+);>%-5NHKJ6VEM[629)8L;E*J2.O!Z=*R/A[X@O-8TB
MXL=7;.L:7,;:[) &_NKXXX(]NQH ZM[>"2597AC:1?NNR@D?0T&V@;S<P1GS
M1B3*#YQZ'UK@M#\2:EK/Q,N+5[QXM(:P-U96Z*O[U1+Y>]FVYY() ST(KJ;7
MQ5HMY>16L%YODF:1(F\IQ'*T>=X1R-K$8.<$]#Z4 :0L[52"+:$8C\H80<)_
M=^GMTI(K"S@A,,-I!'$3DHD8"D],XK ;XA^%$5F;6(@%F\ESY;_(_'WOE^4?
M,!DX&<C/!K0U7Q/I.BS&*]N7618_-=8X7E,<?/SOL!VKP>3@<4 :+VEM(,/;
MQ,/1D!ILEC9S0+!+:P/"IRL;1@J#G.0*K7>N:=9PVTDMR&^U#-ND2F1YAC.4
M502PQSD"H;;Q3H=Y:37,&IV[Q0?Z[YL&,YQAE/(.>,$9S0!IO!#+%Y<D2/&/
MX64$?E21VT$+L\4,:,P +*@!( P!^ K)_P"$NT$6UU/)J*0+:8,ZW"-$\8/0
ME& 89[<<U&OC7PT;V>T_MFT$T,?FON?"A>.C'@]1P#F@#:>VMY)XYY((FFC^
MY(R LOT/:F+8V:7C7:VL"W3#!F$8#D>F[KV%4K+Q-HNH:/)JUMJ,#V$1823$
M[0A'4-G!!^OJ/6HO^$LT,6]U/)J$<"6BJTXN%:)HU;[I*L <'L<<T 7(M%TJ
M 3"'3+.,3+MEV0*-X]&P.1]::^@Z/);I;OI-BT$9)2-K9"JD]2!C S5:U\5Z
M%>ZA]@MM2AENO*\X1KG)3 .1QR<$<=14?AWQ39>)#>?9%D46\[P@NC#>%P-W
M(&.2>.M &BNDZ<LLTJZ?:B2?/FN(5S)G@[CCG.!UI;/3-/TXR&QL;:U,AW/Y
M$2IN/J<#FK=<5?\ C&>T^(NG:2(_^)3-OM)+C V_:RJNJY]0N!CN7/IP =;=
MV-G?QK'>6L%RBMN59HPX!]0#WJ&71M+FADAETVS>*1_,=&@4AGY^8C')Y//O
M4M]?VFFVK7-[.D$*D*7<]R< #U))QBJ$?BO0)(99/[7M(Q$"9%FD$;Q@==RM
MAA^(H OPZ=96]C]AAL[>.TVE?(2,!,'J-O3%);:;86=H;2ULK:"V8$&&*)50
M@]?E QSFJ,7BO09TN'BU6U<6ZH\NU\E0_P!WCKSD8'7/%6+77-+O;*XO(+Z$
MV]LS)/(S;1$5^\'SC;CWH =::+I5@4-GIEG;F/.PPP*FW.,XP.,X'Y4E_HNE
MZI-#-?Z=:W4L!S$\T2N8SP?E)''0?E4$/BC0IX;B9-5M0ENH>8O($,:GH6!P
M0#V--7Q5H#W?V5=9L3/Y1F\OSER$"[BWTV\_3F@"S!HFE6MY<7EOIMI%<W((
MGF2%0TN3D[CC)R?6H[?P[HMI:W-K;:390070*SQQ0*@E!&"&P.:DT[6]+U:Q
M>^L+^WN+5"5>:-P54@9.3VP"#3+?Q%HMU'/)!JME(D"AY66=<1J>A;G@&@!U
MGH.DZ?ILFG6NG6T5E*27MUC&QLC!RO0YIMEX>T;3K&:RL]*LX;6;_6PI"NV3
M_>&.?QHA\0Z-<7<5I#JME)<31":.)9U+.A&0P&>1CG/I570?%ND>([B]ATZ[
MCD>UF:+;N :0 *2ZKUVY;&>G% %G_A'-$S:G^Q[ &T.;?%N@\DYS\O'R\\\5
M-9Z/INGW,]Q9V%M;SW!W3211!6D.<Y8CKU/6I;^]@TW3[F^NGV06\32R-Z*H
MR?Y5F:7J<AT8:SJUS%;07"K*D<F$6!&^Z"V>6((SSUX% %VZT72[Z\CO+O3;
M2>YC7:DLL*LRCT!(S59/"V@Q2VDL>D6:/9G-N5B \HYSE?3FK$>MZ5-837\6
MHVKVD!(EG692D9'4,<X&/>GV&K:=JGF_8+ZWNO*8+)Y,@;83V..E $-OX>T:
MUDO)(=,M4:\_X^3Y0_>]_F]>IJ*R\*Z!IUQ%/9Z-902PAO+>.%05R<DCWXZ]
M:U7=8T9W8*BC+,QP /4UQQ\4_;?'VD6&E:M:W6GSP7!N8H=KE60#:2W7!W?I
MWH ZB]TO3]1D@DO;*"X>W??"TL88QMZKGH>!S38=(TVWO+B\AL;>.YN1B>98
MP&E'^T>I_&HHO$&CSZJ^EQ:G:/?Q\-;K,I<'TQZ^U<G=^*WU;Q)J>C:1XDTZ
MQFM88C:;MD@N9FW,P.<_*H4 A>1G/M0!U>F^'='TB>2?3]/@MY7&"R+R!Z+_
M '1P.!@<5):Z'I5EJ%QJ%KIUK#>7'^NGCB =\\G)Z\GGWK-T#4Y(-!@EUW7-
M,NKF2=HA<6[!(F;=@(OJPZ>M:UGJFGZB9A97UM<F%MDHAE5]A]#@\&@"+4M$
MTS5S&;^SBG:+.QF&&7(P0".<'N.AHO-!TG4-,33;O3K::QCV[(&C&Q=O3 [8
M]J?:ZQIE_.]O9ZC:7$R#+QPSJ[*,XR0#D<US/BWQ?'I\EK9Z3JMB=1^W00SV
MN5DEV.X4C&>#SZ'MTH Z*'0=*@N);B+3[=)I4$;N$&2@& O^Z .G2HIO"^A3
MZ2VE2:3:'3RV_P"SB,! WJ .A]Q6M7&0>*9K3QUKMCJ]_:6^E6<$#1/)MB >
M3)P6)Y. ?RZ4 ;;>%=!;2H-+;2K4V-NV^* I\JM_>QZ\GGWK1GLK>YLVM)XE
MEMV7:T;_ # CWSUID^IV%K9"]N+ZVAM& (GDE54(/3YB<5S_ (QUZZL?"L>J
M:'>6S!YX4$@42JZO($^4@X[]>>E '0RV%I/?6U[+ CW-L'$,AZH&P&Q]<"H'
MT/39-7&JO:JU\$,8F+$G8?X>N,>U2WVJ:?IBQMJ%_:VBR':AN)EC#'T&2,FB
M?5-/M3 +B_M83/\ ZD23*OF=/NY//4=/6@"KIWAO1])N//L+&.!]I50I.U 3
MDA5SA0<#H!TJ.T\)Z!8ZO)JMKI%I%?2$DS+&,Y/4CT)[D=:OPZG87%S+;07U
MM+/#GS8DE5F3!P<@'(Y]:R[G7C;:AI\RRVUSH]^XMUN(6R8YB2%Y!(96(V^Q
MQUSP :FHZ;9:O82V.H6T=S;2C#QR#(/^?6L[3O!_AW2IDFLM(M8IDB\I9-FY
MMISD9.2<Y.3U.:VZJ:G)>QZ?(VG1I)=DJL8D&5!+ ;F&1D $D@$' XH HZ7X
M3T#1+F6XTS2K6TFE7:\D*;3CK@'L/I[4MMX7T>S@O8+>T,<-Z&^T1K,^V3=P
MQ(W=3Z]:P4UOQ++XXN/#:W6DCRM/6\$YL9#DE]NW;YW3WS3K+7]<M_%5O8:[
M+IT%L=-ENIBB% C)*L>=[,?E.=PSC@\\B@#97PCH:)IR+8X736+68\U_W))S
MQ\W^>G2I$\+Z*AU#_04<:B2;M9&9UF/J5)(K0%Y:FT%V+F$VQ7<)@XV$>N[I
MBG07$%U");>:.:,]'C8,#^(H R=*\):!HMA<6.GZ9#%;7(Q,AR_F#&,,6))'
MM4%CX$\,:;-!-:Z/ DD#%XF8LY0GTW$_@.W:N@9UC4L[!5'4DX%,ANK>X>58
M)XI6B;9($<,4;T..AH J:MHNGZY!%#J$!E2*02QX=D*. 0&!4@@X)JF?"&AM
M8PV9LV\F&;[0O[^0-YO]\MNRS>Y)-:<&H65U<2P6]Y;S30\21QRJS)]0#D?C
M45QK.F6ME->37]LEO "9)/,!"XZ]._M0!4N?"NC7MQ>3W-F99+R'[/<%Y7(>
M/^Z1G'';'0\]:KV?@;PU87<%W:Z6D=Q;H4CE$CEE!&.I.2<=">1VQ1-J\^K:
M5I5_H5]8Q137,+3_ &I@28F&6C&,XDY7 K:EO;6">.&:YACED.(T>0!G[< ]
M: ,A/!N@IHZ:3]A+:>DIF6!YY&4.<G/+>I)QTSSUYK= "J ,X QR<U!<7]G:
M2QQ7-W!#))G8LD@4MCK@$\U8H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** .?\;Z;>:SX/U#3+&W2:XND$2A
MW"JN2/F)/IC/'-4KK2=5G\1>&[V.!%AT^UGCFW2#(>1%4$#N 5Y^M=;10!Y/
M;^&/%@DT:\GT6QEU*QOC)<W<E[F2[&' 8MM)5!N&%Y([**Z75_"5U=>.[/5;
M5D6PN(E35$./G\I@\7'<EAM/7Y0178R2)#$\LKJD: LS,<!0.I)JOIVI6>KV
M*7MA.L]M(6"2KG#;6*G'X@\T <AK>E^(=.\9-KFB:=;:I:WELL-Y:33+$0R9
MV,K,#CACQCU^M=9I4=^FGI_:<J27;DO((QA4R<A%]0HXR>3C-7:* .5\466K
MMKV@:MI5A'??86G$L+7 B.)$"@@D'IBN?'A_73!X_4Z3*&UA2+,":+YR4*?W
M^.3GG''OQ7I5% 'FD&C>*-&N=#U6UT>/4)#I4-AJ5E-/&KJT?216+;3R3^'U
MX[O1X[Y-.0ZBL27+LSM%%@I$"20@.!G P">YR?:IKK4[&RN+>WNKN"&>Y;9!
M&[@-(?11U-6J .7\16U_+XK\,7=MI\]Q;V<TSW$D;( @>)D'#,">6SP.@/TK
M&.F:R+CQX6TF;RM4C LF#QDR-Y7E$$;N!G##/;.>>*[V>:*VA>:>5(HD&6=V
M"JH]23TIEI=VU_:QW5I/%<6\@RDL3!E8>Q'6@#S.70?$-G9^&M6308-1N+'3
M_P"SKW3)VCR57&'1B2.JCWP1QR<7M2L?$LEKI)70XX[&2ZDDOM,TZ9(I%0JH
MC4R94'D$O@C(('0<^BT4 >,OX3\0IX3UC38M!=9)O$(OH8HI8]@A.TX&6' V
MX[=?K79'3]2C^+$NMC3IWT\Z-]E$JLG,GF;\8+9Z#&<=?SKM** /++70]<MO
M!/A:P?1KHW.GZR+NX17C.V)97?(^?G(<<#G@UH:JERNO^++J\T:5].GTI;>-
MYF"QS% Y*Y!+#<7 &!G/IQ7H=9NLKI-U:?V9J\EOY-]^Y$,LFTRD]EY!)SCI
MSTH \ZT 76GW.AW'B'1M;V::HM;.:80F.W,I5,L%;<?X5!.<#MGFK*:-J#>(
M[;4=&TF^T;4VO_\ B8=/L=S!GYG(W$9( Q@9R?\ @0ZW3?!VG:;/%+]HU"[\
MD[H4O+R25(CZA2<9]SG':NAH *\>N&N9M7\1VG]BZS/H5_?'SETQ$E69EVAB
M&+ KN*D,!TZ YKV&N57P#I4=W-+;W6J6]O,S-)96]])';L6.6^0'C.>Q% %"
M25M9\7>$-7TVRN'TJ.UN"TX0!4\U%"*1G((V8/&!D5'<>&+W_A8KO#&1H5\(
M[Z[ X7[1"?E'_ CL8^NTUW-O!%:V\=O!&D4,2A$C08"J!@ #TJ2@#R_6]*EL
M?'^J7U]X-7Q#I^J1P^3)' DCP.BA"IW_ '0<9)X[5H1Z7?VOC?PQ,NF_9K6V
MLIXIULXSY,1D/RIQV'&3TXSQ7H%1R310[/-D1-[!5W,!N)Z >] ''_#VRO+)
M_$S7EG/;"[UJ>[A\U-N^)\;3^AXK7\7V]M=^'I;>]TJ;4[622-9;> $OMW#Y
MEP0<KU_"MVB@#RF]T'7KSP7X@TY%O=0MH;F"72OMB[+EU1E9U.[!( !"EN3S
M[5H7R:GXB\5NR:-?VEK<Z%<V27%P@&QW9<%AGY?NGCK[8YKT6B@#S_P?JWB$
MV&F:#=^&;JTN-/5(;B]N%'D>6G&8R.68@ #'3.><<YESI&I-\+M8TY=.NS>W
M&IO-'!Y)W%#<B0'_ +Y&?TZUZA%-%.I:*1)%!*DHP(!'44T7,!N3;":,W 7>
M8MPW!>F<=<>] #XI!+"D@#*'4, ZE2,^H/(/M7$:E9WQ^(MZ5T^\DM=0T=;-
M;J) 8XGWN26)(Q@$'UKNJ* /*O!NFFPBT_3;OP,T>L63HLNH2P*T&Q&&94DS
MDO@<!1G/M6OX6::V\/\ BII;#4(WEU&\N8HWLY%>5)"2A4%<DGTZCOBN]'6E
MH \Q6.X7PIX M9-.U#S;*\MY+E/L4I,(CC="6^7CYF'UZ]*$MC)XJ^(,EWH]
M]=V5ZEK&L?V:1//5$V2;&V\X)XQUQD<<UZ=10!Q/@R#4;/5;VU$]]>:&L$9M
M+C4(&BGB;)S%EP&< 8.2.,X]:Z77V=?#NI&))'D-M($6*,NQ8J0 % )/-:-%
M 'E=C97O]L?#,MI]Z!IUC+'>%K9P(&:$(H;CC+*1^&>E=#X'AO8=9\6-=6]S
M#'/JC2P&:%D5TP!N7( /W>WM79T4 <U\0+2YO? NJP6EO)<3E%98HEW,VUU8
M@#N< \5E7=XVK>//"5]!8:C';Q17GF--92)LWJJKNRN%R5/7'3W&>ZHH \9N
M[6^:SUF\M]+OIDM/$YU&2R\AXWN+<H%W+D GG/3ZFNX\(KIUU?W.I:;H%SI\
M4D2QM/>(T<LK9SM"L2=H]?7@9KKJ* ,;Q;-##X2U7S@2LEK+&%"%RS,I & #
MU-<?K6CW=[XAM-5\/!C:Z];&PU*3:R^6@Y$N#@A@H91GVKTFB@#SV!;>V^+H
MDA@E6SAT,:?$XB81^8LN?+#8P2%Q7(P7<O\ :'A2\73]1B2SOY$N;"WL62"S
M<AOW<:A?F.226R>O;I7N%% 'BXMYW^&WCU(K.=KB\UB:2!1 VZ:-VCVLHQDC
M&X@_6M#79&:]U")K+4;=9M%C6.:QM&9[QBC91Y-IVA>./E[Y/:O6** /&AJ?
M]FZ9X U2."Y2YM+"2$K-;2LA78BL-J@MG/0XQ@<]JD"1GP7=W>CO<ZA>QZTN
MK:G9PQR02'>Q)5%.'4  $'OM)]J]"U?PY=7VL0:MIVLW&G7<<)MV C66-T)W
M?<;H<XY'I5K2=&;3Y9KNZO9;[4)U5);F153Y5)*JJKPH&YOSY- 'G.MW&E7O
MA?Q!J6D:3?(9=--O+>7K3>8[LR[8@LA.[ R21P. ,Y-6KA;1_$WPS0!!'#;3
M,P"\*6A4)GL,N"![BO4:* /%Y5O+JV\:FPBFN5BUR"\:" L&FA5@6V8ZGY>W
M]WUQ6G//H.M:'XAU;1+347F;1KBTDNKR2=FW,/DB42$[B3GIT(_VJ]5HH \W
M4V\6K?#B.*.-?)AE:3:N#$&MRHS_ '<OQSU(]:O?#R_B6Y\0:2R3K>1:M=3N
MK0.%"-)E3O(VY(Y SDCFNZHH S=>UB'0M%N=0EPQB0F./O(^/E4?4UY]K_A;
M4(O 5W=-XF2019U*(I;HB_:-WF;A)RW)) Y[CZ5ZG10!Y?X@\56FL^ M#UZ.
M>.*Z@O[>8J\;O'%.H.Y9=H+*N"<$#/W>.:A34M'U32/'&M1:G:O?WNG-&]O%
MO5418F1.9%5G)+8SC&2!7=>(=!N=7DL+JQU633[RQD:2%_*$L;%EVG>AQG@D
M#D8R:?I>C7<%]_:&JZB+^]6)H8VC@$,<:,5+ +DDDE%R23TXQS0!Y_J<6FV?
MA+PKKFFVJ-IUK)%_:+Z>NV4*(V7<63#?(S$D>I^M1WD.G7_AG7-4\+0:I=0S
M26T]U<R/+NNUCDRZH'P<A1R1ZXKUW%&* /)KRZT+6=(US6M&&H7-S_8MS;3W
M5S)(OE9'RPX889BQ/3.,>XJ(-8+9_"V!H;5HRH,BNJE0WDA3D'OO/_?0]:]>
MQ1B@#QW5ENKQ_B+:Z:#*PNK2;RK;'F.JA?-QCKPI&/7/<U>@N?#&IVVI:MI]
M[J-]*-)GBN)[V5RD"$9$;[@!N+'@9/0FO5,4U8T0$(BJ"2QP,9)ZF@#R.U.E
M6FC?#*:%K2&4S1[W1E4DF$A\G_>P#[X%=)X%U&T77?%FF&8?;#K4TWE8.=A1
M &/8 D'\J[G ]*7% ')?$Z*YG^&^N):;O-\@,=O78&4O_P".AJH^--1L+;1/
M#ES<"(H]["T%W*S>5;/L)65@I&X#L"<<UW+HKHR.H96&"I&01Z5F:/H_]D6;
M6 N&GL4(%M%*H+0IV3=_$HXQD9 XR: /+K.?2+NU\;V.I:Q,D%S?02_:S#Y9
M7<8PLA&  NXKUZ@$\]:['P-JEQJ&H:S#<R6-]):^3&-5L?\ 5W:X8C=@D!US
MR!_>'M79B- 6(506Y8XZ]N:2*&.",1Q1K&@Z*BX _"@#EOB/]K_X0JZ-K!+<
M*)(C<PQ#+20;QYB@>ZYS[9KGKSQ)HVK^.] N-&OH&EDTZZBCF P-[!/+0DC[
MP.?E[9Z<UZ;4:PQ(04C1<=,*!B@#QSP<V@WUIHMKJ5_JLVO6-Y'C39&PT$P;
MYG "@[,$LV2??)KKM U"RG^)/C*%KJW?,=F@0NISM1]XQWP3SZ=Z[81H)"X1
M0YX+8Y-1_8K7SO.^S0^;S\_EC/YT >.(NGW'PRTJ-IK4Q-XDV@B0 (IN6SR/
MN_+SQV(-:VL01V_C#Q-8Z$L$%Y+X;'DPVP"LS[G^Z%_BVD8[\BO2O[.LO+\O
M[';^6#NV^4N,^N,5,+>$.'$2!P<A@HSTQ_+B@#RK2KO1-9.E7.A:AJ-UK5C9
MRQV]F$2-;7,9!$H5%^4,% YZXQ5#^W] F\$>&(9)8(M5M-5M3=QS8$T4HE!F
MD;/(R<DM[XS7L45I;V[R/#!%&\AR[(@!8^IQUIWD1;RWE)N)R3M&<T /5E=0
MRL&4C((.017FCV>CS?%OQ%_;D=H86TZ QK=D ,N"&90W7&""1T_&O3*AFM;>
MX93/!%*5^Z70-CZ9H \6TF230M*\)2:K=75CHK37HBGV B(.P\G=O4X!7?@D
M=&^M7_$HTFS^&^K/HU[<RVLVJ0NETTB['D\Q&=HMH  !!Y QD&O7)H(KB)HI
MXDEC889'4,#]0:BGL+.Y@2">T@EA3&V.2,,JX&!@$<4 <=8W4:?$OQ!%K)@"
M36<!TYI@-K6X#>:%)X^\1D#T'I7-MH%[/\,+Z>VB!?3=4FU'1@5R?(CDW* /
M0@-@=P5KU66QM+B..*:U@DCCQL5XP0N.F >E3[05VX&W&,=L4 >3RWNI6NNP
M^+[:U9(O$D)L((]OS1.5'V=V_P!X@D^@([UT'CRSM],^'D.GPJY*7%I#;XR6
M+B5,'CN<'\37;&&,JBF-"(R"@VCY2.!CTK+NM'DU'7+>ZO9(VL[)A+:P*#DR
MX(WN>^ 3M ]<^F "U;ZM8W6JW>F0W"O>681IX@#E XRO.,<CTJ]4:P1),\RQ
M()7 #.%&Y@.@)[U)0!P-K+'_ ,+SOU\Q<_V(BXSW\T'%3:E:V>I?%JTL[V"*
M>)=$DD\N09!/GIC(Z'IW_I75G2---Z+W^S[3[6#D3^2N\'UW8S3VTVQ>^%\U
ME;-=J-HG,2F0#&,;L9[T >/K>1:;H6B*;M[30X/$5Y$\D2JR1+OD\K(8$;03
MGD''7J!7>^"[32+:XU:;1[^>_BNIEGEN28S"TA!!6/8 ,C SQW%=&--L%M7M
MELK86\@VO$(EVL/0C&#4MM;06=O';VT$<$$8VI'$@55'H .!0!QOQ8@MY? T
MKW")B.ZMR)&X,>94!(/\/!(R*R[W2](T#QB;K18#!:'2+F35([$$+Y8&8V&.
M Y(;'<X-=-XYTC4->T :=806TI>>*23[1,47:CJ^.%.<[<5N6=E;6<&R"T@M
M@_+I"@ SCV S0!Y+H-[IB^)_!+_VCIBVZ6-Q%%'&X+IE4"I)(<;W8ECC:O.>
M#G-26/AK0Y/!OC#4OL5N]U:W.JBW=1_J5VNH50.-N.0.@SD5ZE#I&F6XB$.G
M6D8A<O&$@4;&/4C X)]:6STG3M/61;+3[6V$@PXAA5-_UP.>IH \ZO9=+OO!
M7@G[+-:2-!J6G(S1%6,;X7<..AQU%4+^?2-0U[Q;I?B;71ILCS@1K-''EK<(
MNPQNRD]03M!ZDG&2:]3_ +'TL0Q0_P!FV?E1$F-/(7:A/)P,<9IT^F:?=7,-
MS<6-M+<0?ZJ62%6:/_=)&1^% 'ENN0K:+J5_'-#JEFMC;P:GIVI +=QJ(@0Z
M-V8A@<8QNW8YKUN-M\2-M*[E!VL,$>QJG<:-I=U=I=W&G6DMRC!EEDA5G!'0
MY(SD5>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** ,W7[^\TW0[J[L+5;JYC V1,P4<L 22>P!)/L*Y*W^(J
M0/KYO)+2]M=+MXKA+JQ5E$V_@+M);^+C(8CFNC\5Z)<>(-">QMKJ.WE\V.4-
M+'O1MCAMK+D94XYKGI/ NI:C=ZJ=6U.SDMM3L8[>=+>U*%73=LV98X4;@><D
MD=J .@TZ?Q*+^W34[2R:UF@+R/:D@VT@/"'<QW@@_> '(/%<?\/M?FOO#VG:
M1H<MHUQ TTM\TX+"!&ED*#:&!+'TZ =<9&=WP[X>\2V7V<:WKD%['8H5M(X8
MBFX[2H:5NIP">/?/)%9VF_#V^T>VT:33]3MX-3T]W26X$)VW4#,7\MUSV)X.
M>* +5SXF\1RZKXAT_3K+36?25B?S9Y'"N&C+XP.<]/0#GK5BV\5WNLP:-:Z9
M%;0ZCJ.FC4)&GR\<$?RC[H(+$LP &1P"<]J2'PUJZ:EXFO'N++.LPQHJ*&_=
M,B>7DGN""3]:JVG@S4]-CT"]M+RT.J:39M8N'5A%=0_P@GDH1@'(!YH ;J7C
M;5++1=9DBLK634M$G5+Z+<Q4PL-PE0#G&TYP?[K<\5HKXNV^.H]#EFLOLEQ9
M?:K>92VYCUVD]!QN8>PJ[IOAQ(DU>74#'/<ZN^ZZV+A-NP(J#/4!1U/4DGVK
MF6^&K_\ "(Z?I:W_ /Q,+:Z25KPL=QC'[LJ/^V7R@=,C\: )-8U"74X/!UY<
M1Q*T^N(\)CS@Q>7+M;G^\,''O[4_4?'FHQ/>W&FZ3->6]E>FT:!+2=Y)]K;7
M9'5=@P<X!ZA3R.!6OX@\/W>H77A\Z?\ 98K;2[M;ADD+ D*I4*N <<,?R%95
MMX4\2Z1JNIQ:-J]E#HVHW+7#++"3-;,_+^5CY>O3/ XX]0"UJVNZAJL&LVVB
MP6WE6-N5N6O-RL[M'OV*!]W"D9)[G&.":Q?!>NRZ?X)\&Z5:I";O4HY0CSL0
MB*F68X'+'D #CK[5H?\ "(:YINL:LVBZA9#3-64M<1WB.\D<I7:74@C=GJ<D
M5S.M:)J&E:5X5\*1:KI*WUH)KE9+IY+=&"G"E70[@WSG@'G!SP.0#J8/'5W#
M8:[<ZEI]O'_9=W]B413L3<3$J%P-OR@[E]2.>.*OZ'XIN[[7GTF\L<_Z.)X[
MRVCD\DG."C%U&&'7W'ITKG;'2KOQ!X<U+PM<#3;:2(1W$-_I4LDT:S;]PWLX
MR7RNX\DX8>U=3H%EXG$B2^([^RE:%62-+!759,X^>3/4X'  P,GKQ@ G\0:K
M?:=]FBLH(,S;R]U=,5@MU5<Y<@=S@#D?7BN?B^(-P_@ZRUU-+BF::^^Q/%%<
M\;O,V!D)7# ]>2/K6EXFT+5]2UO2+_3I;!X;/S/,M;Y6,99@ K@*.67!QG\"
M,FN=M_!/B6+PTND23Z3((M6%]&RF2/*"0R$'AN23C'8=VH V[7QL]OJ&LV>N
MV45E)IEHMZY@G,P:,@Y_A7YAP,>_%<_KU]J=]XB\$3ZCIUI EQJ'FP-%,7DC
M78?D?C!)!4Y!P,8YZUJ:IX(O=8\2Z]<W#VJ6&J:8MF"LC-)&XY#;2N",^_:J
MB^%_&5W-X>.I3:$RZ-<HZO$TN^5 I4YR, GCC'X\8(!W.L:B=)T>ZOUM)[MH
M(RP@@7<\A[ "N=TWQMYWB:[T2]2S,EO8?;FFLYS*J@-M:-A@88=?H1P*U_%6
MG:AJ_AB^L=+N_LE[,@$<N2!P02I(Y (!7(Z9KCH/#VLZ'KW_  D]RFB6-E;Z
M-):SPVRN5A53YF0,?-T]N/7J0"^OCK5&LM%U!=&MI+76IQ#:(+LAT+ E2_RD
M<A23CH>.:LIXTU*;Q%J&E6_AYI4TZXBCNKD72A$C<9WC<!D@')'H#STKB-!M
M-8\/6EEK-_9Z-?6\>V2T2/4Y<H9#AO*C.8]S;N H'/ ZUW6C:-JD/B?Q1+?6
ML*Z=JK*T4D<^7 5!'@C'&1S[=.: *%K\3(KK4M.1;*)["_G\B.2&X,DT>3A&
M>,+PK?4XSS3[OXF6=N%N(;:*ZLC=FU/DW.;CABID\K;]S*]=V2"#BF>&=%\:
M:,+?0YKK33HMG(/*NUW&X>%3E4VXV@D?*3V&<9ZTS2?#_C#0WN=$LKFP&B2S
MR207A),]M&[%BH7&"V2<$\#.?:@#K_$%[=Z;X?O[ZQBAEN+>!Y56=RJ_*"3D
M@$]NG?U'6O/M2U'4+CPQX$U+4K"*:YDU&R:-K>7S)90T3,2=RJ%)(&1DCWXK
MT?5[-M1T6^LD8*]Q;R0JS= 64C)_.N*_L#Q)<>'?"UI+8V,4VC7L$C1BZ)#1
MQ1E.NW[QSG';'6@#5MO&4Z_V]'J6D207.D1).T-O*)S*CABH& /F^4@CI[XJ
M&T\9:A=:R^BG2[9-2DTX7UNGVHE.2 4D.P%6!/H:S]3\+>(KCQ#XIOM/EBM3
MJ5A'!:3K,=RNF.O&5R,C(SBFZ)X8U^R\6Z9JKZ;H]E:Q6+6L\5O*Q8$L"7SM
M&YB1WZ<Y)[@&Q\/-:U?7_"\.HZM# IF+O')%*3O&]L@J5&T#  Y;(J(ZYK$_
MQ%FT0:= ^GQ6:O(3<]5=L;RNSD_*1MSW//-6? >DZKH/AV+2=2AMD6TRD3PR
MES+EF8L<@;1R,#GO4-QINMVGQ$?6+*SM[FPN;&.WF+S^6\91V;@8.XD'CH,]
M2* .8\,^(I?"OAUF&B2R:.NJ7$<]U'(JB -<%%"IU<#C.,8]ZZG[7IL/Q#O?
M,THQW\.E"=K_ 'YWP[\;0H]U/OQ6%_PCWB%OAS<:.VFI]OEU$W&W[0FW8;@3
M9S^&W'K6X]AK1\:7FKP6420R:4MI$TDP)$JEI 2H_AR^WK_"3TP: +/A[Q-<
M:Z]O*+&$6%U"TT-S;W/G!2-O[N0!0$?#'C)^Z1S6Y?7D6GV%Q>3DB*"-I'QU
MP!DUQGAWPU?VOBN/5ETV/1(#;NE[:VUP'ANI3MVLJ# 7'S<GGH,=36[XCT^Z
MU=K+3_LHETMY@]\?-"ED )";>X+;2>>@(YS0!RW@^_U32_&U]INNDJ^N1+J=
MJI7 1\8>'/JJA1_P'/>NKU'7IX=8&DZ;8"]O%@^TS!YO*6.,D@<X)+$@X&,<
M<D5S'B7P(MG+I%_X0T>WAU"RO%F)5Q&K1X^93D]_;WJ+7!K%_P".#+I%@S7%
MMIR1W'D7Z02)YC$[)"R.K8QD8Y&<YY% &F/B39/I>E:BND:F+?4[AK: LL>X
MR#("[5<G)92!].<"EN?B +2&WAN-/BM-5>(S2V-[?QPF-<D+ASPQ8C@#\<<9
MPY[34M0LO#UKI7AQX%T#5%-S;"[C?:$4'Y78C>2),Y]0<XK9UG3/$6F>-?[?
MT*PM]1M[NV2WO+66<1,I0DJRL>.AQWH GC^(FDW6DZ5?6>&;4@YBCN)DA$80
MX?>S' P<#C.<C''-06_Q+L;K3;2\ATZ[D$NH?V?,L11_)E^H)W@@Y!4'/M4.
MK:7XMANM'\0VEO9W^IVR3175@)!&K1R,"%C<X&5VCD]<?A1K5CXFU*#0YYM+
M#S1:S%?2VUO-'BUA12-NYBN]CG/'N.PH NQ^.IY)=0LQX9U4ZE9 2/:C8<QG
M)5P^[;S@\#)R.,X.+7_"<:;+I6DWMLK2'5%+01NZQ[0H^8N6(  /'&>2,9IE
MI9:E;>-]<U%]/=K2ZM((X'61/F:/?D$%LC._CZ<XKDXO"_B+2=%\-W]II<-W
M?Z3;R6=WITTB8N(V(Y1N0.1GG_ZQ .@B^)FES:?;726EU(TM^-.ECBV2&&4G
MC.UCN! )!7(..U2S>.66RUXKHMY%?Z1;BXDM;ET7<A4L&#*S#&%/O6?J.D:[
MJ%CH]P='BMWBUB"^>PMI(_W$2*0<N=H=R3GTZ#MDS:CH&JW6M^,'CLSY&J:2
MMK;3&1,-($<8(SD EQSCL: .E\-7]UJ7ARPN[R%HYY;>-V+%?G)0$L-O !)/
M%9Q\8(^KW%K!IUQ/:6UU'9374<D?[N9RH *%@VT%QEL>N 1S5KPBNIQ>&[*W
MU73A8SVT*0>7YZRE@J@;B5X&<=,FN6U/PWJ=YKW]I:;I<NE:NE[C^T+>:-;>
MYMPV<S('+,2O'W<DXZ#H 9>C^(U\+:IXTN6TR_O+>+4RTK6Z@B&,*,DEB >O
M09/TKM]0\5Q0-;QZ?93:C--9F^"1.BX@&/FRQ .20 !FN3BT36HM"\>V\VB7
M,DNJ74KVD?FQ_O%D7:#D/@;>I![>M27.F>(IVTFUDT)[G3AI*VYMS=)$L5P,
M F;!.Y0 , ;A[9H M>*-4M-;T+PEK%NDY@N=6M&5.C%6).TKG!Y _*KMM$L/
MQCO=A8"71(Y'!8D%O.9<@'IPHZ5S<^C^(4\ ^$; Z)="ZTS4X)9XXY(V/EQ[
MLMPW?/ ]N<5U\-G>CXEW.HO82I9/IB6J7)9"&=9&<\!BP&&'4#D'VH H?$6Z
MCL)_"UW*TH1-9C#",,Q8%'.-H^\<@8XJ_8>.]*NWU*.ZAO-,GTV(3W$-_$$8
M1G^(8)!'X]Z;XVT[4KQ=#NM,MOM+Z?JD5U-$"H9H@&#;=Q )PW'(K%U?PG?>
M+[O6-4>!M.-UI(T^UBN<;R=_F%W"DA1G QR>.U &YI/CBPU+6H])DMYK6ZGC
M,ML)'C<3(!D_<9MK <E6P:UM7UJWT:.#SE>2:X?RX(4*AI&P6."Q"@  G)('
MXD"N8\()J<EQ#]I\'6>@M #]JG18_P!^VT@",+@@$G=DY&!CG.0_X@:%?:A-
MHVK6.GP:FVES.TFG3$;;A' 4XSQN&,C/_P!8@!J'CJ.Z\'Z]>Z5;W O].22.
M:$^66MY A(<_-M91CJI.<=#7,:J'TC1-*OK+2]9MY]3>WL;W_2(_WX9T9G/S
M\R/\RA\C[S9QP:Z'4[;5;[P+KJ0^'Q8/>6OV>UL(0AER006<KA1][IG@#U.*
MCUZ/5+[PIX;C31[Q[NVO;2>XA1 "@BP7ZM^7K0!8MM0T[PQ->O:Z?K+RS0B\
MN--5XW^QJ,CA2^ 6P?E5FSC@5L#Q?I\]AIMSI\5SJ#ZDA>VM[95\QE'WB=S*
MJA<@')'/'6N7U>QU'3_&EQK8\+#7-/U2VA0Q[4\VVD0$ $/Q@YY/^'+M2L-?
MT35="U^QT*"Y6"VFMKK3K':ODK(V]=G0'!P"0.<$X&> #0O?'OF6.DW.D:==
M7"WFHK92APB-$P)WQD%A\^%.#]WOGULI>:;'X\O&2#5'UD:6)&MR?W9B#+PF
M3M+Y..#C@\U1UY->NM.TC4KC2)9)+?6(KLV-JRO+#"(V7!)(#-N.3C@;O09J
MU;0W\_Q.34Y--N8+4Z,+8R.%*B4R"3;D$]!QGID4 7=-\:Z?JGA]=9@M[M;=
M[@6T<;J@D=RX3 7=_>/?T-+JOC/3M)DN/,@NIH+0A;RX@562V) .&RP8G!!(
M4-@'FL?2_#-[9^/;]&C T 2C5+<8X^TNI1AZ8&&;'8E364VC76C>*]8:X\%P
M:XE_<M=65^L<3-&S #RY"_*J#W'OP<T >EBY@:T%T)4-N4\P2@_*5QG.?3'-
M<_IGC;3-4O[*U2*[A.H(\EC),@"W*)RQ7!)''/S &M1DO[?PZRQQP2:C':D(
MB+MB:4)P ,\+GCKTKS72=+U@^)_!VJR:#J:-:Q307[2L@".T>W*)N"I&"3PH
M''0$]0#O;'Q79:A=6D4$%V8+UY$M;ORP892@8M@@DC[K8W 9QQFM+4]3M=)L
MVNKN0K&&"*%4LSL3A551R23P *X#PI875MKUC<:/IVJ:39W"R/JFFWD;"WB;
M;P82>A+GH.V>!70>.])O]1T_3;K38FGN-,U&&^^S!POG*A.5&>,\Y'TH T[;
MQ%;7-U<67V>YBU"&(3&SE51(Z'HR_-M(R,=>#UQ7)^#E?Q0$UJZ&HVNH1WDS
M_:$?$;QK(4$.,D%< 9&.H)!SR=5(9-7\86GB#[%>6UGI]E+%F:$I),[E?E\O
M[Q50I[#)(QD4_P"'D$]GX66TN[.YM;A+F=W2>,KD/*S*1Z\$?C0 WXFW,]AX
M"U'4+2ZGMKJV"/%+#*R$$NJ\X.#P3P<UIV&IVUI?6_A\M=27@L_M"O+N?S4!
M )WL3DY8<$_I7/?$0:CKFFWOA2TTFZ<WD4+PWJC,61,I=6/\)"C/)Y_G-K3W
MFD>/M*U)=+OKZS;3I;/-G%O9)"ZL-V2  0O4G% %;QGXBCU3X8ZUJ.E3WEM)
M:R>3N!:&1)%D56''/<BNIB\16$WB.705,PU".'SV1H65?+R!N#$8(R<<5P%U
M8:G-\,?$%C-I-ZEY>:G,R0)$SDAYP^1@?=QGGBMOQS::@MWH>OZ&ZQZBLOV(
M+*I&^.?"C<#S\K8;!Z8- '7:9J4.JVSW%NL@C65X<NN-Q1BK$>V01GVKG?$]
MS?6GBWPM]GU">.VNKIH9K9=H1P(W;)XW9Z<9QQTKI--L8M,TVVL8<^5;Q+&I
M/4X&,GWKEO%\F/%'A9OLM]+%;7;RS206DDBQ@QLJY95(^\1QU[T ;VN:E+9P
MPVUGM.HWC^5;*PRJG&6=@/X5&2?7@=ZS/AW<WEYX$TZ?4+J2ZNG,N^:0Y9L2
MN!^F!^%2:OX8N]1UC^TK3Q!?:?*(! $ACC90,Y/WE)Y.,^N!Z5S?A ZIX*^'
M(U#58]3O6')T](%#VP\QMQ X)&#N.: /1)S*()# %,NT[ W0MCC/MFN U.TU
M[P[JV@WZ^(KV]FO]1BM;RTEVF!E?.XQ)C*!0">IX')KN8[Z&73$U!!*T#PB9
M0L3%RI&>$ W$X[8S7 6OBJ[N=:?4;SPKXBDN$9H;"'^SV2.%&.-S.3]Y@ 2<
M?*.!W) -)KG4?$WB+Q'8VU_<64&E)'!;-;.!ON&4L7;UV_*-IXZY]C2YM4\=
M^&M*OEU2;2K>2$M.UB0)7G5BC %@0J J3CDG(YXY9'%=>%O$WB2X33KJYM]4
M5+FU-O"TN9@I5D;'W<G:03@8)YXXS%N;[P-X,T;PU:V>H27QC_TFZL[%YUM@
MQ9G(P,,^20!GW/'! -[P+>:O=Z3J=GJ=X+F6POI;.&^"C=*JX^8CID$X_#OU
MJ?P-?7M]8:J+Z\DNY+;5;FV66154E48 <* *D\)ZI!>64UO9Z/J.GV-F%2-K
MV$QO*2"6(4\GMECU)-9_P]E9;;7TDM[F)_[7N9U66!XR\;ME6&X#.10!VE<[
M;SVC^/KJ)=8O6NTL1G365A"B[Q^]'&"Q/&<GO^%KPWXB@\3:=)=P6MW:F*9H
M9(;N/9(K  \C/HP-8,5O/%\8;R^-M=&U?1UA$WV=_+\P2;MH;&"<<]?;K0!U
M&J:M::/;)-=&3]XXCCCBB:1Y'()"JJ@DG /Y5'H^NV&O6TDUA,6\J0Q31NA2
M2)QU5E8 @_6N \6SR>([7PWXECT/5KK3+:>=;O3=ACN<,"@<*ISP03U[CU.-
MC2;^QT+0]0U;3?"NIPVQ>-1 +=C=W#="Q5B3M&X<DYX;MB@#N:YWQ=XKB\*V
M=K*]M<3O<W,<""*%G RP#9([X)P.I/ %6H_$5L_B3^PS;7D=P8//65X<1.O&
M0&[D;AD5D?$59_[!LIH8)YUMM3M9Y5@C+MY:R L=HY.* *+>*H[+X@.UU?72
M:=/HT5Q%:21/O\PRL/EB"[\[5Y&"1SFNFA\3Z/<Z-;ZM;W@FL[A@D+11LS2,
M3C:$ W$Y!XQD8/I7+V5X;SXNM>FRN8K8Z&(T>:V8'>)2^,XX.TYQU]1G@<?:
M:9J.G^%=&OY])U*:#3=5NI;VSB62&?9("%=1P3@'.0>^/6@#U_2M;T_6HYFL
M9F<P2&*:.2-HWC;T9& 8?B*CU37;'2I8X)VG>>52RQ6T#S.%'!8J@)"C(Y/%
M8W@R'3IIKW5=,T>[L8;I4!GO2_G7! /.'8G: 0 >_/851N;Z?P_\2;V]OK&]
MET^_LH8K>YMX&F$;H6RA"@E<[L^G] "/P)XD\KP3_:&L:C-=F2_FA@E;,DDW
MSX544#)Z= /R%:&K?$/2K'PS+K%F)[L+-]G\M8'S'+D#;(,93!8<'DYXR:XG
M29+O2_">BVLVF7Z!=8G,EVU@TDULN7PZ+@C+9QN^8#G@G%-\BZF\%>,+9=/U
M82/K$5VHN;9_,:+?"=W3YCA&) Z 4 >G3>*=*MX(997N5,L33+%]CF,H13AF
M:/;N4#U(%:-C?6NI64-Y93I/;3+NCD0Y#"O-=:U.*V\6?VUJ.E:O<Z)J5A''
M#-;+*CPNC/\ *RJP(#!MW//(XZUV_A2TM[+P[;Q6FF/IEL2SQ6KNQ9%+$C<#
MRI.<E>Q.* 'WGBG1;"XEAN;T(865)G\MFCA9ONAW VH3D?>(ZTR_\7:%IE\]
MC=ZC''=)%YQB"LS;"0 0 #D\C@<UQBSO9>&?$OAG5899=7N)+HVZI S?;!+D
MHZD#!Y.#S\NWGI5S1K0Z=XXTJVO"\LNG^'1;27#1L4\W<A(#XP3M!]\4 =OI
MNIV>L:?#?Z?<)<6LR[HY$Z'M^!SD8/2JJ^)-*>]OK-;HFYL$\RYC$3YC7UZ<
M_AUK$^'$9C\.7(,;QAM1N75'C*$*TA*\$#@@@_C5/Q5I.IQ>,;+4=(C#'5+5
M]+NR1\L0Y=93ZD -UZ\"@#IU\1:9)I]E?QSO):WLJ0P2)"[!F8X7.!P">YP/
M>N/\(>-;>W@U"W\1:T&N3JT\%NTP&1&&"KN*C:@R&QG%.\)Z'=:9KDFAW$<Q
MTK0Y9+FQF?)5Q*OR#/<H#,#]1Z5R-XT0^$/BY1&ZW%WK#O&AC.Y\RHRD#']U
M2?P- 'J37,!\=1V_]MRB86+-_9>SY"-X_>YQUZ#GWQWJQ!XGT:YU!;&&^5IW
M9DC(5MDC+]Y4?&UF'< DC!]*YB4_;/'^GR6S,T;Z!)&DX5@F]V0J-V."1SZU
MF^#=:BN-*T?P[/X;G_MG29$CD%Q;XCM]O#3!\8!(SC'))';F@#5\,^--/ALI
M(-9UI'NWU*X@C,ARQ42LJ [1A<@<9P#@^E=W7B2Q?9OA;XD5K61;J;6]Z(8#
MYDB>=&P(&,D;0QS[&O:XY%EB21#N1U#*?4&@!U%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %'5M5M]%T][Z[6
M8V\?,C11ERB]2Q YP,<UEV'C;1K^]MK3==6LMV,VOVRTD@6X'7Y&8 -U''7F
MI?&DC0^!M>D1-S#3Y^/^ 'FN5?P[K?BG1_",<PLK*PL#;WCRQSO),Y1!M"C8
MH7.3GDX_#D ]'HKSW1;WQ1K?B'6436X$M-*U01"+[,O[Y N60MU4<CGD_E5/
M3/%>M'Q!X>@FU W:7\TT-WY=LOV0,%9E\B7:&;& .K#KS0!Z=4<LR1122,>(
MU+,!R0.O2N*T>^U[Q'80^(-/UB**W>]8?898T,0MT=D8%@N_S"!NSN ]JB\*
MV^IR>+/%F[6KF18;I8E6:.-AS$"IX QMST&!ZT =?HVJV^N:3;ZE:K*L$ZED
M$J;6&"1R.W2K]><Z-XLU75M&\)V<EXL&I:RLTLUR(5)6./)^53\N3\H!.<=<
M&M#4-8UW1(;/3+F5+N_OM0:"VG@1-_V<*7W,K;4$F 1UQWP>A .LU+4K/2-.
MFO[^80VL"[I)""=HSCH.>]/L[NWO[*"\M95EMYT$D<B]&4C(-<]HC>(;Y=6L
M=9MY;6'.+*[8P&5T(YW(I905/?&#D<53\5W\WA73-+M;(W5EI2YCN;^WA%PU
MJBJ-N58-P3U8@XQ[T =I52_TO3]5A$.H6-M=Q Y"7$2R#/T(JIX:O+B_T"WN
MKF[MKMY"Y6XMAA)$WML;'8E=N1V.:FUO5$T;1KJ_<;S$GR1CK(YX51[EB /K
M0 NFRZ6K7&G:;Y"?87$<L$*;1$Q4,!@#'0@U?KR7P](/"OC^T#7,\T7B&'9=
MR3021C[8N6R-X'#9( 'K72^(M3\3#Q?;:+HES8Q+=6$LRM<0D^4RE1DD$YZX
MQ@8SGG&" =K6=HFMV'B'35U#393+;,[(KE"N2I(/!Y[5R'AF#Q WCO7OMVMQ
M3/;PVJ2QK:@(VZ-V4+SE55F)]3GM3M*\8:I?^'=%+_95U/5KZ>U$H0B.)8VD
MRP7)).$  )Y)Y- '8:OJUEH6ES:CJ$IBM81EW"%L?@ 35R-UEC61?NL 1]#7
M!>,/[:3X?>*X=6-M)&D1^RSQ<-)&<??7H"#QQUI]QXNO7U"TTO2;6=]FGQ74
M[16PF=2X^5<%T X&2>>H'% '>4UD5T9'4,K#!!&017G=]XPUVQT719]<MSH7
MVEY8[VY%OYZPLN-G )VA^>N<8_&NS\/7%W=Z)!/>W-G<S.7/GV9S%(F]MC+R
M>J[>_7- $-AX1\.Z7>?:['1+"WN,Y62.!0R_[IQ\O7MBMFL'7]9GM-2TK1K%
MHDOM3>0)+*I98DC7<[;1C<>@ R.3[8K%_P"$AUR&7Q#HUQ):C4=.M1=V]X+=
MO+FB(/5-W#9!'!Q[<8(!T-IXGT:^U)=/M[P-<N&:-3&ZK*%.&*,1M<#U4FK>
MI:I8Z/:&[U"X6WMU.&D<':/J1TK!^']M./!.A27DEM.5LH6MREOL:)3&."2Q
MR<<9&W/I5CQ\X3X?Z^3G_CPE''NI']: -JQOK;4K..[LY1+;RC*2*#AAZBK%
M<;?:UK-C?>&=,TR&S=-0MGW-.6!0I&#GCL,YQU.,9'6J5OXZO;73=9@OXK:;
M5=.ODL(VB#)%.\A C8@Y*CGGD].* ._HKEKO6M9\/0:G?:Y':3Z;:V@G2XM5
M,;-)T,95F;VPW3FH9]<U[1KG1Y=52RGL]2N4M76VA='M9)/N9)=@XSP3A?Z4
M =?17#Z;X@\7:MJVHV]I8Z.;;3[YK66626168! 00 #R">?K@=,UDV_COQ5_
MPBMCXJN=.TLZ2T@6ZCA,AF5/,*%UYP ..#GIGOP >G45RLNMZSJ$FL/HT=F(
M=,D:$+.K.UU*JAF4$,-@&=N2&YYQ62?'&KZI+X=&AV=D5UJTGD473.##+$/F
M5L=5#'' R<=NM 'H%%><^(/&^O>'[*XN+V#3+>6S@@9K9R7:\=L>9Y1# HJD
MXR5;FM*YO-<;XKV^GPWEL+%=+:X,3PL?E,J*W(;E^.#T )X- '3:=K&GZL;D
M6%U'<?99F@FV?P2#JM4]3\):'K%^M_>V >[5-@FCD>-ROH2A&?QKG[3Q5+86
M6ORSZ?9136^K"Q@2WRJSRN$P7;&<Y<9..@[UI'7=5L/$=GHNI16DDFH6\CVE
MQ KHGFQC+1L"2<8YSGUXH W["PM-,LX[2QMHK>WC&%CB4*!5FO.=,\>:[?:3
MH.M/IEBFG:E>)9NJRL90S.R;@.@7(Z$YKT:@ HKCYO%6H0:]K^DSQV4$MC9B
M^M'D+;9HN<ECVP1M/OS4>E>,KS5-)\/W*6T"3ZA+*+N([O\ 1TBW>8?J"%7G
MNPH [2BN#L_'>H7M[82V^DRW&G7<BJPAM9S) CY*2LQ385(P3@\9ZG%+9>,]
M>N[W4"=$M5T_3+^2WO;C[5]R-$#%ER!N(ZG@=0/4@ [NBN%TKQOJ=[J&E^9I
M3266I9P8+><-:YY4R,RA2",<@C';(YKNJ ,Z_P!?T?2KB.WU#4[.UFD&42>9
M4)'//)Z<'FE&N:2;"*^&I6GV29ML<WG+L<YQ@'/)SQ7%Z%%J.K>)?%MMJ=MI
ME[:K<QQR0S*2&VQ!D4 @C&2#SG!)JEK,]EJ/PCTJ]M--@L(9+NVDBMX@-L6;
M@9QP/?MW- 'J-(3@9/2N'\2>/I-,U:[TW3K:*XN;-4,D4BREIF9=PC38C '!
M7EB.O3O6E'XGN-4EM[32+(+?/:I=SQW^Z+[.C' 5@ 3O.&X]L^@(!T%I>VE_
M$TMG<PW$:N4+Q.' 8=1D=Q4]<;\-%D'A^_>6)8I'U6[9XE.1&?,(*@]P,=:U
M?%VNW'AKP_+J\%FEW';,IGB,A0^63@E3@\@D'Z9H W:KW-]:V;P)<W,4+3R"
M*(2.%,CGHHSU/M7/GQ>!XRT_0C# (;ZT-U#<B<G?P<*%VC!."0<\@'O69<>(
M#=Q^';K5= M)EO-4,-K(9<F @MY<H!7N%+#&.,4 =R\B1H7D940<EF. *2&:
M*XA2:&1)(G&5=&!##U!'6N&L=4UF^\1^+;6_BLY=/LECB$8D;Y5\MG!"E<$G
M<,DD=!Z<T?!GB6^TWPSX2MKC1]FFWBQV:737"[_,*DJ?+ /RG! .<\'('&0#
MTJFNZQH7=@JJ,EB< "G5Y]<:AJ^J/XXL=0M[-K.TMO*1$E9MF8#(" 4^8G<,
MGC&!UQF@#O8)X;J!)[>5)8G&5DC8,K#U!'6I*\R\%>*KK3/#/A.SNM&D33[T
M)9Q7IG4DR%25_=@9VD@C)/;.*U+_ .(J6MU<206<=S86MR;:;RYC]H+!@K,D
M>W!4'/\ %DXH [FD9E12S,%4<DDX H5@ZAE.01D5P"RCQ3\4]3TR^ FTO1;:
M/;:ORDDSX;>R]&P.!G@=>M '>Q313QB2&1)$/1D8$'\13\UA'0=.TK4QK-E;
M1VOE6TB316T('G*=K#@?Q#9QQGG%9MAXW:?6=&TZ]TY;5]7A>:W47&^2,*N[
M$J;1L)!]3R".U '4&^M%CFD-S"(X#ME8R#$9P#ACVX(Z^M.>X@CMS</-&L 7
M<9&8!0/7/3%>9V!T[3O"OCTW6F+=:=#J]P9+2,A 4"1G Z8_"KVLW5S=/X&@
ML-/MQI]Q(DT=O+<LHRL#.JG"'A< @\Y(&1WH [^"XAN85F@E26)AE7C8,#]"
M*DKD+>]?2;C4+#P[X=25+:02WJI<>6HE= Y2(%3N;!4X^4?,/>HIOB);-;Z)
M-IVEW=\-920VRHRJ0Z DHP)XP>">@Y/- ':4UY$C +NJ@G +'&3Z5QH\<:G+
M>#3H?"EXVI&RCN_L[W"(%#,00S'@8*GKR?2H=6\0Z3JWA+0];O-%DNX9KZ'R
MXG<*;:;?LW$YYPV1P#GZ4 =U17):]XW70O[3E.FRRVFF>5]JE9_+)\PC C!'
MSXSSR*ZN.198ED0Y1P&4^H- "E@HR2 /4UB1^&+1?$LNNRW5[<3M@Q033EH(
M#MVEHTZ D9YYZGUKE/B%=+I?B'3M1UK29=3\,+;/'-&B>8L$Q;B1T/!XP 3T
MYQSUT],U;0/#WA/4-;L+\7.C/.)8$64D1$JB>4-Q^7YQG!P!N[4 =I17%Z?\
M2]&NGU&.X:.)["V^UN8)TN$:/@'#(<;@2!M//(K3M?$MU+J+65SH%]!*UJ;J
M##(XE4$#86R%63)'!..>M '0U7O+.WO[9K>ZC\R%L;D)(#>QQU'L>#7(:?\
M$B"^TT:JVBZC!I1MGF^UR!0N]6"^6.>I) !Z9]@2);3QXMY>SZ;'IZ-J8MOM
M,$,5Y'*DJ@X(+J<*P[@_@30!V*@*H4   8 ':EKA]!\8ZC/X4TF^OM+EEO-1
MD6.W$<B 2%@S;C_<4 $<\\#J:L2?$*RM_#MUJ]QI]ZHL[TV-U"@5FBE! ZY&
MY?F7D9//2@#L**Y!O'9AU>TL;O0=1LX[J\^QQ7%SM5"^ P/4]0>/?([5OVNI
MB[U:^L4A;;9[ \P8%2S#.W'7(&"?9A0!H4A&01Z^E5]0O[;2]/N+^\E$5M;Q
MF21SV4"L:U\5A[^RM;_3+G3QJ"DV<DS(1(P .P[2=KX.0#UP?I0!L6-A;:=;
M^1;(54L78LQ9G8]69CR2?4U9KS.TM9/%OC+Q'9ZQHUR+>)X(XK@SQB2QQ&'P
MA5C@L3G*^HS7I$BRI:LL&TRA"(_,)P6QQD]: )*6O%M"N-,U*SNM$U66[T;Q
MQ(&1KJYFDC:=R3C:X."IX&WN.@->@3>(]07XA)H$>G.]JMC]I:5'3+9<+NP2
M,*OS# Y)[8H WUT^V74GU#86NG01[V8G:H[*#PH/4XQG STJU7+P^.+&>2T8
M6=VMG>7C6-O=LJ['E!88QNW $JP!('2JFC^,;J:\\1RZM8365AIDFW>S1MY8
M6-6*G:Q+,<YXR.@SF@#LJ6N9TWQO87^MP:3+;S6MS<QM+;"1XW$JJ,D91FVL
M!S@XXKIJ "BN&TO69-4TW5/%WV:2Z%M)-'I]MYFU5CCRI?G RQ#$GD@<#OGF
MM=UV\O\ 0_ >MW]G=07!U.W9@F"9U9 Q9$1CD,1P#@\=!F@#UZBN7LO'6FW$
M&KO=V]WI\ND[3<P72 2;6&5("DYW=![U8TOQAIVIZT=(V2VU\8?/2.5HV\Q,
MX.TQNPR.X)!H Z"DILR-)!)&KE&92 PZJ2.M</X:\-ZO:3Z3_:=W=3V_]BO;
MW<<L['$QD5AGWP6&<]%H [N@U\^>!+S2]0N=1M=9O;^XNI=0BM;" :G,CA68
MAF #\A1R2<],=Z[/Q_>ZKX/^%T=C;W%XUT&$/V^-B2J!^"SG!#%<#COF@#U
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MVM+A+:ZO4C!@@D;HK'.?0$@$#(S74@@@$'(/>@!:*** "BBB@ HHHH ****
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MQY7=@!EW8LV . ,G@=JBUG1;O5;_ $Z:/44AMK.83M;M;[Q,XSC)W C&<CW
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M^<ET7(.YE5DP1T&.W'2M'PYH5OX;T2'3+9BR1EF)Q@;F))VC^%<DX'85JT4
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M6CZC;3RR6BVU_%?[@)MI)$@*@X/)XZ5VM% '.^#]&U'0],N;?4IK::66\FN
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^8QHV Q;))+' S[4 >ST5PL%M>KX-U:\FU'49+6:T6_LY&NV\Z$^5N*;EQD
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MX[VTNFALGWK@;<G##'(/ S0![!12#@4M !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9?B..YG\/7]M:6L
MES/<0/"J(RK@LI&26(&.?K6I10!XXOA#Q1)\)H/!O]B*EVTQ,ES+<Q>5&OFF
M0$88L3VZ=S70Q^'M3BM?#OARYL]0N--L(U-Q>VMVD>Z8 !2#O60(N6/ SPN
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MNDZ#?Z!<:UJ%]I\J&S@DME/DQ@ \[8U*D%4X;WXZUZ(VJ/?^#3=7FEWT<US
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MVI/$_@^#QQX(LVMHY[;5;*%?LKW$30NK #*,&&<''YX(KT3%&* .>\+2O9>
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MBC'KDJ *P9DB/P^\;VTL]G*T.JK+$MHV(DRT63&,\*-Q% 'N@D1G9 REEQN
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MG3M*N-:?QSX=E$-KM$#VMO;7+/';RM&S?*V 1\P4D  =>* /5**\7@\0//\
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MR64\B!GMY2"T9]"1P:DFO+>"XM[>655FN&*Q)W<A2Q_("IJX3Q%HVGW?Q/\
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MGM(9GC,;21JQ0]5)&<5RWQ&FN[;P];S6-]<6D_VZWC#PO@'=(JG<.XP3QD4
M=?25YQ<P:EX<\6?V?'K6I7MGJ>GW,\HGFW26\D8!WH<?(#N QTS] *S;636+
M'P1I.NOXEU%Y=4CM;24SNK);^9(H,JY'!"Y&3ZY)H ]:HKA[M;C1_'6DZ5#>
M7\VG:S:W$<L4ER\C0M&H/F([-N4G=C@]>:R_#U[JC12^$;F^N7U6VU4BXN)+
MAVE:T&)!(#G(##:G''S>M '=0:E<3:[=Z>VFW$=O!&CI>MCRY2W51WR/\XXS
M#K6O#1KK2H&LY9AJ%VMJLB,H6-B"><G/13T':N5O]<OM%\0>-+A;B6XCL=,A
MN(()7)1'(D/ [#('Y5GZAIBQW?@75/[4O[N2YOXVE,URSQR,T3-O"9VKCD#
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M6';>+=*N+VXLF:XM[N"#[2T%Q;NCM%_?4$98>PY'0BLB+XH^&9X#/#+=R1+
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M$4B@%_D8JF3@;F PI.1@$C-:U ',ZMI.L6D5M;^#UTC3(GE9KLR6_J!AE5<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/*3?M5 3G.!U[FO4KR^L].@\^]NH+:'./,FD"+GZFI89HKB%)H9$DB=0R.C
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M/X?:3JUGYL6K;]ND^9IMDS9_>Q[]QDY]1Y:C_<-<W)HVL7&B^*I;&QO!=?\
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M;E99BS$]P0FTD^A%>WFDH \FOKC2[3Q;XCT[Q/%JK6VJ.DMF;=YC%<Q^6!L
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MUNK&*'8+L2/&REC@X&">>>W3!-;/B_03XF\+7VDK-Y,DZ@HYZ!E8,N?;(&:
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M=PL&P&.(D@'YF&X_*>!GI[C.?!XIOKGQPVDQ:5=?8X[5)'DW1<>8QQ(WS9
M4C YY.1TK/\ &FBS:IJ,LUKI-^FI06ZM8:K82(C!\G]W)E@2N<'H1@G\6PZ=
MKUMXRE>[L&O(]2TJ"UN+VV952*1=P<E6(..<@#/;\ #7?QQ8Q1Q7<MI>1Z3+
M*(4U)E7R2Q.T'&[<%)X#%<5/J?B^STU[\"SO;N/3U#7DMLBE8,C.#N8$D Y(
M4$@5RW]AZS=> /\ A"+G39%E0I;?;E9/):!74^:.<YVC[N,Y]N:LPCQ+X9\8
M:NEKH?\ :>GZO<"YAN(Y0GD/M"L),]!P/Z9Z  CCU2"Q^+.JW<MS(++^PXY]
MK.2"2X VJ3P3P !U)]37<:5J#ZGI\=V]A=V7F#(ANU59 .Q(5CCZ'GU%>;ZQ
MX/US5O&\M^QFAGM]-A^S:A&%\MKN-@WW,_=/(Y%>@:!J&H:AI<<NJ:7+IUX
M!+"[*PW>JE2<CZT 9OB]M,,NB1:FNH8?48A;O:,RJ)<X42$$?+S^G%,O?'EE
M9WVIV*Z;JEQ=:>JO+%#;;BRG/S#G[H SD]<C&:3QO#>7":&EG93W(BU:WN9C
M$H.R.-LL>OTX^M5+5+Z+Q1XPNI--N_(N8(%M6"#]\8T96 YZY;C..* .MT^_
MMM4TZWO[.026UQ&)(W'=2,BN'\;,+;QYX2#7]U:VUXUQ'=".]DA1U5 5SM8
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M7$JDW$9&/+#;FW'!.3S[$FNAU^76_%G@K6Q;Z#<67FVOEQ6]TH$\S[@3P"<
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MB@B@#"*)(PS%V"*!ECU)]SZU@^*M=FTEM*L;0HMYJEXMK'(Z[A&,$L^.Y '
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M?FXQP"?8]F:)XO\ #C:9KWBBS:2'RXT>_LGC"/%*H(Y]2W"Y_P!GZT =]17
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M#MZ*Y?PQXHG\1FWN(H[)[&>V,I>WN#(\#Y7$<@P,-AC_ -\FNHH :716568
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M@$GJ0, GU%4=;T[4H/%6F^(--MOM@C@DL[JV5U1S$Q5@R%B!D,HR"1D5T]%
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M-!'*8GD0J) ,[<C&<4 >9VOBGQ/I_@>U\4:E?VUQ%=P1QQVJ6PW+(\@ ?=D
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M^VA?MMQ;R7%UM''F/%*Q'T7(4>RBO1[_ ,#QZW/X=N]7,#W>D2;G,2D+,H'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@"AJ6BZ=K B&H6J7 A;=&'S\I]1[\5
M.ME;+<+<""/SUB\D2[?F"9SMSUQGG%6** ,6#PEH-L+D1:7;@749CN,@GSE/
M7?G[WU/-1P>"O#5KY!@T6SC:!66)ECPR[NI!ZY]^HK>HH R)/"VARV$-BVF6
M_P!DA?S(X0N$1O4 =#56[\#>&+^YNKFZT6UEGN@!-(5.YL'.<]CQR1R>]=#1
M0!YEK7@W[1X@F^T>"K/4]/(C2TFMKP6SP(BXVL/E)Y+'()[#M71V'@O3Y?#4
M.E:U8P7,,<K2Q6[.\JV^3PBNWS' /7C.3P!Q7544 8K^$M">QLK$Z;$MM9/Y
MEM&A9!&_]X8(^;WZ\UK2-Y-NSJCOL4D(G+-@=!GO4E% 'GG@/P8MMIEV-<TJ
M6.X?4'N1%-/OC<$@HQ17*$CW&0178+H&FIKKZTL#C473RVF\Y^4_N[<XQWQC
MKSUK3HH Q;SPIHM_>375Q9;I9PHG"RNJ3;<8WH"%?H/O ]*OZCI=EJVFRZ=?
M6R36DH"O$W (!R.GT%6Z* *&K:+8:YIYL-1@\ZT8@F(.R XZ9VD9'M["J6I^
M$=$U>6TEO;1GFM$\N*59G1]G]TL""P]CGOZFMRB@#G?^$&\.?V$VB_V7%]@9
M_,$99CM;).Y3G*GD],5)%X-T.#1XM*BLVCMHY1.ICF=)/, P'+@AB?J:WJ*
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M$A8KCNP)R2H))SZ# XKL** ,2;PS#<:]9ZO-?7<D]K;M;A#Y>R1&^]N&S/.
M>".G&*QF^&>EFU%FFJ:Q'8I<"X@M$NAY<#!MPV#;D >A)_/FNTHH S]8T:UU
MS1+G2;[>]O<1^6Y#8;V.1WR :P[;P#9PZM::G/JFJ7=S! ULQGF4K+&?X&4*
M!CV&,]\UUE% '%K\-[*.SCL8]9UA+"&Y6YMK83J4@96W +E22H/0,2._7FK\
M/A)[?6M:U6'6+M;C58EC<[(SY6P80K\O4#/7@YKI:* .0'@.)= T;1X]5N4@
MTJX2YA81IN9D;<N[CL<_7-33^"HY]8UO4?[2N$;5[46LZ!$PB@!05)'7&1SG
MK[5U-% ',+X,3R?#\3:I=8T,YMRJH"X VJ'^7G"?+QC.<U+_ ,(E"+C6KA-1
MO4EU9HWD9=@,3( %*?+Z =<UT5% '+CP7#<G4Y=4OYKVZU"S-B\XC2(K#D\
M*,9YZGT'0<4Q?!<GG:/+/KM[</I4IDB\U(\-E0F" HX"C [Y).>:ZNB@#D]4
M\#1:E?:Q<+J]_;1:O"L5W!%L*OA-@()4D<=@1FHV\!#S-$G37+Y+K2X7M_M
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M#@",<<D8;)^8&K>B>'#INJW^KW5Q%/J-\J),T$'DQ[4SC"Y8YY.22?PK>HH
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MB1Q1J6=W.%4#DDD]!0 ^BH[>X@N[>.XMIHYH)%#))&P96!Z$$<$5)0 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+6;/VR0K@$Y&$7\^?3&#DP>&]=B\*>$-,^Q1^=I=]%/=8G7&R//W?7.[/X4
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MN880S&220F8JB+DY)/  J'3]4\WXHW\MQ!J&GQ0Z,))8[V0; ?,!+KAV4#:
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M'\L%9 1-YF-NS:-V<^W6KL,;IXS\?7#07(CFL84A;[.^)2L15MIQSAB!QZT
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MQ%,9$@Z'.Y?NGCGD]: .KHKCO 5YK=_!JDVJSV\T8U"XCC*;MP*/MP > O'
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MO!M*>?G&-N=V-P*YQU'IS7-6OB2/PUXF\9.VFZE=P17,4C"SCWB%?)!9B68
M9))P/?B@#TS-&:X^[OM UGQ%X4NS'=337"33:;/&VV/&P,V\9!Z <8Z_C5'2
M;>"W\4_$!6AG>V;[.72%CO;= 6?:<Y!^8G@C&>* .^HKSJW\4'2]#\(0:%IE
MW+IU_(L2O++&9-@#$)\S#YB%SG@#UKJ-*\4P:IKM]HWV&\M;VR1))5N!&!AN
MF"KMG\* -VBJ&C:E_;&D6VH"VDMUN%WK'*06V]CP2.1@_C6'9^)[^X\:ZQID
MNFRQV&GQ1?OMT> 6W$NQW9 P!@ $]2<=* .KHKF8_&MFSZ>\UA?V]EJ,HAM;
MV9$$<C'.SC=O7=C@E1G(KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#'U[0Y-:-D4U*XL_LLXG40HC;G'
M3.Y3TY_.I$T"PC\02:X(O^)A);+;&7C[@)/IU/&?H*U** .1?X>:7-I^LV-Q
M=WTT.KS>?<[V3(DR#N4A!CD#VI8_ D,>K'4_[;U=[MK-K1I))E8E2<@_=QQZ
M8P<<@\YZPL%4LQ  &23VJO8W]MJ5E'>6DHEMY<E''1@#C(]N* .=7P+:IHNC
MZ4FIZ@L&DW"W%NP\K<67[N[Y,$#)].O.:J7WPUL+VWU"W_M?5HK>]NC>-"DR
M[$F+!BP&W)Y'0DC\:[:B@#RC5K:-?%E^;_4O$>G3+Y:6IM[4W"W"(@PRML;#
M%BW QSSU-;[^$;KQ+I>F7FKW]Y9:S9M)Y-Y:[8IO+8G:''(#%=I(' .:V_$^
MOR^'K6SN$LQ<I/=Q6SYEV;-[!=W0YZUNT <C=>!EE&DM!K%['-I]R;HS2A99
M)Y",9<D>F1@8X^@KK12T4 <K?^"_[1GGBN-7NI-+N;D74]C(B,"X(("OC<BY
M4<#WY&:Z6XN(+2VDN+F5(H8QN>1VPJCU)J6N?UCQ*VE>)]"T?[&9!JKRKY_F
M8$>Q=QXQSV]* ..\!:+_ &_X%AMIM5D;36NIC<62HH)_?,P0MU"L-K$=3GK@
MXKHK[P,7\0R:OI.M7ND-<A1>16P4K.%& 0&X4XXR!_.M>RUBY<ZK)J>G-IMK
M8RLL=Q+*&6:(#/F=/E&*U898YX8YHF#1R*&5AW!&0: .?B\*);>)++5K:\:*
M.TL_L4=KY8*F/()RQY+$@<^WUS)'X<E3Q;-KYU#>TUN+5K=H1M\H,6 !SG.2
M>>>O2MJ*XAGDFCC<,T#^7(!_"VT-C\F!_&I: ./M_ GV6P;1HM4D'A\R^;]@
M,(+ ;MQC\PG_ %9.<C&?>M*T\/36OBV^UT7X9;R)(6MS#@*J9VX;=UR3GC\J
MV+FZ@L[=[BXD6.),;F;H,G _4UF#7Q_PF)\/-:.K?8C>+.7&UE#JA&.O5N_I
M0!A_\(+=MH/B'2I=9C9=9N&N'D%GCRF?&\ ;^1@#'I[U?C\*W F\.S2ZFK-H
ML;*@6WVB8E#&2WS''R^G?)]ATU% ' #X:3QZ7'IL'B2Z2TM[];VV0VZ,48/O
M(8GESG."?7D&KR>!I43Q*IU;>=>B$<S-;C,?RE"1A@"2I/MGGIQ6GK'BA=(U
MFPTO^RK^[N+\.;<VYBVML&6!+R+C />I="\366ORWMO"D]O>6,GEW5K<*!)$
M3TS@D$'!P02* .?NOA[.(=#FTO7);#4](M1:1W2P*PEB'&'0G!X]\9.<5-JG
M@%KN"QN;/6;BUUNRFDG343&K&1W&'W)P,$ # X &*[.B@#+T/2[C3+607NHR
MZA>3/OFN)$5,G  "JO"@ =/K5+Q#X=N]6U+2M2T_5!I]YIYE"NT'G*Z2 !E*
M[A_='/M6_)(D,3RRN$C12S,QP !U)K,U#66M#IK6UA<W\5[,L?F6P#+$K<^8
MW^S[T <A<_#&YN-'U[3G\0%QK-REQ+++9@LI5@W\+ 9)4>@QVK?N_#%U?>)[
M+5I[^W,-O:26KVPM6'F"0#>=WF<<@8X.!Z]:Z6B@#ST_#O5QH\>B)XF)TNVN
M(YK-9+0/)&$<,%9MWS 8XX'Y<5?NO!>IQ^(;C4]$\22Z9%?%6OH%MDD$C@8W
MINX1B/8UV=% '.V_AB6T\2VNJ07X\FWL18B"2(NS)N#%C(6R6R!SBNBI*6@#
M@+;P!JL?AF#19=?@:.TOH[FU8V6=BHY<*0'&<D\G-:5[X.EU3Q%J=[?7<+6-
M_IW]GO!'$5<+DD,&W$9RQ[>GX[.N:[;^'[2*ZNXIWBDG2#,2@[6<[03DCC)'
M2K.J7ZZ5I=S?R12RI;QM*Z18W%0,G&2!T]Z .?\ #OAK7=,>VCU;Q&=1M+,8
MMXEM_*8G!4%V!.["D\'OSU K3\4Z5<Z[X;O=*M9H87NXS$SRJ2%4C!P!WJ[I
M=_'JND66HQ*R1W<"3HK]0&4, <=^:MT <O?^#H=8UW0M:U!XQ>::K"5(E.R<
M\%>IR K#< <_UJM!X4U0>+=8U>:]MEAU*U%J5A5A)$%4A6!)QFNQI'941G=@
MJJ,DDX % ' :;X(UZR/A_.K:<@T=I$18;,@-$RA2?O?ZP\Y/3)S@]WMX#U"3
MPIKVAG4+4'5+YKQ9O))";F#E2I/."H&<]^E=+<^(K6U\1:;HK0SM-J"/)#,J
MCRL(I8_-GKTX'J*V* .!U+P5KFH7&JL-2L$BU/3DM)0]NS-"50@B(Y 5"QR>
M/PSS7/Z_%J!UK3-'GUG0[>\T[3E;?>HT,;NS$?NVW!CA5P3D]>G)QZ]5>ZL+
M.^"B[M(+C9G;YL8?&?3- 'GUGI%[XF\/P06=SIVGW6BW:OI][I@+V[D+\R[3
MR1\Q!YP3^-:>K>&/$FK^'[NUN]5LI;Z[>$'$3I!$D3EQM7))9CC))Z8'85T%
MUK5EI6KZ7HS0RK)?[TM_+C'EKL4L03VX'2K.K:G'H^DW.HS0SRQ6Z;V2!-[D
M>P[T 9#Z/JC>-8-<!LO(2P:T:(NV[+,KD@XQU4#Z<^U8)\!:M+X9N;$ZC!;:
MBNIOJEE<V^XB.1B3A@1T^8C\>G8]7+XCM(;_ $JSEBNDEU0$P;H2 "$+D,?X
M6P#QUJ:QUF&_U+4;%(+J-[!U21Y82J/N&<HW\0]?_KB@#E=5\+^*==\,:C::
MGJ=B]]=0+;QK )([>-=P9G(Y+.<#L,=NIK3N-%UBY\3:#J[262"P@DBN8E9C
MYAD #;25X *J1GKT.*Z:.1)8UDC971@&5E.00>A!IU '->%M$U?1+C4H;NXL
MI+"6[FN;<1(WF_O'WG>2<#&2,#.?6K6NZ5=ZO/80;;5]-CG$UW#,3F;;RJXQ
MC ;#<]=H'%;18 @$@$]!ZTM ''>+/!TFHVU@_AZ'3K#4+2[2Y2X9-F-H/R_*
MN2#GD<5@^)(=1U?QBL<%YHD%U9V"+-#<W,T1#2$EMCQLCNN .#P/3)->G,0J
MDG. ,\#-<]9Q^'/&ME'JDFD6]VH9HD:^LAO&UB"!O&<9H YN"QU3Q'H6DPV,
M.C1#1=5CDS;3/]FF$2@@1':>"7(/7!4CFMGQ!H&O-XFM?$'AR[LDNEM_LES;
MWV[RI(MQ8$%02&!)_P \'JXXTAC6.)%2- %55& H'0 4Z@#A]6\*^(Y9M+UG
M3M7MCKUGYBR_:4(MY4D()0 9*J,#'?U.>:9XE\-^)=:TJP1I;&>[CU.*^D7S
M&CBB6,8$:?*Q.>22<<D\=AW=% '(Q:!JD7Q"U/7 EJ;.ZT];:,&8A]ZX/(V\
M \CJ:P+/P#K^E>&/#\=C>62ZSH,T[0DEFAN$E)+*W *YSCOT]^/3:165LX(.
M#@X/0T </JN@^*=9T: 7<FFR7C7D%S+!YKQPPI$P;8IVL6+$'+'';CBKL_A_
M5+GQG>ZJWV-+2XTG^SU F8R [F;<1LQC+8Z]L^U7=4\9Z+H^JC3+R6Z6\9/,
M6..RFDW+Z@JA!'TZ5IZ9JMAK%K]JTZZBN80Q0M&?NL.H(Z@^QH XQ&\4>$?"
MFD6$2:)+/ T=J(=\K-<(!CY.!\YX[87DDXZ=]1BEH \WN/"7B&?0=>LS;:?Y
MNI:PFH(OVMMJH&1BI/E]?W8'_ O;G7NM$U6^\<KJ,MI"FGS:0^GS,+CYT+MO
M) V\X(V]NN?:NQK-O]=L-,U+3K"ZE9+G4'9+90C-N*@$Y(''4=: .7\+Z)XR
MTR.TT?4;W3SI%@RB.X@+_:)HU^XASPHX /MP/6H#X(U.[TCQC:7+6L3:Y,T\
M#1RLQ0X&U7!4#J.2">M>@T4 >=+X6\1ZKKF@ZAJEOIUO;6=K-:3V\5P[.$=-
MF0VW!/MQCU-5I?"/BT^!V\)XTJ6VAEC%O=F9U=HDE5@&3;@-@')R?3'>N_EU
MO38-;@T:6\C349XC+%;G.YU&<D=NQX]C5^@#DO[,U=?'=QK?V*(V[Z4MF%6X
M&3('9^X'R\XSU[XK#M_"FOP>!?#6DFVMFO-*U&*YE GPK)&Y;@XZD'%>DT4
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M#P3X7\1-=27.I3ZA:2S3F8G?([C>A'3"G@#'&WZY[SX@:M>:'X(U*_L=PG1
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MKMBX(&6QEL9..@''' K3\-^&SX;2X@BU.YN+225Y(K>5$"P[F+'!"ACR3U-
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M]LSK=Y^\O_[1M90B![:?^_D#+'\AZ =: *?CNX\4:9X#\1FXOH?+B,8M[I$
MEFB<A'5E'"D%OO#J.PK6O]8U/1]:\):8+F.>'4I)$F9X0'PJ;A@@X'4=NW6I
M+CP,VI>&]0TW6-9N;^[O8EB>]:-4**C;E"HO &[D]SW/3$DWA"[NKOP]>7>L
MF:YT=G?>;8 3%Q@\ C: .!U/J30!4L->\0>(+:YU;1/LC6T-Z;:.RF4J98T;
M:[F3^$GJ!CC'<U2OO%OB*_U/58_#UC/.-.NQ:1H($,4S@+O$CLX*\L<$#C )
M-78OA_+:ZI?FR\07EMH^H2F:YTY$7EB<L%?JBGD$ 9([U+-X'N8O$%[J.C^(
M;K2X-0P;RUBB5PS 8W(3]QB.X!- &XNFB_O=,U:]@6&[MHMPAVJS12,I##>.
M2 &88!P>O/&.:M_%E[-XQN-*FOK6SGCN_*BTZXMBIG@R/WJ2%@&8C)P/3&.]
M=M;V\-I:Q6T$:QPPH(XT7HJ@8 'X5S%SX.N-0FMUU'5$N[6VO_ML.^U_?I\Y
M=4$N_A02!PH.T8XH T/%6NMH.D)-"L;75S<1VEL)3A!)(VT%O]D<D_3MUK.N
M=6UWPSI^KWNM&VOK&TMA-!<1+Y3R2="A3+8&<8/OWZUJ>)O#MKXHT273+IWC
M#$/'-&?FB=3E6'TK)M?!<]SIUW;>)]:FUJ2>!K97,*P"*-L$X5?XLJ#N.>@_
M$ 6]UO6?#^J:(FJR6=Q::I<"T<PQF,V\S E I+'<I((YP>,]\5S-WXT\76>@
M:WK<C:08-&U)K66)(7W3J'53@EOE^\#GG.3TQSUEIX9OWDTT:SJ<5]%I;^9:
M[8-CNX!57D.XY(![ <\UGW/@&XO/">LZ'-J\6=4O6NY+A+,C:6=7("[_ %4<
MYZ4 26OB+7(_&MMHFHK8>5?V#W5N;>-\PL#]UB6^<8[@+]!6#'XU\:'PF?$[
M6>C-86TSBXA02^;)&DI1F7G"X [YZ$^U=9/X:D_X2K3?$,NHQ(+"S:V>(P8#
M@]6W;_E_(_C7(>"]#U'7O!(L7UBU.B7-S.9H8X#YP7SFS&'#XPV"<[<X; ]:
M .E642_%93&?F.@;AD>L_%4=%\2ZI/X-O[^&QTVWN(=2>VW*/*@C0.%:9P6Y
MQEB1D9Q6ZOAZY3QJ=?CO81#]@%BMM]G.0H;<#OW]=WMT_.L"/X?:E!X<738]
M;A\Z+51J4<K6IV.V22CIO.X9.>O84 0'QSJR:#XJGB>PNI]%*-#<>2Z)-&Z[
MN5)SG'<'!X[==2U\1ZY;>)M-LM8BT\6FI6LL\7V;>7A,85B&)X;(;L!5*Z\
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M%Q:.?W,F5_<NK'.<'.>.AX%6]3UN>/7;70M.2!K^:!KEVG)V11*0N<#EB2<
M9'0\UFZ%X5NK3Q7<>(+J*QLI9K80R0:>S%)WSDR/N4<^F!W.2:N:MX>NI/%%
MCXCTR6%;RW@:UFAGR$GB8[@-P!*D'D'!H Q-3\1ZAJ7A/Q99&&*SU72H)4N0
M&9D9#$S*\;<$$CD9Z8K9\(Z;&="T;4;JWM6ODT^***>./#+$44[<G/>J]WX8
MU";1?$(2:U_M37%V3,V[RHD\L1@+QDX7//&2<\=*Z#2+:>STBSM;CR_-@A2-
MC&Q*G: ,C('I0!Y[;:MJ^I6'Q CU5[>:VLUGA"(#A L1P%!XQZY[UI>&_$&J
MV</A33[W3((K'4+18H)DGW2!DA##<N,#< 2,$X[TK^#-9AE\51VE[8FTUPR.
M!*C;U9TV$$CC R3T.< <9JPWAC6#<>$>;$PZ*FV?,KYDS'Y?RC;Z<\]^/>@"
MG#X_U"YO+.>STB:[TVYN?(VQ6DXEC3=M$I<KY9'!R >!CGKCT"N!T/PCXGT,
M?V-!K5H/#RSF2,B-A=)&6W&,$' R21NY/)QCH.^H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .1\?:[K?AS
M2H=2T>&UN0LFV:WEB8LRX+$JP88P%/8_T.Y%KEC+X>77!,!8&V^T^9Z)MW?G
M[51\2WUG;7FAP74\*&>_"A9' W#RY!T/7G _$5QGA_2;^SUFZ\%3VQ_L*RN_
M[125G&TVQ):.+U/[P9.?[A]: .A\">*-3\36>J7^IQV]E':7DEI]F52"FP*2
M6<L<GYL'  XKI+/6=+U&&6:QU*SN8HO]8\,ZN$^I!XZ&O*--U+3HO /CU[D&
MZMVURY+1P2X)1VC"L2,D)GDG!X!ZTZWU6QN/$_B$W&J:==BZT A&MXQ'"Q4R
M$JN2=VT#KGMVQB@#UE=2L7N8K9;VV:>5/,CB$JEG7^\!G)'O0VIV"7ZV+7UL
MMXPRMN95$A'LN<UX_8_8;'PW\-M1MX+6*ZEOXHI9U WL"K(V6ZGC'&<#@=.*
MAU'4M,:[9X+VTLX8_%"375O<L6N21*JO*S$CRH\# &.@Z]10![/<:C8V<\,%
MS>V\$TQQ%'+*JM(?103S^%+<7]G:0>?<7<$,.=OF22!5SZ9->3ZYKFG2^)?$
M^G)-I]P=7LXHHI[FX2$6S>4< [^2O(?*]SZ\U-<?V;X=U[P[IMYJBVFB+HIB
MM[R*.)H9)]P\QB75E&Y0#GOGKR<@'J?VRUQ"?M,.)_\ 5'S!^\XS\OKQZ4Q=
M3L&MA<K>VS0$[1*)5*D^F<XS7E!T?08T\&V=G(]]I_\ :L\44]T%S)&48L%(
M _=ENV,'Z8J;^P- ?4/B- ]C:&WM8T>%#C;"S6^YR@Z*2P&2,= .U 'JT]S!
M:Q^9<3QPH3C=(X49^II1/$41Q*A23&QMPPV>F/6O')KTL_@L:IK1TW39M"01
MW;Q1RH;@A=P;S%90=N.3COSR:DN=%T8>'_#5G;7LFHV:^(TBBN9]JAHRI+K$
M5Q^[W#''!(..,4 >LS:E96]G->37<"6T*EI)2XVJ/<T:=J%OJ=A!>6SAHIHU
MD'(R 0" ?0\UYC?:9865_P#$>QL[2"* :-'*EO&@"A_)E^95Z ].E=OX)DTR
M7PGI[Z8]HZ_9XEF:VV_ZP1KG=C^+IUYH E\7>(5\+^&[K4_*,TR+M@A"D^9(
M1P..W<^P-:.FZC;:MIEMJ%F^^WN(Q)&WL?ZUS=\M[KGBHMIYLI;;2%,3K<EB
MIGD7YN!UVQD#/_31AZUD_#J230VUGP9>31)<Z;(9[8*V08)/F!7/)"D\_P"\
M* ._6Z@>=X$GB:9!EHPX+*/<=13C-&K;6D0-D#!89R>E>,>'K?3O$ECH6ED:
M>]W8WQEO+X7,3&[BW'(V@[V\W(RK@8P<]JUM&\/:;JGQ%\9RS6J2W-E=6MQ:
M NP"2["V[ /]X#/U/K0!ZB)XC*8A*AD'5-PR/PIQ8 @$@$]!FO$O#ZZ9K&CZ
M;J%[XACM]<@OO-FA@MT2]DG+E2A.=[!MP'IC'I5V8Z?K5WXKM==UNVTZ\MM0
MD*/+"OVB.!2#&8G)R!@=%]3_ 'J /8"ZKU8#ZFE# ]"/6O-+?0-+UKX@:W%J
M5O\ :8WTNUD:*8E=[D."S(#][^1/K7/Z3IMG%X)\":U&&;47U:UA:Y,K,VSS
M&0H,GA< #:.* /:F=%959E#-]T$\GZ4,ZHI9B%4#)). *\=GMK3Q#XD\6V^N
MZW::?+;70"^=$IFCMU *-%(Q&SN3M'4\YS6C8Z+I>O?$F_AO8I;JV;1;9VBG
M9EWL3G+KGKT..Q]Z /1=0U>STM[1+J4*]W.MO"O=W;V_G5ZO"M,CBU3PU\-[
MG55CGE>_EB>:=0Q:)&?"DG^'@<&O:K:_T^2865M=6S2I$L@@CD4L(S]UMH_A
M]#TH JWU[JB:G%::?I\,T9B,DL\\S1JASA5&%;<3R?;'O6!I7B[7=5T:WU6+
M0;0V\EY]FD1+UFD0"7RV<#R\$ Y/4<"NTKC/A=.9_!*?=*I>7*H5'4><QY_,
MT :/@WQ'/XFTV\N;FUCMI+>]EM=D;EQ\F.<D#/7T%=%7ALFBP0_#[Q9J;F3^
MTM.UFX:VF25AY+K*G*#H"?7&:Z?4L:[XVUK1K_4+& K90BSCO+=I"%9"7DB.
M]0&W'D\GY1Z4 >EYHS6+X<B63PI9P2:E)J:&$QF\8%&G7)&[KGIWSSUSS7E<
M6G21?">?7C?WD>LZ==2BWE6Z8JA6<KY8&<,"2>N22?PH ]NS1FO.[&ZB76?'
M,5X8X%6VMI3$\GRJ6A+,1G_:/7UK*M[1=5/P\M9[F\5+[2IA<^5<NOFA84.#
MSW+')&"?6@#UG-&:\NM?">GS>.]0\/RWFHMI\&E0%(#>R?,<LN2<YP..!\O3
MCI5;0KV>Y;P[H&JWTESIDEU?P),[DB]$+8B5G'48W''0[1UH ]:S1FO,&M+^
M"?Q?X>TC4?LMM%)9M9+/(0B/+R\*OU ;   Z;O>LG4->ET[PYK<4-C<:->KJ
M%K#J,#SLT5O&_!DC92#M8+@XQUX]: /9<T9KB/#.FS:9XMN&_MBTDM[VS$RZ
M?:JYC3:5 E&68*#G'O\ @:FU.X-_\1[/0[TRI8#3GNHT60HL\V\+@X.3M7)Q
M[Y]* .EU;4[;1M)N]2NV*V]K$TKXZD =![GI6?HVJZQ>79BU'2$MH7@$\4\4
MQ=<''[M@5!#C.?2O/-?2=O!'CG3+F::YM=*N1]BED=B55E5MF[^(+N(YSV]!
M7INBV=G;Z';QV:2);R1*X#2,QPRCN23^M %/7O$T6E:!JNIV<2WS::2LT0DV
M ,%#$;L'H&'3Z=:V;>4S6T4K)L9T#%<YP2.E>0K96EA\//B"T*NNS4+R!%\U
MB N4QP3C/OU]ZZ.QL#HGC;P_]GU*^NAJ=C<&Z-Q<&192@C9&"_=7&\_= &*
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MZ,K"+Y2.X.!Z<UH66IZYI/B;0[._U""YL-3LI7$$=N$^SF)%;Y6SELAL'/X
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M.!GH*O2W]G!:"[FNX([8@$3/( A!Z'<>*;%J5C-;1W,5[;202,$2595*LQ.
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MO&V.$!&W/ Y(/3TXKJLUSVJ>))-.\8:%H?V1'CU43D3^:<IY:;C\N._'?UH
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MGV\<<!L?A5/QS-<0MHQCL+F:V^U_O[FTMA-/;#:0I08.,DX+ 9 SCDBNOHH
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MM[*=/@9[Y=ET67/G+TPV>O%6-/TVRTJT6UT^UBMK=22(XE"C)[T <YXMNO\
MB>>&M+GDECL+ZZD6<QEE#E8R4C9AV9NW?'IFLRUM19^,-<\/6\/_ !(O[+CN
M?(S\D$I)4*H[!@N<=.*[74=,L=6M#:ZA:Q7,!8-LD7.".A'H1ZU F@:9'8W-
MFEMLAN3F?;(P:0\#E@=QX '7IQ0!SWPNL+6V\!:3<P0*DUQ;+YKCJ^"V,_\
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M9!$> <@<>H. *P-,TO6H/!7A_3I=!NH9M/UA;F1%9&'E+,[DCYN>&  ZGL*
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M'3]/DL%BU29X2UQ;O(T950<\2+GZ<5K^&K&6STHS7*%+R]E:[N5/57<YV_\
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MN]UO,%[#\MU:7!8J4;(^9 5*\=A]*]2H **** "BBB@ HHHH **** "BBB@
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MYSV]Z[D9*C(P<<B@ I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)1((5=-X=0G&<]  ><9/I7<T4 >>3^ =2O(-=22_@@EN]234[&6+<WD2KTW
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M+D7E]%9G=,$V>8V 0,'=WXK!U6[M)?B%I?AZ_8#27TUYX(VE(CFFWXPW]["
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M?EGY%Y(  '!'6O5Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH>DQ:>-/33+-;('<+<0+Y>?7;C&:=_8FE&Z@NCIEE]IMU"0S?9UWQJ.@4XR
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M">]@%\\1D*&11M.Y0%//WFW9 ] : .$U;PF]WXMU&[U#PI>7LD\X>VO=.OQ
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M 4444 %%%% !1110 4444 %%%% !1110 44E+0 4444 %%%% !1110 4444
M%%%% !1110!RFMVFJR^/?#M[:Z<\]A:1SK<3"6-=AE"@'!8,<;<G Z'C)XK
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MZUZ[10!Q-M=7/_"QKR_DTC48K;^R8X5<VY(+JSR%<C(SAL#!P3QFN>6SOO\
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M3C8X2XTU=DTDA?F)Y<J43'.-PYZGM7<@A@"""#R".]()$,AC#J7 R5SR!]*
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MT,?=23TK!L-9L+'PUINYHX8_[=NWCU QM)'9$%BK;5ZEE?"@\?-GM7M5'!H
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M?(LK>+S1B39$J[_K@<T >+7NCZ3_ ,*R\8:E%9VS7=OJLZP3A06A43KM"'^
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M.F.EH=/LX8",2,&4/O(8#!#,<8/0# ZUN>(M5?0O#U_JL=N+@VD+3&(R;-P
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MHWB#PU86%E=:;>BX>UNY+G8Z"7<2C+@EFR< Y [DT =WH'_(MZ7_ ->D7_H
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M32[;S[R811D[5X+,Q]%49+'@\ $UAZQK%E?V&G/9^)(M.$]ZBH^T%KC:V&A
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M+-?BG;3&;=;W^B1I9R(C,LK>:Q(! [ @G/2N]H **** "BBB@ HHHH ****
M"BBB@ HHHH :O4_6G4U>K?6G4 %%%% !1110 4444 %%%% !1110 4444 %9
MNM:U::#8"]O1+Y/F)&3'&6P68*,^@R1R:R=4U"]OO&4'ARUO);&,6#7TT\*J
M9&_>!%0;@0!U)./3I7(>(];U"X\)^)-&O94GO=,U&TA6Y,>T2(\L;H6 XW#H
M<4 >CS:/I1NC?R:9:/=)EA-]G5I/7@XSFLK_ (3;2_\ A&KG7A%>FTMYF@=1
M;GS"RMM/R]0,^N*S8[[Q%HGCC3-.U+4H]3L=72;:%M1$;5XU#'&W.4.<?,2?
M?UPDU/4/#_PGUW5=+D"W<6I7+J3&'P#<E3P?09/X4 >I*P= PZ$9%.KCM6UJ
MZ/B>ST>346TJSET\W?VQ1&#)(' ,>9 5  ()&,G/45E6?B#Q%+X)TK4KW4(;
M>:\O_+EE%N P@RX'E)AM[MM4@8.0W3'- 'HI8*"20!ZFLRYUZRM/$%CHDOF_
M;+U'DAQ&2N$&3ENW2O/=1UK5=3\'%I-0G22#Q"EB7$2(\D8F7&\8P".X&.G/
M?/6W.HZE8>-=#TDW@FM+JUN'F+Q*'+)M(.1@ ?,!@ =/>@#J117GDOB76F\(
MR>-K:^C:S3?(FF>2NQX1(5YD^]OVC.1P#QMJ9M7\2:UXKNM-TK4K2TLFTV&\
MBE>TWNGF%L#!/)XZG@>E '>T5YN/&FJ3>"?#^LW)EM8+IG&HWMG;"8P!2RAM
MI!PI(R3@XZ=Z[3P[<R7>A6L\M_#J#.&Q=P@!91N.& ' XQQZT :E%%<'XR34
M9O'/A&UMM0DB@FGFD,012JM'&3O.>2?FZ=* .\HKCTU;6M877)]*NK:)=,N'
MM88Y8-WGRQJ"^\[AA23@8QZ_3:\,ZXGB3PW8:Q'$8A=1;S&3G:V<$9[\@\T
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MG?&,*3E@-RYQ_>XSS6A?^(DM=3ETVULY[Z\AMQ<RQPE1L0D@<L1\Q(.![=J
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MXD:T@O'#RP2V:3;6"A<HQ((X4<'('I6UI6FQZ38):QRR2X9G>64@M([$LS'
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MQI!:6DT4BF49#R;< <<@;>M=310!P&@>&]3A\4VNJ_V8FB8B<:BEO<*\-\Y
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MT"AUN%5D,:R C:>I.X8YQZD5U]% 'DL?A7Q#%\._"^C?V1(UYIVIK<W"B>+
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MN+RWA,!EGO&8RJ3D!_4#C X' XH XJP-]H?P.M=5L=2O(;EE@;_6!U :8*0
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M*&,1>6$.-PP4)YQZ_3%;] '$^,]6O](U6UFF.HQZ"8&$]QIR*SP2YX>0$$[
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M>WA'4WT?Q98F:T!UN>26-MS?NMZA2#\O. H/XT =C:7"W=G!<JI59HUD /4
MC-9VOZV-&@M%2,275]<I:6R,<+YC9.6/90 2>_'%7-,MY;72[6WGV>;%$L;%
M"2I(&.,@>E9/C#P[<>(=,MUL;S['J-E<I=VDS#*B1<X##N""1_CTH J/XFU3
M2K._&LZ;']H@N(8+66%BD-XTI 7;G)7!/S=<=L]*?_PD&IVOB./0;^"T6XO;
M=Y;"YB+&-F0?,CJ><CKD'D>E5+[PKK7B#1ITUO4[5=1WQ2V9LX6\FUDC8D.
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M8[3U)P3^//2L6/P9X@B\/:/8>?IKO87TES+!(SF"Y5G9P&^7.59N.",@'VH
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MY.XE3ALE.-I VGDYP-WP?X=/AS3[J'"Q)<7+SI:1R&2.V!P-B$@9'&>@Y)H
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M)PH.. <G'3.1KR?$6>W\-ZIJ4NCL\VFSQQ2!&=8YE=@JO&63+<GD8'UK.M/
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M\O/7).2<_P Z /8Z3->6ZX;G7O&=MH4U]IRQKI,<T<>H1/(LTC$[G55=1N
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MS%VM\K%3QVY!K1KR?P?K%]:>#_".D6:W#2WJWDDCVRQ&0+'(>%\PA1DN.N>
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M9)&#D#KSGBJ-SX[U2V\-VMW>6(TN>2^-G+<WMK*(HUP2LNSAMK8 Y(P3R>*
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MCWRR@J03E-H^XO"@=/K6EKOANP\1V=K;:D&D2VN([E2, ED]>.AY!QV-:]%
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M(-/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!J=*=3(_NT^
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYF-]!$)I(S&PPA. 02,'GT-<G\3I]1AMO#T=E?&V2ZUJVMY0(PV[+;E//8%
M<=ZJ7$>LGXI265C>VR7C:#$9;V:'=@+,^2L8(&22.IX]Z /1Z*\WTKQ]J.HZ
M!H*M!_Q--2N9[=Y((MRJ(=Q9E0L.2 .^!DGM@]/X7OM=NQ?Q:W8F'R9L6TY0
M)Y\9[E0S8(^O<4 =#17)>,O$=SH5WIL(N%L+.Y\P2ZA);&:.)QC8K88;023R
M?3ZD)9Z[J=Y-I6DQW%A]OGLC>7%TB^9%L#!5**&&=Q.<YXQWS0!T&KZSI^@Z
M=)?ZG<"WM8_O.03^&!S5R.1)8DD0[D<!E/J#7EGBKQ!=:K\.O&.FZBD*ZCI4
MB0RM "(Y%9U*. 22,CJ,G&*V+WQ+J274.C:1%*)+>Q@FEFCLS<_,^=J$!E"@
MA3DD]^/6@#O:*R_#U[J.H:);W.K:>=/OV!$UON#!2"1D$$\$8/XUSNI^*;Z'
MQ;<:2MY96#1^5]DBO8&VWVX OMDW* 03@ 9Y'?H #J;/5K#4+J[MK2Y2::S<
M).JY_=L>@/Y5=KS.2]URT\4>.[K2/L"_9?L\KM=!FW!;<': N.O/.>/0]MF[
M\57S:=H=[$+>RL]0M%N)+J<>;M=D!6)(@P9V.>V>!0!V=%>90_$36;SPWX8U
M"ULK$W.K7ILY$EWA0P9EW @Y XSWJ]+XL\0Q23Z8]M:G5[*V,US]FLYKF-G9
MF\I5"L"H*KDECWP >< '8W&L:?:ZG::;-=Q)?7>[R(,Y=P 23CL,*>3QQ5ZO
M,M5U'6-3U+P%?+IJV>KRM=@VUYN18W\E@2W\6WC=CJ1@<=:U(/&FH06&J17U
MI:R:K9ZC'IT2P,R13O+MV'G)4?-SUZ4 =PS*BEF(50,DDX %5=/U.RU:T%UI
M]S'<VY8J)(SE20<'![\UA6VM:II_BNUT+6?LLXOH9)K6ZM8FC&4P61E+-T!!
M!SSZ5@>&M<DTWPE$((T>^U'6KFVMU<X0.TSDLW?: ">.3@#OF@#NTU6QDU63
M3$NXFOHX_->!6RRIG&2.W)JY7G$FJ76B>/-:U#6/L\ILO#ZR[K5"@D42N?ND
ML5.<CJ>@-7M'\6>(+S6;"WGTEI;.\@9VGCLIX%MI,;@K/(,.IZ;@!SV]0#N:
M*XSPIXC\2>()8KB?3=/BTX37$$[QSL9%:-B%(!'()&/7OQWW->UE]+6RM[:)
M9;Z_N!;VZ.<(&VEBS8YVA5)XY/ ]Z ->LQ?$6COJW]EKJ5L;[)40;QN+ 9*C
MU('4=161:^(-4_M^\\.7<=D-36U%W:3KN6&9"VTY4DL"#Z$YZ\5G_#>R-YX0
MTV[OH[.XV2S36[B(ETD,L@9MQ)R3D\C% '93WUI:R)'<74$3R'"+)(%+?0'K
M5BN-^(N@CQ)I>GZ:K>7/)=L8) <%9%MYF4Y]-RBJVG^+[G7?!%D;=6CUN]E.
MG.G0P3#(D<CT507Q]!WH ["VU/3[RYFMK6^MIYX?];%%,K,G^\ <C\:MUY?X
M N)-$^'^LSZ=9-<RPZI.L<.XDM\ZJ"S=2 .2?0&M2T\<WQB\3QO'IE[/HMNM
MTLMG.PBE0JS%<_,0PVGUY]* .\HKBK#Q=K,FJ^'H[_3+6&RUN!FA:*<M)&XC
M\SYAC !&< $^Y[4EQXUO;/6+"&ZM+>&"\U#[$EJ[D72J256;;TV$C/T(Y- '
M;45R6I^*[Z%M?;3[*WECT- TZS3%7E.SS"% &%&WH3G)SQQS4O/'LL%IIG^B
M6\-U>60O75VEE6)&QL7]W&68G//  P>M '<45PJ^/;^32=!NH] ;S]5N'M3!
M).8VC==W/S+RIVYR<$#L:Z[2Y[VYTR";4;-;.\9<RVZRB0(<]-PX- $UU=6]
ME;O<74\<$*#+22,%4?4FI5970.K!E89!!R"*YCXC*K?#O7=R@XM'(R.]1Z7X
MAU%-:TW2M0TA+."]M7EM2MQOD7RPNY9% P.&&,$_X '645Q%MXZN7UG1[2ZT
MZ*V75I)%BMY)BMS J@[6D0C^+:>.WJ:L6GBV[U'Q!<V5E!9O%:7IM+B%YB+E
M%''F[,8VYZ<]/?@ '7U#<7=M:!#<SQ0AW"(9'"[F)P ,]22146ISW-OI=S-9
MI$]Q'&S(LQ(0D#O@9KRS4[K4-4^'O@_5]2C6YNUU6SFB:)AYDI+$$'( !.>@
M..!Z4 >O45Q\?C>2TDUN'7--%C-I=HEX1#/YPEC8'H=JX.1C'KWJ+P_X\DUC
M7H=->P4I/"95GM6>183C/ERDHH!P#@@X/2@#M:*S-?U9M$T6>_CL;B^DCVA+
M>W7+NS$*![#)Y/85@0^.'$7B19;2VDN=#MQ<R?9KK?'*I5FP&VY# *1@CTH
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MNRIDLT<$3RS.L<:#<SL< #U)H K:98?V;81VQGDN'!+232GYI')RS'TY)X'
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M.N/X>V.O.!7NO"/B2Y\->(M"4:6(K^\EN+>9IGS\\HD^8;#C'([Y]L<^C44
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M![YK@K32I8+N_673/&5OJ$MW+*4T^Z*6KEG)!5MX7&,9+>_TH U]1M==O_'
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MN;JYE.H67V&>$E0ACQCC !!Y/.>]7/#VAKX>TN.PCOKJ[CB58XS<%<HBC"J
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M>(O)$>F\1G:&'3C&?2CQKJ6H:7HT5Q8+=;/M"K=26<"RS10X.616R"<[>H.
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MTMBAN(=OGP/]U\*QV'J#U_QV=0^'L$NGZ>NF:E/8:G82R3PZ@$#LTDG,A=>
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MR;@$LA=E ?D$%P23GY<5T.EZ)XBDLFAU_5K:=UMWMXA:1,@;<,>9)D_,V!T
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MS79T %%%% !1110 4444 %%%% !1110 4444 10DF-2>]2U%#]U<=,'^=2T
M%%%% !1110 4444 %%%% !1110 4444 8\LUV/%4*C5;-+$6K%[%@/.=\_?!
MSG:!_GGBQ_;ND;X4_M6QW3L4B'VA,R,#@A>>3GC [US.HS:?'\6],5GMTG;2
MK@2Y(#$;TV@^O ;'XUQ)30V^%&HWT9LQ.^L;A.&4./\ 2P1@]1B,DCV)/<T
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M[F@#UNBO-+B.\U/QMXPTZ75=22QM[.">.*&X*!'*,>".5&><#&<#.<51\/\
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M'8O-:_:KB.XN$E4@DC:@4H<]QQQ3FU;Q,E_X0@'B$EM?MG,JM9Q;82L2ON3
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MM !1110 4444 %%%% !1110 4444 %%%% #2B$Y*J3ZD5&UI;."&MXFR<G*
M\USJ^,[9O'#^&UM+PO'"'>46LA&XL .0.%QGYCQTYJZOB[1FO!;BY?F<VXF\
MA_),N<;/,QMSGCKUXZT :YMX&*$PQDQ_<RH^7Z>E,FLK2XC6.>VAD13E5>,$
M#Z U/6/XGU.;2]$F>T7??S8@LX\?>F;A?P!Y/L#0!H)8VD=P;B.U@28]9%C
M8_CUIXM;<7)N1!%YY&/-V#=CTSUKG_ NOMXA\'6-].2+I$,-T&^\)4X;([9Q
MG\:)?'_A2"2*.37+4-)(8QR3A@<88X^7\<=_2@#>>RM)+I+I[6%KA!A)FC!=
M1Z ]12M:6SSF=K>)IBGEF0H"Q7^[GKCVJCJGB+3-'95O)I S+OVQ0O*53^\V
MP':ON>.#7.^-M<G@L_#%WI&H$07NLVT#O"599HGW$C/H=HZ>] &OKFF:U,MM
M'X=U"TTM-Q^TEK42%@<8*]LCGK[5K6%E#IVGV]E;KB*"-8TSUP!CGWKG;*^O
M!\2M6L9;R1[)-/AGCB? 6-BS XP!_=[YK2L/%>B:I>"TL[]9)F!,>495E Y.
MQB K\<_*30!IW5I;7UNUO=V\4\#8W1RH&4X.1D'WJ&]TC3=2ACAOM/M;J.(@
MQI-"KA2/0$<5DV']NCQIJ(GOEGT7R08XC;;#!)\N 'Q\^1N)Y..*N67B;2-0
MU!;&UN_,N'1I$'E.%D53AF5B-K 'C()H U$18T5$4*BC 51@ 54U#2--U:+R
MM1L+:[3TGB5\?F/<_G5VLV#Q!I-U?BQAOX7N&W;%!X?;][:>C8[X)Q0 ]]#T
MF6PCL)-+LGLXVW);M;H8U//(7& >3^9I1HNE+=)=#3+,7*)L280+O5<8P#C(
M&.,>E5X_$^BS:FNG)J4!NV=D2,G&]E^\JGHQ'< YIW_"1Z0+"ZOC?Q"VM)#%
M<2'.(G&,AO3J.OK0 L/A[1;?R/)TBPC^SN9(=EN@\MCU9>."?45+I^C:7I'F
M_P!FZ=:6?FD&3[/"L>\CIG YZFJ^I>)M%TCR/MVH10^>GF1@Y)*?WC@'"^YX
MJM<7RW/B?2%M?$%O'$\,DCZ>%5GN5*@J^>J@<G/>@#0M-#TFQDGDM-,L[=YQ
MB4Q0*OF#T.!S3/\ A'M$^QFS_L?3_LQ;?Y/V9-F[UVXQGWJI-XS\-6Z1/+KE
MBJ2RF&-O.&&<=0#[9&3TJ_J.LZ=I C-_=QP&3.Q6.6;'4@#D@=SVH 9>Z!I&
MI+"M[IEI<"' B$D*G8!T XX''3I3K[1-*U)8%OM-M+E8/]2)H5<1]/NY''0=
M/2I;+4[#4E=K&^MKH)C<8)5?;D9&<'C(KGO'VJ:UHNAQWNAF-[E9=K021[A(
MN"Q]P<*: -FZT#1[Z\6\N]*LKBY486:6W5G ],D9IMSX<T2[TZ/3I])LGLHF
MW);F%=BGU Q@=33;7Q#8W/A9/$*OBR:V^T$]P ,D?7M]:YWP'XGU/7H=;O-;
M:*T2QO)(/(VA1$J@-\S'N,X)Z4 =%<^&M$O8;2&YTNUDBLQBV1HQB(<?=';H
M.GI6J %  Z"L^TU[1[^"::TU.SFB@_UKI,I"?4YXHA\0:+<W,-M!J]A+/,-T
M427*,T@YY4 Y/0]/2@"&/POHL6IRZDFGQK>RY\R<$[FR,')S[U-I>@Z5HMK)
M:Z;8Q6UO(<O&@^5CTZ4Z?7-)MK];"?5+**\? 6WDN$61L],*3GFI+[5=/TP(
M;^^M[;?G;YTH3..N,^F10!6T_P .:-I5U)<V&G6]O+(-I:-,8'H!_"/88IB>
M%M"2TN;5=*M1;W3!IXPGRRD=V'>K3ZOIL5FUX^H6HMEP&E\Y=HSTYS38]<TF
M:RCO(]2M&MI'$:2B9=K-G&T'/7/:@!O]@Z4+BSG^P0^;9+LMGV\PKTPOH,59
MOK&VU*TDM+N+S8)!AXR2 P]#CM1:7]GJ$;R65W!<HCF-VAD#A7'521T(]*RM
M7\7:/HNL6&F7M[;PSW9;_62J@C4*3N8D\9( 'J30!IQ:;9PQVR);H1;9\@O\
MQCR"/E)R1P2/IQ5,^&-&.L-JQLE^WL"K3;VRP/4'G!'L>*N3ZG86UU':W%];
M17$GW(I)55V^@)R:M4 <[%X#\+0/$\>AVBM#)YL9VY*MZ_X#H*>W@KP\VD2:
M2=.'V&6;SWA\U\,_]X_-G_Z_/6M>ZO[.QV?:[N"WW_=\V0)N^F32S7MI;-MG
MNH8CM+8>0+P.IY["@#&N_!'AJ_NY+N[TB">>6(0O)(68LH7:,Y/W@.-W7WKD
M_$?@P'5[81>#[;5])M[98+2*&\%L]L=S,Q8G&X'([G&#QR37:ZGXFTG2K&WO
M)[ZW\JXF2&%A*N)&9@O!SSC.3Z &KD^J:?;01SW%]:Q0R'"223*JL?8DX- '
M.:'X0M5T2^T_4].B2RO91(-/:X>X6(!5'WVYW$C/' [>M7XO!7AR#0SHL6EQ
MIIQ<2-"KL-[#H6.<L>!U)Z#TK9ENK:!=TUQ%&-I?+N!\HY)Y[#UJ2.1)8UDC
M=71P&5E.00>A!H 2*-88DB3.U%"C)).![GDUE:CX7TC5+V2\N[>5IY(1!(T=
MS)'OCY^5@K $<GKZTZ)]4'B6Y$US8?V4+=3%"N?/5\C+-VV]?TJ\M_9M+'$+
MN R2 F-!(,N!W [T /BABM+5(;>%4BB0+'%&   !P .@K@_"W@R)Y-<?7-+N
M8GNM4FN5C>[8Q3Q,VY"\:.48CGA@>U=;I_B'3=4U&\LK.ZBEEM&"2;7!^;&2
M!ZXXS5^.X@FD>.*>-WC.'57!*_4=J ,;7/!?A_Q)=PW>JZ<L]Q"NQ)!(Z,%Y
MX)4C(Y/!]:FE\+Z3+J%C>^1*D]@GEVOE7,B+$O&0$5@N"  >.<#-:Y.!DUR/
MB'QFMMX0UK5]%:":;3I#%^]Y1F#*K$8.< L1]10!KMX8TUO$/]NXN1J.T)Y@
MN9,;/[FW.-N><8QGFF-X2T9KF>7[,ZK<R^=<0+*XAF?^\\8.TGIG(YP,YK0T
M^[%W96\C.AE>)'=5/0D ]*G$T9F,(D0RJ,E-PR!ZXH HOH.G/KJ:T8I/[06/
MRA*)Y -G7;MW;2,\XQUYJ!/"ND1W.J7*03+-JBA;QQ=2@R # _B^7 ) QC K
M9KCM#\97-YXRU'PYJ=I%;RP@M:SH2%N0OWL ]QD<#/?TH U/^$.T3['IMI]G
MG$&F/YEHHNYAY3#H<[N<=!G. <"JMQ\/_#=S)>-)9/B[E$\B).ZJLF0=Z@'"
ML2!DC!J/QGXMF\.?8+>RLUN[R[G1"KDA8T9@FYB/]IE '?GTKI5E\J*,7,L2
MR$8)!V@GVR: ,>W\(:3:7-Y<0+<I)>0+;S$7+G,:C"@9/&!P#5>Z\ >'+S08
M-&DLF^QVTADMP)FWPDG)V,3D#VS72YH+ *6)  ZG/% '/W/@?P]=^'H]"FT]
M6L(V\Q%\QMRO_>WYW;N3SFKF@^'=,\-V36NF0&-';<[NY=W;IEF/)K2CE26,
M21NKHPR&4Y!I5D1\[&5L'!P<X/I0!EZQX=L=:FM[B?SH;NVSY%U;2F.6,'[P
M!'8^AS4%QX1TFYT&7198YC93N9)P)W#RL3DEFSDY/)Y_2MH2(9#&'7>!DKGD
M#Z4[<#W'7'6@".V@%K;I"KR.J# :1BS8]R>36+<^#M)N=<N-8(N8KRX0)*T4
M[*KX7:K%0<$@' )'%;V>:-PSCO0!S3>!=);1++2/,O!:6,PFMQYYRC#E>?8]
M![TS4?A_H6IZP^IS1W$<TJA;A()VB2X _P">@7&[^M=3FJLFHVL6HP:>\H^U
M3HTB1]RJXR?U% %@J/+*+\HQ@;>,?2L:/PMIRZ+>Z3-YUS:WI=IQ/)N+,Y)8
MY[$DYX_"MNN>\8>++7PAI<-Y<KO\VX2(*,\*2-[<?W5R?K@=Z )]7\,6&LRV
M#W#3Q_8'$EL('V"-QP",#T_"L^[^'N@WKZ@9EN]FH/YMQ$ETZQM)Q\^T'&[B
MNI#!E!!!!Y!%+F@#!MO"EG::TFJQ7=^;E+06:^9/O'ECL=P))S\V2>OY51C^
M'ND1:?:6:3WZ_8[E[JWF$^)(G;[V& Z'))%=9FC- 'G_ (D\)1Z9H5XFDVVJ
MW4=]>137B07CM+&H8,SQ*QY<[1[G/?&*30-)O'UB![:X\32Z:R2+?)KLN4=2
MF B(WS;MQ!STP",G->@YHS0!RFB?#[1?#]V9[%[W:I+002W)>*W8Y&Y%/ ."
M>3D\GU-.'@/3%T,:,MS?"Q6Y%RL?F@E7W;N"5SC=\V/4GZ5U-% &,_ARUEUY
M]8EFN))Y+7[(\;%?+:+KM(QZDG_ZW%4='\!Z1H<JFRDOA#&S/!;273/# QS\
MR(>,\GDYZUT^:K27]M%?063S*+F=6>./NP7&X_09'YT <T/AYIG_  C^I:*U
M[J#6FI7'VFX+.FYG)!.#LXR0#^':KK>#[%]<MM7-S?+=PVR6SF.;8)T4[AO"
M@=P#Q@'IC'%=#6#KWB-=,\.ZIJEC%'>MI^\21^;L&5&6&<'D9Z?A0!;U[1EU
M_29=.DO;JUAFXE:V*!G7!!4EE;@Y[<\=>M/O]+34=#GTJ6>58YH# \J!-Y4C
M!X*E>1G^''/&*LV5P;JPM[@J%,L2N0.V0#4U 'F/B7PY-HNDZ!I5K=^))-+M
M)W=[RQ*O<6P$95% 102IW'G!P..XJUH^@WNL6EYI\NK>(9=$NK7RI6U1%28L
M2.(]R[@-NX,2.<C'2N^@NH+F6XCAD#/;R>5*!_"VU6Q^3*?QIFI:A;Z3IEUJ
M-V^RWMHFED(&3@#)P.YH R-0\'Z=JOA>'0+U[B:W@"B*4L%E0K]T@J ,@<=/
MKFJ\/@336T.\TW4IKO4WO$"3W5W)OE(7[N#_  [2<C'?UI5\4WXMM+O9=#86
M6HR0HDD=R':(2,H4R+@8^]V+<\5=TC7WU+7];TJ2S\AM,>)=_F[O-$BE@<8&
M. /7K0!F1?#W3TTB\T^;4M6NOM5O]E-Q<W"R2QQ9R50E<*#WX[#TJ=O!=L;S
MP]<_VC?;]"0QVP/EX=2 I#_)SE0!QCIZ\UT]% '++X&LI/[<34+NZOX-98-<
M13[,*1PI4JH(V@#'I@4FE>!;32[*XMSJNK7;RPM;I-=7/F-!&V,K&"-JYP.W
M85U58.J>(FTWQ1HNC&U5UU3S0LYEQL,:[B-NWG.5QSZ^G(!5?P/:-8Z):+J6
MHQQ:-(LMMM:+)*\+NRG.!D=N#SD\U!>>"+6.\UC4K2^UJ*;4%+2V]E=K$"^,
M;ES@;O\ >..:Z^D8X4D#)]/6@#.T&TNK#0K.UO;B2>XBCVM)(^]CZ M@;B!@
M9P,XS51?#, \7R^(S=3M<2VGV,PD+Y8CSN],YSWS1X6\1CQ+9WL_V7[,;6]E
MM"OF;]Q3&6S@=<T^77GC\7V^@_8F(FM7N?M/F# "D C;C/5AZ4 1>%O"\/A2
MP>QMK^]N;;<3%'<.I$())(7 '<D\YIVJ>'3J?B'2=7%_+ VFES'$B*0^\8?)
M(SRO'M6[10!S*^#UEN;5K_4KB]M[2\:\MH98T'EODE1N W%5R<#/IV&*T_$&
MB6_B+1+C2[IY8XIMIWQ-AE*L&4CZ$"M.B@#E--\%M8^(HM;EUW4;JY%L+>42
ME0)@"2,X' YZ#'3)SSG1\3>&;'Q5I0L;UI8]DBS0SPMMDB=>C*>QZC\:VJ*
M.7?P/97>D75CJ5]?W\ER4+7<TH$J;"2FTJ %VDD].YSG-6H/#C)=B_N=2FNM
M0CM3:P7$L:#RE."6"@ %B0,GV' YSO44 <8/ /E>&])T6'6)UCTN[2Z@D:%&
M8LC;E!Z9 )/UJ:]\"I-J][?6.L7VG)J"D7UO;E=LS8(W#<"5//)'Z5T]S=06
M</G7$JQ1[E3<QP-S,%4?B2!^-34 <K:^"(;6U\/6ZZE=,NB,S0EE3,A((PW'
M0*2..?>G0^"H+6YUF6UU*\BCU5I))8/E,:R.,,XXR3C/!)'/3@5U%% ''P^
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MKS5K9Y-0N6!1I"X#LG Z#J0/QX->I:/HL>F64\,K1SO<S--.5A6-"Q & @X
MPH]3W))-7VM;:2)8GMXFC7[J% 0/H* (=.T_3]/@8:;;6]O#,WFD0*%5F( W
M<<= /RKD/%^H:=8^/?"KZF\4-NL5V3+. $R54 9/?/;W%=TJJBA5 50,  8
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MDA6QMEBD.701*%8^XQS2SZ?8W,4<5Q9V\L<?W$DB5@OT!'% 'E5SI.AS^*/
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M:7ING2"Z%OISB2VV7+JR,.AW Y)';-,U#P%X?U/5QJES:R?:BH28I,RBX &
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M8&WN[5KQ"]G+<QA4N0 "=N"2#@YPP!I3XWTM9[8217:6=W-]GM[]HOW$LA)
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MQU2:\U34+-]-NK=+1E"7$J@1SY&<H>^.] %C4]0@TK3+F_N6(A@C+M@9)QV
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M()%B16D$9VDD$+&2.>#@9XIL,\=G+X_LUU;2].FDM('4V9*QQR;)-^T9R6P
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M: .Z$L9?8)%+?W<\T^O+OA_9/9>+_&=UJ8%S?PM;R23^6"P9HV9U3T'. !V
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M<?:-0M9!=I/R!+'+\QP.P#$C\?:@#NZ*YK4?%\5E/JJ0:?<WB:3&LEZ\10;
M5W84$@LP7DCCMS5*?XAVL)T95T;5))=7MWN+6)$1G90NX<*YY(P>O 89QR
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MRPRR(<E=Y&.AQZ'<?2O4:* .$O/M'BJ;PTD>F7UG<6-Y'>73W,#1"$(""@)
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M6;(^8B,JV#MP>N<=^*])\)0VL.F3M8Z6^GVDMPTD2R[A)*"!F1PW()(/!YP
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M:Y!\GYL!F.6P 3C&?2M;PYJ/AW6]2TK4[7[?-J&GQNLPNY'1=/C*$/N)&T]
M ,]\]C7I04#H /I1@#H.M 'BEO/H_P#PJ/1GN!9^;+K"><61<DBY+-N_[9^O
M8^E;VNJMQXUUZVT66)=0?PSY4*PD F3>Q"C'\6W;CV(KT[%&* /+_"NJ>'=7
MET:58M1;5=+C/VA+IYE2P'ED.26^3!P !G/(..#C&M4M(OA)H;;(4F764D<[
M0&!%RQW'OPA'/I[5[1M )('6EQ0!PNB7T%M\5O%-E*7$]W':20J(V(95B(9L
M@8 !(&2>IKNJ3 SGO2T %%%% !1110 4444 %%%% !1110 4444 1P_ZI/\
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MGS[4^\\'W.I36\=_JHN+*VO?MD(:#_2(R'WA!*6/RYP/N@X &: .J+!5+,0
M!DD]J\<U/7K6RU_3_'7VY/-DNS;36N\DK8-\JG;V((\PCU?VKU#Q#IESK.B7
M.G6UXEJ;A#&\C1>9\IZC&X=1QGT)[\TW5]$&L>%KC196AC$]OY#,L653C&57
M/&.HYXP.M %/Q7KUQHZZ3%:",/J-_':>?*NY(@P))QD9/'%83^*/$=K%XO\
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M\)B&$;).">Y]ZFL/#'B);21-5\2B]FCA>*U(M=BJ67;OD 8%SC.!D 9)Y/0
MS=,\8>)I;?PUJ5_8Z8-.UB2.W*0,YE5W4D/SP%^7[O)]ZT?"$NL3^(?$O]H7
M]O.D-Z(0J6Y3&(D(V_.<##<C!)/.:6+P??1Z!X;TS^T+?.C7$<Q?R&/G; RJ
M,;OER&YZ\U8LO#FKZ=J^NW%KJMNMMJ3M<1JUL6DBF*!1D[L%1@'&.?;N =31
M533(KV'3+>+4;E+F\5 )IHTV*[=R!VJW0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 ,B^XO^Z*?3(O]6O\ NBGT
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% ",H92" 1Z&D1%1=JJ%'H*=10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 R+_5K]!3Z9']Q?H*?0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% #(_N+]!3Z:GW!]!3J "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH :GW1]!3J:GW1]!3J "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH :GW1]*=35Z4Z@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHJK-J5C;W"6\U[;QSN<)&\JAF/L"<F@"U13(YHI6=8Y4=HSM<*P)
M4^A]*?0 44UY4CV[W5=Q"C<<9)Z#ZTDLL<$3RRR+'&@+,[G 4#J2>U #Z* <
MC(Z44 %%1&Y@6<0&:,3$9$98;B/I3HY8YDWQ2(ZY(RIR,@X(_.@!]%%!.!D]
M* "BD1UD171@RL,A@<@B@L%QD@9.!F@!:*:TB*RJSJ&<X4$\MWXIU !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:Q1VD^4DN 1($"A20KD$C<>OK6AX@LICJ5I):ZC>)J,UQ'Y$22L(DB4KYI9
M=K#&<D\Y*@$<5M'2+-K^VOG1WNK:,Q12-*W"G&>,X.<#)([5!>>'M/O[J2XG
M%R9)%"OLNY45E'12H8#')XQCDT :M%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 455U&VN+NQD@M;Q[.=L;9T0,4P0> W!XXY]:CTJSO;*U:*^U.
M349"Y999(DC(7 ^7"  \Y.<=Z ,J^UN_M/'&D:.([?[%?0SR%^3(#&!QZ ?-
M[UT=<?K08_$SPS*L4K116]TLDBQL50N$V@D# S@UU%]!/<V,\-M=-:S.A5)U
M0,8SZ@'@_C0!8HK,T33]0TZT>+4=7EU24ON666%(RHP/EPH /<_C6G0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% ""EI!TI: "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH 1:6D%+0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% ""EI!2T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 @I:04M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 (.E+2#I2T %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 @&!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M @I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>exhibit1011-physiciansha002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @CFE>[GB:U=(HPI28
MLI67.<@ '(Q@=0.O&:GJO%#<I>W$LEUYENX010^6!Y1&=QW=6SQUZ8JQ0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'J<]JT_$&EZ#JOQ,T9]1AM9H;C3)R"[#;,59"N><-@,Q Y]>U '?^?"8//\
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MYU&&.<,%8-G:C'& S=%)R, D9S5K^UK'^TFTXW"_;%C\WR<'<4X^8#N.1TH
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MX0,';.%QGJ<' ]C1'KVD2ZJ^EQZE:/?H,M;+,ID'X9S0 FK:#IFNI"FIVBW
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M@QNSMYB'&,AP=V?7GGO6LTD:,%9U#$$@$]0.M,:Y@0(7FC4.VU"7 W'T'J:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI5AAD< C<IX.,\$ CI0!Y'JFMZ61-)'<PV*CQ1'+<V<A+RY61=TSL3\BX'
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M>!VQUJMX7\.:U:V$*7OA+3+2[T^UD@^UHZ--='RRB[,8"9R-S,>>>!GCG9/
M'BI_AA8>'?[)_P!-@U4W;'[1%M\O8PZ[NN6Z>Q]L@'IVA>-;/6]=U#139WEE
M?V*B22*Z51E#C##!/9EX/K5>S^(>DWEU9A8;I+*^N7M+2^=5$4TB]ASN )R
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M=];/-):Q/<0B&9E!>(/NV'N,X&:J:[?PZ5H-_?3G]W# [D9Y8XX ]R< >YH
M;X>UB/7_  ]8:M&NQ;J%9"G]TGJ/P.1^%1^*-=C\-^&K[5I$\S[/'E$_ON2%
M5?Q8@5RWAJ>_\':)X0T"?2F>.[1DGG\X P2ME]NWJ>ISZ8-:WQ&L;J_\!ZG'
M9ION(PEPB8)W>6ZN1@>H4T 9NOVVG:-X=TT^()]3N)Y;^%Y9[5R&DN#G ;D
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MB.W5?E:59#W*Y QR2?3)H [%O%FCIJJ:<]Q(LLDAA21H7$+2 D%!(1M+9!&
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MW%DM]%(Z*(VB8 CG=G/;&.QK#;XO>'HY=0AFM=3BGL)Q!-$;=6;=N*G&UB,
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M 0,9'.<<]:M:9XKTO5M3GTZ W$=S%%Y^VXMWB#Q9QO4L!N7/>@#:(!&".*
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M'7VYKL:*S#XBT==6&E'4K<7Q.T0E^2V,[?3=@@[>N#G% '!Z?X=UZQ^'FO\
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MM"U+6-<\66PLI8;?4M,CM;:[<KY9D0.>0"6 RXYQV/MGT"D+!5+,0 !DD]J
M. \)0:O]HM(KSP98:5+9 B>]7RSYV$*@1[1D9."23P,CG-=-X:UJ[UJRN'OM
M,.G75O.8)(//689 4Y#+P?O8QV((JZVK::++[8U_:_92VSSO.786SC&<XSGC
M%6+>W@M(%@MH8X8E^['&H51] * ,#QW87NH^$KB#3K8W-T)8)4A#A2^R5'(R
M>.BFLXKJ=]X[T;5I=&N[:WAL9XY2Y1MC.P*@[6/.%R<9QG%=K10!Y*^@ZU/H
MU]=1:&T\]MXCFU..QNPJBZA?(P,Y&<-GGT[UVWA9+AS/=/X<MM#A=55( J><
M[#)+,4XV\X Z\$\9K=N;VTL_+^U7,,'FN(X_-D"[V/ 49ZD^E3T &*2EHH \
MSU;2IO$'AJ33_$OA6\GU-3)':7=N8W8C)*-OW?)VR&X_E7/ZO\/]=TRV\(WD
M5I)K#:9 8+RUBN3&V"S-\C#:<#<1D'/"\8S7LUU=VUE"9KNXB@B'!>5PBC\3
M4U 'D/B'PGK$VA:9J7A[P\FGW-AJ7VU=/,H,L@PGSN=Q&XE.1G.,=ZUO%-CK
M'BGX>:U'#X:&G7ER(9! SH9IG1PSYV\=!A<G)]!Q7I%% 'D'AW2O$$WQ%\/:
MI<Z%>6=E9:1'9222E>2$<9(!X^8].3T)QFMKX?:'J6E^*_&%WJ&G200ZC>F>
MVE?:=R>9(>Q)'WE.*]%HH \OM]$UB;Q1\0'.EW$46JV1BLY9-H61EC*8R#QD
MG(SVZXI/"OAF[U3X/2>%]6TN:SFCCE6-KG S(9'=6 Z@ E>3C//;D^HUC:_X
M9L?$8M/MCW*&UD,D;6\IC.2,$$CMB@##^%]C>0^#+*]U&0O=W4,>"?X847;$
MH]MOS?5B>]=A<3"WMY)BDCA!G;&A9C[ #J:=%%'!"D42A(T4*JCH .@I(9HK
MB/S(94E3)&Y&!&0<$9'H010!YK<>%I/$WAK5+O4[W7K6>^8RSV MTVJXP(P%
M*%F"@(,ANQ/';F?-O#\%;S1O$VAZO%+IV/)<0E!LW#8VXC!VDX(] /J/=*S-
M=T*S\0Z8;&\,BIO617B;:R.IRK \\@^H- 'G/@7Q#X=U3QQ<:C)KLE[KEY:B
MW16LC;)L7!( RV6.T'KZX':M+X9:/?Z?J/BB;4-/FMX[Z^^T6YF3&]-S$''8
MC(X/(KJK?PQ FK0ZG?7MUJ5W;JRP/="("+=C)41HHS@8R<FMW% '@VD^#[RQ
MU'5M!UKPGJ6K+<7)FM;F.\EBMFSCF0A@H['."W48/%:=YX7O['XBZY)J&@ZE
MJVD:JH96L+AHP#V5P'4$=00W;!]J]D=E1"S,%4<DDX HC=)8UDC=71@&5E.0
M0>A!H \DNM)U&U^)?A":+0[F.QTZR\J;[-&\L4+,'^4.1R!N7FN6M]#UX_"K
M7-*?0=46^N-52>.+[*_S*0.1QVV'/U'K7T-BC% 'CWBC1]6AU[PMXEBTK5+V
MQMM/2VNK:R:2.XB.""0JD.#\W;^[@X%5_%?A[;X2TJWT?PIJ4!;5/MXMPKSR
M)&$&\R'+;78XPN3T]<U[,[I& 7=5R0HW'&2>@IU 'GGAZWO?^%N^(M3?3KV*
MPO+>..&XE@9%9HU12.>>H.#T./I4'PCTW5]$M]8L-5TRYMI)+Q[CS74!&!"@
M '/.<,>.!CW%>EXHH *X2[\UOBI=ZI#;2SQZ5H95TAY>25W++&!W)52?Q%=S
M)CRGR^P8/S<?+[\U0LM&LK73I;6(R,ESN::;S"))F8<L77!SCN,8 &,8% #?
M#VM)X@T.WU-+6>U\TNK07"X>-D<HP(^JG_ZU8?CA[Y)M%^SZ==7-I]J/VJ:R
MA$EQ -I"E,\KDG!8<@9Y&:ZJVMH;.VCMK:)8H8E"HBC 4#M4M 'CCV.HP>%O
M$&GMH.K[Y-?CNXXQ&9F:+=$WW@6W':AR<D9XSDUT6MV-]JGCF_6T@NHDNO#D
MEE'=M;N(UF9MP!;&!P?SXZ\5Z#BB@#R:_DUO5?#?A73QX:U.VO-+U*U:Y B
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M;.&R!GC\>.:]<4[E!P1D9P>M+10 4444 %%%% !1110 4444 %%%% !1110
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M:PM$#W%U:R0QJ6 &YE(&2>W-<E)X>UM'\ [+ N-%B"7FV9!@^6L?&3ST)^E
M$U[\5-)L[G=_HTMD+O[*[I>)YZG<5+^3][8".N<GJ!CFM(^-)7UV^TJVT"_N
M)+&YAAN'0IA%D&1)UY&,''7UQ6;I&F^,]"\_0;:&RDTUIW>VU1YOG@C=RQ!B
MP=S#)QT'3.16CX?L=4M?&GB2]NM.>&SU%X7@E,J-_JXPA! )(SC(_7% %2X^
M)VDV\D$K&!K*:[^R"1+I#*#DC>8NH3(/.<XP<<UH77C!HTU&ZL]+FO=/TV1H
M[J>.10=RC+[%/WMO?D=#C.*PO#^E^,=#1/#?V"RETN&5C#J[RJ66,N6.8CDE
M^2.PSZ][5MH^O:&FOZ9:627UKJ5Q-<VMR9E00-*/F64'G ;H5#9'I0!#XIOY
M]5UOP>+.UCO-.NKAKF/=* L^(6=<@CC'7GN!756=IIWA?0[F2&W:VM8Q)=RQ
M*[.$.-SA03P.O P/:N?FT'4=/N_!L%I9O=VNBH4GF$B*2/),0P&(SR<UU6KV
M1U'1KZQ5@K7-O)"&/;<I&?UH Y;1=233_"/_  ENHP2SWVH[9=J+EP)& BA3
M/11E>^,DGO5T>-8;>+7?[1LI+:?18XY)T202*ZR E-K<>A!R!BLBS77+WX6Z
M?9:6-FIVBQ6MW;M)Y4FV(A7C#?P,0!AN.#D$9!JMI'A_6--U/Q#+'X5TY+#4
M;:W\NT-PC(2FX,C#'+,&))/&>[4 =GI&K76H3SQ7.G&V\M(Y(YDF66*97W8*
M,,=-O(([CUINK:]_9NHV&G0V<MS=7OF% I"HBHN6+,>G4 5C>#- N=$U'4FB
MMKJQTF=8VM["XN%D\F3YBY0*2%4Y7C/8^U'BZPUN\UG33;:='JNCA7%Q8M.(
M09<?*[DYW)VVX//.#Q0 Y?B#9OI&B:BNG7CQZK<M:HL85C'(I88(!R<E6P1Q
M@<XJ%/'MTQU2V_X1C4#J6G8>:U22-@(R-RMOSC)'\(R>/QKF]"\*>)-.TC0K
M&;2$ TS6WN28[E#NA^8;@#C'W^!U.#G%=-%I>K6_B7Q?>+8.T.HV\*VKK*F6
M=(RA&"W'+9Y]* +=SXXTZ/3-+NH3&9-2A\^"*XG2 !, DLS' QD#C.2?3)&?
M!\2[.YTO2[Z#3+N47MZUBR1E6,4H!.W@_-D#((XQU(K(M_#WBC2++PSJNG:9
M%-?Z=8MIU[837"J9H\C!5P2O4;N>>G':M34;'Q!?GP]<7&C)O@U47DUO;31X
MMH@A0 LQ7>V6W<#'4=AD T[/QO9RPZP=0LKO3IM(*?:89@K-AQE"NTD-NZ #
MOQ6!J%S/=?%7PA-=:/)92-#=8E=U8LOE'Y#CH5SG'^UUINL>&-;U?4O&*16K
M6J:BEH]E<2/&R.]N<X(#$C<<8R.F<^E6-GBG6O$_AO4[WPX+".P-PLY^VQR$
M>8@3< .W<=3P>G< T#\1--1[666!TL+NY%M!="5&W,<@$H#N"DC@X]"<5'XM
MUK[=H/B"RMM*DO[6VMY([F=74*D@3=A03EBORDXZ=LD8K+\,Z/XFT:.'P_+H
M6GM:VLP$6L&1"3"&SS'@L7QQV&2/3)D;2/$VDP^)M(LM+BU"SU62YNK>Z-TD
M7E-*#F-E/)(/0CCD9(Y( .J\' KX'T $$$:;;@@_]<UJE=>,XK>VO;^/3;JX
MTNQF:&XNXRIP5.'94SEE4]3['&<5I^&8+RU\,:;:ZA;K!=06Z0R1K(' *C;G
M(]<9_&N4LM"UO2-"UGPS%8?:K>[DG^R7QE38B2@G]Z"V_*DGH#GB@#6U/QQ#
M9:E!8VFF7FHR7-B;VW-L%(F4$<+SZ'/./;)(%=)9W!NK*"X:&2!I8U<Q2C#I
MD9VL/4=#7&VF@ZAH_BSP^T-G)=:?8Z1_9KW0D12&RN'V$Y(^3G_>[XKN* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HKCO',FI1WOAN/3M3N+,W.I+;RB, JR%&8D@CDC;QSCU!K(QKC:W
M-X3@U2:ZDL; 3+<SWAMY9'=FPQ*(Q8*-HQQ[YXP >D5%)<PPS0Q22*LDS%8U
M)Y8@$G'X FO/+Z]\1:?IFCOJLLNHP6\4T>J2:+,0ZN&VI)@ ,P 5@P&!NSZ5
M7M;>WU7QOX6GCU>]O(FT:21+D3,I=E**6QV)R<CUZ]* /4*C$\1G, =?-"AR
MF>0I) /Z'\J\NU/7M7@O1>6^H7<^-<2U\^ C[&L#2!?*VM]Y\$Y8 X.?F[5;
M4C2_'_C+4UNKN3[!I\-T8?.+!CLD;80>W' XQF@#TJLGQ%K\'AO2CJ-S;SS0
MB1(V\D E2S!03DCC) _&N*T&X\52G3/$,UVD>GW,0FO4FO1(DP9<J(8]@\ML
MGIGGH2:S_$;W7B#X9KXDDU*YS=3P.+.-@85C-PH5,8^\/E)/7((Z<4 >L32Q
MP0R32L%CC4LS'H .2:QM,\30ZI>PVZ:=?PQW%O\ :;>YEC7RIH\CD$,2#@@X
M8 X/2H_&T)F\$ZT!<2P!;*9R8RHW 1M\IR#P?;!]ZY>Z;5],\.^"[;2]8N(S
M>SP0.9(XW"H82<8"CA=N1S]<T >D45P=@-6F\0?\(K=>(;F0V-G]IGNXT2*:
MX:1V"+T.%50,D<DD?2LR\\0:_%X:U2T74C'J.DZM!8B[$2G[1&[H 74CKA^=
MN.E 'I]%>?O%XA/CU] 7Q/="TFTW[:\GV>(R1MYFS;&=N%'U#<<=>:T_AYK%
M]K/AJ1]0F,]S;7<UL9R #($;@D#@'!QQZ4 ='=W\-K:7EQ\TQM(VDDBA&^3A
M=V OJ1T'?(INDZBFKZ5;:A'!/ EP@<17";)%![,.QKS_ ,,?;X/^$ZN5U6Y=
M[:^G"%UC8EEC&&/R\XP !T '2HHO%&OW.E^ Y8=2\N75RT5TSP(X=MI^;  Q
MSR ,#IG/< ]1HKRE+_Q)Y?C*Q_X22X"Z //BN/L\9EES&7VL2-NT;3T //7M
M6H_B35=8U'2M,M!,DTFCQZC.+:2.-G,F%&"X/"G)_$4 >A4U71P2K*P!(.#G
MD=16+X;_ +;E\.I%KSQIJB[HY)("I/\ LMT*[L8/3'M7":'J][HO@A;N/5+N
M:XU/5WL;;[2B2+"[W#@R' !)VAC\Q(R .!0!ZO36=%959E#,<*">IZ\5R9OM
M3T7QKI6E7%_)?V.J02[#.B+)%+$-Q.4505(/0CJ*S]<^TM\6="MEU&[BBFL9
MV5(_+*QL,<@,AZC()Z^A'2@#JM.URVU/5-3T^&"Y273G5)7EBVHY8$C8>XXK
M4KSR]\1:Q%'X^$6H$2Z.J26A,"$1@Q>9CIR2<CGT'O45[J?BFP\0^'(#K4#K
MKL;QO$;0;+8J@;<G(+'D_>./;H  >D4QX8I&1GC1F0Y4LH)4^WI7G/\ PE.M
MZ-8^);.[O$OKS3[ZWMK6Z>)4R)]N-RC:/EW>V?UK=T63Q1#XD:"_BEETB2 $
M373P"5)1U $>,J1ZC(/M0!UE9>MZ]9Z#8"]NQ,\1E6']S&7PS-M ..%Y.,D@
M=NM:,JF2)T61HV8$!UQE?<9!&?J#7CP:\_X4_-/+?3W4L^J*H%P5(5A>_>R%
M#'..<D^V* /9**X:77M6\/>(-6@U2^34;:'2)-41$@6(Q[&(*#'4'L22>.]0
M:!J?C&ZU'2KR6SN)-+O(]]V;AK94BW*"K0[&+XSV;)P?6@#MKS4;:Q>W29V\
MRXD$<4:(69CWX'. .2>@'6J=WXDTRRLKR]EEF:VLV*3RQ6\DBH1][[JG(7!R
M1P""#BL_Q'X8O=8UW1M4L=8FL'L)#YJ("1-$2K,IP1UV >GY5@OX8OO#'@/Q
MC!<:O)?VLUG<R6T;J1Y"F-R1U[D]O3/>@#J-.\6Z+J^B2ZOIUVUU9PDB0PPN
MSJ1VV ;O?ITYJ_I.K6FMZ?'?6+2M;R<HTD+Q[AZ@, 2/?I7CNH6UW\(_%4>N
M6$;2>&=395N;=!DQ-C. . ,9)7VR*Z:X\576G:'X&T;3V6&YUF"!#<,NXP1A
M$R5!X+?-QGCV- 'I--CD25=T;JZY*Y4Y&0<$?@017F5[XPU:+_A-- :^5-1T
M>T-U:WBPC<\>P,=PX&X;E&0!USCBN>T7Q7JOA3X3:-/%="YN=4N6AM4>')@_
M>R;VXYD)..#W/>@#V#6M;T[P]IDFHZI<BWM8R S[2W). , $FJMEXMT+4-9&
MDVFI12WQ@6X$2@\H0&!SC'1@<9S@YKFK&75O$JZWH&JZ?Y]M&R-97^H:<T:2
MJ2,DHR@%E[=,X_&M/3/!%IIVO6%^B0+'IMFMK;,J#SI/EVEI6QS@#  ]3[8
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MG\UHPQ4RB4KY9Z9V#/\ O9XJS<^*/$EUXEUW1-(L--,FFI%(DMU*^UE==V"
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M, 3E0.65L\\#'7I5AO&>J6[-I]WI]M#K$%L;BXB#O(G+,(U4HI.6"YYQC(_
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M631R6=S'R\,B#"OSU/7/KD\UI:+JCZOIPNY-/N[!B[+Y%VFQ\ D X]#UK1H
MY2W\.:Z^C:A#J?B$76H7=N;9)A;!8H4.>0BD98Y/.?3TYR=<.EZ=X.M_ VIW
M'V_4I[%;>T@A@9#.5^6-A]X+@J"23Q@GI7H!(4$D@ <DFL_1]6T[7["/5-/=
M9H&9T27;R=K%3CV)'Y4 .T73$T;1K33XV+B",*SMU=NK,?4DY)/J:H:WX7@U
MK6]'U*25D;3G<E%_Y;*P'RM[;E4X]O>MZB@#GM(\*V^D>)-7U>*1F_M!PZQ'
M.(6('F$<]7(4G_=%9$O@6ZN?#/B'29]2A#:Q=&\\V. @12$J2N"W*_(OH>37
M<44 <C%X5U23Q-I&NW^L03W%E!)#(B6FP2;\YP=_&!C'!Z>_&CX<T.ZT675G
MN;V&Y^WWK7F(X#'Y9954KRS9&%7T[_ANT4 <7<^#-2>X\3B'5X4L]<C9?):W
MR8W:,1DEL\@#)P,<X_&4^%=2,WA67[?:[M#5E<>0V)@4\OCYOE^7Z\UU]% '
M#:;X(U;2KN2RM?$3IX<>5Y?L0@ E3<Q8QK)U"Y[]>O3K6MXT\-W'BO0CI,-W
M':I)(KO*\1D(VD,,#([CUKH9)8X8GEE=4C12S.QP% ZDGL*=0!A7.F:Y>FWC
MN-6M$MTF229;>S9'E52&V;C(< D#/'3CO64/"6IV']K6NCZI!;Z?JLTD\HEA
M+26[2##>40P'/49Z>]=@)$9V0.I9<;E!Y&>F:=0!Q5QX)O(]5DFTO4X+:TDT
MU-.\N6U\UX44$ QMN&,YY'0]3GC":=X2UBQOO#4DFH64]OHMLUL%6!HV=614
M)^\>0$!]R3TKJ=6U.#1M(NM2N5E:"UC,L@B7<VT=<"I[.Y2]LH+J-65)HUD5
M7&& (S@^_- &+X8T6_T=]7>]GMYC?WSWB^2I&S<JKM.?0*.?K4NBZ5>6FHZI
M?:BUM+/>RJRM%N^2-5"K'SV')^K-6W10!Q%OI6H>%=9\3:ZTEHND7:M=-!%N
M,D;HA^<#&"6[C_)Y'PT]SHMMI]_%=>%M0F8@K;V\TK7#/)CS!&NXJKG/.U1[
MX%>RU2MM'TRRN'GM-.M()GY:2*!59OJ0,F@#(TOP]=6UYK[7LT$EMJTS2&.(
M,&C!0)C)Z_*H/08.>M9GASPKXET86VF7'B"&?1+-E:%4@*W#JIRL;-G 4<=,
MY'' KMZ* .&T[P;KNE"XTJUU]%\/RS%TB\EOM$*,VYHTD## .2,D$C/&#5RR
M\/ZQ9>*O$>KK)8O'JD420QEG!0QKM7<<=""2<>U=;37=(T9W95102S,< #U-
M '!)X,UB'PKX;T>.:P+Z1>173R,[XD\MB0 -O&<GZ8'6K,GA/Q!8:[?SZ#K=
MO::;J<IGN8)K<NT4A&&>,@CDXSSW]:[:B@#E-/\ "]WIWBW4-9CN4ECN+&.U
MC29V9\H.&=CUSW[UFQ>"]6LO!VBZ7:W-@;W2;\7<;.KB*09<X('*_P"L/3/3
MWXZC3M?LM3U?5-,MQ,+G361;@21E1EP2N,]1@=?RS6K0!SGBK0+_ ,0>&1I\
M5[%%=B2*1G,9$4I4@E67).T^F3^-8$O@OQ%-)XCDEU#2R-;L4MY(XX'01,JL
MB[3D_* Q[9/^S7H5% '$MX5U@1>#HDDL2NA[!.6=\R 1^7\OR^G//?CWK-NO
M OB5-%U?P]8:KI[:+>&1X!=1N9H=[;B@(.-N<G.#UZ5Z110!E7.G7EQX7DTX
MW$:WDEH8#.JE5#E<;@,Y'//6L+6/#FN>);6#2M8?3#8)+'+)<P;Q,Y0YPJ$$
M)G@9W'@FNRHH XB;PIXBT_Q#JE]X=UBSMK35&$D\-S;%S#)C!=,$9)Z\\?6D
MO/"&MV/B&'6?#FJP+.]JEK>1ZBK.+C8,+(2O)<?Y/-=Q10!Q=[X3UB#4-'U/
M2]1MY;^R$ZW!O@^R;S2&8C!)7!' Z 8':LR?P-X@/A[4K".^TZ:XNM9_M)9)
M Z #<&Y !Y)5>!TR>37::GKMGI%WIUK=>=YFH3BW@*1DKOQGEN@Z?7\C2Z?K
MEEJ>H:C8VS2&;3Y%CN-T950Q&0 2,'CT]O44 9GB71=3UN/1#!]DCDLKZ*^F
M5Y&P2G\"D+R#D\D#H.*K0Z;=^&_$.M:U/J=A#HEY(EQ/YRD2(P0)C=D* 3@Y
MY],<YK=U'6[33)["&?SF:^F$,/E1%QN/KCH/?I5RXMX+N!X+F&.:%QAXY%#*
MP]P>#0!QG@W2["7Q'KNOZ?)YVGW$^+,JV8]S*IG=.WS.J@GU0UM^(M.U'5'L
M;>WBLI+%+B.>Y2>5E,@0[@H 4C&X*W)_AQT-;%O!#:P)!;Q1PPH,)'&H55'H
M .E2T <GXS\+W>LVFGMHHLK:_LKU+J.:;*A=N>/E4D@YY'%<QXIAU77?&45K
M9W&BQ7=E9J+BWN;F:'(D)+*KQD-(I"C(90!D=23CU(L P4D9/0>M4=0T/2=5
M='U'2[*\9/N-<6ZR%?ID'% '%PZ7J?B*TT)T@TF :'J.\BVD<V\RHN (CC/&
M2"3T93U%:FM>'M=C\4KX@\.7MI'-- MM=VMZ&,4BALJXV\[AD_Y)KK4C2*-8
MXT5$48"J, "G4 </J/A/Q%%JNG:WH^L6[ZK# ]O=B^1O)G1G,F %R5 8\#/
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MRO:((X,QC"*.BXZ8]NE55\ ^%X["\L8](BCM;R19+B)'=0Y!R.AX )Z#CVH
M\S\.2W]C\0O!"QW]Y(=4T=)[P2W#.)3Y<A&03C@*,?3US7N)KG8/ WAVVOK&
M]BL'6YL5"6TAN928E&<*,M]WD\=,''2MN[M(KVTEMIO,\J5=K>7(T;8]F4@C
M\#0!Y/\ !R:*WN/&D\[K'%'>!W=C@*H,A))KBM U35-!^$_B#4M+\VUCNM2C
MABE4G,:X^8@]C]U<^_K7MT/P_P#"T$$T$6DHD,Q!EB$K[)".1N7=AOQK9?1]
M-DTHZ6UA;?V>5V&V\H"/'7&WIUYH \XO[^X\*>/M.M-+>>2WNM&FEFM))GD#
M/&CLKC))#$J!GOSWJIX(BNO%FE:1XD_X2::VU.VOY#J*LY99PSC;%L+!5!7
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MT0J#<$ID$*0?-W/\N.<=.#S4EPOBJ75O#>F2>()K6ZO--GDO#Y$9V2J$SM
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MB)M7M]6NK-I[86MU%$JD31@D]6!VGDC(J[X7T ^&M$ATS[?/>)%PCS!1M4
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M!M0\DZ;Q"]O$$.SR Y4YR<G=@G.?3%:5MX"N8GT@7'B;4;F'2IUEMHWCC&
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MFW#%CCOQ7I8Z5X?X8GGL8HFT?Q;#?ZNZC=8-H@\YG8Y97EX8#.<NQQWKW"@
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MS6W7D'B 7.J>"O"NOW%Y=37-WJ5I+.BRGR5#MG 3H IP >OJ237K] !1110
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MDBCCU16:6;[.,1/@2;MH5CMPN3TSC/:@#:N=-L+V59+JRMIY$!56EB5BH/4
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M>HB\\FY*-9X^TI/&T+0@@D%E< @$ D'IBJL'C+0KE;CR;TLT$1F9/)<.\?\
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MR:9#9W4$UVMO<"2;:XRP&(P/O-][([8],XV)[^SM9$CN+J"%Y,E%DD"EL=<
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MG17%\\,;LH9BIP@ST&3]0/<^G2K= '/OX,T>9M8^TQRW$>KE3=Q2R$HQ7[I
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M; C<A0GKR,<XKN_"MK9:?X91-+TV:RLLO);VTK.7VDD@D-RN[KCMGUXK?HH
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M>-X3X=V1P7VUG)\Q0JN.[;0>H[>U:EE-;0_%'5K.RFMT>/1H(8(491M*L^%
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M  < 4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:21VP!F;S !&#R"<] ?7I7E6JZE+JZ>/KC2#)-"\UA-Y21LDLL*H@DQD [2
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MHUQ#<30ZK9/';@&=UG4B('IN.>,^]+'K^CS).\6JV3I;HLDS+.I$:L,J6.>
M1R">M>4KJEH^J^,OM&JP7KW>A*8IE@\I)-J2?<'=1P V3S@9S5J_M]/LOAWX
M3U>PM5%I#):2ZG/81KO\M8V#,Q')VNV>>AYZT =3XQ\6^1X!O]<\-ZC;SRVS
MQJ'BVRC)D52I'.#AOY5TMEK6G:A<S6EM>V\MW;@>?#'(&:,GL1VKR;QA-X?F
M\#>*=1T2XN;G[8MH)KV65BDTBRKA%W8RRJ,G'0&M6^2WMOB7I$6C?98);C0I
MQ%Y1"!V.2G3KSS^M 'HG]N:5_: L/[2M/MA)40><N\D=1C.<UC1ZKJ(^)DNC
MO.CZ<=*^U+&(<%'\P)RW\7&ZN*CEM=4^$VE:9:L?[?MYH5BM@=MQ%=)*-S%>
MHQ\S%CVY-;VJWA?XDZC;6$ZG4$\-NL2HXW"4R$J,>O0_0@T 6O%_C&'3VM;3
M2M6L_MXOX(;BW^5WV.X5AC/!&?J/:NEO==TG3;B.WOM2M+::3[J33*I/X$^U
M>3'Q!X>N? 7ABR,L*7]KJ-F;N"12)8Y%<>;(^1D9Y)8]<XSFK,USH\NN^)M+
M\6ZKJ$'VJZ,T-NO^JN[8JHCV80EB-N.#VXYS0!Z?=Z_I%A)+'=ZG9P21)YDB
MR3*"BY !(SP,D?G6@K!E#*05(R".AKS&&QT6[^*%E87]G;L3X<1/LMT5D</O
M^ZWJX3OZ5Z;'&D4:QQHJ(@"JJC  '0 4 .HHHH **** "BBB@ HHHH ****
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MZ(K'OQC&"#D#M7%:!XBU?P]H&K7-CX?^UZ;::I=O<R^>L95!(2=BX.0HZ]*
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M.3CDU5M-/BLYKB96DDEN'W222/N/LH]%'8#W/4DFW10 4444 !&1@T8Q110
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MC&03CKBNQHH \C\4Z'XCUJ/Q):R>'Y;J26Y!L;@7$:1)""G*IGF0[>2>3ZC
M%;B_\)+H/B[5-1MM!DU&RUE890BSHCVTJ($VODXQC'(SC%>@44 <-<6NO6GC
M?1]4DTXWY?3'L[B2W=42*4R*Q)W'.T 'G!)]*R[W0-9U73_%\=I92VUW/J4-
MY:?: %6<1A,#.>,F,]?4?AZ;10!P%_'XC\<>$=0LKC26T:1H"@CGD#&:8%6&
M/1,J1D]=W3BI?!T5S+=1/-X)L]"GMTVW%SY48:5B,8BV <$\DGC''.<CNJ*
M,[1+^\U+2X[F_P!,DTVX9F#6TD@<J 2 <CU'-:-%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !10:BA,YW^<(_O?)LST]_>@"6BBB@
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M-<T]FG<QQ 7"G>V<8'///%6K[7-*TR98K[4K6VD8;@LTJJ<9QGD],\5Y (M
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M ZP<*?\ @3*#[\5+K<.AZ1X[U'3M5U"\T+3;C3XX[3[(J)"\>6,B?<;&68G
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MH]SX9N=8TO<^MO,U]<7<:R,@ER<H?FW]5' !X.<&O:XXTAB6.-%2- %55&
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MC*"S\>V'AHQY6YA8O-@X27&Y$STR5#''7E?6M^_O8--L+B]NI!'!;QM)(Q[
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M'ILNI.[S[757?[S1AR$)]3M Y[]:XR\T#3+V+XCRW-MYK6CO-!N=L1N+</N
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M@AL;RWO6EN9B)7DB(<@P,N\#;@@;=OICDYKUJ@ HHHH **** "BBB@ HHHH
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MOYD!7YTSN5O[I&T\'TK#\<:[#=>#?$T6GW5U;WVEJHD:,M$R,<$8(QD%3^M
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MM?T*SU&,;#-$C21\_NW*@E>?3.* )X='TRVU"6_@T^UBO)@1+/'"JO)GD[F
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MW<VH2RZ<OF:B-MTR2.GF#C/0C&<<D8SWS3CX2T4RZ7*;:8OI8Q9DW4I\H?\
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M.U6Z 8*CGOGL*]+HH \\\)QO=:CISOX(.E7EFC)>7MS$HP=I4+ V<MN)R3T
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MAU81KSDH=IR3@9Q[UM:/KVI^(O+5_#%YI]W#;NES<7L(0!RN-D)SDY;!S@#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZTBWT+4[^\MXDG*6R*VY&.-PY[>AP3Z=ZT_#JZFUM)<ZG8VVGR2D;+*!@_E
M#^)P!N8D]N  />J%K9:C!\1]0OVTYCI]U9Q0K=>:GRLA8GY<[L'=CIU'XT 5
M]*U/1+3Q/XOG6QN+*ZM%AEU&XF?*RJ$8JR@$X 4$]CSTS2Q^/!OT@2Z-=JFM
M8;3S')&Q=<!LN"1L^4AL9/Y\5FS6E[I^K>.M6U'35BL+ZT189+B=#'((XV3#
M!26 ;=Z9Q[UGZ';ZAHCZ'+K>@:@UO8A+2UFFOK>1;8RE8P51 &/4+R6(% #-
M$\3+X3@\4LFBWEQ9P:[<//+;JJQP1X0=R,GCH.G?&1GI_P#A)=3D^(<6BPV
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M&PN+"-%+ Q+.$C=757/0DL /7MFJFBZ@T>JZ%/XAM-:@:SC^QVDMQ8+#"'D
M3+E9')9L8!X'/3)H ZSQMXBG\,>&+K4K:SEN9E&U-H!5&/"LW(.,D=.O3WKG
MKW7C;>/]*O6@U6..YTR<_8"&:1G$BA0(@2 <9.>..2:WO']G=7W@?4K>RMY+
MBX(C98HQEFVR*Q '<X!K+BNY[_X@Z9JDNCZG:P#2YH\S6S?([2*5#%<@$JI.
M,\9 Z\4 ;EEXMTO4-&CU.V:=XY)C;K%Y1\WS0<%-OKP?8 9SBK.E:[::O->6
M\(EBNK-Q'<6\R[7C)&02/0CH17FLVB:P-$:_CT66[-KX@N-0;3IXL-<6\FX
M@'^+#9VXSGMV/:>#HX)I+W4+;PRVAPSA%"3P"*>5EW9+*.B\@#O]Z@"63Q4R
M>-AH TZ[*K:F=I@@(.755(YSM'S9..M2'QCI:WL,#"Y6&>X^R17AA(@>;)&P
M-ZY!&<8)Z&LZ]2\L?BE#J(TV\N;6YTD6BRV\894D$Q8[R2 HP<Y/6N7\(:--
MHJPZ+<>"A)K%K.575Y(%:W9 ^X2[R<[@.@'.0.1S@ [!?B'X>>]^R)-=/,)W
MMV5+.5BCJ,X8!<C/...<'TJ./XE>&GAM;@W,\=K<LR)=/;N(0P) 4OC 8X)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9+UFDB!?87*[ " ??O7H- !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*>ST&\>VFCBNQ"TC7 A'S.%Y<KTR<=Z 'ZIK>GZ,]FE].8VO)UMX $9M\C$
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MV6JV.HS745G=13R6DIAG5&R8W'53[TFDWSZEI5K>R6D]H\T8=K>=2KQGNI!
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MWY!K5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BC(HH **3(K N]<N[;QMINB^1 ;6\MYI?-W$N"FWC'0
M#YO?\* .@HI"0 23@"J]W?VUC837US,D=M"AD>0D8"COF@"S45Q$TT$D2S20
MLZD"2/&Y?<9!&?J*P+OQ++'XB\.64%O&]EK$<K^<S$.FR/>/EQCGCOZUT>:
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M&9)(D^S[9G5#F-&?=C (&2%!( Z5U%Q-:Z;97%W,4AMX4:65P. JC))Q["L
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MX3EFDF?1+<O))YK<MC?G)(&<#IVK9U'2;#5]-?3]0M8[BT< -$XXXZ?_ *Z
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MI;BTELVO-+W)&F=N=\0('S,"5QG/%=-;W%QIGAI+K5YC)/;VOFW3A1]X+N;
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M=K?7EU=68A>72B8XQO:,[)8U(7)82$*,^GXUW6KZ9!K6CWFF76?(NHFB<CJ
M1C(]QUK+G\&:3,-! C9%T60/;!3UP,8;UR0K'U(^M '-ZC::LWCGPU;?VF$U
M'^RK@37C0JQSE-Q51A<YZ9&!Z&JS^*=;C^'/B:Z;4Q)JFC7\]I]J%NJF0*P
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M 3M )/Y9'=4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK(@=&#*PR"#D$5XW+JMA-INB6L]M_8^E2:K=07\$Z)+##=#E4(/RF/<6.",
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MID%NJ>89<_+MQG.?3%8?A#Q4/%^G2ZC!8O;6JR&*/S7R[$=<J!@=NY_"N/\
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MT5Y]>SZEHVE^']>MM7N+QKJXMH[Z.9LQW"38&40_<()! 4#CKFO0: "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\*6WAN35=4&GP.TC8>,O*Q=GR[%"3RQZ8JXW@I9;.*QN->U>:QB,?EVY>-
MA&%)5 6' ZGM4]CXDG:_O[35]._LW[% MP]PTP>%T.[)5L#@;><@?2LS1_&F
MH^)[.ZU#P_HL<UA!(T<<EU<^4]PPQG:H4X&#P6(_#G !UMW;O<VLD*7,MNSC
M'FP[=R_3<"/TK!\)>";#P9!/;Z9=WKV\S;VAN&1AOP!N!"@YP .N/:J=EX_A
MUKPI=ZUH=B;J>RS]IL9Y?*D3:"2 0&R>..Q]0>*M^$O%K^+O#DFKVME%"-S)
M'%)<$G<O9R$^7MTW<'\* .FHKSG4?B1JVE^$HO$MSX;M18RR!$5-3)=@20&
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MLFUBN&QT/'(['BM&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?QVSH ^?ID'\* /1]:UNPT"PDO\ 4K@06T9"LYR>O3 '4YJ];7"W-NDR9VL
M1D8/Y5Y+\39%\0>']5N(MS:?91((Y%.0\[E23_P%#^;5T_B34]4M;ZUMX+H6
MENUHTBM%&)9991T79UV@=Z .YHKS*'Q;K]^G@O[/):PR:TLOVC?$2 4CW$CG
MOZ>HJ6U\1:_#H_B"">>TFO\ 3+]8%N7 B0HP4[B#QD F@#TBBO-=,\7ZI%_P
ME,;E[_\ LJVCN+9Y(#"\FY7.".X^7@BI;;7];;7-#M8M1MKNWOX&FG:.'<8
MHSVZ ],GO0!Z+17F,/B?Q9J,::KI%B]S;-<L!:F) C1!RK$/NSOXSR,5)<Z_
MXGN)/%(L+RQBCTB7,8>W)+ILW%3SZCK0!Z517G=KXC\0_;_#%W>2V9L-:7YK
M6.(AH28O,4AR?;IBH5\3^*-29=1TBTDN+9;MHA:B-=K1*Y1B7)SN^4D4 >E4
MTM@@%ASZFO.[K7_%%WJOB:TL+BQM1I4<,J&6(L2&1FV'GKQUJFVJZQK&O^"K
MB.^-JNIV<DSPA 4$@B!S[CG@=L4 >I&JAOX%O8[-Y56YD1I$BSR5&,G]:ED?
MRX<L_;D],>IKQC6]8B76[7QK#>.9+:\\O[.-P_T,_(<]CS\WXB@#VP=.>M+7
M+>*/$,NF0Z3':.%_M*[CMEN6Y2$,"=Q]2<<5@7'BOQ#9VWBT^;:SIH,(>.?R
M"/.)CW]FP<=Z /2**\Y?Q/XGL[.RFO!9L^JM"ME%;QEVCRNYRV2 V%Z<BGR^
M+_$&D:?J<NIZ<S".6*.PG,7EBX,AQ@IN.",^M 'H=%<"OB#Q3;1ZHT]D'MXK
M%[FWNI(/* D4'*,H=LCC@\?C5!?%_BB.W\-7D@TUX]941"(!QY;E"V\L3TX/
M'ZT >FT5YVOC;4])M?$J:RD$]QI#1F.2V!591)C8,'IR<5/IFO\ BEM3:*ZL
MVEM)+9I!<&S:$0RCHI!8D@^M '>$XI X)Z]>E>8:=XU\13Z1X:UBZBL?L>IS
M);RPJ&#J6R RGI_">*TO"D^LW'C;Q,EW?)+;6ETD8C\G'!C!&#GC&>: ._HK
MF/$^M7^F7-G%;/#!;REC-=2C>$P.%"#YF)/I7-Q_$#5Y_"&EZK!;VSW%QJ7V
M&52&"L-Q7<HSE>F<&@#TNJ%WK%E8W=I:7-PD5Q=N4AC;.7.">/RKCX?&FIZ7
MJ&OVOB!+1QIUJEY$]J2 RL2 AS_%E:SM9_M=_%?@FZU)[4B6]=E2.,@QDQ,=
MN[/(Q^M 'HE]J=IIEFUU?7$=O @!>20X"Y]:?8W]OJ-LEQ:2K-"XRLB]&^E<
M]\00I^'NN%AD+:L>?:M;P^$C\-:4,;0+.+_T 4 :E%<8_B/6M4.L3:$MF8-+
MF>';.I8W,B#+*"#\H[ ^M5KCQM=WNE:7?Z<D5I:WD#S/<W8RL3#I'M'+$D'I
MVH [RBO.XO'VJ76@>&=1M;*UDDUBY^S-&68 'YOF4^GRYP>16UX9U_4[_5-9
MTK5DM5N].>,[K8DHR.N5Z\YZT ;%_K^E:9,D-[?06\C_ '%D?!;UQZTMAK>G
MZF^VSNH9R!DB.0$J/<=?TKE?&$4<GCKP:2NYS<S#\ @-9WQ)MX]#N]"\1Z:J
M6^H1:E%!(4 7SXWSE&QU'% 'IE%<9-XCUJ]75KK1X;5K737>+9-D-<.BY8 Y
M^7J.HIMMXUN-?DL8= C@WW-E]N>2Y!*Q*3M52%(.2<]^,>] ':T5Q:>*M:BU
M'PU:7^FP6DVJ&=)X&8LT;1@G*MG!! ST[BJM]XXU6ST_Q5/]BLY'T6550[F4
M2*5!Y'KSZT =]FBN"N/%OB2V\0V6EMI5@6U*W:6U_?L/**XW>8<'(^8= *;#
MX^O(M U"74;*)-3LK\:>8X"QCED+  KD9QSG\* ._I"V,\5Y['XYUF&UUB2Y
MTU)$L[0W<-T(GABDV_>0ALD,"#SG%6+3Q=KC:EHB7EA:16NM0L8 DA9XI @8
M;O4'/:@#N#(.GOBG @]*\QT;Q+K=KHWB35K]H+R*VOIHD$"L2"KA,X_N #/K
M75^%M9N]826622QN+,A3!=6CY63.<@@\J01T- '24444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*5(R",<']*+NS34(-66:V\40O?7R7J.FDD&%TVXXY##CH:]AV#OC\!1L'O\
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M=K*".O-/HH 11@= /I2T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 444$@#).!0 4444 %%%% !1110 4444 %%%-#*
M6*A@6'49Y% #J*0L%&20![TM !1110 444C,%&20!ZF@!:*0,-VW(SC.*6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N
M+^*,*-X,EN"9!)#<0;-LK*/FF13D X;@GKGK7:5S?CK2K[7/"TVG:=$DEQ)+
M"XWN$4!)%<Y/T7'2@#I*X[QJBKK7A*0%P[:NB'$C!2OEN<%<X/('.,\5MZO=
M:Q#96TFDZ=%<7#SHLT4TP3RXS]Y@>A(XX^OTK,\6Z=J-_?\ A^:QLS.MC?K=
M3?O%7Y0K+@9/)^;]* .IKA->&WXN^$P&E^>&[=E,K%<B/ (4G .,\@<YKJ=2
MN-6AOM.33[*&>VDE(O'DEVM$F."H[G/\O?(P-9TO4[GXD>']5@L'DL;&*:.:
M42(,&08! + D#J>/IF@#L:*** (;NUAOK26UN$$D,JE74\9%>+"!G^%6N:%,
M)CK.CZDUO#(C'S9':0;&SU.X$CTP,]J]OKB[CPG<-\38=;APNFRP"6Z3C#W$
M89(R1U^[(?\ OGZ4 16U[:^+=-\)_9D7RYA]KEV\;$B #)P>AD*J1T(!JPE[
MI]IXJ\2S6.DW+:O;VL+SEI0J3KAMFWYB!@+R< ^U1>!O"4WAW4M;EG!$373Q
MZ>O&$MR?,XQZLY!SS\@[8J:WTG4F\:>(KQ[-H[2^LXH()FD0@L@8'(!+ '=Q
MQV/2@#F]7U&7Q%X#\.:QJ5G(DIU.SE5D(8L&D&=H7GH<8(R>*Z_3_&4$\NJ1
M:G87.DR:="+F1;K:=T!W8<;21_"<CL>*Y1-(\3IX)\.Z0^@OYVFWMK)*(KN(
MEDB;<QY8#GY<#/7.<8!.EKWAS5-?U_Q!&+-[>TO='2S@NWD0J9%=GY4,6 ^?
M'3L?:@#=@\5QF[T^*]L+BRBU+BSFF9"';&0C $E6(Y /7IUXJHGCJ&7PYK.L
M1:=.RZ1=2VUQ%O4,?+P693G!&#5?^SM8UVW\/6NI:8UFVFW,5U<S-+&RN\2D
M#RPI)(9L'Y@N![\5A7NB>)K73/%^AV&AQS0ZK<SW4-W]H14VR*HV;>#NX^G/
MY@'2KXDU&;QS;:5'IL@L9-/-UO,D>6W.@W$9R N6& ><].*S_BG%YFCZ*0"7
M_MFV5<'U8_X"IELM=MO&FEZFFD^;;MI*V,V+A ()/,#$GN1@=@:G\?Z7J>JV
MFC1Z99O<FWU6"ZF"R(N(TR3]YAD\C % #TFTM/B-?!=/O3K":8KF7>/+EAWX
M"JN[&=W<@=#5:+XF:5)IMCJ7]FZLNGWL@BCN3; J)"2 I 8L3D?P@CWSD59-
MIJ"?$.YU?^R;A[3^R4M4D62++.)&<@ OGG(&3CGVYKG$T'7+;X?^%M-_L2X-
MWINH03W$230G"QON)!WX.<\?CG% '7:7XJM]7OM1T_\ L[4;6[LXEE>&YC56
MD1@<%,,<].^.?QQRFG>*;72O#/AW_A%M%N_[*U"_^SJ9YD+H?,;<H#.<EMK8
M.< =^U:]M8ZE'\5-1UAM.N/[/?3%MTEW)\\BMNP!NS[#('-<WI'AO7[#X?\
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M-J_QBT?5)P'M[FSG:S1AD+$A(1QGNQRV?1A73R>.UAN;9I-+F6PN-1.FI.9
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MEPWEE(V4[LE<Y.W!&._6N^HH YB73]4E\;Z?K!M85M8;"2WE'GY8.Y5N!CD
MKCJ.N:?X0TS4-*M]32_@AB:YU&>[3RI=^5D8M@\#D=*Z2J6JZM8Z)ITM_J,X
M@M8AEY"I;'X $T 8EWI.IV/C(Z]ID<=S!=6JVUY;/)L;*$E'4G@]2"#CCFL7
M6/"&JR>"]6LK2*"74]6U$7LR^;MCB(D1@H)&3A8U&<#))->@(ZR(KJ<JP!!]
MJ=0!!:2S36L<ES;FWF8?-$7#;3]1P:X*Y\,Z_)I'B_2([2S\G5+B6XMK@W!!
M9I-HPR[>  O)SZ8]:]$HH XVZT/6+GQ/X2U)8H8X=+AF2[7SLDF2-5PO'(!7
M/.*SM T'Q=H,#:!"NG-I:3L8-19R94A9MQ&S&"W)&<@ GOCGT.B@"KJ'FG3[
MA88//D9"JQE@N[/'4UQ&J>"+W6;#PVZ,=.O;!!:7?ERY+VI3;(H8=<XX]-Q[
MUZ#10!Q-WH^IGXDZ3J=MIF-+L;1[4N)4'WNA"YSM''O[>O/S>$O$LJPRSZ18
M7.H0:O'=O>R7I,ES&LA90,K^[50<8'IPM>K51CUC3YM9GT>.Z1M0@B6:2 9R
MJ$X!]/\ ]8]10!S$.CZP7\7R362*^K(HMPDRD9$ B.>F!D9^GOQ5+_A'==\K
MP[;RZ;:WFGV&GK!)8S76Q!<+M E.%(=0!P#GKTS7H5% 'D5SI>NZ3X7\/^'I
M;"SEU/\ M.2:W^SW81R TDI=&9,)@LHZ-D$C S5XZ-J&L:1K7AS4-*;3]6U.
M$72WTEVMQY[1NFW>R*NW!V@#;C!..<UWVK:%I>N1Q)J5E'<"%]\1;(9&]5(Y
M'X4NF:'IFC"3[!:)"TIS(_+.^.F6.20.PSQ0!S&G)XOFTB2'4M)L;1DMY%D2
MTE5FO)"NU< X"#DD\YR!T&<YPT/7%\-^";(:-()M)O(9;M?M$7RK&A4D'=SG
M=D#VYQ7I%% 'G^H^%=2U;5/&"-$;>#5H+9;2Y\Q<+)"#@L <@%B.W0'..,VK
M ^,K[3)H]4TNSL98()(\03+(;URA52/^>:Y.>3GCL*[:J6J:OIVB6?VO4[N*
MU@W! \AQECT ]3QT% '$_P!A:\OA;P99KIX%UI-Y!)=*)D(\N-&0X)/)(;(_
M&MGP_I^L:7XCUQ9[6%]/OKPW<=R)L$9C5=NS&2<J/0=3[5U-+0!S?BBTO=5>
MQTM-/FFTR6=7OI8Y$7Y%R0F"P;E@I)'8$<YK \2>#I=/U+1-7\*Z9))?V=UN
ME7[4 KPD8=29&ZGMCW]J]#IDDD<,3RRNJ1H"S.QP% ZDF@#S;7CK-UXUN+C1
M=-O99(["*"[%E?01.C,6;9*)-RD@8P4Y&X\\BI%6[N(?#']D>&;F*+1KYTNK
M59X<P8C*D!BX#G]YG(ZX.>:Z!= \+>)IFURU F:?*/=65W)$)MORX8QL V,8
MYS70VEG;6%JEM:PI#"GW448'J?QSSF@#B=;TS7M*\:3Z[I6CV^LVE];QPW%M
M)*L<D;H2 REAC;@\]34&KZ+XAM+_ $O78M(L-7N$MI+:\T]66-55G+J8RPQ\
MOW<XR?QX[BZU2PLKNVM;F[ABN;EML$3. \A]AU-/O;ZUTVSDN[VXCM[>(9>6
M5@JJ/<F@#BKC2-=FO/#=XVDPQFWU![F>WMGC"VT;(4"YR-[#.20.><=JEM--
MUBU\5^,]0;3)S!J,$*V;Q2Q!G,490CEOE)+9&>,#G!X/:6\\5U;17$#AX94#
MHXZ,I&0?RJ6@#R>U\+^(])TCPMJ-EHZ7.H:;;O9WFG7$T8\R-CG<K[BHP>>O
MIQVK8\06?B+4?",T2Z$BW%S>02+96\L68(HW5R6<E0S$J>F>H]Z] Q1B@#C[
MB'46^)"WJ:5<&S.E-:"Y+)L$A<.,C=NQQCIU]N:R-'U/Q)X1\$Z;;7/A@M]C
M>.UE(O$+,F2"Z@=>=H SDD_GW UG3&N+JW74+9IK1-]Q&)03$OJP[=.].A?3
M=8M[:^A-M>PJWF6\Z[9 #R,J>QZCCWH LSAS;RB+_6%#MQZXXKSGQ!I>J>+/
M#4.G:AX5ECUZ.-/+OS/%Y<+YY<2*V['&2NW_ !KTJB@#BX=+U6#XHOJK64\V
MGIHHLEN?,CR\@??T+;N>1DCK[<US>DZ3XHTSPQ860T6\$2ZG/)?V\5Q''++$
MQ)0HX?@9(!P03@CH<UZQ10!Y"?#7B$>$?%FAP^&Q;C4;OS[81W,95=WE_+U'
M "MD^O0'K72>+M/U6YN-$\1Z=I O9;)9$GTNZ*!GCD"YP>1N!4=S7=44 >=Z
MMINNZAX9\RW\.0VMQ+?VTPL('B#K'&P8EWRJDD@\#IQ[U+K_ (:U+6_'-S.+
M6:&PN= ETX78D3$<KL6Y7=N(P<<#K[<UW]% 'G@TS5]7\,Z;X5O=*GMI+.2W
M6XO<H8"D+ AHSN+,6"@8QQGG%/U'P]J6KZMXUA2VEMDU2QA@MKF0KY;,BL"#
M@[@"6'..F?H?0*,T ><R_P#"3ZQ<^%VO?#4UM+IUZ'NW$\10@(R[D^;..<\X
M].:IZ?HFNZ7<W6A2>%K"^BDN)9+76)!&5BCD<MEU8$LRDGCOP.G->B?VUI7]
MH?V?_:5G]MR1]G\]?,SC.-N<]*JQ>+/#T\K11:U8/(LJPE1<+G>>B]>IP?RH
M S/#UAJ%IXO\3W5S82PVM]-#);S,\9#A(PAX#$CD=Q5CQG9K?Z/#:S:(^KVL
MEPHN((W"R(FUOG0EE^8-M[]S71T4 >6'1_$+>'[.+[)J=U!;Z[!=6L5TZ&XC
MM4()WDMUSNP"<XQTK5U2SU\>+?$%YIFFN3<:0MO:SR[/+,JEC@@G/\7&1C(Y
MXKOJ* /+]$TS4+/QII^M)X<U5(Y;![>YENKE'D\S>A+,-Q & V H&>R@52CT
M/65^$FLZ2=(N_M]S?L\4.T9*F57#=<8PI_&O7:J3:KI]M>1V<]]:Q74F-D+S
M*KMG@84G)H E$^;,7'DRC]WO\LK\_3.,>OM7DUKX<\0P_"C3-+32[E=1@U19
MVB#(&""4ONSNQT(]\UZO/?6ELX6XN88F(R!)(%)'XU,KJZAD8,IZ$'(- '$V
M0U7PSK^O!]+N[^TU.Y%U9RVZJQ#E &23)&P J ">,=ZQ&\,ZSX?;P'<6^F27
MYTD70NH;:1<HTR\ %B!M!)&?05ZG10!7NXI+G3IX0 LDD3* 3P"1CK7FULGB
M&V\#^']/;0-1B6RFCBO1$8C.452-T1#9 S@$\-@G&.M>HYJ&XO+6S$9N;F&
M2.(T,KA=S'HHSU/M0!Y,V@:L?#?B[28_#E]&;V^BG@0RHP9,QD@.7R3A&R<\
M<<YK?TW2]6T<ZEX>:WOIM#U%&>TO5<--9M+D,DF3N."2V[G'<GMZ!10!Y9X.
MTN^M%L='O/ ]K;ZAI\BAM8,$9B**?OJWWB[ 8XZ$@GTKU.BB@ HHHH ****
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M!:I&@20[9)G =MP!QE5*#ZLP[53:W;P):BWT?2-3UG^T;IY9%5U/ER,.68X
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M+ID(B)&W=A57<V.,MGOZTGACPR/#,%U#'J-U=QW$[7!%P$^5V.6(V@<$\XH
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MQ]G>,Q%!P-I&,?E7)0?#X6NG:;;0>(-32;39&:TN,1DQ(5V% "N",>H)S^5
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MHQ\XW':3Z<\].* *FG^)M=CUOPO_ &E-9O::_;L5MX8B&A98E<-N)^;.<'@
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MH:XMO9/#+8QVB3RS!2=S.?D"G.!\H+'(/!7UKG=/CM?A_P"'DTKQ+KD-S8S
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M/:KJOCV*QNDM(;>(70M4N9HKN5XC'O!*H=D;_-P<YQCCKFJUWX=\3Z9XLO\
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M7,2:QK.JZ7KNIZ;>QVG]FSSP00-$KK*8?O&0GGYB"!M(P,'FLC4=0N/$FH>
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M0J!M9G66,N2V<8R=O3@@UKV&OZY#XY7P_JPL&%S8->0FV1AY3!]NQB3\PQW
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MW?(I^9C@?,3V'XI_PA-P\/A:.35(O^) 1MVVQ_?A0%7/S_+\H&>O//M78T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/5H]*:\B%_(AD6WW?.5'4X["KM>8ZL=;C^)V@ ?8)]6.EW W8>* '<<'&6;
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M-&GL6:T:\@=I5D+HI ((7[K<],F@#J**XW3/'$M[K.DV5SI7V:+5XY)+1OM
M:50B[OWL>T;,CI@M3=2\>26%GJ&JQ:2UQHVGW)MKB=9PLI8$*Q2,C!4,0O+
M]>* .THKC[_QS':R_9H[>T6\2T2YFAN[](-FX';&#@[F.#V  QD\BH(_B&MV
M-&^P:)>7#:M;S26Z%U1M\6=R-GISCYCQSWZ4 =O15&POI;C1H;Z[M)+.1H1)
M+;O\S1'&2O'6N;T[QW]LU+2(+C3&M8-7W_9&:;,J[03^\CP-N<<$%J .RHK@
M)?B/<QVE_>GPS=_8]-NVMK^7[0G[H*0"5'\9YZ#\^:Z&\UV634'TS2[!+^X6
MV$\PDF$4:*V=JDX8[FP<#'0<D4 ;B.D@)1U8 D94YY'!%.KAOA+.)O D2^28
M6BN[A6CXPI\UFP,>F['X52UN+P[;_%(?VO;6?E3:.SL)(0P9_-^\1@_-M! /
M7M0!Z-17E'AOQ!?^$?"FJ:A>6-_<:4=4,>EQ2\2B%FPO#<XZ8&/6NF_X32_:
M6WM!X:NX-0N)IEBANY!&GEQJK&1I & !#8 YY'7O0!V-%<I9^.K34/#^GZC:
MV<\ES?W!M8;,$;O-4MN!;H% 5F+>G;M6;KWC+5[;PS?7-OH[6M[:726LXFD^
M5=S* \3%0),[AZ8ZGW .[+H'"%@&(R%SR:=7&7M_9#Q]X:CO]%=-5GM[CR;G
MSP5@4*2R\?>. .HP-W!ZU=M_%K7;6UQ:Z7<3Z9<7ALX[N)@Q)!*F38.D>Y2-
MQ.>^,<T =-17#:E\3M+TVXG9TC>SMKK[+-(+I!*&!VLPB^\5!X)]B0".3UFK
M7DUAI%W>6\"SRPQ-(L;/M!P,\F@"[17&Z/XMNCX3T6[OK1IM1U)8UMX(7&9V
M*[BW8( ,DYZ ?2M?1O$<>J:C?:7-;26>HV.TS02,&RK#*LK#@@_H: -NBL36
M?$!TV_M=.M;)[R_N8Y)DB#B-0B8W$L>G)  ]3VZU2M_&]E?Z#I6I:=;SW,NJ
MN8K2V.$9G7=OW$\ +L8D\].,Y% '445QK_$"&VL]6GO-&U")M(P+U4,;!6.,
M!26!;((.<=*E_P"$[MD61I]/N[5'FCBLGN0(DNPZE@RLW"J%!)SR.F,\4 =;
M17'6GQ&TF>QU.:8>3+IUPEO)$)48,SG"%7SMP3GDD8P<XJYX=\96>OZE=:8%
M2.^MT$I6*=9XVC)P&5UX] 0<$'U'- '2T5EZMK']G2VMK!;M=7UVS"&!7"Y"
MC+,S'HHXR>>H !S6-/X[MK32]8GN;"X6\T?;]LLT92RAAE6#$@,I'.>OMF@#
MK:*Y/3/'"7VLZ9I]QI-Y9#4[=I[.6<IB4* 2, DCCGG''I764 %%%% !1110
M 4444 %%%% !1110 4444 )2TU3D4Z@ HHHH **** "BBB@ HHHH **** "B
MBB@ HJG=:E% MVD?[^YMH//:W1@&(.[;UX&2I SZ5#X?UA-?T"RU:.%H4NHQ
M(L;')4'U- &E1110 4444 %%%% !1110 44R::*W@DFFD6.*-2[NYP%4#))/
M84X$, 1R#0 M%%9>LZTFDBVB2WDNKR[D,5M;1L%,C!2QY)P  "2: -2L'Q3H
M%QXAM+**WOH[1[6\BNU=X#*"T9RHQN7C/7FKVC:K_:^GBY:SN;.0.T<D%PN&
M1U.".."/0C@U5U;Q/9:1)I*RQS3)J=TMK!+"%90[=-Q)''7IGH: )[^QU*Z;
M3VMM5^R&"99+E4MU9;E!]Y.3E,^H)(]ZI:QX?N]2\1Z-JT%_# -,:1EB>V,G
MF>8NQLMO&..G'7UZ5T&:,T 9E[9:G-J]E=6NIB"TA203VIA#"=B/E);J,'GC
MK7+V_A/QA!+=2#Q9:"6[;,TZZ8/-QV"DOP "0!C ],DUW>:,T (!@ 9)QW-+
M1FB@ KFX?"4$'Q N?%*LNZ>S6W,>.=X/+_\ ?(4?G7244 <]X3\*6OA.TO;>
MUP4N;N2X&!C:K'Y4_ <5BCP+J":'XIL!J-JTFNW#S[_(8"'?PP^\<\8Q7=T4
M <')X'UFWDTG4-)UR.RU2SL4L+@FW\R&XB3[ORDY!Z_GVK2;PK?F_P!"NCK
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M_$T2:S':0W+:"RK';,S+&#.N<L<;B2,]!CISU/9Z;J5IJ^GPW]A,)K68$QR
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M(]/UW4=7TJ:"QMKO3%B?[38W,P11*<;6; (<#GC!]>N*Z^B@#RC3O!7BK2=
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MKWJ*EU'%<LD<VT;5+J#@X'KQQ4MMX.TRSN=(G@DNU.DQ-#:J9RP"-PP.<YR
M![8&,4 </K+7MQ\-_%]O>:G>7#:;J$MO%*9-KO'B,A7VXW#YS7IUA9BQMA )
MYYP#G?.^YOIFL)? NF?8=9LIKF^GM]7<RW*23# <_P 2X P>!^0K:TK38](T
M^.SCN+JX5,_O;J=I9&^K&@#AK?4=3USPAK/B2'4Y[>\M9KEK6(-B*-(2<(Z
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M9H1OV- X7+'_ %9.6.<-6EH_P_M-&N(A%JNIRZ?;S^?;Z?+,##$W..V2 3D
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M]=Z7>S1)'>FV12MSM& 2K9 ."<'G% '1Z7+>SZ5:RZE;K;7S1*9X48,J/CD
M@GC/N:\LT.7Q,FD>*M3T*[LH$M=:O9Y+:6 NUR00S#=GY>, 8'/J*]8M+6.R
MM(K:+=LB4*"QR3[D]R>I-<K%X%>V34[*WUB5-)U.Y>XNK8P@R$O]]5DSPK#
M/!..A&: ,^V\5:@?$_A^[N+PQ:!KEF988GB3]U/L#;&?K@C)'OQ75^'+JYO]
M*%_<3^;'=2-+;?(%VP$_N\XZDK@_C7,>)H]*\27,'@N*TN?/M)H)BXA98X(E
MP20_0Y0E!CNWL:[M$6.-410J*,*H& !Z4 <)+]IM?B_>S6-E]I>31(BX,H0
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M\::A=^&[*^_LV.&YDNWM;R21\06GEL59V)P=O' XY."?70B\.W=OXSAUB*:
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MD%SMB0KN$6[>!C[W/<E<@'%,B\7:IH=IX@TR:[FO9K/4X;&UO+A0S*)N<O@
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MGDBDG02-M9I=N$..2#CZ]Z /2**\WU:^\8:%HGB">6[(@CM/M%E/.T4DR.I
M=2%4*5.>#CBHY-7\3)XB\,VR:S%Y?B&TD8J;0;;79&LFY><LQ!(^8XSSCM0!
MZ917FD?BW6M/\+ZJMQ<?;K^VUPZ3#<^4D;$,4PY7A=PWG'0<#/>K+ZAXRTRV
M\0W%UO%E!ILEU92W@@,RRHN2I6(X*GDYQQ0!Z%2!E8L%8$J<, >AZ\_G7F^G
M:[XECC\&W][JD5Q!K16*XMUMU0*6B+*P.,[N"3V] *O^ +:Y&I>)I)M4O;D1
M:Q-#LF*$/A(L,2%!R ,  A0.U '=45S6N:M<#Q)I'A^TNOLDEZLLTDX568)&
M!\J!@1N)/4@X -8.IZ_KNG0^+-+%[FZTRQ6_LKYXD9GC*DE74 +G*L <=.<>
MH!Z'17!V6I>(;#Q-X8AU#54O;?6K>42PB!$6&1(A(&0@9.<$')[\ =!WE !1
M110 4444 %%%% !1110 4444 %%%% #8_NTZFI]VG4 %%%% !1110 4444 %
M%%% !1110 4444 9W]@:/_:!U#^RK'[:7#FX^SIYA8=#NQG/O2+X>T5#<E=(
ML ;H@W&+=/WW.?GX^;GGFL+_ (32SU'7M7\/VLL\%S:P_).L+9,F'+ ;E*@*
M%')X.>,U'X+\96.HZ%HMMJ&K0R:S=6X9D) 9VZD<#&<8..O3B@#H'\.Z+*MJ
MLFDV3"T8O;AH%/E$G)*\<<\\4U/#.@I;+;+HVG^0CEUC-LA 8]3@CK[TEUXE
MT>RO/LES?1QRB1(CD':KM]U2V, GT)K3DD2*-I)'5(T!9F8X  ZDF@"L-*TY
M;_[>+"U%YC'V@0KYF,8QNQGIQ4MY96NH6KVM[;0W-N^-\4R!T;!R,@\'D5GV
M'B?1=3N)(+34(GE2/S2IRNZ/^^N0-R_[0R/>H%\:^&GFLXEUJT9[UBMN%?/F
M'<5X/U!'/4B@"['H&C1+MCTFQ0>2;?"VZ#]T<Y3I]WYCQTY-/L-%TO2_,_L_
M3[6T\P!7$$2H"!T' ]S^=0:5XDT;7)[F'3-1M[J2V.)5C;.WW]Q[CBEMO$>D
M7EZEI!?Q/-)N\L<@2[?O;&Z/CO@G% #].T'2-'EEDTW3+2T>;_6-!"J%OK@4
M[5-%TW6X$AU*SBNHT;>JR#.&]14"^)M':SOKL7\?D6$ABNG(($3#&0>/<4Z;
MQ'HML\4<^JV<3RP^>BO, 3'_ '\'M[T ._X1_2/[0DU Z=;&]D38UP8P9-NW
M;@-U QQQ41\+: ;(67]C6'V59#*L/D+M1R,%E&/E..XJAJWCK1--\-'6HKR&
MZ@<E(/*;(DDSC;D XYQDGI6_:7D%_:I<VL@DA?.U@",X.#U]Q0 S3].L]*M%
MM;"VCMX%)(2,8&3U/N?>H=2T33-7:)K^RBG>(_NW8?,N>H!'.#W'0U&WB+1T
MU$:>VI6PNB_EB,O_ !_W<]-WMUK%\0^*8+7Q)I^@KJL6GM,DDMQ<$INC"J-J
MC?E026!Y!X% &U>>'-&U"TM[2[TRVEM[<8AB:,;8^WRCM^%::J$154851@#V
MK-TYKS3=#1M=U"":>!6,]T%$2%03AB.@XQGMG-0R>+- ALWNY=6M$@CD6.1F
MDQY;'. PZJ3@]<4 )_PB.@?9KNW_ +,A\F\<27"<XE89P6YYZTE[X/\ #VI6
MUI;WND6D\5H L =,^6HZ*#UV^W2K_P#:M@-3&FF[A%\R>8L!8;ROJ!W%11Z[
MI4]__9\6I6K7A+ 0K*"Q*_> '<CN.U "2^'])FNK2Z?3X//LP%MY%7:8@.@7
M'0>W2M*N(\+^+HDAU&#Q%K=H+J/5KBS@,I2'>J$*,+_^OKUKM)98X(7EFD2.
M-!N9W8 */4D]* ,BU\):#8W_ -MMM*MHIP=RE5^5&]57[JGW !HO_"/A_5-4
MCU.^TBTGO4((F>/).!@;O[V.V<XJ>'Q'H=S/#!!K&GRS3+NBC2Y1F<=<J >1
MP?RJQ9ZG8:@DCV5[;7*1MM=H95<(?0X/!H H7_A+0]3O7O+RP66:3;YF78++
MM&!O4'# >A!J6Y\-:+>:Q!JUSIMO+?VX"Q3LN2H&<>W&>/2I;/7=)U!YDL]3
ML[AH,F413*Q0#J3@\#WH77=)>XM[=-3LVFN03!&LZEI ,Y*C//0_D: )M0TZ
MSU6QELK^VCN+:48>.1<@UFV7A#0M-TBXTNRT];>SN>)DBD=6D'H6!W8QQUZ<
M5>NM:TNQN4MKO4K.WN),;(I9U1FSTP"<FG7^JZ=I4:2:C?VMG&YVJUQ,L88^
M@)(H H?\(EHG]DC2C9$Z<&W"U:9S']-I;&,\XZ9YQGFIK_PYI6J6D%M>6ID2
MW.86$KJ\?&/E<$,...#5E=6TY[5[I+^U:W0!GE$RE%!Z$G.!3(=<TJ>P^WQ:
ME9O: [3.)UV ^A.< ^U %67PKHLVDKI<E@ILED\WRM[ ,^<[F.<L<\Y.>>:E
MU'P]I>K6UO;ZA:+<1VS;HO,9BRG&,[LYZ>]3_P!L:9YES'_:-IYEL"TZ^>N8
MAZL,_+^-/AU*QN-/74(;N![-EWB=9!LV^N[I0!F#P=H(NWN1IX5GE69D65Q$
MSKC:3&&V'&!V[5MLBR(R.H9&&&4C((]*I0:WI5U9/>V^IV<MHF=\\<ZLBXZY
M8' IR:OILDL\2:A:M);IYDRB928UQG<PSP/<T 9Z>#?#\>DMI::;&+1G5]N]
MMRLOW2K9W*1VP1CM5[3M(LM*,S6L3B28@RRRRO+))@8&YW)8X'3)XJ#1?$ND
M^(%F.FWL$YB=D*I(I; .-V <[2>A[UD>)_%D.FZSINB0ZE96EQ>M()KB9U/V
M553<"5)'+' &>/K0!LZYX>TKQ)8_8]6LTN80=RYR&0^JL.0?I5*3P3X>ET&'
M13IR+90R"6-4=E97'\0<'=N]\U/I5_<6UI#;Z_J&F_VA(Y$?D/L$RYPA"L<Y
M(QP,\UHW.HV-DZ)=7EO S_<6655+?3)YH Q[?P/X<M8;Z&+2XQ#?($N(BS%7
M QC@G@\ Y'.><YI8/!/AZWNENH]. N%A: 2M-(S;&X()+<\<<]!TK7NM0L[(
MQB[NX+<RMMC\V0+O.,X&3SP":L@@@$'(- &)IWA/1M*:)K6UD/DQ-#$)[B28
M1HV,JH=B%!P,X]*9I'@SP]H5ZUWINF1P3$D@AV8)GKL4DA,_[(%;U% %#5](
ML]<T]K&_61[9R"\:2L@<>C;2"1[5+I]A!IEC%9VWF"")=J!Y&<JO898DX'2K
M5% &)8>%-)TU-0CMXIO)U#<;J)YW=9&;.YB">&(."1U 'I6?8_#KPWI]S87,
M%K/Y]@Q:"1KJ1BN>-O+?='9>GYG/5T4 <W9>!/#NGZT^JVUB4N&D,P3S6,2R
M'JP3.T'WQQVQ3O\ A"M'^W:E=A+E7U$,+A%N7"$L,,P4' 8CC/7%=%10!SMS
MX'T&\T6QTFXM9'M;!@UJ?/</$1TPX.[]>P]*DN?!N@WF@'1)[!7LBWF8+L7\
MS^_O)W;O?/Z5O44 9>A>'M-\.6/V/38#'&3N9G<N[GU+'DTS5?#.F:S?VE[>
M12&>U#*C1S-'E6QE6VD9!P.#6O10!SMUX*TBZN[F;_2H8[MBUW;6]R\<-P2,
M$NBG!)[^O?-="J*B!%4*JC  ' %+10!SI\$Z/_9&HZ6@NDM=1F:>Z"W#9D=O
MO').1G SCKBH]2\!Z'JK64ERER+BTB\B.XBN&CE*?W692"WX^_K7344 >>^*
M-$$6LZ1''H^J2:39630PRZ3<%)8W)'RM\P8KM0<\Y)YJ]HGAA+S2-1L=5@U*
M32[O9Y5MJEUYTR$#);<"=O., ,2-N>,XKM** ,G3_#UG83O<%[BZN'A$!FNY
M3(WECG;SQCU[G SFLQ?A]H*Z!<Z'LNVTZX8$PM=.0@#;PJ9/RJ&YP.O?-=31
M0!S5]X'TK4;Y;NXFOS(;9;6<1W31K<HN<>8%QN(R?;GI35\!:.EOI<*2:@G]
MFY$#I>R!RI55920>A"J,#&,<8KIZ* .7G\ :%/K<VJ%;I'N&#W$$=PRPSL.[
MH#AO?/![]ZZ61/,B= [(64C<O5?<>]/HH Y4> ]/32K+38[[4DM[*Z^UPXF4
ME9,ENI7D9)/U-:EMX?MK7Q%=:XL]R]W<QB)U=P4"#E0!CC'/_?1SFM:B@#AO
MB%9W%W+I#?9=8DLH9)'FET=\7$;%,+@#D@Y.<4WP[X?>ZMK^SOGURZT6ZMUC
M,6N2JTA;/50 &4 =S@YQZ9KNZ* ,33?#%KI]U!=27=[>SVT;16[W<H8PH<9"
MX ST R<GCK56W\#Z5:GR8WN?[.$PN$TXR?N$D#;L@8SC.#MSMR.E=+10!RVJ
M> =*U/5KG4?M6I6<MV@2Z2RNVB2< 8&\#KQQ6SHFC6OA_1[?2[(RFWMUVIYL
MA=L?4_\ ZJT** .>3PC NOW^KG4K]VOT$=S;,8O*>, A4QLW  $]#GU)JA:_
M#G2[673)%U'5W;3'8VF^[XC0C'EC ^[C\>V<5V%% '.'P5ICZ;K-A-)=30:O
M(TUR'D'^L./F7 &#POM\HI8O"$"76E74FJZI/<::7,<DTX<N7 #;LKT( &!@
M>G/-=%10!DZ1X?@T:]U&ZANKF5]0F\Z83%<;\8R,*,< #\*JZIX0L-4UD:H]
MS?V\S0_9YEMK@QK/&#D*^.>"3T(Z\Y%=!10!R-G\/=/L9=$DCU+5&.C%S:B6
M9'&& 4@Y3IM &!C';GFI6\ Z3.-:6\ENKR+5W$EQ%,4VJX^ZR;5!4CCOVKJ:
M* .4LO 5G:ZAI=_+JNK7=WIH=89;BYW$AL#!&,8P,<8SGG/&-G7]#M/$>AW>
MD7V_[/<J%8H<,,$$$>X(!K2HH YN?P= _P!CN(=2U"'4[.-HXM0\Q7D*MU5@
MP*LOMC [8K4TG1X-(@F2*26:6>4S3SS$&25S@9;  Z      "M"B@#%NO#D=
MSXFM==_M"]BN+>(PK#&8_+9"06!!0DY('?MQBLS5/A_8:EKTNKPZEJNG3W 5
M;E;"Y\I;@+P-V!GIQUKK:* .5O/ >G75]/<1WNHVD5Q:I:S6UK/Y<;H@(3.!
MD8!/0_7()S7G^'&FR:?ID$.HZG;W>FH([>_BGQ,L> I3.,;<#H!Q^)SV5% '
M-/X*LF72MM]?J^G3_:4D\Q6>:4C!:1F4EB02.WMC J]I_AZ'3M=U35H[NZDF
MU(H9HY"FP%%VKMPH(P..2:UZ* ,'6/"L&KZS8ZK]OOK.YM$>+-K(%\R-B,JV
M0>..V#^E9=I\.[.QL;&SM]6U-8;.^-_&'='_ 'G/'*GCEO<[CD]*[*B@#%L_
M#PL_%%_KBWT[O>QI') ZIL 3[N" #QD]2>OTJ+7/"T.M:G8ZB-0OK&ZM%>/?
M:2A#)&V-R'(/' Y'/Z8WZ* /+=?\+P^'=.TBPBN_$#V*WLEP]W;*9GM>'(RJ
MCNTF2Q#'Y3ZC%W1M*U#6[#4-,EU_5[S1KJT,1N;JR%O(&)'$>]06!4L"2.XP
M?3T7%&* .:U/P79:QX8M=$O+JZ9;3RS!=(56:-D&%8$# ./:HW\!:7=:1=V.
MI7%YJ,ET$$EW<RYF&S.S:0 %VDD\#DDYSFNIHH X]O *3:+>6%YKFI7DUU#]
MG-U<LKND6<E5&,#.!D\DX'H*LGP:C:GX=OCJ$V_0XFBA78N) R[&W<?W0!Q7
M3T4 <@_P^L;C3]9LKN]N9H=5N/M;XPIAGS]^,@<<!>N>GOBI+'P2UO8WL-YK
MVIW]S<V[6HNKAP7AB;J$!& 3@9)R3@>E=710!S!\%P_9/#]LFHW:QZ(RM!PA
M\PJ-HW_+_=R.,=<U9TKPO%I.N:CJ,-_=M'>S-.UHS#RED8 ,W R3A1U.!6]1
M0!CZYX<MM;ELKIIIK:^L)#):W4)&Z,D888((((QD$53N?!\5YI&I6=QJ5VUQ
MJ:K'=WBB-9'0# 4 +M"XR.G\1]:Z2B@##;PTCW^BW;7UP7TF-DB&$Q)N7:2W
MR^@[8K<HHH **** "BBB@ HHHH **** "BBB@ HHHH :O2G4U>E.H **** "
MBBB@ HHHH **** "BBB@ HHHH X!=2AL/'WBRWNDGC:YL[=X6\ERC*D3[FW
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MJE!*5&X*><9ZX]J ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &I]VG4U/NT
MZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &I]VG4U/NTZ
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF0M9M&8H"3B03%]KL.,@#UQZU/:>+=1N_&%SIGVS3X&@O?L_]FS0,LTD&?\
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MQ<Z-9RSW*[9I'C!9^,9SZX[]:DE\+:%//8S2:7;-)8J$MB4_U8'( 'UYY[T
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MJ33'L4>SE8-+&Y+>81C!8DY8\#J3T'I2OX<TJ2_M[Y[8M<V\?E0N97.Q,8(
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M3Y);2 WKW,T1"X8;V124Y[YQP*ZJ;P5I=UX47PW=M<7-A&%$1E<>9$%^Z%8
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M)8W5XPQ8##J<'+'FJ=YX&L+BRTZV@N[NU%C>_;U="C-)/R=[EE.3DGT'/TH
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MC?:R%BVY&QG.6.2V<U,/ -M)H%[I=[JVIWKWRJD]W<2AY=BG(1200HSGMW-
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MT,H"@%".PVKP<_K3K3P3&VGW5KK6JWFL&>V-J'N=JF.,]0N!U)"DL<D[1Z4
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M?3I)Y4D"A0X; .[&3VXS69'J-AIT'C/1=<"Q7=W=7$T,<@.;R*10(Q'Q\Q
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M 2#GN0?4$^M 'L>:Y_Q/KM]H?V VMG;7(O+A+1!+.8R)7^Z>%/R\'/?VK-\
M1+9OXCTV"20VEGJKQVZ.Q;RU*(Q4$]@2<4GQ#D2)/##NV%'B"UR?^^Z );[Q
MA>>'IK3_ (2328[6TN'$7VZTN3-%$YZ"3<B%0?7!%==FN"^+5Y;_ /"&2Z.
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M+:_@02O;7,11]AZ,.H(YQU^M6M1U>VTPPI*)))YV*PP0H7DD(&3@#L!U)X%
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MKS7=,\+V$M]J<\5TFM)#-*H2-9H3/@$X'"E,< ^N<T =PFEZ='')&EA:JDF
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MK;P'X:L[6&V@TQ4B@N!<Q@2OE9!T8'=GC)QZ9.*V=2-V-,NC8201W8B8PM<
MF,/CC=CG%1V%S(FF6/\ :5S:F\EB4.T38223;EMF>HX)^@H KS^&M'NKF]N+
MBS$LE]%Y%R9'9A(G9<$X&.V.E4;'P%X:TZ[L;NWTU1<V*E896=F;G^\2?FQV
MSG';%=#%-%<1B2&5)$/&Y&!'YBF7-W;6<8DNKB*!"<!I7"C/U- &=H_A?1=
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M(/W -PR1R6'3FO0J* ..T#Q%>>(I(%D\-7EA<01LMU->P[%0[<%(FSELM@]
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M#!."O&<\USND7>_QAX3U#9JLD$-O-;R;K%XH+=O+4".-=ORJ.Y)/N>./8Z*
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M4+.[GG@MKN"::W8+-''(&:(GLP!X/!Z^E9IT5KO7;>]NUB2VT[<+"WCY )4
MR-QP0,A0.@R<G.!IV]A9VDT\UM:00RW#;YGCC"M(WJQ'4_6@"Q1110 4444
M%%%% !1110 4444 %%%% !1110!'!Q"@]%%25'#_ *M?]T5)0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%&:* "BBB@ HHHH **3-+0 4444
M%%%)D>M "T44F1ZT +129'K2T %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R'_ %:_[HI]
M,C^XOT%/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *C
MGD>*!WCA:9P/EC4@%C]20*DI* ,;PIX@7Q3X=M]82U>V2<N%C=LG"L5SGWQF
MC7=8OK!X;72=*;4KZ4%_+,HBC1!C+,YSCD@  $GGTK"^$DYE^&>EE\ (9E_
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M#S?:+B4R7ER#YLA?I.XSSW..3WKLZ "BO+-9UW6+34);V'4KJ5H];2S_ -&
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M[AH ?I.KV6N:?'?Z=*9K63.R0QL@;'<;@"1[U>KF/AT@C^'>@@'.;1#^?/\
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M6MTMI=3VV&,3D GY/O$*&&2.G/H: *"_#Y5\*ZCH1U-S'?7OVQY?)&Y6WJY
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MN<G&!DUS.GRZ3>^%OAM#.;29_MOENL@5N K@J<]MQ7CUQ7L[00O*LK1(TBC
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MGDU6$0WRL]M)@E7 &3SCC&#P?I4NG^*]$U/3+G4;;4(S:VI(G>0&/RB/[P8
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MY&.<D=/PKAGO]?6'1_'HMV-U<*NGR66 !Y;@!2>_,_.>?E9?>MCQ'%'H6H>
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MY))!'<022DB(R,J'!4?-@MZBND9T4J&8 MP 3UKD_B.Y7PM$ !\^H6@/_?\
M0_TKD/'KV]_>^*O)>">:QT]%F^W,,6N5+*+=1SO8[26)&"!UZ  ]=HKRN]DB
ML],\$>-9I$D2W@AM]1D(#?)+&%WG_=9OK\U5K!KVRU'4/"=Q!L_X2+;>VBM'
MG[/$['S8SU&40$CMGZT >NTU71RP5E8J<, <X/H:YGQQ<W.A_#_49=(B>-[>
M!5C%N #$F0&9?3:N3^%8VHZ7I^DZIX3OO#$,5N]W>K#*+4 "YMFC9F9\?? P
M#N.<9]Z /0,C.,C-+7G7@CPWI\^KZSJ4L<QN+#7;I+0F9]J+L52 N<'@XY]!
MZ5Z+0 4444 %%%% !1110 4444 %%%% !1110 B]*6D%+0 4444 %%%% !11
M10 4444 %%%% !1110 &L,>&;8^)VUR2\OI7P#':R7!-O&X4KO5.@;!(_$^M
M4KOQK#;6\^H)IUQ<:/;RM%/?1,I"E6VLP3.XJIR"?8X!'-1+XDO[CQ]+HJ:=
M,]E%:)(9$EC(<2-@2')!P-I& 23D\=* -#Q%X=?7IM,D6_>U^P72W:;(PVYU
M! SGM@GBMZO+?"WB>'POH$HN-,OWT_\ M:XCEO(T!C@W3%5SDY89QD@$#/KQ
M74ZYXWM=&N[RW6T>Y:RA$UP5FC3:#R%4,P+-CG '3'.3B@#J:*XRZ^(^FQ7=
MM;V5AJ&HM=61O8#:1AA(@].<@C#9!Q@C'4BI[7QL+I]7A_L74(KG2X([B6WD
MV!W5U+#9\W)P#^/'6@#K,T9KG[7Q5!?:?H=Y:VLTJZNP$2JR9C&TL2W/0!3G
M&><#O6)X?\0^'M+T'4;O3K2^BC;6'MG@N&7>]TY4$ EL!<D=2,8- '=T5SDO
MC"WL]*NKW4;"\LWMITMC;R>66ED8*5$9#;6!W#DD=#G&*=X=\7V7B&[N[%8G
MMM0M-IFMWD1_E89#*R,58<]CD'K0!T-%([*B,['"J,DGL*YJP\;65_J6G6JV
M=W'#J8D-C=,%,<^P$GHQ*\#(W <?E0!MV^FVMM?7-[&C&YN-HDD=V8X7.%&3
M\H&3P,#DU;KBY?B;I$5K?70L-5>WL+MK6ZE6V&V(K@%B=W3)QZ\=.F=;_A*[
M7_A+(O#WV.[\^:W^TQ7&$\EX^Y!W;CSQC&?PYH WJ*HZ9JBZHMRR6\T2P7#V
M^Z7;B0H<%EVL>,Y'.#P>*S+_ ,865B+^3[)?7%MIS;+RX@B#)"< D<D,V 03
MM!QWH Z&BN4U3X@Z1I>H167V>_O)9K47</V.W,HDC/=<'GC)^@-;.H:[9:7H
M3:Q>&2.V6-7(*'?EL!5V_P!XD@8]30!I45A67B"WU>ZU'2GL[VSN[6%6EBGV
MJ=K@X*M&Q'8]#D5P^G74W_"MO TYN9UEEU2UC8K*PWAICD-S\PP.^: /5:*@
MO+RWT^RFO+N98;>%"\DC'A5'4UDVOBJSGU2WTZXM;RQN+J,RVHNHPHG4==I!
M/S <[3@X[4 ;M%>;:>Y\:ZWKL-Y#K=E)%.L5K-&YB^QA8U/9L!R6.>#D$=JW
M]6\27>E^*M&T:/3[N>*Y25I)@J-Y@11T^8'@LI)('MF@#JJ*\ST7Q9:^'9?%
M4E^-2NUAUB4,T:/.8(0J8+,3\J@[L#/K@<5V5UXFM(7ACM8+K4)I;?[4L=F@
M8B(]&.2 ,]AG)P<#B@#:HJCH^L6.NZ5!J6G3":UG7*-C'?!!'8@@@BO.].UF
MWUC7-9T?5M5O],\2I<RI99N6B01D_N]B [&XQG().>_8 ]2HKSW5]3N-"\6^
M$WU"ZNR9+"=+F")V<32JJ 8C'#-N8]!_*N@A\;:+)H$VL/++#!#.;:2.6(K*
MLP('E[.N[D<>] '0FE%<^?&6DI::K/,;F$Z5M^V1/;L9(@PW*=H!R".<]*AM
M_'FB7<,\D#73B)HD51;.#,T@)01@CYL[3R..^<<T =-17/P^,M)EL[J9S/#-
M:.D<]I+"1.CN0$79W+$@ C(.>M:&E:Q!JRS^5%<0R6[B.6*XB*.C%0PX[\$'
MB@"]L7?OVC<!C=CG%.K&C\3Z=+>:E9QBY:YTX*UQ%]G<-M).&7(^8<$\9Z4V
M/Q/I=[I%EJ-I)//:7\H@@DBA8,6)(S@@' P><<8S0!M48KSKPIXVTW3]/:SU
M/4;N>4ZE<0K-*LDHC7SF6,228(7/ &3^E=(MQ8M\0&@75;TWPL-S:?R( @<?
MO.F-V6 X- &^\:.I#HK ]B,US_C#0+OQ!H(TRQEMK?,T<A:9"P&QPX  QU(%
M36WB_1KR^@LXKB3=<LZ6\K0LL4S)]X(Y&UN_0\X.*X[P3XSL].T[4X]<U.ZD
MD75YHA-*DDHC7<JH'< A 3TS@=: /2H(Q'$!Y<:,1E@@P,T"&)96E6-!(W#.
M%&3CU-4];U5-$T6[U*2":=+>-I#'"A9FP,_@/?H*X#6?%DUPG@C51<W5C%=7
M,?VU-LD4;@QAR,,!O7/0C(/O0!Z;Y:>8'V+O P&QSCT_2E*J2"0"1R#CI6)I
MGB[1M4L+V\BN6BCLFVW*W$9B>+C(W*W(R.GK4^G>(M.U*^DL8GEBO$C$QM[B
M%HI#&>C!6 )&>/8]: -4U&L4:,61%4MU(&,UQ/C/Q(-+\3:3IM_?W.EZ1=12
M&2]A &^7("QER#L &3D>H[9HU5=:L/"_BFY&M3SVJ67GZ9=(R;UVHS$;E'/(
M')Z@]>] '7-IML(I1;PPV\LB%/-2)<C/U&#]#2Z9IT&DZ?%96V[RX\\N<LQ)
M)))]2236%X;\7Z1?QZ;I8OVEU)[1'PT;XD(0%B'(VL1WP3SFKD7B_19M1CLD
MN7WS2F&&4PN(I9!G<BR8VDC:>AH V]H+!L#(& ::(8@K*(TVL26&T8)/<U@M
MXY\-+J0TXZK$+PW*V@AV/N\T]%Z>XYZ>]36GBS1K^_BM(+IM\P)@=XF2.?'7
MRW( ?'L30!JFV@("^1'@=!L'%*UM \ZSM!&9E&!(5&X?C7GOACQI;Z8NN0>)
M-6D,T6MSV\)E4N4B&P)NVC"J3GDX!.:[34M?T[2IEAN9)6F9#((H+>29]H_B
M*HI('N>* +LEK;S/OE@B=MI7<R G!ZCZ5"^DZ;+&(Y-/M'126"M"I )ZG&/8
M5S'C36W/@A-9T/5&53/;E);<J1(K2JI!R#V)Z8.1]16]JNNZ=I>8;NZDCE:)
MI,0PM*Z(.KD*K8 ]2,4 79;"SGECEEM())(O]6[Q@E/H>U!L;0W'V@VL'GY#
M>9Y8W9 P#GKG'%<KX(\1++X!TW4M4O9)9;F28*[@O)*?-? "J,D[1T X ]!6
MROBS06M!<C4X!$;@6I+94K+D#8P(RIY'!Q0!LTR.&.$,(HU0,Q8A0!EB<D_4
MFJ.DZ[IFNV<MWIEY'<V\4K1/(F<!EZCGZ@YZ'-9B>/O"TGE;-8A822^2I56(
M#DX )Q\N3TSC- '0"WA$YG$,?G$8,FT;L>F:8MC:+=M=K:P"Y88,PC&\_P#
MNM4]2\0Z7I,IBO+DK(L1F9$B>0I&."[!0=J^YP*CE\3Z/#<:= ]X"^I8^QE(
MW99L^C %?S- %U=,L%8LMC; F3S<B)?O_P![IUY/-1?V)I.VX7^R[+;<D&<?
M9TQ*0<_-Q\W///>HH/$6E7#Z@L5R2VGY^U Q./*P,\Y'H,\=JO6MW!>6<5W
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MD))=2+I5BKW8(N6%N@,V3D[SCYN?6HKKQ+HMDT8N=4M(O,174M(,;6^ZQ/0
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M,,-E=:';)I\TO^K9<?O%R>-Q8].X ]!7.Z=<Z=)\"]6@,MO\M\RB,D#:3,"
M!V^7)^@->WR013A1+$D@5@RAU!P1T(]Z&ABD"AXT8*VX94'!]?K0!QESJ-A:
M?%FVDN;J&/[1HHBMV9A^\8SYVKZD\=*Y6:=U\*>.?[.V2K%K[2W$,+?,UO\
MNM^,=B P/J U>O&*,NKF-2R?=)'*_2A8HT9F5%5FZD#!- '#W\FEZGXV\,W.
MDSP2F.&=KIH"-OV0Q\!\=MY7 /O7!Z?#I,/P1GO'AM!<KJ("387>K"X7&#U&
M%S^&:]QAM+:V5U@MXHA(=SA$"[CZG'4TU[&SDB\I[6!H\[MC1@C/KCUH IV_
MB'2KK7I]$AO%?4;>)9I(0IX0XP<XP?O#H>XK4K.AT>WBUEM3!/F^0+>- JA8
MTX) P,G)4=2>@QCOHT %%%% !1110 4444 %%%% !1110 4444 (.E+2"EH
M**** "BBB@ HHHH **** "BBB@ HHHH ***Q_P#A*M$^V-:M?HDJ3_9FWHRJ
M)>R;B,;CV&>>U &Q1533]2M-5M3<V<ADA$CQ[BC+\R,588('0@C\*MYH **@
MDNX8KN"V<L)9PQ0!20=N,\]!U[TZ:XCMU5I20&=4!"D\L<#I[F@"6BC-&: "
MBLT:_I1OOL0O8C<99=@/4J,L,],@ Y';%6[2\M[^TCNK6598)5W(Z]&% $]%
M&:CGN(K6WEN)Y%CAB0N[L<!5 R2?PH DHID4T<\*31,&CD4,K#N#R#4-UJ%I
M9R6\=S.D3W$GE0JQY=O04 6:*KO>VT=]%9/,JW,R,\<9ZLJXW$?3(_.K&: "
MBC-16]S!=P+/;3)-"V=KQMN4X.."* ):*** "BBB@ HHHH **I:AJ^F:4(SJ
M.H6EF),A#<3+'NQUQDC-2V=_9ZC;+<V-U!<P-D"6"0.IQ[CB@"Q14%U>6MC;
MM<7ES#;PKC,DSA%&>G)XJ5)$DC5T8,C %64Y!![B@!U%%% !139)(XDWR.J+
MD#+' R3@?K5:]U73M-,8O[^UM?,SL\^94W8ZXR>>H_.@"W13(I8YXEEAD62-
MQE70Y##U!%+O02",LN\C(7/)'K^HH =14,5W;332PQ7$4DL6!(B."R9]1VIC
MZC8Q2R127MNDD0!D1I5!3/3(SQF@"S14 O+4S)"+F$RN-RH)!N8=<@=Z&O;5
M+Q+1KF$7+J66$R#>P'4A>I% $]%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ""
MEI!2T %%%% !1110 4444 %%%% !1110 4444 %><6NCMXBUSQ-I<UWY&G)J
MT5X\0A_>RX1.0Y. FZ/'"Y^4C/6O1Z* //K"T7SXUMM7U"-]3U+4$9$F.V-=
MTS!D7&%Y"-GON[@U"FJZK<^&M0NKR]FTZ6P5-,>5@[H\RR /+\IW!6RHW=5R
MQ[5Z%<P"ZM9(#)+&)%*[XG*NON".AIEE8V^GVJV]NA5 2Q).69B<EF)Y))))
M)ZT >:KKFH)9VSZ?/>FZ%CJ1$+SM<+(Z."C(6SY@'S;,Y.!BKT&KPI9P76DZ
MWJ,]M<:E9*?M63M+L!)'N?G[HW%1@+GC'2O1** /$=4\;3PIJ44.OO#+)974
M@5IV$R3I(IC4JPQ&Q!<;%[#GFO2_#4JIJ.L:>-5GOS;RQ/\ OY0[H'C#=@/E
M/)'Z5T=% 'F6B75M!KEC_9]Y%?Z9/>S2#3[C;]JTR4B0O)D$_)DOG=TW#!.:
MRM!U.71_#6F$:Y<^1=Z++,RF1,0,DL2*4X&T8=\DYZ$]J]AP/2F^5'C'EKC&
M.G:@#RNP\17FI2VFE'Q$8Y#K;6Q-I<QR/]G^S[U^=ERP\S@-@9SCTQ(VM7=P
M-2AO-?*7,27\%QI<L(W&-58QOD8V@*%._&&W8[UZD% )( &>M)Y:"0R!%WD8
M+8Y(H \J_MK4-&$=JFLW$UG/I^GW#3/Y9-K')*T<C1X4#:%"\G.,Y)J[/JET
M;Z.!+\WMG!X@MX;*<R*S2*8BSIN'WMI8C)R?7I7I) (((R#VI$BCC0(B*J+T
M4# % 'D$'B(W.IV>K6VJ&[UM-(U"5]/E<'[/./+(B"<%>A'N(\^IJ_IVM:C-
M;6(7Q8DUO?ZA!%YUOL=HP\4A:/>Z$!BR*=H&5SCN*]0$:!MP10Q[@<TGE1@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 (.]+2#O2T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 @[TM%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 (.12T#I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !10** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 04M%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
<4 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>exhibit1011-physiciansha003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M40[<+C QZ8K#L? UO8ZO8:E_:^K7%Q9PF &><'S(^,*V .!M'3&>^:ZO-&:
M.'?X8:6UK]C&I:HEDET+F"V6<".!MVXA1CU)ZYQGCO6J?"%NOB&^UFWU"^MI
MKZ)$N$B==KLJE58@J>0">.G?%='1F@#E?^$'MUT?2=,35M12#2YUGMR/*W97
M[H8^7R!D_7/.:ED\'PKJ-_=V.I7U@FH<W<%N4V2-C!8;E.UCW(Z_7FM^[NH;
M&RGNYVVPP1M+(WHJC)/Y"L?2-=U#4KFV\_17M[.ZM?M,-RLXD Z81Q@;6(.>
M"1UYH CD\)0#4]&N[.\N+./28S%;VT:H8]C !@<J3R !U[<8-2W/AQI_$,VL
MQ:G<P3R61LPB(A5%SN##(SN#'//'M6O=7<%C;/<W,JQ0H,L[=!VK)'B1#XV;
MPR;602BQ^VB<L-K+O"8QUSG/Y4 4=&\&?V'816-IJ]V+=;A;B0&./?,X<,=[
M;<G. ">N.*J0?#FVM;VX^SZQJ,6E7%Q]HETM77R6;.2O3(4GJ!U'!KM:* .<
MT33M2MO$VMWD]Y>R6%PR^3#<N"JL,Y,8!.U,$#L2<\=":VJ^!H=2UJ_U"/5+
MRU34K<6]]!$$VSJ%*KR1E>"<XZUU9(4$D@ <DFN9TCQ7<ZQ=64D.B7 TF^5V
M@OA(&QMZ>8@'R!L'')[=#T .1OM+CTGQ5X)T*UUUUNK&"YB^T,B%U!1!&K+C
M&#@@ \^^>:M>.M(L]$\":JCWADU#4[R":6>0J'E82Q_= Z!5' [ 5Z710!S=
MGH$\UR-4N]:.H7 @:.SE\E5CB1^2P53AF(Q\WH. ,FF6'@JSM_!G_"+WEQ)>
MV04HC.H5T&<C!'<'D'Z5T]% &#9>''CO;*\U'4I]0FL8REL9$5 I8;6<[1\S
M$<9]">.:=_PC%C_PF'_"2X/VS[+]GQVZ_>^N./I6Y6;)J5PGB"'3AIMP]M)
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M?RRA"GIM.>I!([#O3O\ A$M:L[?PLUA?:>;K1K=[60S0N$>-T52P ;.X;!W
M.3TZ5VU% '$7/@1]3N/%B7\D"VFN"+9Y.=\31#"L01@G."?ICWJ^F@:M?3:.
M=8O+:1-+?SAY"L&N9@A57;/W<!B<#.2?:NHHH \T?X?ZW+\/]9\.R7&GBXU"
M^-T)5D?8@+JY'W<]5Q^.>W/H\ D%O&)@HEVC>$.5!QS@G&16+8>+]*U#4([2
M$W $^X6UP\)6&Y*]1&_1OZ]LUO4 %%%% !1110 4444 %%%% !1110 4444
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MD^?]H72BX,*ONW#WV@X./4<YH HOK^L1>"_%EV-2+W>DWL\5O.8H\E8U4@,
MN#U()P*F@AO)?BC;E]6N6_XDHG\O;'M ,JAE V\!MHR>O'7BK5W\/K>[BUFV
M&KZC%8ZK*T\UK&R!1(V,L#MW8XZ9QZU=D\)%O$ECK,6L7L4EO:K:2(JQ_P"D
M1JQ;#';QDGG '3M0!S-GXVU6/2M8%S/!)?)XB.C63F+"#+*H)4'G W-U[8K9
MEU+6='\66NCSWPO+?4[69[6>:%0\,T:@D$)M#)@@]CVS3QX"MIM.UBROKV6=
M-2O#?&2-1$\$W&&0CIC:,?KG-7X_#DQG^VW>I276HQ6[V]M</$JK"& W-L&
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M>$D@JPQMW J1D#OG'%6[GP3#-9Z>5U*[75+"9KB+47VO(TC##;QC!4C QQP
M.U68/#4BQZI/<7YFU'4HA#+<>3M6- " J)G@#<3R2<G)STH J_#FVFM_ NCM
M)=O,DEG$R(R*!&"N< @9/7OFNKKC+[0-6TSP?I^CZ1JEV+NT=5MI88@N\*IP
MLI/ 3ID]\ 8)//9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVWYM@8')']TBJ+WUU=Z[XEBM=9BU"_O=""V4MK!Y:N07RD>"<XY&[)Y.,\4
M>JV>N:5J-S);V6HVMQ-'DLD4H8C!P>GH>*(M<TF?47TZ+4[-[Y"0UNLZF0$=
M?ESFN!\.>(/#NNV7A^WTFV>XUNPM#$J(K1_8\Q;7+' 7&0 /4D?49WA6ZT/4
M-+T#3[J\U*36]/NHU.G@!7AF4X9S\N=@!8DD\C(ZT >OU4O=4T_31&;^^MK4
M2'"&>54W'T&3S5NO-_&&H:>?%-]:/=VUI<KI!21KT!UDC9CA(DR,N3P2<]@
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M!0!ZK)J%M'?P6)E!N9T:1$')VKC+?3) _&L^'4]0MH=9N]9LH[6SLW=[=XY
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M7$-G;M*GV8@[2RL9&.ULG*G@GZ5JG2/[+\?Z58B^OYX]3L+D7OFW3GS2FW!
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MGBG%K.TR0- 9&NI-TB-UWG=EO;/3MT&-"/PMHT?AUM ^Q;]+*[/L\LKN .N
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MGE02J&61MIPI!X(/I47A[P[9^&['[-:R7$S-C?/<RF223'3)/89Z# ]N:UZ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "FNQ520,GTIU% "*25!(Q2T44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %8VM^(;;1;W3;6>6WC>^E**UQ+Y:@#&<'!RWS  =\]>*V:KW5
MA9WQA-W:PSF&021>:@;8XZ,,]#[T <U;^+KG53-'HMG;74\=^UJZ/<E/)10V
M9)<*2N2APN#GCZ"'3O%NNZB=:CAT&SDETF=H)%6_<>:P&<)^ZY_'%=7;V-I:
M2SRVUK##)</OF:- ID;U8CJ:X[X?.7U?QF6.3_;<H_   4 :UEXDO;OQ7)HS
M:9%%&EI'=F8W1WA7) 4ILX;(.1G\:9-XFO(_'4?AI=.@826AO%N3=$?(&VX*
M^7US[]/RK%:.XN/C/?007TUH#HL;LT2HQ;$I 'SJ?4TEO;O#\;(XY[R:[D70
M&</*J*1F<#'R*!Z]N] &SI'B/5]:;41;:19Q_8;V2RD\Z_8%G0 DC$1X^85M
M:1>W&H:<EQ=64EE.6='@=MQ4JQ7(.!D'&0>X(KAO"FD7EZWBT0:]?V6=<ND
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MFP,\,3T[F@#4HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAVTE['9B\;;J!V["VW&3&/FS^'O0!:C\)E[VUFU+6=0U**SE$UM!<"(*D@!
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M"Z>-88V6W\E8D!)("ACR3C)_V1Z5/J^OV&AR6"7LNQKZY6UA]W;IGV_Q%:E
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M>']%M9UGM](L(9E!"R1VR*P!&#@@9Y!Q4MEI&F::S-8:=:6K/]XP0JA;ZX%
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MYSO;/ICWJW;Q7<OQDUP6ETENPTV#<6B\S(S]175:OX8TS6[RTN[U;DSVC^9
MT=S(@1O4 -C/OBHO^$0TS^V9]662^2^G0))*EY(I91T& <8% %S2FEMT-A?7
MR7-^I>9B!@^6TC[#CL,<?\!K2K-TO0[+2);F:W\]Y[DJ99KB=Y78+G:-S$G
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M>R\-M=_89[IDNI3-*DKAE\P]6' QG\J -RBBB@ HHHH **** "BBB@ HHHH
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MN%K:#[,\T6Y"RKAPK=,COCT]J70X=+T#XJZZL$<%E9#3X@-HVIN!RP'8GVH
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M?N98P\R@NC%0K*,\@X.,5#IZ-+>>+_&E^ITZQO[7[-:+='RVD14VAR#TW$#
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MO)QW]:L?#V^_M/P[/?&%X#<:A=2&*3[R$RL2I]QTJEX/GW^/_',.]2BW-LP
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8%!)]SBK"6UO%*TL<$22-G+J@!/XUR.L:9XDTSP_K+V7B*[F>*V6>SDF2)I
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M8O\ Z2RC.<^;\F?QQ7H*DLH)4J2,X/44 +1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6!XD-YY^DFUTRZO1#>
M+-(86C7:H5E_C89^\#@5OU5O-2L=/"F]O;:V#?=\Z54S],F@#D-/\&W%EXZO
M]1R3HSN+^"U!'%V5*L<?0D^F6'I6?IND:S9Z%XXL9='N?.U6[NKBTVR1$.LP
MVJ"=_!!Y.>@]:[JVUO2;V<06NIV4\S9(CBN$9CCV!INH:[I&DRQQ:CJ=G:22
M#*+/,J%OH">: .;T4:KIO@O3M,N?"MS<W=G;1J$::V,9D0#:<F3CD YQD5%=
M0Z_!XTTC5I-%GO(X=-:VNI+:2)?WKE6)56<$C*XYQU[UV-W?V=A")KR[@MHB
M<!YI BD_4FFV>I6&H FRO;:Y ZF&57Q^1H Y*;2-8\5^*-+U'4[$Z7IFDRF>
M&"257FN)>,%@A*JH[<D_GQ'INBWD_CGQ=+J&ESII>LP0PI*S1X94B*." Q(S
MGCC\J[RJ]Y?6>GQ++>W<%M&S;0\T@0$^F3WXH XOPJ->\(:6="O](NM1@M2P
ML[NR:-A)'DD*P9E*MSCT]^.;FNRZ[>:.EE+ITX_M"X"SBU*L;:VR-ZLVX9<C
M=]T'&X^F3T=IJVFW[E+/4+2X9>JPS*Y'Y&KE 'G?C/PD]K::7J/AZVU"ZU6P
MO(WMXWO)95V_Q*?,<A5('7Z"I/$QU'5M7\*ZC:Z)J#)8S-=74915:-2N-O+
M,V>PS7?)+'(7".K%&VL%.=IQG!]#@C\ZBEO+6%RDMS#&X_A:0 T 9,&K:IJ&
MIV26^D75I8_.]S/=A%. "%15#$Y+$') &![U:\1K+)X<U&*""2>:6VDB2.,
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MSHM]J5JUSHL<UMYGF+B2$ JC@]".B_EZU9^'WC#PYIWP\TJ"[UJRBN((&\R
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MZY^P7K'_ %D#20D*QZ;D$9S[$5=L[.7QB=8U2"[T_P"PWRMI\0D@:<F!"PW
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MSU)).2?P H T:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)?$Y0WPWUP, ?W //^\*)+WQ/9ZGX>LY;C39WF&W4$CC?<V <R)V51CJ<9)
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M&LXO&_P^TY;>.6");J+;*H;<B0KC=GKC%)XXTZW\*W6D>)=#ACLIQ?Q6]U%
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M@3R?L8CV1@;"T1+X],GKZU9O%L],\?ZUJWV*%I;708[G(0!BP>;)SZD*!GT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME!A*V"HW'.> QQ[X/85KUGZUK5EH.G->WTA6/<$1%&YY'/1%'=CV% &7XO\
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MVROM-N;Y-]I]K1-LW&<*R,P!]C@\CUH U=:T^35=&O-/BN!;FYB:$RF/?M#
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M1"85=4O5:25E+NS9$951D;N,GM73WOB+3K"_>RG:Y:=(1.XAM99@B$D DHI
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M)97%_"L-W+"KRQJ" K$<X!Y'T/([U>K$?Q?H4>BOK!OP=/1_+>=8G94;.,'
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M/I+:;8*JF)9&C+S2,278[&8#''?DDFK<>MZ3-(L<6J64CL<*JW"$D^PS5_-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRAV"D<;L#@^U<##HRZ;\3&\.1./[#OU_MAK0#@2J2I7_ '"VUL>JJ.F<^GT
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M&_RI;J0K&/OMY\@"K[D\#ZB@#I[3Q#87OB&_T2&4F\L8XY)E[8?) 'KCC/\
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MZY&/2B\U_6HO'R>'H1IP@GLC=PR2)(7X8*5.#CU.?2@#6L/#.G:=JUSJEO\
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MXA^[&R2,D.C9;@C'7D'L:OZ[XG30+_3;6;3[N<:A,+>%X"F/,.< AF'IUZ4
M8MUX$U+4?"8\-W_B,7%D"@$IL\3[5(*KNWX.,#DKFM6YT'6M0LWM+[Q C02,
MOF""R$9=,_,A)8]1QD8ZTY_%:+XCGT*+2=0FO(8%N#L: *T9.-PW2 ]>.E7-
M-UQ-1U&\L&LKJTN;18W=+C9RKYP049@?NF@"EI?AF;3O%>JZZ^H+*VI)&LL
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MV $0*\G'.2,#.<8QWI(O&$$BV,S:5JD=I?2)';W+PKL;><*2 Q90<C[P'44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8V,O&1W'J/0UW]EIFGZ:'%C8VUJ'^]Y$2IN^N!S3&T72GN_M;:;9FYWB3SC
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **PH/$4DWC.X
M\/-I[QB&S%U]H:4'>"^T *,\<-R2#QTYK8NIQ:VDUP8Y)!$A<I$NYVP,X4=S
M[4 2T5S6G^*+R7Q!%H^JZ)+ITUQ T]L_GK*L@7&Y3M^ZPW#U'OTSTM !1110
M 44A.!63X@\06OA^TAEG#22W$@AMX(^7ED/10/YGM0!K9&<9YHW#.*Y*?Q5=
MZ+);RZ]IJ6EE<2"/SXI/,$+M@*'QV)R,].*N6WB!YO&EWH3VZJD-JMR)@_+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ]?W1N=2MR%C(C$64R< #GGUI%T2[31[S3W\,^(+@W<?ERW,VH1/,5!SM#=
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MSHQ[FEHH :4![G\Z:(4#%L L>^.?SJ2B@ HHHH **** "BBB@ HHHH ****
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M9)/X4 2T5AZ5XGAU2_2T&GW]OYMN+F"::(>7-&>A# G!Y!VM@^U;E !1110
M4444 %%%(3Q0 M%-C=)(UD1E9& *LIR"#W!IU !1110 5A>,M)O->\*WVE6/
MD":Z3R]\[E50>O"G/3I^M;M% &1<QZ[_ ,(VL=@=/BUA40#S2[P9!&[H V"
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M ,]CGJ,7[]-9U'6O"^I'0YXUM)Y9+B/SXB8U>-HQGYADC<"0,\>IXKL<48H
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M&0&4]?Y&O0:* /+\-KWP_P!%\/Q6%[::O;RVT90P,AM&B9=TI8C &T$@YYR
M*]0HI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#E-;O9[[Q?9>&8KV:QBDLY+R6:W8+))A@@C4D''4L2.?
ME[<USVH7FHS^'?'.@WM[/+_8]JYCO-JAIXY(&<))Q@D @$C!Z=*[;5O#UIJU
MY9WS2SVU]9D^3=6[ .H/!4Y!!4^A!JO+X3M)-&U#3OM=X/[1+&\N=ZF6;<NT
M@DJ0!MP, # '&* )/"=M);>%]-62XFF+6L3?O=N4^0?*, <?7)KB?$7B#6K.
MZU"]MM0GDDL]2B@2.U16M4A8JNR7< 3(2QSM)Q\O2O0])T]M+TZ*R-Y<7:Q
M*DEP$W!0, ?(JCC'IFN<F^'.F3K?QG4=52"\N_MIA2X 2*8L&+*,<Y('#9 [
M 'F@"A<?\)%J7BSQ'I]MXBEM+2SMX)8MEO&71G#D*"1]WY><Y)XY'-9UUXBU
MQ?"/A?Q7+J$L5FYA75HXXTP8RV/,&5R.<9QU![5V%OX4BM+F^NH=4U#[3>6Z
M6\DDCHYP@PIY7DC)Y.<Y.:PM1MQHFAQ^"+*PU/5/MEI)#;S21H8H%QC]XXP
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MK%1DG.T@<#K69::U/I?Q#\86-K'%-K-_/:BR@D;"D"')=CG[H7!..3V%7)O
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MAIO]GJLDK>:5RIW?=QD;!QGGGD5T>IPSW&E7<%KY?GRQ,B>8Q502,9) /\J
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MNX[R$17,2S1;W"EE89!P:YS3-8UN\\;Z]I]U8PM8VL,*K''/D@,LC9P0 2W
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MTC2;'38YK:=)9<FY"&;:H!!X. NX'U) Z=]3P;IUUI_ANV.HN9-2N%$UW(P
M9G(  ./10J_A5/Q%IFL/XMT+6-*M;>Y6UCN(95FF\O;Y@7#=#D#;R!S0!RVD
M:M+X2O/&<EOHDUY%!J33S?9B%6.+8IZGJ0#G:.F#[9Z?6/'VGZ9+%%%Y$LCV
M@O#Y]TMN!&?N\MU8\\ =N<<9H'0=:33/&D2VD1EUAW:U F'1XQ'\V>F,9[U6
M.@^)=,U33M8TW3K.[8Z;'8WEE<SA2K1YVLC@$8Y_SV .Q\/:_9^)M"MM7L-X
MMYP<+(,,I!((/N"#7EXN](M/$.K:7X]L7@O[RYD:TU:0G9Y1^XL<G6,*/3CU
MKU;2(KV+38UU%H3=$LT@A'R)DDA5X&0!@9/7&:Y?6-.UG4M"O]'U'0K?4C,\
MPMKC[2NU%9FV,VX!E*@C[H;I0!C^(U&D>,OA_N@DO;J.&XC8P#<TS+" N,G^
M\Q.2<#))-=$OCRS&C:C>RV%W%<6%T+.:T(5G\TD!1E25P=PYSZUE+X4U2QUS
MP+Y:-=V^B6\T5U<[U&2\808!.2 1^6.IJK/H?BA8?$\FGZ?]F>^U**YCC2Z5
M#/"  Z[P?D9MN<\?>ZT ;T?C?9#KJWFDW$-WHL*SW$$<J2;HR"V5;(' 4Y!P
M>.]0VWQ#MYK)+J?2[NTBN%A^QR7)5$N6D!.%8G@+@DD]N>XSSUMX7UZWD\3+
M;>&[.RMM6TQ;>**WND/EOM=.>!N.7#,>. <;CQ6OK/A[7+KPAX>^PP0)JVC/
M#+]FG<,DI1"A7</7/'3\* ,CQEXMT_7O!6MQ[/*NM)N[;SE$@D !E7#JR\,"
MNX?IBNPT_P 71W.M7.EWNG76G2Q6OVV-KC;B2 -M+?*3M()'!YYKG/%&D>)O
M%'@;4+=M(AL[J\\E(K!+A'\K9)O9WDPH)( &!G&!ZG%_5M U+5?&Z71MI(M-
MGT:73YY1(F59R3TW9...G?VYH T5\90C[#<W%A-;Z7?R+%;7KNN&9L[-R=5#
M8X)]1D"L/2+BVTSXG^-[JX=8;:&UM997/11L)8_SJ0^'M9U?POIGAK5K01BS
MFA$MZLJLDT41X*C._<P Z@8R3GM4&H^%-3U?7_&0-I);6NK6$<,%R\J%3)&,
M#A26"GCJ.@/L* (=<U:2_P#&/@R>ZT5[>VFNV>WN))%8N#&P4,@Y4Y*MST^N
M16U??$?2=/D>25#]ACN_LDEP)H\JP8J6V;MQ0$8)Q[@$<UB2:7XOU.Y\*?:]
M"@M_['N T\HO4*R *!N4#D XZ=?YU-H^D^*M#EN/#T6F65SILDLCVVK22K^X
M1R6PT1!+L"3QP/?% &LOCY9O$%UH]OH.J32VEQ##.Z(K+&LF<.2"?EQ@^N"3
MQ@U;\>MIJ^$;O^U[*YN[ LGFQV[A6^^-ISN'&['2J_AG2]2LO%_B:^O+)HK?
M4)(6@D\Q#D1ILY .03UZ59\>6%_JGA"\L-,M#=74Y0*GF*@ #AB26('0?J*
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M]["9P#QD],XK*O8+)+?1O#UEJMUJ[QWDX%K+-A;@*I8K)(?X$W@<!LD8QD<
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M3H8[B.;4'G:Y9ERC1YB4*W4X& 1V&*Z+Q)_:G_"/7@T7:=0* 0AF"YY&0">
M<9P3WQ0 WQ-K\/AC0+G5[BWFGAMP-R0XW<D =2.,D5IPR":".4 @.H8 ]LBO
M)=5U6#5O 'BZ#S]1,T-O&9--U+(FM&#<G<?O*<!AUZ>^*W[*;5-#\>:5I<^K
MSWMK=:=++.)@JI&R$89 !\H[8R>* ._HKRS2-6U>/Q!X:E.IWMY%J4LT-W,S
M VDY",085.&4 C[VT ^]&GZOX@CTCQ!XANM:N98M%O;R*.R>!/WH52%$A4#H
MQ4Y &,'UX /49&*1LX1G(&=J]3[#-9OA[7;7Q+HT.J622I;RLZJ)0 WRN5/
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M[5.=WW<>@QFI;CP]K*:YKUU9S6)M-5A0%92X=66(Q[<@$ <AL\GC&.<CKJ*
M/.E\#ZTOAKPII@?3_-T2]6ZD<S/MDV$E5'R<9W')[8[YX]%HHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI$9?LT9SNDV#KC _/OT(!T54M5U:QT33I;_49Q!:Q<O(5)Q^ !-<N_B'4/\
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M+';S+<R&Y+9?]R'V* >#@]2?3CGC9U;QAJ2Z=9WUHMI86EQI8OEGO%\T22D
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MBS3*TJR[HF#%6!7C)VD8YYJM8?$.WN]6^P26:!Y;9[BV-M=I/O"J6*/MX1\
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M#9I=1SK*6+AF*X*X&.0>YH W:**@NKVWL_)\^0(9I5BC&,EG/0 #\_8 GH*
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M  [HNE3M/I^DV5K*WWGA@5&/X@4 <%)X'\4FW6$3Z/(8-734$N)1)YUP!(6
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M3>0;8&.ZE $9_A W8'.3D#.23UYH \Q6)M4T?P*-1FDN9AK<EL9I7)>2.-Y
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5=+U&XDALUO;F.-$#6\;9QN#,,GAN%ST-.N_&VF6MWIULD-[<R:C;_:+3[/
M6\U< @=L'D=< =R* .DHKAM<\3:'K7P_U*\U"UU--/CE-M=P*@2>)U8<$;L#
MG;W[UKWWBFWT:VNY)--U!K*PC0RW($83!4$8+."QP0.!UXH Z*BN:?QG;>59
M>1INHSW-W:M>):)$HE$*X^8@L!SD8&<G/2J-WXY+W?ALZ;IUU<V6K$OYRA.5
M$;ML )SN! )Z  =Z .SHKE+&[TF'QKKCB74$O$M8I;H7!(@1 " 4!^AR1QQ]
M:M0>,;"6>Q6:"[M8-0(%E<7$86.<GH!R2I(Y 8+F@#H:*Y&X^(FCVW]I[[;4
MBNFS>5=,MHQ"#CYO]WGOSWQCFNJ@FCN8(YX7#Q2*'1AT((R#0!)17-GQMI:&
M*66.[BL)9O(COY(<0.^<#YLY )& Q 4^M86K7QUSXCOX;NK6_P#L*:8SXADV
M?.\@42\,.%&<'G&>E 'H.:*XGQS92:9\,KL1:A?FYL+<&*[^TLDK,"!EF4C=
MGWK!CU:YT[Q3X/MM)UBYO1J,.-0LY;DW 50@_>?,24.=W0@?+]: /5**Y.T^
M(F@WMT88C=A5EEADF>V=8XVC0NVXD<<*>#SQTJ[IOB_3]3O[6T2&[A>]M_M-
MHTT6%N(_[RD$XX(.&P<$<4 ;]%<]_P )IH_GVZ^9*;>XNOL<-V(\PR3<_(&[
M\@C/3(/-9VF^*I-;?Q);75A?6EM92/ )(ES(JA 2?ER=QSD  ]J .RHKE=%U
MC2-)\):0+:ZOKV*Y3;9+-F2YN.K8QQT'T  YQ5NV\9:1=:9+>Q23$Q7/V-[?
MRCYHGSCR]O=OIQ[X!H WZ*Y^#QCIDUEJD[K<P3:6N^[M)8L31C;N!VC.01T(
M.*U["^AU+3[>^M]WDW$:R)O4J<$9&0>E %FBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@*DO'S''!&/QS3YM!\4Z7K=CKFC164TDEA%9W]A/,5!*9PZOC\.GX<\>@T4
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MS;17=M);S!C'(-K!6*DCZ@@TL,,5M D$$:1Q1J%1$& H'0 4 24444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:P[$=C[&O,/%-WI<^CP:OI$=W%H@UM+N^O;/<#(2A#2J",_*VT9QC(XYKI?
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M8=<U.R2[75;BSMP2L/FB-@HVJ3D_F>M=#?:SI>F211W^HVEJ\IQ&L\RH6[<
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MSE9"6&X%B>" <_05W*.D\0>-U>-QE61L@CU!% "3M*EO*T,8DE"$HA;:&;'
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M%.R&:.,NJDXX+$#[W7@\UZ%) OA7P;=)9/-,+"TEDB-PYD8X#, 3U/H/; H
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M/;:@Q6WECA=E8C.1G'!X/!YXZ5IZ+K%KKVE1:C9^8()2P E0HP*L5.0>G(-
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MA>WT^TA:%2L31PJI0'DA<#@'VK)T'QII6N:#)JWG+;PQ$^;YF0$!8A220,Y
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M&CM&SH55UX*DCJ*EHH \F\,6I2WLO#FK>"9GU2S=5^VRP!K4JK8\W>2.=N<
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M3#IMN&=HK5F)9$+$C=DG#$<D9XSBMJB@#S/3K>[O]<^(=M:R207%\$2TE=2
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MQ#<H/48.0?H:ZZUTRPL999;2RMK>28YD>*)4+GW('/XTEMI.G6<HEM;"U@D
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M-5M=\<7MIJNI6&EVT4\NG0HTJ/!-(996&X1KY:D+\N.2>IQC@FK?BOPUJGB
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MHM['5M7LI-/LA^XDM5=9I\#""0] HZD '.!G/-0:?X1U.;Q!IFJZI#I]O?6
M)GO[%SOOR5P0Z;5 '<YSSTQ0!TFO:V=*%E;V\<<M_?S^1;1RN44G!)+$ D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA1U3$0.WJ>K$\ ?J*U;"[^WV$%W]GGM_-0/Y-PFR1,]F'8T 6:*** "BBB@
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MDRPK+:P.L)!B#1@A,=-OI^%5KK2(;S5K._F()M,F)-B_>((R6QNZ'H"!ZYH
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MI\"07"[)D"_ZQ<8PQZD8)'- 'DFH>%M)'P9CU]T>?47TZV4S2RLP4>8G 4G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% %>ZL;:]$:W4*RK&XD57Y 8=#CH<=:L444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%%% !11FB@ HHHH ***0L%4LQ  Y)/:@!:*** "BBB@ HHHH **** "BBB@
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M''2@#95T?.U@VTX.#G!]*X;Q@YN_$45C%)<7C0:=-</ID,Q@7E@!*\@8'CD
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MC/M0!T$,#PVPC:XDEEVX:=U4.Q]3@ 9_#%>16ANY_AGXZN;K4+BY;[7=Q%9
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ML )W'G)PV?<@=.>M5F\ O#J]_<:;X@O["QU&4S7=E"J$.Y^\58C*9]1S[],
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M[1GMIXIE5BC&-PP##J#CO7BNC)I]_P" /"\5U+;W#)XA6+D@-&AD;Y1SE00
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)K0PN"6.6#;NF <C&/2NA6-%C$810@&T*!P!Z8I]% $<5O#!%Y4,,<<?]Q%
M'Y"G-%&R%&12AZJ1P:=10!$EM;QR>8D$:OMV;E0 [<YQGTSVIJV-HD*PK:P+
M$GW4$8"K]!4]% $,UI;7$:QSV\4J+]U70,!] :2>RM+D()[6&4)PHDC#;?IG
MI4]% $ L[5;DW(MH1.1@RA!N_/K2S6EM<O&\]O%*T1W1LZ!BA]1GH:FHH IR
M:5ITJ*DFGVKJK%U5H5(#'DD<=3ZTL>E:=#=-=16%JERQ9FF6%0Y)ZDG&><#/
MTJW10!1BT72H%*PZ991@DL0D"C)(P3P.XX-6Q%&L0B"*(PNT(!QCIC'I3Z*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB8W-\Q [@=>21B@#5HJEI.J0ZSI5OJ%NDJ13KN"S(4=><$$'H00:NT %%%%
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M4;5;JRN([BW8L%EB;<I*DJ<$=>01^% %BBBB@ HHHH ***:[JB,[L%51DD]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^7(&[TY[$].,= _@FRS>Q07M]:V%](9;JQA=1%*Q^]R5+J&[A6 -3MX4MO\
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M-B_.\O*<XR"%!)'^TO3G.0HM?AS9WT^HW%WJ2:QJ+3>7!:;F$L@^88!Y!"C
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M8.K7IEF9%=R6)5<*>/GP#Q]T<<T =7HMYJ-]IPFU32_[-NM[*;?SUF& >#N
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M5&1,X$C*S'9C. ",C QSB@#UW-&:X[POJ</BW48_$%LK):6]HMNBY89F;#2
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M !1110 4444 1R6\,LT4TD2-)"28W*Y*$C!P>W'%,^Q6V;@^1'FY_P!>=O\
MK.-OS>O'%3T4 9I\/:(;+[$='T\VN[?Y!MD*;L8SMQC/O4L>CZ;#?F_CT^U6
M\*[/M B7S-N,;=V,XP.G2KM% &;:>']'L+R>\M-+LX+FX&)98X55G'<$@=^_
MK4;>%]!:RDLCH]C]DDD\UX! H1G_ +VW&,UK44 1?9X?LOV;RU\C9Y?EXXVX
MQCZ8JKIFB:7HR2)IEA;V:R'+K!&$#'U(%7Z* ,XZ!I1UDZP;&'^T2 #<8^?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%-=TC1G=@J*,EF. !20S17$*302)+$XW*Z,&5AZ@CK0 ^BBB@ HHHH ****
M"BBB@ HH)P,FFHZR(KHP9&&0RG((H =1110 4444 %%%% !1110 4444 %%&
M1G&>: 0>E !131)&>CJ?FV]>_I]:=0 4444 %%&:* "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH 2EI!R,TM !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q_A*Z76?$/B
M;56+EK>^.F1*W2-(E7./]YV8GZ#TKL*X_1[8>%=>UNWE#&UU.Y;4+5@OWI"O
M[R//][Y00.X/'0T 9"^-M8ET/3_$,!LVM=1OULX[%HF+PAG* E@?F<;22,#K
M@=,G3\2W<VB^*O"VH JIO9SIUYL)"R;QE..^U@<>F3ZUPVA79AT^+5['Q+X=
MO-4=VN!:3V>ZZ>1CDJ=K!M_.,A/TKO-2@_X2?Q7HT4?-OH\IN[MA\R";&$B!
M[N"2Q] !ZB@#L:*** "BBB@!LDB11M)(ZHB LS,<  =237C<7B6ULO'6D>)G
MU2UD?66:TN;))E9K:!L>06 /!X!;/=C7IWB/3;W5].^PVTMND$K 7(F5CYD>
M0608/&X @GT-5O%?AL>)/"USI*"W@DF"[9"N1$00<C&#QCVH B\1:[JVF:[H
MVGZ=96MR-1:1/WLA0JRH6STZ=/4]>*SX?$_B";2?$2I8V+ZMH\VSRT+&*9=@
M?CG(."?TJU)H.N3ZAX=O;B[L9)=*+^:=CKYV]-C$=<''/?FDLXO^$3OM=UC6
M[ZQ@L=0N5E5\LI0[0@4D\'A1^.: )-.\43:M;^&WLO(D.IQ-/<':<11JHW8&
M>H<A.IY.><5U-<=X%T.TL/[2U&R\P6=W<-]BC;(6.#.?D!Z*SEV'L5KL: ,C
MQ)J=YI.D&YL;07$Q=4R[ 1P@]9'Y'RKU//Y=:YB#XD1)9ZZTXMKJ739X8(7M
M6*QW32CY,9S@9SDY/ )K;\9:!>>(--M(K&XMXY[:[CN1'<H6AF"Y^5P.W.?J
M*YV;X>:CJ!U]=0U.SVZH8ITEM[8I)%.@ 4@EC\BX( ZG<>1W -36=6\5:=HV
MLR/;62O:Z>;N*\C4F+<H8O'M+;MPQD'ISR.U9[ZA<6'A#PJ^L6>G7ZSW5I%Y
MLY8^3N48D^8'+CGG(ZU=MO#?B34=%OK3Q)J]M+/-8RV4)M(V"#S%P9'!QN;@
M=  .?6H)_"FOW_AC1=-O;K3C/IUU!,6C#A2L( "\CDMU)P,=,'K0!KS:YJ=[
M=:G%HEK:3)IK>5(T\C#S9MH8HNT'& PY/<XQQ68OCRXU'_A'I-$TR.ZAUE)F
M7SKCRVB:,?,&X(P#U()/!XJU'H.L:-K>JW6BM9/;:HPFDCNG=3!/C!9< [@>
M,CCIUJ*S\(7.EWOAK[))!);:2DXF:1BKRO*/F8 +@<Y.,]\<=: -3PQK\^MI
MJ,-Y9K:WFGW;6LR1R;T8@ AE. <$$=16]6!X;TB]TN[UJ6\%MB_O3=)Y,C,5
M!15VG*CIL!S[GTYWZ .+U'Q?K2>*;W0-)T"&\GM8HKC>]X(PT;, >"O!&?4]
M/P-;_A8<\DD5Y:Z8]SI3W9M\PQ2M+L#%3+]S;C<.F<X]^*U;/0M2M_B#J&N.
MMF;*ZMH[=0)6\U=G.<;,<D],UE:1X8\5Z(9-&M-4L?\ A'S,SQS%6%W"C.69
M%Q\N>3\QZ9SZ4 /@G33?B)XKNX[1I#%IEO,T5O'EYF'F'H.K' 'Y5-I_C6YN
M]=CT:6TLX[V>Q-TD:7)=H'&,Q3#:"IP1^1J.]\->(+O7/$UW#/:V::E8I:VL
MT<S-(A3."PVC&=QZ'CWJMIGA+7K;7-(O9$T>VM[:RDM'AM%;]WN*DNI(!9B0
M3SC'OF@"MX>\;WMG\.K/6]7\F6XU"YD2V!9^6:60X;"L0J@<  \#%:-I\1$\
MK5?MUE\]D8A"UJS,ETTG"*A95.[) ((X_"LJP\"^)H/"=MI)OM/@N-'NA<:5
M/'O.XAG)\WM@AR, '_'5O?#?B;Q)X=N8M:O[*UU+?%)9BR5C%"\;;@YW<DL>
M#V  ZT 18U&7XI:++J=E:6\HTZY*O;3&3<-R?*Q*J?ES]#N[5WU<5;:5XJN?
M&FFZOJ::5'!;6LL$BVTLC9W%3N7<HY)4<=@.IKM: .4\;:CJ]B-(ATU8 EYJ
M$,$CM.T;\MNVC"G"D*03Z'I4DVOZQ<:C<6.CZ79W,EDJ?;'FNV1%D8;O+0A"
M6(&#D@=13_&6D:EJMGITFDF W=A?Q7BQW#%4D"A@5)'(^]G\*I66C:[HFNZA
MJ5I#:74>J(DMQ;&=HQ#<*NTE&*G*-WR,\?A0!O>']<MO$>BP:G:JZ))N5HY!
MAHW4D,I]P0:TZQO"^B'0-#CLI)1+.TDDTSKPID=BS8]LG ^E;- 'G8O]6UV'
MQI8ZG!9"QMQ);Y69F,>(=RD*4P>H).1SVXJ3PAXENK/1/"-A=Z.\-E>VL=M#
M=M.I)=8=PR@'"MM.#G/J!4O]@>(K?4?%,5O#I[V6K%I8Y9)F#;C%Y>T@*<<X
M.>>!C'/#QX;UF/3O!EH$M&&C/&UV1,?FV1F/Y/EYZD\X]* *=_\ %O2K*Y;:
MEO-:I=_9G*77[\ '!D$>W!4'/\0)QG'->B5Y[H.@>+/#SW&@67V :&\TDD%^
M7/G0(YSM"=V&3@]._M7H5 %+5]272-(NM0>":=;>,OY4*[G?'8"L&U\7W37]
M_I]YI(CO;:R%ZL=O<B0,A)!5B0NUP0>/3FM+Q79ZG?\ AB^M='F$-_(@$;%R
MO\0W#<.F5R,]LUR5IX=\0VNL7%[!HVE6D$^DFS\B"Y.8W#,022OSL2PR3CZD
M]0"Y%\1I);32;]?#M\VGZFPB@E61#(92I(41]<95AN)'3/2KMEXX43Z[!K6G
MG39='A2XE43K*'C92000!SQC'J1S6(_AG71X5\'Z<FGQI-H]Y%<W(2Y&&$0(
MPI[E]Q/8#!!-6;WP9J&L>(_%,MR$MK'5K)+6&57#.K)C#%<=#]<_2@"SI_Q#
MBO-9M]+>SA-Q=V[SVPM+U+C)4%C'(0 J-@9ZD>]&G_$)KZVTB^.A7<.G:E<+
M:K<O(GR2,2%^7J5) ^;_ "9M#7QM(J0ZY#811VJ,-]M+N:\;:57.1\J\Y/?(
M';-947AG7K3P3X9TE+2*6ZTR_AN)\3@(R1N6^4GG)R.W8_B 7_%6OR7NB^(+
M2PT8ZE:VD$D5U(9 H#[<LJJ1\Y4$$]/09-0:/XFDT71?">C1:1=WLUWI,;Q-
M"R ';&F1R>,;ADG QTSTJN^C>*M)_P"$GT_3M/M[ZRU>6>ZMYWN!&8'E7YE9
M3UYZ8_$^EK3="UJVU?PI<7%E&(]-TUK.X,<ZMABJ $9QD?)S]>,T /D^(XAT
MV:_DT"_2WL[@V^H.60"U8,%]?GZ@_+ZBKVN^.+32;R2SMXX+FXB@6>19+R.
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M%^/]$DN&3$C==AVL=K$<@'K]>*YB\\+:KKB^.+":TEM(M5>*2SN9)4*N8U4
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M-92HHE=#T9 "0P]P>.AP:YCP>C^*88]6NI]5M[^'4)93(DC+$Z*Y40E<E=N
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M75[;K'() UI.8F. 1@D=1STK6HH BM;:&RM8K6VC6*"% D:*.%4#  J6BB@
MHHHH **** "BBB@ HHHH **** "BBB@!%^[2TB_=I: "BBB@ HHHH **** "
MBBB@ HHHH **** ..O/AIH%\M_',]_Y%[,;AX%NF$:2$Y+*O3)/KGVQ7,ZMI
M$A\47XNX_%]BI6&&UN='F>19XD7 ,C<G=DG[V/S))]7HH XS2_",]W!IEWK&
MHZFUYI\\LEH9)$,B(QP!(0"&;;@'L,X]ZOZUX)TO6M7CU9YKVSU!(_*^T65P
M8F9/0XZUTE% '+ZIX T74ET\QFZT^?3P5M[BQF,<BJ<Y&[G.22>><YYY.9)?
M!6GO_97E7-[;_P!F3-<1&.0$R2-]YI"RDL3DYY[FNDHH PCX6M_,UF5+V\27
M5QMN'#(2H"[1MRN!A>._OD\UGW_P\TB_TC3+![F_BDTP;;.\AGVSPKV 8#I@
M =.U=;10!SDG@K3GLK"U%Q>J+.Z%ZLIFWR23C(#NS EC@D>F..PIS^$+*;4-
M9NYKJ\E_M>W^S7,3,H39@@;<*"" 2 <]^]=#10!REMX'6SBL#;:_JZ7-E&\4
M4[2(YV,%&TJR%2 $7 QUYZUN:/H]KH>F1V%F&\I"S$N<EF8EF8]LDDGC ]*O
MT4 9D^@:?<^(;37)8LWMK"\,;<8PQ!R?<8./]X^M1Z5X<L=%;4WL-\<NHW#W
M,LAP2';TXZ Y('N:UZ* .3C\"0)X871#JM\PCO/MD-SB,212;_,XPN#\V3R.
M_P!*M6GA4V>NMJZ:M>27#68M#YP1LJ"2&)QG.XD^G.,8KHJ* ,;PQX?7PQHX
MTR*\FN8$D9XS,%!0,=Q7@#(W%C^-&EZ%)IVKZCJ,FH374E]LWK(B@)MR%"X&
M0H!Z'/.3WK9HH YB;PPEOXKE\5#5IK>3RQ'/$(T$3PKSAN,D]]V<C&*Y+P5X
M:.M^&9X)-7F&BRW\S/IH@5<J)2RJ7(W@, I([@UZI10!SESX6/\ ;EQJNF:G
M/IT]W$L5TL:*ZR[>%8!APX'&?3M4%_X%L[G3=%L+.YELX-)NUNX=JAR\BDD%
MB>O)8GUS7544 8 \,(WB34-6FNC+'?6PM9K1HQL*#..>O<_G5:T\%QV]G9Z=
M)J5U/I5G*)8;215_A;<BLV,LJGH/89)Q7444 9GB#1(/$6@WFDW4DD<-RFQG
MC.&'(((_$"L"V\!SP:]9ZT_B*^EOK>U-JSM%%AT[#&W &>?4YZUV5% '(#P(
MD?A2T\/PZK<)!;7(N5E:-2Y(D\P \ 8W'/2EO? [RZS=ZCIVMW>F_P!H1A+^
M*!%99SC&X;L[&]Q_7-==10!SGAOPC#X=6U1;V:Z6UM?LL'FJH,8+[GY&,Y(3
MKTV]>:CF\)SPZEJ-UI.JM8Q:D=UW ;<2 OM*ETR1M8\9R"#CI73T4 <PO@\6
MNI:'<:?>_9K;2(&@BM_)W[T?;NW,3U.T<@<'UKH;E)I+65+>58IF4A)&3>%/
MKC(S^=344 <C+X"M+[PUH^C:I,ET-*DB,4J1;"R( -I&X_> P<'\.*L7WA>[
MN?&5GXABU*"(VD)@2!K0L"C'YLMO'/H<<>AKIJ* //7^&=T;*WLT\2S+;V>H
MC4+-#:(?*?<6.XYRYRQP> ,]#5__ (0:X%MXGC_M:,OKZD.QM#^Z)!4D#?S\
MI]N>>G%=G10!PL'@/4K62Q-OX@$0BTU-,N"MH"7C3[K1[B=C8Z]1WQTKF]?T
MJ71+/0/#^H^*8+6"V@=TN+W3XWMW90JH@5@1N W'+-GYN.O'KU,EABGC,<T:
M2(>JNH(_(T >=Z7HX\6^%KW0Y;ZUDLH&BDL]1TVT^SH)>6.U?NG! )*X!WD<
M$5IMX.UF_P!%O[76/$GVR[N;9[2.;[($2*-L;CL5AES@<D\8P.^>S50JA5 "
M@8 ':EH I:39SV&D6EG<W"7$L$2QM,D?EA\# .W)QQ[U@"V7P]XYO=2D7;8Z
MU%"DDW:*>/<%#'L&5L ^HQW%=910!QT?@NZM;+4M)LM6\G1[^9Y&C\G=+"K_
M .L2-LX /.,@XR:N1^&;FW\9VVLVUS;QV4&G_P!GBT\D[A'G<,-NQG(';I^=
M=+BB@#%\5Z$_B3PW=:7'=FU>;:5EV[AE6#8(R,@XP16%:^#=;CUR;59]>MGG
MN+#[).JV.%&,[=H#C"C(Z\G!Y&>.WHH X.;P!>_\(OX=T:'5;?\ XDUXEV)G
MM3^]*$E1M#\#YCGGTZ4FH?V'XU\6:9'93FXGTF:0WSQ(P4(!CRF8C!!D"\<Y
M"M7>U%#;06[2-#!'&TK;Y"B ;V]3CJ?>@"6N-B\(ZC=ZYI6I:Q=V4DNFN[1S
MVT+)-*"" KL6QMP>>.<=LG/944 >>7/P_P!8GT34]$37+>*PNKUKN/\ T7<X
MS*)-K'=R!C/&"3CD#BKMWX2UZW\3W&M:%K5M;/?PHE]%/;%T+J !(@#=<=B?
MQ.:[:B@#AM4\#ZE#JMCJWAK6/L=_!:BSF-VGFK/&#D%O]K//Y=,4[5/!FKRG
M3-2TW7/+UVQ\S?/-&?*N1(065E!^5<C@#./R-=O10!S!T77XK:-UU6WO+J25
MI+Q+J(B"4% H15!.Q1@'OSDG.:HZ=X/O]$T865A+821R7,UQ/9SQM]G*N.(E
M&20JD#DY[G'.*[6B@#@K3P!<Z7;6%QIU]#%J-C>SW4,>PBW"3??@"YR%P!@]
M01G%3WO@_4=1L->N+F6R&KZO;+:$IN\F"( C .-S'DDDXSQP,<]M10!S]U>3
MZ!X3C2402ZDL @MX(V)$\V,(JYP>3C/H,]AFL.QLM8\*VGA'1=.EM6A1?+OK
M8QDN^<%Y%8<*%)8Y.,G Y)Q7<F*-I$D9%+IG:Q'*YZX/:GT %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 U?NTZD7[M+0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)D#J<4 +12!@0
M"""#W% (/2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,T %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% "+TI:1?NTM !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEU+(EY'Y31!SA(4#$(,;22P!SR<Y.-C2X?%?A;4]7TNVT,:A;ZA>27EK>FX
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M,"6E[>/:1B6Z^R1!Q"IZ9R1DXYVC)QSBH[GQGHUM-IL8DGG&I1M):O! TBR
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MYX[L_$W0[^.UO?L2:4\4LHMY-JLWS!6XZ\=#T..]<[-'J \!WEL=+U4W$OB
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M&<_(V$(;&/T/O7I7@R'31%?7>DZ9<VEI<RAA+<M)ON6QRY63D#)QD\G![8H
MV]3U?3]'@2;4+N*VCD<1H7/WF/0"LE?'OA9[>[N%UNU:.T($I!)P3TP,9;/M
MGI69\4)[>/PU:QSLOSZA;'81G*K("QQZ =:BCGL/^%R3.&A&-#1-^!C>)&8C
M/KLP?I0!U'_"0Z4=)M]4%]&UG<E1!(H)\PMP J@9)]L9X-0R>*M#BTQM1EU.
M!+19O(9W)&V3NA!Y#>V,UYCI>H6MIX%\,AHT01ZM.K7GDM(;$EY"K! ,;B&&
M-P(Y!P:IJ5_X0WQMI]PUV\UQK:,AN8"LDJM)&V2-H&XJK,0 , = * /7=/\
M$NC:KJ,^GV.H0SW4 )DC0G( .,^XSW%-M_%.B7>HQV$&H1O<2[A$,$+*5^\$
M8C:Y'?!.*YRXF@A^*%A-;1J\8T.5(Q$O!.]65 1P,J"0*Y/2[^WBN?!UT5OX
MX+>YE5[..PE$-F7B<",?(6=L]3DYZ\"@#TN_\7Z%IDTT=YJ"Q>0X29_+<I$Q
M&0K.!M4D=B<U)/XIT6WMX+B34(S%/$9HV16?,8ZOP#A?<\5Y5J.M:7,_B7P[
M=ZC';Z7=:L\D[M:SO.FUP9 NQ"A!9/E.[('4&MG5-2T_3O'%]=:R-0DT75K*
M V5U8O,(R%!!0^41NSN)YSU]Z .\G\5:#:O;I/JUHAN8?/AS(/GCP3N'MP>:
MK#QSX8^PQ7AUNS%O*_EHQ?!)S@Y'4<]SQ7%K!I]AXZ\$6,5@EE;V\5WL@ED:
M1X@^[R@Q8D@M@D \@Y Z5!%+IW_"-_$KR!;-+)=7$:! -S;XPJ@8ZY?=CU.:
M /3[_5]/TN..2\NXXEDSLR<EL#)P!R>.:K_\)-H8BM)?[6LMEX";=O.7]Z!U
M(]AW]*\ZU*_M](\4:+K&K27\.ARZ%':"ZMC)MCFW[B&V<\@ ?EZ4LUKHD \(
M6]C;NFGRZR]Q"EV69G0H1YA#C*@N1@'V/>@#NI_&>@QZ!=ZU%J$5S9VN1(T!
MW$-_=P.YK3TO4[?5M/BN[:1'1U!.TY ) .,_C7F>KJDDGQ0@M@&:2WA=$C&2
MV(<.0!UP>OOUKT/PYJ5KJN@VEQ9R&2(1JF[85&0!D#(YP>..X([&@"Y?:A::
M9:FYO)TAB!"[F/4GH .I)[ <FJ$WB?24T.YU>*\BFM;<'>R-G#?W2.H.2!@^
MM8GBV[?3/%GAK4[J-O[(@:>.>8#*P2.H5';T'WAGH-U9)>!=<\9Z_%=0IHT]
M@D/G[P(YIPA!*L>#C(7(X)..M %_P5J.H>(#::Q'XC%S$\.;_3FA3$#L,H$8
M $8Z').>M;7C/Q+%X5\,7FHL\0N%C(MHY#_K),<#'?U/L*A^'MS!<^ -#,$T
M<OEV<<;[&!VL%&5/H1Z54^*4T4?PZU:-Y$62:,1Q*6 ,C;@=JCN>#P* *%K<
M7[ZEIEQ#\0;6?3[B=/W$L,6^X<<.B,N.">P''K74R^*M @SYNM6"!9O():X4
M 28SMSGK[5R/C._TZZU7P-)'>6\B/J:R)(D@(*@8R#TQNP*SIFTF71?B9.39
MM,TDR*[;=Q'D*$ _X&#CWZ<T >C:AKFF:5#%+?W\$"2_ZLNX^?Z>M#Z[I,:6
MCOJ=H%O,?9CYR_OO]WGG\*\TMM;M4B\,VTEU'8W<GAY5&HO&9RY8J&AC4?*7
MW)SD$]@.:S=,U+2[GP/X"L[A[=V75D29)DP !YF1R,'EES]10!Z[INN:7K%M
M)<Z=J%M=0Q,5>2*0,%(]34<6NZ5?PW?V/5K1C;INED256$0P<,><8X//3BO,
MO$2BYN?B%9Z$8Y)A%8O);V_+/L+>: H[XP#^1KK])\0^&O$.HKJ>G0+,T=HT
M%W=R(T:VT7#>6VX!2<]NV#^(!IZ/J45CX7MKO5=>M+X$D'4%"QQRG<<8 ./;
MCTK/\:>(Y+;P%?:UX?U&!WA*!9H=DP.752!U&?FKB=%U*RM/ W@;SY((&6:;
M;?3%BEJPW]0" 7(; #<>QJM+>:>GPU\96QO69SK+2.98]CX,T>"5 &"0K'&!
MT/% 'M<1)B0MNR5&=W7\:J:CK6F:0(SJ-_;6@E;:GG2!=Q_&K<,L=Q!'-"ZO
M%(H='4Y# \@BO._&5]:)XT^R&XCT^[DT>13=RH9#+&TF/)B3(!<D9/4XZ=S0
M!O\ B_Q/#HVF60@OK>&?4+F&WBF9E(C1V :7!."%7)STR1FN=N/%TFF:Y9Z1
M=>+[":UO'DE6_01>9#&$!5'P-F68\''(!K"LM3LA\,O F^[A4Q:S:A][@;=L
MC;NO8 C)[5U^LW>GO\3O"Z?:K?<EK=MMWKSN$87\^<>N* -K3=7&GVUO8>(=
M9TLZN3M(CD$?F9)VX4G.2/USBG"XN$\73K+K5E]B6RW_ -GX42HP89E8]=N#
MCTY%>6^(M2LIX/$$$-W#91IK<;W%I)&SSNPDC#3,QX2/ !&./?G%=BMUIEQ\
M7=ZSVKQ3>'CO.Y<.#*#SZ_+SSVH ZV#7M'NGVV^JV4K>49L)<*Q\L$@OP?N@
M@C/3(J6RU33]2\S[!?6MUY>-_D3*^W/3.#QTKROP[8>'%^$*7UT\%E+()+6:
M_A13)%YEQ@;O4<(>>PKJ_!EWJ$NM:O;ZF+&[N(HX,ZI9<)<K\Q4,.@=0><=F
M';% ':$XJA9:YI6HS20V6HVMQ+%G>D4JL5 XS@=O>LGX@K>-X"U@6"NT_D?=
M3J4R-X'OMW5BWESI>MZCX.N- >,W,<PD @Q^YM/+(D5\?='W5P>_% '81ZYI
M,L\,$>IV;RS,RQ(LZEG*_> &>2.]7Z\Y^&^G:%>C5;Y+:RGO[?6+HK,%5GC4
ML=N#V4@G&..M>C4 %%%% !1110 4444 %%%% !1110 4444 (O2EI!T%+0 4
M444 %%%% !1110 4444 %%%% !1110 45P5IXI\1SWNK336^FII>C7DL=XZ%
MS))$L>[Y!TW#CKUS[<QZ!XN\2:I?:9.^EM)IM\?WH6PEA-J"N582.<2+R,D
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M;6U@L;2*UM8EB@A0)'&HX51P!4U%% !1110 4444 &*,444 %%%% !BC%%%
M!BC%%% !1110 4444 5[^R@U+3[FQN5+07$312 '!*L,'D=.#7.V?@A8'47F
MOZUJ%LA!6VNKD&,XZ!L %ATX)P>^:ZJB@ HHHH 0C((]:Y6S\#K8PK9Q:]K'
M]F+D"R,R[0O]W?MW[?;=75T4 ,BBC@A2&)%2-%"HBC 4#@ #TI]%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "+TI:0=!2T %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 @Z"EI!T%+0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% "#H*6D'04M !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 (.E+2#H*6@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@!!TI:0=!2T %%%% !1110 4444 %%%% !11
M10 4444 %>=ZGHUQK/B;Q!9Z=#9P29M&:]WE98& +;E 7EB..HKT2H(K*UAN
M)+B*VACFE_UDB1@,_P!3U- '(6$U[;7MS'975K!!/JMS;M&8.5D,;.K9SSR%
MXQSGK3;+Q-K=]I4[P1VYO;&W,5TLV(T-WYFT("3@8"D]>=Z<C-=5/I=J\3>1
M;VT,X9I(I?(5O+E(QO ]?YU#::';1:9-9W@6]^TN9+II8QB9SC)*] .  .P
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MF'PYHQMUM_[-M_)2)H%0)@"-CEE'L3S0!S,7B77[GR;5!:07$FJ26!>>W)(
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M !<#"[0Q[Y.<]ZT* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0=!2TB]/
MI2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 B]/K2T@Z"
MEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!!TI:0=_K2T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 @[_6EI!W^M+0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "#O\ 6EHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!!2T@Z4M !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444  Z4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
6%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>exhibit1011-physiciansha004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"]5TLSB?>IC*#&0Q# ?*0"0>AP:2P\5:1J.I#3H;B1;ID,D<<T#Q>:@/WDW
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M':MT    8 [4M% !1BBB@ Q1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ-=2>0&CE!Y#A<\9&W(!'?I72>&]1U7_ (3#7M$U&^-]'9Q6\L,I@6,C>&W
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M_$@'GOBLKP[;17EAX?U^+Q%917HE3SEM[,FZN'D8"2*4F4[ADGG:, 9  &*
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MNVB1=K?*Q4Y'U!H T:**SM7U>/28(F,,MQ<7$GDV]O%C?*^"VT$D <*3DD#
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MV212+D!@?H2.1WK(F^'6BS1:C$\VHF+4=IND-VQ$A7')SW.T9/7TP"176T4
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M+$(;<S%8P<A%R3M7/88%)!X;T>WL[JSCT^'[/=DFX1QN$Q/4MG.X^YYK5HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,FS*#'.,CKC/I0!Z917G?B+XB7=CJVHV6DVL=P^G;5DC:VGE:=R-Q56C4JF
M1RQZYX[UK-XFU35KI+/0;*%)TLH[RX.H!E\OS,[(MHP=QVMD]!@=: .NJI;Z
MG97=]=V5O<QR7-F5%Q$IYCW#*Y^H%<9?:KXIF\2^&8U2VL%O(9Y'LYLL5D1!
MG>RGYA\W 'X\])E\4'2M5\:RWFG6<2:5'!,'MQ^\N=R-M\QL<G"J!QQD\F@#
MN**Y*37]:T?5=&@UN"S>WU1_L^ZT5P;><@E5))(8$ \C'0\5@OXY\4QZ%J^K
M-IFF"'2-0>VN4$CEGC0J&V=LC.<GKZ>H!Z7138W$D:NO1@",USOC?6=4\/\
MAY]5TV.WE6WD5KE9D9L1$X9EPPY&<_3- '250OM:T[3+NRM;RZ2&>^D,5LC
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MJ//DW"2([ CL3DAV;=@D_<(Z4 >BT444 %%%% !1110 4444 %%%% !1110
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M&4A@..N#7544 <7-X%FMDT9M%U7[+<:=)/(\L\ F\XS?ZQB,C#9SCZXJE/\
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M>@:5=7L<!S'91REF.YOFP6R>Y-3^&M/FA2]U2]LHK2_U.8330HP8Q@*%12P
MR0!D^Y-6=-N-7DU'4H]2MK6&UBD LWAE+-(A!Y<'H>GZ_4Z2R(QP&4G&[ /;
MUH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5RGCK5(])L]*EFTRUOTEU*&$"XY\IF)PZC!Y'/I75UR_C;P
M_J'B.TTZWL7M4%M>QW;M.[#.SHHPIZY//;WH S;WQ?KK>(=?T?3=-L2VEVZ3
M^?/.VU@R%@" ,Y/ITZ\U9L_&5QK6GZ!_9=K%'>ZM"\["=BR6\:8#L0,%_F(
M (SG/&*6'PWJMOXL\1ZRC6#QZG:I%#%(S':R+M&\;?NGG.*R[+P)K>F:/X?>
MPU&TBUC1EDA&\,UO/$YRP88# ]#^'X@ J:=KESX?O_&U]=P127OV^UA2.(-L
MDD=%53@ D Y!(Y/4<FM"ZUS5[[2O$.G:EIQ, TJ::.^CM)H(V.T@QE91G<.N
M0<$4DO@'5-1@\0C4=5MXY]4F@N89+.)E,$L2KM/+<C*XQU[Y&<#3M-!\1W]E
M>1^(M6M7DELI+.)+&-EC&\<RN&/S/P,8P ,XZT 8>D^*->T>T\-0ZCIEG%I.
MHQ0V=M,DS/)'*8QL+CH0Q'0=,]>.7:!XIU&TT+6-1U">&^<ZN]I;B&.3YY"R
MHH4#)"#K@9/7J>NQ9^&-3N8M$M=9EL_LFCM')$EJ6)GDC4JC/N V@=<#.3CD
M8K,B^'NH#2-7TAM3@CLYKUKZPEBC;SXIMP92[9VD#&,!>?44 6H_&NH:;%JT
MVMZ;(;2RM?M,=[%:301RG('E;91D-DC'4'GIBJ.K-K;^.O!,FJ+8JDDMPPC@
M5@T3^2<H6+$,,=P!TZ5I_P#"*:WKFB7EEXJUB*9I[8VZ+8QE$7)#>8P/WFRJ
M]@ ,CO5:#PKXKFU30;K5-:TV9=(E?:4MGWS(4V;F);[Y&>F .OS=* *=QX[\
M1Q:+KNK+I>G"UT>_>VD#2N6G5'"MM]#SG)]1Q6OJWBV]76;_ $S2H5,MC;)*
MY:SFN-\C@E8\1_<& #N)[].#6=+X*UR?PCXDT9Y].$NK7TEU'(&?:@D<,P/R
M]L#'UJQ=>%/$D>NIKND:M96=]=6\<&HPR1-)"Y3@.G0Y X ./K0 V\\<WD+:
M1!<PP:'<ZA:O*/[3B=D\X' B+ KM/?)[$<5+?^+[VPNM+T_4)].TJ]N[%9O,
MNHWD@DG_ (HE8. N/4DYW#\;&J>%]4GT];"*[LM0M9(3'.FJQ-(2Y9F,JE3P
M?FQMXZ#!&*AG\'ZG%H5MHEK=6%[IZV26DD>I0LV"N[]XNT]<$#;Q]T<C% '6
MV,D\VGVTMU$L5P\2M+&K;@CD#(!'7!S7'>'-4AO;[Q5XHO=OEV5Q+9Q-G/EP
M0*"V,]-Q)8_AZ5U>BZ:NC:)8Z8LSS+:P)")).K;1C)KF--TRVTG5=>T"^7%A
MK<TES;$D!7\Q LL0_P!H$$@=P?8T *_BG6-/T?2M=U"WM3IUZ\2SPPHPDM5E
MQM8N6(< D \+UXK-L9=9N=3\<M>:E%-!;KY'E>0P 40%AL^<[>7YR#G':M"T
M\&:F-+L= OM2@FT6QDC>,K&PGG6-MRQOSM"@A1P#D#M5A_">I1ZGKT]GJ\$=
MMJXW/#):[F1_+\O[VX?+WQC/ Y'.0# \+ZSKVEZ'X+$\5A_9-^D5D$7<9E)B
M+(^[..=AR,<9[U:E\8>([Z&ZO]#TP74-O>M;I:?9VS-&C;&;S=P"MD$@;> .
MYK1_X0_45T;PSIZ:E:C^Q)HY=[6S'SMB%%&-_P O#'/7G'T,4/@;4K"]U"/2
M_$LUKI%_*TLMH;=7>-G.7\N3/RYYQP<?7F@!MQKWBNZ\6:CH^E0:6$MH8+A6
MN0X.UR<J<'[V >> ,=\UN>,YKVU\%ZS<Z?=?9KF"TDE279N(VJ2<<C!(& >V
M<X-16'AZZLO&-_K7VN!K:Z@C@%N(2&01YVG=NP>ISQZ5J:SIRZQH=_IC2&-;
MNWD@+@9*[E*YQ^- 'F\PUA='^'SS2VT]X]S&T*LC1J@-N<*YW,6(YR1C/H*Z
M*S\0^(8XO$MG<VME>ZII6QH?(;R8Y@Z;ANWM\N.<\TV/P;K/D>'DGURVG.CS
M"12;,KYBA-@7A^.">>><<<<KJ?@B]U5_$RRZK#'%K21*/+MSNA\O 7)+X8$=
M>!^% &?8^-]3GU/4[".:RNQ#I!U&"Y6W=(RZG:R?>(=<]&4X^M5].\:^)#:^
M$]3ODT[['K5PMJ\,,;[U+9PX8G Z=,''J:UF\%:O-JTFIW&O0//+I;Z<\:V6
MV,*QR"H#9'.">3SGH. D?@&X7P_X;TYM4B\W0[I;A)!;';+M)P"-_'!YY_*@
M#MI YC81LJN0=I9<@'MD9&?S%<!%XLUL^#M"U."*P-U>:E]BEA\ME0@S,@VG
M)V\+W#=:] <,4(0@-C@D9 /TKC$\#WD>@Z;I2:Q$%L+_ .W))]C)+,'+A2/,
MZ;F;\,>F2 1'Q=J&A:CX@M]>>UN(=.L8[V.6VB:(L&+#806;G( !S_\ 6Q?$
M?]KR:GX(NM2O;:9;G5891%%;E/))7("MN.1@\Y&<^G2NJO/!B:EKFJWM]>++
M::C8BREME@VD*"2&#EC\P)/;T]*S5^'^H.FC1WGBB>YCTBX6>VW6JACC@!FR
M<]N?Y]@"I+XI\4:C?7%QH=A<3PVMZ]NMK]GC$4Z(VURTS."K<,1@ = <TR*+
M7[CQYXP&AW-I9S[+%V-S$9"2(F(0 $  \@GG';U&JO@&:#4-1^R^(;R#2=1G
M,USIX13DL27"OU0,3S@9QW[U??PS>6VNZAJ6DZHEI_:,<4=PDEMYI3RU*J8S
MN 4X/\08>U '%6GB+5/$OBKP=<?:_LAN(+HO:^3NCCN(U9')!()R"P'/'YUJ
MR>(O%FJB]O\ P_9O/';7KV\5LR0B*9$;:Y9VD#AC@D8  Z8/6M6X\!0I-H,N
ME:C+82:/%)#&WEK(75QAB<\;NISZGI4+> )HK_4#I_B*]LM,U&4S75E$BG+-
M]\H_5-WL/_K ":A?ZOXAC\1PZ=?)IUOIH:W!\E9&EE\L,^[/10& X&<Y.>U8
MVD:KK%AX7\!6>F3VL::A$('\Z$L01&6!R&'''3'/J*Z&X\#NNM:C?Z5K5QI\
M>IQ[+RW6)9%<@;=R[ONMCOS26O@B:U@\-0KJV^/0W+)OMAF7*[<'##'!..OO
MF@#('C'6]*M->L[\VUYJ5EJ$%I;2K&(ED\[!4E2V!@$_Q#H 3WJ['J?C33TU
M;S-)FOH([0S6<TWDI(91_P LRD;G<.X(P>,=Q4]YX 74_P#A(5OM29EUB2*7
M]Q#Y;6[18"%3N.> ,_TJ2'P=J0L9A<^*+RXU PK#;WAB5?(4,K$A0>2=H!)/
M(_4 S++Q5J%UX?UF_P!)U$:Q]F@79$UKLNH9<D.'C  .!R..<$<UK>"M:.M?
M;IHM=75K0>7Y1:)8I86(;<KJH&.0,9%/7P?*VH7FJRZJR:K<0Q0B>UA$2*(V
M# E<DL2>#DX(XP*N:-X;&FZSJ.KSSQS7U^L:2&&#R4 0''RY)).3DDGMTH J
M^+-4U32[WP_]A>);:[U*.UNMR98JW3:<\=".G?M7.W>M^*KB]\8I;ZI:6D&B
MJ)8=ELLC,/+9PIR<#..<Y/L*ZSQ%H%SKDNF-#J"VJ6-VMWL,'F>8Z_=!.X8'
M)_.H+;PM+;WVO71U$.VL "1?( $6 57;SS\IYSU//'2@#*L?$]]XBO\ 2-,M
M;A;"6YT=-4N)HT5V&XA0BAL@<G.2#P,>]0W>L^)=,U7PC9ZA=VWGWMS+!>I;
MH"CA1E2"1E3C&<5/=_#D26^CO8ZW=V&HZ5;BUBO84&7A P%=>A_SQ5R]\#0W
M%AIR0:E=0W]A<FZCOW"RR/(1ABX(P<^G&,#L,4 <UJOB[7K*U\>/#>H6T>6
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M#X571-7U+4SJE[>3ZAL,PG*;<JH ( 48/Z8X[5HZYH]OK^AWFE761#=1F-F
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MN <%LMD;L$Y/4^M:GAG39[*SN+J]@CAU#4)S=7,<;;E1B  H/?"JH)[G)[T
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M(^!_#;:]_;9TJ#[<6WE^=I?.=Y7INSWQF@#7U&>2TTR[N8DWR10O(B?WB%)
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M: .YHKSS3?$FKW'@^QGO=0CCG&HR6=U=1QCS9%1G \J/:P+L548P>,GZ9?\
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MA(HZ<(CYQW'/6O257:H7).!C).30!R+>/H8[._O)M"U9+73[AK>[E B?RF4
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MY( P #CG'&I>7\>F:U=76E:E;:I97FK1M=Z+.,723!T'F18.XXVJP!&,#ZT
M>LUF6?B+1M0OGLK+5;.XN5&3%%,K,1W(P><=\=*GU>5(-%OII8'GCCMY&:*/
M[T@"DE1[GI7D>C:II7]L^!+N/48EMXEG1+6%#Y=HKP<1%SDO)NP#SR3PHS0!
M[11110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP4)V]..G K8#J>C \XZ]Z3S4V[MZ[>F<\4 8>C>"] T 3#3]/""6,Q,)9&E
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MXW XRQ&6P6_BST K<TVP\36%\TUQJL=M8W<#J(7U-[R1Y A97A,B *>.1R,
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M!8 $#VR*WZIQZ;%'JDVH,\DD\B"-=Y&(TXRJ@#N0"<Y/Y"KE !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOYB)(=TCH-PQC).TCU/:@#MZ*XT^,Y;7PYJOBBZ2!]$C ;3O+5DEG7. 6W'
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MW&SFXF"ABH*L-BC<HSSSGTH ZVBO/O\ A-]9U.7PQ_8UG9!=:@G<K=%LPR1
M;@2.P)],G&.*BG\;:_:>#]8OI+>P?4=*U,6$NU6$<H+( R@G(/[P=30!Z-17
M&6WB;5]/\2WNG>($L1!'ICZFCV@;]VB,%96+'D\YS@53L/&.O7-UI5V=*EET
MN]7=/LLW3[*K#*OYA.' !&>!W(]* ._J*YN8K2UEN9W$<,*&21ST50,D_E7*
MZ1K7B'6X-/UFRCL7TF[N"#;D$2I;Y($F_."W&2N.AQUK(\+W7B1H_%MY<ZC9
M71M;VXA"26K#+QHFWD/PF.-N"<DG)H [W3M0M-6T^&_L9EFM9UW1R+G##\:L
MUQMEXEO=0L?#-E:?9H-0U.Q6]E<Q%HX8PJEMJY&<E@!SQUYK-U3QKK6FZ9XE
MMV6Q.K:((Y?,,;>5/#)RI"[LJP[\D?GP >B45R-MK6NVOC>TTG518M:ZA:RS
M0K;JVZ%D*Y5F)^<8/7 Y["I?'.LZGX=TRWU:TDA%E#.BWRO"781,P4LOS#D9
MZ'U]N0#J:SKS7-/L-6L-,N)BMW?[_LZ!&._:,MR!@=>]<O%XRFM_'6JZ5?W=
MO_9L%FUS!*D)4Y4*SH6+88JK \#H?:K"ZIK46O\ A>UOC:8U"&=YE%N1)&ZI
MNP"6.!RH(QG*GGG% '2ZGJEIH^FSZA?2&.V@7=(X0MM'K@ FI[:XBN[6&YA;
M=%,BR(<8RI&17F2)J$G@WX@7%Y?I<$/?0O\ Z.$9BD053D'IM &,?C6CHFJZ
M_INJ>%+&\N+*;3]5M62.&*$JT'EPAP=Y/S$C@\"@#T&LX:Y8'7_[#$C_ -H"
M#[08_*;'EY SNQCJ<=:YSXGM?Q^$_,LK]K5?M,*2A4!,@:5%QD]!S^/2LR]M
MM;'Q.AMK'4+<7QT B2\G@R /M'41@@$]!UQWYZ4 >CT5YQ9^-M6N/#VB1,BO
MJVH7TUHSP1K]V$MO90[!=Q"C )QST/2NF\-77B":74(=;L6BBBE'V.X<QAYH
MS_>5&8!AZ\ YZ4 6KGQ-I5IK,6D33R+?S+NCA%O(Q<=R"%P1QUK7KA-;_P"2
MQ^%O^O*Z_E73>)-;B\.>'K[5I4\P6T1<1@X+GH!^9 S[T :M%<7J.LZSX9O-
M"EU&\AOK74[I+*9%B"&&60$JR$=5X((.3TYK.O?%NKV>L6$9NHG:?6EL9;>*
M#?#'"S%5S*.DN #MSQSP* /1:1VV(6() &< 9->=7NN>*99/&!M=1LX(M%.^
M$FUW,X$7F;3DX ]^3GTKM]%O9-2T'3K^5562YMHIF"] 64$X_.@#&3X@:%)/
M/"@U%FMY#%,5TV=A&PZAB$XQ6UI6L:?K=BM[IEW%=6[' >,]#Z$=0?8USG@Z
M;=XC\8P;?N:FKYSUW1(/_9?UKEKC4E\(_$;QC>6,*FU724NYHE/RBXR H('3
M.23]2: /6J*XF]U+7O#T^@7%U?KJ-MJ%U%9W:"%%6)Y.%>,J =N[CYBV1BF:
M=JGB#7],&NZ?JEI#"+YE^QRJOE+;(Y5M[8+"3 W<$#IQ0!W-%<(NOZJUUX[M
MA?-MTF-);.01IN3="9,'Y<$9&.1G'?/-9]GXE\1:I<^#((M1AM_[8L)9KEOL
MRL0RJ#E<]#SQV]0>E 'I=%>2OXC\6#PYXFN_[<02^'KQX5<6D>;H*P_U@Q@#
M!Q\H!]ZZ2^UW5=2UN33=+-T@BTZ*ZWVGD99Y-V,^=GY1M[<\T =M37=(T9Y&
M54499F. !ZFO/?[6\7'4O"FG7=[;V=W?QW4=\L<:2KNB7AU/9CG..@(Z'D5D
M>)+O5[OP'XCM[_59Y)M*U:.V6:)4C,\;/%@2 +C@2'I@' SF@#UNBO/_ !=K
M&IZ!?6\=W>ZI#I MBPU2V@CD*W&X_P"O 0@(!MQA1GGKV[?3IC<:9:3&>.X,
MD*,9HSE9,@?,/8]: +-%<KXLU>^M]6T71+!FCEU,S%I$=4<+&H8A2P(!.?0\
M XQU',ZYJGB_PYX6F>ZU.$W2:G"MNWRR.;=VP%EP!Z$9&">>: /4*;'(DJ;X
MW5UR1E3D<'!_6N CN=73QOJOABZUNZGMYM(^W).$CCD@?S-A"$+@#'KDCUSS
M6#I5QK.E_#CPC-IFLSK/J.H00.MPJ2(%=FR/N[L9 /7/7F@#U^BO/=:?7_"#
M:7JE]XAN;_2DO-FH[H8TV1.<1M\JYPK'G!YR*Z;P[//?2ZEJ+SS/:SW3):1N
M056-/E++QG#,&/.>,4 6Y-6,?B&+2?L%VPDMS/\ :U3]RN#C86_O=\5HURMU
M?7Z?$JSTU;V464^F33&$*F%D#J P.,YP>Y(KD;?5/$G_  A">))/$$TDMMJ7
ME>088PDL9N?*(? Z\C!&  .G>@#U3SXO/\CS%\[;OV9YVYQG'IFI*\WMR+3X
MI>*+F2XO96M=/AN$02\%0&)3'IG& /?UIEUJ&K6WP^A\;0:O<2WQABNIK9F!
MMV0L-T03&%P&(W#YLKR: /2Z*SM8NI+?P[?7<-Q#:RI;/(DT_P!R([20S>PK
MA?#U[K">,;*QDN]3^Q7^E/*SWC@EYE*@R1JV3&O(PK #GI0!Z717D=C?^(&\
M(^'/%#:]>33_ -HK;S6[E1%)$\[1'*A?F;[O)/';%;-[K;^#/&-ZFIW=[<Z?
M>V33:>DDQ8+*A)>%<GEFRNTG)&<=* /0Z*SM!L)],T*SL[FZFN;F.(>=--*T
MC.YY8Y;G&<X]J\RN9-:/A/Q/K \2:H)]'U6Y%L@=0K"-P ' 'S CC;POM0!Z
M]17$01W^D>/=,ADUN_O8M2L[B2>.Y9?+5H_+VE%4 )]X].M8":GJ0U3P]J$.
MHW]Q'>:L]O-=>>1;7,;&3"QPDD *% W +G!(SG- 'J$=U#+<30)(&EAV^8H_
MASR,_A4U>2VK'PYIOCW6[%[EKRQOY%A\VZE=/N)RREL.1N)RP)]ZUM#TSQ-%
MJ]E>7&M6RZ7>VS1M&FH37#S.49EDC\Q<*W&<+@8!XH [G4[J>RTRZNK:T>\G
MBC9X[>,X:4@<*#[TZPN);O3K:YGMGM9I8E=X'.6B8C)4GU'2O,]!BU27X6W/
MB>?Q#JLUX^CW)"/-\B,I9E91C[PVXR<G!(]*T+@RZI;>&+!Y[RZ\[2A,]G;7
M#0,S;8\2R2J00HR1CG)/0XX .MUW73HLNF)]C><7U[':;@X41EL\GN> >*V*
M\EFO[R\^'W@6ZNKB22Y;7+56D9LL0)'7D]^!C/>O0_$UW]A\,ZA<_P!HKIQ2
M$XNVCW^43P"%[G)P!ZD4 :]&:\S\.MJ=EXSN+*);N$2:"+B."]NVEWRB3:)'
M!)",>X!-5-"M+[6AX<F236DO#(\NL3&:XBBE7!^Z^0C MMP(R1CVH ]7S1FO
M);&"^-UXQUA]3U5YM$OYYK2U^TL8W"Q$A6!R64_+QVQQC)S9T&TU4KH/B2+7
M8##+$1.GGRS&]=USM*MPK @\*!CGH!0!ZCFC->2>'?[9U;3]'\4+KUE K7"&
M[<R3,TK,VUH60ML&20  HQ@$&J]U!/-H/CR^?4]3\W3-0F-F!>R 1%54@\'+
M>F#D#L!S0!['FC->86TES8>,? URE]>22:Y:3M?B6=F21A"C@A,[5P3_  @<
M5F:7%=:]HY\2GQ%;6-]:7CR7#^5-)-$0Y_<LOFX*D8 0+]!D\@'L6:KRWMO!
M=6]M)*JS7!81)W;:,G\A_2O)YK#^TH?B''=7NH/%I<CSVD?VN0".01%@<YR<
M%1@$D#TJX-+L-:UGP!?:G")KB]TB22XD9V!D*Q1,"<'L68_C0!ZI1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 45G:OKNG:##;RZE<B!+B=;>([2VZ1LX' /H>:T: "BL
M[4=<T_2KRPM;R<QS7\ODVR[&.]_3(&!^-:- !1110 4444 %%%9^H:U8Z7<V
M5O=RO')>S""#$3,&<\@$@8'0]2.E &!XSLI4U+P_XABC,BZ1=,;@ 9*P2+L=
MAZ[>#]![5/?:5?:CXQT37K*:S:PLX94;,I+2K(!RN%(XV@]>?:NHID44<*;(
MHU1 2=JC R3D_K0!R=A:KK/Q#G\01@FSL;+[#!*/NS2%]SE3W"\+GUSZ5U]9
M4VJZ;I-_INC%3#+=9CM8HX2(\*I) (&T8 Z9]*U: "BBB@ HK.TG6[/6OMOV
M3S<V=R]K*)(RF'7&<9ZCD<UHT <=IFC^*=)O=4N8GT>;^T;HW+J[2+Y1VA=H
M(!W !1S@?2K4NAZU>P1PW^H6TT,UYYUY$L;!7B  6),DX7@$^ISV)KIZ* ."
MB^'\YT;7/#\UW NA7SL]I;HI+69W;AM)X(SAMO&#T-6++PCK5]82V/BK7!J%
ML('MXDMX_++!E*F20_Q/@\=@23R<$=K10!Q_AWPUXBTLVEMJ7B-+W3K(8BC2
MV\N20#A0[;CD =N^!DUS7@[2-6U[P--IOVZS32+J[N%D*H3,L?G'<@.=OS?-
M\QZ9Z&O4IHHKB%X9HTDBD4JZ.H*L#U!!ZBN:LO$FAV=]#86.GR06D\QMHKNW
MM@+=Y@2"@*\@C:1D@#@\\4 -3PM>VGC:77+#48HK2Y@BAN+9X2S$1]-K9P,C
MCD'J?PN>*M%O-<TZWM[.X@@DANXKG=,A8$QL& P".I J;4/$VF:9JMOI=RUQ
M]LN59X8HK:20N%Y.-H/2I](US3M=@DFTZY$HBD,4JE2CQN.JLK %3]10!F6^
MB:G!XIU;5Q<V9COK6.%(C&V4:,-M).>1EFR,#M^,W@[1+GPWX7L]'N;B*=K4
M%5DB4J&4DD9!)YYK>HH X:V\$:KINJWZ:7K_ -FT/4)C--:>3F2,M]\1OGY<
M^N./J,UH?\(U?Z=K&J7VAZA!;)J@#SQW$!D$<P&/-3!&>.JGJ1G/:NGDD2*-
MI)'5(T!9F8X"@=235#4-8BT[4=.LY+:ZE:^D:-9(8MR1D#.7/\(/:@# 3P=/
M::QX;GL;J$6FC12QE)D)DF,H =B00 >,].I-9]YX&U:ZTC7K :A9*-4U-;\.
M87/EX93MQNY_U:<_7VQZ!10!RUQX:O;WQ?\ VO=7%J;1],;3YK=8VW,K$,Q#
M9XY&.G2J.A>#-9TF6"QF\2R7.@6C!K>S-NJR$ Y17DZE0<<=\#H.*[>B@#A-
M(\!ZEI=P]A_;YD\->>TR:<;==^"V[89/[N[KCJ,CC-6[/PGJEA=:_P"1K$1L
MM4EEN$@:VY2610I+-G)4 #@8SZ^O844 <<O@JYM]-T'[-J<2:MHL?DP77V8A
M)8MNTQNFXG! &2&X/(QTIM_X(N-2TG6XY]1@34=9,8NKA;9BBQH,*B)O'3GY
MB><GCH!V=% '.S>'[ZY\4Z3K<VHV^;&WDA>%+1AYA<#<03(=O*C P<<\GML:
ME80:IIES87*AH+B-HG!]",5:HH XX?#ZP;0]$TZ2XEWZ;)YKSH2&N"P(E#<Y
MVODY&>G%:6K:%>:AXDTC58-0A@CTXO\ N7MBYDWC:_S;QC@<<'!YYZ5OT4 <
M7+X(OC#XCMH-?,=EK1D;[.]H'$+28#MG<"W&<#@#/?%3GPEJ+7_AJZ;5[;_B
M2(R;19$>=N78>?,^7Y,#OSD^PZVB@#%\5:#_ ,)+X?FTP7;6CNZ2).J!]C(X
M8':<9Y%9]KX6U.#Q7;ZY+KJW+QV)LY4DLP&E!8OG<K ##$8 7H,<GFNJHH X
M-/APW_"/1Z=+K4GVJVNVO;*]A@\M[>5B2W&XAE))X/YUT>@Z+<:7$\NH:G+J
M>HRJ%ENI(UCRJDE55%X4#<?4DGKTQLT4 <OJOA6ZU#Q5::]#JWV>:SB>*"/[
M,'4!A\Q.6Y/Y5(WA7[?/=2:Y>G41-:-:*GDB-8XV.7QC)R2%YSQM%=)10!R]
MIX3G#Z>FJ:M)J-KILHELXW@5&#*I56D8??(!/0+[@UDP_#0P6\=I%XAODL[:
M_6_LXEBCS"X.X[F(._DG&< 9Z&N^HH Y(>#9E3Q$G]KLPUM0LA:W!,?R;"1@
MC)*\?7G':MW1M/DTG1+/3GN/M!M8EA679M)51@9&>N *T** .0T_PCJNGWU_
M<Q>)YE^WSB>=5LX_O8 ^7.<?*H'(/TJ_8^#M)L[#4K5TENVU,$7UQ</NEN,@
MCYB,8P"<   =JZ"B@#FK'PE]G;3X[O5+F]M=-;=9PRJJ[2 0I<@?.5!P.GJ<
MGFJ5O\/;6TU*[DM]4OX]+O93/<Z6&7R9'/7G&0I[J#SZXXKLJ* .2U#P/'>Z
MMJE[#JU[:1ZI (KNWAV[9&";%;)&1@'H",^N.*=8^!K;3YM F@U"[9]%B>&'
MS0A#H_#!L*.<8 /;'>NKHH Y3_A K Z7KM@;^_,6M3F>Y;='N5B>=GR8 . .
M0:;J?@.VO[RQOX-5U&RU*T@6W^V6[J'EC'4.-N"<9YP,$YQQBNMHH YQ/!ME
M#J6DWT5W>H^F"7RDW(PD:7_6,Y*EBS=SD>V*KS^!+*ZT[6;&XU'49(M6N%N9
MB6C#)(I4@H0@Q]Q1SGI75T4 <S-X1>3.S7]4'F6RVMSYABE\^,%SD[DX8[V&
M1@8QQ4=IX?N-.\36)TZ:_M])M+00-;/<*;9@ 0H1.6W@\ECCH!SDXZJB@#$\
M2>%[#Q1:P17CW$$MO)YL%S:R;)8FZ95L'K]*S[SP%87^BG3KC4=2D+W*7,MT
M\J--(Z?=!)4C ] !_.NKHH P?^$5MSXL;Q$;V\-TUI]C:+,?EM%G.,;,YW<Y
MS^G%9*_#:PCTNTTZ/6=92"SN4N;?]^A\IDSM"Y0@ ;CVR>Y.!7:44 <;XOO+
MF[5O"4&DWEV^I6A3[>T0,$.<J6<C&",;L#VQ75V5I#86-O9VZA88(UB11V51
M@?RJ:EH R9] MY_$$6M&YN4NXH&MT"E=H1B">"I[@'\*SAX&TY?#;:"+R_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD@EM9)TDC-P2-LD:HS84=^A] *V9=*UKQ%#H=IJ]B+1M,NXKNXN!*C)<-&I
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8;AI#U+;4) 51P#U(/.*Y;1-.C;X*RZMI]H)M6A,L3RQ9:40F8;T'7^ =,8
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MM:@U./2#:7,&+9I%>T:2?S$+[2&Y3:,>WM0!ZM_PE.@BTM+HZM:""[SY#F4
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MR\5ZMK+Z@DD&H)&OV80;2AC&%._<<\$]A6]110 4444 %%%% !1110 4444
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M6+M\Q9F8]69B26)]22:N44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCN_"WA[^TK.VAG?SXXF$K$!0QQG Z\XXR*Z7- !131(C.R!E++]X \CZTZ@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[HEB+6T\)';G<SR:JCN[>K,1DFF2-XA?6EU5O#+^>L1A"_VJFS82"?EV^H%
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M!R21U->RWO\ QX7'_7)OY52_X1O0OLHM?[%T[[.'\P1?94V;\8W8QC..,UJ
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MD:?PMO=.(!N:8G/"Y#=&)...X .V\5:[<^'[2QN+>UBG2>]AMI-\A4H'8+D
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M([9VY&>U3:R]S'HUVUE<V]M=")O*FN?]6C8X+>U<5X&\3Z!H_P /K%[W4[6
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M9GU+[/92:1<V"!KF/SFNB=KPG[P0C^+TK1DNK>%@LL\2,2H 9P#EC@#\3P*
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M'/)JS-+:)YME=I BLR! 2",$9W9&1CVQ0!U]GIUCIRLME96]LKG+"")4W?7
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M4*H50 H&  . *7%9(\0V"^(UT!O/6^:(S*&B8*R#J0W0^GUIB^*--:U:XS<
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M+O\ M#:-WDRL[^2SJ.>,YY'I[5L>);KP_=Z,[Z2J_P!FS:Y:/-<B4B*64O\
MO-@)P  %)*X!)/<&O4Q9VJVWV86T(M_^>00;>N>G3K2/96LD*PO;0M$GW4:,
M%5^@H X_3[;3M-^+-W:V45M;!]%B8PPA4RPE?^$=]NW\,5T>M:KHUA'':ZOJ
M4%D+L,(_,N/)+8QG#9!&,CH>]7A:6RSB=;>$3 8$@0;L8QU^G%+/:V]R +B"
M*4+T$B!L?G0!Y-/X;N;WX<^+-(T6:XO=,^TH^E%I/-WJNQW5#W7>& ]2#UZG
M;U2\MO&'B3PE'I5Q',EL[:C<-&P;R0J@(&]"6.,'G@^E>A*H50J@!0, #M3(
MH(8=WE1)'O.YMJ@9/J: .$U>T\>)X:UK[5J&GW!-C((4L8&24OZ@D^F[WSC%
M8$OB3PS>S^ FTZ>V3[+<JDB!<&W!B*[6../F]>N,UZ]4:V\*.76&,,6W$A1G
M/3/UH \/O];L);=72[2S2W\2+/<631LTD1\_YI)9"/E!'0#'IDX-==KUG>:5
MXL&IZ+"[1>);;[%+LC_U<X4F.8@XX"[L_P"Z:]!-O =V88_F8,WRCEAT)]ZQ
M;#0]277IM0U76#?0QNYL+<0+&( PY)(Y9@,J#Z$^O !L6=G!8V,%G;QJD$,8
MC1 . H& *\7T]?#3>'?'MG?I8G49-5O5M82%,[' \L1CJ?GZ8[U[:^[8VS&[
M'&>F:Y;P;X8N] ;5I-0:SFDO=0EOHVA4DQF3&Y<D=.!^M ' SFWTK78[/QCJ
MFJ:<MSHUK"D\#E8Y"BL)8V(!YR>GU]15];30['Q7X)TR[C"VZVEVL,&HN'DP
MS 1;P1W&< CCIU%>LXSU%+@>E 'F4T=M9_$W5--T>6"VN_\ A&_(M;>(A0)
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MIX;&0JSVI50'3;U&X9!''RDYXKNO!DN@:CJ-_JV@0WDD=PD8GOKEYOWKC.%
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MD$RAXW'1E/0BO/M=TR]T_P :R6FFJ$L_%4/E7+(<&&6/EY!CUB+#C^+!R*]
MD5(+)U2+<D<9"QKW '04 4K?Q'H]W>I9V^HP23ON\M5;A]OW@IZ-COCI0WB/
M2$ODLFOH_M#R^2BX.&D[J#C!/MFO(M-U.T9_!MRDES'#;W[AK"&S?R;/*O\
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MK6+F2UL[A_M$:"1H9H7A?8>C!7 )7W'%-U;Q3HNAW<%KJ5_';SSJS1HP)W
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MP=,\)IIGG:C;S)96\*)+L3EGEQ@9ZX'7&/7@ [73?&.G:C?W-D\-Y92V]O\
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MBE=)_>2VAL[W3([I&D5 Y9&5FVH6!)R,CKP36OX<TB>SO=7U6[3RKC5+A93
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M >B44#..>M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)6"NOEL<,H.#R!U%6[[QKI=C).72YDMK>Z6SN+J*,-'#,<85N=W\2Y(! R*
M.CHK 7Q5;OK>H:.MA?&\L8/M#+M3$B9P"AW<Y_#IS@\4EEXNL;_1=.U6WM[I
MX-0G$$*X3>&)(R1NZ#:<]2 #QP: .@HI*YF";2X_'.J3>=?1WT-@AN%D8BW\
MK<<,H[G(;GZ^IH Z>BL+2?$\6JW%M$NG7UNEU"UQ;33*FR6,;>1M8D$[@<,
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M,0CKM&W(PW#$<5?O?AQ;7>F:Q:+$L::A>K<)$9W*V[ D&9?]LAB=O Z#/&:
M.]5T?=L=6VG:V#G!]#3JY#Q!=?\ ".>)]$OK?;'!JMX+"\0# D=E/EOC^\"N
M,^AQV&.OH 0E5&6( ]S2!T8X#*3[&L?Q?;0W7@[68YXED3[%,V&&<$(<'ZUA
M6G@W1]9\!Z;&+.&UNVL87CO+=!'+')Y8(8,.>O7UH [>BO,O"GC[4GT3PK%?
MVJ74NI7$ME+=>=A@T9P&V[?FR/<<UJ7WQ!FL8?%C/I*.^@/$,+<\3K)R#G;\
MI QD<_7O0!V5U>VMC$LMW<PV\;.$#2N%!8G &3W)[5/7G^M>(;BY\-&\UOPC
M&]BUU;>2DUVC;U<C$F #@J2!CWZUI7OBK6$\47FA:?H$=U-!;I<I(]Z(U9&)
M'/RG!R, <_A0!UU%<;;^.OM^B>'[FUM$2]UN1HHHI9#Y<17.\LV.<;3@8&3C
MIUK0\-^(;S6;[5+*[T^.VDTV;R))$GWB1L Y48& 00>?7% '0.Z1HSNP5%&6
M9C@ >IK'@TS2M3UJW\36MR;B98&MXY89]T3)D[A@<'YA^8]JPK'5=<O/B5J^
ME7$5F^G6]M%^[\YN$8L0VTJ0SD8!' &.IKG/!?B35-"\&^'=VD1-H\UVUH]R
M;@"0,\[@,$ ^Z"<=<^P') /6J@NKRUL8A+=W,-O&3M#RR!!GTR:XG6/B%-:3
MZA_9EBEXFGS^1)%B4R3,,;]FU"HQG')YP>@QGJ;_ .SZGX;FDD@#PS6K.(YX
M^0"F<%3T/- %\7$)M_M(FC,!3>)0PV[<9SGIC'>F6E]9WZLUG=P7"J<,89 ^
M#[X->7>!]1O?!=EH=CJT[3:#JUK#-9WC\"UF= QA8]E)/RGW^N-S0M6?2?#L
M4%K DM[?:U>6]O&[;5SY\K%F(!.%52?P [T =[5/4-4L-)BBEU"[BMHY95A1
MI6P&<]%'OP?RKF;_ ,5:C9W.KZ/+%:Q:K;6#7]K* S12Q 8/RYR&# C&?0^U
M9J:I/#\/_"ESJMC9:H;J:R0&?)*%PH$GS Y<9/.1UH ]$HKD[_Q'JEWJ&K67
MARWMIY](16N%N,_OG92PB3!&#@?>/&3C'6HK_P 6Z@+V'3K2R^SWQL5NYUFM
MYKCRF;(6,B$'N#ELX&.AH [ D*"2< <DUBIXP\,RR"-/$.E,Y. HO(R2?3K4
MGAK5;S6=#AO-0TV;3KLY66VE4@J0>HR 2#U'UKSNUWW5K\0-,AT6XU&>ZU*:
M.-41=FYD &68@+@G.>W:@#UH4M>?:9J6J^&])T;PS+(LFKQZ>T\\K6TUT$ ;
M:BXCY/7&[.!M[Y%._P"$T\1?9= #Z#%!?:A=/:2PW+/$ 5!(=<C.T@9Y&>V#
M0!U N]&TW71IZ/!!J6H!I_)08,NWJYQQGW/)QWQ6O7#0ZYJZ>+_#FG:SI&FQ
M7EY;SM)-$2[1E >$8] 1M/4]2*)O%^KR>&+KQ58V]I-I<$LA%J5?SI((W*,^
M_.%/RLVW:>!US0!VTDB0QM)(ZHB LS,<  =2:KZ;J5GJ]BE[87"7%LY8)*G*
MMM8J<?B#6)_;][J^K7.GZ$;9#:6T<TTUW&SJ6E4M&@"L".!DGMD<&J_PQ\T^
M ;(SA1-Y]UO"=-WVB3./;- '751?5]/CU>/26NXQ?R1F5+?/S%!_%].*YOXI
MWU_IOP\U2[T^Y$$B!%=MF24=PA"G/RGYNO/]1F:Q_;*>.O"RVS64]^UC=#S)
M$:.)5_=\E=S$X';/)]* /1:*\_C\;:K;Z&5N[>WDU8:R=(5H8V,;,/FW[,Y^
M[GY<\GN*W/#>I:]=:AJ-MJ]D5MHBC6EV(3%YH.=RLA8X(..>AH TM0U_2]*N
M4MKR\2.=UWB( L^W.-Q"@D+GN>*AG\4Z);Z=;Z@^IP-9W,@BAFC/F*[DXP"N
M><\5R/B&+Q%X7\7WOBC1[(:Q87<,:7UH'Q+#Y8X*>V#G&#U/'>L?Q1J.EZI\
M-K*^T N\,NMQR>5-\ACE:0LR' X^8^_7O0!Z]5%](TV754U22PMGOT38ERT8
M,BKSP&ZCJ?SKF+/Q'KL'B75]!O(;.^O(-/%_:FW!A5R>/*.XG'S=&].M5?#O
MB_4M3UY=,DN;*=WTHW;O%;MLAG#*&0-NVR+\_53VZT =_63-;Z-X>6^UEK>*
MV+KONIXXR6<#NV 2<5P^F^.?$MQX/MO%-Q;Z<;*=&B6WB5S*9S-Y2$9.-N>V
M>W7GC0;5_$-S!K-KJ&F7"Z>=,E=+J6W6$K(%(*%0[9!'(/'3% ';V5W#J%A;
MWMLQ:"XB66-B",JPR#@].#4]>=>'=5U_3;3P9#=-8/IVHVZ6XBCC;S(L0;D;
M>3@DA>1M&.G/6KA\1ZOJNAZEX@T:>W%M8R3+%9RP;OM"Q=<OG()P<8''&<T
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MW9WKR1XC\PYVR;OFP#SP#Z5L:'9:A9^/]8GGT^86ES:6T4=T BQEH@P;Y<Y
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M@8P<CD_E6)'X.\1Q> ]%T-%TQKJROUN96-PX1E64R  [,Y)..G&.]>DX% %
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MT<VQ0."^_=DDLH*]. >.M #'\:366E7NHWD%I<VJF%;&>RGW)=/(2NSG[I#
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M8=2W\/S$GCUQT%;E !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 4+G1-,N]4MM3N+&"6^M01#.R99 ?0_G^
M=7Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\Q6RNI$ BN2.RD'(SVW 9[9H Z6BJ.KZM::'I<^I7TA2V@ +$*2>2   .Y)
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M;1F<R*A"DS;#R2H;TSD@]:[22TMIHA%+;Q/&#G8R C/KBI-B[-FT;<8QCC%
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M>:9K5VFO7FFZ=<FYM]>AU2VAN(6B%TB*!A2P'<$XZ\>XKK[/6M0U;3;Z]N-
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M^]"H<,$&.0=_4FNSI!0!PGAS1O&NFP66BWUYIQTNS=0MY"S"XDB3[J%2,#.
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M,93&R%D/\:9'S#W'J/6JWAW5;"S\(P70U6^U.$RR1I<7",T\[AV7:%QDG((
MQT%5/W.K>.-,UJRM9X[;3[&=;B>6UDB+;]NR-0R@L1AC@#C/J<5R'V>^;P=H
M][#I5]=IIFL7-Q=60BDBE:)WEPR@@$\.#QZ_6@#T6#QAH]Q8W=TDTH:TE$,U
MNT+"99"<*GEXW$L<8QUJ]I6L6^KK<&"*XB:WE\F5+B%HV5MH;H>V&!S7#I;Z
M7JVB:G<GPIJEG8W<ENDCM&ZWCLK'][M!9L1Y4CO][BMKP.NIQ#4X+R>XO;1)
MD^R7]U 89IQL 8," 6VX W$<_A0!M:EK]EIDWD2+<3SB,RM%:PM*Z)_>8+T'
MIZX..AK!\7>+H[;P/)JNBRR7 N% AN;>,NJ9=5))_A/)QGN*8'N/#_Q!U:^O
M;6XDT[5+>#R+B"!YO+>($&-@@)&<EAQ@_6L*XTB_L_AAJ=HUC=_:]1U![J"R
MCA9VB0SJX4A00ORC/XXZT =GX=TM;.2ZO+>YU,6UUM(L[YF)B<9#,-^6&[CC
M../?AEMXVT:[U.&RB><K/*T$%UY)\B:1<[D5^A(P?8]LUOPRK/$LBJZAAG#H
M5(^H/(KQJ%;Z5M!N7\/ZREQ9ZN9;B"*V,=O;*=V%CC& V>#OP>^2,@4 =?%-
M<K?>/H?MMT5MT0P$RG,.;??\I[?,2:T_AY/-<_#_ $6>XE>65[<%G=BS,<GJ
M365&EPVJ^/#]BO0MU$GV=C:R 2[;<(0O')W#''7J,BM7X>P3VG@/2+6ZMYH+
MB"'RY(IHV1E8$]B/UH :GC_09-:&DQRW#77VDVK_ .CN%C?&?F)' /0'Z]@3
M4MOXUTJXU2VLBEU"+PD6=S-#MAN2!GY&[Y'3IGMFN>\-Z;>SW/CJT:WNK-M1
MN96MIYK=U5E9"H8$C!P>U9?@G2Q;)IUA<> FM]6M)(UGU&YB5H@$ZR(Y.=YQ
MP%'4@YP* .ET.]CTW7O&<E[>2BSM;J)]T\C.(U,",0,YXR> /I5^'QMITEW<
MV<MKJ%M=PV_VD6\UL1)+%W9%&=WTZ^U<EJ^D:CKUOX[M+*TN8YKR:WFM3<0/
M&DXB6,,H+  Y*$>^?2M?PG';WNH0W4/@9-"E@1A-/<6J(^2"-L1&"1W)( QQ
MWX -NV\76%[HMCJMK#=2VM]<"W@VHNXDL5#8)Z9!]QZ5%-XXTF+4FM MU*B7
MBV,MU%%NACG;&$8YSG) Z8!.*PO#'AF_TOQA?VLL>-"L9WO-/R#CS)A@@?[@
M\P?\#K U2'6IIKWSO#FK--:ZW'=C[(JK;-"LJG<BAAYKL!DD@D9Z@= #MK_Q
M_I%A=W]I]GU*XNK$CSH;>S=G"D$[\?W !][IR,$U%?\ C5H]9T&UL--N[NVU
M.)KA9XT4AXQ'N 7+#G)4G/;CG/%&UDN#KGC.>33=0B6ZMH3#NM7/F%8BK*I
M()#$#@G/49'-9UK_ &CI]GX!O%T/4[DV%I):7,,<&V2.1HD09#8PN5/S=,4
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M.>YQT]*S[/XBRW=MIE\?#UW%IU[=BT-R\J_([.44A>K+G&3QSGKBKK6NK_\
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M@EI;Z5=)=J9;<S-+(I+9)WK@$LQ/UXQ0!U5K"\,*B9XY)R!YDB1[ Y]<9/\
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MIJL\A&@ZMOTNT)!QYD;?*W_ VW@'N,4 >D*"% 8Y..2!C-+BL#7O%=KX>O\
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M:W+9>!VT2UTZTM=1P?LI9D4$1L0F54X0#!X&<@=J /1(M0LI[V:SAN[>2Z@
M,T"2 O'GD;E!R,^]6:XVWUV#3_$/BB:_TRRLUTZVAFN+R [I+A2KE<_*#P%(
MQD_6I9?%&IZ5)ID^M6%K#8:C.MO&\$S-) [Y*!P5 .<8)!X/J.: .MHKSVY\
M>ZVFGZ[=P:':,-%N7CNMUX<,BA3\GR9+<D\@ <=3TNZYXRO;:&.XTZWM(;,V
M"WWVW4F:.*3=]V%2/XR.?Z4 =7=:E96,MO%=7<,,ERXC@21P&D8]E'<U:KS'
MQ%JR:]'\.]62$Q"ZU.*38QR5RO(S]:].H *J6NJ6%[=W5K:WD$\]J0MQ'&X8
MQ$YP&QT/!X]JS];UF:SO;'2M/$#:G?;S")R1&BH,LS8Y/8 =R>O%<%H6MW&@
M>(_B!J.K);M=QR6*>7 Q"22,C*@!()&<KGKCGKB@#UBBN3_X2/4]'UNRL/$4
M5DL6H"3[/<69;9$R+N*R;_\ 9R0P]#Q2:1X@UW5XM.U6WL+632+Z8J$1B)X8
MN=LK$D*>1RH&1D8)H ZVBO.W\=ZJG@WQ-J_D69NM%U*6S4;&V2JC(,D;L@G=
MZGI5^Z\5:U-XM;P]I5E822OIR7\5S/,X0*6VG<H7/7H!Z\D4 =K17GEIXYUZ
MYT#2->;2[&/3[BYCM;E?.8R%FE\HLG&  W8Y)]JDUWQYJ%KJVJV.D:=-=/IP
M12BV$T_GR$;BN].(Q@CDYR<\8'(!W]%<,WBGQ)=^(K/2K'3+* W>EB_'VUG#
MP'<JLK@#G!)&!ZCI@UCW_B;7-:\.^';R.:#3YI-=ALKN%8RX9UF(X;<#LRH)
M7J>F<=0#U&BN!\5^+=9\/&[=Y-.@CM($>(31,S:B^TEQ&JOF-5QU(;KR:FAO
M=6O/B/9;+Z!;&71S<I;M;DE5:2/<,A^7.!\W0?W: .GM-1TK7X;V&VFAO(H9
M6M;E,94./O*01SU^E7HXTAB2-!A$ 51Z 5Y_:^,[BPTSQ%<7%A8Q7=OK/V""
M.$%%F=M@#.>I/)8GK@5L'6M9T[Q-;Z)?_9)_M]M(]G=10O&HF099'7+<8Y!S
MG@B@#JZBGM8+GR_/B23RW$B!QG:PZ'ZBO+].^(/B6;P]HGB2[MM+73+R]6TF
MACW^:<NR[P2<#&.G.<=>>/5: "BN?\3ZK?Z6+$VSVEO:R2D75Y=$%8$ R,+N
M!9F.% &>O2N6'CK6Y?"MKJ5M%92W+:R--97A>(3+YFT, 6S&3W!#8S[4 >DU
MA:O-X>@US23JD$#ZG*YCL&> NX;J=K8.WUSQ6&/%NIZ+J>OVVO&SN(=.T]+^
M.2TB:,D'<"A!+<Y& ?Q[\8OB==?36_!5QJEW:,LVK1EH((BODL1]T-GYEP2"
M3CGV.  >ITE+7)>)]7URQ\3>'].TN2R6+4FGC?[1$Q*LD98'(/(]L#..HSP
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MWV9]T>_^+:?3.:NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<[X[TNZUGP/J^GV2"2YF@_=IG&X@@X^IQ7144
M>?Q-J5SJG@RZET/4(%LQ-'.K(K&,-&(U9L'@$Y/KCFL._P##NL:C)XLGM-,N
M4N6U&WU"S%RH6*Z$0^X0>N?FX.,_+7KE% '*>%GN[VX%U+X7BT)(XMKAT3S)
M9#C[NWD(,=3UR..*ZNBB@#F]/(U'5-<M;O2[M+2ZP-UQ%B.5-BHPZ]^>O:N3
MTSP#J6G77B/1EN))=,N-)^RZ=/+_ ,LU9I#Y;$==K.3GT(^E>H44 >=_8M:U
M[0-"T.]T>>TGLKFW>\N'91$%A.<QD$EBVT 8Z9Y/'-O28]5TCQ#XI271KF2U
MNIS=Q7,;*0Z^6%VJ,Y+9'3]>F>YHH \FMM)\2:;H/@[6+'299;S18I+:[TZ7
M"22(X )4Y[8R/P]Q6GXCT_Q/K^EZ?K"Z1;_:;*]6YCTBX=6+1;"K!FZ;B23C
MM]>*[TW]FM\EDUW +MU++ 9!YC =2%ZD59H XNROM8LM&O\ 6(O"=O9X1/*T
MX31Q2, 3O=WQM  / ]CZUU&DWXU31[+4!$\(NH$F$;_>3<H.#[\U+=V=M?VY
M@NX(YX2RL8Y%#*2"".#Z$ U,  , 8 H R?$TFJ+H5Q'H]K)/?2CRXS&Z(8\\
M%\N0.!G'OBN1\3?#737\*R)H=A=C4X CV0^VN?+D4C'#OL'&1_*NZO=3L=.,
M(O;R"W,\@CB$KA3(Q. %!ZGD=*MT ><Z[J&I#6O UY>Z1,E^LUQYUG')&S%O
M(.[80VTCJ1D@FDU'PKJ^N'6=<MH?L%_<26<UC;W!7.;<[@9=I(!8DC&>,#-=
MAJ'AZUU/6+#4YYKD3V#%H%CDVHI(PV1CG(X/M6O0!QYL[_Q#XHT75+K2I]/A
MTE9V(G9"\DKJ$VKM)^0#<<G&>*P)O#VO7/@+Q9IO]D2I>:EJ4US;1M-#RDD@
M89(? P!SS],UZ?10!Q$.E:OI_B+3=>AL)9T;2UT^[LP\8EB*MN5P2VUADD$;
MO3KVT_"VB3Z?=:SJ=W'Y5SJMUYYAW!C$@&U5)!(SC)...>IKI** &R,4B=UC
M:1E!(1<9;V&2!GZD5YB?#NOGX8R:3_8\O]H-J?GB'SXO]7Y_F[MV_'3C&<Y[
M8YKU"B@#BK_3]<E\=SZI8V+0QMH;V<-S*\95)RV]=R[B2 < \=?;FL;0] \0
M6FMZ!J=UH,44MND\6H7,E^LDLS.%_>L<<J-IPH)QNQA0,UZ=3)8TFB>*1=R.
MI5AZ@]: .&@T2*?XESW5C?*^GS0QWM[;IAU-PA*1'/;(RV/6,>O'>5SWAZR\
M->';F;P]HJ06]RB"XEMU8ERIX#,3DG\^./6NAH YCQQIFH:MI-I;Z=;+/+'?
M07#!I @"QL&/)[G&*H^*='UQ?$FG^)-!M;>]FAMVM;FQN7">9$6##:W0-D=?
MI[UVM% '":OI?B?4(M+>6PLIK<7,DM[I<=R40H5 C4OM&\ Y+ C!)Z8%4M(\
M.:S::3JNFZCX;TZYL;K5I+@VR7 (:%P3\@*@+M(3!)!//"\&O2** /.++P;K
M-EHEF]G^[N-/U5KVRLKFX\S9 5V&%G /."Q&,@9ZGK6E?:#J6I:MJ6N26:QS
MMI3Z=:6OFJ68L22[-T')Q@$\9/M7:U1U/6-/T>.&34+N.W6:588]Y^^YZ #N
M: .,70-;72?!%M]@4R:/)&UW^_7@)&8_E]<YS69K/A#Q-J37Y:QL+B<:HMW;
MWDUR=[0"0%(E&#Y8 ZXX..A/->IU2FU:PM]4M=,FND2]N@S0PG[SA022/H :
M .7L-(UW2/%OB#5X[*VN5UA+8HJW.T0/&FTAB5Y7)/(!/'2J\?A&]T>U\*6%
MA +J/3;PW5W.9 FXLKAB >>KD@>@Q7?44 <#K.G6.O>/-+FTS4XFE\EX=3B@
MD#[[=&5@K8SM^? [$@GTKOJYU(?#'@UI6BCM;"6^<R.J F28CJ0HRQ SVX&?
M>K$WBO08--N-1;5+=K2V;;-)&=^QL9VD#)S[=: *WCK2+[7O"=QIFG)$UQ-)
M$P,K[% 217.3@]=N.G>L[Q+HWB";5=+\2Z MLNIVT+03V5RYV2QO@E=P[@C/
MO^&#V4;K+&LB'*L P/L:=0!P^KZ!XJU&TTO4TN[%-<L;S[2EN=PMU0IL:/=C
M<<C)S[D>E9NG6>JZIXO\566JFSAO;K1HH?\ 1BS1IN\Q1RW)ZY[5Z567'HFF
M6>K7.MI RWLL>V:;S';<H[8SC QQQ0!Q]GX:\5EO"8O%TE(M#(1DBFD)E41E
M-^XKP<8^7'7)W<X$NF>'/&&BO>:187VG#19[EY8+A]YN+9'.YE5?NDC)QD]3
MGVKLM*U6RUO3TO\ 3YO.MG9E5]I7)5BIX(!Z@U=H \_UGP?JNMZ@T\EOIT%Y
M#>K)9ZM#,RSQP!@=K*%&\X!'+8Y_/2TGP_K&E>.M<U)&LVTW5'BD9BS>:NQ"
MNT+C').<YZ#ISQOZCK5AI,MG%>S&)[R=;>#]VS!I&. N0"!^.*GO[ZWTRPGO
MKN3R[>!#)(^TG:HZG YH L5YCK7@GQ1J \0PI+I,R7]TEQ!<SF3SE175EAX&
M%4;<9&>_&3D>BZ??VVJ:?;W]G)YEM<1K)$^TC<I&0<'D59H X<:!XHTOQ%<Z
MIHSZ2RZI'&;^*Y\P+',@QOC(Y((/0UG67@?Q'IN@Z$UM>V UG1[BXDCR7\B:
M.8DNC<9!R>".F/QKTFHYYDMX))Y"1'&I=B%+' &3P.3^% '#6GAGQ++<^*;G
M46TL2:W9) JP-)B-UC9!DD'C#'GOCH*1O".NVVB^$H;.33S>Z'(-_FLYCD78
M4)& #G!SC]:Z_1M8L]?TJ'4]/D:2TFW>6[*5W ,5S@\]0:OT <7-X0O]3U'Q
M#_:<MK]BUBRAMW-NS!U>,$!PI& ,L3C)Q@=:6+P]KE_::3IFM/9-::;-%,UQ
M#(S279C'R90J G.">6SCC&:Z%M>TY=?70VF8:BT!N%B\IL&,'&0V,=>V<TNC
MZW9:[;SSV+2-'!.UNYDC9"'7&X88 C!..1VH Y0^#M6;1O%]D7L@^N3O+"WF
MN1&& 7#?)V SQUSCCK5:7P+KS20F._TYD.D+IKBYC>7[,0NUGA P/F[YP?KC
M%>BT9H \ZA\$:]'HWA2SDN=-EDT.[6<[2Z!T7@+G#9)Y).!Z8[UZ+1FC- '+
M^)_#E_?ZKIFMZ)=6]OJM@60?:5+12Q-]Y&QR/J.:Y]?AWJNHR^(Y=:O[$2:N
M8)8VM(WS!-$/D8;CT'3'?VZ5Z1FC- '*KX?U/5M0TRZ\0O8NNG*^V.V#,)Y'
M4H7;<!M&TGY>>3U[5GZ%X.U[2 ND2:W%+X<@DWP1+&1<[0VX1E^@4'J>I&1Q
MV[DD 9/ %9M_KUEI]SIL$IE8ZC,(8'C0LA8J6&6Z#@&@#B;[X?:W+8>)-)M-
M3LH]-UB[:]R\3&57=E+*3G&WY?J?;-;&G^%M5LO&$>NR7-G,$TI=.V*K)NP0
M^_OCYAC&3QSGM78YHS0!P5OX(U:W\"6OAX7]FTUO>K<I,8VV[1+YNW&<_>XZ
M]*FNO"GB*U\476K:!K5M:1:D$-[!<PF55=1MWQCCL!P2/KTQV^:,T <O;>&K
MVT\76VK)=12V]OIGV ))N\QOF#ERW3.5Z8[UC1^ M7C\+6^G#5;7[=;:L-3C
MN# 2A;<6PRY]2>E>@YHS0!P&I^!=;OKO6&CUZW$.KVBPW)DLPSAE0KA#N^5"
M3G'/4]^:T8/"^KV^M:1J,>JVH:VL!8W0^S']XF\-\GS?+]T#G/K6YJNLQZ3)
M8)):7<YO+E;=3;Q;Q&3GYG]%&.35C4;Z/3=.N+Z6.5X[>,R.L2[F( R<#O0!
MQD?P\EGTWQ#97U^B_P!IZB=1@EMU(>WDSD=>N,#T[UM0:)JDU_!J6J7=I->6
M<#QVBPPLL:NX :1LL22<8P,8!/7/&OI6I0ZOI%GJ5NKK#=PI,BR !@K $9P2
M,\U<S0!YT?A]JW_"!Z7X<&I67F6%XMPDWDMAE4E@",]<DY/IBO1%SM&<9[XK
M+USQ!:Z%I%WJ4L<US%:?Z]+;:SIQGD$C'!!_$5I1R"2))!G# $9]Z .=\2^&
MKS6-5TC4]/U)+.YTYI,>;;B9&#@ G:2,,,<&L5?AYJ*::]DOB!"HU8:G$\MD
M&(8,7PVUER2Q&2,# X KO\T9H Y2\\&OJ/B#4[Z]OHY++4=/^P2VJVQ5@HR0
MP<N>02?X?3TS66OP^UB7^Q4OO%CW,.CW"3VX-BH9MN<!VWG)Q@9],\$G([_-
M&: "N>UGP]=ZGXDT75H=0B@32VD80/;&3S2Z[6^8.,?+TXZ\\]*Z'-&: .1_
MX1+4\>)0=9MO^)W_ -.)_<?((_\ GK\WR#';GGVJ*'P1?PWFE7:Z_LGL[ Z=
M.8[, 30Y!&T,S;&X&3\V<=!TKL\U%)<0Q2Q122*LDS%8U)Y8@$D#\ 30!Q$'
MPYFL_#FF:7:Z_,DNEWANK2<VR,$R6^4K_%PYY)Z_E5BY\"WB:R^J:1XFO=.G
MNEC6_P 0QR?:2HQOP1M1R.X&/:NTS10!S=KX5^Q^);?5H;TB.VLA816YCSF+
M(8[G))+;AG/'I@]33O\ P)'J6JZY>7&H.$U>U%K+''$ 8U &TJ<GD<YR.<]J
MT==\5VVCZ2FHPP-?0FZ6U9H)%"QL7V'<2<\-QP#S6_F@#D=.\'7UIK.GZK<^
M([JZN;:U-K)_H\:+(FY6   ^497GJ3ZBG6'@N33+.[AM-9GBEN=3.I&58EX=
MOO+CH5/I^M=9FC- &+H/A_\ L>:_NIKK[3>W\BRW,BQ"-"P7;\JC.!]23[UL
ML"4(4[21P<9Q2YHS0!S.E^#;>Q\)W/ARZNY;RRG$BDNJHP#DLV".^6)_*H]!
M\%_V&$W:UJ-^;="EF+M@RVP((R  ,G!QD]NF*ZK-&: .)M/AU'9Z5IMI!K-[
M'/IES)<6MS&J!D\S[ZE2"&!RW7UIQ^'5JVE:MI\FKZD\>H7/VLL63,<V5.\$
M+G.5&>WL*[3-% '(:CX!AO[ZRU*/6M4MM6MHC"U]$Z!YD))(<;=O<XP!CCT%
M2W/@33YGTV>WO=0L[VPW^7>02J99-Y)??N4ALL23D=36U<:GFPU&73HQ>W-F
M'3R$;;OE"A@F>@)R![9JQ8S3SV%O-=6YMKB2)6E@W!O+8C)7(X.#QF@#,\.^
M&H/#BWP@O;RY^VW#7,OVEE8^8P 8@A1UP/RK:I<T4 <=;_#G2X= ?1I+W49[
M42"6W\V5=UJX)8-'A1@Y)/.>M;ECH:6NIMJ,]W<WMX81 LMQL&R/.2 $51R<
M$G&>!Z5JT9H *P;GPM!/XD.N1W]_;W#0K#)'!*%CD"DE2PQR02>^/4$9SO55
MU#4;32K*2\O9A#;QXW.>>I  XZ\D4 <[:^ --M/"D'AQ;R^>RAG$Z%F3?N#[
MP,A.@;GI^E)JGP^TW4];?5UO]5L;R952X:QNC#YX48&_ ],=,=*ZW-&: (K>
MWAM+:*VMXUBAB0)&B# 50,  5+110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5FZ[K=KX>T>?4KPMY46 %7EG8D
M!5'N20*TJP?&7AW_ (2GPO=:4D_D3/M>&4C.QU8,"?;C'XT 5D\3:A8S7G]O
M:1]CMK>R^VFZMY#-& #AHBQ5?W@QGC((-0R^+-0TZ;2YM7TN&WL-3F2"*2*Y
M+O [C*B0;0.>F02![]:KIH?B;Q%I-UI_BF>Q@ADM6@"V!9O-=ACS&W8QC&0H
M[GKQ3!X=UW5K+0],UM;(6^F3QSRW,4S.URT7"#:5&W/5N3^M %6[^(.LPVVN
M7,/AE)8=&N#'<L;T#Y0%)*_+R<$D],#'6K9U[6[GXA:?:6T=J=-FTMKM8VG9
M68%T&YOD/S#. O3D\U6/AG77T7QE9M;V8DUF>22V(N3A0ZA#N^3C  /&<YQQ
MUJS'H'B"'7M"U2%-/5K?33I]W')*S!!N4[D( W?=Z'% $9^(;R/;W5IIK76F
MS77V?,(D:8)DKYV FW;D=-V<8/L(+GXA:PK>(#;>'(WBT.3%P[WH&4 +$CY>
MI R!^O:C0?#'BW04?0;:^T\: )F:&Y^?[5%$S;BBC[N>2 2>,YYX%-'A/73;
M>-T,-F&UW/V;_2#A<J4^;Y..#GOZ>] %^R\=7<VMZ+#=:0+?3=;C9K"?SPTA
MP@<;T PH(([GWK)'Q(U^33]5U*#PK')9:5=2073B]&=J8W%1MYQU/3@CWQ:/
MA77/,\"D0V>-"C"77^D'YOD6,E?DYX7=SCT]ZP_"MEK.KZ)XOT>S@LTLKW6+
MN&2[EF;?&&P'Q&%^8[<8^8<GVH V;F>WO?BWX7OK< QW.E32JP'+*1D9_ U;
MM?'EPVL:/97NGPVKZF\B+:--_I-MC.UI$('#!3],CK3Y_"NH0^,]"O=/6W33
M--T]K(,TF) "N 0H7!Q@=Q6+9^"?%5O'H8,FBB73+UI6EVR%[@%6!E=NI;G[
MO?\ O4 6='\7:E:GQCJ>L-%):Z;>&%88BW#*JJJIGH&/4^IS6E;>.I8M3%OJ
ME@T=J;1KEKNW25HX"H+,CED'8<$=3VY%4_\ A!-2GD\5:?/=VT>EZS<&Z2:,
M,9T<X(&,@ *P!SSD#MGBY8Z#XIU73IM-\57]D;00O;@V(;?<AD*;Y"W'&<X
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M+6Z,EQ*BGY$<YP%&!D#.0,$XH WO$&MOI(L(+>));S4+I;:!9&VJI(+%CCJ
M%/'?@5GIXDU"VUF]T2^MK5KZ.S-Y:31LR1W" X(*G<4(..[9JUXIT";6X;":
MRN5M[_3KI;NW=P2C, 04;'.U@<''-4VT'5;F_O=9NOL U-K$V5I%&S&*,$Y+
M,Y7))..BC &.>M !X-U_7/$5I;ZC>Z;:VVG7-J)8FCE+/OW8P0>@(Y'^0(O$
M_BK4-%NKT1I8V\%K:B>-[PMF\?YBT<>",$!>3\WWAQ6EX-TJ_P!"\+V>E:@;
M9I;1/*5[=V974="<J,'VYK)UGPKK-[KFK7%I>V(M-2LOL[&YB9Y8#L9<1D'
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MI]VEFQU!YXKF"!"QLG52RH90Q5VP#D#!'M6S/X8O;K6='U&6_@7^SK62 I'
M09#(H5F!W?+C:N.#WK*L? 6K6L6AQR>(49-'F+0K'9*H9"C*2V2<OANO3KP:
M (;#QAXCN7U^\ECTM=,T*]GBN<+()98XER=@R0&XSSG.<<8YM:1XG\27FIZ9
MYFCRO87:DSN;4PBWR 5(8NV\=N@]?:M#1_!O]G1^(+>[O4N[36IYIYHA 8RA
MD&& .XY&..E0Z%X-U'1X[>VF\27%[869+6EO+ %V$ A [ Y=5STX' ]!0!S&
MAZOK^A^$+?4(/[/.F+JTD,D+HS2NCW;*S!MP"D%L 8/3.>U=8VKZCKFLZKI^
MBWD%I_931I(\MOYOG2,I;;]X84< XYZ\C'-5O ]X?"(T :Q"H%Y]J\_[&<_Z
MWSMN/,_O]\]./>M$>&KFTUN[U72M1CM9KZ-!>126YEBD=1@2*-X*MCCJ0>,T
M <OJ>O/XD\.>$-1EM_L]P?$5O%-"#D)(CNK 'TR,_C5K6;[5/%FA^*%TK4(;
M2RLA/9!?)#M<.J9DW$_='S;1CGJ<]JT[KP1G2=&T^POUMTTV]6^,DL'F-/*"
M6RV&7&2S$_IC%13^!KM-0U632_$$UA8ZJ6>ZM%MU<;V7:S(Q/RD]^#0!CZ'K
M6H)X=\+Z'I8E69]&2ZEEBA21U4;54*'95Y).2<].G.1/)XF\96L>B6UUIUI;
MWMY?O9MYXR)$"EEF&QSMZ'*\YQP1FKEU\.W:PT5=.UZZL-0TF$V\-ZD2L7B.
M/E9> 1Q_^NI;CP/>2+I,L>NL;VQNS>37-Q;"0W,A7;R RA5V_+@=L<^H!T>D
M)JD.DPIJ\UO<7Z@B22W4JC\G!P>G&,^]<AX9\07VNZF;.ZU7R[O[/(+[29[9
M8I+:0XP4/5T&2,Y.>"3S7>NI:-E#;6((#8Z'UKEK;PC>+J4&HW>KQW-Y9VKV
MUG-]C"LNX8W2'=F3'IE1DGUH XGPGJ&NZ#X"\+7L-Y;-ISWRV;V?D?,Z23.I
M8OGA@3D  #ZUJ^*O&.MZ+/K-S'.B_P!G2Q&*RBA$JR0DC+3.!^[)R<#(Z#@]
M:W(O 8A\*Z7H*:F_E:?=+=)*81N=E<N ><8R3535?AQ)J,.N6T?B"ZM[/5IO
MM,D"PHP67C))/)7Y1\O'3K0 7?\ R7#3?^P))_Z--6_A[_QZ>(/^P]>_^AU=
MC\*LOBJTU^74Y9Y[>S-IMDC7YU)+$DC'.?0=*L^'/#[>'X;V,WC7/VN[DNV9
MHPI#N<MT/3- &!<7OB?4O&6L:+I^JVEG#:00S1R-:;V&_?\ +@GGH,GVX'-9
M$'BKQ/J5MX7ABGM[._O+JZLKW,(==\2L-XYZ#&[ QDC&<5;@CN+_ .*FOMIF
ML+:NMI;QM^Z65'QNW#&1\R\<YXR<@YK9/@>*(Z&;/4)H6TF9YP[(KM<2/G>S
MGN6RV?K0!4L;G7-2U:X\/2:\(KG2[:)KN[M[9 \\LFXKA7!4*%"YP.2>HK'N
M_&NOKI>FLLEM#>1>(1HU[^YW)+U^<<\ C!QU]Q78WOAH2Z^NMZ?>O8WQB\F<
MJ@=)T_AW*>Z]C5#4/ =M=Z=IUG!>26XM-0&I-(8U9IY\D[FZ#DDY ]@,8H Q
M(+OQ;/XDUOPROB"+S+6!+J.]^PIY@WC_ %87.W&>YR?YBO#XJ\1ZGX<\&7=M
M>06UUJEP]M<[X RL0'&[';[F<#&<XR*ZZ/PN\/B?5-=AU%TGOK86^WR@1%M'
MRL/4CWZUQ>NZ"/#MGX-T*WUB16M]3+I<^6N^-6#G)7IC<V,GUH 3Q%>^(+/2
M/%F@ZGJTER\&G"_MKV&-(7:-B5,;  C&5(R,'KSS6O?VD]E9^"8KB^EO&_M:
M(B25$4J/(DPH" # _.MR?P=;7]MJRZC>3W%SJ< MI9P%4QQC.%C&"%&23WR>
M34:^#B;+2H;C6]0GDTZX%S'*WEY9PI4 @J<*%)&!ZYZT 8C:]J?A_P 2Z]IN
MKZI<7*-9&[THF*)=PZ%!M4;G#$  GGCCFNSTVVOH=$AM[R^:>_$6)+DHO,A'
M)   P#T&.@KFF:T\9>*+/=H]Y'%HES)(US=P>6KN/E54R<L"?GSC^ >M=C--
M';P23RN$BC4N['H !DF@#R:+7/&G_" VWC!M;ADCM96:>S6T0?:(EF*MENS8
M'&W' ]:WK.X\2ZSXPUNRM?$ M;.PDM)D1[-'+)(I=HR>.,<9Z\#GKG.^'NAC
M6?!-E#=:E=/8I<2/-I[1J%+"9G522N[:?E8KGG/7'%=MI_AQ-/\ $6I:S'?7
M+R:AL\Z!PGEC8,)C"Y&!QU^M '&OKFLR^")O'5MJTA92TR:;M3[.(1)@QM\N
M[?M!.[=U]N*T;KQ'=:/XUM9]0U"0>'M2TYYK='C0"&9 '89P&^X"0">I(K27
MP+8);7%@EY>KI5Q.9Y+ .OE$DY*YV[@I/)4''YUHZ]X:T_Q';6D%^A,=K<QW
M*!<<E?X3D?=(R"/2@#G+_4->TS2O"<L]_*MS?:K#%=QO'&?DDW-Y9PHQM "Y
M&">35;49[_Q38>,&CU2>PATUI;."*#')1 SN^1\P;.T#(P!Z\UU>O^'H]?.G
MF2\N;?[#=+=Q^1LYD7.W.Y3QR>/>LO4?A]I]]JU]?PZCJE@;]-MW#9W'EQSG
M!&YA@G//8_S- ',Z3J6J7%EX6T'3S,J#P_'>2"&98F<_*@^9E. .N!USR<#!
M[;PNVM/H*PZ]+;G4XF:*26V<-GT8\8#8(R,8_/%95U\-M,GT_2[>+4=5M;C3
M(_)M[ZWN-DXCQC86 ^[[8XKI-)TJWT;3H[*V,C*I+-)*Y>21B<LS,>2Q)))H
M \CTVVG/PZ\>W<^I7URPN;RW*3R!E.T* YXSNP .N,=A75BYU70/%FA)<:O/
M>V^I6=R\\#1JL<9B167RP.1UQR3]>:T3\/=-$>L01WVI16NJLS36R3#RU+D%
MRH(/+;1R<D#.,9K1;PO;R:CI%])?7KSZ6C1P%G7Y@P ;=\O)( !H XO2=1\4
MZQI^E>(XKP6]K)=>?=&:[3R/LQ8AD";1@J. <YSG)-=MXK?5D\/3MHD32WH9
M/D1E5V3<-X4MP&VYP:SK'X>Z1IVKO>VUQJ"6[R^<=.%P?LOF9SN\OH<'! /
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MO'69&N)+LV_V5@\I*-%W4IT(SS]: .-\/V^NM+H.O/K-JME<A!<L;Z:4WI<
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MFRQX X!KG;G7-2L/'&@:-<FSDCNK*62YF6(JV]%R=ISPI/;]:YKQ+J6M>(?
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MU'4K:VE:/S-DC@$+G&X^@SW/%4-0\;:/IWB&RT:2;,]TADW@':B8R#G'.>,
M?7Z@&_/!%<P/!/$DL4@*O&ZAE8'L0>M9UEH&G:+!<'1=-LK2>13@I$%!/8-C
MG;GM^5+/XCT:VU)=.FU*V2\9UC$1<9W-RJGT)[#K6I0!SV@Z9J_VV75?$)L#
MJ+1"WC6R#^7'&#N/+<DL<9_W170U2U35[#1K47.H7"P1%@BD@DLQ[ #))X/
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M^(HY!J]UJUK?65Y<207C B*2&(R I@?*I/&!P,TNA67B6\BTG59-8BCLM0A
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MVJ,#!^4C'2NQL?A]X=T^^MKV*WN'N;962*26[E<JI&-O+?=QVZ<FF0_#CPQ
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MFA27=VEVL7GWTS,5E<9^4;@.0,9/OCJ#77K%&H(5% /4 =:<JJBX50H] ,4
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M2,$NS' 48SSZ<57T_4[75--AU"UDW6LR[T<\ KZUP<NC6-EX^U;3(H2UE=Z
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MHD8A(EP.^W9GW)H ZRBHX)DN((YHCF.10ZG&,@C(J2@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ ILD:2QM'(BO&X*LK#((/4$4ZB@# M?!'ABRFBEM]#LDDBD\V
M-O+!*-ZC/3Z=JL/X7T22_:^;3H?/9Q(Q&0K.#D,R_=+9 Y(S6O10!D:QX6T+
M7Y89=5TNVNY(?N/(G('IGN/8\5)J/A[1]66W74-,M;@6_$(DC!\L=,#T' X]
MJTZ* ,9O"7A]K=K?^R+01--]H9%C !D_OG'?D\]JL_V%IG]H3W_V1/M<\?E2
MS G>Z?W2<]*T** ,?_A%- _LG^RCI%HUAO\ ,%NT8*!O4 ]#]*5_"N@OI<6E
MG2K7[!$_F);A,(&_O8'?WK7HH SAH6EC4UU(6,7VU8_*$^/FV8QMSZ8JK_PA
MWAO[#]A_L2Q%KYOG>4(0!OZ;OK6W10!E#PSH02[0:19!;Q0EP! H\Q0, 'CH
M,"FCPOH:O9,NEVRFQ&+7:F/)YS\N.G/YUKT4 9ESX>T>\OC>W.F6LMR<;I'C
M!+8Y&?7';/2IGTC3I-1&H/90->A=@N"@W[<8VYZXYZ=*NT4 5;'3+#2XWCT^
MQMK1';<RV\2QAF]2 !DU%)H>DS7<MW+I=D]S,ACEF:W0NZD;2K-C)!'&#VJ_
M10!G:?H.D:3*\NG:9:6LCC#-#"J''IP.![=*GOM-L=4M_L^H6=O=P[MWEW$2
MR+GUP01FK5% %&VT72K-W>UTRR@:2,1.T4"J60# 4X'(QVIMIH6D:?#-#9:5
M8VT4XVRI#;HBR#IA@!S^-:%% &6?#6A&R6R.BZ=]E5_,$'V5-@;^]MQC/O5Z
M2TMIHHXI;>)XXV5D1D!"E?ND#L1V]*FHH KWMA9ZE;&VOK2"Z@8@F*>,.I(Z
M<'BJTV@:-<6,-E/I%A+:0G,4#VR-'&?]E2,#\*T:* *=UI.G7UFEG>6%K<6R
M8VPS0JZ+CIA2,#%.ETVPGL18RV5O)9A0HMWB4QX';;C&*M44 5+72]/L7+VE
MC;6[E0A:*)4)4=!P.@I]W86>H(B7MI!<K&XD19HPX5AT89Z$>M6** *=QI6G
M7=S'<W-A:SSQ_<EEA5F7Z$C(JY110!1.C:43,3IMF3._F3'R%_>/_>;CD\GD
MU,+"S6Y2X%I )T7:LHC&Y1C& >H&*L44 5XK"S@N'N(;6".9_OR)& S?4CDT
MZYM+:\C$=U;Q3Q@YVRH&&?7!J:B@"N]A:2VHM9+6![<8Q$T8*#'3CI3GM+:6
MV^S26\3P8 \ID!7 ]NE344 <SIN@7MCXUU+5-EFFG75M%!'%&QWIY><<;0,'
M<>,\<5NQ:=8P;?)L[>/8Q9=D2C#'@D8'6K-% $'V.U^U?:OLT/VC&WSM@WX]
M,]:06-H+K[4+6#[1C'F^6-_Y]:L44 0_9+8RR2FWB\R0 .^P98#H">]"6EM&
M $MXE )880#!)R3^=344 8^OZ+)JFEO;V5REG<F1)1*8@ZL58-AUXW*<<C-9
M>E^&;\:G;W^K-I"26LC/&NFV?EF0E67<[L2>C$X&.>YKK** .>\3Z%>:[+I*
MV\MO%%97L=Z[2 L69.B #L<G)SQ@<'-;D%M!;0B&"&.*(?P1J%7\A4M% $8@
MB  $2  $#Y1QGK2I%'&"$C50>H48S3Z* .>UKP_J&K7L$<.L-::08C%=64<*
MYF!.3A^JY'!QV)]:WS&A385!3&-N.,4ZB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5%D # 'UP2,_C0!>HHHH ***I:OJ/]DZ3<7_ -EN;OR5W>1;1[Y'YQA1WZT
M7:*C@E$\$<H1T#J&VNN&7(S@CL:DH **"0!DG %<_'XMM[L/+ING:AJ5HC%6
MN[6-#'D<';N8%\?[ ;H: .@HJEI&JV^M:7#J%J)!!-G:)$VMP2#D=N0:NT %
M%%107$-RA>"5)%#,A*G(#*<$?4$$4 2T444 %%%% !11562^AS=0Q.);BWC#
MO#&07&0=HQZG!Q0!:R#WHK,T;4Y=4TV*[GT^XL9'SFWGQO3'KBM$2(W1@<4
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M &N.\"?\?GBW_L/3?^BXZ[ YP<<'M6%X?\/2Z'=ZI,VH&X74+DW3Q^2$"2$
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M<7@,-IZQF(Q27\1#J>N[CG.:R]&T#5-#\[['X0OCOC,,?G:RDGD(>HC!^[G
MYZT 5M-GUN/0/!.N3^(M1GGO]0@MYH6<")HGW9!&,L?EZD]^,<5K>#K"%?'?
MC8^;=9AN(54FZD;@QMG(+?-[9SCMBJPT35AHVG:2OA"\6UTZ<7%L!K$>Y'!)
M!SU.,G ]ZD73-83Q%>:W'X/GCO+M-DNS6E5,[=N_:!C=COSCJ.: *>A:]?WO
MAGP?I]Q?3DZG+(L]WN^=P@)V@]B<#\*FU.\U#29_$VD1:C<FUCT@ZA;3L^Z2
MW;G*ASU4D9&?>G0Z)JL6@1:-_P (<7MH7\R%VUA3)&_]Y6VY!J0:5KC6=];R
M>%7E:^C\NYGEUE?-=<8QN"9 QVH BLWU'3]8\(7LFLWMRVJ*T5Q'+(#&W[O>
M,+T['GWKT]#N0$$'/<=*\S?1]=?^R-WA4DZ4=UJ?[:&5/3)^3GCCZ5T"ZSXR
M"@#PK98_VM6&?_0* *EY<W,7Q3MK>.[F%O+I,TIBW9C#B10#CU%9?AFYN['Q
M+:V.N?;(-3D$FR83F2WOAU!_V6 Z#BIY]/\ $]SK@UF3PI:->+ ;<-_;1QY9
MZC'E8YQ5>PT;Q+IUW;W$?A:WD-L&%NL^N-(L.>I4&/CCB@#TP'KP:\_U_P .
M0^)O$FJ1;VM[RWMX);.Z48>"4%L,#^F.AK2&J^.>WA;3?QU8_P#QNLZ"#Q=;
MZS<:JGA:Q^U3HJ2$ZRV"%Z<>7[T 5/#VMW.L>*;/3-7A:'6-.MIH;Q.0) =N
MV13T(;K62^I7X^%4%V+^X^U)JR1+(TWS8\_;MSWXKI)%\7OJ\>J'PAI7VN.-
MHA)_:QR5/8_NO:L-O!^K/]I!\':=LN)1,T?]LML60'=N5?+PISZ4 =!;-GXO
M7FW[O]CQ\]CB0_\ UZD^%7'@B/\ Z^[H_P#D=_\ "LX:?XL&LOJP\,Z>+QH!
M;E_[7?&P'.,>74NB6OBWP]9&ST[PSI<<!<OM?57;YB<D_P"K]: .C\8W7V3P
MQJ,W]HMIY$6%N8TW,A/ (![YX_&N'TN2]A\1ZA8LMS:V\FC"<0FZ:1@VX_/_
M ++'KBMO5%\8:SIT]A?^&=&EMIUVR(=1?D?]^ZQX/"FN6\BRQ^%M($JP-!YA
MU24L4/7)V<GWH I:6MS9Z3X&UI-1OYKN]DB@G,LY*/&R,2NWIQZ]:==B/Q)X
M-\6ZGJ$TAOH'N(%1967[.J<* H/<<G-7AX;\1-8V-C_PCFBB"QD\RV!U*7]T
MW;&$[4E[X0US4+ZXO+CPUX=::X7;-_I\P$G&,D"/&: .]\-,S>&=++9S]DB)
MR/\ 9%2ZQI5OK.E7>G7:![:ZB,4@[X(P<?I7,V0\;Z=9Q6EIHWAZ.")0B(+Z
M;"@?]LZG^U?$#.?[,\/#V^V3?_&Z .7\(W%UJTMAX5U!=\N@RN;UF!&X1G;!
MGUW D_\  :V9C'J_Q#O-(U)7:&#3TEM[<N5#,S'>W&,D<#VJ2"U\;6U[<WD&
MD^&8Y[HJ9G%W-E\# S^[]ZK:IHWC'5Y8IKK2_#?G1<)*EY.& [C(3.#0!S]U
M<WH\%RH]S<NMCX@2VMKCS27>$2#@L/O8R1S6_$MOK_C'Q'9:KDIIZ1I:P>:R
M!8RN6D !&3GO[4VX\/\ BR\TZ+3Y](\+FTA<2)']HN  P.<\)R:9J'A?Q-JM
M]!>WFC>$Y+F ;4D::XSCT/R<CCO0!H_#&Z@@^'FD)+,B;F>*/>_+-YC8 SU)
M':NXKDM!\+F.QB@UC2M&3[+<"XM8[)&*1/\ WANYSGV%=:.E !67X@U*33-(
MDDMU5[R4B"U1NCS/P@/MGD^P-:E4=0T;3]5DMWOK99GMGWPDD@HWJ,'K[T >
M::E8ZKX0OO#FOW%E:06NG@6.H30W;3-+%(W,C@QKT<ENIY:M7Q-:1:E\5?#M
MI.\K6LUC<&2-)F57P.,[2/7\1P>*[?5-(L-:L_LFI6R7-N6#&-\[21TR.]5(
M_"VB17-G<1Z?&LUDNRV?)S$OHO/ YH X32_#AU7P=XKT.TEE1K'5[B/3OGR8
MMJHRH"?X2200>QK=\(7T?BZ[M_$;62P"TM/LD:E""DQ.9@,]EVJ!]6%7]1TJ
M_P!"LV;P;IFG"ZN;D-=?:G<*00<OP<DYQ_\ 7K7T73?[*TN*U:4S2@M)+*1C
MS)&8LS8[9)/':@#0KC-:.J:QXHC32[6RNK;201.EW.\2-/(G0;4;)6,_^1*[
M.JEEI>GZ<TS6-E;VQF;?*88PF]O4XZF@#@/ <U]H5KK_ (2G14OM-WW-E&LA
MD!AD!90I(!;#<$X'6H/#)\*ZCHOAK5&N&;5V98;@1,#-<SN-LJS Y9DSN8@\
M #CCBO0?[#TG^T_[3_LRS^W_ //UY*^9_P!]8S1:Z#I%C?/?6FEV4%W("'GB
M@57;/7+ 9H \]TRRTJ/P;XYBAM[..X2XU(!8U57$:EMHXYV@@8'2I+6;SM4\
M 6%^J/IDVD!T64 I)<"-, @\$@<C/KQS7>GP_HQDNY#I5EOO!BY;[.N9AG/S
MG'S?C3CHFE'3H]..FVALHSE+?R5\M3G.0N,#GF@#R[Q+8V]KX;\?V%NN-*M3
M;R6T>?D@G89D5/3JAV]MWO6]'I-AHWQ.T%M.@$#7FG7/VDJQ)F(V$%LGYCDG
MD\UV<FAZ3+IW]G2:99O9;MWV=H%,><YSMQC.::-!T=;NWNAI5D+BV4)!*(%W
M1*. %.,@#VH T:\=@DT33+_XC2WZI#('9(O(VI<;#$<B(D9&>O3'<U[%5-M)
MTY[N:[:PM3<S)Y<LQA4NZ]-K'&2/:@#S7PY=V=C\1-/B%[I44;:+L:*T< *=
MZ;%=LX=\$X.%Z\"J7@&Z2!?#\'B*WCDM+BU"Z-<,,Q1R9;>C \"0]F/4# QS
MGU&/P_HL2QK'I%@HC1HT MT&U6^\HXX![CO4C:)I36RVS:99&!6++$8%V@GN
M!C&: /&Y8]-U>^\46OB/Q)+IUZFI.XM!#"9G0$&'RG*;V.   I]..>>A&D:7
MJ7BCQZ;VQBDV6EM(L<R@[&,#$MCINS_%UZ\\UZ0VG6+W2736=NUQ&,)*8E+J
M/8XR*8=)TUI)I&T^U+SC;,QA7,@]&..>G>@#)\!RF;P#H+L^\_88@3G/10*Q
M?B]_R(4F3@?:[?)SC'[P5V]M:V]G (+6"*")<XCB0*H_ 4Z6*.:-HY45XV&&
M5AD$>XH \].@Z9;_ !-L8-&M;6.SFTN4:G;Q*/+DCR%CW+TR3GGJ0#4'AJPN
MK74SX(GAD:RTF[^W),W*R6Y):%">Y\PG_OV:[N?3VM-(NH-#BM+.Y:-O)/E!
M8Q)C@L .F<56\/:7?V44MWK%Q#<ZM<[?/D@4K&JJ,*B \X&2>>[&@#:K@==N
M]-L/BQI4VIO!%$^ERI$TP&&E\U" O^UZ8YKOJCDMX)I(Y)88WDB),;,H)0^H
M/:@#QN^M-,N/!'Q$N9(;:6ZCU6YVR, SH,IMP>HYS3M1O+)?%&G-K^MW^F6=
MWH,"6]U#LV2$Y,BEF1L9R#V[9[5Z^+*T"E1;0A3@D>6,&B6RM9X5AEMH9(E(
M*H\8*@CH<4 8_@NRM-.\*6=I8&[:RCWB![MLNZ;R5;H.".1P."*WZ** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2VW\,X_"NAH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/+\S<NS&=V>,>N: .7F^'?AN<2JUI.J//]I$:74BK')D$LBAL*20.14M_P"
M_#NI:@E_<63_ &@1B%W2=T\Y   LF#\XP .<YQS711RI-&)(W5T/1E.0?QHE
MFC@C,DLB1H.K.V /QH RKCPOI-UJ]EJCP.EU9QB*(Q2M&NP'(4JI (![&H(O
M!VC)::I:/!)/;:G*9KJ*>9G5W/5AD\'@<CT'I6YYL856+KM; 4YX.>F*(Y8Y
M=WER*^UBK;3G!'8^] &%I'@G0-%L[BUM+ &.YC,4QF=I&9/[F6)(7V'%+H/@
MS0O#4TDNEV9B=Q@,\KR;%_NKN)VCZ5NNZQQM([!44$L3V KF_!GB^'Q;97DR
M1F&6VN7B,3*58)G,;$'U7'X@T =(ZAT*G.",'!(/YCI6$/!FA+IL6G+:S"UA
MN/M,:"[F^27.=P._(Y)/7J<]:V+B]M;0QBYN883*VR,2.%WMZ#/4UGW'B73+
M;Q#;Z')<)]MFB:7;N&$ ( W<\$YX^AH E30=.CUU];6!QJ+Q"%IO.?E!_#MS
MMQWZ=>:OS0QW$$D,T:R12*4=&&0P(P01Z5GZ6^J&\U)=1ELGB6X_T5;;.Y8L
M# DS_%5NVO[.\:1;6[@G:,X<12!BI]#CI0!CZ'X*\/\ AV=YM,T]8I&!4%I&
M?8#U"[B=H/?'6I(/".BVUTD\-HRK'*9HX/.<PI)S\ZQ9V \]AQUK4:^M(WC1
M[J!6E<QQ@R %V'51ZGVJ6::*WB,LTB1QCJSL !^)H RAX9TH3:C,(9Q)J0VW
M3"ZE_>#_ +ZXXXXQ@<=*AD\&:!+9:=:26&^#3B3:*TTA,>>HSNR1P.#D8 &,
M5JMJ-DDD<;WENKR+NC4RJ"X]1SR.:S]<U&5=-OX=(U#38M5@16Q=R?)%DCEP
M#D @\>Y% "V/A?2-.N+^>VM6#W^?M0DF>19<^JLQ'<CITXJG;> O#%I-:S0Z
M3&LEH^^!C([%#Z#+=/;I[5/)XJTJTUFUT2ZO[8:C)#YC@2!57H!U/!8G@=<5
M0\,>)9KIM6@UJ\LDGMM5ELH"H\D2!50C"LQ)/S'N: .A?3+.75(=3>W1KV&)
MH8YCU5&()'Z#]?4UFZUX-\/>(KJ*YU;2H+F>( +(V5; Z D$9'L<BIYYKY?$
MMM%'?6"V)@9I;5_]>S \,O/W>1GC^=61J^FEHP-0M"96*1CSU^=@<$#GD@]J
M (/^$>TS^V8]7%NRWL</V=)$F=0L?]W:#MQWQBJI\':"VE2Z6]AOLY9!*T;R
MNWSYSO!+9#9/+ Y/>M:]OK73;*6\O9XX+>)=SR2' 45Q]UXT>]B\,7FCW-K]
MEU*^2"YC8!W160O@D-\K87H1W]N0#I8/#VEVUY;W<-FL<]M%Y,+JS?(G]T#.
M,?S/-0Q^%=%BO7NDL%#O+Y[)O;RS+UW^7G9NS_%C-:%IJ-E?QO)9WEO<(AVL
MT,JN%/H2#Q46GZSIFJF4:?J%M=&)MKB&4/M/OB@"(:!I@O+N[%MBXO$\NXD$
MC9D7T//3T]*LZ=IMII-C'96, @MH_N1J20OTSTKG/&>MZWX;6VU&PCBO;1I@
MD]GY),NP*SNR,&'(5#P0:LW>NG5/"UOK.@7\:Q3/'LD>'>"&<(002,$9/XB@
M#5U31=/UF*-+^V67RFWQL&*O&W3*LI!4_0U#+X<T>;26TJ33X38LVYH0" Y]
M6QU/UIU_KNF:'';IJ^J6MO))A5:9PGF'N0*IZUXPT?0[O3K6ZNX1-?2*(P9
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MLDR37L@BM]L#LKN?X=P! /U-2'7=/6XU&%Y]C:<BR73.A58U*[@=Q&#P,\4
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M1)9('*%PS$'..O0=:V-5\/:1I>LZ?H5A$LX\BYN_LFHS$VP#%0TCLV6+#G
MSR3D5V!\$^'&TZ+3SI<9M(I/-CAWMM5O4#/%6[[PYHVI36LU]IMO<RVG^H>5
M-Q3\3_6@#RC3[YKGX5^"[^]N))98-;A5G9R3L$[<'UX4=?2MN?P[IVL^,_'$
M=\DTD45M:RI'YSA0YCD.[ /4'IV&3Q79_P#"&^'/L0L_['M?LXE,^S;QYA&-
M_P#O>A[=JF/A?16NKVY-@GGWT?EW+[FS*O'!Y]J *G@.>6Y\!:'-/(TDK6<>
MYV.2>,<US?A_0-''C'QM$NF6BK$\"QA8E!C#09;:1]W))SCUKNM,TNQT:P2Q
MTZV2WMD)*QIG R<GK53_ (1?0_M,UP-+MA+.")F"8,H(P0W][CUS0!Y;!I-K
MI7PNL/%$)N#?7%M#;WMSYI)%L\J!P!T&%& 1R,D]>:ZR\TNVTOQSX?30K:&&
MVO[>>.^MX,+') J@JY4<9!8 -U.<9KL+'1]-TRR>SL;"WM[5R2T,485#G@Y'
M3FJ]AX:T72TF6QTRV@$ZE)-B?>4_P_3VZ4 >26VA:<WPITS5F$@OX]3 CNO/
M8/"#>%"%.?E&"3QWYZ\UUFFZ?9^'?B^FGZ7;K!;W>C>;.H9CO=9,!CD\MCJ3
MR>?4UU?_  B7AXV0LO[%L/LHD\SR?(79O_O8QC/O5E="TE-2CU)=.M1?1KL2
MX$0WJN-N W7&.* .:^(-GI\LWAJ:\M[9Q_;,$3O,BGY"LGRDGL3CBN2\9)I4
MMSXF^S26/^AZ;&H:\9=MN?+W1):JN""V0=V<9( !Z5ZQ?Z=9:K:-::A:0W5N
MQ!,4R!E)'3@U5E\-:'//Y\ND6+R^3]GWM I/EXQLSCICC'I0!Y7JVHZK_P )
MG87^C?Z9<?\ "*QO,4?,CIYW[SRS@_O.N,]\]^*W==7PY<?#"TNM @MEL5N;
M0PE% *'SXP=W?=C(.>:[>V\-:'9WD-W;:390W,*>7%+'"JLBXQ@$#@8JN/!O
MAE;5K4:#IPMV<2-%]G7:6 (!QCK@G\Z .4N](TK5/C+=6=_:K/%)HJ7#0M_J
MI'$I7<Z_Q$ C&?\ "N<L+Y%^%GAN:>6%H+'6-KVUQ,JBY19'P@+D+\H(8!B!
M\@]A7JR>'-%CO?MJ:59K=>7Y7G"%=^S;MVY]-O&/2N>U_P %A[2S@T'3]&6S
M@G:>?3;F#;#<,5V@DJ."!TX(S@]J (O!>F6$OB;7O$5K!91I>^2MND4D<DD:
MA<.28RP4.P!P#SMYIWC.:Q/B7089GMDO$CN)8GOI +95VJK%U/+M@_* 1W.:
MM>&?"K:7JAU.33])TUS;M!]FTV,[6RRL69R!NQM  QQD\\UT=WIMCJ#PO>6=
MO<- V^(RQABC>HSTH \=T^+3;WP5X8LY[FWN9K?Q!Y(>.3:ZQ--)]W!W(I"C
M&#V]J[GPU8V>E?$'Q'96$$=M;&TLY/(B&U0W[P$A1P#@"ND_L+2-I7^R[,@R
M-*08%/SL<LW3J3U-6$L+..Z:ZCM(%N&&&E6,!S]3UH P?&$DM[;0^'K-XOM6
MIDHZNV (%&9,XYPP^3('\=<KOU'P?\1;34]8?3XK+74%E+]DWJB2H/W;,&]O
MEXX]<5Z0]A9R7:W;VD#7*_=F,8+CZ'K276G65\5-W9V]P5^Z98E?'TR* /-[
MJ\T-_'/BS3/%TL$"W-O"+22X?8IM]GS!&/ .XD\<DY]*B672K?XE>'KF=1!9
MOH1\MKXC>Q#X4L6ZMC'7FO39M/LKEHVGL[>5HO\ 5EXPQ3Z9'%/EM+:>6*6:
MWBDDB.8W= 2A]B>E 'D<\5SIFC_$F/3HU+K>HYCM^T+!3)C'0["WT.:W]6AL
MIO$GA"?PT+7<\C"46VT*UGM^;<!U7H!GN?6NZAT^RMII)H+2WBEDSO=(PI;O
MR0.:+>PL[,N;:T@@+_?,487=]<#F@#QZ2PT9?AMK]_%%:_:;?6)/+E4C, %T
M-H3^X-O.!@=Z]DDCM[^S:-PD]M.F".&5U(_4$57&C:6(6A&FV8B8AF00+M)'
M0D8Z\FKD<:0QK'$BI&@"JJC 4#H * /%39:Y)I$FF6ENHN_!MS)-#<21Y:5%
M(:*-3W!C+D@=U2N@U]X-6^%WB'Q!<VX0ZE"9K=9P-R1J L6/0D9?ZN:])$:*
MSLJ*"YRQ ^\<8Y]> *3R(3$L1B3RU "IM&!CI@4 <+>W.EV_Q$T.[O);1(9]
M)E6*60KB23S(MH4GJV.F.:Y74;/3+KP?\2+J06WVE=3F"S-M+  1E0">F6!'
M'6O8FM;>0Q;X(F\H[H\H#L/J/2E%M %*B",*>HVC!H X$7%I+\2/#4K30/)/
MHLNYBP)DSL(SZ]&_6N1:UTF'X3W]\D=JETFM928$!EQ=#&#VPA/'H2:]L^S0
M @^3'D# .T<4GV6WV[?(BVYSC8,9H JZPP?P_?LA#*UK(01SGY#7D5S?Z7JO
M@GX>62W,%PL6I6<%U&&SM^0AE;\#@_6O; H     X %1_9K? 'D1X!R!L'%
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M7L8XZY/3G\>V:V_'<U_#!I9M=.GNK;[6#=26L EG@7!PT8/0YXW#D?C7744
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M?K?$(D?P[J,<4,DTLEN\:1QKEF9@5 _,_A6G10!YEIVCZW;^&/"DL%C<K?\
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M@[SC/S&,L@Z8..:=X(TF_P!/U6ZTR\B?[%H326^GRN<F5)2'!^JJ%7(]2.U
M'?45G:+JZ:W8F[CM+NU42/&$NHO+<[3C(&3QZ5HT %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %)2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 0&SMBH4V\) Y
MV#BGK;PI(9%B02'JP49/XU)10 R.&*'/EQHF>3M4#-*Z+(A1U#*>H89!IU%
M$9MX65%:)"J?=!487Z4"WA64RB)!(>KA1G\ZDHH 9Y,?EF/8NPYRN.#GVI0B
MA-@4;<8QCC%.HH 0*%S@ 9ZX%(D:QKM10HZX Q3J* .:TCP_>V?BO7-5NY+.
M6#47BDCC1&WQ&-0B\GC[O7WKHW19%*NH93U!&0:=10 F*7%%% !BC%%% !BC
M%%% !BBBB@ K*U[3+_5+.&+3=8ETJ>.99#-%$LA90""I#<8.>^>E:M% %73;
M"#2].@L;<'RH5V@MR6/=B>Y)R2>Y)JU110!@^+/#LOB738+..]2U$=S'<%FA
M,F2AR!C<N.:UKF*>6QDBBFCCG9-HD:,LH/KMR,_3-6** ,CPQHTOA_P]::3+
M=I=?94\M)5A\O*CID;CS[UKXHHH ,48HHH ,48HHH ,48HHH ,48HHH ,48H
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC3;T,UO.H5PK8.,@]?PH 72M1CU;38KZ&&XACESA+B(QN,$CE3R.GY5=HHH
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MSR)*6&"=K @9'' Z<5EV?@Z_L9;*6#PG")+*0O YUF0E ?X,X^Y_L]/7.3D
MZOPC_P ASQ=_V%1_Z(BKJZ\_T_P[-J<FKV6K:&MO8ZH-]VZ:H\Q>0$8(4GY3
MP.GH!TXKO((4M[>.",$1QJ$4$YX P.: )**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "C
M%%% "%0>U&!Z4M% "8'I1@4M% "8%&!2T4 )M'I2T44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=S7,][#$]N JQ/&\A4AAC);'?(QQ@<4 >LW=Q]DM)KCRI)O*0OY<>-S8[#)
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MG6K"^O+E)_$ @.H/<%%FC>4H8EAR04 & 3CD$@<UU]A_R5K6/^P5;_\ H;T
M=C12(ZR*&1@RGD$'(-+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !13)IHK>%YIY$BBC4L[NV%4#J
M23T%0V-_:ZG9Q7EE.D]M*,I*ARK#..* +-%%% !114<TR00O-*X2.-2S,>@
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M%KINHZOITFDV.T0O;HXN)E7[J.3\JKTSC)XQ6R/&FA-H-UK:W;G3[65HII1
M_P K#&1MQGJ1SBMR&5+B".:,Y210ZG&,@C(H XB3PAJTG@W4]$,ED)KR^>Z6
M02.54--YI!^7J,8_7VJ[%H6LZ9XDO-9TU;%_[4BC^W6L\[J(YD7 :-PAR,'!
M! SC/'2NMHH X.^\!W1\/:)IEE-;;['4TU*XDD+*)9 S,P4 ' )8XR> !UIU
MQX2UZRU/6ET.ZTY=+UHO+<)=JYDAE==K,FW@@]<$\5W5("#G!!QP<4 >;1>
M?$&DV6@W>C:CIZ:UIELUG*9D;R;B$MN"M_$,'T]>U:]_X:UZ_CT:6XO+.>[M
M=274+DY=(R54JL<8^;:N#W[\]S777-Q':6LMS-N\N)"[[5+' &3@#D_A4.EZ
ME:ZQIEOJ-D[/;7";XV92I*^N#S0!:&2!G@]\5YEJ/P\\07MEJEBNJ:=Y-UJ1
MOTFEA=IF^<%4=L@  #L/;@5Z=10!Y+K-K=:MXMU5O[3\.K);Q16LT=\TL)8!
M [?*D@W1DN?OY].W._#9ZQXC;PUJ\<6FP#2YYMZ)(WES#!CW1$+]PC)&?;ZG
MJ[O1-)O[D7-YI=E<3J !+-;J[ #D8)&:SF\8Z6NCWFIHEX]O:77V215MF\S?
ME00$(W<%AV[&@#/U/PSKL'BR;7?#FJ6MNU[&D=[!>Q&1&V#"LH4@Y SQD5%?
M^$-:@U6PUG0]9C&IPVIM+DWZ%X[E"Q?)"G*G<21CM@< <]HK;E##(!&>1@TZ
M@#D[CP_K;6\<+WUGJ<,D,B7MO?QD1S2,<AUQG:%Q@+@\=\\UJ^&-#'AOPW8Z
M0+AKC[,A7S&&,Y)/ [ 9P/8"I5URT;Q&="Q+]L%K]K.4PGE[@O![G)_0UI4
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M)^ZH0#!/KSS7744 <[;:#?3:K#J^K7EM<7UI"\5FL,)CBB+@;W(+$DG '7
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M QGF,# P,'O6M+X9U.XUG0M4N=9BEGTP2[\V>/.,@ ;&'&T   <''<FNHHH
MXU?!5Y:6]]I6G:LMOHE^\CRP-!NFB\S[ZQ/N 4'GJI(S5V'PM-:>+1K-K?0Q
M0)IZZ>EI]F)"HI+*=V_J"?3IQ[UTM% '$Z;X+UG1M/A@L/$4*R174US\UD?+
ME\P'*.OF<C)R"#D5N>&/#L'AK39;6%PS3W#W,Q1-B;WZA%YVJ,  9/UK:J*X
MN(;2!IKB5(HEQEG. ,G _4@4 89\/7G_  F5QXA3481OL?L4<#6I.P!MP8MO
MY^8D]!QQQUK MOA@+;PKIVE+K<T=[I<\D]CJ$,(1HMYR05+$,,D]QV_'J8M?
MAD\53>'S;3I<1V@NQ*VW8Z%MO&#G.<]0.E:] '%7O@&;4--M(+K79IKR*[2\
MFO)(%+2R1@B,!00%09^Z.O/.3FKWB+P@^N7%EJ-MJT^FZS9H4CO+=05(/W@R
M$X(SVS^==/10!R5_X&CN=*M8;?4[F'4K:[%ZFH2*)7:;&&9E. 01QC@# QTQ
M4$OP[AF.O-)K%]))K<,45T[K&3\@ R,*,'&?89Z=,=I6;_:5W_PD1TW^RY_L
MGV?SA?[AY>_=CR\=<XYH H-X65]0T>[>^D/]FVSVPC,:[9D<*&W?4*O3%9'_
M  KA5TZ328]?U"+2%F6:UM$5/]'(</C>P)89' /3WKN** .0N/ ,+:W=:G9:
MWJE@U\%%[';NH6<@8W<K\K$=QCKQBM&W\+PVGB:+6;>YDC6*Q6P6U"KL$2G(
M&>N03ZUO44 4]4TV#5]*N].N=_D7430N4." PP<'UKFK3X?Q6M[I%ZVMZE+<
MZ7&T,+L4P8RH4(1MQC Z]3GKTQIZMX@GM-7CTC3K%;W4&M9+QHWF\I5C4A1S
MM;+%B !CUR16:OC/4+H78L/#D\TUBD!N[9YPDRM(,[57!#%5Y.2M %C2_ ]A
MI^A:EHT]Q/>V6H2-+,DP4$,_WB"H'4C(]*7P_P""X="N(Y7U;4]0%NI2UCO)
M@RP*1CY0 ,G'&3VX&,UTRDLH)!!(S@]J6@#(\1>'K?Q'IT=K-<3V[PSI<03P
M, \<B<JPR"#]#6;:>!;2VO=6N9=3U*Y_M6W$%TDTJX?"E=W"CG!. .!G@=,=
M%!>6]S-<0PRJ\ELXCF4?P,5#8/X,#^-3T <W8^#K>UET\W.H7E]#IF/L,$Y0
M)#A=H/RJ-Q X!;.,^O-)#X.BCN(/-U2_N+."Z-Y%:3&,JDNXL"&"AMH).%S_
M (59\1:[/H;:68[(7$=[?PV<CF79Y/F,%#8P=W?CBMR@#EU\#V,37T,%[>1:
M;?RM-=:>K*8I&;&[!*[E4]P"/PK0F\/0S>([/6OM=TDEI"T$5NFP1;6QN!&W
M/.%[]A43:],OC>/P^UJ@BDL6NUN/,R20ZKMVXXZ]<UNT <==_#?2;V.ZAEO=
M3^RSW)NEMUN (X92P8L@V]R#UR!DXP>:TY/"=E+XA363=7PF$*02Q+-B.=5)
M*[QC+8)/?![BMZB@#D=)^'6BZ-J:W=K/J!@C<R16$ER6MHG/\2IZCJ,DXKH]
M4TRUUG2[G3KU"]M<QF.10<'!]#5)=:EN]7N;+3[99X[12+B<R@*LN,B(=<MT
M)[ 'UXJF_B#4=.T*RU/6=*6U5CB_2.<.;0$X5R>C*!RV.1GO@T 06O@#3;2\
MMKQ=0U:2[@@-OY\EX69TR" W; *@@  'N#4I\#:6?#MGH?GW@LK.99H0)!N5
ME.5YQR >:Z4$, 000>012T <S=^!=*NM9GU,37UO-=1B.[2VN3&ER , N!W^
MA%:^C:1;:%I5OIMF93;P+L3S9"Y ],FK]% '.ZIX*TG5M3N;^<W4<EU"(+E(
M9RB3H,X#@=>M1VW@72;.71)()+M3HP<6@,V0N_[V<CG(X_EBNFHH YEO FC2
MVFKVMR+BXM]5F\^YCEEX\S.=RXQM/ Z>@J73?!6B:9I=UIZP27,-V@CG-W*9
M6= ,*N3T SP!C%;[R1QE0[JI8X7<<9/H*5F5?O,!]30!CZ=X9L=.GAG62ZN)
M8(3! ]Q.7,,9QE5_(<G).!S4 \&:,-#.C!+@6!F\\Q_:'^_OWYSG/WN>O6MS
MSHMJ-YJ;7.%.X88^WK2R310@&61$!X!9@,T <[J/@/0M4U)K^XBN!<21"&=H
MKEX_M" 8 DVD;NW7T%/3P1HD>GZ98K'<^1IDHFM1]I?Y)!T;KSU/'3GI70/(
MD?WW5>">3C@=:-ZE-X8%,9W9XQZT 8X\+:6NLW6K(DZ7ET/WK)<2!2=NS=MS
MM#;>,XS4,7@O0XM$MM(2VD^R6LOG6V9W+POG(*/G<.2>_>JMCXEN;OXAW^A'
M[,;&WL%N4DC)+%BP!R<X]>*Z99H78*LJ,Q&X ,"2/6@#'/A+2FTN]L)4GD2_
M %W*\[>;/@8^9\YQCC P,9H;PEI+RZ3(Z7#/I(Q9DW+G9VYY^;@ <YXK9CEC
MF!,4B. <$JP.*BAO[.Y\WR+N"7RCB3RY VP^^.E '-M\-?";(Z'2AM:83@>=
M)\C9S\GS?*">H&,UHR>%M*%W=WT=INNKBV^RMF=U4Q[<!, X5>.PXR36DFHV
M,DT4*7MNTLJ[HT652SCGD#/(X/Y5G6/BO1]2U^[T:UO(I+JU5"VV12&+;LJO
M.25"Y/ID4 +X6T-?#GAZWTQ-@6(NP6,L53<Q;:"Q)(&<9/7VZ5LT44 %%%%
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M]V[YP#\V23TQ6HWA2^F\5Z7K=UJD5P;.UDMY4:VQYN_.3PV !D #!X'))YH
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M,+.PE19I%B,I@B)^>78/O;1SC\^*XW7M5N-4\%6MW%J-KJZKK=H+6XB7RO-
M*'#CG:VXL#P.,'%>AZM97MY#!]@OA9SPS"4,T?F(XP049<C(.?7L*Y9_AX9+
M.YQJ$$%Y=:A%J$SPVFV(/']T+'OX!(R26).30!-;ZOXBL?$6L:9=R6FHR)IH
MU"T6./R,,2RB(DD\97[Q]?P%#PSXLU*\\46>G7%]%?P7EF]P[I:F-895*Y2-
M_NR(,D9!/3K6MK/@R76M5U"[GU01Q7NF'3FACM\$+DL&W%CR&)[8P<=>:ALO
M!>H6NM:3J4OB%YGT^W-KL^R(JO%\O P>"=O)Y]L4 <A>HL?PJ\>HBA576+L
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M **** "BBB@ HHHH **** "BBB@ HHHH ***K:B\\>FW,EJ\:3K&S(TB%U!
M[@$9_,4 6:*\FA\9^*SX:\,^(/M5B\>IW26#6C6Y&7<NHD+@Y&"OW0.G<UK6
MWBW5M"U/Q19ZY=0:@NEV*7L4D,'D[L@G9C)[X /YT >AU0U?5[/0M,FU"_:1
M+:$9=DB:0@>I"@D#WZ5RUQJ^O:+%H6IWEW'>6M_/%!>6ZPA1 9?N-&P&< D
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M]NO$.E:1,E_J=D#_ &@B+># E2T9NNW;M,O50 N#Z<4 =>[K&C.[!549+$X
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MW!!M[_:I8-"PX&,=!V/3BMSP^NHWFG>'M?;Q"Y2YB#WL,H'ERF0#:B#HA5B
M,=>^: -[P[K\?B+3Y;N.VEMO*N)+=HY2I8,C8.<$C]36OFO&HGU/2?!>M:_8
MZO<PO9ZU,4M55?*8&Y"L'&,MG=Z\8X[UL>-=0U6.ZUZ2PO[YI=/M5F@%D^R*
MTVH78SYX=F[+\W&#@=: /3<T5YY?OK.N>,K72H-=N].MKK0S=R"V"Y5]ZK\I
M(R.2.^<9 (S5'4]3U*.?Q):3:GJ,>KV$<:Z0D1P)_D&&V+\LC,V=P(( / %
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M"X_M"QC0>5A"NURO0$ERN<<T[X6Z98VWAV6Z@LX([AKRYC:5(P&*B9L*3Z#
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MO+H0!/G?;ACG*MDYVY(P.*QYM.T*STOX?V$EWIM[:I>.DLZ,#'*3&V>1U&[
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MG3=869M-OK>[6%_+D,+A@K>G%7JK6268A$UDD(BFP^Z)0 _  /'7@ ?A5F@
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M1DDCVSB@#"\8Z9+JWB3PVC:;>7-E;7$DEQ- ^SR]R%4(8,&R&P>.@'X5L_\
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M8VC3"Q.#MF;C_IF6?_>QZU+XKNM*M?$TFE))969@T4H/MV&@5&) 6*+(RYP
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MU83:QHVDV>GS6T)\C4IHX86M;<D,6&%+8' P ,GTK<H 6BBB@ HHHH ****
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MS\P4D@''ID'\JIZ)JDFL:7'>RZ?=V#N6!M[M-LBX)&2/?&: -&BBB@ HHHH
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MPYFG\1>,?$VC/J=U9G3X(4M%MY6C*M)'N,IVD;\$@8.1Q[UCW=YJNI^(]/\
M#<>IQ7@BTSS6G:[DLQ=RARC,/*R21LS@''4\T >H49K \'#4HM!%MJ^I0:C>
MV\KPR3PDD<'[I) RPZ'BN5@FN?$?AKQ!KHO[NTU.SN+E+;9<NBVPBY5&C!VG
M./FW D[C[4 =GK.MC3+C3[2* 3WNH3&&WB:38O"EF9FP<  =@3R.*GTB_N=0
MLC+>:=+83K(T;PR,&Z'&Y6'53U!KS_4XE\1:I\/KS4%N(Y;])'FCCN98PI^S
MEOEVL-ISW&">AKO-=AN3X<O8+"[6UNFMVC@N)7.$8C"DL>>O?K0!IYHS7D<E
MZPT?Q+:75OJVD:S!H[3FVDOI)4?9G$T4FX_Q8!QCJ,YYKH&N)&U[P#,+J8R7
M4$@F G;;*OV9F!9<X/S<Y(S0!WF:Q=)U\ZGKFM:6]H8'TR2)"_F!A('3>#TX
MXQ7'>'[C_A(_#$7B6[UZ[L+^"^=[DK(2L:JQ7R/*SMP5V]LDG/4U!=Z9]N\3
M_$.=KV\A6WB@>-+:9HOW@M00Y*D$XQT/'/0\4 >I9HS6-X2N9KSP;HES<2-)
M/-80/([=68H"2?QKB5FFUKX=ZIXC34KFVUJ%IY2XN71;9XV)$6S.W 4!>1SG
M)ZT =K;Z\9O%UWH+VNPP6J72SB3(=68KC&.#D'N:3Q-KTGA^TLYTM5N%N+R&
MU;,FS9YC!=W0YQZ<5QL>GGQ+\0V^W3W=H9- MII8K69H6WEV."PP< D\?GTK
M.::Z?P+:VUU?27PL_$T5K#=2'+2QI. I)[]^: /3([W46\0S63Z9MTY+<2)?
M><#OD)QLV=1QDY_QK2S7*P/(GQ2NX!/,8'T>*8Q-*S('\YUR%)P. .F*Y'3+
M2\U?3] D@&I#6&OLZI?1/,D<UN&;?^^&%=#A=H4\9XQS0!ZQFJO]H6W]IC3A
M*#=&$SF,'D("!D^F2>/H?2O)/&MQYUKXIU2PFDG;39XHH;U[IHS92($5HX@"
M2Y)R23M!)[XKHDT?3)/C-//- IE72H;I69SD2^:R[NOH ,=.E '9Z7=ZA=&[
M^WZ>MF(KAHX")A)YL8Z/T&W/I6AFO*WU.XTOP]JP6YN5@?Q0;.XN6E9GAMRR
M*QWG)' VYSQGK6O/I\6B_$#2-.TI9(=/U6UN?MMO%(0GR*NV0<Y5LMC(P3Q0
M!WN:*\9LK$6O@KPAX@2ZNSJ?]H00B9KAB!&\K*R;<[<$'DXR?6O84NK>2XDM
MTGB:>, O$'!90>A(ZC- $M%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ '2B@=*
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHS1
M0 4444 %%%&: "BBB@ HHHH **** "BBB@ HHHH **0LH."1GZTM !12%@#@
MD"EH **** "BC-)N4'!89^M "T49I,B@!:*0$$9!S1O7^\/SH 6BD# G ()I
MB3Q2.Z1RHSH<.JL"5/OZ4 24444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 44F1G%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUW/%/&[QSR,K L=K*0?F)R.O?V (].UKQ%>?V8)H+*V:YAGFF26&0,BQNJC
M+?Q!P>>GO67!X]UF71!JS:-%':W,$<EH6GCR7>54P1OY4!U)8[,$8.,\=-HG
MAR#2HXFE\N6XC,GELBLJ1*^W<B!F8A3M!Y)YR>,XJ6'PMH4$-W#%I5JL5V"L
MZ",;7!.2,=AGGB@#G(_$GB>;4++2WMM.L[V>2>-FE'F[0B*ZL4CE.TD,!M+'
MUS@XJO<>/-4T^Q$]Y:6DCW&GP7D"PDJ(O,D6/#EF (!<-GY1QCWKJX?"^BVZ
MP"'3XHQ )!'L)&W>-K=^I'&?8>E'_"+Z'Y0B;3('C%M]D".-R^5NW;,'C&>:
M ,*#6/%UQY-J]OI=I>-).C"53)P@5D.U)" 2K8*EN.N<<&MH_B35;O6DO+DL
M]I)H=K>FQMH"[+)(S@[>>>5[]O3!)ZFW\.:/:"W%OI\,8MPXBVC&W>,-]<CU
MIUIX?TBQFMIK73X(I;:+R(75?F2/).T'TR3^9]30!R<EEINM_$VTFO-)C82Z
M))(8[RW7>&$Z $@]"!G!]#530M1UI9KFPT:]M&L?[;FM+>6]C>X"QB$R80AU
MR%967DGKUXKN;O0M)U"Z%U>:;:7%P%V"66)68+UQDCI[5)'I.G1+:+'8VR"S
MS]F"Q "'(P=O]W()''K0!A^++*VN;[PT]S;PS2)JBA6>,''[J0\9Z<J#^ ]*
M/%>O7.GHL&F31_:@LCO&(]\GR)N'!(4+TR2>A&.3QN7VE:?J?E_;[*WNO*.4
M\Z,/M/J,]*K-X9T)XEB;1[!HU<R*IMU(#$ $XQU( 'X"@#D#XR\02;[B+^S!
M EGIUR8GMY"S&Y;:R[O,P,$$@[3U'ISLZ=XFO8GU&UU"TGOI[.]-OYFGVQP0
M8TD&5+';CS-O4YVUL+X<T18VC72;((RHC*(%P50Y4=.@/(]*MV]C:6DL\MM;
M10R7#^9,R( 9&]6]30!P?BK6+I-;35[2&[FLM!E42^4H,;%LB?=SD[(V4C Z
M[AZTNOZ+#K7CB]B@T_3KF:?0U,<UP<;&,CJ) P5CD#&",'@<UVJ:-I<=G<6:
M:?:K:W#,\T*Q*$D8]2PZ$G'.:;;:'I-E<I<VNFVD,\<?E))'"JLJ?W00.GM0
M!0LM2&D6/V'4/MLATZS#3ZA-#MBEV*-S!L]3UQ]:YWPQ=W]KXNNH-6M;F!-=
MA^U*ES@J)UR&B7!/2+R^O78:[J\LK74+22UO;>*XMY,!XI4#*W.>0>#R*BFT
MG3KF:UFGL;>62T.;=WC!,1_V3VZ#I0!YQHTEUH9N?#MB&C76I99M.D11M@/F
M%)P/0(H5Q]<4[2;"W_L+P"UE9V4DXGDP95&"1!,3D@$YR,_4"O1;?2--M+=(
M+>PMHH4W;42( +N^]@=L]Z@B\.Z+ +40Z391_97+V^V!1Y3'DE>."?:@#&\*
M6OE>(O%$LUK:0W37<0<VXX(\B,]2 >I)^I-1Z38Z2GC$W.E1PV\<$,EM+*C#
M-Y,65F!/5RFPY)R<N?0UTMMI=A9W,]S;6<$,]P<S21QA6D/JQ'7\:9;:-I=E
M/Y]IIMG!-@CS(H%5L'W H O4444 %%%% !1110 4444 %%%% !1110 4444
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M)%#$H2.-%PJJ!@  = !4E !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444  Z4
M4@Z4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (.E+0.E
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (.@I:0=!2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 @Z"EI!T%+0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "#H*6D'04M !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 -7JWUIU(.]+0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% "#I2T44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>exhibit1011-physiciansha005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6HO!FOR7/@"VUG6[U-VZ<S7$F$4 3.HZ<#@ 4 :TOAC09["&PET6P>T@8M%
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M@6W0!7/5AQP?>DTS7]+UOSETV^CF>+AU7AD]#@C./?&*P_".NRMX<U*^UO4
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M@'UP:QH_'7AB6>"%=;M-\\9ECRV 5 R>3P.!G!Y_.KVC>(=)\01S/I5]'=+
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ML0VC*E6)#?.IP0#S5'0-<T?3?!6EW-H^H3VES*8;-;EO,N)W9VP,DXYP<9(
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M5S!"TGF&*,OG.XJ,_G36M;9KE;EK>(W"C:LI0;@/0'K0!YM8:?I]Y\39+/Q
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M.1C=[=0>.O%37WC#1K"XFBGFF*6[A+B>.W=XH&.,!W VKU'?COBO.]/A.O\
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MVM0W-I;PVP,X*J2TDL2MEB0'^4'.,$]Z .VB\8Z(_P!O$ET\#Z>F^\2:%T,
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MX2M3H-]!-IU_9O*DFS/EP@!W^]P,] >3UQ0!T^J^-=/TE[TO;7EQ;6!47MS
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M+QYC:0@]-V3C!SC//3(YK DT7QBWAC2-!?1K:0Z3>6["Z%ZJK/%$WRX7&0<
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M: .@W*7*AAN R1GD"D$L;'"R*3NV\'OZ?6O%;5IW^&G_  E:Z-<)K,<%P_\
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M. R%0QR#G(/'ISUJ7Q1JNHZ;K'AR&T>W6WOK\6\XDB+/C:6^4YP.%(Z'J/Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,:'X(O[&&WL=8UY]5TRSYM;9[<(0<$#>V26 !( X'Y"NTHH X;1/ NJ:,8[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KFO#&LZCJ6JZ]9ZB+8-I]TD,?V=6 (*!N<GD\^U=+7$^#;NVE\8^,HHY
MXGD-[&X57!.WRE&?IGB@#LY9$AB>65U2-%+,S'  '4FN8\+>);S7M<UN&:!8
M;2W6W>T7'SM'(K$,WH2 #CMG%&KSKXLLKK3M$N[65K.]$.H0W*R*C!028R0
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ME= >02A.UAU(/YFN;N/"7B"\T[QCH1M4CM]3O9+ZUO&E4IDE&";1\V25P20
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M/(YZ*JJ"23[5QWBCQ/%<6>AZCI^I75I;QZ[!:WBR*UO@9RZR!P" !C/;D]:
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M5)!!'H: -DD9QGFEKCKY0/BYI!'4Z5<9_!T_QJ+0M9T+1=!U*\L[6]A0ZK)
M]O*X>22Y+!-J?,1R< <XX)]Z .VHKF5\906PU-=6L;G3Y=.A6>0-M=71LA=C
M*<$D\8XY_.JMG\0;*XOY[&2T=;I;9KJ&.&XAF,R+]X JV XZ[2>G0F@#830B
MOBM]>-[(7:V%KY&Q=OEABPYZYR2<UL5QME\0[:\GT8MI-_;V6KD);74VP*9,
M9VE0Q;VSC!/3CFK\/BIKO49H++3WGMK>]^PW$XE4&-^ 24Z[<D#/'TQS0!T=
M%<E#XW$^A:_J2::^[1+F:"XA,H^;RAEF4X].E&I^-WLKZ&SMM"O[Z:>P-]"L
M)3YU&W(QG.0#^)P!DF@#K:*XB_\ B5I]E#=S_9P8K(JMTDES'',KD*658R<L
M5##/(&00,XKJO[6L1HG]L&=18?9_M/G'@>7MW9_*@"[17,?\)>;?^S)M0TR6
MSL=2D6*WG:56*NXR@D4?=W>V<=\5'!XRN+O6Y]-MO#U_(+:\6UN)PR;(MR@A
MSSR,'D#.!UQD"@#JZ8)8S*T0=3(H!*YY /0X_"N8\6ZYJNE:CH-M86T4D=]>
MB&1WEVMP"VT<' .TY/X8YXQTNKO3?B)K<ECH375U/I]K)-%!(B -F7)9FQD\
M #C)]A0!Z%17'S>/[(Z1I-U:)%]HU2)I8(KN<0(BK][>_.,$@< Y/3C)&KX8
M\11>)=,DND@:"6&9H)HRP90Z]2K#AE.001US0!MT5RMYXNNHY;J:PT>6^TVR
MN/LUU-%)^\WY ;RXP"7VDC.2.^,XJQ>>(KUM4N[#1=,34)+'8;LO<>2%+ L$
M3(.Y]N#V'S#GK@ Z*BN/7Q_;W0T%M.TVYNEU<S*BAE1XVC0ED(8_>R,=0.^:
MI-X^U;R-61/##F^TAMU[$;Q!&D>W>&#X^8E<G&.W6@#O:*Y*Y\:N9]#73=)D
MOHM8MWF@99E0@JH;!!X Y&3GUQGOG'Q_JPTK4KL^&2)=(D9=10WB;4"C<?+;
M'SG:0<$+Z9H [ZC-<CJWC>*UECAL18O,;1;QEO+OR/D;.P+\K98X/';CUJFW
MQ%\Y?#GV#1KBX?6_."1O((VC:,?,#N]\<^F3SP" =UFBN,M/';'3-1?4-,:#
M4K*^%A]CAE$OFROCR]K8'#;NIQC!JS-XLO-)MM5FU_239QV,4<B3PRF2&??P
M%5BJ_-NX(QW![T =517!Z?\ $*XNEU%6TZ*=K>U>ZAEM7D,+[>6C9WC7:P&#
MTP:=#X[U9X-%NI/#+"UU=%6W*7B%_-:/>H(. %(!YSGCD \4 =U17'6WC>6U
ML-<?7[%+2[TAT62.WD,BR^8,Q[3@'G(%1Z/XSU*\U2YL+K2D)6U:YAN+?S1$
M2/\ EFQD12&Z<@&@#M:*\ZT_XAZQ>Z1HFMR:##%I5_<K;32"YW.C-(45E7'*
M@@9SSD] .:O:%JOB2\^(&O6=U]@^PV9@0HDDF45D9U*@C!8[AN)QT&.E ';T
MR1$EC9)%5D8$,K#((/4$5C:QK4]MJECI&GQPR:A>*\@\]B$CC3&YCCDG)  ]
M_:L*]\1ZEJ&B^)M-%O;VNKZ5$PN 79HVC>-F5XV !R<=#T(H Z;3M9T:\N)-
M/TZ^M));4;6@A<?(!QP!V&,<>F*TZY+P)8[_  GH%Y>6EDUS%I\*VT\<>9%C
M,:\$D9!/?!P:ZV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ JCK3LF@Z@Z6AO&%M(1;#_EL=I^3\>GXU>HH \@T'
M4P/%'A:]D.K2PBPFMV5K!D@MFP@"( N0 %.2S-P <U14(GP1D@BCE6\.I[G3
M80Q;[3N! QG[@!_"O;:* /-(M8_L+Q;XH74K:]DCU0136$\-LTBS*(MNP;<X
M()[^N>*W/A>'7X=:1%)#-%)%&R,DL;(<[B>A'(Y'-=?10!Y=KMMX?\6Z?=2Z
MY:7-AKUF\J02PV\D<S;681F/C]X" N,9YZ8I-MXVK_#9]:\UM3@2;[2'4DKO
MBPI?C@EE4?7->I44 >0W=PD"^-&ALGGADU>UD)$#OL7Y-TH4??VLI..F1SD<
M&&>] ?QRNS5[D7^DH(+FZM67S2$E7(PH !9E &!G/ QS7LE% 'EFHK(_PY\(
M7\%C<7,&GM;O?6]F7CE51$4? 7#95FZ>WXU5U?\ LFZ\$>([_2=%O[=;R&*(
MW%V96FN7#_="N6)"@#YO?':O7:* .#U=$NO&&F-8*R02Z/<V\5Q'"WEHSE/+
M&X# Z' ]JQ'6?4_A?#X-?3[B'746*T\GR'54*2#$V\#&W"[MV>>G>O5Z0L 0
M"0">@]: .!U*TO+GQ_J:6T<V^7PV;2*X,;"/S][D#?C&<$'K6!<:U)J/AOPK
MIJZ#K$=[I>HV1NX_L+D0B(@,<@8.1R,=C7KBLK9VL#@X.#T-.H \=DTW3TU[
M7=,UOPMJE_>WE_+/9R1F7[/,CX9 Q#!5P>I/3\*Z+PO:26OQ-\2F:S>*.6VM
M(X9! XB8I& X1B,8!QW[5Z!10!RWCNVLKO3+&*^CU$(;U"EUIX8R6CA'(EX!
MX'0\?Q5Q5Y+JMUX>T[^U+:YOQ!XDBD6XBT]UDN;:/CS711^&>,@#K7KU% 'F
M.J+>+XZ\5W=OID]TLF@^5"KV[F.9P,[,XP>#TSSTJ'0)YU\7Z#>G3M>>(Z=+
M;237%F8HXW_=G"H.(U 4CISC@MUKU2B@#QR"TO#\*/&%K]@O?M%QJ,[PPFUD
M#R*[*5(7&2#@UZM;W:2:-'>;)E0P"38T3!P-N<%,9S[8S5VFM(BLJLZAF^Z"
M>3]* /'[1+F#X7^$8CIFH"XL=7@DG@^R2!U"2,S-C'3!'/O736-Q/H-UXEL=
M2TN\NH[RZDO+5[>W9UN4D4#RR0.&&-OS8XQZ5WE% 'EMII>H^$I_!#7=C>7H
ML[.XMK@V<1E,<DFTJ#@]!@C/3BM/P](]G\1/&][<6MW';S"T:*0VSD2>7&5?
M:0/FP2!Q^%=]2F@#@? FG1:I\,5T/4K2XBW">.>&X@:-E#RNP(W <X(.1T-2
M?#VQU5H9+S6Y8YI[)6TNV=#D-'&YW/GU8A0?^N8KH=>T;_A(K&"*'5KVP$<X
ME\ZQFV,V,C:3Z<_I6A86%MIEA#96D8C@A7:B]?Q)[DGDGN30!@^,+QGAM-$6
M*]QJ<HAGG@MV=88<_/E@" 6'RC/3=GH*Y[QIH]WH]QH6O:8^I:A>Z==!$MDB
M#EH6&)%&Q0%X'?BO2** //-0UBUMOBII5[)!=O%/HD@79:N[IF0'+*!N7ICI
MU('>LRTTG5])>P\1IIT[6PUN\O);%(LS)!.-BOLQG<H&=HYPV..:[D>'&/C(
M>(WU&9G6V-JMML78(R0V,XSG< <Y]JW: .$^SRWGB'7_ !%!9W<=HVEBR1&@
M99+J0%F+JA^; !502.>>PK"NM.U$^!O -L--OC/8:E:RW48MW+1)'N#$C'N/
MKVKUBB@#@[*2[\*Z[XC&H6-[>V^I7(N[22TMWF+Y7:8FVC"D;0!GC!ZUN^"=
M&GT#P=INF71!GA0EP.=A9BVWWV[L?A6_10!Y3J5I=W/@OQA;+I.H23WNK--;
M1FS?<RGR\. 1T^1N>WXBN@F2>3XL6&H+9WGV,:2\)G^SOL5V<,%)QP<"NUI:
M /*5BOD\%6MJ=)U/SX_$'VAD%F^?*%R9=^,=-I_/BNA7SA\4KV^^P7HM#HRP
M"?[,^QY [.0#CD[2!]>*[&::*WA::>5(HD&6=V"J![DT_KTH \2L/#FIQ^!/
M"CW?AV>^_LFXN4OM,EB99&25R0Z XW$#'Y_6M^^TV]?3=.UC1O"XL;;3M0BN
M1IWDB.YGC565F*@X+?-\H)SQGOBO2IYX;6%IKB6.*)<9>1@JC)P.3[U*.E '
M"V%]>7/CZ?6)-!U6WL7T=8@\T !W))(Y!4$G)S@  GIQ@@US&DVVMZ=X"\*V
M;Z)J12VN)TOUMX-MW%DL4\O=C .[E@1QQD9->PTC,J*68@*!DDG % 'C4&A:
MS#X'\7:;'H6H+(^LB]MT<AC+%YL;84[B68*AR><^I-:>JI?0^+#XBN/!DVK:
M=J5HD1MG@22XM70MC*G( 8')_7&,'T^*6.>)989%DC895T.01[$5)0!Y[KEO
M=1+X12/0Y(1;:G]JE@L+<M';Q8< ':,;OG&<=3N(I_B[0YI_&&ERV-PD)U>.
M33]0C[RP %RPQW #+G_:6N]9@JEF("@9)/05A:'X=TFPO[K5[*XFNY+QW<22
MW!E6/<?F$?902!G_ '1Z4 ;JJ$4*H 4#  ["O&;O3?$#?#R3PJGAV_:YL]0W
M^>-OERH;@N"ASD\-SV &2>U>T4&@#SJSUB33/B/XL8:5?W0FCL>+:,.4;RVP
M&YXSD\].*K:?X9U?PQ+X;U3[&;F.RCNTO+2T(9H1,YD'ECC=M)"G'IP*[73_
M  [#IVO:AK"7EW+<7X03I*4V'9PF %!& 2.O?G)K9H \K\3:!JNK^'O%]];:
M7,MQK1M([:UV@2E(B#O<9X)RW!.< 5OW$%]/X\\-7BZ;="UM[&99IBHQ&T@7
M"GGJ-O/U%=J>E4K+5]-U&62.QU"TNI(O]8L$RN4^H!XH Y[QY:7\]OH=SI]A
M+?/8ZM%=20Q%0Q14<'&2!U(K+L[/5/\ A.?$FIS:3=107>F1I&?E;,BIR@(/
M)R<>AQ7H5% 'B]CX6UJST+PG>S>'?[0;2TGMKW3+D(25=\AT!^4D9_3\:].\
M.1W*V<LD^F0:7'(X,%G$%W1H% &\KQN)SP.@P,UM5 ]]:17D5G)=0I=2@F.%
MI '<#))"]3T/Y4 <+=Z%?ZMXC\:6IMKBV@U33XK>WNV \MF5&!Z'.,N.W(!J
M>:SU;Q-8:'IVHZ7+9W%C=PW-Y/(4,9,6?]60226..W )SV![JJQU"R6_6Q-W
M +QE+K;F0>85'4A>N* //H]%O9?%L>I:=I5_I%__ &B?MLJN!:7=L'.6*[C\
MS*!C@?,?QHL](OCXM@U'3='OM(O&OF_M%]X^R74 )RVW<3O88Q@#DG/K7H5G
MJ%EJ"2O97<%RL4ABD,,@<(XZJ<=",CCWJQ0!S/B_2]1NY-'U+3$6>?2[P7#6
MS-M\Y"I5@IZ;L'C/%5([*ZNO$E[XI?3KF!5TLV,-JRKY\IWEV) ) Z*!D^OM
MGL:* .6^']K?:;X0L=*U&QEM;JRC\M]Q5E?DD%2"<\8^AK \2:'J=WX@EO=+
MTFYL];\U5M-4MYD$$D0"Y^T+NR?XA]TDX%>D44 <)>V6OVGB/Q*+/2EN8-7M
M4,5R9PJ1LD10JPZDD\C'7VY(S+;1_$^@/X;UFRTI+N:VTF/2[ZP\]5<!2"'5
MNGWN3[#\O3J* .(U+3_$.H7OAJZNK%7>VU!KJX2&5-MO&5*JF207(W D@>N.
MPJ]H&GZA;>,_$]_<V3PVM^\!MY#(AW"./8<@,2,GD9'3T/%=310!R]]I^H/\
M1M,U2.R=[&&QE@DF#H-K,P(X+9/W?3N/>N8D\)^(+GPSJ*P6PM-4AUY]8L5F
MD0K)EBRJ2K'!P3^..<<UZ?10!P6M:3XF\9^&[^RO[.#228%\F#[0)?,G#!MS
M,HX3Y=H'N2>@JQ8KXHO=*DM]0T&UTY([21)(+:9&-U(RD )T$:\DG)SDCGKG
MM:* /,/^$;UU="\#6PTJ0S:/<I)=KYT7"J,<'?SG/'TYQ5[4/#FHW_B2/5+3
M2GTS58[W!U*&X3RIK4-_RT0,2S%0!C;UP<@"O0:* /,YO#GB6TM/&6D6&G6\
MMOK,]Q<Q7DMR !YJ %-G7.<@$D =><<[ECI.K0>*M)OYK.,06^E&QE9)PV'+
M(V0" 2!LQ^-=A10!Y]%I7B[P_P"(=872;&PO].U6Y-U'-<3^6;61@ Q9<99>
M!P.PZC-=3JNB'6/"EQHMU=.SSVWDO<8 );'WL# Z\XZ5L44 <2NC:SJ^EZ/H
M^JV26JZ?/!+-=1SJRS>5R/+'49(7.X# S6AX:L-2LM:U^:\M%B@OKO[1"ZRA
MC@(J8(['Y<]^M=-10!S/B_2=2U"31;O3(H9I=.OUN7AEDV;TVLI .#@_-46G
MV6L0>*]4U>YL(]MQ8P0HL4X(:2/<6ZXP"7P#[9.*ZNB@#S"Q\)>)]*TOPW>6
M$=I_:ND1RVLUK-+F.>)SG(<#@CCM_+GOM'&J&T>;5_)2YE<N((&+) N  FX@
M%CQDG Y)QQ6C10!P-KHWC#1=7UJVTPV$NEZE=/=0W,TA$EHTARYV8^;!S@9]
M.>M7[71=7\/^(-4O--2/4+34E21HYY_+>*=5"[B<'*L "2.1V!KKZ* //H/"
M&J:5>>%I;:""X-C<W-S?,LNQ2\X(;8".@W' XX%2_P#"/ZR+SQQ*+.(KK,2I
M:?OQU$1C^;TZYKO** //])\/:W8/X+$EE$5TBWEANB+@<%U"97CG &?QJ4^&
M-9?3/&=F8[17UJ1WMG\]MJAXPF&^3((QGIWKNZ* //Y_#_BS2=2L=4T$Z;)*
M=/BL[ZUN9&V,8\[61@H/\1]/H:L7GAW7[KQ'X4U.>2VN6TQKB2[??LR9@%VQ
MKCH@Z9.2!ZUW%% 'F]_X!U;4%\1-]IM;6XNM1BU#3I4D9_+DC& '!4=1Z9QG
MOCF_/X?\4^)?#][:>(;NQM)WA5+=+'<5$BNKB1\]]R+@#H"?7CN:* .+@L/&
MNH:1>0:U+I8F^RR01):NZI.[+MWR$J< =0%'4TQ/#>MII7@^S\NP+:+)&]PW
MVE\-LB,?R?N^<[B><8QCGK7;T4 <)J?@S4-:N/%4=TUO;V^JK ;66*9F>)X1
M\A9=HZD \'CI[U=TFQ\9O$?[>O-,<PP.D26>]?M$A& TK$<#V4=3GMBNNHH
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M_G90 H^4 #WYQ4Z+XFU?QEX<U6\\.&R@LXKB.XS=QN5+A1D =5R..YYX&!D
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M,T9;)'O[34%N67SU"E1.9>&]P0.G6H?$OAWQ/K5QXAADT>TOHKJ'_B7W%Q=
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MK2\$]F+6ZL[J7R\;6+*RL,C/./\ ]? !)%\0;?4=/T6;2+9)KC5A(8H;J?R
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M-YKL-NQO[LY>1W+!3C!V@],UMT44 9&DZ%!I%W>W$5S<227LGFS^:P(9\ 9
MQQP ./2M>BB@ HHHH **** "BBB@ IDL4<\+Q2H'C=2K*>A!X(I]% '-V/@/
MP[ITD+6]G,5@8-%%+=RR1(0<@A&8J"#TXXKI*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH SM9T+3/$%DMGJMHEU;K(LH1\X##H>/J?S-7H8
M8K>&.&&-8XHU"(B# 50,  =A3Z* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>9;JYBRZKQTSU)YH ])HKE-'FUU]>CWZI%J6D%)XY'6U$1BGC<+@D$Y'W_\
MOFD^(FJZIH/A"ZU?2;A(YK7:2DD897#.J\Y],GI0!UE%><:QX@U_3OA+#XIC
MU)&O6MX+AD:W78?-,8VX]MQYKI? ]_?:MX2L=3U"Y\^XO$$QPBJL>0!M ';@
MGG)Y- '14444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M .$>UVX@TO4M,DD1H;IQ$60L6##<<$9)''H/45=^(FNZ?J'POUF6*;9'*!%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2'J1GI^&*TJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $(R,4FP>_P"=.HH
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MM;2J %)SU^Z.F.IJW#X3UG6=)NK3Q=JL5R9;=K:,6*F-0#@F1L_>?*KVP,'
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MMMXJFUK2=7BM1J$<:ZE$]OY@=D& \>3\IQQ@Y'KFNLDD2( R.J D*"QQDDX
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M==O +>YCE@\V.5 20<9'(S_^KG(!*/$.IS7FDZ/]GM[+6+NT:[N5FS*ENJD
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M2"UL #<O)G =BPVK&/4D#)[UHZ'X6@T&_OKFWOKV1+N:2;[/+*#%&SMN8JH
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M'P_T<:0FEB6_%JEU]L0?:3E9<YR#UZ\X]:T?^$:MO[;FU@75Z+R6W^S,PFP
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M<]RC1/=VJ/(BN5*EE!(!!R.O4&O)M#B-A\&O$-]9SW5O<QSW 1XKB1=N'&,
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M*Y74+W4%\-^/M"O9Y+J/3;0FWN9.7:.2)F"L>Y7&,]<$9HU7_D8/AE_NR_\
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MD;>%M[JO_$_MCR<<8>N'\77=B]EXH^SW5K \>J*TL=P?-N9)5,8#)C'E1@9
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M=R%8\OO(4%?[V#DY/;N:V)_"_P!J\06FK7.I7$IM[9K8P-''LD5P-^[Y<\D
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MC&QBN,CIZ&G>&]#FTF_UBY9[A8;VX\R.WFN#+L.6RX[+NR/E&<!1SV'0FEH
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MJW$<TD\]RS!(@FP#[O4DOT]O8T -NO#D$-_?ZU9)+)JDUHT"H\Q$3@ [4*Y
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M+X?M-2U#4O\ A(=<TV/3KX6WV2*V682E$WEF8L./F.WCG 7KS@=12,0JEF(
M R2>U<9K/C99/!^HZSX>N;64V<WEYD4NL@#!25 ([MP>1Q[T =1'I=C#=7MR
MEL@FO=OVENOF;5VC(^G%5Y?#NDS:)%HTEDATZ(*J6^2% 7[O?)P0#SWYJ[#>
MVEQ<36\-U#+/ 0)8TD#-&3TW <C\:CBU33I[Z2RAO[62[B_UD"3*9$^J@Y%
M$0T/3EU2/4Q;G[;'%Y*S&1B0G]WKT[_7GK5:Q\+:+IMY]JM+$12;S(JB1BB,
M<Y*(3M0G)Y4#J:U9[B&UB,MQ-'%'D#=(P49/N:R=0U"1Y;%].U73(X?M@AN?
M/;<7YP8T(/$F>,'O0!K7%O'=6\EO,I:*12KJ"1D'J,BL=O".AFSM+5;'RXK,
M.+<12NC1!_O;65@1GZU?NM7TVQN8[:[U&TMYY?\ 5Q33*C/VX!.37/:MXHGL
M?'&@Z<D]I_95]!<232,.5,:DYW[L =.W8\^@!TUE8VNG6<=I9P)#!&/E1!P.
MY_'/.:XC3?"PU'Q=XAOM9T.6.WO71H)6N -Z*@C9'5'Y!QN .1CK@UO:YXST
M31-!_M:2_MYH')6#RIE;SFSC"D9S[GMWK;M;NVOK9+FTN(KB!\[)87#JV#C@
MC@\B@"AJWAO1M=MX8-4TVWNHH?\ 5*Z?<[<8Z=J9<>%M#N8[*.33HA'8\VJQ
MDH(3ZJ%(P?>J,?BNV:&^UB:[M[;0;1GA69_O3NO#%3Z @J  2Q!]LY=UXU:Z
M7PQ>Z;>V:V=_=)#>1;ED:+,9<J7#84@#!&,\]J .H.@:6VL_VP;4?VAY?E>?
MO;=LQC;UZ?UYZU4;P9X>?2VTQ],C:R>;SVA+,5,G][KUK2L=3T_4X7FL+ZVN
MXD.UG@F615/7!(-0Z9KVD:RTRZ9J5K>-"<2""4/M^N* &KX?TI-4@U,6B_;8
M(O)BF+,2J8QMZ],5"/"?A];6^M5TBT6"_;?=((P!*<Y&?H>1Z&J/BSQ9;^&[
MO2+>>YBM5OYRC32Q/(%5<9 "_P 1+* 3P.3SBCPMXMM_$>H:O;),!-93F(VI
MA=7B4,R@L3P2Q4G Z<#K0!=N_"/AZ_TZWT^ZT>SDM+88@B,8Q&.^W'3/?UJQ
M>^']'U'3(]-N]-M9K*( 1P-&-J # VCM@>E<WKOCZ#1_B#HOAS*&*[RMS(0<
MQNV!$,^YZ^S \5V%S=V]C;/<W<\4$$8R\LKA54>Y/ H JZ?H.DZ3*\NGZ;:V
MLDBA6>*(*2H  &1V  X]J=J6C:9K,21:G86UXD;;D6>(.%/J,TEAK>EZI;RW
M%CJ%M<0PDB5XY01'CKN]/QJO:>*M OYXX+36;*::1MB1I,I9C@G@=3P#^5 #
MYO#FB7$5Q'-I-DZ7+*\ZM N)".A;CG';-.70-(6\M[Q=-M1<VT8B@E$0W1H!
M@*I[#%0-XL\/I]KW:Q9C[&0+G,H_='./F].>*S/%/B$PZ3I=SH^MZ7:F[N4*
M37;C9-#_ !!>.3R/\: -)_"/AR2XDN'T+36FD;>[FV0ECG.3QSSS5BZ\/Z/?
MWT5]=Z79SW<6-DTD"LZXZ8)&>*CO?$VB:;?K8WNI6\%RV,1NV.O09Z GL.IK
M&@\0R0^,]:2\UO2QI%G:J_V8-B>!AC<S^W)_-<>X!OC0M)75SJPTZU&HG_EZ
M$0\SIC[W7IQ6A7G\?Q'L=<\,:O<Z5JEA8WD+NELUV^ %R LC@CC/.,CTS70P
M^)+'3O#NFWFLZM9F2XA7]]%G;.^W)* <D=^* +,WA?0+B_\ MTVBZ?)=[MWG
M-;H7SZYQUJS>:1IM_<V]Q>6%M<36YS#)+$K-&?\ 9)'%02^)-%@TF/59=4M5
MT^0A4N#(-A/IGUX--L/$VAZIJ,NGV.J6MQ=Q*'>*-P2!QS[]1TZ4 ._X1W1/
M($']CV!A$C2A#;(5WMU;&.I]:E_L72S?/>G3K4W;C#3&%=[#;MP3C.,<8JCX
MOEO;;PKJ-[I]])9W%G;R7*LD:.'V(3M(8'@X[8->?Q^*/$UM\*[7QJVN":<$
MF6SGMHA%(/.,8"E55@<<]30!Z?9Z1INGM(;+3[6V,H D\F%4W 9ZX'/4TVPT
M/2=+69;#3+2U$_\ K1#"J;_K@<UR>H>+9;C3O"=]'JEOHQU*2.::"YCWF6(X
M+(IVG!.1@\=:Z#4O&/A_2+B>"]U*..2W56G 5G\H-]W<5!"Y[9H N+H6D):2
M6B:58K;2,&>$6Z!&(Z$KC!-*=$TDR02'2[+?;@"%OLZYB .0%..,'GBN"\8>
M.)]/UKPA=Z7JRIHVIW)CN=\2A"B2(&;++N7AF!Y[#%=?%XR\/W&B7FL0:E%-
M8V>1.Z DH?0KC.>>.* +Z:+I4<4\::99*EQ_KE6!0)?]X8YZGK4T-E:6\GF0
M6L,4FP1[DC"G8.BY'8>E>7ZAX]U7Q#X.MM6\,WEO9WT=V1-:2QEFE4NZQ1K\
MIW,VT<#U/(Q6UI$OBJ\\7>(=.NM7@-DJ+)!):HK-9R%@5C.5P<KG<#DXP>,T
M =G>:7IVI%#?6%K=%,[//A5]N?3(XI6TRP>2>1[&V9[@!9F,2DR@= QQSCWJ
MAX:UHZWILKRQB.\M9WM+N->BRH<''L001[$57U+4YKKQ'#X=L9V@E\C[7=3J
M 6CBW;55<@C<QSR>@![XP ;S11NJJT:D*05!'0CH10(HQ*90B^85"E\<D#H,
M^G)_.L>X\6Z):W_V*6\(E\];8L(7,:RGHAD VAN1P3FJEUJ<^A>*K*UNKEIM
M/UB1DA\S&;>8#.T'NK#. >A'H<  Z4@,"& (/!![U UA9O9"R:T@-H%VB Q@
MICTV],5D^+_$L7A3P]/J<D$LS+\D:)&S#>>!N(^ZN>Y^@Y(%6!XBT\6MK*[7
M :YW>5";243/M^\1$5WX''..X]10!JJJHH55"J.@ P!2U3TO5;'6;(7>GW"S
M0EBI(!!5AU5@>5([@@$5<H **** "BBB@ HHHH **** "BBB@ HHHH 0=!2T
MB_=%+0 4444 %%%% !1110 4444 %%%% !1110!XM9Z/+'\-+[Q!;:SJ5K>V
M4]S- L5P5B&R9SL*#AMQZYR>?3BM"Y76?%_BO6[%;ZVLY;*.$0K)-,DEN&C#
M&:,(0"=Q[YZ 'CKW,?@GP_%/YBV+;?/-SY!N)3!YO]_RBVS/_ :76/!7A[7M
M0CO]2TR.:Z1=HD#NA9?1MI&X>QS0!<T24_\ "/V;RZ@M^5A :\";!-CC?C)Z
MXS7G.ERW"ZUX7U""2ZEAO;N6.349KE@U\I21O]3DA8P0,9((Q]T5ZJD,4<"P
M)&BQ*NP(J@*%Z8QZ5S47PY\)0Q1QKHZ;8Y/,C#32-L/.0N6X4Y.5'![B@"_X
ML6\D\+WT6GW4=K>2JL<,DC%1N9@H7(Z%L[0>Q85YKJ%Q$/!WC&SDL[[3+Z.P
MA,VF3S&6*+#-^\B?)!5L\].5KU?5=)LM;TV73M0A,UK+MWH'9,X8,.5((Y /
M!K.F\&Z'<Z=<V,]M/-#=%3.9+R9I)0OW5:0ON*CLN<>U '.O:GPU\0K!8=2O
M&AU*QN7O&NIC("T>TB3!X4C)X  QP *P]'^U6WB7P?<027#6U\TZR7LMP=^H
M+Y;.'>+D*,\C)S["O0Y/"ND3ZE:ZC-!/-=6L1AB>6ZE<!"NT@J6PV1UR#GOF
MJ$/PZ\)P& IH\9\B7S8M\LC;3SP,L?EY/R_=YZ4 <EX;@NIU\3ZK)JFJ22Z)
MJUZMI ;IFC957(5P<[ADCOV&.^3PE:7LL&A^(I/$-K$)W1)#&TLSWK/UCD#-
MA6!Z8'R\] *[[2/#.E:%-=RZ=#+&]Y(99]]S+()'/)8AV(R>YZU5T_P/X;TK
M4IM0L-+2WN90V721P%W=2JYPA]U - 'G5W8R6WA'4O$-K=WB7UEKTQA"SE8T
M4W6UOD& <@G.<G\*ZR&"W\4^,O$>G:LTKIIWD1VL"2O'L1TW&0;2,L3QGM@=
M.^LW@/PZVCR:2UI<&QEG^T/$;V<[I.N2=^>O.,XSSUJW>^%='U"2.2>WD\Z.
M+R?.BN98I&3^ZSHP9Q_O$]_6@#S.^O[^_P# ?A9M1=I98/$T-NLSGYI41W4,
M??C\<9[UOW0M/%">,QJ7FF?3C);00&0KY,:QAED4 ]6;)SZ #IQ75ZCX2T75
M;&RLKJS;[+9,&MXH9Y(5C8=" C#D=B>G..IJ/5?!/AW6]1^WZCID<UT4V-)O
M==ZXQA@I ;\<T <!ID[Z@_A+09[JW@M&\/1SQ+<*Y2>8X4CY77+*HR.>,D^F
M)KG2IK>3PGI1\1WUX%U.>UEN(97BR@1F,9^8Y(QMW9R.<$8KMKOP)X8OM&MM
M)N-'MVLK;/DH"RE,]<,#NY[\\]ZGD\(Z%(E@AL B6 Q:I'*Z+#[J%( ;_:Z^
M] %BPT]= T%;.U>XN5MHV\OSY-\C=2 6/7K@>V*\VG=Y?A'%XLM+N;^W4*W1
MNA(Q9I?,VM$1G[O)79TZ<5ZY6+'X3T.+4CJ$=@JSE_,VAV\O?_>\O.S=WSC.
M>>M '(ZA86UY\8M(6[LX_P![I$DLL;<C?NQGW(P!GVKM?$7_ "+.K?\ 7G-_
MZ :)_#VEW.L1ZO+;%K^)0J3B5P54=A@XQ[=#5N]L8-1LY+2Z0O!*-KH&*[AZ
M9!!Q0!YSX1\)R>(? GAY=5U22738DCG6QBB$88KG =N2P!Y[5+H^B6VI>*O$
MUU?7U^J:;J220*MVX6/$:L<C/(/H>PXQS7>:7I-EHUDMGI\/DVR_=CWLP7V&
M2<#V%06/AS2M-U"ZO[2T$=U=?Z^3>Q,G?YLG!H \MTV^^RZMX.U2U&^&_NY(
M7O9Y=MS>JP8;I5&0%!(V@D]!P.E:6C-I7B+0)M7U?4)K/6[+47>XEADQ-"5<
M[85'/R%0HV@<D=S79+X$\+*% T.SPLPG4;.CC^G)^7I[59;PGH#ZW_;+:1:'
M4<[OM!C&[=_>],^_6@#FO#>EZ='\1_&(6VB1D:U*;1M(+PDN1CN<G-<EHVM&
MT\*Z/%J=Q*-*N]=N(+V=Y#G:-Q1&8G.TL!GV!]Z]7;PYI#ZTVLMI\)U)D\LW
M./G QC@]CCC(YJ"'PAH$&E7&EIID)L;AMTD#DLI;UP2<'W'- '%>)1:>$-!U
MN/0;N:.&6:VDN(T.Z&RC=]K; I!7<,DC/?C'%;'AW2++3?$\=Y8ZS:NE_:,1
M8V,&R&0*0?.(WMAOF SWSBNEL/#NCZ7I;Z99:;;164F?,@$8*OGKNS][TYIN
MB^&M%\.I*ND:;;VGFG,AC7YF],D\X]J .>\7M*?'G@>+K;&ZN6<$<;Q%\A^O
M+8JCXTBM]2UZZM#';W+P:66E2^E\N"V5F;$JX!8R?+CC& !S77>(-%&LV47E
MND5[:RK<V<S+D1RKTR.ZGD$>A/?%0OX<T[5IK+4M:TBQEU2!,;]N\*?8D<C.
M2,CC/K0!%X%GDNO FAS2RM+*UG'O=FR2=HZGUJE/\-/"MQ!J,+Z;A+^99YML
MC#YUS@KS\OWFZ?WC71:9I5AHUDMGIMI#:VR\B.)=HSZ^Y]ZN4 >3?$ZVV>,/
MA]:6LIMMMV\<;H QC^:$ @-D''O6_?>&(O"NE>(_$EC+<7NOS6DCF[N2I887
M.%    QG&.P%='?>%M!U.ZDNK[2+.YN)  99H@[# P-I/W?PQ6G%!'#;I!&@
M6)%"*O8*!@"@#Q7P%'+?1>&=9@U/3;:9998+Y/,:2YOB[=)1CDC&X$D@ YZ"
MD^'WA&P\3R:X+^>]$=CJ^8(H9RB+LS@8^F![#IBO6-.\+:%I-]->Z?I-G;7,
MV=\L<0#<]0/0'T%6+#1-+TIY'T[3;.T:7_6-;P+&7^N!S0!\^)I=I<Z3\2;N
M56\VQO%:VPY41MYSC( .,XX^A/K72Z8BV/Q(\!RVDTF_4-)#W<AE+-.QC<G<
M2>>0/I@>E>JGPGX=(F!T'2R)SNE!M(_WASG+<<\\\T]/#.A1W$%PFBZ<LUO@
M0R+:H&CQTVG'&/:@#R>QMX9==^*T+Q(T8MW<(1QD!V!Q]<&N;N[/3'^ EK>1
MVEHFHBZ42R(H\PCS'4%N_(!'X&OH&#0=(MKR:\@TNRBNIP1+,ENJO(#R=S 9
M.>^:A_X1C0AIL^G+HU@EE.<RP1VZJCGU( Z^_6@#R;Q1/!IWBKPCI=FNFPZ,
M\#/Y-PN;1[AMR$R!>X..>Q//>H7AFTN3P?H&HZO!J&DMJ\RS>3N,''EF.(EN
M&4,S<=.W537L4OA[1;BP@L)])L9;.#_5026Z,D?T!&!4EQHFE75A'87&F64U
MG&04MY(%:-2/12,#J: /-/ $%G:?%_Q?;V(C6W1%"+&<JO(R!Z '(QVZ5ZT>
ME9MAX=T72IC-IVD6%I*1@O;VR1L1]0*O7%O#=0/!<11S0N,/'(H96'H0>M '
MD_P(/_$KU[_K^'_H-1:MH-OJ_P =Y;&Y,L5K<Z67E6%S&9AC:02.V?\ T&O3
MK#P[HFES^=I^CV%I+C&^WMDC;'U J0Z'I3:F-3.F69U =+HP+YO3'W\9Z<=:
M /'_ !59:+HVKW&B6ES'.;71I$%MJ;CR+9,9W1DC+2MV QUZ\8K,\0RI<?L]
M:!(9%DFBNA'N+99.9/ESU'&WCTQ7N<^B:5=7AO+C3+.:Z*;#-) K/M]-Q&<>
MU5V\*^'GM([1]"TQK:-BZ0FTC**QZD#& 3B@#S30[>VTKXQ^([*S<VEF-%#M
MY9)PVV(E_=N6.>N2?6JW@.TN]"\6Z7HVJZ?:W<%U:3_8-4MDXFB8!V$G'S#C
M^+D%NX->KP^&]"M[DW,.C:='<%2AE2V0-M(P1D#.,<?2I+30])L)'DL],LK=
MW7:[0P*A8>A('(H \1L-VFV7Q4DTBWBBN+6X\N!X4"M%$TKAPI'( 5<\>E;7
M@6#3;^Z\,ZA;:]8K(EB;.XTRWLR'F4*=_G?.>AYW$8/'K7K%OI.G6;L]MI]I
M S+M9HH54D>AP.E,M=$TJQ$PM-,L[<3Y$HB@5?,SUW8'/XT >2_"WPII&K:/
M/JLB/+=:?JTLEGLE(5-H4KA0<8)Q]<"L;PG+'K>CQRWOB*UT[6[;6/M#LUNS
MWDSMA0H.\%E.=N I QS7O-IIUE8!Q9V=O;A\;O)C";L=,X'-1IH^FIJ+:BFG
MVBWS##7(A42$>[8S0!X8KKJWB7QK8Z[K5EI=W]I5XI[N#?(B1LQ7R3O7:0-O
M R3GBO:K#3;:?35EN%,\]W:QI<3NC1O* O=>JYR3M[9-6IM)TZXO$O)["UEN
MH_N3/"K.OT8C(JY0!RWCZ*"#X;ZW$$CCA2Q=43 "K@84 ?7&*U=#BDD\+Z;#
M?+OE:RB6=7&=QV ,#Z]ZBUS1Y-=:&RN'B_LG(>ZAP2\Y4@JN?X5R 3U)QC@9
MSL 8H \8D\/W<MAJG@:U@3SM)NGU*RG,88"(@O$H/]XN=I]@WM711W,?BCP3
MKWB6YMQMN=,:&".6/[BI&6?&?^FI;_OVI["O0A!$L[SK$@E=0K2!1N8#. 3W
M R?S-,>TMI;4VTEO"]N>L3("AYSTZ=: /+WFTRWG^&-SJ+VL=M_9\B22SE0G
M_'NF 2>.I[]S6?=:=I]Y!\3[J>"VN982SP2D*_EDQ9RI['..G/'M7K9TO3VM
MXK=K&U,$3;HXS"NU#Z@8P#R:3^R-,Q,/[.M,3\RCR%_><Y^;CGGGF@"+0Y$N
M_#>G.769)+2/+9W!LJ,_6O*))M-B^&7BJT#VT=X=0N,HI <(+E1VY Y&*]D@
MMX+6!8+>&.&)?NI&H51WX J"32M.G\WS;"UD\U@TF^%3O(Z$\<D4 <+J%A:Z
M1XWACT*&&VN9M!N]@AP#*X9"A/\ >.<\G)/-8_A*7PWJ=OX68ZQ?2:U8LJ"R
MCCB22.7;^^WXC#%/O%B6Y]2:]3_LO3Q/%/\ 8;7S8@%CD\E=R = #C@"GQV-
MI#<27$5K#'/)]^18P&?ZGJ: ./\ BO%;2>"3]H**!>6VUR0"F95!(/8XSSZ9
MK*\;:3I&C2>$!IUI;6J2>([>4^6  <_>/TX7/T%>DRV\4X431)(%.Y0Z@X.,
M9&?8G\Z9+96LX02VT,@12J[XP=H/4#T' _*@#R76+VS_ +:\:Z%-J6GO+JI2
M.*2]N!%]G81\@AA]U<@@CJ>.M7]0T[3?^$[^'^G,UM>VL=E< -A2DN(QA\#@
MY(S]:VI_#'B :I=M&_A^\L[JY>?S-0LFDFB#8 48.&P %&2.%%=/IFD6VF6%
MO;)'&QA!P_E@8))8X ^Z,DX Z4 >,:FRCP+XVCC(\BW\3$JJ?=C3S$Z =!7M
MEGJ%MJFFK>:;-'-#(I,4@!VM[_3-3"V@56588P'^\ @^;ZU*JA5"J  !@ =J
M /,O#"@_ .ZA$3+,FGWL<B,/F\P&3/XYJG>7^C:QHGP_M?/MKF);NWCFC)!4
MD6YRI!ZX) (]\&O0['16TS5KJ>SF5+&[8RS6A3A9CC+H>V<<@YYY&.<Z/V2V
MPH^SQ87[HV#B@#R+7(V3_A9EGH0A281V;B& #[H7][A1WQNS^M;'A ^&M3\1
MV6J:7JNJ:IJ7V9ED>=E MXL?=D"JH^\0 .3GD<"O1UMX4D,B11JYZL% )_&E
M2*.+/EHJ9.3M&,F@"*[L+._$8O+2"X$;;T$T8?:WJ,C@U2OYM'\-65]K$\5K
M:*09+B945&E(R0"?XF)Z>YK5IDD22KMD177T89% 'AGB_0M6UGP&VNRW&BH@
MG;4_-@D9YBSC'E[^AP-JX'_/,4[Q7XFO?$OPRT+5K<"<6-W&VK08^8,O"EA_
M<)R?Q'H<>X""(1B,1H$'(4*,#OTIY4$$$ @]0: /#O&#:+JWA'7M;\'I=R2W
MSPR:G*%=4" \J,XYR02!D8S4]YJ>DZI\9/!DNC2QR6J681=@X4;9,+]0"..U
M>T(B1H$1551T"C %<3J_@G4-0^(>D^(X+JSAM=.41I;^6VYEYW<CC/S''X4
M><>(+F/3?$7Q'M;L/'/?6Z?9D\MB91D'(P.F.<U+XH>WD^$G@>7[0N^*>,;
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M."Z9!R.1GUZ=CX/N/#NLZW+K.A6FH2NUJ89M0NY9R/O*1$!(2&/4DCIC_:H
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MNJZM9:)I[WU_-Y4"D+D*6+,3@* .2236+X3TV:VO->U*2)X(M3O?/AA=2K!
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M^UQ[#*N 0ZCT.:76M;31C91_99KF>]N!;PQQX'S8+98GH,*>:OVLDDUK')+
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M8*X!*^XK3ED2&)Y9&"QHI9F/0 =30!&+.U#(WV:'<GW3L&5^GI2+86:[MMI
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MQ@G2![B)HO->,R!0PP3MR,\$]ZCT#39-&T"PTN6X6X-I D E6/9N51@<9/.
M.]5G\164FN7^A&.[6\M[3[2VQ,[XS@93!))R<8P#D5R]MXEAT'PEH#:)9:IJ
M-I>WH@26Z=6E&9&W [F!+'#!>@'&<=* /0Z*P+'Q9;WGB'^PY-/OK2_^S_:=
MEPL8'E\#.5<YY.,#.,'.*OZ/JT>M637<-O/#&)9(@)P 6V,5)&">,@X^E %^
MEKGO'$VG0^$-0?51>FQVKYOV(XEQN'0\8YQGMBH+SQ?8:)J=CH36&IR7DUN'
M@BBB$A8# VD[NOJ3QP230!U%%<)J_P 02/#$.JZ-I]Q*7OELYA,$4VS[PK*R
MEN6.<#&1SDD5KZKXQMM*<PO8W,MTEN+F:W5X@T2$D<DN 6X.%4D\?2@#I**Y
M*7XBZ(D>GR0QWUTNHV[SVOV>W+F79]Y  <[AZ=/>F7OQ$TZS@>;[#?.(8$N+
MI2J1O;JR[@"KL"6QR57.* .M\J/SO.\M/-V[=^T;L=<9]*?7,R^-;-S'_9MG
M=ZH&LUOG^R[,I"V=IPS*23@_*.>*K+XKOIO'=II,6F7'V&733=;MT6Y\N@#D
M%N%4$@CJ2>AQ0!U](:Y_3_%L&IW-J+>PNVLKN9X;>]&PQLR*Q.X;MRCY& R/
MRKH: $I:XJ#5='T?5?&.I0V.H-=62Q2Z@"P.\!"P,8+8 V\]JMZ=XYMM0U73
M+)M,U"V34X6EM+BXC54E*KN*CG/3U'/;CF@#JJ2EKRJ\.B0?%#7[;6;M;:Q;
M3HY55[EHP')^9DYX;Z<T >F6UA;6<L\L$>)+A]\KLQ9G/;)))P.PZ#M5FO,/
M"_C._P!!\%:1)XCM=2NIKV]-K:R! TKH3\A<$AB3SCCD 5TT?C,S(B1Z)J O
M/(DN);6;9&\4:.4R2S8.2IQ@GUX% '4T5SR>+K2ZATG[#;SW-QJEN;F" ;59
M8@ 2SDG '('?)/'>L74O&][+!H,NFZ9<1I?:B+699]J.I7=NCP?7;][ICWZ
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M+V8,$P7Q@1@_?(!!/(ZCK0-?U23XD-HRV9^PQ:>)^)5^;=( '/&>-K  'O\
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MF:ET/QE)J'B$:-=VL'F26_GQSV4K30@\[D9BHPPQ]#^5 '7,RJI9B H&23T
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M0>N"?3O0!WW]HV7]I?V=]JA^V^7YOV?>-^S.-V.N,]ZLURE[>31^/!96VF6
MNY=*EE@OI2=Y*NH"-@9"9;)P3GVKA_\ A(/&?_"L3K"WFFM'/<$-,'D\Y=]Q
MM*CLH!.!SPH]: /8Z*X?4O&&HV&I1Z,4LCJ:6AN;ADBGFC&6(15"*6&<9)/3
MCKFI+'QC?ZM8:/#;:6;36-0$CR6]Z&"VZ1D!W(P&()("],Y]J .JM=2LKZXN
M8+6ZBFEM7\N=4;/EMZ'W]JM5PO@+[:?$7C#^T$@6Z^W1[Q;D[/\ 5#!&>>1@
MUW5 !1110 4444 %%%% !1110 4444 %%%% #4^[3J:GW:=0 4444 %%%% !
M1110 4444 %%%% !112-DJ=I ;'!(S0!XKH,EGJ'PU\1:'':O<:E<WUPD4*V
M[-ND9L(V<8P.I.>,5TT4ESX9\;B2^MKV]:71(+:.6VMRXGFC8[AQPI.0>< #
MO73^$_#7_"+Z9-9"\-T);A[C>8]A!?DCJ>];V* /'+"7RM \#1WEI<PO;:I-
M-/'+;O\ NUW2D,>.F67FN@U?49_"OQ%_M.?3;NYTF_T]+=9;2V,IAD5V;:0!
MP#N)]R?:O0\48H \Z)A3Q+X+#Z4=/BC^V,EL(3B!7XBW8!"L>XSP2163>7K0
MZ=XF\G3Y;AF\0I-O%LSF"/;&/M"ICY]K(<#IGKD=?6\4E 'D=@8+F]\91WNF
MZ_>6>H16CJTELXFD0#:S#"C!!.0H X'3%)<V&O:KX>\0:?8W-SJ]K%';265U
M<VYAFEV2%V@+$*7P!G=ZGWX];61'9E5U9D.& .2#[T_% ' ^#[C2M4UD7VG^
M'-4L[F* Q7%SJ/F H"0?+7<QW<\]L8]Z[R0$QL!UP<4[%1SK(\$BPR".4J0K
ME=P4]CCO0!XIH31ZQ\&[;PS:PS2:U-<$<6SE8W^TDF1GQMP%ZG/M7:Z"I@^)
M7B-;NUN";J&U$%S);,L<IC0A\.1CJ0>O;VKH/"N@'PSH,6E?:VNEB=V61HPA
M^=BQ! /JQK:Q0!Y/JNEZEJ.F>.H[.QN3/+J$-S;I+;N@N%C\LD+D#=G81QUK
M5O;^?QSX<U:/3O#]U9W4FGR0237T'E.7/2%#U89SGL,#UX]#Q1B@#S/P;!I=
M[JUC<V'A&^TZ\M587=QJ"R*(LJ1LCW-\S$D=N%SG!(KTRBB@#RF&&\3X=:GX
M+O-,O9]7!GBA;R&\NYWR%EF#XVA06!.2.GO6U>Q36/CKPDC07L\5E93PSW,=
MK(Z!F5 N6 (Y*GZ=Z[K>I<H&&X $KGD ]/Y&AG52H9@-QP,GJ?2@!U</XROK
M>[ANM&U?2;J2S-S:>5,ML\B3*98]ZAE!PW+#L3GCFNXIKQI*H61%8 AL,,\@
MY!_ @&@#C/"%I?:/X%N8;]+SREDF^Q0RHTD\=N3B-6503GVYP#VQ@5-/T2;Q
M#\&8M ,<]I=FQ2 K<PO$5E4 @$, <9 Y%>@8HQ0!P#VUSXDU;PHK6%Y:C22;
MF\::%D5)%7:(U)&'RW=<C Z\UD-HU_8>"M5\#I87<MQ/<LEK<) QA,,DF[>T
MG0%1NR"0>!C.<UZMBF1R)*@>-U=#T93D&@#%W*D\?A<V-\UJ=.P;X*/+ ^YL
M+?W\<].]<,-'OK[P/I_@:;3[V*ZANEBFN3"WD^3')N\U7^Z=P  7.<GIQFO5
M6(52Q( '))[4R&6*XB66&1)(W&5=&!##U!% '%1K<>$O$OB&X33;NZMM4V75
ML;6!I?WP7:R-C[N3A@3@8)YXJ+0Y)?AYX:\.:)>:?=73W,OE3W%JNZ*W>23C
M<?3+@?@:[[%5+G3[6[N;>>XB\Q[=MT09CM5O[VW."1V)&1VH MUY-XRAU/4K
MSQ5I[Z%JDJO;J;%[&'9%-B/):5P09&!X"DGT"UZS1B@#,\.RR3>'K!I;6>U<
M0*IBG4*XP,<@$XZ9]:P/$MO=3?$'PA<PVES+;VCW)N)4B)2/S(]BY/U_*NNF
MFBMX6FFD2.)!EG=@ ![DU)0!Y!JF@:MJ&C?$2WATZY$E]=Q36H>(KYZHP)V^
MOW3^E;1FU+4OB3I6N_V#J=O806$T3--& X)YY4$GKP!U/IBO07ECC(#R(I()
M 9@.!U/X4L<B2QAXW5T/1E.0: /(#I&I#X4:%I<>DZB+JTU17>!H&WK&)7?<
M>Q^5AT[UT\UE=R_%'4;E-/N%MYM%^RK<E&\MY=V[&>@XX^H]:[O%&* /*K'3
MK_6/!_A[PL^E7UK=V$\$EW-<P%(XEB;)*/T9CT&,]3G%5H/#IM=7U;3[WP-'
MJ%Y<7LLUGJC1*T!61BP,I)R N>@R3C'N?7L5'++'!$\TTBQQ(I9W<X"@=22>
M@H X[PK#<VGC7Q0)].N8H[J:)X;DP%8Y D80@'ZYQ]>*[6F12)-&DL3J\;@,
MK*<A@>A![BGT ><6-IJ>AZ!K_AR?2KN]EN9KAK.>&/=%.LV<;VZ(02=V?PS4
M5[I-YI'B;P##'97EW;Z+:RPW-S! 64;HA&OZKD^@KTRH9KF"W:-9YXXC(P2,
M.X7>QZ 9ZGVH F[5YIK5A>Z/XWU#49/"Q\1:?J<<10K&CO;2(-I7YAPI&#]?
MQKT>6:*!-\TB1ITW.P _6H/[3T__ )_K;_OZO^- ' O::SX<\76.NQZ ]S:7
M&FBSFL]-5<VC^87P 2 5R>3QSDUS=CIFH:QX#UPV=F\MU;^*9+IK9&!8A64L
MH/0GG\<5[8"&4,I!!&01WK(T#PY:>'(;N*TFN)%NKAKJ7SF4GS&^\1@#K@<4
M <GILFJ2_$V\U^70-1@T^321"AD5=^0^[E=W4X( &3R,XSQ1M['5;;X?Z O]
MC7SW6E:LES/:A )&0.[94$X;AQWZY]#7J6** .$\:6=_-%H>OZ:GV77(9U@C
MBD;=E)OE9& Z[>&XSC:>M=EI]C#IFG6UC;@B&WC6),G)P!CGWK$F\.>'M+UZ
MY\67C".YVC=/<SGRXN-N5#'"DCC\>.M;EE>VNHVJ75E<PW-N_*RPN'5OH10!
MA?$"RN]2\#ZI8V-M)<75Q$$CC3&2=P]2!6'!IVJ'QYX;U!].N1;6^D_9YY6V
M_)(1T/.?J17H-&* /(8_#^OCP5K%LFD3_:7\0#4$@<J&EA,BM\IW8S\O(-:5
M_IVKP^*I->G\(QZK::C;1K+9NT+S6LB9 P6XP1UP>I]N?2ZB>Y@BFBADFC26
M4D1HS@,Y R<#OQ0!P;Z7JT'B_P )W1T8""TBN1<BR5!%;F;A5'(SM[D#W[U!
M>Z)J>F^.M6OCX8MM?L=5\MXI',>ZW=5"[6W]%^G8=Z])J*YN(+2W>XN9HX84
M&7DD8*JCW)Z4 ><^(?#]U=B%9=#N!J=I9)]BU+1V6(12\YCP67Y <8R.A/2M
M-K'7K/QGHVIO8_;F;1_L-U+'*JK'-O1F9L\[>#C )]J[2">&ZMXKBWE26&5
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MUU-8VA: =&65YM2O=1N90JM<7CAF"C.%&  !R3[DULT %%%% !1110 4444
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MW1M;W1*J<A3%)\I*L">N.G851L?B#JTN@1:[>:%%!IUQ OV=A=9:2=I BIM
M)P<YR 3A2<<XH ]"JI=ZIIVGNJ7M_:VS,,J)IE0D>V36%H'B/4M0URXTV^TT
MK&D GBO8H94B;D!D/F*,,"<]\CGBMJ?3[4W4VH&%6NC;^3YA&2$!8X'IRQSZ
M\>E #8-=TBZF6&WU6QEE<X5([A&9OH :T*\]^%UC!=_"W097@CDGMWFE@+'&
MUQ-)CG!QUP?8U+HGC3Q#J^C2:S'H%O+8K#<%1;W):222-R%51MY##OC.0>!Q
MD [F6"&?9YT4<FQ@Z;U!VMZC/0U)7%:7XUN;S7=1T9XK&>YM; 7B/;3GRR<X
M:-C@X(..1GZ5!8>-]8N;#PYJ<^D6T>GZO.ENQ6X)DC9\[6QC&W(]2<>G2@#N
MZH:CKNE:0\2:CJ%M:M*<()9 N>V?89XSTKGK;QA/?>);S2[=;*-[.\6![:=V
M6>2,XS*@Z$9/3G@9)&0*Q;&::7X@^-%U06<EC;V=LMVK(Q#1>6[< GT8YSUH
M ]*4AE#*05(R".]1W-Q#:6TEQ<S)#!$I9Y)&"JH'4DGH*X;1O&][<7FE6RZ)
M-]CNUV_N+*X06G39N9T"LN."5Z>XJ?3M6UWQ6E]9W&BZ:FG+-=6-P\DYD!9,
MJ"$P-R[L Y(/7IW .H?6=+C*!]1M%+P&X4&9?FB'5QSROOTJY'(DL:R1NKHX
M#*RG((/0@US=GX*LK.ZT291"3I43HC^2!(Q8$8S_  I\S';CN.>.8/#DYT_Q
M?K_AX!Q:Q^7>VJG[L:R9WJ/0;P2!VR: .NHHHH **** $I:** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@"C<:+I5W>)>7.F6<UTGW)I(%9U^C$
M9%70,# X%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %,FABN(6AG
MB26)AAD=0P/U!I]% $<-O#;AA##'$&.Y@BA<G &3CV _*I*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** $7[HI:1?NBEH **** "BBB@ HHHH ****
M"BBB@ HHHH *YM++Q%9WVI^6=.OK"[D,D,5Q(\;0Y !4D*P8'DXX^OITE% '
M!_\ "%ZC8Z#HFFZ>]B_V+4AJ$Y=FB7.\OLC4*V!\Q')XP.N>)=4\,:]?ZKXA
MGMKNULDU*SCMH9XYG,L9C+$$C:!\VX@X/'O7;T4 <!9>%/$5IKEOJ2-HD$<>
MEM8?98$D"@;MPP?<CDXX!Z&I;;P5?R_#:W\-7ES;P7UH5:VN[9F=5=&W(Y!
M[\$<^OT[JB@#GM LO$H=9O$E_8RR1(4CCL$=%8G&7?<?F/'   &3[8V;T7!L
MI1:1Q23E<(LKE%)]R 2/RJQ10!R_@;0M2\+^#K?1KS[++/:^9Y;PRMMDW,SC
M.5!7EL=#Z^U9FF>#M6M/AO>^&3<6MM<R&40S6\CLH5W+8.0".I7OQ^5=W10!
MPECX6U^TUF;4RVBH9M,%F;:".1$C*DE0IYP.<DX]MO>GQ>$-4A\*^'=)2>S,
MVDW,4[2$MMD\LD@ 8XSG\,5W%% '#:SX.U'7;^-[MM.'DW@N+?4$5ENH8P^X
M1C P>XR3WZ$BK-GX5O?^$H\1ZA??9'L];A2"2))&+1JB%!U7#;@<GICWKL**
M .*\/>&_%.EBUT^^UVVGTFP(,!AB*3S*HPJ2'H%''3)..M:WA31K[1;:_BO9
M;>4W-[-=J8 PV^8Q8J<^A/6M^B@!'=8T9W8*JC)8G  KB=-LM0U75O$7B+3I
MQ;/=QI::;+.F]#'&/];M[JS%MISR.>0:[62..:)HI45XW!5D89# ]B*4 *
M  . !0!%:+.EE EU(LMRL:B615P&?') [ G-3444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% #5^[3J:GW:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%&: "BC-% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4449H **,T4 %%%% !1110 4444 %%
M%&: "BC-% !1110 4444 %%%% !11FD+ #)..W- "T444 %%%(651EB!SCDT
M +1110 44@(;H0><<4M !1110 4444 %%%(6"]2!DXYH 6BDWKOV;ANQG&><
M4M !12,P52S$  9)/:DCD26-9(W5T<!E93D$'H0: '4444 %%,FFBMXFEFD2
M.-1EG=@ ![DT^@ HJ.2>&)HUDE1&D.U S %CZ#U-(EQ!)-)"DT;2Q8\Q%8%D
MSTR.U $M%%% !1144%S!<AS!-'*$8HQC8-M8=0<=#[4 2T444 %%%% !114%
MQ>6MIY7VFXAA\UQ''YCA=[GHHSU)]* )Z*,T4 %%%% !1110 444R66.&)Y9
M76.-%+.[' 4#J2>PH ?14%G>VVH6<5W9SI/;RKNCDC.58>QJ>@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH :AXQ[4ZF)T'T%/H **** "BBB@ HHHH
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MI+266>SAEGA\B5T#/%NW;"1TS@9Q7$ZGHMOJ7Q%LKC3[Q=DL&[5H(MK+*D3
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M##(P<'V/2@!U%9/B'5YM&TU+BVL9+V:29(4C3( +'&YR =JCJ3BN8MOB*O\
M9OB.6>"WFFT1HU:6TF+PS"3A6!QE0/XNN,&@#O:*Q?#^JWNIK+]ICLWA54>&
M\LIS)#.&W9QD<%<8(R>H/&<5%XBURZTJXLK>V@A N?,:2\NF*P6ZH ?G([MG
M &1WH WZ*\\7XCW=QX7T76+/15G.HWHLFC%S@K)N(^7CD':<$D8SS3IO'VJZ
M;'KEIJNC6\>J:;:?;4CBNB8IX<XW!BN>#QTY]J /0:SO[>TC[%>7@U&V-M9L
M5N)A("L;  X)]<$<>]<I9>-M82^T)M8T>WM=-UH*EO-%<;W25E#*'&, -S@
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M>8^5%E1@@*,=^23Z=]GQ5XFU:RC:YM+B*SM!IOVR#]R)Y9Y1DF,H"2$ VY;
M SUH [VBO.V\6>)-4N?#D&DKI\+:QI;W3&>-B(9%"DG(/*\X QGG.3TJ'4/%
M/BJ6]O-,TVVEEU#3HH4D:UM%DAFN&0,P9G<%(^1C SU.>U '<C7+ ^(/[#\Q
M_P"T!;FY\LQ,!Y8(&0Q&#R1T-:->9W8\07OQ,T]H'M],O9O#I\P2KYXMW\X%
M\ $!CG:!SCJ?8V-.\8ZO<Z%IEK,]LNL7FIRZ<;D)^[41EMT@7UVKP.F3Z<4
M>@32K!!),X8JBECL0L<#T !)/L*IZ-K-EK^EQZEITC26LA949D*D[6*G@\]0
M:Q].U/4[/QE-X?U*9;J&6T^UV=UL"/M#!71P."06!! '':N5\(:Y<6'@/PUI
M<,@CO]5N[B&&5E#")%D=F?'<A< #U(SZ4 =[:^(=/N_$-UH<+RF]M8A+,K1,
MJJ"<#!(Y_#(K5KRR_P!3N?"7C?Q'JM_=&_\ LVAQ20;T5&(,I"HVT ??)YQT
M-;^G77B]]8M$>"4Z;<6K>=<7:VX,,VTE2BQODJ3@8.3[]: .THKB/A_?>)==
MTRTUO5=1M9+.Y@<"VBM]C!Q)@,6SSP",<=OK7;T %%%% !1110 4444 %%%%
M !1110 4444 ,CY13Z@4^F1\*!Z 4^@ HHHH **** "BBB@ HHHH **** "B
MBB@#S:QT?6=(\):KX/?2I[TSM/':7H9#$Z39(>0DY!4L<C:>@QFK=WIM[I_B
M?P;#;:=>W5GHUO)!-<HJ;3NB5%/+9ZCGCCWKO20!D]*KV6H6>I0M-8W<%S$K
ME&>&0. PZC([T )J32II5XT%NMS,(7,<#=)6VG"GV)X_&O/O#WAZ^M]88:5I
MVH:-H]Q92_:[&[E5HEG; 4Q@,Q]<D8& /I7I=59M1LK>\AM)KN".YG_U4+R
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MY)Y)(  '08[YKH+[2]/U-46_L;:Z5"2@GA60+GTR.*LQQI%&L<:*B( JJHP
M!T % '&V_@_4WTJQT'4=1M[C1K*2-E(B(FF2,YC1^=H (7)')"]LU+!X1OK>
M\\5W*7]ONUQ0$!B/[@A"@)Y^;@Y[<UU]% &7X<TR71?#NGZ7-,DSVD"P^8BE
M0P48!P2<<"N<;P3J]EKVHW>A^(VT^PU.4S7-K]F60K(1\SQL3\K'UQ^>!7;T
M4 <?JG@DZO#?6M[-;S6AM%M;!'1B;;&,MG=RQ(&3P?E ]<U[GP7K=[I6E&?Q
M$%US2G8VVH1V_#(P *NA.#D #/M]:[BB@#A]9\$:IK.A+;7&LQR:B]W'<S7+
MP$)^[^ZJH&&!^))Y_"WXC\(WVKZCINLZ;JW]FZS9(8S*L7F1R(?O*5)Z9S_G
M!'6T4 <=JG@V_OO#L>GIJZ/>->1WMS=7$!/FNI!&%5@%'RJ,>@]>:77O"-_K
M\=[97>IV\FGW4L<JK):EI+8J%!$;;\#.TGIQN/6NPK-U/5)-/NM/ACTZ[NQ=
MS^4TD"96 8^^Y["@#GM0\%ZDOB:YUG0?$,FE_;@@O8?LZRK)M& R[ONMBK-M
M9:M8>+K"TL[^=]$@L?+FMYH,A2!A6\T\LY../0'..,].DL<DDD:2*SQD!U!R
M5)&1GTX(-/H S-?TJ36=*:SAO9+*7S8I4N(U#,A1U<8!X_AQS68OA_5K[4+&
M?7-4M;F"PG^T01VUH82T@4J&<EVZ!FX&!D^U;NH7366GW%TEO-<M#&T@AA&7
MD(&=JCN33=,NY+_3+:[EM9K22:,.T$PP\9(Z'WH YF3P5=S:/XBT^35H6_MJ
M9I7D^Q_ZK<JJ0!OY^51@^O/-0W/@*\N)Y73Q \"W6G)87B1VJGS%4$ J6)V<
M,<]>I]L=G--';PR33.J11J7=V. H R2:D!R,CH: .*TKP+>:7>>'YUUWS1I%
MN]MM>T \V-CTR&^7 "@=3D9.<XJ?4O!=W+XBFUG1->GTB:[14O42%95GV\*V
M&.%8#(SS_//744 <Q#X2>T\36>JVFH!(;73S8);O"7)4G=N+[LD[@#TYP?7-
M9]M\/BFC&SN=5,EW%?MJ-I>16_EM!,QR>-Q#+DG@]J[>HWFB2:.)I%$DF=BD
M\MCKB@#'L]"NXKVYU*\U%+G4I(/(AD$&R.!.N%3<2<M@G+<X'05@1?#:./PI
M;:,=6F%Q8W+75C?11['@<G<<C.&Y+>G!QVS7=T&@#C8O 0GO[R[UG6;G4VO;
M 65PCQ)&K+DG("CY>3D =#W-.T'P3=Z-&B3>)+Z^2U4K8),B[;;*E03W<@$@
M9. #C%;VEZM'JYGDMHF-G&VR.X)XF8$AMHZX!&,]^<<<G2H Q/"OA\^&-"BT
MD7KW4,)/E,\85E!))!QUY)K;HHH **** "BBB@ HHHH **** "BBB@ HHHH
M9%RBGN0*?3(O]6O^Z*?0 4444 %%%% !1110 4444 %%%% !1110!QVG>+;S
M6-6EALX+*6V@OY+.Y@\QOM$*KD>85QC:2/R(YSG'*Z/XFU+PWHFN7L&FQ3:5
M9:W<BZDDF"L%:;!$2@'. P/S8Z\5NCPEK%_K&FZGJ,&E1:A979E;4+61A)/"
M,XC9=@'((!))QCIS5-_!/B";P+XBT1QIJW>JW[W2,MPY1%=U8@GR\Y&W'3G/
M;% &YXD\6W.D"XFMH+86MM9B[::\=HUFR3MCC./O?*>O3*\<U4U>ZAU6_P#
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M$9P2C,F>&QSCGM56/P[K&G:[-KEA<V4MY?P)'J$4RLD;N@PCH1DC )&#G(H
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MKQVK0TK6/$SZ]:V][IYFL+B$F6X6W\D6\@R<<NVY3T]:74/"$^LZ]J-UJ-Q
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M:[892,<[0  .2 23DG H P?'<-U)XF\(K%J-U!'+?E3%$JLNX(Q#X*G)[<Y
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M_AZRT62>:%[B>ZN-HEN;J8RR.%^Z-Q[#)X%:M !1110 4444 %%%% !1110
M4444 %%%% #(O]6O^Z*?3(O]6O\ NBGT %%%% !1110 4444 %%%% !1110
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MVXBF(P&&, C/.,'I0!ZQ17!ZBFNZ8^GV%WXDENO/FGD?[+;JEW*NP;$C4*5
M#$[F) QC)%9T/B#Q#=>$_#UTNHF"]FU@Z?.9($;S%$CKEP.^$YVD Y- 'IM%
M>>#7=7\,OXNCOM0?5ETNS@NK9IHT1LN'RIV  C*BM&W35])CBUF;7S?V;V+2
M36\ZJOF2A"X,6T#:, \<\#//6@#LJ*\XT&Z\6:@=&UUKN&.QN1'+>">[4PND
M@P$C0)E&4D#D\G )-.L]<OH/&9L=:O-1TZXEOW6U255:TO(,ML5"%^5\%3R<
MDCKSB@#T6BDKA1<:IXLOO$D6FZS+IT^F7 M;6-5&T.H#&23^\&.Y<= !G&:
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M$EN<JVT#'MTXJIX?TN:;X1Z9%I<\,5Y<W+9MYIBBWJI-(3#G/RY /3J!@]:
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MC<S(J7*V5QY2W"CL_&>@ X(KH-/GN+FPMY[JT:TN'0-);LX<QMW7<.#]:LT
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MDIFGB^TRB-I"02X0-M#<=0 >H[FM\7UH8YI!=0%(21*WF#$9'7<>WXUR^O\
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MR$LH9%LK::*X$:;D+"7<ZGU/&2.O&:P;,7OAQ!;OIMN^JKH]T^FZM8'*7H5
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MK&&T6TBL[=+9/NPK$H0?1<8J2VM;>S@6"U@B@A4DB.) J@DDG@<<DD_C0!P
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M  95#$C"D<\IT _#K5W2KO0O$!TZ\T>_U&]URWL)HXH@J(;4&)AB3:@&-V
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M=O\ "^T,1]<,*\X\+MI>K>'--\27FJ74.K)>;;V17S))(SE?L[+S\AW* H'
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MR#\H&?<UUD\$-U \%Q%'+$XPT<BAE8>X/6O$;2WLH?@9/?+:6T-Q%?!3<K&
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M-TYZUG6&O6&I:G?V%I,LDMBRI,5((#$$[?J,<_6O'8+^Q?P!\-X1<P&XCUN
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MNGMYKP*T<@AD<1L8XW.,*[@;5/(X)'6K>FZE!JUBEY:B40.3L,L31E@#C.&
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ML=<94Y]0/UJZVJV,^KS:&+ATU 6_GF,(RD1DA=RL1@\D#@]:\<73=2/@;Q%
MNEZD9(/$9O\ ;-"QDDBW)R/[S8!)Q79Z?J<FH_%-]4&G:A%IJZ)Y27$MJZAB
M9=_0C(X4\$ \=.1D S_#GC:[TSX;66I7_P!MU&\N;Y[=9#&\NW,VT%B/0'@=
M2< 5T,\>LW^N/=V>I:E;Z;<V$@:&2TV_9WVX5E# ,9,Y.,=O<5Q>C0W47P?@
M0V-X9K+5DGF@%NXDV"X#DA2,GY>>*]<LKH7UE%="&:%95W!)EVN!VR.WTZ^M
M &=X7AU.#0((M7GDGNU9\R2A0[)O.PL!P#MVY%9]EJ&F0>)/$ETVLWK?98HF
MN[:X#+!:J%;YD! ZA221D5U-<"]O+_PE'C>2?2;NZM+NPA2-!"RK<[(W#HK8
MZG< /7M0!U>GZY:ZC>2VL<5U%-%&LK+<6[QY5B0"-PYZ&M.N!\$P7]EKMU9V
M]SJ-YX?CMOW4FI0-'-!-OP8@64%UQDYZ#BN^H **** "BBB@ HHHH **** "
MBBB@ HHHH 9%_JU_W13Z9%_JU_W13Z "BBB@ HHHH **** "BBB@ HHHH **
M** ,2Z\):)>ZA)>S69,LN/.5)76.;'0R("%?_@0-37'AO2KG6X=9EMW.H0@+
M',)Y%V@=L!L8]1C![U#875XFJZN]_JFG26$10PQQ?*]NN.?-)/&<?YZ5I0ZC
M97$_D07EO++L#^6DJLVT]#@'IR.?>@!-19TTVY,4$D[^6P6*/&YCCH,D#\S7
M(>!/!MGINB:7->:;/;ZE;1@/%-.619<8,BH&* G)^8#/)KN>E48=;TJY6=H-
M3LY5@_UQ2=2(_P#>P>/QH H7?@SPY?ZTNL76D6\U^,'S6!Y(Z$KG!/N1V'I5
MF#P]I=MKD^LPV[+J%PNV6;S7.\>A!.,<>G%6/[5T[R(I_P"T+7RIFVQ2><NU
MSTPISR?I5*QEU'_A)-46YU&QEL D9MK:/_70\?,7]B>E "Z?X7T?2[^YOK2V
MD2YNO]>[7$C^;_O!F(/XU'I7@[P[H>H2W^FZ3;VUU+G=(@.1GJ%SPH]ABGS^
M+/#\%A<WIUFQ>"V!,K13J^W'&, ]<\8]:?8^)-*O-!AU=KZUAM7C5W:2=0L1
M90=K'. 1F@".W\(^'[77'UF#2;:/47))G5><GJ0.@)]0,\FI5\,Z*M_>7PTZ
M W%ZI2X9AD2 @ @@\<@#/'..:L+K&F-9Q7BZC:&UF(6.83+L<DX !S@G/%/L
M]3L-0>5+*^MKEH3MD$,JN4/H<'B@#/T;PEH'A];@:7I<%N+@8EQEMP].2>/;
MI52#X?>$[:Y6XAT*T659O.4[20K\\@$X YZ=.G' K:M=5TZ]N);>TO[6>>'_
M %D<4RLR<XY /'-1PZYI-SJ#Z?!JEE+>H2'MTG5I%QURH.: %L='T_3;J]NK
M.U2&>]D$MRZYS(WJ?U_.KU0W-U;V4!GNIXH(5(!DE<*HR<#D^]1-JNG)=06S
M7]LMQ<(9(8C*NZ10,EE&<D8!.10!1_X171/[2EU'["/M<V\2R^8^9 PP5;G#
M+CH#P.P%,N?!^@75C;V+Z<J6MM)YL,,,CQ*C_P!X!".?Y5:_X2#1=\"?VO8;
MYV*PK]I3,A!P0O/)SQQ2:OJUCIL!2YU:RT^:1"8GN74 8ZG!(R!D=Z +TEO'
M+:M;/N\MDV'#D'&,?>!SGWSFLZ#PQHEM8W5C#IL"6=T,36P!\IO^ =!]0!FL
M[PMXC6Z\#Z7K&M7MO#)<QC?+(RQJ6). ,\=NE;)UK2A:0W9U.S%M.P2*;SUV
M2,3@!3G!.?2@"A9>#/#FGM"]KH]K&\,9CC;9DJISG!/.3D\]:NV6A:3IUI-:
M6>G6T%M/GS8HXP$?(P<CH<BI[+4++4K?S["[@NH=Q7S() ZY'49'>L.;Q=I]
MQJFJZ+9WT$=_:0!E=F!!D8/\H7/S%=HR!ZXH NQ^%/#\4<$<6C62)!)YL2I"
M $?^\,=#P.:LQ:)I<-W<W4=A;K/=*5N)-@S*#V;U'UKG/ ?BZ'5O"^D-JVK6
MAUB\5V\EI$21\.P&$&.P[#M70WFOZ1I]TEM>:G:6\[$ 1RS*IYZ9R>,]O6@"
MO8^$O#^FVMS;66D6D,-T3YRI&/W@/.#[>W2ICX=T9M)&E-I=HVG@[A;&(&,'
M.<A>@K2(R" <'UKE?"=[K%]JFNK?WZSVMA>M9P*(E1FPJL6<@=<, ,8[Y'2@
M#17PAX<3S=FB6*B6(0N!"H#(#D+CT_GQGI4W_".:-_H?_$LMO]"_X]?W8_<\
MY^7T_"K]S=6]G;M<74\<$*?>DD8*H[<DU7T_6-.U6W>XL+V"XB0X=HW!V'KA
MO0X]: (6\.:*^JC5&TFR.H [A<F%?,SZ[L9S[TFH>&]$U6Z2ZU#2;*ZG0 +)
M- KL .V2*++Q'HNI231V>JVD[PIYCA)0<)_>_P!WWZ5&OBOP\]Q;0)KFG-+<
MG; BW*$R')'&#SR"/J,4 :X  P!@"LY] T=[\W[:9:&[+!S,8EW%AT)/<CUK
M0=2T;*KE&((# #(]^:\_\-W?BG7[K70OB&*%--U.:RC5[!'WJF,%B"OKSC%
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M ZDJ2, 9&22,9'<UE2_$3P_#I%IJ4DERL-S=?8PIMVW139Y1QT4CK@GL<9H
MZK8N,;1CZ4;5SG S]*YM/&^F3P1M:V]]<7,GF'[&D&V=50X9F5B-H!&.>IX&
M35'6/$&@ZCIGAW4WO-16WN[^+[&;0,GF2$D!).V,YR">QQG% '9!0!@ "E
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MAW3"@\X&3W) ]2*[NC- 'G%HEWI>B^(_#M]IEW<7-Y<74EHT=NTD5RLN2,N
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M+@ 84=@.P]*X&]TG4KO1/'UO%87'F7\C26@9=OG#RD7C/NIZ^U>B!@>A!I:
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M!D,,0212S$=%7>H)Z"@#M_#5E+9Z8=VJW6HV\[^=;/=J1+'$P!",3\S8YY8
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MOM=O?MG=)N26..3E&4#G*@CCGG\*Z*V^(OAB\O$MH=1)9S(-S0NJKY:EFR2
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M/)XSSUU;Z])X L/"K>&M4-]IMW"'F2,&&15D.&1\\Y&.V!W(H ]G=!)&R,6
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M11(=K8A4C(S@GD\^]2:EHM[+HGC/4HK&Y^T:[$L-O9!!O 6/8&89P"223SP
M._%%_9:C<ZUX N(]+O/+L%?[62@_<[HU0;N?4'/MS0!OW_C2RL?M,WV.]N+"
MSD,5W?0(K1P,,;@1NWG&1DJI Y]#CHH9H[B".:&19(I%#HZG(92,@@^E>>Z?
MIVKZ#H6N^'6TJ>_-U-.]G<HR^7*LN?\ 6,3\I!)SQ],UTNF_;M%;0] 33I+B
MSCL1%+J"R +&T:@ %>IW8H L>*]9/A[PKJ6K*H9[:!GC5AD%^BY]LD5B:1X;
M36/#%MJ%]>WAU:^MUN#>QSNK0NX##RUSA5' VXP<<YKH/$.BP^(?#]]I$[LD
M=U$4WKU4]0?P(!K!TN_UO1?#UOI$VA7-SJ5I"MO'+$4^SS;?E5M^X%1@ G(R
M.>#0!F^'/B,@\,PS:[',UW%J)TN:2"+<&E&,,0.F0<X&>0<"NIT7Q'#K-[>V
M7V*\LKJSV&2&Z102K@E6&UB"#@UQ4GAB_P##GA_0H(K.?4;XZTFIZ@]L@VAN
M=^,XX&0!ZX/2NCTI+N/XBZY/)I]TEK<VUND5RR#RV,>_=SG/\8QQV- &]JVK
MVNBV0NKHN0TBQ1QQKN>21CA44=R36>OBFW6[NK*ZLKJUO;>W-T+>386EB'!9
M"K%3@\$9!''K5;QOHM]K&G:?+IH1[O3M0AOHX7?:LWEG[A/;KQFJ5[:W>NZB
M-8_LN\M5LM.N8(XI@@EGDE"\  GA0IY)&2W' H O^&_&EIXHE3[%I^I1V\D!
MFCN9X-D3X;:5#9Y.?Z^E9WCZ2*ROO"^H-%-))'JJIMA4LS QR':%'4DA:O\
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MH [:DKA;CQ;J5UXRT*TTVTCETV]LWNT8S[3,I5>2-OR[<].<^U7;GQM);7\
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MI;F9MP26=FCB;;MRB= <<9]"0, UM5S?_"43IXV@T";3TBM[JV-Q:WAN#F;
M&Y0FS[PSTW=.?:M#0-5FUK3FO);1;9#/(D067S/,16*A\X&-V"0.>,<T :E%
M%<=;^,M4NM?OM.C\.$PV%VD%U<_;% C1E#>9C&6X.<#MWH U]%\.1:)?:A=Q
MWUY<27\GFSB<QX+X W#:@QP /2MJN$LOB!<WEUITL>CM)IM_*(TDA,C2Q GY
M9'&P+M/LQQFI]2\:WT6E:MK.FZ;;W.F:8[QLTMP8WF9#ARH"D  \<]<'IP:
M.TJ"[O;6P@\^\N8;:'(7S)I BY/ &3ZUBVGB26XUVQTQK)%%WIIOEF$QX(*
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MXSQ0!Z917*^&G\21ZQ>P:NDIT]HU>TDNI(3.&'#@B+ (YR#CC\:ZJ@ HHHH
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ML_MXL/M4/VPH9/(WC?M&.=O7'(YI+S4++3HUDO;N"V1V"*TL@7<QZ 9ZGVH
MY-M.\0Z9XS_M2"SCU1;G38[22?S5A"2HQ.]E/\)W'[NXC'2L:U\/>)+/PWX7
M!TE9;S2=2>>:W2Y0%XV+\JQ..-_0GM7I^*,4 >=-I_BO1O$FH7FGZ#8ZE;:M
MY<\@ENEC-I*%"LI)&67@=!7>V44T-C!'<R)).L:B1T7:K-CD@=AGM2QW=K-<
MRV\5S$\\./-B5P63/3(ZC/O4] 'FWBS0/$&M7WB"!M&M[^WGM0FF3RW*JD!V
M'=\A_P"6A;HV/3YABK=KINOCQ%X1N[C1]L=C92V]TT=S&PB+!57J06^X"<#O
MP3BN]JK/J=C:WUM97%W#%=76[R(G<!I-O)VCOB@# \(V&HV>K>))[ZPDM8[R
M_P#M%N7DC;>FP+_"QP?E[^H]ZO\ BFTDOM*6V&CP:M \H%Q:RN%)CP>4+$ ,
M#MQDCOR.HVZJIJ5C)J3Z<EW"U[&GF/;JX+JO')'4#D?G0!YV/".NMX%U73HH
MYU;[;'<Z=97MTLKHB,C>67!P,E3CDXSUZU<GT;Q%X@\037&HZ5#8V5]HTVG2
MXNE=X-YSDXX8Y[# P>N>*]"Q1B@#AO#$7C.VMK31=2LK:"TT\(G]HQW(=[I$
M^ZJICC( !+$<9[].??P9X@G^&.K:";!4OKK43<1AIDV["ZODD'M@C'K[<UZS
M58ZA9_VE_9WVF+[;Y/G^1N&_R\XW8],\9H G0ED4LI4D9*GJ/:N"ETSQ5I.K
M>((-,L+2]T_5W:XBFDN!&;>5D",&&,L/E&,?G7:W^HV6E6C7>H74-K;I]Z29
MPJC\35D$,H(.0>0: /.M+\-:_H]IX6U**U62]TVS:RO;%+@9EB/3:QPNX$ X
M)Q[\"G:QX,U3Q#8:[>L(K'4[V6VDM(F?<(_(R4WD9&XEFSC(''7%>B8HH Y*
MUMO%.MV5W#KD5GIJ/9R6PAMY/-\V1UQYA/\ "!V7D\G)Z5SEMX;\7?V+X7TZ
M33["./1+V&5\W1)G"!AN!"_*.>F"23VQSZA10!P!T#66T[QQ!]@ ;6&<VG[Y
M.=T7E_-SQC&?I3[G0=:FNO!$Z6FPZ2"+S$Z_+F,1D#GYNA/T_*NNLM8T_4;J
M[MK*[BGFM&"7"QG/EL<\$],\'BB?6=/M=6M-+FND2^NPS00G.YPHRQ_  T <
M7I&@>+="EO-'LTTXZ=-<22PZH6Q- CL68;,?,PR<<@>N1Q3CX>UDP^.U^PC.
MM*RVG[Y.<Q^7\W/'7/T]Z] HH \ZL_#?B#3[GPA>P6=O++IVG-8744EP%"$A
M0'! .X<$X'-4[WPKXJGFEE?3]-NKJ#5([V*^EN3YDZ+*&6,?*?+4+Q@>G ).
M:]1HH Y.#3]=L?&^H:C%:6DME?VT E<SD,C1!_E5<<Y+]20 /RK"TKPGK]GX
M4T+9#!#K.B7<LT<3S9CN(Y&;<NX?=RKD9QU'H:])HH X74?#NK:G)KNK/901
MW]]IG]EVUN9P?+C)8L[OCU;.!GA1WZ,_X1G6'N_ MT8(%_L.)HKM#-R=T:QY
M7C!QM+=OSKO:H_VSI_\ ;?\ 8WVI/[0\G[1Y&#GR\XW>G6@#-\*:QJ6KP:@=
M2AM$:WO'@BDM&+1RH """>IY(/N#TJMX]T._\0Z%!9:?%$TRW<4Y:678JA#D
M] 2<]/QSVKJ%144*BA5 P !@"EH Y:YTG59?B!9:TL%O]A@L7MF!F/F;G8,3
MC&,#&.M=-*KM"ZQ.$D*D*Q&<'L<4^B@#R^S\'^*X)-"GDM]&-WI]TTD]R)I&
M>Z+(R^8[%<DC(XYSV(%6Y/"?B";P?XITLP6*W.KWTMS"?M+%460C(8[.HV^G
M.>U=WJ.HVFD:?-?W\ZP6L*[I)&!(4?AS4MM<Q7=K#=0/OAF19(VQC<I&0>?8
MT <-XSM8M4T_2+""^AMO$D%U!Y*03!I(BP E]]HC+-R!G:/I6QK]Y?>'=-TN
M#1(K#8)H[<PW+-N:/A=L87JW3KP!DFMF/2-.CU234TL+9;^50KW(B'F,,8P6
MZ] /RJYB@!:Y30]$U2U\0>))[Z&W6SU24/$T4Y9U"H$P05 &0,]3CISUKJ^E
M9]MK5A=ZO=Z7#,6O+15::/8PVALXY(P>AZ4 <IX;T'QAI4%MHEW>Z?\ V/9N
M/*NH"WVAXE.5C(P%&> 3Z9'?-96I>'_$/AOPGXHT^VGTY]!>WN[F.1U<W"JR
M,QCP,#U&[/OCM7J%5[ZQM=2M'M+VWCN+>3[\4B[E;ZCO0!R)TC66NO#^M:,;
M)WCTS[)-'=LR@*X1@XV@Y(*].,^OIG77@[Q')X"UK0=^G3W6H7TLRR^8T:A'
MDWEB-IYR/NCIGJ<5UTVJ:+X<2#3LB';'F*UMH'D94'?8@)"^^,4EUXKT:TTK
M^TS>"6T\X0"2!&DS(2 %&T'G)Q]>.M &<FDZT_Q AUZ2WLDM!I_V*1!<,SC+
M"0L!L X8;<9Y'/M69%X:\7:/K>I1Z'J.G#1]3N7N7:Y1S-;._P!\Q@<'U&3C
MI7?44 <.WASQ)I/B34+O0[JRGL-46/[0E^S[H9%4)O7;][('(R,^O%;'@G1K
M[P_X1L-*U&2W>XMD*9@SMQDD<GJ>?:N@HH YC6M$U1?$EMXBT5X'NH[<VD]I
M<N4CFBW%@0P!*L&.>AS6'K?@+4M2\,:O:1S68U+6+Y+JX=F81Q*N"%4[26QM
M R0,[B>.E>A4M #(3*84,RHLI4;U1BR@]\$@9'X"N7\3^'M8O-<TW7= O[>W
MO[-'A>*Z5C%-&Q!(;;SU /Y=,5U=% ''7'A75IVTW5GU..37;*X>XP^X6Y$B
M!'B4<E4VJ,'GG)(.34.L^$-4UK2]=>:6R34]4MX[5%5G\J")&)^]C+$EF.<#
ML.V3V]% '&W/AS6[KQ7X9UB0V 72X'CG42OEVD7:Q7Y.@ZC/7VJRG@]$^($O
MB,2CR)+==UN#UG7*B0C&.$8C\374T4 <7-X6\06'BN]U/0-6M8+/4B&N[>ZB
M9_+<*%WQ@'DD#O@?7M:@T'5[3Q:=4CEMKBV32EL4,\K>=(RDL'<A<<L<''U]
MJZJB@#SJ/P5K\?A'3]*$NF&YM-6%^6\R38RB0R!?NYSN)'T%:%UX7\16OB*\
MU#0-9M;2VU)D>\@N(#)Y;A0I>,]R0!P<"NUHH X^#PMJ-IXYAUR.YAFMX=+&
MFA9Y',K@'?YC-CEBV ?;)Z\5GP>!]7M_"@TV.]LA>P:FNIV\A5C'O#^9L8<'
M&<C(ZCL*] HH BMEG2VC6YE268#YW1-BD^PR<#\37+2>#)I/$.N71U"/^S-:
MB5+NU,&7.(S'\K[N.#GH:ZZB@#C+;PEJTECI^CZIJ-M<:7ITL4L;I&PFN/+.
M460$[0 0,XSG':NSHHH X>Z\$:G);^)K2#5[=+36I'EV/;$M$SA58[MPSPO
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MR-H@_=EH5_>G9LYQT&W@ ?B35[0_#:Z)JNL7RW;S'4Y_/=&0 (W3 ]L5NT4
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M %%%% !1110 4444 %%%% $</^J7_=%25'!_J4_W14E !1110 4444 %%%%
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M%_;F-GD/G*GFKAR,8&2.@/0BNI?PQ./%=C?1>0-.MM-?3_+,C>9M;!STQQM
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M86RW-W%$S10LX0.V. 2>@KEV\%:A%X2T[1+?4[4M9WB77G26S -MD\P+@/\
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M'&XDGZ=: ,RQ\2^*QI.H^(+N[T^33]+ENXIK9+<J\WEY"LIW';R!QS@9.3G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@"*#F)/]T5+45N,0H/114M !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C':I.
M"<#.!UK@(=%G\4WVK:AJ9U[2FE4VZVZ;%5[8#@<ALDDN2,_Q8[5Z!10!Y/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 1P_ZM?\ =%24R+_5K_NBGT %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!Y)XVU.7Q!\5-%\%R.ZZ6"LUW$#@3G:
M7VG'5<#&/<^U==K6C^%[AK> RZ98WEC/#*A1DC>,*ROL(X." ./<&JWB[P3/
MJOB'2_$ND3PP:OI[#Y9LA)T!/RD@$@\D9P>M9GB/PEK?B[Q+X=U&>UL;"+3)
MO.G'GM*9/F0[1\@_N8R?6@#"^),-E#\4/"5_-:I<VLR_O(XH/-:8!L_= ._A
MACK77^"=/TK588_%%MID%C)<QW5H\"0",-$)R$#J.-P$>#ZY/H*I^+?#7B+5
M_&FB:QI]MI_V?26+*DUTRM-D@D<(=O3WK3LK+Q*NK6S'3]-L=,MS/<&WAO7E
M>:>3<>6*#"[G8]#C/L!0!YOJ5C?_  \U_P#X372$,FEW-]<V]_:HH"HHG=0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!D7W%_W13Z9%]Q?]T4^@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** &1?<7_=%/J.+_5K_NBI* "BBB@
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MCA_U:_[HJ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP21WM\E\2X=#]ECAV$>RCD^]:U '"V6I6+_&3484O(&D.DQ1!1(,EUD8E?J
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M_P!#<@[F5 I!8G'/7C&0* -9?%PO4T>'2[42WVJ6@O8XIY-BQ18!+.P!/\0
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MB0A0IZC;T.:U,444 &*Q]>\+:/XF-I_:]H+E;60R1JS$+DCG(!Y'3@UL44
M&.E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!'#_ *M?]T5)44',2'_9%2T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%4]4U%-*T^2[>&>?:0JQ01EW=B0 H'N2.O'K0!<HK!
MT3Q*=4U*\TR[TVYTW4+55D:"<JX:-ONLK(2IZ$=>#5O6-8.EI"D-E/?7=PQ6
M&V@*AFP,DDL0%4<9)/<>M &G16!X:\50>(FO;<V=Q8W]A(([JUN -T9(R""#
M@@X.#6_0 4444 %)D>M#YVG'6N0/C&\DUO4])M=$N)[C3@C2[)5 <,,C;GJ?
MKB@#L,YHK&\.^)+#Q+IBW]@SE"Q1T<8:-AP5/N#Z9K5$Z$?Q#)P PVY_.@"2
MBF>:O/48&<XX_.E$BDXSCZT .HIGFKG'.?3%()D)(!.1_LF@"2BF&9%ZM@T>
M8N,YZT /HJG/J=K;7,%M+)MGN"1#'W? R<?0>M6?-7H,D^E #\XHR*HMJ5L=
M1-@LP-T$$AC')"DXR?3FJVC7M_<Q7#ZC8"R=)VCC42!PZ#HW'3.: ->BH_.3
M&>3QGBE\U..O/(P* 'T5'YR9QGGM[T]2&&10 M%5=1N)K33I[F"))9(EW['<
MH"!R>0#SC...OIUKDK#Q;XDUG0DUK3/#EG+92QM)$DFH,)F R,;1$1G(.!F@
M#MZ*C@E\ZWCE*%"Z!MK=1D=#4F: "BL'7=>N-*UC0K*&VCDCU*Y,#R.Y!CPI
M;@8YR >];U !116/XDUO^PM,CG2(2SSW$5K"K'"[Y&"@L?09R?I0!L45E:9>
M:F(;PZW;6]K]GD.R>*7,<L> =_/*XY!!]/2LC5_&/V5?#-Q80)/::U>1P"20
ME65'&0P7'.1SS[?@ =91110 4449H **,U5O=0MM/2%KF4)YTR01@GEG9@
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MN&U6#RIXA,C*2W[O.-[8'RKGC)P.M6+SQ#H^GRK'=ZG:PNT9E"O* 2@_B^E
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MTRR;XP:Q*Z9?[%!*6\QAAS(V.,^FWCI62NHWNG^'[F'[3,+2Y\2FTFG)^:*
MD!OF[#(QGM70OX8UF35;;4SHOA[[7;1+#%(+V<%57H/N<X]Z(/"^LP6-Y9+H
M_AYK:\?S)XWNIV#MZ_<ZT 0W=C_8OC;3K#3/,6QU*UN!=V_F$A3&N4?GD')Q
MG/-<W9V_D>!_#?B);J]DU'^T(T#R3,5"&9E9<#C&..:[&ST+7+-91%9Z)NEC
M$3R/<W#OL'1=S#.!]:A7PAJ*Z9!IHTS0_L<$HFCA\^?:KCHWU[T 9/B4-I^O
M76IZI%]KTIKF)%O+6<K+8L"HVLG0KD\D>O2O4()XI'>)94:6/[Z!@67/3([5
MP[^%M6>]>Z:QT3S))!+*&FN"LC#&&(Z$C ZBNKTW1K.QN[K48[6.*_OMANY$
M8GS"HP.M %C5?^0/>_\ 7O)_Z":X+X?Z1>7?PXT&2+6KN%%9)3!MB\LJDVYE
MSLWX(!'WN_IQ7H-Y:07]I+:W*EX95VNH8KD>F00:QT\%>'X[#[ EDZV>"/LZ
MW,HCP3G[N['7F@#CO%-S8^(KZ^EM/*U&.WTGS/+NI?)AMPS,1*C %F=MHQ@
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M?VFMZIIFKW>M7DFAW$<TTACV11[=RJX5% ;(XSS][T&/4XX8HDV1QHB_W57
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MYR/I_3(!?HHK-T?4+S48KI[S2Y=/,5R\422N&,J#&)..!G)XYZ=: -*BBB@
MHHKD4\;23Z.VN6NB74^C .RW"2IYC(N<OY9.0N0>^<<XH ZZBL(^(BOC9/#A
MLR-]DUX+@R#! 8+C;CU)YSVK=H ***2@!:*YWQ5XED\-C22EF+A;_4(K(L9=
MOEES][&#G@'CBNBH **2L71-<FU34M9LY[1;=M.N%ARLN_S 4#AN@QPPXH V
MZ*Y_5/$$^G>*M%T@6T)AU(R?Z0\V""BY*A<<GD=_6N@H **** "BL#4O%NGZ
M9XKTSP_.3]IU!&96!X3'W0?][# ?2M^@ HHHH **** "BBDH 6BD#*20"#C@
MX/2DW*3@,.>G- #J*S[;6;&[U:]TR"8/<V:QF91T7?D@?7"Y/U%:% !1110
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MOC#9^1,JJVU_*;&0P(P3P>.E:EOX-MX?[#9M2U"231PWD,S(=VY=AW KTV\
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MOC)]FG $@C;:2 0<9^H% '$VT%_IGC+P_:_VOJ5Q:ZQITRSQRR_)&412IC
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MAC3;JTN;;3F$UHY>!GN)&\LG'3+=..G2I5\!>&E\1?V\-+C&H[_,\P.VW?\
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M'FE)8PZ-\/-'U9;ZZCDUA;"'4;FXGDD58S\Q8X8$#G:<$<<5T.B^!;);B?\
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MBBB@ HHHH BMO^/:/_=%2U%!Q$@[;14M !1110 4444 %%%% !1110 4444
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MHD,L44<]TLL7D'[;*9ML7_/-0> OL*K6OP[T2TFL9$DU%_L$WFVJO>R%8?\
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M\?DR20S/$9$_NOL(W#ZYH \WL+S5/$\/@!K_ %"]MY-0CO([DP3%/-5(V ;
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M5=^ [D ] .O [GTJVT72[.TFM+73;."VFSYL,4"JDF1@[E P>..:9%H&CP&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** (X?]6O^Z*DJ.'_ %:_[HJ2@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (X?]6O\ NBI*C@_U
M2_[HJ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVD$R0S74,<K_ '$>0!F^@/6GPW$-QYGDS1R>6Y1]C [6'4''0\CB@"2BB@G
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M<GMSV5% "*P90PZ$9%+110 4444 %%%% !1110 4444 %%%% !1110 4444
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M** "BBB@ HHHH **** (X?\ 5K_NBI*CA_U:_P"Z*DH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@".'_5K_NBI*CA_U2_[HJ2@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** (X?\ 5+_NBI*CA_U:_P"Z
M*DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".'_5+_NBI
M*CA_U2_[HJ2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (
MX?\ 5+_NBI*CA_U2_P"Z*DH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@".'_5K_NBI*CA_U:_[HJ2@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** (X1B-?I4E(!BEH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
,H **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>exhibit1011-physiciansha006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]7-SJUI=VZS*((85 :V '*N0>N?7T]\"U9ZUI>H3-#9ZC:W$BKO*12JQV^N
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M"RCN5SG'4U4M[6:3Q)KOB0V5S%;O81VD,9A(EG*EB6V?>'4*,C)QGIB@#/\
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MHIY/N122JK/] 3DUSGBWQ9%HNH:3I27D%M/J$^R29W7-O$ 26PW R> 2,=:
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M#PI(P9=@)"L1@ XZG..O'H5% '":4^L:1/XMU4>&[DO/<1W%O:K(@,W[M%8
M@GYNI/!&<@$UV\#R26\4DL1BD9 6C)!V$CD9'!Q4E% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 ([*B,[,%51DDG  JKIVHQ:G:BZMU?R&8B.
M1A@2*/XE_P!D]CWZ]"#7,_$F\:#PW;60R$U/4+>QE(ZB-V^;\PI'XU9UW4IX
M_$NA>'[6X-FEZLTDDL87=MB481=P(&21VZ T ;5_JEOILEO]J#I#,VSS\?NT
M8D!0Q[9)P#TSQGD9O5S46F7USX:U?2=:OX+]W\Z-)%7#")A\@D Q\PSU ':E
M\ :K-K7@/1[^X#><\&QRW5BA*%OQVY_&@#I**** "BBB@#"3Q3;OXL;PX+&]
M%ZL/V@N53R_*SC?G=G&>,8S[5=N=5%OJUKI_V.YD>X5G65-FQ0N-Q.6!XW#M
MWXKE8@5^.DY88#>'QM)[_OQTKHKUE/BG3(]^UVM+HC&,XW0\C\Q0!KTWSH_/
M\GS$\W;OV9&[;G&<>E>/3Z]XBMO %YXH;7;EY]-U!H8[?8@CF43[3YO&2<-C
MY=H  XSS72:=9F7XP:PQO;[$%E ^PS?*VYG.W&/NC/ ]>>] &S<>,5L?#>HZ
MW?:-J5M#93O$T;HJNZ@@"10Q&5.1_GFNE1BR*Q4J2 <'M7E&KWMY>?"CQJM[
M=RW3VVHW%LDDN-VQ)5"C@ ?D*]1L'DDTZU>8$2M$A?(QS@9XH CU74K?1M)N
M]2NVVV]K$TKD=2 ,X'N>@]ZEL[N*_L;>\@;=#/&LL;>JL,C]#7*^+GCU/4K+
M19+2XO;-/])OX+= Y9>1$C<C +9;_MG6?\-+R4:=JGA2[2>";29C'$),I(;:
M3+1D\\'&>G3B@#T&BO*_[9U0?"M-1_M*Z-[%JGE"<R?,R?:O+P?4;>*T]9U6
M[7Q7KEC>ZA=6,$-A'+I?V<D;W(;<>!\[;@ %.<XZ<F@#T&BO.[&[UZUO? D>
MJ7UU]KOO/^W1.0H8B$L%*@ <'%*+W7I8_&5OIDTES<VM_$EK%+-@A"J,Z*QZ
M$@L >Q(H [^>>*U@>>>5(H8QN>1V"JH]23TJ2O&-?O8=9\"^(Y1>ZQ'-:36P
MDT^^E826KEU!!P?G1@<C.>0:]AMH!;6ZPJ\KA<_-*Y=CSGDGDT <WK7CJTT:
M>Y!TS4[NULR%N[NV@#10DX)!)()(!!. <=ZTKKQ'901::;<27DNI<V<4(&95
MV[BV6(  7G)([=ZK>)V^T:=+H%FBF]U2*2( #B)&!#RM[#/XL0.]8BV46E_$
MCPY91E19PZ--;VN[&2Z,@8?7:!^M &Y_PE]B=&^WQP74LWGM:_88T#3^>"08
M]N<9&"3SC SG%,T3QE8:PVH0R076GW>GC=<VUX@5T3&0W!(*\'D'^E8O@N2.
M+6?&EW</&MK#JSLLKD!4(0!SGM@8!K8T.R-WKEYXDN(O*ENX4M[2,\,+=3N#
M,/[S,Q..PVCUH =9>+X[C6K33+O2M0T^6]C:2T>Z5 LP49(&UB5;'.UL&NCK
MA=>?5]-^('A^^F>UN]+N)FLHH!$5DMW=2=X.2&.$()XP,@ 9)KNA0!#<7,-I
M&))Y%C1G2,%N[,P51^)('XUGVVN"X\37FB-:2126UNEP)692)%9F48 /'W3U
MKF/B78)>S>%4=KC;)K4,++%<-'\I#$G@CD%00>HQQUIDNB+?_$2^L/M]]!;Q
MZ+;*?(G*R/B20#,GW^,9X(SWR.* /0**\GTGQ'J>HZ+X/TVXF$K:@MT)I9;M
M[<S&%BB*70%LG@\<DCZUVOA&SU'3K:^L=1U"*[:*Y+1*LKRM!&P#"-G;EB,\
M$\X(H Z.BN(\6)=S^./"]A!J=Y:6]XMV+A()"N]40$#V/S'D<CJ.0",'[1?Z
M9_PD6@2:QJ$MK:ZA9I:OO,ES*LV&:!7R#D@8SD$ DYH ]5JO>WUMIUL;F[F6
M&$,J[F]6(4#ZDD#\:\LN9K_3O#_CJUBFO+);".&6UB%XTC6Y>/) ?KSUQD@'
MH3UI/%OAB*VT[0]0NM0U74I[O5+)9(Y[IM@SG=Y:KC:6_3 QB@#TN2]ODUZ"
MR336>Q>!I'O?,4!'! ";>IR.<_\ U\:-<=>0G3_B!X<MX+BZ^SO9W8,,EP[J
M2@CP3N)R?F/)YKE?#T&I:_I=CXK_ +;MK&Y:ZW7+B24D_O"/(9"^S!R !M!^
M[WH ];HKS*0-I'B];G7X)Y(KO52;#5;6Y9HXP3M6"9"<*!C'3&?<$UZ+>6J7
MUG-:R/*B2J5+12%'7/<,.0: +%%>)?VEJD7AVS@,M[+K/AF[DEU3_29 9;97
M!(;GYMX92,]HVK8UO4R+:77+*[\FUUW58+(7$CL$2W5=I;(8;0[*WS+@[3G/
M>@#U6BO+=5TF^T'P[XI!UI?+EL3=V]K9M*IMV0 ;@Y<D!B/NYP<'T-1ZS8MH
M.BZ,L&J2JNMW$"7LVH32/$&$3,/NLI4,V,@,!\H[9H ]6HKD/!NF7FC:CJMG
M=:M;W0?RYTM+>-PEMNW X+LQPVW.W/&.@!JOX\@DGUCPK%'>75KYVHF)VMYB
MN5,;$C'3/'7&1VQ0!VU+7CU[J=[X5E^(MMI,L_E64=I);+)*TAA:5 '8%B3Q
MG/X"NCOM)M-#U_PY-HDCK#J,SVUW;K*SK=1-$S>8V3U7:/F'][DT =I9ZA:Z
MAY_V6991!*89"IR X )&?;/Y\5:KSKX1Z?:6^C:E/%$%E_M*XB!!/W PP,5J
M>/1;W)T339I97:ZO?ELD(5;L*A)1V)^5.03U[#![ '8T5Y/;Z7<ZA\/->M[7
M"7>EZI</911S,Z1B-@WE*>"R$;EP?7I5=?$\=MXALO'$=A(NB7ML;:7 R3<"
M,,&4=B2/*SGDJ: /8**\PN=&L+.ZTO0#'%<W,&FRW$UE-*([12YP\S<%BV<A
M0.F.HKFXFDU7X=_#R6YN+@RS:TEL[K,P/E^;( ,Y[!5P>HP* /<Z*\FNM)L[
M+QB/"WVFQM-,AT\RV46IQ-.CM)(QD*GS$^8< $Y( XQR3WOA"U^P^%[2T_M9
MM5\C?%]L9<&3:[#'4],;<Y.<4 7VU. ZFVF1.'O5@,Y3G"KG W''&3T[G!]*
MSO"&N7/B'0OMUW#%#-]HFA*1$E1L<KU/7I[?2L2#3M+_ .%MZC--:6GG+IMO
M*C.BY\PRN-P_VN%&>O2N*&EV\/PZFUU7F_M&#628)?-8>2/M>TA0#@ @G/KG
MV& #VZJIU"V&J)IWF W3PM/L!Y"*57)],EACUP?2O+O'+6MR/%]Q T,EQ:11
M*\UW* ;9P@95MU'S DG)8D<\ '!K>AM-,D^*5O<2V]HSG15E\QD4DRB8#=G^
M\,8SUH [J66."%YII%CB12SNYP% ZDD]!7-7_BB58_#=YIR0R6&KW:0%I<[P
MKHS @#CHIZ^M;6LVT%WHMY!<P1S1-"Q,<J!E.!D<'W ->81V>FS>!/ 5K'Y,
M)GO[0W/V=A&Y+02C+%><G!&>M 'JTTLCVD[63123JK",,?EWXX#8[9QFJNDW
M-\VBV\^LBU@O"F9Q ^8U.>@)_#\:XK1=+L--\4>-=(M(%@L/L=M(+96.P%HW
MW$#/!.!DCVJAIFEWFI>!O!<EA)837-K;O*+"_!,=TN K>N"-W!P<;J /5000
M"#D'O5;4+Z#3-/N+ZZ;;! AD<XR<#T]ZQ_!-[:WOA>![2S>RC226-K9R#Y3K
M(P901P5!SC';%5_$K76IZM8:+81VTQB9;Z[2=RJF-&^13@'EGYZ'_5F@"]X3
M\0Q^*/#EMJB1&%WRDT)ZQR*<,OYBM@S1+*(C(@D/1"PR?PKSSP[-+X9^)&H:
M%=QV]O!K2'4;:.&4NJS=)%!*KUP6QCM61JT=MJ1\5:',=/GU"]OR+>\EO(E,
M"[4P"&82#9@\*I!Y'K0!ZT\L<?WW5>,_,<<4Q[NVBDBCDN(D>7_5JS@%_H.]
M>?:IX:T.^^(.DZ;<V<#6[:/,&BC/EB3:\>W(4C/4D?3/:N=>TT>_U?Q5I>M:
M_'I0AN5C2*:*+=]G5%$91W&[C'\)]^] 'L=Q>6MIL^TW,,/F-M3S'"[CZ#/4
MTZ2>&$$RRI&%4L2S 8 ZGZ5Y+<#3K[Q;J.G^(M8EL()--MEM_MT, >6'R_G^
M=U(5PY).WOTZ<7+31=)N_'>@6TL$MY;_ -AR$?V@ TDJK*NPR <-QTR/3N*
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M!M9+C[2ML+IA'#)NW$HO\.3G\SC%<_K>GLGBJ]>XL_%\1=X5M[C1IF>.5%0
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M'Y,>QSEEVC#'U(J2B@!B0Q1DF.-$) 'RJ!P.@I)8(9U FB20#D!U!Q^=244
M1"V@67S1#&).F\(,],=?I2I!%&[.D2*[\LRJ 6^M244 -"(KLP50S?>(')^M
M*0&!! (/!!I:* &QQI$@2-%1!T51@"A8T1F944%CEB!U^M.HH 0*H<L%&X@
MG')'^2:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI'Y411WCPG]T[2-P]CGJ?4T 8&F78U?Q-;:!JFJ?;H[;2EF21&,(O)"[*TF
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MQ;R9(?(55!7[OK@]^: .QK"M?%>GW=_9VL27.R],@M;DQ_NIB@RVTYST!()
M!QQFK^LPRW&C7<4-U+:R&,D31!2RXYXW CG&.G?UKSGPWJ%]HOP^\,10ZI*T
MNL306D/G1(5M%.XL4PHR<# WD\X]Z /5**Y$ZAJFG>+$T&6_DN8;^RDFM;J6
M./S()$(# A0H9<,".,Y_3E6U;QB?ALWBW_A)$1C8B5;=;&/ ??C.2/3]<?B
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M;Y2",+D]!QBJO@S5KCQ''H]C-->)=:,LG]I@73Y>96,:I(<Y;=AGP<CY<=*
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M).SY> .QY_.L&_BBT2/PIJ^@SW$LE_>P03L\S.;R*522S[CRPV@@]N:N:?\
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M1M<L?$,-U):)-MM+IK:03Q%")$P3P>1C(ZXIS:[9KXCCT(B;[8]NUR#Y9";
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M2QRPOMDB<=&4^O)K8HH YQ/!6EG1[O3KN2[O3=E3-=7,Q:=BIRA##&-IZ
M<^IS:MO#J0SFYFU&]N[L0&"&YN/++P*<9* (%R< DD'./3BCQ3KC>&_#EWJZ
MVOVH6RAFB\S9D9QUP?7TK2LKC[986]SMV>=$LFW.<9 .* .8E^'UC+X:L-!;
M4]2%I8S+- P:+>"OW03Y?(!SV[\YJW-X-L;AYDGO+Z6SFNA=R6;2+Y32!MV?
MN[@-P!P& XZ=:W;6[@OH/.MI!)'O=-PZ95BK?J"*FH P/^$2LGUC5=0N+BZN
M/[4@%O<6TI3RC& 0 ,*&& 3W[UGVOPYTJU.G?Z?JTJZ=-YUHDMV2L7!^4#'3
MGZ\=<<5M^(M;A\/:)/J,T;2^7M5(EZR.Q"JH^I(I-*N]6FN[RWU/3HK=(=AA
MN(9MZ3@@YP" 5*XYSZ\4 8K?#;06UFXU%3?1K=2&6XLX[EEMYG/.70=><G&<
M<GBM>T\-V=GK]_K,<UR;F^55G1G&Q@HPO&.PX%)XKUJ;P[X:O=6@MDN6M4WF
M)Y=@(SSS@_E4.H:_+!:Z0EM#&;W57$<*RD[$/EF0EB.2 %QCN2* ,J+X7>'H
M88(4DU,1V\PF@47\H$1YX0 _*.3TY]ZU4\(:;%?:C=PRWD;:AN,R+.=FYEVE
MPIXW8[\TS1K_ ,47%U>1ZMHMI:1Q1XMY8[O>L[@GVRJG@\C(]ZG\(Z[)XE\,
M6>KRVZ6[7 <^4CE@N'*]<#TH B7P;I2Z-I^F_P"D%=-8-9S^9B6$CIM8#IVP
M<@CKFG7?A'3K[2+[3KF2ZD6_8-=3&3]Y+C& 3C@  #  'YFM%]1A:ZNK*V>.
M6]MX1*T1? &[.T,0"1G:>QX[52\)ZXWB3PO8ZP\:1-=*S^6C$A?F(QD]2,<^
M^: &R>%[2;5M+U.2YO&NM-C,4+>8,$'AMPQSD8!^G:MRFEU#*I8!FZ GDTZ@
M"A'H]C%K<VL)"!?30+ \GJBDD?S_ $%4W\):+)X<N- :S7^SIV9WB!QRS[\@
MCG@]/H*HVVNZUJDYN=*M+.;3H[][25)'*R[$;:\@/3@@G;C.!UR<#J: .4A^
M'?AZ&X:X\N\DG>U>TDDDO)&:6-A@AB6YXZ=AQCH*T].\-6&F7YOHVN9[D1>0
MDES.TICCSG:N>@R,^OO6L752H+ %N ">M#R1H5#NJECA03C)]J ,[Q%#=W/A
MO4K>Q@CGNI;:2..*1L*Q*D8)_&N"T/PTJ7%@=+T3Q#I5W \9EN;V^#1A 1O7
M;O8/D C&T#G/%>@RZS81:S%I+W""]DA:81[AD*I5>?3)88]<'TIFDSZI-+?K
MJ<-K$([AEMA!(6+1?PL^>A/I0 W3O#]AI>IW^H6HF%Q?L'N"\S.'(Z'!.!@<
M<=JGL=)LM.N;ZXM81')>S>?.1_$^T+G\A^9)[U:CFBESY<B/C@[6!Q2>?%N"
M^:FYB0!N&21UH YZ/P!X9BULZO'IH2Z,HFPLCB/S!R&V9VYSSTJ;_A#='V:L
MGEW &K'-YBYD'F?KQZ<=N*VWGAC<))+&C'H&8 FI* *NFZ?;Z3IMOI]H'6WM
MT$<:NY<A1T&3SQ5;4M T_5;JWN[F.075N"(9X9GC= >HRI'!]*NI=VTMQ);Q
MW$3S1_?C5P67ZCJ*YG4-=U&^UN^TK0;BPBN+&".4FZ4N)W<MA!@C: $.3S]X
M<<<@%C4%O?#6G6MKX8T".]\R8B16N?+V;LDR.Q!+<]3UK2T#25T/0[73PP=H
MES(ZC 9V)9B!V!8DU>A,C01F9524J"ZJ<@-CD ]Q7.:-XP@U;Q?J^A+&%^QH
MKP2<_OU!*R$>RN-O'?- &]J%A;:I8S65VC/;S+MD179-P],J0<4R'3+2#2ET
MV)'6T6/RE3S7R%]-V=WZU@>(_$&J:9XIT'2;,69CU8RKYDT;,8C&H;LPSG/M
M4GAGQ//JNM:SHFH6\4.H:7(@9H6)25'&589Y'N.>M &+XE\$VT6@6NAZ#I$S
M6K7T-S/$MP=@16R^"[\$@]!UKL-/T/3M-6<VUL0USCSGFD:5WP, ,SDD@#MG
M%:-<MH7C.#7/%6KZ*D#1BS >WE.0+A,['8>P<%<CK0!H:=X4T32KB.>RL1&\
M6X1 R.RQ;NNQ6)"9_P!D"EC\+Z1%<ZC<1VSK-J0Q=N+B3,@_[ZXQT&,8' K!
M\:>,[SPCJVD@VL<^FW1=KJ0*V^WC5HU+Y!P1F0=OYUTFKZO%I>B2ZBJ&XPH\
MF.,Y,SM@(J^[$@#ZT 5XO"6A0Z(NC)IZ'3U?S$A9V;8WJI)RI^A&*9>>%].D
MT"]TJWL[?R[OF3[1ND#MD?,YSN8C'!SG@<UQG_"<>()OA//XQC>QCG$F4M_L
M[%502>65SOR3G!S[8QWKI?$FIZUHW@&;5H;NU>_MH?.D9K8^7(/[H7?E>HYR
M>E '0Z981Z7I-GI\+,T5K D",W4A5"C/OQ5JJ6CR7,VD6LUY*DL\D8=F2/8O
M(S@#)]<=:NT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[37](N=,OE8V\Z[6VD CG((SWR*BE\.Z=-K.G:J80MQI\4D-N% "JK@#ICL
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M\27%W#X4U6XT\/\ :TLY7@VCYM^PD8'KFGS^'-$N;U+V;2;*2Z0@K,T"[L@
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M.W'<YV+K0-=L_#6NV%IK\CWEL5O+*&WFEW0+R?*9BVYE8*0 >E 'I-%>4_\
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MSZFFCRO<I-M+E_W>W>.YX;&?0UJ>#=5TC0]$UPR74,%A;:W/#&$.Y8PS@(H
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M,8VH/88XIWV.U\[SOLT/FXV[_+&[&,8S]* /&HDL)_A;X4%UY)MX_$*QR%B
M(XS<R9&?X1MQ^&*Z7^R].TWQQJYT.*WM[/\ L)OML-L@2-)=Q\LD#@,5W_@,
M]^=OQ7X<N]2@TN#2+33TBM=1AO9EE<Q!_+.=H"HV<],G]:Z*VTZRM+5K:WL[
M>&!LEHHHE5#GKD 8H \GT_[*/A7X%FF\GS(]5M?+=\97_2#NP3TX'-:+ZEH<
M?B'QCI7B^40FY9&@-P2#+;; %6(^H.[A><D]\UZ.VG6+1K$UE;F-22JF)<#/
M7 Q4CVMO+)&\EO$[Q_<9D!*_3TH \G\1ZEIANM9@+0Z;,="BCFCO_P!Y+)E6
M9(XT)QD$_,W)SCCO5ZTU+2XM6\"WMW>6BPOI$L1FDD7:T@6$;=QZMD$8ZUZ6
M]K;R3"9X(FE VAR@+ >F?Q-)]DMML:_9XML1S&-@PA]O2@#Q^SN])O\ 3M2T
MCQ-J=Y%K%OJ$DCV$ C5YY?-)C,)V;V)R /FX'H*N3:I96UAX_P!/U]XX=3E\
MYX$NFR98/+Q"$S][!'09P3FO53;6YN!<&",S 8$A0;@/KUH>V@DE65X8VD4$
M*[*"0#UP: .?^'[K)\/M!*,& LHP2#GD+@BN+M[FRG^%.NZ;J9C&M)+=B6&4
M 3/=-(S1,!U).4P1Z<=*]85550J@  8 ':HS;0&X$YAC,P&!)M&X#TSUH \N
M73[2Z^+&FV'B&.SNY_\ A&$CE68!@\WF$' /5L;O?%4]5U+3K'Q%XQ\/M?Z=
M"NJ110J]ZQA%N?*VX'RD,JC:1R,'@>M>OM%&[*7C5BIW*2,X/J*X^?PWXACU
MB\EM+_1Y[*\N#.RZA8M))$=H7"D, PP !G% &'JEYI6F:UX?L8-0@M5&D.L6
MJE?,$J?*NR)!\K.VT'G/' R2*P?#TFDW?A3X?6-Q+:SE=4F1XI2I.!YV RGW
M9.#ZCUKUW2=(@TK3;>S&)3"S/YC(!\[,68@#A>6/ Z XJZD,<:A4C15!) 5<
M#UH \J$L$<WQ5@$T/DBW#I&KC:K&W8'CH#D 'W J!?$4,'@OPQH.F7=O;:KJ
M>G0QS7K2!/LMNH^9BQ[Y+@#/7->O;5YX'/M2;%_NC\J /++_ %+PYI<GAK3M
M+N88[:PN9;<:L9-T5N_DAF)P=KN^_'.1DMP>E<^=1B7P%>&&XD:6Q\3BXEDE
MB*%%,V5=@5 &>I&!CT%>Z;5QC Q]*,#&,#F@#SB_U&SOOBWX:GL[F)A+IUSY
M;G^+.=IQU(.#CU'2LNVFMC\);[PY?R+_ ,)"K31-:2']_)=-(61E'5LDJP89
M'?/!KUO:,YP,T8&<X&?6@#SVU?3H_B;)#J-Q927,'A^%)FE=6(</(9,D\_=.
M3G^$\\5SFC:SIMMX;\'KY\$ 2ZO574>76R.Y\+M!V[W5L+NR,<@&O9=JYS@9
MHVKC&!^5 '@VI7ML/A!XNL_/E:9=:<YFB,;-F=2,C: &(4DJ ,8/ KVK5+FU
M_P"$>O+J7=/9_97D;R#N+Q["3M]21TJ_@'J!2T >9^&IIX;R32;74[;7-*32
MY3:70 -Q:J"H\F0CUXQGGY/:L"SU'2[GPU\/DN&#06%XJW9DC(2)E1OO$@#Y
M6QGL.]>U  =!BC Z8XH \XUR2Q\,_$_1-0GA6STQM/F@1X8"4,I<MM 0?>.<
M].:YN.::W\(6VHPV%Q+'IWB=[R]@$#!C'O?#8(^8C*_3 ]*]KQFEH \U\27U
MEX@\&>)[W1-,D,4]LGFW?V9HWN'4CC:0&8*O?&.<#H:DUW7]/E\3^#O$2R7(
MTE3>(TS6LBA2T8"D@KNY/X<5Z-10!XIJEVMSX,\=&2VN(6NM8B>.&>$JSJ6B
M/3'/",<=1CG%='XR:UT_7=#UUX+J30FBECFDTQY(VC=]FV0F)@2"% _QXKTB
MB@#FO!=MI<6FW4^CV%Q:65S<-*K7+R%YR0,R$2$L,D=^N,]ZP8+Y-'?Q;I>M
M6\BR7=Q-<VK"-I!=Q2*%"K@?,R\*5ZCZ5Z'10!Y;=6]QHOACP'IU_.WVBTO+
M>:Y3RRWEQJ#DLP&%5-P7)_I7I<UW!!9->,^8%3?N0%LC&> .OMCK4]&1G&>:
M //K3PS/XE\.WMY>:W?VPU@-+=6H@A"H",*AWQEP54*.O4$BLVVU>YO_ (,:
MC87T-W_:EO9O9,C6\FZ8X*HRY&6R,9/U)Q7J1P.M+0!RG@C0-(L_#VDWD&F0
M17WV.)993%B17V#<,GD'.<BK*:9J&G:B^JW_ (EO;FRA\Q_L?V= H!Z#Y%W-
MCMU-=$,'I10!PVF:,/%&@7UW?7U[ NK,[7-L(D4*OW54[XRP(0+WZY(KG],U
MFXN?A!>:7?V]]_:5K"UJ ]I+F90?D8<<Y7 _"O6:* /.=7T*\N_%<&HZ&C_V
M=XA@^S:JQ5DV(F#OQP0Q0,@ST)I]A<VME\5M1=8+B*SCTI+9'6UD\L-&Q8J#
MMP<+Z=>@YKT.DR 0,\GI0!YI\.[339XO$)U#2PTSZK<72-=6+ M"VW:067GO
MQU]J3P)J46C6?B^;^S[[8-4N;V"WCLW5I(#M"[ 0!^'7VKTPD*,D@#U-+0!7
MMKK[7IT-VD4L7G1+((Y5VNN1G##L?45Y=KUO8^+?#<%U/HFIV?C)84\AHK&6
M&07 Z?/C;LW#.2?E'<&O6:* .'OX;]/&W@V2XM[F=K>UN([NXA@=XTD=$ )8
M# RRM].^*Y233=1?X<^.K1=+U#[3>ZS-/;1&TD#2QN\95E&W)'RGZ8YKV.B@
M#S^=9Y/'/@VZ6QOS;P64R32?8Y0L3.JJH8[?EY!Z].IP*SF2Z?P_\0XUTW4O
M,OIY3:H;*4&8/$$4J-O/(/T')KU&B@#S6X?4)+SP]#)HFKOI[:6L;R647DS^
M=D Q2.2K1H-H/503W(K'L8M1M]!\"0SZ'JT;Z9>DW(^QNY50&!;"Y.,L.N">
MH!%>Q44 <-JT%P?BYH5VMG=O:Q64L4DZ6[M&C,?E!8# Z>O%1R^'IXOB-+%;
MRJNDZFB:A>0]Q- P QZ!F*$^NPUW!:*X26-9 <91]C<J2/T."*R/#?A6P\+V
M\L=I-=W$LN \]W,9)"HSM7/  &3@ =Z 'P:\9?%=SH3Z==P^5;B>.[=<13CY
M=P4]\%U!_'VSA^*4U&3Q3IT7]DWMYI3V[*SV+*CF;.0DCY!6/ SU )P#GI76
M16-M#?3WJ1?Z3.%620L22%' &>@]A@9)/4U9H \=MM(UNW\%^$5DT.^\W1M9
M$EQ JJTC)YCG<@SR/F R<>O3FO4=2,D_AZ\+:?\ :)'M7S9.P/F$J?W9/3GI
MZ<UHT4 >8:/H-]"=;T_1X=5AT6;3988[/4P1Y-P1A5A+$_)@G)!QTY-)90:W
M=0^!T_X1Z^A31G$5VTI13E83&64%N4SSGC/& :]+@N;>Z5VMYXIE1RC&-PVU
MAP0<="/2I&*HI9B H&22>!0!YMH-MXH\-IJF@QZ&UTDUY)-9:@TJ>4%<YW2
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M$L:Q%23,O/"C Y]2!GG%498](N=#^)UU+'9F1+B94DRI(/EC;@]LN!]2.^*
M/5[[5]-TS9]OU"UM=X)7SYE3<!U(R:;<ZSI=F4%SJ5G"7C,JB2=5W( 26&3T
MP"<^U>9WFLV"WUG"]S#9W4WAN-!>2HTQN$?_ )9Q)G:6SR3@D],51T270]3M
M?AQ%>M:3JD=Q#(LV""XC&%.>OS$#'3/'6@#U6?Q%HMM'#)/J]A$DR"2)GN$
M=3T8'/(/K6'?:_<:=X^MK>YU.WBT673I+E@ZJBH59 &,A/3YCZ#GO7':D-%T
MWQAXCTGQ!J%QH^G7EO!'9Q6\2B*6 1[2J_(V,,3P,<DXK1LK33$\<^%;)DW0
MP:-+Y$5ZP:11N79N!Z-M[8XQ[4 >AQZKITNG?VC'?VKV.,_:5F4QX]=V<5#%
MJEKJVFW,ND7T,SJK*'B(?8^.,CUZ'!ZUY587UO;Z&+F+RY]'L/%<TEU'"0RQ
M0EF\M\#^ ,RMZ<"NMM+B"\^)USJVFWT$FEQ:0%O9XI T1D$A*Y(.-P4$Y[#Z
MT 6_!7B.6\^'EAK>OWL:2N)#--(%C&1*R@8&!V _^O5?PQXIEU?QIXEMSJ4-
MQI-G%;R6S*JJJ!E);+=>.ASTQVKB=(U..P\)> ]1N'5]%M;^Y%\P^=8I&9Q$
MS =,%LY/3@U'JUU_:^I?$=_#TZS//9VDD9@&?-C4#S<?WAC(/KGWH ]<M/$N
MAWPG-MJMI(+==TI$H&Q?[QSV]^E2V>NZ3J%W]ELM1M;F?R1/LAE#GRSP&X[?
MXBN$TK4?"&LW::S8M=W4T%E(MU/=32;+2':24DW_ "DENB\]">@K5^%]OI3>
M!](N[.*U:Z6U$,TT:J7!SED9ASUYP?:@#J[W5-/TTPB^O;>V,S[(O.E";V]!
MGJ?:B+5=/FOIK&*^MGNX1NE@64%T'J5SD5C^.-$?7/"US%;LR7ML1=VCKU6:
M/YEQ]>GXUP4U_K?VC2_'EE:LLFL*-/>SR,!74"%B?^NN3GKM910!Z4WB;1$L
MX[MM2@$,K.L;;N7*9WX'4XP<^F*GEUK3(;."[>^@-O<8\AT;<)<C/RXSNX!/
M'85PVKRV7A_Q%H&EO*;&5=/:*/4C$TKR$LH:.-<%3(2 Q)!Z].:P-'N]/G\'
M^%XH]?DT;5++[0D5Y)'^ZCD!&Z*4-A>0P^F/7@@'KNGZC9ZK8QWMA<1W%M)G
M9+&<@X)!_4$5%J&M:;I147UW'"S*SA3R=HZM@<X&1D].:R? EU<7OA6&>YLH
M+61Y96Q;@B*7,C'S$!YVMG=^/'%<_P"+-2@C\836+>98W$^E^7'=1V[S270+
M$F&, %1@X).TGGMC- '9-XBT=;FQMSJ$!DOUW6@5MPF'JI'!IUIKVF7_ -K^
MRW:S?8R1<!%8^61V/'7VKS6W5;OX1:!KNG[VO/#RQW(^5EWA /-3)'(*YR1D
M9&.QJ>:PUNWUV,QQS0IXNB*W87_ESD4[L^S>1N7W9<T =W<^+-"LUB:XU*)!
M)$)@<$XC/1VP/E4]B< TZ_\ %&@Z7-Y5]JUG!)Y7G;7E .S^]].>/6O/O&,D
M3:KXETZ""XL;EM+$<0M[5Y7U$>6V!NVL%C4_*< '/\0 JOH]QI^H>-O!YN$6
M2+_A'Q;D7$) \S[NTAAU.&QZCID&@#T>Y\6:#9NBSZG" Z+)N7+*J-RK,P!"
M@]B2,UL*RNH92&4C((.017D<Z:58^*=?TKQ'9ZPR74PDLH[9Y_)O(]BA8@D9
MV_+@+SQZD8KU'2HS#H]E$;;[*4@1?(\S?Y6%'R[OXL=,]\4 8)\6VNK#7;+3
MYYH;FQ5D67RCG>$W$X9<8' YZ_E3?"'BW3M1TK1;&XU2*;69["*62,GYG;RP
MS<],]R.OM6%:ZK::5K7CBQOFE@GN)&N(@T#[6C\E5W;L;>O'7D\5FFYL+?PM
M\-2K1))'=6Y<J,% (V60GT&_ .>_6@#T2;Q/HT&I)I\M\BW#RB!05;89#_!O
MQMW?[.<^U5-,\86.J>)M0T:%9@]H43>T3#>Y5F;MP %')QDGCMGS36-22[BD
ME\N]M#:Z_'//IT-FY2,"4;II'VDLS=0 0.P!P37:Z'>);?$WQ-!+%<+)?BTE
MM\P/AD6'#,3C  /'..>.M &GX_O+S3O VJWNGW<EK=01;TD15)ZCCD'_ !JU
MI7BC1]4N_P"SK74H9[Z.,.\:DY.."0>AP>N,XK-^)LB)\.M95C\TD/EH.I9B
M1@ 5D7%WIT7C[P68&B2$Z=,B%%PH#A!&/09(8 4 ;NA:K:6FCWMU=>(QJD*W
MSH)S& 4)( A 7[Q!/&.3GBMO3=4M-6ADELY'98I#%('B:-E< $@JP!'4=J\G
MT,Z==^%M>CNY+N.-O$DLZ75IG?;!L&.?@?=RIYZ=:[?P)=ZE<V^I)?317L,5
MP%@U..+R_M@V@%B.Y7 7(X.WOUH E\47][9>(/#$=M=R1P7=\89X@%VR+Y;-
MR<9ZCL:T;SQ/H^G3M%=WHBV.L;R&-C'&QZ*S@;5/3@D=17/^.;N"U\0^$&GD
M"*NHL[$C@+Y;+D^@RP'XURR-:VFHZ]X>\0Z-K%[=7E_-<6<,4TWDW<;MN7(5
M@@P0,D]/PH ],O\ Q%I6FW#P7-R?-CC\V18XGD,2?WGV@[![G'0TS_A*-'-O
M;3QW9E2ZS]G$,3R-*  255020 1R!CFO._$&L6NA^,=9M9;HVAU#3H+>;S+.
M6=5(5@&0IS@!L<\D_2K!O]-M+?PE;:5<77]EK!+;1ZM#9M+.'^53$ 5/EEB#
MDE3]T8QUH VO%_B,R^%=-UC0-380S:A!'YD0&)%,FUE.X9'0CL:[FO&=EPWP
MRLM.6RU)[FUUO=*KVLA; N7<GA><+@DCCG'7BO91R 1T- &/=^*='LKB2*>Y
M<"%PDTJ0NT4+''#R %4/(ZD8SS4LGB'2XM8_LE[AOMWDFX$(A<EHQU8$#!_
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MJ%K+I5U*ED9+YF5 %RH*N2'&>.<Y^M>@^#=2O]8\(:7J&J0^3>SPAI%QC/)
M;';< &Q[US'@S1X9?$/BB;4M%;-QJ+7%K+=V1 :/U5F7CGMUK?\ $/A.37KR
M*>/Q#K>F"./R_*T^Z\I&Y)R1CKSC\!0!:\4ZC<6&BNE@ VHW;K:VBYQ^\?C=
M]%&7/LIJAX"UN?Q!X1@>^WKJ%N6M+Q3D,LJ<'/N1@_C43V[Z]XN,4ZZG;V>F
M08@D\N2$33-E7</QG"X4>NYB,CFLO2[>Y\,_$O4H(;/4YM(U*".62Y,,DJQW
M(R/O8.<KC)]<#MP 5?"&M:AIWC?4=(U2^GGL+^XN%TMKB5I"C0R%6CW-S]W!
M_"E\9:[>S^--!TZQO)X;!-1CM;PP2,GG.XW%-RD'Y5"D_P"_[4V]T6\U;PY=
MW.GVEQ'K.G:O-J-@)[=XM^92P7YPN0R]1GTS4FNZ/?6Y\)8L[BXN+74!J&I2
M6\+.H9LF1ACK\Q.%&3@#B@"U<:HMA\819W>J26^G?V,+@137;+$9O.VYP6QG
M:#Q^-":JM]\7[:TLM5>?3SI33O%!=LT7FB3&2 V.F..GM4@L9KOXNG57T^=M
M-&C_ &/SI;=@OG>;OQAAG&T_>QCMFGOID\7Q<MM2AT^5-/72VM6F2+"B4R;L
M<>W?I[T =??QW4MA/'93+!=,A6*5EW!&/0X[XKB)=-O/#WC?P]%8:UJ5RE^9
MA?6]U.90ZHF?, /W/F(Z8'(KN;VX:ULY9TMY;AHU)$40!=SZ#) KA="U776U
M?[5?^$]2^W7<JQM<3/&L5K!N&57!)P.6Z98]<<8 .ZNIVMK66=8)9S&I;RH0
M"[>P!(!/XUS2^/\ 37T.QUA;*_\ L=[<?9HV*Q@J^XJ-^7^4$@C)].<<5UE>
M:2> +N[OO$&E2.4T.5WO+(9^[<RKU'H$8$@?[0H [&^\366G7-[%<I,JV<*2
MR2@*5)<D(B\Y+D@X&/YBH;;Q5'+?R:?<Z9?V=]Y!GAMYE3=<(.NPJQ4L.,@D
M$9KG)/#OB#4_ L4]RJIXB^UPZ@\+, KO%M"QD].50>V36K]GN_$/BG1=2ETV
MYL(=+CED8W&T,\DB[?+&">!R2>APN/8 L?\ ":V;:-I6K16=Y)::C<I;*V$!
MB9GV N"W3/IFJ$)CM?BWJ#O*4A&AI,YDD)5?WS9/)PHPHZ<<5SB:?XGA\)Z3
MHD?AR9Y--U2.::0SQ@2HL^\&/GG(/4XQ[UMZOX?U'6_%FM$6T]M:7>A_8$NB
MZ@"7<S= VXC# ' ]10!E^,];DU/4O!S1Z=?P6DFN6YBN9&58YDW#'RAL\\,-
MR@X!Z5Z>Z+)&R-G:P(.#CCZUY9=V?BS5K'PK9R>%Y89-%U"VEN)/M<6R18Q@
ME/FR01S[9QSSCU6@#R[POXSM/#?A&U2\L-3>S2ZN5GOD@+0P9N9 -S$Y/49(
MS^?%=/K7CO3]':\VV\]Y'8QK)=26[QXB##('S,"QQ@X7/!'K6#'HNM2>!;SP
M@^E21W$\TR_:V=# (I)F?S,ALY ;[N,Y]N:BDT#5= \2Z@;?PM:>(+#4722*
M>9XU>W?:%*MN!.WY0>!Q]30!Z-9W<-]96]Y;OO@GC66-O56&0?R-8DOBDC5Y
MK.VTRYNH+>>.VN+F*1/W4CE<90L&*@."6 ]?0ULV$,EOI]M#-Y?FQQ*C^4NU
M,@ ':.P]!7!Z[X<U.]UU]0TO2I]/U=;Q NJ6]PB13VXQGSDW[FP,C&W)P.@X
MH Z4>*H"=?7['<"31 #.N5_> IO&SG^[ZXKDM7UN"3QGX,UV#3;F>2^T^XD@
MMT53*^Y$*#K@8#,<YP 35N_TKQ%;ZUXN2RTA;JVUN!?)N#<HBQL("A5@3NZX
MQ@8YY('-0Q:!KMM<> ]0.EM(VBV<EM=V\<\>\$Q",,"6"D<9ZT 3:MXIT7Q%
MX'UAM6T>_*6#JM_IQ(26)@00<[AE<CJ#^%;>K^,;31Y8+*.%9;I[7[2(GN$A
M"H.@W.1DD@@ 9Z<X'-<SXFT>Z@\)^-]=O81;W&J01@6X<,8XXUVKN(XW'))Q
MD>YJYJ>E:[8^)K3Q!I.DV^L6]Q81VMS:R2I$\>TY#JS<=SQ0!LV/C:SUC3M-
MGTFWENKC4$9X[<L$,:H<.SGH K$#C.21C-96J^-]3%CH<^G:-,'OM0^R30SR
M*DB.I;=&,\<[#\V>GOTCU'2_%EEJ6C^(=/LK2\O(HI;>\TZ.18P(I'#@(YP,
MK@#)ZXSCFIM<T_Q-J%AH^HG3XYKZUU5+UM/2X0"*((4V"0@ GG<3ZDXXP* .
MWA=WMT>2,QR,H+1E@=IQR,C@UQ^B^+KMX_$E]K%O%;6.F7LL1=9MWEA(X_E
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M*?[GWLMTZ8/6HO#^LZ1:Z5K5\NLWEU:V]_+Y\EZC PN=I,:+M!P"P &.IP*
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MDJI P<G@UD^)]4DN_$VA:8NG7-_IUQ%/<,D$D86YVHNW!+C*C>20<<[2,XH
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MZ%H\5M#H]FMFBI;F)6C"C P1G/XYS0!=HJCK&JV^B:3<ZE=!S#;IN81KECV
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M!R,\=^U>A:7_ ,@BR_ZX)_Z"* +=%9NNZW:^']*DU"\95C1E0;F"@LQ"@9/
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M,V[EH@/,&6&.!EEY/K7KE% '"6)6'QSXUGE@F"2VUL(I/(8A]L;!PIQS@D#
MK+MQ(G@WP!;-;7(FM[VV:9/L[YB"(P8MQ\N"PZ^M>H44 ><W[W$7B;QO-%IL
MM[YNE0I%"T3[+@JKAD!Q\WWAD YK#L7>/QA;7OV?7+@3Z#+;--/8F-%8$':J
M!1L4<COR1@GJ?8J2@#E?ANBQ> M)A-O+!-!#Y<L<L31LKYRW! /)Y_&NJ(S1
M2T >?>&(&NY?&MJD,UO<WE[+)!-+ Z!D:,*K!B!G!STZ9]ZRO!T=O*FDZ=>^
M#KV+6K"1%DGGC<01[/\ EJKDD9(' '4^W->K44 >7:##<6>O:1_8,5^--GGE
M>\TR_MVVV)P07CD91CDGC)SN/X8K"ZC^$&IZ!+I.I&^BNR6C^R,0_P#I0?"\
M?-E03D9'')Y&?:J6@#AO'DZ7&@Z,]M;W+J^I6LX6.VD9EC1P6)4+E<#UJD=5
MO?#?B[7;>[T#4=2L-6=+FUEM8/,5CY:H8WSP/N]_ZUZ+10!P*OJ.G_$;3[N]
MTJXD^TZ)%:.]C"6ACF\TLP))^50#GD]*RTL-4N=%\23V-C<M*OB%=3A@EB>+
M[5$AC;"[@,YV''N!ZBO4Z* .(E'_  D'B_0]=M;:[AM=*MKAKAIK9XW9I% 6
M,*1EB,,3C(Z>M<REIJ,'PCTFU_LK4#>VVIK-);?99-X47#29QCIM(YZ=NM>N
MT4 >8^(+:9-<OM2\/0ZK9:[)+&OD_9I)+74T"KR^5V+P2,DC&T^N:].HHH Y
M+QR]^BZ2;73IKJV%V&N9;:$2SVZ@'#1@@X.>-P&0.G7-<?IE@18>++/5/"FN
M2:?>WL4X1\O*RDH-P;<69P07.,XQ@GM7KAI$=9$5T8,C#*LIR"/44 <GX,BU
M:VO-4MKFXN[K28S']@N+Z$QSG@[E;< S!> &(&>:ZZBB@#RM[>]D\(>/X%TO
M4?.OK^:2V0VD@:97554J,<C*GZ#K6O/Y\OBKP-<K8WWDV]K<).QM) (2\:*H
M?CCE3].IXYKO:* /,=/T^[B\16EWH-GJFF/-?L=3L+J)_L;1@G=*A88#'@KM
M/4]  :].IGFQ^=Y/F)YNW=LR-V.F<>E/H Y#5([[1_'D.NBVNKW3KFR^QRI;
MQ&1[=@^Y6VCDJ<D''H*JV7A0ZOI'BD7UO)9QZ].9(X'/S1 *JJ[ =&++NQ]*
M[FB@#RM_#WBDZ7I7B4 'Q0C);NC D+;LOEE6'?#$RGW)]*Z&\TZ2Q\5>$H;.
MQN'L=-MYH7E1,I&&143)_P" \^E=G10!Y5J6@:MJ6G:\(=*DDDBU]=5@@NDV
MQWL015*#/<[3P0.U7EM'N_"NO2V/@G^QI+G3I+98EAC6>>1P5 PO\ ]3USG'
M'/H]12W5O!+%%+/%'),2L2.X!<CLH[_A0!Q6H6$-WX"T.RU30K^[2)8DFC@4
MK/;,D1'F* <DA@!Q_>[]*Q!9>(Y- TA;VWU&^^S>(8[J$S1_Z1]C3HTO/WN3
MP>2,5Z?#=VUQ+-%#<0RR0,%E1'#&,XSA@.AQZU-0!PL]G?+XP\53C3[EH+K2
MXXH)53*R.JME1[_./;@U@%[O2+#X;BZTVZ%U:/)%+:JH,GRPE20._'S8'\Z]
M9K#UCPU'K.K:9J$FH7MO)ITGFPI 8PI8\'=N0DY'!&>E %#PY93W'BC6?$4E
ME+90WL<$,44Z[9'" Y=ES\OWL 'G"UU=%-+JK*I8!F^Z">3]* /.K'3=4T'P
MWK?AAM(N;XW+S_9;B,J8I5FSCS"2-I!)W9'TS3KC1;[3/$_@.&WM;JYM-&M9
M8+JYCC^7YHE1?KRN3Z<5Z+10 5S?BX2WL%KI L;V>UO)E%W);CA(0<D$Y!&X
M@#CL37255&I6!DN8Q>VQ>U -PHE7,(.<%QGY>AZ^AH X;QMX?N]/FT76O#MG
MJ-[JEE> D&[>7]P01(O[QCC/ XJ?55OM1\>>'-4CT._-E913+.SH@VF95"\%
MLG!'..E=O;W,%W;QW%M-'-!(-R21L&5AZ@C@BI: *.J:3:ZQIKV%UYH@<@GR
M96C;@Y&"I!'2N8U+PX-/TF/0=+T[4+K3[ZY5K^0W88K%QN7,CAOF"@87L6[U
MVM% 'G7B[P8]FVGZSX6TZZN-;M;Q9 S7K-F/G>K&5\8(XXYK=NOMUYXIT:Z;
M1+Q;5+6>.=G:$B,R&/ (#DG&PYP#U&,UU%17-U;V5L]S=SQ001C+RRN%51ZD
MG@4 <3X7\*WWA4ZBT@EOK6T+Q:1;1LN]89"'?DD#); Y(^X?6L4:)XA;X*MX
M9;0;E=3""$)Y\.UAYF_=NW],?CG\Z]0MKF&\M8KFVE66"9 \<B'(92,@CVQ2
M75W;6-L]S>7$-O GWY9G"*OU)X% '*>+[;4=5^'EQIUAHUR;N[MQ$MMYD68>
MGWF+XQQV)KH="6:/0;"*X@>WFCMT1XI"I*E0 >5)';L:6'7-(N+.6\@U2QEM
M8ANDF2X1D0>I8' '!_*K-I=V]]:175K,DUO*H:.1#E6'J#0!E>+HM9G\-7<>
M@E1J! V@OM++GY@K'HQ&0#V/I7$6OA[6K6_UJYMO"ZVL&HZ.8!$MZCN)?G&&
M)^\QW#))Q@?>)XKU*B@#SM-)UH:?X B.CS[]+9!>CS8OW06+RL_?Y!)W<9X'
MKQ5"7P_XJM/"VO>$XM+BN[:X,TEG?+<J@VR/NV,IYW D^WO7J=5-/U2PU6*2
M73[R"ZCCD,3O"X=0X )&1WY'YT .TY9TTVU6YC6.=8E$B*^X*P'(!P,UC^-]
M-O-9\(7^F6$(DN+E B[G"@<@Y)/TKH:I:EJ^G:/"DVHWD-LCN$0R. 78] HZ
MD^PH P+RQU*\\>:1JBV#I:6EK+%*[R)]Z3;C !).-O/UXS7(6?A+Q+)JFA:G
M=Z+;_P!HV-^[7MX]X&>Z!!^<<?*@XPO7G[HKUF21(HVDD=41 69F.  .I)J&
MQO[34[..\L;B.XMI,[)8VRK8)!P?J#0!YA<>%/%-OX2UGP?;6%K<V=Q(\MK?
MFYV85I ^UE()+9SST]_7TW38YH=-M8;A466.)4<(VX @8X.!G\JM44 <YXUT
M&Z\0:&D6GS1Q:A:7$=W:M)]SS$/ ;V()%00W'C!M-N9WTNP@NT@\NWM([G>C
MRGK(S8&U1V49/)YZ5NZCJ^GZ2;;[?=1V_P!IF6"'>?OR'HOZ5=H X31/#VK>
M&/$:OIL+S:3?1*^H)/.NY;D_>E7US_$!@>G0"L?PW;ZOJ_@S6]%MK*)8+R_O
M(/MCSC"(\C!R4QDD9.!WXY%>I$!E(/0C'!Q5+2]'L=%MGM]/A,43N9&4R,^6
M/)/S$]30!A)I%_!XZL+R*U!TVUTQ[+S3*-V2R,#MZX^3'XUS\G@_7;SPQ<1+
M'%9:M;:R^K6#-*'0L9&8*V.G#$>E=]:ZM87M]>65M<I)<V947$8SF,MG&?R-
M7: .5BMO$^I:1?'58K&WN9;5[>&T@F8IEN"[L1],  X&>>>*$F@:[:6G@^2T
MMK.>ZT:(P31O<E$;,/E[@VPG ZXQFNYHH Y2QTVYTKQGKNO7_P!CM["\MX%\
MX38P8P1E\@ 9W<<G[M5/!^D01^(M<U*SN1/I9N&%B$8,BM($:<J1U!<*/8JP
M]:ZV_L+35+":QOH$GMIEVR1N.&%+965KIMG%9V5O';VT0VQQ1KA5'L* +%<G
MXBT76;[Q)IM]:)87=A;Q.KVEY(RJLI(VR@!2&('8X[X(SD=95/5-4L]&TV;4
M+^;R;6$9DDVEMHSCH 30!YA=:'JFE>%]"\*W;:1)>MJ4DUL6FDC#(I>4L' R
MC!F4?+GKCN:T18:E<6.O^&9+'3H]5U.R>4W$5\\V3P@\YF7<O!^7@@A6Z5V]
MWIVD>)=-@-[96]]:R*LL0GB#8!&01D9!Q4NEZ+I>B0-#I=A;6<;'++!&%W'U
M..M '*:CX2U>[\':!!:SVUIKNB^4T#[B\3,B[""=H.&'/3V]ZEU'PYX@\2^'
MKNWUB]M+6^?RFMEL]S10R1MN#DL,DD\8[ #J:[2B@#BU\/\ B/Q#H][8>*[R
MP2.>U:W6/3T8J7)!$K%NXP, <=?PH?\ "-^-+V+0(-2N=&9=)O4N#+&9-TX1
M2 2-H .#C'?KQTKT.B@ KF/%&B:I?ZOH>K:1+:"YTV64F.ZW!'61-A.5YR!V
M[^HK7.LV2ZZFC%I!>O TX4QL%* @$AL8/+#@&M"@#C[;0-<T34-6;2GLKFUU
M24W#BYD>,V\S##LH"MN4X!VY![9[UOZ#H\&@:#9:3;,SQ6L0C#-U;U)^IR:T
M:3<-Q7(R!DB@"IJD=[+ILJ:<\*79P8S,"4.""0V.Q&1^-<8/ ,DUMXFVQ6FF
M'6+40"UM)&>)9!NQ*257DY7( '0]2:[^L[5]:L]#MHI[TRB.69(5,<3/AF(4
M9P.!DCDT <Q!X:\3R^(O#^JW]]I833(I(7A@B<[E95!()/4X^@P.O-0Z)X-\
M1:$\NDVVMVW_  CC3M(BF-OM4:,<F-6S@ D]>3W&.E=]3/-C\[R?,3S=N[9D
M;L=,X]* ..'AK6&LO%UNYL1_;9D,)65_W9:,1_-\GH,\=^/>NCT"SNM/\/V%
ME>F$W%M D+M"24.T8!&>>0!6C10!E^([&YU3PWJ.GV9A$]W;O K3$A5##:2<
M G@$FL"^\(ZC?^$='LUOHK+6=),;6UU#ETW(NSD$ D,O4>OKW[.B@#E(M(\5
MMICO<Z[;'57DC/R0'[.L:$DJ%SDELD$Y'&!VK,;X?S2:5K\<<MI8W.K7$$XB
MMU9H(6B<,#@X)+$'/ ZCTR>^HH Y:#0M:7Q79ZW<W]C(4LVM+E(X&3>"^_*9
M8[<':.<YP?7AEQX1>_U;Q#)?30OI^LVT<#1(I#IL! ;/3^(G\!7644 <GX9\
M.:]I:V\.K^(!?VUFFVWCC@\LMP5!D;)+84X _$Y(%95GX"U>R\!WWA5-7M6M
MI5:*W8VY!C1G+,6.X[FYP,8 ]Z[Z.2.4,8W5PK%3M.<$=1]:?0!R\OAR_BUV
MUUVPNK:*^^RBUO(Y$9XIT!!4CD%2#GUZUEZKX N;WP[)I\-_ MU=:B-1O)WB
M.UWR#A%!^4<*.2>!ZFN\K%U/Q/8:7<Z1"ZRS#59EAMY8 K)DC().>F/3- &=
M>^&-2NO%5QK46IPVS2Z8^G((X"7CW882!MW)#]!CI[TRS\+:F-:N=;OM1LQJ
M;636<,MG:&,8)!$D@9FW,"!@< <^O'47<_V6SGN/*DF\J-G\N)=SO@9PH[D]
MA46F7IU'3+:\:VGM3-&',%PFV2,GLP[&@!-*@O+72K:#4+O[7=I&!-<! GF-
MW.!TJY110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5!=VD-];M!.&,9Y(5V0_FI!J>F3.T<+ND3RLHR$0@%O89(
M'YF@#S'P5KNH^'9++1_$-R]S8:B2=-U"3)._<089&)//I_D#HM*O[;1H?$5Y
M<&5HXM3,,:!BS'*1A(T!/=GP!QR:?9^'(]:\"QZ+KVGR0'# HSHS(VXE75E)
M (S6!;^#O$:>$I[:YN([C6+76$U"VE9P%N1&$V[O3(4]>_7UH Z>/Q4QOI=,
MGTFZMM5,336MK+)'_I*C^ZX8J".,@GC/>L?3/B!-%X1T_6=7TF\VW<_E&6$Q
M&-"TA"]7!"C@9([5I1V5]K7BS2M9N+"?3X=-@G3R[AD9I7DV@XV,PV@+U.,Y
M&*S-#\,W][\.;CPMK>GBTVQO#')YZR>82Q97 &=H!QUYXZ4 ='#XEMY?$5]H
MC6UQ%<VEN+DO)L"21DX!7#9/([@8K';4-+U3Q%X=U";3-2CU&6SN)K$,RJ-F
M!N5@'QD@J1GCYAGD<8;^#-?GL-(U"5D.O3N8-6?>.+:6,(X!SR4"J1@D;LD=
M:Z;5+"]/C;PY=VNGN]A907$<TJ/&JQ^8$"_*6!.-G.!W&,T <IXAUC4/$7PX
M\7-<6$\/D32QIN>,K&(G52H(.2?E9CD8Y.">*Z70_%@;4-,T2YTJ]M#<VF^S
MN)@NR?8HW\ Y7 ((R ?IQG%FT;Q$/#'B_11HWF?;;FZELYDNH_WHF<D9!(VX
M!YR?H#6E<Z=J\GB7PA=QZ5-Y.GVLR7+F6+$;21JH&-^3@KSC/7C- %[3_%TV
MJO%-9:/+-I\YE6&Y6X3+N@/RE<_+DJ<9/IG!XK(T#QY?2>%Y]7UG2Y$4W3PV
MX@D5S*YE9!& ,8Q@#<>O6FZ+X<U&#Q'I^IQ:0=$F^?\ M1;>X5K6YRAQLC#$
M[MVTY(&,'[W>A;Z/XTL/"4NCVNF(GE7[R,T=ZJ/=P/*SLJ$?ZLX.,D@^E '1
M3^.XK/3=:GNM+NA=:,RB[MXG1\!EW*P8D J1C/<>E6+'QE'=ZW8Z=-IEY:#4
M(&FLYI]H$VWEAM!RO!!&0#ST%<B_A37?L7C&VM] M[6+6(H1:Q0W*80A0A!Z
M>[,?7.-U;E[HFJZAXG\':E]A:*'38)UNPTR;D,D80!<'G!&21V(QSP #%^)>
MMOK'P_U*6UTE[C31(JI?&0##!PI=4ZE<Y7/?/IS74-/I?_"QGC_LB<ZS'I;2
MK=[QB2'>!L4;L9W$\L!TZX-<C<>&_&*> +_P:FF6MQ$A"6M\+H()(O,#<J>=
MPYSG ^IZ];_9^J?\+#CUHV'^B#2#:.5F4GS"XDX!(R.,9..?:@"A9?$I+RTT
MZ_\ ["OH].N[H6C73LF(Y&<HO&<L,@9(X&<<D&M'5?&0L[K4H[&P-^FD(LNI
M,LPC,*E2WR CYV"@G&0/?/%<[!X7UV+X>Z/HQL%-Y9:BEQ(!.FTHLQDR#GJ0
M<8]1575;;6=0\5Z])I>B/=V%QY=E>BUU%(#*!&-P<.#E@&VY4C@8SG- 'HVC
M:HFM:3;:C%!+#%<()(UE*EBI&0?E)'?UJCKGB(Z5?V.FVUJES?WH=HHY9Q"A
M5,;OF(/S?,,#'//2K7AZX2YT*U:.R:Q6,-!]F9@WE&-BA7()! *\'N*R/&&C
MOK)AMKC0X]5TXQ/O"R+'/#+E=K1LQ&.-V>>P^E #(O&T@O-!M[S1YK5M7>6)
M0TH+0R1D@AACD<#D'O3QXVB@;7DO[%X)-(DBC98Y!)Y[2@&,)P.3E1SZUBQ^
M&O$UEI_A6Z9HM2U#29IC-'/-EFBDR -Y'+*N!FH;CPAXCU9?%4EVMI9W.I2V
MUQ:-%,7"O %V@\9Q\H!/Z4 :>LZO>:CH'B'2]7T)K.1=+FN$;S!-$Z[2 -V
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M,*3@;LD]#CK5ZSTC68?$_B+49(K+R-0ABBMP)FW#R]P&_P"7C.\GC.,8YZT
M9?A76);#P+X3L;.!+B_OK95B21]BHJKEW8X)P!V'4D#CJ-[1/$,M[J^H:+J%
MLEOJ5D%D(BDWQRQ-]UU) (]"#T/KFL*U\':M8:-X=EMY;/\ MG0U:) 9'\FX
MB9=K*QP"I/!!P<$=ZW='T>\37K[7=3\A;NXB2WBA@8LL4*$G&X@$DLQ)X]*
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MGBO158,H8=",\UR\'@>VM[%-*2^N/[$CF\Y; JA7[^_86(R4W<XZ]LXXKJ:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0JD.Z@+QR1S]*6#Q#KM])HFBW4<>DZW=Q2W%WA5E\J*,X^49(RY(QDG !ZT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***3(!QF@!:*** "BBB@ HHHZ4 %%%(SJN-S 9.!D]30
MM%%% !1110 444WS$\WRMZ^9C=MSSCUQ0 ZBBD9@H))  Y)- "T4V.1)8UDC
M=71AD,IR"/K3J "BBHY9X8-GG2I'O8(N]@-S'H!GJ3Z4 24444 %%%% !14#
MWEM'=1VKW$*W$H+1Q%P'<#J0.IQ2W-U;V5N]Q=3Q00)]Z25PJKVY)X% $U%(
MI#*&!!!Y!'>EH **:SJF-S!=QP,G&3Z4Z@ HHHH **** "BBB@ HHHH ****
M "BBJ5YJ]AI]W9VMW=1PSWCF.W1CS(PZ@?F/SH NT5GKKFEO+?1KJ%N6L #=
MCS!^XSG&[T^Z?RJ>PO[35+**]L9TGMI02DJ'(;!QQ^(- %FBJEIJ=C?7-U;V
MMS'--:L$G5#DQL>@-6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** *VH7T&F:;<W]RQ6"VB:60CLJC)_E6)I&J/#X>'B'6IWA^VI'
M,+?!80*V!'&J@9+'<,\9+'TP _QW93ZCX$UNUM@6F>T?8HZL0,X_'&*YKQ)%
M/J'P\\,:G8VTE[!8R6M]/!"Q#R0K&0P7'<;LX]J .G75+;Q);WUII&HRVNH6
M; /NB9'A<@E=\;@94^_!'0]ZG\,:XOB'0H;XHL<X+17$2G(CE0[77Z9''MBL
MCP>^G7MW>:GIFA75A#,BJ]S>*R2SL"1C!))50!R?7 Z&H?AG"_\ 9&KWVUEM
M]0U>ZNK=3T$9; Q[?*: .UHHHH **** .(\637,7C;PS91:E=VMKJ9N(KE8I
MBH;9'E,9^Z<GJ,$\5!HVJZA:_$JY\/0:A-JNE+9":224AVLY=Q&PN!SD#HW/
M/L:/&,,=[XX\+M+I\][9V+7+7@6S>=$#Q )D!2#DCWJO;:.[_$O3]2\/:7=:
M;I<4#KJ+M";:*X.T[ (R 68$\G&.!Z4 =0WB_2([R."22=(Y9C;I=- X@:7)
M&P28QG((],\9S698^/K>YU778)K.]CMM+=4WK:2.QX)9F"@X' P.O?Z<?X8T
M:*QBC\/ZEX.NI]8M9_W=\ZL;:5=^1,7SQ@<XP3P.YXZ7PS;WFG^._%-O=Z7>
M>1J%PLT5SY68"@3!RQ/7G&.30!N'QGHH@TF<SS>3JSK'9R?9WVR,QP!G'RD^
M^*LW7B/3[.6ZCG>4&V:.-\1,VYW^ZB@<LQR.!ZBO.AX)UR?1]3TOS7CCT*=Y
M-$89S))E94/X+^['4?,WI6CK^BZQJ7@FPU";3&NK\:DFJW>G!MK,FUAY0_VE
M0H/4[>G:@#L;?Q5I<\-\SO+;RV!47,$T162/=]WY>^[MC.?K40\7:8BWWVD7
M=K+8PB>:&:W?S/*/\84 [E]2,XP<XKC[W2Y-4\.WTNA^#Q8^7]GD6*]B$<]X
M8Y [1D<G;A<#=U)]N9V$>H:)JMS8^#)M,D.ES0LTMEMN'D=<+'&%Y*YR2<8Z
M>] '1:=X[T/4]1L;*WEN-]]&9+:22W=8Y<#+*KD8+ =0.G3K4WC/Q*/"?A>[
MU;[-).\8VQJJY4.>%+^BY(R:YP1W*VGP]3[!?$VA07.+63]SB QG?QQ\Q'7M
MSTYK8^).EWNL_#[5K#3X&GNI$1DC7JVV16('O@'CO0!EZEXD6V\5>&[^9M0M
M8+JUNQ):.K[I77R]@$(SELLV,#)S[5T-GXOTF^T9]4BDF$<<YMGA:)A,LVX+
MY93KNR1Q[UARW,M]XQ\*7O\ 96I1PQ6]U&[2V;CRRXC52V =N2K=<$=3@$&N
M<O-(U:XT_7)K;2KFXDMO$O\ :BV<\#QK>P;0I52PP>Y[]!QR* /1]*\0V6K7
MEW91>=#>VFWSK:=-CJ&&5..X/J*EU'6;73KB"U;S)KN?)BMH%W2,!U;'91ZG
M Z#J163X76WGN)KVT\,MHT+QJK-<6ZPSR-D\$ GY1[]SQ5+65O\ 2/B#:Z\F
MG75[ITVG&QE^R)YDD3^9O#%<Y*GID4 9_@GQ)!::#K%Y?WM]-%_;DMM;"YWO
M-DA D0!)(.3C&?7-:6N_$"TTWPWJ^H6UK<27FG,(9;:2(@Q2,/D+\_<.1R#7
M.?9]8BT34WCT"]A6X\1BZ=!;QO-' 0N9(E^8%PR]1G&<BL^\\/:K<Z/X\LK3
M1M33[<EM-:FZ8NTVP*6RQ8DN<$XYQTXZ4 >E+XBC6WL_,L[QKNYC,@MHXMSA
M1C+'G 7)&,GG(JYH^L6.O:;'?Z?-YMNY(R05*D'!!!Y!![5Y_J:70UW2/$$_
MA2\U'3I=.%G/;M;AKBW97+!_+ST.?_U=*[?PU;?9])&-)@TI))&D2TB4*44G
MC>!QO(Y./ISB@"AXXO-231&TW1&QJU^KI <D%%52SL,=\8 ]V%6O"^L1^+/"
M%EJ# J;J';,J.5*./E< @Y'(/O6>FDR:YXGO=1N9-1LA;H+6S$9:+='PSOG'
M\3<8]$![UG>$;"\\*>)=:T=;2^DT*:1;FTN63<$D*_O%)ZG)QCC'!]: .235
MV@\ ZGJB^([R/7[:[EAM5:^>1F"RX5/)9B&R.,E2>]>P:9-<7&E6<UW&8[F2
M!'E0C&URH)&.V#FN0^'>AK9:=<O?Z.+?4/MLTJRS6X#E&<E<-].V>*UM;\&P
MZYJ2WLNM:W;%=NV&TO/+B!'?;CJ>] #/&]W??V.=)T:8QZOJ*NENRMAD55+.
MWMP-H/8L*G\(ZY'XJ\(66HG(:>+9,%8@JX^5AD8QR#56WT]==\1WVH7UOJ5M
M]G1;:T_>R6X:/[S."C#.YN,'LB\5E^&+*]\,^,-<TZ*QO3H%RPNK>8JSB.;'
M[Q<DECN]>>GO0!F^ -7OM/\ $U]HVJ7L\]M?RSS:6UQ*TA41321O'N8DDX4'
M'H#ZU)XGU6]O/B3X<LH+JXBTM;J2WF6*5D$\H3<P.TC(7Y1]=P[47?A[5+_P
MG:W.GVTEOKNE:I/>6B3Q[0ZO.[;23_"48$X/;%2ZSHUY8:SX-6VLKN]CTV66
M:]N(H\Y:0?,W7DEBQQ[T ..KVFF?%_48]3UC[)9KIT<D4=S>F.+S"V"0K-MS
MBI-.O[/5?BY(-/UDWMBND^>8K>]9X4F\T#.%;;G!Z>]6;&VO4^+>HZB^GW2V
M,]@ELEP8_DWJV3^&.]2.+M/BR+_^R[TV1TP61N5C!3S#*'SUSMQWQ0!T6LZ?
M<:I;Q6L5[+:0-(#<-"Q61XP#\JL.5R<9(YQG'7-<WX8L9-&\::QI-E>7<^D1
M6T,WE7$C2?9YW+916;)Y4!L9_BK=\2W^J6&E,=&TV6_OY3LB5"H5/5F+,!@#
M\S@5C^#WUN!UL[SPY-91D-+<WUS=Q227$IQR1'W/OP ,#H!0!K:]XC30;C3H
MI=/O+A+ZX6V26 )M21CA0VY@1GGG':H+;Q=;SZ[J^D-8W4$^F0^=*\IC".AY
M4J0QZCGG&.^*?XST-_$/A2^T^' NB@DMV)QME4[D.>W(Q^-<C=>#=:GNM*U0
M.OV_4@;?7., 0OABH]E">6/K0!OW?CR&WA5ETC4))5L1J-Q#F-6@MSGYCE\$
M\$[02?7%69O&%NYL$TRRN-2EO+3[:L4+(C+!Q\WSL 3D@8'/6L#Q?I.N:IJF
MJVJZ1/=Z=+IOD61AN(XHTF(;+2 L&;'&."!SQR36>_AZ[N?">C6M]X=U*._L
M=-1+:]LIHUGMYQE2I^<?*<*?Q.<'H >DZ??KJ.DVNH112*ES DZ1O@. RA@#
MSC//K7F]LUMK^L>)+GQ'IMU%'872F.]:6)7L$CC5PH97W DY/RYSGD^GH/A^
M+48?#VGQ:O()-12!!<.#G+XYY[FN,_X1G4]9L_&NFW-I/8)J]SYMK<.R,I 5
M0,A6)&2G/'0T =##XM3^T;&UO],O+"/4.+.:8H5D;&=AVL2K$<@'^?%4[?X@
M6][=RV]GHFLW!@O)+2X:.W!$+H <L<XP>1U[>XS!-I^K>(8O#MK?Z0]@VG7D
M5W<S-+&Z9B!VB/:Q)W-CJ!@9[\4_P;9:GI2>)_MFE7$?VK5;B^MQOB/FHX&T
M##\-\O? Y'- $4'Q,M9[;3+XZ+JR:=?OY:7?D[@LA)"KM4EF)QV!&3@9K5TW
MQC;W4VIPZC8W6DR:?$+B07>WF$[L."I(_A.1VKEK71-<M/AYX6TQM&N'O;#4
M()[B))8OE2.7>3DN <CI@_E5_6O#^HZ[XA\0PFRF@M+_ $A+2*[9DV>8K.W(
M#;L?,.W8_B :&G>/].O-;MM+GB^S27D;26SF>.0.%Y(;:QV-CG!_GQ6!XMUY
M]9C\-SVVFS'39=<M?(ORX D D'.S[P!.<$]<9[BM#1+7Q+J%LFFZOX>L]+$<
M+Q3ZA%*CF;Y2H,:KRI).22>WOQBKI'B]?"VAZ$_A]'ET?4+>7[0EY&(YXXVR
M"N?F!QUR!ZC.<4 >BZ_J%QI6@WU_:VPN9K>%I5B+A0<#/)KSR^U6ZO+?P!K>
MHV,ANWF5OW #O.&MRV0J],D].WTKT?6;66^T'4+2$#S9[:2- 3@;F4@?J:X2
MQTOQ'+:>"X;K0FM_[&=5F(NHW)5(?+W=1U)R "> <XXR ;+^/%M]'UJ\O-&O
M8+C2&47-IOC9L, 58-NP1@]N?8U)%XUEDB#-X?U*)YY8XK%'"@W1=2V1S\H"
MJ6.[&![\5DZWX?UF_7QM'!ISG^UHH4M6,L8#%$"'/S<>OT'KQ6EK>DZO=6GA
M[5+" )J.E2B1[.1U_>(R;)$#<@':3@T 6'\8B%-6AN=/EAU'3;?[6]HT@/F0
MXSO1QP1P1]1BI?\ A+(S)X<'V.3R]<0-$^\?NCY?F88=^/2LZY\/WFO:KJVJ
M3VBV#3Z.VF6RS,&D.\EF9]A( !V@ $GJ?:L:RTKQ=*WA%;G1+:"/0W\J4F\4
MM*!&8]XP.!CG'))/;K0!O:GXZCT^SU348M.FNM,TN?[-=31R 2>8" VU".0I
M(R21[9 S6+<:A<6GQ1>\L-"GN+VZ\/QN;56C1BWG-S(^=HX4#.3V S6:]AK&
MI7FL26?A\WVB7>H22/%!JD<,-SL8#<59"V24R<, Q]NO46$=[>^-X/$L&GR?
MV9<Z''"C&1 P8L90-N[T8#Z^W- &[X:UV+Q+H%MJL,,D"S;@8I/O(RL58'\0
M:Y./Q#JVL^*/%>AW>E0-IME;I$^9@VP,DC!BI'S;OEXXVX[UM^ M,O\ 1_"Z
M6&HVWD3QSS,!YBN&5Y&<'*D_WL?A67_8FNZ=XR\3WUK80W5GK$$6V0W 1HVC
MB9=NTCDDD<Y  H S?!7BJYT_PUX5LYM$N5TZZ2.T6_:10#*0< 1_>*Y!&[CV
MSWT=7^)^G:7->E5M9H+&X%O,IOD6X8Y 8QPX)8*3ZC.#C@9JJNAZ];^"O"EB
MFDF2]TJ\AFGB^T1@%8]PX;/?=Q^.<58L]'\7>'M7U"STB.PN-)U"Z>[6YN'*
MO:,YRPVC[^#R/7N1G@ [6>^M[;3Y+^>41VT41F>1NBH!DG\J\Z\2ZE>:O=>#
M+Z;1%MK:7687@N))@9E4YPK)M^7>,-@,<;>>:[[5],_M;P_?:6\Q7[5:O;F7
M'(W*5W8_'-<$VC^.+RP\/6%WIVFDZ/?03&Y^VG%P(U8 XV$KP0#U))X&* -V
M^\;RV%X[2:7MTZ/4%T]I9)MDK.2HWI&1\Z L.0V>IQQ45OXAU7_A8.M65TEL
MFF:?9QR'$[95#N8OC9RQ Y' &.IK$U3PMXINSJJM8:?=3-J"75O>RW)\UX5E
M5UA (/EA0O/;V)YK6F\+ZM=>)]2N;F&S:QUG3H[6[(F;= RJP8*NWYQDC!)%
M #-(^)EMJFMV%BD-O)%? [&M;@S20' QYR[ %SD#() /YUJ_$#4]4TCPA>7F
ME>0)% 5Y)'9616(7*8'+<]R,=>>E4/#&E>,;&UL=(U2?3TL+#:JW-LS&6>-/
MN(5(PHP!D^@QWS6UXQTBYUWPGJ&FV9C%Q,B^7YAPN0P;!/X4 <AXBFO[?XG^
M&+F/389M1:RNAY$4XVL<8&9&5> .>GK@'O/J/C"'5?AWKE[J7A^*<Z=<M9WM
MA)/E-Z,O(;;R,D'I5Y]&\07OC3P]KEW;6:+9V\T=RL4Y(4OD#;D<X&/2LA_!
MNOOX3\7Z5]GM1-K&I27=NQN.%5V4X;Y>HV_CF@#I-0\3R:?K,&@V=K:&]^Q"
MY6*:X\I9>=HCB.T[F^4^F./7CI+29[BR@FDA:&22-7:)NJ$C)4_3I7'>)-$U
M7Q!F"ZT33KFW>S7RF>YVRVESELE7"9(^[R,?=Z5U%I;W6GZ'!;^8;Z[M[94\
MR1MIG=5QDGG&2.O/6@#A?B)-J%WYU[ILQC3PR8[Y^<":;J8\_P"S$23_ -=
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M<4K>,-.DTS3[VP2?4#J +6T%JJF1PH^8X8@ +T.3P2!U- '045Q'PXN3=?\
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MV)"%0% &!SG)(Y.,8JS9^-;JXUN'36TV&0W,#R036T[O&KJ"=DC&,;<@=>:
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M%3&V.C@<\5P_A3Q?JT/@'2[[4&AN;O5+N2.U(21B"7D9BX4$D#:<!1TP..H
M/3J*\_N?'6LV?A[6;J71C]ITUTVS2P2P07,;G 9 XW;AG!4G\>:L7_BCQ1ID
MNGQ76BV DOM2^S0JMT3F,IN4DXX.003[< YH [BBN$B\3^*II]=TU--TK^T-
M*V2-*9W\DHZ;U4#&XM@$9X'\J?J7CIX]&\.7<?D:>NLH'-W>*9(+<[0P5B"O
M+9P"2.A- '<4E9VF7MP^A1WFIB".8(SRF!LQX!/S*<G@@ _C7*R>,-8CT"#Q
M;Y%HV@R%6DM0C?:8X6;:'W;MI/()7 XSSWH ZO5=<TW18U?4+I80P9@NTLQ"
M\L=J@G [GH*N6US!>6L5S;2I+!*H>.1#D,IZ$&N)GBU9_BTB?:+$Q'27(5H&
M/[KSUR#\_+=.>GM4OCC^U+&VT*WT6YM+*VDU*W@,9MR1G=E>C#"@J,@8)]10
M!U,.K6%SJ=QIT-U')>6ZJ\T2G)0$D#/Y'BFZGK.GZ,EN^HW26ZW$ZV\1<'#2
M-G"\=.AZUP^-?_X6/JL6G/8?;CI5KYUQ<(WE!@7SA <\GWX'KW>/&=SJOA'P
MKKD=E9$W^IP6\ZS*7\HF0H6C]#P<'MGO0!Z&*6N$U7Q;J4?BB]T>VNM.L9X/
M*-K#?Q,/MP8 MLDW  CE0,'D5W18*"20 .230!%]J@^V?9/-3[1Y?F^5GYMF
M<9QZ9XJ:O&[K7;6V\4Z9XX_M6V<7%RUE/9QSJ6CLVXC8KGLPWM_O@=J]$\1Z
MS=V%WH^GV3013:E<&$7-PI:.(*A?[H(RS8P!D<F@#H*ANK2WOK9[:[@BN('&
M'BE0.K#W!X->>WGC#Q-8Z/XINW&F2?V),(DD6W<+,3@G^/@@, 1DX-3:CXM\
M26$=G'+;6AFU>0-8)9Q//)#"$WR;U.W>PR ,$#DD],4 ==IGAS1=%9GTS2K.
MT=OO-#"JL?Q S6I7GB>,O$.FZ!<RZMI,HNFNXK6PE:WV&X$F0&,08D,,$E<C
M.0!BF/XC\866AZW<SVBB.TM#=6UY=VGE%R!EHVC60X/H<_44 >C45Y[>^(O%
M5CKNAVS/ICIK<3)#$8VQ;.JJVYF!R_4\ +]>],M_&^JV6C>((;Y8+G5-+O8[
M**:*(JDS2L A*9XQGD9YQU[T >BT5Q-IJOBL7.H0RVKBU6R,T%[>6RILF7JA
M1'^93U!R".G-4=.\1^)_)\)ZG>SV#V.L-';RV\<1#JSQ%P^[ZJ<C&!P.>M '
MHE%<=X,%\^L^)GNM1EN%CU-HMK1H,XBBP>!Q@<8_K772LR0NR*&<*2H)P"?K
MVH ?17G6D^*-9?Q/HMA<7T=Q_:<$YG1;<>1;RH@;$4@_U@!R#\Q^HK-;Q?XJ
MM/#;>(+B^LI(;;4S9R6R6F#,HE*$[MWR\=!S[F@#U.XF2VMY)Y Y2-2S!$+M
M@>@&23["J>E:S9ZUHT.K63.]I,I="4.X@$C[O7MTK#FO-7UO6]8L],U)+"+3
M-D0S LAFE9-_S9Z)AE&!@]>13/A=_P DTT/_ *XM_P"AM0!OZ-K-GKVG_;K%
MI&@,CQYDC*-E6*G*GD<CO6A7D5C<>*M+\)ZIK>F7]DEE8:A>3&R>#)N$$SE]
MSD_*>N-H[=:ZO3M:O?%FJZA#8:B^FV]C#",1QQN[RR)ORV\'Y0"!@ 9.>: .
MQ9E7&X@9.!D]ZS+'7K/4-:U+2H5G%SIXC,WF1E5^?=MVD]?NGGIR.M<!=:MJ
MWB+3/#4TM]+87BZX;"Y6V5#&SH)/G 8'NHP"2/;H:L_9]6;QUXP&G:J+-XK*
MS9YS LCLPC?;P?E SG/'TQ0!Z516-X3U6;7/">EZG<JJSW-LDD@3INQSC\:V
M: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "J&N6#ZIH&HZ?%)Y<EU;20J^<;2RD _K5^B@#RKPE9S+_9MA=> 4L]
M2T]D$VHRP*8MJ=71NK.0!T[G.:FO-/U0>(;?QS::3,+O[0;:733;#S7M_NB0
MMV?'S9]"%SUSZ?10!Y7JFDM;^-;_ %.^\'/XAL=66%[=O(1I+5U3:48/C:#@
M'.0!4]Q;ZUX5\5:=K<'A^2]LY],2QGM-. )M&#%@%' V\XSP.IXKTVFNZ1QM
M)(RJB@EF8X  [DT <+J?]N1:GX:UN?199S;R70FM++:SP)(H" Y(#$ ?,0<9
MZ5A:MH6O7_ASQ&AT>:.XDUR*_BB#JWFQXC!"G/+#:<YP/0FO5HI8YX4FAD22
M)U#(Z$$,#T((ZBGT >6ZUIEQ)XL7Q!?>#'UFPO[58S:R1QO/9LA."021\P.<
M \=#TYNFQU;0=;T77+;0,V8LY;.?3; +NM0\GF*0N0I/ #8/4'UKT6B@#SK1
M-0UC0+3Q3J,_AG4&:;4FNXH=\8+1LJ*>=QY 4D\8]Z[<W4E[H7VNR5UEGMO-
MA5AA@S+E00>_(ZU/>65KJ%N;>[@CGA)!,<@RIQSR.]3@   # ':@#S/Q'I$O
MBS3[&5O#MY8>*$DBV78"@6Y# LQE4X90,X R<XX!K=M1=V_Q$U2[EL+QK8Z;
M#$MP(OED="[,!@_[0Q[Y%=?10!Y/80>(K/PQX7M/["U![:VDF34((2(KC)SL
MVMN&$.[D@CI@UE'P[KUIX6N--&@7>4\2"]C$9#AH@><<YX ')ZYKVVH8;RUN
M99HH+F&62$A941PQC)Y 8#I^- '#>+]+OE\1V'B*WT)-=M/LAM9]/E"[H\MN
M$B!AC.>#WQC\*VHZ3J4EUX7F7P^+:&#4C>2VMDJ 6L>T*-Q& S;CN.T=,CMF
MO2** /*]5\+:SK6J>.X([::WCU,6LEC+(0(Y&@P&!P>,D#&1R.>U= W]H>)M
M9T*6?1+O3AID[7%Q+<[,%O+9=D>&)8$MG/ PM=I5?[?9F^:Q%U";M8_-:$.-
MX3.-Q'4#)'- 'F]QX9UC4]-\70V]A+:2W>I1WUD;DKB;84..#E<E#UQP1[U>
M:?Q!K?C'PQJ4OA:[LH+'[0ESYL\9VF1%4D8/*@]^IYP*[NTO;2_C>2TN8IT1
MS&S1.& 8=1D=Q4] 'E6B^']7TPRZ%-X0TZX99W,&MR)$R^6SD[V4Y8L 3A?8
M#WKI_"UKJ-IXG\3/=Z;/!;7ET)[>X9T*N BJ1@,2#QGD=*ZFYN8+.VDN+J:.
M"",;GDD8*JCU)/2E@GBNK>*X@D62&5 \;J<AE(R"/;% '*^+XM;EU/2UL].E
MU#2<2_;+>WG6*1FQA,L67Y,]0#SW!Z5QUKX?\3V?A)=)?0)&:WUU+N)8+B(J
M81)O.W)7 [#/)ST&*]?HH X75=)U'5O%^K)]@N(;&^T,Z<MZQC**Y+MDKNW8
M^?'3J/3FLH6_BZZT30=+N/#/ER:3>VCR3"]CVS+$<;E'7H ><=>]>GT4 8?B
MJ;4TT":+2K&>ZNKC$.(713$K<,^68#(&<>^.U<]XP\&Q3>$ FAZ=<MJ-LT4E
MC&+D_N74C!P[[>!D?RKLKC5+"UO;>RN+R".ZN3B&%I 'D^@ZGI5N@#S76-2U
M5_%/@6\GT69;_9>B:R$L>[/EH&*G=M/<C)'X47_@[5]:FUG7$B6RU&YNK2>S
MM9Y,@"WZ"0H2/FYX&<<5U>MV>@+J^EZKJ]RL%W;R%+(R7)C&]L A5R Q/ /!
MK?H Y.*SO]=\3:3K-YILVFII<4P$<[HSRR2J%.-C$;0 >21DGI6%%H.N'X;Z
M[I!TJ1;V^N+AH8S-%]V5BP).[ QG!_3->DU3_M2P&K#2OM47V\P^?]GW?/LS
MC=CTS0!RQLM7TWQ5%X@MM-ENK>]L([:ZM%DC6:W="2K<MM8<D$!O?FM;PMH\
MVE0:C/<_+/J5])?/$"#Y6X !,CJ0%&3ZYQQ6_10!Y)K7AWQ1J<=]]IT*.\O8
MM36>VO9+Q<^0)052)3PGR]>GXFMBUL_%_AWQ#J;6&DVM_8ZQ,+HL;P)]CF*@
M/G*Y=<CC !( Z5Z'10!PUYHFM1^,5N5@%]:WND+IUS=>:L31,'):0KCG(8D
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MA()Z=./>M72]%U?3O&>L7X:R;3=2>*5N6\U&2/9M QC&0#G/X>G4 @],&EH
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M>ISP!6]J'B;46U37K33(K0#1;9)9?M(8F=F0N%7!&T8&-QSR>G'.*GP[U1/
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M'^;KGKS747&OZA!XPUC2(6AF:+2EOK2&3"#?N92"_P#=R%Z^M5HOAXD?A8:
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MMGCN#OB9@0<$]CN;@Y'- $?@2]M;_1[J2UU*^O46\D4K?AO.MC@9B;).=O\
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M/&-NTMM''H!W]: )?#MK%9^'K"*$N4\A#EY&<DE1W8DUIU0T?1;#0=/6QTV
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHI"<"@!:*:IW#].F*=0 44SS 6(4J2.H!S0TFU@O&3TYQF@!]%(&R:6@
M HHJ)IU20(Y"[B N3C<?04 2T444 %%%% !1110 4444 %%%% !13?,3S?*W
MKYF-VS/./7'I1'(DR!XW5T/1E.0: '4444 %%%% !112,RHI9B%4#)). !0
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MX:XO$=T=(B8U"C)W-V]J -.BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD6J0 VP2[4KNV!=IYX/'6M'41?ZG'X3G:T@A;3K])IXC>1L4C"[<YS@GG.*
M.BO?&#0R7_V+3KB^@T\[;N6%@"C 9(4'[Q ZU'=^.K:*^TRUM+2YOCJ=N]Q:
MM"!APH''/3J.:QK#[;X?O==MX/L]]9WT[W5I*;M!Y+LN&1P2#C<,\9ZU4TW2
MCHVN^$%MYK:2STNQGM[F?[4GWY-IXR<D94_G0!VOAGQ&OB"RGD-M+;7-M<O;
M7$$I!*.#ZC@\$<UO5YSHAUK3XO$<^F65G=WESJC7$$/VQ0K1,0"21TX!KT53
ME0?:@#(\2WLMKI)@M)1'?WKBUM3U(=^-P'?:NYS[*:Q/ASJDTVD76A7KE]0T
M.<V4KDY,B#.Q_P 0/TJ]<Z?-K'BH?VEI)?3+6 BVDD>-E>5B-S%<Y&   <=V
MZ9K)'AZ]T+XBP:CH.DJFDW5MY.HB-T0%LDJX4L#D<9]LXR: "Z^)!AMM6N(=
M O)DTF[:"\/F(HC1<9?.>3R<*,GCG&:V1XLC/B:PTC[&XAU"W-Q:WA==DH"A
MBH'7<,YQZ<URS>'-;?PWXWLO[)*W&K7DDUJWGQG>KX !^;Y<8S_P*I_$MICP
M5HEM]I6Q\0Z>]J;./*N_G B,# )RK9.>V.O0B@#M=,U&347O#]G\N&"X:".3
M?GS2IPQ QP <CZ@_BFKZM!I%HDLH+RS2K!;PJ0&FE8X51G\\]@">U2Z7I\6D
MZ7;6$))C@C"!FZL>['W)R3[FL7QIHVH:M86$^E-$;[3;V.]ABF.$F*@@H3VR
M&/- '+:7->2_&K49+W2%M)_[!YBAF63S_P!ZOS!L+R?N\X^[Z5HZ#XCTK2O!
M6C2:1I:VD6H7<EM:VLUSM56WODM(<XSL)[G) &:FTRQ\27/CU/$&H:1:6=O_
M &6UHT27GF.K>9O'(4 GY1Z##=21BJNG>&M1L_ FG:%J.BVNI1QSR_:[<RKR
MC,[*T;' W LO7'0\]* -*^\;SZ5!IO\ :&@W:75[=26BP1.KX=<[<$XW!NH(
MX&>:K/\ $-[?2M;DN]$EMM4TA5EGL)+A3NC;HZN 0>,URNK:7J7A^V\(6TJ/
M.Z:^7M+62?>T<1'RQF0\$CGV&<9XS72:EX5U3Q!#XDO)XH[*YU+3TL[:!I0^
MW;N;+D# RQQP3@?E0!MW?B6XM]?T[2H].60ZA:R3P2FXVC<B@E6&TX'S+SS]
M*PM!\<7<7@VXUS7XH8P;N2&';./F<RLH0Y "A< ;B3P"3BG6NF>*[OQ/X<U2
M_P!.T^WBL+>:&:-+LLPW!06SMY)QD*.F.6YXSXO!_B:3PE/HWEV-K/9Z@;VR
MG:<N)G$QD&Y0ORK@XZDY'0"@#I/#?C>TU_6[S1P+<7=M$LV^UN1<0R(<#(<
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M_B+^?##,!:MC(5V9 &!&/F&!G\SVE<EX;TGQ99):V>L:E8265D L3VBN);@
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M6I>(VU"UL1BWB6U$))"E1O8,=^ ?;G!-5K8:?\/O#\\?B+5(9+:]O965A:.
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MKL-IXITS58=/EU#2K3[5%,L9,-Q$58@,F[(/RD8SW]N7_P#"1:VUQX-MK/[
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M9K<O==O3KMQI&F6D$MQ;6J74C7$I0,&9@%&%//RGGMD<&@#9N;VUL@ANKF&
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M]>?$/2[:T:U33Y-+-X(9'<$@N@);'!8 X Z=30!K_P#" ^%/^@#9?]^Q2_\
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M4N$V!@0"24RK#/)P1^%=WI%O/#IT'VJX6XFV#$HB"';@<<4 41XT\.;"[:M
MD:R&)I),HBN.JEB  ?8UNA@P!!!!Y!%>0VUOK.M:'XPT#3]%6:.\UJ\3[=/.
MBPQ$R#)*Y+Y&.,*><5MF3Q3INLZ;X1TO4+']WHJR_:+B!F(=&5"3S\V3QT&
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MZ<=IE\+:JMAX3MA<V>=$9#(2K?O0L9C&/3*G//>NKANHIHX7#@><F]%8X)&
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MR;B>-HR.N?7.><<"A9_#J:"TT>UG\27L\.DW*3VJ"&-54+NP#P<GYL9.< <
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MP[ #I72SQ2RVKQQSF&5EP)54':?4 \5,:S=+OK^\FOTO-,>R2"X,4#M*'\]
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MTK&[U2;5=1@O--6WLH606ER)@YN 1\Q*CE<'UK2H PW\,0RZ_IVLOJ%\T]A
M8(TS&$<,,,6 3.3@'@CH,8J;6] M]:%M(TTUM>6CF2UNH" \3$8/!!!!'4$$
M&CQ-JUQH7AR^U2VM4N7M(FE,3R^6"H&3S@\X[5H6DQN+."<C!DC5R!VR,T 8
MZ>%8!IVHP27UY)=:E&([N^8IYKJ 0 !MV* "0 %[D]>:N:!HL7A_1X-+@N;B
MX@MUV1&?9N5>PRJKG\>:TJ* .2O/A]IUVNKQ#4=3@M]5=I;BWBF7RP[8W,H*
MGDX[YQGC'&+S>%4?4])U!]6U%I=+C,<0/E;7# !M_P"[R2P !P1TXP>:WZ*
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MG2M1>VN0]LZF:!64%PA8%' ;.#Z'Z5?B\72Q>/KG3;G487TEM/:Y@D6'&UP
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MQ+-A1]T9/ [#UI-4T>ZU'6-,NUOHX[:QE\[[.UOO\Q]K+DMN&,!CCC@\\]*
M. \":E8:+XYN]%M+^:YLM4A6XADG1U+7*C][]X#EN6K;\1>*KW3_ !+/ISWZ
MZ2OE*;"2X@!M[MR,L'D/W2#P!Q^.0*V?%7A>X\13Z7/;ZD+";3KC[1'(+?S&
M+8QCEA\OJ._%0ZIX3OM8COK2]UA)-/OA&)[<VF=I55#&-BQV9*YZ'!H R/$W
MBN_L/$5SIJZ@FE-Y*G3I+FW!MKMR,D-(?ND'@#C\<XK6>]UC6]5UB#2]0CLH
MM,D6!5, <S2[ YW$]$^91Q@\'FDU;PA<ZI'<Z>^J+_8MR(U>TDM][QJJA?W<
MA;Y2=H.2#CDCGFIF\*2VFK7E_HNIO8&^14N8VB$JDJ-JNN2-KXXR<@]Q0!E:
M3XNOO%"Z%;VI&G27]I-=7,@42,GE.(RJ9R.6).2#P*GU'4O$NDZ+I37T]C]J
M?58;2=HHBPEB>4*&&2 C%>HP>O&*6_\ A[;O;:,-&U*YTJ[TA62WN8U$A96^
M\'!X;)Y_$\5-?>"Y[G2;6TBUAUGCO4OY[J: 2/<3(05) *@#Y0,#L * ,;QM
MXKU;0CJTL5XL#6D<;V=O#;B?S@1\S3\$QKG('*]#U[37BZG=_%'2PFL3P0R:
M6\XA2-"J_/&& !!Z^IY':K&H?#R6_FUS&OW,-IK"@W%ND*$>:%"ALG)V\9VC
M'89Q5^7PA</J.EZ@NO727=G;-:S3"&/,\;$$C&W"'('('3WYH S)_%M_I=IX
MJFNG@GDL+Z.VM,1[$!D1-N[DG +\G/05<O=0UGP]K>C075^+^TU20VKL\*H8
M)]I967;C*'!&#DC'WJDC\$K.NO0ZM>K>VNLN))(E@\HQL %!5MQZ!5_$9JU:
M^&;C[79W&IZJ^H-8!OL8:$)M8@KO?!^=@IQG@<GC)S0!PZ>*O%S>$-:\0?VE
M:9TF_DB\C[* )T5E!#<Y7KQCGKD],>L1MOC5L8R :XN+P#,?#NKZ-=:TTL6J
MW;74\B6P1AO.6"Y) R0.3G'-=A:12PVD44THEE1 K2!-H8COC)Q0!RUI++?_
M !4U)92##IFG1)"N>C2L69OKA /PJMXVFT_5[V#PW?270LS&;B]%M#)(<<B)
M3L4XRV6YQ_JZN:A92:+XT7Q)'#+-:7ENMG>+"A9HB&RDI ZJ!D''3@^N-C3=
M'_L^_P!1O&NY;B2^E$C^8JC9A0H5< ?* .A]SWH YSX7ZQ)?>%SI=TSF^TB0
MV<V]2I91]QL'! *X'(!X-8?@*;Q%'#XA&DV.F3V_]N766NKMXFW97(PL;#&,
M<YKL;?PFMIXMO_$-OJ=U'-?*JSV^$,3;5VJ<8SD8SG/KZU)X:\,1^&H[Z.&^
MN+A;RY>Z<3*ORR-]XC:!P<#B@#C_  RD\?A7X@BYBBBN#?WK2I$Y= QA4G!(
M!(R?05T_P[./AWH/_7FE);>#?LL&M0KK%VR:O(\DX9(_E9QM8K\O'&!SGI3;
M?P=/:>'X]$M_$6H16<<7DC;'#OV=,;MF>AZ]: &>-]4@CTZSTYA-+#J4FV;[
M-"\S?9EP9" @)P053/\ MUC?#/4EMKW6/#)2YB@M9C<Z<ES$T3FVD)( 5@#@
M'V[UU]KH7V76WU%;V9D,"VZ6S*FR)!T"D#/7KSS@>@JMJ'A:.^\5V/B%=0NK
M>YLXS"L<038Z$DE6R"2#GUXZCF@#,O+B73_BWIJ1Y\G5--DCF51QNB;<KG\&
M*Y]\>E=G7*Z?I\NJ^,Y?$EQ!-;PVMN;*SBG0J[Y;+RXZ@'@ $9P">*Z.]MY+
MNRFMXKF2V>1"HFC +)GN,@C/U% 'E7C*235IK[7;2.^-YI,Z-I;I9RO$5A),
MIWA2OSDL,YQ^[7-=#XXOXM?^#VHZC9 M#<V:3J#P0NY6.?<8/Y5U.E:0NDZ!
M;Z3#<2.EO"(4E<*6P!@$\8)_#FN?M/A[#9^#KGPO'K6H'3Y@5&X1EXU)RR@[
M>A/K^% &(L5U)\4]!B&IW:1?V(94C7RRL?*A@H*GAMHR3D^XXJ33=8\6>(=-
MAUS29,*UVX\F5XA;^0LC*588W[MHSG<.?:NEG\'6\VIZ9J(U&]BN[&U^R&2(
MHIFCXX;Y>.1U7'6JMM\/--L]2NI[>]U".QNY3-/IJS8MW<G))&,X]LX[=.*
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M  @V],'IS79>$O"6G:%IUE,NF);:BMLL4K%]Y!P-V#D@ D9XK2D\-Z-+JO\
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M-[BV&2"0[DMM8@\'N#CO0!UE&:X'Q=>WMWXVTOP[%-!%;SV<LX2>62-+B3<
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MM264N=Q_VF"@8!Z<F@#O,T9KS<K:0WGA7PXVJW5_I,LEW$\DTF?M$D8&V-V
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M8'YCG)!YYZXJ&YBT:TTO4+S2-1O-5TN74[.?5I<1F'9N8N%"*H_N%\=B,]Z
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MZC;VKBY2&YF\BWO6BQ;S2<_*KYZY! ['L30!T1 (((!![4*JHH55"J!@ #
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M;O-9ZA&%4#)9=BX!(SGC:?7->GDA5).< 9X&:7%% 'D2"X7X03VG]G:B;O\
MM,.(!8R^81]K$N0-N<; 3GIVZ\5T>GW%QH'B[7KJ\LKV>SU;R;JTG@M'D8[8
MPIB< 90C P&P/<'BNZQ1B@#R270=1T+3_!]Z=/O9X[+49[B:U@4RR6Z2Y*H
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M7'B[0+6\:TFU:U2X6=;<Q[^1(W1?KQ^%1>)_%=EX6@M&NDE=[NX2"-41B.6
M)) ., YQU.,"L/P_;65Q\1_&+S012.\EH8VD3(8)$,[2>#M<=NA J?XEH_\
M8VDW"QR/%:ZQ:SS%$+%(U8Y; Y[B@""7Q5'IWCV?[?J[)H[:1'=1I*FT*[2E
M>!@,3A>^3UK4U[5;*[TC2[RV\2KIUM/=Q-'/$H<7(S_JA_O?ICFLJUNK2\^+
M!OP/W+:"@226,KM/FLQ'S#(.T@D'G%<J(T_X5%HL3HZRQ:T'6,*<C%R[$D8X
M&PY_*@#T^_\ $^CZ9=M:WEZ(YD"%QL9@FXX7<0"!D^M:<\T5M!)/-(L<4:EW
M=C@*H&22?3%>:>*IS9:]JEWH]U(-4<PQW&DW,7F0ZDFT;?+P,AL-@D'C'( Y
MKLO&4CQ^#=79-/\ [0;[,X^RD$B3(Q@XP<=^.>.* %L?%VA:A]H\C4%'V>/S
MI!+&\1$?]\;P,K_M#(KF_&?C?3Y/"&IG0-=1=2BM5NH_(P6\LLHSR.AW?7FL
M?2=3A7QU%?//J%Q:RZ%) D\UB\48<2*Q51M&%4=R3[L33(K".]^ 36^G6#/?
M)9B)XDMR)=X<,XQC)]??K0!W^F>+M!U;4IM-L=3AGO(%+21KGH."02,, 3VS
M6'#XKL=!\.2W[ZU-K23Z@T4,WDM\I9P-F5&,+GKWZ#TJ.X2TUWQ3X9N-%C(C
MTT/+/<+&8T2%DVB+.!EB<?+V .<5@>=YOP\U1HHII#;:^;EU2,EC%]K#[@.I
M&WGB@#O+KQKX=LM_VK5883'$LKK(K!E5C@$C&?PI\OB_0H;N.VDU!0\DB1*X
M1C'YC#*H7 VAB"#@G-<FUQ::K\8-,NS [VL^ALB>? 1\QD+!2&'RDKDX..#[
MUSGB.[:YL]=MTL]0MI8M964V5K9L8W59(P9Y'VG<6 X (Z#@]: /0H?&]A/X
MSNO#ZB0&VB!>1HG'[PL1MZ=,#.[H?6D\-ZQIUMX9GOI/$C:K:1W#@WLR[<9(
MP@P/FQD 8ZD\>E8UG=?8_B[?7,]K>+#J6G0"W<6SD<==Q ^3'?=C%<SHD-ZO
MA>VO8+62>+3?$DE[<VXC)<PG(#JO4XSD8]* /4(?%.CSPWT@NR@L5W7*30O&
M\0]2K*&QP><57L?'/AO4KRSM;35$EFO 3 /+<!\#)&2, X[$Y]JY[4]NJ^(-
M2UNR>3[#!H4MM)+Y159G<EE4$CYMN.<="<>HKG;=@O@+X>QK!-OM=4AGN%6!
MR8D0N)&8 < %ER3ZT >N7EY;Z?9RW=W,D-O"I:21S@**Q;KQ#8ZEIFK6^GWD
M\-[;6C2E6A>&6,%258"11QQUQ5;XB65_>>$I#IL#7%Q;7$-R+=1DS"-PQ7'?
MIG'M5*+7X_$=EJ-[9:%=VZ#3Y4FN;JT*2NV/EB3N^#N)[ XQR: )?"7B>*+P
M)H%WK-[))>7J;5^1I99GR>BJ"3P/3BM=?%^AO8VMZEZS6]U<BUC<02'$I;:$
M8;<H<\?-BO/M/:[T[PCX*272[Z,1).EQ<PV!DNK0X("HI4E-_3=CH/QJMI\-
M[!X,U,#2=79K/Q*EX4EB+S21"922/[[ +R1QGO0!ZB_B+2X]2O-/DN3'<V=O
M]JG5XG4+%_?W$8(Z]">AJ/3O$^FZE))'&UQ"\</VAA<VTD/[KLX+  BN/GN9
M=1\9:MJ+Z'J4FG3>'O)59('C,X#NS+TRK$9 !P>G'(JE:Z9J]S:ZSH>DSW]W
MI$VD2I!-J=NT<T,S\"$.Z@LI'7CCUH [G3_%^D:G?PV<$LR2W$9EMC-;O$MP
MHZF,L!NQD?SZ5NUYQX7F@U2YTS/@N:QU.T/^E7%W:E$@P,$Q,?O%CC ';.>E
M=KHVK'6+26<V-W9^7.\.RZCV,VTXW ?W3VH XGQ_%JNA^%[W5XM;OTO'O5V+
M%.1''&TN%4+C^[C/OFG>-[+4O#^A7>I6>OZB+?-NI26Y)9&\] 2&ZA2K,",^
ME6_BTLL_@MK.VMKFXN)KB)DCMX'D.%<%B=H../6IOB+)_:'P_D-K;7-P9YK=
MDB2V=G($JL<IC(^53U H V=(\7:/KE_/965Q(9X8_-*R0/'OCSC>I8#<N>,B
MDMO%VD7-]:VJRRH;PL+262)ECN-O78V,'V]>V:YW4%>^^)!\FWNA#<^'I+5)
MS;2",2/(& +;<#Y1GGITZUE>$(4VZ5HU[X+N8]8TUD66_N(!]G38?]8DF>6(
M Q@=3Z"@#TC4M4M=)MDFNF8"2188T12S2.QPJ@#J363+XVT.WTF\U*>>:*&R
MF^SW*M;OOBD[*R@<9R.>G(YJOXYGO;>PT][:QGN8!>(;F2VA$LT" 'YXU(/S
M9P,@9 )^M>?W%AJ3>&?&NF0Z%K6^\NXIK?SXS*SC,?!;)+' 8]P,8)' H Z/
MQ'XPLI[G1+^RU&[M[:VUI;2[Y>-)%,9?E?X@1M(XYS6]!XOT/Q!IFK0PW5Y
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M1TQVO-,U.*YN46:+A$=F.#NP20PQ^N* /0]8U>TT+2+G5+]V2VMTW.54L>N
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M?;HND74LLICN0258.!@8 _BSC/0>O MZSX.U376\5Q_+9_VB]M+9S>8#AX0
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MC\BC!SG ).3@\X]Z .UHKFKOQQI5E,OFQ7?V(W/V1M0$7^CK+G;M)SG&X8W
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M/TW1Y9;N2Q6X%H9-@MX@H #,1US\H !)(YP.: .EHKDYO'5M#9:4\MJ;6ZU
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MO3XE6^T6PU'3=2-^#=,C#['>0"0 NX+8W;.> &SGZUZ!+/# 4$LJ1^8P1-[
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M.J27)5M.AFD;2DX/EK,0\N.X^8!1GW]: (].UO0M&O/&%]]AN;)K.=)+YY)
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MJ(YM-6%;B:*ZT]D9;NU5=P5B2^&R0N<+QN[X)KF?#>OZ[H'@[3KR&TL'T?\
MM*2";>[&=@]RR[E PHP3WSGVKJ;3PKJ<VJZ3J6K-ITFH:;O_ --MU99;A2C*
M$?V^;)Z]. ,FJT'@;4_^$'B\/S7MHDL=]]J\Y$9E(\WS<8..<G'TH 7Q?XRU
M7P_-J,D<=C;V]G"DD"72EY+\G[XCVN"@48!)5N35C5)/.^)7A*7&-]E>-CTR
ML=4M9\!ZSJ5]X@:'6+5+76H4602VY>2,HN%16R $SSTSSZ\UKQ^&M3;7]"U2
MZU&VD.FVTD,B);E?,,F,D?-P!M4#KT.>M $/@'[_ (J_[&"Y_P#04K)\5G4!
M\5M _LI+9KTZ?<"/[4S",'U.T9./08SZBNH\-:%<Z')JQGN8IA?W\EZ B%=A
M< %>2<_='/'>H-;\-W=WXFT[Q!I]U"EW90R0B&XC)20/[@@@C\: .?\ ^%@Z
ME8V&HV6K:?&NO6EY#9JEJC212F;)C=5SN(VJQVYR<8R,\;/A37M=U34KZVU3
M39(K6-5:WNS9/:B0_P 2E'9CD9&"#@\U!?\ @)-3TJ^^U7O_ !.;JYCO!?QQ
MX\J6,8CVKG[JC(P3SDGJ:U="TC5[28W6MZR-1N1'Y4?EVXA1%R"3@$Y8X'/M
MP* &^(-:N[75-+T73O*2^U(RE)YT+QPI& 78J""QY  R.O7BJ3ZUK^GV=K9:
MA#9C5;O4#9VTZ@^3)&%+^<4#9'RJ?DW=1U -6/%GA677Y-.OK#4&T_5=-D9[
M6Y";P P =2IZ@@55N?!U]>Z9$UUK;MK<5VMY'?+"%1'4;0@C!^YM)!&<G).>
MU $4GB+6M/U'5]$NOL<U];Z>VHV=T(F6.2,':5D3=G<#Z'!![51TSQ7XCW>%
MKW4DT]]/UL+$8X%821R-'O#Y)P02&XQP,<GK6S<>&+Z[GU/4)K^W_M*[L?L$
M#K ?+@B));C=EB2<]>P_&F/!FI+8>%+0:I;;-"D5W/V8_O\ :-JX^;Y?E)]>
M>?:@#(\5:GJGB+X>^(=3L;JVBTT)-#'"T.YI8XV*.Q?/!.#@ < #/7C=TG5[
MY?%NGZ(7C-C)H2W8&SYUD#HGWL\C!Z8K.N?AWJ(M-5TK3O$1M=#U#>PLVM0Y
MA9^2J,3PA)SC'Z\UHW7A#43J6E:EI^N"UO+.S-C-(UJ'$T1(/W=V 00#W_I0
M!D:?XXU*;1[:)Y+5]4O-9DTV%_+(2-5/+LN>2%'0$<L*3Q_<>)+'P%KS3W<4
M:PR1+#<P !KB*1E5E9?X"-Q&0>?:I5^%X_L":P.LS"[&HMJ-I>I$%>WD)^OS
M9'7I6A<^!KC5?#6HZ?K.MRWE_?)&CWGDJBQA&#J$C' &>3W/?M@ 9K7B/5=/
MU>+0[2.ZN[I;0W4T]O9K(<,Y5!M,B@#Y6SR<X'2H[#Q+KNHII&D75H-+UJ[C
MEEN'DCW"..,@;E7/5B1@$G'/7C,^J>"]3O+NQU:T\22VFNV\1@EO%ME*31%B
MVPQYQ@$\=??/6G7G@0S#3KNTUBXM]:LY'D_M QAS*7^^&3@8/8#H.* &>"DN
MHO$/BY+V:.:X6^B!D1-H8>0FTX['&,]LYQ5[Q3J=[83V<4-['8VLJ2-)<"(3
M3%U VI'%U8G+$X!X7M4GA_PW<Z+J6IWL^K2WS:@Z22!X43#J@4GY?IP.P]>M
M&L>&[J_\066L6.KRV$\$+V[J(A*KQL03@-PK9'7!Z#CB@#E[3QSJMY\/--UQ
MX)%WW30W]S:0;V@C4L#(L9SUPH.<XR3@]*ZWPIJ$^J:2]W)J%M?PO,WV:Y@4
M+OBP,;@.C Y!''3H.E9&D^"+_0--@LM*\1S1QP7;W"+-;*ZE&#9C8 J6Y;.2
M>H& *V_#V@0^'[6Z2-E>:[N7NKAT38K2-C.U<G:, #&30!SGB7Q1>:;XCFT^
M2^_LJ,VZM83SVX-M<2G.4DD/W3QQ@CN3GI3M5UKQ#?ZUK-AH*3*=-2-(S''
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MH+9$<8 [G:>>@&.N:J7GB36(;/37DT^#3&G@::\N+XEH;5EP/+^4C)8DXY'
MZ'I0!UU%>?GQ_J<WA7P_K5II-M(=3O19R0FX(*N9&0;3MP0=IY.,9'6MKP]X
M@U.]U_5=$U>SMH;JQ2*59+61FCD1P?[P!!!&/\\@'34R*:.="T4BNH9D)4Y
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M.>@]37(6SZMJVKZCX:?7KF*XT>U@8WD*+&UQ-(&8,ZX/RJ ORCKDY[5<GO\
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MUN[1NI")+YN6QG+$A1@<  \FO1Z* .3\1>']9U/4]%U73[RTBNK /O@N4:2
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MEU@:W,$DX4;VW9W-Z9))/?K45WX0>XN]%NH-7N;6XTR%K<211H3+&P (^8$
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M)J>LI#]J%Y% MW^[@D#;LJI7'4]\UL6/A:UL/$EQKD5W>-<3P);O'(ZLA1
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M] %C?F&+1Y'E EB\QIW?.]F;<.3N8\#J?PK0TGP^VEZ]J^IB]:4:FR/)"T8
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M,)- P)(8$<9!)[=Z>G@.TGT2^TW5]2O]5-Y&L;3W3@O&J\KLP, @\YYR>N:
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MV.T;'9@ALJ00<@'(/6I=,T*RTJ>:XA\^6YF 62>XF:60J"2J[F)P!D\#^?-
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M+BUE #QMGG!R.1R#D=10!Y[8S7L?BC7M+<7%A;G1!<"V6_:5XI S*'W _(Y
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M26?VB36K*74%M9?.8F$;F!PN<'@EN<G)SZ5Z)X?\.Z?IUI;7"Z5%:7OD".3
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M?I6[=>.?#%D9!<:U:)Y<IB?YLX88R./3(Y]Z\]1O^*=^&2E)%,%Y'YH="NP
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M 9+E&CEG90<DJW.T9 ![_-Z#/3T %%%% !1110 4444 %%%% !1110 4444
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MOB#X4L]WGZS"NV4PL0K, XQD<#MD9/09%:EUKVFVGV8/<&1KI#) D$;3-(@
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MS8*_NPP/X  ]QBO3;^WL;+PW=P>5]FL(K60,ELH78FTYV < XSBM$@$YQ2T
M>5:%?M8WL>G_ -IV>M:5'I,KVNI*0LMI'A?W<V#C! 7!.#D?6JUI+H]EX-^'
M<R264,AU"W:1U*AL^4X<D]>I4'WQFO7%BC0L415+G+8&,GU-+M'H* /#_$>N
MV;PW\?G_ & P>(4FGT_R6>1@)%S-(YSM!Z@# Z 9KM;75;"X^,$CQW<6'\/Q
MD!CM/^M9\$'D':0<'L:[O ]*,#.<"@#AOA1<P7'A:[$,R2%-2N=VULXRY(_,
M$&F+/H[?&#4DN7M6N$TF+:),$KAG9^O0[2I/M[5WH '04F!G.* /&/#-^;;P
M[X(U-I!)HUA=7:7IC^;R'<N(V<#H &SGL"/6M36[7^TCXZU+2-TUC<:6L+-$
M,I/<*&W%,?>PNT$CN3Z5ZG@#M1@4 9GA_5K+6M%M[W3Y3+;LH57*,H) YQD#
M/I^!KSB=+9O"_P 2F,<9N);V=5.T;G&Q0H'<C<&Q[YKUK%+B@#R?5-3MGU V
MC&:TGGT&-(9[:!Y9KT88F-3@A0IZ\9YZC%/F$EQ\+/#6OZ4)#>^'X8)B-C(7
M18U69!D<@KG)'!VD5ZIBEQ0!YKXHTO4HO MK>/!<F?\ M--3U.&SE*R^622R
MJ1@DH-@'/\ ]*T_!7]B7&HW5]HEOJ$RRP@7%_J#S&1FR-L8\SE@ "21P.!SG
MCMZ,4 <-XOO(]*\<^$]2N8[@VD:WD3R0P/+M9U0*,*"><'\JPK^[L[BP^)DB
M$%I1Y<9*$%R(%C &1S\X('O7JV** /'XKJ/2]3TS5=9CU&71[W1K:V2YM'E!
MAE0'<CB,AB"23R#S^->C>%;6TM/#UO'8:<^G6A+-#;2$[E4L2"0>03UQVS6U
MBD.<''7WH \FTC4=+MM5\?V=[&99KJ]>..!82[3Y7 1<#DY/3/?/'6K.AP7G
M@K5M'GUT3?8O["CLVN%5I%AG60L4(4''! ![[:['P]X:?0M0U>\>]%PVIW'V
MAU$.P(W3 ^8\5T&* //+;PL=7\(>)X5@>W35+V6\L$D4HR-A=CX/*Y==V.#A
MNU936_B:[M]'\80VSKJM\OV"Y@7.(H)%VH[#_9D'F'C^/'09KUBD) &2< =S
M0!YIXHTB'0]>T.YETJ]OM"@L38,+)G\R!L@JY5""0<8/^.*COA8VD7AO[-HE
MQ8V?]L_:Q&+:1W\H1,OFR@ E6+$=3G&#ZX]0HQ0 U54* H '7 %>-:?IVL+X
M-^P0:;>&\TG7?M\T+0E5FC27=M0G 8G.0!_=^F?9Z,4 <2W_ !4OCG0-6TU+
MB.UTV"X-S+-;O#O\Q5"1C> 2>"3V'XT[XA1ZC;QZ/K>GV+W_ /95YY\UM&?G
M="I4E1W(S7:44 >>:V;_ ,3>'KJ_T;19;<QW-M<K%<P"*:],3[F!![8"@9Y)
M!'I5XS1>(O%FBZQ9VM]'!I<5PUQ+-;21$[T"B,*P!<Y^;C(&WWKM<48H \GM
M],U"'X7>&K-],O?M5IJD4L\ MV+JJS,Y.,=-I%=.[RP_$6_OC97K6O\ 8\<0
ME2V<JSJ[N5!QR<,/QXZ\5V.*,4 >7V]G>0^ _!=G+IM\;BSO[>2XC%JY,2QD
M[B1CW'U[9K>M%FA^(^N7SVEV+5]/A1)?L[E79"Q8 XY/S#IU[5V6*,4 >1P:
M;K-K\.?!@CTJ]:ZTG58IKJV$)\T1@R;B%.,\,/SKT36[2;7?".H6<:/;SWME
M)&J2XRC,A #8)'4\X)K8Q1B@#S?PFEQ_Q+[>X\!PZ=J%D MQJ#VT>P!003$P
M^9F; Z>IY/>YX:M+RW\)>(;>;3[J*>>ZNYHHWB(,BRDE,>_(R.W?%=O<7$%I
M;O/<S1PPH,O)(P55'J2>!2P30W,*S02I+$XRKQL&4CV(H X*YT75;CX<^&XK
M2S*ZEHS6EPUI-A3(T*@,@/3GG!SBKEU!-K^NQ:L--O8+6STZY@*S1>7+.\FW
M"JIYX"GD\98>^.UQ1B@#S_1M)FA^%%CH^JZ)/<N@6&YL\@/CS,EE.>H!W#![
M5J>![34[)-0AN)+U],$B?V>=0'^D*NWYE;G)4' &>>OM768HH Y$0:GHOCC5
M=1%C+>:;J4$)#6^TO%+&-NT@D<$'.17.ZCX9U.W^'<>G#3)+F[N=3%[-;0E2
M(E,WF%2<@'"\<=Z]0HQ0!'#+YT"2;'CW#.QQAA[$5YQ)9>(Q:>.9+#2GCNKV
MY1[,3;,2H%5&*Y) ;"DC(ZD=:]+HQ0!YYX:TW4K;QV^H/H-Y:V5UIB0M)<7*
M2N'5R29#N)).1P,_AT%$?#W4#I6LZ>TO[BQFEET!0<>6[%90V<]F&P?\#[-7
MJ.*,4 9/ANSN;/0X?MRJM].6N;I5Z++(2S*.O )VCV K6HHH **** "BBB@
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MH<$J:S"H/,;ON CQV'F N/\ =%>B4 <5JVOKH7Q S>WUP+!M(>86R@N#()4
MV(!DMC/ZG@9K:C\6://HD>KVUT;FVD;RXQ!&SR._]P(!NW<'C'OTK,U%SI_Q
M'M=1G@N39MI4EN)HK=Y0)/-5MIV XX!ZUQEWH&JV,:^(AH]S<69UN>^?3(<B
M7R9(]@?:#G=_%MZC=]< 'J&CZY8ZY!))92/NA?RYH94,<D3_ -UU/(-2ZGJ4
M&D:?+?70D^SPC=(T<9<HO=B!S@=3Z 5C>$XK,O?W=AH<NF6\[(=]Q&8Y;A@#
MEF4\@#.!GD\]L5T4L231/%(H>-U*LI'!!ZB@#*_X273FATJ:%IYXM4D"6KQP
ML0W!.3QD# )R>PJ#_A,-'.IK9++,Q:Y-GYZPL8?/'_+/?C&ZL#P+H.HZ9>W&
MGW\3?8M%>2#397.3*DIW[NG\*[5[]6'&*Y>]75;O[/+_ &%J\%U::^EQ-!;6
MWEV\<0D^\H7'FLP();!/7H.H!Z1JOB_2='EG2Y>=EMMGVF6*%G2WW8QO8<#K
MGZ<TNI>+-+TR::.5IY3;PBXN#;PM(((CG#N1T! )^@)KD;>]U/PUKNOZ;>^&
M=0U6UU6\:\M9+:)9(VWJH*2%CA0-H&3[]JK>);;6+R;7K.?1;_S)],2*"32H
M@D5Q)Y1SYLF0Q56) 0DC;G@DT =;J7C!++7],TV&QN[B.\A>;S8H2P95 (V\
M\_>&?2I[_P 9:1ILLHN7G6"&98)KH0MY$3D@;6?H.HSV&>:Y2Q_M&R_X02^F
MT?5)_LNF36UPD<.9(Y"D0&X$C&2AY/XX%9$'A\6>K:QI^J>!9=5N[B\EFL]2
MV*T,@D8E?-;(V@9YQS[4 =]X@\26%I!?6A-_))#;^9,]C$SF $$@EE^Z>"?7
M'-/\"3S77@31)[B5Y9I+1&>1VRS$CDDUSM@^K>'-=\0V<V@WUY#J$HN+2>R1
M6C/[M4V'+#9C:,9XQ^&>@\!07-KX&T>VO+2:UN(;=8WBF # CCH"?UYH U=4
MU6UTFW26Y+DR2"**.-"[R.<X50.IX/Y&LN/QII)T_4+J875O)IR>9=VLL#>=
M$I&02HSD$<Y&1[U3\::?J$E_X?UBQ@DNDTN\,MQ;1_?>-EVEE'<KSQWS63K^
MFW.JMXGUBUL;I4FT5M.@0P.)+F1LG/ED;@ 2%!([D]!F@#JM#\4:=XAFGCL/
M/80I')YCPE4=7!(*D_>Z&M*^O;;3K*:\O)EAMX5+R2.<!16=X10Q>#]'@:">
M!X+.*%H[B,HZLBA2""!W'7H:K>.='OM=\(7MCID@2].R2+<<!F1P^T_7;CTH
M DTWQ79:A?364D%W8W,5O]J\N]B\LM#G&\<GC/7."/2HX_&6FM<6:2Q7=O;W
MS^7:7<\6V&=CR ISD9[;@,]LUEPWNN^,M%O;*71+C1/-LY8));O&6D="H" <
M[03G)QT'OC,NK75_$7AS0] N=+O+6^M+FW:\G* 1(L1Y9'Z-G P%SUYZ4 ;<
MOQ#TE-3N-/CM-4GN+>Y6VE6&T9MK-T)[A3Q@GKGC/.$L?B/H=^X,:WL<&R9V
MN)(,1)Y?W@S9X/?'7D>HJOX7AN['QAXMGNK&YBMKR=)K>4P$B147:W(&>O0'
MKU%8NC>%]5O?A1J^@26\ME?S32RQ+,-H;+AU!/(P<8/UYH [&R\76%SJ?]G7
M$%UI]RUO]IC2]14\R/NP()Z8Y!P1Z4RU\9V%U<V\*VM\@NXY)+*26(*MULY(
M3)SD@Y&X#(YKE=,TJ77;.>T3P-;^';@VLT$UZT,2G<T94",KAL$MDG&, CO6
MAX0O_%36>FZ+?: ]@]@%BNKR5E,<D:# $>#RQ^7GH.><T 7]%\:B\T>^U+4;
M"XLH;>YDA4ML.XB38J##'+YP/3)Z]ZN67C32;IM02=I+&33XQ-<)=;1B,C[X
M*LP([<'KQ7&3Z%K=[X:U/1UT:<SV>KR:A&)S&+>^4S%Q'R3N!5CU& 0,U-<>
M';W7?"^J0:9X1L_#=S)!'M!2)7GE619-N4_@^3&3U+=!B@"W/J\NH_$OPJ38
M:E8J\=V=MRP"3*(\JP56(!&6Z@-R,UZ)7G@GU_6O%OA74Y_#%[:1V2W"71>6
M+"M(BKD?-DJ#WZGG XKT.@#G=0\7064UZL6GWUY!88%Y<6R*R0G&XCE@6(!!
M(4' (J/4/&^FV-SI<*07MY_:<32VKVL.]9 %W8'/4\<=LC.!5"SAUC0;S7[-
M]+GU*VO[F2[LY8V0@F0 -$^XC: >YXP?;%9MCX<U'0]7\"V*VDUS!I4%PMU=
MQX\M6D3&.2#@'VZ$4 ==X<\1VWB6SN)[>"XMY+:=K>>"Y4+)&ZXR" 3ZBK^H
MW\&E:9=:A=,5M[:)I9"!DA5&3@?A7.>#K6]MM6\3M=6,]O'<ZDT\#R 8D0JJ
MY&"?[I/T(K4\5IJS^%M130U#:DT1$ .WDD\_>XSC/6@"I;>,(9KRXLI=-OH+
MN*R%^L#!&:6+./EPQ&<\8.*RK?XHZ5<+IL_]G:I'87\@BCOI( L*N3@*QS^H
MR/R-9.EZ9J]OXU36%\-7%K:7&E/;327-ZLDJMO#%I"223@< 9[=.<4_#,>H^
M(_AGHOAY=&N88G\II+^1X_)6))=^Y<,6+';C&T8)]* .IN_B':VUUJ5M#HNL
M74^G/MN4@@5MBXW;\[L8QVZ^U6;GQWI*66GSVLB3R:A";B"-YDA_=CJ69R .
M2!CKGMP<86DZG?Z?XM\9"ST6ZU O>1!#!)& '\E<!][ A>G(SW_&K+X+UC04
M\/W-EIMGKQL[(V5W92LB;@6+[T9^."2/7'U. #H[3Q]8:II.G7>EVL]U<7\S
MP16N55E=%+.&8G:  ,YR<Y&.M<_X\UJ#Q'\)-7O8X)H)+>Y2%XY"-R2+.B,.
M#@C!/YU>U>V\5W=II3'14FM6ED-YI5O>)#Y<>T+&IDX#KD,6 X.0,$"L*Y\+
M>(Q\//$'AV#PZD;7&H^;:)!=QE/+,JR<;BN% 3 SR21\HY( /7*Y'Q)XFU#2
M_&'AW1[2Q:6*_:9W970&0)&3L&[IR5;.1TP,\UU<3M)"CO$\3,H)C<@LA/8X
M)&1[$BN0\6Z3JTWBOPQK>EV(O1IKW"S0^<L9Q*@4-ENPQVR: +U[XK,']H26
M>EW-];Z:=MU)"RC#!=S*@)^<J",]/09/%;>GW]MJFGP7UG*);:=!)&X[@UQ^
MG6'B#PU+K%I;Z4-4M]0N9+V"59XT6&23[T<@8@E0>=R@D@].U='X9T5?#OAJ
MPTA)/,^RQ!"_]YNI/YDT +K6MKI#642VTMQ<7LX@A1.!NP3EF_A  Z\TSP]X
M@B\007C)!)!-973VD\;D$"1<9VD=1@C!K.\9V>LW:::=,M?MUJEP3?6(N!#Y
M\94@ L?X0>2O?I@U5\!Z+JFAR:W#>:7:6-K<7[W-NMM*&7#*@VJH P!M/)P?
M:@#J-3U&UTC3;C4+V416UNA>1SV K(M/$\KW:1:AI-U8PRVANX[ASO0(.JN1
MPC 8.,D<]:M>*M"7Q+X7U#1VD\LW,6U7/16!!4GVR!6%96'BG6M*DT?Q!:VE
MC:BU>WEFMI_,-R60H"%P-@&=W7)..G- %R/QDHATR]NM/DM],U.18[:Z,@8Y
M<9C+J/NAA[G!(SBG?\)@@L_$DQLSOT(MYL8E'[P*F_(...,]1U%8]KH>OW7A
MG3?"NH6$$5O9M;K/?"<%)8H75E$:CYMQV*#N  R>O%0:EX:\0Q7/C"WTZRLY
MX->B)2YDN"AC/E%"A7')ST.0.<GTH T9_B$%FT:"UT2]NIM6L?MD"1LO VAM
MIY[=S^6:31/$.N:CXXN[*[L$M;5+&"80&;+Q;]QRWR\MQ@@=,=36=8>&]=L-
M=\'W36"2Q:5IGV.Z:.=>&*[<KG&<8!/UXS6V-*UFV^(MSJEO;VTFG7EI%#)*
M\Q#1%"Q/RXY)W<<\?I0!UE<K=>+YH[&_U2UTO[3I=A)(D\PN LC",D2%$Q@@
M$$<LN<''OU5<)9^&]9T?2-3\-V<%M-IMZ\WV:Z,NTVR2YRKIC+$9.,'GOCK0
M!!XEU2ZU+Q)X+%E';S:=>M)=1I+<&,3$0[EWC8V -V1UR?3K79Z3I%EHUM)#
M8VRVZ2RM/(B.67S&Y8C/09[# ]JY>]\'7D=_X0_LS[,;/00ROYTK(\@*!. %
M(SQGKWKMZ ,&^\0S)K<NCZ99)=WL%M]JF$LQB55)PJ@A6)8D'C&..M5T\3W=
MXFG6UGI;1:I>6SW+6M\YA\A%(4EB%)SN88&.1D\52U7P[KUKXT;Q'X=FL&-S
M;+;W=K>EE5MN=K*R@D'IQCM[TO\ PC.LVNN:?X@ANK6\U1;=[6^6<M%')$S[
MP$(#%=K8 R#D=: &3^/V@TN[N/[(=[NQU!+&[M1. 5+,%5T8CY@=PQD+^%2M
MXLUK^WIM"'AQ!J/V874&;X&)HMQ4EVVY4@X& &R3U YJGJGA'5KO3M1FB%B=
M4U'4;>[F#S,L<<<)38@8(2QP@YP/O'TYU1H^J'Q__;QCM!:#2_L803MOW[]^
M<;,8SQU]_:@#*_X6)++X9T/6;32&G&IWBV;0B8!HY"6! R,-]TX.1VJ>W\>2
MVEWK5CK^F"RN]-M?M@6";S5GAZ J2!SG"\]S7,ZCHFK^'/"GAO3VBL/MJ>)H
MY($CE8Q$.9&4$[ 1@DC@'IGVKI]1\&7'B.XU6[UB6*WEN[$6$$=JYD$*!A)O
M+$+N;> <8& />@!+7QAJMSJBZ9_94/GW,+/;3HTK0QN!G9*QC&..XSGI5'0?
M&6HVO@JQU+6A:RW%_<>3:A)7R[M(^=PVDJJ@<;=W K6\/Z=XQBFM8]?U+3WM
M;,84V:OYET=I4&4MP.N<#J<>E8L7@376\*VFF27VGP7NE70N-,N8D=N0[-^\
MSZAL8 /3J: +<_C^\M-.UV>;1P\FF1+/'(CNL-PA.#AF3(8=Q@_6M"W\3:NV
MNZ?876DV]O'J5K+-:O\ :=[!D"G$@"X&0P/!/6J=[X=\4Z]X9U.TUF^TY;RZ
MMQ;Q16OF"",;LEVSRS'CM@8]S5Y?#VI+JOABZ#6FS2;62"<;VRY=44E?E[;
M>>N<<=: &?#[4M5U;P^UYJ;P.SW,X#1[LY$KC&#T P .>E=;7-^$="U'P[9S
M:?<7%K-9K-+) T:,)#O<O\V3@8R1@?G724 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $+VMO+.D[P1-*GW9
M&0%E^A[4]H8I&5GC1BIW*2H.#ZBN5T[5=.L-4\47#ZQJ-VMHT<MU!-$Y6S7#
M<1C&2, DXSP!6L_B73$FTF/S9&&K(7LW6)BK@)OYXX)7G!H UZ:57=NVC/KB
MN9B\?>';N\^PPWDQN&ED@VBVD#*Z+D@C;D'@XR.2IQG%5_#.N:7:^%+*6#5=
M1U>.>X>&">X1WGG?+$C&,X 4]<8 H ZP01"8S")!*1M+[1N(],UQD'A'7(8O
ML,FJZ7<V1+M]HN--WW0WL2>2^TGG[Q4^X-;@\5Z8VE0:A_I(2>=K>*'[.YF>
M5692H0#.05;Z 9KC=/UZ*['CA[_5M7L].AFC19BL@FM 4^;:H4E/FST'I0!Z
M%9:?;6.G6]A#&/L]O"L$8?YCL4;0"3UX%6!$@  11M&!@=*Q(->TVQTO2$2[
MN;YKNW0VN$:2:X0(#YA&,],$DXY/J<5F7WQ!L$;0CIJ27D&JSE%FCC)"A0=R
MXR#OS@8QQWH [&DV*&W;1GUQ7,6EWI[>/KV,:EJ/V[^STDDL9MRV\4>1AP",
M;LGD@GJ?>K$/C/1II;0>9-'#>2F&UN9(66*9^P5B,<X./7'&: -_:-V[ SZT
M;5.?E'/7CK7+WGQ!T"R>^1Y+MVL)#'=".SD8PX&2S?+PO/WCP>V:Z6":.Y@C
MGA</%(H=&'1@1D&@!VU=V=HSZXI2%;&0#]:X/6+UM8^(#:!<)J264>F^:HMB
MT9$K2E/,RI!P .#TY/%:47BS2M)T^%)I[ZYL;9ULY-5E3=&9 =AWOU/S<%@-
MN>] '5%5)!(!(Z'%)L3GY5YZ\=:YC5/B!H>D:A<6,_VU[F!4>1(K1V.UCC<.
M.5'=AQT&<G%=)=7,-E:375Q((X(4:21ST50,D_D* ) JCHH_*LGQ%HLFMV$<
M,%])8W$,Z3Q3(BN R'(#*W##/./4 ]JK6'C#3K^YBM_(O8'GM3>6XE@/[^$=
M60+DYY'RG#<CBLV+XF^'IH[29!?&VN9O)^T?96\N)]Q4!VZ*21G'7!!(% &A
M9^'KZ2>WN-:U5+V6V=I(%@M5A1'*E0^,L20&8#G')X/&-C3]/BTZV\F)I'RQ
M=Y)6W/(QZLQ[G_  <"J-KXCL[KQ'=:$L5PE[;1^;()$ 4H<88'/(.>W3'.*M
MZ5J<6KV"WD,4L<;.Z 2@ G:Q4D8)&,@X/<<T 72,C!HP/2L35O$]KI5Q/;_9
M;R\FM[?[3.EJBL8XR2 2"1G.T\#)XZ4EOXJL;K75T>.*X%V]@-0CRJ[7B) X
M.>#DXP<=* -RC-<[;^,]-N=*2^2*Z#2736<=L8P97F4D%0 2.Q.<X !)(%<]
MXSU^SU7P9JLL$EW:W6EW<$=Q$7:-HR94!#;&VNI4GN1^(H ]#HK"TGQ59:MJ
MTFFQVU];7"P"X07<!B\V,G&Y0><9QU QFM'5=4M=&TV:_O7*01 %B!DDDX
M[DD@ >] %RBN83QSIXDOH+BTO+>ZL[?[4UNRH[O#G&]2C%2/49R*HO\ $_1$
MLS>-::LMIB)A<&R81L)#@$,>#@\'W'&: .UHKFH?&EK<Q1"WTS5'O)I)4BLG
MM_*E<1XR_P Y 5<,O+$=0.O%-G\=Z3:Z#>:M<1W4:6,XM[N QCS8') PPSC'
M(Y!(.>,T =/167HNMQZW'<O'97ML()?+_P!+@,?F# (9<]5(-7;R W5C<6ZR
MM$TL;()%ZH2,9'TH GHKS77-(MM.\?>"M-@DNA:W*W:7"-=2'SMD0*ELMR02
M3FHO$MM'X8\7>#EAEOIH'O+I_*#O*QR@P@!))Y/&>F>P% 'I]%<S:^.-,FTW
M4;NYBN+)].G%O<V\X4R+(<!0-K$')( .<5/I7BVSU/7)]%>WGM-0BA$XBE*,
M'C.!N5D9@<$X(SF@#?HK&\1>);3PS;VUQ>PW+Q3SI &@CW[68X&1G/Y GBLV
MU\?:;)+JL5]:WVFS:;!]IEBO(@K/%C[Z $Y'0>N2!0!U=0W<)N;.>W6:2$RQ
ML@EB.&3(QN4^HZBL/3_%]O?WGV(V%W!=O9+?PP2&/=-$3CY<.1G/8XKG+WXH
M&;PW<ZGHWA_5)HTMFF%S/&L<"8;:06).2.N #G\\ '7:!H2:%:/&;RZOKF5M
MTUU=R;Y)". ">P X ']36O7&:K>V-R_A:;6=-ODN9;U/LK)(NU)BI(+[7Y!
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M323>1?V@\9D6W!R^T=R.P^M>?ZAXDE\5?"6XU">*..9;^"!Q&"$8K=1C(!Y
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M7##!Q[\U-<3"VMI9V21Q&I8K&A9C@= !R3[53T'6K;Q%HEMJUFLBV]R"R"4
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M@:E>_;&N%LR#&2ZN0!YGJHP<\<]:[DW$*W*6QE43NC2+'GDJ" 3CT!8?G4M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#H=7O-&FU;3]#U.U6YFO-\D$<EOYD?R#)))&!^/^%;$44<,2Q1(L<:#"HHP
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M3G.,+CI[\ 'HE%>;W-WXPU+Q18Z3;:_;::UQHPNYC%:I<+'*KJK;"2,Y)[G
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MPBCCA\+ZA%" (DU6X5 #GY01CFKNI+CXL:+@MA],N0PW'!PR8XZ=S0!V5!(
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MM/\ 9XEB$K*%+!1@9 XZ8K%E\'DW&I?9]8O;:SU.4S7=LBH=S%0K;7*[ER%
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MG78M;S4;>&?Y<HS<KN.%+?W03TSB@ LO#NC:=="YL],M8)E78CI& 47^ZO\
M='/08%2/H>D/=SW;Z79-<SKLFF-NA>1<8PS8R1CCFLB6]OH_B1:6/VMS8S:9
M+,;?:N ZR1@-G&>C'O5V+Q7H4^JKID6I0M=LQ1$&<.PSE5;&"1@Y /% %BVT
M#1;)X'M=(L(&@+&%HK9%,9;AMN!QGOCK3HM#TB"UN+6'2[&.WN23/$EN@24G
MKN &&_&L:QU:SM-1\17EWXH@NK.W>/? 0JK8<$;2PZDG\<C'6K,?C;PU)<O;
MKK-KYL<)G8%L80#).>F0.HZCTH U[+3[+3+86UA:6]I "2(H(Q&H)ZG &*L5
MGZ-KNF>(;$WFE7B75N'*%E!&&'4$'!!Y'7UK0H **** "BBB@ HHHH ****
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M_P!(2!H#(\KN70YSOR?F/)&3GCBHQX"\.#06T7[ 39&02A3,Y96'0AL[ACL
M>.?6@#E-?1;J^^(]O([R0PZ1%,D9D;:C^5*<@9XY _*DU02V*^#-$TZYM[6&
M_A>5Q=RR[)I%CC"JQ5P3G<2!G!(%=G9^#/#UA)<O;Z;&INH?(FRS-YB$$$')
MYSDY/4YIC^!O#4NC)I$FE1O8I)YJQL[DJ^,9#9W= !UZ#% #/!UI>Z;9WUA?
MZG'?3PW18"/>5MT95819<DG&2>22 P]JH1B+Q)XTU_3=427R=-CMQ:Q!V0$2
M*6:48(R=PP#SMV\8R:Z?3-+LM&L([#3K9+>VCSMC7/?KR>2?<U!J.@:;JMQ%
M<W4+^?$A1)8IGB?:<$KN0@D<#@T >8ZE+<ZO\(9;C5"\\]I?K:PW#-\TL:W*
M)N..IX(R?3/>O6[6UAL[=8(%VQKG W$]>>IK/O\ PUI&J:7!IMU:;K*#;Y<"
M2/&HV]/ND9Q[UIQ1K#$L:%BJC W,6/XD\F@#SW!.K?$S#R(PBA8-&Y1@1:Y!
M!!!%9R6?VYOAG%)=7J)>6#K<"*Y=!)BUW9.#PQ);+#YN>O3'>)X4T:.74I%M
M9 ^IC;>'[1)^]'O\W'IQC XZ4R'PAH<#Z8T=FX;3,_8R;B0^2#U RW3M@]N.
ME 'GB^'+271?&MH]SJ!M]&FF>PC^V28@;R5<'K\V#TW9QSW))Z.:26XUGX?7
M<LTS2W"2"7,C;7S:LV2N=N<]\9K?'@W0EBU",6DFS43F['VF7]Z<]_F_EVXZ
M4]?"6B*E@@LVQIX(M/W\F8LG)P=WX?3CIQ0!Q.EVVBZ+I/CJZRMB\-]/"+BW
M0-/%&8H\!._4G';/TI_A^U">.&TZZL[.&RN=##26JS"83$2H%>48V%R&/(SG
M/4UVLWA30;G4+R_FTNWDNKV+R;B1ADNF,8]!Q@9'-0V/@OPWIES:7%GI%O%-
M:*5@< DJ"<GJ>3[GF@#SO[+;6W[/]O<6H\BX,<$CO Y1G)F"_-M(W#!88.1^
M5=>8[/6_B%J^EZO$LR6UC"UI;R<H4?=YD@'][.U<]1CC&:U4\%^'$LKFR72+
M<6US+YTT0!VNV<C(ST!)P.@["K5]X;TC4X[9+NQ23[, L+[F5T [;@0<>V<&
M@#S)ENKSP_X8AN[V\8Q^)FLHK@3LKR6X,@'S \_= W=>.M::6"VFH^.M"L;S
M[#:M#9_9Q+(QCBEE5E//4!B%!^M=Y<>'M(NA9":PA86)#6H P(2,8*@=.@J*
M;PIH5Q+?23:9!(]^ +HL"?- ((W?0@8^E &%X*80:QJME=:.FE:HD,!GBMW#
M6TJ@N%ECQTSSD'G@=\T>-=/U"]U33IK"VT_5/LT<CRZ/>L )@2H$B9X#J>,G
MIN]ZZ72M#TW1$E33K58/-;=(<EF8]LDDGCL.U-U+0-*U>>&>_LHYYH05C=L@
MJ#U (]<4 >=VD.D:[=>!;>V%TMBT%\3!+*1)P5!1B.J[@P]"!W%-C^Q:9X:U
M?2&DGCM$\2?8[.V23"N"(W$+,W2,Y;.>WKT/HA\.:.;^UOO[/A%S:H(X) ,&
M-1T QT%5T\'>'4MKNV&DVQANV#7"%<B1@<@G/?WH XG0&$-Q\0;3-C$JPHRP
M6+?N4)@8ML''?J<#FETZ9IO!OPU=\ B^@3CT$,JC^0KN8_"N@Q>=Y6DVD?G0
MB"0I&%W1@8"\=L4Q_!_AZ2SM;-]*@-O:.7@C(.(V/4CGVH MZ]<PV?A[4KFY
MEEB@BMI'DDA^^JA3DK[^GO7FOAY;:S\<:+&1IEM#<:1)$\-O,&>1<IL,Q&%9
MFW$\#J3R>*]8DC26-HY$5T8%65AD$'J"*R(?#6BZ9% ]CHMH)+0.UNJ1JI5F
MQG!/0G Y]J /)K30]-E^#Z:U$9#KEO._V2?S6+QRBX(6-!G@'/3U8FNAM?#6
MD:_XV\8VVLQ[HUBM',7FE%5FB):3 .-P.3GMD^M;?@3PBNCZ/;+JNDVB:G;2
M2;9T(<L&=F#9QP0&V^N!UYI+7PG]M\;:[J.M:-:7%G=M UJ\I60J8T*'*XX#
M=<>W- '+V;7KZ)\.S?RO-(-581RR=7B <1M^*[36AJ5F_ASQ;J6D66GK]D\5
M0[;<PQ#]U/C;+G_9V$R'Z'%>AW.E:=>M"UU86LY@_P!2985;R_\ =R..@Z>E
M8VE:;K\^M?VAXBETUA:^8ME%8HXP&P"[EC][:,8'')H W;2QM;&PBL;:!([6
M)!&D2K\H7&,8KR99;?2O#?CIM/C2&]36)E(M0JSK:@P^9LQR %+>PZU[#5:'
M3K&WN9KF"SMXKB?_ %TJ1*K2?[Q R?QH XV\LM.M_%'A.\\.BW@:Y:19%MD"
MI/:^66+-CKAMF,]VI_Q=B\SX9ZJ1"DC1^6PW#[G[Q06'O@G\ZZRTTC3=/E>6
MRT^TMI'&&>&%4+?4@<UD>.=&OO$/A&^TC3Q;B>Z"INGD**H# YX4D].E '+Z
MEH&GZ?XUT5M"@@"W%E<_VD ^X36^T /)S\Q+'[QZGKFN=T+2[2V^!?\ ;EG:
M@:I]EEBEN(^9/)-Q^\7KC[B_ASCJ<^O6&DZ?8V[);Z99VGFKB6.")0K>QP!D
M?458M[*UM%=;:VAA5SEA%&%#'&,G'7B@#S"-M*N6;4_"FM37NK?V1,EO;VR1
M(D2A,KYJHHPP) 4-W[<&K?A#4O"6IVGA>6TVR:W;1F+R8"5E1RF)FE4$97()
MW-U)&,D\^AVMA:60<6EK!;^8VY_*C";CZG'4TD&GV=M/+/!:0132G,DD<85G
M^I YH \CU6..Z^&7CJ/!<+XAF=]@W%5%Q&6;CT7)^F:V=6UC3[CXA02Z3>V\
M]XFAW2VAC<,'GRI101PQQDXKT2.PLXDE2.T@191B0+& ''OZ]32Q65K 5,-M
M#&5!"[(P, G) Q0!XM<ZEH=U\-/#A$UI_:D.HV_VD2%1.LHD_>LV?FR2<DGK
MFIYGTJ]\0>+=/\4Z_+8"2Z\U(5CB_P!(ML Q['9&<G_94]^!UKV#^S[+S&D^
MR6_F,P9F\M<DYSDG'7-/DM+>69)I((GE3[CL@++]#VH 9IXVZ9:C9*F(4^28
M@NO X8CC/K7BUOK.FRV_A*]BOK2W@&MF06[MNG@5VD+--*3QD_PX QCEL9KW
M*H%LK1,[;6%<OYAQ&!\W][Z^] 'G7@W2])O?'7C&2:UMIIK?4HI8"5!,9 )W
M+Z'/4CKWKGX[#1M1^%%T4M;?^W7NY_LJ1JOVI)OM#%%7'S#CMV&37LL5E:P2
MO+#;0QR/]YTC +=^2.M*+2V6Y-PMO$)V&#*$&XCZ]: .&ME0?%2[M[AH6NI?
M#T7FJ,9D<2-GCOQC\,5P]K=:/>?##PC971MT>#68([V(X!0>9(#N]"5&2.N"
M/45[C]DMOM/VG[/%]HZ>;L&[ICKUZ4JVMNA)6")26+$A ,D]3]30!YUXAET?
M1/%ME8VD=GI#M8SRB[>(LC!V&Y(HQ\K2$J,]\= <C'/Z#JMA;^'_ (>7$UW%
M'!974T=U*[82%C&^ S'@'D?G7L[0Q.Z.T:LT9RA*@E3TX]*0V\)0(8HR@;=M
M*C&<YS]<\T >8WLTEW\4M7.CRQB]G\,'[-N^4F0OE<@X(.,'FH9IK'5/AYX<
MTW32JZ[;W%JB6RC;-#,C 3,R]5& Y+=^N>:]6V+NW;1N]<<TH50VX 9]<4 >
M6H^B7/B/XD3.;"0QVT:AVV':! 5?!/;<,'WKL? 4R3> -!:.19 +&)25;/(4
M CZ@@BN@\M.?D7GKQUI0H48  'M0!YM:7EE;6'C32O$ 5+F>]N9%AD^_=0NH
M$1C Y?@!1CD$#O2/,=*'P\MM9O8H[VWRUSYT@#(/L[KELGU(7)ZGZUZ45!()
M )'0T%%/50>W(H K7\HBTRYF$33A86;RX_O284G QW->-Z/KFG-KG@2YCN9!
M;0"Y0VT5K(8[0M"0(@Y!9V!X/S'UP!7MV*0(HQ@#CIQ0!X\7L$^'^H748A!?
MQ)YI=5&YE%T&!]3\G/T]JZ3Q7;ZGIOB6PU[0$CD.HQ?V=<@-P2W,,OOM.<GT
MKOL5@6OA^]'B.;4]0UF:]MD<O8V;1(BVQ(()R!EC@D#/0$]2<T :UA9Q:?I]
MO90 B*WC6),]< 8YKSN/5M/TO5O$OA_Q'IMQ/)J-\;BV3[.TJWD;A0B @'!!
M7'. /7BO3:* .&GOA%\2-(,R)'<_V-,C6Z.&VR%HV$>?7"MCUQ7"#5(I4\)7
M48NXK>SU3=-80V4C)8@EOEW;2SL>>Y]E'%>Z8HQ0!Y?>:A"VH_$Z$R1@/81F
M,EL%V^SE"!ZD-M7'JP%.$^DM=_#?:L @59,*8L!"8=HXQQ^\P/J/:O3J* .,
M\'[!XN\8[5*J][&Z_*0&Q&%8CU^8,#[BNSHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?1M<;5;_ %:T
M>U,#Z=<" GS-V_**X/3CAAQ6Q7E=WILMU>_$.\:^NH8[0^;;I;3M%B9;96WL
M5QGHN 3CKQ4EGK&H>(9O#.GW5W&#>:)]K8/*\0FFRH/W""2!DXZ=3C@8 /4*
M*\IN;'4+5?#>E7'B2ZNY!J[V<TUM/(A\ORRWEMR<L.F[J/J*L+IUS=>(M0\+
M)JDK"PL(EM?MEU+YCA]Q:7Y"NX@E5SV '3)H ].HKSK2'N4\9^'H9]7;46DT
MFX6:X1BJ7#)(H#;<XR!D9ZFN:L;B^N?"^FJNJ7\3MXM^R++'<-N$18_+R2"!
M@8R#^IH ]JK#U;7I=,\0Z)I@M%DBU.22/SO-P8RB%_NXYSCUKA[Z^O/"=YXX
M&F7%U*MKI]O<0)<3M-Y4C;@S@N2?]HCIQ5FZTW3;7Q7X$O=/N'G%S+,S3F8M
M]HS <.<G[Q]?>@#TNBO(-.BF\3:3>:[/XBATO4;.^E:>7R7>6U"R';%_K0"A
M7 QMYSW/-:D&FMKOQ-\1V-SJ.I);V8L[F!(;EE"2;<D@'.!UXZ<GVP >ET55
MU!=^FW2Y9<PN,HQ4C@]".0?<5Y-;Q2VG@SP3X@-]>S:E+?VT+RRW+D&-V(9-
MN<8Z=L\<F@#V.JT^H6UO>VMG+,JW%T6$,?=MH+'\ !UKA])BB\5W/BPZL\D=
MW9W\EM;GS"IM(E1=DB8(VDG<V>^/2L.QL%\0:SX#U?7(1)=7MA<?: V0'V("
MC\'C(.?QH ]<;<%)4 MC@$X&:QO"^M3>(-&^WSVR6[&>:(1I(7 "2,F<D#NI
M[5LUXG#I,,GPVUO7/M=W#J-A>W36<J7+*(2)<[54''S$G.02<_2@#VVBO-5T
M3_A(?&5U::M+>0B?0[6:XAAN&0"8NP)&#QC;TZ>H-5],CA\0>"_$>JWIE36+
M:XNAY@D(ELVBR416[  +QT.3G.30!ZE17G'A^]NKCQUHEQJ:^3=W?ADO,IP-
M\GF(<D=,XR?:L&VN)U\ :N;&["Q#Q,\:Q(X!GA\Q1Y,9SW'0#J 1TH ]<N[A
MX]/GGM1'+(D;,@9\*Q Z$@''Y55\.ZJVN>'-/U5HA"UW LQC#9"Y&<9[UR.D
M:+'_ ,))JVK65K)9:4+$1Q6V=BF<AM[B,' ^7 Z<D_C7-Q6T>D>"_ .L6C2_
M;I;ZS@>5Y6.8W5@4QG 7V_\ KT >LVVJ6EY?WEE;RB2:S*";:00I8$@?7 Z>
MXJY7G_@[3].M/'7B[R[6&*1+R(0Y0*PW1;FV^QY/OUKJ_$FC1Z_X?O--?Y6E
MB812=XWQ\K ^QH U:S-:N=3@L"^C06MQ=+(@=+B78H0GYCD=P.?\XKRN+7+J
M6RT+Q0]N85\.[+/6"Z'<[,?*D&.Y0!6_X'QT-7_&]HJ_"V]U0H8[G4;Z*\<@
M;&P\@"*<>D>T8/?- 'HTFMV2ZU_8ZSH;\VYG$98  9"C/<9)XX[&J7A+7Y/$
M&@17]U'#!-)--$(T;(^21EXSR>!7,?V3I/\ PN^>6:SMBYTI+E3)$O$PFP'4
MG^+ '/6N7ATFTB^'-MKBH_\ :4.L_N9S(<Q W>TA1G !&<^N30!Z]'+J?]NS
M12Q6@TWR0T3K(?.+YY!7&-OOGTJZ)HBRJ)$W-G W#)QUKSVX17^+NM1MDH_A
MSYE)XYD /Z 5S&AZ39P_#GPCKL:%=4&J0#[26)<JUP49,GHI!/ X_,T >V5R
MNN^+HX/#6N:CH\EM<SZ9N5@[Y0LJJ3C:><;L=N0174D!@00"#P0>]>.K:Z=;
M^ _B$MO!:QW"7]]&HC10ZQ KA1CD*...E 'KT,R2*HWKYFT,R@\C/M3O.B\W
MRO,3S/[FX9_*O+7M4T7QAX&GTR(BZU&RNA=N7)>Z(A5U#L>3\W.3TK$\-6>G
MZO9Z/J5YXJ$6LQ7JO););1K=M.7*E&/WV!R>O '7 % 'N%1"ZMVN6MA/$9U&
MYH@XW >N.M/=@B,[=%&37C.DW>G)>>$M0M[JS1)=0G?SI95:\EC*2EGF<8P.
M@VD''&3VH ]E::)/OR(O..6 Y]*;+<009\V:./"ESO8#Y1C)Y[<C\Z\E@T'1
M=0L_'K:C&NRRO9FMR9"!;$1@AD&<*<@<CK@"IM)TNTU;Q3H$'B*(2W%QX;1Y
MH;@X,\H=?OC^(@#//IGM0!W'B;6[G3-/T^[L'MY([B^MX'+ L"DDBJ2I!'8G
MUJXDNJ?\)/)$TME_9?V4,D8)^T&7=@DCILQ^IKS6VMGL/"4MJDCOID'BN%-/
M9N@A$Z< GJH;<,^QK?OUEM_B9K4FG1J+UO#7F1X4?/+YKA2?4\** .YCO;66
MY>VCN87N(_OQ+("R_4=12+?6;79M%NH#<@9,(D&\#_=ZUYQX0O\ PE?:/X;N
M;55EUN)EC:*&3%QYK8$SR8(++]YR6X('T%8$NIZ:8_#NI07EG!;MXA\W]_(&
MNRI=_,>1^-J_[.#P5R: /1=#\22SZMKMGJUS9Q"RO5M[=A^[W@H&Q\S')Y[5
M-JFMWECXVT'25-O]CU*.X+94^8&C4$8.<<[AV[&N+72_#>K7OCVZUJ*WECBE
M#B=L,\2&!2&3G@Y],9P!3+87JZU\*1J1?[7]GN_,\P_-_J5QGWQB@#U+[=:"
M[^R&Z@%R1GR?,&_'^[UJQ7B6EC2]5TZ:WUS7KFSUZ#4I)7LX(XEN6G#G;Y9*
M;VR"H')&..@KVP=* .5T_6-5OM:\6Z<TULK:>8DLWV;54O%O!?DYP2,_3I6O
MI=XT6E6 U34+*6]DC&^2%P$E8#DIGJ.M<63%)JWQ.C<HW[B(E3@\?9?2N=M[
M2TN['X5QW$,4J2"1'5U!#+L'RGU&>U 'KDFM:5%:?:Y-3LDMM^SSFG4)N]-V
M<9]JJZI)J/\ :^DI87]C# TC&Z@GYDF3;QY?N,$__JQ7G>E:-HLNJ?$.&XL;
M0V]LV8HV0!(<Q$L5'13D#D<\5>L9+<M\+[R9XO/>W*-,Y&YLVC8!;K]X]/4T
M =GI?BO2=8U6_P!/L[R&62S*JS+("&)&3M]<=S5N'7='N8[B2#5;&5+89G:.
MX1A$/5B#Q^->7P7NE:7>?$>"]3]Z79TMH6"3/$8\$IW Y'.,#K4F@ZE9R_$+
M1S'J>DRVLND&W:.U7"'YUVP@DDNPX]#@9P.E '83>)X]=\*3W_A_6=.LY1(5
M6>[8%$42%<L.VX*2,^M=!=ZG8Z8D9U"^M;;?PK32K&&/?&37D,USIC_!"]MH
MWMFO+><-,HQNC)O#MW>AQG'MFNUCOK>'XE7\>J"(1W6GQ?V?-*?D>-=QE4$\
M9R03[ 4 =9)J-C"L#2WMNBSD"$M*H$A/3;SS^%)8ZG8:FCO87MM=I&VQV@E6
M0*WH<'@UX^EI /#GAJ*\6 V,OBIOL2R8P;0^9@#/\!_+!%=AX5CLK/XD^+[2
MS6"&,163"&'"@'8^XA1T[9_"@#L[J\M;&+S;NYAMX\XWRN$&?J:BM-7TV_N9
MK:SU"TN)X"1+%#,KM&0<?, <CGUKEOBRL/\ PKK4))U&V.6W;=CE?W\8)'<<
M9Z5AZOIUG)XPTJ7P;]D2X&E7AF:SQ@(8P(2VWJ2YXSZ9[4 >A0ZWI-S=/:P:
MI92W" LT27"LZ@=20#D8[U$=>TF=3#;:SI_GNC^7BX1CE1ECC/.WJ?2O,O#$
MWA_5QX<C6_U6XUG3V5#IH5(_LQX$Q?$8^0<YR>>G4UH?"VQT.;1-1OWM["2[
M@O[D^>RH7C0Y'WNH4@GVP30!VF@WQM_"L%WJ^O6-^R;O.U&-D2%OG(ZCY1CA
M?J*TK#5+#5;<SV%Y!<Q X9HI VT^AQT/L:\:\*W#1> O UW(ROI%EJ,YU+&&
M$+%W\MI!V +!LGIE36UXCBN-1U#Q5J7A2X\Z-]&2*9K1MRR7'F9^4KU<1!AP
M<C</6@#>U7Q>LGC+P[8:/K%K/;7-Q)%>0P[)"0$+ [N<#/IZ=:[BO+KCQ!X;
MU;5_ [Z5+"S0W6SY(ROD*87'EMQA3G&%]N*]#T_5[+5);V*TE+O93FWG!4C:
MX )'(YZCI0!B>/+S6M*T!]3T6Y59X'C7[,\*N)R\BJ!D\C[W:H5\6?VU\/\
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M+(,.X4 M]3WI1#$H(6- #P<*.:Y>+XC>&9I;=!?.JW$)EBE>!PCX7<55L8+
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M>5('V^F<&K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M -/;R7VNRPN"=X&%P3C)(YJ";RM<\"^'M$M8Y8]9M)[13"8RLEJ\1 D=AV
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MD%2,@CH10!P,EKJ#^)O&LJZ7>&*\T^.&V?8 )G174A23ZN,9QT-,33-730?
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MB^&-$\/-,VD:;!:-, )#&.6QG'\S6M110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 <!I_C&#3?&7BNVUW6
M5BL[66V2U6X*KMW(S,%P.>WKTKK;[7]*TVQ@O;F]C6WGP870&3S 1D%0H)(Q
MSD=JXF%[!_%WQ!ED\@DVD"*[@<@1,K@$]1NV@^^*YR.6*ST_P;J.IRZI'I/]
MD_8Y)].FD1H)LJ2'\OYL$+C'JO3B@#M?&&O3#2= U+0]4(MKK5+>%VA"LLT;
MMR,D$CIVQWS6W>^,/#NG-.MWK%I$T$@BE!DR4<@D*<=^#7GFJP:=8^$]*.G0
M7%O82>(X+F)[J1S)*@(WRL'&Y1D'KVY.,ULPWVA6?Q&\6/JP@5GM[8+)-%N#
M1^7\R XQD\?+U..AQ0!Z#!/%=6\=Q!(LD,JAT=#D,I&00:Y[3?&>G:GXJU#1
M(68/:+& [(P\QVWE@..@"KSWR?2F?#O3KK2O NF6EXDD<JJ[B.0Y:-&=F53Z
M$*0,=JYV]>?_ (3+QOIEN)DO]4T^W2Q(B8JS"&0$EL84 D#)[F@#LK7Q3HE[
M?)9V^H1M-(6$60P64KU",1M?'?:36Q7F+SQZWX8\+:/:0/!J]G=VOFVYB(:S
M\G'F,<CY1@$ G[V<#.:]%U"&2XTR[AA.)9(71#G&&*D#F@#/B\5Z+/>1VL=X
M3++O\G]RX68J,L$8KAR/1233(?%^AW&G27\-V[V\=R+1RMO+N$QP FS;NSE@
M.G>O._"@TR]CT33;K0=9.O:5)$KK=W-P8+8QD!I02^P#"DA0,$X&,<U/>2M:
M>*4\;6MA--I\UV+6:R6"3S/E7 N?+Q]\?,!Q]TCN30!Z)J?B/2M'8B^NC'M0
M2.1$[B-2<!G*@[!GNV.A]*JZGXV\-Z--Y5_JT$+F$3@89LH<8(P#GJ*X'4GL
M;+QEKDGB&TUJZTS6HX6LY+)IU25/+VM$Z1L,GMAATSTS6I:V-K;^-_#=LVF-
M!:1Z1-"L#HTJP%R"L;,<@-MR.3[=QD ["^\5Z)IL:R75[LC,:2F01.RHKG"%
MR 0@)Z;L55-Q;-X]BC&OR><;$D:4HRA&[/FD^O;FN1AU2'PWKGB+1->T6ZO(
M-3O#<V8CM#/'<(54"/T^7:!@\"KKK<CXJZ7/<V13;H+1RK"A,22;BQC#8QT!
MQ0!UEEXHTC4;N&VM;EY'G#F%O(D5)0G#%7*[6Q[&F6_B[1;F_BLX[L[YV9()
M&B=8IV7JL<A&UR,=B:\^T:*<7D>E>&I[N?3+BUN";6^MV632)&C.W;(P!P68
M+MR>YYY--\(:=IQ.D65QX6UA-?TZ6-9'N))_L\13 :4$OLQ@'  Y)&!B@#UU
MF5$+NP55&22< "L6S\6Z-?7T-I%<2*]P";9I8'C2X &3Y;L 'XYX-+XNTZ[U
M;PEJNGV+!;JXMGCCR<9)'3/;/3\:Y*\N%\7:1X>TVWL[B'4[6\MI[F-X'C^Q
M^7]\DD >H SSD4 =(?'?AH7PLCJ:"Y-P+41^6^3(<8'3W'/3WK8U35+/1M.F
MU"_F$-K"NZ20J3@?0<URGA.2WD\8^+,VT@DENXY8Y7MV42(L:KPQ&#AMWYY[
MUL^-O^1#\0_]@VX_]%M0!!8^//#FI:I!IMKJ&^ZN$W0J8G"R8!)"L1@D <C/
MMUI;+QWX<U#4HM/M=0\RYED>)5\IQ\R D@DCCH<9ZX-<M;&U\26/@FWTZUN#
M/I\D%Q),]M)&D$:)\P+$ '<0  ,YZ].:7PS:2:IX6\7Z;:QRVE]<W]X\4DUL
MR;EER$8%AR"./4?E0!V%IXLTB]N+:**>4+=$BVFD@=(YR!G".P 8X!^N.,TZ
M;Q1ID-Z+;=<.?M*VAEC@=HUE8@!2X& <D#V/'6N.N'F\4>&M#T=-.NK35K2Z
MMGGCDMWC2V\DC>P?&TC .W!.=P]#BNZ2P>+7F\-G48KBXU79J&FW5LS6TBJY
MW3HY7:IP-V0W7 ] 0#MKGQ?HUG</'/<2+''.+:2X\E_)CE/\+28V@\@=< G!
MI^J^*=*T>6:.ZFD+01":?RH6D$,9. SE0=HX/7T/I7GEE;"TFU'PUJWA*\U&
M[DNYY+2X*%K:X5W9U:1LX7!//4CZUIB^O_"?B_7$U#0[[4[36GCFMYK*#S06
M"!&C?)X P,9XQ0!V5OXFTJ[U>/2X+@R7,MH+V+:AVR0G&&5NAZU@ZE\1+./3
M=.N]*M[B\6]U)+#/D,-AW?/D=<X#8'<CVK.NUU#2?B#H^MW>DW#PRZ-]B:/3
MX3((I]^[9QT7' 8X'':N:@TC68O!.F%]&U!9+/Q0M]+$("9##N;+*HY/4=N]
M 'IU]XMT[3P_FQWCM#$)[A8K9V-O&02&DP/EZ'CKQTK8M;J"]M(;JVE66"9!
M)'(IX92,@C\*\OO]/$/C?4-1U?PA?:K8:Q' ]NT$/F/;LL81DD&["YZY)Q^N
M/2-(MOL>D6MO]EAM!'& +>'[L0_NCUQZ]Z .77Q8=;O?$^E1V]Y;+I\7EI,J
M,C!]C,6+ _+T7;_]?%1^$/&NF2:/X;TVXNIY+RZLXT%PZ,8Y)@@+)YAX+^HS
MUXZ\50M8[[2?%'C9)]*U"2+40LL$\-NSQE1$PZCJ<D#:,GGI@$U7=+E/"?P_
M3^S-2\RQN[=KJ,6,I:(1QLCE@%R!DCZ]1F@#L[[Q;IFG22^?]H^SPS+!/=+"
M3#%(2 %9OJ0">@)P2*W&.%)P3@=!7E%AITVE7FJ:'J7@H:O<2W,DUCJ+6:2P
MRB1BP\YV^[M/7G/MTSZI%'Y4*1X0;5"X1=J\>@[#VH \WM[Y/$6H>(Y=0O\
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M+Q3HLJ0^$K/3[*XG@TW4H)I/)'W(D5EW'IGDC(ZGFJOV'4?-\?O_ &;=XU%
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MH5Y4'."3GZ ]*N>%HO%AFMH=:TO3]/BLU*R3V\BNUX=N%P,?(O.3SDD#H,T
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M418I9C]\3&=H"[MVW/09QCV]ZQ?$%MJ]QK.BZ?I4-G)J>G::7G07;02)NVH
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M!F@#I))8X0#)(J D*"QQDGH*?7FNH-<:_P#$RYTC4_#PN["*Q"*LDZ$1H\C
MS@9X) &,?,,=JZ[5M1@\&^$VNA;W-U;6$*KM5PS[0, DL1GMD\F@#=HKD'\>
M11;Q<:5>69DF2*S-YMA6Y#*6+@M]U0!DYY&0,9XIMK\0K"YTO4KI;69YM/N4
MMI(8760.[MA=C@X(.>O&,&@#L.@R32(RR(KHP96&0RG((KD-2UF/6]$\5Z5=
M6/E7&GVA\U2XD1MT;,I!'IM[@<BK7PZ_Y)WH/_7HE '3XHKB[[QW=PZAJUC8
M^&;^]FTME^T;98U&QEW;@<G)(.0HY]<4V;XBQNND?V;HUW?MJUJ\]H(W0;F0
M LAYX(SR3QZ9Z4 =M17,1^*+^\=X=/T*26YM[>.6[BFN%B,3.,B('!W/CGL.
M1DBJK?$*TDMM'N++3;RZCU4R)$$VAEE16)C9<Y#97&?NCJ3B@#L:*X^V\>Q)
M;ZJ-7TZ73+[3=ADM9)48.)#B,J_"D$\=@.]0?\+%BC?4H9;&.6:SLS>I]BNU
MGCEC7[PWX 5Q@DJ>W3- ';T5YAXB^(.O#P;-JEEX?FL(9HH&ANY[A<XD.,JH
M!Y!Z9QP0?:NI_P"$HN[;Q+INBZEI26[W\3/'.ESYD>Y02R9*@[OYYH Z:BL_
M2M1?4A=OY*)##</!%(LF[S0O!;H,?-D8YZ'FL;Q!XODT6?4%333+#I]H+J>:
M:4PHP.<)&=I#/\IXX],T =317(W7C6==7TW3;+0Y[N74;+[7"WG*BJ..'Z[0
M,\GZ  YHM?' NO#Z7HTR5=0>];3UL#*I)N%)!7?TV@ DMCH#Q0!U(NK<W1M1
M/$;@+O,6\;PN<9QUQGO4M><Z)+='XV:JMWIUM:2OHZ,3#)YGF8D4!MVU3WP0
M1_ .V*Z[7=>3138PK"9[N_N!;VT6_:"Q!)+'G"@#D@$^QH 9J?A>TU/54U/[
M5?6EXL/D&2TN#'N0$D!AT."Q_.KFF:5:Z3%(L'F,\K;Y9II"\DC>K,>?PZ#M
M6/)XJNK6VO!?:/+!=Q74=I!&)"8[IY" ICD*C(YY..,&I+7Q#/\ \)#'H&LV
M$5M=7-NT]N\,WFQ2J#AER54A@,<8P10!LKJ=@UL;E;VV, 8IYHE7;N!P1G.,
MY[5:KQBXCMX?@G?L\<:Q0:LQ7Y>$ O ./3C(X[5W6N^,7L-1N=/TZV@N+BTA
M6:<32.H^8$JB[4;+$#/.!R.N> #K:*Y*S\92ZP]A:Z7I^V^N;1KN6&]<Q?9T
M5MF& !));@<#@9^N1K?BGQ(;[PI#;:=%82:C.XFM[J8AMR Y4E5/R'@@]3QP
M* .^2\MI+N2T2XA:YB4-)"'!= >A(Z@&IJXR'7+.V\>:S#<Z5:VTUKIJW5QJ
M$;;GD08X/R@X&/?H*?-XQO;"QTG5=1TR.+2]1DCC+1SEY+;S/N,XV@$>N#QG
MO0!V%%<+>>-=;CG\11VN@6\HT1@TKM>;0Z;-_'R9W8[8Q[FNOTN^75-(LM01
M"B74"3JI.2H90V/UH MU2OI=-L2NH7S6T+1@HL\VT%0?X0QYYQT'6N=G\6ZA
M)I^JZIINF175AILTD3*9B)9O+_UA0!2..< GG':L_6;^]U'Q3X+N[ 6S6ESY
MT]OYKL"<VY/S #C@G% '<6=Y;7]LES9W$5Q _P!V6)PRM]"*GK+EA@\/Z)=R
M:786Z+$KS^0I\I&;JW(!P3]*Y:U\>:C_ ,(_#K>HZ/#:65W%#]C/VDNTDLC!
M=I4+G'5N 3M'3/% '>T5P'_">:I#I^LW$NC>:EC:FZ@NECFA@G /S(2Z9# ?
M7/M5ZU\5ZN^OZ197FEV]O;ZO;22VI$Y>1&1 Q$@QC!!'0G'K0!TVIZ=;ZMIT
M]A=;S;SH8Y51RI92,$9'."#1I^G6^EZ9;Z?:!DM[>,11 L6*J!@#)YX%<!HG
MB_6+7PAK^O:K%%-]FOY8QLWXX=8\@<XC7J<<_*3USGK_  _JMSJBSN[V5Q:@
M*8+RR?,<P.<C&25*X&1D]1^ !8TC0;'0_M?V(2C[7.;B;S)6?=(<9;YB<9P/
MRK3I*X_0_&$^MZF8X6L1''<RPW5FS%+FU5-VUV!.&!*CH!C=U.#0!V-%<!%X
M]U"\BLM0T[2Y+_3[FZ\HI;V=P72+<1YIDV[#C'*C/UK0\*76LW/B#Q&E_>02
MPV]Z(E1(F&T>4A&W+' YY&#DY.: .OHS6%K6N2V6JZ7I%FL+7VHM)L:8G;&B
M+N9B!R>P R,YZ\5@ZEXAU*XT?Q=I4HAMM3TNU>031JQ26)HV9749RK<$=3@C
MO0!T:^*M":25/[4ME,<9F.]MH* X+*3PRY[C(JSIFMZ=K'G"PNDF:!MDJ8*O
M&?1E."/Q%>:Z_9WH^%FB73O8%ECL41Q:L)%1FBPN[?Z@9]?:O3[.V,(:69+<
MW<N/.EABV>9C@9R2>!QR30!:J.>"*Y@>">))89%*O&ZAE8'L0>HJCKU]=:;H
MES=V5NMQ<1@;4=MJC+ %F/HH)8^P-<A:^-]2-IXH57T^_DT6T6[BNHE>..=2
MK-C;D]-N 02#0!W(L;<:>+$(1;"/R@@8_=QC&<YZ57O+[3/#VE^?=2PV5C"
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M H#@@#N3@]1TQ6/>>*O$ T*X6&XACU+3=9CTZ:1H@4N59U"MCG9D.,X![XH
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M)9;>>"59[:YA.'AD'1AGCH2"#P0:U:SKO4+R#6K"RATN6>UN YFO%<!;<@9
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MGF$.2IW_ "]P!SQQUJG>>.=<BTC4]4BT>S6UTF]D@N]]P29$1@I\K &3R>6
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M:PN7O'\PVTA^^K$Y!C"N3C@XQWKN--\.6&B7M]?V8N#/=[3,&E+!]HPH /3
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M=]/#,@C=9)8XUS\G)"G('7.=QZ;>0#T1K6W>Z2Y:")KB-2B2E 653C(!Z@'
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M$Y0GY6^8$]<8(QZ;5]J6OR_$!]!L;RS@M&TP78D>W+O&?,V?W@&/'L!GH<4
M7=>?PYX=E_X234K&(7.](?M26^^3)^5>@S[9].*Z*O-HO&NLR_#N+6 ]N+^'
M419W#&'Y9!YP3*C/RG!![]#Q6E=:OXBN?B/<>';&]L[:T73ENQ(]L7=,OMX&
MX GZX'/0T =Q3719$9'4,C AE89!'H:\]3QGJ_\ PB&D75RL,5U<ZG_9UW=
M#9"!(R&0*3C)V^X!/X5L^'=1U2X\3:SID]\MW9:=Y0CG:%0\A=-Q!92%ROLH
MZT ;5CH.C:7,9M/TFPM)2-I>WMDC8CTR *T:P?$6JW-I=Z3IMDZ17&IW+0B=
MTW")5C9V('=OEP,\9.><8.#/K>M:/=ZWHLM\MU/:Z4=3M+V:%=Q )!5U7:I.
M5." .#SG'(!W=9RZY9MXA.A@R_;A;&ZVF,A?+#!<ACP>6'3WKB;36O$UGH.C
MW][JMM<2ZZMG;6J"V %M)(N6D)R-WR@G' W<# J-VG\-?$F\OM1U2XU&.W\-
MRW ::-%956925^10#T)Z=Z /3*2N(TB]\57=]I5_MF?3[R/?=K<"W6.(,H*&
M'8Q?K@88G(/:F^![OQ+KEM;ZM?ZM"UHLUS"]LEL 90KE5;=GY2",8'8=R> #
MN'=47+L%&0,DXY)P!^=4KS1M+U"=)[W3;.YEC^Y)- KLOT)'%<K\0X+N>^\+
MQVVIW-F)=42)A$$(SM9@Q# Y(*\9X]NE6(+C5-<U?5]+MM8N+(:0L4 F2*)F
MGE:,,7<,I&.1PH7OSTP =@.**P?!FMW/B#PS;WUY&D=UODAF$?W2Z.4)'L2,
MU@7%QXFU;QQK>AV.MBPM;:WAFCF%HDC(S9^7GC![DY^[QB@#OJ*\DM_&7B74
M[+PO;QWT-K>W6H3V%Y*( ZL8QC< ?KGC'/MQ5N\U/Q7<ZM=>&["ZN[R\TJVC
M::\MS!;&69P65F5PPV@8&T=3G- 'J%%>;:MK?B#3[31I]<GN[&S%LZW]YI:)
M+Y=T& &\%6^3 ;.!U..U.U#7=<O;O2M"TR:6]=M)COI[VQGBA>8D[,@NI4*2
M"2 ,\CH,T >CT5YA/K/C*WE\+Z;>WD%I?ZA+<6MRR(DN-JY63C@/@@XSC('&
M#BK<NH:UX1\5Z5%KWB&:_P!+N[68-(;:*-1.@W<[1D KG R>: /1**\]N=8U
MY(_#NDB2:2]UA9KF5S(D4L:* PB4[< X8 G!/!P>XZ/PHNO0V,]OK[Q22QRD
M0.L@9VB/W?,P -W49 &: -QY8TD6-G4.P)52>6QUP.]9^BZW;ZY!<RV\4T0M
M[F2VD690#O0X;H3QFN2U?3IKCXN:8!JVHQ(^GRS"**50J;60;0"IX;OW/J*P
MYFU73_#7BK6K'6)K7[!K-W*EO%&NV0^:,^82"2,<8&/QH ]<HKS[5M1U[6O%
M>M:/I$LL']F01!#%<I$3)(N\.P9&W <#'3KZC'9:(]^^B69U1H6OQ&!<- V4
M+C@D4 7Z8DL<C2*CJS1MM< Y*G .#Z'!!^A%>>76K:A%XJ-IK%_?Z6\FI(NG
MRQ#=9W,.1^Z)QPY&<Y[GT%1:-%<Z;I'C.]@UF6*>WU"XC2:_E+Q+A(\.PP22
M.V/0#% 'I=,CECF021.KH>C*<@_C7F]I=:E<Z[JNBSW6KII\^C?:HWNG59MP
M8 LA7YE!SR&P>.@JMH37>F^!_!%Q;:C> W5[;12QM)E"C[LKC'3B@#U2BN*>
MZUG_ (2+Q;9:==EYHK*WELX[A_DCE<29QZ#Y1[<5!X)U47>LW%I+>:K#>PVB
M?:=+U-B[H^1F5&_B4Y[<<C  .* .\HKF?%^IW-H='TZVG:V;5+Y;9[A,;HTV
MECMSQN.W /;-8DZW>E>)==T^'5=1DMET(7<*S7+.89-SKE6//\ /.>I[<4 >
M@T5Y['J-^^B_#_4#?7/VB]E@BNL2';,KP,[;EZ$Y4'.,TQ+R^U_PKKGB"#5;
MJTO[2>X^SI#*?+A6$G"-'G:VX#)W _>XQQ0!Z+15+2+Q]1T6QO9$"/<6\<S*
M.@+*#C]:X*2^OM5\$:MXNM]5OK>]MWGF@@$A6.%868")H\X;<JY;.3EN",4
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MJEB2I[$C'4=ZY..74],^&/\ PEO]O:I)>+"\!1Y=R*KW&S?C'+*"2"<_D *
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M.N +ZW-P[H8G&WS,%CRF[(^OM6_H-C#J&GWU]=0QRQ:M,9Q&RY4PX C!!]5
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M( ]R,_6NXH **** "BBB@ HHHH **** "BBB@ HHHH 1?NBEI!T%+0 4444
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MHZ<KSG1O,6XN/*:-2^1LB.X#?A@7]B!ZUWE9-EKUK>>(+_18X+A+FR1))&=
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M\4:?H;6LI>]BDE2<,NT! ,C&<]Q^= %"3P19/<Z/<+>WJRZ7*\T;%U<S2/\
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M0HH;>!@G:01SG\\?2GV?ADV>IZA?KJEU)->P1P-O5#M6,$*>G+?,Q)/4GI0
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M;F186F"HK DC.S'!!]^:N^)?"2+K5MM\+7.I:1;V"6ML+*^$3PD.2<@LI/\
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M?19M/\LV]S%FW9?N>6OEJ<=.IP#SR:[ZVTC3;-I6M=/M(&F4+*8H57> , '
MY '%0V_AO0[1D>UT;3X)(V+QM':HI1CC+# X)P/R% 'E+16FNZ9J?AZ1[![F
M36FE;5)[F,#:) 3\K$2%@!Y87&#V.,&MI?#^CWOQ<U>TN--M9+9-(B983&-@
M(.T';TX7@>E367@2]AA>QO-!\,7C,7+:M+#NE8L22QC*\MS_ 'P.*[:T\/Z7
M:0PH+*"62.W%MYTL8:1X]H4AF(R<@#/K0!XYI>GV@^$_AG7O+C_M./5(0;MV
MS(JK<,BJ">P4#Y1QQG%;&HS:=J7B+Q;I'B77TTO?*@C6>*+]Y;[1LV.X)R#D
MX'.3D<YKT@^%_#YLA9'0]-^R*YD$'V5-@<C!;;C&< <U9N=&TN]FAFNM-M)Y
M8/\ 5/+ K-'_ +I(X_"@#@;#1]+N_B3;0W5N+I/^$:@=A=H"\KB0C=(IX9\
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MA'RR!^8.>^ TA/NJUSWB74=.-IXE@ANDLI8]75YK,JTDDSK*F9F=L^6F!QC
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MBBB@ HHHH **** "BBB@ HHHH **** $%+2"EH **** "BBB@ HHHH ****
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M5WW@;3VT>WU#36U5+]8KC>HAA*16^\9\M,LW3KC/&X4 =917 ZKH=EJ_Q/\
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M 4X/$.C74OE0:I9R/Y338693^[5BK-] 0>?:EM/$.CW\-Q-;:E:R1V^/.82
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M?6NGWIO+4(&AN+9E\HOD(S\CY>.Q]JV[OQ):6J)_HU]-*T33F"*V8R*@."S
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M-E>);/ \TXE/RH059MS$MDG/)''7IGO: "BBB@ HHHH **** "BBB@ HHHH
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MZ@ 4E]J=AI<"SZA?6UI$QVB2XE6-2?3)(IO]L:9Y=K)_:-GLNSBW;SUQ,?\
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MO5)GALKZ">5%#M&K?,%/1L=<>_2GZCJMEI,227LXB61]B#:6+'K@  D\ F@
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M$H(K0"'RU?<4P!P>^<$'GGFK=</8>(=$T>W\4ZH-*.GM:WNR[RZEKB4@8/7
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MUC;-;H=RQ&)2JGU QCN: ,3P-;Z7:>&4M]$FN9]-260033D'S!NR2F /EW9
MX'0]L&O,]8UK3KB.9TNK6U1/$J32V\^6N"5D4-*S'&Q ,8&#@<;NU>X*JHH5
M5"J!@ #  JNUA9.TK-:0,TV/-)C!WXZ;N.<>] 'E&O\ B"PMO%GB6S-SIUU'
MK-A!'&]U.(DM\QG')^\A#!\KW..M6KS2=!L[GX=6 EL;JT#2(9U"A+C]SC)Q
MU#-CCG.<'-;][X7UT:[?7EI)H5Y!>2B0_P!J6;220@*%"*5(RO'3CJ3WKH-%
M\.V6CV2PK%%+*7>1Y?*"Y9VW-M'\*YZ*.F!UZT >>:FFC>'/&EYIVHWDNAZ5
M/IZ16+P11^4R98RQDM&V"68D@8SW[56:6QT'6=#^TZCJNF>'SI;PV-W.B,V\
MR$D-N1@NY-I' .  ?2O7I[:"Y4+/#'*JG<!(H8 ^O-++!%<1^7-$DB9SM=01
M^1H \G33=!2Z\#6MH'N---_=>0][M+2IL8Y P/D+]!CGCUI38Z(T_P 3#]GL
M2\,9\OY5/EY@YQZ9<=NX]:]8,,3%28T)7IE1Q2>1"-W[I/FZ_*.: /'+O4+6
MVG\%7VI:M>V&E-H8@CO;-@0D^$W!CAL9 P>/ZU8U"T\.P:7X62T5_P"S)?$*
MLCWQ'[Y"C;F .,1ECTP <YZ$5ZYY,7E^7Y:;/[NT8H:*-PH:-&"],J#B@#R/
M5%B7Q#\2K.S$:AM&C(ABP,L(B#P.XS^M>A>$=5L=6\,V,MA<+/''#'$[*#@.
M$7(Y],\^_'45M"*,.7$:ACU..33E144*BA5'8# H \DNKJX>W^(>C:7(W]MS
MW330P*"':+9&&(Q[;@/?%:U[J%AX@;P6V@W,;7D-Y'(8XB T-NJ$3*X'W1C"
MD'O@5Z+M4,6"C<>"<<FD6.-&+*BJS=2!@F@#D?B)?VFGZ+I\MW$A!U. 1S2L
MPCMW!+"5]O)4;3QQG(Y'6N N[ZUETOXD0F\^TO/';S1NT/E^;F-1N5< <L1C
MUX//6O;F574JP# ]01FDV+DG:,GVH \X\1V&@VWACP]=P6EDFG2:E9R74BQ+
MY;1A2-TAQR!TR:&M].;Q;K^KZ7Y*:6FB-;W<L6T0R3[B1@C@L%&#]0*]((!!
M!&0>H-($0)L"J%],<4 >,_;$@\(?#74+JX5K>TNU2>95.(L*0%(QG( QTZCO
MUK=\+PZ9J?Q-\92W%O!.^ZSDM_.B&X;4^8J&&00VW/H<9KTHHIZJ#SGIW]:6
M@#Q&QUFR2X\)7:^99V=KJ4Z/IT5K(XM&<2;59L%GD)ST]>%XS5B5;NYT7XA:
M!:K</J<VJ2W,-LBL"T6Y"2#C W*"!Z]*]E(!QD9Q2T >;^#)/#NJ^(+?4]*D
MUF[ODM6CFDOY92+9#SL)888[NP)'4UJ>.UM/M6DR-KLNBZA$97M+O:&B)PNY
M) >H.1^1KM** /()]5NXD\+Z]K]A/!IVVZ@N9-.>5%C9W!68!"&VOMS^)XZ5
M=OFTBUT/3M4TRRN+72?^$B@NY+F4R.9AC#3$/EE!;CGKC/>O4J* *RW]NVG"
M_=S#;F/S2TRF/:N,Y(."/QKRC23)JOP:%EI86[O+2Z-Q<62MAWC%TTFW!_O*
M,@=Z]@HH X*\O++Q/XI\-:CI$Q==/,T]U<!2HAB,>/+?(X8G'R]0 2163X9L
MK6_^&7B"WM+4R:FZW[!&@VR;I=X0J2 2&7;R/IVKU.B@#R]]1M[[0? B/%,3
M;7T G$EK(@4I RL?F'0,RC/3/TKH/#\D7_"PO%>T$>:+4JVT@.40JV#T."0#
M784@H XCQ X'Q4\*/M?9%!="1PA*H74!<GH,D&N.<%?A?XN,%LYNYM9>6)/(
M;=*#,C(0,9(P"?SKVFB@"DTC7FAF5!N::VW  =25]*\EO[F.[^'G@>T^RW1>
MTU*T^TQR6L@VK&I$F05Y R.>G/UKV>DH \[BG,/Q,\63.LPMSI<?S")BK%%Y
MQQR1GMZUE:?:VMY\/_"J7@U;3Y[1'$>H6L+A[24?+AAM/RMDC/3CWKUD4M '
M/^#9-3D\-Q-JP!N?,DQ*(?*,R;SMD*?PEA\Q'7FN;U^/1?$5K>6WBK2+JVNX
M+B:.SNHK20N\8<A&C90>2,?*>O7&*]$HH \ENK'7--T_PCJVNZ?>ZBMC;SPW
MZ6K%IT#XV.0I&<*HW<^M3:M#<6MEIGB/1O#=W':6FJ&[FM75A<2QF+8TI4DG
M/)QWP >AX]3I30!YQXC$_B?P9J=W8Z'<6\<LEM-"IM]MS<LL@+,R#)P%QC//
M![8K0U"6XO/'_A34(M-OQ:BWNEE=[=AY.\+LW\?+DKT/(SSBNV5@V<$'!P<'
MO2T >86T=[;^ M3\(7^F7-QJK?:(8 ENQCN0S96;S -H&7!.2#D>]:&DZ?/8
M?$N6XFBO'@M]"BM/M'V:0I(ZL&;#8Y. .F<Y]1BN]+JK*I8 M]T$]:%=69E#
M LO4 \B@#C/A5:76G^ [:TO;6XM;B.:;?'/$T;#+E@<$#(P1S64T%VVG?$:,
M:??%KWS/LH^RR#SMT'EC;QS\WIVYZ<UZ510!YYY5RU_\/'%C?;;2-UN2;60>
M23!Y8W\?+\W'/UZ<US6K:=K-XD$K:%JHN[?Q EQ);V\02V$0<D.B@X=F!&7.
M3G.2!7L]% '">*](N6\2Z7J.FGR;C5(VTN\0GYA$RE]XQQN0*WYBNYBBC@A2
M&) D<:A451@*!P *P=-\+:=HFK7^M&YNY9YRSL]W<%T@4G+!,_=''Z>E;T4L
M<T2RQ.LD;@,KJ<A@>A![T >;6UGJFF^#-8\(SZ1>7-U,]U':3JNZ*9)68K(\
MGW4(+DD'GY:NZ5HM[IGQ*M9V@GDL;;PXE@;K8=K2JX;'Y#/Z5W]% 'D-EHNK
MV_PSM=/?2;S[9'K*W#0B/YO+$P<MZ=/UKI_'6FW;W>BZQH\R0:JEP+-2X(\R
M*888$#D[?OX[;2:[>L"WT#1QXMN=7%P\^I;0?)>XWK!E=NY4_A) (S[GU- &
MO8V4.G:?;V5N"(;>-8D!.3@# S[UQ5K!J>E2^+8#HUS<R:C>/-:;0IBE5XU4
M;FSA0"#G../6N]HH \H'A:_\+ZQILK^'8_$=@=,@LI]JH9(9$)^95?@@@^H]
MR._HNAP3P:3&EQ96UBY+,+6V V1 DD+D<$^I QG-:5% 'E&E:'JNARS:!)X-
MLM3!GD-MK$RQ,HC=BP:4$;B5SR,Y.,#L:V],LM0M/$'C2ZET^Z,-ZD0M6 !\
MW9&4(49X&>@/:N\HH \W%CJD'AKP19'1[UIM+N(9KP(%/EK'&\;?Q?,<L" ,
MY&36O$NIZ%XPU:^&EW%]I^KB&5&MMOF0RH@0JX9AP0 <]!SFNQJO9WUIJ,'G
MV5U#<P[BN^)PRY!P1D=Q0!YY;>&-7TBR\(6ZZ>UPUEJ$MY=_9W0+")-_RC<P
MSC?V'8^U:6JVGB#0_',^NZ/I1U:TU&U2&Y@6X2)HGCSM8%N",$\?6NYHH \U
MU[0_$;ZUI7B)M$L=:F\B2WO--=TVQHS[DV,XP2O0MWQTYXL7VD^(@^D>(;72
M;87=A<RL-'AF5!Y$B!,;^%,@QG/3G';GN[R]M=.M)+N]N8K:WCP7EE<*JY.!
MDGW(J5'61%=&#(PRK Y!'K0!QGAJVUUO&^LZMJ>C_8;:]MK=8_\ 24D*LF<@
M[?\ >/Y=ZD\0Z5J7_"=:#K]I9->6MG%-#/'$ZK(-XP& 8@$>O.:[&B@#D=+\
M.AW\1WFMPQ1+KKJC6V\?)"L>Q0Q'&\C)."?J:3X>Z==6NA?:+VX^TR28@MYC
MU:VC)6+/U!+?\"K9U_PUI/B>UAMM7M!<PPRB5%+%<,..Q''/2M.*-(8DBC14
MC0!551@*!T 'I0!ROCS1=2U6+1+C2[=+F;3=4AO&@:01[U7.0&/ /(K.M-$U
MQ?$OBG4KG3@HU/3X8XA%.C RK'M91D@XR3@D#@<XKOJI3ZOI]MJ=KILUW$E[
M=!C! 3\SA022!Z  \T <#9Z!XIT6T\-ZGIUA!+?6-A_9U[837"J)(P00R.,@
M'(S^7%=WI"ZC]B\S5&C%U*Y<Q1'*0@]$#8&[ ZD]23VP*T** //+&ZU6/Q/X
MUM].TD79DN8@DKSHJ*Y@C&'!YVXYX!],5%)X/UC3#I.EVEK:ZOHUO8&W\NZF
M\M8IRV3,RX.\<\#!Q[=3VFF>']-TB[NKJRCF2:[;?.SW,DF]O4AF(SVSZ<5J
M4 >3:7X0\2Z=IO@RWFTV%SHMY-),8;I23&QX/S8Y^8\ G@<D$XKK-7TS6E\>
M:;K6FVMM<6XLWLY_-GV&(,ZMOQ@[NG0?I71:GJEEH^GRWVH7"6]K$,O(_0=N
MU6E8.H93D$9!H \[G\'ZMJ=MXJLID6S_ +0O5OK&Y$@?:R%=H91R/N ]^&]1
M@[%FOC6YLKE]3BTF*=+5TA@A=G2>4CAGR/E48Q@9SN/H*ZVB@#C_  MX<N-*
MUZ_OUL8=+LKB%%^P6]P9(S*"29 -H"\8&!U]J["L6^\6:-IM\;.ZNG219$B=
MA!(T<;O]U6<+M4G(ZD=:VJ "BBB@ HHHH **** "BBB@ HHHH **** $%+2"
MEH **** "BBB@ HHHH **** "BBB@ HHHH YZS\8Z9>^*;O0HF;SK:-&,A!"
MNS$_*OK@#KTYJW%XFT6>_6RCU*W:X<E44-P[ X*JW1B,'@'/%<C<SW$'Q$\2
M6\<<\-U>Z9#%82")F#N _P V0, *3R3CI5!S'JGPVTK0([9X]?M7MHEM?+/F
M6\L;J&D/HN,G=T(/O0!Z;=74-E:RW,[%8HEW,0">/H.37!ZKXU.I>%]+UC2+
MM[19=3@BF0JI)B:4KALCC(&>#QZUZ$*\8^UVDGPLT*PG5M]MJD"744L+ +^^
M9F!R,'"C)]B,]: /38/$NCZMI]_+IVLVN+9666<,,0''#'/&.^>AQ5?2M;M+
M#PQIL^H:TNHM*F%NTA.;@C))5%!. !Z=LU@?:;2U^*'B!C((XSHT?G%LA2ZD
M_AD*5_.L'3EM&\$^#@VKS:-JD-O.;6]$>Z-&!4/'(IXYR.#C[I_$ ]7LKZUU
M*SCN[*=)[>0$I)&<JW..#]163XOU.\TS0)O[+3S-4N/W%E'QS(03GGT 9OPI
M/!<][<^%;2;4+:."Z<R,XC7:KY=CO /3=][_ (%6<\,WB/Q;+<VM_/9QZ5&8
M8#]G!WN_,C#>N"  J@C_ &O6@#7\*:[%XD\,6&JQD;IHAYJC^"0<.OX$&FS>
M+] @<++J4:*93")"K>6T@ZH'QM+<'@'/!KE/" D\+^--8\.R/<W%C=N+RWNF
M@VHLS?ZR,E5"@DX( P.,=:Y?2=6TEM)TS1=0OY;"PL-0-Y'Y]E+YA"2L55G
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M\4K G<48D@@D$$G(^O05@Z?H?B:PTGPYJ=OI#&_T:>[673YI8U,\4[9RC@D
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MB(D!W'';Y?;K7?5A^'="N=%?4GGOH[DWUV]VX2 QA'8 8'S'C"BMR@ HHHH
M**** "BBB@ HHHH **** "BBB@!!TS2TB_=%+0 4444 %%%% !1110 4444
M%%%% !1110 48HHH **** "BBB@ HHHH 9)&)8GC)(# @D'!&:Y2R\%WUK91
MZ;+XIU"?2T7R_LQBB5FCQC89 N[&..,'Z5UU% #414144851@ =A3L444 &*
M*** #%&*** #%&*** #%&*** #%&*** "BBB@ Q1BBB@ Q1BBB@#(\2:#'XD
MTEM-FO+BVA=U9S;[=S;2& ^8'C(!_"M5%*HH+%B!@L>I]^*=10 48HHH ,48
MHHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH ,48HHH
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M1E3D4 .HHH)P,GI0 44BLKH'1@RL,@@Y!%-DFBAV>;*B;V")N8#<QZ >I]J
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M?]WD.%Z[F;) '& ?3-=-'X9T&(J8]&L$*,K*5MT&"N=IZ=1DX^M6CI>GM?\
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M)%A&))+>0RJA5EV+M7+;3N).1P>M7-3N[Z&:VMKK7G_T?6XX7F58HSY;0>8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ""EI!2T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 B_=%+2+]T4M !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 (.@I:1>@I: "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1?NBEI%^Z*6@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** $7[HI:1?NBEH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!%^Z*6D7[M+0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% "+]VEH P** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BD)P"?2H89VEDD5HF38VT$C[WN* )Z*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I  *** %HHHH **** "BBB@
K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>exhibit1011-physiciansha007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$"LH8HA!!8 G&0:Z;P7JJZMI=S/'K#:G$MQMC>6)8YHAL3,<BA5&X-N[="*
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M3N/\(.1MYR!R*J:5)KUU\-+[Q+<^);Z2=;*\*1!44*T<C[6R!G/R?3!Q@8H
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M3,BJ[)GD*Q(!_':WY5)7FT5M%HWC;QKJZ27\KV=I!=+"+AV#DQS':5SA@,<
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MY(4@'(&<^Q]:U-8\1RIX9UKQ5IUS-);2M%;6K+(S1QQA@KRA>@.YF&?]@>]
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M&VMH[74H9DO[6  ))"%RLA4<<$XW=]V.:D^'NEZ;;2:]/;V5M%/'J]U KI&
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M_?AR"<9"[@>N!DG)/K6WH.JG6M&@OWM9+1Y"ZO;R'+1LK%2I]\@UHNP1&8]
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ME\U\,=V[^]P-WS8'&><9K1_L+3SJT.J&!C>PP^0DIE<GR_[I&<$=^>_-:-%
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MRL;33K9;:QM8+6!22(H(PB@GKP.*L444 %%%% !1110 4444 %%%% !1110
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M+.3ET0G<4)!P<'O0!HT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@*!DDG@"LU?$>AO;/<+K.G-!&P5Y!=(54GH"<X!.#^5:=>4>7#H.H>//#D\
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ML%51);W9P5CD8OM*]1N'%)KXU^*\\(Q7&J0+/->[+@0V_P"[9Q%(V>6R0,8
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MI^G:C8:?=3^7<W[,MLFQCO*C)Y P/QH H^#_  S;^%?#MKI\4,"SA%^TR0C
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MAQI+VT\16^AZ]#'J.HWC7L4OV"51!G:&!60#=P ,^I)Q7H]% #8PZQJ)&#.
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M$NQ9G8]69CR35^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !2.BR(R.H96&"I&012T4 -CC2) D:*B+P%48 IU%% !1110 4444 %
M%%% !1110 4444 %&*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK%\26(O;1/M
M.LRZ9I\>YKEX9!"S]E'FY^4=<^O'([@&U17+> ;B6X\/R[M2.I6\=W+':W+R
M!W>$'Y=Y'?KUYQBJGQ"U*YLK2R01:VE@SM)=W>CX\V)5&%'/0$MD^RF@#M**
MP_" L3X:M9M-U.[U.TFW2)=7<IDD?+'()('0Y&,<8K<H **** $) ZT@=3T-
M)(@D0JW0CL:\C\/7&A"SUB37M5D$EMJ%PBJ]\X*QJ<C !]* /7@P)(!Y%!('
M4UR$>NV/A.RTBQN9+V[-YN6UD6,R,PQN )]<57U#X@0_\(QJ^I6=A=FYTX^7
M+;3($>-B!@L">F"#0!VV]1W]J=7"ZI?Z==W?A>;5X=2M[R2Y_P!%2(D*TF"?
MGP<8P,\U=C^(6ERZJ^G1VM^TL5W]EF;R#LB.,[F/9>.M '6T5RJ>/=,-_8P2
MQ3Q07[%+6Z;;Y<C#MP<CVR.:ZC>,XH 5F"]?Y4 @C(KA?B1J6K+8"PT!L7\:
M&^D(S\L49SCC^\1C\#71Z7X@LK_PQ;ZVL@%J]MYY(_A4#G\N: -BBN5C\=6K
M7&FQ/IU\BZF<6;E%(E[^N1QSS44/Q#TZXU633X;#4'>*Z:VFD$!V1, #DGTY
MH Z^BN1B^(.FO=V<<EO/%;WTODVMRS(5D;.%& VX9[9%)<_$32K6XB$D<GV6
M2Y%K]I#(0KEBHRN<@9!&<=J .OHKCKOXB65LVIA-+U*?^S9?+N3'$,*,9+ Y
MY&.:FM/'NGWFK:?9)97R1:BK&SNI(ML<Q"[B!W''/(H ZNBN.U#XC:5IQEED
MAF:RAN/LTMRK)A7R ?ESNP">N,4^\\?6EMJE]IL.F:A=W5FB2,D,8(9&!.X'
M.,8'ZT =;D X[TM<'J'CJ6:;PO-I-C+-::P['>2JM@1L=N">#D?I7<PL6AC9
ME*L5!*GJ* 'T51U;2H=9LA:7#R"$R([JC%=X4YVD@YP<<UP.D:#ILGQ,\1Z4
M]N6LHK.W:.)I&.PL.2I)R#[B@#TRBO+[6YD\._$C5H8+6[U.2+2+5!'& 99-
MO&\LQ  XYYY)& :V=4UW1-9TSPKJLUE>S07>HP-9NA">3,3A?,^;D?>X&0<4
M =O17.OXLB.HW-M:Z?=7<5I=):7,T)3]U(VW^$D$J-PR1[]<5T5 !17)>/FO
M[[1FT+2)C%J%[%(X=>JQQKN/?^)MB?\  R>U7_"GB*/Q!X1L]9?$9>(F<=D=
M<AQ^8- &]17&R_$.WBBTNX&C:C+;ZL^RQ>(Q%I3VRK.-N1R,GZXJ:/QW!/K5
MSIEOI&IRM:7BVMS,L:^7#D<.3G[O7W '..,@'645R%O\0],FO-,C:%X[?4Y/
M*M9C+&Q9C]W<BL64-V)'<9Q39?B/I4,D$C1O]BGN_L:7 D0G?DC=Y>=VW((S
MCWQB@#L:*XRZ^(4=N=6*:#JDR:5*4NW41[8U"AB^=V#QV&3ZXJY9^-(KO6=-
ML6TN]@@U1'>RN9@H64*NX_+G<O'(R!0!T]%<3>_%#0K)Y':1'M8[G[-)(EQ&
M9 0=I819WE0>,X]P".:L3^.]FLZSI5MH6HW-SI2+)-L,84J5W @ENXQ@=3GI
MP< '745PEYXSO;O5O"9TBS\S3M6\R7<T@5Y-L3'9@\+@X).>2O%=V* "BN'U
MGXF:9I%Y=IY<<UO8R^3=,+N-90W&?+B)W.!GGIT.,XJ]<>.K&QU@V%] ]NDE
MH;NTN"P*72\?*G??S]W&?3/% '545S.J>+FT=-*6ZT:]:XU%S''#"4<JX4L%
M//4X^@[GBL^;XBQ6UAK;SZ+?17VCJKW%H[Q@E&!*N&W8*\=LD9'% ';45QY\
M=&"T>:^TB6P,LJQV(NYUC6Y#)OW%C]P  YSDCCC)Q5:/XFZ=_9>H3S1(EU8W
M,=LZ).'A=I#A&64#&S@DG&1@\=B =S17*W'B^XTW2+J\U33(K9XKJ.VBV7>^
M&7S NV3S"HPF6Y.TD8/!Z4Z[\7MIFF-/J=@MK=&\%G#&UROE2L4#!Q*0/W>"
M<L1D;2,9XH ZBBN*@^(UF;#69;F")9]+>-7%O<B:&7S,!"LN ,9."2/EP:WM
M%U2_U![A;W3X;81A&BEM[GSXIU8'E6V+Z>G<4 :]1F>$7"VYE03,I=8RPW%1
MC) ZXY'YUS?C_6-2T3PK+>:9'"9#)'$SR2%2@=PF5P#DY;VQUYZ'F-3N+^U^
M+NF7":3'-J,NC2!H+><;2WF'!,C*OR@ <[<^@- 'I]%<;)\0K2W\*P:Q=VIM
M;B:Z:R^S32@*DRL58,X!^4;2=P!X'3/%6_"/C*#Q6VH11P+'+8R*CM%+YL4@
M;)4HY"D]#U48H Z>BL?Q+XBM?#.E"]NBOSR+#$KOL5G;.,MV'!).#P#P>E<K
M!\3=VBZM='3HKBYTV,3-]EN"8)HS_$DC*#D'@C;0!Z%45Q<P6EN]Q<S1PPH,
MO)(P55'J2>!7.1>*=1;Q!'I,VA&V-U:R3V4LMTI\TIMRKA0=GWAS\W'OP.?B
MU^]O?ACJ>J>(-'M+^U5YRT"73?O%69P5(*?*%V@#!)(&>.E 'I ((R#D45QF
MH^++K2KS3]%TGP\]W-<6)GMD2X5$4*%^4YZ  ]?8#OQ5U+XCM:O=?9--28V)
M5+J!YR)C)M#,B!5925W8.2,D$#UH [VBHK:X2[M(;F,,$E19%#+@X(R,CL:Y
M;Q/XOO-#EOO(TV-H+&U%S+/=RM"DQY_=Q':0SX!_'% '745RK>+I+R?1+32;
M6)[G5++[>/M,I18HL*>< DL2P&!Z$UF/\0KY?#<^KG00!!>K8O']K!/F;]CD
M?+T#8 ]<]L4 =[17%W'C2_L4BM=3TRWT_4YYI/)BDN?,C\E-O[PLBD\[L 8Y
M/H*K0_$A)-)B:2R$.I/>-9B.1G$)*@L9 ^W)3:,_=SGCCK0!WM%>=77Q-GM/
M#>K:@=)62YTV=(W D98I4=L*\;%,GW! QZU>/B_7E\22: ^@6ZWTUK]JM/\
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M@CJ*?0 4444 %%%% !6/KFM+I)MDETG4;Z*X+*S6=L9Q'C'WP.<'/H>E;%%
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MLI<::H^U'<I\K$7E^OJ?RKHQ\-O!H&/^$=LL>FP_XTO_  K;P9Q_Q3>G\?\
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M;LM/TNVFLKR&1C!>/)#@-YIRY4L7)7G//S@YKN]7\.Z-KRQC5=-MKSR_N&5
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M2,CGK6_+X2CNM7UB[O+D3VNJVZ6T]J8@!M4,%(;.<_,WZ>E5=%\$R::$AO\
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M9]BNK.<MM*J._/.:99^!H;35K'5'UK5;B]M(#;B269<2)D$!@% P,#IC/?-
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MMDME<VL#K]FB>62%F8;I&7/*A<MM'/0$]30!Z+17F>M:UJ][X'NKJUUS3[J
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M!$9Q,8T\T+M#[1N ],^E244 %5GT^SDN1<O:0-<#!$IC!88Z<]:LT4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !35C1"2J*I/7 Q3J* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS4'L+?4;:6[0$F%9 6P#@D#O@\''0UHT %%%% !1110 4444 %%%% !1110
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M-MK 'T/:N;_X5]IG>\U8^W]H2?XU%8?$2RO-1N=/-J3=Q6INXTM[F*994!Y
M8-M#CJ5)_$T6/Q!CO7T65M%O[?3]7<107<I0#S""0I4'.#@\^W&1S0!+_P *
M_P!*_P"?C5C]=1E_QJO>?#32;R%5%YJT,J'='*E_(2C>HR:M>%?$.JZQK&N6
M]_8K#%9W?D1[)%(0!%(![DG.<].U=90!PMG\,=.@53=:KK5[*K;EEEOG!'T
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M7(7.6Y8<#VYK:L_%DD_B--&NM(GLY+BV:YM'EE1A*JG!!"D[3R#WX_*@"O\
M\*ZT+UU'_P #I?\ XJF_\*]\/B0(7OMY&0IOY,X^FZFWGCU;/P*_BA]-9HHI
MVAF@$WS+B4Q$J<<_, <<<&J=VB+\<=.=44,^C2%B!R?WF.: -'_A76@_]/\
M_P"!LO\ \52'X<Z"W!^W]^#>R8_+=4<OCTC2H-8ATEYM+N+O[)#*)U$C-O,8
M;81@*6'][/M4FL^-I-(&I2-I$C0:;'$]S)).(\EQNVQY&'('7D<\4 =1:6T=
MG:16T6[RXU"KN8DX^IJ:N1DUS5Y/'UOI\$%O_9_]FFZ&Z<JS@NBEF^4\KS@
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M[MI!+;SQK)&Z]&4C(/Y5QFNZMJ^L:5XE71WT^.RL(Y;5VN$=VFD5,R %6 4
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M9>,+[5!X-N?LUM&FJ2S17*/$=\4D:N&V$G@;E(Y!.* ._JC<:Q86NK6>E37
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0:O=Z]9V4VK2WB7VFR7#/+9JD<4RE/\ 5, OF)ER,Y.<=: /0T18T5$4*JC
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M;7KF?QH%\27<,6EGS+98XXPP/D"0 G'*C)&,9[DT >CO-%')'&\B*\A(168
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MLJ&7S-VPL5*D;3GTR!WK4NO >BW-MIT0^U02:?(\L%Q!<,LVY_ODOU)8\DT
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M3X?[+M/"\7EMY4,;"=MI#;/[@0D#/'3([UU% 'FSZ%H]_P"*O'/VNQMYA'!
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M60/E7"[PP;;V8*#N_"MR36=%U;XKV*Q75M<0'1YHW8X,;Y96VY/#?+DD=N]
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MD423J7=<9R!G/3GZ<UQNHFUNO'.H:G93P/IRZ$ZZA,C!H6?=F,,0<;P,GG)
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M>?5[6WM[(,OV2*1&68R,/-RHY4!1C/RG/>@#T!E5U*LH(/8BFM%&X :-6 Z
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M@T;,[8)PH]>?0"NHG\:Z8EKILEG'<:A-J,)GMK:T"F1T !).Y@!C/<]01VH
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MVRZP1Y"C9NC!4ON<;N@4$G&: -ZDK.U?6K?1Q:K)')--=S"""&(KN=B">-Q
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M* "BBB@ HHHH **** "BBB@#RR6]9='\?:58SXUJ6_N)8;9"?.:,Q1\J!SR
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M8HV))C4DC:<CJ/2D,,1=7,:%E& 2HR* /")?L,OPC\:/#]G>XEUMA&4P6?\
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MEMGWL/M(<-C&2-@SGVKV+%&* .%N;B#3OB=)JEY%*MG<:/'!#.+=W5G\UF*
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MIX(=/<1F62(@9V[F+-T48QC./7O5FU\6Z1>7=I;)-,C7@)M6F@>-9P.3L9@
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MC1M0TN*>[AU2\2VC=820GS8<$<'=@-@>HJPE]I\OCZ%?M^IQWKZ<S_8I%9(
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MR<5D6VIIHOBSQA<7=U<O96UM:7 C>5I-I82DA%)XR0  /85D>*;2YFUJ^O\
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M:-]@U"XO7MS/$D$2L)%! (!+  \]6P.#STSHZ,DT>B6,=Q \$T<"(\;E25(
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M*RA1\C;1GJ1U&:M:5XQEU*U74?[-3^RGLY+L7,%SYI79C]VZA1M<@DXR>A%
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M;C6+VZFM5\Y,%)AM!)SP1U(_*NEU+0[C7/ $FC2_Z)=36:Q<D,(Y !C)'49
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MU""SWV-A'<">;S5&#*H PN<G&WGZUSDOA+Q!>:?K+Q0QV=\->76+#SI%=9,
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M4,CY_># "Y7G''/&<^V3VM9^MZU8^'M)FU/479+6';O94+'D@#@>Y% '"?\
M"OM9DL]6;[99VU^^MG6;"6-V=4D[(X*CC'&1GKTXYZ[P_#XA;-WXBGLUGV>6
MEM8[O* SDL2QR6.![ ?4UM(ZR(KK]U@",C'%/H YM-*U5?'=UK12S-F]@EI&
MHF;S,JS/DC9CDL1UX SSTKF8? VO1_#B^\-%M-^TW%WYRR^?)L"^8)#G]WG.
M5Q^.?:O2J* .(U+0?$UKXF_M_0)]/$M[!'#?VEV7,>Y>CHPP3@$CM^O&1XCB
MU :SI&D0:GI]WJUM;S7CO?R26S%G8 >6\;!@.7 0' "\]!7HNH7T&F:;<W]R
M6$%M$TLA5<G:HR<#OTK/-GHGBW2[.]NM.@O+>5%EA^U6X+*#R.&&10!Q,.F:
MSK6DG1[6/1(7TJ_BEFBAEDDM;L$%F20D%MV2&.<\X)K0@\)>(8+7Q5&UQI,A
MUF(+$J))$L;&,1G/WL*HZ  Y_P!FNIU*_P!+\):"]W) +>PMMH\NVAX4$@<*
MH]36HC!T5UZ,,C(H Q+;0/M'@>'P_J@0YL5M)C"Q8<+MW*2!Z9Y%9D'AO6+J
MQTO2=8FLI;'3I8I1/"6\RY\K_5AD*X7D L0QSCH,\=A6;KFM6?A[2IM2OS*+
M:'ES%$TA'X <#W/% &3X=T?5]/\ $FO7]\MB+?4I4E003.SH54( 04 .0,YS
MP?7K3O$NAZG?:WH6K:3+:"?39)=T=UN"NDB!3@J"<C'%=(I#*&'0C-8=[XOT
MNQO9+:47++%<1VTT\<#-%%*X!568?[R^PR,XS0!RM]X'\0SZ!X@L%O--FFU:
M_CNM[[XP@783T#=2@ '8'.XUL:AX;U/5/%ZZA<"S73GTN33YE29S+^\P691L
MQP1@<].?:NPHH XG0/#GBK3HK73M0UJUFTNP8&W:%&6><+]Q)"> HXZ9)QBH
MQX.U5_!U_H4UU9B2YOC<BX0-C!E$I&T]#NR.IXY]J[JB@#E;[P]J=QXUTKQ#
M'):$6EN;>2!F9=P?[S!L'IV&.<=1GBM;>%-4TJ#5=,TR[M1I>I2RRAI582VA
MD^\$4##CN,E<>]=G10!RMOX5FL?$^EW]I/"NGZ?IW]GQV[ ERO'S;O\ @*\8
M]:IR^$]=M/$>HW>B:Y%:Z?JK>9=0RPEWB? !>(YQN/OP..#7;44 <3-X0U?3
M=?;5/#6L1P"ZBBAO(;]&F5A&H17&"#N"CN>?6I;GP?J)UVTU.VUA&=+ V4IN
MH#*?F;<TB?, K'\J[&B@#S[3?A[J&F:3X>@CU:WDN-$N)982]L0CK)D%3ALY
MY)S[XQ6M<>$9;FW\0SRW43:GK-K]E:01D1PQ["H"C.3U)))Y/I75T4 <-<>"
M-5^QZ%<6&MK::UI5M]D-P(=T4\6 -K)GV!^OX8Z;1--NM.LW%]J#WUY-)YLT
MS+M7=@#"KT50 ./J>]:=% 'GS_#[538+91Z[ L,.JC4H6:TW.S;R^)3N^;!/
M;'2M+6/"%YKDBPWM]:O;)=)<PS?9R+F':P8JC[L#.,9QP">#77T4 ><:/#JE
MYXR\;PZ=?VL$,EQ%&[-&7>-O)4%EPPY'(P>XK0N/ -Q97&F77AG6&TN>RLUL
M6$D F2:('<-PR/FR6.>Y/:NPM[&TM6=K>U@A9_O&.,*6^N.M3T <7JG@>\NI
M-,U"QUZ:WUNP,G^ER1AUF#G+!DS@#T Z#\*74O!%U>V&GD:RSZI::BNHF[GA
MW(\@&,; 1A0   #VZ\YKLZ* .2UWPE?Z];W5C=ZI;36%RR-B:S+2P%44$QL'
M !)4G[O!8]:T_$^A2^(/#TFE0WBVOF-&3*\1EX1@PXW+SE1SGUK:HH YJZ\+
M3WOBW3M=GOX3]EM'M98!;$"7?]X@[_E]A@_4U1T/P/>Z,([(^([JXT6"82V]
MDT(5DP<JADSDJ#@X &<>G%=G10!S6A^%'TZPUFQU"]BO;?5+F:XD5+<Q;3+G
M>OWVR/3ICWK.T+P%>:3)!;7?B6[U#1[4_P"C:?+"JA<9"AW'+@9X' R!Z8KM
MJ* ./@\#O!H[^'_[4+^'VDR+5H3YJQ[MQB\W=]W/'W<XXS5F7PO=OXZ@\21Z
ME B0VOV1;7[(3^[W;C\^_KGH<8'H:Z>B@#GO"]OJT,FIG4-0GO;:2Y+6C7%O
MY,B+SE<=U'&"0,\G&"*FU?PQ9:SK6E:G<9\S3V9E4=),X(#>P95;'J*VZ* ,
M'2_"]OI&MZUJEM*?,U)U<(RY6$X^;'/\3?,>F>/2LN3P*\G@YO#IU8^4UR;@
MSBW&_/F^;C&['WOTX]Z[*B@# 7PTR^,V\2_;<S-8?8?)\KY=N[?NSGKN_3CW
MK*/P\@E\,OH\^I3EUO6OK:[B01R02EBV1R<\D_G^-=I10!C:%H=QI7FRWNK7
M6J7<@"&:=57:@SA550 .I)/4ULT44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% '%V_BS7;C6M2LTT.V-MIU
MVD5S<?;,!(R@8L,KEB <D8'89-4M/^(5YJ6I:<]GIOVK3KZ98]L,,WG6R,<"
M60E=A7IG!XSU-:WA_P .ZAI^H>(6OQ:/::M<-.!#*Q9,J%VG*CMW!JAX?\+>
M*M%@M]';7+1]%MI08Y%B87+1 Y\HG[H!Z$\G'3V *[_$#5SI^O7T&@6\D.B7
MDEO<_P"FD%E3&YD^3DXR><<>M:=IXOO'\2Z7IE[ID5O!JUO)/9R+<;W 0!L2
M+MP"0<\$U2'A'63HOBZRSIZ/K<\DL165\1[U"MN^3D@#/'4GM5F3POJK^(_"
MVI@V8CTBU>&9/.;+ETV$K\G08!YQGIQUH JIX\O8]<TZVO+.T@CU"[-K'9M*
M1>0C+ 2NAXVG;V[,.34C>(FTW_A-+FVT6SCNM**RRLLI'VG]UO#,=F<A<<?K
MWK,C\ ^)(K338%U+2C)8:E]M^TO"YDN22WSR'/WL-T[XZ\5IW7A/69_^$R4/
M88UV-4A8R.#'B,1Y8;?[O/'?CWH DTSQ9K3ZYHEMJFFVL-IK4#26S0S%I(V2
M,.?,!&.1T )QZFJ">*+C2M$\7:A;Z%86]QIMZWFQ),0)CM4F0L%Y)R.,#ZUJ
M'PYJ[ZEX2NR;$#1HY$G42N=^Z,1Y7Y/09Y^GO6>?!6LS:/XML9KBR!URY::*
M02.WE X&T_*,X &,?TH TK'Q-K \66>E:KIUK#;ZA:O/:203%V4IC<KY &<$
M'C@=,FLU/'>J3:58:[!864FF7]Z+*&!IF69"SE%=VP0.0<J!QQR:U;G1-2;Q
M+H&KR&S6WTRTECN%$CEF9U ;;\O(&T8SUSVKS_0KF9+&/6!?>%KV1IGO5AFN
MI5E,A)/$(8HDG.!A<@^M 'KFJZI%HNAW6J7JD1VL)ED6,[CP,X&<9]!TK%M-
M<UR.ZMY=4TZW33+BU>Y:>%S_ *)M&[9(2<,2".1@9!Z]:V-7TR/7O#]WIMR&
MC2\@:-O5-PZ_4'^5<SHGA7Q$D$6G>(=:MKW2K:-H8H;>(QM.FTH/-.>RGH.^
M,DXH 2?QEJ=CHUEXEO+.V70[IDS$K$3PQR$!)&).T]1E<#&>IQ2WOBCQ$;OQ
M%;6&FZ?NT<*_F33L5D4Q^9@  '<1@=@/4TB>"]1E\/V_A>_NK2?1;>1")0K"
M:2)&#+&5^Z.0 6R<@=!6@OAV_6]\3S^=;$:PJK&/F'E;8_+&?7CGMSQ[@ HW
MOC=W@T-K62RT_P#M:S^TQ2ZD&,9;"XBRI&&.[.<]NAS4D^M7O]L^#8+K2K+[
M5J43O-(_+VS+%O=4]/3.>V/>HW\)ZJ/#%AH;'2KVVALUM98[I&VDKPLJ\'#
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M<7.P,XRSJ43)P.">OTK4L=)UG7;KPYXAO+Z*WGL%F!@:Q8&97.W<<N"A**I
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***IZG!=W-J(;2[^R,S
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M+&9,;<!F!;&1G'KWYP6GB+5+GQU?Z0=,=;.UMXW5Q-&=X=FP_K@[< 9]2>U
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MH6N4BLC=7'[B-(_,D\PCY !DYQQQ7,'QJ;>WTR^O]*FM=,U*5(H)_-5F0O\
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M=8AFTGQ(DVG1WMEIT++.GFD>=^[WNG*\84CN>N*IKXIATZS\/:=865G;-?V
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M;<BD[1D@9QGTKD[35-<O/$OB^QO/LK6EG#$J*DC#RU:)W&!M^9CD9)QT'7%
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M 4D"Y5AP,XYZ=ZZCPJUY8:W=:?J.F007MW&;N2YCOOM#R;2J /E5(P&&WC&
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MDS&,Y)X<'-=!>>'=1U'Q7;:E=1V7V-M+DL+J-9WW9D(+%/DP0,8&2,YSQTH
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MM(C$D<MLS!H#,V5^_C<?7D>U3:7XC32=$O$32]/M)QK1TJVM[./9$TI*J&;
M]R2<#@8ZT =[17-#4?$]FNLB[TVVO/LT EL9+7,?VEB#F,J68@@CKGO6-I/C
M'4]6UZ?0X+O2I;@Z?]JCN8(G*0R!@KQNN\A\$]58=* .RU35K#1;%KW4KJ.V
MME(5I).@).!5L$,H(.0>0:\IL=:U:#X-0ZUJ":=JFYTD$=U Q&&FP2WS$,P8
M@C 4#%=K-K%_?>(+[1M(-M%)801R7$US$TB[I-VQ JLIZ*23G\* .BHKSNX^
M(>HQZ5I\L>F6_P#:#ZR-&O+:21E5)N<%6Q]T\'.#P>];^AZSJTGB34=$UF.S
M,T$$5S#+:*RJR.6!!#$G(*]>_H* -;5M%TW7+5;;4[*&[A5@ZK*N=K#N/0TF
ME:'I>APO%IEC!:JYR_EK@L?<]3^-:%<;_P )-JU_IVKZOI(L9+'3YI(T@>-V
MDN1%]\APP"YY ^5N@/>@#LJ*X"Y\9ZWJ&LV%GX=M;"2/4-).H0->;U*G(P&P
M?PX]0<\<]7J,NL1^'99K*.V.K)!O6-U9XVD R5&"#R<@'/I0!J45YTWQ"N1:
M>%;\3V#6>IA5OPMN[- V0K$8?"J'94^;."<\]*U[WQ%K$5MK%W9PV4]K;7BV
MT+L=@B50/.EE9F (1MPP-OW3S0!T][>V^G6,][=R"*VMXVDE<@G:H&2<#FBS
MO+?4+*"\M)1+;SH)(W'1E(R#7":9XTO=2T_Q9#_H=XVCP)+#.;=XX[E'C9_F
M0DGHI'!P00:EN_%6KZ?IO@[4(X-/33-4^S17@\EQ]G:1005(; 7G R#C Y.:
M .]HKCK[Q9?65GJ=X88I(?[133]-5(7+2-D*[,-WS8?> !C.SKSQ1/BKQ-:Z
M7K=Q/IF8K*T>ZM[RXM6@5RHR8VC+DY]&!Q^- '?U1&L:>VMMHPN5_M!8/M!@
MP<^7G&[.,=:S_#EUX@O%>YUB#3X;:6**2V2V9BZDC+!R>#CCI5=M4O(O'\VG
M&"V>#^RS=1LB$3,1(%VEL],YQ@=Z .FHKA_!_BV\\07Z(][82?NF:\LO(:&X
MLY1MPF&;YUR6&['4#UK1\8^(Y?#R6#%A:V=Q*4N+]H#*EN,?+E01]X\9/ P:
M .GHKC;;Q'JUY_8^G++I_P#:-^)YWN85+PBV1B$D1=_)8%, L<9.1QBJ&H^-
M-5TNP\36T@LY-4T-(I5D,3>7<1.,@E0V58=#R10!Z#4%Y96NHVDEK>V\5S;R
M##Q2H&5N<\@\5BWNM7EKXWTK1U$#6E[;3RL2A\Q6CVXP=V,'=Z5RK>-M>N/#
M=CKMC]C+WVH&Q33Y(&+0Y=E&XAP2XVY(XX/;K0!U7AVT\,6%[?V.@VEK;W-J
MRK=+%"592V2H+$<]#W-=#7G+-KJ>+/&#:3-8Q3QV]I(\L\;."PB8[54$8!/<
MDX]#U$3:KK6OZIX(OK;4(K*/4()IC!]G\Q5D6+DGY@3PQ '&/>@#TNBN?\<2
M7D/@G6)["Z^RSPVDDGF;-QPJDD#G@G&,]JQM+U/5(;?PYH,5W#)=WEE]IDN6
M@P(8%5  %W?,Q+ 9SZG% '<TA8*"3T'-<]H&L7MQK.K:+J2QM=:<8V6>)2JS
M12 E3M)."-I!YQQ67J3:B_Q5TNWCU%H[8Z=-*(?+! (= ?J3Z]NW>@#J=,U>
MQUBWDGL)C+'%*T+DHR%77AAA@#Q2:EHVEZRD::GIUK>K&24%Q"LFTGTR.*\X
MAU/6]#T#Q1K%A+9K;66MW<CP2QL[3CS0"-V1LZGL:Z#6_$^J?\)%>:-H]G<R
M26ELDKR10)+EWW;00SKA0%[9)SVQR ==9V=KI]JEK96\5O;QC"11(%5?H!4]
M9N@7>HWNA6EQJUD++4'3]_;@Y","1QR>#C/7O7!V_C+Q1K&-4T/3+B[L_MC0
MK!Y$:Q/"KE2V\R!_,P,] HZ8.,D ].JEJ6JVFDP)+=R%?,D$42(I9Y'/154<
MDUPLOB7Q//J7C"&"[TV"#0U$B.]JS%AY9?:1OXZ<MS["H=<O+W78? 6K+<BW
M%Y>0R"$1!A&[1.2<GD]QB@#O=(UNQURUDGL9'812M#*DD;(\<B]592 016A7
M'I=ZOK&KZMI^EZC%8?V6T<;2&V60W$K(&)8'HO(&!SUY%9,'C/7-7L_#TE@+
M*UFO[J:RN8Y8F<))&KDLIW#*_+D#'MF@#O;:PLK*6XEM;2""2X?S)FCC"F1O
M[S$=3[FK-<3;WWB#4-2NM &IPV]_IEG%)-=10J1<2ONV_*P.U,*-V.<G@C%-
MN]?UR?4+/05BD@U0Z>+R[?3Q%(4._8 GG,%QD-GJ>@]Z .XK-L-=L-2U74=-
MM97:ZTXHMRK1LNTN"5P2.> >E<Q:Z[XB?^R-"U.);#6+UY]]ROEMB&, ^8J@
MLNYLJ,<@')P15/P%!<VOQ"\=0W=XUY,LEGF=T5"P\MR,A0!D# X SC- 'H4L
MBQ1/(P8J@+$(I8\>@')/L*Q8KKPYXSMYK9H[?4$M90);>ZMR&B?'!*. 0<$X
M./6MVO,M0T?4].UK5/%V@H9;Z"]9+JS4G%Y;A$RIST=3D@@?G0!WECJ&G&\E
MT>S5HY+)%#1"W=$C4_= )4*1QQ@]JT:\\C\:67]G:_XIT\K+#]BM6C60X <E
MU"OCIAB :T9K_6] U?1/ME]_:5EJDHMI_P!PB_9Y2I93&5 ^0X(PQ8X&<T =
ME62VHZ3<>)UTMX@^J6UN;E&> _)&2%)5R,<YP<'^55_%>KW&E6%I'9-&EY?W
MD=E!)(,K&SY)8COA58@=SBN1EDNO#OQ'U2_OM1FU);;PT]PAEC1&"K+DK\B@
M'D$YQW]J /3*S]*UJRUE;LV3NWV2Y:UF#QLA610"1@@'^(5RNDW_ (LEU+2+
MMHIY],NX\WGVG[-''%N *-#L8N>>,,3UJCI5[<Z?HOC6YM+BWMY5\0S#SK@X
M5%(B#$9ZM@G [G H ] N[*TOXA%>6L%S&#D)-&'&?7!J6***WB6*&-(XT&%1
M% "CT %<)INH:]JTWB72;35;N.>TB@EL;F[M(TERZN<.NP#:2@ZJ#@FI/#?B
M*Z\06/AV.'4I?MF'DU0&.,-^[^5D8;<+F0J!C!V@\YYH ZS6-4AT72;G49XI
MY8K=-[) F]VY[#O5FVN%NK6&X175945U#KM8 C/(['VK&\9W]YI7@[5=0L)A
M#=6UNTD;E V"!Z'BL?5-0U^7QAI6D6-\D%M?:?+++)Y"LT)7;\XSU.3@=OFY
M!Q0!VU1O/$CE"X\P(7V#EBH[@=37,> M6O=2TS4K;4+H75SIFI3V#3^6$,@C
M(PS <9P>U9L5G='XQW0.KWQC&EQW B/E[0#,P\L#9PORCI\Q[DT =1X>\06?
MB;2AJ-BLRP&1XP)E"ME3@\9-:M>%Z+?ZUH/P[M=;L=5,<$.JM&UD(5*RJTQ#
M;F.3WXQC'UYKK[_5_$FN:UKMIH+31-I<B0P;'C2,R;0Q,@=26!.1@8&/4G-
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MK1D JP!!![]1^=:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/OJ%^L$+QW$T3^7D(!&Y7/)]!0!<TOP]8:1?7MY:>>)KU_,N#),SAV]<$X!
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MC--@RL85)DYS\W'///-8OAN[U'3_  _=7'B34OM AG;9=O;^07CPN/DZ_>W
M<9/&.HK6TS6]/UCSA93,[P%1*DD3QNF1D95P",CVH F&F6"W1NA8VPN&7:91
M$N\C&,9QG&.*?:V5K81&*SMH;>,G<4AC" GUP._ KC?$EWJ<7Q%\-Z7:ZM=6
MUGJ27!GCC6,\QIN&"RDC)ZTFCZYJ=K\2+GPM<7_]JVHLA="=HT62W;=C8^P
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M>JVME:V2,EI;0P(QW%8HPH)]>*BCTK3HG+QV%JCF3S2RPJ#OY&[IUY//7DT
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M1]TC.3[5>M8]<.M>(/#*>(+N21+6*[M+V54\R)VR"I^7:5RO3'0GZT =_17
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MMZGVJU0!A6/A>WLY[.:2^OKN2RB,5J;AU/D@C:2-JC<<<9;)_6LS_A76G?\
M"+W/A[^TM3%E<W)N96#QARQ.2,[,;<@'IVZXXKL** .6U/P)I^J:K#JC7VIV
MU^D2PR7%I<>2TZCL^T8YSVQ^%=':VD%C:16MM&L4$2A41>@ J*XU&UMKVTLY
M90+B[9EBC').U2Q/L !U]2!WJW0!SA\%Z>)+Q8[B[BL;Z4S75@CKY,K'[V05
MW -QD!@#Z=:;K_@?2_$%Y:WDDU[8W=LGE)/83^2YC_N$@=*Z6B@#EM5^'^A:
MK8Z?;>7/:-I__'M/:2F.6//7YN<Y/))YSSUI;KP'I-S'IP6:_MY;!G:.X@NF
M65]^-^]^K;L#/.?I745C>)]7N]!T6XU2WLXKJ*VC:2:-YC&Q4?W2%;)]CCZT
M 9<'P^TFTC"6EWJ=OLNC=0E+HGR7(8?*&R,?.V<@YSSFK$W@C2[C19]+DENS
M%<W/VNYD$H$D\N0=S'&.JKP !P*GL/$D6M^%FUG2 CMY9;R9VVE&7[R/C)!'
M-7M)OI;O1+6^O5AA>:)96".2JAAD#) ]: *MUX9M+G4EU%;F[MKWR/L\D]O*
M$,J=MXQ@D<X.,C-0R^#=)<:.L:RP1Z0_F6J1/@!NY;()8GOGKDUT ((!!R#3
M)9$BC+NZHH[LV!^= &7IOAVSTO6=3U2!YS<ZDRM<;W!4E00N!CC .*=J6A1:
MC>PWGVR]M9XHWB#6TVS*MC((P<]!CTJMX6UNXUNROIKI($:VOI[4&$DJ1&V,
MY/K5G7M4?3?#&I:K9B&9[6VDG0,WRML4DC(^AH IV_@S2;74=+O;830OID+0
MVZ*_R[6SNW9&23G))-53\/=%:PNK1WO2MQ??VB7$Y5TN/[ZD 8/Z5N:9J'VO
M0["^N6CB:X@CD;G"AF4' S]:NF1%.&=0?<T <Q%\/]%A;46C>^#:C!]GN2;M
MVWKC!)W$Y8C(R<GDXQ4K>"M.:TT:V%S?+'I#!K3;*!@C@$\<X''TKHA(AD,8
M=2X&2N>0/I2NZQJ6=@JCJ2< 4 5=4T^'5M+N=/N&D6&YC,4AC;:VT\$ ^XXK
M,3PCIJPZ3&\EY)_97_'HQN&!3C'.W&[Y?EY[<=S6X)$,?F!U*8SNSQCUS0DL
M<A8(ZL5Z@'.* ,&;P?I4U]=W(%Q&MZ0UW;Q3,L5P1QEU]^^,9[YJ;4O"^F:K
MJECJ%PDRW%F"D9AF:,,A(.U@I&5R <>U5O$.N36FIZ=H]C<6MO>7WFMY]PN]
M(5103E0RY)) '([GMBK^E7EVMG;P:W)8Q:JP.Z.WERK@' 90W..GT)H M:CI
M]IJNGSV-] D]K.NR2-^C#_/>LG0_!>A^'[:>"RM"RSIY<AN',I*?W/FSA?;I
M5P/JY\12QL;$:5]E!B 9C.9MW)(Z;<50\)>(9]9T>2YU+[+#<)>36V(B55MC
ME>-Q)[4 3:;X1TK2YXI(!<NMN3]FAGN7DCM^,?NU8D+QD9Z@$@<5%_PA.B_8
M=3LS'=&#4Y/,NU-U(3(W<YW9&>^.M;WGQ&1H_-3>HR5W#('TH6XA<X6:,G;N
MP&'3U^E '/GP-HA(VB]3_1EM&\N^F7?$N=JMAN0,GK5BY\(:'=:A87LED!-8
MQ"&#RW9%$8.0A4'#*".AR*U;6]M;U"]I<PW" X+12!P#Z<5C^)=6OM)N-$^R
MF#R;S48[2=9$);:V3E2" /NGJ#UH (/!FB06FJVHMY7AU5B]XDEQ(WF,>IY/
M!/MCH/2F3>!M!GTZULI+:7R[60R12"YD$H8C!S(&W'(P.3T '85LC4K%H6F6
M]MS$K^6SB5=H;.-N<]<]J/[1LA%%+]LM_+E?RXW\U<.V<;0<\G(/'M0!CKX'
M\.II^H6$>GK':Z@X>XB21E4L"""H!^4@@=,=!4>H> /#.JV=I:WFF+*EH,1-
MYCAP"<G+ Y;)))R3DDFND9@JEF("@9))X JM;ZE8W<3RVU[;31Q_?>.56"_4
M@\4 2VMK!96L5M;1)%!$H2.-!@*!T KG;SX>^%[^>\FN-+5GO'$DN)'4;\@[
ME .%8D#)&"><]36]'J-E-,D,5Y;O*Z"1$652S(>C 9Y'O3(=5TZXCE>#4+65
M(1NE9)E8(/5L'C\: )[:WAM+:.WMXUCAB4*B*,!0.U11Z;:0ZG/J*0@7=Q&D
M<DF3EE7.T>WWC4\4T4\*S0R))$XW*Z,"I'J"*K-JNG*4#7]J"[[%!F7YF]!S
MR>1Q0!7D\.Z1-H<FBR6,;Z=(26@.<'+;S[_>.?:JMCX+\/:;?1WMGID<-S'$
M85D5FW;3WSGEN2-W7!QFM*^U;3M+$9U"_M;02MMC\^94WGT&3S3YM0L[9PL]
MW!$S*7 >0*2HY)Y[#UH @TO0].T73CI]A;F*T)8^4TC./FZXW$X!]/<^M2VN
MFV5EID>FV]M&EE''Y2PXRNS&,<]?QK)A\::%<:[-I46I6K/# )GE$Z[.2?E!
MSR<#/L*UDU33Y+)[Q+ZV:U3(>=95*+CU;.* ,O3_  3X;TG[6;#28;=KI&CE
M:,L#M;J%.<J/]W%7M&T/3O#]E]BTNW-O;;BPC\QF )]-Q./H*N7-S!9VTES<
MS1PP1*6>21@JJ!U))Z"LC0O%ND:_I$FI6MY ((F82[I5S$ Q +\_+D#(SV-
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MU5LY(QT)!KT72+*?3M+@M+F_FOYHP0US, '?))&<>@./PK'E\#:6Z::L<M[
M=.E,\+13?,TIZNY()9CSG/7-=-0!Y@VI7VI?#V^\:6^JWT%_&9IX81*?*B5)
M"!$T7W6^48)(SDDYZ5/)'K'B;Q4]I%KVH:7:S:-;7IBA(#1R.[<#T'R\]STS
MCBND;P1I+7%RP-REM=3>?<62S'[/*^<DLGN>2.A[BK*>%[1/%)\0BZO/MAB\
M@IYH\OR^R[<= >?K0!:UD7H\/7R6$RI?FV=;>5R /-*D*3GC[V*X"SU5Y-)\
M1PM+K6G:G9Z:T[6-[<O(T;J&82QR[CN4G QTXZ8->AZOI=OK6E3Z==-(L,P
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MP2 .WN.>AXH -&O[<:;IEM+JJ75U+;*R/)B.2Y ',@0G//6JWCG_ )$?6?\
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M3Q;I(I<PS[9<O-&6/W"23QQUJ]XEU)])UW5;O2]5M;QFN(1>Z!=;=\S;(\-
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M(_:!&RQ17A;>,A"RJ$SZ9PP&: -6SU*VOO&"O:^)8KB&33PZ:7$JL,%@?.+
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M$)#20RJZJ1UR0>*;8ZUI>IM,MAJ-I=&'_6"&97V?7!XH JGPKH1TP:;_ &9
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M6GM+<RE(=ZIMP%&>>ON>:Z"\\0:-I\LD5YJME;R1IO=)9U4JO')!/ ^8?F*
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MD>2+_0VWAED8X (Q][&<_A4WA\7?G7-X?$B:OI,B+Y+,D>Z-U^_\Z  C\.*
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M/I6O')'-$DL3J\;J&5E.0P/0@T <+-X1UE[V[$\7AS4X+BX>=9]0LBTT6[
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MZ/;"[_=6TCE8,X\Q@%R%]SVYJ+4KNRO-:\//'KMS;"5FD@@MP?+O04R QQC
M )Y_PH WEM+9/,VV\0\P$/A -P]_6JEQHUO<W]C</Q'9$M# J@*'(P&SUX!/
M'3OU J*U\2Z3>G41!<.3IV1=AH)%,6!GH5&>!GC-%QXBT^WAMY!]HE-Q$9HX
MH;=WD,8 )8J!D#D=0.2!UH UJCC@ABW^7$B;SEMJ@;C[^M84OCGPY%!I\QU)
M7CU!6:U:.-V\P+U P.N>-O7/&,UHVFLV=_HD>L6AEFM)(O-39$Q=A[+C.?;%
M %V.&*+_ %<:)P!\J@<#H*<R*Z[74,OH1D5Y?JWC.?7/AQ-K=J;W398KR/8Z
MJ\0,9N F-_1OE^]@X!KM]-\5Z/JVH3V-K</Y\,0G*RPO&&C)QO4L!N7/<<4
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MDDR04P<8(P<DG P3FJ=QXFM=9TS7-/C@OK6^M+1S<1NI1H6*$K\ZG&3U!!H
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M0U8&LW7_  A?Q)TG5K[4H6@UB)K.\_=B,+MP8Y",^IP6/05Z;@9SCF@J#U%
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M<U)O%=EJMAI<VBW NV.HO'/']FNX06P2BN27;@Y*C!)ST%)X?TKQ7HT0\/\
M]DV!LXICY.L>:I(A+ECF(\E\$@=ORY]$HH Q?%FAMXD\+W^D)/Y$EP@V28SM
M96##/MD#-8LNFZOXDN?#YU?3#8_V9<B\GD,Z.LDJ A0@4DX).[+8QC&#75P:
MA9W-W<6D%U#)<6VWSXD<%H]W(W#MG!JS0!ROAO3]2LO$OB*[N[(Q6VH7$<L#
M^8C$!8PI# 'CIGOUKJJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<#J>@K5D\=Z!#I#:G+=2) EQ]FE#0MNAESC;(,?(?KBO.K#3-5L/"_A#4YM
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M*X>348%BCF !4.$+88DYZ ]C5^PU37=2AN;N\T2?3K:.V9%M&9))IY3CD8/
M&"!D\[LG&*YVWTW6+3P;X,F71[F6YT>X4W5F"HEV['C)7)P?O ]>GI0!UO\
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MZIJ.J:U\'-7O]5BMY"UTSQNLK.RL+H+M"LOR@ $##'CZFO8.W->:OX+\3?\
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MR<?Q#KZ"NMKFM"TSQ+'+;OX@U>VN!;!@BV<;1^<2,;I><' SA0,9.>H&.EH
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MM^(O%*>';O3K=].N[HW\WDQF#:?GP3C!.>WTYY/% '04R6:*",R2R)&@ZL[
M ?C7&?\ "PQ;6FN?VEHUS:W^CH)9K42*^^)C\KJ_ (QU]/>JWB+7;35/"-Y<
M:YX7NY-(W6SQ[IU7SE=QM<;6RN"5R.O/(ZT =\*;+-%"NZ61(U) RS #)Z"L
M*3Q*+;QE;>')[(Q?:8&FM[DR#;(%ZJ!C.X>GIS6/XEUO3+WPJM]JFC"ZT_\
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MNK&^D(\M@N58,H[ X_/BN@;P-X6?5#J+:%8FZ+;BYB&"V<YV],Y[XKH>@P*
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M\MO9-9R11685&7<"-OS9'(!/7VQVK0^ ]03P3?>'7U:V+7ET9VN1:D;0S!V
M3?UW#CGIVK=TSQ3%J>H06Z:9J,4-S"9[:[DB7R9D'0@AB5R,$!@#@UO4 9]W
MI\NI^'Y].O9PLMS;-#-+;KMP67!*@YQUX!S6!8>$+T0:/9:KJ4-Q8:/Y9MHH
M+?RS*T8Q&TA+-]T<X7&3S[5U]% '"VO@+4;"[N;2S\230^'KF5Y9+ 0*9!N.
M6193R%//OCWYK>\5>&H_$^DK:-=2VEQ#,MQ;7,7WH95^ZV._7IQ]16Y10!R,
M7A35I]%U"'5=?^V:G>6S6@N&M@(H8FZ[8U(RQ[DGJ!V&"EYX0U*[\(6&@C6K
M9/LAA_?BQ)++$5*#;YG!RHR>_H*VM$UV'7$OC#;W$#6=TUI(LX .]0I)&">,
M,*TW=8T9W8*JC+,3@ >M '):OX.U&^UFVUS3_$#Z;JR6XMYY([820S("2/W;
M-QR?4TS4O  N8=,FT_6+JRU;3Y'DCOV42F0R',F]20#N.>. .G3BKNE^+QJE
M[:)'I-^ME?*S6E]M#1.%!)W8.4R!D;NOZ5TM '&ZAX%GU#1K6&76Y'U6#4(]
M1.H26X(:5!@?NP0 N  !GMWJW%X6OD\8VFORZPLWD61LWB>U :12=Q8L& !W
M8/"]./>NED8I&SA6<J"=J]3["LG1O$5KK&DOJ/EO:1+.\!6X(#!E<IS@D<D>
MM $'_")V0\;'Q0#BY-KY!C"\%L_ZPG^]M.WZ5FW_ (&N7\17&K:-XAN](%[C
M[=##$KB8@8#*6^XV.^#772R-'"[K&TC*I(1,9;V&2!GZFLGPMXB@\5>'X-8M
MH9(89F<*DN-PVL5YQQVH GN]$MKKPU-H0:2.UDM#: J<LJ%-O4]3CUK#'@NY
M-II<DFNSOK&F;A;7Q@0+M90I1HQC*X XSG/.:ZZB@#)T?0QIDUW>3W+76H7K
M(US<%0@;:NU0JC[J@=LGJ>:Q+OP%N\17>J:=KM_IL=__ ,?]O;[2)CC&5)^X
M?<<^F*[&B@# MO#$=GXE76+>Y*!+%;".V$8V+$I)7GKG)_+BLB'X=1V]CI4,
M.LW<<VEW,UQ;3K&F1YN2P(((/).#CC-=M10!PLOPTMVL]2M5UF^\K4+U+V7S
M%1B)%.20=HZD#/TXK2O_  ])#K\GBI;B>XO(-,>U%K"@7S0,O@'LQ;I^ J[J
M?B'^SO$FCZ0UE*_]IM(JW 90B%$+$8ZD\#L!SU[5MT >/:%YUO86QT77]5FU
M4(J?8Y-(49<8RLKF,$+GJQ;WR378W'@"U?6KN^M=6U*QM[Y_,O;*VE"Q3MC!
M/3(W=\<GVKL*,4 <W8:5>V_C6\ODNKW^S3;"'[-*Z^0KC9M,2CD  ,"3CD]^
MW2444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% '(7/B;77\3ZKHNG:3:2M9V\<Z2RW)565@>"-N021@ <=R
M:Q[;XDZC<:'HFNMHL,>EZA=):2$W.9 Y8J650N-H96ZG)QVK=@T36(/&.L:R
M/L+07EHD$,9E<,"F=I;Y<8.XYQG''6N>C^'^M0_#[1?#JSV#7&G7XNC*9'".
MH=G ^[D'+8_"@#IG\0WU]JVIV&B6MM.=,"+.T\Q0/(PW>6N <<=6/<XQQ56T
M\;QZU'I$6C0K)>:C&\S),V%MD0[7+XZG=\H'<T+H&LZ-XBU+4]$^PS1ZL8WN
M(+J1D$$BC&]2JG<#GD''3K5%O 5[I1T:^T"_A74[!9$G-VI\JZ60[I,[>5^8
MDC'3\* ,FSNYK#P]X]NM1TBPN6@OR\MDS9A<"*,C^$YZ X(Z^E7O$,U_>ZUX
M%6W2UCMYY3<)"VX*KK 6&<=AGC%3OX0\0S:'XHM+B\TR2?6VW@HKHL;%%4^I
MP O QSZ\X%F]\.:]-<^%IX/[.5M&'[P-,_[TF/8P'R<#'?WH =H^LOI7BG4M
M"O[.QT^)8#J$<L!8"XW',CX/0@YR.O>NCT6[NK_2+:\NX5AEG7S!&N?E4\KG
M/?&,UR7B:#1O%GB32=.MKP2:E8W+_:E@.3';E2)4D]%;Y4QWW?6N]  &!P*
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M6QM8HW,D?FKE7\PM@^I&WCID]:WD\,7L>H^(+L:I#C5XU39]D/[G:NQ2#O\
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MQ10<[5'8>OK@>@JMJ_@N'5=<DU-=3O[3[1:BUNH;=U"S1@D@9()7J1QV].:
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MJM]/6UTM;".XN2%C*":24R2\_P 6YLY/UKGE^'NE)X7A\/)=:@EA#<?:$"S
M,&SN SMZ;OFQZT 8LS:]XIU#7AI=^UE-I]Z;:W)O9(A#M"G<T00K(&.3ECR#
MQC%5YY-6\0^/H=+C\1W5K;7'AU+PMI[X3S#(!N3(S@\'/7&1D9KI=4^'VA:O
MK']J3I<QW#*%G\B<QK< =/, ^]Z5>/A:P_X26/7TDN8[V.$6ZA),1^4/^6>W
M&-N>?KB@#B[<^(-?@UBXL-6%M=6%^\"33W[HL"Q$#YX0FQ@R@L2Q_B[8Q6[I
M,UQ<^,-5LIK^:6UFTRVN=L=PVQ'<N&,39RH.T$8-6[WP!H%]KQUB2VD2X<YG
MCCE*Q7'_ %T0<-_7OFK6H>$-)U/68=4GCF%PD7D,L<S(DT><A'4<,H/.#Q0!
MPVFZCK.J>&_!,G]N7L$]]>3PW$R%274"4C((()P@ S^52S:]J7A33O&EHM]=
MW_\ 9DEO]EN+MO,DC\]%R6/'"DY%=7:> ]%L8--AMS>HFFR-+;#[4^%<]3C.
M.<GC&.3QR:LKX0TD7.JS2Q2SG55VWB3RLZ2 <#@\# X&.E '*ZKIL6G?$7P,
M8]0OKDRF[R+BX>4/B'[XR<*?F[ #D>E9^EW'B;7=(M_$EOK-E:*EVTL[/>S,
M@0,08FAQL'&/?H<Y.:[&P\ Z%IUS87$,=T\M@2;5I;N1_*!&-JY;A<=NE.MO
M 7AVSUJ35;>Q,<\DGFM&)6\HO_>\O.W.>1QP>10!A:#I^H:QXHUR6?Q#JR6^
MFZJ%AMHY@$90BL5;(.5.0,< <^M>@J0PR"#VXK'TGPS8:-J-[?6C77G7K;[C
MS+AG5V]=I. >W';BK&BZ'8^'[%K/3HFC@:5I2K.6^9CD\DT :-%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!7@L;2VGFG@M88I9SF61(PK2'U8CK^-6*** "BBB@
M HHHH **** "BBB@ HHHH JPZ=96]P]Q!9V\4S_?D2)59OJ0,FK5%% !1110
M 4P0QK*TJQH)& #.!R?J:?10 57AL+2VD,D%K!$Y))9(PI))R>1ZGFK%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %-=MJYVLWLM.HH 0&EI ,4M !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ=#=0:0YBF\V8H\TBJ&=4 4] 1@GJ3CCK5*[\?R2W>D6^BZ3]O.KV;W-HS7
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M:]=3ZA8ZLFJ7=L8(9)[5438BD[1M)&3R:I)I=_\ \(!X4L/[-NC<65Y ]Q$
M,QA2<GK@_A706?PG\-6J 2K>W; \/<7DC,/H01BK@^&OA<?\N$OT^U2__%4
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MQY<I89*J>Y7&#6*WPS\+$8&F+R,<S2$?^A5T]G:Q6-I';0KLBC&U5!)P/QH
MH>)_-;PSJ,,%O-<336[Q1QQ+DLS*0/8?4UD^*O#4FO6]KK.D_P"A^(+(>99S
M2+M/O'(.ZGD<],_6NK9U099@HSC).*=T&30!Y?J^BZI;V_@_5CH U:'3M/\
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M->HT4 >;A/$^A>)UUJU\/SWMKJ-C#!<6JS1K+;RQY"Y.<8P3T..?:I]9TWQ
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MPPP!XS0!S^G^%=4?Q38:YJKZ<MQ90O&TUBC*]V67;^]SP .2 ,\XZ8KLZ**
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M+(H!R<D@GC(XK9MTU/6/$'AG7K31TAL;2VF@FC^T+\A8A#LQPRC9D$<,""*
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M5HV_B&6_72#9VMO<)J%J]R^VX/R* O3Y,')8+SM_0U2U+P>U[X[M=:24)9M
M%O81_P MWC<-%D>QY_X"!WI/"7A.7PO_ &FWF?:!N:.PC) $<&6D"9QP=[L.
M_ 6@#G!K]S:^"/#LWA?2;73K74-5%LT#3D%,SL, A3C=M.6YV@X /;1DDO[/
MXFO+::3#+J5SHD;31K<;8E82MDM(5R1@8!"Y/' &2*]MX1UZ'P%I.G"&U&I:
M5J*W\<9F)2;$C2;"V/E/SXS@]/>NAL]*UK_A,&UN\CL%1M-6T*13N3O#E\\I
MTR<=>V?:@"+3_&RZGH^DW%M8D:AJ4LD$=I)+M"/'N\PLV#\J[>H&>1QS3+CQ
MK-9)KMK=:;''JNE6C7WD"X)CN( ,[D?9GL1@KU]N:RK/P5K6GZ9I5Q%)9G5=
M)O;BXA19F,4\<S$NA)4%3@X!P1Q[\:L_AB\UR?5]0U+R[2XOM+?3(88W\SR8
MVW$LS8&221P!P!U.: "3QM+CPHT>G(4\0(&&Z<@P$H'Q]WYASC/'TI_@S5M8
MU6]\0?VBEOY=MJ<ENGE2L=FU(\* 5&1R3NR.2>!6):^$/$SQ>%?M3:7%_P (
M^X1421V\Y FS?NV\$X'RX_'M70>&]$UC1M;UIII+%],O[V2]0H7,P9@HVD$!
M0,+[T 0>.=9U?29M CTT6XCO=4@MI"[D,V23MX4X4[<$\GGI62+C4K3XFZPV
MGZ5#<WLFE6SR)]H\N,,&?.7VDDGH/EYQSBNA\8Z#?:Y;Z4^G26ZW.G:C%?*M
MP6"/L##:2H)'WO2H+#1M:M_%U]K5PNGN+BQBMPL<SKF1"3G!0X4EL=21CO0!
M2'Q$MI?#VC7\<,4-SJJ.\<5P[;8PG#$E%)(S@#@9SVK8\)^)QXFLKB1K1[::
MVF,,BG<4;'1D8@%E(]@:Y:R\#^(M+T/PZ;"\TZ/6-&,L?SL[07$,ARP;Y00>
MG;MUKM=%MM3BCFGU>YBDNYV!,5N6\F$ 8"INY/<DGJ3["@#*UGQ1J-CXHMM!
ML-'2[GNK=IXI6N=B+M8 [_E.U>3R,G.!CGC%D^)L]OH,UU/H974;34$T^[L_
MM &UVZ,K8Y![9Q]>]3ZV=07XM:.VG1VTCC2Y_,2XD,89-Z]&"M@YVGIV-5-7
M\ ZI>Z5=F&6Q.IW^J1ZA<,[LL:*GW8U(4EL#N0.I..U %_4M6O?MN@G7/#%D
MDTFJBW@=KH3&(E21(OR#L#UP00*MW?BC4C!JE_IMA;7&GZ7+)%/OG82RF,9?
M8 I QR!D\D=JE\3:/JVKW6@S6B60%A>I>3"6=QDA2I5<(<_>/)QTZ54MO#.K
MZ0FM6&ERV)T[4I7FB,Q97M&D&'PH4AQGD#*T 1W'CRYGU"RLM%TE;Q]1TTWU
MD\EQY8/^RXQ\O&>A/.!P"2.O@DN9=/BDEA6&Z:(,T1;<$<CE<CJ >,BN1M?"
M%]IWBC0+JS^QMINE:>;$F21A,X(&6P$([=,]STKMJ /.;KXB:G;^#]5U<Z;:
M+?:9?FSFLC,S$XV@D' SR2W3[HK;U+Q5>6LE_+96UK>6EEI(U!Y/-*;F.XJH
M.#P50GIZ>M$G@R*;QM=ZU.Z/8W-NH>T(R'G"M'O(Q_SS8J.>YJMI?@NXTKP)
MJ6@)=I-<7:2PK-(2%2-E\M!TS\J!>/7//.: *%_XFU>Y\'S:IJOAG3Y-.D6T
MDBCFN-XD60C)*[3RK%#@XZ]>.=*:\UP_$:33[>6S%M'I@FBC=6P-TNTDX/)^
M0?05+J/AO4+[P!!X>66V6XCC@B:4LVS$3*<CC/.SIVS4]QHNKMXSMM<M+JRB
MB:S2TNH98GD; <N=A!7GG&3]<=J .=\.^*]1L_"$.H:FT-S->ZE+;0[0X_>&
M63.0 QV@*<  G  ]ZM7'CS4K73M?F;1BS:7&LL<[K)%#<H1D[=RYW*3@COZB
MJR> M=_L&32AK%G;_8[\WVEW$,+F17+LV9,M@\.PP![Y/2M*^\.^)-;\,ZG9
MZMJ%@;V]@%NBVRNEO"N<EL')9CQZ#@8QSD MV7B35F\2V&G:CI<-K!J%K)/!
MMGWR1E-N5D&,9PPZ$^G/6M;Q!K4/A[1+C4YXVD6( +&I +LQ"JH)X&216=/H
MVI7'B30M5+VBK8V\L4Z L2YDVY*\=M@Z]<_C5SQ1H$/BCPW>Z//(8UN$&V0#
M.Q@05..^"!Q0!GR^(=6T=[B77=-ACT^&R-T]Y:REE1QUB(;!)]".OI4-QXGU
M/1[C2I]8MK5;#4YTMT\@MYEM(ZY0/GAQD$$C&/0U!;^%M>U72I;#Q9JUO<P_
M9GMD6S1D\S< /-D)/S.,<   $D\FI;?PUJUU9Z3INLW%G+9:9+'*)(=WF7)C
M'R;E(PG."0"V<=LT 4KCQMKB:7KNH1Z19"+1KF2*;?<M^\"!2=F%Z\GKCMUJ
M75?'#I?6=M9365D;JS2[MVU)&"79;GRD<, C 8R3G[PXHD\):O+H/B?3&N+$
M#6+B2:-AO_=;P P/K@*,8]Z2Y\(ZO>:.-'NY=+N=/-A%:A)HV8P2JI4RH<=<
M$'''(ZB@"34/%]^UY)INGQ1)J-M:1W%RC6DUT [@D1XB^[T^\3W& :C?QCKL
MMUX<MH-#CMKC5HYS)#>NR-"\:\C[OW>00>21Q@=:67P7JFF:C9ZAX;U>*WN(
M[**RNEO(?,2Y6,85VP0=X']/QLR>&-4&N^'K\7T5Q_9BS^>\Y;?,TP <@#(4
M#&0.@Z< 4 8&O>)_$,O@+7S)]BMM0L+X6%P\(<HZ.4&Y.<J<2CD],'OR/1=/
M2]2QC74)+>2Z .]K>-D0\\8#,3TQWKCKOP5J6H:=XFL9[VUBCU:Z2[@>-69H
MG4H0&SP1^[7IZFNNTU+^.PC74YX)KODR/!&43KT4$DX'3DT <Z=?UO4AJUWH
ML-DUKID\EN(9E9Y+MXQEPK*P$?/RC(;)&>*YSQ%K-[KNJ> [[3+N*"TOYS-%
M%-;LQ20(>7PXW 9(P,=SDYKI;?PQJ&D7>L?V-?016NJS-<,LT99K>9@ SI@X
M;.,X.,>IZ5'=^"/WOA@:?=1P6^@G*1R1ES+\H7D@C'3/3J: .IM;9+:-ML<*
MRR-OF:*/8)'P 6QSUP.I)Z<UYM\2K^PU:>XT2368;"73[;[9&&G6,R776)>3
MT !)_P!Y:].;?Y;;"H?'!(R,UEZ!I=UI=G.E[<Q7-S/<23R31Q>7N+'CC)Z#
M"CGHHH R-(\5RZK\-1XBM1"]W'9M)(CD[?-0'>#CD<@_F*RK7Q;XIB@\.ZKJ
M5EI?]DZJT$3K;&0S1O*HVOD\!22..<9QD]:E;PW=^'-'\87#ZC#)I]_#<7*V
MPB*^1(4;)#%CP>_'7'2CPMHU_J_A;PP=0O+5].M(+:YBBAB(>1E0% Y+$#:<
M=!R1VZ4 3/XDUV^T:]\1:4MDVGV;S*ME)&QDN4B8AF\P'Y"=K;1M/N3GBE+?
M1:G\4_"6H09\JZTB:9,]=K#(_G6I!X0OM.@U+3-.U&&'2-0EDE96A)F@\S[Z
MQD'&.N"1QGO5N7PLP\3Z+JEI-;P6^F6S6RP&)BS(P QNW8& !CCUH PM-UG^
MP[3Q1.BJ]Q/XC:UMU?.TR2+"JYQV&<GV'K6Q'K.JZ5XNL-$U1X+R+4XY'M[F
M&$PF)XURR%2S9!&"#G(Z'/6JX\#RW.F:W9ZA?1.=0OOM\$L$!1K:7Y<$98YQ
ML7T[^O&I;Z#=3:U::KJUY#<W%E"\5LL$!B52^ [G+-DD #'0<_@ ;U>>>,)K
MJ#XI>#Y+.U%U.(;S;$91&&^09^8@XXKL=#L=1T_3_(U/5&U*X\QF\]H5C^4G
MA<#TK%UWPQJNI>+-,UVRU*RMVTZ.1(8IK1I WF+AMQ$B_AC'XT 7+*ZU.<ZE
M>WFCI#>VR%+6(39\Q2BMC?P.6&,XXQ7-:-XUU(:_IUEJ5S:7*7MI-+,EM 5%
MI-$ S(L@8K(.2."2".<9YV[CPYK6K?:%UC6K=H7LYK:.*RM6A57D7:9#ND8L
M0"0!TYK,M/ &J1W>A3W7B4S#2HW@$2V4:HT+*JE0.<$A<$G/L!W +NCZIXEU
MJ/3-:M_L/]EWLA+VC*1)% ?NOOS\S]R,8YQ[UR<6I>(-&T;QGJNE2V,5O9:W
M=2NLT;2/,<IE>H"C'?DD^F.>CT3P%J&BW2VJ>);A_#\4_GPZ;Y"@J0VY5,GW
MMH;!P,9_$U:D\$22>'_$.DMJ2[=9NI+EI!;\Q%R-P W\\*,=/QH ZN&7SH(Y
M<8WJ&QGID5Q\VM:]J%GK>I:5/:11:9/-!%:RPEC.8?O[GW#&2"!@<=\UUMG#
M);V4$,TJRR1H%:14VAB!C.,G'YUS;^#[B&?54TW5FM+#5G:6Z@:'S&1V&':)
MMPVEN^0PSTQ0!SNKW=YK^K^!-5M;L6L=\[RPQ-"',),!)R<_-Z=J](@A\F(*
M=I<\NRJ%W-W./>N>O?"1DO= DL+N*TMM%SY%N;<ONRFSD[A_#T]^3GI713+,
MUNZPR(DQ4A79-R@^I&1GZ9H \J^(EW:ZW<W\4>IF&?1D5[)$1VW78(=CE1CA
M0$&>A9O2NN_X2F34?AI-XFTMH4F6QDN0)4+J'1267 ([J1G/OS6OX?TF;1M(
M6RGNUNY0[NT_E>69"S%B6&3SDGFN-N?#C^#? /BBWFUB&6SNK6ZDBA: 1".1
MT;Y4.X\'LO6@!R>(?%.GW'AG4M0GLKC3=9DAMI+:&$JT#R+E6#Y^;OG@>@]:
MF?7];N_"E[XNL+V(V\#230V'E+L>"-B&#M][>0I.1@#I@U)X7T*75= \-75_
MK"7]I8Q1SV\44(4&4+A2[!CN*9(&-O(YR:O1^"C;V]_IMMJDL6B7SL\EEY8+
M('_UB))G*JV3D8.,G!% %(WB:A\1O#-[&"J7&CSRJ#U 8QD?SK-L=5_X1T>)
M%LT19[[Q.+6$ODHDDR1DNWJ!ECCOTXKKY?#:/XET_6(KDPBQMVMH[9(QL*-C
M(SU[#&/2L]O EK<6.KVMY>SS?VC>_;ED4!'MYN-I0C^[M7&<].<YH :FK:AH
MOC;3]#O[UK^VU6&1K:5XE22*2)0S!MH *D<CC(/'/6NNK#T_0)XM3BU/5-0_
MM"]@A,$+^0L2QJV-Q &3N;:,G/;@#FMR@ HHHH **** "BBB@ HHHH ****
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M7: V0H.=H48SCVKJ+6\UO2O%^@V5YJBW=MJMM.6MQ J) T:HPV$?,>N/F)H
M[FBN9\4:A>6FHZ1;P7OV>WN))%F2W3S+J4A<J(U*L,9Y9C@ =Q3? 6LWVM>'
M9)=29C<P7<UL6=%5R$; W!?EW>N.* .F#HS,JLI*G# 'H>O-.KS&V&H:9I7Q
M O[;6;W[39W4\D;2"-\E8(V&<I[;<#  [5<EN?$VG:1:7]_XC@9+^6US'':C
MS(P5/F)  K%W8[<9!P-QXH ]"HKRJ\\3Z_;^$/%TZW]S%=:5>(EL\\4/F!&V
M?*X4%3]\].>E=##=:YI_CVWTRXU4WT-YITMP8G@1$CE5E V8&[;SC#%C[F@#
MM*YZX\7VD-VT<=E?7%O'=BSENK>,/'%*0." =V!D D+@&N9\+ZW?7FN1:7JN
MHZE8:RT<C75A=HFR3Y<![=@F, C(&?7@\DX^AZQ<>&_ GB;58+B[N)8-6N;=
M8W"%%=I%'F<*#QNR><9SQ0!ZS<VEM>P&"[MXIX6P3'*@93CV-+;6MO90+!:P
M100KG;'$@51GDX KAK.'Q987<\MQ?-#9302$K=W4<TPF52P:+"!<''*G@ $@
M"KG@,:YJ.E6&O:IKCW2WEFNZT$"(BMG(8$<YQG/KGV  !V59^KZQ;:+:Q37
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MZ%@RG! R,C!J&_\ !MC>V6EV45U>6=KIDD<MM%;%,!T^ZQ+*Q)'UY[YKHZ*
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M.*X2WL[C[5;,+A]T,N2=RG/')/'3GI5L^%=,D@O8[@3SR7H1;B>29O,8(<J
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MV(EEBBD\TQN1@Y3.6 ]< XQ@<5V6D^&SI6N7^J?VA/<27L<4<RRJO/EJ54Y
M'/)SZY[5F)8V_@234]8N-1U*YLKRZ:06B1!UA>5]S, HW'GOV'8T )H.NW7B
M&;0);*_E-L=/-S?'9'AV)"*I^7(.Y9?NX'R&M'4;2\T30]7O=&B>]U6;=,JR
M8RQ[* ,#"CH.^.<DDF/P9HL&F6%Y=Q6IMFU*ZDNS$R;3&C'Y%QVXY([%B*UM
M9TTZMI<MFMU-:LY1EGAQO0JP8$9XZB@#G_ ^KMJQOF&MS7\48C7[/=PI%<VL
MOS;TD"JO^S@X[$=JA^)(G-AX?%LT:3G7;3RVD4LH;<<$@$$C/O6WI.@&PU2[
MU2ZO#=WUU&D3R")8UV(6*\#J?F.22>@Z5)X@T&'Q!9P02W$UN]M<QW4,L.-R
M2(<J<$$$>U '&W6J^)?#VI:MI-YJPOA)I4^I6EYY"1O"\?5-O(*].H[U;NM?
MU:.S\"727K ZK)!'>)Y:;9-\6XG[N0<^A K?M_#$1EO;C4[E]0NKR VSR.@0
M)"1RB*/N@Y)/<GZ"LBW^'D<8T<3:]JDXTF1'M5<QA5"@@#&W!Z]3DX  Q0!F
MQ>(-6_X3/^S]1U.?3+MK[;#9S0I]ENK4'CRI-N3(003\W7C Z!;S7->AMO'F
MW4U\W20KVK_9UPB^3O(QZ\]3GZ=JW1X,61[5+O5;NZMK6_\ [0AAD"_+)N+*
M-V,[03T_#I4<_@A9X_$*-JMR!KF/M!"+E !MPO'3;QSF@#.T[5/$-GXA\+Q7
M^JI>6VM6TI> 6ZH(62(."K#D^G/J3["A8:UXOUVWL?$>D[C9RS,S6TTL(@,
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M(K6^NC.ZDNR[B2S;20/N[C0!=C\=I+X4TS7AILFR_O%M1%YHS'F4QAB>_3.
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MO;R2'3_LIM6N)6F:W\Y1O8%LG )W8]JW?#>DZAI^MVNH'6+5;&^C(-K'<2W
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M,5RN@>'DF^&FG_V+#IZWUQ=[IX;AB$O5CDD/E-CV&<?[//% 'KE%<?\ #U[
M:=J=O::=/ID\5\WVNQD<,L$I1<B,C@H0 1]3VQ784 )6$-:N_P#A.O[">WA6
MU.GM=I,')=B'5<$8 7J?7/'3I7"V\%OKW@#7O$%^@A\06TETQN22)K22(G8@
M/50%"_*.#GWJ\=-C\4>+M&BUV.0M-X;$MS"CM$&<R1DJVT@XR<X]A0!U7C#7
MKCPYHT=];PPR9NH87\YB JNX4MQU(SZC^AO-+JX\11Q+;VQT<VQ9YBY$HFW=
M .A7%>0ZNLUO\,?$%A]IEN+"QUQ;:RDE)8B)9$^7)Z@'(S[5WLT:I\8K-UW9
M?192WS''$J#IT% '9TA=0RJ6 9N@)Y->*VFDR^(-,M;%8(Y]>&JM)=ZO%(FV
M6 2-N(<-N*X(4+CL/3-3>-$LGC\6SVWD/)IZP1)/=2 /:.J#:EL!\PR>2<C)
MR/FH ];-_;?VF-.\T&Z,)G,8ZA 0,GTR3Q]#Z56T>;6)7OO[7MK:!5N66T\A
MRQ>'^%F]#7'VUCHTGQ/2YGMK%G.C17'FNB$F83,-^3_%P!GKQ6$]U/H_A+QA
M)8ETQXC:&>17.Z*#,88YZXP2,]LY[4 >O*ZOG:P;!P<'.#3JX2?2+#2O'&@I
MH<$%O:ZC!<)?6]L L<D03<LF%XSN(&[J=U>?6=K%#\+="U]=_P#:D.JK'%<&
M1BR)Y[?*.< <G([YH ]Z,B!PA90Q&0N>33J\H\400Z=KNJZ[?V=KK6E">%9I
MHV5;O2V7;@+GJN=IP,9W'/<GU>@#G_%NN7F@V=A<6D4$@GOH;:7S<\*[!<J!
MW^M;RNCYVL&VG!P<X/I7'?$V,2^';"(NZ!]5M%W(VUAF0<@]C7,ZO;GPOK/B
MNU\.Q/;(V@I<^5"QXDWLAD'7Y@H_$C\: /5DECD9E1U8J<, <X/O2B1&.%=2
M<9P#VKRO3-.T29K/4-/UN&<7.GRPFRM+9$$D7EDGS@IS\I[G^(@=ZRH=*L-,
M^$VG>(8#)]IGBMX+ZZ+&7%N9EWKMSC ^[CTR/6@#V875N8C*)XC&#@OO& ?K
M3A-$75!(F]AN5=PR1ZBO*I-*T46GB6XL-7MM26YT65I;>S@C%NA1?W;L%) ?
MKC/)P?2KBW^E3Z[\.4CN;22Y$$BMM=2P4VK  GT+<8]: /2#/"K!3*@);: 6
M')]/K3+J80P,1+#'(01&93A=V.,^U>,W6@:2/ASXFO[6)1/8:M.;&=7+>0J3
M+@)SQD<$CKQG.!76_:]*O?B'XBT_Q&;5HX;> 6*7@4+Y+1_O2F[CEC@D<\ =
MJ .A\):Y-K/A2UU6_,$<LK2!_+^5!MD91C)] *W/-C\L2>8OEGD-GC\Z\0LK
MJ"+P[X%M6U&&STHRWZO<2QK+%'(&;RMV[C.&;&?7-7-:TC2;'X=:K%;ZK_:4
M8U:"6.Y&Q8XY'D3>(2AP/E)SC &3[T >R(Z2 E&5@#@D'/-,N;F"SMI+FYE2
M&")2SR.V%4#N3531]$TW0;1[72[5;:"20RLBL2"Q !/)/H*DU:*.;1[R.6-7
M0POE6&0>/2@#G=4\6.^BZ1JNBR026UY?V\#^:A+>7)(%R,'@X]<]:Z>&[MK@
M2&"XBE\IBLFQPVPCJ#CH:\E@?2[GX3>&K>*>W#&^L$NO(E"NK&09W%3E6QGG
MK6E<Z1I&G>,_$6FVMG:P6,OAY9Y;94 C:17?#%>F0,<_CWH ](CO;68D17,+
MD()"%<'"GHWT/K207]G=1O);W<$L:<.T<@8+]2.E>2-H^FZ?\,M"UFSM3)]I
MCLH]7N8W+LUKE6E5N?N@@*1V48Z"NKO+2%OB'HUUHQ@*7%E.-16'!62$*/*+
M8X^\0!ZC..!0!V37EJGE;KF%?-.(\N!O/MZTRXU&RM)8XKF\MX9)/N))*%+?
M0$\UXPVK:='\)/#-B]Y MW;ZC"LT)<;XBDQW;A_#C(Z^HK6UO5+./Q3XLTBY
M:QNVU."&-'N+J.!;;]WC:V\ABHSO!0'DXZ] #K=4\2W5GX]T#2X9K5M,OX+A
MY6*Y93&I;(?.,=.W8\\\=1;75O>0B:UGBGB.</$X93^(KRNXT/2K;Q?\/-)5
M;2YLDL[D$QJ!'.PB'SX'!W,,]\Y[UT/P\\N*^\6VL(1(HM:EV1(  @*KT Z=
M* .XJM)J-C'=K:27ENER_P!V%I5#M]%SFK->'^)]5TZ:P\1BTN[6U:+6U,D$
MS;[F65)8U,BG(\M  <8SWY&<4 >S3:E86WF>?>VT7E8\S?*J[,YQG)XS@X^E
M-;5M.26*)]0M5DF :-#,H+@]"!GD&N&M++0M8\>>*)I8;.ZB.GVK(3AEPZR;
MF],D$?-UP>O-95E;W-S\(/#NO:>_FZEH:"YC._EHT)62(GT*9&/8"@#U5+FW
MEGE@CGB>:+'F1JX+)GID=LU+6#X50W%E/K4D#PS:K+]HV2+AUCP%B5AV.P D
M>I-;U %*76=+@O5LIM1M([MB L#S*')/0;<YKF]8\4>9XMC\-V.K6MG*UG),
MUP2CE90X1(R#QU))'7CC%>>^+-1LI]-\4)!>0V;Q:RK26C9>::17C4RDY^2/
M XX_'G%=<MY93_'"VFCGA:.7PZ-C;A\Q,^1CW((- $5EXKU?6;[4-)M_$.BV
M^JV,4(BV%6@NW*EI#S\VT#CY<8YJYJ^N:]H_P\M]2.J6%YJ'VI(Y;BUC#1,K
M2["%[<=,XZ@U%X.FLV\?>.D:6 @SP':6'*B,AOP]:P+:\M$^ $*FYA4BX52"
MX&#]LW8^N.?IS0!Z3-<7:^+;:$:K9)9O;,38,!Y\C@_?7G.T#^7OQ9AUW2+J
M\-G!JEE+=*2#"DZLX(Z\ YXKC-7N8$^,>A3*RO\ \2J<X0@EAR0!ZYYQ7+Z/
MK5@;KP;<'4+:.UMKF5%LXE9VM T4F%ED(W-(3@8XSC@'K0!Z=I'B[1M:O;^U
MM+^V>2TD9"HF4EE4*6<#.=H+%<],BM"QUC3-39UL-1M;ID +""97*@]"<&O)
M$EG7PY\1--LF8:L=9N+C[,HQ*]OO0L0,=&3<!ZYKJ/"]]X=UWQ+;:KI5[?W]
M^+-HIGD 46\9((23"@$[N@R>A(Z4 >@5GG7=)6]FLCJ=F+J!"\L'GKO10,DL
MN<@>]:%<+XS2[T7Q-HWB?3[=KESNTZYMX^&F63_5<] !(!^= '41Z_HTVG-J
M,6JV3V*-L:Y6=3&&XX+9QGD?G67'JO\ 9FH:]>ZGXBLY]-@,>RV15WV?!R&(
MY)8C@'GBN4T#1KS2_$3^#YD>6P$T>L&?:-K8'S)T'_+958#T!%7+6:&;Q3\1
MK>*1'FD@AV1H<LQ%N5.!WP>#[T 2:MXX>XL?"6H:5>10P:EJ$$-W'E'*(XW%
M&/\ "0.O2NRTS6]+UF*673+^WNXX7*2-#(&"GWQ7D=UJ.EZEX1^'5J98I4@O
M[2*Z25<*-J8<'<,$#H>W-:.NVANM=\?Z?HLJO?7>F6S>0CC)9=RNJCUV[?Q;
MWH ](M/$&D7UU]EM=1MI9]GF"-) 2R_WE_O#W&147_"4:)_9<FIG4H!912F&
M28DA4<=5/H>:Y74;RT\2W?A!M!E475M>K/*(QEK: 1L)$<?PYRJX/.?I7,ZE
MJD-IX2\=Z#)%<MJ<NI74RVZ0L3Y4C@K)GIMQ[_S% 'I#>+-/'BP:!N;SQ!YK
M,4;&2P50#C!ZG)Z#BM^N%;5;2V^)UM/*TJQWNBQQVY$#G>WG,<8 X(!!.>@Z
MUW5 !1110 4444 %%%% !1110 4444 %%%% !124M !1110 4444 %%%% !1
M110 4444 %%%% &;_8L']O?VQYT_VKR?(QO&SR\YVXQZ\YZTP>'=.BT^_L[>
M(V\=_))+<F(X9V?[QSVSTK/U'Q'=GQ*?#VC6EO/?QVPNIGNIC'&B%MH VJQ+
M'Z8'KVJEK/C#4=)\):MJSZ1$EUILZPRV[W)*D%4.Y6"\C]X,# X].E %M_ >
MC2:7I^GEKQ8M.8M:/'<LDD.1@@,N#@^]5Q\-M %I=VH-]Y%U=B\D0W3']X.A
M&??DGJ>,DX%=5;2F>UAF(P9$5B!VR,U+0!@77@_2;[5+C4+M9IYKFR^PS!Y/
ME>$\E<#WYR.<U53P3INGM#?V:WMQ?V4+);>=?2'>!@JC$G[N5''3U!KJ:9*9
M!$YB56D"G8KMM!/8$X.![X- 'DND:!>C1K:TL['Q1INLH  3>%+."0<E@"Y5
MHP?X0"2.W>NUU+X?^'=6U9M3N;21;J0 3F"=XA-C^^%(!_SFKG@_7)?$GA2P
MU>>%(9+E68QH20N&('7V%;E &-%X9L(/$9UR(SI=F 6Y59"(_+ X7;TP.OUK
M9K!US6KS2]9T2VBMX'M=0NOL\DC.=Z'8S<+C&/EZY_"KNOW]QI?A^_U"UBBE
MEM8'F"2L54A1D\@'L#_]:@!NJ:);ZM-:32RW,,MHY>*2WF,9!(P<XZCV-4)O
M!6D3"TS]J5[6Z:\619VW-,>KL3U/;TQQTK2T:_;4= T[4)PD;W-M%,X7A064
M' S[FM"@#F[SP-HNH3ZK)>)<3C5%5;E'F;:=IRA [%<<8J2Q\&:1IVI#4;?[
M6+S[/]G:9KJ1F=?5LGYB,\$].,=!4FI:QJ%CXFTJPCTU)K"]WI)=>> T;A2P
M 3JPPIR1Z_GM[UW[-PW8SMSSCUH Y]O!.AMH4&BB"=;""7SXXQ<R95\D@YW9
MX))QG&>U;Z+L15W%L#&6/)^M.I%96SM8'!P<'O0!G:YH.G^(]/\ L&IQ/+:[
MP[1K(R;B.F2I!X//U J"X\*Z1=ZD=0N;>2:[-H;)I'G?YH2#E2N=O.2>G7FM
M=71F95925X(!Z4I8+C) R<#/>@#FK3P!X>LI[*:*WN&DLF8V[27<KE >-G+?
M<Q_#T_,UL2:18RZU#J[P*;Z&%H$E/4(Q!(_3]3ZU<:1$*AG52QPH)QGZ4/)'
M'C>ZKN.!N.,F@#"UOP7H/B&_@O\ 4+-FNX!M2>*9XGV_W25(R.3^9K:MK:&S
MM8K:VC6*") D:*.%4#  J0LH(!(&>F35#5]:L=%TM]0O)E6!<8P1ER>BKZDT
M 7)X8[FWD@F7=%*I1U]01@BN?@\">';:*RB@LYD2QE\ZW O)OD?&,_?YX& #
MD 9'<UT2.KJ&1@RGH0<@TZ@#'7POI"W>IW1MG>34TV7@DGD=95Q@ J6(&!P,
M 8'%1:'X-T'PY,9=*L?(?:4!:9Y-JDY(7<QV@D#.,9Q6[10 5EOX>TV3Q NN
M-'-_:*Q^2)!<R!=G]W9NVXSSC'7GK6I10!SFJ>&+<#6M2TRW!UF_M&A+3SR&
M.0[<*&0MMP/IZ^IKA]$\%&%HX[#PA>:%>*8]^H-JS.JD'E@BN=_? (QSVKUN
MB@#!C\':)%#J<207 34R6O!]LF_>D]>=_&>G&...E$G@O0)DTY9;)I/[.&VU
M9YY"R+_=+%LLOLV16]10  8&!6=K&A:;K]M';ZG:B>.*02Q_.R,C#H0RD$?G
M6C10!D7?AC2+RZCN9+5DG2/R=\$SPEH_[C;"-R^QR*TK>WAM+>.WMXDBAB4(
MD:+A54= !VJ6B@"CK*R/HE]'#$\LCP.B(F,L2I '/UKE? '@^#3/#.E'4;":
M+4;926BFG9TCDR?F5-Q13R>0 >37<44 8%UX(\-7NN)K5SI%O)J",&$ISRPZ
M$KG#'CJ0:OVVAZ?::I<ZG! R7ET )I?-8^8!TR"<<=O3M6A10!F66@:;I\UU
M-;6[*]T<W&Z5W$IQC+!B03CBHM-\+:+I,Z365EL:,$1!I'=80>HC5B0F>^T#
M-;%% &1:>&-(L;2]M;:U:.&]8O<J)G_>,>I)W9R>YZGO3/\ A$]$%I8VHLR(
M+!_,M4$T@$3>H^;KR?IDUM44 9]MHFGV>J7.I00,MY<C$TAD8[P.F03CCMZ=
MJT*** *#:+I[ZRNKM ?MZIY8E\QN$_NXSC'?&.O-4(_!7AR%)5ATJ&'S9Q<,
M8BR-Y@SA@001C)P!P,UO44 5=/TVSTNW:"R@6&-G,C8))9SU9B>23ZFK5%%
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MJ^@J_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% "4M-4Y&33J "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?9_M'VGROW!&<;=^?O<],5Q6E>(=9BDU7PY?ZC)<:ZFII;V\QBC4K;R+N63
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M\>#'A%W')SGICH.XH X1I;N#6] O-,\/^(K6TT>W-M':MIT<GF(V V6\X8)
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MCG2Y@@C'S9P5RP.15E+6^CT;1],7POXG\K2YQ-$V+?<Y!R W[SGJ:]=V#_\
M71M^GY4 >4E-1GNE^T^&/$<]F+PW:VDWV;RU?<2.?,R "<XKT31]/FL&O'FU
M"[NS=SM.B7)!\A3TC7'0"M/;1B@#)ET>>7Q/!JYU!_*AA:%;0Q*5&[!+;NN<
MJOX#'>L_Q#X2EUS7=+U:'5I;&?3=QA\N%6R6X;)/4$8&/K73T4 <W;>%9;/Q
M%K>M0:I(MQJL:(085(B*#"$>N!GKUJ[X9T,^'- MM)%VUU'; K'(Z!3M[ XZ
M_6M>B@#G+CPM(NK7E_I>K7.G-?[?M:1(CAV  #KN!VM@8R/RXJ'4_!<=U9Z+
M9Z??/I]MI$R3P1I$K@N@(4DGGHS9]<UU-% "*"% )R>Y]:Y"V^'\$&F+IS:S
MJ36L-VMS;Q@Q@0E7+J!E#GYCDD]:V/$^NGPWX?NM6^Q27:VZ[FC1U7 ]23V^
MF3STK4@E\ZWCEQC>H;'ID4 8TWA:TN==N-5N+BYF>XLOL,L#%/+:+).,!<]6
M)SFJ.A>!+70KJ)QJ>HWEM:G-E:W4VZ.V)!&0,#)P2!GH#^-=7FC- ''?$_RY
M/ EY;.6W32P*JIDL0)D+8 YX )_"M"P\/[[@:E<ZO=7]P(F2RG=8U^SQN.J@
M+M+'C+$'.!QUST%% '.:=X)TNP\)OX9D:>]TM@0([HJ2H)W8!55_BY!Z@U:L
M/#D5G=6MS/?WU_+:1&*W:[=#Y8( )&U5RQ  RV3^9K:S69!J-]+X@NK!]*DC
MLH8E>.^,@VRL>JA>O'//M0 P^'; ^*QXC*M]N%I]D'/R[=V[./7M]*AO/"]M
M?:^VKRWEX)'M&LF@4IY31-R01MSUYSG].*O1:SI\UA'?)=1FUED$22<@,Q?8
M /\ @7%7J .>L?"-M:7=A=37]]>S:?$T5FURT9,(8;21M1<G'&6S56W^'^DP
M^'YM&>>\GMWNOM:R2.HDBESG<I51@Y]C75$D D#)]*PO"OB4^)K;4939&T:R
MOY;)D,@?<4"Y;( QUZ<].M #T\-0B:ZN9K^]GO;BV^R_:Y#&'CCZX0*@4<\Y
MP><>E41X%LAI.BZ:NHZ@MOI$ZSV^&BW,ZYV[CLYQDCC'7G-=3FC- '.CP?:>
M<IDOKZ6V2]^WI:.Z&-)MY?(.W?C<2<;L?AQ6CKFC6^OZ/<:7=O*MO< +)Y1
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M8DX Z#M4FI:!I^JW5M=W"2K=6VX0SPS/$Z!NHRI'!]*MWU];:983WMY,L-M
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MT*21MT93VIPN[<W1M1/$;@+O,6\;POKCKBEFN8+>,R3S1Q(" 6=@H!)P!DT
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M.V\4Z/=Z_<:+!?0O>0*I=0XZG/RCGEAMR0.F: (;;P5X<LQ:_9M(MXOLKF2
MJ""C'&6!SG/ Y] !VJW%X=TB&6\D2PAW7H(NBPW>=G^\#UJQ!JNG7-[+907]
MK+=PC,L"3*SIVY4'(H.JZ<)$C-_:AWD,2KYRY9P0"H&>2"1Q[T 4++P?X<TZ
M:":TT6RAEMV+1.L0RA.,D'UX%;=8@\5:2WB9M!6\A-XD6]QY@^5L@!/=CG..
MO%;= !1110 4444 %%%% !1110 4444 %%%% "4M)2T %%%% !1110 4444
M%%%% !1110 4444 <A>ZQJ<7Q.L=%2Y46,^GR7'E^6,AP< D]2.^.*YR76O%
M*>%K_6SK<7_$MU.2$0BT7]^JS^7ASG@8/\.#[FNSN_#(N?%]MXB6]DCGM[<V
MZP^6"A4G)SWS6<W@4OX:O]$?6+AH;VY-S)+Y*!PS/O8#C'+8/2@!\6I7\GQ&
MU+0C>2"S;2UN8\*NZ)R^S*G'3C.#GD_A6%#XD\1WVA>#[BWO84N=4N7@N"\
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M=E?^#M"U359=2O+(R7$T/D2_O6"R)C #*#@X[9''X"J\7@/0+9(5MH;JV,4
MM@\%Y*C-$"3M8AN1ECU_I0!RNI7,YTO1;^"&[UKP^FDJ+GR+@Q74>0,3[ P+
M$A3W/0^^;T%Y'-XI\"2V&H74]G=:?< EY&"RA(TVLR9QN^8Y[_E71S>#]&E>
M%DAGMC%;+:*+6YDA!A7.$(5AD#<??FI#X5TG^TM-OTADCETV(Q6BQS.L<:$8
M(" XY& >.<#TH \^OQK.J:?K=DKZBOBAM2=;*XM'E6)(0R#B13L50A(()SDG
MC-:UQH<.I_$F\TFXO=1_L\:/%(T O9,.QD9<DDD]!Z\GKFL>W\&L][.;WP;>
M#4III7DN[35!#;MN<L#\K!@O(XVD\=S7H-GX7L8IHKVY\Z;5/L:VDUT+B0&1
M0N#P&P,G)]<G/7F@#@=+36-4^'_AJ6W5-7E@>Y:?3[JX*-=Q*[(.3P2N5QGC
MI7=^#+FUN_"UK+9&Y\G?* EUDR1D2-E&))SM.5SGM38?!'A^WM+>U@LYHHK:
M1I(!'=S*8V88;:0^1GTSBMJRLK;3[2.TM(5B@C&%1>W<_4YYS0!Y];QOXCT+
MQ5J$M]=0:E:WMS#!+%.R?9A#]P  XQCD^NXU6O85U?Q3\-[S4(6%S?6MQ)<K
MN9?F^S*W0'CD]J[6^\(:+J.H/>7%JY>7;YR),Z1SXZ>8BD*^/]H&I[[PYI>H
MZG:ZC<PRM=V@(MY$N)$\O/!P%8 9'!XY'!H @\801S^"M;CD7<GV&9L9[A"1
M^H%>>)I\?_"#_#M(9)8&N-0MF>2-_F!\I^1G.*]=DC2:)XY%#(ZE64]"#U%<
MY#X \,6]M;V\&F>5';S?:(A'<2J5D'1LALDCMGISCK0!Q6J27/A2U\>P:3=W
M2QP164L7F2O(83*6$CJ2<YQSUZBNDT#1(],\06VH6^NV[V]];D"SMX7"7!^]
MYN6D?YO4]ZZ"/PUI,>HWE_\ 9F>XO4\NX,DSNLB^A5B5P.PQQGBH]$\):#X<
MEEETG38;6248=E))QG. 23@9[#B@#!^(ML9Y/#")=75L9M8B@9X)F0[&5R>.
MF<J,'&1VK!O;2V\*:KXDTVWU:]M=&ETI;APCF1[69I/+&PDY!89ZG\>..G\>
M:%<>(8]$MDL7NK:#4X[BZ"RJF(U5@<$L#GYAT]#6Q'X9T=+"[L39+)!>#%R)
MG:1I?3<S$L<=N>.U '(^&X''CBZL)[."QMY]%CD-I;3D]9&&YRN!O(ZD=L<F
MN,OO#-D_P3;Q%<2W5SJ)LU4-/,75<SKT4]"!D9]SZUZQ;>!_#-HT;V^D0121
MPF%)$W!U4]<-G.?]K.?>K5MX9T:TT:;2(=/B73IL[[8Y9#G&< GCIGCOSUH
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M=Z)K32ZH+VYTQ[Z#[-JUK<E_LNTHGE31Y P2IR><[SWKTU)HI'=$D1G3AU#
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M1CH 3C&: /2**\MT!)M&\3Z5'JUJ;B2\N)FM==M)]RWH=78),O7A3QU VC'
M-=/XZN(DLM,M7GD#75_'&MJF +P8.8F8D!4/4GG@8P<XH ZNBO&+Z66W^'_C
MZW?]S':7H2&"UN&,<.X)\JGC*Y8Y7 '7BMZ/3T\/^.] FL)+EGU'3KDW:R3O
M)Y[1HA4G)/.3VQCM0!UOBO7I?#FB_P!H16R7&)XHF1I"F [A<C@Y()'''UK<
MKQ?4X-)U?X76/B.5X[C5I+RW>:Z9\NLIE4/'[* 3A>@ SCO7K^HQ+-IEU$Y8
M*\+@E'*GH>A&"/PH LT5XG::3'8^ O"GB?3[FX77//@B5FG=_M"LY4P[<X P
M2<8'0]ZN20P^)3XADN_$-CIVHV.IR@7#VS-=6T<<F8]C>8/E*KT5><GJ30![
M!17F\/AFQU_QUX@BOY;UDBAL)U"W#QXD(D.[:#P>.G09.*YN_P!,@'@/Q;JV
M^Y^W:;K5R;.8W,F82LJ@$<]<=S0![96*-7GTW2[V^\0+;VD<,[B+RY-V^+.(
M^O\ $?3UKGHM'M-#^).D_8?-5K[3[D7323,YF*M&0S%B>>3S^'2N6U?3[(_#
M[Q.)8T86OB!Q"TP\PH#+&" 6R1D$C- 'K$FJ6D6JV^F-)_I<\3RH@_NJ5!)]
M.6%6MZ[]FX;L9VYYQ7G,VC^';3XIZ68;'38K<:=-)E(T"B594 /IN!R/45S?
MAZS@U2TM/$-UXDM;74X[[,RP66+PS%ROE,Q<LRG=]W;C&,<"@#U?Q)J<VC^'
M=0U"U2&2>UMY)UCE<J&"*6/3GH/_ -57-.N&N]-M;EP \T*2,!T!(!KRN[&E
M:_X0\:7NL+ ^M6LEV@,C;9( @(A5>X4@#CHQ)SG)KTK2)HX_#-C.S@1+9QN6
M'/ 0'- &B'0NR!@67J >10'1F90P++]X \CZUXII,EO:^)? MY9F*.&]:Y)G
MDE5KJY1E/S3D #.XD#KCUS6UI%L-+\3Z3+?VEK?Q7UY-)8ZY:';*[L'_ '<Z
MGD\$C/0;0.W !Z@)$9V0.I9>J@\BL_19M5FM[@ZQ#:0S)<.L8MG+*8AC:3GH
MU>?Z%;C2/%&D27]C97ZW]Q*]EX@M"%DE9DD.R9<9)VD]\ @>E9MD7M_AKXL6
MUF$177YD99),><N] 8@>OS+\O/K0![&DD<J[HW5U]5.:0R('"%U#MT4GDUYM
M8Z!I6I^(M0UNVTF&RLX],,*P916:5@=S[$.%PI*9/7MQS6!:Z796?@GP)KEN
M&.IR:E:QM=M(6?8S,&3)/"]MO0?G0![.TT2.$>5%<]%+ $TYY$C7<[JJ^K'
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M\J2[D55SCK@D9 XXS7F4MSH=W?>)M'\4ZC<VETU\THMEVC[1'\OE&,E"Q;
M !SQQ6GI^L:=IOC'7+?Q.YMC<6EJEE]OP6DA\L>9&".&.\G('4^N* .K\$ZM
M=:YX0L-2O7C>XG#EVC7:IP[ 8'T K3GUG2[6\2SN-2LXKIR D$DZJ[$],*3D
MYKF_A=-!+\/=-6!U81>8C ?PGS&.#Z'!%><>--4LI='\31V5Q%92IJP:>T<L
M]Q.ZN@\W)/[M!Q@ 8]^<4 >TWNMZ3ILRPWVJ65K*P#*D]PJ,03@$ GUXJ\2
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MQ;;9+C[1+ 4C.[^#)_B&>1]?2@#6HHHH **** "BBB@ HHHH **** "BBB@
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MO?V-\UNS75C'Y=M(9G)C7&,=><CKG.>]:E% '.S> O"MQ-/++H5FSSL&D^3
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!%.1FEIJ?=IU !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 -3[M.IJ<+3J "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>WB1[B1U$;8W*0201P.OH/2G0^'M-M[BUFAA>-[6W-K $F<!(SC( SCL.>O
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (!CBEI*6@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ Q1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -3I3J:HP,4Z@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $I:2EH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*6DI: "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD+J#@GFE
MH **** "BBB@ HHHH **** "BBB@ HHHH **** $!SS2TU/NTZ@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!I0$Y
M/6E&:6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :GW:=34^[3J "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :GW:=2*,"EH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>exhibit1011-physiciansha008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ?$6232%U8>'KM;!;O[+<2M,@\L^9Y>0.K#.,XXR< GG&U#XD=O&<WAVXLA
MRV_VF&=I<B=,X.T8Z@]1FN4E\(Z]<?"W4/#WV>"._N;II8R9\J%:82\D#J.F
M!GZUH>-K"WURXT9+74$M=<BNA$%A=6E6*1<3+CG&(]S9(_A]Z .LT?46U73U
MO3!Y,<C-Y0W[MZ D*_08W 9 ]"*R=;\47&E>(;'1[?1Y;R:^BD>!DF51E,9#
M9Z#D<_D#70V\$=K;Q6\*!(HD"(HZ*H& *XKQ/+=Q?$KPLUG;)<2?9KP%'E\O
MY<1Y.<'GVH C/Q(>'2&N+G0KB.^@U)-/NK)9E9HV;&&4X^<$'CIG]:U(/$VJ
MW$BV T)8-8822?99[P!!"C!1(756^\2, +Z]AFL+4O!NL3PS:A;V]H=5N]7M
M]0FC,Y")'#@(F[')X))P.6/I6]>Z-J,?BJT\2:?# \S6AM+RUEE*Y4L&!1L$
M9!'<#(H HW?C\VWAV^U7^RF9],N3;:A;&?#PL& W+A3O7G.>.*W(]:EN-?\
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M=-;1[\RO;FXW^;;F0DLF ,%<DX.>,]#7>V,<T-A!'<F-IDC"N8P0I(';/.*
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MPI(3!7IQU^O&<9M1^,=:_LWQ#YNC6W]JZ(P::W2Y)26,KO!5MN<[>V.<=LT
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MD\I)O/78[Y(V@YP3D'CVK&BOT/Q+NM-?2;1)#I@G%\#F65/,"[#QP =W&3G
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M9)C K;=X.=J]"=FWICFI;WQ1XFN==GTW0=-TVX'V.&]AEGG8 QNS#YNG)"\
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M ]O2L.71=4TSQ=>:WI*P7,6I11I=VUQ.8MKH-JNI"MQMX(Q]/2NIHH \^O?
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MK5+?3!(#&Z$O)YBE6YZ  8(]\UL:9J$>J:9;7\44T4=Q&)%2=-CJ#ZCL:MT
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MOK7A*\UR;[/=ZG$^EFY6Y$9MOW\15@VV.3=\H)!YQG!(KK*8LT3RO$LB-)&
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MS1^9G=QOP>O'IWS0!SVEZKJND>#?".GVLLEW=ZK;QK!Y<,>^"-8=[!=[*K'
M RQ]\'H;I\1^*-$T2]?6;(+*][#:Z=/<&(%A(VW=*L3,HV]3@C/M5Z[\ "^\
M+:;I$VJR1W6EE/L-_;Q>7)%M 49&XYR!ST[>E2W/@2/5="O;#6]5NM0NKO9F
M\*)&T>PDIL51@ $D^^30!3U^'Q/9>'?$*2ZT&@BL'N;>\6-$GW*A+Q[0  O
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MUE96VG6,-E9Q+#;0($CC7HJCH*I:7H4.E7E]=1W5W-+>N))O/D##<!@$<#'
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MF27AS/F>4!SQ\V V W Y S0!EW?_ "7#3_\ L!R?^C35OX>?\>6O?]AV]_\
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M(M4OV<N9@O.X]6 Z ^] 'F>L)I_BCX=>)M:U14GU>TN)XU#L=UF%?"1J,\#
M!Z<DFO5?#W_(M:5_UYP_^@"J5[X)\-:C=SW5WH]M+-<?ZYB"-YQC) .">>O6
MMFUM8+*UCMK:)8H(EVHBC 4>@H \@\8*)(_%.JP2">:QNXUBOIY?*DLY%V8B
M@ R2,,<D[02>C8S6OXWCN+;5=3U6>R&JZ5';K'(;>3;=:40N3)&#V(8$XQTY
MX%=E<^#?#MY=7ES<:1;237@Q<,R_?]_8\=1S3F\(Z"X4'3(0@18RBY575?NJ
MR@X8#'0YH U;>9+JVBN(B3'*@=21C((R*X*VTRSO)O'ME=0_:+<7*.$F8O\
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M R,Y[GVH Z16#*&!!!Y!%+3(HDAB2*,;410JCT Z4^@ HHHH **** "BBB@
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M<IX?:T00M8->+<>9DMAU7&W''4]Z\_M-6O-.\/:K87-P]I;GQ&NGLZ7!?[)
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M<_\ ?)KR";2;:V^&DVNQF8:E9ZJWV:?SFS"/MNPA1G !!.?7//:NG6'2-/\
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MR/Q3H<LDT::E 6BC>5ADC*)D.R_W@,')&<4 3?\ "/Z-FX_XE%A_I/\ K_\
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M#\*1X(7E65XD:1/NN5!*_0T >+Z?K=G;>"? 5^VHPLUA=.DEO-*%1L(V<L>
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M>)=L<2!$7T & *X#0+*>]TGQO9);3P75[?W<EL]Q \099(PJ,&91QG/3I^-
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MM#T[5;C2YIYGO8(1,T$,#R,0<8"@#YCSGCMUQ6KI.K66MZ9!J.G3B>UG&4<
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MS[9KF[#PQXI2_P! U&X\/VIU&RNV^V7DM\'EN04*^86P2$Y&%&3_ +(H O\
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M4MZQ9Y3"/D4DD[5SSM ( )Y.*O4 %%%% !1110 4444 %%%% !1110 4444
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M'OMD:W*6&W[3MN(T?D D(K$%R 03T'. 2<@ '84C.J8W,!GU-0VEU%?64%W
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M-'EWZO+NM,SQ8(V*F6^?C[N?QKNIM>T>VNVM)]5L8KE< Q/<(KC/3@G/-:%
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M]>_NM0/V2/1+;4+!X+N"VG\Q))BP*R*N  !@^F<XP.2>]O\ 5M/TL1_;KR&
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M.:3R87D$;R%1G8@RS>PH \DT5;B^^"UWKDFHZB-62*X=;Q;V4291V"@G=R,
M#%='X?\ $%QJ%GJ?ACQ"Q37M/B82,K%/M,>/EF0C'7C./_K5F:'HVKV7P;N]
M"GTNY74F2>-8/E.XNS%3G.,<\\UT'B[PP_B.QMM3TXO9Z[9 R6CO\N?6*3U4
M]#_AG(!#X;T&/6/"VA7E]>7TBR6$<LD8NY5\R9U4M(S!@2>. >!D^M8W@#29
M/$'@RUU.XU/4?[2:Z8M</=ROO1)?N%2VT@J-O3WKM/#<4^G>#-*BN;9UN(+&
M)9($7D,$ *@?7BL3X8V.H:/X073M3T^>TN()I6P^TAU9BP(*D^N* .8\/SZ
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MEC$B#<)%4<!N<'U'OS7?URD6@7NK>+K;7]8BA@33XW2PMHY-[!GX9Y#@#..
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ML^G>O1*Y+QOH6K:Y+H;:9':-_9VHQ7[_ &B=DW;,_(,(W7/7MZ&@#EC/9?\
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M+,QQ[G\L5H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %0W-W;6<7FW5Q%!'G&^5PHSZ9-35#=6MO>VSV]U#'-"X
MPT<BA@1]#0!)YB>7YF]=F,[L\8]<U1_MS2-I;^U;':#C/VA,9_.O-_"-Y<^
MK?2;'4YVF\/:O%'):7++G[).Z@F)ST"DDD'Z^]7-:MX#\,_&688^+N\8?*.H
MDX/X8% '?1ZUI,LBQQ:G9.['"JMPI)/H!FK%Q<P6D1EN9XX8P<%Y'"C\S7&6
M4^FW=OHVGOX8N;?[6\9:5K58UC>-#*K;AU.4P.G4U6TZ1?$_Q4UF._42VV@Q
MQ):6[C*"20$M(1W;C ST% ';+JNGO"9EO[5H@"2XF7: " 3G/J1^8J+^WM&_
MZ"UA_P"!*?XU OAS3X_$?]M1011W#VKVTP5 /-!9&!/N-F/Q]JX7P5J<4'PW
ML;4Z!=WH=Y8F80@1%6G<$E_[H!YX[4 >DW6H65E:_:KJ\MX+?&?-EE"ICZDX
MJ2&>&YB$D$L<L9Y#(P8'\17G_BNTU/PUJ6@ZO8:6^LZ7IEHUI-;GYYHU.W]Z
MOJV%&3Z9Z9R'6\6G>+/!WB.7PA=K;SZIR\>WRVBE"@%6'8L!@D>I/- ':VVL
MZ7>2M%:ZE9SR(VQDBG5B&]" >M7))$B0O(RHHZLQP!7E^A:]I>J:KHVCZ]HS
M:#XAT^0&V1XL)*%4KA']",\=.!@FMSQ\K:U;_P#"-07XLY)K=[J63S G"\1I
MD_WI,'Z(U '9R2I#&TDKJB*,LS'  ]S5)-;TF1U2/5+)W8X"K<(23^=9G@C7
MCXE\'V&H2D&X*>5<#_IHORM^9&?QKS*:\T^Y\%W'A?\ LMVU#4M3NH;.:6,1
MPB3SF(/F'N!@8'4\4 >SW5_9V6W[7=P6^[[OFR!,_3-*]]:16PN9+J!+<])6
MD 4_CTK#N_"L>K>!8_#NK3&XD^R)$]R1D^8JCYQ^(S[]ZY7P_J&I>)X5\':O
M;-'/I<@75I,86:)#^Z5?:3 )_P!E6_O# !Z5#-%<0K+!*DL;#*NC!@?H16>/
M$FA$IC6M.._(7_2D^;'7'/-:84*H50 H& !VKRBWN;>T\:^/+6[T*^U/[6T"
MB*VMBX8&(\,PX3.>I/OVH ],N=4T^S=$NKZU@:12R++,JE@.I&3R.1^=+8ZE
M8:G&9+"^MKM!P6@E60#\0:\M?2]0T+X;>%+?78&N;JVUFV<6Z*)'1"YQ&/4X
M./QQ6GX?\GQ%\3[G7]*@^Q6UA UC?1R?)+-+GC=&.@'8GKM]J /0+W4++3HA
M+?7EO:QLVT//*J GTR3UHM]0LKNU-U;7EO-;KDF:.5608Z\@XXKBO"MTVM?$
MGQ9<W8WMIC16EHK'(B0[BV/=BH)/X57UN---^*NFVD$>+7Q':30:A$I(#E%.
M'X_BQQGTH ZP>,?##$ >)-')/  OHO\ XJI&\4^'DMUN&U[2U@9BBR&\C"EA
MC(!SC(R./>N5\0VL%M\4/ ,,42)&JWR@ =A",4SXJ6=O9^$_-@@ :?5;>:15
M_C?A>_&<*!0!U]IXDT*_N([>SUK3KF:0D)'#=([-@9. #DX'-3ZCK.FZ0B-J
M-_;6H?.P32!2^.N >3^%9*2C5]4M+2[\/7EG'!F\BFG,8 D1E  \MVZASUQG
M'>N?^&[+K>J>)?$EVN^_;47LHR3D10QJNU5].O/K@4 =DOB#16M9;I=7L#;Q
M;?,E%RFQ-QP,G.!D@@>]0_\ "5>'<L/[?TO*C)'VR/C]:/\ A&]-.K7.H&%=
M]P87D0 !6DB+%7/JWS#K_=%9FC@'XC^*@0"#:V.0?I-0!M+KNCM<06ZZK8F>
M=!)#&+A-TBD9#*,Y((YR*??ZOIVE[!?7D,#29V*[?,V.N!U-<9=VL-C\6_#%
MI;IL@@TF:*-<YVJO 'Y"CX:RMJU]XFUR\YOY-2>T(8<Q11@;$]NISZD4 =G_
M &QIG]G?VC_:-I]A_P"?DS+Y?7'WLXZ\5/;7EM>VJ75I<0SV[C*RQ.&1A[$<
M&N#T]O[/^-6J:; I%IJ&F+=S1?P>:&"[L>XZ^N:P/#%Q=^ ;/3M1DD:7PQJI
MS<Y'_'A.3@/G^XW?T_F >L6>HV.H>9]BO+>Y\IMDGDRJ^QO0X/!]JEN+F"S@
M>>YFCAAC&7DD8*JCU)/ KGO!F##K3 @J^K7#JP.0RM@@@^A!!K%\2RG4/BMX
M9T2Z4OIZ0R7WEG[LDRAMI/KMQG'O0!V-EK>F:C,8;2^@EF"[O*#C?M]=O7'O
MTJK?^*]!TN]-G?:I;V]R!N\J1L-CUQZ5ROQ>D?3_  W9:Y:$IJ.GWT;V\B]?
MFR&4^JGC([XJ/Q-=W%E\7=#FM=/FOY1ILP\F%T5B-W7+D#]: .YTS6-.UF%Y
MM-O(;J.-]CF-L[6P#@_@15;4?%&AZ3=&VU#4[>WG"ARDC8(4YP?T-/T-S=6;
M7\MB]G=7+L9H7^\I4E #VSA1R.#U'%0^(;2"'P[K\\<866>SE,C9Y;$1 _(?
MU]: &V_C'P[=LRVVKVTI6,RD(V3L'4_09JQ9>(=)U&PEOK._BGM8OORQDE1^
M-4M"M8)_!^@S21AI+>PB>)NZDP[3^C&N,^&.MZI:?#O2H+?PQJ%[$OF[9XIH
M%5\RN> T@/'3D=J .X_X3'P]]@-__:UO]C#;3<9/E@YQC=C'6IT\2:.\T40O
MXP\SA(PP(W,>@&1UKR68EOV:[\E2I-P20>W^F"O2_-U#4[BRLK_04CL"ZR/+
M).)"&0;TP%Z'>H.>>F,<\ '0RR+#$TCDA%&20">/PJIIFLZ?K,!GTVZ2YA!Q
MYD>2N>XSTS5ZN#^$'_).K3_KO/\ ^C6H ZO4-=TS2KB&WOKR."6?/E(^<R8Z
M[?7%%GKNF7]X;2VO$DN!&9?*Y#; 0"<'MD@?C7'>/9;B'QOX(DM;<7,ZW%SM
MB,@3=^[7^(]*W5NKZ5K_ %#4-%2UN;"U9K4^8)2=P)<!@.^Q./84 7M1\3Z/
MI=P;>ZO!YXQNBBC:5U!Z%E0$@>YJ6/Q!I,VFRZC#J$$MG$2)9HVWK&0,G=C[
MN!USTKE_A.HD\ 6^I-^]OK^6:XN97;YI)/,9<D_115,ZG'J'A[QZL6DBQ>&*
MX2Z87&\23"'!(&!@;0.>] '6KXJT5H;>87Z".YW>0Q1AYP4 DID?,/F'(XYJ
MLGCGPY+=1V\6H^8[R+"&C@D9 Y.T*7"[0<D#!/>H_ =M"?!7AZY,:F==-BC#
MXY"E02/S _*L3X:6L%[X;URWN8EEADUFZ#(W0_,M '30>+-'N;^:PAFN'NX$
M9YH5LYMT8&3\PV<9P< _>XQG(JUHVN:;X@LS=Z7=+<0JYC8A2K*PZAE8 @_4
M5S7A[_DJGC/_ *Y6/_HMJYWPV_\ PB?BRUN&8KI?B.2:%^>([M)7VG_@2\?7
MZ4 >A:OXDTK0[JSMM0N6CN+UBMO$D+R-(1C. @)[BKM]?6VF6$]]>3+#;0(9
M))&Z*HZ].OT%>5ZD3J?COPEXB?=MO;^2.T4\;;9$^4X_VB6?/HR^E=-X[DL]
M3>#P[>S-#8RQ-<WLBJS%4&1&/EZ9?YN>,1D4 =E-<106LES(X$,:&1G'.% R
M3Q[5S_\ PGN@?:+>W\Z^\^Y4M!'_ &;<[I0!DE1Y>6 'I67\,M7.M>#3IM\"
MUUIK-8W"2 @LH&%)!Y&5XY]#3/$0 ^+7@D#@>5>_^BJ -E_'7A^*""9[JY"3
MS&WB_P!!G):4?P8V9W>W6KEKXETR[OX;%&NXKB8,8DN;*:#?M&3@R( 2!SBN
M<^(2FT'AN6S@A:=_$$#A))/+5W,<@&6P<9P!G!K;L'UJ[UH'5]*L[:"&+? \
M%P9\2$E3\Q12IVDC@=">: -34M2M=)T^:^O7=+:%=TCI&S[1W)"@G'O60/''
MA_RK.9[N:."\*B">6SF2)]WW?G9 HS[FK/BW_D2]=_[!]Q_Z+:N*.FVVL?"O
MP=IUXA>VN7M(Y &(."IZ&@#T#5=6L]%L6O+YY4MU.&>.%Y-ON0@) ]^E9]YX
MQT:P-Q]HENU%LH:=EL)V6(%0WSL$(7Y2"0>G>N!NM5OM"\/ZMX-\0SM-<QVY
M?3KY^!=0@CY<G^->X]O;)[?QS#%%X"\1M'&J&2RF=RHQN;9C)]3@ ?A0!(/&
MFBM"TJO>;1 ;@;K"="\8QEEW(-P&X$XSQS38_'.A2V(OHWOWM"A<3KI=R8]H
M[[O+QCWI)X(I/ 0E>-&DCTIMCD<KF'!P>U8/@:;6Q\/M CM["R>U98D>0W+%
M_*,@#G9Y>/NY_B]_:@#HM0\9:1IE_%8SF\>YGC\RWC@LY93.N,DIM4AL#D^E
M7-*\0Z;K0G%C<%IK<XG@DC:.6(^C(P##\JX[Q5YMI\3?!8L+6.5X[>\$<&_R
MU($0X!P<<>U'P^5=9\1Z]XJF?[/?W#+:S:81\UILP!O/4D[0<X'?\ #:C^(.
MD37-Q;0V>L336S[)TBTR9S&WHV%.*T1XHTS^Q!JS//';M(85C>!Q,T@8KL$>
M-Q;<",8S7(^%I-3C\9^-_P"S[6TFS?1Y,]RT6#L.,81L_I6CKWAZ\\0>&-'_
M -+ATSQ#;O'=1, -GVK9N=2O?^(]^F>: -J#Q;I4MU/:.US;W4%LUV\-S:R1
M'REP"X+#!&2.AJ@_Q#T>.X@MFM-8%Q.A>*'^S)M[J.I"[<X]ZR- U^?4/$RZ
M#XOT5+?7%M)HXIUY@NX6*[P![[ <<]#TZ5/K'_)9?#?_ &#[F@#>'B_2C807
M6;D-/.;>.V-NXG:0=5\O&X8')R.!S5K3-?L-6NKBTMS,MU;*K30SP/&Z!BP7
M(8#KM/X8]:P/&?AJ\U&ZT[4?#][;V6N6,DD\"RCY9PRJC[A]-HS@]<=\TSP=
MXEEUC7-0LM9TEM,\0VL$:SJ&RDT09L,GMECZ_>')H ["[N[>QM9;J[GC@MXE
MW/)(P55'J2:P5\:Z8)HA<0W]I;3.J0W=U:M'#(6^[ACTSVW 5A_%EQ_8FC0S
M.ZV4^L6\=WM&08_F.#[9 KH?&L%M/X&UN.Z53"+&5CD="%)!_ @&@"75_$]C
MH=[:6EW%=M->,5MQ# TGF,!D@;<\X]:FT_7K;4;Z6S2"\@GCC$I6YMFBRI.,
MC<.>17G-O<:G)H7PUFG1'OC.V!<.4##RG"Y(!(RN.QKT?23J,DEX^J6T,4HF
MQ"8G#J8MJ\!L GYMV<@<^U &G5&QU>RU&[OK:UG$DMC*(9P/X6V@X_7\P:9K
MNJ#1M%NK\1-,\28BB09:20G:B #N6('XUYIH3+X4\<Z8Z)>I::W;+!?RW5K)
M"#>_,X;+@<L2PP,]30!W^K^*;?1M1AL);#4)[BX4M MM")/-"XW8P?X<C.<=
M>,U-I7B;2]8M+FXM[CR_LC%+J.=3$]N1U#JV"O0\].#6%XHEN8OB!X1^R1P2
M3,E\H2>4Q@_(A/(5CGCTKC_&WAK5]'\+>+=>N+F!KK5I8!/%;!MD4"L%P"<%
MB<KDX'&?7@ [\>-M/-E_:(M-1.E[L?;_ +,?*Q_?QG=L_P!K;CWJSKOBJQ\/
MVMK=7,5Q-;7+K'%-;*KJSM]U>N>>QZ>]6Q#I\OAT0*$;3'M-@W'"F$ICKZ;:
M\<M7NW^#'A?[7N^76H5BW#DQ^8VW\* /;XY7>W65H)(V*Y\IMNX'TX)&?QK'
MT+Q3;Z_>7MM;6-]"UE(89VG1559!_#PQR?IQ[UM22QQ*&D=4!8*"QQDDX ^I
M) KC/ 7_ "%?&/\ V&Y/_0%H ZO4M2L](T^6^OYU@MXAEG;] /4D\ =ZR!XO
MMHI+?^T+#4-.M[E@D-S=QJL;,>@;#$H3VWA:YOXE3"35_!\?F*UHNMQ+<C(*
MAOE*AOP)./>MSXDK WPZUT7&W9]E)&XX^8$;?QW8H ZJL_6]9LO#^DS:GJ$O
MEVT.-Q[\D  ?B:A\+?:CX3TC[<"+K['%YH(P=VP9S[US7B_R?$&K_P!AW%A=
M7>GVT#R7!MX?,Q.ZE8P?0JI9_J4- '9W5R;>T>XC@EN=H!$<."S#VR0/?K6?
MX>\2Z=XFL'NM/=_W4ABFAE39)$XZJR]C6#\,=5GO/"_]EWX9-2TA_L=Q')PV
M!]QB#ZK_ "-84VDWOAUCXST"(R$3W U6Q0'-U&)W^=0/XU&?\YR =G-XLAM[
M'5+V73;]8-,8K<-B/(PH8X&_D!2#^/%5)?'EG:Z=%JE]I6J6NES(DB7K1))'
ML8 AB(V9E'(Z@=:PKG4[76?AUXVU*QD$EM<B62-O8VL7!]".A'J*Z73);>7X
M<64M^%%L^D1M.  !L,(W=>.F: -ZWN(;JWCN+>5)89%#)(ARK ]"#6)+XOL;
M;Q=#X:NH+BWO+B,R6\C[#',!GH0Q(/!X('2L;X0I=I\--+%V",^88L]?++G;
M_P#6]L57\=:-/JESJ5W8*#JFEVMG>V9P<[TDG)7CU&1CZ4 =;XAU^S\,Z'<Z
MM?E_L\ !*H 68DX  )'))J;2-2_M?2K?4%MIK=+A!(B3%=VTC(/RDCD'UKS/
MQ+JT?CCP?>ZG 0+#3]+:9XP<C[7(A&T^\:D_BX]*ZM=4GTKX:Z7+9QF6_FL;
M>"TB'5Y610O7TY8].%/(H V](\0:?K<^HPV,WF-87)MINGW@ 3CVY(SZJ:HW
M7C"ST[Q+:Z)J-M<6<EYN%K<2E/*F*XX!#$@G(P"!U]ZXC34_X0SQ]IDJZ7>:
M?I>JV\>G3-<^5\]RH^1SY;MRV.<]R375^*=#T[Q)K5MI-^.9=/N'BD4?/$RR
M0X=3V()% &WJ&JO8W]A:BRDG^V2^4CHZ@*0K,V<G/"J3QG/2F>)/$%GX7T*X
MU:^)\F$#Y5^\Y)  'XFN+TG6M17Q-HOAC7@QU>PN9'2YP=MY!Y$P64>AZ C/
M7\<:'BIY]7UU--71;K5=.M('-REN\2CSI%*J"78?=0L<<_?4^E ';Q2I-$DL
M;AXW4,K Y!!Y!K#B\2O?W]U:Z3ILUXEJ_ERW1=8X=XZJK'EB.^!@>M<]\/+[
M4&\(7N@7<<L6KZ/NMO+D*A]I7,1X..A SDCCK4GP@F@?X<V4$0"3V\DL5PF?
MF23S&)W>AP0?QH U)?&+1:1K-Z^D7,<ND-BYMY9$#%0@<LI!((P>.F>:5/%-
MZVA6VM?V'*UE/'%-F.=6=8WP=Q7'. <D9[5RM[JVHZCHOQ%M;R6%X]/@D@C*
M0A&<>6Q!8YY(Z5L>&K/65\*^&;MM;B2PAM8)IH?)\O\ ="'H7R<XR#TYQ0!H
MW'BRZC\6S>'8-&>>ZCM#>*PN%57BW;1UZ'/:KOAOQ/9^)K:YDMHYH)K2X:VN
M;>< /%(O4'!(_$&N'UH:Q=?%N>3P[=VT-Y_PC8DC:>+S%D'G<+U&W)(YYZ=.
M:VOAA)IC^'+B6V,ZZC)<O)JJ73 RK<GA]P&,#(..!Q[YH [FBD1E=%=&#*PR
M"#D$4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !4<QE6%S B/*!\JNQ52?<@''Y&I*CGGCMK>2>9ML4:EW;&< #
M)- &%:>'Q>^#(=!U^UMI46W2WD6&1G5@H # E5(/&>G'K6 /!6L6?PYOO#%M
M=6MU/<O*HN;F5TPC'()PK$MCMT]ZZ/\ X3#P^-(&K?VG%_9YD\L7.&V;O3.*
MN76N:;9:;%J%S="*TE*A)65L$M]WMGGM0!CQV_BR#P]!IUO#I45S';I!]J-Y
M(^TA=I<+Y0R>X!-0S^%K_3O%+^(=!N(#-<PK#?6MV65+C;]V3<H.UQ]#^IK:
M3Q%I4FJKI:W?^GLN\6YC8/M_O8QT]^E-?Q+I,>LKI#W+#4&/RV_DR;F']X?+
MRO\ M=.#S0 V*+77G>[N6M$9(V6&RAE8QLQ/#/(4!Z#H%XR>O&.>\,Z5XQ\-
M^'+?2$M="G,'F%93>S+G<[-R/)[;O6NDT_Q'I>JWLUG97#R7$'$R&"1?*/HV
M5&T^QY-17'BS1+6ZGMGO=\MN,S^3"\HA_P!]E4A?Q(H IP:?XFM+FTNENK*[
M?[+Y=Y%,[HK2ERV48*V -Q R.@%4X/">H11^([V&>VLM4U=XW00,S10E.AS@
M$L222<#K6K/XQT"WL;*]DO\ -M>L4MI4B=UE8'&T84\D@X'4XXS4^J^)=*T2
MW@GU*>2WBGQY;O;R8)(R%.%X8_W3@^U &1?^']4\0ZAI$NKP:; FFW:W:S6L
MK22.R]%&Y!L4G!/)Z8]ZM:;H$DM_J-[KNGZ9-/<R*R,A\[8@4*$^9!@#!.>Y
M8\"NABD6:%)5#!74, ZE3@^H."#['FGT <=H/AS5O#VNZY<6BZ>-,OY/.@LE
MD=?*D"XSG;@!CR0 <<8SCF"T\$3W?A"_\/:Y]E:.>:6XAGMG8M&[NSYP0,%2
M>#GD=0.^_<^*-(M->BT2:XD&I3 -' MO(VX>H(7&!W.>,'/2FW?BW1+*:ZBG
MNV'V0@7+I!(Z0D] [JI5?Q- $OAZWUBTTJ&UUF>WN;B) GVB$MF7'=@1P?QK
M,T;P_J%AXUUS7+A[4P:FL*B.-V+1^6NT=5 .?PQ[UTEM<0W=K#<V\@DAF021
MNO1E(R"/PJ6@ KF=%T74[#Q7K>K7+6C0ZF82$B=MT7EIM'48.?PK0NO$FE66
ML6^E75RT-Y<MMA62%U60XSA7(VD_CUXZU-JNL66BP)/?/*D3N$#) \GS$@ '
M8#C)( SU)H R_%^BZGK=O81:;-;0-:WD5WYDQ)Y0Y   /Y_I534_"^H?\)3:
M^)=$N+:UOFC$-_!+N,5RG89 R",<''8?0[NI:Y8:4D!NI'\RXR(8(XF>60@9
M(5%!8X[\<=Z-.UW3]4>:.WF99X #-!/&T4L8(R"R, 0,=\8H QG\-W]AXDN?
M$.C2VPN;Z%$O;.X9A%(ZCY75P"5(''W2"#TS4^G>')V\2R>(M8EAFOQ'Y%K%
M"I\NUC[@$\LQ[L0.N!Q3_P#A-=#*VK":[VW9Q;'^S[C$QQGY?D^;CGBM+3=8
MLM6:X6TDD+VSB.9)(7B9&(! (< ]"#0!C:YH6IZAXLT/5[;["(M+:4[968/)
MYB;",@?*!U[YXI/''A[4?$VE6]C92VL(2X2=WF+=4.0  ._K74UG:SKEAH%F
M;S4I)(K4??E6%W5/=MH.!G _&@"E=6_B2]:"'S;&RM_-5IWA=WD9 02JY4!<
MXQGT/%9T7A74=#US4-1\.W=JEOJ+B2XL;M&,:R]W1E.03W&/Z5T(U6 Z2-2$
M=P8-N_:(&\S;Z[,;O?ITK-7QKHGGV4<LUQ +XJ+26>UD2.8MT"L5QD^AQ0!>
MTVSOXI9KG4;Q9IY0JB*%2L,0'9022223ECR>.@&*R].T/5K7QGJ.MS7-HUM?
M1I";>,,"BQYV-D\$_,<\#&:U]4U:#2($FN(KAT=U0&"%I"&8@ $#U) K,O/&
MFF6.JII<L&HF]>+SEABLI)&9/4;0>G0^E $5[X<OKKQW8>(4N;=(;.!H!"49
MFD5NISD!2#TX-)'X:N]'UR_U/09X%34&#W-G<AO+\P#'F(5^Z3W&#GVK1TSQ
M-I.KW<EG:W1%[$NZ2UFC:*5!ZE' ..>O2FZ7XGT_5]4O=.M5N?M-D0+A9(&0
M1D] 2>.>U %;2?#DMAJ>H:U=7$=UK%Z AD\O;'%&OW8U&2<=R<Y)J;2?#ZVW
MA9-#U+R+R$1F)_D(613Z@D^M2/XDLDU"]L?*NS/91":8+ Q 0YP0>^=K8 Y.
M*?H/B"R\1V"WVG"=K5_N2R1,@?D@XSUY!H J^$/#*^$])ETV.Y>XA-P\D3/]
MY4.,*?7&,9H\0^&8]:NK#4;><V>J:=(9+:Y";N",,C#(W*1P1D'T(IVN>+=+
M\.WEI:ZB;E9+Q@D!2W=U=B<!<@8S[>]6M6UVST46ANUN";N401"*%I"7(R!@
M=.A_*@#(N_#6H:_=63>(+JU:SLYA.EG:1L%FD'W3(S$Y _N@=>I-/NO#=]<^
M/++Q$+RW6&UMVMUM_*;<RMU);=C/IQ73*=R@X(R,X/6EH *S]<LKG4M%N[&U
MEBBDN8FB\R5"P4,""< C)Y]:BC\06<NORZ(L=S]MBC$K@PL$"$X#;NF"0>_8
M^AI(_$=C)XBDT%1/]OCB\YD,1VB/. V[IC- ":5IU]I_AJ#39)[>2XMX%@25
M8V5"%4*"5R3VYYJCX1\.WOA7PC%H@O+>XDMP_DS&)E'S,6^9=W."W8BMB_U6
MSTR2SCNYA&UY.+>$'^)R"0/T-)JVJVVBZ;-J%X)/LT"[I6C0L57N<#G% '%/
M\/-2D^'D_A%M5M/+FE\PW MFR,R^;C&_UX^E;EQI/BF^M?L=QK.FQ6S[5E:T
MLI$E*9&X*QE(!(R,XXS4R>-=&-YI]M-)<6SZB/\ 1&N+=XUFZ$ ,1C)R/SJ]
MJ6N6NFW5M9LDT]Y<[C%;0*&=E7[S<D  9')(ZT 7YQ,8'%NT:S8^0R*2H/N
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M[1"!(\*!MF2 ,@D=20.*K'QA8PZS::5?VM[87%YD6[7,8"2MQ\H921NYZ?\
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M<MM!8Y(&<9/7%;%4=(FOY]-1M3ACAO SI(L6=AVL0&7/." ",^M7J "BBB@
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M30-,70%T-K1)=.6/RA!)\PVCH*SG\$:9)8'3I+G4I-.)YLWO'*$?W2<[MO\
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MR 2IY],UUZL&4,IR",@US\G@O2)M/CT^5K][.-540-?S;-HX"D;N1[&NAZ#
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M(6V05:('D@]R2>?3- 'H]-=U1&=CA5&23V%.J.X,8MI3*,Q[#O'MCF@#E_\
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M.E^'M4L[NPNM1MO#T;7&F:@H\NX@8 LRL>%;*8)Z=,X'4 ]7CD2:))(W5XW
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MI0!V^BWTD6AV)UC5-/GO)05,\#@1RMD_<]>/Y&M&TO[._5FL[N"Y53AC#('
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSPZ5OT\BX"7Z*EPHN9,.%QR>>IP,GJ?SKIWD2-=SNJKZL<"GT 8M]X4TC4]
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M/$'C2V22=]/L8+:YAAEE:0B1T.5!8D_,0HKKF\*:*UKI]L;,^3ISA[1?.?\
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M]D$MRI3B5P206]3DF@#CAI=IH/C[PY)IL!6>[TZZ,[;R6N6548;R?O'))_\
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M@ D_G0!X['K6D"'P[=P:A9VUBFN><UM*X:XCSYI9YGR-O)^[COU-;\T.G_\
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M1SJV'<X0'9RS,2W3.<FLY]>T^:+0YTNH+.U@\1K(]@P9IH,LY9YI&Z$G)"@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*5X8U:68(HE= K/CD@9(!/MN/YF@#G[#QUHVI?8VMQ?>5>$BWFDLI5CD(!.
MQ7&3M( [GI6KHFLVFOZ1!JEB7-M/NV%UVGY6*GCZ@USOPTABG^&F@B6-7"Q[
MUW#.&#D@CW!KC/#5[X@T;P/X;U&WU.!=/DOUM38_9P=R/.ZLQ<\[LGC&!]:
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MK%C/F-$N2V.YQ734 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2[#DW48S%#M&<.<\9Q@5IX% 'E<.HWMO:V427&N3&W@,,B3:([13*<  KQT
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M3P,<?F* /-S%-<Z!J%AJ(\5WMS=P_9S<2Z;RB=PHSCG R35QW674="NI-/\
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M8ZUK&D:E<@^=I<S2Q8 PQ(Z'Z$*WU%5_$G@^S\1W=C>M=WEC?61;R;JSD"2
M'JI)!R/\]S6C=7U_#K-E:0Z6T]G,KF>\$RJ("!P"IY;/3CI6CF@#EY?!-L]O
MIT4>I7\;65U]M,NY'>>?&-\A93DX)&!@<^PPR_\  EGJ=UK<USJ%\PU>*..:
M-2BB/RSF,H0N05/J3G/.:T=*UV34==UG39+3R/[.:)0WF;O,WJ6S[<8XK:S0
M!QX\ 1?VE_:+Z_K,EXUHUI)(\R'S$.<9&S'&<X'&1D@G.6GX=VG]A:-I*:KJ
M"0Z1<BZMG B+;P25SE,$#)[=^<U=?Q3<7.M7FG:/I+7_ /9[JEY(;A8@I8;@
M$!SN./7:,]Z@N/&CQKH$D>E3"+5KTVC&9PK6[!F&&49R?E;C/;K0 3> [.74
MM7O$U+4H/[5C*7$,,H6/<4V;P-N=V,GDD9.<5HZ9X;CL=2&HW-]=:A>I;BVC
MGN=@9(\Y(^15!R<$DY/%;>:,T <WXC\&67B*]M[_ .VW^G7\"F-;O3YO*D:,
M_P !.#D9YI9_!NGR6^G"&:ZM[O3BS6]ZDFZ8%OOEBP(?=SG<#UKH\UE^(M4E
MT3P[?ZI!;+</:0--Y32; P49/.#VSVH RK_P/97^@W.ER7UZK7EPMQ=709#+
M.ZD$9)4@ %5P   % J\/#<1\1PZY)>W;W4=I]DVDH$9,Y.0%ZDX/!'3CCBM'
M3KLWVEVEX4V&>%)2H.<;E!Q^M6LT <6/AMIJ:3#I\.IZO$EM="YM'6Z^:V(W
M85,C 'SMVR>YX%31?#[388=9A2^U+R]74+<AIPY/RX8Y8'ENY.3Z8JZWB*X7
MQZGAPV2^2U@;P7(D)/W]N"N..<]SVJ7Q-KTV@6]C-':I.MS>PVKEI2I3S&"[
M@,'/TR* (HO"5M%JFF:A]OOGFTZ V\ 9DVE#C(8!.<X'Y54?X>Z/<:3?Z==R
MW=S#>W1O':5U#QSGK(A51@G\O;K769HS0!S,'@;25T:ZTV^>[U,7:!)I[^<R
MRL <J Q^[@G(QCGFF6'@/3;'4[#46OM4NKFQ5D@>YNR^U2 -N.../UYSQCJ:
M* ,?7_#MOXA6S6XNKN 6DZW,?V=U4^8OW6.0>G/YU!+X2L+G6KS4[F:YG-Y;
M"UGMI&7R7C . 5 ]R<Y[FM_-&: .7T?P)I>AAA:7.HL CI;K-=-(MJ&Z^4IX
M4^^"?UJ?3_!NEV'A>3PXYN+S3'!7RKI]Q53S@$ $ 'D>AKH:HZU>3Z=HE[>V
MT,<TUO"TJQR.45MHR<D ]@>WY=: ,C1O!.GZ%:RQ6EWJ+R-$8(YY[DR/!&<?
M+'GA1D9Z=:@A\ :;!9:/:1WNHB'2)C-:KYJG#$Y^;Y><9(_$UM>']1?5_#FF
M:E*BI)=VL4[(O12R@D#\ZT<C.,\^E &-IWARWTW7M1UB.[O99[\ 3)+(&0!?
MNA1CC ) Y[FFZEX7L]3NIIY+F^A^T1B*YC@N"J3H/X6';@D9&#@]:W*0L%&2
M<#WH R8?#FG6VJ-J,$<D5RULMIE)&"K$OW5"YP,=L"LQOA]H/V*QM8X[N)+"
M9I;9X[N0/$7/S@-G(5NX!KJLTA900"0">E ',1> /#\5AJEBMO-]FU.027,?
MVA_F(P>#G(Y&3W/<UHR^';";4M/U"3[0UUIZ&.W<W#G:",-D9PQ(ZDY)K6+*
MHR2 />@D 9)P* *&L:+8Z[9K;7T;,B2+-&R.R-'(OW65@0014%IX;TZVAN%E
M22]DN8A#<37C^:\J<_*2?X>3P,#DU;U*6]33+B33(X9;P(3"DS81F]R.U3PN
MYMXS.%64H"X4\ XYQ[4 8NB>#-"\/W FTZT='4%8_,F>01 ]0@8D+GVJSKWA
MK2?$L$4.J6@F$+^9$ZNR/&WJK*016KN7;NR,>M9^K:YI^B6:75[.$C>5(4 Y
M+.Q   []?R!- %9O"FBOHRZ4UD#:JXE7YV\P2#GS-^=V_P#VLYI6\,:6]E?V
MKQ2N+]/+NI6G<RRKC&TN3NQC(QG')]36P"",CD5S/C+Q?#X1@T^22+S3=721
MN #^[BR-\AQZ9'XL* +7_"):5C2OEN<Z5G[&?M4F4XQR<\\<<YXXI]KX6TRT
MGBE5;B00RM-%'-<R21QN<_,JL2 >3CCC/%;((QG/'K1N4G ()H YV;P/H$T>
MI1FTD2/4CNNDCN)%5R2"< -A<D#.,9[U;N_#6F7VB0Z1=Q2S6L)5HB\SF1&7
M[K!\[@1ZYS6KYT8E$1D3S"-P3<,D>N*P)=;OHOB!;Z&4M_L,UA)<AP&\S<K*
MN.N,<^E $EIX.T&SGN9HK &2ZA\BX,DC/YJ=P^XG<3GJ>:;H?@KP_P"')I9M
M,T]8GD&TEG:3:IZA=Q.!]*3PGKMUKEMJAO$MTFL=1FLB(-VT^7@9.>YSG\JW
M8KB&<,894DV-M;8P.#Z''>@#F?\ A7/A4%\:4H1IA.(Q*X1'SG*KG"_ABM[4
MM*L=9TV73]1MDN+24 /$_0X.1[]0*M,ZHA=V"J!DDG  J-+NWE@,\=Q$\(SF
M17!48Z\]* ,(>!/#0,I_LJ,M+"8)&9W+.A[$DY)[9ZXXSBM'3]"T_3+AKBVA
M?SVC$7FS3/*P0=%!<D@>PXJZMQ \[P+-&TR#+1A@67ZCM7-^-O$<^AZ*\^G7
M-E]K2:)7BF.YMK.JG R.><]Z -B\T/3K_4[/4KF%WN[/)MY!*Z^7GK@ @<]#
MQR.#53_A#]"^R:A:_8W,&HR>9=H;B0^:V<Y/S=^^.O>IM3U*6#5M)TZVQYMW
M*[R$C(6%%RQ_$E%_X%5U=1L7O6LDO+=KM1N: 2J7 ]2N<T 9EWX.\/W]M96]
MWIL<R62[;<N[%HU_N[L[B/8G%.3PCX>CL+FQ71K(6MT_F31>4"KMG.?PR<>G
M;%:$NI6-O+Y<U[;QR95=KRJ#EB0HP3U)!QZX-5O$5W=Z?X=U"^L7A6XMK=YE
M\Y"Z':I;! 8=<8SGB@#F/%GA&*V^'U]H7A;1$WW3(/*A9$Z,I+,SL,\+CJ3T
MKI=(T/3=./VJUT\6UQ*@#;VWN@Z[ <G ![*<5G^"/$DOB70//O$BBU*WF>WO
M(8C\J2*>W)X(P0<GKU-9FD>,=0U?XD7VAQQ6T>EVULTT<NPM),5<1L0=V -V
MX=#]WWH Z"T\*Z#8:E)J-II%I!>2;MT\<8#?-UP>V?:D'A/0AI\NGC38OL<T
MGFR0Y.UW_O$9Y-78M6TZ>]:RAU"UDNTSN@292XQURH.:8VN:2A0-JEDN^3RD
MS<(-S\?*.>3R..O(H @N_#.B:A+;2WFEVUQ);+LB>5-Q5?3)ZCZTU_"F@2:3
M_93:/9?8 _F>0(0%W?WOK[U=O-5T[3B@OK^UM2_W1/,J;OID\TMUJ5C8PI-=
MWMO;Q/\ =>6545OH2>: *4GA;0Y=/MK!M,M_LEJV^"%5VJC?W@!W]^O6I_["
MTO\ M*?4391&[GC\J64C)D3&-K>HXZ5(NKZ:]L]RFH6K01J&>43*54'H2<X
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M=#CO+@VD<;[9=^UC$S*>">YSQTP<$8-Q?:EK?A?PA<7FIW N#X@%K))$$7S
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M/0 < 8'M0!P&FZGJ]OX&\+^*KC7-3N;F74EBE@:?$3QM*ZLK+CYCQP3G' '
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M(P#C-3746AR>!/'UP@L#(-1G\J12N1]TIM/;Y@<8ZG->OK9VR8VV\*X?S!A
M/F_O?7WI_E1XQY:X/M0!Y3XGUS3Y=3UBVBNHK6=]$ >>0^:;Q2K%8X5SCN=Q
M /X8S56/7['3O^$!U-=0M62WTIH9(YI=D8/EQJV'P1O#<$>QZ8KU]K>%F5FB
MC+*I4$J,@'J/I7-:]X?U>;4K>]T2[T]$CMS;-97]L9(=I.<KM((/08Z':/2@
M#A-0ALM*\$6MY:ZDMU9G7A>7\FE,DGV:-MY"@XY"L4ZCKV' JOXHMM#NO!OB
MN_TG4[J]\^.V:6_NI (I)$D!")A5RX48_$#UKU+0-";2DN9;E[:2[NBOG?9K
M<0Q *" JKD],GDDDY^@&LEO#%$L4<,:1KT15  _"@"GI%CI5I:"72;:TBAG"
MN7ME4"7C 8D?>X[UH4@ 48  'H*6@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ.X@2YMI8)-VR5"C;6*G!&."
M.0?<4 253U2XN[72[FXL;3[9=1QEHK?>$\QNPR>E>0.^IG0)- ADN9M?\/WL
MMQ*QG<&>V3YQO(/S;PRJ ?0^E=/=:A_;OA?Q/XGL[B>.W;2V2R:.9D*E(R[-
M\IZAR%_X 1TZ@&_>^)+ZP?PY%<:8L<VK2K#,IGS]F?9N(X'S8P1G(Z5<L=;E
MNO%.J:-):K&ME##*DHDW>8)-_; QC;[UQ$]VW]A_#"XN'DEDDN;8,['+,S0$
M9)/7D\UTNE_\E-\0_P#7A9_SEH ZNBFNH=&0Y 8$':2#^!'(KQJ"QDC\!3>(
MAJ6HG4++5V\AFNG*JOVGRRI4G# ACDG)[9QQ0![-4,UW!;SV\$L@66X<I$O=
MB%+']%-<19P0^+/$WBNRU1IPUG)%!:H)"IMT*9$B8/#%LG=Z #VK TY/[;UC
MX?7>J$W%S-!?QO/O*F58^$;@]QS[YH ]=HH P !7G;_9/$7C3Q1I.KW<D,MI
M#$EBIEV"%&3)F3G[^XCGMA1F@#T.EKS[3[NV\0>+8-*NIY;W38M&CGMC,Q N
MRS8:5A_$< =1QDG'>L*Y-^VB7]BU]>B"Q\2PVMG<B<[Q&TB IGHVW) W _I0
M!Z]4<\T5M!)/-(L<4:EW=C@*H&22?2O.OLB:!XRUS3;+49K2UGT$732W-PSB
M.<R.@EW,20>G3_"L6XLXAI?B'2]:T7[%JT&A33?N'W6URJ#Y9E.<APV,@\\\
MT >F7VH:D;?3;C1K&.\BN9H_.,DHC,<+#)<9ZD<<5<BU&UGU*XT^.4/<VR(\
MRCG8'SM!/8G:3CKC![UP.I6EOIOAWP2-/+P+)JUEYBQRL ^]<MN&<'. >:L:
M%I&E2?$;QFDMG;'FU"@J.-\)W8^N3GUH ] JO#?6]Q>7-K%(&FMMHF4?P%AD
M ^^.?Q%>6V-Q#)X!\ 2O.K79U.V1&+_.09#O'J1P,CV%69O)T*Y^(E_I=G;K
M?VH1[?:%5DS;*68?3)8COCWH ]2HKS+POIZ_;?#^MV_B.U>*=#%]FLK-U-R2
MI)\TF5B2I4G<1G.?6O3: "BO%M>,DL%[J^EF-K@Z\L=OJ4\H%QN\Q5,2#^&-
M<$?,>1SMQS7M (8 @@@\@B@!:Q/#NM7&L2ZPES!%"UAJ#VBB-RP90B,"20.?
MG]*P-9F@U'XGV6@ZNJ/IC::\\%O-@QSS[]IR.C$)G /UKF);A="\*>*UTYUA
MLU\2+',Z@N(H&$._@'[O4?0XH ]@R,9S7)Z'XCU?7Q8:G8V5I+HEW+*C-YA6
M:%$9E5SGAMQ7H ",CKR:H:!X>T:/6[N./4+2^M-1L_,DTZWMU%KM#*!)M!(R
M3D>_/H:XW11;:1\'=!OHTAM([V_6/5+I8LEH1+*!YF,%E!V@C/0D>U 'MV1C
M.:,UY-J^DZ5IFC>*F@UB"5+K26N/L=I$(K>-APD@VL0&9NV?FYJY;Z7;Z-XX
M\(7%DCQ&_L+A;R4N6:;;$K+NR3G!Z?ET % 'IN11D9QFO(-.-UHMWIWF6T.H
M37,=S-I>N6F-]VQB=@LZGDGG/7J![T[PQ#INJ:?X>UE?$%O#J<4R><EO;@7,
M\S$"2.7YBS DG/& .> * /7:HPZM9W&KW6EQ3!KNUCCDF0?P!]VT'W^4G'H1
MZU>KS-K>SL?'_C"\MK.T_M*#3X9++**K^<R29VG'5C@''7- 'I>1TSS2UY-]
MELW^&OAWQ!IQ4:T)K5Q<I_K;F9G"2HS?>;)+Y!/\/H*]9H H/JUJNMQZ.) ;
MU[9[G8"/E165<GN,EN/7!]*R?!7B*Z\2Z7>75Y#!#)!?2VP6'.,)@9YZGKZ5
MC7=II:_&2*2ZM[,;M%,NZ5%YD$Z@-D_Q8XSUK@[BPAL_AEXCUI4(U2PUV0V\
MXD),+>>@.S!P,Y.<=?RH ]ZR!WHKRC55L-9\9>)M-UO4K*RD$,2VS7<*L4@,
M8):)F8;6#$DX'7'IQZ-X?8-X=TYA<S70-LF)YUVO*-HPS#U/6@#1X%&1ZUYW
MX\N?^*PT"QOK^"RTV>&;;)<P++$T^5P&#<9P3@GU/K7/ZEHNEVWA6SLK?4&O
MXD\20)'<*!&(][+OCA*GA1[=#GTH ]CR.N:Y#P_K^O>((M/U>WM[#^Q[MY5D
MA8LL\"JQ56W9*ODJ<C:,9')K.TC1]+TWXC:WIEM9V\6FRZ7!-+;;!Y18.PW%
M3QT _G7,:4EG9_#/PK</;1)8W.IA-3F1 -\7FR;1(<<INVYSVXH ]CM[F"ZA
M6:WFCFB;H\;!E/XBECN(9F*Q31N0H<A6!^4YP?H<'\J\\UG38+#Q/J$&E06\
M=C=:'.^H6T485 R\1/@<;CDCZ"L"XTFRTKX0Z?K=E;L9Y[2UCU&X5V9VMRRE
MUZ]/X?8<=J /8;>ZM[N,R6T\4R [2T;AAGTR*;!>6MT\B6]S#,T1VR".0,4/
MH<=.AKS;Q#<:*-*UN]\*7DCWLVDJ7CTYP(XX58?-@#Y7VE@.^ >F*ET6T\,:
MAJT-_IFLB\>;3Y(9+*"*)(S  ?\ 6HJC&"0!GN1VS0!Z&E]:2/$B74#-,"8U
M60$N!U(]<4^&Y@N#((9HY?+<H^Q@VUAU!QT/M7BUEHVE1^ / NH?9HDNY]4M
MHI;H$K(49G#+OSD+CMG%;5[;/H_B[Q59>'(%MI&\/K+%;VRA<S L P4?Q8H
M]-@O;2ZDECM[J&62(XD6.0,4/H0.G0TS^TK'S(X_MMOOE)$:^:N7(." ,\X(
MQ7F?AH>&M7O?#EU::V\FH11-']BMXHHV"E/WBS*%SL&WOW/'6L2STS3(/A9I
M6J)#"+Q=:0_:#]Z/%VPPI_A&WG XY)[T >MIXCTN3Q!)HJ7D)O8HP[IY@R"2
M<+C^]QG'ICUK6K@[273K7XNZNL[VT4DMC:^2'*@LY=Q\OJ22.GK7>4 <?X5\
M53:A=:[%K%U9Q&TU62RMP,1AE4#IDY)R<_C73G4;$7GV,WEO]JZ>3YJ[^F?N
MYSTYKR2PTGPY?VOC^;78K<M%JUSLF?'F1=,%.X)..G7@5HWUI?\ AO1?#'C*
MXADDU&PMXK;55QF26!P%.>Y96(_&@#TZ"ZM[G?Y$\4OEL4?RW#;6'8XZ&I:R
M?#EC-9Z2K78 O;EFN+GVD<Y*^^T87Z+4FOZO#H6BW6H3,@\I"45VQO?HJ_B<
M#\: ,6+QK%)\06\->0PB,+>5<D$!YT 9XP>APC*>/>NEGO+6VDCCN+F&)Y<^
M6LD@4O@9. >N!S7E_BKP[K>D^%;+71?V,E[HTYU%A';%#*[MNE!D+G(.3_",
M@ 5H^*+O0M9N_!>JS_9GLKJ[(,LH&"K0OA&/IN(&#QF@#O;/4++4+;[397EO
M<V^2/-AE5UR.HR#CBH[+5=/U5)3INH6EWY9VN8)ED"'T.T\5Y-KEC_9\_BN7
M0X2- \RS^V16JCR]RN/.55';9C=CU(/>NON8[6Z^('AZ^T2:$J+:?[<ULPVO
M;[ (P^./OD;<^AQTH IWOBS6[?X=:YK"S6OV^QO9K=6$!V%4F\L87=P<<\D_
MC7;WNJ:?I,$;ZGJ-K:JWRB2YE6,,?;)%>5ZG<0O\(?%Y6:-O^)K<]&!ZW((_
M,5U:ZC:Q_$>X.HR1"VNM-B_LV9R/+906,H!/&3E3[@"@#LXY$FB26)U>-P&5
MU.0P/0@]Q2LRHA=V"JHR23@ 5Q_PYA:'2=3\IF.FOJEP^G?W1;Y&-@[+NW8]
MJT/'4]M;>!]7EO('GMQ 0\22%"P) QN'('//MF@#1M->T>_29[/5K&Y2 ;I6
MAN$<1CU;!X'UI8M<TB>Z@M8=5L9+BX3S(8DN$+RKR=R@')'!Y'H:\PL]3TIO
M&M_++K%C=I<Z R,84V6^4;A4R3NPH.3D]^G2HM/32+/P7\/KI/LD-TVH0%I0
M55SPPDR>O]T'/M0!W?C'Q/::/I-]!#K5C9ZNML\T$<Q5F)520-I(ZXP,]^QZ
M4ZXU:^/AG1#!-C4M3-O$LFT$@LH>1P,8X17/3'%<,^N:5#X?\<:3KDBKK$D]
MVXAN(]SS)M/DLO!R  ,8^[C/ YKJO"TPU>[TJ6(J]GINE1*''>>11D?543_Q
M\T =%-XBT6WU1-,FU6SCOG("V[3*')/08SU/8=Z=>Z_HVG-,M[JME;M"%,JR
M3JK(&.%)&<@&O.(;NVD^'>NZ#K15?$)FG62VZRRW$C%HF0=6SE<$= /:KUG8
M:==?$:*PUZ*PN[\>'K=9DF"OOFWOOX/4X(/K@^E 'I((905((/(([UP/B;Q9
MJ7ACQQIZ3R"3P_<*JW.8U!MV<E5;=UVY&3GW]J[Y5"J%4  #  [5Q6O6FF>(
M?$>I>'[FZ@\RZTD1["X+JV]B#CU'#4 :_C#6Y="\.W%Q:J'OY%,=HAQ\TNTD
M=>P"EC[*:@\.:V5\&:9J^N:DGF7L4<A9U5%#. 0B@#GK[FN+L;C6)_ >KZAX
MB_T2;2M,N-.@,CX:2;:P:3/')PBCWW>M-37M,MO!O@%Y#!M"!!J+AG2RD2,
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MO3[:XFN(+&UBFGXED2%5:3_>(&3^--_LC3?(\G^S[3RMV[9Y*[<^N,=:NT4
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M>R&DW&OQ3:2D0A4?85%P8^A4OG'3^+&>2>#S7:44 ,AACMX(X8EVQQJ$5<]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !69K&N
MVFBHGG)<3S29*6]K$996 ZD*.<#C)Z<CU%:=5KU;@6\CV20-=[<(9R0OXD G
M% $>DZM9:WIL.H6$PEMY1P<8(/<$=B#P14.L:]8:$MN;UY0;F5880D3-N=B
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MTB&=K?:2"#C&X$C.!T% 'I@8$<4M<UX-U&+4M%:>'57U)!*ZB25-DB8.-C#
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MJLI01[1P>!R2,Y/4=*Z6VNI_^%GW&GF[G-K)HD=QY!F8J)#*REE&?E. .F*
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MQBV2]FF,K;2RRQLYRK =P>E '>45XW]BU ?"9O%#^(M9>^DTU3M%XZHK;^&
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M0;R$!NPNWS^/OX]^M>6Z?;W^OZ)H:I'JIUEM3SJ5]!+*D4MN';S/WZD*R$8
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M2(-W R3@]R?;% '3Q6\,&?)ACCSUV*!G\JDHHH **** "BBB@ HHHH ****
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MC%I8Q<O@9?>0HS\H+<D"K<?A>PBU:'5%DNS>0VOV-9&N&.8O0Y/)S@YZY -
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M348[E-7,B)/;L'DW3AASCYCM!)QTKN+BXC;XM:9(NXQG294\S8=NYG5E!.,
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M^_J#TKS*^?5+GX:V/AA] U8:I87,,<H%JS1L$D^^KCA@?;W[<U=\9IJ.K?\
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M,Y&X#&=OZ\=>*YNQL-4G\-6]U:Z;=F2P\3OJ$EO+ T4DD!9CE58#)PX/X>M
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MI9M&TNYL8K&?3;.6TAP8X'@5HTQTPI&!BH;OQ+H=@^R[U>RA;RQ+M>=0=AP
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M<K;17,@F>$SQI+;R1F6,=63<HW_\!S0!KM%&[AVC1F P"1D@4AMX"5)AC)4
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M>7HN(KCRCY/E^4HSOZ9R,8'//3&:[.B@#E/B'INHZEX7QI<33W%M=0W/V=2
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M]JUX88[>"."% D4:A$51PH P *1YX8Y8XGE19)"0B,P!;C/ [\ _E0!Y'?\
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M5!Y)X)SC'6K?AKPQ<Z5XG?4+6P72+*6V*W=G'/YD<T^1AT4<* ,\\$Y^Z.M
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MT.YB9Q'<D[XXT"@\J.3R<=O6@#I_#OB2XU;4]5TN_P!/%C?Z<T9DC642JR2
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M;H?(4'WE& 6&>.W4>^+_ (H\2_\ "/R:9"L<&^_N#"LUU(8X8\*3\S '!.
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M"7^R9-V$PWS#.$&UA]WG/YGLM5\.W&H^*='UJ/4?(&FB11!Y ;S!)@/EL\9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ=D%[).ZN8M^[:4VG#>^<8&.:VI]'\6:7XIO-8T9=,N(]5CB^UV]S(RB&2-
M@*,!EEQZ@5W5% '$Z_X=U#5[3^SM0TVSUFW:VR+B27R9(;@LQ)3Y20O* 8/
M7'--_P"$?UV'5?!LS^5>_P!D02)>7#S[6D9XPA(!!)QC/.,UW%% 'CXM-0U3
M4-7U2SL]*O=)DU!Y&1]1:WAD,38!DCP03E<DG[V >F*ZS3(M2U+QA%XJCL42
MPN=%2"-'F_>;RWF#(Q@==O7MFMA_!OAN34SJ+Z)8M=,=Q<P@Y;U(Z9]\9K<H
M \R@\*>*$TK2(6M--D%G?W-Q/93W3&&<2L60G"<["Q/(ZC-.MO!OB:VT&XM0
MVE-/;ZTNIV:)O5),/O*L?X1S@ 9QCKS7I=% '!W.A>+M/\22:YHLFD/)J,,2
M:C;W&\(LB# =".2 ..>?;GCL+"VGLM.2&6X>[G4%FE?@NQ))^@R< =A@5<HH
M X6V\.:\WASQ1IL\.GQR:R]S-"5N781&50NU_P!V.G7(SG';K5B^\+:E?^$-
M'M6DLX=;TEX9K>12SP&2/@9R VUEZ\9&>^.>RHH X\Z+K6K7\FK:G;6-M=16
M,MI:6T=PTB[I,;G9]@Q]T   ]ZJ'PKKI\.>$;$#3OM&BW,,LQ^T/LD6-"@VG
MR\Y(.>1P1WKNZ* .:TG1M2L_&VO:M.+3[%J,<"QA)6,BF($<@J!SN/<XQWIO
MB;0]6U#7=!U32);))-.>?>+O=@B1-F0%')')QD9]173T4 <+J7AG7[RZ\6,J
MZ:4UBPCM(6-Q(I0JK+N8>6>HD8X!.-H'.<AI\*ZV(O!:*NGG^PD5;@FX<>9B
M,1_)^[]!GG'I[UWE% 'G][X(U36;SQ5]ODLX(=6\AK62WF=GA:'[A92H!SP3
M@\=.>M;6@V7BLW44OB2^L&6W0B--/W@3,>-TF[ X'10,9.>PKIJ* .:\7:'J
M6J_V5=:1+:)>Z==BX1;O=Y;C:5(.T9[U5AT'7-(UR\U/2WL+@:DB->V]Q(\2
MK.JXWQD!S@]U/H.:Z^B@#(\-:(- T9+)IO/F:22::8+MWR.Q9B!V&3@>PK*L
M]"UO3O&&MZE;3Z>^GZB$E$4@<2^:D>P+D<!20"6Y/;'>NLHH \W7P'KD?@[P
MWI"SZ<]QHNH)>[B[A)0A9@OW21G<03@] >^!O6>AZM;>-]4UXBR:&[M4@2(2
MON4I]TD[,8))SZ<=:ZJB@#SF#P#K-EX>TA+'4;6WUO1YIFMY\,T4J2L69'!&
M0.<<9Z?EU^A6>J6]O)/K5W#<:A.1Y@MU*PQ@#A4!Y]22>23Z "M>B@#DY]#U
MRR\5ZAK.D3:?(FHQPQS178=3%Y8(#*5SN^\>#M[<UFZU;>']"\&S>%=2O&GN
M+Z*5TB5/WMQ*S%\HO0'>>!VXKOJB>V@DGCGD@C>:+/ER,@+)GK@]J ,_PYI7
M]BZ!:63,7F1 T\A.3)*>78GU+$UFW'AZ]D^(EOXC66W^S16#69B);><L6W=,
M=<"NGHH \ZL/AY?V^CK%)?V\6H6NIMJ5G/$I90S=4<'!*GIP?\*Z >';N^O;
MW4-3GMUNY[%K");=6*11L<L22?F).#T&,8]372T4 >?OX.\12^!['P_+?:8[
MVLL!218W4".(@J#R<L2HR> /2KEUX7\0V_BB[U?0]9MK1-22,7L%Q"90CJH4
M/'R,G Z'CUSV[2B@#AKKP7J]AKZ:OX;UF.WEDMDM;Q+V(S"8(,"0G()?_.:Z
M_3K1['3XK>2XDN9%!+S2=78DDG';DG Z <=JM44 <1#X/U6]U73;_6+NQ^T:
M>) MU9QLL\^Y=H#L>P!R?4^E5+#P-KUI#H41UJQ"Z/<%H@EF<2H49=[_ #9,
MA#>N._->A44 <7;>%-9L5\2V\&I6;6>J2SSP(\+;DDE^]N8'H.V.O7VI\7AK
M6H/#.E:6MSILZVMF;.YMKB%V@N%PH5NN00%]#G<>E=C10!PI\#7MMH_A_3;'
M4(#%HUP+M3/&Q,T@+87[WR)AS_>(X].8=7\ ZKJ-QKZPZS;PVFM1J9@]MOE1
MU4 ('S_J^,^H[8Y->@44 <1>^#=9.JV6LZ;K\=KJJ6PM+IVM=T4T>2<[-W!&
M>.>PYZFKMWX3NGGT:YLM8,5UISSNTMQ!YQF,OW^-R[>^.PXXXKJJ* .03PGJ
M5A<ZHFE:O%#8:I(\L\4UN7>!V&&:(A@/F/.",#WZ5(O@YK75_#]S87L4%IHU
ML]LEN]N7:16 #$N'&#A1V/.>M=710!Y_XBFT'QKK]AH-O+)-?:?>E[ORXW7R
M8E5A(I8@##':I /.?:O0*:$568JH!;J0.M.H X>^\!7DUSX@^PZ^UG:ZW\T\
M8M0[JVW;P^X?*>XQGMD59L?!U[9ZQH-XVKQ20Z18FS6'[(0T@*@%BV_@_*O;
ML?6NOHH X4_#V>;2=0M;C6@+FXU0ZK;W5M;>6UO.?0%VR/Q'UJ>/P/<W7B%]
M6UK6%OVETUM-EACM!"KHQ))^\2.OYYZ# '9T4 <=H?@S4-)6*WN/$MS?:?:'
M=96TL"KY;#.W>X.Z0#/ X' ]!6GX0\/W'AC0TTJ6_2\CB9FC<0>61N8LP/S'
M/)./3WK>HH YW7O#=SJNN:5JMGJK6$]@)4.(%DWI( "!NX!^7@X/TJB_@AWT
M'7M*;4QMUFZ>YED%OS&7P& &[_9&/QZUV%% '/OX>N)=8T74)+]"=,B>((+?
M DW@*QSNXX48].>M4[;P?<MJ&DW.J:N+[^R23:N+;9,Q*[3YDFX[ACL ,X&<
MUUE% &9J]A>WJVSV&H_8I[>4R!C%YB2#8R[77(R/FSUZ@5S5Q\.+:6P'DZC-
M9ZH+UKY;VU39LD<!7"IDX4@ 8S]2:[BB@#D;WP+%J^@WEAK&J75Y=73H[7N%
M1D*?<V*!M4#G@==S>M2P>$)7L;V'5=;O-2GN;)[$32*J>5$XPVU0,;CP2QR3
MM'I74T4 <:_@BZDTK2;)]>ED.FW4-S&\ENI&8@%10 1@8Z]22>HJZWA66WUJ
M_P!2TK4WL&U%%%U&(1(K.!@2+D_*V/J#W!KI:* .77P;%;:AX>GL;LP0:)%)
M%% T>_S X 8LV1R0/SYIUMX7NK:'7ECUF6.35I6F$L401[=RH7*G/. J_E73
M44 16\;0VT432-(R(%+MU8@=3]:EHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BDR<XQ^- SWH 6BBB@ HIGF9Z8/XTJMG@CD=>* '44
M44 %%%-!.>10 ZBBFLVTCISZF@!U%("3U&*0,3VH =1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M* "BBB@ HJ(6\0NFN0G[YT$;-GJH)('YL?SJ6@ HHHH **** "BBB@ HHHH
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MPAMSNX\5^(0OI]HC_P#C==910!R7_"%SAMR^*/$ 8]2)XQG_ ,<IW_"'W/\
MT-/B'_P)C_\ B*ZNB@#DU\%2@?\ (S:^"3R1=*,_DM._X0R7_H9]?_\  L?_
M !-=510!RO\ PADO_0SZ_P#^!8_^)H_X0IC][Q)X@)]?MF/Z5U5% '*_\(5_
MU,?B#_P-_P#K4?\ "%?]3%X@_P# [']*ZJB@#EO^$*7_ *&'Q"?^XBW^%'_"
M%+_T,/B(?346_P *ZFB@#EO^$*7_ *&+Q'_X,6_PI/\ A"(S_P S!XB_\&3?
MX5U5% ')GP+"1SK_ (A/L=18_P!*U]&T1-&\X)>7UR)2#_I5P9-OTSTK5HH
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M[GT'1[FV-M/I-C+ 93,8GMT93(<Y?!&-W)YZ\FG7&C:7>"W6ZTVSG%OCR!+
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M*$+#@[L' YZ&J%K'>VWPZ\,:7X@5O[+O;PI>37!R8X,EHE8G[H;"C/8<<'H
M=SX1U>_U*?6+6\9;F*PN_(@OT0*+@8R1@<94\$C@_G577/$4L7C.R\.C4%TI
M)[8S)<O&K&>3=M$2;OE'<G@D\ 8[UOANDUC%JVCQ77V[1K"X6/3[S(.]2NYD
MR.&V$XR/6I_%J>&=8U$:%XEC@C1K<3VUS(=A5BS!@K]%/RJ<9YST.* -K09-
M8+:A!K!B<P7.RWGBB,8FBV(P8@D\Y+ XXR*UR0 2>@KSSP=JK>'O#NNS:AJ<
M]_H>F7!6RO74NSQ;1D C[P4G;GIP>PP.ZW0:MI.Z*0FWNX,HX&#M=>#STX-
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M/S%BJ*#P,Y)[>O2NG?Q7I L=/NX)VNDU#/V1+="[RX!)PHYX .?3O0!M  #
M&!00",$9%<Z_CG0(](LM3DNG6VO+@6T1,+9$N<%6&/E(P>OH:KM\1= 4WD9:
M]^T6A_>VWV*3S0N,[]F,[<<Y- '58&,8&/2EKSGQ5XEB36O!6J6NHSKI=Y))
M)(L9;;*FP%<J.2<GIUSQ6[%\0_#LNBWVJ_:)EAL7"7,;0.)8B>FY,9 /J>*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@*JMTZDUUOBV]U%M<\+0Z9JLUM;ZC-)'(R!6#)Y98,..O'7M0!WNY?45&\@
M;G..P]J\GN=:UOPNVL://J\UX$DM/LM[, TD*3MM8MQAB,'G%= );W0/'.CZ
M='>7-U8ZG%.)$N'WM%)'M(93V!!QCI0!;;Q[;_\ ")77B#^S[GR;:Y>W>/*[
M@RR;,_3-=<DH94)ZL,UXX!CX+>(5 Z:G/C@_\_0/\JZF2ZGU[QGJ&B&]N;6W
ML+2!T6W;8[O(#ER>X' Q0!WU%<'H2ZOXG\.36=QJUU975CJ#PF\ML!IUB?'/
MU[UWE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVYUS3;35;?2YKH"^N%+Q0*K,S*.IP <#@\GTH T**** "BBB@ HHHH ****
M"BBB@ HIH=2Y0,-P )&>0#T_D?RIU !163;>)=+N]=N-%AEG:_MP#+$;64!
M1D$L5VX/8YYK6H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH Q_$NH2V.DE+5L7UVXM;3C/[U\X/T498^RFL'X
M;WTT>EWGAR_D+ZAH<YMI&/62,DF-_P 1_*M"\TN;6O%.-4TQ9-'MK9E@,A1@
M\S$;G(SD84 *?=O:L=?#5WX>\?0:EX>T@?V;/;>1?H)E7<<Y5U!;EAT.>W2@
M"2Y^(LZ'6/LOAG4+@:3-LNB)$&U H);J03R?E&>!DD9K5?Q>EXUG#H=F=1NK
MNS%\B-*(52$G +,0<$G@  ]#TKFM$N=7CU/QI;Z=I0N_.U.18Y3,J+'(8E'[
MP$@[?N_=R>O ZU?TOPKJ?A75--N]/_T^W73(]/O(!($8LF2LB;B%/)(P2, ]
M^: *'C36;3Q)\+M4N1;-%<6=U'#-!, 7MYEF16&1QT8\CJ#6W=1Q1_%?3Y@B
M*[Z1<;W  +8DBQD^U96L>%M8N_!VO0Q6D;:EK-^MR8$E4)"JLF 6.,G;&,X[
MMZ5L7>G:A?>,[&_?3Y$LCILUK.WFINC:1E/3/.-I''J.M #)O'0M[!-:ETQQ
MX>>3RQ?"4%PI;:)#'C_5D]\YQSMKIKZW@O-/G@N(HYH70ADD4,K#W!KAQX8U
MB3P7_P (7<6ZO:JRP#41(H#6X<-G9]X/M&W&,9YS7<WK2QV,I@@:XDVX6)6"
MECTZD@4 >=_"^[?1([CPM?S?ZJ%-1LW=OO6\@!(Y_NMG/U-5?#]PVK_&(ZC=
MHQCGT9[JT28<11>>$C90>A*J6S_MUKW_ (+N]:M/#DS%].O+*+['>C>K>9;,
MFV101D'..#VR3P15W^Q]17XDKK::>JZ>--_LW*RJ'_U@??MSC8!Q_>]J *8^
M*.G-?V8C6TEL;N[%JDD5\KSKDD"1H0,A"1UW9P<X[5%XZUN[U/P?XEBL='2Y
MT^VCDMY;F:?8=Z_?:-"IW!".I(Y!QG%+X<T?QGH21^'5^P'18)3Y6H;SYPAW
M9V;,8WXR,]!G/.*JW?ASQ;9Z3XB\/6-I97FFZBUQ+;7$ET4>$29)0KMY.2<<
M@=S0!K17-E!K_@Z&?25EN[FQ=;>_+@&$+%N9<=3D8_.K</C"YO1#>Z?HLMYH
M\MY]D%U#+NDX8JTGEA3^[# C)8'C.,5670]9EUGPA=3V]JJ:5;RI=;)R?F>,
M(-N5&<8![=:SO#OA[Q?X=#^&[9K$: LS/#?;SY\43-N*!?[_ "<,>!G/. *
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MLL@%Y>PO*@STQT!_WL/C_=]Q2>+=>N/#FAMJ%M8"]D$L<0B,PCY=@HYP>Y%
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M)ND/5_F)Y/?Z5K44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDTL<$+S2N$CC4LS'H
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M7:HC.T7"A> 0!CD=@,9[T ;^J0RW6C7L-OS-+;R)'@X^8J0.?K7*?"B\MYO
M%C9QCR[FQ+P7,!^]'('8G<.HSG/XUV-I;I:6<%LA)2&-8U+=2 ,<UF7?A30K
MZ_>^N--B-U(NV25249Q_M;2,_C0 :CK]K::3?WMMBYDMY/(")_RTG. J ]SN
M95..AR.QKS?6+36?"BZ'XBDTI(!I4I6_N([OS7N(I6_>%AL'\1)'/&:]-O/#
MFCW]I:VEQ8QFWM2&@C4E%C(Z$!2,8J?4](L-9L#8ZC;BXMF(+1N3@XZ9P>:
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MT9PRENQ[_B.YQ72T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'D6S6RP>5U5B"26W=<@=JV\4 >&ZC<"'POXYL7CU)Y;J[B>%[JW8/*,1D9P
M,D!CC' '(%=UXNN;.&#PUJ]O"YLDU2.>5X+=F.TQ2*&*J,GJHZ>E=QBC% '
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M@)PS%?E7.0,=#BN-N+B.'PA=1O-/*+#Q4EQ<2RVS1%(RWWF7: N3SM [].:
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M=2K%;PH9))&Z*H&237G?A9?[0N--M[OP7=6NIZ?M^T7EXF(8R!@M$V<LQ('
M&!GKQSV?B@W8\+ZG]ALH[VZ-NPCMI$#+(2.A4\-]._2@"&P\6Z9J%\+-%NX9
MWM_M4236SJ9HL_>3CGMQUY'%4+?XC>';LVAAFN&BNIA LWV=_+20L5".V,*Q
MQG!YP0>]<SH_VQ/&6A:C_8^O&V_L^2"2:ZCP5<E"?D!Q&J@'@!<X^4&JG]FZ
MK%\)-*L8=,O5U&WU)96A^S-N&)V?=C'(VD<_A0!VOBGQ+:65AJ=I']MDN8+5
MI)'LHV8V^1E2S#[I[^N.>E6O!,LD_@;0Y99&DD>QB9G<Y+$J.2:YJ235='O/
M%%@VAWUZFIL]S:75M&&#;XU01N21MVX[]OPSTG@B&XM_!.C6]U;2VT\-JD3Q
M2C# J,'C\* )-8\06EA.;!H+ZZF:/?*EE&6:&/IO8@@KT.,<G!P.*Q?"&O?9
MOA]HMS=FZO;NYC8I'&#)-,VYB3R?3J2<5'&^I^'O'&M3-HUWJ%KJWE2P3VBJ
M2C(FSRWR0%&>02<<GWQR(\/:F/#?A.\O/#,^HQ::)K>\TN5!OVN<B1!GG&![
M_AS0!TGC3Q):ZM\/+R_TR\N;>6"\B@9 6BD23S55XW'^Z3Q6]/+IX\=J3<:D
M=1BTYRMJH80/&&&6 ( 9\L!P?Y5RFOZ3)=?#FZATWPS)IHEO(9+6P@MQYS!7
M4L\H7(!(#?3 YYQ71RM+)\2=/O%M+LVO]ER0F;[.X57=T903CCA3].AH NVG
MB_3;W09=8@2Y-O'/]G*&+$GF;@NW;G.=Q QUINK^,M/T:659[>]EBMPINYX(
MM\=MNQ@.<]<$'@'@UBV?AJ_L_B%>K&NWP_<2+JN #C[3@H4Z]SB0_P"ZM9=S
MI#Z5XMUHWO@I-?AU&87%I=+!%)L8J 8W+_<&1U]\\T =+JOQ"T32KIK9EO+F
M46JW:BUMR_F1DX!0\!ACG(XP#SGBNIC<2Q)( 0&4, PP1GU%<19VMW9_$>UN
M)=+=+8:)%8&6U@/D1RARY5>X3' /0<"NXH P+/Q;:WUW;16]A?-!=M(MO=[$
M\J4H"3@[LC.TXR!G%0OXWL$\,+KYM+W['YY@==B;XV\SR_F&[INXX)ZUSNA:
M;?V?B*PGTBPU'2X9W<ZMI\W-H@P3OB). Q;& G;KC%95]9^(O^$-U+PS%X;O
M))$U$RBY#IY<L9NA*"F3DG!Z'  !)/:@#T#5O%-KI4]Q#]EO+Q[6'S[G[+&&
M$"<\L21R0"<#)P,XKD+[78K;XK:??0&]O+:[T+S8;>W#2&0M)P53.!\HR3P.
M.:L,_B'PUXPU*_M] N]4L=:6*0!)D\RVE5=OEMS@*/7H..35FVTW6?\ A9FG
MZI?6Q>-=':WGN(E_=K*9"^T=R .,XYH ZG0M;M/$.EI?V8E6,LR-'*FUXW4X
M96'8@BC5-9@TR2W@,,]S=W)(AMK< R.!]X_,0 !D9)(ZCUK)\$V]W;VNK&\L
MI[1I]4N+F-9@,E';*]">U5_$,6L:=XQTW7M/TZ74;06LEG=00LHD0%E8,H8@
M'D=/:@#)\&ZY;V%IXKU&[2]AA35RBPW&YY]Q2-0F,DDDG &374Z=XHM[S49-
M-O+6XTR_2/SA;W>T%X_[ZLK%2!WYR*X@:'XCN[;6[F/2)+:\76XM5M(II8R)
M@H4%,@G!P#UXSWK;U+1KSQ7XAANWM;G3[6VTZXM\SD!I))UVXV@GA1R2>^,=
M* -&V\<V5Q?6,+6-]%;:BQ2QO)(P([A@,X SN7/8L!FD'CFR/AB\UW[#>^18
MSO!=183S(RAPQ'S8(!/8UE^%;GQC!8Z?H5_HHMFLRL<VHM,C1O"F,;5')9@-
MOMG/M6+>Z)XE@\-^*/#=GHC7!O;R:XAO#.BQM'(P; &<[NV#@>_J =E?>,X+
M35)-,BTK4[N\6V6Y2."$'S$8X&#G'KDG XQUXJA%\2M,FM[*Z73]3^QW$JP2
MW)@PEO*6V[')/4'KC(HLDU)/B!%>2Z1=QVK:/':O,2A5)59G(X8YZXR.]<Z-
M)UH?"Y-,_L6]^VC4_.,/R9V?:/-S][&-O'U_.@#LM;\96>BRW:-;3W(LHQ)=
M-$R#R@<'&&8%FVG=@9X^HJ.3QQ9'4(+.RL;Z^>YL_MEL]O&"LRY48!)&/O<E
ML 8ZYXK!N]+U?2?%NHW-OX5M=;L-5=)T:1XT>VDVA6#%@?EXSQ6I::9JMMXU
MT^ZEL UK;Z2]K)<6_EI&96='PJ;MP7Y2.G^- #+WQQ+-H6EZCI>G3$W>I1V4
ML<S*CPMYH1D()^\<$>@SG-:=[XJ^R2744>E7=S-9PQRW4<+(6BWYP,%OFP 2
M<<?6N6ET;7HO"[^7HTKW=OXA_M-+8S1@RQ><9."&(!P<<_K4GB+2=6U>[6[A
M\/W.GZZ8X_LFIV=U'B$XRR3'<"R@Y'W3D=/< ]'KEY?&]K'/%BQNFM)-1&F"
MY&S;YQ.W[N[=MSQG%=+$)!"@E96D"C>5& 3WP*\GU+0O%MX\5W=Z#]NU&TUB
M.Z2X:]C :!9,JD2_\LQ@#.<'N<]@#N)/%T/]I75K;V%U<QVEU':W,T6TB)GQ
MR5SN*C<,D#U]*Z&1S'$[A&<JI(1<9;V&>,UYSJ^BZK=ZVMY8:'=:7K)ND/\
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MR2^:H.Z3'1>N!M'YUSC>$_$,^F:D\$<5GJ,>O-K-B)9%=),J5\ML=.,_F.:
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M+CR6M3<',)&[?D[,DJ%.1@?6CPW9W6@V>K3ZN;.V@N+V:^#_ &C(C5SG#DJ
M,>H)%9WA'1['_A*-;U73[I;G3&GW6H0AHTF=5,S(PX(.%&1T.X>M '8WDD\5
MG-);)&\RH2BR,54GW(!/Z5Q'AWQ;J*^#-(OM0MX[F\U.816H6X.99'9R=V5^
M15 [;N!BN\D3S(V3.-P(S7G]CX+UV#PQI&GS7&GK=:)=)<6;QLY2<*6R),KE
M<JV. <8SSG  .ETWQ#)<>(;K0K^S2UOH8%N8_+F,J31$X+*2JG@\$$=Q6[7.
M:7INHW/B-M?U6&&UE6T^R06L4OFE%+AF9FP 22JX Z =>:Z.@ HHHH ****
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M[R7*Z@F^VCA0EY%QDG;V &,DXP2!U(%3Z-K=AK^GB]TZ8R1;VC8,I5D=>"K
M\@B@#0HQ7*7WQ&\.Z?->0RS73RV4ACN$CM9&,>!DL1CA?]KH>V:T(?%FE7&I
MZ=80RM(^HP&XM9%7*2(!DG/;Z'% &V !THKFYO'.BV^FWM_</<Q065W]BN"U
MNW[N7CK@$ ?,/F/'/6H/^%B^'1(JRS7<.Z9H5>6SE168+NX8K@Y'0 Y.1@<T
M =7@>E&*Y[3O&NB:E'J++/+;-IHS=QW<31/$,9R5;G%26'BRQOM1BL)(+RRN
M+B+S;9;R+R_/7OLYZCNIP1Z4 ;M%8-OXLLKF\@A2VO!#<3O;P71B_=2NF[<
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M)%&N%4?2K%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !103@4F1C- "T4@(-*#D9H **** "BD
M#!AD=*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *HZK>75E9[[*Q>]N78)'$K!1D]V8_=4=S5ZHYF55VM
M*(R_RJV0#D],9[T 8OAS6[_4I+ZRU;3UL]0L759%BD\R-U895E;KT[$5;\0:
ML^AZ%=ZFEF]V+:-I7C1U3Y5!).3[#MD^U<WX:BO](\;:[IDU])?V+0QWIN9U
M4.DK?*49E !^500,# Q6IXKO+:_^'>N7-I/'/!)IMP4EB8,K#RVZ$4 7['7(
M+GPM;:]<#[-;RV:W;AFSY:E-Q&>^!5/0M;UC5Y4DN=!2SL)(_,CN/MR2%NF!
ML4<'GUXQ5?P[;6-Y\,]%MM22)[.33+=95E.%(V+P?QK)T?0X?#'Q$%CH1=-+
MN[)Y[NTW[D@<, C+D_+NRPQWP?3@ [ZBBB@!#TKE9/$MWJ6MWNDZ!;6\TEB%
M%W<W$A6.-R,A1M!)..W'UKJGY4UYK\.IETK5_$^C7RB*^_M%[A5<<S1OR&']
MX4 =7H^K7\^I76G:E9)!/;1HZR(Q*2@Y&Y<C@#'(K9BNX95W(ZL/56!'Z5R7
MC76--7PSJ<<MU-&(_+21[0Y8%FP%W=LXYST!KDM*\N/Q3XDLF^RQ0S:,D@MK
M2;<N_##GU< #)% 'K@N(F;:&!;&0N>2/6LI/$%IJ#:A:Z?+'+=6GR$,PV[]N
MX#([>IKR:STFW@\$>%]>L)I#KYFMT683%VE#,0T?IMQVQ70>&;#2HM:\<1?9
M[:*473K'L 1MAB!8 =<9S0!W^CW=Z=&AGUD6T5V5W2^2^8UYXY/M5Y+J*2'S
M48-&>0RL",>N:\AT:Y#:-X!L+W<VEW(F$Q;E&E&?+#G_ !ZU=O[9-/O/%EA8
MJHT/^R!</&K?NX;@AAA<'Y254-@>WK0!Z@+N%GV!U+8W8W#./7Z4"\MS.(?.
MC$O_ #S+C=^76O)8;"UT\?#_ %.V!2]NYHXKB<R$M*IA)*GG!'%2!$TGQ3;W
MES;VNJV5WJX,5Y$^RXM96. K@G+ $=.U 'KM<7XB\3Z]H&C7VL26%BMG;W'E
M(DLCB1D,@C#G P <[OI74V6IV6HF86=W#<&!S'+Y3AMCCJIQT/M7(?&$@?##
M5<GJT./^_P E "^*O$?BGPYH6H:@UCIKI! LD<RN[+N,BH5*\'.&!'/K78VM
MW'<1JHEC:944R(K#*DC/([5R?Q5)'PPU@@X(2+!_[:I6)<V":)XYT=M$MTBN
M[O2+II#RQGD"JRER>6.[N>: /2ENK=YW@2>-ID&6C#@LH]QU%2%E7&Y@,G R
M>IKQ7PC#IVH6WA_5)_$BG4X;P%K&&VC6X:9FPZN1AV!R22>,9/:NL^*5O:S6
M_AE[G"+_ &[;1M+NV,B-NW88<KT!SGL/2@#O4D20$HZL <':<U'!=V]UO^SW
M$4VQMK^6X;:?0XZ&O)]<TW2_#/B'7QIT5Q;Z0^A$ZC%8L%V2%PJ;2<A7*YZC
MID\YJ70GT^/XCQ6K7.D?9[K0S$UM:,"C?.NQ7).)'*DG.T<'IWH ]5%Q"7V"
M5"VW=@,,X]?I3;>\MKQ&>VN(IU4[28G# 'TXKQ[1M)\/V7P877;N"8W,UF]O
M+<02XE8/+MV;CD 9 '0X&??.EHEREK\0]4MEU#3;83:(N#9D%$=6(&23^\=5
MR2<#CL,4 >G1WEK-/)!%<PO-']^-7!9?J.HIS75NL@C:>(.6V!2XR6QG&/7'
M.*\>\/06/B2R\*V$R:=&^GSF6:=KF%S>#!X5 =Y+G#$. 1CG)K9T[1= &I>,
M+^YLP5TR^\^(VY*M#M@5B4 (PV<_4@9Z4 >C17EK<320PW,,DL?WT1P63Z@=
M*/MMKYB1_:8=\A*HOF#+$=0!WQ7DOA^[TS_A*/"?E76EQVDMA<1+;1N&D52%
MVB:3C>['/&T8.>N<U4&@Z%+\--3NXHXUUB"]G6TDB8F:.43OY4<8!RN?[HZY
MS[T >D6>O7"^*M<L-1GM([.RBMY89,;,"3?PQ+8)^4>E=&K!U#*05(R".AKS
MRTTJQUCQMKHUJUAN9HM,LPZ2X(5F20/QTS[]L\=:W?AU*9?AYH3%RY^R*N2<
M].,?AC% '0->VJ7:VK7,(N6&5A,@WD>PZTC7]FEVMJ]W MRWW83( Y^@SFO+
M_#NH^'[K1DM?$./^$DMM4::2WWD7,MP'.PJ."1M*CTP/05GZ_JEF_P#:QM[J
MRM FO1&:.=M]W*Z2HI;.1Y48QQPV1W&: /8)K^SMU<SW<$03&\O(%VYZ9STS
M@_E5#4?$NDZ9?V-E=7L"37I/EAI%&%"LV\Y/W?EQGU(KAK6Q\+:M\1_$[:HE
MC/$]M:2P"5AY;*T9W..Q/*_-UYXZFLS1F33'\!S:I*L-G'+J"Q371"CR-A\K
M)..JXQF@#TRSDU)O$5^LMW82:;Y<9MX8R?/C..2_;!.<5<@U.PNKJ6UM[ZVF
MN(O]9%'*K.GU .17G=X7_P"$E\>#1]GVV;1X9(UCX9FV/D@=<\C\2*=?RV%Y
MI7@B3PV\"72WL"QK"WS)#L/FA@.< #YL^E 'H,NKZ;  9M0M(P9/*^>91\_]
MWD]>1QUI;S5-/TXQB^OK:U,IVQ^?*J;SZ#)YKR:?3M(D\,?$><V]JTT-Y.L;
M8&8QL0KM_NY;/3KCVJ]>3R?9-.U.TU2P>^CT"![S3=1"^5=0$,25;JK9# XX
M^[GW /5%=7171@RL,A@<@CUJO;ZG87=U+:V]];37$0S)%'*K.G..0#D<UBRR
MSW'PU>72;>>WN)-(+6L.<R1L8OD7/]X' ^M<UX?UCP[JFG:#_8L"OK=M;/%%
M!$=K6A*8D:0=-NX#KU)&.: .\&KZ8U]]A&HVAO <?9Q.OF?]\YS27.MZ39B8
MW6IV4 @*B7S;A%\LMG;NR>,X.,]<&O,/.L[[X1V&G6QC7Q!!-%'%;MQ.EV)1
MN..H/WB3Z$D\5IV-MH\WCSQK)?I82RQ6EL"\@7 S$XDZ],G&?UH Z[4_%NBZ
M3?Z?9W5_;I+?,?++2@*J;2V\GH <8'J3Q5V;6])MYXH)]4LHII=OEQO<(K/N
M^[@$\Y[>M>8:=J-E:Z1\--0N+J)+.V$L<T[-\D;>05"L>@.>,&J7C;6;"[TW
MQE#!<1V<IEC$EJR%Y[IE$867G[D>,=!VR2,XH ]1>XN5\5[/[7L5L8[,M)8'
M'G!@P_>$YR% ('IS[U87Q!HK2V\2ZO8&2Y)$""Y3,I!VX49^;D$<=QBN274]
M,F^+,%RMU;^3-X?D =F #XF![]?E4GZ#/2N2T^/1[?X3:/=C['%=?VQ'(9=R
MJ^X71&<]>(_TH ]>NM:TJQN%M[O4[.WG;&(Y9U1CGIP3GFC4=5L--B'VW4;2
MR,@/EM<2J@) ZC)&<5Y=/=:(^L^*]'\3ZG>6JWMV)HH50%;J$HH0H=C$D;>,
M'TQSFM>RU33]!\:7,/B ?9(YM,MHM/FO#NS&J_O(BW0MN//KQ[4 =)X"U>[U
MWP=9ZE?3+-<3/,&D10H(69U7 '&, 5+8ZB;:ZUFXU+7].FL8IE\M0R)]D7'*
MR-GKGU__ %9'PGF@D^'ME'"P_=37"LH&-O[YR!CMP17-:E>V'V7XH+]IMN50
M*-Z\GR O'ONX^O% 'IMOK.EW5XUG;ZE9S72J&:&.=6< C()4'.,$51USQ7I6
M@7EA:7MQ&D][*$0,P4*O=V)X X[]3^-<:C:5:>*?AVMH]K$6LYU/ELHW PC&
M<=<MGZG/>M[QY<P6,OAF[NI5AMX=81I)7.%0>5*,D]ADB@"I;^,/L7CC7K75
M]7MHM(M8+>2W:38@!D&>&ZMG^E;6NZ@SQ:1)IWB*QL%N+N,AI-D@O(SUCCR>
M2<CD<^]<OIUSH][\5/$=S<K:^6FF0$O. #L*Y<L&Y7@@$'I@9KGK+4+!?A7X
M(\RZMP\6L6^=T@RFV8EOI@$$^Q% 'J]WXATBQO!:76H017!95\MFY!;[H/H3
MVSUK3KS#Q%*^E^(]5O-+U*&XEEN(!>:#=#YKDA4"M 1\V[ 'J,@YZ5V_B/7%
MT'P]<Z@RCSEC_=1,?O.> #CL"><=@: ,*+QH\GQ)&AM'C39(GA@GP,274>&D
M /H <?4'\.LO=0M-.A$UY<1P1E@BF1L;F/0#U)]!7FOBWP]J6E^"[:_BUN*>
M;29DO;<K;!6FE+<_,#D[MQ/3DXJUXP\2Z>;'PGXB6Y\A4O/, F1C&N8VWI)A
M696QD A2<]NX .R7Q5X?:">;^VK );C]]F=08^<?,"<CGCFEB\3Z%/%-+#JU
MI(D#K'(5E!VLW1?J?2O-=0O-*U/P+XSOK#4[6\OM2*326]J6(B'RJB@, Q)
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M!# $9P<9Z@^]%XUEI?B3Q!IGB+2-:NK?4;@2VGV-IC#/&45?+*HP&1MQR/R
M% 'J-S/$MA+.;A8HA$6\_(P@QG=GI@=:Y_3?%&BV&@Z8U[XCCNA=*WDW<Z^6
M9]I.21@8 P1G@<5LZ>BV6A6D;VXM4AMD4P!BXB 4#;GJV.F>^*\LT2(#0OAW
M;W%M*7M;R4W$30,3"1N +#'RX9DY/3(H ]*L_%.B7^FW.H6^H1M;6K%9V960
MQD=F5@&!]..>U%IXHT>[AOI4NVC6Q :Z^T0O 8@1D$AU!Y KAY3I]UJ_CVUO
MDNWMYKBT)^RHWF  (AD3 YV-R<9^[TJG=Q>([W0=;AMYCKD=I)9S6UZD)BEN
MDCDWM"6&"Q7KE3G)/<X !Z'#XJT6>*ZD^V^3]E4/.ES$\+QJ>C%7 ;:?7&*Q
M-6^)_AO3K*26WNVO9Q DRQ6\3L-KD!2S 84989R<\XQG K)L[K1-3CU#6K'2
M-4CDCTZ6":^U&6;<F1Q$H=FWY)/3@8]ZBU"P#_ VVBM-/D^TP6EH)8EMRL@*
M21O+\I /4,Q]>O>@#N9_$>FV]K#/*UT!,&*1"SF,I"]28PF\ >I&.1ZBF-XI
MT?\ L6'5X[P36DYVP&%&=Y6SC8J ;BV01C&1@YZ5Q.OZF(?%=EXCGLM8GT"Z
ML?LBO:&:*2*02$[F12K;6&,9ZX''2H_LO]@7WAO6M/\ #U[!HL<]R);8(\L\
M/FA569E)+<[<D<X!]30!N>"=9DUCQ-XJ)OKN>"&:!(8+E#&8%*$D;" 5.XL.
M1GY170ZIXCT_2)O)N#/),$\UX[>W>9HX\D;V" X7@\GT/I7-^"Y3<>,O%MX=
M/OK=+N6W>*6YMWC$B+'MXSWSDXZX/Y2V\MQH'CW79]0@N&L=2B@EM[F*%I%4
MQKM,;!02#W'K0!M7GB_0K&RL;V?48Q:WS!;>9061SC/4<#H>M00^)--\0:5J
M@TJ\F6:T0B0&-HI(R02IVN <''!Q7#_V9<:9HGA>*YLKA,^(FOC L#.;>$F3
M&[:#C&Y?S]C6O')-!X^\9NT%T+:;3X=CBW<K(R(00I Y(W=!Z^U %GP_XRM=
M/\*^&$U>6\FO=3@01R")I/-D/8MZ\UUJ:I;OK$FEJLIN(X1.Y\L[ I) ^;ID
MX/'7@UQ%AH<VM?![3[!"]GJ-M;QR023H8VAGC.0?F&1R,9]#71^#UN[C1EU?
M451;[4PMS(JCB-=H"(/HH'XDT 3ZKXJTS2+J2VN#/)+% ;F98(&D\J+^\VT<
M#@_D:+OQ1I]O#921+<WGVV+SX$M(&E9XOER^!T WK^?K7'^+/M\WB35[3^R-
M2>.?31':2Z?"%^T-ALB67(("DC"Y //!R :D48N_#GAF.YLM>TJ\L--58-2M
M[:1FBD"JC(T:@Y5L \XSCMGD ]*M=2MKO2X]11REM)%YNZ4;-JXSE@>F/>LG
M3/&>EZKJ%O911WD3W<;2VCSV[(ERB@$LC=Q@@\XZBH],DUS_ (5\LE]:I+K7
MV.0^2R@"1\-L#*. 3\N1V)(KC-(74AXB\*:@VB:\X@@FM[GSH!&D+LB !(\A
M4C&#S@9&.210!Z#K?B73/#SVBZE++%]JD$43+"[+N]"P& ?8\GM6./B1H9BN
MR(M2^T6I_>VGV&3SE7&=Y3&0F/XC@#C/44>.TGED\."WM+JX\G6(+B4P0-($
MC7<&8X''WA5>V$\/CKQ9=/8WOV>2Q@$4HMG*RE%;<$./F/S#@=><4 ;,GBW2
MULM-N;<S7AU)"]I#;Q[I)5"[F.#C&!USCGCK67JOCZ"WT[2+W3]/O;R+4;H0
M I#S&0Q#H02#O^5@!Z@^E<QIL>K6OAWPC:RZ-JJPPV\\5TUK!LN8Y.-J;C@Q
MHW4L",X'( .66-OJ=CX.TJ%O#^K[](UW[1+%Y0=Y(S)*<I\V7P&7)]^IZT =
M=IWC,ZEXON=(73KR&*WMDE<SQ"-@6)RQRPPH&.Q))/IS/;>.])N+RQ@:.YAB
MU D65Q*BA)R!G@ EAGMN SVS6"UEJ<OQ"O[A])O$MM7TE(!, I6W;^(2'=C(
M]!G/:J'A'1[BV;3].N/ UG9:EI[1^?JSP(R.B'[R,.6D8#\"2?:@#K-/\>:9
MJ>K1Z=:6FIO(T\EO)(;1A'#(F<J[=CP>.OKBNHKE/ \=S##K"75A=6C2ZI<7
M4?GIMWI(Y92.>N.HKJZ "BBB@ HHHH **** "BBB@ HHHH **** "BD'04M
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MCP/-J6F:4=2%S-,EW H>3#LS<NR*P(#;?H/PK:T[Q%H^KW5Q;:?J-O<S6_\
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MJ&[<QVZ0QDR2. 25"]00%.<X'%6]%UVQUZVEFLG?,,K03Q2*5>*1>JL#T(H
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ML]\8YSTH [*BN3\.>-H]<UN?2)+>W2YCMQ<K):78N863(!&\*N&!(XQ[UUE
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M1MH]PIE$5T'S&L>S/(')ZX&>.]1ZEX.UW5]1\6-\EI'>S6USITID4XEA &6
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MU"[L8_,\ZUV>;F-@OS#(PV,$X]#Q69J7C'1-)U"6PN[IUO(XO.,*0.[,OJH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** $'3-+2#TI: "BBB@ HHHH **** "BBB@ HHHH
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M444 %%%% !1110 @I:04M !1110 4444 %%%% !1110 4444 %%%% !1110
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M6CE4,3)M554<80M@8Z>AKU<6T A,(@C$1&"FP;2/I2QPQ0Q+#'&B1*,!%4
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M"G(!^9 !^(KU>B@#B?#$^GZKJT5[9^'K^TF@B>.>?4%=6A;(_=KN)W$\DXX
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M!)(Q]YE /<\#D4 >EZ=K^DZKIDFHV5_#+9QEA)+NP$V]=V<8QUYKF(_%1O\
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M;<G/3&/O8QD<'MJ:GX>UG4=1\7:<MBJ6>LHCQ7S3#:A6%4VE1EB=R^PQS[$
MV],\;6.H:^FC21&WN9H3/;YFCD$@&<K\C'# <X],\\5T]<CX;G\1WEQ"NKZ!
M;:2+8'S98Y4D^TM@@! .57G<23G@#N:ZZ@ HHHH **** "BBB@ HHHH ****
M "BBB@!!TS2TB_=%+0 4444 %%%% !1110 4444 %%%% !1110!E7WAG0]2U
M"._O=)L[B[CQMFDB!;CISWQ[U-J&B:9JC(]]90SO&"J.R_,H/4 ]<'TJ_10!
M0N=%TN[TL:9<:?;26  5;=HQL4#I@=!CVJLWA70'29#I%F!-$(9-L0&Z,'(7
M([<#BMBB@#)'AG1%CLT_LVWVV6/LP*Y\GG=\OISZ5-'H6DQW%Y<)IMH)KT8N
M7\E<S#N&XY'M6A10!EVOAO0[*RN+*VTBQBM;@YFA6!=DG^\,8/XUB>+?"[W_
M (?MM(T;3;!+9+J*=X6Q%%M5@Q7:%(^;D=*Z^B@"A:Z-IEK;2PP:99P1SC$T
M<<*A7XQA@!SQQS4</AW1+<PF#1]/B,(81;+9%V!OO;<#C/?'6M.B@"C;:+I5
ME9RV=KIMG!:S B2"*!51\C!RH&#D5 ?#'A\QQ1G0]-V0Y\I?LD>$SUP,<9P*
MU:* (X((;:!(((DBAC4*D<:A54#H !T%53HFE-J7]HMIED;X?\O)@7S?^^L9
MJ]10!G2Z!HT\MQ+-I-C))<@"=WMT)E P0&)'S=!U]!3[G1=*O);>6ZTVSGDM
MO]0TL"L8O]TD?+T'3TJ]10!2?2--DU#^T'T^T:]V[/M)A4R;<8QNQG&.,4ZP
MTO3]*A:'3K&VLXF;<R6\2QJ3ZD*!S5NB@"G>Z1INHNCWVGVMTZ#"-/"KE1[9
M'%+=Z5I]^L:WEC;7(CR$$T*OMSP<9'%6Z* (X8(K>%(8(TBB0!41%"JH] !T
MH6")9WG6)!*ZA7D"C<P&< GN!DX^IJ2B@"JVFV+V9LVLK=K4MN,)B4INW;L[
M<8SNY^O--.DZ:1"#I]I^X_U7[E?W?.?EXXYYXJY10!7@L+.UEDEM[2"*27F1
MXXPI?ZD=:;%IMA;PRPPV5M'%+_K$2)0'^H YJU10!1.C:685A.FV9B5BRIY"
M[03U(&.M6I8(;B%H9HDDB889'4%2/<&I** *:Z1IJVS6RZ=:"!VW-$(5VD^I
M&,9I1I>GB6&46-L)(5"Q/Y*YC Z!3C@?2K=% %5--L8QA+*V4>9YORQ*/G_O
M=.OO31I&FJ92-/M 9AB7$*_.,Y^;CGGUJY10!%!;06L*PV\,<,2YVI&H51WX
M ICV%G)=+=/:0-<)]V4Q@N/H<9JQ10!#<6=M=H$N;>*90<@2H& /XU*  ,#@
M4M% %=[&TDF:9[6%I678SM&"2O7!/I3IK6WN#&9X(I3&VY"Z!MI]1GH:FHH
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MBBB@! H48  'H*J6^FPV^H7-]OEDN)P%+2/D(HZ*HZ*,DGW[YP*N44 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 (.@I:1?NBEH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!%^Z*6D7[HI: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1?NBEI%^Z*6@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** $7[HI:1?NBEH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!%^Z*6D7[HI: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1?NTM(OW12T %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 @X&*6BB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>exhibit1011-physiciansha009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $)P":8TR)MW,JECA
M<G&3Z5)4,UK#<;/.C5]C;ESV/K0!*#DTM(!BEH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4QN&4L3G;P!MZ#IQ5&&/3+ZZUVU\2>()[.]BU.25K)8(DGE(;]RT,A7>20%
MVGH,=#0![66"J22 !R2:SFU2VOK"[.E:E8R3QQOM?S0Z1OC@OM/0'&:BUY+>
M?PEJ"7\\MG;26;B:7J\2E3D\9Y%<+I4;FZU31M432+EO[%<Q:K:[4ADA)P!*
MHX4Y.X'IC.* .[TJ^>#PY:W6L:A8O*(AY]U%(!"S=,@GBIUUO27MVN$U.R:%
M1EI!.I4#U)SBO*8;R"R^'7@+4'O(D%K=JWE2R;(Y" ^=S<[2!G&>YQWJ:Y71
M+OPEXZU=[S2)CJ"-,EO;SK+Y#!-J$G (=G ;ZXQ0!ZK!J5A<W3VT%[;2W"+N
M:*.56=1ZD Y Y'YU!'KVCRWDUG'JEDUS "98A.I9 .N1GC&.?2O/3#I>B^,O
M!;V$$$(DTNY\U;< -*/+# <<L2VXCU.:PM(UC2A?^![B&]MH+&*YN EF#YCV
MN]7XDD)R69B.,#MP>M 'IVF>-]!U-M0V:G91QVDYAWO<H-X 7+C)^[N;;GH<
M>];)U&Q6XCMVO;<3RIYD<9E7<Z]=P&<D<'GVKRQ+ZT;PC\0])$H:_%[J$WV?
M!+;#T;'I[U<&NZ3J'BOP"UM=PS1QVUQ')*IR@8PH A;INS_#U&1ZT >@0:]I
M%U=+;6^J6<L[!BL<<ZLQ"_>. >U&GZ[I.JSS0Z?J5I=RP_ZQ()E<KVYP:\KT
MO2;6_P#AKXEFT.WM)=6%Q>+&\*AI!&SD%5QR-T>0 .#D5K^%+CPYJ^O:/?6&
MIZGJ6IQ6[(4E=5%G%M(97"JHQNP #GG!' S0!Z-=WMK86[7%Y<16\*]7E<*/
MS-9]UXFTBWT*?6%U"VELX@?WB3*5+#^'/3).!CWK"\63&R\8>%K^\0?V3#).
MLLK?<@E9 (W8] .H!/3-9^^SBU+QIJEI<1)I,]DB22EP(I+H*X8J>A."@)'4
MGN>@!H>#]1U/7/L6K1Z_:WME-; WMFJ)FVF8!@J%1D8S@AB3QGOQTESKVDV=
MXMG<ZE:Q7+%5$3R@-EONC'J>WK6;X&N[:[\#:&;:>*81V,$3F-PVUUC4%3CH
M0>U>8>,M2L[VQ\56\<CV3I?H\MB(6DFG9"@\]V)(2/@ 8 ' YYQ0![!=>(-&
ML7G2ZU6S@> !I5DG53&#TSD\9ILGB/18A9E]4M +T VW[T?OL]-OK^%<+:SZ
M1J/QGN+MC:RPMHJF-Y5'+;N<;N^PY_W3GH:HZ!I$VO\ P?ABTZ1!JVG74L]D
MP(S%(DK,J^V5..>,,#TH ]274+-M0;3Q<Q&\6,2M!N&\(3C=CKC/>J][X@T;
M397BO=5L[>1$\QTEG565>!D@G@<C\ZR?!D]SJ]A)XAO8/(FU((T<1;.R%5PH
M_$EV_P"!5B>)I]&M?BGHDNM/9QP#3I]CW94('WKCEN <;L4 =BVOZ0NEIJ9U
M*V-BYPDZR JYSC (ZG(Z#FH5\5: VG'4/[8LEM!(8C*\P4!QU4YZ-[=:\P$5
MAI$,ETD21:3=>(O-TRX*L8K4A/FG"J1N4D$*#QP#TZY%S<6]QX+\?V\ES/-+
M+J$<T3RPF-I@60J<;0.0"< #CG&* /5+_P"('AZTN[2VBU"WN9+BY^SMY4@9
M8NI)<C('3IW_ #K7LM?TG4;Q[2RU"WN+A%WM'&^XJOJ<=.M<EXJ_L;2(/#FI
M6<<$-@=8CN)9K:/*L/)D4,=HY["D\5I=Z9KVE>*]$0R2WR#3IHF!7>).87((
MR-KXSQG'% ':6.J66I67VRSF$MOEAO"D<J<'J.Q!K%T+QMI6O3:D(91%%92,
M-\F5W(H&YSD *,DCKT&>*VM+T^+2M+MK"#/EP1A 3U..I/N3S7ES-?W&E>/M
M"BM[B2]_M&2[AMQ"W[R$LC$;L8.\ @#OVH ])L/$>D:I.L%G?Q2RLGF(G(+I
M_>4'[R^XR*M7^HV>F6WVB]N8X(MP4,YQECT ]2>P'-<1>7-MXF\1^$;C1@1+
M9S22W!$9!M8O+(:-_P"Z2<+@_P JO_$6Z@M=,TM[BV5D&I1$73QM(MFPSB4J
MIYQT&>,GGT(!LGQ9H"Z7+J3ZK;):0R&&21VV[)!U0@\AO;&:=;>*="O9;J*T
MU2WN)+5/,F6%MY5>YP.OIQFO'=6GB?PS\0+5[FY>:ZN;::&2ZMV1I@-C= @
M) X&!QSTR:[:6[L8_BAX;^S30+#)I4D:^60%(8J47CUQD"@#K(?%&C7.C'5X
M;U9-/#^7YZHQ4MD#CCGD@?7BM22:*&%II9%CB1=S.YVA1ZG/2O/=,T;4-/\
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MS?9G\M%D/WL\9X#8 /)'IS7<VMP+NUCG$<L8<9V3(4=?8@]#0!*%"@ # '
MI BJ6(4 L<D@=3T_H*<>G%>1Z+JS^)HM0M+C7]2TSQFIE3[(;@I$C G:J)]Q
MEP!D_>Y)ST- 'KF*YV#PY?\ _"2R:G?:]/=V:2F:UL#"JI Q4KG<.6P"<=.N
M>M5+V2QC\6>&8K_4=1AU4Q2"&UC)\B<^6=YDXP2/KG)%6-2\<:3IANWE2[DM
M;*7R;N[AA+Q6[\?*W<GYAT!QF@#I<48KF+CQYH]O>Q67EZA)=30">&%+*3=*
MI./E! S_ "X/-/3QOI,VAV>J0K<R+>3FV@MUB_?-*,@IM)P"-IZG''6@#I,4
M8KBM;\?I:>%KW5-/L+J2XMKD6DT,J!3;RDJ/GYY^\,;20<CD5MQ>)K1]=@T:
M6"Z@O9X#<1I*@P4!P>03@Y[&@#:Q4-U#)/9S0Q3-!))&RI*H!,9(P& /IUKG
MKCQYHUKI<VHS_:D@@O#8RYA),<H(!!QP ">N:6W\;6%Y;)):66I3S/))&EJ+
M;9*WE[=S8<@!?G7DD=<=>* +/AKP]+H<$KWNJ7&J:A/M\Z[G 4E5SM55'11D
MG&3R36[7-V?C?2]0L+2XLDN)Y;J=[>.U55642("SJVXA5( SR?3&<UL:5J*:
MMIZ7D<$T 9W0Q3J Z,CE&! )'53WH N8HQ7->+_$5WH"Z4MK8RSF]OX;8NA3
M #-DJ Q&6(! Z 9R2*KZCX^M=-U2737TC5Y;V*W6X:&&W$AV$XXVL1QSD]/3
M- '6XHQ7+S^-[6&Y8#3[V2RCO%L9;Q0@2.8D+M*EMY + $A<?6HKWQY;6FHZ
MK81Z3JMS<Z8JO,D$*G*$$[@=V,8Q[G/ X. #K<48KG3XNM9ETQ=/MI[V?4;4
MW=O$A1"8P 227(&?F Q_09JK+X[M8[K3[0:7J4EU?V0O((8XU)88!V9W<$9Y
MS@<=: .LQ6#8>'I;+Q7J>MM?F07T<<;6_D@! F=N&SGN<^N:QE^)=BVEG41I
M&K"W@D,=ZQ@ ^R$-M.[)^8Y[+G'?%6]3ETZ/Q_IQ>QO9=5%C.ULR2!8G4=5P
M6'S<XYXY_( ZRC%>6R_$37+?P7K.L2:%.&AN98DF,\1C@.\1J"-VYL$]EY/M
MS76MXL%NME;7.GSQZC<1-+]E>:(%44XW%M^WDD8 .>>G!H Z6BN5T_QYINK:
M397FGP7$\UY.UO':#:) Z\OGG: !R3GH1ZUG^!I7E\6>,B]K+:$7<'[B5@2I
M\KD\$C!Z\>M '<\"@8(R*YKXA(K_  ^UW<,[;1V'L0,@UGZ5XWBC&BZ?/I5_
M;B_MU%E<S*HBG8("%RI)7/;(H [;%&*Y6V\:I=^']7U)-/ECGTR5X);2:10[
M2KCY01D<D@#UKIX6=X(VEC\N1E!9-V=I[C/>@!6944LS!5'4DXI1@@$'(/<5
MY]XMO+F;XB^&]*DT\W5B\=RYMV9"EP1'U(8X^7)Z_A1;^+=.\+VT]I8Z3<_V
M'IU[]AGN3/DQ2LPR%1N2@+ 9!'L* /0L4E<SJOBR:SN-1CT[29=173$5[UDE
M"%<C=M08)=MOS8X'3G/%1W_C&1+UK/3-,-Y<K8+?F*6<0.T;9P$4@DM\IR#C
M''K0!TQN(%N5MFFC$[*76(L-Q4=2!UQ4N*X^_P!1L(_B#H\,NBF34I[.4P7A
MD **JY* >^2.<=:H2?$TQZ)+K1T&X_LVUNFMKR7[0FZ$B38"J]7ZJ3C&,XR>
M2 #O\56_M"R\B:?[7;^3"S++)Y@VQE>H8YX([YK!T_Q;+<>)_P"P[[29;&:6
MV-W:LTJOYB!L$,!]QO;GOSZ\?>S:5J?PE\5R6>AQ:='%<SAH#ASYJE<N>P.?
M3IC@T >JJRN@=&#*PR"#D$4[%<7KOCJ/2KB.QTZ*UN;A;5;EQ<7!A4(?NA<*
MV6.#QP!CD\BN@\.ZTGB+0+358X);<7"DF*489&!*D?F#SWH U,48KBO&NOZY
MI>O>'M/TJWMG2^N""TLS(7*@DH<*<+R#GGTQ4DGB[6FUZ\TFT\-FZ>RDMQ<2
M)=*%"2#)89 R1Z>@/2@#L:*XH>.KE=2TN.?2XX;;4KQK2%'N"MRN"P$C1%1\
MI*GH>A'K5>Y\=ZS':Z]<0>'8G319W2X+7H4,BJ&RORY+8.<8 QW)XH [VL[6
M=#T_Q!9+::C 98T<2H5=D9' (#*RD$$9/YU@ZAXQE_M;3],TV.R%W=V:WJ+?
M3-$)%8D!$(4_-QSGVZ\XBE\5Z^^OV^C6N@V_VF?2Q?#SKHJ$;<JLK_+D8)8<
M DG'09P ;FD^&-,T:7SK=)Y)\%1-<W#S. >H!<G ^E7SJ%FNH+IYNH1>M'YJ
MVY<;RF<;MO7&>]>?M\1]9C\-KKTN@016%M/Y%^SW?S!O,\L^6 #D E>3CN/>
MM^XU2*'XBVE@^D6C2SV#RQZ@,&8*IY3[N0,G^]0!U5%<5X:\9WWB*>WFBM;1
MK.621)DCE;S[(J&*B52/XL =L$]ZD\,^*[_Q&\5Q;QZ?)9O$YDCCD836TH/R
MQR CN,Y('4'KP2 =/8ZC9:I;?:;"[@NH-Q7S(7#KD=1D5:K@="\1B'PI8?V=
MH]E:7=]J,MG#:1/MB5@[[G)P"0%1CTR>!5N]\7ZCI<^MV%Y96[WUAIS:E;NC
M,L5Q"OWL]2K \8YS[4 =G17 :;XXUF2Z\-/J6F6<5EKJXB\F9FDC;8&!((Q@
MGMG('7GBN_H *9)#%*R-)&CM&=R%E!*GID>AKDKGQ-K%Q;ZMJ&CVEI+9Z7.\
M+QSEA)<^6!YA1@<+CD#(.<=JI7'C?5M1U&QM?#=A9W*:CIK7MM+<RLNT@@$.
M /4XP#UQR!0!WM%0VC7#V<#7<:1W)C4RI&VY5?'(![C.>:FH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XKXC7E
MK:6VBM=!$(U))(KF=V6&W=58AWP1N]AW-=K371)%VNJLOHPR* /G_6+^SE\&
M^-;<WL=Q+)JT4\;%-A=28_G [9YQZC.,X-=WJ":9IWCO3H]#^Q07$FB7*0K
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M$59?O]<G@G X[5W5% 'F*>&[B_\ ">AZ=J_AJ[,EE9^4)K::);FVF7 #*WF
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MS36,5I>VEZ[;04^ZRLOU/_U^W:Z9%>0Z?$NH3I-=G+2O&,*"23M7_9&<#/.
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M@"S!XSTJY\.C7(EN39F<6Z_N3O9RX0 +U^\<5M7U];Z=8SWMW(([>!"\CGG
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MP6I>6:)BCARYR%8\=AC/8\=@#I-6UF'2?LZ-#-<W-S)Y<%M;A3)(0"3C<0
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M82ZC.8UN#*3R0 ,8 &<GOB@#J]1\7O::K?65GI,]\=/1'NC%*BL@<9&U"<L
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M[@9QSS@#UH Z&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^TTRU6VLH$AA4D[5[DG))/4DGJ3S5FBB@ HHHH **** "BBB@ HHHH ****
M"LG6O#6E^(?(&IPS2BW?S(@ES+$%8=&PC#D=CVK6HH  ,#%%%% $%[9PZA93
M6EP',,RE'"2,A(/4;E((_ U!I&CV.@Z;%IVG1-%:19V1M*TFW)S@%B3CVJ]1
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M["YNI;6"]MI;B+_61)*K.GU .13?[7TWS8HO[0M/,E=HXT\Y<NPZJ!GDCN*
M+E%58-2L;JYEM[>\MYIX?]9%'*K,GU .144.MZ5<ZC+IT&HVDE[%_K+=)E+K
M]5SF@"_16<^OZ/&\2/JMDK32&&,&X7YW'51SR1D<>]4QXNT=O$YT!;V WBQ[
MG!E PVX 1^[')..O'O0!NT5'--%;0///(L<4:EG=S@*!U)/85R'B_P 7);>"
M+[6?#^J6<K6SQJ\D>V8*&D5#P#P?FSR#TZ4 =G15&RUC3;^XGM;/4+:XN+?
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MOXVDT^>55V72J-Q( )*\$'# <4 ='17*?\)]I8NK7=%,-/N[@VL%_E#&\N2
M-H.\ D$!B,<>F#6YK.I-I.DW-^MI+=BW0R-%"5#%0,DC) .!VH OTC,J+N8@
M#U)KE4\<P.OAZ4:=<"WUS:(9BZ;8V(R%;YNN/3Z=:I>+]:TJ[\.Z]%J^EWD^
MG:?-'',;>4 N_P KC&&! &Y,Y]?K0!W&:0,#T.<<5QLOB74W^(__  C8TQC9
M#3S.S+*@9PTBKYG7@*-PP.3GITKG_"GBN+PYX:83:;?S6::I-#-=(O[N#=.5
M7)8Y;J/NYQP#R: /4Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXP OIP3^?O6_XWM=NH:YJ4)L=3M8K6./5-.NEVRPQA20\#GH<,3]??BO0/[
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MBA@Q1]N"5;&#CL:S=)\)Z@UY;SZO8^'+06\@D4:5:D.[#IEV P.N0!SZXR"
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MF[]T&\O@EB6Z<9)KV46=JLJR"VA#J %8(,@#@8-$=G:Q7$EQ';0I/(,22+&
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MKD='UC3WUSP%);WULEO"\R?9($;%H'7Y4:1N7<GKT]@ >?<A9VHD206T(=
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MJ'!/&.?ITK9M-07PCXLA;5;2YM].N-'MX;/;&\PMC$#NA)7)+9/7'/%>ET4
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MG5'N_+>[F_=^3O\ FQC8JC?C)/'<$]:J^(88?^%P^$6\N/S'M[P2':,LOEG
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M%AD8)X/X5IT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/HH 3:/0?E1M&,8&/I2T4 )BF/#%(5+QHQ0Y4LH.#ZBI** $(!ZT;1Z"EHH
M3:*,#.>]+10 F.:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS6]!;S3:,3%@$X()]NM:"31R)O2163^\IR* 'T5&L\+.$65"Q&0H89QZU)0
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MEBMO^P#)_P"CTK;GT>9M5TVYMM2GM;2R1D:RB \N8$87/T[?TJ%] 9_%T?B
M7A$B6IM!!Y8VF,L&/.<YR.OZ4 <)XU_M'3?',VK>%&:ZU==-(U"TV!@D&?E8
M'.=^<$*,YV_GV'P^_LL^"-.;1WE>T968M-]_S"QW[O?=GVJ2]\+LWB%]=TS4
M'L;Z:$07&8A*DJ @CY21AAZ_I6AH&B6WA[1H-,M6=XXMQ+OC<[,2S$XXY)-
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M(Y&T'/:O-[UM-NOASXH2QO&OM3U&[2ZN+:*WD0JSR*0J(P#$ *>>^#TZ5O\
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MC4C?(S$# !(SCJ?8&L__ (2"XC\>3:1.]JNG+I@OEEP593YFPAF)QC@GH.M
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M+G<22,#&#U[<]* -A]+T^1'1[&V99'\QU:%2&;^\>.3R>:4Z98&9)C8VQE0
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M3.67( VX').> .: ,5?!FLPWUYLU#2;FUN97E\Z]TT2W,6XYP&R V,X&X8
M&,<5V&F6,>F:9;6,1+)!&(PQ !.!UXX_*H]'U>QUW2X=1TZ836LP.UL$'@X(
M(/((((J/4-=LM.N5M9!/+<M&91#;P/*^P<%B%!P,\<]3TH TJ*XCQCXRBM_
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M^W6@N2ZA%40PLP#%(\<;1D' X&?K6DOA304T=](72;7^SW?S&M]GR;N.<>O
MK0L;"TTRSCL[&VBM[:,82*)0JC\* .0UB[T^;XEVVE:T\#V;:9YMK!<J#&TQ
MD8,>>"P11C/0$XZFN TRQT]_"[VT<GD6\?C,11R02E&BC+(,JP/' X/M7LVJ
M:%I6MK$NJ:?;W8A;='YT8;:?:JD_@[PY<6WV>71;)H?-,VP1  N<Y8XZGDT
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M([<=*6UT;2K&X:XL]-L[>=@09(8%1CGKR!F@#C_BQ;VTN@::\X@7;JENIEE
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M1[K:V,8X+!1SWY%>GQV=K#$\45M"D;_>14 #?4=ZDBAB@C$<,:1QCHJ* !^
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M)< ++(T'F';G. -PP<@<\T <O+)IOB'Q5X8O]"B'D:6DLEQ,L1B6&$QX6,Y
MYS_".@!Z5DVNF2:I\&KZPT^S<:M&TC-$T+12MF??@9 )W( ..O3M7JELDR6T
M27,J2SA0'D1-@8]R%R<?3)J6@#S7PBVAZMX@M=1TO0=4BO8%=;RYU&:<^1E2
M"@WN0S%C^62<'%86E:G+;^ /#FG'3+])+&^"7EQ_9[O)9-F0[D4KRP'?#!=W
M0D@5[/10!XK#8WSZ/\0K.+3]6D>Z1)H'NHFWR*%'4GJQSG YX/ Z5TVK:DM_
M>^";E+.^CC2\+-YELX*KY93<P .T;F ^;'<].:]$HH \VLY)M&T_Q-H&IZ==
MRW%Y=7,UIY-NTJ7*39VC<!@$'@[L8Z]*BTBQGTGXC>'[:YBF;['X;2SDF6%F
MC$J\D;L8Z G].M>G44 <+\*O,3P[?12PSQ2#49WVS1,A*L<J1N R#4\\T^@>
M/]0U*_BN)-,O[.&.&>&)YO*>,ME"%!*YW$CC!/O79T4 >2ZMI-Y9?#S7H5LK
MQYM8U9KNTLXK=F:./SD< JH^0[4+8/TZ\5ZE9W<-_:1W4!?RI!E=\;(?3E6
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M;&2S=8T>3:0?/;<"0"1M4G'7@]1'HUAJ+:EX$N+C1KR%--TV2VF:15S$YC1
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M8#!//\ZO444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %(RJPPR@CW%+10 A52NT@$>F*P=?T"[U*XL+K
M3=0BLKBS9RHEMA-&^X '*Y&" #@@YY/K6_10!BZ9HMU#>M?ZI>0W5T8S$@@M
MQ#%&A() 7+$DD#DD].,<YV BA=H  ],4ZB@! H48  'H*3RUV[=HV^F*=10
MT(H& H&/:G8HHH 3:H&,#'7I2XHHH 3:.>!SUXZTO2BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(E3=@L6/./HH9OPH WJ*9%(DT22Q,'C=0RL#D$'H:?0 4444 %%%% !1110
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ML%Q+;$+.D3AC&3T!].A_(U!J'B+2-*N/(OK^*"0*'?=G$:DX#.>B G@%L#-
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M-M=ZI$MQ;*&EA56=P,$]%!)X!)QT'6K5SXBTJUTZVOGNA)!=8%OY"-*TQ(R
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M$.CZ9;ZA+J$&GVL=[*,27"0J';ZMC)JKHV@6^CS7UQ'Y9GO91)*8X5C48&%
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M=KJ:*CM*=Y)N2".O/RYX]*ZV[N$M/'GBFXDN6M4BT.)VG5=QB ,GS =R.N*
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MB/[=?2":2\729=WF+]P@'LN,8ID,TO\ ;)U6ZG\4S79LGM25TAT SSE1CCD
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MHMI(SQG!.*[JW@BM;>.W@C6.&) B(O15 P *R]5\.6FL:KINHW$MPLVG2&2
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MG'J5U<+;>7:-E&=Y-J[=QR< @MZ8-<Y:^&=,T/XBQVVC0+':7>ERG4+3):/
M90C$,3RQ+#WP?>N.TRVAG^&?P\>=(2HU]1(\H&-GG2E@2>QQT[\4 >ZA@P!!
M!!Y!%<S?^,(+'QUIWAUX\)=0L6G(.%EZHF>F2 W'^[ZUM/>V-CI#7HDB2PAA
M\P/'C8$ SQCC&.E>7ZWX:\5ZEX8N=0:#3([IKG^V$;S'-Q&ZC*I]W;D( F.G
M&: /7:A:[MDN5MFN(A.PRL1<;B/8=:H>&];@\1>'K+58"-MQ$&91_"W1E_ Y
M%>5:[>64\L]W;2V4,<'B-#*]V^;MY%D16*GC9&HX .[Y1VH ]/\ ^$NT(:C?
MV3ZG;1R6*JT[/*JJI.[Y<D\D!>?3(JQINOZ;JNDIJ<%U$+9E#%GD4; >F[GC
MUYKAK./0W\:>,TECT]C+%:M;*RH=^8&8E/7/7(K.L;_0U\$>#[>"2P-X9(&)
M:94BCF$3'=/CD]#@'!)QR* /6([F":#SXIHWAQGS%8%<?7I6%XGUN6U\(:EJ
MNBW5G)+:0M*&8>:AVC)'RL.?\XKRJ34XK+0]51KVWO+1?$T=Q?I:)M62U(0N
M5C!/[LL0.N#Z\UU>OW7ABX\/^+;W0Y89I+C2_P#2I[>4&$$*5C4C. QYX [<
M]10!WFE:C%>V=N#<0O=&!))8T8;E)4'D=NM3KJ%DUV;1;N W(ZPB0;QWZ9S7
MG<&GZ=I7BOP$-.AAMY)[*Y\WRSAI0858;N[?,2<GO7/>&UT35='TH:AXAU(:
MU9WH8Z;$((YOM._#8Q&'93N))+'C.>E 'I/C+Q -&T&^>SU*Q@U2&W>XBAGP
MS2!020$W ]NO./0UHW5Y<1^%Y;Z)D%RMF9E+KE=VS/(!'&?>O+KC4]&N_A]X
MNL]8E@&N"XNFDBN"!,T@),14=2 H0#'&%]*]/M;BUN?"<4RRPRVS6?+A@4*[
M.>>F.M &?X-\2IK/AW2I;Z]M?[4N[?SF@5U5R,GD)G.*V9]8TRVO4LI]1M(K
MN3[D$DZK(WT4G)KR/3K73+3P-\/[^)+>*[;5K</.I <@E@X+=2,  BI3)H5Q
M<>*]'\4ZG=6UP^IRS+:%4#7$9(\HQDH6)P%  .>!0!ZQ-JVFV[NDVH6D3HRJ
MZO,JE6;.T')X)P<>N*275],@ODL9M1M([MR L#SJ)&STPI.37 Z5I&@:I\0-
M:M=0LK6286-DRVTY#,&PQ<D=V!V9/7GT)S@13:+>6NL:%XEU#4H]335)9ET]
M%57G<N3$8VV$DD$ ?-Z=L4 >F6'B_1M2\17FBVU[;O<6P0<2C,CG>611_$5"
M9.,XS[&M&'6-,N;MK2#4;26Y7.Z%)U9QCKE0<UYY<7(M_%?CRPM)8X]6N[.W
M^PQ?QR.('R5]QGK[TQ)M-U?P7X1MM,FA_MFTN+3RX48++"Z$"8NHY P),Y%
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MF)+FSU*)/+6[M)-DA3KM;@AAGG!!J2S\/6ENTLMS+/J%Q+$87FO&#L8SU0
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MUQ?^7<>6[*KH!RK)UR#QC&>U=EHOB'3M?%T+&20R6LGE3Q31-$\;8SRK $4
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M5'(P#GL<G@^N.M:54]4TRTUG3)]/OHS);3C:ZABI(SGJ.1TH \L>ZFAT'Q+
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M$X80N'/D(P#"(LQ)8=\$]#S6;XW34TU>WN+:UDU/3(+-Q=Z=;W)BECW'Y9E
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MN(KBXTZTEFA $4DD"LR '("DC(P?2EM-)TVPFDFL]/M;>63[[PPJC-WY('-
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M*!=6LX95#1'J?NJ0/0?6O3+^5+?3KF:19'2.)G98_O$ $D#WI?L%F+C[0+6
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MOOM?B]_#42Z==6EUI]_'=W[31%%@*(=R*Q&'W%AC:2,#)KOJ* /(];T[6/\
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M5A:=X2TS3-=N]8A^T/=W)8DS3,ZQ[CEM@/"Y/^% &W'&D,211HJ1HH5548
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MG\L)YJY+==N,]>1Q[TD>JZ?-?/8Q7]J]VGWX%F4R+]5SD=#7EWAKP_I5]?\
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MZE&+BW"G=#B9OO\ ]WJ,9ZT >S7'B30[3S?M.LZ?#Y,@BE\RY1=CD9"G)X.
M>/:JFK7DCZGH@L]?M+.*:;<\#!':\3&0J9Y_$5P:R:9/XO\ B;)(]H^+")59
MBIP/(*N!G_:V@^^,U#8ZC9#0?AB\UW!YBS[<O(,@"-EQ[ ':/K@4 =O;?$/P
MW<7][;-J4$*VL@B,LK[4<XR2">,#IG/-;+Z]I:6=M=F^A^SW4@B@E!RLK'.
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M&>F>:[;1]276-&M-12%X1<1+)Y<GWDSV/TH SK7Q19ZG=0VL-K>FWNWDBAO
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M*N<^62/F.!G Y(P1P:I'XC^&"(&2^EDCEE$)D6VEVQN6*A7)7Y#D'@X..>E
M'5>7'DG8N3UXZTGE1X \M..G XK"U_Q!96:7>G[[MKH6K2O]CA>1H%((#$J#
MM[X[\'TK%\"^(5@^'^A2ZC<W%W>WAE5,*TLLS!W)/KP!G)Z4 =7K%E=WVE7-
MOIU]]@O)% CNA&',?(['KQQ^-1Z'I+Z19.EQ>27MY/(9KFZD4*97( SM'
M  '0"JL/C#19]%FU5+IOL\,I@D0Q,)5E! \O9C=OR0,8[UA^']8EU#XEZQ L
MFH1VZ6$3M:7>Y1%(6()52<#*[3D>M &UXR\/S^*?#5SHT5W':K<%=\KQ%R K
M!N!D=U%;<,>R)0RINP-^Q< GOQ7!>,]3&A^/_"MY-?W45DZ71GMT9V60J@"
M1KG+9?T_E6J/B-X=;1;G55GN6MK640W.+9]\#'IO7&0/?IVH ZI45/NJ%^@Q
M2,N%;RPJN0<$CC/O5$ZU:BZT^V(E\R_1I(1LSPH!);'3@C\2*S_$7B5M#O\
M2K5+&XG-]<>67C3<  K,0.>6^7IZ9H 7PKX?F\/V=U%<W,-S)/=RW7F1PF/!
MD.2.6/?WK?*J<$@$CI[5YQ!XH@T'QIXL:].IW**+22*UC5YWB4Q%G(7)"J">
M3P!Q[5LZOJNCW6J>%;K^T=04W<I>R%KN$4X90<2<8QC'!YZ\=: .N  )XZU3
MU6SN+[39[>SO7L;F1<)<QH&:/GT/![_G6:_BRR2^^SQV]W-&+Q;%[F*,&*.8
MX&UCG(P2!G&,G&<UOF@#+T'1VT>Q:.:]EOKN5_,N+J8 -*V .@X    'M6I7
MG>G^*[W_ (60OVIPNA:LCVVG%F(S+ Q#''0;B7QZC;79:KK=KI+VL4JRS7-W
M)Y5O;PJ"\C 9.,D   $DD@"@#2HKDY?B%HT&GZE>RPWZIIL@BNU^S$F-\XVG
M''XYQ[U)#X\TNX<Q16NH&8S>3%&]OY9E^7=O4N0-NW!R2.H]10!U%%<W!XYT
M>ZTR2\A:=G2Z^Q&VV8E\_P#N8SCU.<XP"<\&J[_$+2(-.O[JY@O8)=/=$NK4
MQAY(M_W6.PE2I_O XH ZRBN3;X@::FJMIS6&K"X>/S+5?L;?Z6,X_=]_Q; Q
MSTJQ:>-M+N_#KZPL=TBI/]E:VDBVS"?<%\O;G&[)'?'J>#0!TE%<A)\1-*@L
M=4FN;6]BN=,57N;/:CRA&QAAM8J5Y'.[COBI[3QQ9WNK?V;'IVI)<26K7-L)
MH1&+E5ZA-S#GZX]>G- '445R_@GQ+>^)=.FN;O3)K0+/*J.SHR$*[+M&&SD8
MP20!Z9JNGB>XOO'5]X;;2;HVT-NN]PT8&&)S(3O!"XQ@#+<G(% '7BEKS3P9
MXMM-%\(:9;W-GJ+6_P!JDMY+WRB8HW>=]H+$[FSQRH8 G!.:Z/5_'5CI$VIJ
M]E>SQ:6(C>S0A-L7F8V\,P+<'/ - '44E<A'XON[CXA)H,.FS&T&GFZ\W='^
M\#.BK( 6R% W<?>.>G%)\29-4A\,QS:?%--;17*/J$5NY662V&=ZJ1SSQG';
M/;- '84"N"\*-X>U[4XM6\-W>RU%M)#>:>964JS%=I,6< _*PW#KZFLOPAXP
MMO#WA"'[99:A):1WTT$MXJ#RH2T[!02S D8QRH('3KQ0!ZE17*:UXYMM)NM2
MA33[J[72HXY;]XBBB)7&5QN(W''.!4>J?$"UT_5?[-@TC5+^Z:R6^B6UB5O-
MB)QD?-G/7@@=/<4 =?2=\5QFH_$C3=.$TKVLS6ULRI=.9(U>)CMR!&6W-MW
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MH\@N3:/ EO,JDA6!<EE.,9&#65;>._$?_"*P^)[VVTJ+3[F 1P1H9&<7!D"
MM_L_>.!DX'4F@#TVBN%/B+Q39MJADTB2^MX+ SVTZVI@+3#@QE"[$^O'TK/D
M\3ZKJGA37;[3];T^:&WTUIED@@,<\,P#;D=&8E>G!_GB@#TJBL+P9')'X.TC
M?=BZC-G"8I/**'9Y:XR"3D^];M !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !6%XSM+^^\&:O:Z7G[9+;,D8'5L]0
M/<C('UK=HH \TU+4;+Q4GA&+0G47]IJ$$TT*C]Y9PJK>8KC^'LO/7C%7/#$\
M)^*OC)Q(NR=;,0MGB0I%AMI[X/!Q7?XHH XGQ]<Q6%_X6OKDLEK!J@,L@4D(
M#&R@G'N0*R[*6QN?''C.ZF*I#-IUOLDEB.0OED/P1GC*Y'7.!7I5% 'B]O<O
M'X ^'D8<BX@UF S*>6C0,X8L.P 8=>F16IJSFR\1W4FBWQGDN-1C%[H5XF[S
MF#)^]A[C'RL3TXR3P!7JE% &+XIUK^Q-#FGC=%NI,16V\$CS&. 3C^$9W'V!
MKB/%OAV31?"&F:KI^L3W,^C21SVBR1Q$2Y^\ 54,2P.>2<X[]:]1HH \S\4>
M)+1=2\*>)+1Y =L_RRPNT>QE7>C;%9E?.W'!'!S6)J-QI$_PUU2.&\%W<W>J
MQ75]%';O%M9Y%)"QD!MNU#SWP37HFM^&KR_UNVUC3=;ETZ[AA-N1Y"S1NA8,
M1M;H<@<@]A5W2-%;3YY[R[O)+[4;A%26X=%3Y%+%555X4 LWN<\DT <3XYBB
MMM9\.>((K.[N-%B\[[5_9A='7>@"R9C(..W7H,=ZR]1M+/\ L>#7-&T'5XM*
MCU-+N[ GF%S=J58-* 6W\%NN1GD].:]@Q1B@#R#7$TW4? ?B2\T/2=10WL4$
M7G79F>:ZD$GW0KEB0H[CU([5K.8[CXB^#KB*-I((M,DW2+&2J%EPN3C R00,
MUZ3BC% 'BUS8W=WX<\03065U<11>*6U$VT:NC7-M\HRA&"0>H(],U;N+;0[K
MPOXCOO#_ (?U.&2>P:V>>Y69I9I&( C56+$XQR>W'O7KV*,4 >?2E3XK\!RQ
M6TXBBM+A9&%NX$6^- H;CY>01@XJ'PGKHT#P_K,%UI>IO/87=S-*B6QY#2Y4
M*3@,2&SQV!/IGT?%&* ((+I9[*.Z*21(\8DVR+M901G!'8CN*\KLX;BZ^'GC
M>PBM+O[5->W<\,36[J9$9@5*Y W9QVKUO%&* ,+PA>?;/#%A_HMU;^3!'"1<
MQ&,L5102 ><9R,D#H<<<UP5K!:M9>-X]6TS49[.ZU<2!((9!(R%E D3C)VGG
MCTKUK%&* .-\%?VE'>ZI;7%U<W^G1"(6E]=P&.9^"61B0"^W(^;'\1]Z+^Z2
M'XH6,CQ7/E1:7-&\JV[L@9G1@-P&,X4UV6*,4 >2>:1\*?(^Q7WV@ZMYGE?8
MY=^/M?FYQMS]SG].O%:U^MS<^*_$UA!:WZG6],@BM;Q(&\M"$E!+,<;<;Q[U
MZ+BC% 'E?A1(KQM,MIO!EY::KIQ0W%S>Q.88PH^9HR6Y8X^4 '&>^*QIM-U$
M_"#4M._LR_%]-JY9+?[+)O8&0.#C&<;0>?PZU[;BHY98H(FEFD2.-1EG=@ /
MJ30!YVMW?Z'XN\03W.E:E?V.N1Q26<UG 6(VQ[?+8?P'W/IDUS5IIM_8^&?!
MVH7/AW4;FTTS[5#=V@1EG"R-E751@D ?3^M>U1R)+&LD;JZ,,JRG((]C1)+'
M%M\R14W,%7<P&2>@'O0!Y?>:;<#2+'7-!\-7%M!:ZI'?-IY!6YN5VE6=ER?F
MRW ZXR:U]#O;G4/B7>:@=&U2UM)M,CA26ZM_+&Y78G//'7CZ>A%=TS*BEF8*
MH&22< "A'22-71@R,,JRG((]10!Q'C.*YM_&GA+6A9W4]C8-=BY>WA:5H]\8
M"DJH)QD'H*71O#PU;5/%6IWUM+%IVN+'!';RJ4=HTCV%RIY4DDD9Y[UW%9FN
MZ,NN6 M6U#4+$*X?S;&X,+\ \%O3GI0!S'P[L;]8)Y=49)GTXOI5I,!RT43D
M%L_[1"@_]<Q5WQN+N&;P_J%MI]W?)9:B)9HK1-\@4QNN0,^K"NEL;*#3K&&S
MME*PPJ%4$DGZDGDGN2>M6* /-K:.\;Q?XVO7TS4(X;S3X1 6M7^=EBVLH(!!
M() P"<\XR!6=';W[:9\.5.DZDKZ?,HNU-H^80JA"6XX&>?IS7K6*,4 >8S6=
M]#XO%WHFG:OIU[-J6+Y/+W65U )#F4D\*Q3GC!SQCG-==XQU&]L- E73K6[G
MN[D^1&UM TIAW<&0A><*,GW.!708HQ0!YUXR\) >#K=M&.I27MA)#-IT.YWV
M.I 'R]N,\GI4/B_5KV;_ (1748-%U1-4CFEE,$,0DEA4)M<;.C EE&<\ ^O%
M>EXK$UOPM9ZY=6]V]Q>V=[;J4BN;.<QN%."5[@@X'44 >?WRMJO@?Q)I]EH^
MMC6]0=)YTO;41O(S,,%0#@(!&1^'O6QXSTN]U*^\.^(8-!.J06HD2YTJY52P
M60#D*?EW*1S]!]:['2M%MM)#,DMS<7#JJR7%U,99' S@9/0<G@8')XK2Q0!Y
M?K/A_4+W0K6_L/"=A EKJ"70T4PQJTT00JV_'R[SG('. !U/%.U73[J\\':N
MNG>#ETK[7'%%%;0P1K/(X?<S/LX" # SSG/J*].Q5>XO;6UFAAN+F&*2=MD*
M22!3(WHH/4_2@#EKB2ZE^(.DWZZ7?_9%T^6*24Q "-W9& /.> ISC/.*YEM$
MUJ[\/:NT&DR?:H/$3ZM!;7: +=1%B0HYZD9X/MZUZM2XH \TUB+5=6\':Q]F
M\)MIS7%L+:.T2-//DD)R6)7 " ?B>>!@9TY5NY_%OA*Z32;T16UK,MQ*T0 B
M+HH"MSG@J<_45W&*,4 <?X!M]3TRQN]*O],EMQ!=3R+<.ZE9M\C,-@!R1@\D
MX_PK26>JZ5\3KW5HM+FO+*^L8X_-B=0(BA^8,"<YQT ZY'OCN<48H \L32]:
MN/A;;:9'HMV+ZWOQ,T,A1"5$YER"6Y^4X^M0^+=%\1^(&\06TVCS7'G0J^FR
MB8)#&@&2&3/,QY7)!]B!7K.*2@#SVRT[7;3QUINMMHSM#-HRZ?(HG3-NXDW9
M?VP.V>>*ZO7WU>*.QFT>V^TO'= W$/F*F^'8P(RW&<E2/<#MFK]K?V=]YOV2
M[@N/)<QR^3('V..JMCH?8U9H X*ST)[[Q_;>)+71I]'2UAECNUE"(UX[#"X5
M6((')W$C/'7'&-=^%_$%Q\)[G05TEQJ#W[2)&9XL%#-YNXG=@<<8SG/MS7JU
M&* /,O%N@^(M>N==A_L;[5!/;(-->6\1$MSL&\%,G+[LX;GKC<!5S2-)UV'Q
M[IVKW6CO%:IHBZ?(RW$3;'$F[)&X$C&,X!YZ9ZUZ!6=<^(-'L[]+&YU.TBNG
M8*(GE ;<?NCV)[#O0!R%GIGBOP_J^L6MCI-EJ5A?W4EW:W4UP$^S-(<L)%(W
M,H/.%_/GBU8Z5J]KXRUS4);":6WN-/B@BF5XAYLB Y^7<,9)XR /I7;T4 >6
M>'/"6OZ-I/AB^^PM_:.D?:(+BR:X3$T,K,VY&!*[AD=2,XP>U;R:!J,^H^)-
M<DM/*NK^R%I:6C2KN "GEV!*C+'L3@"NUHH \YB\/^)-(M_"FH:?:17%UI=D
M;&]LFF5?-0A>4<\=5!YQV]ZKS^%/$^I0>(YFMK2RN[J]M[^R!G$H+Q!<*PQC
M'RXSZ]L<UZ=10!Q+V_BG5]!U..^TFSL)9;&6TCM8)UD,TCC'F%L#8H[+DGYC
MGH*Z/P]%=6_A^PM[VW$%S# D3H'#C*C&01U!QFM.B@#SS6O"VI:IKXOH-,CL
M=2BO%>#5K>X"!X PRLJ#EB5R ,'H,D#BI3H.M-:^.(/L" :R'^R'SUR2T7E_
M,.V.O>N^HH \SB\*>(PWA^*>RL;RRL]*6T>VN;@A(+@<>=@!@_ &.._;K4=A
MX4\1V/@WPSI+Z?;O/I6J+=N8[H8:-6=NX&&._IR..O.*]0HH Y.PT748/B7J
MFM20*+"YLXX(W\P$[E(/(ZXJ3Q9HTFMF.WGT>VU/3C&V4:7RIHI?X61L<#'!
MY';K7450U#6M/TJYL;>]N!%+?3>1;J5)WOZ<#C\: ..7PQXCTS_A%;RU>VU*
M[TJ":WN$N)VCW+)C&'P?NX R1R!TJJO@[Q'-X<UZRN1IWVF[U==1A9)657PZ
M,01@[1\G'7KS7I6:* .7AL;^_P#$MAK.KQPV LXI(;:T6<2,\DF-S%L#LN H
M^OM7'Z3X<U+6/ ^E7VCS0P:IIVIW5S;&X7,<BF60%3['CGV_$>C:OH.EZ]#%
M%JEG'<K"_F1[L@HWJ".15VWMX;2WCM[>)(H8E")&BX50.@ H X74_#/BGQ-H
M+R:G=6-GK$,\-SIZ6^YHK>2,D[B2"2S9/J!@=>:MSZ)XIUS0M5@UFYL(;BXL
M9+2W@M&<P[F',CDC.<@ <<#/7-=I10!E>'H-3MM&@M]56T2>)5C5;9F90JJ!
MRS 9)()Z# ('.,GE7\,^()O"_BG37M[!)]7NI9H2+IBJ"0 $,?+[;>PYSVKO
MZ* .1N-'UJZ\4>&M2:VLHX=-AF2X N6+$R*JG;\G.-O?&<]JH1>#M3N/$&D:
MK>)86U]8N3<7]G*P>\3!^5H]B@9)Y.3WQUP.]HR,XSSZ4 <]XF\/SZK/I>I:
M?)%'J>ESF6 S9V.K#:Z$@$@,.X'&!6?=>'M6U!]4U6>*SBU2ZTXZ;!;I<,T4
M<98DLS[ 2<G.-O;'?([&B@#*\-:?=:3X:T[3;PPF:TMT@+0L2K!%"@\@'D"L
MRVT75K7Q5K^KH+)H[^"*.W0RN"IC5@-WR]"6/3ICO7444 ><0^!-?LM+\/S:
M=J5G;:SH\;6^X[G@N(6.2&& 0>G^<8O:EX8\37]CIK27]C<7\&J)J4ID+I$N
MP;5BC4 D+CN3G.3WKN:* (;BW6\LI;:<?)-&8W"GL1@X-<;H'A?Q1I"V^ES:
MY;3:)9N&MPL16X=5.4C=N@7ID@$X&.]=)J&OV.FRZ=',SL=0G%O T:%E+D$C
M+=!T/Y5J4 >>2^"]=G\&^(=%>73EGU6^DNED61RL8D<.P/RY)&,#USVQSI3>
M&=:;QG9>(K>^LH)#IZV-ZC1M)P'#DQ\KR2,9/0<X-=C10!Y^/ NJ_P#".>)=
M+^VV2OK=[)=M)L8B'S"-R@<9QC@\?2M7Q)X7U'7;/2KFVU&.PUO39/-BG2,O
M&25VL-IYP?QQTYK:U+68M,N]/MY+:ZE-]-Y*O#%O6,XSESV'O6AF@#(T'3M3
MM(YI]8U%;R^GV[_*0I#&%'"HI/N22>N?:L^70-6/B?4]5ANK)8KNR6U2-XW+
M*5W%6)!'=SD>F*Z5I8TD2-G57?.Q2<%L=<#O3Z .&;P;J_\ PC/AS2TO[$2Z
M-=1S^8T+[91&"$&-W'!.?TQ4]QX)N+R[\10W&I*=(UGYVMU@'F)+L5-V\GH-
MH.,=0/?/944 <5IWA/Q%!:-#J?B8:@(('BLE-MY8#%"@>0@Y? )XSWSG-)8>
M Y#\._\ A$]4O4=4XAN;5"C)AMZL<D\AL],<<5VU1QS12O(D<B.T3;)%5@2C
M8!P?0X(/T(H Y*T\+^(C92_VEXKDGOUB,5K-%;!$BR5)=E!&]OE Y/ )'<TQ
M? TMY<:U>ZG>6HO=3L&T\M8VQB0(<_.P9F+/R.XX&*[2H;JZALK2:ZN'$<$*
M-)(Y_A4#)/Y4 9WAK2+G0M#MM-N=0^VFVC6&-Q"(@$50JC )/0<DD\^G2M>L
M+2/$<FJ7PMY-&U"S22!;B">:,&.1#C@LI(5N?NGFMV@ HHHH **** "BBB@
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M PP3UP3C(QD53LM$UBW\53ZI%X=U%+6?0I+0F>Y268REMV7);J<8 !/&.G.
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MC(%6M'T2]3Q7XIN+NP\FPU=8A&XF5C\B%#D Y&<Y%4?#.E^-]'AM?#\YT_\
MLJT<*NH+(3,T(;(4(> 2/EYZ#UP,@$E[\3].LYS($MI;!;G[.\D=XIG&"5+B
M$ DH"/7..<5/=^-M4CO=:M+/PQ+=2:7M9V^V(BO&RE@V<$@X (4 ]><51TK1
M/&FAF;0;-K Z*\\C07QD/G6\3L6("]"PR<=LUHQ:7K$>J^*KDV"F/4HHTMO]
M(7)*(8_F],YW=^/?B@!+7QW//>Z*TNASP:5J[".VO7G4MO*;E!C ) .#@Y_
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M854H959!N1A_"=Q.* .RHKS2[\5>(+?P5KFHQ7D#7>G:R]DK20#YXQ*L8''
M/S9S@U/J^H>+?##6&H:OK%O/I\FI+#<K;6RJ$A?&ULL"1AL@\G@C!S0!W&JZ
ME;Z/I5SJ-UO\BWC,C[%W-@>@J2RO(=0L;>\@+&&>-94+*5.UAD9!Y'6N5O\
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M#@5SUO&NO_\ "M=1U)II[NZ::&>1IGRZID#OP?4CD]Z /;J*CB:(?N8V4F,
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MMHKNTFM9UWPS(8Y%/\2D8(_*N:B\ Z7#8:?9QW6HB*PG6XM]UR6*,HPN,@@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11FC- !1110 4
M444 %%%% !1110 4444 %%%% !111F@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **,T4 %%%% !1110 44F1G&>:6@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_%6K_P!@^%=3U0'#
MV]NS1]/OXPO7_:(K8KSGXM327UIHGA>%@'UF_2.0YY$:D$G\RI_"@#'U"]\1
M:#\%H=9CU"^FU:Z6*2>XED9S#&YR-JGA>"HSCO\ 2M_PT)-1_L37]+UW4;O2
MA;.;V":8R$RA,<@\[LL?E'' ([9O7FH7%EX@N],N=!O;KP\;&*)&B@,J!@6W
M+L&2P*LH]MM<3X8\/^(M \+^-)K33[R&VO XTS3W'[W#9 ?;R0P4KQU./84
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MERUK;Q>7^\N'&/\ 5KW'.<\8[XP:XZ3PGJ.JWG@32+W2)8=)TVU\Z\!8,GF
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M .GS7<LLMU>AKN5Y79F8N<@Y)/\ #MJ/4?B1IME;:A>P6T]WIVG3+;W5U$0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 -D021LA+ ,""5)!'T(Z5EZ)X:TGPZLPTNU,'GD-*3(SEV'\1W
M$\\]:UJ* "J.I:-I^KB'[=;"5H'\R%PQ5XV]592"#]#5ZB@#/L-#TW3+B:YM
M;4+<SX$L[LTDC@= 78EB!Z9JS=V=O?6SVUU$)87^\AZ&IZ* *FFZ78Z/9BTT
MZUBM;<$L(XEPH)ZG%6Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **!10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%%  **!10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%%  .E% Z44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 #I10.E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444  Z4
M4#I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  .E% Z44
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 "B@=** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH !THH'2B@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ****  =**!THH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ '2B@=** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH !THH'2B@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **,T4 %%(6 QD@9.!GO06"J68@ <DGM0 M%%% !129&<9&
M?2E!!&0<T %%%% !11UH) ZF@ HIID0.J%U#MG:I/)QZ4Z@ HHI 01D$$>U
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$?2S9^(O$,-Q&]U<VUW%'J<^FM#%;%'FV1NX?.XX.4 V@=ZZH>&M" E T:P
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M=!)8!=V%SUX!K;N+2VN[<V]S;Q30'&8Y$#+QTX/%4X/#NB6L$D$&D6$44O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH !THI!TI: "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH 0=!2T@Z"EH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!!T%+2#H*6@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** $'04M(.@I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH 0=!2T@Z"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@!!U/UI:0=Z6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** $ [^M+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
K %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>exhibit1011-physiciansha010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8AF<8+,S8/IP!VKC].&KZ;X+L=;M-;N(HXM5>(62QKY3H]XR,&XR3\Q.<C'
MQWH ]@I*X"_UF;PCXYG_ +5O;J;2M1M'ELA)*=L4R<M$!WW#&,\]A3=7FU_1
M=,T62>/4KZT$+OJ8LI<W,<A (([LB_,,?3- '8:CJTFGZAIUJNG7EREY(T;3
M01[DM\#[TA[ ^M:5><6^KW;'P1-9^()[^UO;F6*:38%$ZA7(W C<&& #SVJQ
M87=_XCL]5U.#Q"UC/8ZE)'Y9QY,,,3X*NO?<H)+'UXZ4 =8-6D/B-M)_LV\$
M8MQ.+W9^X)SC9N_O=\5IUQLVH7B^.+^.+5<6?]AB[A$Q'D1.79=YP!E<*#R?
M6N?T#4]7B\5^'86O-2FM=4M9_/GN7!CN71 WF0H>8UR>.%!!'% 'J5!.!DUX
MJ^KZY%X"UCQ&^OZB9])U9H88PR[73SD4[QCYN'(QT&!@5[1N#1;C]TC)^E '
M*GQU#_9MQJ\>DZA-HT);_38PA#A2075"VXIQ][],<UIQ^($?Q?)X>:TF25;/
M[8L[%=CIN"\8.>I/7'2O.)-.UCP1HKZEH-PFN^"YXFGETZX&'B@<9)0GG;@D
MG]1U-;-Q#_PD?Q*LY(+V\LH;CPX)B;=@DA4S A=W)7J#QZ8S@T >CT5Y;8ZK
MJ=SX'T>.?6+E[G^U'MG$>?M-]'&[CRU8$;6(498D<9R?7)U+7=<A\"^(MM_>
M6MSI^M+;PM]H,DB1L4^0N>6QN/.?QH ]HK(UK7/[&FTR-K229;Z\2T#JP C+
M=">YX!Z#MVKC=475-&\3:+H"ZM>WT>J37%R[W=VT!)2-<1K)&N5&26V@#J!T
MJEJUOK$&FZ;IM_KD#W<?B. 0S1L9GMD=6*([.!O89X)ZY&: /5J2O*M1\0:A
MX.U+Q?:V]U>7T=MIT-W;?:YC,T4C'8<$_P .6#8]JV-3-UH-QX6O]/U*\F2^
MO8K2ZAGN7F6=)1G> Q(4KC/RXX]J .DT3Q =8U+5[)K*2V?39EB;>X8ON7<#
MQP.".]+?Z_\ 8?$^DZ*UH[?VBLI6XW@*GEKN(QU)Z>G6N'N]7GT)OB'J%JZQ
MS1WEJBR,,B/>D:;\=\;L_A5NZTFWTOX@^#9+:[N[I9H[QF>>Y:;S#Y(^<9)
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MB "5_>8Z#N*[NB@#D+OX>Z=J7A:QTB^N)Y;FR)DAU!/DF64MN9QUZDY(.?S
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M?6XN6#W=G!<%+>Z8=Y$'WO<9P><]376T4 8-QX2L+S6Y]4N)KIVGM&LI(/,
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MX'N?6@#&&H:AXC\3ZYI=CJD^F1Z3'%$&ABC<R2R*6W-O4_*N ,#&>>>F.?\
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M+AS;;0\DLF3_ !!OE4#IZGFK7_""69TK6-.;4]2,&K3M/<Y:+=N; ;:?+X!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"TPB5$P#M7@[GP<[>![T =E2$@'&1D]JX+4/BE96=SHZV^FW%[!J\7F6CV[
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M1GKQG&<9XJ[IIO#I=H=0$8O?)3[0(_N^9M&['MG-6J* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M3<*6N9U'5K_0K[S[F%KK2V):6:,?-;^@VC[R_J* .FHJM#?07%N+B&1'B(SN
M!X'U-4M-\1:=JMW<VMI<+)+;8,@"D<'/(SUY!Z4 :U% .1FB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M) '"\CYNGO0 [S?%_P#SX:3_ .!4G_Q-'G>+O^?#2?\ P*D_^)JQ9^+]!O\
M61I-KJ,4UVRED"@E),?>"/C:Q'< G'X&F+XRT-]533A=/YKSM;)(87\IIAUC
M$F-I;VS0!"9/%Y/_ !Y:0/K<2'_V6F[_ !CVM-(_[_O_ /$U:N/%ND6VJ)82
M2S&1KA;7S$MW:(3-C"&0#:&Y'&>,TSQM<75EX-U6]L[J2VN;6W>:.2/'WE4X
M!R""* (_-\8GC[+HP_[:24A?QAT\K1USW#2<5=\+///X5TNYN;F6XGN+6*:2
M23&2S*">@  YJ#5?%^BZ1<SV]Y<R9MU1KEHH'D6 ,<+YC*"$SCOVH P3#XIU
MJ]BNWATEX;1SY:,9-K/TW$'T_K6N&\9 <1:/C_:>3-+?^-?#NBWS:?<792Y$
M/GB&*!W+(3@%<#YLY[9Z$]C4,?Q&\+S)921:BSQWCK'&ZP.55F) 5SC"'(/!
MQTSTH F_XK#^YHV?^VE)GQEW31OSDKIJX7XEW.NZ9I]A?^'KJ2.]$[*\).Z.
M6-(I)6!4@\XCXQ@\XH MZEI_BC5=.GL;J#1I()UV2+^\&0>M.M[3Q5%:1VOD
MZ*(8T$:HWF.-H&!]3@5=;Q3;2^#8O$-HC3+<1(T$(Y9Y'(58_KN.T_C6-\,+
MW5-4T6_N]8OI+J]2^EMF).$ 3&-JC@<D\]3QGI0!=CL/$L(816N@(&SG;$ZY
M!Z@X-4=)\+ZIH<LTVF:9X?M9IS^]>-) 6Y^M,\3Q7<OQ T'38=6U*UM-3CG:
MXCM[@KS$@*[?[O7G&,U%KVHZMX%U71ISJ4]_H5Y<K:7*7FUI(&;[K*X )'!S
MNST]^ #H-GBT'AM'Q_NR?_%4;?%W][1_^^9/\:Z*B@#G@GBL_>?2?P63_P"*
MI?+\5]IM)'MY4A_]FKH** .?\KQ9_P _.D_]^9/_ (JCR?%G_/WI7_?A_P#X
MJN@HH Y_R?%?_/YI?_?A_P#XJD,'BS/%[I7_ 'X?_P"*KH:* .>\GQ:/^7O2
MC_VP?_XJD^S^+O\ G^TG_P !W_\ BJZ*B@#GOL_BSM?:5^-N_P#\52?9_%O_
M #_:3_X#O_\ %5T5% '.?9_%O_/[I'_@*Y_]GIPMO%F/^/[2OPMW_P#BJZ&B
M@#GC:^*B.+[2@?7[*_\ \73?L?BT_P#,3TO_ ,!9/_BZZ.B@#G!9>+.^JZ7_
M . C_P#QRE^Q>*N^JZ;^%H__ ,<KHJ* .>^R>*Q_S%--_P# 1O\ XNC[)XK/
M75-- _Z]&_\ BZZ&B@#G_L?BG_H+:=_X!M_\71]C\4_]!;3O_ -O_BZZ"B@#
M ^Q^*/\ H+6'_@(W_P 72?8O$_\ T%-._P# (_\ Q==!10!S_P!B\3G_ )BF
MG#_MR/\ \73H+'Q"+B-KG4K"2$'+(MF02/8[SBMZB@!!WI:** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "N"^([^9>^%(HTDD>'7+:XEV(6
M\N)2<LQ X SWKO:* .*^)#--H^DQQHTT<FJVS2JD>\&)6W,3@'C@<UE>(;.?
M5?'&M6VG%DEN?#?V:.8*0AE\QFV[L8SM([]*]*HH \PNKD^)O#'AS2K2RN8=
M6M;RU>:%X'C^Q^5]]VXP!@$#GG(Q5-D=;;XGJ89MUWN%O^Z;]]^[*C;Q\W)Q
MQ7K=% 'E"(RR_"Y8X)A]FAQ<!86'E$PJAW<<?,".?>L>[NIYY=+D;2M6@DM/
M$:75U:Q6+BWB02/EP<9=VR"3D]\ #%>WT4 >42QS1:Z]UX?6_0SZU_I^C75L
M7BD(E!-PC$?)]T/G.,X],'LOB X'@36(@LCR3VKQ1)&A=F<J<   UTM% '!Z
M5XPM;#P5IUM;V][+JD5C%"ELUC,!YP0* Q*@ ;NISTKE?&3ZA?/XML&T?4(9
MWCC,/V"T/EW84<R2R8RV.@7/'3!->S44 >8Z)(7^)FE7DEM=0PKX92 M- R;
M9!)NVG(X.WG'I7-&"X'P9N;5;2Z^U-K&X1"W?>1YH?.,9QM&<U[G10!B0>)K
M:?Q1)H(M;M9EMQ<).\6(I%^7(5NY&X9XJ#Q%=Q0:WX<5_,RM\TC%8V8*IMYD
M!) P/F91^-;*V%NNH/?;6:X9/+W,Y(5>,A03A<D G'7 ST%6: /-_#GAO4-#
M\1WUG<83PSIMP^H6>$/S-(I 4<=(QOX'=E-)X)U"7P]X1UVZN=,U*22/49KD
M6R6KB62-V&UE# 9&,GZ UZ310!Y]KE\TOQ!\*:@FGZD\-K!<&Z\NRD<V_FQK
ML#;5//!R!G&*C\307WCO5M+TNWTV]M]&M+L75[=W<!A\S9]U$5L,<Y/.*]%H
MP#UH RK/63=ZW>Z:;&ZB^RA3]HD3$<NX=%/?%:M($48P.G3VI: "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *Q?%'B:Q\)Z,=3U GRA(D84?>8L<<#O@9/T!K:KRSQS"WC"ZU+3XM'U&_M
MK&)K>WFM1'L2[.UF8[G4_*-J\ _>>@#U!9HW@$RR*8BN\.#P5QG.?2N0TSQQ
M<>)+JX'AO1C>6-M)Y4E[<7 @C9AU"#:Q;\@/I7(^%M7O_$7P<UG0X@W]LZ9;
MO:&(??*@':,>I 9?JM:_P0G@?X?B"/ F@NI5F7ON.""?P('X4 =%%XUM8M$U
M75-7M)M,339S!+%,0SL0JL-N.#G=QZ]:JZ=XOUG5-&_MNV\,.VFLADB7[6/M
M,J#N(]N.>PWY/XURWQPA-YX.$VGA)%M]03[=Y*@D$1D N1Z!E'/]X5Z%X<OK
M*X\):9>6K)'9?8XV7+<1J%'!/MC!^E ',:]\2SH.G:'?S:.9(-7A1X@+C#QL
MP!*L"O0;AR#SSP.^X/$>H1^(+/2KK1T1;DN@N8;L2(CK&9-C#:""0,].AKSK
MXV203V/A.2S>,V\DS-"\>-NTA-I';&,5V_A^*?PT]_%KEW]IN=0UDFTE*J&F
M#11@$*.F K X[*: *,/C_6+G7M7TBW\.6\MQI,?F7&-1(WCKB/,7)QZ[:ETO
MXAR^)+?37\.:0+I[H3^>MU<^0+8Q>7D$A6SGS5QC_P#5RND:;>:K\6_&UK:Z
MI+IX>)4D>*-68@A1P6Z=^1ZUZ9X:\-:=X4T9-+TQ'$"L79I&W,['J2?P% '%
M:?\ %#6-4L-;N[3PO;NNC$BY3^TCN8#=DK^ZYP%)[5HZGX^U&R\=6OA:VT6T
MN)KR+SK><Z@R(4PQ&[]T<'"'IGMS6!\%O^0GXQ_Z_E_]"DJKXN@N+GX_Z%#:
MWKV4[6.$N$17*?+-V8$'/3\: .^T[Q#K-WJ5YI\^C6<4\5LEQ!)'?F2&8%BI
M&[RP5P0>QKG](^)6K:QI>IZE!X:A:WTR1DN4342TORC)**8@#QGJ1TKH_#5P
MNE6&D^'KV;?JHM&D=2P+$*0"QYSR6_G7 _">[L;+1/&-Q.R*8;MY)V(Y\L*<
M9_$/0!Z7X:\1V'BK0X=5TYF\F3*LCC#1L.JGWJ]J%_;Z7IUS?W;[+>WC:61O
M10,FO+O@)87=MX7O[N966VNK@& '^+:,,P_'C\*ZKQE<7%[=66AVFF2:FK,+
MJ^MXY$3]RI^56+D##.!QW"L* -?PMXBM_%/ARTU>V4()U^>/=N\MQP5)P.A]
MJY:;XH#3/''_  CFMZ4MG&76);]+DO$7958#E%XPXR<\9].:YOX9WESX3\;:
MIX/U&U>RAO&-W912R*Q7VR"0V5 Y!ZI6_K?@^U\:?\);82,L=S'J$4EM/C/E
MO]E@_0]"/Z@4 =)'K>KW/B#5-)M]-LA]B2*0327C_O!)NVC:(^#\ASR<9'6N
M9T?XF:KK5CK-U;^&8<:0V+F+^T278#<3L_=8)&T\9&:I?!Z?5WU'Q#:ZX)!?
MV*6MJ_F<L0OG8R>_!Z]Q@U2^$=[;V#^-[VZE6.VANO,DD/0*#(2: /2/"OBK
M3O%^BKJ>G%PFXI)'(,-&XZ@_F#^-:MU<Q6=I-=3N$AA1I'8]E R37EGP%TV\
MM/#.H7=Q"\<-U<*8-X(WA5P6'MSC/L:Z[Q;<R7EW8:!:VCWCSR"YNX4D5,6Z
M,/O%NQ?8".I&Z@"YX.\40>+O#D.K0H(R[,CQ9R8V!Z'\,'\:SKGQI->>+I?#
M&@6<=S>6Z;[JZGDQ# ..,+DLW(&..3[&N*\!S3>"?B1J7A2^'V>SU$?:;*,N
M&4,3P ?<9'U04_P KZ-\7O%=AJ3&*YO&:6W\PX\Y?,+#;GKP<\>A]* .Y37M
M=MO%.GZ-J.F6@BNXY76]MYV*L4&=NPK\IY'<USFG^./%.I^.-2\+6]GHZW%C
M&TC32-*$8 J.,9.?G'ZU9M_&FKR?%$^$9[73RL2^:;E ^=NP-@ G@X.*XF"#
M6KCXS^+QX>O4M=26TD:)GC5U?!B^4Y! SZ^HH ]$T#QQ/XDT_688+..RUK2I
M#'/;SLSQ @D9#  D':W;(-8OACQWXJ\5:#+JMG9Z'"$N&MHX9Y9%:60*& 4]
M.=WZ51^$=WI;^'];B9'B\0[I&U+SV_>2'YL-VP 201V.<]16%\)M&N+WP]9:
MC%>R""PUTRSVS.HB">0!YG/.[YL=<8[4 =QXD\<:[H?@;3_$@T^S!E2,7%K-
MO5D=NP]A[U>M]=\5I?Z8MW9Z1+:W+H+C[++(9+=7!*DANQ((S7/?%G5;;6?A
M2]]:-NMY+T)&_9PKLNX>H.W(/<$5J>'9SX7TA]7U749KN/4(+(P&:1=Y9EVF
M-0,< MGIT)ZX)H 2Y\7^)T^(!\*6]KI#2-!]HCGD:0#9Z$#//%:?AGQTFM>(
M-0\/7UBUAJ]CDO'Y@=)%! W(V >X.".AKF;IX5_:-L_,*[O[-(CS_>VO_3-4
MM#C;6_V@]4U;3SYMA:1>7+.O*%O*5-H/?YL_D: /8J*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>)+./PMI&J:S?6MH]Y:PR,9'"*795) R?4TFL>,-&T:XTV"XO8/,U"0"+]Z
M-AY,A/0+[]Z )8/"6A6UU-=0V"I<S1^7).)'\QER#C=G/4"JT'@+PM;B18M%
MM@DA!D0Y*N1TW*3@]3UK3NM=TFRGMH+K4K2&6ZY@1Y5!D]".>:N7$\5M;R7$
M\BQPQ*7=V. J@9)/MB@!888K>%(88TCB085$4!5'H .E9\?A_2X=7DU:.U"7
MTGWY@[9;V/."/:N+B\3:QXC@U2[T+7]*LFL[R6 07>TQ^0@V^:2/FR6.0?N]
MOKU]CJ]M;:3IQU/5[*2YFMQ(9E8(LV$W,ZC/W< G/3'I0!%>>#?#U_J7]HW6
MFQRWH.1.SMN4YR,'/'X5:TWP]I6D7,]S86@AFG_UKAV)<^IR>3[TR7Q/H,'V
M3S=8L8_M:>9;[YU'F+ZCGI5!/'&AOXM?PZ+V'[4B#)\P<R%B/+'JPQD^E &S
M)I5C+)=2-;J)+M%CG=25:15SM!(YXW'\ZQ[?P!X4M"3#H5HH/52I96^JDX/X
MUMWVHV>F6QN;ZZBMX00N^5@HR>@^M<[XF\0O'X8M]8T+4+>2)KJ!#(BB19$>
M54(!S@?>_2@#J8XTBC6.-%1%&%51@ >@%9G_  C6CC6SK(L(QJ)ZW&3N/&/6
MI[#6M,U2:YAL+^WN9;9MDZ12!C&>>#CIT/Y5'#X@T>YU)M.AU.TDO%)!A64%
MLCJ,=R.X[4 5[OPCX?O[^2^N]*MY[M\9FD7<PQTVD_=_#%6=2T'2M8,1U"P@
MN'B_U3NOS1_[K=1^!IMKXBT>]ENXK;4;>62T!-PJ-DQ ==P[=*9)XHT*+3K?
M4)-6M%M+@D0S&0;9,9SCUQ@T 267A[2-.N'N;33K>.Y<8>?9F1OJY^8_G4-O
MX4\/VEZMY;:/9072MN$T4(5\_4<FM.VNH+VVCN;6:.:"1=R21L&5AZ@BLP>*
M] ,-Y,-6M#'9,%N6\P8B). &].0: ";PIX?N+N6[FT6P>XFSYDK6ZEGSUR<<
MU$G@OPQ'&\:>']-5'^^HMD ;ZC'-6G\0Z/'!:3R:E;)#=@F"1G 60 9)!]AS
M6;?^*-(O]*O(M-\26-M<&T,R7.]7$2[M@?!."-W'UQ0!>G\*^'[FU@M9]%L)
M+> 8BB>!2L8Y/ Q@=3^=,7PAX<22&1="TX/ 08F^SKE,=,<<5E2^-]+TFZT+
M2KK48[JXNX \MUC:FP1%O,XX^8XP/]KVYN:%XTTCQ!?:A;6<XS:2%,MQY@"@
MLP!_A!.,^U %F7PAX<FN6N9=#T]YV.3*UNI8_CC-:=G96FGVXM[*VAMH0<B.
M% BC\!698>+O#^I&X%IJMM(;:,RRY;;M0?Q\XRON.*;:>,?#M]>VUG:ZQ:RW
M%TI>&-7Y< D<?D<>O:@#<HJC;ZQI]UJMWID%TCWMH%:>$9R@89&?J*O4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *HZKJUKH]HMQ=%SOD6**.-2SR2,<*J@=2?_ *_2KU<YXT\)KXOT>*R&
MH36$T,ZSQ3PC)4@%2,9'4,>X_I0!>DUR W=[:P6UQ<2V2*\NQ/E#$9" G@M@
M@X'0$9ZUD^&?'FC>*KZ[L]/:=+FTQYL<\>T@$XXJ+3?!:Z+XGU'6DU:\G2\@
M\LVLARH<[=S\=2=OH,9->8ZI)_PA?B+PUXO6-A974)MK\1C.<$C)'J5(_$4
M>H:S\0-(T;Q##HDJW,VH3 ;(X8\@YZ D]#740RAXD<KLR,E2?N_6O"_$]K+9
M>//!$MUD7-Y<S7,P/4,SH0OX# _.M[QMKFM66HZ[Y6IMBTM1/:06!)>$@9WS
MY& I]#F@#UK>HZD"E#*3C(S7C?B3Q;KI\+>"=2L]2DM;C5)XX9V15(;<.<@B
MM'PYKFMMXA\;Z,=5$XT]4:SFO2N(G(;.X@?=Z=N* /4BZ@X)I2RCO[5XII?B
MC58?&7A:W^W7%RFH^;%?N<M;SNH/S0YP=N<<X JIKGB#Q0Z:^SWM[;:Y;WZ0
M6%A .'A/.0F/FR.] 'NP92< C- 93WKR34M9U>;QG:^%DDOR(-,^T-Y$J+)+
M*>F6;&0*I^(]9\6Z7HOA-KJ^:TU>:_\ LER(F5T<9X+8!&<4 >D>(_&&F^%[
MK2[>^6=FU&?R8C$@8*>.6Y''S#IFD\/>,M+\2ZEJMA9"9)],F\J82J%W<D;E
MYY&5/IV]:IV'A&\>UD@UG7;K4(VO5NPI55!"D,J=,A=PR0.N/3-:,^A/%#K5
MS:Z@\.H7\9473JN( H;8  !PNXGG)))YH W**Q_"]KJ%GX=M(=4U-=2O "7N
MDZ/DG&#WP,#-;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4C' )I:* /)_%/B_1;/QW"U_K"[=.#1-9-9.^"P&6#
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MTK3HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBD) ZF@!:**:9$5@I=0QZ GDT
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M"ZU%K)5BM;R59_)'1'QAL>@.%X[<UYXWB">U^(.G^*9IU_LG4Y7TI8PX_=Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .1\<>(KW3(K/2=&
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M=UZ"@"O S6>LVVEV^D,MC%9#9?!AM3:=HBQUZ<UKT44 %%%% !1110 4444
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MM%% !1110 4444 %9VO:K'H7A_4-5E *6=N\V"?O%02!^)XK1KS'X[:I):^
M%TR _O\ 5;J.V&.R@[V/T^4#\: .P\%^(F\5^#]-UQX! ]W&6:-6R%(8J<'T
MR*WJX[X56QM/A=X>C(QNM1)_WV2W_LU=C0 4444 %%%% !115#4-:T[2KFQM
M[VY6&6^F\BW4@_.^"<>W ZGV]: +]%>&^,_%VLZQI-_K>D:K>6-NM\FFZ%!9
MOM-_-O DD;CE>"%' XKVNR-P;"W-V MR8E\T#H'P,_KF@">BBB@ K"M_$T-U
MXUN_#=O TC65JEQ<W ;B-G/RQX]2OS9K=KSGX9-_:/B'QSK3<F?6#:JW^Q"H
M"_HPH ]&HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *\_\%_\E%\;?]=H?Y-7H%>?^"_^2B^-O^NT/\FK:G\$_3]495/CAZ_HST"B
MBBL34*SWUW2H];CT9]0MUU.6,R):EQO91W _/\CZ5+JNHPZ1I%YJ5P<0VL+S
M/]%!)_E7F/@GP<_B75-*^(VL2^7J%R\MV+91P%8!(5#?W50$X[EO:@#TK6=:
MT_P_I4VIZG<""TBQN<J6Y)   ')))'2KP((!'0UYO\2Y6O\ Q7X'\.=8KS4C
M=3I_>2$!L'VY/Y5Z30 4444 %%%% !1110!1UK5K70=%O-5O2PMK2)I9-HR2
M .@]ST%.TK4K;6=)M-3LV+6UU$LT988.UAD9'K7FG[0&LR6'@%--A_UFI7 1
MAW\M!O8_F%_ UVGP_@-O\._#L;=1IT!_- ?ZT ='1110 4444 %%%% !12%E
M#!2P!/0$]:\G\1_%35K0'5-&M+"704U&/3DDG#M+>/SYABVD *N, D')_*@#
MUFB@'(S10 4444 4+?6M/N]9O-)@N!)>V21O<1A3^[#YVY/3)P3CK5^O.OA4
M?[1E\6>(",_VCK,JQM_>BCPJ?S->BT %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?Z'_
M ,EH\3?]></\DKT"O/\ 0_\ DM'B;_KSA_DE>@5M7W7HOR,J.S]7^85P'Q?O
M)5\&1:1;MMGUJ]ATY#[.W/Z#'XUW]>:_$0BY^(?P\L#T-_+<8]XU4BL34]#L
MK2'3["WLK9-D%O&L4:CLJC 'Y"O.?%B_;/CCX'MB<B"WNK@CT^4X/YK7IM><
M:K'M_: T"5ONOHTR)_O!F)_0T =W-JNGV^IVVFS7D,=]<JS0V[. \@7DD#OB
MKE>2QZA;ZW^TIY*R*PT?2G1>>LA(W >X$F/P->C^(=;MO#V@7VJW++LM8'EV
MDX+D#(4>Y/% %#6O'?ACP]J=OINJ:Q;V]Y.0%B.6*YZ;L [0?4XH\5^,++PB
M-+:]AED74+U+13'C"%OXCGL*^:_&>E)8>&?#WB'4TDE\1ZW/)J-W*7.$AR-@
MV] #N7^5>Q_&J.*XM?":LZ;3KD&1GJIR"?IR* /3[BX@M86FN)HX8EQEY&"J
M,\=34E>0?& W/B:67PS9,_D:=ITVK7VSNRJ1#'GU+9..X'M7?^!;B2Z\ >'I
MYI/-E?3H"[DY+'RQG/OZT =!7@W[0.J>1KOA^T;<56UNY%51G,CIL3]17K7B
M[Q78^$O#5UK%RPD\O]W%$IYEE/W4'OGKZ &O M8T<S_%;P9'K=Q=2:MJ'D7>
MI?:>$1F;<L*#L!C;CUH ^C=$L5TS0=.L%&%MK:.$#_=4#^E4_$7B_0/"D$<N
MMZG#:"0@(ARSM[A5R2/?&*V)IHK>%III%CC099F. /QKYB\66\'BCP;KOQ U
M2*:2[OK\6FC)O(6.!#RVT=?E5\YXR": /H36_%%CHWA"Y\2+F[LHH!.ODD?O
M%.,8/XBM*RU"WOM*M]2B<"VG@6=';CY&4,"?P->7ZC-'/^S.K%E7=I$8 )ZE
M<<#\C5S7)ED\ >$_"%FY$VNP6]IN4\I;+&K2O_WP,?\  J /2X9HKB%)H)$E
MBD4,CHP96!Z$$=13Z\W^"+SKX#ELIYO,^P:A/;(#U15(.T_B2?QKT<.I8J&!
M9>HSR* %KQ3]H;5)=-MO#CP,$F\Z=E?NGR!<C_OO/X"O:Z\E^*&AV&L?$OP#
M#=0^=]HGF26-F)1HTVO@KTZDY]>_2@#DO!6HWM_K&G75KX2U;4M(T.U$&C)%
M&L<32'B2=W<@;B<D8SC/J,UZ7;?$+4+35[>S\4^%KO0X+N016UXTZ3P[ST5V
M3A">U=TB)%&L<:JB*,*JC  ]!7F_Q($OBC7M"\$6,G$TXO=2=#DPP1X(SZ;B
M>/<"@#L_$'BC1?"UC]LUK4(K2(G"[LEG/^RHR3^ J>RUS3=2T1=9L[N.;3VC
M:43KTVC.3[8P?RKP7QJ+'QC9^,/%]_'+/;:8ZZ3HT0<A6DW8:3C[QW-N Z8Z
MYQ7HGP<:WN/@]I,,Y0Q.)H7#' ;,KC'XYH H> ?&_B;Q=KNN:S-;_9_"<,#_
M &-9(0I9E/!#=6X#;N2 2!5_X(1$_#B*^;[^H7EQ<O\ 4R%?_9:R=*-QX&^V
M_#R^)>SO;>YDT2\'\0(8M$_^T"<\=<^XIGA+71X<_9KBU1&"2PVMP(C_ --6
MF=4_\>(H ]4T[4['5[07>G7<-U;EBHEA<,I(.",CWK/\6^)K+PAX;N]9OC\D
M*X2,=9'/W5'U/Y#)[5A?!^VBMOA7H0B 'F1-(V.[%V)K@_B=#?\ Q#^)FF>"
M-/D(L+)!<WLB\A">K'W"X 'JU 'JO@K7YO%'@_3=:N((X)KN,NT4;;E7YB!S
M] #^-;]>5_#B#^POB/XR\,:<6_L6T,$\,621#(Z LH/OS_WS7JE !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %>?\ @O\ Y*)XU_Z[0_R:O0*\
M_P#!?_)1?&W_ %VA_DU;4_@GZ?JC&I\</7]&>@4445B;'GWQ?N9I/"UGH5JY
M6XUR_AL 1U",<L?I@8_&N\M;:*SM(;6! D,*+'&HZ*H& /RKSOQ8?[1^,W@K
M3&/[NUBN+YA[[<+^J_K7I- 'F.L WG[1'AZ'@K9:/+<8]"Q=/\*].KS:PB+_
M +0NJR39RFB1^3_NEQG]<U#I5VVM_M ZO)%,QMM(TM;5E#<>8S GC\6_*@#T
M^F-+&LBQM(@=N54GD_051U[6+?P_H-]JUV0(;2%I6&<;L#A1[DX ]S7S%JMK
MJB^*?!GB;7=5DFU/6;N.Y-L5*_9H1*NP#GH0>F!T[T ?3NH:[IFEWVGV5[=I
M#<ZA(8K6-@<R,!DCV[=?45HUY9\4XC)XZ^'1!(_XFAY_&,_TJI\9/%&N6C+I
M_AR\>V?3K<:E?RQ]0N]5C0_4Y)'<#TH ]>HJII5R][I%E=R*%DG@21@.Q903
M_.JOB3Q#8^%M N]7U"3;!;ID*/O2-V5?4D\4 >,_'"Z&H>,M-TD.N;?3I&53
M_$\["$?S!_"O=+.UCL;&WM(L^7!$L29]%&!_*OFV;3]8U_X]^'DU^XMI;V18
M;N6"W7"6R*#*(CW)  R?]JOI>21(8GED<)&BEF9C@ #J30 /+'$ 9'5 3@;C
MC)]*I:QK6G:!IS7^J72VUJKJAD8$@%B%'3W-?,OQ!DU'Q;X?N?'5]J<L>GMJ
M)L])T_8<&,9^?K@' /(!R1UKU/XL@W/P/C=6/S+9MGZE1_6@#U;K17 ?$K5-
M2L_"]GHVB3M%JVIGR8Y$^\D2)NE<>F ,9_VA6C\,=:O?$'PYT?4M0<R7<D;+
M)(>K['9 Q]R%'XT ==1110!XK\;M>ET?Q'X=^QNRWCVMY#&2^U4,RK&&/IC+
M'/M6#X?\3>#7U_3X[S45BT'PM&(]-B\IW>\N3]^<JH/&1D<#D@^HK>^(GA2+
MQ;\:_#>F:C=2-I\MD\CPH-I4(6)Y_P!HX&?:O6=)T'2="M$M=*T^WM(4Z+$@
M'XD]2?<T 8_AKXB>&O%=Y+9Z9?'[5&,^1/&T3NOJH;&1].E=-)+'"F^6147I
MN8X%>;?$ MJ'Q$\$:5I\*_VA'=_;YK@+\T5NGWAGT;YA]0*\V^)T]YXUT_7_
M !*VJM#H>CWBZ?8VB@E;F4$!GZX_B)SSP.U 'TE+-'! \TKJD2*79V. H R2
M:\W\-_%5?%B>*IK/3Y(M.TFW:6"[8G]YA6/(['Y<@>G6M/PM8?\ "0?!;3M.
M,Q4WFCBW,F<E28]N?P-<CHE\FG_"/Q'X.N+9;'7](TVY%Q % \Y2K8F4_P 0
M((R?7ZB@#JO@S:_9/A1H@(PTJR2GWW2,1^F*[RO++;5QX?\ V<(+]'V2+I 2
M)@<$2/\ *N/Q;-=9\.8&M_AOX=1G9V:PBE+,<GYUW?\ LU &KKVNV'AK1+G5
MM3E\JUMUW,1R6/90.Y)X J;2=3@UG2+34[99%@NHEFC$B[6VL,C(KQ/XM7&H
M^.?B'IGP_P!+)\B$K/=L!PK$9+-[*A_-L>E=G\*M5O\ _B>^%=2F:YF\/W0M
MXKD]7A.=@/N I_3TH ]%HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "C-%>8R*L_Q/UK3KSQ#J5E8Q6T4\,:ZBT:AV^]
MC)Z>W04 >G45YWX.\4W:1^*'O[N?4])TNX'V6^6,.\D7S;N5 #A<9R.>OL*Z
M?_A*[!M%L=6@CNKBUO94C@\F++,6Z';UQQ^% &[167:Z_97FOW^BQ>;]LL41
MYLH0N'&1AN_!%:E 'G^A_P#):/$W_7G#_P"@I7H%>?:(=OQJ\2*<@M91$9[C
M$=>@UM7W7HOR,:.S]7^85YI\3W.F^)_ NN$8AMM5^SRR=D64 9/X UZ75#6=
M&T_7]+FTW4[99[64?,K<$'L0>H([$5B;$'B+Q%IWAC29=0U&8*JC$<2\O,_9
M$'=CZ5YHO@OQ?>W-KX\@FAC\4/.\JV%VS"*&V=-JPG'1E!R>.I-=WI7@/1M-
MNX[V4WFIWL)S#<ZI<O<O%_N;SA?J #734 >.3?#;7_#<&B^(]$>/4/$UI++/
MJ:O)M^V^;RZ@GCCD#./7KQ5?Q-\,?%7C/0;_ %;7KU&UTKG3]-AD_<6JY!*9
MZ%V QGI[GM[710!YFGP_N_%>E:O-XIM[>SN[^SBM+2W@?S/L$<?S#G@$E_F(
M'& !FL37_A1KU[X6:]O-6_M7Q-8K#]AV#9&D<1^XN>K-U+'J0.U>ST4 <5X#
M\+7VG:;J=_XC\J76M<E,U\J\K&N,+%GN%!(_'OUK#T[P]\0O"^BW'AO0I-)G
ML1(XL+^YF826T3$G:R;3N(R<<X_E7J-% 'S_ *O'I'A+QGH&@ZU>--I^C6;Z
MO.6Y>^OG<@8'\39Q@>F?<UUL7P[E\7:-?ZYKH-EXCU&1+FSD ^?353_4H/H/
MO>I/J*]"NM T>]U2'4[K2[.>^@&V*XEA5G0 Y&"1D8-:- 'FESX-\7>+K%[?
MQ?J-E';PP,D-I8%MD\V,+-*3C@'!"CC/Y54\'>!]<N[#2[3Q596MIINE6,UG
M#912[VFD<%&F8C@90L ,D_,3QFO5J* /(4^#FH7'AR70]6U\7EA90S)I$"Q[
M!%(^=LDA_B(S@#H,FKWPQ\(>(;2ZBUOQ8$CNK6Q33M/M P;[/$@ +'!(W-M'
M3U/TKU"B@#SA/#/BSPGXBUJ[\*IIMYINKRFY:UO)6B-O<'[S# .Y3UQQV';)
MVO _A6]\/PWU_K5^+_7-2D$MW.N=B@#"QIG^%<G' ZUUM% !7A?B;Q1'+^T7
MHT%[<)8:?HT3AIKI@B$M$S,P)]<JH^E>Z5FZAX>T35YTGU+1]/O9D&U)+FV2
M1E'H"P.* .+U+Q]?^))&TGX>VQO9V^675Y4*VEK[@D?.WL,_CTK=\(>"XO"^
MFW6^[DO-7OSYE]J,GWY7P<8] ,\"NEM[>"T@2"VACAA086.-0JJ/8#I4E 'D
M'@/P!XBLXM/TK7[:SBT?1[V:Y55?>U],<^7(0.BKN)&3G(''%:>A_"F73;U+
M*[U?[1X9L[PWMCIRIM/F$Y'F-_$JGH.YY/I7IE% 'F0T;Q-XQ\>:;?:_ID>E
M:;H$LDD*I,)?MDA.%88Y"X )S]._%>R^'.NKKEOI-W<VC>#+&_DU"WMU)\R0
ML=Z1.,8VJQ8^_P#+U6B@#QZQ\+_$/18+OP?HLUM::*]R\UMK!EW/;0,3^Z5.
MN_OGMD\^E:Q\)^)?AKXMU"7POH1UNTU*UCC6YGN0K13#[S29Y(+98@>HYXKV
MJB@#G?!_AIO#VG3/>3+=:Q?2&XU"[ QYLI[#T5>@'I]:Z*BB@ HHHH ****
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M1M64R]-N "1Z^@Y&-J/F7GBO2O#_ (OU87&G>&K'^U=5GE("S7#'Y4/J!N4
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M>DVES:Z19Z;/9:A<S1&-YFD#+Y)!ZE<AO;\J]EHQB@#PNQ\.>(?%&FZ7\/\
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MG$P!Q@ A\X8<'.,G(-:FC6%LFI>)_M7B&[LQ!J&&<W*1[@((OF;(_7BA?U^
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MPO 2/^)_JQRVS_C]_B].G6ET#J=117-+X4AD!V:YK#8.#B\S@^G2E_X1%/\
MH,ZU_P"!?_UJ .DHKFSX/C/_ #&M:_\  O\ ^M1_PA\?_0:UK_P+_P#K4 =)
M17-_\(?$/^8SK1_[>_\ ZU(WA")AC^U]:_&\(_E0!TM%<Q_PAL7_ $%M8_\
M YZ/^$.C_P"@MK'_ (&M_C0!T]%<U_PA]MWU/6<_]?TE+_PA]M_T$M7_ / ^
M2@#I**YO_A#K8_\ ,2U?_P #Y*/^$.MA_P Q+5__  /DH Z2BN;_ .$/MO\
MH(ZO_P"!\E.C\)6\<B.-0U8E2#AKYR#]10!T5%-4;1BG4 %%%% !7/>.\?\
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MFBA3?+(D:?WF8 5Y+XUOKV&RTSPQJ5GI]O9W1$TEK8PS2!88^=C+$A(4OL'
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MIBG37,%OCSYXXMW3>X7/YUY3IGA:XUJ#6WDTKP[,)-3NUFGN86\X'S#G:XY
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M3A0H& N .@ 'XYJB;GIU%<WY'C#_ )^M'_[\2?\ Q5*(/%__ #]Z./I!)_\
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MWUQ]OCN;;4)+C;(T*NI6%5(^0  Y.0#SP2<T =#>>+KFVO\ 6M%L?"S72:3
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MI<27%M96T,TO^LDCB56?ZD#)JU10 SRH_.\[RU\W;MWXYQUQGTJ(6-HN-MK
M,2F88C'$AZM_O<GGKS5BB@".&WAMPXAACC#L78(H&YCU)QU)]:DHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3^[GFD!):0?Q  $ 'C/-1ZA.?!7Q T2VL 8=%UD-;R6BK^[CF4 (R#HI.5!
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MP;J',T1P!&J!&(?ACMSQD<]:QK7PYK:?"*Z\*OIS+J 1XT;SD,;[Y2^0V<X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YOX@_\D]U_P#Z\I/Y
M52\*SZ[=6^B)J%C:#3#I:R"9)S,[2CRMA;<B[3@N<#=SGG@9W?$&C_V_HT^E
MO=26\-P-DS1J"Q0]0,Y )]<&IM(T]M*TJWL#<-.EN@BC=E"ML484''!.!UH
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M9$37!4LJ_P!W*J,CKUYYH UJ*** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV>V#O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 9U]X?T75+@7&H:187<P4*)+BV21L>F2"<
M<FJO_"'>%_\ H6]'_P# &+_XFMNB@#$_X0[PO_T+>C_^ ,7_ ,31_P (=X7_
M .A;T?\ \ 8O_B:VZ* ,R+PYH<,8CBT;3HT'14M4 'X8I_\ 8.C_ /0*L?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD\JX&<%F1 I!4]0.#U]:9K6G3:[X?U>\TV"Z35M+U5M0L3);O&7(QPNX#<&
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MR88D*"H'Y8KK-=NI+GP?>R0V-X\MQ:NB6XB_>AF4@ KVYK=HQ0!S/A"XFM/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.1I7=S++*X4%W/4X4 #L, = * .)U_3+7Q1K/BO1HKF WS6%HUN!* R3(TS
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS7CW$LL,#-<?9RB$RC]V6[*6/09JSI_B73=2NDM[=KC>X?89+=XU8HVUP"P
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M%CZ\4 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "C%%% !BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ Q1BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
A** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>exhibit1011-physiciansha011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV6]M@C?N(2<*G( /R$?\"4FOH".1)8UD1@R, RL.A!H =1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS9&<#./3M6EXF^(EIXBTIM/72?%=E%(P\TQZ=&_F+_=.YCQZ^O3IFO7L48H
M\5\1^-+#Q/X<31K[2O%8C)4S2KID6Z0@@@CYL+T[5W_P]N8;CPK$EL=8^SP.
M8(UU:-%F55 P/D ROH3S75XHQ0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M86T-[?)>^99>>X1)H]L8W$[AMPH;@D<B@#TN1%DC9&SM8$'!QQ7BWAV]L_\
MA8?BVQUS69X=-MF98%GU*2-4^?'RG>#G%>H^%]7NM;\*6&JW=IY%S<0^8T*\
M#/.-N3T(P1D]"*\YTSP'?ZAXM\4R:]H,R:9K)80R^; S0DMD/@.2"/;- &Q\
M)-3U?4(-;6[GN;K2H;K;IMS<$LTB98$!CRP "?G5+QSXTOM$\:Z3=PB3^PK"
M<VM_*C_*TLBY*D#KM7#?7(JWX+L_&?A&PU'1KO29-3L[;<=,G2XA7>.<(0S
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M<ANI*D8P><-WQ7':%:OJ.F>.]'M-$FU"[N[^2. HJJD)W,0S.Q 7! ('?&*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU<W=K'<.[HBX+H"0 H P,_7WKSZ*UU%_ >M3:^NR?2].N=(LBY/[YMK!I%!
MY?$:CJ?E/]ZNI\.>(+'2O ?A?SO.D\Z*VL3Y,9<QR^6!AP.1@C!H K6-UK>H
M?$+7]%/B"[BL[*&&2$)! 6!D7."3&<@=OYU:TKQ%JMCXU?PMKSP3M- ;BPO(
MH_+\U1G<C+DC<,'IV%8VG:YING?%;Q1=7=VD=O-!;1QR8+*S*N& (!Y!ZU<@
MM+GQ7\1[373:W%OI&C0O';//&T;7,KC!95(!V@=SU(^M '?TV21(HVDD=41
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M1M$T4L*#<"& (!PP]#D'I74^&K.YMM'6:_(.H7C&ZNL# 5VQ\@]E4*@]0N:
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MFCNOLLQ^RMMA;&07/\*GGD^AK*:TU37=$T/1+[2)X+FTN('N[A\".,0D'<C
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M)\IVX)0C Q]WI78T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% $9MX3)YAAC+YSNVC/YT_:N_?M&[&,XYQ2T
M4 %-=$D4JZJRGJ&&13JQO%B.?"FJO'//!+%:R2QR02&-E95+#D>XZ4 :T<4<
M0(C14!YPHQ08HBS,8T)888E>H]#7DLFKZEHF@>#-6L=7N[J^U1[:*ZL[F<SK
M*KIEF"DDJ0>ZX'-:EKXLM?#/BGQ9%J=SJ-Q!%<0M&BK)<>2AB#,QZ[$!;VH
M]%-O 6W&&/=C&=HSC&,?E3?LEOMV_9XMN<XV#&:S!XHTMM4T_3TDE>;4(?/M
M66)BDJ8W%@V,=.?6G3^)-/@CNR3,[VMPMJT:1$L\K ,%7^\2&!X_'% &L %
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MRW\\3W+2(Q#1QQ8; QSEFVJ/J?2MOPYK]OKOA:SUD.JK+ 'EP>(V ^<?@0:
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M=RH)C"C&1@G) JO:_$VVF\/W-[+;Q17,%TEIDRM]F=G)"N)=N=G!).W(QC%
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M]:T+:>.^TG5+NU\"3Z.ZV$L+N]@!/*[ !4C"#<RYSDD =/?'I P1D<TO0<T
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M"7<:Y7[RX;W'4\=J ,*[\8:AINCZ=XAO+2W&CWC1^9&A/G6Z28V.23M;J,@
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M7&:L^A>-O%^D6UA<F>[TB[E^V^6K+LC4$,C$@ AG"#OD;O>N_D5GB=5;:Q!
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M):>(%,\VJ2:@S36NY90R%3&X##(.5.1C!'2J\OPX$FEE8-2%AJ8U ZC%<V<
M6."4J%*K&3]T@<@GD\^U &SX3U#7;V.\CUJR>)8746UR\8B:X0@Y+1Y.T@C\
M<\5T=8^BZ1=V#SW.HZFVHWLX56E\H1(JKG"J@)QU)/)R3]*V* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB1))2#(RJ 7(& 2>_ Q4E 'FY\!Z[!I>DW-G>V,&N:5=W,\3?,\,J3,69&R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;8,,1D#IQ\HYZ4 >D_\ ":^'A80WS:DBVTMQ]F$C1N DN0-CY'R'D?>Q3/\
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M0$QV'#9#$*N.,EB!R!U(KD_&'BFWU/P;;:SI4MQ'+::K#%)#(S1E)%D&Z.1
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MQ[+M&3:S*<D _7&#GKQF;4]'\1:KHUIJ=MHMGIM]8WT-[#IBR(3)Y>\,&D
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M)SP!T ]ZZ*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNY!:\6Y! R^3D#)Z#)X/% '9T5BW_B&VAO%TZ"UN[^ZDMS.T5IMRD?0,69E
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M.4A0Q4'.<@>HP<<$T =117-Z9XSLM4M]9E6SO+<Z0[)=1SB,,&4$G&'([=>
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M["#5)X9KI5'EP!KAE7)8Y;&1G:#C([UT/G:2/BH(?LMV-8.E%_.+_N6A\P#
M&?O;L]ATH ZRBN>T?Q4NLRV;P:?.ME>QO);W9D0JP7L0"2I(YP1['GBM/6-5
M@T32IM0N<F*+:,# R68*HR>!R1R>!0!=9E12S,%4<DDX I:\W^(]TVL_#SQ%
M!<V$UG-8^3(I=E8-EE.5*GTR/QKH;#QE;S:TVD7>G7MA,+,WD37"KB6('!(
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MM?M4TV^F>.3>)X3#-Y<J.O1T(YR*@TG0+*&[6].J7NJ30,RQO=7(E$+8*MM
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M(62)@RD@X/(]Q4TN?*?:@=MIPK' ;V->?V/BF;3/!4-]8>'K6V7^TVLVLH9
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M5,?W1<";=G=C&T8^OYUZU10 R&0RPI(8WC+*&*/C<N>QQWK@;73-;T?3-?\
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MPA"!1CY%R022<\8&,FD\,^'K^Q\41:A:Z7+HML\3_P!IVQN%>&XF(4JT2@G
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MF#RV.O;/M3?#&A^*].%G9:OJEA-IVGKM@-LC++. "JB3/  !Z#.2!SQSV5%
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M,DKG+22$[G<GU+$G\:OT44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 50UK5[70M(N-2O"PAA7.%&
M68DX50.Y)( ^M7ZP?&GA^3Q1X2OM(AE6*:95,3L2 '5@PSCG&10!%'XEO+6[
MN(]:T:6QMX;-KPW4<AGB"K]Y68*,.!SCG(Z&JP\7W-K-I\NKZ6++3]2E6&UG
M6X\Q@[?<$B[0%W#/0MC'-4XM-\5^)])N].\2Q6>GP/;/ ?LLOF-.[+M#GLJC
MKM[GZ4TZ/XCUBPT?2-7M8(DL+B&>YODGWBX\HY4(O# L0,EL8YZT 1W7Q'N8
MH]<E@\-W$T6C3F.Z8W2+A1U(ZY/L.PZ]JOV?CEKC7]*L)]'N+6UU>)Y+&ZDE
M0F7:H;E!G;D'/)]*Q3X6UMM,\;VWV)0^M3-):GSEP WR_-SP0.>_'O5O_A'-
M8DU/P+<&T5$T2W>.[W2KG+1K'\N.N-N>W!'?(H )OB/<PZ7?:FWANY^QZ=>O
M:WK_ &E,Q[6"D@?Q')Z#CCK6K9>++R?Q -(N]"GL7GMGN+*2:92)@I *MM!V
M'D''.,UAW'A36I_!/BG21;Q+=:KJ,US!F8;0DCAAN/8@#GKVK?N-.U&Y\8:'
MJ@M EM:6DT<VZ5=RM)LXP.N-G)SWXH JQ>.'F\'6/B)=- 2XNQ;20FXYCS,8
M=P.WYN0#CC@TMUXPU'^U=:TS3O#\EU=:8L;$O<I&C*ZLP)/;@# Y)SVQ7-CP
MQXOA\--X:@LM/-K:7XN(+J2Y.;A/M E *@?)C)R>>F #UKH['2-8M_%'B749
M;6'R-2MH%B"39(DCC*D<@<$L<'';H* *UWX@T[7--\):I+HRW4%_>QB%IGQ]
MEE(;G&/F(PWMQGTJ+3M=\43^-O$=M]BL9XK%((X[47Q3:"K.&Y0Y9@P!X &
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC'H^G0ZM-JL=G"M_,@CDN OSLHZ#/X#\AZ5>HH **** "BBB@ HHHH ****
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MT5LW_<=/F<$ JN3CGDX/'%3WOBUX/&.F:+#8S2V]U \QN57(< +C9ST&[)-
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M,FT^.:_?4D\RVBAVAB@ +,=Q 4+D Y.<G'6@#>HKSSX9W$EQJGBUGAN+?&I
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M'O3M4>=H_'JV0,T$6K6TUQ!%\Q:$']YA1U^[S]#FO;54(H50%4#  & !2XH
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M/L.1]W:1ZCVJ[=76D:';>&VTRQN].T^6\N)(=0N899I(LJ 65#G#2;B%W@\
MG'->N8HQ0!XI'>6,OA:33;EKB5H_%(><7,#*[1F<L2PV@9V LP XST%=O;W5
MG!\4=3R\:Q_V1"&('RY5W8@D<9"LIQUP1VKM,44 >*6;0)\+?#5O<J%"Z\C2
MQR)]V,3LQ+ CA=I!YXP:Z2_6R/CGQ5!(SQ13Z$J.;9?WC%=^[:!]Y@I7CZ5Z
M/5+5]-75]'N].>:2%;F)HC)'C<H(QQF@#R/P?KNEZ]J/A2TU#4[&)]%C\JTB
M190]PYC"+N+H%4@#H"<G %=]\1[B&V\%W4EQIZWT(DCWHX9D0;Q\[!2"0O7
M/-26GAW79'6/6_$GV^TCD218HK)(2Y1MR[V&>X4_+MZ>G%=10!XU9:I"_B?Q
M9.;V\NX;O1 T4\UJT8FP",JH4<9.%XYZ9)K5 @AT_P"&L<**DD<D9<(F-@,)
M5]V.F7(!SU->GXI: /%Y];CMOAUX@\+ZI:W@UY6N6>-K=I/.W2%Q+N (P,KR
M3V'M7IZI/?>#MED[1W$UAMA9@4*N4P"<C(P?:MFB@#R+PI+H]Z^AZ7=V.MOX
M@TMXU>VGEF,5NR?*TO)V!< X'?H!71^$KR-?%_C-GF @:YBEC)/RL!$ S#U
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M6*@%@#CD@8R!7H=% 'A>E+/8^!_!>HW%AJ%Q8Z?)=P7\-JTD<T1D?*OA2"0
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M#7X)I;%Y,P2F&:.6-HWC<=596 ([5Q=I:7B7OPY#Z?> :?9O'=L;=L0L8!&
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MI9B3AV!^0@L02V..F<5GZGX8DL[73[:!=7@UG3=*BBMM5T]&=96!8&%QTVY
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M&'4X[!Y-7,"W4TID\B#F.!< ! < MTR2>Y/;% %R_O8=-L+B]N&VPP1F1S[
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M:16+%]P&W!&3CJ/7VK(L1XI\"^";"P?^Q)9H;E8(8R\I:X0[B57 '[PG&!C
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M7X+8_P!I7?$DKN6P.,A0>F<"L*^\<W,NH)8:9#:V]V]@EY##JA>)[@MG]VH
MX9<<\GD].":[:%G>&-G7:Y4%E]#Z4 /HK#\1ZQ>Z4MFEE:HYN)"LMS.2(+5
M,EY".@[#D<US!^(]P/#5MJD=C;7+G5_[,G$4Q"YWXW1Y'(*\C)&,CK0!Z'56
MZU*QLIH(;J[AAEN'"0QNX#2,>RCJ?PKE[;QC=V>KZQ8^(+.WM?L-B-15K:4R
M Q9((.0/F!&.G-8^O7FM7]WX-O+RSLHK.XU2&51&S-+"2K%58G@Y!.<=QWH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?83&L#)G#%P<[C_%Q]/>@"EIGC34=2\/:.RVUJNLZE=2VP3YC"GE,P>3&<D
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M2_L)O.M;A &V$C# @]5(X(H YR^\1:]I,'B6PGGMI;W3; :A:W9AXEBPV5=
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M#D%F !?!Y X ].!0!!X1O_%>M_9M0O+VP%A'<W,$T20D/,$9E5P<G;A@!M]
M3DYP$^* E.B:<HU&:SMY=2MXIO+4,"I?J1@DXQG _6M_PUH+^';*6S%\]U T
MSS)YD85D+L689'!&3D<<>])XJ\.1^*-'%@]S);.DR3Q3(H8JZG(.#U'M0!1C
MO-2OM=N=#@U/RCIUK$]Q="%#)++)NQA2-H4!<G [@9&*G\':Q?ZMI]['JD<:
MWVGWLEE*\0PLA7!#@9.,AAQ43>$IH]2CU6SUFYBU3R/L\]Q+$CK<)NW#<@
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M V^H:P=6@U?5-.O942.[DL9O+%R%& 6&.#CN*Z>SM(-.L8;2W79!!&$0$YP
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M[;Q.B:B[OI,\&/\ 2Y(?-691DE!'U!ZD=OPKIM8U.'1](NM0GR4@C+;1U8]
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MNBJFFVAT_3+:T:XFN&AC"--.Y=Y"!RQ)Y))KS#4[[4EU$ZC:SW]S'_;\< U
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MWV?RI(W+&02*S9/;H!P/?DUT%<%X+M].L/'_ (RLM.6"*%#9[882 J_NVW
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M<DJ#P1TXQ68?AWI<NCW>G75]J-RMQ>&_69Y$62"<G)>,H@"G))Q@CGI77T4
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MN%&3CC<VXXXS4FC^&H=%U"]O+>^O9#>R&:XBE9"CR''S\*"#@8X('MTK;HH
MR?$/A^T\2:?':W4MQ 89DN(9[:39)%(O1E.#SR>H[U!;>%;6UUAM3BO+_P"T
M-;"U)>8-^[&<<D$D@DG).<ULS-(L$C1*'D"DHI. 3C@53T2XU*[T>WGU>R2R
MOG!,MNDHD"<G'S#KQ@_C0!AR_#O19_#R:-+)>-##,TUO-YH$UNY.248#C)R>
M_6MK1-$MM"LOL\$MS<.W,EQ=2F664],LQ_EP!Z5<NWGCLYWM8UEN%C8Q1LV
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M2RF_WF.>144 -M92QP20,]?7BO3/^$;TK[;?W@MF%Q?Q^5=2"9\R+T Z\8'
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M%U]IE?9<(&!93U"DJ"H('RYXQ6)X=\%F#5;34(/#%OX<>WEW2.E^T\DR8(V
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M=17*Z38"XA4)%*+9-Z*!@!3C(&..*6#0])M;6>UM]+LH;>?_ %T4=NBI)_O
M#!_&@# \%VNC0WFL3Z+JT^I1W,J2SR;HS LI!R$\M0 V,%O^ UC>)]0@M/B/
M#%KFHOI^FR:=BTG:.-HO-+GS%)D1E!*X]...]>@VEG:V%NMO9VT-O OW8X4"
M*/H!Q3;W3[/481#?6D%U$&#!)XPZ@CH<$=: /,[_ $"SA^&\5WX>N+J]_L&[
M^VV$]R5?S5C;+JI4#,>-V,=QZ58U0W.H?#?Q+XFLH9HKK5HA+&N '6V3"@<>
MJ!F_X%7I7E1^3Y)C3RMNW9M&W'3&/2B*&."%(88TCBC4*B(,*H'   Z"@#S3
M3?\ A%=7U&WU"QU>;4;A]-DB>V"0B.*#;G$RHBXP<  ]_8&L!+73M/\ A[X"
MU*P6)+M]5M?,N0<N2=P=2QYQQC'08Q7L,&E:?:K.MO86L(N&WS".%5\QO5L#
MD^YIYTZR*JIL[<JN<#REP/TH X/PG=65I\3/&5G--#%=3W$#01,0'<",DE1U
M(Y'YU+\37A@NO"-Q<-&D,>N0&220@*JX.<D]!7>""(3&81H)2-I?:-Q'IFEE
MACGC,<L:2(>JNH(H X&UBT+6_B-K,DXL[R!=*MB@D(90I\S)P>/NE>>P/O7,
M:5JMDF@^ X?MEM;WBV]P8KN\;=;P@#:P*Y&Y\8"@D <_0^P&QM"[.;6#<P(9
MO+&3]:!8V@0(+6 (K;@HC& ?7ZT >+6&H:<G@O1E:[@9;+Q4DD[< 1QF:0AF
M'100,XKVNUN;>ZM8Y[65)+=URCH<JP]0?2@VEN8W0P1%)&W.I088^I]34I4%
M2" 0>"#0!P'PXN(9M:\9^5-&^=9D<;6!RN!S]*G\9JS>)-+ET[6[:PUJVMYG
M@@OES;W$3%0ZD]0>%/'.!^-=E#9VUNQ:"WAB8C!*(%./PI\L$4Z;)HDD7.=K
MJ",_C0!Y99ZY9V^K>"=9U"*+2;.2QNX<N_[I&RN '/&#M)&>Q'6LC5;S2;[P
MIXB5YH0#XH5V#_(ZHSI\W.",A7Y] :]JE@BF4++$CJIR R@@'UI#;PL,&*,C
M<6Y4=3U/UY- '">,?#MCIWAE-;\/65O!<Z5<KJ4?V9 HD P)!QU!0=NN!4.M
MQK)\*?$6KW*[)=6A>\(EP"JLH6%?J$"#'][->A^6GE^7L79C;MQQCTQ2E%(
M*@@$$ CTH \[\6JD'AGP[XQLMDTNBF*8LGS>9;NH211VZ$'/;!JKXFBO-.\'
MZ5JMQ',L<FJIJ.J"! S1HV2#@J1\@V#D?PCZUZ>RAU*L 5(P01P12T <5X-.
MA7FNZGJNBW=]?O=1Q_:;R7 B9APJ@!5!8#K@<9'K7:TV.-(D"1HJ(.BJ, 4Z
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>U6J* *=QI.FW?E_:=/M9O*QY?F0JVS'3&1QBI+JQM+Z-8[RU@N$4[@LT8<
M^N#5BB@"*2UMYI(9)8(G>$[HF9 2AQC*GMQZ5+110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;;T8L6!0'+$_Q'O3+O6+N;6)])TB&WEN;:));A[AV5$WYVJ-H)+':3[#'7/
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M]Q'&1'"R8_=@KM^8X'/.<DGO7<4 %%%% !1110 4444 %%%% !1110 4444
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MKD@8YR>E0VGAW6[&P\):A%8;KW0HFMKFS\Y?WT;(%+1G.W/&1G&<XR*]'HH
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M2!?+8AV )(R!@< GDU>H X>70?$NGZEKHTEM/GL-8)F(NG96MIB@1CA5.]2
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MM]5N;JV%]?QW!"B8L V"<-]T8"C_ &1TJSXINOL/A"Q\5V< AN;!()RD0^]
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MYL93-8+:ND:.GS*2P(SGC+8^G/M6+#!I/@OP:_A_Q9J%L8[]K@QB-'S*K'+
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MHQZ9SVH [&ZM+:]MGM[NWBN('^]%*@=6YSR#P:DCCCAB6*)%2- %55& H'0
M5YYK?B?Q%=:Y>Z9H5O<M-IT$33?98894::12P5FD=3LQC[HSWSV,&K^+=>MG
MTU=2=_#T4UEODNOLRW$(NMQ7RY&Y"+P&XYYZC!H ],K+FU^Q@\1V^A.9?MMQ
M TZ 1DKM!(.6Z \5QNN>)]6TZ73H;W4AIL$M@CKJ<5NLUM-<D8*NV#L7."",
M9!ZUH-X@U:#QOX?TN>YM7M+W3WGG\J/.75<DA\\KGD8 X]: .VHKSF7Q'K[^
M#Y/&UM>1FT4F9=+,*[3 &VD&3[V_ )ST[8JV^J>)-2\97.DV&IVMI:G3HKV)
MWM=[1[F(VXS\W3KQQV[T =W4,\-M>PRVMQ'#/$PQ)%(H8$>A!K$\#ZQ=:_X-
MT_4K[9]JE5Q(4& 2KLN<=L[<UQ]AJE]X;N?'.KWNIS7J:?,O[MXU'FL8EV#(
M'R@%@..U 'IT,,5O"D,$:11(H5$10JJ!T  Z"GUQ,NH>(-!NM$NKW4H]2L]3
MN8[6>(0HGD/(/E:-EZKNX.XD\CFMGQ=J&I:9X?EN=*M9KBX#H&$,?F.B%AO9
M4_B(&<#UH W:KW]Y#IVGW-]<;O)MHFEDVKD[5!)P._ K@X_$VH2>$;Z^TW7K
M74=MS'"EU<1K!) IP'WQX +@YPN.<C /0QZ+XIUBY3Q?8_;9)9=(ACFMKJ\L
M?)E.Z,N0\6%_NX!P.,'F@#O-+U*WUC2K;4;3>;>YC$D>]=IP?45!I>NV6KWF
MH6UKYI>PE$,WF1E!OQG SUX_G7,67B+4=3M_">FI=B"^U/3Q?75T$7<%"*2$
M4C;N9F],  \4?#Z"YMM8\70WEV;N==2 :=D5"X\M<9"@ '&.@H ZB;6K6'7[
M?166?[5<0M.A$1*;5.#EN@/^(]14\>EZ?%?O?QV-JEY(,/<+"HD8>[8R>@_*
ML.\U348_B%8Z3'<(ME<:=-,4\H$B164 D]2.>G%<C%X@\7-X3;Q')K-L([34
M# ULMFO^D)]H\L[FS\O7C'/'7G@ ]4W+OV;ANQG&><4M>9K-J5O\5]>D?5KA
MK:ST]+DP>5&=T?)\H$KE1[C!)ZYJ?1-9\8ZF^BZK';3OI][AKJ.8VRQ1QOC:
MT15O,)7T;EO8T >BT5YEI.N>+)[;6]4N=5M7LM#U"[BFA6T :YCB3. <_+R
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MGKSICB_^&.?^>3_^DE:'Q6O+K3OA[?WME<S6US \+1R0R%",R*#TZC!/!XH
M[6@UYO=W5SX9\<7=O:W=_=++X?FO!#<3M*'N$?(8 \+D9&% 'M56Y)TOPEH'
MBC1[N>ZU2ZFM5N)6F9_M8D.'1E)('). !\N,#&* /2(;^VGOKFRBDW3VP0RK
M@X7=G STSQT^GK5JN!\%Z996GC7Q<T0='2]C"@S.<[H@QR"?F.2QR<GK7?4
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M7@$A3^'UKM<T9H YO7_!UMXAM[ W%_>P:A8_ZG4+9Q',"0 W08^;'(Q4%_X
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M*ZMY+>>-9(95*.CC(92,$$>E/S56^U*UTY(6N90GGS)!&,\L[L%  _'/T!H
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M]U_X]SQQSGCCI5G6=$T_Q!IS:?JD!GM'8,T7F,@8@Y&=I&>><>PK0HH R_\
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M%RXRV<]<YQGG'KS0!SNHMJGBOQ1KVD6]T+233EC2W!NYH63<N[S@$P&Y]<C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI?%OAN"**277],CCF7=&S7: .,XR#GD9!%6['6M+U-F6PU*TNF3[RP3*Y'U
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M<0V]Y?P0SS,%BB=QO<DX&U>I_"O/_B+X27QEXFM[!)?*N8])FGMGSQYBRQ
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M\1:3%HJZR;Q'TYAN^T1*9% ]3M!P!CDGIWK.'Q \+M9F\&J VH.#.(9-@/\
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MQ*_EQE7'OG!]^1WK \(:MJNB>(],\ ZY$S365^);2=1\IB\N3C)ZCD$?B.U
M'N%<YJ?C?1=)O;JUN&O&>S"M=O#9RR);AE# NRJ0 0<]ZZ.N3\=VEO;^!/$\
MT4862YM7DF;^^P0*#^2@?A0!)IOCW1M5O;&WMH]0 OV86L\MG)'%-M!8[68
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M5T/@OP3!X1CO9GN3>:E?R>;=7+)MW'DX4=ADD_C]*TKGQ3H]KHD.LO=,^G3
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MS]FM9)A ",C>54@9'..M,'C+0W2R>*YFF%\KO;""UEE,BJVUFPBG R1UQUH
MJ1:+K@UJWO"^FPV=K',T-E '56FD/+L<<]6XQ_$:P_"_@/6/#4FLL9=+O%U*
M=9RDH<"-E9F';G!(/;I6RGQ*\*26EU=IJ,S6]JP6XE%C<%8B3@!CLXYK2N_%
M.F6E\;(?:KFY5%DDCM+628Q(W0MM!QG'3K[4 <QK?@G7M<\(WND76I6375]=
M_:9[G:X"@;=JJOH @'7MZ\U4UGX97>I>'?#]O;W=K::QI"I&E^@;)1!\OOU
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M-3GU&)X]1M;*WM+DMQN9'FYQU!P>??-=YIN@C3M3O;\:C>W#WA#2I-Y>W(
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M/+9M&GEW,LLBDLP4A1@>V>?:N%^$::O=:9HK1>4VE6NLSB5$B)D5C:MAV;.
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M5# C:2""#P>]>??%/_DHW@#_ *_E_P#1T5>L)#$DCRI&BR28WL% +8X&3WH
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M1VW,X$LG)/<GUKV"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$$DL5W;S,0S(5^0HPX.&SU.<?6@"/4O FF:KK\6M7%UJ/VZ$YA=+D@1>RC'
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M:=$=I3*6J [2,$=.A!(_&M2B@#/M="TBQG$]II5C;S $"2&W1&&?<#-:%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9X<A2PXP.!@]:->\97L>HBUMKR#2A<6<<VG27MONCNY&!.POD!"/E&/?/H*
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M2UNK%( \-NGS;0LP&#( N2-Q^]]T8JY:33VWC#X@3VKHD\4%HZ-(A901 QY
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI&.!0 M%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#/&>>E '3:OK,&BQVKSP74HN+A+=?L\1DVENC-CHHQR:T:YP>(M3.AZ;?_\
M"-WHN+JX6&:TWC?;*6(WMZC@'Z'M71B@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
ML;Q'H+>(;**T-]+:Q),DS>6BL7*,&7J. "HZ5LT4 (H(4 G)QR?6EHHH ***
M* $I:** "BBB@ HHHH **** "BBB@ HI&8*,G@4*P901T(R* %HHHH ****
M"BBJIU&U&HC3S,OVHIY@BSR5]: (;9],TZ2'3+=HHG<,Z1#JV#RQ]3GN>M:%
M<9X7O/[7\5^)+V. K%!<I:)*SY+&-?F &.%RWKS79T %%%% !5:^O[33[.2Y
MO+B*"!!EI)6P!4SRK&I9C@#DDUPNA6\GC'59O$&H'?IT,QCTRU;[N%.#*PZ,
M3V],4 :O_"<Z+L\Q!>O;_P#/=+*4Q_GMK>L;^TO[9)[.X2>%NCH<_GZ5,8CQ
M@@<8Z=JY'Q26\,^5KUDJK#&X6\MT&!)&2 6QTR/ZT =D#FBFHP= PZ,,BG4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ&?/NTQM=SZ8/*COWKKX&U*VO+F[A\(F.XN"#-(M['F3'3/-61J&N* J^&9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@# O\ QKX?
MTS4'L+W4/)NT&XQ-#)G'K]WD>_2M:PU"TU.SCN[&YBN;:3[DL3AE/8\BN#OK
MF>U^.(>"QFO'/AW'EPLBD#SSS\[*,=!USS5*"U\0^"?#^K:PB6<-UJ6JI*-/
M;YTA620(%# @!OFY.".!Q0!Z#J.NZ;I-W86M]<B*:_E\FV78QWOZ<#CJ.N*T
M:XBXU+Q'IE_H,&L#2)WO=3>$F")SLC*%E*DD8888'@Y!'O69J?BKQ7##XJN+
M>;2UAT.48W0.6E7:K;<;OEX)^;)^@ZT >E5G:OKNFZ#%'-J=S]FBD.T2,C%0
M?=@,#\<=_2N/:_U34?B!X>FAODBM;O2GNDMWAW!,^7NR0PRQSU[>E=%XX('@
M/7R5# :?,<'H?D- &M-?6\-B;UI-UL$$F^-2^5/<;<Y'TINFZG::O9)>64C2
MV\G*2%&4,/4;@,CWZ5PFBW,OP^UZ/PWJ#NV@7TA_LFZ=LB!CR8')/3^Z?_KX
M?IVJ7VF^!?"(MY(;:SEM8Q=7;X=XP(P56./J[,?0' !XH ]#HKS"W\=>(+OP
MU875N++[6^NC2G\V%E$B[N&QG*'L>#WQBM.'4O%DWB'5] &H:;YEK!'<K>&U
M8$!P?D$>['WEZD\#L<\ '>45YY9^-M3OM"\*;(,W^M)*TCPQAMHB&6VJS 9/
M'4X'/!K2L+GQK>:#JD+VMI::I%,%L+BZ "31[A\SHA;:<9Z'J10!V-%,A\SR
M4\[;YNT;]G3/?'M3Z "HYK>&XB:*>))8V&&1U# CZ&I** ,:+PUH6GW O(M/
MMXY4&$D8;O*'HF?NCV&*TIN+=V7J!D8[UF^*+'4-0T5H-,>%;GS$?$P.UP#D
MJ<=,^M9EAXI5)EL-?M&TF[(^43,&B<?[,G0GVZT 5?A9(D_@6VDSND>>X>0G
MJ6,K9J:\D_MSQFFE*2;+3E$]ZO\ ?D;_ %2'U &YC^%<SX0GUK38]0T?1+.W
MN?LFKS+<?:)RGE1MAAM ^IJ#2)=7M/&VO6.IZM:Z1<7;QW8**&\]=NW"-)P
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\A,]* .(+> HM'N],MIM/M[:YB:*01?*Q!&#@UKV/B;PQ8VL5M#JUN(HD6-
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M]* ,(>-/#A/_ "%H/U_PIW_"9^'?^@K!^O\ A6T8D(^Z/Q&:;Y*CLO\ WR*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444$9&#0
MF<]*6JD5HD%S<3J\A,N,AF)5< #@5:7[H^E "T444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7(>+
M=8NM,US1H$U8:?:7:3^<YB1P"B@J>1GDG&._:NOK+O=&6]US3-4,[*U@)-D8
M7(;>NTY/T'% '-V'BV]AD%UJ\$ZPG3DN9(HH<"+]XX,ASR 553@DD9Z'%=%#
MX@M9I9(EAN!*EW]DV,H!+;=^X<_=V\Y]CQ46K>'5U62^+7+1K>67V-P$R57<
M3D'/7YB/RJ"PTQYO$\NJ2VTT"PVZVZ>85 E<%@9 H)Q\IP"><,1B@",>*K34
M].\^T%\D+2PHEQ"L;9+R!0.20.< @X(#=!5H>(XI_M'DVMXUNB2[+J- 5D:/
MA@O/7.0"< D'%5(O!Y5I)I=0+7,C0%Y(X%C$ABD#JSJ#AG) !;CCL*GMO#!M
M/M$4.J70LW:62.V(7;&TF<\@98 LQ )Q^5 $:^*;6S.FVTZ73+<) @N9@BEG
MD "\ C<2>NP$#/I5C3_%%IJ%U# +6[@\]Y8XGF10KM&<.!AB>,'J.QK.;P./
MW035[D*@ML[HT9CY 7;AB,@$J&(]2?6K]IX9%K/I\IO7?[%-<3*-@&\S%BP/
ML"QQ0!G>(M8OK'6_L[7[Z;:20+]EN# K0R3EFRDCD';P%QT[U;AUYK36[^SN
MS=3H;V.*)UA79 '2,JI(QU9CZU:U;0I=56[@:^VV=Y%Y4T+1!L#!!*'/RMSU
M(/3I23>'A)-<RB[=6GNX;D_(#CR@H51_WR,GZT 5O^$SLU6_:2SNX_LD8F*,
M$WLA.-VW=E>>S8)'-,N/'&G6EY#:W,%S!(VTRK)L#0[CA=RAB3G&> < @G%1
M1^"0EJ]J=5G:%[=[<CR4!(+A@Q(&2WJ3UZ\=]"?PZTNJRWT6I7-N;F)([F.'
M $NWHP/53CC(/2@#,T/Q5L6:WU4W)9;J[C2[>)1&RQ,YQE>X1#V[4[5O%+MI
M.HQP)<6%_%:B[@\Q48O%D#<.H]B#R,U9_P"$0A:*.&6[E>%9[F9EV@%O/#AA
MGL!O;%,?P>9[66*ZU.::0V8LHY?+4%(MP)R.[':,GVZ"@!FO:_<I>V$&GK.(
MEU2"UN;A=A3YB-R$'YNA'('7C-#^/M)26]5EF*6T<DFY-K;PAPW&<CU&<9'2
MIKGPF9[UIDU2XBB>[CO6@"*5\U,<@D9 . 2*9-X.$VGWFGMJ][]BG618X3MQ
M%O.6YQENIQG.,T =!;7#7%N)9+>6V)_@FV[@/7Y21^M8'A[Q))JFLWUK/M6.
M11=6.#G=!G9DD#N5#^H$@':MG4;&34-(GL1=/ \T7EF:-1N&>"0#T[UG3^&H
M4O["_L&6UGLE9=L42@3A@ 5<^G'Y\]J (8?&-M-!)<"PO?LXMFNXY0$(DB4X
M+ ;L@]\'G%-U#QK9:9=Q6UU:W$4S!6DC8INC5FV@X#'=T)PN2 .:Q]#\.:@L
M$]G+'/;)/:M;W,DUO;@Y8?P,A+-R2>>.<]:Z*?PZTNI+?1ZI=03/ D%SY6T"
M=5)(ZCY3RW(]: *DGCK2TO[FU6.:40+*QDBVL"8@2XQNR,8."< XXI1XT@#/
MYNF7T4<9B:21@A5(Y/N.<,>IXP,GOBG'PD!'?6\>J7B65UYS"U&W9&TH(8CC
M)'S,0I. 3FB?PDL]K=0&_E5;B*WC8B-<CR>0?Q[T 0/X^TQ;F]B6*:1;:.:3
M>A4[_*SO&,Y7H<;L9QQ3KOQ?)';79@TNX^TV\MNIBF95W),VU7^]W((P>1QF
MI#X046VHVB:I>+97GG$6_P I6(R@AR#C)'S,0#P"<]:?/X4%P;QWU&82W,=L
MA=8U^5H&W*P&.YSD=* (O&>K36?A'4+BPOEM=0MXEE 5D9E^8 @@@^N/K4=Y
MJ=WX9U:RAN;R;4+.\2;B1$$L;1IOX*A000",$>G-7=5\)Z?J>DWEDJ1VTMXH
M6>ZBA02R8()+$ 9)(S1-X86[N'N[V^GN+KR'@A9E4) '&"RH!]XCN<T 6(-3
MFU'1+B\2VN++,;- TNPLR[<JX ) Z]#SQTHTB\F/A:TO[IY;F9[1;B0J@W,2
MNX@*H'T JS%IYAT5-.6=B4MQ )2HSPN,XZ5DCPO.VEPZ;-K-R;6*W,"K&BHQ
M!38"2.N ?SH CC\:VLMN'2RN))3=+:>7#)&_SLNX?,&QT]^#UJS8^*8KN]M[
M:6QNK4SK(%>;:%\R,XD3@GIZ]#V-5H?!_EW,<SZK<R[+J*ZV-%&J[D7:  JC
M QVJROAB)IK.2YN3<+;O<LR21KME\XDL"/09H L:[JALM)+VLD1N9W6WMRS@
M+YC< D^W+?05S^J>(;FX\ V>K6UW-97)FACE\M%<[O,$<B\@]]W('85OMX=L
M?M5JT<,$=G;JX6S2!!$6;'SXQUX_4^M43X/A:"]M?M]Q':75VEWY,"(@C92#
MM'RG@E5)]Q[F@!NB:S) U\FK7NVT%QLL;F]"P/.NT;AM(7.&R,XYJ+Q'XDDT
MO6+)8IHEM+:2,ZCO8#"2DHGY'YC[ >M=-/:6]T%%Q!%,%Z>8@;'YUDS>%=.N
MK748;H-<-?ES)-*B&1-R[?E.WC  QUQ@4 9>M:Y=Z-XQMF>X<Z284%U&P7;%
MO=E60'&>&4 \_P 7M3#K-_J'BF^B@O)(=.CT^8P"-5^>1&"%\D'HQ(';Y<\Y
MK6/A6UEBDCNKJZNEDLA9.9BA+("2&)"CYLGK2KX8MXK@307=S&5L38H@V%50
M\[L;<ELC.<T <Y;:[<WNE^%1#J>H^==W"+=3/:[!(#&[L QCV\%0!M[9Z]:W
MO%9U*#3)KVQU-K5K>(M%$D:-Y\I.%1BP/!.!@8.3UI@\(1IIFBV"7\XBTFX6
M>(E%W/MR%#<=@Q''6KFL: -8N+:8ZG?6IMR61;<QXW?WOF1N<'% &I;F4V\1
MG"B8H-X7H&QSC\:DJ.WB\BVBA\R23RT"[Y#EFP,9)[FI* "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ J&Z%R;9_LAB$^/D,H)4'WQS6//I.NR:^+R+Q
M,\6G"16.GBRB(*@#*^8?FY(//;-;4TRP0O*X<J@R0B%V_  $G\* ,;PCJ]UK
MWA'3]4N5C%S<1%F" A<Y(]_2H?!^LW^LVNJG4/)\ZTU.>S'DJ57;&0!U)/K4
M7P[AFM? .DV]S;S03Q1%7BFB9&4[CU# &H/ ,<T<.OF:VN8/.UJZGC$\#Q%X
MW8%6&X#(- '7T5A:[I&M:C<P2:5XDETI(U(>-;2.8.?7YJW$!5%#,6(&"Q'7
MWH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** #%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !BBBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
=BB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>exhibit1011-physiciansha012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5PK-^Z]L@?(W)XXJA8:-.WQE\4ZGJV@ZE)H6I6;VR2FPD<.3Y7\(4G^!N<4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%&<T %%&><=Z* "BBB@ HHHH **** "BBB@ HHHH
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M:SICO9ZY<3L4>!BI:2**=BG^ZSQ#@^M=K8>,H]4^']MXAM(U:YN8ECCMR?\
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MO(FU>S'"N5.5F _O \'U!SZT 4?BCH5KI/P\\0:M;O.NH%TE6X$S@INE0;5
M.  IQQ_6NUTSPW8:;J$>H62R0LUN8I(_-9D?)4AL$D C:>1_>-8WQ3TZ_P!9
M^'NIZ5IEE+=WET(UCCCP.DBL222 . :ZRSD,MG$YBDB)4920893Z&@"'5[&W
MU'2KBWNH]\;1MW((.#R".0?<5YS\/M?U#1QIWA;Q3,9UO[1+C2;^3D7",H+0
ML3_&N<>X_#/I=_(T=A.RQ22ML("1C+,<=!7*OX4A\3_#K3M'U.&:SN[>VA$<
MF,2VLZ( '4@]CZ'D4 <_K6LS>$_ MY+I(6+4=0UR?3[>9AN\LM<2*IY[*JG
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M[#6-.EBM]2U:ZF5)0,2P2@ '@G'0\=10!TESK4=KJ%E9M;3,UU%),70H5B1
MNYF^;./F4< \FJFF>)TU06,L.G70M+^%I[:YRA5E ! .&RK$'(!'KG!&*PO
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MTFPJ",Y_A.<#BNSH \=TC4=(N+F_\.^,6GTKQ;)-+Y>H2R-&90S'RV@E!&%
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MV2>G7G !Z;2;EW!<C<1D#/.*AOKN+3["YO9R1#;Q-*Y'95!)_05R.@:TUKX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %8GBH:E+HDEIIEG-<2W1$,CQ2(ABB8@.P+,/F"EL8[XZ5MT4
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MNDD%R0,#RU'(W'!^;&!D?3F9O#'B&3X4:MH(T>4:C<Z@\\<9GAP4:X$N2V_
M^48^M>K4WS(_-\K>OF;=VS/./7'I0!PT=CKNA>/]4UFUTB74-.UR&#S4CFB6
M6TEB7: 0S %2#U!/T]<"Q\+>+-/\,:1=VVG0#6-'U.YNELI+A2MS#,S[E#=%
M.UQ@GTKUJB@#S_Q#I7B3QCX0N5;3H=(O8Y8;BSM)9UD+/&^\[V7@ \  =,9/
M7 =)'XBUGQIX5UB;PY+8PV,=TEV)KJ)BC2*@!&UCN&1QW// XSWU,BECGC$D
M4BR(>C(<@_C0!A>./#TGBOP9J>BPS"&:YC'E.W0.K!US[94 ^U9%YIVK>+'\
M-C4]*DTXZ9>QW]T[RQL'DC5@%CVL206;.3C@>O%=J[K&C.[!4499F. !ZFE5
ME= Z,&5AD$'((H Y+P1IVI:;=>)#J&GR6R7VKRWL#-)&VZ-E10#M8X/R'\ZG
M\>^'[SQ%X:\C3I$2_MKB*\MA(<(TD;;@K>QY'Y5T]% ''S:;?>)/$_A[5;O3
M9M-ATGSIF2>2-F>5T"!5V,WRCYB2<9XXZXYFX\,^)/\ A7'B7PTFC[Y[FZN&
MMI5N8]LRR3;PV"1@ 9SG!SC /;U222.&,R2NJ(O5F. /QI#+&LJQ&11(P)5"
M>2!U('XB@#CM0TW5+WQSX9U)=+G6SL[6YBN7:6+,9E5 . ^3C:<XS^-9_A.U
M\8>'[*'PM-HMO+:VC&*WUG[2FSR,\$Q_>W@<8Z$XYQS7HE% '(^&].U*T\;>
M*[Z[T^2"TU&:"2VE:2-MPCB"'(5B1R,CCIZ53N?!,MYXPU?SPC>'-4@2>Y@S
MRUR%:/IZ%2K$_P!Y%KNJ* .4\#:-JFA>'-NL-]IU%!Y *$9:&+*1 $G'(&[D
M]7-<_HWAN^A^'.F>']<\,?;HQ=3"\MC-$62-FD=9$;>!D%D'!!Y.*]+HH \L
M_P"$0\3V.@6TVG/)<W.DZNUYIEEJ$X9VM2FPPM)D@$[GQR<# ^G<Z!=ZSJ"O
M<ZII"Z2FT*EL9UFD)[LS+P!T  ]R>U;#21HR*[JK.<*"<;CUP/7I3J .2\::
M;J.HWWAI["QDN4L=5CO+AED1=L:HZG&YAD_,/RIFGV&IVOQ$U_5I-,G-E=6E
MO%!(LD67:/?GC?D9W#&<>^*["B@#R?1O"'B'2]!\&WPT\_VGX?GN5GLC-'^^
MAG+!BC!MNX @@$CO6GK_ ()O/%]UK^H2QMITEYI"Z9:1S,I;(D,I=]A( +;1
M@$G /TKT6FI)'(7".K%&VMM.=IZX/H>10!YQ=P^*]:'A-KGPT]O<:5J"2WC-
M=P[& C=2R88DCG/(!Y P>2-G1+#4['QQXLU.?3)A:7_V8VS"2(F3RHRC#&[C
M)Z9Q^%=A10!YGI_A[7HO@O?^&Y=)D75)(KF)(_/B*L99'8'=OQ@!AG/ZU8OM
M-\2Z5JVB^(M*T@7[)IBZ=?Z:\Z1R* =RNC$E20<]^GZ>B4U9(W9U1U9D.& .
M2IZ\^E ' Z_I7B:^;0/$D&GPG4M+O'F.E+.N3#(FQE$API?'/IR1DXR9+*'Q
M"OC?6/$/_"/R1PSZ3''!#-=1!WE0NP0[2P!)(&<D#/7J!WE-=%EC:-U#(P(9
M3T(H S?#FJW&M:%;WUW8FQN7+I+;F02;&1RAPPX897((Z@UB2Z=JUI\3I=8@
MT_[3I]UID=LTJS(IB=)&8Y4G)R&XQWZXZUU:&&$I;1F-"$RD2X&%&!P/0<"I
M* /*)/#'B%_A1J6@C1Y1J-QJ#3QQF>'!0W(ESNWX^Z,?7\ZV+FV\3:#XTU#5
M],T(:OIVLQPM-!]ICBEM9D39_$<%2 ,X)Y'Y]_10!6L!="QB^VB(7)&Z18N5
M4DYV@\9 Z9P,XS@59HHH YC5[235_%%E:WVG,^CVL;S&5I8]KSD +E=V["J7
M[=6'IFL+5] GT?QWH>N^&=*$D:1R6VIK'/&@DA;!7&Y@2RL-WI[UV=SX?T6]
MN'N+O2+">=\;I);9&9L# R2,GBJDOA_PM!)''+H^C1O*<1J]M$"Y] ,<T <5
MK!U"3QAKMQI6BW-W;7-O#:7<FGZA!$9&"$E9!+_&%< %#P#USTFF2;4X_"#:
M1H-Q:V^BWY%Q:R30JUNJQM'M!+_-]X'()R.^>*V+[X4^#;_46OFT@02OC>+6
M9X4?ZJA _+%:T/A3PM;K':1Z'I(*)\J&VC+;1QGD9/UH P-=@UW1_&__  D.
MBZ?#K%I>6:6EY9BY2*1&1F*2*7."/G((J+7K3Q(UUH?B:QL[.XU&Q,R7&E"X
M50T$NWY5D. 778IST)SVQGJO^$5\._\ 0!TO_P  X_\ "C_A%?#O_0!TO_P#
MC_PH Y/Q5!K_ (E\"7EO_9$<%Y<S6YBLENHF:-4E1V9W)"Y.T\#../4XT+NV
MOI_B5I.L)8O]A@T^:WED,T65=V1@,;\G&T@X_6MP^%_#B@EM"TH =2;2/_"D
M'A?PXPR-"THY&>+2/_"@#@&\,Z_+I&LR6UO';:E'XD;6[!+B>,I.O ",58[2
M1NZ^HY].@FO/$&N^&-7CNM!3399;&6WBM/MD4LDLKK@'<"%51[G)R>!@9Z#_
M (17P[_T =+_ / ./_"C_A%?#O\ T =+_P# ./\ PH XY]*U8Z=X A&FN7T9
MXFO1]HA^0+ 8SCY_FY.>.WY5L>%['4M+\5>)5FM$-E?WOVR&Z6=2"#&J[=@^
M;(*]P![UL_\ "*^'?^@#I?\ X!Q_X5/:Z#H]C<+<6>DV%O,N0)(;9$89X/(&
M: -"N#C@O)?B/XD\0V-I]J-AI<>G01;P@N)LF9D#'@8R@)[$^QKNV7<A4DC(
MQD'!J"*QMH+/[)'"@@((*8R&SR<^I))))ZY.: *GA[5)M9T*VO[FS-G/(&$E
MN9 ^QE8J<,.&&1D$=00:TZ@MY[60-#;2PL(?D9(F!\OV('3Z5/0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !67X@UVV\/:7]MN5>3=+'!%$F-TDCL%51G@<GKV&:U*Y/XBPF[\*FS
MBM$N[JXN84MX/.\IV<.&S&W9PJLP)X&,G(!! )HO%D__  E$WAV;1;@WT5L+
MO=;S1M&T1R 07*'.X%<;>#[<UF:;\1GU'0O[='AO4ETK[-+.9U9'8LCE?+"
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MVC$!BXW;]Q[*NUB3Z#@$D"L;PIYG_"V/%QFL([.8VMF9%C8,KG]Y\X; SGW
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M@?=X.3V/&*T-$U)]8T>VU!K8VZW">8B%MQV'[I_$<_C7*^-]!FOO$6AW6G7
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M#H@ 65'))8CLIJ/4=/U.Z^(N@:M'ILOV&UM+B*>0R1Y1I-F.-V3C:<XS[9H
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M<B[#N5T8G:>2W?H?R[S2'OY;$3:E;QVT\C%OL\;A_)7LI8<,>,DCC)P,@9H
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M2F3&-P.,'&<=?;F@":T\>Z?=^&M/U8Q&"6^G:VCMIY%0K*A8.&;H -C'/H.
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M:):EHGSNB&",XP#SWQD>M=!5733*=-MQ/;O!*(U#1N5)4@>JDC]:M4 %%%%
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M%#?@"3^% '1B>$[L2QG:^QOF'#<<'WY''O3@ZEF4,-R_>&>17.7_ (<ODN-
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MK'&XJ-K#:001Z53LO'][/'X:O+K0A;Z;KK1Q1S?:P[QRNA=04V\J<$9SGV%
M'<T5QFM>.;C1(+V^GT@II]I?)9EIYC'+-DJ#)$A7#*"_'S<[3TQ6I=^(I?\
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M.Z78%()((Y'(QC@<UVM% 'F%MX3\1Q>!O".D2V5N;K2-2M[F8)<@@Q1$DX)
M^8YX'3WKI(]*U(?$V;73:#[ ^DK9 ^8N_>)&?.WTYQUZ^U=710!YS!X*U#4_
M"_B_0]3B6U&LZA/>6\R2!P@<J4# <Y!49 XQWK0FT;6O$D'A^UUJSCM3I=Y%
M>74RS!UGDB4[1&!S@L03NP0!CG.:[:B@#D_"FEZGI6I>)9[RS"QZA?M>6^R5
M6)4HJ[3Z'Y?ISUKFAX0\0#X5)X;^Q1?;UOOM!/GKY>W[5Y_7KG''3K7J-% '
M(2Z1J\OQ&.MQ6ZPVK:,UBLC2*624R;PQ7NHZ=>OMS7-6GA7Q6(?#4D^FZ?\
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M-^39^L:TUM%U/1?'VH:_I]L+ZRU6WBCNX%D5)(Y8@0CKN(!4J<$9![\UV%%
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M_B>Q\3:KX9NDL6B@O))(BMJLQ4-$K NAE R&<9!(X'3U)ZRB@#AM%T36M/\
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M9CLD#JP>1G&#]&Q^% '45R7C?4Y8I=#T.!V236;];>1U.&$"@O+@]B0-N?\
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M=+>Y24, ?O#!SCD=1784 <AX2U!H/$?B/PNQ)BTN:*6TS_#!,FX)]%8,!Z#
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M>,;6[%ENL8[*6W>0R+DL[QM]W^Z ASWYZ5@>'/!%SX6T_6XHG-XLC2PZ7!N
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MZ7I\4^E22B^D-X7>Y9XBC3,VW))/."2><<4 :_@B*.'Q?XYCBC6-!J,)"J,
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M;8MVDH'FY8=&) (["KVOZ?XF\2> M8L[FRMK>_OX?)ALX[@.D([LTA R3[#
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M_P!IB<''&*MZWH7B"]\3:K(MM9WMA=V @LI+B<K]A?:P<A-IR6R#D8/ &0*
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MQP-A8 YW87GN:T;OQ1J.B7^BC6K.V2SU:=;57MW8M;3L,HC9'S@X(W#&".E
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M>F6X^7L&ZG&* /3?[.L?^?.W_P"_2_X56O5T;3H//O([."/. 711DXS@<<G
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MD1D).&&"58@_@1R*S-*TC2?#5N+2Q7[-%<3%ECDG=]\ARQQO8\GDG'7DUJ@
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MH 6YU.PLYXH+J^MH)IB!''+*JLY)P, GGFK5<-\3_#X\3Z7I.DAS'--?.89
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MX[J)[RW17E@# NBMG:2.V<&N&U#Q-K%_K?@233!;PV>L127+12LV2?LY8*Q
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MO<6DSR&%V=70$,B]&0=#S6Q8Z9XKUG3+C3O%<FF16\EM);N=.9V:X+J4+'<
M%&"3@9YQT P>PHH \Q?PEXQE\):7X=F_LAUTJ[MGAO/M$@,T4+ J&39\IV@
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M3S+T+*7'F?)\A"D+_%P !C'/3VNAZQ!\0+[7I%L6M9]/CM%"S.'WHS-DKLP
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M&<JX]0>XJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-\;$8QL(Q@'ZD=JZ!=%U"_\ $UMXAU"WMH9[&TD@M;6.<N"\A&]F?8,#"@
M'J3[5SDVAZAX:^ ^KZ-J7V9I[73;I=]O(S*P.]@>5!'7% %\>-M:LM5T$ZOH
MUM!I.MND$$\-P7DBF9<J)%P!\W.,$X]:LR^,=0N-"U/Q!I-C;W&FZ?+*OENY
M$MRD1(D=".%Y#8!!SCJ,U'::+J'B#3_"O]HQ6T%GIC0WI,4I=II$CQ& "HVK
MEMQZG@#WJ&P\)ZWHNCZUX>L&LY=,OI)GM;B65E>U6;.Y60*=^TDD<C/0XZT
M277C?4KO5]*LM TVTNH]5TQ[^TFN+AD' 4@. IV_>[9Y].32:[XRUG0],U&^
MN]-L[5=/@BD*3S'%Y(4#2)"W'"],D')["I;;PC>Z9XI\/7%@MJ=*TG36T_\
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MAZ1J L'?4[>9YHK96W64T:JQC9M[*_4@XP<C/0UEZ<!_9?Q1'_3W<_\ I,E
M'HUG>0:A8V][:R"6VN(UEB< C<C#(//J"*GK!\#_ /)/_#?_ &"[7_T4M;U
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M&JD* 3@L<L23@=ACC)[*B@#DXO#FHZBVB+K;6:P:/(L\:6KLWGS*A5';<!M
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MK6TBQ\8>0_\ ;VH:9/)%$4A2S1XUE8C&^4G/;^%1C)SZ8ZFB@#AK7P=J=O\
M"=_![3VAN3:/:"X!;9M;/S8QG(ST_6K-SX:U6XU'PG=![(?V('\U?,;]Z6B,
M?R_+QQSS]/>NPHH XV'PYKUIK/B74[2YL8Y=5FMI80Q=A'Y052K<#(90>G3/
M?K5GP]X4&D>(]4UE;>UL?M\4:/9V;$QEU+$R$E5^8[L< =.Y-=310!SWC+0+
MGQ#HT,-C/%#>VMW#>6[3 F,O&X8!L<X/(XK*3PSXC?Q/?:[)J5A%/<Z1]A5(
MHG/E2!G92"3T!8')R3SP.*[:B@#B#X%&I:[+JFI6]E:27&G36-X-/9O],\S
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M<?\ UP">7X@ZM!X?2^ET#9<)JR:;,LC/&KAG"K+%N4;E8'C.,>]7E\2^(_\
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M4?V=HMPE,F#OW \ 9QC% &C1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!1U31]-UNT^RZI86]Y!G<(YXPX!]1GH?>
MFZ5H6E:'$\6EZ?;6BN07\F,*6QTR>I_&M"B@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *I:IH^FZW:&TU2
MQM[RWSN\N>,. ?49Z'WJ[10!GZ5H6DZ'$\>EZ=;6BOC?Y,84MCID]3^-:%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^'_$EQX*?419V4>K6MU_;:2"X<RK*OS;-NS!P@$>,_PBKOC'5++Q#X-\*:]
MJ&*;5["97."8@9!N&>V#D'Z5Z&]E;2V1LI(5:V9=AC/(*^GTK.3PKH$>CS:0
MFD6:Z;-S):K$!&QSG.WIG/.: .801?\ "Y]62UDBBF;P]'O=<?*_G/RWN!MZ
M]L5SVC^'W\1^&_!]M]CA>:RO?/O;YG1TN81OWD'.Y_-)4\CW.,"O09O"VGV=
MI-+H>G:?::HEHUO:7#0 B+[Q Z9QN8D^N3G-<59_#Z*YMH[6?P/I>F7:H$.I
MP7F2C 8\Q JABV>1G'/4T 6[*&R@\6_$J&6.".W-O:.R, %Q]G;)(Z=?UK,T
MBSU2Y\#^"+O1387EY:Z8['2[WA+J,B,,5;HKJ< $_P!\]B:]'N_#6B7^IIJ5
MWI=K/?(GEK.\8+[?3/\ +TIB^%-!CAM8H=*MH4M PM_)3RS%NQNVE<$9P,^N
M.: /.'.CZROP^N(M'2U@;4[B![6YC5C$564-%G&"H<''T%>MJ\4=N'5D6%5R
M&! 4+C\L8JA<^'=&O=/@T^YTJSFL[=@\,#PJ41AT('8\G\S5VYM+:\LY;.Y@
MCFMI4,<D3J"K*1@@CTH XK6K'4--^(F@:M8:G<W"ZA*]G<V,I5D6$(S[TP!M
M"E1D]R5_&;QK_P C9X'_ .PI)_Z(DKH]+T#2=%7;INGP6V%V HO(7^[GKCVZ
M4^^T33-2N8+F]L8;B:W.89)%R8SZJ>Q]Q0!9DN[:&XAMY;B))YL^5$S@-)CD
M[1U./:BZNH+*UENKJ9(8(E+R2.<!0.I)K,U;P[::OJVF7\\$/FZ?)YL<Q7,@
M/!VJ>P) SZ@8[U>U+2[#6+-K/4K.&[MF(+13(&4D=,@T 8.G265_X@&MW5S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*/GW/@]"0. 221QC)%WPKXI7Q(NH1M;"WN;"X,$HCE\V)^,J\;X&Y2/8$8H
MZ&BH;N66"SFEAC221$+*COL#8[9P<?E7)1^/3)X:\-:VNF?N=:NX+4QFX^:
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M> #B@#NZ*Y*;QE<:?_8]SJNE+:Z=JLJ0Q3I<;WADD&8Q*NT 9Z9#, ?SKK:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M73-0%Q)#)+Y>Y"C(<-@\C<#4&G:9J]KXV\0:O-8;H+ZTMXHO+F4DO$&SP2,
MEN/ISBNBL=<TK4[F:WL=1MKF:$!I(XI0S*#T.!V/KTJ_0!Y7I_A#Q3HOAOPI
M=:?!;-K.@K-!-9RS 1W4,I&X*XZ'A2,XYS^/H&B2:Q<6[W.L6T-G+(1LLX9?
M-$2CU? W,?88  ]R=2B@!DJ>;$\9. RE<_6O*[?PMXM3PCX<T(Z99*VB:G;S
M&9KSBX2)RVX +E01CKDY[5Z9J&IV&DVIN=1O(+2 ''F3R!!GTR>_M5N@#B[+
M2=7MO%7BW4I+#,&IP6Z6VV9"2T<;*<Y(P"6X]ASCI6!I_A'Q'HMAX/U&TM(9
MM1T2WDLKNR:<*)XGQ\R/T!! /.,_S]3HH \SNO!NO:Y/XT^U16^G+K*VDEI(
M+CS&CEA52NX!>FY1G\<9ZUT>A7GC&Y"G7=(L[+[.AW_9KH2F[?&!M! $:]^2
M3G Z9KJ:* .'\+:-K>A_#*#1I=/MI=1M]RF"256BG1I2S#/H48CD=?6JVD^$
M+C1YM?DTBPEL--OK+RXM*>=2OVD[MTB@,51<%1P>>>!@5Z#5:RU"SU&.22RN
MH;A(I6A=HG#!74X93CN/2@#S:[TO5++PEX-T!=/M[C6K%E?R/M8BD AC(,D<
M@! &2@.1R&QCG(MPQZI/IGB'1I_"[V.K:O932"=K^.X%P^T19=AC;MWI@8Q@
M' XKLM:\-Z1XA$']J62SO 2890S))&3UVNI##/L:9!:Z'X4M@P:*S2:1(O.N
M)BS2.3A5+N2S')X!/>@#F)- UEK?P*@L/FT1D-Y^^3M"8CMYYY.>W'O3=(TW
MQEX9O+[1["RL+S2+BZEN+2^EN=C6BR,797CP2^"21@C/<C/'H-% '#6NCZ_X
M=\;:O?6%I%J6FZSY4CE[@1/;S(FPD\<JPYXY'IZZ'P[T?4_#_@FQTO5888KF
M R<12[P0TC,,\#!^;MGZUU-% &?KB7<FCSI96L%U.VT?9YR DJ;AO4D@CE=P
MZ5P'_"N)9K+Q%9:6LNB:;J-O$;>RDE#K%=H^_P Q0I8(O"# /// P*]/HH Y
M#35\6:[8RZ?XDTZSTZ$P/#/+;7/FFY+*5RJ[?D7G=R2<@#IFJGA2#QOIMI9Z
M!J5G8?9+$+&-5CN<F:%,!5$6W(8@ $DX')Y-=U10!Y0/!6OVVHZKX@TZU2WU
MW^UGN[-FF79/;.$5H9L'IA2>^#C!KU&UEFFM8Y+BW-O,1\\18-M/ID<$5-51
M=4L'U-M,6\@:^6/S6MA(#(J9 W%>H&2/SH Q/'FC7^M^'4ATU(Y+J"\M[I(I
M'V"3RY Q7=VR :H#2-9TWQNWB:"R2YBU"R2WOK.*9=\3H24=&?:K#!((R/49
MZ5VM% '.^$] ET9=5N[K8+O5+Z2]E1#D1@X"IGOA5&3ZDUI:[!J%UH&H6^E7
M"V^H26[I;3-T20J=I_.M"LZ/Q!HTMT]M'J]@]PAP\2W*%E.<8(SD<T </IOA
MWQ##X@\+ZF=%LK5+&VGAO%%YOD9G5,R$[?F)*GJ23W(J*3PIKTOPZ\4:']A5
M;W4[ZXG@_?IL"2R;QN.>"!P>/3'MZ''J=A-J,NG17D#WL2;Y+=9 71<XR1U'
MXU;H X[4-*U6\\8>$]42P*VVFQ7"W.Z5-P,J*HVC/."O/MTSTK.\,:9XS\-V
MX\,):6,VE0R,MKJQN</%"6) ,6T[G .!R!TSGOZ%10!Q%MHVK0>(/&EZU@3#
MJT<*VF)4R2D1C.[GC).1UX]^*QK'PIXCT6'PCJEG9PSWVD6+:=>V33JOG1D#
MYHWZ9!&<'&?:O1M0U*QTJS>[U"[@M+9/O2SR!%'XFK*L'4,IRI&01WH Y'PM
MI6M6GBSQ-J>HV=O;V^IR020A+CS&&R)4((VX[>O7U'-=?150ZG8+J:Z:;R#[
M<R&06WF#S"HZMMZXYZT >=3^$O$?_" ^)?#2V5L[7EU</:S"Y'SK)+O!8$?+
M@9!ZG/MS6]?:3JEYXS\,:H+ K:V%M<17.Z5-P,JH!@ \@;>?KQFNHU#4K'2;
M-KO4;R"TMT^]+/($4?B:L@A@"#D'D&@#S_PMIOC3PY:Q^&/LEC-I=NQ2VU<W
M.'2#.0#%M.7 .!R!TZXY]!HHH YW6]/N=7US3;:XTU+C182TT_F,A#RXP@*'
MJHRQ/N%P.*PO$OA":UU_P_K/A/1[.&[L+AOM(CV0++;NN'0X'+=,9&!S7?T4
M >;ZV-7NO'%U>:)I"7CP6,=I<F#4EM949B7,<F596PI4C&"NX\\\,FL+_5M"
MT*PTWPY_9K:#K-O)/9FZ1E1(E#X1P?F)$@ZXYSFNDU'PYX4U'Q)FZCC36IH?
M-8073P2RQJ0NY@C L!P,G-:TLVD>&M*#336NG6$/\4CB- 3SU/4GGW)H YSQ
M+I?B&V\4V/BCP[;07LJVILKS3[B;RO,C+;U*OR P;/7M4.O:-XJU&UTG7+5;
M*/7M.NFN([%I28C$Z;&A\S R2.=V,9)[8-=R"& (.0>12T <)XAL/%/BCP'K
M%G<Z;;6EY?0B""R2Z$@CYR7>3 '/H <8'J<6M0TO5;OQ?X3U-+ BWTV*X6YW
M2IN!EC51M&><$9/MTS78T4 >:7?@S6]2B\5A%2QN;W48-1TV=W5@KQ!-H<#.
M,E/?@^V*Z#3[CQ=J-A<?VQH]I8,D#((;>Z$IN9", Y( 1!SQDGGVYZNB@#S1
M/"^NQ^"?!ND_8%-UHU_;7%S^_3:4B)SM.>2<\ X[YQ6_I.D:MIWC_7]0-O V
MFZJ+>03>=AXS'%L*[,<DG!SG&/RKK** "O/YO!VI7UYXTTZX2%-,U[$D=VLN
M71O*5,;,=F4'KC%>@44 <$^@ZWKVA:'HFLV26_\ 9]Q!+=W2S*Z3B'D>6!\W
MS$#.X+@$]:[VBB@#B=>TGQ!I_C>'Q1X?M(-06:S%C>6,L_DD@.6216((R,D$
M'M]>#Q-I&OZQHVCJUO#+>PZK;W\\<<H$<4<;[MBLV"QQ@9P,G)X&!7;44 ><
M>(/#GB75;SQ3$;*TNX-1LO*TZXGN,&T!B*M&$P<$L2=P/.>3P!5JVT371XB\
M(7UQI\:QZ982VUUY=PK89U0#;G&<;.>G7C/?LDU.PDU)]-CO('OHT\Q[=9 9
M%7(&2O4#D=:MT <H^E:C_P +177!:9T\:2;'?YB[O,,HDSMS]W QZY[8YIO@
M[3-2TJ^\12:A:"&+4-3DO87$JMA"JJ V#P?ESW'/6NMJAK=GIFH:-=6FL")M
M/F3;.)7V*5]VR,?G0!ROA;P]]A\::]-#<!]*M[AGM( .(9YE5I\?3"XQT\QA
MZUW-8NA3^'+2TATK0[K3Q#$"(X+:=6([DX!))ZDFMJ@#D]:TC5F\>:+KFGV\
M$\$%K/:SK)-L,>\H0XX.X?*>*Q1X;UL^'/'5B; ";7+FXEM/WR8"R1*@W\\$
M;<G&:]&HH \[DT7Q3HVJ:5KVC6%O>2C2XM.U#3IKD1$^625=).1P2W7L>F>G
M;Z7_ &@;(2:H(4NI"6:*%MR1#L@8@%L=SCDYZ# J[5:'4+.XOKFRANH9+JUV
M&>%7!:+<,KN';(&10!E^,=!E\2^%+W2[>X%O<R!'@E/1)$<.A/MN49JGHE[X
MQN8]VM:/9V9MXSE;>[$INY,8&,@"->_))Z=LYZFB@#S]_#^OV6NZ9XGL(/,U
M6YS'K5LTZB-XL?*$YQE#@*>XSD@DU:?PWJ4GC'Q%,\$1TK7;&&"2;SL20E$=
M2-N/F)W]<X'Z5VU% '#>%(?&^GVMGH.IV=@+6Q"Q_P!JQW.XSQ)C:HBVY#$
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M444 %%%% !1110 4444 %%%% !63K^MKHL%H%B$UU>W26EM$6VAI&R>3@X4
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M6;W+B&Z21G9<MY><H7! *D9&>PH NR_$6Y3P9XAUF&QM+F?1;I[=Q'<D13*
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MX<AUD2-<JY Z#?P.Y&3BKL7BZ"RUGQB=1T^"UBT2&":6XA;>]PK(S#/RCD
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M5<W!GD@# -O+[5+$J@8\D*"%!/IT'2MR@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL;Q'X@@\.
MV=M--Y8-S=):QM-)Y<:LV3EVP=HX/;K@=Z -FD9@JEF(  R2>U<IJWBV_P!$
MTE[^\T>/"7\5H1'=DAUD*!9$.SD9?!''W3S5R37!/XRD\+7-A&\;Z<;T3&3<
M'42!"K(5]3GJ: -NWN8+R!9[:>.>%L[9(G#*<'!P1QU%2UX[X,\87WA7X7Z!
M>7.@R2:#&OEW-^MPN^(-*PWB+&2H) SD'VQU[J;Q9+)JVJZ?IMG!=SZ88Q-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&<JS% 67\ X!]\BO'OAK8:II/B77_AU<1N^FVMXMX9FZ>3U"_P#;3$7'IYE
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MO$%[_P +$NM GCMELH],6^21<[\F0IAB3C'RD]._6LGXGV=I<Q^%S<VT,O\
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M%^M7/AWPIJ.L6EM%<26<)E\N60H"!UY /Y<?45J6<YN;&WG8 -+&KD#H,C-
M&=X8\/V_AG1$TZV5%7S))6$:[4#.Q8A1V49P!Z 5L444 9>K^&]&U\1C5]-M
M[U8^46==RJ?4 \9]ZM?V;:?V?]@\G_1=NSR]QQM].O3VJU10!C:?X4T'2K>>
MWT[2[>TAG&)8X!L5_J!]*2P\):!I5O/!I^E6]I#.,2QP#8K_ % ZUM44 <[#
MX#\*VT,D,&@V,44GWT2/:&^H'6K$WA'P]/I,&E2Z1:/IT!)BM3'^[4DDY"],
MY)_.MJB@#+E\-Z+/HPT>;3;:735QMMI$W(N.F >F,=JJW'@GPS=VEO:7.BVD
MUM;#$$,B;DB'^R#P/PK4U#4;72[3[3>2B.+>D8)[LS!5 ]R2!5J@#$C\(>'H
MKRWNTTBU^T6S;H92F6C/JI/2G-X3T!M6_M9M+MSJ.<_:\?O>F/O=>G'TK9HH
M *PI?!GAR8S;M)MPD[;YHDRL<K>KH"%8_4&MVB@"G<Z3I]WIO]FS6D36.W9]
MG"X3;C&W:.,8[=*KV/AO1=-TZ;3[+3;:"RG!66W1/W; C!RO3GO5O4+^VTK3
MKB_O95BMK>-I)7;HJ@9-6%8.@8=",B@#"7P3X9337TU=%M%L7?>]L$Q&S>I7
MH3P*C;P'X5>U6U?0;%K=?NQ&/*#Z#I6KJKZE'8EM)AMIKO>@"7+E$V[AN.0"
M<[<XJ[0!SUQX4L;GQE9^(6M;:.XM$8+,B?O925* ,?[H5FXYSD=-O/0T44 9
M^K:%I>O0+!JMC#>0J=PCF7<N?7'3-5;3PAX<L+F&YMM$L8YX %AD\E2T8'0*
M3]W\*KZIX@N]/\9Z!HJVL+6VJ+<$SF0[T,2;L;<8YR.<GOQ6OJ;WR:9<-ID4
M$M\$)@2=BJ,W8,1R!0!0U'PEX?U:^6^U'2;6ZNDQLFF3<RX.1@GISZ5)9^%]
M#T_41J-II=M%>A"GGJGS[3U&>N*TXC(8D,H42;1O"G(![X/I3Z "J&K:)IFN
MVPMM5LHKR '/E3#<N?7'0U))J-M'J<6FF5?MDT+SI%GDHI4$GT&745D>$O$%
MUX@CU<W=K#;R6&IS6(6)RX(0+\V2!UR>PH UK+2[+3K 6%G;K!:J-JQ1DA5'
MH/0?2JFF>%M"T6[DNM,TNVM)Y?\ 6/"NTO\ [V.O4]:M7#ZD-5LDMX;9M/99
M/M4CN1(AP-FP8P<G.<FKM !3)H4N(6BD&48889(R/PI]<Y-XPLH/'MMX493Y
M\]J\ZR_P[UP?+_WMN6^F/6@"[I'AG1- :0Z3IEO9>9]\0)L#?4#@U!!X,\-V
ML5U%;:-:0178Q<1Q)L64>C <$<GKZUNT4 <ZG@/PK':M;)H-BMNYRT2QX0_4
M=*N2^%]"FBM8Y-*M2MI&(K;]V 8%&.$/5>@Y&.E:U% %+3](L-+:9[.V6.28
M@RRDEI)".!N<Y9L=LGBJMWX8T6]O7O9K",7<B[))XB8WD7T9E(+#V.:UZP?&
M>N77AKPEJ&LVEM%<R6D?F>7+(4!'X Y^G'UH T;+2=/TW3Q86-G#:V@!Q% O
MECGKT[^]9EOX%\+6C2-;:%90M)]\QQ[2WUQUK<@D,MO%(0 70,0/<5)0!1TK
M1M-T.U:VTNR@LX&<R-'"@4%CC)/OP/RJ=+.VBO)KM($6XF54EE ^9PN=H)[X
MW'\ZGHH S=7\/Z3K\21:M807L2'<L<Z[E!]<'C/)YJF/!7AD&W/]B69^SL&A
M!CR(R.A4=L5M3SQ6MO)<3R+'#$I=W<X"J!DDGTIMI=17UE!=P$F&>-94)&"5
M89'Z&@#*O/"'A[4-1_M&\TBUGO1TN)$W./H>HZU?T[2-.TB)X].L+:T1VW.(
M(@FX^IQU/N:LS316\$D\TBQQ1J7=W. J@9))]*YG5_%DMG-X8>RMHIK+6[F.
M'SG<JZ*Z%P0N/0=S^% %_1?#EIHVHZI?6T$,#ZA*))(X00I(+'<?5B6))X[#
MMD[5%% %"[T/2[[4;?4+JPMYKRV!6&=T!>,'T/Z^U5?^$2T#^S[BP_LJW^QW
M$GFS08^21^NYAT)SZ^U;-% &/-X5T"XO8KV?2+26YBB\E)9(PS!.PR>N.V>E
M(?"7AYM-M=.;1K(V=H_F00F$%8V]0/7D_6MFJU_/-;:?<3V\22S1QLZI(Y16
M(&<$@''Y4 6<8&!4%Y9V^H6<MI=Q+-;RJ5DC;HRGJ#ZCVK-\):U)XB\)Z9K$
MT20R7D"RM&A)"Y[#-;- &3_PC&BC[#_Q+H?] &+3K^X_W/[OIQ4]GHNG6%]<
MWMK:1Q75U@SRKG=*1TW'OCMGI5^J6HOJ2?9/[-AMI=UR@N?/<KMAYW,N <L.
M, \4 7:R=;\,:'XC$(UG2[:]\DYC,R9*^N#UQ[5K44 4+S1-+O\ 3XK"YL()
M+6$J8HM@ B*_=*8^Z1V(QBF'0-*;39M/:QB:TG),T;9/FD\$N3RW0=<]*TJ*
M ,H^&M&9K)C81%K 8M"<_N!_L<_+QQQVXI;;PYI%I<+-!8QHR2-*@!.U9#G+
MA<X#')RP&>3ZU1\9^(+OPSHL>H6MK#< W,,#B20KM$CJF0 .?O=,BNBH SK;
M0=*M)[R:"QA22]_X^FQGSNWSY^]QQS5"V\#>%K1H6@T&Q4PR&2+,08(WJ >G
M7\*Z"B@#%N/"'AV[UQ-:N-&LI-20@K<M$"V1T)]2.Q/(Q5J+1--@U:758K.-
M;^5=LEP,[W'H3W'M6A10!@R^"O#$[WC2Z%8.UXXDN"81^\;(;)_$ GU(YJZ^
M@:1)J4&HMIMM]M@B\F*<1@.B?W0>PY./3)K1HH S+;P[H]G975G!IMNMK=DM
M<0[,I*3U+ \$GOZTZPT'3-,5A9VBQ%HQ$6W$L$'10Q.0H[ <"M&B@#%_X1'P
M_P#V8VF_V3;?86?S#;;?W9;.<[>F<\_6MA$6.-47.U1@9.>*=7*)XCU?5+F[
MDT.QMKFUL=2-A<1S2%)'V[?,=3T&TM]T]=IY' H ZL@$$$9![5E6'AO1M,G6
M6RTZ&!D+&,*/EC+?>V+T3/?:!FM6N3LO%.HW5UXKMVL+83:*ZK$HG;;*#'YF
M2VWC@CM_C0!MQZ%I<.K2:K'9QK?RC;)<#.]QZ$]Q[=*T:R/"NL2>(/"NEZO-
M$D4EY;I,T:'(4D9P,UKT 4]3TK3]9LC9ZE9PW5N6#&.5=PR#D'ZU!'X=TB*^
M^W16$,=UY/D"6,%6$8Z(".BCTZ"M.B@#('A705TB;21I-K_9TS%I+8QYC)SG
M./7/.?6I]'T/2_#]B++2;&"SMMQ;RX5P"3W/J?<UH44 %9[:'IKZJ=4-HGV\
MQ^4;@9#[/[N?3OCUK0HH QO^$3T#^SIM._LJW^Q3OYDMOM^1VSG)7H3GFG7O
MA?0]1DLY+W2[>X>S&V!I5W%!Z<]1['BM>B@#'_X130#IEQIW]CV?V.YD\V:+
MRAB1\YW-ZG/.:6]\+:#J!LC=Z3:2_8AMM@T0Q&O]T#TX''2M>B@#$D\'>');
M&2RDT6R:WDG^TNGE#YI<D[R>N[D\^]/3PKH$9NS'I%G&;R-8;C9$%\Q ,!3C
M^'  QTK8HH KV-C:Z;9QV=E"L%O$-L<2?=0>@'8>U6*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *X;XJ(Q\,V;I//"XU.T4-%*5X:50<@<'CU!KN:X[XDZ7>ZUX<@L++3Y;UC?
M6\LB(RKB-) S9+,.P- &.="B\/\ Q3TRTTE[I++6+"Y.HP?:9&YCV[9<EB0Q
M+XSG^9KF--@;2/@>?%]DUU)KL5G-"EPT[L41K@JQ"YQ\HRV<=<FO7;30["W,
MD\<4XGGB$;RRW$CRA.NT.S%E&23@'KS1IGA[2M'TEM*L;14L&# V[,TB8;.X
M88G@Y.1[F@#CO$%I#H6I>#M2\.#RWN]1BLYQ$>+NWD1BS/\ WR NX,<GKS7/
MMHUI=^%OB3+<-<RR6%_=R6K/<R$PND",K YZ@XY/;BO3=-\,:1I+PO9VKK]G
M4K ))Y)%@!ZB,.Q"#''RXXXJ-/".B):ZC;+:R"'4F9[Q/M,N)BPPQ;YNXX/J
M.* .(-LMGK'P]UB*2?\ M#4CY=[.\S,9U:V+$,"<$;@"!T':I;6UN9M7^)6G
MV>HO:2O);1V\\TK,(F> 'J22 6;MTSQ79OX4T9QIP:VD(TW'V/\ TF7]S@8&
M/F]./IQTH/A+1&?4F:S9CJ8 O-T\A\['3.6[ 8&.@XH \ZN/$%UHVD^)T;0C
MH7B2VTM92EJ0]O+$'*^?%CN-YSGG@9SCCH['P_%#K.D>(+'7;*WMY87C,=G;
M,JWZLA96<F1MS+@MN()X.3756V@Z;:O,ZP-*\T0AD>YE>=FC&?DRY)V\GCIS
M5#1? WAKP[<33Z5I45M),I5B'9L*>H7<3M!]%Q0!R'A66;2/$>C:3K^EHFH2
M12+9ZS9OOAU(!-S&3N'VC=\V><XZ\]1XWEM/LNE6MS+<%[G48DBM82 +MAD^
M7(3QY?&6]E[]#HZ?X9TG2WMGM;9P;5"EN))Y)!"I&"$#,0O''&...E3:SH.F
M>(;6.VU2U6XBBE6:/YF5D<=&5E((/)Z&@#RZ=9H?#OQ0L2?LT=F/.@@M9F$<
M#&V#D(1CC/)& "<\5IPV$.D^+O %U:-,L^HV\T5X[2LWGJ+<. V3CAAD8Z=J
MZX^!O#6+X#2HT^WHL=UL=U\U0,8.#W &?7OFK+>%M(:;3IFMY#)IH(LV-S)F
M$$8./F]..>W'2@#S"Z^S>*/@SXEU[48UEU8M=EW8_/;%'(2)3U50@7Y>^3G.
M37K.GLR:#:NB[V%JA5?4[1Q63=^ O#-[<WT\^EJ6O_\ CZ1)I$28_P!YD5@I
M;_:QGWK>M+2"QM(K6UB6*")0J(O10* /.O"MKIOB?P5HOB2\OY8=4CN1<7%[
M"P$IE#D- Q()V'.W9Z;<"I-%M[?Q@GC'^V1F\MM3GM(7)P]I$BKY;1G^#NV1
MU)KI[;P/X:M-=?6K?288[]W,C2 MMW_WPF=H;W S5B[\+:->W\]]-:,+BX01
MW#1321B=1P!(JL XQQ\P/''2@#S<W-]+X \'^/=01I+W361[_(_U]LQ*%R/X
MB 5D![<FMGQ)J!LO"FJ>)[:18$U"\MXOM2@_N[/S4C+@@@X8;FR"#AUYX%=_
M/86MSITFGS0(UG)$87AQA2A&"N!T&.*;)IME-IATV6UB>R,7DF!ERA3&-N/3
M% '&+X72RU:>_AU>WAMKW3Y(VL-/@:!)\?,)@1(<,,@;AU! SS7(Z;91VG@O
MX<ZY%)/_ &G-J-G;R7#3,2T4A8,F,XVD=L>_7->E:1X'\.:#;7-OI>FBV2Y3
M9*5ED+%?[H8L2H]@0*?_ ,(9H/\ 9UCI_P!B<6EC*)K6(7$H$3C[K+\W!';T
M[4 >=>.)8Y/#_C'5M-:2>XL;U%.H3R;7M)4,8\J# SM&>22!EC][FNAU#2[;
M4OC(+2Z:>2UE\/N\D'GN$<_:%'(STQC@<''-;]UX#\,7LU_+<Z3%(U__ ,?(
M+OB0_P![&<!O]H8/O5N+POH]OJ4>HPVK1W<=O]F21)Y!MBSG;@-C&>?KSUH
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MDOA\220&=]C-Y^WD9Z8 XZ<5T7_"#>&AI;Z8NEHEE)-]H:%)'4%]VX'ANQY
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,Z=K-O@)=PARH/W&Z,OX,"/PJ'Q?XA/A7PQ>ZT+)[P6J[FB60)QG&<GZ^AH
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MJM(%.U6;:">P)P<?7!K@/#7C:^_X0I]<UV")FDO9;>W2WF+-+(;AHTB *@
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MP]B.M<OJ^MOJD&O:?I^F0ZA#81F*[,TVQ6D*;C&@VL&8 @G.T9(&>N#X8_\
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MCP;X4N/#EYJBS2*]DMPZZ7&/^6,#MYC#V^=B/H@KKZ* *NI)<2:5>):$K<M
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MH2PL;QY(8FEEE;)=@_NQ.#GC(Z5S,.G:WIOPAN/#>NV%M+= "QLA/< K<AG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[R;6;6>=(Y64!I9P60@'!"@[0#_=J[;:99'XWZC*;=/,_L>"?=WW^:XW?7
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MY/RKSU&.#71Z1HMI_P )GXP\-H9TTR:SM9A%YS$QR.) SJ220QV@Y]171Q>
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MR5&/E6Z( _ 5[E7.R>!?#<MI?VK::/L]_*9;F-9I KL3N/ ;@$\D# ) XXH
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M% 'I55KK4+6SN+2">54ENY3% G=V"LQ _!2:L*RL,J01G'!K@?&VG6=WX_\
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M(U6"S@N[0F&R=)+:..5XEB9/ND!"!D=O2M1%"(J#)"C W$D_F>33J* .>O?
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M=_KSUK3CGBEA25'!1U#*?4'H:>74,%+#<>0,\T 9=AX=TS39X9K>&4R01F*
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MX0L/+\[X?:C90>99WPOI5"91K4XE7D_>(D(CY_A!KU2ZL[:]2-+J!)5CD29
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MC)R>%K"T_3].'QGUR9[.U$BZ=:RHYB7(<O("P./O'@9Z]*XF/3+.+X06^NK
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MLM/ADBMK=464YE)RS2'&,LQR6...2>*RK?P-X6M4B2'0K)4BF$Z*8\A7&<$
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MB\J:5XP3(N-N#^'&>N.*=#X6T.VGLYX--ABELD\NV:/*^4O<+CH#W]>]:]%
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M(G4,CHP*L#T((ZBGUP'AKQ+;Z1X(\):>'M?MMQI$4JBZN1!&J*B EGP>[
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MSA N/O?+Z_Q+ZUF67CJ*?Q/9:)<06P:_B=[>:SO%N &099),*-C8Y'4'!YH
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MX<O=-O8+]&CU#3FO$BDR<$LC,=O50<$CG/KQZO-<06X0SS1Q!W"*78+N8G
MSU)/:N0?X3^!9'9V\.6I9CDG<_)_[ZH NV?B8W]RAF^Q:=9J#YBW-Y$\LAQ@
M "-RJC/.2Q/&,<Y'E7_"&W-IX$U;P-;7NGO;WFJK<PZBU[$(T@^0_,N[?O&S
MH 0<]:]'_P"%2> _^A;M?^^G_P#BJ/\ A4G@/_H6[7_OI_\ XJ@#E[[1Q#\4
M?">K6-S92Z1HMA]C>0WL0=OD=00I;G&X9_&L[PYX;N8/!_C;1[V\TVVGUF66
M6U8WL;+\P. VTDCG%=Q_PJ;P%N*_\(Y:;@,D;WS_ .A4O_"I/ ?_ $+=K_WT
M_P#\50!P&L:)JFI_!?3_  H#IB:A;/&N/[1B*[4))8G.!G(P!GOFM?5+*>]^
M)/A'7HY+(6>EVOE7.Z^AW!BK X&[G&X5U'_"I/ ?_0MVO_?3_P#Q5'_"I/ ?
M_0MVO_?3_P#Q5 '%>&?#T]OH'CO3KZ\TZV?77FDM7-[$ZC>& #;6)'45C0:!
MKDEAX"@FCTN)?#EV9)P-4A9Y%\Q6R!G'1>!G.>N._IW_  J3P'_T+=K_ -]/
M_P#%4?\ "I/ ?_0MVO\ WT__ ,50!SUC;26OQKU?Q4\MFVF7-A]EB*WL.\L!
M'SMW< ["!]1G'..(C\&ZLOPFO_#)DTW[?<:N+Q3_ &A#L\O:HZ[NN5Z8[UZQ
M_P *D\!_]"W:_P#?3_\ Q5'_  J3P'_T+=K_ -]/_P#%4 <'XS\2VND^,?#U
MY#IL]Q=0:6RFXTF>.2X1B=I1Q\R[ "3DCJW!X.>G^%WBKPG)H5QINEVDFBFR
ME!GM]0D D=GYWEB?F)Q^&!VQ6A/\'? %P@5_#L*@'.8YI4/YAA3T^$7@)$"C
MPW;$ 8^9Y"?S+4 4?BHJ>)_ ]UHNDW5C-<W#QD,UY$BH%<,<DM[=A5&PU+4]
M)\&Z=86%A8#6K73DL1=2ZG (UP -W#$M@C(&!6]_PJ3P'_T+=K_WT_\ \51_
MPJ3P'_T+=K_WT_\ \50!SVNV;W?Q=\.>(;:XLY=-TRW:&:1KV(.Q97&0"V3C
M>,YQWI=.LVA^-.L>)9YK(:5>V(M$?[;%N! CY*[LX.P^_(XK>D^%'@"*-I)/
M#MFB*,LS.X 'J3NI(_A3\/YHDEB\/6;QNH975W(8'H0=W(H XKP)HESX2EN]
M"N;3P[?Z>;DRVVK37<)9$.."GWB<#(' R3SCFK>F6NK>#OB)KU_I#Z3JFCZY
M+Y[^9J<<+029)R<Y) +-T!R"/3%=;_PJ3P'_ -"W:_\ ?3__ !51_P#"K/AY
M]I^S?V!8^?LW^5YC;MN<9QNSC/>@#"UVQN7^*^@>++.\TBZBMK%K6X0WJ1;'
M(D^;G)*YD[9/%>BV5SJ4VIZA%=6,<-C$8_L=PLP<W *Y8E<?+@\>]<O#\+/A
MY<JS0:!8RA6*,4D9L,.H.&ZUVR(L:*B#"J  /04 .KD_B1I&H^(/ NHZ/I=M
MY]U=JJ+F145<.K$DD^@/3-=910!S<EYKTEE!;V_A]XK@;$\^>>$I!GY6< ,2
M2 3QCGIWK)\5>']6\1K=WD<4MIJ&EN'T-DD3F08)=N>C8VE3T7GDD@=U10!P
M&KZ?XIEU'0?%=CI<+:K9P26U]ICW*J)8WVD^7)R!AER,]:F\0:1XHUK1['4X
M([2UUO3[Y;VVL6EWQ[0I1HFD &2P9N1P.![UVDUQ!;^7Y\T<7F.(TWL%W,>B
MC/4^U2T >>>*KK7K_P"&GB:XUK3(=* TZ54M$N!.Q.WEF8  #L /?/;%H:5?
M^)H/":W-BUG:Z7+%?RR/(C>8Z1E45-I)QELDL%X XYXZO5](LM=TR;3=0C>2
MTG7;+&LK1[AZ$J0<>V:?8K9VD8TVUF!-JBJ8FF,CHI^[NR2W;C/I0!SOA'2=
M5T75?$,-U:Q"SO-3FOX+E9@2XD"X79C((P<D^V,U:\;6>M7NA)'H8WS+=1//
M )O*-Q &R\8?^$L.,^F:Z.B@#SJPT/Q!IVO>([^VT'3X[?4+*W6WMOM"[ T8
M<&-AMQSNY/0>IJ]X4\*OH?BB[O=.LI])T:XM0)--DF5T^T[L[T568*-N1U&<
M].*ZX:A9&^-B+RW-V%W&#S5\S'KMSG%6: ,OQ#%<3Z+-%;:?#J!=D62UF*A9
M8RXWCYN,[=V,]\5YEK_AF7P[\/\ QO\ 9HKBRT6XM4:TTZ>82&%P3YC+AF"J
M<KQD]#TXKUG[=9^1+/\ :H/)A)$DGF#:A'4$]!BJ^L:/I_B+29-/U"-I[*<#
M>B3.@<?5""1^- '.S:5?^(]0\-S7=BUE;:5)]KD9Y$8RRB,JJIM)^7+$DM@\
M#CDXSO#.G^,_#4'_  C$>GVD^F0R.+35S= &.%F) :+!+.N<#H#QSWKM3<:=
MH\-M:S7D4"G$<(N+CYG]@6.6/YU>H X"TT[Q7X7\2ZRFE:9:ZGI6K79O8Y9+
ML0FUE8 .'&"67(!&WFK]]I.K2>/?#FI>0;BVL+2>"YN0R+N>0)\P7.<94Y^O
M&:["B@#D- T_5+'QGXIU.YTV1+74G@>W(EC)/EQ;""-W!)''UYQ7-0>#?$<7
M@?38[>WB@UO2-6DU&"*653'.K22$H64G&5DQ]1^->J44 <5J@\:ZWX2U/R+2
M'1M2>)4MK9;L2.3N!<F0 !25RJXZ9R3TQ5TC1-8M/'D.M+H-M8V#:1]D>&.Z
M5GC<2[^<##,?7..Y-=_10!Y9)X4U^3X1ZOX<_L[&HW5S*\:F>/9M>8R EL]A
MQ]?SKH_'UC+J'A*.[@_T75[*>&YL-^"5N P54."0=V[9UQ\U=A6&?#_A^\\3
MG7/L\,VKVR"$R>:6,?4C*9P#R><9YH O:/IPTK2+:RW^8T:?O)#UD<\NY]V8
MD_C6'XQL=:N[K1GTZV6^T^*X8ZA8F81>>I4A,D\%5;DJ>O'6NJH) !). * /
M)[OPAXD?P?XTT9-+MEDU:_:XM?)N5V!6$?'(& -A'J3CC'-=1J6G:I>^.O#&
MK1Z=(MI8PW*7!:6/*F55 P-W.-O/Z9KI8=4TZYMY;B"_M98(B1)(DRLJ$=<D
M' J6UN[:^MUN+2XBN(6^[)$X=3]".* /-[CP?KU]:>)_)B6RO;C5XM5TV661
M60M&$VJX4DC)0_F*Z&UN?%FJZ3>#5-#ATYOLKQK;Q7:3-/(PP#G@(HYZDDY]
MN>MHH \U'AO75\(>!]-_LUC<Z-?6T]V!-'C9$K*=IW<D[N.G3G%26^A^)-#?
MQ5I=IID=_I^L33WEM<BY6,PR2KAD<'G /0C/O[>C44 >86OAWQ;H-IX6U73K
M"UNK_3M,&F7VG-=!?-B^4ADD(P&#+FM'Q#HWB?6+31]<CMK5-7TR_%W'IOGY
M0Q%=C1^;@ N1D[L8&<=LGOJ* .*TRPUV?XD2:_=Z2EG92Z2EH0]TKR*XD9L8
M7([^N,8YSD#:\7VNL7OA/4;?0)Q#J<D8$#E]G<9 ;^$E<@'L3FMNB@#@-'T+
M6+?QY:ZPNA6NGZ>^DFSDC6Z#-$_FA\M@?,3Z\^I/:J-AX2UJ;X;0>!;VQ$"J
M1%<7XF1HFA$F\F, [RQ' #* ,YSQ@^FT4 <78Z1JOAGQ?KE[9V#:AIFKF.<+
M%*B26\RKM(8.0"K  Y!)&,8IMGX"4?#:\\-7DB&XO?-FED3.V.=W+@KWPK;<
M>NVNVHH XMO"FHZM\-KO2-4N436M1A\RYG7E5GPNWIV7:B\=EJUX=O?&5VT,
M6NZ1:6 MU/G3Q70E^UM@@;% ^0$_,23GC&.>.JH(R,'I0!A^%M7U+6--FDU;
M34T^\@N'@DBCF$J' !R&'!ZX/H016?XLL-:N]8T26RLX]0TJ)I?MUB\XB$A(
M C9L\,JG/R^X.#@8ZF**.")8HHUCC485$& !["GT >52^$?$C?#[Q;H7]FVX
MN-2U">:U\JY4J5DD#9.0-H &/4^@KI-5TW5+WQEX2U2+3I!;:<ES]JW2Q[D,
ML80 #=S@CGVZ9Z5V-% #)HEG@DA?.R12K8]",5YO:>%M?A^'EQX$FM5=,/:P
MZH)$\HV[-G<RYWAPI(VA<$@<XYKTNB@#C+_1;^/QQX:O++3WDTW2K2>W>3S4
M#?.J!< D$XV<].O>NSHHH \U?PUXAB\->-M%73HI!JMU=SVDRW"C?Y^-H(.-
MNWG.?; -:$^CZO+K7@>[73G$6DQRK=YECRI>'RQCYN>>?I[\5W5% 'GGA[3_
M !GX:67PW!I]I<Z6)I&L]6:Z"F")V+8>+!+,N3C& >.1UKT.BB@#SJ7P=JU[
M'XUT>6.*&SUJ<W-M?";)5C&@"E ,\,@R?3I6SX?OO&=P(HM=T:UL_LRGSIX+
MI93>, 0 B8&P$\Y8]L=\CK** .$\-Z)K&F_#?4='NM/*WS_:_*19D(?S7=EY
MS@8WC.?3C-5)/#VMGPMX%T\::QGT6ZM9;L>='C;%&R-M.[DDG(_7%>C44 <-
M+I>N1>,?$FK6VEI+%=Z=%;VPFE3;))'O)##)PK;L=/K2^%?"CZ)XJNK[3K&?
M2-(N+7$VFO,KH;G<#O159@H"@@],Y''%=Q10!@^,[36;WPK>6^@2;-0;9L_>
M>674,"ZA_P"$E<@'MGMUKF].T36K/QI/J\6@6UK8SZ.MJ((;E-R.KNV", %C
MN'.<>Y/%>A44 >7P>%M>A^'WA+1CII-YI6HVUQ< 3Q[=D4A8[3NY)!X_'.*T
M+/2/$7A_6_$<5GIB7^F:U,UY%+]I6-K>5T"LK@\D<#!7->@44 <YX"TS4-%\
M#Z3IFIPQPW=K (G6.3>./?&,_3/UKHZ** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S-;UJ'1;>W
M9XVEGNKA+:VA4X,DK=!GL  23V /7I6G7*^.]"U+6--L+G17B&J:7?1WUO',
M<),5!!0GMD,>?Y=: '2^+VTR/6I->TR:QBTN))C<1DRPW"L.!&Y5<MGY2N.I
M%.E\57&G:MI=GK.F"SCU1C%;31W'FA9<9$<@VKM8C.,%AD$9K-UC1M>\=>#M
M4TW5K2'17N856" 7 G(D5@X=V4 8RJC SQDGL ^YTO5_%+^'1J^G?8#I=XE]
M<OYR.)98U8*(]I)VEFR2P4X&,<\ %:;XC7B:7KFH1>&IG@T6\DM[O==HIVH%
M+,O!R<,3MZ8'7G%=!<>(UFU.UTO3+=+N[N+3[8RRR^6D<). 6.UCEB<  'H>
MF*Y3_A'-<;PIXYTXZ:PN-:O+F:T'G1XVRHJ#<=W!&W)Z_C4T6B^(-&\3Z;X@
MLM-%Y'+I4>G7]D9T22)D.5D1B=K#J,9]Z ,+1-1MM&^'OC:\O] 2ZM8=<N_/
MTW<FP#Y,C)&" ?0?A76:CKVL0>/-"T>RM+7[#<6<UP0TY0MMVC!PAP%W<#O[
M8K!E\*^))O WC/2WTV%;K6-1GN+94NE8!9"O+$@8 V_7GH*W]1TK67\6^&];
MM+&.1+:TGM;F*6=4,1?9ALC.X#:>G- "V?B?2;/4O&%S<Z6NG'2C$]]<_*7N
M!Y6Y2=O4A< #)ZXXJS+XNGT^[TA=7TO[':ZM(L%O.L_F&.5AE(Y5VC:3R."P
MR,>]8=WX-U#7+CQY:W<)M+;75@^R3EU;!CC"Y8 Y'S*#]/0U<GT?6O$MCX>L
M=8T_[&VFWD-W=S^<CI,T0.!%M);#-@G<%P,]30 VX^(-\MMX@GMO#4TJZ',R
M76^[1,HJ!RR\'+8.=OMU'2M:3Q=%-J%A8:=%#+<WMB+^)+FX\G=&<8"_*V6Y
MZ=A6"F@:T-,\>0'36$FM22M9_OH\$/"(QN^;CD9^E)>>%Y=5T'2]*UKPTUW%
M:Z=%''-;SQI/;7*C:Q5BP^4X4@@]N0>P!W>GW,EYIMK=36[6TLT*2/ YR8R0
M"5/N,X_"N9N?&[IHU[KUGI9N]&LI9$EF6?$KK&Q61XTVX95(;JP)VGVSM>&;
M/4=.\,Z=9ZM=?:M0A@5)YLYWL!ZGK]>_6N.TWPWKNB^$M8\'PV2W%M.;A+"^
M\Y!&D4VX_O5)W94LWW0<\=* )/%.K7MYXH\$?V;%;W.GWD\ES%NN"@G(MW9=
MPV'  .X=><<#K73O9Q>&O#VH3:-IUM%+B2[,&\K&TI&6.0#@<=A^5<_>^&KZ
MQU3P3'IMF]S8Z KI+(9$5F4P>4N 3R>YZ5V5_;M>:;=6RD*TT+Q@GL2"/ZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***R-;U#5[10FC:.NHS[2[>;
M<B",#L-VTY8^F,>I'&0#7HK'\*^((_%'ANTUB.VDMO/W!H).6C=6*,,]^5/-
M;% !1110 4444 %%%<AK?CN.S\40>%]'L#JFN2IYCP^:(HK=,9W2/@XXP< $
M\CU&0#KZ*YS^W=7L]7TO3]2T6-5OY6B%U:71EBC*QN^&W(K G9@<$>_:NCH
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MJ<BV\P?5!B\/VJ7][QCGYN...,<<4 >?);Q:UJOPJO-13[1<7=A,9Y')R_\
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M=!MK!-1N-1%MNA^TW#;I'*L003W(^[^%:M0VMK;V-I%:VL*0P1*$CC08"@=
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MO4)I[?3KB:V2-YHXV9%D8A20.Y -<CXA_P"2H^!_^N.H?^BXZZ[4/^0;=?\
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MRLK.?2;5K:Q.;6,)@1?[N.GN._>EB\*:!!;W]O%H]FL.H'-U&(AME^HK8HH
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MYP20W''/;BH-#\(^'_#3SOHVE6UF\_\ K&C7EAZ9/0>W2MJB@#FQX \)@O\
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MW%#CJ& *X]Q7544 >2-XIL[;QCI_B^&-CH&I69M"P8D"Z\OSE*KTW$9BXY+
MCM5[Q#H_V/\ X06QF9TFDU<O<-$Y!WM#(7"MU R2!CH ,8Q7<)X;T>/2K33$
ML(ELK.5)H(@.(W5MZL/?=S3]3T#3=8N;.YOH9));.3S;=EG=/+?IN 5@,XR*
M .&TJT2RU;XAZ+;2W,5A;PV\T$:W#YB>2%BQ5L[ADJ#UJGHNJ-)IOPTTB^F;
M[#J5C(\^]CBXE2)2B,>X.YC@]2!UKOQX6T@7>I70@F$^I(([MQ<R@RJ!@ _-
MQ@$@8Q@&J]UX(\.WGAZ#0KC3A)IUN0T$;2N6A(Z%'W;EQ[&@#CO'>CVVB_#O
MQ%9VE]/+')?6TX@=@5M \\?R)QPO!(7MGWYU+6SCT7XOPVMG).(+[1Y9KA))
MWD$DB2H YW$_-AB/QK??P7H$F@_V(UB3IY<2-$)Y 9'!!#.P;<QR!R2>@]*M
M?\([IAUJ'6#%*U_!%Y$<S7$APG=<%L$' )R.30!R_P 5+.WNM'T5IXE<IK5F
MJD]@TH!_,<46_D:I\2=4\/W\*MI^GZ; ]G:/RC[RV^3'<@A5![<XQDUUNL:-
MI^O:<UAJ=N)[9F5]NXJ0RG((92""".H-5;GPMI%S-:3&V>*XM$,<,\$[Q2*A
MZJ74@D'J02>>>M 'G4=UKB^#M7L8[BXN+;2_$@LU)D)FGLQ(F8E8G+-\VWKD
M_=Z\5K/9WNFZWXE\0Z9;W<&FVVE&2SMG,L,;W01RQ6 D#&-@.5Y/3G)K4\7^
M']WAZQTS3]!74-,CNQ+=VD4PCF91EMR.Q'S[\$DL">><G-0>%_#4-IJT5]I^
MDZOH]NJL)XK^_,PN 1@*(_,D P>=Q(/&,$$X *.C:+)J-IX9\2VVO6T.1&T\
MT43E[X2 !HY"9,$[CU(^4C@#%8UCIUG:_#OXF200+&R7FJ0J5[(%&!7?:3X"
M\,Z'JK:EINEI!<LS,,2.40G@E$)VJ2.. ..*ED\%^'Y6U,M8$?VF6-X%FD42
M[L;N V!NP,XQG'.: ..MK)-(\3_#ZYM);@2ZC;2PWA:=F$RBVWJ""<#!'& ,
M56T^RN_&7A:XU@ZW;:=J=O?3/)>>2[369CE/[L_O -FP ;<8(.2">:] /A71
MVFTR5K>8R:6"+-C=2_N@1@X^;GCCG/'%5)/ /AB7Q VN-I4?V]W$CL)'".XY
M#,@.UCGG)'7F@#F;;0;;6_B9XJM+ZXOGMX8K">.-;N50KGS#D8;(&1TZ<GBN
MM\9:))XA\*:AI\$CQ7;1%K:5'*LDH&5.1[\'V)JU;>']-M-;NM8@AD6_NE"S
MRF>0AP.@*EMO&3CCBM.@#QT>*()M2\+^,EC$.F1QI8ZL=Q"0S2*0,KT!C90"
M3VD%:?C"S>U^&CZAFXMKNYO[>Z=4E9-HEN$Q&P!P0$8+CID$]:[IO#>CMI5Q
MI;6$1LKB9IY8<</(S^82?^!<_ITJ36=#T[Q!8_8M3@:>WWJ_EB5T!8'()VD9
MP0#^% '-ZC_R630O^P1=?^AQT?#[_C^\9_\ 8PS_ /HN*NA?P]IDFLV^KO#*
MU_;1&**8W$GRH>HQNP<X&<CGO3M+T#3=%ENY;"&2)[R4SSEIW??(>K$,QYX'
MY4 <Y?746I?%%/#^I;7LETC[5!;2?<FD,I5B1T8JJC /3)-95XHT75/"'A1=
M2NKS2KF]NDN99Y,LQ1"\<#,.JY8#'?;@]Q78:_X3T3Q/]G.K67G26S%H94D>
M.2,GKAT((!],T^X\+Z+=:-!I,EA&+*W97A1"4,3@Y#JP(8-DD[@<\GGF@#AM
M2BFTOQ-XJT2RDGCTB7P^=16.*5D%K.&9 (R""@8+NP../K5*RM!IUA\,M7@G
MNOMUZUO;W$CSNPDC>V8E2I., @8X]^O->D+X<TL6=Y:F&5TO5V7+O/(TDJXQ
M@R%MV,9&,]SZU7/@_1&MM-MS:R^5IC*UFOVJ7]R0, CYNPX&>W% '%W-S/HW
MB7=KVGFXL+K5PUEKMG)N:%C+A8)EZA01L[KTXSS5SPAH]C_PE'CH+"8R+]55
MHW9&4- A;!!!!)).>M=8GA72$G:402D-<F\,3W$C1><6W;]A;;G<=W3KSUIP
M\,:0NK7FJ):%+V\4+/*DKKNPNT' . V.-PP<=Z /*8;>/4?AC\.)[T&XF;6K
M9&DD8EB&D?=S[X%=G8P1P?%O4=/C7;9MH4+>1D["?-=2<=,X &?:MO\ X0OP
M_P#\(_#H7V _V;!()88O/DS$X.05;=N7!]#W-/O/"&A7U]:7D]E^_M8O(C:.
M5TS%G.Q@I =<]FR* /*XH(M1^&_@N6[S<./%"1!Y'+'8;N1<9)] !]*ZN:#^
MW_&FN^'))+5(+&TMUM+:>-VPC*2TB8=?F#8&[DC P1GGI%\#^'%T,Z,NFA;'
MSA<",2N"L@;<&#!MP.>>"*;J_@3PUKCVDE_IBM+:)Y<,D<KQ.J?W2R$$CKP<
M]3ZT 6_"UI<6'AJSLKO53JL]N&A>\*;3(58CD9/(Q@G)R1FN%TX+XI\%>)M6
MOY9(]7M[N\6.=7*R6)BSY:H1]T !20.N3G.:]-MK:"RM8K:VB2&") D<:#"J
MHX  K)G\(Z)<7EW=/:.K7F/M21SR)'<8X_>(K!6XX.1R.#F@#@K)KGQ#XC\$
M3:K+=(^HZ'-+=PI.Z+(P$?.T'Y<[B3C&<X/%5(-5GT3PQJ=A%>/!81>+3IHE
ME=F%O:DJVTMD$+D[<Y! 8\UZA/X>TRXUBVU:2!_MMLACAD69U"*>H"AMN#@9
MX[563P?H*6.HV1L!):ZE(9;N*:5Y%E<XRQW,<'@<C!X'I0!G:'X=FT7Q7<W*
MZI;K:WEKG^R[>!DC#JPS,N7..& ( &<@T>)_LUUXGT73V+W=P8IY5TUB!!(N
M%'F2D@\+G P"<MTXR-/P_P"%-%\+PR1Z19^0),!F:5Y&('0;G).!DX'3FI-6
M\,Z1K=Y:7E_:&2YM-WDRI*\;*&^\"5(RI[@Y% 'E1DNYOA79^9>W22VWB(6R
M-'</\L?VO:%Z_, .!N!Z"MVZ=O"/CK7_ .RA,T0\,OJ+6\DSRB2X21@&^8DY
M(X/K75#P#X96R>S33/+MWN?M9CCGD0>;G<",,, 'D < ]!6@/#NF#6_[9\B0
MW_D?9O-:>1LQ9SM*EL$9YZ=>: /,M5LK.Z\ >"];WF>_N-2TZ:>[+DO*[NI<
M,>X#$X7HN !C%>F>)K>*Z\+ZK#.@DC:TEW*>A^4FLI?AQX52+R%TUQ;B<7"6
M_P!JE\J.0'.Y$W;4Y] *Z=H8VA,+(IB*["A&01C&* /'WL8(_A?\.UA!A-QJ
M6F-(\9PVXCJ#V-7;V>?PCKOCB/13,$AT.._BB>1I0L_[P%QN)] 3ZXKLX_ ?
MAN*PM;&.P=;>TG6X@074H\N1?ND'=GCL.@SQBK\?AW2X]8GU86[F]GB$$LCS
M.P>,=%*EMN.3V[T <II6A%[WP_XBLM<MHH&0"3R8G)U%77@2$R'<P/S;B"1S
M6YXUMM2N]%BBTEK=[H7*.+6X?8EVJY9H2>V0"?3CGC-+HG@3PUX=OWO=*TQ;
M>9MV/WCLL>>NQ6)"9_V0*U=3TFSU>&**\1V$,HFC,<KQLCC(#!E((ZF@#SB+
M6-+NO#]W:/;ZGHUXVM6\-QI*D%FF8)B!&R%\IU3.<@8+=N"R%;B)OB9I[9LX
M;:SAG@M[2X<) [6[L2A&W&2H)  &:[J[\':%?V$MG=V1FCFG6YD=YG\TRJ %
M?S,[@0  ,'@<=*C7P/X<22]D33MKWT(@N66:0&5 ".3NZD$@MU.3DG- '!/I
MJ6^F_#?48;J]CO+]K>UN9ENG!DB>V)9>N /E&,8(ZCGFG7MW<>$;CXBPZ,\T
M<-I8VMS!&7:00NZN'==Q/H&^HKT!_"&B/;Z;;M;3>5IC*UFOVJ4>25& 1\W8
M<#/;BIX_#>DQ:G?:B+5FN;Z,17323.ZRH 0%*DE< $C&.YH YS3?#YAU_1M=
MLM:M(K66)HWAMHGVZ@&3<I8M(<L,%MV"3SDT[XM;D^'6H3QS312Q20%6BE9.
MLR*0<$9&">#6KH/@?PYX9NGN=(TX6\K @$RNX0$Y(0,2%!]L5HZUHFG^(=.?
M3]4@:>T<AFB$KH&(.1G:1G! /X4 <=J>G1:A\88;.XFNFM)M"D>2!;EU1B)D
M'0'@8ZXQG'.:Q](AU>Y\#/9:7)%=2:?K]S#%97LQ NX(W?$!8Y[<C.1\G/%>
MB'PYIAUB/5S%,;^.#[.LQN9<B/KM^]C&>?KS56+P7H4%MY$-M/&@NS>@K=S!
MA.007#;L@D,V>><\T >;Z[/I>L^ ;DIIES8W-KKUJMQ877)M92\094(XVE3D
M$<88XP*W]8T&TO?B?8:1))=II\VB3^9;Q74B*<2(!C!^7KVQG'.:Z^?PIHMU
MI-UIEQ9^=:W<@EN-\CEY'&,,7SNR-JX.>, #I1%X5T>'5+;4H[:1;RVB,,4G
MVB3Y4)R01NP<GDY!R>3DT <KH=I#;>,?&VE@N;*"SL1'%)(6"_NGR>3U. 2>
MI//6N<L3->>$?AA++>WGF7%VL4S+<N/,4QR$YYZ\#GJ.Q%>EWWA+1-1UC^U;
MFS+7AB$3LLKJLB#H'4$*^,\;@:AA\#^'K>TTZUAL7CATV3S;14N91Y3_ -[A
MN3R>3GK0!R>E>'+"X\;>+M!E-T=)CBM)TM/M4@19)$?<WWLY^4'KC//I67H.
MMWM_X?\ A[IU[>(8]2@N1*]V&=9Y(L"-'PPW9!)P3R5'6O2X_#>EQ:G>ZE'%
M,EY>H$N)5NI074< ?>P,9.,8QGBJ4W@/PU/X<C\/RZ8KZ9$^^*%I7)B;KE&+
M;EZGH>YH X;Q9H=UX>\":_$-<DD O;:>WM[<O$+-9)D5D'SG*GDA3P/2MN/3
M8-,^+,=A;M.;74=%FDNXY9WD$KK*@#G<3SAB,^AKH3X(\/'03HAL#_9YD$KQ
M^?(#(X((9FW;F.0.I/0>@JX?#NF'6H-7,4K7\$7DQS-<2'"=UQNP0< G(Y-
M'+?"&SM;7X?VLL,2QN\UPK$=PL\@ _ 5WM<ZW@3PV^EWVF'30+.^D\R>(32
M%M^_Y?F^4;N<+@5T0&!@4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45Q
M_P 4_P#DFFM?]<T_]&+5SQ'I%Q;>"-6L?"EO#8WLD#FW6V18OG([8P Q P#Z
MXH Z2BO//"=OX<\2:9INI:+:?8;K39_].LX_W<ID5&'ES#(WG?M8%NZYSUK0
MTSQ1I5OH]SXA,^JM#J-^8+>VN6$C-*#Y0C@4$@*64]\=3P* .SHKGHO%T$GB
M)]!;3=1CU!81.4,:,OEG.&+*Q4<@CDCG\ZH0_$;2I[+3[R.RU%H;V\6S4B)/
MW;M(8U+?-C!(/3)QSC&* .PHK)O=?MK2\FM(X9[J>WB\ZX6 +^Y0YP6+$#)P
M< 9)QTQ6#JGCMCX4TK5='TVZFDUF=;:R638I5G)"LP+=-H+ >@Y*T =I16+9
M>)K6]\0W6BBVNHKFUMDN9'E50@5F*XR"><JW;'&02.:HGQWIG]B:5JXM[PV>
MIW(MX'VH,$E@&8%AA<*6R,_*,T =117/P^+K&6WFE>UOX"MX;."*>W*274FT
M,#&IY*D'J<8P2< $U;TK78-6O=1LTMYX+C3Y$CG27:1ED#C!5B#P1D9R* -6
MBO/_ (JRVTUIH.CS2I"VH:G&K3,VTQ0I\\K!NW  _P"!4RRCC?XBZ;)X5#1Z
M+!:S?VK+"3]EE) \I5_A9P<DE>@/)[4 >AT5S-QXWT^"&SN%M+V:TOKM+.TN
M(D4K/(QP-N6!V\,=Q !"D@G(S-=^+K*"XU2*WM;N]_LJ/?>M;A-L7R[MN69=
MS;><#.._) H Z"BL"T\7Z;>Z39:A#'=;;]@MG"T.V6XRNX%%/\..=QP  22*
MMZ/KL&LRZA%%!/#+87'V:=90I^?:K<%20>&'?@]: -2BO/?B;+;7.H>%M&FR
M#=:CY\SJI+"WB7=(/EYPQ*C\:T-.L/"VK/'K6G6\=I!I5VY,ZH85DVH0V<X^
M56;N.J?C0!V5(6 (!(!/0>M<\GC+3V33K@V]VEAJ,ZV]K>.BB.1VSLXW;P&Q
MP2N#QV(-9JPPZI\7)+@11[=$TT(TFT ^=.V<$]\1I_X_0!V88$D C(ZCTI:\
M]\&:AIND^'+_ ,27 6%-<U226VCBC^>12WEPHJCJ2J \?WB?6NF7Q-$;^ZTY
M]/O4U""V6[%J?++RQ$E=R$.5.""""0?S% &Y17/V_C+2+C3="OEDD5-;9$M(
MV4;R64MAAGC&,'W^M+=^++*R-TL]M=(\-]%8(I51Y\L@4KL);&,,.21T- &_
M17'>*38Z_P""O$,MWI.)K"VN407D*,T;B+=N0@G'4<@]JW/"_/A+1O\ KQ@_
M]%K0!JT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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84 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>exhibit1011-physiciansha013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1011-physiciansha013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-\0:S'X?T
M.YU26%YD@"DQH0"V6"]_K6E7/>.-/O-5\&ZC96$!N+J14\N(,JEB'4XRQ '
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JE=:1IE]=0W5WIUI<7
M$/\ JI9H%=T[_*2,C\*NT4 %%%% !1110 4444 %,AABMH$@@B2**-0J1HH5
M5 Z  =!3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *XCQY?ZEI^L>%8[#4KBUCO]42T
MN4C"$/&02?O*<'CJ*[>O/?B1<1)KG@M2XS#K,<TN.?+CVL-S>@R1R: (?%GB
M#7/!_BRWOXI;C4/#Z6WF:C:LJL\"%]OFH0H8XXR"3QGZCH]1O6OKWPU<Z;JD
MHLK^X*MY!4I-'Y$L@.2"1RB],4C7=E/X]^SM-#()-,*%205;,F=OH21SCTKE
M;#PYJGA/Q[H^EV:M-X5FNYKNVSDFQE\B4-%_N-NR/H?Q /1=3MKB[TRX@M+M
M[2Y>,B*= "4;'!P00>?:O+CXCUV\^"5SK$6LW%KXATUWBNF*1G=,DFUHRNW'
M(Q@ =2*]<KS:U\/7MM\5=2LEASH%\8]9DR/E\]08RGU+[9/^ "@#;GU236/"
M^@2Z3J-Q#-JLD!CF3:7V8\R3=E2,[%<=.N*IS7NI1_%^ST5=4N?[-?2&O&MR
M$P9%DV]=N<8/3-4OASH>H:5JFJ:;>(18:'<36VF,?XHYBLI_[Y78 ?\ :85)
M=7,(^.]E(9%\L:&]N7_A$IFR$)Z;L#IUH @\5_\ "0>'[;PUCQ/J#W&HZS;V
M5T0D.P))N+!!Y>1C  )S6CXFT[Q#I?A_5KJP\3WIF5(VM&F2$E'W896Q'@J<
MKVR.:K?%*>-7\(INR\7B&TN)%')2)=^YSZ*,CGI6_P"-+NWB\(W3M*NV0)LP
M<[_G4\8Z\<\4 4_"?BA_%.CW=E>J^G:_8'R;^W0@-$_9USG*MU!Y'UZU@>(M
M7UFP^%N@ZO;ZQ=)?W+67G3;8SO\ -V[^"N!UXP.*T_&?A^[EG@\8^%2C:W9Q
MX:-#\FH6_>)L=3W4^OX8Y_QGM_X4SX;M)4+2LNGEH-I9MJA"V5ZX !S0!WGV
M&>#5;)(O$=Y))N:5K:?RBLT0P&Z(",%U.01SBN9TK7CK_BC7M(O-?NM*U>TO
M'BL[)-B#R0!LD"LI\W=RQSG QP.IU(;KPA8ZO:7.C6MFVI2_Z)&MC %+*[*6
M+E5X4;=V3Z'')K'\11^#O&%K=Q^)573M1LKB:&"Y8&&<!)&"O"QYD! !P,C.
M>,T 6?$^O:IX8\*>'VU:\E@\ZYBM]6U&&,%H5VG+ 8(7<P SC@'CG%;NCP7?
M]K07EGKDFI:#/:.4#ND@67<FTK(HRP(W=2<8/KQ@:%JU]I_@7P];>+[:6Y:]
M$D%VT\#2%8_F*-*N#@%0H8MT)Y[U0\,:-8Z/\2%_X0N[:3P_<6LDFI012F2V
MAER/+V-R YY^4'( /;% '6^/%U@>#=1N=!O9;74K:%IXC&JMOV\E2&!SD @>
M^*Y#Q5XLN;3P?X4\56.M7,%C<7%NM[$ C&6)P2_)4X9<'.,=Z]3(!!!&0:\G
M\->"[BX'B3POJ46-&L&N+;36(S\ER!)D>Z# !_VS0!W.I-<W/B/2;.SOYX(P
MDES="+:0\:@*JG(.,LP.1CA&K&\)7VI77COQ=8W>IW%Q::;- EK$X0!0\>XY
M(4$\^II/AA;ZJ?#@O=<C\N_"K88/7RK?* GW+^8WXBLCPO8Z-J_Q)\;/?6=G
M=B6>V-LUQ"KAPL6&V%AR 1SB@#6\/WFI7?Q)\6Z5<:I=2V.GQVIMH2$&PRQE
MFY"Y/(XR:J>#+G4M:MO$,VI>([]%T_6;JSC9?)4+%'C&<IUY/-0^#3ING_%'
MQJEJMO:V<D=F8/+4)$^R-O,VXX."><5F>"D\*S1>*?[>M;!WN-=O)(VN[<%G
MA8KM*DC)4\XQ0!L^,K[6-'\):)/9Z]<F>?4H+=KI4CS-#(YP2"F VTKR .14
M[ZQJVC?%'2?#JZE+JECJ%K++/'.D?F6FP95]R*ORL>,-GGO6/X_U"RU+P3HJ
M6\<AM5U>V6)9$.^2"-BK2%<9"\'DCI@]\5<MXHOA]XRDNH81+X:U]PQN(DWF
MSN,="PR?*8#CLI'84 7=0N]3?XM6^AIK-Y;Z=-I#WC11B/B02[>"RDXP>E7[
M_6%\)Z1K^M7.K3ZG9V,2 0R[-T<P!)4,JC[V^+KG'-<WK4^BW7QFLKC4!:7.
MG+H;H9)8Q+$)#+D#." V,GZ?6KVKZ1HWB?PQXA\*^&HHHUN8?M+R1)L@2?*[
M%&!CYC'DXZ8R>M &SI&FZQJV@6VH:CK=Y;ZE=0K,%M=BQ6Y89"*A4A@,@'=D
MGGIVYR3QEJ>I?#3Q+=>>;+7] >>WG>W VM+%T8!@?E8=OK70:#XMT^W\-6<6
MKR_8-3MH%BN+&8$3>8HP=B=7!(R"H.0>*XV;1;K2_A?XVU#48FM[_P 02W%U
M':-S(@?_ %<9 ZOCD@>OM0!U^G07UUIFASCQ/>B^N4@N&AD$1290%:5<"/(!
M!(R",$BNQKE/!VA:$FBZ-J=CI]G#>)9HCS00JCDE%W*Y SG(Y![BM71O$FFZ
M]<:A!8R2&6PG,$ZR1,A# D9&1R"0>?8T 4M1\76UCXOLO#QM[II;B!YVE2VD
M=5 *@ $*<\MR>@QSC-<WX;\9VFCKXC7Q%K4SB#79[>*29&?RX@L87=L7"+DG
MDX&<U=UZ8:?\5?#U[/'-]GDT^ZMU=(F<&0M&0O ."0#U]*Y9I87\ ?$R,%3+
M<ZG>-"N/FE#(@0J/X@2#@CK@T >J7^LV.F[1<22,[(9%C@A>9RHZMM0$XY'.
M,<BI=-U*RUC3H=0T^YCN;29=T<L9R&'3^?&.U>8W.J6NA^*+'5-:-^-%U#1[
M>"&]M'F"PS1ER4<1'/._OW'UKO?"EIIUGH2+I.GRV-C)(\D4<N\.P8YWD/\
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MUKAO#NOZ%JFH>#UU#7;>.ZTB+RH(Q;S1&>5XQ& Q=0%X[ G)(Y[&5)H&\/\
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M[LH=Q_N#UK+>]TO2/$_B71O%L&J>7J=T9[1X#<-%>1/&J>7MB."PV[2".F*
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MO';W4R-+-<,&8GA5RV-K=!T7/3FL>SN[:/XP:Q,TT:PG1X%,A.%++(Y(STR
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M#P9\6;NREO9KFQUZW6>2:55'DW2\?-L557<O? R<4RTN+<+\3B73$SN8\_\
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M%C$O8'.>1W&3CI0!QWQ.\5Q6?@G5VTK5+JWO;=A&)[:)M@DW %#+M*@X)X#
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M 6PHX&2![DX&:X_Q3XEMI)?!FN:?J\RZ7=Z@%<Q.RI+'Y;G#+U)RHX/?C&:
M/0Z*PM&\8:)KJWWV2[9'L/\ CZBN8F@>$8SN97 (&!G-.M_%FDW-[:6HEFB>
M]4M:-/ \:W  R=C, "<<XZD<CB@#;HK)TWQ)IFK3ZA!9R3/+I[^7<H]O(A1L
M9Q\RC)QSQFD'B73GLK2ZA-Q,+N,S6\4=LYE=!C+;,9 Y') '(]10!KT50T?6
M;#7M-2_TVX$UNY*YVE2K X*LIP00>H(J_0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %5K:QBMIYYP7>:=@9)'.20/NKQP .P]R>I)JS10 4444 %%%
M% !1110 4444 %%%% !6=KVDC7="O-+:ZFM1<Q[/.A(W+SGOP1V([@D5HT4
M<Y;:%K4RK#K>O0W]JK*QCAL! 9"I!&\[VR,@'"A?RXKHZ** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^PKT.B@#SS_A4Z_]#UXV_P#!M_\ 84?\*G7_ *'KQM_X-O\ ["O0Z* ///\
MA4Z_]#UXV_\ !M_]A1_PJ=?^AZ\;?^#;_P"PKT.B@#SS_A4Z_P#0]>-O_!M_
M]A1_PJ=?^AZ\;?\ @V_^PKT.B@#SS_A4Z_\ 0]>-O_!M_P#84?\ "IU_Z'KQ
MM_X-O_L*]#HH \\_X5.O_0]>-O\ P;?_ &%'_"IU_P"AZ\;?^#;_ .PKT.B@
M#SS_ (5.O_0]>-O_  ;?_85Z!%'Y4*1[F;:H7<QR3CN?>GT4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "$!@00"#P0>],@
M@AM85AMXHXHDX5(U"J/H!6'-HVG><Y?6=11RQ)7^TY%Q[8W<5&VCZ6D4DKZ[
MJ*QQKN=SJT@"CU)W<"@#I**PH_#=I+&LD>JZNZ. RLNI2D,#T(.ZG?\ ",6_
M_02UC_P8R_\ Q5 &W16)_P (Q;_]!+6/_!C+_P#%4?\ ",6__02UC_P8R_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1T6
M1&1U#*PP5(R"/2EHH 155$"(H55&  , "EHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** *#:WI*7HLFU2R6[+!! ;A Y8]MN<Y
M]JM7-U;V5N]Q=3Q00)]Z25PJKSCDG@<UXS\:?#LM_->Z_8974=$MK.Y1T^]Y
M?F3[OR(5O^ FK7BOQ#%X[^%$EY#CR8]*:^NT'19N45/H&$C?5%/>@#UBRU&Q
MU*-I+&\M[I%."T$JN ?J#4PEC,K1!U,BJ&9,\@'(!QZ'!_(UP?P8*Q_"'1&8
MA5"S%B> /WTG-<;+XCU/P_\ &G2];U.0KHWB6V%O #P(H]V(\YZ')1CZ>:U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M92WE]<1V]M"NZ265MJJ/4FO,/B!:W%CXNF\7V",]YX?M;.>1%ZRVS/<+,O\
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M)]R:MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% &/;V%_'XJN]2<VWV6>VB
MMPBLV]?+:1@W3!SYF,=L=36?_P (59P^/X_%EHWD3/ \5W"!\LQ( 5_]X<CW
M!_/J** .,L?#FO:=XQU[7X9M-8:L(%,#[_W8B4J/F YSG/05T&EV^JQO=SZI
M<P2RRL!%%;AECB0#@<Y)8DL2?H.U:=% '*^&/#FHZ+X@U_4;J:UDCU:X6X"1
M%LPE5VXY'S<8YXJ[XQ\.)XK\*WNCF7R9)E#0S=XY%(96_,"MVB@#D]?\"6.L
MVOAZV5O*CT:XC=/5X57:T9]F 7/TK4\3^'+/Q5H4VEWI=$<AXY8SAXI%.5=3
MZ@UL44 <S<Z?XHO](?2I[VPA\R/RI=1A#>8RD8)6(C",1WW, ><'I6?XB\#/
M>>$M,\.:&UM9VEA/#*C3;F/[LY P.I)Y)SZUVU% '*:SX7O;K7].\1Z3<P6.
ML6Z^3<AP7BNH#R8VQ@\'D'M3)/#FJS?$*T\3.]DL4-@UD]L&8DAGW%@V/TQ^
M-==10!PNF>#M7\-^*[Z]T"[LH-#O&$DFE2!RHD[NA'W"?0 C],=;J]M<7FCW
M=K;>4)IX6B#2$[5W C/ YQGI5VB@#CM7\#1>(;?P\=1D6.YTF0;V@)(FBV;7
MC.<':^!D>F1S4UQX<U*7XC6WB99;46\%BUEY!+;V5GW%\XP#TXQ^-=710!QE
MAX<U[3O&.OZ]#-IK#5A # ^_]T(D*CY@.<Y]!3]=\.:]K_AC6=,NKZR$^H@1
M(45Q';Q #H.K,3NR>.H]*["B@#DI]!\17WA^/1)-5L[&W\@6\T]I$S3,@&"$
M+$!"1WPV.U5_$G@4WW@:V\*Z&UO96D#1%7EW-@(P;H.I)')SW/K7:T4 <MX@
M\*W&KWNEZW9745AK^G;O*EVF6*1&X:-QP2I]>".U:-K%KMRT8U)[*VC1@S+9
MN[&0CG&Y@-H]1@YZ9K8HH Q=&T[4+;5-5OM1:VDDO)%,9A+9CB5<+'R.<'<V
M?5SQ678^&=4TWQ_JNOVL]H+#4HHUGM#N#%T&%DW8P#C@C'XUUU% '$:)X:\2
M:%JFN7D%SI4BZK>&[*2+)F(D8VY'7@#L*Z;1K;4;>VF;5;F&>[FE+GR%*QHO
M 55!).,#GW)K1HH PX]*NW\1:E=W26LEA>VL5J8LL6VH9#DY&#N\TC';'4US
M\'P\;2_AWJ7A;3KM7DOA+&UU<DG8C?*HP,YVH%7&0."?:N\HH Y3^P=8.CZ!
MIK26)@TYH3<C<_\ I'E ;,<?+\P5N_W0*?X[\,W7BK1(+2QN(;6\M[J*Z@NI
M 2870Y! '4]1U[UU%% &#<V&L76HZ-=O]A!LB[3J'?\ >%D*?+QP.<\Y]/>J
MOBCP59^(]4T?50WD:AIEW#,DRC_61K(KM&WJ#C(]#^-=110!BVVG:@/%5UJE
MVUL]NUNMO:HA;?"H8LQ.1@ESMSTQL7K69?>&=3/Q$M?$^GSVD4:VAL[J%]V;
MA,[AR.%(/3K76T4 <FOA2[T?Q1>Z[X?N($&HX:^L+D$1RN.DB.N2C=<\$'-.
MM?#FHR>.'\5WLEK',NFFPBLX69EQYF_<TA /7C 6NJHH XKPUX;\0^&_[8\N
M?2YQJ6I3:@=PD'EM)C*^X&.M7I='UV:'3FGNK.>Z@OC>3L=ZH1AE$:#G: K#
MDD\@G'-=/10!S$'@VUMO'5YXJB<^=<6R(;;.$\X KYGUV87..A;UJOX8\.:M
MX>?Q!(\ME.VJ7\E\@#.HB9\#:>#D #KQ].>.OHH XGPEX;\2>$O"=KH4%SI5
MQ]F$FR:19!G<[-RH]"WK6FND:NM[HD\ES;W!LDD^TR2%@TSNN&*C!"@') YX
MP.,5T=% '+^)?!5GX@UG1M95O(U'3;J*02J/];$KAC&WJ.,CT/U-6O&6B77B
M3PI?Z-:2PPO>1^4TLN2$&>N!U/XBMZB@#'2#4+'PE]F6XM(+^"T\N.=\M$KJ
MN [ X.,C)'\ZD\.3:E/X?M)-7"?;RI\THA0-@D!MIY7*X.#TSBM2B@#D['PY
MJ=IX_P!3\1M):-#>VT=N+<,P9-G1MV.<\\8_ESJ:#IU[86]Y#??9G$]U-<+Y
M1)P)'+;2".V<9[^@K8HH Y/P[X#T_P .3:[#;@/I>J,"+-A\L0(8.@_V26)
M[9-1:!X?\0>%+0:3IUW8WVD1$_9?MA=)K="<["5!#@=ONGM78T4 8]U9ZVMC
M$MCJ-O\ ;&N4DN))XB4,>1N1%!^7@8')]SDYK8HHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBL2X\6Z/;:P^D/-<MJ"1^:;>.RFD;9G&\;4.5SQGI5O2];TW6EF.GW<<[0-L
MF095XF]&4X*GZ@4 :%%%% !1110 45BS3W=WXGCM8+HV]I81+/<A5!\]GWJJ
M$GH %+''/*T_PO=SZAX9L+^X<O)=Q_:03V60EU'X*P'X4 :]%(6 (!(!/0>M
M+0 45S'@G5+K6;/5;ZXD+Q/J<ZVO/ A7"ICZX)^I-=,&!) ()'4>E "T45R-
MKXW@U#Q6^EVGD+;VSRPW4DT@5E=&*_*,]"V /[V6Z;"" ==14<\\-K;R7%Q*
MD4,2EY)'8*JJ.223T%96BW[ZEJ&KS+,)+6*>.&WVD%2ODHY88]3(?R% &S13
M%EC:1XUD4NF-R@\KGID=J?0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX$)_C1_;>D_]!2R_\"$_QH OT50_MO2?^@I9?^!"?XT?VWI/_04LO_ A/\:
M+]%4/[;TG_H*67_@0G^-']MZ3_T%++_P(3_&@"_15#^V])_Z"EE_X$)_C1_;
M>D_]!2R_\"$_QH OT50_MO2?^@I9?^!"?XT?VWI/_04LO_ A/\: +]%4/[;T
MG_H*67_@0G^-21:KIUQ*L4-_:R2-]U$F4D_0 T 6Z*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMYK>2.T5GC+[_P"\2#]T9)]. ,YH ZS^Q],_Z!UI_P!^%_PH_L?3/^@=:?\
M?A?\*\VM_%OB>3P+H'BV748 );J&WN;)+9=DRM-Y3,6/(;^(8P!TP:V[[6M?
MUF?Q!#H NHY=,F-K;^4MN4EF$:N?-\QMVTE@ORXP!G)S@ '7?V/IG_0.M/\
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M#K3_ +\+_A5VB@"E_8^F?] ZT_[\+_A1_8^F?] ZT_[\+_A5VB@"E_8^F?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+ET9@<Y1^!DG:2,C&=?0]9CUVP-Y%9WMK'YC(JWD!B9P.CA3SM/8T :5%%%
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M"W.F>5YYECVJ?,#%=O.3PI[=Q0!KT444 %%%% !1110 4444 %%%% !1110
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M7&N+8R20K&_FP,KLK/\ *,. HZ8![@YKT#1["YTW34M;K4I]1E5F/VFX50[
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M&!74CIUS110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR/H >:GN/^2]67_8NR?^CQ74VOAVPM]034'\^ZO(U*1SW4S2F,'J$!.%SW(
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M0 4444 %%(2!U(%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 <C/XHU8>/G\+VVFV3D:?]O6XDNF7*>9LV
ME0AYS[U:T3Q4VH>(M1\/:A8BRU2RC28JDOFQRQ-T=&PIZ\$$#'O7.7MK-=_'
MD)#?W%FP\- EX%C)(^TG@[U88_#/%4] MCIOQ<USP_J##66U+3ENY+^91YJ(
M&V"%P,(%[C:J]1U[ 'J=%>4Z-"+7[7\-9XR\D5^)DD89,E@Q,N\GN1CRB>Q*
MUZ'%HVF0^()-4B3;J#6JVQQ(<"(,2!LS@<YYQ0!IUD>))9!IB6D,C1RWT\=J
MK*<$*Q^<@]B$#D>X%:]8OB"VGDETF\@A>?[#>^>\28W,IBDC.,D<CS ?PH H
M6<=GI?BEK9 MM8Z=IMM;6ZD_*#-*Z[1[DQ1C\16S=Z[I=AJ$.GW5]#'>31O+
M' 6^=D4$LP'7  /Y&N;U#PUK6L7[:F;N&T)E@GCLW3=@P.6C5V!P0Q9BV,X.
MW!.,F&3P+J5YK#:K>ZU$;Q9"T<L=KP$:$Q,FTMC"[G*]<%LG=SD ["SU*SOU
MC-M<QR&2%+@(&^;RWSM8KU .#C/H:Y?5;DWOQ5T#3XI.+"SN+V:,'LX$2D_3
M)_[ZI-(\'ZII$4,\.J6_]HO;"UN9C 678NT1E 3P553P>"6)]C6T/PKKD=VV
MNW%W'9:O=Q-#<JRB?"LV[*G. P/RJ.5"A<@D4 =,OB;1I+F6VCU"&2:&Y2TE
M6,[MDS9PAQT/!_*M&"Y@NHS);S1S(&9"T;!AN4D,,CN""#[BO/[;X=ZK96JR
M6NN0QWS&VDE+6Q=&EBR-_+9Y#$D=V .0"173:+H%SH<@M;6\C&E)(TJQ&/,I
M+*!M+9QC=ELXR<@=CD R?'?BB^T>[TW2-,@EEN]224AH$9Y(PA3G !P#N(+8
MX'/.,5JV_B;2['3H$U/43#.CQVKM>1F%Y96'!"G^]R>..OH:BU.WUD>,;2_L
MK"&XMHM/E@5WG"!99)(R=W!.W$8Z ]>U9>I^ ;G5;E9KG5(S+(I>>7R#DS!D
M9"J[N$!CC&,YPA&27)H NZAK4&I>(-/T^-)DBM=3(GDD7:DA2WDD.TYY"L8\
MGIFMB\\0Z58PZ=+/>1B/4IDAM&!XE9QE<>V*YZ_\%ZAJ-]-<2:G%"956.1HH
MB#*#&Z2OC.$<AU /.!$N2W:!_!&J7\^F_P!JWUE<06ML;4+'"4,29CRR=?G<
M)@G(V@\9Y) .\HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH Q;CPGHMWJK:I-:.;]D\LW N)%?9G.T$-PN>PXJ
M2VT:QT&VO9]'TN'[7*I=@#M>X< [0TAR>O&3G&:Y^\\=2:'X]A\/:W!#'97<
M2-;:A%N"K(Y8+'(#PI.QL'/;\M[4+^_M_$&F6, MC;W8D+LZMN38 >,'!SGV
MQ[T 5?#]KJ-Y?RZ_K6F1:=?RP);1VJS"9HHU)8Y<  EF;H.,*O?-7I]-LK/4
MI]>ATUKC4V@%NS0D"22,-D*-S!>O/)'2M+S8Q((]Z^81D+GG'TH:1$!+NJ@#
M)R<8% &/_;M]_P!"OK'_ 'W:_P#QZD_MV^_Z%?6/^^[7_P"/5LET#*I=0S?=
M&>3]*'D2,J'=5+'"Y.,GVH QO[=OO^A7UC_ONU_^/4?V[??]"OK'_?=K_P#'
MJVBRA@I(W'D#/)K.U_7+'PWH=WJ^HR%+6V3<VT9+'H% [DD@#ZT 5O[=OO\
MH5]8_P"^[7_X]1_;M]_T*^L?]]VO_P >J&TN?%%U8)?M:Z=;LZ;UTZ0N7 (R
M%:8'"MZX0@'N>M9D'BS5GU_PG97%E;V\6L6L\MS&=QDADC0$J#G&-S8Z'I0!
ML_V[??\ 0KZQ_P!]VO\ \>H_MV^_Z%?6/^^[7_X]6RKJZ!U8,IZ$'(HCD25=
MT;JZ^JG(H QO[=OO^A7UC_ONU_\ CU+_ &[??]"OK'_?=K_\>K8$D;,%#J21
MN !ZCUK-\1:C-I6@7][:^0US!;R31I,2%<HI;''/:@"#^W;[_H5]8_[[M?\
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M(DB29V.K8.#@YP?2@#&_MV^_Z%?6/^^[7_X]1_;M]_T*^L?]]VO_ ,>K;HH
MQ?[=OO\ H5]8_P"^[7_X]2?V[??]"OK'_?=K_P#'JVZ* ,3^W;[_ *%?6/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEMY& 95!R0PP<'.#D9[XK NM#T>ST'QQ-::@M_\ :K)KF>$+&8(91"X#*%&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-SHNG$31+#(/LR?/&OW5/'*CL*>?#NBDVI.D6!-H,6Q^SI^Y'^QQ\OX5I44
M9EQX=T6[U:+5;C2;*74(L;+EX%,BXZ8;&>.WI4QT?3&U/^TCI]J;_;L^TF%?
M,V^F[&<>U7:* ,>'PIX=ME18-"TV-4F%P@2U0;91T<<?>YZU;@TC3;6_FO[?
M3[6*\G_UMPD*K))_O,!D_C5VB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW?AZ^\'6L_A>S>TTHLX2%U*L&#'=G).>>^3744 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'GEYX=^(DU]/
M);^(="6%Y&:-7TX,P7/ )[G%-?0?BA(FU_%.ALOHVG9%>BT4 ><1^'OB=$28
M_$^@H3UVZ;BF?\(S\2O^AC\/_P#@L'^%>E44 ><-X>^)SJJOXGT)E7[H.FY
M^E.CT'XH1+MC\4Z&@SG"Z=BO1:* /,T\*_$>.Y-RGB#PZMP>LHTL!C^.,U.^
MA?%&1=LGBG0V7T;3LBO1:* /.(_#WQ-B8F/Q-H*$\973<4T^&OB63D^)- SU
MS_9@KTFB@#SF7P_\3[B)HIO%&A21MU1].R#^!IEOX;^)=I%Y5MXDT"&/KLCT
MP*/R%>DT4 >:_P#",_$G_H8_#_\ X+!_A4D?A_XGQ B/Q/H2 ]0NG8S7HU%
M'.>$M.\2:;;W$7B#4;"\&5^SBSMO)6,<[LCOGBNCHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#:<J"[;!M.<KOK"\3(_@WQ]H'B:74Y[M+O.F7ZR)&&$)^9'Q&HX5AR2#U H
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M[\4 ,TNYUO4_&/C'3)/$]Y;6VE-;_9F6&W(021%R6W1\@'W''YUK_#;Q)?\
MBKP9;ZEJ4:"X\V2(RQKM28*V!(H[ _S!KA_^$?T_QEXQ^(=B;E8IKAK,V5PK
M<%DBY('1U####GBNN\.^-[6+PW.FMQ)INJ:2C17EF%V@E!UA'\2MQC;ZXH C
M\2>,;S1_&VD0(@_L,3K9:A-_=GF7,0]MNU23Z2"NJU>SO[V.VBL=1EL )@T\
ML2(SF/:WRKO5@,MMYQT!KB;OP@_B'X?7JW6O2+_:4;7LH A,*3GYQ\^S=M5@
MJYW9PO:MWX>^)O\ A)_!UC=W!*ZA'&([R-QAED7@L1Z-C</K0!AZ(VOZOXI\
M6Z0_BK48X]+D@CM76"V)^>+<2W[KGGTQQ5F2_P!;A^)VBZ++JTWV6;2WN;F%
M(X]K2H0.#LW '/3-0^";J"3XD>.RDJ$3W%J8B#Q(%B(8KZX(P<4FIW=NOQRT
M8F9 J:3-$S9X5RX(4GL3@\4 7M$UB]\:ZSK+6U[+9:-IETUC']G"B2YE4 NS
M,0<*,@ +C/4GM1%K5]IGCA?".H7TL\6H6K7.G7VU!,A4G?&V%VM@#(..G!SU
MK/\ !RQ^!=5\0Z-K$B6MI=ZC)J%A>3-MBE20#*;SP'4KR#R<Y'%2_9QXE^*%
MAXBMV_XDVAV<J+=GA)YI 00A_B55Y+#C/'K0!!X.\9:G#K\WAWQ1*9'GN+@:
M3J#(J"Z2.5HVC;: HD&W/ Y!^F>JT9[Q]?UR.?4)YX+>:..&)U0! 8D<\A03
MRQZDUSUOH.F>-_ ]Q8/<!94U"[FM[F$_O+:3[3*T<B]QP0?<&K'PZDUQ_P"W
M$\1P+'J<5XD,CI]V<+"@$B^S  _7/3I0!V]%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 45Y[=SS-\8FT>;5KR#37T3[9Y*W3(OG>=LR#G/W>W2I/#7B&\7QAXBT
MK[=-JVC:?#'+'=A!(\4A'S0[D'[P]^A8=#F@#OJ*P[7Q=HUYX:_X2&WGEDTS
M) E%O)DX;;PFW<?FXZ5;BUNRFUQ]'5I1>I;+=,C1, (V.T?,1C.>W6@#1JI?
MZA'IRV\DRMY4LZ0M(.D9;A2?8MM7_@0[9JW6'XM1[KP]<:; H:ZU!3;09. K
ME2=V?]D*6^J@=Z -S.**Y:_TBU?PO-J,\7FZDEM]I6YG ,J2*N\;3CY,$=%P
M*N)XOT<LGG3O;12X,$]Q&4BG&<91SP1_B#T(- &[135D1QE75A['-.H *CFG
MAMU5II4C5G5%+L "S'  SW)( %25C>)X8)M'07$@BB2]M)3(6V[=MQ&V<]NE
M &S15:RU"RU*$RV-W!<Q@[2\,@< ^F10^HV,2EI+RW0!S&2TJC##JO7K[4 6
M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:MVNC:;8W2W%G906SB-H_P!Q&$!!(/('7[HQZ<^M4OL/B/\ Z#ME_P""T_\
MQVC[#XC_ .@[9?\ @M/_ ,=H VZ:Z+(NUU#+Z$9%8WV'Q'_T';+_ ,%I_P#C
MM'V'Q'_T';+_ ,%I_P#CM %VYTFUNKDW+>=',5",\$SQ%U'0-M(SC)QW&3CJ
M:HVG@[P[9RRRQZ1;/+*6+R3KYK'=][E\GD\GU))/)-+]A\1_]!VR_P#!:?\
MX[1]A\1_]!VR_P#!:?\ X[0 J^$]"BP;?3HK1@,"2T+0.!Z!D(('MFM2TM(+
M&W6WMTV1KDXR222<DDGDDDDDGDUE?8?$?_0=LO\ P6G_ ..T?8?$?_0=LO\
MP6G_ ..T ;=%8GV'Q'_T';+_ ,%I_P#CM'V'Q'_T';+_ ,%I_P#CM &W16)]
MA\1_]!VR_P#!:?\ X[1]A\1_]!VR_P#!:?\ X[0!MT5B?8?$?_0=LO\ P6G_
M ..T?8?$?_0=LO\ P6G_ ..T ;=%8GV'Q'_T';+_ ,%I_P#CM'V'Q'_T';+_
M ,%I_P#CM &W16)]A\1_]!VR_P#!:?\ X[1]A\1_]!VR_P#!:?\ X[0!MT5B
M?8?$?_0=LO\ P6G_ ..T?8?$?_0=LO\ P6G_ ..T ;=%8GV'Q'_T';+_ ,%I
M_P#CM'V'Q'_T';+_ ,%I_P#CM &W16)]A\1_]!VR_P#!:?\ X[1]A\1_]!VR
M_P#!:?\ X[0!MT5B?8?$?_0=LO\ P6G_ ..T?8?$?_0=LO\ P6G_ ..T ;=%
M8GV'Q'_T';+_ ,%I_P#CM'V'Q'_T';+_ ,%I_P#CM &W16)]A\1_]!VR_P#!
M:?\ X[1]A\1_]!VR_P#!:?\ X[0!MT5B?8?$?_0=LO\ P6G_ ..T?8?$?_0=
MLO\ P6G_ ..T ;=%8GV'Q'_T';+_ ,%I_P#CM'V'Q'_T';+_ ,%I_P#CM &W
M16)]A\1_]!VR_P#!:?\ X[1]A\1_]!VR_P#!:?\ X[0!MT5B?8?$?_0=LO\
MP6G_ ..T?8?$?_0=LO\ P6G_ ..T ;=%8GV'Q'_T';+_ ,%I_P#CM2VMIKD=
MRCW6KVLT /SQI8E"WT;S#C\J -:BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB)*(XBK88J!P?S[5/:>;#\6=8O9+.]%HVEP1+/\ 9)"C.CNS ,%P3AATZ]J
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M.!&H((R %/'+$&I_#VGWFG:]I,_AY=4MM/NY7;4M&OK=Q#9Y1B7C9P-OS<
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MQ&O0M]..: .VHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **\R^*&EMHO
M@#7M9MM2U-=1\Y)$F2_F01AIT&U4#[0 IQT]ZZ2\T?3=#L[W4Y9]4>R^PR1W
M5O\ :IY]RG!W*&8E6 ##(QU]J .IHK@SXL73(/!5CHNE7DVGZK$#$6="XB6
MNJ?.^2_"DDG& >2:?HC>3\5O%.^641"PLY2LLI8(3YF<9)"CCH.* .YHKFQX
MTT];S3(IK>\@M]4?R[&\D11%.Q&5 PQ92PY&Y1FM33M634KF_@6TO(#93^0S
M7$)193@'=&?XEYZT :%%%<K\0_$\_A/P?<ZA:(KWSNEO:J_W?,<X!/TY/X4
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MLU2XE$<JLSR*F0HP#@$YX/J!7I]% #8W$L:NH8!AD!E*G\0>13J** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%10CL1G).2<] ,<Y&QX3N]>N]+F'B&R%O=PW+Q1N H%Q$,;)-H8[20>1GJ*
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M)A$7=!YL31ME6*GA@#U!J[7 Z-XGUW4OAY!J[RV$=XU\\-Q<28CBAA6X9&<
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MR%W_ "/\HYR1[8X,4?PYNH?#":0FN[I;?5!J5I.]H"$82F3#J&&[)8Y(*]L
M=^^HH Y2Y\+:G_PE4&O66M1PSM8K8W@DM _F*'+AD^8!&RQ'.X=,@XYRH/AS
M?6_AK2M'378B-.U0:DDCV62S"1I A <<;F.3_*O0** .5\3>$[S5M2T_6M)U
M<Z7K-DC1"?R1+'+&V"R.A(R,C(YX_EM:/8W5A9E;Z^:^O)&WS3E @)P!A4'"
MJ !QSZDDDFM"B@#F#X6O#\0QXJ_M*#:+'[!]E^RG_5^9OSOW_>SWQCVJSXM\
M.S>(]-M8;:_^Q7-I>17D,IB\Q"\9R R9&Y?;([5O44 >?:KI%[X6B\4^*+C6
MY96OK*-)%M[,*T4BJ45UY;"C?G&"1C))QSD^'6N-+N;$:-XG\+:ON,<36UE8
M*D\D18;CNCD)&!EB2,9'->KU%#:V]N6,$$418Y;8@7/UQ0!QEMX'U72]5OAI
M'B62TT2^G:XFL3;*[QLYR_E2$_("?8X[<\UVZJ%0(HPH& /:EHH X&W^&TD7
MA.UT1]:9GTVZ6ZTNY2V"M;NKLREAN._[Q!Z CL#S706>@SMK\>N:K<PW%[#;
M&V@6"$QQQJQ!<X+,2QP._ &/4G>HH Q]?TF]U=;.*WO8;>"&YCGFCDMS)YVQ
M@RKD.N!N /?H/?-;QKX8;Q?X;ETA+M;-WD21;@Q&1HV5@P*C<N#QUSW-=#10
M!RUWX9U.^UGP[JEQJ]LT^C^:7VV9 N&D383_ *SY>/KS^5,@\)7T%[XGNAJE
MN6UP+Q]D.("L8C'_ "T^;Y1[<_E7644 < ?AW?VVGZ ^EZ^+/6-&MOL<=V+7
M='/!Q\DD9;GH#G/7\,7]2\':CJ=CI:3ZXLEW::E%J4T\EID2O']U%0. BXXQ
MR>^<DFNPHH Y&[\$G4M?UB^O[V.6SU33QI\MLD!5E0;B&#[SSECV]*SO^$$U
MV73M$T^Z\2P2PZ->Q7-M)]@Q(ZQA@JR'S,$X(&0![Y-=_10!REMX4OK?4O$U
MZ-4@9M;"#:;0XA*Q^6/^6GS<?3FJ9\"7O_"->&M'76( -#NH+A939D^;Y6=H
M(\SC.>3G\J[>B@#B[CP9J]KXEO=5\/\ B,Z;#J+*][:R6BS*9  /,CR1M8@>
MX]<]*NQ^%;B#QA;:Y#J2&.#33IZP2P%V9=P;>S[QELJ.WK73T4 <&?AY<MX5
MOM'?68_.GU/^TX;A;0@12>:)<%2YW#(QU%=K!'<1VBI-.LMP%^:7R]JEO9<\
M#VSG'<]:GHH R=!TNZTJUN(+J[AN?-N9KA3' 8]OF2,Y4Y9LX+8%9&G?#W1M
M-MO$-C"A&FZV2TEJ!@194A@A[#G(]#76T4 <A:^#KQ].TG2]6U2.]T_2YHY8
M@+<I)-Y?^K$C;B#C@G &X@=.0=^RM=1AU+49KO45N;29T-I;B )]G4+AAN'+
MY///2M"B@#+\2:3+KOAS4-)BN4MOML#V[2M$9-JNI4D#<.>?6I]'LI=-T>SL
M9ITG>WA6+S$C*!@H !P2<=/6KM% '.ZQX;N+_P 3Z5KEGJ(M)K**6"1&@$@D
MCDVYQR-K#;P>1[5GP>";K3[76-+TW54@TC5)))&A>W+26YD&)!&VX#!Y(R#M
M)[UV5% %:RL8--TVWL+-!'!;1+#"O4*JC 'Y"L'PSX7N] U?6[V;4H;I=5NO
MM31K;&,QMC& =YR, =JZ>B@#GM<\.W.K^(-#U2*_B@72I7E$36Y?S2Z%#SO&
M.">QYJE':0>#=3\0^)M9UFW2RU*6%I,P%!"541J-VXYSQVZUUU-DCCFC,<J*
MZ'JK#(/X4 <CX(T:QMKG6M<L0XMM5NS+;!LX$?=E!Z!Y"[CU!4TY_!]U?7.C
MR:M?V]T=*NOM,%PEL4G;&=J%MQXY&>/FVCIUKKJ* .*E^'ZW\?BF#4[]9[;7
MW21DB@,;0,BJ%(8L<XVJ>G4?A6AH.A:_8JAUGQ&-3:W0I;8M!$,XQODPQ+MC
MCJ!R>_(Z6B@#@8_AW>0^$K+1X]<C%S8ZG_:5O<?9/E+^8S[73?\ ,,N>XZ#T
MJ6;P'J,\_B:5]?0MK]FEO.#9#$9$;1Y7#],,<#.>F2>_<T4 <A)X/O7D\+/_
M &K #H/3_1#^_P#W?E_\]/E^4^_/Y5O:[IDVKZ1+96]X]G,SQNEPBAC&4=7!
M /!^[6C10!R]_P"&M1UV;3TUK4+26SL;I+L);6K1M-(G*;BSM@ \D <^H%)#
MX5O8-;\2:DNIVY.M1QIY9M#^YV(4!SYGS<$YZ<UU-% '!V/@#4=,7PV]GKT2
MSZ-;26>Z2RW)+$^.=N_Y7^4<Y/T[5$/AQ?)H;:6GB!#&-6_M-'EL@2")/,"G
M#C)+=3P/0"O0:* .6\3^$[O6KO3=5TS5CIFM:>&6.Y6$21R(P&]'0GE3@8YX
MJOJG@[4]6T>TMKK7DDO([Z*^FN'M,JS1D%41 XV+QZD\D]Z[&B@#EKCP@]]X
MJO-6OKR&:UO-+_LR:S%N5S'N+$[]_7YCVZ55M?!%T-#L/#^HZJEYH]C+&T:&
MWVS2I&P:.-VW$$ A<D*,A1TYKLZ* .4G\&F]\1ZUJ%[>1RV6K6*V$MJ("K+&
M-W(?=U^<]O2LD> -<?1](TF?Q+#):Z1>0W-HYL/WI6(_(KG?@X&!D =*]!HH
M XI_!>KV7B*^U'0/$K:=:ZDXEO;5[19AYN #)&2?E8@<Y!&?7@5?@\+7%MXT
MAUZ/44,$6FC3A;/ 68H'W[C)OY;/M7344 0W:7$EI*EI-'#<,I$<DD>]5/J5
MR,_F*HZ'I<VC^'[;39+B.XEACVF<1%1(W=V7<>222>>236I10!YK)HEU\/OA
MQK-G)K9:SD9Q;26]F4-EYS8SG<W[M2Q;.,@9YZ5#X=DNM/U&TCT?Q%X6U>.5
MDCDM].L%BE\K/+[HY#@*"6Y&#TZD5Z@1D8/2HH;:"V#""".(,<D(@7)_"@#G
M=!\)/IECKEE?WD5];:M=SW,B+;F+;YW#)]]LC'TJGX;\'ZUH8M["X\427NBV
M9'V:V-LJ2[5^XKR@Y95XZ 9P.W%=G10!PVF>!=4T:YGLM/\ $LD7AR:9I?[/
M-L#)$&.6C27.54DGMD9XP>:UK7PY>VGB_5M>348#]O@BA$#6I_=^7NVG=OY^
M\<\#\*Z.B@#@4^'EXG@*Q\+#6H-MI<K.+@V1RVV7S0-OF>O&<]*M7/@S6+?Q
M)=ZOH'B,::-1"&_MWM!,CR* OF("PV-@>_OFNTHH YA?"EQ#XMLM;BU)2EK8
M-8B&: N[AF#%V?>/FRH[>M9;?#RXE\+ZOH\FL1^9?:D=2CG2TQY,AE$F"I<[
MAE<=1Q7=T4 <!XWO(8X?#>G7.I6T^IC7+%Y(U*HY'F]1'DD+Z=>.YZUW](54
MG)49]<4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
F444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>exhibit1060-kumaremploym001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>!?NQPH$4?0#BIJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$X5LL=K>PQWS0!U ((R#FBN6^&O_ "37P[_UX1_RKJ: "BBB@ HHHH ****
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M\$:2RH#RJ-G:3[':WY5FW?C#P]8V=I=W&JVZ07D?G0/DG?'Q\_ X7D<G@9H
M=IOAY-.\3:YK0N&=M5^S[HBF!'Y2%>#GG.<T-X=BD\73:])+O$NG#3VMF3*E
M1(SYS[[L8Q3[WQ3H>G74-K=:G!'/.L;11YRT@<D(5 Z@E6Z>AJ7^W])_L,:W
M]OA_LPJ'%SGY,$X_GQ]: .6MOAA9VO@K6/#D>H3'^TCAKJ1-SQQJ%6- ,\A5
M4 <^IK0U3PIJ-QXI&O:7KHT^<V*V3HUFLP95=GSRPQRWZ5OZM?2:=I-S>0V<
M][+%&62V@&7E;LH_'\JYVU\4:Q;:K-IFMZ/"MU_9\FH6ZZ=.T_F*A :/#*IW
MY9<8X.: 'WGA;5]6\/ZKI&K^(A=1WT'E(Z6*Q&+U/#?-4GC;P7;>--&6RDNI
M+.XCSY5U&N60,NUUQQE64D$?0]JAT[Q+K:ZYING:[I%K9C5(I)+8V]TTK1L@
M#%) 47!P>HR,C%=;0!B^)/#R>(O"=YH+W+0)<PB(S!-Q7&.<9]JUXD\J)(\Y
MVJ%S]*X_5_%NMZ5]MU)]!C70[*Y$$DDUPR7$J[@IEC39M*Y;C+98#Z4NJ>+]
M5AN-8ETO2(+O3M$.V]DDN2DDC!!(ZQ*%()56'WB,GCWH U1X8@D\77/B"\E%
MR[VJ6MO \8VP("6;'J6;!SQT IMSX5MI/$]CK=LRVSP02VUQ"D0VW,3X(5O3
M##(_&JFH^(M<>1WT'1H+JRBM$NFN;RX:%9@P)"181LG R2< 9%+J7C:WL_ M
MMXDAM9)GO;=);2T)P\CNFX*3VP,DGL%)H K6G@[6-&@-AH/BF2STL$F&VGLD
MN&MP3G:CDCY1V#!L5,/ =K'I>EV45]<$V6JKJLDTP#O<2[F9MV, ;BQZ#CTK
MH=*O3J6D65\4$9N8(YB@.=NY0<9_&LKQ3XB'AP:3+(T"6]U?K;W$DQP(X_+D
M<L#GKE!^= $NK^'EU'6=+U>WN6M+ZPD(\Q4W"6%OOQ,,C(/!'H1D5E-X1UBV
MU[5M3TGQ(+)=2E2:2%[!9=K*BIPQ8=EK7M/%F@WL,4UOJ<#I+<BT3D@^<1D(
M01D,1S@UH'4+0:FNFF=/MC0F<0Y^;RP0I;Z9(% ',ZGX2U?5]*M(+WQ&'O;/
M4([Z"Z6Q50I0$!2F[!Y).<U=L=(\307L4MYXICNK=6S)"--2/>/3<&XJ[J_B
M31M!:)=4U"&V:4%D5\DE1U; Z*,C)/ J+4?%N@:4Y2]U2WB<1I+MR6)1MVU@
M!G(^5N?:@#)F\ P3>&]5TG[?*DE[J,FI0W2( ]M*T@D4KSSM(Z\9&:M0^"[2
MUG\+M;3M%%X?618X]F?-WQ&,DG/!YW>YJ_>^*=#TZ"SGNM3MTCO%WV[!MWFK
M@'<,9^7!!ST&:B\):Y)XB\/IJ4JQ O<7$2^3G:5CF>-2.3U"@_C0!CV7@[7=
M)DOAI?BI;>WNKR:\\I].20HTC%B-Q;GK6FOAR[GO=#O=1U7[5=:7+-)O6W$8
ME\Q&3& >,!O?.*HZ5X^TR6\O++5;VTM;N/4IK.&/)&Y5?:A8\@%L=\9/2MFY
M\3:+::NFE7&I01WSE5$1/(+?=!/0$]@>3VH S+WP1;7/CO3_ !3#=202V^3/
M;JN4N&\MXU8\\,%=AGG(P.U7]3\/)J7B;0]:-PT;:29]L03(D\U-G)SQCK5*
MR\?:#>:W?Z5]K6.>UN4M07R!*[!>!Q_>;;]:VX]5L)=4GTR.[B:^@C666 'Y
MD5NA(H N=:XFR\)EO MYX*GED@2/?';W*IN!B,A>-AV)7(4CU7T(-;$OC7PW
M"EJ\FL6JI=()(6+<%"<!B?X5)XR<"K%_XFT73-0CL+W4H(+J3:1&S=-QPN3T
M7)X&<9H HGPU>OKDVK2ZI$\TNF_8&7[+@?>+;_O^K'CTQSGFJ^G>#9;!O#&-
M21TT&W>W4?9\&960)DG?P<*/7FM#4?&/A[2;F6WO]6MX)HF"2HQ.8R0&&[T&
M&4Y/'(K;!# $$$'D$=Z .;TOPH;/7;?6KN[BN+^*T:T>:*W\EK@$J=TIW'<1
MLXZ=3[8Z6N,\0^/5T/Q/;Z8MCY]FGE'4;SS,"S$S[(LC'.2,GD8'-=%JFO:5
MHGE?VE?16QE#&,2'E\8S@=SR./>@#GM<@ME\;6FJ7MGJ=\EG:-%;V\%@98D=
MS\TFX=6P N,<#ZU1U1K"_P!6TG4K?1]:L[G3IF;,>E,1-$Z[7C8<<'CGL174
M?\)7H/\ 8JZQ_:EO]@9_+6;=U?.-@'7=G^'&:QO%'CF'3_!%QX@T*6UOO*N(
MH,/DJ"TBHP8 @A@&Z'':@#@K:2Z63P_IMO;>)IK71]029+.?2&C-O"H;&]QD
M2$ A5P1P><]1T\4-D/#VKZ/+I_B)H]1O)[OS5TUE:)I)/,&WKRK8P?:NAM_$
ML[_$#4]!F2".RL]/BNQ,<ALLQ!R2<8 'I5W3/%>@ZQ+)%I^J6\[QQ^:0"1E/
M[XS]Y?<9% '(2R7FI:9>6NL2>(;J6;RC!)!HQA6W>-MZ.JY;+;@"<G!P!@4V
MZ>\U32;FTU9]?N9)I[>56CT9HXXQ#(L@"IDG+%>26/;TQ6G;>*_$VL:>=9T7
MP[:3:2<M;K<7K1W-U&/XT4(57/8,W/'3-;-QXPT6PMK.34[O^SI;J$3""Z4K
M)&IQG>/X<$X)/&>] &(;Z ^(=0U;^S=?W7EC'9F/^S'PH1I#NSWSYG3VK&MK
M6;2[;31HYUZTNK73H].EF?16E$T:?=;;D;6!+$')'S'(-=[>>)M%L-1BT^ZU
M&".\E,8CA)RS>82$P!ZE3^5):^)M%O=6?2[;4H);U"P,2GJ5^\ >A([@=.]
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MXM9ANCEC.0PZ?SXKG[OQ<MOK.K(1&FE:+;A[ZX8$L9G&Y8TQZ+@DG/WE'K0
MD_A*YN+K7+A]40OJUA'9/FU^X%#C<,/R3YC<?3\8[?P9=:?J-O?:?K"P3?8(
M["\5[7>EPD>=C@;P4<9/.2.>E58OB/I\UUH<_FPPZ;J%A-<R/(&+I(AB C&.
MI_>'. <XXKH'\5:%'H\&K'4X#8W#;(95);S&Y^50.2>#QC(P?2@!WAC16\.>
M&K#1S=&Z^QQ"(2F/9N Z<9/\ZUJKV5]:ZE917EE/'/;3+NCEC;*L*L4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5QGQ"BG T&^2[EM+:SU'S+BYBA$I@!AD17*D$8#, 3CC=GM79
MT4 >66MA#-?>'[N"ZN]2BN?$DET]Q/;")686CKO50 -N4&&QR<FH/$T4D(\8
M3F&3R8]=TRX8JA/R*MN7; Z@8.<>E>K37$%LF^>:.)<XW.P49].:CAOK2X?9
M!=02OC.U) QQ^% 'E&JB&[U/Q-;W6MWUM:ZVT,EK!;6*RF]A:"-!Y;,I.X,K
M#&1MX/&<UO66F7$VO?$58$87=S'!##,PP6/V4 8/^\:]!HH \;L[)M:T-;6T
MUC4;O4[30KFWCLS8K"MJSQ!/*=@H(;<%P,G.W/O6I8:KI^L>(_ "Z=!*QLHI
MXYR8&46Q^S$>6Q(&#E>G^S[BO2;R^M-.MFN;VZAMH%(#2S.$4$G R3QR2!^-
M3T <-\5X99O"-NL4;R-_:=H<(I)P)1DU2O+,LOQ2?[.2\\(53LYD L4P!Z\D
M_C7HU% 'D6I17#ZE?6""1+S4_!L=K9Y4_O9AYI* ] ?F'7UK7L]0L]>U_P &
M)H\<F=,25[P&%D^RH8#'Y;Y PQ8J-O\ LY[5Z-2;U_O#KCKWH Y/QS?262:/
M^^2SMWO<3:@;83&UQ&Y5E# A68X7<0<;CZUP^G7%K!%+-=:SJ6EZE!JEW)!J
M$]D"I64(V)DV@#S!A@ %/RGD'BO9 00"#D'H12T 8WA2YN+SPMIUQ=6D=K/)
M%EHHXS&HY/(4\J".<'D9KSFVD5_ ^E^$5BE'B.#5(C)#Y3;HV2Z\QYR<8VE0
M6W9P=V.]>OT4 <1X.BDC\<>.G>-U5[VW*,5(##R5Z>M2>//$4-EIFIZ+-:W/
MFW^F2K9R1Q,ZSS,&3RA@'#<J>>Q]C78LZ(5#,JECA<G&3Z"DEEC@C,DTB1H.
MK.P 'XF@#QSQ;->_V?XBTEIYK:YALX$BLK.R5GO46%6:1Y"A)53O7@C&SU(K
M=DB2[@^)EW#$9$O+9#$X0_O5^PKC'KR3^=>B075O<@F">*4#KY;AL?E38[ZT
MEO9;..ZA>ZA56EA60%T#="5Z@'M0!YSINI0Z#K]R=06=&O\ 0;%;55B9C.Z"
M4,BX'WLLO'O6/I]U=0:!H.G///IQ;PW"L+06*R3WDK9#0!G1@ ,*2./OYR *
M]EHH \N\ QK/XGTB[\ICY7A"SM_,9"-KK*X=>>A!7D>U1QZ=<+XS_P"$&\IO
M[*34/[=#8^7[-G<(O_ CMZ"O4+BZM[2,27,\<*%U0-(X4%F("C)[DD #N367
MHWAV+2;R\OY;VZO[^[VK+=717=L7.U%"JJJHR3@#DDDYH G\0:Q'H&@7NJR0
MR3K;1EQ%$,LYZ!1]20/:N.\,ZU8RMJ&J_:7UCQ-+:M(\$,$D:I&G(@AWJ !D
M]3RQ.3V ]!,L:R+&SJ'?)52>3CK@4AEC658C(@D8$JA89(]A0!YMI=[I^H_$
M33-1T"6^N9;F.;^TX[M)&%G&5W  N/W3>8%&Q2 >>. :] TO4[76=.CO[-F:
M"0L%+(5.58J<@\CD&KE0VMI!96ZV]O'LB4D@9)Y)))R>I))/XT ><W_BG2-9
M\3W%MK=Y):Z5I=ULBLOLTI-W,A_UDA"D;%8?*O<C<>PHN]3C\/1>,M'N8;AK
M[4KB6XTZ-(6;[7YL**%4@8R'!!].O2O3** /+M4U>WLTT_P5J5]+86%GI\":
MC/'%(SW/R >3&RJ=H(&6;K@@#J2+.OZ?J][%/J^C6^EW.C1Z0\&GQ22RQ/"K
M(=[*@C/S$!5'(P!CC)KTBF2S10A3+*D89MJ[F R?0>] '-^%]3:TT'PWINJ(
MD.H7=F/*CAW.I6-%/+%1@[2"0>^<9Q5/XA,D7_",7$T$DT,&MQ2R".,N441R
MG=@#.!P?PKJY[>V,\5Y.J[[=6V.S8" CYCZ=!U^OJ:62]M(HTDDNH42091FD
M #?0]Z /-I-,_P"$PF\:7FDD^7,+1M.NMI4/=P*6#J3U ;8I/L16Q\/[E_$D
ME_XRG@:%M0$=M;1N.8X8AAA^,ID/X"NFU2R.N:8;>UU6YLTD/S3V3)O*]"H9
ME;&?4<CL:L:=I]KI.FVVGV40BM;:-8HD'90,#ZT </XROIQXDFL1<RV(DTO%
MN]M9)+->R,[@PAF5@ ,*<<??SD 55^'R+<:K#<F)CM\+Z?;[W0C#*TP=.>X*
M\CVKTL,&&001ZBD1TD0.C*RGH5.10!Y%X0NXO#LOAF_UA9;>UE\."UBE:)F"
MRK+N9. 2"5*X'?;78?#%#'X%MU-M);?Z7>$0R)M9 ;F4@$=N,5U]% 'C5]<V
M_P#PBGC/01;S#5M2UFY%I#Y+9N&:10KJ<8(!')SQMSZ59O;-O[6\0:/J6MW]
MJ]_J:2Q6=O8I(URK"/9(CE2?E*X)S\NSM7J\US!;('GFCB4G&78*,^G--AOK
M2Y?9!=02OC.U) QQ^% 'F%];&\N?B%I2!UU1IXM2LD*'YS%#$R,IQ@_.@%9E
M[<:BNG'QC96=P+S7YKRQ1-AWHDB+';EAU !MU/MO/K7M-% 'D&HZ5%X?U/5M
M*N=7O-/T^YTVVMK:*"Q6<WD:1&,QJ2I^<'/R@C[^?>FZEI_V._\ $.DZEK6I
M6L.HQVZ0P1V*327L?V=(L*Q4G>&5L@$8SGC.:]:O+ZTT^W-Q>W4-M"&"F2:0
M(N2< 9/J3BIZ /.)K%EC^)N86=Y;=8PY3F4"R4?CR3^)-=CIEREAX0L[JYW*
MD%@DDG!) 6,$\>O%:U% 'D^D>$_$WB+PUJMW=WVFVJ^)RUQ<07-@\LL2,-L:
M;Q*OW4"X^7@U#;:^W]H^")_$,<B7FF/?V=[(T9;9)'&J>;T^ZP(.[I\WH*]>
MK.O-'M[O6=.U62219=/641J"-K>8H!W<=L4 >96K"+6X?%$D4H\/GQ%<W D\
MIL*KVHB6<KC(4R!OFQ_%GO53Q:DFJ>&/&FJ6$,KV%]J-A]F81L/.,9B5Y%&,
MD9&,]]IKVC()QD9QFEH \F\4:7J&H^+_ !Q!8PRM-<>&XXX=H/[QLM\H/J1Q
M^-:5Q<V7C#Q#H,6B"00VME=K=N(606R21!%C;(&&W8.WK\E>CT4 >=^&_&EC
MX>\*V.B:Q;WEOK.FVZ6C6*6LCO.T8VJ8L##AL @@XYYQ6=XHU/4+Z;4;:Y6?
M2+NYT5/)L[:U2>:\=Q)NA,I0C:AP"!C&XG(%>IHZ2 E&5@"02#GD=13J /.O
M!ZI=>-EOT0LO_"-64:3%".=\FX9/?(&1[5D^#K,F3P]I5]K6H/J.F7#R/IPL
M440.JR*S/)M!V,&.#D[MXZUZW10!Q/Q22-_#%EYYF6W75;-IGA+!TC$H+,"O
MS @9.1R*K>'[SPBNJ>7I.KZO<WDL;HD5U<WDJ'C)XE^7.!UKOZ:SHK*K,H9S
MA03R3UXH \PTFS>'P3\,D6W9&BO(&D4(04S;S;B?3D\_6L_2]3EN=:\*7-S=
M3*8M2F%U816*Q6^GN\4RJA(3=N+-CEB#DGN*]AHH \9T.YM[KP5X0T"V@F35
MH=5@N'@,#*T:),TCRDXQM*9Y[[L=>*:UE>B'Q+<H;BVBM_&"W4LR0>8R1!5'
MF!2#N"DANA^Z3VKVBB@#R::S@O8[>^@O[O5UNO$E@TMQ+:K'&Y0 ;D"J 5 P
M"V,97VK3O[,F_P#B;(+<EI].B56V?ZS%LXP/6O1&D175&=0SYVJ3R<>E#ND8
M!=E4$A02<9)X H \=GB>TGO$U+5KW3K?4M'LXXXXK%9S=*(BCQ+E2=X)/RC'
MW\UT6F:;]FU;Q?&T<LF-*LX%DE3YI L,@(/OZ@=Z]"HH \M\,3#3O$O@][T2
M0K<>%8K6-F1L--NC.S..#CGFNC\9M]CUGPQJ]RCMIMC>R&Z94+"+?"Z)(P'8
M,<9[;JZ^B@#QSQ2KZKX.^(NJ6$,KV-\]L+5A&P\]D6-7=1C)&<#/?::]@A_U
M$?\ NC^5/II=%=4+*&;.U2>3CTH \PTK1+Y_!5KJ^F0E=<TK4;Z>W1AM\^,W
M,F^$^SKT]PIK$TJ2=M/T#73=W>D6/V_56>Y:U#F$S2[H]ZLI"@@,,XX)QGFO
M;** /+);1-"T#1O%=D]]>I8ZC/-.TMMY<DMO<.5E*Q@#Y=Q60# X&<4D:W>A
M^'_#\]]*-.N-4O)K_4-0^RB9[::1&8(NY2%8@B/.#PN.]>J44 >-:+>+INH:
M-J.I-="TL]5U1;F:X@*M$TYW1/(JJ NY<]  "^.*FM]2,*:C=1*=.L;OQ3)(
M;^:RWM;H;52LJJZG:78 !B.-Y]:]?HH \^\$ZQ;Z7IVK?VA/=L\FME%>XM]D
MC^>4$3LJJ H;.>@QGG'-;WCF[EL_"\DL4<9!N(%DED@\Y8$,JAI=G?8/F'H0
M#VK=N;2"\C6.XCWHLB2@$D?,C!E/X$ _A3O/BP3YJ8#;,[A][.,?7/:@#A?
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M2W, A9B\A)8( ,*3EAP.#FNBHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-X+6_6&VC8+O8K'C+'@*.I-7_ J6M]I-SXGDNC>Z]<*T=Y)*FQK5EZVZH?\
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M.U";R8(-7>RM]2D+8AAGW"103AE!P<$ '';I5UKRV2Z6U:XA6X<96(N [#U
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M*:Q=RFT.$96##.<L,'OSTQ3-4\8P:+XR.F:A(J69TY;E/+A>65I#(RD!4!)
M5<]./6JG@F\T^XO;B:2YO+S7KJ,/=7$VGSP1JJGB./S$ 5%+<#.3DDY.:CU2
M^BT;XH_VG>VUS]C.B"'[5%;/*J/YS-M.T$C('Z#U% &]<^,= M;&SO7U /!>
MH9+<P1/*TB#JVU 3@9&21@=\5GW7BF;_ (3CPYI=D]O-INJ6<]R9@"Q8*%*%
M6!Q@Y]#7!Z5IU]H[:5J-_=ZQHMK<6=T$:SM%E>(O=/*L;JT;E<HZGH.5Q[5J
MVFB2VOBSP1%9P:BMK#I5XOFW<0$D)< J)-HVJW/3CIB@#MK;QEX?O-16P@U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME68@_C6S110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYL)6=$D:*17C:-XW'565@"I''!'>@"_16'J7B[1M(OS9W=Q*LB!&F=+>1XX
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MC.WYWY'RC)SQC(-3_P#"=^'AIL-\]W*D4UTUFJ/;2"03J"QC*;=P;"G (YX
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MU5I+>WDE4-T)521GVXKC;+7O&[^&+3Q"UEHM];36J7;6=N98IMC*&(4L64L
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M]%-I5_=+>":U=%CS#/M;<1@@EEPP)&2.]>G7NHV>FV5U=W<Z106L1FG;KL0
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M*YL98T4#<S'80!QU)KC-'\3WMIX$TS2-/\.:W-K,6GQ6RQS6$D,22B,+EY'
M4*#WS]*](HH \IDT;4M"M-/\-F35FMX-&2&W;3(3MN;HLP=9)-IV*/D(W%1A
MB>U,TJWNQ=Z )+'4(1<^%/[*$C6<O[FY#("LGRY0<$[C@$#(->GV6HVFHI,U
MI,)5@F>WD(!&V1#AEY]#5J@#S/P5IJF]T-+G_A)FO=,M662.]B"6UL^P1E Q
M1=X/.W:6X )KH/%D<UKK_AO7/LUQ<6=A-.MRMO$TKQB2,J'"*"2 1@X!.&KK
M** /+9-.OM3U.768].NTM;WQ+93Q1RP,K^5%$$:5D(RH)'\0!P :ZS2+6XB\
M?>)KEX)$@F@LA'*R$*Y59-V#T.,C/U%;][>V^G6%Q?7<@BMK>-I99""=JJ,D
M\<]!4,6KV,^HC3XY]UR;<7038V/+)P&SC'7MG- '*:NLUK\3$N6L[M[>ZT1[
M..:&W>1!+YN[:Q4$+QSDX%4+#2[Z/PO\-8397"26DT)N4\H@P?Z+*I+C'R_,
M0.>YKNI]6L;::RBDG&^]8K;[5+"0XSU (''<U=H \J\'Z*8)=!TR_;Q*]]I<
MK,\4D06SA95=0XD* ,K!B %8GYN>AKI_B'#.^AZ?/!;3W M-6L[F5+>(R.(T
ME4L0JY)P.< 5UU% 'DU[I8N=2UVVO3XH\C6;E+BW@L+?$4\;Q1K\[-&?+92I
M#!V7  K<@TV[6;XC.;.8->-BW;RS^^ M%4;?[WS9''?-=[10!P5EIETE_P##
MMC93*MGI\J3DQ'$#&W10&X^4Y!'-97V!;:WNY=0MM=LI!KM_-;7^G6[O) &;
M@E K%D<?[)7CMQ7J5% &/X5GU*X\-64NKHRWK*V_?%Y;,-QVLR?PL5VDCL21
M6Q110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7.>,KQK>PLX(KV^MYKJZ6)8["(/<3@*S%$+'"<*
M26/0 ^M='67K>A6^N):^9<7-M/:3>=!<6KA9(VVE3@D$8*L001WH \_M=9UR
M]MM(T\:C?VKMX@GT^2681FX,"P2.%?&5WC@9&>0#S4D^J:Q937WAU-8NW!U^
MVL([V0JT\<,L"RL V,9^\H)&1N]A75V/@?2M/NHIX9+P^5>F^1))MP$QC,;-
MDC)W!B3D\GFI;_P;I>H?VBTIN$EOKF*[:6*7:\4L2JJ/&<<$!1Z]_6@#'\*V
MDMC\0_%5O+>S7@6TL-DDY!D"_O\ AB ,X.>>N,=>M+<KJOB+Q1K]G;:Y=:6N
ME) EJ+<+M,CIO+R @[QRHVY P#W.:W-$\,6>AW][?Q7%W<7E\D:W,UU+O:3R
M]VT] !PY'&!@#BH-9\&:=K5[/=27-]:M=0B"[2TG\M;J,9PL@QZ,PR,'!(S0
M!@3/K&MW_B=AKMU8G1@D-LEH%5#)Y"RM(X8'<"6 P3C ]3FJ>DW^L>,+JY=]
M9O-.@_L.POEBM"JE9I4D).2"=OR]._%=/?\ @?3+V>>2*XOK&.YA2"ZALY_+
M2XC4;5##!Q\ORY4@XXS6E:>'["QOKJZMHVC:YMH;5D!^58X@P0*.WWS^E '$
MZ#JFK>+[O1;>?5KJR4>'[?4)FL]J--/(Q7)RI&T;"=N,9;FLKP]JFHV&E_#^
MTAO"L=[J5]'=!  LP#RG\L\UV_\ P@>F1Q::MI=ZC9/86@LDFMI]CR0#'R.<
M<\C.1@@YP13[7P+HUG#HD4"SK'HTTL]HOF9PTA;<&XY'S'% 'G,USJ7AWX<>
M,M3L=7OOM<>O20(\CJVT"Z5"PXZE3@_TKL+HZGKWB#Q-%%K5YIT>CK%%:I;%
M0#(T(E,DF5.X98#'3"GUK0NOA]I%Y9:Q8RW%]]CU6X%U-;B8;$EWB0LG&1EE
M&>OX59U7P=8ZK?7-W]KO[-[N)8;M;2?RUN4&0 _!YP2,C!QQF@#EM'U'5O&.
MK6*2ZO>:?;7'ARTOI([,JA\]WD!()!P..G? ]\TDUK7K[PSH6K7]YJ\=@^GL
M9[S2HD=DN V/,E3!)3:,X4$9SD=*]%L] L+#4Q?VL9B=;**Q6-3\BQ1LQ4 ?
M\"/Z5D?\('I\=C;6=I?ZI9Q06YMC]GN=IEB+%MK9!'5FY&#R>: +NLRZE<^#
M99=#G$]]);J\$T6U3(#@EDW?*"5SC/&2*X>X\1W4-C;Z=97_ (AEEN=32WGM
MY[=!?VJ>2\A52<!MWE\-S@%L$X&/1+G1;.YT,:0!)!:K&D<?D2%&C"8V%6'(
M(*C'TK*_X0?3WMIEGO-1GO))HY_M\DX\]'C!"%2  , L,8P=QSG- '#:E'K%
M_P#\(_!J%SK5I&OB006LEP42>2%H&<,V 065@R@^G7FNQ^)ML9_AKKP%Q/%Y
M5E*Y,; ;\(?E;CD'O5FX\$V%UID%I+?:D9H;P7R7OVC,_G %=V2,?=)& ,8[
M5KZII5OK&B76DW9D-O=0-!*5;#%2,'GUH X+1;>^N;O1/#B:WJ4-FNBIJ$DD
M<BB5V8JBH&V\(N"<#U&356+6->U.X\/Z-_;-Q [ZKJ.G7-Y$J!YHX ^UNF V
M%'('7)Q7;7GA*RN5T]H;J]LKFP@^S0W-K*%D\K !1L@A@=JGD=1D8I;3PAI-
MDVCM DRG2GED@)D+%WE5@[.3RQ.YCGU- 'G>LZ=)!-\32^IW\XM]&B4+-("'
M#02'YN.<'..G4UU.F_VCH_B_0[.75[N]@U/3YY)XI]NQ)(_*(,8 &T?.PQD\
M8[\UK:CX*TW4[_4[N2XO8_[4M/LEY#%*!'*NUE!((/S ,<$&M)]%M)-4T_46
M\SS["&2&'YN-K[=V1W/R+0!RVOV,VH_%#2;>*_N+)3I%T9)+<@2,OFP_*"0<
M<X.1SQ[USZ>)-9F:PT.:XU:Y\J\U&&>YTY$^TSI;R*B9)P!_K!N(Y)7W-=]J
M_A>TU?5+?4VNKVUOK:%X89K64(45B"W!!!^[CD$>W2JP\$:9'IME:VL][:S6
M<DDL5Y#-^_WR$F0LQ!#;B<G(QT]!0!Q=Q/JEQK?P\.L17"7::G>1YN$59)(P
MC"-F"\!BFTG'?-3G5M9/A ^-O[8N_/\ M^!8?+]G\C[3Y/E;=N<[>=V<[ORK
MLQX/TSS-&D9[IY-(EDF@>28LSNX(9G)Y8G)-5_\ A!=+^V>9Y]]]C^U?;/[.
M\[_1O.W;]VW&?O?-MSMSSB@#D-5U_P 0KIE[H5C?R?VY;:I=!)2 6:WCB-PF
M>.A#11_C75>'-;F\1>)]0N[>X8Z3!96J11C&UI9%\YF^H1XA^)K43PQIL?BN
M7Q($D^WRVWV9LM\FW(R=O]X[5&?0"LV'P3:Z3X4GT/0YI[42SI-YIF(=2'0G
MY@,X"H% ]!B@#2\57O\ 9_AJ]N!>R63[51)XH?.=69@JA$[L20![D5Y[<:]K
MEEI'B2U@NM4MY;2;36M7U/RWGC\Z<(X.PD%2%Z'GD].*]+UG2+;7=+ET^[,B
MQ2%6#Q-M=&5@RLI[$,H(^E8A\ :6[W3S7>H327BP?:GDG!,S0R"2-VXZ@C'&
M!MXQ0!S6OZOJ_A"X\06UOJUU>A='CNX'O=CF&9IFB+#"@;>0=N,<5H0:7/I7
MQ0T2&75;N_0Z3=D&[96=6WP;CD <'CCM@XKIM2\+Z7J]W=W%[$\IN['[!*F[
M"F+<6X[@Y)YJMIG@ZSTW5X-5:^U&]OH8'MDFNY]Y\MBIVX  X*]>O)SF@#&\
M26<EQ\5/"1%_=PH;:\8QQ. N4\L]".^[!]@.E<[H8U'2O"FB:O!J]VHDUW[*
M;,;?(,4EX\; C&2?F+;L\'VKT;5O#MKJ^IZ;J+W%U;W>GLYADMY N5?&Y6R#
ME3M'Y5"GA/3(]%M=*'G?9K6\6]C^?YO,$WG#)QTW'IZ4 <7H^N^(=2U*UU*"
M+7)?.U1X9HS%']B6U$K1\<[MR@!MW4D$=*VOB0URO_"*M9V\5S<#78O+AFD\
MM'/DS<%L''Y&M>#PA8VVJ?;(;J_6$7#70L1/BW$K9+/MQGDDG&=N3G%6?$/A
MVU\1V]I%<W%U;M:7(N89;638ZN%90<X/9C0!E27GB"+1]6GOM'T_33#8RR0S
M6EZ9FWA21P8UQZYR>G2N;LQKLMWX023Q+J!&NV+O>@;/E*Q)(/*^7Y#R5)Y)
M!/?FNMM_"$<(F6;6];NXIH7A>*YN]Z$,,$XQUYXJY%X<L(9=&D7S=VCPM#:Y
M;^$H$.[U. * .#AU/7)UTG25UNY1O^$BO--DNR%,LD$:2D G&-V .<=0#67X
MVN;V+PCXMT2ZOI[Z+3M0L#;SW!!DV2-$^UB ,X.<'K@BNNUSP6LNH:,EBMR(
M#K,^H7<T<H5X6>&3YE/^^5P.??(S6A+X"TFYT.]TNZFO+@7UPES=7,LH,TKH
M5*Y;& !L48  P* ,N[?5-<U?Q48M;O-.31MD-I';E N_R5E+R J=X)8#!XP/
M?-4M-\;W>GAM3UF4M9ZEH,>KVL9X"2H@\Z)?KN1@/<UU&J^#+#5;ZZNC=W]H
M;V-8KV.TGV+<J!@!^"<X.,J0<<9K)\0^'&\0:UH6E+H[0:3I%PERUVSH$=53
M"PQJ&+$$[=VX 87OQ0!@M?\ B-;FQT6_N==>ZBTF.\N'TN.,O]HEDDX?=_ F
MS  X/?I23Z]XFU.Y^R7$6N6M]:Z5;RM%I<49 NI ^YI=QY7* !>GWL]J[S6/
M#-MJ]['>B\OK&[6(P--93>6SQDYV-D'C/(/49.",U7O?!FGW31-!=:A8,EJM
MF[6EP5,L*YVHY().,G#<-\QYYH L2WM__P (0]]<1FUU'^S3-(@ZQ2^7DC\&
M_E7!PZKKUUX1\-ZK>7NM"PETOS+F[TM$>1+@X(>5,%F0+GA0>^1TKTZ6P@FT
MQ]/(86[PF @'D*5V]3[5@?\ ""V$6GV5E9ZAJEE':6HLP;>XVF2(=%?((/?D
M 'D\T +XEO+X?#V?4])O?-NH;5+R.>)0!.J8=L#T=01C_:KGSXQG3QI)J;7A
M/AD1-9JF!M\Y;<77F9]=NY?PKO[>QMK73HM/AA5;2*(0)%U 0#:%_+BN9/PX
MT ^$$\,%;DV"2^<&,W[PMD]6QTP2OTXH P?#^KZ\/%'A&RU&^E?[?I$]Y=1-
MC!D9@R@\?PAMOX5R>G?\DZ\$_P#8Z1_^E$M>QS>'[&;Q%9ZXPD%W:6[V\05L
M($8@G(_ 5F0^ =%@TC3=,3[3]GT[41J4&9.?.#LXR<<C+'B@#DM5\1ZW$_Q!
M6WU!T;3[NPCLL@$0A]FX =P<G-3Z_J^K^#KK78H-6NKX#0S>Q&]V-Y4XD\O<
M,* %^8';TXKK)_!6DW#ZT\GVC.L2PRW6)/XHL;=O''W1FI=<\.6FHF_O&M1=
MW,VFR6/V>279'*A.[:2 2N3_ !=J ,.WBU31/'FAZ6^NWE_9W5E=2RI<[2QD
M3RANR ./FX';FF^*K.2Y^)7@X+?W<",MV2D+@#*(#GD'KN(/MZ55\,>']1;Q
M98:K=6&JVL=A8RV[2:I=QSR2.Y3")L8C8H5OF."2W>NNUCP[:ZS?:=>R7%U;
MW6GNSP2VT@4X8893D$$$ 4 <(FJZS_PB$/C8ZQ=F9[]0;#Y?L_D-<^3Y07;G
M(4YW9SN_*NQ\9?VJ-'A.E"\8"Y0W:V)07!@P=WE[N-V=OOC..:A7P+I:WBR"
M>^^QK=?;%TXS?Z,)MV_=MQG[WS;<[<\XK6UC2(M8MXHWN;JVDAD$L4]K)L=&
MP1P<$$88C!!'- 'GDGB&ZNY=)TJTU#Q!>6S1W4T[VUND=Z#'(B+%(&QC;O.3
M@$X7L3F6.Z\3:IJ7A72;[4;_ $M[JUOC>%%1)I%BD01OT(5BN"<#^)L=L=2?
M ^GK;VXAO-1@O(9)91?QSCSW:3'F;B000V%XQ@;1C&*N6OA?3[2\TRZC:X:;
M38)8(6DE+EA(5+EB>225!S]: .0OO$FJZ/I_BG1VN7GUB.[CBTIWQN9;K A[
M<[&WCZ)5+4M5\1G4=9M]/?7KFZT?RK>S%M%&8)I!"DC&?/)+E\''08(YKN[[
MPKI>H^);#7[A)#>V*E8L/A&X;!9>Y7<V/3)J+4?"%CJ.I3WIN[^V^TA!=PVT
M^R.YV\#>,9Z<94C(&#0!F?%)9)?A=K;K+- PM2Q"-@D="I]CG!K,_L.XN?B-
M-8IK>I0)'H%OOGC=1/(?/GQEMN,#)Z 9P/?/<:SI-IKNC7>E7RLUK=1&*0*V
M#@^A]:JZ9X=MM,OQ??:KNZN_LB6C37,@9F17=QG '.7//IB@#SNS\3ZSK5IH
M%K/+K+E])-U<2:1'&)99?,,89MW 4;2<#J6'85Z)X=N-2NO"ME-K$+1:B8,7
M"LH4[AD$D#@9QG ]:H#P-IT-EI\%E=ZA8R6,3P17%M,%D,;'<R,2"",@'ID8
MXQ6_9V,-AI\-C '\F&,1KO<LV ,<D\D^YH \W^'D_B4> ]"6W\.:3-:_9D"S
MR:B5=E]2ODG!]L_C5C7)]8NM4\:^3KE[9PZ19Q7%I';[0!)Y+/\ -D'*Y4<=
M\GVQKV7P\MM-LH;.R\0^(8+:%=D<27V%4>@^6M@^&+ _VN6:=FU:!+>Z9GR2
MJH4!''!P3SZT <8=0UG3[G2+E]9NKAM7T:ZN9XI OEQ2I'&ZF( ?*!N(QD\8
MSD\T[2;O6;"+P1JMSKEW>G6_+AO+>79Y?SV[2*R *"I4J.<\Y.:ZC5/#%K+I
M]NT"RM<:=83VMHN\<AXPN#ZGY5K/\*>"H=.L-!N;V:^>ZL+-!':33AHK:4QA
M7*@#KRPY) !.,"@#C?"5Y>?V'INC6=W+9C5/$5]'-<18WK&GF2%5)! +;0,]
MAFM74-5UO1&UV.+4KJ\@\/7=I>,9<-)+:2*3+$Q &=HW,#UX%=3'X$TB'1QI
MT+W402]:^AG27$L,S$DLK8_VB,$$8)!S39])7PYHE_\ 8-,O==O=0<_:/-F0
MO.Q3:#(S%0$  7"C@=!UH YWQ!XGU0S:_J&E74OV"T^R:9;^0JONGFD0R2*#
MP659$ !XSG-4=3U?Q+IN@ZM]F?6+:%9[#['<ZJB&57><)*GR_>7&T\\_,1Z5
MUGA[P1::;\/K?PQ?#S@8LW+HY!:4G<65NN0V,'J-HJPW@JQFL+BUO;W4;TW$
ML,LDUQ/N?]TX=%&   ".PYR<T 72LGAWPQ<R-=W.H26D$LWFW3 O(0"V#M '
ML,#I7'V5UJ^F6WA#6)M;N[U]:GBAO;>79Y7[V)G!C 4;-I Q@\C.<UZ,Z+(C
M(ZAE88*D9!%<WIO@C3=,N[.9+F_GAL,_8;6XGWQ6N05^08R<*2!N)P#Q0!R&
MFW^MKH'A[Q#-KMY+-<ZNEG);ML\EH7G:+!7;G=C!W9SGVKL/&9U5=.M&TU;Y
MH%N0;U=.*?:3#L;_ %>[C[^S..<9Q4\?A/3(M&L=+7SOLUE=K=Q9?YO,60R#
M)QR-Q_*K>L:-'K$4 :ZN[2:"3S(I[278ZG!!Z@@@@G@@B@#E- UN>Z\1Z':0
MZO<WUG)87S2&XA\J0O'-$JB1<##H&93P,\G'-4+/6-5UB[L-&;5+FW2\U;5%
MEN("HE$5O(P2-20<=5YQG"UTC>!=.$=D8+S4;:ZM&F87<,^)I#*VZ3>2"&W$
M ].,#&*4> ](BTV"SM9;VV:VNI+NWN89_P!]$\A._#$'(.X@@YR.M '/ZGI.
MI#Q5X3TZXUV>60?V@/ML:*L_E80JI."-V, M@9Y. >:Z#P1=WD]AJEK>7<MV
MUAJ<]I'/-C>T:D%=Q  ) ;&<=JL:?X/TO3)[">$W#3V;3N)9)=S2O-CS'<G[
MQ.!Z8K1TS2;;2?MGV;?_ *7=/=2[VS\[8SCVX% 'E=G<W^B:7KTEK?ZI--=^
M)VT\E"DDBIE=S(" /,*C;D\=..*NWVJ^)K32&@BFU6S236;*WLKG48T,QCE8
M*ZMC(8!L]><$#M77OX&TMVU/_2+Y8]0N!=M&L^%AG!#>;'QE6RH/4CVJ4>#K
M%[1(;FZO[MUOHK\SW$VYVEC(*9X "C:.  * ,.6RU*3QG#X<7Q%JB64>CFX>
M4.GGR2><0"6VX'![ =![YR-#U/7?[+\&:[=ZW=7$VIWHL[JW*H(6C*2X(4#(
M;,:G.>I/; 'HO]D6O]O_ -M?/]K^R_9/O?+LW;NGKFJ$'A'3+;3-(T^/SO(T
MFX%S;9?G> X^8XY'SM0!S_AB]U*+Q(EGKE_JT&I2B;=;7,2-:7(!R&MW48&U
M<?*3G!.1QFK7C&\G;5K>PM;[61*MK).UKI,<8?J LCR2$ *,, O<YZXK4TWP
MA9:;J$%VMYJ%P+4.+2"XGWQVX88.P8STX&XG X%2ZKX7L]6U-+^2XO()1#]G
ME6WFV+/%G=L?C.,D],'D\T <?H^H:QXKU#189]8NK."Z\.07UP+/:C/,S8)!
M(.T<]O0=LYCT+5M8\2MX;TJYU>ZM]UC=W-U<6VU)+AHIEA0$X..I8XZG%=CH
MGA+3M!FMY;62Y=K>S%E%YT@;;"'+!>@Z9P/8"JS>!=,6UT^*UN;^SET\R^1<
MV\P60+*VYU)((*DXX([#% %7X<)+'H^K1S3^?*FM7JO*0!O(E(+8' S[56\/
MIK&OJ/$ UZXMS_:4T?V(JK0?9XYFC\O;@'>0N=V<@GTXKIM!T"R\.6$EG8>;
MY+S/.?-D+MN<Y/)Y//K6=_P@^E_VK]L\Z]$'VO[<;'S_ /1_M&<^9MQG.[YL
M9QGG% '))JNL_P#"(6_C8ZQ=F:2_0-8?+]G\AKD0^4%VYR%.=V<Y'X4V]O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN?\ II4/A[4O$>J7NGZM%::XYGU"07323P_8A;;W3:L?F;@4 4YV[B5.<YH
M]3HKRC3[C54\/:!XADUS49;J?6DM'B:8^2T+7+1%2G0G'.X\Y[XXJ=-8O?\
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MILAC?##^,$G&#D=<=:L?V?J-SXX\9S:5?72:D-+M3:JTY\L.ZS8!!R, ],C
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M?V/(R78E4 J @?>,$Y4J<@UES^/K."QBOO[)U=[4V:7UQ*D"XM87R0TF6'.
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M)"ES]D>^2)3 LN,E3\V[VW;=N>] "P^$M/CM[:&:XU"[%M>+>Q-=WCS,LBC
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M_,@8R:23QWIT%C%/-9ZA'.]__9S69B4S1SE"X4@,1R ,$$CYASC.')XYT_\
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MHFA6WN([2Y>%)XU&%5PIY !(['!QG%:=MHEA9ZF=0MX?+F-K'9@*<*(D+%5
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MH(HRUJC1EG+DL!G/8%B<'&<5L7OC>PMA&UK9W^HH;-+Z5K.)6$,#9VNVYAU
M8A5RW!XH UTT:S34;^^5&\^_BCAG.XX*H&"X';[[5D2^!-&>VLX(FO;9;:T6
MQ#6UT\;20+TC<@_,.OOR>>:V+N^4Z#/J%G(KK]F:>%QR"-NY3].E</::QXGT
M_0_#NO7NM6U_!J<EG'+9&R6-A]HVCY&5N2I;.".0#TH [2UT*PLM5?4K>(I<
M-:QVG#':(D)*@#VW&J5EX/TO3]22]@-WB*1Y8;9KES!"[YW,D>< G<WL-QQB
MF1^,+5]8CL'T_48HIKE[2&]EB58)9E#$J/FW?PM@E0#C@FL74_B7$GA[6M2T
MK1]1N/[-CG4S21*(1-&Q3:3O!/.&./X??B@#=L/!VCZ:MF+:&119W<MY#F0G
M$L@96)]1AVXK2L]*M;"\O[J!6$M_*LTY+$Y8(J#'I\JBL"+Q'%-XGTFWN'U*
MQGN;"6X-E*D7E;58 LY!)!';!Q@\T^T\>:9<*)9K6_L[62VDN[:YN8@([F)!
MN9DPQ;[IW88*2.0* )=4\#:+K%U?37:W12_4"Y@2Y=8I6"[0Y4'&X #!_P!D
M'J :M)X6TU=.U6R83R1ZJNV[:24EI/W2Q$Y[':HY]>:71/$(UF1XSI>HV#+&
MLJ"\B4"1&S@J59AVZ$@CTJ#7?%EOH4\L<FFZE=)!!]IN9K6)62WBR?F8LPS]
MUCA=QP.E #+[P1H]_=&X?[7$9+=;:X2"Y>-+B-<A5D /S8!(^A(/'%;.G:?;
MZ5I=KIUJI6VM84@B5CDA%  !/?@5BZAXUL+&^FMH[2^O%MK=;FZGM8@T=M&V
M2I;+ G(!.%!..<57C^(&G7%SIEM:6&I75QJ-E%?PQPPJ2L+G&YLM@8[_ %&,
MDXH LV'@C1M.O;>XA%TT=H[26EK)<N\%NS9!*(3@<$@>F3C%+%X)TB&YFE3[
M5MDOUU'R3<,8TG#%MRKT&6))'>FV_C2QN=3CMEM+Y;6:Y>TAU!HU^SRS+D%%
M.[=U5@"5 )& 318>-+'4-0M[=+2^CM[N1XK2]EC407+H"2$(8MT5B"R@$ XS
M0!;O?"^E:A+J4ES [MJ,<,<Y$A'$1)C*D?=(+$@CG./2JZ>#-*^RM#.UY=,]
MS#=/-<7+/(SQ$%,L>P(Z#CKZU?UG6%T>"%_L=W>33RB**WM$#.[8)_B(4  $
MY) K)'CFSEM[1K73=2NKNX:=?L,4:":,PL%EW[G"C:Q4<,<Y&,T =115>QNX
M[^P@O(ED2.:,2*LJ%'4$9PRGD'VJQ0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*^-(+D2:!J=K!
M]IDT_4EE:V614>56CDC(3<0"PWY R,X-=56)XM?0H?#=S<>)$1M,A*NY96)5
MMP"E=OS;MQ&,<\T <"UGJNN:YXGO(-.,=Y::EIE['8O(F]Q$H8HS E0Y7GK@
M$@9[U>US0=8\7S:SJ,6FS:?G3H;6S@O&0//(D_G'.UF"KE549/<GI79^&K/3
M+31T;2M/FLH)V,K1SQ.DK-T+.'^8G@<GMBIKS7;&PUO3-(G=Q=ZEYOV90I(;
MRU#-D]N#0!Q>N:1JWCBYGD.E7.E10Z->6<?VQDW23SA!@!&;Y%V<GOGBI[-=
M<U;Q+X4N;CP_=6%OID4Z73W#QG]XT04; K'*Y'7C.1QUKK=&UVQUZ"YFL'=T
MMKF2UDW*5Q(APPY[>]:5 ')>,;6_N+_22EGJ-[I:^=]JMM/N/)=I"%\HL=Z$
MH/GR,]2">E87A3P_K%C?^'5N],DMTTV35%F8RAUQ+*KQE6SN8$$C)&<@YKTJ
MB@#S0:'K.F:G%K2:9-<_9/$%[<M;1,GF2031E ZY(!()!P2#C-;_ (0M=275
M_$NH:CI[V*W]Y'-!&[JS%!!&G.TD _+R,]<]>M=910!YWXP\,:M?>(V33("V
MFZ]#%:ZM(KA?*6*0-NP3D[HV=./:J_C/0=7U:[URR33+^\BN+ 0Z68KSR;6
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M!1(8S)MW!,9!4<AN<D9V]!&O^'Q_8$6AR3+_ &E-*-0:1!!]FDE:0L?FW>8
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M<G!7WS7JU% 'G>E:;J7A+6'FL?#<\MK?:9;0I!;W*R"UFB,F4=Y&!*?O/O\
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M^\,19?G#RNR<YQR".OKS7HM% 'G=QH^IZ]XOTC4GTVYLK0Z+<VDQG*;X7<@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MADMY1E'*E<C..A -6: "BBLZSURQO]:U/2()&:\TT1&Y4H0%\Q2R8/0\ ]*
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M(=2A,\$HMWV!0 ?G;&$)SP#UK7H **1B%4L>@&36?H6MV/B/1;;5M-D:2TN
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M'++2DE,K0(?,E(P9)&)9V_%B3^- &M1110 4444 4M9_Y >H?]>TG_H)KBO
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M]Z5B1QMY_=\G&4P<9YY)J&WGU"<Z-HYUG48X%\27U@THN6\V2!$E*HSYR3P
M#U'!!R :](CT'3HI=+D2 A]+B:&T.]OW:E0I'7G@#KFN>UOP5;W>H:.MK;,+
M--4GO[TK.R,'DBD&]3G<#O92-I&.U '$>,FGM/"OB_13=W-S:6&IZ>;9KF9I
M719#$Y0NQ)(!)QDDX-=/>0SZ[J?C":XU74+1M(*PV26UV\*PX@63S&52 Y+,
M?O C Q71'P1H+Z)<:3+;2S6US.MS.TMQ(TDLH((9G)W$_*O?H,4_5?!VC:Q>
MRW5U%<+).@CN5@NI(EN$'19%1@'')'/;CI0!QEGXPOM#3^UM6FEE@U?08M2M
MHG8E4NHXU$D2#MOWH0!WS3+_ $W7-'TZQGUB[UV\M8--5KFYTZ_*S6ESN=Y)
M6CW#S4P5 'S !"-N#72:[X>N/$/B#1K6;3;>'1=(N4O%G,@+2NJX2-4 ^503
MDYZ[0 *U-7\):3K=VUS=I<B22(03""ZDA6>,$D)($8!Q\S=?4^M &O#(DUK'
M+')YB.@97_O CK7FWPY/C#_A -"^QKH7V+[,NSSFF\S;GO@8S7IBHJ1JB*%1
M1@*!@ >E<G;_  V\/6ENEO;-JT$$8PD<6KW2JH] !)@4 8.NPW>H:OXY9M7U
M.!-,L89K..VNWB6.3R7;=A2,\J.#QUR#V6T>]L-6\-W/]J7\\FL:3<RWJS7#
M-&TBQQNK(F=L>"Q V@<5VP\.Z8!J/[AR=1@6"Z+2L3(BH4 R3P=I/(YIMQX>
ML&BLVB@/G:?;26]F=Y^160*1UYX5>3GI0!Y_HAOK'0_ >N_VSJ5U>:G-!;WB
MSW;R1S))"QQL)VAE*@[@,G!R3DU0T"XN?[-DTR&ZFM8M2\9W=O<30.4?RP'<
MJK#E2Q0#(YQFNS\'^!;+1M)T*6\AF_M*QM$7RVNGDAAF*;79$W% 3SR!W/J:
MU?\ A#="_LRYT\6C+!<7C7S%9G#K.3N\Q7!W*<],$8H XG5)-5T6Z\00Z9J&
MH36^@-9:I'#)<O*S1L'\^%F8EF4HA8!B<'%+K^OZE?RZQJND7ETVGQR66DVP
MMIM@D>61&FD7<0H?;(J*QZ'/(KKY=';P]I%VN@:7_:%[>/\ OC>79)D)7&Z2
M1R2R@ # [=!3=!\%Z?I7@2V\+W,:7%N(MMQC*B1R=S,".1\W(.<C ]* .-OI
M_$NDV%S:)8:S;6-[?6<%O'-J4<UR-Y;SE24R,5#!4 +,,%SC'%==X,AU>V?4
MX;^SOK:Q$J-91WUXMS*H*_.N\.Q(!&1N.?F]*MQ^#=%73KNSDBN+A;MD>::X
MNI))F9.4/F%MPVD9&",'D5>TC0[+1(IDM!,SSOYDTUQ,\TDC8 !9W))P  !T
M% ''^.;B6XU*ZM[1M9EFL=--RZV5Z+6*V+%MLKMN4NWR-A3D84\<UG7]UJ9M
MK'Q!JLVK_P!F/IEK-]KTNZV"RDV[I'EAR!(IR#DAL $8KN-3\*Z3J^HB^O(9
M6E,0AD5)W1)HP20LBJ0' )/# ]35'_A7WA_RHH1%>"!(EA>(7TVR:-?NK(-V
M' !P-V>..G% '23F3[-(8<&38=GUQQ7(_#)+-_AII6T(WF0L;O>,EIB3YN_/
M4[MV<UV5<Q>?#_P[>W=S</;W,0NF+W,%O>2PPSL>I>-&"DGOQSWS0!SJ:3I.
MK>.K"VTRZDAT== )B&FW#1!U$^  Z$$*/0'DCGTK.T_6M5=/AVDFI7;F?4+R
MWN&,IS<)'YBKYG][A0>>_->EP:)IUKJ$5[;VRQ316HLX]F0JP@Y"A1P!D#M5
M.+PCHL/]F;+0C^S)I9[3]Z_[MY"2YZ\YW'KGK0!PGAZ;Q)JUSI^KQV>L%KB_
MD%W.^HI]F-OO="BP^9E2@ P0H;*G)YJ]\+=)@M;_ ,6SI/>NT6NW5N%ENY'4
MJ!&<LK,0S_[9^;WKJX/!^C6^K#48X9A(LS7"0FYD,"2MG=(L6[8&.3SCN3U-
M7M,T:PT=KUK&$Q&]NGN[C+EM\K !FY/'0<#B@#BOB5HZ>(-;\+Z4[E/M+WBI
M(.J/]F8JP]PP!_"N?U_69O&_A:&PF4I)I^F75_J\?39<1*\2(?\ MJKOCTC%
M>KW6E6=[J%A?SQ%KFP9WMWW$;"ZE&X!P>"1S51/"VC1?VR8[)4.LY^WE68&7
M*E3WXX)Z8Y)/4T ><I-JVIM:Z=:VNL316>@63P#3K]+41RR*_P"\?<Z[_N
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ML1;+=7=R=Q9I;J8RNS'KR>@]AP.PJ]110 4444 %%%% !1110 4444 %%%%
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MD+@0VL2()%DA8+)&^Y@%()/.<?*>>F67_P 1+2P.ILVD:E);Z5.L-_<(L>R
M%5;=R^6'S\A02,'(Z9J:7X9NK77_  Q>PZ.NGVMM%?M<P_:O.,3S%"N6)RS'
M:2<9 .>>A,6J^&=7N?#/CZSBM-T^JW326:^8H\U3#$H.<X'*L.<=* .CTGQ2
MFIZU)I4VF7UA<?9A=P_:0F)H=VW<-K'!R1E6P1D<4[5O$PT_54TJSTR\U._,
M'VEX;8QKY<6=H9F=E')!  .3@U&^F79^(L&JB+_0DTF2V,FX<2&5& QG/13S
MC%4M1M]4TCQK-KMEI4VJ6UY81VLD5O+&LD4D;NRG]XR@J1(1P<@CI0!SGBOQ
MG?ZF_A6+0(M42RU:=O,EM3!',^Q6W0CS&^5E9?FR ., GI74^+_$5]X9T&RN
M;33YKN>:ZM[8JS)E=[JISEE!8@D#!QN()XKGK3P?K-J?!)>!'>QO[J\ORD@V
MP^<)&P,X+8+[>/3-=%X\TV_U+P]$NG6QNKBVOK:Z\A756D6.568 L0,X!ZD4
M 8__  E^H6'B?Q"DFE:E>PVUM:W!M83%FU4QLSY)< G(Z*3G!Q5YO%FEGQ/;
MR"\U#R9-";4P@"_9C#N!WD??\S!^F/>G6NEZE+J?BF^ELG@74[*W6".21"V\
M1.&4[20""P&<X]"16)I7A?7++7=&O'TZ)TM/"0TZ1995V&Y!4^6V"3@X.2 1
M0!V&A^()-99EET;4-/!B6>)KE4*RHW0AD9@#ZJ<'FJ7C/6+ZR@T[2]&F6+6-
M5NEM[>1D#^4@^:60J>"%0'\2*H>#=*O=/UBX>'2;W1M(-L%^PW5VLR"?=]Z(
M*[;$ R.P.1QQ3+KPG?>(O'-[JVISWVGVME"MKIAM+H([@_-+(2N2,G"X..%H
M N:!XO1_ LVLZVPBN=,$D.IJB\K-$</@#UP"!_M"EC\=1+>BROM%U.PNC937
MPCG6,YBCV]U<C)W8QU&#G'&>6UGP3J&F1^)+6QNI)=)U;3_/ENM0NE/DW<1R
M"[,0=KJ "><;>:GU"XU77O&5FDVDFRD?0+]8X'GCD<LQB&248J%)P%)/.#D"
M@#H+7Q[#>:3:ZA#HVI%;YTCT^)A&'NRR%R5!?"JH5B2Q P,C/%3_ /":V[V<
M)ATV^DU*6Z>S&FC8)EE0;G#$ML"A<-NW8((QUQ6'?^%+R7P=X.CFTZ2[GT>.
M$75C#<")W'V<QN$<,HW*Q!^\ <$9YJG<^#BUKIM_%X8N(XX+V>6?38]1)N)$
MDC""0R&0#>-B97?C'?- '1MX]M"-/BATS4)KV^DG@2S54$D<L.-Z.2P4>N<X
MP,YZ9KP_$>UE@6Y;1=4BM8[P6-Y,ZQA;2<R>7M;Y\M\Q7E01AASU JZ5X:N;
M;6?#E[!HO]G6\$E[+<Q-=^<T9D550LQ8Y8A1D*2!ZU'<^&=7D\(:[8I:9N;K
M7C>0IYB_-%]J23=G.!\JDX//% &Y<>-+:#498?[/O7L8+I+.?45">3',Q4!2
M"VX@%E!8+@$^QQ5N?B%:VYO91I&I26.GWAL[R\58Q'"P8+G!?<P^8$[0< \U
MAGP>T6O7\5QX:GU!+O4S=I>_VB8X$C=@[;T#YW*=V $(/R\CG%N]\-:M-X*\
M6:?':YNK_4II[9/,7YT9T(.<X' /7% &SH_B:_U'QMKFBRZ5+%:Z?Y06X+1X
MRRELMAR<,,%<#@9S@\5'/XLN[?X@2Z%)IL@T^+3Q=R7>Z,!1N(WG+YV#!7&,
MYYQCFETNRU*P^(>OW$FGR-8:FEN\5VDB;4,<94JREMV<], CWJGKNB:C=^-[
MB:.RDET_4M$;3'N8Y$'V=R[G<RLP)&&_A!YH O:;XW@O[K3EETK4+*UU3/V"
M[N!'LG.TN!A6+(2H)&X#('KQ5W7?$T6AW^G6'V"[O;S4?,%O%;!<L4 )!+,
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M\Y/W6+1XSW^;YR!QG\JP;'0-:T[1=/V6<,MS;>)YM2:'[5&-UN5EP0=V,G<
M!ZD9P,D '0:YXUM/^$2UV>]BUC2;C2WB2ZBMS%]ICWLNQD;+(0V>N>F[O6E:
M^)[ZX^(5[X>_LJ86=O:13?:MT?!8O\Q^?.T[0H 7.0<X&#7'>)=#U?Q)X=\9
M7,5B+>[U;['%:64US%YFR%@2S$,4!.6XW= *ZB&.ZL_B9=7XMA-I]]I\$'VI
M)X\0O&TA(92P;G<,;0>M &KXQUU_#WAFZO;=!)>MM@LXO^>D[G;&N._S$'Z
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MY?+66-XO]9N)8( ,KSNYW+C.:8_CRS9=+6UTW4+JZU(3B&V145TDA(61'W,
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MVC2Z5+#:Z<T:I<%H\99=WS8<GY@01@<#K@\5C7?AK5I?!'B/3DM<W5YJ\MS
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M]!6WH6J^(M<ATG78+RT33YYW6ZMI9!@(6*A5 CW"16 '+8)S[8 .Y)VJ2<X
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MI&GOK\XAU32'NY"MO#NAD0Q<QDJ<9\PYW;NG&.P!TG_"&^%O^A;T?_P!B_\
MB:HZEHG@G2!;&]T#2(A<W"6T1&FHVZ1R%4<*<9)ZGBN<TW7_ !!JUOX/B_M<
MV\FI&\ANY4MXR7,(<!P",!OESZ9[8XJO=:CJ=WHB66K7 NKC3/%UG9K=>6$,
MZ"6)U8@<!L/@XXXH [G_ (0WPM_T+>C_ /@#%_\ $T?\(;X6_P"A;T?_ , 8
MO_B:YJ^\1ZM<:'XMUBRO?LTFA74T<5J8T,<BPHK-OR-WSY;D$8!7'?,ESXDU
M+2]:F2[N)6@U;3UFTB%D13'<\!H<A<DDO&1G/&[TH Z'_A#?"W_0MZ/_ . ,
M7_Q-'_"&^%O^A;T?_P  8O\ XFL&YO/$5]J6I:%IFIHE_IUG RSR%$\Z5PQW
MNOEL"F5 PN._MA;*ZU_4_&,]@VMK!!!8V5ZR6T,;HS.T@D169<E&"=>O0@CD
M$ O:;H_@76#=C3]%T2<VD[6TX6QCS'(O53E:TX/"GARVGCG@\/Z5%-&P=)([
M.-65AR""!D&H=>2]TW1[VZT6 S:A+-'(R[U#R+N4,J%OE#; 0H/&<4WPEK$>
MM:;<3I<W4K1W+1/%>0"*:W8!28W4 #(SG/<$<F@#:N;F"SM9;FYF2&")2\DD
MC!511R22>@KG['Q]X=U"\M[6*[F1KIMML]Q:2PQSGL$=U"L3VP>>U4OB=M'A
M!&G&;!=0M&OAV^SB=-^?;U]JZ#5IM'CL(7U4VIM6GB$7G*&4REAY>T>N[&,4
M 95Q\0/#MO>W-FT]Y)-:RF&80Z=<2JKCJ-RH1GD=ZN7?BW1;#2;;4KJZ>*"Z
M.V!&@D$LK?W5BV[R>.F*Y'PU'XH?4?%)T:ZT>*V_MR?*WEM+(^[:F>5=1C&.
MWK6@?-C^*VC?VNT+3-HDJV[(I6,W'F+YOE@DD';M[DXS0!T&C>*=(UZ>:VLK
MB074*AI+:X@>"55/0[' ./?&*V:XSQ!L;XF^$!;X^UJEVT^WJ+?R\?-[>9LQ
MGO79T 9>N>(=,\.6T$^IS21I/,((A' \K.Y!8 *@)Z*>W:JNG^)M%\22RZ=
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M?(NDR^7J?[V,B 8!#*<_O/E8-@=J .KN=&L;S5+74IXG:[M5=(9!,Z[ V-W
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M)Z>V:T+'Q58W=UK$#AH/[+5)9'<@J\+IO61?]D@,/JIH W%544*H"J!@ #
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MY]ZN6WC":ZTVZDCT*];4K6]^PRV*,K%9" P8N#M";6!W'Z=:Y_Q-XKN[O3M
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MQ.X@,2A%'(^\2<XZ8&>M;=AXXTC4+VUME2_@%X<6DUS92117!P6PC, "2 2
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M1S'(K(4>)QU5U8 JP]"*9<6NCZ*^H^('L[>&<0F2[NDA'F.B+GD@9. O3VH
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M()51D$HCPXW=0-AR.M8/A7P6^BWNG6LWAFSS82.3JS7.[S% 8(R(#D.<KG(
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MHJ>8@W(RGG=D$ CCD9(Q7I=9NK:U;:,^GI<I*QO[Q+.+RP#AV#$$Y(X^4^M
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M>7@YQFM&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6EK'A70]?FCFU/38;B:,;4EY5POIN4@X]LXH PO#\L+?$3QA=V[H+)4M(II
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M8?(6'(W?=R.?FXYKS'5II-/ATVSL=#GM=4M?$-JYTQ[T20EFAEV&.0]%;'/
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MC&[J#7=MX3T%M'CTDZ9"+&*0S1Q+D;'))+*0<@Y8\@]S3)_!WAZXL;6RDTJ
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M/8:3#I^H:I>1D%]0G69P!C!6-4_'[N<^_M4&H^%]#U:_2]O]-@GN$"C>P/S
M'(##HP!Y .<4 >?^+[RXTWQ%+86U_-!8:G%"VO21$D:<&8()%;/R&094^@&_
MM6I/I.G:SXIU^QU6:6&STFPMA9;+AHQ;(RN6F4@_>!4#<<XV5V@T731'?H;*
M)EU DW889\[*[?FSU&T8QZ52OO!WA[4EMEO-*@G%M$(8M^<B,=$//S+['(H
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MKFO'NC7_ (A\(W6E::D)N)WB(,TFQ5"2*YR0">BXZ4 +8WMH^K$6?B"XOQ!
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M"RXY7) Z]CQ5B/2=8O\ 0[J'4_#NA1O(J126D4A9+A=ZEV+;!M^4':.><9-
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M+ ZR^E1VFI2W4?D&0):/B-9<A6;/11M.3V_ X6/QEI+7MI;N\D,=[&\MI<R
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M<-CIF-A7=31K-"\3%@KJ5)1BIY]".0?<4 9U[K]E8WNFVK^9(VHSM;PO$NY
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M_,,9.'#L7&&!XP.M9.IW\WAZ?XB:I92S_:8)[8(6F=Q&KPQ;W"L2#M#,PXX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8NB%0RO@?(XWKQSUZ\57T3QEJ]WH&@*VD+=ZSJ%B+LH+E8T,05,REL?+N9P
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MZJ'5CSAM_P!T\97CC-4M$U_4;[2\N9CJ&@VDRZE#O/[ZZ7*JI]0VQG^C)ZT
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MO&Y1I7CE^6,,.1PS,<$'Y1VSD ]*_LVP_P"?*V_[]+_A1_9MA_SY6W_?I?\
M"O/I-1UY?#VIWHN[J8^'=8D5MAPU[9IM9U;'5E5B,CJ4]S5W4O$4T>GPZO;W
MA%AJVJQ6L,CRE$C@P1O#8.W>ZGYL='4C!YH [3^S;#_GRMO^_2_X4?V;8?\
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M;POH-QJ\.K3:19O?P ".X,0W+C[OY=O3M6"/&>IP: ^K7>EV,D#/;""6QO\
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MJ^'0N4#KO R5SSCUH X"Y^'D\FKZYKEM-;6^MS7R7>FW@R3&%B5/+DX^XQ#
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MR34DU)].M&OT&%NFA4RJ/0/C(_.@#Q[5H=&D\":]>7RVW]O'7I$:1L>>&%T
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M%%)YL:")=J/DG<!C@Y).?>@#R+Q-::?IR>,;)(X[/35U32)'CA'EI'N:/>P
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MC8.C ,K*<@@]"*=4<$*6]O'!$,1QJ$4>@ P*DH **** "BBB@ HHHH ****
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M%N++4%?Y^/W,A8+M;GDC(&#[9P]<\>:NOA/Q/]E&F+J>F6\4OVBRNS-$$EW
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MQ\86T4L"KK,?EVN2?W8^S+"-_'JN>,\5TNG6S6>F6EJY!>&%(V*]"0H''Y4
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M;^A^HKSIHM-/BSQS/Y=I]IDT:"2%PJ[VW13;V4]3GC)'XU2\)Q65P? T.M)
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MC?:;:1[+A[V]^QMY<HS"WEN^6'_;,C''6N%FTR#2+OPC-H]I'!>S:5>*TD2
M/,WD*PWGJQWX/.>:H:9%X>2U^&,FG"T&H23(TK18\Q_]&D\PR8Y)WGOW)]Z
M/75N;>2=[=)XFF09>,."RCW'45':RV0 M[1[<!5W".(C@9ZX';.:\G\%V,\S
M^&KR:\T*WOA=3--Y:-]MN)-LGG1R'//.2<\ JOM72_";2[*V\$VE_%;1"\N7
MF\ZXVC>X$S@ MUP !@=.* .LO=;T_3]2LM/N;E([F]+"%">NT9/T_P :K>'_
M !':Z]IL%R-EO-,\JK;M*"Y$<C(2!W'R9Z5SOBVVT]OB1X,FO8+4@B\7?,B\
MD(I49/H<D>]<O8:580>!M"U2.TB&H'Q(A-UL'F<WS(1NZXV\8Z4 >IVNHR23
M7XNH(K:&UDVI+]H5MZXSN('W/H:NQ313Q++#(DD;#*NC @_0BO(HK2WOK[QS
M;SWMK:%M?MFB:\3?!)(JHRQR+D95B,=?2NV\"SPO8:E;QZ?9V4MM?/%.MA(7
MMY)-B,7CX& 0PR,<,#WR: -7Q'K5GH&B37U[%)/%E8A!$H9YF=@JHH) )).,
M5)H.L6FOZ%9ZI8AA;7$89%8 ,G8J0.A!!!'J*XOQ/<ZGKGQ L--TBP@OX- "
MWUW'/<F%#.X(A!8*W*C+XQW%<]=76LZ#I'C?0+JT2QFO+*?5M/BMIS*%5N)U
M5MJ\@_-@#C?0!Z_%>VL_^JN89.2/DD!Y'7\J!?6C+(RW4)$:AW(D'RJ>03Z
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M#NP' (.#QSUX. #/T+P=<V.KV]_J-UI\OV2"2&"*PL!;(QDV[Y'&YLL0@'&
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M2IQG&0,X..V:?A/7!8:'Y-Q)<7=W<ZU>VEK&\A=WVS2'!9C]U40DDGH.YP*
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MN&N]0@M6^8#:KL,]>I(R!Z9SVY -9M,T]X9H6L;9HIY/-E0Q*5D?(.YACDY
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M]6XBE!;SC$LOFK$5QCA@!NSR!T!IT5OIGB#X@)J>EWPFBM(6BU)(N8WFC?\
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M=641ECN)"'KNZ=L=:6?0M8N]3T&^N);+=I]W+/)'&6"A&C:-43CLK DGJ<]
M>-UM6TU9[>!M0M!-<J&@C,R[I0>A49RP^E.?4K&*^CL9+VV2\D&Y+=I5$C#U
M"YR: ./G\':K-H>JV ELP][K*ZDK;VPJB5)-A^7K^[QGW]N:5I:7FM:W\0=*
MMI+18KR>*"65G)>(-:QJQ"@8;C.,D<BN]74K!K]K!;VV-ZHW-;B5?, ]2N<U
M0FUW1;#Q%;Z,\UO%J%U$TJIE5) *C![Y)88'?!]* ,+4_ G]IWM]"TL<6EW&
MB)I*!6)E3:Q97Z8.,CC/;WQ5Q=)NUN],UGQ#<6B?V);3'S(6;;(S(%:5L@;
M%4_+S][KQS;\->++'Q#I=A.9;:WO;N+S19?:%:11D\XX)''7%:@U33GO9;$7
MUJUU&NZ2 3*74>I7.0* .8\):=8SZUK&N:==&XTN[E+6@'^K#.JF=T/<,RK_
M ,"5O6I/#.@^(] MX=)DU&QN-(L@5M6$;+</&,[(W/W0!P-P!) Z"MG0O$&E
M>(+>=]*N8IDMYG@<(P."K%<X!^Z=IP>XK"M/&FK:G]HDTSPC>W=M#<RVXF%Y
M;H&:-RC$!G!Z@]J -7P?HUUX?\,VVEW;PR2P,_SPD[6#.6[@8^]C\*P-7\&Z
MWJ%[?2K?6#B34;:]MI9XW,D:1-&WD\' 7*$\=2QR.<UUC:S9VMI'+J=Q;Z=*
M8EDDAN+A 8MW8G..N1D<$CBI8]4T^6\%G'?6KW102"!9E+E3R&VYSCWH Y#4
MO!VJWVG>*[83V:MK<\<J/N;$85(T.1CG_5YZ]_;EVH>$M::X\2#3[FQ%KX@M
MB)XYR^ZWF\KRR4('S*0!UQC&?:NK36-,ENH[6/4;1[B0$I$LZEV )!(&<G&#
M^59FB^*%U75_$-E);K;)H]PL+3-+D2 H&W'@;<9]30!HZ;:W%CH5K:.T4MQ!
M;K$2N51F5<>Y XKE=,\&:IIMAX2C2ZLS<:&)8Y"P8K*CH5R.A!'!Q^M=7!K.
ME75L;FWU*SEMPXC,L<ZLH8G 7(.,Y(XJU)<0Q2Q1231I)*2(T9@"Y R<#OQS
M0!RFG^$IX/%4&NR+:6MRJRI=R6;,/MP;[GF)@ %>N>3D=A6MJ>DRZKK%D;J"
MTGTJW5W:&7+%I2,*VTC! &X8_P!K/:K]KJ=A?&86=];7!A.V7R95?RSZ-@\'
MZTMEJ-CJ4;26-Y;W2(VUF@E5P#Z$@]: .=M/"\^D^.)M7TF.QMM-NK1(+FU0
M%"\BL2L@ 7 (#%?<54'A+5&\&^(]$:6S$VK37<B2!VVQB=B2"-O)7=^/M76M
MJ%DEO+</=VZP1,4DE,@"HP.""<X!SQ46J:BMA9SO&ULUTL+RQ0SW B#[>N6.
M<+R,G!QF@#(GT/4;C6O#=^QM572TE69 [$N70)\OR]L9Y^GO64_@[57\/W>G
M^;9B2?6_[4#;VP%^T";9]WKQMS^/M6M_PE3KXKTC0GLTW:A8O=M,D^Y8RN/E
M''S#G[V1]*D\)>*$\3>&%UJ6W6R3S)D96EW!1&[*6+8']W/M0!A:IX-UR_O;
MN;[;8/NU.WOK>6=':2-(V1O)XX"@H2,=23D G-37_@K4+P^(HTU&"!-2N8+Z
MVF2,F2&XB6+:2"<%=T0/J<^W-CPSX\M_$EQJL@2RMM.L99(UN'OE,CA&P7*8
MPJ'LVXUL7VMQKI45_IDEC>QR2I&':\6.,@M@D/@@D=AW/% &?_9OB._TF2'6
M6T:ZD<HCVBQ/]GDC!^?<6!.6[<8&!UJUX3\/GPWI4MB)/W+7#RP0"1G6V0XQ
M&K-R5&">@^\:K:IXXTJQAU]+>6*YOM&M&N9;82A2^$9MH/)R-N#QQD5J6VO:
M7<0R,-0LP\,8>X3[0I,.1_'S\OXXH YR\\%7.JQ>+;:]GAB@UQXY(GA8L\#)
M&B*2" #S&&Z^WO5R30-3U&^M=2U,V?VRRLIK>!87;8\DH4-(Q*Y48084 XR>
M3Q47@WQS#XNLY+WRK2TMFE\JV4WJR32?,X^=-HV$["0,G(SZ5?\ %WBB+POX
M8U35TB2\ET]%9[83!3\S #)P=O7/2@"QX7TNXT3PMIFE7+Q/+96T=N7B)VOL
M4*#R!C..E9^J>#K?5?$CW\\F;*YLC;7MICB=AGRV/^Z))/QV^E.;Q=%%XT.@
M7$,<,*Z0-3:\DF 509?+V$$?CG/X5T,MQ! (S+-''YCA$WL!N8] /4GTH XZ
M;P9?GX=#PZM]'<7S^49KN?(#E&4@G .?E15_"K-WX<U*YU?7[U6M%74],CLD
M4R-E&7S/F/R\C]X?^^??CHKW4[#31&;Z^MK42-M3SY53>?09/)HNM2L;&2&.
M[O;:W>=ML2RRJAD/HH)Y/TH Y"#PIK^E7>E:AI-YIXNH=,BTR]AN5=HI%CY2
M1"N"&!+<'C!QGO5]_#VI_P#"1SZF9[>82:2+#+L59GW,Q<@ @#+8QSC%5]&^
M(%MJ)TYKR"'3X+O37OVFFN0%BVRK'L)( .=V<\>F*Z>?5=.MK)+V>_M8K1\;
M9Y)E6-L],,3@YH I^&=,N-#\*:9I4S123V5JEON0G:Y10H/(R,X_#WK$T#0O
M$.@:1>642Z5-)/=SW2222R81I'+@%=G."?49QVKI[C5-/M(EEN;ZVAC9#(KR
M3*H*C&6!)Z<CGW%*=3T];V.R:^MA=R+O2 RKO=?4+G)% ',3^%M3DN/$LGVB
MVD_M?3HK)'=F#*R(ZEV 7'/F$X'I[\0W?AZ^M?[,OYI;00Z7HT]G+B1LL65/
MF&5Z#RQU_O>W/1:MXCTK0[JPM]0NXH)+Z4Q1!W Y"LQ)R>%^7&?4@=ZL3:EI
M@O5TV>]M!=R#Y;9Y5WL/92<G\J .,\':3<ZQX5\$W5TUL+;3+2*XA$3EFED\
MG8N[@;<!FR 3DXZ8YEM_!.I6]O97"7-JNHV&K7.H0<L8Y$G9R\;'&1PY&X \
M@'':NSFFM--M&FGE@M;:/EG=@B+]2>!31J>GFVBN1?6QMY03'+YR[7 !)P<X
M. "?H#0!S5U9Z1HL>M:CXGNK6%=>D2WF0L?+VB+8L8) +$@,<X'7IQ5:R\'7
M5S\.(]*FU">/4Y?*N1>2H#(DL91HMR]RHCC4^N#75IJ>F7&GF_2^M);)/F-P
MLJM&N.^[..*HZ7XDM]7U_4=.M1%+!:6]O.EU%,'642F08&../+ZY.<]L4 9-
M]X?\2:YH1CU+4K"VU2&:*>S>SB8Q1R1MN#,&.6W=".P]:WM&CUI87DUN:S:X
M; $=DK"- ,\Y;DDY]N@'J3A)X\MKCQQ<^'K9+)H;.-7NKN6^5""0QVHF#O(V
M_-R,5U?VJW+0CSXLSC,0WC]X,9^7UXYXH YN;P_J?]OZ[J4+6+)J%M;P1QS9
M8?NBY(<8P0P<CCI_*;PKX9'AQM1$*QVUI=3+)%802,\5N=N&V$@8W'G   K!
M?XIVT/@E=?EL8TN);U[."S:["^8RR^7NWD<+W)P<5T5CK]U<N_G6^GA%L1<Y
MMM0$Q+9.5 V@[>.'[],4 86H>#=<O-0GG^W6$F-7AU""::-VD$:,I$)P>%&#
MC'7/8Y-7!X3NF\4P:Z4LH+R":5GN+9V1KR$A@D4J[<<93YB6/R<=>*^G_$,W
M]AX0NO[+V?\ "0RO'M\_/V?:&.<[?F^[[5UU[J5CIRHU]>VUJLC;4,\JH&/H
M,GDT <7X6\$:KX5GLI[.XL\LKQZG$&;9<C<6CD7Y?E=0Q7/< #TQ>\/^'=?T
M5?[(?4;*70(I': B-A<^622(B<[<#.-W4@=!U'6+<0M*\2S1F1%#.@894'."
M1V!P?R-5I]8TRUMX;BXU*SA@GQY4LDZJLF>FTDX/X4 <79^"M?M-,T+2/MVG
MO9:+J"7%O.ROYLD*AP%9>@8!L9!YQV[]+XIT:YUJRLULY88[BTOH+Q/.!V-Y
M;9VG'(R,\TV;Q596GB2[TN^DM[2""TAN1=3SA%8R/(H7G _Y9YZ\Y]JW!(C1
MB0.I0C<&!X(]<T <>WA/4H?^$AM;6YM39Z]EYFD#!K>5XQ'(RKR'! ! )&#W
M-7?$]K!IGPTUBSB.V"WTB:&/<>BK"5'\A6U::II]_#)-9W]K<Q1DAWAF5U0C
MKD@\5E1>)K#4?$=OH]J;:]MIK*6Z-S%,LB QO&NS R/^6F<YXQTH R-.T2\U
MC3]!U&=K0&QTUDM5BD8B1Y8E0NQV_* H/ W?>Z\<O7P=?)X4\-627-NFIZ \
M+PR?,8I=B%"K<9 92?7!]:TQXHT\Z[I>DZ<]K=17@N-TMO.K"$Q!3M(7/)W>
MHQ4<?C*PM;#2I=8GLK2XU&9X8TAO%FC!7><^9P",)R<<$@4 26OAI)KO6[W5
M$B>36(4MIH(V+(L**RA=Q +$[W).!U [9-.#PI>6_P /;WP^UZES?W5I);/=
MRY ;*>6K' [(%'OM]\UN66I27%WJ4<Z6L45I(%5X[D2$KMR2ZX'EGV)/'-26
M^LZ7=VLMU;:E9S6\/^LECG5D3ZD' H YNU\,ZQI>NV^JV%Q9%I=/AL;V"8OM
MS'G9(A R3\S?*<9]16;I?@KQ%H%CH,NF:CI[:CI]D;"XCGC?R)XBP88(^8,I
M'7'.>U=S;ZE8WEQ-!;7MM/- <31Q2JS1GT8 Y'XU5EUZP.F:A>6-U;7ILHG>
M1()U;!52=I(S@\4 7;*.XBM(TNYEFN,9D=5VJ23DX'. .@Y)P!R:GK*\-:S_
M ,)#X9TW6/(^S_;8%F\K?NV9&<9P,_E6K0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*>.8+::'2
M6EU.SL+J&\\RT-_%YEO+)Y;@HXR ,J6(.0<CC/2NKJ*XMH+N$PW,,<T3=4D4
M,I_ T >.V]W]KU;2YA_PCVEV@L[V*/[7$9[)Y5N,2M"=Z#Y@ P_V<CIFM#0=
M&LI?%GA.UN98=4MX- N)()6A*HP\Z,(0C9. K8&?0&O3Y;&SGMTMYK6"2!,;
M8WC!5<=, \"I'6"(^>ZQH8T(\Q@!M7J>>PXH \GU.&2#5M2^'D898M9U*.[A
MQQMLY-TER!Z -$Z_]M15?Q#',->^)J6B/QIE@&6(<^6%;>!C_8W5Z[NM'N(G
MS T[(?+;(+%>^.^*D6&)97E6-!(X 9PHRV.F3WH \N\6S>&+G1-1/ALV1N1;
M6ANY;92\"VGVA21($(4C;O)'#;=W(%12V%C<+J\USXGT-/,DL<M8V1%I',CL
MT9E!=E;=PI^8<!>G%>GV<%BEN38Q6RPRDD^0JA7/0GC@TZ.PLXK5K6.T@2W;
M.Z)8P$.>N1C% '*>#];LDM;N&X73+:=M4-J)=/8_9[R8Q*^Z/T.W@CG!1N35
M7XI?\>_A/_L9K'^;5V\=G;111Q1V\*1Q',:*@ 0^H';J?SI\D,4VWS8T?8P9
M=R@X(Z$>] 'FFHZ98W=Y\3Y[BUAFE%NBJTB!BH%FIXSTYP>/0>E:VN7B0_#'
M36N8;>X6Y2QB8WA/DH7:,;Y,$$J#@D9&>AZUVODQ'S,Q)^\^_P#*/GXQSZ\<
M4CP0RP&"2*-X2NTQLH*D>F.F* /$[BYM_M.K1W-]I]SIZZYIDMZ]K!Y-NT7"
MLVPLP*AU0,V2,K[5/XDDTR:_\<2:087M/L.FF[:UP49!._F_=X(\O(./0U["
M+&T"E1:P;3'Y1'EC!3^[]/:G16=K;ILAMH8TV[-J( -O/'';D\>] 'FEU-HD
M_C[4'T5K1U_X1:X$KVA4IGS$VC*\9QCWP5]JRO#GV&&+X5SWOV=$.GW2>9-M
M +;$*C)[YSBO7H;"SMDV06D$2@%=J1A1@]1QZTKV-I)%'$]K T<1#1JT8(0C
MH0.U 'C-GY0L=3>\V_V8GQ F:^,G^K$?\)?/&WS/+SGBK7B5;&[?QB=,,+Z7
M)_94<S6Y'EM<?:!OP5XW;#'G'M7K@BM#YUNL<)W_ #2QA1\V[NP]\=^M$=E:
MPVPMHK:%( <B)8P%'.>G3K0!Q\:6&B?$R\E2."RM$T!99O+0(@"3/\Q ]!G\
M*D^)DT5S\*M:GAD#126@='7H5)4@C\*ZRYLX;N&:.10#-$T3. -VT]L_C1'9
MV\5C'9")3;QQB-8V&1M P!S]* ..TBYT:/5K8I\29=1<OM2TEO[1EE8\!<(@
M8G)X /7%<BVD:?/X'662TA:6;Q<5>0J-Q!ORA&>N-I(Q[FO6TTK3HW5TL+57
M4Y5EA4$'U'%3_9X-FSR8]F[?MVC&[.<_7/.: /'_ !I;6=I/XVA\E(K,C17E
MCB7 YN&#' [X 'X"KFO-I<NJ>*7T)K1K,>$9EN39E3'O^;R@=O&[;OQWQ7?>
M(]%@US3C8>?';33302^9L!9Q%*LF,9&?NX]LYK0%O86<31B&V@CG?#*%51(Q
M[$=R: /,?#<FG0:CX5DUQ[9+0^$K=;-KLJ(_,X\T MQNV^7[XJOI^-#\,Z'X
MOC#)8:=J-U$< _\ (-GG8*<=2J_NW'L*]5DMM/O$-I)#;3I#M_<LJL(^./E[
M<=*RO$NA2:]%;Z?+J26NE2,%N;58AON0#N$8<GY5..0 21GD4 >?2V5Y#8^&
M=5NI;&TDU;4I]1N7U*(R01RR1-Y"N R\J@"C)X8>M0QVTEKJ6BO%K>@R6$D^
MHO%/-9M]BCF9H\HBF0<\38.XCEP*]CFMX;B!H)H8Y(6&#&Z@J1]#3)+&TEM1
M:R6L#VX  B:,%!CIQTH XFSM+BW^#VI0Z3?1WTK6EXUI+:1-&GS&0JL:DDX!
M.U>3P!CBL/5I?#-SX,N$\++"^L?\(]((S8?>2#";E?;QN/8-SD''>O5D:($P
MQE 8P/D7'RCMQVZ5%';6=D)I8X8+<.=\KJH3<?5CW_&@#SV:W\.ZSXK\/6>A
M"SELY=,NXKQ;/;C[*Z*JJ^WI\V, ^A]ZH^&9+O7=6T;0+HEY?"<<IO"PX>X4
MM#;D_5 TGXBO3[.VLH5:6RAMT68[F:%5 <^I(ZU,D,4<CR)&BO)@NP4 MCID
M]Z /(?!%L9O^$5:;6-&2]MEE,EK;VC"\=_+83),WF'^(Y8E0"RCU%/T'3[.T
M\%_#.ZM[:*.X>^AW3*H#MO@EW MU(/\ 0>E>L1V=M%<27$=O"D\G#R*@#-]3
MU-.%O"$C00QA(SE%"C"GV]* /'M*U*VF\0>$KY)M'M4N-3N6-I;0GSX-\<X(
MFF+G+,V/E*C+=/NU+I6GV=OX#\&7<5M$MTVNPLTP4;R6F=3ENOW>/IQ7K L+
M,,Y%I "[B1R(Q\SCHQXY/O2JEH3]G18"82&\L ?(>H..U 'DUI!HSV6OVDNH
MZ?IM[%XHEDA-Q$KID$%%E3(_=GG!) SC!SBNQ\*:G&WA;5+A+"S5K6XG$@TU
MB8+EU 8O'Z9SCV8'K73/I]E(TS26=N[3 "4M&"9 .@;CG\:FAABMXEBAC2.-
M1A410 ![ 4 >*V%W;"]TAHKK15CGT"\"V^FPE/)#)&RQO(7;S&X)Y /!..:V
M].T^VLK?X8RV5M%%<20.&D50&<M8NQW'OE@#SWKTE-.L8U"I9VZJ'+@")0-Q
MX)Z=3ZU*((AY>(D_=?ZOY1\G&./3CB@#QC39M#;PQ\/H8FMCK*:K!]H5<>>D
MF6\[S.X^?KGOCVKM/&EY GB'1[65M)M6^SW-PM]JL9DCC"^6K(B;U!8ANI/
M!]:Z];"S29YEM(!*[!W<1@,S#H2>YI\UK;W.SSX(I?+;>GF(&VMZC/0T >.^
M$[O2UNO"SZY-:"QBTN^AA-T D<<XN%!7#'"L(_X3R!D5#H%EIU_=>%+86ZR:
M<=?U8QPR+P442% 0?3"\'TKTW6]&EO9[9=-U*UL9XV>5X);5)XYLX^9DRIW
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MXDBW!.XR,@E0><9%9OAG1H]*L[B8WPU"[OIS<75X% $KX"C !("J%"@9.,4
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MP7PY9K:QW2%BL3238!#Y.=H YYI-'O4L_@#;W,]N+N--)VM"[E59<;<,1R%
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MK["O2]2\.?VAXMT+7?M7E_V4EPOD^7GS?-55ZYXQM]#FL#4/AP;[P_XKTO\
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M=<11KG=E3)!P/^FB[?\ MI6/=:))H-S\-;"4E[E+^62Z?KNF>-FD8_\  F-
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M]X=P.F*V+>^M+RQ2^MKF&:T=-ZSQN&1E]01QBO+]!UO2K>\\'ZQ>7UNNEQ:
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M^H16"ZU8&[F8I'")UW,P8J5 SURI&/4&LOP*NQ/$2A=JC7;L@8QU(/\ ,FN
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M>0#_ ,@"89QW\Y:YOP3"LK^&-/N_$*-J6F22-)ID=B!+#($=9/-<'(4[C\Q
M#$K0!Z;IVOZ1JT[P:=J=K=RQHLCK!*'*JW0G'K7+M\0[>;XA2>&[6YTM8+9
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M5!C228+OSQD9[9.,UY_X[UC0-=\$>+)]$1;J9=/B2:^@7,;#?E8]W=EY)&.
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M (!ZBC&:**  @$8(R*" >HHHH " 1@\BBBB@ K,T+18M"T]K2*5I5:XGGW.
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MC-%%% !1@<\=:**  # P*.^:** "@ #H*** "@@$8(R*** "BBB@   Z#%!
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M7%;-NDD5M%'+*9I%0*\A4#>0.3@=,U)10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%(2 0"1D]!ZT +12$A1DD >]+0
M4444 %%%% !1110 4444 %%%)D;MN1GKB@!:*** "BD!!S@@XXXI: "BBD)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KSZ+5XXM1\8^+[Y#-%H>^QM(L_<6.-7DQZ%W8#
M/HHKT&N!ATB(ZMXL\)ZAN2TU[?>VLH_B#QJDJ@]-RLH;'HP/K0!IP6FO:U;W
M&E^)['3Y-.O;3)DLRRF%\C]V0Q))&<AQCE>@XJ;P'J=UJGA&V:_D\R]MI);.
MXD/5WBD:,L?<[0?QJO#_ &SX>MYM6\2:U!<6EE:&-(+2W9/.;(^=@6),AP%"
MCC+'KFK7@72KK2/"5K%?ILOIWEN[E/[DDKM(5_#=C\* .CHHHH **** (;Q9
MWLKA+5U2X:-A$[=%?'!/XUY?X>CTBRO]&@U6#7-#\2+(BR7%R\C1W\N,.GFY
M:-PYR0.#TQ@UZ3J\D46CW;337$,9B*F6V1GD3/&Y0H)R,YX!KSAM1NM26QLM
M;UE[C3[2XBN&>#P_>)/<-$P9-Q(*K\R@G Y]LT 6]$\0>(X=$\0WU]?:2QM]
M7EM4ENF:** +(%9B6;[@'(48)/&>:D@\?ZC<:6AM%TR^N_[:CTKSX&86\H>,
M.)%Y)&-P!&3T-8SK'&UX+?49#%_;)UBU6;0KPXD8DLDF%Y7DX(YR :EA^SG4
M'N;O5KJ;S-6@U5]NA7:G>D7EL@^0_+@+M[COF@#;G\9ZUIL>L6-Y;V%QJUK=
M6EM:M"'CAE-R0$+ DD;3G.#R!VJNEYK5AX[UJ>^33Y;VW\/QO$Z.8()!YLA!
M;>3L .0>3P,]\"GK!TK4[O6;N*_U"&>\DLY[5CHMTWD2VYW*6&SY@3U''&:I
MWRQZS-JMWJ>K3FZOK&*U1(-!O!%$8Y3(."I+*3UY[F@#3?XCW=OHGB.X6?1]
M4GTJVANHY[ MY+B1F4H06)W#8><\@CI6S/K7B=-1TS11'I4>J7JS73N4D>*W
M@38 I&X%W+.!G('!.*Y#58QK<>LF]U>42:K81VDBQ:#>!(3'(S)LRN2,.V<\
MYZ8'%;VO:S:7>LZ;K6D7=S!?6:2P%;G1;QXY8I-I(.U 0044@_6@#*TKQ)J&
MB:=>>:VG6$MWXBO(KB[O-S6T# 9QD%?O$8!)']*],TF>ZNM*MI[Q;=;ATR_V
M:3?&?=3W!'(^M>;6-X^DZ=/%:ZQ+<3W-]/=7*7?AZ[,,XEQD$!,K@CC!(P<'
M/6M[PUKNB^'_  _;:89;^4Q%V+)HUTB L[.0J^6=J@M@#/  H T]8UG5#XDM
M= T5;-+E[5[R:XO$9TCC#!  JD$L23W& #UK@?&FJZIXF\.:'!+'8Q9\1QZ;
M?VS*[QR2I(R^HS$< E3SR.>*W]9UJTEUZUUW1KNYAOHK=[22.ZT6\>.6)F##
M[J @AER#[D5E2P:3)I&E6IU'4&NK;6UUFZG.BW0$\F]G8*NSY1\V!R< =Z /
M3].MOL6F6MJ8[>,PQ+'LMDV1+@8PB]E]!Z5YIJTWA=OB!XBC\374Z%([7[,J
M3SK@&,[MHC/7./>NS_X3;1?^HE_X*KK_ .-UD:?KNCV7B+6=4,^H.NH"#$8T
MBZ!3RU*]?+YSF@#'L_&&H:+H>@:9?ZC8V%]<6\]PUWKSE<0K)MB5AN4F1E9<
MY/&UB<FKMCXZUG7[O1;71;;3@U_837,LLS,\<312B-]I4C<I.0.G4'VI=;UJ
MSN=8M-8TFYN(KV"&2V=+O1+N2.2-RK?PH""&4$'W(IEEJ5A#XCT_6+O4;^YF
MMM-DLY2-#N8_,=Y$?< (\*/DQCGKUH Y^&[O-(\?>.O$NIPZ=>2:.D&W$+>8
MH: [$A8L?+!) ;@YR:[/_A(-?TG5+>QUR/39&O;.>>W>S5U$<D2AFC8,QW @
M\,,=#Q7/SQZ#>W7C!KJ\U(P>(4A4!-'N@T'EQ;,Y\ODYP?PIT>H+?ZC%?:[J
M4TTEI:36ULMKH5Y&-TH :1\J><*  .!DT 7+;QEXF?PKHVM2V6F;]8N+6&VM
MU+C8)0<L[9]<$8' R.31<^*O%]NGB2+R-&:;0(Q<2R[)0ES&8O,"*N[*-@,"
M22.G'6JT<VDIX8\,:1]LORVC36LK2?V-=XE\D8( \OC-2W5YI-P_BQA=Z@O]
MNVZPI_Q)[O\ <XA,>3^[YZY[4 6/%'CR[T:W6^AN-%M[<6"7JVU[,?M%UD$E
M(P&&W   8@Y)Z<58OO$WB&?4M=M]'@TU8=*MHKD/=J[&7?&7V85A@\'YNW'!
M[<S>0V\L.IV=KJUS#:ZII\5G<NV@W;2KLC,?R';C:<\@CCG'7(U-/O\ 3X#K
M4MU>7CS:G:0P-Y6C785&2,H3RAR#G- &I'XJUK79X(/#UO81R#2X-1G-[O89
MF!*1+M(P?E;+'...#6=KGQ&N=-N[FW:71=-N+"SBN+BRU&Y'FSRLI<PQ$,!P
M,#=A@2PXK.AF3219S:'JL\-TNE0:;=&YT&\='\H'9*H"C##<W!R""/2IGO/L
M5W+/I.M77F7=M##=SWV@74LGF1J5\Y,(!N(/*D8R![B@#TNRNH[ZQM[N'/E3
MQ+*F>N&&1_.IZS--DN;J<WBW7F:;+ @@B>W,4BN"VYFR >1MXP,8]ZTZ ,OQ
M*[1^%=8=&*LME,0P."#L-><^%;7PS<Z;HC2^'_$K7DL,!>Y:*\\HR$+ERV[;
MMSSGICVKT[5;(ZEH]]8JX0W-O)"'(SMW*1G'XUS.F:1XWTO3;/3XM6T!H+6%
M(5+:?-N*J HR?.QG H SM7\:>(+.#Q-?VUIIQL= NA'(LF_S+A-D;L%(.%8!
MSR00>.!C)L7GBS7]'N-7M]2MM.:6#1)M6MA 'PICX,;Y/S<E?F&W// JWJ'@
MJ6]T/Q;IXO41M=G:5',9/DYBC3!&>?N9[=:B\<Z([V>O:X)AM3PY>6?D[>26
M&_=G_@.,>] #]-\2:ZNLZ'!K%O8+;:W"[P+;;_,MW5/,VN22&RN[D 8([URG
MP\UJ^L_ 'A;2-*CMS?ZE<7NV6Y#&.*..5V=BJD%CRH R.O7BNIT+P]JL]UH&
MHZKJ%M-;Z7:D6B0P%'=GC"[I"6(R%R. ,DD\=*JZ3\/[W0]!T*&QU*W.J:/-
M</'++"3%*DS,71E#9'5>0>JT .'C;4[*<0ZE:V@^QZLFG:E+#N"A945H9DR?
ME!+H"#G&>M.USQY/IEWK(C2S2TL9K:QCN+ERB?:9>6+MG 1$92>_49J#6]+L
M=&\'Z^/$5Z+B^UUW9OLT+ O+Y86*.%,DDJ$7&3U&>*M:;X.O'\!6EE=70CUP
MW":G-<NF\?:]_F'<H(RN?DP,<=* ,P_$Y8M/NXVU#0KBZBO8+6/4(9L6>)59
M@[_,2NT))E=W) Y&>.D\'>)QXCBU")KFPNI;&X$37.GON@F4H&5EY..I!&3@
MJ>:ANO#>M:EIZO>ZE9#4H+R.\L_)M2((2@*[2"=S!@SY.1C=QC'.UHUMJ=O;
MRG5;NWGN))"X6VA\N.)< !5R23T)R3U/88% %'QAKT_A[28+F$VT7FW*0/<W
M08PVRL#^\?:0<9 '4<L,D5RU_>ZU?>)O!\T)TJ2^DBU!4N(G:2V9,1XD !R<
M@?=SU/7O7<:S;:G<VL?]E7<%O.DFYEN(?,CF3!!1@""!R#D'J!U&17/:+X)E
MTS4M,OGNK??;27DTL-O"8X]T^SY8QD[5&W\22>* *P\8ZI_PC\DUQ+HMC>6V
MIRZ?=75U(5MEV9^=5+!F+?* N[N>>*P-1U]O$DG@.^D\@R+X@E@=[=B8I#&)
M$WIGG:V 1GUKI'\%:A;7RZA87]I]KCU2YOD6Y@9X]LR[2" P.Y<<'/J.]5X?
M %\L^EM/JT4RV&LRZH'\@JTOF;BRGG .YCT[4 .^'O\ R,/CG_L-M_Z+6M_Q
MCK=UX=\,SZG9V\=Q<1RP1I%(2 V^5$(R.G#4SPYX;?0M2U^Z>Y68:I?&[50F
M/+!4#:>>>E4?B9$\W@6YBC=HW>ZLPKJ,E3]IBY_#K0!F:QXRU[PXFM0:E!IL
MUU;:6=2M7MU=8V"OM9'!).02O((SGH*O2Z]XD6?2M,\G3(]4U0S3HQ61HK:W
M15)##(+OEP."HY]JKZIX(U77XM9EU;4[/[7>::=-MS;6[+'$A;<SL&8DDD+Q
MG@#O6UK6@7EU>Z5J>F74,.HZ:)(U^T1EXI8Y% =6 ((Y52"#P1WS0!BV_C;4
MHKRTM]1M;5?*U=M)OY(MV [1AX9$R>%8LH(.<$]:S_&WBR0^'?&#MI=C?:7I
M,EM;*ERK,L\Q=#(&P1PF],?[0K;/@F2X\+:S87E\CZEJL[7DEU'%M6*<;?+*
M*23M3RTZG)Q[U7U#P!+??#2Z\+_V@@O+R3S[B],1P\IF$KMMSW(('/ Q0 NN
M:WK5[>>([#2H;'[)I5J!<?: YDG=XR^U"#A,*5Y(.2>U<]9>.7TCP]H6EV^H
M:)9/;:!:73G59MGGLT>%CC^88/R'+<XW+Q74ZGX5U:35]8N-*U.VMK;684CN
MUF@+O&RH4WQD,!DK@<@X(!YZ5!;^#M6TB*S;1M2LDN%TNWTZY:ZMC(K>2"$E
M0!A@C<W!R#QZ4 =3H^I1ZSHEAJD*E8KRWCN%4]0'4-@_G7&ZQ?:XWQ!U'3DN
MK<:6FA&X,)1LX+,I/WL;LKUQTXQGFN[MXWAMHHY)3*Z(%:0J 7(')P.!GVKF
M]4\-7UUXL.L6=Y;QQ3Z:=/N(IHF9MNYF#(01@Y;O0!SWA'7-:TS1O!-O?16'
M]EZC91P1",/YT12VWJS,3M8,$.0 ,9')I_ASXDC6=6TF-[W198=69UBM+6?=
M=6F$9U\T;CG(4@X"[6('-;L/A)X[#PC:M=(W]@JHD.S_ %V+=H>.>/O9[TGA
MWP[K&AFSL6U.T?2+!#'"B6N)Y4QA%D<DCY1CE0"<#IR" =57D>GP:?I\MK%X
MHCUK2?$0N@3K)>1H+A_,R ) 2@1A\NQ@  <8S7K;+N4KDC(QD'!KB;GPIXEU
M'2_[!U'7K.YT@E5DG-JWVN6-6!VLV_;N. "^/?&: ,^[^):V^MW*?;M%6UMM
M2&GO8//_ *:_SB-I5&[& Q)V[3E5)R*G?Q7XIN;?Q->:?8Z:UMHMQ/ L<@<R
M7!C ; P<#Y3^)/08YUK?PYJ^GZI<#3]2M(M+N;XWLBO:[YU+$-)&K$[=K'/)
M&1N..Q&AX?T)M%.L>9.LPU#49;T +C8'"C:?7[O7WH IGQ2;W6_#]EI2130Z
ME:O?SR-DF.W"C:1@]69U'X&N7\)>*;N[\'^%K31--TRPN]5^U,L>QOL]O'$[
M;R%!R225XR.6)S70>#O!7_"+75]-)>"Z$@%O9C9C[/;*SLD?7G!<\\=!6=I/
M@"_T'P]X>@L-3MSJFBFX"2S0,8IDF8EU90P(_A((/5?>@!=5\::GI,FG:;J<
MNB:/J4Z3R2W-]/FW*1L%4H-RDE]P(!.5 .<XJHGQ%O=1BTLV4FC6;7=L\BO?
M2,8KF9)&C:**0$#JF<G/#+P>:V&\+ZY'-9:I'J]K<:S"L\<S75N3!)'*RML5
M0V5"%5V\GC.>O#M6\-^(-0TH:>^JZ;=0SVOD72WFG@J');,L85A@X;&TY^Z.
M<YR =;&6:-2Z[7(!90<X/IFN4U'7-?NM=U+3O#UO8.=+AC>87F[,\C@L(T((
M"?*!\QSRPXXKIK*V%E86]HKM(((EC#N<LVT 9/OQ7-ZGX<UD:UJ&HZ#JEM9G
M4X(X;K[1;F0QL@(62/##YMK8P<C@4 4[GQ-XBNYM:DTFTT^.#1E43Q7>YGGE
M\H2NBLI 3 8#=ALGVH3Q3K6MZO#9:!%810SZ/;ZFD]ZKMM\QG&PJI&>%'.>.
M>O I]SX0UB"758])UB".VU=%%VUU 9)4D$8B:1"& )95!P1C(S[5J:5X7CTC
M75O+>;_18]*M]-BA(^8")G(8GZ,!^% '+Q_$+4K^#1S;_P!DZ?+?:>MTHU%W
M"7$VXJ88W! !&W.3DX9>#S5BX\12:?XL\6O!HML]Y8:3#<[XP3+.<,0C$=0,
M<8&>M/\ ^$(UF'PK!X>AU/39[$V9MIDO+(N%8ECYL>&'.&'#9'R@C'.;MMX-
MO+'6]6U.RU;RI;O3X+.!VA#M$T0(#MGAL]QQWYH Y_6O$_B&Y\*I=Z?JNASH
M^H6<27NGER"'E4,A7<2I!P#SRK$8!JQK_P 1I]%O]1MGOM!BDTB&-KFVN92D
MUXYC$CB %OE&" ,ALDX[9JS>^ ]3U*'4KJ>]TVWU.ZDM)$^RVK+!NMY#(&<%
MLLS%B"<C  ZXK0D\.:_%J%W=V&J:?;OJ2Q->L]H7,<JH$+PY;'*@<-G! //(
MH S=0\8^(#'XFO-,M]--EH>),W <O<)Y"3%1@@*<,>>1R..IJSI>JZU??$VZ
M@%S -)&EV]PMN4;< YDP1\V-V1R<= ![UH3^$Y)K+Q=;B[4'7@P1MG^IS;K#
MSSSRN>W6BS\-7VG^+8=6M[RW:V?3XK*ZADB;>?++%61@<#);D$'I0!LZY<WE
MEH.H76GQ1RWD%N\D,<@)5V520IQSSC%<Q_PGCS>(?#UM:V\3Z=J-M%-<3DG=
M$9E<P@=N3&P.?45VW6O/K/X;S6/AW5=/AU11=3W44UC<>5_QZI"P:%,9YVD'
MTSN- %=O%4FIZ]X9EGTNQEBN]7O;>RG=6+QQ1*RB13GAF*M^!%8LNH^(KW0Y
M9KZ:UNY8?%T4%LBAT 9+D+MR2<)P,<9'/6NR'@81-X.6"[58_#V=P*9,^8]A
M/7@DY/?K5>+P1J"/<0-J-L;)M=36(@(6$@/FB1D8[L'T! H U?#^L:K/KVK:
M+K"V;7%E'!/'-:*R*Z2[Q@JQ)!!0]^<CI1\0+V_TWP#K=[ILRPW4-I(ZR,#E
M1M.2N",-Z'L:NVFBM;>*]3UDS!EO+:W@$6WE?+,ASGOGS/TI_B31_P#A(/#6
MI:1YWD_;;9X!)MSL+#&<=Z .*B;Q&_CNT6WDTXZB_A]6EGEC<Q >><80-N)/
M'\7J?04'XDRRZ?HH>ZT;2;N]MYIIYM2E(@0Q2>650;E+%FR1SP >M=)H_A_4
M+;6X-6U*[MI;A--%BZ6\3*I(D+!ADD],#ZUF6?@G4='M],ETR_LS?V<=Q!)]
MJ@9HI8Y9?,Z!@05.,'///KP =!X6UQ?$GAJRU9513.K!A&^]-RL5;:W=<J<'
MTK8JKIT%S:Z=!#>7(NKE$ DF$8C#MW(4< >W\ZM4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5SGC
M?Q?:^"_#DVISB*68%5@MGF$9F8L!@$]AG)P#@ UT=<)\855OAK?DJ"1/;8)'
M3]_'0!N6WBK3(=&LKW6-7T6U:YW!&BOU:%R"1\CMMW>_'!IFJ>)C8>+?#>C1
M0)-%K"W+>>'^X(HPXP.^<UAW%WI&C?$?5YM?FM+6WFTJ!;)[HJL916E\Y%)X
MSDJ2HY((KF-#AG@UGX41W$<D;"'4BB2 AEC,>8P0>F$*\4 =]X=\7PZMI.JZ
MC?B#3X+#4)[-I))@$VQL!N+' &<UL6NNZ1>P03VFJ64\,\GE0O%<*RR/@G:I
M!Y; )P.>*\ATAHH=+2ZO=HTNW\;74EXS_<08<(S]@HD*<G@'%:&J>1>W?BWQ
M!H[1SV>G3:??Q36Y#1R30;FGVD<$^40IQ].U 'JJW]F\]S EW TUJ ;B,2 M
M$",C</X<CD9K.AUZ&74K@?;-+.G1V:W2S)> OM.3O9>@CQR&S@UY3>W%Q!:/
MK%MN\[QJEQ9QL!T9YE6V/X0LY_"KNMVD5AXB\<6=NNV&#P>L4:^BJK@#\A0!
MZG::WI.H7LUG9:G97-U ,RPPSJ[H/]I0<BF6WB'1;RX-O;:O83SK)Y)CCN49
M@^"=N <YPK''L?2N%U6Q^SWOA.+2X5BN&T6^BB\H8)/DQE1_WU@_6LO3+WP_
M=2?#.#3&MWO+5Q',L0&Z#_19-R28^ZQ8=#R=K'UH ]5U'5=/TBV^TZE?6UE
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MWG[P'OC8IX^M6-;NO#&M>,;]H+^$6#>&Y([F]L@)%3]_%C[H(.T$$CL",\4
M>GZ=JVG:Q;FXTR_M;V%6VF2VF610?3*D\U'>:]H^GWL5E>ZK8VUW-CRX)KA$
M=\\#"DY-<YX(U+[;J6L0M-I5^\(@SJFF)M2X!#85P"P#J!S@D8<=*YO4KO2+
M*T^(=EK;VZZG>2N8(9L>;<1-;HL C!Y;Y@0,=&S0!TFL^/8+'QO8^&+1]-:>
M5/,N);J^$0B^8 1@ $F0YR%.,UU-[J=AIJ![^^MK56#$&>54! &2>3V')KS_
M $ZWEC^*^A)>H#=KX6_?%ADF02H"3[YS6AXXGT^V\7>#)]4:)+2.ZN&9YL;$
M/DG:6)X #8Y/0XH ZL:[I#:2=5&J61TX#/VL3KY77'W\XZ\=:/[<T@6,-\=4
MLOLDV?*G^T)Y;X!)VMG!P%8\>A]*\EN7$E]<:GIU[9VN@GQ1YB7DL/FVRM]D
MV&0@,H*^=QNR!NP>U69=/L[A=!SJ5KK%M>>+?.=[>U,4&X6[AE0%F#+N4DD$
M@DM[T =1J7Q&L8_%>F:%I=SI-S]JB$\ES-J"HB(2H55P&W.P;('&1CUKJ$U[
M1Y=5;2X]5L7U!<[K5;A#*,=?DSG]*Y&YMX5^-^FJL,84:!*0 HP,3)BN8L;B
MQ?P-X=T:*2 ^*(M8A,MN"/M$<ZW&Z9V7[P&W>2QX(/O0!ZF_B+1(YI(7UBP6
M6,.SH;E 5"MM8D9XPW!]#Q43>*O#J1W,C:]I@2U<)<,;N/$3'@!N>#P>#Z5Y
MG<65LOPR^(5RL*"XDU74 TN/F($V ,]<>WUKJ_[+L$^+-FJV< 6+0'"*$&%Q
M,JCCV!(^A/K0!T]WKVCZ?90WMYJMC;VL^/*GFN$1),C(VL3@\>E.O-<TC3XA
M+>ZI96T9C\T--<*@*9 W9)Z9(&?<5Y/H>HQ6NB^&K62YTW3@EC>-'>7L'G%A
MY^WR8E+*,D8R.20  *N> 4MK[5_"7F".9[7P]<)A@"8I%FC4C'8@$C';- 'I
MD^N:1:Z8FIW&J645A)C9=23JL39Z88G!S276O:/96$-_=:K8P6<V/*N);A%C
M?/3:Q.#^%>7:%-9Z9<^&;G4WAM](@O-9A228A889C<'R\D\+\HD _$=ZFN;G
M3EUW1[_2+^PT;1)+6]6VN-1M?,MVD,RF39F10N\ LISRH.!B@#U/[?9B6WB^
MU0>9<J6@3S!F4 9)4?Q  @\>M6*Y#PFNC:=HWAVQ>]@O+J2*9M.G:U,3-'G<
MWEJV2BA2HZ\@"NOH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXT9#U4J"#^%#PQ2Q^7)&CI_=901^5/HH 3:I() R.AQTI:** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF!BNPMC ;(( )!/;K6;XN\?:=H.F:HMG=V\FJV<>1#(C% _!",PP-V#G;G-
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MIEQJ*:DGV:WE$,I9&5TD.,*4(W9.1@8YSQ0!N453TS5;'6;,7>GW"SPEBA8
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M+C4;6]5; :M%=226[%K9VE4@OM7 R&'(&/F],X]>GN[:U>!+B>.)IY/*B#L
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M;WT4 0B=5! .64E&PQ&5[8Z$9J_;>'X[3PG;^'X+RZBC@M4MH[F)]DJA5 #
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M:N5^4X. ?F]1FNWO/"]G<^$XO#T4LUO;P1PI!(A!>,Q%6C;D8)!13R.:RI?
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M;^=- $3]W*=F75L9YV#@\<FMNTT""SUB[U))I&DN;2&U93C 6(O@CW.\_D*
M./T7Q%KWBR71;>WU%=,9]$BU*YDBMUD,LDC%0N&SA,HQ..>0,BN@\%ZEJ6O>
M"H;O4)T74)7N8VEB080K-(@*@\' 4=>N.:YZ_P##X\+R:(FGG7U6UTXV#7NF
MP1SL\:D%4="IP<Y(<# YSUKHO &DW&B>"=/L;N%H)E\V0Q.VYHP\KN%)[D!@
M#[T <5X3U'6U\+^&M.AUB07&M7MUNN9(49K>.-I7?8,8+,0.6SC)XKM?"^HZ
M@^J:YHNI70O)=,FB$=T8U1I(Y(PXW!<#<#D9  /'%4K;X?QV>G6]I;ZS>H;&
MZ:ZTZ8)'NM2V_<OW?G4AV!#9X]*V]"T%-%%Y*]U->7M[+YUS=3!0TC!0H "@
M *%   H \OOH]3/ASQI+)JCW++XDMH8XYHU"AA-:[6.T ],# .,#UKH-7\2:
MYX4N=<M;C4?[3,6FPW=K)):JIBDDF,.-L8&Y0=IQU[9-;4_@2&:35D_M2Z6S
MU*\BOI+8(F$F1XWW!L;L'RE&"<<FKVK>$K'6;^]NKN2;_2[!;%U0@;55RX=3
MU# G(^@H S/".LZC=ZS>6-Q/J5]9K;I-%>7NEO9L)-Q#QX**&&-I&!GDY)K!
MN[J6Q\??$&\@*B:#0894+*&&Y8Y",@\'D5W6CZ1=Z?+--?:U>:E+(JH/."(B
M*N>B( ,G/+=3QV%4;GP;:76J:]?M<SA]9L5LIE&,1J%9<KQU^8]: .?TC6=<
M\0Q^']-MM3&FR2Z#%J5U<Q6T;L[OA5558;57(8G ] ,5#JWB37X-4_LB?4)K
M6]L].BGEDTS2I+Q)YW+@!L(VQ,1YQP3N.#\M;W_"$+;6VDC2]7N["\TZQ&GK
M<QI&YEA '#JRD9RH((Q@Y]:5O! MQ;MI6MZC83):+9S3J4E>>,$L"Q=3\X+,
M0PZ;CQTP 95GJGB7Q'K7V**_?1%.BVE\\?V56EBGD,@9<2 X'R\@C/RC&.:S
M#XPUJ[T/0M4NM1DT>SNM,69[V&P$\)N<X*R\'RTP >W4_,,5WMEH$%CK<NJ)
M//)+)9PV9$K;OEC+D,2>2QWG)-8L?@62UT:UTJP\0ZC:VL5F+*5 L;B6/GG#
M*0K_ #$;AUXSG H C'B'42OC0_:(F_LNW1[1D0;5)M1(2/4;CGG-4['5_$.L
M>*].TZ+5%M;0Z):ZC<%;=&:1V=@RC(X# <GMCC&<UH77@""1[V.TU:]LK*_M
M8[:[M8@A$BHGEJ0S*67Y< X/.*U--\,6VF:O%J,<\KR1Z;%IP5L8*1L2&^IS
M0!QN@>,M7U34=,O%EU"X@OKMXYK+^R)%@MX3N".L^S!(PFXEB#DX Q73^(K_
M %&3Q'H^@:;>&Q-['/<3W2QJ[JD6P;4# KDF0<D'@5)IGA1]+O8C!K5^-,AE
MDFAT\;%16?<2I8#<R L2%)P..N!5K7/#XU>YL;V"]FL=0L2Y@N8E5L*XPZLK
M @J<#\0#0!YEXVN]5U7P5J%E?:D6ETO78;*21($ NE+Q.C,,8! ?D# )'3M7
M>^*[W4O#7P^O[RVN_/U"UA!2>2-!N;<!RH&WH<=*9/X"LKGP[+I,U[=.]Q?+
M?W-TVWS)I@ZMD@# 'RJ, < "IOB'8SZEX!U>SMH)+B::(*L42DLWS#H!STH
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MO"G  Y.\Y^@K/M_ *:>NG_V7K5]8R6U@FG2R1K&QGA3E<[E(# EL,/4T /\
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M\VD0_P#".7>B7EWJ/]KS2 FU8Q&-YVD6X\TKLP%8'KNR,8S0!UG_  E&C?\
M".#Q!]M']ED B?8W=MN-N-V=W&,9S6OGC->6QZ7<#Q^WA#RB='2]'B$-_"$.
M<1?^!&7QZ"O3;II4M)F@0/,(V,:'HS8X'YT 8VG^,M"U2XDAM+QV98GF5FMY
M$66-3AFC9E D )'*D]:;IWC;P_JU[:VEE>O))=H7MF-O(D<P"[B$=E"L0.H!
MR,'(X->?:>][<W^A7<W]N7+_ &"Y@NOM%B8HK>X>(?ND01K@94C/(X7G-;=C
MIMW'H7PSC%G,CVIC\\>408?]#D4[^/E^8@<]S0!HZKX_L?M&G6VD7'FR3ZK#
M9N[V\@C=2^V01R$!7(_V2<5V4TL<$,DTSJD4:EG=C@*!R2:\CL6N!X7\(>'3
MI.H?VCI6K6WVW-G($A"2$&3>1M8'.<@G@D]C7JFJI')I%ZDMK)=QM X>WCQN
ME!4Y09(Y/3J.M &5;>-?#]U:W5RM\T45K$)Y3<6\D)\L\!U#J"RD\ KG)XJ2
M'Q=HDVF7FH&\:&"R(%R+B"2&2(G&W*.H;G(QQSGC->=W4&IZAH]W8:5<:W?:
M5:K:W"M=V)CNH#'<(S0H70>:0BD@$-@J!DYJS=:;]LM+S6=/?Q#JKP7FGRSM
M?6PC-Q%!*7*Q((T9BH9CRO)P!G% '=6OC'0KN(.EVZ'[3':&*:WDBD663[BL
MC*&&>Q(Q[U8OO$ND::=0%W>"+^SXXY;K*,?+20D(>!SDJ>F>E<=X@U-=:M%U
M.PT6^^RV&J6,\MR;-TEN(T?+E8RH=@@/IW..AK'\2K=:]9^/;FSTR_:"[T^Q
MCM2]JZ-<;7DW;5(#<9Z8ST/0B@#MW\5V-Y>:,;'54B@O+J2 )+9R$W15<XC8
MXVCONY!'2H=%^(>C:O-+$WVBU;^T&L(?.MY5$KC./F* *3M;Y2<C'/)JKXPL
M;B;Q?X'DM[65X;>^E,K1QDK$OE$ L1T';FL:UTB?5/#WC#1!#<6VJQ:Q<ZA9
MO) ZJ'\WS(75R-I!('0YP30!Z(-4LCK!TD39OA;BY,04\1EMH8G&!R",9SP:
M@UGQ#I?AZ*"35+H6ZSN8XOD9M[!2VT!0><*<#OT')KG?AY++K=K?>+[F!H9M
M9=?*C;K'!&-B#\6WM_P*K'C"SFN]<\(-';R31P:MYDA5"PC ADPQ]!G')[XH
M NW/C;0;1X5GNY8S+%',2;:7$*/]TRG;B+/^WMIVI^,]!T>]GM+V\=)+>,27
M!2WDD2%2,C>ZJ50G' )!/XUQ7B'363Q)XFAO[CQ$EMJR1>1!I=LLJ72^2(FC
M+&-@K J?O,HPP/J:CU68^'M/\>:9=6-_/)J$+2V<@MGD2:,VJQ_-(!M7:4.=
MQ''(ZT >CV>MZ=?W#P6UQOE2WBNF78PQ')NV-R.^UN.O'-9B^)+2]U?P^++5
MH!;:I!+-# ULY>Z55!#*_ 3;G)##G-<OI-XVB:T+B>RO9DU#0+&.U:WMGE62
M2,290LH(4_.IRQ P<YJAX?TS4(M3^%K26-RBVFEW27):%@(6,2 !^/E)(Z&@
M#N+?QUX;NK>ZN(=1W6]JF^:7R) B_-MVY*X+9P-HYY''(J0>,]!_LV74)+UH
M((9TMYOM$$D3Q2.0%#HRAESN')&,'/2N'M=%O_\ A3]C"EM>P7%MJ?VN:*&+
M]_L6\9RRJP.6"_, 0<X'!I+O3$OM.NKRQ?7M2>?5-,62;4+4)YB1S@DH@C1M
MJACN8KCCKP: .N;XB>&DCG9KNY5K<_OHC8S^;&N,[V39N"8YW$;?>KNH^+]#
MTM8&N;QF$\/VA#!!)-B'_GHVQ3M3G[QP*Q9+&<^+O&,_V60I/I%M'%)Y9Q(P
M$^54]SRN0/45R=K87.F)IT^H7'B"RAN?#MC;JNG68E9I(U??"ZF)RK?.,9VC
MEL]* /0M0\:Z!IL\D,]Z[RQ1).Z6]O),1&P)#_(I^7 .6Z#C/457E\=Z4GB6
MPTA/-D2\LC>+=)$YC"Y39R%(VD,26R N!GK63X:T9]-UC684M+M+=-%L+:!K
ME07;8DH*EA\I8?+G'>L/189M+G\(/J.EW\D,GA=K!XTMG8^<3$?*; ^0D \M
M@>I% 'H6C^*=(UZ9X=/N)'D6,2A9;>2+?&3@.F]1N7_:7(JQJVM6.B01S7TD
MBB63RXDBA>621L$X5$!8G )X'0&N2\$SW":O]ALI]5N=%BLN!JEFT4MG(&4+
M"'95+C;NS][&T<\UJ^-4M#;6$MT=5MVAN"\-_IL1D>U?8PRR@,2I!*GY2.><
M=: +,WC308+*TN_MDDL=V':%8+:660A#AR452RA3P<@8/!JN_CG3/^$GTS1H
M!+.-0M3<QW,44CIC*!,$*00=Y);("X&>HKBU_M;^T=/UK6+S6K**2RGM5NM.
MT_\ >2%9RR&2+RW*&1"K8P.1SC@5HZ79KH'BKPFPL]52Q?29K1&N(#))'(\L
M;JDOE@JAQGK@#'M0!W^J:A%I6F7%].LC1PIN(CC9V/T"@G]*XGP=X_\ M_A2
M/7/$%XBM=2*L5O;Z=,A5FW8C3.XS' SE!Q@UW-^K/IMTJ@EC"X  Y)P:\OT&
MSO-(\*?#W4KRPN_)TP2K>1+;NTL/F1NJN8P-V >#@9 ;- '=?\)IX?723J<F
MH"*U6X%J[2Q.C1RDXV.I&Y#R.H'7-48OB!I=SXCLM(MX;QC=VKW"S/:3)M(=
M54%2G .6.XX P,]17):C87>KS7^JPZ?=?8K_ ,1Z:\,<ENRN\47EJ\I0C*J<
M'D@<+FNEU1GLOBIIMW+;W)MKC29K-)HH'D42F:-@K%0=O )R<#CK0 >#_']A
MK>E:+'>W.W5+^$$[;>187EV[F19"-A8 'Y=V>*ZV]F^SV%S-YJQ>7$S^8RE@
MF 3D@=<>E><Z7IEY%X&^'4!LITEMKZW>>/RB&B'E2Y+#'R\GG/K7?:ZCR^']
M2CC5G=K65551DDE#@ 4 8UKXSTFWTC2I+W5!=W%];&>%K:SES<A=H8I& S?Q
M#Y>3C)Z UMZ5JUEK>G1:AIT_G6TF0K;2IR"0000"""""",\5Y]X*TR\@G\"M
M<64\?V;0;B.4R1$>4Y:#"MD?*2 W!YX-=/X'MI[73-32>&2(MK%](H=2N5:=
MR",]B#D'O0!)=^,+.U\8Q^&C!<&XDM&N/-$,A4'<H4<+C!R26S@8P>36?X/\
M?6&N:7HL=Y<[=4O[=6(6WD6%Y-NYD1R-A8 'Y0Q(P:;J;/9_%2RNI;>Y-M<Z
M/):1S1P/(@E,R,%8J#MX!.3@>]9&F:;>1>"OAQ ;*=);:]MWGC\HAHAY$H)8
M8^7DC.>YH [*T\6Z+?:M_9MO=LUP7>-"876.1DSO5)"NQRN#D*21@^AK:KRC
MPEI!BET/2M0NO$DE_IMR[M;&V1;6%E#CS/,,8W(P8XPY)W_7'J] &#XOUV;P
MYH0U""&.5_M,$.V3.,22JA/'H&S1XOUV;PYH0OX(8Y7-U;P;9,XQ)*J$\>@;
M-9GQ.L)=3\%O:16TMP9+RTW1Q*6)7STW=.< 9.>U8GC7P!HUEH45QHVD2F]C
MOK4KY3RR$+YR;CMR>,9SQQ0!V5UXMT6RU;^S)[MEN0Z1N1"[1QN^-BO(%V(S
M9& 2"<CU%(_B[1(]9_LEKM_M7FB D02&(2D9$9DV[ Y!'RYSS7!WND'^V-=T
MO4;KQ(HU'4A-#;:?;(T,\;B/#^88R%VE2&RXP$&.U1:W-J-Q?3M<C6FEL]?@
MG:SM[(_9TM([A")<A,R$J W#%LYXPIH V9/B)+I2>+;G4H/.@TG4$M+:."-L
ML&4$;B V.2>2,=!U(J\?']G:^(]1M[UY5L([*VN;<)93--\YEWLR!2P4!%Y(
M&,\]:Y+4]+U%]%^)&S3[MC/J<$T*B%LRHIC+%!CYL!3T]*Z_2,WWC37]3BMK
M@6MSI=FL,LMN\>_!GW !@#GE<CW% '6VMU!?6<-W:RK+;SQK)%(IR'4C((^H
M-35SG@"":U^'WA^WN(I(9H[")7CD4JRD*,@@\@UT= !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0W
M5W;6%L]S>7$5O F-TLSA%7)P,D\#D@5-7!?&C_DDVM?6W_\ 1\= '>T5QFHO
MK.J>/;S1;;6Y].L8M*@N1]GBC+^:TLJ]75N,*,CV&,<YYW_A)M=O/#NA:K?:
MCJ&GV,VG>9-?Z?9).JW(;!:92K%8\#/R@#DY(P* .TU?P=8:S=SSS76H0K=1
MB*ZAM[IDCN$&1AQ]"1D8)'%;T4201)%$@2-%"JJC  '  KC(=?U"1O&)%\DJ
M:?:Q26DD:*%4M;;RPZY!;GDFJ&GZEK^M^*-(L!K,EK:-H%KJ5QY4,9:64N01
MDJ<!N^/3C&: /1:*\VL_$FH?\)3ICQ:K?WUG?ZE-:.&LECLP@25E$3[=Q93&
M 3DAOF]JKZ=K'B+^Q/#_ (@N==FE-YJR64MGY$0B:)YFBSPN[>, YSCC&* /
M4:*XC0Y/$'B!WUR#6FAA34YH!IS0H83;Q2M&03MW^8=I;.[ ) QBL?0/%&NZ
MG?Z;J"'6)XKR]>.>U;3L6D-N2P5DEV9W+A226(/S<#C !Z+?:G8:7"LVH7MM
M:1,VU7N)5C4GK@$D<\&ELM0LM2@\^PO+>ZASCS()5=<^F0:Y'XARI#=^%))+
M"6_0:L<VT2*[2?Z/-T#$ ^O)[5B7D^HZ.VN>)-,T9M"CNHK/3X(;B.,%YFF*
M&=D0D#:) !DY..>* /4J"0.IKSO5]2UKPO<ZK8?VU<WX?0+K4+>>YBB\R":'
M XV(H*G>#@@X*^AK-UBTUJYTKP7=7GB2]-QJ&J0._E10JL1>%F 0%#]W;QG.
M=Q)!XP >K57M+ZUOXY)+2=)DCE>%RIZ.C%67Z@@BO/=2\1ZA:^(UEM=6U"ZA
M75X+!X4LE%FB.Z1LC2%=QD!8G*MC/&.M9=M/K&C>&->\0VFKRQQV.NW;"P$4
M9BEC^UD.')4MN.3@AAC XZT >G/KNEQR:DCWL0;3$$EZ"?\ 4*5+ M_P$$U0
MGET/4M<T"[-\K7GE2W&GJK\3(R ,V,<C:0?QKD=8UB_O6^*FF7$^^ST_34^S
M1[%'E[[5V;D#)R?4FDT;5=1BN_AYHUO>-!9WV@,TP1$)W+#'M8%@<$9SZ>H-
M 'IP(/0YHKR+PC?:MH7AGPYJTNK7%SI=SJ=Q;7T,R1XC\R>14D#! P_>8SDG
M[YZ#&.Z\,:E?:QJ&N7TD^=,6\-K8Q;1C$0VR/G&3NDW#D_PC% '1T5YMKOB3
M4+/7IKFSU6_GBM]3MK1K>*R7[&B.\:.CR%=QD^<G*M@':,=:KZGK'B)-&\4Z
M['KLT0T749([:U2"+RY(TV$K(2I8Y#$#!!'7)H ],N;B&TM9;FXD6.&%#)([
M=%4#))_"G0S1W$$<T3AXI%#HPZ$$9!KS?Q!/J^MV/CJ6+5Y;6TTJ*2UAM$CC
M,<N+<2.9"5+<[\#!&,9YKM]!=8_"VF.[!46RB+,3@ ;!S0!=:^M%OEL6NH!=
MLGF+ 9!YA7IN"]<>]3UX%<>)M.N6NO':7$IUF+4EFM(!!)DV"9C,>[;M&]&=
M^O4BO2[W4+SQ#XGM]*TK69M/LO[+74?M-JD;/-O<J@^=6&T!23@9.1S0!V5%
M<+O\1ZKKQT%]=-A/I^F0W$]Q90(?M$\C.H.)%;"#R\[1C);KQ20OXBUW7=2T
MQM=?3I-)M;=6:RAC*SW$B%F=O,5CL&  HQWYH [NBN#\'>*M1\0:KIAN758;
MG08[N2%5&WSO-*,P/7''3-9VEZUX@UP^%K3^V9+8:A#J#W<T4,>\B*553;E2
M 0#CIT)XS@@ ]-) ZFBO(KZ?5]5@\/V]QKEVLUKXHFT\W$4<0:4()=DC H1N
M 7' P<DD$XQIW_B/4+;Q+'+:ZMJ%U!_;$.GO"EDJV:(SK&R&0KN,@))R&QGC
M% 'H5I?6M^LK6LZ2K%*\,A4_==3AE/N#5:37=+ADU&.2^A5]-C$MX"?]0A4L
M"WM@$_A7F23ZQH_ASQ3XBL]7EB33];O)%L5BC,4R"?YPY*ELD$@8(QQ[U?\
M$&L7]Y)\4M+GGWV5AI,1MHMBCRS);R%^0,G) ZDT >@1ZWIDMQ96\=[$TM]"
M9[9 >98P =P]L$?G5\$'H<UYGI&JZC'J/@/1;>\>"SO?#[/*$1"=ZQ)M8%@>
M1GZ>H-9_A._U;0?"'AO6)-5N+G39M2F@OX9DCVHLLSHL@8*&&)-I.2?OGMC
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M8Y/+<-L<=5..A&1Q4%KK&F7UW/:6>HVEQ<P<30PSJ[Q]OF .1^-<!IBKX?\
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ME2.8#YXB Z,K!E8$@C((!Y':L"?X?6=XNI_;M5U*Z?5+,6EX\C1@R $E' "
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M-% 8E&3#<<C#D_4"LNY\!6EU-<1R:KJ?]EW-Q]IFTL2)Y#N6W$9*[PI;DJ&
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MURUU>1[8.J0&2RO4 16:0D%4*KE2<JWR#KQ7?7NJ:?IK6ZWU[;VQN)!#")I
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M$@C:,5Z=J*/=Z+=I$C%Y;=PBD8.2IP.>E7*KB_LSJ!T\74)O1'YIMQ(/,"9
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M5+U988].S]GFC=(U.]\;4*E3G<1P!C->ITR::*WA>:>1(HD&YW=@JJ/4D]*
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M XP,@&)XET&2Q\-^(-0;5KVX)T"6VEBEV;9&6-L2G"@ANO3CD\5F:)?^,E\
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M:BT,=M8PW:6Y1I7?<3O#D$"-< !2>ISUQBMFZ\'V=XVN&6[O,:U"L%V R ;
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 7![  ZY_%NFIHEUJQ$_V:VO&LI/D&[S!,(3@9Z;CU]*CNO&-C::L;&2TO\
MREN8[22]$/[A)GV[4+9SR649 (!(!-<9>Z?K@\/ZQX=BT*\DEEUIKQ+D%/):
M!KI9L@[LEL<;<>M)K^E:W>WE^TNEZQ>7<&JPW,#K=E;86D<L;A8X]X5GPIX*
MYSDYZ4 =3=?$'2K62\W6FHO;V-T;6\ND@!BMVR!ECG..0> 2!R0.*L:IXVTW
M2K^YMI+>^FCL]GVVY@AW16NX C><YZ$$[0< @G%<[?:#JD_@;QI9QV,GVF_U
M">:VBXS(K;,'K['\JN*^N>&]9\01V6A7&HMJEVMW9SHZB)28TC9923E I3/
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MJ=]#J>'LL(]H\IC$_HZL$^4@'&"/7!H W:*XR;Q)=V_C$:7J$LU@DUTJ63-
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M[T =AJ6J6.CV37FH7,=O;J0ID<\9)P!]<T)JEC+JDNF)<QM>Q1B62$'YE0G
M)^M><Z_J][J?@+QA;7V\MI]_';Q-(BJY0^0XW!?ES\Y'&.,<9KI8O^2N7?\
MV H?_1\M '645R>J7VM2^.8=$LM0AM;:;2Y;G?\ 9P[JZR(N1DX/WO3\^V;X
M?\7:AX@7PY822K:W-_ILM[<W$2#)*,J;4# @9+%CD' &.^0 =]5:'4+2XN[N
MUBG5IK0JLZ?\\RR[AG\#FO.IM;UC59-$MYKU[:>V\22Z9</ BA+@)%(RR8(.
M.B\9QG/H,:.J:GJ=Y9>/["6[54TZW_T=HH@I"M;[R#G.3DXS^6* .LL-=TS4
M[J6VL[M)9HT65DP02C?=<9'S*<<,,@^M:-<#!>W_ (?TKPC?27@?2IHX;6]+
M0H&CWH!$=P'"AR%/^\#ZUU>A7-Q?:>;V:7?'<2O);C:!B$GY.G7*X;GUQVH
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MJ;OL3S&Q$8)8;E EW]@,XQWW9[57N?$MC<6MU#IU^@O?LCW,!:)L2(H^^F0
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M3KC4(UO 8U,(5F(\P[4S@=">,]N] #;KPKI=T=.;;<0OI^\0207#H^U\;PS
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M=\O!4YQR.I'-.T/Q_:>*;/[3INEZL+(I+YMX\<:K"R;OE^]RW (P"/F&2.<
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MUW-?+#%8X^U"5&1X<C(W(0&&1R..>U &Q15'3=7L-8CF>PN!.D$IBD(4@!@
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M<VDBSVFI)*-1W+L:);CSO-'.[<5^7&,[CZ<UT?A.RO;+4/$CW=E);I=ZHUS
M[,A\R,QQJ#\I)'*'@XKIZHW6JVMGJEAITI;[1?&00@+D'8NYLGMQ0!RWC+1M
M0OM1>\TB*^M]4BL]MM=V[H8IVW,?(GC8X*=#DCC<>>QH:KHNMW2>/%&ER/)J
MNG106K(\86600NC8RV0-S#[V.*[O3;]=2LEN5M[JW#,R^7=0F)Q@D9*GG!QD
M>HJW0!YS-I>J6NN7$ESX:FU?3]4LX(V19XU-O(B%&2168 H0<Y&>_!S71>*=
M%N=1^'FHZ+8PPBYEL#!%$AVINVX"C/0=AFM%]>L8_$L6@,S_ &^6U:[4;?E\
ML,%//KD]*TZ //?$?AK4?%K-<6]L^FR1:1<6B?:2H:664H0IVD_(NPY/^WQF
MH+S1=3\2>'M0\OPP-&UC[((A+=3I(97619/+5E8_NR4.2<=1QUKTFB@#@]:M
M-;\6^%[WR]!.E:@! RI=21EYWBE63R]R$_)\I )ZELX ZNU;2M0UK4[S68M.
MN("-"GL$MY&0232R$$+PV,+MZDXRW%=U10!PEAI>J0ZKX+FDTN=8].TJ:WNF
MWQ_NI&2( ?>YYC;D9'2L:TT/7],T_1;UM#GNC97>H+<V"SHLC17$QD21"'VD
MC"\$CJ:]4K&N?$^GV_B2'0 MS-J$D0F9(8&=8HRVT,[#A1D&@#D]1\.W$MM;
MS:;I%[HE\D4TMM-I\L9,3NP/ES*6VR!R QZ@$?>[GI=6AUE_ <\,-I:7.L-8
MA3;LJF%Y=H#* W!&<X!XZ9KH** .#T;0[NY\1:\=2TJ]33=6TVW@9[N>-W)7
MS0ZL%8X)WC 7Y0/3I6=;>$O$N-&N[B93>QJ^D7I$GWK#!'F?[Y*!QW^?':O3
M:B^U0&[-H)D^T",2&+<-P0G ;'ID$9H \_\ &VD:YJ@\06%II#RVUSI2PV<M
MM)'$&D&_*RDL&.,C:O*_,<^HU])L]1_X3N\U*XTR>WMI]*MK=9'>,XD1Y&93
MM8GHZ\],@\UUU,FECMX9)IG6.*-2[NQP% &22?2@#S_PAHU_9IINE:MX:'VC
M26VIJKS*\3J 0KQC=N#L.",#&3SV/<:;=7%[8)/=6,ME,Q8&"5E9EPQ )*DC
MD '\:LQR)-$DL;AXW4,K*<@@]"*=0 5RWCO0YO$.E:=91VHN8AJEK+<1E@!Y
M*R N3DC^'/ YK9TS6;35]&CU6U+FUD5F4LN#A20>/P-2Z5J5OK&DVFIVA8VU
MW"LT188.UAD9';@T 4](\*Z%H,\D^EZ5;6LTB[6E1/G*^FX\X]JYWX?:!J>B
M?#)=)U"U\B__ -)S%O5OONY7D$CD$=Z[FB@#S"T\,:_I?PX\+26NGAO$6A.'
M%J94&]6W))'NSMY5L]?X15FX\,ZGI?AKPUIZ6][?VL$CR:O;V5P(I;B1U9BV
MXNFY?-8DC<,\=<5UVC>)]*UW1[+5+2XVVU[(T5OYPV,[J6!4 ]_D8_05:TW5
M;75?M?V4L?LER]K+N7'SIC./4<T >;6/AC7;&.ZDBT)XVMM>BUBVMQ=(XFB,
M(C:,,6_UBC<?FPN1P2.:W?$7]I:YX)UJ[U&S71VM&%YIOGR*98VA =7D*L57
M+*1@'[IYKL;^\73[&:[:"XG$2[C';Q&21O95')-5M0T?3-?M[;^TK);B.-A*
MD4X. W^TO0_0T 97@.TN$\/?VG?1>7J&KS-J%PAZIOQL3_@*!%_"L&YTZ_L?
M'OB'49?!TNM6E\EJ+>5'MOEV1D,,2.".2.W:NMUWQ+I_AXV<=V+B6>\D,5M;
MVT+2R2,!DX4=@.36NIW*&P1D9P1@T >2:OX,\07GPZU^QM],2"74-2BN;328
MYD*VT0>,L-V0@)VLQ ..>*Z[QOH<NJ2:/>I97%_'87#M-:VUP897C>,J2C;E
MY!VG&X9&:ZZB@#S2?0;Z&PTPVWA[48=,>]GGU#3;?4MUQ+E-L3N[2#/W02@<
MCIUP:IZ?X9UW3HYIH]#=&L_$"ZM!;K<HXFA>#RFC5F;_ %BY.=V 2."<UZO4
M4UU!;O"DTR1M._EQ!FP7;!.T>IPI/X&@#B]2M_$/B)M%NIM'^R1VNNQ7"P/*
MAE2W6-P7DPQ7.YONJ2<8]ZU+32[V/XCZGJKPXLIM,MX(Y=P^9UDD+#&<\!AV
M[UM6=^MY-=1K;W41MY?*+30E%DXSE"?O+[BK= !7'WFGZ@?&VKWR:=-):S:*
MEK%*K)AY0\C%0"V>CCD@"NPHH \VM/#VLFR\#6LFGSP-I^FRVMY*'C/D.T C
M!X;GYAGC-.T+3-6328+6Y\(PQZOI=G)#%>7,R202MY11?+^8L _R[@0 !D>E
M>CT4 >96.E:[_:7VR71+Y?-\//92>;/#\L^0=H57VJIZ +@>H%6K'1M7@/@G
MS-(E(TW2)K6[#/'A)&BC4*<-R"4/(SVKN[Z\BT[3[F^N"1#;1--(5&3M4$G
M^@IUI<QWMG!=0DF*>-9$R,'##(_G0!R'@[1]2TC4VB07L6A_9!Y=I?NLCVDV
MX?NXW!),87U) P,'KBY<VFH6_P 0SJD>GRW%G+I(MC)&Z#8ZRL^"&8'D-Q@'
MGKCK6AJ'B?3].UVST5UN9M0ND\Q8K>!I-D>X+O<CA5R<9-7M/OUU&!Y5M[J
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M]+?^RYHX7U%KEXC)<%7Q(22 P497..OK6SXYD>XU7Q%8M<SB!?"LMQY4<S(
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M$I&#((MVP.?[V,T >>6PFE\*>&/$;ZI?C4M2UNV%UF[DV2*UQ@Q>7G: H&,
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M1)@ J)%8-@@#(SSB@#@["6]U/4-"T>XU2_:TCU75+)I$N762XAB!V!G!!.,
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M*XP[!U8,,C@@''M4+^!/#CV@M18/%"MS]J18;F6/RY=NW<A5@4R"<A< YYH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4A 8$$ @\$&EHH 9%%'!$L42!(T&%51@ >@]J?110
M 4444 %%%% #(H8X(Q'$BH@).%&.2<D_4FGT44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !15>_GGMK&::VM6NYU7]W K!2[=AD\#ZUD>#]:OM=T22YU&&
MWANHKRXMG2W)*?NY63@GD_=Z\?04 ;]%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !63J^CW6IS0O;Z[J.FB,$,EH(L2?[V]&/Y8K6HH K:A?)IUC+
M=R17$J1@$I;PM+(<G'"J"3U[5R'PZU!GM+^QFT[5+65K^\NU-W8RPH8Y)V9<
M,R@9(8''7KZ5W%% &3J&CW5[JD%W#KNHV<46W=:P"+RY<')W;D+<]#@C@5K4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
F%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>exhibit1060-kumaremploym002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *X3P[._B3Q-X@\0W+.UGITTFF:?"&(4!!^]D]RS<
M]@N*[NN ^&X,&@>(=+<?Z39:M>1R+W.YMZM]"&&* ,%O$'AH? ^TU0Z-??V.
MUQM2S^W/YH;SF&3+G<?FR<9Z<5UFIZAI:?%/1M/FL9WU*:QF>&Y$["-$&<J8
M\X8GGDBO,'TK4?\ AF6PL?L%U]K6\R8/);S /M+'.W&>G-=[K-I<O\<_#=TM
MO*UO'IDZO*$)12=V 3T!H N>%9I=$\8ZSX0DD=[5(EU+3=[$E(78J\>3V5QQ
M['VKMZX6#_3/CE=RP\QV&@I;SL/X9))MZJ?^ KFNZH **** "BBB@ HHHH R
M/$NO)X=T@WAMWNIY)4M[:VC(#33.VU$!/3)/)[ &LRWU+QA:7UF-5T?3YK.Y
MD$<C:=.[/:D]&8.H#+V)&,>E+X\L+VZTBRO=/MFNKG2]0@OQ;)]Z94)W*O\
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M:AQ\RP !(5/_  !0WU8T )J'C6VT;QA>Z9J<R16D5A!<Q%(7DD9F>4/PN3M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW-M"UNZQA"L\3,K%&W*<<J.1@U0TOP)I^E6FDV\-S=.NFWTM]$7*Y9Y X(;
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M9- "T4BNK9VL#@X.#T-+TH **16#*&4@@]"*6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU^VR"XM)(F:#!/F*& ++P>E2Z?XQT?4=0^QQ27$;M UQ$]Q;O%'-$N-SQLP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44C,%4LQ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO-!&K6%]YJ8>*UNT>2,@Y##!)!! (/8BMRT@>VLH8'N)+AXT"&:7&]R!C<<
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MOJ^E7>FW:LUM=PO#*%."58$'![<&HUU#3[74;?1OM"+>- 9(H"?F,:X!/\J
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MSFU)+2PN+RV$5QL=!\TJD*0H?<NX@$\<=Z[4$$9!R#4<L4,SQB6-':-O,3<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/]4Q4X 5% (*]<=SG/&&)X"L+;2](M+#4-0LIM*B:"VO('3S?+;&Y6W*58'
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MNOK298#;2BV=5$\1.[8V5)'.>5*GD\T 8'A'Q+J>M:KHHNIAY=UX=2]EC5
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MZN;:(/%;1MRK.<@] 6^4$@<D8K5U;6+/1=*DU&[=C NT*(UWM(S$*JJ!U))
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M3>.XMXVQE4).5^ZO/)^4<UJ:9IIM/#UGI=W*;HQ6J6\LCY/FX4*Q.>>>?SH
M\YTK5]3AU*R9;C76M]1TNZG,^I21[9V549)(HU<F+[Q^4A>&'&15C1IM3LE\
M":G-K.H7<NL1;;R*:7=&X-JTHVIT4@J.1R><YS72VW@#1K5K5UDOW>U1H87E
MNW<I$5V^4,G[F.WL/2M./PYIT4.BPK&^S1L?8_G/RXC,0SZ_*QH \VC2\O\
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M^Q'9S:2^7(^)U &X<@9.>/0=L@\[:Z_K.H#2M'F;6;Y8O[0$TNF2QQ3W'D7
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M<]: .!U77M8E\-R>(8-1N(H=0\100V:HY 6T601\#T?:S'UR*F\1K>:WX?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3C(X(R<$&NFH **** "BBB@ HHHH **H:QK.GZ!ISZAJ=Q]GM(R \I1F5<G
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M&)L.@4,3G&!@$<$YYK4H **** "BBB@ HHHH **** "BBB@ HHI,C<%R,D9
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M?*3[]:[JN4\*Z+?)K&L>)-9A$&H:BZQQ6^\/]FMH\A$)!(W')8X)&2/2NKH
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M-\)Z<\"BYT[489[E?,7"HK.20<\\$=*SIO#_ (GC\,OX6@TF-X(M4%RE\;E
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M?_#]5\N:+1(KI;V56  :2+ V@\D;L_A0!N^-_$%_X;T&&[L+(W,TEW;P$%E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "HKFVAO+66VN(EE@F0QR1L,AE(P
M0?;%2T4 5[&PL]+LH[.PM8;:VB&$BA0*J_0"K%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5&$H(RP3YLDJ.HX]LUI6EW!?V<%W:RK+;SHLD<BGAE(R"/PH FHHHH ****
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M677^YY'R_AUKNJY:\T.]L_'=KXBTM%DBNH19ZG 6"DH"3'*N>I4D@CN#QTH
MX3PUH*^)M'^)VD' >XUNY$3'^&0'<A_!@#5[P[J[_$'Q-X:EE!,>B6'VR^4C
M@7KDQ!2.Q79(P^M>DV&DZ?I<EU)8VD5N]W,9[@H,>9(>K'WINGZ+IFD27<NG
M6$-O)=R&:X,2@&5SW/OR?SH Y0?\EW;R^G_"-_OL>OVCY<^_WJ[JN7\+:'>V
M^J:OX@UA$34]3D55A5@PM[=,B./(X)ZLQ'&3[5U% !1110 4444 %%%% '(_
M$8!O#EF" 0=6L 0?^OF.N,\3EO"UA+X3ES_9\]_:76CN>@3[5$9+?ZH3E?\
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MHNMSQ3ZGIEO=2Q#:K2)D[<YVGU7/.#Q5M=-LDGN9UMHQ+=(L<[ <R*H(4'V
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M\D$DYN60K_RU)R7!ZALD\CUI&\,:&VB_V.=+M?[.W;_(V?+NSG=Z[L\YZYH
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MR[E9O*FA8#Y7B;C# Y[C@_@0">W\2V=S?V]BD-RMS<6CWD4;QA2R*RJPY/#
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M=\Q^[@=<BEHGAKQ!#KVFZEJ%O9K(NERV5[,+MI9))&:-O,Y09!*'"YPH/X4
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M5TZ.-U?3FB5W.,/O0.,?@:TJX7P/;6%EXN\9VNFA$M8KJW58XS\D9\D95?0
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MS/:W+<O;E9$(\L_P\DYQUSS0![&6 (!(R>@]:-PW;<C/I7FCV.@ZEJ?B^_\
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MMQ0!U=QX?T:ZDMGN-*LI6M4\N O I\I?[J\<#@<41^'M&B%D(]*LE%B"+7;
MH\@'KLX^7/M7':5XNBMM-U(Z=I!^V3>(Y],A@DO&99ILY,A9@2BX5FV@$#&!
MUJY>>.KW2;+5DU'2(SJ>FR6H:"VN"R3QSR!%9&90<@[N".J]><T =*/#VC+8
M/8+I=HMH\GFM"(5"E\YW8_O9YSUS3I-"TF:S6SETZUDMED\T1/$"N_.=V#_%
MGG/6N9NO&^H:.VKPZSI-M%<V5G'>Q"WNR\;H[F/#,R+MVL.3@C'/:N@T'4-1
MO[>1]1L[6$AAY4UG=>?#.I&<JV%(P>#D?0F@"W;Z786M[/>6]G!%=3@":9$
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M/IMQIUM-9.V]H)(PRLV<[B#U.><]<U$_AG0I+VVO7T>Q:ZM55()3;KNC"_=
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MUGZ<#<& Z_=S46O:[=:?J&FZ5IMG%=:CJ'F-&)YC''''& 7=F"L?XE  ')-
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MMVMHUS"+EAN6$R#>1ZA>M5;/4I)IKU;J*"W2"X\F)Q<J_F#C!('W22<;3S0
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M=1ZD=10!P#>!=7N(+R[OAI5W?OK0U2*WDW-;NI@$31,2I(XW8;:>0IQV%_\
MX1/4)[?1V-KH^GO::RE_);V*E46)8V3:&VC>_P P.2%';MSUPU*Q,JQ"]MS(
M_P!U!*N3SC@9]01^%3-+&LJ1-(HD<$JA/+ =<#O0 ^N)U_POK%[XAU6[L39-
M:ZIHQTZ3SY61XG'F%6 "D,"9 #R,8/7I78W%U;V<)FN9XH(EZO*X51^)ILM[
M:P6OVJ:YACMR ?->0!,'IR>* .:O/"<]])X=266+R+"TGMKD!CEO,A$?R<>N
M>N*K^%/"]_HUQ:)=:7X?ACLK<P_;+2+-Q<M@*'/R+Y?&<C+9)ZUT-UX@TNSU
M&PL)KR)9[\,;<;AA@!G.?0]O6GV&HR7$=])=PPVR6UP\2L+E9 R+C#L1C83W
M4\B@"Y<1F6VEC7 +H5&?<5YQ<_#6_N/"_AK3EO8(+JQMQ8:B\9;;/:-CS44X
MR22HQD#J:]#BOK.>W%Q#=020%@HD20%2<XQD<9SQ3K>\M;P.;:YAG"-M<Q.&
MVGT..AH XS5_ L^IWGB5A):I!J-O9):HRE@CV[,X#KC&TG:, GC-1S^#M0U'
M0-3MFT_0='N9O(>U6P0L!)%() 9'V(2"RJ,!>!GDYKM[FZM[.$S74\4$0X+R
MN%4?B:&O+9(DE:XA$;C*.7&&&,Y![\ F@#C6\.^(]4UF^U/4_P"S;<SZ-+IL
M=O;S/($=F!#%BBY!YSQQ@=:@TWPEKOAZU\/W.FG3[G4+#2_[-NH9YGCBD7*L
M&1PA((9>Z\@]J[V*6.:))8G62-P&5U.0P/0@]Q427MI)<R6R74+3QC+Q"0%E
M'J1U% '!WG@WQ!>WCSWLFD:A<7FFK9S7=PA!LVW2%FA3:0P(<#DJ?D!.>E.L
MO NI2ZI8W&I26B0Q^&VT6=8)&<ERP^9<J.-HSSR"<<]:ZS4=96WT^:;3_LM[
M/'Y9,)NTB&UR "6.0.,D>N,"KL^H65LVV>[MXCN"8DD"_,>@Y/4T <58>&O%
M#77A9=2?2TMM!<AF@E=GN1Y#Q!\% $/(^7)ZGG@ ]S/"EQ;R0R#*2*48>Q&#
M38[NVFN)+>.XA>>+_61JX+)]1U%4M,U4W.E0W>H);V4LF\F-;I95 4GD., \
M#)]/PH Y6P\*:_\ 9- T34)-/_LK1)XI4N8I',UR(01$I0J G\))W-G''6M_
MPEHESH.EW-K=21.\M_<W*F(D@+)*SJ#D#G!&:UA?V9LOM@NX#:XSY_F#9CIG
M=TK'\0^*H="M=(N(X5O(M2U&"Q1HY0 OF$C?G!R!CI^M %CQ7I,^N^$M6TFV
M>-)[RUDAC:0D*&92!G )Q^%<_J?@2>_\3:1?K<Q)9)'"NJ6_/^DM =T!'&#A
MR<Y[ 5W%5X+ZTNI)([>Z@F>(XD6.0,4/N!TH XFZ\"WD]KJY8V$\TVNC5K6*
M<%HG41HGER?+QD!QP#C(//2G2>%-7-O9ZA:6&A6&I66H"[AM+4,D+1^6T;(\
M@0$L0[$-LXX&#UKM8;RUN7*07,,K!0Q5'#$ ]#QV-)<7]G9@FYNX( H!/FR!
M< \#KZX/Y4 >>ZSX%\0Z[H/B^"YGTZ.]UTVS0JDCF.'R]H*EMN3PO7')["MJ
M^T3Q'8ZYJE]X>DTXC588EE:[=E-M*BE!(H"D.-N/E.WE>O-=3->VELF^>ZAB
M7;OW22!1MXYY[<C\Z22^LXKF.VDNH$N)!E(FD 9OH.IH \^UGP)K5^^N1QC2
M9WU!HYDU*Y!\]2D:+Y6T(0JED)R#P'/RDUO67A>YDN?%;ZBT*Q:Z(QL@<L8Q
M]G6)P25&>0<>HQTZ4Z?QG&/'$?ABSMHYY%A6:YG:Z5!$"Q7:JX)=N,XXKHH;
MRUN)98X+F&62$XD5'#%#Z$#I0!ROA7PW?Z3=6_VO2O#]LEK;^3]IL8LS7#\#
M>247RQ@'*Y;)/7CG5\:?\B+XA_[!MS_Z*:M./4+*:"2>*\MWABR))%E4JF.N
M3GBJE_J0-K9M:0VM_;W=PL$A:Y54$;9#,,Y#D8^Z.30!S&B:+KFI3>&KS4_L
M"6FE6I:%X)':2X=X?+#,I4! %9L@%N33K;P7J-M\/M!TA+BU_M71Y8;B)R6,
M+R1D_*3C.T@D9QD9SBNP:\LK>XBLVN;>.=A^[@+@,1[+UHFU"RMFVSWEO$VX
M)B255.XC(')ZX[4 >?>(] OY[/5O$NN75AIUW'':?91$TD\-NL$WF@R-L#'<
M[<D+\HYYJCY.H>,O$'B6%+O3)9;CP[]B#64YFMX'D9]JM)M!)/+'Y> 1QW/J
M%Q=VEN\<-S<01M,=J)(X!D/H >M8MGK5K!XUF\*6VG) L=@M_P";&0JG=(4V
M[0.O&<YH H:SX9U"XG\/W%O;:;?'3K>2"2VOG81;G5 )5PC9*[",$#(8\BJO
MAWP;JNE7VA/=2V31:4=07="S RK.ZNAV[<*1A@5R0,#!.>-[Q5XD7PQI]I=-
M:FX%Q>PVFT/MV^8V-W0]/2KUO?S2ZK?VLMO%'!;",QS"X5FDW D[DZIC'?K0
M!R[^#=0;PS=::)K;SIM=.I*VYMHC^UB;!X^]M&/3/?O72Z==7\^I:M%=0QI;
M6\ZI:NBL"ZF-6).>"0S$9''&.H-5M9\2VFE^'I]8MC%?1121QD0S#!+2*GWA
MGINS5]M1@DM+J6RE@NI+=6RBS* & SM9OX?QZ4 9WBG1;G6+*S>QDB2^L+R.
M]M_.SY;LF058CD JS#(!QG/-<WJ_@W6_$-CK]S>M86^I:E;V]K!#',\D4,44
MA?YG* DDLW\/'%;<GBQX-:\,:7/8*LVMQ3.62X#K 8XPY&0,.#G&1CUJ=O%-
MM8VGGZQY%D'OOL<(6X67>2X56)&-O7)'\(ZT ;]<EXB\.ZA?^);34[6WTR[C
M2T>V*:@21;LS ^:BA2&.!@CY<X'(KJ8KB&>,R0S1R("061@0".O(IT<D<T:R
M1.KHPRK*<@CV- '%>#O".IZ#?6,M]):-'::2-.'DNS%RLI8/@J,97&1V/K6%
MXATV7P]\/]+TQ+VV'B:UOQ/ID<;;C+*\S<!3@E2DC!CC Y]*]-CO;6:YDMHK
MF%YXO]9$L@+)]1U%0_:-,ENY)/.M'N;52)&W*7A'?)ZJ* (]!TB+0= L=*A.
MY+6%8]YZN0.6/N3DGZUG>(='U&?6=*UO21;27FGB:)K>YD:-)HI0NX;U5BI!
M12.#WJ2W\3P:G8:;?:.L-Y:WDXB9VN%B,:G.6P?O'@?+U.:UGOK2.[6T>Z@6
MY<96$R .P]EZT <-<^#-:DTW[6LE@^LOKD>L21&1U@^0!!$'VEN%4?-MZYXJ
M]-X4U*XT#QE9O):I<:Z9&AVNQ2,M;)%ACMS]Y3T!XQ]*ZJ34+*&18Y;RW1V?
MRU5I5!+<?*!GKR./>K- ' 7G@N^35[RZM--T"^^WI#OFU*,L]K(D8C)5=A\Q
M2JJ=NY><\\UT&CZ%/IOBC7]2=H?L^H?9O)2/.5$<>PY&,#GI@FM=+ZSENI+:
M.Z@>XC&7B60%U^HZBN>T/QG'K_B74M,LK6,VEA(86NC=+ND< $[8P,E>?O9H
M W-7LXM1T6_L9F98KFWDA=E&2%92"0._6O+M+O+C7-:\$6,FHZ3>P6J3[AIT
MK.SQ_9GC\V0, 8N65=ISRQYXQ7K%S=VUE#YUU<1019QOE<*N?J:@WZ78&2XW
M6=N9%\R23*IN&?O$]QR.?>@#C[#PGKPL]!T._DT_^RM%N(IDN8I',URL6?*4
MQE0$_AW'<V<<=:G7P5=+\0#JIN(/[$\XZ@MKSO\ MIC$6[&,;=N6SG.X]*[&
M.ZMYBHBGB<NGF*%<'<O]X>WO3EEC>1XTD5GCP'4')7/(R.U '#VO@V[L=;G\
MG2] GLY]1:]-]<Q;KE%=][QA=F"=Q(#;Q@$<'%/G\&ZA+X/\6Z0)[;S]8O+F
M>!BS;563&T-QD'CG -=#;ZZL_BN^T+[.5-I:PW)FW\-YC.,8QQC9USWJ9M3=
MM3LX+:*">UN$=FN%N5RI7H%3JV>>0>* ,C7_  W=ZKK*7D$L"QKI-W8D.2#O
ME,>T\#H-ASWZ<&F6WAB\AN?!\C2P$:+:/!<88_.S0J@*<<C*GKCBNBCU"REG
M6".\MWF9=ZQK*I8KZ@9SCWK-UOQ+::.D84Q7,[7=O;/ DP#Q^;(J!B.3QNS[
MT <S/X$O<F[\C3+ZXBU>[OH[6[SY,L,W&UCL.UQ\ISM(R/>M&S\+WR7_ (?O
M)(=*M/L$]S-/!8H40"2,HH7@;B.,L0N<=.U=@3@9-5[>^M+N)Y;:Z@FC0D,\
M<@8*1UR1TH XK4?!NK207TMI)9M<MXBBUFWCED949$6-=C,%)4G8W0'M5+4O
M!&O7K:KMM]%\Z\O(KY;R1W:8%/+(@SY?RH"F X)^4_=R37H<%[:704V]U#,&
M!8&.0-D X)X]Z+:]M;U6:UN89U5MK&*0, ?0X[T <_X>\/7NF>+/$VL73V_E
M:L]L\21.6*>7%L8-D#OTQV]*@^)RN_P_U!8W"2&6V"L1G:?M$>#CO6YINJFY
MTU+F_2WLY&9QY:W2RKA2>=PP#P,GT_"II+O3KC3S<R7%K)9'!,K.ICX/KTZ_
MK0!QFK^$]?\ $AUBXU#^S;6XFT>72[.."9Y$)D(9I'8H"O*K@ ''/)K7U;0=
M2,^@ZGIAM9+_ $E7C,-Q(R1S1N@5QO"DJ<JI!VGI[UJ7/B+2K2_T^REO8A-?
M[C;@."& &<Y]/3U-2:[J\.@:#?:O<1R20V<+3.D>-Q"C.!GC- '!ZMHEUHT,
M?B/4;_3;;5Y-;2\Q*[BU&8?($)DVY4;/XRH&[M5.QTO4/%UUXGECN[&5GU73
MY/.@=FM_W&QW1'QEB  ,X&6STZ#L+?Q%J.HR0V]QX+U6.VN"JO)-);,BJ?XF
M E)('7@$^U;D5SIMLT5G#/:1$DK' CJN2.H"CT[T <SXB\+ZAJ7B5K^W@TRX
MAGL!9;KW):S.]B9(UVD,2& (ROW%YIGA;PIJFE7$<U^]GE-#MM+Q!(S9>)I/
MFY4<%64^QR.<9/61ZA931R217=N\<;;'99 0K>A.>#4%WK%K!IE_>02Q7/V*
M)WD2.0$@JI.TXS@\4 <WIWA"_L],\$VTDUL7T(YN2K-A_P#1WC^3CGE@><<5
MT&BW>H7BWYU"".+RKV6* QJP#Q*1M8[N_4'''''%1:-XCM=3\+:=KMRT5C#>
M0)*%FE ";AG;N.,UJI<0R.J)-&S,GF*H8$E?[P]O>@##\3:->W\^E:CIC0?V
MAI=R9HX[ABL<JLC(Z%@"5R&R#@X('%8%WX,U?5+?4;N[DLHM2U#4;*Y:*.1F
MBBAMW4A Q4%F(#'.T#)QQUKN);VU@25Y;F&-8<>:7D "9Z;O3\:)+VTBM!=R
M74*6Q (F:0!,'H=W2@">BFHZR(KHP9&&593D$>HIU !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<=
M\0N;7P\K_P"H;7K,39Z;=YQGVW;:[&L[7M&M_$&B76EW198YU&)$.&C8$%77
MW5@"/I0!QNL6D.H?&>UL[E \%QX<N(I%/\2M* 1^1K+\-27&MZKH'AB\)=_"
MS2R7Y/1Y(B8K8_BI,G_ 17I=E9O'%;RWWD3ZC'"(I+I(0A;UQU(!/.,U,EM!
M%+-/#!$D\V/,D" %R!@;B.3B@#E?#W'Q)\9A/]5ML2V.GF>4V?QVB/\ 2LJY
M30Y/&OB[_A)ULV1;.W^S_;-O%MY;;]F[MOWYQWQ[5UOAW0_[$M;DS7'VF^O+
MAKF[N-NWS)&XX&3A0H50,]!5Z[TRPOWB>]L;:Y:(YC::)7*'U&1Q0!Y9X2AC
M7Q3X1EUF*$7LGA;A[A1O:42Q;>3R7V_CUJ/0-+L;+P9\.+ZWM(8[R34(=]PJ
M#S&#Q2[@6ZD$8&/0#TKUF>QM+J:&:XM8)I8&W1/)&&:,^JD]#]*46=JD4,2V
MT(CA(,2!!B,CH5';J>E 'DOA*SFGET">XO\ 0[?4$U*=I0D3?;I9<R":-SNY
MR,DY&.%]JZ;X2Z996W@2QO8K:);NY\TS3[1O?$K  MUP   .V*[)-.L8[Y[Z
M.RMUNY!M>=8E$C#T+8R:EA@AMH5A@B2*)?NI&H4#OT% '"^(H])E^*N@KJXM
MVA.EW7E+<8V&3S(L9!XZ;JY32-/L=2UGPO9R013Z,=8U@VD1 :)X%R4 '0IN
M&0.G KTR_P##<&I>)K?5+L0SV\=C+:-:S1!U??)&X8YXX\OICO6LEG:Q^1LM
MH5^S@B'" >6",87TXXXH \NOX="$'Q"&N1V:WD;%;<3!0Z6XMD\D19Y W;L;
M?XO>I+'3HYOB?X:;4[*%[UO#7FW)EB!8SAHQN.1]X=,]:]*N-,L+NYBN;FQM
MIKB'_52R1*S)]"1D?A4QMX#<K<F&,SJI02E1N"GG&>N/:@#QKPQ9F:PT&XO=
M4T:SND>X:Y-O$_VZ1O+D$ZN<G)!RQR.JK[5/;6NEPZ;<:'<W.AI#+I \G6]/
M3 ,*R1JHN(LXY9E.<X(W].:]9CTVQAO9+V*RMTNY1B2=8E#N/=L9-,M](TRU
M2=+;3[2%;C_7+'"JB3_>P.>O>@#Q[Q/-&/"&M61LM+ANH-1T]II]*8_9Y]TB
M[3M_A<!<$<\;>36WJ*:(][\06\1+:&Z55\DW.W<MO]G79Y>>?O[_ +O\7O7H
ML6D:9!9_9(M.M([7=O\ )2!0F[KG;C&?>GW.F:?>7$5Q=6-M/-#S%)+$K,G^
MZ2,C\* /-/#VD1:IJ&KMKUG'<WJ>'M.647*!BKM%+OX/0DCKUXK'^T07WAC3
M89XM)$]OX4MW>YU-&F>59%8!(8]RC=E.6&225&#7M(@A$DD@BC\R0!7;:,L!
MG )[XR?SJ Z7IYDMY#86I>V&V!C"N8AZ*<?*/I0!YMX<N/M7Q%\*SF7S2_A!
M2S[L[CO3//UKHOB%Y!7PXM]L_LUM9A%V)<>65V2;-^>-OF;.O&<5U,&G6-JR
M-;V=O"T:%$,<2J54G) P.!GG'K4ES;07=N]O=0QS0N,/'*H96'N#P: /%?$P
MTP:+\4AI(A%J(;+B#'E[\'=MQQUSG'?/?-;.OK8V%]<ZJW]D:DJ06@O-/N\I
M=1;0"AMW]3G(7'+ X.<UZ6NE:<EN]NEA:K ZA&C$*A64= 1C! HETO3Y[J&Z
MFL;62XA&(I7A4O'_ +I(R/PH \[TP>&2^L2>(O(_M=?$3!&Y^TAO-7[.$V_/
MC9LQCC&>V:YW4/LW]G>-/MAQ:_\ "76OG'.,)YD.[],U[0VFV+WRWSV5NUX@
MVK<&)3(H] V,UF:[X<AU:RC@@\JU;[?;WLCK$#YABD5R#C&20N,F@#S[Q+'I
MT5QXW30TMDLO^$7S<K:!1'YV9=F=O&[9G\,58TW_ )';P#_V+4G_ *!'7I4&
ME:=;6TMM;V%K%;S9,D4<*JKYZY &#FI!9VJR12+;0AXD\N-@@RB_W0>P]J /
M)M!TNQL_!WPXO[>UBCO)-0A#W"H/,8/%+N!;J01@8] /2H],O+:3Q#X4U&!=
M'LDN]4N6\B!6:Z4-'-N\Z4MSEL?*5ZX /RUZZMG:K%#$MM"(X2&B0(,1D="H
M[=3TJ$:1IBO(XTZT#22":0B!<NXY#'CEAZ]: /,_#GA*WU;X47,ME;Q)K4EQ
M<SP76T>8)HKES$-W4#**,=.36YX+U!?&6OW'BWRREO!:16%LC#[KD"2?KW#%
M$_[9FNMOK.[72WMM$FM;"8GY'>V\Q$R<L=@9>>2>O7KFF>']$@\/:);:9;NT
MBQ EY7^]*[$LSGW+$G\: .?\;S0-J>A6,D.F&21YIH[C4\M!#L3!.P,H=B'X
MR> ":XSPU+83GPG%JKV<FEQW&K(JN@6 3B;]T-K$[?W9?:IY KUZ[L+._C6.
M\M(+E$8.JS1AP&'0@'O4<NDZ;/#-#-I]K)%,_F2H\*E9'_O,".3QU- 'FQA\
M*_\ "7>"I=,CMO[,WZDD3RK\FY2#A"_\(?=MQQ_=K'M?*-AJZWFW^S#X^D%]
MYG^K\KC&_/&WS/+SGBO8Y=,L)X889K&VDB@(:%'B4K&1T*@CC'M3A8V8AGA%
MK!Y4[%ID\L8D)ZEAW)[YH \C\36]A)?^);?2UA&EO)HZW"VV!']H-V V-O ;
M9LSCGI78Z78VFF?%+4+>PM8;6"31;=WC@0(K,)I5!P.,XXKJ(=+T^WM!:06-
MM%;!@XA2%50,#D':!C.0#^%6/)B$YG$2><5"&3:-Q4'.,^F2>* .,\1K9R?$
M7P^FLB!M.^Q71@%QCRS<[H\9SQNV;\?CBN-BLK._;1K011RZ*_B^Y%I&!F)H
M1#(2JCH4+AQCH1D=*]AO+&TU" P7MK!<PDY,<T8=<_0\4"SM0D""VA"P',("
M#$9QCY?3@D<4 .CA2WMEAMHDBCC3;'&BA54 8  '05YCX0'A?_A'/#LET(/^
M$D;S@QCS]H-SM?SO-V\X^]G=Q]WVKU.JL>FV$5Y+>1V5LEU*,23+$H=QZ%L9
M- 'B][IEE9?LW6MQ;VT23W,=D\\P4;Y#YZ8W-U.,X&>@X%=!K6E6%_JOQ*FN
M[2&XDBTV+RFE0-Y?^CN<KGH<@<CT'I7I36%F]F+-K2 VJ@ 0F,;!@Y'R].*>
M;6W8S$P1$SC;*2@_>#&,-Z\<<T >=Z5I]II_B;P)+:6\<,MSI-S]HD10&F^2
M%LN>K'<2<GN37,^"+*VU#PU\-;>[A2: W>HLT;C*MCSB,COR ?PKVH6T >)Q
M!&&A4K$=@R@.,@>@X'3TID5A9P+"L-I!&L))B"1@",G.=N.F<G./6@#RL_9+
M2?4=(2RTX12^*G6W^VY%K;L+592Q12 V2&PN0-S9[5D23(_A[2HHYK618O'4
M(7[*GEQ!2Q8%%).%.21R<YR*]IGTS3[J&2&XL;::*5_,D22)6#MQ\Q!')X'/
MM0=,T\N7-C;%RZR%O*7.Y1A6Z=0.A[4 9OC0W@\#ZZ=/W_;!83>5Y?WMVPXQ
M[^E<A:QZ%'XD\$_\(TMF-UK/Y_V0+DVWD<>9M[>9Y?7OGWKTNJMKIFGV,DLE
MI8VUO),<R-#$J%S[D#F@#C_A)IEE9_#K2+J"VB2YN;<--,%&^3DXW-U( X [
M"J^I1:'+\7YUUM;-E_L"(QK>;2G^OFW'#<9Q^."?>N^A@BMH5A@B2*)!A410
MJJ/8"L6X\+VM[XHN-6ODM[J":QBM?LLT(<!DDD??SQ_RTQT[4 >;^&=-MM5O
M? ,&HVZW-JNGZB\44Z[E:(2IY60>H";2,^@/:I=532#X9\?/J2VW]N+?3B N
M!]H!VK]E\O\ B_N;<=\^]>N?9H!)')Y$?F1*4C;8,HIQD ]AP/RJ*73+">]C
MO9K&VDNXN(YWB4NGT8C(H \S_L[_ (N7KLD=E =37PY%-&5B7<+DL_SCC[V>
M_6L[1=.LYM)TZ676=$LK<Z%<),=.A<7#0M$ [2'<<E&PQ)&=V?4U[&+>!;EK
MD0QB=E"-*%&XJ.@)ZXJ&#3+"UFGFM[&VAEG.9GCB56D_WB!S^- 'E7V>P:"\
MT:ZE\/6LZQV4L6I6,>;6X"S'RHYXLX&64_Q'(;@\8JOJMQ%+::# EC86LUOX
MVLXYSISEK:9S'NWIZ<, 1V(/7K7K,6C:7;VLUK#IMG';S<RQ) H23_> &#^-
M/CTO3XK>&WCL;5(('$D4:PJ%C8=&48P#R>10!Y1JJ:4WA;QY)J MSKXU"X$#
M/C[0&^7[+L_BZ;-N/?WJ]=:19W\_Q%GU*S@N+I+.)=TJ!O+/V-2=N?NG('(]
M!Z"O2I=,L)KV.]EL;:2[C&$G>)2Z_1L9%2FVMR9B8(LSC$OR#]YQCYO7CCF@
M#QCQ%=0WV@:FSQZ3'<VWAZV5[B_1IKB<O$S*(1N 0AC]X9RW4?+73:+,+CXQ
MM,)!()/"\#;P<[LS'G-=VVEZ>\\4[V-LTT2>7'(85+(G3:#C@>U/@L+.U=7M
M[2"%EC$2M'&%(0<A1@=/:@#B_BQ_R+VD_P#8;LO_ $97/:E=06GBKXGR7-LE
MS"\&EQ-%)(8T(=2GSLO(4;LGV!KUB>V@N45+B&.558.HD4, PZ'GN*8UC:.;
M@O:P,;E0LY,8/F@# #?WACCF@#Q/6WAAL?'%I)<:84^S:8[KI4)ACXN&#%1N
M;+ ;06![ <$5T&K1:3#X@U== 6S6U/A2Y-R+,*(\[AY).WC./,Q[9KT=-'TQ
M$1$TZS58T\M (% 5<[MHXX&0#CUYIT&EZ?:I.EO8VT*3DF98X542$]=V!S^-
M 'E.B_\ (3^#G_8,NO\ TE2LRWAM)/#/F7D4#1)X\(=IE!54,X#9)Z CK7MB
MV-HAMRMK IM@5@(C \H$8(7^Z,<<4U],L)+66U>QMFMY6+R1-$I1V)R21C!.
M>] 'F7B"270-6U;0=+PD7BR.-M.,0^2.9BL4Y&/2,K)^!KTZQLX-,TZWL;5-
MEO;1+%&@[*HP!^0K'C\.3R^)X-6OKN&2WL$>/3;2"W\M8-X 9F.X[FVC:,
M GCFNAH \2T^\#ZEX9OM-71[26^2\DAMK56:X0O!(RK-*S'<Q<#@@?,#CI72
M>#H?!LVD^%T2.UDUB;3V4K&N7D)C'GB8#K\V<[_XO>N\32-,C8E-.M%+2B<E
M8%&9!T?I][WZT^#3K&UNIKFWLK:&XF_ULL<2J\G^\0,G\: /%M+%F/ WPO\
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MC(R,!S@JQY'0@&@#C[[QG!JFE:++<6>FZA-'XGM].:2&4R0JY^99HB#UVL"
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M7MC>:7I>EQ6[ZAJ4CK&UR3Y<2(FYV8+R>P &.3UK,?Q%XD-YI^B?V=8V^M7
MGDDDDD+P+#$5'F*%.X[RZX4D$<YZ<ZGB+1+S4+O3-3TRX@AU'397:(7"%HY$
M=2KHV"".Q!'0@<5EMX9\0+=6&LC5K2?6[<SI()866W:&4J?*7!W *47!.2><
M]> "I_PF^K/%96D>GVAU1]8ETFX4R-Y2NL32"13UVD!6P><$CKS56X\;>)[3
M3-<O)K#2V70+CRKPJ\G^D+A7_=C^ A''WL\UJ6?@JYAFTV[GOHI+R/5Y=5O&
M6,JKN\3Q[4&20 "H&3_#[TZ_\&3WFB^+K%;N-6UV<RQL5.(@8HTP?7[A/XT
M5[_Q3XB.H>)8]+L-.:WT/8Q-P[AK@&%92BXX5N3R>.1QUK'?7[9/B?\ \)$5
M?[(/!7V[;WV>=OQ]<5,FF:YJ'B3QU::7>V<$5U-!;RFXB9C&#:1@NF",G!/!
MXX'/7.L_P^A?7#,;@?V:?#G]A>3CY]N[[V>GW>/K0!D)\0;^ZL[N"*[T&:]E
MTN:^MS8W)E^SM&%+1R@'DX;AA@$J>*6U\:ZE8Z+X=LKS4-$@U"\TU;R2\U&9
MHXRFU HY(+2,6)/.!M)YZ5NV/AS6FL+BPU2]T[[.UB]FC6EJ5>0L-OFN2>"
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M8B\Y&,9#;QL;!ST<\CTKH/$NC2^(/#%UI8FCBFF5<.REDW*P;!'=21@CT)H
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MFZF$42Y(!9V/0 $D^N,"N0A\#ZW9+IDMOJ=E-=:;JES>Q//"P65)P^\,%/#
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M87&G7*27?V6<M>*IC8#)50 =SCCY.#S5EM<TA+N.T?5+);F5RD<)N$#NP."
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M-]I=A9I#J<4,NIVYE@5Q=8V@;T"ML!QD] PQ0![.\V;5IK=1.=F^-488DXR
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MQG?C/W<<YZ5:LKZTU*U6YL;J"ZMVSME@D#J<>A'%>2:)I&GMX8^%NZS@)DN
MSDH,L3;RN<^OS*#^ KM/!$:0:GXOAB14B76V*HHP!F"$G ^I)H Z*;6=+MM0
MCT^?4K.*]DQLMWG59&STPI.37.7?CJ%/'L'A:S6QE?REEN)YKX1[,OL\M%"D
MO)WV\5QVJS:7'X6\=V5^T']OSZA<>1$Y'VB1FQ]E*#[QXV;<=,'WK>L;5/\
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MDAUR8R*2 ZHQC5"0.=I9@!VYH ]"HHHH **** "BBB@ HHHH ,4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1CG-%% !1110 4444 %%%% !1110 4444 %%%%
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M8]*=10!%#;6]N (8(XPHP B 8&<XX]Z22TMI8/(DMXGBSGRV0%<]<XJ:B@!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&??Y4J2;&*/L8':PZ@^A]JDH ***9%+'/$LL,B21MRK(V0?H10 ^B@D $DX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVCM;JT,4F]"09&W ,,@8VXQW% '15Q'Q4$;>$[99H)+B)M4LUD@C&6E4S+E
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MWRL^7ND#[<9YQC&<BJ>I>!;^\&J6\&N);V-]>+?B/['N=9@4(#/O&Y-R [<
M]MV* .0U3_CP^,/_  #_ -$"O5/#O_(L:3_UYP_^@"N=G\ M<6GBZ&34QO\
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M6K-(6F7B)0N[)^7AC@9]*UO >AW6@^$;2WU!S)J<V;F]D8Y+3/R<GV&%_P"
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M5OJUF]E;?Z^;S0%B_P!XGI^-<3XGU;1?$.G7EWHML]\MK+8RW]W;P[DEMTN
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MKGH?2N&\.>,;Z]\366GW.I:;?QWT,SD6-O(J6[IM("RL<2J02,@#D9[XH ]
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M:XE,B2LRJ9"WW-V&QMSVSBM9/ E_$MI#'KRBTL-0:^LXOL?0L[,PD._Y^'8
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M"<J2"3C';/O? -Y=0:G81Z]Y.E7UZ;\P"T!D60R"0KOW<IN&<8!YZXX/<T4
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M8J?)=B67(Z;L!?\ @57SX(\.QW-A<VFF6]A<6,@>&6S186QT*,5'S*1U!ZT
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MU$BA<PI&C,2H7*%FPO/. >E8NFZAJNC^(]3A>Z26>Y\3VUI/*(@/,B-HIZ=
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.'10F77@_,H(XZT 4QX">65)KO7[VYF%A-IS,T<:JT$B@8V@8!!4-NZD\'C
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M[6$P6MM*$543C&XJ 7(  !/OW.:IZ7\0M&U"VU6YD::U@TZY-NSRP2#?R%&
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MZ(X)HCMNH9%X!'#*W([\&J^B:'::!9/;6IE<RRM---.^^2:1NKLW<\ ?0 4
M:5>2WUM=L/%UBMC>27*:];ZJ(%MW(N+9#;EMC8VL?D;Y0<G'2O4?[1L3 )Q>
M6_E&3RA)YJ[=^=NW.>N>,=<U9H XS2K@:[\1&UFQAN1I]OI1M7GFMWA$DK2A
MPH#@$[0IR<8&[%=A,"8) .3M/\J;]H@^TFV\Z/[0$\PQ;ANVYQNQUQD8S4M
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MF-O!F=8?-<;T1E;=C<&^Z>!Q7L-1&X@6Y6V,T8G9"ZQ%AN*@@$@=< D<^XH
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M)8XIXY'B;;(J."4/7!'8U+0!QVC2+J/Q"O=6@@G^R3:-;)%-+;O'DB:;<N&
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MY'I76: ZQ^%-+D<X5;&(D^P05EGP3'))JDL^LZE-+JEBME<NWE#<J[P& "
MX=AZ<YP3S6_I]BNGZ9;6(D>9((EB#R8W, ,#. !T]J .?TWQ#JE]I^G:Z;>U
M_L2[MGN9<$B6VCV[D).<.2." !@GJ<56A\7WZVGAO5+BWMSIVO21Q)'&&$EN
MTJ%XMS9(<'&#@#!/>KFB>"K;0_\ 1XM1OY],C+FWTZ=D:*#=G(!"[F') #$@
M9]<&GZ=X-M-/AT^U^UW,]CILIELK>7:1"<$+SC+!0Q"Y/'&<D @ PE\::_\
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MTBU:RCE7RRTL!VY1LIC^!>0 >* ,NQ\9ZSJ-OX7,%I8+)K)N4D+L^(VC5R"
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M"6;8E7+K"A ?/&UQDL<=ASQI7W@ZUU'2]7M+F\N?-U=!'=W*! [(%VA5&T@
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MIM"@@MEF/<8"FM"P\(1:??VM['JE\\UMIW]G(9!&08\@[C\GWL@>W'2JEKX
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MZ#CI0!AZ5XSUJZT#1]5O+6Q1=:\J.SC@#NR2,KNY<=QM3( (.>">]7$\4ZQ
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MB,[Q229F<;,@1X.,@_>Z\ UH+J>GM??85OK8W?/[@2KYG')^7.:X>%9KC5/
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MVB)62:*971".H)!P,=ZQ=+\3_P!I>+]4TR*>RFL;2T@N$F@?<<NT@8,<XXV
M_C7(:W8ZD;WQ5+8:9=R6_P#:>G73P);LOVN&-8_-5,@!C\O('7&.<T:U%?:U
MJWB>YT?3KX_:]'M!$9;62 7#1RR,\>748)0A>?7TH ]$77='>VGN4U6Q:"W.
M)I1<(5C/^T<X'XU/;ZA97<<TEO>6\R0.T<K1RAA&R]58@\$=P:\SUZVM-=\)
M>(M0T[0=<&H76G"U;[9!,)'8'*HL9SN();Y@,#.,GG'IEA!:P6JFTMD@CD <
MJL7EDG &2, YP .>>* .6N_'5O<6>DWVBW%I<6MUJJV,Y=LE%+NNX8/&=A(S
MV(-;5YK=M-H,U_I.K:45!VI=33!K<,",AF5OKWZUY_!9W/\ PB>@:9<:3?F6
MS\1F2X1K.1E$?GRMN^[@KM93GISUZT[7+"YET/X@6\.F7K_:M0AEM8TLY#YO
M[N$,R#;S\R-DCTH ],FU*PMKE+:>]MHIY" D3RJK,2<# )R<G@5:KS_6(M0C
M\3RWVCB[D,MU:_:M.NK-V@N5&S$T<F!Y;(.N3C,?(]>I\27D]KI#I:I<FYN6
M6WC>"%I#$7(4R$*#@*"6Y],4 4_#WBR+7M:UG31 T+6$B^2S?\MX6&!(/;>K
MCZ >M;%SJNG64HBNK^U@D."$EF53STX)[X/Y5PVJZ1=>%O$GAO6;$W]_%&/[
M+N88;7>4M2,JW[M.B,%//J<5F^(OL\NK^*=+N$U/[#J<MJTUQ'ILUQY11$)V
M&-2.@7AL%3DX(Q0!Z.^N:3'*L3ZI9+(Y151KA 27^X ,]6P<>N.*DCU33YKY
MK&.^MGNU!+0+,ID '!RN<UR.FVEI?_$/4;Z.PWV<^E6?V2Z:T/E%E>1LJQ7&
M0&C/Y>E8>@Z?+?:38Z7=Z3K$'B72H98DNIC(MO'(8V0S+)]UP^0<#)R>G&:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%8GBGQ#'X:T8
MW?DFYNI9$M[2V4X,\[G"(#VYY)[ &M.SF>2W19W@-TBKYZ0ME4?'(&><?6@"
MQ163KFH7EKITKZ2+&:\C=5:.ZN/+103SD@'!QT'>GSW>HIX@MK6*.S-@\+-(
M[S$3!QG&U,<CU.: -.BL#PUXBDUB74K"^MUM=5TR?R;F!6W*5/,<BD\E67D9
M]".U;] !1110 4444 %%%% !16?JVNZ5H-ND^K:A;644C;$>>0(&;&<#/? K
M/LO'/A74KR*SLO$&G7%S*=L<4<ZLS'T H Z"BJNFZC::OIMOJ%C,)K2X0212
M!2-RGH<'!JU0 454U+5+#1K)KW4KR&TM4(#2S.%4$G Y/O6;IWC3PSJ]]'8Z
M=KNGW5U)G9##.K,V 2< >P)H W:*** "BJ>K:K9:'I<^I:E.(+.W7=+(5+;1
MG'0 GJ:M(ZR1JZ'*L 0?44 .HHHH **** "BBB@ HHHH **** "BFQR)-&LD
M3J\;@,K*<@CU!IU !167<^(])M-<@T6:[_XF,ZAT@2-G.TG 9MH(49XR<"K.
MFZE:ZO81WUE(TEO)D*S1LA."0>& (Y![4 6Z*** "BJ5WJ]A97L%G<7"I<3H
M\D:8).Q!EF.!\JC(Y.!D@=36=8>-?#.JW/V;3M;LKNXV,XBMY1(Y &3A1R>/
M2@#>HJMI^H6FJZ?!?6,ZSVTZ[HY%Z$?T/L>15DG R: "BJNFZC::OIMOJ%C,
M)K6X0212!2-RGH<'!JU0 4444 %%%% !1110 4444 %%%% !14%[>6VG64]Y
M>3)#;0(9)9'. J@9)-0Z3J]EK=@E]I\CR6S_ '7:)X\^X# ''O0!=HK%U3Q?
MX<T2\%IJ>MV-I<$ ^5+, P!Z$CL/<U;N-<TJU-EY^HVL?V]@EH6E&)V.,!/[
MV<CIZT 7Z*K7^H6>E6,M[?W,5M:Q &2:5@JKDX&2?<BL[4?%WAW2!;G4=:L;
M47,8EA\Z8+YB'^(9ZB@#:HK-TCQ!H^OI*^D:E:WRQ$"0V\@<*3TSCZ5H>8GF
MB+>OF%=P3/./7'I0 ZBJFF:E:ZO81WUE(TEO)G:S1LA."0>& (Y![5;H ***
M* "BBB@ HJK)J5I%JD&FO,!>3Q/-''M/S(A4,<XQP77\ZM4 %%%5(-2M;G4;
MNPBD8W-H$,RF-@%W@E<,1AN!V)QWH MT455?4K2/5(=,>8"\FA>>.+:?F1"H
M8YQC@NOYT 6J*** "BBB@ HHHH ***0D $D@ =2: %HIJ.DD:NC!D8 JRG((
M/<4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#A?%O[[XF> K63F#S;V?:>AD2$;?Q&XFH;^>'PC\4WU&=A%
MINNZ>QG;L+BV4MD_6+/_ 'S6IXZTB]N[73M9TJ(S:IHMT+N&$'!G3!62(>[*
M3CW JWK_ (;TKQUH-O;ZI!<K 66=%YAE0E2,'N.&((]Z /)/$]E,/@=>ZY>(
M5OM=U./490>JJ\@\M?H$"_F:[/6O^2_^&?\ L%7'_LU=?X@\+:9XET$:+?1N
MMD&1@D+;"-ARH'MQ3KGPWI]SXHL_$<HE^WV<#P1$-\NQLYR.YYH YU?W'QUD
M2+A;GPZ))@.[)<85C^!(KNJX[PKIUY>^)M9\6:C;2VS786SL;>92LD=M&3\S
M \@NQ+8/08KL: "BBB@ HHHH **** $*JWW@#]17%_#5%_L#4SM&1K-]SC_I
MLU=K6=H^BVFAVLUM9AQ'-<2W+[VR=\C%F_#)H \S\)+J&D>%? %_'J]XZWTL
M5I-:,P\CRFBD( 7'!!53NSDG/;BKGAG6?$.J7>DZLD&N2"\NG^V"81?8UMSO
M V -N!4A.<9.&SUKM8/"FF6^E:-IT8E^SZ1*DMKE^0RJRC<>_#&H[+P?I]AJ
M27<$]\(HY7GALS<'[/%(^=S*G_ FX)(&3@"@#,^)QF'A>U-NB23#5;'RTD;:
MK-YZ8!.#@9[X-:NE3>)9+T#5-(TFUMMI_>6M\\KY[#:8E&/QJWKVA6GB+3/L
M%X\Z1B5)E>"38ZNC!E(/;! JCI_A--/OHKH:YKMP8R3Y5S?M)&W&.5/7K0!P
M6ESZ]<:!X+U-_$NH_:=9N1:70RI3RS'(V54KPX\L?-R<D]N*L7&H:U:RSZ)!
MKEX!%XFM[%+J5E>4020!V4DC!(+'!(/;KBNZMO"6EVNG:-8QB;R='E$UKE\D
M,%9?F/?AVK%\4>#4OIK9[*&9S=:W!>WK+-L,82(IO4Y!& $Z<YYH Y/QM+>6
M7A;Q]H,U_<WUK;6=I<V\ETP>1/,<AD+8&1F/(SZUTT"7WB/Q%J6G?VO?:?;:
M99VHA6S<(6DD1F,C$@[L8  Z<'BM63P)I,^CZKIUU+>W7]J[?M=Q--NED"XV
MC=C  QP .Y]:GU'P?8:A=?:EN;^RG:W6VF>SN#&9HAG"OZXR<$8(R>: .3\/
M^+[^-] U?6KL_P!G:QI3>82,)%=0@NS#T#H'./\ 8JG'J^OW2Z);7K:VYU*V
MN=5FBTPH)D4R((HLL1M1%<9P<DX[9K?\5^&#K=CI7A*TT8QZ-#)#))=F10D,
M29!C0;MY=E&WIC#GDUT6K^';76'M9C-=6ES:[A#<6DOENBL &7H05.!P1V'I
M0!P\<_B75-4\+Z1J&HZAICW-G>F\\O8DT@BD01MD9"L5()Q_>8"NW\47HT[P
MQ?7'VV6S81A$GBA\UU9B%7:O\3$D >Y%):^%]-L[S3;J(3>;IT$EO"7E+960
MJ6+$\L25!S]:MZQI-KKFE3:=>;_)EVDF-MK*RL&5E/8@@$?2@#S)]>UJS;5-
M'BN-7M/-N--AAEU)XI+B 7$K)(P92PQA.,\@D\=*L:_>ZQX>G\5V<&N7D\5I
MX>%Y:M,X:2&0O(,[L<GY>I^G:MS5_ MJFG:C<6L5YJ5_<PQI*D]\8VN&CDWH
M^_'RR+SM(P!P.!5+1O!TFIW^N3ZM9:A:V>H:>E@RWMVDMS-RY=V9&95&&50
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M_,C)SM;J.O0]1DX-6GT^.U\/MIMC"$BBM3!!$#P%";5'/X"@#S[2;S6+#2?
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MT>%]4O+Y#I%V0;MP[JWF09.<#@\<=L'%7?&4NHR>(O"^EV6I7%A%J$]Q'</
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M\P<DG&W<#VDT5/$.@:HFL:MIFH:B][IL=O(8%C>:)XI)"@D (&621<D<;@:
M.DE\;:6;/3I[&*\U%]0B::W@LX=TA1<!F()&T D Y(Y..M0)XIL=1U[PX+/4
MKI8M3@N)(K80+LEV 9\PL-R,ISP.^<USFB:-K'A&;1M4N-*N;S-C=075O9[9
M)+=Y;CSUP"0&')4D=P.U7KFRU_4_&G@[6;C2_LS06M[]I4.'6W9U C5B.I.!
MG'?- &W9^-K"]NA!'9:DOFQRR6CO;[5NQ']X1\Y)] P&1R*S]#^(46I>&K#4
MKC2[X75]*\=O:P1!FFQN.4RV,!1R20 ?PK T'3M9&N^&=1O=+UQ[JW,D>IW%
MY=&1?.>,@M''O*B,-GE0."O7G%/3= U./P]X92^TC6HSHCW-O=QV<QBE82'(
MDC9'!=054$9Z-T.* .[?QOIGV.QF@M[VYN+V22**SAA_?AX\B0,I("[2,')]
M.N13?!6N7&O6^LW$TDC)#JDT$*R1[&C10F$(P#D$G.>:YRWTJYT2_P!!UVTT
M#4S;H;U;FU:?[3=+YQ0K*VYN2?+&0"<;N^#70>!;74+>WUN;4;%[*2[U::YC
MB<@D1L$VYP2,\<X[@T 3WOC?2+#1-2U6?[0(-.NS9SHL>9/,#!<*N><[@1['
M-1^(_%5A865W"+RX@E&F2:@+FWB60Q1*0-X#<$DG@$<X-8E]X:OKCXC&,VA?
M0+N2/4KB3(V^>D+P["/?]TW_  &L6U\+Z_+X'\517ME*VH?V<NCV*$@M-%"C
M!7'/\;.3^% '50^,Y&\2:?HD5E=W$<^E"\-X8@"22@#$ X"\G/'!P!5;P;X\
M74=%\.QZG%?&ZU&%4%\]N$@FG"%F4$8P?E;L <'!J*UL-2T[Q5H-U)IEU+ W
MA\:=(\0!$,VY&^?G@8!YYIEAH6IQ>$/A]:/9R+/IUW ]VG&8E6"523^+ ?C0
M!T/C+Q+)X6T>*]BLI;MY;J&W"HN0-\BJ2>1V)Q[XK$'CJ6Q\0>($O+/4KBUM
M(K:=8(+96:UC:+<Y?D=^V2>#@<&M3X@V-Y?>%U%C:R74T%[:W)ABQO=8YD9M
MN2,G /%4H+"_N;KQE=_8)X5U*TA^S)* &8_9R"I&>""<'WH TM0\;:98E?+A
MO;U/LJWLKVD'F"&!L[7?D<'#$ 9/!XK8N[P+HT]];.K@6[31..0WRY!^E>8K
MX:O+ PRWFE:[=+<Z-9P"+3+UH=LT<95HY0KJ,'(PQR!\WX^C&P^S>%#IUM 4
M\NQ\B.$/OVX3:%W'KZ9[T <CX?N_$^M:'IFI/XRTF%[RWBG:W_LP$H64';GS
MO?'2MC4_'^E:5=:E!):ZA,-,91?206^Y(%9%<.QS]W#=LG@\<5R/AJRTO2M"
MTF&\^&%])J5K;Q++<+IMLQ:55&6#%\DY&<]:UM4T/4[C3?B.D=E(7U./%FO&
M9O\ 1$3C_@0(H W8/&^F37-S"UO?0&*S>^C::#:MQ O5X^>>HX.#R.*32O'&
MF:M?6-M';7\"ZA&9+*>X@V1W "[B$.>N,GD#(!(R*QO$NF7@O8[W[.WV:W\-
M7T$LG9781$+^2M^55-"74=;C\#1?V1=6L.DPK<W%S)M$;?Z,8T$9!RVXOGH,
M <X/% %GP?XVE;X?Z;JFMR3WNH7EW-;PQV\*F2=A(X"JHP.%3))P,#)-;EOX
MXTJ>:V@DCN[:>:]^P/%<1;6AGV;U5^>-R_=(R#GK7%^&_#^M:'X8\)WLVEW$
MD^DW]X]S9IM\WRIC*H=03@D;E.,YP36A>Z#>:SI/B_5YX'TR6[>&YT\7)57B
M:VC!21L$A<LI[YV]: .KU'Q=I>F7E]:SF=I;**&2411[LM*Q2.,8Y+L1P/<5
M$/&NG"PN9Y[>^@N+>9+=[&2']^9'QL55!(;=G@@XZY(P<<?#HFH>(? 3Z\]K
M/_:6J:C!J[VT,QCE\E&4)&CY&&$2@CD?,>U%WX8:]T^34++2-?C:+4+::07.
MHR&[N8HU=3L)?*%?-8@;@6Q]* /0=&UNWUJ&=HHKBWFMI?)N+>Y39)$^ P!&
M2.0P(()!!K(U+QYINFWVI6AL]2N7TS:;UK:WWK C('#DYZ8/;)X/'%/\':?%
M:QZA=1Z=J5F;F9?FU*Z:::8*H 8[F8J.H SG !XKEY[V]@\0_$"TM-&N[][M
MH8H6MPI D-H@ ?)&U>0<\CK[9 .JU3QMIFEL6,%[=6Z6Z7<]S:P;XX(6SM=S
MD<8!.!DX&<4ZX\8V$.OR:+#:7]W>Q)'(ZVT&]51P2&+9  XQ^(ZUPNL>&]=.
MCW>@R6FJWI318;33C:W;0VH=82LADVNNX[AT8$$8'K75>%;&]3Q;K.IW%C-;
M075A8)$9@ =R++O7&>HRN?K0!GV_CW^U?#%EJEQ]OT@2ZLMHC1VZ.)@9G14^
M8G@A0&(P0<XK>O\ QOIFGZA/;20WLD-K*D-U>10;H+=VQA7;/^TN< XR,XKA
M?[#UN7P1I>B_V/=I=:=XA2>4L%V/$;F23>ASR K#/UKH[636_#FI:W96NA7%
M\^H:D;NTN591 $D"!O,;.5*[6['(QB@"V?&&GZ7<>)KF]U"[FM],N((YHF@4
M+;^8% "%>6!+ DGD=JN6_C739'OX[JWO["6RMOMCQW=N59X>?G0#.1D8QUS@
M8KA/$FEZC8V7Q O);,B.]U'3WM"Y 68*\0/X9XK7UB/Q#K.JZCK.E:9?Z?+;
M:.]G#YVQ)9)7E5V\OYB.%3 ;IEAB@#5U3X@PV?A[6KV/2]0BOM.M1<?9+J$(
MQ5@VQSAC\F5.<'(P>*L6_B1+KQ%HMO)/?6<MY92S_8)8$"L%(!9FY92.P!P0
M>:XV\\/ZE=Q>)DL-'U=(=2T+[/;-J%RTTCRHSDAB[L4SO&!G'!/&:V'TS4=:
M\8>'M2_LV\M+1=(NK:9IU"M"[84 @$]<$B@#>L/'6EW]U9HEO?1VM](8K.^E
M@VP7# $X5LYY"DC(&<<9J.+X@Z3-+#MMM0^S27AL3=FWQ"D^\QA6;.>6 &0"
M.1DBN?T^PUB[T?PGX;FT6ZM9=&N;=[NZ?;Y&R $ HP.6WD+@8X!.<8J5=!U0
M?#R"P^Q2?:UUT7)BXSY?]H&3=]-GS?2@#L?$U^FE^&-2OI+J:T2"W:0SPQJ[
MQ@#JJMP3[&LIO&UE:M%9);:GJ-X+&&\*V]L&=XGR-YY !RIR/<8S5GQY8W6I
M^ ]<L;*%IKJ>SDCBC7JS$< 5G>&=)OK/Q,US<6SQP_V%8VP<XQYB-+O7ZC</
MSH Z?2]2M=8TJUU*RD\RUNHEEB;&,J1D<=JMUSG@&PNM+\!:)8WL+074%JJ2
M1MU4CM71T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5%<W5O96LMS=31P01*6DED8*J@=22>@J6N,
M^(HCD@\.P76#I\VMVZ7:M]UEPQ4-_LF0)U]J +<7B+PCXPDCTN/4;>[DWI<Q
MP[FC+F-@ZLN<;@"H/&1QSQ745G:G;Z0\NGR:FML)(KE39M,0I$Q! "'U(SQW
MKSJ"]U(>#=/\:'5K]M0GU"+S+8SGR#$]R(C"(ONC"GKC=D9S0!ZM5:XO[:VA
MNI&DW&UC,LT<8+NJX)^Z,DD@' QSVKS#4)=3'A_Q/KXUO4EN=,UB5+2-+AA$
ML:RJ-C)T<$$CG.!C&*DN()+'6?BAJ%O?7R7%M8AX3]I?",;9GR!G'RG[OIVH
M ].M;F.\LX;J(.(YHUD0.A1L$9&5/(//0\BIJ\RT=K_Q!?>&;.ZU?48[>?PO
M%=W @N&C>:7,8W%AR#\Q)(P3ZXR"_P +:QJ=S>^$(;F_N)A)'JL4Q=_]=Y,R
MI&S^K #K[GUH [[4;^VL(X?M*2LMQ,MNHCA:3YFX&X*#A?4G@=ZMJJH@1%"J
MHP !@ 5Y1J>NZI'I\+QZC<JQ\;BR)64\P>81Y?\ N]L4NL2:F^B^.-:76]2B
MGT>^E^PQQ7!6./9%$^"HX8$DC#9'H!DT >KTUW6-&=SA5&2?05YQJ4FH:I<^
M,[X:S?63Z-$J6<<$Q2-"+992[KT?)8CGH!Q@\UUNDS2W/@2QGGD:2633(W=V
M.2S&($DGUS0!>TC6=.U[3TO]*O(KNU<E5EC.02#@BJ>CW&@OK&M0Z5/$]^LZ
M2:BB.6*R% JYSP/E0# ]*\N\$:RG@/PU%).I:RU+18]2M4'\5U&BQR1CW?,1
M'N345A%J/@^/Q<D3RMJTD&E?:)8MN\S7$L@E92QQG,C8).!Q0![A6=<ZW8VM
M]<64DCFYM[3[:\:1,Q\K)&1@<G*G@<^U>=WEUXCTO3[VW6+6M.L+VXL;:"?4
M;N.>>!Y9O+F*.KN<;2I&3P2<4[5+:70/$?B@6FHWDC0^%&F@DGG:26%@TN,.
M?FZC(R3@^V* .[N]*TGQ39V-S>VTD]N MQ%%*9(U.<,-\>1GH/E<'![5L5YG
MHDU]XG?P[IEYJNH0PCPU;W\DEK<-%)/,^%W,XY.,$XZ$MSFH_$=S>K;R6T&J
MZUJ=YIFD^=)<:=-';1(_S[9I#O&\G8?D^8?*3CF@#T ZW8+XA70C,?[1:U-V
M(MAQY0;:3NQCJ>F<U%K/B71O#WD?VM?Q6IN-PB#Y^?;C.,#MD?G7%:7=27OQ
M>T:[F(,L_A(2/@8&6F4G^=7_ !D=27QYX0.DQVCW>R^VK=NR1XV1YR5!/Z4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **KV]]:7DD\=M<PS/;R>5,L;AC&^,[6QT.".
M#4Y(52S$  9)/:@!:*S/^$CT0:0NK?VO8_V:[;5N_M"^43G;@-G&<C'UJS)J
M=A#J$6GRWENE[*ADCMVD D=1U(7J0/6@"U14%G>VNHVB75E<PW-O)G9+"X=6
MP<'!''45/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6!XWUN3PYX)U?5X<>=
M;6S&+/0.?E7_ ,>(K?KF/B)I$^N_#W6]/ME+SR6Q:-!U9E(< >Y*X_&@#%AF
MN?A]I'A"R6.%["[N1;:G/("9?/E7(DW9[R9R2#P1TK8O/$=XWCQ= LHH'M;;
M3GO+^2122I)VQ(I!P"<$G(/'I4%]!#\0OA:1:N-VH62RP,#CRY@ R\]BKJ ?
MH:B\$Z)K%O8ZQJNOVZ1:YJ\VZ6-75A'&B;(TR#CH"?\ @5 '(MXXN1\"+/Q)
M_8^C>=)<[#:?93]F'[]ER$W=>,]>M=?J>NRV_P 6=#T065D\=S8S3&Y>+,Z%
M<\*V> <<C%<8W@+Q(?@'9^%Q8+_:\=SYC0>>F OGL^=V=OW2#UKLM4\/ZE<_
M%W0M>BMPVFVMA-#-+O4;7;.!MSD]>PH BT'_ (D7Q1UO0(N++4+1-8AC'2.0
MOY<N/]X[6^N:[JN%TW_B;?&75M0AYMM*TN/37<=#,\GFL ?4*%SZ9KNJ "BB
MB@ HHHH **** .5^(&K7FC^'89[*_%@\E_;0/=%4811O(JLWS@KP">34/A^8
MS:O&%^(,6LA58M9HMKEAC&?W:[N"0>*G\?:7>ZMX?MXK"Q^VRPW]M<-;[T7S
M$CE5F&6('0'K2:/<7@U.)6\#-IB-D-=":V.P8[A&+') '% '*^'O%$S^"?#]
MYK&H:F]Q=^(#9I);,H+DRR!4DW#F/ P0.>!71:K\0[72X]5NCI.HW&G:9(8+
MB]A$902@#* %@QP2%+8P"?3)KF++P5K\/@[PQI[V0%S8^)5O[A/.3Y(!+(V[
M.<'AAP.>>E5_% U+3?!OC;2X+2&XM9KV:?[<EU&5C\UE8Q,F=XDRV ,8Y!S0
M!T/B;Q!]FE\9065YJ,>H6.B&Y4%E\B(E'*M&/O!LCG/'2M?1_%WVR\LM/N],
MOK*2\M3/9SW&S;<A0-V K$J<,#A@#C\JP==\*ZQ>ZWXUN;>U#Q:GH2V=H?,4
M>9*%<;>3QU')P*T+2PUS4_$>@SW^DM80Z-;3"25IXW6XE= @$84D[<;CE@IZ
M<4 9_@?QC>/\/O#LEU%=ZQK.H_:"D:,@=UCD8,S,Q"@ ;1UZD"NXT;5H-<TN
M*_MTDC5RR-'*,/&ZL5=& SR&4C\*\PTGP)J5AX5\)C4M%EOIM,CNX+JQM[M8
MY )9=ZNK!U4XVC(W=&]17HWA?3AIF@PP?V:FG,S/(UJDYFV%F)Y<]6.<GMDG
M&>M %"\\:6]IJ%Q'_9UY+86EPEK=:@FSRH96VX!!;<0-ZY(! S['!=^.+"Q_
MM&*>VNEOK*XCMULPJF6Y:3_5&,9P0W/.1C:V<8-<W<>#677]32?PT^IQW]^+
MF.\-^8H8XVVEQ(F\'<I#8PISQR.:LZOX<U[4?$<GBR*WC34-*D$6EV3,F+B
M9$F]N<,^YMO/RX&>K4 :NH>.EL[_ %6T@T/4KQ])5)+UH/+VQHT8?(W.-QP3
MP,GY3[9DO?'-K#E[#3KW4H(K-+ZYFM0F(87!*G#,"Q(4G:N3@>XSSANM9'B;
MQS#IVB27KW8MXU"SQIY,AM5'[S<P^7D<KN/!XJM)X$GTJ54;09-=1],M;5&B
MOOLZQRQ1F,^8"ZY1AM.0&(YXH ZF]\<Q17E[:Z?I%_J;V=O'=RM;>6%\IU+!
M@789.%/'4TZ3QQ!(86TW2=1U.)K*&_E>V5,Q0RYV':S!F8A6.U03QZX%1:;X
M?N['5O$+):I%:W.GVEM:A) 03''(I49YP-RC)QFN;N?#.L)X<T>S3P]-_;%I
MI$%M;:G97R0O;3JF"LIW#<@;!P X.3Q0!UEWXUM[6_N(_P"SKR2PM;A+6ZU!
M-GE0RMMP""VX@;UR0"!GV.)K3Q5]MU=K6#1]0:S6ZDM/MZA&B$J9# J&WA<J
M1N*XS]0:Y-_!LL>M:A'=^&VU47U\+E;[[>8H41MN\.F\'*D,1A3GCD<UH#1M
M2_X3.*]L]#FTR7[:SWE]#>+]FN[?# ;HMV3(1MZH,$9W$=0#=\<:G!HW@S4M
M0N9KZ"&%%+26#*)URZCY"W&>>_;-5K_QD+34KO3;31M0U&YL[:.YE$)C $;A
MN<LPY^4\=3V[X/B/HU]X@^'VKZ5ID(FO+B-%BC+A=Q#J3R2 . :6RT>^A\4:
M_>O"!!=V%K#"V\?,Z"7<,9R,;UZ^M "2^-[>6.P_LG3+[59;RR74!%;[%:.!
MNC-O8#).0%&22#Z5E-XGFG^(FEF">X72I] EOC;.NTE@XP2IZ,!D54T31O$'
MA5='O8M%?4)?[!M].N;:&XB1X98B6!RS!2IWL"021@<&KK>']>O_ !OIVK7\
M%N@_L&6TNI('^1)W8':H)W$=>?:@#>A\5V<]GX=N5@G":Z5%N"!F/="THW\^
MBD<9YKF=5\<7%_%H\VFV5_;6-WK-O;17Y*>7<IYNUQ@,6"L V"0,@=LC,6D:
M5XD>+P58W6B-:Q:#(%NIWN8F$FVWDB#QA6)*Y(ZX/S#CJ17L]"\30Z#X=\-G
M12(M'U.WDEOC<1[)H(Y<AD7=NSMP2& Z'&: .JM_&EO/J,48TZ\73Y[MK*#4
M6V>5),I(( W;@"RLH8C!(]QGIZ\TT+P:VFZI;6MQX:><V]^]P-4>_P 0[-[.
MC",/GS!E1@H!D$YKN=&U.358+J26U^SF&[FM@/,#[Q&Y4-D#OCIVZ=J .6F\
M4ZAIWC3Q':IIVH:I!:V]M,L-L4 @4JY<_.RY)P,*,DXKH-+\4V&L:A#:V8D<
M3:=%J,<I "F.1B%'7.?EZ8K"N8?$&D^+/$6HV6A/J%OJ%O;QP&.XB0B1%<?,
M'8?+EN3U] >U'1] USPC?:2]MIAU1$T.'3I3#.B".9'+;CO(^0[SR,D8Z4 7
M/^$^N;S5_#,6FZ/<2V>KI.[,S1AE$9P<9<8QPQ]01C)R!UVJ:@-+TV>]-M<7
M/E 8AMDWR.20 %'U(Z\#J<"O/]*\.Z_H\7@B=],-S+IBW<-[%#-&#'YQ&UQN
M8 @8YP<\]*Z[QC9ZC?>&Y8-,6628RPM)%#-Y3S1"13(BOD;2R!AG(Z]10!0N
M/'UKI^DZE>:GIE[9S:;-#%<VK;'<"5E",I5B&'S=CG@\5+)XON$^S0)X<U*3
M49HGN&L0\(DBA5MN]B7VY.1A02>OH:XV?PCK$EKKT%GX?-G!J$NGSV\1N8V*
M"*8%U<[S\^T%N,C'&2>O0>+/#DEUXHM]8.BSZQ ;(VKP6]V()(V#[E;)= 5.
MY@><CC@T =?I>I6VL:5:ZC9L6M[F-98RPP<$=".Q]17,R_$*WC-S,-'U%K"S
MOVL+N]'EA(I!)Y><%MS+D@Y . ?7('0:!8C3-!LK,6D5GY<0#6\4AD6-CR0&
M/)&2>:Y"Z\,ZM)X(\0Z<EL#=7FKRW4">8OS1M<JX.<X'R@G!YH UM2\<0V%Q
MJ7E:3?WEEI1Q?WD'E[(#M#$ ,P9]JD$[0<9]>*;8^*KR^\?W6B1Z:[:=%90W
M"W8>/'S[R'/S9*G:  !G().!@UDWVE>(+&W\5:18:0;R+7)I9;>\$\:1P&6-
M482AB&^4@D;0V1@<5>TG1=1T/QUYB64EQILVDVUG]K61 (GA\S[RDACG<,;0
M>M #_B/J=[I6BZ9+87,EO)+JUK"[(<%D9\,OT(IEQXML-(UCQ?-,^IS?V1!;
M37$#%#$H9"1Y(X()_BW'KTJQ\0-%O]=TC3H-.A$LD.J6UQ("X7$:/ECR1T':
MN?USPCK5[??$.6"T#)K%G:Q6)\U!YK)&0PY/RX)[XH W?^$YE.IMIB>&M5-^
M\'VFVA)A'GPYP7R7PF#C(8@_,.*B7Q=I^J:GX/FADU2'^UOM)A@0HL9*1G<L
MX.3\I!QM/4>E:1TN\/Q"M]5\H?8DTF2V:3<.)#*C 8Z]%//2N4TKPCK=K?>
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MG "$' Y'- &U<?$*W@-Y,-'U%["QO397EX/+"0N'"9P6W,,D$X!P#]15J_\
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MW!X<@,K$@DX8X;I@"@#T2BO)-0\V;PAXG\6/>WB:U8:A<K;,MRZK"(9=B1!
M=I! &01SO-:T5I#KM_XFU+5=7NM.GTW4%@MYENVB2SC2.)P=I.P[BS9+ Y!Q
MVH [JWOA<7]Y:_9;J/[,4'FR1[8Y=PS\C?Q8Z'T-2W=W;V-K)<W4R0P1C+R.
M<!1[FO)]7U;4[?6?B)';7-P=MWI5O$%G*>4DH17V$\(2&/S#H3GM5?Q1I-];
M^#O$<5W9RV6G 6<MO:MJ;7#1R^;M<YSD*RE>#QD$]: /9J*\ZU34Q\/=?OG+
MSR:9?:89;.*65Y,74 QY:EB3\ZLOU*FNN\+:;<Z3X8T^ROKB2XO$B#7$LCEB
MTK?,_)[;B<>V* ->LBX\+:#=ZLNJW&DVDE\&5O/:(%BR_=)]2.Q/(KSOQ%;R
M7%O\1=2:^OEGTJ19+'R[IT6!UMHGR%! .3ZY'7U.9]9>Z\*:E>SZ7=7;S2^&
M+N\D\Z=Y0]Q&8]LF&) /SMP,#MB@#U2BO'M0M=:TGPUK-S##<V-H^@SM(TFK
M&Y>68!2DR\Y4X+Y(]5]!6N/#T!\<Z=IKWNI/:7VD2W-[&;V7%Q*CQ@,?FR/]
M8>%P. ,8XH [RYU:VM=7L-,DW_:+Y96BPORXC +9/;[PJ]7CNE6_]M2^!;34
M+RY=-VKP%O/99)4CDVJI<'=]U%SSR!SP32FXU#[0OANW6[O]/CU^ZMTA-\T3
MR1);K*L1E)W%59FXSDA,4 >PT5Y--9:LS^&M'U"XNK2";6;F(1Q7YDD^S>0[
M")I%.3CE>N0 .<C-:&HV+:+XB-[=IJ$VE17%K%:WMGJ+%K  1IY4L3'YE9N6
M;YB1)ST!H [/1+C3-0?4-0T^$I))=/!<NRX,DD),1/T&W ]JMV]\+B_O+3[+
M=1_9BG[V2+;'+N&?D;^+'0^AKRC[ MIX5U;Q!#<W::A;>))?(9+AU1%-^$9=
M@.T@AFSD'.?88/$.I7T5U\4MFH7$(MAIWD,)#B#*#)7T]3CK0![%17FNJZ7/
MI/B272-#U2YMSJ>AW+N]S=R2!)E>-4FW,25)\P@D>W'%;/@HQVM]J.FR6.H:
M;>QQPRRV=Q>FZBVMO DB<DG#%2#G'W1P.<@'8T5Q_C+9>ZGI6DK;7E[/*LUQ
M]DAO#:Q,B!5+2N/F."ZX [G)Z5RNA-<>(&\&6M_?7;6\MIJ0G2.[?]\L<T:H
M&=2"V !SU/?@D$ ]:JC8:M;:E=:A;0;_ #+"X%O-N7 W[%?CU&'%>9Z>9;V\
MTCPU<W=VVF#6]3@*FX</)'!N,4;.#N(&<XSSL'I72> +>.TU'Q=;PS231Q:Q
MM5I)"[ ""'Y2QY..G//'- ';5#-=V]O-;PS3(DEPYCA5C@NP4L0/7A2?PKDM
M7MEUSXB0:-?RS_V=#I1NU@BG>(22F782Q0@G: ,#MNS7'6ELNKZOX/BOY[JY
M6WU?4[..=KF0-)%$)?+)8,,D8 W=3CG/- 'JVE:M;:Q!/-:[]L%S+:OO7'SQ
MN4;'MD&KU>.M8+:^%]9\00W-VFH6WB2;R&2X=413?!678#M((9LY!SGV&+<0
MU[4]6O\ 4[:TF^U6^N-"EX^I[(TACF"&+R<XPR ]LDMGTH ]7H  Z"N$\$6/
MVO6_$6JW5U=SSV^L75M;H]P_EQ1_*2 F=O4]2.,#&*M?$=K@Z3I$-O=SVK7&
MLVD#2P.48*SX."/8T =C66=?LE\4KX=/F?;FLC>CY?D\L/LZ^N3TK@=7TVZD
M\2WFAV%E>W%GIVFPM:A=6> P/(TN92Q;+ME0 23C:?6HOML]C\1;:^UB8I<0
M>"&FO);<AL,LH+LG8\@D=J /5F944LQ 4#))["H[:YAO+6&ZMI5E@F021R(<
MAE(R"/8BO(X()X;B[T^6WO;6VO/#=Q=21SZH]Q+,Z-'ME?!^1_F;.TX/3M2:
M=:3O8>$-'M;"ZO;.30A?26RZD]OOE(B7<6SDA=W"@X&[..!0![%5'2-6MM;L
M#>6F_P KSI8?G7!W1NR-^JFO/])L[_5]?TG1/$=S<.+32)+@)#>L/,D\\HKL
M\9&]E0+SZL3UK=^%X"^!H@)C,!>WH$K')?\ TF7YC]>M '8T5P%W8P^(?%7B
MA-3U*[LX]*B@6TEANVA%L&B+M-P0I.[/+9&$QTS6;- NMVGC/5+S5+O[3I;-
M'8S0W3QK B6R2+(JH0IW,Q8D@@CCI0!ZC4,-W;W$]Q##,CRV[!)E4Y*,5# '
MT.&!_&O,=2DO7CMO$FKQWT]C_9]K+)-I]\8I=,?;ND8PY"N#N!/4X&,$5'::
M$\USXZ_LN9X[UM6BB427TL8ECVP.\6[)VEQN4,!D9P.* /6**Y?P3+ +74+-
M+;4+*>VN=LUE>W'G_9V**P$;Y.4((8<]2>G2J.H6B:[\29M-OI[I;2STJ.X@
MBAN'A_>/*ZM)E",D!% STR?6@#=T_P 26NJ1:=-:6M[)!?-*JRB'Y(O+)!\P
MY^7)! ]:V:\9\+75Q%<?"Z"*\E:"=]5\W:Y"S8#D%@.#SS4EJMY!\/K_ %N.
M[OIM1N=3?3PYO'7RH&OMA5,G:AQG#XR,]< "@#V*H;J[M[* SW4R0Q!E4NYP
M,L0H'XD@?C7EUW'K6CV=Y:&*?2M,OKS3[<(-2,\EN))MDS*^=R!EV@<\'<14
MGC?P]I=AX?N+.VU"YE0:CI[FQ:]=S;;IE4D?-N <9."<97(P: ._BU^RE\33
M^'U\S[;!;+=/E?EV,Q48/KD5J5Y;=:+]N^)7B#1[2XFMF?PU##!,LK;XV$C;
M&W9W'! YSDU=T#7;KQEK7A]2\D/]F6CW6JQ(Q ^U9:%8V ]&29L'T6@#T6@
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MJ78.JPPB=[<HP^0XY!Q@]1P#FH[FY\/KX2^T7369T#[,I_>*&A,6!M&.A'3
M^E><ZXCV?CSQ'XFM5+2Z&=/N751R]LT<BS+_ -\'=]4% 'I6I^)-)T?4].TZ
M^NQ%=ZE(8[6+8S&1AC/0''4<G%9USX_\/VU]=6;2WTDUK*8IA!IUQ*J. "1N
M1",X([]ZX35'77O%FE^)PP>V_P"$BM]-L&'0Q1K*9''J&D)&?1!6QX=C\3OK
M'BPZ-=:1%;?VW+N6\MI)'W>7%G!611C&.WK0!Z!I]]!J5A%=VPD$,HROF1-$
MW7'*L 1^(JS4-H+D6<(O7A>Z"#S6A4JA;OM!)('U)J:@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MN0\=Z'JWB6#3M,L8K9;47D-S<7,LQ#((W#85 IW$_45U]9^L:C/IMI'):Z=<
M:A/+*L20PX')S\S,>%4 ')/L.IH IZEX/T'5[Y[R^L!)-(%67$KHLP7[HD52
M%<#_ &@:=J/A/1-5U!+Z\L1)<+&(BPD= Z DA752 X!)X8$<UFCQNK6$'EZ5
M<OJLU[)8+IPD3<)D!9\OG;M"C=N]".,\5GZEXVUB.ZT*&U\/W,4UWJ$EK<P7
M#HIRD;MA&)P0<!@XXP".M '567A_2].GM9[2T6*2UM!8PL&8[( 0=G)Z94<]
M>*1_#VE2:=<V#6:FUNIS<31[FP\A?>6ZY^\,US">,;/3=2U]WCU&6*UU2WM+
MEI9@T<'F  .@_A0%AD>^:T_$7B>WLI=3TLQ73-;Z/-J$\UO($:) " %/9SAL
M>FW- $]WX)\.WUU=7%SIP>2Z;?+^^D"[^/G"AL*_ ^8 'WJ:7PGH<RZ@)+!6
M.H-&]RQD?<[1@!&SG*D8&",&N<T[Q;J$NM^%-.LM/GFT_4-(%V\UQ.K2XQ%A
MF)ZE0QW?WBW'2G:)XO@&B*]C;:C?75UJEQ9V]O<7"L[.A8L=YX6,!2?88'>@
M#:/@[2X[>S@M(_)6WOTORSL\KR2*,9+LQ).,#)SP,>F-Z:&.X@D@E7='(I1U
M]01@BN5_X3<RQVL%KH]Q+JLT\UN]BTT:&)X@"^7)P1AE(QG(8=.<=)I]VU]I
M\%T]M-:O(@9H)UP\9[@XXS]* ,O3?!N@:1>P7=CIXBEMT,<&979801@[%)*J
M2.I !/.>M+9^#M!L-26_MM/"3H[/&/-<QQ,V=S)&3M0G)Y4#J:W** .>C\#^
M'(IQ-'IVV1)_M$9$TG[I\DY3YOD!).0N <\@U='AS2!H<NB_88SILN_?;L25
M.]BS=3G[Q)]NU:E% &/I7A;1M$NVN["T*7+1^4TSS/([+D'!9R2>@Z],5:U;
M1K#7+,6FHVXFB#B1?F*LCCHRLI!4CU!!J]10!A'P;H!TN+3A8;;>&4SQE)76
M19#G+^8&W[CDY.<G-6+;PWI%F=.-O8I&=.\S[+@G]V7&'/7DG)R3D\YZUJT4
M 8]SX5T6\U&[OY[/=<WEN;:X82NHEC*E<,H.#P2,XR/6I$\.Z3&VDLEFH.D(
M8[$[F_<J4V$#GGY>.<UJ44 9+>&=&D75%?3XG75"&O58DB8@8!()XP .F*J)
MX(\/)I\UD+ F.:5)I':>0RET^ZWFEMX([8/'/K70T4 <\W@;PV]K<VQTT"&Z
M,;3*)I!N:/E7R&R'&!\P^8]R:N0>&](M[B>X2R5I;BV2TF:1F?S(E& K;B<\
M$]>3WS6K10!AZ=X/T+2GE>TL2K20FW+2322%8C_ NYCL7V7 X%7$T/38XM,C
M2U4)I8 LQN/[G"&,8YY^4D<YK0HH S="T>+0=)33X6#1I)+(,+@#?(SX R>!
MNQU[57O?"6B:CJ?]HW5EON"49\2NJ2%/NET!"N1@8W ]!6U10!AW'@[0;K5&
MU&;3PUPTJS./-<1O(N-KM&#L9A@<D$\"EO\ PAH.IZI_:-YIZR7)*%SYCA9"
MGW=Z [7QVW XK;HH RG\-Z/)+JLDEA$[:JJ+>[B2)@J[5R"<# ],57C\&Z!'
MI=[IWV#S+:^ %R)IGD>4#[H+LQ;CMSQVQ6[10!QVH^%9]4U71K%[2WCT#1[A
M;R.22X::>:55.U?F'R@,Q))8DX KL:** ,R;P_I5Q!JD,MFK1ZI_Q^KN;]]\
M@3GGCY5 XQTJ:32+"6]CO)+9'GCMWM59LG]TQ!9<=""57\JNT4 <_;^"/#MK
M;7=M'IV8KJ VTJO-(_[D_P#+-2S$HOLN!6K_ &99_P!HPZAY ^U00-;QR9.5
MC8J2N.G55_*K=% &%-X-\/SV]M ^G@):M*\!25U:)I6WN58'();G.>.V*<?"
M&A?V-'I(L +2.7ST"R.'63))<2 []_)^;.>36W10!DVWAG1K1+%(+%5%A*\U
MN=[$K(P(9B2<L2&;);/6H[GPEHEWJW]ISV6ZZ+I*W[UPCNN-K-&#M9A@8)!/
M ]*VJ* ,QO#VE/ILVGM9J;2>X-S)'N;#2F3S"V<Y^_S6/XI\(0:CHFNKIEM$
MFI:L(?/D=SB7RR-N>H&%!' KJZ* ,*W\&^'[5;Q4TY66\A\B832/)F+^X-Q.
MU>?NK@5:TCP_IFA><;"!T>;;YDDLSRNP7.T%G).!DX&<#)K3HH R]7\.Z7KK
MV[ZC;&5[?=Y;+(\9 ;&Y<J1E3@9!X..13+#PQHVF7$4]E8K#)"TS18=B(_-(
M,@4$X )4' &!VQDUKT4 8MUX2T.]M&MIK$>6UTU[E)71UF8DLZLI#*3D]".M
M6=)T+3-"BFCTRT6W6>3S90K$[WVA=QR3SA1D]^IYK1HH R]7\.Z7KC0O?V[/
M+!N\J6*9XI$!Z@.A#8.!D9P<5!<>$="NM/L;!]/1+>P;?:K"[1&(X(R&4@\Y
M.>><\UMT4 9C>'M*?3I]/:S4VMQ<&YECW-AI#)YA;KG[XS4$OA/0YM8_M62Q
M!N_,68GS'"-(HPKF/.PL,##$9X'/%;5% %2QTVSTW[3]C@$7VF=KF;!)WR-C
M<W/K@47^FV>II EY )5@G2XB!)&V1#E6X]#5NB@#(UCPOH^O3)-J-H9)40Q[
MTE>,LA.2C%"-R_[)R*>_AW2);_[:]A$9_L9L,\X^SDY,>WIC/M6I10!@6?@G
MP]8RPRP:>1)"CQH[SR.VQE"E"68[EP!A3D#' %,7P+X=73;>P2QD2"V9F@VW
M4H>+( (5PVX*0 -H...E=%10!AW?@[0+RWL8)-/5$L4,=MY,CQ&-#C*Y0@E3
M@9!X/>M#2]*L=%L5L=.MDMK56=UB3[JEF+-CTY).*N44 8FK>$="UV[6ZU&P
M6:8((V82.@D0'(5PI =<YX;(YINH^#M U6\:ZO-/5Y755D"R.B2JOW1(BD*X
M';<#6[10!B:AX1T/5+_[;>6.^8A5?$KHD@7[H=%(5P/]H&FW7@W0+R]O;N>P
MW37P47!$KJ'*[=K8#8##:N& ##'6MVB@"AI.BV&B6\D%A"8UD?S)&>1I'D;
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MEB2>2>]6J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH^7/O]ZNZH **** "BBB@ HHHH J:GJEEHVFSZCJ-PMO:0+NDD;H.W0<DDX
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M BBD3/!NH8=\0^KIN7W*BN\\'Z1-HGA:QL[IR]Z4,UTY.2TSDNY_[Z8CZ 4
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M4+XSGIGM4+06\D]CI$DSC2(?&$MI;KYI"^5]F8F('/W?,9EQ^% 'LM%>-ZI
M^GZCJWA_2((3I#:W8Q&SDG:* >9"6>+< Q56=8\@ CYL8YIVHZ-=6]O8Z7=&
MRM;.;Q/;(MCIMZ\HME:%O,CW%4*!OO;0!C?Q0![%59;^U?4I=.68&[BB69XL
M'*HQ8*?3DJWY5Y5XWL;**#7H].TJU5-"TM%2XN;QX_LC%7=/LZ*I^?./F)&3
MM':FZI MOX@\8:S9P(-5A\-PW,,Z#YTD9)@SCWP!^5 'L%%>?^#M&NM+\10R
M1VVCZ?9SZ<2]O9:B\[W+;DV3E6C3H"P+\D[QFMSQ[:3W/@R_DM,_:[,+>P;3
MSOA82 #Z[<?C0!TE5&O)5U9+,6,YA:$R&[!7RU(.-AYW;N_3'O7E,_B?[%K5
MYX\CE9]/NA<Z=;J3E6\J!9(\#U,L4R_\" JQI6B_V?X[T+0KW,RCPI(ERCG(
MD=I1O)^I+?G0!WZ^*-.EN=&CMF>XCU<R"WF0?+\B%B3G!Z*1TK:KQ3POH>FW
M.@_#:W>V40W9N9;E4./.;R&SNQU!V@$=P,'BN[\ P1V7_"2Z?;KY=I9ZS)%;
MP@_+$AAB?:H[#<[''O0!V%8^O^(K;P\=+%S%+)_:-_%81>6!\KOG!.2./E[5
ME^.!%=C2-):P2^EO;L^7;SW!A@;9&S'S2%8LH SMP<G'I7GKR,V@>&("8O+M
MO'*PQ)!(9(XT#R85&(!*C/''3% 'JVE^(K;5M;UG2H8I4FTF2..9G VN73<-
MN#Z>N*V*X/P9_P E%\?_ /7U:?\ HBM'XC.8_!LCABH6]LB6SC ^U19_2@#I
MKJYALK2:ZN)!'!"C22.>BJ!DG\A57^TB]U8I;V<\]M=QM)]K3:(X@ "N[)#?
M-GC /OBO//'@M[W5O%]M)ME6+PF7,9.0KAY64X]1A3^5$%M!I_C;X;VUE&L-
MN=.O',<?"DF)"3CZDF@#K]+\71ZSI;W^GZ9>SJE^]D\:[ RE6VL_+8VCKZ^U
M='7A$3LGP\A*,5)\:8.#CC[0:[+4?#VD^)?B"D5I8Q*FFRI=:G>ID-)-C,<
M/Y,WMM'>@#T6LR?6HCI][<Z?!-J4EI*8'M[; <R @,HW$#(SGK7FLSH_B+3=
M=M+&WMQ=>(3:K>RWC-=S .\;ILVX$?RD!=QP #C-9&J:;9:;\)OB!-96Z6\H
MU>>'?'P0BW";5^@S0![F#D D8SVI:\\;2],\0^,?$D7B%$FBL+2V^RB5B!!&
MT;,\B>AW _-U^4<UB^$M/C\6:GIO_"1Q->[O"]G(\4[$K(QEF D8=VQW]S0!
MZ[17+_#F:6?X>:(\TKRN+?;O<Y)"D@9/T KJ* "BBB@ HHHH **** "BBB@
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ML'.T8 /+=>,T]?'EQ=MH]OI^CB:]U'[4ACDN@B02V[!7#,%.5R3A@.<#CG@
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MVD%K;Z9:QP6\XN8D6,867^__ +W)YZURUW\0KZVM[^_7P]YFF:?J;:=<2B[
ME9A*(PT:;<,,LN<L.N.<9JQ/XZN],&LQ:OH\5O=Z?;PW*)%>>9'*DKE%)<HN
MS#+\W! '/- '0WGAO1=1U 7]YI=I<78C\OS98@QV\\'/7J?S--C\,:'%=VMW
M'I5JMQ:0^1!((QNCCP1M!].3Q[FG:)?ZC?02G4M/BM)$8;&M[D3Q3*0"&5MJ
MGV.5'3O46OZKJ&FK;KI^GPW+REM\ES=?9X8@!_$VUCD]  /7I0!-I7AW1M#>
M5]+TRULVEP',,84D#H/H,GCI6DRAU*L 5(P0>]<7#X[N=0_L2+2]&$]SJMK/
M.JRW6Q(6B958,P5LC+'# 'H..<@A\=75W9Z=#::.C:S>7EQ9M:2W6V.)H"PE
M8R!22HP,87)W"@#H1X;T0:3!I7]E6G]GV[B2&V\H;$8$L"!V.23^-6FTZR;4
MTU)K6(WJ1&%9ROSA"<E<^F>:YGP)>WE]<^*'OHY(I8]7:/R6E\P1X@AR%/\
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M1Q3M2T/2=8ABAU/3+.\BB.8TN(%D"'V!'% 'D\]A;ZS?:A#:-I=[I=MHUO\
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ML8[<F!]ZD$#:'&TE0,'<?6FZU9V>EWOB/2K:&*ST235=)%U!"!'$L4A42\#
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M]48-%TJVL[>S@TVSCMK:02P0I H2-P<AE&, Y)Y'-7J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF-U*CJ2%C!XR.]-M/B)?7<.BSKX9F$.MQ_Z"?M2[FDV;\.,?*N QW9/ Z=J
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MO-^]###;CORQ(XR35+P]X\UF]\.Z1+<:3#-J.J2S+;J;M8D=4+$DG;P0,
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M]%:274-S*MU<I;)]GCWD.W3(S_+-:U<?\0FD6T\/F$1M+_;MGL61MJD[CP2
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M\"S0VFJ2VSHDL1+I#(5(5@2 2 <'H,XZ4 9L?C.R87(EL;Z&2"P74?*=$+/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5DZOH]UJ<T+V^NZCIHC!#):"+$G^]O1C^6*UJ* ,?Q1JMWHOAV[OK"PFOK
MM %A@BC:0EF( )"@DJ,Y..P-8W@F6SWW*B#6)-4N )KV^U#3I;?SF' "EE "
MC.%0=!GW-=C10!DZAH]U>ZI!=PZ[J-G%%MW6L B\N7!R=VY"W/0X(X%:U%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
D0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>exhibit1060-kumaremploym003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIN]<L-PROWAGI]: '44U
M)8Y,^6ZMCKM.:=0 4444 %%%% !1110 4444 %%%% !1110 444@96) 8$C@
M@'I0 M%%% !135=7SM8-M.#@YP?2G4 %%%(&4D@,"5Z@'I0 M%%% !1110 4
M44UW6-=SL%'J3B@!U%%% !12*RNNY6##U!S2*ZL6"L"5." >AH =112*RN,J
MP(]0: %HHHH **** "BBB@ HHHH **1F"J68@ #))[4@DC)4!URPRHSU'M0
MZBBB@ HHHH **:SJF-S!=QP,G&3Z4Z@ HHHH **** "BBB@ HHHH **** "B
MBB@ HII=595+ ,W0$\FG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 5[Z[2PT^YO) 2D$32L!W"@G^E>.^)K74%^!XU'SX?M
M.LR6]YJ3NC%Y3-)&54$,,*H*KCGY1CCK7LEY:I>V-Q:2Y\N>-HVQZ,,'^=>?
M6>AW'B?X9#PC<SBSU+2W@M+AFC+#]RZLC 9&5=%4@^_L: )Y+ ^$?$/A>XAB
MLK=;^1]+O8K"#R8'RKR1,$R<%2K#.?XS7H%<AK2-KGCK0]/A4M;Z0[:C>28X
M5RC)"F?[QWLV/1?<5U] !1110 4444 <9\3X3=>$$M1--"+C4+.%I(7*N%:=
M%.".AP:P=6UR^E\$W.E:E*5US2M2L8+IU.WSD-S'LF'LZ]??<.U=5XWCMKC2
MK2WN);F+%[!<!H+*6YSY4BR$$1J<9VXR:Y?QC%HWB>]T^]M[G5K*ZMY(Q,W]
MAW;"XA619!&P\L='0$'MSZT :VH>*-?D'B&_TF'3O[/T.1XWBN$<RW31QAY-
MK!@$X; R&R1VKK[:[CO]*BO(<^7/ )4SUPRY'\Z\VU%TD?6[73-2OK;3-;<O
M=))X>O'EB9D"2&-@H'S*HZ@X.3STKK;;Q5H=I9PVL,.K"&&-8T7^Q[OA0, ?
MZKTH K_"^62;X9Z!)*[.[6V2S')/)[US'@W7M:C\*>"]+T[[*\VIVUV\EQ>;
MW\ORW!!P""WWB,9';D4RTFO=%TY]%T/7+J#2,N(&G\-7LEQ;(Q)VJP 5L9."
MPX]ZT; Z!I5UX<-BVKI:Z+:SVZQOHMV6E\P)\Q/E]<H2>.<]J +8\8:I_P (
M^TMS<:+87EOJ<NGW-W=,PMQLSAD0L&8MA0%W<9)SQ4FA^-[K59?#\1CM'^W7
M%[;SRP[BC&#=AX\G@-@'G/!_&L)EM[:]34-/O;P7<>IW5Z@N?#UZ\>V==I4@
M*#N'8Y]1WJ""+[";2XM-5O9+VSU"YNX9+CP[>E9%G!\Q7"J.<L2",=!Q0!H^
M(?$VOW*"/3I[6T,'BB'3-Q1SO3]VPW88<$L0P[CCBH/[1\0Z/>^/-3T\::T=
MA.EU<"='/GE;2)F5,,-G"G!.[J..,U6DMH3I5P@U/4'U%];CUE)G\/7GE^8H
M3Y"@3.WY3WS@CDXS6BTUA-I?BJVFN=1\[7T8%TT*\"Q,;=82<%"2,KNZ]\>]
M &P_B'7M8U:^M/#R:?$EA;0RR&]C=S-)*A=8UVLNT!<98YY;IQ5+3O&NL>(]
M8TFUT:VL8;>\TF+4Y9+H.QC!D*N@VD9/  /'<^U9\EU]AOKBZT+4;RV:]M8;
M>Z^T^'KV3#QJ565,*,':<8.1P*FT+^PM UBSNK635S;6ND1Z8D3:+=[CM<MO
M)\OOGIB@"[X=U.]OH/%9TNWTC39K/7)XGEDA8I*JJI:23# ESGDY XZ52C\>
MZM!X7M-1U)](M6U+4#;6%W*KQ0" *S>>ZL^<$(VT;AG<O3-95S9P'1M?L+34
M]0C&L:NU_-YGA^]*F%@NZ$X4'!V@$@C@D=ZT[G4I+ZQLS<7;QZAIUTMQ8O;>
M&KY(5 1D*.A!)!5V'!&./2@">S\?7^J0VNGZ;+I5SJD^IO8B\CW/:E$A\XRA
M0V3\N!MW?>SSQ5_P4;T^)_&(U 0BZ%[;JY@!"-BVCPP!R1D8.,G&<9/6L>]O
MI+V#3[R34[PZU87C74$G_".7@@560HT6T)N*[6/)8G/MQ5SPWJ=IH]]K%]?W
M>I7=SJ<Z3N8]!O(U0K&J;0"AX^7CG.* -&.63_A<EQ%YC>6- C;9GC/VA^<>
MM4-;U.[TOXCZC=6T,ET]MX7>XCM5)Q(ZS$@8'<XQZU#K>H6T^O6_B#1+O4+/
M4XK<VLBW.@7DL,\1;<%8!%((;D$'N:@L;I%N]2U>^U;4VUV\M1:PW%OX=NUB
MM(P2P"(R-N^8Y)8\^U %EO'EW:>')=2DU+P_>I+/!;VUY;NT<,3R$AA,K,2N
MP#=U!/3"UM>#O%)\0/J5J]YI][+8R(/M>GD^3*CKD$ LVT@A@1D],]ZX^2*"
M^N+O4KR[GAU9VMG@>S\-WJ1*\+LZLZE27+;RIY'R\#UKI]'\5+!'.^KW-]<3
M2ON5+;0+N..)0 -HS&6/.223WXQ0!->ZSKU_XBU+2M &G1#3(8FF>]C=_.DD
M!947:R[1@#+'/WNG%<-K]U=^-]?^'TZQ::;'4H;FX2SOK=IHUD6$%O,&X!\'
M.W@8//-;M_J7EZ[?:IH-_>6KZC#'%<K=>'KV7:R A9$PJ\X;&#D' J"WAT.R
MU#PA+:3:NMOX=AGA"/HEV6G\R,)G/E\'(R>.] 'H.JZ18ZU9?8]0A,L&X-M$
MC)R.G*D&N \$>$]&FUCQ%++;2N^G:VT=J6N93Y:K'&P&-W/))YSUKK?^$STC
M_GGJW_@GN_\ XU6)X?U72M$NM;F:359?[2U!KP :)=CRP41=O^KY^YG/O0!B
M^%-9US1O#&B7&RP;2;C56LC$5?S_ -Y<NHD#9VC#'[NT\=^PL2^+Y](LO&M_
M8Z38+<:?J\%OA$*FYWM&I9SGEL.<'V%)#_9D7A?2]'^U:H6L=22^,O\ 85YA
MPMP9MN/+XZXS52YLM-N+/Q+ +W4U.LZE#?*?[!O/W0C>-MI^3G/E]>.M '3?
MVOXJ?7+?04;1UOTLS?74YAE:+:9"D<:+O!SPV6)[?=YQ53P)KVFZ1X!L)=:U
M"RTUIKJ\PMS<J@+?:9,@%B,XS4.K:I')XDBUS1KN\MKDVALYTNO#][*CQ[MZ
ML-JJ0RDMWP<U+X9O-$T/PW;:3=_VE?M!),_G2Z%=9;?(S]/*Z_-C\* ,G59_
M"D_Q UP^(YI'C^S6C6GE/.1@JY8KY7K\O]*MV6O:UHWA+14N=1T^P>;[05GU
MUF:5HUD/DIL#*Q8QE=Q)XQR"36G8:SI-CXCU;5=VJ,E_';HL0T2['E^4&'7R
M^<[OTJGJ^JPW/B*WUC2[N^MI5M7LY?/\/WDI",P;='A!AN.^0>..* '0>--<
MUJ?P[;Z1:V$4FK:8][(]R'=8&5D!QM(W#YB!TZ@]B*H6?B;Q-IFG^)]7NYK.
M]M-.UHQ31"*0-' OEB0I\Y  4[@,=0Q[TWPZMAHE]H\\UYJ4ZZ9836*!=!O%
M+H[HRL24/("8/KGM4UGJ^CZ'+X@.I7=R^B:M</.8Y=$O$=7D559"Y3:5(7@8
M!YH ZZ+79[OQHVD6B0O96]BMS=3\DAY&Q$BD''*J['KQBL/QY-+%XG\#K'(Z
M*^K%7"L0&'EMP?6LGX;ZC9^'_#6-3366U&Y?=*9-(NF=8T41Q(2L9!Q&B].Y
M-:'B&_TO7-6T"]6;5(1I5Y]I*'1+QO,&TKC/E\=: &:EXP\1V]GXDU.V@TP6
M&A7CQ/'*CF2X151FP0P"$!NN#D]ACF.Y\3ZQH_BGQC>W5Q;S:7I5A;S):[64
MG<LA4 [L*2<!C@Y '3%0W9TRY\/>*=+%SJBG6[B699/["O#Y.]$7!'E\XV9[
M=:CU)=/O]8UJ7[5J*Z?K-C';7,9T&\,J-&KA'C;9@<L#@@]* &7WC)]8\.>*
M=)GU+1M1D_L"YNEFTICM3"%61@6;D;E(.1GG@8JOILBP^(OAA*YPB>'IF8^P
M@CK2EU2XU+1-7T_5]4NG^V6#V<0M?#=Y&JEE*F5LH23R. 0./QJ"VBTJ'4?"
MUS)<ZFZ:)IKV+Q_V%>#S]T:IN_U?'W>G/6@"71?B@MY=6$MU>Z/-;:A#+*+2
MS<M<V82-I0)/F(;Y5(. N&P.:U].U?QA>Z7!J;V^E+:7UDUS$$5]UH2H>,29
M;][D'!VA<'VK(T:\6PM8-)N]1OI]$MK=K:.%/#MXLTL97:HD<H1\J\?*!D\G
MTI-&O9+%+.QO=9U*;2[&V:V@BA\/WD<DRE=JF9BA!*KZ 9//M0!:\%^(M:.F
M>#+74IH+MM6LY9GGVMY@5(T*Y)8Y8ECD]^.!5RY\7WXT_4)A/I-A]FUB2P^T
MWS$1I&JY#;=P+N3QM!'7/:N9L%FTW3= 2#4IFO=#$D%N[^'+[RY8&0+AUQG?
M\H.00.V*=!"EDT-Y;ZG>2ZE%J<]_ON/#MZ8F\Z/8PVA001U!S[>] !K6OOXC
MTSP5>2FW:6/Q;';O);9\J0H95WIGD @ X.<9KL_B/(\7PYU^1'9&6S<AE."/
MQKBA96K)81SZIJ4HL]>&LB0^'[P-)G<70_)@99C@CH.,5T_B?6]*\0^&=1TA
M6U6!KN%HA*=%NV"Y[X\OF@#'TD:'_P )=HO_  AAO<;Y/[2P9S!Y'EMC?YGR
M[M^S;CGKVJ?3/&_B*Z\(6NNSVFFA]2GBL["W0./WKR^7OD;)^3@G YP.O/'3
M#QGI  'EZM_X)[O_ .-5Q]O%I<'@/3_#XO-56[T^5+BWO!H5V0LJ2>8I*>7R
M.Q&>030!H:QXRUWPW%J]K?PZ?>7]I:0WMM);QO''*CR^6RLI8D,#WW8.14NH
M^,M7\+W-]%K\-A.%TN74+8V8>/F-E5HFW$YY=,-QWXKD_%5RMYH6N:CJ%S>S
M:I=6\%I"+;1;N"*&)9@YP9%.6)).2>P 'KJW(M=<N;V;Q!?7\QETZ33H/L?A
M^\B\M78,TAW(V7RJ<=!M]Z )Q\2+J&QUH+?:%JMU9Z4^HPR:<S&-2APT;C>3
MU*X((R,\#%2ZKJGC$WGA3-UIEHVHW['R8XI& 3R'94D.\;\<YQ@9"GMS!=W]
MQK&@:MIFK:K=-]LLFM(OLWAN\15)!!E;*$DG(X! %6->O[74(]#FTZYOX+W2
M9Q-&UQH-[)')^[:,@@(#T;/7M0!=D\;7UOX9UF6:U@.NZ??'3X[9<A)978"
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M9Y=/BGM(2V&=O)?+HO4X89)'0C)JSK-]Y>I1ZG ]EJ]FJ62SV9?;=6Y+ I)
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M^$;FV%K\,0ETN[_2XV7S>N(I.",]<X]^: /8:I:OJ!TK1KW41 T_V6%YC&K
M%@HR1D_2O++>]U2STR^CTT6VHWDFBW,^FZO8'][, 4XG3G][DC#9.3D8SFM<
MWGA6^\-ZSJ>@7@8OH4J7"12?(GRDJ9AVER2,M\Q - '?Z9>C4M*L[X)Y8N8$
MF"$YV[E!QG\:M5YGI5U:W&JZ%9ZR8'T>7PY"UIYY'DO,,>;R>"X79CN!NQWK
M-C;5!X:TB2:ZL[R>W@O633]5<K]LM!*-DBR'[L@0)AB#P_.,DT >O45Y'=ZC
MI>IWMQI^OWTFCPW.FVLNE&Z3$J(8_F\ICTF5^N.3\O7%>DZ;JMC-<'25OA+J
M-K!&]Q%(0)5##AF Z$^WK0!:O)KF$0?9K3[3OF5)/W@3RT/5^>N/0<FK-<=X
M_EBA_P"$:D>;RF_MRU S)M!!8Y!&>:XK5Q8QZ7XVU 7/^EV.NPM:R&X),)Q;
MY*\\9.X'Z$=J /9J*BF:0VDCVVUY-A,>3P3CC\*\T\,W^FZGHNGWEA<2/XQM
MK&9+FW#8E:XV?/\ :%Z[?,7Y=W )&* /4**\MTR6*YL_!%[I4Q_M25Q'JP#X
MD>/R6^T>?WRL@'+=&(QUK,T0V-MHO@[4HKH"]?Q!<6S3&X+,83)< IR?NGY#
MCUP>] 'LM%>,O]@ATO4-32Z'VNU\7K'!,;DDQH;B-649/0H6SZCKTK2DN;#4
M_$&IV.K:NUCKEMJHDLDCC N9(@08A"3]Y&7@@<<L3US0!ZI6?/J3/9WDFEPK
M?W-M)Y1@64)EQ@E=QX! /]*X72+[2-1U:YM-:N7B\36FMR-%$C[9WC#GR@@Z
MF$QE<X^7&XGUK!OETNR\!^.8H3;VUW#J\Q*QD1NJF5=@.,'!!. >#S0![117
MG=_/9WOB3Q7::]*D<2V<,FF.[[<0^6=TD)_O"3.2O/"^U9NEVXU/Q-HUMXH?
M?=2^%]][!-,5!D\Q,EESC.,D^XSVH ]6HKEOAO=O>_#G09Y9S/(;1%9V;<21
MQR?7BN8\1Z)=-K6M^'K&'!UR%-0LIRORV\T7$N3V!_=\=,RGL30!Z1?37-O8
M3S6EK]KN$0F.#S GF-V&X\#ZU'-J$44C6ZX>\$!G%N&&XJ#CKT'/&?KZ5YUK
M=TFL?"C7O$LUNUE-=:;LB0DQM'L7[O\ W\+_ % 6KY.DP_%$W4_V1'GT")X9
M7VYD82/DJ>Y"XR1T'M0!U_AW6%\0^'=/UA(3"MY LPC9MQ4$=,T_7=5&AZ%?
M:J\#31V<#SR(C ,452QQGC.!7EW@X65DOPUN+>94N+RTFAN&\TDR*(20I&>@
M8# [&N^^($D<7PZ\2&1U0-IEPH+'&28V 'U- %FQUN\O(["<Z/,EM>!6$HE1
MO+#+N!8 YQT'&>36U7"Z!=Z5#9:!,?$;7$C6L=NEF+A&W,ZKR%7!RH!Y[#-<
MA;QZ</#NC7HNL7/_  E,EL)Q=,'$+7,BL@;=D*4(_0T >TU2UC4#I.BWNH^0
MT_V6!YC&K %@H)(R?I7E&N&SL=-\;V-I<?9[2RU73Y(XX9BHAW^1YA&#P"2V
M>V<UI7ME;:5J'B\:3-C1I/#[27*^<7C6Z.\ @DG#%.3_ ,!)ZB@#TC3;P:CI
M5G?!/+%S DP3.=NY0<9_&K5>::7=6MSJ^B6>LF!M'E\.0M9^<1Y+S#_6\GC>
M%V8[@9QWJK!#?V'@W0_%=R)KF?1;B5G+Y:2?3R[J&/\ >98RL@)Y^7W- 'JM
M%>:ZW,-%AT*?5REGIVHW4TVI/+$'CBED7,22CIM&2N3QE03ZU2FN=-T9=#@E
MU<S^%;B6[ N[J,/;+(2AB3/3R@/-"DY''L#0!Z'K&KR:2]AMT^>ZBN;I+>22
M(K^XWD*&8$Y(R1TSZUJ5@>$;.TM_#MK%:WDVH6L3NUM<S@$E23C8?[H!(4_W
M<=1BN8DN'M?'*3?Z'JEI<:IY(9&VWEA-Y>W:P_CBP"<<8#9YQF@#T:BN<\=W
M5W8^#;ZYLQ+NC,32^2"7$/F+YI '.?+W]*X'73H+>%-;U+1==6XMYVLRR6C"
M*WB?SE' 4\.5)W#T ) XH ]AHKRO4=-T7_A)O%MD3']D&C0W?DF<[?._? R8
MS]_ 3YNO0]ZATY=-US6_#BZW=>=!>>%%DE$MTRI+(&CR3\P!/4_AGM0!Z'J>
MN?V;K>C:<;5I!J<TD0F#@",K&TG(ZG(4BM>O)]'DGMX/AY%?W+.PU*\$#W#_
M #O!Y4XB)SR<H4Q]13$GGN_":7*OL\:P:SY;KG$VXW."A'4Q>2<X^[M&>V:
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M;68':R_PGH3G)Q6[H/B34[_Q3+8WFI6,$JS3K)I$ULT4R1*6$<D;DXER I)
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M<[U@:?R0WF;OO\AL8QV]ZD7Q%XCGC\7Z@MS9Q66AR744,/V<L\S)"'4LV[@
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MXV.3\AQ(P/!]L'FJ$'@._M%=;7Q"T(NK**SOMMH"9A&I173+?NVV'!/S#@'
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M=W#K@]_J*N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKBUEE6)@&E9BRQ\@98 -QVW>];6IK%H]SX'U*XB:/2K"*2*9EC)6W9X0J,P
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M!A&=JIN5@I?)&<'@$=ZVM"T"#0X[EA<W%Y=W<OG7-W<E3)*V !G:
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MSHW@6^N+40EY/%\D)\V,.-K3@'@]_>MSQ1?ZWK7A[QU-;W\5OI^FQW%DMH8
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MT,;*6B-C;@.H/*Y"Y&1QD4LG@NVDT2]TLW<HCN]3_M)GVC*MYZS;1[97'TH
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M@ V#TS6Y533;-]/T^*VEO)[R1 =\\Y!=R222<<#KP!P!@5;H **** "BBB@
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M8-<);Z2C7WA:YMAJMY!+KT]W+/J%NJ.3Y#J)-JJH525!&0#DY[UVOC6VFO/
MNOVUM$\L\NG3I'&@RS,8V  '<F@#%7XA6G]LV E8Q:;=Z8UTH^S2M,91(J[5
M4#<1C<>%[9Z5M3>,=!ATRRU$W_F6UZ";8PQ/*TN/O815+<=^..^*YWPXZZCX
MOT;4(8)_LZ>'F@,DL#Q[9!+'E?F P>#^58>G2WVG6&C6MR^I:;:-)J3&>SL?
M-G:0W1*1#*/L#*2W0;MHYH [.7QYI"Z]HVF0N]P-5@:>&>*-V0+E0O(4@Y+>
MORXYQD5/XOUR^T.QL&TZ"WFNKR_ALT%PS!%,A(R=O/&*X+PP\NFZCX+DOK6^
MB$$%_8S%[9V,<S2H55MJX&0#\WW>#S73_$^WCN-$TD7$%S-:IJ]M)<"V21G$
M0)W$>7\W3N.: -6TN_$UH\ESKRZ+%IT,3R2O:22LZ@#.<,N,<4Q?B!X7>38N
MJ;F,?F(!!)^]7('[OY?WAR0,+DBN8C/A,:?JT&@VVL_;[C3KB)!<0WQ5AY9.
M/WHV@\#'?L.M7+/3Y4U/X<DVD@6UTZ97/EG$),$8P?[IZB@#HCXU\.KIMIJ!
MU)!;7<CQ0-Y;Y=USN3;C(;Y2-I&<\=:Q_$_CN*V\$SZYX?FAN'ANXK9UGB==
MC-(JLK(=K*P#9P<=17+%CI6KZ3<7EI<&-?%FI2[%A9FV&.4APH&2!][@'@<5
M#XFM;K6/#OBW4["RNGM;_5K$VJ^0ZO*L?E*\@0C.W(/./X<T >DZIXOT+1KQ
MK2_OO+FC022A87D$*GHTC*I" XZL15^TU:QOKV[L[:Y62XM-AF0 _*'7<AST
M(([C-<+>7:Z%J/C2VO[*\FEU4B6R\FU>47*FW6,1@J" 0RD8..&!Z5F:W9ZQ
MX0T[P]=62%]2O=*C\/W 4YQ<%!Y,GOM8."?1J .ZF\;^'8;."Z;4-\,_F>48
MH))"PC;:[;54G:#P6QCWJ74?%VA:6MNUUJ"[;B'SXS%&\H\K_GH=@.U.?O'
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M8V'C*#6(?#5U;W<-FNJ9W6MQ;R%Y&\L.41N -N?O$$$=*T?^$RT#^U?[-_M
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M#QE1GVJ_110 50O](MM2O=-NYFD$FGSF>$(0 6,;)\W'(PY].<5?HH ****
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M!'&B]%4#  _"I*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBB@ HJJVI6*?:=][;+]E -QF51Y((R-_/R\<\U81TDC62-E9& *LIR"#W!H
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MM ";2=Z;,$@IGUZUZE7FMW_:HN+^/3[[Q);6-Y*\CPOI(G:,M][RI&/R@\D
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MK$G+/V"@Y %=M7*:IX4U.[\4MKMCX@^R2_9Q;QQO9),(ESEMI)XW'&?7 ]*
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MH7B=XKQ-0FTRVMKFWN)+![;=YKLI4HW4#9PP_O>U;]_X!-U=ZP\&K206VII
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MMNK,8CE4,0#C)VMCJ,\'-9>I:AK&H>+WT'2;V&P2VL4NY[A[?SF9G=E1 "0
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M%[>+)_#W]LV WV"WRW8L>8CO*&,)OP1G!W$Y !'?(Z?Q'HJ>(M NM*>=H%N
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M"L8['X?Q6MN;MXQ:.R?:HA'+AMS ,@^Z><8[5RVCZ>5L/A2K6A'D0EI 8_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% ',OX+MYM16>?5=4GLTNQ>KI\LRM"LH;<#G;OP&Y"[M
MH/:NFHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD41IX:O]-U74="\120PW5O!%/)' BVL+^:NPRH%4;CG:P)^YG..*]4I  !@
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MID660AP <9 V'/H?0UT4.CS75[<ZEI7B60V5])YCHL<4Z[@H0^6Y!P/E'!W
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MJWLK=KBZGB@A3&Z25PJC)P,D\=30!XU<V^D6GACQ!<VWV:.;3?$D:Z>RN/\
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M:9J?B"XL]7U&[MO$EKK#S6\4,2B:6+S"8MC%23$8RH/., YQ7JU)@9SCGUH
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M4O(;QAH;E)XX/*)!G3(*Y(X/<=CTXR=?Q=J]QIBV,<&JVFG"XD8/));O<2L
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MVH/"-<^S[F$0;R?*"CCGG.WVK7@\/I#K&K:B+AB=1MH;<IM^YY8<9SGG._\
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M]XMBN+0:5:7LD2Z>;<EY((YO*9C)NX<X9@,8X YZUWNGVTMGI\%O-=RW<L:
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MXD,:$YYRP5B.,]C5FB@#@[+Q/XROM=U/2(]#T07&FB$S,VI2[2)%++M_<Y/
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MFE0.%8GA<XW'^ZN>YP*RI/'>GZ=XBUBPU>[MK6WL_(,#_,6<.FYBV,\ D<X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M PW C(Z\@CVJAH6A6^@VDL4,T]Q-<3-/<7-PP:2:0X!9B !T       K4HH
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MYE ,F!P,G'MTP6/@TV*^&E34"RZ#&T4.81^]4IY?S<]=OIW_ "KJ:* .,D\
M!K0B+6+BWOX]2FU*VO(8U#0R2D[UVG(9#N(P>W>K\GA:>>;2+BXU>:>YT^Z:
M[:62)?WSF,QXP,!5"L0 !Z$Y.<])10!R3^"!)97<!U.199M675HY4B'[J8,K
M8P205^4<'GWK;UC2CK'AV]TA[ED%W;/;23;06VLNUCC@9P3[9[5I44 <OJ7@
M[^U],;2[V_$MA);Q0/$T )4IG]Y&<_(Y!Z\XP,5I>)-#'B+0+C26N6MTGVAI
M%7<P 8-QGW K6HH YS6_"\VIZC8ZK9ZO-INJVL;0FX@B5UEC;!9&1L@C(!'H
M:?<>&7FO]$NQJ4ADTIY)%,L8<S/(K*Q8@C'#'@  'VXKH** .7M/!\NGZQ=3
MV>MWD.F75P;N73@B%#*QRV'(W*K'DJ#SSZTW_A#<^&=;T1]18QZM-<2R2B$
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M)A %!(4D<XSU[U96VN1JSW1OI#:M (Q:;%VJX8DONQNR00,9QQ5NB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBC.* "BBB@ HHHH ****
M"BBB@ HI'=8T9W8*JC)8G  ]:2.1)HUDB=7C895E.01Z@T .HHHH **** "B
MD=UC1G=@J*,LQ. !ZT*RNH96#*PR"#D$4 +1110 45'Y\7VCR/-3SMN_R]PW
M;<XSCKC/>I* "BBB@ HID<L<R!XI%="2-RG(X.#^M/H **** "BBB@ HHHH
M**** "BBB@ HH) !). *9#-%<1++#(DD;<JZ,"#]"* 'T444 %%%% !13)98
MX8S)+(L:#JS' 'XT^@ HILDB0QM)(ZHBC+,QP /4FF"YMV>-!/$7E7?&H<9=
M?4>HH EHHHH **** "BHY)XH2@EE1#(VU S ;CZ#U-+)+'#&9)9%C0=68X _
M&@!]%%% !1110 444C,J(7=@JJ,DDX % "T4V.2.:-9(G5XV&593D$>H-.H
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MRG)'-=7I'_(E6'_8.C_]%BN%U6,W=SKBZ?=:U9V&N)B\A;PY<R.K^6(RT;X
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MI1E+DD J,$$=:U[CP5]HT'6]+^W[?[3U$WWF>5GR\NC[<9Y^YC/'7I6=\0]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDG!X]* +]%(K*ZAE(92,@@Y!%4;[6])TRY@M[_4[.UGG.(8YYU1I#T^4$Y-
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M2OLWF>5YOVR/9O\ [N<XS[59O]>T?2QG4-5L;3Y5?]_<(GRL2%/)Z$@X^AH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%J7_ ""[O_KB_P#Z":\)L)?#;_"NP4^,KB74XK)'CTC[8LR/,HRL1M\$L"P
MVU[K>I]JADLXKY[2X=,K)#L,B#/4!P1[<@]:Q%\+:@C;D\6ZLI]1;V8_]H4
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MTS38EUC5WBOKZ+>D&V7'EQKN4!F#GOT4X%5=&G25_AO&L@:2#5M1BD7;L,;
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M/(AD#3L[(B-(NSY#& ,G*KQQ7L<D4<R;)8U=?[K#(HDBCE4+)&CJ#D!E!&:
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MXGO;[2/#UE?:#;+#;WED9E:'$@=(?G3H2#M ).Y.*Z?PYI< ^(UPMSB\FM-
ML(TGFBVLQW2 MM/*D[0?45Z$\4<A4R1HQ0Y7< <'U%)#)#.@FA>.16X#H00<
M>XH \HTVVDEURR^'K*QMM(U.2_?(X-FN)+=3ZCS)57'_ $R-490 WC&69=UC
M#XJM);X8R/LZF,N6'=1P3[ U[,C12,S1LC,#L8J0<$=C3@BC=A0-W7CK0!Y9
MXHO=$U!?MN@7%I'%#JUFVI:CY7G6APCA"V&"MM8QY.1C*Y/%1"#3A')J1\8Z
M<+AM8\Z"\6PV6(N!;[&4Y<J=RG[P<?-G!SD5ZFJV\>+51$N5)$0 &5[G'IS^
MM.-O"8/),,?E8QLVC;^5 &#X(O5U#PO%.MK:6X\^=?\ 0Q^XE(E8&2/_ &7.
M6'U[]:Z*D "J%4  < #M2T %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBY8AB0!D;1C/7CGKK;P?]GT?PK8?;MW]@R1OO\K'G[(7BQC/RYWY[],5EP^
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MIVMW]Y::]#JOG620Q*)I(@08C$Y4G:5^5@#@?-G&2: /5LCUHR*\6U:#2O\
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M(R*** ,K6='FU<P1C4[BUM!N6ZMXD0BY1@!M9F!*CKRI!Y/L1J@   # %%%
M!00#C(Z444 %%%% !1110 48&<XY]:** $P 2<#)ZTO08%%% !1110 4444
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MBAT*2\B6_EA,RQEU' *@#K]X[L@=P#5RVU*PO+B:WM;VVGG@.)8XI59HSZ,
M<C\: +5%%<;;>,]6U%[MM,\(WEW;V]U-:^<+R! S1N48@,P.,B@#LJ*SCK-I
M:V<<VJ3V^FRF)9)8;BX0&+/&"<X//&1P2*FCU73I;Q;.._M7NF02+"LRERA&
M0P7.<8[T 6Z*I+K.EO=1VJ:E9M<2Y\N$3J7?!(.!G)P01^!K,T?Q.NJ:YXAT
MZ2W6W31YHXS,9<B0,F_<1@;<?4T =!15&#6])NK<W%OJ=E-"'$9DCN$90Q.
MN0<9)[5:>XABFBADFC264D1HS %\#)P.^!S0!)152TU33[\3&SOK:Y$)VR^3
M,K[#Z-@\?C3K+4;'4HFEL+VWNHU;:SP2JX!]"0>M %FBJMSJ=A93PP75];03
M3G$4<LJJTA]%!//X5DV?BRQFU/4[*\FMK)[2]%G%YUPH-P?*C?*@XY_>8P,]
M/>@#H**J7&J:?:74-K<WUM#<3\10R3*KR?[H)R?PK N?&1M]<\1:;]@W?V/I
MRWWF>=CSLJQVXV_+]WKSUZ4 =5169X=U;^WO#>FZOY'D?;;:.?RMV[9N4'&<
M#.,]<5IT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7F _Y%/XI>9_Q\?:;W?GKL^RIL_#;C%>GUC+X?2+Q-<ZO#,%CO;<0
MWMJT>Y9BO"/G/! )4\'(QZ4 <3I+Z-)XB\"+H)M3+%9S_:Q;XWK%Y(!$N.0?
M,V_>YW9[YK?\%?\ (=\9^5_Q[?VQ\N.F_P B+?\ ^/5TQLHXEN'LXK>WNI5Q
MYWE _-C@L!@L!Z9JKX?T2'P_I$=C'*\S[FEGG<?--*Y+.[>Y)/TX':@#4HHH
MH **** "O$?#%M#>?#/P/;W$:R0OXC?<C#(8;[@X([CVKV>\AFN+22*WNGM9
M6'RS(JL4_!@0?Q%8"^&M51$1/$]PJ(VY5%C; *?4?)P>30!YYX]@BM?#_P 3
MH;>-(HO] ?8BA5W$)DX'<X%=*YL8/BEJPF^SQW$V@P& /M#NP:8-MSR3CKCM
M6\_AK591()/$]PXDQO#6-L=V.F?DYH?PSJLLR32>)IWEC!".UA;%E!ZX.SB@
M#SGPQ>P)X/\ !5K*^DVC+IEU.M]JD1E10)%5D1-Z@L<@YSP!P.:?H$RRZE\)
MP'#&+^THF &-A6(C:1_#@8&#TKT%O"NHLD2-XCF*PMNB4Z?;80^H_=\'Z4J^
M&-41PZ^)9U=69@PL+8$$]3_J^I[T 2>-&T3^Q8HM?:6*REN8T6ZC8I]FDSE)
M"X(V8( W=,D9ZUP^I7LITWQ1H5OX@_X233/^$?NKGS9/+EDM90N$1I$ #;LD
MC(W#9FNX?0-:E1DD\5W;HPPRM96Y!'_?%1V_A?4[2(Q6WB6:&,G)2.PME!_
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M)U%4&I^#-0@O4$;EU:TSN!#$ D")I4Z#[M>@Q^'M8A39%XJND3).U;*V _\
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MV3:7MIX?!DEU" W#R>8[ P1('4$@J 2,DDJ *]>AL+.WD\R"T@B?IN2,*?S
MI\EM!-+'++!&\D1S&[("4/L>U 'D.AW%O)JOAN=9K8WEQX-$=M*[+E[D-&
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M;OHS> FAM3:_\)"WB(F%1CS_ #?MW!'?'E@\],9]ZEU,$W7Q$+@FT75].:\
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M-;M\C SYC$>1S\O SWJ"'P7J$4-E&;ZU/V?7)=7)\MOFWESY?7C'F'YO8<4
M.E\?R6UEJ%S<:%<(NEW8MK_$Z$1 ["&7^_PZG&!WK3U#Q2+9]6^R6+WB:0H:
M]*2!6&5WE4!^\P4@D$CJ "3P,O4/!5_?:9XGLQ?6R?VW=+<*_EL?) 6-<$9^
M;B,>G4U;?PO?0ZAK<]C>01PZW&OVF.1"WDRA-A=,'Y@5Q\IQR,Y[4 )-XW$E
M[]FTO2I[_=IB:G#*LJ1I)$QXP2<CIW'7MCFM1/$EF_@Y?$P27[$;'[=L"Y?9
MLWXQZXK+MO"$NG:LL]C/"MI#HR:5##(I+ (20Y/?KC&/QJ]I.B7ND^"+70X;
MN'[7:V:VT5SY9*95=JL5S[#(S0!SOC/5I=0\#W%W&FU([FRD@N+.Z,D<ZM<(
M"%88SQD$'UK:B\6R%]9@FT:[6]TP1-]FB*RM,LN=A&WW!SZ8SS61/\/7:PU:
M&RDL]/&HSVLS6\",8(VAD#EU7C#.0 <8& .IJUJW@_4M1NO$%Q#J4-L^J06L
M:8C9MGDL6(;D;E<,5(XX/>@!UWX_ALK'6)I-/>:72KB&"=+699%/F[=K*QQG
M!;!&,@CIWJS/XNEMF-M<::MMJ.R286UQ>1J#$K85MPR,MV'L<D=\F]\":K>0
MZVG]I6"#5&M'VI:LJPF$KP!OY!" 8]\^U:^LZ!J\VNVFNZ+J-M:WR6YM;B*Y
MA:6&:,MN' 92"K9(.>] $4/CJWO1;)96;M=3V*WRVER_DS,I+*512#N<%#D<
M8XY.:N^,[ZTT_P -33WUG/=VPEA5XX9?+()D4*=P(. Q7I^6*SO$/@ZY\0V9
ML[VXM;A3 HCN9(BLUK<;F)FB(/'5<+D8VCDUJ>*=#GU_PW+I4%RD3R/$QEE4
MM]QU?H,9)VX_&@!O_"2I+KUUI5K DTUG-%'<)YP650X5O,"8Y0!ADYZ@^E06
M?BT:C'<SV5HD]O 9U=EN!OC>(D%9%Q\A;!(Z\=<5!JOA*;6=:M[ZY:T22UNX
MKBVNXD*W$*+MWQ;OXE8ALYXPQX-,A\&-)K\6K73VT=TL,T$\]HAC>\1QA1*.
MAVCG/.2!TZ4 6[/QA!=MX>/V5XXM;LVNXG9Q^Z"HKD,/HPY'O5>T\>65S>6(
M,.+*^A>:&Z20/Y:JN_\ >J!^[RN2.3Z'!XJEI?@G5;5_#B7FIV<MOHMO+:!(
M[9@9HF14&27X;"_3V/:QHOA/6+'2SH&H:S#=:%%"]O J6Y2X:(J55'?<5(53
MV4$X'N" 9]YJ]QJOBSP+?1VTT%C>37$D+&<_.AMI&7?'T!(PPZ^^#Q5SQ3<7
M5GX\\,2V=O/=2O!>C[,DVQ7(5,$[CM&,GGK]>E,T_P 'ZY;/X;CN=7LI8-!D
M80L+9@\T?E-$ WSX#!6ZCN,^U;>LZ+=7FN:1J]G/"LVG><ODS*=LBR*H/S#E
M2-H[&@#,@\>QS6=G</I<\'F:E_9=VLLB@V<^< ,1D%22,$?WE]:Z.RU!KV[O
MHA#MCM9A")=V1(VT,<#';<!]0?2N2UK3](TGPS?Z-J4[SWVO2SS*L,;;IK@@
M$>6!G:5PFW)_A!)ZUU>BZ>VE:-;6<DIFG1,S3'K+*3N=S]6)/XT <I\0=6U.
MTA632)PLFD!-3NX@<&>,-CRO^!*)3]47UK:U;Q7;Z;I.EZE!:S7UOJ,\$,)@
M*C_6D;3R1US_ /JZT^QT!=U]/JT%C>75S.TF\PY 7 54^;/ 4 >_)QS7#ZMH
M]YX3\'Z%I%QJ5I(L.O6ILW92HCC\[<%;+<A<XSD<4 =-#X]A66_L]1TVXLM3
MM9X(%M&=7,QG.(BC X()!SZ8.:B\0Z]]KT3Q3HUS#)9ZE9Z7)=+Y4Q(>,HVU
MT<8/#*000.1W!I=3\$/K,UYJ4UVD&JRS6LUM)&I=+<VY+1@@X+@EGSTX;';-
M6;[PM<ZF-8N[F>W34=0TS^S$**3'#'\Y)YY8DN3VZ >I(!EVDC)XK\%N9I L
MFAW!D!D.T[5@P2,XS\QY]ZUHO&D#Q:5>O:.FE:K.+>TNMX)W-GRRZ8^57QP<
MGJ,@9I(_"]U_:F@W4UQ;M%INGRV4L81OWN\("P.>/]6..>IJMI_@J>VTK2M$
MNKR.?2]*NTN+=MA$KK&2T2-SCY3CD=0HX% $?Q(M]5>QTR?0[F>'4H;LRQ)'
M(RK.(XI)/*90<,&V 8/K6?XU\4OJOPT>\T&ZE@DO-.DOO.B;:\,2+EN1T;>5
M3\6]*[34;&ZN]0TR>&2%8[.=IG5P27S&Z8&.GW\]^E<U)\/8X/#_ (DTO3[H
M1_VR9%0RJ2MK&^2450>@=Y&[?>]J +9\20Z/IUE8Q*MQ>+IZ73)/<["5Q@?,
MV2S,0V/H<D<9EA\51:U#%;Z;8SS3SV(O)897-N\,;$JJD]0Y(8 =/E)R.,UK
MCPQK<.H:?JND:I:07\-DMC=1W$#20SQJ<JP 965@2QZ_Q8J4^&=4M?$B:UI^
MJ0M-/:+:WRW4)99=K%ED7:PVD%F&WI@]L9H P?!VI0#0/A_#>VUS<75W%*8;
MHS$"-Q$Y;>,Y8E01R".<]:ZFR\3/J$MC-:Z9/-IM[+)%%=QG=MVY^=UQ\J-M
M.#GN,@9K)TCP5?Z9:^$H7U"VE_L(R;B(67S0\;)@?,<8#9SWQT%6?#OAC6-
M3^RUUB%]#AD=[9!;D7"JQ)$;/NVE5)_NY. .E $]AXM2^UBRTNXL)K22_MY9
MX5=\2HJ%01(F 8R0P(Z]^>*A^'):3P7&)'DD/VN\7<[EF(%S*!DGD\52T;P5
MJ^FWVA7,^JV<[:7'<1.PM6#W(EV9=V+GYR4&3[FMWPKHMQX?T+^SYIXIW$\T
MRNBE0?,D:3!!ST+8_"@#E?!^I0K:>)K>\?5;@IK-Y"C".YGV1J^%574';CT!
MJ7P'KK6_@/PM%*\U[JNJH^SSYV)<KN9F=VR0H 'KU Q6YX<\/W^A6>L1/<VT
MTE_?SWJ$(RA#*<[3R<@>O>LK3/ EYI>C>&HHK^!M1T!I!#*8R(YXW!#HRYRN
M1CD$X*@X[4 5O%>O)J_A"_"+/9W^FZK:6]Q")2"K&XB[C&Y&1\C/4'H"*L^.
MM;>Z\)^++73H))/[.LY%N+A)S$8Y#'O 7'WBH*LW(&#CDY%6-1\%SWVEZHBW
M4*7^J7]O>7$I0E%$+1E$49R1B(#)[DGVJ'4O!>J2CQ+;Z?J5K%9>((6\^*>%
MG:&9HO+9D(89! '!Z8_"@"S;:I;0^(;: Z?<R7T>A_:%F$PVR1AD!0*6QNR1
MR0/K3M&\<#5KC1%?2;BUM]9MFGM9GD5LE5#E2!R.#P>^.E2)X:U"/7(-2^V6
MSF+26T[;Y3+N8LK;^IP,J!C]:IV/A.\TFV\+,]U%*GAZWDC<1Q,6N 8]GRC/
M!P,XYR>* +-KXYBO)-$>'3II+76I)([.5)%S\@))=3C:"JLPP2>,8!XJ]HGB
M5->G)M($:US*C2K,&:)T8+LD3'R,>2!D\#M7">$;J876G/:7F@Z@XE+-:)%,
MES:B5\R'9O98B,G.%4'!'>NHB\)W5OK(UT2V<.IQ6LT3W%O"P^UE@-C3(#\V
MW&>,DGICI0!V-%4-%?4'T:U;5?+^W%/WIC4JI.>#M).,C!QVSBK] !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %8/C/Q*/"'A2]UUK4W0MO+_<B39NW2*G7!QC=GIVK>K@_C."WPGU
MH $G-OP/^N\= '4:GXDT31G9-3U6SM'558K-,%.&W '!]=K?]\GTI;_Q'HFE
MV4%[?:M9V]M< &&6290L@(SE3GD8YX[5APV\4GQ;U&62)69="MD#,N< S3Y'
MXX%<9X0O[/0AX6U'6YDMM.;0'MH)Y^(TE$H+)D\ E N/7:10!Z_#-%<0I/!(
MDD4BAD=&!5@>001U%9VKZC)87&FQQSV$0N;I86%W*49P03B, ?,_' /O53P]
MJNC&STW3]/MY+$7%JUS:V<D)1EA# $XY"\LO!.<'I6'\103J_@C )QK\6?\
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M>"7DC#&+P@"I8?=;= /SP2/Q- '=0>*= N;ZWLH-9L);JY020Q).I:12,@@
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MS\06YNK?;F6&3[7\TCCJ =WWCP=PH ]8\0ZA)I6A75[%/80/$%(DOY3' N6
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MZ5H\FD+& <O=D9N2ON0J*/J: /4;#Q'HFJPW,UAJUE<Q6PS.\4RL(Q@G+'/
MP#STXIEKXIT&]T^XO[;6+*6TMO\ 7S),I6/_ 'CGBO.)KVUELM5U>UUJSU]K
M?1C;O;)IVV".)G7 EVD\H QV'!QNZ5E>(;^.XL_&>W68]3^T:!"(;B*%8DFV
M22;A'MX<+O )!.,X[4 >T6&IV.JQRR6%W#=1Q2M"[0N&"NO521W&:MU#9V\-
MI9PV\$:QQ1H%5%&  !@5-0 4444 %%%% !1110 4444 %%%% !1110 4444
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M,"41Y'"[F () !)QGG%<EXEU'7X--\3^'[O4K:65-$DOX;R.UV$QX=9(RN_
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MQNH#-%+%=>8\/0A)5*C#$'^$L 01[UH:OXATG05B.J7T5MYN?+#DY;'4@#G
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M_-F;?@(G/SY/\/!^;IQUH S?^$*$<FFRPWP62UU*74YV:#/GS2*ZM_$-HPY
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M3)))P%'11G '/ ZFKM<WX!\17/BSP58:W>1113W/F;DA!VC;(R#&23T45TE
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MDPFCPT4F\$!@!@'#=N.>*U7O([#QC]FTN[DF:YU4&ZT:\L]Q0D@-<128RJ@
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MYBN;>0926%PZ,.G!'!H XWX.Q20?"S1XYHWC<&?*NI!'[^3L:[FBB@ HHHH
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M8I-6N8)[N;,C?9UQ%&#R$0]6 '&X\GK[5P_Q&UC1;WQ%I'A/6=0MK73G!O\
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MI3:@][)<SS6=O:.60*"(MV&P.YW_ *4 <+/?:YK>A^%-?O+^)[74-:M)19"
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MTVE/;RC?(R2;8F"^8 J[EQU/&37=Z[I$6O:)=Z7-(\27";?,CQN0@Y!&>."
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MA# ,S[>Y"HV!ZXK5U7Q)XA\/3ZI;37B7ZZ2+74))?LZJ\MF[.DJD+P&786!
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M<;2"#6]IDUY%KFBR>+[2"VM9M!6)5D0""*YW?O$(^ZK%-F!_LD"@#T>6:*!
M\LJ1J3@%V &:'FCB&9)$08SEF XKR2RC>SL-*TS4[6=6>SOULYKB&2;$#2CR
MX0G_ #T,>T@MR%&,')PFA6.F:U>^!HM3M([D-X=D@N5N8C\S@0A5;<.3P^,]
MP2.E 'H7BSQ"?#>B2W\44-Q*C1CR7FV$JSA"PX.<;AQ^M;M>,ZY/ WAGQ3I^
MJ6Q_MQ-7$L2- 6=X!,GDM&0.4$?R\=.0>O/LJL'16&<$9&1@_E0 WSHO.\GS
M$\W&[9N&['KBL"^\0W9UB\TO1[."[N[*&&:9)I_+WB1F 53@_, C'GCH._'#
MF&XN_"4]@Z%/&<&LF1&VXE+&YRLJGJ8_).,_=V@CMBNDT:&Q'Q4\1R"& 2FU
MM/+?8,E_WWF8/KR,X]1F@#I/$&J/HGA[4-52W6X^Q6\EPT1DV;E12Q .#S@>
ME8=SXRN],T*UUW5-'6/2I4CDEFM+DS-;J^,,ZE%RHR,[<D>E7?'; > /$*D_
M-)IMQ&B]V9HV 4#N2>,5S6JZBFH_"Z/0=*C:_P!4OM-2S6")21$S1A6:1NB!
M>3\V.F* .Z2YN)-1546W:P>W\Q9A+EV?/0+C&W&#NSU[58%Q"59A-&54;F.X
M8 ZY->;G3+32_%,EA/Y4BQ>%%M9I&48E9&QSZG SCKBLZVM+31O 7A#58;-X
MK;%L-:EM;</+A8'56D4J=P21AD$$CC'04 >L^?$8?.$J>5C._<-N/7-5KK5[
M"SELHIKF-7O9#';C</WA"ECCVPI.:\X=]-T4Z3JEI]ON?"\FJ33W<DL!*+(\
M>$D$848B#Y_AQN.?0U8U*ST2"3PI>66G2+I(UB:0M) [C$D,IR%()5#(>!@#
MI@<B@#TDS1"41&1!(PR$+#)'KB@RQJX0R(')P%+#)/\ D'\J\IO89[OPUXAT
M^9"OBP:L\MDVW$K$R@P21GKL"8&1P K XYK3L]+TBX\9^,[BZM(Y)(#!-%)&
M@WHP@P[Q>C9X)'?&: /0XYHI2PCE1RIPVU@<'WI]><^%M1_L*2_.H2VE[I]I
MIT3KJ]G;LKM$I8+%-&H/[P9)X['D"O158.@9>A&1Q0 R>1HK>61(S(R(6"+U
M8@=!7+?\)/K:^([?0GT.Q6\FLFO03J3;%5652I/D]<L/;WKK:XFYEC'QGL"6
M&!HDT1/8.9HR%SZD G'M0!I:=XFN;CQ!+I>H6$=B8].@O26GW%3(S*4/R@#!
M0C/.:Z&6:*%0TLB1J3@%V !/I7G7B*ST^_\ &WB$7T$$\:^'45!,H91('F/&
M>-P#+[C=[UDQWEN(=#3Q)+=II5[X=M[>.=;<3*+C!$T;91BKL"GIG9CJ* /7
MJ*S]"MDL]!L;:(W/E10*B?:CF7:!QO\ ?&,UH4 %%%% !1110 4444 %%%%
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ME)'49%0-XDT)&*MK6G!@<$&Z3(/YU'X7M9K/PW813WDEVWDH0\B(I VC"X0
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M&Q0.IZ]>!7F=YJ6J2_#CPYXD\0:H]U]HU'3;EHH[=56%5D!)4*-S%AR1SSP
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MF@#TFYN;/47OM&BOHUO%A'G1H07B5P0&(]^<4NAZ6NAZ'8Z5',\T5G D$;R
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M[JIX!9B1GK\N*S=9M(-$USQ=IFF1);V-YX9EOIK>(8C2<;TW!1PI9>N.NW-
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M3QI--GRHV<!GP,G:.^!Z5P=MX2\/7_POL);C3K2"9=)BF%Y%$L<L+B(-Y@<
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M=JN1VVD GDU<U;Q!JPU;2-'T^*SLKZ_MI+EVU'+K'LV QJJ,-[Y?LV %)YH
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M/3TQ6W7*7GB#65\:3^'["TL93'IRWZ/-(R;LR,FPX!QRO7WZ4 6M$\+-HDT
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M['T- %G6]$@UR*RCN))$%I>0WB>7CEHVW '(Z'O56W\)Z;;>,;KQ.GF?;;B
M0LA(V+]T%@.S$(@)]%%;M<VWC*S3QK-X;>"X5X;1;A[DP2>6,[N"VW:%POWB
M<9^7J"* *7_"OK>'2=$LK+5]0LY-'>5[:YB$;/F0,&R&0J>'(Z5=B\+7C6M]
M:ZAXFU34+>[M9+9HYXX%";QC<"D:G(&>O'/2G6OCC0;NWNITN9DBMK5KQFFM
M98]\"]9$W*-Z^ZYZCU%-'CSP\;:*Y%W-Y,TYMX'^RRXG<(7Q'\OSY .",Y/
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M&15&Y2=^<D =>>*]2HH \RDT>&'Q#JRG1[CR%\,0VL>^W>;]X#*"@?!WMM9
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M4(K$1LCEL!@1G@$>X';BNIKE?'&C7&MQZ%! L^V+5HII9(&VM$H23YP?8E:
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M<8C54FPK-\N20/E'.,#N>:ZZS\":?9W%IB^OY-/LIS<6FG22*8(),D@C"AB
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M% ''Z=XIUK4-=\&(+A0NJ:%)>3P[0$>;8A!Z9 R3TJ_X)U*_EU$V>K:IJ?\
M:?V7S+G3M1M$3$@(#20.B@-&"2, MU7D=]6V\#Z5:W&CS))=$Z38-I\ ,@^:
M)E"DM@ [L <C%3:1X5BTO4([V75-1U":&!K:W-Y(C>3&Q4L!M522=BY+9/'6
M@#G?B;K-H#I/AJYE=(=2G$E\8XGD*VL9#,,("?G;:G3N:RO#'BNUT72O&&FZ
M>S2PZ3%-J>FK+"\>Z!E9]@5@#A)-R_0BO0H- M(/$MYKV^:2]N8([?\ >,"L
M4:DG:@QP"3DY)YJOK7AFQU;4(-2EC=[FWMI[;RPX1+B.5<-')P3MX!&.AYH
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ML,UG9)8E%92D\*G*AP5/())RI% %'Q??3KJ5C86VIZG!(\4DK6^E6JR3N 5
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MV.N>QP00>00000>017*V_B+Q-X@^TWGARPTP:7#,\,,M_,X>[*,59E" A5W
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M-A0C=NR1\N,G(JIH'BI=>\4:O96S*UE9VUM(A,3QR!Y#*&#JV"/N+@$ \^]
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M#@ _H:27QIX=@T^VOI=21+>Y=XXB8WR70$LA7&0PVGY2 <\8S0!O45SWBCQ
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MXR.@XK3\66%YK/B>36[#2Y)K'1!&+R!D93JFUA)L5>-WE#YER#ECM]:]1HH
M\FUFW2?6?$8O+_Q#!9ZW%"]M;Z?9)(+N-H%C*9>)BC@@Y!9<!@>.36E%=Q^&
MM0\3:?J6E7NI2:A<QS6<0M6E%ZAACCV%L% 59#G<0 #GI7H%Y>VVGV<MW>3I
M!;Q#=))(<*H]2:GH \FUVXDL=(^(>C-87TE_J+R36D<-J[K+&]M&NX,!MX*M
MGGMCJ0*U&+VGC;7(IK>Y!U#0H$MF$#LCLBS;EW 8!&1P2.HKT6@D $DX [T
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MRDRDQJN4?:'!8Y"\X !YKUBB@#QK3;2^8>"8GL[X2V6OWQN?/A(:,,TK!F(
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M45O;0VD7E01B--S/@?WF8LQ^I))_&@#S2;3KH?#C6H5LYO/D\1/,$$1W,O\
M:"D-C&2-HSGT%5]1,EKX:\8^&);"\EU;4[VZ:S1+9V6=9SF-PX&T!00"21MV
M?2O4[FY@L[:6YNIHX((E+R2R,%5%'4DG@"H=-U.QUBR2]TZ[ANK5R0LL+!E.
M#@\B@#G_ !_:W$OPQUNUB22XN#8,@6-2S.V.P')K$TVZ'ACQ"U_JMO=BVO=%
MLHH)8[:27:\6_?$0H)#'>I /7GTKO[F]MK/R?M,Z1>=*L,>\XWN>BCW.*GH
M\R\%:-?:?K7AD7ME+$8M%O"0Z?ZDR7,;JA/0,%.,>QJII<<^BZAHFJWME=BQ
MM]1UB*0I;/(8C+.3&Y506VD*1G&/F'K7K%8VM:;9:Q<6UJVI3V=_ 3/"UI<!
M)0,;2=IR&7G'((H \PMXIKDW&K1?VCIUI;^*[F:=[:W#SP+);!1(8V1N[#<"
MI(#GICC5M=*1]7\,W=M_:U[#-KMQ=RW&H6ZHQ/V9D$@544*A*K@E02>>XKT+
M1=%M="L6M;4ROOD::669]\DLC'+.Q[DU/9ZC9:@]REI<Q3M;2F"<(V?+D&,J
M?0\B@#G_ (DV\UW\/-8@M[=[B5XE"PHN2_SKP!7*^*(I_&=_>C0[6[7R/#]Y
M;2-+;O#F64Q[(?G R?D;/89'K7I2ZC9/J;Z:MS$;U(A,T ;YPA. V/3/%37$
M\5K;2W$\BQPQ(7D=C@*H&23[8H XCPE';7OB(:BFI>(+Z:"Q,!.H6<<$4(=E
M)CXB0EP4''( SZUG>)K9[3Q?K,U[J&MVEIJ%C"D(TVS2<7)7S%:([HGPWS @
M94'>?3CT:UNH+ZTAN[65)K>9!)'(ARKJ1D$'T(JO+K.E07ZV$NI6<=XV-MN\
MZB0YZ87.: .)T[2)++4_%$*6UR8ET&RMH'G3+OMCG!4D<%ONYQW-)IMA<1+\
M,Q]EE06UBZS?NR/*)M ,-Z<\<]Z]%H(R,4 >-^&;I-5\$^!-&LK.Z%[;WMO=
M2@VSA(XD+,TF_&W##C@\EL=<T^TTZ^M[;5[Z2PNFAM/'$E_+&L+%G@  WJN,
ML 6#<9^Z<5Z?I6G6?AGP];V$,CBSL8=HDF8$A%'5C@5=MKF&\M8;JVE66"9!
M)'(AR'4C((/H10!YW<Z3_P )OJ7BBYLTGAL[G3K:VM;F6)HM]S$\DBR*& .%
M+(,X]0*RH8-3\:^"O$'B5K69+Z]A@MK>!%!<1V[!I50'():3S<#OA:]0U;3?
M[6L'M/MMW9AS\TMI($DQW&2#C/MS[TFCQ:9:6":=I3P?9[$"W\J)PWE%>-K<
M]?7/- 'F.J6 U;2M6U*PN_$&M3PQVGF&\LTB62..X$K1HJQHS. K$C!^]CJ<
M5T>E7\6M?%#^TK*UNOL0T4PBZEMGB5W\X-M&\ G /ZGT-=U10!PNIW\.B_%*
M34KVVNA9G1$A^U16SRJC^<[;#L!(R!^@]17,&&_\(^"] \6+8RK=64MRDUF5
MVNUO<RL40CKD.83CMS7L-9&I>';75]3L[R\GNGBM&62.S$@$!D4DJ[+C+$$\
M9..!Q0 SPGHS:!X8L=/E;?<JGF7,G]^9R6D;\68UM5!9WMMJ%JMS:3I/ Y(6
M2,Y!P2#S]014] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %<1\2X[J6QT%+;4)[3S-;LXV,2H<YE&
M#\RGE2 1V]0:[>LCQ%H$7B+3HK:2YGM9(+B.Z@G@V[HY(VW*<,"#SV(H X&X
M36K2\^(&HZ?KDMJVG&.<!8(W^T2)9QL?,W*?E.!PNWJ>>@I^J^,-:N[_ % :
M?-J<,ME:026]M9:6;F*XF>(2D2N$8JIW*H *D<G-=D/"=L;/7;>6[N96UJ/9
M=2MM# ^2L)*X4 $A<],9/IQ5>X\%HTQDL=9U+3Q-;QVUTMLR SK&,*<E24;!
MQN4@X^@H T]3U"YA\)7FI0PM'=)8O.D3#E7$98*1ZYXKG/#'@_P[?_#ZPBN=
M/MKO[?9I/<W,B!I)I)%#-(7/.[))!SQQCI7;[1LV$97&,'G(KC1\/8X;:33K
M/Q!K%IHLA;=IL,D>Q5)Y1'*%T0Y/ ;OQB@"-3JFJ>(KW0M,UNXTVST>RM@DD
M:1S23R2!L%VD5LJ @Z8))/-9>C^(=?\ %=[H5M'J9TU;O1I;JZ:WAC9O-CF2
M/*;U8 $D]0>/?!'2W7@R 72W&CZC=Z,WV5+.060C*O"F=@PZM@KD@,.>:LZ9
MX3T[2+^PNK+S8Q8Z>=/BBW KY996R>,ELH.<]S0!QFDZ[XE;2?#6MWFL^=]L
MU,:=/:+;QK$Z;WCWYQN#Y0-P0O.,4V77/$L/AW5O$S:T3'INK30)8BWB\N6!
M+GRR'.W=NVY ((Z#()R:Z^'P;8P:/IFF+<7)BT^^%]$Q*[F?S&?#<=,N>E<]
MH7@B>]L[Z/4KW4+>RFUFYNI=/P@CG N&>,Y*[@I 4D @''N<@$>L>)]0L_$3
M2VNK7=Q#%JMO9/:Q6 ^R(CNB,KS%<^8"Y/#8!P,=:@U#6_$B:/XDUV/6VC31
M]4DA@M%MXBDL2NN5D)7=T8@;2".IS707O@""\:[4:QJ,-M->"_CMXS'MAN-X
M?>"4);YAG:Q(Y/'3%R;P;93Z%J^DO<7/DZI</<S."NY68@G;QC'RCM0!AWWB
MS4M%A\6V-U()]2M'232\HH\U+CY85P!SMERI/L,UV4!N+#1(VO9OM-S!;@S2
MA0OF.J_,< 8&2#7)WVC-XD^).FZ@VG75O:Z*DGFW$PV+=2$CRU49RRJ07W=,
MXKN&570JP!5A@@]Q0!YKHMU+IWPMTJ__ +2>TO\ 69DN9[B*V,\TTDQ+LL:8
M.7V_*,@@!>G%0VWB7Q!=PV-A#J,\4S>('TU[FZM$29H/LS2@LFT .,C!  .T
M9&"0=31?"]TV@0>'[J6[LI] O-^G7\2J1)'AA&PW J?D=D92.",]Q6E9> [2
MSU!+O^TK^8I?C4=LK(<S^2T3,2%!PP;)'0$#&!Q0!S\^OZ]927V@#5GFNO[;
MMM/@U&2"/S$BEB65B5"A"P&X [<<C(K3\+6UW:?$7Q/!>7SWK+96&R>1%5V7
M,_WMH"YSGH!QBM/4?!5CJ$FI3&ZNH;B\NX+Q9HBNZWFB151DR".B\@YSDU/H
M?AA-&U34-4?4;R^O;^.)+B6XV#/E[MI"JH"\/C XX'?)(!2U[_B9>-_#FE#F
M.V\W5)Q_N+Y<>?\ @4N?^ 5/XMU*^MI-&TW3KC[+<:I?"W-SL#F)!&\C%0P(
MW$)@9!'/2M*#1H8?$5YK1E=[BXMXK8*V-L:(6;"_4N2?H*;KNA0Z[:P1R3S6
MT]M.MQ;7,!&^&1<@,,@@\$@@@@@F@#A=;\1^(-"L/$>GQ:E]JO-.FT]K6[GA
M0,R7$H0HX50IQAAD '#>HS7H6EVMU96"07NH27]P"2UQ)&J%LG.-J@  =!].
M]8+^!;2YTV_M[W4+RZNK^X@GN;Q]@D8PLK(H 4*JC;C '<]SFNJH \;O-5U?
M7O".^;5)87C\7)9AH8HQ^[6Y0)G*\E2 ?<CG(KI9=5U:Q\7BSU+6[RRB^TPQ
M68EL4:UO8RJ;@TJKE9F;> -R@';A2*T3\/[!= NM*BO;R+SM2.J)< H7BF\P
M2#;E<$ CH0:GE\'O<W"?:M?U.XL_.BN);23RRDDL94@YV;E!9%8JI"YS@ '%
M %CQA<ZI::(LNEBY#>>@N'M(5EFCAS\S1HP(9NG&#QG@U@Z1XBNY]6\.6T&M
M_P!I6EV]ZLTKVPBD;RU4JLBX&UU).<!<^E=;J^F2:I:I'#J%U8312"6.>V89
M!&1@A@592"<@@C\0#6$W@2();3PZQ?Q:I!=271U "(O(\BA'!4ILVE0HP%XV
MB@#(;Q'K-[>MI$-]]GFNO$-Q8QW2Q(6@@CA\TA01@L<8!8'J>N*N7DOB.SO=
M(\.2ZV/.O[F<C4HX$\X6\<88 J5V>86(&0N,#.,U<3P#91:<T$.HWZ77]H'4
MHKTNAECG*[6(RNT@C.01CYC[8<? \)M86&KZ@-4BNFO%U,E#+YC+L;Y2NS85
M^7;MQ@#OS0!C:SJVO:1<Z3H=YJEX\EQ]IF>^TW3_ #[AXHR@0% C*K'S!N8+
MCY>,9JG/XB\1G2M-N-2N-5TJT"7"7%]!I89S(DFV)Y8F1BB,@W'"CDXR!73?
M\(3'';VKV^KZA%J=O++,-1)1Y':7'F!E92FTX7@* -JXZ5+-X5N#;VT=KXDU
MBWEBB:*68R)*9PS;B6#J5#9)P5 P..@  !SUYKVJPZW;M>:[)96,B6IL[J&Q
M62QO"P&_>^"R%B2%&Y0 0<FH;[7M?/A_7?%D&K-%#IEY/'#IHAC,4D4,FQ@[
M%=^YMK'(88R.*WY/ <!MH]/AU?4H=($<,4FGAD:-UC554!F4LH(49"D9Y/!)
M-%UX#M;J:[B_M.^CTJ]N?M5UIJ;/*ED)!;YBN\*Q&2H;!Y]30!7TJ\UK5O'^
MO6[:HT.E:7+;^7:I A,OF0*Q5F(R "2>.<GK@8J3P&?LC^(=$7_CWTS5'2V7
MLD4B+*$'L"[ >V*V;?2;;1]1UK64-Q++?F.6:-5W8\N,( @ R20O3GFJ7@O2
M[NQTV\OM1B\K4-5O)+Z>$G)AW8"1Y]515!]\T 4;B?6=>\6:QIEAK,NE0:7#
M!L,,,<AFED5FR^]3\@ 48&">>:Q-*\2>(/%>I^';>WU(:;%>Z*U]=>5"CGS$
ME1#LW XR3WSQGO@UU>J>%/MNJ3ZC9:O?:7<74*P71M?+(F1<[3\ZMAAN(##!
MY^E2Z?X3T[2M4L;VS\R,6.G'388<@H(BRMD\9+90<Y[F@"3Q5/JEMX<NI='2
M1KQ2F/*C#R!-Z^844\,P3<0#U('6N(U#Q3?6WARQGL->DOV?7[:SD:ZLEBN(
MHWQNBE0J &ZD$*IP1]3Z'JNGG4[![9;RYLW+*Z3VSA71E((/(((R.0001P17
M/S> ;6]MP+_4KVZNFU"'4);EO+5G>( (N%4*%P , 9]Z *7A*"\'Q!\9R3:I
M<311W4*"%TC"_- C Y"@_*#M'/(Y.3S5_6+O4]0\9V_AZQU*7384L&O9YX(X
MWD<[PBH-ZLH'WB>,].E:-GX=2P\3ZCK4%]<@:@$-Q:$(8RZH$#@[=P.U0,9Q
M2:QX<&I:C;:G:ZC=:;J,$;0BXMPC;XV()1E=6!&0".,@T <=9>(/$6K:CH^C
M_P!JBVE-QJ5I>W4,"%I?L[H%=0P(5B#SP1R>.F.H\%ZA?7NFW\.HW/VJ>QU&
M>S^T%%1I51OE+!0!G! . .E.T[P;I^F7&ESP37+2:>+C#2,"9GG(:1W..6)&
M>,#GZ5HZ1HT&CB]$$DC_ &R[DNWWD<,Y!(&!TXH \K\1P7HC^*$DFIW$T<2P
M*L#I&%^:)&7D+GY<D#GIUR>:Z#5]>UOPAJ.H_:M3;5(QH=QJ*1RP(@CFB9!A
M=@!V'?T8DC'6MK4_ EKJ5YK<K:E>Q0:S$B7=O'Y>TLBA5=25)!PH&,XK2U/P
MS8:OJ1O+SS) UA-I[PY&QHI2I;/?/R#OW- '/^$]6UB;7Q9W4VKWMG)9F62X
MO]+-H(9U91M0[%!5@Q(!R1LZ\TOB^9[WQOX2\/3_ /(-O6N;BYC/W9S$@*(W
MJN3N(Z' K=T70)]*G,MQKFHZCMB$$27+(%C0'/1%4,W ^9LG\SF77?#UIKT5
MMYTDUO=6DHFM;JW8"2!\8R,@@@@D$$$$=10 S5;'2K#;K\UND3Z7%++YD2 -
MY8C;<ON,<X]163'XJU"%_#L][;6QM-=PD0BW!K>5HS(BL22'! () &".ASQM
MQZ.\T31ZI>R7Z,C1E'140A@0<A1R2"1SQSP!5#3O",%A'ID,E[<75OI6381S
M!3Y7RE%)(&6*JQ49['G)YH P;?QKKTNFZ3J+6&G>5>ZI)IK1"1PP82R1JX;'
M R@R,'.<\=*DN_&NL:?I^L":RLIKW3-3MK-MCLD<B3>5M8 Y((\W!&<<9]JT
MHO T$6EV%@NIW?EV6HG48V*Q[FD+L^#\OW=SM[^]9'C/PU)!H^KSV<E_<W6J
MZC93R)#!YAB\N2(%E"J< )'GG/2@"[_PE6NV>HZSI5_I]@U]:V:7UJ\4Y2%X
MF8H=[/C:5()/J/2JM[X[U"STKQ+-%;VMS-H[P;)"KPI,DH4YVG)R,GO@C!S6
MQJ/@VUUJVOVO;RY:ZO8H8_M**J-$D3^8@52,#Y\DYSG//& *UWX AOHM82XU
MG47.K)"MRV(AS'C!7"8!X ]/YT $GB#Q"FHZYI:65A+J%I8QWUHD;.5E5BX\
MMB<'=F/ 8<'/05=TC7_^$A&G&U\B:SN=/^TW1*'*[OE5<9XR1)D'.-A'>EO+
M!=%U2\\4'^T+^=K2*U>TMHE=F57)!5>"3EV)YZ?2G>$]%BTBQNYDM6M9+^ZE
MNW@8Y,0=B0O4@<<D#@,S8H S[VXM/AYH&GVL");:<;AUEN?(9X;4/O?)13E5
M+$*.<#(R?7I-)NI+W2K:ZD>WD:5 V^V?=&WH5/<'K3=0L);R2"2&\DMVB+94
M*K)*",%7!ZCOQCD4W1-'M= T>WTRS#"" ';NQG)8L>G Y)X' H \NTBVNK@^
M+TM_!5CK>[6[Q1-<31(2<CY<,,X'U[UH>&[^ZFT?PAX9TC6+B!'M+@W=X85\
M]3 50Q!7#*IWOCD'A>.N:Z*/P++:W6H26'BG6;*&^NY+N6" 0;0[G+8+1%AV
M[U,/ EA:V&F0:7=W>GW&FM(T%W&RR2$R<R;]X(?<>3D=0,8Q0!@_\)'J8L+C
M3+K6IHKRUUA[#[1:60FN;J,1"4;(PI4/AAN;;M 4G R*IV_B7Q'J:^'M/M]3
MDMI[O4KZQGN9;5!(R0ARK%",*^%'&,9ZC'%=0/ MO#!;-:ZK?P:A#=2W;:@/
M+:6621=LA8,I3!&  %&-HQTHT[P'8Z;J%G=QW]]+]CNY[N%)65AOF0J^3MR<
MEBW)ZGTH Y[69M<U73?&:IK<D5MH]NUHL'D1E;EA;!Y'D.W(+;\#:5 QG!Z5
MW/AS_D5](_Z\H?\ T 5CZKX&@U.\U21-6U"SMM6C"7]K;E-DQ";,Y92RDK@'
M:1D 5HV.DW-AJUOY=W,VG6^G):K"[Y!=6X? '7:,$^X]* *'C#49K673K2WU
M6[LGN&D)2PL_M%S*% ^X"K*J@D;B1Z#(S7&_VK=:WJ?PSOKT[KEKV]CD8IL+
M%%=,E>Q.W)'8FO0=9\/?VKJ%E?P:E=Z?=VJ21"6V"$M')MW*0ZL.J*0>HQ69
M9?#_ $^QET=DO;UTTBZGN;2-V4A?-!RA.W+ %B02<\\DT 4/AG_Q\>-/^QEN
M_P"25K0:M>OXM\26+39MK*RMI8$VCY&<2[CG&3G8O7TJ]H/AVU\/OJC6TLTA
MU*_DOY?,(.UW R%P!Q\HZY-5-3\))?ZS/J4.J7UD;NW6VO(K<IMN(U+%<EE)
M4_.PRI!P?QH Y?0M6\1>);C1[3^W)+)+CP[;ZA/-!;Q&1IF8@D;E*@'N,=N,
M5/X<\5:O-<>&+C5;E'L]6M)[>0B-45;N)B0^<<;T5^,XRO%=+HGA*RT*XM)K
M>>XD:UTR+3$$A7!C0DAC@#YN?I[53N_ .G7?@V'PT;J[CA@D\V*YC91,C;BV
M0<8_B9>G0T <M_PE^LW=MIDCWE]!;:U=7=S;O86 GGBM(MJQJJA&^]N#%B#P
M<>E3R^(/$;:3ITU_-J^G62/=1W-_;Z6#,2C@0O)$Z$HC)N+$+U'85V%_X7M[
MBUTR.QNI]-GTM=EG/;A28TV["A# J5( X([ ]JAD\+7(M[5;7Q+K$%Q"LBR7
M!=)3-O;<2RNI4$'IM VC@<<4 <E%>WD?CR75FUM[V"#PQ'?%;>.-89QN?(7@
MD*Q7=USDXSCBJUMXUUZPTMM5D;5+^-M*GN[A;K2FMX+>98]Z"-]BY0\KR6)X
M.:["W\"V-EJ%C<VEW=11VVGC39+<['2X@!) ?<I.<L22".M+9>"HK>T>QNM7
MU*^TW[(]E%9SNH2.)@ 0=J@N0  "Q) ]^: ,!+35K;QKX+?4M8DU$SQ73MYD
M,:>6_DC(38H^7GH<D8Z\UO\ C2]U.RM[%[*2^@LS,1>W&GVRW$\2;3M(1E;C
M=C)"D@4W3?!*66J:9J%UK6I7\NF1O%:BX,85(V7:0=J#<< ?,>3@5KZQI,^I
MBW>UU6\TZX@8E9+<J0P(P0R."K#ZC(/0T <):_;=<\9:.]GXB#&30IB^I6MN
M@>11<(!A7!56SC=D<$$8'9\'B34[[P[HR7&M74%]++=QS'3K 37%P()6C#!=
MK*B\ L2.I &,UU>C^$++1;^WO(+BYDFAM9;<F4J?,\R7S7=L ?,7R>,#GI5.
M/P)!:_9&L-6U"SFMS<J9HO++21SR^:Z'<I ^;&" ",=: .<M?$/B/7O^$/M+
M?5/L#ZG:WAO)TMD+YA9 &56!"L>>.@W'C@4DOBO7)-7OIK235IC9ZF+-+&#2
MC);S1(ZI(S2A"0Y^=@0P P!CK74:1X'L='NM,FAN[N1=,%REK'(5(5)BI*D@
M9.-O!)SSR34K>$@NK375MK&HVMK<7*W<]E R+')*,9.[;O4-M&X!@#SZG(!C
M:7K&J?\ "8FSU75KJTG>[G2+3Y[)1;SP#=Y9AF"Y+[0K'+'^(;1U&OXJU&_C
MO]#T?3KHV<NJ73QO=*BNT4:1M(VT,"NX[0 2"!D\4Z/PGC58+JXUG4;JUMKE
MKJWLYBC)'(P89W[=Y WM@%B!QZ"KVNZ%%KD5J3<3VEU:3">VNH-N^)\%>C @
M@AB""""#0!YCX\N=5E\#^-=&O-6FG_LDP.MQY4:M<12A2$D 7&0<\J%S@>^?
M5-)M)[31X;>:^FNI G$\B(K<].%4+Q].U8=QX"LKWP]K&EWM_>7$NKLKWEZQ
M02N5VA< +M4 *  !74HH2-4'10!0!XO9VVI-X;L7_M>::>;Q>R(\\49$3":8
M%P%49)ZX/&1@8%;NH>)-;T Z[I;ZE<7TL-U8PVUVUJCS1K<$AODC4!RNUBHV
M\D@'-=%;>!+6VD*C4KU[5=4&J0V[>7MBEW,S $+N*DN>"3T&.^;5_P"#['4;
MC5+B2>Y274/L[%XV ,#P$F-TXX()SSD<>E %7P;J>I7EQJ=K>'4I[6!HVM;O
M4;$VLD@8'<I&Q0VTKU '#"LV?_DO5G_V+DG_ *4"NJT?2IM,6=KG5+S49YW#
M-+<E0%P, *B *H^@R3UJ)_#EJ_C"+Q*99OM<=BUB(\C9L+[\],YR/6@#B-'U
MOQ(=&\*Z]>:VTXU*^2TGL_L\2Q%'+J&!"[@_R@]<=L5EZYJVK:QX:\41R:E)
M"++Q1%:1>5%&/W7FP@*?EYP6SGJ< '(R*]!@\'6-OHFCZ4L]P8=*N4N86)7<
MS*20&XQCYCTQ56;P!I\NEZW8B[NT_M;4!J+RJ5W13!D8;/EQ@%!P<]Z ,R;7
M]0T[QMJ^F7&J1BTL?#RW8GN85P)0S R/L )'&2HP/0"LG^W-1N-.\2:9=7VH
MWL#^'YKM9=0L1:N'PRML 5<H<@C()&.M=7<^!+&_N[ZZO[V\N9[[2QIEPY*+
MN0$G> J@!LGZ>U,/@59KB>YO=<U*ZN;FQEL+B23RAOB<<  ( I4Y((ZDG.:
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MSQ@(P215QN*.1M?&>=I.* -JBL/3_&&@ZI<R6]G?B22.-I>8G5713AF1B '
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M[OEO]EO:%!<&:%XVCWD!2590P!SP<8JO)X\T :?J5U#=O*=/@\^6,02*Q0Y
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8 $D@GC/"Y]*;:W$B^&M#\/BQOCJ-EXAB>Z3[+(%BC%X6WER-I4@J1@G@YZ
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MF:G<WYMF7;(+*XF;?&5/0[&5\'H5KUJLC6?#MMKTUM]NN+HVL#B1K-) L,S
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MX3+#@YVCK736G@JPM=0MKEKW4KF*TE::UM+BXWPP.P(W*,9. S ;B<9XKI:
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M'/$TVDW6I.NIH97TN"(2)).< L,*7&< D @9'X5OZEX1BUB\OKZ+4KVT34[
M6=U"B*/,4!]I^9=RD>8W3% $,>MSW?B71(1862RWVCRW4=TZEWB8>5E.WRDN
M"1GG:.E9&C>*M;MO!?A_6]1>UN+:]N52]F,;*8%D<@/][& Q"]L CTKI;7PK
M':ZGI-\+^YD;3+)K*-7"8=&VY+84<_(O3'2LBZT6/0O"G_"*06FI:O!?1S6\
M.Z-#';J1P)'&W:HW?>Y/'K@4 =-IE[/?3W[L(_LL5P88&4'+[0 Y//9]R_\
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M3YC\O/0<]<P:?X'^PW.BR/KNH7":-O6TCD6+A&79M8A,MA>,]>E=6S!$+'.
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M&.YZ5W,GAZS;PD_AN,R16)L38J5.76/9LSD]\5HVT"VMK#;H25B14!/4@#%
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M<<DDD\8Y- '*ZQJWB:-?&<]MKS0Q^'DCDMT%M$WG$6Z2,)"5^Z3G[N#\QYP
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MA4$;$*3P<[2OIFK^KRR^*M8:^T[3]02WLM%O89'N+.2%I)90FV)5< L1L).
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MP,'.X=!D ''-<UHNA>(-<UC6/$YU*;2&OI3:P6T]BKN+6(E4R'Y7<=S$>XH
M[.Z\2:59:'!K,UU_H5PL9A9$9VEWXV!54$L3D8 &:I)XY\.M9W]T;YXX]/\
M*^UB6WD1H#(Q50RE00<CICCJ>*X.UTW5]!TZRTBYLKV]M?#6N17$<T5LS>?9
MNCX* 9W&-GY5<D!14.MB;Q /B#]CTRZ)N$TORX6MV$LJASEC&1N' /!&<#)
MH ]"?QOHB6=O<B2\=;DN(8X[&9I9%3&YP@7=L&0=V,<CGFI+SQCH=G;6=P;J
M2=+N$W$(M;>2=C$,9D*HI(49')Q6!XNLY8/&%AJLESK-M8FPDMC-I4!E=)-Z
ML RA'.UAGD#JHS6&-&.B7^FWGF>*+'3I-*\E#;0":X67SGD*2JD;X)$G' 'R
MX- '<WOC70;&2*-KJ2>6:V6[BCM;>2=I(6SAU"*<C@_3\13;'QQX?U.]L[:S
MO7E-Z,VTWV>012G;N*K(5VE@,Y7.1@CJ,5B>%]%;3/%MAY-E>PV<7AV.!&NE
M!9&\XMY;,OR[@,9 ]*S=(TF^A\&_#R!K"X26UU-)+B,PL&A7RIP2PQ\HRPY/
MJ/6@#M+7Q=HU[JPTV"YD,S2/%&Y@D6*5TSO1)"NQF&#D GH?0U6M/'GAZ^NK
M6"WNYG%W)Y4,QM95B:3G]WYA7:&X/RYS7&^%=&,$^CZ5J$GB62]TZ[>1H3"%
MM(BN_$GF% &5@> '+?/R.#BS8Z5?1_#_ ,)6QL+A9X-:AEEB\HAHU^T.2S#&
M0,'.3ZT =7X8\76OB>?4XK>VNH38W309EMY$#A<<Y90 <D_+U&!GK4VI^+]%
MT?4#97EQ*LJ!&E9+>1T@#G"F1U4J@)'\1%9/@<R6FH^)M/N;6ZAF;5[BZ1I+
M=UC>)]NUE?&UL\\ YXKF_'J:MJ+^*-/$>LL[6JKIUM96Q\FX3RLNTD@4@D-N
M&TL#P  2: .SU'QUX?TNZO+>YNIO,LF"W?E6DL@MP5#!G*J0JX8?,>.OH<2:
MOXOTG2IGM9+B1KD6_P!H/DV\DJ1(<[7D900BD@\L0.#VKF&M+F\TGXC3Q6-U
M_P 3&#-J'MW1Y@;%  %(!)W9&,9SD=:AM)+G0=1UA+O2M0G;5=,M!:>3:O(K
MND)1HF8 A"#S\V!ACS0!VGA/4KC6/"&C:G=[?M%W913R[!@;F0$X'U-96G>,
MM.CT6*ZN=4?4GGN9H8C9Z=*'<HQW*(E#,=H&"W3\ZO>!K>:T\!>'[>YADAGB
MT^!)(Y%*LC! ""#R#7GNA:<=/\)6!U.VU_3;J+4+YX;VPM7>2WW2' >,*Q*.
M/52/E'(XH ]9L+^UU.P@OK*836TZ!XW (R#['D?0U8K(\+SZC<>&K&;5HS'?
M-'^\!C\LGDX)7^$D8)'8DBM>@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL+Q5KDOA_3H+P1,;<
MSA+F=8&F%M&58^844@D9"@XZ;L]J -VH);RU@N8;:6YACGG)$,3N TA R=HZ
MG !/'I7,67B>\N=7T&U2?3KJVU2VNI1<6RL5/E,NTK\QX(<9'4$$9KGIM7U'
M7IO!.H+'9IJ#:I?P*2K>6-D=Q'G&2>BYQGD\9'6@#TFYN[:RA\VZN(H(]RIO
ME<*-S$ #)[DD ?6IJ\\N?%NK1Z)J,>HV6FR:AI>K6UG. C&&5)'BV2(I.58"
M0'!)P16E>^)==GGU$Z#IB7BZ?>+;/"P ,V ADPYD4(0'XRISM]^ #L:*Y>#6
M]8U66[FTB*R:WL]2-E)#/N#NJ$+(X<'"D$G VG(7KSPWP?>:I>:AXE^WWD4\
M=OJKP1*L)4HHCB( .X\8/3'7)SSB@#JJ*X&\\3W^AZ]XROKVX2?3]*L[:6*U
M6(J3N60@!MV 2V,G!SQTQ6PNN:E8>*-*TG4UM9H]4@E:&6VC9/+EC 9E8%CD
M%3P>.G3F@#IJ*YSQ-K5_I<JI:&T1?LDTP,J-,[NFW"B-"#MY)+]!QZUCV_BK
MQ#K-]IUKI<.F0&^T2/4U>Z61_+9BHVD*1D<X[>O;! .[HKSS3_&NO:T/#\5G
M::?;7&IPW8G\\.XAFMW"-@ C<I.<#(/O26_C77[BWTV#[+IT6H2:Q-H]WN#F
M,.D;N)$YSMPH.#SSC(ZT >B45Q0\2:[-9ZV;==.:ZT-%2X3RWVW,PB$CA#NR
MBX8 $AN<U)!XRD;5=*EG\B'1=6TMKZUE:-O,5U579&.['W"6Z<[3Z4 =C4!O
M+5;Q;-KF$73H76$N-Y4=2%ZXYZURFK^(M<TS3DDD6PCN!ITMVR&)Y&:1<$1B
M-6W!0#\SY(!QTJ".\&I>._".H^6(VN]$NIBHYQN-NV,]\9H [)KRU2\CM'N8
M5N9%+)"7 =@.I"]2*GKB/%*7I^(/A?\ LTVR7;6E^%DN%+(O$/)"D%OID?6J
M\7C764TJ"^O;>RB2SU8Z9J[(KLJ#<%$T9W#"Y9,YSC<?2@#OZ@N[RUL(#/>7
M,-O""!YDSA%R>@R:JZ5>W%]+?2OY7V1+AH;8JI#,$^5RQ).?G#@8 X7/>O.-
M>NM3OO!GC<W]U#<);:ND,*"$IL"M;XP=QP.?3.23GG% 'K%%<1=>,-2T>]UR
MTU**TGDM(K26U-NK(#]HD:)5?<QSA@/F&,@]!6UHM[KTVJ7MOJM@B6B*CVUT
MBA-Y.=R%-[D$<'.<$'VH U[F[MK*$S75Q%!$#@O*X5?S-%O=6]V@>VN(IE(!
M#1N&&.>>/H?RKC-)D;5?BUXC%Z-XT>WM8K"-NB"56>20#^\2 N?08K4UR>T\
M,2MJ=K;1B_U>YM;#D81I"Y57;'7 =B>Y"@<4 =+17 ^(?&6K^'U\06CQ64UY
M8:<NI6THC=8Y(RQ5E9=Q(8,O9N0>U79=9\2_\)/<Z)&VDJ[6 OH)FAD(C&\J
M49=XW\X^8%>_% '8T5Y_I_C#7M=DT&+3H--@?5='>^+7"NXBD5HP1@$;E^<\
M9![YXP7Z3XWU+5H;*Q6RBAUAS=K=!$\R-&MY%C;:"ZD@LX(^;@9ZT =?INDV
MVE&\^S!_]+N7NI=S9^=L9QZ#@5>KAU\1>*6O?#^GW.GV-A>ZC'=>>LV9!&T6
M,,NUN58$':3GMGO4*>.[R'PWI^I:C'%;(]U<VM[>1V\DL,#1.R!BH;<JL5ZD
MD#H>N: .YN(?M%K+!YDD7F(4\R)MKKD8RI[$=C5/1=$L]!L6M;,2$/(TTLLL
MA>261NKNQY)/]!7+ZWXNU33=%:^A?3)?*TC[?F(/,+AP"6"A6RD>!PYR/F'I
MS8M]2U:\^(0MX[N%+$Z-'=);M"3AG<@Y(89/RCG'3C'4T =7:W=O?6R7%I<1
M3P/G;)$X96P<'!''4&IJX/0/%MS?Z=X;LXK>RM;W55N93LB/DPI"Q!PN0222
MO<=S[4R7QKJZQK;+:V7V^#74TBYW!Q&X<!ED3G*Y4C@YP<]: ._J"ZO;2QC$
MEY=0V\9. TT@0$^F36-X9U>_U"[UJPU,6S7.F7@@\VV1D216C213M9F(.'P>
M3TK&\*2-JOCWQ;>WHW7%A<QV5JC<^1#L#97TWDY)[X'I0!VL-Q#<IO@FCE0X
M.Y&##GZ5)7,:I/;>&KV!=.MXH[S7K](3E?W8?82TA QD[$QC(R<>YK(U?QIJ
M^DVWB*W,%G)J&D&VD238RQ30S-@';N)5@0P/)' /?  .^HKB+K7O$T.LZQI2
M-I/FVE@FH0S&&0KL8R#RV7?R<Q_?!'7[M+:^*=9U;4-#M[&.QMTU713J(>='
MD,3@Q<8#+N'[SID>N>Q .HO])MM1NM/N)P_F6$YN(=K8&\HR<^HPYJQ!=V]T
MTRV]Q%*89#%*(W#;' !*MCH<$<'UKAM*\9:W=6OAG4+N'3UM=5NVL988E?>D
M@$G[Q6+8VYB/RD$X/WJJZKX@U9M!UM[5K.RGM?$4-BSPPG][&SP D_,/F/F8
M)]!CCK0!Z317!3>(=3T?Q'XKN;^[AN+'2M,MK@6\<!3<2)B=I+G:25&2<\8'
M&,FS=^)M?T5+ZZU/2XY-/BM!)%.@$6)RX41,/,<D'<#NXQ@\4 =I5&?2;:YU
MFSU60/\ :;..6*+#<;9-N[([_<%9^CWNORZQ<VVIV"+8B%9(+M%$>7R0T93S
M'/H0W YQ5.Z\0ZE<WOB"WTA;4-HJ)N6X1F\^1H_,V@AAM&TJ,X/)/''(!T=W
M>VFGVYGO;F&VA'62:0(H_$TQ]2L(H(IY+VV2&4;HY&E4*X]0<X-<-)JMSX@\
M4>!]0M)8HK._L+FY6":$N5RD60V& )PQ ...>N:L?$FU@LO!NGV]I:Q1Q0ZI
M8K%!&H1 /.7  ' % &YI^GZ++XAGU>"_^W7[1E%W77FB",D$B-0<*"0,_0<U
MOUSN^\2YU"[?1[>UFM;/_1IR^\2;BQ=3C' \N/CWK"T_Q5XCO3X7++I2KK]B
M9E BDS;R+&KDGYOG4@GY?E(X^8]: ._J"ZO+6RC62[N88$9@BM*X4%CP ,]S
MZ5PT'C+7KB/2((X-.^UW6J7>F3NRN$W0B7#J,Y /E@X)/7&1UK.UW6K_ %3P
MKJ^GZQ!;+J.E:U8PO); B.16GA='4,25RK<C)^M 'J-%<?>^*-1E@\276E1V
MK1:%(8WBG5BUPR1K(X# C9PVT'!Y&>E$?C&1-7M'N_(AT;4-*-_93&-O,W*H
M=T;YL9"$,,#D9].0#L**XR3Q%XBE,FGVEG;MJ]M8174Z>5E/,D+[8\&12,;"
M"V3UZ4B:]XGO/$<.DPVFG63G38+Z9+G=(T;-(5>/*-@D;3@CCZT =?#<P7#2
MK#/'(T3[) C@[&]#CH?:I:YS4+5/#%CK.M:7IPFO+AEEECMX>7P<%MJX+L S
M,><MTSTQ8\,:W'K^G37D-]:7D'G%(I+9&3 "KD.C$E7!+9![8XYH O'5],$O
ME'4;3S,XV^>N<^F,U=KS6S\\>-?B EOH<>J;GM<PO(B!S]F7Y3NXYIG@77S;
M>%O"VA6=T)[Z[:YC>2XC;%MY)+/'M)!)7<J#D<<]L4 >FU1U'2;;5)+%[D/F
MRN5NH=K8^<*RC/J,,:YF'Q9J3I>V<L=E%?6&IK97$S;O+:-D#JZ1YW,Q!4;
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MX[*V>8O"Q(#C:.GR_J/45FWOBY[CQ9X(BTFZ232=;6[>4[.75(0R=>5P>H_
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MD9E 9'+88%#W(((H Z70/!MIX=D5;74-1ELX2QM;*>8-%;9SG9@!B,$@;B<
M\5!;> ]/L[#3;:WO;]9-+E:2QN"Z&2 ,"#&/EP4()!# D^O Q)=^-=,TF.)+
MXW3RK:QW-T\%L\B6Z-G#R%1A02&_ $]*?J?C;2-+O+NTD%Y//:1K-.EK:O+Y
M<;#(<E1C;@4 %SX-LKFW6,W=XDOV]-1DG0IOEF0C:6RI&!M48 ' %3ZOX8M]
M;%U%=WET;2[C2.>U&PQL%).1E25)S@D$=!C!&:U[6YAO;2&ZMI!)!/&LD;CH
MRL,@_D:Y+QUJ?B?0-'U'6]+NM*^QV=OYOV>YM)'D8CK\XD _2@#I[6R:VN[R
M<WES,+EU812L"D.%"X08X!QDYSR:I>(/#T'B*&TBN+JZ@6UNH[I/LY09D0Y7
M.Y3P#VKG-7UCQ-X?T"/4]5U+3'1[RS3-K9O'LC>95DSN=\_*>,8Q6U;^-='E
M@U*69KJS.G(LEQ'=VSQ.J-G:P4C)!P0,<Y&.M %S4M!AU2^TN\ENKE)--F,T
M0CV89BA0[LJ?X6;ICK61<?#_ $ZXM9XC?ZBD[Z@VI174<B++;SL,$H0N,$<$
M$$8K7T?Q!9ZT]Q% ES!<6^WS;>Z@:*10V2K;6'0X.#[$=JQT\>62>(==T^\M
M[FVMM(B222Z>%]G(8G)Q[#;_ 'L\4 =!I>G#3+3R?M-Q=2,V^2XN6#22-@#)
MP .@ P !Q7.R_#VQ:*XMH=3U*WL)KQ;X6<3Q^7',)!)E,H6 +#.W..3Q5O\
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MN1/+/<N4M[>WB:664@9.%'8#DGH* ,<> ;%98V74M36.+4FU*&$2IMBE;<7
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MG&<8SUK,U#13J.@:S/I]CX@GN)FL8@^J;O,E5+@.0J, P"@L<D8.3CI7JM%
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M[1YYSF3S,YW$$CTQQC%.B\&:/%:Q0E)Y&2^34&FEF9Y)9TQM9V/)Z 8Z8&*
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MT3J&&&7*]B,9^@H \]TJ_P!7UNX\+Z=<ZKJ%M'*^JPW.V8":58)0L89UR-P
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MVXVY9>F.>0UR[U%- \6:5-_:EO#%:V%Q"FJW"7$L;O.RLVY6;Y3L4[2>"#P
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M9O)O[:L9);^.:3,(Q;B4%4Z)M(QQU'7-=T=#L6OM1O"C^=J$"6]P=QP40,%
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M=PW@R2R6,FY.GF(1Y&=_EXQ^=<\NB:JL/@,1VVV33866Y+$8A;[&T8SSS\Y
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MQI&]OMAMS<A=IQY88+G/U/2KM>:1:(M]X[L=/N-;O;R*'1)5>Y@N#%)-BX
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M;Q%HVG76I3P?;M-BA#79>:-9SB14ED;*EL8!)X+9&* /5)[B"UA,UQ-'#$"
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M:&D;V^V&W^T[=IQY>[;G/U[5=KSNZL_^$B^)-FMY_:&G*^@M));1W!AESYX
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M+2*WW%@LKL&4NWR-A>1@'(YH [^BO--+6[\5Z_8PZAJ>H);2^&;*\DAM;IX
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M)X.T5='O]+>WEF@U'/VQYKB1Y9^ /FD)W=  .>.U;4,*6\$<$0VQQJ$49S@
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MOEL[Q.Q564JY7JK @D$8J1O&C>9:6\?A_5)+Z[$DL5H/*63R$VYE;<X"@[@
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M_:**AA\X':1C=OVAOEW;<9[XYI;/QI;7>H6\0T^]CL;JX>UM=0<)Y4TJ[L@
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MQFNOM;NWO;=;BUF2:%B0'0Y!P2#S]01576]9L?#VC7.K:C*8[2V7=(P4L>2
M  .I)('XT <)/X=UJ$R>;IES>:?)KEW=3V5K=)&\T;C]TQ)=05#<E21V.#BE
M\-^&-9L-4T;[1I8MH+'4K^=RDZN@CF1BFWG<<%MO(!XSTKT#3;X:E8178MKF
MV$F?W5S'LD7G'*]O6K5 'G4_AO6K>]NM6@L?/FM_$;:E#;B5 ;B!K986VDG
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M?#?P5I+60%]IFJVMQ=Q^:G[N-)&+'.<' (X!)KU.J>JZK9:)ID^HZC.(+2
MR2%2V,D < $DDD# ]: .!U3PIK5S<?$IXK0,-:M;>.P_>H/-98"C#K\O)QSB
MJ]QX/NK:Z6XN/#MQJYN-+M;<)!?^0()HT*LLGSKE#D<C<1@\<UZ3IVH6NK:=
M;ZA8S+-:W,8EBD7(#*1D'GD?0U%=:M;6>JV&G2[_ +1?>9Y.%R/D7<V3VXH
MX=M%UO0YM?LM+T+[1;:M:0I;217*".U=8!"4?>0Q4!5((!)]J[+PS9SZ?X4T
M>RNDV7%O8PQ2ID':RH 1D<'D5-J.K6VF36$5QOW7UR+6':N?G*,_/H,(:O4
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MG:\"06W[LAPR;@=Y;D':0<C) %>BV=R+RR@N1#-")4#^7.FQTR,X9>Q]JGH
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M>VE8MM)(!!) P!@'%2^$O[?OYM$US[)<1R75R[7MU-J>Y)XVW@QB$G"[3MP
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MZT[3GB_<SSI)I_\ : :+!^5G1(U SRSL^!VX-9]]X5OY_B/#J")&=$E,=W=
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ML\.C,\[*'4!\[=I1@VXXP ?2K'C33;[5-'@ALX#=(EW%)<V@F\HW,()W)N)
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M)(DB-G&&0D!ACD>XZUCOXPO+7QKK-A>6/E:/INGQW4MSYBDH#YA+D9R00@
MY!!/>F^#]$O-,U>\G32&T33)(%7^S_M8F0S;B2Z*"51<<<8SZ#%5]<\,ZGJ/
MB77XUM@=.US1UL3=B51]G=1+RR'E@=XZ4 :FF>+Y+O4=/M+_ $6ZTX:G&TEC
M)+(C^9M7<58*24;;S@^AYR*T[W78K#Q#IFDS0N#J*R^3,"-N^,!BA]RN2/\
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M!()HBZYV. 0&'H<$_G4]% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% $%G9VVGVD5I:01P6\2[8XHUPJCT J>BB@ HHHH **** "BBB@
MHHHH **** "H;NTMKZUDM;NWBN+>5=LD4J!E8>A!X-344 4M+T?3-$MC;Z78
M6UE"S;F2WB" GU..IJ[110 4444 %%%% !1110!0U31=+UR!(-5TZUO8D;<J
MW$2N%/J,]*M6UM!9VT=M;0QP01*%2*-0JJ!V ' %2T4 %%%% !1110 4444
M%%%% !1110!!'9VT5Y-=QP1K<3JJRRA?F<+G:">^-QQ]34]%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV4/"O]TJQ]" :T+'QW;7LM@YTK4(-/U*3RK&^E$8CG;!*\!BRA@IVE@,^V:
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MKF?A_J=QK/@RTO[F:2:266X^>088J)Y H([84 ?A734 %%%% !1110 4444
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MY,8?.]2< ;,$@'/6N\TK1=-T2&6+3;**V65S))L'+MZD]2?K5^@#DO#UI?\
MAW1_$MS<V@,CZE>WT$9E4>:A.Y/FY"YQWZ=ZW!+)JGAP3+"8Y;JTW"(GE2R9
MVYX]<5H$ @@@$'J#2T >=>$?"^L:7#X(6\M/+.F6%W#=_O%/ENYCVC@\YVGI
MFND\)Z9=Z9'K NXO+-QJUS<Q?,#NC=LJ>#QGTZUT-% 'ED_A+71X>\7Q)8;[
MB[\1+J-I$)4!FB62)N#G )"-PV*T-6T[5=0UN._LO#=[IVJ/) R:C#>QJGE#
M:72Y0/\ .0-ZX"N#Q@CMZ'10!SOC"R^WZ=;Q2:$VL6XF#210SB*:+ .)(V++
M\P/'W@<$]>E<UI>E^)-$O]-UN?3[S4F%K<V4EJ;F-[F&)IA)"6=F"N0HVM\W
MIR:]'HH \QD\(ZY)#H-PUFHN#XG;5[R%95(MHF+\9S\Q *YQGG.*?I_A!K/6
M#:W'AN>[']J/=IJ+:B5@$;2F528P^?,4D#;LP2 <UZ710!S'BVPU"2\T+5].
MLVO9=+O&EDM4=5:2-XGC;:6(&X;P<$C.#S7':]X9\2Z[HWBU_P"R##<:I>V,
MUM;M/&6\N+RPVXAL @(21GZ$UZQ67<^(M+M-0CLIKDB9YEMQB)V196&51G V
MJQ!! )'4>HH Y7Q%I&I77B1KG3=#N;?4?-A\C6+6\5(FB!7<+A"P+8^<8VMD
M8P1VFT2'Q)H#-H=MHRRVYU*6==2DF3R1;R2M(V5W;_,&XJ!C&<'.*[.YN(K2
MVEN)B5BB4NY"EL =>!R:SH/$NDW+:2L5T6.K1F6R_=.!*H3>3G''R\X.#0!R
M">$-3F^&=WH\UL!>_P!I2WB0&8*)5%V9E7>I^7<H SGC/;%5=0\*W-]X3U]-
M,\,3Z?=W"6ZPI=WXEFN!'('(/SLJ#KM^;DDYQ7I]% 'GM]X=U3Q!XUN=2FL9
M;&RO?"TNFLTLD9>*9Y<[2%8Y^7G(R/>I+*PU[5)O"UG?Z,]A%HD@FN;AYHW2
M9TA:-1$%8L02^[+!< 8ZUWU49M7L;?5[72I9BMY=([PQ[&PZI]X[L8XR._<4
M <99>&M6A\%>$M/>TQ=6&I0SW*>8OR(KN2<YP>".F:[#2=3DU-M0$EKY!M+Q
M[8?O _F!0"'XZ9ST[8Q5B[O[>Q-N)V<?:)E@CVQLV7.<9P#@<'DX'O5@ #H
M._% ' QZ1J0\8QW=EH=SI<AO)'OKJ*\4VEW#A@"8MV3(?D.=@(.>3W2P\-:M
M!X/\#6$EKMN=,O();M/,7]VJQR G.<'EATSUKT"B@#RO3_#NNQZMH=_=:%=2
MWUCJ+R7][+>HYN%=9$#1*7P$&]200I   !YJ$^#-?_X0I]/^P_Z4?$WV\)YJ
M?ZCSMV[.<=.<=?:O3=4U>RT:V2XOYC%$\J0JP1F^=V"J. <9) R>.:NT <[X
MWTR[UCPK-96,7FW#7%LX3<%X2>-VY) X52:8-*O?^$\U+4O)_P!$FTF&VCDW
M#F19)21C.>C+STYJ\_B;2DU"XL/.F>[MPIFBCMI79 V=I.%/!P<'OBM"RO;?
M4+1+JUD\R%\@-@CD$@C!Y!!!% 'E]MX5UR/2=%TZ^TB>\BBT2*T2);U4AM;H
M$[WE <;A@I@J&^Z0!S44/P]U/69='>_AN-,ET[P_;VT,PG1A%>PR95BJL0Z\
M!AGC!['IZY10!YOJ.C:KJ=_IFN:QX;N;J<63V=W9V5\L3)('!61&\Q0R-\W!
M.1D<=:ZFSTRZLO YT_3K:+3;W[(XAA68RK!,P)'SGDX8]:THM7LIM8GTE)B;
MZ")9I(BC#",2 <D8.2#T/:KM 'FWAG0=2L?%>DZD?#UW:0BPFM+N6XO4FE,K
M&-O,;]XV5)0@$<Y/( K;U>WU72_&?]OV&E2ZI#/IPLI(8)8T>-TD9T;YV4%3
MO8'!R,#@UUU% 'F.NZ#XDUN2Y35-(^V37>F)%;F"\V6ME.0_F%E+AFZI@@-G
M&.!3H_">KZGKR37-D]G;3^$&TF1WD1C%.7^[A6.>.<CC\>*],HH X)(?%&K^
M&)O#L^B)IZ?V1+9S7$TZ.)9C'L3RMC$[>I)8 ]!BC3;77[_Q!X7NKO0I=/MM
M+M9H;AIIXG)=HU4%0C'Y<KP>O/0=^]K)3Q+I3IIC>?(HU-S':;X)%+L 2005
M^7A2><=* //-&\+:]IGA#PWI]_I%U=06TUXU[I]K>)&S,\C-"S'>H90"<C=_
M$#@XJ;3?#_B#2(O#<O\ 84DK:1JM\\D%O<1G?%.)=CH6894>8 0V&X/%>C:?
MJ]EJKWB6<QD:SG-O."C+LD #$<@9X8<CCFKM 'F"^$=<C&OW26:F<>)8]6LX
M6E4?:8TVY&<_*2-V,XYQFI-?T'7/$Z:_J0TF6SDGTV*PM+2>:(R2$2F1W8JQ
M51R !N['I7I=&1G&>?2@#GY=,NV^(=IJHB_T*/2IK=I-PXD:6-@,9ST4\].*
MP?%VAZIJVO7*G3)]0LY]/6&S(NQ%#:S[GWO*NX%L@QX(#'Y2.,UV#ZM;1Z[#
MH[;_ +5-;/<K\OR[$95//KEQ5Z@#B/!NCZI9:K'=W]@]J@T*RLB'D1B)8FEW
MCY6/&"I!]#ZY Q_#6B>(?"AT:[.B2WK?V*FGW$$$\0:"5)&=22S %3O()!.,
M=*]/HH YOP'IE_H_@ZTLM4A2*]26=I$1@RC=,[#!'8A@:Z2BB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N>\4:Q/IT^BV-O)Y,FJ7ZVIGP#Y2[&<XSD;CLVC(/7/:NAJAJ^BZ?K
MMC]CU*W$T(=9%^8JR.IR&5E(*L/4$&@#SY=2NO#VO>*PMT99[G5]/M1<S[5V
M"2&,9.%VY X!QC."0><S>)T\1V^C745_JP$7]J:>;4P2(9A&\Z*RR?NU!&[)
M7 YZ'..>K_X0O0&M]1@EL3/'J0478GFDE,NT *268G(P.>O&:='X.T*+19=(
M%FS6<K*[AYY&<LI!4^86WY! QSQCB@#"NM0\1:G>ZY8Z+J$,%SI$L,2&Y= L
MF8DD+R@1D[6W,/E*_=XJ73YM<U;Q?K=J-=>WM+"2V>.**")MRR1%F7<5R1DY
M!Z\5K7?@KP]?:C#J%QIX:YBC6+>)77S$'19 &Q(/][-7H-#T^VU"^OX8Y4N;
M\*+AQ/)\^!@8&["X' QC% ' Z/K?B.\T_P %WDNN.6ULR07*?9HMJXBD<.GR
MY##9W)7G[M3R>(=;MO"^H2?VF\ESI_B&/3Q</#'NFA::)<, H7.V0C( Z5UM
MOX1T2UATV&&UD2/3'+V:BYEQ$2"#CYN>"1SG@FFOX/T.2UN+9[64PW-T+R5?
MM4OS3 @A_O=<@'TX'I0!R>OZSX@MW\;S6NM/#'HD,5S:QBWB(.8BY1B5)*G&
M.Q]ZT;S5=?UK4]8T[0[J&SN;""!HA(R[6>1-^YP48E/X>"#PW?&-Z?PGHUU_
M:?G6TK_VHJI> W,O[Y0, 'YN...,<5%?>"O#^I7=M=W=@7N+>(0K()Y%9HQ_
M Y#?.OLV10!E^.;VX_X1'3X6:/\ XF5[9VERT+93RY)%$FT]U(ROT:MN_P##
M.G:EJ+WMPL_F26;V4B).RI)$V>&4'!(W-@]LFI];T>#6]&FTZ4F-7VM&ZCF)
MU(9&'T8 _A5RV,YMT-RJ+-C#A#E<^H]J .&U"PBTOQ]X"L89)Y(X8+]5>>4R
M.?W:=6/)-5/%EW_97Q2TK4-/B\RXAT>]FU&-.KP(H,0;_MH"!7::AX<TS5-1
MMM0NHYS=VH802QW4L9C# !L;6'4 9]:FL-$T[36N'M;55EN"#/*Y,DDN.!N=
MB6;'N: .2@N/$MUI\&I'5H/[.O=-=V*2)O64IO1H<1CC&[(8MP >H-4O#VIZ
MD-%\(:)!?2^;>Z*+PS2.BN2J1 (A,; XWECD$\#GK76:1X-T#0I)GTW3Q#YH
M92AD=T56.6"*Q(0'N% J&;P)X;GTJTTU]/;[/9OOMB+B020G&/ED#;@, # .
M, #L* ,![GQ8VI>'='NM=@M[N\MKU;J>SA21=\138R[EX;#?,,8SG %4]7UK
MQ%9:=XQNH]<DW:%<Q^0OV:+$BF*)V5_EZ'>W3!]Z[A/#6DQW>GW4=LR2Z>C1
MVQ69P$5L;N,X.<#).2>]17'A'1+J'4HIK61X]3</>*;F7$I  &?FXX '&. *
M ,*XU'6=/\0:UIK:M).HT;^T('>&,&"0,ZD* O*\#AMQ]ZK6VK:WJ,_@N!=7
MDMUU;1WN+MT@C+&18XCN7*D YD/8CVKJIO#.E3WDMW+#,T\MK]C=S<RY:'^[
M][W//7FDA\+Z1;RZ=)%;RJ^G0FWM"+F7]U&0 5'S<\ =<]!Z4 <KH^OZMJ>C
M:+'+J;F]F:]CE6VAC\^X\F4QJXW#8BC +9QDD =<&GI6IZGKU_\ #Z^N=1GC
MDO+&YEG2$($=U5/FP5/)W$>V>,5UT?@GP_$+01V3K]D>5X2+F7*^8<R G=DJ
MQY*G(/I3[?P=H-K!I\,%CY::<S-:A9I,Q[N&&=V2I&!M.1@ 8XH YA/%6JPQ
M36TUV7DG\3G28K@QH##%M##  P6X(!(/+=^E0^(O$6O:./$=A!J#,]BME<VM
MV\*%@DTOEM&X  .-I(( .#[5V'_")Z(;.\M&LRT-Y<?:I@\TC$S9!W@ELJV0
M#E<=!2W'A;1[NPN+*YMI)8KATDF+W$A>0IC;N?=N.,# SCB@#+TN6_E\5:_H
M&H:C+>6R6MM<1NR)&Z>:9%= 4 X^08[C/4]:Z)=,LUD9_)4YA%N%(^58_P"Z
M!T ]?7 ]!45OHMA:ZK-JD4<@O)XEBDD:9VW(N=HP3CC)[=SZU9O/M)M9%M-@
MG881I/NJ?[Q'?'IWZ<=: .;^&]W/=^!;'[0[.\#S6RNQR62*5XU.>_RJ*GU[
M4+ZT\6>&+2WNC':WT]Q%<1;%.\+ [J<D9&&4=*+?P=8V9T!;?>HT8.(I/,8,
M^Y<-D A3N/))!]ASD:M[HUCJ-]97MS$[7%DS/;NLSIL+ J3A2 <@D<]C0!P6
MG:[X@^Q:)J5QK#S"?7I=-EMS;QJCQ>;*@)(7=N&Q<$$#CD'K76>*-2O=.?2!
M;LT5K<7RPW<Z*&:*,HQ! (/5@H)P< D\=1(G@_0X[6WMEM91#;W1O(E^U2_+
M,26+_>ZY)/IR:I>,M&N]8&FB*PBOK6WF:66#[6]M+NVE59)%Z8W-D9&<CGL0
M#&CU[7K.VM8[VYE_XF6NG3[2YD@1&6V&\K)C:!N8+@$C'((&.*9JGBS5M"U'
M5])DG^T".XL$MKV2-<PI<N4;?@!25VL1QSD9SWV]*\)0'3+BTU*WE^RS.DD=
MI+?RW)@=3D.LK'<K9Q]TX&W(/)K6?P[I4MA=V4]H)X+S'VCSW:1I<  99B3Q
M@8YXQQB@#C_$GBS5/"6H:M:M/]MA&G17=M/.B@P2/.(2'V@!ERP?L>&&>F+U
MI:SVOQ;"S7TUWG020TRH"#YZY^ZH&#UZ5T(\-Z2;2ZMIK4W,=W$(9S<R-,TD
M8SA2SDG R2!GJ2>IJ'3?">CZ5?17MK!/]IB@^SI++=2RD19SL^=CQGMVH QM
M2MYG^+6C%;ZX1?[+NF"*$P )(,KRI.#WYSQP1532O$.J3>(=!B.H-=V>IK>;
MY5B187V<H8>-^ .,MPW49ZUU\NB6$^M0ZO)%(;Z&,Q1R"9P%0D$C:#MP2!GC
ML*S[3P1X>L9K26VL"C6<CR6W[^0B$M]X*"V O^R.,\XH XV;4-6U32-#:XU:
MY64>*9+-WB6-=Z))*$R-N#C8O;&>N>*CU6[U/2+OQ_J^GZB\$EA=6LOE^4C"
M?%M#E7R#P1_=VGW[5W7_  B&A_V?]A^R2?9Q=?; /M$NY9LEBX;=N!R2>#W/
MK1/X/T.XAU&&6TD:/4BINU^TR@2[0 .C<8  P,< "@#<K@O$&K:YI^MZOI<&
MI2+->V*SZ)^ZB.V<-L>/E?F&YHCST5CZ9KIK308+3Q%<ZO&762>!('!F=_,"
MXPS!CC(Q@8]223GB[<:=9W5[:7D\"/<6A9K>0CF,LNUL?4<4 ><ZYK<OB7X7
MZYJ45S+]D71"DL3*G_'R5)<-\H(*C:.,#D\<5=U'Q%JWAF^UE9;PW\,&A?VE
M%'+$JB*0,RE1M .SH<$D\=:ZZ7PWI$^C76D/9J+"Z>1YX4=D#EV+/D@@\DGO
M[=*/^$<THWYO7MFDG:U^QL99G<-#_<*L2"/J* .2UT^)(- UVX?6(S8/HDT\
M#QRH9UF12VY"L:C85(SU(.,$9J"WLKN;Q=X>MX=4N()6\.3$W(CC:0#S(. "
MNWTZJ>/?FNKTSP7X?TBSN;2ST_;;W,30R1R2O(/+/5%W,=JG/08%26OA31[*
MYM[BW@F2:WMS;1/]JE)6,X)7EN>@Y// ]!0!R>B>*=8UZR\.V7VA8KR^TV6Z
MFG0K&TCHZI\NY&7N6(QZ=!D&1KGQ9)J?A_1KK78+:[N[*\^U364*2+YD3(%9
M=Z\'YOF&,9R !P:WYO GARXTNRTY]/;[/8N7M2MQ*LD)/7;(&W 'TSBKR>&]
M)BO+&[CMF2:PC:*V*S. BMC<-H.#G SD'..: *7BF^U73+&REL(+F[19?],2
MT"&X,00Y:-6X8AMI('..E9&C^(;G4=>T*&VU>2[T^_TRZF9V@1&,D<D:AL;0
M58;F!'3(Z5UM]IEKJ+P/<"4/;N7B>*9XRI((/*D9X)X/%49O">BS+8@VC)]A
MW^0T4TB, YRX)5@6#'DALY/7- '+>'O$^I:M%X;T^ZOFBGU&&]FENE1 \GDR
MA%11MV@X;)XZ+[T:A;:F_B;P;:W6KI)?JM_')>V\*@G"KR%.5#8P#P1G/':N
MAD\"^')=)MM,.G;;:UE,UOLGD5X7)))1PVY<Y/ .*N#PUI*W&GSK;,DFGJRV
MI29U$8;[W ;!)[DY)H H^"]0O=6\+E[ZY,MU%<W-JUP$56?RYGC#8 V@X4'I
MC/:N-T>^UJU\%^&9+;6KCS=0UE[:=YHXY#M:6;)&5SG*YR<\^W%>D:5I%CHM
MJ]M81-%$\CRLK2L_SL2S'+$]22?QK/7P9H*1Q1I9R)'#=&\B5;F4!)<D[@ W
M RS''0;CQR: ,E;W7=.\5/I/]H-J9CT)[I%EBCC\VX$@4$E0,9Z8Z5!H&J:]
MJ>H:-+'>7$]G-I9N+]9+=$6.X^7:@.T$9W/QR0%!SSSOZUX?CN_MNH6,<8UF
M2Q>TAEGD<Q[3T5D!QMSSTKG-&\)WMDT<MCI\FD301LJB369[J*0["%4QD[=N
M2#G (QP/0 30M7\1:I<^'9#=3XGBFDU>'[.@2!UQM53MX!;*CDDCD'@FI= U
M/Q'KUKHNNPW]K'IUZ&-S \BG8&!"B/\ =YWJV 0S$'!J'PYX.N;"6QQITVER
M6I3S)8M9FFCD"XRJQ'Y=K8(P0,9X&0*Z2Q\&Z!INISZA9V'DW$S,[;)7"*S<
M,RINVJQR>5 /)H Y71]1\5W7@J#75U&34;F8[&LHXH8V*K.P<QDC!?8IX/''
MK74>%]537=#FFAOKJ1Q-)$QN(%BGMV'\#IMP&7([<\'FIX/"^DVND1:7!!+'
M9PR^=&BW,NY'SNR&W;AR2<9QS5ZQT^UTZ)X[6/8))#+(2Q9G<]68G))Z=?04
M ><1^+]7LDTS[?J,CR:?J4EGKN(HE7RR^R*4G;E02\3<8RN[TS6W+K.J/>Z/
MI\=VROJXNKJ*1BD;+$A4QQK\A&=KACD$_*>:Z.X\/:3=IJ23V,3C4U5;S(_U
MP"[1GZ#I3=;\.:3XBM8;?4[03)"XDA97:-XF'=64AE_ T <E+<^+$O\ P[H]
MWKD$-U=M=PW,UI$DF0B%HV^90 ^",C&,]JD&I>)=3&IG2]1M4FTF]6V?[2RI
M'(J*A=I0(R1N!8@JP X]#GIT\,:1'-ITJ6KH^G;OLI6>0;"WWB?F^8G)R6R3
MGFHKGP?H-WKO]M36 -^=N^19'59-OW=Z [7QVW T 1^++_4].L[6?3K:XN8Q
M/F[BM-AN#%M;F-7X8AMN1UQG%8ND>(KG4-=\/Q6NKR7>GZAI]W*[M B,7CDC
M521M!5AN8$=,CI777VF6NHM UP)=]NYDB>*9XV5B"#RI&>"1@\51F\)Z+,EB
MK6C)]A+F!HII$9=YRX+*P+!CRP;.3US0!RWA_P 3ZEJL7AO3[J^:.?44OI)+
MI40._D2[%11MV@X;)XZ+[UHP:CJG]N:;X9O-84W+6=Q<2WMO$BM,R2*BJ 05
M!"MEL#J.,#-:$G@7PY+I-OIAT[;;6TK3P!)I%>%R224<-N7.3P#BIK_P?H.I
M6=E:W%C\ED2ULT4KQR1$]<.I#<]^>>^: ,(ZCKTVI6_AP:I VH1Z:UQ+>0;8
M_-D\PQY"LCCY2OS#'5AT'%5-5\0>(-&L[:369S' +(+<ZAI4:SQ6]R&8,\J,
MN[RR .0."&![$=/J/@W0-5ALH[JP&+$$6SPRO$\0/4!D(;![C/-33^&-(N 5
M>V81FV6T:*.9TC>%<X1D!"D?,W4="1TH Y^?Q%>VOBZ.SOY;FULKF[1+"YBC
M22UN%*@>4[ %DD+;L9(S@8KGS=:EHGASXA:K9ZK<BYM-4D*%XXF!80P?,1LZ
MXX],=L\UZ'_PCNF?:S<F!RQG%QL,SF/S0,!MA.T$8';J >M1IX6T9+;4[;[(
MSP:FS->1R32.)2P )(+'!P ,C'04 9=YJ-Y_PF.JZ4UP6LAHBW21%5^60O(A
M((&<84<$FN;T09M/A0 2/]#?D=O]#-=I;>$-%M)WGBMYO/>V^R/,]U*SM%DG
M:6+$GJ>>HX'84^'PKH]N-+\JVD4:4"MD/M$G[D$;2!\W(QQSGCB@#G=.UG5V
MOKOPS=:E(VLQ:@I6X\J,%K(_O ^W;C[JM&3CAZW?$-[<6]WI5K;WC0O<S.&A
MAC5IYU5&.$+?*H!P26XP,9R12:+8W\^IRZWK-A:6FH- +6..";SML88L27VK
M]XD<8XVCU-7M4T+3M8EM);V!GEM'+P2)*\;(2,'#*0<$<$=#WH XWPYXIU/6
M5\/Z;=WC6]Q>07LLMRB('D,$PC55!!4$@EC@?P\8S1?6VIR>*?!UK=:NCWZP
M:A'+?6T*@D@1C(4Y4-C /!&<\5T$G@+PU+I\-C_9NR""=KB'RYI$>)V)+%'#
M!E!R> 0/:KH\-:2MS87"VS)+8(T=L4F=1&&^]P#@DXY)R30!R%GXDUJ3P[X9
MN9+_ '3S:XVG73^4@\^-994R1CY21&OW<=35NTU7Q%K;MJ.G7EK!!:ZM+:W%
MO/(H3R8Y3&RD>66$A # [L9([5O)X/T2.UMK9+640VUT;R%?M4OR3$DE_O=<
ML3Z<GUH'@_05UY];6P"WTCB1V61PCN.CM'G86'J1GO0!AVFK:LFL:KX;NM2E
M;4OMD3V4_E1@_9'&XG&W!*A)5)(/(7UI@U7Q%K$NH76E7EK FFZFUM)#<2*(
MS%&0'W_NRP++E@0PQE??/8G3K-M434S;H;U(3 LW\0C)#%?ID UFR^#]!FUX
MZV]@/M[%6=UD=5D9?NLR [6([$@D8'I0!P^N:G=^(_!;ZNU[)'"NO0P+9JB;
M52.]2,!CC=N.T/U[XZ5ZI7.W/@?P]=374DMDX^U3+<31QW,J1O*I#!]BL%W9
M YQDUKVNF6EE>7=W!&RS7;(TS&1FW%5"C@G X Z8H XRQ%^?BKXK^P/;*WV&
MQSYZ,PZ2XZ$5:O[S5X-6\*:;'J"6SWIFBU!8(HV_>B R$C(.#NY].1D'OMMX
M6TIM4N=3"74=Y=!5FEBO9D+A<[00K@8&3@=LTJ>%](CEL)5MY?,L'DDMW-S*
M2KOG>Q);YB=QR6SUH XE-<\0V^DM?2:U),;#Q"-,9&MX@+F$W"QYDPN0VUNJ
M[1QT-.U35?$XL_&5_::Z(AH%RSP0-:QE98U@CE,;G&<?,P!&#SU/&.O;P?H;
M6DMJ;64PRW?VUU^U2\S;MV_.[.=P!^HK*TCPKYFL^(Y]6LY?L]_>I/$AN24D
M18T4!T5L'E"<$'((SZ4 8^KZ_+I'B+7M?2VW30>%K>Y6%NS>9,0#[ ]:UYK[
M5K/7]#T]=5EN;?6;:96F\J/=;RI&'$B87!4Y(PV?X??/0OH.FR:I<:E);;[J
MXMQ;2EY&97BY^0H3MQR>W<^M00:#::-:M+I5GYEU;V[16D<]R[*HZB-68ML4
MD*#@= ..!0!S_AW7]3U*.TTZZNY/[5TV68:QLC3Y_+X4 ;>!)N1UQCY0>:@T
MG6_$5[I>E>)Q=6LFFW%J\]U:-*IR2A95BQ&"&5AM(+'C/>NFT'3KB%[S4]0M
M;>WU+4'1YXX'WA%10JKOP-V,$YQ_$1T INF^#M!T?4I;^PL!#/(S.0)',:LW
MWBJ$[5)[D 4 9'AV\\1:C+HFK27]I)I=_:EYXFD4G>R;T,($8/&&!#,>/<'+
MO$>K7^C>)84DU&:+3=0L9DMPD4;&*[0!@!E<L67=A23RI]16KH_@_0= NY+G
M3+ 6\CECM$CLB;CD[$)*IG_9 K2O-.M-0-L;NW28VTRW$.X?<D7.&'N,F@#E
M/".LZGK]G9Q7%[+%>V4,L6JJ$C_X^0YC ^[@#*.PQCC;G.:QK;4[S6-$^'6H
M:A-YUW/JI:23:%W'R;@=!P.E>AV^F6=JUX]O (FO9/-N&0E2[[0N[(Z'"CI6
M=#X1T2WM=.MHK618=-E,UH@N9?W3G(R/FYX8CG/4^M &?X-_Y#'C#_L-'_TG
MAKGKS7?$%O8:_J0UERNE:]':QP?9XMLD+& %'.W/21L$$'/4GC'?:?H]CI=Q
M>3VD3I)>2^=.3*[[WP!NPQ('  X]!5*7PAHDUK>VTEK*T-[<"ZN%^U2_O)00
M0WWN/NKT_NCTH P+S7M5OK3Q?=V-\;.30I7C@@,:,LGEQ+(3)D9PQ8C@C  (
MYHT&[NM3^(4EX]U=113:%9W0LVVE$,C2Y7[N>, ]<YZG&!727'AC2+J[GN9;
M5C)<1K'<;9G5;A5X D4'#\<?,#QQTJPVBZ>^M1ZN;?%\D/D"4.P!0$D J#@X
M))&1QDXH Y77M+AU?XG:5:W,DZP?V1=,Z0S-$9!YL/!92#C)!X/8=JP+":34
M-'TK19!J>ISI>ZBL<"WY@62&"8Q@S2YWG:&0  \GKG%>G-IUH^J1ZFT(-Y%"
MT"2Y/",59ACIR57\JR[CP9H%S%#')8D"&:69#'/(C!I6W2<JP)#'JIX/I0!Q
M&@:O>V-KX2UZ]OIFLK@W.E7?F3F11B5_(<D]2#'LW]3N%55N-7U*VT2:2*]N
MXO$-[=7[6:WIMSY*H/(B#Y&%V8<J,9(^M>AR>#] ET.YT1].4Z;<2F9[;S'V
MARP;*\_(-PSA<#KZFK6H>'],U2P@LKJVS!;E6@\MVC:(J, HRD,IP2.#T- %
M#P9#J=MH;V^IJRO'<RK KW(G=8=V45G[E<[>>>!FNAJIINF6>CV*65A (;="
M2%!))).223DDDDDDG)JW0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !6?K&I3:9:1R6VG7-_/+*L4<
M,  Y.>68\*H .2?;N16A7,>--,O=3M]-%O9MJ%I#=^9>6*SB(W$>QP!DD @.
M5;:3@XH @?QY$EG9L=)O#>7&H2::;-2A>.=59L$YVE3M^]G&&!..:2+QY$K+
M'?:7<V<R:FFFW*,Z,('D0-&Y8'!1MRC/8FL/1/"6L65[IZ/IEO:VUKKLFH8@
ME4QK#);NNU1P<JS!3P,]1Q6EJ?AHSVGCG^TY([6SU%HYH+EG'[ORX(P)#Z;7
M3/X4 =+#KD5QXGNM$BAD9[6V2XFF&-B%V(5/7<0I/TJAKOBMM(UNST>VTJYU
M"^O())H8X711A"H(+,0!PV<^V.I%4OAQ;WLOAPZ[JJ!=3UIQ>3C'W5VA8U^@
M15./4FKUWI%W-\0=+U=$4V=OI]Q!(^X9#N\948Z]%- &6OBZPTR^\632?VE,
MVG7%O$T+R!U:210$2%>-N2P!SW.:S_%7C:[&@Z_IYL+W2-6M-+-Z',BL%4MM
M!5D)SW_(U4UCPQJ%LWC+4YGM+>.XU&QOK*2XG5(W,)0[6/\ #DKM&>Y%5M<M
M=:\4>(?$%G]@BM[N;PZL,5MYZN5+3$C>P^4$X; ST&>_ !UC^-+F.:[M9M!N
MX+I+![^U266/]_&A ;.#\C#<IP?6M'P9J]]KOA'2]3U&U^SW%S;1R-AE(DW(
M#O !. <G@\BJ>LZ%>W_BF"\B5!;C1[NS9V;I)(T17CKC"MS5GP1;ZA8^#M,T
M[5+$V=S8V\=J5\U9 ^Q%7>"IZ'!X/- &):>/+J&X\43:KI<L=CI=VMO"8F1G
M=RL86, 'EF9\@\  @'I6[I/B22]UB32-0TN?3=06W%RD<DB2+)%NVDAE)&0<
M @^HZYKE;[PMKD\_BBVALX]EWJ$&JV-TTZ['>+R3Y3+]X9,9&<8YK=TNRU;4
M?&7]OZEIW]FQ06#6<,#S)([L[J[,2A( &Q0.<G)Z4 :NLZM>:=);P6.C76I3
MSAVQ$RHD:KC.YV( )R,#J>?0U4T?Q=9ZW>V5M;03+]KT_P"WJT@ VKO"%"/[
MP)^G%9_BW1K[4M<T^;^RDU?3DMY8VM)+@1HDS,FV5P?O  ,.A(SP#FL/P]H/
MB3PU-H]PNC)=M;:?-ILL<=S&F/WP=)1D_<(SQ]X>AH Z!?'4=U;:;_9^EW-W
M>:A+<I%;"1$VK Y1W9B< 9 QZ[A7.VWBEFTI[K49=6C,GBO[%%'',$>++ "-
M^H* Y! //:I-)\.>(M C\/ZB-/CO;NS^WPW=K%.JDI//YBNC,0.-HR"0<-[5
M#/X0\0W>CPK/:P)='Q6FK21I,"J0;@3@\9(Z>IQTH Z?P[XCU/5O%?B'3;G3
M3#::=.L44OF(>L:-@@')+;BP]!P>:-;\1ZGI_C?0M&M=-,]M?1S/+)YB _)M
MSC)_AW GUS@=Z-#T[4]-\:>(Y9K+.GZC+'<PW:RK@%8D0H4^]G*DYZ4>(=.U
M-O&/AS6+&R^UP6:W,-P@E5&02A '&[J!L.0.: ,/PMXTO(=%TXZE87T]O<:C
M+9'4GD0CS&N'5!M)W%1\JYQQ^%;J^-(VU +_ &9<_P!EM??V>-1W)L,^[9C;
MG=MW_)NQU]N:RH?"VJIX(TG2VA3[5;:REW(OF# C%X92<]_D.<54T[P4UCK1
MBE\,VMTO]IO=KJLEU@"-I3*/DSN\Q2=HXQP#F@#HOB'JE[HO@'5]1TZ<P7<$
M0:*4*&VG<!T(([UEZ[%XF\)Z/<:[;^(I]6ALD,]S97UO"OF1+R^UXT4JP&2,
MY''2M?Q_I%YKW@75M+T^-9+NXB"QJS!03N!ZG@=*R=:A\5^+=,ET-]'AT:RN
MQY=W=R7BS.(C]Y8T4?>(R,D@#- %Z^\=0VS7,MMIEW>6-C#'/?74;(! CKO'
MRDY8A"&('0$=3Q50>.+FV\2>)(;ZP9-(TFVBF\^-T9CN5V!QG+;\* !TQSUK
M,U7P04U[4Y8O#-MJT%^L/D22W7EK;%8UB*R+G)7" _*"3DCBI-9\(ZI>:IXI
MLX+./[!K-C;I!<F4!89(5;".OWL$[>1GB@#7N?'7]FV&J3:KHUU97-A9_;OL
M[2(YEBR1E64D9!&"#TR.N:=+XUFB.G1MX?OA<:G)*ME#YD>Z140.';YL("">
M"<C!R.U<]<^#[F]\->((++PI;Z1=W6GFUAW78DDE<G+#()4)PN"3D^@KJ]1T
MB\N/$WAB]BC4P:>+C[0=P!7?%M7 [\T 94?Q&S:-=RZ!?Q6UM>"QOY6>/%M,
M9 F,;LN 64DKQAAUY +KQA8Z-K/B^:4:E-_926;3Q-(&B D7CRE[=<MZFH+O
MPKJLOA/Q%IZ0H;B^UHWD"^8,-%YT;Y)[<*>*J:QX/UF\U/QU/#!&8]76P%H3
M(HW^4/GSZ8]^M '1VWB]S?WEE?:)?VEQ!9&^BB&R9YX@<$*$)^?.!M]Q6?JG
MCF^L]#UR1]"N+35+#3_MT<$TL;!HSN ?*G'RE3E>OIG-.\5>']:U'6;V\TIA
M$SZ%-9Q2B78PE:16 !ZC(!^;M6 W@W4I?[<6Q\/6^E6^J:'+8I&+A&9)OFPT
MI!.=V[&03@+D]<  W[;Q$UQX@\+0ZA#?VE]?V<\OD).OD855),@&<G!!7GC/
M-367CR.[:PN6TF[ATC4;@6UGJ#NA61B2$)0'<JL1@$CN,XS6=#H&LZAXD\):
ME=Z=]DBL+"YMKM&G1V1F157&T\YP3QT[U!8^'O$#:/X>\,W6GQQ6NCW<$LFH
MB=2LT<#;D"(/F#-A<Y  YY- &H/B"I4W/]B7HTV/4#IT]X70+')YWE A<[F7
M=MR0.,]\&M#Q_>7.G^ -=N[.=X+F&SD>.6,X9& X(-8DGA;56\"WFEB%/M<N
MM->*OF#!B-\)LY_W.<?A70>-=+NM:\$ZSIED@>ZNK5XHE9@H+$<<GI0!E7'C
MU[%9A>Z!?P-]ADOK56>,M<QQXW@ 'Y7 8':>WO6Q/XFM$N-"AMD>Y.LDM;F,
MC B";S(<]@-H^K"LFWT_6=7\6Z9?:KIL=G;:7:SQ$^<L@N9)=BDJ!R$ 0_>P
M>1Q6/\-])D75M2G>99[#1VDTG2I%.<Q>87<Y[D9CCR/^>1H W/B'JMSI&@V<
MUMJ9TT3:C;037>$_=1.^'/S@J,#G)%0>'KRSFU3-M\0VUQHXV=K(26C;ACJ?
M+0-QD=ZN>.M+O]5TBQ73K1;N:VU&VNF@:14#I&^YAEN.@I=.NM8FO!%/X033
MXI%96N5NX7V_*<<+R<G _&@#,M?B3]KM](N4\.ZC]FU==MB^^/,DNW=L(W94
M<-\QXX)Z<U.WQ!CCLD>71[T7IU7^R7LT9&99_++KAL[2I&WG(Z\XP:K:7X7U
M2UT7P%;2PH)='<-> 2 [!]GD3CU^9ATK(UW3=4TK58+E+>.22[\7)=6T9D \
MQ/L94C/\))1@,^U $_C;QC>O\//$Y@BN]'UK2S LB>:I9 [H5974X(921^!%
M=-J'BV6UU&ZL=/T:[U.2P@2:\:&1$$88$JHW$;G(!.![<\URGB+PIK_B/P]X
MQF_L];:^U@6D5M9O.C,J0L#EF!V@G+G )X K=N++7M%\0ZW>Z7I::C%JT4+*
M?M"1^1,D?E_.&ZH0%.5R>O% &KH_BZQUK5!96R2 2V$6H6TK8Q/"^1D=P5.
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MVWEL<=LMZUSVI>"M9O;&2PN-(@OFDT:"TM)Y[D>58R+&5D^3/+%L$,H.> 2
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M'E29<,_S ;0PV_4H3ZUVE !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@5K444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
I44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>exhibit1060-kumaremploym004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"9=;M()#!,\9:-WPRDJ1P16U8:+*NOS:[?O$U[):I:*D(.R.-6+'D\DEF_
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MJ'DO"S1NL<:Q^5(-PW [0WU XH ;>>.;F?2K2YTNSA:5M;32Y]TX*@^8 2C
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MJ>G26DD4\4$+&3,-PT@XV2$#@<[LCC!Z\58T#Q NMRW\#6S0S64HC<JWF12
MC(:-\#<.QX!!!!K,O_#.MZUHFS4=9@BU:*>*XM)[2W*Q0R1DD'8S$MG)#<C@
M@8XYV]'M]6A@9]9O+>XNGP,6L)CB0#T#,QR<\DGTXXH KWFO26GB2VT;['EK
MJVEGMYFEVJ[1XW1].&PP/TSZ55T/Q:NO:9I5[:6>1?\ FL8Q,"T2QDAB>,'Y
ML+UZL.W-6/$WAQ/$4%DOVA[::UN5F65/O;""DB9[;D9A^(/:F:+X8BT/5=7O
M;>7*7TWFPP$86#*C>%_WG&X_A0!SMIXGEAT;PT=#TL0VVI:I/;/%<W)9T*M,
M6&2&^\T;'.>.@]J^G>(9?#EWXIGELKFZL8]=6.:8S@^2KQP*,!CEL,V<<8!_
M"M*V\$W]MHFC6D>I6PNM+U.6^24P,4<2&4E2NX'CSC@Y_A'K1>>"K^[TKQ#9
M?;[93J^H1W@<Q,?*V^7\I&?F_P!4.>.IH [5RPC8HH9P#M4G )],]J\OGU[4
M]9T'PCK-U;%+B77=JQ6TYQ(O[X;2#M'&U1D^F>*]17=M&[&['..F:XBV\$ZC
M:Z7HNGC4K62+2M3-[&3 RETS)A#\QY_>'GV'% %^W\;0-8W#W=J;2\@U'^S6
MMY)E*F;:''S]-NP[LXS@'@G@Z'A_7UUQ;U3;-!-:3^2^&WQR< AHWP-RD'T!
M!!!%8-UX'OITU.6'5([:]FU9=6LYDB+"&18UCVL"?F4JI!Z?>-=/I$&J0VS/
MJ]W!<7;GG[-$8XD Z!068^Y)//MB@#DO%$J1?$GP]#-)??9;BSNVFAMGF(=E
M\O:2L9[9/..]7%UZUT'2$OK:RU.>&]U1;013R-OB8N(<XE.X*2N<>_;-7-6T
M#4;SQ?IFNVMU:QBPMYH1%+&S;_,VY.01C&T5%JWA[6-8@C6XU"T5H[^VNHT2
M%@BK"X?;][)9CU/ICB@"K=>/+FSAUMI?#]QYFB@2WBK<(0(2F\.I_B.W/RX[
M'GIFS?>,KB+5;K3M-T&ZU">"SCO1ME1!)&Y8#&3U^0\=2?SJ+4/"-]?'Q:!>
M6Z+KULMNO[MB8 (S'D\_-P<]JS+/[9#\2[RSM+JQ-S'H-K"^_)&]9)?F !SQ
MD$K_ +0Y'< F&M6VM^+/!>L64LJVE]8WDA5W(  6/[RYQD$L,_K6I%XTA>+2
M;U[-TTO5IQ;VEUOR=S9\LNF/E5\<')ZC(&:AM?! L+CPXEM<(;+1[6:V=)%.
M^?S0H9L@X'W<].YZ4S3_  5/;:7I6BW5['/IFDW27%L=A$KB,EHD?G'RG'(Z
M[1P.: +EKXM:XL]18Z>8[RROUL6M&F&YG8J%(./ND.&!]/2HKCQQ;17B)%;?
M:+?[;]AD>&4-(CAMA;R\9*!@03G/!.,<U6TR#3?$'CE_$.F3RO;00>3<81DC
MEN%+*AY RR(T@/\ OKZ58T_PUK6DZM>)9ZS -#NKM[MH'MR9XF=MSHC[L!68
MD\J2,G'K0!+IOB*X\0W5]8QZ+=0VL,\]E/=-<(NQT Z!3NYSU'3C\&QWD?@_
M3M'T:>Y$]Q</)'!)>7)"\98(9&!)(!"KD9.*N^&]%N=%.J_:)XIA>W\EXOEJ
M5V;\?*<GG&.O'TI_B#1WUJ*.VDALKJQ*NMQ:7D999,XVL"/NE<'G!Z]NM &E
M93R7-C;SS0/;RRQJ[PN<M&2,E3[CI4]9V@:4=$T"QTMKE[DVL*Q>:_5L?4GC
MTY/%:- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %5[R_L].B66]NX+:-FVJ\\@0$X)P"3UP"?H#5B
MN(^)4EG%;>&I;\*;1-=MVEW#*A0DAR?8=3[ T =+;^(=%N],EU.WU:QEL(LB
M2Y2X4QICKELX'4=:6UU_1[Z&WFM-5LIX[F0Q0-'<*PE<#)5<'D@ G YXKS/4
M=5LFU?Q+J6GOITVE7-WIENU]*!):Q3 L7E." VP&+N!G;D\5'! ^M6?B\V&H
M0WVJV=];ZK82QQB,3/'$F'5 3E6V,FX<-G- 'JMUJVFV,K17>H6EO(D8E999
ME0A"VW<03TW$#/3)Q5:7Q/H$%@;^76M/2S$IA,[7*!/,'5<YQGVKR_6ID\2?
M#SQ=XPV.L6IB&WLPW#+;12*./3,AD/Y5U>L_V;H'CSP_=7WV:RTB*PN8+>23
M$<,,Y:(@$GA245@,]<$4 :GB'Q='I5IH-U8""^M]5U2"Q65)<J%DW?.I&0<;
M:ET/Q')JWB;Q'I+VRQII,L,:R!LF3?'OR1VQTKS6\"OI.C7-NN-/N?'L<UD0
M,*T)+?,O^R6#D>N<UU_@S_DHWC__ *^K3_T10!U.H>(]#TJ1H]1UBPM'4J&6
M>Y1""V2,@GO@_D:?=Z[I%C(D=WJEE!)($*)).JLP8X4@$Y.2"!ZX-<-<ZGX?
MTSXB^+)-=FM85DTVU16N2 '3;)O12>I/R_*.3CVK/\"::P\4Z NI6^;JW\)0
M;5F7)C/G,!P>A X]>M 'HY\0Z*-7_LDZO8C4>GV3[0GFYZXVYSG'-.FU[2+?
M58]*FU2RCU"3&RU>=1*V>F%SFO*VN;+_ (0&3P^98O\ A*SK1/V7(^T&?[9O
M$N.N-F&W]-O>M>RU#0+*?7],\0(DNISZ\98K/&;B<,R&!T&02  O(X&TT =\
MFN:3)JS:2FIV;:BHRUH)U,H&,_=SGIS6/X@\:Z9I$<D-M>V5UJ,5Q!%)9BX7
MS$$DJ1DE1R,!\]/2N&T&$2W=AIM]XCLX=0M]=EN&TY;$M=&02NQ)8/G:R'[^
MW&UA5.:_TI/ <&D7,D)U^'Q"KSVYP9DD-]DR,.H!0@;NAW 9YH ]A;5-/2VG
MN6OK58+=S'-*9E"QN#@JQS@$$@8-1R:WI46H+I\FIV:WK/Y:VYG7S"VW=C;G
M.=I!^AKRK6=7L+3PAXTT>:ZC74WUF5UM-W[THTB,'V]=NWG=TK;_ +/:Z\2?
M$N2TA#:DUM#%;.!\RL;3@*>V3CIZ#TH [BRU_1M2:Y6QU:QN3:_Z\0W"OY7^
M]@\=#U]*?IFM:7K43RZ7J5I?1QMM=K:99 I]#@G%>5Z=#I.JZ=&+KQ-;7%O;
MZ#/;S6VF:<4DM[=U0,LA5FPRD#"L <AN.M=!X:\2V=I<:O-?:GI&H6EG:P,^
MM:?#M#(6<+'*%+#<O7Y3T?H* .^N+B"TMY+BYFCA@C4L\DC!54#J23P!5*TU
M_1[^VAN+35;&>&:7R(I(KA65Y,$[ 0>6P"<=>*I>,XK&;PI>)J-V]G:DQEKE
M$W^41(I5B,$;0P!.>,9SQ7G\^M1R265[=W.E3V]AXAMFN-9L%V03J8)%#.<D
M J652=Q R.G2@#T#Q%XEAT6S,L+03S1WEK;3Q>: 8A-(JY;'3AMPSUQ4O_"2
M:;>Z-?WVCZII=W]DC8M(;M?)C8 D>8ZYVKQR?3FO,/$5_I^J#Q;=1L+K3WU7
M2 6C&]9D#1AMN/O X(XZ]JN^)+RPU6X\:7NBSV]S8IX5:&XGM6#1F7]X47(X
M+!,_0$4 >B2>(M+L-/L)]6U73;1KN-2A-THCD8@$^6S8W+SP?0BI]1U[2-',
M(U/5+*R,YQ%]HG6/?],GFO*DD^QSZ;+?:UIVE6=QX6M(HI-0M1*DP ;S8URZ
M_-\R$J,D@CTJ_ITVC>&=4N(O$UZDEG)X>LX;.>]C\LW$2"02H%;G>=R$IUY%
M '=Q^+=%E\52>'$OH#J20K+Y?FKDYW?*!G)8!=Q&. 0>]&H^+-&TKQ!8:)>7
MT,5[?*S1(\JKC! &<G.6)PO')!]*Y;0[G3;7XG&$*+$7>@V8LK:X^20A6ERH
M!.2RKC(Y(Q5SQ/<VEC\3/"%Q>S0P1/!>PK)*P53(WD[5R>YYP.] '3)XAT63
M5FTE-7L6U%<@VHN$,H(Y(VYSFK=Y>6NGVDEW>W,-M;1C+RS.$11[D\"O(K.Y
MLG\"Z)H$<L1\4Q:Q"TEL"/M$<RW.Z61EZ@;-Y+'@@]>:[3Q^\<$6@7EW@:;;
M:O%+>LP^1$V.%9O11(4.3TX/:@#H;76])O;>WN+74[.:&Y<QP21SJPE< DJI
M!Y. 3@<\&EN=9TNRBNI;K4K2!+0J+AI)E40E@"H?)^4D$$9ZY%>?ZOJWAUK[
M2=9TUHHM.B\1*;V_! MY'-LZ;P^=I&2BEN!FJ<MYI.IZGXEOSK*6$ UBSDL]
M1:,20"1;90&?/RF,X89) .1@\B@#N+SQUX;LIM*235[)DU-V6"5;B/9@*QW%
MMWW<KMS_ 'B!6@_B'18M6729-7L4U%L 6K7""4D]!MSG->9IK-JVI^$]4U Z
M7;VL.L7L4M_;8CM;AC;N!*"3@;F..I^8'DU#=W-DO@76M DEB_X2F;6)2EL2
M/M$DS7.Z*15ZD;-A#= !UXH ]0N?$FA6=TMK<ZSI\-PTODB*2Y16\S .W!.<
MX9>/]H>HJ2RUS2=1GN8;'4[.YEM3B=(9U<Q?[P!XZ'KZ5YEKUK WAKXJSM"A
ME-SC>1S\MO"5_(DFM+Q,T.C>)+F:VT^*=(/"5U_HNWY9%62/"D#M@G\": .W
MM/$FA7]K=7-IK.GSV]H";B6*Y1EA&"<L0<*, \GTI]IKVCWUT;6TU6RN+@,R
MF**X5FRN-PP#GC<N?3(KR'4[^!QXA1=:L-023PI<112V4*Q0L4R3&F&.XJ&S
MC)(!^M=;K>G1:1X-\/Z_I]NL<F@^5=,L:\M;E LX]_D);ZJ* .\CO+:6ZFM8
M[B%[B *98E<%XPW*[AU&<'&>N*@?6-+CL6OGU*S6S1S&UPTZB-7#;=I;.,[O
MEQZ\5A> X'FTJZU^=2+C7+EKWYARL)PL*_A&J?B37&:EI/\ :?BW4? CJ1:7
M=U+K)..!$\)7_P!*&W?A0!Z-KVM1:787!BO-,BO8XA,L=_="%-FX*68\D+DX
MSCJ0.]4[WQKH]GK,^B&\MSJD5F;D0F91DXR$ZYW$?-C'W>:\HUN\F\1_#/Q=
MXCND82I96>F#<.0\;(\V/^VDA'_ *['5KFTM/B+=K<S0PO=>&!';B1@IE<22
M$JN>IQC@<XH ZGP[XNTO7K*Q"W]D-3GLX[F6QCN%:2/<@8C;G/&?2H?"WC73
M/$.GZ=YE[90ZK=P"8V"W"F11U^[UZ<].E<MI=K!;:;\*C!"D9V\E5P3NLI&;
M\SR?>J6C6L$'P_\ AT\4*(YU6!BRK@Y99=QS[T >E+XAT5]6.DIJ]BVHC@V@
MN%,H/7&W.<UEZ1XL2^U/Q+!>+#:6VBW"Q&=Y<*5*!BS$\+C-<#;7-DW@32=
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M;>%[J2[9W'$D6!]C&>^!(?QAJFFGVDO@&P$EM$WG^+QYF5!WYOV0Y_X#Q]*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,R2.1G 'MW/;%<VOC:]A%O<ZEX5U2QTRX=$6Z=HW:/<0%,D:L60$D>N,\XH
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M4,B LV1N#'(.,L:Z1[2VDBEB>WB:.4YD1D!#GW'?H*?%#'!$L4,:1QH,*B*
M /8"@#S34O\ DJ?BC_L5A_Z&])I.GV=C_P *PEM;:**62)A)(B@,^ZS9FW'J
M<L >>]>EFWA,C2&&,R,NQF*C)7T)]/:@00CR\1)^Z_U?RCY.,<>G'% 'A^FK
M:#P9H4]ZL @C\8OYDDP&U5,DF<D\ =/TK3O;RWM?$/Q,F:WM[JW<:5%LE8B'
M:Z! SE?X!NW''8&O66L;1[=K=[6!H&.YHS&"I.<Y(Z=:=]CML2C[/#B50L@V
M#YP!@ ^HQQ0!XGK<Z?V)\1K?[=IMRQTRU<'3X/)B;#2*Q5=[;L?*I8'J ."*
M]CTYQ'H%HY5G"VJ':HR3\HX J8:=9! @L[<($\L+Y2X"9SMZ=,]JL !0   !
MP * /)5U'3-$TZSU#P;XHD:.:XB2/P]/*LP;>X#1(A_>1,,DX!P,=,54UA;.
M*/XAP(L*S_VE:R3Q( )3:8MS,<#G9MW9[=:]=33[*.[:[2SMUN6ZS"(!S_P+
M&:?]EM_M+7/V>+SV78TNP;BOH3UQ[4 >2^,FM;B_U9O"Q@DC7PY*+TZ>5*[3
M*FP?)QNV";'?&:L>-9_",_@[Q&= %J]W_8HWO9?ZL0[QL5MOR[LYQGYL9[5Z
MC;6=K9(R6MM# C'<5B0*"?7BFQZ?910R0QV=ND4IS(BQ*%<^I&.: .,\'M-:
M^*]5MO$:QGQ+.@FBN$),<MIV2'/*JC9#+U)(8YSPOQ*GO-1M;#PCI8C>^UF0
MB422%%6VC^:4LP!*AN$Z'[QKN&AB>5)&C0R1YV,5!*YZX/:@PQ&83&-/-"[0
M^T;@/3/I0!YI+_;7A[QWINKZQ8Z7:Z9JD:Z1<+97#RKOY,+,&C7'.4SSPWTK
MG/)N);.;34#M+X%AEG3U9UN \/YP0L/^!U[=+#%.FR6-)%R#M=01D=*06\(:
M5A#&&E_UAVC+\8Y]>* /)DO(+Q+?6'&G*=>UN>XMKW4U+0P10Q-'$2FY0Q*(
M2H)'WB>HJAID5IJB>&;*=K:Z@7Q1>[HXXMD94I,ZXC).U#G(4D\'O7LLEC:2
MVRVTEK \"X*Q-&"HQTP.E*+2V$OFBWB$F[?OV#.[&,Y]<<4 >8ZH="M=6\>P
M:PMG'(;2!;*.4*&,/V?"K$#S_K-^ O\ %CVKL/!M_:CPOX=T\SI]L;1[><0Y
M^8QA$4M],D#\:W9;.UGF2::VADEC!".\8++GK@GI48TVV74H;Y4VS0V[6T87
M 548J2,?5%_*@#F/&\-N]_I$_P#:>FVE_")VMXM4BWV\ZD*'!.1M8#&"#G&[
M@C-8/A6'3=;\6Z=<OI5M%"OAQ/*ML>9''^_=24R.5('!Q]T^]>E7-I;7L7E7
M5O%/'G.R5 PSZX-/6&)7#K&@<+L#!1G;Z?2@#R#PFUE#<>$&UEH%TY--O8[0
MW)'EK.+A1CG@-Y8('L#BG:/<6MCJ>@7IEBM]$_X2'4Q9S,P6$1/%(%VGH%+;
M]O;TKUB6QLYK;[-+:0209SY3Q@KGZ=*=-9VMQ;"VFMH9(!@")T!7CIP>* /%
M_$-W!?>%?%-S;2++ _BNV*2*<AAMMQD'N/0]ZM>(9=&30/B5%J[6O]K/<2F%
M9<><R>0GD% >=HYZ?[7O7KQL[4QF,VT)0L&*[!@D8P<>HP/RILMC:3S^?+:P
M22[2GF/&"VT]1GT]J ,O4/\ D1;K_L&/_P"BC7G&GG3'TSX?1^'#:_VPL3&0
M0[?,5?LK^9YF.1^\*9S_ !8KV$HI0H5!0C&W'&/2HHK*T@F::&UACE90K.D8
M#$#H"1VH \GTMM(D\.?#^#3/LQUM+V#STCQYZD(WVKS!]X?Q;L]R/:JEK;Z7
M/H@T_P NU9_^$T*7$"A=VS[2^U64<[<= >,5[''96L5S)<QVT*3R??E6,!F^
MIZFD%C:"9YA:P"5V#,XC&68="3W(H Y?P];PVGQ$\5PVT,<,1M[!]D:A5W$2
M@G [X4?E5+7-2L=+^+>CW&H7MM:0G1[E1)<2K&N?-BXR2!G@UW8CC61I%10[
M@!F Y..F3^)J&XL;2[*FYM8)BO ,D8;'YT <%>:A:^*O'MA=:+,EW9:-8W?V
MN\A.Z(O*JJL0<<,?E+'&<<5;^'(TK0?AEH5W((+7[3;0"68@ R2.0%!/4G+8
M&?7%=O'#%#$(HXT2,# 15  _"F_9H/)6'R8_*3&U-HVC'3 ]J ,SQ;_R)FN_
M]@^X_P#1;5YKX<LKWP9HVA>,II9=6L+C2;:&_#Q@RV$.P%6A '^K4$!UZG&[
MGFO86571D=0RL,$$9!%(L4:Q")441A=H0#@#TQZ4 >6^(YH;[QA?7$FIZ#%I
MUSHD1MYM3@,T<D1:3S/*(D49Y0GJ3E/2K?AW1K2?Q=+#?^5J;0>&["(3S0_Z
MP$S MM;D%L#KSS7H#Z=8R111/9V[1Q'=&C1*0A]0,<5.(XQ(T@11(P"EL<D#
MH,_B: /)? UG;ZAJ/@[[9"EP(O"[L@E7< 1+&H.#[$C\:H::DL*^&E6XTNTL
MHI=7BA;4H3) L@NB%4 .H#; X7GH&&*]FCMX(BICAC0HNQ=J@87T'M[4R6QM
M)K<V\MK!) 3N,;Q@J3G.<=.O- 'E5C:Z;I^M> FN+ZPN[4G4A%="+RHB"P:-
M$WD_*N2%Y/ XIFG:=9P> ?#-[';1+=MXBB9IPHWDF[93\W7[O'TXKUJ6SM9T
MC26VAD2,AHU= 0A'0CTI1;0"-8Q#'L5MRKM& <YR!ZYYH S/%4FF1>&+\ZU
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M7;QPK$H13YL(R%QCN:[0VEL1(#;Q$2,&<;!\Q'0GU/ J0QQF42E%,@!4/CD
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MI4$3AB8UCWX8GO\ ?Z>W6@"X/%D-U)8PZ;:O<W%YIW]II&[B/$/RXYY^8E@
M.G!R1WJVOCNSO],TZZMK?RY=0MVNH(KR=(OW:X&68%@"2P '7KTP:Y75XFT:
M\T+29]7TFQGTW21;>?J"2Q1W ;"D1R(Z'.(P2A) W+UZC:@T36KR'2-9TJ?3
MM-U"QBDLQ$+=VM+BV)&,)E64?(I'/Y@T 65\?M=)I2V&@7]Q<:E:S3PPNT<1
M#1$!T)8\'+=>AXQG-2?$B21/ 5U<*9HI4EMV CD*L"9D!'RGG@D8Z5:.@:D_
MB+1=5GOH)C807$4V8RID,Q0DJ,G:%V  '/'4]ZN^*-$;Q%X=NM+2X%N\I1ED
M9-P!1U<9&1D97'7O0!ECQS#:7FHVFLZ;<Z;/9VPNT61T<3Q%M@*E3@-N(4@G
M@D<XYJ]H_B9-4UBZTQ[8)-#$LZRPRB6&1&)& X PP(Y4^H(R*H:IX-?Q"+^?
M5+E8;NYLA9PM:@D6X#B3>">6.\*>W"@>I.IH5IK\"%M>U&TNI578@M+<Q*?5
MVRQRQP.F .?6@"MKGBR#2+BYMHHDN+FVMQ<RQ&=8V*$MA4S]YSL; XZ<D9&:
M+^.C))=1V.B7EP8-.BU$;W2+=$^[L3D$;",'G/YU8U/P_K*^)SK>@ZG:VSW%
MNEM>07ENTL;A"Q1UVLI##<PQG!!IK^&;_P#MC4[X7D,GVS2X]/!D4[LH7/F-
MC@Y,AX&.E #K#QFM]?:9"-*N8X-5LVNK&5G3,H558J5S\IPX(R?KBJ.G_$1+
MT:+<S:)>6NFZO+]G@NY'0@3'.U64'(!VD ^OMS4UGX7N]/D\*S37EKY6@63V
MTI((\T%%3=D_=P$!YSU_&L3P%I4FO>!?#'VB>W:RL)_M0$62[NC/L5NRX)!/
M7.!TH O>'=9CT>#7!,TT\DWB.6SM8VD+,SL$VKN8\ #)/H ?I5_4/' TVVUC
MS]+E-WI CDNH$D!!@?.)4;'S*,'/ (VGCIFL_@:[EM[HF^ACO!K?]LV<BQDK
M&^,;'&?F!7()!'WO:KES#I^AW&H^(/$=Q AU".&R=51FC5!NVITRQ8NV3@=A
MVR0"_?\ B:VTYKEYD#6MM:I<23)(",NQ5$&<9+$<'..F<9K/_P"$[M(&U!+R
MV96M(XY$:WD$T<_F-L5$?@;]Q"E3CJ#G'-4])\%++\.IM$FNKJ)[L;TFD'[V
M *1Y (]45(P1ZJ?6IKWPMKVO^')[#7-:MOM8,;6TUE;%%22-PZR,K,=Q)49
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MZCX[DT=6(M=.LX[J8 XWRR,P0'V4(QQW+#TIEMXP6;6++3YM.F@DODG>W1V
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ME(9F)+9Z]!@<=<@#Y_%(M6L+>XMHH+N^DE2!)K@+&^S^Z^.=P(*C'(],4_\
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MRTSPM9F\MG.AW+3LX1AYP*.N /X>)#Z]*QO$NF7&@6T+SWMF)-0\5VU]%NR
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MOQ,T9PP!&X'!Z\X]ZZG3'U<ZQJB7S0/8J8_LC1PM&PX.]6R3NQA3D<?-CMP
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MEN)Q]GM["ZLI8PO,@F5%)![8"'\ZHKX2U>_T2ZT76=6M9;![!K)/LMIL=R0
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MF<Q%R=NT,QYQG  ]ZK#PCJE]JD5SK&I64_V:WF@CN(+3RYYA(NW]X=V.!S@
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M10 @10I4* IZC%-6&)(Q&L:*@_A"@#\J?10 F 2#@9'0TFQ<8VC&<XQWIU%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHK(CUU;CQ1-HMM 9?LL"RW<^["PEON)C
M'+$ GM@ >HH UZ*P;SQ-#'J]AIU@D-[+>)<%62X 57B53M) .,[@/;T-6] U
MN#Q!I$5_#&\3$M'-!)]^&525=&]PP(_6@#3HHHH **** "BBN:O?&VF6/C"V
M\-R1SFXGV W"J/*B=PY2-CG(9A&V!CTH Z6BH9[NVME+7%Q%$ I8F1PN%X&>
M>W(_.@WEJ(EE-S"(W4LKEQAE R2#Z8H FHJ&.[MIHHY8KB)XY3B-U<$.?0'O
MT/Y4YKB%!(6FC41#,F6 V#&>?3B@"2BN>\4>++;P[X6EUZ*-+^%)(T BE #;
MY%3(;D<;OTKH: "BN,7Q^\S:@]IX7UJ[M+"YEMIKB#R""T9(;:ID#'IZ5T5E
MKNFWVB6VL17<:6%S&LD<LK;!ANF<]#[4 :-%1&ZMUC20SQ"-QE6+C##&<@]^
M.:;%>6L\,<T5S#)%(=J.D@(8^@/<\&@">BHGN8(UE:2>-1$,R%G V#W]*=#-
M%<1++!*DL;#*NC!@?H10 ^BFR,4C9E1I"!D*N,GV&2!69X=U^V\3:/%JEG!<
M16TK,$\]5#-M8J> 3W!ZT :M%%1R3Q1/$CNJO*Q6-2>6(!.!^ )_"@"2BLO0
MM<AUZTN)X8)H/(NI;5TFV[@\;;6^Z2,9![UJ4 %%-D8I&S+&TA R$7&3],D"
MN<TWQE%JVC0ZO::/J;V$N<38BX 8J25\S=@$'MVH Z6BBB@ HI&)"D@$D#H.
M]9N@:W#XATA-1MX9H8VEEB\N8#<#'(T9S@D=5/>@#3HHHH ***S;W68K'6-.
MTZ2UNV-\75+B.+=$C*N[:[9X) ...QH TJ*** "BBLO7]<A\/:<M]<6\\T1G
MBA/D[<J9'"*3DCC+#ID^U &I1110 45EZKKD.DWVEVLUO.YU&Y^S1R)MVH^Q
MG^;)ST4] :MVEU)<M<B2TFM_)F,:F7;^]  .]<$_*<XYP>#Q0!9HHHH ***I
MW5^(;2\FMH9+V:U!#6\!7>6VA@HR0,D,#R>] %RBD4EE!(*DC.#U%+0 4444
M %%%% !1110 4444 %%%% !1167XAUR'P[H\NIW%O/-#&R*RP[=PW,%!Y(XR
M1_A0!J4566ZD.I/:&TF$2PK(+D[?+8DD;!SG<,9Z8P1S5F@ HHK+37(7\3RZ
M#]GG6>.T%WYK;=C(6V\8.<Y!Z@4 :E%1S3Q6\?F32+&F0NYC@9)  _$D"I*
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MB4:K>!;&6WFM%-X_DQEK?))7."A)S@\>F*H>%Y+W59?#U[#?32-!ITCZ@O\
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M-U*^2VFTG5/L-W;2%P)$,D,P((*2(",CG((.010!Q/PZL=(USP?'8?VS?WD
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M3P._ (!W*<)&P_$$<U&O@J_MK*UO+:_MSX@AU"74'GDB/DRO*I1X]H.0FP@
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MK%XUA/IHT^]O!>2-/;%YXB=OF(G\)#;3@G[NX]>*SIO!.M_O8;:^TY8$U?\
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M,ZCABB!21^5<%'I>N:KK'CNRTR\LX+>\O%MYC<1LS1!K6(%TP<$X;H>,@<T
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MO"FC2>'?"FF:/-*LTEG L32(,!B.XS6S0 4444 %%%% !1110 4444 %%%%
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M,-<NI;"ULX[!9[S6KW3M\L;E4CA\S:^ PR<("1D9Z<9R #N#86;%2;2 E6+
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MF3RSAQMZ'YN<9''>K%IXGUZ/4]+^WBP:UUC3IKR"&&)@]LT:HP5G+$2 A^2
MO(H [2WM+:S5EMK>*!6.YA$@4$^IQ0/LMYAAY,_E.0#PVQAP?H:X/2/%?B1K
M/PMJ^J#338:ZT<+6]O"ZR0.\99'#ER&!*\C QN')QDXWA/6;S3-'O[335@-_
MJ?BR\M(7G4LD7)=G*@@MA4/&1DD<T >H_P!F6&T+]AMMH.0/*7&?7I4AM+8W
M0NC;Q?: NT2[!OQZ9ZXK@[WQCKFASWUOJ(L;@:5<VCWEQ%"T8>SG+*7"ESM9
M&4D\D$#M5GQ%XWNM(OM;^SQVK66EV]O&TDV1_I4\@" D'[BJ59N,_,.10!W-
M5+:ST^TN9/LMM:PSN TGE(JL03U..>QKSY/B'>A+NPMKS2]4OFFM(;.\MX7C
M@+3N4(=-Y.4VD\-R".E:>@KJ<?Q/U>/59K:>=-(M0LUO$8UD7S9CG86;:<Y'
M4],]\  [/[';?:_M?V>'[3C;YVP;\>F>N*8=.L6WYL[<[SELQ+\Q]3QS7.ZG
MJVNWGB6ZT;0)+"![&SCN9I+R%I1(\A<)& K+M'[LDMSU'%5/[;\4:MJ6H6>F
MKIUA-I=M"US'<Q-/YMQ(F\QAE==J@8&[DG/3B@#?UK0H=3T6_L;=+>VFNK9[
M83^0&**RE>@()P#TS4VBZ3%I&F06H2 RI$J2RQ1"/S2HQDC)_4FN1L/%NN>)
MK[3[?1OL-E%>:-%J32W,+3&-V<J4"AUSTZY&,'KG%4+;Q%XAUS6? ]Q%=VMG
M'?0W;75N(7=&>+"O_&,@_P .?NGD[N@ /0H;73I$*0P6K)'NB*HBD+SEEXZ<
MXR*5].M@G[BWMXI54B*00J?+/8@?4YKSRQ\6:A!8:H^FZ;I<-PWBV32P%B*)
M("0/-?!R7Z$MWQTJ]=>+==T>/7;6]:PNKO3I[ 1SQ0/$CQW,H0@H78AE^;!W
M>E '6:)I=SI\4DFH7_V_4)MOG7(A$0(48554$X Y.,GEB>]:,L4<T;1RQK(C
M=5<9!_"N/\3^,KKP_J>I0K;1316VE1W42G(9YGF,2J3G[N=O;/6J^H>(_$/A
MN>>UU673KR272KJ^M9;>W>()+ JEHV4NVY?F!!R#P: .W@MX;6(16\,<,8Z)
M&H4#\!4<EM9IYD\D,"\B221E Y7HQ/MZ]JYV?Q+?1W'AF..WBE.J6LTTJ $'
M<D(<!#GC)..<URTWB._\0?#WQ,]SJ.DW(_L:=YK:VB>&>SE,9S$Z,S$CK\QV
M\CH<\ 'I"Z?ITD64M+5HWP^1&I#>AZ<]:4Z;8G=FRM_G^]^Z7GZ\5QOA+7KB
MR7P]I%Z(4L;KP_!<V<V"#OC11*C'.#\K*PX'&:Z#PCJUYKWAZ+5KR*.);MWE
MMD12"("Q\HMDG+%<$GCKTH TIK6P'EM/;VPVCRHRZ+P&XVC/KTQWJ1K.V<J6
MMX6*H44E <*>H'M[5Y?J>KZYK^@:)K,S6(TN\UVT\FV2)A+%&+H!&,A8AB=H
MR-HQNZ\<[\WC#4(_!^K:N(K;[1::L]E&I5MI1;H0@D9SG:<]>O;M0!V'V2U2
M19OL\*NBX#[ "H ]>PQ2216>I6H$D<%U;OR P#H??TKDH==UW4?$OB*T5=/3
M2M(?8P>)FDG#0*X7.[ PQY.#D$# ZUC>&_$VLZCI7A*QTFVTC3_[3TZXN)-M
MLWE6_EN@&R,.,@[R,9')SGC! /2I+>"6W-O)#&\)&TQLH*D>F.F*C-C9M D#
M6L!AC^Y&8QM7Z#M7#6GB[7=1CTO2H?L$.KW%]>6L]RT+O"JVS$,ZQ[P26^3
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MRAHVW,V[[X(;C.UN*UY-?GLO&SZ1?B&.QGL3=6<^"#NC.)48DX. R,, <9H
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M+C5X=2M;"VN5A:.%O/56#NF\GY06R W.!TH [J".UMV:"W2&(C#M'& O7C)
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M&BHBC"JHP /84ZL?PMK3>(?#-CJCQK&\Z'>J$E=RL5;;GMD''MBMB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "L/Q5H$WB#3;:&VO%M+JUO(;R"5XO,7?&VX!ER,@_45N44 <O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU[]:KZZGAN7P;KVI:)JKW-M<O:%O+"Q6Z2"51\@55Q(5SNQS@#.*]CI  !@
M 4 >3:W9:<D_Q"TW3XH&AF\/QW"V\>&#S[9\N!W?B,D]?NFN[\/:KHOV#2M/
ML)[<-/:>=#%"N%=5P'88&/O-S[FM^C ]* ,7QA+'%X+UQI'5%^P3C+'')C;
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MJ]HTQM_'$,:FRU2VN;V[,=U%\MW9N-Y=)ASNC'W5/&/D'I7H^!G..?6C SG
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M,!LXZUGZI#I5KX&^(-NL5M!>1ZC,0BH$<*2A3IV.3@=^<=Z]F&TG(P2.,TM
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M'=EVR/88_&LC3O!9L[+2M-N-0^TZ;I,XGLXFAQ(-H(C5WW88+NXPHSM7/0Y
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MC\SYOE^[@'ID\#UXHZWJSZ_X<T^:]M(8KVQ\46UI)Y9WJ'2Z52R$@'!'\\4
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M*9W H>V#QTJU_P )5K%IK\VE:AHT/F36$M[IXMKG<9O+QF)RP 5_F7GD<]:
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M(SB?C) )/&!5VW\<RZII]@^FV?\ I=SID>HM&Z22!0^0J?(I/)5AN.,8Z'/
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ME./W>"I )['([5I/XBU\^(;C18]-T_[0;(7MO(UR^P)N*E7^3.[..G')YXY
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M1$\0:0UB;A[9Q+%/%,BAC')&X=3@\$94<5A7G@)KZWUY+C6KAWUJ**.X;R4
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MVU3A<$?,>!ZT_4_%^@Z0\27NH*IEB$X,<;R*L1X$C%00J?[38'O0!+X:T/\
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MXC4G 9V4$("0>6('!K&O?&<NF>-=7T^[5/[,L-(2_P!T<;-(6+E2.,\8 [4
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M- Z2>7OQYQ<X 3'&,9[]*GM_&?A^YLKN[34 D-HJO,9HGB95;A2%902&(P"
M<G@4 :FGVCV5FD,MU+=2\M)/+C<['J<  #V & ,5C0^%B-6L]3N;U;B\L8I8
MK>8P!7P_&)&!^< =!QZG)YK3TG6]/UR"26PG,@B?RY$>-HWC; .&1P&'!!Y'
M0T[5=8L-$LQ=:C<"&)G$:_*69W/15502Q/H 30!P6K:#)H>F>'M#6YU V-BL
MCB]ATP7B[^BK)$%8YPS$-@ 8]3QKV&@:AJNGZ:+R^VQ:;?K=6;?V?]G:153
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MDI08,DARSGN3[D\U-4<$\5S;QSP2+)#*H='0Y#*1D$'N"*DH **** "BBB@
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M8<@8YI1]GNCKVH7T.M6$,FO)<6=[;VK>9;XM$592A4G81N4Y4_?P0.<>JT4
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MP9*KYIV+NZ9R,<DUZ_10!YGK$I\1ZEK^J:7;W4EG'X9N+,R/;/'YTSG<J*&
M+$!3T'5\=:R[*TNM*C\-WMY?ZSI5NWANVM=]E9K,PF3+-&ZM$Y4D,,<#.TCM
M7L%% &3X7L8M,\+:990+=I%%;HJ)>!1,HQPKA> 1TP/2M:BB@ HHHH ****
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M[\^6.!V2/?$%7+ 8&3Q7-7.FW'_"/^(!'I-Y]HE\3Q746VSDW/$LT3;Q\O(
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MSN["ZDN$E(8R%8490< <*2<5H^#H]8U?3='\3RZ_<$WRF:YL9%5H/+8':D8
M!4K\O.3G!SG/ !UVG:E::M9B[LI3) 69 Q1EY4D'A@#U%,;2;1M;35PC)>K"
M;<NK$!X\Y 8=#@\CTR?4UYAH6N:]K.A>%(WUFXAFU#5KRWN)U"[VB03$*,C
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MXG@O)7N,VB:CI*L,D[L1&$?279C_ *Z"@#OZJZ=J-IJVGP7]C,)K6==\<@!
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MD<GDL5<IE3]]L'K@C-:-Y>KIWQ-\87C7@LQ%H,+"Y,7F^4<MAMG\1!QQWZ4
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MS,&FR7'S9  R,\<=A3]/\1ZMJFG>'M#-TT6M_;WMM4D0#(2UYE;VW_NO^_M
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MDW/FR>5JD+W$!V?=C2/S&+#M@<?4@57M_'.F2VM]<36U_:"SLC?E+FWV-)
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M;5UU+5+&[:W6W<V5SY89%9F&>#W8TZ+PC:K#;QW.HZG>_9[Q+R)KNXWLKH"
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MO<LV .Y/)/N:L52TG5;76M.COK0OY3EE*R(5=&5BK*RGD$$$$>U7: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *X[XE:;/J?ARTB@TZ34%CU*VFFMHT#EXED!<;3P>,\&NQJK?ZE8
MZ5;_ &C4+RWM(<@>9/($7)Z#)XH \_M],^T^)=&G\-^$;CPZEO<>9?W3P16R
MRP;6!B*(Q\PDD'D<8SFJ\&EZN?"5AX*;2+Q;BWOXS)?%5^S^3'<"7S0^>25
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M,^T!L YY! R#W%>DT4 >6V&E:MI*>$+R72KN5;'4-2-Q'"@9T69Y?+;&>AW
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M".:)P\<BAT8="",@T^@#A=1L;_3T\&:I'IUQ=+I2&*ZMK=0TJ!X-FX+GG:P
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MBR23O%T5"Q5(RP(W*H&&7KSCUNJMCJ=CJ:SM8W45PL$IAD:-MP5QC*Y]1D4
M>6W.D:M<Z#JVG:3I^MQZ4]K$$LM38.8IA,AVPDDL4"!L\D<#%=R]A='XE0Z@
M(6^R+H\D!E[!S,C!?K@$UT=% &!XVTFZUSP;J>GV05KJ6,-$C' =E8,%)[9V
MX_&N>U"/4?%.LPWT>CWUC#8:7>1'[6@1I9IE0!% )R!L))Z=,5Z!5::_M+>]
MMK.:=$N+K=Y$9/,FT9;'T'- &=X/M)M/\$Z#9W,1AN(-/MXY8VZJXC4,#[YS
M61\0M+OM4M_#JV-L\YM]>M+B8)_!&I;<Q]AFNQHH \YU#0M3E\#^-+..RD:Y
MO=2GEMXP.95)3!'Y'\J]&HHH \N?PRZ:WJ=E>Z9KUVM[JAN8FM[UX[,Q.RON
M<!L H<Y!&3M&,YJAXF_M'1O!/BS1IM'NW\Z_FNX[P*OD&&242;BV<[ADKMQG
M(';D>P54U/3+36--GT^^B\VUG7;(FXKD9SU'/:@#SS7+76(+3QYI%OHE[=2Z
MQOFM)HE7RF5K9(R"Q/# H>._&.M6WT'4Y?'E]=+:.+:7PNMDDIP%,V\G9]<&
MO0Z:[K&C.Y"JHR2>PH \JNS>:5\,?#NMG3KBUU7PP($-O<J$:8;%AE1>3D,&
MX]2HKO/"6CR:'X8L[.X(:[*F:Z?^_.Y+R'_OIC^&*<^FZ+XF.FZRP^V1QA9[
M1O.?RCW5]F=I(Z@D$BMF@#D?&*:@^IZ4JPZO-I.V;[3'I4ICE:7Y/*W,K*P3
M_6="!G&>*XE_#?B&+PMID5GIES%J*R7VDW8+[BL%Q(6$H<G+JI"G=UY->R55
MN-3L;2\M;.XNHH[F[8K!$S?-(0"3@>P!- '"6OAK4;?X@?9X;,IH=H\FIVLC
M?<\]H4A"8]CYK_\  JS]"L=8_M[PQJ-]IVO/<P&2/4Y[RX9T$SQD9CCW%1&&
MS\R@#!7KSCU6B@#S&ST'5K/X8^'(_P"SIGO=*U&.]FLUQYCHLSE@H)P6VMN
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^$.GSF>S@-V_EP$@@A1G[N&/!SZ=.* '^+=;NM#2SG$5U_9Y9_MES:PB9[<
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MMFNHY--,OV>02_,%D.75CCYE)YP<_P JT-5T"RUBZL;JX-Q'<63,T,L$S1L
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M.FW<06Z>/=-/,JJ%7:Q^4;3\QQG(KI?"-E<:;X,T2QNHO*N;>P@BEC)!VNJ
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M[?2=9UF+PKI5YH]QIZ:1 QN[EWC*,WV=H5$>UB3DN3R!@"@#IM(\966KWMM
MEE?6\5[&TEC<W$:K'=JO)*88D<'< P4D<BK.L^)(-(O[6P2RO;^^N4>1+>S1
M681IC<[%F4  L!UR2>,UR/@SPV;"\T>*[\.ZG%>:9 4DO;G5'DMQ($\O,,9D
M8$,"W\*[0?7BMC6Q>:;X]T_6+:PDU%)-.FLWM[>6-94/F(X<!V4%>"#@\9%
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M4I_'UA:W%W"LC6_V.$E"?X>6!KI]4\;6>E7=_;FPU&[338A+?7%M$ICM\KN
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M-)+N%/4 L20/I0!SG@OQ9=R?#V+5M5^U:C=O>S6Z)!$#)(?.9$4#@#@#DD
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MCM)']X X8>QR*T ,# Z444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M%6STZTT\W)M81&;F9KB;!)WR$ %N?H*+?3K2UO+N[AA"7%XRM.X)^<JH5?R
M XJU10 4444 %%%% !1110!!>V<&H6<MI<JS0RKM=5<J2/J""/PINGZ?9Z58
M0V-A;QV]K"NV.*,8"C_/-6:* "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***XR+5]1U#Q!X@OK599[/1L65O9QR!!/.55Y'8D@':&
M50#QPW<T =G17CGA[5_$*?#6+QG<W6I2W%LPO)Q/<J\5W!N82JL:_< 7D9&<
MJ.V:]ACD66-9$(9' 92.X- #J*** "BBB@ HJEK$\EKHE_<0MMEBMI'1L9PP
M4D&N M-1UO3-+\,:M)XIFU&34YK2.:PN(8 &$V-Q0HBL"N2W4\*<T >F45S:
M>+)!K-O:7.BWUK:75T]G;WDVT"250Q^YG<%8(VUB.>/45DZ=XQM;;3-0F@BU
M.^N&UZ;38;>>56=Y\_=0G 6, $C/0 T =U17(>%=8OM3\6^)H;R*XMA;"U5;
M29PPB)1BVT@D$'@Y'Z'BM_5]/N]1M4BL]6NM,D5]QFMDC9F&#\I$BL,<YZ9X
MH T**\^\$1:_JLE]=WWBO4)DL=5N+00&"W"2I$^T;B(P<GO@BGZ5XVM+;0;:
MXAM]6OC>:O-I\232J\OFC><9) "93 ST!YZ4 =]17"R_$9[>TU*>;PYJ"_V1
M)MU,"2(BW7 8,IW?O/E.[ [=>V='5?&D>FW5\(M,NKNSTU$?4+N)D"VX9=W
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MRIPZ%ON@=:ZRZ\6R:=>-H]II]YK5W;:?%>/.CQ()8SN4L3D+N)3. .=W' .
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MD[64E<@^M '7T5Y_X6\67O\ PAWAJ$6EUK&L7FG_ &F0"55.Q<!G9W(&26
M[GZ&NST?5+?6](MM2M0XAN$W!9!AE/0JP[$$$'W% %VBO./'.JZX?'/AS0[*
M+4$L[D7$LGV.ZCA>Y*(I #$Y4+G)!QG/>MB7Q[%$9KL:3=MHL%W]CEU(.FT.
M'\LL$SN*!^"V.Q."* .OHKG++Q6VH^*+W1;72KIUL)O*N[LN@CCS&'4\G+9S
MC '&,GC%:FMZK'H>A7^K31O)%96[SNB8RP522!GOQ0!?HKE[#QE]IU.WL[S1
M[VQ6]MWN;*20J_GJ@!8;5)*MA@=I&<>_%-M?%KWDDMI?Z/?Z7)+8R7MOYKIO
M>)<!N 3L<;U^4],^QH ZJBN'T?QC&WA_P['IMEJ.IW>IV[S11SSIYHB3&YY'
M) ZLH]R:O> ]4N=7TS5+FZ:?<-6NHTCG/SQ*KX"'KC;TXXH ZJBN5\5>(]2T
M;6_#]C8::;M=0N7CD(D120L3MM&XC!R <], CJ:SU\96.E+XGO774[A;#4XK
M:6.1P^&D**/*'9?G!QUZT =U17&-XZO%O+[3_P#A%M0_M&TA6Y>W\Z'!@.</
MOW8SE2-O7/MS5A_&\=Q#9/H^E7>IO<6":BT<;(AB@;[N=Q&6.& 4?W3TH ZN
MBJVG7]OJNF6NH6C[[:ZB6:)B,95AD?H:PM3\6O::G>V6GZ-=ZFVGQ++>M"Z(
M(@P+!1N(W/M&<#MCGF@#IJ*\NUWQ+J>L^-/#-II*ZA_9%Y:/>H;2YCA:Z&U"
M"23D!=W*G&?>K7@G5=;UOQMXAGU&*_C@M+DVT<!N8S!;@(IVE%/S,<YW<B@#
MT>BL/QCJ$.E>#]4OIWNTB@@+LUFX24#_ &&/0UF/XR>*Y?3M/T6^U&YM[&"\
M;$B+F-PW5F(^;Y.G?/L: .OHJEI&IV^M:-9:I:;OL]W"D\>\8(5AD ^_-7:
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MON1QQ4.D:O9Z[IL>H6$C26TC.JLR%#E'*-PP!'*GK0!>HHI&8*I8YP!G@9-
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M7)._(.2V23DY/)]30!R4UQ?7K^)]"EU>Z/\ 8VG1A92$$D[R1NQD?"X(P N
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M< GOCKWS0!P>M_\ (H_$K_L*C_T5;UZ3KNH/I/A[4M2BB\Z2TM99UC_OE$+
M?CBJ\OA;19[>_MY;/?#?R"6Z0ROB5^.3S[#\AZ5K+&JQ"/DJ!M^8ELCW)ZT
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M[7<VN;@Q&%I$=D+QYSL?:1N7V.1R:=+H>G3:A:7SV_\ I-FI2W=791$IP"
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M-O8.KVL?G/B)E&%*_-V'3T[4_P 164^H>&-3T^T56GN;26",.V!EE*@D^G-
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MM%]OL+R*]ACF8JDI0G*,1TR">?7% $\?BO2WCN2[RQ36URMI);O&?,\Y@"J
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M?2:0L#3,-7B:6S8Q$*ZJ,G)[$#G!Y_6MF!I7@1IXUCE(RR*VX*?3.!FO/9_
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M]R5"G/?-=/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M' YYP?>@#3LO#.AZ=975G9Z7:PV]VI6X18QB52,8;U&"1@U-'HNF12V,L=C
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M?2H!J&FV\-VL=M<EXYXI)-F58H""""""/3UX .XCCCAB2*)%2-%"JBC 4#H
M.PIU4=)GU&XL1+JEG#:7#,2(8IC+M7MEL#YO7''N:O4 %%%% !1110 4444
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MEBE(R$<@X;'?!P:L44 >>Z=X3\16NH1ZA)%H_P!I_L:6PFW322^=,2K"1RR
ML&*\@\@'^*MGPIX8D\/7U^\*)9Z=<+&8].BG:6*&0;M[)N VALK\H&/ESQG
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M8_NWRPRN/XN. *9XJO[_ $W6YKZ3S[K1HA D_P!BNFCGL6W9W&/($B-E<]\
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MCMTH N(ZR(KHP9&&593D$>HIU-CC2*-8XT5$0!551@ #H *=0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD #![?C0!Z-17BNERZQXIBTR*]LO[2\OP_;3H9M1>U*N[2!IP0IW/A$Y[?\
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M[2OX'NX+G5%CM]4M+XEH&;""WEB/&P-E>,]<D \UAZ=ID%GX0T;787G74?\
MA(1&)1,V!&]\T;1A<XVE2<C'))- 'L=<G-\0M(@T#4]9:&\^S:=J!TZ91&N\
MRAU3*C=@KEASD'':N1\]CXCTG6[.U>**]UY[87L^HLTTZYD1H_)"[1&-IP,Y
M&T'&:P=0_P"25>,_^QMD_P#2F*@#WBL_1]8M];LY+JU618X[B:W(D !W1NR-
MT)XRIQ[5H5XNMA;6W@G5O$-M-,-8M-?G^SR+,P\L_;<>6%SC#!CD8YW_ $H
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MCYLJ/F[8H ]%T/6+?7]$L]6M%D6WNXA+&LH 8 ^H!(S^-:%<G\,O^29^'?\
MKR2NLH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJAJ>KVNDFS^UEU%W<):QLJ%AYCG"@XZ9]>E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:H8X) 7!'KG)%=910!Y7KVEZGX>^&NM:-)$KZ=:W$']F3-(-QB,\9"/WRI)
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MB+75N'UE%Z2W$;!H=OLI9AGT1:;JWAC5-2G\;HD4<::SI\=M:2/(,;TC=3N
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M(2Q<QP1!%+'J< =: .,TWP[J^FZU?6C:/I-Y87%])>0ZE*P\V%9'+LA0J2S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]Y0ZE=V1SVQ65JGC"ZTW2/%EWHUM</=6.K1VLANKO>BEB@W(I!"K\P&T>N:
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MEV_CFXU*STY](T22\N;K3TU&6 W"Q^3$W"C<1\S$A@!@#Y3DBEA\=-J4\?\
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MN568=>!S@\4NG^.8=3N=/L;>PE.J3RR1WEFS@-8B/B1I#Z9*A?[VX8H O?\
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M9=W#"1G7&/;R_P!:YRT\?SZFNCQZ;H<EQ<ZII[7\<;7"HL:AE!#-C_:Z@'G
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M4X[QDG<HK(JN",@'!.X#IQG/:NDK(\2^)-/\)Z,^JZF9?LR.J'RDWMEC@<4
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M:2<A2J,% !5CD%LGU SG(TO"WA^_L/$<FH-H]GHMN]JT=S;V=R7BN9RRD2!
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MCRUN#(<'N=IZ5I>%M+U/1]6\00W5M%]CO-0DOH+E)LEMX4;"F,@C:><UU%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCZD@ Y]Z .EHKQZYCE3PGXD\2+J5^VJ:=KERMH?M<FV)5NL"+9G:00<8(/#
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MY4+M'MNZ5"_CN.Q35QK&E76GSZ;;1W1A+I*9HW+*FTJ<;BRE<'OCF@#KJ*X
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M9QW%Q]HN)XVM8'"^>?)8J#D@8!^;)Z8S0!U]%<E'XY1[-T.E7*ZNM_\ V?\
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M"U920(HR "H .,8 [=JQ(O'*O82E])N4U2/4/[-&GB1"S3%0XP^=NW8=V[L
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M7<N?,FA@5';)R>0.YH XKPMX*?1KG3[27PS9AK OG5C<[O, #!&1 <ASD9R
M!\V,\5;TOPMJMKX?\"6DL*";1YU>\ D!V 02IP>_+KTKOJ* /-]6\%7UY<:G
M=R6$-XO]NIJ,5H\P7[1%]F6%AG^%LEB,XY4>M6;7PM<J-&FMM"MM*6'6A>36
M\<X=A$('C#.<X+Y(X7.!CT-=I%>M)J=Q9FSND6%%<7#J!%)GLISDD=^!4EY>
MVUA )[N98HBZ1AFZ;G8*H_%B!^- '">(O"NL7T?BM[2WCD>]N["YM4,H7S1#
MY189_A/R$#-=7JNGMXB\)WFGW<!MI+ZT>)XV8,8F9<=1P2#W'I6O10!Y3<^#
MO%5SX2CN0D*>)KF[G>Z_>C:L<L)@.&[[5$3?5:['3= ETWQC)=0Q*NFIH]O8
MPG<,@QO(<8_W67FMX7MLU^]B)E-TD2S-%W",2 WT)5A^%3T >:Z1X.UFTO/A
M])-!&$T6*]6]Q(#L,D>U,>O/I6CX;L?%&BZ?I_AP:=:K8V3/')J#SAA- -VP
M(@PRN<KG/ P>N17<UFQ:U!]F:>\AGL%%T+1!=*%,C%@BE<$Y#$C']* .6L?#
M&J0>%O MB\2"?2+F"2['F#"JL$B'![\L.E:'CC0[[7%\.BQC5_L.N6M[/N<+
MB)"VXC/4\CBMNQUBWO\ 4]3L(ED$NG2I%,6 "DO&L@V\\C#CTYS6A0!P9T+4
MW\9PZA!HL>G3+>,]SJ5M=XCN[?# *\0.6<C;DL.",@]JU-=T_4K?Q1IOB'3+
M,7Q@MIK.XM1*L;E'9&#*6PN04Y!(X/M6B/$NG276D0P2-.NJ^8;:6, H0B[B
M2<^@XXK7H \\MO">L?:-*OIX8DG?Q!+JMW$LH(@1HGC50?XB!LSCN371^-M*
MN];\(WVGV**]S*8]BLP4'$BL>3[ UT%007MM<W%S!#,KRVKB.91U1BH8 _\
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M[=P9R2" P/& >:T* /,]5T/Q/+I?B_2[31XG77=UQ%</=(!$7@1&C8==P*$
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M9 )YYJ[0!B^$=%E\/>%-.TJ>19)X(OWKI]TN26;'MDG%;5%% !1110 4444
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MQ<O#Y7)QMV <>O-;FD6ITGQ=:S:A \[7][<+:ZQ:7Q=+C<)'$,T9Z;54@8R
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M%EN9GFE^S[3)(V6;:2!D]S@"NGJO8V%KIEE%9V4*PVT0PD:]%&<U8H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ K(\0ZZ-#M[7R[5[N\O+A;6UMU8+YDA!/+'[H"JQ)YZ5KUSWBK2
M;V_&E7VFK%)>Z7>BZ2&5]BS+L9&3=@X)5S@XZ@4 9EYX_P#[+TO5IM2TF6&^
MTN6W2XM8IA(&29@J.C8&X<GC .5(KJ-,N;VZT])]0L/L-PQ.;?SA*5&>/F'&
M<=A^M<-J?A/7-;M-=O;B"VMK[4IK$16HFWB*&WE#G<^ "QRYP!CH,UZ!<QR2
MVLT<4GER.C*C_P!TD<'\* .9LO%]U)J,5IJ.B2V'VJWEN+7?.K.PCP2LB ?N
MVPP.,GOSFLZ'XCS/X6MO$4OAZXCLKN6VBM5$ZM)*93M.%QQ@XQG[V<\5EZ+X
M+U:PO=&NAH6E6DEI;2VMY+#,&FNF= #,S[02-RYP23\Q]*U5\):F/A_X7T4B
M'[7IMS8RW'S_ "XB=6?!QSP#B@#1U#Q-K>GV23/X89I$MWN+I?MBA(@"<(K[
M<.Y SC@>]0R^-KFXO9[71M$DOVBL8+_>]PL*F.4,0.0?F^7@=^>1CFGXJ\*7
MVM>(+F;^S-.U&VN;!;6WDOFR+"0,^^01E3N)#+R,'* 9 YJ?PEX=U739[J?4
M(88FETFRL@J2[_GA$H8YP.#N4CZ^U $T?CA]1;3(]$TB6_EO-/34G1YUB\F%
MN%&3G+DY ' ^4\BH[+QY)J^GZ7)I.CO/>Z@MQ*MM-.(A%%#)Y;,[8."25 &#
MR?8FL+2]/U'P??:&B/I<M]_8$=E<6UQ>>3M\EL^:K;3N4%R".O0UG^'_  K+
MJGA?PYJ[Z18:YY4=Y');7>$5UDN"Z2H6! Z=^S]?4 ZV/QY+?W&GVNE:++<W
M=Y:2W CDG6(1-%((W1VP<8;(R,\@>N1%IWQ!FOHM(O'T&>#3=1NA9>>\ZEHY
M\LN-@'*[U*[LCUQBI]#\,W>G>(=+OC9Z?9V]OI4UM);V/RQQRR3))A1CD<-D
M\9/..:J6OA+4X?"N@:<PA\^QUD7LV'X\OSY'X..3AAQ0!H0>-6FO8'.ENNCW
M%ZUA#?\ GJ2TH8H"8\9"%U*@YSTX -5+?X@3SQ6E\V@RQZ7/J']GM=&X7<LA
ME,08)CE-P )R",G@XS5'1O [:5K$49\,Z',D5])<C5Y,&8QEV=0%VY\P$A<Y
MQA<^U6X_">IKX)L=)(A^TPZPMZ_S_+Y8O#-UQUV=O6@"]X2U_5]9UGQ%!?V4
M<5M8WYMX764,5Q'&=N,#.=Q;/OCM765QFG:=XAT34/%#6EA:7"7UV;ZTE>YV
MAF*1H8V7;D8V,<Y]*[.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *>H:3INK(
MB:EI]I>)&=R+<PK(%/J-P.*M(BQHJ(H5%&%51@ >@IU% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4OL^4[LXSDY(&0#C-7#XPM%UE+![#48X7NC9I?/$H@:8 _(#NW=B,[=I/>N
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MJ<X!(!P3C!Q0!K1^.-/2VU"74++4-,>QA2XD@NXE\QXW)5"H1F!RP*XSG/!
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MMZP\6KZ;-+J"F^D'G,BQ,"N#^[Y<_<V\<>M 'I]%>00:EJUQ!I.A_P#$UU*
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M5$0%F9C@ #J2:\LFC\0LWAK2;^ZU/3DN=7N81_IH>=[7R795>1&.2.5!)R,
M]>:[#QE9)'\-M;M5EN D&F2[7$[B0[(R1E\Y.=HSD\\YSDT :RZS8R:K!IL<
MV^XGM6NX]HRK1!E4L&Z=77\ZDNM0CM+JTMWBN':Z<HC10LZJ0,Y<@84>YKS;
M2]!AN?$7AFQ-WJ"6Y\-R2R%+R42/F2$[?,W;PN3G (Z =.*KV6KZH&\#0-J5
MXX;6;ZTF9IFS/'$TJH)#_'@*.OIF@#URD=UC1G=@JJ,EB< "O/\ P_\ ;--\
M5P0:U)JZ7UU).(KC[89K*^'S.JA,GRF5!D *OW3R:L_$_598- AT2S2XDO=:
ME^RA+9-\H@QF9U7OA,CZL* -[1+W0?$4G_"1:1-'=,T?V3[2A8?*K;MN#[G/
M3O6U7F/AC4X=&^(,NG6^E:AINE:S;JUO%>6YB N84VLJ<X^:,*?JE4+22^;P
MQX3\1G6]2%]JNKVPNT-VYBD1Y3F)8\[5  Q\H&0"#G- 'KM9VG:%IFDW%W<6
M5JL<]V^^>4L6>0]LEB3@9.!T&>*\X:ZU*VT3QQXA&J7\EWI]_=VUE$;AC% O
MR\["=I(W9&>!@8QSE+^;Q+X?TG5IK:RUBTM'M(HU-]J4=S*)VF2,O&QD;:2C
ML><*"H/% 'K-%>2ZL?$6C^&O$+PPZMI=G]GMFMFO-16YECG\X!RK"1F"LI7@
MG&0<=:U1H!;Q]<Z&=9UHZ=)I27CQ_P!HR[C/YK)N#[MRC'.U2%R!QQB@#T6B
MO'=-U;6M?M/#EI/%J^H+_8OVF7[!?BUDDE\S8'=RZ%L!>F2,MD@UK:79ZQK/
MB*TTOQ#?ZC T>@Q27$%M>&+?-YTBART3=2 "=IP>,],4 >D27$$4L44DT:23
M$K$C, 7(!) '?@$_A4E>/Z;'+KE[\-[G4+V^EG=+Q))%NY$+^4K;6.TCDXY/
M\0X.17L% '.7OCSPUI^H7%C<ZB5N;=MDJ+;ROL; ."54CH16SIVHVNK6$5]9
M2&2WESL<HRYP2#PP!Z@UP.B?\)+_ ,)/XP_L4:28/[5&_P"VF3=N\B+IMXQC
M%7M;CU*^\5>%=,OKZ:W6YMKQKV/3[B2))2HB( 8$,,$]>#U'<T =U17D$*W]
MIX<_M;^VM5ENM/\ $0L(/,O'*FW%X(MCKG#Y4GYF!;ISQ4VH+>3:)XZUO^W-
M2CN]'OK@V*QW;K'#Y<:.%* [6!)QA@1@\8YH ZRQTSPD/&MU;VM@BZS:*+QQ
MAMB&3(WJ"=@8\Y(&>:ZVO']7UF\TSQ3XVU>T'EWD?AVVE0XSY;'=SCVSG\*W
M;W2)M*U[2-'L=:U4QZS9W<%Q)+?22L'6,,LZ%F.Q@3_#@<CB@#J(O"&@0ZO_
M &I'ID2W?FF8-EMHD/5PF=H8Y/S 9YK;KS32O$&I>(6\-:69YHK^Q,T^M"*0
MJQ:W)B",1U$DA#8[A36?X:O?$TEEI/B%+'57^T6\EQ?S7.H));S*T3.OEP^8
M2F'" !5!VYS0!ZW17F?@G_A(9KO0M1>UU;[/>VIDU&XO-1CFBF+1AU>.,2'9
M\V  JCY6YZ5K>,DNKWQ=X5TJ/4;RSM;PW8N1:SM$TBK&& R#QR.O49.,4 =M
M17E%T_B.^U36I-+L]7GN=.ODMK*5-22.WC5$C)62-I!O+Y)9F4GYA@\4S4!>
MOH'C;7O[<U)+S2-0N#8JEVZQQ"-58(4!VL#G&&!&#QB@#UJBO.8)+V[\8^*K
M^:^OC'I,%M<6MBEPZQ>8UN6.Y0>1D=.F23UK-T.+Q;=6%I=6*:G;R7^ERFXO
MK_48YH7F>+=%*D8=O+P^.%4 *>1Q0!ZQ17D5UJ5[I6FSZ9#'XAM-4N)[*&:S
MN;\3,4>4JTEO.S'!?!7.5P<' -372^(;.".S8ZMI-C<:S91VWGZ@L\ZH^X2I
MO#N=O (#$\M[4 >IW%Q#:6TMQ<S1PP1*7DDD8*J*!DDD\ "I*\=\76KVGA[X
MA:0M]J$EE:6=K<P+->2R,C.'#KO9BQ4[ =I)')K9\165UHMV;J>;7GT.VM$\
MN[L=1=I+%@S,\DL;-F52"O)WX"D8Q0!W^GZ=::59BTLH1# '=P@)/S.Q9CSZ
MLQ/XU:KG_&%XEOX<8":]1[F6*"+[ P6:1G< (C$@+NZ;LC ).>*X%[W5H+34
MM+CNM1T[R==TZ&)9+TW$T"2F/<OF$L6!R3@D]<=* /7JI'5+4:VND%V^V-;F
MY"[3CRPP4G/U(XKS;7+F^\-S>*-,T[4[\0&#3FBDGNGF>W:>=H9&5W)(^4 ]
M>#R,5LZ9I46D?%A+:"ZNYHCH3L$NKAYV0^>@)#.2V#CIG&0<4 =[17 >+M;O
M?#.O7MPL\K0WVC2"TA+DJ+N-P%"CH"WG+TZ[*S--U'48+C2?#-UJMT]QI>HW
M,M_=-*QDDMH4$B;SU(/GP@YZX- 'J5%>4Z'?7T.M:5)&VLI;:II]U,TNHWPD
M-SA4=)%B#$1$9Z+CAL8XJI NIQ?"_P /:FNO:H=3U:ZTY)KE[IV*JT@7"@G
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MB/2I]1AL([K_ $B<.T&Z-U68+][8Y&U\=?E)XYK4H Q-3\*:3J^IKJ%U%/\
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MBQ9G'SXDRJ\9^^I9,=?FKK_!NE3:3X9MDO!_I]P6N[P^L\I+O^1.WZ 5?O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CN+B&TMI;FXE6*")"
M\DCG 50,DD^F*P[GQMH-E8V5U=WCP+>Q>=!&T#F1H_[Q0 L!R.2!UK/^)!,O
MAZRL&.(-0U6SM)_>-YEW#\0,?C5W7]0M])OX3I^GQWGB*]A,%K&!@^6IR2[?
MPQ*6R3ZG R2* +\/B+2[B\L;:&Z5S?P&>TD7F.=1C.UNA(!!QUQSV-:E><>(
M-$'A7X>:'''-YMWI.HVDB2@;=SO.%D '8$2.,>AKT>@ HHHH **** ,+6?&.
M@>'KDV^JWXMI!'YA!B=@%YYR%([&J\7C[PW<6DMS;W[2Q1&,.5@D&/,=47JH
MSEF%+\0O^2<>)/\ L&S_ /H!K&\9(TGPGMT20QNQT\*X )4^?#SS0!WM%>6>
M(;J_\)7OB"UTN_U"5'TB&X07-TT[1RM.8F=#(3MX.<?=R!70>$K;6;/6[N.>
MQU2UTI[9&1=2U!+IQ.&(8J1([ ,I&0>,KQC- '9US3?$'PHEX;9M:@W"3RC)
MM;R@^<;3+C9G/O5GQFUTG@?7FL=PNAI\YB*?>W;#C'O4&DP:$?AY9Q,MJ=".
MG)N#X\LQ;,DM^&2: .CHKSP6Z^(];\11_P!JWMK9Z7!;QZ>+&[>%(PT(D\W"
M$!^6P-V1A>E4-$GO_&.JZ4FI:EJ$$-QX9M[N6*TN7@#3-(PWY0@CUXZ\9R!0
M!ZE17DWA^;44TSP'KDVKZC<7NI7(MKL2W+&*6,PRD#R\[01L4[@,DY))S4=H
M]_!X*L_%7]MZG-J*:N(1&]V[1/$;TPF(QYVGY3U(W XP< 4 >NT5Y9<:E=#Q
M'::I8R:P\$VNBR-U/>!;9TWF-XD@#8*@@X;:#E2<U YOT\,W?B,ZQJ;7MKXA
M>&%3=OY0A^W>48S'G:PVD]02. , "@#UJBO,M3UO5-%_X2;PXMW/)J5U/&VC
M2R2%G"71V8!/.(G$A]@!7H]I;_9+*"V\V27RHUC\R5BSO@8RQ/))[F@":J6G
MZI:ZH;L6KLWV2X:VERI&)%P2/?J.:XOQ5]ML/$,VIZA)K"Z0BP^3=Z;=X6R(
M/SF:'(#J>"6(?CL,5@7MK-;:!XVUZWU*_@N[#6)I+98+EHXU(\LG<@.'ST.X
M'CIB@#V"L.?Q;I%O-KL4DSA]#A6>^ C/R(R%P1_>^4'I7$>+=3NDU#5=4TZ3
M6'.G7=M"9Q>"*U@;,>Z/RMW[W(?DE3RV >*IZO\ \A7XQ_\ 8*M__25Z /6+
M*\AU"PMKVW8M!<1++&2,$JP!''T-3UC>$?\ D2]"_P"P=;_^BUK&\7N;S6-/
MTN%=7N)O(EN&M=/NQ:C:"JAY)=RG@G 4$Y))(XH [*J6E:I:ZSIZ7UD[/ [N
M@+*5.4<HW!]U-><>&+J]\77FC6FIZG?K%%H,=V3;73PM-,TKIO9D(W8$8X/&
M6/%5/"PFO].\'Z%)?W265P=3N+A[:=H&N&CG(4;T(('[PM@$=!0!ZEI^J6NI
MM>"U=F-I<-;394C$B@$CW^\.:35]9T_0;!K[4[D6]LK*A<J3\S' & ">37-?
M#J$V\'B.$W$EQY>N7""21MS$!4')[GL3WQ1\3?/_ .$9L_LWE^?_ &M8^7YF
M=N[STQG'.,]<4 :FF^-/#^L7\=C8WYEN),[4\B1<X!)Y*@= :WZP]*/BK[:/
M[771A:[3_P >AE+[NWWAC%><:3#J,WASP-J3Z_K!N]6NA:WCF]<AX6CE; 4G
M"M\@^<#=G)SF@#V.L_6]9LO#VC7.K:B[):6RAI&52Q ) Z#KR17FEU-J%K<3
MZ';ZSJ,5O%XIMK2.5KIVE$,EN':/>Q)(RQQDG''H*J>-A-IWAGX@:&MW=W-C
M;V=G<0"ZG:9HFD<AEWN2Q'R X)XR: /9$=9(U=?NL 1]*=7 PVLGB7Q1JUC=
MZCJ%K;:;96HMH[.[>##2(S-*=A&X\  '(^4\<UEZ%XJOK&/P]K^M7LK:=JVE
M-'<%F.R.XA#.) .B[T#YQC)44 >I45Y)%-K]RVA65]%K%Z^H6MSJUS;6=_\
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M_P"$CTO<X$\A"1R2;A;R%65" Y5MN&P2.F:6/Q%I4KV*)=@F^MS=6QV-B6,
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M-U+3Y+8FUU*5IKI/,;YW;&3G.1]T=*LZ;J]CJZ3-93ES!(8ID9&1XW'.UE8
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MMKJ2 RQ?W'V,-R\GKZGUK)\4^&9=>ATWPU%I=M%H,,D,LTYD VI&>(HT'.2
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M,IEL5D7S#%)'LW9)VEU/. >A(!)ZXVI^&M5F_M._M]/E9]0URQO!:B2,&.*
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M-9WT6GQ0C+*3#/&J[7!4D<.H/!KLJ* .%UO1]:U+X7ZG;260EU[4X-\T$;J
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M[I2EW*&$KYW-G=GG<<CH<UI6=C;:?9I:6D0B@7.%!.<DDDD]22223U).: .
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MD,]PZ/ND#.AVJI7Y5[YY..E:_A#1UTW[=.OA^'1O/9 L8G$LCJH/+D$J.6;
M!/% $VM^)VTG6;#2;?3+B_O;Z&66%(F55_=E<[F8@ 8?.?;'4BLMOB)!]GT\
M1:/>RWUY=3V7V(% \=Q$"61CG;CC[V<8YJ/Q+/?6WQ)\/36%E]L==.O=\ D5
M&9=T'W2W&<XZD<9YJGI7A368]:T35;JWCC?^UK[4;N)90WD+-$R(N?XB/ESC
MOF@#7O/&LUO+>I;Z#>78TV))-1,4L8\@LF\HN6_>,%.3CCD<\U)/XVA:\$.E
MZ;=:G$EG'?7$T!0"*&3)3 8@LQ"D[1S@?A6=>Z9X@TR_\2QZ7ID=]!K9$L,Q
MN%C%O(8EB;S >2ORAAM!/)&*H66GWW@[5KBST_[%>A]%M(I&ENEB:V,"O&)7
M4\F,CG(YRI% &I;_ !#2_?2(=.T6\NKC5+$7T4:NB[(]P4[F) &,Y_(=ZT5\
M62+K,%I<Z+>VUG<W3V=O>3%0))5#'[F=P5MC;6QSQV(KF?AWHM\J^%=7:("S
M3PT+8L2 =[2(XXZXV@G-5H/">MQZGIU[+H<4M_9:JUS<ZB]TK274;,X&S)^5
M0K@E3C&T  T ;0^)"?9[>]_L#46L)KQK!9U:,DSAV15"[LD%EQNX )^M;N@^
M(6UB[U&QN=/FL+ZP=!-#(ZN"KKN1@RD@@C/T(KG+?PKJL?A+1]/:%/M%KKPO
MI5\P8$7VIY,Y[G:P.*NW::CX=U/Q;XB2S2XCE@M6MHC*%,IC5@P[X//''- '
M95P6D#7O&EK/K4?B*ZTFR>>6.PM[.&)OD1R@>0NK%BQ4G P ,5WM<)IEMXF\
M'QW.DV&B1:OIOGR36,J7B0M$LC%S'(&]&8X9<\8XH T3K^JZ3#IFDWMFFJ^(
M;B.1V2R81QF-" 96+XVYW)QS\QP..:B/CZW:VT\Q:7>R7EY>36!M 4#Q3QJQ
M96.=N/E^\#C!!JLVF>)K'5M)\030P:K?I:3VE[;VSK"%6219%\LO@$+LV\D$
MCGKQ5?3?"FKQ:EH^HW,,22G6;O4KR)) P@66%T10?XB,H#COGM0!.WQ',=G=
MW4WAZ_CATZY^S:DQDC(MFR!Q\W[P896..QJQJ'CPV=UK4<&A7UW%HKC[=-&\
M8"H8UDW*&(+'!/ ]/<9HZCX5U6X\+^-+&.%#/JNH-/:J9  R%(ADGMRC=:SV
M_MR?4_'^GZ5I:78OKI8%E,ZQB!VM(E+.#R5P0?ER>#Q0!T^K>,_[-C>[BT>]
MN]+@MTN;B^3:J)&W.5#$%R ,D#H,=^*@U/QV;&ZUJ*WT.]O8]%VO>RQO&JK&
M8EDRNXC<=I/ _N^XSRVO> ]5N[74],32X=1WZ?%;:=>W%P EJ$A"LH0G(8L"
M00,?,,GBN@30=5N-/\:M):"&;68%%M$TJD[OLBQE20<##@C/XT ;NG>)[/4-
M4U"QVO"UI##<B20@++#(I(=?8$,#Z$58\/ZPGB#0;35H[>6"*Z3S(TEQNV9.
MUCCU&#]#7 >,M&O$_P"$7M+&9(=3U"V.B7:*WS&V9 TCC']S82#_ +7O7IUO
M!%:VT5O @2&) B(.BJ!@#\J ..OOB)'8KJ5P=%OI-/TN]^R7MTC)B,Y4;E7.
MY_O D < ]ZO6_C!S=ZC:7NB7]K=6EF+Y(%V3//$2P&T(3\^5QM]QS6/?>%=5
MG\*>++".%#<:CJK75LOF##1DQ')/;[C<&I_%/A[6M0UG5+S2R$,VB"TB<3;&
M,@F+%0>JY4XW=LT 3W'CPZ=:W[ZKHEW9S6,<%Q-"9$D_<2.4\P%3CY2K;AU&
M.];D^NPQ>(['18XGFGNK>2Y9T(VQ1H5 9OJS #'O7(Z'X5>'7=2DN/#L&FZ-
MJ6F"UEA6=&92K/N\S!Y+!^H)X7DTOPLL;N2PN=8OYUN7(73;.<<B2UMR55P?
M]MM[>_% &]XWU2#2-%M[BXDOD1[V"(&RE$;Y9P "3_#ZCN*IZGX\-A<:VD&A
MWMW%HC WTT;QJ%0QK)N7<06.UCP/[ON,R_$'0[[Q!H%M::?&LDT>H6\[!G"_
M(C@L<GVJM=>'=1ELO'L21(6UA6%G\X^?-HD7/I\RD<T 6]0\9^1=SP:;H]YJ
MJVMNES=O;%!Y2."5 #$%W*@G:.V.Y K$E\4SZ?X[\27,LMS+IECH$=^MKDCD
M;F)"GHQ QS4\6F^)?#NH7UQI6EPWYU&SME!>X6,6T\4?E_.#RR8VGY<G@\<Y
MJ+4?"&L:EK_B:>3R FI^'QI\<P;"F?# _+R0N6H ZBZ\2VMG>Z9;S1NJW]M-
M<B0D;8UC56;=^#]O2N7D\7W^JZMX0>/3K[3K+4;UGC=Y$(N(?L\K ,%)*G[C
M;3_2D;1?$&OW^DG4=+73;:UTVZLI2;A)&+RQHNX!3]WY>._J!W;8Z3XGN6\'
MVM]I$5M!H<H%S,+I7\[%N\0= .=O/0X/S#C@F@#<TSQI'J-Y8@Z9<P:?J3O'
M87KLA6=E#-]T'*AE5F7/4#M3_B#JEWHW@74]0L+DVUS"J;)@JG9F103A@1T)
MZBN=\(^"WT2[TRUG\,VJOIVX-JQN=WF@*51D0'(8@C.X #G&>*Z7QYI5YK?@
MK4=.T^)9;J94\N-F"AL.K$9/ X!H R-$O+*YUFVBM_B:=5E+$BR$MFWG  DC
M"1AN@)X/:A/B2KVME>C0-1-A=W3644ZM&2TX9E"A=V<%E(W' !Z\<UH6%[K1
MOX!)X*CM(RX#W"WL+&,'J<#D\=A65:>%=5A\)>'=/>%!<6.M"\G7S!A8O/D?
M(/?AAQ0!<E^(,=G:WC7^CWD%Y9WL%G+:*R2,3-CRV4@X8'=T]1BJ7B3Q?=OX
M4\56QL[K1]8T_3S<H#*K$HP8+(CH2.JL#Z$5G^,-+U*SU'4-1CBB(O=;T@VF
M]\!V1E4AL9(&[VJSK/A[7O$D/BB^ETT64]YI"Z;9VKSHS.078LS*2H!+@#GM
MSB@#7MO%5S';:9IUGIMSJVI-ID-Y<;)40(C# +,Y&68AL#V.<5;T?QK8:UJ%
MA:P0SQK?V37=O)* -Q1]DD9'9U)&165:Z5KGAW5(-1L]+&HBXTFVL[B!+A(V
MBEAW8.6(!4[R#@Y&.AS6+KNC7_A;X?Z'<02P'Q'I][OMU4\32W,C"2)>Y'[T
M]OX : .G'CF.Y;R=.TNYO+F2\GM;:-71!,(<"27<3@(&.WU)QQS3U\;+=06*
M:=I5U=:C=>=NLBZ1M!Y+;)=[$X&'(48SDD8XYK&U3P(MM8>&4ATQ=7BTB"6W
MFMC,(GE\P(6D5B0-V],D$C.XU6N?!++_ &1?_P#"+6LR117$4^E076#'YCJZ
MNKL0&8;<-S_$<9Q0!WNC:M!KFD0:C;I(B2@@QR##(RDJRM[A@0?I5^LKPWI_
M]EZ!:VOV&WL64,S6UNY=(RS%B QZ\GD^N:U: "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKQO4CJ5Q;W7@ZRNITO=.O[V
M]C97.\PI'YT )[C?/$O_   B@#UG4KXZ=I\MVMG=7ACQ^XM4#2-D@< D#C.>
MO0&HK_6['3X[XRR[I+*T-Y-"G+B+YL''OL8#Z5Y)XNUB77?!?C#Q/9W,R6WE
M6%I9E)",#?'+(1CN3-M)_P!FM76M+L_^$O\ '-WY1\^/PZLBMO;AF2=6.,XZ
M 4 >GV=U'?6-O=Q!A'/&LJAA@X89&?SJ/3;XZC9+<M9W5H2S+Y-T@5Q@D9(!
M/!QD<]#7 :/ID.BZ[X(ELY)Q+J%E*EXSS,WGXA5P6!.."., 8' XKG_"PEU;
MP[X(M;JZN3'<ZOJ"3[9F5I$59SM)!SCY0/I0![517(>!XEL;SQ/ID+/]CL]4
MV6\;N6\I6@B<J"23C<S''O60;9M,\9#4=0ADNH;K4_+MM5M+XDQ%OD6WEB)Q
MM!RO&><$@'F@#T:BO*[&^E_X5]X*9KE_-FUJ",DN=S_OGRI]>!T]JO>'K&PU
M&W'B/5-2N+75O[9FB,WVDK@K.T:6VTG;M*A1MQDYSUYH [;1M7M]=TT7UJLB
MQ&66+$@ .8Y&1NA/&5./:M"O'+'3(;/P?IVO0O.NHKXB\M91,P"QM?M&R!<X
MVD$Y&.22:]!\:6%SJ6C16UI)"9#<QL;::X:%;M5R3#O7D9 )Z'[O/&: .BK)
MU/Q#9Z5K&D:9<),9]4D>* HH*@HNX[CGCCTS7FS2R7][I&A6FCW+V\<EZ;G2
MKS4BBK,GE$()%W;T"REE7WSQMQ4C07UOK?PZM]1D1Y8M1OT79<>?MC"OL0R<
M;BJX4GKE: ._L/%%IJ?B&^T>TM;R1K%O+N+KRP(4? .S).2<'L,>]:-Y?&TF
MM8Q9W5Q]HE\LM @81<9W/DC"^XS7F_@G2X=+UOQK=Z7IAN;RUU,Q6\/V@IE2
MB9&YB1W)R:N^*M0U.6_\$/>6CZ;-)K822W6X$@*[&QEEX(/I0!Z!=6MO?6DU
MI=0I-;S(8Y(W&5=2,$$>E2JH10J@!0, #L*\@O+)1X8\1:^9[DZE9>()A:S>
M>X\A1=*-JC.,$$YXYS[#&U+;-IOC+^TK^&2Z@N=36.WU2TOCN@+81;>6(G&S
M=E>,]<D \T >C45Y79WLH^'GA!FN7\V77H8R2YW/_I+Y7WX!X]J+".UM],\;
M:_?SZ@\UOJ-[;0M!<%7AC) VQ@G:K%F^\1QQZ4 >J45XKJHO-&L?%VGQ6ZZ6
M%T:"X%O;Z@]SLD,KKO+,HVN0!D#.< Y-;6OPOX1UO4FT1[A))/#-[=.'F:3S
M)XFCV2'<3EAO;GO0!ZA17F&LV5CX8\(7.HZ)JES%J-QI#-L-V6^T#Y-UP=V3
MN7=G>.F[G/%:_A'2]0TOQ%.IL8-.T^2S4FU34FNBTH;B7#*",@D$]R!0!W%%
M>?7&D6.O?$?Q#::I-,UO#IUH\< N&15),H,F 1R,#GMFL#PW'+XJU7PG'K-Q
M<S1/X=>>5/.9//99D"L^"">H;W- 'L%%>0ZA'YO@SQ)XK>><:_9ZE<"WE$[@
MPF*?9'$%SC:5"@KCG>?6H_$,$=YX4\?:[=7ES#J=G=SVT$JW#KY,:J@2, '&
M&#<\<E\]<4 >Q45YY86<%[\2=?NK^6=X=,M;&>&(2L$1RDA+[0<$X7OZFL;0
M7EM]?T"Z@M9+6#5[&ZF,D^I-/<7:;%=7E3:%5AD$8)QDCB@#URBO&M'T:&32
M?AW<M<WIN-57R;Z3[5)F>+[.[[&Y^[E%'';ZUVG@4)8_\)%IZR,MI9ZR\-LD
MDA;RU,<3; 2>FYFP/>@#L:J:EI6GZQ:?9=2LX+NWW!_*G0.N1T.#5NB@!$18
MT5$4*JC 4#  ]*6BB@ HHHH **** "BBB@ HHHH **** "BBB@"![.VDO8KQ
MX(VN8D:..4CYE5B"P!]#M7\A4]%% !69JGAW1=;DBDU72;*]>+_5M<0*Y4>@
MR.GM6G10 BJJ*%50JJ,  8 %+110 4444 %%%% !1110 5!!9VUM-<3001QR
M7+B29E&#(P4*"?4X4#\*GHH **** *4>D:;%JTNJI8VZZA*@22Z$8\QE&, M
MUQP/R%7:** "BBB@"MJ&G66K6,EEJ%K%=6LF-\,RAE;!!&0?< U-##%;01P0
M1)%#&H5(T4*J@=  .@I]% !1110 4444 %%%% !1110 4444 075G;7J1I=0
M),L<JS('&=KJ<JP]P0"*GHHH *I3:1IMQJD&IS6-O)?0*4AN'C!>,'LIZCJ?
MSJ[10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 52CTC3XM8FU=+2)=0FB$,EP!\S(#D*?:KM% &,OA305T!]
M!72X!I;MN:U (0G=NS_WT :?>^&=&U'4?[0N[".2[\AK8RY(+1,""IP<$89N
MOK6M10!3_LJQ$ME)]F3?8J5MC_SR!7:0/PXJO:>'-'L([..UL(HDLI7FMPN?
MW;N&#$?4,WYUJ44 5[:PM;2>ZFMX5CDNI!+.PZN^T+D_@H'X5GCPKH:ZS_:P
MTZ(7OF>;YF3C?C&_;G;NQ_%C/O6Q10!@P^"_#D%Z;R+28%G\[[0&&<+)NW;E
M&<+SR<8SWJ7_ (130O[:_MC^S(/M^_S?-P?OXQOV]-V/XL9]ZV:* ,X:%I8T
M]+ 64?V5)_M"Q<X$GF>9N^N_YOK4NIZ38ZS9FTU"V2>'<'"MD%6'0@CD$>HJ
MY10!B/X0T"33(M.;3(OLT4AEC +!E<YRV\'=N.3DYR:GC\.Z/$--$>GP(--+
M&S"C'DEA@D?4=:U** *EGI=EI\]W-:6Z127<OG7#+UD? &3[X I+W2['49K2
M:[MDFDLY?.MV;_EF^,;A[X)JY10!G/H6EO8W-DUE&;:YF,\T?.'D+;RQ]]PS
M4'_"*Z'_ &S_ &M_9T7VWS/-\S)QOQC?MSMW8_BQFMBB@#!B\%^'(;XWD>DP
M+.9Q<!N<+)NW;E&<*=P!.,9[U>_L/2_L5]9FRB-M?.\EU$1D2L_WB?K6A10!
M@+X(\-K$T8TJ'#1-"Y+,2Z$@D,2<MT'7.,5JR:=9RWZWTENC7*PM )",GRV(
M++]"57\JM44 8FG>$/#^DFX-EI5O%]HC,,@P6!C/5 #G"_[(P/:I](\.:1H)
ME.F6*6[2@*[ EF*CHN220!DX'09K4HH Y*Y\$VFJ^+-5U+5K:&XM+FVMX80'
M974IYF\'&/E.]>,D''(XKH(M(T^"\@NX;2*.>"W^RQ,@QLBR#L Z 94?E5VB
M@#%F\):#<:M_:<NF0M=^8LI<YPSKT<KG:6&!@D9X%<KXH\"W^NZCJ:I8:)Y.
MHJL9U!FD6>%-H5LQA2LCXSM;*D9QVKT2B@"I!IEE;7EQ=Q6Z+<7*(DTG=U0$
M*#],G\ZR[7P5X<LGB>VTF&)XI/,C92V4.", YX7#'Y>G/2M^B@#/BT/3((=.
MABLXUCTW_CS49_<_*4X_X"2/QIKZ!I4GF[[*(^;=K>OG/S3KMVO]1M7\JTJ*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BFNZQQM([!44$LS'  '<URWA#Q9<^)]1UA7M%@L[=HFLVYWRQ.
MI(=L]-V-P'H1GF@#JZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
MG5]'NM3FA>WUW4=-$8(9+018D_WMZ,?RQ6M10!B>+-(OM=T&33K&ZAMS,Z^<
M9D9EDB!RR$*0<,.#@]":P_"EAXAM?&GB"75/L7V:2.W :WM9(UD94P-A9B,
M9!'/..E=O10!DZAH]U>ZI!=PZ[J-G%%MW6L B\N7!R=VY"W/0X(X%:U%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>exhibit1060-kumaremploym005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ%HFDLRZCK%A:,NTE9[A$(W9V\$]]K8^A]*X74+&U.H_$^0V\1=M-B!)4?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
MKQI( )$5P#D!AGFG5Y;::[KVE#Q9=-?PWDQUR/3K2&6$A$DD$"*Q(;A0&Y4=
M2"<\T >HLJNI5@&4\$$9!H"J%"A0 .@ Z5R^DZEJ]GXN?P_JUW!?"2Q^VP7,
M<'DL,.$=&7<0?O*0?K3;_4=:U+Q;<Z'H]Y;V$=E9QW$\\MOYS.\C.$0#<
MA)/7D=* .JP.>!SU]ZRHM"AC\1WVL-)O-W;06YA91M7RV<@_CYGZ5QEOXO\
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M9P2I&1GBU?:OXJ%_KUA:ZE8H=&T^"Y:=[,DSR,CDC;OPJDH?4C/% '?B-
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M\(F_=8[98%%SY0);RF5ONY[[?6M6T\7:!?6EY<V^J0/%9Q>=<$Y4QQX)WD$
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M?##!!#(XR.H]P>AR* .5T#4+/5/BKJ]Y8HWDOH]M^^,903$2RC<,@$CHN?\
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MXC17>(.-RJV0"1U .#@^QJ6@!D/^IC_W13Z** "BBB@ HHHH **** "BBB@
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M&.9=)NM3U/XGPW)U%H[670(+LV@C4J-[L"N>O49SU[=*Z1O"\#?\)#_I,O\
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MC+;6)Z+D<]^>",<T]+\3:]XGUW1H+*[AT^UNM#@U2X_<"1MYD(9%ST!Z9.<
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MKC#=0.>E7O!6@R^&_"=EI]S(9;W:9;N4G)>9SN<Y[\G&?0"IKKPY#=>+M/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(]_=@]1+*=Q7_@(*K_P&@"_K'B+2]!\D:C<-&TVXQI'"\K,%QN.U 3@9&3C
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MQHT)(7DC )^E;-<I\-4>+X=Z+#+&\<L<&UXY%*LIR>"#R*ZN@ HHHH ****
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MK!@"I&1PV#4-YXST'3[9[BYO2D2WK6!/DN?WZJ6*  9)PIQC@]!R: -A;?\
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M[$$8(7;@9Z$]2:;XC\-P^(8;4_:[FQO+.;S[6[MB!)$V"#U!!!!(((P:VJ*
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MKA--)0PQR,=Q(.W=MW'=MW8S2+X&L3X0?PY-=W<MN96GCGW*DT4AD,H964
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M5VD$]>E8&G^"(+;29M)O]4O]4T]K=K6*"[9,11$8P"J@L<<;F)('3'.>IHH
MYZV\*1H+7[5J%U=O96SVUI)(%#1*ZA2Q( R^ !N^O')J"Z\#V>HQW_\ :-U/
M<3WNGG3I+@*B.8NN3@8+Y[XQQP!SGJ** (+*W>TLXH)+F6Y=%P9I0H9_<[0!
M^0J>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\[=Y9V#:I"G.#@"@#<TWQ=8)X6M-6U+5K2X2>5XDFM()%69P[ *D9W.2-I!
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MD(P.3\YC/_ :Y>W\-WFF:[I'A<6\SV%V;*_NYPI,?F6Z-Y@8],L\=O\ 7)H
MZG4/'5KHFG:S?WEW!>I9Z@MHD5K!(K1L=N$<G(+#).X8'0=:0?$'3[;7]3M]
M0N%BL(;6VN+9EMY#(PD#EV90"0HVKR0,9YZUQ]]87H\,_$,_8[DEO$$5PBK$
MQ+QK)"S,HQE@ I/'I76::%O_ !5XKU&&&1K>ZTRS$$KPLN\;9L@;@#W&1]*
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MTT_,UQ<#"M 6DC;:!@'L#G.<"J#:7?\ BCP7X7T'2[>:VU*QTS=<7D\<D0A
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M\MG/7@ \9%:YLM9_X2[Q6++7I;66VT^S=[@6\3O/($EQN!7:%X.0H&<\$8Y
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M4%W;@!R>.>*RU\;Z#)8?;8[BXDA:;R(O+M)6:=\;L1J%S(, \J".#SQ0 ?\
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ML3LWG$*0BJ!ER0ZX"@]?K6-J7Q'T>RM+&X@CN[D7-^+)XUM)A)"_!8.FPL&
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M(^,[#(%*[\$?+G-69?%NC0ZS_9;W$HN!*L#.+>0Q+*P!6,RA=@8@C@G/(]:
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MN&XBC#L&,IF*L[N<<L67/&.IK*T;X@63275OJT[),FJSV2/';2&) )BD:O(
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MBL5\L)'+YHD.#MW%=V?E)P,_3&@_C"T3QNWAEK>Y$JVHN&G\B38,D\$[=H7
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M@SE5(5<,/F/'7T.)]3\7Z)I%PL%W=/N\I9G:*!Y4BC8X#R,H(13@\L0.#Z4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%LRQ2S1RI^XEW#[A*\@=0,C(Z^S7E_:Z?'')=S+$DLJ0H6_B=R%5?J20*L4
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MQD$5H>(M0?5+/3=7M]#OXK.T\06\SR?9'\Z>)4*F8Q!=^ 2%&1G SC%>CT4
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M0C^Q^0WFF(6WDXVXSCSB7SZ<U[)535-4L=%TZ;4-1N4MK2$ R2OT7) 'ZD4
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MGM0!P?P_T:^\)7-UH6HPO<231QW,>IHCLD@"JAA9CG!3&%!/*D=P:T5LI_\
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M&L+:!YURS;%F!7<.&8?+G'<BL'P_;W6D7O@N6^TN^:-O#9L'5;9VV3%H2$?
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M:3 )4NBL B>-F,;!3E3RQ48;.>M>C2)I/A@:IK%S.;>.]G26XDD)*A]J1+C
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M1QN&-H<8'(&,J"0>07S:SK=E+?>'EUBXDD.O6VGQ:A(D9FCAEA65NBA2P^8
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M63P\MT\ \O\ =_OUS#RA.S/7^+/\0KJKGP3:2NK6NIZG8;K6.TN!:RJOVB-
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MB>(27$88L ^8RN06.&4 C/6M6WT'3K;PZ-!B@QIPMS;>5N/*$8.3UR<GGWH
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M#-@FU?1O%EE8SZS<7T-_I=Q<.DL<86&6(QX,>U00N)",$GH.37/:7K_B'4?
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MKE2%)[\8^8X'3#1JOB%M-\J6^U::RL=4O+.[O=.MXY+HHA'E%EVD$<G<57/
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M6BZ5;Z%HMEI5JTC6]G"L,9D(+%5&!D@#G\*H0^$M+A\2ZCKP$K76H0>1-&S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#[:]JYB2!Q:2?Z2\@)"1#'SL,$''3!STJ5_&VCKIT5V/M3/+<FT6T6V<W'G
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M4,/F X]QD9'-5(_B+H,LD$:"_8W47FV>+*3_ $L#&1%Q\Y&1G';GH,UC:O\
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MB2>8RC'F$ ;R.G4YQTH [RBN!NSJ7A?7K"R76KZ_BU&PNS)]K96*2Q(K+(A
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MO8^1';2V<-R1%/&@P%<')Z<$@@D=<TZ^\#:5?W=U))+>QVU[();RRBG*P7#
M 9=<=PH!P1G'.:T[K6K".U)-]';F2V:XCED0[508^<YP,#*]2.H]:Q3K=\NL
M^$+:*_@N[/4[:5YIU@V^<5B#*Z\_*#G./UH LZMX(TO6+ZXN9I;V%;M%CO(+
M><I'=*O $@'7CCC!(X/%+<^"-'N9M9E83I)JWV<SM')MV-!CRF3^Z00#]13O
M"&JWNJV6I-?R1O+;:G<VJM&FP;(W*KQD]AZUEZ+XWM4OM4L=>U6SBN8]6DL[
M9=OE@H%3:#R<$DD9)Y/2@"U)\/M(GBU%+B>_G.I6RV]X\EQEI=K%D<G'#KG
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MAD9;%K2WMH+;>2L?E[\D \#(9![[>:LC6+!KY;,7&9F=HU^1MK.H)90V-I(
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M6U[YWV>3S/)D:*0@$8<<$<^E5KG7M+M+G[/<7D<;B18F)!VH[8VJS8VJQR,
MD$Y'J* &2:!8S7>G7,BNSZ?#)#""?E*NJJP8=^%%9^F>"-,TN[LYHY[Z>*QW
M?8K:XN"\5KD%?D'7A20,DX!XQ5 >-;;2_%.OV6O:G:6UI:O;BUW+LP'0EMQR
M>^/FX'3IFK[ZU=1^/H]-:>#^S'TF2\^[@AED1<EL],,?2@!G_"":.-+EL8VN
MH@VH-J231S8EBG8Y+(V..I&"",$U'+\/=%N-*U?3[B2]F35_+-Y+)/NDD*8P
M=V.#P/;L,"M#2]:M?["LKJ?5X;_[2S)%<P1%1<-EN$09)P%/3/W2:EB\3Z)<
M6JW,&I031M*(0(CO8R<_(%'.[@\8SP?2@"6/1+.+4;^^42>=?0QP39;C:@8+
M@=OOFN.U?PP=+N=.CTS1-4N[6WTU;'S+#44A>14/RQS!RN4P2=RG<,GBNANO
M&>D6YTGRYFN$U.=X87A1F *JQ;.!P04(QUS]#BS:ZM;?;M9:76;66WLV3S(P
MH7['\F2'?/.>3VQTH A\(Z)+HG@K3='N]GG0VP241GY0QR2 ?09Q3;3P;I-G
MI.BZ;$)_L^CSB>US)D[@&'S''(^=JN#Q'I @O)GOHXELE#W(F!C:)2,AF5@"
M >QQSVIMGXGT2_GEAM=3MY)(H?M#C=C$?]_)XP.Y[=\4 5M6\)66JW\E\+J_
MLKB:$07#6<_E^?&,X5^#TW-@C!&3S5FS\.:;I^H6UY:0F%K:Q%A%&I^180P8
M#'KD#FK5GJEG?R21V\K-)$JLZ-&R$*V=IPP'!VG!]JAN-?TJTO?LD]XB3>8D
M1!!PKO\ <5FQA6;C )!.1ZT 5(?"6F6^F:7IZ";R-,N1=6^7YW@L>3W'SFI-
M7\-VFL7UM>O<7EM<01O#YEI,8R\;D%D8CL2H/&",<$5;;6+!;Y;,S_OVD\H
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M^O8HM'_LL7:;H65P_F%3GN> 3T&!GZT =)I.FKI&F0V*7-S<I"-JR7+[W([
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M+&[J58<X&0#UK>@LM1T_X@65\VFW$UI-HD=DTT10B&5)&8A\L"!@]1FNVHH
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M (XX[5OU2TO5+76;'[99NSP^9)%EE(^9'*-P?]I35V@ HHHH **** "BBB@
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M*LZE78DGYB0S9+9Y.>M$OAC2)]/U&QDMB;?4;@W-RGF-\\AV\YSD?<7@<<4
M<1J%O=:C>^/;A]<U. Z6RO9)!>/&ENPM4?=M!PP)_A;(Z\<FL^74O$?B2>^D
MMK35Y+JWT^U:T:ROX[>*":2 2%W1G7S,LV""&&%QZUTZ>!+;4=?\276KQ3_9
M[^ZC9%ANWC6>(01J5D5&&X;E;AO4^IK9U/P=HNK7/GW,$REHE@E2"XDA2:,9
MPDBHP#J,G@]B1TH X^[@U#5KWQ@][J>IVKZ?9P2P06MX\2P3&WW,1M//S#H<
MKU.#FH[^ZU-K6QU_5)M8.F/I=M-]KTN[V?8I-I:226'($BG(.2&P 1BO01H6
MG"34G%O@ZDBQW6'.'54V  9X^7CC%9MQX%T&Y\L-!<)$L$=N\,5W*D<\:#"+
M(H;#@#CYLY'!R* ./U?4[D:]_:NGR:Q)&FN6]DUR]X$M0IE2*2%8 WSCEOF*
MYW<YP*RKN.71_!GQ*U*QO]1BNX=3DCCD%[*2H"P'(RWWN<;NN,#.!7H=UX#T
M"\GN99H+C_2)A<%%NY51)L@^:BAL(^5'S#!Z^IR^Y\#Z%=_VJLT%PT6K#_3(
M1=2".0_+\VT-@,=B_,,'B@##M[>;Q1XHU&QO=2U&"WT^PM# EI=R0$O*KEI6
M*$%C\H SD<'CFLCPY=:AXNOO#\.I:I?K#-H+SW"VMP\'GR+,J!R4((R.>,>G
M3BNXU/PAI&JS1S3)<Q2K!]F+VUU) TD7]QRC#<O7KZGUJY:Z%IME>6]W;6JP
MRVUI]BAV$A4AR#M"].JCWXH ROA_=7-WX-M6N[B6YFCFN(/.E;<[K'.Z*6/<
M[5'/>N2U"&\O8/'VHMKNIPS:1<2/8I%>.B0%+:.3E0<,I/\ "V1UP!DUZ1IF
MF6FD60L[&(QP"1Y I8M\SN78Y/JS$UR5MX"M;[5?$-QK$,QBOM0$J)%=NB3P
MB*,!9%5@&&Y6X8>O8T <UXHUN^N+'4=8LVU@W6G6=O([Q7@@M;24HLFTQ[AY
MI(=<@J>" *EU_P 0:M8:Y\0Q;W\Z+;6=@+8%R5MS)E6=%/ /.?PKM]1\$:#J
MUU=SWEK*XO(PEQ"MQ(L4N%VAF0,%+!< -C(P,<@5*OA#1 =1,EHTS:E;1VMX
M9IGD,T:*54$D]<$\]3USF@#G+/2(M&^*NF6\%[>SQG1;EMMW<O.RGS8<MN<D
M\^F<<< <UJ>,)KB;5/#FC)=3VMMJ5XZ7,MO(8W9$A>0(''*[BHR00< U=TKP
M?I&D:BFHVZ7,EZD+6ZW%S=RS/Y9*G9EV/ *C [<^IS>U?1;'7+1+>^C=ECD$
ML3QR-&\3CHRLI!4C)Y![F@#S36[S4],BUW1;'5[](K35M,6UN'N&DEB6=DWQ
MEV)++WPQ/#8/%>H:;81Z7I\5G%-<S)'G$ES,TLC9)/+,23UK-C\':)'IQLC;
M221O=)>2/+.[R23(05=G)W,057J<8&.E;M 'D-P]_%X4U_Q,-;U-K_3M:N%M
MH_M;^4L:W6T1&/.U@02.02 0!@ 5I^??IJWCO63J-]*=$=WL;3SV\E6^R*QR
MF<,,G@'@')')K3T/P#:+]KGU>"4RR:M<7HA6Z?R909F>)WC#;6(&WJ.PST%=
M5;:/86EQJ$\, #ZA()+K<2PD8($Z'@?*H&!0!P/V*XT\>%'@UO59I=<#6UZT
ME[(_F;[9Y/-0$XC*LH(*8P#BFZ7K>J:U;^%O#S7D\>J6]U*-7DCD(<I:':VX
MCG$CF/ZAC77Z7X-T71[V&ZM8;@O;HT=LLUU)*ELK=1&K,0@(XX[<=*M6?AS2
MM/UV_P!:MK41W]\%%Q+N8[L #@$X'09P!G S0!YII>J:GJ5A#IUQJ=\([WQ;
M=6<LRW#+(L"*[B)7SE02@'!'&0*2^>[T/5O%%CIMQ?7#3ZCIEIN6Y_TA8W3)
M02N>&(^4,QR-PYSS7H+>"M";3)M/%K(D,MXU^62=U=+@G/F*X.Y3GT(I(O!&
M@0V=];"TD=;\HUR\EQ(\DCIRK[RVX,#SN!SD#TH XR=O$%G;II<Z:IIFFZAK
M%K;0M<7ZS7$<3*QE02J[, 2@ ).1O.*V_"MBFF_$3Q5:QW-Q/&EI8;/M$S2N
M@/G':78ECZ\DGFMG_A"]$;2[BPEAN)EN)5GEGENI'G,BXV/YI;<"N!C!XQ5G
M1_#.F:%<W5U91S?:;M46XGFG>5Y=F[:69R22-QY],#H!0!S?BW3X[SXD>#2\
M]V@;[7D0W4D8^2,,.%(]2#ZC@Y%81N;X^"3XU_M34/[5_M'_ %/VI_(\O[7Y
M/D>3G9C;QG&[/.:]$U?P]I^MSV4]VLPGLI#);RP3O$Z$C##*$'!'!'>J?_"%
M:'_:?V[[/-G[1]K^S_:9/(\_.?,\K=LW9YSCKSUYH L>+?\ D3-=_P"P?<?^
MBVK \)GQA_86A[UT+[!]F@SM:;S?+VK[8W8_#-=C>6D-_97%G<IO@N(VBD7)
M&588(R.1P:YN#X>Z%;+&D,NL(D8 1!K%UM4#H,>9C'M0!QFKMJ3:%XMUN/6]
M3BO--UHQ602Z<1Q*&BRI3.UP=Q&&!&.F.<V/$C7GAN7Q59V.JZD8_P#A'#?*
MT]V\CQSAW7>C$Y3( X7 XX KOI?#&D3:?J%C):DV^H7!N;E/,;YY"5.<YR/N
M+P..*S_&/AE=7T36Y+* /JUWI<EC&QD(!4Y(7DX'S'K0!C)#<:)XJT*.+5+^
M[CU:QN3=I<W+2HSHB,)%4G"<DC"X&".*YGP(9M0\+> =":ZNK>QN;2]N)_LT
M[0O,8Y %3>I# ?.20",X%>D:5X1TK2KH7D44[7 @^SIYUS)*(8S@E(PS$(N0
M.%QT'84Q?!&A1Z+8:5!;S6]OI[%K1X+F1)82<YVR!MW.3D9YH XR/4M3T>=[
MQM2O+C3=#U]M/G\Z9GWVLR1X+DGYS&\B_,<G&>:;J.K:O>QRZA;2ZA-::QKJ
MV%M;VMSY3?9H4DR8V9@$,CQME@02,8/2NFUWP[-!X3G\-^'],A>+4%EBGGN;
M@GRC)]Z5RV6D;DGKG('-:_\ PBVEMX:M-!>%C9VJ1K"5<HZ,F-KJRD$-D9R#
M0!P%S/XEM([/1Y[#6%M+S566"#^THS=M MN9#%Y_F<#>K')?=M&,UVO@R/5X
M=+NH=6@NH1'=N+1;NX6>40$*0'=6;)!+#DDX S4G_"&Z-_99L#%<%3<?:C<&
MZD,_G8P)/-W;]V.,YZ<=.*T=*TBST6R^RV2.$+M([22-(\CMR69F)+$^I- '
M.1W]R/%'C.)KJ7R;:QMGA0R';$3'*25';.!DCTKGO#L5WXEOM)M;_5]4%LWA
M6PN9$@O9(C),Q<&0LI!SQSSSQG.!7:ZGX0T?5M2:_NHI_.DB$,PBN9(TG0$D
M+(JL X&3U!ZXZ59TWP]IFDS0RV5N8WALHK!"9&;$,>=B\GMD\]: //O#-U?>
M*IO#>GZGJ=^(5T5[N1K>Y>![B42B,,[(03@#.,X);)K,TFXU#[#H^C0)J6H0
M3WVK33BQNUMI9S'<84F3<F!\Y8A2,\=LUZ-)X'T)[33[>.&YMQ8*T=O);7<L
M4BHQRR[U8,5/'!/:E_X0C0DTRWL+>VEM8K::2>W>VN)(I(7<DMM=2& .X\9Q
MCM0!QIA\076H>$=%U6^U.P%P^H).([P>=+"F&B#O&Q&[;M!8'/WN03FO2;JU
M632Y;4R3*AA*;TE99 ,8R'!W ^X.:HVOA?2+.337@M2KZ:)1;,9&)4R_ZPDD
M_,6ZDMDYR:V" 00>0: /%?"NC1W.G?#F#[9?QI<V=W+,4NI _P#JX\JC9S&O
M X7'?&,FKESJ>IV-EI5E%JE\4@\;)IX=[AF=[?D^6[9RXYQSG@"N_P!)\&:+
MHCVC64,X^QF3[,LES)(L(D #*H9B ORCCH/QJ2;PCHLY0R6A)34AJJ_O7&+D
M?Q]?TZ>U ',C[;IOC03:Q)K")<Z@4L[RWN]]FZ,,)!)#G"'MNV\MSNYK0^*7
MF?\ "O[WRMOF>?:[-W3/VB/&?:M1?"&CIJW]HB*X\SSS<B$W4GD"8]9!%NV;
MN2<XZG/7FKVLZ/9:_I4VFZC&TEK*5+JLC(<JP8$,I!&" >#0!0TP^+?MR?VJ
MNB"SP=_V5I3)G'&-PQUQ7GEI'J4WAGPYJYU_5Q>WNM&RE?[6Y7R&FE0J$)VY
MP 0Q&X''/  [^R\%:587L5W#/JQDB;<HEU6YD4GW5G((]B*MQ^&-(BTZRL$M
MB+:RN?M<">8WRR[F?=G.3RQ.#QS0!YYJT]_I,7B32K+6-0BAM]5TQ;>:6Z>6
M2%9FCWC>Y)*]>"2.3VJ7Q-%+HT?C#18;V]N+"7PS+>;+NY>=HI?WB$AG)(##
MMG&1Q73^+?",6JV%T+.U62XO[ZREO \A DCBD3/4X&$!Z=:OP^#-%BM=2MVB
MN+@:E#]GNI+FZDED>+! 3>S%@ &/0]Z .1T&&37KS1M&N;V^@L+3PU9W*16E
MT]N9)),J6+(02%"# SC)J/1-<U*S7PUK.H:C/-83376C7;2R'82LSB"8CIN/
ME[2W?<*[.Z\':/=162".YMVLH!;02VMU)#((< ;"R,"R\#@Y]>M97BCPQ+J/
MAVW\(:7ID$.CR^6DUPTN!;QJX8[5ZLYQP?4Y)H YR";5=5'AN[FU74;>+Q!K
M%Q-Y<=PZ;+3R)#%&,'Y0516XP06R.<&JE[#?67AKQ??1:WJYDT'43'IX:^D(
M10L4F'Y_> ^85^?=P.*]2ET:PFETV1K< Z:Q>T"L0(SL*=!U^5B.:KS^&-(N
M+#5+*6V+6^J2F:[7S&'F.552<YR.$7ICI0!P6JW'B34]<\0RZ79:M-=Z?=I!
M8/!J$<-M%MCC?$D32+OW%CDE3P1CI46L?;Y-#\<ZU_;&J1W.D7TIL4CNW6.+
M9%&^"H.&!)(PV1CH!DY[S4/!^C:GJ3WUS#-YDI0SQQW,B17!3[OF(K!7QQU!
MZ8Z5/-X:TJ?3]5L9+8FWU5VDO$\QOWC,H4G.<CA1TQTH YC0+",_%CQ1=&>[
M+QVMDRH;J0I\ZRY!7."!V!&!DXQFM/XA:]/H/A&X:Q5WU.\86=C'&,LTS\ @
M#J0,M_P&M4>'=/7Q#_;D:S1WQB$+E)W5)%7.W>@.UB-QP2.,U->:-8W^IV&H
MW,)DN; NUL2YPA==I.W."<<9(X[4 >9:#=6WA3QAHD5II6JV&EWUHFE7+WMJ
M8E:X3)A?.3EF^=3]12:I+?S^#==\3C7-2M]0CU62W1([MUBCB2Y$(C$8.T$J
M,[L;LGKCBO3M8T:QU[3VL=1A,L!=),!RA5E8,I# @@@@=*X'7/!-]JFHW]K'
MHT,4-Y>I.;U-0D\E5W*6<VY./.(!7(&#G.1S0 MY/?IXB\>ZI_:-\PT.))K&
MS6=A"'-F&.Y <,,\X/&23U-9QO/$^@Z%>:O;VFKQP#1II9IM1U".Y#W 53'*
MBB1MO\>0 %QCCBO3H=&L+>\U&[2W'FZD5-T6)82;4"#@\#Y0!Q6?I_@S1--,
MGE6\TJO;M:A+FXDF6.$]8T#L0JG X'H/04 <+>CQ%I&@>()XX-:L;(:'/(9K
M[4TN)!<J!MDC*R,R9!;.,#(&,5H+H\Y\9:5IKZWK#6NHZ5+<WB?;I!YDB-&
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M)I!$A4%L#/5B!^M<+JWAZ_2]MTTCP]-9WT$=O#::G8WP6)(T"@I.K,&=5^8
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MF\:6>H7NE6B64%Q<Q)>1O>6UM.(I)X &RJL64==I(W#(!'>N,LO#6NZ5J/\
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M:)P2I978$MA6.T G Z=,Y-KI^O>&M0M]0M=%DU+[1HUM92PQ3QHT,\.[&2[
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M#IUX_P#9&IZ=<W+1] ^%4J6'8C)JCI]SJVC^,]82TT6749%TC3XWBAFC5DD
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M-4 ;=D[P3D#&#UXJ/2?"FO:3IMI>_P!G^;>6'B"ZOQ:"9-TT$H=,J<[0V'W
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M\JW+A2,@L&. REMH. :GM?%D5]XHO-"M=-OI)+*41W5SA!%%F,.I)+9.<XP
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'U6XN[>WDO+]3#'?L[M $W)&\BG)VGY>N<"@#T9?L.C6-K;!HK6V3R[:!"<
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M_6OY?FXQYGEYV;_]K&?>B#PEH=MJ_P#:D5CMNO,:4?O7*+(V0SK&3L5CDY8
M$Y/K6U10!FZ)H\6B64UM$P82W4]R< @ R2,^.2>F['OUXZ50;P-X<:XDG.GG
MS'F^T B>0".3=O+( V$);D[<9[YKH:* /-CX&OKC7("^DZ7:PQ:HM^][;W,I
MWJLGF ) P*QNQ"AB#@\GG.*Z\^$M#.L_VJ;'_2_-\_\ UK^7YN,>9Y>=F_\
MVL9]ZVJ* ,L>'=)&F+IWV-?LBW'VH1[VXE\SS=V<Y^_\WI^%.@T#3+77+G68
M+<QW]TH6>197VR8  )3.W. !G&?>M*B@#&U?PKHVN7*W-_:,\PC\DO'/)$7C
MSG8VQAN7.>#D<FK4&BZ=;7\5]!:1Q7$5J+.-DR L(.0@7H!D#M5^B@#/U?1;
M#7+:.WU"%I$CD$L921HW1P" RLI# X)'!Z$UFOX%\-O:36O]F[89IHYV6.:1
M,2H,*ZX8;6P.2,$]\UT5% &*?"6AM?75XUB'FNX!;W.^5V69 NT!T)VL=HQD
MC..]-L?"&AZ='=)!9L?M4/V>5IIY)6,7/R!G8E5YZ @5N44 9_\ 8FG?9]-@
M^S#RM-96M%W']T50HI'/.%)'.>M177AO2+U;\7-DDG]H-&]R2S NR !&!S\I
M&T8(P>,UJT4 <KJ?A^:P\.76D^&M/M6;4-Z7$U[<NVW>NTR.6#-(<8&">P&<
M5M:%I%OH&A6.DV@_<6D*Q*3U; Y)]R<D_6M"B@#/ET/39]<@UJ2T1M1MXC#%
M.2<JAZC&<=S^9JLGA30XK#5+%-/C6VU21Y;V,,W[UG^\2<Y&?08K9HH QY?"
M^CS7EA=M:$3V$7DV[I*Z%8^/D."-R\#ALU+'X>TJ&RTRSCM%6WTQU>S3<W[I
ME4J".>?E8CG/6M.B@"I>:99W\]G/=0"22SE\^W8DC8^TKGCKPQ'/K5#5/">B
M:S>_:[^R\V8JJ/B5T650<A9%4@. 2>&!'-;5% &)+X2T.;5_[4>R)N?-68@3
M.(VD7&US&&V%A@8)&>!Z5C>'/ -A:0K/JEHLE\FH7%VNV=S&2TSO&Y3(5G"L
MO)!(QUX%=I10!BR^$M#FUC^U7L<W7FK,?WKB-I%&%<QYV%A@88C/ II\'Z"V
MM?VL=/7[7YHGSYC[/-QCS/+SLW_[6,^];E% &;IV@:9I-]>WEC;F&:]D,MQB
M5RKN>2VTG:">Y &>]13>%]&N-4NM2ELE>YNX?(N<NVR9,;<.F=K<<9(SBM>B
M@#'TCPOH^A3O/86K+,\8B\R6>29@@.0BEV)5?88%/U/PUI.L7L-Y?6GFSPJ4
M5A(ZAD)SM<*0'7(SM;(]JU:* ,G2_#6D:-+')86GDO' ;=#YCMMC+;]HW$X&
M3QZ=!Q6'XD\*S:AH$?A33+*U@T6Y?-U-),Q:)?,\Q@B$'+$YP21C/M7944 ,
MBBC@A2*) D:*%55'  X %8,W@CP]/)>.]BX:\G%S*4N)4_>@Y\Q<,-C>ZX)[
MUT-% &!!X+\/6UREQ#IP5TF2<#S7*F5%*K(5+8+ '[Q&2<$\@5IP:596NI7>
MH00".ZNP@G=6/[S:,*2,XR!QG&<5<HH RKGPWH]Y>WEY<V,<L]Y;"TN&8D^9
M$"2%(SCJ>HYJFO@?P\MI+;&RD<2NDC2O=2M,&3.PB4MO7&3C!&,GU-=#10!@
M2>"O#\MA;V36+".WF:>-TN)%E$C<,WFAMY)!P23S3O\ A#M &EOIJ:<L=JT_
MVG;'(ZLLN -ZL#N5L#J"._J:W:* *>EZ59:-9"SL(!%"&+D;BQ9B<EF8DEB3
MW))J*/0=+CL;ZR%G&;:_DDEN8FRRRM)]\G/K6C10!@P^#- ATZ^L!8M)!?((
M[GSIY)'D0=%+LQ; R< ' R:==>#M!O;F.XN-/#ND*P8\QPCHN=H=0=KXR<;@
M<=JW** ,.+P?H<%W9W4=HZSV=O\ 987^T29\KG"-\WS@9.-V<=JFL/#.CZ9'
MIR6=DL2Z:DB6@#L?*5_O#D\YQWS6M10!ROB+PO'/I;1:9I=E<L]^+Z>&XGDB
M+N1AFCD4YC?I@CC&1CG-.\%^'9]#35+BY@M[:74+D3?9K>0R+"JQJB@N0"S'
M:6)QR6/UKJ** ,B7POHT^JW6I2V2O<W</D7!+MLF3&W#IG:W!QDC.*32/"VC
MZ%</<6%JRS-&(O,EGDE98P<A%+L2J^PP*V** ,W4M TS5[RRN[VW+W%BY>WE
M25XV0G&1E2,@X&0<@XIJ^'=)33K;3ULU%K;7 N8H][?+('\P-G.?O'/I6I10
M!BS>$M#GCODDL!_ITZW-PRR.K-*N,.&!RI&!RN*N:5I%CHMH;:PA,<;.9'+.
MSL['JS,Q+,>!R2>@J]10!S$WP]\,7%W<73V$HEN)6FE,=Y.@9V.6.%<#DUJ6
M/A_3-.G@GM;8K-!;FUC=I7<B(L&*Y8G/(!R>:TZ* ,N/PYI,5C9V26:BWLI_
MM-NF]ODDR3NZY/+-U]:Y_P /^ ;"V1[C5;19+P:E<7B;9W\LEIG>-F0$*S $
M<D$C'7BNTHH RF\-Z.\VJRO81NVK*JWV_+"8*NU<@G P..,56MO#]IX=M[JZ
MT/3O/OW15'VF[=F< \)YC[RJC).!Q[5O44 <QX7\*)I>AZA;ZC';O=:M<375
M^L&1&6EZHIX.T+@9[\GC-;":+IT<NG2K; /IT;16AW']TI4*1UYX4#G/2K]%
M &-<>%-%N;22UDLL1O=->925T=9F)+.K@AE)R>A'4BI+3PWI%C]A^S62QFQ,
MC6YW,2K29WDDGYB<G).36K10!C7GA31+^TN;6XL0T5S="\EVR.K&<  .&!!4
M_*.A'2K-]HFG:E8065[;^?;0/'(D;NQ&Y#E2>?FP0#SG/>M"B@"*YMH;RUFM
M;B-9()D:.1&Z,I&"#^%<'KW@R<W2)I.A:7<VR6*6EN\]Y-$T.W.!(!N$R#((
M!Y&#ZYKT&B@#$T+PS9:);:=M027MGIT6G?:<D%HTQQC..HS2V_A+0[75_P"U
M(;';=>8TJ_O7*([9W.L9.Q6.3D@ G)]:VJ* ,6Q\):'IVI_VA:V/EW +E/WK
MLD9?[Q1"=J$\YV@9S4T/AS2;>STVTBLU6#3)!)9IO;]TP5ER.>>&8<YZUJ44
M 9-SX9T>\BOHY[)66^F6XG.]@6D4*%<$'*D!5P5QTIMMX6T:S@MX8;/Y;>Z^
MV(SRN[F;:5WLQ)+'!(^8G]!6Q10!DWOAG1]1BU*.[LEE34MGVL%F'F;  AX/
M!&!@C'2I;'0M.TZZ^U6T#+<?9TMC*\KNQC0DJ"6)S@LW)YYK1HH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-2M]2%R;?S?]'G>WD\R)H_G7KC<!N'/WAD'L: +=%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCRW7>>6!"YP2>I'2K]Y;:W8:]K.B:-JM]<23Z.MU"+NYWLLWFLK;&883<OX
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M>0*TI R0H/)P.>*J'Q!I*ZXNB?;X3J97?]F!RX&"<G'3@9YKE/&O_)0_A_\
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ME1%@RL%!4;R .K>E9.D3ZS:>%K$_:=32P&H:E]ON=(MTDF$GVEMC;"K'R_\
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MLXKN+5K%[::7R8Y5N%*O)G&T'/+9XQUH KV_A;3+7Q9=^)(T<:A=0+!)EOD
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M106VLIZ@'!'..M=O10!QWB_^T-8T&.;3+*XDCM+ZUNG@=#')=1QRAW0(P!Z
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBB7EG=@JCZDUE:WXFT[1O#%YKIGAN+:"%Y$\N5<2LH)"*>F21BLWQBEY'?\
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M\0H [VROK74;87-G,LT)=TWKTW*Q5A^!!'X58KD/AB)!X&MQ,ZO+]KO-[*,
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MC+(GC*6%6P!A$DF51QZ* * /4K35+&_N;NWM;E)9K.017"+UC8C.#^%6B0"
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M#TNBL7PI>K?Z!%,NJ/J8#NGVB6#R9.&(VR)@8=>AX&2,X%;5 !1110 4444
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MB6XN(I+9+QI;6V>5(H&SMD<J#M4X;KZ'TH BF\$6I$/V/5-3T]ELX[&9K61
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M8EAN8K&T8W\<\,>F.:CTSPC!I5]%+!J>I&S@=Y+?3VE401%\YQA0S ;C@,Q
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MQQS#8VU9G9E.>S1,P_$5W/@:QFMO#BWMXA2^U25]0N5/56D.0O\ P%-B_P#
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M %/E9NK8&&.&KU.B@#SJ[74+?Q.)M+L]9L]4FNX#=1I&9-/NX_D$DC,050A
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MJ'G=A[$8(Y'%=5110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,:[U%D,[R-GA%VJJ^@ SQ[FDFT"QG\01ZVRN+M;5K1L-\LD3'=M8=\'D?4T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA<7=H+>Y@.T$I(@5>_(.T<'OUH Z:BO.+/Q/J!\5Z:$U:ZOK._U":T=/[/\
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MNA*%PVR(1\!0,9 R?<\8JE8^#FM+9K63Q!J\]JMJUI;1><L?D(<#(9%!9P
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MC*O,JW7F< ]=R+QZY%;&G7S:W\3K;4[;3=0BL4T6: W-U:20 R&:)MF' .0
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MYCE>=8TD1IBB/F39QD \\' Q7JE]J=EIK6HO+A83=3K;P[L_/(V<*/<X-6Z
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M[?Q#/W\^HIWB33M1\2)XEU*TTF^2"X33;6"*>W:.2<Q7/F2-L/S;0&QDCL:
M.UD\;:9';6TOV;4VDN0[QVRV,AF,:$!I"F,A>1@GKD8HN_'.B6J02+)<W,4M
MLMX9+6V>58H&SB1RH^4'#=>?E/'%8OBW39H_&%MJSC7/L3V!MB^C[C(D@?<
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M+)J>XR211/DOL(#*JAB,D#IZ4 =A<^-]+M(87FM]25Y(#<O"+&0R01 D;Y%
MR@R#UY.#@<5)<>,]'M[Y;;?<2K^ZWW$-N\D,7F8V;W P,Y!^A!. :YKQ-IDT
M'C&]U":/Q!):7MA#%%_8Y8YDC:3,<@ . 0X()P/O9-5+K3KG1KBVBT#3]>L=
M4BAM88A'^^M+M%55Q.V"BE1N4M\K?*"">* .L\->+4\1ZAK%JMC=0#3[MK</
M+"RJX"H3DD8#98_+UQ@]ZCC\:6Q\7:KHL]K<0PZ=;)/)=O$PC&1(6+-C 7"#
M![G/I5?P>ES8Z]XILKJRNXC/JDE[#.T)\F2-HXE&U^A.0>.O%8OB+2-0OO$7
MC#3XK.Z_XG>C106ERL1,/F(LV5=^B_>4<^M '5Z3XPTO5[V*TA6\@EN(C-;?
M:K5X1<1C&60L!G&0<=<$'%6-8\1V6B30P3QW<]Q,C2+#:6SS/L7&YR%!P 64
M?CQ7-V\MWXB\3>&9X](O[&+2DFDNVNX#$%9HO+$:$_?Y).5R,+UYJUXT@B:]
MLK@VVNQ7,<4@@U'1T,CQDE<QN@!RK8!^8%?EZB@"]>>.-$LQ&QEN)XC;I=R2
MV]L\B00O]V20@?*" 3SS@$]!3KOQGI-IJ\FE 7=Q>QHDCQVUL\NU&!(<E1@+
MQU]Q7"2Z5JWVF[N?$%KX@DN=5T^VWQ:0<1R3"+9)%)C(3GG)PN&//%=7X:T>
M;3O&^NRFUECM#86$$$LG.[8L@8!NY&5S]: -AO%.DKH5AK(G9[._:%+8HA+2
M-*0$ 7KG)Y],'TJ*#QAI-QJRZ?&UQEYWMH[AK=Q!),F=T:R8VEAM;\5('(KD
MM#\.ZE%XO@T:XLY4T'0[NXO[.9E_=RF4 Q(/^N?F3?3"U7\/^'WMKVPTN_MO
M$<MS9ZB\^?,(L5 D=TE#$;2""/E!W98Y% 'H6LZW9:%;137C2$S2B&&*&,R2
M2N<D*JCDG )^@)K-/CC0TTQ[Z::>!(KI;2:*6W=98I6QA63&>001ZYXJ#Q;;
MW,6K>'=:AM)[N#3;J1KB&W3?($DB9-ZJ.6VDC@<X)KF;G2]1U74KK6DTR[B@
MO->TV2*&:(K)Y4&T-*R'E1G/7!PN30!W.C>(['7)KN"W2ZAN;0J)H+J!HI%#
M E6PPZ'!P?8UAZMXV:WUS6M$M[*Y6:RTPW:7)@8H'VR$9.,;?D&#T)R.U7M-
ML[F+XAZ_>/!(MM-96:1RE?E=E,VX ]R-R_F*PM=MKV/QEKY73KR:+4M %O;S
M0PEX_,3SB59A]T_,N,]<T :_AOQM8ZM%I=K.;E;V[M!,DLELT<5PRJ#)Y;$8
M.,YX[<C(J[I7C#2=8O8[6U:Y!F1I+:66W>..Y52 S1L1A@,@_0Y''-<]/HE]
M<0^!X%MI8_L]G+%<-L/[@M:%!N]/FX^M4O!6C&&[T*&\M/$8O=+MRLAO)#]E
M@<1^61&2,.""=NW.!C.* .A\1^)Y-"\6:'9MYKVMY;W3-!! 99)9$\K8% &>
MC,3VQR>E6?\ A-M%.D0:BDEPXGN&M8[9+=S.9ESNC\O&X,-ISGH!GI6?XF-S
M:>./#FJIIMW=V=K;7B7#VT)D:+?Y6T[1R2<'@<XSZ5SUEIVIV6H6?BF72KTV
MQUJ]NGM%B+7$<,T0C1S&.<Y0$J.0'Z=: .R'C71SI;7H-UN6Y%F;7[,_V@3X
MSY?EXSG'/ICG.*CF\>:%!IUK>RR7*K<W#VJ1?9G\T3*&)C*8W!OE( QR<8ZB
MN2GCUEK^_P!:2TUBSTO5-5B,\=K"1>"WCMM@?8 64-(JYP-P7TJOI.CZD-4T
MM)-+U)$@\22WC-=!I"(7MVV.SG()S@'DX/% '7ZKXYT^SMKB...^%U'9"ZD_
MT-V%H&4E/.X^0\'@],$G YK4\.ZE)>^#])U2^E023V$-Q/(<*N6C#,?0#DUR
M>H_;]*UWQ?&-'O[W^VH8VLGMX2\;,(/**.W1,%<_-V;C-;-GI%W=?">WT5E:
MWO)=#6T*R#!CD,&S!],&@":P\<:1J,\44*WR_:(GEM&ELY$6Z51D^42/F..0
M.I'(K&\ ^*=3\4:MK4UVUQ':P7<UO;VQL3&B*C  M(>3)URO;TJ&S-]K=YX0
MM1H]_8MH[^=>R7,!C2,K T6Q&/#Y9^JY&!FM+X>:?>:=8Z\MY;2P--KEY/&)
M%QOC9\JP]CZT :5]XQTG3]5>PG-R6B>..>=+=VA@>3&Q7<#"D[E^F1G&:R?&
M'CNUTC2->2P:X-]I]L^;A;5G@AF*;D1WQMR<KQ[C/6N>\7VVM:C-KUO)::[<
M3)<Q/916P9;0VRB-B3CAWR'&TY;.,#'--U9-2@\.>-M%BT+4[JYU:6>ZLWCM
MB8W26)>K=%9<$;3SD# .: /0]+UZRU WD*RD3V&Q;H.NW860.#SV(.<_6L>S
M\8:=?ZW:2PZLZ6<^DO?K;26NT&,/CSBYY''\/<'-8'B[1=934$_L:UF9=?T]
M-+OI(UXMR'7$S>F(WF&?4+5J^T*:W^(T,MMI$EQI4'AF6S5 ,1N?,&(=QX!*
MC'- &_!XXT66SNKN9[JSAMH!<L;NUDB+1$X#J",L">,#G)''(I8/&FDR0W[S
M+>6DEC:F\FANK5XI/) )+JI'S#@CCOP:X:;3-8O='O\ 3](@UR72X(K:YBM-
M7C*NLL4Z/Y,3/AF4HA')(!"X/-:&NQ7WBBZU?4;+2M0A@B\.7ED@N;=HI)YI
M<$(J-R<;.N,988S0!TB>.](EM(KB"'49EGD,=LL=E(6N,+N+1C'S(!_%T]^E
M;-OJUK>:,-5MA--;M$955(F\P@=1LQNW<$8QG/%<GJMC%'X;\.1W5AK*26UN
MJK=:2K&>S<1@8**"2IY!&".!D5T7A:35)?#5D^LA_MY4^89$".1N.TLHX#%=
MI('0DT <=X.\?3WVE:CKFNW%Q';?:6AM[9=/95'[PHB(P!,CG@$=CZ5TW_";
MZ,NFZA>W#7-J-.V?:X;BW:.6(.<*2I'(/8CC@^AKBM)T/5K/P'I4CZ;<M/IO
MB![^6T"?O7B\V3E5/4X<,!WQQ2^*-.U'Q+9^+-3M-*ODAN=/M;*VAF@:.6X9
M)F=V\L_,  X'(YP: /2=)U6#6;+[7;17*0EB$-Q"T1<#HP# ':>Q[U>HZ44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M7F5UKE]'XF@O+.]UBYMY-;6Q=VCC2Q"%O+:(*6WLRG/S@<L#SB@#TVBO*I;W
M6D\/ZCXB.NWOG66O26T-L"HA,(O!$4=<9;Y6(SGC QTY]5H *JWVHVFG+ UW
M,(A/.EO%D$[I'.%7CU->=Z?KM]_PD^CW,%[K-W9:E?7$#S7$<<=I+&(Y740I
MN+C:8U ;'S $D\BL]?[0U/PYX/\ $5YJ]U-+J.LVDTMM(5\E TA*JBXRNT8'
M7GG.>P!ZIJ.HVFE637E],(;=656<@G!9@J].>2P'XTR+5K*6]OK19\36(0W(
M9&54#+N!W$8/ [$X[UY;K)U#6? E]X@N-7NLR:NL0LB5\E8DO5B5 N,AOE#;
MLY)]J=XKU'4+Y/BKI\M_<+:V%E:M;QHP 0/ Q=>G1CUH ]2?4[2/4X-.:4_:
MIXVEC0(Q!5>IW8P.O<U;KSF;4[_0_&&@:;'?75Q9C1KFYDCF<,977!7)QVS@
M>U16%YJ]GI/A#Q%+K5W=3:S<6Z7EM(5,&V="<(H'R[#C!!Z YS0!Z717E6G7
MNM+X?T#Q#-KM[+/<:PEI);L5\EH6N&BVE<<G'.[.<^U6'UR^7Q-9WEI>ZQ=6
MMQK)LFD>.-+$QY9#&B[MY92OWP.2IYQQ0!W^G:Q8:LUXMC<"8V=PUK<84C9*
MN-R\CG&1R.*N/(D94.ZJ6.U<G&3Z#WKA?AI_Q\^-/^QENOY)3OB!9O>:WX/1
M;Z[ME?52A^SR!?\ EC(=W0\C&,^A- '=52U;2[76]*N=,OD9[6Y0I(JL5)'U
M'2O,]3\0>(8]'FT6SOI3K5AJ-XSRG!>6WA0SH#Q_$)($_&K6I^)]2U+4[F32
MM0D@TZYNM/TJ"6, [&E'FRR+D$;]CHH]#0!Z?17(Z))>:7XWOO#\FH75]9G3
MXKV%KI@\D3&1T9=V 2#M!&>G-6?&=]=V]MI5E9W+VKZEJ45F]Q'C?&A#,Q7(
M(#$)M!QQF@#I:*X'4H=7TV_TGP\GB&[DM]4U!P+E@OVF&%(&D,>_')9EX;&0
M"1SUK+U/5=:TV34]#M]8N6-KJ^FQ6]W+M>58[AEW(QQAL'/49P1F@#U*BO,9
M[75UU+Q9IR>)M66WTNSBO+9O,4R"1T<X9MO*@QYV]/F/M4VGW&K>*=?L[:;6
MKRRMI?#MI?2)9LJ,9G9\L"0<#U ZX';@@'I%%>30>(-2UK0=+634=9EU".RG
M>:+28XD9BDK1+/([D* ?+/R#J<]A5_2;S5O%>JZ5#/K%Y9V]SX;MK^9;,JC-
M,[,"02#@>P]!VR" =_<ZE:6E]9V<\A6>\++ H1B&*C)R0,#CUQ5NO+-,\2ZS
M<S_#A9K^1C?O>1WN !]H\M&"EAZY7/'>E\-:WXBU2ZTK58X=<D%Y<O\ :UF2
M,620'>%V '<"I"<]3AL]: /4J*X'P==ZC%K,=EKE]J\6K/;.T]K>HK6\[@KF
M2W=1@*,_=SG##(XS7?4 8%YXX\*Z?>2VEYXATR"YB;;)%)<JK*?0@GBIK+Q9
MH&I/;+8ZM:W1N9F@B,#^8&D5"[+D9 (49YK#^)$:?V=H1V+DZ_89..O[X4GC
M.T>Y\2^#[>WN'M&DOIP980-RC[-)G&00"1D9[9H [:BO*KG7-7T^*ZT-+W5+
ML#Q"+!9X=C77D&V$Y56. 6SD;CS@GN!78>#)M5DL[Z+4H=02**Z(LWU *)WA
M**?FVD@D,7&>I &: -JZU*TLKNTM9Y&6:[<I"H1FW$#)Y P./7%6ZX[Q;JE]
M8^,/!MI;7+Q07EY,EPB])%$1(!_&N;2]UI/#@\1MKMZTT.O&U6WRODM ;TPE
M&7')VDX.<C QTH ]+U'4;32;"6^OIA#;1 %Y""<9('0<]2*2'4K2?4KG3XY"
M;JV5&E38P"AON_,1@].QKROQ&=0UGP/XFUJ;5[I?+U&6UCLP5\@0QSB,*5QG
M<<;MV<Y([<5JZIJ'B"\\3^.=.TS4)DEL;"TN+"-<863#.5'^_MVGZT >D2E1
M$Y8D*%.2.H'X5B^%;'1[;2C=Z,9I8KUO.>YN'D>69ONY8R?-P!@ ],5@0>)9
M_$NO:?)I5R\>G6^D'4;H(?O/,,0QM] LC?@*P_"VKZOXFTOP9876KWD)O+"Y
MO;NXA<++,8Y%15W8X'SY..N!0!Z;9:C::B+@VDPE^SSO;RX!&V1?O+SZ5:KR
MKPY=WVGZA9V8OI)!/XKOH+A\ &=5AD(W #&<JI.,<BM'4-;N_MGB6T?4[Z(+
MJ]M:6J6<2O,P:WC=HH\X"D_.=QZ#)H ZKQ+)HL4&GRZW+Y4:7\)MC\W-QG]V
M/E]_7BMJO%M:U"]O/#<5M>F])L?%UI;Q"^*-.J8C<!RA()!<\Y/&,\U[30 4
M5Y?IFOWP\2Z-<PWFLWEEJ5S<H\US''':S(L4LB>2@8NN/+ !(^89)/(J*RO=
M<_L/P?K[Z_=R2:UJ%O\ :[9BOE;)-S;$ &5P !UY&<\T >JT5Y4-6UNW\.^*
M_$!U:\EGM-1NK"SM@%,<:F<(K;2/F9=W&3C  QUR7FM>(M%TS5#!#KXM9$M8
M[>;4DB>>.:2<1/LP<'Y7! ;@,/0T >E:GIEGK.FS:??PB:UF&'0DCH<@@CD$
M$ @CD$54T?PYI^ARW$UM]HEN;@*);BZN'GD<+G:NYR3@9.!TY-<4LOBLV6J6
M]C;^(/LBFVDB:\:$797>1.D39()VA2-W<L!VKJ?!M['>:3.$OK^Z,-PT;)J,
M7EW%N<*?+?@9(SD'N&')ZT = 9$5U1G4.V=JD\G'7%.KA/$-F\_Q7\+,+Z\B
M7[)=OY<4@"Y0Q'&,?Q9P?4 =*R+35-8'A71?&3ZQ=R7%]?0":R)7R/)EF$?E
MJF."H88;.<KSG- 'J5%-<XC8CK@UY+I4^OW&B>"=0?Q+J!GUJ06UV/D*",Q2
M/E1MX<;!\W/)/TH ]<HKS-=4O;6QU?1YM9U21X-<6SM7@19+N=#"DIB5C@ \
MO\YZ*#56TU?7+P:;I@U'4;,_\)%-8.]P8VN/(%LTFURNY2P)X//0'K0!ZM17
MFC:E>6$.N:+-K6J2>1J\%M:21(LMW*LD*2F)6. #]_YST&?055M-:UF[AAT)
MKW4K0R^(6L#/<-&;J.!;83E"R[EW$_*&Y./>@#U6BO*=0UK6]'NM?TI=3O[T
M)J%A9V\B*C7$<<J[G"YPI?&0"?8]:ZSP;-JK2:G!?0:HME'(C6;ZF$\XJ5^=
M25)R PR">?FQVH ZAY$C*AW52YVKDXR?0>_!JO9:C::C]H^R3"3[/.UO+@$;
M9%ZKSZ9KCO']D]YKW@Z-;Z[ME?4V0_9Y O/D2'=T//&,^A-<Y,NH:?H?B_7K
M/5[RWEL=;F>&WB*B)L.F[>""6R"1UXXQSG(!Z]52WU*TNM0O+&&0M<V>SSU*
M, N\;EP2,'CT)QWKSC4M;\0W>M:W-ID.N2SZ??+;VD-JD7V1E549EEW$$EMS
M<]@5Q4>O>)-8M;CXGB"_E0:7!9-9 8_<%XMS8^IH ]6HK/T:PGT^P$=SJ%S?
M3R-YCRSD<,0,A0  %]!VKG-074/$'C+4])AUB\TR#3K&"6,VI4%Y93)\[9!W
M*HC V].3F@#LZ*X2&+5O$'B/5-,N-?N[4:5:6RK)8;8A--(C,TI!!R.!A<XZ
M]:R="U76/&%_H<-QJUU9176@&ZN19E4+RB4)N!(.T'.>/8=,T >HT5Y5HNHZ
MX-'\(:Y=:Y=W%Q?:B+&X@;:(7B_>+G:!][Y%;=GJ3VX$,=WK\GA_3=97Q%?)
M<W&NMIX3Y#$L+7+Q<J1RP'()] .E 'J6H:A;:7837UY(8[>%=SL$9R!]%!)_
M 5*D\4A4+(I9DWA<X.WUQUKRW7]5U?P_H?CVUMM8O)6TV"VGM)YW#2Q&0'<-
MV.1E>/3-7[>WFE^*3W3:A>97P[#<>6)!L)+NI&,=.-V/6@#T>BO)=*EUZXTW
MP-=R>)=1,VNKY-X/DVA/(:3*#;\K_)C=UY)ITFNZQ:L^@B\U:[1=?FL_.MMC
M7;0);K,$#' SN;!;KM!H ]8IKR)& 9'502%!8XR2< ?B:\RM[OQ)<WNA:3<W
M>J:?%<:A=PB2<1BYEMEA\Q-V,C<#E=W7C/7FLW5A?7EC%IUSK&H2+8>,(+&*
M;S )&C81.-QQRREC@^U 'L-%>?/<:EIOC!4U;4-9MH7O(XK&9422RFB*JHB?
M RLC-N^9L<D8..*[C4':+3;J1&*NL+LI'8@&@"S17DUMJ6MV_@7PS>S:IJ][
M>>()+=)_L^PO&@ADD(A! "LP0 DG/4C!Q5TS>*FT@H]OX@^P0:B=Q4Q+?R6I
MBRO?!VRD@X.XJ![T >F45YK97=YKVO:-IMMXEU$Z?)I=S--*J"&>1HYT0*P*
M_*ZYVL0 3M/3-0Z7J^L:Q>:5X;N-6NHPMWJ45Q>PE4FN$MI B#=C )W@L0,G
M;[F@#U"BO+GU76_,AT1-9N0T'B;^S3>84RR6[6S2X8XP6&<9QU4$YJ>23Q##
M_P )#I%C>ZE?QZ?J%L=R2)]K^SO$KR(CL "03QGG&0#G% '?WFI6EA-:Q7,A
M1[N7R80$9MSXSC@''3J<"EL=1M-2CFDLYA*L,SV\A (VR(Q5EY]""*\YF\07
M48\)1V&L:A-'/KK6MRMY%Y<ZKM8F&48&2..>XQUZG/7^T=*\+^)O$=IK%W%)
M8:Y=R16B%?)=1<?,KKC+%LL,YXXQCN >I6VL6%YJM]I<%P'O; 1FYBVD>6)
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M!I6DV-I/?6ATH.MI<P3[955_OJ3C!!XX(["I;;QOI=UJ<5HD5X(9[AK6"]:
MBWFF7.45^YRK '&"0<$TRT\=:5>7=M&D-ZMK=SFWMK]X,6\T@R-JMG/)! )
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M*;[;]H\C/R^9M_BZ^^,9YS70U2TO5+76;'[99NS0^9)%EE(.Y'*-P?\ :4T
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M+O\ 47GE%M8WYTZ=O*;(F#*N .XRPYK?GGBMH))YY4BAB4O)([!510,DDGH
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MO;TW]PGG/\\Y8-NSG(Y4<#CCI6MJ%A:ZKIUSI][$);6YC:*6,DC<I&",CD4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KSSQCXXGC\/ZXVDV6H(EE+]E.IIL\M)@ZAE W;\ G;NV
MXS^=>AUY;JFA^)5\.>(?#5GHC7 O;^6[M[W[1$L9CDE$I4@L&WC)7ICOF@#M
M9?%-G#!XBF:&<KH0)N  ,OB%9?DY_NL!SCFLN#QA>7?C2;1UTJX73QID=Y]I
M#1Y7?O\ F/SYQ\NT #.X$GC!K+UK2O$,<GC6QL-&:[CUV/=;70N(TCC)MEB9
M7#,&!RO& 0<C)')%NVTG5['QBEU_9LDUI<Z%#8O,DL8$$L9<D,"P)!W  J#0
M _0_&,#^%]"?3[;5]7N=1BDD@BF:(7#(C8=Y&)5  2HZ\Y JX?'4$\5JVF:3
MJ.H336[W,D$(C5X41]C!@[C+!P5VKDY!KCM+\#ZEI_AWPHVI:)/?2Z?9W%K=
MV-M>+'(A>0.KJP=5;&W!&[^+/:M._P##DJ:/I\$7@Z99(X97@DTW4PD]E.[E
MB#(SJ2IR"2"PSG@C!(!W%_JRV.C?VBMG>7&50I;PQ'S6+D!5VG&#DC.< <YQ
MBL23QY:VMA/-?:9?V]S;WL5E-9X1Y%>7:4(VL0P(8=#GMBC7M/URX\$V-K^]
MN[Y#;'4$MIA"]RJE?.5&RN-V#W&1QD9KE[?PIK"7=P(-!:SM9M7T^_C3[3&_
MEQQ,H<,=Y.\!=QQD<X!.* .I_P"$[M;>UU=]3TV^L+C2UB>6VD\MWD$I(CV%
M&*DLP*XSP>M5]+\0:AJ'Q$&GW-G>:=&FD&9K.X9&!;S5 <%&8'C(Z]CQ5'Q/
MX6U?4]2\17-G;HWG6VG/:;Y% EDMYWE9#Z9^49/'S>QK0TJ#6K_Q]_;E[H\F
MG6(THVJ+--&\GF>:K'(1F !'3D].<9Q0!?F\61IXK?P];Z;>W-U&L,LLD801
MQQ.6&\DL.!MY'4YX!YQ!8^.;.\GMVDL+VVL+P2-97TH3R[D(I8X 8LN55F&X
M#(!I]EH]VGCS7M1FBVV5Y8VL$4H899D,NX8SD8W+U'>N8\+>$9]).FVDOA<_
M:M-C=?[1GU M!(RH41HXP['Y@>057:"<9XH WO\ A/HHM$N=8O-#U2ULHK07
ML4CK&PFB)&,%7(5N0=K8./H<6+?QM:_;)K?4M/O=+"V;WT4EV$VRP)C>PVL2
M",@E3@X/2N U[1[^P\)>(9(-&NM#TPZ4ZSV4MVLT+7!="K0JKML4 .#]W.5^
M7BNCUC0=9\9W\BWNFMI4,&D7=DLDLR.)9IPJY4(2=@"9RV"<CB@#<TWQFE]?
M65M=:1J&GC48VEL9+GR\3A5W$85B5;;\V& X!],56TKX@VVJG1YAI&HV]AJY
M$=K>3",(TFTML*ARP^ZPSC!(XXP:JVUEKNLZKX<:_P!&?38]&#R3R23QN)I3
M"8@L>QB=OS%LL%Z 8J*P\-:M!X1\"6$EJ!<Z5=027B>8O[M5BD4G.<'EATSU
MH U['Q<NJPR2)I.IP6,D,LEO?[8RDJIU(PQ*$]5W@9_2N<M?%T_G>"IM-&K:
MC;:E87CBWE,?GSLIBVF0Y" @%SG('U.!4EAH6JKJ\LEIH5QHT<D%P+^-;U'M
M+J1E.PQ1ACM.[G<53C(.<U6T30/$6@6?@>8Z.UR^DZ?=P7T$<\0=3(8]H4E@
MK'Y2>N, \YQD V;KQE8WL&AS,=5LI9M:&GO;1^6&2<;LQS=04XS\IYXQ67+X
MDN+>]^([:A?7XL=+-N8?LA42PJT0+>7NXR3SS4,GA/7;H:3>O8".:3Q5_:]S
M;F9";:#:5&3G#' 4D+GD]Z=J_A'6[J'XD+#9ACK*P"P_>H/-VQ!3W^7G^]B@
M#<M_%EZ_C"UT.+3+J2Q?2EO#=,\>_D@!S\XX'(( SNYQCFHM!\96\GA70Y-/
MM]7U>YU%)7MXIVB%PR1L0[R-E4 &0.O=121:3J]CXQTV]737GM7T-=.FDCEC
M'D2!]V6!8$KC^[FN;TGP-J6G>&?"9U+1)[V;3K:YMKNQMKQ8Y%\R0.KJP=5;
M&W!&[^+VH [(^.8)X;,Z;I.HZA/<0R3O;1"-)(5C?8X;>X&X/E=H)R0:VKW5
MTL]#_M06=Y."B,EM%"?.8L0 NTXP<D9SC'.<8KB;WPXZ:/I\"^#9MR)-)$VG
M:F%N+*9W+?ZUG4D'(+$%AN!X(P:VM:T_7I_ =C:%I+O4D%K]O6VF$3W*J5\Y
M4?*X+ -W&>F1F@!__";Q):SB?2;Z+4H;N.S.GDQF1I)%#)A@^S:5.<[N,'O4
MDOB]TCM(ET#4VU*Y>5%L&\I' CQO;<SA"OS+@ACG(]\<K;>'+VV_MM)?!GGZ
M9?RV\RV?VR,R*JJ5(#%^)00K=0,$@-D<S#0]2;0X(-3\.7^I6RW4TEK'_:*?
M;K%"%$>)3(,_QYQ(2 5'.#@ Z*7QF&GAMK#0]4O;QK5;N:V54B>WC8D /YC*
M-Q*L HSG![<T-XWM)[72Y-)L;O5+C4H&N(;:#8CK&N S.790N"P7&<YX%86B
MV'BCPU>G4;C3)]9FO]/@AG$=S%YL4L32;0[.RA@5D +#)RI.#FFZ3X<UOPD=
M"U"+3SJDL.GSVE[;VTJ(R/)*)@R%RH(#;E/(.,&@#8'B>ROO$7AA4?5;=]2A
MN7CMBJI'\BC<)E/S;E/3:<9SU%6+7QE]HODMFT+4X/M*2M8M,(U^U&,9*@%\
MH2.1O"Y'I65/I'B/4O%WA#6KRSMXGL[>]%YY,@*0-(H$:\G+'C!(R,@]JR=
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MD;LX.U-B\$YQQ3]<\/:[<3>.+.WTIYHM8$$UK<K-&$)2.-"A!8,#E2>F,=Z
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M6-05W9V]0><XI_BWPO?>(-798E"6TVA7MB9RPPDLK1;,CJ1\K'@=J -;1O%
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M? FHI$DD%G-J$ES(C *HD,@4@$Y()/&.QJ>Y\'LNO:I'/X:EU.._OQ<QW?\
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M=I8A<]^2/K6;;>&=;GU"PU6>P\AYO$C:G/;M*A:WA^SF)=Q!P6X4D*3][VH
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MI\M DPSG.#RZ],]:Q='M=9USP2F@0:2_V6?6)9&U#SHQ''$EZTC97=OWY4@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%>1:G!,?#GBW7CJ%_]OT[6)?L3+=R*L"JZ?*$
M!VD')!R#P<=J /7:@:\MQ=/:B53<K%YQA!R^S) ./3((_"O.[ZV_MG_A-]1O
M;^]@NM)D>*R\FZDB%JJ6Z2*X52 268DD@Y''2H=#@6_\?2:O<B=;V3PS:7;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "LN3P[I,NGWU@]FIM;Z5IKF/>W[QV().<Y'0=*U*Y?\
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M[%YL9WO, 8R'SMP0>2>F#0!U]82>#M!CU4:DMABX$QN OFOY0E/601[M@?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@'->JT4 >?Z!HVNZ;K^@WT^ECRDT./2[K%PF8'1\[NOS*1TQSZUG^&_".O\
MASP[X3G^Q1W&H:.UXEQ9K.H+QSNQRCGY=PPAP2.,\UZA10!Y['X7UFYO(M5N
M;>.&YN?$$6HS6XE#>1 D!B4$]&;@$X]?:K6I:!?OJ?B6X;1K75+/4'M,6L\B
MCS41"'QG@,#@C..G4=:[BB@#G/!FF7VE:3<0WD4MO$]TSVEK+<^>]M"54!"^
M3GY@QQDX# 9XKF;7P=K,2ZF&@C'VCQ='JL?[P<VX>,EOKA3QUKTFB@# L=+N
MH/'.LZI(BBUNK.UAB;<,EHVE+<=OOK7'^,/!^K:Y>>(472+>^>[C3^S[VXN!
MMM56, QJAY#%PQ! Q\^2>,5Z?10!SWBO3+WQ#X"U/3H(1%>WEDR+%(X^5ROW
M2PXZ\9Z51TG3=6F\96NN7MA]CC_L8V;Q&979)1-NQE3R"HSGWKKZ* /+(O"6
MM)J=A>R:'!+?V6JM=7&HO=*TMW$S. $R?E 5P2IQC:  >M:T?A;55\#6&EF%
M/M<.LK>.OF# B%Z9LY]=ASC\*[VB@#S\Z%J9\6+J$.BQZ9(MQ*]Y?VUW^ZO8
M-KA0T0.2YRA)8<$'!-9/A&QUO6_"'@>SDTZ.&PL3;WSWOGJ1(B(2B*GWMQ)7
M.>!@X)KU4@$$$9!ZBHK2TM["TBM+2%(+>% D<4:X5%'0 =A0!YEI?A+6K75M
M"OYM#@:]L+YWOK]KI7EO%=)$WJ2<A1O#%3@] !Q5^+P7J#_"ZTT2XMX7OK6[
M-U]G>3"2@7+2;"PZ;E.,]B:]$HH \ZC\)W#PP2V?ARVT@C5K*X:,7 >1HHFW
M,SD$KQEL $_K4WBGPGJNK'QE]ECC/]IZ=:PVNZ0#>\9D+ ^GWEY/K7?T4 8F
MH)JVJ^#;V*")M-U:XM)$B5I0QAD*D+\Z\=<'(Z5P,G@S5674FL/#5OIL=_H-
MSIWEBZ1Y/.8 J\C9^8,> <DC&3UX]9HH XGQ%X4O=;?2H%VI"FE7ME/(6'R-
M-$B+QWY!Z>E5K#3_ !->ZSX3EU#28K.#1Q(ER_VE9#(Q@:,,@'\.?7GYNG%=
M_10!Q_C3PX^K:CI&I#2TU5++SHY;-I1&S+(%^922!D%!P2.":S3X=U.PF\+:
MAI^@VT7V"YNI+FPMKD#8LR%0=S<,1P6]\XKT*B@#@9?"VJOX'U#2Q"GVJ?6G
MO$7S!@Q&]$P.?79SC\*K7_@O5[W4_'$\:PQ_VE+87&GL[\.]N%;#8Y4%E _'
M->CT4 <+K,7BWQ!I=PDND1VEJLMN?L NQYUTJOF93(IVJI7  [X.2,XKG-1\
M#:U<:%XBL+'0[6Q34;BSN;:"&=-L8C9-Z-_M87<2..< FO7:* ,7QAIMSK'@
MS6M-LU#W-U92PQ*S  LRD#D]*J#1[S_A,](U+8OV:VTJ:VE;<,B1GB(&._"-
MS72T4 >81>$=8@LM)@O-'CU2UAEU!I;%KI40/+<%XI6SPP"%ACDC=P":N^#/
M"^KZ/JFE->VD44-A8WEH7BD4JY>X21"H!R%*@\'IBO0J* .!T;PMJMGJ>B3S
M0H([34=3N)2) <).SF,^^0P^E4]1\%7UQ-=7DVFQ7X37I;Y;-I@GGP/ L?#9
MP&!&0"1]WWKTJB@#S^S\*W<=[X=NK?1;73(K;4Y[JXMXIMY1&@:-2Q_B<_+G
M&0/PKM8IKUM3N89;1$LTC0PW ER9&.[<"O;&%Y[Y]JMT4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7!>+/$L^G^+HM,;Q/9Z%:"P%P9+B%',CF0J -Q'8$\5WM<WK-Y?:
M;KBW$?AA]4MI+7RQ<6GE^>C[B=C!V7Y""#D'KG(H V=+9WTNV=[Z._9HPWVJ
M-0JR@\A@ 2,'VJW7)^#['4_#V@Z/I-QIW,K7$L[12J4LPSM(D?\ M ;MG'''
MI764 %%%% !1110 5Y]XAD\6:7KNBVD'B:/RM5O7@ .G)F%1&[CO\WW<5Z#7
M+^)],O+_ ,0>%;FVA,D-EJ#RW#!@-B&%U!Y//) X]: 'RZU<>'TM=.O/MFO:
MK,LDH6RMHXV\M2,L07"@#<HZY)/ -0S>/],6738K2TU"_FU&U-U;1VT(+,H8
M!@=S#:1GG..A[X!H^+M#>?Q19:P^G:EJ%H+-[62/3;QH)8WWAE;B1-RGY@>>
M#@X]&Z'X=N-/\4Z%<QZ4;*QM]'N(9(S<^?Y,LDT;["['<QX8YY'OTH MWGQ&
MTNQ:]>2PU-K2PN_L=Y>)"IB@?( +?-N(^8?=!(SR!D5++XQM;BSUN":UU32[
MBQL&O#YL48E,)#8DC&Y@2"IX;'.,BL2^\.ZK+X0\66269:XOM9:YMTWK^\CW
MQ'=UP.%;KZ5=\3:'J-]K7B">VMC)%=>&7LH6#*-\Q:0A.3_M#GIS0!:MO&EI
M%9Z/;06VJZI=WNFI>PA(H_-E3"@L_P RHK?,">0.P["K*>-;2YTG3[ZPTW4[
MYKXR".V@A42(8R0^_<P5=I&/O<GIFLKPKH6I:?JGAR:ZM3&EIX:6RF8LIV3!
MHCLX/^R>1QQ61;Z)K5I9Z7;7NF:E<V"S:@TMI8W8A;S9+DO"TA#KE-A;N<$C
M(H WI?'OFZSX:MM.TRZNK36(I93*$4,@3 (P7&"I/S9'3IDT[3_&%A;:=JUT
M]SJ5Z8M:ET^.&2)/,:;< (H@N 5'8L<XR2>*Y[1M'UO2&\'2S:+<O_93WUM=
M)#(C$"4C9(I9AN3CJ>?:DLO#&MV5G>WG]GM)-;>+Y]7BMA(FZXMV!3*DG&<.
M2 2/N]J .JD\>Z;:Z=J-U?V=_92Z=)"EU:S1J94$K!48;6*LI)Z@GH>_%7M(
M\30ZKJESIDFGW]A>01+/Y5XBJ9(F) ==K,,94C!P1Z5Q^K:+K'B Z[JJZ7/;
M&[;3H+:UG9!*R0W'F.[ ,0/O' SG"^XKH[JVOK7QS>:U%8RW-NFB")%C9=TL
MJRNWEC)')!'7CF@#H[KS_L<_V79]I\MO*\S[N_'&?;.*X_\ M+Q+_P )O_PC
MO]IZ?C^R_MWG_8&^_P"9LQM\SIWZUV4$C36\4KQ-$[H&:-\90D=#CC(]JY7[
M%>_\+8_M/[%-]@_L;[)]HXV^;YV_&,YZ=\8H K0>+I=)\1ZG9^)+^UAM[:PM
M)QY<1 5W\P2'N2H*#GH!737^NZ9ID(FNKI5C\OS2RJSA8_[YV@X7_:/'O7*:
MKIFH3:YXQFCTZ>2.^T6.TMG&W$L@$V5'/'^L7DX'7TK/CTW5=.O;2:[\/W^I
MV-YH]M930VTZH]O+$'!5U+JK(V\\Y.,'UH ](#K<6XD@E4K(NY)%PP((X(]1
M7$^&M=U[7/"4&K2ZEIT%S+-)$D1M3M9EF:-1G?GYMH^F:Z[3X%T_1[:W6V2%
M8(%000<J@ QM7U Z"N \):1)H_A*WBOO"$\NKV]Q+.A"0[BQF9T_>;N."N?;
M(YH ["]\7^'].ENHKK58(WM"HN%Y)BW=-V!P/4]!WQ4B>*=#>>ZA74[??:Q>
M?+EL 1@X+ G@@'C(S@\5RNIZ3JD\OC[;ITSG4]-CM[5E"XFD$+H0,G@;F'7%
M1W]A?I>6=VUA.EO;^&;FTFD(7"2$1D*><_P-R..E '5V'BS0M6O5L=/U6WFN
MWA\Z-!GYD(ZCIG&1D#D=\50\+>(I+KPM'?ZS<1^>UY<6P,<>/,*3R(JJ@R2=
MJ]!D\&L+P]ITVKV'P_NX[*6!-(LA-+,Z@9#6^P(G][<6#<<87G!XJ#2]$UNP
MM?#U^VG3DZ9JM]+<V>5WM%.TNV1><$J'!QG."1UH [9O%&BI9QW37Z"&2X^R
MJ=K9$V<>61C*MGC:<&K<NJV,$\\,UPL;P1+++N! 5&)"G/3D@@?0URB>$SJL
M'BYKP/:0:U,DENIX:$QQ(JS8'1MZ[O7@9YR!2?3->UGX>)J)BCFUVYFM;]X$
ME*)*(F1EC5N-H94W#T9C0!V,/B'2IXKF1+L#[,ZQS1NC))&[8VJ4(#9.1@8Y
MSQFJE]JTNI^'KZ;PW=PF^@;RQYL#.4D!&4>/Y6!QZXQD'I7)ZCI=_J%@NM:9
MX8N[2[AO+>>:VNKD+<WB1AU9=P<@8#Y7)&2#P.,]9X9MXQ'=WR:+-I;7;JSI
M=.&GE(&-SX9AZ <YP/PH N2ZU:V*1IJ$JQW C1YEC1G6/=P"2 =H+ @$XS@U
M>GGBMH'GGD6.*-2SNYP% [DUQ'BS2=3GUF:_T-+VWU18(XXW&U[2]7<V8ID/
M "Y/S<$!N">E;GC73;_5?"EW;:8%:]5XIHHV?8)#'(LFS=VW;<9]Z )G\6:%
M#;W<\^HQP):,JW G5HWC+?=RK -SVXY[5%)XT\.Q?:M^JP@VN/.4!BP!R0P
M&2N 3N&1P>:Y+6-,NM;\):Q+:>%+VSU"[BAA*W4JO/,5D#8SO(V+S@DC.>@[
M[%U97LGC35M073[AK:?0TM8Y-H^:4/(Q7&<]'7KQ0!LWGBW0+ H+G5;93);_
M &I%#;BT7'S #.1\PZ5GZGXD=[KPK<:/>V\^FZK>F%W1=WF)Y4C@JV>.4],U
MS.A+<:/XA\&VU[87'VFU\,2031JH=HV5H%)X/(R,9&>OIFI[/PUJ6FVWAB-;
M&3$.N7&H3Q1E2+6*03;5ZX./,4';GOB@#MY-?TN*\6UDO$61IO(!(.SS>OE[
M\;=_^SG/M21^(=*EM[^=+L&+3V9;MMC?N2!DAN.PY/M7#GPYJ\W@V_\ ",]I
M*;E]2::&_P CRVC:Y\[S2V<A@"1MZY [<UK:EHMQ_P )]&MHR#3]6A$NI1$\
M[K=EVL/7>&5&'<"@#9NO&/AZR:Y6YU2&-K4(9U(),089!88XZ<YZ=\59L_$.
MDW^H2V%K?Q2W,4?FLBGJF<;@>C#/!(S@URFJ:5J,U[X],>G3NNI:9';VC#;B
M9Q%(I YXY=>N*ANM"U2_O-+BCM)K=?\ A&[G3Y)VP!#-((@H.#GC8W(R.E '
M6KXHT5GE4ZA$AB@-P3("@:+IYBD@!E_VER.1ZTVS\5Z'J$PAL]1CGD-O]J58
MPQ+Q\?,O'S8R,@9(S7)Z997MYI+"]\*75KJMGI\ML9YKA95=F3;M@.\G#$ G
M(4 #OVFTC2M2M[[P&9-.GC73=)EMKQCMQ%(T<*@'GGF-N1D=* .I\.>(+7Q-
MH\>I6:2K#(6VB1"IP&(!Y Z@9]LXK#TKQC%#JVMV6N:C;QF#51:6N(]H"M'&
MR@]<99R,D\FK?@"SOM,\(6>FZA926MQ:;HV#LI#_ #L=R[2>,$=<?2N9U71=
M6N-%\:01:7<--J&J0SVJC;^]11""<YXQY;=<=O6@#N[[7]+TR7R[R[6$[E5F
M*DK&6.%WL!A,GIN(S4/_  E6A?VI_9@U. WOG>080<D/MW;3Z''-<E=:7?+K
M^MV=[X<N=7T[5YDN+>9;@+"A\M$*3H7& I0'(#$CH,C%7K?1+^YU#QS";>2U
M75$2.TN6QAL6RQ9&"2,,#UH W_\ A*M%!F!OE'E0&Y;*,,PCK(O'S(/[RY'O
M4_\ ;NE^?%";R,/+;&ZCSD!HAC+@G@@;A^8KB;#2K[5]$EM;OPO/8ZM!ILUF
M;JZN1(A9X]F(3O)VL<$D@  8YJ32(-7.M^&KR;0KV""QT::SG,ACRLG[GL&Y
M!V$#N?3'- '56'BS0=4NK>VL=3@GEN8S+"%SB11UP<8) YQUQS63XB\5_9=0
MT2VTR[C)N=6CL[C,)967G>JO]W<",$#)'/3%8>A:)JUII_P_@FTR>*32_.%Y
M]T^3NA= >O.68=,U6L=,U^#P[X9T2XT*[DNM'U:*2>X1XS'+&I<^:K%@3D-D
M@C.<^V0#T)_$&E1W\=D]XBS2.T:;@0CNHRR!\;2PP<KG/!XJ+3_%&AZM>BSL
M-2@N+@J[;(R3PC;6YZ<$@5R.@:3?6UQ'I&K>'+BYDLK][F#4GN UL5\QG60+
MOR),,1@+UYS@FM[P+975AH]Y#>6<EM*^I7<ZJ^/F229G4\$_PD4 :5_XET;3
M+M[2\U"*.Y2'SVA&6<)G&=H!-,M/%.AW]Y;6EIJ<$TUU'YL 0DB1<;CM/0G'
M.,YQVK.FM;M?B2FI?8IGLDTA[<S* 1YAE5PN,YZ ]L5SFAZ)JUGI'@"WFTN=
M)=+GD:\'R_N@8I4!X//+KTS0!V\7B32)[@017BO(5D9 $;$@C.'V'&'VG@A<
MXI]OX@TN[T^VO[>[$MK=2"*"5$8B1B2 !QZ@\UPND:?KS:[X9O;S0;BW:TFN
MTNEC:)8(0X(4QHK?<[[L;CGO6OH&BW%EXNU&S5D;1;*8WMH@/,<TZG<GL%_>
M,!Z3#TH T?&6LW6AV>F75O<0PQ2:G:V]PTJY'E/(%;DG"\$\U>L/$VBZG:7-
MU9ZC!)#:MLG.2#&WH0>1GMZ]JH>-M/N[_2[ V=LURUKJ=I=R1(1N:..56;&2
M 3@'C/-<[KWAO5M3NM:UW3;1DED-@T%G(_E-=?9Y3(VX@_*2"%7."-O;B@#N
MM/U>QU1ITM)]\ENX2:)D9'C8C(#*P!&1R,CFJ8\261\4R: %F^TQVRW#N8FV
M ,2!SC'\+<YQQCKTJ^&(5EEN]2_L&YTJ6X6-)#>2!YY2N?O89OE&<#)SUX Q
MG+UW1=3O?%>K?9[>06^IZ!]@CO%90L,H:4_,,[NDBXP#0!T"^*-$9IE.H1(8
MH/M+&0% 8NGF*2 &7_:7(Y%5H_&_AF7;LUJU^9HT7+$9+KN4#/J ?I@YKFM/
ML[V^TB7[9X3N[35;73Y;8SSW"RAV9-NV [S\K'!)(4# Z]IIM*U'_A$?!%HN
MFS^?I]S9/=1 +F)8D*N3S@X/IG/:@#H/^$V\-^3YIU:$()O(?<&!C?(&'!&5
MZCEL#D5+-K-I:ZY>)<:U;I#:V:RS6C( 81N/[UGST(P,>V:X[6]$U6[TSX@P
MP:7.TFJR1FR'RCS<0QH3UX^96ZXK1U6PU"Y\3ZQ>1:=<-!<>'A:1MA?FFW2-
MLQGT<<GCWH Z.P\4:)JET+:RU&&:8P"X51D;H^/F!/! R,XZ9YQ35\5Z+)#-
M+'>>8(K8W>$B<EX?[Z#'SK[KD<CUKE+72]7AF\(/'I3E]/T.>UG67;L29HX@
MJ-SR"8V&1D54TK2-;EU2PN)M%N[??H$]A-YCQ+'#,3&0JHK86/Y2%P,\#/K0
M!VNG>*-/O]!L=6/FQ)>1+(D1B=I#E0Q 4#+8!Z@$<5-_PD.ER6%O=07L<L=V
MK&W:%6E,F.I"KR0._IWQ7"PV&NV&F>$+Y]"OYUTW3VT^]L8;A4G7*Q?O$VN
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M!Y)!.<5JV%MK6HZYX?TC7KW4(,Z7>/<PQ7A5I@D\:QEWB;[VT@DJ<YR,X)!
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M<D 1I$9FE.PC<<\#=D?*>.M '>T5XY:>*M9AT-;NXO)FNM=\/PFS+,<"\#B
ML@Z#<9HF('I6QH=_J%SJVA^&WU"ZDFTFZO7OY3*=\T<)V0[SGG<)HV(/7;0!
MZ!INH1ZII\5Y%#<0I)G"7,+12#!(Y5N1T_*K=>-^$[O4M<\-?#^"[U?4<7TM
M^+N1+IUDF5/,(4N#GL!G.0.A%7+>6\DU&'PNVIZ@-/;Q'/:F3[4_G>0EJ)EB
M\W._!8]<YP,9H ]8HKC?!GGP>(O%>GOJ%U>6]G=PQP?:)C(8U,"-MR3G@GKU
M/4Y/-45MI/$&J^)KRZUR]TV32[Y;>T>*Z:.*W18HW+,F0C[B[9W@\<<4 =-'
M;:;>^*I[S[)>+J-A$(!</YJ1LD@#%4YV./E&< X(&:VJ\A\0:SJD,WQ4\G4;
MI/L4%DUIMF8" M%DE.?ER>3CK6_=Z6R^(M$\-RZGJC6=U!=7UU)]MD22XE7R
ME"[U(95^<MM4@=.,4 =_6=INA:9I%Q>7%C:K%->2&6=]Q8NQ)/4DX&23@<<F
MN8TYKBQ\:Z)I8UJ?4;9=.OMSO+NWLLT04/@X9T!*Y//7/)-8%M=7VJWFB6;Z
MK?+!=:_JL,K17+JSQ)YQ5-P.0!M &.G;'% 'J]%>/7,%Y9>&/$VH1ZSJQFT/
M5S#I^Z^D(CC#1-M<9_>9WL/GW<8%;U\EW8>,7NM6?5UM+B_BCL[ZSO2;>-6"
MH()8-V%RY(W[3RP.X'H =]!<P7*N8)HY0CM&Q1@VUE."IQT(/!%2UY!H5O!8
M>%KJ".;69+C4/$5Q:I!;7SB2?9+*VW>[_NP55BS@ACCDDTZQN=3NY=-TB2^U
M&TB7Q)<63(+UI)1"+5I/*:4'+8)(!SD<8.0#0!Z[17E4ES>V5Q?>&X=2OULF
M\1VUBLSW+M-%!);K*R+*Q+#+?*#G(W<&K6O076D7FG:!I][J>I6MY?.TEG'J
M&VXB18"PB\]G#A21OY;. 0#B@#TNBO,VL/%#Z);175GJ<MM;W\Q:PCU4)=RV
MQ7]W^^5_F*,2,%P2 ,D]^I\.16^I:;I&J6^HZK*EO%+$$NI,,YW;6$R_Q.A4
MKGV/)SF@#HZ*** "BBB@ HHHH **** &31)/"\,B[HY%*L/4'@U4TG1[#0K!
M+'3;9;>W4Y"@EB3ZDDDD\#DGL*O44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 50U;1=/UNW2#4;83)&XDC(9D:-P"-RLI!4X)Y!'6K]% %+3
MM*L]*C9+2-P6QN>65I7;'3+N2QQSU-7:** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ K.UC0['7888[U9<P2B:&2"9X9(W
MP1E70@CAB.O0UHT4 8-GX-T*PN(YK:S>-HKD748\^0JLOEF,N%+8R5)SZGDY
M/-)JVGSV-MJ4^AZ5#=ZAJ;C[0+B<I&3Y>P.V<\ *H*J.:WZ* ,;PIX?A\*^%
M]/T6!@ZVL05GQC>YY9OQ8DU#J?@S1-6OKB]N(;A;FYC6*>6"[EA,D8!&P[&&
M5YY'>M^B@#.M]!TRTU""^M[58IX+06411B%2$$$(%SCJ!VSQ5-/"&BIK']IK
M;RB;SS<B+[1)Y(F/63RMVS?[XSGGKS6[10!S</@/P_!/#-';7 >WG^T6_P#I
M<N(&R21&-V$4[CE1@'.".E26W@G0;34OMT5I()%=Y(XFN)&AB=\[V2,MM0G)
MY '4^M=!10!E1>'-*AL]*M([7$&DLKV2^8W[HJA0<YRWRL1SGK4NKZ+8ZY:I
M;WT3,L<@EB>.1HWB<=&5U(*GD\@]S6A10!@-X,T*30+K19;1Y;*[D$MSYD\C
M23."K;FD+;B<JO?MCI6Y+$D\+Q2J'C=2K*>A!X(I]% &'I7A'1]&-D;.&?-B
MDD=L9;F27RD?8&4;F/RXC3 [8XQDTLOA+1)EB62S)$6H_P!J)^]?BYR3OZ^I
M/'3VK;HH PH?"&C0:L-12&?S1,UPL1N9#"DK9W2"(ML#')Y ZDGK5ZXT:PNM
M8L]6G@WWMFCI;R%VQ&'P&PN<9( &<9J_10!1U71[#6[>*"_@\U(9DN(\.RE)
M$.58%2""#7 WO@B^OM6> :/;6\#ZHEZU['?R-$$642$K;DD+*VW:2 !RQSSB
MO3** *%OHNGVIU Q6R_\3&4RW08EA*Q4(<@G &U0,#BL^P\&:'IRSK';2S+-
M;FU*W5Q).%@/6)0[':GL,=!Z"M^B@#G8O ^@QV5[:-;W$\5Y!]FE-Q=RRMY(
MZ1JS,2J\] 16M_95G_:T6J>3_ID5NULDFX\1LRL1C..JKSC/%7** ,"7P9HD
MEA:V:03P):/(]O);W4L4L9D8L^'5@V&).1G'3T%6[+P[I6G3V<UI:")[.V>U
M@(=OEC9E9AR>22H.3D^_)K4HH P+GP9H=U9Q6S6TT:17<E[&\-S)&Z3.6+L'
M5@PSO;C..:OZQHMCKMA]COXF>(.LB%)&C='4Y5E92"I![@UH44 <_%X*T&*W
MNH1:2.+MX9+AY+B1WE>)MZ,S%B20P!SGGH<BKM[X?TO4;FYN+NT6:2ZM/L4V
MYCAX<D[<9QU8\]:TZ* .?T_P5H6G70NH[>::X$#VWFW5U+.WE-C,?SL?E^48
M';GU.66_@;0+:VNK<6T\D5S:M9LL]W+)L@;K&A9CL7V7'0>@KHZ* (X(8[:W
MC@B7;'$@1!G. !@5B#P9H:W\]X+:;S)KM+UT^TR>7YZD$2!-VT'(&>.>];]%
M &5=^&])OI-0>ZM!*VHQ1PW.7;YUC+%._P I!8D$8.?H*=I&@V&B"<V@G:6X
M(,TUQ</-(^!@ NY)P!T&<"M.B@"@^C6#Z['K309U"*W:V27>W$98,1C..H'.
M,UG0>"]"M]22^CMI0T<YN8X#<R&".4YRZQ%M@;DG('4YKH** ,&Y\&:#=V6K
MV<]B6@U>437J^<X\UQC!R#E?NCICI3M5\(Z/K%S]INHKA)C#Y$C6]U+"98N?
MD?8PW+R>#GJ?6MRB@#)N_#&C7S:4T]C&?[*=9+(*2HA(  P 0"!@<'C@>E26
MN@:99:W?:S;VH34+]46XFW,=X48'!.!P!T S@9K2HH Q=-\):)I,&F065F8H
M]+,ILQYKMY9DSOZDYSN/7.,\5F^(_"T4NG2?V;I45U-+J"W\Z/=R0.7VA2\4
MBG*/@+CH,9'>NLHH Y3P3X>N-%_M:[N;:.T?4+E95MDG,QC545!ND/+.Q!8G
MGD]35S4O!FAZMJ3WUW:R-++L\]$N)$CN-GW?,16"OC_:!]*WZ* ,2Z\(Z'>-
MK+3V1<ZRL:W_ .]<>:$7:O0_+@?W<5/K'A_3M<CMQ>1RB2W8O!-!.\,L1(P=
MKH0PR.",\UJ44 <]+X(T&2TL+9+::W6PWBW>VNI8I%#\N"ZL&.X\G).3SUJ>
MR\)Z)IQLOLEB(A93RW%N%D;$;RA@YQGN&;@\#/&*VJ* ,B7PQI$]AJ-C):$V
M^HSFXND\QAYDAV\YSD?<7@8'%0OX0T:35SJ30S^:9UN6B%S((6F&,2&+=L+#
M .<=0#UK=HH YM_ F@N;DK#=1F>Z^V'RKV9/+F^;+QX;Y"=S9VXSGFI;+P7H
M.GWB75M9NDL<XN5S<2%1+Y9B+[2V-Q4D$_Q=3DC-;]% &/=^%M&OH]02XM-P
MU"9)[@B1PQD155'4@Y0@(N"N.E5E\$Z$NG-9^1.=UP+HW!NI3<><!M#^;NW[
ML<=>G'2NAHH Y]_!>B-8V]JD5S%]GD>6.>&[E2?>_P!\F4-O8MWR3GCT%6[3
MPYI5B]@]M;-&;".2.WQ*^%#X+Y&?F)(SELG.3GDUJT4 %%%% !1110 4444
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MKE0>Y /% %RBBB@ HJM>:A9:>L37EU#;B:18H_-<+O=C@*,]23VJS0 4444
M%%%5_MUI]O\ L'VJ#[9Y?F_9_,'F;,XW;>N,\9H L4457O;ZTTVSDN[ZYAMK
M:,9>69PJJ/<F@"Q12(ZR(KH0589!'<4M !14%Y>6NGVDEU>7$5O;Q#<\LKA5
M4>I)X%212I-$DL3!XW4,K#H0>AH ?1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+J=^ETTFR,NB>1((V*J74G+$$#=P,]:Z7P_=ZI>Z/%+K-@+*_#,LD2L&4X)
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MUZ#--%;0O-/*D42#<[NP55'J2>E,MKJWO+2*[MIHYK>5!)'*C95E(R"#W&*
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MO4,DJE"K(0O&/+3CD<?6GR>$K22YU"=KR],E_9K93DNIS&N[&,KU^=N??Z8
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M#)8E@.,G"Y/.,UTT_@K2W33#:O<V-QII?[/<VT@$@#\N&W A@QY.0>>:@A\
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MZ;:V%JFRWMHEAC7T51@?RKB+;1-1C\ >-K(V<@NKZXU-[>/',HDW;"/KD8H
MUXO&5C;V&CQ_\3#4[F\L$NQ]GM=TABVKF5U7A<D]!WR #BLN7Q]%<:SX>N--
M-U<Z7J-M>E8(;<-)/)%)&BD=P!^\/4#')JEHMMJ?AO4-"NY=(N[O?X;MK"2&
MWV&2&:(YPP9AA3O(W= 5YJOX L+V7_A$[\VV((+?54F=.4C=[I2H!]]K8^E
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MV\*":X&EV[EI!U;<6R>>]='=Z3J%P?B#(EE*/[2L8TM 0,RM]F*[1[ACCZT
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M&>2-RG'7&:U)O#UWXBL/&%_<6\NF_P!I&%[ 7.%DC:! 4E89.WYQT/.!SUH
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MS((@Q4.ZYR =K$ 9) Z5R6JZ5K.M-XBNUT:ZA2]OM+DMXI0-[1Q2+O) )Q@
MG'ICOQ6WXVM9GU$7%EINM+J2VFVSU'2I!R^2?*E4G;L!VGY@1R>F.0#HO^$E
MTXIK#AI"NDH'N2$[&(2C;Z_*15+4/'&F:>B2-;W\T0M4O)Y8+<NMO"V</(>W
M1C@9. 3BN7O8->M#XNM)-%NKN[UJSC,,UL%,/F?9A$X9B?EPRDX[@C&:IZWI
M&NWNFW>ERV.LS%]&A@T^.UNFAMTD\HB3SMK#)#8X;((P .M '::EXXTW3KV\
MM!;7]W-9Q)/.MI;^8$C8$A\YQC /N>P.#4">-H[CQAI^CVEE<3VMYI_VU+M(
M\J59D"MU^[ACD^N*HZ)I]^]UXCNI+">!;S3;2.%95VLS+%(&7'J"0/QJEX?T
M[4]'USPC/<Z7=M$/#<>FS-&H;R)@8B0_/ ^4\^U '2^,/$[^%]/M+B.QFNWN
M;R&V"QKG =U![]<$X]3BHK[QSIMA-/&]IJ4HM(DEO7AMBXM%9=P\SGJ%Y(&2
M!S3/B!9WEUH5G)96DMV]IJ5I=/#" 79(Y59MH/4X[5ARG5--/BF&+0=0N_[=
M(N;)D1<!G@2,QRDM^[*LO.>,'CTH ]"BFBF@2>*17B=0ZN#P5(R#],5SEIXZ
MTJ[+GR+^"/[+)=P23VY1;F*/&YH\]>H.#@X(-:.F:?=:3X0L]-A='O+2P2!'
M/W3(L84'Z9%>:1Z5K,[:?=/I?B"6X.F75K>2WUPTF;F2(?<C+E53<I&Y0 <K
MZ4 =Q:>/-+O9K=([7456ZMWN+21[8JMT$7<PC.>3CD9QGL35UO%FE?V%INL)
M)));:D\,=J$3+.TI 48['KGTP?2L6#2+])?A^3:N!I\++=<?ZD_92F#_ ,"X
MK'\.Z/<+\0+G1&56T?P]<2W]K@Y >Y7*)CMLW3_@RT =7X]U2\T3P)K.I:?+
MY-W;6Y>*3:&VMD<X((-0W/C2STJTM_MD%]<2+91W=W+;6Y=+>-@?G<CH/E8X
M&3@$XI_Q#T^[U7X?:W8V,#SW4]L4CB3JQR.!7)>(M*UR_@OM-DLM9G632(X=
M.2TNFAMUD,;"3SBK+D@XX;((X ZT =K-XOTJ"RUBZ=Y=FDLJW "98[E5EV#^
M+<'&/4U/!XETZYFT>*%WD;5K=KFVVKQY:JK%F]/OJ/J:XB;0]4NO$>BM#I\Z
M:;J45G)J7F #R7M"SJ'&>K'8O_ :L^$M(U/1]4U6[O[&46^CVLEEI@!&9XC+
M)+E?3Y1"OU6@#T6N.L_&>G6=GJEU=ZA=W<<.MR:<,VH!BDXQ$H3EU&>#RQS7
M3Z;>KJ6EV=^B-&MS DP1^JAE!P??FO-=/\.:O%%?B33Y09/'!U!<@<V^Y3YG
MTX- '80^-]*:RU.XNH[RR;32GVF"Y@*R#?\ ZO"C.[<>!CJ>*P/&/CR6'P'K
M]YI(N]-UC3EA8Q7EN!(BR2* VTY4@C<,\]#T-,\1^']5O-8\1W=I9O+_ ,@N
MYMUR +@V\KNZ GC.,#GN13/&\FM^,/ 'B*RL_#UY K) MJEP LT[B56?Y,\*
M !R3SSZ4 =M'KEF][J-GE_.TZ&.:X^7C:X8C'K]TUFMXXTPKIQMK>_NWOK-;
MY8[:W+M' V,.XSQUQ@9)P< UD7R:GIGBGQ \6CWEXFK6%O';20!2BR(LBE9"
M2-GWE.?3..>*S_#]KJOA>ZTB[GT6^NTF\.V=BZ6RJSPSQ;B48$C ._KTR#F@
M"YX>\62W^G^$);W5IA<:I-<J$BMT*7(0O@,<?(  "".O>M6+X@:1--"%@O\
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MHA$3L4*&XP 1MZ]:@DDU)? WC+7SK6IF]M[J^MK7_2G"01K.<87.,C'!Z@8
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M#3M1OYP?#EQ>XN[AIPL\;JHD4,2%X<Y PO XH ] OK^Q6]MM(NBQEU&.41H
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M4#;=TJ*>""#P365KDWBCP=IDFN2:VNLV-KA[NUGM$B?RL_,T;ICY@.<$$'%
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MRR-(&W,I/8DXP,8HG\$:!<2Q,UFZ1QVZ6I@BG=(I(DSL1T4@.%R<9!ZUT-%
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MA2S%CC/;+'CM5ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY^1'?)#'K_$< @9XKGO#_@6[NH;W5]<O]4L=6U2=YKJWL[W:B+DB.,[<AMJ
M#->A44 >7Z?X8U_0(M/B@L7OK?P]JDKV">>@>YLY8G7:"2!O0N1\VT$#BM+5
M8_$VHS:%K4N@DM8:I)*+"*>/SEMVA:,%BS["VYLD!N 1UYKOJ* *EG<7<\]X
MES8FVCBEV0.90_GIM!WX'W>21@^F>]6Z** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KEH-?ENO$NM
M2O=+;:'H<?E3L5'[V8H)').,A40KP.I8YZ5U->:PZ3/J.E_$;PQ&P2_N;J6>
M+<<!DGA7RSGTRK+^!H Z"/Q,OB*"YT[2FO=+U5[7[39O>VNT2)D8<!LY7)4$
M<, W;@UI^%]<'B/PW9:IY7DR3*5FBS_JY%)5U_!E(JEHNOW]_.%N="NM-M(+
M7=<3WFU-LO'R( 3N4#<2W3@=<\5?AI&__"&QW;*46^NKF\C4C&(Y)G9/S4@_
MC0!UU%%% !1110!!>1W,MG,EG.D%RRD1RR1^8J-V)7(S],BN#M[GQM/XPOM
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M*N&R@N_[-AB" CG+*V0#6=IF@ZG#X0\"6LEC*L]CJ:S7,9',2A9OF/XLOYT
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M<?6@#T74M.MM6TZ>PO$9[:==DJ*Y7<O<$@@X/0CN.*L1QI%&L<:*B( JJHP
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**P_%VL7.@^&;G4+)(7N5>*.-9@2FYY%3G!!_B]:/#]QK-SYSZE>Z-=1#"H=
M-5QANX8LS>U &Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5DZOH
M]UJ<T+V^NZCIHC!#):"+$G^]O1C^6*UJ* ,3Q9%#-X<N$N-&;6;?=&TMDG+.
MH<$D#^(C&[;WQBN=\+VMM-XYNM3T31Y],T?^SE@F$EFUHL\_F94B-@I.U=P+
M8_BQVKO:* ,G4-'NKW5(+N'7=1LXHMNZU@$7ERX.3NW(6YZ'!' K6HHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>exhibit1060-kumaremploym006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5CS\P)8<<< ^M5I_!.I:Q=:I=:WJMN\FH:2^F%+2W*)$I)(8;F))Y).?;TH
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MNQTSP1_9^K>(+TWHD74D>.VC\O'V579Y''7G+R$]N@JM8> )+*V\&1'44?\
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M;)R<.&"@\*!AQR<5/#XD\1Z?HCZ_K-GI\FEG3GOBMH662W(4.L;%B?,R"1N
M&".F*DO?!VH:SJ,/]M:A9W-C;O,T;QVGEW+I(CIY;.&V[0LAZ*,[126W@_5Y
M]-_L?6M;CN-)CL)+%(K:W,3S*RA \I+,"RJ., #))]J "T\0>(;+4]&@UQ-.
M:+5XY/*%HCJUO*L9DV,68[P5##("\CIS5'1?&'B*ZM/"VJZA!IJV&N2+ 8($
M?S8F:)W5]Q8@@E#\N,@$<FM.Q\+:O)J.EW&MZK;74>DQ.EJMO;-&TCLFSS)"
M6/.W/ P,L3Z"G6O@V2VT#PKIAO58Z%/%*TGE_P"NV1NF ,\9WY[]* .6U76M
M;U_0=&U>2.Q72;O7;000HKB:-%N@%=F+%6SMZ!1C<.3BN@N?&-]#X4\0:LMO
M;F;3=1EM(E(;:RK*J MSG.#VJLG@/5H[*QTA=:MAH^GZC'>VR"U/G,JS>8(W
M;?@@<@$ 'H>Q!74? NK7=KK.EP:S;0Z5J5X;T@VI:97+*Q3=NQMW+GIG!Q[T
M 79==\1ZAJFJ_P!A6NGRV>E7*VKPW&X2W3[4=]C[@J8#@#(.2#TIGA2]UR[\
M8^*XK^\MY;*UNTBBB6-@4S%&PVDL0!@G(QRQ)X'%2W7A;6(]2U-M'UJ*QLM5
MF6>Y!MRTT3A55C$VX ;E0?>!P>1Z4R?0M<TB\\4ZGI%[ _\ :,7GP0M;EI4N
M%B5%P=VTJ=G0CJ>M '8UYE8^++JTL]:DTW2=.CN/^$M;3-JJR+,6*+YKD'[Y
MR,GVZ5Z7%O$2>807VC<1Z]ZXJV\!26Z7BG4$;[1XD&N#]T?E&Y3Y?7K\O7WZ
M4 :?A[5]5GUW6-%UC[')/8I!,D]I&T:NDH? *LS$$%#WYR.E4/&5[KEOXD\*
M6NE7EO!%=7DBR++&[!RL,C8;:PRO?'J%/;%;EGHK6OBG5=9,X9;Z"WA$6W!3
MRO,YSGG/F?I57Q-H-[JUSH]]IUY!;WFF7+3I]HB,D;AHV0@@,IZ-GKVH XO2
M=9US0M'U34X4L&TJ'Q%<Q312*YFD62\*%E8$!<%^A!S@\BKM]\2_LVM7:B^T
M9;6TU!;%["1S]LE&Y4>1?FP,$DA=IR%/(S6U+X+DD\+:AHWVY0UWJ;WXE\OA
M0;D3[<9YZ;<_C4L/AW6+#5;G^SM5MH-,NKW[9*CVN^=6)!D1&+;=K$'DJ2-Q
MQV( -[5+J6QTB]O(+=KF:"!Y4@7K(RJ2%'N2,5Q%OXYU$>&[C4Q<:+JK.UO!
M:BQ9X]EQ*X3RY58L1@L#G@D \"N[O(9KBQGAM[EK:>2-ECG50QC8CA@#P<'G
M!KC+CP)?:L]_=:KJ%E'J$T4*0S6%H8PKQ2>:DCAF)<[@.,C R.] $.MZQJ\5
MCXAT#6S8S2OH-Q>P7%G&\:E0"CJRLS<@LI!SSGH*R-+\9/H_ACPKH\&I:-IT
MG]@V]T\^JL=KY4*J* R\DJV3DX '!S73OX2U+4Y-4O-8U&U>^N],DTR#[+;L
MD<*/DLQ#,2Q)VGJ.% ]ZCM?!VIZ/;Z0^CZE:+>6>EQZ9.UU;,\<J)]UP P((
M.[C)!#8]Z .A\.:PGB#PYI^K)'Y8NX%E*9SM)'(SWP<\UY[XFUK6]=\'7VHK
M'8KHIU2.VBB"OY^V.[1/,+;MIRRGY=HP#G/:O3K*&:WL8(;BX:YFCC59)V0*
M9& Y; X&3S@5Q%UX#U:73KG1(-:MHM%>_P#MT49M29E)F$QC+;\;=V3G&>E
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MU[*UO5AB!-O=)NBD^91AAD9%9]QX@\17&J:M8:/%I<,>FV5O<[[F-VWEU<[
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M59#*5R/+7'&?KS7&:*;&VT;PAJ45R!>-XAGMC,;@LQB,EP"G)^Z1M./7![T
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MMI6+RSN>(]F$F<D<\+[5G:'9#6/%VF6OB1GDU ^'+:>X@:=E/GK)G<5!&&&
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M+F*!V2[FMH$'3[H*.QR<^G8UFZ?XD\7W=IX3NFO--'_"0Q[#%]E;%L?*,GF
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M(=A1UCV-U5@,&G*4(PI4@=A7G7Q%@L[CQAX2COM#DUJ I>DV<<:.6.V/!P[
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M3RQ))+GL.G-/?6I=8\8?#75;N(12O%J?FJJE1E(PI(!Y .W(SV(H ]6(!QD
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MTB_QM\W4^@]* /3WO--LWFCDN;2!E3SI59U4A2<;F'IGC)JRD42KA(T"XQ@
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M'3[F P!]Z9<JRMD;2"Y]<X[5T<4L<T22Q.LD;J&1U.0P/0@]Q2QRQR@F-U<
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M3+^2,V-C?XO&MM\>7DB(5UR.""<#<#\N>U=^\MV-3AB6&$VC1.SR&4APX*X
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M.,9!Z5RUC/\ Z-/HNC7$VI6']EW:I:W5ELN=,.SY8R^!G).W:>>!R0*];HH
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M '21P?P.#^%85MIE[XCTS2-2GDN='\0::'@=S"&&X@+(-K##QL5# CT!!ZT
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MJ/9/;PZ=(+>),/MQ<%<-("HW#)'+ #BH+7Q%XF.C:=X@FU*!K>76/L#V0ME
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M#VU?$^M3^'_"5_K,=K'/+:6YF,+R% <#)&0#2:[H#ZW'/;R72"SN+<P36\T
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M0LI57A8_=9@7'(/4'CI6G=>#DU&_AN;^]:9K9[AK>5(@DR+*KJ4,F>54.<#
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MX'4^E;T>ER:;XSO-5A0M;ZK;Q13X&3'+%N"L1_=96P3V*CUX73/"T%EX?O\
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MQ%<'2WLDETBQ2.$Q@"/"39C!'!VY ('M5WP3?+9>&?"VB7,-Q'>OH\<NUXR
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M+BT<&,%@-QRO\.1\H]172?$0/'8:)=^5-)#9ZU:W$YBC:0I&K'+84$X&1T%
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M-'%DMUI]JLY:57W$.#')@OG.<#)4\T =K>^,= L'MDGU)-UU")[<1HTAEC)
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M*X;Q3:)I,I7_ )93 _+*?I$TO_? H ]%T[4[/5M-AU&QF$MI.N^.7!4,OKR
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MP.@      Z5J5YS_ &[JEG8ZWIMWKTOGV>KQ6<%Z+-9+B5'C238D:+M:3#,
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MGI0 0>$;*WTOP]8+/<&+0Y$DMV)7+E(VC&_CT<GC'-6->\.VOB$Z6;F6:/\
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M+MV!LD#&>IQUH Y_6O!@T^SN+^"?6M0NI+R"\=X'B\^.9!L,R IACMX,?3'
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M_?RMIUHAM[&<($MI&B"MT4,2 64;B<9-:]QXTT*!+(B[>X-] ;BU2V@DF:=
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M'&!/<2KL 7U"(6R?5@.QIS>)[*PU?Q%]NUA#;:7' \UN+1P;4.I.2_/F;NO
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MO8A';6TAB\LH&**'!S\NTL, $UZM4-W=P6%E/>7,@CMX(VEE<@G:JC)/'L*
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M/WG/G%W<YXY&9&X^E,U+P1INIW=Y,]S?P0W^/MUK;S[(KK "_.,9&5 !VD9
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M@@@8XXR.QK$G\$*GBC18]/%W9:;8:7<0QW-M, \<K21D9+9W%AO)R"#R>N*
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MGNDD=K^VBMI@'(PL;,R%<<A@SDY]AZ5-H^AQZ0T\GVV^O9Y]H>:\FWMA<[5
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MT*UT>P\S[+:J5C\QMS8))Y/U-:5 !1110 4444 %%%% !1110 4444 %%%%
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ML.I"VO&,5O<?9&,<LH!_=*1U<[2  ,$C&<U=B\;Z6^FW5V\5[#+:W*VDEG)
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MDT"Z>+4;F8XV^='"\6P^Y/DM_P !-8D'A?7I_!WB%+VPF:^BMK?2+)#@M+!
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M$#1!(R"=^2^<CC _"I/&UK<-J37-AIVM1ZJMIML]0TN0%7?+$13*3MV@X/S
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M-L[]K*&V%FBQQ_O(T7<_WO,R_(S@ FNM\1>(4L+76+.VD9-2MM)EOXVV JH
M8*>>"=R]*XT>'=8'@[QE -/E-S/XBDO[>'@-/$LT4F5R>X1L5=OX=4U[5M>O
MXM&O;>WG\.26=N+A KR2[G.-N>/O #/\L4 =9X0O[G5?!FB:A>2>9=7-C#-*
M^T+N=D!)P.!R>U;58?@NTN-/\#Z%9W<317$%A!'+&W5&" $'\:W* "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *J:CJ5OI=NL]T9=C2+&/+B:0[F.!PH)Q[]!5NN-^)FHWNE^&;6>Q
MN9;>5M2M8R\;8)5I "/H10!V5-DD6*)Y'.%0%B?0"O,]9_M*[D\?7:ZYJ5O_
M &.!)8QV\Y18W%HDG(_B!;^$\<GUJ9)K[Q-J.N//JMY9KIVG6S01VTNR/S)(
M3(SNO1QG P>, T =_I]_;:KIMMJ%G)YEK<Q+-$^TC<C#(.#R.#WJS7G'P^O;
MG[1X?L?/?[*/"EK,(<_+OW8W8]<<54\/W^H^)1X>TJZU:^BAFL[V\GFMYS'+
M.R7 C1=XY  8G ZX% 'J5%>9:E/JZ:U9>'VN]<U:*VT]IWN-)EB@ED<RLBF0
MLZYVA<8!P2<D=J?8KKVM>(=,TK6M0U"P?^P?.NXK:81,TPEV;MR$@$CD[3Z#
MIP0#TJBO*-$N]771_!FN7&MW]Q=7VH"RN8Y)/W,D1651\@XW?(IW=2<_02>&
MM2\1ZI=Z7J\=IKC_ &F\?[8TT\/V+[.6=<)'YFY2F$P=H)P<YS0!ZG3(YHI3
M((Y$<QML<*P.UL X/H<$'\:\KTVXU5/#WASQ!)KFHRW5QK*6DD3S$PM"]PT6
MTIT)Q@[CSGOCBMSX<V M[OQ5-]JNY2-:GAVS3LZX4)@X/\7;/H!0!W=07EY;
MZ?93WMW,L-M!&TDLC=%4#))_"N?\;7EW!::396ES):G4M3ALY9XCATC8,S;3
MV)";<]MU<3XQ@N+;2?&F@-J>H7%E;:1'J$!EN6=T9O-5HV<\LAV X)- 'IVC
MZS9:[IZ7]@TS6SGY&E@>(L.N0' )!SP>AJ_6)X1LEL?"NFQK/<3!K>-]T\ID
M(R@X!/0>@K(U!+C7?'MQHTFHWUG96>FQ7"I9SF%I9))'7<6')"B,8'3).<T
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MIAM+F:0R2QB>10R%CRPX/7)PV*],TRP_LS3X[3[5=76S)\ZZE\R1LDGEOQ_
M4 6Z8TT221QO(BR29V*6 +8Y.!WKD+]+G7O'MSHTFHWUG966G17"I9SF%I))
M'==Q8<D*(Q@=,DYS7)Z8]UK^O^!+J_U"\:XVZE"[Q3%!+Y$FQ7P.,L!\WKTH
M ]3TW4[35[(7EC+YL!>2,-M*_,CE&&#SPRD?A5NO(-*BO-,\):=K=OJM\DG_
M  D#0"V67$!B>_:-U*=#G<QW'D$\'BKEGJ7B/4M6EU&SM-<EECUE[?(GA%D+
M:.<Q.IC,F[.Q6;=MSN]J /4Z*XCP$E]?S:MJM]JM[<&/4KVT@MVE_=)&LQQ\
MO=AC )Z# K0^(5Y>:?X&U&ZL+A[:Z3RO+E3JI,J#^1- '3T5YX-'O'\=W6@G
MQ'K7V"32TO6_TLB03>8Z95P,JN!G:,#(';BLJTUF_P!=\-^'EDNM<N;]M*-S
M/%I<L<!SD*)I)&=1U5L*,Y.21Q0!ZJ9HEF6$R()74LJ%AN(& 2!Z#(_,4^O)
M-)N+G5/%'AG6[N[NWN6\*M>ND<Q5'D#0Y&T<88]1T/'I5GPI>^([K^Q]2:WU
MUH;ZT>74)[R>%K8[HBZ/"BR$IAL  */E;GD4 >CZEJ5OI-B]Y=F7R4*@^5$T
MC9) 'RJ"3R?2K=>-3WNLV'P.C\1G7M1EU2]CLF:5ISB,>:JX0=LJ<,>I[UJ^
M-=8O;>]UB^TVXUN5]+,*EH)8XK2V?"L4=6<&4L&&?E. P P: /0+?6K"ZUJ]
MTB&?=?621R3Q[&&Q7!*G.,'.#T-:%>731:G-\0?'\>C.5U!M/L?)(8*3PV0&
M/ )&0">A(KI_!=TDJZA:^=K"S02(9+/5COFM]R]GR=ZM@D')'!^E &_J&I6^
MF1127)EVRRK"OEQ-(=S' R%!P/<\#O5NN-^)&HWNF:3H\EE<RV[RZS:0NT;8
M+(SX93[&N>UA]4FT_P >:HFN:E ^C7#M8QPS;40I;QR88?Q*2?NGCKZT >IT
M5%;2&:UAE8 %T#''N*X@0W_B/6?$<PU^\TMM+O$MK01/B*,+%'(7D3@2;BY^
M\>@XQUH [RLW6- T[78X%OX79H'WPRQ3/#)&Q&"5="&&1P<'FN%OIM1U/3?&
M.NC6KZTN-'GGCLHH)ML*"&)7!=.C[B23NSP1C%'F:CXBOO$4LFKZC916VG6M
MS!#:3F,1RO"S$G')&0..AYSGC !Z!I>E66BV"66GP"&W0E@N2Q))R2222222
M22<FKE>:Z5+J/BK6=.@N]7O[>WF\-6E[*EG,82TSL^6R.1]!UP.PQ658:]K.
MM6GAZSG_ +;O =+DN)FTJ:.&:602^6K.S.G "DX!Y+<B@#U^F&:(3K 9$$K*
M7$>X;BH(!./3)'YBO.M-.NZ_JMCHFN7NH:;-;:.MS,+6812RS-*\89F3(X5
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M9UG^QH[9][Z1*%E@FSGS'3(,BA>PST.0<U#9:S<W#>,9(]2DG@M["WFM9<X
MW6Q;>H[9/S4 =[51]3M$U>+2VEQ>2P/<)'M/**RJQSTZNO'O7 :0VH>*[F*R
MN-:U"R2TT*QN%>VF*-)-,KEI'/\ $!L'!XY.:LZAITVI>/= M9M6GW?V'<&>
MZLV\EI\209(()* G!X/MG% 'H-%<SX#N[JZ\,E;RYEN9;:]NK432G+NL<[HI
M8]SM4<]ZZ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*VA3<L:'!9BS!1R1@9R>PJNOCG[5XHT/3]/TZXN;#4[%KP7*JHPI,84\L"
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M]0N'NIP)6#>8[!BRL#E2" 1CIBL#XG>(M4T'1+)-*CNDGO;V*W-S D;F)6<
M@!SC>P.!P1USBKFG^+8H]2M_#QLM9N=22*%YVFBBW1H^1OD*L%&,<X]> ><
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MN(XRUJ7&5D;YBK+Z%2W/;K73>%'NY/#ML]])J$EPPRS7ZQ+*?PB^7'IWQUH
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MQR2!N"[<G&:?8>++?4=3%K#IVHBW>:6".^:)?(DDC+!P"&+#E&&64 D<$\4
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MF D7"_*#NVMP2.V#8NO#>H+IWC^VM[(A=0M4BL%#@^9BT$> 2?[PQSBO0:*
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M:TM.\,>!]4^U_9?#>E-]EN7M9<V*#$BXR!QSU'-7?^$#\(_]"SI'_@''_A0
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M=R[,6&WM@\=1S4;^!]!FT:^TNXMY[FWORINFN+J6267:05S(6W8&!@9Q^9H
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M4(H9_#-M=RP6MT]N))C(X,GR$$?AP<C.<"J&FZKK.NQ:)I\\>K:E''973O\
M8K\6LDS1W)A21WWH6PJ@X!Y+Y(-=C>>"X;_QD;R2*2#3X])BLX'M+E[=T99'
M)4&,@A=K+QT_*M2?P;HDUE8VB6TMLEA&8K9K2XD@>-#C<N]&#$' R">2,]:
M.-M;;7-4\1^'-(UO4-0MF.CSRWD5O=E#,R31JA9HSC<0025/J.A(K/@TZ[L+
M/QGK6E7>HF\TO7C<>3]ME9)XHXXF>-E+8;*EADC/"CL*],M/#NDV%W9W-K:+
M%+9VILX"K-A(B5)7&<'E0<GGWK/O-%_LB?4-6T'3#=:E?G$T$EZT<#,0!O9"
M2N?E4$A<D4 5= U*3Q'XOU'5+6[E;1[2VBM+=%<^7+*X$KOCH2%:-0>WS4[Q
M;)-<Z[X;T07-Q;6>H7$QN6MY6B=UCB+B,.I!4$\G!!PM7_!OAN+PGX5L='C*
M,T*EI708#R,<L1[9/'L!5W5]$L=<MHX+Z-V$4@EBDCE:.2)QG#*ZD,IY/0]S
M0!Y%X[@<>"/'.E/>7T]KI%U;-:-+=R,RB01,8W).9 "Q(#YQD>@KV2PL8M.L
MH[6&2XDC3.&N)WF<Y.>7<ECU[FLI_!FA2>'KK0Y;1Y+&\?S+D23R-),^0=S2
M%MQ.57G/;'2MZ@#S;PW_ ,)/_:GBO^QCI'V;^W)L_;/-W[MD>?N\8QC]:T-6
M@OM1\:>']+O[ZX@BFTRZDO(;"XDA25U:$#!!#  L<'(.,CH2#I7'@#0+B^NK
MPI?Q374IFF^SZE<1*SG&6VHX&>!V[5HV7AO3+">SGACF::SAD@ADFN))6"2,
M&8$LQ+9*CDYQC XH \WT\7UOX?T766UG5)KR/Q NG@RW;E&M_M30[&3.UB5&
M=Q!;/?BEOC>CPSXN\1#6M2^WZ5JMS]C5;QQ'&J2 B,QYVL#DC# \$ 8KT9?#
M&D+I\-B+4_9H;S[<B>8W$WF&7=G.?ODG'3MC%<]I/@&S>?4Y]8MY&:?5IKQ8
MDNG$4RF3=&9(U;:Q''W@>@]* .8UC4[O2?%'Q)OK*3R;E+#3PDF,^66!4M^
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MWFC)*Y8B64B$Q+GLLI1L#H'KII_ ?AZXNIYY+6;_ $BX^TW$2W4HBGDSD&1
MVUL$#@C%5K[0KO7O'&F:A?V,$.GZ*9)+:0R!Y+B1P #@#Y57&>3DD+Z4 =#I
M-D^G:/9V4MS+<R00I&\\SEGD8#!8D\DD\U<HHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD_B!J
MUYH^CV$EGJ2Z:;C4K>VENF1&$<;MAC\X*\#G)KK*Y3Q]IE]J>DZ<+#3_ .T'
MMM3M[J2VWHN^-&RPRY _.@"'0[HF_:3_ (3Z+6UBB9WLXDM<D ?>_=@-QQ[5
M#;?$F"ZCTN:/0-6\C5H\V#[8OW\FW<4QORO&?F;"_*3G'-6=.EOI+AX?^$&;
M2Q+$Z&Z\ZV(7Y3@$(Q;D@"J&E^&]5MM-^'L,ML%?2!_IH\Q3Y7^BO'Z_-\S
M<9H O'X@VD>F)<S:7J"7)U/^RGLU5&D2XVE@,AMI!&,$''S#ISC'\9>-+IO
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M*Y#,-S8#':N3@>XSS>OMJ&CP^/H+:U@N;:]A:Z:Y^U1@6FZV",)4)WYPFY<
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M @$@'!YK+NX/$MU?Z/XDFT93-8W%PG]FQ3)YWV:5 H)8ML,@*@D!@,'&<CD
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M9SM8( :X+2M'\3?V=X-TJ?1#;IH-RGVBX>YC990D,D89 K$E3N&<@$9'!YP
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M-B2*(SB0N68*H5L+UY)&,TI\:I-%9K8:-J5W>W$4DS685(Y($1MC;][  [N
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M'.NY&=58,(^I0!UR<CO@'%;=C<W5R;H7-B]J(IVCB+2*WG( ,2#'0')X//%
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MR(P6<?DVZJS*4CXRF002IP,@\'%+>^#_  _J$\,MSI4#M%&L2@952B_=1E!
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M\_>.=QP,#WR:W=:\83Z7!)?0:)/=:7;VJW=Q=F58P(SDGRU/WV"C)''4<Y-
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M"2A&A#.JY'').<<=,Y[4 ;EGX2T&PL[NTM],A\B[01W"R9D\Q " I+$G:,G
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M!A\I&>."*Y^?PEK.H/)J=Q%;PWMWKUE?R6ZR[A#!!L7&[ W-A2>..<5Z'10
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M^DOI20/<66I17;+,^Q65 V1G!QG('0XSFNDK'N?$5M:^*K#P^\4QN;V"2=)
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MM;:&XEDN(KCS/M4B1-&FQ=H*CYBQS].>M%IX4U.'P?X8TQUB^TZ=J,-S. _
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MWW>4K1C";CE@/8GDCH: /.[6VTF^\1:UJ]I;L2_A6WNK>68YE&])1N8_WBN
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M(\3,=DN)XL;A_$.<X/<"L_4=)L;C0_#4$]NLR6_C-].B\PEBML)Y@(\G^'
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MUM4U>Y\+Z3<RS3:6NM:I:Q9E8^;;1K)L0MG++\NWKR!BNP\?0RPZ/H6EV-M
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MMKN=@5=%8'?QP.1TS71'1;K_ (36QUC=%]F@TR6T89.[>TD; @8Z80]_2@#
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M;C#D%1C[J\UH:9X<NK'Q<NJ$6:6JZ-#8>7;H8P)$D9CM3HJ888&: .HKB?\
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MZM8^ _#4EMI\=\\FDQ3SW-Y>^0N1&ORABK%G;)/.!QR:?8^,M3U+QE81V]M
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M\9EW<E5R/WBX./6@"I<>-+R30].U;2]'BFM;JQ%Z[W=X+=5! /EJ=K;I.O'
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M$1CC:Q"MSR.@.2>P&:ATKQ]=ZBN@WLNA_9M+UB7[-%,UT&E2;:QP8PN-N48
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MAO8Y;)R<UC:0EO?Z!X=TB33]/NS;IJ,R'593]FAABN#']S!#L 5 S]T \\T
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M*)9)+=3M)W!B@W'C)VGOQWKR_P"(CPSMXIU"*QTY)]+C@B^W7<C-.DFP2)Y
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MU4[)<!E)['WIX="Y0,I8<E<\BO,M4T;3-:\4^-7O[:&]6'1[5H3(H958I/\
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M(Z<GUH ]G61'4,CJRDX!!R#2Y&<9Y]*\HO?#RK<^,K30K:*VETR>RU/3[>%
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M=U:V*6^J6\DMHMO>^9*FU-X25<#:2F3P3@@CWH ZB[\/:+?V$%A>:38W%G
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M*].#F@#J=0TVQU:S:TU&S@N[9B"T4\8=21TX/%01:!H\$PFBTJQCD!C(=+=
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MJ"2(0V%I<02*2=S-)Y6"..G[LY^HK1_M'RC?O>6[VMM:$$7$K+LE7:&+#!R
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MFUTQF,;LI8F5LJOS'<!P.@Y)KJZ* . U+P+J%Y=^-)4N;4+KILS;ABW[OR0
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M9)#G9Y*,,N6Z@'J2:G&G6(M!:"SMQ;#I#Y2[/^^<8J:&&*WB6*&-(XU^ZB*
M!^ H \F\4@3:1\0X9YYI8;:^M&C62=F$0*0L<9/ R6..@K5\07<FGZF]_;LN
MIZ) +>.9+>Z9;FR._(=.<2*V0",Y.,<@8'?#3K(>=BSMQYX(FQ$O[P?[7'/X
MTATRP,T<QL;;S8P C^4NY0.F#CC% #=67=H]Z-[I^X?YXW*,ORGD,""*\XTD
M/J;?#J&YOKUH[W0Y6N46[D7SBL<)!;#=<LW/4]^*]1DBCFC:.5%>-AAE89!'
MN*K+I6G*8RMA:@QC"$0K\H]!QQU- 'E5DT-QI_@2XU*Z=TAU>_MO/FN&!"*+
ME4!;/7"*,]3BM'3[Y=9U)VNO$26&LV6M2(UJH;SGC$K!(MN_#1M&5Y"XZMU!
M->BKIM@D2Q)96RQJXD"")0 PZ-C'7WIQL+,WOVTVD'VO;M\_RQOV^F[KB@#R
MM/,AL7U)=0OFN;?QA]DC9[R1@(3<A#&06P1M)'.3^0J:Z2VM+;XI-!<R6][&
M))H_+N721?\ 1(WW##9^]W_#IQ7I/]D:9L*?V=:;"V\KY"XW>O3K4LEA9S&0
MR6D#F4!9"T8.\#H#QR!0!Q-E<?VIXH_LG5II5M/[#MY[,"9D$C$L)9 01EE^
M3GJN<C&:Q]&>_P!7NO!$6L7MZS7=A?"<+<O']H1&01.P4CDH0<C!.?2O3)M,
MT^XABAFL;:2*+F-'B4A/H".*=)8VDTRS2VL#RH,*[1@L!Z T <]\.YY;CP7;
M>=/).T4]S"KR.78JD\B*"3R<*H'/I7'ZQ=/HM]\1KO37=-10VTB!)"7"-$GF
M.JYYP-Q!QQBO4[>UM[.,QVUO% A.2L2!1GUP*46\ G:<0Q^<R[&DVC<5]">N
M* .2MB;7Q]IL>CW#RZ9>Z9+-=1^:9$&UD\J4$DX9MS#/\0&><4SXA0VKR^%I
M;IMD::U$K.9"@4&.3/((QR!S76VMC9V*LMG:P6ZL<L(8P@)]3BI)[>&YC\N>
M&.5,@[9%##(Y!P: /,Q?1ZOJFIPW/B./3=3L=5 MXAN,QB!7RE1?, =)%QD;
M3DL>]26=@EU:^-;Z74-2,^GWUVEL1J$H$2_9T.,!NQ/&>F!C%>B/86<EXEX]
MI UT@VI.8P74>@;J!35TVP1)46RME6;_ %H$2@/_ +W'/XT ><:;9K+J?@E'
MO;]DU719&O5^VR8G*1PLO\7&"S?=QU(Z$U%8WES_ ,(SX4)O[HM'XEDL]QN'
M)DB6:=51^?GP$7KGI7I8TO3U:-EL;4&,8C(A7Y!Z#CCJ:0:1IH14&GV@56WJ
M/)7 ;U''7B@#R[4/,ATGQ7J:ZA??:=.\1Q+:L;R0B-2;8%<;L$$.PP<C!JQX
MCUJ&/5KNYMM2>.:UU^R@D:>YVLBDQ!XXT&,1%6))/4EN. :]).DZ:RNK:?:%
M7;<X,*_,?4\<FG-IE@[N[6-LS.%#DQ*2P7[H/'.,#'IB@#R^\O8]$G\>WEE.
M8[A;^U=RDC,RV[QV_FR!0<G"ESD<CL177>%$M/[3U"XT_7X=1M;B.-_L]MEH
M8&Y&X$NV"PZC/;/UZ?[-;^=)-Y$?FR*%=]@W,!T!/<4VTLK2PA\FSM8;>+);
M9#&$7)[X% '(:[#9K\5/#<]RXC+V-VJLTI4,P>$J!SSU/'>N7\.I]BTCP7J-
MO<W"S7.MW-K(!.WEM$S7)*[,[>JJ>F<UZS-:V]PR-/!%*4)*%T#;<C!QGIQ4
M"Z3IJJBKI]H C;D A7Y3ZCC@T >>Z%?+K5Y9W-QXB2TUJVU26.YL5#><X#LO
MDLA?!CVX((7@+N[$UUOCT@?#SQ+DX_XE=S_Z*:MD6%FMZUZMI +MEVM.(QO(
M]"W7%/GMX+J(Q7$,<T9ZI(H8?D: .4T)1::9H%U/KT\D,EI' MJ_E@,[J@7;
ML4,2.>I/!)[9KD+=)/[ T>^&I:A]I/B>2R\W[;(286NI$*<M@_+W// YX%>I
M1:/ID$HEATZTCD7HR0*"/Q I?[(TSRQ'_9UIL#;@OD+@'UQCK0!Y?KDDFFZ=
MXSL[;4;R"WL-4T]H&^UN6A$OD>8-Q))4[F.#D<GBM#4+.32-4\76-G=74NE/
MX?>YFCN+AYA#<'S ,,Y)&Y021GMGTKJO$_A>/6]&GL;,6EI+<3122S&#<6\N
M19,'&,Y*XY/>MB+3K.*S:V6RMDA?F2)(@$8_3&#TH X31I_MVLZ/HVHLZZ>W
MAN">U02%%EDZ2'((RRKLQW&21UJC;W6J6GA#0?%E[=7<XTNXE6ZS(Q^TV)D9
M%E91PS*NR0'N 3WKTB72]/FMX[>6QM9((CF.-X5*H?88P*I:KI5[J5S!"M_'
M#I.W;=6HM\M,,@X#Y^52!@C!R">G4 '(:G?2:=-H(U.[%E9:Q-<S7#W9<QQR
M, T,+?.NT!2PQG!9<XJJ;V/3;C1-)O/$<=SHMPMV([ZZ#>3)*&0I$7$@R%4R
M!26.2O<@$>EW-I;7L#07=O%/"WWHY4#*?J#Q3)M/LKFT6TGL[>6V7 $+Q*R#
M'3Y2,<4 9?A:TCC\/6*/J1U<0,_DWTJY+#<P!!).<#Y0V>1SDYKG%N[NR\:0
M272B^T^ZU.2&VO+:=A);R>6Z^1-$>"@PQ!'3 )'>N_551%1%"JHP !@ 5733
M[*.Z:Z2SMUN&SF98@'.>O.,T 8'CW5)=(\/PW*S&"V-[!'=S@$^5"S@,QVD$
M#H"01P37*:LD=MHMS-IWB5[J"35]/*+93,L5OOE1716#MD,/F*$X&<XYKU&2
M-)8VCD171@0RL,@CT(JJ-)TU;5+4:?:BW0[DA$*[%/J!C H \VU6Q2*7X@6T
M=[J"PZ?I\=[:J+Z7]S,89&+@[L]44X)(SVYJTMO'K_B_[)J6I7R6\_ANWNW2
M*^DB42%W#2#:PQ@ =..A(->@-I>GLTC-86I,HQ(3"OSCWXYK%/A.)_%[:O-'
M9267V%+..T:W!V;79PP)X_C(QB@#DM#NM0N9OAQ-J<CS7KV]Z=\G#2@1_(Q]
MRNTY]Z;87]]=>%/#6MP7,_\ ;\NJQP7L9D;+DR,LT3IG 55W$#'RA 17ILEG
M:S3QSRVT+S1_<D9 67Z'M2)86<=V]VEI MRXP\RQ@.WU;J: .%$5W8>)K_PH
MTEX\&JS)?VEP9G8Q0 CSX]V<KM*@+CIYR^E8GB!9(M+^(%W'J%^LVEWD4EFP
MO)/W#>3"W W8QDG@Y')'K7HVEZ7?07LU[JNH1WMP0T<!C@\I88BV=N,G).%R
M>^U>/6XVE:<_F;K"U/FG=)F%?G/J>.: //==N+WP]KGB--'GNW<^'A>B-YGF
M/FB1U,BAB<';V'!P.*HZW+:/X5\0:KHWBKSXWT9I!!8RR*$=3E96;S&97.2I
M!QNP<YP:]3CL+.*<3QVD"3!=HD6,!@.F,XZ5&FDZ;'!)!'I]HL4K;Y(UA4*[
M>I&.30!P\MJL'BK5--2XNI;:\\.FXEBDN7??('9=PR>,@XP,#IQ6Y\.OLW_"
MOM"^S2JX^PP>9B3?M?RUR.IQ].U;\>GV44ZS1V=NDJKM#K$ P'3&<=*E@MX;
M6(16\,<48R0D:A0,]>!0!YEJ?GZ=K_Q#O](61]3MM-MI8 '9B'*39.W.#CJ!
MCZ5J1;!XD\,G1KN>73]3L)VO0+AVWQA%*39SD/N8#<,$[O:NU2QM(KEKF.U@
M2=OO2K& Q^IZTV'3;"W658+*VB6;_6A(E4/_ +V!SU/6@#D_AA9J_@W2]7EN
MKRYO;NS0323W+R!L$X^4G /.,@9/>H9G&E?&?[7J#B.VU'2%M;*9SA/-20LT
M6>S$$,!WQ[5V]O;06D7E6T$<,><[(T"C/T%)<VMO>P-!=013PM]Z.5 RGZ@T
M 8'C+5K&R\.:B\UW/"T42J\MHP$D8=U4#<>$R2.3VR>U<'JFIRQ:9XZ@@U!8
M_LAL[B!+2Z8K!D+YA1L@X]<8&2>.:]8CTZRALS9Q6=NEJP(,"Q*$(/7Y<8I5
MT^R1'1+2!5=!&X$8 9 ,!3QR,$\4 <#J.II<>+?$MK9:\EJLFBV[12^>6CBE
M,DJE\ \<;,D8P,&L^Z\07>FVLMMJ%M_9#1:I;0ZG(DS36JPO&VUT8%2J,RH&
M'&,\]3GTM-+T^*,QQV%JB&,1%5A4#8"2%QCIDGCWIT>GV45J]K'9VZ6[YWPK
M$H1L]<C&#0!S?ARYTW2(KH/XEMKNUN;T);9D BBD=1^YC8NV>F=N>,\5T>I6
M2ZEIMS9-++$)XV3S(G*.F1PRD<@CK5>ZT+3[JQ@LC:PI:PRK(D21*%!4Y&!C
MY?PYZ^M:5 'D-EKNIV<FB:O/#=2BQ#Z'J4/F.1+=\JCA2<'YD0;N<^?UXK<N
M=%A_X3KP]I5U//*JZ+=B5EG=6E/F09RP.[!.3C/MTXKOO(A*E?*3:6WD;1][
M.<_7(SFHY;"SFG\^6T@DF"[?,:,%L>F?2@#S31K^ZGT3X=SR7]R\DFH2V\A,
M['S46.<#>,X8_(O)R:O^&]1L=9^SSW^KSV_B&VU6=)[6.?$C8=U$)C.<Q;-K
M<#^'=G.37<+I6G*(PMA:@1MN0"%?E/J..#4@L+-;Q[P6D NG78TPC&]E]"W4
MB@#RFP3[)96&IP7-PEPWC":V.V=@AC>YD5E*9VG(.>1GIZ"O0O&;,G@?79(Y
MI89(]/GD22*0HRLJ$@A@01R*O_V1I@0)_9UIM#;POD+@-Z].M69H(KB%HIXD
MEC;[R.H8'Z@T >9QRWVDZI;R:7/=7%W=>%9[KR99WE$UPGE>6=I) /S,.,<&
MK%E*TW_"$7NEWD\YU.-H]04SLWG1F L[OSPRN ,\$%MO?%=_'IUC%+'+'96Z
M21C:CK$H*CT!QQ2P6%G:S2S6]I!#+*<R/'&%9S[D=: /)]):&T^&7AQK.[DB
MF76[9)EBN6'!N]I5E!Z$9X/%;D&HV&J:MK=MJ^KSV.K6.K*+:.*?9+Y(V&)8
MT/WED&01@[MQ'ICNFTRP="CV-LR%S(5,2D;SU;IU]Z<UA9O>)>-:0-=1KM28
MQ@NH] W4"@#SG3[Y=8U)FNO$26&LV6M21O: -YSH)2$BVE\-&T97D+CJW4$U
MVWBH3MX<NDMKZ*QG<QI'/+G9N+J K$<@,3M)'(#5H?8+/[;]M^R0?:]NWS_+
M'F8]-W7%2300W,+0SQ)+$WWDD4,I^H- 'E=W?3S06-I<QWFC7<?B2"UO(8+Y
MC$0\(.(V!'R,-I (!4D]#3;V[N_#%QKUK!?W*^'X=4LD:>>62;[*LBYF7>6W
M;<^7GYN YKM]?\+KJL&EV]F+.VM[*^2\>%H,K)M##;@8 SN///TK<2SM8[4V
ML=M"EN008EC 0@]>.G- 'FUY?PZ)#'+%XA%WH=UK$"WCV['R;.-HVR@DWMM5
MG$989P _8-5K7/L=GH<4FD:S=SP'Q!:$,ET6CC#S1AH5*G!3!)VG(!)^@[U-
M.LH[$V4=G;I:$$&!8E$>#U&W&*0Z98&VCMC8VQMXO]7$8EVI]!C H Y&VL+6
M3XLZUDR!O[)MF^6=U()DG!Z'CC'T[5S6CZVYT'P7;ZMJ:0V%]8W&^YO&9DEN
M R[5=]Z\[3(1D\GW QZF=-L3,TQLK8RN"K/Y2[F!&""<>E(^E:=)9_8WL+5K
M7.[R6A4IGUVXQ0!YS>+?V6BV9L]47Q';6=G<&>*2X:":6'?Q-#)DAF0 J"3R
M,$'GGT;3IX[W2;2>/S1%- CKYGRO@J",^AYI9M-L+GR_/LK:7RAB/?$K;!Z#
M(XJR0""" 0>"#0!Y-:2SS^'?#"MJ-]F3Q/<VKN+N0-)%YEQ\K'.3PJX)Y&."
M*ZWP,6BE\26 FED@L]7>*!996D,:&*)]N6).-S-^=="-(TT*JC3[0!&W*!"O
M#>HXZ\5-!9VMJSM;VT,32'+F- I8^^.M '&ZG81ZI\3Q87%Y?+;-H_GF"&\D
MC7>LX 8!6&/PZ]\UD:#?+K5W9W5QXB2TUJVU.6.YL5#><X#LIA9"^"FW!!"\
M!=W8FO2#96IN_M9MH?M(&/.\L;\?7K2+86:WK7JVD NV7:TXC&\CT+=<4 >8
MZ'KD$OB3PO<6NJ,;:_%Z)#/<[II^Z&5?NJ0PPJX) &/456EUC6]'T'4$6,W&
MI#1GN;/5+*8R17D09 TK(W*R@,&[@Y/. !7JR:=8Q.'CLK=&#F0,L2@[R,%N
MG4CO1;:?966_[)9V\&_[WE1A=WUP.: .*NL0^)--71;R=],O])N9;O9<N0%4
M(8I@V<JQ+$;@<M[XK(\,S/:'X?WS7UY))J.F2_;#)</()0L"N/E)(R".PSR>
MN:]+ATRPMXI8H+&VBCE_UB)$JA_J .:1-+T^-HF2QME:+_5D0J"GTXXH \V\
M,:Q$_B;PR]OJ;/;:CIERSB:ZWRSL&B*-*!\HD^9A@#CD9/04O"5DUIX=^'VH
M:7>79OKET@N8?M+O');[&,F8R=JA,#D 8/7DUZQ%IUC;LC0V=O&R,S*4B4%2
MWWB,#@GOZTL%A96LTLUO:00RRG,CQQA6?ZD#F@#RY=6;3-/NF>Z2VT^;Q==0
MWMPX)2-#OV[\$$*7" G('//!-=OX0@BM[2^2WUD:I;&Z9XV3)C@R 3&C%FRH
M//7C..V*V%TRP2"6!;*V$,W^MC$2[7^HQS^-36]O#:P)!;PQPPH,+'&H55'L
M!TH \ZUZ^@O]4\;:=JUP8?L>G(UA&TQCRC1,6D7D9._*D]MH'<YRK/4K?4+:
MUT?4-=M]+@.@6;V$TCLHSL8221L)%&]6"]<D8^N?5;G3K&\D22ZL[>>2,$(T
ML2L5!ZX)'&:2;3;"X6!9K*VD6 @PAXE(C/\ LY''X4 ></+9:7XMU6^OM0N!
M*GA>WG-RN4FD9?/W.L9.-V #MQ@&ET2_1O$-U91ZB!;W'AZ.98XKYG;S S_.
M7!'[PK@L5QVZXS7I;VUO),)G@B:4*4#L@+!3U&?3VJ%-+T^- D=C:J@0QA5A
M4 *3DKTZ9YQ0!YYH]P]Q#\*IIYFEFDMY&9W;<S-]C.22>IK?^*,4<OPWUGS
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M!S0!0U/7XI+*R.IZ-J$+#6H;,*)#&HD\Q0DH8$%XB2#T.>014O\ PF@&I:I
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M&N?VONPV,>?YWE_GQG\<5)JGA#4-07Q<@N;9!KT"0H2&/D[8RF3_ 'L@Y[4
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M+9?:>Q21G\SGE<Y0E@IRR]:NV%K;V%G\,);:U17\EB?+4!GW63LPSWRPS]:
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MJ5G=M;G;,()UD,9]&P>.AZUXWJ]S!<1^,K=]4L;_ ,^STTK)9PB&.4+<.K%
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M(8$]Z /6#K.EC5!I9U*S&H$;A:>>OFXQG.S.>G/2I+[4;+2[5KK4+RWM+=2
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MG Y/J2!^-4)?$6@PV8OI=9TU+8R&(7#W2!"XX*[LXR/2L'XJH)/AMJJ-G#-
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M 0B5E(X(W@\CN#5[58#/K'BFPO\ Q#IFF2W6I1-''/8--=.-D7DO$1("0",
M!3@AO>@#TWQ!X@T_PSH\NIZG,(K>,@=0&=CT5<D9/M[&EN/$FA6D%O/<ZUIT
M,-R,P2272*LH_P!DD_-^%8'Q453\-M69E!"")R2,X E3)_+-9<6J^'+;QMKM
MYJ]YIPL+K3;;[#-*Z&*6!?,$JQGH?F/('J* /100RAE(((R".]+7,_#R&ZM_
MA[H<5XDB3+:K\DGWE7^$'W"X%=-0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !39(TE0I(BNAZJPR#
M3JSM6U9-,:SA$?FW5]/]GMXMVT,VUG))YP JL2<'IT)H O"*,*5"* PP0!UX
MQ2/!#(R,\2,8SE"5!V_3TKG7\4W5J]C'?:-);/=:F=-YER,[699$.!N0A3Z'
M/:JUYXY-G8ZE<'2I)6L-5CTQTCF'S%_+PX) _P">J\>W6@#KF4,I5@"IX((Z
MU$+.V!!%O"".A""N9N?&%U:B2VETA$U.& W$EHUUD;-S*FUU4Y9]C$# QW(K
M7_MOS/# UJ#3[V4M;"=+,18G)(SLVGHW:@#3\N,J5V+@G)&.I]:S/$>B1^(?
M#]_I32^1]KA,1F";BH^G>L9O'=M;Q:X;N")6TGR/->&X\V(B4X!+;05"D'=Q
MP!GFM_2;^34;9YGBA5 ^(I()_-CF3:"'5L#(Y(Z=0: +:011ERD2*7.7*J!N
M/J?6A[>%X?)>&-HO[A4%?RKSWQ/K4FMV.A7UG;?\2X^(;6*.Y\\AGVSA"VS&
M-I*D#G/0XYK;N?&\<5X%M["2ZM5OOL,LD+%I$8-L9P@7E%;()W \$XQ0!H^(
MM#GU[3QIT>HO8V4@,=TD,0+S1G **Q^YD9&0#P>U:L=O#%;+;)$@@1!&L>/E
M"@8 QZ8KC].\8WB0:Q<ZK;VZK!JQT^V2&8G+?(H!R@XY+%N3UXX%+/X^DM;2
MZDET2X:2VO;>U/ER?NY!,RJKQNRKNY;!&!@C\: .P^SP^1Y'DQ^3C'E[1MQZ
M8Z4]55$"HH50,  8 %<J/%6K#5X=(?P[Y>H36DUTJ->H4PDBI@L >"&!SC(S
MC'4B'3/';Z@N@W#Z/);V6L2-;QRM.I:.8*[%2H'*_NV&[/;I0!UHMX5D>188
MP[C#L%&6^I[T[8GR_(OR_=XZ?2N(C\66VE:?JM[;:',"NNBRGC6X!+RN8U\S
MG@9WK\H].U7E\:K!_:\6I6!M;G3YH(O+682"7S\"+#8&,DX/'&#UH Z=;>!?
MNPQCY]_"C[WK]?>E$,055$:;5.Y1M& ?6N47QRJ/=6]SITB727$%O;>6Q:*Z
M>7[NR1E7I@[N. ,\U!X7:Y/Q#\7"YA$+B*R.Q)C(O*R\@D#\L#I0!VC*K !E
M! .>1WHVKN+;1N(P3CFO./[8OM \5^-;JSTB;48('MIIU6X"%$\@,VP-G<>I
MV\#WKH[/QA!=:JULT"PVKZ:NIVUT\O$T)ZG&.-N1GGC</6@#H8H(H%*PQ)&I
M.2$4 $^O%+'%'"FR*-$7.<*H K'OM8OK?P7<:TEC''>1V37(M9I3A2%W;68+
MG./;KQ[UR3WVIR^(_!5^UJL]_<Z7=,T:7!5'.V$AF)4!?O'HIQGO0!Z,(T"J
MH1<+RHQT^E-%O "Q$,8+-O;Y1RWJ?>N5M/'4-]ING2PVBI>WJ3O]GGFVK'Y+
M^6^756_C( PO/7BMK0]43Q%H,-[)93VOG!EDMKE,,I!*D'U''![C!H T@BAR
MX4;B,%L<FD\F(3&;RD\TC;OVC=CTS7B-OJ7V7X1F]A;5DUE;B98=05I0D;"X
M95:20_)Y8& =V1@8Q7J1\03/>#3+""&_OXK)+N<B;RX\-D+M;#9+%6([8')Z
M4 ;KHLB%'4,K#!5AD$4QK:!H! T,9B&,1E1M&/:N4;Q[%-H,.L6.GN]H]G)<
MO)=2^0J,C;3#NP09<AACI\IYIY\:7-SJ5I9:7H<MVUUIT>HQLUPD0\MF4$'.
M>1N_']: .J\J/^XO7=T[^M$D,4I0R1(Y0[E+*#M/J/2O//%FM2:UI&FWEE;9
MT]=?M8$N?/(9BERJ,VS&"A8,HYSWQBNF\9WMK8: )KVP:]MS=6Z-&LNS:S3(
M$;/7ABIQ0!NO#%(Z.\2,Z?=9E!*_3TIRJ%4*H  & !VKCM6\<W&FS>(%CT.2
M>+0TCEN9#<JNZ-E+DJ,') '3OSR.,[^LZY:Z)X=N];N [6UM 9R$'S,,9 'N
M: +\=O#$K+'#&BN<L%4 ,?>B*"&%0L421A1@!5 P*Y>[\;+I-_J%MJUA]G2Q
MT\:A+-%,)%,9+* ,@$MN4C'TYYJQ+XL&FZG%9:W:"Q\^TENH95F\Q2(@&D5O
ME&&52#W!&>>* .@6W@175(8U5SN8!0 Q]3ZT_:N[=M&[&,XYQ7-0>+O](T;[
M;8&VM=97_0YO-W$-LWJD@P-I*@D8+#((SZ\_KFLR:Y)X/U*VM=FG3ZU'Y$_G
MG<Z;9,%DQC:V,CDGID#/ !Z'+#%.H6:))%!R Z@@'UYI2BEPY4;@,!L<XKE?
M']Y?6NF:;%9I&4NM4M;>;?*4W(TJY3A3PW(/L>AS5276K;P7'/"FD?9[+[7#
MO!NB SS%0WV=6'S(I89 V@?-@4 =J(T$?EA%"8QMQQCZ4P6T M_LX@C\G&/+
MV#;CZ=*XS6/$']F7?C&YL-+0:GIFF17+333G;.FV4K\H!QMVM]<X..M4Y;O4
MQXW\/72V:SW\^B7):%;DB-B'@()8J,=3T4\GOUH ]!$,07:(T XXVCMT_*EV
M+N+;1DC!..HK+T+6_P#A(/#5MJ]K;%&N(BP@D?&UP2"I8 ]P1G%8EEX\2Z7P
M\SV*P+K$TMN0]Q\UO+'NRC#;R<J1]>.X) .L:W@<QEH8V,?W"5!V?3TI6@A=
MR[1(SE=I8J"2OI]*Y;4-:AFNM >\TKS%N-5>"TE6XXC94D DQ@9#*KX'(P0<
MUS/B+6-3U?P9XFDO8(8Q8:Q';P?9YV) 66$8^ZN<Y)R3_%C'% 'IPMH%55$,
M8"KM "C@>GTJ3:N[=M&[&,XYQ7(W?B<S6?B>RU+1G#Z;9B>6W6X#>?!(K]&&
M-IPC@CMV)H@\4SI<Z=I&F:&TKSZ0+Z -=!$50478203QO'./PZD '61PQ0[O
M*B1-QW-M4#)]334MX(XFB2&-8VSE%4 '/7BLW1_$$&K^%;;7XX94AFMOM!BQ
MN=<#)7CJ>"/>L*Y\5P:IX*U;5'T^&]TM=/,["UO-PE4JV^,G *,H'(]Z .RC
MBCAC$<2*B+T51@#\*3R8A(T@C3S&&&;:,D>A-<M?^+3HCZ7"^EM]DOK?%I*L
MI(,P3*0$;>&;H#WP?I3[_6]9@\6:#I<=G:+'>VT\TP:X.0T>P%0=G0;\^Y],
M<@'310Q0)LAB2-,YVHH _2AX8I&5GC1F3[I902OTKF[#Q;)?:?))_9PCOX]1
M.G/9M/DAPW)SMZ;/WG3[O/M4GB;4Y8M2T+1(':-]5NF21U."L,:-(^#V)VA<
M]MQ(YH Z'RT 4;%PGW1CI]*188EE:58D$C##.%&3]37 :KK\C^)=6MCI][/H
M?AZWB-Q!9%!YLC+O.X%E+(B8^09R2<@X J2QNX/&'B?6+>.9O[+L],M#8^4Q
M0 SJ[^:,8PP 0 ]1@XQDT =W+%'-&8Y8UD0]5<9!_"E$:*00B@@;00.WI7G>
MG^*+L^"O"?BN=CYUS);VM^!P)4D;R]Q'J'VL#Z;AWKL]7UE-+DL;=8_.O+^?
MR+:'=M#$*68DX.%"J23@_3F@"^\$,B,CQ1LKG+*5!!/O1Y$)E67RD\Q1M5]H
MR!Z UP7AS4;S3[_Q;(=/DEG.M11>2DQ=(PT,67+D9"#)8G' [5>;Q\HT.XU1
M;!)(;/4OL%VZ7(*1#<H\T-M^9/G4G@$<\<4 =CY:;2NQ=I.2,<$]:3RH_-\W
MRT\S&W?CG'IFL#5_%<6CC4)9X4%I9O!$UPTNU1)*P&&^7Y54,K%N>&%:NF7L
MM_:M-+#''\Y"&*;S$D7 (96P,@Y]* ++00O*DKQ(TB?=<J"5^A[4-;PO(9&A
MC9RNTL5!./3/I7FUE?K)=:KJ^NV:275IKWV6P:"Y;S!*1'&D(.U?W9W$G)QR
M25K;UW73=:=XDT&^MC:W\&E27:>5,726(JP#*V%((9<$$#MUS0!U[0Q/(DCQ
M(SI]QBH)7Z'M2^6A# HN&^\,=?K7GMFPCU[X?RL[*&T6X,A+'!"QP$$CIQD\
M^];47C5'@T>_DL2FE:O,L%K<^;E@SY\LNF/E#XX()QD9 SP =54:6\$:.B0Q
MJKDEE50 Q/K7(2^/3;V+7%QIR0F+5QI5PC7/^J8D!9,[>5((;Z$'UQ-XEUJ%
M--N&O=*^U64.I6ULI2XV[G,D>'Z#A791@9R5(H ZL(@8$*H(&T$#MZ4GDQ>=
MYWE)YN-N_:-V/3-<AJWCJXTV;7PFAR31:&L<MS)]I5=T;+O+*,') [=^>1WO
M:GXM6SN;^"TLS=/8:>-0G#2^7F,[L!>#EL(W7 Z<\\ '0?9X?,:3R8][XW-M
M&3CIDTXQQE64HN&.2,=36-)K<\G@R37;6T42FS-U%!-)@$;=PR0#V]JY ZAJ
M=SK7@/4I+9)K^ZT^X=HX[@JDA,49#,2 %Y8G@'&>,T >D%%+%BH)(P3CMZ4Q
M;:W2 P+!$L)ZQA %/X5S%IXYAN]*T^=;417MZ\\8MI9<+&T+E),N%/ 8  A>
M=PX'.-;0=7'B'1A=2V,UJQ=XI8)U/!4D'!(&Y3U![@T :/V:#=N\F/.S9G8/
MN^GT]J<(HPI41J%;@C'![5Y9X1-E=>%"E[:ZG/<3:E/:BZC,G[L-<LBG?G@*
M"/RQ74ZGXRNK*\UZWM]$:X.C6\=U*S7*H)(V#L=O!Y 0X'?U'< ZEX(I&1GB
M1C&<H64':?;TI6AB>1)'B1I$^ZQ4$K]#VKEH_&DAOHX9-(D2.ZTZ34+-_/4M
M*B;=RLO1#AU(Y/'H>*@TSQW)?7&@B\T2:SLM=@#6ER9U?]X8_,V,HY7(S@]\
M=!0!U_D0^?Y_E)YN-OF;1NQZ9I9(HYEVRQHZYSAER,UP7A'6$TO14LD0SW=[
MKE_;6L32$9VS2L2S')"JJ'G![#O5^\\=FQM=1>;3,3Z7=Q6^H1^?\L,<F"LP
M;;\R88$\ C!XXH ZX11A]XC3=G.[:,YQC/Y4-#$\J2M$C2)]URH)7Z'M6)J/
MB>+39;WS8 T%NT$2R+)]^>4@+'C'& 5).>C UD7/CZ2SM[QYM$G=[6ZMH,PR
M9BE69@JLCLJY()P5QP>^#F@#M&574JRA@>Q&:;+#%.FR:-)%SG:Z@C/XU@_V
M;=:S>:1JE];RZ;=V,LI,,=V7#*<J 0N%8, #R,CIU.0NE>*%UC4IK:TAB>."
MYEMI\3_O8&0L,O'MX#%>#GH1ZT ;K11NZ.T:,R?<8J"5^GI33:VY*$P1$QG*
M?(/E/J/2LN_U@C5QHEG;+<WC6IN9%>8Q*D>=HRP!.6.0,#^$\CC/(^"?$0T_
MP/H-F(Q)?7,5S,J3RE0JI,02S ,<Y=1T.>?2@#T-X(I)4E>)&D3[K%02OT/:
MG[%RQVC+=3CK7 /JW]N>(_ NIBUNK-YI;Q)+>?*LI6%P01T(R,@]Q@U-%XJ@
MTG1=7U.WT4Q0V^L/;WH:YY5BRJTQX/RY8$@= ,T =MY$.Y&\I-T8PAVC*CV]
M*:;2V9 AMXBH((!08XZ5D:EXECTQ[LRP PP/# CK)R\TI "8QQC<I)YX:LBY
M\?26=EJ$TVB3L]E<V\),4F8I5F8*K([*N[!.",<'\Z .Q>,,=P"B0 A6(R16
M/H7A]]*NKZ_O;Y]0U.]*B:X:,1@(@(1%4?=49)ZG))-58/$M_'KNG:7JFC"Q
M-^)O*D^U"0%H^=O"]67YAST![BM*QUA;C1I-4N46WMD\QP^_<#$I.).@X(&X
M>Q% &A+%'/&8Y8TD0]5<9!_"D>WAD1$>&-E0@JK*"%(Z8KG(/%^Z71'NK V]
MGK7%G/YNXARA=%D7 VEE!Q@MR,5E>&+:77]:UB^U>UB,^GZPZV\T5R^^+9&@
M$8PJYCP22"<$DY7O0!V\EM!+'Y<D,;IG=M901GUQZTLD$4P42Q(^T[EW*#@^
MHK"B\4"ZUZ[TJT@AEEM)UAG1KC;*@*!A)Y>WE/F SGU]*J0>-1-INF7IT\JM
MYJCZ8R^=DQNLCINZ?,,H3VZB@#J7ABE9&DB1V0Y0LH)4^H]*RK7P_!;Z[JNI
MR,LQOS"WEO&,1F-2H(/?.:K1^))[R2.6QTN6ZTY[YK%[B.3YU*L4:39C_5AU
M()W9[XQ7+>%M?FT.V:"2P>2PN/$=U8BY,XW1LT[JF%.25X )R,>AH ]'>*-W
M1WC1F0Y5B,E?IZ4GD0[ GE)M&<#:,<]:R?$>OMH$>GLMC)=F\O([0!'5=K/T
M//7I_P#JK-B\;*L%\E]IYM]0M=0BTX6R3!Q++*$,>'P."'!.1Q@]: .H$$*Q
M+$(D$:]$"C _"E:&)Y5E:)&D3[KE02OT-<1XF\;7VE:5X@MX[*&#6=.M%N4#
M3%XWB<E1(IV@DA@05('(ZX-:<NJ00>,[2#4-/6&\&ESS_:UN"R)&KQ[U P,]
M5.2!TH Z9E5U*L RD8((R"*C-K;LD:-!$5C.44H,*?;TKGH_%KBT@U*YTN6+
M1Y[*2]%XK[O*C50X\U<#:64Y&"W0CBGZ5XI?4-:33Y=-DB6:V^T17$;&1!@C
M*.=H"OR#@$@\\\4 ='1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRWT%K&T:V!$2^2Q^4+YGW&5BI&<\YSVK2\,^&X?#D=^MOY<<=Y<FX%M I6&
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M;6WFE5)KIS'"AZNP4N<?0*36?X>UQM<CU!GM?LS6=]+9E?,W[BF/FS@=<]*
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MBI(Y# J.Y;/4UHP3&U\>PR*;+5;>?4Y4#+\M[8R^6ZL&_OQ8!QTP"O7 KT?
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MX?\ A^:28RRG3X1(Y;)+! #D^N>M=%110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%XHUVYT"VL
M);:R2[-U?0V95IO+V^8P4$<'/Z5NUC^(=#?78+*-;H6_V6\BO ?+W[FC;<HZ
MCC(YH Q[GQ7J\"W-JND13:K9VXGN+>!I948L7V1HZQ]2J9RP &0.>2&:WXXN
M='L'OY-+\F".W@N/*N9=DTN\_.JH 2#&,9SQDXXZU>U/PM=3^(?[:TK6Y]+N
M985M[M4A25)T4DJ<-]UAN.&YZ]*HZMX .I?VM&FM7,-OJ=M#!*C1K(RF(84A
MCS@]2.YR<C)H NR^*Q_PE4VA1K;)=121 0W$ICDGB<*6EBR,,%R00.<J>G&:
MD_CAHM%;Q"EFCZ&EX;:202'S0@E\HRA<8(W_ ,.<[>?:K>H>$WU:XB.H7ZW$
M,-U#=PEK<"6%X]G".#\H8ID_+_$P[\0Q^"(8[.YTH7A.B7%Y]K-F8OF4F02%
M ^?N%QG&W/)&: *6I^.=3L/^$@E&CVS6VAW,<=PQNSNDC9$;*#9]X!^AP..I
M[7?$/B^XT"XG,EC$;:&6W0;YL23K(ZJSHH!P$+#KU.1QQENH>"&U"U\26[:E
ML77)$DD(@YBVHJ +\W/"#KWS4>J>!)M3DU<G6Y88]3>WFE1;=6VR0[,;223L
M.P';ZYYY.0#&_M#4M!\3^.;W2-)MKN*WEM[BY1I_)8J+=2VP!2"QY/./QS5E
MM8T^'QTWB3:5M&\+&]=POS-&) XSZG;6W-X2D>\U>2/5'2'6(TCO%:$%_EC\
MO,; @*2HYRIYY&*=/X.M;C5&G:118MI3:2;,1\>23V;/7MTZ?G0 NE>(=1O=
M9CL[G2)8[::V\]+I$D"1L"/W;ET7G!R".N#QZP:WXOETV;7DM;..;^Q+%+V<
M2R%#*K!SM3@]!&>3W('O5KP[X>U#14CBO-?N=3@MT\NV26)$*+T&\KR[ #&3
MCOQGFN7\0Q2W7C.\:6XNK,I'%#;B70C?1S*/G+(RKQ\S8*DYR@/I@ Z.'Q)>
MW]XVGV-E;F^ALH[R=)9V"+YA;9&#MSD[3DD#''!S5?2O&Z>(1IL.E6P6ZN[.
M2[D2Y8@0*C^65. <G?D<=E)] 9K70-0>_M]?^UQVFKS6:VUZOD;HI0"2K;-W
MRN,G^(CDCG@TVW\$V^F3Z7=:/=-:W5A;O;%Y8_,6XC=M[!P"O._YL@C!)[<4
M 0Z=XW_M=[*PMK-8M5GEN8KB"63*6Y@8+(20/F&YE Z9W9XP:9\-T>/1M81H
M(H776KT&*(Y13YAX!P./P%2MX$C@GL+[3=0>UU2TFGF:Y:(2+.9VW2ATR."<
M8P1C K4\.: V@6]]&U\]VUW>2W99XU7:TC;B !0!QVDM<W":YJ]]I5I>WECK
MD@@D^T;6A(V1YW$#$:(23Z@'BKFI>+X[SPQK<EUI-I?QZ=J$-K+&TI\J8,8F
M21<J>AD4X_V>#TJ^_@>632M0L_[797NM3&J+(MN,)*'5]I4L0R94<'\Z9<^
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M_9_^6GF^;MQN^[N_''YT 27OB^XL-;MK.>QB2.XU%;%4\[,NUE)68@ @*2"
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M4;JX@NDN;*$1K#-$"%<(2P).Y@V3R#BNATBPO+&W;^T-2DU"Z<C?,T:QK@=
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M"!&*RJ02"QY*_+@#M[UMZ5H;:;K.L:B;OS?[3E25H_+V^6414&#GGA1^/Y4
M<S?^/-7L[36M0708)+'1;UK>[*WA\QHPJ,71=F"0'R02.G!-7K[QK-:6_BF9
M+"*4:';QW*?OR!<(T9D_N_*<#'>LO1M&EUQ_&&GW%PT.G7NK.9(C;D-+$8XP
M2CD@;6VE2<'H<$5K:QX';4Y];\C57M+;6;1;:YA6!6(*H45E8G@8/(QSCJ*
M'S^)M8D\2?V/IVD6DK"RAO?-FO"@V.Y5A@(?F&TXZ@^HZ'+M?'^J/8Z7JMUH
M<$6E7E\;"62.[+R0N96B5]NP IN !.0>>GKT%GX>>Q\0_P!LR:AYH73TLF1H
M0,JC%@V0>N6/;&/SKFO!6A2ZGX3L(=0F9;6VU*:Z^R/;F.3<MP[Q[B3RN2K_
M '1GCG'4 T[KQPT&C3>($LTDT2WO&MI9!(?-V+)Y32A<8P'S\N<E1G/:K5OX
ML%UXHN-&C%LDUM/Y<L$TI2?R]F[SE4CYE)P./KGM42^!X5M+W2Q>$Z)=W?VM
M[,Q9927#LBOGA"PSC;GD@'TLW?A7^T-4M+N^NTF6SO#=VQ\C$T?7]WYF?N<]
M,<]* *>G^,KO49],GM]'N)M,U!699XXI-T*[=R,^5"D,..#P2.O6I- \63^(
M].FNM.BLIG6V+B 7!5X9_P#GC*"N4.?XL>O'')H?@ZZT-?L<.OW<FCQ%C:63
M1J##G.%,@^9E7/ XZ#DXI5\*SV]S=:L-0 UA]/-DMW;VBJS<@B1U)(=P0,9P
M.O8\ '2VS3/:Q-<1K'.4!D1&W!6QR <#(SWQ4M5-*2]CTFT3495EO5A43NH
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M#Q9 (!RP.#@8.:YOP5<QZ%!X5UC44E33I?#HM$G6)I%CE$H<J=H.-RXQZ[:
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M^\5W%O(VN1V5G+ T-WITL9AMWE-Q&C1$2(P!5(U7(PO<'GG!ZW0I%?XC^)I
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M]J7,$Z!T+QLAP?56 (_&@"U1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5FW^BVU_J>GZBSRQ7=B[
M&*6(@%D88:-L@Y4X&1Z@$$8K2HH *S=&T6VT2"=('EEEN9WN)YYB"\LC=22
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M7%JP61,$'@D$=L=.].T^QBTVRCM82[*N27D;<SL22S,>Y)))]S5FB@ HHHH
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M)ET>\U9;Q1961E6XD9&'E&,D."",Y&#V^E &I17.^*_$,VC^#I=:TV.*:0F
M0K<*RJ1+(B L.".'SCK2Z>/&/VZ+^TCH7V/)\S[,)O,QCMN..N.M '0T5RX^
M(?A<O&/[28)(S(DIMI1&77.4W[=N_P"4_+G)[#D5.OCCP\=/FOI+YH((+A;6
M;[1;R1/'(V-H9&4,N<@Y(Q0!T-%<?K/CBU/A#Q!J.BS$WVEVQD:&ZMI(F1MI
M*ED<*V#C@]#BKG_"8Z=8Z=IC:E-(;V[LTN6AM;:29@I4;G*QJQ5<GJ>* .DH
MK,L?$6DZE>16EG>I---:+>QA0</"3M#@XP>>,9R.]5;CQAH=NDK&[DD:.[:R
M,<-O)([3*,LJJJDM@=2 0.: -VBN>NO''AVTM+*YEU#,=\CO;".&1VE"$!@%
M52=P+ ;<9Z\<&M2YU:RLYK&*XF\M[Z3RK<%&^=]I;;G'!PIZXZ4 7:*R4\3:
M/)+JT2WR%]( :^&UOW(VELGCG@'IGH:Q+KQM9V1UJ^^WBZM;+3XKQ;*.SD65
M%=25+-@Y#<=AMY)H [&BN%3XA0-K.F&19H]/O=+>Z$0M)6G,PD1=JH%W,,%C
MPO(&>E;LGC'0DTFRU);QI;>^8K:B&"2225AG(6-5+Y&#D8XQSB@#=HK'M?%&
MC7D-E+!>!EO;AK:$&-@QE4,S(RD91@$;(;'2L_Q'XYTSP_9W<I$MS-:W4-K+
M#%$YVO)M(R0I_A?=[\#J<4 =1163J_B&ST?PQ/KTRRM;10"8)Y961\XVKM8
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M$T# E3R"0>1D'/XBHM)TNTT72[?3K&/R[>!=J@G)/<DGN2223W)- %RBBB@
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MO-;"@9).N7@ _P#(M)%X1TB>))8K[69(W 9737;PA@>A!\WD4 <--9ZAX/\
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M&<'#@(<*,J [>_OQ3I/ MI+%>![ZY\Z;4QJL4RA0UO< !05XP5PN,'.03ZT
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MR\ L4Z^U6=.T^_NO"WA?2GM+F#7M+U2.2ZD>)AM"NQFD\S&&612W(/S;\>N
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M7CMY=&<SO>7+VI>Q;<ZM B@QY7)!;</E]_6C3=-B36O LC:3,J0:/,ERQLG
MC<K#@.=O#95^O.<^M '<W6H;H]/EL;S3S#<3J"\LF1+&0>(B#RQXQVZU*=8T
MQ9TA;4;02O*850SKN:0 $H!GEL$<=>17F=A9SQ^&?"D1TR]62U\22R%#92!H
M83+.0Q&WY4VLG/3D4R^TPC0/%QBT>Z^U2>(H9[8I8R;VC#VYWIA<E1MD.1QU
M]: /4WU&QBO$LY+VW2Z?&V%I5#MGT7.>QK+/B?3[U=8MM,U&Q-]IX9&,\H$:
M2;0?FP<[06 )'3D=:X?Q ]Q/?7WE:5J$!AU^QNF2"RDD%Q&K0YG+[3GY1C8F
M"-IR#SBSJ-O.=/\ B39R:;>/+>H\UJ!:.ZR[K2-%VD @MO!&!R"* ._DU*TL
M[2":_O;2#S%!WM*%1CCG:2>14EQJ-C:8^TWMO#E#(/,E5<J.K<GH/6N)TXS6
M/B:.YU2TN7TV[T."W@8VSN(G0MYD3* 2I;<IY'.W';%96AZ%<V&H>!H=2T^>
M4VEI?"1GMVD$"LRF%'8 @$*, $\8H ]0AN(KJW2>VECFBD7<DD;!E8=B".HK
MGO#7BE-5BFBU">RM[];ZYM8[=)<-((I&3*@G)^[GBH?AU#);>$$MY;:>V:.[
MNML4T+1E4,\C+@,!QM((KD6T#[9HFJ:8FF21ZZ_B&2YMYVM64QJ;KS%F$F,;
M?+SR#S]WJ<4 >GIJ>GR).Z7ULR6YQ,PE4B/_ 'N>/QINH:K8Z7I4VIWES'%9
M0Q^:\Q;Y=OMZY[>M<AJ6DW5OXUELK2('2_$<8DO@"/W3P[1(<>DD95#[X/>N
MA\7VLUYX)UVUMHFEGFTZXCCC09+,8V  'J30!G-XQB_X2#381-9+I%YI\UX;
MIY0"A1HQ@G.T#]YS[BNAEU*Q@LEO)KVVCM7 *SO*H0@\@AB<5P]NJ7WBOPK=
M2Z;>&V@T>X1VGL9 (W)AP#N7@G:^,\\>XSA:.;[1=)\*W=YI^KKIUO%>6LZ6
M]K)YML[R@QN8]NXKM4KD#C=[T >N1RI/"LL,B21NNY'4[E8'H01U%<IH_B'6
MM9&LF*#3HAIM_-99E=P'V '<3CY0=WOBM7PM8VFF>';>WL;2XM;12[Q0W!8R
M*K,6Y!Y7.<[>V<8'2N(T&RT]O^$J&KV&KQ_:-9N)H2EG<C?&0FUE"K@\@]CG
M% 'H#:Q9VMNK:E=VMG,L2R31RSJOEYP.23TR<9J:/4]/ENOLL=];/<>6)?)6
M52^P]&QG./>N,\J.]^(1U&ZTB=89=  8RV;,%<R$["=N-^T\CKVK%\.Z=);6
M7PW5]*NHI;=9DO=UDX,>ZW=,2?+P"VT<^U 'I46KZ9/<QVT.HVDD\BEDB2=2
MS*"02 #D@$$?A6;H&O3:BVN_;UMX%TW4'M0ZL0NQ8T?<Q/?YSZ#BO//#NDVV
MI^$_"R:;8E-3MM9^T/<+;E3'$DS[R7Q@J4&T#/)P.W%ZXMM2\K69X;"\>&+Q
M7%?3P_9W#7%JJ1 E 1\^&7=@9SLH ]'&KZ8;0W8U&T-LK;#-YZ[ WINSC/M4
MXN[8RQQ"XB\R5-\:;QEU]0.X]ZXU= A\0^(_$DCPR#1-3TZ&VEWQE/.G!?+J
M& .50H-WJ/\ 9K/M[/Q%K7@?6GN$!UF&SETJW*M_KS&2KR*>QD8 >VP4 =TF
MLZ7)%/+'J5F\=O\ ZYUG4B/_ 'CGC\:L6]Y:W@D-M<PSB)S')Y3AMC#JIQT/
M(XKRS68;'Q!X5UW4++1-<.IOH[V;)=VLJLK9RD2IM^=@V3N4''KS7I>D6MI;
M:?$;.U2W615=E6'RR3M RPP#G  YYXH E.HV(O19&\M_M9Z0>:N_IG[N<]*Y
MV7Q1<7_B&^TC1)M->XL##YL=S(<S;B2ZJ5/RE5'7#<G! QFN673]1NO!;:!+
M;7*^(X-9\];@PM@G[5YGV@28QM\LGG/^SUXKI]!#K\0/%<CVURD<WV7RI7@=
M4DVQD-M8C!P?0T ;-YXATRRUFUTB:[A2_ND9XHF< D# Y^I( ]><=#6?X5\4
M)K6G1&_FLX-1DGN8UMHY,%EBE=,JI.3PF2:KZV)8/B%X=O3:W,EL+2\@:2&%
MI CL82H8J#M!"MR<#BN1L+"2+0_#\@TJ\2Z3Q1+/*?L,@=8FEF^=OER%*LO)
MXP: /43J-B+X6)O;<7A&1;F5?,(QG[N<]*R?&>O7'ACPQ<ZQ;P13M;M&#%(2
MH8,ZIU'3&[/3M7(Z1;I/?KH^MZ;K#ZI9ZO)>0R*CBW<&5G682@;<!&P5)R<;
M<=JV_BG#-=?#S4K6VMKBYGF:$)%;PM(S8E0GA03T!- &]%/JT=]$EVEB;=E8
MNT3L&3 X.#U'8^F14R:UI4D@C34[)G,9E"K.I)0=6QGH,'GI6+:MI$.KH]G8
MZD\D\313&6VG\M8P"V29%QG/  Y.[H<<<5HNDB/0?A['+HUPLMO>R&Z5[%P8
ME,4HR_R\#)3K[>E 'J4>JZ=-:Q745_:O;S-LCE692CMG& <X)SQBL;Q)XH73
M_!>IZ]HLUE?FSB9P1+OC)7J"5/7VS7!:A;0Q65P+O3YEMSXTBDC22T<;XF*9
M**5^920W3.>:M:_HLG]E?$"ZTFPG%GJ-G#%;P06[9GG56#LB 9P0R#(')!]*
M /3;G4;*Q6,WEY;VWF?=\Z54W?3)YZBG_;K07@L_M4'VHKN$/F#>1Z[>N*XT
M,;?Q?KDFK6=S<:;J>GVZ6C"V>0%5#B2$@#*L2V<'&<^U9?\ 9&M>'/"/A36/
M)^T:[I44=I<0,XS-#,0AB+=RK&,CW4^M 'H,FJZ=%:M=2:A:I;JQ1I6F4(&'
M4$YQGVI;C5-/M;5+JXO[6&WD *2R3*J-GD8).#7$ZS;S^&]4T"XGBU"YTR.U
MG@NI["%I'2XD9',K(H)(8A\D#@M[UFBU@\/:AIX.E:U'X<N-.>VA6&*2>2!V
ME9R)$ +*'5EXQQM .,< '>:CJ&H6^J:3'96UO<6=U(RW#F4B1%VY5E !!'KD
MCMCDU>34+*2[-HEY;M<C.81*I<8Z_+G-5O#]E#IV@6-G;6\UM;PQ!(H9G+NB
M=@Q.>0,<=NE<CH<6H6GBJWBMC/=:3-<74CPWEJR3:<Y+,2LF 'C=B0 ><,""
M0#@ [FZO+6P@,]Y<PV\0.#),X1?S-1R:II\4:227]JB21F5&:90&0#)8'/(Q
MSFN6\7SW&G>)=&U.6WU";24AG@F:PB:1X)',95RJ@DJ0K+D#C/O65;:+8V?B
M+P<MGHUY%8017S?O[=W,0<JR;R0=F3N(4X(Z8'2@#O(]8TR:6WBCU&S>2Y7?
M JSJ3*OJHS\P]Q0VL:8EPENVHV8FDD,21F==S.,94#.2>1Q[BO,+33FM_#FF
M>7I%W'-%XK,^%L9 Z0?:7(;&W(38PYZ8-0W&D6>JZ'XVTRUT_?JTVM2+9NEN
M<H^(RK!P,*%.2>>.?7D ]%T_6KFZ\7ZUH\T4*P6,%M-$ZD[F\SS,[L\<>6.G
MK6A'J^F2PS31ZC:/%#CS76=2L>>FXYX_&O/O$>G:O?:AXY@TZWN3<7.E6<<#
MF)D2<H93(BN1M)*MCK_%6P+6/7_&.EZE:6DT=@NEW%OJ"SV[1!U<IY<+*P&2
M#YA([?B,@'6_VA9%(7%Y;[9_]2WFKB3O\O//X5$FM:5)*L2:G9M(T9E55G4D
MH.K 9Z#!Y]JY/PAI]Y;S7&FZDGF67AXO9V<A^?SD=0RDC^\D11/?<U<YI&DA
M/#O@&.31KA9;?4I&NE:P<-&A289?Y>!DQ]?;TH ]3BU.PGL?MT-[;26>"?M"
M2J8^.#\P.*1-5TZ2WBN$O[5H9FV1R+,I5V] <X)]J\RDBO[*+4;N#3=1:SMO
M%+7<T$%NRO);M"%\R-2/G D.[ S]W-3ZAIFG7$&E7>GZ1J4D%UXABNYVN;65
MF<;"'D*%<HOW0<@9QG&.2 =S?^*=$T_2/[4EU*V>S,@A22.56#N3@*"#@G/Y
M<YZ5HO>VD=H+M[J%;8@,)FD 3!Z'=TQ7F.IV-R-*\9QVVFWGEG7+.[BC2T<>
M9&IMC(R#'S<H^=N>AKN/%,,NK> ];@M(9'FNM-G2&)D*NS-&P4;3R"21P>:
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M[5FEM3%)L:X=E'S ':5V'TX'I3IO,L_B5?W$EK=-!<:-#''-';NZ%DDF+*6
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M!Z+<ZQIEF7%UJ-I 8RH<2SJNTMG:#D\9P<>N#4D6H64]W+:0W=O)<P@&6%)
M70'IN4'(_&O.;W2E^W>.5;2;AC-HL$,!-J\GF2".4,JOM^=LE,D<GBE73[K[
M?X>&G65Q:W#>'+JW>;[*Z".9A$4#MMX.Y6//<'UH ]#CU73II9XHK^U>2 9F
M19E)C'JPSQ^--BUC3)Y&2'4;21TB$[*DZDB,C(<X/W<=^E>>:1%8ZGI<#SZ+
MK4>JZ=IDMK-'<V\BI$"@!1>-LH+*NT#/'/'=WAZP:TNOAV5TRY@>'2I8KQOL
M;IY;F*,;9#MX)96Z]Q0!WFB:[IWB&P^VZ9<QSP;V7<C ]&*Y]@<9'L16#KWC
MJUMM!UR[T6>TN[O291%+$[Y&?DW8"G) W@?4$=JD^'*RV_@^WLKBVN+>XM9)
MDD2>%H^?-<\9 W#!!R,CGK7*ZY;78\._$'3AIM_)<76H"> 1VDCB5&C@ *D
MAN5;@=,'.* /38=1L;DW @O+>4V[%9]DJMY1'9L'Y3]:I7OB;1K'1KO5I=2M
MFL[12TLD<JL <9"\'[QXP.^17$:]!Y&M^)GL] GO+2?0((Q;I;2)'.XDERN5
M R0C+P#G' JCJ-M?ZC#X]6"UU*Y;4=%@-L\EB\(F95F#*JE1@\J I^8\=>M
M'JMK=07MM'<6TJ2Q2#*NC!@?Q%355TVY6[TVWG2.5%= 0LT31L/JK $?B*M4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+FUAMM@VR-!O.XE3D9'3CJ<]L=?9Z['%X(MO$&I.$0:<EY<,HZ?NPS8'Y\4
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MO((E(#,R\;<$XP><\ 9% $?_  @FEPP62V%S?V%Q:1R1K=6T_P"]D5VWN'+
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MK68GBB9?NG& 6V]MQ.*Z&?QKI^FQQQW:7<SPVT<][-! 7CME<<-(1T'!.!G
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MIL8Y8XL-\N)-N[([_=%<E8^/H[*?6UU=;R6"TU62W^T16V8K:+Y F]A[D^I
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M$[[L.!M CR</G(X.,#/ H DUGPC:ZQK,.K?VAJ5E>16YMA)93B/,9;<0>#W
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MV^H!XSZ@U?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>(+74O%4NKW]KI%_;11>'KNQB2ZC$<D\\NTA57.<#9UZ$MQFNJ_X0;PU_P!
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MR22G3X KB,*53RU(7/H*M?\ ".VC6]^DLUQ+-?Q""XN78>8\8! 4$   !FZ
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M64=':,'!;@>QQS1;>"])L]:FU.W:\C\Z;[3):+<N+=INOF&/.-V>?3(!QD4
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M#=1DD<8Q3_ WA>6T\,:1%K,-RES8R/*EI-(C)%(6;#C;G/#'&20,\ <5?MO
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M(R<@\9Z ]\ \]?:->IX&\0ZW=0_V??#4WUVSCG9=T)B"; Y!(!98R",G[^*
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M''.W/XUR?BOP[J5]XRL);*V,FG:@L,6J.& "+;S"9,@G)W NG'K0!N?\)II
ML](NF:58=3@DN(V90/*C2/S':3GY<#@]>2!4>F^-;/4+RUMY-/U&Q^VQ--9R
M7<2JMRJC<=N&)!V\X8*<=JY.'P3JU]/XET^YB$%G'8W=EI,K,"&%S(TC' Y
M7]VG/8&M2"WU?7M6\-?:=%N=-32%DDNI)VCVM(86B"1[6)89<G/ P!W- '00
M>+-.N-+T+4$2X\G6I$CM@4&X%D9QNYXX4],US7A[QI-!9:_/JSW%[)'XDN--
ML;>"-3(X&W9&HX' W'+'H#DU0TC3]>.E^"]'FT&Z@_L.\C^V7$CQ["$BD0,F
M&)8'<#G QD?A#9^'-<TW[5J7]ES3/;>+[G4UMD9-\UM)&8]Z9.,_-D D'@T
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MKNP=V[:0,E>H&:R='TK6]".AW4N@WD@TV^U%9H8)4E<I<.71T+,-ZC@$D@T
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M8<#'3&3G@'G&9#\2[2:WL+M=$U;[#?RFVMKC9&1).-V(PN_=R5(#$;<]\<T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(S("?F( 8<D<U0TKPUJUMH/P_MI;7;-I,H:]7S%/E#[/(GK\WS,!QGK7H%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y*+Q
M#)/XBUV[FN_LV@Z#'Y,OR@B6;8))&)QG"*5  ZDGKQ76UYK%I,VH:?\ $3PN
MC!+^YNI+J'<<!TFB4H<^FY&4GMB@#HDUZ3Q%;7FFV2:AHNJFV%Q;->0H"5)^
M5P,L"N<!@<$9Z#(J_P"%=</B+PU9:F\0AFD4I/$/^6<J,4=?H&4U@^%["WMM
M4FU271-7TXP69C>YU74WGQDAG1%:1QM&P$OQT&.]6?AK%(/!D5W(C(+^ZN+U
M$88(269W3\U(/XT ==1110 4444 07D=Q-9S1VEP+>X92(YC'O"'UVY&?I7
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MRQQA% (7>X7+<CCG''<BL,>-;JS\4:U%<:=JMS;PV=K<1V<$"&2W#"0R%CN
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MC!!X *X&.G;!YIIN;Z*63PVNJ:@+-_%"V/GM<N9UMS;"?RQ*3OY;C.<X.,T
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MV[8%VX;=NQ@CN<5$/&\$UK:&UTG4+B_N)9H?L"^6LL;0G$FXLX3@XZ,<Y&*
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MW/V=@C['(!)7=C ; )VDAN.E1Q^.O#,MW!;)JT1DGG-O'\C;3*"1L+8P&R"
M"1GMF@"W+X;TR76[35Q'+#>6L/V>-H)GC4Q9R$95(#*#R 14SZ)8/X@CUQH2
M=0CMC:K+O.!&6W$8SCJ.N,US;:_=0W?C2*_U=;.UTXQ"WNO(#?9@\(<L5Q\^
M">_I6_>>(--TJU66]NVVK")I'2%WVI_?<*#L7@\G X/H: (--\(:)I$&E065
MHT<>E-*UH#*S>69-V_J><[CUSUJ27POI,VGW]B]L3;W]R;JX7S&^>3*G.<Y'
M*KP..*@\0>(K2PT>\>WO0+E;-KF-HHFF"K@[7;:" I(ZG X/H:M^&;R?4?"N
MCWUT^^XN;&&:5@ ,LR DX' Y- $<OA?1Y[K5[B6TWR:Q MO>Y=L2QJI4#&>.
M&/3%4W\#:,]K:P%M0!MHVA29;^993$QR8V<-N9>G!/';%6[CQ7HMI'J,D]X4
M7375+LF&3]R6Y&?EZ$8.>G(]:9KNN65GIE\'U-M.ECM//-RULSB!3D*Y!&"<
M@_*>>#Q0!'=^"]#O);:0V\L!M[<6BBVN)(0T Z1,$(W)['W]:T;#1K#3=%CT
MBU@"V$<9B6(DL-ASD9//<U0?Q);_ /"10^'T^T&ZELC<_:!;L4'*JIZ8YR2>
MPQCO67X(\90:QHFCPZC?*^L7D+N0(BJR%2<A2!MR!SM!SCG% %V/P)HD6FVE
MC$+Y%LF)M95OIA+ " I5'W;@F !MSCCI4Q\*64-II5I8*;>"PO1=_?9F=L/D
ML2<L6+<EL]^^*U-4U&#2-*NM1N1(T%M$TKB)"[8 R< 5R)\9O_PD.ARRS20Z
M7?Z5-<O;FV8R>8IBQM^7>W#MT'.,T =9JVD6&N:?)8:E:I<6SX)1LC!'(((Y
M!'8CD5E:?X)T73[^&^V7=W=0?ZB2^O);GR?]P2,0I]QS5]/$.ERZ=:W\-R9[
M>Z7? 8(WD:08R2$4%CCOQQWJUI^HVFK6$-]87"7%K,NZ.1#P1T_GQCM0!CCP
M5H8U+[;Y$^?M'VO[/]ID^S^?G/F>5NV;L\YQUYZ\T7G@K0[[4);N>"?]_(LT
M]NMS(L$[KC#/$&VL>!U'.!G-0R:W=ZKXON_#^F2K;QZ=#'+?W6P,X:3)2- >
M < L6(/88YR+]K->65]>C4-1MIM/CA5XY6"I(A&[S/,P<$ ;3D =\^M %34_
M V@ZO>7=S=P3DWJ!;J*.ZDCBGP-H+HK!6(&,$CL/05IW^B6&IZ(^CW<)>Q=%
MC,>\@E5((Y!SV%-M-?TR]NFMH;DB=8A/Y<L;1$Q]-X# ;E]QD4EGXATN^NX[
M6WNLS31&:$-&R"9!C+(6 #CD<KGJ/6@"75-'LM9A@BO8BX@G2XB97*M'(ARK
M @Y!_H2*H2^#]&FU<ZD\,_F-,MP\*W$@A>9<;9&B!V%A@<D=0#U%9>L^*L:]
MX<M=+O"8;S4&MY_]')25%CD)VR$;3AE ^4UULZNT#B.0QN0<. #@_0T <\W@
M/0'G:4PW(/VC[5&HNY0L$I?>6C7=A"6Y.W&<GL:FLO!FBV%Z+F&&=M@<102W
M,DD,._(;9&Q*KD$C@="0.*X[3/&VO?\ ".^$=7N)[6\DUN[2WFLE@V.%8L"\
M9!_AQDY!&.XKO=3\0Z7H^_[=<^4L:JTK"-F6)2<!G*@A 2#RV!P?2@"GI?@W
M1M'O(;JUBN&>W1H[99[J25+93U$:LQ"#''';CI5B+PQI,&F:;I\=L1:Z;*LU
MJGF-\CKG!SG)^\>M.N/$ND6EV;::\"R+)'$Q",R(\F-BLX&U2V1@$CJ/45*V
MM6"WPLS,QF,HA^6)RHDV[MI8#:#CG&: );#3;;35N!;*RBXG>XDW.6R[G+$9
M/ ]AP*32]*L]&LS:6,1CA,DDNTL6^9V+L<GU9B:KCQ'I)O(K7[6 \LK01L48
M1O(N<HKXVEA@\ YX/H:J_P#":>'OM'D#4D+BZ^QMB-RJ3< *S8PN20 20">!
M0 FI^#-%U>^GNKJ&X#7*JMU'%<R1QW(7@"1%8!\#CD=..E:,.CV-OJTVJ10[
M+N:!+=V#''EH6*@#H,;C5X\CKCWKR^[\9>(-.T#Q+K9N[2=-%U9[-;66#;Y\
M0*#&X'ASOX.",CIS0!TWB'PR^N>+=%O)%D%I:6UTKS0SM%)'(YBV%2I##A6Z
M=N#UJP_@C0VTRTL4AN(5M)FN(9X;J1)UD;.]_,#;B6W'.3SFIE\7Z&=1&G->
MA+[>D30&-B4=EW ,0,#@=<XJQ:>(M*O;N&U@NPTLZ&2#<C*LZCJT;$ ..0?E
M)X(/2@"K;^#-"M8$@AM&5$OUU$9F<DW"@ .23DG@9SU/)Y-9M_X/&K>.;W4K
MO[1%:OIL%M%-:W3PR;@\I=<H0=I#+UX/U%;D/B+29]0AL8[L&>??Y.48++L^
M^$<C:Q'< GO38O$VCS7:VRWJK(\331F1&1)8U^\R,P"N!D$E2>#GI0!7N?!V
MBSVMA!'!-:#3XS#:R6=P\$D:$ %0R$$@X&0<],]:9+X*T1K2RMH(KBS6S1XX
M7L[J2&0*Y!<%U8%@Q )R3D\]:NIXATR1)G$\BB)8W8202(2)"53:"H+;B"!C
M.3Q5NRO[?4$D>W9SY4AC</&R,K  X(8 ]"/SH Q;KP-H-U'!']FF@CAMQ:;;
M:YDA$D(Z1OM8;UY/7/4^II]UX+T2[OC=/!.@8QF6"*YD2&8H $WQJP5L!5'(
MZ  ]*L7VK,/$-EH=JP%Q-"]U,^,^5"A"\?[3,P ]@Q[5A:+XQBAOM8M-<U%?
M,BUEK*V(A(55*1[%8J,+EF(!8C)XH Z36-$L=<MHX;U)#Y,@EADBE:.2)QD!
ME=2"#@D<'H35%_!>AR^'KO0Y;622RO)/-N?,G=I)GR#N:0G<3E5[]!CI5N^\
M1:5IL_E7=UY1$B1,_EL8XW;&U7<#:A.1C<1U'J*AA\7:%<:DVGQ:@C72RO"R
M!&PKHF]@6Q@?+SDGG!QT- &CJ%A:ZIIMSI][$);6YB:*6,DC<K#!&1R*HZ7X
M:T[2)XKBW%P\\5M]E66>X>5O+WE]I+$YY/X#CI44GB?2)4NH8]1^SS1VIN-T
MD+*1'T\U0P&]0<<C(Z>M10^*]'M++3HKK5_M-Q<62W,;K V^Y3"Y=44=3N!V
M@9YZ4 2P^$=%@;2C':L#I4DLMI^]8^6TF=YZ\YW'KFDTWP?H^DW\=W:QW&Z$
M,+>.2ZDDBMPWWO+1F*IGIP.G XJ8>)]'>RLKN*\\Z&]1GMO)C>1I5498A5!;
MCOQQT-96O>+H(+?03ITTDD.L7*1I=6\#2[8BCON7"D%ODQ@@GDG'% &[;:-8
MVFL7NK10D7MZL:32LY;*H"% !.%')X&,GFH-6\/V.J7,5]+;1R7MO!-#"TC-
ML*R+AE< _,IP.#^%9?A_Q*K/JFG:C>2S3:2^V>]FM&MU8$;QD8V@A64=MW)
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M>%V<<YSA2H&,Y([<UZH1D$>M4=,TBQT>&6*QB:))96F<&1GR['+-\Q/))R:
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M:26W1#]H8D%,A1V 8CJ#UZ@58\0^%HKRPU*;3[=)-3N[06;&ZN9-DD.>4/)
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ME68<!CCZ<]3C-6M0\+ZKXA\6WFHW-I]AM+[PQ+IC[Y5=HIGD)P=IYPISD<4
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MSG.>: /2J*\JTW5M8@\*>']5N=;O9I=7OH]/G9]@2%#,_P Z@+PQ"A,YQ\W
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M)$ \U&698YU0?WSS@#GD8YQ5+7KCQ%I_ASQ=J,.IZA;VD#1_V7YR*&"X3?\
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M*,!G!XXZY[9K&\2^+TU'P+K]QI$][I^HZ:52:*6/RIHF)4C(.>&4Y!'YT =
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M\<<@M@$<@F@"I::5XFL+&.RM+CP_#:QKL2)+"4*H] /-IUGIOBBPLX;.TN=
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MU2USY%W DZ9Z@, <'WYJ[0 4444 %%%% !1110 4444 %%%% !1110 4444
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M=-_MQ+:V:?5+=]/4W@M(1(RN92SA$8;"<!B1UY'?% &':6'B*?Q=#KM[IUE
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M=_T*NB?^ $7_ ,30!PGB/1]/OS\3KZZMHYKBTB22UD<9,#K9HP=/[K9 Y'/
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M0Z=96TL<L%I!%)'"+='2, K$.B CHH].E/M;2WLK=;>U@B@A4DK'$@51DY.
M/4DG\: /%[J"YGLG\+6I;SO"LU[J,:YP3Y95[4?BLI_[YJ?5?(\3PRZ\&8VN
MJ>)-/LH&5B#Y$1"'!'3+M+TKUY-.L8[RXO$L[=;JY55GF6,!Y0HP QZD >M1
M1:+I4-C;V46FVB6EM()8(%A4)$X.X,JXP"#SD=Z .%N])T^U^+.@:5!901Z?
M_8EU']F5!Y>TN,KMZ8.3^=<E86=G:_#OX=26MO#$\_B:V:9HU +L'E&6QU.
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M-TA$L]%*:8;Z*V_=QP&2X*S8"\+NBV[L8XYKUJ[M+:_M9+6\MXKBWE&V2*5
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MCBO86TK3WDLY&L;9GL@1:L8E)@R,'8<?+QQQVI#I6G%KUC86Q:^ 6[/E+F<
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M1%!&$4$\DX'J:O4@ 4    < "EH **** "BBB@ HHHH **** "BBB@ HHHH
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M:71M8RK_ &8'SO,;!8*.%&0"2<<9Q7876JPV^AR:O''-<VZ0?: L"@NZ8W9
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M49AU&""01Z5@:KJ!A^*":=<ZE>0:=)HYN?*BE<#S1,%S\O(^7/'2M[P_%X@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FNZ1HSNP5%&2S'
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M]U,7"%O4*J''NV>PIL?CB6Z\*Z)?P62'4M4NTLOLC,<12AB)L]\($D/X#UH
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M8S03Q*@0X^ZRYC!Z@]O>NDU[Q'IGANUAN-3N4A2:>.!-S*"6=@N>2.!G)/8
MFL^W\::6VKZG9WEY96D5K+#';S2W2J+GS(EDRN<?W\<9H ;IVBZQ<>)8=<UV
M6Q$MK:O;6\%EO*_.REW8M@Y.Q0!VYY-,U[PY?7'B!-:TR/3)IVM/LDL.HQDI
MM#%D=2 3D%FR.X/48K>NM7TVQNH+:[U"TM[BX.(8I9E1I#_L@G)_"H?$&KIH
M'A[4-7DB:5+.!YVC4X+!1G - &!J'@F37VM;76[J.73;2TV1Q6R>46N2,&?
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M7/B33=.TR:SOH[V.X:2XMIU?RVB\OY3MSDGS/7C% '1@   # %%%% !1110
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M['",^>-HD*=>,XKK!:VZR-(((@[D,S!!DD="33I3%LVS;-C_ "X?&&SVYZT
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MEUP@ZL=W&!GFO27MH))?->"-I-I7>R G!ZC/I0]M!)(DCPQLZ#",5!*_0]J
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M5LI$,*[5R<GZGWJS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7)^/;FZ%GI&EVUS+:C5M3BLIIX6
MVND15G?:W8D)MSVS765D^(] A\1:5]DDFDMY8Y4GMKF+&^"5#E7&>./3N"10
M!R-WIW@CPKXAT]8+NZT?44EC.8/.9;A6.T1RDAE8,<<GD'N*GO\ Q5X@-KXA
MUG3DT_\ LO0YI8GMIHW,UR(5!E(<, G\0'RMTYZU<G\,>(M9$%KKVOVDNGPS
M1S-'96!A>=HV#KO9G8 ;E!(4#ZBH]0\%:A.NLZ?9:O#;Z/K,K2W<36Q>9"X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLC%@\3*L@R!SM).WUYSBF_%-=3NK_P +Z= +9[&[U-$DBEE=/-8*YVOM'W.
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MQ#:QR#0[AE:TD9HVS/!QA@""/Y$?06]2U>&U^)4-I_9\;W(T2:Y6Z,C!@JR
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M^ULK=3G<@A1TRWUW#IZ5N-J.];&6SMWN[>[8?OH67;&A4L'.2,@X XSU%7:
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MH\;(TCG'$F&!QR"=V3R,>BU6LKF6Y68S6<ML8YGC42%3YB@X#C:3P>HSS[4
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MWA71I= T"/3IY4ED2:>0LF<8DF>0=?0,!6S110 4444 %%%% !1110 4444
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MV?9>7+']CM]DRA9%\I<. , $8Y ''-)+IMC</ \UE;2/;\PL\2DQ?[N1Q^%
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M[UT?BR^EM]<\,V<KM%I=[>2173JQ4,WE,8HR1V9^W? '0D5T:6%G%>R7D=I
MEU(-KSK& [#T+8R:?<6T%W T%S#'-"_#1R*&5OJ#0!Y3XF28>#?']C+-++IE
MC.GV%WE8["T:,\>[/*JS$ '.,X[<>K6T$=M;I%%N\M1QN<L?7J22:C;3K%[1
M;1K.W:V7[L)B4H/HN,5-$D42"*%$1$& B  +^ H XX,/^%VLN1G_ (1P<?\
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MU2UDL+5[=#N2%H5**?4#&!3Y+"SE>)I+2!VA_P!46C!*?[O''X4 <YX!D?\
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M\*7.H7OA'2+G55*W\MI$\X(P=Y4$Y'8^U;%%% !1110 4444 %%%% !1110
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M0L"=HRZK@C.3TQDCFK2SO?$>C:]I-O<Z'<KJEHR2:G832S!7P$ =F+;CM)(
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MLDFH2:>\)E7=&\>[>21QP%)X/3'KBK?B?0F\0:2MM#<FTNH9XKBVN5&3%(C
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MV)9CCJ2>M=-6-X3T>;P_X5TW2+B6.62S@6'S(\@.!P#@]*V: "BBB@ HHHH
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MBN,ETK3V\;^,MUE <:+;C'EC'S"8'CW"J/P%9&@,7\5?#MF))/A=LD]_DCH
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MHVOX2\B[6'!('E@X]0*CBOU\7Z%XO\8!"MO_ &(]A9@_P@0F28_]]L%_[9T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/%&TJ<*Y4%E^A[5)10 WRT^;Y%^?[W'WOK5/6--75M!O]*\SR5N[:2WWA<[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>exhibit1060-kumaremploym007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBD+*&"E@">@SUH 6BD9@JEF( '))[4H.1D=* "BBB@
M HHHH **** "BBB@ HHHH **"0 23@#O2*RNH96#*>A!R* %HHHH **** "B
MFLZH0&8#<<#)ZFG4 %%%(S*BEF(51U). * %HH!! (.0>AHH **** "BBB@
MHHHH **** "BFLZIC<P7)P,G&33J "BBB@ HHHH **:'4N4# L.2,\BG4 %%
M%-+JK*K, 6Z GK0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]'21_,9G.[ R">,_>  J6W\=VUQ%9H;86UW=7$ULL=W-Y<9>+&0LF"&W9!7
M^8>F*I)X&U2UTRR-EJT$.JV%_<WEO,8"T3K.S,\;INR1\^,@YX!K4OO#VH:K
MIT5MJSZ=J<<@?[7;S6Y6)B=NTQ\L4VX/<D[B<CL ,@\0ZK<>,[+2FT](+:72
MOMLJR2_O$8NJX(QU7D8SSGVK6U+64L;^QTZ*(37U]O,,9?8H5!EF9L' &5'
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M1TQPK[,GCT4GM573)-9OO#E_*+0QZQX?T^?3X=L>/-NPOWT'<%5B(_ZZ,.U
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M-G]E>VF>.TFW[ENO+QY@''#+N4XYX;/:KMEXLM7CUZ?46BL;72;XVC322<,
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MVZT1&>:Y+&*+<<#>%P1W&.N>M;-GJ5I>S7%O!<QR7%J56X1>L990PR/<$$4
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MM+N;Q56[C>W6>*8J,*^TD$,!QD'D 9%:.J^*=#T2<P:EJ4-O,$63RVR6VDL
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M!&L<:+T55& /R%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR"22-6!V8VY09[\\#CE]SXXU.QMM02?2K:2]L=4MK"18KDA&6;RRK*2O7]X
M0<=.M7(O!#1:386 U,E;+4SJ2.8!EG,C2;3\WW=SM[XQ6/XR\/SV=G?W=O//
M//J>KV%PR0VQ<P^7)&"P SD!$R<^GX4 -\2:Y>7_ (=\:>']<TVV@N[72)+N
M%H)3+'+$R/M8%E!#*RXZ=>16]9:Y=32+HVE0P275EIT%Q,T[%5RX(1!CN=C$
MGMQP<\2WOA-=4M=9:ZO,W>K68LI)TAVB*'#?*BDG'WV.23R?0 4L?A:2UU2'
M4['4/(O?L:65P3#N2=$Y1BN1AQDX.<<G(- %&P\<MJ#>&[I;)8=-UGS(C+(Y
MWP7"AOW1&,')5P#GJO3D58;Q7,?L<*6Z>??M</;,J22*8(F $A502=VY"!TP
MV<\8JCK.BV*Z%:>"+2RU%@RQR17D<;;82L@8RF4<+(#EL<$DX'6M;7/"B:D-
M,FT^^FTJ]TO(M)X$5@J, K(R-PRD <>PH HV_C"^N([.TETJ2RU6:*:5XI8I
M9%18W";@%7<0Q8$9 P,YY !LV]D/%NGZ)JNJZ9)I]]:3>>(9<^9"ZG!"GCAM
MHZCE3T&>&7_@Z>ZDT^^MM>O+;6;,.IO_ "T?SE?!=7C(V[?E7 &,8%=%8VK6
M=G' ]Q+<.N2\TN-SL3DDX  Y/0  =!0!S]CXK^W^*)]'C^S1S6]P\<UK,Y2<
M1A"5F4'AU8X''0'.>U:.N:V-):Q@2,R7-].881L9@,(SLQ"@D@!3P.Y'09(J
MR^%A=ZM9WM[=B?[#=O=6Q,($J;@P\OS,\H-W3'8<X&*G\2>'5\0VML$O9[&]
MLYQ<6MW  6BD (Z'A@0Q!!Z@T 8C^,=9ABL%FT(1S7.JG3LS2/$KC8SK*@*9
MVD+SGD'/6JT_CC6;33M7NY]*LB-&OEMKS9<M^\4^608_EZ[9 ><<C\MF?PM<
MW4>F&ZUF6XN;*^%\TTD*CS7"% NU<!5PQX'?G.<YK7G@@WNGZ_9MJ15-:N5N
M)66$9C("+A>?2->OO^ !#J7BO7HM2U^TTW1K.X_L>**=C+=LIF1E9L* APV%
MX!X]ZH1:SI]QXXTWQ*J>5;3^%9[QV*_,(_,A?GU(!-36NGWU]XW\6PBYEM8+
MJVM86F^R-B3".KF)CP&&?]H#(XK9'@ZS75+6='"V5OI;:4+,IE3 Q7(W9SGY
M%'TS0!53Q;>)_8,]U90QVFNX2W99"6@E:,R1J_'.X \CH1CD<T[2O%=YJ5A
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M6'T9M*TQ;]-.^VEQ>.8B?,*;?N ]OU]N;-SX3N[VRLDO-<FN+JWO8KQKAX%
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M].BB,D(CD)F9D#;%95(4[2#ENYQ@=:;J/@)KQ==AM]8FM;37$/VVW6%6'FE
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M0\8KC%76AXI\"W6KZG%>"Y^T3,! L7DN;5B54CJO/?GCKSQZ%=V,%]ID^GW
M:2WGA:"0$\LK#:>?H:Y:T\!NEWI4VH:[>7Z:7')#;1/&B#RWC,9#%1EFP1\W
MMT&3D R-%\4:K?Z[9V(UK[6FI6]P1-'ICQP0.H!5H)'4"5>2.2<\'BL3PYXE
MU2R\(^%;.?6KF-M2MIKN2ZCT]KF2)$*@1JJJV<L^2S#@#'<5VFF^!I=/N=&G
M?7KNX_LA3#:H\2*H@*[2A '+$!?F_P!D8 YS#IW@";2=/T^"RU^YCGTSS([*
M=H(V*0/C=$PQAQE5.>#E10!M^$M4N]8\.07=_$R7.^2-RT#0^9L=E#A&Y4,
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MN>?)-ZV\#>5./W>">"0.,]*Z:2^LXG"274".7$>UI #N/(7Z^U>8^!DTW3_
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MK;S,N,-T.<]#VKS74-,T>6VT:XLK2[GM;GQ&EU(]U;L-P:-A(X0J"D9.T'(
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M8A;3_:[8VZQ ,"L978H9A\W(S@<9Y%6/B>CR_#?7((HWEFFMS'''&I9G8D<
M#DT :]O>:NUS:K/8V8@FR7>*Z9FC&TD':4&1G Z]Q5Y;^S>5(ENX&D<,402
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M+HDR*F3M#9Y'&.#R.G:M6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M66"9!)'(AR&4C((]B*\RDFU33M7^)FHIJT[265FLD,31Q,BM]F,B_P &2%/
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M-4A9X6D4Q%5#8!3'S%L@]JQGN-9U?0_!_B"^U9IH]1UFUF:R,,:QP*SDH$(
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M=;?9"<"?S5V$YQ][..O% '/0^!;>2_EO=6U2^U6>:PETZ3[3Y:JT+E21M15
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M]C6\^P&V*,SO&S*R8Z'#=5[$]LBI5UW2'<HFJV+.(O/VBX0GR_[_ %^[[]*
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M?*!@ 8  %=5UJ&ZO+6Q@,]W<PV\0X,DSA%'XFH7U;38XHI'U"T6.5#)&S3*
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M  <+& VK:WJ=Q8QVSVMM:R.@2&-AC^%07(  !<G ]^:M1>%[.*/P\BS3D:$
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M:G>:AY\>;>6\D);:>3M7"X^N,UIZ?J-IJMFMW93":!F= X!'*L58<^A4C\*
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M^RM,JRM)$0" #@E5?!/T[UV=5;74;2^FNX;:8226DODSJ 1L?:K8Y]F4\>M
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MI.3C&*W?BC!/=_#G5[2UMKBYN)HU6.*")I&8[U/103T!KL*R]8\1:3H'V?\
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MD[CD<YVDCKBNK;P59S6,T%QJ.J7$\LL4PO);@&:-HSE"F!M7!S_#SDYS42^
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MXFNV5G1G:56&0!P=@..W-6XO!>F):O%++=W$TE[#?37,TNZ666)E*;CC&!M
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M+/+ LV$28;2)4XRK@HISGMTIQ\&6,NGRVEW>:A>&:YBN9)[B?<Y:)E9!P
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ME3P07%[J,5IYLT/FJBL&R=N1GH.]='7*^.=&DUVUT:U6"6:%=5ADG\IV0K&
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M@9Q]46$?@:IV/AZ:;1'MFT?Q!_:5IH]Q"6O;UG@29HO+V1*6(8-S@C   ^E
M':V/CC3=0NX;>*VU!3<V[W%H\EL56Z50"?+)ZG!!YQGJ,BG^#/$[>+-"_M%K
M&>US+(@$B85@KLH*G// &??-9RZ5?#4_ TGV5PEC;RI<G'$1-N% /X\5)\.(
M;NP\++I5]87-K<V<\RL94 63=*[ H<_,,$<T 8EQ\1KFYTR2\BM+JP2UUZ&Q
ME:2#.^'S0KKCD[\9R!R,C'-=-%XWTQK74I9K>_M9=/,?G6T]L1*?,.(]JC.[
M<>!COUQ7(Q:5JNV[TYM)NPZ>+DU$2E!Y;P-<!]RMGG"\D=JO^(K#7(_$&OWV
MGP7H@GATV-I+3 E>)99?.$1_O!&'OSQS0!?UGXA06'AZZU"WTV^:ZMKN&UFM
M)H=KQ-(RX+#/0JPP02"2!6CXJ\4-X>\%W.OI83R/'"'6!TP58CC>,\ 'K7!7
MNB:HVE^)DM=%U8I<7%A>6J74S3S2QQ2)O!9V)WX4D(3TQWXKM?&]K=^(?AKJ
ML%C9SFZN;7,=M(NV3.0=I'8\=* *4_C.XMO& M6LM2DMI-)2YCL(K4-.'\UU
M9B.PPHZG'3N:TV\<:4UE87%G%>WYOH#<Q0VEN7D$2X#,R\;<$@8ZD\ &J^F)
M=7WCLZT;"ZMK671HX1]HCV,KB9R5(SP<$'Z$5QFG>&[_ $R'1[R_L==\L6$M
MK)'I4[1RQR"=W7<%8$JP?KT! SC- 'IDVKQ3^%YM8TZ5)8FLVN8'QPPV%E./
MZ5R^@S^+-7T?3-2?Q3I$?VRWBG: :825WJ&VY\[KSC./PK:M=*-I\/CIMM92
MV[_8'1;5Y?-=&92=A?\ B.3C-<5X<L=$TO1])6Y^&=\=3M;>$2W"Z7 6,RJ,
MN&W9SN&<]: .LOOB#HVGSWR31WS1V%P(+R=+<M';DA2&=O[OS#IGOQ4J>.=*
M(U$S07UL;&S-^RW%N4,L SET!ZCCH<'IQ7.:KH.IS^$_']M'8RM/J%^TEJ@'
M,RF*$9'XJP_"I?'EA=?:M>U#R&^R#PG=P&7^'>3NV_7 )H Z/2_&6FZKJ4%E
M'#>P/=0F>TDN+<QI<H,9,9/7 (/..#GI7/\ @WQS+-\/-#U/6GGOM4U&6>*.
M*V@!DF9))!PJX  1>3P..>M+I@O];USPG+_9%W9PZ1;2/<RSJ C,\(C5(R"=
MX.2<CC '?BL/PGH>L^'O#7@J^NM)NG?2VOHKNTB4-,BS2,5<+GYL87@<X:@#
MNK7QKI-T]E'_ *3%)=7;V.R:(H89U7?Y;Y^Z2!D=0>,5+J'B[2M-O+ZUF:9I
M;)(6E6*(OEI6*QQJ!R78C@>XKD;O0KW4/#7BO5YH&TZZN+U=3T]+C"M"UO&@
M1GYPI8QG([!N:KIHE_KG@9=>:VN?M^HZI%K$UO;R[)O(!"I&C9'S+$%(Y'.?
M6@#L1XTTP:=/<RQ7D,T%PEL]E) ?M'FO@H@0==P(((.,9YX.-'1M:MM;MYI(
M$GAD@E,,\%Q'LDB< '##Z,"",@@BO/+SPTUWI_\ :-GIOB%/*U.">7[1>O\
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M6X,-S;%))(V.U61>=V6P,=02,@9KD;/PWXA\1^&/$=UK-JUOK5WI\>FVT<C
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M:Q;G\P(R-)F/=_$0"O/>@">/XE:')':S"'41:W4C0PW/V1C&\PS^Z!')<[2
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MZ@=*^'D#6LJ-81JMW@<P?Z$Z'/\ P(@?6@#=TSQEIFJZA#:P1W:+<[_LEQ+
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M)P6MHI&D*[\' ."N?<T =A/XZTF"\FB:.]-K!<BTFOUMR;>.4D+M9_9B 3C
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MD2.Y@M[AHXKE$X59$4X8 <?3CI4MSX.TJZU1[YOM4?FR)--;Q7#I#,Z8VLZ
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MX.1S5;_A"]"_M/[?]FEW?:/M7D?:9/(\_.?,\K=LW9YSCKSUYH Y+4]6OXO
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M-S;QF-)X)2DG*Y.TX.TC./SKH=9TO7]?AACO]!T<M _F0RPZU<121-C&5=(
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M59TCD!;:6(&<>I% &7#XSATWQ+XBAUK4&6PM3;-;YMF_<K(F6+[5RHR1\S8
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MP$;@X/%:7BK3]2O-:U6]TJ9!YNC16T;QW2QLSB=G=%.<J2A(#< $]: )=?\
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M4!V[MX4L-H8KC..QS5>?XD6ENL]PVCZFVGVU^^GW%XJ(5CE$GE@!=VY@3CD
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MG7,9#CD;B-IXYKI-?TF^'@6+3-(MRDD*VZ&UMIRA:%&3S(DD)&,H&4$D?A0
MW_A-XHK:Z%UI-]!J-O<0V_V M&SN\O\ J]K!]F#SR6&,&MK2M3?4;*2>XL+K
M3Y(G9)(;H $$<Y#*2K+@]02/Q!%>?VOAR^MI=<#>#%FTS45MG6R>[C+@(6#
MDOQ+R'&#M_VLBNG\*:7?P:#?V=^EW;V\T[BSM[NX$\UO 44!6<,V?FWD#<<
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M#_#'_0N:1_X Q_\ Q-'_  A_AC_H7-(_\ 8__B:VJ* ,7_A#_#'_ $+FD?\
M@#'_ /$T?\(?X8_Z%S2/_ &/_P")K:HH Q?^$/\ #'_0N:1_X Q__$T?\(?X
M8_Z%S2/_  !C_P#B:VJ* ,7_ (0_PQ_T+FD?^ ,?_P 31_PA_AC_ *%S2/\
MP!C_ /B:VJ* ,7_A#_#'_0N:1_X Q_\ Q-'_  A_AC_H7-(_\ 8__B:VJ* ,
M7_A#_#'_ $+FD?\ @#'_ /$T?\(?X8_Z%S2/_ &/_P")K:HH 155%"JH50,
M 8 %+110 4444 %%%% !1110 4444 %%%% !5&]TBQU&YM+FZA9YK1_,@82,
MOEM@C(P1S@D?0FKU% !1110!0@T33+;6+G5X;&%-1N5"37(7YW   &?H!^0]
M*OT44 %%%% !1110 C ,I!S@C'!Q5/3-)LM&M6MK"$PPEVD*;V8;F.6/)/4D
MD^YJ[10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAE4C+ \G@&K>O:'=/I/CN[L-/NA!JAMEMK9+=P\DB "201XR,Y R0,[">X)
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M5M/LH].TZWLHB2D$80,W5L#J?<]3]:LT %%%% !1110 4444 %%%% !1110
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M\RJ[;2#D=>>#@4 3OXCT.-V1]9TY60X93=("#[\UHQ2QS1)+$ZR1NH9'4Y#
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M&5@>A!'!%<]82^(+K5)[/5+"%])GM,B=DC&)<X,902/N0J<Y]B#G-5-:U!/
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MED5BY'!"Y7'3OZ6(O%FOQ:7JNKW;:<UK8WT^GK!'"RM(XF6*-]Q? &3R/U]
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MGW7CC2X+N&TMH+Z_N)[)+^*.SMS(7@<D!NV.G?'4=S0!;G\.B[W_ &O5=0N
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MLUR3<1NGW&5P!M*Y.,#')ZY-:VDZ3'I-J8EN;J[D8[I+B[E\R1ST&3P, =@
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M)^I9?SJW?Z?K5K>ZS+';:D+"ZUY);C^SV*SRVWV5%RA!#8\Q5!P0< UZ0"&
M(Y!Y%+0!Y$ND:M::<S#1-4(M?$\&IB)Y#/*]N449#,Q+N,?,,G![D59U/PSK
M.J:KX]G@L)$&H1:;-9"7"B9H1O9,]CE=ISQDUZI59+^TDU&73TG0W<,:RR1
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M& #'L]=UW4;WPU:17=K NJ:(UY*_V;<R2@0Y(^;&/WAP,<>]5=*\4^()M/\
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MM\A8,B9V]>XW-SU.3G-55\'Z2T!@NUEOH_L;6*BZ?>5@;&Y,\$YVKR<G@<T
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M-V"R0ORR,/*Y&>1Z50M_"E]#!=0S^&8KU;FW%JQO->DE980<A%)CRHS@\<Y
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M))=&&_NUO;@"7!:4%2"#CCE$X''RCWS)<>$M/NGU=II+ECJ\*P7G[P#>BJ5
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M)))JS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !61X@\16GARWM9KN*XE^U7*VL26\>]FD8,5&,CK
MMQ]2*UZXSXAR30IX9EM[<W$J:Y PA# %\1R9 )XSCID@9QR* )Y/B!IEKI>I
M7M_9W]D^FRPQ7=M-&OFQ^:P"-\K%2IW9R">A[C%32>,T1+9%T+6)+V>-YOL*
MQ1B:.)6QO8%P #D8&=Q].#7*ZQH6M:_!XDU%-)GMVOYM-BM[6=D$C)!,'=V
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M/S(_,*;=N6 8\9Z] >^ 0#KX_'-A-IL-Q#97\EY+=O9+IRQJ+@3("74@L%&
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MYJ3Q@EHV!. ?E(SG'?..:YGP[HFM>&++PIJ,NDW%T]II,FGWMK R&6(LZ.K
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M8Y8]Z /2M7T;3]=LQ9ZG;BXM]X<QEF 8C(YP1D<G@\5=1$CC6.-55% "JHP
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MT"]M'U!WM_B$=>,4+R-9+):-E0/O?NT#<9'?'-1VOQ'^U1:3.GAW4O(UB/\
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MMA:(ZD@+"#N"!>F,^U85QXQN8[B6UMO#UY=W5G;1W&H1131#[,7!81@EL.^
M3@<=.>:5O&\%S/9Q:-IMWJIN+%-08P%$\N!CA2=Q&6.#A1SP: .FG@BNK>6W
MGC62&5"DB,,AE(P0?PKGX_ 7AN)%46,C%89+?<]U,S&)UVM&6+9*8 PIX&,C
M!YK,B^(\-Y#HYTW1KV\N-7@FFM859$.(W"G<6("\'.3Z8ZD"M*Y\626FK);S
MZ)?1V#7:60OGVJIE? 7"$[BA8A=V,9]N: -631-.EBTZ-[8%--=9+0;F_=,J
ME >O/RDCG/6J.H>#- U6\NKJ]L/.DNDV3J9I DGR[0Q0-M+!> V,CL:QI_B/
M%!'-='0]0;3K?4'TZ>Z0H=LHD,8VIG<P)QR!_$.X.-K0_$;ZKJ>H:;=:9/I]
M]9+'(T4KHX:.3=M8%21_"P([8H LQ^'=+BMK^W6V)CU",1W6^5V:51&(^6)S
MG8 ,YSWZ\UROB7PE=W.H.VG:'IEU$UDEK#+)>2P-$5R!YJC*S(,@@$9&#ZYK
M;U/Q3+;:O<:9INCW6J7%I"L]UY,B((E;.U?F(W.=I( _/FJ;>/K>XNM+MM)T
MR[U*74[+[;;B-D0!-P!W%B N,_F,=: +$?@71Y-&TJQOHGFDT^R2R$T4TD+2
M1JH!5MC#<IQG:<BMB'1=-M[J2YAM$CEDMDM&*D@>4F[:@'0 ;FZ>M)K&I2Z9
M9K+;Z?<W\\DBQ1P6X&23W8GA5'4DUS]QX_@M-*ANIM*O?M3ZE_9;V:%&=9]I
M8 '.T@X&#G^(9QS0!NP^'M*MXM*BBM J:4,60WM^Y^0IZ\_*2.<U7LO".AZ=
MJ7V^ULBDX+E 9G:.(O\ ?*(6*H3DYV@=35 >,;@^(+?0AH%X=1>VBNIXQ+'M
MMXW=E8LV[!VE>@R3GCO4UKXLDEUJULKK1;ZS@O998;2YGVCS7C#,<IG<H*HQ
M4D<@=LB@#0B\.Z5#8:;91V@6VTV19+1-[?NF4%0<YR<!CUSUI=,T#3='N[VY
ML(&ADO93-.!*Y1G))+!2=JDDDG &:Y_3OB"FH)I5T=%O8=-U*<6L5X[I@2G<
M "H.[:2I&['7VYI+CXAQ00RWHT:^DTM;T6,=ZK)MDE\T1D[=VX+NR-Q'./<4
M =%J^@Z=KBP"_A=G@8O#+%,\4D9(P=KH0PR.N#S4!\*:(=)MM+^P)]BMIUN(
MHP[#$BMN#DYR3NY)).3US5"?QI'#?S*-,NGTRWO%L9]1#)L29B%QMSN*AF52
MV.#GT)JA<_$:*V2ZNCHE^^G6>H-I]S=H4(202>6"J9W,"2O0?Q#J<@ ';UA/
MX.T)[N\N6LF\R\F2>=1/($>1&5E?9NVALHIR!SCG-4!XYBMQJR:KI5W87&G1
M13F LDC3)*Q6/858C<64KC/7'--N?'::98:C+JNDW=G=6 @DDMMR2,\<TGEJ
MZ%20?FW CKQ[B@#=NM"TR]N;FXNK..:2ZMA:3[\D/""QVD=.K-[\TS1_#NF:
M$9FL(9%DF"B26:>29V"YVKN=B<#)P,X&37/ZAXXO+2QUQ'T*YM=2L-/-_%#-
M+&PDB^8;LJQ *E3E<Y],YKH/#FH7>J^'K&^O;4VUQ-"KLA96SD Y&"1@]<=J
M ':WH&F>(K6*VU2W,T4,HFC"RO&5< @,"I!Z,>_>J%GX(T"PE>2"VN,O&T3"
M2]GD!5A@C#.1T-=#10!GQZ'IL3:8R6H!TR,Q6?S-^Z4J$(Z\_* .<U@:[X+M
MK^\TE;:U06B:I+?WH,K LSPR*74YR&W,IX(QC(QBNOHH P1X,T :1+I;6)DM
M99UN91)-([R2@@AV<MN8_*.I[8IVJ^$-$UJ\:ZOK1VE>,12F.>2(3(,X60(P
M#CD\-GK6Y10!R6K^'KK7O$FD)<6-I#HNCSK=PN'W232!,(H7 "*I))Y.=JUK
M:QX8TC79HYK^V=I40QAXIY(6*'JC%&!93_=.16O10!0M]%TZUU!;ZWM4BN%M
M5M%9,@"%22J!>@ )/:F:-H\>CQWJQL&^U7DMVV 0 9&R1R3_ /KSTZ5I44 <
MKK/A1=;\9V6H7:$V4&GS0;XYWBE25I(R"K(0P^56&0>^.]6Y/!7A^2RL;/[
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M4 %%%% !1110 4444 %<%K&OZG<'QA=Z?=&WL]!L)88MJJ?-N_*\PL21T0%
M!W).<\5WM>;P6EP^F_$GP]%&7U">6XN8(\@&5+B !",_[2LOU% &WH_BZ'5Q
M9:9-!J5E<W]F9+6[FB55N,*-S1\G!&=V&4<<XQ5SP?J]UJ>F7-MJ+*VI:9=/
M8W3JNT2,F"L@';<K*V/4FL2PM=7U/7O"_P!IT:XL(]$@D-S+*R%))&B\H+'M
M8EARS9(& !WXJYX&_P!*OO%&KI_Q[7NK.(&'1UB1(BP]061ORH ["BBB@ HH
MHH @O(KB:SFCM;@6UPRD1S&,.$/KM/7Z5P-L_C&?QG?Z ?%4"K:V<-R)O[+3
M+%V<8QNXQM_6O1:Y>RTR\B^)>K:F\!%E-IMM#'+D89U>0L,=> P_.@!]SXRL
MK"]DM)K>]GBM9([>[U".%?(AE<+@,=V?XE)P"%W#)%(/&]@VJ:E8166H2G32
MXNYDA7RXML?F#+%OXAP,<Y'.!S7+WGA7&N:Q;WFA:KJ4>HWPGBE@U22"U\M@
M@82JL@ *D,?N'<-OX;-CHU_%!XZ#VQ5M1NI'M>1^]4VZ(".>/F!'- $D7Q&T
M^>2R1-*U@_VA"9M//V=?]+P 2J?-P0#G+;1@$YQS3;WQE8W>DZ5>I/J>G^=K
M,>GO"L,?F";<5,4@;("DCDJ<],&HK+1-0BN/ +/:L%TVRDCNSD?NF-NJ@'GG
MY@1Q6+J/AC69K2!([%V9?&@U$C<O%MO)\SKTQVZ^U '2WWQ!TVQDU'=8:G+!
MIL_D7UQ%"ICM^%.XDL"1A@?E!([@<9MZIXQL])OY+>:QU"2" QBYO(H@88-Y
M&W<2P)Z@G:&QGFN?O] U27PCX^LX[1FN-2NYY+1-RYE5H8E!'/'*D<^E9GBS
M0]<U1M>MVTO4[V=_+;3I$O?+M8X5C0LNP. 9"XD'*G)*\@= #>G\:2R:AXNL
M)K*^L[;1[4O]MB1"R_NF<L 6()(P5&,<<XZ5=A\86T.GZ-%;V^IZO>7M@EVL
M<,4?G&+:O[R3+*BY)' /)S@<5@:AIVK3W?CN./1[LKKNEJ;23*;0XMBGEM\V
M0VX@=Q[U)I.GZMX9N="U*32+J\3_ (1ZWTVYAM2AD@FC^;D,P!!W,,@G!4=J
M -QO'NEM!I3VMO?7<FJ+,;:""$>86B(#HP8C:P)/4X^4\UK:%KEMX@T]KNVB
MGA*2O!+#<*%DBD0X96 )&0?0D5Q_A[PWJUCJWAR[N[785;4[FZ575A;M<2*Z
M)G/)QD<9&0:Z'PEI]UIZ:V+N$Q?:-7N;B+)!W1L1M;CUH P/#GC[;IR_VO!J
M$JG4Y[-]1$*B"-C<.D2,<@]-@W!2.1DYS70CQEI?_",ZAKKB>.WL))8KB)D'
MFK)&Q4IC.,DXQSSD5Q<>EZ]-X3D\*R:%<QR7.K//]LWQ^4D'VLS%V.[.[:.%
MQSD>^)]3T>:7XGC18-C:3J30ZS?1@_<>#*X(]'<0'WV-0!U/C'Q-/X:\*-J\
M&GRSR[XD$1 ^3>P7Y_F'KC@GDCMS6,/&EW:>*=9BGTW5;F"&QM;B.R@AC,EN
M&$GF%CN SPO&XDXX!YK6^(.G7FJ^";ZTT^W:XNB\$B1*0"X29'(&2!G"FJ^F
M6E]<>(O$6IR6$]M#?Z?:I"L^T/N43;E(!."-R]^] %BY\=:;%%!+:6E_J,<E
MDE^YLX@WDV[9VN^YAUPV%&6^4\5:\2ZR]EX%U36],E1GBT^2ZMI,;E.$+*<=
MQTKSVQ\)WNF6MA)?Z)J]\9=$L[4PZ?J+6YBGB5@R2;94!4[A\WS8PWKSW&O:
M-*WPRU#1-.L]LO\ 9+VMO:K+OP?*VJ@9NO89/6@"AI#ZS<O8RR^.;"<2;'>V
M2RB#.#@E 0^0>V<5-=_$;2K-KMY;+4C9V5X;*[O%@!B@DW!?F^;)!)'W0>HS
MC-9FCK96;6.WX975O<Q[%^U+:68*-P"^X29]\CFF7GAW59?!WB:R2S8W%WKA
MN8(]R_/%Y\3;NOHI//I0!M2?$#3;6WU26_L=1L7TV&.XEBN(E#O$[%5=<,01
MD'J01CD4X^,8KM=0LDL]0T^^CL)+RW^UPJOFQ@8WI@GH2N0V",C(KF?B3IUX
M#XEU(0?Z*^AV]NDK$;3(+EV*^O1@?QK3N[;5?$/B%K]]'NK"*RTBZM0+AH\S
M3R[/E7:QRH"?>..HH =X;\:2?\(;X;DO8KS5=9U*T\[R;6-/,<+C<YR550,J
M.2.2,5LV'C32]0NM-MXUN8Y+]IXD$L>WRY8?]9$_/RN.>.AP>:Y+PYH^L^&+
M7PKJ4VDW-TUMH[Z=>6UN4,L+%T=6 + ,,J0<'N*34M(O-.\!:GKMW&MGJ5OJ
MLFOP0O("8L-D1L1D9:,%3@XR_>@#K;OQIIUK<WULL%W<3VMS%:".",$SSNF\
M1ID@$A>3G  [U!<>/M+M-,AO)[6_222^_LYK3R09H[C:6"%0<$D 8P2#N7UK
MG)?"EY)X2T2\GM+JXOEU%M5U&WM;AH9G,R.'",&4[D\Q1C<,A,=ZE'AN9X=%
MGL-#O;,#Q#'>W"WEZ;B8QK"R>:Y=VP?NC:"< #Z  [&Z\0P6&F6%]>VMW;I>
M3PV_ER(N^%Y&VKYF#@#) )!/6HX?%6F3>(=2T0/(MSIT(FG=EPFT@,<'/) 9
M2?3<*7Q=I4FM^$M3T^#_ (^)("UN?25?FC/_ 'TJUY]J'AGQ+=:!;W\-BT6L
MZK<7D.H1"1<V\%SA<DYP=BQ0]/3B@#I+?QK:7>L+<6YU602:"-3CTXPQ!6C,
MF ^<Y\P],9VX]ZS+3Q[J5X?!][)I]X@U.UN'ELH(E)N'"1,ICRQPOS,069>,
MYJ_)X;O$^),UU;6NS3!X8_L^*7<-HD$I(3'7[N#TJEX5TO5E/@@76DW-I_8]
MC<6=UYQ3AO+B4,NUCE25;!]J .A7QUIKZ3#>):WS7$UVUBFGB(?:#.N=R8W;
M1@*23NQCG-/A\;:=)"#+;WEO<"_BT^6UFC420RR8V[L,1M((.02,5S*Z%J^G
MZDFM)ITMP;/Q!>71MHV7?+;S1E-Z9(!(R#@D$C-1WVC:U>OJ/B)=)G1Y-7L;
MN+3V=//:"WP&/WMH8Y8A<] .] '0>+?'">']-UUK2SFN;W2[>*9E*CR_WNX(
M3\P. 4.<<],5KWVO1Z;X5NM=N[6>!+:V>X>WEVB0;03M."1DX]>]<+K>CZ[X
M@M/&\\>CSVQU+3[6.RAF= \AC,A8'#$*>1QGN.^0.UU&R_X2SP;>6$\$]B=0
MM7A,=P%\R(D$ D*2.N#UH Q(H/'TVEQZLNJZ?]L=!-_9#6F(<'GR_-W;MV.-
MW3/;%:FI>,;72;MX;G3]0:* 1_:[J*(-#;%^FYB03U&=H.!UQ63!K_B^/28]
M,_X16?\ MM(Q%]K>:,V18#'FE@V_;_%MVY[>]8?B[0]>U9]?MY=-U"_N9%C;
M3Y8KLQ6B1K&A<;/,&7+A^&!SE><#( .[E\46$-OK\[+/LT,,;K"C)Q$)3LYY
M^5AUQS567QG9I?"WBT_4KE%$1GG@A#);^: 5#_-N/!!.T-@'FN7U6VUP0>-;
M*UT"\G.OP>9:R[HPB;K58F63+9# J> #G(Y[T_5=+U-;R!]-T74K765BMDAU
M&TNE$$JJ%W"X0L 0OS#!5B1C![  Z;_A-+#^U/LGV6^^S_:_L/V_RQ]G^T9Q
MY>=V[.[Y<[=N[C.:OZWKUMH4-N9HKBXGNIA!;VUL@:29\$X ) X )))  '6N
M%L/"OV;5WLKS0M5NV.K/>)=C5)$LQ&9C,KF,28WJ2!MV<LN>^:Z;Q797O]J:
M!K=E:27O]F7,C36T14.T<D3(67<0"02#C/(S0 V7Q_I-KI5Q?7<%];-;7<=G
M<VTD0\Z&1\;<@$@@A@<J3D=,U<U+5[A_ ^I:K#;W5A<I93RQQW**)(V56P2
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MR#AC@COUSG@ ]#M]5L;O4;O3X+A)+JS"&XC&<Q[\[<]N=I_*E?3;.35(M3:
M?;8HFA68$@["02IQU&0#SG!Z5P.JZ[)X=\1>-=4B16E2TTQ$$@^56=Y$#-[
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MQTH [^F2R)#$\LAVHBEF/H!UKS+6-4UB;P_K-G/JLQFT[7[2T6XBC1&EBD>
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MIBN.OO$FJ6VMVWE7B7%O)K:Z>Z11+Y*1LI&TL0&,H(R=I*CH: -O_A _"/\
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MMQY7<I;D;C@X- '36_A/P;<W]Y9KX5LE>U*!WDTX*C[AD;&*X;'?'0]:M_\
M"!^$?^A:TK_P$3_"N&U/7-5L=4^(D5OJ%RJVTFEV]L6D+"V64*CLH.0#\Q;/
MJ,FKGB(7'A:ZU.QTW4M1:"X\.7UT1/>23/#-$%VR*SDLI.\]"!D"@#K?^$#\
M(_\ 0M:5_P" B?X4V3P/X.BC:23P[I"(@+,S6J  #J2<5A:;#<:5XI\+%=3U
M"X.JV,YO5N;EY$D=4C8,J$[4()/W0!@U;\=:M;+<V&@WAN(K"[S+?31V\D@:
M%2/W(V*>7/!_V0WJ* $31_AU)X</B!-(T9M*$;2_:/LB@%02"0,9ZC&.]7D\
M&^#GL%O&\+Z='&8_-*R62!E&,\C'!]JX32;ZVU/P7X+TV%F-M)KWEW*M&R*P
M0RS*O(&02J'CCC%=%J$,NN>)?%:7.I7UM'I-K"MHD%R\2(7B9VD900'YXPP(
MPN,4 6-,TGX?:M/:PVWA_30]W9I?6XDL57S86QRN1R1D9'49'K6Q_P ('X1_
MZ%K2O_ 1/\*XZ'_1O!?PNU"+BYCFL;=6'4QRP%'7Z$8/_ 17J5 '/?\ "!^$
M?^A:TK_P$3_"G)X&\*1R+(GAS2U=2"K"U0$$=^E<K>I<:ROC74YM5U"TGTB6
M2&Q6WNWB2 1P)('**0K[F8D[@>.*719+WQ)XXBEO=0OH;>/1M/OS:03M'&9V
M9R<@'D<8*]#QG.!0!V6M:/H&IM;MK=C87#!O*@-VBM\S?PKN[G'0>E8^G^%_
M ^IR7J6WAW2V:SN#;39LE&) JL0..>&'-4_B/817UUX2626Z0-K4<1\BY>+A
MHY"3\I'/RC!ZCG'4US.H64MMH7C[6[?4=0M[K3M2EEM1#=.B*R11'+*#A\]#
MNSP.,<Y ._\ ^$#\(_\ 0M:5_P" B?X56U#PGX'TK3Y[^^T#2(;6W0R2R&S4
MA5'4\"N5UBX\1ZKKOB)],L]5ENM/FCAL'M]02&WA80QR?O(VD7?N+G)*GY<
M=*ZCXE$GX8^(2PP3829'IQ0!C6A^%M]=PVMMI6FO-,X2-?[*898G Y*8%=)_
MP@?A'_H6M*_\!$_PIFE?\)AYUM]O&A?8\#S/(,WF8QVSQFN$O1J+>']7UQ-<
MU2.^M?$KVML5NG\N.(WBQ[/+SM888_>!QP!P* /1+7P;X9L;J.ZM- TV"XB;
M=')';*K*?4$#BM2\NXK"QN+R<D0P1M+(0,D*HR>/H*\K\2RWOA[_ (2O3].U
M?4(XDL]/NH9)[MY7@D>X9'*LY) (49&<=:T-8MY=#U;5M*@O[^XL[SPY=W,L
M=W<O/ME0JH<%B=NX.<@8' XH ] TO4K;6-*M-2LV+6UU$LT3,N"589'!Z5;K
MRCPHDFLVWA#0KB[NX-/C\-I>-':W#P--)E$&60AL*.< ]6&:ET[5M3T\Z9J5
MQJ-U<6%CK-UHMTTLA(DA:4I#*_8LKA%+=<$T >I45Y+/JFKZC':7D;:C<VNO
MZQ+Y-M:W?D/]DAB?RU1BRA-Y3S"002#1+-XDCFTO0[S3]8>VFN;N6.VCU-%N
M7@18BBO.) 2 TC_Q[B$7.>: /6J*P?!ZZM'X?6+6(YDN(YI5C\^999#%O/E[
MV4D%@N 3GG%;U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %9VN:%8>(M-?3M3CDDM796:-)6CW%2&
M&2I!X(!_"M&N9\:>)+WPW::;)9:<]X]WJ$%J0I08#N 1\S+\Q&0#T!Z\4 :2
M>'[);F.X,E[))$&$9EO)7"%A@D MC."1GJ,GUJK;^#M&M+?2X(89UBTIS)9K
M]ID/EL00>K<\,1SGJ:J7/C>"UNIE?2[XVEI)'#?7B^68[61PIVM\V6V[UW%0
M0,_6C_A-X'U75;*'2[^5=*+B\N $$<>V(2#&6R=V<  <$<X&#0!0\1^$ +>T
MCT>SN9?-UN'4;PK=8(VGYF!=Q@],!?2MZY\*Z5>Z;?V%U%+-%J!!NV:9@\V
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M9XQ'.\>)%.5;*D<@\UGZ[XM70IY]^D:C<6EI"L]Y=Q*@C@0YY^9@7( )(4'
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M/1-,U=]-AN[6YFF>.".1F,9CV_?4X^\:6UU36M!\5V.B:W>Q:E:ZG'*UI>+
M(I4DC7<R.J_*05R00!T(Q0!N7/AK2[O1;329('6VLPGV8Q2-&\)085D=2"I
MXR#W/K59O!FBMIT-FL5PGDS-<)<)=2+.)6!#/YH;>202#D\CBJEMXU\^3RY-
M!U2VDFM9+NS2<1JUTB;=P W_ "-\RG#[>#]:H:%X\N[_ ,,Z+=7&B74NJZG&
M9(K6W:("1%52TH+/A4&X#YB&R1QS0!UVF:9::/I\=C8Q&."/) +%B22226))
M))))).235NJ&C:M;ZWI4.H6RR(DA93'*N'C=6*LK#L0P(/TJ_0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7+^.M.O[_2].DTZT:[FL=4M;QH%=5:1(W!8*6(&<>I%=110!YA/X2D
MEUC4C=^%;B_75+I+E)6U'RHH594#I,JR=5(;&U6#9'-;MIH6HQ1^. ]N =4G
M=[3YU_> VZ(._'S CG%=-JNIVNBZ3=ZG?.4M;6)I96 R0H&>!W-,T;51K.F1
M7RV=W:I*,K'=($<CJ#@$\&@#FK/0=2BN? KO;@+I=E)%>'>O[MC J =>?F!'
M&:Q=0\):W/:01QV8+)XR&J,/-08MMY._KZ=NOM70W?Q%T.QNTM;B#6$FDD:*
M-?[)N/WK#)(3Y/FX!/&>.:Z'3-2AU:Q2[@BN8XV) 6YMWA?@XY5P"/RH XV_
M\-:M/X3\=V,=J#<:K<SR6:>8H\Q6AC4'.<#E2.<=*RO%?AC6]6FUZ+^QYKZ>
M;RVTZZ>\58(8UC3,83?PY=7YVX.X$L *]3HH \SU;PYK6JWOBR$:5(L.M0VE
MQ;S//&%22%%S%)M;<"64#*@CG.:L6WA\?8=3E3P,ZB6&*%K:^U$2RW*;\N%^
M=U7'!4EAD_W>M=_=3_9;2:X$,LQB1G\J)<N^!G"CN3VHM9_M5I#<&&6$RQJ_
ME3+ATR,X8=B.AH YSP587]A;7Z7$%[:V+S@V-I?7(GFACV*""P9N"V2!N.!^
M58Z^&=6'@&WTPVH^V)K8NVC\Q>(OMYFW9SC[G..O;KQ7H%027EM%>06DDRK<
M3JS11D\N%QN(^FX?G0!P(\.:C#?^-)KK08]2L]3O;>2*V:9%,\2H Q7)X8$9
M&XKR.HZUO^"['4+"PO8[N*\M[5KDM8VU[<">:"'8HVLX9OX@Y W' (YK;T^^
M-_%)(;2ZM=DK1[;E I;:<;A@GY3V-6Z /-/"7@]M(NM*LKGPU+YFG.V[5)-0
M+0L%#!'CC#D[B",@JH&6Y/&;.F^&-7M_"O@BREM0MQIFH+/=IYBGRT"3#.<X
M/+KTSUKT*B@#RWQ3IVI:?>:A>BV5OMGB;39K,-( )=J1)SUV_,I'/UJ?7=!U
MWQ+;>++[^R9;.:\TJ/3K*TGFB,DA5G=F8JQ51EP!\W8]*]#N[&UOUB6ZA640
MRI/&&_A=3E6^H-6* .$M;#6O#>LC4;?1IM2CN]*M;66*":)7AFAW8SO904(?
MJ"2".G-8NM:-J/A/P!H%[;M"?$.FW1\J,-Q*]R[*\*^HS(#_ -L\UZK6;?:7
MI#7T>MWUK US91L4N91DPJ,DD>G!//6@#G;?PI/I=YX*@M(_-M=(6<7,Q8 [
MGA*[L$Y)9R3QZU1O?#&KS>$O%%BEJ#<WVL&ZMT\Q?GC\R)MV<X'"MP>>*Z^/
M7;*;6+;3(B[RW-FU[%(H^0QAE7KUS\X[5IT >:'P<T6O7\5QX:EU!+O4S=I?
M?V@8X$C=@[;T#YW*=V $(/'(YQ;O?#.K3>"O%FGQVH-U?ZE-/;)YB_.C.A!S
MG X!ZXKT"N9N_'>CVFIW>G^5JEQ/:.(Y_LNFSS*C%0V-R(1G# _C0!%I=CJ5
MA\0]?N9-/D:PU-+=XKM9$VH8XRI5E)W9STP"*CN] O;KXG_VJ8<::^@R6+3!
MUR)&F#8QG/W<G.,5TNFZA%JEA%>01W$<<F<+<0-"XP2.48 CIW%6J /.+#1M
M?GTKPQX<N]):WCT6YMY)]0,T9BF2 ?)Y8#%\L0N=RC'/6NC\%:5>:1I5]#?0
M^5)+J=W<(-P;*/*S*>#W!'%=)65:^(+.[\2:AH4:S"[L8HYI2RC85DSMP<Y)
MX]* .?N[#5]!\2ZM?V.D'6-+UA4:XMXIDCEAE5/+) <A65E"YYR"*YZ'P!>S
M:;XBEL=$M-#^VQ6HM-/$P8EX)3+ND*Y5=QPO!. *]6HH \[UG0-7\;W-U)=:
M;+H\2:/<V,(N98W9YIMO/[MF&Q=@ZD$YZ5++IFM^*;[25U#2)-*BTZWG$TDD
MT;B662$Q 1A&)VC<QRVWH.*[^B@#S:PTWQ+/#X,T^YT)K:/0KB/[5<-<1,L@
M2!X@T8#$E3G)R 1D<'G&[XK\-_\ "0>(/#37&GP7NFVL\[W:3A60!H6525;[
MWS8Z XZUNZAJ]MIMWIMM.LA?4+@V\.P @,$9^>>!A#^E2:E?'3K%[H6EU=E2
MH\FU0/(<D#(!(Z9R?8&@#C5\%'2]2UW3M(L+>WT/7K%U=H51/LD^S9TX)1@<
MX&<,#TS69I_A?48],G6Q\.2Z7K$&ERP17\^I&0?:&0*/)&]L*>3N8*1QQZ>H
M44 >6V?A[4;?5I+VW\'N+2XTJ2SDM;Z]21Y'W*Q\TEVX8!E!&>>6P#PL?AG6
MO)-QI^F7MK9V%_:7MEI-_>K(Y9-XF"-O8(I5UV@MC*GH#7J-% 'FNM:!KGB0
M:[J9TJ2SEN;:SL[6SFFC,C+%.9'=BK%1]XX&X_=]ZZHZ9=GXB)JOE?Z$-):V
M,FX?ZPRAL8SGH.O2M&VU>VNM:O\ 2HUD%Q91Q22D@;2)-VW!S_L'/X5?H \R
M\:^&=8UR\\00#2IK_P"UV@CTVX:\"06W[LAP4W [RW(.T@Y&2 *L7^EZM>:S
M;WMIX<N].U0R6Y&I0WL:QF(;-Z7"!_G(&]<!6'3##MZ+10!Q7C::YM_$O@Z:
MTM3=3)?3D0!@I<?9I,@%L#.,XR0,]QUK)G\-ZWJD\^K2:<UM->>(;&\^RR2Q
MEXK> (I9B&*[CM)P">W6NJBUKP[K/BM]*21)]7T@F4 HP\HE0K%6Z$X< XSC
M=70T <C?V^JZ-XSNM;L=)FU2VOK&*W>.WEC1XI(V<J3YC*-I$G4$D$=*PYO"
MFOZ3X.T*XTN"*X\1Z7/-/Y*R!587!<R1AFP, N#[^6*]*HH \]N_!E[:6?@2
MRL(O/32+Y9KR7>!_ V]^3SEV)XYYK/U+0_$J>&M=\,6FB-.MUJ$MU!??:(EB
M,3S"4@@MNWC)7&,=\UZE10!YI+X.9-?U*.X\-2ZE'?:C]JCO/[0,4"1L5+"1
M X.Y2&QA"#QR.:@U'0_$J>&=9\,6FB-.MQJ,EU!??:(A&T3SB;!!;=O&2N,8
MXSFO0]2U>VTJ73X[A9"U_="TBV '#E6;GG@80_I3]6U2TT32KG4[^0QVEM&9
M)7"EB%'L.30!SWQ+T74/$/@+4-,TN#S[R9X2D>]5SME1CRQ Z TO]BW_ /;'
MC&?R/W>HVT,=J=Z_O&6)E(Z\<D=<5/:>/-#NKVVM':^M);IQ';_;;":W65CT
M56= "3V&>:Z6@#'\/VESIO@W2[.8)#=VVGPQ.'.Y4D6, YP>0".QKB=5@U3Q
M+#96U[X9M;36H9X7;6DN83'#L=2SQ$-YO(! 4@=<$UZ5<6\-W;R6]S#'-#(I
M5XY%#*P/8@\$5D?\(;X6_P"A;T?_ , 8O_B: .)TKPS#8ZNEK<:%]J*:F]VF
MI-J>V 1F4RHWEA\^8I(&W9@D9S6GX;?7-!AM/#L>G0-;07<A?4I+F,Q/;,[.
M-JAM_F?,%P1@')R:E:#P6?$MSH-OX0M+JZM8EDN7ATR$QP[E+(&)QRP'  -7
MK;1/!\\5B9O#&F6<]Z#Y5M<Z?$LN0"2" #R ,]: .-N-!UF?P=-H0L%$UOKP
MO$E-U#LGA:Y:0LOS9&%(R& //&:W+Q-5TG4/$\>GZ<NH1:T1-;S)<Q(L,AA6
M)A+N8':-@;*AN#C%=-_PAOA;_H6]'_\  &+_ .)H_P"$-\+?]"WH_P#X Q?_
M !- '/\ AG09M#O-1A>6%X/['L;*&82K^\>%)%;C.1]Y>OK5O2M%,OPOL/#=
M]>FQN/[-BM9V@E0O&0@# 'D'N/QK5_X0WPM_T+>C_P#@#%_\31_PAOA;_H6]
M'_\  &+_ .)H YFP\-:A:>-$NI?$,MQIRZ6;7<R6R _,<1[44$  ALC'3&<<
M5C:?IXUGX7Z!8^4EQ=Z#>+'=62W'DO(8=\3J&R,$JVX<@'CGFNQUK0_!VA:+
M>:K=^&=+:WM(FED$=A$6*@9. 0.:LQ^"/"8E:=?#6D[I%&<V<>,#IQC Z]J
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MPXD\GG!<-NW$YR3N&<D\T 7[*RM].LX[2U0I#&,*I8MCG/4DDU8HHH ****
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MS;P22[1<"$$.A/\ #D$@'UQ6[X0T==,2]F&@6^C>>ZA8DF$DCJHX+D$C.2V
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MKQE64]!T*^]9VC>$9X+26(^%;+3[J/39;<W:W7F&:5E"_NP/NH>2=V#R..M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)VL<=>F5SZU7M="O)M3U?PW% ND/<Z(MQ'%#J+W#+.LG[N5R57:V>N,YQUH
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MN6%H4W1[\Y R G7@'%2^)!-X?U?5=$T+S$TZXCTTS0"Y9%B:6Y:-P'Y,>]
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MJX5HV_NMM.00.1T]9?$>H3KKGBJWCO)8X'N](M9WCD*F&*1]LF"/NDJ<9]Z
M/0]7UBWT6W@GN5D99[F&U7RP"=\CA%)R1QDC-:%>8^*M#TG3;$Z;IE]/'YNJ
MZ89;-+@M]EW3@!TS\R%L'OU7([UM>'+*#1O'^NZ78AX[$V-I<B$R,RK(S3*S
M#<3C(1<^N* -35O&.FZ1J_\ 9<L&HW%YY"W!CL[&6XVHS,H)V*<<J:N:)XAT
MWQ!%.]A+(7MW\N>&:%XI8FQG#(X##CVYKDK_ /MO_A;EY_8G]G^9_8=OYGVW
M?C'G38QMKGC<:E/X9UK69Y$&M:EJUIIVHVL+FW6V5)5C\K?EB-RM_K/20$#B
M@#TSQ+X@L_"OA^ZUJ_29[:VV[UA4%SN8*, D#JP[UK=17BGC+3[_ $WX;>,H
M)[6VL;)A9O!8PWQN?)?S5#GE05#80@>NX]ZU?$-MJNL^)/$ZPVL3OI\4*65Y
M+J;6WV',(?S H4@_.6))/(7'04 >K45Y#XLN)Y&U;68+4FYTV>U@>_EU%HQ!
M,!$Q2")5(*G>,[B-Q8]JUY[8Z;XQ.IW\#W=O<:FD=OJ=I?'=;LV(UMY8CQLW
M?*<9ZY(!YH ]'HKR7P5;ZU=-X<UUK:"WFNY'>^NWU1G>\5D<M'Y14 %6 ( /
MRA"/6NI\81+J'B7PMH]VSG3KN>X>>(.5$S1Q%D5L$9&26QWVT =#IVL6^IW>
MI6T"R!]/N!;3%P "VQ7^7GD8<>G.:T*\?L4CT_79+>SN)# OC2.+)E+?+]BQ
ML))R0#@8/H*E\774[CQNEO>RQM'J&DQH\4G,1+0YQZ=: /4)[UH-0M+06=U*
M+@/F>-08X=HS\YSD9Z# //I2+I.G)JKZHMC;C4)$$;70C'F%1VW=<=*X;4K&
M'0_B/X"TS3S+%9E=1+1F5GWGR@<L6)).23S6'I5BEOX7\*Z\LURVIRZU' \[
M3N28FN'0QXSC;M[8Z\]: /8:@O;VVTZRFO+R98;>%2\DC=%'K7D%Q!%+X'3Q
M'->7":U<ZZL<L@N&!<"]V>3MSC:$487'\.?6NQ^+5O%<?#35O-7=Y:HZ\D8.
M]1V]B: .EBUBWFU^ZT95D^TVUO%<.Q V%9&=1@YSG*'/'I6A7G0\*Z5J'Q#U
M33YX9#90:-:*D"S.!DR3X)(.21SC)XS7.:1)JGB6W\.VMS9?VM&OAV*XV3ZB
M]M^\9V1I,A268!4Y/3=GO0![1163X7%ZOA;3%U&XCN;Q;9!+/')YBR$#[P;^
M+/7-:U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %9'B;0U\0Z#/I_G&"8E9;><#)BF1@R/^# ?49K
M7K&\0ZZ^BK8QP6@NKN_N/LT$;3")"VQG.YR#CA#V))P,4 78H);W1UM]6@@,
MLT/EW443%HR2,, 2 2#S5/4O"VB:O!:PWVG12K:KM@.2K1KC& P((& .,\XK
M.E\5:B9+2RMO#\KZM+#)/-:2W*QK"B/LSOP0VX_=P.1R<5)HGC*VUO58+*.U
MEA%SIZWT#R$?,-Y21".S(V >3UH 35?"XO8=(T>TBMK70;299YX8Q@OY9#1Q
MA0,;2V&8Y_AQW)KH+JUM[ZTFM+J%)K>9"DD<BY5U/!!%<G;>.I=32W72=':Z
MN+N6Y^S*]P(T>"%PAF+8. 6( &#G-*OCI[N72[?3=&FN+O4()Y!%),L8A>%U
M21';!QAB1D9Y XYH U+/P9X=L5E6WTF >; ]M(6RY>)L;D)8DD':O!]*C7PO
MI^C1"ZT+2+3^T8$98#+,Z!MV 0SX8D8 Z@]!C%6_#>N#Q!I O3;/:RI-+;S0
M.P8QR1N489'!&5/-8/B/Q7>(OB"RTS2Y9TTRU/VN[2X$;1.T9<!%QEB%(8\C
MKQDT :/ACPPFD:/>P7ZVT]WJ=Q+=:AY<?[IWD/*@'JH&%YZXR>M7](\.:1H+
M2MIEBD#2@*[ EF*CHN220!DX'3FN:C\5:EI7A33;H://J$,.D0WEY=R7 CR-
MF6"[@?,?"DD<=1SS6W8>*K6\U35+*6,VXL8(KI97;B:"121(/0 JP/N* +US
MH>F7=]+>W%G')<S6ILI)#G+0DY*?3-2#2K$26,@MDWV*E;8_\\@5VD#\.*HZ
M5KYU+PC%K[63VZRVS7*P.V6V8)7)QW7!]LUBV7CNZOM$L=130)4;5'BCTV%[
ME=TY9&=BW'R*H5CGG('3G% '1ZMH6F:['"FI6:7 @D\V(L2"C8QD$$$<$T/H
M6ER6-U9/91&VNY6FGC.<2.2"6/OD UAVWC</J%C8WFFO:S37LFGW&90RP3K&
M)$&<?,'4Y!X^E+?^.8;2\U.VBT^6Y>SNK>QAV.!]HN91GRQG@;05+$GC)]*
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M2X2STV*,7$7DRDDL6C_N9))"\]!Q6S10!#:VL%C9P6EM&L5O!&L44:]%51@
M?0"LZ3PMH<NLC5WTV%KX.)/-YY<# <KT+ =&QGWK7HH S&\.Z0VE3Z8UA"UG
M/(TLL1&=[EMQ8GJ6W<YZTK:!I3RZC*]C$SZE&L5X6&?/15*@-GK@$C\:TJ*
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MZY9_9-2M4N( XD"MD%6'1@1R"/45>HH QHO">@PZ?=6$>E6PM;O;Y\17(D(
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MJ"#G:<#(Z'%;E% $<$,5M!'!!&D4,:A$C0855 P !V&*DHHH **** "BBB@
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M8,P^8$[0<"K&D^)K_4/'&MZ))I4L=I8+#MN-T>,L&.6^?.& &,#C!SBLB_\
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M'?[BNP!"D\8R1U'J*Y*Y&K)J7@J'6[FVN;^+5YT>6W.0R_9IBN[Y5 ;:1G
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MWD9'MUZUJ>*/$.IZ?<:E<6&H-(EE>6<1ABB3RHA(\8=)2PW,S!\C;]T;>G<
M[^BN+M6US5?&6OV2^(+BUM-/E@,4<=O"25>(L5)93QDY'?CG-1^&];U74GM-
M&N[Y_P"U].N9EU5A'&-Z)]P@;<*)-\;# !P&YR* .W) (!(YX'O5>SOX+XW
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MY [^?N4!QLC0&+#@D<]!@\U9AM9[;XKZ=YVH37F[0KC#2J@P?.AR1M X/'%
M'<4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M99=VW)R",G@XJW+XT:.]E<:5(VCP7RZ?+?\ G*"LI8)D1XR4#L%+9ZYXP,T
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M+12HQ5U)'!P0>>XQ69J_BNZTB_?S=$F.EQ3PP2WK3*IS(5 9(R,NH+@$Y'?
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M'R "0TB 9C5@.#D]0#C-<M>>,]0D\&>*K_6[">*VT_4?LR?8;[RI1B5$V!U
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M+=Q)Y:RK(Z%DSG:VTC<N>S9%,OO!?A_4I[N:ZT\.]X$$X$KJK[,;#M# ;A@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&CA"K#N'7:VPN?\ KH:]*OM/LM3M_L]_9V]W!N#>7/$)%R.AP1C-6  JA5
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M)*CK I*YCPHVYSCCI\QQ9OO!NM2W7C"XC2!X]5O+*>* S%?/BB"^;$S ?+N
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M=G ZXZ5MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY_$6K66HR:'-<RO:?\)#%IRW['YQ"\(E\O=_>W$)NZX/7/-=RV@:0VG1:?\
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M$X[P.9!*NCR JQ_B'[[@^XYJQ+X3U>;6%U>7_A%WU!2"+@Z3*7R!@'/G]0.
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MM-9%HMNLF$C2.YC4*R]"2/GR>?F&#@5Z1+H>ESP6L$EC"8K1Q);H%P(G'1E
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MR.Q.,8QAAWK4BT77M4U^TU#5H[&"/3[*>"#[/,SF>24*"Y!4;%PGW>3D]>*
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MJ33(XQY$L9C,921]F"_S%@VS ( ]Z .J\.ZX=<M+DRVZV]W:7#6UQ$DOF('
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M@[^EZ%?V'B+Q'J(DMP-0CMEMCRVUHXRI+#CC)'0\CTH RT\>7Z>%KGQ#<:'
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M-L(8;K[\GF,NQCL&U5"D[^20"<#I70^!=+U30_"5EI&JQ6R2V*"!'MYC()4
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MX\SW+X #CY%\L$ D@ELD^V2 6-=US6[/Q]X?TFQMK>2QO(9Y)C)/L9MFW/\
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MTN&0=)&C+O*1[!G"Y]5/I0!K1>(%/BN]T*YM_(:"U2\@F,F1-&25<XQ\NU@
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MMEPMM#Y2;MTK9VKUXS@\]*FL]52[NVM3:W5O*J>8!/'M##..#D@X[CW%<O\
M$A79/"JQR>6Y\0VH5\9P</SCO5K7VO\ 3]!\0&;66:Y;3Y9[0Q+Y;Q>6AR0!
MG^(KS[X["@#K:*\YLX+N7Q'X?M)-8U5H-4T62>Z7[6PW.GDX92.4/SG)7&>_
M>J&E7VIZI;>"()]:OT%W-?VUP\<VUYEB$H7<<9+80<]>_7F@#T/6=;MM#BM9
M+J.9EN;J*U0Q+G#R,%4GD8&2*TJ\GGDOUT.:PO+R>]AL/%UI;VMS<-ND>(31
M-AF_B*EF7/M[5H7^JWUYHWC;4!?W-IJ.B7,HM(TE*JB1QJ\>Y,X</S]X'.[
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MSE(N3,5E?RYU_P"6BC:5SD@%5^4<4G@/2YH[KPOJ:-H=M]HLG:9K:=S<WX9
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M/^$5TR:)+<ZC?Z+(6"#<;S]V&D:;@[R&YRW1J .[AUH7T&E7>F6SWEC?@/\
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MC,"E99,@[V&,%L@')YX%4_$VJW%A916FG;6U;4)/L]FK#(5L9:1A_=1<L?7
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M=VP3@# P!R2*Z&U\;W0U6WTW4=-B@N!J1TZ[:.8NB.T/FQ.I*@E7''."#ZT
M=-J>BZ7K421:IIUI?1QMN1;F%9 I]1D<4R]T#1M1-L;[2K*Y-K_Q[^=;J_E?
M[N1QT'3TKEE^(RFP\3W3:?C^R<FU7S/^/Q=[Q*1QQF2-E[]C5G19KC2O'E[H
MLI/V>_LAJD46XL()=X29%)_A)*,/<MZT =9;6UO9VZ6]K!'!"F=L<:A5'.>
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M)4]: .-T[P[KNM6^@RZC<V4%KI]BXMY;9G,LLDD'EAV4@!-JLQP"V3Z56M/
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M7FHW::FI:#[5(JLBD CYEC+*,_W33K?1;2XU3P3IUW-8ZE8->:FZQVZDV^T
ML(P&SE%88 Y'RCM7J]Y8VFHVQMKZU@N8&P3%/&'4_@>*5+&TC^S[+6!?LX*P
M;8P/*!&"%]...* &V]S9F:6QMI8?-M50201D9B!'R@@= 0./I7$ZW!I%Q\6]
M/CUA+:2+^QI3$ET 4+^:O9N"=N['XUVD&FV]OJ=WJ" ^?=K&DAXQA,[>@_VC
MUS69?>&+;4O$ZZI>I;W-M]@:T:UGA#JQ,BN&YX_A]* /+]*BEGET"WC_ ++;
M20VJ_P!G+JBE[=E%P FT \D1[MN?X=V*TK#1+*ZUOP-I]])9ZK9I:ZDR>6I:
M!T$D910&SN51@#.?N@UZC<:5IUY9)97-A:SVB8VP2PJR+CIA2,#%2K9VRO"Z
MV\(:!2D3!!F-3C(7T' X'H* /)KD:/IMY\0 ^G6,DLE_:VXB=A"-DJ0+EF7Y
MA'N;<W8X.>M96NE8?#/Q(LUETP[;2S<IIL1BAW98,0NXY/RJ"1W&.HKV>;2-
M,N+B6>?3K26::/RI9'@5F=/[K$C)'L>*:-$TD1^6-+LA'Y7D;1;ICR\YV8Q]
MW/..F: .*L]'T[5O'>JC4;*"Z5-#L@J3('4;C/DX/&>.O7KZU@>')'EUKX3O
M(Q9O[&NADG)XB05Z\MM DK2I#&LC*$9PH!*C. 3Z#)X]S4::?91-;M'9VZ-;
MJ4@*Q*#$IZA>/E'TH \FT;2K&U\%>!]1AM8DOGUF'=<A!YK!GD4@MUQMXQTP
M!Z52,>B'P5I,\PMO^$A?Q%']H88\\R_;?G#_ ,6,8X/'"^U>SBQM%ABA6U@$
M4+!XT$8VHPZ$#L?I7)S^";V\U?S;O4K*2Q-ZEXQ33U2ZDV.'2)Y0V"BL%YVY
M( &>] &EX^ACG^'OB-)8ED TVX8*RY^81L0?J" 1[BN.T6WT&7Q-I<5]%IS:
M<OAV)[-)%0P^87/GD _+OQY>>^#7J3*KH4=0RL,$$9!%9S^'M%DLH[)]'T]K
M6-BZ0&V0HK'N%Q@&@#$^&I)\#VF"3;":X%J2?^7<3/Y6/;9MQ[8KK:1$5$5$
M4*JC 4#  I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD=001@[<$'^'WXV[WP_=ZS8QZ?K5Q!=V<B.;R-%:,2N?NA1DX1>PR3D YXY
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MZ8!YXQ4?]N6]WKOAPSZ9=+<WD%Q-:NL_R*H4$AER-Q(VD9'&>H.:SV^&T/\
M9_V9+]T>/4?M%M(HP8+<LVZ!?;;+*,_[0]!6[J6B7-UXGT75()($ATU)U,3
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M:\^\+WL&JC3+PZNJ^*K7S5N]/C3;/++@ATF!;)C!Y!P /EQC@54LM1TF\LO
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MA(P88R..JCMTKC_!/B;4?$,I:ZOM)E_<;[BR@C>*YL9<C]VZLQ+#[PW87E>
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M<54L]>\677B>TT25-+MWCTRVO[^0PN=K,[K)&@W_ .R,$],'KD  '=%0RE6
M((P0>]5F:P"R2.;8"+Y9&)7Y.V">W:N(M/%^O/I6E>)IQI_]C:C>1PBT6%Q-
M#%+)LC<R;\,<E21M'!X/%<7XB_Y$GXK_ /873^<5 'N(@A&TB*/Y<[<*.,]<
M4@$ E6,",2(N548RJ].!V'%8OB?6KC0O#BW-G%'+>2RP6MNLN=GF2NJ*6QS@
M;LG'I7+_ &G6=,\=ZM-?S:;/=V_AY9(I\&V@8>:Y&\,S; #G)R>.>* /1)88
MIE"RQI( 0P#J#@CO2-;P/"87AC:(]4*@K^5>5:KXTU>Z\*^*[>UU?3KBXLM-
M2ZCO[*WDB 5_,5E +DAALRK@XY''%:&J^-=1TFZ32IM9T2VO+:P2ZEFNK>0+
M<NY?9&B^9E>$^9B6Y88% 'HS11O$8FC1HR,%"H(QZ8IKVMO+$L4D$3QKP$9
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M_:K:PD?2 L/^BB6XU NT@,*9[# R "?GSP*])HQ0!YIX'^S:AXCBNU\N<?\
M"+6$8E^]_','7/U7!'M6/X.U&RT*;PM?:U/':V<GAS[/;S3\()1+ED!/1BNW
M [[:]CHP#VH XWX6A!X#MQ%"T,?VN\V1,NTHOVF7 ([8':NRHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPV$H-Q7!Z%LY X)ZUL7>E6S>.M6TQKF]^QRZ*EW)#]MEP9?,D7?G=D'&.G'
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M'C:,9')QDU]/\8^)9-&TCQ#>QZ8--O+Y+.6VBB<2JKRF(2!RY'WL';MZ=\T
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M/8.&L+4ASN8&%?F/J>.37(P_$25K:RU"?0;B'2Y[YK"6Z,Z,89!*T0)4=5+
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ME=^,#8:K;6EUIYBCN+];"-GFQ([%<B14(^:/=\N[/X4 =.JJB*B*%51@ #
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M6\HQER&/S?-DN<CCIUK)N/AZ9-.UFWM+BUL&U2:VEDC@MSY,;1,&+*FX?,Y
MR>.@ZD9/=44 <Q)X8O(=9U:_TZ_BA&KPHMU'+"7V2*NP2)AA_#@%3Z Y]8+/
MP6^F:B);"[B2UCT=-*AADB+,H4DARVX9//(P/K72W\UU!9/)96JW5P"NV%I1
M&&R0#\Q!Q@9/X5!KFI-HV@W^IK!]H^QV[SF+?MW!5+$9YQP* (_#>DR:%X:T
MW29)UG:RMTM_-5-@<*  <9..!ZUJ57L+K[=IUK=[-GGPI+MSG;N .,_C5B@
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M63:H- +P!U3=YXD.T\_Q=/?%9^E/#=67@FZTIP-:$JQZN,XE,?E-]H\\=>'
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MUQ9PS6;QR6SH#$T1!4KVQCM7E0LKV^^!FI6@CEDO1>W!O8T!+N%O6:4<<DE
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M]L,9"GG)(8$ =B,"D\+7FEW7B/P^+:2V:UU#1KF*6#_6/(P:([)VZ22@%BW
M(RW8Y/KD,L5Q"DT,B21. R.C JP/0@CJ*?@4 >,Z-+I</@GX>>2]O%.FJPQW
M&PA3O$;AP_J00N<\CCVJU?227?A[Q LC!/&5OJK_ &/G$X/FCR/+[F,QX''!
M&[/>O4UU"R:S:\6[MS:KG,PD78,'!^;..M2PRPW,:7$#QRQNN4D0A@1[$=J
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M!Z8W9[UZAJBL^C7J@%G-NX  SD[34TUQ;021"::*-Y6\N/>P!<_W1GJ?:IJ
M/(?#>G6JP>!KWPZR'5Q9A-2,<I;]T+<@K,,\8E"* >AX'3BYX'ETG5+W1;K^
MTKI?$EI$\>HV:Q*DA<KB3[1\N2N\9!)ZD8ZUZB% )( &>3CO0  20!D]3ZT
M<9\2A -(TB2XD,42ZU9;Y!(4VJ90&.01CCOVKF+R/3= E\3FT5O^$:DDL!MA
MFVP1W#2?O,MR%CQY9DQU!(KT+Q%H;Z[!91)=BW^RWD-X"8M^YHV#*.HXR.:V
M%4*H7 QZ 8% 'BNHWEFOACQO;"[MC'%JEK- ( 8XP'6 DHN3A6.\]<'YC6GX
MFO\ 3KB7QY9Z\\ N18;M)6<CYX?()!ASU/F;L[><XST%>HP7MI=22I;W,,SQ
M';*L<@8H?0XZ'CO4Q56ZJ#]10!F^')$E\,:4\;!E-I%@@Y'W!6G110 4444
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MYZS;,9Y^[C/OG%2:OX.@UC4-4NI;N2,WUG!;*$49A:*1I$D!/4AF!QC^'WH
MY:7QYJEKI6L_9KNUU2:T6UDM[H6CVZ/YDPC>-E)/(Z@CLP].;&OZOXET^#Q)
MI5QJ=I)-'H;ZE;W,-J8S$5+*R8WG/ &&SD9[XK=NO"VIZKH][9:OKQN7N'@*
MM%:B*.(12!^$W$DL1R2WI@#%6=7\*1:OJ5_=2W3HMYI,FF,BKRJL22X/KSTQ
M0!R<OB+7-(T_1+:[UNQLHYM.29-0O+)S#-,>D3L'Q'@8RQ.6SD=,5W6L3ZC%
MX9O;C3Q"=22U>2%2"Z&0+D#L2">*P3X2UXZ/%IW_  D\9B^R?8YU?3@R.@R
MRKO^5\'!))!P..*ZJRM(["PM[.(L8K>)8D+')PH &?RH XE?'=S=>(O#Z6B0
MG2;RV@DNW()9'N%D,(!SQ\T>"/\ :%0Z?XJU[Q!?6MA836MH+U[RZCN7@,A2
MTAE6*/"[@"S$YR3@#M5FV^&L-IX<U72H=4E62\NDN+>Y\H;K01LK1(HSR$*^
MV<FM!_!AM8-$;1M0%C>:1:FSCED@\U)8B%#*Z;@3RBMD$8/KF@#-TSQ?JL^I
MZ5IET+8S_P!K76FWDD:$+((H6D5U!)VY^3(R>]87Q"U>YU+PKXEMIPGEZ?KE
MG;P[1@[3Y#\^IRYKISX%DAL[-[35VCU>WOY-1:]EMPZRRR*RN&C!'RE6P #Q
M@<U!=_#LWVB:K87.LR22ZEJ$5_+.8!\K((\J%!Z'R^/0''.,D J>(]4US5K3
MQE'87%I#I^DV[VQAD@+/<,8!(YW[ALP' '!Y&377^'?^13TG_KQA_P#0!6)J
MO@FZO;K6OL6MM966M(!>P"V#MN\ORRR/D;<J%!X/3@@UTVGV0L-*M;$/O%O
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MQH-QXN2:S&DPWK1"P-N=[P+/Y+/YF[A^"P&,=![UV/AS1E\/>'-/T=)C.MG
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MJX7'4G))YH Z?3HKR"PBCU"ZCNKM0?,FCA\I6.3C"Y..,#J>E6J** "BBB@
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M(&]SP>:TZ* .>_X10_\ 0PZ]_P"!8_\ B:/^$4/_ $,.O?\ @6/_ (FNAHH
MY[_A%#_T,.O?^!8_^)H_X10_]##KW_@6/_B:Z&B@#GO^$4/_ $,.O?\ @6/_
M (FC_A%#_P!##KW_ (%C_P")KH:* ,*W\,F"YBF_MW6I/+<-LDN@5;!S@C;R
M*W:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **S]<UBVT#1;O5;S=Y%M'O*
MJ,LQZ!0.Y)( ]S5._P#$#Z'X/DUO6+413Q0"22UA??\ O#PL:G'))(7..IH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!BX>)X\'G@?/G\* /.)]1LTU'6;FQ;31I-[X@MHX;ZX7?:P2K;9DE #*&.Y
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M3]J[BVT9/!..M 'CWANXL;;4/ \NI31Q)<>%&AC=SAI)-T.%3N7QT Y]*VO
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"55W?8/-FP<N0"2<8S@"M=/ "QQ^'@-29I-+U"34)Y'AR;J63<7Z'Y>7/K@
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M_+P74G:I4@,#TP:W$U?3GM;>Z2^MVM[F0102B0;9')P%4]R2",5YOID^E?\
M">Z--X6U:]UN23S(;]KF5[I;>WVD[A(X)C.\*, _-W'2J&FZM9-X5\(:(LP;
M4[37(5NK8 [[?;,^2X_A&2,9ZYXH [KQ)XXTS1K>YBM;VRN-4@EA1K,S#>-\
MB*<@<Y ;.*U+SQ1H.G7SV5[K-C;W4<9E>*6=595 SD@GC@$_09KRJ^U#3H?
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M _-$^]OE8=C7)W=S;)X&UGPR[K_PE$^K3%+7'[Z61KG?',HZE0FT[^@"]>*
M.LC\?Q7OQ%D\,V4VF>3;JHFDEN?WDDAW9CC4#!9=O.36KXQ\5-X4THWB:7<7
M[ %V6,A$C0$ L[G@?>&!@D^G!(R-%4_\+B\5'''V"RP<?[])\5]9TZP\#ZA8
MW5Y%%=7</[B)C\TF&7.* -W7]?N-,O-/TW3K!;[4K\R&**2;RHU1 "[L^&(
MW*. 22:R_P#A.9&TR#9I)_MB74CI9L7G 1)PI<YDP?DV#<"%R01Q5/Q+K&AW
MZ:)K]GXA2Q,,\L-OJ8A$MN-R_/'+D@ -M&#D<J.:Y-+<C1A>ZC>7(T;5/$C7
M4VJ,GE2)$L(5)5(&8E:2, ,,85ASSF@#M)_'5Y;6MY#+HJ'6+6_M[%K5;O\
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M&QD8  %58@LBL!R >YQC-=/10 @50  !QT]J7 SGO110 4444    P!@4@
MP!@4M%    , 8%%%%   !T%%%%  0#U&:, ]1110 4@  P!BEHH **** "C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*J:F-1-BXTI[5+S(V&Z5FCQGG(4@],]ZY_P[JWB&\\2:EI^IG2Y;6QC0/-91
MR)B=OF\OYF.<)@GTW+[T =71110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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..BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>exhibit1060-kumaremploym008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@#O/"VI7VL>&;'4]1@CMY[N/SA$@(V(Q)0')/.W;GWS6Q2*JH@55"JHP !@
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M/,NI<)"[M!("ZL3C:S=#P":R)4R/&$LJ%[&#Q9;37RXR/LZF,N2.ZC@GV!H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:U:* &B-%!"HH#') '4T[ SG'/K110!DZYH<>L"SE69K:\L;A;BVN$7)1NC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ.LZM
M:Z%HUWJEZQ%O;1EVVC);T4#N2< #U-8UYXMGL8M-M'T:>XUZ_B,HTRVE5C$H
MQN+R-M55&0,]SP,T =/17*)XOO7@U&%_#MW!JUC"+@V,LBD3Q9Y,<B[E8\'@
MX.<#C.:Z'3=1M=7TRUU&RD$EM<Q++$_JI&10!:HHHH **** "BN=UKQ-<Z=K
MEOI%AHESJ=U-;/<D131QA45E4Y+L.["IM)\466HZ==W5TCZ8UE,;>\BO65#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ7;W$=O-(\,B2R(74&.5).0""<[<=>]0V5OXS6]A:_U+0I+4-^]2"PF1RO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#R:Z:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD6JW5DXTE+":Y&EM<Q3K$?E"[6RDOS,1D,"#WQ7;V6O:3J)M19ZA;S&ZC::
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M-$U6X:XN[8VNZ8%\&14DW@*&(/521DX]H[;XE:3=3Z/.MS;0Z9?6$MU+-+(
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M)=$M?/USPY<FW86-QX@U.[LU=" (C%(48 ] 2"P^H-=?X.0QZKXO&W:IUIF
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M(ZBGT <I\-%9/AKX?5E*L+- 0>HKJZ** "BBB@ HHHH **** "BBB@ HHHH
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MQPV?PH B\7ZO<::]A#;ZM;:<+AGW,;5[F=]H&!'$HY'/S'MQZ\2>'_$<FH>
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MGN+QI8'C\EGC\M8CN ^?+,<#^[76Z?JL&KZ+'J>GAY(IHR\2NI0MUX(/(Y%
M%:Q\5Z%J5[+9V>IP2SQ*S,H) *J<,5)X8 ]2"<4_2/$NC:[)+'IE_%<O&H9E
M7(.T]&&0,J<=1Q7ENG7OVR\\-SWLU]=PFVN8;NQ@T]8(;222$_Z.@"*VXD,N
M"QZ#ID5U'@B^9]9^P6E_)JNEP6(\NYN;/RI[4AE"P.^ &R,G& 1LYZT =1JG
MBC1-%NX[74=1AMYG4.%;/RJ3@,Q PJYXR<#BH]3\7^']&GE@U#5(8)8@ID0Y
M)0$9#$ <#WZ#O7#>/;J[N+OQ-IJSW-K))I@2UMK.Q1WU'*/G?(R,=JDD8!!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %9VDZ/!HXO1 \C_;+N2[?S"#AWQD
M# ''%:-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5#:VL%E:QVUM&(X8UVHH)
M.!]3UJ:B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB32YIY[-K"]M;A[:[M'DWF&13TW8&05*D''>E3QGX8DE,::_IK.(?/P+E?\
M5XSNZ],$'Z<T ;E%9<7B31)]'?5XM5LVTZ,D/<^<OEJ0<$$]CGM[T6OB31+V
MR^VVVJVDMMYRP>8LH($C$!4/HQ)  Z\B@#4HJG<ZMIUF\Z7-];PM!$LTH>0
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M"[6"]'AG3;W74FO-.BD6;2DL0)(6\IHY5F8'(!+'E@-QP:]>&.HQSW%+CG-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1T/M0T4;IL>-67KM(R* /+?#&DV2^-/#<!F74((/#]S-;S/;&(8-PFTA&R5
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M$Y%@E+R>(-R*$.6'F0<CU% 'M=W>6]A8S7MW*L-O#&9)9&. B@9)-8Q\<>&
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MGQ& A!! 4A' ;OD?WJ[7P7:Q6GAB/[//<W,4TTUPLEQ"(6;?(S$A,#:I))'
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MU XR,5/J]\UUXWT;P_\ \N[6\U_<KVD"%413[;GW$?[(J*Z\4:G:^*SH#Z;
M)[A5DT^4RMLGC!_>ECCY608..<Y'3/ !;'A8'IX@UPXXXO/_ +&C_A%/^H_K
MO_@9_P#8U!J]ZVC^-=!\OB'5VEM+A!T+K'OC?ZC:RY[AAGH,/\:ZIJ6EZ?IS
MZ:85>?4[6WD,F?N/*H(&/7H3Z$T /'A=2Y0>(M<+* 2OVT9&>G:N@1=D:IN9
MMH RQR3]:\TGU.^\.>)/'.J66GVDWV:VM+JZ1I3&&"Q.6VX4Y8@'DXK?U+QA
M<JU\NCZ:]])8QQO)"(Y"TI=0^Q2JD*=I!R3U...M '26EA#9R3RKEI[A]\TK
M?><@8'T    _J2:E>YMTD,;SQ*X )4N 0"< X^M"2O-:++'&4D>/<J2C!!(X
M#>GO7E%LT9\"GQ%K.B:=JMQ#JTP5YF.X%[QHB>5.0OR8'HHZ8% 'KE%<L/$6
ML3^*=2TFUTJU>#3C TLK7+!GCD#$E5V?>&WH3CWYXQKCQU>:AX'UG6-)>P\V
MTT]YRN]O,M90"3'(A (88.#P"1T Z@'H5%5-->Y?2[=[D1^>T8+;&)!X]2,U
MQ1\?:O%IXU>XT2V72H=2?3[MTNRTJ8F,(D5=@!7.,Y(//3C) /0**Y*[\775
MEKEK93V<*QW&H_8%3S=TJJ4++,<9 5BI 4X..?:EM/%=[/%J-M+96\>K6FHI
M9+:B5B'#[2LF<9VE"7Z<!6]* .LHKC#XRU&*ZUV6XTVUBTS0YG6\F%RS.4$
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M3EB3[#!Z\"NET34+C5=$M+ZZL)M/N)H]TEK/]Z)NA!_Q[B@#0IK.J %V"Y(
MR<9)Z"N&NO'MU8V,TUW96L4MKK TV[0S-^[1L%9A\O(VL'QQQGGBHO&5S->2
MZ1,+2!Q:^([:*U?=@N0#OR<?*-V5.,_=- '<7D,$\(%RP$*L'8%L*<'(S[9Q
MQ5BN U;Q5,_A3Q+_ &IHEC=2Z3=+;W%LTQ:&56$;JP)3)P''!'4=:W+WQ!J$
MEWJUMHFGQWLVE^6LL4DOEM,[*'V(3P,(RG)XR<>] '0AU+E P+* 2N>1GI_*
MG5YI<ZE>>'O%'CK5=.TZVE6VM+2[N4EE\LLJQR,V-JG+$ \GCBO1H)A<6L<\
M8XD0.H/'49% #T=) 2C*P!()4YY'!%.K@;/QC:Z9H"7<EA::5#-J]S9S2C+0
M0NKR R.0!]]EQDX&6Y-=GIES+>:;!<3+"LDB[B(9/,0^A5NX(Y!H MTU'21
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M544<#DDLV/H"?0&Q'XZG>TT^[?3XX83J;:7J1:8G[),&* @XPREMHSQ]X>]
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M7XOY-0N_-NKW3&TR6XAA$3.C=7?DAGX&#P!SQS6@_C/P]%I<6I2ZG'':R3-
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M7U#2+&>\\6R:59P!XTCDM99&7+-M^8LHQR5'XG.* +/AK19?#VC1Z8U\]W#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9YI66FZ7_P )=X;=K"W\@Z%*+@M"-IDW1%0_&-W$AYYZUZ910!XQI-OIPA\
M)JEM&(HYM0A=;B+A$&\HK CA<;2,\=*NG33IFA%8('BTZ7Q;!=6,*H<1VXEC
M+,%_A3<KL.V#GH:]$U#0HM0US2]5>ZN(Y=.,ABCCV[&WKM;=E2>GH16M0!Y;
MJ,$T^C^-]*O[>5]8NKN2;32$.Z92B_9S&W^PP .#\N"3C.:T=6TS4M*\06LU
MFH>3Q#;+INH21X!29%+"?\(_-_)*]!K+M]#CAUJ?5)+V\N)),^5#/(#%;@@
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M(K6,RK'LW9;8=H ]<XQ[XKCM-LM/N/%GAZ2]LX9(5\,F.5IH<J'#185LC&X
M/P>>#7IM% '*_#8.GP\T:*1722*'RV20$,F&( (/(XQ75444 %%%% !1110
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MZR-U9C[EB3^-9S^$C-JB7%SK.H7%E'=&\CL)2C(LN21\VW?M!)(7=@<#H,4
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M^[C3:_"?+\O&3D'%;'@W4]1OH]1AOOM\L=O.%MKJ^LC:R3QE ?F0JHRK;AD
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M+-YEGMBHG@N('AECW#*DHX!P1G!Q@XKSF&UOH]+NH?[,OVFTOQ4^IS0BU?\
M?6YG<AHSC$APP;"DGCZ5U6A,^K^.M3UZ"VNH-.-A!9QO<V[PM.ZO([,$<!L
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M*P2/-&PC+= P4D8]C0!V/BWQ/!X3T3^T9[>:<&:.%4BC9LEV"\E5..">O4X
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M+\.W:7WAZQF2*XB'DJA2X@>)P5&#E6 /4?C6I0 4444 %%%% !1110 4444
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MLK#=\JCEN_;C@"F'4M3MO&QAU34]2L$EO1'9QFU1[&YA*C";PN5E)S]YAR.
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M?RQ>?\PN7AD"0LP/WB(R6&?K7IW]B:/%K\.J);0PZD(7A5XSL,B$@D$#&X#
MZYQF@#12WACGDF2-5EEP'<#EL=,GVYJ2BB@ HHHH **** "BBB@ J.XA^T6T
ML/F21^8A3?&VUER,9![&I** ,[1=$L]!LFMK,2'S)&FEEFD+R2R-U=V/))X_
M("M&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS94#]W[UWU% &;_8EK_;MSK&Z7[3<6B6CKD;0BL[ @8ZY<]_2J=KX1TZTL]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX)&MC$S*(ID3?Y;DYR"N<. /N_=YJ;P9K6K^(M&M=7OK6RM[2[MHY84AD9I
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M8$+QW5H+.Z51DJ58M&^.X^9U/U4] :O:7I;Z;!<HUV]S)<3O.TLB '+=N.H
M  ]@!0!E:Y>Q:Q\/Y]:TR7#BR.H64PZHZIO4_P!".X)!ZUK:5>C6O#UE?KNB
M%[:I,-IY3>@/'TS7.Q^$YM&\%7?AC3KR>X2\62&%YD4"U20G><@#A0Q('7.!
MTZ=796D.GV%O96Z[8;>)8HQZ*HP/T% '/Z9X8U*PDT5Y=?:X&GQ2PS*;1%%P
MC?=Z?<*X7D?>QSUKD+C3(_#.G7=MXF\+)?Z4+J2Z?7+)U,RAI"XDD7B167(R
MRDX KU.5S'"[K&TA520B8W-[#) S]37F#Z+?O9R:5]A\8C0I"=VFYL"-A.3'
MYADW[.V,YQQF@!^I>,=7;5]6ET^74G&GWBV\%A;:2\\-R@"%R\P0X8[FQAAC
M R#FMFRN?$>O7^IWVGZM';0V.IM9QV$D"F*6.,J)"[X+AC\V,$ <<'FJ$MM?
M_P!J7%S9Z1XLL;6ZF2>ZM+9K)5D=0HR&\W<F0JAMI&<=LFHKC3KN74;F6'1_
M%EM87ERMW=6$+60264;>=WF[U#;5W $9_$T 9!U#6=#\#>/M7CU>2XN+;5)H
MXA-!$5#*T:[L;><CC'3C@5U8N];\0>(=0TZPUAM+ATVTMVW16\<C332JS9;>
M#A  .!@G)YK$O-#FO-/\0Z<^B>*5L-:E,\D ^P_NI&*EF5O-SSM'!)%7+ZVU
M";4'OM.TCQ5IEQ-;):W+6_V%O.1,[3\\IPPW-AAZ_2@"+1/$/B#Q?>Z;!#J8
MTN*?1$O)V@@1V$WFLAV[P0%..^>![YKJ_!6JW>M^#]/O[YD:ZD5EE=%VAF5V
M4MCMG;G'O6!I, T6_M[FR\(^(46WT]-/CB+6A41JQ8'/G9+9/)JYH-Y<^']&
M@TRW\*^(9(H2Y#2-:;CN8L>DWJU '*^*-:L-<\0:?J$FIVR6>EZW;6]K"9U!
M=Q*/.F89Z#&P$]@YZ$5I?V9I^NVGQ O=0MX9YQ<26\<SJ&:*..VC9-A_AP6+
M<=SFK>JV=IJP@\SP%JD3174=R6CAL@7*-NVM^^Y![U3U73+G4;R^>#1?%=C:
MZDJIJ%I;FRV7 5=O4RDH2H"DJ1D ?6@"C:"*XN&O_$NB76J#5M#LQ:2)9M<
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M5QH,[ZI<S/HZ.D?F(G[T,FP[L =% QC'OFF67@FTLK6WT];J9])M;O[7;V;
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M2"1D'T.,CO@UI56L+3[#9QVYGEN&7)>:8@O(Q.2QP .2>@  Z  59H ****
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M6)B<!<=, 98\XR.#GB4^+!)9:*(+)_[3U> 3PV<K;/*3:&=I&Q\JKD#IDD@
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MN=-G\/06+FWM7D:&=?\ 6)(@4L-P*C..2E 'I\^J:?:L%N+ZUA)4-B295X)
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MCH0.WJ*\[\)6-_H?A_P;J=_IU\L&GW.H)=1+;.TL(E=]DAC W$<8R!T?/2M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCE0=JG!_ $]!6U+<I%9O= /+&L9D B4NS #/R@<DGL!UH P[7PA#:WNE7?\
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M=9>J>(M)T6ZM+6_O%BN+LD01!&=WQC) 4$X&1STH XW2-'OX=)^&D<EC,C6
M_P!*4QD& _9)%^;T^8@?4UEZG%=Z5K$5S-I]Q()/&9N(HU3YI8_L1&Y!_%T;
M&.I7 YKUAY$C +NJY(4;CC)/05EO'I6OWJ?.9I]&O=V%)7RYO+Z'U^27Z<T
M>:^+-+U3Q!X8\<W]EI5\!J4EC':6\ENR32B%TWOY9&X#D]1G"YKI+B:Z\/>)
MO$T\FD:A?1ZLD,MHUI;F5698O+,;$?<Y4'+8&&ZUWE->1(D+R.J(HR68X H
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MBGDA9<1Q@8V;LC>HV@%>>3CUPRQJQ0NNX+NVYYQZXJ#3M1M=6T^&^LI#);3
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M=D"2;8 .3U!PV".#@^E5KC0M0BNEU&:#5HK:#7M0DD_L]6\\12CY)%4 EER
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M26<QWKAI@7=F);'0DG..V<5N444 %%%% !1110 4444 %%%% !1110 4444
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MV1=E24E64*2N , ANG3BK8\$:8]CJ%O=3WMW+J'EBXNIY@TK+&<HH(   .>
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M2T04*!C^$A "._- &S1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP7INMUEXNM[>-;N599D0,C!7=20Q&XC.3QCFN]^)A(^'6L%5W$1I@9QGYUH
MT](\6Z!KMRUMI>K6US<*N\Q(_P ^WUP><>];-<9]EUW7?$^DZE?:,FE6^E^=
M)O:Z2628O&4"#9T7G<<GJ!Q7+:-<ZP?A[X<OIM=U&2]\075K:3SM-GR(R6SY
M8/"L5&"W)).?3 !ZY17E/B:^U/PVGB72K#5[UHXK"TO;:>XG,LEN[SF-AO/S
M%2%!P3Z^M3>)-0U/P5?ZA'8ZI?7BS:'/=@7DOG&*>-XU$BYX4'S#E>%^4<"@
M#U"F2311-&LDB(9&V(&8#<V"<#U. 3CV->5W\_B/2- \1S11:_:6::-+*L^I
MW<4LB7*]&C*2,1D$DC@ J,8S4VLZ%)_:'@A;G6=6GFN]0>2:0W;+AS;.3L X
M09& !T!([F@#U&JDNIVD&J6VFO+B[N8Y)8HPI.53;N)/0 ;EZ^M>>76MZM9:
M=K/A07TQUIM22TL+EFS)Y%P2ZR9ZDH@E&?\ IG70Z*GV[Q]K5YN9XM,MH-+B
M=CDEB/-E)/<_-$#_ +M &[J^N:7H-J+G5;Z&TA9MBM*V-S>BCJ3["FZ/X@TG
MQ!#)+I5_#=+$VV01M\R'T93R/Q%<[*L<_P 985NP&\C1/,L@_0.TQ$K+_M;1
M&/H:=XWN[30]-U;5=.:V@\0M9QQB7(,@B,H0.5[A2Y.2.V* .RHKS77[R_\
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M-*R?VRV=S2>:>?*S]XYJ\(]?&MMK \-V/VQK86I;^UVQY88L!CR?4GFNMHH
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M>3VR>!VJW10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X#2;Q5E\>>(KB[CM
MIH+I[..XE0NMO%!$I7Y>I&YV8@=<UW]<8?#;?VUXATJYMY)-#\0)]H,L1P8)
M]@213Z;@%93ZAO;(!3\+7]Y>:_>Z)J$VJ7EE-IJSD:M;1QN6+%'VA0/D88X(
MR,5I?#>>5_!L-K-(TC6%Q<6*NQR62*5D3_QT*/PH?PZ^@RS>(+>ZU75]72U:
M 1RO&3<@D%%8!0% ;G*[>K$YK2\):(_AWPQ9Z=-();E0TEQ(.CRNQ=R/;<QQ
M[8H VZ*** "BBB@"MJ7_ ""[O_KB_P#Z":XGP;X=T35_A-HL.IZ?:2Q2:<GF
M.\:@CY?O!NH(ZY[5VFIF0:;<>5:R73E"HAB=59L\'!8@#KW->9V_A*_ATN'2
M9--\73Z5$@B^Q/JMFL;(/X24*L1[9H I:'XGUF^T3PY82W>M*#I;W$EQIMLL
MT\V)3'$6W*V%VKN/')(Y]9-0@U?6?%?PYGU*^U#3[^XCO%E1(XT,+I"<NJLA
MP7[@Y !XQUKH=0L]2NY+.:R\-:UI,]I";:*6PO+-2(3C]V0S,NWY1CC(QQBE
M-C>F^T&\/A76FET19%MB^H6S;]Z;&,A,A+''.<CF@#*O?$^O);>-!;ZAMEL-
M8LK6S9XU(C222)6!&.0=QZ\\\8J[J>HZSX>G\4V(UJZO?(\/MJ5O-<I'OAF'
MFJ<;5 *_*IP0<8I)-$N)1JX;PIK7_$UO(;V?%]:</$R,H7Y^!E!G.>]6]3M+
MW5KK4+BX\)ZN'O\ 33ILH2]M0!$2QR/G^]\YYZ=.* ,K23?ZMXT\&7MQJUX)
M)O#ANI%01A78F N,;>C$C..>!@BH]#\3:[K.EZ38/J<D-QJ6M7EM)>)&F^."
M$.VU 5V@G:!D@\9[UH)I5_#<Z%<6OAS7;>71[86D1COK/]]"-F4DRQR#L'3!
MZ]*AB\/W%MH\>GVWAC786AO7O[>Z2_M/-AF<DDJ=V,89A@@@@\YH 9J&MZ]I
MLNHZ)#J\DL]KJ^GP07LT2,_E7!7*N  &Q\W. 2"*LW%SXDL+OQ)HUCJ5]J4E
MO!974$CI";A$DD=9@GRJC-LC)4$=:2+1[Q;<K/X9URYN'OX=0FNY;ZT\V:6(
MJ4W88 *-H&T <?G5B_L]1OKZ^O?^$:URWNKN*",RV^H6JF/R69T*_/URYSG(
M(XQ0!M>#;];[3[H#5;R^,-P4*7]MY-S;_*I\N087)YR#M'!'7&:T/$FN0>&_
M#E_K%P,I:Q%PG]]NBJ/<L0/QK#\/Z)=-YSWJ:W9W1NXKN6YGNX"]V57:$80_
M+L  !7 S^=;FMZ!::^EE'>O-Y-I=)=B)& 61TY4/D'*YYQQR!0!Y'X<U;3O#
MFM>'-2%U-)>ZGNM==9[66,&69S(CEF4+\LC%,YZ-79W&I:G:^-FBU/4]1T^"
M2]CCL1]E22QN(BJCRRX7<LK-N&68<XP".#UFNZ+9^(M$N])OPQMKE-CE#AEY
MR&4]B" 1[BLMO!L,EXDDVKZK-:K/'<M9RRHT3RH5*N?EW?>4-M#!<]NU #_$
MVHW=CJ?AJ*VF,:7>J>1.  =Z>3*V.>G*J>/2L#5=6\02ZAXEMK"6[>&RO[1"
MMG'&T\5NT"-)Y088+9.><G!..U=9KV@P:_;6\<ES<VLUK<+<V]Q;,H>*0 C(
MW @\,0001@UF1>![6!+MH=5U6.\NKB.Z>\$R^;YJ)LS]W:01U4@KZ 8& #E9
MO$]U-_9&F6FLZU>03FZDGN+6P47J"(HJQ.A7"D&3YFVC.%]<FUINJ>(=<U#1
MM$O+V^TN3[+=7-S,L"1SSK',L<1*LI"[E8.0!UXX%=!_P@]HD,+PZGJ4.HQS
MR3_VBCQ^<[2 !]P*%""%48VX&U<=*?<>#+:1-.>#5-3MKVP61([V.96FD60@
MN'+JP8$@'IP0,8H I_#A9DT;54N)1-,NLWH>0+MWD2G)P.F?2N<D\3Z^]OXC
M6'4=DUOXGM]/MG:)2(XGDB4KC'(^8^_O7?\ A_P_9^&]/DLK)YWBDGDN&,[[
MVW.<MSWY]>:SQX'TM?MV);K_ $W5(]4D^=>)D96 'R_=R@XZ]>: (- EU"R\
M9ZMH=UJESJ-O'9V]W#)<J@=&=I59<HJ@CY 1QQ6%K-K._P 2]:?^TKL1)X<\
MT0#9L.6D4K]W.,C=USGOCBNYBT>VBU^YUE6D^TW%M';.I(V!49V&!C.<N>_I
M5'4?"EKJ.O?VO]LO+>9K,V4T<++LFB)) 8,I/!8D$$4 <AX8?5=)@\ EM8GN
M+;5;58)K1T011J+4R)LPNX$; "23G)JOINO>)-3\*K=M<ZE+#'K-U#>2Z;#&
M]RD"E@@12I! ;;G +8_&N[B\,6,4>@(KSXT, 6N6'S?NC%\_'/RL>F.:H6_@
M:TL-/6UT[5-3LG6[ENUGAE0OND)+*0RE67GH5.,=: -/PS>+?^';2X74O[2#
M!@+HP^4SX8CYD[,,8/ Y!X'0>1:_K.G^(M3\0ZTMS,NH:=(D.@E+661=T#;V
M8,JE<2293KT'->OV.A0:=H+:3;7%RJ.)=UP7!F+R%F>3.,;BS$],9[=JET31
M[30-%L])L5*VUK$(TW')..Y/<DY)]S0!R4WB*?Q1-X4@TG4)K"TU>VGO)IH
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M3#RX@+>141E:'Y.,;B,-N[9S6U#X*MTL+NRN=7U:\@GLGL$6>93Y,+#!"X4
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MK @#D2<8/:@#LZ*YGPIXI'B9#-$]HT8B!ECC8B6VESS%(C<@CUP,X/ []-0
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MARNW=CG;G/M69KWC_3[0);Z7=1S7@U&WLW#POY9W3*DBJ^ K. 3P"2,<C@T
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MI]PSM"0)(Y(GB=,C()5P#@CH<8/:FZOXDTK0Y(8K^Y99I@S1Q10O-(RCJVU
M3@9&3C% &K16%=^,_#UC96=Y/J<7V>]1I+9T5G\T#&=H4$D_,!CKS6K->V\&
MGR7\LFRVCB,SN5/" 9)QUZ4 6**YI?B!X8>0QKJ>Y_+\Q ()3YJY _=_+^\.
M2.$R15D^,=!&CV^JC4 UI<R&*$I$[/(X)!01@;RPVG(QD8- &'H<IT"34W70
M-?NKB_O'NI[AX8<L3P /WGW0  !67J>F)J)\1JNB>)((M>@2.YC2" A748\Q
M?WG4C /K@5U[>,?#Z:0FJOJ<:63S&W\QU9=L@SE&4C*D8/! J.;QQX=MDMWF
MOV19XA,-UO*-D9) >3Y?W:Y!&7P.#0!@W@^V:CX?O&T#Q$K:*SF)1##B3='L
M^;]YZ<\50O-)CO(?%,;:)XD4>(=GG$00?NMJ!?E_><].]>FD_(6!&,9S7+:;
MXSTM/#NF7NHZS;7#WHD,,UM;2*LY5L$(AW-D<#'4GI0!@SZ?%<ZM%?3:!XC(
M32'TEHQ#" T;$9;/F<'BJ]IIUY%>6-U=VOBB[DM+62R :UMD5H'"C;@/PV54
M[NIQZ5T>I?$30['3=/OX9);F&\O19C9#)N1MV'W+MR"O]T@$]JTI/%VAQ:HF
MG27VVY=D3!B?:KN 45GQM5CD85B"<CCF@#A[+3=0T[3],BM8/$R7FF1M;6UT
M;*V/^CL%'E,N_# ;%.>N1^%=[X<>4Z-%'-'J2R1$HSZCM\Z0]2QVDC!)]L8Q
MBH'\9: E_<V1U &XM?,\]%B<^5Y:;VW$# ^7D>O09-5U^('AAY#&NI[G\OS$
M @D/FKD#]W\O[PY(X7)% '2USUSX9:XU?5M0%]M;4;)+)D\K(C5=^".>3^\;
M]/3F4^+]"_L:WU9;_?:7$ABA*1.SNXR"@C"[RPVMD8R,&EF\7Z%!IMIJ#7X>
MWO'*6_E1/(\C#.0$4%LC!R,<8YQ0!2A\&K&^@^9>^;%H]F]DL9AQYR.JH=W/
M7"+T[Y]<"#3? \MCI<VD2^(=1N=*$$EO:V[!%:W1E*_ZP#<Q520N>!Z' Q4M
M?&K7VF75Z-1L+6!-<%A!,\#NLL9VX7 .0YW$9/ [BN@G\6:);:R-)EO@MYYB
MQ$>4Y19& *HS@;58Y&%)!.1ZT 9-MX&E@ECF?7+B61-+.F<V\84Q]C@#J/KU
M]N*G@\'- =!VZDW_ !)K*2RB(BP75D5"Q.>" B].^?PN/XMT9[^YTR#4$-_#
MYBNGDNPB9%W'=@8 P<]1GD#FJ]KXOTVW\.Z9?ZAJ<5RUZA,4EI:RGS\<EDB
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M>JL PY!'(XZ5E>']!TRUU*>^AU2\U2\ME-B9+N<2&W'RL8Q@#!/R$DY)P.:
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M+(=Y7&0.YST[U:\2W-_<W&J1S/JJRV^L02BPM;$>0;:.6)O/=Q&6<D+GALY
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M<CZ5V=% '/> H9;?X?\ AZ&>-XY8]/@5T=2K*0@R"#T-=#110 4444 %%%%
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MY5FN+Z4;8Y(@@Q"#_'N8)NP,#:: .J\-#5/^$:T]M:E\W4GA$EP=@7:[<[<
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M<VMU:Q- RQ!"LT3,K%&#*<<J.1@^]5[;P=8VVBZ%I:3W!AT::.:!B5W.45E
M;C&/F/3% '(6GB+Q(G@W4/$,VJK+*UY)IUI;FW01QDW?DK*Q !)7/3." .,\
MU:U[6->\*-JUD=9EOR=!NM0MKBX@B$D,T.!T10I4[P<$'IU.:Z6+P;IJ>%;G
MP\[SR6EQ++*7+ 2*[R&7*D#@JQR/H.M11^"K>8W\FKZE>:K/>636#2SB-#'
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M-I[:646?V?<)0N/F\S^'&>G?-;M<7JVG7LOQ8T"_CM96LX=.NHY)PI*(S%<
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MVY6./RX7CRK='!)SE<C'7&145C9:YI>G:W_HNJ6]O=>+KF:X:SA)G:T9>'C
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M$KKQ*$AVG![X/'UJ3QM:W4EOH]_:VLMT--U.*[F@A7<[QA71MJ_Q$;]V.^*
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MUUM%#7$MZFQI%B@9UC1AD.S 8"^I)QS45GXXT2\AFG,MQ;016QO!-=6SQ))
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M,%=FEL_LV,JIPJ_Q+R<-WKI*S/#<,MMX7TB":-HY8[*%'1A@JP0 @CUS6G0
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MH?B!X1U2U!0:Q87$$RG^)%19H\^ZG=_WT:["_N39Z?<W03>88FDV^N 3C]*
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MCR< @9]JAUKPY:ZW<6=T]Q=VEY:;Q#<VDNQPK@!E.000<#@CL*V*YC4?%O\
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M=<TN>SGNX[^ P0/Y<SE\>6_'RL#R#R.#SR/6LGP[XAFUCQ+XALC-!+:V#P+
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MTC;L8; P,#I[U8L=?TC4[N6UL=1MKBXB02/''("RJ>^/3M0!!-X:T^<ZYO\
M-_XG40BN\/\ PB/R_E]/EIS>'=/DNM.N'1W;3[:2UA5CE3'($#!AWX1?UK)F
M\6+)XTT;3+&\M)K&[M[B68A3N'EA=K!\X*G)Y _AZU=LO$FFP:7#<:AX@TR8
M3S2K#<1L(TD"LW"@L<[0,$@]B: (M,\$Z;I=Y9SI<7]PE@&6QM[F<O':@C;\
M@QG[N5!8G X%3Q>$],AT?3M+7SOL^GW*74&7YWJQ89..1DFIV\3Z&EK!=-JM
MJ+>=%DCE\P;2K'"L3T )X!..:GO-:TS3Y1%>7T$#G;P[XV[CA<GMD\#/4]*
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M"YM(-TT,MO$59XL J",G+9R,CC&#QS0!>UK0[37;>&.X::*2WE$\$\#[)(9
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M<ZZ\B>5!R(G5!YI!(^7*G/?VYKNJQ]?US1]$BM6U:0YFF"V\20/,\D@&1M1
M22.O3B@"CXZM+JZT6T:TMI;E[;4K2Y>*(9<HDRLV!W( )Q7.:QI]]>-\0&32
M[O?J6E10V@,))D<1.I4$<<,RCKCOT&:](1@Z*XSAAD9&#^54;C6=/M6LQ)<J
M?MER;2$IEPTH#$KD9P1L;.>A&.M '"3VEW!K%PNI:#JVIZ9JNGV\*BTD9?+9
M4*O%*N]< [LY/')KHO%>D7%U\--2TFPM0;AM.:&*WC;/(3 4$]>F!FNHHH \
M[U 7B^(WOKSP_K%[I6J:=%;>7;.5D@=&DRDB!P-K"3.2>.AQ5[2=*:S\=Q.-
M+>"RBT&"SC(0O'&Z2,WEASUP"O/?'K7;44 >6_V3>GPXD!TNZ,G_  E9OF0V
MYSY'VHR;^G39^/:NIT"WN(O&WBFYDMIH[>Z>V:&1XRJR;(MK8)]#Q74T4 %<
M%H\=]::AJ&B:GX=FO-^K27UK?,B-;['DWJ[,3E73.,8S\HQ[=[10!YC+H>JW
M'@_6/"LUI<'49M3>:WO A,;H]P)1-OZ J"<J3G*X .12:_I-]<VGQ%2'3;F2
M74O)6TQ"?W^V%$.#[,#U^M>GT4 <+>6]ZGB?7[D:==RV^HZ)#%#*D>0'3SLJ
MPZ@_.O&._L:J0:7J-EHW@*^CL)BND(B7]HL>)%S;F(N%_B*,3TR2"<9KT6B@
M#S+6]#U";2/%UU:V=RR:M?VDMK:K&=Y$?E!Y"O\ #G8QYP?E'<XKTQ6#*&&<
M$9Y&#^5+3(9HKB)989$DC;HZ,"#^(H YKX@6D]_X5-M;6LMS*UW:OY<:%CM2
M='8_@JFL?4;"YEUGQQ,FGW#)?:/#;VSB!OWKA)@RCC_;3_(->@44 >6P65[9
M7*1ZIH&K:EI^I:3:VQ6T=E,3QHRO%*F]?E.XG<>.3ZU'XETK59+#6M+M= N(
MT%M9BV%DJLDXCV[M\A.YBF"JKZ<X.>/5J* /-]5T^]NY?'[KI=UNU+2HH;4&
M$DR.(I%*@C(X9E'7'?H,T:EI^J>=#?:/'J$&IK:VT3V\T!>UOE'5) 1^[9<M
M\V1P>_;TBLK_ (2+3#?ZK9+.[7.E1)-=QK$Y**REEQ@?,2 >%R: ,/XCE5T;
M26>(RJ-;L"8PNXL//7@#OGTK#U_PYJ>I7^OZUI5I(J2MI[+;.OE->FWD,CY#
M8(RI"C=C)7TP:[>[T_3O%&G6,TXG-N'BO(,%X6###(Q'!!!P<'\15MM1MX]4
MCTPF7[2\)F7]TQ3:#@Y?&T'VSF@#C-5THZUKFH:P=/OFT^31Q8RPA&AFF8R[
MOE!P<H,X/3+<'K50:5JD]C/9ZE<:M<V\5]$]AJT-OY5[%B-OG=-OSA3A,E?F
M#GCBO2:* /,!%XCL;G1]5U73KS4H8TN[2?\ LT&";#RJT<YB5A]\)EESP3G'
M:I-1T"6VL+<Z%8ZCHUY!9R&VBCC^TPRAW9C;SJ=PY.#G. 6/S<<^EU6O[^UT
MO3[B_OIU@M;=#)+(W15'4T <-=6.LIX@%_I\=U!>2W%I]OL9(O-LKI0L>Z17
M(_=L@!&<Y/EC@Y%4[K2-7<:U<VUA<-Y7B:#4Q 4VFZ@1(@VW. 3E"0#W4>HK
MT'2=6M=:T^.^LC,;>3[AF@>(D>NUP#CT..:NT >9^*]&OM7B\6:E865UY=_H
MT5C# 861[B8,YW%" 1@,JY.._85L'S[3QS-JL6F7DEK'H(C410$%Y%D+^6H.
M/FP>!P,G%=I7-WGCGPG;WD^G7FMV<4R.898Y7VA6Z$$G@?G0!+J#W'B?P'>'
M3!+:W.H6$BP";Y'C=D( ;'0@]Q7-6#7]YKG@R<Z!J%JNG6MQ!=B2$*L+&-%
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MR\LVH*TL"6]T8[R1#=HHP!+@_,<$C/7!(S710PQ6T$<$,:QQ1J$1%& J@8
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M.NS&WFZ=&\5N=QPJN IR._"BH] \/67AJP-CI[7'V7<62*:9I!$#_"F>B^U
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MW'!'3"] *R=%\&S7VJZG<ZMIUW:6EWI9TYTN[_[3<3AB2[%PQVJ!@  ^IP*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME6*Y(4L-N&++E02-P7('%3^'?%MKXFDE^PV-^L$1=6N9HU6/>CE"@.XDGC/
MQCOGBN;L;'6]2@\):1=:+<6(T2:*:[NI'C,3F*)HU$6UB6W%@>0,#.>>*W_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9P!=)DQCJ_7[OOTJ*[UVTGTF"]TS6=+6*:=(X[B:0/%)\X#(I##+$9 YZ]J
M-JBLBT\2Z5>ZQJ&EPW<1N; +YX+@8)!)'X#&3T&:M6NL:9>I.UKJ%K,MOS,8
MY5/EC&<MSP,<\T 7:*YC3_$QU'QS<Z1;7%G<6$>GI=*\/+J[.5VL=Q&, $<#
MK5OQCJUWH7@_5=6L1";BSMVF19E+*=HS@@$']: -RBLN/4&?7([7[?8[?L9E
M>TS_ *0&W+A_O<)@XZ=2.:@OO$-J^C:E<:1?V5S=6MJUP%#B08 )!(4@[3@C
M.: -NBL#P[XIT_6=-M-VI6+:B;**YNK>*9=T6Y Q)7.5'/>J%UXBU"VLO#LT
M5YIE\NH:F+.>:V1C&R'S"#&=YP1LP<YYSTH ZZBN=O\ Q19Z-;ZUJ%_J=C)9
MV)4+%;G,L9V_<?D_,6S@8''7UK4MM9TJ]N&M[74K.>=$WM'%.K,%]2 <X]Z
M+U%16UU;WMNMQ:SQ3PO]V2)PRMVX(XJ6@ HHHH **** "BBB@ HHHH ****
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MCTV'3!?7:*>'DF^6.-O]T+(2/4"IM6:[U?QW'H*ZC=V-E#IOVUS:.$>5VD*
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MY\V1I &DWD94",87H<MGM4=D=>\0^('L=2U.^TLIH=G<SV]HRHR7+M*&.<'
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M,88N@&.,@9![TW1O"5^VLZ DNC7]C;:3,\CM=Z@MQ"B>6Z+%;@,6*DL#EE!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPMVD5BI7:&!RN<8RN2#R*SO$$NJ7&CW^E7&MWLG]G^)K*VCN,1"1XW,#@/\
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M(QA1A01QW]2:M2:WKA\*3^-5UB=1'?LJZ;Y<?D?9UN/)V'Y=V\@$[MW7VXH
M]/JM)J-E%YWF7ENGD%5EW2J/++?=#<\9R,9ZUYQJ^J>(!I/C+6H==N(/[#O9
M!:6T<4>QU2.-RLF5)8'<1P1CGKVZZ^\':1JAU22XL[8MJD<:7&8%.X)T8Y'+
MC)PQZ87CCD Z*BJ&K7$NFZ#>7-HL9EMK=Y(UDR5.U20#CGM7)VGB7Q'<WF@0
M$:4HUS36NHV$4A^SNBQL<_-\X(DX'RX]3W .[HKA=,\::CJ5GIELMM"-4NOM
MGFM'&7C46\OE,54NI.XE3C=P,]:G;Q%XBCTVR-]8VFG7LD5PTJ.#.6=" FR-
M&W%6!W$Y.T#!ZYH [.BN%M/%NM:M/X:BLH;" :UI+WQ:97?R741G& 1N'[SI
MD=.M1)X^N4\-:+JM_'#90W?G1W5YY#S06\L;[%! (*JQ#'<3@8P>N: ._J&W
MNK>[1VMIXIE1VC8QN&"NIPRG'0@\$4S3YY+G3+6>1X7EEA1V:!MT9)4$E3W7
MT/I7#Q>+-5ATJ&6WLM-2:7Q%)I<BA65"/-9-_!^\<9)YZT >@]*JV>I6.H&4
M65[;W)B(600RJ^PGD X/%<%X@UO6+KP/XZL[F6TCO-*22$SV\3*LD;0+(, N
M2K8?&<GITK7M+N>/Q!%HUFNG1ZH^EI=7-Z;0X:,,4B3:'R<9?DMQC@?-P =A
M17G\'C76M2&AP65K8P7=[=7=C<B?>RQ30*^2N",J2F<=<'''6EO_ !3XGM$\
M3*$TCS="M(;ICY<A$V8F=U'S#'W3@\X[@YX ._HKC[;Q+J_]O)9W$%E)%=Z3
M)J-JD99&C*,@\MW8D$'S!\V%Q@\513Q?JT_]HVBR6?GIHG]HPW,5N^Q7R0RC
M<V)%X&&!P?>@#N);JW@FAAEGBCEG)6%'<!I"!DA1WP 3QV%35PFF:OJ,4/@.
M*[%I=G4HOGG>)A(A%J7RI+'DXP3WR>!2_P#";7I\.V?BA(;=]'N+T0- $;SD
MB:;REDW;L$YP2NWH<9XR0#NJCFGBMH7FGE2*)!EG=@JJ/4D]*X*;QCK\-OJ-
M\T.F_9-.UM-.EC"/OEC9XTW [L*P\S/0@],#J>L\3JK>$]85@"#8S<$?[!H
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M><XH ]'HK/T2^.I:/;WAN+6Y$H++-:',;KN."O)[8XSP<UH4 %%%% !1110
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MLVN;43*$D,4D<\31R1N.JLK $'I^8H R;GP58WDL;W%Y>R!--DTLIN0!H9
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M#_*#\ORGGW'J*6X\9Z/"NGF%[F\-_;_:H$L[9YF\GC]X0HR%^8=><G% %=O
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M "C'+81B5_AQSB@"76-+CM-#F\.VFD7=^-7$XFN3L*)(_+23'((Y;(VC^'
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MUDNKRXBM[>,;GEE<(JCU)/ H \RF\(ZAJ7B/6M$FM)8](1;V[L[DKA#-<QH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ\G&2#TXK:\*ZKJ6JR:O]M>V>WM;UK:VEAB*^<J@$ODL0>6VG  RI^@Q]?\
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ML]NG.1>T[Q!KE_J-AHEY;V^FZL;![R]QB95Q)Y:A,-CYB"QY.!QU.1-)\/\
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MHV(8J0RL.H!SC/O0!R^D^--5UN"PLH[1(=4DANFNC$JNJM!,(3L#NN06YZG
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MR_:M0U:VEN3,(EW*J;2W#. S$N.<CC/%:>G^(->N=3L- O[>WL=5>">YN)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNVD"7#) 3'#E ZEFZ $' ]2#Z59UK7[31/LL<L5Q<7-VY2WMK:/?)*0,M@<
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M\\ Z!<W4TDT\MA"\DLC%F=B@)))Y)KH* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "L?5_#.FZU<Q75R+F*ZB0Q+/:W,D$FP\E"R$$KD9P:V*P==\2MH
MLQCCT?4;\1P-<SO;*@6*,'DY=E#-P?E7)X^E %BW\-:1:3:9);V:Q'2XGAM
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M5+(20ORAMX5B, E0#QZBHS\0K4-)*-(U(V$%^VGW%[MC$<4HE\H9&_<5W8Y
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MH9N Q9?E.1N R,UBW7C:XU2Y\,26-CJ-E8ZAJ:+%<RA EU#Y<AZ!BRYPK ,
M2.?6@#IM.\(Z)I5II-K9VACATEY)+-3*Y\MG#!CDGG(=NN>M23>&-(N+#4[*
M2V)M]3F,]VOF,-[D*,YSD<(O3'2L'XI:]JF@>$6FTF.X6>::*'[5#Y?[@-(H
MZ.>I!(& <'KCK4T'B>;3HXM*BT?6]2U"WMA<74;O TT*,S!=[!PC,=IPJDG
MH V)?"^CS7.L7$MIODUB%8+[+MB5%4J!C/'#'IBJ:^!=# M0RWK_ &>+R 7O
MIF,L6[=Y<F6^= >BMD=NG%5I?B!8/+I<.G6%]J4NJ69O+5;=5&Y 5!#%F&TC
M=DY]".N 9X_&EM)J20C3[T6#WAL$U$A/):<$KM W;\;@5W;<;AC- $MIX*T2
MPN=.N+6.ZBETZ(P6[+=R_P"JW;A&WS?,@/13D# I4\%:%%H%KHL-K)%9VDIG
MMC'.ZR0R%F8LL@.X'+-WZ''2H+7QI!>:A%'%I>H'3YKEK2+4@B&%Y5)!& V\
M+E2 Q7&1UI;7QE#-J45M<Z5J%E!<>:+6ZN44+-Y8);Y0Q=> 2-RC(% %NV\)
M:-:V\$*6\C>3>"^$DDSO(\X&-[N3EC@XY)[>E,UCPM9ZE::LL0,-SJ:Q+/,'
M;_EG]T@ \$>W7OFL:]\?7"^%M0U>V\.ZFBQZ>U]:23+'Y<T8 (8E7^7 (8J<
M,5S@$C%64\:SBULE;P]J<]_+9B\GMH/)+11YQN_UF&W$$A5)..H!XH ZJXMX
M;NVEM[B-9894*21N,AE(P01Z$5@V/@C0;".YC6UEN%N+?[(PN[B2?;!_SR7>
MQVI[#V]!6I:ZB;J^EMQ97<<:11RK<2Q[4DW9^49.=PQR"!C(K*OM6M[?QYI^
MFO<:@)Y;&:988RGV=E4C)?/S;O3'% $EEX,T:R%QMCN9WGMS:,]U=RS,L)ZQ
MJ78E5^F.WI5U="TY7TIA <Z4I6T^=OW8*;#WY^7CG-8.E_$&VU3^R)ET?4H+
M'5ODM+N81A'DV%]A <L.%8 D8)'!Q@U:'C?3F\(0>(E@NFBGE6".U"KYQE:3
MR_+QG&X-D'GL: );/P3H=AY @@G$=O>&]@C:YD9(92&!**6PH^=N!QS2ZGX+
MT/6+RZN;VVED-W&([F(7$BQ387:"R!@I8 \$C(P/08A/C2V_M(P_V?>_8!>?
M8#J.$\D7&[;LQNWXW_)NVXW<55/Q"M09)1I&I&P@OVT^XO=L8CBE$OE#(W[B
MN['(!P&'?( !<O/ F@W\B/<0W3GRDAF'VR4"Y1/NB8!OWN/]K-7XO#NG6_B"
M;6X4FCO)XUCFV3N(Y HPI:/.TD#@''%<K<^-+F7_ (3."^T_4+*QT9"!=VK1
M>:!Y:L<9<_.=Q9>,8QG!XK6_X2U(5T^RT_3M2U:\EL([QD0Q!TA(P&D9F5=S
M$'@=2#VH U=0\/:?J6JV&ISK,MY8D^3+#.\9VD@E6VD;E)494Y'%5M.\'Z-I
M=^MY:PS!H]_D1/<R/%!O^]Y<98JF?8#TZ51_X3VQG&EKIUA?W\VJ6\L]M%$J
M*?W;*KJY=@%(+<Y./E(SG *1>.H+JRL7LM)U"YO;MYXQ8KY:21M"VV7<6<*,
M' X)SD8H U(?"VD0:1IVE1VQ%GITL<UK'YC'8R'*G.<G!]:FDT'3I9=4D> E
MM4B6&[.]OWBA2H'7C@GIBK5A=B_L(+M89X!,@?RIXRDB9[,IZ$5BZWJMO9^+
M/#5C+<:A'->R7 BCMRGDR;8]Q\W/. .1M[]: $N/ VA7,B,\%PJ"*.&2&.[E
M2.=(QA!(@;#X Q\P.1P<BM;5M*L]:TZ2POHV>!RK?(Y1E96#*RLI!!! ((]*
MY;_A95D(8;K^QM5-A+=O9"Z$:$>>'9 @4/N.2N 0,9(&<YQ8E^(%G9Z=JMSJ
M.F:A9S:7-!'<VSA'D F90C+L8A@=W8YX/% %I/ N@H\C_9[AWE,+3,]W*QE:
M*3S$=\M\S!AU/...G%7M0\-:3JDUY+>V@F:\M5LY]S-AH@S,!C/!!8G(Y]^*
MR7\=V]K%JIU+2=0L)].LC?FWF\MFF@&?F0JY7.1@@D8)%*/&Z/;V;1:)J3W-
M_(RV-J1&KW$:J&,O+X1,$?>(/(XYH OZ5X2TG1]1_M&W2YDOC";<W%S=23.8
MR0=I+L> 5&/3GU-7Y]*L[G5K/5)8BUW9I)'"^XC:LFW<,=#G:.OI6+8^.+"]
MOK&R>TO+:XNKF:S9)E7]Q/$H<QN0Q&2O*D9!'>G7GC6QM;S4+..TN[F>SN(;
M14A5?W\\J[A&A+ 9"\L3@ =Z "X\!Z!=3SRR07.99_M05;R55BFW!S)&H;".
M6&2RX/7U.99/!>ARR:DSP3[=1<2W$8N9 GF J1(JAL(^54[EP>.M5)?'EG;6
M227&FZA'=G4%TU[(*C2I.R;U'#;2&&,$''S#ISBI+\1XX(-2>7P]JZR:4V=2
MCQ$3;)M#!\[\."ISA23P<XXR :O_  A6B_86MBMV7:<7)NC>2FX\T+M#>;NW
MY"_+UQ@D8H'A.TMWT@63211V-V]TY>5W>9F1PVYB<L2S DMGI^46J>-;73KB
MY6+3[V]M[.%+B]N;8)LMHV!()#,"QVC<0H) ^HJ'4?'<%G=ZG;VND:CJ!TR-
M)KJ2V$>U(V3>&!9QNXSP.>#0!T.H:9::I'!'>1F18)X[F,!B,2(P93QZ$=*J
MWGAO2;^;4);JT$K:A!';W.7;#HA8J!SP07)R,'\A7/OX[=?%HLETZ9](&DC4
MFO%*<(>=^"^=H (QMW9[8YK:T/Q!)K+$2:-J&G@Q+/$]RJ%94;H0R,P!]5.#
MS0!G:EX.M(O#>IVEA9_;[F[V-)_:-Y*[3;""H,I)9<#.TCH>?6J'ASP>S:GJ
MUYJNF"WM;VRCLC:W%XUW),H+EWDD).<[@H&3@+VX%;&N^+4T*></I.HW%K:1
M+/>7<*((X$.>?F8%\ $D*#@5!J?CB*QOM4M+?1]2OWTN-)KMK<1A4C9-X8%G
M&>,\#G@\4 7M,\):1I<TLT4=Q/+)#]G,EW<R3LL7_/-2[':OL.O>H;+P1H=A
M'ID<4-PRZ9*TUD);J23R25VX&YC\H7@+T%1S^-+;[9#;Z=IU]J1:S2^E:V"8
MAA?.QCN8$DX)"C)X/%.\!:C<:EX!T?4+VX::>:V#R2OU8Y/)H 1/ >@1SI,L
M%R&BN/M$ ^V2[;=RQ8^6-V$!).0, YQTI6\": UO=6[6\[6]S=+>/ ;J3RUE
M#E]R+NPN6)) P#WJO8^.[:]EL)#I>H0:=J,ODV-_*(_+G;!*\!BZAMIVEE&>
M.F:YN;QYJUYI O9-.N[ 0>(H[+">6S31B8JT6%=B7XP>@)/!- '>OX?TV1-6
M1H"5U88O/G;]X/+$?KQ\H XQ7*>)?"]S)J0DT_08KR(V*VJ.NHR6_P!W.%G4
M'$L8R",@GJ,'-:B>.;9(-4-_IE_97>G-"KV<@C>20S'$00HQ5BS<=>#UIESX
M_L].L+J?4M-O[2XM)X(9[5E1Y%$QPCC8Q#*>>AS\I&,T ;7AS2CH7AG2]):0
M2-96L<#..C%5 )'Y5IU4TV[FOM/BN9[&>QD?.;><J73D@9VDCD<\'O5N@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K@?%^A:IJVNW2'3)]0LY]/6&S(
MNQ%!:SY?>\B[@6R"F" Q^7'%=]522_$>IP6/V:Z8S(S^>L1,28[,W8GL.] '
M)^#]'U2SU5+N^L'M4_L*RLB'D1B)8FEW#Y6/&&4@^A]<@9/A[1-?\+'0;TZ+
M+>NFC?V==6\$\0>&19-ZMEF"E3D@X)Q@5Z;4-O=6]V)#;S)*(Y&B<H<[74X*
MGW!H P/ >FZAI/A2.UU6!(;S[5=2NB.&4;YY'&".Q# _X5E>&K?Q'HME9>&O
M[''V6VGD674GF0Q/;EF92BAM_F'*C!7 Y.373:[K]EX=LX;J^\SRYKB.V7RU
MW'>YPOX9HL]?LK[Q!J6BP^9]KTY(GGW+A<2 E<'OP#0!Q%CH6O-H&@>$Y])>
M*+2[R"2;4C-&89(H'WJ4 ;?N;:HP5&,GFK4_AK5G\"ZMIJVN;NXUN2[CC\Q?
MFB-Z)0V<X^YSCKVZUZ#4-U=6]E;/<74R0PI]Z1S@#G'6@#S?Q!X=UZYB\?:?
M;:3),FLI'-9W"S1A&(BC0H06#!LJ>V,=ZW?%FFW]YJVEL-,N=3TM()4EM+>Z
M$ $Y*>6[Y9=R@!QWQG.#78T4 >8>']$\0>&?[(OSH<MU):6MSIUQ;03Q!BK3
M"2.6,LX!4XP02&&>E:QM?$;>*_#>N7ND+(_V2XM;R.TF3%J9)(V4G>PW *O)
M7/(.!TKI9=?LH?$MOH#>9]MGMFNDPOR[%8*<GUR:U* /,M$\)ZW9Z?ID4]GL
M>#Q1-J$@\U#B!EE ?@_[2\=>>E2>(-$U*#7]0UE((F5=7L+JUCDN$C-ULB,3
M(I8@!LN< XR0*])JMJ&G6>JV,EE?VT5S;2C#Q2KN4\Y'Z\T <AX3N+N\^(7B
MNXN[/[(QMK!1 SJ[H,3'#E25W<YP"< CFH?$ND:E=>(FN=-T.Y@U'S(1;ZQ:
MWBQQF,$;A<(6!8#YAC:V1C!';K]*T73=#MWM],LHK6-VWN(QR[>I/4G@<FK]
M 'E^H>'=>FTKQ;I$>DR/]NUB/4+:X$T7ER)YD!*X+;@P",>0!QP36WXKTK4;
M_P 16['3+C4]--HT<<4=V(HX;@M_K)1N4LNW'(#$8.!S7:U##=6]S).D,R2-
M!)Y4H4YV/@-M/H<,#^(H \RT3PWKMG-H4=UI$XB'A]]%N7CFB)@?>O[PC?RA
M )&,GU HTKP8YTL:==^'9+&X@TV:VDU.?43)%O:(Q[HDWM\I!8G<JX'%>IT$
M C!Y% 'EUI>:G=:Y\/(+O34M8X#*/-%Q'*LY%HXWQE"?W?3DX/S#BH(?!.JI
MI,SW>F23M!XENM1%I%="-Y[>160%7###?/N +#[N#UKT#3/"N@Z->/=Z=I5K
M;7#*5WQI@A2<D+_=!/88%;% 'G#^'472$W>![DPRW;S-%#J0-["P1527>9
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MM]/!*\4T>C%DDC8JRD1<$$=#61<VS:#KND?8;^]E_M33+QKPRW3R"5DC1EE
M8D*<DCY<##8KJ_%&BR:EX'U31-.5%DFL7MH%=L*"5VJ"?2ETWPAHNFRO/#9$
M3R0?9V+3.X2,]40,Q"+GLN!TH X'2[27_A%/!*3:CJ#-XAE@&HW#7<FZ15MY
M)%C!S\@) 4[<$@<Y)IVIS7&FZGJOAJTOKR/2WU/3(=WVEV>!)R?-C60DLH.Q
M>_&\XZUZ)+X:TB?0K?19+-3I]NJ+!&'8&+9]TJP.X$8X(.?>H%\(:$NCW.E&
MP#VET_F3B25W>5QC#-(27+# P<Y&!B@#SGQ%;+H&H^,H]-N[E!%H]BR$W#NT
M.9Y,J&)+ =^O\7I70>--9OM*\0ZC+8SN)+;PO=W*1!LJ)%D3:Y7ID<_K726_
M@OP_;0WL2Z>'%] +>Z,TKRM,@S@,S,23\QYSGISP*=IWA#0M+G:>VLB9F@:W
M:2>9YF:)B"4)=CD?*.#T[=30!Q^O^'=-T_P5J[0ZS>O)<Z%/*]M+?NYN61 _
MGC+;@0< [?E(;!&,5U6B6L6G^ ;6.V,JJ+ ."\K.P)3)Y8D]3^':GV'@KP]I
MJ7*6VG#;<0&VD$LKR8A/6-=S':G^RN!5NVT2UTO0'TK38WC@$3)&DDSR8R,
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M[<%87>>20QJ1@JNYCA<$_*.!Z5+IGA+1-'OOMEC9>5,%94S*[K$K'+"-6)5
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M&23U/O4M5M.LUT[3+2Q1RZVT*0ACU(50,_I5F@ HHHH **** "BBB@ HHHH
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MD'///I0!0UCQ0^FZ[;:+::5<W]]<VSW,:Q.B*%5E!W,Q&/O=?P[U!!XQDO\
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M,0?F^0;3NRW4 ]^*O6WC"6^TA;BTT*^FOOMDEC)9*5_<RIG<7DSM"\<-GG(
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M";.Z@%NX023( LW&=R$$Y';G%8_B6YT+PM;W'B_4-.62>V1(FN(H5:?:SA0
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MQ17CUH)[NTTO2II7@@C\636AAMKQY D0MY&,0DPK%<DCH,=N@J6YC^P:M?\
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M#UJ*&WTW3TAMX5BMK:(*D<8P%11P /8"JGA[7;7Q-H%IK-BLJ6UTA>-9E 8
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MS4W2VU:TOBVTMN"V\T1. JX*\9&0"<'- 'HU17-S#9VLUU<2+'!"C22.W15
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MG:6(]0>GN:P1<ZEX<>_:QM#82OX7N;U8_P"T6NI))$*;)I 5 #C<W(SGGTH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=K!;0:?$L4%Q]JC')(FP1O))R6P>IS4\NBZ;,NHK):1L-27;> Y_?#9LP?\
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M9I"-N!^\D9R,<\#<156R\'>'M/CN8[;2H%2YA-O*K98&(]4 ).U?]D8%;E%
M&5IOAO2-(D@DL;)(7MX6MXFW,Q6-F#%<DGC(!_"JS^"_#DEQ/<-I4)EGE\YV
MRP(?<&W+S\I+ $D8R1SFMZB@#%;PCH#G4"VF0G^T6#W0.<2-G.[&<!L@'(P<
MC-4-6\(VP\-/I>C:;IQ5KA9W@O=Y68@C),@RRO@##\D8%=310!Q>@>"(HK76
M4UFPL%AU1HU:PMF9XDCC' +D*68L68G Y-;FI>%-"UB>*:_TV&>2)!&"V1E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HK&\5ZU)X>\-W.I0PI-+&8T19&VH&=U0,Q[*-V3[ U2T;
M6-6_X2>ZT'5_L,\L=I'>)<64;QJ%9F78RLS$'*Y!SR,\#% '34444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %9.KZ/=:G-"]OKNHZ:(P0R6@BQ)_O;
MT8_EBM:B@#F_'EO?77A*YAL89IMTD0N(8/\ 626_F+YJI_M%-PXY].:Q?"%E
M:V_BZ[F\/:9=Z?H+6*K.L]M) LER'^4JD@!R$W D#'3TKOJ* ,G4-'NKW5(+
MN'7=1LXHMNZU@$7ERX.3NW(6YZ'!' K6HHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>exhibit1060-kumaremploym009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBFAU9F4,"R]0#R* '44C,J*69@JCJ2< 4H.1D=* "BBB@ HHHH ***0LJD
M L 2<#)ZF@!:*** "BDW+NV[ANQG&><4I.!DT %%(K*ZAD8,IZ$'(-+0 44U
MG5!EV"C.,DXIU !1110 4444 %%%% !1110 44T.K,RA@67[P!Y%.H ****
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MHHH **** "BBB@ HHHH **165U#*P93T(.0:6@ HHHH **** "BBB@ HHHH
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MMC=RQ&%SU4 G:.G.:&E>![^PATNTFU*WDM-+U22^MMMNRR,CB;*.=Q!.9N"
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M8<_*-V>.>"*JW_@C5KA=2MK;5[6&SNM074T#6I:0RJZ.$=MX!3*#H >@SQR
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MD5<F,@OECMSAQ@ CD54_X2O7M/M]%L;B_P!%@N;C3TN$N;])%CNY#P(E;?\
M*^,$DDYW#"UL+X7UZ^TV\L-9U^*:WDTZ2PC6UMC&&WKM\Z0%CN<#H!@<GUX@
MF\+^)KC0(])FU;2)K=K,6<T4NGLR #($B#?G=@\@DC(&,<Y .UC+-&I=0KD
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MFU.;1/"NK:K;HCS6=G+<(LF=K,B%@#CG'%96BZ+J?AYM*L+>>*2T:2[GOA%
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MBBB@ HHHH **** "LIM#B?Q.^M/)N9[);,PLH*X#E]V?QK5KD=5U'7KGQO\
MV!I=Y:V=O_9HO'N);?SF#>8R8 W <\=>F#Z\ '6,BL5+*"5.1D=#6+K'ATZW
M?VAN;Z1=,@D29[!(U"S2JVY2[=2H.#MZ$J,UR-OXN\1ZP?#-E9R6-I=ZB+Z*
M\F:$R+&]LX0LB[AD'#8!/\0].;5YX@\236?B/5]/NK*.TT*22(6LML6-T84#
M2%GW#9DDA<#C&3F@#OW19%*NH93U!&0:-HP!@8'3CI7 OXMU"?Q1%;C4;+3;
M>8V[65M>VS 7T;JK.5FS@."S*% )RHR#FJ<_BKQ/#HVL>(C<6(L=*U.:W-G]
MG):>!)MA._=\K!>F >5YZX !Z28T9U=D4LOW21R*AM[*"UGNIHE(DNI!+*2<
MY8*J#Z<*/\FO.[[Q_>1:S?M!=P^58Z@+,::+*1Y)T#*LC^:.%;)8@8QA>>O&
MS8ZGXFUJ]O+_ $V>Q6PM-2>R^PRPG=+'&^R1_-SPV0Q VXX /7- &]HVA1:.
M+W;)YS7-[->;F4 H9#DJ*U-HP>!SU]Z\LT[6/$FGZ5XCO7U$7*QZZ]J\GV)I
M/LT8*AI0BL25 Q\HZ<GGFNZ\+ZA+J>B+=2:G8ZDI=A'=V8*K(@/&Y<G:PZ$9
M[=N@ &R^'FN_$T&KWM_)/#:9-E9^6JQPNR[6<D<LV,@9Z;C6TT:,RLR*67E2
M1R/I7G>D>,]0FUZUM9=3L=02\BN&*VEI(L4#QC<NR9N)5QD'WYXZ4[1?$GB2
M2W\(:IJ-S926NNE8I+6*W*F(M"TBN'W'.2G(QCYL=LD ] EF@MP&FDCBWLJ
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M8'![ U)=^(?$FDOX@T^66"_N;*&TN(;B&R;*1S2,DA,2L2^P(S  Y/2@#T#
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MIR:9JD<$$<EM(]KM#,7 9)(B2"!P0<]_:HC(?^%T1R[5S_PB1;&./^/CT]*
M._M9;6YM$DM'AEMG!VM$0R,.^".#1;S6DWF1VTD+^2WE2+&P.PC^$@=#STKR
M?1]7UK6++X<SVMW:Z<E\]R9(+>UQ%E(Y?X0P&,=NQYJ__P )K<:?;^)&6.QM
M95\1?V=%.ML2%!529)%7F1@N[ZX% 'IRQQH@144*.B@8 IGG0?:#;>9'YY3>
M8MPW%>F<=<=LUYP?&VJ_V7<B.[22*WOXX9=7739"J6[QEO,,.<Y#C82.!D&I
M]=O9O^$5T7Q9]OLKVZTZ_CVWECD1W%O)*(G7&3C*L"5R<,OM0!Z&8T8J6125
MY4D=/I4:O;2W+JK1//#@. 063/(SW&:Y/XES:C!X8@;3K[[([:A:1NP3<2&F
M08ZC'.,^HR.]8;?\)#;>(_&=QI^HVD4MG;6LTLDMJ7^T2+;YQMW#8IP>Y/(]
M.0#TP1HKLX10S=6 Y-9@T.+_ (2>XUIY-[36<5H864%0$=W#9]?G_2N,U[QM
MJ$&FV^H6NI6%H3I*:@ME]EDN99792VU]O^KCX #=R3Z<V]*O-6O_ (I3-_:
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MD5MWFC&<J!DD <D]N]+?^*="TRUM;F[U.WCANEWP.&W"1, EAC.5 ()/09%
M&;J?A*[U"1K7^V2FBO)#(UBUL&9/+VX6.3/RJ2@/0GDX(S7.Z-X1U#5[#5[2
MZU*6VTJYURZFN+-[8;Y5%P6 1R1M1@HSP<\X(S79W_BO0M,V?;-4MXS)$LR
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M=1VT (7?(<9)X 'J3Z#FJ4?BO09--&HKJML+3SA;F5FVA9"<!&SRIY'!QUH
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M8*2OUYK:U+Q9H.D7PL[_ %2WM[C"LR.?N \ L>B@^IQ0!E7/@2*Y_P"$E/\
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MU"]U %:6%7!>,-]TLO49[9J>@#QC5;N>\\&>)]/L[YM<LHM' AO6L_+GB.[
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M#&'90>H<JZ9[Y->K5EZ]HQUW3S8MJ-Y9P.<3_92JM*A&"A8J2 ?5<'WH P_
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MXQ7J]O?6EU+/%;W4,TEN^R9(Y QC;&<,!T..QJ3S8_.\GS%\T+NV9YQZX]*
M.1\(6IB\7>-)WB(>2_A'F%<;U%O'T/<9)JM?0RGXV:5,(W,0T2=2^T[0?-7C
M/K7=5335=.DU)]-2_M6OT7>]JLRF55XY*YR!R/SH \F\/WFGQ>!_"_F:M=Z-
MJFFQ36_VK[(9(X7R-\,JL/XA@CI]TX/KVJ^(KK2_A@NMS:<$O5M<QVD$)4/*
M3M0!.JAB5..H!]J["B@#R:7P!XN@\"QZ?'J^F/=6LG]HQXL7\]KL,9,^9YN"
M2Q*YV]#TK1746U_QYX#UF.WECCGTZ\>160CRF*IE3Z$$$?A7I%% 'E?V>?\
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M8XXI7)"J>-Q+*,G( SQ7:Z#X4F@GTC4-0U2ZNO[/M?+L[:6-4\@NH#%B!EF
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ML%S>>(+R]-G#+%9&6- \6\ %F<#+L  ,GZG)YKH;*"2VL+>WFN'N9(HE1YY
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M( ^'MYDCW1ANF3G@Y&&[XKI_!NJ7VIZ/<#494FN[.^N+-YD38)?*D90VWL2
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M6>)859#(6(WX/8$'Y>ASS7I%AX>AL-9.I)/(SG3X;#80,;8V=@WU.\_E68?
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MW*R21,S0-#YH1RJR!&Y4,H#8/3-;E5-,LY-/T^*VEO)[R5<E[B<@N[$DD\<
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MPX) 8X/..:Y_1+FXTG1_",^J1ZC%I::;-9R/#:F5K:;>N!(A1B 4&T''MT-
M'L*L&4,I!4C((/!%1->6R726KW$*W#C*Q%P'8>H'4UF^%K"VTSPU96=E%=16
ML2D0I=$^8$+$C(/(X/ ."!@<8KD=)EM7U*_T77=+O)M636WO;9O(DVR+OS#*
M)0-H5$PI!/\ #C!Z$ ] -Y:BZ%J;F$7!&X0EQO(]<=::;ZT",YNH BML9C(,
M!O0^]>82VE[=>$-1T:6&5?%*:RT\$GEG<S&X#).K8^X(R!GH I7VJ/Q5OAM_
MB)IYL[I[F^>">V2.V=Q*GDQ*6! QPRL.O4>I% 'JLEY:Q2B*2YA20E5",X!)
M;.T8]\''KBDBO+6>5XH;F&22/(=$D!*X]0.E<58Z=IM]\3=:NI]-CD5K*REA
M>:V(_>JTI)&X<.,I[CBN<2#6QH=YIVE$ZI!_8[_8IS"8KNW4,F;67L69<X.
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M QY0P;3%+D#<QDP<'G@FM+PII=U::O)H$\.=-T"9I;*4\AUE&8E^L:M*I_X
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MX&&K>AOU2Q@EU PV<[0"66)I01'P-W)QD G&<5YWIUKIEWKGC5-3DOX(;R\
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MYLD7F(R>9$V'3(QE3V([51T6QM-+@DLH+V2[N$8/<2SS"29V( #.1WPH X'
MK+\;7^I6%GI)TVYC@:XU6UMY2\9;*-( 0,$8'KZC(XZUR]UJ6I>'=>\=ZI86
M]C)]CAM+JY63<OF!826"@=">>23VX/8 ]/I'=8U+.P51U). *Y'4_%6HM/J$
M&AV(N;BPBCD,+Q.WGNZ[Q&&! 3Y<?,<\GH,<]0C?:K!6F@*>;&"\,@!*Y'*G
MMQTH 47ELS!5N822< !QS4U>6?#JWCN/A_X8AD\.++')MWWA$?R;69@_!W9W
M*HZ5JZOXSUNPB\47$5E8&'0)DWJSN6FC,:2$#H V'Z\CCH>M '?45QMWXIU?
M3M0UBTN;2Q>2VTHZG;>6[@8!8%')')X'( ^@J/3O%6L2ZOH-KJUA9"QUZU9[
M=K=V9HW6/S"L@88(*YQCIC'/6@#LH9X;J$2V\R2QG(#QL&&0<'D>A!%9VA:%
M#H,%U%#<W$ZW-U)=.9]N0\C%FQM4<9-<9X(UAK/P[X>T.S6);J^DOW5Y%)2*
M.*=\G:",G+* ,CJ3VP;LWC?48-,NKJ2UMD.E:H+'53ABJ1$K^_3GIM=6(/3G
MGCD [NJFI61U'3IK07=S:&48$]JX21.<Y4D''Y5AZAXGFLGN"L<<D3WT5A:%
M48EI&7+DX/S!>1@8R5(XZU4'BO5K>86-]IICN;B]^SV=P('V3)Y32%_*R6!7
M85*YY.#G'0 Z:SMK72+&*V60A V-\SY:1V))))ZLQ)/U-7*Y2*RG\8:--:>(
M]+2!K>]_=.8\"55Y66,$YC)!(YR0<T7GBQH/%O\ 8;26UK,9(?(CNT9?MD;8
MWM%)D+N7)&W!.5]Z .FGMHKG8)EW!'#A<G&X'()'?!YY[@&I:RO$&LC1-.2?
MRS)+-<16T28)R\C!1TY(&<X'7&*YS4/%GB#2]-O[B?286%O>6L,%Q(KPI<1S
M.J$A"2P92V#DX/!'I0!W%%<+>>*/$=M-XCM1:Z69M'MDO0Y:3;)&RNVS'7=^
M[8;LXZ<5,_BC7=0UB'3M&LM/4W&DQZC')=RO@;FQM(4?A^O;! .P>XACFCB>
M6-9921&C, 7P,G [\<U)7F]MK2^)=9^'^M/:"VGFDO4EC/)1DB=67/<;E-:(
M\;W)T/3_ !(+>!M&O+Q;<H ?-CC>3RTEW9P?FVDK@8#=3CD [>BN0C\4:BLV
MMZ=<16JZI9W,45I&%;;/'+@1R'G."=P./N[#UJGJWB[7;(^*3;VFG,F@QQSD
MR,^9T,?F,!C[IP#CKCWSD '=T5QDOC*[TS4;M=5MK?[&FCR:M$;<L75(R R-
MG@D[A@C'?ZU'>^*?$-A9ZA=MI,4UM!IDEZDQ1XDCD0;C$V[)?(Y# #IR!F@#
MMZ*XRU\3:U-J:V%Q#81-=Z.VHVLD8=_+92BE7!(W?ZP'C'0CWK2\"WE]J/@C
M1K[49UGN+FTBF9U0J3N0'GDY.<\\?2@#H:A2\M99'CCN87D0X=5<$J>G([5R
M7Q*O[FUT33+*WE>%-4U:VT^XFC8JR12,=^".F0-N?]JMZX\-Z3/;6D L8(DL
MYHIK?RHPOEE&##&.@XP?4&@#5HKB)_&]RGAX^*(H('T5+TV[Q8/G>4)O),H;
M./O#.S'3OFH-3\::W8KXBN$L; VVAW<<<@,CEY8V2-CC@ -A^O3C&.] ';W5
M[:6,8DO+J&WC)VAII @)],FGP7$-S&9()HY4#%=T;!AD'!&1W!!%<9?PW5]\
M4?L,[6LUBVB/FWFA+!D:50X/S8R=HYQT[&H?#_B7%AI>EV6G6%C=7M_>6T<4
M*$0Q) [AWP,%B<#CC);- '<Q7$,YD$,T<AC?8^Q@=K=<''0\CCWJ2O,_#6KR
MZ+)K%EY4)O;[Q)/ GDQ,47%NCL^P')X7[N>IZ]ZU)O%?B*VATY+C1[>.>ZU8
MZ>&E9HUE0HSK*J\E0=N""201WH [BHQ/"UPUN)8S,JAVC##<%.0"1UP<'GVK
MS[4O%&NRZ'<JKVEK?66OV^FS21(S)(C21'*@L"N1( >3T.,9R-K^U[N#Q5K-
MH--LIKNUTF*Y2:,^6]P2T@",S?=7<AQDD#=G- '4R2)%&TDCJB*,LS'  ]2:
M1)8Y(EE1U:-E#*ZG((ZY!]*X*[\12ZOIWB/2+Q+6=4T3[8LT,;!&WK(I4;B0
MP!3(=3@Y]JZGPK_R)^B?]>$'_HM: -..>&8D12HY'7:P.*DKRS2-5E\,>%?&
M&J:?9V\DL7B2Y4HY*@AI43L.V[I73)KNL27_ (@TFX6RANK.SCN[>:$,R[9/
M,&U@2"2#&>1C.1P.E '30WUI<7$MO!=02S0\2QI(&9/]X#D?C4]>;^$[PVVD
M>"[<16;ZSJ6EXCO&A.8[=(T=@WS9<EV7N!R3VYN3>.-3C@\A+"U.H0:W'I-R
M&D8(=^"LB<$X*L#@].>M '>45Q#^(?%,>J7NDO;:.+RUTQ;XRJ\K1L2\B[<8
M!_@_#/?I3](\7ZE?7WAMKFSM8[+7K-IX5C=C)"RQJ^&)X(()Z 8]Z .TJ.6>
M&#R_.ECC\QPB;V W,>@&>I]JY#3?%FI7FMV6F316<<U]9SS#RPTBVTL;(-C.
M&VR_?YVD8*D=ZR](\0:E+X/\'W^IPV6H2ZG?Q*TDL9#0E]Q#*"3\PP0",8!Z
M4 >CT5Q5]XUNH=$U7Q!;6\$FF:7>/;S0D'S9$C<)(ZMG (.XA2#D+U&>(-7\
M9:W:/XH>TL]/:WT.&*YS([[IHVC+D<#AL#KT'OG@ [RD9E12S$!0,DD\ 5 ]
MR_\ 9S74$/FOY1D2(L%W'&0,G@9Z9KDK#Q+/J][=Z/>Q6DR/I(O-\*-L!)*M
M'DDB0 XPZG!YXH [*&:*XA2:&1)(G 9'1@58>H(ZT^O,]$\4_P#"/^!/!\$L
MD%G#<Z3'LO;N-C!YH1-L;," F[).X\<=ZZ4Z_J-_J6HZ=I4=K]JTVVAEF\_+
M+))(K,L:D$;1A?O<_>'!Q0!T]%9?AS6X?$GARPUF"-HX[N$2"-NJ'N/?!R*U
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "L+5O#0U77=,U<:C<VT^G"
M40+$J%?WBA6W;E.> *W:Q+O55@\7:?IIU-(VGMI919&V9FEVX^829PN,]".<
MT 5M3\)'5]/O+2]UB^D%RT)+[8P8Q&^\!0%P,MR202?P%23^%DGU/4[]K^X$
MNHV2V4H"IM5%W8*\=?G;KD<]*CT_QYX?U2YLH;2ZF<7W%M,UK*L4K;2Q02%0
MN[ /RYSP1UXJ:'QEHD^KC38[F4S-,UNDIMY!"\JYW1K*5V%A@\ ]B.U '/6V
MAW>G>.=*M;.>^2ULM!-DMXUMN1B)$VJS;=N[:N>,<C\*W$\'6<#:']GN;B)=
M(EDFB VGS7D5@[.2.2=['C')K.\(^,6U#37EUF9%FEUFXTVU$<9PQ4L5!QG!
MVJ>3QQ6Y>^*-'T]=2:YN]G]G-&MR/+8E6D ** !\Q.1@+GDXH HV_@JRM[<V
M"W,YTG[7]L6P8+L5]_F;0<9V;_FV^O?'%116<6O>,X-7DTJ\M#I"SVZS7*!/
M/9B "H!.Y  Q!/=ACO4%EXXMKCQ%K"S3&WTO3].AN9/M-N\,D3L\@8,K -T5
M,#'.>,YK2C\9Z(]C=7;37$(M6C66&:TECF!D.(P(RNX[CP, Y/TH AN/!L;Z
M_=:G::OJ%E'?;?MUI R>7<%0%!Y4E"5 !*D$@=CS2?\ "&1Q:Y=W]IJVH6MK
M>R"6\T^)D\F9\ $\J67( W;2,UKZ1K-EK=M)/9-+B*0Q2QS0M%)&X .UD8 @
MX(/(Z$&LV]\76UEXTL?#;6MT\MS;O,9D@D94(9%49"D8.XY;.%P,]10!>\1:
M)%XCT&ZTB>>6"&Y78[PXW8SGC(([>E5W\."379M7.H7 N);$6)4*FT(&+;@,
M?>R3[>U8GA#X@6>K:5HZ:C-(NHWP*>8MK(L#R\G8),;-V!TSVQUK;@\7:-<Z
MN-,CN)3,TKP)(;>00O*N2T:RD;&88.0#V/H: ,>+X<VD%K%;1:OJ*1+I7]DR
M >7^]@&[;G*<,-QY&,TW4=%BU&'3/"4UCJ-S!8M!,VHSHJQ[$SE0RXRS %"H
M'1S79S316\$D\TBQQ1J7=V. J@9))]*P+/QQX?O8[F07DD"6]N;IFNK>2#=!
M_P ]%WJ-R^XSU'J* .B/0X.*Y2/P-!'I]K9C4KLI;ZF=45BL>3*79R#\OW=S
M'CK[U=L?&.C7YN%26YAD@MS=-'<VDL+F$?\ +15=067W&:AM/'6@WT\<5M/<
MN9H6G@;[',%N%5=S",[<.P'\*Y- %5? ,"2PE-8U%8K?4WU."(>7B.1]^\9*
M9(/F-U)(SQ6R?#]D?$Z^(,,+P6WV8C/RD!B0Q']X98 ^C$5P6D>/[W5-"\1:
MQ>:H-+MK2:1(&?1YG2!%D"AF8D>8QZ%!@C/08KLM3\7:5I4OV2>>5[H6XN'\
MFVDD6)#D!Y"H(120>6(Z'TH @C\&1V^MW=]::MJ%O9WLWVBZTY&3R99.,MDJ
M67=CY@I&:T_$&B1>(-)-C+<36^)8YHYH2-R/&X=3@@@\J."*P=)\=6:>%-#O
M=8DE:^OM/2[E2UM9)2J[1N<J@.U 3U/%:-[XWT*QF,+7,T\HMTNMEK;23DPO
MG$@V*?E^4Y/;C/49 *-Q\/K.\CU47.IZA))J$T-R9=R*\,\2JJR(548;Y![>
MU3WG@M-2T<6NH:QJ%Q?)/'<1:CE$EBD3.PH%4* ,MQCG<<]::_CO3CXCT;2K
M:*XN8]4M3<Q7,4$C(%R@0Y"D8.XY.0%P,XR*-/\ %UA%HDE]=ZJ;]3?R6D1M
M[&17:0$_NEC&68@ \CK@GI0 ^^\&)J6E0P7>KZ@^HPW"W46I@HLT<J@@%0%"
MA<$C;C!!.>3FK47A^XB@ASK5W-<JSF:6=$87&X 89 H4* !@+CIWR<XWB#QH
M4LO#5YHDJO#J.N0Z?/YL15E4EPZE6P58%<<CBNVH Y0^!+-=$;1(KR==,DM/
MLLMLR(RD%F8NN1\KY<\C@8'' KHIK-9-.>RC=HD:(Q!EY*C&.,_UKF]-\9Z7
M#H5K>7VM"\%U=2VT,T5C)'YCJ6/EB,9.0%(']XCCJ!5'Q5\1[73? NIZWI"3
M2W5L_P!G$4]I*ODS?+Q*I *## _-@'(&>: -6Q\&PZ?)H+Q:A=-_8MH]I;A@
MF'1@H._Y>3A%Z8Z5H^'M#C\/:4-/AN9IXQ+)*&E"[LR.78< #&6-9%GXNM;#
M3+)-4NKR\U"='DV0Z3.DI16P6, 4LBC@9/7M5J[\=>'K2WL9FO6E74(6FM%M
MX))6F52H.U54G(W#CKU]#@ CL?!L6G:O<W-KJM_'87%R;N3304\GSB<E@=N\
M GDJ&QGVXHB\%64,,UBMS.=)EN_MAL"%V"3>)-H.,A-XW;?7C..*6[\?>';*
MXGAGNYE-M.(+EQ:RE+=CC'F.%VH#N&"3CKZ&I[/QEH=Z]ZJW4D/V.#[5*;FW
MDA'D\_O%WJ-R<'D9% %.\\#V][::[;2:C=JFLSI/.5"90J%4!/EX&$7KFIKG
MP?%=S:[+)J-T&UJT2TN-JIA4564%/EX.';KGK534/B+I%KX>U74X([R62PMQ
M.;:6TEA=PP.QL,F0C$$;\8'.:M6WB.&^U_2H(K]H!>6DDZV$]C(DDFT@%MS8
MV >A'.<B@"&7P0HO[6^L-;U'3[J.U2TGDM_+_P!)B3[N]64C<,G#  C)I\G@
MF%=9DU#3]5U#3UN8HXKR"!U*W"H-JDEE+*VWC<I!QWSS5BT\:Z%>ZA%9P7,Q
M,\K0P3M;2+!-(N<JDI78QX/0\X.,U'#X\\/3W4$$5U,WG7!M5F^RRB(3;BOE
MF3;M#$C@$\\>HH G?PQ%_;-_J4%[<P-?6J6\T*!"AV!@K#*Y! <\9QTXJI:^
M"K?3TT9[*_N8KO2K7[%%<$*3+!Q\D@Q@CY001@@CZUU%<]9>-M"U"]AM;>XF
M)G9EMYFM9%AN&7)81R%=KG@]"<X.,T ,C\&V<%WI5S!=7"2:?<3W6?E/GRS!
MA(S\=][=,8_"K^A:''H4-Y''<S3BZNY;MC*%^5Y&W,!@#C/2N7\(>,;WQ/XM
MUF%GDAT^SG:""W;39D+ *IW/*V K9)^0@'%=;J^M6.AVJ7%]*RK)((HDCC:1
MY7/15102QX/ '8T 0W7AZPO/$-KK4R$W-M;R6ZC/RLK8^\.^/F _WS5$>"]/
MB\#R^$X)IX;&6%X6D4@R;&)R,D$=#@<< "JFJ_$/2K#0?[3MX[JY(O([)X/L
MTJR12,R@AUV[E(5L@$?-P!U%5E^(%K9Z]K4.HM<"SMH[>:$1V,KR1QO%O=I
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MKB8-;E1<RQVTCQ6Y;!7S)%4JF00>3T.30!H:UHMEX@TF;3=0C+V\N,[6VLK
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M .5!VC /)P..M8=AI-_'X \'VQL+A9[?5X)9HO*(:-1,Y+,,9 P<Y/K7<_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KBM7;4M0^)5KHT.K75E8?V4UW*MMM#.RS
M!0,D'&<\^PQWKM:SSHUJ?$*ZY\_VQ;0V@^;Y?++A^GKD"@#S[2-=\0ZEJ5KJ
M4$6N2^;JCPRQF*/[$MJ)6CXYW;E #%NI((Z53T*]:TTKQ7''>WEM+<^,KF%!
M90B2>;[K&.//"DA3\QZ $UWL'A"QMM5^V175^D(N&NA8B?%N)FR6?;C/)).,
M[<G.*@/@32EM[F.":]MY9]4?5A/%*!)'<.-K%201C!(P0>": ."OI]0U?2+*
MVNK[58#:>+8+)/.>,3^61&XWE<J64MP?IG)K2U;Q1K&DZQXZA@O7==.M;!;,
M2@,(GE&TOTYY(8YXXKIG^'NDFTN;=;K48Q/=Q7WF+<9>.X0 >:I(/S-@9SD'
MT%6SX+TB2?5YKE9KEM7MXK:\$TF0ZQJ54C&,'G.1WYXH YO6)]4\*:@]E%K5
M]>Q7FC7LX:Z96>&:%4(=2%& =YXZ9 Q183ZW9:CX5E.M7-Y+K5G*;B&XV^2)
M! )%*  %0#QU.0><GFNAM_!5A&;I[J\U"_FGM'LO.NYP[Q0M]Y4P !GC)().
M!DU<D\,Z=-_90D$K+ID3PP#?C*M'Y9W>OR_2@#S+5KV^_P"$'\0V.K7VKIJO
M]D-)<6.I1)L=PRAI8)$&TH"<8!/WEX'?JB^IZ)XL^PMK-Y>Q7>C7-TXN-N(Y
MHVC 9  -HPY^7IP*T&^'^F36EQ;WE[J=ZDMJUFAN;C<886*EE0X[E%R3D_*.
M:V;K0[.\U6/49?,\^.TEM!AL#RY"I;CU^04 >=:!JFN:_8^!+>76[J#^TM/N
MY;V6+:))2ACVX)!P>>H'0GZCL/!-[>W%EJMG?74EV^FZG-9I<2@;Y(U"LI;
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M,++2[^+P_H$1TR[6>#Q++>3+Y#96)I9B'/'3:Z^_..QKK_'6F7^K^#-0LM,
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MBU%-.NKFVN-)>T5[= P642A@&Y^4$'J>.*R/#NCZG'IWPY$^GSPMIJ2+=+(
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MC73=*O;NV>"^N!8HKWLMM;F1+52-P+D?[/S8&2!S3+[QUI=G=7-M%!?7LMO
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M)?WMN9Q8P6^Z54& SD9P%R1@D\Y&*T?%EE<:EX-UNQM4\RYN;">*),XW.T;
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M%<!>^,-27PQJOBBU:,VVFWTD)L63_60Q2>6Y+=0YP6'8< @]: .PU+6M-T=
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M,1M)\E985TIF>U5'X#,I5BV<[B0S9)]2>O-9*>+=/T^[\437-YJ$R:;/#')
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M4RZRN$4J58J>3R"01W% %V;PMIMW8ZC:WHENCJ,(@NII7^>1 "%7*X  R<8
MY)/4FDB\,6D.HKJ"W-Z;I;0V?F/-O)C)W'.0<G=SG^G%-UGQ9I^AS7L5TEPS
M6>GMJ,GEJ#F)6VD#)'S9'3]:JCQM;O:6TT6D:K)+>2LEG;")%DN450QE7<X
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M4J3)&DJLP^<@'Y0>IYJ/0Y+6/5H1;_#VZTEWRIO#!:($&.Y20M@XQP#78T4
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M!N+JZDO T3PEW""&,R;<!64_=7 4]2:]6HH \H?PWJLFGSVMQHU^XL/$4^I
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MDJ "MRN_!53GC#94\$'@6+_2=<AT/Q-X7@T>><ZO=W$EO?*\?D)'.<L9"6W
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MAAAO1@Q#8YR>>O6F2>!_#[Z5%IJ6<D-O#=&\B\BXDC>.8YRRNK!A]YN <<T
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M\QOEE63S V<Y/S'.#Q^% 'GM[/>OX/UWQC_:=^FK66H3B"-;IQ#&D4YC6$Q
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"$K^N*QO"VC:)-\---LC;V\NFW-@CS[P,2ED!=V/J222>N: .LHK@X(IM?\
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MZM;2)I-8M[.*2503-!*P&XJCG8P.1W!Z@"JNH^)O$]A:>*S]ITR1_#X6??\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=5;35O;J\U2^M)YD0KQY4D>67@8PB>O8=ZT#X^L(=)NM3O--U2SMK>!+D-/
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MJB!HD&8G8-E&)7&1GKG->B:=J5GJ]A%?6%PL]M+G9(O0X)!'/(((((/0BK5
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MZB+S3K6)([#46MT65(]C1S;9%&WH=V&ZM]#Z;::A:WS7*VTHD-M,8)N"-K@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC/BO\
M\DTU;ZP?^CHZ[.L[7-#L?$6F2:;J2226DA!>-)6CW8((R5(/4 T <_JM]KDO
MC2XT:RU..TMO[)^UHPME=UD\S;U8X/3T]?J,26_O?$,7PVU.6[>WFO9/-D6%
M4VB0VDI+ ,#[C!R,'UYKMF\.V#ZHVI-]H-VUK]D,GVA_]5G.,9QG/.>OO5>+
MP?H\,&DP11W"1Z2<V0%S)^Z^4KZ\_*2.<\&@#G+SQ/J9\.^)->L)DB71+V:)
M;-HUV2I"1YF\XW!F^8@@C&5X/.;EI?Z_K'B[5;.WU2*SL[-+2=(VLP[%9%<L
MC$M[#G^7.=N7PKI,UW=SM X6\=9+J%96$4[KC#,F<$\#/K@9S5B'0K*WU6^U
M.(3+=WR*D[^<V&"@A<#.!C)Z8ZT <+I/B'Q+>6'@Z\EU2'.N&2">/[(NV,B)
MW#KSG=\F.>.>G'-^Q\0:J^GRVUQJ47VFWUR33C,(1YUQ&JE@(T *^9R,DC:%
M#$XQ6_;>#M&M+?2H((IUBTIR]FOVB0^62"#WYX8CG/6HW\$Z)(&S%<JYO3?B
M1+N576<C:6#!LC(."!QCM0!R4VL:OJVEZ&9K^>WE7Q/)I\IC2,&1(WE"EQ@C
M<-B]/ES^%:&J^+]2T6;Q9YDD4R:>]E%:;H\!#/A=SX/(!8$].G:MX>"="6S:
MU6WG6,WOV\%;J4,D^22RMNROWFX'J:G?PIHTKZHTUJ9AJD:QW:22,RR*HPHP
M3A<#H1B@#!UC6]9T35[[3%NQ<J^C3W]M<30KNADB(#*P4*"IW*1QD'/6C0M:
MUIM<\/PW]]'<P:OI#W;1B )Y4B"(Y!')!$ASGN.,=*WU\,:=]GN(9?M$QGM_
MLKRRSNTGD_W V<@<\D<GN31!X8TRVNM.N(DG$FG6[6UL3<.=D9QE<9Y^ZO)R
M>!0!LUS'B\1:DEOH$L%Q/;7>Y[Q+=<MY*]O;<Y4>X#5NZ;I\&E:=!8VQE,,*
M[5,LK2-CW9B2?QID.EVT&JW&I)YOVFXC2.0M*Q7:I)4!2<#&YN@[F@#A-$U:
M_;X4ZU8RW,]MK&@V\]I)+@"3]VA:-\$'[R;3GZUV7AA)(_"VEB2=YF-K$=S@
M \H.. *C'A72?[2U._,,K3ZI$(;P&=RDJ!=H!7.!@$C(&:OZ9IMMI&G0V-IY
MOD0J%3S96D; X'S,23QQ0!Q_BCQ)JFEW&HSV=VDB65Q:1^1%&&5%D= XF9AG
M<0_ 0Y VDCFH[K_D:/'O_8%M?_0;BM[4/!&A:G<7\US!<;K\QM<+'=2HCNF-
MK[58 ,-J\]>*L'POIAN=0N-D_F:A;K;7)^T/\\:@A1UXP&;D<\F@!/!__(D:
M!_V#K?\ ]%K7/PS:DGB_QI)'J<I^RVENT$<B*R)F.1L8P#@')Z]^<UV.GV$&
MEZ=;V%J&6WMXUBB5G+%5 P!D\G ]:I3>&],GU&\OVCF6XO(!!.4G=0Z@$#*@
MXR Q&<9P: .6L==UW4I?!\"ZA' -7T9[JX=;=2PE5(CN7/ _UAXQCZU6TWQ)
MX@;3/#NIW6H0RK=:L^EW$"VRJLBB26/S,]0V8P>,#G&*ZVV\*:59RZ9) DZM
MIENUM:?Z0Y\N,@ KR>>%7KGH*CC\&Z-%96EFD5P(+2[-["OVF3Y9BQ8MG.3R
MS'!XY- &/8:UX@UEK?4].,:V@U*2WN()FC$8@25HR0?OB7@'DX.<8Z&I-"\1
MWESXF_LO59;BSO<3,MI-"OE7"!ALD@E ^8!>H)SST&*U(?!FBVVN3:M!!-'/
M-+Y\D2W$@A>7_GH8L["W?..O/7FI!X6TZ.,!5GD,44L< DN7_="08;:V<KGI
MGL.F.E &W7G-S#K#^-/&4NCZE%8SPVEG)F2W$HD(24A3D\+USCGW&.>VT33?
M['T:UT_SI)1 NT-(Y<XR2!D\D#.!GG %5[OPSIMY?W-Y(DZRW<2PW0CG=%G1
M<X# '!QDCUP2.E '.Z#XGU#Q?,+>WF.ER+I%K?$K&KEI9PQQA@?D7;VP3NZC
M%9^DZYJ7B/7/!=]-<RVGVJRO7GMH@IC,D3HA89!.#EN_ /&.2>TN?#FG7-]#
M>K');W,4'V99;:5HB8NNP[2,KGD>G;%-E\+Z1(^F,MLT)TQ62T\B5X]B, "O
MRD9!VKP<]* .#\+:AJFDZ+X:EBO$:RO=:N[*2T,(Z-+<-OW]=P9/I@].]>CZ
MOJ"Z1HM_J3H9$M+>2=D7JP12V!^59L7@W1H+2QM8XK@0V-TUY;K]ID.R4EB6
MSGGEVX/'S&MV2-)HGBE17C=2K*PR&!Z@B@#SMFOKWQ+X!U"ZOS*UY%<2E$C4
M)&S6Q;Y#C.!G'S;N@J73_%&KSZ'X5O);E6EO]7ELKG]VH#Q@S@'IP?W2]/>M
MVQ\#:)IT]A+;I>#^SV9K-&O962#<,%54MC;@D8Z8H3P+H4<L3K%<@0WAO88_
MM<H2*4[B2B[L*"78D#@YH Q;'4_$MW8>(=1;5[=5TRXO;>.$68(?RQ\C$[LC
M&#QWS1::SKVIZAX:LX]2CMTU/0VO)G6V5F$H\GYAGC_EH>,8]C73V_AK3;6Q
MU&SB6<0ZC(\MR#.Y+,_WR"3E<^V*9;^%=+M+BPG@2=9;"U-G;-]H<[(CC*\G
MG[J\GG@4 <SI?BO5+W2?"TE[.EM%J'VB.\OD10%DCR$'S JN_:QY'\.!UKH?
M!UWJ]_X<AN]:Q]JE=\ 0^7^[#$(<9_B4!O\ @58&K^$#9OI5KIFF7L^EV:3;
M19ZJ\%S%)(P).XN-R'!XW=3TKIO#>G76FZ<\5U-=/OE+QI=7)N)(EP!M,AY;
MD$]\9QD@4 9,INW^+$4/V^=;9=':46X"[,F90>V><#OGBN9\$:AJFFZ1X'B%
MXCV&I&:V>V\D#9M2216#=<Y3![8/3O7H5UH-A>:O#JLB2K>PQ-"LD<SIE"0<
M$ @-R 1G.#5.U\':-9PZ7#!%.L>E.TEFOVB0^6S @]3SPS#G/6@#&T+6O$&N
M1Z/K=NT8TR\9OM,,S1A8T.0OED?-O#8!#'!YX'%=9JO_ "![W_KWD_\ 0367
MIW@S1=*U634+*":)WD:7R1<2&!)&^\ZQ$[ QR>0.YK9N[:.]M);:4OY<JE&V
M,5.#UY'(H X?P$=4;P+X3#P6/]FK:QM.[2$N$6,LIP5 &'"'KQ5/4O$?B.VT
MOQ/J,>I0#^QM66"*'[*NV6,K"2K'.?\ EH>1@Y[]JZRU\'Z396-M8P?;19VV
MSRK<WLI0!2"H(+<C@<'@TD_@[1KFTU*UEBG:'4IQ<72_:9!YD@V\YSQ]U>!@
M<"@#F/$'B+Q!H7_"56ZZC%/+9:3'J5M*]LH\MBTBLF >1\@(SDC/.:T[?4M=
ML/&=KIFHWD-[9:G837$>R 1FVDC*9'!Y4B0=><T[QCX3%_H>N2Z;;S7&KW^G
M&Q7-Q@,O.T$,P4 %B<]>36SI^AVL2+<2)<BZ:V%ONFF+R11]2@8$XYQD@Y.!
MDG H XOP/JUPVA>#/#UO,UK]HT9KN2X55+80HH1=P(SER3D'A??-3MXIUR+1
M9=2GF41:+K#V6J-'$N)[=6 \Y0<[2 RE@..']L=/%X.T>WLM-M;>*:$:9D64
MB3OYD((P5#$Y*D<$'(Z>@J+5-/NK72UT;1M)AFMKT3)<SS3X$)?K(P8$RDEF
M)&<G\> "A?>(KV'R9(9B\&J:J+"S8!!Y:*CEF!/!+-&X7.1@J>>A@?6O$.G7
M-II.H,C3W]^\5M.C1^=Y B9QN&-@DRI'3!';-=#>^%M'U#P[#H5S:!K"!(TB
M16*M'L V%6&"",=15:?P3HEUH@TJXAN)HA,)Q-)<R-.)1P)!*6W[@. <]..G
M% !IEEJ.IZ1=V'B3R92MRRJ4*EI8."OF # 8@X.W'J,9K-UGQ'>:9XH2TO9;
MBQL)9K=+6[6%9+>0DC?'*V"T;G)"]!R#ZUT^F:9;:19BUM?-*Y+,\TK2R.QZ
MLSL26/U/8#H*JW/AW3[RYFFG$SK/)'+-"9F\MWCV["5SCC:O3&<#.: +FIWH
MT[2KR^*&06T#S%!U;:I./TKCHM4\426$.JQ7%N;&YTUYV,PC/ER[-Z&(+RRD
M;@0Q)Q@YZUW3*KJ590RD8((R"*YS3O NA:5%<0VD-RD$R/&(3=RLD*M]X1J6
MQ'G_ &<&@#G]/UCQ'<W'A-'U>/;KNF--+BT7]RZQQON3W.XCG(]NU1VWB7Q#
M=67AZ);ZW2XNM6N]-N)C; [Q%YP5P,X!_=@X'&?;BNN@\*Z5;R:4\23JVE0F
M"S_TASY:$!2.OS< #G/2L#5O"'D7?A^'2+2Z-I;:I)?7+K=?,A=) 6!9LY+N
M"0..OT(!B:UJ>JW'ACQ#I.KSI=7&EZQ81)=I&(_.C>:"1<J. P#8./:MZ[U[
M5+Y?%<NG72VKZ$WEPPO&K+,RQ+*3)D9VG=M&TC&,\UN7'A32;O3)=/GBE:&:
MX6ZF/G.'EE!#!F8')P57V&T#H,4MSX6TN[O+FZDCE62[B6&[$<S*MRBC $@!
MP>"1GKCCIQ0!SD?B^[M;^SO=0=UTS5])%W8PA%W)<!0[0YQRQ5@5SZ,.:G^T
M^(SXHLM!DU>.(RZ.]S-,ELC,)EDC4E<\8^8X&.GJ>:TKS3[K5]=M;6ZTBWBT
MG3)TNK>Y,H8RNJ$*%0#Y-K-US_",=>-*70[*;6EU=A,+U;=K99%F8 1L02-N
M<=0#G&>* .*T3Q-KUS;>#M2O+V&2/5YGM+BV2W"J"(Y&$@;KG,?(Z8/3C-7M
M'UKQ#KD6EZS9-$NGW,[K<0SF,(D>YE781\_F!@H()P>>G%;5OX.T:UMM,MX8
MIUBTN4S6B_:9#Y;D$$]>>&8<YZFFV7@S1-.U:;4;2&>*261IC"MS)Y(D;JXB
MSL#'UQ0!RVE^(_$+V7A_4KK4(98[S69M-FMUME4,@DF56SU##RU]L=<GFMOP
M,;N27Q%)=7\]R5UB>)1*%X"A0.@'8 >G%7XO!NC0V=G:)%<"&SNS>P+]ID^6
M8DL6SG)Y9C@\<FKUAHEAIE[>W5I'(DE[*9I@969"Y RP4G"DX&< 9Q0!F^*-
M2O='NM'O8[C9IKWBVU\NQ3A9,JCY(XQ(4!]C6-X>\2:CJUQ<:7)>/]NBU'<K
M^4@W6)7?')C'1EPN>NX]NE=CJ>F6>LZ9<:=?PB:UN$V21GN*;'I-C#JSZI';
M(MX]NML9 .?+4DA?S8_IZ4 >?:SJ^KWOA[6!+J+1/:>)H+)&MXU7,)D@&TY!
M_OD^_?CBG:H^J6/B7QI=Z?J/D3V6C6DYD>!7,K(MPP!'0 X.<#OQBNND\'Z-
M+8ZA9O#,8=0N1=S_ .D29,P*D.ISE2"B],=!3G\):3(^H.R7!;4+9;6Y)N9#
MYD2@@+UXX9N1SR>: -+3+IK[2;.\90K3P)*5'0%E!Q^M<7=F[?Q?XP1[^=K>
M+1H&2W(78-PN,CIGJ,]<^N1@#M[.TBL+*"S@#"&!!&@9BQ"@8 R>3Q6?=^&M
M,O=2GU"6.87-Q;?996CG= \?S8!4$ D;VP<9&30!P^B:[J?A[2O#7GW"W5A<
M>''NOLRQ!3&T$,3#:W4Y#$'/?D8Z5T6A7OB&[O=,O9I8I=*O;3?*)#&"LA4,
MIAV\E2-V0Q)& <]:TH?">DV\FF.D,I_LVW:VM0T[L$B8 %2"<,"%4<YZ"F:'
MX/T?P[,SZ;%.BX(CBDN9)(X03DB-&)" ^PH @^(?_)./$G_8-G_] -&C'5GM
MM(^U0V*6*V8(D60NPEP@3@@8X+C@^U;&K:5:ZWI=QIM\KO:W"%)421DW*>HR
M"#BJD/AFPA^R@27KI:D&*.2\E9%(&!E2V#CMG." >HH XNU\1>)9-'T34FU2
M!FN]8ETV6(V@V%?-E0/P<Y&P="!ZYZU)?>)?$&G:=KT"W\,USINL6EK'<2VX
M!>*;R>"%P,CS2,@=!^-=2G@W1H[&TLTCN!!:79O85^TR?+,6+;LYR>68X/')
MK(\7>$1<:/J"Z39W$]YJ5]:W%UBYQN$4D9)!9AM.Q,#;CH/K0!FZSJ&LVT/C
M'P_JMW'?Q#0);ZWN%@$10,LB-&P'!Y7(/7'7-:6DZI>:A?6_A^TNVL1:Z+;7
M)E6-69WDRHX8$;5V<]R6ZC'.\WAO3KBTOX;A)I#J,(ANGDE/F/'@@)N!X #-
MP,=2>I)IK>%M,\VSFC6>&XM(/LL<\4[K(8?[C-G+#@'G)!Y&#0!RUEXNU:;3
M/#6OWKI!I]Q</8ZG&B#:DN]HTE#'D(9% //\2^AS>;7]1>;2+5)I-VLO<SP.
MBQJZ0)@HJ[AC<596.0>-P]Q=UG1Y;FPA\+VFC6YT.>$1SSM, (4##*A,$LQ&
M<-G@\FM+6_#6E^(;2"WOX'Q;N)+>2&1HI(6 P"C*01Q0!RDFH>,%U'0]'N=1
ML[6YO&NXY9HX%E.$3=&Y&<!L$94<9YZ<5WL(DBMHUGE$DBH \FW:&(')QV^E
M9,?A72HKC3;A$G\W3MYMW-S(3E_OEB3\Y/<MFMEE5U*L 588(/<4 <'H_B+5
M[C7M'M)+U+F'4[&YE,R0@0>9&T>UH>CLF'(RW7@@U5\/>)/$%S'X.OKZ_BFB
MUEYH)X%MU0*5CD=6!ZYS'CTP>F>:Z.R\"Z%ITEC);172-8*\=J3>2MY2/C*C
M+?=X&!T&!4UKX.T:S@TN&"*=8]*D:2S7[3(?+9@0>IYX9ASGJ: .+O-4N_$F
M@^$]?:[*P7>OV[+:!%VH@E95&<;MPP,\XR3P.*]/F?RH))-R+M4MN<X48'4G
MTKG!X"T .-D-TD2W8O4MX[R58HY@<[E0-A>>>/\ &NBFACN()()D#Q2*4=3T
M92,$4 <1H&O:M?>(++3KB]:6&]T9[S[0D*JGFJ\:EH<@,8_WAQO&3@'G-<WI
ML=\GP_\ "CQZK=)Y^N1QMM6/H;AR>=N>H!Y[^W%=]8>"=%TRXM+BU2[6:T@:
MV@=[R5RD38^3EC\HVC Z#&>M.3P;HL>APZ,L,XLH)A<0J+F3?'(&+AE?=N!W
M$GKWH QKK6/$.H3ZPFAR()M)NDMPDYC$4H"([F4D;AD,V"N , \\U9T.\UW4
M_$^LQS:I"MCIE^(1 EJ,RHT". 6SD89P<]\'\+USX*T.ZUC^U'@G2Y9%2817
M,B)<*HPHE4-B3 X^;/'!R*T=/T6RTR]OKNV6437T@EN"TK,&< *#@G X ''H
M* ,3XD27,/@:^DM;N6V</"I:+&65I55E.0>"&/2L75H]2B\>ZLUCJ9@N(/#<
M,GGO"CLQ6:<CC 7Z\?3%=SJNE6>MZ7/IU_$9+:< .H8J>"""""""" <CTJC_
M ,(KI?VN>Z*W)GGM!9R.UU(2T0).WENN68YZY)YH YRV\3:OKZ6=I8,;:\ET
M.WU(M$(SF2;< ,/GY%*\XY^8<COV.DR7LVDVKZBL"WQC'V@0-NC$G1MI],YK
M&N/ >@W$.FQ^5=0MIL/V>VFM[N6*58O^>9=6#%>!P370P016MO'! @CBC4(B
M+T4#@"@#A;%M07XJ^*_L$5M(WV*QSY\C(!Q+CHIS5J[O]9@UCPSI<5U;VC7\
M4_VY8X5<K,L8=B.<#YF)Z>YSTK9/A73?[7N]51KR.]NU19I([R5-P7.T8#8P
M,G\Z6/PKI<5S87*K<&:Q:5H':YD8AI#\Y8D_,3G^+/M0!Q]MXC\11Z=97UQJ
M44OE:^=(FC%LJB=/M!AWD_PMC!^7 XZ'--U+Q!XJATKQ5JUOJ=J$T&_=5MC:
MC$\21QN49LY'#'!'.?R'6_\ "&:-]C%IY=QY(O?[0Q]IDSY^_?OSG/WN<=,]
MJR=$\+O+?>(FU>TN$M[W4_M,<33@QS1A(PNY58_Q(<@]1C.>@ ,O5O$#:!XB
M\6ZZD&][?0K*5(G_ +Q>? ;VR1G\:V[B_P!7L/$VF:0VH&XAU:TG*7'DH&MY
MHPIW  8*$-T.3D#GFMB3PWI<^H7U[- TLM];BVN5DD9DDB&<*5)QCYF[=S4<
M&A6VC6YN+"WEN[NUMFAM([BY9B%X(C5FSM!*J">3P,YP* ,/P]XBU'5(+&TN
M)RNIV4DZZPJHO6+C:!C@.61E]5SWYJ#3/$.OW>FZ9XD'EOI5Q:O<75N[1C8-
MA9!"5&XL"-I#$YYZ=*Z'P_ILL,U_J][8PV>HZDZ/-%&X?8J(%52X W$<G/\
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M1GCD&LI/'%F^J:I:_8;U;?26D%_>LJB&$+&),_>R<CC !/'..,Z?AO1E\/\
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MMX)XEC DC4,CAF#!@00, @Y&2.:[?5;">]\(WNG1 "XGL)(%#'C<T949/U-
M'/6_C^5-/T);K0M0DU75K1IX;:#RCO*A"Q!\S"@A]PR>@.<'@ZL_C&QM]#US
M57M[GR='F>&= %W,R*I.WG&/F'4BL+0])UF35?!]W=Z3+9IIFF3V=R)98V*N
M5A"D;6.0=C8^G.*SM=T7Q(=&\9:%9:(]S_:US)<VUW]HB6+:Z("I!8,&RI X
MQR.0* .O?Q4HUN:P@TC4;F&WN([6XO(51HXI'56 *[MY #J2P4@9]CB#P;XF
MOO$G]JF\TJ6R6TOI;:-G:,@[#@J=KL=PQR>G/!-9.M:1J4_BK[7IVAW-I?\
MVJ C5K:\58)8 5WB>/<"QV[E V'^'##MI^#;+4M*NM?L[W3Y(HI=4N+R"Z\Q
M&25)&W  !MP([Y _&@"QKGBY-#N)Q)I.HSVEI&LMW>1(@B@5B>?F8%\ 9.T'
M _*N?O\ 7-2C\9>,+2.\D%O9Z$EQ;H,8CD*O\P]^!5/QKX9UK7+KQ% NDS7Q
MNK95TRX:\"06X$>&4IO!WE\D':0=PR0!5Q] UF[\1^)]3.G/#%J6@QVT"22Q
M[O.VME#AB 02!GI[T =)X'O;G4? NA7MY,TUS/8Q22R-U9BH))JI;^.(9[6>
M]_L;4TTY()IX;PHC1S+%G=C#$H3@XWA<U=\&:==:3X)T33KV+RKJVLHHI4W!
MMK!0",C@_A7()X;U6YO+N&RT6?1$NK6ZBOQ]L5[.X=T(1HXPQ(.XABVU.,@Y
M)H [/_A);,3:+&T<H_M>-I86(&$"Q^8=_/''IFL23QRM_IDTEMIFI6L%U9SR
MZ??R(GES;$+ C#%DR!N7<!D?E69::7K^K77A>*]T273[;3;6:VNI)9XF)9H/
M+#($8Y7(ZG!Y' J?3(?%4?ABV\,OH:PI::=):3WCSH4GVQ%(_) ;(+':3O P
M,B@"YX6\9/>6WA^RO]/OXI-1LU:"^F";+F18PS\!BRY&2-RC('%:7B_6KW2;
M&RM],6(ZEJ5XEE;-,"4C+ LSL!U"JK''<XK.@T'4D_X0/=;X_LJ,K>?.O[H_
M96C]>?F('&:T/&.C7VJV%E<Z68O[2TR\2]MDE.U)2H*LA/8,K,,^N* (K32_
M%FG:G:2-X@35K-VVW<5U;1PLBX/SQM&HY!Q\K9R#U%1P>/+2>6WE_LR_72KF
MZ^QP:FPC\EY"Q0<;MX4L,!BN,X]<T^UU7Q3JFHV<8\/G2+1'W7DUY/'*74 _
M)$L;'DG'S'& .AKG+70->_X1K2_!LFDND%E>Q/)J9FC,3P13"12H#;][!5&"
MH )/- &Y-\0K6)KJ4:1J3V-G?&QN[P+&(X9!($S@ON9<D'*@X!]<BL:'7M:U
M'XJ:K8S1:M;Z;ID$96&"2W"#<'_>298LP; V@<CN!5B[\-:M+X)\2:<EKFZO
M=6FN8$\Q?GC:X5P<YP/E!.#S6C9:'J,/C[Q3J;V^+.^LK:*WDWK\[(KAAC.1
MC(ZT 5]%\:6Q\,^'VL8-7U:YU1)&MXYC$+AD0_.\C95 !D#KW J'0/&<IL;Z
M6>WOKR[N-;N+2SL@%64!1N*'<0JA0&R2<<=3D5E^'/#OB#PQI/@^[;2)+NXT
MZSN;.]LX9HO,02.K*REF"G!0 _-_%[4P^$=7G@74-2T:2>1-;NKR2PMKP)(T
M,R8!1PRC<IQP2,X/M0!U3^/+-8;$+INH27EY<RVBV:JGF1SQ@ED;YMHZ?>SC
M'.<<UG:I\0KB+2H+BQT2[-W_ &Q%I=U;3&+=$Y9,KG>%)96&T@D9()P*;IOA
MJY@U'PY=VVB'3H(+ZZN+F%[OSG0/"T:,[%CEC\N0I8#UJKJOAO6A%JMS;Z>U
MPX\3VVJ0PI*@::&-(0VTD@ Y1N&(Z?2@#:@\26T7B+Q"LG]KM-864%Q-9E4D
M1-RDA8E3)+G&#R1G&*IZ_P"+KE_"/B<1V=[H^KZ?IQN52<QE@K*VQU*,P/*,
M.N016??:!XDFUKQAJ=E:RVSZEI]FEKBX19"R ^8@8,=K8)4-TR<@]ZHW'A75
M9;?Q.FG^')[.#5=%%M;1RW<;N)5,G$A,AP6WC&"1@<D&@#T?P_/+=>&]+N)W
M+S2VD3NYZLQ0$G\ZT:S]"MI;+P]IEK<+LFAM(HY%R#A@@!&1[BM"@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "J&M:UI_A[29]4U2X\BR@V^9)L9MNY@HX4$]2!TJ_7!?&C_DDVM?
M6W_]'QT =[6/KWB6Q\/?8TNDN9KB]E\FVM[:(R22,!DX [ #)-<]?Z8FN_$J
M_P!/O;F\^PQZ-;R"WAN9(E,AEF&_Y"#D ?R]!CBULTU[_A5UUJ<MU/<70EBF
ME^U2*SA(FP<JPPWJPP3W)H ]L1MZ*V",C.&&"/K2UY-?QO<>&/&'B.2_O8M4
MTJ[N4LG6ZD58%@P(TV9VD-@$Y!W;^:T[&WDU;QSXFN;VYO MA!:2V]LMPZ1Q
MR/ 2Q*@@'IT/'6@#T:BO'M)TQY=/^'UP^IZH9]8B\N_?[;+F>/[.T@7[V%Y0
M#*X/7G))JY!)Y=E?>'@VIW8'B.2ULK6*],;/&L E,;RL=PC&6/!SP!R.* /3
M[BZM[7ROM$R1>;((H]YQN<]%'N:BM[\7%_>6@M;J,VI0&66(K'+N&?D;^+'0
M^AKR&6V_M/3M#M;\W %KXN>Q2-;^1S''L<E/,!!;!& QY & >M6]4U;4;/4_
MB/';W]S$L,^EV\3^:3]F25421DS]TX8G([\T >O45Y;XEA/A>ZU>PTBZO$MI
M_#-]<R1O=22&.6/:$D4LQ*D[V'!YP#VK1TZS.C^+O"S07E[(VIV%P;WS[EY!
M,RK&RMM8D*02?N@<''2@#T&BC( SVKR72+R8>(/#^H6B:A':ZQ]K;[1>:B9'
MNX_*>1281\J $+C&,#CO0!ZU5'5=6MM'@@FNM^R>YBMDV+GYY'"+^&2*\TT"
MWELM'^'FM"_OY;_498H+N2:ZD=98WMY&VE"=O!5<'&>,]235,6JWG@_PWXBN
M;RZ;4[[7K5K@O<NR.3=?ZO83M 7:,8 (V^YR >RU1N]6MK/5-/TZ7?Y]^9!#
MA<CY%W-D]N*S?&5G?7^B)!8,#*;B-GM_M)MS<H#EHA(.5) _3'3-<-';VFK:
MSX8TX?VM:)#?7T-S:W-T6E@80!C$)58DI@@@ACPV,]@ >LUA^)-0TC3)-'GU
M6%I'DU&.WLV5<E)Y RJ>O P6&?>N&ADVV=YX>#:G>!?$4MM9VL=Z8R\2P+*8
MY)6.X1C+'@Y. .1D5E7MQ<2^'?#\%P6_T3QQ%;QH]P9S&BNV$\P\MMR1D]A0
M!ZMI^OV6IZQJNEV_F?:=+>-+C<N%RZ[EP>_%:E<'X._Y*5\0/^OBR_\ 1%17
MVF+KGC3Q1;WEW?"VM=/M7AAANI(E21A-\_RD<C:/:@#LAHNFC63K'V*(ZB4\
MO[01EPOH#V_"K,MW;PW$$$LR)-.2(D)P7(&3@=\#FO-/#AE\7WFC6NM75U)
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M/>RZ;8>(M4_M"\T\:1:RRW&G7YBFT]PA>24Q9"N#D$GDX4C:15>>TATSQO\
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M[)E68DC< .,XX]ZVFT:"R\;R:1'<7[V5]HLL]PDE[*Q>5)8P'#;LJ<,<[<4
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MT;Q)E2" JE>A'<=S5?Q2TEU_PMFTFN+A[>TM+)H(S,^V,^02<#/0GJ.A[YH
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M!V%=/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#.<X!';G.* -BTT>PL=1O]0MK<1W5^R-<R!B?,*+M7@G P..*<NEV27MW>+
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ME$H4Q.K*2F3\I) Z]:DO?'&@Z?/>PW%S.K6#HEV1:2L(-P!#,0N N"#NZ>]
M#K7P1X>LX+J"'3_W=U;M:R*\\CXA;K&FYCL7V7 Z>E;D$,=O!'!$NV.-0B+Z
M # %0:G?Q:7I=UJ$R2O%;Q-*RQ+N8@#/ KC7\83R:MX3O!)=0V.I64\L]FML
M69G5(V7:-N]OOGIP<9H W)/ WAV6XFG;3SYDLWGDB>0!)-P<N@#80E@"2N,]
M\U='AW21ID>G"S7[)'<?:ECWMQ+YGF[LYS]_YO3\*9;^)=+O-+M=0MII)H;L
MLL")$QD=ESN&S&005(.1QCFK6E:M9:W8)>V$WFP,S+DJ5*LI(964X(((((-
M&$N@WNJ>.X->U2UM8(-+BEAT]8Y#))(9" 9'.T;?E& O.-S<UOZEIMGJ]A)9
M7\ FMY,;D)(Y!!!!'(((!!'((JM!XATZXFV)*X0I(XF:-EB98SAR'(V\$^O/
M49'-10>*M'N+EX/M1B=;4WO[^-HPT .#("P *COZ9'K0!"?!>@'2Y-.:R9X)
M)EN'9YY&E,JXVOYI;?N&  <\#BG1^#?#\5C>68TU&@O=OVD.[L9"OW6+$YW
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MWT>"XB*')R"!D]2.GY43:'J]MX@N;D^&K+6++4[>$.MS+&K6DB)L(;<#N0@
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MYB+Y!#EU9&<88#<5/0G ..U=Y5:\OHK+R/,29O/F6%?*B9\,W0M@?*OJ3P*
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MJ/L\AF$('DAEW;L8QG./UKD/"MCK.B^"=&TB;P^[ZC8H$69YH3%&_(WY#[B
M&/ &3TKK-)UBRUJ">:Q=V2&=[=]\;(1(APPPP!X-7Z /.M9\.:U>Z5XZMH=/
M8R:Q,C6F98P& BCC)/S<<H3]"*E\56-^U]XAU=[)X[)_#$MMO9TR)!O<@@,3
MT.,^OYUV.E:S9:U%<2V3NRV]P]M)OC9")$X888 \&DU!K.[D71[R"69+R*3<
M!&QC*# 968<#.[H3SS0!RVD:;=ZK+X0U26R>WBTFP9LLZ%IGDA5 JX)^7&3E
ML?P\=<4-'\-:[IEIX6O39%KC29;R.YLQ,F9(YV)#HV[;E<+P2/XO;/H5K:PV
M5K%;6Z>7#$H1$!)"J.@&>U1ZEJ-II&G3W]],(;6!=TCD$X'T')/8 <F@#D9?
M#$+Z'XH.K3)8C6;EKI,N,VI2-0CY!QO!CWG!/XXS4-SH&MZEX$L[AX[:;7VN
M8=3N()AMBF=<9B.>@V +]5%:D>J^'?%6I6UA?Z7,+R'-W:Q:I8-&3MP"\>\8
M)&1GN,CBNJH \_U+1M3U'0=UOX7M=-NI+^SG>V@DBWE895=F=QA3P"%'/UYX
M[JY\]K&;[,$%P8V\L2\J'QQNQVSUI;FYAL[6:ZN)%C@A1I)';HJ@9)/X57?4
M@+NQABM;F>*\5F%S$H,40"Y&\D@C=G P#SZ4 <!9:#XD%_:7USI)\[^PY["Y
M+7B,3,QC(*C[JH2IP!@#T'>S;>&M7:'P?;2VDD(T[29K*[E65#Y3O$B KALG
ME">/:O0Z* /-].T;Q*EGX-T^YT=$.@7(6:X6Y3RY8U@DB5T&=W.X$@@$>_;I
M?&FG7NIZ98PV-L9Y(M2M;EP'5<)'*KM]XCG"\5T=<]:^-=&O-6CT^&2XS+*\
M$-RULX@FD3.Y$D(VL1M;OS@XS0!S^LZ!K%ZGCQ(=/8_VQ:QPV9,L8#,(BAS\
MW R<_3\JZN_LI[_PE=6"IY5Q/8O"%<CY69"O)&1U/:I;?6K:ZUV[TF!99)K.
M-'N)0!Y<;-RJ$YSN(^; ' QG&11K6LV^@Z<;^\24VJ.JRR1J"(5)QO;G[H[D
M9P.<8S0!RUAI6M+JG@^YN-+:)-,T^>WN<3QMM9DB48YYYC/3L1[@9-OX8U^P
MTW1+L:+!?3Z?<WPGTZ>6,>;%<2^8&1B2H9<+P<?Q"O3P0P!!!!Y!%5-6U2UT
M72;K4[YREK:QF65@I8A1UX'6@"'0[4VNF*K:=:Z<SLTAM;8#;'D]R  6[D@=
M3WZGC+;PGJQ\(0>$;FW_ '=OJ"2KJ0D4JT*W'G XSN$A VXQC)SFNAL_&UA>
MW4%O'INN*TSA%>729T09/4L5P![GBNDH X0^&=3U#1O'&FRQ&S.LW$KVLS.I
M!5H4C&=I)'*'/L:=:6OB&\\2>'-1O=$^RK86=S!=?Z3&PWN(\%,$Y4[#C.#Z
M@=^YJO?WD>G:=<WTP8Q6T3S.$&20H)./?B@#@-'\.ZW:1>$UFTUU.FZE>7%S
MB:,[4E$P4CYN?]:N?H?;,D&D>)+19?*TYC!-KT]Y/$EQ&DKV[J=I1]WRD-C=
M@@XR >37:Z-JL&N:+9:K:K(MO>0K-&L@ 8*PR,@$C/XU>H \UL?#>NVEGH]N
M^EJ!9>(I[]_+N48>2YFP1D@G_6KQUX.<<9U_%VEO?:]I$NG7:0WLS/I]VH/S
M/:.A9^G0KM!4]B?>NSJE#I&FV^J7&J0V-NE_<J%FN5C DD   !;J1P/R% %Q
M$6-%1%"JHP !@ 4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %<[XHU>73KK0K-)C;QZE?BUDN!
MC*#RW<*,\ LRA?Q..<5T54M5TC3]<T][#4[2.ZM7()CD'&1T([@CU% '+7E]
MJ.E:KI.ARZNUQ'J.IS1M<[ LD$0A,B0%N06)P-W7:?7FLO4->UK3Y-6L1?2L
M-.UK3X8;DJNZ2&=H]T;\8)4.1GK@COS7:#PSHPTF/3!81"TB<2QH"05<'(<-
MG<&S_%G/O3YO#VE7&E3Z;/9I+:7#;YD<DF1L@[BQ.XMD#G.>!Z4 <3XEUW6+
M.W\>?9-4EB;38;:6U(1#Y1="6'*]#[\CL16AK\NM^'O+E^U:GJM@1-+=-;>4
M+FVSLV.B;1OC7#_+R?FYW8K</@SP\T-W$=+B*7B*ES\S9E5>@8YR?ZGDU<N=
M#T^\:)YHI&>*)H5<3NK;#C*DALD' SG/2@#C5U?5O$D^H66B:M%%):V5M-:W
M+2;!)YD>\3,A1MRG.,9&,'OS7>VDCRV4$DC1M(\:LS19V$D<E<]O2LF_\'>'
M=3N;6XO-(M99;6,10G;MVH.B8& 5_P!DY'M6YTH \U7Q+JTW@NU\6PW4AN#J
M0AET_ V&-KGR/*QC(8 @[NN1Z'%:WARV=?B+XN<W<[A6M?D8K@YBSSQV[?UK
MH8_#VE17KW<=FJRO-]H8!FV&7_GILSMW_P"UC/O4MMHUA9ZC=:A;PE+J[(,\
MGF,?,P,#()QP.!Z4 8GC:\U"S@T;^S[][1KC5;>VD945MR.2"/F!].V*YJX\
M0:UX=U#6=)GU-[R".\L$@OKK8C0I<$AU=E3;QMX.WC>,YKJ?&6BW>NVVEP6L
M,<BV^HPW4P>4Q_(A)(4@9W<\=/K6F_A_2I=.NK":RCFMKLYN4FS(9C@#+%LD
MD #!)XP,=* .,UF7Q-H\>QM;1$FU>PCMT0K-)'#+($=79D&5)!*GKU!/%3:C
MI=Q;>.O"$$NL7]RXCOB9I/+#'A",X4#H<=.@%=%#X-\/V^FQZ?#IJ):QS+.J
M+(X/F+C:Q.<DC P2>,#%7KC1K"[U&UU">%GN[4,()?,8&,-][&#WP,^N* .$
MD\2ZM+X+E\5V]U(+J#4VA;3\#88Q<^3Y)&,[BN#NZ[CZ<5:MI-:O+CQ7<'Q#
M>QKI5Y-';Q)%#M*_9D8!LISAFR/ISG-=:OA[2EOI+Q;-1+)*)W 9MC2CI(4S
MM+\#YL9X'-+%H&F0K?B.W*C4"6NOWK_O21@D\]< #Z#% '$:;>:W<7'@U9-?
MO"NN:4TET D7RLL4;AH_E^4DLP).>O;C!;:[K)\/:%(VIRM*/$;:;/(43-Q"
ML\B#=\O!PHY7'>NTB\-Z3"]@\=J5;3XS%:$2O^Y0C!5>>F !] !VJ-?"FBK;
MQ0"S(BBN3=HOG/\ +-G.\?-][))SZD^M '$:CJVNV]CXHU%-<NLZ3K,45O%Y
M<6QHV$&4?Y<D8D8#&#WR:TO$6H^(6OO$5KI\EU'=V\%NVD+;1!T=FSN\S@J"
M6!!WX 4 CN:Z67PKHL\%Y!)9[HKV83W*&5\2N,88\]>!^0]!7-:CX-N+WQ#>
MW=SHVFW\<[+Y-T=0FMI8T5 H5E13O(()W;LG/;B@#N;>.2*VCCEE>615 :1\
M98^IV@#\@*\EOHIAX&\5L][<3/\ \)&D:F9@V-MU  >@[8&.F .E>K:?:M8Z
M;:VCS/.T,2QF5R2SD#&222<GW)K/G\)Z%<_:_-TZ,_:Y5GG"LR^8X((8X/7(
M!^H!ZB@#D=0\1:GX=G\5P/J,EU%9BPDAFN@@, N'9')*J!M7&X9!Q[BNGT.#
M6+;5[Q;Z_@GLIHTDMH?-\V6(\ACNV+E3QC.<'..*NGP]I3SWLTEFLKWL0AN?
M-9G$R $!6!)! R?S/K1HOAW2?#MN\&DV,=K&Y!8*22<=!DDG [#H* .<^) D
M*>%1"Z)(?$-KM9U+ '#]0",_F*N:W-K&GZ%K]Q/J5NMW'8R36,EM $9-B$M\
MKE\_-MR>G(Z&MK5-#T[6OL_]H6YF^SR"6']XR[''1A@CYADX/45"?#.DLMPL
MEL\GVB$P2F6>1RT9ZIDL2 >X'6@#D[276)M?T.R?7[WR=5T=[F?"19C=/*P8
MSL^7/F$'.?SYJCI6L:[JZ>$+=]<N(?MXOX;J2*.+=)Y+%5<94X; Y[>U=XGA
M[2X[BUN$MV6:TA,$#B9\QQG&5'/3@?D/05@7O@U$U_P\VG6BQ:7IS7+R!;ET
M=6E &4QSUR3R.IZY- '.R7NI7.DV5IJERUW+IWC""SCNF4*TT:NI5FP ,C=M
M.!U6K]_XAU6X\.>+-<MKU[>YT2]GBAML QE(0IVN",G>,G.<C<,8QSV4OAW2
M9K2VM7M!Y-M,+B)5=EVRYW;\@Y+9).3SDDTLOA[29KZ6\DLU,TQ0S89@LI7[
MI=0=KD8&"P.,"@#E;W6]4TG7KJTN;F=EUFS5](CD"CR;G(5XL@<\NC9.< -Z
M4MW<ZYJ.K:QH6FZH(+O3+: PSRRA"SLI;S741D.N>".!P>Y!&^+#4K_Q"ESJ
M<-BME82-)8^4S/([,FW<^0 N%9Q@$YW=L<RZKX4T+7+Z"]U+3(+FY@7:DC@Y
MVYSM./O+['(H Y5]4U_79]:MM/U.SL[S3/(V2>=B+YHDD,C(4.Y&+,O)'"\8
M/-=K)$OEMJ&8ENEMBJR.QV(#R?H,@$GJ<#TJGJ'A/0=5U2'4K[2[>:\A4*LK
M#DJ#D!L<, >QS6M+$DT3Q2*&C=2K*>X/44 <?X0UB]N-4FTS6%OK;5H;5'EM
MKC:\4G)!FAD7@J20,<8XX'-7O$6K30>(O#VBQS-;QZG+,99DP&VQQ[MBD]"Q
M(YZX!QSR-:PT:PTU]]K 5<1B(,\C.50=%!8G"^PXHU71=.UNW2#4;5)TCD$L
M9)*M&XZ,K @J?<&@#SBQN;[1XM2-M?S;V\:1V\KL%)DBD\E65N/0XR,&I/%M
M_?W&E^.;-M1N!#97-FL 0JI59%C+)D#)!+'K].G%=O\ \(AH'V"[LO[,A\B[
ME$TZY.7D&"'+9SN! .<YI5\): L%]"-+@,=\JI= @GS0H &2>>PY]>>O- &#
MJ^LZEH?B>[CCNIKNVMO#MQ?+;2!?FEC=<'*@'D<5';R^))+)-4L]:L6@O-+D
M:(3S[U:XV;DE7]VH51SN'(Q^O50Z!ID%]%>Q6H6XB@-NC[VXC)R5QG!!/)]3
MSUJG8^"_#>FQ7D5GI%O#'>1M%.J@X9&^\H&?E4^@P* *7A#69-0N]0M+M-0M
M+^V6+SK"^VL8B=WSI(O#HV#@^JGITJ'Q3%++XW\'HMY<PHT]SE(V 4D0.<X(
M.3U'T)]:Z:RTRTT]Y'MXV$D@57DDD:1V"YV@LQ)P,G S@9/K3=0TC3]5:V:^
MM8YVMI/-A+CE&P1D?4$@CH: ."F\2ZM+X,NO%=O=2"[M=2>$V&!L,:W'D^41
MC.XKAMW7<?3BO2'4O&RAF0L"-R]1[BLX>'M*6^DO!9J)9)1.X#,$>0='*9VE
MQ@?-C/ YXK3H \?TR&XE\+^!"=0N3--KLI,KE79#LNLD9')/7)SS^5:\'B35
M+2W.FS7S3$^))-*6[N&5&$?E&106"D;B<)G;W]>:Z^/PEH4+0M%IZ1F&X-S'
ML=E"2'.6 !X^\W_?1]32R^$]"N+&]LI].CFMKZ7SKF.5F822<?/R>&X'(YX'
MI0 WPY%JMLE];ZK?0W3)<$P;'W/'$0"$<[5R1SSC.",^M8/BI;AOB7X,%K+%
M%+Y6H8:6,R+]R/L&7^==;I>E6.BV2V>G6R6\"DG:N3DGJ23R3[FH+_P_IFIW
M\%]=V[/=6X9891,ZM&&X;;M(QG SCK0!S?BF]UG2?"MW/_:<2:I'>6_[RVA
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M^%/!%XFKFXM[V2"QETYH(PB!E8$J0-^]2I+98@_-P*[?;XQ_Y[:%_P!^IO\
MXJL:V\(ZG9ZPVK6]AX:COBS-YHAFX9OO,!NP">Y R: ,&*ZG@^&FN7J3O!<7
MNORI>3(VUXT:\$+'/48C &>U=?:^'M"TYM8TNUN76*YLP;C3FGWI&A#KY@4Y
M*[AD'G!V^N:R;/PQXIM)]8MV/A^XTS596N)H)HY659& #@+GE6QN.3U)XYJ*
M3P?XBL]$OM,T1/#]C_:"^5<3QK-YBH5*[@6+$D X / SVH W/AW>27/P\\./
M=2?OY+&,#<>6 7&??@ TWXE_\DS\1_\ 7C)_*KNBZ$;6TT]=0M[$SZ8IALFM
ME8"*,H%Q\Q/.!C\JU;ZQM=3L9[&]A6:VG0I+&W1E/4&@#"TJQ\61S6KWNNZ7
M/:  O%%ICQNPQT#&8X_(UY_?:<LGAO6]:^U7::E!XG>&WN$N'!@C:]6,JHS@
M AF[=_85W]O\/?"EK<Q7$&BP)+$X=&#-\K Y!Z^M:K:#I;V<UHUE$;>:X^U2
M1\X:7>)-Y]]P!H \N\66\?A__A+[#3;B>SM/L&GW/$S'RY&N'5G!8G!(49]<
M<UJ:OI]OH.O:K8:8TJ6MWX:NY[F)IFD!D0JJ2'<3\Q#.">^/:NI\6^%TUW2+
M^.TB@74+M((FEE) :..4/M. >/O=N]7;+PKH6G)=K::;#&+R/RI^IWI@C9R>
M%Y/ P.: ///"MI#K:>#M'U/?)IR>&ENDM][*DLVY%)(!&[:IX!Z;LTNF7EQH
MS:=KCW<SZ78ZO=Z--)+*6!M&F*PNS$\[) J[CV)KT&Y\*:%=Z?9V,VG1&WLE
MV6RJ2IA7&,*P((&..O-9GB/PQ<:EH,/AC2[;3[31)E$=TQ)#QQA@2L:!<$GG
MYB1@\X)H XMO[2U*WT:Z>W:\C\2:E<7C6DUVT"O"L1^SQ%@#QL4/MQR13Y;7
M6EFT70;FRM[RTDN[Z1;#^U6V!4"&.)Y=N6V;Y,*1_"/2O3;[0],U/3H]/O+.
M.6UB*F./IY97A2I'*D>HJM)X4T*728=+;3(?L<#^9%&N5*/SE@P.0QR<G.3D
M^M %?P7;WUIX=%M?O&SQ7$RQB.Y-QY<?F';&7(!8J/EYY^6NAJM86%II=C%9
M6-O';VT0PD<8P!W_ )\U9H **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME=<;BP1=D?\ LX8_ER :'_"::HUMIC#0H(KC57)LH[F_"*T00/N=@AVL<\(
M3[C!IB^)O$,WCO2-,.E1VUK/ITES<PRW WH1)&I.0ISMR< $!@V3C&*N:QHU
M]-X?TS3O[(TK5[>*%8[JTO7*98* K(^U@""#U&>>",<Y%CX2\0:7?Z%<Q26T
MY@TZ?3[DM<N&MUDE5U9"5)DV!=H!P3@=* -2R\97CZK%9:CHZ67VF"::V478
MDE'EX)65 H\LD'/!;N*@TCQS>Z@WA^XNM"%IIVN +;3?:P[I)Y1D 9-H^4A6
MP03VR!GC&T?P1K-A<:),-*T:U:QMY;6Y>"4F2Z+Q[3.S; 2<@':<GYCDUMVO
MA74(=$\$6;M!YFB/$UUAC@A;=XCMXY^9AUQQ0!C:IXMU/6++0;ZWTYK72;S7
M+6.WN8[O,DB";&9$"C:K ''S-VR.:Z71?%%[K6HN(M)3^S!<S6WVE+L-)&\9
M929(MHV@E3C#$\C(&>.=MO"?B>'2=$T IIPT_1]2@N%NOM#%[B&.7<%V;/E8
M*>?F.2OOD:4'AS59?&5IJL^FZ5926\TC3ZA92L'O8BK*L;Q[?="2S-@IQUX
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MNWV:'**1[,_F-]"*@N;F#3?B_%-?NL,=]HXM[.60X4R)*S/&"?XB&0X[X]J
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M8^.RUNYM8M%M(A#!)Y1VD,@4,/N#D<]A0!Z-K&H6>@Z-JFN_9UD^SP--,8@
M\@C4G!/<XX&>E6M.U"/4=+LKY08UNX4F1&(R RAL?7FO(;ZU_LJT\>::EMI=
MD@\.+)):Z83Y2O\ OADY ^?;MR<<C;FK5_IT#Z+8ZO-::;K$%GX>M?M5E<3&
M*XM$"LWFP-SM9N?[I)C&&H ]?K"U[Q3;Z!>V%D]A?WMS?"5H8K*(.V(]NXG+
M#^\*U+2]MKI=L$RLZ(C/'NRZ!AE=PZC(]:XKQK'<R^/?"2VFJ+ILOD7^+AHE
MD &(>,-QS0!U&CZZVKO,K:1JEAY8!S?0K&'S_=PQS6IYD8!)=<*<$YZ&O.O&
M,%['\/-9CO?$(U1W:WV-'"D31#SDSC9]1SVQ31X/\/M\2KS33I-K_9[Z-%.]
MIL'E/+YLB^85Z%]O&X\\F@#TAF502S  <DDUC:YXC@T.]T:VE@DE;5+L6D;(
M1A"5)R?;BO,_"MI8:W?^";?6UCNXW\-R[8;GYEE99(P 0>&PH)P?3/:HH2%@
M\&PPL6LH/%MS#9'.1Y"O*$ /< # ]A0![5O7>$W#<1G&>:7->-WEI9OX%US7
MY(HCXIAUB98[H@>?',MSMBC5NH&S8 HX(/3FKVNRW&@ZEX@\*V;%'\2NDVFD
M?P/,1'<X_P!T R?\"H ]5+J" 6 +=!GK064,%+ ,>@SR:\=U;07FU3Q-9Q0Z
M+##I=O;065YJ%P\<FGQ"!2DD1"': ^XYR,E<'I1J.FZEJNI>)KF;^PHK^TNX
M4BU*]N'CEL\11-&8\(=J%B3U&XE@: /8Z175L[6!P<'!Z&LWQ%?1:9X9U2^G
M25XK>TEE=8FVN0J$D*>Q]^U>27"7?AYM;@TRVTW3K@^%I9_)TN1F.59=KNQ
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M5MD#M$A&XC('&?K7FDNFWVI:OK=^1H=O>6^N+''J-Y<.ES %9/+C7Y" K*0
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M,<:(B[G=F )P.!@#DD5@77C^^L[40/HL;ZNFKII4MJES\F]XS(CJY7[I&WJ
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M?NXP%Y# #-;6J>/-3L4U^[@T6"6PT*Z$-U(]T5>1-B,3&NPC< _() X&#SP
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MQ6-MIMXA?_2+3401',F#QN"M@@X/W3TK8JGJ>J6>C:?+?7\PAMX\;F())).
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MZE<P3S0HZ(PA"DC<P4'DCC)%.U_68?#VA7FKW$,TT%I$99$A"EMHZXR0/UH
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M;F4.\ES,L$$28W22$$X&2!T!/)Z T <;XH\"ZCKFG>+;>WN+5'UF>TE@,C,
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M/3B@#S&_DNX=*\4:FFJZD+C3?$44=K_IDFQ$)MPRE<X92'88;(&>,<UT4-C
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M>*YG$AC&X1L8T+C&T,P]1G&.A-9,ER+/6O#^CQ:O=W>D7MY>"2X:<D[U3='
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M=.AMC)>!V+2[H2=V.@9>@_6NSTK6[^7Q&VB7\-L)8]-BO'D@9B"SR.F!GMA
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M>IPY&T\' YJ"3PWX@T_4;V[T?4;.5]1MH8[J2^C8,LL:;/.4)P<C&5X&1UH
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M6"6N\@2!1Y@;UYA&[ZUT>@:-+H\FKM)*DGV[49+Q-H/RJRJ,'W^6LM_!SO\
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M#_?G_P#135-9:K;7&M>&+HW6DVROK,YDL+>#$MMO6=3YTI<G<S$9!49)XZ4
M>DZ7XQT#5M-NM0M]3M5M;65XII))D4)M<J&)S@*VTE2>HQ5Z37-)BTQ-3DU2
MR2P?[MTUP@B;Z/G!_.O'[.6%?#VE1P7VG6ILO$MT;YKF,2I;DO<"$S(&4@;B
MN"2 "0>U;"6NGQV$=X/%FE"X;69KBUN6L2EAYOD[)(\,Y!!^8[@X^8MCD$4
M>IP3PW,"3P2I+#(H9)(V#*P/0@CJ*9=WEKI]J]U>W,-M;QC+RS.$1?J3P*YS
MP=KEC<:)IMN8[2SN+IKDPP6N3%*(Y2'DBX^XQ(8>S"J7Q$\Y&\.3"ZM;2UBU
M/=-/>0F6&-C%((V==R\;B "2 &*F@#H+W6D6ST^[TZXTZX@N[F.(2R781&5B
M03&P!#OQPO?UK(U3X@Z3:VFMFPEAO+S271)8!,HW;B@)&,G W@$XX(Q7#ZM!
M%%HNC2PZK:ZE'<>-;67S+.V,,*-P&5 6;(W DD$C+&C7FL5MOB38L\"7<EY;
MN(=P$AB*6^6 Z[<]_6@#UFSUC3-1>=+'4;2Z:W.V98)U<QGT;!XZ'K4=OK^C
M7=K/=6VK6$UO;G$TT=RC)&?]H@X'XUYYXXL&@UC5K?2;=8I'\*SKL@3!95F0
M8 &,_*6 'O61KZ6]QX9\2WUOXATC4"F@>48-*L3"BH7!C+MYCC(PP"\'#&@#
MV2UOK2^61K.Z@N%BD,4AAD#A''53CH1GI6'XH\8:=X=TV_D6YLY]1M8?.%@;
ME5E8<?P\D#'.<5L:;8VNG:?#;6D$<,*H %10!T S]:\=\0W>CQ>"/'%CJ#V_
M]M/J\[K ^//8;U,3*/O;1'CD<  ^] 'LK7EIBY#7,&+8?Z0"X_=#;N^?^[\I
MSSVYJ&76=*MGCCFU*SB>39Y:O.JEMY(3 )YW$$#UQQ7G>LZM8:;<?$NUO+J*
M&YNH$:W@=@'F!LU0;%ZM\P(X]*L^';*UNOB);33P1RO#X7LC&74'83))R,]#
MQUH [*PUI)(KJ2^GTZ!8KQ[:-HKL2 XZ!B0-LG7*<X]:LVNM:5>V,M]::G9W
M%I%GS)XIU:-,<G+ X&*\AT^WBNM/NX)XUDB?X@R!T89##=T([CVJ_P"*888-
M6\5@Q*NG+=:--?(J_*81(?,) [;5&?84 >HV6KZ;J8!L-1M+H,N\>1,KY7.,
M\'ID8S2ZAJFGZ3 LVI7]K9Q,VU7N9EC4GT!8CFN*T&YTB\^+6IW&C/;RPMH\
M/F2VQ!C=Q*PR"."0-H)'ICM3?&+2P>.]+GEU/3-.MCITZ13ZI;^;#YF]"ZC]
MX@5BN._(#>] ':7>MZ3I\?F7NIV5LFP2;IKA4&TG ;)/3/&:2+6])FO8[*+5
M+*2[EC$L<"W"%W0C(8+G)&.<UYYX3TJR7Q;HD+31:E!%X=D:"9K<QJ5:X&W:
MC$D *VT>WUJCHEC:VO@GP%-!;QQR_P!NC]XJ@,<F=2,]>@ ^@ [4 >H+KVCM
M>16:ZM8&ZE)$< N4WN02#A<Y.""#[@UG:3XG&H^(_$FERP)!%HSPJ9S)PX>/
M>2>!MQ]37F:3Z._@74+&W>V_X2"3Q$Y@B&//:7[;\K*/O8"CJ.,!O>I=81GU
M+XE_*SP+?:6]TJC), "&7CTV!L^V: /5K?Q#HEW:2W=MK&GS6T3!9)H[E&1&
M)P 6!P"3Q5JYO+.T,?VJX@A+DB/S7"[B 2<9]@3] :\^NK+1O%OC2\LM,EMI
M]/GT"2VO9K0JR*S2+Y.2O&X .1W K,TNZO/%,-U=:DC"7PWI%Q8S;A]Z^8,D
MK#UPB*?^VM 'I(\2:$6F4:UIQ:",2S#[4F8T.,,W/ Y')]:E;6M*72QJC:G9
M#3R,B[,Z^41G'W\XZ\=:\ZTW2=/$_P +Q]C@_P"/&1S\@^9OLRMD^OS?-SWY
MK+*26US T=U96%C;^*=0'FWD'F6\+E#Y>Y=R@<E@#D %A0!ZP^L:3#;)>/J5
MDEO,AD29IT"NHZL&S@@9ZU0U'QEX?TRRL;R;5+5K:^G6&"6.="C$G!;.<;1W
M/:N%TG3K-_$7A?\ TZTU6VEO]2N$>"V,4"ML7(12S J'#$$$C)XZ53OA9VD+
MR3B"&SM_'2EF<!8XD* G)/ &3SVYH ]C5E=%=&#*PR"#D$53U'5],TB-)-3U
M&TLDD.U&N9UC#'T!8C-+9ZG8WMQ<6UI<QRR6VSS50YV;U#+[<J0>*Y'4;G3=
M/^*$EQKLUK!:R:,J6<MVRK'N$KF906XW8,9(ZX^E '6W6L:98PI-=ZC:6\3H
M9$>6=45D&,L"3R.1S[BK2M$L1E5D$9&_<",8]<UX_P"'M/ANK_X?Q7=L'M?^
M)M-;13)D>3O!A^4]@A4CTX]*]%\9W2:?X*U>=K2.YC2U<-!)D(RD8.['.W!R
M<=@: 'W/B[0+?0[W6%U:SN+*R5FF>WG23! SMX.-QZ =S6EI^H6NJ6$-[93Q
MSV\R[DDC<,#Z\CC(.0?<5XUJL\,J>,H%U+3=0,GAGY&T^W$43&,R$A1O;>4#
M#D'C(':O6_#US97?AZQFT^:":V,*A7@8,I('/(XSG.?>@":#6-+NM0FL+?4K
M.:]A_P!;;QSJTD?^\H.1^-1PZ_HUS>1V<&K6$MU(GF)"ERC.R]=P4')'O7E>
MAZM;W'B#P;=_:])MTFN[C=8VL.U[1I(I<)+(7)+LW8A<L#@<5/HUE:V_@'P#
M/%!&DS:Q QD"C<2QD#<]>1Q]* /5!J5B=/\ [0%[;?8MN_[3YJ^7M]=V<8J/
M5M7LM$T>YU2^F6.TMXS([%@,@#H,]2>@'<D5YFUG(NO2?#GRV^PS:DNJ+Q\H
ML"3*R?3SUV?1J[CQ]'YOP\\1ILWG^S;@@8SSY;8H GMO$,.H7>E'3Y[":ROH
MI)-YNQYOR@<(@!WX.0W/RXJP/$&ARW"VZZOISS;#,(Q<H6V#DMC/08//M7G\
M-S97?CSX<RV$T$T']G7@#0,&7(C3(XXSG.:S=,TJPD\"^ B]I"S2:ZI=B@R^
M3-G)[C@#'H * /5HM<TF?37U*'5+*2PCSONDN$,2XZY<' _.K%G>VNH6J75E
M<PW-O)RDL,@=&^A'!KR/7HFM_$6MB"6UL[*'Q%8RSR7$.^"+-F,.ZAEX\PQG
M.1S@GI7;>!H(U36;F'5[/4EN;XN[6-L88$D$:*P3+L&S@$D'&XGOF@"75?'6
MDV!UVU@GAGU'2;%KQK?S5'F$*[;!R3D>7SQP&%:NEZ]INK8BMKZTDNUC5YK:
M*=7>+('#*#D=>XKSKQ'+96^N?$F"5X([JX\/HUNCD!Y (+C>5'4X[XJ3Q#IQ
MM5\.PZ-;K#=OH&H10^2N&9O(C*CCK\V#]: /1;;7-)O!<FUU2RG%KG[08KA&
M\G'7?@_+T/7TIIU_1EMKBY.KV @MR!/*;E-L1(R-QS@9!&,UY;9QVUSI,EQ;
M^(-(N7M_#=U&+33K!HF6(HO$K>8P!5@, @'.[WJU<V2:=X7^'\MM+8:?:CRY
M)[F[M_,A$S6QV/( RY)8MAB?O,* /2YM;TJWTU-2FU.RBL'QMNGG41-GIAR<
M'\ZY_P 7^/+'PU8:;+;R65W/J5Q'#;K)>+%'M;/[UGP<1C'+ 'J*Y*.>UT^+
M3436=#EBN]2O+J/59[-DM;9E0!TB0R8)8ER&W$?>QFLN-K>Y\+>#4)AE>+QF
MT3@1;"H,MPP4H<E!@@[3T!% 'I^D>,-(U74)=,2_LVO[>".698;A9(R6!)"-
MP6"XY.!P1ZUH6^O:/=V<UY;:M8S6L!Q+/'<(R1G_ &F!P/QKR_Q&(8]5^(ME
M;F"*]FL;1H80!ODB"-YNQ1@L-H.0*@U]()_#/BR^@\0:3J+#0UB>+2K(Q1JN
MXF,LWF.-P&X <'!]* /7[6^M+Y9&L[J"X6*0Q2&&0.$<=5..A&1Q5BLJT?2]
M#@TW38_)M3<_N[>)5QYC*FX].^U2<GTK5H YG5_%-]9>)5T/3="EU*X^QB[=
MEN4B"H7*8^;KR/UJ_I^KW3VK3:UIZZ.?,$<:S7<;B0GI@J<9SQCK7$>*9=.B
M^*RG4O$LF@QG1$VS1W4<!D/GO\N7!!]<"DUN31]0\-Z=9V?B'_A(83K]B)Y)
M+F.<J&E4;"4 &" >".YH [G_ (2GP]]E6Z_M[2_L[2>4)?MD>PO_ '<YQGVZ
MU/?:YI.F9^WZI96F I/GW")@-G;U/?!QZX/I7!7FEV#:_P#$5FLX"1I4 &8Q
MQF&7./3.U<_[H]*I:)>:);>++.?79K2/=X3L@DMX5"')D+C+<9([=2 ?>@#M
M[SQ*MGXOT+0H;:.2'5()YA<+)P@C4$8 &#G/7-::ZYI#ZB^G+JEBU\@)>V%P
MAE4#DY7.17D_A>.6/7_AHLBLO_$OU Q!P<B,X,?_ (X5IVGS6#^"/#.F0O ?
M$\>L0&6 $?:$G6?,[N/O ;=Y)/&#[B@#UH:AIZ:<+\7=LMCMWBX$BB+:>^[.
M,4TZOI@U,:8=1M/[0*[A:^>OFD8SG9G.,>U>916<HUX?#@QM]ACU+^U!Q\OV
M#/FA/IY^$^@J"UMS/J5U97NOZ59W@\2-,MJU@SWK.)]\9#"3.UH]HW;,!"<\
M F@#U5=7TQ]3;3%U&T:_5=S6HF4R@=<E,YQ^%4O%/B.T\*>';S5[PH5@C)CB
M,@0S/@D(I/<X]^]>;Z% 9[RRM+W7]*M[^'7Y9FLQ8,UZT@F=B"XDSM:/^+9C
M:PKL_BBB/\,O$&Y5;;9N1D9P?6@#1\,>(5UW2[>>:73ENID,@@L[T7&$&.^!
MR"0#Q@'O5^76M*@@$\VIV<<1+@2/.H4E,[^2?X<'/I@YKB8[W3M#\9^'[F^N
M+:PM9?#\L:2S.L:,X>%B,G SCFN>T6&UU67P.)X1+;R:SJ\GERIP</,RY4^A
M .#Z4 =IK'Q&T:QL];-C<V][>:7:"Z,*SJ!*""<*023@#GCC(]:Z2TU?3=0N
M)[>SU"TN)[<XFBAF5VB/HP!R/QKR?Q<]C:W7Q,M6:WAN9=+MFMXCM5W41/N*
M#J0.^*V/&.FFTUO[-HENL-P_A?48HE@7!8@P[ ,=P3Q[F@#OK;7-(O(KF6UU
M6QGCM<_:&BN$80XZ[R#\O0]?2IK34;*_,HL[RWN3"VR3R95?8V,X.#P<'->2
M[+6YT74KJV\0:1=F'PO=1"UTRQ:+;$4&WS&\QP"I7 4X/+>]>C^#[*VL?".D
MQVL$<0:SA9MJ@%F* DD]R3R2: +\VL:7;ZC%ITVI6<=]*,QVSSJ)'^BDY-,G
MUW2+6[>TN-5L8;F-/,>&2X175?[Q4G('O7E?B_4X7N->;[3I=E)!JML&MO(+
MW<WEF%O/+E_D4+T(7 "]<FJ?B"[T3_A!O&EI>R6SZS)JT\R1Y!G92ZF)U'79
MY6.1QMS[T >R2:MIL5XMG)J%HETSB-8&F4.6(W!0N<YQSCTI+35],O[F>VL]
M1M+BXMSB:*&=7:,_[0!R/QKBK.P6X\>>/;F&%'U"."U2VD8 M&Q@/W3VR0OY
M#TKD+.UEO?"UHNG:]IDFI6V@W20V%A8,ER,P[625O,;#!]OWE&6'K0![%9ZS
MI-]'.;'4K*X2VXF,$Z.(O][!^7H>M2:?JFGZM T^FW]K>1*VTR6TRR*#Z94G
MFO*H+;2-2LY9+GQ3I;6B:%)!*FDZ<R&&!BFUI3YCCY2.%('!?L#CK/!%^+G5
M=7MF?2+V6&.W+:GI2[8[@'?M5P"0'4#) )X<=* -O4]=-IKFF:-:P"XO+PM(
MX+;1# F-\C<'N54#N3U&#6@-0LC;I<"\MS#)((DD$J[6?=MV@YP3NXQZ\5S%
MOQ\8;_S?O-H<'D9_NB:3?C\2OZ5QEOJU@O@K0]'^UQ'4HO$L:RVH8&2+%^22
MR]5'(Y/'S#U% 'J<FO:-#=QVDNK6"7,LACCA:Y0.[@X*@9R2#QBLZQ\3?:_&
M6MZ"]NL4>F003?:#)]_S 2<C'&,>M<%J5E:CP'X[N_(C-Q_;4S"4J-P*RIMP
M>HQV^I]:B\2QW$OB7XD);9WG3; OA2W[L9+\#DC9NX[T >J6VN:1>64U[:ZI
M93VL.?-GBN$9(\==S X'XTS_ (2'1/[,_M/^V-/^P;MOVK[2GE9]-^<9_&O.
M);;2[]-7N;KQ=I+Q-;6<<DNF:>5@A*S[X7D/F.I&1@@D?*><#FFB]M+TF2;5
M=!L=1LM3S!J4,&ZPOI#;X(<%L*^PX^_D$<$\B@#U>">*Y@2>"5)89%#))&P9
M6!Z$$=155-9TN6Y:WCU*S>=4=VB6=2P53M8D9S@'@GL>*S?!-XE]X4M9X[2V
MM5,DR[+0YA8B5@7C_P!AB"P]FKSY=.3_ (5IXPN;6",74FLW?G2F+>3"MT/,
M! P2NP-E01GGUH ]3M-9TJ_LY;RSU*SN+6+/F3PSJZ)CDY8' Q4=OXAT2[A:
M:WUC3YHDC:5GCN49513@L2#T!ZFO+-;BBGTO7=037=,U2'9IZW\6E69CB$"W
M&XLQ$CACLWY&<A0,\8I_B>?2M4UOQ4VA-;W.[PE,KO:$,CN&.!E>"P7'X8H
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MQP",XQD5DWNM^)]+CM=.N8M.DU.^U!;2SNT1A"T?EF1I&BW%@5"L-N[DXYH
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M9IPC16W*BAL;<@=O2N%L/%'B!(?#VJZFNG'3=<FCB6V@B=9;7S4+1$N6(?H
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M?9;HCR%MP\SYSD!5 *@ CKCG5L_'.K:LNCVNFG3);F[OKJRENMKM!^Z0N)4
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M<&TF,32(&)<^8N%(. G-2_#:[UK4?!:7FIWL%Q---<&)_*8%<32##$N=PR.
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M)H/VQS TL<\MO));DF*0HQ&],\[6&"/3..:WJ "BBB@ HHHH **** "BBB@
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M,T@VQ1K)&5BE.>%4N),,>/G![U!K!EU :C?Z)+&MI>^*M/-C<%-T3R!8U>0
M8W+O'4==IYKV8@$8(R/2C  P!P* /*;46%EX:U#1->NWTS6K*_BNKG4MGF"9
MS(&BNFW9!C) !!X7&WC KH_"?B2V-I.;V?3W>XU3['!?V$)6+49#$K!P!GG
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M-O+$;IBT39(PWRKP"&QG@UZ5X9UJTN]-TRR^SK87S:;#=G3UC*B"-AM '
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M(-<7XC-MK%GXMOK(I<:1>:CI422Q\QSR+*@E*D<,,% 2.X]J]E(R,&D  &
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M4D.S_6K,$!.<\8">AZ^U &3%=>*;G0IKK5!ITMC>Z9+,5MD:-[5RF50EF/F
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MK6:;6"?GW,F?LTPW$9R<#)P",XQD=:+SQSJ>CVFH66I7&FK?V^JQ:>E\8F2
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MYD+>4[A_,+88$QGC:, CDXR>DLM N8O$)UJ[ODGN'TV.QD6.#8K,KLY<?,<
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M8P.1*V6;+Y /&%XZ5IZ/9:U;S32ZQJ\-X654CCM[7R8UQG+'+,2QSSR!QP*
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M#S%42D'/.XHIZ#I4>G>!&LM"TJQEU0W%S::F-2GNC#@W#@L<8W?+P0,Y/W:
M(?\ A)=;L8O$=G?W6D?:]+-NT=[(C00;)N[J68Y7#<!OFX'&:Y_6/%VM7_A/
M5ELM5LS<6.I6</VZWMI(Q-'*\?12^5(+8/)! (XSD=7JW@N34-0U*_@U!(;B
MYFLKB$/!O2-[<DC<-PW!L].,52O? 6HW]KK*W&NQM/J;VUP9!9X$4T+*R[1O
M^YA%&WKWW&@!9/$NLP^+?[&FU#1K>6)H%2"Y@DB.H!E4R/"Y<A<$L F'.5Y/
M.:KW'B_7ET:]\51?8/[$M+QX?L;0N9I(8Y?*>3S-^ V0Q"[2,#&:T]1\+ZYJ
MX%MJ&N6DMC)+#--&+##HZ%21"WF?("5S\P8C)YZ8@G\"W<EO=:0FKQKX>NKP
MW4MJ;7,PW2>8\2R;\!"V?X<@$C- &7J'Q'EMM:OME]IBV]C?K9G3GC8W,Z[E
M5Y%<-A2"20NTY"]>>-"?QM?V?ASQ"]Q;V[:WIM\;&"!5(69Y"OV<XSG#!TSS
MV;I6FGAO5;/5;I]-UJ.UTV[NQ>3P&UWRA^-ZHY; 5MO.5)&3@\\1ZAX)BO\
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M%'J\D7AZ6W*6UD(HXU/S*K$$C>,-\AY )H ]*_X2SP\(I)3K5@(XY7A9S.N
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MKJEI<7F%W 0K*"Q([@<$^PKCM>O[#5[KX@WFELD]O)X:C'GQ#*3,//!*MT;
MPN1_=QVH ]&?Q1H]C!8+JFKZ=;W-W$DB#SP%DR!RF>2I)X)J:[\1Z)8ZI%IE
MWJMG#?38V6\DRAVSTX]^WK7FE]>VNDZ/97<.IV\.HR:!:QRZ7J%KYD.IQJC%
M8TZ'?EF7"Y^\,K6A;ZKHVF7'B?3O$=H9+V_U))H;#R]\MU&T<0B$8XW;2I'!
M^4J>E '4Z5XJ-YXC\4Z?=K!;VNBM"!.SXRKQ[V+$\#%:-AXFT+5+:YN+'5[*
M>&V7=.Z3+B)<9RWH, G)XXKR_5K::?4_B6$@DEC6]TN6:-%+%X4"-( ._P H
M;BM36;K1/$WB&^N[6Z:XT>+09;>_O+!?,VEI4* $ @LH5VQS@=1S0!W5OXIT
M"ZTR?4H-8LI+*W.)IQ,NV,]@Q[9R,>N:N:=J=CJ]FMWIUW#=6[$@20N&&1U'
M'<>E>2ZAJ5UJ,+2KJNGWUKI^HV4TVOVEF"K)B4 2J"58QML8D' #@X&*[CP.
MD$AUC4+?61JJW=VK/<1VPBB9UC524P2&& H+#N#0!;TKQQX?U=]5$&HVZKID
MC).[RJ!M 4F3.?NY;&3W!K2TK7=*UR*232]0MKQ8R%?R9 VPGID=J\LNIX?L
MOBBRD.][;Q3%J%Y: $N;,/ 6?;U*\9^@-=;HU]::W\2KS5-'GCNM/328[>>Y
M@.Z-YO-9E4,.&*KG..FX4 =%JGB31-$FCAU35;.SED&Y$GF"DC.,\]L]^E5+
MCQCHMMXGMO#[WD0OKB S(/,7'50J]<[FW9 ]%-<Y<ZII>@>,_%;^()8X4O[:
MW-IYP_X^(EC96C3^\=^[Y1S\PXYK)\,E]"\0^#X-:?[-/+X9-H@FX)F\R(B+
MG^(#M[4 ==X4\<:7XAT_3%EOK*+5[NW$S623 LI(R0 >>G..N.:V(/$.C7.K
M2:5!JEI)J$>=]NLH+C'48]1W':O.='MD@\ _#;RX0C#4H&.%P06CEW'\<\U!
MX3A$DVA:7>^(5&I6%_+*^F1V(\Z.0>9O9W!R$8,?F(PVX>M 'HJ^+_#C1SR+
MKFGE+>-996$ZX16. 2<\9/ K0T[4K'5K-;S3KN&ZMG) EA<,I(X(R.XKS+P_
M::;!\'-)DN[I],Q=F<7R1!O)F$[%7D!&-O !W<8QR.*Z3PEXDMWLF^W36327
M6IO:6][96[)%J#^6&\P 9P<!E)R1F,X/2@#J-2U2PT>T-WJ-Y#:VX(7S)G"C
M)Z 9ZGVK/N]>A:/2+C3M0TM[6^N5C$DT_P#K5(/$6W(9^.GL:PO'YFM]4\-W
MYU!-.L[>YE$MY+")(X':(A&8$@ ?>7<>A8>M<M=VT20^#YK6_?4(;GQ6;@3_
M &?R5)8/N*+_ '2P)!'!SF@#J[WXDZ4UCJDFE3P7-QI]]!:R(T@PRO)$C.,'
M.T>81GU4UT6G^)-$U6*YEL-6L[F.UYG:.92(A@G+'/ P#STXKR_4IK632O&N
MCS,ANG\26\[6K?>:%I;4;L?W3TS6CX\L[BXUSQ!%9QMN;P_;LXCCW%D6Z8L-
MO\7R!ACOTH [VV\4:#>V$U];:O92VL#*LLJS*50D@ $]LY&/7-6]/U2PU:V-
MSI]W#=0!V0R0N&7<#@C(KR'Q&+75?#7B74(/$*:TS6=I;RM;6@BB ^T!E&Y2
M07&6XZ@$9KU;6K20^&-1M-/C"2FSECMTC&,-L(4#TYQ0!D2^.-,GUS2-.TF^
MLK[[7=O;SF*8,8@L4C@C'O'CTZU;LO$MHFG2W>JZII$:"ZE@26"XS'\F3M);
M'SA5)([8-<)INK:-J-]\-K;3BCW%D6BG5$YM3]D<&-_[K%AT/)VDUE:/:K<:
M3HT4\.]#XXG8JRY!P)2,_CB@#U:7Q9X>A%F9=:L8_MJ"2VWS*/,4\!AGL3QF
MI=0\1Z+I-[#9ZAJMG:W,V/+BFF568$X!P>Q/'UKSOQ.J6_B?Q1;:EKD>F6VI
M6D*11/9"9KJ+RRA2+G)8-N^49.6![U9%]I'A[5/%-EXF#7)O8K;[/%)%NDOX
MA J;(U_B;>'^7/!;/&<T =%?>/\ 2HV\1V=E<0S:CHUI).T+.,2,J,Q48.>"
M &],UI^&_$$&NZ/IT[20)?7%A!>36R/DQB1<@XZXSD ^U<)J%W;P:E\2[&1A
M#<W6DI+;V[\.Z+:,"0.^#P<=ZA>YD\*>$/!?C*&!Y1;Z/#87D2 DO&\2F/\
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M/;&.0?:@#OLC.,\^E!(&,D<]*Y>74)!XVM[.32+0:DVDS3178N"0 )(P8ON
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M,,RN1O:(E,2!!G/3.#TXR =9BBBN2MO&4]Y=V#6FCW%QIUY<M;BXB20M& 6
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M!?D;8THZH),;"W!^4'/%8&B>.9]>^(6I:-;R6\6G6)1%5K28S3L8RQ.\D+&
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M6X)FB6-V,8$8D). <#:0<].<=: +.CQZK'<:E_:-W]I@:Z9K3, C9(_[O!Y
M/ 8\GD],5E:+X2O=#NVAM]>F;1!.T\.GF!=T99BVSS<Y*;B3C&>V<9!VY]9T
MZVMK*XEND$-])'%;,,GS6?E0,>HYI=5UG3]$M5N=1N1#&[B-/E+,[GHJJH)8
M\'@ ]* .=/@>8Z7/;?VJHG;6/[7BE%MPDGF;]I7=\RYXZ@TM]X)GOHO$L<FJ
MKC784AD;[-S$%39D?-@DCV'/Y5J#Q?H']DC5#J<26?GBV,CAEV2_W&!&5/U
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MI%#HZG(92,@@^E/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH;_L5[;7.S&_R95?;GIG!XZ&K5 '*^"K^.#P[X;T2>.>.^&AV\Y5XR  J(C
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MXAZA<Z9X"U:XLY#'<M&L$<@ZH9'6/</<;L_A5VR\,V.G:VFIVI>,QZ='IT<
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MZR>VL_M$D<4,;F61%"DN6=&49!  SCBKWB/0?[/\%7?A[3[/4-3O]6>1_M1
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M!V7RV (3'S*2#CGJ_!FJ:AJ$.HPWWVZ5+:X"VUW>V36LD\913DH549#%ER
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MB6)HVQ[JP##Z$"O'=4L[RZTWQFEM;ZY>K>65E+:2WEL_F7"Q2MOP-BX(SPI
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MVF(6UO)/^YX_>-L4[4Y'S' KG/#]O/-J/B.[^QW*1W.DV21-+ Z%R(Y0R@,
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MF..@!QS7.>(].:'Q/XA^W3>(DM=4@B$$6E6XE2Y C,;1,3&P5N/XBHPV<]:
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M.>!HVCG5=_EN"/E)7D9Z]JTX]7LY=;GTB-V:\@@2>50IPBL2%R>F3M/'7 H
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MP,+MQQQW.<Y-3'PS&[7-Q)J%XVH3I%&;T;%D1(WWJJ@+M W$D\'.>>,8W**
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MV;$9F!P%!SEF[]Z?KFAVNOV4=O<M+&T,R7$$\) >&5#E77((SUZ@@@D5IT4
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M23K:V%W#9RZ$D*O<0-$0_GN2A##(.,''I@UV5% 'E/V'4O\ A#/^$(_LF_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOJ,G'MGM6-'I$NDZ'X]TB>"\N]2DL9I(=0F9YI+R!HW$:[CGYD)*;1CL<<T
M=E_PEVDV&F:5+J.IPM->VRSH\$+D2+M!:0* 2J<@Y;IGDU0O_'=C;ZGH3P7<
M$ND:@EWOG5&=F:(JH" <GYBPP <XXKG_  _*WAZ_\/7VI6=Z()O"UK9QM%:R
M2E)D.YHR%!*DAAUQG:?2JO@>U>3_ (0:86;1QP#5\C;D0DS8 )' [C\Z .NU
M'XB:%8V.EWL4SW,&H7?V5&CB?*$9W[AMR",?=(!K3C\6:)-JXTI+X&[+F,+Y
M;A2X&XIOQMW8_ASGVKSZ]BFL8$O)[6Y%O;>-GNI66!V*Q%7&_ !)7+#D#O6E
M;W?V;Q;'%HLNI%;K4F>\TJ]L28T#9+7$<FWY >&'S$'=C )P #TBH+R<VMC<
M7 4,8HV< ]\#-1Z;J$6J62W<,<T:,[IMFC*-E6*G@]LCCU&#1JBE](O54$L8
M'  ').TT <WX*\:MXI\.RW=S:+::E!$LLUKNR-CIOC=3W5E(_$$=JFT_QOI[
M>%]$U759!;3ZI;+,EO#&\SDE06VJH+$#/)QQ7+KI5_IG@7PUXCT^TF;4+'2(
M;:^M%0[[BV,8W)MZ[T/S*/9AWJ+PRS>'/^$3U35;>YBLSX<6R,@MW?R)@R.5
M8*"5W =QU7% '6:CX_T2Q;1&CF:YAU:5DBEA1W"J%8EN%.3E0NWJ,^QK2?Q5
MH<>E6NIOJ,:V5U.+>&4@@/(6*[<8R#E2.?0UYW#%/IB^'=9O+.[@L6\0WUYL
M^SNSP0S+-Y99%!9<D@XQQNYHN/#=YJFO:QX7-M,EA:F]U"TG*D1^9<1J(PIZ
M95Y+@^V!0!W7B7Q+:Z597L<>JVEG>6J0RR/<PO*D:22;%+!<'YB& YZ\]*SM
M9\?VMI=>(M,M$8ZAI6G-=HTD3F-I DC;3P!@; <YYW8'2N'UF#4M?^%OB37I
MM.NDO]6NK,+;&%O,6.%XEQMQG[PE;Z'-;GB/?#XB\<VSV]P9-3\/HMGL@=EE
M9(Y]P# 8!&1P3W% '6Z+XRT;5O*MUOX_MGV;SW4HR(0 -Y1F&U@">2"<54O_
M (C>'K70=1U2WN6N?L4'G>2(I$:0'.TKN7E21C>,K[UFZC8G[?X05M/GGMH=
M+NXYH8DYP8$&SL 3C !(YKF[TWM[X2\0Z3I4VH:MIRZ*XA-Y8F.XMG! $&[:
MOF97)Q@D;1DG(H ]!G\<>'K2VMI[F^:);B(S*#!(2J X+N N47.1N; XJ;4O
M&&@Z3.\%Y?A9DB69HXXGD;RVSA\("2ORGGH.^,BN&U[59M9>ZBM9]4@M[C2%
M2Q2ST_Y[Z0F171W>,E54A>/EX8MG%:G@N)IM?ENS;RB-O#VGPJ\L3+\P,P=>
M1U!QD?2@#I[SQ;H5C%9237ZE;V/SK?R8WE,D> =^$!(7!'S'CFL31O%\^IZ;
MH-W-?Z?;MJ%]<0!/)=OM"I)(JB,AL*<*"2<@\US'A"9O#4GAR_U:UO([>7PW
M%9HRVLDA299"Q0A5)!(9<9'.VJ^EV%Z+#X>YTZY@\G6KQY8FB(,"EYB-WH.1
MSTH ]$/C?PX+U;3^TT\YK@VO$;[5E#E-C-C:K;@0 2,]J74/&WAS2KNYMKW4
MXX9+5=TY*.5CXW ,P&T,1R%SD^E<;/I]P/ASK<2VDOG2>(I)0@C.YA_:"D-C
MJ1M&<^@K-\3W*Z9X-\?Z/>6-V]Y<W5Q=18MG,;Q.%99/,QM 4#')SE<=<4 >
MQ AE!'0\BJ.K:SI^AVJ7&H7'E([B- $9V=SDA55068X!. .QJY%_J4_W17*^
M-KRXM9]& GN+.S>X<7%];6HGEA_=MM"@H^W<>-VT^G>@#1?QAH$>GVE\VI1B
MWO"RP,%8F1ESN4#&=P((VXSGC&:=9>+=#U 6AMK]6-W.]O"K1LA,J#<R$, 5
M8 9PV#7G_AJVN'UGP^DUM?%[?7-2EE:[@*NHDCD9'?"A<D,#QQDXJ[>Z-=W.
ME>,KBWA:.^L]<&IV#,I 9XH(6&/4-AD_$T =1XH\<:3X7MKIKB1IKJW6)VMX
MT8D"1BJY(! SANOI[BJ'_"P=/MO$&HV]]<"+3XK2VN+=EMY3*PD\S>64 D*-
MB\D#&>>HKF+Z"XUGX8^(/$RVD[7&MW,-W'$J%I%M8Y8Q&,#_ &$+\?WC72Z4
M4O\ QCXEU*&&1K:YTNS$,KPLF\?O\@;@#Z9'TH V9-=A;7M)MX-3L_L]];23
MI#Y;-).H (='!VA0#DY!SGBFZ?XV\.ZI>6MK9:DDLMVNZW(C<)+\NXA7(VE@
M.2N<CTK@M!L+U-6^'#/:7"B#0)HY2T9'EMY: *WH?8U>TO3[B+P3\-8OLDJ2
M07D#3)Y9!C_<2[BP[<GG/<T ==_PF_AS[<;/^U(_.$XMA\C[6E+!-BMC:S;B
M 0"<=\5T%>,_:5M?!WASP_<V-VNI6.O6PN/,MG5(S]J_U@<C:V[=Q@DG<?0X
M]FH Y_5O%]AH_B72]#N%E,^H*[*RQLP0# '0'.2<>W4U(GC'0'U4::NHJ;DS
M&W!\M_+,HZQB3&PO_LYS6/XHE^Q>/_"-_-'-]E1+R!Y8X6<([K'L!V@XS@\G
MTKEX!*W@>P\&BTNQKT.IQ>8#;.%0)="5I_,QMVE03G/.['6@#URN?U?Q?8:-
MXETO0[A93/J"NRLL;,$ X'0'.3Q[=3Q705Q?BB7[%X^\(W\T<WV5%O('ECA9
MPCNL>P':#C.#U]* %\-^/].U&UM8=2NXHM2GNIK=42)Q'N65U12V"H<JH."<
MG/ Y%;?_  E6B?VS_9/V]?MGF>5MV-L\S&=F_&W?CG;G/M7#6^GW*?#C2(A:
M2K,OB*.5D\L[@/[0)W$8SC;SGTJO8::PU)]'U'4M>%P-=>[2Q@LHS"P^T&9)
MO-,6=F,%COSU7T% 'K-9>L>(M*T$0_VE=>4TV?+C2-Y'8#J0J G R,G&!FM2
MN+UJ[30OB!:ZU?QW']G2Z6]HLT4#RB.42J^"$!(W#H<<[<4 :]WXQT"RAM9I
M-15TNXO/@^SQO,7C_OX0$A>>IXIUUXNT&SBM))=1C9;R$SVWE*TAF0%<E H)
M;[R\#G\C7)Z=J-OHGB=M9OM(NM,T_4-*A2UC6T9O(9))6:(K&#M9@ZMC'/(Z
MBJ_@_2+VRU?PF;RREA,>FZC)M=/]1YEQ&Z(?[K;&QCV/I0!T=_\ $/0K.+1I
MXIGN;?59VBCDBB<[0JL6) 4G(*[=O7GV-:"^,?#[WMU:#4H_.M%D:X!5@L(C
M)#EFQA<8/4\X.,UP!272UTB_NK:Y2UM?%E_+*RP.Y2-S.%;:H)VDL.<8Y%:5
ME'?:=X/\<W%K8%[J75[R6-)+<OYBDJ-VPCYQMR0.^,4 =7!XS\/W.GWM\FH;
M;>Q027)DADC:-3T8JRAL'!P0,'!J73O%6B:K>K:65\LL[B0HOELH<(5#%20
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M3T ]: )U=6+!6!*G# 'H>N#^8IU>:^$+Z72/'-UIEU<32+KL U!3)&ZJEVH
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M(8SA3V!R,_2J]IXR\13Z9H>HO;Z7Y6HZC)IS0@2!E8/*JN&R>/W8RN#GU'0
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MYI986$9Q.V/D#9]OO<=>>E '0?\ "'VG_04UW_P;7'_Q='_"'VG_ $%-=_\
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M=@P!G/'6IM6^(NGV/AZ\U.WM+V6:TN8[::UDMI(Y(W<KC>I&0"&!!Z'('4T
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MZ@S9C.)"NPKC9@H1C@\\=0:C?QSH<.G2WMU-/:)!<1VT\=Q;O')$[XV;E(R
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M#9]IECMW>*VW_=\QP,)G@\GH<G H >?"\(U6VU*/4+V.Y@L_L1*F/$L>=PW
MIU!YXQ[Y'%5;#P19Z?%H$<5_?%-#+_9@YC.[<I0A_DY^5B.,58F\8Z1!K!TU
MWN"ZSI;/.MNY@29@"L;28VACN7C/<#J:H:9X_L+Q-<FNK>ZL[;2KHP&66WD
M? 08^[]\LV @R>GK0!O:YH]MK^B7FDW;2+!=1F-VC.&7W!.>15!?"R#5FU-]
M4OY+IK'["S/Y6"FXMNP$^]DD^GMBKFCZ[9ZVLXMA/%-;L$F@N86BDC)&1E6
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M!YMXWT;4;VZ\8&VL+B9;K1+6&'9&3YKK+*2H]2 1Q[UTK65Q_P +0BOA;O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX0Q!SDXQR,5-XTTZ6_TVSDM["ZNY[6[2939W*PW$(PP+QEOE8X.-K$ @GVH
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M+S8  TF!G)  )7;D<5'JO@/3-6N=1DDNM0AAU)0+RVMY]D4S!=H8C&<X Z$
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M*[?PC@3\#5]-/UFUT72YKFUU9(]1O[F]U6#3G*W"M)DQ(2I#!0-JG!_A&>*
M.GG\>Z-!8:?=D7C_ &^62"&%+=C+YL>0T93J&RI7'K^=5M=\=6ME8ZE';07_
M -KM;+SY9%M2RV;-&602^AZ$CG Y.!7-Z!H>JPZIX<6?2KR%;'6M1GF,SF7:
MDL<IC8R$DO\ ?4;LDYJ[JD.JZ;=^-+*'1;V].MIYEG-"H,9)MUB*NQ/RX*YY
MZ@\9/% '6V>LBW\$0:YJ+LRQZ<MY<NJ\G$>]B /QXJOIWC72M2OXK18[RW-Q
M"UQ;2W-N8X[B-<%F1CUP"#VX.>E4-9@EM?@Q?V\Z&.:+P](CHW56%N00?QK&
M7^V=;N?#TMAI%U9S:183N9;E%6(S/!Y<:(<_."3G/3 &>>* .GTSQCIVL2F"
M&.^MGDMFNK=[FV,8GB& 73/4#<O!P?F'%4=+\:6*^&M$N3<7^KW&I*YM_*M
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MW."HYS[>M<!XHTBXD\?QZ+;*#IWB98I]04'[@MB"YQZ2*8TKM/%G]ICPK?\
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MT8&J6C^&M+T*:::RAF,\RJDDUQ<23R%5SM7=(S$*,G@'%:U% !1110 4444
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MAFMWDMI(X[@+]XQNRA7P.?E)XYZ4 ;]%<U!X_P##5U87-_#?LUI;(K23?9Y
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M<6LL3+&3@.%9064GN 14MCXPT/4;BX@ANV1X(#<MY\$D(:$=9%+J R?[2Y%
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M44 %%%% !1110 4444 %%5K_ %"TTRW6XO)A%$TB1!B"?G=@JCCU8@?C5F@
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M!LUO=4NP9/-U.)(I_FXVHI4;>..&-4K7P=I=G?:7>1&?S=,T_P#LZ#+@CRL
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MFBU:**RFMCL\N-6MF9&C 7*E-@YR<\YKTR>UBN+&6T?(BDC,1P>=I&*Y[3?
M^G:1/831W.HW,6F1E;*UGG#QPDKM)48!+8R.20,G&* .>LO$>L:AI.BZ ;MD
MU[^TVL=0F4 ,([<[Y9!V&]/+_P"_M:OQ7C=_AKJY2XEA*HI)C(&X%@"IXZ<T
MOAG0YIO&&L>+;W3)-.ENXTM[>WF=6D"*!OD<*2H+;4& >B#-='K>CVGB#1;O
M2;X.;:Z38_EMM8=P0?4$ T <4-#NKKXB:G91Z[J-N(]&M-UQ&R>=(WFS[2S%
M<8'/  SQ^.1:>*M9UVVT*&6760TFB17LTFCPQEWF=F0,V[@*-A.!P2W/ KT7
M3/#UOIE_)?\ VJ[NKN2VCMI)KAPS.J,[*3@#G,A_2LU? FG6]EIUO8WNHV+V
M%L;2.XMI@LCPD@[&)4@\C.<9'8B@#5\.7&H7?AO3I]6@,&HO OVF,KM(DQSQ
MVR><>]:E06=I%864%I &$,$:QIN8L< 8&2>2?<U/0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7->
M-M7U#2--T\Z9-;PW%YJ,%GYL\1D5%D;!;:",X^M=+7'?$C3I-2T/3D73)=2A
MBU2VFN+6.,2%XE8EQM/!X[4 7M-C\0V]T9M3\0:;>VB(S/#;:>8G/'7=YK?R
MJE!\2=#N%LGCAU(Q7\>ZSD^QMMN&P#Y:>K?IP>>*IZ)#H<-[(FE>!+S2+F:"
M2/[4=.CA4#&=I93GD@?CBJ^DZ)J,.E?#:*6RE5].'^EJ1_J?]$D7YO\ @1 ^
MIH W#X^T5-+COY1>1!KXZ>T#6[>:EQ@G84&3D@<8SG(]:R/%GCIT\ ^(=0T8
MW%CJNEB,/%=VX62(LRX)5L@@J3@\C\JQM8MK[2[K[1)82R&7QHES#$,!IH_L
MP&5R<$_*V.G(IOBC2-6\1:#XZOK32;R,ZC!9VUG;S1[)9?*8EFV=0/GP,_W:
M .XU#Q?8Z9<?9&M[Z\N8K=;BX6SMS+Y"'.&?'3.&P!D\'BK>G>)=,U74#96<
MQDD-I%>QMMPLL,F=KJ>XR,'TXKG-]_X:\3ZU>G1KZ_AU.WMV@-I&'Q)&A0QO
MS\O8@GCD\\5SVJZ1JW@SP=X4OK)4?6[*#^RGB##$AG7"J#WV2B,_0&@#MCXY
MTIXHVM8;V\DEFGBBBMK<N\@A;;(X']P'C/<D8IMSX]T6!=.\H7EW)J,#3VD5
MK;L[R*I4,-O4$;N0<8P<]*YS4O"?]AW6@-#'K$VGV6FO8R-I,K),)-R,'8*0
M65BK9]\$U:T70)[+Q-X9GATRZMK.#3;SS!<2^:\,DLJ/M=^['YC^= '::IJE
MIHVESZC?R^5;0+N=MI)ZX  ')))  '4FL>/QMIA@U%[F"^LI=/M&O9K>ZMRD
MAA )+J.C#@C@Y!X.*7QQIMWJGA:6*QB\^YAG@ND@R!YOE2I(4R>,D*0,]\5S
M&NVNH^*)M<U&UTF^MXD\.7=A"EU%Y<D\TN#M5<YP-@&3U+<9H [?0]=MM?M&
MN[.&Z2WW8CDGA,8F& 0R9^\O/7O7*ZKXX71+'Q/>QS7.I2:==1P?9C;!%MV8
M# W#EEYZGN<5U^BPO;:#IT$B&-XK6)&0_P )"@$5YIJGAS69M+^(RQ:=.[WU
M[#-:* ,SJ@0G;Z_=- ':W'C73[698I;/4MRQ)+<;;1F^RJY(4RX^[T)P,X R
M>*Z2O-_$;7MY>-J>C:1X@L=:EMT^R7$(Q%.03B.Y0G:H4DYW#.&X/:NK\83Z
MK!X5O5T6W>;5)E$%N$_@9SMWD]@H);\* .<TWQS?W?C%$FB@'AN]NI]/L+@*
M=[3Q $DMG!5R)0N!_!3?$OBO58?B)IGAZQ%_;VOD/<3O;V2RM/@K@+NR-@R<
MD<@U5U#X87MOX.CTW3O$VIR/IZK/86[QP",3Q_,G(C##YN^[//.:T+:WU34O
MB#X>UV?3)[:+^Q94N0ZX\F9F0[#[\'\J ,;3O&^IZC+XNO[R\U'3M/TUIHH5
M73D98 BJ=S%LDR<GY#Q701^(;Y_'WA_3(KLR:=>:.]W)NB56D<%=K'C(X/0<
M5AOH&K'P=\2+46$WGZCJ%U):1XYF5HT"E?J0:T+'1M1C\=^%;Q[.46UKH+6\
M\A'$<GR?*??@T :&C^,;/_A%M/OFNK[5Y+R>6& QV86:9E9\C8N  H4\G' ]
M327?Q MDNO#R6-A>74.K32QL5@.Z/RU?<NW^^'7!'8 FN4T#2]=TGP7X<L+R
MRUF*T6YO#?0:<Q2?+2,8<E2&"'))((_ASQ3],T[5M*7PU//HNI,-,UC4&N(U
MS/($F$I1PQ.7'[Q<MGKG- '=1>,M+EU9;%5NMC7#6B79@(MWG7.8P_KD$>F0
M1G-.TOQ;I^KWRVUO#>JL@<P7$MNRQ3A#AMC=_P <9'(S7&:-X;>UU&WTV^T_
MQ!/-;ZH]RL@NV%B$$K2I+C=MSRN4QG=GZUH>&[>^M?$UNFG:?K&FV#><=0LK
MM@]K$W53 Q]7YPORX)X% '6:SX@M-$-K'-'<3W-VQ2WMK:(R22$#+$#L .I)
M 'XUFS>/=$M])@U&1KD)+>&Q\G[.WFI< ,?+9.N[Y2,=\C&<BHO$D-U9^*]#
MU^*RN+VUM8;FVN([9-\D?F;"KA>I&8\''/(KG%T+5;J6RU%]-GB%UXL74C X
M&^" 0&,,X!X)*@X[;AWH ]&M;Q;G3X[QXIK='C\PI<)L=!C.&'8UA6?CK2;Q
M)G\J^@1+-[Z-KBV9/M$"XW/'GJ.5X.#\PXYK<U+[7_95Y]@V_;?(?[/NZ>9M
M.W.??%>4C3-5N)H;D:9XAE>71+VSGEU"5Y&^TNB' 0L0BDH1E0 3@=A0!W,/
MCO2KC38[Z&WU%XIY5BM%%JVZ[8J6_=#^( !B3P."<XK8TC5[76['[7:^8%#M
M%)'*A1XW4X964]"#7$:GH-Y_PC7@N5K?4<:7$B7<.GR&.XC#6^PE=I!.UL @
M<X)KI?!UA'9:3.\=G?VOVFY>=EU"8R3.>%#L221D*#@G([T 5KSX@Z-93WT<
MD=^\>GS>3>SQVK-';GCEV';GMGU-6I?&.F1^()-%5;J6[A"-,8H2T<2,NX.S
M=%7W-<-+/>S:;\0-$L]'N[N?4M1N+>"6% 8P[P1H=[9^0+D-D\8Z<UNV/AJ]
M.K>,;9T:..^TZTM+>Y8<.5AD1B/H2/SH V-,\;:5JEY:01Q7L*7P8V5Q<6S1
MQ76!N^1C_L@D9QD#(K'U/Q]'<2:0ND"[2*ZU:&U%U);8AN4WE7",?H>>,X)&
M<54M(-3UB+PAI4FC7M@^C2I->SS(%C4QPO'MC;/S[F88QVZXK.L+365\.^$_
M#K:#?+/H^IVQN[AD A\N-B-Z-GYL@@\=!G..X!WK>*],31KC52TOV6WNS9N=
MG/F";R3QZ;SU]*KWWC;2;#49K25;MH[>5(;F[CMV:"WD?&U7?H#\RYZXW#.*
MXR\M-87P[JWAV/0[^2X?7&NUG"#R6@:[68,&SR=O&T<CGTK:LY]7\.:AK=A%
MH-U?RW^IF[M9UP+<I($SYC_P%,-P1DX&,YH W#XRTL:M]@VW6T7/V,W?D'R!
M/_SSW_WL\>F>,YXK#\1>/HTLF&D"[5QJ4%FMX;;,$C?:$25%8\$XWC.,<'!R
M*RK/PV\.K3:=?:?X@N&?6'O$:.[9;+RVG\Y9#\VW*Y&5QDLOOFJ[6>LP^$(/
M"JZ#?27-IJ\<KW(0>2T(O!*)%;/)*D9'4?-GI0!W'CG5;K1/!>IZE9S"&XMX
MPR2%0P7Y@#P>.A-59/B#H\$=V]S#J%M]FMQ=%9[5D,D&X*9$!ZJ"1GH0#TJ;
MX@V%WJ?@/5K*QMS<74L06.(?Q'<.*R_LT_BKQC!<76CWEIIUKIES:7 NT"^:
M\S1@HN"=P 1LL..1B@#J+K6K*TU'3;%W9Y]1+BW$8W A%W,Q/8 8Y]QZUE^*
MO%9\-W>C0+I]S=G4+KR#Y,9;: C,<>K<# ],^E<W\.+*^N-2N;C4SYG]@QMH
M5I+G(D".2\GU*B%3[J:V_'$%W]H\-ZA;6-S>1V&J":>.V3>X0Q2)D+WY84 4
M;#Q]':3:RNKB\DAM-6DMOM$5J3%;1Y4('8#U/N>03QBMR^\9:7I^I2V<JW3+
M \<=S<QP%H;=WQM5W[$[E/? 89Q7+WVB:G-X$\:6B6,QN;W49YK>+;\TBL4P
M1^1_*JVI>&W.MZ[:7NG^(+N+5+Q9H197;1VTD;(BL),-A2I5LY'( QF@#M?&
M.K7.@^#=7U6S"&YM+9Y8Q(,KN XR*HZ?!XJ:XMI+GQ-I$T!96DACTPJS+U*A
MO..#CO@_2I_'ME<ZEX!URRLX7GN9[.1(XT&2S$< 5SVCP>&[2_LY+7X<7MG=
MJRA;H:5$GED\;MP;('/6@#7G^(NA6TDWFK?"W@O&LKBZ%LQAAF5RFUF'J>F,
M]1G&14W_  GFD1V>J7%U'>V?]F+')<Q7-N4<(YPK@'J#@_3!SBN<GT+4V\&:
MQ:"QE,\WB4W21[>6B^W*^_Z; 3]*K_$.PNT'C"^-NWV:;2+.*.1ONNZSR$K^
M&Y?SH Z:X\:6US8:M#:1WEIJ%OITMY +NV,?F( <2*&Z@'&0>>1D5!HOC,)X
M1\-W&HBYO=6U.R280VD&Z20A07;:,!5&1SP.0*SM5AU'Q+K-S>1:/?6D=IH=
MY:XN8PIEGFV81.3N V'YAQR,56T/3]3\-P^$=4N=+O)TM]#.G7<,$>^6WD)C
M8'9U(^0@XZ<4 ==IGC'2-6O;6TMI)A-=12R1K+$4(,3!9(R#R'4D97TYIMQX
MSTJ"2YB1;JXF@O/L(B@A+M+-LWE4'?:O)/ &#S7$ZCI]]HOA.?Q=+:M;W]IK
M4NKQ6LC /Y$C"-HB1D!FC.<<_-@=:L7/A2\L=#\,W,\>HRSV\\USJG]FR,EQ
MYEPI+NNT@L Y P.=OTH ZUO&FE_V?:W,4=Y/+<S/!'9Q0$S^8F=ZE#]W;@Y)
MP.G/(SJZ5JEKK.G1WUFS&%RRX=2K(RDJRLIY!!!!'J*\XG\-M$-(U:+3_$4-
MJMQ=M<QQ7;M>_O0@64X;=@^4,KDD;N>AKM_"-A'8:"JQV=Y:>=-+.T5[-YLV
M6<G<YR>6^\1GC.* ,VW\8Z=8Q:U<WNIW%Q!:ZJ+%@;4+Y#MM 0;>7 +#YNO-
M:^C>)+36[J\M(X+NVN[38TL%W"8W"OG:P'<':?R.:X*+P]JP&NAM/F_?^+[>
M]CROWX%DB)<>P"G\J[&SL;J/XBZO?- XM9=-M8DE(^5G5YBP'N R_G0!:UGQ
M/9:+=1VCP7EW=O$TWD6<!E=8P<%V Z#)QZGMFJL_C?25%K]B2\U)KFU%XB6-
MN9"L)Z.W3 )R .IP>.*I:JUYH?CE]<72[W4+.ZTQ+3%G&)'CE21V *Y& P?K
MT!7G%4[>?5M%\2SZW?Z#=R+JFFVR-#8 3FVFC,A,9Z<$2#YNF0: -F7QSHZB
MP%M]JO7U"V:ZM$M8"[2H" >.Q&[OC&#3/^$]T9K739HEO)GU'SA;P1V[&5GB
M(5T*]0P.<YXX)S@9K"\(>'-4TC5_#QO;4H(=(O%G92&6*66XCD$>1W W#C^Z
M:9X?T/4[;7]$GGL94C@O=8DD9APBRS9C)_WAR* .D3QMI4FE0WT<=X\DMRUH
MEFL!^T&9<[DV=B I)).,#.:5_&FE#3;:[C2[FEN9GMXK..W8W!E3.]"G8KM.
M2>/?D9XR[\.:BMRVH36FJ""#7[R9UT^0I.894"K(FT@D9 R!S@FK5OI4^D76
MB^(+31M7>WBN;LW5O-)Y]V1,JJLI!.?^6:Y7)(#?6@#7N/B':_;]"@L;"]N4
MU&>:&7$#!X6C5MR%3R'#*,@]!D^E6+/Q986T&O75WJ=Q<Q6.I&T\LVH#1N=H
M6&,*,R9+#!ZG-9>ISZO=ZKX5U^;P_>10VM[=>9;Q 23)&\3)&[J.A/!(R<9Y
M-9$?AW68DUZ\&G3.T/BM-4B@& US NW)3)P3C)'J5H [(^.=)BL-1N;M+NR;
M3E1[F"Y@*2(CG"OCH5)SR#V-6M*\4V.K:I+IR07MM=)"+A4NK=HO-B)QO7/4
M9XYP1D<5Q/B+3=4\3?\ "0ZI;:3>0Q2:=;V-O#<1[)9V6<R.VSJ  0.>O-=;
M)8W1^)5OJ @?[(NCRPF7'RAS-&0OUP"?PH U3K%HNN_V.S,MW]E^UC*_*8PV
MTD'U!QGZBLNS\<:+?Z#:ZS;R3/:W5TEI$/+(=I&?8HV^^<Y].:R/B-I>K3I8
M7^A6SS7H6>P?R^J13QD;S[*ZQM^=4[7PO>6GC^VL(K-U\.VTBZI'+_!YRP"W
M$?UXWT 3-X]73] M[V)KS6#<:S]@W_90A3]Z%9<+U(&0O]XT^/Q\NGZQXD34
MH;^6TL)HF AM"WV2%K>-V:0CI\Q8]SP>PKG[30M8L?!$/F:7=/-:^*1J#V\:
M9D: 7&[<J]^.<5O2:9?W6F_$)UL)U;5(LVB.F&DS9(F,>N[*_44 =X)HV@$X
M=3$5WA\\;<9S7%WGCN*YT_1]1TBYMOL=SJPLKDS*=RQ[G4L#D;<^7GD=#VKJ
M](B>#1K&*52LB6\:LIZ@A0"*\XMM.U&/PUH&G3Z3>B6P\0F>?,)9?+\Z5]XQ
MG*X=3GWXS@X /0[;7=)O=/>_MM1MI;1',;S)("JL#C:3ZY(X]QZU/8ZC9ZG
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M6D8M=-ETZ&65YA!,Y:0%CDLV2<$G)QGC/KFMB@ HHHH **** "BBB@ HHHH
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M) _&LG3_ !UX7U6^BLK'7+2XNI3B.)'R6.,\?@*S_BD9!\/;\Q!3)Y]KM#'
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M20@#<<GG XK"3QR^EZUXICO[;4+RTTZ[0E[:!66T@,$;$L<@D9+GC<<9[8H
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M5[<7D!E:]M%LY@7(!C5F9<8Z$%R<CGIZ5KURNN:]?6'C_P *:/ R"TU);PW
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MLKI(1<(EY$$\V(G;O7!/?J#@C(XJWK.L1Z-;Q2-:W5W+/*(88+5 SNQ!/<@
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MN>1BC3O$=EJFH?8H$N%F^Q17N)8RF(Y&95!!Y#90Y!'% %+4O!&D:G(KNUY
M3;+:3"VN7B%Q"N<))@_,.3[\GFKT/AS38#J/DPE!J$20S*K8&Q$V*%';"\5F
MCQWI\UCIMQ8V6H7TNH0M<0VMM$IE$2D!G;+  9('7DGC-9;>.&D\569L8;Z_
ML+O2#<Q6EO OF%_-VECN(VX&0<D#/'7% ':6%E#IVGVUC;@B"VB6&,$Y(50
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M69W=F*K@#"@G"@X&=H&<<T <5KWAO[)XEFNX](U>]L9]/AMH(M*OWMO+>(N
MCA9$^4AUPQSC!]>=30M GTSQJ)TL/LVGQ:!:V46)?,",DDA,88\M@%>3UKLJ
M* *FGW4]W%*]Q926C),\:J[ EU5B XQV8<@>]<UX@TB_N_B1X.U*"V9[.Q6]
M%S*",1[XE"Y[\D=JZ33]4L=5CFDL+E)TAF:"1DZ*Z]5_#-7* /.Y_#^JMX!U
M?3ULW-W/KCW,<>1EHS?"0-U_N#-=QJJWC:/?+IS!;XV\@MRW02;3MSGWQ5RB
M@#R.+0M5DN%N(M$UD&;0[RQFDO[SSI&N76,@D-(P524(!7&3V P:ZF/1[\7O
M@5S;-LT^"1;HY'[HFWV '_@7'%=7?7UKIMC->WLZ06T"%Y)7.%51W-"M;:GI
MX:.036MS%E7B?AT8=0P]0>HH \Z\':/.GC:]T]]K:5X9EF6P*G(W7.'V_6-"
M4^CUUWC72+C7?"&H:?:#=<.JO&GF%-[(ZN%W#[N=N,]LUHZ5H]AH=D+/3;98
M(-Q<@$DLQZLQ.2Q/J235Z@#@--\+V6L6VLPRZ+J]E'>67V,W&JW[SRMG)(56
MD?:%."#D9)X'&3FV7A;Q#KWA?Q%/K=O]GUN]L8]/MT>0$;8DSG<#P'E+GZ8K
MU&B@#RN]\.2ZEX>UXV/AW6H+Z32WM8WU/4GG=W8@M&BM(XQE5.[(SV[UT^M:
M1?7GBRRN88";=='O+9I,@!9':+:#]=K?E70WVJ6.F&V%[<I";F98(0W5Y&.
MH_&KE '%>#]1O-*\.>%M%O\ 1[NUN#&+"0S% $>*#=N&"<JVP@'VK;\8:?<Z
MKX+UO3[-/,N;FQFBB3(&YF0@#)]ZV"B,ZN54LN=I(Y'TIU '%:!:ZA<>*-.U
M2?3+FS@30_LCBXVAEE$JG& 3U )^E<W;^%;^RM]%O+[3-5F2!;^">#3;MH9X
M_,N3)&^4D7<I Y&>ZG'''K-% &/X7L$TWP[:VR6$EA]^0VTER9W1G8L=SDDL
M26)/)Y)Y-<9>Z8EOXZ\0WNI>!Y]<@NS;FVG2WMY0H6(*P_>.".?3TKTNB@#A
MX[*:]U;PE<V7AZ?2;+3[NY,MM(D4?E*T#@-MC8C!9NW<FJ.H>'M5F\(^,[..
MR=KB_P!6:>V3(S(G[GYAS_LMU]*[75->TS14WZA=K H7>Q*DA%SC<V =JY(&
MXX%: ((!!R#T(H X*]U&YTSXK:A-#I5UJ"'0[8,MKM,BGSI\<,1P>><\<=N1
MD:;X-UBWU#P4MQ;%4M;/4%O9$8$6[SC<%Z\X+$<>E>EKIUHFJ2ZFL(%Y+"L#
MRY/,:EF48Z<%F_.K5 'FEAINM7.C^%?#<^C7%L^C7-O)=7CLGD,D X,9#98N
M0O&!C)SC%-BT>=OBE-HB;6T:*=?$+@'.R=@4$9';,@,H^E>FUG:3H6FZ&LXT
M^U$37#^9,Y=G>1N@+,Q).!TYXH X*V\+-!K-S97FB:O>>;J[WB7":G)'9B)I
MO-#L@DQN0G[NSDJ#WR#1_"S6>IPV%YHFKW,D.IO=+=G4Y%LPGFM*DGE^9C<,
MJ-FSE@3TYKTZB@#.U^$W&@WL/]FKJ0>(JUFSA/.!ZKD\ XSCW[CK7 1:+K-P
MD45M9ZLNDPZMI\]O;ZI,LDT020F8@EF/E@;, DG(;'%>H44 >?\ B'2M=_MK
MQ%>Z=!=>7<6^G1AK60)+)&DLAG6,Y&'V-P>.O!S7.:OX9U>Z\/>,[.PT+4(E
MU2VM7LDN;GSI&V/AE=F=B&_BQDC'OQ7L=% '&6^CZ@GQ:35VMF%@/#JVAFR,
M>:)]VW&<YQS5WQUIMWJN@V]O90&:1=1M)64$?<29&8\^@!-=-56^U&RTR%9K
MZYBMXV<(K2-@%CT ]^#0!Q?BG1)?^$P.L/IVL7UM/IZ6P72KY[=TD1W8;MLB
M95A)U.<%>V:CM=#N])\4Z48-%GBT^30?[.Q#*)EM)/,#8=F()4#/S8.<=*ZB
M+Q=X>GD"1:S9NQD\K E'W_[OU]JOZ;J5GJ]A'?:?<+<6LA8)(F<-M8J?U!%
M'G>CV6NR6/@?2YM!N[;^P[A!>3RM'L^2WDC!3#$LI)ZX'4>^)U\.:J/A1J.D
M_8G^WRWTTJPY&65KLN#UQ]WFO2*J:CJECI%J;K4;J*UMP0#+*VU02<#)[<G%
M &0^GW1^)$.I"$_8UTAX#+D8\PS(P7UZ FH/&<.H3#2Q!!J%QIZW+&^@TZ;R
MIG38VS!#*=N_;D!A^6:V;;7-,O+I;6WO89)V4LL8;YB!U('MD5H4 >1KX9UL
MZ?I%HNCW$)M/%\6HNKSB7;;G<V[>6);;D ]\^M=;X7TF_L?&WC*^N;=H[:^N
M+=[:0D8D"Q;6(^AXYKKZIZGJECHUA)?:C<I;VT>-TC]!G@4 <_XSLTNWL6ET
M;4KL1^88[S2KCR[FU<XQCYERK#.>2/E&1W&-ID?B71]<M=2U'2;K4;F[T6"U
MD>!H\I/')(V)#N &1(,L,C(->BT4 >7^'=*UKPI%X?U&?1KJ\,>D-I]U;VI0
MR0R"7>IPS %3R#@\<5T.E6FLW'C.UUC4[!;4OHQAE6.0.L<IFW;,]SMZGI77
MT4 <[X&T^ZTOPE;6E["8;A9KAF0D$@-/(R]/4$'\:Z*BB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "N;\8ZGJ.EVNEOIT\437&J6UK)YD6_*22!3W&.O_P"JNDK/U;1K/6HK>.]$
MA6WG2YCV2,F)$.5/!YP><=* .%U/7/$MA:^,-FKQ.V@*MS"[6BYF4Q"3RW[!
M>",@ \CGCFWXJ\4ZIIMMJ5[8W49^Q6UO.MM%&'"[F^?SRPX!& H4[NIQBNBN
M?".DW?\ :_G).PU= EZ/M#@2*%V@=?E^7CC%5[SP'H-^;O[1#<L+N!(+A5NY
M%64(,(6 ;!8#H3S0!@WVL7FB>)O&^J/=S3PZ=IMK-%:L%V<B<XX&0,C.<YYY
MS@8LZGJ/BG2]-UF_6YA:TBTF6Z@DN%C9UG0%L*J8!C(]22#W.:Z(^%]):^FO
M'MW>2>U%I.KS.R31@, '4G#'#,,G)Y-4K/P)H=CI=UIL27C6MS";9DEO)9/+
MA/6-"S'8I[A<9X]!0!EW&I>(=.M/#]U/JD%P-3U*VBD06@79&\>64'//()SC
M/--N/$FJ0:[8!+N.XMKC6GT^18HQY*1['(7<0&,H*?-@E0<CJ*Z2Y\-Z==VF
MFVTPG:/3I4FMOW[ JZ#"DG.6P/7-4CX%T(S^;Y-R,7IOU1;N4(DQSN95#87.
MYL@=<F@#GK.]U#3T\87&FVLUS*OB >9';A6E\KR8-YC5N&8#. :ZOPKJT6M:
M(+N&^-XOFR)O>+RG3#'Y'3 PZC / ]>](OA738WN9(C=1R7-V+R1TN7!\X+M
MW#GC@ 8Z$#!%:&GZ;;:9#)';(1YLK32LQRTCL<EB?4__ %NE ''?\))JB>(=
M+07<=S:WNJW%D_E1#R%14D9 K$!C(/+&XC*YW#M5*#Q)XB6&&_FU"!XD\2'2
M7@6V"B2(S^5G.201P1CTYS72IX%T&.:*1(;E?)O&O8D%W*$BE;=N*KNP =[9
M X.:D_X0S1_LGV;9<^5]N_M#'VE\_:-V_?G.?O<XZ>U '&^+-4N_$/@?Q%>)
M=&&VM-3%FML(U(98IT5BQ(W;BV2,$ #'!YSW7BN^NM,\(ZQJ%BZ)<VEG+/&S
MIN&40MTR/2J5[X#T*_DOVEBN4CU!UDNH8;J2..60$'>54@;OE&2.N/7FK?BJ
MRN+WP9K&G6,+SW%S8S6\*;QDLR%1EF(]>230!R[ZWXFT[4]-CN+^VNH-7TZ>
M:,"U"_99HXU?/!^92#CGOZ=*33O$.NC2/"\][J44DOB/[,BE;94%KF%I)"#D
M[F;  R, DG!'%=#I7AJV72[7[9'<_:ELA:'S9]S0H0-ZJ03C)49(.3@<\"K#
M>%=);0;31C#(;2R*&U_?-O@*?<*OG<".QSTXZ4 <EK'BG7M+3Q!8Q7$,EQIE
MU8^3=2PC][%<2!=K 8 9?FY Y&.!2ZCXJUWPQK&HZ;J%S!?JT%M/:W(@$7D^
M;<"!E89P0"=PR>V">]:GB_PR]SX5N[+2[2:ZN[R[MIIW,P$CB.6-B2[,,85,
M #IQC%;,GAC2KRTO8;ZV:Z%_$L5R;E]S,BYVKD= "21CN2>O- ',:[JOBW0]
M+U*X-Q (EGM!9O<*C38>58Y%8)A<?,"#C/8^M2O!K,/Q"T6SN]?FG5[&\F/E
MP1QKQ)%@;<'G#8S[<8R<ZZ^!M%&D2:9)]NF@D>-G::]E>0^6VY%WELA5(R%!
MQ^M:-[H=E>7]EJ,L<K7EBKK ZS,F0V,JV#A@2JG!R.* .;TC7=5N97T&[N_^
M)Y;:DT<[K$H!MA^\60+CA60JN>SGVQ6KXZU2^T7P9J.I:=*D5S;H'5GCWC[P
M!X_&ET*PNKC5+CQ!JNEPZ?J,\"6HA242LD:EFY<  DLW0=E'N*TM9T>SU[2I
MM-U!'>UF $B)(4+ '.,@@]J .6U?5->/B'Q#86FIQ6T-EI<5[ 1;*[!B900<
MGD'RQG],=:9I6OZW/JGAEKB\A>'7M,DN3 L "V\BI&X*G.6'SD$$_3%=')X9
MTZ6\O+M_M!GO+9;2=_/;YHAG Z\?>;D<\FF0^%-+@?2WB6X5M+@:WLS]H?\
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M21+N42VYQ@;)-VY1CC .,5<B\+:7#=Z==(DXFTY7%NQN')^?[Y;)^<MW+9-
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M8+F2XBA50C.B8W8(/7)'7C/%7%\7:G$ES;SS1-/+XF&CP3+$ (HRBMG'<XW
M9[D=1Q706W@K0[2VTV"""=$TV1WM<74F4W##+G=DJ1QM/'M3V\'Z,]I?6SP2
MO'>W7VR7=,Y83C&)%.<HPVK]W'2@#EO$7BC7=#@\4V45RDD^G6D%[:7<D*DE
M)&92C@87(*'!QT/3BM_2]0U2+QOJ&BWUY'=0BQAO8F6$1F,L[HR#'5?E!&<G
MW-7+KPGI5]IU[97:33)?;1=2-,PDE"_=!8$$ >@P.3ZG-F'0[.'6FU=?.-ZU
MNMLSM*Q!C4D@8SCJ2<]>: ,V[U6ZN_&;>';:Y:S$>G"]:9$5G8M(44#<",#:
M2>,G(Y'?DKW5=0\1:'X4NKF=K6Z7Q +2<0*NQWC:5-Z[@>,ID#ISWQ7?W^A6
M6H:A;Z@XEBO;=&CCN()"C[&QE#CJIP#@]",C!J"?PMI5Q:Z=;&&2.'3YA/;+
M%,R[9!G#'!^8\GKG.3G- %;QJT]GX UZ:TN9+>XAT^>59HPH;<J%L],<XZCU
MXQ7-QVE_)XVTB"UU-H;@^&Y/])>%'8#SHL8& OIU!X]^:[Z]LK?4=/N+"[C\
MVVN(FAE0DC<C#!&1Z@FLNU\*:997D%W";L7$%J;1)'NI'(B)!(.2<\@')YX'
MI0!S.C^+M4U^QT"V0M#>WVE->S2VXC!+*RI\HDR,9))&">G2NPT"35)=#M6U
MH6XU(*5N/LS9C+ D9'UQR.QR*RI? &@2:;IUBL-S"NF[OL<T-W)'-"#U"R!M
MV#Z9K?M;*"RLDM+=3'"B[5^8D_4D\D]\GDGF@#S_ ,$#5GT#48K2VLI;9]=N
MEE\V0[C&;DB3Y=N#\N[O5[5-6UR37?$-G8ZI#;V]EI<-];,MLKG<WF\$DD$'
MRQ^'3'6MFV\%Z59V<]I;2:A#!/(\DBQW\R[F<Y8Y#9!))Z58;PMI;75Y<".9
M'N[5;.79,P!A7.U0,X&-S=.>30!SNEZ]K<^J>&C/>0/%KVF27/DBW 6WD5(V
M!4YRP^<@@GMQBLW2?$WB<Z7X2UV[OK:YM=6N4M+FS2V";-^[;(K9SD%>1TQ]
M,UV,?AC3;-],N((;EY-)@:"S03L=J$ %>3@Y"J/F]!S61X%\*MIGAC1HM6MY
MUOK!6*PRSB1(I#D%UP2.C$#TR<8S0!CZ9K4NDK?6UN0DNI^+I[(2D9$0(W$X
M/&<(0,]R.N,5H7FJ^)1/XFT:PN!-J&FP0WEE.T2YF1PV8G &-V48 @#J/0YW
M3X.T9K*[M&@E:.YN_MKEIWW+/D'S$;.4;('3%23VLVB6D]SI&FMJ5_/(GG"6
MY"/(!\N2[9&%'0#CKCDT 8%UXU+Z%>>(M.F\W3K>RA*K(JX,\A'WCP1L5D+#
M(^]VQ1J>M^(?#L-]=WACEL62!;9[@QB6.5Y5C;(3"F,!U;)P>"">0:WM+\-V
M5KX:DTBZM+=XKKS7NXD7]V[2L6<#VRQ ]@*@L_!&A6FDW.F-!/=6ES'Y+I>7
M,D^(^R*78E5'8#'.#U% !ID>N/>ZC::I(&L)8U-J\AC\]3R'#!1M*C@@X[X.
M:SO$VJ3>%8;*&WCN;71(;5HWNK2 3_967:(S(A!;R\!LD#/'45O:'X=L?#\#
MQV;74A8 &2ZN7G?:/NJ&<DA1DX XY-/U#1+749S-*]PCM"T#^5,R!XSU4@<?
MCU'8B@"#5];&E>#;S7$V70M[%KE2A^67";@0?0^OI7-ZKJ?BK3-)U74H[F!K
M--)ENH9)UC+K.@W?(J<&,KZDD<<FNU%C:C3AI_V>/[&(O(\@K\OEXV[<>F.*
MP;3P%H5EIEUIT27C6ES"UN8Y;R5Q'"W6./<QV*>X7&<#T% &7!?^(I_$MEI1
MUB-8M0TEKW>+1=T#HT:D)V(/F?Q9Z>_%'3_$WB'5[?P@D=[;6TFJQ72W,@MM
MQW1 C<H)P,XSCIGU'%=C'X;T^+4+:^3[0+FVM3:1/Y[?+$<$C&<'E5.3SP*Y
MRZ\(&RUSPM!I-K=KIFFM<L\J7(W1&1<#[S;F&<DC!'- &/<ZKJ6HZ19VVK/'
M->:;XNMK)KB--@G"R(ROM['#@$#N#6I?>*-5ET+Q/KMC.D8T*[FA6T= 4F2
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M* .9U[Q#XBM&\9SVVHP1QZ$L4\$?V4'S 8A(48D]#R,CGIC'?7U+Q%=:%XG
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MW%?G P1NX.1WKI_!.BZAI%[XIDOK?RDOM9ENK<[U;?$RJ W!..AX.#0 R_\
MB#:6+:FXTC4Y[72I_)O[F-8]D/"G=RX+## D*"0!R.F;6J>,HK"^O;:VTG4-
M1&GQK+?26HCVP!AN ^=U+-M^;"@\8]:QM0\-ZM/X3\>64=INN=5N9Y+-/,0>
M:K0QJ#G.!RI'..E/GL]=T74_$7V'19=1CUE8Y()(IHE6&40K$5EWL"%^0-E0
MW4C% %VV\93WOCBVTBSTZ6?39]-2^2\4I@JY&U^7!V=1C;NSVQS5[7?%D.BZ
MO9Z4NG7U]?7D,DL$5JJ?,$*A@2S #ALY/& >^ <+1?#VI^'/%.A[;*2\LHM
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M-ZL21SO<LZ22X<;EV'MN(Y^7)H WQXZEO/$OAZSTW2[BXT[5;)[LS_(I5<H
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M0<@XX-87B#PYKVH7.J&31;F^O1?Q7-K=F]581;HT;>7'&7&'^5A@J!R26Z4
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MIU_"@#:N[6&^M);6Y3S(95*.N2,@]1Q3-/TZSTJQBLK"VBMK6(82*)<*O?\
MGS7#ZIIVA^%M*O9+35-21KFP"&TM[[=+.6=4692Y)5]SA2XX^;GD"N6U:2^T
MC1?'%A#'_9@@L;&>.W@OWN1#(\C@L&8 J2%7(]LYYH ]JJAI6KVVL)=M;"0"
MUNI+23> /GC.&QSTKC;O0;)/&&A^')'NFTQK2ZO71[J0FYN T2Y9MV20&9L=
M,G.*O?#:-(=)UF**9YHX];O$61WW,P$F!ECU/OWH UG\56?_  DTV@P6M[<W
M=O$LMP\,0,<(8$J&8D<G' &:23Q9:6\NB0W-I>V\^L2-%!%+$%:-E4L=XSQP
M.V:XG2]&L8?B;X[GCCD66VM;:6)O.?Y6>*0L>O/X].V*R='GEN=*^$DT\KRR
MO<3%G=BS$^6W4F@#VJBO)O#D6MWUSINNBU$4\NIR_:KZ75#^]B\QU:'R2,?*
M!PO8IGUK3\(V[Z-KUI;ZG%<?;;JWE:/4X;\SV^H@%6+LI.4?!!'&,$@''% '
MHU%("&4$$$'D$=Z\ATRT\CPOX9U\75VVIR:W' TS7#G,37+1F/;G&W;VQUYZ
MT >OU!%>6\]U<6T4R/-;E1,@/*;AD9^HYKRF\5I/!6N>+7N;D:_:ZG.(9!<.
M/*\NX\M(0F=NTJ "N.=WO4&JV_\ 9NI^/[S3UE2[:_L+?>MRZ%4G$/F8;)VY
MW-\V/ESQC% 'JNKZO;:+:Q7%T)"DMQ%;+Y8!.^1PB]^F6&:OUXYKNF7]CI=Y
M;7$*Z5ITM]IC1P1ZB;AX'^T8>0$@% 1M/U4GUJUXD>;PC=^)K/0KBXM[=M%A
MN6'G/)]GD:9HVD4L25)3)^J9H ]9I"=JDGL,UY7XJ1O!%TW_  C4EPAGT._F
MEC:=Y1NB5#'-AB?F!8\]\UHQ:?;^'_$?A0:5<7#+J<,Z7F^X>07*K#O$K;B?
MF# ?,/[^* .KT^ZTSQEX<L=0%NTEE<^7<Q).,,"K!E) /4%0>O:MFO&?AC>S
MZA%X:T_61-8VEMIXGTJ$. E\ZDAY&(/)3C"'L=Q]N@\)V[Z-X@M(-3BN#>7<
M,QBU."_,UOJ(&&+.A/R,!@CC'4 XXH ]&JO=6%K>R6SW,*R-:RB>$M_ ^TKN
M'OAF'XU."&4,I!!&01WKQS3K<0>"-'\20WMW)K']LI")#<N=R-=F(P[<XV["
M>,=>: /9**\@(GM/"GCCQ%%=W1U*WU&^MK>8S.1;0^=@[5SM&,ELXR,#L*O^
M(8O^$+U%/^$=DG4SZ)J$TL;3O*&>)$:.4AB?FW$C/?- 'ID\,=S!)!*NZ.12
MCKGJ",$57TS2[#1K);+3K6*VMU)(CC7 R3DD^I/J:\\M-.M=(\1> S8WUT3?
MQ3R7"/=/(+DBV+>80Q/.6ZCU'H,4/#UK!%\+M(N[AM2O=2UJ2"W;;?-&9L.Q
M6,L20B;5(8J 2,]2: /7J*\<5KO['-I+226447BNUMA#;7SR^3&\2%XUE(#8
MRS=A@DXZ5/?:!:1_\)_;)->K;Z7:K<V$2W<@%M*UN7+K\V<[E!YSCG'4Y /7
M**\LU03J\7B+4TN+ZP6SM7DN+*_,<^FL%#.WE9"L&W!CWQQ@C%>I!E8D!@2#
M@@'I0!7U#3[75+&6RO81-;2@!XR2 PSGM]*?:6EO86D5I:01P6\*A(XHU"JJ
MCH !7%3:=;>)?'>OVFKR3FWT^TMOLL27#Q",2!R\HVD?-D ;NVVN;\/BX\6:
MKX3BUBZNI8I?#TL\Z+,\8N&6:,*S;2"<Y#>] 'K]5+Z^-D;8"TNKCSYUAS;H
M&\K.?G?D848Y/O67XRLKK4- -M9S1K,T\1\F2X: 7*A@6BWKRNX CC^6:X#4
M+T06GANTM(M0TZ2'Q=;V]U93W/F^43&7**X)W1D,K 9_B[=  >K?8+7^TAJ'
MDK]K$/D"7OLSNV_3/-/N9OLUK-.(I)?+1G\N(9=\#.%'<GM7D.KV;2^'O%^M
M?;;U-1L==*64R7#C[.-\7"KG;SN.<@YZ=JU-6M5\/ZKXJLM.FN8[>3PP]VRO
M<.Y\X&5?,!8DAB,9(ZX% ':/XHLXM5T/3)K>[AN]8BDE@CDC ,?EH&99.>#A
M@,#/-;=>1Z?,SZ[\(YYY&=CH]R[NQ))/V:,DD]ZD\.3R)XI\,WUM;W%O;:RM
MS)YUSJ)FGO(S&9%:2/ 5<':1@\ XXH ]8JFVH;=5-BUK<A1;^>;HH/)'S8V;
ML_>[XQT[UR'PHT]%\%:?JTLUQ<7]Y#B:::9WRJLP50"<  >@YZFL[Q*6N?B=
MJ=C++*;5O"$LAB$C*NX3\-@'K[T >C6EU!?6<%W:RK+;SQK)%(O1U89!'U!J
M:O&M+LI7TSP7I%KIK7MG-H7VZ2U;4'MUDFQ"I8MR3M#'"C@;L]JT].TV[U'7
M_#NDZ[<RS(-)O#-'%>,ZRA9XUC#NI&\A2N3Z@^] 'J5%>.Z7:&V\-^&]9%Y>
MR7X\0+8B62Y=O]'%R\/EX)P5V =NO-;FE6[Z3XOMI=2BN)7OKZX6VU:UOS)%
M<;A(ZPRQ$_+M52!@$ QCD<T >C45R/B\?;=?\,Z-<22+IU]<3&X1)&3S2D19
M$)!!QGG'?;6+<6%D?$&A>&(]4N;O1WGOGFA-T6VR1JA6W9@=Q5=[':23P,\"
M@#TBH+N\M["U:YNYDAA0@,[G &2 /U(%>52+,UQ'H<=[>#3K?Q:MI$RW#[A"
M;4NT6_.[ 9F'7([8P*J>*--M[?1_%^DIYWV&RU/39+:%IW(B,AB#@$G.#DG'
M0$YH ]GJI'?&35)K+[)=*(HU?[0R 1/G^%6SR1W&*\L\<[;6#7[C2[:Y+Z%:
MQ1I=3:F\26D@0.HB0 EV(9=VX_-D#-3>)KRZC\2_$%$N9E6+PTLD:K(0$;:_
MS#T/N* /6*J:;?'4M/BNS:75H9,_N+I DBX)'(!..F>O0BN)L]/31/&GAS[+
M/<EM2TZZ-Z99W?SW00LKD$D!@6;IC@XZ5R_@\3:UX:^'5M>WEV\5T=0^T@3L
MIF"ER%9@<D<#OTXZ4 >TT5Y' C-<P>&GN+E=(;Q3/:E//?/E+;><L.[.=I?M
MGMBNF\%Q+:>*?%UA!=33VMK<VZ0K+*TGE P@E 22< D_R[4 =M17GUY86GB#
MQ5XJ76+ZYMH]+B@%K+'=-#]E5HB[3#! SNS\QS]S'3-1M?.L7Q%?[>\D<-K&
M\4IDX -DIW#' R>>.] 'HM00WEO<SW$$,R/+;.(YE4\HQ4, ?P8'\:\NO898
M+:UU[4$N;[3H=.M&>>SOS'<::50,S^7G#ALAB>I'&"*IW%NFE0^.[NQDFMIW
MUJWLWN$F?=%#+]G$A&3P<,WS=1VZ4 >R45Y5XFMD\-76O:?H\L\%I-X7N[J2
M'SW81RH0J2#<25)#,,CKM'I4T?AVU_X2WP]:-<7SP:EI,TU^C7<F+IT,6UF^
M;U=CQCTZ<4 >GT5XU92ZA>VOA_11;RZE:+<:HIMY;YH?-$$^R(,_);:K'@]<
M ]JNC3;Z\U3P=HNLW,WD.VIK+%!?,Y>)"ICC>12"Q4;5)Z_*0>IH ]8HKF/'
MMW<:3X!U*6QF>WDCB2-94/S1*SJK,#ZA23GVS7-ZQ8P^&=<-EHTEQ';WFA7T
MES$;AY &C";)?F)PV689[Y]J /2Z*Y;X?:;%9^#],O/,GFN[^S@GN9IIF<NQ
MC![D@ 9Q@8KE]0TVVU76/B#->WMT'T\1R6H2Z>,6K?9$;S%"D#.1W_NGU.0#
MU&JDFHVZ27<,;&>YM8A-);Q#,F&W;<#U.UL?2O']?U.[U#PW>ZXD%P^H:=I=
MI)+>3:@8$M9VB67]U$JG<QWKNW8SD"MJ?3[:'Q9\1KV(2)<PZ7"\;B5_E9X9
MBQQG'8?3MB@#TJSN3>64%R8)H#*@?RIUVNF1T8<X(I$L+5-1EU!85%W+$L+R
M]V122H_ LWYUY)IK:CK5IX5T^2RDU2 >'(KHQ/J+6VZ5B%,A89+$ #'IOSWK
M4TK2[G5_$>E:;XANI+I4\/AYDANV*3.)MJNS*1N.WOW//84 >D37EO!<V]O+
M,B37+,L*$\N0"QQ] ":CU*^.G:?+=BTN;LQX_<6J!Y&R0. 2,]<]>@KR;2+*
M+5+_ .'CW[SW$BOJ,.]YWW%82XCR0>2,#GOWS77?%VXFM?A;K4UO-)#*JQ;7
MC8JP_?(."* .V'(K$UGQ19Z+J>GZ:]O=W5]?[S#!:Q!VVIC<QR0 !D=ZY.]T
MJ'6_%/BZ.^FNGAM;"U>")+AT6-RDAW@*1\WRC!K"M-.MM:\7_#V\U 2S7%[H
M33W$AF<%W$46#P>/?'7O0![)17D)5CX%/C#[3<_\)#_:G^L^T/P?MGE>1LSC
M;L^7;CWZU=M[(7!^(&JS7%T]Q8W%U%:#SW"P VJ$E5!QDY[],<8H ]1J@=$T
MUM976&LXFU%4\M;AAEE7T'I^%>;VF@VYU3P4C7-\RZMILK:CF[D_THK%&Z[O
MFXPQ/3'''3BFV9%QIL'A[R;S4"FMW\5K:M?-#&T,+-@2R8+%5W+@#.3CL* /
M4I[RWM9;>*>9(Y+F3RH58\N^TM@>^U6/X5%:W@O9;R![.YA6"3RMT\8"S#'W
MDY.5YQ7DEC:1:PW@A=0WR[-9U&U&+MWQ''Y^Q0^06 VJ W!('X5+)J%Z9/%E
MM]MN(X)_%%K92R+*08H)#&'"G/RY!QD?WJ /2]*\+:%HET]SIFEVUK,Z["\:
M<A<YVC^Z,]A@5KUY'XMC/AP^)],T>>>WLSH*7?EB9F$,WG% RY)*EEZXZ[:Z
M6PTZ+0OB7:VEE+<^3>:1/+<++.\GFR)+$ YW$_-AVY'K0!V]%<7XQ2/4M;T[
M2ELIK^9;>:Y:W:_-K;A 47>[*"Q8$X4#@98GM7)Z.DGB>X\#VNI7EU+;3Z/=
M/<(ERZ^?L>(+N92">QSU..>IH ]@J"\O+?3[.6[NYDAMX5W22.<!1ZFO+8(=
M;U+5;[5(+4+=6^NM"E]+JA0)#',$\GR<8PR#&.Y?/7%=)\6K>*X^&NK>:"?+
M".N&(P=ZCMUX)H Z:+5[:;7KK1U$GVFVMX[AR0-NUV<+@YZY0_I5^O.AX6TR
M_P#B'JFGSK<?8X-'M D2W$B\F2?#$@Y)'.,GO]*YW29]5\2V_AZUN;27547P
M]#<;6U%K8F5G9&D) )9@$7D]-Q/>@#V>BLGPP+X>%],74YHY[T6Z"::.0.)&
M ^]N'7/7/O6M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !5#5M%T_7+:.#4;83)'()8_F961P",AE
M((."1P>A-7ZQ/$OB(>';>QD^Q37DE[>)9Q11, 2[*Q'7C&5Q[9S0 ZU\*:%9
M3QS6NFQ0O',)TV$@+((S&& S@'82.G-,U;3[RWM;Z3P_8V+:AJ#C[1)=RLJ?
M<V!R K;L *-O&1WK'N?B"--TS5YM3TB>WO-*EMTGM4E63<DS!4=&'4<GC .5
M(JU)XKU);BSTY/#TAUBXBDN&LVNT"PPJP4,\@R,DD8 ![^F: -7PSH-OX8\-
MV&BVIW16D03=C&]NK-CW))_&DU7PSHVN7,-SJ-@D\T*E%?<RG:>2IP1N4_W3
MD>U8?_"?K-'I26>D7,][J$UQ;?93(J&&:'AU=NF!@\CL.,Y I\7CDS6@B32)
MO[9-^VG'3S,O$JIYA/F=-FSYMV.^,9H U)_".@W&G6M@^G(+>T+-;B-V1HBV
M<[64AAG/.#3YO"NASZ/!I+Z;"+&W8/#&F4\MN?F5@00W)Y!R<GUK$N?'XMK.
MT/\ 8UR^H3Z@^F/9K(NZ.<(7 W="I 4[N.&!/0BL^Y\<Z]8:]J\=SX?+6FG:
M7#>30QW*,Z$[RY!Q\WW<8_V<]Z .FE\&>'IK"TL6TR-8+-F>W$;,C1EOO$,I
M#<]^>>^:L6WAK1K(6PMM/AB%K.]Q $R!'(RE68#W#$>G-0S^);9=1T.SM8S<
MG5E>6-T; 2%4#&0^WS*![L*36_$$FFZA8Z98V#7^HWBR21PB41JL:8W.S'.!
MEE X.2: +4OA_2I[34+66RC:#4)#+=H2<2L0HR>?15Z>E0WWA70]3U)=0O-/
MCEN1MRQ+ /M.5WJ#A\'IN!Q7!^-/&&J7_AS3TTNUN[*:76H]-OA'=+'+$X?!
MB5Q_>&"''8CUKJO$6J:AX:^&]YJ%K;.;VSLBP2>X\UHV"_>9S]_'4^N* -F3
M0=+EL]0M'LT:WU%V>[3)Q*S*%)//<*!QZ5#>^%M$U'4!?W>GQ37/D&V+,3AH
MB""C#.&'S'J#UKE%\0:__P )G;1II<T\\VB+,U@+M5B1O.8;RW3)&!P"><=
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M64K36X5V4QNQ)8@@YY).1T-7M5TJQUO39M.U*W6XM)L>9$V<-@@CI[@5<HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2=S$'.":H7'@74K#2/&&A:2H?2]6MC+9B:X9FCN67;(K,Q+$-A6R3W->DT4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;!QN (!YJM)X?O(;/3C!X:OX].>[GFO=,@U+,TC%56)Y':0 _=Y4.0,@\XH
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M4?*"F3?;[0W0GSX\9]J '2>/+:T34_[1TG4K":QL6U#R9EC+30+P63:Y&0<
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MR85F8#D$KU(JY-8)+JO@C2EUV^N[&[M;R6>=+MT-\=L;@EE((&22 #P..F:
M.M_X0GPG_P!"QHW_ ( 1?_$T?\(3X3_Z%C1O_ "+_P")K@[.>[N-2M?"TNH7
MITL>(+NU,GVEQ*\,=OYJPF7.[&YB.N2%QFIIK35'OM9T'39;J]L--U*"06;Z
MB\4LT3VY9H5F)W?*Y5P">G&<4 =M_P (3X3_ .A8T;_P B_^)H_X0GPG_P!"
MQHW_ ( 1?_$UR_A[41+XIT"VM;C4UMQ9ZBDMM?REI(Y$FB&QSD[MF2 22<=S
MFLAI[S5#I%H=4O4BNO%.H6\CPW#*S0CS_D# Y P !CIQC&!0!W__  A/A/\
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MZE?^'=%BM+:,R2O_ &?&<*/8+DUQ]W)>07=QH%OJ=^EE;^);2VBE%RYD6*6
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MD8S[UVE% &&?!^A?V+'I/V'%I'+YZ8F<2++DGS!)NW[\D_-G//6F?\(7H/\
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M:V[+=_9DM#,\SNQB0Y526)S]>OO4UYHVGZAJ%A?W5N)+FP=GMI-Q'ELPVL<
MX.1ZYJ]10!E2>'-)ETZ]T][0&UOIFGN(][?.[$$G.<CD#I4ZZ-IZ:Q/JPMA]
MNGA6WEE+$[HU)(7&<=2>U7J* ,+3/!VA:/>QW=E9LDL2LL(>>21( W41HS%8
MP?\ 9 ]*G7PSHZZ$NB"S TY7$@AWMPPD\P'.<_?YZ_I6M10!3_LNR_M.;4?(
M'VN:!;:23<?FC4L0N,XZLWOS66?!'AXBR7[ 0EE MM$BSR!3$IR$<!L2*#SA
M\BN@HH P;7P9H5C<Z?<6UI+'+I\1@MF6ZERL>=VP_-\R@]%;(';%(/!>@+H]
MOI4=B8K2VE::#RIY$>)V))99 V]2=S=#WQ6_10!D6_A?1K6UM+:&R"QVES]K
MBS(Q;SL$%V8G+,=QY8GK3KKPWI-XUXUQ:!VO9(9+@^8PWM$08SP>,;1TZXYS
M4?BG6I= T)[RW@6>Z>6*WMXW;:IDD=47<>P!;)]A5/1=8U9?$5QH.NBQ>Z6U
M6\@GLD9$>,L48%6+$%3CG."&'2@#I:*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>exhibit1060-kumaremploym010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]3BTV\FTKRQD6["7F#Y$B<L?+4D@-P<Y-=O'X,DC\+6.C?;E+6NIK?F7R^&
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M)&K6S7/'F G[H?;C!/(^8=<T >D:CJ\EAJVF6?\ 9\\T-\[QM<QE=L+!=P#
MG)S@] <8YK4K(\-VD5OX?TZ-;FXO1##LBNKL?O9$[$G'< ?48S7(:-</;^-;
M>-_L>IVUW>7GV>_MVVW%NPWEXIUYW*O*JW;"C R* /1J*X[XFE$\(K,\SPK'
M?V9,B2%-JFXC#$D'T)KC?$]C;Z5:^.$TF=TT<Z/'*X6X8HEZ2_W3G[Q0*2.^
M5)ZB@#V.BO,M8&C:'K.EPW4\%KH&I032O<7.9H)+L^7@N6. 2BG!/&=W<U';
MV&F+XB\'Z<^HW&H6;Z=?KNNYCF>,-%Y>1G!7!;!QRH[T >HU6MIKF6>Z2>T\
MB..3;"_F!O.7:#NP/N\DC!],]Z\BTIK&VT#PIJ$=T/M:>(7LEF:X+,+?S9D$
M>2?N;=O'3H:U Z2GQA:V^K6]K)_;T/DM=,9(6;RH2(Y!G.QF#*>>I_"@#U*B
MO)&UQ(8M)35[6#2=)^VWEM?$XFL_M V[""<#RSF3&> W'\-3W5NEGI6F+H^J
MVFJP0Q7<L5GJS!8KN#<A)B?^$I]U&((VL><<T >J45GZ#.EUX=TRXCAF@26U
MB=8IOOH"@(#>X[UYUX>N-.U>_LCJ&K-;^)K._E%U9I&%GD^9@ROGEH=I!]
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M76F^3<65C;2S7$<N\SJS2!$ P,88,!Z[NU '6K#$BE4C15)R0% !-. "C
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M10 PQKCY50'L2O0UC^&?#Y\/V,EN]Q'<N]Q-.)1#Y9'F2-(5ZG@%CBMNB@!
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MDR,CY%(P1C%*OAN];7]'U6?5EFDL(9XY UO@S&8H6((;" ;  ,'CJ3UKI**
M*EM#>QWEY)<7:36\CJ;>)8=IA4* 06S\V3DYXQG%6Z** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0L 0"0">@SUH
M6BD)"@EB !R2:7K0 4444 %%%% !1110 4444 %%%(S*N-S 9.!D]30 M%%%
M !1110 44C,%4LQ  ZDTM !1110 4444 %%%(652 S 9.!D]30 M%%% !111
M0 4444 %%%% !1110 444FX;MN1N(SB@!:*** "BBB@ HHHH **.E(K*ZAE(
M(/0@T +1110 4444 %%%% !1110 444@96SA@<'!P>E "T444 %%(K*ZAE8,
MIZ$'(I: "BBB@ HHHH ***:98QG+J,'!Y[T .HI"0H)8@ <DFEH **** "BD
M5E=0RL&4]"#F@LJD L 6Z GK0 M%%% !12,P498@ =R:6@ HHHH **** "BD
M#*6*A@67J,\BEH ***.@R: "BFJZ/]U@WT.:=0 4444 %%%% !1110 4444
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M&&!SQ][WZ4V^\$ZE/!JVDVVJ6\6AZM<O/<(UNQGC\P@RHC;MN&.>2.-QZ\4
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M8:C/:Z?.+C3M0E*^>BLH9DDYVRH !DYP&[4 >R45SUW/%<_#R6YQ-;12:69
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MEO-.D^X;1Y90$8Z_QBN!UB>71=;UT>')&-Y-X9^U+&DID:28.P$F"3EMI_'
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M:9:?8+B:*^D:,W$97;"P&1N!.3G!Z XP<UIUC^&K2*W\/:<BW<]^(8MD5W=
M>;(F>&S[@#GN,5R6DW$MMXU@CD%IJ5M=WUX+>_MVVW$#C>6AG7^)%P55@>,*
M,#(H Z[4-<%AX@T?2C:N_P#:32JLP8!8RB%^1U.<5KUQ'C6"TN/%7A"._8+:
M/<7*2%I#&IS V%+ CJ>,9YZ5S(0:196LHN'31;7Q6BV5Q+*2L=J4PPWD_P"K
M\PL!DXX'M0!Z[5:[GN89+9;>T-PLDH29A(%\E,$[^?O<@# YY]J\SCNXKX^*
M+?3]7LH';786MA<_-;RY@B8(P!_U;D-R.I/&>Z_V@DEMX39[;^S)X_$DEO+
MESNB8[9BVP\!DW8QQQT[4 >J45XU<"SATG6M32[;[79^+(TMY6N6)C4S0A@,
MGH5+ ^HZ]*T3=V.J:]J-GJFL?8-=M=6WVD:(!<R1!@8A$2?F1DX( QRQ/K0!
MZI17F]A=26GB^,2FVU&TN;V\$&H6S8N;9U$A>*9>=R+@JI[808Y%,\)ZK%HM
MRPU:2PDMHM+^TIK=I)B.XA#*-TZG.V7G.<G=\WI0!Z714<$\5U;Q7$$BRPRH
M'CD0Y#*1D$'N"*DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ IKHKC#J&&<X(S3JS]7U&738(7AM#
M<&281L2^Q(EP27=L':H ZX/) [T 73#$>L:'G/*CK5#5=.O+NW2/3-2.F2^:
M&DECMTD+I@Y7#<#KG/;%<\GC[S=,T^ZATHS/=ZH^ELD=PI59%+C<K$#<IV$@
MX'6IX/&N;.Y%WI_DZC#J:Z6MJD^]9)F564A]H^7:VXG&0 >#W .FL[6*QLX+
M2!2L,*"- 3DX P.>]/,,;,6,:$GJ2HKC?"IN#\0/& N8$A?%D=J3&13E'Y!(
M'7TP.:U)/$MQ)+<MINE/?6UI>K9SLDN) V5#LJ8PRKN&<D=&].0#>$,0((B0
M$=/E'%"Q1K(TBQH'?&Y@.3]37+WWC5;2PU+5(K$SZ5IERUO=3++B0;2!(RIM
M^8*3SE@?E; Z9JZGX]N+!M>>+1#/;Z)Y<EQ+]J5=\3('W(-IR0IS@XSZB@#L
MA#$!@1( ,C&T=^M(((@01$F1T^4<5@3>*T_X2)]&MH89+F,0NT<EQY<CQR'E
MXUVG>JC)/(Z$?7-_X2G3]'E\37<FG"T>UU&""YF>;Y)&=(PLCG!V*%9<]>E
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M3X[_ $Z'2OM4WEW! E5E8E =O]P$YSGD<<T =40",$9%,CBCA0)%&J(.BJ,
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M=G*MI<M&5BN!$KF)L8#8/!QZ&HM)TYM-M&2:Z>[NI7\RXN74*97P!G X
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M4 =28(3&T9BC*-]Y=HP?J*<D:1@A$50>RC%4=7T/3-?M$M=5LX[J!'$BI)G
M8 C/'L3^=<'\.O"6@F35[TZ9";FRUZ[BMI#G,:I)A .>@H ]'C^SS 3Q>5(&
MY$BX.?QIRPQ+(\BQH'?[S!1EOJ>]>6>#M5UW1_"GA.=Y+%M+O+M;$VPA;S5#
ML^)/,W8SD?=V]#US5S3OB-->ZQ9L+W3I+:[U!K,:='"_VB)-S(DIDW8)) )7
M:,!NO'(!Z0D:1YV(JYZX&*1X8Y&5GC1F7(!902,]:\]^(\=I-XG\)Q7^EW&I
MVK-=[[2W3>SXC7!QD9P>>M-%QIOACPKX@UO0/"UQI%W:6F\?;H-BS8R0.'.0
M,<].HH ]#:WA<H6AC8I@H2H.WZ>E*T4;R+(T:%TSM8CE?H:XC^U/&!\41Z&;
MK24:\L6ODG^R.WV8*X5H]OF?O/OKALKW..@JIIOB_P 1ZXWAZTM!IUM<:A:7
M<EU,\+R+$\$JQ[D7>,@DG@GC(.>,$ ] FD@0(L[QJ)&"*'(&YNP&>II?(A_Y
MY)Z?=%>4:[K-WK%OX3&H+"+ZQ\8QV4[0 A':/S!N4$D@$$'&3BMF^\6:^NEZ
MWXCM#8#2=)NI839O QEGCA;;(WF;P%.0VT;3T&>M 'H*HJ#"J%'H!BFF&)NL
M:'G/*CK7'2>-)M-C\5C48XC-I*BYM!&I'GP2+F+@GEMX9#COBL35/'VK:=-<
M6MQ?:1:7^FV4,MQ;2P.QNYV3>T:$-\B@8 )W')]N0#TP11C=B-1NZ\=:%6*W
MAPH2*)!G  55']*\TUGXERP7FHR6=YI\$6G11.+&YA=IKTM&LK*K!@$^5PHX
M;+9SQ5SXR-=3?"V_EM+B.*!O)\Y7B+-(C2H  0PV]><@Y&1QG- '=QBTNHQ-
M$(94;D.N&!_&I/)BP!Y:87I\HXKE] N+O3O$;^&)%T_[/:Z;'=!K*T-NF]YI
M00$W, ,*._7)[X&%:>,/$FL1^%;>Q&G07.LVES---+"[K"8F3!50PSPQ&,]2
M#GC! /0I$M88R\JPHF1DL !GH/YUD:9X=-CXAU;599X9_M\D<BQ_9]IA*($&
M&W'/ '85YSJ]SKT^@>.6O=0@NX[?5[:&* 0M'A@UL1M8NP5<'D8ZDMGG%='J
M7B[6O"]QK$.KO87I@TQ;^W>"%H &,AC\MLLV1N*G=P<9XH [[RTW[]B[_P"]
MCFHI+<>5.+<K;S2J?WJH"0V.&([X]Z\TN?B-J%CI.MO%?:9J\]G91W<,]M;O
M'&"9 CQLI<],@@Y&<\CCGO[ ZK;Z3)+JLMG+> -)B%3%&@QD*223QW;\<"@
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MP_,S7<MLS!$+6YR4\S+MT&=PSDG':M-?&&J2^';*:XU'2--NVO;FSN;B6)Y
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ML=,U%5EM;'49!<RVI>)C)/&^QU# _P 1Z,#E<^U=O8^)=$U.\GM+'5;2XN(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-R?=V\ ]2:0^,/$T>C7GB&0:8--L=3DM)+40OYLL*W!B+A]^%8#MM.=IY&0
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MOKV&TE@:&*!7<(#;JS!0#A<DDT >FT5R\FM3:-?:1X?L=.DNWN;*22"2:Y
M\O8,,Q!/\8YP3[&JEAX\EO+?1[N317@L]1NVL&D-PK-%."ZD;0/F3=&1NR#[
M8H [.BN%N?B)/:6M[J$OA^<:9I]^UE>W'VA"T6&"[PG5@"1GG@>O.([?5K?P
M_P")_&]]<>8T4<ED$C4Y+.\8557)XRS#VYH [ZBN:F\3W=OJ5WI4NE!M3CLC
M?6T,5QN2Y0':RJQ48<' P1_$.>N'6GBZ"\T[2[](H_LUW9/?3/YI/V>- "<_
M+R06QCCD'T- '1T5QP\?10L)KW3IHK![*2\6YB)DV! &*2#: CD'C!()!&?7
M1TKQ+-?ZX^F3Z:\/^CBXCN(V:2(C."C,57:XR#CD$=^* .@HJAJVH2Z;;120
MVCW+22K'PVU(P>KNV#M4 ')P>U85MXYM[C2HKE;4&>75#I21I,&C:4,1N$F/
MN8!.<9[8H ZRBN+N?'LMII^KW4FBR,=+OX[&98[A2&=V0 J2!D8D0\@=?:K5
MQXMO+9FM)=)2/4UB>X-L]UE?+#%4(=4/+[3@8XP<GU .JHKD)/'2R6:R66F3
M/="Q2]EM+DM#(@;<%3 5OG)1Q@X' YYJ6+QK'=7\-E:V>+J2U@NOLUW+Y$Y2
M0G.U"IW% #N&1CI0!U5%-<N(V**&?!VAC@$^YP<?E7%^'O&-]>:%I4M]:V[:
MCJMU/#:PQ3':0C2%BQ*_*JJF,X)/'<T =M16/HFO+JUSJ-E+;FVO].F$-S#O
MWCYE#(RM@95E.1P#UXJ34-8-MJEKI=K L]_<Q23JCR;$6-"H9F8 D<NH& >O
ML: -2BN<M_%$]U)862:4\.K7-M)<R6EU+L$"(P0EF ;JQ&,#D<\51C\>+/%I
M?V?2IGGO+Z73I86E53;SQJY92>X^0\CL0?:@#L:*X@^/;J*PN;RXT(QQ6&H"
MPOR+L-Y;%T4-'\N7'[Q2<[>O>I-3\<WMC<:ZEMX=FNH]$*-=.+E%)C,8D+(.
MY"G.WVZC@$ [.BN%CO?M'Q$&HZ:AN1<>&Q<0QM(4$F905ZY"DC':MC2/%7]L
MV&BW-O:#?J(=I(C+\ULJ9WY^7DJV$(X^9A]: .BHJAK=_-I6BWFH6]H;N2VB
M:7R ^TN%&2 <'G XK&M_&D$VLVMBT<"0W6E_VG#<?:,JR<9&-O;.<^G/8@ '
M445R:ZMY_BC28Y]%$6J7&ESSPR/<G;&-T>Z(X'<LF3CC!QFN7?6=3UG1?!&M
M7=M&;N?63LC@F.&4QS_*<@  %5]>!GK0!ZI16-X<UU]<M[WSK3[)<V5V]I/$
M)/,4.H!RK8&00RGH*IZYK&IV?BS0-+M(+=[:^\]I6DE*L=B9P,*<#Y@?<C''
M6@#I:*\U\,Z]-H4,\+Z>\MA/XEN;'[09QNC9YV5,*<EES@'D8]#6_)XV7[9"
M+;3Y+JS>^-B\L)9I$8,4+E N/+# @G=G'.,4 =713719$9'4,K#!!'!%>6>"
MVL[OP38B\M-2GNI[N6#[8ID^3-PZJWF9_A&/RQ0!ZK17'ZIXVNK";Q"D.B-.
MFAQ)/.YN53?&R%R5&#R IP#U]1WGC\83?VG):3:2\8?3GU&T83JQEC4J"&&,
M(WSJ>I&#U[4 =317&:9X[EOKC01>:)-9V6NP!K2Y-PK_ +PQ^9L90/ER,X.>
M<=!5+PCK":5H<=DB&>[O=;O[:UB:0@';-*Q);DA55#V/8=Z /0**XZ]\=-8V
M&JRRZ6?M.D7$<5_#Y_$<;@%9E;;\R;3D\ @!N.*T]1\3Q:;)>-)"'MK9(!YJ
M29WS2MM2,#'NI)ST8&@#>HKB[WQ[+I]AJUQ/HDS-IYA.8I"8IDD;:"CLJ\@\
M%<>G6M)]-N]<NM-O[ZUETVXT^Z=D6.[+;TZ<A<*=PQD-G'..N: .BHKGM.\4
M+JNL3V-K#"XMKJ2VN!]H_?0E <.T>WA6(X.>=P/TN>)-:_X1WPY?ZP;9KE;.
M%IFB5@I8 9/)H U:*Y ^.A8ZG-:ZYIDFFPBQDO[><RK()8H\;P0/NN 0<<]>
MM7(?$[G4]+L-0T\VJZO$[VDBS;_F5=YC?@;6V\\$C@\],@'1T5YEH%[;67@K
M05N[%[Q)?$$L$3&8KY+F[E".>[8]*ZS_ (26>>9GT_2I+RRBO_L,LL<F'5@V
MUW"8Y16X)R#P3C Y .AHKCK;Q)I]A<>()/[.:WN(]4BM7!EW?:)GCCVMWVC:
M5SC/"DX)XI7\>1VT%TVH6/V1H+N*V\^61A;.)!E7$I0?+P0?EX; [YH ["BJ
MFFW4UY8I// L#LS#:DGF*0&(#!L#(8 ,..AK"\2^+SX;2\GFT\M:6D4<CS23
M"/S=Q(*Q#!WLH&2,CJ/6@#J**X_5O&UUI]UK\,&AO<+HMO'=3N;E4#Q,KL2H
MP>0$.!W]1QFSJ.OC48[[3]-M!=O'8+<S[YC$$60-L4$ Y8A6.. ,#)YH Z>B
MN;^'S,_PZ\.,Q)8Z= 22>3\@KI* "BBB@ HHHH **** "BBB@ HHHH ****
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M[(V^ZVMW"HA8,[;068DE5Z= ._6JGACP[8M8ZU,J3BPUB63R8904,<#9R I
M*AG>5P/1QZ5V%% '&V7@S4WT"?0-:U[[=I?V9K6$1VWE3;"NT&1]Q#%1TP!R
M,G-:GA_2]=L%5=9UR/41%'Y41CMO)+#CYI/F.YN.V!UZYXWJ* ,3Q+HESK=O
M8K:WJ6TEK>)=8EA,L<NT'Y'4,N1R#UX*@]JX[7=&N-!T>2VN=5C,>H:T;XW3
MZ<SQ6QYD^?:^0"ZJ P*XXYZY],HH \[M-'U'Q'X<OM*6_P!,%M)/!<IJ%K8R
MJLKK*)&!5Y"7.43+[CUQU%;VL>'-3N->MM<T;5XK&_2W^RW"S6QFBGCW;A\N
MY2""20<]\5TU% ')7?A75X]:AU?2->6WO&MEM;W[5;><EPJLS*^T,NU@7;&#
MC!QVHUOP;)KL2V]Y>1311F)X)Y(,W-NZ$%G20$8+8] ![CBNMHH *XFV\!W-
MG8Z8D6K1_:M)O9;FQE-L0 DA??'(-_S9#D9&WH#CKGMJ* ,G2-%_LZ]U+4)I
M5EO=1E229D7:H"($55&3P .I/))Z=!2\0>';W4-6T[6=(U)+#4K)9(MTT'FQ
M31/C<CJ&4]54@@]171T4 <S+X8NUUC3M:@U)3J=M!);7#S192XC=@Y7:""F&
M *\G X.>M5U\%/%+I<L%_&LEKJ<VJ7#-;D_:)9%<,!\PV "0XZ]!UYSUU% '
M%77@>\N=&US3_P"UH%_M34EO_,^R$^5@QG9CS.?]4.>.IXK/LK2YU?Q7XZT^
M"_MXH[O[/#(PCW. ;=4=D^;'J.<X/7/2O1:* .7.AQ:#K0U_[6L6F6&D?8OL
MPMV=EC0[MVX$DXQC 6H_"&F6@O\ 5]=L_/%IJ,_F6J2H4"J54R.JL 5#ODG/
M7 />NLHH ",C!KB(?AO90V-C;"\ES9W[7$;XY^SG<OV;_<V-M_,]Z[>B@#$N
M=#GN/&%AKBW<:QVEK-;?9S"27\QD).[=QC8.WK6)9^!KZTTW0;'^V('AT>_-
MU$39D%UQ( A_>=<2'YO8<=<]M10!B>']#GT6?5Y);N.X&H7S7@"0E/++*J[?
MO'/W!SQWHUC0I]1UK1]4MKU+>73FERKP^8)$D7:P'S#!X&#R/8UMT4 <5_P@
M][_9PM?[6M]PUS^V-_V,XSYOF^7CS.F>,YZ=JM:;X6U72=4N4M-<5=$GNGNS
M:-;9EC9VWNB2;N$+$G[I/) (ZUU=% #7#E&$94/CY2PR ?I7):%X6USP_P"&
MET:TURRPK2LMP=.;>N]V<D#S<9!8XSZ#@UU]% '(WG@ZZNF\4!=3B5-<M$M0
M&MBQ@"QLF2=_SG#$]N:9?>'I[.:+6)]2@\NQT::P=/(*[]VT[MQ<XY0<8/4\
MUV-% '!>"]&EU/PKX.NKRZADBTRSCDABCC(/F^3Y8WDD\H&88[GGC&*L0>!+
MBWM+1DU2/^T++4Y]1MIQ;$*/.9R\;+O.5(<C((/0_7M:* .4N;?2_#T6IZCK
MLAG?6Y4@G$-L[JP\O8D850QQ@-R>I8],@56L?!(D^'4>@SW=S#=.L<WVIB&E
MBE0JT9)Z$IL1?<)7:44 <AJ'A;7=:\,W>F:IK]O)=3^6HFBLBL:*CAL[/,Y8
MD#)SCT []:FX(H<@OCYBHP"?I3J* .7;PD]QXEL]9NY[=KBSN)9(YX8#',\3
MA@L+MN.Y5##MSM' YRGQ(8#X<>(5)&Y[&5%'=F*D #U)KJ:* .2?PM%XDBCN
M=7NHKJ)M-DLHA;)L 68+YCY)/)"J!Z<]<\3V/AB[671I-3OXKMM'1EMF2 H7
M8IL#O\QYVDC QR2?0#IJ* .*A\#WD6@Z;IG]K0$V6K?VEYGV0_/^]:79CS..
M7(SGIVJU8>%M3TK6+YK+6ECT>]NVO);1K?,J2,<N$DW<*QY/RDC)P1UKJZ*
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M)E*) )I 86.?N!E$F"<?>]ZFO+ZQ37M*UK3KU/#^C2V]Y'#=W5HIB:5IE9B
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M&?#R,-1^$8VG"6^HCIT'E8%7;&V2+X<>&V2$*Y\212,0O.3?,"?RX^E>LT4
M>*:M>Z=!X#UG1+Q<ZVNN/.\)0[_FNPRS>RF,@;NASCOBN_\ B&C'PW!,8VDM
M+;4;2XO$52V8$F5GR!U  R1Z U)?>#GU&\D%SKNHRZ7+<K=/I[E&0LK!@H<K
MO$>Y0=H..W3BNHH \Q\0ZIH>L!=5TJ'[196FK6,NJ7T,>Z*:-=V.1]_RR5+<
M<#Z<9?BV>UUU/&&I:4Z7.ER:=8VTD\/S1SSB=B<,.&*HR@D=,@5[$  ,"C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKH[5CC?[.!)( 0WEACD] 3QGF@#T>^UV)=#?4M*FL+Y5=55FO5CB.6 .9,$
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M;K5&TQ8#YBN6\YXEDWY(4;E&5VGC)!YP+%[XSUW2+'Q!'=V^GW.H:7<6:QM
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MQE9#N=2HPQ]3ZG@5Y7IOBNX\/V-]%<3:98WU_P"(KN)[B\<_9H=J!F;JI;.
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M <X4(Y'/]VL[3OB8+W6;)?MVBO:WE^UDEA'*3>1#<RI(WS8.2HRNT8##DXH
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M>^ATW77^U:)J=Q8Z9]OBET_?Y08$@QOECG'&&!&0>@H ]$_L^R*A39V^T($
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M5ZR$ D*/<]*X6S\>7X\+7^MRS:/J210QF*.P=D:.=V""&56+$<L/FX[_ "T
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M+36D!=;FQDR,1RJQ.[N"<+R.A!H [&.-(D"1HJ(.BJ, 4ZBB@ HHHH ****
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M[M!GH27Q6WH_AW6-'N8K2#5;8:+#<23)$+7]^5<LWE%RQ&T%NH7. ![UU-%
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M$[1TYSU-% ' KX"U)?!DOA]=6MT:WO/M6FW:6[!X3YQD^<;L,?F*\8X-6G\
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M(V.<AF$;8&/2MS4+ZWTO3KF_NY!';VT32RL>RJ,G^5>0V^A^,-=\(:C=C1;
M7NLW*ZK#=R:BR30,-K0 )Y1 V*JC&[N>F: /8;B[MK39]IN(H=[;4\QPNX^@
MSU-#W=M'<I;/<1+.XRD1<!F'L.IKRW4-3LO%%CI_B)'T6:Y_LIQ=:3JXVKMW
M8D\M_P"!PZ,I.#VSCBF32Z9%>C7(H=,OK:XEL&FL;HE+^R<I$(Q$_5L HVWC
M)W<\F@#TNRU&2=[\W4,-M%:S%%D%PK[T !W-C[GT-6$O[.2/S$NX&CVA]RR
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MI]\WQ3N[BUAGEBLD:&1U#&,BS# J3T.0#D>@]* /4DO+626:-+F%I(?]:JR
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M%S$ZZ;+=3W!=2IGDGR7(QG: 6) YXP/>H#X,U$Z2]G]KM=[:[_:^_:V //\
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M0M)+%YT:+("7CX^8#NO(YZ<BLC4_&?A_29["&ZU2U4WL[P1L)TVJRAMQ8D\
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M>]5X?#>N:=KNH2:9J]M'I&HS_:9X9;<M-#(0 _E,& ^;&?F!P>QK0\2^)(=
MM493#+<M/;H;=I0K".698M^.N!N//3(Q5ZQUS2=3AGFL-4LKJ* D3/!.KK'_
M +Q!X_&@#$'AK4K>\U^2VN[)[?5+F.Y\FXMRW18T=&.<%66,CI_%[<UK#0-3
M\+6T<&AFVC@N=46:2QV/)'! P4.D39&WH7R0!DD = =2_P#&OAZQ\/76N#5;
M2YL;?*L]M.C[G_N#G!8^F:K-XYTB+7)K6XU#3X=.6RANH[][I1'(9'D3:#G!
M_P!7V/KZ4 :^O2)#X>U*21U1!:R99C@#Y37)>#]*GU?PQX-OKB:V>'3+*.6W
M6(D^9*8=@WG^':&8$#.3SQC%=?>ZYI&FVL-S?:I96MO/CRI9IU19,C(VDG!X
M]*6ZUO2K%T2[U.S@=PK*LLZJ6#'"D GG)X'K0!S$7@>X/@:UT*6^C2]L;H7E
MK=QQDJLJRF525)Y&201GD>E2:OX)?Q&-2N-2N4M[VZLH[2%K4%A;[)/-#Y."
MQW[3CCA0/4UU5Y>VNGVLEU>W,-M;QC+RS.$1?J3P*KP:YI-SIZW\&J64EFSB
M-;A)U,98D +NSC)) QZF@#G[WPUK^MZ"]OJVLVT>HQO%+:3V5N52*6-@RNRL
MQW$D#(X&,@>M6O[*U^\TPQZM<Z5>2R.HFMA;,+:2(!@5(8L=Q)!ST&T<<'.Y
M9ZA9ZC9B[LKN"YMFR!-#('0X)!Y''!!'X56MO$.BWMZME:ZO83W3QB588KE&
M=D(R& !R1CG/I0!S,?@/RM!317BL;S2R]P[6-SN*0[V!C$3\LH0;AT&=W&VE
MM?!^O:)>6USHNNP.SV4%G??VA;M+YIB!"S+M8$-@D8)P>*Z>/7M'FU1M+BU6
MQ?4$SNM5N$,HQURN<U6T/Q5H_B*XOH-,O89Y+*8Q2*DBL3@#Y@ 3\N3C/J#0
M!DZSX.FUF[@>XEMV>VFADM=0VE;JWV;=X!'#!\-Z ;CP>!6UH\FK/=:FNI&!
MH%N2+1XXFC/E^C DY(_O# /.*?>>(M$TZ?R;W6-/MI=XCV37*(VX@$#!/7!!
MQZ$4^^UO2=,N(+>_U.SM9K@XACGG5&D[?*">?PH R?%?AE_$L+VLT5E/:/"5
M07"G?;R\XEC8<@C/3C.!R.]6#PG?Z;>ZE+I^H1R)JEM%%<FZ4ETE2/R_.&/O
M94#*G'(SFM:Y\5:/:>)K;P_/>PIJ%Q$TJ(TBCH5 4Y.=S;L@8Y"MZ5:MM<TF
M\NKFUM=4LI[BVSY\4<ZLT6.NX Y'XT 8D/A*2PU3PU)82Q+8Z):26BQR9+R*
MZHN<C@$; >G.3TI]CX3:/3_$&EWUQ%<:=JMQ<3!%C*N@F)+ G)!P2<8 K4@\
M1Z'=71M;?6-/EN!%YQBCN49O+QG=@'I@@Y]#5+3/&WAW5=+NM2AU:T2TM9GB
MFDEG10F'*AB<\*VTE2>H(H SK#P-]EU#1-0GU!Y[NSMVCOG*_P#'ZV592W^Z
MXROIP*KZMX*U;4+O4I$U2TV7-_;7L+SV[/)&(FC;RLAA\F4) '=C]:UM1\7V
M%G=:(T=S:2Z=J3S!KW[0OEQJD3/NW=",KCK4/B3QI:Z3X6CUS3&MM3@DN8H%
M:*<%#O<(2&7/3- #8?",LUMXHM-1N(WM]==F;R00T0,*Q'KUX0'ZTZPL/%EC
MI,Z7^M6-S<06S1VLD=FXWOCB25=Q+'C[JXZGKQC;N=:TJROX+"ZU*S@O+C_4
MV\LZK))V^52<G\*MRRQP0O--(D<2*6=W8!5 ZDD]!0!7TM[V32;1]11$O6A4
MSK&,*'QS@9..?<US]QX2DO\ 4_$SWLL36.N6L=JR1Y#Q*BNN<]"3OSVQCO6S
M:^(=%OK&>]M-7L)[2W!,T\5RC)'CD[F!P/QJS9ZC9:@)C97D%R(9#%*89 ^Q
MQ@E3CH>1Q[T <_9^&[]IM%FU2YM[B318W%NT:LOGR%/+#OG.WY2>!GDYSQBJ
M2^#+\?#NW\,?;+8S131O]HV-M*I,)?N^IQMZ^_M72#Q%HC7T5D-8T\W<I98X
M!<IO<@E2 N<D@@CZ@^E2C6=+-^M@-1M#>,[(+<3+YA95#,-N<Y"D$CL"#0!A
M77AJ_N-4\07@GME&JZ='9*AW'RBHD&XGO_K#QQT'K4-KX5U2QOM&O+6^M%EM
M-+&F7'F1,P9 5(=,$8.5Z'CGVYW;;Q'H=Y)<QVNLZ?,]JI>=8[E&,2CJ6P>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?(W0+%TS\WW<]NN/>N4\21_V%JFJPP:C>6O]H:?$DL:Z8\WVIT0QCR)%.$?
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MW4IVP6VKV4TTA'$:+.I+'T K.B6UOM7\?7D2QS1W&G6_ER@9$D9MV(P>X.:
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M'Q!]@EOM422*T%B)9KA2(_*>,YR0"H''W=ASBNQ^((*Z/IUTZ,]G::I:W%X
MI;$*ORQ ZA3M8^PS0!L0^)]"N-(EU:+5[-M/B.V2X\Y=B'T)['D<'U%%OXET
M.[T\W\&K6;VBRB%IA*-JN2 %/H22.#ZBN'UW5=$U.>TUK38/,TVTUNVEU*_C
MCS#,!$ZJ^X?>$;-'DXP/PXR]>:UUR]U_4+#9=:1<WFC6YF0;HKB1;@;RIZ,
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M"KY9B!U .&/L*X?QK<VVNP^+]3TB1;G33I-I;2W$!S'+.+AFP&'#%489(Z9
MH ]:T[5+#5K=KC3KN&ZA5VC,D+AEW#J,BK=,AACMX4AAC6.- %5%& H'0 4^
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1I(6B + 2M\FW82O7=P"#Z@8>NZO)XAC\(ZM#9PC3Y==A^SS&0F79\X#;=N
M&QG&?[OX 'I-%9.K:T-/O]-TZ&)9;W49'6%7?:H5%+.S'!X P, <DCIR1@7'
MCR>VAFC;20U_:ZK!IMS;BXP!YI79(C%?F!#@X.WO0!VM'6L+0==N=3U#5M.O
MK**UN]-F1'$,YE1U= ZD$JIS@X(QVJCJ7C";3-6AM9["-8I=1BL4W7 $KB3
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MEE9KW898V0O\HV'YL#H>/?I5)=7T^7QW8>(E_=V<WA>6\:0K\WE^9$X)^@-
M'H%%<K%XNN%ET-KO3DAMM;7%K()]Q20H9$20;>-R@\@G!&.>M&F>+;G4-/0G
M38HM2&I-I\MF;DGRV4DLV[9S^[&\<<@CGF@#JJ*Y&'QE<W=S9/9:-/<Z?=W+
M6XGC23,>"P$C?)M"$KU#' (/J!9\*>(M3\1P+>3:3#:6+>:@D%UYC^9'*8\;
M=HX(4G.>V,=Z .EHK,UW6HM#L8YWC,LL]Q%:P1;MN^61@JC/89.2>P!Z]*P=
M4\:W&CC7+>ZTR,WVF:?_ &DB)<'9<0<@D-MRK J001Z<\\ '8]\T8YS69I-[
MJ5[9RSWNGPVK$AK=5N/,WH5!!8[1M.200,].IK#L/&TE[I_AN[.FJBZS=26K
M*+C)A91(<CY?F!\H^G6@#J+.S@L+2.UMDV0QC"@L2?7DGDG/<U,""-P(.>XK
MF=&\6-KMW<06<%JQ@::.:%KDK-"Z-M42)MR W)SSCWK(T7Q6R:/X4M](\/V\
M,.KQ3>3 +K8EN45FP?D.1QU'/7@T =]67K&AQ:M-87(E>WO+"<36\Z $C(PR
MD'JK*2"/H>H%8EGXV>YLM/$E@L6H7>IS:8T7G;HHY(M^YM^T$C$9QP"20..M
M:?AK7;C74U SV26IL[R2S.R8R;V0X8CY1@=,?7MB@#<K+MM#BA\07FM2RO-=
MSQK!'N  @B7G8H]VRQ/<X]!61'XPF'B"PTNXT^.%KZ>X@1#<9EC\M696=0,
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M*=;7=M>Q>;:W$4\><;XG##/U% 'G/B"5;;QAXM@E619-0\.JMJ/+8B5D6<L
M0,9&1Q[U+=:?.Z^!+>TB:)UTZXB4A<",FT &?3G'Y5Z/10!Y;X'@CN+SPY%+
MJ^HS7FE6;*UBU@D26A\L1LDC!0>N,#)SMS[UTOQ/B>;X;:Y'&CNS0#"H"2?F
M'3%=;5:34;.'4(;"2ZB2\G5GB@+ .ZK]X@=P,T <)HMYX(AUFT:QU?69;LR!
M(DGNKZ1&9OE *N2IZ]^G6LH:>7\!Q1-:,6?Q9YCJ8^2OV\_,1Z;>_I7K-% '
MDGCJ$K)XZ=[=Y(I(-)^4+_K,3MD#U/05=U>[A\0:[K%]I*RRVUOX9NK:>00L
MH\UV#)'R!\P"L<=L^]=[KFCP:_I$NG7,DD<4CQN6C(#91U<=0>ZBM&@#R?PK
M<Q>')O#6I:PLEO9R^%[>UCF:)BL<RMN=#@?*6!7&>NWVJ$17'AKPGI7C(VDT
M8T_4+N5[8H5?[#<S-\I7J",QOCM@UZY)(D4;22.J(@+,S'  '4DUC:KH5MXC
MDLII[^XDT^-DF^R1,GD7# [D9SC<P!P<!L' R#0!P5QH][H5EX4U"\OYM.D,
MEU<:E>16ZR^5<W"ALL&4@#[R;L<<#O4MAID7]N^"YH7O+VWDU'4;LS75L(B6
M:-SOV@ *I;YEX'4&O4Z* "O((Y ? L'A 0S?\)&FJKNA\EMRD7?FF?=C&W9E
MMV<<XKU^B@#C_ ]MY.I>+YFA*/+KDF&*X+J(H\?49)_6H/B_#+/\+-;BAC>2
M1EBPB*23^^3L*ZY=1LVU)].6ZB-ZD0F: ,-X0G 8CTSQFK- 'FVL-91>.=?M
M=5@NGMM2\/Q1(D$3,\P4S>8J$#[P4].O2M/P5J,]WJM_ NH#6+*&WB\K4WM/
M)E!R_P"Y<@ .0 &R ,;CD<UVU(S*B,[L%51DDG  H XKXCB]U73[+PKII,=Q
MK4IBFG*%EAMT&Z1FP1U&%QD9W'FLC5].\0^&]=T7Q1=W=A=6UFPT^ZBL+!X2
M+:4@9.9'R$8*< #O7I)GA!P94!P#C<.A.!^9XJ2@#@-"@E7QA\17:)PLCV^P
ME3AO]&QQZUR\5I<_\*M^&L7V>7S(M:LFD78<H SY)'85[/3)9HH%5II4C#,$
M!=@,L3@#GN30!Y!K=K<,/B]M@E/G0VWE80_/_H^/E]?PI-?N;N72M2TOSKFS
ME?088[:VM;%7EU F)LAG9&.U22, @KDG/->O&YMPTJF>(-" T@+C* ]"?0<'
M\J=YT0@\\RIY.W?YFX;=O7.?2@#R2^=K^^\0VEH93<ZSX7ACL/D8>>ZI-N4'
M& >1U]:G@ATO6(;JYNM7UG4XH-)>WF2'3UB-NCLAV_*@)D4ID+S@*>.<'U9'
M61%=&#*PR&!R"/6EH X+PYXE%L-5N+_4/[3T^%K:*+54LC&\K2,5\M]HPQ0E
M?F  &_G&#7>U#=6L%Y!Y-P@>/>K[22!E6##]0*?%-%<1"2&1)(SG#(P(.#@\
MCWH \C20'P+!X0$,W_"1KJJ[H?);<I%WYIGW8QMV9;=GOBNO\#VQAU7QA,\)
M1Y=;?#E<%U$,6/J,EOUKL** ./\ B>"/ MS*1F&&YM9IA_TS6>-F_  $_A5;
M6XI'^+_A*9(V:);*]#.!E1D+C)KM+JU@O;2:UN8EE@F0QR1L,AE(P0?PJII5
MI#HNG6>E?;9)O+7RX3<.#(ZKT';=@8&>N!SZT >.M9W7_" S)]FFW_\ "9^9
MMV'.WSQ\WT]Z]"U#]]\6]#2'[]OI5W)/CLC/$J9_X$I_(UV%9EAHEO8:IJ&I
M^9+->7S+ODE(^1%&%C7 &%&2?4DDDF@"AXXNIK/PG<RPQ1N?-A5VD@\Y84,J
MAI=G\6P$M_P'/:O,]8S?Z;XP@-S>ZFMW_9DD,]Q;!#<QK<!790B*"H/&<>_(
MP:]NHH X7Q3!(?B?X"DCA=HHC?[BJ\+F  9["N2G6XN]#OO#_AZXN-1M7TJZ
M2.TNK+9<Z:=HQ%YF!G=RFTY/ Y(%>ST4 <'X1-MJ/B7^T8M;O]3DAL/(/FV*
M01Q*SJP0E57YP5^[V!/3-:'CZ*3^S=*O/*DEMK'5;>ZNEC0N1$I.6VCDA25;
MC^[7644 >1>)91K=UX@US2HII],B@TU'ECB;$SQ71E<J,9;8AY(^G:K.NWB>
M(M2\5W&E13W$$GA5X(I1$P$S[I3A,CYOO <=^*]4HH Q_"M];:CX7TV>UDWQ
MBW1"2I7#*H!&#Z$5QE[?6VB7OCBSU2&9KG5&\RS58&<W:&W6-8TP#DAE88[9
MST->BW-W;647FW5Q%!'G&^5PHSZ9-3 @C(.10!YKIFGWMEX\\&PW<;F6V\./
M#.^,@2#RP03ZY!KT'44:72[N-%+.T+JH'<E34T<T4V_RI4?8Q1MK [6'8^AI
M] 'C^C:XJ^'?!ULM[+IL5OISP3WD=AYLZ7"+$/LZ[T;:2"2>#NV@#I5?3;F'
M3_#>F3?VG>Z3K-M;7%LWVBQ\Z&?$S$P2*!]_.#A<<-QD=/9F=$QO95SZG%(L
ML;G"NK'T!S0!XU?:3KFKZ_J-_'8A8H-/TNZN]$,1"7942$P!NVWYL+R"=H/%
M:NOZW:&>;6-$N[F.]O+.(C3+JP,D.IJ-VV,#&5<$LAP>.XQS7J=% "9.W..<
M=*\:TW47N]1\+7-Y-=2JLMPEYI\%@L,%C))!(!",(&W%CMY8Y/)QD5['+-%!
M'YDTB1ID#<[ #)X')I] 'D5I<6<UC/I)O;_5-!BT[_7"Q*7FF;9(@D98*-V/
MO$8R/)R<U5\17=]JW@_4HQ.-6BBU*P\G4HK/R6N!O!96 &&*<?, !ST&#7L]
M% 'E&O7=OIEE\1=.U&VGDN]0#SVP$#,)XC:HJD-C&$96SD_+C-:_A:UW>)-0
MF>'(;P_I\:N5X/$VX _ED?2MS6?!\>LW-TTFL:K;VMZ@CN[.&9?*F4#&/F4L
MF1P=A7-=%'&D421QJ%1 %51T '04 >+:.MQI5KX>O+W5;O2+67PW;VRRK9K,
M&D1G+QD,C8)#)@<9P>N*U]!:R\(ZM<VVHQWSV]YHME%I_P!HMF,DJQB0-"0H
M(#_,N5]Z]4I&944LS!549))P * .8^&\4D/PX\/Q2HR2+9(&5A@@X[BN<UI)
MI/&/C'38M\=[JV@QQ6'RD"5U6<$!N@(R._>O28Y$FB26)U>-P&5E.0P/0@]Q
M3J /-K*_M=<U/P1;:3#*LNE[I+Q3 R?9$%NT9C?(&"691CVST%=5XY@EN? /
MB&""-I)9--N%1$&2Q,;8 '<UOD@ DG % .1D4 >?>&)[?4_&MEJ%L#)"/#D<
M2S&,C#"8[EY'7C]*Y?28KG2H/#M_<:G<Z-:"QO+87*6JRA'^T[MC!E;;N4 C
MCG9BO8A>VK7+VRW,)N(UW/$)!N4>I'4"FV^I6-VP6VO;>8D$@1RJW (!/![$
MC\Z ,SP?916'A/3[>![IX@A=#=1".3#,6&5'W>O3L,5PVN#0HOB9K,FOW6I6
ML;V-H+=[2:YC#D&7<"8>N,KUZ9XKTX7EJR1.+F$I*^R-@XP[<\#U/!X]C4]
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M5R#CG)/>N9\:+I*?$C3YM;GO[:R_LB55EM))XSYGG(0I:'GIN.#QQ]*],HH
M\MU9M!OO!=Q9:#<7]]&-2L'G6[>XE8 W$?0S9.,*>!Q6V]IN\?>*9C 2'T2W
M17V?>^:?(![]%_2NWHH \@\+:I8Z#K>BSZL'@ \'6,9F:)CL.]\J< D$X_\
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ME<7^B7=O<2-)/IM_<:>97.2XC<A&/J=NW/J<UT<\ODP/((WD*CA$&68^@_\
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MUX4TJXOIEFN);2*1G4$;LH#DY)Y]:V*S]$TLZ+HUKIWVN:Z6VC6)))@H;:H
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MO(+*XFL+^ZT]K:%+=V+R(Z^=(J 9P5P"V.=IH ]*_MK2O+,G]IV>P!B6\]<
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M3<<X^4J.,8ZGK6U<>(]:3Q+K5I&FGKI^DQV]S,[JYD>%Q(7 P<;L)P>GUSP
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ME(9@.&'&5Y'?U'.</Q)K^J6UCX\2U%G:W6F64,D5U%"=[AHW)W<]1CY?3WH
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M(AO+5HG7Y&*/M<#*DJ?RP: +WA_P?!X=9$AU34KFT@!%I:W4P>.V!XPN%#'
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MTNS=2W-E&DMT+:TDD$2$9WG .%X- $=SX&L[JQUBT?4=0$>K7*W4Y#1Y5U"
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M2[N;MHC,8+.V>9UC!QO8*#@9X]^V: *=[X'TW4?[;^V7-Y*NKF)IAN5?*:,
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M+28V!Y -JYW+W_B&<9H LGPWIQ\)'PR%D73C9_8\!_G$>W;U]<=ZR)?A_:W
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M;=X62-Y(U (.XD9P.,$@9KU&B@#EOB-976H^ =4MK*WDN+@K&RQ1#+/MD5B
M.YP#Q4&D)/>>,=<U7[%=0VUUIEHD+7$#1L65I]RX(R",KD>XKL** /'=,T2^
MTFUT*[OX/$,,9T"WM&32U8R1S1LQ*2* 2,A^"> 0<D5Z?X=L(],\.:=9102V
M\<-NB"&9P[Q\?=+#@D=./2M$R()!&77>06"YY(&,G'XC\ZK:EJ5II&GRWU](
M8[:+&]PC/C) '"@D\D=J /(/"FC^'+#PUI\&L_#_ %675(D_?R_V2[;FR><]
M^U==)87EQJ'CFY6QN%2_TRW6WWQD&1A#("H]P6 (]37>44 >?_V9>QR>"&-I
M*J66E7$=P=AQ"Q@C #>AR"/PK$\-/=:UX5\ :9;Z5>Q-926]Y/</ 5A6)(FP
M1)]UBVY>!SR<XQ7K,B+)&R-]U@0?I6;HHTNPB_X1_3I/^05#%$T1R3&A7Y,D
M]<A: /.-.T35K&RFOY-,NW%GXQN=1:W6,^9+;L&3>B_Q8W[ACK@XK5FT&?Q?
M+XMO/LUS8P7UK;06+W,1BD,L.]UEVM\R@.R@9 )VFO1JQ?$L6EWEG;Z=JMQ=
M117LXA1;>22,RL0?D9H^0I&<Y(% 'G]G8:GXQ\ :OXC>VE74M6DMI8H(F ?R
M;9T(1#TRQ65A_OBEUC1#JGACQ!+I]CXBN;F:*T@#ZHK;YE6<.56-@&PN222,
M')QTKU2VMH;.UBMK:)8H(4$<<:# 50,  >F*EH *\G6QU.![L'2+]WT[Q7)J
MS(L!Q/;N6 ,9Z.P#[MHY^7UKU=F5%+,0J@9))P *JC4K,ZDFG"=3=O ;E8P#
MS&"%W9Z=2/SH YSPZEQJ/C'6=?\ L=U:64UK;VD NHC$\I0R,S[&PP'[P 9
MS@U%>2S^'O'E_JTVG7]Y9ZA8011O9V[3-')$TA*%5Y 82 @GC@Y(KLZ1V5$9
MW8*JC))Z 4 >5>'K'4_"NJ:'=ZAH][)$FDW*7!M83,;=Y;D2JF%R20./ESZ]
M.:2TT_4],?PSK-QI-]Y7]LZA>36\,!DEMTN!+Y>Y%R1]Y<^F>:['_A8G@S_H
M:=(_\"T_QK?L[RVU"SBN[.>.XMI5W1RQL&5QZ@CK0!Y;)'K-SJ>G75]::_/>
M6FM&6[4H_P!EBAWNJ&) ,/\ *R'(R0-Q)'2ET[0M42WNUDTZY!;QR;U0T9Y@
MWJ?,_P!WCK7K%% '%R7$OA[Q+XOUZYL;J2R2RLW4PQY,FP2[]N2 <9!//%;_
M (F@EN?">L001M)-+8SHB*,EF*$  >N:TIH8KB%H9XDEB889'4,#]0:?0!P]
MOIEXNL^!)#9RB.RTV>.=MAQ"QBB #>A)!'X&L5+?6-/7RIK?68--GUS4IK@Z
M=$QF8-(3"?E&X(V6.X8[9.*]2HH \@L=&U;R?"<#Z7?I)8>([J:Y\Y6<I&[2
M.KE^C##K\V>N:U;K1M1;P!XBM%L)S<SZ[-/'$(SN=#>*P8#N-HSGTKT!]1M(
M]3ATUY@+R:)YHXL'+(I4,<]."R_G5@R(KJA=0[9VJ3R<=<4 >:ZD=;T[6?&P
ML+'45GOI+2>WN;>W+AH52))=C8*^8%#X4\Y P#6#KND:E=Z-XT@LM,UV==1T
MZT^QO>I))),8Y7W@[N5/S A#@XYQ7L&GZC::K:"[LIA- 7>,. 1\R,48<^C*
M1^%6J .1TS3[J/QCKUS);2+#-I=E%'(5X=E\[<H/J,KGZBKG@:UN;#P!H5K<
MPO#=0V$2/%*"I5@HR".U=%10!Y/HT6L3:YX7U#4+3Q!+=0RRIJ;W,;"&&:2)
MU'EH!C9NXWJ, 8R>35_3-&U&+P1\/K5K&=)[*]MWN8S&0T($<@)8=N2/SKT&
M^OK73;&:]O9T@MH$+RRN<!5'4FH=,UBPUBSBNK&?S(9@3&61D+ =2%8 XY'.
M.] 'F20:I#X2TSPO_8>HO>V&LPR33?9SY/E+=[_-5^C94@X'(YSC%=KX]TVZ
MU/PQLM$N));>ZM[DQVS;976.568(?[V 2/<"NFHH \MGT8WFGW-U866OS23:
MEIH>35 WF21Q3AB0C ,%4,V21SSV%;&OZ9?3Z_XJEAM)GCN/#2V\+*A(DEW7
M'R#U;YEX]Q737OB+2=/U>UTJYO%6_N@## J,[$$[=QV@[1GC)P*U* /-K&SO
M]%M/ >JW&G7DL5AI+6=Y##"TDL#O'%AO+'S'!C*G )&:K1:-J=UJ6GZHVFW,
M<5UXJ;4/)DCPT,(MC&KN/X<E0>>FX=Z]2HH X2ZN;WPWXJ\17)T2_P!235(H
M'M!:Q%U=TC*&)VZ1\@'+<88^F*P[K093J6LV.IV7B%AJ=VDT<&G2'[*Z.D:L
M&?&U2A5@=V,A1BO5ZHZOJ]AH.ES:EJ=P+>SAV^9*5)"Y(4< $]2!0!2\96T]
MYX'UZUMHGFGFT^>..-!EG8QL  .Y)KG?"FEWUKKF@S7%G-$D/A>&VD=T("2A
MD)0^C<=/:N]HH \JTVPU'24\%7=QI=\T=G>:DMPL-NSO$)6D\MBHYVG(YZ<B
MG>'- :VN].TN_M_$<ES97[S<L19(%=V24,1M(((^4'=ECD5ZG10!XS/X>UEO
M!&KVHTRZ,\GBUKI(_*.YH?.4[P/[N!G-:>HZ W]M:]87]OXCGCU.^6:%+!B+
M:6-TC4[VQM0J5.=Q' &,UZG10!P-C<ZAX>O=:TP^'[W4)[W5FNK9TC_T=XY2
MI)>7!";/FR#S\HQG-8^H6&IBR\9Z>FDW\D\FLPZI 4@)2>%6MR0C]"_[MOEZ
M\5ZM10!YGJESKFH:UK6LZ-I>I6^=$C@MI)K8I(["9B^U&'W@K' (Y(Z8QG+O
MM-OKF'Q8+33]?GBU#0!#:27Z2/)+(AERN&Y3[XPI SR0*]@JK#J-I<7]U8Q3
M!KFU"&>/!^0."5]N0#TH K^'89+?PSI4$R-'+'9PHZ,,%6" $&M*BB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRI$8(7 ^C'- '#V-WJ]AI_A#79M;N[R76KB".\MI2ODD31LW[M0/EVG&,'D
MYS5&UU#7(?"%GXKDUZ\FG751 UJ=ODO ;LPE",9+8.=V<@@5V6G>!],TV[LY
M4GOIH+%BUE:3S[X;8D$91<9X!(&XG /&*QO"O@-8M)LFU9[Y)(;V6[-@;@&
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MNO>'O D<VM744FI_;A>3Q[?,D5"VW!(P#P!G'3WYKM/!-S>26^LV5W>37?\
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M9@QP<<#(%<5XN\*ZAJ5QKUA9:+?A=5V[9HK]!9LY15,TL9(8.N,X4,&VJ>M
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MV$.E:59Z=;;O(M($@CW')VJH49/K@5:H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"\5ZJFD:5#<
M/J+V :ZAB\U+<3%BS ;=IZ9Z9[5NUQOQ,TZ]U3PS:P6-M+<2KJ5K(4C7)"K(
M"3] * +FI>/-&TNZU"WF6]D;3B/MK06KR+;J4#[W(& NUL_@?0U&/&UM_P )
MC<Z(UM.MO!8I=M>F-O+ .\DEN@3:OWNYR.U9MWI-\]K\2 MG*6OT(M<+_KO]
M#1/E]?F!'UK)O]%U.;4M0L1878_M7PM'I\-PL9,<<RB7*R-_!]X=?6@#J?\
MA,[/4-,U$V NH+N*PDO+<75LT7FQ@'$B!A\RYQ^8R.:Y_3/%^LW+_#<2W"$:
MW!.]]^Z4>85A#C''R\^E,T[2C>6]U*NG^)/MD.D3P!M3D)1'=5!BC!^_DJ/F
M7CY1SS5;2-"U6&3X6&33[A1IUO<+>90_N"8 H#>F3Q0!VUEXQTG4-3CL83<C
MSG>.WN'MV6&=TSN5'(PQ&UOKM.,XJ"W\=Z-=7(AA6]=9!)]FE%H_EW31@EEB
M;&'.%. .N#C-<AX6\-O;_P!D:1?6OB)KO3I'W22S$6<15759$)X;<&X4<C<<
MXQ6UX-N]2T_2]#\-3>'KM9[&/R+NZE79!&J*0'C?D2%CC '9CG&* +WA?QW:
M>(--TF>6VN+2?4WD2"-XF"L44N2&/4;5Z^O%:-SXMTJUBO'9IY'M;Q;%HHH6
M=WG958(BC[W# ^G7TK@- @U+2] \%RW.B:INT*YFAO8DMF9P'BD4.BC[ZY9>
M5SUJR%UU$U.Z-AJ]G9WOB$37"VB'[2;7[,@5E"Y(RZH&V\CD=C0!K^)O&DBZ
M!IFH:)*\+2ZU!87"3P;73+[71E8<'_\ 6*ZO6M:L?#^E2ZGJ,IBM(F17<*3M
MW.$'3W85Y7/HFK2Z*]HFDZF)%\56U\HN-TKFW(0[RY)R1@[N3M/%=I\3RP\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 445A>,M:NO#WA*_U6RBAEN8%7RTFSL)9U7G'/>@#=HKB[
MGQQ(/AS?>(H+5$U"R4QW-G-D^3.K!71L'/!.1Z@@]ZLZEX@U>[\33>'_  Y;
MV9GM(4FO;N]W&*'?G8@1<%F(!/4 #ZT =717(6GB#7;;73X>UJ#3TU"ZMI)]
M.O+;?Y$Q3&Y&0G<I&5)P3D'J*S+C7?'-OXLLO#Y_X1TS7=K+<K*(I]JA"H((
MW=3NH ]"HKB];\4:QH&H^$].NHK&:XU:\:WNGB5PJ@<@H"<]#WS4UWX@UO4_
M$E[HOAN"Q4:<J?;+V_#L@D<;EC1$(+';@DY &: .NHKC;OQ#XDT;PUXAN]6T
MRT%UIELT]O<0.3;W6%)QM)WJ01@@^O!J2RE\=W5M;W!E\.".5%?'DSY (S_>
MH ZZBJ6J#4S9$:0UFMWN&#=JS)COPI!S7%:9KOCG4]?UK24_X1U)-*>))':*
M?#^8F\8^;L#B@#T*BN/DU_7M8UV_TWPY#I\<.FNL-U?7P=U:8J&,<:(03M!&
M26'7&*M:#XAU";7KOP]KMK;P:I;P+=1R6K$PW,).W<H;E2&X(.>HY- '345S
M/B#Q#?VVM67A_0[6"?5;J)[AGN6(AMX5(!=MO+9)  &.>XI^EW7BN#64LM:L
MK"YM)8V9;[3]T8B88^5XW8GG/!!/3D4 ='17"^(/'ESI'BI;."TAETBR:!-6
MNF)W6YG)6/';CY2V>S"M7Q?XCN?#K: +:&*3^TM8@T^3S,_*DF[+#!Z\4 =+
M117GEI\0-0N/"OC75FM+43:#>W-O @#;9%B (+<]3GG&* /0Z*Y73G\;7'V2
M>XE\/BVDV/(L<4V_8<$@9;&<56BU_P 1^(M0U!?#D6F6^G6-PUJ;K4%DD,\J
M</L1"N%!XR2<D=* .SHK@Y_'.HV.@>)A?6%M#KN@P><\:.S03HRDHZG@[3@@
MCJ".M&I:]XST/P_)K]Y%H-U96\(N)H(?-BD*8R=K,2,X[$<T =Y17#:MX]ET
MGQI86$MK'_8D]E#//=G(>W:5V1"W.-F54'T+#FMT:U/_ ,)R="\N/[.--%YY
MG.[=YI3'IC% &Y17*> O%-UXLTK4+N[@AA>VU&:T419P53&"<D\\U0TGQY<Z
MAXR-C+:0IHEU-/::?> G=--"%W@]MI_>;<==AH [JBJ6KWCZ=HM_>QJK26]O
M),JMT)520#^5<KH]]X[UC1+#4XY/#D:7EO'<*C0SDJ'4, ?F]Z .WHKA-7\=
M7FC?$?3O#]Q;6YTVXMX3-<C=OCEE:1$[XVED _X$*=\2_'-SX+TRW;3K6&ZO
MIBTA2;.U(4 W.<$'JR*/=J .YHKD+[6?$ESXRO=$T8:5'%:6D-PSWB2,S&1G
M&!M8=-GZUEZG\0-3T[P-K6J26-H-5TB_2QGC#,T+L7C&Y3P<%9 <'D&@#T.B
MBN+MM?\ $OB6XO)O#L6EVVEVUP]LES?K)(URZ'#%50KM7<" 23G'2@#M**XV
MU\3Z[?:9K=G#IUHGB;2&426A=FAG5AN5D;@@.H.,]",&DO/'L,_AK3KS0X1=
M:IJK^1964N05E'^L\P#E1'@[OI[B@#LZ*XN\UOQ1+XQD\/Z7_8X-OIT-W++=
M1RG<SNZD*%;@?+W]>M/UO6_$OAGP9K.L:D-)GN+6(/;I;)(J'G!W[FSW'2@#
ML:*YB!?')EB,TWAWR2P+A(9]VWOC+=<53?7?$FJZIK4&A#2$72IO(-O>!VFG
M;8KYRK 1J=V 2&S@F@#LZ*AM9)9K."6X@-O,\:M)"6#&-B.5R.#@\9%34 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R_Q$M;
MB]\":E;VL$L\[^5MCB0LS8E0G '/0&NHK'\1>'H/$EC':3WNH6BQRB4/8W!A
M<G!&"1U'/3V% '"_$_0]3M;/4K[0[*>\BUB%;;4+2W0NWF*1Y<ZJ.I&-C>Q4
M]JV;A[KPEXZU75YM/O+O2=8B@+S6<#3/;31*4PR+EMK+@Y ."*C_ .%4Z=_T
M,?BG_P &S_X4?\*IT[_H8_%/_@V?_"@"6V-SXL\=:7K,=A>6FE:/!.(Y;R%H
M7N990%^5&PP55!Y(&2:GU&SNG^+6B7B6TS6L>F7*/,$)16+I@%N@)P>/:J?_
M  JG3O\ H8_%/_@V?_"C_A5.G?\ 0Q^*?_!L_P#A0 WQ_I][>>+O TUK:3SQ
M6VI,\[Q1EEB7 Y8CH/<TY)[GP9XPURXNM.OKG2-7DCNHKJRMVG,,H0(Z2*@+
M ':""!CG%'_"J=._Z&/Q3_X-G_PH_P"%4Z=_T,?BG_P;/_A0 :_J6J>)_!'B
MI(-"O(+1K"2.R\^-EN+ERK9Q#C<!T SR>>*QM+B\&6<%E*WA/7UNX51BPTJ\
M.' '/3'45L_\*IT[_H8_%/\ X-G_ ,*/^%4Z=_T,?BG_ ,&S_P"% '> Y /K
MZUQ_ABSNH/'WC:XFMIHX+B>T,,CH0LH$ !VD\'!X.*I_\*IT[_H8_%/_ (-G
M_P */^%4Z=_T,?BG_P &S_X4 )9W,_@CQ%KL=]IU_/I6IWAO[>\L[9[C8[(J
MO&ZH"R\J"#C!!ZU:T.*\USQU<>*)+"YL;"'3Q86B7<9CEFS)O>0H>57A0 >3
MR:K?\*IT[_H8_%/_ (-G_P */^%4Z=_T,?BG_P &S_X4 6/$45[HGC>Q\506
M%S?V36+Z?>Q6J;Y8EWATD5!RPSD$#G!SS5J+QC<7MS))I^@ZD^F6]O)-<7-Q
M;20NS 96.*-EW2,3GL /4GBLW_A5.G?]#'XI_P#!L_\ A1_PJG3O^AC\4_\
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MQ"\,1V'PHU'2]"L+F=WN(9F2,//-,_GHSNQY9FP"2?;VJU_PJG3O^AC\4_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%O0'O7GNJ:/J-_+J3V&GZ]/%/IT/DR:GO+RR0W"RNA#?ZO(& #M!.<#'4 ]
MB\>:*[W,<HO;:>VLI+^:"YM7CD6!,9;!'/7C'7![@TL?CG2)=/2]B2^DCFF$
M-LJV<FZZ;;NS$,?.N 3N''!YKCM=NKCQ#XFU06VE7L+2^$;Z&%+B'9+*Y=.
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MS6\M[!LN!:JGS/*H P Y89(!Q@F@#L-2\?Z#I4M\MS)=>38MY=Q<I:NT,<F
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MG,27"+G:K@>@)&1@XXSBBY\'V%UJ374EU?B%YTN)+);@_9WD3:58KUZJIP"
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M":9=2W5I&9<K$TF=RCC[O)('O2S>!=&GT;6]*<7'V;6;I[N[Q)\WF,5)VG'
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MTD\A=W9CDLQ/<D_3TJ[110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7&?$.66!/#,T-NURZ:Y PA
M0@,^$DR!G SCIDCFNSJI?:9::BUHUU%YAM)UN8?F(VR $ \=>&/!XYH \WUK
M1]6\00>)M2ATFZA6^FTV*WMYU"RNL$P9W*YX'S'&><+72ZQ'>:3XXM]?33KJ
M^LY-.:RD6T4/)$XD#J=I(RIY&1T(%==10!YI_P (]K%KX7@UF+3W_MFWUJ75
MX[%67?Y<LC!X<YQDQ.<\XR*AU+PIJH^'VB6RVKSZK)K%OJ6H!,9#M*9)"?9<
MX^BBO4:* //Y[2_B\9+-I.F:O87,E^K7;+*&L;F#@-(P)P'*#L VX#.1S6/I
M?A[6M-T^._?3)Y)+'Q3<Z@;5<;Y;>0.F] 3@D!]P&><&O6** /,=1TC5=;N-
M7UB/2[F".\OM*6"WF 64QP3!GD9<\#YFX/.%Z5JZ_I,\_B;6;J;19=2T^;2+
M: Q1N$,A6>1G"'(^=58,.1R!@@UW-% '*^"H]1B34$N/[4_LX2K]A&JL#<!=
MOS@GJ5W=-W/7MBN<O[#6+;1?%GAF+1KNYFUBZN7M+I OD;+@<EV)^4IEL@CG
M:,9S7IM% '&66BWMK\53?F!VL%\/Q6@N#T:19B2OUQ@U-XHLM2M?$.D>)M+L
MGOS9QRVUW:1L!))#)M.Y-Q +*R XR,@FNMHH XN\UKQ3K-EJ7]BZ+/IT<=A-
MY,NH!4FEN2O[L(@8@ <Y+=21[FN=@TF_?4KR>VTG7?(N]!N;-9-2N&FD,_#<
MAG;8#T&, D'C&"?5J* /+]*\.ZO!=_"YY+&55TJSN([TG'[AFMU4!OJ010GA
MC67\.>+HELF^TR^)#J5K"[!?M$:212  ]/FV$#/>O4** /-]:L]3\47.LZC;
MZ1>VL2>';K3X8[I DD\TN&P%R>!L R>I;CI6M-I-Z9/ FVU;;I\F;GI^Z'V2
M1.?^!$#\:[*B@#RSQ7X<UB^TKQ=%;6$LKWFLV<]NJX_>1HD 9A[ HWY4GB_3
M-;U.?7X&T_6;N?SHWT_R;IH[06ZJC$%0X#R%A(,,"22O0<CU2B@#F?'5I=:S
M\.]8M;*VEDNKJR8108PY8CICUJ+1O$MSY-A82^%]>A;;'"TLD$8C0X +$B3.
M!]*ZNB@#RBTT_6Y-7T&^OM-UR:^L]3=]0FFN6:$!EE13#%OV;1O4[@H('U-+
MIVGZU-X2T3PO-H5Y;W$6IQW,MRP7R4A2X,V[=G[Q  VXSD^G->K44 >6MI6L
M?\(A)X(&D79G:_)%_A?L_D&Y\[S=V>NTXVXSN_.NK\*:==6.K^*IKFW:)+O5
M/.@9O^6B>3&N1[9!'X5T]% '(>(+74M+\767BC3["7481:/8WMK 5\T1EPZR
M(&(#$$$$9Z'BJ.M_\)!XUT#6M/M]'DTZQDLF2#[?A)IY\@@;0Q"I@8);DD^@
MKO:* /.]7LM3\;W]N4TF\TR.VTV]AD>\55S-/&(U1<$Y Y);IP*@MH]7U>]\
M&02:!?64>F"2.]FG"A48VKQC9@G<N>_3E??'I=% 'F7@SPZ]C<:':7NE:Y]L
MTI")+BYOW:TC98S&&B4N0VX,<  ;03G&,5O^,Y-/MKW2[NZU:?1[N+S1;7XC
M#0KD+NCDW K\V 1G!^7@UUU% ')_#OS6\.32S'S99KZXD:[V%!=Y<XF53]T,
M,8'3CC/6L9+Z_N/%D^HZUX:URX%I<-'ID4,,;01(/E\[EQN=N3DCY0<#N3Z+
M10!Y3K.B7D@\26\WARYOM=O+F1]+U5%0B%"!Y)$I.8O+/4<="1G-=?JFGWU[
MXF\,)+&TUG9^==7,H'R^<J!(\C_@;D?2NGHH XV];4/#GC#4]4@T>]U.UU.U
MA519A2T<T6\;6!(PK!E^;H,'-3>%DG\-:9X?\.WENSW5Q;S332QD%(Y 0[+Z
MGF0@'VKK*:8T,JRE%,B@JKXY .,@'WP/R% '$?$;2M7NH["^T*W::^59[%]A
M *Q3QE2_T5UC;\*IVOA:]M/B!;6<-HR^';=UU-),C9YZP"W$?UXWUZ+10!YS
M;:#JB> M L6LI!<V^MQ7$L?&4C%XSEC[;3FJ,OAK6A<^*;R/3Y'8:_:ZE;19
M ^U1Q;"P4DXS@'&>X%>J44 <)J\VL>)K>V*:%=6MK;ZO8RQ?:,+*ZK*&E<ID
M[57C'.3SQTSL6%A=1?$'6[]X66UGL+2..4]&9&F+ ?3<OYUT=% 'GKZK<:5\
M1_$\D.D7FH![&R %JJLP<>=M!!(X///08YIG@OPQJ>A:]H_VNW.RV\-I:2R@
M@JLWG;B@/M_2NZATRTM]3NM1BBVW5TD:3/N)W*F[:,=!C<W3UJW0!Y;)I6L#
MPA<^"!I%V9Y+]RE_A?L_D-<F;S2V>"%)&W&=P_&K7B#PSJ=SXOFL+6U9]!UR
M:VN=1E! 6(P9+J1_TT"0K^=>D44 >9ZYX5U75?$/CH0VS+%J6CPV]I*Q 620
M*WRY[<X'XTFL6NK^,KZP1-$O=.A72K^TEENU5=DLT2J  "3M!'7H>U>FT4 >
M8Z7H@EMV:?PQKMU<6^FR0RQ:GJ+-&[,%5H8@SL"& /S# X7GGC=\%PW\%[?Q
MJFL1Z*(XOLT6KMNE27+;PI)+; -GWB><XXKL:* /*O$^FZWJ%SJZ2:=K5W<I
M?136ABN62T%JC1M@('"N_P K## G//0"M.*VOT\7Q7&E:5K&FRS7Q>^5I UC
M/"0<R8)P)"-O"@'=UR,FO0J* .1^(&EWNJ6>A)8V[SM!K=I<2A?X(U8EF/L*
MHW0U/0M>\4/'HMYJ*:P(Y;1[8*R[Q"(C'(21L&5!R>,,?2N\HH \YT/POJ>D
M>,?"OF0M);:?X=-E/<+]P2@KQ^AQ67X5T'6?#_ASP=?7.E7,DFERWR7=I$ 9
M529V*N%S\V,+P.<-7K5% 'F5UHVKW%CJ_B2'2YTOVUFWU*RL'($K1Q(D3 \X
M5G02<9[C-4SX.UB$^'[ 6K26^I6\ UN0$81XIOM#;O\ >:21:]9HH \_^R7\
M/C)9=*TS5]/FDORU]^]#V%Q!SF7!. Y&W[H#;NN1S7:Z=>2WL$DDME/:,LKQ
MA)L98*<!A@G@]15NB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M75LOG0C?&/(R<[^/]4W!YZ4 =3J'CGPWI<]S!>:FL<EJZI<#RG;RBPR"Q"D
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MV8SN[6[RS .JLQ)P0H.W./F/8UZEI>F6^CV"6=J9FC4D[IYGE<DG))9B2>:
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M>9I79CU)9B3R?P]*\Y6&?2[NY35EOS=7L=Z+?48;\S6M\-DCA'C)_=E4&0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(U'PO
MHVK:BE_?60EN%01D^8X5T!)"NH(5P"20&!QFM>L'7O$-UH\C+;:'>:@D5NUS
M/+&RHB(.P+$!GX)VCMZ9% $/_" ^&L0K_9[[(8UB"?:9=KHIRJNN[$@'8-G
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M&_3U*6IW']V"NTCKSP,<YK(7P#X;CMQ!%8RQ(LK2Q^5=S(8RWW@A#@HI[JN
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M])OM9\*36NG1+-=K/;SI$SA _ES(Y7)X!(4]:R3:^)-.U/6KZQT1;C^VXHI
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MLGF^TJ_F[;=XE= .=N2,@X//3@FO1Z* /-K7PSJS7=[);Z''HPGL+F*\C@O
MUO>3.H",D8.%YW'<0IYP<U=\*^&-4TJX\*O=Q(HT[0Y;*XQ(#ME9H2 /481N
M:[RB@#S)-'U/0-4TB_$5M-=KJFI[+)KI(WGBN',@*$\%@%4D>F:V?AT]Q,GB
M:>Z$0EEUR9B(FW(,1Q @-WP05)[D&NGU32]-UBU%IJEG;7<#,"L5Q&'&X9Y
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M\PC&_83MW8[XS0!R?AG4==URWT'Q NI6R6=V&^V6S3;@Q8'"(NP;61AC[QR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD=^AK<9@JEF("@9)/04 +16/;>)])NKFWMXIWWW4;2VI:%U6X51DF,D8;CG
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M;9P_RJ?E^4Y;H._44EUXWT"T>%&NY96GM1>0_9[:27S(<J-R[5.1\PZ=!R:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSNB33QVZ%8V;YW8*H.!QDD<G J35-3M=&TNYU&]9TM;:,R2LD;.54#).%!-
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MXG8ZG:W]K!<R)LNEBA$;QM@G;GYL$CTKN-1UNQTMK-;J1@;RY6UA*1LP,A.
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MFN[>*TO;;;)"A(0&&=?O(68G#?[:\CG/<5G/H.FR7LEV]N6EDE29P9&V-(@
M5BF=I8;5P<<;1Z5HT >?7>GWFH?$/Q(EEK%QI<B:79L)H$1OFW3XW;U/R^H&
M,^M)X6\0ZMK6JZ-]MN'B2_\ #AO)8550!-YB+O7C(R&)QG'-=?>>']+O[QKN
MXM0T[Q>3(ZNR>;'S\CA2 Z\GALCD^M%]X>TG4;FUN+NRCDEM5*0MRNU3C*D
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MOEMI-*6^5E2+?%)YC)A#LX7 '!!/'7KFMX9\1ZCXFGT73[J[DMFF\/Q:C++
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M%7D.V0)M^5R!\N0&'?&0: -.\\>2Z3#J"ZMHLEO=6$<-S-%'<"56MG?895;
MSM(;(('2M+6O%]GHNHK;2QM+&MA-J-Q,C#$,,>,''<L3@#V-4;;2+K4=9U36
MO$=K;V5M/IRZ<MKYXD_=;F9V=L #.X  =A[US7@[PQ<Z_P"!-;^VW8E?4;8Z
M78W1!(-K"&2)_7YF+.?7(H Z67QO<6%IJ#ZMH<EE<6VFR:E#"+A9/.B3[RY
M^5P2H(Y'S#DUH:=KVJ:AI]K>KX?E2.YN$5%:Y3<MNRY\YAVQ_<Y-<LG@VYFT
M+7+:#PIH>CW5SI4MFDELX+RRNN#\P4;8\@<'GZ8YZRYNKW1=+T6"&U2>1Y[>
MTF&\C8I&&9>.<8SCTS0!/XAUQ-!L(IOL\EU<7$Z6UM;QD RRN< 9/ '4DGH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% $5M:V]E;I;VL$4$*9VQQ(%5<G/ ''6I
M:** *][8VFI6CVM]:P75L^-\,\8=&P<C(/!Y -31QI%&L<:*B( JJHP !T %
M.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHY]#70*P= RG((R* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&X8VY]:[ZB@#@K"P\26&NZ'JE_8?;KC^R'L;IK=XT$4ID1PS D#;A3G9G!Z
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M4_LN[2/4;V#NMQ&=D9]M^%;ZP>]=I6?I6AZ7H<<T>F6,-JLTAED$:XWL>I-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ(U2:[6"5/+,\?VOS@N3_>0 ?D#0!W7_  D.C_9[J<ZC;K': -<%VV^4#T+
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MC$VV1ZQOLXXW 8Z"M/5](NH4\(Q?9Y+F6VU87E[)%&652T<N]_8>9(,#T^E
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MRRIXJ34=Z(-CP&Y67<K$X/RYR.V.<4_Q-I>H7<?CU(=,NY3J"6BVP$)(F**
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M D_P@GC)P,U7O/%6@:?)<1W>L64+VQ43*TPS&6SC=Z=#7)ZM97$7BK6[?4=
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M]@">DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+J<@3RY9]K'&-V\9VL 2N"1Z<UN6?C2VO-0MXAI]['8W<[VUKJ#A/)FD7=D
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M@\L1W#H&!+9R3%D$<8.16IIOBI=4U$0PZ1J(LI)I8(K\JAA=XRP;(#%E&58
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MK1R1. 0&5U((."1P>AJ@W@O0WT.72&MY3;S3BYDD-Q(9FF!!$AESOW94<Y[
M=*Q_$'CK4=+\.75\GAK48+N&:W3R[GRBFV5PH8,LFT\_+@'()7( .:WM<UJY
MTKP?>ZTNG3&XM[5I_LC,FY2!DAB&V\=3ACP#C)Q0!)#X;TR"&_B6*5AJ$2Q7
M323.[2JL?EC+$YSM&,]3UZU4O?!.AWPA$D-PBQVRVA$%U+$)85Z1R;6&]>3]
M[/4^IKF[?QAJ\NOZ&[:5?.U[HLDYTZ)HOFD#Q8DR7VJNTMC+9P0,9.*W(O'-
MM=Z=IT]AIM]=7=^9ECL5"+*AB;;+O+,%4*W'7DD8SF@#;MM'L+/4[C4;> 1W
M-Q%'#(P8X*1[M@ Z#&X]*I)X1T.-=:"V0 UK/V\;V_>Y!![_ "_>;ICDDU=T
M?5K?6]+AU"V61(Y-RE)5P\;JQ5E8=B&!!^E<WI_Q$L]073[D:3J4.FW]P+6*
M^E6,1^<25"D!RV"PV[L8SWH UV\):*VFZ3IYM#]FTF>.XLT\QODD3.UB<Y;J
M>N<YYIEOX/T:UU,7\<4Y9)7FC@>YD:".1\[G6(ML4G<W0?Q'UIC^,;!-!N=8
M,%SY%O?&Q9=J[BXG\C(YQC<<]>G;M7.V?CF?3)O$DE_8ZC>V-AJLB2W<00I:
M0[4P,%@S 9).T' .: .FTKPAH^BWBW5G%.'C1HX$EN9)$MT8@E8T9B$!P.@'
M3'2I=8\,Z;KD\4]T+B.>-&B$UK<R0.8VQE"4()4X'!KF9-=ND\=>*[::]N?[
M-L]&BN42 C=&2'+,F>-V!QGCI5VR\80IHNAQZ?9ZKK%W?6"W<<1,0G\D!<R2
ML65 <L!QU/04 ;MKX<TFRO!=06:K(+1;) 22J0+T15/ 'KCK@9Z51D\#Z&^G
MV5FD5S EB'%K)!=RQR0JWWD5U8-M/3;G& /05I6>KV]]H2:O%',L#PF;RY$V
M2+@<J5/0C!%86E>/K75)=)8Z5J-I9ZL,65W<+&$D?87V$!BRG ;!( .#C/&0
M#3M_"FBVEUI5Q;V0BDTJ*2&SVNV(U< -QGYB<=3D]ZJ6_@+P_;7,,T=O<'R+
MC[3;Q-=RM'!)N+$QH6VKDD\ ?I4%MX\M+F6UE_LR_32KRY^R6VI,(_*DD+%5
MX#;PK,,!BN#QZBN:?Q1-;:-X_NM5U'4EM=.U00Q/8E!-"G[O 3<-O5N_8F@#
MJYO /AZXN9II+:<K+<"Z, NI1"LVX-YBQ[MH8D<D#N?4U9F\'Z-/JQU)X9O,
M:9;AXEN9!#)*N-LC1!MA88')'8>E5]4\8Q:;>SVMOI6H:B;.!9[U[54/V=&R
M1D,P+,0I.U03CZBK-CXJTZ]_M?/FP#2B#<><H'[LQB19!S]TJ3UP>#Q0!5O?
M /A[4+FZEN+:=DNI/.F@6ZE6%I>/WGEAMN[@<X]^M;6JZ7::UI5SIM_$9;2Y
M0QRH&*[E/;(Y%5[/7;:Y\,Q:_,DMG:/:_:V%P &CCV[LL 3VYK)M/&PN9[:&
M70M3MGOH'FT\3>4#=;5W;!A_D<KR ^WC//!H VET33UU&SOQ"?M-G;M;0/O/
MRQMMR,9P?N+R>>*S[CP5H=UJ,EY+;S?O9EN);=;F002RC&':(-L8\#J.<#-<
M]\+]7UC7[2_U353J),MQ*J><T/D(%D90D:H=P( P2W![$U3U_P ;ZN;'QI#'
M8W%BNCM&D-X&C.,^63G#DDL&)&!C;UP>* .WG\-Z5<PZQ%+;EDU@8O1YC#S/
MW8C]?E^50.,58_LBR_M.VU'RC]JMK=K:)]Q^6-BI(QG!Y1>>O%8B>+H[B;4+
M"[TW4M,GBL'O8S)Y>Z2$<%DVLV&!QPV",C(JGIOC.$:'HXT^PUG6);FP^V88
MP^>(00-SY95+$GHN<T ;6J^%-+U?45U&X6YCOEA\A;BVNI(75,D[048<$DY]
M?P%1S>#-$DT^PLXH)K5+!62V>TN9(9(U;[PWJP8AN^2<GGK5W4-:MM,T"36+
MA)Q;I$)?+\O$ASC"[3C#$D#!QSUQ7,Z]XYU+3-(6>/PUJ$-Y]NM[9HKCRBNV
M1U&582;6)!*C!X;&[ YH WX/"NC6UYI=U!9^7+I<+PVA#MB-' ##&?F)QU.3
M3HO#&DPZ9I^G);$6NGS+/;)YC?(ZDD'.<GJ>M9]_XR&FS'[1H>IK:PB'[7=;
M8]EN9,8!^?+XR-Q0,!ZFJ,7CJ6'7/$\&HZ7<0:?HVS$Z[&+$J"!@.22^1M '
ML<'B@#'U#P3?7^JRVZZ-!;P2:HEX;Q-0D:$(LHD++;DD+,P7:2!CDG/.*] U
M'2K/5EMEO(C(+:YCNHL,5VR(<J>.N#VZ52T;Q#_:EY<6-SIUWIM]!&DQM[DH
M2T;DA6!1F!&5(/.01]*K:[XM30IYP^D:C<6MI"L]Y=PH@C@0YY^9@7P 20H.
M!0!9UCPKI6N7*W-XEPLWE&!WM[F2$RQ$YV/L8;ER3P?4^IJ#4O!FC:A,+AK>
M6.5;<6Q6WN'A26)<[8W52 ZC)X.>I'2JNI^.8;&^U2TM]'U*_?2XTFNVMQ&%
M2-DWA@6<;N,\#G@\5-/XSM_MD-MI^G7VI%[-+Z5K8)B&%\[6.YADG!PHR>#Q
M0!0T/P+:'PWH$>K13Q:E8:>EI*UM=O'N7 W1L48;UR.AK8M_"&B6ITCR;/9_
M9#2-9 2-B(R AN_/!/7.*K^ -0N=5\!Z/?7D[3W$]N'>5NK')YK*T3QE;'0;
M-[&'6=6N+R[N(8(IVA$S&-FWDL2J!1CCG.,4 =&OAG2%T6ZTC[(&L;J2266)
MG8Y9V+L<YR#N.1@\=L557P5HG]FWEC-#<7*7I0SRW%U))*Q3E/WC,6&T\C!&
M#S6E:ZFMSHXU)K:YMU\LR-!/'LD3&<@CUX]<'L<50A\5V4]GX>NEAN FNE1;
M @93=$THW\\?*I'&>: )-)\+Z7HM]-?6B3M>3Q+%-<7%Q),\BJ21N+DY(R?P
MP.@%.N/#6F76NC698I/M?D?9Y-LSJDL?S?+(@.UP-S8R#UK&L_B%:WGV"==(
MU*/3[RZ^Q)>R+&(Q-N*!2-^[!88W 8SWK<O/$6E:?<B"ZNO+;S5A+^6YC21L
M;59P-JDY'!(ZCU% %72O!VC:->175K%<-)!&8K<3W4DRVZ'&5C5V(0< <=AC
MI4^K^&=,UN\MKR\2875JCI!/!</$\0<KNVE2,$[1^&1T)JN?&OAX7!@_M%=X
MNA9L1$Y5)CC"LVW"Y+  D@$\ UG:MKEY=^+)?#EA>3Z=)'8?:1="S,B^87*C
M=N7&P!3D@C.<;@10!HGP9HG]DVVG1P311VTK3PS17,B3)(V=S^:#N+-N;))Y
MSS6EINE66DZ<MA9P[;==Q(=BY8L26+,Q)8DDDDGG-5;/Q'I=U+#;K>AII83-
M&3$\:SH,;FC+##CD'Y2>"#4%GXT\/7ZN]MJ22(D9D+>6X& ^S@D8)W8&T<G(
MXY% %6#X?>';?[/MMKAQ;Y6$2W<KB.,J5,0!;B,@D%.A[CBGQ^ ]!2":%XKN
M<21K$K3WLTC0HK!E6-F8E,,JD;2#E1Z"M&'Q'I4\=TZ71!M9%AGC>)UD1VP5
M780&RV1CCG/&:CC\4Z-);O,MY]RY%HT9B<2B8\A/+(W[L<XQTYZ4 5?^$(T-
MK(VLT%Q<!KJ.[>6>ZDDD>5,;"SELG&!@9Q[5S'BWP?J&KW^LQ6NBP.NJ1+&M
MX-0DCC4[-N^:#.UW7JI /1>A&:U]?\6I F@7^G:BBV%QJOV.[W1<X"2%E(8;
ME8,F,8S3?$/C"*X\#ZAK'AO45,MI,D3EH3N1O,565D< J<-W% '0VV@V%K)=
M2I$3+=P1P3N7/SJBE5XS@<,>GK5"X\$:'<6UG;^3<PI:6HLXS;W<L3-   (W
M96!9>.ASW]35[4O$6E:06^W77E+'M,K^6[)$&. 78 A ?5B*7Q!_:;:%<G1I
MTAU# ,+M#YH)R.-N1U'&<\9SVH IWO@S1+ZYAG>VEB:*!;7;;W$D*R0CI&ZH
M0'4<\'/4^M:6GZ39:9H\.DVL 6QAB\E(F)8;,8P2>3^-5-.&MC7+[[=-!)IY
MBB,")"4,<F/G7=GYQGG.!C('/-;% '.:;X&T+2;NRN;:&Y:6QW"T,UW+*(%*
ME"B!F(5<,1CZ>@Q<B\,:3#IFG:=';$6NG3+/;)YC?(ZYP<YR>IZUKT4 <R?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5$:C)W 88D].!69X3\-:K#KZ6>I6\D>F>'H9[?3)F/\ KO.<[6'^Y$%3ZL:
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M>O)YXE/GR>7,LNQ@Q;,G^L4%LYSF@#UJBL_3=4&HW&HP_9Y86L;HVS;\?/\
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M5=-M$LPR@&5EB8,H&>H) -=BVGW7_"R;/4!;M]D31IH#+CY0YFB(7ZX4G\*
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MIKS,D=OM,,BQHX8'<<YW'(X[5J?#F:]NO!MM=7UXUU-++.Q=U .?.?/3_(H
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MH(\[$&<#)R>ON37F_C'5KO7_  -XIN(;A(;6QOC9"#RP?,$<B!V8]02V<8P
M ,YS7J% %"^UO3-,E2*]O88'<J!O. "QPN3T&2"!G&2.*OUYI<ZE+H>M^/\
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M_-\N Q&1ST].=FYU_4[^X\3)I<T4#:(%6..6/<)Y/*$IW\Y"D$*,8/!.3TH
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M2C,<L9RK#.,@_A7':7J"ZM\0]*U)(VC6[\,^>$;JH>6-L'Z9K,\$ZQ-%X?\
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M--?SZ/:R:I#%!?F,?:(X7W(KC@X/IFKU !1110 4444 %%%% !1110 4444
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M<@<=*6?P=IMPNKK)+=E=6A6"[!ESO15V@ D9'RDC/4YYYYKH** (K>$6UM%
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ML.[.X D<@Y.0P(/X#'144 93>'--DT2]TF2$O;7PD^TEFR\K/]YB?7^6!C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZYK3HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
IHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>exhibit1060-kumaremploym011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[1U:TEMQ$MC9K?1RM+E;B%@Q#K@=!M(/H<=:@U'QH-/BF!L0]W:VR7-S:?:
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M(/*O);6:)[BV:26+R2AV;@X&PE-V !RQ^M &Y#XF2ZURZTRU@25[2X6"X'G
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MX27=;;@2#A5Y)]2!Z]*Z.V\;VUQIEK,\ M[R>ZFM/LT\P54DA+"3+\C:-O4
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MN82@<=4;JK#W!P?PK)L?!L5EXALM7^UN\D5H8KE2,?:9LDB5L=_WDW_?8]*
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MHPQ31)<QB01SIM=,]F'8CI5VH;2*2"UCCFG,\H'SRD8W-W..P]NU34 %%%%
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MCDGDRQ/S,&ME&"#GEG!/11CC-=6EU87OQ0E#3V\T$OAY"06!5U,S'\1CGZ4
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M^8J#C!&%Y'H.E 'M-%>0W]]'H5YXHM;*7RM(MM5L7NXXLR"&!XU\UMH.=NX
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MR7W?*P!XP/X<GK@=/XTU^3P[HD<\+QQS7%U%:I++&TBQ;SRY5>6PH8X'4XH
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MF>9L7?C;NQSCTS1Y:;2NQ<'J,=:P_%NLW6C:5 ;!8C>WEW#96YF!*(\CA=S
M$$@#)QGG%<QK?BG7_#-MXAL[FYM;V[L]*&I6=R+?RP?G*,CIN(." 01C@^U
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MG*AMP4L3@%3ZC !Z915#1+F:\T6TN+BYM+F62,,9[,DPR>C+GL1SC)QZFK]
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M:YIRVXN'MIXIH[BWN$4,8I4;*G!X([$=P353PUXOTOQ5]N&G2%C:3M"P(/S
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MCQZE U^&*>2#SN R5!Z%@.2,Y%)!XIT*YUAM(AU2W>_5F3R0W)9?O*#T+#N
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M/9"!58*<A5>3/S*H/  '09)Q65>_$JP?3M4FTQHWFT[4(+203 A61Y8D9^V
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M"2.X;&XX.'QCVSWJQ;>+= O-3_LVWU6WDN]S((U/WF7[RJ>C$8.0"2,&I_\
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MDW,MO?ZM;P30L%E1B<ID!@6QT&&4Y/'(H J:AX+M;O3?#FGP3M;0:'>6]U$
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M[BW\.75N(FL%A2$.H/EMM4?."G"\XP>F>>FBLE3QMX.9;;"0:-<J"$XC/[@
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M_'QQCTKTF;6-,MVD6;4;2,QRK"X>91MD;E4//#'(P.IS1+K&F0S30RZC:)+
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MSQIG:Q+CB0;F^;WZ=* .>UOQCK=OJ6I6J71M[W2[:$_9+739;J.[N&C$C*9
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MP><"C#D_=(.>N>,=*?I^L^)D\,0^,+J]M+BPET^2_GT_R=AA3RS)&(W&2QX
M.[KDD8QBNA7PM;@^'LSNPT5"D8('[T&$Q?-^!S6=8^ UM8X;&?6+VYT:VCDB
MM]/8*JJCJ5VNP&7 5B #TXZD"@#/\)>)M3OM:L[:YN[B_AN[1IIF;2I;5+64
M;2%5F4!D(9@,DGY1SS6A=7FN:UXJU72]*U---ATN"$EOLZRF:60,PSNZ( !P
M.3D\UHZ'X?O=)EC^TZ]>7\$$'V>WAD1$55XY?:/G?"@;C[\<FHM3\+SW&KW&
MIZ7K%QIEQ=P+!=>7$D@D5<[6&X?*X#$9_3B@#SV6YU#Q=XN^'NIM>K;/>65W
M((A;I(L#JB!]N[J"<XSTKT;5]5NK/Q5X<L(646]\]PLX*Y)"1%EP>W-0P>"M
M/M-1\.7-K++%'H5O+;P1<$.LBJI+'U^7/U-6M?\ #[ZQ-I]W;7\EA?:?*TD$
MZ1K(/F4HRLK<$$']!0!R][XHUUI;BWM+B".7_A)UTN-Y(@P2$P*_(XR023UY
MZ4VXUWQ)8)K^G?:WO9=/N;7_ $V*R#RQV\H!=O*7ARN#T'0YP<5LVG@6"V52
M^I7,\G]L#5WDD"Y>7RPA4X  !QGCIT'%6KKPN[ZAJ>H6>K75E=WKP2;X@I"&
M)2H!!X92"<@T <_;^(]3U$Z+I6FZ_;7+ZA-<DZG'; .D4*J2IC/"R;G .1@#
MG%87C#5+^Z\,WFF:G,EQ=:7XBLX/M"1A/-1C'(K%1P&P^#CCBNP'@8J([R/6
M+A-:2[>\^WB)/F=T6-E,>-NPHJC'7*@YS27'P_MKO19+*YU&XEN)]1CU&YNR
MJAI94*X& ,!<*J@#H!0!D:IXPOM(\0^-O+BMY!IMG9M:@Q@$R2@@;V')&XC\
M,U=U^3Q-X>\)^(+R[U.TU**'3VEADDM51TF&<J4 VLF,$9Y['/6M*[\#:??Z
MEXAN[J:9TUNVBMYHQ@>6(P0&4^O.?J*AF\$W&H:9JEKJWB"]OGOK/[$'*)&L
M4?.2$48+DGECZ=J .?34=27QKI]^^HLMK%X8-^]JD*A6^9-RCTR0#GMTZ5'I
M?CS5(X8K^XGGU"&;3I[RXA.ERV\=HZ1^8JI(R@,I 9>223@@\XKJW\&H-4TV
M^AOY8_LMA_9T\1C5EN8,@X.?NG*]1ZT:;X0EM+?[#=ZW>7NEQVK6<-G(JH!$
MP"_.RC+D*, GW[\T <U&-<D\1^ +S5=2BO!=RS3,BVXC\EVM)#M4CJN"1SD\
M#GFMKQEK5Y87T-M9ZP;)OLTDWDVVG/>3R," I955ML?7)X)/0C%.T[P-+::A
MHES=:]>7JZ+O6SBDB10$:)H\,5&6;!'S?[/3DYOZMX7;4=:.HP:I<6?G6HL[
MJ.)%/FQ!F8 ,1E#\S#(['U - '.V.O>(?$VJZ=;6>H0Z9!=:!;ZG(ZVZRLLK
MLPVKNXQ]<]/?-0:9XF\1^()_#ME#>P64EY:WIO9D@#X>WF6/<@;@9.>#D8;V
M%+8^$-4T[Q9;VUCJMY;QV6@PVD5^;961P)I,(P(VE@NSI@\9Z$@RR>$+C3_$
MOAJSTBZO+>*PTZ\'V[RA(#(\D1/F9&TELN<<=,CI0!BZUJM]J=KX6BU)XY;R
MP\:1V4DT:;!+LWX?;V)4C(]<UI/XMU2'5?$]G;_9DG&L6>G6DAA&(_."@N^,
M%R 21D]@*W?^$ M6L=*@DO[B2:RU8:O).RKNN)\L3N X .[H.@ ITW@*SGDU
MR0WEPDNJ7<-XLB!0UM+%C8R<<X*@\_2@"'4KG7]!TBY&H:_9[7N(8[6^-H6G
M*M]]!"BD._'RX'.>1QSRNHZWK.L:/:0KJL\3VWBBVL?/>Q\B25#Y<BL\; %2
M"W3 #8Z<UU\O@JZN(_M%SXAO)=46[CNHKIHDV1%%9 JQ?= *N^>Y)SG@5!+\
M/=]O=H-<N_.GU"#4TF>-&,=S&%!;&,%6VCY>@[4 96H>+M0T36_&@V6]P=+L
M+1X"8@I>60$9<CDC=@X[#.*O7VJ^(/#6H)9WVJ1ZB+S3;N>*0VRQF&:%5;@+
MP4(8\')&.M:,G@2RN[S7;B_NIK@ZS9PVMR,!,>6I&]<="2<^Q%+'X-EGGDN-
M7UJXU&<64ME;N\21B%)  [84<N<+S[=!0!D:9K7B2*[\+3WM_!=QZ[;.SVBP
M+&L+B#S5VL.3TP<\<Y '2K/@G7M0U2\:'4M662\%L)+O3)[(VTUK+D?<_OQ\
MD;N?X>>:V#X5@*>'U^U3#^QHVCC*\&0&$Q9)['!SQWINE>&;BSU:'4-0UJXU
M.6VMWMK8RQ(A1&*EBQ49=CL7D^AXYH XV:&ZM?C/K&H2Z@72ST5+G8;="3$)
M'/E GIT^\.:T['6_$5K;>&-8U#4(;FVUR:**:R6W5!;^=&738P^8[2 #NSG)
M/%=,/#-L?%=YKLDKN]W8K8O P&S8&+9]>=V*S=.\$?8YM+CN-8NKS3M);?86
MDD:#RR%*IN8#+[5) Z>^: (_ FH:YKEM/JNIW\36WGW%M#;1P!?N3,H=FZYP
MI&.G?K6&/&^I3:U-+;W%Q)'%JQL?[-CTN5D:%9?*>3SPN-P^9_O8P,$9KN/#
MVAQ>'M*^P0S/*GGS3;G !S)(SD<>A;%4(?"L]KJDDMIK=W;Z=+=F]DL8T4!I
M"=S /C<$9N2O?)YP<4 <G>>)/%2:5JFMP:C;".PUQK".S>V!6:/[0(AO;J"-
MPZ?W><YXFUKQ'XB\.1>*+634(KZXLK"WOK69K=8]IDD=&0@<$?)QWY[UTDO@
MNVET2^TLW<HCO-2_M%GVC*MYRS;1[97'TK+\?^&6N]&\1:A:K<7%W>Z?#9BV
MB0L2$E9LKCDGYS^5 #;R^UO3-6FTC5=0BOX-0TFZN$*VXB,$D>T,HP>4(DXS
MD\=:Q?!.H:G<^&O!WA[3+Q;#S-(>]N+GRED?:KJBJH;CDODD@\#WKKX/",AU
M":^U'6+B_F-F]C;F2-$\F-R"Q^4?,QVKD\=.E5K;P(NFZ=HL6F:K/:WNDV[6
ML5UY2OYD38+*Z'@C*J1C&"* ,NR\6ZS!=:<=0EADM8=7GT6_D2(*'?CR)1_=
MR=JD9QEJ;?>*=>F:>YTZ>".TFU^'2;,R1!AL&4E<_P![]YNQR/N>]3^(]$32
M_ UUX?L[74=4U'5'DD6=8B<W3,&\Z1P-D85MI&<<+@9Q6U%X/MH_#^A:5Y[A
M=*GAN0X',LB9))S_ 'F))^M ',7>I^+;=?%D"Z]"3H$(NHIFLDW7&Z'S/+<=
M HVD9 R=W;'+-5\<ZE->72V5W+:/:6,$\5O%IDMT+F:2/S-CLJG8N-JC!!Y)
MSQ787'A:"X?Q&QN9!_;D"PRX _= 1&/*^O!SS527P;+'+OTS7+O3C+:Q6MUY
M4:,95C!574L/D?!(R/;C@4 8=QKOB74W\2S66H)IL.EVL-S#"]JKNS-;B0H^
M[H,YSWYZC'*Z7=:EJ_Q*L[A]0*6D_AZ&[:T$2E,.^&3)YZC.>O;I74?\(Q!Y
MFO/]IE/]L1+')GGRPL7EY![G'/-4AX772-2L-9M]0NE_L_3%L9H4@$IN(H_F
M& !D-G/W>O2@#.\)Q7ZZ5KV@:=>K:MI6K-!:2R1>:(X#LE"8)&<*[(/08]*V
MO%VK7NFV>GP:<\<=WJ5_%91S2)O$6[+,^WN0JM@>N*Q])T77%\):C<PL]CK6
ML:A]O9?EW0*SH C9XXB4 _CCG%=)K^AQ:]81V[SRVTT$Z7-O<18+12H<JP!!
M![@@]030!Q6O>*-?\,V7B6RDO8[V[L+.VO;2Z:!4++)(49'4?+P4." .#[5V
M*R:AHOAJ\N]3O$OKJ"*2X9DA$:C"EM@ [#&,GFLBY\!IJ.FZQ%J6JSW-[JJ1
M1377EJFR.-MRHB#@#)8]R2375W5M'>6<UK,,Q31M&X]01@_SH \QDNKGPY\+
M?#EY"8I;W4KZTGNY9HP_F/<,&=N>_P V >P K;MIO^$@\:^-/#>H10OI\=K:
MH (@'(DC;=ENI]L].U0:;X9GUKP;8^&]8-Q;7&AW<*B98_EN%A.8W4G@AEVY
MQR#D=JU;S2_^$<U'Q#XHLX[J^OM1A@C2SCCW9>-2J 8Z EN2> .: *?AO4M1
MU'X3)=->,FHPVLT)N=H8EX69-V#U)V9_&L;2=2U'3O 7A*)_$+PR7EFDFZ+3
MVN;EE$2$(D:JV0"?F<CT]:[#PUX=&C^"K30KF3S'6W9+AU_B=\F0C_@3-659
M>!+K3[;2DM_$=TD^FP/9Q3BWBR;9@GR8(QD>6I#?7(- '&WGCM+*^\*^)M60
MO,=*OX_+C0Q^;(LL:]#]P':2<_=&<]*Z35O$&LZ4NB:??ZJ(;O45GNKBZL;!
MKD1(FS$<:*K9&9!\[ \ ],C&GI/@"STRXLF>[ENH+.*Z@BAG12#%.RL58_Q8
MP1D]<\TL/@=K*SL8M/UFZ@FTV246,SHLAB@DQF!@WWT&%QGD;5YXH M:!KEY
M>^#9-2OMD%S )U::YA>"-Q&S!965AN564!B.V37(0^--7@M=95=3DOVBT&;4
MH;B;3'M526/ PF]1YD9W @\].O-=W)H"77A:YT*^O;J[6Z@DAGN96'F-YF=Q
M&!@?>. !@  =JPY_ ,UZTLM]X@NKB>?3I],E8PHJF&0 #"@<$$;L]\X/&  "
MJ-0\4PZGIEH^K02R:UIUQ+$OV956TG1492IZLOSX.[T[=*?8^+[[6K3PG#9[
M8;_4)';45* ^2D (G7'8F3:@/^U707.BP17FE:J\L['1[:9%CCCWF0,J@\#D
MGY. .N:P?!.A[?$6O^)FL[FSBU";;9V]TI1TCP#(^P\IYDF6P>> >] %OQ?J
M]W97]I:6NL&Q9X9)?+MM/>]N)"" IV*K;8QDY/K@ BLO3?$6N^+7TJVL+Z+2
MI)-$@U.XE6W$NZ24E50!NB@HQ/?D<BNCU;PT^H:TFIVVJ7%D[6WV2X6)%;S8
MMV[ )&4;)/(]?I65;> I=.M[ :9K]U:7=G:?8!<""-_,MPV45E(QN7LWN<YS
M0!2LAK[_ !4M(M0U*-&30UFGM[=-T1;S0K!2PS@D9R>1TK-\,>*=:UGPUX5M
M()[>SO-6FO#-<QVRXBCA=ON)]W<?E&3GN<&NMM_!XL=;TS4K/5+I&L[(6,JS
M8E-S$&W?,S<AL\DCUJE8_#Z#2] TFPL-3N(;O2II9K6\V*Q_>%BZLIX*D-C'
ML#F@#*N/$_B&V=]'6[MWU"WUV#3C=O -LD,L/F!B@.-PSSC .WMFNA\,W^IG
M7-=T;4[U;XV#0/%<>2L;,LB$[6"\<$'D>M-@\$P(D,D]_/<7@U--4GN7509I
M%78%P!A5"X  Z8K6LM&CLM=U355E=I-0$(="!A/+4@8^N: .*O?$OB#^PM:\
M5V]_"EEIMY-&FG&W4B6&&38Y9_O!SM8C' XX-:^F:CKFJ^/M<M!?Q0Z5I4L
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M-)NCRH.#\ZXS@>]5/#R3Z2WPYN+^TNH4CL;RVE(MW;RI7,>U6P#MSM/)XXH
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MTFJW4.I0M)=I-I30V]H2F]#%+L&5XV?,S;L@B@#T:66."%YII%CB12SNYP%
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M7&I.][;;&RMA)B-8\XP=BK&_UW5V7B"PNKKXS>'GAUBYA62PN)(O+CB81@;
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MYCA02P('S' ' D;7_$CZ/"T[ZU;V4-_+#/J$6E@730A T;F%D.!EBK,J?P<
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ME9(V=8T5(VD>1ST554$L3Z 5ROB#QP%T[0[O0Y01=:[;Z;=)/"R/&&)WHR,
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MY@G 8F,IMW!_E/!&2< =1G%\6>/5M_A]J^MZ!*1>6$L4+Q75NR/$S2("'C<
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M;^>BLT4L;+M) /RE@-Z\_>'!K;H **** "BBB@ HHHH **** "BBB@ HHHH
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MOK=JJS  E,EAD \9';/&:P-7UO6/#=WK.B0:C?WH+:>;:=PDEQ"+B5HY N0
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MW38GB@^;C:ZJISZ\**QK;X?Z;9:9:V5K?ZG$+.5I+.99QYEL&&"B$KC80>C
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M[T^&WTNQO9K*':/W[%]R,2"=O!! ZX'/KM^,[^\MK;2;*RN7M9-3U**S>XC
M+QH59F*Y! 8A, D'&:T[30K*RUB;5(!()YK:*U8%LJ$C+%<>_P QYI^LZ+::
M[8"TN_,4+(LL4L3[)(I%.5=6[$&@#SKQ'J^M^'8?$6E6>KW,S6R:?<VES<X>
M2+SKCRW1B -P.W//.&//2O2=+L9--L$MI;ZZOG!):>Z*EV).?X0!CT&*Q3X&
MTN6POK:ZGO;J6^EADN;J>4&5_*8-&,@ !01T '4^M=-0!Y%?ZEJ.K_#/XCF[
MO[@FSU._MX2I *PH%Q'T^[@D?C6GK+:IHIMFN=5UV'1XK%&BU"V1)Q#-N8NU
MRNW<R %,8&, YP>:ZJ/P;I,>D:WI>V9K;6KB:XNPS\[Y0 VT]AQQ567P):3V
MP@EU?66C>#[/<C[4/])C!.%?Y?1B,KM..,T =+)<10VK7,LJ+"B&1I,_*% R
M3],5X0^OV\UK-XX6#4O[=&IK?0H-.N-OV%1Y8B\S9LP8BSYSC)KVO6-&MM:T
M*YT>=I8K6XB\E_(;:VSN >P(X^AJW':P16:VB1(+=8Q$(\?*$ QC'ICB@#S;
MQ+:QZQ\3O ]W:ZK>I!>VUY)$\$B@(HB0@IE3C<#SG/X5GZ7:7.EZC\3;^WU6
M_,]DK,A>12';[+N#-\O)!Z=.E=WI_@C2=,ET.2!KICHJ31V?F2[MJR\,#QR
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M/K@5;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7)Q]S/3% 'H%]K&G:9Q?7L,!V[SO;&U>FX^BY[GBG#5M/;4ETY;V WK1><L
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M8D66YMMVFPRJ<^9'"[+YGLSD<_[HH ZB[O+>QMS/=3)#$"%W.<#). !ZDD@
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M[AEBIY.#@C.,' ZZ;6M,M[U+.:^@2X=Q&J,X!WD9"_[Q'('4UP%IINH1^ /
M]D^G78NK"^M&NHO);,2QYW,>.@SVZ]JOZ/'?6FH:CHFI^'9[POJTE]:WK1J]
MN4:3>KLQ/RNG3&,_*,4 =>^MZ9'?I8O?0+=.Q18RX!+ 9*C_ &L<XZXYJ*S\
M2:)J%Z+*SU:SN+E@Y$44RLQ"G#=/0\5Q>C:;.MX-'UGP]J5S<6NJ27EO?&=C
M:,IE:19?OX#@,1MVY)]B2-+PR9M#T/7[R72+UYAJMY=1P1P8EF224E2H.,Y&
M._;F@#MJY3QQXK'A_0;N:QN[0:A 8QY<REQ\S 8.",,021GTZ&NDLKN._L+>
M\A#"*XB65 XP0& (R.QYKR_5[+64\.>+M"DT>^NKN\U)KRUGACWQS1-(C+\V
M<!E"[<'^Z,<4 =\^LVMMJVH"YUG3TM;2WC>6!B%>W)+9>1BV ",8! Z&I(/$
MVB7,4TEOJEK,L+*C^7(&(9AN"X'.2.<?6N4UFSO;C7?%<Z:?=F.[\/I:PD0D
M[Y1YV4&.,_O%]O?@U'?V5_9:1X0U"#2;VX@T^$17UG:$Q7"[H@FY0"I)4@C&
M>C'% ':+KNE/817R7\#VTQ(BD1]V\C.0,<DC!R.V#Z52D\7:,FHZ791WL4S:
MDC26[QMN0HHZ[AQR2 /_ *U<HMK<Z#K6E:]I_AN__LR0727%FA\RYB>9HV\X
MH6/+&,@@'(!&><BM&6QN+?Q!X3O;70I+:SA2\C>WMT0?9_-V%-P!P,[23C(!
M/4T =0=:TQ;Y;(WT N&?RU0N.7QG8/\ :QSMZXJ*V\2:)>7ZV%MJUG-=LSJL
M,<RLQ*?>& >V>?\ ZU<+'H>JS^"AX6GM+A=5AU43+>[#Y93[5YWGB3IG:2,9
MW9XQ6WX;6;2;;Q3>RZ5=O(=4N+N&)(,23H57;LSC).TC&: .SHJKIM]'J>F6
MM_$DB1W,2RJD@PRAAG!'KS5J@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN4\=3WL4&A0V5]-9M
M=:O!;RR0G#>6RON'IV_/% '5T5Y/?VVIVUMXZCC\1:P(]!A%S89NB65S;B4A
MV/+KN& K9 !-.U+5O$&LZIJB6,&N/<6=I;_8_P"SIHHX4F>(2;I5=UW@E@,$
M$84]Z /1=6T6SUH6HO/-(M9UN8O+D*8D7[K<=<>AXJ])(L,3RN<(BEF/H!7F
M.IR:OJ,_C*:;5M1L7TS3X+FWM[:?8L4QMR[9Q]X;EZ=#SG/&)XI=0L]3T.27
M5;VZ&M:/=37D4TF8Q(J1L&C3HGWV&!V_.@#T'3[^VU33K;4+.3S+:YB6:)]I
M&Y&&0<'D<'O5:70M/FUR/6)8Y'O(H_+0F9]BCGD)G;N^8_-C/-><>'4O=#\-
M^ -2AU:^G^WFWM)[5Y<PF)X&("IT4KM7D<G!SG-3^#M1\1ZG-H6K_9=<=+YF
MDU"2YGA-IY3HQ7RD$A9=K; ,*"1G/- 'J5%<1\,4OKSPK:ZUJ.JWM[=7:,I2
M:7,:*LC ;5]<#D]3],"NV?A&/M0 M%>3:'<ZM;>&/!GB*77=0NKO4+NWMKJ*
M6;=#)')E<;.@9>#NZY!SUJSI^L7I\4:+>VUQK<]EJ6HSP-<7<L:VL\?ERLHB
MA#EEVE%PVT9 .3S0!Z;--%;PO--(D<2 L[NP55 ZDD]!3Z\4O[>^U+X+:QK=
M_K6I3SR>=&L9N"(U1;ED VCKP.2?IT KKFTRZO?&]YH9US5XK"VTFWE417;+
M(9&DF&XOUZ ?7 STH [VLZ31+.77H=:;S?ML,+0(PD(41L02-O3DJ#^%>7:=
MK^N>(;?1[>8:[<D:'#=.^DS10NTSNZ>8Y=TR (^%&1DG(Z5LZ4=?UCQI8V6L
MZA>V+0:':WEU:6\H0/<^:ZMDKD;3CD#KQV% 'I-%%><^.]0NA>:G_9]QKCSZ
M;IOV@I82QPPVSG>RR2EG'F9"_<PW"GCF@#M--T+3])N;NYM8Y!-=R&25Y)GD
M.22<#<3M7))P,#FM*O-/M6IZ_-XCO3K-Y8OI5E ;6.WDV1!VMQ,SNO1P2V.>
M@'&#S69#JVN:S'96R#7[AX= LKA'TR>*,_:)58F24NZ[_N# Y'WLCD4 >O4Q
MIHEF2%I$$K@LJ%AN8#&2!WQD?F*\\M(M9\0>(+NRU74]0TYHM%LIY;:SG\OR
M[E_-W$,OH5Z X.!G.*R_#[W&O>*? VIWU]=FXFT"2XDV3%59PT.<J.,-_$.^
M!Z4 >M4QX8Y)(Y'16:,DH2,[21C(]\4^N"N8[WQ!XA\4HVL7]BFDK%%:):SF
M)59H1(9' ^_RP&&R,+TH [VBO,-%U#5?%GB30OM.J7EI;S>'+?49X;63RQ),
M9"/P4YY Z@ =.O7>.=3N]'\&ZA>6)<70"1QL@!92[JF1NXR-V1GC(YH Z&H;
MNVCO;2:UE+".5"C[&VG!X//:O+[Z_P#$>CZ3JHABUNRLIQ:0P7&JSQ32PRR3
MB*1D97<XV.",\ CBF>*I=2\-7>NVMEKFI/#%X;ENH1/<M(\4HE"[PQYZ#C/3
MG''% 'ING:?;:-I5O86H<6MK$(XE9BY5%& ,GDX I+'5K/4;.UNH)2L=UD0B
M9&B=R,Y&U@&SA2<8Z#-8.IZA=1>.=*M([F18)-)O)GB#<,ZM"%8CU&YL?4UP
M.A&[\06GPPN]0U/4'N+AKOS9%N&5F*QRD'COVSZ<4 >LZOHMEKMM';WZRM%'
M*)0(YGBR0".2I!(P3P>#5Y$6-%1%"HH 55& !Z"O,I-:U:'2K[PC]OG_ +=_
MM9;"WNBV9?LTI,HFSZK$)!GU2N\U^^DT?POJFH0+OEL[*6:,-SN9$+#/KTH
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M$-KLAC!,TTB[Q&F2 2%Y.< #O0!HZ/H=MHJ3^3+<SS7#AYI[J9I9'(&!DGL
M. .*+K0K&\UVPUF9&-[8I)' P<@ 2 !LCOT%8]QX^TRTTQ+NXM-0CE-\-.>T
M\H&:.<J6"$!B#D8P5)SN%:EWX@MM.\.G6M0@N;2((K-!(@,P9B%5-JD@L20
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M6 ^5>6+$ 8/-)_PFMBUC!+%8W\MY-<O:+IR1K]H$J EU(+!1@#.=V,$8)R*
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M%)?+9^88P<X&,X[&M&SU*VOY)HX#*)(=OF)+"\9&>G# 9Z&HM<M_M>@W]O\
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MV3Z;&Q_O(P[5=T5-1TCP#IT/]G22ZE::?%%]D$B M(B!<;MVW&1USTKG=?\
M!UV_@ZWDTU;V77[.:.^MUDN?E^TA]SL5+[!N+/G!_B.* -GQ%KTMMXBTG0H)
M;JV:^29WN8+4R,@11@+E&4\L">#@#G&:PHM>U6].L6TOB&:P?1&B2:\_LH^7
M,OE*\CLK*=I^?@!A]T'!!K9O(-4OO%_AC5/[(N(H+:WN5NMTL1,+2! !P_S<
MJ>1GM5--+U;/CK.ES#^U"39_O(OWO^CI%_?X^93UQQ0!;DUB\37_  A!;ZC]
MHL=1MIGF<PJIGVQ!E?IE<YS@8J[I_B'3UL9;B76&O$DOY+:(_9RK!]Q_<JBK
MEBH!&<$\$FL>VTG58[[P+(VFRA-,LY(KP^9'^Z8PJ@'WN>0>F>*I6VF>(K.S
M8+H\K))XAN;N:-)81-]GD+E6C8OA3E@#R&P3CUH Z*]\;:7;6VF3P?:+J/4+
MPVB&*WD.QUW;PPVY##:PVD9R.G!Q?N?$FDV=TEO<71C9YE@#F)_+$C8VHSXV
MJQR."0>1ZUP]IX>UZUTRQ!TB1I++Q-+J'E"YC9I(',N&#,W./,7[Q!.#QZVK
M30]2M]8U'3[[PQ;:C:W5^]Y;ZC)+&T<0=M^)$8[B4;.,#GCIUH ZB*?4;'5=
M9NM3O(CHT<:20$P[##A3Y@+9.\< YP.N.U:%GJ5M?R31P&7?"0)%EA>,C(R.
M& J+7;?[7H-];&Q%\)860VI<+YP(P5R2,9'?(K&\(:7JFE2ZA!<SWDNF?N_L
M(OW5[B,8.]2ZD[E!QMR<]>V"0!NCZO>^*[[59+2[:RTRPNWLHFB16DGD3&]B
M7! 3)P !DX)SVK2M[^XTR%UURXB>5[EH[4V\+9F3;N&$&YBP ;./0G@5B:!I
MVI^#[_5;)--FO]+O+V2]MIK9X]T1DP6C=79>AS@C/!YQ4^LV.L3:]X?U^*S,
MJV,DZ3622+Y@BE0 ,"2%+*5!(ST8@$XY -)_%V@Q6,-Y)J")!-<_9%9D8%9L
MXV,,90YZA@,=ZJ:CXTT^'PMK6L:>TEP^F1R[X6MY$99%3<%=2H90>#DC&#G-
M<_>>&=5WRWL-A(SWGB.VU)K99(P888@@).6P6.PG )ZBI=3T76+BV^(4<6ER
ML=8B$=E^]B'F'[,L63\_R_,.^.* +^EZA='6M*-UXFG9+^$O%ITVG"-I&5"7
M^?:"%'##(S[D$4>(_%7DWVAPZ5>N//U>.SG(MRT<BY(=1(5VY!&.#G@^APMQ
MIVISZ[X/N5TZ98K&.873&2/]R6BV#^+GGTS7/V6B^)+7P]X=T*;19I9=&U:*
M62[2>+RYX59SYBY?=DAAD$#G- '>3>(])@OHK26Z*22S?9T8Q/Y;2_W/,QLW
M<'C.<@CK56+QKX>GN8H(]0W/+<FT4^3)M$P.-C-MPK9! !(SVS7.:/H>HV>H
M2Z7?^&;:\A349+RVU:22-D"-*9064G>)%W$# QD Y%5SH.M_V+)!_9$WFGQ0
M-2"^;%_J/M(DW9WXSM'3KF@#>G\8V5S:>(XQ<W.F#2BT+WKVCL(SL5MX!7!Q
MO'!Z@9QCFM*[\3Z1I<0%[?G,=ND\KB%VV1L<!WV@A 2#R<#@^AKF-1T36FT[
MQ]8Q:8\O]KAY+.59HPLA>W2+;@L""&4YS@8Z9JKXFT;Q'JNG:KI\>D2/%<:*
MD%LT5Q%'B8*^Y9CNW-U&T<IR<XSD '4+J5[_ ,+'.EFX#6#:3]J6+8O$GFA<
M[NO3M4&JZKJ%M\0-$TN*[V6-Y;7$TR>6I.8MF #C(!W\_3C%,LK'4SX\M]3F
MTZ6&T_L86S2&2,[)?,#[2 V>G< C/?O2ZM8:C-\1M!U*'3Y9;&SM;F*:99(P
M TFS;P6!/W#GB@"[;>-?#]Y<6T,&H;VN9FMXF\F0(95)!0L5VAOE. 2"<<9K
M(E\0W6I>(]9LK?4Y=*AT@P.TLMD6B=<%Y/,+J-HV\ AE]<D5EV^@ZW'H.F6[
M:1,)H/$CZA(OFQ?+"9Y)-V=^,X<<=>M3:OX8UC67\<VT=L]JNJQVXL[B1T*.
MT: $$*Q8 D8Y'0T =:GB?2&:=#=-&\$'VETF@DC;RO[X5E!9?<9JG%X\\,S1
MQ2)J8\N5HDC=H) K&4$I@E<'(!^F"#BLK4M,U37M1L]6DTJ:SELM-NH6@:2,
MM++,J ("&(VC:3DD=1[XA?1M7_X0SP98C3)3=:;<63740DB_=K$N'.=V#[8)
MH VV\=^'$AEE>_D189O)G#VLJM W'^L!7,8Y'S-@<]:NWWB72-.N9+>ZN]CQ
M&,2D1NRQ>8<)O8 A,GU(KCM;T#6KVP^($,&ERLVK^6++][$!)B%(R?O\<J>N
M.*9XKTGQ'K$>N6\6C2O'-':O9&.XBC5MI4NLOS L^00,Y7&,$'.0#J&\66<F
MKZUI9^TV[:; CR7+6[E5+!CD?+C "@C/7)QG%6+/7;&+1M+EEU"2^>ZM5FBE
MCMF,EPNU29/+1<@'<">,#<!W%8IT_5HO$/B6Y_LN1X=4L(!$Z31_+(B.IC(+
M YRPYZ8SSVJCH6B:UHEUX9U"33Y9EM]!CTJ\MDDCWP2)M(<9;:RDJ0<'/W3Z
MX .GD\7:#'#83'44:/4-WV4HC/YI4$D# //!XZY&.O%7M*U>QUNQ%YI\WFP[
MVC)*,C*RG#*RL 5((Z$ UP]CX7U33M0\/S"R=TCU>^U&Y5)$Q;).LH5.6&<;
MUSMSWKH/!UA?6$6LB]LWMC<:K<7,09T;=&[94_*3CZ&@"];^*-&NKI+>&\W/
M()3$?*<+*(SA]C$;7P?0FH-/\9^']4N;."SO_->\#_9SY,@20KG<H8KMW  G
M;G..<8KD]-TKQ)_;7AW4+[1)5ELI;M;OR[F(1 .I"F) V O3L&)ZYZTND:!K
M=KHW@JWFTJ59=,U"6:['FQ'RT9)E!X?G_6+T]Z -?Q3XJ^RRZ5%I=ZZO)K-O
M93E;<M&X:0+(GF%=H8#(X.1@]Q6SX@\1V_A\Z>L\-Q*U]=+;1^5"S@$\DG:#
MV!P.I_/'#P:)XDM?#FEZ!)HTUQ)IFM177VQ)XO+N(5N#*7&7#!L$Y!'4=>:Z
MSQA87U['HL]C:-=/8ZI#=20HZJQ0*ZG!8@9&X'K0!G67C*&PU[Q#;:WJ!%O;
M7L,5L?LYQ$DD4;#>57Y1N?&Y\>F:Z"Y\2Z19WK6D]WME26.%R(W*)))C8K.!
MM4G(P"1U'J*XO6M UR]TSQU#%I,IEU:6%K0>=%APL4:$Y+<<H>N.,4OB/2O$
M>JR:JJZ+*X-_9W-H8KB*-'BC>)G#C>"TORL,MQ@#!&.0#K]-\26VIZ_JFDQ0
MW*R:>R([O"ZJS%=QP2,8P1CGGJ..:DN/$VD6J:FTUTR#2P#>9A?]T",@GCD8
MYR,C%9VB6.HV?C'Q#<3V16TU!H)HK@2*5RL*HR8SNSE?3&._:L'Q)HNMR3^-
M;>RTF2Z37-/1+:99HU176)D*MN8,#R,8!!SR10!V<^O:=;3"*29RQ\O.R%W"
M^8<)N*@A<GUQ3+CQ'I5I>1VL]T4>2<6ZN8G\OS3T0R8VACZ$Y[5R>J:%J\]_
M%J&EVEYI^K)';IYJSQM;W*#&Y)TW'.W+X8#/(P3TI+#0]1M=6OM-OO#-MJ%K
M+J,E[;:I))&417D,GSH3OWH20,#G Y'6@#N+W4;73UB-S(5,K[(T5"[R-@G"
MJH))P">!T!-9TGB[08K&*]DU!4@DN?L@9D<%9LXV,N,JV>S 8JGXDT[4&\1>
M'];L8&NH]/>9+BV1E5F25 N]=Q )4@<9Y!.*Y^^\,ZJ7N+Z'3Y'>]\16NHM:
MK)&###%Y88G+ ;CL)P">HH [BVUG3[K1_P"UH[@+8A6=I9E:+:JDAB0P!&,'
MJ*YV'Q.\_CZ:Q6ZF734T<W;12VC1LK^8%##<H8C&?;K6AXWTB]UWP=?Z?IS(
MMY($>)9#A6*.K["?1MNW\:R[5=9O/&R:W/H%W:V_]CM;,DDT+,)?,#[1M<Y'
M!P?SQ0!K:;XAL(]!T^>75)-1,]L9UN4M6W3(N-TFQ%^4<CL!R*L7WB?1].A,
MUU=[(UB69W6)W$<;?=9]H.P'GEL=#Z&N&M?"NJIX0\/6CV&HV6L:;I[117MC
M<Q!X9>/D8%]KQM@'!R..U:-G9^)M'UJ\>XT6'5H=7M;;SFAFC2."=(A&ZLKG
M/EG&1M!(YX- &Q!K%PGCS4[*>\3^S(=+@O$#!56,L\@8[O3" \FM.V\1:5=W
M)MX[HI+Y'V@+-$\6Z+NZ[P-RCC)&<9'K7)^(?"^K:YJWB&%(C!#?Z%'8Q7>Y
M0AE5Y&(VABP4[P.GK5JXTS5-;U#1M2N=(-M+IEG<B6":1"L\LD83RU*L<IP3
MDX_A]\ &Y+XLT:WLY[N:YECMX(DFD=[64 1N2%;E>0<'D5/=>(=+LKF[M[FZ
M\N6TMQ=3*8V^6(DC?G'(R#TSTK@IO".MMX;U[2-/6\33KG30MI9:C.DCP3Y)
M\M) Q/EX 'S' .,'&:OWUEKFIZSJVH?V#<01W?AXV4223PEQ-OD.UL/@?>'.
M2,>_% '36GB[1+Z%I;6[>9044!;>0ERR[UV#;E_E!/RYQ@YZ&KMAK%AJFG-?
MV4YFMU+*VV-MRLI(92F-P8$8VXS[5QU_HVLQZ#X2NH-(%Y/I,0BN],>5%9U,
M01BK9V[E(!'/(S74^'K46VGNW]DPZ49Y6F-K'M+ G&2Y7@N<9)!/;DXS0!';
M>*]%NQIA@NV<:F6%F1!)B4KDM@[>, $\XX&:G;7]-4<S2%C,\"HL$A=W3[P5
M0N6 P<D CCK7$7O@W6XHM1^P%,:;J']HZ%'OP&=R))$;T&3(@]I#6S=Z'J&F
MZ]X>U6TB:_BL[>>VO(T95<F7:QF4,0"=Z<C.<-QF@#;C\3Z/+%92QWH9+V<V
M\#"-N91G*'CY6&UN&P>#6-XI\3&/PY=W>B7NRXLM0M[2?,/*EI8U9"'']V0'
M(]161/X9U6TMDU&"Q>>9O$IUA[&.1 ZQ%#'@$L%W=&(W8R2,FH;S0]?N=%\3
M0C1I1-?ZW;WL"">(YB4P%LDL "/*;CUQC/6@#I_%_B.+2-!U?[-=O'J-M9/<
M*8X&E\HX.PO@$*"5/WL=#Z53\2:UJ5C\+GUJUNQ%?I9Q3&4QJV2=N>",=SVK
M-U/2]>@NO&4$.E37UOKUKNMIHY8QY,GD>48Y S @9 (*Y')K4UO1=1U/X62:
M/%;!-1:QCB\EY%^^H7(W X[=<XH UK'Q7H>HW%Y!;Z@GFV:>;.LJM'MC_OC<
M!E./O#(]ZGL=>T[4+Z6QMYG%W%&LK0RPO$^PG 8!P,KD$9&1FN4\0^&=1\5W
M-[>QV[:;(='EL85N&4M))(ZO\VPL-@V =>=QXXYT_#$%U-=_;K[PI!HUVD'D
MR2F2.1Y"2#A&0G]WD$\X.<<<4 :NH^(]*TIV6]NC$$9%DD\IV2(L<+O< JF<
MC[Q'4>M1MXJT=;J[M3<R?:+22..>+[/)N5I#A!C;SN[$9KE[K1-1A\2:U!/X
M9M]:T[5IDGBN998]L+>6B,DJL<E1L!&T'K4VM:1J[^(;?Q-I^E%KS3Y5M4M"
MT0^UVQ!#ON+84C<2F2",'/WS@ VF\8Z=%KFK:=.EQ$NF6\4\T[6\FS#[R>0N
M, )U[Y(&<&IK3Q=HE_"TMK=O,H* ;;>3+EUW+L&W+_*"?ESC!SC!K"U#2]7_
M +<\43PZ7+-!JVDPPPNLL8VR(LP*,"PYS(O/3KS5>^T;68_#WA*Y@T@7=QI$
M:QW>F22HK2*8O+8JV=NY2,CGD9H Z,>,M ,-K+_: VW4KP1#RGW&1 =R%<95
MAM/RD U%'XY\.R)&ZW[!7G^S$M;2KY4N[:%DRO[LDG WXS6-+HUZ]SX=N;3P
MXEC'%JSWUS!"\0,:M"\>YR&PSDL"=N>.YQS0O] UN;PWXJM(])F,]_K:7=LO
MFQ#?$&A);._C_5MP>>E ':W_ (CTK3)3'>71CVR)&\GE.8XV;&T.X&U"<C[Q
M'4>HK$A\3G3==\5G6;TC3--:V,;"#/DJ\>YL[021GN>E9DFB:C'KNL6MUX7M
M]6L-4N!<PW<TD>R$E%!29&.2%*Y&T'-:^GZ//)XH\6-J-@1INII!'&SNA655
MB*.,!B1U[@4 ="-2M3>6]IO?S[B)IHU\MN4&,DG&!]Y>#@\UF>)M?@TO2]06
M.Z>.^AM'G7RX&E\H8.UF !"@D'EL#@^AK/\  6G7EMILDFH7*W+PLUA:S#J]
MM"[*C'_:/.3WP*I:CINMV7B'Q1)!IDNH6FMV:+!+#+&I@D2(IL<.P.TYW C/
M4\4 :&BZX;N+PU]KU9A>7>E"YEM!;@_:240E]P7Y=I)X&,[NG2N>OO&NHG1=
M;\0VMS<1)I5S=1"QDT]FBF6,%5W/M#*VX;B=V ."*T-*T?5X-1\%23:9*B:9
MI,MK=MYL9$<C)$ .&R?]6>1ZBJ<^A:W-\/O%VEC29A>:C>7DEM&98OG65R5)
M._ X/.: -O3KRX3Q'9Q7/B:XECO(GD@T^?3A$[;0 Y+[5( /(& ?FZD$5K)X
MGT>2\BM$NRTTRR-"!"^)@GW_ "VQAR/12:R-4T[4=0\4^'+M+&>.WM[6ZCN)
M?,CS"TBH%XW9/W3TSVJ+P7!KMCIVF:+JNAQPG2HO(_M#S4=)D5=JF( [@2,9
MW =^M &[;>)=(O!IC07F]=4#&S81OB7:I8X., X!.#CI7-6/C.;3M-O)M6:>
M\?\ X2!],@,5N3A?,5%SL'8$GU)X'6LW0=$\06</@NSGT65%T.XF2YF,\15U
M,4B*Z -DK\P/.#[&I6T#6_[&O<:5*9U\3KJD</FQ;I8!,K_*=V < \$B@#K_
M !!XCM_#^DQ:A-#<2+--%"BI"Q.9&"C<,97KWY[=2!3[SQ+I-@KM<W#QB.)9
MI?W$A\E&Z-)A?W8X/WL=#Z&J'C/3[_5?"ZQV5J9;N.ZM;G[.)%!81S([*&)
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MZ]16)K]E9_\ "/7NF7.DW6FW=OJ&FRR6AOFG@VR3[!)$V<_, X((!RH.,\T
M>T45Y#XS*VXUN\TNUFSHGV>W6\GU)XQ:N%1@L,84[LAUW;B-Q.,FK6M:9%J,
MOQ&N[F:Z:33U$EEMN'06[BS1]Z@$<YQ^7N<@'IAOK87KV8E5KI(A,81][820
M#^8(_"FZ=>'4-/ANVM+FT,@SY%R@61.<?, 2!^=>=Z596]S\2)]2E5FNSX;M
M;GS/,;_6,9%)QG'0#CIWZUD>&7;6O _@[3I;6?5+M[.YNGAFOVMX2BR!=\C
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MZF6)'E2%2QZN[!57ZDD"IZ\6UC3K8O<Z.?-ETVQ\66$-LK3.?+258FDC!SG
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M'F0$[E93@_,K9P.X9AD5B/XOM-4/@^\-O?PMJ5W+$L4=R4$<B!@PD XD4%2
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M>J ,3A?]D8%+IGA'0='GCGL=.CBFC1HUDW,S!&QE<DDX^4<=L<56\->);OQ
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M%1T; W#D\$ Y4BM+1_$5S?:Y=Z/J.E-I]Y! ERB^>LJR1.S*#D 8(*D$?J:
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M.#)YGF;OKO\ FI^DWMU?69DO=/DL+A79'A=PXX[JP^\I['CZ5S8\>,8QJ/\
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M98XT0N,Q;XGDR?7[F/QJ+3?%]SJ=W;RP:%=-H]S</;PWZ.')*EAO:,<K&2I
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M.P\:Q0S);W.KSRR64RN?DW0(BL2.00RFNMM[6WLXS';0101EV<K$@4%F)+'
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M1--LH?B'I=O:1QV$6BQ7L=N/N1S;+@%U'8G8OY4[0="TJYO/"6CW=G$=+FT
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M) [V<+-!$T$19 =D; !E'L0HR/:J-GX1\/:>83::-9PM"7,96(97<NUN?0@
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M*W^?M8*_Z[*A/F]?E 'T%02^'M'FU"WOY-.MVN[:+R89B@W)'@C:#Z<GCW-
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M3/+R1W(YQZ9KD;'9K?AG2+2YL8=1FL=&DGDEU*]>.*&/S&17 "L6D_=GYN,
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M7<(M[@N@/F1C.$;U'S-Q[FKB*J(J* %48 '84 +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYFUF).#R<$XY/K5CQ+:C0W\7:193W36$_A::[>&>X>;9*-Z;@7)(W#KSSMH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4$-O\X^9E@*'/IR:S])T7Q%X:O+>>TTR*]^TZ-9V<X-RJ?9YX%89.?O(=_\
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M$9&6 R<9KU6\O+?3[.:\NY5BMX5+R.W0 51@O-.\0PWUC+:O(D3>3<VUY;D
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MH<"WFR,]CC..V<5EWGA?7-7_ +2U*:R2VN;[5K"=;1IE8QP6[)DLP^7<<,<
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MJ'_(-NO^N+_R->:^%;'6];\,>!;:;3XX+#3UM[UKP3JPE582(U5/O!CN&<X
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M>01I:_9YH]$8.#M:64SDD?P[9!&!_NU>TOPOJ\?_  CEY>0QK>KJUSJ6I!9
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MLP9054?*?+''N:]"TR%HM(MHC/+(WE#]X^"W(^F./I4+^'M*DGO)I;0227D
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M$Z'=QP,L/6N=TF#Q!I/BS5+72[6RNYX-&TZ"5)KAHE#A90&#!3D @Y&!G(H
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MWUS<LT!.TB25G'7IUZ5D7'A'49?!^MZ4KV_VB]U:2\B)<[1&UR)1DXZ[1^=
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M/KVVAU6]CT$/IFDWK6EW.UV%<@,H+1IM^; 8$@D>@)JYHVNZU?>/O$&E7%K
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ML>&]&N?%-[.L]C?+<7-D_E>:T;QA&'7YAN(+=R/>@#TB21(8FDE=4C499F.
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M/4CI7&0W]_K=YJ,\>NQZ==:;K#0M$TCD>4KX5##D*PD7!!P3EN#P!6E\6/\
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MYG:YN/"_GR$3NJM(7@R=H..2>1C!XST%>DPSPW,7F02I+&20'C8$9!P>1[T
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M#Q<([P(PO?#FDSM.@'34V#Q8QZJ(W/\ VT6@#UD.K$@,"5X.#TH#*20""1U
M/2O(-&TF6UTVVOH1H5I'<:%<&06=R[SWZF-2)'!0;F5L$L22-Y'>NT^'&D6.
MF^!M'N+:!4N+RPMYKF;^.5C&#ECWQG ]!Q0!U>]0X3<-Q&0,\T%U#!2P!/09
MZUY!K[0RZO-K=O8Z?!)%XBMK07LTS->.ZRQHZIQA(]NX;<X(R<<U'?:18?\
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MRQO:2F6-4\QMJ!B 3L&$_P" UT5 !1110 4444 %%%% !1110 4444 %%%%
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M[9V$UC=6T%O#'RS((]^05*XPVX<9_A'7MT+Z9827\5^]G UY$I2.<QC>BGJ
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M(9X4[A@< ?,3@<T :[>']&?61K#:79G4E&!=F%?- QC[V,]./I3?^$;T,P-
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M#/S*#SR3]: .A6V@22:1845YR#*P7E\# SZ\#%4?^$<T3["MC_9%B;19?.6
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MKZXLVN)!'/%*6*JS"/.5+ [<$-BF:7X-UNPAT"!VTUH]+U6ZO&,<CKNCE\W
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M;/NMI5C6,LF%^<%57@[>1U%=!K=E<WWAR^T^U,;7%Q:O K3-L7+*5R2 ?7/
MI-4UR#2K[2[6:"=SJ-Q]FBD0+M5]C/\ -DYZ*>@-:= '+:/I_B'3M!T;2FM]
M+4V44$$ERMR[D*BA69%,0^8@$#)XSWZ'*N/"&MS:#J]B/[/$MYK:ZC&3</M$
M8E23:?W?WODQZ<UWU% 'F7CS2;^UT3QWJ\_V86M_ID$4825BZF+?G(*@8/F>
MO;WKIY=$O[_71K-U':QS6^GRVEO%',S*S2%2S,VT8'R*!P>I-=#<VMO>0F&Z
M@BGB)R4E0,OY&J%IJULVM7&AQV=S ]K$DBNT&V&1#C_5MT.,@'TH Y?0_"&L
M:!)H-[$UE-<V6DC2KN$S,J2(I#*Z-LR""#D$=#UXY@U?1[#2?!MUI%SJ,$6M
MWUU-J-FJ. YO#+YB>4IY8*Y1?<=<9KT.HW@ADFCF>*-I8\['*@LN>N#VS0!R
MFK>%]2_LO19-(N;8ZKI<YGS= ^5<LZL)0V,D;B[-D X-%]HNOZDVA7$ZZ:DU
MEJ0O9HHY7"(@B>/8AV98_/NR0/2NOHH ;)&DL3QR*&1P592,@@]17GUO\.;F
M*TTI6U$-<6-P\!D(/S:<0R"W_P"^-ISV;/M77ZSKD&B?83/!/(MY>16:-$%(
M1Y&PI;)''TS6I0!S]UI%_)XYL=:B%L;2WL)K5E:5@Y9V1@0-I&!Y>.O?VK!M
M_"&MP^%-%TLG3S<6&KB_D;SWV,@G:7 /EYS\V.F.*ZG5=<BTVXCM8[6XO;V2
M&2=+:WV[V1-H8_,0.K* ,\D_7&A:SBZM(;@1RQ"5%?9*NUUR,X8=B.XH Q?&
M&CWNNZ!]AL?LXE-S;S$SR,J@1RK(>BGD[<?C6'K/@O4M:O/$;M/:VZZC'9M:
M2*[.T<MNQ=2Z[0-I)'0]!7=UCZOXB@T?4M/L)+2ZGGU!F2W$(3#,JEB"688^
M4$\T 95WX:OM:OKC4-1%M:W#:3-IT4<$C2J#+@LY)5>!M4 8]:V?#EI>Z?X>
ML++4!;BXMX$A;[.[.AVJ%R"0#SC/3C..<9,UCJ1O)YX)+*ZM9855BLX7Y@V<
M$%6(/W3WJ]0!S>F>&7T[Q9J>I+.IL+EA<16P'^KN&4+*_P"(1<>[/ZUBS>"]
M6FAOY1-9QW8U]=:LL2,R$JJKY<GR@C(##(SC=[<]]69J6N0:9J>EV,T$[-J4
MS012(%V*P1G^;)ST4] : .>U?PIJ&KP^([MA:Q:AJNEC3(8_-8QQ)A_F9MN2
M<R'@+T4>M4M>\(>(-9L[ZR:339+:YTA;2%9I7(M)PK!G50F&W97YC@C'0]#Z
M#10!Q=SX3U*_U.[>YDM%M-2T-=+N_+=B\3 R<H-N&&),9)7IG'.*O^&;/Q-:
MQQ0:XVEE+:/RUFL]Q>Y(& S!E 3CD@9R>X P>EHH Y#Q3X=UG6M0G6"2RETZ
M?39+80W3N/(G8G]\%"D.<$#D@C'!Y(,>D^'-;L=8T^^G73V%MH@TYE2=^9 P
M;(RGW?EQGK[5V9X!.,^U<[9^+8]1%\;/2-2G%C</:S[1%Q(F-P ,F3U'3KF@
M#E[K21IG@+1?"\^I64/B>R$+Z<(9=[&5&VAU4@,5(+!N,!2WI7H-A91Z=I]O
M9Q$E((P@+=6P.I]SU-+"+>[$%\L*EVC!CD9!O56YQGJ/I5B@#@XO!.H#PW/X
M4EDMGTA[WSX[CS&\Y83-YQC*;<;LY7=NZ'..,5/<^%=4EC\4:<KVGV'7IB[7
M!D;S(4>)(G&S;@G"D@[N_/3GM:S-)UR#5[G4X(H)XGTZZ^RRB4+\S;%?*X)X
MPXH Q_\ A'=0A\2:E?6ZVGV2?28K"!&F8.&0R$%OD( _>8X)Z>]<O<VM[HO_
M  B.C)<:/'K&EZ8ZL\]X\ =<)'\C[#N!VDE2O&%.1@9]3J"ZLK2]14N[6&X5
M3D"6,. ?7F@#A=,TW5+ZVTA;*STN+2[ S03V7VMY;>8D*5F1]G[W:=^0P'S$
M\Y -/T'P?KFD)X2+R:>[Z/;7%I.!(^&23R\.OR\D>7T.!SUXY[U5"J%4 *!@
M #@4M ' -X+U=X+B82V:7L6OG6;,"5V1P1M,<AV@KE2PR <9%2:]X.U+6K3Q
M!<+]CBU#58+>V2-IF,<4<3%LE@F2Q+'MV%=W2$X4D G Z#O0!R-_X?U:Z\1:
MEJ0M]+F@N].@L_L]Q*S*^R1F<,/+QM*N1GGIG%7/"7AV7PY%?0*_EV,LP>UL
MA,TJVJ[0"JLP!P6R=O05.WB6.&?1(+G3KVWFU=F2-) F86$;.5DPQP<*>F:L
MZ-KD&MG4!#!/"UC=O9RK,%!+JJL2,$\?,* .5UGPAK5Y:>,;.U>P,.N,LD+R
MRNK1MY4<9# (1CY,@@G.>U3ZUX0U#7M6U.6:2VMK:]T9=/#QRL\D<H=G#8*@
M%06'?M[UVU% &#X>A\1J,Z^-+1HX]@^P%F$S<?.=RC;T^Z,]3STJIK&BZO<>
M-M(UNRCL7M["VGA9)KAXV<R;.1B-@,;/UKIFFB69(6D42N"RH3R0,9(^F1^=
M/H Y#7=%U_6])EMC'IEN?MMM/'$L[E0L<JRLQ;RP2S$8QC X.>M1WWAK5[F]
M\73(+$+K.GQVD&Z=\HRI(I+?)T_>9XST]ZUH?$R7*ZP+;3;Z:?2[@6\D"A-\
MC%5;*?-@C#@\D=ZW: //+"+4]/\ B#;VD4%I-<P>&8(I%-PRKE97&0=A)&1Z
M"KEAX,O-*F\*);R6TMOI(N#<L[LC.TP.XHH4C&YB<$CBNO%C:"\-X+6 71&#
M-Y8WX]-W6JFBZY!K8OC#!/";*[>TD68*"74 DC!/'S"@#EK'P5J$7AW3_#%U
M);/IEA>I/'<J[>;)%')YB(4VX#9 4G=T&>IP)H;2PUGXA?VEI6HQ7%K'"/[2
MB@<.C3QL1#N(/WAF0D=?D3VKMJCA@AMU988HXPS%V"*!ECU)QWH Y*WT+Q%I
M>O:DMA+ILFD:A<FZ,D^[S[5F WA5 *N"1D9(QGG/=-.T+Q%I&L7UO;2Z;)HU
MW>27BS2[OM%OYC;W0+C:WS$X)(QGD'&*[*B@# \7:1>ZWI=M;6/V<21WUO<L
M9Y&4;8I5D(&%/)VX_&LG4/#&KW<WC%D^PA=;L4M;?=.^4(C="7^3I\^>,]*[
M6B@#SG7/!?B+5],OM/>33)8+C2H[6W\Z60BTF52&*KLP=V1\_##'0]*MZW9V
MNO>(]'MH=0MAJUON@U6WMI _^B,@9XW'4*6$8!('WNG)KNZC2"&.625(HUDD
MQYCJH!?' R>] $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %<=\0;2"^3PU:W,8D@DUR!71NC
M#9)D'U!Z$=Q78U'+!#.8S-%'(8W#IO4':PZ$9Z'D\T >5:E'8:9JOBC3(M-L
MS:75_IB);2$Q6RR.H^=PN,KE!D?Q8 /6J26S_P!F^*;JQ-C)=:%JT&IP1Z=&
M8X24A3S0BY/WE$BG!Y;->N7&F6%VEPES8VTR7  G62)6$H'3=D<X[9H@TRPM
MF+06-M$3&(B8XE7*#HO Z#TZ4 >4:Q*VOZ1XA\5P/$UE<WEIIT$DV?+^Q1S*
M)6;'.QG:3=C^%:Z[P78-9:UK;"YT?;(MOOM-*4K'"X#?,0> S+MZ?W176165
MI!9_8XK6&.UVE?(2,!,'J-O3')IMCIUCI=O]GT^SM[2'.[R[>)8USZX  H \
MWU^WBA\?>*I[."!=6_X1I9;-PBB4S?OUW(>N[  R.P I=/M]$M]1^'[^'4M%
MN)4?SFM@NZ2W^SL7,A')^?9][^+WKT>73K*:]AO9;.WDNX01%.\2EXP>H5L9
M'7M3+32-,L+B:XL].M+:>;F62&!49_\ >(&3^- '-^.)();K0M/DM+":6>YD
MDB?46;[/$4C8DL@(#G!. ?KVKB/#]O9ZK/X5LKA;6YM$UG50(8DQ 5 D90J$
MG"=" <\8KUZ]TZQU.$0W]G;W<08.$GB610PZ'!'6DCTRPBN/M$=C;).6+^8L
M2AMQ&TG.,YQQGTH \MDT[[%I/B+4M+MU23P[XC>]MH8EV@1"&(S1J!T#(\G
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MVT72K.(Q6NF6<$90Q[(H%4;3R5P!T/<5)8:98:7"8=/L;:SB+;BEO$L:D^N
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MNP=(E5LMC<<@=3@9]<55U'2V8SWNDQ:?;ZQ(@C%[/:^8=N1D'!5B,#@9QG%
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MY'!YQGM7=)#%&C(D2*KDLP"@ D\DGZU5@T?3+6WEM[?3K.&&48DCC@55<>A
M&#U- 'E\UO<Q?#SPCJT=U=W^I7MSI4A6\NW9&E&",9R$R3@D#G&3DUW/@N]A
MU/1WO!/=/>M*RWT-Q*Q-O.#\T80DA #P .V#SG)UCHVEM;0VQTVS,$+;HHC
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M6S6SL?W++N\_/?Y C_IZUU=Y-);V-Q/##YTL<;.D6\)O(&0NX\#/3)X%>?\
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MXZU"SM+&:.QFBN;D32N-^VTB+)'@<' )R?4<=<74\ :E;>'7M+>]M#>IK_\
M;$!D5O+/[S>$;'/3N*U6\*WLVG^+8IKBW$^O1X4H#MB8VR0G.>2-RD_2@#J+
M6X6[M(;E 0DL:R*#UP1FN(G\;ZJFGW?B&.PLV\/6MXUN^96^T.B2^4\J\;<!
M@3M/4#J*[2PMVM-.M;9F#-#$D9(Z$@ 5Q<_@K5GTZ[\.QWMD/#UU>-<,Q1OM
M"1O+YKQ ?=Y8D;CT!Z&@#2T;Q#J^L>)]5LDLK2+3=,O&MI9VD8R2?NU9=JXQ
MD%N<GH1BK7C#Q!<>&](@O+6T6[EEO(+81,^W/F.%X/KS4F@:'+I%]KMQ),D@
MU&_-V@4'Y%\M$P??*'\Z/%&ARZ]8V=O#,D1M]0MKLEP>5BD#D<=R!0!S]WK,
MFG^,]#BUO3[(WYTZ[GDNK9W(A5,$J@.,@C&<CJ*6R\8Z^[>&Y[W2K*.SU^91
M$8IF9X$:)I%#Y !8A1TXZ^U:6M>%'U;Q?I^KO,@M+>QN;26+!WOYH R.W8UP
MVC7DVHZCX*TF#6;'4%TNY.8;:)TF2*."1-]PK',;#*KM(Y+&@#0\*Z_K.D>&
MM)F>SM'TF;59+)F:5O/S)=.H<#&W 8@8ZX&>.E36OB_7["#Q->WYT]X+;6%L
M8FDD=8[?(B7<YQQ& VXGKDGH.:VHO!MU'X2TW1S=0F6TU1+YI,':RBY,VT>^
M#CZTD'ASQ#IMYKIT^[TTVVH7OVZ-;B-F+%E17B<= I"G##G..* .@T&]OK_3
M?.OTL]^\A);.;S(IDXPZGJ.N,'N#67J.N:O/XDGT30;:R>6TM4N;F:\=@H+E
M@B*%&<G8Q)[<<&I_">@2Z#9WJS"TC>\NVN3;V2E8(,JJ[4!]=NXG Y8\5!J.
MB:Q;^))];T&>Q$EW:I;7,-Z'VY0L4=2O.1O8$=^.10!POBC5-0\8R>!S%;6J
MV.HW$GF6=Q*^#-&KAEDV_>4%3CU/:O78E,5LB; "B ;4Z<#H,UQL'@.2T'A!
M(;U'70YI9IW=2#.TBMN( Z?,Q.*Z^]M_M=C<6PD:,S1-'O7JN1C(^E '"6WQ
M O%NY[:\71Y)_P"S[B\6WL;T3/;/$ ?+FQQDANHXRI^M6;/Q9X@FN-&%QIMA
M''K=K))9JDS%XI%B\Q1)QC!&>G3WZU2B\"Z[]ETZ&2YTF)++3Y].6*WB=59)
M(PID)_O95?EZ#GDYK>_X1V2W;PK<2W4*QZ%"XG9L@.# 8\@]AGGGM0!5@\;R
M7OA_P[=VEHAO]7NDMFMG8_N67=Y^>_R!'_3UK?\ $.JMH?AZ_P!42 SM:PM*
M(\D;L#N0#@>IP>,UQ?@S3;;4/'6MZ]87'VC1(I7_ +/91F,SS!#<.A_B&4 R
M.,L^*[W4HKR;3IX]/N$M[LK^ZEDCWJ&]QW'8_6@#E8_%NI16-G<3QZ5=Q7>H
MVUI%=:?<F2)TE;#$=PR_D<CWJ;6/&<FDWNNV_P!C68V$5G]G4/M,TMP[(JD]
MAN"\^A-9;^!=4F6]OE?2K+49+NTNX8+6-OL^^!F;<_0DONP2!T5>N*FG\$ZK
MJC:[<ZCJ%K'=ZC'9M ;>-BEM+;NSKUY89*YZ9^;IQ0!4\6WWB1-'BBU/3K7S
MHM5T][>:SG(CG)G7,9W?,I! R<$$,/<5TFA:UJEQK^I:+K%O:)<VL,-S'):.
MQ1XY"XP0PR"#&?KD=*H77A[Q)K4:MJVHV*E+RSGBMK9&\I%AE#L=S#<6;IZ#
M ]S6S;Z-+#XPO]:,J&*YLH+98P#N!C>1B3['S!^5 %;Q/KU_I%UHUIIUG#<S
MZE=-;#SG*JF(W?<2 >!MY]LU@W?CO5].AN+2XTRUEU>VU6WT]HX96$4HG4-&
MZDC*]<$'.,'K5SQREW)KO@\6$L4=T-2D,;2J2AQ;2G!QS@@$9[9S4#>"=2O)
MFU"^N[0:A/K-KJ,RPAO+2. !5C4GDG )R<<F@!FK>-M3TN[?3I7T&*_L[-;J
MZ%Q>&))68MMCASR3A,ECP,CCFM+2/&T-]=W_ -JC6VM(M.@U2VE)YDMI$)9B
M.Q5E(/X4FL^&]2?7[C5=(.F,]Y;);S+J$)<1LA;;(F.IPY!4X!P.15?Q9X'G
M\0C3?L]]';M'$;*^;R]OGVK%"Z #@$E!CL-QH H6?B5K_P 1>#9]2TB"&[U&
MQNKE9-[;K9 H8 #H25*YST-6K+QIJ\MKH^M76GV<>B:O<QP0JDK&XB$I(B=\
MC:<G;D#INZG%:NI^%WO_ !GH>LI)$EKIUO<0/ 0<L)% &.P Q638^#-8BM-&
MT6[OK-]%TBYCGA=$;SYA$28D<'Y1@[<D9SMZ#- %H^,K@>$)-:^R1>8NJ?8/
M+W'&W[7]GW9]<<_6G:;XIU'4_$]U8PPZ;]GM;M[::W-P1=QJHXF*$8*DXP!V
M(.>U9LW@K7FL)]'CO[!=+.JC48V*/YS W G,;=A@Y^8=<#@5HW7AG5M0\26=
MW>2:8T%E>&Y@NTA*W?E_-B$GIM^;!.>0.F>: -KQ+K<?ASP[>:K(@D$"C:C.
M$#,S!5!8]!N89/85R$WQ'N;/3]4W+I6HWEFMM+&=-N=\4J2S"(J3U5E/YY4\
M5V'B311X@\/W>F&41-,%,<A7<$=6#*2.X#*,CO7/7GA76=6T2^M+U](M9)GM
MC$EE"0BB.59&+,1DEMN .@P.O- #&\1>+?[<OM#&G:1]M@M$ODF\^3RO+8NN
MPC&=VY#SP,<^Q99>-=9UZYTRVT73K-'O='CU-I+N5ML6YBI3Y1EN<8Z=S['H
M/[#E_P"$PO-:\Y/*GTV*R$>#N#+)(Q/T^<?E7$:3HNM:!XKTS3--N+&6[L?#
M44$@N XBDQ,PR".001Z'N/< !=:\_B#Q!\.=0>$VTLE[>Q3PA]P62-&1AGN-
MRG%:X\;ZJ=.7Q%]@L_\ A'FO1;#]ZWVCRS-Y(EZ;<;N=OIWI;3P#<VLOA.3[
M=%(VCW%S<W3%"/.><,6VCL-S'KVI%\%:L--7PX;VR_X1Y;T7(;8WV@QB;SA#
MC[OWN-V>G;- %F3QO+:^'?$-U<V:#4M(NGM1:JQQ,[$>01WPX=/S/I6=??$>
M6PO+LS-HZ6^G3QVUU ]WMN96(7S&B3^ZI?@'EMIZ5%/8V?B+XM12Z9=K/96<
M:3:NL6&C-S"S"!2P_C!=B1V\M<UL/X6U.VUJ^DT]]*^Q7]VMU))<VY>>$X4.
MJ=F#;<@G&"QZT 3Z/X@U?6/%&JV265I%INF79MY9VD8R29C5EVKC&06YR>A&
M*T/$VMRZ)86QM;=+B]O+J.SMHY'VH9'/5B 2% #$X':FZ#H<ND:AKMQ),DBZ
ME?\ VI H.4'EHF#[Y0_G2^)]$FUNPMA:3I!>V5U'>6SR*63S$/1@.=I!8''K
MF@#G=4\<:IH%CKT>IV-H^HZ9;0W<?V=V\N>*1RG0\J0588Y[5U^DOJDMB'U:
M&VAN68D1V[LZJO8$D#+>N.*Y#5/!.K:_8:]+J-W91ZEJ=M#:1+ &,4$4;E^I
MY8DLQ)P.U=[0!Q^H>)=;DU+6H=$L;*6#1E7[0;J5E:>0QB0HFT$+A2O)SR>G
M&:R%\2ZOK/BI1:/;C1;GP\NH+&Y;>%D[\<;P1CTQ[UKZAX;UR+4]:FT2\L8X
M-953/]J1RUO((Q&73;PV5"\''(Z\U$G@R\TW6+";2[BV-E#HRZ1*EP&WA%.5
M=2.">>0: ,OP=X@UC3]#\%6]_:6@TW4K6.VB=96,R,L!<,V1@A@AX'3(ZU:T
M'XB_VMJ6EAWTHVFK.Z6\-O=;[F#"LZ&5/]I5.<?=) YK2M_"5Q%I?@ZS:XB8
MZ$4,QP<2[;=XCM_%L\]JC\-^%]4T*2RLC)I9TRP#)%*EN?M,R8(17)X7 (R1
MDG';)H G\#^(-7\4:1'J][96EK93I^X2.1FD+!BK%LC 7(XZGOWQ4OB#7=4L
MO$.DZ-I5I;33:C#<2>;<.RI%Y7E\D 9(.\C'KCIS5GP?H<OAOPI8:1/,DTEL
MK*SH" <L6XS]:P_%*:@WQ$\+MIDENMREG?L%N =CC]P"I(Y'7.1GITH 0>,]
M3?1FD>'2;&[MM0EL+V>]N]EM$R#(92<,VX%<#MDYZ<P)X]U/4+/PX-*L+*:[
MUE[J'+SDPH\!(+A@,E#M8CC)&/6B'P1J]K<6>J1W.FW&IB[NKJY2XC?R-TX0
M93'.4$:@9Z@MR,U/HO@G4=.OM#DN;ZWFCTJ[OY@RH5:5;C<1D= P9CG'&,4
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M);>14M)=0@ESQDD*B@Y !_#-<YHNE:>VB_"D&SA.\EWR@^8FU=^?7YE!^H%
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MO].>E<QY+^7X#U*52L^K>()-2D!])5=D'X)L'X5G>(O^1'^*_P#V%T_]"BH
M]QEN(H+9KB>5(843>\DC!50 9))/057M=8TR^NYK2TU&TN+F#_70PSJ[Q_[R
M@Y'XUC^//^2;>(O^P7/_ .BS7)^)].:UN=%@T6W6&[D\.ZE%"(5PS$1P[!QU
M.XY'N: /0+?7]&NY+B.VU>PFDME+3K'<HQB ZE@#\H'O4?A_Q'I?B;3S>Z7<
MI-$'9& 92RE6*\@$XSC(]00:X2QN-$O]1\ P>'WM))K='-PEOM+0V_V=E=9
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MKN+%K>R\3ZOI\.+G0?$AOXHXQC<@MX?.0?[R,_U.*ZOP*HU%-4\4,#G6;G?
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MYH(RRO+'*K*I7[P)!P,=_2LK3/&7A_5-)GU2'5+6.S@E>*626=%"%7*@DYP
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MUG3WL;;4FT^&?*W310AI)$(P0K'[I(XW8-:5K:PV5G#:6T8C@@C6.-%Z*JC
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M\@R(DF\ !CGJI(W&NVHH XO5?!>HW5UKR6&L06EAKD(2YC:T+R1D1>5^[;>
M 5 SD'IQC/#M4\(:KJ.GKI#:Q:MI+Q0QR1S66Z6(H "8G#@*3C/S!BI.1Z5V
M5% &3XAT9]:L(8X+D6UW;7$=U;3%-X21#QN7(R""01D<'K6;<>&]5U.VM/[5
MUB&6X@U.&_ AM=D:+'C]VH+%N<9W$GD],<5U%% '-W'A4SS^*)/M@7^W+9(
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M"S<X')S^ K9HH XO3_!>H0#1K&^UB&YTC195EM(DM2DSE%*QB1]Y!"@]E&2
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVL=O'^KSD9Z^W.OK?@[4-8L/%$@:TBO]:M8[.-3(QCBC0-@EMN2278]/0>]
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M^S#G&=P\M0Q( /MS7%:-X?TE](^%[-80%KH'[0Q09F'V5WVN?XEW*O!XX H
M]?2[MI(4F2XB:*0X1PX*M]#WZ'\JQO$WBFV\/>$;[Q#$JWT-JH;9#*,/E@N
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M=PK;7 4QN[A0<C('/?VKQ^[MK> ^)M/*Z&5/A25_(TR(B(,F2F22=[KG(/!
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M<M&\<:L!+Q@@@\[>F,<]:O\ PVU+5M8\$6.H:O+#+-.&='3.2NX_>SW^G;%
M'2BQLP+@"U@ N<^>!&/WN1@[O[W''-!L+-HK>(VD!CMF5H$,8Q$5& 5'\)';
M%>>:9XLDL],O9-+T6U2:;Q3-IIB$K!9')_UK$YP20"<#IT%=3X=UK4;W5=7T
MG5H+5+O3VB;S+5F,<B2*2O#<@C!!H UGTC3)+J6ZDTZT:XE"K)*T*EW ((!.
M,G! (^@JQY$/VC[1Y2>=LV>9M&[;G.,]<9[5Y1XKU37;FU^)%G<RVQT^RLT6
M)$+;DW1[EQVR0?F]QQ732^+]3T34)XM?LK2.W_LN?4HC:R,SHL.W=&^1@G#C
M!''6@#K;RQM-1MS;WUK!=0$@F.>,.I(Z<'BC[!9^1-!]D@\F8DRQ^6-LF0!\
MPQ@\ #GTKD_#/C675M;ATR[FTB62YM&NHCIMWYWE;2H:.3W^<8/ .&XXK#\9
MVNI:I\5?#FGO'8SV(MYYXH)VDVEE"99P."P_AH ]%GTK3KJ[AN[BPM9KF#_5
M320JSQ_[K$9'X5;KCE\97#>$8=9^R1>9)J@L#'N. OVOR-WUQS]:QK?Q9X@L
M;OQ/<W@LY[:UUBWL8HP6!3S# G'MB0M_O$]J .U;PQX?9BS:%IA).23:1\_I
M5Z.QM(MWEVL";HUB;;&!E%R I]ADX'O7,>)/&%QH=UK<45K%*-.T8:DA9B-[
M;I%VGV^0?G5*]\9:KI]OID=^-&L+S5&DE@:ZN66*"!54_O"<;I,L!A>.>O'(
M!V@L[51 %MH5^SC;!A!^Z&,87TXXX[5B^%O"=EX=TG3X&@M9M0M;<0->K JR
M.![]<>V:G\+:^OB/0DO]L0D662"402>9&7C<J2C=U.,@^A%<W8_$"9-7^RZH
M=(PUM<7#06%X)IK3R@&*2@'!)7/(P,@CGK0!VO\ 9]D(;B$6=OY5PQ>=/*7;
M*QZEACDGOFJDVER66D/:>'$T_392<IFUS$N>IV(5R<>]<S8^+O$#77AHZAIE
MC':Z\Y,9AF9FMU\EI KY !8@#D<<-QTR_3O&MU+XLM='O3I&Z\DFC6VM;P2W
M-L8U9@90..54],8) YH Z+P]H<'A[0X-,B=IMFYI9G W32,2SN?<L2?TJ>#1
M=*M;::VM],LH8)_]=%' JK)_O #!_&N \.>+)X_!WAQM'T6SA;5-1N+1;?S6
M$<1!F;?GD]4R?J<5>N/'.IV%G?07\&FP7]IJ<=A)<M*ZVB+)$)%E8GD#!"X_
MO$<\T =\    , = *A>RM))WGDM86E>+R7D:,%FCZ[2>Z^W2N%OM<\4MX@\)
M6\?]FQ+>RW/FB*9I(IPD;$,"/X2N& ZANO2NC\1ZW=:;<:9IVFP0S:CJ<[10
M^>Q6.-50N[MCDX Z#J2* -C[+;@P$6\68!B$[!^[&,?+Z<<<4Z>"&Y@>"XB2
M6&12KQR*&5@>Q!ZBN$O?'>JZ=!<6DVF6LNKVVJ6U@\<4K"*43@%'4D97K@@Y
MP0>M='J6M7/A[P?<ZOK$4,ES:P-))%:$[';^%5+<\\#)]: -.UT^RLEVVEG;
MVXV"/$42I\HSA>!T&3Q[FHKC1=*NK:&VN-,LYK>#'E120*RQ_P"Z",#\*YM_
M$VN:3?1V>N6=@)+JRGN;9K21R%>)0S1ON'/#<,/0\5%I'BW6KF[\./J.GV45
MEKT1:$0RL986$1E&[(P00#P.G')H [8    8 Z 52FT72KB[>[FTRSDN778\
MSP*79?0L1DCVKE?$\NI1_$;PXFE1P/<26%ZN;AB(T&Z [F Y/3&!W-5&^(EP
M(K:QF&E6&K-=7-M<27ER5MH_(*[F4G!;=O3 X/)].0#N)M+T^XOHKV>PM9;N
M'B*=X5:1/]UB,C\*F2V@CN)+A((UGE $D@0!G Z GJ<5YH?$5]X@\0^$;[2X
M;0WCQ:G;N&F+0*T;1*S!E&67Y<KCKN'3DUL)XQU-_#YN)(M)L[N#49;"[N+N
MZ\NUB,9;YP3AFW84!>OS<]* .K@T;2[47"V^FV<(N<^>(X%7S<]=V!\W4]?6
MK!M;<O$Y@BW0@K$=@R@(P0OIQZ5Y;K'B!O$=OX$U#]RKGQ'Y$AMY=\3F/S$+
M(W=3MR/8U/X3M=2O?BWXHO=1CL99+&2")7#2%H5:#($0/ !S\V>^: /0[31]
M,L$F2STZSMEG_P!:(8%02?[V!SU/6I+'3K'3(3#I]E;VD1;<4MXEC4GUP .:
MP+_7-9N?$=WHV@VUBSV-O'/<RWCN%+2%MD:A1UPA)8],C@UPOB74K[QIJ'@,
MQ6]I_9^I-/(UE=.Y4RI&VY9-OW@I!QCO0!ZU>6-GJ-L;:^M8+J G)BGC#J?P
M/%"V%DD,$*VD"Q6[!H4$8"QD="HQP>3T]:Y?QYJ.L:5I6D#2)+>*2?5+2VD+
M[L8:51M&/X3T/L36#_:OB#2M<\<7UE:V$PLC!<W(GD<!]MI&62/ XZ'D^HX/
M. #TZN>\/>$[+1K=#/!:W-['<7$L=V8%\Q!+*\FT,<D8WXZUSVL?$<VUQ<"R
M?28TL[.*[EBO[ORI;@NI<1Q#U"XY.1E@,=ZO_$'4B_PMU#4;*::(26\4L<D3
M%7"LZ'@CD'![4 =?%;PP-(T4,<9E;?(44#>V ,GU. .?:J]II.FZ?-+-9:?:
M6TLQS*\,*H7_ -X@<_C7%:##X5DURU%C!XI6Z#%HS>?VB(L@$_-YIV=N]1_\
M)WXA.G6^JII%@]E+JCZ8(O/997?SFB1P<8"[@N1R>IH [BTT?3+ 3"STZTMO
M/_UODP*GF?[V!SU[TZTTK3K"VDMK.PM;:"0DO%#"J*V>N0!@UQE[XWUC2+'Q
M M]I]G-J&E26FU;9V$<R7#A1][D,/F]NE-UO7=7&G^)-"UFVLXYVT*XO;>6S
MD8J5"E&5MP!W E>1UST% '9P:-I=M8R6-OIMG%:2Y\R".!5C?/7*@8-+;Z3I
MMI"8;;3[2&(Q^44CA55*9)VX Z9)X]S7#^&M<U0Z!X5T+1H;1KMM!@O)Y[QF
MV(FU44 +R68Y[C 4]:OZ+XXN-0U;2[2\L8[9;W[5;,5<MY=Y;N0\><#*E0S
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MMV*:1;W-M9:/,Q-]%';_ +R92VXJK!@%W<[C@GDUT*JJ(J(H55&  , "O,]
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MQW5S(Z0VX62;[Y]/D"(,CJ,FN]M-2GC\/'4M5BAA>*)Y9A;R>8A5<G<I[@J
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M-6=8P6/5F8*H^I) _&@#EI_#.JZGI,.FZA=6,5K/=&74(K.$QAX1]V!3U()
MW,>2,COQGZIX!OKOP=J?ABVOX4L)+F*;3_,!)MXQ(KM$?5000OH"!VKJ=.UV
M/4=;U;2Q;312::T0=Y"N)-ZE@5P3Q@=\'VK5H Y#7O#.K:WJ:++-IC6,=U#<
MP7#P'[5;!&5BB$<<E3\V1@,1@U0;P/JFS4H5NK!HVU<ZO8M)&S$2,V6CE7H5
MP67(YYSVKN5N87NI+99%,\:+(Z \JK%@I/U*M^5$MS##+#%)(JR3L4C4GEB
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M5N5:9LC]XY/W>!]T9')Y/%/O_#TUWXYTC7UGC6&QMIX&B(.YC)MP1],5T-%
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MMV., 8QG/544 87A/0I/#^E36\IME>>YDN##:H5AAW'[B ]N,]N2>!6[110
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M+4M-N]3,,%W;3$36LGEE?)D3HT?!(QT^\1WKO'L;261Y)+6!WD #LT8)8 Y
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M-. @<<=65,$#MDFH(6U.W\'Z?XEEGNKK^Q+^<Y:1B;O3Q(Z;F&?G(3#J3UV
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MN K.%&Y@,X!/MD_G236\-S'Y<\,<J9SM=0P_(T <-XS93\&Y&W@*;2VPP/\
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M>%QU;J":]%_LO3]H7[#:[0=P'DK@'UZ5+]CM?M?VO[-#]IV[?.V#?CTW=<4
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M0VZHV[(C+DEF/4EO3TH I>+?&5]X;,KPW^D11VEDEP+.9'DGNNNX?*P\H8&
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MC(05#*>C>O:LF[\"WD\&HZ3'J\4>@:C=-<W%L;4F8;VW21I)OP%9L]5)&XT
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M,1M!9?49!Y[XS71>(;^UTG7+N2TO[:6\N#:BYT*^MM_V[ 4*T!X.0/3< 5Y
MYH [Q_$>BQZRNCOJMFNI-C%J9E\PDC(&,]<<XIK>)M"75QI+:O9#4"VS[,9E
MW[NNW&>N.W6N)T?4]%L#?Z)K4!N-8D\02S)9B/=-(6FW13*#CY53:=V< *?3
M%8\ES;#P)=>&"Z_\)2^L,PM<?OFE-WYBS ==NS#;^F!UH ]8BU2PFLY[N.\@
M>VMRZS2B0%8RF=X8]L8.?3%5)?%&@P7%I;RZQ9)->(KVZ-.H,BM]TCGH>WKV
MKSWQ';7%KXCU3P?;K(MOXJN(;B-T!Q&IR+SG_<C!^LE0:[;10ZUXKTJ_UV/2
MX=1:%;>V%B)9;B+R41?)Y!)5PPPH.#SWH ])O?%&@Z==/:WFL64%PA(:*290
MRX3><CMA2&^AJY+J5C!!;SRW<*0W#HD+LX D9_NA3W)[8ZUR'AW3[>;QYXX^
MTPK*TC6D+LZ_>3[,N1]#GFL3PK;7=YXCL/"]XLC0>#WE=G<<2EAMM#^$3,?J
MHH ](U/5M/T:U^U:E>P6D!8('F<*"QZ 9ZGVJ#_A(M%_LV'4O[6LOL,S;8[C
MSU\MFP20&SC.%;\C7/\ BRX@TWQEX7U74I%ATN 74;W$O$<,SJFQF/1<@. 3
MZX[UQ]Q!#J3174<0DTF^\:PS6V5^25!#M9QZJSJW/0\^M 'IM[XETJQ\,R^(
M7O(GTU(?.$R,,..P4]R3@#U)JM%XV\-R:7;Z@^LV4,$\7FH9)U'&0I[]F(4^
M]+XUB:3P#XBBB0L[:7<JJ*,DDQ-@ 5R&B3Z?K7C7PC=6\D-W#%X?FVR+A@L@
M:%3]",L/SH [.WUR-+C66OK[3$M;!U!:.?YH5VY/G9P%/I[5E>)O'5IIO@+4
M?$NB36FIK:%%PLF5W%U4@D<@@-G'TKC9+LV%_P"/Y6BM_+?6;%'FNHO,B@4A
M 967C(3[W7&0,UC^*+Q+GP?\0D&I?VA)-]AGBF\I8_/0.BF1%'5<KMW#KCZ4
M >ZS3Q6]N\\\B10QJ7>1V"JJ@9))/05FVGB?0KZPEOK75[*:UA<))*DRE48D
M  GMG(QZYJIXWNC9>"M2G%M!< 1JK)<1^9&%+ %F7NJ@EB/1:\PUF[AO5\61
M/JR:HMW8Z<8IUA6-+A4N6#[ O#JNY02,]<9H ]<L/$FB:H+HV.K65P+09G,4
MRL(QSRW/ X//3BLRU\::?JGB?3],TFZM+ZVN;:XFDFAE#%&C,0 X]1(3^ KD
MOB'933:MK$-E S,WAA@8XEY=%N%)4 =?EW#'O6A::QHVM_%'1+G198KB)-(N
MD:>$?(/GA*IGU7GY>HW>] '3ZAXNT?3/$MAH%U=QQWUZC-&K.HQRH4')SEBV
M%]<&K$7B;0I]7;2HM7LGU!6*FW692^X=1C/4=QU%<[XBNX-/^*'AB:[F2"*:
MSN[>.20X5I6:':F?4XX'>N4T^ZM9?!GACPW"R_\ "26NJV[3VH'[Z%TFW32N
M.H4KO.X\$-WS0!ZOJ6J6&CV9N]2O(;2W!"F29PHR>@Y[^U5IO$NB0:/'J\NK
M6::=*0([DS+L<^@/<\'CV-8GCK4182:&)+BSL89+QMVI7<0D6U(B<@KD@!FY
M4$^IZYKAM!U*VL-7TS4-2N\6-IJFIB>>>,1"*2;:T,CK_P L]R[\9Q][WH ]
M$O\ QWX=T^?2(Y=3MF35&(@E292FT*QWDYZ97;QW(%;6HZE8Z39M>:C=PVML
MI ,LSA5R>@R>YKSJ_P!5T2+5/!VLVL7V#1O[4O29Y4\N-F>*0>8/17;)!.,Y
MS70^.]1%A'HWF36EG#)?@-J-W$)$LR(W(89( 8D;03P-U &O-XJT"WTJ'5)=
M9L4L9SMBG,Z['/.0#GDC!R.V#6E%=6\]HEW%/');.@D657!0KC.X'IC'>O'=
M,OK&)9KB;Q*NEZG;:K=R07EY:J(7654;$B' 7S!AEY4G#8[BNT35)3\)9]2&
MCVWF#3I7%BD1$,F W1.NQA\V.N#0!T.E>(-'UWS?[*U.UO?)($GD2A]N>F<=
MC@X/?%3MJE@GVW=>0#["-UUF0?N!MW9?^[\O//:O/O">H02_$*+;K<&I1S:/
MY4,\$"PPLR2 F./'WMH.<9.,_6F^-8)8/%_]G0HWE>*X(+20J,@&*4>83]8)
M&'_ : .]GUJP2Q@N([^TQ=H6M'>4!)OD+@@CJ-H)X[ FL7_A.])L5T*#5-1T
M_P"U:JI*O:SAH<!2=P9L$J2-H..2:XW3+>2?5-1TF2-A#X5LKZ.,D8!,[-Y.
M/I""/^!5#H=W!IFC?"J]OI5M[6.*>-YI/E56:!@H)[$G@4 >E_\ "5^'_M\5
MA_;5A]KF<QQP^>NYG#%2N,]=RD8]014Q\0Z,NL#2&U2T&HGI:F5?,Z9QCUQS
MCKCFO-WMHT^&NJ2)"!*WB=I"P7DL-1 !^N !]*BMH0^J76CW_B%+6\;Q$UTF
MGK8AYW/G^9'(&SG84"Y;& N1VH ],M_$6BW>J3:9;ZK9RWT.?,MTF4NN.N1G
MMW]*72_$.C:V\R:7JEI>M#CS!!,KE<]"<=N#S7GEE>V$&L1Z3:7L6JZ?)+>&
M2P:UQ?:9E)&=@1SM))0;@"=ZX)K3\"ZC%)K2:;::E9:W96^G#R;^.W"3VJAE
M"P2D<9(YQA3\AR* .NU/Q+HFBW$<&IZM9V<T@W(D\RH2,XSSVSWZ4:EXDT31
MR1J.K6=J0BOB695.ULX..X.UOR/I7&W>IZ5H7BGQB-?DCA^WP0&U$P_X^81#
ML,<?]X[]_P HY^;IS47@?3I[7Q+ID>I0G[;;^$[.)_,'S(?,?<I]^ #]* /0
M7OHGTMK^UDCGB,)FC=&W*XQD$$=0:Q/#'C/2O$-CIJ_;[(:K<V<=S)91S NA
M9 Q&.O&:S_ ZE?A-9+C&VTE 'H 7P*Y/0;W3K_P_\.=*TID_M6TEBGGA5<20
M1B!_-=QU56+#D_>W#&: /3[;Q#H][J4VFVNJ6DU]#GS+>.92ZXX/'L>#Z5C^
M%?'.E^(-/TU9KZRBU:[@$IL4F!<<9P >>G..N.:XOP5"LK>&-/NO$"MJ6F/(
MTFF1V($L,@C=9/-<'(4EC\Q W$KBI='MHX?A]\.?+A",-4@<X7!RRR[C^.>:
M /1H/$6BW6K2:5!JEG+J$>=]LDREP1U&/4=QVKB;OXJ+I_@[5M8NK>U6[MM3
MFL+6V:;8)MDBINR>> VXX["L2RUJ.XU?PS/+?VL CUF8SZ=;VRQK8,ZSH!(_
M4.S,.N-Q)(%9]RC?\*A\5#:<GQ.YQC_I[CH ]BT74?[0T*"_FN;&7>K,TUG(
M6@."1E6/;CG\:@M/%OAV^BN9;76[":.U0R3LDZD1I_>//W??I57Q_:W=[X U
MRVL4>2XDM'"QQ_><8Y4>Y&1^-8=OJ>E^(/'?AN;P[-%<0V-G<_:GMQ\L,;*@
M2-\=#N&0IY&T\4 7? 7C9O&L5Y= Z?'#'(5BMX9R\Z*&90T@Q@;MN1BH[[XD
M:4;'5GTJ>"YN=-O(+:2-I!\RO)$C.,'.T>81GU4TSX1 K\.;,$$'[3==?^N\
ME<IJDUI)I7CK1YG0W<GB"VG:U;[S0M):C=CNIZ9H ]1T_P 1Z)JJ7+Z?JUG<
MI:\SM%,K",<G+<\#@\].*?I6N:5KD4DFE:C;7B1MM<P2!]I[9QZUY[X\LY[C
M7-?ALHF+OX<BW+''N+*MRQ8;?XOEW#'?.*V?![VNH>);S4[?Q'%K#BRC@D:V
MM!%$HW,R@L"07&6^7J U %V\\4:R?$]_HVCZ!!>FQBAEEEFO_(_UF[  V-_<
M/>M.#7&M-.6X\2)9:/*\C(B->"16 4MG>57G 8XQT6N U>XT.W^)VOG6O$-Y
MHX:TL_)^SWCP>;@2;L[>N./IGWJ[=S:/J0\')I>IR:O:PZ_AIYYC,P<6\K8+
M'GC*D?A0!UR^-?##16\@U_3MERYCB/VA?F8'!'7U('XBIK_Q5X?TNY-O?ZU8
M6TRN$:.6=596(!P03QPRG\1ZUYYK=I$/#?Q6=8%#O.>0O)Q;1,/_ !XD_4TZ
M[U;1-.UOXAQ:K)%'/=PP1QK*.;C_ $10(T_O-D_='/S"@#MF\22CXBQ^&1!&
M8'TDW_G9.[<)0FWTQ@YJU:^*_#]]<3V]KK5C-- K/(D<ZL55?O'KT'<]J\VC
ML-3'BJTL0KKJ8\ &#G@B?<!U]=U7["_TS5QX!T[1FC>]TYPUW"B_/:1+;.DB
M2C^#+%5P>IH ]&?5M.CTV/47OK=;*4(8[@R#8X<@+@]#DD8]<U#'XAT:76&T
MB/5+1M13.ZV$JF08&2,>H'.*\ZT:QG;Q/:>!I8W^P:#?2:D'(^5K?AK9,]\/
M(W_?FJ_A^$27>G:3?>(4CU"UUF6X;3$L09PXED8NS@YV,I/SXQA@* /3K'7]
M(U.[:TL=3M;FX5#(T<,H8A0VTD@?[0(IMYXBT73]2ATZ\U2S@O9L>7!),JNV
M3@<>YX'K7/?"RVB@\#Q2+$J237EXTC8P6/VB0 G\ !^%<EX\U,R/XMM/M=O9
MS1B';916@:>]18T?SF8\[%RPR!\NP\YH ]$TSQ=H^K^(=2T2TNXWO;!@LB!P
M2W W8&<_*3@^AXJQJ?B70]&=DU/5K.T=0K%9IE4@-G!P>QVM_P!\GTKFO"NI
M63?$/Q; MU$9;M[6ZME#?ZZ+[.@WI_>7/<4^2VBE^)FO221*Q_L"! 67/!DG
MR/QP* .CMO$>B7FI_P!FVNK64U[L\SR(YE9BN <@ \\$'\:F&LZ8UG;7@O[8
MVUTP6WE$@VRD@D!3WX!_*O.= MTAT?X4&.((0&)P,?>M)"WYGDUGZ+JUE+X7
M\ Z+','U&RU.%+NW4'=;E5D4B0?P\],]>U 'H6B>./#^OPS2V>HV^(KLVF&E
M7+.6*IC!Z/M)7U%:MQJ^G6OVO[1?6T7V2-9+CS) OE(V=K-GH#@XSZ5Y/!J%
MK!X:D2695?2O%QN;Y#]ZWB-VQ#N.RX.<^E6=4U^UN-:\4:A9-:SV,@TF+[;/
M%YMO&OFR9FQP&"'G.<9'7B@#KO$WCFTTWP'?^)=$FM-26U9$ 63*[C(JD$CH
M0&SCZ5)-XPCL_&][HU]]GMK"UTQ+Y[N1]N"TA3!SP!7F'B>\2Y\'_$!!J/V^
M2:2PGCF\H1^>F^-?,51U7*[=PZX^E=G-I\.J?&#6K&[CWVUUX:2&0>JM*P/Z
M&@#OKB^M;5[=+BXBB:XD\J$.P!D?!.U?4X!/X5#JNM:9H=LMQJE_;V<+-M5Y
MY H8^@SU->?^"?MVM:_:0:FKE_"5N]E([# ENF8H''K^Y13G_IK6SXCO;71O
M'^B:KJ\J0:8MC=0)<2\1Q3LT9&3T4LBL 3UP10!T%[XGT+3[*VO+O5[*&VN1
MF"5IEVRC&<J<\C'I3KGQ%HMG:PW5SJME%;SQF6*5IU"R(,9*G/(^9>GJ/6N$
MT_5="TOQ;9:S)$-)T*YTF2*QDNT\I!)]H9I,9X7>"K <$CMVJIX8LO\ B<^#
MI);9D@:;6+FSCD3!CB>0&/@]/E;(]C0!Z1::_I%^+0VFI6LXO YMO+E!\T)]
M_;ZX[^E.N=;TJR-V+K4;6'[&BO<>9*!Y2MG:6],X./6O-I;9[71]6UVWC/G:
M'XGN+T!1R820LRCV*,Y^HJ"YMKFX\-0>*WF^R?VEKT>H37$D/F""U56C@+*>
MJJ/+;VW$]J /2E\2Z&VG1:@-7LOL<KLB3F=0A8 L5SGJ K$CM@U3O?%-C+X9
MN=7T;5=)ECB=8_/N;C; C;E!#LN2#@\#U(]:X9;6TN[_ $B\CU5-8BN_%,<L
MDR6HCA,B6D@W)@D,/E7+#C(-4OB!&1H/Q+5$(#7>G-@#J<09/Z4 >JWOB'1]
M-OX+&^U2TM[N?'E0RS*K-DX'!]3P/4U%?^*O#^E7#07^LV-M,KB-DEG52K$!
ML$$\<,I_$>M>=>)$1?$7BVQU/7H]-AU-81# UD)I;J+R53$7()8.'^502"<]
MZT)K) GQ/,B"65K5(VD9>7 L5_J2: .O_P"$OT;_ (2[_A&?MD7]H^2)=F]>
M2>0F,YW;?FQZ<T7WB[1M.\3V7A^YNXTOKR-G16=1@@J%4Y.<L6X'?::Y30[R
M"T^(FF+=S+$]YX8M8X/,./-=9'+*OJ0"#BM'7+RWT_XK>')KR9((I["ZMHGD
M. \K20[4!_O'L* -FP\26HTQKS5-3TF-/M,D"RP7.8_ER=I9L?.%4DCM@T#Q
MMX7,$$W_  D&F^7/(8XV-POS,, CKVR/S'K7F?A^W6;0M 26+<O_  F<[;6'
MH)B#^>*U-:LX?[*^++B!=[J.=O)Q:(1^I)^M 'HE]XAT?3;^"QOM4M+:ZGQY
M4,LRJS9.!P?4\#U-$GB'1HM872)-4LTU%L;;5IE$A)&0,9SDCG%>7ZRJC5?$
MUEJFOIIL6J06XBA>R$TMU&8%3$7.68.'^502"<]ZT[J\M])\4-;6>IV][-<:
MG;?:]%OK8&9I/W:_:(6Z@*JJ^2"HVG!% 'I]<;'XNUV^U35[;2O#4-W!IMT;
M5Y'U(1,[!5;A3&1T8=ZZ>PU*TU-)WLY?,6"=[>0[2NV1#AAR!G![CBO/O#WB
MS0O#WB#QC;ZMJ<-K-)K#2)&^=S+Y48R !D\@T ==HWBW3M6LFFEW:?<170LI
M[6[(5XISC"=<'.1@@G.1BM&XU?3;0W(N;ZWB-JB23[Y /*5B0I;T!(./I7EE
MXLSPZCXPNK::ST^[\0Z=<HLT95DMH2B&9EZJ#R>><8J'Q;J-KK-K\0;JPE^T
M6S:58+'-'RDF))<E#_$,\9'<&@#TA_$EK<WFG+IFI:5-!/<R6\A>X^=F5<E8
ML9#,.X]*F_X2OP_]OAL?[:L/M<SF..'SUW,P8J5QGKN4C'J"*YCQC;1VWC#X
M?PV\2QPQ7TJJJ+@*!"0!6(UM&GPTU&1(0)6\3M(6"\EAJ0 ;ZX&/I0!Z'>>*
MM T^^ELKS6K""ZB3S)(I)U5D7&<D$\<<_3FM&ZN[>QM9;J[GC@MXE+22RL%5
M1ZDGI7C7B>]TZT\$^/='U!0=6EU"XN$MRA,CH2K1RC_9"@?-T&W%>C>/+S[#
MX5DE,=LT;7$"22747F10*95!E9>X3[WU H T+?Q-H5UIXOX-7LGM/-$/G"9=
MHD/12>QY''O2V7B70]1L;F]L]6LIK6USY\R3*5BP,_,<\<<\UY--/!J&K7\$
MM^NIK<ZUI,JRM"L:W,6\(751PR9&W=T./I6KXT@8ZOXO9(6>%;;2)[E$4G?$
MEQ(9.!U^13GV% '9Z;XPL]9\4C3=,N+6[LS8&Y-Q#)N(<2!=IQTX(/Y5I:EX
MBT71[F&WU+5+2TFF_P!6DTRJ6&<9P>V>,UR>D:II>L_%J2]TF6*YA_L/8US#
MRCL)@=H;H2 1GTSBLGQ]J#/?^)=.%S;V4S:2L<,*V@DN-2#+)\H)_@4Y' XR
M22* -O7?B);:;XWM/#D%SI<9\KSKN>\N=@C^8 1@ ??(.0#CBM;2O'GAS5M'
MN=4BU.VBM;:9H97EE4;2'9%)YZ-MRO<@BN;TJXCO?BIH=U!*LT,GA8D2J<AO
MWR=ZYJQNU7P[HJ+J<5D=)U^\.H/)$)!9EWN/*>1"1@$D $\#<#VH ]9;Q)H:
M:=#J+:O9+93[O*G,ZA'V@E@#G' 5B?3!]*CU;Q/I6D>%Y?$,URCZ>D'GHZ,/
MWH(RH7/!+< ?6O.S8VEQ)X<F34!JUO=^*6N3,+;RHF86[@E!R"NY,[AP237:
M_$2)Y/AOXBCB0LQT^7"J,G[I[4 5S\0=(35XTEO[*/29=/%W'>-,,,YD9-@.
M<'[IZ>A]*V[SQ)HEAI]O?W>K6<-I<X,$SS*%ER,_*<\\<\5RNB7-AJ_Q#M-1
MLY(;J'_A'E6*=,,/]>0P!^HP?I7(Z.\FFP>&KV;5X-&LELKZWCNKFW$D2/\
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M*V=(\3?VU#HLMI;1LFH6K74I\X_Z.HVC'W>3N;;@XZ'TH Z"C ';K37+!&*
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MJL*1WJ&WW@NJ[!)'\PV';Q@[AP/QL2>-/#D5FMVVKV_D-*T*NI)W.O+  #)
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M>,B@"#P_H^KZ:H&JZ^^J&-/+B/V<0X7CE\$[VX'/'?CFMMPYC81LJOCY2PR
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MNBQPV;("[# 9LR'< ,_+QR<]A6;8^#I[(^%P-3C==!@:!0;8@S QB/)^?@X
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MD(Q]T,PY[9S5S4(UUG4=2U.UA>;2KW7](6)S&0L_EN@D< CE>0N>AVFO7**
M.5TV-E^)VOR;"$?3;+YL<,0\_?UZ52U*_MO#_P 29-4U9S#8W.DI;V]RR$HL
MB2NSID X)#(1ZX]J[>B@#R;PKID\7B#P8]S9R1*L&K7$*21D&%))E:,$?PG8
MW3MTKJ_BA$\WPTUV.-&=VM\!5&2?F%==10!YYXK1M*\7Z5?'5'T;3UTV6UCN
M8[5941]Z'RSE2%W*!CUV8K,NXCX+T7P[XGTZ*]NX[>VGM)DDM]DTD4NZ2+*
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MY\ME.2V?XL>U>N44 >6:69=*^$ES+':1J\FJS&=YK;S1$AO2IF*'[VQ,,/\
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M(U :/<IQYF67<5R?+('45Z710!XK9+-):>#(2ERTUKXINO/$T6UTW/*P+@
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M._)_#'Z5V-5FU&Q1RCWENK*<$&500?SH Y>VML_&#4;EH3\NB6Z)(5Z9FE)
M/X"N3\)60E.@:/J.LWLE_IUS(\FFBQ0")PL@9G?;G8P8\D_-O'6O7$=9$#HP
M96&0P.012T >5>&["[F\2:?X4N89?L/A:XGN1(ZG;*IXM #WVI(WXH*R_LEX
MMOXBN5>>UBM_&?VF69(/,*1! /,"D'<%8JW0XQGM7M-00WMI<W%Q;P7,,LUN
M0L\:."T1(R P'3(YYH \LN(XK6QF\8V=_>:N]EJ\-S+/]E$8E3RQ!+Y84#<-
MCC)QR8_:J*Z-?6ITG0Y;>0_\)3#;3WY"G"2)*T]QD]MROMY]*]HHH Y'XHQ/
M-\--<BC1G9H  JC)/SK6;XOC?3/%FC7W]IOI&GQV$]JMU';+*D3EHR$(8$+N
M53@_[..]>@44 >46^G"T\2_#1;4W<]NK:E+YMQ!Y3 /&6&Y0,*/FP!QQBJNB
MZI)=:YX0NKB[E79>3+<V,5BL-OI\LD4JK$2$W;BQQRQR>>,BO8:B@NK>Y,H@
MGCE\J0QR;&#;''53CH>1Q0!XQIDKQ^'?#1^WS:?_ &1J5XE_*+;S#:-(TVQF
M5E(P<XW=MXK6$>FV-C::FGB/4;.XFO+N>WU6:P7R6+[ Z,F,;7*[E^Z3@D'U
M]6JF^KZ;%]L\S4+5/L0!NMTRCR 1D%^?ER.>: *7A2YGO/"VG7%U:1VDTD0+
M0QQF-1SU"GE0>N#R,ULTV.1)HDEB=7C<!E93D,#T(-.H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=V#8'0_O,?A0!Q$7C[4-2M-#C>^;3);C2A>W$UMISW9>0L4"A5#;5RK$YYZ
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M$"K,S"-02QVH0!ZD9X%+:^%KF/6+.\O=;NKZ"PDDEM(98TW(SJR?-(!E\*[
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M5U;RR+%H]B]E% P!#HP )8^O'ZT 85CX@\1)I?ASQ#>7\,MKK5S!%)8+;A1
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M#S[5!>6":Y=PZ3<WGVW[$L2824R"0C=C.S>"VWU/7'% '7:A_P @VZ_ZXO\
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MV101VLJM&/,9%!<DB5FP.$&1_+I/!MG%9>&8$@:_:.226<&_C6.4EY&<DJH
M4$L2!@8!' Z5YYX>LKRQ^''@Z[N;*Y\K3-8EN+N$0L72,O.H?8!N(4NK<#IS
M0!Z-'XOT&72[C4AJ"I:VTJPSM+&Z-$[$!0Z, RY++U'>K=EKFFZAI+:K;W2F
MP4,QG=2BA5SEOF XXZ],<UYCXDMY-?LO%^IV5G<2Z?>-I=O#N@=3<&.;,C!2
M 2H#@9Q@[3Z5Z+XLFN[;PCJLMA;+<W26KF.$Q^8&..FS^+Z=^E $5MXT\/W=
MC>7D6H 06<8EG,D+QE$.</M902IP<$ @XI@\<^&R+P_VFH%I%Y\Q,3@>5G'F
M+E?G3)'S+D>]>::V)KR'Q$;>XUC58[OP\T-O<W5GY?FR*Y+(BK&F  PZCJ2!
MG%=WJNE)?>.]+MY;4O8R:+>VTV$^3:SP#:3T&1G ]C0!TMSJEE9RV44]PJR7
MLGE6R@$F1MI; Q[ G/2JFJ^*-&T2[CM-0O5AN)4WQQ!&9G7<%X"@YY/]>@KB
M? =O?ZAKR0ZFK,/"<#Z9'(W2:9FQY@_[8K%_W\-;]Q:._P 7;&Z,#-%'HDZB
M78=JN9H^,],XS^&: -9?%6B-K/\ 9(OU-YYABV[&V>8!DIOQMWXYVYS[4EOX
MKT.[U@Z3!?J]YO>,+Y;A6=/O*KD;688.0"2,'TKS_2]-9=0CT?4=2UX746N2
M72V,-E'Y)'VAIDE\TQ9V$$$G?GDK[5##>7MQJF@W-W)JAFMM9D:\LDL!';60
M83(N"(PS$EA\VY@=Q)QD4 >B6/B[0=2NI;>UU%&>-&D)961613AF5F 5@.Y4
MD"DTSQ?H.KSF"ROP\@B,RAXGC\R,=73<HWKR.5R.17G,EO>7NCW_ (>\.R:C
M<6DVEW48L=0LS')IS[1MB$I49#$E-I+<#(.!6X]['XDUSPV^EVEVBZ9;7+W?
MFVKQ" -#Y8B.X#+%B.!G[F?2@#I]/\:^'M5O;:TLM2666Z3?!B-PLHV[B%8C
M:2!R5!R.<CBGVWB[1+Z_EL+.^62[42;5\MPKE.&".0%?!Z[2<5R&FV%Q%X3^
M&48M)5>WN(&F7RR#'_HDH8MZ<GG/<UD:;=WMSJGA:\O)-4>6.YG6]M?L BMK
M&62&55C7;&"?F.,[F'<D9% '8^$/'VFZ_IFCI=7D2ZM>VRR-$D3K&TFW<RHQ
M&TD<_+N)&*3P]XU%QIVOWVMRP6\.GZU<:=$8T;+*C*$&.2SG/0#GL*Y/0)#>
M^%O 6@P6%Y#J5C=6]S<QR6KH(8T1BSEB-OS9P.>2^.N:JV^F:A%IVH79^WV<
M5MXUNKN6:"W#R)"R,@E5&5@R@N#G:>,GM0!ZWI>K6.LV?VO3YQ-#N*'Y2K*P
MZJRL 5(]" :H)XQT"351IJ:BIN3,;<'RW\LRCK&),;"W'W<YJGX)MX%M]3O8
M+O4[P7EWYCW%_ D)E98T3<BJJ_+A0,E1DJ3SU/%VPE;P3IG@X6EV->M]3B\P
M&V<+&$NA*T^_&W:5!(.>=V.M 'I+>(-*73IM0-X@M(;@VTDFTX602>65Z9^^
M<52TCQ?8:QXCU;1(%E$^G.$9FC8!^ 3R1@8)QUYZCBN!OKEXO"NM>'OL5\^I
M'7VG\M;60KY+7JRB3=C;M*^]=#IR7)\:^,].BN;G3KR]EM[BUN5MMZE%AC5F
M4LI0\@K@T =;JVN:=H<,4FH7'E><_EQ(J-(\C8SA44%FX&>!7+>+_B)::/X/
M35]&EANIKB98+<R12%%;>%?>  05S]TX.>*CU."\T#Q)X<U75[RYU*UMHKN"
M:\%J,Q/)Y91F2)>!A&7..XSUKG-:L;R\\%ZW>065R(=1\20W=M$86#F(/"I?
M81D E&;D#@YH ]1T6YEO-'MKB:>.XD=<M+';O K<]0CDLOT)K-M/''AN_O+>
MUMM4226X;9$?+<(S]=F\C;NX^[G/M5NXTW5)=;CO(M>FALE*[K$6T15\=?G*
M[AGV->7Z%=QZCX%\,Z#9VMS_ &BNK17! MWVI&ER9'EWXVXV@]^IQUH ]*D\
M8Z!%JITU]147(F$#'RW,:RGHADQL#<CY2<TZ[\7:%8:L-,N=02.[W(C+L8JC
M/]U6<#:I.1@,03D>M>>W E7P3J?@XVEV=>GU.7RP+9RL@>Z\U9_,QMVA2"23
MQMQUK7MK^'0[SQ#I.I:1=7]U?ZL;BVMUM6D2ZCD$>UMY!0!-ISN(QL^E &WI
M?BU#;^(+K6)H+:VTW57LHW53RH6,J".2S$OCCKQQ6C=>+-$LM333KF^$=RQ0
M%3&^$+_<#MC:A/8,037F\.E:KIWB/5_$\D$U[IUCK\SMII@).QHXP;F/^^Z]
MA@\!L<FIM2L1+JOB+3[[4]>ABU:\2:WMK"RCD6ZC>.-0P=HB5*E2#EEVA0>*
M .[TCQ?8:SXCU;1;=91/ISA&9HV ?Y03R0 ,%L=>>HXJQ<>*M$M=8&E37ZK>
M%TC*[&*J[?=5G VJQR, D$Y'K6'X;E^R_$+Q=:3QS)+=3P7$!:%MDD8@120^
M-O# C&<US5SIK?VOK>D:CJ6O1&^U83PV5E91O'.C%"L@D:(X"X^8EQMV?3(!
MZ))XET>*RO[R2^C2"PE,-TS @Q/Q\I&,Y.X8P.<C&<U4U#QOX=TNYGMKS41'
M-;[?/3R9&,0*A@7PIVC##DX'O7%Z[:7-WXPF\5V^ERR:1I5Q%'=6P1M]^T>X
M&=4_B\G>-O!W;6QT6EN-:L;'7_B!'-;7,KWL<"0>3;/+YY-HH$?R@X/S#@X^
M][' !W.H^+="TJYCM[S4$CD=%DX5G5$8X5G900BD]"Q -1ZGXT\/Z1<SV]]J
M(CFM\&9%B=S&" P9MJG"X(^8\#/6O-ETBZTB*\TW6=1UNU6\TJS@$&GV<<XN
M]MN(I(PS1OAMP;C<HP^?4UTUOIDMO/X\C$$S![&"&-Y$RTNVU(QD<,<^G<T
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MSV=27'E1AEVG.!R><@UR/AJSNO#>M^"H]5MYXB=#ELB5B9Q',TL3+&Q4';@
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M$J)4*L,$@Y!Z'(J[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN#+Y=]Y$KVZ,"OEQR'<-A.6^8\'' H ["&VAMVF:*,*TTGF2$=6; &3^  _
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MDVED"$$#&TAR2W1<#/6E\4>)'T#7?#\3,_V2\DG2:..$R22%8\H% !.=V.E
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MK4FNV%MJLZV]JQC;+.Q( (QE>002>E $TWAY[KS/M6LZC.KP/"JL(5";Q@N
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MWT"Y"AODX(W'E<9[YIJ^*)K;X@:YI]]<1Q:1I^E17I8J/D)+;F)ZD8%27GQ
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M39H8'7;+"@8)DLI8$;FY!&>]0R_#VQEADA&J:FD4VEKI4ZJ\?[Z%0P4M\G#
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M[?=4<;F-:E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP]8:&]S+;&XEN+DKY]Q=3O-+)M&%!9B3@9.!TY/K6K0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7-?\
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M+R[6+SIC*K1;8^?G^8#*\'YAQ2P^,-!GTZYOUU!5M[5D6<RQO&T>X@+N5@&
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M45X@5C0M)\HP 3]S/IGIO!5_=76I:A#]OGU73XH8?(U"YL_(EW$OF)CM7?M
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MK$@9'!X'(YKG[K7?$J:/K.O+K(6+3-9DM8[,6T92:%;@)AV(W9PV 5(Z#.:
M/3J@CO+:6[GM(YXVN( K2Q!LL@;.TD=LX./I7)?%,7/_  @\K6MY):L+NU#&
M-5.Y6F1<<@^H/'ICH2*R#9:U_P )?XJ%EKTMK+;:?9L]P+>)WG<)+C<"NT+P
M<@ $Y&",<@'H3ZC9Q:A%I[W42WDR-)' 6&]U'4@=P*LUYS8^*]6U#Q#X35/)
MQJ>@O>RP[!@S;4(PW4#)Z9J]X(UF_O[U[;4]8N)+];8276FWMB+>6"3(!,9
M >+DC/S?P_-S0!VLTT5O"TT\J11(,L[L%51[DUGII%F^NKKUO*ZSR6XAD\IA
MY=PF<H6&.2N3@@C[QZBN-^)&M:8VJZ)X8U&[C@LKJ47FH%\D&",Y5"!_?< ?
M1367X<\91Z1\/?$=II]Q'>3>'-\=F[$D20-S Q]AG:?]R@#U6>-IH)(UE>)G
M4J)(\;DR.HR",CW!JKH^DVFAZ5;Z;9*RP0K@%CEF).2S'NQ)))[DFN2:[\1Z
M)XHT[3+O6_[0M[G3KJX9WMHT<2QB/^Z -HW<#KR<D\8QK;Q+XBA\#Z#JM]JT
MTMUKTD$0^RZ>)6M5\MW9HT127=@G<$ G(&!0!ZI17EDGC'6HX[?3)9=8B$U_
M)%'J1T5_M,MNL(DRL!C^]O;86V;<*3BK-OXA\2WLF@Z<+JXLY+O4+JU>ZN=/
M\F2:%(BZ2"-U&UL8'3&0>,<4 >E45Y7+K?BJTT'6M3?7O,_L/5/L@C-K$/M<
M8=,F4[>#MDP-FWIGG/$VJ>+]9_MC5Y+!]4?^SKU;>'3[;2'GAN%4(9-\PC.&
M.YL888P,@YH ]'O+5;VTDMWEFB5Q@O!(8W'T8<BL7_A$+7_H*Z[_ .#6?_XJ
MN2U/7?$L>D^)]<BUD11:+J,D4-H+:,K-&I0E9&(W=&(&T@CJ2>VKX?BOF^*7
MBQI-4GD@ACM ("B;2&1V SC(VY.,'G/.: -C_A$+7_H*Z[_X-9__ (JC_A$+
M7_H*Z[_X-9__ (JN>\<^(]0TNYU%]/U>XC?3['[2+.UTXW"EOF/^D.5(1"%
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M:M<7EK/JS6+P)IY6T1/F "S%<M(I49PQ&<C'% '3?\(A:_\ 05UW_P &L_\
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M Z;_ (1"U_Z"NN_^#6?_ .*J*Z\-:=96DUU=:WK4-O"ADDD?5I@J*!DDG=P
M*Y>XUWQ*FCZKKXUD+%IVM26B60MH]DT(N1'AVQNS@X!4CH,YS47BJ[UK6_#'
MCNZCU3[/9:>+BRCL1 A214A!=F8C=N.XXP0!@9!YH [%?"5HZ!UU;7"K#((U
M6?D?]]4O_"(6O_05UW_P:S__ !55O%6J7VC?#][_ $V1([R-+<1LZAE^:1%.
M1Z8)K"UCQ%KGA*\UF"?4CJ@32!?6YEMT0Q2^;Y> (P"4RRG!R>.M '3?\(A:
M_P#05UW_ ,&L_P#\51_PB%K_ -!77?\ P:S_ /Q5<@_B_7-)L=699-2OXTM(
MWM[O4])>S$=P\JQ;?N(&7YU8#KA3DFM77;OQ)X2T:ZGFUC^TDG>W@MYGLP9X
M99)0CD1Q* X"G*C!.1CG- &]#X5MH)XYAJ>M,48,%?4YF4X.<$%L$>U;M>:K
MK_B4Z=JD5J=:N8;>6V9+^?2##<^4Y(E"1-&JR,FT'A3P_0D43^(=3;2+"XM_
M$%Y<:7Y\Z7>J6>F*]Q!M"[$EB*';U?<0@Z+P,YH ]*HKS/7?$^H1Z?%+8^)6
MFFATH7?_ !+-,\]9W^;$DI*L(XSMX *G[W/%7[?5M>UWQG%8VVIBPL!I-IJ,
MB1P([L[NX* L#A2 ,GJ,#&,F@#O:*\ZA\5:S/X=M-*^T*OB9M6_LJ:41K\NQ
MM[S!,8P81NZ8RPJ_\2DO'LM!2UU":T\S6K2)C&B-G,@P?F!Z$ XZ'OF@#MJ*
M\\N=2\17L'B:_LM;-JFA.T$$!MHV6Y>.%9':4E<X8MC"%<"M;Q+XBO8/AH^O
MZ85ANY+>":(. P4NR<'/LQ% &]K>D6^OZ'>Z3=M(MO=Q-#(T1 8 ]<$@C/X5
M? P *\\U75]?\-WNI6<^L&_\S0KK4+>5[:-#!-#C@!1@H=X.&R?EZFDM]1\2
M2Q>&K&77"MWKRM=2W$=M'_HL:1!S'&"""264;F![\=  #T2LC7O#UOXB@BMK
MRZNTLP<S6T,@5+D<?+)QDKQT!&<G.:\[\0W^M7-N^C7&L2^?IWB2QMOM4<,8
M::.0Q2(6&W;N4GL #@9%6M2\6:Y%J6K?8I]5GDTJX2WAL[?1WGBO-J(TADE6
M,A6;<P 5E"X!(.: /4  H    X ':EKB;:Y\1Z_J.K7>FZM':0Z?J)LXK&2!
M6CF5-OF&1L%P3EL;2,8'7FF>!(KXZ_XOEN=4GN475FB$3H@&1##AL@ Y PN.
MF!TSS0!V=U=6]C:2W=U,D-O"A>261L*BCDDGL*E5@RAE.01D$5Y#XDBOFNOB
M@TFJ3R00Z5&! 43:0T,C 9QD;<G&#SGG-;=WK>M^%+V-[[4?[1MYM%N[XVY@
M2,0R0+&V$*C<5(<CYB3QUH ]$J 7EL;YK(3QFZ6,3&'=\P0D@-CTR",^U</X
M2U[6;K6K2"ZFU2^MKJS:6>2ZTA[2.VF&T@(QC4,C L,$L?E'/-+J5GJ-]\5[
MB&PU1]-']A0L\T422.3Y\N  X*XZYXSP.E '?45P'@[Q7JNMZMI=O>R1E9-+
MN))U1  \T5R(=X[@$ G'3FJ!\3:[-HFG7MQJ%Y:6+7%^EU?V5BMPT1CG*0AD
MVMA-H;+!>JCD9S0!Z*=1LUU)=--U$+UHC.+?<-YC!P6QZ9XS5FO/5\2:B?&5
ME9I?VUS;R>&7OC-!$NV64. '4G)"D<[<XJ'1]:\0Q1>#-4U#5_M4.N1A;BT%
MO&B)FV:560@;LY3G)(.3@#B@#TBBO+_#?B[7]4FTF]0ZE=KJ:NTUK+I+Q6UJ
M#&SQE)]@# $*I)9L[LC%.T_Q!XBETG4%CU.ZN-=CLUDETNZTY8IK>3<H=H1A
M1(@!;'+9(7GG! /2+RUBOK*>TGW>5/&T;[&*G!&#@CD'W%8VD>%+?2M1&H2:
MAJ&HW:0?9XI+Z57,49()5=J@<E5R3DG YJ'P;J9U*TN\ZU)J?E2A?])M!;W$
M!V@E)4"KSGD':.#WZUSLOBC4(O%5OY.K7%W:RZM]A>W33RMHB'*X$Y7)D4@9
MPQ&<C% 'H]0WEY;:?:2W=W/'!;Q+NDED;"J/4FO-UUWQ*NACQ#)K(,4.MFR^
MQ"VCV2P_;/(^9L;@P!X(('RC()R:I^+KO6M;\%>--0&J>59VDT]E'8"%"C1Q
MX5F9L;]Q.XC! ''!H ]3O;VUTZREO+VXCM[:)=TDLC;54>I-2HZRQK(C!D8!
ME8="#WKG/'^IW6C> -8U&R=4N;>WWQLR!P#D=B"#^-9(O-?UGQ+)I=IK1T^W
MCT>UN]\5M&[^:[2 _>4C:=HR,=AC'- '=T5Y3I>IZKK_ (D\#ZI/J<L!GT>>
MXFABB38S*T6\<@G#?F,<8YJSX5\6ZUJU[HMXSZI<P:GN-S;OI#Q6]HA1G1HY
MO+ 8 A5)+,&W9&* /3:H:QI46LV/V66>YMR'61)K:79(C*<@@]/P((/<5YQ8
M>*/$B?#[3M?OM5DEN=6FAM8T@L%D^S NP:141=TCE5)QTR1QP<V3XA\2?8+B
M-'UMK*"^C#ZFVCE+K[,T;$D0M& Q60 $A#\K9QGF@#M]$\/V^B&[E2XNKNZN
MW#W%U=.&DD(&U0<    8   K6KR_[1?:KXK\$S0>)VNH)4O3YT%NB"3R\?>4
MKPQ4[6'&"IP%-:OA36M4N=>^R:QJTT5^4E,VE75B(E7#<-;R #>H'4[FSG/%
M '=U3U/5].T6U^U:I?VUE;[@HDN)0BECT )[^U<]J%UJVK>,Y]#T_59-+M[*
MQCN9)888Y))7D=U4?O%8!0(R3@9.>HKAM5NM4\3/X!O;C4FM[A]3FMG$,,90
M31>:AE4,#R=O0Y ],T >R1R)-$DL;J\;J&5E.00>A%117EM-=3VT4\;SV^WS
MHU;+)N&5R.V17'_$U+Q?!D"P:A- XOK-))$1,R9G0<Y&!SAN,=,=,BLA[;6H
M_$?C*2QUV2UEL[2UD:86\;M<2+ 3\P*[0O'(4#KP1B@#TZF2RQP1/++(L<:
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M D 13E?E//;C/496X\8Z';VVGSBZDG74(S+:K:V\D[R1@ E]J*2%&1DD<9H
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M^&&6X2/1)C/#\P)E8A@Q<D<DEB3C')K7UK58=#T6\U2=)'BM8FD98T9F./8
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M5J4NH7.K27,2QVDC1O"\J.'$@&TC&>,YR,8KURJ6GZO8:J]XMC<+,UG<-;7
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M:]0==Z,NXKD8RIP1]*R]'T.Q\/QS^3+-)-=2AY[FZE+RS/@ 98^@   X'84
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M%;2W2'(_B*J 3^)R?QH X3PKX\N;MO$&L:Y/>PZ=:7DMO!;_ &(!$"R*B*&
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M1:W0W4?'RR[1NZ<=<]*T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@*% ZDD@ >IKEM=\:M_PC/B%;>VOM*UBRTR2\ACO(D#;<'$BX+*0&&".W<4
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M6;B);IPERT8 5I #\QPHR>^!G-11^.K#[)?7%U8:C9&TLFU#RKF%5>6!1RZ
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M7'IBLW1_%EB+6>22\O[L/KCZ8IFB13'*6P$&W&4'8GGUJ]JOC/2M'DU)+L7
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M++$\A._#=<'<00<TH\!:$-+ET[RIS!+?+J#[IV9FG7;\Q8\G.T$^ISZU%/\
M$#2HK73IDMK^=M1EGAMH880TCO"Q5AC/<@X[8Y.*EN?&]A:W<D4EEJ'DP-''
M=W2Q*8K1Y I"R'=G(#+G:"!D9(H GN_!^F7FHZG>2-=*VJ6QMKR))R(Y5V%
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M^<89$?;D\#<%(Y[D5S7B'3=8\5'6]0@T:[M%&@7&GV\-UL66>:0AC@!B !L
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M.6.2>>:]$HH \L\/^&-9M/#GAJVN+!TFM/$4MW.A9?DB/GX?KT^=??FM/5=
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MCEL)$O"EJENHC8J$W@&0LKC!4Y)!SBO4)[B&UB,MQ-'%&"%+R,%&20 ,GU)
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M$; , 5Z80&!! (/!!K TWP7HFE7T%U;0SYMMWV6*6YDDBMMW!\M&8JG!(X'
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M5L+>-H5>UO)8G9&.YE=E8%P3DG))R2>YI)/ V@O.CK;SQ1 1!K:*YD2"3RP
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M-8HUR3A5& ,GV%34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC*!PQ+D[P$+$#(YP": .AD^(0B_M&)_#>L?:]-42WEN!"3%"5W"3=YFUL@'
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MS@-SD9"G&,\UD+X]TAK;Q%/LN F@[OM&5'[S;N&8^><LCKSCD&K'C/3;S4=
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MH:+-I=MIMM.KK<2Q.9I90JD*$9OD 4\G&<CB@#7N/%&GP)HC())_[9=5M?*
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MV<=Z]TL;OYH8[F ()")D>V>]8[Z+8CXM^)9EBD$L>CQW*$3/Q(6?)Z_IT]J
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MI'S J!D],>]5=0BU/6M2UM;)FU 6%I;+I^IOJOD"#, <3X4;6W,22W0A<=*
M/7:J:KJ,.CZ1>ZG<AS!9P/<2!!EBJ*6.!ZX%>6ZE'K^L:IXBF2U0W]@T,=K=
MG5# EDP@CDR$QAE+LQ)/WAQVHUVTBU?P]\1=4U*>9;ZQ,]M;[;AE6&-;9"J!
M0<8<NV>.=U 'K,$RW%O%.F=DB!USUP1FI*\NU&W>SO4UJ^BN+O38HK0"YLK\
MI-IA"KD&+.&5B0QZDACD$8KIO&S)<+I6E_9KB[FO+H^7:QW7V>.4)&S'S7 )
MV#K@<D@=LT =717D&E>?J3>'-+N;B>.V&MZC:O%#>._[I$D(B\SAF48QDXX%
M/9&ADE\.+<7":2_BQ+,IY[Y$!MA-Y0;.X*7[9[X[T >FVNKVUWK&H:9&)!/8
MK$TI8#:?,!*X.>?NG-7ZX;P?96VG>._&%G:.YAB%D%1Y"_EYC<[<DDXYR!VS
MCIBN?U&P@O;7XB:C<7UVMUIEQ))9E+IT%JRVT;JR@''+?GC'K0!ZS17EVFK<
M:EXF\1ZK=/<2W6GV%G=6ML)76-)VMV8G8#@G( P>.3ZTRQM(K#2O VL6EU<R
MZAJT\$=](UR[_:UEA=I-P)QP1D8'RXXH ZC2_$>E6PU'2M%TC4)K?1B\4GV:
M &/S!@M$F6!+_-TZ>]=%%J%O)<16Q?R[J2'SQ _#A,@$D>Q(%>,6VF6VF>"?
MB;>V0FAN;;4+R"*19WRJ!8R._7/?K[UO0:;!<^/+2Y>=H+G_ (119Q<M*P$<
MFX*)#SC@<\\<9H ](U+3;/5["2QOX%GMI,;XV) ;!SV^E36]O#:6T5M;1)#!
M$H2..-0JJHX  '05P_@B Z3J[:7>V-S9ZDUD)&=;YKFVO%5@K3*6.Y7RPSD#
MAAUQ5=;9KGQ[XQOI)+B:32HK>:RM_.<1K*8"2=H.&)P!S[^M 'HM%>0:,NO6
M&D6>O6EL(7ETB>XN)I-3-PU\YAWH_ED8W!P.G0,1TJ_/:VOA[P/_ &]IFK72
MZQ/H<TX5[LR?;7\H.92K$Y93\V5QC..G% 'I=Q-]GMI9O*DE\M"_EQ#+/@9P
MH[D]J2SN/M=E!<F": RH'\J9=KID9PP[$=Z\PCL-4TK3]7FBMA864F@W+.O]
MJM<O-*%!289 (."V6'7*^@I=&U23P_9>"_$%]=RG3[_1%M+QI')59%B\Z-SG
MN0LBY[Y% 'I@L+5=1?4!"HNWB6!I>Y0$D+],L3^-6*\?BAUBZ3PY!>6DM\VL
MK>:M<V<E\UNI<F,QIN&>$1_N=,C/:KVFV-Y?ZWH'A_Q!*SVL5K?7"11WK2"1
MDG18U>0$%V1&(Y[C)YH ]#TK5[;6([I[82 6UU+:/O 'SQMM;'/3/2C1=7MM
M>T:VU2T$@M[A=R"0 -C)'(!/I7-_#6-(M&U:*.9YHTUJ]59'?<S 2D DGJ??
MO7%^'[&'3O _@[7+.XN#J,NJ06SOY[E7C>8H\6S.W:%SQCJN>N: /9ZR;NPT
M2RU1-=NX+>.])2V2ZDY8%V"*JYZ$D@<=<UY\]S>1V]S\/1=3B]?55BAF\P^8
M-/?,Y?=UX57CSZ@5O?$ZPMKO1]%29&*C6K*/"NR_*TJ@C@CM^5 '566KVU_J
M>I6$(D$VGR)',6  )= XQSSPPJ_7D^H:#9SW/Q#G9KE6L(HVM/+N'3R72S0A
MQ@C+<+R<]/<Y@NSK'B.]U _9FN);;2[1K>X.IFU%H[Q%S,% P26SDGLF.F:
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M?LA9ZI:K<VX<2!&)&&'0Y!!J_61X@UU=#MK8K:R7=W>7"VUK;QL%,DA!/)/
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MYGO98VMH9-@F_<28#9XP#AN>F,]JBG^(2V6G7$MYH]Q'?VNHQ:?/91R*[!I
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M3U%8\?@KP[%'(BZ8F)8'MI29'+2QO]Y7).6^IR1VK'?XC1KI8NQHMX9CJ_\
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M4_@#7M1\2>%+?4]2M5ADE+E&5P0Z[B <#IC&/PS0!H:AX4T/5-06^O=.CEN
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MOVB5HS'E0 -J8+'GGD#%=)'K5G+K\VBJ9/ML-NMRX,9"[&8J"&/!Y!Z>E:%
M'+^!-#O?#^AW-I?J@EDO[FX78VX;'D++^.#5#6_$MWI^KWEM_P 235-/D556
MWEU"*WD@<##*X8$,"><]1R,5V]59-,L)9&DDL;9W8Y+-$I)/UQ0!Y(NAZ19V
M>C37#^'=7:V6Z2;3C?QK'$)I1*OE%N,)C;SC(/X5IVT\/A^^L-6TH^'&8V#V
M=SIUMJ4<*1$RF561FX(RS!N!G.1Z5WM]:Z586XF?24E!D2/;!:"1LLP7. .@
MSDGL,FK/]DZ;_P! ^T_[\K_A0!P46HR0^+]$UNZU30KN3^S7L;\P7Z1K"S2H
M^Y0QRP 4CU/M6/H=FNAZ)H5PFJ:+/J.E7]W,UK_:,:B6*8N" ^<!@&4\\<$5
MZK_9.F_] ^T_[\K_ (4?V3IO_0/M/^_*_P"% 'FS1PWUY)JUSJNC075UK=G>
M/;+J$;"&"!0H!;."QP3QQSBNCT[4-*MO&>N:I)K6E?9KRWM8XB+R/),?F;LC
M/'WQ73?V3IO_ $#[3_ORO^%']DZ;_P! ^T_[\K_A0!Q&H:M'I/BB_P!8T6[T
M34%U.UBAFCEU..$Q21;]K9.<H0^".HV]\UN>'-%ME^'=MH,=_#=QBR-I)<6[
MAD+%2&VX[ DXK;_LG3?^@?:?]^5_PJO?ZGIWAV&T66,PQW5U':Q+#"2OF2,%
M7.!@#)ZF@#EK'0_$-VGAG3-3LK:WM="E262ZCN-_VEHXVC38N,J#NW'/3&.:
MU?!.AWNA0:XEZJ WFLW5Y%L;=F.1@5SZ'VK:UG5K70M(NM4OC(+6VC,DACC+
MD*.O JY&XDC61?NL 1^- '%:SH.L2^*M8N;2TBFL]4T;[%YIG"&&1?-(RI'(
M.\#CI5J/P_?K<^"W*Q[=)B=+KY^A-OY8QZ_-70ZKJ=MHVE76I7AD%M;1M+*8
MXRY"@9)P.:L6\R7-M%/'G9*@=<]<$9% 'F^E^$-3T[P19Z/J&@:?K"+=W$LU
MN\X5TW2,T;QN> 0"<]#SP>.>OT*SU72/!T-M.1=:E!"^Q'F+ G)*(7/)P-J[
MCUQFMVFLZIC<P7)P,G&3Z4 <%H7PQTZ/0E36WO9]2N]TVHM#J,\<<LTG+_*C
MA2.<=.0*S+/2M9\+W'AQ96L[FXTY[S3[2&:[$;W5JVUHV4D$!U"*"OH*]"TO
M6K/6'ODM#(38W)M9A)&4PX56. ><88<U+J&EZ?J]K]FU*QMKR#.[RKB)9%SZ
MX((S0!YKH.E:EKEI]J7[.[0>,'OIFC?,?EJI5MA/WL-\N>,X/2M3Q%X/DN/$
M]_J<?AS3-:%_!$B&\D"?9I$!7)R#E""IXY^4\<UV5Q/I_AS19)C$MKI]G$79
M8(3MC11DD*HZ 9Z"JUKXFTZ\%HT0O/+N]ODR/93*C;AE?F*X&1ZT <;J/@1H
M]:OYH?"^CZI'?)"(I+EMBVC)&L94K@DQX52 ISU''6M6Z\+W[P^.8X8X@NKV
MBPV0#8&1;>7@_P!T;OTKM:* .*U3PE=ZK/I$3E$MXM&N]/N7#9*M*D2C [_=
M:LK3O!ES'I=Y;#PMH^G77]ES6OVN&4,\\S)M!7 &U#R3NYY''!->A7][#IMA
M<7MQO$$$9DD*(7(4#)P!R:+"\AU'3K:^MR3#<Q+-'N&#M8 C(^AH YQ= OA?
M^#IML>S2H)$N?FZ$P!!CUYJOX-L/$/A_PUIVC3Z;;DVMRT4DPN00T!+MYBC'
M7)4;3ZGTKLZ* ,+QAH,OB3PS<Z=;SI!<EHYH)'&562-U==WL2H!]C6#JMCXI
M\76UMI&I:19Z78BXBFO+A;WSC(L;A]L:A1C+*.6Q@=C7=TC,J*69@J@9))P
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M;:M/%9ZA?V]O8K$NXSH& 94R1M:0AQN)P  W%<]?7E_?Z/-:W5RX>T\86MK
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MZ#<A2T$H)3 *@?*PR0.VTXIWAZ_FO;K0/#SSS6UJOAJ"\4POL:5SM3[PYPH
M./\ ;YS78Q:)8"UGA>U7_2D"7&Z1G+KC&TL>2HR0!TY/'-,?P[I+P6<)LT"V
M2E;8HS*T*D8*JP.0,<8!Q@ 4 </#KNM1>'=)\1WUY,UOIVH36FI[ %2XMUE>
M(3D <%2%8XP" W;%:%UK-[&^BJ;AEAUZ]E9#+.8@L00F*-7 )4N &]<Y /2M
MW5])OKJWAT>PBTZ#1)86@NU8,)%C.!MC4#;RNX<D8R#STK1U31=,UK3CI^I6
M,%U:$@^5(F0".A'H1ZB@#AIQX@@U70=(N/$<N+G4;N"1K8J76+[.\B*S,G+K
MQ\V/0XS6O\0+>2W^%>M0_;+EY(-.8&<OMDD*KU8J!U[XP#DUMQ^&=&A2Q2+3
MX8UL"6M0F5$).<E<=SDY/4Y.:T+JU@O;2:UNH4FMYD,<D;C*NI&""/2@#D8;
MB:\\72^&VO;N"WMM*CN8G27$DKN[*6W=PFU0!T^;D'BM'P3J=]K7@ZRN]2(-
MVWF122(NWS-DC(' [;@H;TYJ\WAO1VCM4%A$@M5*0&/*,BG[RAE(.#W'0]ZT
M888K>".""-(HHU"HB* J@=  .@H \BM[=_\ A"=*Q>7#2/XL"[Y)/,*XO9 "
M-V>>_/4UJW'B'4=#.O6+ZA+-#;ZQ:6J75TX#0Q3)&S9<+@#+$ D'&[VKLV\*
MZ$Q<_P!F0*7N?M;;!MS,#D/Q_$"20>Q)/>I7\.Z1(+]9;"&5=0Q]K60;Q/@8
M&X'K@  >F* *GA^WU.TOM2AOK^.X@+1RVT'FF62W4@@AG(!8$J2,\CD9Z5@1
MI?/\7]:%E<6\+?V1:[C- TH/[R7H ZXKKM(T33-!LOL>E64-I;[MQ2)<9/J?
M4\ <^E0R^&](GU"6_DLE-Y*H5Y][!V4=!D'H/3I0!SFJ7&IPWGA&P&KND\UR
MUKJ)ME4"1Q;.['D'!W '\:PY=0UFST#5KX:Y?22:/KR6<"N4(DB::(%9/ERW
M$K#.>P[UZ OAS1XQ:!+&-?LDC2P;21Y;MG<PYZG)R?<TQ_"^BR6UQ;O8(T-S
M,+B9"S$22@@[V&>6R <^P]!0!Q6KRZW/<>.9(/$=[:_V+LGLU01[ ?LZRE7^
M7E<Y&/?G/%1ZIKU]8:M>:^MJ/M\?@];KR2#A9/,+8(] >OTKHM/\)M_PD_B#
M4-3MK:6VU"6%X56=V)6.-4Q(I #<KD9+=:Z%M(L'U-M2:V1KQHO(:4DDF/\
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M^%;B.ZU)2/$(@D2Y/ES1-F7*./[R<*#SP/>M34M1U#0?$E]IDEY<3)K%LO\
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MRKM>3C!+#L<YR/6M.H[>WAM+>.WMXDBAB4(D:+A54= !V%24 %%%% !1110
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MF99I[?! B>/;R<$ DL1QD=@-3QGI%_JVGZ>VF)#)=6.HV]Z(II#&L@C;)7<
M<$@]<4 4;WQIJ$)U6:RT);NST?Y;^7[6$8.$$CK$NP[]JL.I7)X%=5'=0W6G
M+=PMOAEA$J$<94C(_2N)N= \2P0^(+'3[?3VM]>9IFFEN6!LY)(ECD&T)^\
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M;J374U@^"]&NO#_A#3]*O7CDN;=&61XS\K$L3D?G6]0 4444 %%%% !1110
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MNMV$QW7BY#$SIW;&#NRPSTQF@#O-;UBTT#1[G5+XN+>W7+!!EF)( 51W))
M]32:+K5GK^BV^JV3-]FG4D"0;64@D%6'8@@@CU%<7XTO+[5_&.D:#IFG_P!H
MQZ<5U2_A$RQ D$B%2QX^]EL=]HJ#PQYMOXDU[PQKVCQVUGJP;4[.TED2=&R0
M)TR.#\V'VXXW&@#5B^)5E)X0NO%#:7?1Z8CJEJQ,9>Z)D,8VJ&ROS8^]C@YK
M:6:35WM[?5/#A6!H3<,UR\,JQ2*V F 3EL<@CCWS7C":!H__  SQIVH?V79_
M;9+B'?<>0OF-_I>WEL9/RDCZ<5WR65KIWQJL+.QMXK:VC\-RA(84"(O^D \
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MZXO;72;*&ZN 1--' JM(#UR0.<]_6KUM;065K%;6L,<%O$H2.*-0JHHZ  <
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M#3+.*</Y@D2!58-MV9R!UV_+GTXJIK6EWTFGW,.@FPLKF]<_:;B6$L<%=I<
M8W. % W<<"MNB@"CHVDVNA:+9Z59J5M[2%8DSU( ZGW/4_6H+SPSH.H7S7U[
MHUA<731F)II;=69D(P021R,$CZ&M6B@#+N/#>AW=X;RXTBQFN6B,!EDMU9C&
M005R1TP2,>AQ4T>BZ7#;3VT6G6J07$8BFC6%0LB!=@5ACD!?EP>W%7J* *_V
M&T$\$_V:'S;=#'"^P;HT.,JI[ [5X'H*SX?"F@6HS::-I]NXE\]'CMD!27!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
*HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>exhibit1060-kumaremploym012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$$ @Y!Z$4 +1110 44A90P4L QZ#/6EH **** "BBB@ HHHH **** "BBB@
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MUZ#JN@ZD?$*Z[HE[:V]V]J+2>.[@:2-T#%D8;64AE+-[$&L]? 7E67AJWCU
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MGDMI$34+MUL[(LV )I#M!SZ*,M]%K#\!7$.@Z[J/A!=2%];I"E]8SF;S&9"
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M*M[VUT^./4+Q;N[RS22I$(UR23A5&<  @#))P.235R@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
M/Q1X@D\.V%K/!8F]GNKR*TBA\T1Y>0X&6(..:W*X7XJ- F@Z2UU=M9VXUFT,
MERK[#$NXY8-VQUS0!N:;JNOW%X$U/P['86NTEKC^T$EVX']T**F7Q9X<>1XT
MU[3&=(?/8"[C.V/ .\\_=P0<^A%<QHNI>&3=S0Z=XWN-7NI;>14M9M168'Y=
MQ(4#J #^&:P]%TZS.B?"=3;1$$ES\HY8VLCY_P"^@#]0* /28_$.BRZ='J":
MO8-92L4CN!<)Y;, 20&S@D!2<>Q]*Q_$7C>RTWP-J/B71Y[358[,#B&<,A;<
MH(++G!^;-<)J9LK:2X:]1!91^.D>0%?E4?9E8DCTSR?QJOXSN+34/#_Q*U#2
MY8I].E@L(Q/ P:.296^?##@D Q@D4 >LWWB+1M)%N-4U6QL9)P#&EQ<+&6^F
M2,U=BO;2>YEMHKJ&2>)5>2)) 616SM)'4 X./7%< -1T?1?&'B23Q)/;01W=
MA:_9C=$ 30*C!T3/WCO)RHY^8<5B1R7_ (&\,^%?%%Q;3/,-*_LV]@*DN<J7
MMP1ZAP$]O,H ].NO$>AV-LUS=:Q800),;=I)+E%42CJA)/WAW'44Z^U_1]+M
MH+F_U6RM8)\>3+-.J+)D9^4DX/'/%>;3:5/X3U#PS'=:S8Z8J:;<K+?7T EB
M:[D='E&2ZA6;YB"3R%(JI;Q)HM[H\A\2V%KIKZ/*EM?:CI^(I-T[.T:JSKL^
M1HP!D[E7CB@#V165T#HP96&00<@BEKFO"4]AINB:+H::@US.;#SH#) T3/"I
M W;3]W&Y1@G-=+0!BV_B%)_&-[X>%LP>UM([HS;^&#LPVXQVVU8UC4)-/6Q,
M<MA'Y]Y' WVRX\K<&SD1\'=)Z+W]:XB;7](T#XRZM+J^I6UC'+I%LJ-<2! Q
M$C\#--\=:UIFO:?X4NM)O[>]@3Q58QM)!('4,"3C([X(_.@#J]+\317<GB!K
MWR+.VTF]-LTTDH"E1&C[F)P%^_C\*OSZ_HUM>VUE/JMC%=7(!@A>X4/*#T*C
M.3GMCK7D\T=W!XEU_5KU%NO#-AX@\R^LU4E@WD18G;^^D9VG;CU/.!5C6?*N
MM6\5V=YXEL=/CU.:![='LO/FN(C#&(W@(<%L,&P%!PP)[T >J2:QI<-C->R:
ME9I:0N8Y9VG41QN&VE6;. 0W&#WXJ'6=7ATZSN-EWI\=XD#3QQWMR(DVJ0"S
M'DA 2 6QQD5YQJ>EB]\97W@:8$V>I78UB0XX\HPLK_\ D=%/XUD3W,^O^ O%
MVMWBMYUEHT6CDG_GK&N^<_B[*/\ @- 'KDGB'2;,V4.H:KIUO=7:*T437*CS
M"?[F2"PST/>II=<TF'58]*EU.S349!E+5IU$K#V7.:\RUJ\LM*MOMD6HZ>UY
M)H]JMSHNI09%_&JL46$Y!WDLPP PSC(%121>=J>M:9J'B&STZYN-<2:.S>Q\
MV[D.Z-H70AP2  HR%(4*V>AH ]AK!N_%^C6GB,>'Y+V!=2-N9UB:51TQA,9S
MN(.0,= 36I::E:7T]W#;3"22SE\F=0"-C[0V.?9@>/6N,U6YM+/XMQ?:YH83
M<Z"\4!E8+YLGG [5SU;'8<T ;/ACQEIGB'3]-S>V4>J7=I'<O8)<*TB;E#8V
M]> ?2M6WUS2;K4YM,M]3LY;^')EMHYU:1,=<J#D5YOH]K!;>#_A:\$*1N;J(
MEE7!R]K*6Y]SUJMX,A$S^&K*[\1V8U*PN97?38K$_:4E"R"42N')"G<26*@,
M2OJ* /1O%.O-X<T7[>EF;R1IX8$A$@CW-(X0?,0<<M4.G:MXBN+Z.+4/#4=E
M:G.^X&H))LP"1\H49YP/QK)^*S1+X*#3W#6\(U"S+S*VTQKYZ98'M@<YJOH.
MI>%_[52.Q\=W&J7,BLD=K-J2RASCLH')&* .F3Q9X<DE:)->TQI%A\\JMW&2
M(\9W]?NXYSZ5+'XBT2;3X]0CUBP:RD<HEP+E/+9@"2H;.,@ G'L:\RT33K,^
M$_A8#;1'-V'/RCDFWE8G_OH _@*BU=K&UU2Z:]1!91^-X9) 5^5?]##%B/3/
M)/U- '=>)/&]EIG@74?$NCS6FJQVFT 0SAD+%U4@LN<$;LUL7_B+1M(,":IJ
MMC923C,:7%PL9;Z9/->2>-;BUO\ PW\2M0TN6*;398[!!/ 0T<DRL-Y4C@D
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M,:F*,%@-S!L]R0N *YCX?+;WFN^&ED"2R6>C7Z%64!H9!=1K@K_"P5L8[ T
M>F7'B'1;33(M3N-6L8K";'E7+W"B-\]-K9P?PJOX<U\:^FI2(L?E6M\]M&\;
M[A*H56#Y]]U>;Z)<V>DZAX:O-2EAM=+@OM:A268A(H93<'8"3PN5$@'XUU?P
MUDM9K/Q%+8J%M9-<N'BPN 5*H00/0YR/8B@#I[O7M(L-0@L+S5+*WO)\>5;R
MSJKODX&%)R<GBDO/$&C:?>K97NK6-M=,AD$,UPB.5&23@G..#S[&O+OB!J8=
M_%]J+JQLIHHX5%J+;?=7JK&LGFYW9"+EAD#Y=C$FG:QJ>B)IWQ$M]1FMY;W4
M%\^R7(9[F$VJ>2T7]Y58,<CA<$G% 'IUUXBT2QFM8;O5[""6Z -NDMPBF4'H
M5!/(/M4;ZN(-<NK6XN=-BM+>T%R^ZZQ.@R<LZ$86/ ^]GKFO*?$FHB30M9L1
M<V-E.- MXTA-MYEUJ ,+,-I+<*I)&5!P0Q)XJUJMS%>>)_%5S!,DT4O@G<LB
M-N# [^0>] 'J-GK^C:A?365EJME<W4(W20PW"NZ#U(!R*S[SQSX:M-&U#5%U
MFQN8+!"TPM[E';.#A ,_>8C '<URUW9V5O=^"(_),=O_ &5=QR"!#O\ +^SH
M2!CDGO\ 6N=OKR&;PCKVEV=[IFN00>'9#!J%I"%F@C4J!#-M)&2/F'W3\C9%
M 'L>GZA::K80WUC<17%M,,I+$X=3V.""1P01]15FJ&B7MGJ.BVEUI]Q#<6SQ
MC;)"X93C@X(]""/K5^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "D*AAA@"/>EK!\6ZG/I6E120:A
M:6#2W"1&>YC:0A3DD1QKR[\<#ZGMB@#<$: Y"*#["EVCC@<=/:O.+;QEKE]9
M:5!:36K75QK4VF27,MJZ*R+$[B3RR05; 4[<\D$<9X?-XLUW2(]0-_-;746C
M:M!!?3I!Y>^UEC0[]N3AD,@)[$ T =CK&BQZO)IKM*8OL-ZEX JYWE59<'_O
MKK[5I+&BIL5%"?W0.*P=/U>[U'QEJUE%Y?\ 9FG0Q1,VWYGN7&\@'T5"G'JU
M0^(-3U/_ (2+2-!TJXAM9;R*>XFN98?-V1Q[!A5R!DLXY/0 T = CVUT6V-%
M-Y3E3@AMCCJ/8BLG5?#S:SJUE/=W\AT^TD6=;!8U"O,I)5G;J0#@A>F0#7$Z
M1JNH:7HVK>9J5A8W,OB.XBFN&A>4M\H)\F(9+,2!P3P,]<5:L?&&NZL-"L[2
M>T2>]O+ZTFNI+5@"L&=L@C)!4D#[I/!/M0!Z,Z)(NUU5E]&&10Z)(,.JL <X
M(SS7F9\3^*[?1;_5)[S3WCT?5?L$T2VI!O%\Y4+YW?NSM<8 SRI]<"YKWC"_
MTKQ!(L>IV,D,-[;VQT^*UDD8I(R*QDF'RQN-Y(7I@#KF@#T' SG'/K2UYKK/
MBKQ-'H?B3Q!IT]BEII=U+:16<MN69Q&P1I"^[KNR0,8P,=3D)KWCZ\LM7U@6
MMW B:3,D2V!LI)'O/D5W_>#A#A\+[KD\&@#TDHC'+*I/N*9*]O;0/+,T<4,8
MWL[D*J@=R3TKB[?Q+J4OC6339]2LK/;=&.+3;FV=&N(-H/F1RYP[=3M XP0<
M=:V_&MZ^F^"-;O8XH97@LI9%CG3>C$*3AE[CVH VXVCEC$D95T<;@RG(8'O[
MTIC0LK%%)7[IQT^E<):ZOK^J:IIVDZ;<V5A%)H4%^\IM?,V.S%=JKN  Z?0#
MWR(M*\5:[XFAT.QLY[2PO;FQFO+RY,!E4>7((@J(6'WF)/)X QWH ]!P,YP,
M^M&U<$8&#U&*Y?2-8UIO%$6C:LEHLJZ4+F;[/DJ9?.9,J3S@J <=L]37/6_B
MSQ)JL?A:VLIK*WN-8%\)IY("XB$+@*RKN&3C(QGJ0>V* /2#&C,K,BDK]TD=
M/I040N'*J7 P&QR*X%?$^NQ7?BF]N;BU.E^'6DW1+ ?,NL6ZR8W;ODPQSG!S
MG'&.<Z+XB7VGVE[<7%U;ZJ$TJ6]_<V4ENL$R;<1$M]Y6W<'K\I]: /188;.R
MO9MKJES?2><RL_S2%453@'L%5>G]:GGDMXC&T[Q)EPD9D(&6/  SW/I7 K%K
MD/Q!\)C6;VVNV>TO'#0P&+8VV/<N-QR.F#UZYK1^(YN!I6C_ &3R_M/]M68B
M\P$J&\S@G'.,]: .QVC &!QT]J0(@<N%4,>"V.37G>I^)O$N@2:S:SS6VH2Z
M9!;:EYD=L8S+:L[+,FW<<,H1B#71V^NSZEXT&GV#Q/IEOIZW-S*!DL\I_=*#
MV^568_5: .B(##! (]#44+VTI?R6B<QN4?80=K#J#CH>>E<A\0I=4C?PTFFZ
MB+/S]8BADS%OW95B,_,.!M.1WSVQSSB:AK^AZ;XQUJRN[1;;3]8EDDMY+<L;
MG"Q[QNW#8,=, \T >K[1QP..GM69K&BQZO+IDC2F+[!>K> !<[RJ.NT_]]]?
M:N(UWQ_>6>KZQ]ENX$32IDB73S922/>?(KO^\7A#\V%]UR>#7HEX<V%P?^F3
M?RH >OD*FQ?+"?W1C%.:-'*ED5MIR,C.#7C'@G2?#UQX2T0W/PUNKR:2VBWW
MOV2W99"0,ODR;B._3/M73ZWX@\2)=^+CIUU96]MH$,=Q&LML9&G_ ''F%"=P
MVC@\\GD>G(!TVJ>'FUC6+*YN[^0Z?:2+.E@L:A7F7.UV;J0#@A>F0#6TZ)(N
MUU5E]&&17G\WB;Q#IUQ$]Y/9RQZAHUUJ$$4<!7[+)$J,%W;CO&'P3@<C/&<5
M-I>O^(H;OPO<:K<64UKKR;6@AMRC6TAA,JX;<=PPI!R!STH [:WN;:\C\ZVF
MBG3)7?&P89!P1D>]3$ C!&17D'@?5K^V\)Z/I&EO##=ZIJ]\GVB:/>L,:-([
M$+D9;@ <XYK;N?%VMZ.]['?R6UPFCZE;QW]PD)3S+2=1B3;D[61F&>Q"GI0!
MZ'@9SCFD$:+NVHHW'+8'7ZUP?B'QK?Z=>ZXUK]G%E8&ULDDDC9Q]JF<;F.TY
M*HC(2HY).*SG^(-Y:6%_";Z"[=+BUAM]2:QDC0"8L&W1]6*;&. ><K[T >FL
MBNA1E#*>"",B@HI7:5!&,8QVKE_!OB"XUB34[6>X6\%G(GE7J6S0"9'7."K?
MQ*0P...E0>,M>O=+NX8+35[*QS;O,(VM)+J:5@1@;$^['URWKQQ0!M:_HL^M
M:;_9\&I2Z?;R I<>1&I=XR,%5)^YQW'-:5K;0V5I#:VT:QP0HL<:+T50, #\
M!7GESXUU2=M*F^W6.C0WNFVUW;M>VSO#<S2 EHC*"!'CY1Z_-GG&*]%D<QPN
M_P @*J3\S87\3V% "E%+!BH++T)'(KG]:\-WNI7,KV>OW=A!/!Y$T"1)(N.?
MFCW#Y&()!(]N.*Y;3/&NL27;V\=W9ZU/-I=Q>0QVMG)%&L\>S;'&[?ZU&WXR
M.> >]/@\7:N_AZ^O+75[+4GB:W68Q:?(D]AN?$I>WSN8*O(Z'@]0* ._L+"W
MTS3[6QM4V06T*0Q#J0B@ #/T%3[$#EPJ[R,%L<XKSBX\;W,.GZ7"OB#39A?W
M$P75;>U>0+%&H)!B!XDW,%QG '.,\5&_CC5)-+T^6:^@TVV,US#<:L^GR/$6
MC91$=A(\M75BV6. 5(SWH ]+"('+A5#'@MCDT+&B%BJ*I8Y8@8R?>O/[[Q5K
M$&JV=M-JVDZ>)+6"2WDD@=[6_E;.]5GR @X&!R?F!YJK<>/[P:U=M#=P&&UU
M,6/]F"RD:26,.(WD\T<!@2S 8QA<'DT >CW,EO#"9;IXDB4@EY2 HYXY/O3R
MB!_,*KN QNQSCZUY3XJU/7-<\%Z_J2W-JFEQWYM$L_(.\I'<+&9/,W?>+*3C
M&,<=>:]4N/\ CVE_W#_*@ AFBN8$FAD26&1=RNC!E8'N".HIX4#& !C@5Y5X
M0U+7]&\'^"KB:ZM'TV_$%C]E6W(>(.A$<@DW?,<J,C&,-CMDZT?C'59O"UO"
M%@7Q*^J_V1(NPF-95?+OMSG;Y0+]>XH [YHT="C(K*>H(R*4HI4J5!4]01UJ
M"^G:UT^YN%:%6BB9PT[[(P0"<LW9?4^E<;X0\4WNI>(&TRYU&WU%'L1=K/#9
M26ZHP<*RKN^^GS AAZ<]: .Y"JH "@!>@ Z4;1@C P>O%<[XDU348M6T?1-+
MFAMKG46F9KF6+S!%'$H+87(RQ+*.3@<]:S'U/Q2^K:=X;>YL+?4)(;BYN+Y(
M"ZM#&ZHA6,L-K-O&020,'&<\ ':X'/ YZ^]&T9S@9QC-<)I?B[59]5TG3+H6
MYG_M6[TZ\DCC(63RH6D5U!)VY^0D9/>H=7\8:W;#4H[);4S0^(;?2X!*AV^7
M)'$?FP>N7//I0!UNO:3<ZQIIL;;4Y=.CDRLSP1J7:,C!52?NDY^]U%7K*SM]
M.L;>RM8Q%;V\:Q1(.BJHP!^0KA[<>(8_BE86-UKD4\::.\\JI:;%D_?(#\N\
MX/3!YQR.]=%XMUFYT71XGL4B:]N[J"SMS*"45Y7"AF () R3COB@#;*H6#LJ
M[ESAB.14%G=V5Y&SV5Q;SQJVQF@<, 1V.._/3WKS[Q+J&OV^G^)?#]WJ=O-*
MNB27\-XEIL)0!EDC*[L9Z88=,]#BM[X:V$EAX T<.]NPFM(9E\FW$6T-&O#8
M)W-ZMQGTH ZHQHVW**=IRN1T/M3@ !@#%<9-J?B75M9UI-"N+&&'2)DMU@N8
M2WVJ0QK(P9PWR##@# /.3[55OM?\1W4?B34],N+*WM-#D>);6:W+FY:.-9)-
MS[AM!W;1@=LG/2@#O-HP1@8/6D:-&969%++]TD<CZ5Y]<>)O$&JW6M'2+JTL
M[6QTRVU"(S6YE9S)&[[#\PP/DY/4=J=9>)O$ N=!N;R:S>VURPFN$MHX"IM6
M6(2*-Y8[^"0<@<]* /0,#.<#/3-(L:)G:BKDYX&.?6O/-)\3>)%L/">LZI<6
M4MGK;102VL-N4:$R1,Z.'W'/*\C'\7'3-5M!\>ZAK-YICQWUO(FK-(GV1+"0
M&Q!1FC<R$X?[JAAQDMQC% 'IQ /44C(K AE!##!!'6O(]#\5:MIO@S0_MFLQ
M";5;RY'VN6T:0VZ(\A;Y0Q+DD*!T ![XK6M/%^NZFVC6-I-:K/=7UU9R7DEJ
MX1TCCWK*L9(()&.,XSGM0!Z+L3^ZO3'2G8&<XY]:\JUC6?$=UI<5HVJ0Q7=G
MXIM]-DN(K<@3*6B=&*[N/O@%<X.,<9KU*)76%%E</(% 9PNT,>YQVH 9;W%M
M=PB6UFBFBR0'B8,N0<'D>]2[5P1@8/7CK7FOA#Q7?76F^& +>R@34=3O;>=(
M(-B[8UF8%0.A)09/?FK&L^,-<M[J_MK 6GFIX@MM+@\U"5"2PHQ+8/.&;/';
MB@#NS)9B5; O )&3>+<D9* XSM],U*T4;*JLBD*<J".E<+/JFJZ?X\L]*DCL
M]1NQH4]R;A;8122R+( %4Y.U3QQD\\UGP>.-4B\-:A?C5-.O[R.."/[(UJ]M
M+:7,LBQA9(R22@+=>#\IZYX /1Y+NVA=DEN(D=8S*RLX!"#JQ]AZTL#030I-
M;F-XY!O5XR"&![@CKGUKS74GU?2O%VI2ZC<VFH20>%KJ6.3[-Y:OB125=-Q!
M&1Z\@X[9-[2=>UC6+'PQI>ERV6G3W6BIJ-Q,+7>B#"*J1Q[@ "6/?@+CO0!Z
M 45@05!#=01UJ*UN+:Y@$EI-%+""5#1,&7(X(R/2N#MYO$\OQ*T>VU"_MH"-
M'EFN+>"(M&Q$T:M@EARW!!(.W)'.<U2\/>*]3O?#.BVUC%86=_JNJ75LLB6^
M(H8XS(S/L!&6PGKR3DT >FF-&.2BD^I%*$48PH&/05YU>>*_$.G376CF6RN-
M1M]4LK5+EH2B217 X+(&X8$-G!YP.F:W_#FHZJ?$.M:)JMU!=M8I;S17$4'E
M%EE#_*5R1P4//O0!TVT8(P,'KQ67I^A16&JZM?\ F>:VH7"7!5E'[LK$L?'_
M 'QG\:RO%VLW6G7%C;V^KVFG"99&8O:O=3N5VX"1+_#R=S=N!WS7.2^.=5N-
M-T2\>^LM%AO=/$_VJYM'D@DN<X,3/D>6O&>>2&]J /3,#.<#/3-,:(!9/*VQ
MR./OA1U[$^M+$S-"C/LWE06V'*YQV/<5P.@^,+^Z\4V%C/J=C?Q7XG#):6LB
MQV[(-R[)FXE& 0??GCI0!T^@^'_['EO;NYO9+_4;YU:XNI$"9"C"(JCA5 S@
M>I)[UL;$#EPJ[R,%L<XKGO'6M7OA[PE<ZEIR1/=1S0(BRCY6WS(A!_!CS7/Z
MQXDU;1]2M-#O-=L[>Z-J]W->C37D5R7VI&L:L< 8;))R<#IF@#T$(@<N%4,>
MK8Y-*0",$ CWKS2;QQJ\\>F327=EH27-C'-&]]:.T$]R697B,F1Y:C:N,\D/
MGMBMJX\3ZC%IWCF<"'S-%5C:_+D<6J2_-Z_,Q].* .L^TVWVS[+YT7VKR_,\
MK<-^S.-V.N,\9J3RT\SS-B[\8W8YQ]:\PGN;N;XIRW4$R0W;>#!*LA3<%;SR
M<[<C/YUU'PX:^D^'VB37]Y]KEFM(I%<IM8*4& Q).X]?F[^E '4;1@C P>O%
M075[9V6QKNY@M_,.Q#+($W'T&>IKD+[6?$-_?>(GT>ZL[6WT0B-8YK<R&ZE$
M0E8,VX;5PRJ,<]3[5S5V;OQ/\2O".H+<VR6]WI#WMO#/:"40AA&6'+#+'/WN
M,>AH ]:9%?&Y0V#D9&<'UI0J@Y"@'V%9WB&^ETW0+V\@GL[>6*,E9;QB(D/3
M+8Y/T'4\=ZX(^.=7BT[5X[:ZM]0N+.YL%@N);)[8.MQ+L961N>,'##U'I0!Z
M:T:.A1D5E/8C(IP '05Y_>ZUXJTR?7]-6XL]0OK/3HM2M76U,88;W#Q%=QSD
M1G:<YYYS6M!XGDU?Q'HEKI+1M8W%@VI7;LN2(FPL2CT)8L?HAH Z262WBDC,
MSQ(\I\I-Y +GD[1GKT)Q[5SVN>%+K6)KR--?O+;3[V(0W-HL:.-F-K"-B,Q[
MAP<9]>#5+X@B[,OA5;%HEN6UN-4>52RKF"8;B 1G R<9&<8R*RM4\7>(=$LM
M=LY)+2\U'3;NQ6&?R3&LT5PX7#+DX(^<9!]#B@#T2*WA@CC2.-56) B<?=4=
MJ>$4# 4#C'3M7GNL>)=6TC5+?0KK7K."[2S-Y->_V:[K*6D94C$:L=J@*<DD
MDX&,<U#J?CC4VT:POXK^RTV:33/MC63V<MS,\O.595QLBR,;CR<GICD ])P.
M.!QTJ*)[8RS0Q-%YB$&5$(RI(R-P]QZUQD>O>(/$E[-#H4]G8_9-/MKIA<P&
M7SI9E9UCR&&U0%&2,GYO:LHR>(H_$7C.\L+FSL9K:VM9YDDA,X>06Y.P'*X7
M@\]3D=,<@'IJJJ*%50JCH ,"EJEHU^=4T/3]09 ANK:.<H/X=RAL?K5V@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "L7Q!H<VKOIUQ9WPL[W3[@SPRM#YJ\HR,&7(SE7/<8-;55-1
MU.RTBR>\U"YCMK=" 9)#@9)P![DG@"@#FK#P*]G?P7$NKR7 AU-M3 DA 9I'
MA:-P2#C!+;A@#'2EUO3]/T:R\275]'=WT6NL$-I;6S2.3Y C"#:#U"?>. ":
M?KOC_2--\':AKUE<PW8M@T:1@D$S;<A&&,J>_(Z5H>$M7N-<\/07]S/9S2R<
ML;1'5%X'R_.<Y'K0!6\!:#<>'O"%G:7SF349 9[R1CDM,_)R>^.%^BBI]>\/
M3ZGJ.G:II^H_8-0L1(B2- )4>.0#<K+D9Y52#G@BLG3?%7B'5+.UUFUT*UFT
M:YE"HL=V3=+&6V^84V;>.I7=D#OFMZ3Q-HL6LC2'U*!;\L$\DGG<1D*3T#$<
M@9R: .?M_ -S8K%/::ZXU&+4)[X7,]LL@8S)M=2@(^H((QZ8J;2O ITS5+.\
M?5I;E;2[N;I%DB 9FG7#[F!P?F);@#KBMEO%.AIK0T=M3MQ?EQ'Y.[G>1D+G
MINQSMSGVK!_X6%IVHZ'JUYI=_9VSZ?<B!I;Y7\K&\+N.W!YR0/?&: +EQX*C
MGT+5]+-\X74M0-\9/+&8SYB/MQGG[F,^]4]0\"75X-1@AUUX+*[O5U!81;!B
MDX96&YMWS)N0';@'WXK=U7Q5H6B72VVI:G!;S%/,*,22JYQN;'W5SW.!1J7B
MK0M(D\N^U."&3RUE"9+,4;=A@!DD?*W3TH \U\4Z9=/!XA\.V,NKAM2NA(ED
M--/ES2OM+2+<#*K%NRQ!((((Z'![RX\,7RZM>W.F:Y)86M_*DUW MNKL7554
MF-R?DW*B@Y#=,C%=#:W4%[:0W5K,DUO,@>.1#E74C((/I7.ZKXAU;^VKC2]
MTRVO9K.!)[IKFY,*C?NV1IA6RY"D\X X]: %NO"]]?:K%)=:VTVFPWJWT=JU
MLOF(ZG<JB7/W >VW..,XK4\0Z0NO^'=1TAYC"M[;O 9 NXIN&,X[U<MIGELX
MIYH6MW>,.\3D$QDC)4D<<=..*R;+QCX>U&66*TU:WF>.-I2%)^9%^\R\?,!Z
MKF@!NE^&4TS5K>_6Z:0PZ7%IH0IC(1B=^<]\]*RK?P)-IMMI;:3K)M=0L(IH
M/M#VPD66*1]Y5DW#HP!!![=\U'X(\;R^+]3U7#V26EM/)%!#&KF9E1@!(S'Y
M<'T R*V?$GB[3/"\NG1ZA(5-]/Y*8!^4;22Q]A@#\10!G#P9?VUY8WMCXCN5
MO8K1K2YN+J$3M.A??D9(VL&)QU ! Q@4_2/ T6DR>'F2_DE&C+=*F].9?/.>
M3GC'ZTRP\?:9]NU&TU:]M+26#4GM(%R1N0!=K,>0,EB,G .*U#KL5OKFIV]W
MJ.GQVME;).Z99980<Y:0D[=O'&* (X/"ELB^(HKB5IX-<E9YH]NW8K1+&5![
M\+G/O52/PE>W6EW>F:UKTM_936362QI;K#A2,;V.3NDP!@\#KQS6UI.N:9KD
M4DNFWD=PL3;9 N04.,C(/(XJQ?WUOIFG7-_=R".WMHFEE<]E49)_(4 <WI_A
M+4(M<TS5=4U]K^73H9((D%J(E*N%!)PQ^;Y1D]#V [Z7B;P__P )'86UL+V2
MS>WNXKM)8U#,&C;<,9XZ_6L_P5XOF\40W:7VG'3;^V\J1K8R;SY4J!XWS@=0
M2".Q4BKS>,?#J7TEDVKVHN(Y1"R;O^6A8+L!Z%LL 0.1GF@#.734\/'5==U^
M\EU2XO(H[=Q;V+8$2[ML:Q+N)R78DY[]A4?PT\.S>'O"J"[25+R[?S728Y>*
M, )%&3ZK&J#ZYK;7Q/HCZHVF+J4!O59T:$-\RE%#-GTP"#S3;#Q5H.J17,MG
MJMM)';)YLS;MH1.?GYQ\O!^;IQUH C\3^'Y/$%K9+!??8KFRO([R"8Q"0!U!
M&"N1D$,>XJC-X+6X\-Z_I$E^Q.L3R3R3"(#RRX4' SS]WU[UH6WBW0;O3[J_
M@U.!K:T -PYR/+!Z$@C(!['O4!\=>%U\_P#XG5MF @.H)).<X*C&6'!Y7(X-
M $4_A>^75KRYTS7)+"UOY4FNX%MU=BZJJDQN3\FY44'(;ID8KHYH_.@DBSC>
MI7/ID5DW7BS0;+3[2^GU2W6VO%WV\BG=YJXR2 ,D@#J>W>B^\6Z!IRQFZU6W
M3S(5GCPVXO&V<,H&=P.#T],T 86D^$/$NBZ3::99^,$6VM8EBB#:6A(4# R=
M_-:4WA)9T\3![UMVNP+#(PC'[K$/E9'//KCBDN_'>AVNJ:-9"[27^UD,D$L9
MW)LQP<CKD\5MZG<O9:5>7<85G@@>10W0E5)Y_*@#FO$7AC?IB7<<[O)INCW=
MG'$L>3+YD:C/L?W8XYZU6\,>%;W[-X;O=3U22>'3+16M;1K<(T;M$$/F-GYB
MJEE' Z\Y-:'A_P =:-J^GV?F:C:KJ$EDMS- A.%.P,X7UVY.0"2.];+ZWID>
ME0:HU[$+&?R_*GSE7WD!,>N21CZT <S9?#X:;HMC:V>JO'?6%]->VUV8 P!D
M+;D9,_,I5R.H/0Y%)?Z7::#X=UN366N]8NM:)2X%M:,6F8Q[$C1%W; %7 )/
M4Y)YKL;FXAL[66YN'"0Q(7=C_"H&2:XB#XF:=>QZ!?0211:=J#S)<O-G="4C
MW*![D[1WSG YH FT+P3+'\.[?1M1N9$U21EO)[I2&=+H.) WH=K*H]PM7Y_"
M^H:AILT6I:\\U[Y\5Q;3Q6RQI;/&<J5CR<Y.=V2<@XXJ^GBK0GT8ZNNIP&P#
M^49<G[^<;,==V?X<9J]IVI66K627EA<QW%NY(#H>X."#Z$'@@]* *^CV.H6<
M<[:EJAO[B5]V5A$4<8  "HN20.,\D\FL[5O#%Q?ZX^HVNJO9BXM!97:+"'9X
MPS,-C$_(WSL,X/7ID5'X@\0:M8^(=,T;1]/L[JXO8)IRUU<M"J",H/X4;)._
M]*LVFJZI96EU=^*(-,TZVBV!)+:[>4')Q\VZ-<<E<=>O:@#&/@74_P#A'HM!
M_P"$E)TXV*V$\;V2MNC4%04RWR,4(!)W#(R *ZV[L(KS2Y]/D+"&:!H&(/(4
MKMZ^N#6,?'OA813R?VU;%86"N 23R"00,9(P"<C(P#5F[\7>'[&."2XU6W59
MX1/#AMQEC/1E SN'TH Q(/ VI++83S>)93-96<EC$\-JL>V)U494;CB0%%.[
MD'&-HJPOA/5FNI]1F\1G^U6BCABN(;-8T5$8MATW'?N).>1[8I=6\8"#4O"J
M:6UK=V.MW+1&<$M\@0L"I!QG([UIMXLT!-7_ +*;5;<7OF"'R]W'F'HF[IN_
MV<Y]J ,=/!%S$_\ :$>LA-<^V/=F[%H/*):-8F3RMWW2J+_%G(SFKTF@ZX+6
MV%OXF<72"03O<6BR1S;VS_JP1MV]%Y.!P<UJQ:SIT]A<WT=Y$UK:M(L\F<",
MQYWAO3&#FJ<OB[P_!<VUO+JMNDMRB21*2>5?[A)_AW=LXS0!B3> KDZ(N@V^
MO2)HSVJ6L]O+;+(Q4#!,;9&PM]" >1BK\7A>^M-4G>PUR2VTVXN_MDUHL"ER
MY(+*LA/",1DC!/)P1FM$>)=&.LC1QJ$)U$NT?V<$EPP0.01V^4@_C6K0!PU_
M\/;B\M=2TV+7I(-(O;LWAM1;*620N)& ?/W"XSC&>>N.*[>1/,C9,XW C-<A
MXS\2^(?"]C>:I;Z3IMUI=LJ'<]ZZ3-DA?NB,CJ?[W2DU'Q+K^AV=M<ZW9:3:
M1RW]O;%X;MY56-R=[$LB;2 !CJ.N: (])\!7&GP:'8W.N/>:9HS++;VYM@CM
M*JD*6<'E1N)"X],DXJKH.EQ:Q\2=0\4V\%W%IT<"QPBXA:(37)&UY51@&P(P
MJ9(YYQ746GBK0KW3[N_@U2W-M9G%S(QV^5QGY@<$<=/7M5G2M:T[6[=Y]-NT
MN$C?8^W(*-C."#R#@@\^M "ZUI<6MZ'?Z5.[)%>6[P.Z=5#*1D?G6+IGA?4+
M7Q#;:U>ZY]KN([5K21!:B.-HR59=H#':0RY)YSG'&!C8U36],T58FU*]BM1*
M2(_,.-Y R0/4X[563Q9H#Z4NIC5;8633>1YS-@"3^Z<_=/L<4 -U_0)-6GL+
MVSOC8ZC8.S03F(2KAUVNK(2,@C'<'('-9G_"&WT;V5_!X@G.M6YF#WEQ#YJ2
MI*0S(8]PVH"J[0",8[Y-:$WC3PY;VMK<S:M;QPW2&2%FR,H#@L>.%![G K4M
M=2LKV>Y@MKF.66U<).JGE"5##/U!!H Y@^!7AL[)[/5WCU:VOY=0:^D@#B66
M5663='D#:5;  (Q@<TD?@(^7)Y^K2SS2ZS!J\DC0@9>,(-@ /"G9QZ XYQFM
M.?QMX:MK6VN9=8MEAN59XGR2&13@MP.%!XW'CWJP=5)\4QZ:MY8F)[$W(@^8
MSM\X&\'[NSMZYH @O?#TTWB^R\06NH?9WAMFM)X6A#B:(N'P#D;3D=>?I5KQ
M!HD>OZ2UD\SV\BR1SP3Q@%HI48,C '@X(''<9KF?#?C6\UOPEX:U>ZETRSGU
M2[:&2*0/AP'==L7/WR$!YR.M;TOC+P[#?+92:O;+<&8P;"QXDW;=I/0'<"!G
MJ>E &>?!T]XFL3:MJWVN_P!1L&TX31VXB2"(AONIN.3EB22><#I6]HVG#1]"
MT_3%E,JV=M';B0C!;8H7..V<53O_ !=X?TN^EL[[5K:"XBC\R1';[BX)^8]
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MWMH+@8DM[4,WDQD=L!F..V[':NAT_P 3Z)JM[+9V.I6\]Q$&9D1NH!P2#T8
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MWF4/'+&V593T(-34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5R/CD&&3P]J4L;O8V&J+/=[$+;$,
M<B!R!SA692?3KVKKJ* /)/$!_MC1?B+JNG1R2V%W800P2+&0+B2-7WLH(R0
MRKD==OM7INE;DT*R^0EEMH_EZ'.T<5>J.XA^T6TL/F21^8A7?&VUER.H/8T
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M9B,<^4_0_7&?PKN:* /'_#JG[!I(74+Z_P!3T;3)L:2^GJB0N(=ABD8*#RV
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !5/5-6L=%LC>:A<+! &"9()+,3@*H&2Q)Z  FKE<GXWC
MECD\/ZGY$L]IIVIK/=)%&9&5#'(F_:,D[6=3P#QD]J (]>^(.F:?X.U/6]/D
M-S+:!HQ"\$BLLVW*K(I4,@[Y(''?FM3PCJ=UK'AVWO;RXAGGDY9H;22W5> =
MH60DG'KT-<'KT4^M:-\0M5L+2Z:TO;""WM<P.K7#QJ^YE0@,1\ZKG'.T^E>F
M:2K)HUBK*59;>,$$8(.T4 <EKGQ#@M%\4V=A$W]H:-9&=&EA<QN^UF(/   V
MCO\ -GCI6[I7BW1M6N39V]ZK720^>RM&Z*R# +HS !U!/5217#>)EE34/B-9
MFUNFFU+28C9A+=V6;9#(& 8#&0<#&<\UJ>+-(O+_ %+2[6Q@=6?0-2ME=5PJ
M.Z0A 3T'.<?0T =3I'BG1M=N'@TZ\\Z14\T Q.F],XWIN WKG^)<CD<U9U;6
M=.T.U2YU.Z2V@>01*[@XW'.!Q]#7$^#;>&[UC39VU#Q#=75C8/&T5[9QP0VN
M[8&B)$2$ME1@ L/DSZ9T?B1*L%AH,SPO,D>N6CF.--S$ D\*.2?8<F@#8M_&
M&@W.G7M^FH!8+(A;GS8GC>(G&T%& ;G(QQSVS35\9^'VTU]0;41%;1SK;2--
M$\;1R-C:K*P#+G(Z@#!S7$ZE?75WJGB#7M*AN4T^0:=:-=-8LS )*QEE2-UR
MQ17'.TX([XK*NK:>\GU.$1ZM?1W.K:5/%->VI5IX5=59\!% 48/4 X /2@#O
ME^(&CRZ]I.F6_P!HD_M**22.7[-*H7:ZH 04SR2>> ,9/!%2Z?XKL8]$FU'4
M-6MKB-;V2V5[:VD7+!L",)RSN,?PCG!(%4M=D^Q?$WPY>313_9I+.YM1+'"[
MJ)7>(JK%0=N<'DX'!KB-,TO4+;0[&\F;4M/AM/$=]+--;6P>6)'615D",C97
M) )VGAB?>@#TV3QCH,>FV]^;XM!<.T<0CAD>1G7.Y?+52X(P<@CCO6K97MMJ
M5E#>V<R36TRAXY$/# UYK]DTVUTZ'41J/B>WFFOY[B'5WLE+*Y1$.Z)8_P#5
MN%!&4&2"<C(SW/A2XOKOPQ8SZC"(;MT)=1$8L_,<-L/*EAAB.V<4 <WJOQ(@
M6R\1#38R+K1YHX]UQ"XC<%HPQY  QYA&,Y.,]*Z*R\7Z#J!O!;Z@H^QQ>?/Y
ML;Q;8N?W@W@;DX/S#(]Z\^UN*5H?'^E-9W3W-W?6]S"@MG998L6ZDAL;3R",
M9SP?2MOQ>NI6_B74;W3[%KB1?#DJ)F#S$9_.4[=O1CC)V]\4 ;%U\0-"BT#5
M-5MYY9UT^#SI(3!)&Y!!V<,H.UB,!L;>O/%;FDZG!K.E6^H6X<13IN =&0CU
M&& /7VYKRB_CN+X^)A:S:SJBWOAN2"VN+NT\LS2*7+(@6-, ;A@$<DG&:]0\
M.7L.H>'K&X@\S8857$D31L"!@C:P!ZB@#EM;^(\%M'XCM]/C(O=':)=T\+^6
M^YE#9X &-W'//49%='8>+="U*2Z2VOUW6L7G3>;&\0$?/[P%P-R<'YAD>]>>
M^)HI6O/B!IYL[IYK]K*:W5;=V6:-4B5B& QP01C/:M7QUH]_JFMZG#8V\KM-
MX9GA0JO#/YR$)GID@'CWH ['1_$NDZ\\J:==&1XE5V1XGB;:V=K . 2IP<,.
M#CK5G5-6L=%LC>:A<+!#N" D%BS$X"JH!+$^@!-<EX2CMKWQ$^I1ZGK^H316
M7D%]0LT@CC#.&\OB)"7!7W !/K5[QK'+%<^'=5,$T]GIVI>==)%&9&5&BD02
M;0"2%9P3@=,GM0!'K'CJQ@T>VU'3;J%H1J=O:79N(WC:!78;]RMM92%.1D>]
M&M>.;0>#M>U70YTFO-+@+M%<0O&4;&5W(P5L'L>_8UR.M+-J6HZEK]KIUY<:
M=+J^E>6HMG#SB!B9'5" 2,,!G'.VI/$XD\0P>-M3TNUNWM'T.*R0FV=#<3*T
MC':K $[0RCIU.* .VLM>>XU?2;66_M$>ZTS[6]IY+^8QXRZOG:%&<8/-267C
M?PYJ%U!;6NIJ\MS(8H!Y3@3, Q.PE<,,*?F&1[\BN-GTJ_N?%^C+%;S+N\)R
MV_FE"%24[0%)Z ^U06NHQ7 ^'&GKIUW!<V%PL%QY]J\0A=;613&"P ;)4GY<
MC"@GJ,@'>6_C'0;J^ELX+[?-&)#@0R;7\O[X1MN'([A236-9^/K36M(TR_L[
MN.P6YU1;,K=VTK^:"SJ$0@* S!<@\A>0>:Y?1[N]N-<\)WMZ^JM+%>3+?6WV
M#RK:QDDAE144",$_,<;MS#N2,BJ<$-Q-X/\ !VFI9WGVS3?%<37<;6SCRE\Z
M9MQ)&"N"#D9 R* /3;SQEH%AJ3V%SJ 2>-UCE/E.T<3-C:KR ;$)R.&(ZBFZ
MEXU\/:1=7-M>ZALFMB//189'\H%0P9MJG:N"/F/'O7#ZB9+3PYXR\,RV%Y+J
MVJ7MTUFB6SLLZSX\MPX&T!<@$DC;L^E:JZ;<QM\0@]O([SVD4:/Y9_?$6@7Y
M?[W.1QW- '47OB[0M.O8[2YOU65U1LK&[HH<X4NZ@J@/;<1FMJO)KJ2;2K:U
METTZI;ZVVGVB-8R6)FMM1P@ 4_*=C#)4G<I&,D$<UZAJ,$EUIEW;POLEEA=$
M;T)! - &3:>-?#U]>"UMM0\R1M_EGR9 DVS)81N5VR$8/"D]*Q/!7C6Z\6>(
M-9C,D,=C:7$L%O +.99&5"H\QI6.T$Y/R;0P_"L?3I6U'2/!&@6]A>0ZCI-S
M;O?));.BVPAC97)<C:=QX&"<[LUO?#JUN+8>*OM$$L7F^(KN2/S$*[T.W##/
M4'UH NZKKFK-XG&@:+%8"X2S6\EEOG;!5G9 JJO).5.3G R.N:L1^(SIVBP7
M7B2 :==O*T'D1;I_-<$X,80%F! W 8R!U'%8WC!O#UQJT=MXFT:Z\F.(/9ZG
M;Q2L0Q)W('A&Y", \G!S[5S/V?5UMM"U*]O]<M=.M;R]CAO#;B6[CMW \EI5
M=&.#M9<E<X9<XR: /0Y_%^@V^F6FH-?AK>[)6W\J)Y'D(SN 106R,'/'&.<5
M0D\?Z,-:T;3[>1[E=5B>6*>*-V4 $ =%/4D@]-N.<5R^G10^'=9TC7Y!K-QI
M4R7ZR7%W:9ECEEEC<2&.- 55]C8^4=1G&:N27J#Q9X/U?^Q[K3K&6.^B"?96
MRCR-'L+JH^0O@MSCJ<\YH Z*Q\4V46EZC?ZCJ]I+!;7\EKO@@=-C!@!%M.2[
M@G'R]>PJQ'XQT"33)]1.H+';6\J0SF:-XVB=B H=6 9<EAU ZYZ5YSIEA>V6
MGOJ$]C=&WLO&=S>3QB!F8PD,@E"@98 N&X!X!/:K6M02Z[+XBU6RL[E]/NKG
M2((B]NZF<Q7 ,CA6 )4!@,XQ\I["@#T/2/$FDZ[-<0Z?=-)+;[3+&\3Q,H;.
MTX< D'!P1P<5#XEUN?2(;*"Q@BGU"_N!;VR3.5C4[6=G<CG:JJQ..O [U2BM
MY1\4[NX\EQ"VBP)YFT[2PFE.,],X/3WJGX_TV*YFT#4;RSDO=.L+UFO8$B,A
M\IXV3<4&2RABI(P>,\4 ;^@W6JW5I*=6M[6.9)"L<MI+OBG3 (=<\KU((/<=
MQ5>_\9:!IFH/8W>H".:(J)2(G9(2WW1(X!5,Y'WB.M9/@.WC2[U^XTZSDL]#
MN+M&L86A,*DB-1(Z(0"JEO89P3WKG]1D?3]%\;^'Y["\FU+5KFY>R2.V=UN1
M-&JH0X&T;3P<D8VT :^I>.+@?$NT\+V4D,,"P+-<RS64TK.QD">6FW 48Y\P
MY4?A73^)-=M_#7AV^UBY1WCM8FDV("2Y X' .,GC/0=37+Z?I]Y;?%VVDEBD
M>*/PND#W&T[#()^1NZ9[XZUN>/+:>\\ >(+:VB>:>2PF5(T&68[#P!W- &5_
MPL&S37;=)G,>FW&F"ZC_ -&E:8R>85(" ;B %)^[VSTK5F\26MQ=>'WL=6LQ
M:ZH[^6K0N[7("9PC @(1U.X>W6L;0)%U'QO9:G!!/]F/A]81+) \>&$W*_,
M0>.GXUS>FZ;?(_PYW65PHM]0OVFS$P\I29-I;C@'(QF@#T6P\5:+J>I-I]I>
MB2Y&_ \MU63:<-L<@*^#UVDXK9KSGPS.]MXEL[#27U-]-)G-SI^HV14Z:>2-
MDNT<%OE"[FR#D' KH/'EWJ$'AB6TTB*5]1U&1;&!D0D1&0X,C$= J[CGU H
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M+W21_OXSCC/*1*%)'935C4M*NK;QI*EE;L^G>)+<1WLB#B)XNK$]M\3,H/\
M>5: .QDO[.(PB2[@0S\1!I /,_W?7\*L$X&37F6N);'Q-KVD:_!JGV'4D@%C
M]CM?-25%0 Q!@A*,'#,.5 W9XZUZ1 A2UB1@V0@!#-N/3N>_UH YG4/&MO\
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M8MQY;2AY>G&"^UE]\&JNCQ*;CX<R75NWF1:/-#=O)$<I^YC&V0D<<AA@]\T
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M#(WER>HWJC#&<9QB@#T0@$$'D'K7.:=X+L-.U"UNS>ZC="RW?8X+JX\R.WW
M@E>,D[20"Q. :Y&3Q?K%S!8RF\O8;36;^Z>VDL;$3S16<0"H%4(V2YPVY@<
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MY7!+'@'-7K;7/%(34+>P;5]1D.FM/'-?Z3]F\JX5E!6/*(K JS%5.3E.2<T
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M?_BZXJ[;6K-_B'J^G:NUD=.N/M*PQPHZS.EI$Q5RX)VX  V[3R3GI7J%K/\
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MUH [JSO;;4+2.ZLYTGMY!E)(SE6YQP?PJ>N2^&)8_#C12^-WE-G'3.]JZV@
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M31F6%1EGC#*-X (^[D\CUK2GU_3+>TTZZDN1Y.HRQQ6C*C-YK2#*X '<<Y/
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MDC/J-P+B4.1A6$:QX7CIA!U[YK,;Q[X:33$U(ZCFT>Z-FL@A<YF"EB@&W.<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7%?$^QN]0\,6L-G:S7$JZG:N4A0N0HD!)P.P'>NUIKND8!=U4$A06.
M.2< ?G0!P5WIMXUK\2]ME,6O8R+?$9S/_H2+A/[WS9''?(JC:/=:#J&LQW6D
MZA<-JNFV@M/)M7D5W2$QM$[ 80@\_-@88\UZ';:C:7=U>6L$P>:S=8YT /R,
M5#@?]\L#QZU:H \<T_2KS2H-'N=0/B*TBE\.V=KMTRV,CB:/?NBD7RV*D[QC
M.!G=DUIZ9<VOA/QHL+6&IFV@\-V<*A8&N9HL22X1Q&#R<8R!MRO7D5ZA5&/2
M;:/7)]74/]JFMTMG.[Y=B,S#CUR[4 >5:;H>H:''HEWJ3:[81/I;Q,-*A,LD
M4AG:41NH1R,K(!G&,I@GI73>%]%;3?%6G&&ROH;./P^L2M=J"Z,9MWELR_+N
M [#TKO:JSZC:6U]:64TP6YN]_D)@_/M&6_(>M 'F'AF*[\,WNBZGJ.F:C]F:
MQO+-O)LY)7AD-V9%W(H+ ,O0XQP*JV>E:A!;Z1J=Y!K>F6\5]J@F6Q@+3P":
M;=&2@5B4(7&5!ZCM7L=4M1U>PTC[)]ON!#]LN4M(,@G?*^=J\#O@]>* .'T;
M1FM]>\+7-M::K]F']I3RR:@@\Q&E9"&?  0O\Q .#R<C.:SKRROK**.]DTZ]
M:*W\927D@BMGD?R"KCS J@EERPY ->DVFKV%_J%]8VUP)+JP94N8PI!C++N4
M'(P<CGBKM &3XCLIM8\(ZM8VA*SWEC-%%N^7#.A SGIR:XR_N+KQ5X-N- L-
M OH+P:/)$\UW;M ()=J@0J6 W[B#RIVX YYKTFFNZ1KN=U5>!EC@4 <+'.?%
M'BKPY-;Z7?6]OIL-PUY]LM'A5"\8C$0W@;SDDG;D87KTK-\*:'JG_"1VNE7]
MK<1Z=X76=+.XD0A;@RL1"RD\-LAR#CH6KTZB@#R;PIHC0Q:)IEZ?$TFH:4'W
MPR1!;2!UC=-P<H ZL&(4*S'YN>AJ_8:7?P^#?AQ"+"=9[.Y@:XC,1!AQ;3 E
MQCY1N(!SW->E44 >2:.VISZUX6OKZ'7I;B-Y4U$3VC)!:S21.H5%"#Y-W&\9
M4#&3S6AINE7T7@GX>6YL+A)K2^MWN(S$0T($4H)88^7DC.?6N^U;5[#0M,FU
M+4[@6]G#M\R5@2%RP4< $]2!5V@#C? 'FVL>MZ=<VMU!/'JUU-F6W=4=))69
M&1R-K9'H3CO2:EYMG\5-.O9+2[>UN-*ELUFAMWD193,C .5!V# )R<#CK79U
M5T[4+35M/@O[&836LZ[XY " P]>>: //M,TJ_B\#_#RW:PN$FM+ZW>XC,1#0
M@12@EACY>2,Y]:S[)]4N-8\.7M_#KLES;:I(;^-K1EMK4LDR*(U"#<N67YP6
M !RQYKUNJE]JEEIMI)=7=PD<,3I&[<G:S%54$#GDLOYT <Q\-_-MO#]QI=S:
MW5O=6E[<F036[HK!YY'4HQ&'!!!RI/45G>+&N+/7KJZT:/6K?6VCB$2PVK36
M>H8Z+)\I5,9(+$H0.>1BO0Z* /,]2TJ_?P/\08$L+AI[N_N'@C6(EI@8XP"H
MQEAP>GI5'Q4-6O9-;@EAUR2>*]ADM[6UMF^S-;(8F,A8+^\;AOEW%L@ # KU
MJB@#R;4]+U&YF^*TL6GWC)J%E;"S_<.#.1;$$(",D@\$#D'BO1_#L4D'AC28
MI4:.1+.%71A@J0@!!'8T_5]:T[0;'[;JEVEM;[P@9LG<QZ* .23Z"K5M<17=
MK%<PL6BE0.A*E201D<'D?C0!YM;Q7@U233=$BUJ&VN?M:WNG7]L?L]L620AX
MIBN/FD*X568$.3@8INBSW5]+\/K1-)U.(Z4#'?//9R1+"XM'CQE@ P+=QD=.
M>17J%% 'G>A>&)]1^#TNAW$$EI>2FY:,2(4:.7SW>-R#SU"GZ54LK75M>\*^
M+O$&I:9=6^IZAI;65M9R1$2*B0'("]?FE=R!W&VO3Z* /++FTUC0/"?@_7]-
MTNZN-3L=*6PN;..(F0J\ VAEZ_+*B9] 6IUWX8E\-GPP6N=7CM;2PGM;JYTJ
M(RRB>1HY"S*$<E797R0.NWFO4:* ,/PA8Q:?X9MH88K^)':2;9?[?.!>1G)8
M+P"2Q..V<'FN!\0'5;J[O?M$.NRSVNM03BUM[5OLRVD<\;"0%4_>L5&< ELY
MXPM>L.Z1KN=U49 RQQR3@#\Z=0!YE<Z5?/\ #[Q- EA<F>XUR:>.+R6WR(;M
M6# 8R1M&<^@IOC33KR/Q<=,L5;[-XOA2UNBAYB,)'F/_ ,"@++]56O3ZY:R/
MAP^.[SR[Z:[UV.,HT<CO(MJAPQ5>-J9P"1U.!0!T\<:0Q)%&H2-%"JH&  .@
MKQVRL;U-!T:.:#6[-M&U:\-ZUI:/YJ),T^R2/*$2+\RYV!L!J]DHH \PAT4M
M/X;N;.UUF:)_$$EY/+J,6),>0Z"1E"C8I*KC< <GWK6GT^Z;7_'<HM)BEUIE
MO' _EG$K".8%5/<@D<#U%=S10!P-AIMY'=?#HFSF5;.PD2X_=D"$FW0 -_=.
M1C![BL+P/HVI6MIX)%UIUU$UM?:D\PDA9?*#"3:6R.,Y&,]<UZW32Z*ZHSJ&
M;[H)Y/TH \RN$U33[G5"8M2M;"Y\2.]Q<6=JTDPA^RIM9 %8[3( I90<<UF1
MP7MG8VDTVFZRRV7BL7TOFVTDLQMWB<+)\J_/]X9"Y(/!KUC3]1M-4M!=64PF
M@+O&' (^9&*,.?1E(_"K5 'DNI:'JM]J7Q#FM].N66XGTNYME:,K]I6%4=U7
M.,GY2N/7BKGB+[1XIN-6U#3=.U 6\'AN]M,SV<D+S32A2L:HX#,1L/08R0*]
M.HH XU["Y'B7P5(MK*(K:RN4F81G;$3'& &/;.#U]*L^.+6YDL](O;>VEN5T
M[5(;N>&%"[M&H96*J.6(W!L#GY>*ZFB@#RW7K:\\0VGC;5;#3[X6]SHJ6-LD
MEL\<ES(OFL2L; -@;PHR.><5Z'H4;P^']-BE1DD2UB5E88*D(,@BK]% 'D^I
MVEXUKXVTG^S;Y[BZUBWO8=MJ[1RP[K8$JX&TD;6R,YP"<<&MOQ5I][<:_KLL
M%I/(DOA::W1DC)#R%GP@(ZMSTZ\UWM% 'DWV>;3?#'AYTA\0:=KD&A01136=
MFTZ2N%_X]YH]K $-_>"_>.&ZUZ4+RXMM %[>6SM=1VOFS6]NI=BX7)50,Y.<
M@5==TC4M(ZJH[L<"G4 >7:/X#U[5/"U[_:>N/9R:^7NM0LS91N4:0?<W-\PV
MKM'L1Q2:3=:Q97OAO4]<TS497TVWN])NWAM))6\P-'LF"J"S(ZQ_> (R:].G
MFCMX))Y6VQQJ7<X)P ,G@5CWFFZ;XLLK"_CN+J/8/-M;JUE>&10PP?0X(Z@B
M@#SS3;6YU*.SFCTZ90GC>6YEB";C"NU_F?&0,$C)Z FM#Q'ICP^*-?:\?Q%]
MFU2WB$$>DP^8EQA"C1,=C!#WRQ48;KP:]!TC2+/0]/6RL498@S.S.Y=W=B69
MF8\EB222:JZEXJ\/Z-=K::EK5C:7# $133JK8/0D$\#W- 'GFH>'_LFH:[IM
MZ?$[6VHK"MO!I\8D2YC\A(F5WV%48%#DLRC!!%:FHZ3>FQ^):1V=Q(UW;*EL
M?+)-QBS5?EX^8[LCCO7HRLKJ&4AE(R"#D$4M 'G7B+0M0U*[T^UM;:52_AJ^
MM/,V$+'(ZPA%8] 3@\>Q]*R1IG]HZ'J#1)XIN;^WT&Z@$=_;[(XG>, PJ-BE
MV)48V[A\O7D5ZO)<11"0O(H\M-[@<D+SSCKV/Y5%87]MJ=A#>V<ADMYEW1N5
M*Y'T(!% '*M87(U_P0ZVLHBMK.X29A&<1$Q1@!O3)!'/I3OAAYL'@2PTZYM;
MJVN[%3#/'<6[QX;<3\I8 ,,8Y&178T4 >4>.4U;4'\367E:W))L3[!:V5N1!
M-$(U9W=PN&;=O&TMGA0!S6K)9W-U9_$:>*RN<:C #:AX&5I@;)  %(!)W9&.
MH.1UKLM6UW2M"A2;5M1M;*.1MJ-/*$W'T&>M789HKB".>"1)8I%#(Z,"K \@
M@CJ* /-K![KP_J6J+=Z3J%P=4TNS6U\FU>16D2)D:)R!A#D@_-@8)YKJ_ EO
M/9^ = MKF&2&>*PA22*12K(P0 @@\@UT-9<'B+2;K6Y]&M[Q9;^W&9HD5CY?
M ."V-H//3.: /.[NTO&M/%6DG3;YKB;Q';WT>+5S') 9K;+*^-IP%8D9R #G
MI6MXKBUB#Q)K5_IEI<.QT.WB26.#S.1<2%PH((9U0E@O/;CFO0&=$959U4N<
M*"<;CC.!^ /Y57L=1M-2CEDLYA*D4SP.0"-LB,59>?0@B@#R#6+&]N[3Q8+.
MUU^]2\TNT-K->V[^9/Y4SLX *C:1N&%(!/) (KV&QO(]0LHKN%)DCE&56:)H
MG'U5@"/Q%,M]3M+K4+RPAE+7-GL\]-C#;O&5Y(P<CTS5N@#R>UM+Q]*?2VTV
M^%Q;^+DNI UJX0PM=EPZMC:R[>203COBK7B[1=2O?$&NW-O;WOE(FE3A[9/G
MD$4\K2",D$,ZJ00.><>HKTFXN(;2VEN;F5(8(D+R22,%5% R22>@ IMG>6NH
M6<5W97$5Q;2KNCEB8,K#U!'6@#F?!MK;?;=4U&"379S<>5$UQJT7E&4(&(V(
M41@!O()(Y[9Q4.JW+Z-\18]3GL;Z>TN-*^RH]I:O/^]64MM.P';D-P3@<'FN
MSHH \Q\(Z7J,-WX+DN].N(#;VNIB<21G]RSS(5#'L2,X]1G%4IM'O[>ZCU&=
M=7M+6#7=2:22PA+3*DI^20+M8LAVXR >&STS7K=% 'G&D:.8M=\,7=K:ZLUN
M;G4+B6748P)%9T #L !LW8R 0#SR,UG>(='U*;PCXG@BT^Z>6;Q+'/$BPL6>
M/? 2X&.5X//3@UZQ10!PTUV_AKQGX@O+O3K^Z@U."W:U>TM'G#M&K*T1V [3
MG!&[ ^8\\&L[P;X>U'1_$7AQ+ZUD!M?#+022[<I'*9D/E[NF0,_@*]*IN]/,
M\O>N_&[;GG'KB@#@-!O+C14D\.W&A7MW>MJ\THD-NWD-%).T@G,I!3Y5;IG=
ME<8K*\-Z*T%SIFE7[>)9+VQOY)O)\H"S3:SLLOF% "K C@,6RQ&.M>K55CU.
MQEU*;3H[R![V% \MNL@,B*>A*]0#0!Y=I#:I/K?A:^OX=>EN8;F5=166T9+>
MUEDBD5510@RNXXWC*@8)/-)H27EUX3\%>'?['U*VU"RO;>YN?.M'2.*.,LY8
MR$;<L,# .<M@CK7JL=Y;37<]I'/&]Q %:6)6!9 V=I([9P<?2IZ /%M4T/5I
M/A_X\MDTR\:>Z\4-/!$(&+2Q^;"=ZC&2N 3D<<&NBU72=0N/'GBR6*RG:*Y\
M."WAE\L[))/G^0-T)Y'%>CU5N-1M+6\M+2>8)/>,R0(0?G*J6(_  GF@#S/4
M+R73/ OACQ9:V5TMYH,4=K<6T\#PR2(Z+%(FU@"</L(/0[>*[SPEHSZ%X8LK
M&=M]UM,MT_\ ?G<EY&_[Z8U+J7AZRU;4;.[O6N)!:,)([?SB(2ZG*NR#AF!Z
M9]O2M6@#SB\EGT2X\9V,^EZA=S:O(9K%K>U>5)]T"1["Z@JFUE.=Q P<T_1=
M$U#3?B#H G@E>*T\+"SEN0A,?FK(F5W=,G!./2O1** .>\:37\'AQWT\3[O/
MA$SV\/FRQPF1?,=$P<L%R1P?7'%>?O87EQ/JT<=EK5Q%<ZEI5S!+?6[EY8DF
M4.Q^4;<8)VG!"\D"O8:J3ZG:6VHVNGRRE;J[#F%-C'<$&6Y P, ]S0!RNI>'
M_P"V_&6OVMW;R"POM"@M?.V';O\ ,GS@]-R[E/MQ5+X<G4-:N[O7M8CQ=6D*
MZ-&2<[C"?W\@]FD_] KN-2L1J5A+:-<7-N), RVTICD7G/##D4W3=-L]%TN"
MPL8E@M+=-J+G.!U))/)).22>I- '/^+8YK;7/#>MBVN+FTT^XF%REO$TKHLD
M3('"*"6 . < G#5QOBC3=1UKP9X^U"STV]VZK-;?8[=K=UFE6,1*7\LC<,D'
M&0#A<UZF-3LFU&/3UN%:ZD@-RB#)W1@A=P/3&6'YU;H !T%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %</\3+9[FRT!$O+FW#:Y9QMY#A<[I!SR#R" 1[UW%9>OZ#:^(M/2TN
MI)XO+FCN(I;=]LD<B'*LIP>0?:@#SV\L[^&X^(5_9ZW?6DFG;)H?)*?O)$LX
MVS)E3N!P!C@<GVPNI>(=?U34-1%@-:$]G:6[6B:=%&T)F>(2$S;CE@2RKCL
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M=!&P&01M*C&"#4"?#_1DC@B$EX8H-3CU6-&FW;9U!YR1D@DDG)Y)H S?!O\
MR4;X@?\ 7U:?^B*O^)Y-0F\6>'=*M=2GLK:\2Z-R8-N]@BH1@D'!R>OH3WP1
MLZ=H%EIFKZKJ=OYGVC5'C>XW-E<HNT8';BIKG2;:[U>PU.3?]HL5E6'#<8D
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M.W>W7C$;-$Y)'U('Y4^?X?:3>:1J=A?7.H7C:EY0N;J><&9EC;<B@@   YX
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M=U&R8VRV<OV/5XT\^%<X1\@YQD\C#<GF@"/3K:\@\=^+KJ75;F2XMM+M&PA
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M18]($["\O+R>=@TD]W+O8X& !@  #T %)>:!97WB#3-:F\S[7IJRK!M;"XD
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M,US>1@Z?#Y]S&IRZ*<X.WKS@X^E00:Y!?WVD_9M4LT6ZA>1K-OFEE&!@J<C
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M+U"DY.2._)'H<5HT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9@,"0$ AL>_6L;6[W4O!VIWCV^J7M[O\/WEZR7<GF*)X3'M=5Z*/G.5&![4
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ME9F5%"@L<GCU-244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %,FACN(FBF17C;JK#(/UI]%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &<NB6::^^MCS?MKP"W9C(=OE@E@NWIU).>O-:-%
M% !6;I6A:?HIN&LHY ]PY>5Y9GE8\DXRQ)"@DX X&3ZUI44 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5GZSHMGKMDMK>K)M219HI(I"D
MD4B_==6'((K0HH YP>!]&&F_9,71D^T_;/MAN7^T>?C;YGF9SG;\OICC&*MV
M/AG3+#3+VP6.2:.^+&[DN)#)).67:2S'D_* /0 <5L44 85KX0T:T\+GP[';
MN=.;<2K2,7+%M^[?G.[=R#G(('I3(_!NEBTF@F>\NFFGAGDFN;EI)&:)@T8W
M'H 1T''7UKH** ,75/"VE:Q/=S7<4C275M';2,LA4A4<NA7'1@QR#]*HGP#H
MK&Y:4WLLEU%''<O+=.S3['WHS$GD@\ ]AQTKJ** ,R\T#3K^^GN[F$R23V36
M,@W$!H6.2N/ZUD#X?Z4MK#;K>:LHC@^S%EOY TD/.(V(/*C)QW&3@\UU5% &
M??Z)8:CH,NB30XL)(?(,:$KA,8 !'3@4EWH>GWVH)>W,/F2I:RVF&/RF*0J7
M4CH<[!6C10!S4/@71XK.[M)'OKB*YM&LL7%V\GE0-U1,GY1TYZ\#GBKVI>'+
M'4[2SAD-Q"]D0;:>WF,<L1V[>&'J."#P:UZ* ,%?!^D*FE+Y<S'2YVN;=GF9
MF,K9W,Y)RQ)8DY]:D?PMI;Z1<Z6T3_9;B[-Y(OF')D,OFDY]-XSC\*VJ* *E
MMIT-I>WMU&93)>.KR!I"R@JH4;0>%X Z=ZMT44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN"02\Y/.2%3J3TK%\/ZKK?BN+0M/?6KJR9M"BU&XN;9(_,FE=BHSN4@*-I)
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M8"Y?.2"V!UKL/!NHWMY;:K9W]R;J;3-1ELQ<,H5I4 5E+!0!NPX!P!TJO;>
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M[G$4J03W*6[M!#(^-J/(!M4G<OTW#.,UB2^/HKO2/$\I-YI*:3,8A>O9-(%
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M$:#?B9),$.6RN%'/S'.,4 =#8>-]%U&_CM89+A1/O^S7$MNZ0W&S);RW(PV
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M7>C6>MV^MF&,6\]HGF6MX1G"3C!50"2"6VD Y![4 =]+*D,3RRN$C12S,3P
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MR10!Z+J^JVFAZ5<ZG?.8[6W3?(P7.!]*S++QGH][<W$!>XMFAMS=YN[=X1)
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M/"SQL2 ZA@,KD$?SKA=?T_4?$9\1:M:Z7>QP3V]A9P13P-'+.8[@R._EGY@
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M7:0A5#.Q!(C4G 9R!A5)R,M@<&@"E'X1TU;Z[O96N+BXN[!;"X>:3/F1#/7
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MO$Q1MG#$'@, 2 <'O5'PEXMLM:T?2DN+^!M6GTZ*ZGC7Y>JJ7([<$\@=,\T
M; TBU&NRZQA_M<EJMHWS?+Y:LS#CURQKD$\!BW\3V,=G+?V>G6.C"T@N[><+
M(K>;G:?7*\\C'3N!6Y9>*-*M],AN+[Q#97"W$\R0S@"-7VLWR@9.=H&">^W/
M>M/2=:TW7;,W>EWD5U KF-FC/W6'52.H/L: ,V+P7H\":(D4<RC1I'EM?WA.
M7<$,SD_>)R2?<U%_P@NE&],OFWOV0W7VPZ?YY^S>=NW;]F,_>^;&=N><5NWE
M_;6"H;F7:9&V1H%+,[8)PJC)8X!/ Z U@^(O&%IIOA-]9L)H[D/(D,+*"RAV
MD$9W8Z;23D'!R,=: *<.B7&L_$:/Q%>Z4]E#IEN]M;-+(C/<N21YF%8@*JE@
MN>?WAX%:=WX/L+O5)K[[1?0BXD26YMX+@I%<.F K.HYSA5!P1D 9S5[1UOA#
M,]W?+>1/)NMG,'E.(R!PXX!.<\@#C'%5I?&'AV"1XY-7M0T<XMI/FR$D./E8
M]!]X<GC)Q0!;T_1[73;W4;NW#^;J$XGGW-D;@BIQZ#"BG/I%J^O1:R0_VN*V
M>U7YOEV,RL>/7*BHK3Q%H]\UXMMJ,#_8U#7!W8$:D$AB3_#P?FZ<'FB/Q#I,
MHN/].C0V\0FE$H,96,]'PP'RG!^;I0!5B\):9#I=AIRB;R+&\^VPY?GS-[2<
MGN-S'BJ7_" :4)4<76HA8;HW=K&+CY+:0L68QC'&23USP2!C-:-IXLT*_BDD
MM-3AG6-8V;R\L?W@)3  R2<' '/!J]I^I6>JVOVBQN$FB#M&Q7@JRG!5@>00
M>H/- '+Z+HEQ?>/+[Q;?Z4^G-]E6RMH99$:1\$EI6",R@GY5'.< YZUOZ[H%
MEXBLHK2_\WRXITN%\J0HP=#E3D<CGTJ*[\1VEOXDM] _>"\N+9YU;RF9% 95
M&2!SDMZ\8YQD5D>#?&,&JZ5I\.IZA;G6+EYU$2+MW;)'& .@.U0<9SCF@"Y'
MX)TO[)J,-U+>7DNH>7Y]S<3YE_=G,>U@!MVGD8'7FM'1]$BT?SV%W>7<]P09
M)[N;>Y & !P  .>@'4T1^(-)FO5LTO8S,S2*@Y"NT?WPK8PQ7G(!R,'/2H+;
MQ?X?O+FWM[?5K:62Y=HX0C9#NI(*@],_*>.^.* '3>&M/G.MEQ+_ ,3F(17>
M'_A$?E_+Z?*:D&@6(O=-N\2&33K=[:#+<;'"@Y'?[BUJ5Q/AOQ7=>)/$MU%;
MZKIJV=NS[].>TE2[5!E58LS 8)PV0I&#CKS0!JZ9X-T_2ID:&YOW@BC>*VMI
M;@M%;HW4(OTX&<X' Q5'6_#$5KX-T_2=,T^XO$TV2%K=8KL0W$83C?&YX+@$
M\' .2,U4M_&MU+I&G^(V$7]D7VHBS6'8=Z1-(8DE+9Y)8 D8QM;U&3-H_BR^
MO-;MHKE(DMKIM04Q[<-;"VF$89CG^($DYZ$C'N 5/#W@XW2>()=6L[RUAU.6
M!HDN+D/=*8AD2LZ,0'W\C!. H^E;<G@G3Y]-EM;F[U&XFDN$N?MDEP?/21/N
M,K 87'H!CDYSDUJZ7=3WT+W<BA+>5LVR%<-Y?9F]VZX[ COFDUS5X-!T6ZU.
MX5F2!<A%ZNQ("J/<L0/QH JZ)X8LM"O+V\@FNI[J^$8N9KF7>TA3<%)].&QQ
MQ@#CBH=5\'V&JWT]Y]JO[.6YB$-T+.?RQ<(,X#\=@2,C!P<9I)]6U:RU&WLY
M--GNFEM))C-;Q?NO-4$^66)^0= "0=Q/;!K-M_%M]JFH:5HUE;/::C<V;7UV
MU];E&MHE?9_J]WWF;H"W &3GI0!O6OAW3K+58=1MHC%)!8KI\:*?D6%6W  >
MU3:WH]IK^CW&EWP<V\X ;RVVL""""#V((!_"JC#7;>[DC:YMI;3[*[I.8"'2
M4%<!ANP006Z8Z5S&E>.-1O/#7A5G2UDUOQ$3Y2K&RQ0HJEG<C<20JCID9)'(
MH Z&3P9HTESH4YAD#:&GEV:J^!MPH 8?Q8VJ1[BI)_"FF7&E:QIKB;[/JTKS
M7.'YW,%!VGMPHJEJ>MWWAK5-)CU*:*ZT_4[I;(2K%Y;PSL"4SR0RM@CL0<<G
MLV&?Q>!;^8;!\:F8Y-MM(OFVIQR,M\C+E^3PVT8Z\@&A+X4TFXU34[^>%I9-
M2M%L[E';*-$ 1C';J:SA\/M(:TNX+JYU&\^TVWV/S+FY+O%#D'8AQP,@9/).
M!DUJZ9JS3:OJ&CW17[99!) P&!+"^=KX['*LI]USQG U7#%&",%8CAB,X/TH
M IOI-M)KD&L-O^U0V[VR?-\NQV5CQZY04/I%K)KL.L-O^UPVSVR?-\NQV5CQ
MZY05P-SXV\06O@#6-6D?3UU;1K][:\A-NWELJN -HWYR496!SSG%=C)J%W=:
MGIL.FW5N8)K5[F61H2^5^4(1AAC<6S[A30 V/PEID6EV>G*)OL]G>_;HLOSY
MOF&3D]QN8\>E4CX TKS%<7.HA8KHWEM$+CY+:4N78QKC R2>N>&(&,U#X+\8
MV^LZ/ID6HW]N=9NDD8Q(-N[:S9 '3(4 XSG'-;I\0:2M\MFU]&LS%PF[(5RG
MWPK'Y25P<@'(P<]* .?T'0Y[SQQJ/BZ_TM].DDMDL[:"61&D(!R\K[&903A5
M&"3A.>M=%K&C0ZS#"KW%U;2P2>;%/:R['1L$'GD$$$C!!%5;3Q?X>ORXM-6M
MIMD7FML;/R[MF??YN/Q'J*OZ?JMCJBS&SG$C0/Y<R%2KQMC.&4@%3@@\CO0!
MB/X%TSRK+R;K4+>ZM'ED6\BN,3.93F3>Q!!W$ ].,#&,4#P)H\>F165N]Y;F
M"[>\@N(IR)HI'SN(8YR"&((.<YYS6[>:A:V.P7$A#/DJJHSL0.IPH)P.,GH,
MBJ\>OZ7,[)'>*[BV6[VA2286Z.!CE?<4 99\"Z4+&V@AFOH+FWGDN$OH[@BX
M,DG^L9G.=V[N",<#C@4?\(-I<=I9Q6D]]9SVIE*7<%P1,_F'=)O8@[MS $Y'
M4#&*U'\0:4EC;WOVQ'M[F+SH6C!<R1X!+ *"2H!!)Q@9%)/XATFWLXKM[Z-K
M>6$SQO%F0-$ "7^7/RC(RW09% %"X\&:?)%9"WNM0LIK2 VZ7%M<D2O&2"5=
MCG=DC.3R#R"*2Z\%Z;/+9RP7%_92VML+,26MR4:2$<[')R3SSGKDGGFM"[\0
MZ38VR7,]]&('B$PD3+J(ST<E0<)_M'CWI\VMZ=;S)%)=+N<Q@%5+*"YPF6 (
M&X],GF@ T31K/P]H\&EZ>K+:P;O+5FR0"Q;&?J36,G@+2HK*:S2XOUA-W]MM
MP+C!M)=S,6B./ER7;(.<YQ6T-:T\W8MOM(\PLR E3M+*"6 ;&TD8.1GC!JGI
M>M6IT.&]FU>"_2::2.*XABVB4AV 14&2Q !'&<[2: )]%T&UT1;EH9+B>XNI
M!)<7-S)ODE8 *,G@8      JM/X1TJYO-<N9DE9]:MEMKP;^"BJ5&WT.&/-3
MOXGT..RBO)-4MDMY9_LZN[[?WN=NP@\A@>"#T[U8TS6=.UE)GTZ[CN!!)Y4N
MW.4; ."#ST(/OF@#";P%9/:I;G5=9V_9_LLQ%W@W$0)PK\=MQ&1@X/6MG4]#
MLM5T4Z5,KQVV$V&%MC1E&#(5/8@J"/I3=;ODLEL5;5(+!Y[R*)?-CWF?+ &)
M1D8+=,]NM3?VQ8?;ELO/_?O(8E 1MI<*6*[L8W!03C.>* ,,> =-$UQ<"^U0
M75PL?FW NCYC/&Q*29Q]X9*^FTXQBI!X(LDB!BU'5(KWSGF>^2Y_?2,RJIW'
M&TC:B#&,#:,8K?O+RVT^SEN[R>."WA4O)+(V%4#N36?IWBG0]6OVL;#4[>>Z
M6,2F)&YV>H]1V..AZT 9\G@72Q#;):7.H6+P0&W,UK<E7EC+%B')SG+%FSU!
M8X(S4UUX,TNYO[:[#74)ALOL!CBG(66#^X_<@>N0?>KB>)=&>:2+^T(59(3/
ME\J&C'!=2<!E'J,CFJD7CCPQ,%*:W9D,8@OSXR9<[,?7!^F#G% $NC^&+;2+
MQKS[9?WMQY/D))>3^88X\YVKP.I R3DG YIFK>$K+5=0>^%W?V5Q-"()WLI_
M+\^,$D*W!Z;FP1@C)YI&\;>&EA>9M8MU2.7R9-Q(*-Q]X8RHY')XY'-6'U.!
M/$<ML^KVRK#9&:6R*C>@W?ZUGSPN.,$>^: "S\-:98:E9WMI"87L['[!#&K?
M(L.Y6QCURHYI^NZ!9>(K**TO_-\J*=)U\J0HP=#E3D<CGTIZ:]IKI,PN"ODA
M"ZO&RM\YPF 1D[B,#'4]*J7NN6<BV)M]8AM#+?+!MFA):9A]Z$*<%6.1SV]*
M *P\#Z4]AJEM=RWMX^IA%N+FXFS*0GW I  7:>1@=>>:8O@33#)<3SW>I7-W
M/;K;O=2W1\W:KAU((QM*L 1C ]N3FEH_C>UBU#5K+7]5LX9XM6>SM1M\L%-D
M94'DXR6(R3R:TK36;K_A-=<T^[GA6PL[*VN8SMV;-YE#%F)Y^X.>* (I_ 6E
M7FDWUA?7%]=_;I(I+BXFGS*WED%!D   $= .Y]:U#H%D;C5I\2;]518[GYNR
MH4&/3@U+8ZSI^HW$UO:W(:>$*TD3*4=5;[K;6 .TX.#T.*OT <Q/X%TN1(DA
MN=0M46TCLYEMKDQ_:(4&%63'7 )&1@X)YJ:[\':?>7[W#W-^L$DD<LUDEP1!
M*Z;=I9>O\*Y (!QR#5*WU?6KSQOK>C)=V<-K806\T;M;%F/F;\@G>!QL].]:
M,/B&SL;6SCU?5++[7<J\D1B!431@DAE7)/W=O<\G H 9;>$+&WU2*]^U7\J0
M3/<06DMP6AAD8,"RKU_C; )(&> *L>(?#6F^)[:U@U)'9+:X6XCV-M.X C!]
M00Q!'?-,M_&'AZZ>S6#5K=S>-L@P3\S9(VGT;((P<'(-,F\:^&K>X\B76K-9
M//\ LQ'F<+)Q\I/0=1U^E $R^&M-7Q6WB0(_]H-;?9B=_P FW(.=O][@#/H*
MCC\)Z9%H]AI:B;[-8W2W<.7Y\Q7,@R>XW&H+76+O_A.-8TVZFA%A:V%O<Q_)
MM*;VE#;F)Y^X/2KR>)-(D$Q%ZH\F'[0X964^5_ST (RR?[0R/>@"I#X/L(-5
M^VQ7%\L7VAKH60N"+<3-DE]ON23C.,G.,U-'X5TI-#OM',3O9WLTLTRLYSND
M<NQ!'(PQR,=.*MQ:SI\\%C/%<AXK\XM753B7@MQQ_=!/T&:;!KVEW-^MC%>(
M;AU9XU(($BJ<,4)&'QWVDXH S'\%:?<:3J6GWMYJ-ZNHQ+#/-<W&Z38N<*O
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M]W=T([YQ;.CRIJGA6XL]"FL[:'4+BZN(LAVA$D+J&D.XY8LP)P3C/MFN^HH
MYCP7:75G%K0NK66W\_5KFXB$@QOC=LJP^OIUJEXMM=4NM8:&WTJ6>UFTN:%;
MFU\M9#*3Q&[L0RQX /R]3USTKM** ,;PE%<6_@_1K>[MI+:X@LHHI(I""RLJ
M!3T)':N=MX-4T[7-=TRZ\/OJ=GJ=Z+RVNSY;0+E$&V4,<C84!& <C&.17=T4
M >9:YHVJ76F^/HH-,N'EU*YA:S  _?!8HE)!SQ@HW7%'BNQUO4VUR*'0[IE>
MXLI[5K;RT6=$:)F:0E@S2#:RA3P %QZUZ;10!YEK>CZK>Z?\04BTJY\W5?(^
MQJ0N92L"(><X&&4]?J*7Q DT^OZ]#;:9JL]KJFG0VE\]I#',5.'XPTBF-PDG
M<-]X''KZ97*:K8>&8_%MC#=1W$.K:OYA3[-/-$L_E("WF!&"MA<#Y@?2@#"F
MBF76EU"#0M3U30]2TV&T$5O-Y<MNT9D!21&=05(<Y))P0?6N^TRU6RTJTM4@
MCMUAA2,0QG*Q@ #:#W Z5/%%'!$D42+'&BA511@*!T %/H \T\2:-JM[%\08
MK?3;B1M3MH(K,@#$S+&5;'/&#ZX]JZ&VMKEOB.VHBSF2R;1TMQ*RX D$K-MQ
MUZ'Z=JZJJ5AJEKJ4E[';.S-97!MILJ1B0*K$#UX8<T 8_C;3M0OM-L)M.B,\
MMAJ-O>O;!@#.B-EE!/&><C/=16?)X:_X2'6]?O+F"6VT_4M+BT_9(NUY&!D)
MD*]1MWJ!GG(/;!/87-Q':6LUS,2(H4:1R!G  R:98WD.HZ?;7ULQ:"YB6:,D
M8)5@"./H: //;7P[XFN+O2-2OPHNKVW.FZQ&'RJVZ@$,/<E)/<>?[5HZGIU[
M)XE\4W":?.\-WHD=I;N%&))!YV5'/^VO)P/RKMY'6.-G;[J@D_2L"U\:Z)>6
MFBW4,\ABUJ0QV1,3#>PSG/IT/6@#DH=.U72[C3)[K0M2U&QN=$MK"X@M)PDE
MO-%OR&4NH9&WGG)Z>AK:TC29['QS!*NE&VL8]#CLT,?,<3B0MY8/4@ CG&./
MPKM** /.;#2=5L+N7[!#?KIL]M<FXTZ[4.+:5ON_9WZ[68GY<D ==IXIVBZ5
MJ-K-X \W3KA!IFF2V]X=HQ$YBC4 X/.60],UZ!<7$-I \]Q-'#"@R\DC!54>
MI)Z56U75+71=-EU"]=DMXBH9E4L1N8*.![D4 >:?9[K2],\*1WMA.DJ^*KB;
MR2H+%'%RZL #S\K XZ\>M=GX:TJ6VUSQ%JSPM;PZG=1O#"PPV$B5"Y'8L03C
MK@#//%:VHZ+8:K/9S7D<CR64OGVY69TV/@C=A2 >"1SGJ:OT <MX@L[^+Q=H
M&MP0275G:)<07,47+H) NV0+_%@I@@<X;@'FN>U+P]J:^%->6"QFDFU36XK^
M&U3&Z.-982Q/. 2(V;&?X@.N:]*HH :C!T# $ C.&&#^5>::OHNJ7.@>.K:+
M2[AYM2U!);1=H_>H$A7/7 YC;KC]:]+D<1QLY!(4$D*,D_05!I]['J-A#>11
MS1I*NX)/$T;CZJP!!^M ' >+O#^K:]J^N_V?;21K=:)!!!+(-J/*D[R&,]QE
M2!D\<FM#4+*]UO6[;6H]/NK46NE75O+%(H#RR2[-L8&>0NUCGIDC!/..XHH
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MA?M=6@QO\N=Y"DBC.&VAAP.<,>]>G5')<0Q310R31I+,2(T9@"Y R<#O@#-
M'G&H^'M1=KZ^AL9F2_\ $5E?); #,<,7E!Y&&>"VQCCKT[Y Z30;2ZA\9>*+
MJ6UEBM[N2W:"1A@2;(@C8[\$=ZZ>HS<0BY6V,T8G9#(L6X;BH(!;'7 ) S[B
M@#G/&UG=7MGI"VEK+<-#J]I<R",#Y8XY S-SZ =.IK+BTO4[;Q>E[I:7MO#-
M?NU_9W(#VS)M8?:(F/*.?EX!Y).1CFN[JE/JEK;ZM9Z9(["ZNTDDA4*2"L>W
M=SV^^M %/Q?_ ,B5KW_8.N/_ $6U<?%HESXDM/"\MK!+9?8=(FC>>1=N&EMQ
M&J+C[PR=V1Q\H[FO0;^QM]3L)[&[1GM[A#'*JNR%E(P1E2"./>ELK.#3[*&S
MME98(4$<:L[.0HX RQ)/XF@#@M!L[N:PMTU'PM>V^IZ;9R0&YGN/-0DIM(@^
M<DAL ]  !]*0:1J*?#[P;8?V9/\ :K"YL&NH0HS&(BID)YP>AZ9S7<:3JEKK
M>E6VI6+L]M<)OC9E*DCZ&KM 'F^M:/J5U#\1$@TV=VU6WCCLSM \YA $..>,
M-ZX]:NWFGW=QXFGNGTBXN;1_#CVC(<*)9"V[RLYR"1QGISUKNZ* /-HM"U#[
M!?Z=<C5[_12+4VLDI$=];.KDD*XP7$?RL"<]2!NITFF^(9-+TN*\CGU![;Q!
M%<)<F%8Y7M4 _>2J,?,.1TR0!Q7HLCK'&SM]U02?I69_PD>F_P#"+?\ "2>:
M_P#9GV7[9YFP[O+V[L[>N<=J .-O= U"ZTGQEH+:;(9=9OWEMIV ,01XXU$A
M;/!4H3CKP, T_6_#^K:AJ?BJ*SAD7[7I-K;VMQ(<)++$TC,I(.1G<HS[FO0D
M<21JZ_=8 CZ4Z@#B=,N9HX[K7SX0U*WU""T\ETN;A9)I?F!\N-C(04!R<G;U
MX'6NOLKI+ZPMKR-'1)XEE57&& 8 @$>O-%P]JS):7#0EIP=D,A&9 .3@'KBH
M=*U2UUG3TOK)R\#NZ LI4Y1RC<'W4T <;_90?XB:]J&H^'9+VQN+:VAMY'MT
MD!9-^_ 8Y ^8=N:G:TO)?$/A*XCT>XMK*P^TQE& )@C,8CCW8)Y.,\9P",UW
M%% 'F(T?5!H!A&EW(F_X2LZAL"C/D?:O,W]?[G;KVQ4+V4FM:;\0=#@L9);B
M_P!4:**0I^[5C##AF;ML^]SSZ9->J50T[1;#29KR:SCD1[R8SSEIG?>^ -V&
M)QP .,=!0!P^O>&=5U6^\4VEJDJ"]T.WL[>ZDX621&E+*3U (< GW-:\=G=Z
MYXHT#5Y-/FL%T^UN$NDF !+R! (A@_, 5)R..!C.>.PK-U>2SE2/2KVWN)HM
M1#P'RHW*@;>=SK]P$=R10!R_A?0KNVN]5TUIE&GZ6\MMI;J<E%F59"#[QA@B
MGTR*S=#T._O-%MM'U#P_=6FJ:=9R6B:E-<^9 A,1C#P_.3EN#C:,#/H ?0;#
M3[/1].2TLH!%;0@[47+'U)R<DDGN>32Z=?1ZGI\-Y%'/''*,A+B)HG'..58
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M\4,HF8-&HE0!5.<@8.,#UIFLPW=[/\0;IM8U2$Z4JR6,=O>/&L+BT23.%(#
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MG9 Q.,,64$(Q!8#('TJIX;T>^@\4-J<T!6TET.SMD<L,F1"Y9<9R,!AVKG]
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M^94,4I0D'[K%DS@XW 9Q5C6O$*:3=V=C#8W.H:A>!VAMK<H#L3&YV9V5549
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M<XQCOGBN9L-'U^XTKPOX=N](:VCT2X@DGOS-&T4J0 A/+ 8OEB%SN48YKH_
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MJ0HL*#^% !M'X#%6:\JNEE\*R:#>Z3=W<T]]I=V]PLMP\JSM';^8C[6) (8
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M9"_F'<V7.X\EL\)CUK6\/VEQJOQ"UR;5+FY9]/2R>*VCN7$*2O!\YV@X;D<
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MS9%Y[VW^S7)$SJ)H\%<,H8 G!(!QD>M1/XUT.*TU.YFGN(4TP*UTLMI*CHK
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MM;R\G@@EDM'#,ZL^8L*@P5VE0",G;WH O:7X1T/1C:FPLC%]D:0VX,TCB+>
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M'A;":#6;J:>WO?,7;$LV-P=2=V4.<8!R,=*[*+6;*;7+C1T=_MMO"D\B&-@
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MK7L-W)'<MY+1MN:.(@,J.=JY89ZXY&*:_@[P[)IEUISZ1:FSNI?.FBV<,_\
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M'IVM" :A;F86\@FB'F,NQQT88(^8=CU% &-K$NKV&CZY//J5NMREC)+8R6T
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MUU!<ZIIL%S/ "(Y&!# 'JI(ZK['(INH>$M U748-0O=*MYKJ!0B2%<':.0I
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MB"#[-&YD<[8N/DY/3@<>P]*H#P9HT,VDM:645LFFRM-!Y><J6 ! YX!P >O
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M;.">R8!P.NX9XK:BT>QAU1M32%OMKQ"%IC(Q)0<A3DXP"2?J2>]0:SX;T?Q
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M%T=;0&2YL-KR64FYOWLD9Y>/ '3.-K<=QO:+X6T/P\\KZ3IL-HTOWC&#TSG
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M5<37TTMJ6>_B$-T?-<>:@R I&>F"1CW/J:=?:>5\-W.FZ?$.;5H(49S@97:
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MYMS'*S.)'X^8Y/#<#D<\#T%)'X3T.&RM;..P5(+687$*J[#;*.CYSDM[G)H
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MN?L][I4ES%<,%:2UF1U7<"1@JV\'!SRIQ@5T)\/Z4TVH2O9I(VHJ$NQ(2ZS
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MGAR_T>\N8(I=<CL[J!D\MP1NWQR*1D$%1Q_.MV^\6Z;8"ZEE$QL[28075VB
MQ0.<<-SGC<N2 0,\D8..?D\(:E'%:RQ);M<2>(?[9ND\TA47!78IQ\S;=OH,
MYI9O"6JC2_$V@Q^1)8ZU<S3QW328: 38\P,N.2#DK@\Y .,9H Z)/$UB]UJ]
ML8YTDTF,2W&]0 4*EE93GD$*>?;'6HM0\76&FVDMS/!=E+>!;BZ"H"UM&V2"
MXSG. 20N2 .G2L35=*L]0\7:3%IFH1&2*)K35($<.6M4VN%?G@[]J\]1(]2Z
MAH.LVWB^]U+3]/TK4K/4DB$J7SE&MI$&W<IV-N4KC*\'(H U(O&6FW.L/IEK
M!?7,J-"'>&V9HT64$HY;^Y@?>Z?KBYK?B&QT V8O1<$WD_D0B&%I-S[2P' Z
MD*<#J:S]#T?4+#Q7K5]<)";6\AMHXG1L-F)64Y7&%!W<8)JGX]>5+CPFT,:R
M2#78L(S;<_N9L\^N* )U^(.B_P!G3WDJ7T)MKM+.XMY+9A+#(Y 7<HZ [@0>
MASQ4L6OV=]X@TJ)O[7LKF:*Y,=K/"8HY A4,S@CDC@K@]&SWK&U;PEJE\NK7
ML,4"WFI:C97'DO+A8XK9D(!8 Y8[6Z<#(&3C-;&L:+>ZEXLT:^6-!96UK=0S
MGS<.#,$ VC'.-A[]Z +$7B[3)9;'_7);:A(8K.[9!Y4[C)VJ<Y&0#C( ;'&>
M*-)\66.M7\EK9VNH$1R2PR3/:LL:/&0&4L>AYX'M6#I_A+5/["\/Z#?B#R-$
MO(IENXY.9DA),0"X^5C\H;)QP<$YK;\):7?Z3;ZHE]'$AN=2N+N/RY-_R2.6
M / P1GF@!]]XBDM/%^FZ$EA-(+NWEG:=2N%",B]V!XW@GCTQGG GB[3'EL_]
M<MK?3FWM;QE'DS2#(V@YR,[3@D -C@G(S%J^CW]QXOT?5K58'MX+:XM;A9)"
MC*LAC(9< Y(\L\<=1S6)I_@_4T\.Z/X:O/(-II5[%,MXDG,L43[XQMQPQPH/
M..I!/2@#H_%FO/X;T&344M)+IA+'$%0C"EW" G)'&6'3_P"N.</BJ31_%GB6
M34!J4UC;V-G<BW2(/]F4^<9&PO &%!/))QQG%=!XRTB[USPO<V-CY7VDR0RQ
MB5BJL8Y4DP2 <9VXSCO6+>>'];N[OQ9.UO:J=8TJ*SA"W!(615E!W':/E_>C
MGK\O2@#=U'Q3I^G023[9KF.&V%W,;=0WEPG.'()&<A6.!D\'BM2WN(-0L(KF
MVFWV]Q&)(I4/WE89!'X&N%3PUKVFZI;7UKIVE:BD^GV]I=6]Y*5\B2($!T?8
MV5(8Y& >!7=01R6]C%&0CR1QA2$4(K$#L.P]NU 'G7AC77U/PRCW_BNXCU66
M\FM8U4Q;MWGM''E-O(P%S[9KJ-0\;:;IUQJL#V]_*^EQI+=^3;$A$8,=V3C(
M 4D_IGFLOPUI/B+0/"ITMM,T^XN5N)IXV:[/EY>5I%S\F>"1^5.O/#NL377B
M]U2!QJ^G16ENYEVDNJ2*2XQ\H)DSQGI0!KP>,--GOFM1'>*QM6O(7:W8+<1*
M0&:/N<;EXP#R",BJVF^/='U2[TVWB2]A74XO,LYY[8I',=NXJK'^(#G'MQFJ
M(T+5(=3T6]EA@6'3]&FLI\2Y.]A'RHQR/W9].O2LWP?I-WK?@_P*\\,<-MID
M45YY@DW-*1"R(H&./OY;/I@9SD &KX7UYK?2+MM2NI[N=M:N[*V5L&24K*P5
M!T'"J3V  ).!5^X\;:7::?>7<T=TAL;A;>\A,8\RW9L;2PSC:=R_,"1@]>N,
M"#PAK4,=O>(ML+ZRUVYU**$S$I-#,7#(6Q\K;7.#@C(]\C4.CV,$OB+4?$4M
MK:P:X(K9X99@%6-8RH!8X&\Y8\>W7% &Y=Z[9V-Q<17(D06\"3R/M!4!V*JO
M!R6)4@ #G%4X_%^F&>^MIQ-:W=GY1DMY5!=A(=L97:2&W-QP>O!Q7/6?A74=
M4^&DEG-?J^JW8BFCNIX^#Y3(8-Z]<%8T+#U9JDO?#FNZYX=E2;3]&TG48I(9
MK>.$F6*62-P_[P[%.PXQM&<9))/0 &R^KIXAL]8TO3YKRPU2T"I(JB/SHBPW
M(RDED(8 \Y/?H14\FM_V1;16E[YM]J$%D+BZ^S(N2JC#.%)'!8' &3[4OAV#
M44BEFU'3-/TZ1PJBWLW\P<9RS/M7KG@8XQU.>,KQAX:N->N/,M[54NH;<_8=
M1AN3#/;3DGJ0.8S\N1ST/!SP =7<7$-K:RW-Q(L4$2&221S@*H&23[ 5QLWB
M*:;QYH05[VUTV?3[JX=+@*D<BKY95_4$!CD-@C(X%;VO:)+KOA"^T66ZVS7=
MHT#3A<?,5QNQZ9[5S%QX<\1Z[=:5_:MM8VT<&FW=A=20W3.6,J(N]!L']TG!
M/_UP#?'C325N?)N?/M=UH]["\R86:%!EF7!)R 0=I ;!Z5%/XUM(K'49ELKP
MW%E8#4/LS*JM)"P;#*=V/X3D$Y&.E96EZ-XKAT*:Q>UT2PO[>S>"WU&W.\SR
M;"J.5*#8.A/+<]L56B\(ZW/=ZC+-;6-L-0T$Z?(PNGE?SLO\[,4!;.\<DYX[
MT 32^);X^(?"MTZ7RPW^G7,LMA$@;S'41%2 "?[[=3TZXKK]&U>UUW28-2LB
MY@F!P)%VLI!*L".Q!!!^E<U9Z)K:ZMX7O+FUM572[":VG6.X+$LZQ@;<J,_Z
MLYZ=>^*U/!>E7NB>&H["_6)9TGGD_=/N4AY7<<X'9L?A0!'8>((KRXUS4;BX
M$&EZ3,]MDG +1J#+(WL"2H'^R3W&+,?BBR:]6SG@N[:XDMVNH(YHN9XUQN*!
M2>1D94X89'%<U#X7:\T;QEX4GE,#ZA=SW5O+C(,<V&#>^U]RD>WN*TQI&K:E
MJFCZIJ=O!%<Z5;3KLBFW">:150D' PF 3SSDCCCD T_#_B>S\2PB>QM[U;9H
M4FCGGMRB2!L\*3U(QR.W%5E\5JOBC5M+N+22"TTVTBN9;QRH0!O,))^;(7$?
MIG.>V"9?!>EWFA^#M+TJ_6,7-G L+F)]RG'&0<#^59&M>$K[5M8\0KOA33]:
MTN.S:;S#YD+IYN#LQA@?,'<=#0!N6GB6RN=1MK%XKBVGNX3/:BX0*)T&,E<$
MX(!!*G#8/2H_$GB&307TJ..QFNFO[U;4%"N$R"QZD<D*<?K[T+71-4O]3\/7
MNK1002Z-')N,,N\3RO'Y>5X&%P6//.<#'&:N>*])O]371YM/6!YK#4H[LQS2
M% ZA74C< <'Y\].U &!9>+?[&UCQ.-6EOY[2WU**-9/*WK:H\,1^8C "[G/3
M)[^]=%JWBW3-&\][KSC;6LB175PB@I;LV,;N<]&4G . 1G%<UJGA37+W3/&%
MLD-J)-9N8I;<F<@*%2-3N^7C_5D\9ZBK'_"/ZY9^(]3EMM/TF[L-4E6X\Z[;
M][9R;%5QC:?,7Y00,KSD9'6@#K-9:1-#OI(97BD2W=TD3&5(4D'GBN.\*:P-
M6T+PW++XHFDU:]BBEEA#1,'8)OD5E"Y4$!AVP2*[+5H9KC1KRWMD5YI8'C16
M;:,D$#)[#FN=T#3O$&D^%M%T=M/L?/LH8H&N3<E@@4;6=5V<G;NP..O)H FD
M\?Z/$DLK0WXMX+W[#//]E;9%+D*-W?!+ < ]><9%/F\=:5:V>KW%U#?0?V4J
M27,4EN=^QP=C@#L<'KC&#G%8EUX5UN?P]KEBL%L)K[6UU"(F?Y1&)8WPQV\-
MB,C'(Y'-4_'>EW]OI/CK5IHHEM+W2(8HL298-%YF<C'0^9QSVH ZJ'Q58ZI?
M7NCP_;;._2V,\9G@,9DCZ>9'N'(!QU'?I5+PGXC9_!OALW;3WVJWVGK/Y:8,
MD@"KO<EB !EAR2.2!5A]'OK_ ,00ZW<6\<+VFGRVL,(EW&1Y"I8DXX4; !W.
MXD@8YQ]"\*:SH7_",WJI!-<Z=IATN\MQ-@.F58/&Q'4,@X.,@^W(!OQ^,]*F
MCTR2(7#QZA<M:1MY>/+F7.8Y,D%6&UN#Z<9XJW+X@M(I;B)HYO,BN%M54 ?O
MI2@?:G/.%.23@#G/0XY35-"L]-\&ZM9ZA?P6VI:C=SZG;A)!N2YWAXQ$#@N5
M(0<#DGMFKFK^%M4G\.Z0UHUG-K%A=_;I4N0?)N9'5Q*IX.T'S&VG!Q@4 :UK
MXOTV\@<PB8W2736;694"43*NXKUV_=^;=G;CO5>;4)?%>A^;X?O[BRNK>]\J
M8;$W1NAP\<@;(QW.WKQ@X-96I^'=<O;73=3@T[1X-1LKIIO[,+;H)(V0HRM)
ML'S\Y#;<# '/4]7HD%U#8$WEK:6DTCES;VAW)&, 8W87<>,DX'7':@".77[:
M._EM$AGF:":*"=XE!$3R8VAAG/1E.0" #]:N7]_!IMJ;BX8A-RHH R69B%50
M/4D@?C7*:SX7O;_Q,-5LX4L;Z.X@,6H6]P5,ENNWS(YH\8?^,+UZCD8K5\8Z
M)=:[H/D6$D"7L$\5U +A<Q.\;!MK@?PG!!^M "1>,=,DDN;=EGCO;:XCMI+1
MPHDWR#* '=M(89(.['![BH+SQ<T&IZ):0Z5>,=1N)X7W!%,?E*Y(QNY.5'/3
M;DYZ53ET2_U71'@U7P[I"QSRH)K"&;/R*&RXD"K\^XJ0.V/O<\5K7PKKMF?#
M\RW"WC:9?7$BI>7#%TMY$=$4R;2690P_EGC- &_%XMTZ;4(+14N,7%S-:0SE
M!Y<DT08N@YR"-C\D ':<'I531O&*:CI]S=W-C/:[+^2RAB;:6E=79-HPQ^;Y
M23T '? )K%'AKQ-+J^EWUY'83SV.K37#737+;I('615"KLPFT.HV@X)7.><T
MR?P=KW]E30P+IS3VFN3:K9B9V:.Y61I"8Y!M^3Y92,C=R* .RT;7;/6UNA;B
M2.:SF,%S!* 'B< '!P2""""""0<]:=K]W!8^'M1NKF:YA@BMY&DEM5)EC7:<
MLO!Y'7..U8OVG7-*TRWN%T;3(KBXNXXY+*"<X2,\$JP0;W[XP !WX).OXEL;
MC4_"^JZ?:*AN+NTE@CWMM4,ZE02>>.: .>U;6IWU/PSI-NFH/9ZC#)))-&ZI
M+(JQ K\P8$'+!CC'0=>16CKFJ3^#O!INF^TZK-;A(O-DVAG9F"AGQM'4C..3
M^M4_[$U7^U_"5UY$'E:5;2Q7/[[G<\:H-G'(!7/..M:?C+2+K7?"E[IUD8A<
MR>6T?FL54E)%?!(!QG;CIWH P;GQ+/I7CG43<KJ4UDFCPW8LXXPYB/F2AS@<
M=$'4GV]*WKKQ;IMO9"[B6>[B^R+?-]G4$I P)5R"1U ; &2<' XK+N-%UFY\
M1:IJ3VULJW>C+8HBW!.)0TC<Y4?+^\ SUXZ5D6/A3Q!HTNF7%OIVDZC_ ,2J
MVT^\MKN8J(Y(00LD;[&RIW'(P#TH ]!L[RWU"Q@O;259;:XC66*1>C*PR#^1
MJ>H;2)X+.&*0H71 K&--JYQS@=A[5-0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !63XA\06WARQAN
MKF"YG\ZX2VCBMD#N\CG"@ D=ZUJXGXF+(^E:(L-R+:0ZY9A9RH;RSOX;!X..
MO- &SI?B5]3OEMFT#6K,$$^==VZI&,=B0Q_E6WO7<5W#(&2,]JYFRM]2@%R;
MWQ5'J<;6[A8!;11G..N5.>@/'O7 :-X;TEM*^&DC6<9EOX_+O),?-<1_96?9
M(?XDRB_*<C QTH ]F#*RAE8$'H0>M8_B?Q%;^&/#%[KLT3W$%JH9DB(RV6"\
M$\=Z\PNK+3X(#I<BI!I<7C=85A4[(TC: $H .BDL>.GS&HO&=I:Z9X>^)6G:
M9#';Z;%!82+!" L<<S,=^U1P"0(R0/6@#VI94,:.6"[P, GU[4^O.?[-T?6O
M%_B-/$D%O<16=A:_9A= $0P,C%Y$S]T[P<L.?E'-8NFZO/X4TKPUXPU,R-#J
M&C"TOR_WGDC0R6[GU9@'3/JPH ]?9U499@!TR30S*@RS  G')KR!?#U_%?>'
M=)O;+3+Z:XL;K4+F#5'98I+N21&D; 5MS*'(&1P,FHX-+O;V_P!'TJZ70=:M
MX-(E> 7=T[6^//928VV'<R1^4NX@$<^M 'KL=G:P7$US%;0QSS8\V54 9\=-
MQZG\:Q?"WBI/%5G/J%O87%OIRNRP7,[I^_VLRL0H)*@%3][%.\-V G\#Z?8Z
MG-:ZK&UJL<DBMYT4Z8X.2/F!&.3UKS#PAIVF+\,?#MO'HMC<7NKZE+$WG'RH
MI3').Z^<0"7550X4YR<4 >Q7UW<6ZVIM;%[P33I&YCD1?*0]9#N(R!Z#).>!
M5'2O$<&JZ]K>E1P21R:3)%'([$8?>F\$?05Y0[;='T6W0VPBMO'L,4<=H3Y,
M8ZE4ST7+' ]ZU_L::CKOQ)LWO+>T\Z]T]5>Y_P!6[;$Q&_(RKGY"/1J /659
M64,I!!Z$&LF6+0O$<]S;7%K9W[Z?,(I5N(!)Y3E%? W#^ZRGBLGP.(+;^UM.
M72+;2KJUN5^T06<V^W+-&I#1C VY&,K@<\G.<UPEU86%C9^-Y;>V@M=VOV]M
M=30J$=+1S;F4;AR%.6)^I- 'LD(A6%4@"")!M54Q@ =ABGLZH,LP4#N3BN(T
MJPL-&^)[V.B6T%I92:-YUU!;*$C$@E C8J. Q4R<]2![57U/1--USXH:A#JE
MI%=P+H,)$4R[DW&:8;L'C<!G!ZC)Q0!W^Y=VW<-V,XSSB@.I8J&!8=1GD5Y!
MX;T^UL]-^&NKQ1 :C=R&.YNCS+,AMI3M9NK ;5P#TVC%+X=:$>*O".IVMCI]
MBFKO=2@QS-)=SQM$[_OV(&[Y@IQS@C Z4 >E>'-<A\1^'[/6(8GABN5+*DA&
M1AB.<?2M3<I8J&&X#)&>:\5^',DLX\,0>(X0FG>2[:( ^8I+A7?<9./];CE!
MTQG'S5<\+Z;?7,^C:S(-#M;U]4F\^\:X<7EP=T@D@8;,'@'"[L#8,=* /7F9
M47<Q 'J32YKD/&^D_P!KSZ3'&-+NYXI))5TS4S^ZNQMP>Q^9<@@[2!G\:P_"
M-]8R>+=/EMX38VP\/NBP2S;_ "_+N2K@.3\R@C@],8Z"@#TIG55W,P"CN3Q6
M;-K<,'B.WT9XV\R>TENQ+D;55&12#[_./RKS#PO#8ZS_ ,(C8ZI'#<Z3-;ZG
M/##. T4TXN1MRIX)",Y&?4FM.UT;P[J?B_0+&V U'1H=+OO*2<F1&VW$0VG=
M]Y5.0,Y'RC'04 >G@@C(.0:R]:UN#1;>"61&E\Z[@M=J$94RN$!/L"<UC?#E
M!#X6EM4XAMM1O8(4S]R-;B0*H]@  *X"&RTIO!GAG5YHX1KMUXA@^T7' FEE
M^U?.CGJ0,?=/ VB@#VO<N_9N&[&<9YQ5"?1](N;\7LVF6,]]'@K,\"-(N.F&
M(R*\PT[3;Z^U%]5<:';7J>(I$:_GN'6[PLY408V8PT0"A-V""#6AHEE:Z/XB
MLWDM-/O?[1EN_LFM64Q$TI(>1DN%_C "D9R0"HX'% 'H>G7<]UIL5S>6;V$S
M@[[>61',?.,%E)4^O![U<R/6O$?!%K::GH/PZT[5HHI]-DM+^403@-').L@V
MY4\$A6D(S[^E2:?8Z?>1V5C$QGTYO&D\:C>2'C%M)\N>ZX&/<4 >T!U9-X8%
M?4'BJU]JEGIUO%/=3JD4LT<$;8)W/(P1 ,>I(KS&XM['3KSQ'H%MID#V5QK5
ME#;6)D,-LKO CG<%!^0E22H'S'CO6-<6%E/IES975IICV]KXPLXEAMTW01*X
MA\Q$##A22V1TR30![/%=7$FIW%L]C)';QHK1W1D0K*3U4*#N&/<8]*LJZMG:
MP.#@X/0UX]X@>?3O$/Q".EY@:#0;41>0,&- &!*XZ87.,=,5J:IIFD:)KVF1
M>&[>WMXKO1[TW2VH $T*QJ8Y'Q]X[CPQY.X\T >F,_#!-K2 9"[L?2L_0=;@
MU[3?M<,<D+I(\,\$N-\,J'#(V.X/YC![UY[H>D6&EM\-;^SMDBO+R'9=7"C]
MY.K6;.0[=6&Y5(!Z8&,5T&@7,%CXW\;^9-'!9K<6;LSL%197A4-R>,G"?B:
M.UJK-IMC<7D-Y/96TMU!_JIGB5GC_P!UB,C\*M44 %%%% $$-E:6T\\\%K#%
M+.P::1(PK2$< L1U/UJ>BB@ JK=Z;8W[PO>65M<-"V^(S1*Y1O5<C@_2K5%
M!1110 4444 %%%% !1110 4444 %%%% #)88KB%X9HTDB<89'4$,/0@]:CM+
M.UL+9;:SMH;:!/NQ0H$5?H!Q4]% !4%W96E_$L5Y:PW$:L'59HPX##H0#W'K
M4]% !1110 4444 %%%% !1110 4444 -*(S*Q52R_=)'(^E.HHH **** "BB
MB@ HHHH **** "H+RRM-0MFMKVUAN8&^]%-&'4_4'BIZ* &QQ1PQ+%$BI&@P
MJJ, #T IU%% $$UE:7,\$\]K#+-;DM#(\89HR>I4GD?A4]%% !1110 4444
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M<%?D'\/!(X[$U4A\+>'[>0R0Z)I\;F=;G<ML@/FC.'Z?>&3@^Y]:UJ* */\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7@>YJIJGBBTTS7;'1OLUY=7]XAD6.VC#;(P0"[$D *"?<^U &Y1110 4444
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M+G2FB6<NH"GS$WKM.>>.N0*UJ "BBJ&M:M;Z#HE[JUVLC6]I$TT@C +%0,G
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M+[3K'0E@\/0Z+:3QW(7,[L[(V[9ALX4GJ=V<<5V=GIUQ<36]YK4-C)?VCO\
M9I+8.!&K* WWCU/- ',?&#_D1/\ M_M/_1RU2U/1-/N?CGISRP%F?2))V/F,
M,NLJ!3P?3MTKOM3TJQUFS^R:C;)<0;UDV/TW*<@_@12MI=D^K1ZJUNAOHX3
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MET2Y>91,R?:=DT81G*D$Y&UL]_QJAJ=E!IGP]^)-Y9>9!<IJLD*R)*V0@,)
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MKS2">:X^'OA>2>5Y7_X3*,;G8L<">3 R:]LL;&VTVQ@LK.%8;:! D4:]%4=
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MN7A\07R3>9,LA$EU,R2;XG'.X#!^7^'8,8Q3].NU;0?A2@G!DD:(D;N6 LY
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MT7XN16FE0QVT?]@R.UO$<(N9XP&QV)QSZXJ7Q4[+\5O "AB%;^T<@'@_N%H
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M>F:ZVO#=&_Y$+X4?]AA?_:M>B?$6/SM!T^'S)(Q+J]C&S1N58!IT!P1R#@T
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M"RDMH;=KB26\OA!YA&<QQ#:2SX&><#D>O'*:]=:MKOQ,\/V\$$$NFOI[WUO
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MB *OAAD>G#-T]36+_P )G?7FB:?J&G:?8J)_-$[WU^(889(VV&,.%)8E@V"
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MHBE+<8",=W P._/3'/-1^*M0N?AY:ZKXAT^&[$VL"&$07CQG_CY= 3M5<!,
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MNX8Y[>92DD4BAE=3U!!ZUB^)/$4FC3Z?96L5K)>WS.(S=W'DQ(J#+,S8)[J
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M*4'\/()'%=510!P<WA#55O-+NX[/0)GALY;>2%XBD%L[N'\R)-IW' P0=I;
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MDJ.#GKQ5G2M(U^7QG_PD&L#3X4&G-9K;6LKR;3YBONW,JYS@]AC Z\FNLHH
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MG$S VXA($** < $!21CYMYSG-3:EID>KS>/[N_:X,UG!');(L[J+>3[&K;E
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MK,D]S#)X5L;B2+SF57E9I,N0I&3U_/V& #U&L_1]8M];M);FV614BN9K9A(
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M>&5SVSGM3+SQ??QWE[;6&@M>2:;!'+J&+I4\MF3?Y:9'SL%Y_A'(YYH CM_
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MACC( ?EP%/"[N^ ,]ZBUGQ#/8ZM::1ING?;]1N(GN/+:81)'$I +,V#U+
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MU>YA@ACE\.IIQ02[BLP<DCITP>M=Y69XAUVS\,Z!>:S?^8;6U3>XC7+')
MXY)(% '$Z/X5\0>']*\'2PVEM>7>D6MQ:W-O]H\L$2E3N5B"#@H/SJ>R\(ZV
MK:9+=BU\Z'Q%/JDXCD)41R)( %R,D@N!VKM]-NYKZPBN;BPGL9'SFWN"A=.>
M,[&(YZ]>]6Z //-=\%R3^)M3U"/PWHNL?VD(BDVH$9M75 AR-I+)A5.%(.<C
MOFND\4Z%-JWAQ;/3S#%=6TL%Q:A\B/?$ZNJG'13MQ[9K?HH XQ-&UG5]9O\
M6-1LX+%SI3Z=;6RW'FDEVW,[,  !D* .>Y]JUO!FDW.A>#-(TJ\V?:;2V2*3
M8V5W <X-7-3UF#2KK3+>6.1VU"Z^RQE,85MCOD^V$/YBM&@#R_3_  7K%IJ.
MD7C:-I?VNPU%Y[K4/.!N+Y7$B[MVW( #@[23T &,5K6WA/4XO!V@Z6PA^TV.
MJQ7<V'X\M;@R'!QR=IKNJ* /-9-*74/BZ\%G<1RZ8HAU74(D.=EU&&CB!(X!
M8;7QU_= UM?$P3'P>!;E!.=0L?++_=#?:8\9]LUT]GIUCIRR+8V=O:K*YDD$
M$2H'8]6.!R?>J45_8ZSJ>IZ3+:"0Z;)"9/.161F91(A4>HX.>Q'% '(ZOX;\
M1>(9M7U&:VM[&=[".QM[9;LOYJB822[G"C:& V#CH23BLVZ\":O-!KD5CHFE
M:9!JEO9K';VTBJ(7@G+$-M4!BRL3D>@'/6O5J* .7\2Z7J<_B/P[J^FV\-R-
M.DG$T+S>62LJ;=P.#TQTKG;72EOOBW=Q6EQ'-H]L8]6N(T.0E\4:)5/;)4>9
MCU />NL\.>*(?$_VN6SL+N.R@E>%+N;8$G96*MM 8M@$=2!3+C5-"\+:7K+6
M=K#$NEP_;+JVLX50X8$@XX!8A3_6@!OC;2+[6-"ACTU(Y+JVO;>[2*1]@D\N
M17*[L'&0#S65+IOB6PU+6;O3M.LYO[;BB=EEN]GV.=8A&V?E.],!3D<\'CFN
MU63?")%4G*[@._2H-.NI;W3X;F>RFLI7!+6\Y4NG.,':2/?@]Z ,23PW+;?#
M27PQ:2+),NDM8QN_RAG\HH"?0$UEZYX0EOM)\-&33++5)-)C$<UC=, DJF((
MVTD$;@P4C(YP>E=S6%J?B_2-(\0Z?H=W*ZWE_CRMJ95<G"[CVW$$#U(H YN#
MPUJND76C:QI>A:5!-;"YBGTRTE\I!'*4*D/MP7'EKDX .3CH*RM'TS6KRVFO
MX(+:?4=-\57%U+;><41P8RC*KD=1YG!(&<=LUZM44%M;VWF>1!%%YKF23RT"
M[W/5CCJ3ZT >;:YX-\1:WX<\6PR16<5[K%W:SP1K,2J+&(@06P.0(SVY-=59
M:#<1^+_$>H7&S['J5M:PQ[6^;Y%D#9';[XQ7244 >>^#_!CZ%>:=%+X9T.!M
M/B,;:K$ 9K@A=JLH"@J2.6))[@9SFMKQ)I>IS>)O#FL:=;PW*Z>\Z3Q/-Y9V
MRH%W X.<8Z5U%% '"CPGJ8\#Q:1B'[4NL?;3\_R^7]N\_KCKL[>M5+7P.;/Q
M!.3X9T.\2;4GO1JMQ@RI&[^85V[<EP20ISC&#VQ7HM% '&?$,W07PRUDL;W
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MU"UMKRUM)I@D]VS+ F#ERJEF_(#-%_IUCJEM]FU"RM[N#.[RKB)9%SZX((H
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MN< 8Z#->B44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+%*S%V^4*RY4<$+DYZ9QSUH U$\;17&A^'+^SM#--KDT<,=N9,&/(+2$G'\
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M["W\@L<Q8&TOG^+.<XXZ4 6Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ JO=6%G?&,W=I!<&,Y3S8P^T^HR.*L44 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#/:6UR8S<6
M\4IB;?&9$#;&]1GH?>IJ* "BBB@ HHHH **** (Y8(IPHFB20*P=0Z@X8'((
MSW![U)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0E& Z$N@&<],T >CT5Y;J7B#6-?TSPYJKV=K%I-[KEH;?RY&,R()OE9\C!W
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M:(DAL@$$Y[XZ^]:U !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD^S?9[V:TV^9OW>6VW=G QGT[>M '-MX(UX:5'H46H6"Z1;:BE[ QC?SF07
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MVMS)%)<6T,KQ'=&TD88H?4$]* /*KO\ LBWN/&L'B.:WFOC8VRVSS@"65!;
M Q _-DR[S@<[O>HM.$)\2>$A<2/'"?!;>8\8)95VIDC'.<5W/B#PQJ6KWDTE
MKK4=K!/!Y#QRV2S/$""&:)\@H2#SG<..E;EEIUGIUM9VT,: 6T*V\+, 6"*
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MO@NXOA;I%YMVC23[0N?).T$GWZ>]=<-,M1J,%\L866W@>WC"@!51BI(Q_P
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M7JWL:6ZB.X1&173^' 8D@;< 9]*W:  !@# %% !1110 4444 %%%% !1110
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MI8]1@!\_AK5K[7[*ZO[^QFM+&\:ZMY%M-MT 0V(BX.W:-V"0,D 9YR: .?\
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MT]K"-R-Q13'L!]\"L_0_#>HV6JZ?J.HWEK+-:Z8VGE;>)E5OG1@W)/9.?<T
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M.2"K,"01USVJ>73[71;+7=7\7WUO(=6C2VG6&)EC6)595C0$EF)W.?<GIQ0
MGB/QQ+HM_JJPP6\MGIEA'-/+(Y4>?-)LB3=T"XRS'!P"*QI_B9<6FE:R\=SH
MNL75C#;W$<NFR%HG6241LC#<2&'4<\[AP.E6O"G@RYG^&DECJL\T>IZF$GDG
ME0&2(H%$&X>JK''D>N:T]2\+ZYKWA_4=/U34[%7N?($2VMJ5CC\N0.S'+%B6
MQC&<# ]Z .DTK^T_L*G5_LGVLDDBT#;%'8?-R2/7C/H*NT44 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ ILD:2H4D174]589%.HH 8T,3A@\2,&QN!4'..F:<5
M5EVLH*^A'%+10 TQQLZN44LOW6(Y'TI(X8X01%&B G)"J!D^M/HH 3:N2=HY
MZ\=:-J\?*/EZ<=*6B@"-8(4 "Q(H#%AA0.3W^M.$:+C"*-O3 Z4ZB@! H&<
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MHXH_+CC1$_NJH _*GT4 1K!"L/DK$@BQC8%&W\J58HU7:L:A<;< <8]*?10
MQ(HXP D:+M&!M&,#TIP50Q8* 3U..M+10 Q8HUD:18U#M]Y@.3]33R 1@C(H
MHH 9%#% NV&-(USG"* *78H##:,-UXZTZB@!NQ/E^5?E^[QT^E)Y4?F^;Y:^
M9C&_'./3-/HH 8(HUD:18U#M]Y@.3]32[$V;-HV^F.*=10 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%8/B3Q;8>&1;BZBN9Y)W10
MEO'NV*SJF]B<!5W,HY/.>,T ;U%8NM^(AI%U:65OIUWJ.H78=HK:VV [$QN9
MF=E50-P')Y)&*GT'7+?Q!I@O;>.:'$CPRPSJ%DBD1BK(P!(R".Q- &G1110
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M78Z.S*-N#GJC=0* -2BBB@ HHHH **H:IJ]OI=A?73J\QLK<W,L,.#)L^;D
MD#^%N_8U/87B:AIUK>QJRQW$*2JK=0& (!_.@"Q1110 456BNI)+^YMFM)XT
MA5"L[;=DN[.0N#G(QSD#J.M+?70L;"XNVBDE6&-I"D>-Q &3C) S^- %BBJ>
MD:E%K&C6.IP(Z0WEO'<(KXW!74, <=\&K$,T5Q'YD,BNFYEW*<C()!'X$$4
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M'<6L\<\$@W)+$X96'J".#7+>'_"NJ:"TAD\0QW"W5TUU=AK%5,\C_>YW<#@
M#L *ZFVMH+.WCM[6&."",;4CB0*JCT ' H Y#Q"1_P +3\%#//D:C_Z!'3-7
ML(M3^*5K:S2W$<;:%/N\B9HF/[^+^)2&'X'M76RZ;83W<=W-96TES']R9XE+
MK]&(R*)=-L)KG[3+96TEQL*>:\2EMI[9QG'M0!YAHWB"YU#3?"5GJ^K"WAOM
M)D?[1<.ZBXG5E7!=70[@N3UYR3U QZ%X7CDA\-V44NJG5GC4I]N*;3, Q /4
MYXP,Y.<9[U/+H6D36*V,NE6,EFC;EMVMT,8;U"XQFKH6..-8P$5,;57  QZ
M4 >=>$[&[NX?&)M=8FLL:_=@A5C*<!,Y)4L,CC((QVJU="/7/'4\"ZC??V=<
M:"MRB07<D2EC*P#KM((R .F,]\UU+^&] ^9GT73?F.6)M8^3[\59;2=.:8S-
MI]J93'Y1<PKN*=-N<=/:@#SCP[<7<@^'U]-J5_+/J]K+'>E[IRLH%N6!VYV@
M@J/F !ZY)S531AJ \/>$-<M]8U*XU&XU06L\<MV\B30F202*4)QE54MNQD;>
MOIZ?_8^FQ+$8-,L@]ODV_P"Y51&?]D@?+^%97@_PM'X;T6WMIX;.2]AW@W44
M0#.&8MR2,]\=3T% ''MJ<^FQZR8Y7AMKCQBEO>3HQ4Q0LD63N'W<G:N>V[M6
MK<:9J-]K7BCP]8ZE>P6AL8)[6=;EPUI<MO&T/G=M.Q6*YQSVS79KIFF1I/$M
MC:*MUGSD$*@3>NX8^;\:KW>G7%MI36WA[[#IT^Y64O;;HAR-V44KU''6@#BC
MXBU+4?"&J>([6.ZM[G3=.:V-ON8A+E?]>=I.'V8 !/HU0:AJ+:9I.I:YHWBA
M;VWDL(W:W@WRB)?-4-<9:1BK!&;CC.W/537HFFV"Z=IZ6V\RMEGDD(QYCL2S
MMCMEB3CMFBSTG3=.CECL=/M;5)CND6"%4#GU( Y_&@# \,1Q#6+NXM/$<>I6
MEQ;QN+6%FD2(Y/[P.TCD;AVXSM)]:SM9L(M2^)<EO+-<Q)_PC[$FWG:)O]=Q
M\RD']:[*QTRPTN)HM/L;:TC9MS);Q+&"?4@ <T2:9I\URUS+8VTD[)Y;2M$I
M8K_=)QG'M0!YEI>O7&J67A:RU?5UM([[0A,)YG=/M$_RAOG5T.\+@]?XB>H%
M6[:PFO\ Q'HNDW/B34KV"31)VDN;>X>W^T,DT060!6ZX/W@?FZ\@UWLNA:1<
M64=E-I5C):1MN2![="BGU"D8!J4V%A]LCN3:6WVJ-=J2^6N]5] <9 H \^TZ
M]DUJ^:>7Q*MAJ=EK4D4MG\Y=D$I5(2GF!2K1[>0O^UU!-95E:SVWAB/6--O[
MU-4C\130Q6Z7#>5*K7K*\;19VD%2S$XR,9S@5ZK_ &7IW]I?VE]@M?MVW;]I
M\E?-QZ;L9Q^-$>EZ?#>O>Q6%JETYR\ZPJ';ZMC)H XFX-]IWB?4?#1N;]TUQ
MDN;"X-Q(Q@08%PBMGY-H&Y<=W KJ_$DEQ:^$]5DLKI+6XBLI6BN)F^6-@APS
M$YZ=<\TW3],U!=5FO]5O8+EUWQVB00&,11,P)W98[F.U1G@?+TY-6-<T^;5M
M$N["WNOLLD\>P2^7O ]05R,@C(/(X/44 <9I$4^HZ@]]#>7D5@FCA7A.HLS?
M:3G+X5SR%ZL>IP1R":H:.R0^%O"%U<ZMJ<U]K*6^])KYQ%.RP.Q#,2=B\Y.T
M98JH(.2:Z32?!L$5ZEW>V&@))$&7&FZ>(=^5*D.23E<$_+ZX.3BN@.D:5+9)
M:'3K)[6-]R0^0I16'<+C - 'F5AJ%U?Z-X9C.L73,?$=S92-#>/EX ;C:I.<
ML,(N">>!@TV_3?HMW:7%U=26^G^,;:"%I;J1FCB+P-@N6R<%VP2<BO4#HVEE
M@QTVS)$IF!,"\2'J_3[Q]>M']C:689X?[-L_*N#NF3R%VRGKEACD_6@#BKV^
MNM/\3++(TM]HLU_;00W5I>/YEFY6-5CDC)Q(CDAMW)^?)SP:T?B7#%+X;M&E
M9U5-5L2661DP#<("201V)^G6NF&E:<MW]K6PM1<\'SA"N_@8'S8STXJ:YM;>
M\MWM[J"*>!QAXY4#*WU!X- ' 2W1U*[\86T^H7-M_9=O$U@\=TZ^7%Y.X3 @
M_/EPV2<_=P>^>NT*2ZU3PEILNJQM'=W-E&URBDH0[(-PXP5Y)Z=*MSZ5IUS+
M%+/86LLD(VQ/)"K%!Z*2..G:K= 'C>@6]O/X5^&D*7,N9+H^:4N&W*?LTV0#
MG*?AC';!YJ]'K5QIEBME/J<D.FIXFN+"2ZN97D\J$(S1HS[@VW?M&2W3 )Q7
MI"Z+I2F,KIED#&YD3$"_*YZL.."?6@Z1I2VMQ;G3K,6\YW3Q^0NR0^K#&#^-
M &;X2MS:V=["-;_M6(7;M&X!(@4@'R@Q9BP&>I/&<=JP+"VGNOBIXM6WU":S
M86=CS$D;9XEZ[U/3^M=S:VMM96L=O9P106Z#"1PH%11[ <"JDWA_1;B=YYM(
ML))7.6D>V1F;ZDCF@#DM09I]>\'62ZM=2(QN;6[>WN'19VC@.[.",D,#R.0<
M\@BL*-KJUT7[:FJ:BTVG^*180&2\D8?9_M00QL"<.-K$9;)Z<\"O3ET?3$^S
M[=.M!]FSY&(%_=9Z[>/E_"F_V'I'E&+^RK'RR_F%/LZ8+_WL8Z^] 'FFK174
MNG>/+V/6]4AO-(O3)8!+Q\(P@B=4V9PP9B5VG(YX R<W=<U+5-/USQ+J%I%_
MQ-(?"UO*J*-VV023DD#OCDX]JZ;1O#$=AK.KZA?0V$SWUZ+F!O+R\.$1 H)'
M^QG(QU-;WV*RCO&O?LMNMRPVM/Y8#D>A;K0!QHW+XD\-QZ7?7=QIVK6,YO ;
MIWW(J*4F!SE6W,!N&,[AZ"H_#$NH37D?AN\N+V2ZT&XD>YN7F?-S&1_HY9L_
M-N#Y(R1F(C&*[!-*MK&VN1I-K9V5Q*AVNEN N_G!8+C<,G.,^M1:+IUU90RS
M:C<Q76HW#!IY8HO+3@ !54DD* .Y/))[XH X;PK=-X@CT74Y?$_E7[F2*_T]
M#)YDCD$/&R^9\FP@D,%& /0UL?#.V>7PEIVL7%_?W=W=6P65KBZ>13AVP0I.
M >V1R>]=0FCZ8EW/=IIUHMS<+MFF$"AY!Z,V,D?6IK:TM-/MQ#:V\-M"#D)$
M@103[#B@#SG48;:+Q!\16:5UE;2HF56G;#9@FS\N<'IZ<=L5%937NB7.DMIL
M]W/)<^%IK@V\L[2(\T:PF,JA.%/S$84#K7I$^F6%U*\MQ8VTTCQ^4SR1*Q9,
MYVDD<C/.*;'I.G0RQ2Q:?:I)"NR)UA4%%]%..!]* .-\(S1:A>:3JUIXI6[6
MYLB)[)"[F5L [W#2-L93D$@#[V/05;\60/>>,/#-A]NO;>WO!=I.EM<O%Y@$
M61]TCD$]1S73V>F:;92S7%C8VD$EP=TLD$2J9#ZL0.?QJ2:PL[BYBN9[2"6>
M'_52O&&9/]TD9'X4 <!=3W^GWGCVWLM5EB:STJU>VEN[AG6!O+FRV6)QG:"3
MZ\U)9I+>7>H:A!<W*::FC;3;2WYE_P!((;<VT.P/RX!)ZGD=S74ZUH,&H:??
M0V9MK*^O4"-=?9U9G ()5AP64@8(ST/45FZ3X,@@O%N[[3]!CD563;IVGB$2
M!A@AR2=R_P"STS@\X% '->%HFLY? 4<=Y>&+4]!=;F)KERC;(H2FU<X0C<1E
M0#S6]\+$@C\ Z>L4C,^'WJ92^T^8XZ$G;T[8KIH](TR)X'CTZT1[<8A98%!C
M'HO''X5/;6=M9JZVMO# KN9'$2!0S'JQQU)]: /*KR];04\=W=G/-'.NKP+*
MPG8M% Z6_FR!2>H#-\V./7 KK;(W%C\16L+.>:72Y]*^TRQR3-*(I1(%1E+$
MD;U+<=#LSZUTWV&S\^:?[)!YTZA)9/+&Z11P Q[CV-)9V%CIR&&QM+>U4\E(
M(U0'MG H YO6+MK7XB:%$]Y+#:7-A>>:AG98W9#$5.,XR 6YZ]:Y33-0UB[\
M)Z/=V<[:N8OMYN;%K]XYYHUGVK(DF>608 #'HXY!Q7I]WIUEJ'E?;;.WN?)?
MS(O.B5]C?WAD<'W%0MH>D/&D;Z58LD98HIMT(4M][ QQGOZT >>MK$6NW1TZ
M37WTJVET6VN=.FNG>.1@X;=+D2*"ZD)D'/3T)SVE[&UQX$GCGN7NF;3COG"F
M(RGR_O8!RN>N/?%:%UI>F:EY)N["TNO(;,)EA5_+/JN1P>.U72 1@]* /*M/
MMK:YM?AC;QW,VR2W?S#'<MN!-EDJ&SE?H",9XQ3+/6[BU@T[3+S5&ATXZUJ-
MD;JZE=N(W;R8GDWJW(SC+<[0.:]*31=*C\C9IEDOV<DP[8%'ED\G;QQ^%(VB
M:2UG+9MI=D;69MTD)MTV.?4KC!- %'PG UMH[P'63JR)<2".X(/"YR$W%F+[
M<[=V2>,'D5S&E65W?>-O'\=GJL]C(9K90T21L QMEP3N4GCVQ7H$$$-M D%O
M$D4,8VI'&H55'H .@JA)X=T.61Y)-&T]Y'.69K5"6/N<<T <Q?NFI^-?#]M%
MJ-VUE<V%ZLRV]U)&DK1M$H(VD=RWS#!/KBL#29KN+0_"FIG4]0ENFUV33W:6
M[=E> 2SQA64G:QPBG<06R.M>FC2=-#PN-/M \*>7$PA7,:_W5XX'L*C_ +%T
M=(XXO[,L51'\R-/(0!7]0,<'WH \PO$O_P#A'/$.KVFLZH=4TS7I(;&,WCLA
M_>HJPLF<.&#8P<]1BK_B#4[S2-0^(-]8%EGAM].RZ#+1H=P=Q[JA9OPKJ_#G
MA==*N=1N;V"RFN;F_EO(IDCR\8<YVY(SQSR.N>@K<33[*.YFN4L[=9YAB658
ME#2#T8XR?QH Y&:VD/C*'2["^O#I>HZ3+)<;+MV,+*R".5'))4MN8<'G;GL:
MJ>';_5;RT^Q3&Z?4?#<,T-UF5\75QC$1//SAD&\@YP76NP;2TLM-N8="@LM/
MN70^6PMQL#=BRKC(_&G:1I\MA:R&ZG2XO;B0S7,R)L5WP!PN3@!550,G@=30
M!YYIFI7%SHEKXATOQ*MWJ!TJ=I-.4.[7$PBW#>ID(1D<8X4#G;T(%;'A*6&^
MU#3M4L_%*7D=S9'S;)"[F0\'S&W2-L93P< =<>E=A;:7IUE=3W5K86L%Q.<S
M2Q0JKR'_ &B!D_C3;73M,TV6>6TLK2UDF.^9X8E0N?5B!S^- &+XI@OH+/3H
M=$6W,B7!<Z>\S0"[4(VY Z]&R=_/!*\U<\)WL6J>%K2XB6\1'#H4NW+2HRNR
MLK-DDD$$9SSC-:5W9V5^$CO+:WN AWJLT:OM/J >GUJ6**%+=8H4C6%5VJB
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M5(W$C!BW)/EJJ$@#GC&><UHIX(UF%+:WBU6R%K8ZHVHVZ_9FWREI&8B5MW.
M[ $#DX)Z8IR^!M22&\ACU.U4)J[:QITA@8M'*SLS)(-V&7#,O&#@YH BU;QM
MK'A^P\01:A;64^HZ7!;W436ZNL<\4KE/NEB58%6'WCVK4M]=UNQ\1Z7IFO0V
M"QZG%-Y4EIOPDR881DL><INYP,E35'4/ ^H:UI^N/J6HVW]I:I%! &@A8101
M1/O"@$DDDEB3GN..*7XF21W.DVNEV,[+XB>YBFTM(UW.L@?!<^B!2^XGC&:
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MDG'?OZ"KM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<3:_:D  8\E<!@#_ '0.U 'I,&IWO]FWMS>:5);S6KN/*$RN)E49W(W'!'J
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MHN%4 >@&*-B[]^T;L8W8YQ2T4 ,$,2RM*(T$C#!<*,D?6G*JJ,*H SG@4M%
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M;Z7).UQJH:5!&[[2L<8(!;*<MU' [UVMOI6G6=W-=VVGVL%S/_K9HH55Y/\
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M@:R:R.M*+K3)(WO QM]-!$-N_EIN4 ]">&('=C7,:2KGQ%XMV^,SH@_ME_\
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MPQN5Z%E!Q1+!#. )8DD Z!U!Q7DFNP7&CV'C*TLM0OH],MIM/>W<W<C&"9W
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M[>]AU&X=?*N61U&(R#P<X)/XYJ]\0M6BC_X23[-?O%?6.FPRQF6XV"%B793
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M7(OH<#*D$,#@9!%6GO=,L+F*S>YM+:><YCA:14:0^R]37-^'_P#DI?C+R_\
M5^78;_3S/+?/X[=GZ5QOQ!O8I'\6E&TFTFM5@C/GPM+=W)$:R*T9WCRU7<>0
MI^ZQ/2@#U>XU?3;.3R[G4+2!]XCVRS*IW$ A<$]<$''O5B.>&9I%BEC=HFVR
M!6!*'&<'T."*\QOK#3M0?XFWDEO;W+&V3RY64/A?L2L"I[<X.1Z#T%5M1O[W
MPJ8+ZR#O)XFTB&VAQS_Q,%54C8_[ROS_ -<Z /5H[JWFM_M$4\3P8)\Q7!7C
MKSTXP:S;[788[</ITMA=R"6))%:]6,(K]#GGG'('>JS:3!H/P_ETFV_U5IIS
MQ _WL1G)/N3D_C7G6J:?:6/P7\)-;6\<3SSZ9+,ZJ TC$J26/<Y)ZT >M3ZI
MIUM<&WGO[6*<(9#'),JML');!.<<'FLM/%=BNNZIIUY+;V<=EY 2>:X51,95
M+8&<<C'J<UYKXE?1%\,?$6+53;?VRUY,8EDQYY7RD\DK_%M"^G&-WO6\NEV-
M]KGC>6[M(9W73+9%,J!MH,#DXSTS@?D/2@#MCXCTI?$0T$W<0U P^?Y9<=,X
M Z]>^/3FKEGJ-CJ D-E>6]R(VVN895?:?0X/!KR72_[+.K6#:K-' +GP1!F<
M@>:3\P9DXR7"^F371^!IH(-<DTU#HMZT>GQM'J6E+LWQ!L*LJ D!NI&#S\W2
M@#>U3QGI>GR:Q:QS1S7^F6+7CV_F!=X"N=@/)S^[.>. 0>]:.EZU8ZK%&(;J
MW-R84EEMTF5GBW '# <CKW%>=>(180>*?'RRBVCNIO#J- &VAW/EW&\KW/&,
MXJ6[TV/3[CP?_8]M'!>2:3>(K1* SM]G5AD]2=V#SWYH ](M]1L;R>:"VO+>
M>6 [98XI59HSZ, >/QK#\1^(#I^KZ?I,&@RZO=7<4LR1H\2!%C*AB3(0/XQ7
M'^ [:*2^\,SQ:OHGF0Z<X^RV%HR3O&54,)FWMR'VDY ^;/?-7_'#6Z_$'PV;
MK7GT2/[#>?Z6DL49SNA^7,@*\_3/% '6Z7J][/%.^K:++HT46T(US<PNKY.,
M#8QQCCKCJ,59.O:.L,LQU:Q$4+^7(YN$VHW]TG/!]C7G_B>33IOAWK5M;>+&
MU]F>V+EKF&1H@9T''E*N ?>M%= TC_A:EW#_ &9:>2-!B_=>2NS/FR+G;C&=
MO&?3B@#L[G4=-M )[J]M(1Y>\22RJOR$@9R3TR1S[BLK6_%,>DWF@0PP+=QZ
MQ>"V65)0 @*EMXP#NZ>U><>$Y-*^W^!FUI[?RQX;D$)NB-@<21@?>XSMW8J.
MW""#P8;?'V ^++HV.W[OD;Y=FW_9ZX]L4 >PMJFGI?K8/?VJWC#*VYF42$>R
MYS4J7=M) TZ7$30INW2*X*KCKD^V#FO'[TZ?_P ()KT$IM_^$J;69=BG'VDW
M'VG,)7^+[FS&.-OM5[7HKC3];U?P7;[TA\4W$<]JR#_5J_%Y^2H6^LE 'IK:
MKIR36\+7]JLMR T"&90TH/0J,_,/I3GU&QCODL7O+=;QQN2W:51(P]0N<D5Y
M+K5@K:MXML+C5-$TQ#);I;F[M&DN$B$,8B: AQP'#8 4_,#ZTLEK+<ZIK=O>
MZQHME=G7493/:,][N#1F$QD2 X*A0,*1C=[T >O3/#%&9YVC1(@6,CD (,<G
M)Z5SWB'QC:Z-H=KJMF(=2@N+R&U#0SC;\[;<[@"#CTJK\1"BZ+IS76W^S5U6
MU-_O^YY._G?VV[MF<\8KDO&\GAV31YCH B+?V[8?:WMR3"TF5QMQ\N[;C.WV
MSS0!ZE+J5A!>Q64U[;1W4HS' \JAW^BDY-5H-5)O]2BNA:06]HT824709FW#
M/SK@>7SP,DYZUY=XTOX)+CQ%,KZ19RVVH6T;)+"TE[.R")Q(K;QY:A3QA2,*
MQ/4U!KNR:3XKE6RCOIV&4]047D$4 >MMKNCK%-*VJV(C@?RYG-PF(V]&.>#[
M&I;G5-/LXHI;J^M8(YB!&\LRJ'STP2>:XQ= T@?%<PC3+00C05Q%Y*[,^<RY
MVXQG:2,]<$BN5TJ.V_X1#PS=?VAI"WD&DRQ_8M93,,\&\9VOGY6&T#(SP1D=
M* /7-4U.TT?2[G4KZ98K6WC,DCDCH!V]2>P[FH4\0:0VEV^I/J5I%:3@&.66
M954D]LDXS[5SNO20ZC\%[^>.R,$4NA-+';.-QB_<Y5>>Z\<^U8>F3Z%_PE.C
M2WLNG?V8?#RBS>1D\GSO,_?!2?EWXV9[XS[T >G(ZR(KHP9&&593D$>HIU<E
M\-ACP;&8P19F[NFLA_T[F9S'CVVXQ[8KK: "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *PO%&@2^((
M=/BCGAB2UO8KMQ+$9!($.=F,C .>O/TK=K/U;49=-@A>&T>X:681D[MJ1#!)
M>1L':H ZX/) [T 3?V;8_95MOL5MY"G(B\I=@/KC&*=<6%G=0)!<6D$T*$%8
MY(PRKCI@'I7*IX^633=/NX=+DG:[U-],*13J5612XR&.-RG82#QU[42^.IK?
M1-2OY]'*/I=\+2^B%R"(E(0^:&V_,H612> 0,^E '536%G<3)--:022QXV.\
M8++CD8)'%+)96LMU'=26T+W$0Q'*T8+I]#U%5[?46N-7NK-(5,-O%&S3B3.7
M;)V8QU  /7HR^M8UYJUO:>,KR,:7))>P:0;@3B8 21B3[@7. <Y.30!T45G;
M02O+#;PQR/\ ?=$ +?4CK4BHBLS*J@N<L0.IQCG\ *Y/2?&D^IW&C(^CM;1Z
MS8M=V;O<!LLJJQ1@!\HPXP>>G0=*M:3XJ?5M-M+A+ 17,U[)9RVKS?-"T9;?
MN.WL$)QWR.>: -V*RM8+B6XAMH8YY?\ 62)& S_4CDT^6"&8H98HY#&VY"Z@
M[3ZCT-<O#XWCN+VQ%O827%E>3M!'/"Q9T(SAG3;A48J<-NXR,@9X@L/'DMVN
MEW$FBRP6=]?R:?YIN%9DE5I%'R@<J3&><C!/0]: .G_LK3MFS^S[7;NW8\E<
M9]>G6I396AO!>&UA-TJ[1-Y8W@>F[KBN"O/$]S/X4\676MZ3%=6-C>26WV>"
MY*DHFP8SM!ZG.<YYQCBNEO?$<D=YJ5IIMA]METR%);I?.\L_,"P1.#N;:,X.
M!RO// !MSV\-U T%Q#'-$XPT<BAE;Z@TQ[*UDM/LDEM"UM@+Y+1@I@=!MZ5R
MT?CIM0NX(-%TE[X7.F#4H)'G6)60L!M/4@\XZ'GVY"IX]MKJTTF2SMT,^J6)
MO;>"YG$)DQC]VAP0S\]/QH Z9]/LI(8X7L[=HH_N(8P57Z#'%(VF:>WF;K&V
M/F'+YB7YOKQS4.KZQ;:)HESJM[N6"WC\QU498GLH]R2 /<UDW7BR73;]['4-
M,,=TUE)>6RQ3AUF$>-Z;B%PPR#W&#UH W1I]DKQ,+.W#1<1D1+E/IQQ2#3;
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M8QJEQ)9I!;7DJ,!<"$$ACT)Z;N<'&>:KZ+IMQI]O(]]>"]OYV#3W B$:L0
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M=7111L(_=^80<N=V0/8\\<@'1>'M"&AVMQYEP;J]O)VN;NY*;?,D;C@9.%
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M""0W#R (%/0[NF.: (- TV71_#VG:9+,D[V=O';^:B; X10H.,G' ]:YS4O
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M$I=7U>VO;RXM2]K=Q7-M<1VY2>%4"[H@VXY5B&SGLQ&#P:M:?J?B>>_BBO\
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MER.HR.]01>(=&GUA](BU6S?44SNM5F4R# R1MSG(':@#G+?P9JVCWT%QHGB
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MJ$L57!ZFM?QQ<V>G:Q;7PUVUTG4%LY8T&H0>9;7<18%HSR#NR!]TYP>AKN\
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M?)#'M.(6/9L\[<9&#T[Y<VHE--TS3S=6VGR/X7MQ"QM1+<7Y=2#!'GL-JD@
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MOGD5;2#6;&>68GY4C$JDL3V'O76)?V+_ &=4N[=OM&1 !(I\S'7;ZX]JL]:
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M26RC][&BEFED8=0I4GGH=PKVDC((]:S?#^C1>'] L=)BE:5+2$1+(X + >M
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MC4*B(,!0!@ "I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOPW_ .0EXW_[&&?_ - 2IK3X??9CHJMJTDL>DZC/?0[X1O<2;B49L\D%V.[
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M4M-DO[/39+F;3'M7AGLIP 0I5FRZ=06XY QUX]$L+.>UTN.UN;Z:[G"D/<N
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M,L!D@<DX/"CJ<#C->::UIUQ(NH>&M/EU<)-JRS1:>^G$(-TZR/)]H&5,/WF
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MO*^^3)))Y?7@?O,9]NE6)O!B2ZKXGOOMK Z[9QVC)Y?^I"HR;@<_-][...E
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M6!GE*L5ZJ#RW/]X4 >J0ZC#'H46I7MU;K"+=9I;A24BQMR6&[D+WYJI;^+-
MNK"2^BU6V-M%*L,DA;;L=B H8'D9+#&?6J_CBZEL_!][-%!%*08E;SH?.2-#
M(H:0I_%L4E\?[->:7T@O[O7(GO;G54NYM'>*>:V5!<1I=%7*A5 *@D#./S&*
M /4+?QCX=NH)IX=7MGB@D2*5MV-C.<)G/9CP#T-:<VH6EO>VUE-<(ES=;_(B
M)^:3:,MCZ BN,UC0H]>\;:_ILZ%8+WP]!$9 . _G388'U4X/Y57\ W%]XEU>
M;7=5A:.XTRV72 K#K<*<W+CZL$&?]DT =EJ_B#2= 2)]4OX;42DB,.>6QR<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% &?K&EG5K-8$O[RQECD66.>T<*ZL.F0058>JL"#4.AZ#%H@NY#=W%
M[>7DHFN;JY*[Y&"A1PH"@     5K44 %%%% !1110 4444 %%%% !6=I.C0Z
M1)J+PR2.;Z\:[DWX^5F55(&.WRBM&B@#.L=&AL=7U34HY)&EU%XVD5L878@0
M8_ 5HT44 %%%% !1110 4444 %%%% !1110!5U&UFO;"6WM[Z:QE< +<0*C.
MG()P'!7D<<COZU%HNCVN@Z5#IUF',4>27D;<\C,2S.Q[L222?>K]% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS\IDR68@ G(X XIUSX7O+C5M;OAJ$"_VGIZ6.S[,3Y6W?\V=_/\ K#QQT'-
M$$GC2XGO[:STG0Y;V6ZTQ=2A+W"1*4) P2<X/S?G[9(RH]<@\2>(O NL6T<T
M*W!O4>&0X*,D;*RL.F0P(S4=C9W>E>/])TNWOK1Y[3PX+5GDB(#E9%Q\H;(.
M!NQD\9^HVK3P4UA=>'I+:_01Z2]Q)('@RUP\V=[9##;RQ.,&@!6\;Q+86VK_
M &,G1)[O[(MV)?F4F0QK(4Q]PN,9W9P0<>DMMXMEGMM3#Z<L=]8WRV1M3/DN
MSE=C [>%8.&!QT!SC!JI;>!F@T@: ]\DFAQW@NHX3$?-"B7S1$6S@KO'7&=O
M'O2:=;Z=X@\<-XAT]K@P6T!@G+1/&DLZLRJ<, 245I!GI\Z^E %B]\;+;7$G
MV?3Y+NW@O!9SM"S-*K9"LRH%.Y5)P>0>"<<<DOC9!>1"WL)+JS:^-B\L)9I$
M8,49]@7&P.""=V>,XQ1;^%]5T_6[Z33]<6'2+^X-U/:/;;I4D;&_RY-PVAB,
M\@XR<>M&F^%]5TG5;I;/7%71+BZ>[-HUMF6-G;>Z))NP$+$G[I(R0".M &]J
MM]+IVG27,-G+=RAE588NI+,%R?11G)/8 FN>7QY:C3M5N);=3)I][%9%8)A)
M'*\NS85? X_>#.1Q@]:UO$^C3Z]HCV-O>"UD,D<@=H_,1MCAMCKD;E;&",C@
MUR'B'0[K2-)UV>[U&*6/6KNV,C+IK/';;0BLSJ&)\O;'CC!&1\V>0 :FI^/)
MM*B\0F?1G=]$BCEF\NX!60.,K@D ],YX[=ZNS>*;JWN%L[C2TM[Z7S9(8IKH
M;6A3:-[,BMM)+@;<'H><5S=MI5_XFT+6-&CU+2IK;48#YFIVME,"'^4 -OD/
MF':.S?+M /45TFN>'=3O=1T[6-+U6*RU:TC>%V>W,D,\;[2RLFX$<J""&XH
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MXL]-U>YN=&V3:1=)#>1K<[E2-U5A*&V\@*X)&,C!ZXJ(>!=0$3(=9@;.MKK
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MLYIH9IKD*&$91,,2"<_,.<'GMW$>F>&]7TK5-:O;?5;%O[4N1<%)+%SY9"!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/8;$7]<UIT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>exhibit1060-kumaremploym013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **1F51EF &<9)H9@JEF(
M R2>U "T4T2(2H#KEAE1GJ/:G4 %%%-9U09=@HSC).* '4444 %%%% !1110
M 44C,JC+, ,XY-+0 4444 %%%% !1135=7SM8-@X.#G!]* '4444 %%%% !1
M132ZJP4L S= 3R: '444BLK9VL#@X.#T- "T4T.I<H&!8=1GD4Z@ HHHH **
M** "BBB@ HHHH **** "BBB@ HI-R[MNX;L9QGG%+0 4444 %%%% !1130ZE
MR@8%AU&>10 ZBBB@ HHHH **1F"J68@ =230"& (((/((H 6BBD9E7&Y@,G
MR>IH 6BBB@ HHI%96&58$9QP>] "T444 %%(S*BEF8*!U).*6@ HHHH ****
M "BD#*20&!(X(!Z4M !1135=6+!6!*G! /0T .HHHH ***1F5!EF '3)- "T
M444 %%%% !1110 44UG52H9@"QP 3UIU !1110 4444 %%%% !1110 44CNL
M:EG8*HZDG %(SHF-S*N3@9.,F@!U%%% !12;EW;=PW8SC/.*6@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!.7NY[C<%VX\R1GQC/;=BL#Q#JM]I_B&6;2]4N8V\I8IK2YT:[NK?(R0\;1
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M9^\"?F#9P1P<$X.>:M^'=!NM,OM3U&^FLVN]0:,R)90&*)=@(!P6)+')R3Z
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M*W4ELGM1KOQ,_LW4M4\J]T>&WTMHU>SNG(NKO**[^7\P"X#8&5;<P(XK=O\
MP<]Y8>+K87JH=?\ NMY>?)_<)%SS\WW<]NM!\,ZQ9ZE>2:/JUM:VM_)'+<B2
MU\R2-U149HSNV_,J+]X'!YYZ4 9>J>+?$<<?BF[T^'3!9Z Y8B=)"]P@@25E
M!# *<,?FP0<CC@DV=+U/6KWXGWT'VN#^RDTRVG6W,;;@',F"#NP'R.3CD #
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MU*W:RCUL:O !;L)!F1G9&.[!Y; ( H K7GC?5-"BURVU?^S&O+&6T2"X0-#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^[L[N2U5MZK<+M5@"=KL,[.G4]* -"BLR'6[2/3K&XU*ZL;.6Z12J&Z5E9B
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MV#Q^- &C15'1]7LM=TFVU*PF66WN(UD4@@E<@'#8Z$9Y':KU !1110 4444
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M9?M7P 02KYI/AO.&&[)%OQ^.0*S_  _:Z1J?BGPKY<5I<P1>&Y'4(%9%DWP
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M[<9]/ES^-9U_X#U>XT[4]%MM8M8='O+UKU5:V8S(S2"4Q[MV-N_)SC.#CWH
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MK*V%L)=T<<+LL*@LQ8A8@&+$=<[CGFK]C\/M0TKPIX=TZRU.V-]HM[)=I+-
MQCEWF7*E0P(XEZY[5:E\$7[S:TB:E;);WM_'JELQMR9(+E/+QGYL,G[OI@'#
M'F@#.3XBWC6=W%:2Z/JUY;WUE;K-92$02I</L'\3%6!# \GL>^*Z/0=8U:7Q
M%JFB:P+)Y[6&"YBFM$9%9)"XP58D@@QGG/.>U0W'AS6-5LHTU34K0RIJ-K>(
MEM;%(XTAD5RHR2Q+;3R3QG@>NI;Z*T'BV_ULS@K=6<%L(MO*F-I&SGW\S]*
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M:(->A$4?R?ZC$ BYYYZ9[5)>^%9+J^TZY%VJBTTRXL"NS.XRB,;NO&-G3WH
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MV>WM3% )%LVSL!9@PW(&W D;L]\UUWA%%B\2>,XXU"1C5(V"J,#)MH23^)H
M;K/Q"TFP@\0Q6<\%SJ.C6QG>W,RCS" 25&"3\N,-QQD5OV&N:5J=Q-;66I6=
MQ<P?Z^&&=7>(_P"T <CGCFO+_%-Q9P77Q1M9)88[N?3H9(8F8!Y%%N=Q4=2
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MVCRZ4VJQZK9/IR?>NUN%,2_5\X%80\9Q7DVN+ILVFRV]A:07$-Y+=A8)#(9
M=S@$*!Y?7GK7$:I<6<VNZAK$$D3^&QK^G/<7"$&!F6-A(^1P5#F')Z97VJ+Q
M'=Z;?6OQ0NM+>&6WDTRS)FA(*2L/-!*D<-TQD=P: .QUWX@PZ7X@TG0K>727
MO+R,RW$ESJ BB@ "D#(!)+;OE! S716>KAY=5-Y<:<EO92[=\5T&,:A<GS<@
M"-O;TKB_*C;XD>"=R*<Z).3D=?ECK F&'\9RRJ6L8?%%I+?+C(^SJ8RY([J
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M?)B#LXC3<V"6VC)QTI=B<_*O)R>._K7!6/BGQ!XEU&TM=*-CIZ7&C0:B\ES
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M$>T..RKWXP>N>*&B>+_$-Y!X4U:]&GK8:[+]G:TBB;?"WE.X<2%L$$QGY=O
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MN1\I)PP(8'D] >]<7):Z-=>.O%IU7PKJ&LR+>Q!);:#S%C7[/'\OWACGG\:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&!GU[UKW.J:?97$-O=WUM!-.<0QRS*K2'T4$Y/X5YK>V&FWEI\4+O[/;SY@
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MU#Q#*XF*C>I6Z7&#U&/ZGUJ35+S3=,UGXBB>WL99Y&LPL%PVT,CQQJSMC#%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHH SM!T:W\/Z-;Z;;,[I$"6DD.6D=B69V]RQ)/UJS'8VD4+PQVL"12'+HL8
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M#5HK,T[Q%HNKW<UKIVJ6EU<0<R1PRABHSC.!VSQFK&I:I8:/9M>:E>0VENI
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M;+?:O96YNE#0>9.H\Q3T8<].1STH U:*YV+QQX?DUO5-*;48(YM,0/.SRJ%
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M9[!<[Y0/*+\J&]">P[TP^)=#738=2;5K(64S%8[@S*$8@$D YQD!6)';!]*
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M9ZU9:IJUO:7/]M7K^7*2#M,AP:ZVU\'R6-G!:6WB;7([>"-8HD#P855& /\
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M59E^[F3FJ'A:]M-"N?"VH:O*EKIPT^_MH)IN(XYC<@[<]%)12!ZXQ7L5& :
M/$=/?[/%I6IPWJZ-IL6LZJ!<W%MN2W+O^[W*V F5#J"<8SCO6MIFG6I\3>"W
MCNCJ-O)<ZI=),]MY2EF .53^[NR5/?((KUC&1BHKBZM[.(2W,\4$>X+ND<*,
MG@#)[F@#)\7W3V7@W6+B.SCO&CM)#]GE0NCC:<AE'5<=1W%>2^(+V&ZCUY1K
M,6J1W&A1Q0SQ0+%%(4FRR1[?O;0P[G&<9X->ZT8 [4 >:>.+">77;^UTV$B:
M3PE>Q1)$N"<21!5&/J0![TVTUC1-9\;>"6T9XYEM[.YC=HEXA!B7$;'LPP?E
MZC'O7I NK=KIK43Q&X5 [1!QO"G@$CKCWJ7 % '$_$66V@?PK/>)NMHM<CDD
M.W<% AE.X^P."3VQ7(ZO*-3U+6]<TJ[0:,-6TYY+Z.+SHLQHP>3'1U5FBR>@
MV^U>OVUU;WD"SVL\4\+$@21.&4X.#R/?(J7  Q0!R/@=()I=9U&WUI=6%W<H
M9)XK811,ZQJI*$$A^-H)'=<=JIZK?V.C?$YKO676*UN=&6WMI)$)5W$KF2,<
M<L0T?R]3BNZ P.*QM8T6\U"ZAN;'7+[398T:-EA"21NI(.2C@C<,<,.>2.10
M!YCX*N[+1/\ A%]3U0K9:4+"_MH);CY4MYC=YVL3PK% 0,]=I%6X86L= B\7
MP1.EM8>(+B\A&P@FPF?9(0O7!!,@_P!T&O1=!MM*TFPBT'3[J.4V28>-I0\H
M).2S@=R22>!R:UZ /();2[3P[HOB6YN!8-J&MMJEY<2P^8MLCQ2) 74X^55\
MH9/W2<]J=-96ETFA3IJ U>"\\6I</,+;RHF86[@E!R&7*YW#@G->NT4 <(EK
M$_C#QS(\*LQTZUC!*Y^4QRY'TZ5Q-@WV2QA_M37(M+MK_P -6$4?GV8F-R@B
M8/&F2/F!;.T9)W@XKVV&>&X0O!*DJ!BI9&##(."..X((J3 [T >507&G>'=3
M\0V&M3,[WFDVD5G]HC(DO$6%D9%7NV_.5'.6KL_ ((^'?AL$8(TRWX_[9K6^
MDD<HW1NK@'&5.<&GT >+:%;K-X9TF.:+>G_":2,59<CAY"*[W04V_$'Q<0N
MPLFZ=3Y;#/Z"NLHH \J\?:@TE]XFTX7,%E,^DK'# EH)+C4@RR< G^!22.!\
MN221193QWOQ$FNH)!-#)X-0K(IR&_>GO7JN.<T4 <=\*@5^%WA\$$$6O0_[Q
MKL:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*L71&DS\R*V"!M!X )- &)X)TZ]/Q/\ &-W=7EM/)!<0)(WV,!W!@&W:VXE
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MHH **** "BBB@ HHHH **** "BBB@ HHHH ***KWE_9Z?$LM[=06T;-M5II
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ML [Y%3K_ ,"S0!BZ3X0U:QMK31[C6HI= LXWBC@C@*331E2JI*^X@A0>P&2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ_=W<>Y]:];,:&02%%+@8#8Y ^M17=L+JRGMA++!YR,GFPMM="1C<I[$=<T
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MWX>6ENDGB>Z$*?:'U^\#2;?F(#\#/IUX]SZUV@C02&0(H<C!;')'UIGGVZ7
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M$ZR1OH,#(Z'(8&VD((/<5Z#X)_Y$+P[_ -@NV_\ 12UM[$&<*O(P>.HIP
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M>8!@#DY*D9!_2FR^&=6U32[ZRUS7EN!-$B0FUM!"(G1MRRD%F+/N"GJ%XZ4
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MY(&,(2$ [Q'NSN;<@QNP,D^U=9X.UZ3Q#H;7,S0O+#<26[RP*5CEVM@.H.2
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MO[:[NI/%,BP%XG41D-<J2WSG<HZA1C  7/>O4?#VB1^'M$ATZ.9YRC/)),X
M:61V+NQ Z99B<=JYZP\"W-FEK;/JT<EG9:NVIVR"UVN-QE+(S;\-S+P<#&.A
MSP 9][XUU70X-7LM2GT][VTOK:UAO?):.';.H;>Z;B?E&[@-S@=*W/!OB237
M7U.UEN[6^:RD0)>6L31QS(ZY'RDG# A@>3T![TW4/!GVV^U6]CU PW-W<6MU
M;N(MWV>2 84D9^<'G(XX)'O6SH]IJ=K%,VJZDE[/*^X>5!Y,<2X VJN6/;))
M8\GM0!S?_"3:F_C>;23?:7:".Y2.*PNXG26ZA*J6ECEW;6.2V%"G[N"1U%:R
M\9WK>+[+3YM1TJZBO+N>U-K9Q.6MMBNRDS9VN<)AA@8+>U:^I>&-2U344%SK
M$3Z4E[%>I UGF>-HV5@BR[@ NY?[N<$C/-9]EX%U*R_L>,:[$UMHUT9K2+['
MC<C!U82'?\S;7(##&.I!S0!DV/B[Q==:1X;U4G2/+UNX^QBW\A\PL5<B7=O^
M8?NR=F!P<;N]3W7CC5-(L]1L]1N-/%_;ZM%IR7QA980LD0E\QH]Q.0NX8#<D
M#D5MV?@K[)H?AK3?M^[^Q+M;GS/*QYV%D7&,_+_K.O/2B\\%M/=ZG>P:CY-W
M<ZA#J%M(8=P@DCB6/!&?G! ;/3AOQH E\&^(Y->BU&*:YMKM[*X$2W=K&T<<
MZ% P8*2<$9*D9/*^]<YJ/Q&FMM9O_+OM.6"QOULSIS0NUQ.H*J\@<-A2"6P-
MIR%Y//'=:1::C:V\O]J:BM[<RR%\QP>5'&, !47)..,\L3DGZ5D+X;U2TU6Z
MDTW6UM=.N[L7<\'V4/*'^7>$D+856V\Y4D9.",\ &9>>+-;MM>D\+K;6S:U<
M3K)8S>6WD&S.2TKC=G<FUE*Y&25(X/&=+XBUK0]=\=ZA=7L%S9:6D'DVIB9?
MF>,% &WD*,MACCGKQTK:N? GVJ2ZU%]2(U][M;FWU$0_\>X3(2)4W<Q[2P(S
M\VYCU/#KSP3)>ZIK\LFI*+'6X(TN(%@_>1R(FQ71]V!C ."IY'6@#G9?B)J-
MI8:L(;W2]8N+:UBN89K:!XHP3*L;QL"Q_O @Y[\CCF_K&M>)]/.N:7<7NGM<
M#19=2MKB"U=/)*-M9"#(=W!&&R,'D@]*U;SPMK6L:-?6&L>((IOM"1)'Y%EY
M2)L<,6*ER2S8P>0!V%7=5\+IJNKW-[)=,B7&DRZ8T:IR!(P)<'/;'3% #O"1
MU&3P5ICWEY%/>26<;B81,!R@(W L2Q]3D9]J\XL[GQ!?>&/#%W<7]M=7<OB>
M58&DB<",@W2DM\Y+*,9"C;@ +GO7J'AS3;S1]!M-.OKR*[DMHUB66* Q HH
M7*EFYP.3G\!7/Z=X%N;&&QM7U:.6ST_5FU&U06NUP&\XLC-O(/,W! 'W>G/
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MU,/$6C'6?['&IVIU'I]F\T;\XSC'KCG'7'->4:9?:==> M*T*S*_VX^NK,D
M7]X"MZ7:;_=$8/S=.,>U7-+@#Z@FCZAK[0WT?B"2Z&FI8AIF(N&D63?UV,F,
MOT )':@#O-2\<^'=-@O&?5K-YK6*21X!,-WR-L(]CO\ E^M9GA7Q]:ZGX437
M=9O])M(Y74*D,Y/EEAD1MNZO["LWP]:I%X(\:NL(66;4-49CMY;YG _05GZ5
M-%I>D?#35=2/DZ9:Z<\<TT@PD$KPH$9C_#P'7)_O>] 'H1\3Z$-,AU(ZO9"Q
MF8I'<&9=C, 21GU 5B1VP:KS^,_#5M;I//KEC'$\:2JS2@91\E6QZ':W/L:\
MZE@CU+4;2]BA\S2KWQG'/;90[9%6U(:0#NI=6Y[]>]=/+;))X\\72/"&/]AV
MT:L5[$SY'XX'Z4 =/:^)-$OM3;3;35;2>]5=YACE#-CN1CKU%&K:C)8WNEPI
M<6$0NKCRF6Z<J\@P3B(#JW'0]JX71+98;7X4;(MF+5RV%Q@M9DMGZMS]:T_'
MZLWB3P,54D#6,G Z?NVH ?H7C^/Q#XYU#1K.?3?L-F0BMYQ::Y;9N)0#C:IX
M/TKH]3\2Z)HLC1ZEJEK:R*JN4ED ;:V[!QUP=K?]\GTKG/!BLOCKQV2I -];
MX)'7]PM6H;='^+>HS/$&(T.V16*]C-/D?H* -J^\2:)IME;WEYJEI#;W(S!(
MTHQ*,9RO]X8YXJ]:7=O?6L5U:3QSV\J[HY8F#*P]01UKR3P=>6V@MX6U/6I5
MM;!M >V@N)^(XY1,&923PI9=N,]=I%=K\/(G3PW/+Y3Q6USJ%W<6D;J5(@>9
MF3@] 0<@>AH U8?%6@7%S=6\.L63S6B.\Z+,"8U7[Q/L._IWJ[_:-D9+2/[5
M%OO%+6XW#,H W$KZ\<UY3%<1O;7.A:-=QZO;/I]\L=K+:;;S2V,;?*S#L6.S
M# $\<FK=MK-KKFH>"8-(N?.G@L;A)'0'$$AM@ K'LV0>.HQ]* .Y_P"$LT6=
M[ZVL-4L[F^M(I':!)06^4<\#K@\''2J_AGQGI6OV6FQ_;[,:K<V45S)9QR@L
MA9%9@!UXS]1WKD_#^K:%+X3T31!9M+K=AILD<L:P_/8R+"5E,F<;-QR/]HL/
MK4FF6RP:/\*O+A"%0A;:N,;K&0MGZGK[T =[JNM:9H=NL^J7T%I$[;%:9PNY
MNN!ZG )I]MJNGWDL<5K>P3/) +A!'(&W1$X#C'52>]<WXWDL[6XTJ\FUHZ+=
MPM+]FO981)!DJ R29X^8=.0?E.#7.:)K]MI_B32]5UB*#2XKS1#%$(XF2*21
M;ACB-<9RP(<+UPW>@#O;KQ/H=EIL6HW.JVD5G*Q2.9I1M=@2"%]2,'IZ&B]\
M4:%IUA;7UWJ]G%:W(S!*TPVRC&<J>XQSQ7FGA>]@T8>%-8UDFUTT66H0++.I
M"P3M<!@&/\)*JP&?0BM2VU;1-*\3:9K<MNVE:#<:7/#:/<1>6B2&?>W'.WS!
MAAG!('KQ0!V]]XGT+3(;::]U>R@BNEWP.\RXD7CY@>Z\CGIR*=?>)-$TV\@L
M[W5;.WN)P#%')* 6!. ?H3P#WKS6XN+2TUI;U+S_ (1O1[W18H[2.ZL%8.HD
ME+Q!2?E8AT;:.2&''&*-1>U\,V<:66J>9?#2K6&32=5LMPU5$4A%0?>$G)4@
M9 .,CO0!Z6OB/16UDZ.NJ6AU$'!MA*-^<9QCUQSCKBJECXCMDT2?4M5U/2D@
MBN'B,]O,3$,-@*2W\?8CUZ5R,5_;V/C!++3KZ*\%QJS/<:-=VO[^UD;.Z>-^
MH7^+)!&&X(X%8'A[%EHVC:E?*RZ99>)[V2Z9E.V+<)5CD;T4,PY[9!H ]6A\
M2Z)<:<-0BU6T:S,HA\[S1M$A.-I/8Y(X-2:3KVDZZDKZ5J%O>+"VV3R7#;#U
M&?K^M>8ZD(-9U#5=1M$%QI%[KVD)'(JYCG9&42,O]Y>54GH=I]*[334V?%'Q
M P7"OIMD2<<$AYQ_+% "S>-].TWQ'JVG:Q>6EC;VBVYADEDVF0R*Q;KV&!S[
M\UJZCXFT/2# -0U:SMOM"[HO,E WK_>'MR.>G-<RMM&_BWQW(\(9FT^VC#%<
MY7RY<CZ=*Y%M0E/AZSTYKF.QF?PK:I"JV:RW&HEHV!B4L#\JD#( XWDD@4 >
MJ:EXCT?29XK:^U.UM[B9=T4<LH!8=,_3/&:A\.Z\-4\&:?K]]Y5L)[-;J;!^
M2,;=QY/85Y_H.M:58W=[+JDJNFIZ'8I994M]I"1NLD2>K;SRO7GI7:?#I2OP
MW\.JP(8:?$"#V^44 +IGC_PYJ/AY-:_M*"WM6D\H^=( 0_.%QZD#./2I)_%"
M-X@\.V=@UO=66KQ7$GVA'W<1JI&TC@YW&O.?#VO6]KX1\(V7V^TT][9KB*ZO
MIK<2/9RKG$0#<([ACUZ@$ <UGP6FJZO%X<TW2-2:RU)9];B>>6'#PEI-P#*,
M;&967IT#9 Z4 >R3^)=$MK.:\FU2U2WAF-O)(9!@2CJGNWL.:;-XGT*"R@O9
M=7LDMKA&DAE,PVR*" 2I[X) ^IQ7G,][#]@\*SV[)X<@TF>>TO5> 2I8W'EX
M&[/&T_-B0]=X.<FK6B6-M_PD_A6XANGU"&6?5+I+A[;REW-LRR+_ '2=Q![Y
MR* /2-.U*RU>QCO=.NHKJVDSMEB8,IP<'\C5"3Q;X>AOTL9-:L4NGE,(B,PW
M;P=NW'8Y!'UK-\#(8QXC7;M']NW1 QCKM/\ /-<#>W^FGPIXXT1=O]LW^M7*
MVMOM_>3R&10C)Z[2.HZ8YQ0!Z'9^*6E\8^(M(NE@@L])M[>?[0S8X=69BQ/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*L%O;0 &2>5ONHN>,]>O0 FLZR\3:J-5M++6?#5QIZWA*PW$4ZW,8< G:^T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>W?CWPO%8:B;"?[-?'SA"LO'[G(VMQ6K_P (WJF0?^$PUC(Z?N+/C_R!2_\
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MW*Y"C(//K73/X7U!U57\6ZLP0@J#;V9P?;]Q3_\ A&]4R3_PF.LY/4^19_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M84[_ #B-W&>(\GKC%8V@VEC/??#M]3@MY$DL]12)[I 2\2NGD#+=<(05^O%
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MTZN2^'"+#X6FMXU"PP:E?11(.B(MS( H]@*ZV@ HHHH **** "BBB@ HHHH
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M^TCLFR&MTA41G/7*XQ7,:EXIUKP_I<S:U9Z=#<M=0VUI="XV6LOF=6;=\R!
M&SGK@8//&#J_C:&]T"9;RUTO5);/5[2W9K6<O;N)""DBD'((R1@D\K0!Z-#I
M6G6]D+*"PM8K0,&$"0JJ @@@[0,9R ?J*F:UMWE:5X(FD>/RF<H"63^Z3Z<G
MBN9/C$67_"5#4X4B;0QYR["?WT#1[D;GN2&7ZBL.]^(FH6:M',NBVEY9V$5W
M>6UY=^4\LCJ7\F$'N /O'/+ 8H [RTTK3K#9]CL+6W\M2B>3"J;5)R0,#@$C
M)J-]$TF22XD?2[)GN2#.S6Z$RX.1N./FP0.M6+*[BO["WO(<^5<1+*F>NU@"
M/YUPEEXXUV32K#7;K3;&/2)[X64BK*_G+F8PB0<8QNQ\O7'.>U ':7=I<1Z?
M/'HQL[2[D8NKRP%H]Q.69E4J23SSGK5?PYH4?A[1TLEF:XE:1Y[BX90K33.Q
M9W('3)/3L,"L1_&5ROA&ZUG[)%YD.J&Q$>XX*B[$&[ZXY^M1?\);K4FJ>(Q!
MIEM)8:$T@DP[>=<$0"150 8SDX.>Q&!F@#MJ9-#%<0O#/&DL3J5='4,K ]00
M>HKAH_&NIIX<DU=UT>]@,MJD4UA<%TS+,L;(P/(90P.>_H,5L:CXCN[37M0T
MVWLXIVMM)%_'OE$>]R[KM+'A5^4'/UH WH[2VBD62.WB1UC$2LJ $(.B@^GM
M0EO'!;&"U2.!0#L"( JD\YQTZG->?'XCW4&G:TW_ !*-3N=.2UE5],N?,B<3
M2F,H3GAUP>_.1TJ[?>)?$5FVMZ==6^G1WT&E-J-K+ [L@4$JRMD DC'!'!]!
M0!:D\&W\NH#4)-4TY[U2"+AM&B,@QT^;.:DN/"FJW=W#=W.M64US!_JII-(B
M9X_]UB<C\*O^#;C4;SP=I-SJ<D4EU-:12%XR?F!0$%L_Q'O[UR&C^+?$-OIN
MHR7J6=W=SZ])I=C&'=563>5.XXXC4*2,<G!]: .@F\*:K<WL5[/K-E+=P_ZJ
M=](B9T_W6)R/PILOA+4Y[B:XEUBPDGFC\J61]'B+2)_=8YR1P.#Z5<T/6]0F
MUV_T/6(;9+ZUABN4EM2WERQ.64'#<J0R,#R>U4-9U+7(OB3H&FV<MLNGSVL\
MLR/NR^UHPW3N WR^Y.: 'WGA'4M0BBBO=7L+F.'_ %2S:/$X3_=!/'X58&@:
M]YR3#Q%;^:B&-7_LN/<JG&5!W<#@<>PKD_!6O:UI7A7PJ9[2S;2KV<60/F,9
MPS%]KGC;C(Z=<$'/83VOBY=,L_$5Q::?863)XD>QDN)I&$()"YGE/;L.,#)'
M2@#N=&T^ZTVVDBN;N*Y9I"X:.V6$#/)X4\DG)S[UI5G:'=WM[I:37Z6HF+,
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MW)/ K=JMIU['J6F6M]$DB1W,*RJDBX90P!P1V(SR*LT %%%% !1110 4444
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M)'\NY^_$VXDE<C>"W;:OI5GP:+C4M/$&I><D^APRZ;/('9/-F!PTF<Y/R*C
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M.F/FZ\UZ=_9]EMC7[)!B+_5CRQ\G?CCBE^QVOVO[7]FA^TXV^=Y8WX]-W7%
M'E&O*8['QY?K?7@GTW4H'M&^UR8A/EPDX&[&,DC!XZ@5ZCJNK6.B:=)?ZC<Q
MV]M'C+NP )/  SW)I[:=8$.6L[8ACN?,2\GU/%2/:VMQ D4D$,D*X*HR J..
M,#I0!P%WJ&AS>&O$^H"73]8NKV)6O;>"<2QPQX$:*[(>%498G(.0Y'M@ZQH&
MKV7A[Q7X<2=]8:72H[FVOF):X,:-CR'.3G@,5QURW4YKUV&SMK8,(+:&(/\
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M*DC(3NP0=F!QWJYKG@UM8U74+X7P@>XM;6. B/<898)FE1SS\PW,... >>:
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M/W68 #USSBGVOA?5I]*FT?6M5MKC3&L7L0EM:^7)*&4+YCL6;Y@HZ+@9)/H
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M5/>M=RP1BJ[F X&<9->;:;JOAFQ^(FHZCI]U81Z:- CFDEMB#'A99"Q^7N%
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MF1985N!(H59-P(!\L$*3[^M:D&F:,GB/PCITEU+?67]FWRYU!_FFCWQF/>.
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M)'W&XXH VM:TF?5A!"FJSV=M\RW,,*(?M*$8*EF!*_5<'D^Q&H%55"A0% P
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M/82FXN"((98F92#)M_B*?+D#K[8(!VE)M4G.!GUQ52WO6_L=+Z^C6V(A\V9
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MR2!W)[GU-3U@SZ;!I&J:KXG2.9Y6L\20Q,S&;RQD?*3C=@8  '4YSGAWAOQ
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MF)ZM@ \$'G% '=456T]+R/3[=-0EBEO @$TD*%49NY .<"K- !1110 4444
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M^A:%-HUYJT\EXEPNHWANRHA*>6Q54QG<<C""L%DO)OBIJGV&\BM]VCV\6^2
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MC.1D44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7P8%9U8 <*=N.<@]JR?A_'YNL^&Y6B8M;^%4MW9D(V2+*JLO/0@@C\*]2HH
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MT33HH_$?A*>&2ZNX&.JW*SW-N(CND9"6"@#:&)8C@9!KK/\ A%!_T']=_P#
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MP#X?BO PN$T^ .&Z@[!P?<5K7]C#J5M]FN,M;L1YD8Z2#^ZW^SZCOT/&0;5
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M'&X.A)7KD=?;M0!QVJ>+-:\-3:QI5Y?)>7$?V)K2\-I\R+<2-&VZ-/O%=I(
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MEE"JN^-8TC5<]$7C)SR>^!TQ0!+JNA:1K*H=4TJQOC$&\O[5;I+LSUQN!QG
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M105/R': !^&*\^TJ+2;[4/ <,EO"UM'H]PL\<L.U/,VV_P!X$8)RK=>ZGN*
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MI:U9QPWILH6E,?G;0=HR1D \^U<.E_X=O?"-Q?V6BW\VH6NBO:W=M$DL#HI
MW1.<#+;@>>3C<1[YU^#=V_CB"Q1[@7OA^!H!:V;I'(5$RG8,<X&T9R2>G;
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M'8IR,Y^5L?0U9\(K97]WI,6I/J:>*-,GD-Q#]G"8<Y#NT@0;HV!R,L<Y'?%
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M"PM+9XT6!)%FFEC\S]X6!.P#:,+@]3GI0!M_\(G'_P!!O7?_  /:C_A$X_\
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MQ@'((';'<V#XGU"/Q5:&'5KJ\M+C5FL7A73]MHB?. %F*Y:12HR0Q!.X8XH
M[VSU&RU'[1]CN8I_LTS6\WEMGRY%QN4^A&1Q5JN#^&/W_&7_ &,UY_)*DL]2
MUF[\8>)C-K*6VDZ+*FR$PIM<-;JY\Q\9"J3NX.>3S@8H [BBO*[/Q#K%RUS9
M?VUJ,Z76B3WJ74^G+;!)(S'S"&0;D(D/W@2, YYJOI6LZEI_AWPAHZZKJRQW
M&BI>R7%EIPN9E 2)4B"K&P"#<<LRDG &>: /7**QO"E_?ZGX9LKK4X)(+U@R
MRK+"T+$JQ7=L;E=P ;!]:SO%%[JJ^(O#VE:;?_8H]0:X6>41*[!4CW KN!&?
MTYY!Z4 =517ETOBO6;6V_LF;4+N6X&N3:>U_;6(FN# D/FY$2(5+\A<[< 9.
M*JZA>:[J\?AR.?4-3LRGB(VL<\UBL$EQ'Y+.DI21.HY7@!203CI@ ];I&944
MLQ"J!DDG  KG_&&JWNE:/;)I\BQWE[>V]C'.Z!A$9'"E]O0D#) Z9Q7+ZY-K
M%LGB/PY<:Y<7*?V(U_#=O#"LJ@%U>-MJ!2IP,':",GGH: .[TO6M+UR"2?2M
M0MKV*-_+=[>0.H;KC(^HJ>YO;:S$1N9XXA-*L,>\XW.W11[FN9^&MI-;?#O1
M/,O9;@2V,+QAT1?)!C7Y1M49 ]3D^IK@K>WU,Z"&.KRSSOXR\J-IXDQ&RW#K
MOPH&2>"1G'&!@4 >IZMH2ZKJ>E7S74D+:;.T\:(H(=BC(=V>VUCTQ2Z]H2Z[
M'9(UU);BTNX[M3&H.YXSE0<]L]:X?4O$NN>'Y]:TF34[B^DCN+&.VNS9J\T2
MW!8/^[C4!R A*C;U(SFND\&ZGJ-[-J=M>'4I[>W>,VMWJ%@;62564[E*E$!*
MD'D <,* .JHKS37M9\2*WC>[L]:-K#H!22V@6WC82?Z.DC(Y922I)/0@_,>>
M *O1ZOK.D^(%BU'6HYK:[T:?4"9X42.TDC*="H#&/#]&)/R]: .]I"0JDDX
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MPEC;Y\X=D(_=KQSD_+QG&10!!)X#M[NTU-;_ %2^NK[4&A9KUO+22+R6W1;
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M%2F0",D'&&(VCDXK0N?&VAV=Q'#/-<HS)&\A-G+M@$GW/-.W$1/H^#ZT 6=
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M-$LL3J\;@,K*<A@>A!H YRQ\%V-E+I\XNKJ6YM+R:^>:0KNN)I$9&9\ #HW
M &,"M33=&@TR^U2ZBDD9]1N!<2A\85A&B8''3"#KZFL@:[JMQXSU#0+>*R"V
MMK%<B:3=E@Y8;<#N-O7O6M:ZEY=E"VJS6=M<2M)M"S#;(JDD,I/7* -[<^E
M&1=>!-/NSXC+W-R/[>:)KC!7]WY:@#9Q[<YS6P^C0/XDAULR2?:(K1[0)QM*
MLZN3TSG*"G1ZYI$HMC'JMBXNB5MRMPA\XCJ$Y^8_2EEUG2X)EAEU*SCE:3R0
MCSJ&+X!VXS][D<=>: *U_P"'K;4/$>D:W)+*L^EB<1(I&UO-4*V[C/ '&,53
MM?"?V+4O.M]8U&+3_M+W8TY&18O,8DM\P7?L+,6V;L9/IQ4T&M73^.+S0Y(H
M1;0V$5W'(N=Y+NZ$'M_!^M:,6K:;.)C%J%I((!NEV3*?+'JW/'0]: .8?X=V
MS*ML-8U%=-BOEOX+%3&(XI1+YAP=NXKNS\I.!N/?!&@GA/R-5DN;;6-1M[*6
MZ^V26$3((VESDG=MWA21DKNP3GL2*V5U.P>&&9+ZV:*9MD3B52KMZ*<\GV%"
M:E8R7S627MLUVHRT"RJ9 /4KG- &.?!U@VBZSI;3W'DZK=2W4KA@&C=R#\O'
M8@$9S[YJE-X"CNSJ$E[K>HW,^HV#V%U(XB&]#G:0 @"E=S8QP<\YKI8M2L9[
MR2SAO;:2ZC&7A252ZC..5!R.:S]'U:\ET^ZN-;BM+(PW+Q+)',3$Z<;6#,!W
M.T^X.* -#3;&/2]*L]/B9FCM8$@1GZD*H4$^_%6JBM[F"[@6>VGCFA;.V2)P
MRG!P<$>XJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N*^*%E=W_ (8M8K.UFN)%U.U<I#&7(42
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MJ#!V*D@7*R8 )W-G((P1BN]KGAX1@.JI=R:GJ4UO'<F[CL9)5,*2G)W#Y=^
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MNEQZM->20OIR6=U=QQEX3=2&-B=JJ"%QN (]NE=:O@_3ETF/31)<^1'J/]I
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M')<%-"_X]=S#+?NFC^?CGY6/3'-,TGPC;Z/=PR0:EJ36EL7-K8/*OD0;LY
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M$NLZ/_:&@(=+,&Z3^SYCYGF(6X'G<8QCO7;Z?:I9:9:VD:LJ00I&JLVX@*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MIH-@2.4D*2SJO..?XJ -RBN=L6\9&^B&H0Z"+3/[TV\LQDQ_L@J!GZTP^/\
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M)*$JP4E3@X(X.#S0!UU%4=&NY-0T/3[V8*);BVCE<*,#+*"<>W-7J "BBB@
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ML+?6-2BG6_\ [1AN"8W>*<H4<\IA@X)R#D<\8IY^']DUI>HVI:@UW=7L5_\
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M0H2%!( <GDYZ5-<^#+.=KV:.\NH+JXU!=1CN(RNZ"98UC^4%2""JD$,#G<:
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MS*JQQ$*HF0&,90_*>I/WN>"!7=:1ILFF6KQS:A=W\TDAEDGN6&22 , * JJ
M!@  ?B2:@?P_;/XMB\1F6;[5'9-9"/(V%"X?/3.<CUH \^M/%?B*[\'Z?/!?
MQQWUUXD;3C,8$(6(NZCY<8., ^IQUK4U'4=:T;78[74O$-]:6J"!;6\DL(WM
MKIB?G$[JGR,3P,%!T/-;5IX"TZSTVSL4N;HQVNJ_VJC,5R9-Q;:>/NY8^_O4
M^L>$_P"V+JX\S6=1CL+K9]JL5*-')MQP"RED! &0I&?J2: ,GP'!>#7_ !?-
M<:I<7*KJS1>7(D8&1#%ALJH.0,+C.,#IGFH/%LMM#\1=%:ZT:?5H_P"S+L""
M&W68@^9!\VUB!CMGWKIM+\.II.N:IJ-O?7)AU&3SI;-PAC67:JEP=N[H@XSC
MKQ5F71X)?$-MK322">WMI;94!&TJ[(Q)XSG,8[]S0!P=LMWH>F:A/%Y_ARWU
M;5U:SLHK59KA4\H!Q'$H95=V1FQ@A1DFG6'BO68;33[^ZNII+"VUF33+XW%N
ML4C1O@12. !M9790<8!STKM-=T(:U]BDCO;BQN[*?S[>X@"%E)1D((<$$%6(
MY%<OK?AS^R/"VLZ/8V^IZQ)KC.41]I6*=E ,CR8&T;L.2<X(X Z4 5M4\2Z_
M*U_=Z=?)!:-KMKI-F&A5A@.$F<\9(+L5Z_P<8S3+B?Q1'=^*K!/%%QMT:UCN
M[>=K6 RR,\;-L?Y-NP%#T )W=>.>GM_!UK'X9T?1I)Y2-.F@N?-0C,LL;ARS
M9!^\V2?K5N3PU:R7FMW)FFWZO;I;S $8155E!7CKASUSVH X:\\8:QJ,^RTN
M-2M)(=*MKI$T_3#=+-/*A;$AV-M08 P"I.3SQ6A'J/B37]6U*"/5)M&2WTJT
MO!"EM&TD<TBR$JV]3P"O(QG@8(YSLR>"8T$']G:SJ.G,ME%83O;F/,\48(7.
MY3M89;#+@\GVQIVWA^VM=3O[Y)9VDO;:&VD#ONPL8< @GDD[SDDGM0!PFB7F
MI>(/&WA+4YM3FA-SX<:[D@BCCV%B\&]1E20&."><C P1S71_$[6+[0/A[J>I
MZ;*(KN$P['**X&Z9%/# @\$U+:^"+;3[C09[+4;V"32+06*D>6WVB#*DJ^5/
M4H.5P>M:/BCP[:^*_#MUHMY+-%;W)0L\) 8;75QC((ZJ.U '-ZMK&J6?C)X;
MS5KK2[(S0)8YLEDM+E6"[UDDVDHY8LH^91]T\YK>\::O<Z%X0U#4;/9]JC14
MA+C*J[L$!([@%@?PJ+4_"?\ :E[*\NLZBMA/)'+/8 HT3LFW !92R*=JY"D
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M11[0SD=@,$G/('7!XJSXRT34]0?QR+2QFE^UZ-:QV^U?]:ZM,65?4@$<>XH
MZ6#Q#%=>)["U6]N+<W%A)<#3YK(HS!7 WECRN.FW'.<TW3O'VA:K/81VSW?E
M:@=MK<O:R+#(^TML#D8W8!X]01U&*QXXKO4_B;HVM1:=>Q6/]BS1,]Q;M&4<
MR#"L"."<9P>U5=-T?48O!'@"U:QG6>SOK>2YC,9#0@1R EAVY(_.@#HAX_T%
MKF.'S;H)-=BR@N#:R"&>8OLVH^,-AO?L3T!KH[B86UM+.R2.(T+E8T+LV!G
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M/_/M<_\ @=/_ /%U'XKN&T_0[*U34-0CFFN([=#:1K)<W. 244G 5B%)+GH
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MZW\/07LJ:?'$J12M&6$L[N0&!V_<'8$XY%:NF7+WOQGL;J0 /-X021@.F3<
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M])PZB1XP&92QQRR] <>M'BK4-1O+3XI:=+J-S]FTZTM?LZ!@-H: EQTZ,>M
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M@5;.]GN+BW*I+<-#<^0F3@XX^8X')Q72^"+G4-2\/ZC'J.H27%S'J-Y:_:5
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MW8/F=!V'KS5'3=3UO5E\*:=)K=U%]HN-2M[JXCVB69('94.<8#849..Y[\T
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MS4;NXL$:*V:ZN-XCC9=I4# XQCGKP,DX%5[;QM8V^C:7(?[2U22XL$O'E@M
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M.BC; FP$O(>B@G.!WP<# H T](TF+1[5X8Y[FX>60RRS7,N^21B ,D]!P ,
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M'&KKN5V;H%Y_PZ&@#2TG35TC3(;%+FYN4A&U9+EP[D=@2 .G2KM%% !1110
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MW0!YF/#^J#X/7VE?8)/M\EW,X@P-S WA<'_OG!^E=0+"Z_X67)J/D-]D.CK
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M;&Y<P12/G<ZQYP"=S>PW'&*FC\+:5%I5AIJ1.+:QN%N8%\PY$BN7!)[\D\4
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M D: DX'U/)/N>M6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=XPT>&)923GH.HZ\XZ#QS9WT\6A7=C8S7IT_5HKJ:&$J',81U)7<0"<L.,T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4\GB@"W1110 4444 %%%% !152PU.TU,7)M)?,%M.]M+\I&V1#AASU^O2K=
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M*Z@ OV/EQRO&%,48/W\D<%<CY1SR*]<IBS1-*\2R(9$ +H&&5!S@D=LX/Y4
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M0X;&)%! )]>&/% 'F^I:GJNAS:YHEI>ZI=Q?VC800MYPDN8TF7,BH\A')VD
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MV*&. N#^@]!5'P;X$M]*T7P_)J"W7VZPMD/V5[HO#!.4VNRKDKGEN1QR<=:
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M!U(8<CE16;9>#K:QO8;I-7UZ5HFW!)]4FD1O9E+8(]C0!P5I)K,WASPYJ_\
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M1K'&@.=J@8 Y]JFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@-SC/KSBN-DT36GTR[&FZ;JZ:;:W-C=6NG:E<J\Q>*??*L1+MA=@7 9NH.*
M.ZU#Q5IFEW6HP7;2QG3[2.\F?9D%'9E4+CDME",8[BN;\1^.7CT"Z>&UU'2;
MZUGLG>.[@7>T$EPB%EVE@01N&.H] <51U?1==\2W?B*\CTF6S%QI]D+*.ZD0
M-(\$[RE6VDA2>!UZ$>X&AKLNO^*-)F@C\/7%E;QW-BZ+=.@FD9;E'D("L0$5
M5ZDY)S@4 =%H_B:'5M2NM.>POK"]MHTF,-XBJ7C<D*Z[68$94CL1W%94GB^=
M_%6NZ*^GW<-K86*3&\C5"5+"0EN6Z$(-O'4'.!BKT6G7:_$>ZU,PG[&^DPVZ
MRY&#()I&*XZ]&!_&L>^T_4XO&7B-TTRXFMM6TF.&&YC*;$DC6;*OE@1G>H&
M>M $]AXVLHM(T!(X]6U2YU2S:>VQ#'YTP3;NW<JBMAP>PX//3+[3XBZ9>"RE
M33]42VN;D6;7,D"JD%P6V^6_S9SNXR 5R>M9?A3P[JNGR>"#=6;1C3]'N+>Z
MRRGRI&,.U3@\YVMT]*1?#NK#PA%9_8V^T#Q)]L*;E_U/VXR;^O\ <Y]: .B3
MQI82:HMJ+2^%LUV;)=0,:_9VG!(* [MWW@5SMVY&,UH:SK*Z/';XLKR]GN)/
M+BM[1 SL<%B<L54  'DD5PFE>%#9ZI'8WF@ZI=/%JCW:7G]J.MF(_.:5)/+$
MF-X) V;.6&<X.:Z+QE;7]Q<Z3Y5KJ-YIBR2?;+?3[CR9')7]WD[T)4'.1N],
M\"@"3_A.K*6VLWLM-U.]N+E9G^R01+YL0B<))O#, "KG;@$DGIFM+4?$-EIG
MA>7Q#.DYLHK<7+*(\2;2 ?NMC!YZ'%>>6>@WEIH\5GJ/A;5O.MKN\>WO-+OE
M$\!DE+J%8N"R%6 )8GE>5[UTVOZ7KFI_"*ZTRYC^TZY-IHCE5"OSS;1GG@=<
M^U %UO&D'D6S1:1JTL]W(XM;58D66>- "90&< )AEY8@\@8H?QQI[P::UE9W
M]_<:@LC16MO&HE01G;(7WLH7:WRG)Z\#-9OBW0I+C5]%U0V&H7MM:V\UM/#I
MUTT$R[_+*L"KIN ,9!&>X..*HV>DWOAS5=&UFS\.7IMS9W5M<V,5T+B>!I9E
ME#EI'&XDJ=WS'!/4CF@#H=*\;Z7K$]E%;Q7:->7%Q;Q^;$%PT'W]PSD>W?U
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M<O%]IC?=U_NJ3Z\5GO+JDR?$'2=/T6XO7U"^DMX9HV0)&[VL2GS-S A0"#D
MYY'U -[_ (266W^)6IV]S?A=$MM"2^((&U3O;<^<9^Z*NV_CJTF*K-I.K6K3
M6TEU:+/"@-VB+N(C <X;!!VMM-<UJ'@C4[S7=:MD3;:W/A9-,ANF8;3,">".
MOH>E:]K'J^N^(?#EQ<Z)<Z9%HZRR7+W#1D/*T1C"1[6.X?,QSP, >M &X_BS
M31I.CZC&99H=7EABM%C4%F,@R,C/  !)],&H+'QI87^HV]LEI?1V]U*\-I?2
M1J(+AT#$JA#%NBL064 [3@FN5\(Z/.GCJ^TYMK:1X;FF:QVG(#W(#[?K&I=?
MHXI/"?A0Z9<Z3I]YH.J//ITK%KZ;4W-J H8))''YA!+ @;=@QEO3D Z_PQXM
MM/%EN;JPLK^.T*!DN+B)420Y(*K\Q)((P>,>YYJK?^.]/L+B]!L=1FLK"417
MM_#$I@MVX)#98,<!ADJIQWI_P]TR[T;P'I.GW\!@NH8V$D9()4EV/;CO7-W^
MEZW;Z/XJ\-6^C3W)UFZN)+:]5XQ B7'WC(2P92F6XP<X&* .JC\76EQXHN-
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M@MR2%D<%A][:2 N6(!XKFO&.A7=E?Z'8:9,/-UFS&A7A!PQA4!C,!ZJ@E'_
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M19+@A1A@8_,&SGGY?IS7-_\ ":SIXON(X;+4M0M)=(M;VWM+6)"Z;VEW.=S
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M"/AKH6[&?L^>.ARQZ>U=;0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !5#6=9L/#^DW&J:G/Y%I  9
M'VENI   '))) _&K]>??&>SCN/AW<RN\ZM#/;[1',R*=TT8.X @-[9S@\CF@
M#K;'78+^>WA2TU")IX6F4SV<D84!MN&+ ;6[@'DCGI6I7GSO<:9\4;#1[>^O
MFL5T&>7RIKJ27<_FC#$L22PS@$\@<5@:<FI+\-/#>IG7M5;4=6O-/BGN&NG8
MJC2A<*"<#Y3SQ\QY.: /5KS3K34&MFNH1(;687$))(V2 $!N/9C^=6J\LN=)
ME6_\9V":UK2VFF6<5U9H-1FW12O&Y+;RVYAF,$*25Y/%=I;:K=?\*_AU=L27
M?]E+='C[S^5NZ?6@#2O=4M=/NK"WN'99+Z8P0 *3EPC/@^G"-4<VA:9<:U#J
M\UJLE_ FR*5V)\L<\JN< \D9 SCO7G5OIYMY?AWJ3ZG?7=S?3B>X%Q=/*LLC
M6DC;U5B0F,D87 P1GH*3PDWB+6%T356M-85-1#MJ5Q+J:F&2)T8CRXQ)F,JV
MS;M52 #F@#U."X@NHA+;S1S1DE=\;!AD$@C(]""/J*DKQ30!=VW@[PK8V::K
M=)J=W=O=0V^H-')((S(0JN[C8"?F.T@G:?4UJF'Q!-?^&-%U&[U33H;F_O8\
M"]#3O;+$717D1CDCE<YW8&<YYH ]6I"< GT]*\JUJVNG/CZ1=8U:,:);126"
MQ7LBB)UM ^XX/S9(&0V1R3C)S6KIZW6F^+=$QJ5]<?VKI%Q/=K/<,Z-*GDD.
MJDX3[[#"@#':@#M]-OX]4T^&]BBN(DE!(2XA:*08)'*L 1T[U:KQWPI=:EKN
M@?#Z"\UC4MM]%?&\=+IUDG"GY0S@[O3G.0.A%2F_U1%B\/POJE_;C7[NUVQ7
MOEW$D$<7F+'YS,#C)Z[MQ"XS0!Z[17E[6/BEM.M1>V6L2V%M<W(-E!JH6]:$
MA#$QD20>9L/F+M+Y.5)SBNXT1[?5O"=F8KR[N+>XM0OVB1C'.PQ@EBN"K^I&
M"#0!.^NZ<MUIT"W"R-J+NELT7SJY12S<CCHIK1KQ/POI*7&@?#B(7=]']KEN
M9)76Z?>/W$F0A)S&"!CY<=21@\UMI=2P6>I:";O6;K9X@-G9PP79$\L?D+,8
MC,S!E098EMV<#&>: /39KB"WV>?-''YCB--[ ;F/11GJ3Z5)7C%Q%-JNGZ+:
MW\^HQ_9?%IL40ZA(9$C*,VUI%;+,IX#$D@<9Y-=]\09[JQ\"7TEC=36UPA@6
M.9'.]<RH,Y[\'\: .IHKRWQ%=WW@V^UY=,U"^E7^P&O%%W<O/LG$FSS!O)QP
MV2!@<#BMF&T?PUXS\/6=IJ6H74&I07"W2W=V\X=HT5EE&\G:<Y!VX'S#B@#I
M-:\2Z1X=%O\ VK=_9S<%EB'ELY<@9. H/:F:/XHT?7YI(=-NFF>-=S@P2)@=
M/XE%<[XV_M'_ (3/P=_97V7[9YMWL^U;O+_U/.=O/3-;"VFO7^DZC:Z]=6=F
MLD6(KG2Y9(WB/.6W-C&.#^>>* .BIDTH@@DF9798U+$(I9C@9X ZGVKRK0_%
M>K:KI6NZ[<WA%UHNEO\ 9;2+<D=U\A8790XW*Y7Y1R  W<UMP:8VDZ =2A\1
M:A)<7.D2R217%VTOGR>6&\U Q^0K_L8&&'' H ZS1(;%-.^T6%K+;17DCW3)
M*C(^^0[F+*W*DD]*T:\DM3K-]X-\,ZI=-K5_8C20UR=.OVBN8YC@^<1N4R\
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M]..!P,#BNSTZUET7XCQ:=%J%_<6UWI,MS,EU<O*#*DL:AU#$A,ASD+@=..*
M.THKB/%T5SJ'C?PQI*ZC>VEE=PWIN4M)VB,H01%1E3D<GKUP2.]8#2^(]0U;
M5+K3K/5IKFRU7[/;2KJ*);)%&4#(\32#=N7<22I.6&#P* /5J*\\MOMNF^,
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MU\+[W4+N^>XO$F2:2*\DC)VPL=PV,-K'NRX)Z'BI=D^C0>,I]-GU)KF77X+
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MCO7]V6A"@=>>1CC-9_A";5O"WA71-%U#19$G6\^PLYN(RK*WF/YJ;221P."
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M" :<NG,S/(UJLYFV%F+<N>K'.3U&2<$]:V*** "BBB@ HHHH **** "BBB@
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M3*DKK<.6VJ]T/E)/RG'&5P><YSS7KLVBZ=<:E8:A+:J;K3U=;60$CR@X"L
M<<@ <U2MO!^A6<YF@L=C&[^VA?.D*K-\WSJI;"_?;@  YZ4 9?A&'^S_ !+X
MHTB"6=K&UFMW@CFF:7R]\0+ %B3@D9QGN:J:K9'5_BO;6%Q=7:V,>C_:6MX;
MAXU>19\*6VD9QGIWP,UV,&G6EM?7=[#"$N+LH9WR?GVC:OMP/2D_LRS_ +7&
MJ^0/MP@^S>;DY\O=NVXZ=>: /,M"_M_4;RSUM+2X29]6E6XO)-3_ ';0"5XV
MB\@G "J.!C.5SW--B6ZT/3M1@U'^T8M5FTB\>._CU!I[;4"J;O, )S&XX(
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MT,\PF1X]V  I&TJ<&F'P3JLMK#>ZGI-M?SQ:O>7<M@EP 'BG_N.<#<I"]<9
M/2@#T'0]8CUO3S<+!);RQRO!/!+@M%(APRD@D'U!'4$&N+\/>-+VSTP2:AI]
M[<V9UB>RDU!I5(C+73I& I.XJ,HN1T]\5U?A73!I>BB+^R[?3&DE>4VL$F\+
MD\9;NV ,XXSTKG3X6U7_ (04Z5Y2?:_[:^V;?,&/+^W>=G/KLYQ^% &I)XT2
M._D TRY;2XKU;"340Z;%F+!/NYW%0[!2WK[#-5U\?Q,VL2G2;L6&D2S07-UN
M3!E0X"(N<L6R/89'/ICP^"FMM?N5D\,V=\D^IM>+J<MQ@1QN_F$%,[BZG(7
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M/#OB%_%=Q?75^UF)=-GB@VS><R!E38BL" Q8<G[O-=YI.F-8^%H;!;.VLY!
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M .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,R'PYHEO
MJSZK!I%C'J#DEKI+=1(2>IW8SD]SWK3HHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH S-/\ #FB:3=RW>G:18VEQ+D22P6ZHS G)!('KS6G110 4444
M%%%% !1110 4444 %%%% !1110 4444 06=G;:?:1VMG!'!;QC"1QKA5'L*G
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBN?UVUUZZOE-GK4>D:7#;L\DZ1))*TF>A\Q2J
MH ,YZG/;% '045YUI7B#7_$T'A[3X[X:;<W=A+?W=W# K,R(ZQIL5P5&_=NY
M!XZ5TOA#5+S4M-NX=1D26]T^]FLIID3:)2A^5]O8E2I(]<T =!1110 4444
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M4J!NW;=P*[BNW/?'-<]_PG4M_P"$;S4M5M-4TN*'5?LL<EDT.]QYY0+RS=,
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MY@1R&(^9>5(R#[4 =-17-7_C;3M/N]3MF@NII+![>$B)%/G33?<B3GEN03G
M 8<TP>.+.WM]3.JV-YIMSIT232VLP1W=')5"A1B&W,"O7KP<4 =117,Q^,"+
M>]-WH.K6UY:K&XM#&DCS"1MJ;"C%3SP<D;>IP.:QO$'C29='6:.VOM.O++6+
M.WO+5@CR%'="0NPL&#*V.#ZB@#OZ*X/Q!XQG?PIXHCCM+W1]9T[3S<+'.8RP
M5@VR161F4C*D=>"*V/#7B.._:WTJX$PU!-,MKQI) ,3K(N"RD'G# @Y Y(H
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MEL8/%:R^&O"K:K)8?\(A8 I$)?/.F1B$Y.-H?;@M[>E6_P#A#/"W_0M:-_X
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M\X)Y.1QGH?!EGJ-CI-Q%?I=Q1&Y=K."\N!--#!A<*[@MDYW$?,< @9XKHZ*
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M7\J37!WL"TB*JJP(.5("K@KCI4^DZ-8:):O;V$)C1W,DC/(TCR.< LS,2S'
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M\221I(X3S$>-5Y!8?*0<C/(J4^++/3=:\6$KJ4\MA+9Q-"\JF,O, L:Q X"
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M_AG[9+XU_M1HX-.U2&$1SLX^39#@N?3:P!Y]*3X9P7UQX=;Q!JV#J6L%)Y"
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MV5 +6]-J+=MP)81Q;6R.W- $^O>)O[&U/3=-ATZXOKS41+Y$<+*HS&%)W%B
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MQMV$KMQVSUH ]=EC2:)XI%#QNI5E(X(/44VWMX;2VBMK>-8H(4$<<:# 50,
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MDX'"C/6EAE>X^*ES-(<O)X.1V/J3*2: .]\/ZY:^)-!L]8LEE6VNDWQK*H#
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M>HDL]MPZ"W<6:/O4 CG('Y>YRB1IKTWB:_U6\G2?3=-MFM95G:/[/NMO,:0
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MLM1DM9+RW29K283P;_X) " P'J,FGWUC:ZG8SV-[ D]M.A26)QD,IZ@U8HH
M\\\2^!;W5;R_CM-.T,P7ELMLE[,TBSVZ;-A)0 K*P&=I)4CCTKM;32+*RN/M
M,,"BY,$=NTW\31IG:#],G\ZO44 9%KX6T.QU9M4MM-ACO&9F\P9^5F^\57.%
M)[D $YYIEIX2T"QNYKJVTR".:571B,X ?E@HSA0>^W&:VJ* *$>BZ="-.$=I
M&HTU=EGC/[D;-F!_P'BH;GPUHUW:7%K/I\3PW%Q]JD'()FX^<$'(;@<C%:M%
M &9:^'=(L8[)+:PBC6RD>6WQG*.P*LV>Y(9LDYZTV\\-:-?VU[;W6GQ2Q7LJ
MS7"G/SR*%"MG.00%7D>E:M% &5IV@VNF:I=WML-OVBW@M]@!X6(.%R222</C
M\!27_AC1-4U%;^]TZ&>Y""/>X.&4$D!AT;!)(R#C/%:U% &98^']*TR&:*SL
MDB2:)89 "3N100JDD] "1^-5[KP?X?O8[)+C2X'6RA$$ Y&V( #8<'YEX'RG
M(K;HH KV%A:Z991V=E D%M%D)&G1<G/\R:I0^&M&MX(((M/B2*"Z-Y$HSA9C
MG+CW^8_G6K10!633[1-2EU%8%%Y+$L+R]V122!^!8_G5&U\+:'9:LVJ6^FPQ
MWC,S>8,_*S?>95SA2>Y !.3FM>B@"C;:-IMIJMWJEO9Q1WUX%%Q.H^:0*,#/
MX537PEH*:O\ VHNF0B\\TS;^<"0]7VYV[O\ :QGWK:HH QI?"FA3:T-7DTR!
MK\.)/-(/+@8#E>A8#HQ&147_  A?AS[1)/\ V5")9)O/+ ME7W;MR\_+EN3C
M&3US6]10!A0^#/#MO>PWD6DP+/#(9D(S@2$D[]N<%LD_,1D4^]TV?3XK^[\.
MV%C_ &G?2*TSW,K(C$#:&;:K$X&..,^HK:HH QO"GAZ#PMX:LM'@8/Y"DR2!
M=N^1B69L=LDGCL,"GW_AG1=4U%+^^TZ&>Y1 @=\\J"2 PZ-@DD9!P3Q6M10!
MP>M^"YS=V_\ 8^CZ'/;P6@MX/MLDB/;D,2#D!O-09!"'&".#S70Z!X9LM"L-
M,C5%EN[&P2P%R1AFC&"1CL"1FMNB@#(7PMH:ZS_:XTZ$7V\R>9SC>1@OMSMW
M8XW8S[T6OA;0[+5FU2WTZ&.\9F;S!GY6;[S*N<*3W( )R<UKT4 9^KZ)INO6
MB6NIVB7$*2"5 Q(*N.C @@@\GIZTAT+2VL[^T-E&;>_)-U'SB4E0AS_P%0/P
MK1HH PKGP9X=O+FXN+C28));A<2DYPW 7.,X#8 &X<X[U:MO#^E6>KRZK;V:
M1WTT:Q23*QRZ@ #(S@G  SUXK3HH R+_ ,+Z)J>H"_O=-AGN=@C+.#AE&<!A
MT;&3C(.,\4ZT\-Z/93K/;V,:2K:"R#Y)/D Y"9)Z9-:M% %73M.L](T^&PL(
M$M[6!=L<2=%'7 JA#X4T*#63J\6F0+?%VD\T \.PPS!>@8CJP&36S10!B2^$
M- FL?L3Z9%Y'VEKH*I92)6SN<$'()R<X/>E3PCH$801Z7 BQW,=VB*"%69!A
M' Z @>E;5% &=)H.ES6E]:R64;07TIFN4.<2N0!D_P#?*_E3KS1-,U&:66\L
MH9WFMS:R&09W1$YVGVSS5^B@#.TG0=,T*.5--M%@\U@TC;BS.0,#+,23CMSQ
M3;CP]I-U-?S3V,3R:A"+>[8Y_>Q@$!3[8)K3HH JMIUH][;7C0(;BVC>.&3N
MBMC<!]=J_E2S:?:7%]:WLT"O<VN\02'K'O&&Q]0!5FB@#(NO"VAWNK+JESIL
M,EXI5O,.?F9?NEAG#$=B02,<4D?A70XM8.K)IT2WI<R^9DX#D8+A<[0Q!/S8
MSR:V** ..\(> ]/T+2]+>\LK9]6LX\--&S,H?D%E!P,XXW8S6U%X6T.#63JT
M>FPK?%VD\P9P'88+A<X#$=6 R<UKT4 8UOX4T*UUAM6@TR!+XLS^: >&;[S
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BN8U#Q#JMIXWTC2!I\2:9>/)$;F23+
MR,L+2?(HZ*, $MU.<#C)C\0:EXIM9=0GTVWTR#3K"W\[S;_<QN2%+,%VL/+
M QE@>>V* .KHJGI%_P#VKHMAJ(B:'[7;QS^6W5-RAL'W&:N4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>exhibit1060-kumaremploym014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI%974,I!4
M\@@Y!I: "BD+*N-S 9.!D]32T %%%% !11TI%8,H92"#R".] "T444 %%(S*
MN-S 9.!D]32T %%)N4L5##<!DC/(I: "BBB@ HHIKNL:EG8*HZDG H =1110
M 44$X&32*P90RD$$9!'>@!:*:CJZ[D8,/4'-.H **** "BBD5E;.U@<'!P>A
MH 6BBB@ HHHH **** "BD9E12S$*HZDG %"LK9VL#@X.#T- "T4BLK9VL#@X
M.#T-+0 4444 %%)N7<%W#<1G&><4M !1110 4444 %%%% !1110 4444 %%%
M-+J'"%AN(R%SS0 ZBBB@ HI&947<S!1ZDXH9E12S,% ZDG% "T444 %%-9U3
M&Y@NXX&3C)]*=0 4444 %%(2%4DD #DD]J%8,H92"",@CO0 M%%% !1110 4
M44C,J*68@*.22>!0 M%%(CK(H9&#*>A!R#0 M%%% !1110 4444 %%%% !11
M10 444@92Q4,"1U&>E "T444 %%%% !1132ZJRJS %N ">M #J*** "BBCI0
M 44BNKJ&1@RGH0<BEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KGO%NMW^BV^E_V=!;RSWVH16>)
MR0JAPWS<>A _#-=#6/KVB-K+:45G$7V'4([PY7.\(&&WKQG=UH Y"Z\5>+[6
M#Q,"FBO+X=7SYI/*E"W49B$H55WY1@,@DEAG'%3>*O'=WH:M=PW6C06\=DEV
MMI=.6N;K.2RJ%8;.  &(;)/M6S>>$GND\7*+Q5_M^ 0K^[SY/[CRLGGYO7M6
M7J'@/4;F'5[.VU>""SU:SCM[EC;%I5*1>6-C;L;3P2"#_%CKD %__A,3877B
M:+5HXHUTJ!;Z ID>=;,A(/)/S!U93CVXK;TB>_NO#EI<:I%%#?RVZO/%$"%1
MB,E1DD\=/PKA=>TQ/$GC'0--2?S;NRCVZV\$3+"8%*2+&Q.?O2(N%R3@M7I3
MKN1E]1B@#RWP5K>NZ/X/\&274=@VD7ODV(C17\^,LI"2%L[2"0,KM& PY-7-
M&^)7]IZOIH-]HTEKJ-T]NEC Y-W;CYMCO\Q!SM&1M&W<.3BKFD>!=5LK+P_I
M5]K%M<Z7HTB3QA+8I-+(@.T,VXC:"V>!G@#U)T]#\.ZQHLMO91ZK;?V):R.T
M42VO[]T;<5C9RQ&U2W4*"=HZ<Y *WQ :Z63PJ;)(VN?[<C$8E)" F";DXYP.
MN!UQ6?>>.M2T:UU6UU5M+74+2_M[..ZPT5MB9 X=P6)&T;LC=S@<C-=7K>BM
MJ]QH\JSB+^S[];P@KG>!'(FWV^_G/M61J'@R6[O]5OX;](KJYN[6\M6:+<L,
MD*!<,,C<&&0<8X- &9:^/+BZTC4C%J6@23V-U%"VI"4K:&.0 []N\DL/F78&
MY(ZU OC_ %:XTFR-A'IEY>S:V=),R;Q X\HNLJC)('W<C)Z-CM6U>^'->U"W
MM+BYU:Q?4K2_%Y GV0BV0"-H]FW=N/WBVXMG.,8%5+?P+J"WT4]UJ\4X365U
M<D6Y5B_DF-T^\0%S@KW &#GK0 7.L^);N\U33+4:66TJRC:]9XI/](ED1F*Q
M_-^[& .6W=>G%:WP_P#^2<^&_P#L&6__ *+6JVH^%]4;7-2OM)U2WM8=5@2&
M\2:W,CJ4!4/&0P .UL<@C@'GI6KHFB_V5X2L-#DG,GV:R2U:9!MW;4"[@.U
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MC4-0EU>QU5;8WFF7GV=I+566.53&DBL%8D@X?!&3TK)T+P%)H]IH4#:@DO\
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M]>U5H?!=]IXM;K3=1MQJ%M=WLJM<0%HGBN9"[1L P.00F"#U7IS0!L>$=?\
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M;9 'Y.)#R,=*U[+PYK.FZA(EGJUK'I4UZU[)&;3=,"[;Y(U8MM"LQ)SMR Q
M[$ '*>*-:UO7?!VHZ@J6*Z-_::6T<05_/VQW:IYA;=MY93\NT<'KVKJ/B<2O
MPVUQ@"Q$ ( [_,*SKOP'JTNG7>BP:U;1:-+??;8T-J3,I,PF,9;?C;NR<XSV
MKIO%6B-XD\,7^CK<?9S=Q[/-V[MO(.<?A0!SE_XB\6:7>S6$]MI=Q>7&G37M
M@L"2 >9$5W0OEOFR'&&&WGM6C'XN.IWWAF'2$BDCU:!KV=GR3#;J@]",,7=%
MY]^*;%I5Y8ZU_P )'XCU:UECT^SD@@\FW,056*EY'RS98[%&!@#GUK,^&VB)
M;S:OK*"865S</%I:3(4,=H)&?@'D*SNY&>=H6@!_Q.^_X,_[&BS_ )/1?^-K
MRP\5Q6,EWHK0R:A'9"QC<O=!7P!(S!L#D@["N<=ZW/%/AM_$9T0K<B#^S=5@
MU Y3=Y@CW?)U&,[NM8D_@C5RLL%OK%I':IJW]K6ZM:,7:0S>:5E;?\RC) P
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MM&SLK$[6F1<#!&.2,^V1WR,(3^)+3Q9XMFT]],^T6]G9RW#SQ.4D98G.U%#
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MQ,-C#Y6[Y+" PPC))^5"3CKSSR<FM*BB@ HHHH **** "BBB@ HHHH ****
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M\US/@2=?$-SJGC'8PCU)D@L@XY6WB!'X9D,A_*H/%^IQVWBNRMI;O3]-_P!
ME=+NZMQ-)-EU!@B4L 2< D#)/R@"@#JK[Q!HVF1B2^U:QMD,8E!FN$3*$X##
M)Z$\9HNO$&C6.G0ZA=:M8P64^/*N)+A5CDSR-K$X/X5YO\/5M[S6/##/Y<TE
MMX8,?.&,3K,JL/9AR/;D55\.75EI%QX2O=5FAM=,B&KP133L$BBF-S\H+'A2
M45P/H10!Z3X;U[^WX-0F5(UCMKZ6UC:-]PD5",-GWS5J[U[2-/OX+"\U2RM[
MR?'E02SJKODX&%)R<GBN9^&;VTFE:U)9)LM7UJ[:$!=HV%@00.P(Y'M7*?$'
M4P[>,+5;JQLIHH8E%L+;?=7JB,2>9G=D(F6&0/EV,2: .RO/&4UMKGB;3Q9H
MRZ-IBWR.7.9258[2,<#Y>M;GAS56USPSI>K/$(GO;6*X,:G(4NH;&?QKSF_F
MBN?%OQ"G@D26&7PW$\<B,&5E,<A!!'4$5VWP_P#^2=>&O^P9;_\ HM: +[^)
M=!COH[%]:TY;N20Q) ;E-[.#M*A<YR"",>O%2_VWI7]HKIW]IV?VUW:-;<3K
MYA95#$;<YR%(./0@UY%?7FD?\(CXVTM7@&N7>N7 MH#@332F8"-D'5@".HZ8
M-=%::>]Q=_$R2RB!U21S#!(H^8-]D3: >WS-0!W%CXAT75+R6SL-7L;JYASY
MD,%PKNN.#D YZTZVU[2+W4IM.M=4LI[Z#/FVT<ZM(F.N5!R,5YW;7VF:JW@2
MT\-S6[7]DK-*D.-UK$+9T=9 .4RY08/4CVIOAZ]T2?P?H>C6\:R>*;>RFC6*
M,?O[2X$3"1Y><H"V1D]2PZT >BV>O:/J,]S!9:K97,UMGSTAG5VB_P!X \?C
M4=OXGT"[LKF]M];TZ6UM?]?,ETA2+_>8' _&O,-$ATS4=+T^.[\1V\T=GHEQ
M#/8Z?IQ6>"%H@LB2%68JP." 5!++P*F%]IUW;W=G>:]I=Q;VT=G)!X@L+9<0
MLLN8H[@ E, C/51@G(7@T >JV&HV.JVBW>G7D%W;-D++!('4XZ\CBJ3:N(=:
MO;>YNM-BM+:U%PY-UB:,<Y:1",*F!][/K67X&U$ZC::FS?V=,T=\4:^TY-L-
MZ?+0^8.3SSM/)&4/-<=XF_Y'#Q__ -BG_22@#TNSU[1]1OIK*RU2RN;J 9EA
MAG5W0>X!R*L7U_9Z99O=W]U#:VT?WY9Y BK]2>*XI+6"T\4> DMX4B4:==)\
M@Q\OEQ''Y\UH^/+]+&UT@2/8VZ3:BBF^ODWQ6A".P?&0-V5V@DXRU &V-?T=
MM/AOQJUC]CF)$5Q]H3RW(!) ;.#@*Q/^Z?2DM/$.BW\$$]IJ]C/%/*88GCN$
M822 9*+@\M@9QUQ7E.F26VH7-A;2W$5X5\8F9OW0CW*UJ[I)L[*Q!8'H>M;.
MI:-+J5[X[33D"W]I>V=_9;1_R\1V\;C_ +ZQM/\ O&@#TDWEL+T61N(?M9C\
MT0;QO*9QNV]<9.,]*K:GK>DZ*L3:IJ=G8B4[8S<SK'O/MN(S7,>!+E?$MWJ?
MC+RV6*_V6UDKCE8(AS^<C2'\!4/CB>SL=8M[W^W-/TW4%LI46+5(=UM=1%E+
M)DD8;('W23@]#0!VBWUH\DT:74#/ JO*HD!,:L"06'8$ X)]*J7GB/0]/M;:
MZO-8L+>WN@&MY9;E%64$ @J2<,,$'(]:\\T[7M/T^^UR34$CTJ34-#L);2Q<
M[6;]U(#'&O5BI(7 &>G%0>&[_2M'?1KKQ%-;P65QX1LHK62ZP$;:"9HP3P6(
M:,[>I&/2@#N+KQEIVG>)+O3]2N[.RLX;."X2ZGG"!VD:1=HSQTCS^)KHHI8Y
MHDEB=9(W4,CH<A@>A![BN \.VNFW'CF>2WT\PVP\.626\-Q'AXHF>;Y"#G'
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M=9@<L!SEFD!.?<<5G+>:2/!F@Z5,8FUZU\0PM<PXS-#(;SYW<=0&!X)X.X4
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MX6V@;'G3R$J(C&.K8;TZ$'I71:?I\D^N?$:2WC5M598HH90/F#_8UQ@]OF-
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MV4]Y<:E9Q6L$ABEF>=0D;@X*L<X# \8ZUYKIVO6D.N^&]6U%],L;0-J=NU[
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MSZXK.UJPNM2L&M;+4Y-.E<_//%&KOLP00-W0\\'MBK\LJ0Q/+*X2-%+,S'
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MZC% ;+5)].GADWAHT5TDR""KHW##G/8@@&F^']#30K*:+[3+=7%S</<W-Q*
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M>D%]'J#:A;W,MLKE9'CV2JPR RMDG V[>,=*4_#^1H+Z1];E;4;C4(=2CNS
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M:J^IP&RN3M@E4[O-//"@<D\'(QQ@^E:-G>6VH6<5Y9SQSVTRAHY8VRK#U!H
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M=^&OMS[+F>68S^6,KOF,N,9[9QUK2@\5Z%<:;-J,>IP&U@D6.61LKY;,0%#
MC(R6&,CO4FD^)M%UR5XM,U&&Y=$\PJA/W=Q7<,]1E2,CCB@ &BJ/%9UWSSN-
MB+/R=O&-Y?=G\<8K#L/ ,5C-X4D&H.__  CRW"H#$!Y_FKMYY^7'XUI7?B.V
M-[8PV6I:>%>_:RF6;<69U&6CCQQO'OQUJQ_PE.A?VU_8_P#:EO\ ;]_E^3NY
MWXSMSTW8YVYS[4 <\WP_N/[*NM/BUPI%_:8U.R)M03;R"4RD-\W[P$GVJ^OA
M;4X+Z>:S\0/;07LD<][&EJNYY5559HV)_=AP@R,-WQBM.W\3:+=:N^E0:E!)
M?(64Q \EE^\H/0D=P.1WJ]<7UK:3VT,\Z1R74AB@5NLC!2V!^"D_A0!R&K^
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MKJYUB2P26:/5[:#7[(QZFEGY1G 5R0X PQ0X^88'/08->M44 >8:_/<6&O\
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M8M;M)'-Y9P\3!2#\Y&0!D8(KH7\"-,EU<W&LSR:O/=070OO)0",P\1J(^FT
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MA<;A@O\ >Q@8QFJ6L7^MZ[X.CUR:_B^P7&LP(EB( /+B2]5%(?J7)4$YXY/
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M)04S[BK5YX -S_:\,>N7<-CK%PTU];+&A#@A5*JQ&5R%P3SQZ54UC1H_$GQ
MT;RK"\AM=&#&[N)(6BBF *-%$N1^\ =5?(R!MZY- '9:2E\FCV:ZG*LM^(4^
MT.JA09,?-@#MG->8>&M2ETSPWXA>'48[!YO%=W%YIMVGD(+9*Q1J"7<XX&#Q
MD]J];KC8O $=I _V+59X+L:O-JT4YC5]CRJRLFT\%=K,/6@#+T7Q?JLMWI?V
MNX,ED=4N=+GEFM#!(Y\KS(79& *'@J1@ Y'%5+3QUK=SH&JN6B&HW5Q;MH_[
ML?ZBZD*0Y'\6 KL3[5NS_#R*?0]5TQ]8O&%]=I>K<%5\V&<;2S@@ ?,5Z8P,
MD#BKLO@?3WUS0M2266-=(A$,=N -DH52L9;_ '=S$>YH Z8#  )R?6N2O-7N
M8_BMIFD*(?LTVES3L3&"^X. ,-U YZ5N:5;W\%QJAO9VEBEO"]J&(^2+RT&W
MCMN#^_-5Y_#D,_C&T\1F>036UH]HL0 VD,P;)/7/% '!VWB?Q:?A[:>)7U&U
M>YO;JWMX;;[, B W C)9NI+#TQCMSR=#6-?U;3-8BT&;7IDG@L1=27L.CM.9
MW>1PBE(U8(H"'/<\8/!K=C\#VL?@^P\.B\F,-G<13K+M&YBDOF@$=.3Q5O5_
M#L][JJZIIVK3:9>FW^S2O'$D@DCW%@,,.&4EB#_M'(- &'HWC&^_M&-M>06E
MK>:*FI1(\90P/'Q<(<\G&Y6&><9JII&N>)M>ET?3GO4TZXO+"359Y5MU=TB:
M0+#$H;@$*WS$@GBMSQ'X'M/$FE:=8W-[=H;([?/W[I)HRA21')Z[P>3ZU;U?
MPXU[J-IJ>G7\FFZA;0O;K+'$LBO$Q!*,IZ@%01C&* .8L_$^N:K-I^@I=PVN
MHM>WUM=7Z0!@4MB!N1&. S;TZY ^;VJYJVI:YIEKIUCJ&NP6]Y(\VZ6PT^2Z
MGN$4C85A"MMX(W\$ X /-7/^$%A@LK#[#J=S;ZG9SS7*Z@R([RR39\W>I&TA
ML]!C&!CI2+X)FAFM+JW\0WZ7\:31W%TZI(TRRNKL ",)AE&W P!Q@T <Q8:A
MJ_B;Q#X4O8+N.QO+G1;O[1.L&XJ%FA!*HW )('!S@$U7U;5;W5$\))J+QR7E
MCXO^Q2S1IL64Q^8 ^WMD8R/7-=/:?#UM.?3Y;#7;J";3HIX+5C$C@1RNK;7!
M^_C;CL>_:K \ VGV/2(FOKAY=/U0ZK).P7=<3DL6+8X )8].@ H RG\6ZQ#X
M;U&P:2)O$T&J#2X6,8"NTC Q2[>F/*;<?]PUU^OMJ,/AG4)-+D']HQ6KO S(
M&#2*N1D=.2,?C7+6.D+K?Q/E\1K8WMK9V5L(0;J)HA<W(WJ)%1@"0J.R[N^[
MCI7>T >?IXXN[WQ/H1M#'_8MS;V_VKY<D2W*2-$ >V#&H(_Z:"JB^*M5O].L
MKDZU]A6_ENI[>.UTU[NX:!9 L.$56^3;\S,?[P (K5@^&MA;>&=2T6&_N4^V
M727,=R -]N4*&-4]EV #\:O2>#%BETU],U.XT_['8C3F\I$8R0#! !(^5AM^
M\/6@#GK7Q7J6JZIX XMX6UFPNI;AA"&*2+$I!0GE1DDX[]#4]OXOU:]\.:':
M(T:>(;O43IUUA 1&86)G?;T^XA(_WUK3TWP%;Z=>>'9QJ$\HT%+B*V5D4;DE
M 4!B/[H Y[U;L_!ME9>,[OQ(D\K23JVVV./+B=@BNZ_[3") ?Q]: .6T[QOJ
M5]JUM<17%Q-%/J;6C:<NER^7'!YC1B3S]N"PP&/S8P2,9%:?A37]3O\ 76M-
M4U1([W;*9](GLS"\6&^5H7_Y:+CJ<MG(/'2M:R\*SZ?J -MK=W'I8N7NA8*J
M@;W)9EWXW;-S%MOZXXHL/"UQ;ZM9WE]K=UJ"6 D%G',B!DWC:2[@9<[>,GZG
M)YH J_$.1Y-&T_25=DCU?4X+"9E.#Y3$M(!]51E_&F+J,J?%@: L5NM@N@"X
M"B%=P;S]F-W7;C^'I5[QMI5WJ>A1RZ>@DU#3KJ*_MHR<>8\;9*?\"7<OXTV/
M3+63Q OCC-ZKG2/LIM&MV#A-_F_<QNWYXVXH J^ &:VM];T0$F#2=4EM[8'G
M;"RK(B_\!#E1[ 5G>.?$]_HUS?-8ZN(FL;'[4MG!ITET9&&X_OW52(D(4 '(
M_B.<"MKP3IMW9Z7>7VH1&&^U:\DOYH6ZPAL!$/N$50??-1ZSX*&K7FJ.-6NK
M:TU6!8;VWB1/WFU2H(8C*\'! ZX^M &7=:MXBU35]?@T_4XM/M]/LK>YB_T9
M969WC=MI)_A^7GOSP1WDT;QC=M?Z?+K#Q1:?JNAQZE;L%P(I$4-.F>XVLK#/
M8&MG3?"RV+ZC)+?27$U_:PVTKE N/+1E# #N=WZ5R_B7PPFI:?X;\&6MM?R?
M8#"LNH>4R1I;+&8Y 9,8+.F5VC^]D\"@#K?!][J6I^&+34=4PMQ>!KA8PH7R
MHW),:_4(5S[YK<I%544*H"J!@ #@"EH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JGJFK6.BV1O-0
MN%@@#!,D$EF)P%4#)8D]  35RN3\;QRQR>']3\B6>TT[4UGNDBC,C*ACD3?M
M&2=K.IX!XR>U #-:\<V4/AQM5TNYB80W]M;7(N8WC,*O*BMO5MK*=K$C(]^:
MN-XOTJ^T?5[C3M2CBEL+=I96N;:1?)&TE7:,A69>">.N#@UPNOQSZO\ \)#K
M5EIUW<6%Q>:2D*?9V5KGR9@9&5& .,,%R1@[3V%3^)[A=:/C#6+**X%A#X7E
MM&FF@>+?+F1]H#@$[1U]-V* .UE\7Z1INFZ?+J.HHTEU;+<!X+>1@R8!,FU0
M2B<]6X&>34VJ>+M"T<PB]U!5\Z+ST\J-Y?W?_/0[ =J?[1P/>O.X89;)](U"
MXU+5["RN?#=G!')IUHMQYCH&+1L#%)@D.I'3//7%:.F&W\$ZG+]MLM4FL+G1
M;.WL]]JT\A,0D#0/Y8(#G>O'0\^E '4)XVTVX\4SZ! SF5+-;E;@1NT9W!CC
M(&,;5!W9P<X'-%CXOTZ'PSIFI:AJL%R;W(BEL[:3_2&&<^7$-S\ <]>E8-LY
MM?'=QYNFSV*W_A^WBMH5@+(CH92T6Y1M4J"!C([8K#\(Q3Z!H_@75-3L[M+2
MVT^[M9_]'=FMI'=65F4 L 0A&<=QZT >B-XQ\/IIUMJ#:E&+:ZE:&%]K9:10
MQ*;<9#?*WRD9R,=>*N:/KFG:];27&FW!E2*0Q2!HVC:-Q@E65@&!P0>1WKSR
MPL+JYU;3-1^PW"VEWXJGO8EDA92L7V5T61E(RH9ER,X^\/6NK\.6\T/BWQA(
M\+I'+>P-&S*0''V6($@]^01]10!E:Q\1X8K3Q-%IL3?;=%* -/"_EOG9N/0
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M(<R631Z=;9Y\M%B61L?[SOD_[H]*YW1_%NM77A_X=7,MTC2ZM>/'>'R$'F*
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MC:&],[EQ]16C7CFL:EJ_AG1?B)>0WXEU&VO;)4NGA0E@4@7++C;G:<'  SR
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M@-6AGTY(1;Z?;:4T\<\AA25DF?82I.\)@%2,9/6@#O=>\/V_B*WCM;VYNUM
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M4U"YFUB*".ZG<H&_=,Q4J H5?O8QC& .^2=76_#J:QJ.EZ@E]<V5WITCM%)
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M(7DD;/R@?3D_05DQ>,M$DTV^OI+B:VBL-OVE+JVDADCW?=RC*&.[M@<]!S0
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M)&H 5/E4 @ =3S[UJU#:7=O?V<-Y:2K-;SH)(I$.0RD9!%34 %%%% !1110
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ME3S(?F QR, \^U:'BK3KVXU[Q))!9SR)-X5>WC9(R0\NZ7" CJW(XZ\UW]%
M'F.D07>E:C\/I[K3[X1IH9LI2EL[^3,P@PL@ )3[K<G &#FLJSL;U- T>*:#
M6[-M&U>[:]:UM'\U$E:?9)'E")!\RYV!B QKU;5]7L-!TN;4M3N!;V<.WS)6
M4D+N8*. ">I J[0!Y;#9#2;[1/$,-IKUS8KJ-U)=/=VY>X_>0B-9O*10P7Y
M,;=WS9QS71>!A</>^*+R:PN;..[U3SH%N(C&SQ^1$ V#ZX/N#D'!!%=A52WU
M.TNM1O+"&4M<V>SSTV,-N\97DC!R!V)H YCQ<9K;Q7X5U(6%U=6MI)<M</;0
M-*8@T6T-A03U/0<]<9K GTF[U+P[XIUV"VFM9O[475M+6YC,3DP1Q@,5;!7?
ML<<@<-7J-9>N:#:^(;-;.]EN1;9S)%#,T8F7NCXY*GN* ,?P#')=:3<^(KB)
MH[G79S>[7^\D. L*GZ1JI^K&JWQ(L;N^M/#BVEK-<&'7[.:01(6V(K'<QQT
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MAMIC;S8!&R0 $KS[$?G0!QGBV'6(O$MY?Z39RRS)X=N(XG$.]3+YJ$* >"V
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MR(0RC&2,#J/2J?BK^U;V;6H98M<DGAU"&2"UM;9OLQM4:)O,+!?WC<-QN+9
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MJUZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:0Y\J"-8TW')PHP,_E7#V7@0:C=>(CJLE_;VU]JCR-;Q3A8[N';'MWCDX)#
MX()'!XQ0!!9ZGJE[XF\37\NI726.D0P7,%A&5"NSVP=E<XR1GH 1R3[4RQN]
M8TZR\(:W-K=W>R:U/#%>6TNWR<31,X,:@#;M(&,'D9SFNVM-#LK/4M3OHE8R
MZD8S<*QROR)L  [# K,TWP/IFFW=G*EQ?SP6!)L;2>??#:D@K\@QDX!(&XG
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M;0;Y!$I +L,\ $@=>2>,UF:!XZ1_#MK=WQN;Z[OK^[AM(;:WS))'',X'RC&
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M&R3RF)"N!GD$@CKQCG%1R_$#2;=;UKFVU&#[+;?;,2VI4RP!@ID0=P,C.<$
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MEXLL-1UZYT>T@O))[65H;B00'RHF"AAN?H,YX^E<9<>&G76]6LKW3=?NTO\
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M!Q6G10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M34-8NO/DMXW#^2@&%4L."V2S''&7-=710!2N=*M+O5+'4948W-D)!"P8@#>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYN)!'#"ADD<]%4#)/Y4 2T5'!/'<V\<\+AXI5#HPZ,I&0:DH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M C09Z+MPV.^ZNXKSO4M)U&YUBXU.PT7Q%I5U< +<O87]HJW&T8!979AD#C(
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M^TQN9!OE8EBPD./F#%CGIFME-"M4U/4]0#2^=J,,<,PW#:%0,!MXX/SGU[4
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M^T1W5L\4D8E;:C;2/NDYY]CZ5<TCQ/8:S?7%C"EW!=0(LIBN[9X6:-B0KJ&
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M76D/IZ/HLD;1DAA$YG5@A8#&XJ,D=N>N,U>\!V=S8>$H;>[@D@F%U=,4D7!
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MB#(WJ<G .TC!/>JWA_0M3M]9\.WMS82PB2\U2\EC(S]F6=MT:L1P#@]/7(H
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M(R"/J#4U9GARPCTOPWIUE%;RVZ0VZ*(9I [Q\?=+#@D=.*TZ "BBB@ HHHH
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M;A7=.W(!R* -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6SU:/^V9,SSW*1E3Y47RX92<=_QKU&O-)-#U>/4]0N[&T\760O;@W$L=K?6
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M[08/#>DQZ;;7-S-;Q$B(3LI,:YR%& .!GOD^I-5X-*?3O%M[JD"%[?4XHDN
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M83&(MYFW.X ;RV[&01C%=8/!6C#I9VZ_\3$:D-D*KLE&W!3^Z3L7)ZGYO7C
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MEV#[V .!TR1GB@##?QAK6GPZOIUU'8W>KVM[:V5K-"C1PRO<;=N]2S%=N26
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M\S,/8C!ZCBN1$6IIX:@\.#1-2:[MO$"SRR_9F\GR?MWFB17Z,-I' Y').,4
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ML[2-(,9610 /+].])IWCJ(Z1!)J=M+_:37-Q:-:V$+SF1X'*NR #.S@')Z9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR:O+;0V]OYFWYY2,@M@_=&XGC^&N0%I/'\3'\*"-OL,FJKXA#8XV>6<KZ?\
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MGDR!MN>F?KV]:;?>(M%TR_AL;[5+2VNY\>7#+*%9LG X/J>!ZFN+\):A%/\
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MIS[([_C&* /5:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.3\PZXJ#PIX+FT"ZT^W?0/#R16 9?[4CC!NKA<$(0-@V-@C<2S9P<=<COZ*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BFRRI#$\LKA(T4LS,<
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M W%021[9K9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@\-D'H:GL_#6J7&MV^KZ_K$5S/:Q21VT%E;&WCC\P ,Q)9F9L 8Y 'I74T4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6@OHH)#_ ,>\<RL1$!VV[,'WS0!WU%%% !1110 4444 %%%% !1110 4444
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MW8,MS?S#;+>7+;Y7'IG "K_LJ /:M6BB@ HHHH **** "BBB@ HHHH ****
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M]26$+>/"('D!(W("2 1T."3@]1D^M6J* "BBB@ HHHH **** "BBB@ HHHH
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M]:S=.\86.K>));&PN;2YL(]/%V;N*4, WF,I4XX& N?QH ?_ ,)WX;_Z"/\
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M[\-_]!+_ ,@2?_$T?\)WX;_Z"/\ Y D_^)KHJ* .=_X3OPW_ -!+_P @2?\
MQ-'_  G?AO\ Z"/_ ) D_P#B:Z*B@#G?^$[\-_\ 01_\@2?_ !-'_"=^&_\
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MDY[FK=% $%Y="RM)+AHII1&,E((R[M]%')K#_P"$Q@_Z NO_ /@LE_PKHZ*
M.<_X3&#_ * NO_\ @LE_PH_X3&#_ * NO_\ @LE_PKHZ* .<_P"$Q@_Z NO_
M /@LE_PH_P"$Q@_Z NO_ /@LE_PKHZ* .<_X3&#_ * NO_\ @LE_PH_X3&#_
M * NO_\ @LE_PKHZ* .<_P"$Q@_Z NO_ /@LE_PH_P"$Q@_Z NO_ /@LE_PK
MHZ* .<_X3&#_ * NO_\ @LE_PH_X3&#_ * NO_\ @LE_PKHZ* .<_P"$Q@_Z
M NO_ /@LE_PH_P"$Q@_Z NO_ /@LE_PKHZ* .<_X3&#_ * NO_\ @LE_PH_X
M3&#_ * NO_\ @LE_PKHZ* .<_P"$Q@_Z NO_ /@LE_PH_P"$Q@_Z NO_ /@L
ME_PKHZ* .<_X3&#_ * NO_\ @LE_PH_X3&#_ * NO_\ @LE_PKHZ* .<_P"$
MQ@_Z NO_ /@LE_PH_P"$Q@_Z NO_ /@LE_PKHZ* .<_X3&#_ * NO_\ @LE_
MPH_X3&#_ * NO_\ @LE_PKHZ* .<_P"$Q@_Z NO_ /@LE_PH_P"$Q@_Z NO_
M /@LE_PKHZ* ,?3?$,6IW?V=--U6W.TMONK)XDX[;B,9K8HHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH \]^*K6B)X6>^O'LK5=90RW,<IB:,>3+R&'3ZUGZ'/IH^(=
M@_AG5KK7(KBVFCU*>XE-R+:-1NCVRD97+\;,X/7'&:]2(!ZTU64@E2"!Z&@#
MR31)(-(^#/AN18K*!9[J+SKN[BWQVQ,K'SF&1D@@ $G )'852BFM]0NKFVEO
M([_S/%=C/N,0C$T;0H!($'&QBIP>C8S7LT<D-S LD3I+"XRK*0RL/8]Z2&>"
MXWF"6.7RW,;[&#;6'53CH1Z4 >5>+(PFM^*Y6C+6<4^BW%ZJKG="LK&0D#J
MJC/L*K>)[FU\1:QXJE\/,MX)/#L:O+:?,)]LS%U4C[QV?+Q].U>P221PQM)*
MZI&HRS,< #W--MY8)X$EMY(Y(6'RO&05(]B* /-=8U+2]>URUN/#MQ!<P6>A
MWRW<EM@K'&R)Y<;$=#N!(4\C!XJ;3[:*W'PM$,2IB%Q\HQULF)_,C)]Z]' 5
M<X &>3BG4 <IXXE\/BVL(/$:3Q6LDQ,6H1N8UM)0ORL9%(,9.2 >G4'W\_\
M$5_)<> ?&ME9:U<:YHD%I ;:^G(D(E9SOB$@ $@ "'/.-V,U[60",$9![4@4
M!=H  '84 >?6UM#-XUUUY85=AX<M4!9<_*QFR/QP/RK.T&WC@T_X3F.)4)A<
MD@8^]9NS?F>3[UZG2,512S$*JC))X % "T4R&:*XA6:"5)8G&5=&#*P]B*?0
M 444A95(!8 GID]: %HIDLL<$32S2+'&HRSN< #W)J%M1L5BAE:\MQ'.<1.9
M5Q(?]DYY_"@"S14<-Q!<JS031RA&*,48-AAU!QW'I4E !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCDA<G )[9.*P#X7NKBXT.ZO]7>ZNM,NY;IG, 42ET=-H /RJ _'WCQU[UTE
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWQL11_>)(% &K167X<UC_A(/#>G:N8/(^V6Z3>5OW;-PSC.!G\JU* "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M],5;HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BN8U#Q#JMIXWTC2!I\2:9>/
M)$;F23+R,L+2?(HZ*, $MU.<#C)B\?>+IO">AO-86\=UJ3(\L<,F=JQH,R.V
M.=H&![LRCO0!UE%(#E0?44M !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>exhibit1060-kumaremploym015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1060-kumaremploym015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+8[(U+' F4DX%8_B>+15^)]Q/KZZDMJVDP)#)9BZ +B64D$P>Q'!]: .FO\
M7M=T718Y=2LM-;4KJ]CM+6.WN7\G+D ,[L@(P=W0'L.]:&CW?B!M0GM-:T^T
M1%C$D5W9REHV.<%"K ,&'7N"#VKG&O?#'_"(RV]MI6H:KHIN5CO8[B&XD>)6
M&?,VR@NP!"_=Z9R.E,\&^1'XJFB\.W&IR^'!9$RK>>:8HKC>NQ8C*-WW=^X
MD#Y>] 'H-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:CKNLZ6UKY)TUXE\SS-WFATW XQQQ0!L4444 %%5I9KI;^WBCM5>U=7,LYE
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME!R,F@#T6BD!##*D$>HI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[1L\O&W;CTQQBL:/P+X;CC*+I@(,,D#,TTC,\<BA65F+988  !)Q@8Q7144
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M36T#VIM6B0VY3RS%M^7;C&,>F.*PQX'\.C3K:P73RL%JQ:#;<2!XLC!"N&W
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M,"DMM!))).223R22<DGFK=% &:OA_2DT^VL%LT%K;3BYACR<)('WANO]XYJ
M>%-#&L_VL-/3[9YGG;M[;?,QC?LSMWX_BQGWK9HH Y]/!'AR.?SDTQ%D$_VA
M&$C_ +M\ELIS\@)))"X![@U+)X0T&72Y]-?3D^R3W)NY$#L"9BV[>"#D'(SP
M16W10!F)X?TJ.UOK9;1?)OT"72EF/FKY8CY).?N "JVH^#O#^K/"]]IL<K0Q
M"!?G9=T8Z(V"-Z^S9%;E% &#=^"O#M]=7%Q<Z7$\EPNV4;F"M\NT-M!P&VC&
MX#..]:%II%A8S74UO;A9+K9Y[%BQDV*$7.2>B@"KU% &/I/A71-#N6N-.L5@
ME9/+#;V;8F<[$#$A%SCY5P.!6;JWA*/6O&4&HWT2R6,6G/;C;*R2+*9%8%2N
M"/E##(/?'>NJHH S+?P[I%H--%O8Q1#30XLPN1Y6X8;'KD$YSGK52]\&>'M0
MO+JZN]-266Z'[XEV 8[=N[:#@-@ ;@-V.];U% &%-X.\/W.I1ZA-IJ/=(4.Y
MG;#E/N,ZYP[# P6!(P*6Y\'Z#=SZC-/IZL^I)Y=X/,<+,..J@XS\J\@9XZUN
M44 8FI^$-!UEH6O].25H8O)4AV4F/^XVTC<O^R<BC4/".@ZI<QW%YIL<CHBQ
MX#,BLBG*JRJ0'4=@P(%;=% &++X3T.;5_P"U9+!3=^8LI;>P1I%QM<IG:6&!
M@D9X'I5K5M$T[7+>.'4;?S4BD$L9#LC(P!&592"#@D<'H36A10!C6GA/0K"X
MCGM=.CA>*;SX]C,%23RS'N"YP#L)'3GZT^[\,Z-?PWT5U81R)?2K-<9)!=U"
MA6R#D$!5P1CI6M10!EZ3X=TG0Y)Y--LU@DG55F?>S-)MW8W%B23\S<GGFL.?
MP1::IXJUK4-7MDFM;N&WC@V3.CX4.'5MI'RG*\9(..1Q7844 8VH^%=$U5;9
M;JP7_1H_*A,+M$4CX^0%"#MX'R].*F_X1[21)IDBV$2-I8866P;1 "NT[0..
MG%:=% &.WA70WL+ZQ;3HC;7URUW<(2?GF8@E\YR&R <C&,<5''X/T"/3DL%T
MY#;K<K=X9V9FF4Y#LQ.YCP.23TK<HH QKKPIH=[JPU2XT]'N]R.6WL%=D^ZS
M(#M8C P2"1@>E%OX3T.UU8ZI#8*MWYC2AM[%5=L[F5"=JL<G) !.3ZULT4 5
M=.TZTTFR2SL8%AMT+,L:DD LQ8]?4DG\:M444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%<-XFUC48_&UIH\'B&#1;1].>Z:6
M6&-][B15"Y?V8G\* .YHKD(M>3P]HD^IZIX@_MVW-Q% 'M+>/,;.P4#"'GE@
M?7'0&I1XZM(H]2%]IFHV5S8+"[6LR1F2596*1E-KE3N8;>2,'KB@#JJ*YV+Q
M="#:QWFEZE8W%S?"Q6&XC3(<QF0-N5BI7"GE2>>,4S5?&^EZ,FK/=1W6S2YK
M>&X*(#DS;=I7G) W#/?K@&@#I:*YB7QEY:V\:Z!J\E]-$\[6*I%YL42MMWOE
MPHSV )8^G!K6CUBWNO#Z:S9))=V\EN+B)(@ \BD9  8@ _4B@#1HKS*R\>ZI
M?Q>#M0DTZ\C.HK<>;9P*A^U$1!E*9<X7)/+%<8.<"NGA\:07&DF[@TK4Y+H7
MC6+6"QIYR3*,D$[M@&!G=NQ@CGG% '345PU_\09$?0QI^BWTQOK^6TN(66,2
M1-&K[H^9 -^5!SDKM!YSBM?QOXCN/"WAJ34[6Q>[E$T4048PN]PN6RR\<X&.
MY';) !T5%<"/&5]9^*=<CETK5;J&&RM+A;.%(B]L"LAD+$N%SPO 8DXXS@UJ
MW/CJQ2**6RL;_4HVLDU"5K2-3Y$#@E6;<RY) 8[5RWRGB@#J:*I3ZM8V^C/J
M\EPHL$@-R9NWE[=V[\JQ]/\ &4%Y>PVMUI6I:=)<P/<6OVM(P+A% +;=KMA@
M"#M;!Q^- '2T5QUI\1M/O="36(M+U46D[0QV>Z) UW)(2 D8W]01@DX'7!(Y
MJS!XYLYO[6C?3-4AN]*2%KFU:%6DW2E@BKM8AB=O4'&".>N #J**Y23Q[8VM
ME<37^G:C:3VUU#:S6CQH\JM+C8PV,0RG/8D\'C-0WWC*VET3Q"+JVU;2+C2[
M833KMB,ZQL&VO&0S(?NMU/!'- '8T5R>I>,X]!T2#4)M)U>\L1:1SO>1B# !
M' 8-(IW]. .I&*FU3QI#I2&671]5D@BMDN[N5(D"VD;9^_E@21@DA-Q % '3
M45QS>,+B7Q7K6C-IUW'965@D_P!LB\LE2PD);E^A"J%^7.0<X&*--\8VJZ!H
M7V.'5=7N]2MC-!$5B%P\:XW/(2RHN,@=>I&* .QHKE3X^TTVMA)%9ZA+/>W$
MMHEJD2^:D\8):-P6 !^4\YQWSCFB'Q%>ZW%;3:7;3VAL]3-OJT%T$#PQK&S-
MT8@\M&05)X/UH ZJBL#0O%,>O21^7I6I6L$\'VFVN+B-?+GCXY!5CM/S [6V
MG!Z<'#M9\3QZ5J$>GP:;?:E>M";AH+)4+1Q XW,791R<@ $DX.!0!NT5PUEX
MDGU/XHV-M:W4ATBZ\._;DA9-OSF8 ,01D':<8I-#\<V">&=$GB_MK4WU26>*
MU\Z.(SR.C/D-M(4?=(!Z8 )(Y- '=45Q&I^,[*?PXU[(=7TQX-3CL9XHDB\^
M.7<OR-DLI4AE)()X/%:.H^-;33]0NK<:?J%U!9,B7MW;QJT5LS $!LL&; 8$
M[5; /- '345SDOC"W@U=;*33-16V:Z6R%^T:B'SFQA>6WD$D#=MVYXS5+P7J
MU]J6M>+8;RY:6.SU5H+=6 _=IL4[1CW)H ["BN?D\5Q+K4NGQ:7J-Q%!<):S
MWD,:M%%*X4A2-V_&'7)"D#/)ZXBB\:6<NII;BQOA9R7;64>HE$\AYU)!0?-N
M^\I7=MVDC&: .EHKC(OB1ILMK)>C3-473HK@6TMXT2"..3SO*P?GR0"020#P
M?7(&IKGB.SL+J;2W^UBX.G3WKR6RJ3#$@QN^8_>)/R\')!S0!OT5R%EXQMH]
M$T,6=MJVL75_9"ZBC58O/,0"YDDRRH#E@.#R3P*FD\<V;0VSV&FZGJ$DUK]L
M>&WB57@BR5RX=EYR&&T9)*G H ZFBN8E\<67FI]@T_4=2@^S174L]G$K+#%+
MDHQ!8,V0"<*&..U:GB#7;3PWHTNJWRRM;Q/&C"%=S?.ZH#CORP_#UH TZ*X]
MO'Z+=7=E_P (YK?]H6T0N&M/+BWF$Y_> ^9MQP1C.[/&.M69?&]FT%C)INGW
M^J-=V8OQ':(FZ. ]&;>RC)Y 4$DD' XH Z>BN7NO'-@B0R6%E?:HCV:W\C6:
M*?)@;.UVW,O)PV%&6^4\5%9^,9;_ ,=#1;;3II=/?3XKQ+U=FTARV'^_G80,
M#Y<[L\8YH ZVBN0\1:_>:3XVT2T@ANKN*YL[MC9VRJ6ED5HMIRQ & 7Y) _'
M%17?C"PO+'0;Q9=5LOM6LK8&"-(PXF!=6BF!) 3*G)4YX&* .THKD-2^(FG:
M8NHSOINIS6%A,;:>]AB0Q><" 4&7#=2%SC;GC-4)/&EQI'B+Q:ES9:CJ%GIT
ML,A^S(A6UA-NCL3N9<\EC@9/7B@#OJ*9#-'<01SQ,&CD4.C#N",@UR5S\0[&
MV6:X_LO4Y-/CO!9+?)&ABDF\P1D#Y]V Q(W$ <$ DXR =A17/S^,-.M]%U?5
M7BN3!I5P]M.H5=S,I )49P1\PZD4V_\ %\&GZF]M+IFHFUBGBMYK\1J((Y)-
MH4'+!B,NH)52 3R>N #HJ*\W'B6YBE^(CZCJ%ZEEI4D?DM:JAE@0Q!CLW#!.
M>>:T&\<7%KX@@TV/1]1O+,:/_:!F18C*_P!W!QO ]01C.XC''- '<45A/XLT
MT:7HNH1":>+6)8HK18E!8F12V2"> %!+>F#4VM:^FCRVENEC=W]Y=E_)M[4)
MN(0 LQ+LJ@#([]Q0!KT5QT7C6XN?&.FZ1!HM\+6[L&NGDEC5'C.]%!(9P0JY
M8-P3DKC(R:M6GC:VN+M89=,U*TCFBEEM9KB-%6Y6/EMH#%E..0'"Y% '3T5R
MFE>/++5;G2D73-2M[;5D+65U<1HL<K!"Y7ABP. >H .#@G@G)U/QU)?#17TR
MTU"WL[O6(+:.^=$\JZ3S"KA<,6 (!P65<@<4 >@T5SJ^+X/[9CL9-,U&&WEN
MFLXKZ2-1#),H)*CYM^/E(#%<$C@U3A^(>F36NIWOV'44L=-,J3W3Q+L\V.39
MY:X;+,3@C QR,D'B@#KJ*X%O&LT/B]SJ-K?Z98VNAW%]<6MRB%CMDCVN"C,"
M<%AC.?4=*ZG1]:?57GBFTG4-.FA"MLO$3YE;."K(S*>AR,Y'<<B@#5HKG=4\
M7P:3J$L$VF:B]K \:7-\D:^3"9" N<L&;J,E5(&>:J:C\0++3Y=54:5JEQ%I
M,FR_GAC39"NQ7W\N"PPW102,'(Z9 .MHKE=:\90VDM_9V5C?7;VEH)[FXMD0
MI;!E)0MN8%C@9PH8X[5>\,:D\_@71]3U"XR[Z;#<7$S\9)C#,Q_4T ;E%<I:
M^/M/EB-Q>6&HZ=9M:/>P75W$H2:% "S#:Q(."#M8 D'I4MCXS@N;J.WN]*U+
M3GGMWN;7[6D8^T(@!;;M=L, 0=K8.* .FHKB[?XDV-RNFR1Z+K'E:I'OL',,
M?^DMM#% -^5.,\MA>"<XYJ<_$'3DTN*[EL-129]1.EM:>4K2I<;20I ;!S@8
M()'S#MG !UM%><>,_&]Q_P *]\2W.G1WFDZSI?DK)%<*GF1;W3:P*EE(92>0
M3WKL;+Q!9W>I:GIY$D-QI@C:?S0 &1UW*ZD'E>",\<J: -:BL!?%MFW@H^*A
M:WGV$6YNO+\M?-,0_BV[L<CYNO3\J?+XKTV+Q-8:#^]:ZOH#/%(J@Q[<,0"<
MYR0CD<?PF@#<HKC'\7V%]X@T.."75(_M%W?6T,<:1^3<M I#ER3G;D':1C)'
M/%83?$#4[VPT^].G7MF@\0FR9$1&-Q&/. C #M\^44-T&>AQS0!ZA16/H7B&
M+6Y+Z V5W8WEC(L=Q;703>NY0RG*,RD$'J#ZU5;QA:_\)/<Z#%8WTUQ:;#<S
M(B^5"CKN#LQ8<=NF>#Q@$T =%17,:?XXL+V2(S6=]96MQ ]S:75TBK'<1(,L
MRX8L/E.[#!21S4>G^/;.^OM)M7TK5+0ZN6-C)<1(%F0(7+\.2HP.A /S#C&<
M '5T5S\'C#3I]%TG54BN1!J=REM I5=RLS%06&< 94]":P= \4WD<WBZ6^^U
MWZV>M&TM+>",,^"$"HO0=6ZD@#N: .^HKA]8^(,EGHPN;31;W[;'J<&GW%I,
M(]T+.R'!Q)@[D<;2"1DC.!FK2>*+"V\1:S]MNM1MQ8Z;%>7-O<+'Y,"$$_+M
MRQ?@@C)''% '745RT'CBV+LE]I.IZ<[6DEY;K=)'FXC0 MMVN<, 0=K8//UI
M-.\=V5_=V,3Z=J-I;ZA T]G=7$:".8*N]@,,6!V\\@9 .,T =516#H7BA-=D
M39I6I6D,T N;:>YC7RYXSC!!5FVGY@=K8.#TZX37?%4>A3/&=*U*]6&W-U<2
MVL:E((LD9)9ER?E)VKDX'3I0!OT5R][XWM;>_N+*STS4M2G@M8[QA:(F#"^[
M# NZC^'IU.1@'G"MXWLI3IRZ;87^IR7UF+Y8[5$!C@.,.V]E'). !DD@\<4
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M-T.YD^&%IH%T/L]TVCI92@D'RW,(0\C@X/I7344 >=SVGB7Q#X/E\+RZ(=.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1:7J%E-<RS2R -"Z&+$9P<;OWN"/45T,GB;0XM'BU=]5M!I\QVQ7'FC8YY&
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MHH **** "BBB@ J"ZLX+V)([A-Z)(DH&2/F1@RGCT8 _A4]% !1110 4444
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M$XGM49$ECE4E3M9F((*L#R>E8OBCQM>>']8F3[9HJV\#PC["[,UU.KD!F&&
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MWN+.S-Y<7D5U$(W9'D@$B-T<94[20#T."<XH ].HKG_$^LWVG/I5AI:VYO\
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M?W><YS0!Z8KH^=C*V#@X.<'TIU><:3XFEAT#Q#=VD&B:4T'B&XM'GFS'#@,
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MNPO!Z#!X.>,WPU\2&UG5](CDOM'FBU;>$L[5R;BSPC.OF'<0V0I!PJX8@<T
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M@<C"X(/5>G-;'A;P_<Z!#J7VN^6]GO[Y[UY%B\L LJ J!D\ KQSTP.>M;U%
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M]0.10!/14-S>6ME&)+NYA@0D*&E<*"?3)[T)=VTC!4N(F)9D #@Y8=1]1W%
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M_P 0W*O!XX%>M6VF:?9RS2VMC;023<RO%$JF3_>('/XU(MG;(L"K;PJL'^I
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M2ST>_NT&OB!M#N9I[G46BVI<K&&C>+8Q*@_/\N /NU>2\U30=1T&[DU:]O\
M^T=-N9KJ"=@8R\<2R*44#Y.<CCL><GF@#TBBO.+>76-+\$)XP_M^YNKA]'DO
MKBTN 'BDD,/F+Y8&/+"GTSD=>>:G@.I:#JOA=CK5]?C5Q)%=I<N&4OY#2B1
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M7'S%BS<GD9&,8I=1U37[S4=6@TR/7&FTR"".P6P\H0>:85DS,'8%@2P4C!
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M>XDDF=1N<#HH4X P.1GI6/I^J:SK5UX9TV;6+J)9)=3MKN> A'N%MY J-G&
M3CD@=VQCL >IU4M]2M;N^O+*%W,]F4$RF-E"EAD8)&&X]"<=Z\PCN=:M?#TV
MK/X@U":;3-?&GQ([KLE@%VL1$HQ\[%6/S=>!C'.;\FH>(K_7O'UAIUS<2/9S
M6 MH8W562-D5IEC+<!F7=@GOB@#T"_U*UTQ(7NW=%FF6!-L;/EVX ^4' ]SP
M.YJW7E&HZ_=6FA:>NGZKJZR_\)':6L\.HIMN8$?!:)S_ !*?O \\-U.*EUBX
MUB33?'.K1Z[?P/HMU(UE#$X"+L@CDPPQ\RDGH>.OK0!ZE17G-Y=:KJ][XLNX
MM9N[#^QH(Q:10L!'N-N)F:0$?-DMCV XP>:[#PO<37GA+1KFXD:2>:Q@DD=N
MK,8U))^IH UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *P=:\)66MZI;ZE)=ZA:W=O$T*2V=R8CL8@D''7D#\JWJS=4\0:/HLD,>I
MZE:VCSY\M9I I;'4\]AD9/2@"KI/A/2]&-U+ L\UW=KLN+NZG:::1>P+L20!
MZ# J.X\&Z1<^$K;PS(DW]G6XB6,"3YL1L&7)^H%:5KK.FWK6ZVM]!*UPCO"$
M<$R*C!7(]0"0#]:ANO$FBV-D]Y<ZI:Q6ZS-;F1I!CS5)!3W8$'CKP: (M7\+
MZ7KFJ:9J-[$[7&G.7@*N0"<JV&'\0#(I /<"HM7\)V&L7K7<D][;2RPBWN#:
M7!B\^,$D*^.N-S<C!Y/-5-9\7K9W7AC^S3;WEIK-X+?SU?< FTMN4C@]*9?^
M-K+0K+5+[5;VP>"UO5M8TM927!.,*X; #C)) [#- '1W5A;W>ES:=(I%M-"T
M#*IP=A7:0#]*SM-\+Z;I4VFRVRRAM.L380;GSB(E#SZGY%YJ[IVL:=JZ2/IU
M[!=+'M#F)PVW<H89^H(/T-2V5]:ZE:)=V5Q'<6\F=DL;;E;!(.#]0: ,N/PG
MI<6EV>G*LOV>TO?MT0W\^;YAEY/<;F/%<]HW@*.;^TGU?[9''/K-S>&T6Y_<
MW"^<7C9U&>VTXXZ#(XKO:* ,ZUT2QM+S5+I(RSZFZO<ASE6(0(,#TVJ*S=+\
M%:7I5Y:7$<M[,MDK+907%PTD=J"-IV _[/R@G) X%='10!C67A?2]/\ $E_K
MUO$ZWU\H64ER5'"@[5[$[5SZX%06G@_3K+4UO(9KT1QS/<169N&^SQR/G<RI
M[[F..@). *Z"B@##@\)Z7;Z9I6GQK+Y&EW N;8%^0XW=3W'SM27?A+2[UM1>
M59A)?SQ7,DB2E6CEC551T(^Z0%'^36[10!@P^$=/CAA26:\N9(KU+\SSSEY'
ME4;5)/H!@8  XI=2\(Z5JJ:NMTDI&JQQ)<E9"#^[SL*^A!.:W:* .8F\#:?<
ML?/OM4ECD5!<Q-=G9=;>AD'<X !QC( !K4\0:%9>)M$N-(U$.;2XV[Q&VT_*
MP8<_516G10!FKH=DM[J5V _FZC$D5Q\W!5%*C'IPQJ6STJTLM%@TB./?9PVZ
MVRI)\V8PNW!]>*NT4 <U;>!],M[6YMFN-0N(9K-[%$N+IG$$##!1,]. .3D\
M#FM)M!L7N=,N&5R^FQO%;@MQM90IR._ %:=% ',6'@+1;"=& NKB"&.2&VM;
MF<R0VZ.,,J*>@(XYS@<#BIM*\&Z;I-[;W23WURUI&T5HEU<&1;9" "$!]@!D
MY..,UT-% '*V7P_T>PEL6CEOWCL)_.LH)+DM';GD;47T^8]<GWJ^GA33(]'L
M]+59?LUI=+=Q#?SYBR&49/<;CTK;HH YN3P1I,LNJ,SW@CU*47$L*W!"),"I
M$J8Y5\HIR#VIX\&Z<UDUO<3WMTSW<5V\]Q.6D:2,@IST &T<  ?G70T4 -D0
M21M&WW6!!^AJMI6FV^CZ3::9:!A;6D*PQ!CD[5&!D]^!5NB@##F\):3/8ZU9
MRQ2-#K$AEN@7YW%57*^F JD>XJ2+PQID,FB-%$R?V*C1V:JW"JR>6<^ORUL4
M4 4M)TJVT73UL;,,(5DDD 9LG+NSMS]6-0?\(]IQOM5NWB9WU6&."Z5FRK(@
M90,=N';-:E% '/VW@S1[31])TN&*1;72KE;JW&_GS%+'+'ODLQ/UHA\'Z?#J
MJ7HGOG2*=[F*TDN"T$4K9RZK_P ";C.!G@"N@HH R-<\.VFO-927$MS!/93&
M:">VE,;HQ4J>?0@D&HY/"FF2:1>Z6RR_9KR[:\E&_GS&E$IP>PW#I6W10!G6
MNAV-I=ZI<I&6?4Y!)<JYW*Q"!,8]-JBLW2_!6EZ5>6MQ'+>SK9*R64-S<&2.
MU!&TA ?]GY<G) X%='10!RME\/\ 1[&:R:.6_>.PG\^S@DN2T=N>>$7T^8]<
MGWKE[GPA?W6IQV4>B7=K;)K"7HF.HJ]G&BS"0M''NW!VP1M*X!9L'%>I44 8
MD_A33+C2=6TV19?L^J3//<@/R6;&<'M]T5H:GIMIK&F7&G7T(EM;A"DB$D9'
MU'(/N.E6Z* .83P)I!MKR*[DOKZ6[6-'N;JY9YE6-MR!&XV[6^88YSR<U)'X
M*TT07JSSW]S<7@C62\FN29E$;;HPK#&W:W(P.O7-='10!S$O@32[BPFMY[G4
M)IY;B*Y:]>X/GB2/_5D-C V]@!CD^M=)#'Y,$<6]WV*%WN<LV!U)[FGT4 <_
MIO@_3M*OX[FWFO3' SM;VKW#&" OG<43MU(&<XR<8IA\$:,?"MYX;*3?V?=R
M/)*/,^;+OO.#VYKHZ* ,35?"UGJMS#<_:;VSN8X3;^=9SF)GB)SL8CJ,\CN.
M<$9JK?\ @;2+XQE)+VSVVJV3BTN6C\Z!>D;^H&3SUY//-=+10!@'P?I:ZJM_
M ;BV868L6A@E*Q21*&"AE[[=QQ4<W@C1I_!T/A=TF_LZ ((B)2)$*MN!#=<Y
MKHZ* ,>_\,Z??6%C:J9[7[!C[)-:R>7)!A=F%/IM)!!R#5O2],@TBP2SMVE=
M0S.SS2%W=F)9F9CR222:NT4 <W#X'TB#4TO%:[,4=PUU%9-.3;QS-G+JG8Y9
MCCH"20!45EX!TFPGT^:&?4"VG2;K/?<EA F"IB4'^ @X(ZD <\"NIHH PH_"
M.E1^%X?#RI,+*#!A82D21L&WJRL.0P;D&K>CZ+!HT4PCGNKF6>3S)9[J4R.Y
MP .>@   P !6E10!R^J> M'U:?47GEOHX=1'^EVT-RR13-MVARH_BP![':,@
MU-?^#-,O[EIC-?0>;$D-S';7+1K<HO"B0#KP2,C!P<9Q7144 8DOA73)M2U2
M_9)?/U.T%G<8?@Q@$# ['YCS4%]X)T;4?"5KX:N(YCI]JB)%ME(D4(,#YOID
M'V)KHJ* ,C5/#EEJD5F-]Q:2V6?LT]I)Y;Q C:5!Z8(P""".!Z"F6WA;3;6X
MTJ>,3M+IBS"!Y)2Y8RX\QG)Y8DC.?>MJB@#C9=#N-=^(EEK5[I9M+71HY8[>
M661&:ZD<X#!5)PBC<1NP<MT&*Z^6))X7AE4-'(I5E/0@\$4^B@#E#\._#[>%
M+?PVT,[:?!-YZYE.\L2Q.6ZG(8@^QQ6Q)H-C+XD@UYE?[=!;-:H0WR[&(8\>
MN16G10!S>E>"-*T<V MY+QH]/GDFM(Y9RRP[U92J_P"SACQ4UUX0TJ[COED6
M=7O+Q;YI8Y2KQSJJJKH1]T@(/U]:WJ* .:/@?29-,O;.=[R>2]DCFGO)9R9R
M\9!C8/\ P[2!@  #TY-(G@72/)U1+AKRZ?5+5;6\EN)RSR(-V#GL1O(XQT%=
M-10!2L-,BL=)33FFGNXE0H6NG\QW4YX8]^#CZ5B67@'1+,E7^UWD"VSVD,%W
M<-+'!"XPR(#T!  R<G QG%=110!S=EX)TRSD,CW%_=NML]K";NY,GD1, &5,
M],@#DY/ YJ[!X:TZW_L38LG_ !)HS%:9?HIC\OYO7Y:UZ* .(U_P6EQ=:2EC
M%/Y+:V^HWDB3;&B+0R+O4Y!&&*8 S^6:TT\$:2+&:VE>ZN'GO(KV>XFF+2RR
MQE2F6]!L48  P*Z2B@#&U?PU::O>0WQN+RSO88VB6YLYC&YC8@E#U!&0#R.#
MTQ26?A72K"32GM87C_LN.6.V&\GB3&\MGEB2,Y/<FMJB@##?PGI;Z7<Z<RR_
M9[B^^WR#?SYOFB7@^FX#CTJ.;P;I4UUJ]SFYCGU62&6>2.8JR/" (V0C[I&!
M]:Z"B@#F6\"Z3+;)%<R7ES(M]%J#7$TY:22:, (6/H  ,  5=F\+Z;/8:U9.
MLODZR[O=X?DEHUC.WT^516S10!YSXK\.7L^I:A]@T&\N5O;)(/-MM16*&5@I
M4?:(V8$A<CE=V1P1VKN-%L&TK0=.TYG#M:6T<!8=&*J%S^E7J* "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N$U+4K#0OB;<7>M2
MK!;7>CQPVLDBDJ[++(9(U]6.Y#MZGBN[HH \:\):A9:);^"-1U!UL; V&HVX
MDE^54=IT94)Z D*V/7%26.L"VMK.5YX=*@N=;U24:C=VH9X#YC;44-PK.&(Y
M[ C&37I^@:-%X?T6#3(97ECA+D.^,G<Q;M_O5I4 >)V,AEM_!,.Z1YK?Q1=K
M,KQ['0EY6&Y1]TE64X]Z6_5D\._$61D;:GB*"5CM)PBR0%F^@ )_"O:Z* /+
MO%M_-I>JC5] 83Q^*K,:=%+#RHNLXAESZ;&DY]$%=UI0TW0UT_PQ;.5D@L@T
M,>P\Q)M0L3C&<D=\\TR;P\+OQ+!J]Y?7$Z6N6L[,A1% Y7:7X&6;&<9)QN.*
MVJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBCH,F@ HI@EC(4B1"'^
M[\P^;Z4^@ HI%977<K CU!I: "BBB@ HHHH ***:SJA 9@-QP,GJ: '44C,J
M#+, /4FEH **** "BD5E=<JP(]0:6@ HHHH **** "BBB@ HHIJ.LBAD8,IZ
M$'(H =1110 4444 %%%(S*BEF8*!U).* %HHHH ***:'4LRA@67J >10 ZBB
MB@ HHHH ***0,K9VL#@X.#T- "T444 %%%% !1110 444A(52S$  9)/:@!:
M* 01D'(HH **** "BBB@ HHIN]=^S<-^,[<\XH =1110 44TNJLJE@&;H">3
M3J "BBB@ HHHH **** "BBB@ HIKNL:[G8*/4G%.H **** "BB@G R>E !12
M*RNH96#*>A!R#2T %%%% !12%E! + $] 3UI: "BD+*N-S 9.!D]32.ZQJ6=
M@JCJ2<"@!U%%% !12,P52S$ #DD]J 0P!!!!Y!% "T444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5Q&MV__  DGQ!A\/7LTPTFUTT7T
MMO%*T8N9&D**'*D$JH4G&<$D9Z5V]<YKWAR[O=6M-;T?4$L-6MHV@W2Q>;%/
M$Q!,<B@@XR 0000<T 9UY86OP\TO5M:TUKEK,0*$TMIBT7G%MJLI;)3)8 @<
M=\4LFL:Y9:E_8VO?V?+]OT^XG@FLHWC"/&%WHP9FSPX(;CH>*=-X/U+6K'4T
M\0ZV9IKVW$$<=G&8H+8!MP94+-N?< =S'M@8%30>&M5N]574M=U&TGG@LY;2
MU2UMVC1?,V[Y&RS$L=JC P ,]<T >>>'_P#D"_"'_KO/_P"BWKLHO&UVGB^U
MTR>[T66.YOI+3[':N7N+<*KLKNVXJ<[!E=H*[AR<4[3OA[+8V/@ZW.HHY\/2
M.[-Y1'G[E(XY^7K[TEMX(U>V73(%UBT^RZ5?M=VR?9&W2!B^[S3OY8+(P!&.
M>3GL 8GA;6]<T/P=IE^T=@VBG4GM9(BK^?MDNF3S V=O#,/EV]._:M:[\9:W
M'I>I^)((=/\ [#TZ[D@:W=',\L<<GER2!]VU3D,0NT\#KS3[/P)JL.FV6BW&
MLVTVCP7PO706I$SD3&41[MV-N[!SC/&*ENO VH36NH:+%JENGA_4+MKF:(VY
M,ZAWWR1J^[;M9L\E<@,1SQ0!9L]?UW4/&.MZ?!#8)IND2QJ[ON\V8/ KA5.<
M*0Q.21C&..IK&L?'.J7LUW8IJ&A7-TVF37L;V.Z1+9XR@,;G>=_W^&&WE3Q7
M2+X4S<>*FDNSLUX*OR+AH0(!$><\GC/:LRT\&ZQ]LL)[[5K-DMM/FTTPV]H4
M7R7"?,N7.'R@SVQP!W(!AZ=XUU+3O#7A:TO]9T>WO+_35O&O]1W[/+"1A5(+
M@O(Q8DG<!P3BNRT/7[CQ#X)36+*. WDD,HC0,7B,R%DX(P2A9>/8UC:;X.UW
M2K'1VM]4TYM0TNU;3T=[1_*FML)@.N_(<&,'(..2,=Z[#3H+FUTZ"&\N_M=R
MJXDG\L1AV[D*. /;]3UH XI?B%/--X4:"VA-MJ<$<VH,V<V_FLL<87G_ )ZL
M0<YX4U5U/Q5+>:CI3S:983VS>*/[.M))8RS(J*5:53G ?>' /H*NV_PY-OI_
MB*V7406U%O\ 0F\K_CS59'FC7K\VV20GMVJPW@-O[)\*V2WZAM$O4O9I#'_Q
M\. V_C/R[F<GO0!R6JW^OW?ASQ@U]<VUU';>(+:""%59"&66U( )8A4YZ8ZD
MG/.*[O1]7UD>*KO0M9^PR.MG'>PS6:.@"L[(48,QR05'(QG/05FW'@>_F.NV
MRZE;BPU/48=153;L98Y%>%F7=NP5(BP.,\^U="NBLOC"37?/&U[!;/R=O((D
M9]V?^!8Q0!G:AK&M7?BBXT/0C80M9VD=S<3WL;R F1F"(JJRX^XQ+9/;BN<M
M?%&NZ[XD\'36DMO:6M[;7;75JRN_[R)U209# 'G.TXXY)SG Z;4M U1?$,NM
M:%?VMM<7-LMM<QW<#2HP1F*.-K*0PWL,="#VQ5"#P/<:7+X9ETO48M^CI/',
M;J$M]H$Q5I&^5AM;<I(ZCF@#GO"VLZYHWAC1[@1V#:3/JSV31%7\\B6Z=?,#
M9VC#'[NT\#.><"[9?$O[5K5LOV[1FM;K438+IZ2'[9&-YC65OFQRP!V[1A6!
MR:VHO!DD?A;3=&^W*6L]22^,OE\,%N#-MQGCKC/XU+I7AW6-(NTMK;5;9=%2
MZDN%B^RYG(=F8Q%RV-H9CSMS@ >] #/!^N:YXA>\N[R*QATZ&XN+6-8E?S9'
MCE*A\DX"[1C&,YYR!Q65XI^($FCZUJ-E;WVBVITVW29X=0D(DNW8%O+CPPV_
M*!\Q#<L..*ZCPQH3>'M,FLVN!.9+NXN=P7;CS)&?'7MNQ5'4?#VKC6KW4-#U
M.UM#J$4<=R+BU,I1D! DC^8#=M.,,".![@@&9J7CJ\TV=8_[/6X.JV\<NA>6
MI'GR, #%(<_*5+!B>!MSW%5?$'CV[T?4;C3VU'0;6ZL+*.>=;QF3[7*P)\N$
M;P5&%^\=WWAQ6KJO@8:[>7MYJ5^SW'E)%IDD:;38%2&\Q?5RX!)XX4+TSETW
MAS7X[Z2_T_5[&&\O;6*"^>6S+KO3($L8WC!PQ^4Y' ].0"JOBC7=>NKG_A&;
M>P\JSM(+ATO0VZX>5/,6-2" GRE?F.>6Z<5='B>]SXK#VT,;:/"DD2'))8VX
ME(<@X."<<8XJ._\ "^LIJE]>:)K4-H=2@CBNVGMO,=612HEC*LH#;3C!!&0#
M[5!?^#=5DN]9%AK,,5IK%LD-T9[<R3*RQ^7N1@P&67&<@X/(H J:5K.OZE\0
M;%&NK5-/FT&&]>V$;]7;!Q\V-VX<''W>,9YJIX"\6S2Z1X10Z9I]CINKQ74:
M1VD918;B.1B% )(PRJY]<@UOV?A2^T[Q#I6I6M_;F.WTN/3+F.2$DNJ'<&0A
MAM.<]<UGVGP]GLOAQIOAJ'5%34--G%S:WXAX202LX.S/3#%3SW- %:\^(EPB
MLXFTNQMKK5)K*RO+TD1"*%3YDK?,-V7!50"O;FHQ\1;FXTVR>.\T:VWWD]I/
MJDH>2SW1A2FW##&\,",MQAAS6ZW@Y[+1=!MM(NHH;S11^YDGB+I+E"D@=00?
MFR6R#P<5--I/B9K"!1K&GSW!,GVF&XL,V\BN05 4,&&S&!ECG)SVP :7VG47
M\,&Z_P!$CU$VWF94F6$/MSD$8++^5<1X9\1>))O#?A33Q<64^J:M:M<_:[B-
MV$4"(F2Z[\NY9P,@J.?;GM-#T)=&\,6VB^=YJQ0F,R!=H.<YPO.!SP.PP*YK
M3?!.LZ7INAB'5;$ZAHB/;6TAM7\N6W95!61=^=V54Y! XZ4 ;WA?6KO5H=0M
M]0CA2_TZ\:TG,&?+<A5=74') *NO!)P<\UQ'C#6M;UKP9XDNH8[%='M[MK)8
MBK^>XCE5&DWYV_>!^7;T'7-=WX;T.31;:\:ZN5N;Z^NGN[J5(]B%V 4!5R2%
M"JH&2>F>]<WJ7@/5KK3]7T>UUJV@TC4+MKS:UJ6FC=G#L@;>!L+@GIG!(]Z
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M^UGMI8]O^M$D:H<'/'3WZTOA[1=<TLVUO>ZO;7%A9P>1"D-KLDEQ@*TC%CR
M/X0 22?:@!NKZQJS^)X/#^B_8XI_LC7D]Q>1M(J)OV*JHK*22<\YX [U@_\
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M+'A74 D-D^@KF=-\+W7B_P -^)8VU A-1UF*YAO7MBJS+&L.2B$Y"%D95Y/
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MS*$>5LL<M@< 8 R:;:^$-:%]9W=YJMDQ@TZ;33#!:,B")PF&7+DAMR#/;'
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MLEL8XJZGB;Q!K=U?S>'+:PELM/:*,PW.X2W3M&DC!6W!8\*Z@$ALG/05>O\
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MM#:7EU<6]XM@D<"*3<3F/S"B$L!\J\L6P!@UIZ+K,&MV<D\4,UO)#*T$]O.
M)(9%ZJV"1T(.02""#0!I45RL?CW3I)]5'V._6UTEYDO+QHU\J-H^JYW98GJ
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M517G?@K7]9\0>,]?>^CU2"TM+EK:&V86X@A 53A]I+F3)SD$K[UZ)0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<'XJTV\
M/CO3-77PY)K5C%I\UN\<9A.R1G0@XE91T4\BN\HH \KN?"&K:S'XAGMM%70[
M2[M($ATWST4W$\<OF>8WE$JA( 3(.>YZ5)?>&)=0\*^)4TWPQJ%E>76G_9H3
M?ZB9I9FR25 :1U50<8.X9)/'KZA10!R6AZ/?VGBR.\GMREN-!M;0ON!_>H\A
M9< YX##GIS7->'M,UCPM=>'YY-+>[N/[)FLY[.&XA$T9$P=7 9P&7G!(/&17
MJ59FK^']*UX0C4[)+@PDF)R2K)G@X8$$ ]QGF@#!^&9E;PC)).J+(^HWK,(S
ME<FYDSM/<9S@US=IH6N_VKHM]=:+J$U_9:F\M_>2WJNLJ,)$4PH9,! '4GA2
M , 'FO3K*RM=.LH;.R@CM[:%0D<4:[54>@%3T <5XYFN+?7?!\UK:M=2IJ4A
M$*L%9Q]FER 6(&<9QD@9[BLM]!UG4]1GUE],EMC=Z]8W*VTKIYD=O H4NV&(
MR>3@$G&*] N=/M;NYM+B>%7FM)#) Q)^1BI4D?\  6(_&K- ''W'AE]4U[Q8
ME_#MTW5-/MK9)<@Y*B4,0,Y!7<IYK \'6NHZQX/U37=3T^'5;V_A2S2W:0!;
MBWA&PX8\#>WFN.WS+R.M>AZGI5EK-B]EJ$ GMG(W1EB <>N"*L000VMO';V\
M210Q*$CC1<*J@8  '04 >4:MX9U[4?!VM:=I^G:G'9R7%FUC8ZC=))+'LD#2
MD,7;"8"X!8G@XZBNCD37_#VO>(&TW1'U$:M-'<6LXE18HI!$L;+-E@P4; WR
M@Y!QUKN** /-=0T#Q(NO>.+^Q@D1M0MK%;66&94:7RP1*J'.5;!(!..2.>]9
MMUX8U69=?6P\/7EM;ZC9V:VZW%VLD@:*=F<2%I&P2&R "1@<D'BO7** .>;3
M;L_$:/5/)/V(:2UN9=P_UAF5MN,YZ GTK-\0:!?ZE\0]#OHX3]@AL+R"><,/
MW;2* O&<GOTKLZ* /*]%\*W]GIUO:P>'[VVUG3K"6.+4KC4V>!;CRC&CPQ^8
MP(;)."JA0?PJJWA'5-0>18=$U"S2]T*ZTV6>^O1-(+A_+8.^9&^0E",KSGJ
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M0=3(H#,@/(!S@D>^#^1H =1110 4451U+6+#2#9B_N!";RY2TM\J3OE;.U>
M<9P>3Q0!>HHHH **;))'#&TDKJB*,LS'  ]S58ZE:C5ETLNWVMH#<!/+;&S=
MMSNQMSGMG/M0!;HJE<ZM8VBVC2S96[G%O"T:-(&<YP,J#@<'DX'O5V@ HHHH
M **** "BJMCJ5IJ2SM:3"403O;R_*1MD0X9>1V/X5:H **** "BBB@ HHJHV
MI6JZJFF%V^UO"9E7RVQL!P3NQMSGMG- %NBBB@ HIKR1Q &1U0,P4%CC)/ '
MUJO::E:7T]Y!;3>9)9S>1.NTC8^U6QR.?E93QZT 6J*** "BBD9@B%FZ 9-
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M:W%PSQ01MU5%/;  YS@<#B@#D8+&[AUGX>WMUK-Y?27DDDTZW#AE\QK21MR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>IHYT'X6 (V5O;+=QT_T=NM='\4(I)OAEKZ1HSM]E)VJ,G ()_04 :=SXO\
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M;LA,EXCP(L0C'\6"-O'W2#TK0T:PDCU?Q6M[$'NET:RAD=AG<?)DW#/?)'-
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M8?L83[1OD \K?]S=Z%NP[UB>/86MK'3_ !%"I,VB7:7+;1DF!ODF'_?#%O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 -=!)&R$L P()4D'\".E<YIO
MA%K34[*]OM;U#4S8(Z6:76S]UN&TLS*H+MMXRQ/4]SFNEHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME<$X(RV-IZ\5IMK7BZ76K[1;?^QA<V5C#=27#PRE&=S(-@3?D [!SGCG@YX
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M %F"@G R<<UQ=OXVN=0T+PU+9VT0U/5KH6TT$@)$!CW?:#C.?EV,!SU*U/\
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MM(2>7]T?:1-LQGVQG\:IW7@C5Y!=06VKVD5J=5&K0AK5B[2^:)=DAW\H"".
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MN0#UXKKZ* .5NO#6JZK:Z?\ VIJD$EQ:ZK%J&(;?9&J)_P LE&2??<2>2>V
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MM#'L^^7\OYLYXQY?3WK>HH XF'P1>V$5A<Z?J,"ZE8WEY/&\T!:)X[B0NT;
M,#Q\O(/5>G--N/ M]+I9<:G =9?5X]7DG:W/DM(F $V;LA J@?>SQGO7<44
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M;7C^9?R;KB]D_OSR$O(?^^B0/8"L/5?!&J7QUNVM=6MH++4[E;P[K4M,)55
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MQ!SE@'1@V#W&<=/04MWX-T&]M+*U>R:*.R0QVYMIY('C0XRNY&#$' R">>]
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MJ<QN%'RL.AQFJW@SPW<Z1J6KZG<VD5D;X0QI;+<M<.%C#_-)(W+,Q<^O '-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN80KR0#/SH Q].A((R,@58N;"^L/A_)I^A0"UOX=-,5G#YN_RI!'A5#MUP<
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M@C9XXA)&J( 1@CYB"3S@]:T_#S:[X?1?#T>A3S8U*:3[>SJ(#;23-(7SG=O
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M(@9@&QLY&<X)/:@#N- \1V7B.&[DLDG3[)<&UF6>/8RR!58C'MN ^H-9-_\
M$+2M/EOQ+::B\&G7 M[VYC@!CMR0I#,<Y*_,.@)&#D#C,'P]EGGE\537%O\
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M2+NZE@\)VL-Q#;!6EC<.1T) (R"#@^G;)%OP[X:U:QU/PA/=693[.FIS70#
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M(JQ+9 +$D#&"*[7QI%J$L.F"VBU":Q%WF_BTZ7RYWCV/M (93C?LS@@X]LT
M$GCS2XK&SN6M[_S+J[>Q6V$&94G4,3&R@]?EQD$CD<XYIK?$#28M/ENKFWO[
M>2&\2QFM9(/WT<K@% 5!.00005)SGBN&CMM2T*\T5)-%NU<>))KF&!YQ*\D3
MVLAP'9CN< '.3]X8SWJQKD&I>?/K[Z7-";[Q#IIM;.<JLKK$ N3R0I8YQD]A
MG% '82?$#2K;3]3NK^VO[%M-,/VFWN8@)%65@J.,,05)SR#V-32>-+=([-5T
MG5GO;L2-#8B!1.8T(!D(9@%7E?O$'D#&>*Y'Q%H^L>)D\1ZE#H]U;BX@L+2V
MM[C:LDOE7'F2.0"0  V!D\X-=-K4-[IGC6S\0PZ=<W]J;"2QFCM0IDB)=75@
MI(R#@@XZ<4 2/X]TD6FG310WTTE_++!#;QP?O1+'G?&RDC:P((YXXSG'-,D^
M(6D0:8EY-;W\;M?_ -G-:F#,T=QM+!"H)SD 8P3G</6N16VU+1=;\-WUQILK
MW5YJVI7S6,;*9(TDC;"@YVE@N"1GU JW_8.KZAJ4&L-IDT N?%$-\;>0KOBM
MX[<Q!W ) )(SCD\B@#I8?$<$GBZ.VFGU"U=M'-\^GSP($C428+L1EMXZ;02,
M>]-'CRUDL[R5=*U.*:&R-]##/"J-<0C +)\W09&0<$9'%9NMZ1KK_$6]U;2X
M"/\ BF);6VN"1M%T9=R+S^!]*Q['0]2DU59XM'UF..YT2ZL9)M2NS*_VAMC9
M8-(VQ3M(!7&3V P: .FTWQV+G0M'N9M(U"34=0MA<"SMHE+;0JEI!EL!,N ,
MG)R.,UTNF:C;:OIEOJ%FY>WN$#H2"#@]B#R".A':O,;;1KXVOAR^OM$U]4L]
M)&F7$%E<F"=)$V$.-DB[HSAAU[ XKT/PS8)IGARRM4LGL0J%C;27!G:-F)8@
MN<[CDG)H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK
MD-7U/79O'UKX?TR[M[2V?3C>2S20>8PVRA<*,CKD#GIS0!U,%W;7+S);W$4K
M0OY<JQN&,;?W6QT/L:62Y@AFAAEFC268D1(S@-(0,D*.^ ">*\XC\3ZJD/BM
M[6"&+['K@MGGM[(R-%!A=TK(O,C#/7\><51UKQ5;6,_@_7]3U>UU"SM[R](N
M[.,CS%^SN%4IVDR=N/7'3L >M45C>&;G4[_25U'4WMPUY^^@@MR&6&(C*KO'
MWVQR6'&3QQR>,U7Q1XG@T_Q)K%M=6:V^BZF;>.U>WR;A!Y>0SY^7A^"!UZT
M=CJWA'0M<N_M6H6 EF,?E,RRNGF)G.UPI =>3PV1R:V8T2*-8XU5$4!551@
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M':Y&!@L#T%;M%% !1110 4444 %-,:&02%%+J"H;'(!QD9_ ?E3J* "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQP15:37]'AU=-)DU6R347QMM6G42G/(^7.: -&BN,@\9W-U9>*)%33;1]'U
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M,7CFUUJ2(7M_9PM:Q2_?N8_LBJHC'5L2!^G0\UZYM&",#!I"BE@Q4$CH2.E
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MMWJ<[-XH>TC>&Z*N 9L*I)ZH.Z^E=/J_C[^S1K5S#HMU=Z=HY*75U'(@_>!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5FW7A_1KW
M4HM1NM)L9[Z+'EW$MNK2+CIAB,\5I44 %%%% !1110 4444 %%%% !1110 5
MFW/A_1KW4HM2NM)L9[Z+'EW,ENK2+CIAB,\5I44 %%%% !1110 4444 %%%%
M !1110!G:?X?T;2;F:XT[2;&SGF_UDEO;K&S]^2!S6C110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:HX^7=N7.>:@M4NH_"^F^(FU34GU#^WQ;@M>2&/R6OC$8RF=I&TGDC/3G
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MKC5?)_TT0&V$NX_ZO=NVXSCJ,YQFK=% &3%X:TB&PT^RCL]MOI\XN+5/,?\
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M&.G' QR\'@>^DUNRWZ/8V4%KJ7VUKJ&]E=&56+A8H&R(BQV[L$#@]>*]+HH
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M7/7G)9N#D<\5$O@W04UC^U!9-]H\XW 0S2&(2D8,@BW; YS][&:WJ* .<L_
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MA21L[G6(ML5CN/('<^M067@3P[I]S;SV]E(&M9?.ME:YE9(&.<^6I8A =QX
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2RQP1/+*ZQQHI9W<X"@<DD]A2HZR(KHP9&&593D$>HH =1110 4444 %%%%
M!14/VNV^V?8_M$7VKR_-\G>-^S.-VWKC/&:FH ***ADN[:*YAMI+B))YMQBB
M9P&DV\G:.IQWQ0!-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %>?^(-(TW6OBSH]KJEA;7MN-'N7$5Q&'4,)8P#@]^3
M^=>@5S.N>%[S4?$5GK>G:R=.NK:VDMO^/99@RNRL>&/'*B@#G+\6GP\\76AT
MB-H=+O=.O)[G3XV/E*T"*XD1>B$Y*G'!XXJ#3_&'B#4(O(LKZ"^O;O3I;B-5
MTZ2)+6X50RQY;AT;)7/7(SWKJ;#P9$EW>7^LZA/J]_=VS6C33*J+'">J1HH
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M(R%^0!!OQCG!;UYSGMBM*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ JI)=SIJ<%JMC,\$B,SW09=D9'12"=V3[#%6ZX+6B?^%S>
M&QDX.F7?'XK0!WN1G&>:,C.,\UXYX?TFRL/#'P\UFWA"ZG/>PQ2W>?WCQO'(
M"A;J5P  .@P*V/"5AH<VFZ5X@U*7R?$$VI3(]RKXFEF\R13 W<J%&-O0!0>*
M .R\-^(K?Q-8W-U;0RQ+;W<MJPDQDM&V"1CL:V:\7\.-LTS2&+;5_P"$VN 3
MGU68#]<5<\07$=SKGB2V:;-A/KFE6MZ5?"^450.I(Z G"GZD4 >AS^(%35M0
MTRWLI[FZM+)+P)&5'FAV=0BDD#.8SUP.16I!*TMK%++$T#N@9HW()0D<@D<9
M'3BO(]>L--TJ[^(5II4<<$,?AJ/=!#PD3'SSA5'"\8.!W.>]:&D:/8:YXBT6
MWU2V2[ME\*6S^1,-T;-OP"5Z$C)QGIF@#U'I17CWA>TM=;N/"FEZVBW6GQ:9
M>O;P7)W(\L=PL8R#]XK'TSTR376?##R?^$;OA;S-/;C5KT12LY8N@F;:<GKQ
MCF@#M<C..]&:\4CT_3H_ MSKMN%.O6_B!TM[@-F6-S?8$2GJ%*L<KT.XG%:!
ML5CL_B/KUO&S:M975TMG+DEH/]&3)3T)SR1UP/2@#UL$'H:*\C3P9=7=M=6=
MI'H>FK=:07AATZ]>1YYD='@N"&C7.&!!?DG?S1<:[=>+K>^\0V&]&T3P](\:
MKP4OYHB6 ]T50/J] 'K@(/0TF1SR..OM7BNHZ/<:9X6U:Y@BT.PMI_#EP7AL
M+UY9+OA2D[*T:Y(RP+Y).^N@O/#^EZ;XJTVWMK.-8]2T6]%\",_:BGDD-)G[
MS99N3SR: .WBUI+VVTV\TRVEOK*^((N(B%6-",AV#$''T!/M6I7BFF6EM9>'
M?A2;2&.'[1>QRS>6,>8YA.6..IX'Y5?O3-:+JOP[A=D?4=43[*5."EE/NEE(
M]EV3K^(H ]<R,XSS17C[:5?WVI:S>Q0:);7%GK*PP:C=WCQSVR(T8CB51&0$
M92!MW8;><]:[/XA/_P 2;3[>5RMC=:I:P7I#;086?!4GLI.U3[&@#K,C&<C'
MK2]:\WUG3O#NG[O#^D6D5R][J4*/I;3F*TAD\II/G 4X4K'N* '<<<#-<V+9
M+O1;+2I/)2UC\:"U\FRD;RDC,1+1H>"%RS#C'4XH ]KR..1STI:\CUO06NO$
M.NZ=;Z?HJV>FZ= MF][=O!]@C*N3+%M1@OS Y;(/R 5V^OWAL/AW<SZBS7+B
MQ5)FM9MGFNP"DJ_\()/WL<#F@#I00>AS0"#T->'ZO:/I<'BO2H[?3]-7[!I\
MC6VERL8XY#<D;N57#[=N3CD!36IXMLX_"U]XA7P]#]A\WPS+-(+?(W.LH7S#
MZN%9OFZ^] 'I5UK,-KKVG:0T;M+?13R(ZXVJ(MF0?KO'Y&M(D 9)Q7G$&CZ%
MHWQ*\+PZ'%! DFFW;M' ?E9?W6V0@=2W/S=3CVK1UZRLM:^(NG:5K4,=QIO]
MESSPV\XS'),)$!.#PS*AX]-Q- '2'685\2#1#&_G&S-YYG&W:'"8]<Y-:72O
M,+'1- UCQEIEHK'5=(BT*00_:6,BR 7 4;L_>"\@9] >P-9&F:=;ZQ'X!TV^
M#36?G:K"T3.</'&S!$;U4!5&/08Z4 >RY''(YZ4I('4XKRB]TK2;VT\>WFK1
M1"]TMVBLY'.'LH4MT:$Q'JF6).1C)]:?8:/;>)-8UM_$%HMU,NB:>[1S#(25
MHY=S8[,".#U'..M 'I,MW.FIP6JV,TD$B,SW2LNR,CHI!.[)]@:MY&<9Y%>/
MZ3=W<^O_  ]N-[373^&9GRQR7?RTY/J<UM>!].\/)I?A763/Y>NW\!,DJO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK
MF-0\0ZK:>-](T@:?$FF7CR1&YDDR\C+"TGR*.BC !+=3G XR:6H>(-=D\5ZA
MI6FW.AVL%HD&&U!7+2O(&.%VN!Q@?G0!VE%,A\T01^>4,VT>88P0N['.,\XS
M3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** (YXVFMY8EE>)G0J)$QN0D
M=1D$9'N*HZ-I=SI<,J7.L7VIEVR'NQ'E/8;$48^M:5% ' >*M:$7C;P^ZZ5K
M,\6F7$SW$MOILTB8>W95VLJD-RP''3FH_$7]@R:CJ9U/P3=7EQ>6J""YCT]K
M@W(*8V9"GR64\?,1V.?3T.B@#%\.6&H6W@O3+#4;B1=0CL8XII58,RR; "<G
M()![G.<5/HVEW.EQ2I<ZS?:F78$/>"/*>PV(OZYK3HH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>exhibit1061-loanandsecur001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#F+SQO9VNMWNDQ:7J][<V6SSS9VGF*F]=R\Y]#6OH^K#5[9YQ87]EM?
M9LO8/*8\ Y ].>OL:X2SL]8NOB9XS.EZY#IJJUEY@DLQ-O/D<=6&,<_G6GXJ
MMI;7P/--JVL?:=3M9EFL+NVMA&XN,XB14!.XDG:1GD,: .D\0:W!X=T:34[F
M*26*.2-"L>-V7D5!U]V%:,CE(G94,C*"0BD98^G->-ZD&O\ X;^(KW4F>/Q%
M/J5M%J48.#:E;B,1QIR?D"$,I[[B>];FIZ18>'O'$,6DVRVD=YH=\;E8R0)F
M0Q[6;U8;C\QYYZT =C)XB2"^T*RN;*X@N=7$FV-BI,)2/>RN02,]N,\UHWUS
M+:VAF@M);MPR@11%0Q!8 GYB!@ DGGH*\G2UM-0T[X26NHMFVFM2KJS8$A^R
MC"GU!. 1WSCO5?7+>'25\9Z5IBB'2[>\TB2.",XCAE>9/,"CMD!"0/6@#V :
MA:G4VTT3 WBPB=HL'(C+%0V>G4$?A46K:O9:)8M>7\WEQ!@J@*69V/154<LQ
M[ <UR%MI6GGXW:A=FTA^TKH]O,LFT;@YDE0L#Z[0!]!7<S*A3+A25R5)'0X(
MX_,T 8B^,=(/A.W\2%YA8W(7R5\HF61F;:J*@R2Q/ %2Z-XFM-9O+BR%M>65
M] BR/:WL/ER;&R XY(*Y!&0>".<5YQIC+%\,_AQ<RL!;6^IVS3L3P@(D52?0
M;V6NLNKF!?B[#-YT<<=IH4GVN1F 5 \R; Q[9VL1F@#7U?Q79Z3J T];2_O[
MWRO/>"Q@\UHX\X#-R ,D' SDX.!5;4?'_A[3-*LM1ENI)(KU%DA2*)FD*$A=
MQ7^$ D EL<\=>*YZ'3KJ^^)?BZ(Z[=:6&ALYX?LWEAY$$97<2ZME58-P,#+'
M/:J6KZM<Z[\"SJ=^8WO)6A1YD0+YH2[50X'HP&['3GB@#U6B@$'H<T4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5F1D)'*MC(_+(KG;VQO=6\4(+BVO;;3[.+-O<PSHHDE;(8D!MPPN ./XF]J
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M$K[MJ[&(7JW'(]ZF7XE*JZY#)96TE]I>FC4Q';WF^.6+&67?MX93QT.<CUX
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M1"[JI)P,[0<<D#F@#FM8\'ZMJB:WJ$5U;6FKW\5O;QHLCM$D,3[BC. &._+
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M[MI%E@G19(Y%Z,I&01^!JAI/B/2M=N+V'3+HW#64S07#+$X1)%ZKN(P3]":
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M&H79<6]O&9)"D;.0H&2<*"35:+7;2:/29(H[ETU10\#K"Q504W@N1PO'KWH
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M33X;/5(Y4W9DN-/EBC.TX.'90I]N>:MZ)I$.@Z-:Z7;2S26]K&(HC,065 ,
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M;W;O/NW@*5W $8!()'3 [ 5*OA"S4Z$1>7N=$&VT^9.FS9\WR\_+Q_\ 7YH
MY.&\F\/^)_B'K+WEU<KI\%O.8&$8$V+=F"DA,@#MC'OFM&YUK6=(A\*:G)J!
MO8-7N8+2Z@:) J-,I*O&5 ("D="6R/?FN@M_"UE!JFK7SS7%P=654NX9MAC=
M54H!@*,#:<=>>^:BT[P?8Z>EA#]JO+FVTYMUC;W#JR6YP5&"%#-M4D#<6P#0
M!S.FWOB>_L/$.H-XB*+I5[?6\<(LXB)%C7Y-QQD$'!XZ\YSGA='UO7UN_ MQ
M>:L;J+7K4BYMS;QHJL+?S0ZD#=G(.><'/ %=19>%+6QT[5K**\O&CU2:6:=F
M9"P>3[Y7Y>,^G;M447@VRA&@A+R]QH:[;,%DZ;-GS?+S\O'_ -?F@#!M-?UB
M31_$1GU>"*:TUXV45Q+",K#F+Y455.Z0AF"@@Y8BM3PCK&H7NN>(]-O9)Y([
M">'R#<(BRA)(@^&V<=<X[X//-/E\ Z9-9WMN]Y?YNM0&I>:LBJ\5P,8="%X^
MZ.#D5?TGPO9Z/J]_J<%S>RW%\(Q/Y\Y=6*+M#8]<#Z#L * ,"[F\1:GXZU?0
M[+7CI]M#807,+I:1R,CNT@Q\P.1\HSG\,=:Q=-\4>)M;B\'Q?VBEE/J$M[:7
MK1VZ.&>!9!YB[AQRN<=,]B.*VETZ[NOBIJMTDFIV4#Z9! EQ%!A)&5Y"R[G0
MKP&4@^_!ZULCP;IL<^BR6TES;+HV_P"RQQLNW+@JY;<"6)!.23W)Z\T 9.F7
MFL:QJFMZ*NMRPSZ-'!;_ &E+>(-/,\>\RNI4@+R %7'1N>F.=O-6O?%?AOP#
MJ\]Q+9W%QK4<4L<"IM$B"=2Z[E)ZH< DC!Z'K7?7/ABVEUJ;5[6[N["\N(EA
MN6M64"=5^[N#*PR,D!A@XXS45UX/TZXM='M(9+BTMM(F2:UB@90 Z@@$[@2>
M&/7KDYH P[K4_$6KW&O6>AW,L=SI4JVT#'R=LDGE(^Z4,N<,6Q\N.!D<](-:
M\4ZGI>HK'K%Q/I-M/!!]FOK>))K03$?.DKE25RQP#P,<UN:AX%T^^UY]8COM
M4L;J9%CN_L5T8EN@HP/, '4#C(P<=ZGO?"-E?1WEO)<W:V%XJ+/9(R>4RJH7
M RNY<A0#M(H PM1\37EAXN;3]3N[O3(9KR%=/G\A'M+F/Y-T;/M)60GS!R1_
M#CWK:IXRU/03X[GFF2Y326M5LD>,*L9F1?O8Y(#."<GH*ZBY\*6EXTR7%W=R
M6<URET]FS(8MZ%6&/EW 913@-CCW.6MX/TR:XUR2Z,UTFM*J7D,Q780J[5VX
M (P..OOUYH S;Z_U;0O%FA:>^HRWUIJXFMW,L48:"5(RZNNU1D'!!!SVKG-.
M\0^)?^$;\.Z[<:T9C<ZR+">V^S1JDD;7#Q9) W!A@8((''(/)/<V/AB"SEM9
MI;Z]O)K.)H;22Y9&,"L "1A1EL #<V3COR<TH_ >GQZ)9:0E[?BVL[P7L/SI
MN$H<R#)V<C<2<>_I0!A>(/$>L:=-<W5OJ7GK!K%O;&&WB0P1PNT:%)&9=QD^
M9B=A./ESBM6P_P"2O:W_ -@BT_\ 1DU/N?AWI5TE_&UYJ:0WMV+YH8[C").&
M#%U&.I*@D'(] *UK7P[;6GB&?6DN;IKB:W2V='<,FQ,E>V<@DG.<G/- %&]U
M.YO?&O\ PCEO>/9+'IWVUY8E0R.6D**!O!  P2>.I7ISG/AU76AKFB^%K_48
MA?R64UU>7MI&H\S8X150," 3NRW';C&:UM>\(6.O7]IJ+75]8:A:JR1W=C-Y
M<FP]4.005/H1]*=<^$=/F&FR12W5M=Z:6-O=Q2 RC?\ ?W%PP?=U.X')YZT
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MGY<$X]1SWS7":_X170O#GA[1-);5KBUMM9MYP50S/;1JQ+,"J< $YP<^P[4
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MD]2:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO$'@VV\16NE:=-YZ,ZV0N'1R%8K@.5(R=O&0![BM[P]XGT[Q'X=BUNV<PV[
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M-H$C>:GE_4<<>WM0!WZWEL]TUJMQ"UPHRT0<%P/4CK227MI$VV2ZA0[Q'AI
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M+] TFT>SF@OIIH;G#[I(BD3., ' Y7O[UQNOJ=*\4^*H/#$<5O=OX726.*T
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MHKB'&Y;3RF\]7 Z $*#G^+'>@#T7^T++8'^V6^PG ;S1C/IUJ43PM*8EE0R
M;B@89QZX]*\EU30+MY?$7@S3K94)G&N:=.8_EBSEM@[ ^>FW']USZ5?U2_NM
M7^'-_P"+8K.>.2\2VWQ(G[U;..13*N".<YF/NI% 'I$-]:7,;R074$J1DAV2
M0,%(ZY(Z4Z&Y@N"PAGCD*XW!'!QD9&<>HYKRW4T\*:IHOB;6=,U@ZG)+H,L<
M^/*\A JDQ[U5%Q+DG;GD 'VKL_!.F:7:>&=.O-/M;>.6[LK<SS1*-TQ"<%F'
MWCR>3ZT ;HO;4W9M1<PFY R8?,&_'TZTIN[83"$W$0E+; F\9+8SC'KCFO&Y
MM9TJ1M!N[6XMK2./Q4[2V\C[KB,LTH=Y6)^7<>BXZ$#)K6T;2K"ZO?'LVG6=
MI+JMK?R26!"*6AE-LNTI_=)8GD=2/:@#TZ.\MIKB2WBN87FC^_&K@LOU'44Z
M>X@M83-<31PQ+U>1@H'XFO,O"$OAG6Y_#5W:ZO=2:Q80M&;%!$DD.4Q*LRA
MVT$=6/+8QDFM?Q+K%KHWQ%T:;7)4@T:2QGC@GG.(8[HLI^8GA28P0"?5AW-
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M!('6@#T-[^SB$)DNX$$^/*W2 >9G^[Z_A27MW':PY>XMX9'^6(SN%4MV'O\
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M-C Y YXYW:* $(# @@$'@@TV.*.($1QH@/7:,4^B@"*.UMXHVCC@B1&.654
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M.*LT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB&!Y(_-SMR 3SCF@"Q-=VUO+%%-<11R3-MB5W +GKA0>I^E35Y/-=:C>Z/\
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M9'!SQAP?$*YU"+PZ^GZ3&6U6XGM98Y[C:UO-$KEE.%((RGWO3MVH [RBN?\
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MBU\;:K(-8O;G2K2#2M&N[F"]E%TS/MBC#AD78-Q)/0XZB@#N:*XZ'QC?0ZE
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MTNXOV1IY;6)RZL6W90'))'4]ZV* "BBB@ HHHH **** "BBB@ HHHH ****
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M/3Y%49/0=S7:1[S&OF!0^.0IR*JZ5JEIK6E6NIV$HEM;F,21/C&0?;L?:KE
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN-OG&,)M)&/E8%F!QCFH+'6;^72[N&?6)E=/$T]C&H7=-/"C'$*$8P2!]X]
M"21UKJ)_!>C36VFPI'<6W]FL[6TEM</'(N_[X+ Y.[OZU7/P^\/BV:&.&YB_
MTXZ@KQW<BM'.<Y92&^7@D8'7O0!Q]WK^NQ^"?$DT>HW-O<Z;KR6D#/L=Q"TD
M V.V#G E;D'/3DUJ7LFI6GB'Q'HCZS?7%M)H7VY'=E62&3=(IV%5&T$*..W:
MMV3P!H$EK?6QBNA#?7"7-P@NY/FD7:0W+<'**2>I(&<UH'PWI[ZS+JL@FDNI
M;7['(7E)5H<D[2O3J2<]>: */P]A,/P^T#,TLGF:?;O^\;.W,2\#VKH9X_.M
MY(M[Q[U*[XSAESW![&J6B:)9^'],BTZP$PMXAA!+,TA4 8"@L20   !T%:-
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M0["PM[Z&TB,"WT\EQ.8S@M(_WFSV)Q6=%X*T>"QTFRC%RMOI,HFLD^T-^[8
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MT((X(J"]U;3=.95OM0M;5G&5$TRH3SCN?6K$$$-K D%O%'##&H5(XU"JH'8
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M34VUW1TV-9.AC-FP39)N(4?*<8&3SD=Z /2(-6TZZNFM;>_M9KA028HYE9@
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M5-%6VGD+6$]M+M$L6W.2&)&X<YP2,"MJ;7-)MY;6*?5+*.2[ -LKSJ#,#T*
MGYNHZ5Y/XIO?[-^)GAW4]1O)K;0+G1S:1WL2"2..1B2P.58#(VC./Y&J'BG1
M--T^X^&.D0275SIMO?29:]'SF%I$(+\#"'D#('% 'K\?BGP]+'!)'KFG,EQ*
M886%TF)'!P57GDY(X'K4L?B'19K*6]BU:R>UAE\F299U*+)Q\A.<;N1QUY%>
M7_%K1],L5\'Z?9V4%M:-K:RS10($4*2-[D#H.>34OQ/T^'PU-X5U+3+(6>B6
MVJFZU V,"X1V"A92H!!( ;DCT'<4 >G-K>E+I1U5M2M%T]1DW1F41CG'WLXZ
M\?6N2\/^.KC6OB=JOAV-["XTNVLENH+FW!W,24&"=Q!QN(X Z5P?C'2K6S\,
MV.JZ1=W^HZ')XC74]0DE0;#NP690%'R9R.F,FMOPO>6M[^T'K]]9G?:7&E1K
M'.J$)*W[H\'&#P#SWQ0!ZAJ^HII&BW^IR1M(EG;R7#(G5@BEL#WXKD?#OBO5
M_$7A_3M:TZZTJ^6>:%;NSAC</:J[@.-V\Y9 3G*C.,C X/5:]??V9X>U*_\
M(^T?9K62;R<9\S:I.W'OC%>+:QX3TO2M9TSQ#\-]2DM]4N+N-'TF-SRC'YMR
M'YD4?Q!N /3B@#NHOB&;3XD:_H&M7&FV>EZ=;QS174A,3$N$(5BS8/WCT SB
MNTFU;3K>RBO9;ZV2UE ,4QE&V3(R-I[Y'I7BFN)!)\2OB7+(B,&\/-'"[#.7
M\F,%5/KGC YI+/4;>P\$?#0RVEPUZL[I%=J)'2T.<-NC3EV((PI]#VR" >S#
MQ%HK:2-5&KV/]G$[?M1N%$6<XQNSC.>*=;Z]I%U/+!;ZI9RRPPK/(D<ZL4C(
MR'.#PI&#GWKP+3M\?P5^(%E*LXN/[68K'+$58Y:+'&!S\IX'ITKJ]?\ #49^
M WG^']/B_M.?2[5;B6WC'G3(I1I%)')/WLCV(H ]2M]>TB[M9[JWU.SE@MUW
M32K,I6-<9RQSP,<Y/;FLG6O$%Q<:!<7/A.[TR]O8&0F.5RX8'^#"<AFZ#->?
MQV7AGQ5X;U+5QK.JN+W2X;&\*PJ$M<2)MRJHN65L\ GY0?45N?"FZUII]<T_
M6)[;4?L#0PPZQ;G<+M-K$*6Z,5!&3U&[!)Q0!TZW7B1]>U.W5-/-G'#'):,
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M,8F5B&4JQ!^ZW<=/I2:=XTM-0U33K(Z??VPU*V-Q9SSQJ$F"J&91ABP(##J
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M9)EAM?Y_E/RMZ],=>* .JHK%N/$MK;/=K+!<*8+E+5#\F)Y64,%3YNP()+8
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M/@OQ?HT6D6\<FI:@;BT2&X79M;R^.0, ;#[^W>O3YYHK:WDGF<)%$I=W/15
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MTH0&_NXK?[1*L,(D;!D=C@*!W.33H=2L[C4;G3XKA'N[54:>('E ^=I/UP:
M//-2\*^(M8MO'4;V5O;-K26YM-UR&Y2-05.!QTQGU]1S6]>:9J>N:WIVL2:<
M;-M+M;GR8+B1'::>5 N#L8@( #U.22.!BNOHH X'P]X:O-$UB>ZTW3[K3=+F
MLG\_2FN4DB-R2"#" Q"#&_/*@Y7CTS=,\+^(M&TSP7?0Z>L][H<$MI=V/GH#
M)'( "T;$[<@J#@D9]J]0HH \ROO#GB*^T7QW!_9:QR:VZM:)]I0GF)$^;L,;
M3GGZ9ZU?UO2?$6IW<]N^G)<Z;/I/DP12W*HEM<88,TBC.\\K@C.,=LDUWU%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ%P0=Q.?D'KU-=4[K&C.Y"JHR2>PH Y#PU>/;^.?%6@C_CVA:"]MU[)YRGS
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MX!!_6L9?$/B2P\5:3I^IIIKV>M12BU>W1PUM*B;]KDM\X(SR O/I5OXDL?\
MA6>NH^!+)9.BJ#G<Y'W1ZU/IVBO?2:5JUUJ$5W)96S+9%(=J*SJ%+M\QW-@8
MXVCEN.> #GM+\9^(I/"=OXDOTTPVUP?LT=M!'('\]KGR4;)8C9R21UXZ\X&Y
M::AXGEU'4+2>VB2T%J)K;4'MB@63.&C:/S"3QR""/?.*9;> [=? 3^$[R]DG
MMB69+B-/+D1C(9 PY(RK'(^@JYI6@:M9VLPU#Q%+J5V8C##-+;)&L:G&244C
M<QP,DGMQCG(!Q_@_5;G3O G@V)EM[B]OX_+M7%L6:!1&SN3\^7)"XX*]<GI6
MAJ/BKQ9I6BW%Q<:=:K+%J<%M!+-&46YAE=5W!0Y*,"Q!SD=P.U73\/1_PB6D
MZ,FKS0W6CNLEAJ$,062-@"/F4DA@02". 15B_P#!U[JFB+97VOR7%V;F&XDN
MGME&3$P9%5%("KD<]2<GGT *-_J_C&QU[2=%,VB//J2W;+,+>4+&(PI3(W\_
M>Y&>W6B?Q+XDN+?4DTJUM[F^TMUMY(UMV:.YG$:/( Q<;%^? SG&,G/2MZ_\
M/S7WB71]9-\J-IJ2H(A!D2>8 'R=W'W1CT[YK/N?!EVOB.[U71_$-UI<>H;3
M?6T<*2+*RC;O0L/D;  ) /2@!%U[4M;O]6T_3U@LFTVVB,XN8S(3-)'O\OY6
M  48R><D\8QROPP_Y)EX=_Z\DI[^#9+;Q!<ZKH^JR6 O8(X;V Q"59=B[4=2
MQRKA>,\@]Q6EX6T+_A&?#=CHPNY+I;2,1K*Z!21]!_\ 7H P_#/B^?7=6^QR
M7-K!=PM(+W2Y86CN(,'Y2I+?.O3+ 8.0>.E<SX-UG6-$\&^$9%-D^F7NH&P>
M$QMYH\R63#A]V!@C[NT\=_3LH/"4W]HZ5?WNH1W5WI4<B6LYMMLAWH4_>-N^
M< $\#;D\U2@\ R6_AW1='75@4TF^6]CD-MS(RLS!6&[IECT]OQ (=6\7ZMI6
MI()!9>6VL0V/V5$:1A!(RJLC2*V$<D[@K <<>]2Q:]XBN?%6N6,;Z7%8://;
MM*[Q2%Y(7CWL!AL!P.AZ<=*9/\.Y98;JW37[F.WDU4:K"GD(QCE\P2$%CRPR
M..F.^:VM+\-OI^NZSJ4MZ+E=5\KS8FA"[?+38.<\Y'7CKTQTH Q],\2^(M2?
M0]0M]-$VF:CM:>,0[&MHW7<CB0OA\< C;SGC%/\ #/B^?7=6^QR7-K!=PM(+
MS2Y86CN(,$[2I+?.O3+ 8.0>.E3>'_!5UX?DCM8_$5Y/HEN^^VT^2),Q\Y"F
M7[S*#T''09R.*L6OA-_[4TG4-1OUO+C2E=;>86_ERL&4K^\;<=PP3P .<$T
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M5$9!Z@KC'-,U+7=.T=6-[<%-J>8^V-G*)_?8*#M7W.!3+KQ%I-I")I+Q6B,
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MQ(VD81KC<Y"@D*,CD\42Z[IL4%O-]I$L=S%YT)@1I=\> =X"@_+\PYZ<CUH
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M6!X0F6VNI(;=KLS2Q6[ND8:':NY@"!D\5BPPW5CH_C;0=1L+N>ZU"ZNIK,I
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M(X]:U*.&82S;75DE4-%D X!/!;G@].:Z'6?B/'I-[J-B+&*6ZTJQ6\U!#=A
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MNY)9/,N(E=BJ-\GR;5;  )'';N :5CXPO8=0\63ZO#!%IVD3K&IBF+-CRU8
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MT*<QW>G1KJK[?^6AC?,<1'^V5<_\ 'K6XOB[3?\ A"HO%+,QLI+=)@J<L2V
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ME\I5C?.P$X;YFPV!C^$Y(XS7?QI'Y%B@M%M;^ZM?M1M=3G%J85SC:Q()W$Y
M '8GCOD0^%_$VC:EIVJZ.VF2W']F0Z=?VMS,ZQMY>=DB.$SGD\$=#5O4] \3
M0:W8>(-'N["YU!;4VE];W>Z.*9"^\%"H8J58D#.>.I]0#?\ #6O1>)=!M]4A
M@EMQ+N#0S#YD9201[C(X/<8-:U5=.CO8[)/[0EBDNVRTAB!"*2?NKGG Z9/)
MQGO5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB%T/+U>QFDN4,:D%UA5PPXR.6/&<4 =M574=0MM)TZXO[QG2VMT,DK)&SE5
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M[4 .A\1Z7<:Y-HT4\C:A"H>2'[/(-BGH2=N,'L<UJUPVD_\ )9O$?_8+M/\
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MT"BN+MM2UWQ';:I>Z/J,-I)9:F]I%;S1J8G2)PK^8=I?+#<1M(Q\ON3##?\
MB&]\9^(+0:S';V&DRVLPC2S5VDC9"[QY)XR!C=UZ8QR" =U2 @D@$''!]JX/
M2-7\4ZU;Z#K5F'^Q7Q5[R"4P"*.%QP8B,OO4D<-UYX'2L_P_=:G9^&-=NQKI
M\X:[/;^=>A3A1<!"5"IEI"HPJX(S@ =J /3:*\QO_%>O6NA^.3#=NL^BB.6T
MFNK=/,VO$'PRKA>O3(S@\C-:&N7/B;P]I<.O3Z[]IL4NHI+V".SC7RK9L!]I
MP2=I.[)YVY],T =]16/I5W<:AJNI7"W)?3HW6"W0*NUG49D<,!DC)V]>JM[8
MS3JMYK'C'5M"M+V2PCTVUAD:6*-&>227<1]\$;5"CH,DGKQ0!T5]?6VG6C7-
MW*(XE*KG!))8A5  Y))(  Y)-5M*URRU@77V8RI):2F&XCFB:-HVP#R".F""
M"."#7FVJZOJ'B7P7H=S=SO:WD'B*WLKD6ZKY<DB7(3>-P)[9 SC).<UZ?<6T
M;:3-;7EP[Q- R2S.0K%2""Q(  X] * ,U/&&AR-;[;J41W,JPV\S6THBF=CM
M4)(5VMD],'GKTK<R-Q&1D<XKRN.\UOP!;V.C^)[:/5O"\<T$5KJT VR6VUU\
MH3)Z A?F'IW)Q6I92:A#XW\<SIJS9M+:W:!+PH($S%(RAR%RJ*Q)X(/7.: /
M0:0$,,@@CIQ7!:-K>JW?BE-&DU&YEM[K1#=K=-;QQLLH=4+1?(/D._(WJ>@Z
MBLKPEK>H6O@GP?;"ZN[F[UHN6D/E%XPJN[;"P +$@<MNZF@#U.BL'PRVO!;Z
M'7 &"3YLY6*"5X2./,"?*&!R,C /I69'JFJ>(=1\26VFWYL#I,JVT $2.))?
M+#EI-P)VY8* N#@$YY& #I[_ %&VTV%)+ER/,D$4:*I9I'/15 Y)X/X GH*B
MTC6+/7+(W5DTA19&B=9(VC='4X965@""#7G-UJMSXLMOAUK/VB>R:]O27AB"
M%4D$,P++N4GL0,Y&#TSS79^.6N(/A]KLMM>3P3P:?-(LT>T/E4)],#..<8//
M&* -"XUW3[76;#2997%W?J[6ZB-BKA%W-\V-O [9SR*TJ\RN;:[&M?#N&*_?
MSVM[K$\L:,4!MUZ  #@=,@^^:FLO%VK1:<;&YF-U?'Q#+HZ721QH[(JF0-M.
M$W[1M';.#@]" >CUFWVNZ?I]VMI,\SW)C\WR;>WDG=4SC<0BD@9R,GK@XJCX
M<;Q MYJ<.L O:*Z-8S2F,3,I'S+((_EX8<$=0>:Q/$>D^(K#Q--XF\)2VUW.
MT$=O?Z5<MM$ZIDH4?^%P'/7CF@#K]-U6QU>P6^L;A9K9V9%D&0"58J1S[@BK
ME>4ZEKL?B#PIHUSI;7NCL?$D%O?6F%#QS&<,ZME3G#'<.QSR.U:7C'Q!K.AV
MFN3VFJ>;)IEK#+##%"C]LNUR2H"[NP0@XY H ]#R-P&1D\XI:X*:>Y3XK33/
MJ-V+6'01=BW4(5'[TAE&5S@[ <YS[XP*=HVJ^*-630-9MU9K&^59+V"8P"*.
M-UR#$5._<I(&&SGG@&@#NZ*YWQ5KDVE2:-96S".?5;]+03%0?*7:S,P!X+87
M SQDYP<8JA!J6IQ^,-2\+7-_+*C:<NH6EZL<8EC7>49&^78>1D';T)Z]: -B
MV\4Z5=ZI!80RRM)<K(UO)Y+".;8</M?&#CZ^XS5F_P!;T_3;F*VN)F-S*"T=
MO#$TLK*.K;$!.T>N,5S?PIADC^&NAN]S+,)+565'"XCZ\# !_,DU3\#2/=>/
M?'=Q=\WL5[%;J&ZI J$Q@>@.2?<\T =A8:WI^I74]I;3,;FW57FADB:-XPV=
MI*L 1G::M7=U%8VDUU.6$,*%W*H7( Z\*"3^ K*\2%K#2K[5+*:RM-06W$:W
M-V2(U4-_%CKC<<#U..]<_I^M7]UJOBC2;F:XFM;;3XKBW>ZA2.7$BR!@0H''
MR C(!'.: .E@\1Z?<V&E7L)GDM]4*BV9('.=RE@6P/E&!U.*36/$VF:&)3>2
M2GR8A/,(86D,41)&]@H.%R#^1]#7%:+JNH:9X.^&L=I.B6]\;>UN$,8)93 S
M<$].4'2IX99-+^(GC+4Y;ZZDBLM,MKEH@L>'4"=MGW,X&#C!!YY)H ]#C=98
MUD0AD8!E([@TZO/I?$>LV'A[PSXEDO!<PZG-;)=V?E($C6XQ@Q$#=E2R_>)R
M,]*?I%WXHU;4->;^W888=+U.6W6(6*MYJ>2K $YR,%@<YSUSQC !WU5+348+
MVYO+>(2A[2012;XF4$E0WRDC##!'(KSW1?$GB)[#P1JUYJ:3Q:U(MO<VHMD1
M?FB=PX8<[@4^F#T[UH)X@UDP>,4?4K**33KZ."VGN(]D<2,D;'@ EF^<XSG)
MP* .]HKD?"VM7]YXH\0:5=2W$MO9I;2V[W,2QRXD5\A@H'&4R,@'GFNNH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q/%.AMKFE
M1) RK>V=S%>VC/\ =$L;;@#[$94^S&MNB@#G;GPY;:QJ]MKQGU&PNQ:FTFBC
M<)YD1;<4?@]&SAE(/H<5%I?@N'1;&QM-/U?4XH[.%H$W/&^]&(.&#(1Q@8P!
MWZY.>GHH HZ3I-GHNCVVE6<>VTMXQ&BL<\>_UKF4^&NG16,>G1:KJT>FP7:7
M=M9K*FRW=7W@(2F[;GL217:44 <I-X"L'URYU.WU'5+-;PAKVTMKC;#<L!C+
MC&02."5(S6E_PCD \4_\) MY=K<_9?L@B&SRA%NW8QMSU[YK9HH Y.3P#82Z
M1?Z8^HZCY%]?_P!H3'=%N\W>'X.S@;E4X]JNS^$K&\UFZU*\GN;EKNQ_L^>"
M39Y;PY)Q@*#G+$YSWK?HH Y?1O MCI-NUK+J.IZE9^4T$5M?SB2.&-AM*J !
M_"=N3D@<#&3FM;_#NSMX=+M_[9U>2UTJY%Q90O+&1#A64)G9N*@,1R20!@&N
MQHH S==T2U\0Z1+IMXTJQ2,CAXFVLK(P96!YY!4'D$573PQ9R/<RZC)+J4]S
M;&SDDN0H_<GJ@"*H )Y/&3QSP,;5% ',Z!X+M_#^U8M6U:ZBA0I:Q7=P)%M0
M1CY!M'(' +9P..YS%#X!TR#0+/24N[[%C<F[L[HNGG02%BQ*D+@@EFR"""#B
MNKHH S=-T:'3[JZO#++<WMUL$UQ-MW,J@A5 4  #)X [D]ZR_P#A M!_L3^R
M?LS?9/M_]H;<\^9YF_'^[CY,?W>/>NFHH P/%FER>(=+_L(*PM[MT^U2XP%A
M5@S 'NS8V^V2>W.W+%YENT2.T65VAD ROTR"/TJ2B@#F]-\'0Z/I^F6=AJNH
MPIIT<D,1S&Q9'*DJP*8."HP< ^]:NC:1::%I4.G62LL$6XC<>268LQ..,DDG
MCCFK]% '/VGA&SMFUK?=7=S'K)9KN*8IM.4"'&U01\H Z]JIV7@*UL[G1[AM
M8U:XETA'CM6EE3Y490NT@( 0 .N,GN3@8ZRB@#DQX!L!H(T?^T=1^S"]^W!M
MT6[S?,\SKLZ;^<8_2EO/ =E<7NJ7$&I:C9IJT1COX+=T$<YV[=^&0E6QU*D9
M[UU=% '(W/P]T^4:7):ZGJMC>:=;"TBO+6=5E>$=$?*E6'?IUJS>>"K&>XTV
M[M;V^L;_ $]6CCO()%:21&.763>K!P3\QR.O-=+10!C^'_#EMX<CO4MKFZG^
MV74EW(;APQ#N<MC '%5Y_"=O)JNHW\&H7UJVIHB7D4+)MEVKL!!*EE.WC*D?
MGS7044 <;XCLK;4;)/ \&A7ALY880+E8MMM!$KCH^<AU"Y QUV]LUV$<:0Q)
M%&H1$4*JJ,  =!3J* .;?P>@\1W>NV^M:I;7EW$D,GE^04V+]T -&>F3SUYI
ME_X&L-4TF6RO[[4;B9[E;M+YI56>&50 K1E5 7 '  QR?6NGHH Y:?P/:WFA
MOIEWJVJ7!DECEENI94:9S&P9!DI@*",X '?U.;-UX/L+[5KR_O9[FY-Y8_V?
M/!(4\MXLDXP%!!RQ.<]ZZ"B@#DK/P%;VL^D2R:UJ]S_9#,;-9I8_D5EV%20@
M+#:<<DGWIVF^ =/TG4I)[34-32Q:<W TS[0/LJR$[LA<9 W<[<XSVKJZ* ,C
M0_#T&@OJ#07=U/\ ;KI[N43E"!(V-Q7:HP.!Q[5/KFC6GB'1;K2KX,;>X7:Q
M0X8$$$$'L00"/I6A10!DIX;TR/7[;68X EW;V9LH]OW1'D$#'J.0/9CZU"/"
MUF=9U74I+BZD?5+=;:XA9E\O8H8 #"@C[S=^];E% '+6W@6TMH=$B&J:FXT9
M]UJ9'C/\'E@'Y.@3CC'KUYK2TCP_!H]_J=W#=7,KZC.+B99BFT/M"_+A1CA0
M._2M>B@#%N/#=O-XD_MV.\O+>[-L+5UA=0DB!BRD@J>06)ZX]016=#X!L(-%
MTC2H]1U$6^E78N[<EH]V\$D;CLY&6/YUU=% '*'P%IZZW=ZC;ZAJ=M#>R>==
MZ?#<!;>X?NS+C//?!&>];^K:;#K&ESZ?</*D4ZA6:)MKCD'@]CQUJY10!A'P
MPD]Y93ZCJ=[J"V,OG6\4_EA5D (#G8BEB 3C)[YZ\U1A\ Z?;:S<WUM?ZG!:
MW4QN+C38[@"VED/)8KC/)Z@'![C'%=710!RS> ]/&N7>HP7VI6T-])YMY80S
MA;>X?H69<9Y[X(SWK1L/#T&GZ_J>KI=W4DVI>7Y\<A3RQL&U=H"@C XZ\UL4
M4 <KHW@+3]"O-]GJ&I_8%E,T.F/<9MH7)SE5QG /(!) /.,XID_P]TV:WO(!
M?:E$MQ?_ -I1^7,H^S7&_>6C^7NW.&W>V*ZVB@#D;CX>Z?=)K2RZEJC?VS$D
M=X3,AW;5VY&4P"0/H.P%6]=NGT[3(-'72M0UAKR%[<,L2M']W'[YA@(ISUQV
M-='10!G:#H\&@:!8Z3;\Q6D*QAN[$#EC[DY/XU5O/#4%QKJZU;7=U8ZAY'V>
M26WV$31YR RNK X/(.,_AQ6W10!SEWX+TZYT>PTN.XN[6WLKE;M/)9=SRJ^\
M,Q93DEB6/J36Y<VJW5A-:2NY66)HF?@,01@GIC/X5/10!S;^#X9[.WT^\U74
M;O38&C86D[1E7V$% [! [ $ X+<XYS1J'@K3=2O]6NIY[P)JUL+:[MTE CD
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MZ^<UR'W^825*YR.FW&. !56_^'FFZ@VK"34=42'5H4CO(4G7;(RH$$F2I.[
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MH;*A@LBX4!7&XXQ\H]*Z&U@^RVD-OYLLWE1JGF2MN=\#&6/<GJ:EHH ****
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M!RF>0I) /TR#^524 %%(3@$@$^P[UR!^(EBD6JW$FD:LEKI-PUO>W'EQ,L+
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M8(! XZ&J8FO-)TKPO*VKWTS>('MHKI[N\8(A%N[!4(&8R[;02.3CU.:ZW3_
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MSG+\]. .Y% '2!0HP !WXI:BMIC<6L,QC:,R(KE&ZKD9P:EH **X+Q-;Q/\
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M&?)"["%&48[@>=W(/;LX4T;PTUK86UNMH+Z=EBCAB;:TF"Q)P,+P"<G&:UZ
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M(P<A3TS0!=D++&Q1=[ <+G&?QKE/ NBZMX:\*OI]]!;/<K<33)Y,Y*L))&<
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MY4JR<$' # @XZ]>*Q_#_ (?BT+4O$&LWT=GI\&KR19M%D'EIM4KEC@#<Y8Y
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MJ&>)WAX8<@<2D'&,X]S737NK:Q<:QJ&AZ;)<-<:?:12M<1QPDO+)OV[@[ !
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M+NZ=>V3@XQ7:P^%=.M+C6[FRWVUSK#!KF:/:2"%V_*""/4\YY8FLD_#G3_\
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M%% !1110 4444 %%%<WXTMKZ[TZRBTV6T^U"[5TM;S/E7@5')B;'L"P[904
M=)6'XOU^7POX8O-9BLUN_LP#-$9?+R"0,YP?45P8U"&>#PQ-#83Z5/#XG-I=
MVTD@;RG*2,T:L.&C)*X[=..*I>*)HWTCXI0PR@PQRVFU%;*H3'&6P.@^;.??
M- 'LM([K&C.[!4499B< #UKSG4M*CT#QW9-I%Y<VL5_I]X^ILTSRA515V3D,
M3\P9L9[_ )UFPQR06>JZ%KNCV\=]_84[QWEH^^VOXUVYD8'D2 E3SG.3STH
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MI-LNL^ 2KW"G4["6.](N'!N%6W5PK<] 1T';CIQ0!ZI4-Y=V]A93WEW*L-O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGA.]N(+%=.\0*$\F,.987,)D#;R<,#M(QM&/4UH?$N]O].^'NK7>G7*V\Z1
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MANV@$@>N* .RHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-68 81<G:,*.YYR>]:=Y.]M9S3I$96C0L(PP&[ Z9/2J/AO61XB\-Z?K"P&
M7D"S"(MNV9[9P,T 9MQX/CN=?U>^EO&:RU>T2VO+(Q#YPJNH(?.0,.>,=0.>
MU1V/@^:.VT>RU'4Q?66CRK+:*8-DC,BE8S(VXAMH/8+D@$^_207=O=27"02K
M(UO)Y4H7^%]H;'UPP_.L;Q!XE.@ZAI-H;%[C^T[D6L3K(%".03\V>V >1GZ4
M 7/$.E2:YX?O]*2Y6W%Y \#RF/?M5E*G R.<&L"\\$7FJ>&+;PWJ.M*VE1QQ
M0RK;6GE23(F,*7+MC.T9P ?I6EK/B5M(UW1]*-@TTFJN\<,BR@*C(NYMV1G&
M/3-=!0!S;>%7L_$4FLZ+>1V4EQ;);7,$L!ECD$?$; !E(902.I!';O56/P,E
MI+X>:QOO*31YII\20[VN))0PD9B&&,[V/ X)].*ZZB@#"@T":'QG=>(#>HRW
M%HEJ;?R<85&9@=V[KECVK+3P'Y.F:AH<6H[=!OIGE>T,&9(U=MSQI)NP$)SU
M4D9//0C6T7Q =7U;6K!K-K=M+N$@),@;S-R!P>.G##UK;H P]8\+6>L:CHUY
M(S1-I<I=53@2(5_U9_V=P1O^ 8[TW1_"ECHUSK4L9:1-5N#,\;?=0$<H/8LT
MC?\  S6]6)I'B ZIKVMZ4UFT#:7)$A<R!O-\Q-X.!TXQ0!E^'O!VI: (K(>)
M;BYT:U.;2RDMU#1@?=5I0<NJ]AQT SCBM/PMH$OAS3I[-[Q;H2W4MR&$/E[3
M(Y=A]XY&2<4_5M;N]/N)D@TB:[B@M_M$LRRHBJ,M\HR<D_*3^59>F^,[K4])
MLM3B\/W(L[V%I89#/&>B%P&&<C(4\T :'B/P_-KTNE-'?);#3[Y+T P>9YC(
M" #\PP,,:2Q\/SVGBW4==>^CD%[!% \ @*[1'NVD-N/]\YX]*M>'-9'B'PWI
MVL+ 8!>0+,(BV[9D9QG S6I0!QL/@(0:-<^'EU 'P]-.9?LA@_>(A?>T0DW8
MV%L_PYP2,]"+H\+W":UKVHQZA&/[6MXX/+-L2(0BLJD'?SPYST[5TM% ''P^
M"9X+#PO:#5$*Z ZM&QM3F;$9C /S\?*Q_'\JVO$VA1^)?#=]HTL[0+=1[/-4
M9*'((.._('%:U% '-S>&[VYUW0]6N-522;3(YE(^RX$QE #'AOE VC Y]R:S
M9? 4\WA?5=$;5T"ZCJ#7SS"TY1FE$I4#?TW ?A^==M6)I_B WWBG5]$:S:(Z
M?%!*)C(#YHDWXP!TQL]>] %.^\(_VIXAGU*^NXY(+C2WTR:V6 KNC8[F(;<<
M'/MT_.D\-^&-5T7R(;[Q+/J5E:+MM(7MUC91C:/,<',A"G Z>IR<8L^*/$Q\
M,II[FPDNQ?7D=E&(Y%4B1\[<YXQQUS45QXOCTS4K.RUK3KG3A>R"&WNF9)('
MD/1"RG*L>V0 ?6@"UXFT!O$%E:11WAM)[2\BO(9?+\P!XSD KD9!Y[BJ:>%K
MJQUR^U72]56"748HUO%FMO,#R(NU95PR[6QP>H/'%=-6)J'B V'BG1M%-FSK
MJ8F*W'F !#&FXC;U.>/2@"YHFD6N@:+::59*PM[6,(FXY)]2?<G)/N:P&\%3
M"P\3V$6KE;377F<HUN&,+3*%<YR-W XZ8R<YK3\/>(#KLFKHUFULVG7[V1#2
M!MY5$;=QT^_TYZ5MT <Q%X4N(]7T+4#J4;'2;-[0)]F(\T.%!8G?P?D7]:H3
M> 9Y_#&L:*VKH%U._:^>46G*%I!(5 W\C*C\,UVU% '(7/@[4D\17&L:/XBD
MTUK]4&H0K:K*DK*NT.FX_(V!C^(=,YK1MK35K;Q2HCOY)-%2R$9MI(!\D@(V
ML)3\SDC=D=!CU(J^^J1?VL=.A'F31QB:X.<+"AR%S[G!P/12>.,X6F^-&U.6
M&XM]+E?2[A8&BN%D4OB61T5V3LN5'0D@'D=< &AX@\.#6KC3;Z"Z-IJ6F3&:
MUN-F\#<-KHRY&58<'!!Z<UEZKX&.KZ7KD,^H*M]K*QQW%REO\J1Q_=1$+<=S
MDD\L?8"U?>,([:'5+N"RDN=/TF0QWLZ. RE0&?8O\6P$%N1W R14NM^);C3K
M 7NFZ-<ZM;K!]IDD@D1%$>,Y4L1O. 3@?ID9 '#P]<'Q?:Z_)?QEH;%K(PK;
MD!@S*Q;.\X.5'KQ2^(/#T^L7VD7]IJ)L[K39WE0M")4<,A1@5R.<$X.>.:T]
M,U&#5])L]2M2QM[N%)XMPP=K $9'K@UBW?C"*WM]6O8[1I=/TB5HKR82 ."J
MAGV)CY@H89R03@XSQD G\,>')/#B:C&VHR7B7E[+=C?$J%"YW,..O/?@>PJK
MK_A*7Q%%?6=[?Q/IUU)'(L3VVZ2W*A0?+DW?*3MSG:<$FKUYX@$>K#2M/M3>
MWJVWVN1!($"1YPN2?XF(.![')%5QXQT^YT_2+C3U:ZEU=BEG!G820"7W_P!T
M(%.[K@C&"<4 4I/!M_;^(;Z_T?Q%/IUGJ+B6]LQ;K)NDP%+QL?N,0!G@^OI1
M-X+O+?Q%=:IH>O3:9%?)&M[;_9UF$A1=JNA8_(VWC."#W%;FC:U#K"W:*C0W
M5G.;>Y@8Y,;@ ]>ZD$$'N#V.0*][XB\K5I],L+-[Z[MK<7-PB.%\M"2%7)ZN
MVUL+P..2.,@%2X\*3CQ+%J^G:JUH/L*V%Q&T(E+QJQ92K$_*PW'DAL^E9VE^
M 9]+MO"\*:R)!H+2%"]K_K=ZE"#AN!ACCKS6L?%]A<6VCOIG^F3:PI>SC#;
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MC&X>. )A8V!R&7^Z0><C%.E\/:1/ICZ=-I\$EG(^^2%UW"1O5L_>/ Y.>@H
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M9K>&TNGVP.8"6"$8."0"1@#KQ7H\GA709;6\MI-*M7@O7\RY1DR)7SG<WJW
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M/44BZ98KIITX6<'V(J4-OY8V$'J".AS0!RBQ23_&V2>($PVWA\13,.@=YRR
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M@R16[D,RRN^P'&"VTY"]>:ZO2-5M];TF#4;191%,"0LJ%'4@D%64]"""#]*
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M$369+R&+3GA6<7$C!5V$9!R?8UA7_P 1?#EH(A!?QW<KW<%L4@RVPRD8+8'
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M9EL8]1CTYII&V.SOM =$(^9 7 SG/!P#BK7_  D_GZO>6-E:+<FQNHK:Y F
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MG^SI.QCB2*17(W[,LS8] !QZ$F]'I.JQ^/KO7O)M3:RZ9':(GGG?O5W?)&W
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MQ]22.!CG0D\7:5#:"\G%Y!:'&V>6SE5&SP.2O&21C.,Y&*W&8*I8YP!G@9-
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M?VC9))#-:7,C".>*3:64.!D$%%(.*-3T;4];TV"WUW2],U&WF9VNK/S"!#P
MGE.5R6&&R3M^\<= *ZVB@#RTZ9J?A[7? %A))]ON8'U# DG)(C*95-Y&6*J0
M,D#.WMVT=2\$:K=B_P!9M+BVMM>FU.'4;='):%?)C\I8W(&3E"V2!U;CID]9
M):Z1J6M++):0W%]8?=G*9-N6 .T-V8@@D#MC/49T+F=;:W>=U=D098(I8X[G
M Y/X<T <;J^A>)_$WAUOMLEAIVJP7$-U8QPNTL22Q-N!=BH)W=, <#UJ;4=)
M\2>)O!^L:?JJZ?8W-W:/;P0P2M*@8C[[N5!Y.. .!GDYXZV">*Y@CG@D26&1
M0Z.ARK*>00>XJ2@"GI0O5TRW74(H(KD( Z02%U7 QPQ S^0_K7#W7@75KW2_
M$NF&>TA2\U,ZI872NS,LNY&573;@ %""03G/08Y]$HH YB/1]0U7Q+I&MZK;
MP6K:7!,L<4,QDWRRA59LX&% 4X[G=SC',GC'1K[6;#3CIWD-<V.HV]ZL<[E%
MD$;9*[@#C(/7!KHZ* ..CT+6E\2Z_J;Q6134-/AMHU6=LAT#Y)^3A27]SQ61
M8^%/%.@6WAV^TO\ LZ:_T_31IE[:33,(IXP059'VY# @]1T->D44 5--6^6R
M0ZD\+7;$LZPY\M,]%4GD@#N>O7 Z"W2*RN@=&#*PR"#D$4M !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %>?\ Q8=_[-\.P2'&G7&O6D=]G[IBW$X;_9R!^E>@53U32['6],GT[4;9
M+BTG7;)&_0C^A!Y!'(- $UU!!=6DUO<HKV\J%)%;H5(P0?PK@9_[0_X79>?V
M=]E,G_"/Q9^T%MN//?IMKJ+/PV+:)+>;5]3O;1,!;>ZD1EP.@+! [#V9CGOF
MG1^&K:/Q5+XB%U=&]D@%LREEV>4&W!<;?4YSG/O0!QGB@WO_  D?PVM]7$82
M:Z:2^V#"-=K"/+_\>W8^E>CW,$%Q"$N$5HU=9,-T#*P93^! /X54UO0]/\0Z
M<;'48?,BW"1"K%7C<<JZL.58=B*AL]"-N8Q=:KJ&H)$0T:731X4CH3L12Q'^
MUGGGKS0!KUY-XT^T:HE[XCL;.\DOM&NDDTR1(28V2 GSN?1R9%/J$2O5;B(S
MV\D2RR0EU(\R/&Y?<9!&:J:?I46F:+#I<$TQAAB$,;OM9PH&!VP3[D'/?- &
M#J7BI;FU\,'3)_*BU^=52YP"8X_*:0X!R-QVA>0<9/I5?5-0UKPZD=G/JD=R
MVIZM#9V4[QKYEO%("3O  5B-CA3CKC.>14\?PYT6/PM%X=\V^:RMYA/:L9\2
MVL@)(:-P 0<D^O6K-QX'TN\T&32KR>^NB\BS&\FN2;@2+]QU?^$KVP .O')R
M 8FH:EK.F^(O$&FIK-S)#;:#_:%NTD41>.7=(.H0 C]V."#U-2VVOZK)=_#X
MM>DIJ]HS7L?EIB1A;>8&Z94[O0@>U,TW0FMOB)?13)J5Y8SZ)':/=W@=Q*XD
MD+*7P!]UATP/QS6G8^ -,L9=(D^VZG.VDEA9^==9$:E=NS@#Y0O'J>Y.!0!C
MVVN^(WT/Q') TVHW-AKKVRK"D:S?9E\LL(QC:7VEL9Z_E5>_\67$O@.]UC1=
M<N))(=2AA(N+9$F@5I(D:&12HP1N8YQGD<FNI@\'VEM'=K!?W\;W-]_:#2+(
MNY9B,$CY<8( !4@C';DTV\\%:;?Z=>V<\]T?MUREU=3*RB261-NS.%P -B<
M#I[G(!EVL-U)\7=87^T[M8TTNW=8OD*+N>48 *\#@'CG/4GI69I'B[5KC0?#
M5M<7A-]J^J75K)>>6@*1Q/+]T8V[B$51D=R>379OX;M&\0C7!/=)>_9EMG*2
M8615)*EEQ@D%B?3GI5"/P)I,>@PZ3YEV8K>Z-Y;3&0"6"8L7WHP'7+-UR.2.
MG% '-Z_XAUW16\6Z7'J+O)8Z2-4L;QXD+H/F!C?Y=I^9.#C..N>M:=AJ&LV?
MC/1+2[U5[RVU7399WA>%$6&2/RR"A49P0YR&)K9N?"-C>V&IVUU<74TFIQ"&
M[N691+)& 0$X4*HP3T ZD]3FI%\,6PU73-1:ZNVGTZ!K>#+)@HV-VX!><[5_
M*@"3Q1=SV/AR[N+:^@L9E"A;B=2RIE@#A0#EL$A1@Y8C@UREOKGB)[OQ?I]E
M]HN)[*WMIM/CNUB27,BOD9 QSMRH89!.#Z5V&O:'9^(](ETV^,HA=E</"^QT
M96#*RGL00#64/ VG"ZO;O[;J9N;R**.:4W1W,8SE7] P)^@[ 4 1^#=?BUR7
M4 E]>O)!Y:RV&H0+%<6CX;(8!1D'@@\]#S2>+K_5+37/#-MI]^;:*_O7MYU\
MI7W+Y3L#R.""H_KGI6UI^BP6%_<WYFFN;VY1(Y;B;;N*)G:N%   +,>G?Z4S
M5=!M]7OM.NYY[B.33YC/ (F4#>5*Y.0<\$C\: .$N=0\21:;XVC7Q)<;_#Q:
M:VF-M#OE'D"8))\FTJ#D?*%//7M6W8:]>^(_$/\ 927<E@D6DP7LC0*F]Y)L
M]-X8;5 ].2>>G.G)X.LI$UU6N[S&MC;>#<G(V;/E^7CY./\ Z_-+_P (A91W
M%A=VUW>6U]96WV-+J)DWO#V1P5*L 0".,@]^M '')XI\17MEHL/]H+;78\0R
MZ+>2I A6<()/W@!!P?D' XSGMQ6H+KQ#<:CJ/AVVU6XFN]-M(F^V*L,;RR2;
MR&=2I&T!5&% [YZC&[-X-TV2#3(8Y+F!-.NC>0^6XRTQW9=RP)8G>V<]=QIN
MM^"]/UK5X=6^U:A8:A''Y)N+"Y,+21YSL?U&?Q]Z -31'U%]%M#JWD?VB(PM
MS]G;,?F#@[?Q'X5R-I97#_%[6L:I=IC2K9L*L70R387E#P.W?U)KM[6VALK6
M*V@3;%$H51DG@>I/)/N>M9T/AZW@\2W&NK<W1NKB%8)$++L**25&-O&"3SG/
M- '%6'BC6Y_!?@S5)-08W5_JL=K=GRH\31M(X((V\'"CE<593_D8OB7_ ->M
MO_Z2M6I'\.='C@MK<76I_9K6]%[:P?:B$@<,6PN!G&6)Y)/H0,YT?^$4M!=Z
MU<BZNQ)K$:QW7S+C"KL&WY>,+D?_ %^: .2L]1U'0O"'@/5EOI$T46MK;ZE"
M(T(57B54DW%=P <J#@]#79Z%<7-\;^^DN7DM);EELXRJ@)&GRY! !.Y@S DG
M@K6)JVGFVT"'P39Z3?WMI<V1M4O) AAMTQL_>-D'*KR, DX'?D=;:6L-C906
MEL@2""-8XT'\*J, ?D* .>U'5KBY\=6OAFWN7M$_L][^>6,*7<!Q&J+N! &2
M23C/ Z<UQWA_5;W1[.XTZ*=I;K4/%=Y:M<D(K<!G)&1M#-L Z8Y.!TKO=9\+
MV6LZC9:D9[JSU"SW+#=6D@1]C?>0Y!#*?0@^U9S_  ZT.72+S3I6O72ZO3?^
M:URWFQ3DYWQM_"1Z_GF@#.N;GQGI6FZBTB/?1QW<3P+ T;7GV8_ZQ<;0A8$'
M;QDC/<5%9^,!?KI%II^L2S+JFIRV[7$\*I-:K'$7:)D*@"3("C(/#9YKHH/"
M5O;V4<*ZGJCW*3+/]MEN/,G9E! !+ C;AC\N,<GCDYAOO FCZCITUK<&Y,TM
MX+XWB2;)UN  HD5E "D* .!C':@#&\37/B7P]H,TB:[')*=4MTMG:!"X@ED1
M-D@P >2W( .!US5F[FUS1/$_A>PEUV6]@O[RY6?S+>)"R"%W1<JHZ$#D8S6C
M<>"K"ZT8:;/>ZC*//2XDN))P\TLB$%"S$'@%1@  <=*OZAX?M]2U/2]0GN;D
M3Z:[/!L*@%F4JQ8;><J2/QH \WA_MVRT#QIK6D:U]D.FZS?7/V4VZ/'.$PS*
MY(W<@8&TC'OVW3KNN^)YM6M]&DDLKBSM[<Q!6CP)981*#('4DK\P7 Q]UN^,
M;Y\&:<7OT\^[^PZA.;FZL?,!AED."Q.1N .!E0P!Z8P2*9JO@C3=4UM=82ZU
M'3[TQB&9]/NC#Y\8Z*^.N.Q&#[]* *&FZMJNN>(;C19[P6$VG:?;RW1L]K>9
M<2AL[2ZGY%V\<<EN>E+\*0R_#;2P[;F#7 +8QD^?)S6E<^#=.EU:VU.UFN]/
MNX+<6I:SE""6$=$<$$$#L>"/6KGA[0+/PSI$>F6#SM;QLS+Y\I=LLQ8\GW)H
M RI]0U$?$R+2%O66PFT>6X$0C7Y)1*BA@<9/#'@\5RFE^(/$9\.>%==N=;>=
MKW5EL;BV^SQK')&\TB9.%W!A@8((''3J3WTWA^WF\1IKOVFY2\2V:U4*5V"-
MB&/!4\Y .?;TXK.B\":;#HNG:2EW?"UT^[%Y;_.A82!BX).WD!B3CW^E '45
MY7XWBN-=74=5L;2\DOM&F1M)ECA+)YD+;I3G_:;,9'_3,5ZC+&TD+QK*\;,N
M Z8W+[C((S^%4]+TJ/2-(BTZWN)VCB4JDDI5G'OG')[Y(.>^: .4\1^*+JY\
M Z7X@T"]%O\ ;)[3!,:N"LLBJRG/IN(.,'BJE_I^JVOQ!\*6USXCO[H2B_DS
MY<*!0JIM&T)@G#$9(SCIBM>#X=Z7;^'ET**]U$:>MRMTD?FKE'#[Q@[>!NYQ
MTS^-:^I^'+35K[3;VXFN4N=/+^5+#+L+!P ZMCL<#ICIQB@#C[CQ=JFEQ>+#
M-=K,UIJMM96CR1J%@681#)P!D*9">>N,5O:A9ZK9VNN?:-6^V:?)ISF**9%$
MR2!6W'*@ J05[<'T%32>"M)N(=;@N_/NH-98/=QRL,%@  5P 5("KCZ ]:=8
M>$+6PTVYLSJ.IW;7$)MS<7=SYLB1GC:I(P!^&3QDG P <OH&KWK:/X/T"R:2
M,R^'X[MWB9%=MJQH%4N"/XB3QG@>]=AX8&MKHXB\0202W\4CH9(2/G3.4+
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MEU:PF")$*B-8SU7;M[X'OQ5[5M)L=<TR?3M2MDN+2==LD;=^X((Y!!Y!'(H
MGNH(+JTF@N45X)$*R*W0J1S4U8EGX<^S1I!/J^IWMJF-L%U(C#CH"P0.X]F8
MY[YK:8$J0&*DCJ.HH \CTC2-5\0^'?'6B6*V4<-[XAO8I+FXD8M&I9=Q"!<,
M<=/F'/TKJ-)>]T[QC+X6CU"9M/M="MY(=R)N1][Q[@=O/"#@YYS6YH/ANU\.
MF^^R7%S(+ZZ>[F$S*V97QN88 QG XZ>U-U#PO9ZAKT6L&XO+>Z2#[-)]GFV+
M-%NW!7XS@$DY!!Y/- '#Z=XA\1ZKI/@)QK#0S:P9X[R1;>,[ML4C!@-N 1M&
M.V0,@]#M6<^MZK>:[H4&O217NC000I<^1&#-.\>_S9%*D;>0-JXZ-[8T++P%
MI>G0:+#;75^J:,[/:YE#89@0V<KSD$C' YZ5+JG@K3M3UT:RMUJ%C>-&(9WL
M;DP_:$'17QUQV(P?>@# FMK^]^)UM"-3^RW3>&OWUS:1JV6\\9*;PP )]0>/
M?FDT7Q%JVJ^&/#,]SJ82XNFN([A+>)?M%T8RR#RP0549 9B< <<C-=4OAFTB
MUU-7@GN(9X[/[#&B%?+2'.0 "I[@'/\ 3BLVW^'VE6L&EQP7>HQ-ICS-;2I.
M%<+*<R(2!RI//J.Q% &!9>*?$$O@K3=3EAO;L1WUQ!J#6449N?*C>1%8)C:3
MD)NVCUQ5NU\4S:FVAZ?I>J/?)?PW5R;U!'%(ZQR*JIAEP& ?YOE!^3MFMNP\
M$V.E11QZ??:E;>5<2SH1.'P9"2RX<$%<DGD9SSG(!J.]^'^C7NGVMN&N[:>U
MN)+J&]MIO+N$ED):1@P&/F).1C'3C@4 7O"XUQ-,EAU^6&:ZBN'6.6,@L\75
M"X4 !\'G QW[U!XNN=UG;Z2L4TIU"39,D*;F%NO,IQZ$83/8R"M72],ATFR6
MVADFEY+/-<2&221CU9F/4]/H  , "HQI"#7CJYNK@R^3Y B)7RU3.>!C(.<'
M.><#L!0!QWPYN1I6JZWX1>*:"*TF-[IT<R;&^RRDG:!Z*^X?B*J7/B+Q!<V\
MXMKZ2#6DUS['_9JQ1MBWW@!L%2<>6?,WYQ^'%=E=^&+2[\46OB$W-W'?6T1@
MC\MU"&,G)5AMY!/KT[8KA+'2]3D:X 'C'3-5EGEF:""=&LUD9RV0[[E*<_4\
M\=J -NWD\0:AXZUO2U\0RP6FG)93HJVL1+AMY="2.C;?J.,$8(,.C:KXHU^P
MT/Q!83(MK=3J]U;S21^3]G8D%5PN\2+QC+<D'/8#J--\/1V.LW6L-=3R7U[%
M''<@E1&VP$+A<9&,MW[\YJAIO@+2=)U1[NSN-02V:8W T[[4WV5)2<[A']><
M9P#@XX% &+8ZMXHU^PM=<TF9(XOMKB2"9XQ ;=)&1E/REP^%SG/7/;BJ&H:O
MXD&D>.+V+7Y8GT*Z=K55MHB&584DV/E3E>2.,'GJ>E=3;^ M)M-:GU"VN-0A
MBGF^T2V"73"U>7.=YC]<\XS@^E22>"["6SUNU>ZO3%K3E[P;T^8E0IQ\O'R@
M#\* ,=M:U;2O%.DFZU&2\L]3TVYNI+4PHJPO$L;#RR!NP0Y&&+?6DT:^\5:M
M!H&MP7,?V*]19+V*5X_+"2+D>5A=P96( !)SWYKH3X7M6U/2[][J[>;3(7@@
M#%-I1P P8;><A5_*J6C^ M*T*[,EC<ZBMJKM)#8/=%K:!SW2,\=R0#D \@4
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MY'4I;Z=?'/C'3DF32;V:RMTE0$-/;Q%5GE7OMVY 8=LGM0![7YF^-S"4=AD
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MB/23,OVUX&N!$#R(U95R?3)88]<'THO]4L],-L+J94:ZG6WA4GEW;L/PR3[
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M>N3ZU!J&H:7>Z=\0H-=>U_M>![A+:.Y*^8L A!@,0/."<M\O\1)H ]9#*>C
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MS16?H>DQ:)HUMI\03]TGSLJA=[GEFP/4Y/XUH4 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5SGC'0
MKOQ#8V-M:_9@(+^"[D^T,0&$;AMN #UQCV]ZZ.JNH:C:Z7:&YO)?+CW*@PI9
MF9CA54#DDD@ #DT $&GV=O:-;165M%#(#OACC 1LC!R,8-5[G3?)L)?[&@L;
M6^2 Q6TCP#9'W (7!VYYP*YC2/$#R?$#Q(EU>W4>GV=A;S&*[7RUMR3(6(&!
MQ@*<\_6MU/%ND?:KBVGFEM)H+8WC+=0O%F =9!N R!W[CN* +&BZ=<V5O-+J
M,\5QJ%TXDN9(HRD>0H4*BDDA0 .I/.3WJ?\ L?2_*:+^S;/RV8,R>0N"1W(Q
MUY-5X_$6GL+IIFEM5M8%N)FN8FC"QG=ALD8_A/N.^*K'QCHZ374,\EQ!-:VO
MVR2*6VD#^1G'F!=N2,C!P,CN!0!JIIUC'.LZ65NLR#:L@B4,!C& <9Z4V+2]
M/@DN)(;"UC>X_P!>R0J#+_O$#G\:Y;4?&OA_4M N)5U/4[*V"V\GVRVM9%.)
M&!3:Q0@Y(VGTR0<&JUUXG_L'XB:Q%J%W?3V*Z;;SQ6T,#3%"7D#$(BDXPHR3
MT]>E '8?V-I?EK'_ &;9[%.Y5\A< ^H&.M2OI]E*\KR6D#M,H64M&"7 Z \<
M@>]4(O$VE7.G6=]9W!NXKU"]L+="[2@=2% R,=#G&#@'DTR#Q9H]UIEO?V]R
MTL=Q,;>*-8V\UI1G,>S&X,-IR". "3QS0!IVME:V,1BM+:&WC)R4AC"#/K@4
MV[TVQOVC:\LK>X:,Y0S1*^P^V1Q7+>"]6N=3\0^+(Y;JZF@MKV*.!+E=C1 Q
M*67;@8^8GZ^IZUK:C?V47BK1[274+V&[D2=H;6-#Y5P HW%SMP2O4#(.3WS0
M!J7%A9WC(US:03E/NF6,-M^F1Q4^Q=FS:-N,;<<8KF!\0?#K887-QY?VO[&\
MIM)0D4N[;MD8KA/F./FQ727#R1VTKPQ^9*J$HA.-S8X% %:+2[&RC0V6G6<3
MQ!O)"1K&%+=<$#C.!G [5B>"O"H\-Z';VUY;V,E_"TG^E0IEF#NS=2 1C=C\
M*YWPKKD_BG2[66T\27,?B"">(ZIITRHNP"1?-C\MERJ@;@&'/3))S78ZKXHT
MO1A.UW)-Y=MM-S)%"\BP ]"Y4''!!]@03QS0!K2Q1S1/%*BR1N"K(XR&![$=
MZKSZ7I]U;1VUQ8VTT$>-D4D*LJ8Z8!&!5'4?%.E:9'-)-,\B00"YG:WB:411
M'.';:#@8!/J0"1TJDGC*UF\6V^BP0SRQ2V'VT7*0LR,K,H3:0/NX))/3H,]:
M .E1%C1410JJ,!0, #TJM#IMC;3F>"RMHICUD2)58_B!6)H^NZ1%H]Y?KJUW
M=6POY8B]TC;UE+[?)1=H; 8[57!/;FK7_"6:0L>HM-+-#)IT8ENH9('$D<9&
M0^T#++P>1D<'TH U)K&TN)HYI[6"66/[CO&&9?H3TIL6G64$[3PV=O',WWI$
MB4,?J0,UDZ=XST75+^SL[::;S+V SVS26\B),H )V.0%8@$9 /'X&MUPS1L$
M;:Q& V,X/K0!7.F6#63636-L;1CEH#$NP\YY7&.M.-A9FQ^Q&T@-IMV>1Y8\
MO;Z;>F*Y_P  :C?:IX9:?4;IKJY6]NH3*RA2529U7@  < 5H^(+:2XL23KDV
MD6L:L\UQ"45O;YG!"J.<\9/'(YR 6SI.G&UBM3I]K]GB_P!7%Y*[$^@Q@5)'
M86<-P;B*T@2<C!D6,!B/KC-8W@:\U&_\&Z?=:I<QW5U(K'[1& !*FX[&(' )
M7:2.QS6A?:W9V%S]F?SIKGRC,8;>)I7$8.-Q"C@9X'K@XSB@"R]C:272W+VL
M#7"_=E,8+C\>M.FM+:YB,4]O#+&3N*2(&!/K@UR7BGQC##X8TZ_T>=YXM2N[
M>".X@B9\1O*JOC X;!8 'G/;(K<T>T;3K6ZF-]?W5O,YGBBN@S20+@909&\\
M@D Y/.* +?\ 9.F[8U_L^TVQ',8\E<(?;CBE.EZ>6F8V%KNF&)3Y*Y?G/S<<
M\^M>?:MXUFU?P-::Y92WFF :O%$X*% T7VHQX+$<_*.=IX)P:[*Q\5Z1?OJ*
M)/) ^G*'N5NH'@*(02'PX'RD \^U %[^R=.Q$/[/M<1?ZO\ <K\G?CCBG2:;
M8RWJ7DEE;/=(,).T2EU^C8R*IV?B33KW5CI:M/#>^3]H2&X@>(R1YQN7<!D9
MZCJ.XK,\9>(;K2I='TG32BZEK-W]FAE==PA0#,DF/XB!T'J10!OOIMA).\[V
M5LTSC:TAB4LPZ8)QS4D%I;6L/DV]O%#%UV1H%7\A6-=:-J<,,#Z?K=ZTZ3Q-
M,+@HZSQAU+KC:-I*[ONXKF8-9D7QYXLT_5/$\UE8:?':R6RM)"FT/&S/RRY;
MD#Z4 =L-$TE7WC2[(/G.X6Z9S^57BH*[2 5(QBN%O=9U.WU+0/"EIJ;S7NHB
M:YFU*2-/,CM5)9<+@+O(*KG&!@G%;\FDZC;7=C+9:M=/ DP-U!<%7$J%2.&(
MRI!(/!QP>* -*UTRPL8I(K2QMK>.3[Z11*@;Z@#FF?V/IGD^3_9UGY0;=L\A
M=N?7&.M9?CJ[N]/\#ZS?V-U);75K:23Q2( 2&521D$$$5RXU[6='UOP;#_:D
MVIQZW"3=6LT<9>/$8;S4**" "3D'(]* ._?3-/ED>22QMG>2/RG9H5)9/[IX
MY'MTI4TZRCN1<I9VZS@8$JQ*&QC'7&>E90\8Z(VE0ZF+F7['+=?8UD-O)Q+O
M\O:1MROS<9/%,D\:Z)'K$ND^;<M>PSQ02QI:2G8TGW"3MP%/'S=.1S0!KPZ9
M86URUS!8VT4[9W2I$JL<]<D#-1:OI4.KV8@E+(\<B30RK]Z*1#E6'T/;N,@\
M&J0\6:.]Y:VHN77[9*T%M/Y3"*61<Y57Q@G@X[''&:YCPOXR@L+>_@UN_NYW
M&N7-FEP\+.D8\W9&KNJ[4SP!G'6@#LKO1;#5H8AJUC:74L94[FB!P00>,\@9
M'3/L<U<DM;>:W^SRP1/#@#RV0%<#IQTK(U#Q=H^F3W45S/(!9M&EU(D3,EN9
M,; Y XSD?0$$XS4][XAL+&>:*4S.;?9YYBA9Q%N^[N('&>OL.3@<T 7#IUB;
M)K(V5N;5OO0&)=A^JXQ3DL[>"R-I;0010[2JQ+& @!_V1@8]JS=4\4Z5HPG:
M\EE$5L5%S-'"SI!NQC>P! X(/L""< YK85E= RL&5AD$'((H S['1+"QT@:6
MMO$]KEF:-XUVL68N?EQ@#<2<8P*NQP110+!'$B0JNT1JH"@>F/2N*\:^++[0
M-6TV6V53I5G/$VL.?X(IBT:?D<L?HOK77:CJ5II5DUW>3".$,J@X)+,Q 50!
MR220 !ZT 2VMG;64/DVEO#;Q9SLB0(,^N!20V5I;32S06L,4LQS(Z1A6<^I(
MZUC-XST6*74(9I+J*;3H_-NXS:2DPIC()*J1@CD8)Z'T-%EXTT74(GEMY;AD
M"Q%";60>;Y@)01Y7YSP?NYQ@YZ4 7].T:TTY+P1PQ?Z9*99PL856) 7[H[8
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MP0D&-,RN"RX'.54>IH [6BH+.[COK5+F))E1QE1-$T;8]U8 C\14] !1110
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M$H8@Y((7&<<<XQ7:44 >4+H>M-HCW,&GW'GV/BN75Q:.NQKFW,C'Y<\9VOD
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M(W1]S$8VY&,YQTK0\*0W,/BGQ7-/9W,,-Y>QRV\DD159%6%$)'IRIZXKKZ*
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M^BQ+.VLQ:>'F$D*3Q2, LJ*PW+G)!!)P1WJ9_'%WHY\3IKMM;,^CQ031FS+
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M:BUY QLOG<-OW"0[_F?]X<-P/4&M-_",UYJ^F7^I7EO/+IMT\\%Q';%)RA#
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ML:/R,Y!^?'4]*R/A[H\GB'X::!;7-];R:;#*)WABC^=C'*75&;=C 8 GC)
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ME?&-S,@)/'J:Y6.\O=-U_7_"TU]=R7-^T<^DRR3LSK#)\KA3G_ED59O4C&:
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M&5E.00>A%>;:,1;Z3\3!>\2+J%W))N_YY&W4I^&VNI\!QSP?#WP^EWE9DTZ
M,&ZCY!P?H* .BHKS#3M5OAK?A*X@U.\O+74KNZBFNI9"L=XOER.I2')"*I4
M'Y2<="#5S2=6O;7Q79V&O"_@N+BYG:TO8KAI;*_C(<JF,XC8+@@8YV=3F@#T
M.BN1^(US>6?AF*XL;Z>TE%_:H6A8 LKS(I!XZ8)K-33[J3X@ZGH#:[J_V"72
MX;T@71#K*9)$.U^J#Y0=JX&?;B@#T"BO+?#7B34=9M_!&F7]W-C4+.YFN)T<
MQO<-"0JKN7!'!+'!!.!VSFMKFK:W8:5XMTZ'5+Q1I.HV2V=WOS)Y<[1EHV8\
MMM#GDG.",F@#UNBN"NA=6'BJR\-)J-Y=0WL%Q?;KN_:)W<,@$:2(NX*H+-M&
M.O7 Q71>%K;4K+2&L]5U&._N8)G42JQ9@G55<D#+ $ G'/!H -6\1IIUU+9V
MUA=:C>0VWVN2WMMN\1;BH(W$9)(; '7:?;.O!*)[>.8(Z"10VV1=K+D9P1V/
MM7#6NF02?&#6-TMV/^)3;2?+=RKR99<CANGH.@[5CZ?K.IR> _!%_)J-TUU<
M:U%;SR&4YEC,TBE6_O<*.OI0!VJ^+(&NO$%O]@O/,T1$>9?DS*&4N"GS8/RC
MN16GHVIQ:UHEAJD*/'%>6\=PB/C<H=0P!QWYKBXO^1G^)'_7K;?^DS5GPSW6
MB^ _ WB..ZN5T^RM+5-2MTE8(T#QJOF%1U*,0WN,YZ4 >HTR5S'$[K&TC*"0
MB8RWL,D#\S61X==[Q;W53-*\%[.6MD:0LJPJ JE03@!L%^.SCTK(BO)-?\=Z
M]HT]U<V]OI=M;^3';S-$SM*&9I"5()QA5 /'7(YH W?#FN0>)= M-8M8I8H+
MI2R)* & #$<X)';UK4KR#P9J5S_PCO@K0$<+%>6-W,<W+VYF>.0 *'0%APS,
M0,9P.<9!VKB/Q3I&EVT3SOKHM;R9KBUM+MH[HVY4%!O^4NR;QGINRO>@#T6B
MO.M(\0P:WJN@:3!J-\=.N[*ZN1)*[17$TJ2A1$S A@4!?.#SM';JFKP:IIT_
MA;2U\3WT_FZI+:SS(0K-&8I'"L><LH"C<3VSC- '<S7\T6I"U33KJ6,V[3?:
M$V;-P( CY8?,<Y';CK4'AS78/$N@6NL6T4L4-R&*I, '&&*\X)';UKG+)+S2
MOB1INC_VMJ%W9C0YI"MU*'+.LT8#L0!EL$C)KC-(BU+2/A=H7B33M7OQ<P72
M1BQ\P&"9'NC&8]F.2=V=W7], 'M54]5U!=)TF[U"2&6:.VB:5XX<;RJC)QD@
M=!ZUP9N-;\30:Y<:?J<>GW>G:G+!'*UY(J0)$PX>$+M8,H))8G[W48 "7=Y+
MXFTWQV;B[N8#IGFVEO!!,T815@#;V (W;F8_>R, #UR =]I5_'JND66HQ(R1
MW<"3JK=5#J& /OS18WDMV]VLEE/;""<Q(9MN)E !WK@GY3G'.#P>*S_!O_(C
M>'_^P;;_ /HI:X#4M4U>'P-XWGCUB]%Q8ZX8K>;S!N2/]R-@XX'S'ICK0!ZU
M17&:<;O3OB?/I?\ :5Y=6ESI'VQDN9=X643;,J.B@@]!@<=*W_$.H3:;HL\U
MJGF7KXAM8^/GF<[4'/;)R?8$T +I.OZ=K<^HPV,WF/I]TUK<#TD !./;G&?4
M&M.O+M/1O!WQ"TQO[/NK+3-:MDT^9KAXVWW48)C<E&;YF7<O/4UJ&TO=7^(^
MMZ=)KNJ6]G;VMG<QQ6TP3:Q:3(Z?=(7!'?/L* .PO=0%O87EQ;027TML#FWM
MR"[, #M&2!GD5;1B\:L5*$@$JW4>QKR*W2;3/ACXWOK"_OK>ZM]0U#RY1<NQ
M&R4X^\3SZMU/K74I>RZWXNGT"XO;FVC@TB&YB$$S1/*\C,K2;E()"[5&,XRQ
MSGC !OW^OPZ?XATG1Y+:=I-3,HBF7;Y:F-"Y!YSG ]._6M<C(P:\_O(IH/%7
MP^@N=0_M&>)[R.2[V!#*RP,"2!P#D56TVXUOQ+I46NVFIQV4\&H2><7O)#&L
M:2LIA>#;L'R@<_>S@YYH ](X52<<#T%9>B>(+/7UOFLTG465V]I+YT90[U"D
MX!YQ\PZXK5KCO 7_ !\^+O\ L8)__1<5 '8T5RWC/5[C3Y-!LH9'@CU/4X[2
M:=#@JA5FV@]BQ4+GKR<8.#5&%KJW\=:IX;:ZNY]*FTI+^,O<.9+>3S"A429W
MX;&<$]CCB@#8TSQ0FJW=H+73;U["\1W@OU53$VPX^;!RN>JY'-:\]Y'")@H,
MTT4?FF",C>5YQC) YP>I'2N4^%-LD'PUT.16E)EM59@\K,!U^Z"2%'L,56TZ
MSC_X6OXGE\RX+)I]HX!N)-N3YP(VYQCT&, \CDT =5X?UJ#Q'H%EK%M')'!=
MQB1$DQN /KC(S6E7CWA4W>E>%_AS?6^I7F+R=+.:V,G[EHFCD.-G3(*@[NOO
MCBMBRN-;\2Z9+K-GJ<=C<VNI3+(SWDGEQQQ2LIB> +MY0#DG.3G/:@#T=W2*
M-I)&5$4%F9C@ #J2:PK7Q3%J%I]NL-+U*ZT\Y*7<<:;9%'5E4N'8>F%Y[9JA
M\4([R7X9>($L0QG-J>%ZE,C?_P".[JV_#DMK/X8TJ6R*FU:TB,6WIMV#% &7
M)XWLEDT..&POYWUN(RV0C6,;@$#D'<XVD*>]7XO$5N!?G4+6YTQ;&)9IGO-@
M78V[Y@RLP/W#GFN3\7(S^._ *Z9-!"3+>^4YC\Q /(Y^4$9[]ZJ?$VUU:#X;
M77]HW*W:+J,,MT\4913;>8#C;DX XSR>A- '7/XM1-*?5FT;5?[.6(S>?Y29
M9 ,[A'O\S&/50?85NK,)+99XU9PR!U48R<C(ZG% DBDMQ(&1H67<&!!4KCK]
M,4L/EB",0[?*VC9MZ;<<8H Y&+XDZ0=.?4[BSU&UTV.Y-K+>2Q*8XI VTAMK
M$@;N-V,>]=@K!E#*001D$=Z\C\->'+WQ7X$U?1C?PVNG7.LW0N"L!:4H)\E5
M); )P.<''I70V\D\'B;Q=I:7=RMG::7:R6\?GM^Y8K+DJ<Y'W5Z>E '>45Y5
M9W.JZNGP\@DUS485U72IFO&@E"M(RPH0V<?>RQY_+!YK5L([K7Y?$>DC7;^T
MN](DBL[683'>@$2,)I "!(78MG=Q@<8YH ZFW\00W'BF[T#[-/'<6ULER9'V
M['1V*C;@D]5/4"M>O.9;$ZM\2=2C&I742MX?MF\^SD\IG/F2X8,.0.^ ?TJ+
M0M8O->T/PB+G4;J:]NM-DFFL[=S"TY&U?.>56!15)Z#.2_ .* /2Z*\MTS6/
M$5WX$\-:GY5UJP59_P"T+>VN3%=2JK%%D0@J7VXY&1DL.]6K#Q!_;E]HFDV%
M[/<65SIDMTLEQ=26LTSK($*LZ@MN3YL@$9Z]J /2**Q?"UOJ5GHBVFK:C'J%
MW!(Z&=#DE<Y4,<#+ $ G'.*VJ "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IZII5CK5@]CJ-NL]NY
M!*DD$$'(((P00>00015RB@#.MM#L;5+@1K,9+A0DLSW$C2LHS@>86W #)P >
M,GU-.T?1;#0--BT[3(6AM(AB.(RNX4=<#<20.:Q-$\8KJWC'5]">#REMD66S
ME/\ R\QAC'(P]ED4K70W>H66GJK7MY;VRMG!FE" XZ]30!4N/#FEW6L'5I+=
MQ?&'R#+',Z93)(!"L 2"3@XR,\&JD?@O08;#3K&.TE6VTV436D8NIL1.,X(^
M;W/7U-:3:QIB(COJ-HJ2$JC&=0&(&2!SSQS4<FOZ-#:0W<NK6"6TXS%,UR@2
M0?[+9P?PH SV\#^'7U]];.G 7SN))&65PDCCHS1@[&8=<D=>>M="1D8/2JEY
MJFGZ="LU]?6UK$WW7GE5%/T)-$VJZ=;[/.O[6/?&94WS*-R 9+#)Y '.: ,R
MV\':+9/)]CAN;:&1B[6T%Y-' 2>O[L,%&>X P:MWWA[3-1GM)YK=DGLP5MYH
M)&A>-2,%0R$':1VZ4H\0:*T=K(-7L"EXVVV87*8F.<80Y^8Y]*FO=5T[361;
MZ_M;4R'"">94W=N,GF@"E/X5T:YM+.UDM&\FSN/M4(2>1")<D[R0P+-DDY.3
MDD]Z<?#.E&]U"\\F83ZC&(KIQ=2CS% ( QNP, G&,=35JZUC2[%I%O-2L[<Q
M)YD@FG5-B9QN.3P,D#/O5'4O%NB:5-ID5SJ%LIU)\6[>:NUEVEM^<XVX'7U(
M]: .>N_"1A\7^&EL-.NTT;3+.X@$L=YM,1?9L )DWD *1CD=*Z"Y\(:'=V-O
M9RV;>7;W!NHG2>1)%E.<OYBL'+')R<\YYK<!! (.0:* .<;P'X;:WNH!IQ6*
MZN%N9D2XE4-*N"&X;CE0>.X!ZU/>Z1#I]Q=:_INFRWNL_9A"D;7CIYR@Y"98
ME1R2<D=3[U-;ZN;_ ,07>G6FWRM/""ZD(SF1QN$:^X7#$_[0'KBW'JNG37S6
M45_:O=KDM LRF08ZY7.>* ,_P_ITT#7VJ7MI%:ZAJ4JRSQ1L'\M50(B%@/F(
M R3ZL<<8I?#7AZ#P[;7D-NI2.YNGN?*\UY!&6 ! 9N>2"W;EC5[^U=.^W_8?
MM]K]L/'V?SE\SIG[N<]*P;?6]5F\6^)-)WVHCL;2WGM6\EN#)YF=_P WS?<'
M3% &JWAW3&U6YU0Q3"]N81!+*MS(-T8SA<!L#&3T'<U2C\"^'(4T]8[!T&GH
MT=MMN9051NJ$[OF0X^ZV1[4GA;Q%_:/@72M=U>XMK=[JW625RPCC#'L,GC\Z
MV5U.P;3Q?K?6QLF&1<"5?+(SC.[..M %33_#6D:5HLNCV=DL>GRAP\!9F!#Y
MW#YB3CD\=*==^'],OM _L.>VSIOE+#Y"2,@V 8"Y4@XP/6JVI^+]"TK3[6]F
MU*U>"ZN$MH7CF4AV9PIP<XPN<D]@#4HU)3K!?^U]._L\67G&#</,SN_UN[=C
MR]I Z=3UH 5?#6EIJ<.I+%/]LAM_LJ2_:I<B+KM^]@\@'/7(!KE_$/@Z&WL=
M+L-,T&2_TF"YEN9[:/4'BG61@<-&[N,<NY(W+DD>]=DNK::UFMVNH6AMG;8L
MPF78S=,!LXS[42ZMIT%]'8RZA:QW<APD#S*)&/LN<F@#"\):%)I4MQ.EO?V-
MK*BJME>7[73!@3ELEG"\<85CGOT%:.H>%=&U75%U*\L_,NA";<N)74/$3G8Z
MJ0'7))PP-9UAXCG'BSQ-8ZI<V<-AIJ6KPRD>7@2AR=[,Q!.5 [?2M_\ M*P\
MNWD^VVVRY(6!O-7$I/0*<_-^% #-)TFQT/3(=.TZ'R;6!=L:%V<@?5B2?3DT
MZ73+*?5+;4I+=&O+:-XX93U17QN ^NT?Y)JW10!@:AX*\/:K>7UU>:?YDM_$
M(;H":15F4# +*&"E@.C8R.QJQ#X8TBWU"SOXK>1;FSA-O _VB3Y8S@D$;L')
M ))R21S2Z]XCTSPY!;2ZE<QP_:;B.WB5F +,S!<\]AG)/8"L:'Q:(?&&K6FH
MZAIT.D6]E;7-O<,PC'[UG'+EL'[HQC% %IO 'AIF?=8.5:Z^UB/[3+LCEW;M
MR+NPGS<G;C/>I+SP-X<O];_MBXTT&](42.LKJLH7IYB A7Q_M UL7.HV-E:K
M=75[;P6[8Q++*JH<C(Y)QTJ6">&Z@2>WE26&0;DDC8,K#U!'44 /=%D1D=0R
ML,%2,@CTK'T[PMH^E/ ;2V=5MBQMXWG=T@W9!\M68A>"1P!@$@<&MFH;F[MK
M* S75Q%!$#@O*X51^)H I6&@:=IFHWFH6D4J75ZP>X=KB1_,(& 2&8C@<=.E
M-UKP_8Z[$%NO.258Y(HYH9FC9 X 8?*1D' X.1P.*MKJ=@U@+];VV-F1D7 E
M7RR,X^]G'6F#6-,.GMJ U&T-DF=UP)U\L8ZY;.* *%QX0T2[TN;3I[61[>>8
M3S?Z3*'E<8PSN&W-C ZG' ]!1HW@_0] O'N].M)(YWC,1>2YEE.TD$@;V..0
M.GI6E;ZG87=U/:VU];37%OCSHHY59X\_W@#D?C4<6KZ==>:EKJ5G))&A=MDR
MML']X@'I0!!9>'-*TZXCGMK4JT(985:1F6$,<L(U)(0'_9 XXZ52TSPCI]E:
M:O:26ZM::G<M/);&5Y%!;&3ECD$D;N,8XQTR;VGWZPZ!;7>IZI8S$H/,O(6"
M0NQXRN21@_6LGPKXEEU>Z\1?:KJRDM-/O1%#/!\J&+RD?))8@_>.3G'% &Y8
MZ19:>T[P1,9+C'G22R-*\@ P 68DD 9P,XY/K4-AX=TO3)XYK6V*M%&8H=TK
MN(4)!*QAB0@X'"XZ = *ECUS29;.:\CU2R>UA.V6=;A"B'T9LX'XT'7-)$<L
MAU2R"0R>3(WVA,(_7:3GAO;K0!#_ ,(YI7VXW?V7]X9_M.SS&\OS<8\SR\[=
MWOC.>>M06GANVM_$NJ:N(P#J$213)YC.LNT8W,K?*..  /7.<\+JGBW1-(L[
M&ZN-1MC#?3I!;NLJE9"S %@<XV@')/0 58@O'GUUDBU*QEM#:*ZVL>#,&+']
MYD-]P@@#CKWH -/\/Z9I<R2VENRO'%Y$9DE>3RH\YV)N)VKP.!CH/04U/#FE
M1WHNUM<.)C<*GF,8UE/601YVACD\@9R2>I-68=5TZYO&LX+^UEN4R6A296<8
M.#E0<\&HWU[1XY$C?5K%7>8P*IN$!:08^0#/+<CCKR* (KWPYI6HW,L]S:EW
MF54F D95F53E1(H(#@9/W@>#CI6I@8Q@8]*6B@#FK?X?^&+7[+Y.FE1:3&>W
M4W$I$+'.0H+8"G)R@^4^E7K3PSI5E-!+%#*?L\C20))<22)$[ AF568@'#,.
M.F3C&34^K:G;:=:MYM_9VD[HQA-TX )'MN!(Z=#65X6\2K?^!=)UW6;FUM7N
MH%DD=F$<88YX&X^WK0!JZOHEAKUHMKJ,+RP+(LH597C^93E3\I'0@'\*C'AW
M31J\FJB.<7TD MFF%U+DQC)"XW8'))]<G-6'U;3H[.*[?4+5;:7_ %<S3*$?
MC/#9P>*675=.ALDO9;^U2UD^Y.TRA&^C9P: ,N/P9H,.EV>G16;QV]E(9;4K
M<2!X&.<E'W;AG)X!P<U+=>$]%O=*DTVXM7>UEF$\H^T2!I9 00S.&W,<JO4]
MAZ"KKZQID44,LFHVB1SJ7B=IU D4 L2ISR  3D=A5+^T)+S4LZ=K&F26TEB9
M8H0/,<ON&)<AQF/! X[GK0 NN>%=&\1VMO;ZK:&<6S;X)!*Z21GID.I##WYY
M[U?T_3[32K&*RLH1%;QCY5!)ZG)))Y)))))Y)KG_  5XM@U[P[I$M_?6*ZO>
MVWGM:I(%<C)Y5"=V.*WI=6TZ"]CLIM0M8[N0@) \RAV)Z84G)H @CT#3H==E
MUI(I1J$T8BDE^T2$,@.0NW=MP"3V[UF#P!X:7:!8/M2Z^UQI]IEVQ2Y+91=V
M$Y).%P"?H*F\7^(8]!\/ZC<0WUC#J,%K)/!%=,#YA520-NX$Y(QQ6GH]U)?:
M'87<V/-GMHY7P,#+*"?YT 5/^$8TD7.IW(@E$NIH$O&%S+^\4# &-W&!QQCB
MLO4]+N[?3(?"NCZ,K:-<6K6TEW+=[A:H1MVA&RS_ "DX[9 !P*ZRLVYN)5UV
MR@34+..%HY#):R#]]*>-K)SP!SG@]: +T$$5K;Q6\"".*) B(O15 P /PK+U
M#PMI&IZM#JEQ;R+?11^4)X+B2%FCSG8VQAN7/8Y%6%U[1VF@A75;$RSLR0H+
MA-TC X(49Y(/4"M"@#F9?A_X8FT*VT5],_T*UD\RW432!XF]5<-N'X&KJ>%M
M(B@LX8()8!9[_(:*XD1AO^\2P;+$XYW9S6S52ZU73K&:.&[O[6WEDP$26949
MLG P">>>* ,J_P#!/A[4M.M+&YT\>3:2&2W:.5TDC=CEF$BD-DDDDYY/)S4S
M^$]%D33D-HZKIS^9:A+B1/+<YRW##<QR<DY)R<]:JQ:S?_\ "QI]#D,!L5TM
M;R/;&0X8RE""<D$?+V ZUK0:UI5T\J6^I6<S1+OD6.=6*+TR<'@>] #'T/3Y
M-=CUIHI/[0CA,"2B9P!&2"5VYVX) /3L*K67A/1=.>(VUJZQPRF:&!IY&BB<
MY^9(RQ53R>@XR<8S5X:MIK1V\BZA:%+EMD#"9<2MG&%.?F.?2E;5=.2\%F]_
M:K=$A1 9E#DD9 VYSG% &3=>!_#MYKQUJ;3@;YMID=97592O0N@(5\?[0-/O
M_!FA:EJ-S?W%I(+BZB\FY:&XDB$Z8P!(J, ^!QR#6D^K:='?K8/J%JMX_P!V
MW,RB0\9X7.>G-*=5TX7HLC?VHNR=H@\Y=^<9QMSGIS0 NG:?:Z5I\%A91>5;
M0((XDW%MJCH,DDUDR^"M FL;^RDM)FMM0G^TW49NYOWLG'S'Y_8=/0>E=!10
M!F)H&G)K2:P(I3?I!]F$K7$A_=YSM(+8///(Z\U+?:/9:E<VEQ=)*TMI)YL!
M2=T"M@C.%(!."1SG@GUJG8ZR=4GU)[:2*.QL9'MO.<9WRJ/G/4852=ON0>@'
M-2;7+C2/#UAJU]>6=]: (M[<VJX3#$+YJ<GY02,CTR0>,$ T=;\.Z7XCA@AU
M2!YHX)1-$%GDCVR#HWR,.1V]*6V\/Z;9ZQ-JT,4POIHUBDE:XD;>B_=!!8CC
M)[=SZUIT4 8,G@S0)8-3@:Q;R=3=I+M!<2!9&8Y;@-\NX]=N,]\TFI^"M!U@
MV37MG(\MDNR"9+B1)57^Z75@Q'L2:T[O5M-L)4BO-0M+:1\%4FF5"V3@8!/K
MQ1=:OIEBTBWFHVENT<?FN)IE0JF0-QR>!D@9]Q0!6E\-Z3-=:;<FU*R:8"MG
MY<KHL((VD!5('3CD=*IKX'\.QZ^^MIIP6^DD$KE97$;R#HYCSL+=\XSGGK6P
MVHV26*WS7EN+1@&6<RKY9!Z$-G'-8'A7Q#<:YK'B*WDN+2XMK"ZCBMI;4?*R
M-$K\G<<G+8R/2@#J",C%9NEZ%I^C27;V$4D;7<QGGW3R2;Y#C+?,QP>!T]*T
MJHZSJUKH6CW6IWC$06T9=@HR6]% [DG 'N: %U72;'6K!K+4;=9X&(;:2058
M'(92,%2#T(((J*WT*PMH[E428O<J$FF>XD:5P. /,+;@!DX /&3ZFJ\]SJ$<
M.F&>^T^RN)KE?.AE&=Z$',49W#+YQ\W?!XYQ4B37LVHZK%!J6GR>6L7D6X3+
MP'!SYN&Y#$<<# !ZT 3Z/HUCH.FQ:?IL30VD0Q'&97<*/0;B2!4-QX;TJZU=
MM5DMW%\\/D-*DSIN09P"%8 D9.#C(SP:?H6L0ZYI:WD:&-U=X9X6.3%*C%70
M_1@>>_![UI4 8,?@S0H;+3;..TE6WTV42V:"ZEQ$XS@CYO<]?4TP^!_#IU]]
M;&G!;Z1Q)(RRN$=QT=HP=A8=<D9SSUKH:YF\\86,LFN:?I=]:-JFFV_F%9#O
M7?M9BNT,"<!><'C/UH Z8@$$$9!K!MO!VBV3.+.&YMH'8LUK#>3)!D]?W0;:
M >X P?2F^%O$=OK.B:2;B]M#JUSI\-U-;)(H<;T!)V9R!DUJ'5M.&H#3SJ%K
M]M/2W\Y?,/&?NYSTYH JWOAG2=0U&QU"XMY#<V&?LK)<21B'(P=JJP'(XZ=*
MTYH8KB%X9HTDBD4JZ.N58'@@@]13Z* ,*R\(:/IZ"&VCNEM5^[:M>3- OL(R
MQ7'MC'M6VZ"1&0E@&&#M8@_@1R*XW_A/8QIPNY+2ZC U4Z?./L4I,'!(R!RV
M<*-PX!<=<<YDOC+Q)-\4-0\'V8TI5M[+[7%--!(2W"D(V)./O?>]NE '::+X
M?TSP]!+!ID$D,4LC2NK3R2 NW)/S,<$]Z@U#PIHVJ:H=1N[5VN6A\AV29T62
M/)(5U4A7 ).-P.*Y[P-\3-.\4>%1JVIO:Z3(MRUJZSW"JCR !OD+8SD,..M=
M:NLZ6]U<VJ:E9M<6JE[B(3J7B4=2PSE1]: ,^V\&Z%9R:6]O:2QMI:,EGBZE
MQ$K#!&-V#D  YSTI-2\%>']7U@:K>:>'O-@1W65T$JCHLBJ0''LP-7(/$>AW
M4EM';ZSI\SW19;=8[E&,I7[P7!YQWQ3X]<TF?46TZ'5+-[X;LVZS*7!'7Y<Y
MX[^E $1\.Z8=6N-4\J9;VXA%O)*MS(N8QG"@!L#&3T'<U1C\">'(8]/2*P=!
MIZLEMMN9041OO(3NRR''W6R/:L'P7\1XM8&IQ^(+O2[">WU-["V'F>5Y^W'0
M.Q).3V]J[/4=:TO2%#:EJ-I9@@L#/,J9 ZGD].: ,ZT\%Z%I\-M%8VLUJML9
M##Y%U*A3S""XR&Y!('!X&. *;J/@CP[JFG6=C=:<##9,6MFCE>.2(GDD.I#9
M)Y//)Y-:=SK.EV5M#<W6HVD,$^/)DDF55DXS\I)YXYX[43:SI=O8Q7LVHVD=
MK+CRYFF4(_\ NG.#T/2@"6PL+73+**SLX1%;Q#"("3[DDGDDG))/))JS4<$\
M-S!'/;RI+#(H9)(V#*P/0@CJ*DH **** "BBB@ HHHH **** "BBB@ HHHH
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M(S@C/(Q2T44 <!X3AO8QX^M8CLU(ZO<20D]0'A0Q'Z8Q^55/!NJZ#K&D>';
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MW)P!P1P0:Q_&%O%-IWQ$U"U:.32KNTMQ$RD,DMV 0S1]B<; 2._'4&O9:.E
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MM>V[L(U GMBDF96DQ\R@("#NZ_*.XJ[%<:5>OK'ACQ+=:BFJG599XK*-,-=
MR[X9(F"9QC:,[OE"\X%>O8&<T8&<]Z /(K[5;6VTOXD:3KDB1:M<-<RVT<P^
M:XM_) A\O^\%VG@=#DG'->C^%I5F\)Z.Z$E39Q#D8Z( :UL ]J* "N&UY[1/
MBOX7+M"KFROED)P#@B/:#]<-C/H:[FB@#Q!1IL7PWFFB%JEPGB?>CKM# "]R
M".^-F3]*]N5@RAE(*D9!'0TM% !7F"ZGH\&M^+?#OBZ%WEU&\$MM$T;L;RW,
M:!$C*\DJ5(P#P3]:]/HQ0!YUJ%Y!;_$C4F> S&/PMAK2-_G<B1V,8(_BQ^/.
M:R/#FJ64_B_P7/;7*&W?1Y[:.&WC;RX,>3MA#')9E ^;)[9(7->N44 >(V.I
MV4/@?PII;RXOM/\ $<0NX I+6^+F0_.,?+P<C/4=.AK?-W-8>*5.FWMOJFG7
M>M;;C2YUQ=6<Q?#2QD<E!C<01]W//6O3\#THP,Y[T >0Z1/I6H1'PYXANM1&
MOVNJ23BP1-K22><SQS(P3.T@@[MV ,YXJ_!=3:?XKB33KVVU;3+G6I5ET^88
MNK"<LX>1"#S'G<?F'W6X/->GX&<]Z,#.>] !1110!Y_X!1(/AK>6VH;!);W5
M]'=^;C&_SI"<Y]B*RHY(C^S65)#$:+Y6T<D2;=H7'KN(&*]'M],BM-1N;NW8
MQBZ(>>+'RNX  <>AP #ZX%+?Z;'J3P+<MNMX9%E\G'#NIRI;U (! ]0#VH 7
M2HIH-'L8;DDSQV\:R$_W@H!_6KE%% 'DGCW4+223QQIR)]DO#I<9;Y&DEO@(
MV*E <A43)!(&<Y)(Q6A83:3>_$[3KJ0VTBGPUNWRJ.6\U>>>^W)^G/2O2Z*
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M0#UH(!&#0!SG@;2;'1/"MO9:7=75S8J[O!+<@!BK,3Q@#Y<DXXZ>V*Z.BB@
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M;S65(]IV!R@/S'DD8!Y(IVG^&=7?X1ZIX<GM!;ZC-'>+&KRJ58RN[KRI./O
M'-6O[/UJY\2>$=1FTAX8M/MKB.Y N(V*&1$5?XN>4.<9ZCKV .C\/Z];>(M.
M:\MHIX#'-);S07"A9(I$;:RL 2,@CL369_;6EVOBC7&\C43>V5C%+<#),;1Y
M?;Y:[L9X;)P/K1X*TV_TR+6UO[1K<W6K7-W#ET;='(V5^Z3@^HJE<Z3JI\7>
M([]-.D>VO-*CM;=Q+&-\B^9G@MD#YQR?0T 7--\=V&IW6CQ+8ZC!%K$/FV=Q
M/$JQR$)O*<,2&"Y[8.#@FI_&?B&X\-Z+'=VUD]U)+=0V_P K* F]U7)R1GKQ
M[XS@<USMGH&M067P_A?37W:* M[B6/"XMVBX^;GDY^GOQ6_X[TJ^UCPR8-.A
M6>ZBNK>X6(N$WB.57(!/ . >M &'/JUQI_Q0N76RU2Y\S08YO[/C<2%7\YP2
M 7V*<*.C ''&2:TKGQ+HFJVOA;4"M^T.HW:&R:(E LI5L"7##C ;(Y&11!9:
MM_PL.77)=+D6U?1TM?EFC8^:)6?'WAV8#/KGMS6!IWAK7K7PIX*T^32W^T:3
MJ0N+H":+"H!(,@[N?]8./8_B =I'XEMY[MH;>TNIH4NS9/<1["B2CJ"-VX '
MC..OYUM5Y_-X9OW\61:QIUA/I5__ &A_IEQ#<)]FO;4,?OQAB2Y3 !V@AN<^
MG4^)?[1DT66WTRVEFGN,0LT<B(8D8X=P6(Y"Y(]\4 <KI7B341\1%6]ESHNO
M6[?V4.R- 3G_ +^(?,!],#M76WVNP6>J0Z7'!-=7\L#W"P0[<B-2 6)8@#E@
M!SR3[''*^,/!9?0+27PU92C5]/N(9[%6N3LC*$9!WO@+MR./:H]>EU2?Q9IM
M[I>C3OJ5OI[BZCM[R%)HED<;4??E&4E&(QSE>W((!II\1=)DTK3M22SU)K?4
M+O[' 1;\F3D8(SZJP^H-6QXPB-H)!I.I?:EA,\MDZ1I-"FYE!8,X'S%&P 22
M!7+KIUU=:-X?T_3/#UY:'1-;CFN[>>XB9E 5G9MX?#EO-#<=\].*T=<TG6+'
MQJ^MV&A6VN65]:QV]Q;R2I') \98JZE^"I#D$=>,T ;,/C+3;ZPL[K2TFU W
M=M]JCBAV*WEYQD[V4 YXQG.0?0XJP?$+2+Q-&:S@OKD:NLIMO*A'WHP=Z-DC
M# C'I[XYK)U/0]=L?$%AKMKH-AJJ267V.[TY)$C\DB1I%:-G !QO93TSUQZ7
M)])U:3Q'X3OO[+BCBL6NGNDMG0)#YJ%549(+$<9('/)'I0!(_P 1]/CTNZU"
M32=66*QN&M]0!A3-FP(R7^?##D'Y"QP<UJZMXIM-*^U!;:YO&M(1<7 MMF8T
M.2#\S+DX4G R<#W&>2O/#FN7'A/QUIZ:8XN-8OI9K0&:+!5XXT!)W<<H3^(J
M:XTG7=-\4W&J6_ANVUBSU.W@$L,T\4<MI+&NWJV05(QG&3D?F ;8\>:=/>VU
MI86=_?RW5A_:%O\ 9XAMECRHX+, #\W\6 ,8SG -*\\?"73_  Y>Z3IMS<0:
MQ>_9CNV(\17?N0JS#Y\QL.N.#STS+!I6J6_CZRU1[!3:Q:,]I(]NR*@E:1'P
MJD@[?E(SCTK!L_#.OVOACPY'_9FZ[TO7)+V6W,\8+Q.TQRK9QD"5>#Z&@#TY
M264$J5)&=IZC\J6J%E=:A-?7L-WIRVUO$8_L\ZSB3S\KEOEP"NT\<]>M7Z "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ****  \C%0)9VT=J;98$\@YRA&0V>3G/4DDDYZU/10 8P,"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q]4\
M+:+K%ZE[>V6Z[1-@GBE>*3;G.TLA!(]CQ6Q10!!9V5MI]LMM:0I#"O15'<]2
M?4GUJ>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH Y^XT.34_$CW6JVFGW>G1P".UCD!=HV)R[$%<9;"#KP%[Y-<WH/@
M#4/#?Q'U+7M,DL+?1M04+-IZ%AC&/G7"X!SDXZ?,1GO7HE% '"Z#X*OO!6L:
MG+X=:TGTK49/.:QNI&B-O)ZHZJV5.>A'8<U'X2\"ZAX=U?Q3K4MQ:2W>MS&5
M;9"P2'YG;!?&6^__ '1TKOJ* /)='^#KQ?#:^\):O<6LSR7+7=K>0[LPRE5
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MT8C+:6T=N6B8E6V*%SR!C..E:=% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4450O-;TO3KJ"UO=0MK>XG.(8I9 K2'T4'K^% %^BBB@ HHHH **** "BJ
MESJ=G:7UG93W"QW-XS+;QG.9"J[FQ]!S3=4U?3]$L6O=3NXK6V4@&20X&3T
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M9H)&C.0LBXRN?;(H NT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1152PU.SU2*66RN%F2*9X'*Y^5T.&7\#0!;HHHH **I76KZ?97]I8W-W%'=
M7C%;>$GYI" 2<#Z T_4M2LM(L);[4+F.VM8AEY9#@ 4 6J*;%(DT22QMN1U#
M*?4'I3J "BBD9E1"['"J,DGL* %HJMIVH6FK:?!?V,ZSVLZ!XI%SAAZ\U9H
M**** "BBH;JZM[&UENKJ9(8(E+/([850.Y- $U%065Y;ZC8P7MI*);:XC66*
M1>C*1D'\JGH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X;QI_R/7@/_
M *_[C_T0U=S7/ZYX:DUG6]'U-;\0-I4K311^3N#LR[3N.1Q@GIB@#G-2\3>)
MTF\9+:2Z7&GA]4FC,EL[&93 )=A^<8/.-WZ5W.FWG]H:7:7NS9]HA27;G.-R
M@X_6N?F\'23/XG8ZEC_A((Q',/(_U0$?E?+\W]WU[\^U;^EV3:;I-I8M+YOV
M:%8A)MV[@HP#C)YP* .;T[6]>UZPMM9TA;)K*2^:(VLH(;[.LC1L^_/W_EW
M8QCCD\U5G\5:M>:#KVNZ4+3[/I-Q/&EM+&2;A8/]82X8;2<-MX.,#.<\6]-\
M#R:3J%P+/7+N/19[AKEM+\M"H=CN8"3&X(3R5'OSR<O;P4(QK-K9ZB]OIFLR
M/+=VWE!F5G&)#&^?DW#KD-@Y(Q0!0A\3:WK?B.+3])FL+>TN]%BU2":XMW=X
M_,; #*' ;@>HQGOBJ<7Q"N/^$7\.:OJ(33[;4(Y!=WJP-+%;RJ0J@@'Y58[C
MD],8[Y'2P^&/LGB;^V+2Z2)4TY=.BMO)RB1JQ93G<#D$_EQ[U4TGP?=:)I&G
MZ;:ZNLD%G%-"R7%J'2=9&#?.H8<@@X((X8Y% $;^(=4BUGP=:M+I\\.K+-]I
ME@0D%DA9PT3;B-I('KQWKF?&6LW_ (E^%NM:M;2V\6FFX,,4+1$N\<<X0L6S
MPQ920,8QQUY'4VO@:&P?PV+.]:.'0O-,2-&&\TR*5?)R,##' '3WZ51N?AL9
M-)U71;77;BVT:_F,XM1 CF!BX=@CG^$D9QCCUZY +.J^(M;N;W6[3P_;+)/I
M>Q%5X0XGE,8DVD[UVKAE&?7)[8JM)KOBR]\3KHUFFFV$KZ1%J!6ZB:1H9#)M
M:-BKX;&",C'XU=N_!=U_PD$NL:5XBO=-GNXTCOPD,<@N=@PKX885\<9 _"KU
MMX9^R^*TUN.].U+!=/%NT>?W:MN!+$Y+9/7T[=Z ,.^\7:MI^K6<<QLV6?6E
MT][:*-G\N%R0CM*#A9#PVT]CC'>F:5?ZXNL>.96O[>;[#,JP)+;G"@0*ZCAQ
MQ\QSW).<]JG/PZ;R%MDU^\2VAU7^U+9/)C)CDWER"Q&6Y8XSTSSFM-?";0ZC
MKMU;ZI,B:NH\R%HE94<1B/>#P3\H'&<9_*@#-TKQ;>ZM#X6L8_L\-_JNE_VC
M<2^62D2A4R$7/4L_&3P >M9]_P".=;LM-U>'RK$ZII&J6UG,3&PCGBF9-CJ-
MV4;:_(^;!%;,/@9;2T\/FUU%H]0T.'[/;W1A!$D)4*4D3/S @#H1@C(Q2ZAX
M'CO],N[<WY2YOKV*^NKGR02[QE2B@9^51L48YX!YR2: )=&UC5O^$SU+0-5D
MM)Q%:0WD$MM"T6U79U*,"S9P4Z\=>E6=>UV6PU?1=&M/+6\U6:14DD4LL:1H
M7=L C)Z #/?/;!?;Z!)%XNG\0/>!WFLTM&A$6%"JS,"#DG.6/X?G3O$'AV/7
M'L+E+A[6_P!.G\^TN44-L)&&4@]58'!''U% '.WFO:K+#XNT"XDMTOM.LOM$
M-VD1VRPNC$97=\K@J1G..AQVK6\!V\B^"- EN3!+(--@$3I#L*1F-/E)).>@
MR1@' XJ5O"YD@UEY+P'4-6A$$]R(<*B!2H5$SP &8\D\DYSTK1T+3&T;0[+3
M&N//6SA2!)-FTE54*,C)YP/_ *U '+V=QJDWQ&\46\M]&]E;V-J4@,)^56$Q
MP#NX.1DD@YX'&*PO!>L:QH_ACP$CO9OIFI*MF81$WFH?+=U??NP>4Y&WOU/6
MNUE\,N/$M]K5KJ4D#7MJEO- 8E9&*;MC9ZC&\\ C/%9UMX%:VTKPYIZ:H3'H
M4XFA8P<R85E ;YO1CTQVH JIXH\1:G;PZIHNG"ZM#?-";8Q@%H%D,;.)"XPW
MREL;<=N>M=5K]Y<Z?X>U&^M/*^T6UM),@E4LI*J3@@$'MZU@V7@>73=3N39:
M_>PZ-<SM<RZ6(T*[V.6"R$;E0GJH]3SS6OXK=4\(:R68#-E,HSW)0@ >Y/%
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M C$?R_-_='?OS[59O?"]S>V4EC)J<;VD]BME-#+:AU(7=^\4;OE?#=\C@<4
M4M0\1:S<WVIZ?HL*-=:=!$Q)A$BRS.A<*?G7:N,<\]>V.:.J>-M2L)K6VU)8
M-!N;JP26![V(R0/='<&A:16"KC"]^=V>V#?F\!O;:G!?Z!KMYI$HM8K.X"1I
M,L\<8PA(<$!P.-WZ5<U+PF^H6=UIYU$G3KJT6UE@N(1*1C=F16)&'.[J01D
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M7; PP^2PC8R%2Q^8*Y^7=R0*U)O"4LUWHMT^K2R3Z9.]PTDL08W$CH48M@@
M;6(  &./2J-UX :Y^WR#6)(I[G4XM4CD2 8BFC"@#!)#+A1P>_.: ,J_\<ZS
M:^'/&%S!]FDN="D3R9)[5XQ*CQJ_S(6!##<>>AP.*V4U?7HO&4FA7<]CLNM,
MDO;:2&!LV[JZH5;+?O!\X.?EZ=!4%[\/&OK;Q##+KMRRZZL8N"T*?*555)7
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MK#;7NI:8=2N792ZQ("JX09&27;C)X /6G?#99UA\3K=/&\XU^Z#M&I56.$Y
M)./IDT6WP]-A;Z$VGZQ+;ZAH\#6L5UY 830'&4D0GGH#D$8-;/AKPX?#W]I$
MZC->-?WCWC^8BJ%9L9QM'L/_ *U &=XLU[5-)EO/LLEI#%!I[W,(:-II)Y5W
M94HI!6, +EO]KJ,<MB\4WFH7WANRA2.T.KZ:U\TSKO 8*A\M!D9/SDG/9??(
ML:KX-.HZU?ZA%JUS:IJ%B+*ZA2-&W*-VTJ6!V_?;..OL>:Y/7M/_ ++GT/1;
MK6KVUM]/L-D5[-IB7,$[$A0I7855U5.IYP_!Y.0"U%XS\32^&=&U/9I@EO\
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MM>.FNOE.J,GV@19'S$J><Y.?I6KIW@6>QO-!N9-?N9GT:![:%3!&JO$P4!2
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M1@MW9F"J/Q) _&IJ\4N[6?\ LYM+N[JZN[33/&%I;64\T[EQ&S1DH6SDE=Q
M)Y%>SQK'!;JJL?+C7 +,6.!ZD\GZF@"2BO*=+OIO[;\&7=K>W4UIJ4]VLEU/
M<$27J>6[AFC'RJH(&WG(&.%Z50NEN8/!WB'6%U/4S>Z9XBDCM':]D(1!<HFT
MC=AAM)'S9XH ]<U"Z-CIUQ=B%YC#&TGEH0"V!G )(%5] U9==\/:=JR1&%;V
MW2<1ELE0R@XSWZUQSSCQ%K'C:SOYIE.F1I#;0I,R>6C0[_-&"/F9B>?10/7.
M[\/?^2<>&_\ L&P?^@"@#I:*\XNKV\TSQ4K:O#//IMYJJI9ZK97+$1,6""WF
MCSPNX%<C(S@GGFLG4;Z[@^'/C.4:C>)-9Z]+';R?:G#Q*)8P%#9SC!/'3F@#
MT75=<:RU"#3+*V6[U*>"6XCA:7RUV1[026P<$EU X[]L5EKXQO+F*8V'AZZN
M+BS$/VVT:94FA:10VU1]UBH()^8<'C)R!0U#3[>7XRZ8[F;+:/<2';.ZC*RQ
M < \#VZ'O5;P[I=N/%7CO:]TI2XB566ZE!&;9#G.[KZ'J.U '=:=<7-UIUO/
M>69LKF1 TELT@<QGTW#@_44FH7-W;1PM:6+7C/,B.JR*GEH3AGYZ[1S@<FO-
M?#FLS7.G_#[3-2NYC;:E832RN\K W,R*NU&;.3PS'&>2!5_Q#:MHVCZ5;VFM
M7]QY7B2VC):X;*(\RDPL0?G4 @?-GTH ]&HKS:X6\\5ZEXJLO[;33;O3KH)
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MXV&P[0X4JR#)R,'<>N.+=CISZCX^\4B>^U)TT^2RN;:!+R14#^66(QG[I/\
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MGH36-Q8MIZ-:W,WGS0EF*R29SO89Y.<'/J >U7[[4[+31']KN$B,I(C4\LY
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M+"'2Y87@FE:38;52  4C"D-P3QD<XS71T4 16UO%:6L-M;H(X84$<:#HJ@8
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M!W'^Z*[ZXC::VEB25X6="HD3&Y"1U&>,BL[0M%.CVSK-?7.H7<I!FN[G;O?
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M8$KA\8? ST)Q6C110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %<!\8-;UKP[X%N-3T:_6TD21$8^2'<AFQ
MP2<#KZ'\*[^N!^,&CZGXA\!SZ3I%A+=W<TL;!4*@ *V226(':@#M--D>72K.
M21BSO C,QZDE15JN4O\ 4O$.FZ+H0TC03>2R210WD<LH0P)C#-UP<>O(^M=7
M0 4444 %%%% !7F%MXDU+QO\3=5\/V5_-I^B:(I6Y:V(6:YFW;=N_JJ@ANF#
M\O7GCT^O+K/PQJW@CXGZMX@L;"74M$UH%KA+8J9K>4MNSM)&Y<[NG/S>W(!V
M,=A>:/K'VR369WT..SE,L-VX;RI R$/O(W$;0_WB<?C4>F>-M)U:YAM[=;E9
M+JU:[LQ)&%^U1 X+)D_3AL'!!QBH];@U#Q9X9UC2X;*6QBNK*2&*6Z(5VD88
M'RC)"^I.#[=ZYCX>Z/=VMAIJZSX4N[;5M'MW@%Y-<"12NTJ!"-YY88R,!>O/
M2@#9TOXI^'-:>R73QJ$YNY'B39:,0C*N[#'H"0.!U_#FJ?A7XGVFLZ+K>MZE
M;S6&F6-S(J321Y58U" *2,Y<LQ.!Z@<T?!K0=3\-^"7T[5[![.[^UR2E&*G<
M& P<J2.WZ5SGASP_XK\/?#;Q1HJ>'H[G4'O)9K=;DQ203JQC&0I/S$ ,V& &
M0!STH ]!TWQKIFJZO=:1%'<Q:C!;+=B"15S+$P&&0ABIZCN.M<IX9\>Z;HGP
MZ77-5UW4-8M3>O";V2TV.I/(4IDG'O\ R&*SO"7AWQ%IOQ*CUV_T6\2VET,6
M\DCW$<K+*"I((#<9*G"J, $< 9QSG_""^*O^%&MX;_L2?^U3JGG^3OC_ -7C
M.[=NQ[=<T >PZ-XTTK6]?O=$MUNHK^TC69H[F QEXVQAUSSCD=<'FN8^-FLZ
MGX>\%1:GI%_/9W8NTBWQMP5*L2"#QV'-.T?1=6C^-^J:_+IL\6EW.EI;QSL5
MP9!Y9((!R/NL.G:CXTZ%JWB;P9%IFC:?+>71NTE*H54*H# DEB!W% &=XR\3
MZS\//^$?UH:C/?Z/>.L-]:W05BI*[M\;@!@<!N"2.!7:ZKXXT;2+FZ@F>:4V
M4*7%XT";EMHW.%9^>_7 R<#.,5Q_B_PIK'Q"3P_H\FGRZ=I-DZSWL]RZ;W(7
M;LC56)S@MR<#GO56\\+:CIWQ,UVYN?#UWK6@Z[#$,6MP$\MD4+MD4NH*]>N1
MC&.XH L^+?$VI7_Q+T7PMI]W>VEA>64DOVBT7YG=D;9(ISRBG!Z@'!SFI_"O
MBB/1[+Q7=ZKXBU+6$TJY5+@3VBQM:XRI "G#<CG'''N:6Z\.ZE%\7O"^I6VD
MNNDZ=IAM))(F!2)BK@*,G<0-RC.*P(_"GB'^Q_B9"=&N!)K=TTM@I9/WJEV_
MVOEX(/.* .^TKXBZ%K&LV&EVXO(Y]0MOM5HT]NT:3)@D[2>X /MQUKF;+QTF
MB:'XRUJ74=0UK[#?L@M9;<1_9&)($602"H/!;IQP,GFAI?AC7X/&'PZO9=(N
M$MM(TG[+>N63]U(8G3&-V3R1R,\&JD'@OQ%<^%?B/8G2Y(;C5[]KJQ61T'FI
MYFX#(/!P.AQUH WM0\6SWNF^![JXU/4=&FOKJ#S%2T#)>,RIE/O?*A+<'D8S
MQQ73ZEX^T33+O4896N)4TOR_[0GACW):^8<+NYR??:#COBN'US0?$&I:+\.T
MBT*Z631[JVDO$9X\HD80,?O8.2K8 YP.W2J^I^#-=LXOB#IUMI\MV?$<\<UC
M,A79\SDNKDGY-N[OU'3TH ]"U/QWHVEZW8Z3*+J:ZOX#/:"VA,HF7!/RE?I_
MD<U7M?B1X>N_#$>O12S?9Y+L62Q/'MD\\G CP3@'G.2<8[URH\(ZQIOQ \"3
MQV<MU8:+I9M+J[0KC?Y3*, G)&2.W>LSPYX'O3\.=0T'Q'X>O'6ZUE[@K%(G
MFQ1M&-LJ'=C(*X(]">#G% 'KVF:G'JD4SI!/ T,IADCG3:RL ">YR.1R.#VX
MJ[7EWAE?'/A/PC:V:Z=)K+G56AB^TRA)8K'@*[<G!X)P2=H('; ]1H XKQ)<
MWD/Q(\(V,-]<Q6E^+LW,"2$+)Y<89/IR>V,UL:ZLO]KZ ([JXB2:]:*9(I"H
MD002N 1_O(IXYXQ6=XMTN_;Q%X:\0V-J]X-)EG6>VC($C1S1["RY(!*D XSS
M5WS+G6]9TV9;"ZM;2PD>X:6Y4(9',;QA57.>DC$D@#@8SDX *LGQ$T&..XE)
MO?(MKO['<S?8Y D#Y ^<D?*,L!S_ "J-;RX@^*]U;27LWV$:&MR87D_=H_G,
MI8#H. .:YJ_T/6;CP-XUT^/2;DW6HZM)<6D9*#S(V:,AL[L#[AZX-:^KZ+J&
ML^,=49+6>"SOO#C:<MTX&$E9W.",YX##G&* .@B\7:6^H6MG(9[=KR)YK22>
M(HEPBC+%3[#G!P<<TL?BO3F@-S*+BWM?L;7RW$L>$>!<$N",]F!P<'GI7,>&
M[>]>UMK>]\"6UGJ5A"RRWDD<)CD8(5_<LIW$N<9R  "<D]ZNFZ!?:9]JBTS3
MK^30I],F%QH>H.&6.8XVQ0L3]U@7!P=O3GT .]L=6COKJ:V^S7,$T4:2LLT>
M,JY8*002#]T\=1WJS>WMMIUE->7DR0VT"&221S@*HZFN2\&Z/?Z-JUW!;RZ@
M?#QMT-O!J)W26\N3F-&/S% N.N1GH3S6EX[T.[\1^"M2TNPD5+N55:'<<*S(
MZN%/L=N/QH L0^)[*34!82175O>20-<00SPE6G0=2GJ1D94X89Y%<5JGC&YU
MKP1INNP&\TP'688V )0/%]J,94D=?E7Y@.,DUNR6=[XD\3>&M4ETZXT]=*$T
MTXN, ^8\>SRUP3N'))(XX'KQS4.BZ[%\/].T1]$NOM5CK,<S$/&5DC6Z:4NO
MS=-I'7!R>E '=V7BW2KQM35FGM7TU5DN5NX&B*QL"5?##)4A3^5,/C#3(KNX
MM+I+NVN(;4WGE2V[;I(0<%U R3CN.H[@5ROB#PYJVMZUXL6VM7A2_P!+MH;6
M>7&QY8G=RI&<@'(&2.YJW8)<:AI]U,W@5=(O8[.2)W,<.]Y&7&R(H<E<\EC@
M=.#U !H)\1M#DM(KQ8]1^R2K 4N#9N(V\TX0;B,=>#V!K8A\0V<VM7VDJLXO
M+*)9I5:/:-C9VD$\'.#T].<5B:9X=DU/X36GAO4H'M;C^S$M)%?&8Y%0 ,""
M0<, 0?:L-?"_B2\FT/6+L*FIWT+6&M('X2V9 ?E]""AZ?Q2F@#IUUO3+_P 0
MZ%MNM2AN+JUFFMK8H\<4T>%)9P1@D#&!G(W=.:OV?B.ROIH$ACN#%<AS!<%/
MW4@7J0<\>V<9ZC(K*UBQO)?B'X9O(+*5[*SM[N.:9<;8S((P@QG/\!Z#CBN?
MTSPUJ*:A&NEQ:AI5A?07"ZIIUPP>"WD9"%>#DX)<YPIQC.<'B@#KXO%NERZA
M8VA,\8U ,;*>2,B*YP,G:WTY&<9'(S6[7G?@ZQO8HM-TS4_!-M:W^FA4DU1D
MA:)@@P'C(.\NP'H,9.3V/H,J&2%XPQ0LI 8=1GO0!P/C7Q.)=.TV32I[^.-M
M8MK<74 *Q2_O@KIN')'##/W3@C)KI-4\6Z7HZSRW1G^RVTBQ75RD1:.W9L8#
MG_@2YP#C(SBN CTSQ'#X!TOPQ)X>NY+W2M0MBTT3Q^3/%'.&WJQ8=5'0@8/6
MM&+2[[3M<UFQO?!D6LV^HWCW=I>LL+(@DP3'-N.5"G/(W9'04 :.KZK+JOCL
M^&V;4X++^S#,);)GC?S&D"B3<ISM4 X[9)R#Q4FC^)M$T+PT]S-JVK7T"Z@U
MG)<WT3M)YY8*5(VC8H8\ @ 5-'9WL7Q0%_\ 8)18+HRV?VA%4)Y@EW8"YR!C
MVQ7-2Z)K3^%-2M!I%U]HF\3?;XX\IDP?:5DW9W8^Z#QUS0!W%GXNTJ[EU*)F
MGM7TZ,2W"W<#0D1D$AP&'*G:?RIT'BK39-3DTZ?SK*Y2W-V%NX_+#P@X+@GC
M [@X([@5R7B3PYJVNZ]XE%K:R0QWVC06]M<2X"--'([[2,Y .0,D>M-ETB\\
M5>&]2LE\'0^']1DL9;=KF5(N9&7&R-D).PGJQQQV.> "YJ?B)[SQMX,%E)J,
M%G>RSL0RE(KF,0.P./K@@-@]#BN](RI&2,CJ.U><J==U34_!<\WAJ^MGTR:0
M7H9HMJ$P-'E3O^9<G.?3WXKT8G )]/2@#SOPIXP@TZPN8=7N;^X)UNYLUNI(
MWD2+]\4C5WQA>P'ID=,UU6K>*M.T9;F2Y%P\%GM^US0Q%UM\@$;\<]""0,D
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M#;E8$$%64D^N0<<=:S9? LRP:8MK?PK-;:NVKW,DD!/VB9M^X !AM'SX'7
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M6MO#<R-):G.UB)&.[:W/'0$'%=O!X0\/V^@S:(FEPG3I^989,OYAXY9F))/
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M6PHZ#)YH X;3K*$?%#Q?-OGWK8V;@?:'VDLLP.5S@CT!&!VQ7.^%UGTOP_\
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MC6.- %5%& H'0 4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MECW V$<GL1VJ3Q'J,,]MK,<4$UF]MXBMY9;6*W=S*!+%FX=R#PP *[<# [T
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MC5+I]BDA(?/0[\#^'J<CCK7J.L"YU#POJ TQF2ZN+.06S$%"'9#L//(Y(ZT
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MQTZ5$9KFQ\4!](O4O[.[U@+>:-=Q_OK:3?AIXF'.T8WD'(QGF@#T2_U*QTN
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MIKE@BDD0_;%;?@<[=O.?2@#TV/48[KQ!!';:U8R0-:-)]B3:TC_,N)0P;.T
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M50#,N[JN=P4E& ..WH<URNC^)SX7?Q=--INJW]G;:U*TT\)$@MXO*BY)=MS
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MR5P1\V"IWKR.>>E68O%XDU._TY]&U&.]M;47D4#"/=<Q$E<IA\ Y&-K$'D4
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MK":9BSLK2,R@GN0"!^%:% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]6B^(,6L36_GVZ:-]C>5&12\WF!R0I/"\8^OMS76T4 <UX!TJ^T/P?:Z;J,
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M!8M1<"W7[4R&8Y+"/[J\]!ZXZ9[]<#I4U-1UD171@R, 593D$>HIU !1110
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M;R1A#@L6^<$/Z+T[58N_!/VL>)@VI.J^($6.<"$?N@(_+^3G^[ZYYY]JL_\
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MTDU:^,MSJ7]J0W(V![:X&,.N!STYSQR< 4 9WC\:VG@#Q-%JAM9K=&MS93Q
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MGIUCIUM]FL;.WM;?)/E01!%R>O &*S]+\6:%K"7K66HQ.+'FY$@:,Q#&<L'
M(7 //3BIK'Q!IFH:A)803N+R.,3&":%XG,9. X#@;ESQD9% #4\,:!'#+$FB
M::L<S!Y46U0!V!R"1CD@]ZO6ME:V,1BM+>*",L6*QJ%!)ZDXZGWI;N[@L;=K
MBYD$<2D#)YR2<  #DDD@ #DDXJA;>)='NH;V5+U8Q8G%TLZ-"T.1D;E< @$=
M#CGM0!9U+2=.UB!(-3L+:]B1PZI<1+( PZ$ CK4+>'M%=)$;2+$K)*)G!MU^
M:0='/'WAGKUJNGBS1GNIK7[1,EQ#;FY>&2UE1Q$" 7VLH)&2.1[^AJ:/Q'I,
MO]F;+P,-47=9-L;;,-N[@XQG:"<&@":31=+ETU]-ETZU>Q?)>W:%3&Q)R25Q
M@G//UIJZ%I*:0=)73+,::1M-H(%\HC.?NXQUYJ"/Q1HTU]%9I>YDFF>")O+<
M1R2)G<BR8VEA@\ YX/H:Y*XUG68]/^(I759O-TC<]E)Y<>8@+82A<;<$9/<9
MQWH [.PT#1]+E$NGZ596L@01AX8%0[1SC('3D_G4]]IMCJD*PZA96]W$K!@D
M\2NH([X(ZUE:1XBLY(])TZYNF.JW5C'<;#$V7&T;FSC&,GGGO6M::A;7SW"6
M[LS6TIAERC+M<#)'(&>HZ4 ,CTG38;UKV+3[5+MD\LSK"H<KZ;L9Q[57M/#>
MA:>EREGHUA;K=?\ 'PL5LBB7_>P.?QI=2\0:9I$IBO+AED6%KADCB>5EB!P7
M8("0ON>*KWGC#P_8FW%QJD(-S!]HA"Y<R1\?,NT'.<C'<Y&* +\6DZ;!IS:=
M#I]K'8L"K6R0J(R#U&W&.:@M_#FB6NF/IEOI%A'82'+VRVZ"-CZE<8-4H_&_
MAJ32[74UUBW^QW4XMXI&R,R9QM((RI]<@8[U!)XKTW6]"UMM!U7_ $NQ@<N5
MCVO"P4E25D7H<=<8- &NNA:0DT,RZ59++ GEQ.+= T:_W5..!["J-[X0T6[M
M(K5-,L(($N5N2([5 =X/WEQ]UCTW=<$]#R,O2-9%SH?@J2_UR2WO[ZWAE,2H
M";UC!EE;Y3@9RV1CI6Y=^)]'L;GR+F\"-YRP,_EL8TD;&$:0#:K'(X)!Y'J*
M -:LR3PYH<JSK)HVGN+B7SI@ULA\R3^\W'+>YYJ.?Q1HUM>-:RWNUUG6V=A&
MYC25L;49P-JL<C@GN/45S$?C.WT+QAXHM]?UAA96QM3:JT6XQ*\99^$7.T$C
MYCTXR: .RCTC38K[[;'I]JEWL\OSUA4/M_N[L9Q[5'IV@Z/H\L\NF:796<DY
MS*UO L9?ZD#FL'5=8N?^$S\()8:@7TS4A<F2.,(R3!82Z,&QGOG@XZ5L3>)M
M(M[V*TEN]DDLWV=',3^4TO\ SS\S&S=P1MSG(QUH T;FUM[VW>WNH(IX)!AX
MY4#*P]"#P:JG0]);3?[-.F6?V$$$6WD+Y8(Z$+C'%6KF=+6VEN)!(4C4LPC0
MNQ ]%4$D^P%86B>,=/U?PU;:VXEMH+@@1K+$X9BQ(55&/G)X^[GF@#4.C:6V
MGMI[:=:-9N<M;F%3&Q]2N,&D&B:2)[:<:99^;:KMMY/(7="/1#CY1]*73M8L
M-6\\6<^^2W?RYHG1DDB;&0&1@&&1R,CD5@>.=7N=$E\.W,6H&UMIM6CM[L$+
MM>(H[')(R/NCH1WH WAHFE#4#J TVT^V,P8S^2N\L!@'.,YQQFK;P0RRQ2R1
M(TD1+1LRY*$@@D'MP2/QK*TWQ9H6KV=Y=6>I1-#9$BZ,@,1AP,Y<. 5& >2,
M<5)!XCTNYN);>.:7[3%#YY@>WD21H_[RHRAG&>/E!YXH T$MH(Q,$AC43,6E
M 4?.2 "3ZG  J@/#6@BWCMQHNG"&.3S8X_LJ;4?^\!C /O7&:EXXDU/PUH6N
M:;<7.GP3ZU;P3"6':KP-.5.6=?[HR2IXR037:Z3X@TS7'NDT^Y\V2U<).C1L
MC(2,C(8 X(Y!Z'M0!0U[PS%>Z7J*Z3;Z?:ZC>*JR3R6P/G*"-R2$<D,N5SU&
M<BLK1?!B6^JVNH3>'O#^D36SEP^E9+RY4K@GRTVKSR/FS6UXD\3VWAS^SEG@
MN)7OKM+:/RH7< D\DE0>< X'4]AUQS\'B^/2O&'B>/6=4E_LZVALY;:-X"6A
M#K(7^5%W8&!DL..,F@#NI(TEC:.1%='!5E89!!Z@BLV;PWH4^E)I<NC:>^GQ
MG<EJULGEJ?4+C /)_.GW.N:=:V\,[3M(D\?FQ"WB>9G3 .X*@)*\CG&.1ZU8
MT_4+35;"&^L+B.XM9UW1RQG(84 0/H6D2K:K)I5DZV@ M@UNA$..FSCY?PI[
M:1ICWSWKZ=:-=NGEO.85+LO]TMC)'M45YK^FV,[PSSN'C*"0I"[K&6.%#,H(
M4G(ZD=1ZU176M.M];UIY==+)96\37%HRC9:CYOFW 9);'3)^[0!<'AO0A:Q6
MHT73OL\+^9%%]E38C_W@,8!]Q4L6B:5!>&[BTVTCN"YD,JPJ&+GJV<?>.3SU
MJE8>,-!U2^M;.SU!99[J'S[<>6X$J8!.UB,$@$97.1W IUUXMT*R8BXOUC43
MFV,IC<Q^;_<WXV[NV,YSQUH UY88YX7BFC62-QM9'&0P]"*SU\.Z(L5O$NCZ
M>([9M\""V3$3>JC'!]Q3!XETEAJ!%T3_ &<BO=#RGS$K L#C&2" 3D9XK&U'
M6KB3QCX._L_4&;2]4CN'>-57;*HAWHV2-PZYZ^G% &VWAG06DFD;1=.+SRB:
M5C:IF20'(9N.2#SFM![>&2:*5XD:2(DQN5!*9&#@]N.*S(_%&C2WT5FE[F2:
M9[>)O+<1R2IG<BR8VEA@\ YX/H:@@\9^'KG4ETZ#4XY+IKAK41JC']ZJ[BI.
M,#COG!YQT- %[4]"TC6O*_M33+.]\D[H_M,"R;#[9'%7P JA5   P .U5[_4
M+32[-[N]F6&!2 6.3DD@  #DDD@ #DDUFR>+M"AL+Z]FOQ##8-LNO-B='B)
M(!0@-R""..>U %Z?1M+NKMKNXTVTFN6B\EII(%9S'_<)(SM]NE1+X>T55ME7
M2+ +:G=;@6R8B/JO'R_A4=AXFT?5-3DTZSO5ENXXO.,>QEW)G&Y20 PSQE2<
M&N;\3^*U%]X<CTC4IE6YUB*VFV0'RIX\D.!(5P<$#[K>M '4_P!@Z/\ VO\
MVO\ V79?VEC'VOR%\WIC[V,].*T&574JP#*1@@C@BFS31V\+S3.$C0%F9N@%
M<_:>/?"]]>V=G;:O"\UZ/]'^5@LA] Q&-W^SG/(XYH O_P#"-:%]D6T_L73O
MLROY@A^RIL#_ -[&,9]ZL1Z1IL5ZU['I]JEVZ;&G6%0Y7T+8SCVKE]-\1OI^
MO>,CK.HR-IVF3P>6[Q B%&A#G.Q>F2>3^)KHWUW38[^*R>Z"W$T#7$:LC /&
MN,L#C!QD9Y[T )8^'=$TQ;E;#2+&U6ZXG$-NB"4>C8'(Y/7UIL'AG0;41"WT
M73HA"KK&$M478&^\!@<9[^M9]OX^\+W2,\.L0LBP-<%]C!=BOL)R1C.X@8ZG
M(P.14MYKMM?Z1K*Z9>RPWUC S.&A*20L4+(2DB]#CC(P>: +@\.:&+>" :-I
MXAMW\R&,6R;8V_O*,8!]Q2OX>T63[3OTBP;[5_Q\9MD/G?[_ !\WXU7\'WEQ
MJ/@K0KV[E,MS<:?!++(0 6=HU)/'J36/KFOR3>-+7PS%<7UI'+92SR7%M;.S
M[PT:I@["-HWDD],@ D<@@&_+H.G?)+;6%E!>01&.UN/LR%H..-O' 'H,5Q5C
M\/9)(8K;4M \,QRH &U:U#?:78?\M -@VN>N[><'GGI746GB&PL+>ULM1U<7
M-TKBTDO3;M'%+.."NX#8K$\;=W7CKQ2W/C7PY9ZA+83ZI$MU%+'#)&$8[7?[
MH) P,^O0<9QD4 :$>B:5#>&\BTVT2Y9S*95A4,7/5LX^\<GGK5UT61&1U#(P
MPRD9!'I7/)X]\,2+;.NK1^7<RF".4HXCWABNTMC"G(.,D9[9JU:>*]$O1?F&
M_7_0%#W(D1HS&I!(;# 94@'!&0<4 2CPUH2P0P+HNG"&&3S8HQ:IMC?^\HQP
M?<5,FC:7'-<S)IMFLMTNVX<0*&F'HYQ\P^M+9:M::A/-! THF@"M)'+ \3*&
MSM.' X.T_E4E]J%KIT2274NP.XC10I9G8]%50"6/!X [&@"E9^%_#^GLC6>B
M:=;M&&"&*V12H;KC XS@5*/#^C+ILNFKI-B+&4YDMA;H(W/J5Q@U3NO%>G)H
M&I:I:.]Q]A5Q+$(7WI(JYVNF-R]NH'!STJCX.EU#5;.QUR75KJ6*YL8S<6<]
MKY:"=@K;XR5!"X)&!D'CG(Y -D^'M%;24TIM(L6TY""MH;=#$#G.=N,9S3AH
M6CB.ZC&E6(2[4)<*+=,3*!@!QCY@!P :SYO%%L/%X\-+%=K<-:&X:9;=RJY8
M*N#M((Y;+'Y1@ ]Q6%X)\:VTVAZ?!K>JF75+J\N+=7>+ =A-(J*2J[%8JHP#
M@GL* .IO/#>AZA:6]K>:/87%O;?ZB*6V1EB_W01@?A4NH:)I6JPPPZCIMI=Q
M0G=$D\*N$/L".*@U#Q-I&ERLE[=^4$=8Y)/*<QQ,V-H=P-J$Y'WB.H]16H[A
M$9SDA1D[02?P Y- &>GA[18XA$FDV*QB<7(46Z@"8'(DZ?>R3SUK2KG-!\9Z
M?K>C3:GLGMH$N'A'G0.I;$C1KC(^9B5^Z,D$XQFI9/&?AZ&RN;N;45ACM95@
MG6:-T>)VQM#(P##.1CCF@#0N-&TN[O8[VYTVTFNXO]7/) K.GT8C(I]QI>GW
M=Y#>7-C;374'^IFDB5GC_P!UB,C\*R(_'?AF69(4U:,RO+)"B;'!9T7<P''/
M&,>N1C.:8?'_ (7%G]K.J*(1*89"89 86!P1(-N8^3U< 4 :J:#H\=M=6R:5
M8K!=DFXB6W0+,?5QC#?C4NG:78:/:"TTVRM[.V!)$5O&$7)ZG [U!>Z_ING2
MR1W,[AHE5I"D+R",-TW%00N<=\5?FECMX7FFD6.*-2SNYP% Y))["@"M+I6G
M3WR7TMA:R7B+M6=X5,BKZ!L9Q5?_ (1K0C:O:_V+IWV9W\QH?LJ;&?\ O$8P
M3[USDWB9[KXB^'[&POKC[#=6MS+-;R6QC5MH78ZED!(.6Z$CBNA3Q-I$FHP6
M(N\3W!98"T3JDQ7[P1R-K$8/ )Z4 277A[1;V\M[NZTFQGN;8 032VZLT8'3
M:2,C%+<^']%O+J:ZNM)L9[B:/R999;=&=TQC:21DC':N,/B"X\07VOK#K=[H
MD>E7*)%+]A)3RQ&C2&0.F,G<0 2",*0/7H+/Q1HEAI6C1W6NBY>]MP]M<2H0
M]T FXO@#@D#.,#GCK0!J)H.CQS&9-*L5E,0A+K;H&,>,;,X^[CMTIB>'-#CC
MMXTT;3U2V;? HMD B;U48^4_2F67B71]0TJ34K:]#VL<IA=BC*RR @;"A ;=
MD@;<9.1CK1;^)='N8+Z9;U8UL#B[$Z-$T'&1N5P" 1R#CGM0 \^'=$:*XB.C
MZ>8[EM\Z&V3$K>K#'S'ZUS&K^#[FZUV:X.A^&]7T]HXXK>+4$,;VBJ.57$;@
M@DD_PGG'85-9^(9KWXI_V;!>7)L/[&>Y:UFMC%LD\U%##<H8@@GKD=:[2@#+
M\/:+%H.DK90I%&F]I/*@4K'&6.=J#LH_Q/>M2BB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N2\>
M6=_+!HFH6,$MTFF:I%=W%M$-SR1 ,K%5_B9=VX#OCUKK:* .,MK=[GX@7GB>
M*"ZCT]-(6S.^WD1YY/,+\(1N.T8&<?Q8'0U-\,X+BT^'FCV=W;7%M<V\&R6*
M>)HV4Y/8@5UM% '$:P]YH_Q,LM:FLKRZTF?3&L2]I \YMY?-WY9$!;:P &0.
MJC-<I%9ZO;Z?_::Z)JDL5EXFO+N:SC1XII8)?,4/& 06(WYP#SSVKV*B@#S7
M6[2&]^'OBB;2/#^I03:G!Y:K-#(;FYDVX!9#E@!P 3CH>V"=+6A-<Z]X'N(;
M*]>*WN)'G86LG[H&!T&_Y?E^8@<UW%% 'DFI6-]-X'^(-K'I=^UQ?:I+):QB
MSDW3*5B 9?EY&5;GVJ_?%[#QAJSZIH>M:AI6LPPM;R6*2L%*QA'BE12-N<9^
M88Y.:],HH \ZTZ.Y\*^-FEN-'NUTN]TNVM[7[' ]PMFT1;,+; 2!\^=W3CK6
MM\,H+FU\"VEM=V=Q:3QS3[HIXRC -,[#@]L,*Z^B@#B-3M;T?$QIH[6Z\B\T
M(V<=U%$62.7S2WS,.%P#GGKCC)XK(\(1))::/I6J^%M6CU;1]BM-<"1K:,QK
MM\V-RQ4Y X"C.3C&.:].HH \PL+.['P?\2V!TV^6\G.H".!K20/(97D,>%QD
MY#+SV[UH-#.WBCP'.+&\\JTLKA)W-I(!"S11JH8[?ER5(Y]*[^B@#RJ#2Q=6
M&JP7UIK=H9?$\]U:WEI;2K+;YC.R<#:<J<%3P1\_-=GX+;6#H;KK1$EPES*D
M=QY'D-<1AOED:/\ A9N>/Q[UT5% 'G?C.QNVU>]U#16U.TUF*S14"6K3VFHK
M\Q$,B[2N021G((#YZ=)H$NQXX\07EUI]TJS:-;Q!TMI&1I%\PNBL!\V-PZ=:
M[ZB@#RKP_P#VC9:?X1L;K1=1BB32&@EN(+)O/68%1Y#.1F)"!G=D D#YABJ^
ME6FH1>"? -I+I.I1SZ?JR/<HUHY,:*LH+$ ' RXY/7Z<UZ[10!R'A^*>/XB^
M+9Y+6YC@N%M!#,\#JDFR-@VUB,'!(I_Q M+FYTK2Y;>UFN1::O:74R0QEW$2
M2 L0HY; [ $UUE% 'F7B?P_J/B74-=U;1[>6+?HR6<(F1H6NI1-YI&&P0-JA
M<G'WSV%;/A>:RUC5(M23PWJUC>P0-'+/J@D5H\XS&A<G<"><CCCU-=I10!R?
MQ!M-0GT2RNM/M)KQ["_BNY;6!RLDT2Y#*A!!W?-D?[M<SJ]H=3T:76]"\-ZF
MDL5Y9W-S'>(ZW-ZD,FXQA'))VC!&>IX&:]2HH \W2]_X2#XCO);VEW;^=X9F
M1%O(3"Y)F4?=;D<^H_2LW23?/8?#NV.BZLCZ1*(KTR6;H(F%N\?4CE<D?,,K
MSU[5Z&WAZ%O%:^(?M=T+E;4V@A!3RO++!CQMW9R <YK7H \A/]J71\/W$N@:
MI!<66OM)<6EO9%(+=#YH!3  ?=N5C)R,DY*YQ6E<VUX]G\3D73[XM?HPM!]E
MD_?DVHC^3CGYAC]>E>F44 >?:[:74'@OP_K]C;N-6T-(9$@E4QM*A4)+"0PR
M"PZ<=56NQT2P?3M)@@F8/<G,EPXZ-*Y+.1[;B<>V*@N_#T%]KL&ISWE^RPJH
M6R$Y%L65MRN4[L#CG/8<<5KT <'XJ:]E\2W5F-*O#;S:2R0W5E;;FGD+-^YD
ME _=J.& RN23SVK TF=K#5/AJM]8WD$EOHUS!)&]LYD1EC@4DH 6 R",X_3F
MO6ZQ[SP]#>>)+#7'O+I)[&.2.*)"GEE7QNSE23G:._:@#S;5].?3;634Y;6:
M*VU'QC:W<-L8CO* JI;9C.6*L<8SR.,\5T-]I\M[XF\0:_;6ERMLV@FP -NZ
MO<S%F;Y4(W' VC..^.QKJ=?\/P^(([))[NZ@%G=1W<?D%!F1#E<[E/ /:M8#
M  SGW- 'F<-M>+I'PSC.GWP>P:+[6OV23,&+9HSN^7CYB!^O2IM"FO-,?4_#
M.J^'+R]F?4IKFVN#;>9:SI)*9%=Y#\JE2>0>1M&,GBO1Z* /(_$RZG?6VN0?
MV'J230ZU!-%#9V9$4T*RQ'SRRC]ZY"G(R2,#Y1@FN@MG?3?&?BJYO=*OI(=2
M@M6MU2U:43;8BK(2H*J<G&&(]>G-=Y10!YAI6@ZAH-S\.;"XM[B9M.BN1=RP
MQ/)'"7B(4%@,8R=OX9Z5%H-F8X_^$:USPUJUW?V]Z\D5RWF&SE!E+I-OW;%(
M!R1C.1P,G%>J44 -D!:-E'4@BO)-(LM7M/"?@>X;2M0']@7)6_M&MV#D,CQE
MT3J^W=GY0<@\9P:]=HH Y+1;"6X\?ZOXABBFAL9[*"U42Q-&9I%+,7VL < ,
MJ@D<\XH\>6UQ+'X>NH;6>XBL=9@N;@01&1DC"R MM7)."PZ FNMHH \L\4^&
M]4\02^)M7TBUDC$]I:0PPRH8FO'AE\U\JV" 5P@R!G![<G>EBD\1^-?#.L6E
MK>6\.G0W+W+7-N\)_>(JK%A@-QSDG&0-O7D9[6B@#R"TM-0C^'GAG2Y='U-;
MK3];MWN$-FYPB7#.S# Y4+@Y'!SQDYQU^B1SK\2_$URUK<I;W%K9K%,\#JDC
M()-P#$8.-RUV%% '(^/H+EX- NH+2XN4LM:M[B=;>(R.L8#@MM7).-PZ5E>7
M<-XB\=7#:=?+'>:;;1P$VKGS&6.4,JD @D%U'&:]#HH \DLH[_0_^$7U"^T;
M6KFP.@0:?<)91RB:UGCY):-2&*G)&>?NBO1?#5G;V.AP0VFFG3;<EG2U;[R!
MF)^;DX8YR1V)Q6M10!YOXGLM0BU_4=2\/#48-5#PI):26S2V6IIM7J=NU" 2
MI8$8V\U-=PW(\5^-9OL-ZT5SI$,,#K:R%9759054@<GYUZ>M>A44 >9V-K=Q
M_P#"L0VGWRFP@9+O_1)!Y!-J8\/\O'SX'Z].:R(YK.&"XTN^M];AT>#7)+Y7
M3299@ DQ?'GIE=I<$YQD XZ\U['UKF+#P5;Z=$+2#6-7.FC(6P>X4Q!?[H;;
MYFWVWT <[J!N;7Q#XTV:=?W*:SIL+6,MM;M)')MA=6!<?*IR1P2,YXSQ3;"W
MO%N_AH9-.OT^PV4D=UNM7Q QMU0!SCY<L".:]*50JA5   P .U+0!Y"_]J7?
M]@3RZ!JD%Q9>(6EN+2WLBD$$9\X!DP )-VY6,G(R3DJ#BNN\$12PZKXL::TN
M8/M&KO/$\UN\8DC,<:@@L!D95O\ )KL** .;\<37<'AY7M-.-\PNH/,5+?SW
MB3S 6E2/!W.N,C@\X.#BN"U*RU"6P^(L,.E:S)_:5K ;1YK9V:<^4%/;KG^'
M V]PO2O8:* //-6M+V^\6:8UE;W<(;0;JU%R;:14AE?R]@8[?E/RD^V*QHYK
MV;PIX*TIM U:*^T?4K-;R/[$^U%B5E9P^-K*>N5)Z\UZY10 U_\ 5M]#7C_A
MZS/B'X5>#])L[2X%U%=6]P9FMV5(%CD+-('(VG*Y P<DM]<>O31F6%XUE>(L
M,!TQE?<9!'YBL_P[H4'AK0K72+6>>:WMEV1-.5+!?3*@ _E0!PNHZ7J&H#XF
MV\%C=;]0A06A>!D6<K;!"%8@ _,,58M;R>^\9>%M132-6CM+?3+F&:2:RD3R
MW/E<$$9'W3VY[9KT:B@#R_24U'3O@QY$>A33WT4S[[.XLF9MK7);>(V WD*0
MX'J!]*?8QW2:_P",+C^S]9D@O]*@\B>YMGW2LJR@C&.&RR_( ",_= KTVB@#
M \#Q2V_@30;>XAE@G@L((98IHRC(ZH 001GJ*S;I9A\6K&Y%I=FV32)K=KA;
M=S&)&EC8*6 QT4UV-% 'DL>D:G-\*[SP/<V%V=9$SPI*8',4FZ?S%G$N-N,'
M<><Y!&,X%=/X?AFMOB%XKGFM;L1316:Q7#VSA9?+1@^UL8."1TZ]LUV=% 'D
M2V-[_P *PM[(Z7J'VI=>$YA^QR;Q']M,F[&WILY_3K6OK5J+KQGK\EUI&H7>
MFW.APVS"*WD'FD2R%E5L?>"N"/>O1J* .-\&0ZO9ZGJ%I<7EWJ.DI#$;2]O[
M<Q7 .7S$Q(!DVC!W$?Q$=<X=XOM[Z'Q'X7UR"WGN;+3KB9;N&!"[JLL>P2!1
MRVT]< G#'BNPHH \\GTZYDN?'.MPVMT+?4M/CMK>$6[B2>1(G!;9C=U95&1S
M@]L&NI\(!T\&Z+#+#-#-#8PQ21S1LC*RQJ""& /6MJB@#CKM+BS^*T%^UC=R
MV<VCFV$T,+.JR";<0Q'W?EYYZXP,GBN3MK*^3X=Z):G2]0%S#XB6YDB^QR;U
MC%VTF\C;TV$'/X5Z[10!Y:+<V^K:]HFN>&]7U./4+V2YM)(/,:UGCDP0DA#!
M4*D8.X= *]0B3RXD3 &U0,#H*=10!Y#'8ZS;>#K:./1M2EGT;7IKNYMD5HVN
M(6EF_P!2V1O.V0,-IQQCK5KQ%:V^J>"M;NM)\-ZK%/?/:*WVBWE:XN3'*K'*
M-EMJJ#@G&>0.V?5** ..\0I+/XX\&W45I=26\$ER\LBVSE8@\)5=QQ\N2<<U
MS5[97DOA'XCVR:9?F:_O97M4^QR9F#11J"OR\C<K5ZM10!Y?KMI?FXN-4T!=
M5M=96WA0VTMF\EIJ:[1A) 5PK#+*3D$#K[=3\0-,U'6? .JV.FH&O98E*Q!L
M>9M969,_[0!7\:Z>B@#SF[OI_$7C#PQ>VFE:M:QI:7L4TEQ8R1?9I'6,*&+
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IZKJUAH
MFG2W^I74=M:Q#+R/T']3]!5#3?%6G:MJ<FGVT6H+,@8DSV$T2<'!P[*%/Y\U
M5^(G_)./$G_8-G_] - '112I/"DT9W)(H93C&0>13ZIZ3_R!['_KWC_]!%4'
M\5:<FN_V.8M0^U;PFX6$QBR1G_6;=F/?- &W1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5GZYI$.OZ+=Z5<3316]U&8I3"5#%2,$9(.*T** (+*U
M%E90VHEDE$2! \F-Q Z9P /TJ>BB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>exhibit1061-loanandsecur002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y[4/^$C_ .$B
MF%E! VGOI["&=Y]ODW/S8W1X^8'Y.>P4^O/0T4 >2>*O&/B.PB\+>%8D&EZ]
MK,HCN9A,+@VT>_;N5B,%B.>G&"!V([2Y\*3P:?&NE:UJT5VCHSR7%]),)E#
MLK!R0-PSRH7'TXK$^(_@C4->U'1/$6A-$=8T:<2)#,VU9T#!MN[L<CZ<FNFM
M=7U>]\E!X>N;%RR^<]Y+$409^8+Y;L6/IP!ZD=* ,W4OB+HVFW.JQF*[N(=(
M,8U&Y@12EN7. #E@S$=]H.*P-2UJ[?XX>&[*SU*X.DW^ER3O"DS>5(=LFU@,
MXZ!3D>F:R=2\!Z_;0^/--L;(W:>)+B.>UN1*BI'ERSB3)##;DXP#FM"'P9K&
MF?$;PA>P6;W.F:-HXL)KD21@LX1UR%+ XY':@"M\/?&_]F^#M>U3Q)J5S<1V
M^MR6D+3.7?&$"H"Q]2>I '))KKX?']A.GB&-;"]6_P!"3S+JS<)O*[2P*L&*
MD$#U_"N TSPIXXTCX?Z_I]CI,2:E>ZR;J-9986_<,%R5))4."O?IG(YK2\/^
M"M?M?$GC.2?3DM;36K!8K>4W@FVOY97#$_,3D\DCUY/< V?#'Q(6Z\ 0>(]<
MM)[?SYF2$($(N&:5U2.(!LD@ #Y@O3/3)K4O/B'I-AI.LWUS;7B-HTJ17UL%
M0RQ;\;6^]@J<C!!_E7G\O@#Q3=?!W1]$&G)#JVB7HNHX9+A&6YP\AP"#@##C
M&2.A''!.[X@\-:AK7PZUR#3_  C#I>JZFD"- )XC)(4<$EW!V[0,@<Y]A0!N
M1_$[0VL;W4);;4K?3[6TCNS=S6I6*57("JAS\QR0/3T)'-6]/\9:=KFK:AH
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M5I]MXF\-^(-:M;31TU#3]3O&O;:\^THBV[NJAEE4_-@%<C:#Q^E^TT_5=/\
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MD4<A1@_F*3DN6(VD@@<<KR: .CN_&-A;:PNE16M_=WCV?VR-+>#<)(]P'!)
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M=VX=70NK=79@05)'0B@"WJ'BFSL7OPMM=W::<H:]>V16$&5W<@L"QV_,0H)
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ME)9<,O!'(Z52\%Z5J>D6M]:WEQ=RV0N,Z>M[())XX=JY5F!.1NW8R2<8SZ4
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M?VAIEI>^4\/VB%)?+?[R;E!P?<9H X9_&5OJOP_U/5=;L=3L;%+B6$M:.!(
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M%GGYA_#^-:=M=6][;1W-K/%/!(,I+$X96'J".#7GNCW.H6WQ/\?&PT]+QO\
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M3SGF8+B15=L;"<Y&,CT-);0WL/QFA6\NH[D'P_*498O+(_TB/((R>,]/Z]:
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M2X!#2 JF-O3)R3TQ@FL>)-?L]/:>:.VTZX323=_9=OVF1K@9+(0IXB7 &_\
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MRY[?A7:44 <QJGA!]8M;RPO]3>YT^\:-I8I85+J4"@E&& I.W)X."3C%/O\
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MND&]DC?5I3->W0C!=V./NCHH 55'7 '<\UTT"2I BS2+)(!AG5=H/X9-244
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M"[.W]XE0>, >E3Z=::I#XDU6XGOYI]-F$?D02HJB%P"&"8Y*].3W/'3G;HH
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MP]I-K=6VGZ1:VL-V,3K$FWS!Z$^G)XZ<F@#B/AI?+?PZ/8:L);:[L](MGTZ
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M/5C6;XVU&:TO?#=EYCPV6H:FMO=2HQ4D;&*ID<C<P4>XR.]=8JJBA5 50,
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MSM48&3G]:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ:J*SQ_-_K21\W0A=OXUY[JFF75OX/\ $4R6]QY&H^(HKNSMUA8MY8FB+/M
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M9'1K^4#<!\N])V!ZA2LF<]=V.] '7+KVE/:VETM]$;>\.+>7/RR\%N#] 3]
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M;K5H8)@HTV9HI'DRH(559FYZ %L9]L]*O66MZ;J-R]M:WD<DZH)#%RK%#T<
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M]W.-0A5+/'VGS#L,.1D;@V",CIGKVJM>>+M&L](U+4GNMT6G+NN8U0^8AQD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHK$\3^(T\,V%O=RV5Q=)-<Q6V(=N5+L%!.3D\GMF@#;HKEG\
M8M"4MKO3ELM2=9)!:WEY$@\M6VAMX)'S=@/0YP!FJ5O\2+:^BT5K'1[^XDU8
M3B*,&-2DD0.Y&RWJ.O3'.>U ';45PQ^)4$6BWEY<Z-?0W=A?1V-Y9Y0O"[LH
M5L@_,IW#!7.?UK1?Q@T#):WFFBPU&3S7CM[R[B13$A WEP2!N+  <G.>P)H
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M?A[PW;:18,C:E:![*R,F/*B5 278YP%!49Y))%87A'6H-$@\5W%[";9G\1-
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MMV_B3P_9:Q:)(D%W&)%20#<O8@X]"#6G0 4444 %%%% !1110 4444 %%%%
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MO/<9/8"KE 'G4'A;Q7H7]B:EIUU;:EJ%I:265Y!>SLHFA:3>FV3:3N3@9(Y
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M'X+ABJELY&"1VKK/^$?MQXI/B#[3<_:S;"T,>5\OR]V[&-N?O'.<Y_#BLQ?
M6EQ:W<ZC!=:C!%=2^?<V$5R5MII.[,GOW&<'N#0!EOXEO+?Q?_96K7=WIDDU
M\%L2T"-:7D/9%DVDB3KD$@YX'!Q6?>>)M<@\"^*-034G^V:7K,EM!*88^8EE
M10K#;@\,><9KL'\*VLLRF>[O)[=;W[<EK(R&-9=V\$';NP&.0-V*S[[X>:5J
M":K#)=ZDEIJ<PN)[6*<+&)<J2ZC&<G:,@DCN #@@ K3QM+\7IXTF>%F\. "2
M/&Y?](/(R",_4&N;T;4]7TSX0^'=3M]6G:>XN[99?-2-\K).%< [<\[B<G)]
MZ]"C\.6T?B0:X+FZ:Z%H+/:SJ4,8.[!XSG=SG.?PXK,3X?Z9'X?AT2.\U%;*
M"X2>)?.!*%'WHHRI^4-SZGN30!EWMYK]WXH\5:=;Z[):6]C8V]S;>7;1,R,P
ME.,LIR,H,Y&?0CNEOXKU"\L_!<MW<"QM-7LC-=WB!0!-Y2LL8+ A0V7/OMP.
M]='_ ,(M;?VGJ>H"]O!/J4"6\^"F-B@A<#;P1N;\ZY/6M .E7&AZ="GB1=+T
MZS>*WO=*</*K$J/+=0/NA5&#M/7J,<@'1>!KS5]0T26ZU>X:=FN94MW,2Q^9
M$KE4DP /O  _J.#6386=R_Q9\0[-4ND(TZU8#9$1@M-A?N=!V[^I-;OA2UO[
M6UN!=7>I7%N[@V_]I[#.HQSG8!QGH#R.<^@FB\.0P^(+W6H[Z\6[O(5AD&4*
M!5SMP"O;<?SYS0!P>G^)O$=M\/[+Q1>ZR+B6]VVB6[6J+''(]QL$Q(P>%SQT
M/'UKI;F_U;2?&VFZ(VHRW5IJ]K.8I98X_,MIH@I)^50"I#=".HZXXJ_;>"M)
M@\(-X7E\^ZTME*A)W!906W<, #D-R#U!JS:^'8K>X6ZFO[V[O(X#;PW-P4+P
MH2"=N% R2JY)!)P* .!T[Q!XGF\+^#-<?7-TVK7<=I<0-:Q^41('^?@!MP*C
MHP'MZ]7X7OM2_P"$G\2:)?ZA)?QV#6\D$\T:))ME0DJ=BJ" 5XX[T^+P)IT&
MC:1I45Y?+;:3<+<VOSH6#KG;D[.0-QX]ZT['0+>PU[4M8CN+A[C4!&)U<KL^
M0$)@!01@$CKSGF@#E_&>MZMIRZ_-8:F5;3].%S!;VL2.8V =F:<NN IVJ  0
M2 Q /6NL:ZO)_#1N[..-KZ2S\V%'.$,A3*@^V<5EZGX&TS5;[5+J6XOXAJMN
M+>\AAGV1R@*55B,9R <=<'N#6JFC0+X>.B^=<-;FW-L9&DS)M*X)W>O/X4 <
M$GB^]F\/>()8=4OK76=-TI[B73]1M8UEAE12=ZX4!T;&,\CITS5J'5/$FEZS
MX4N;S5A?V&N8@GM3;HGD2&(NK(0,G[ISDG\.,:'BCPXL?AG7+I7OM2U2;2)K
M"!G0/)M93A $49RV,D^G6KOAS0(_[/T6]O)KV:XL[4)!'=J%^SL4"MA=H.[&
M5RV3C/J<@'&_VGJ&C?#SQGJ6F77V:ZM]>O&5_+5^LX!&&!'0UOS_ &A/C!*Q
MU"\^SQ:&+@6Z*C+_ *XAE VD\[0>/F)[XP*T9/ >G2Z#J>C27E\UKJ5RUU<?
M.FXNS;FP=O ) ./;BM"3PW:R^(+76VN+L7L%O]F8I(%69-VX!P!SAN>,?EQ0
M!S7B;QM))X(UO4-%75+"\L(!,DEWIS1 G.,#S4PWOCFM&\U+4E^(%OI4-\R6
MEQH\USL,2$)*LD:A@<9Z,>"<5T&KZ5:ZYI%WI=\A>UNHFBD .#@CL>QK$A\(
MV6FW\&LRW^JWEY:6KVZR2RF1G0D'!55&?NC@#ZY/- ''67B+Q7%X1\,>+9]9
M6ZBNYX(;RP^RHJNDK[-RL!NW@D'KCV]?6:\_^'WAAO\ A"/#\6K&_$EAB3[#
M=($6*92<'&T,<9R,DC/T&.FT32;G3M3U>XDO;R:WO)Q)%#<S>9Y1YW;/[J'(
M 7L%]\  P?/\0:EX_P!9TF#76M+.SAL[F-5M8W/S,^Y,D="%QGKTQCG-;2M8
M\3Z_8:3KVFR!;:>YW7%O,T0A^S;BI"X&\2* .2>2#QC@=7;>'[>U\1WFN)<W
M)N;R)(I48KY>U,[0!MR,;CW[UF6'@+2],U:2\M+K48[:2<W)TX7)^RB7.=P3
MZ\XSC/;@4 9<.M:O::GXCT"\U*274@\3Z3*T48)BF^53@* VQPVXD'@5>;4M
M7M_B#)I"7GVBV&AFZCCE1%S,) FYF4#K^7)XK=N-"L+KQ!9:W+#F^LXI(87S
MT5\9SZ]./]X^M5KKPQ:7>O2ZO)<70GELFL&164)Y1.2,;<YSSG/Z<4 <[X7\
M17>K7<NGW>H7UEK,-D3<Z=?6T:LDF5'FQ$* Z9W#J1R*J:#XMU35=,\$64]V
M4O-;MYKBYNUC0-B)<[5&-H)+#MP >YR.L@\,P174=U+?7MS=0VS6L$\Q0O$C
M$%L849)VKRV3Q[G-2+P)I=OHVE:=#/=QG27WV%TKKYT'8@';@@@D$,"".M '
M*:[XI\0:7IOC"QCU#-WHLEI);7K0H6DBG(^5QC;N7YAD 9XKI-.O=6M/B+/H
MMYJ37MK-I@OD#PHGDN)=A5=H!VD$<,2>.M6[[P7IVHZ3?V%S/=L=0E26[N R
MB68IC:"=N !M7  '3W.9;GPS#+J\FL&]OS>&P:QS&Z+^[)SQ\HPV[D'(P?;B
M@#>HK+\.:=<:3H-M8W5U/=2Q;AYL\GF2%2Q*AF_B(4@9[XK4H **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ H) &2<45Q'Q1@AF\.Z>9>"NKV0#!MI7,R@X(Z<4 =J70*6+*%'<GBE+
M!5+,0 .I->9ZK;:+H/C.RT6X^Q:9HEQ92RVRW$2M;O<M)^\'S_*&V[<>Q('7
MFK:2Z5H6K^%]*O=3-YX::WNUM+F]93"]P'7:"?ND!-X0G\,\4 =QXEUZYT.3
M11!;131W^HQ64C/(08P^?F  YZ'N/QK>+*&"EAN/09Y->::Q;:38Z+X5M]&F
M:33U\3P>2YDWKRSDA#_<!) QQQ6+XLOM-D@UZ\M)H(KFUUZV5Y;J0-<^8LD*
MGRNACC"YQUSE^@H ]E+*&"E@">V:-R[MNX;NN,\UYAKLCV6O7FM+#8ZYHK7]
MH9U4XN["4"+RS&W(=#E&V\'YSCJ:=-YVF>*4O)K>SU?2;O6Q''=1_+>6%P6V
M;&S]] 1CL0I] * .\%[=VD6IW.I);QVEL6DA:%RS&(("2X(&&SNX'M6+8:SX
MGU/^RKZVT[33I5_#%<O))<,LD"-@E,8.]MK @\#((/8USEG:6;:7\3('AA>%
M+N5PCJ&52+5#GGT/-5Y[&QM_ _PWF@MX(G?4=-8M&@7<S1_,3CJ3@9^E 'JQ
M900"P!/0$]:"RA@I8 GH">M>7I/H&KWGBW3?%5RD&HPZC^Y+R!)U@ 0P& ]>
MHSA>K$^M97CV]T^:R\8S6[Q0WUH]J'>[<-,LBA&40+P44 YW9.3OX[T >MKJ
M=HVK-I:S*UXD(G>,=50G )],D''T-)IKW[VA;4H[:.X$CC;;N63:&.WD@<[<
M9]ZXJ"+1Y?C'>RNEBQN-&MWA<A"9&,LJEE/<XP,CMBN:TNY^Q^#_  U#)@:+
M)XCN8;[^YM\Z;RU?_8+[<YXX&>M 'LH967<K J>X/% 92<!@3UX->2^*K!;2
MX\>VME&J:0= %S+$@Q'%>8DP5 X#%%4G'7Y2>M:-A866E^._!TMC"D,M_I-R
M+IT^]<;5A*ESU8@DX)H ]*)P,FD#*5W!@5ZY!XKC?'-TT&K^%8;H#^QKC43'
M>[ON%O+;R5?_ &2^.O&0*Y'Q;8BU@^(EK:1JNCKI<5P8EXCBNR&SM'0$J%8@
M>H/>@#V $'."#CKB@LH8*6 )Z#/6LGP]HNFZ39>;I]LD37:I+.ZDDRMM W$G
MJ??O7!;;75M$^(!UM475+*[N#'(_$MO$J VS1GJHX!&.ISW)H ](DU.V75!I
M:2(U^UNUPL);'R*P7)] 2P'3L?2LWPAK\WB/P_'J%U!%;S-//$8HW+ >7*R<
M$@9^[GI7&:+%&?B'H5QKT%LFJ3>&8GE:9%#-<^:@)&?X^W'-8=I8V47@?1=9
M2&,:A'XGVI=?QJK7SJR@]E()RHX.<T >V%E#!2P!/0$]:"R@X) /UKR6[.DZ
MY?\ BC3?$6LQ:=J$&H9B+JBW"0@*86@8\]NB]R>,MSIZ5H&E:G\3?$PO[59V
M@ATVX02<%90)#OP.-V0/S/8F@#J?&.O7/AKP\^IVUM%<%)HHV620K@/(J9&
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M4'I0!J3:987,<4<]C;2I#_JE>)6"?[H(XZ=J;)I.FS2322Z?:.\X"S,T*DR
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M=VQNK<0V\DGG1@ DKM4YX(.!SSFHH_'OA^:]%G'<W#7&^%"@LYLJ91E"WR\
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M&YBV.20Y7D9"XP<$'(R.:Z'Q=XC3PKX<N=5>WEG,>%1(T+?,Q &['1<D9/\
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MN426VD0RQ#JR K\V..!S[55LO'OA[48UDM+J:2-XTDC<6LH63>VQ0I*X9MQ
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M1M'T:X=M- .2IG4.4([>6&91_LRUT_B;14\1>&M0TEVV_:82J/\ W'ZHWX,
M?PJQI6E6VC6"6EKYK*"6:2:1I))&/5F9B2Q/J:DDU"RBOH;&2[@2[F!,4#2
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M2>1@GC@'C/IZLKH&5@RL,@@Y!%+0!E^)(Y)?"VJPPQ/++)9RQI'&I9F9D(
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MYJ7@>^M[&V>YN/,@E6&/[SA)D=@/4X4\5TDMO%-)$\B!VB.Y,]%/KCU]ZEH
MXN/[3+\38=6?3KV*S_L1H"[PD[9#,'"G&>=HS^G7BN2T_2=8TO0/"U_+H%Y>
MIILM]%?:>J8F"32[DD120&QA> ?XC[X]<N;FWL[=[BZGC@@C&7DE<*JCU)/
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M#MQIL5Q/!9P7LCHU]<H6AB8 %5;!&"V3@D@<&N>UF?49_&/@:X$-F=0DBO\
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M=DL23D#C  JGIW@V;1K::+3KBTBBN;V2ZN;-K8FW970*8U7=\HX#9YYSQ@X
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M2=)O+2$H8BJ*F,[CGA1V'- &5=>)=?DUSQ'IEA9:<#I5O!/%)/(Y$@=9#@@
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MX5F'^\C+G_<%==7(/IT^I^,;S7X)/*BL]-:QLYC'O#2LVYY O\2KA![G<.U
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M(TKR3%DD9K5VWA>B]^% &#["M?QU-(=:\'6))%M<:PK2^C&-&= ?^! 'ZJ*
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M=$T_7]/-CJ4!E@WK(-KLC*ZG*LK*05(/<&L]?!.@+_:.+.3.I0B"[/VF7,R
M8Y.[.2.">I[DTG@?6KSQ#X/LM4OQ$+J8RAQ"I5/EE91@$D]%'>L^ZUW7W^($
M_ANR?35C73!J"23P2,3F0IL.''IG=C\* -C_ (1;2/-TJ7R)M^E*5LC]IE_=
M C:?XOFXXYSQQ5O4M(L]6%N+Q96%O*)H_+G>/#CH3M(SCWS6)X4\:6VO>''U
M._6'39(+F2SN%DF&P2H<':QQD'M6^-2L&MX;A;VV,$[!89!*NV0G@!3G!)]J
M *VN^'],\2:?]@U:!I[;>'\L3/'E@<@Y4@\&J6I^"=!UB[M;N\M9FNK:/RDG
M2ZE21H^NQF5@7'LQ-:UGJ5AJ,+S6-[;742,59X)5=5(Z@D'@TRWUC3+N.>2V
MU*SF2#_7-'.K"/\ WB#Q^- &=JW@S0=:>RDN[(K+9+Y=O);2O \:=-@9"#M]
MNE3W7AG2;I;#-L87T\$6DEO(T3P@C! 92#@C@CH:NVNI6-\[I:7MO</&JLZP
MRJY4,,J3@\ CD>M6'=(HVDD8*B@LS$X  [T 9%UX5T>\T4Z3-:G[*9?/^65U
MD\W=N\SS =V_=SNSFJW_  @WA_%^#:3,=0A6WNV-W+NF0 C#'=DGDY)Y.3S5
MS1-7_M;21K#E(;"=?-M]_!\GG#L3TW##8[ BL>U\2W.I>.+[1["]T^>SCTQ+
MN&6)=^V0R,I5R&P1\O;'6@#77PQI27NG7@AF,^G1M%:L;F4^6A !&"V#D =<
M]!5>'P9H=M%Y=O;SP*+DW:>5=2KY<AW9*_-\H^=_E'R_,>*N:%K$>MV#3JGE
M3PS/;W,).?*E0X9<]QGD'N"#WJQ=ZKIVGNB7M_:VSO\ =6:94+<XXR>>: ,7
M4O!NGW<-E%#&T;6]^+[S_M$@?S,Y9C@_.Q''S' 'TQ6EXAT6'Q!HEQILSF/S
M,-'*HR8Y%(9''T8 _A6?J&LW]IX\T;1T,!L;ZVN96S&?,#1[,?-G&#O].W6C
MPAK-]K,.L?VAY!DLM4GLT,*%%*)@ X)///K0!;N-&AUN*RGU6V:*_LV+1RV\
M[(8V(PQ1E(.TCL>HZBB?2C9Z-<6.C1B&6Y+9G=BQ5F^]*Q)W.W\R ,@<C-UO
M7M4L/&^@:);?8_LVJK<,SRQ,SQ^4@;C#@'.?P]ZZHD 9)P!0!1TS2;32=%M=
M)M8P+2WA6!$;G*@8Y]<]ZR+3P#X;L7L6@L9 ;!V>UW74K>3N&"JY8X3!^[]W
MVK2?Q%HJ65W>_P!K636UHNZXD2=6$0_VL'C^M9:>/_#K6VCS-J5LG]JX\I6F
M7*?NRYW\_+@8!]R!WH LMX,T)]-U+3VM9FM=2E,UW&;J4^:YQDD[LC.!G&.E
M;"VL:6@ME,@C"[ ?-;=C_>SG/OG-13:KIUM=16L]_:Q7$V!'"\RJ[YZ8!.32
M2ZOIL-Q]GEU"TCFWK'Y;3*&WMG:N,YR<' [XH R;3P1H=AIYT^S2_M[0[OW,
M6I7*K\Q);I)W))_&G7W@[0KJZM+Y[!Q<V4 @A-O,\1:(=(VVL R^S<?K6K#J
MFGW-TUK!?6TMPN=T23*SC!P<@'/!J>:>*VA>:>5(HD&6>1@JJ/<F@#A_"G@]
M)_ 6EZ3X@TZ>VN;&XDFC"7&QXF,CE61XFR/E?'![FMO_ (0?P]]CU*T^Q/Y&
MI$&[07,H\T@ <X;T SZ]\UI/K>F)I<VI"_MGLX@=\R3*4!';.<9SQBL'PGKF
MJ>)(;'5TN]-DTRZMO,FM8\^=;2'!5=P)!X)#9 .1D=<  JS^';B7XD6EV+2]
M33+?2&M$NH[K:1(9 P!._>1M!Z@\X^M;LOA319K?3X&M76+3YOM%LJ3R)LDY
M^<X8;F^9LDY)R?6J<OB&ZU#Q5=>']%6!9+"))+Z[N%+I$7Y2-4!4LQ )SD #
MUZ5<AO=5M-4DAU4V7]GK;&5;V,&,;@P!5@S$+@$'.3GGIB@!6\*Z0TVJ3&";
MS-50)>'[5+^]4#:!][CCCC'%5+[P%X<U"TTZVGLI NG)Y=I)'<RI+$F,;1(&
MW8QQ@FM=-8TR2.>2/4;1DMPIF99U(C##(W'/&1R,T^#4K&YLC>V][;RV@!)G
MCE5D '7Y@<<4 4?^$7T<7>FW2VK)+IJ-':%)G41JPPWRAL'..<@YJ!O!>@OI
MUY8-:2FWO+G[7,#=2EC-N#>8&W95L@'*D=*HV'BB74/&>JZ9!>Z?-I]OI\=S
M#/%\VUV9U(=@Q!QLSQCK5G_A*]/TJWT2VUC5["2]U 8$L#A8GPA9G&2<)\N,
MYZD4 36OAFVL_%3:U K1-]C%HP\]W\T J02I.!MP>>2=Q)/KH:KHVGZW:K;:
MC:K/&CB1"25:-QT96&"K#U!!JZS*J%V8!0,DD\ 54MM6TV\CEDM=0M)TA&96
MBF5@G&>2#QQZT 4D\,:;]NM;R<7-U/:$M;M<W,DHB)&,@,<9QQGK[TV;PEHT
M]W=W#VSC[80UU$DSK%.1QET!VL<#!R.1US5Z#5],NKE+:WU&TFG>(3+%'.K,
MT9Z, #DK[]*P/'/BH^'M$FET^]L/[1CEA4VTY#.RO(JG"A@0<-G//2@#7O?#
MNFW^HQZC)'+%>I$81/;SO"YC)SL)0C(SS@]#TQ4-]X1T34+*QM);/RTL&#6C
M6\C0O <8^5T(89[\\]ZV9 YC81LJOCY2RY /N,C/YUS/@37]1\2Z"VI:@MJC
M?:)85CMXV 'EN4R26.<XS0!8A\%:%;B;R8+A'FN%NGD%Y-O,H& ^[=G..OKW
MS4.K>#-/U#3TM8HW1_MJWK7!N)!()0,>9D'+,!@ $X&!V&*W+W4K#38UDO[V
MVM48X5IY50$^Q)JA>>*M&L=;L](GO[=+NZC:5%:11A1C!//<D >O/I0!?U+3
MK75].GL+U'>VG0QRHLC)N4C!!*D'!!K-7PCHJQ:7&+>?9I1!LA]KE_<X7:,?
M-S\O'.>*?H_BG1]=^VG3[^"5;.5HY&613]T#+=?NY)&>G%6XM9TN>UFNH=2L
MY+>$XEE2=2D9_P!H@X'XT ,T_0]/TJ\O;NSBD2:^D$MPS3.^]@ ,X8D#@ <8
MZ5)8Z18:;9RV=I:QQV\LDDLD8&0S2,6;.?4D\?ATJ6VO[.]:5;6[@G:%ML@B
MD#%#C.#CH<>M)>:C8Z=&)+Z\M[5&. T\JH#^)- &-HW@;P_H$LLFF6<D!<,J
MC[1(PB#=1&"V$S_LXIT?@K08M.T_3X[69;73IQ<6D8NYOW4@S@@[LG&3UXY-
M)XK\56OAS1H;H3VQENIHH;?S) %.]U4OU&54-N..PZC.:N:(^I21W#WUY8WE
MNTFZSGM5(WQD#[XR1D'(R#@C'2@!G_"+:+]KU*X:R#MJ2[;M'=FCERH4G83M
M!( !(&3BEL/#6FZ<4,"3LT4)@B>:YDD:*,XRJ%F)7H.G/ ]!6=9>(+[Q#K&I
MVNBFVALM,G-K-=W$;2^;.!ED10RX"Y&6)ZG '>KUIJ5]:W%\FNFSM[>#R_)N
ME8HDH;.2=Q^4Y&-N3VYYH B&GCPCX=:W\-Z/)>>6^Z.R^V$9W-EB'D)QU+8[
MU8\/:6=-LIY)H(H;R^N'N[E8N5$CGIG SA0HSWQGO5DZSI:VLET=2LQ;Q2&*
M24SKL1QU4G. 1Z5*=1LA8B^-Y;BT(#"<RKY9!Z'=G% %+4_#>E:OJ%I?WEN[
M75J&6*6.9XSM;&Y6VD;E.!\IR*IVW@;P]:0V45O921QV,[7%LJW4H$<C9R1\
MWN>.G)]:S--\3WVJ?\)9''J.E1KITJQV=X5_<@-$KAG._G!;!((Z5M/XHTJV
MURST.XU"V_M&XMS-M#A1C*@=3_$6^4=3@T -E\':#<1:I%/8F:/52&O%EFD<
M2D  '!;Y2,#!&,8'I1I_A#1],U*+48([I[V*#[.D\]Y+*WEYSM.YCD9QP?2E
M\8:M=Z#X3U+5[(0--90-/LF4LKA1G'!!'UK#?Q=JVE7_ (935(K*YM==98E>
MU1HW@D90PRK,VY>Q.1CTH Z/4_#FF:Q?65Y?0RO/9/YENRW$B>6W3("L!G''
M-6M2TVUU;39]/O4:2UN$,<J"1DW*1@C*D'!'O4/GSGQ%Y OK/[-]EW?9,?O]
M^[[^<_<P<=.O>I1J^FFX:W&H6AG4D&/SEW#!P>,YZT 0VN@Z?9SP30QS!X+;
M[+%NN)&"Q9!P 6([#GKP.>*H1^!_#\6B)HT=G*MA'.+B*,74N8I VX,C;MR'
M.3\I'4U4T#Q49[S6K?6[VP@:UU5K&UY\KS1Y<;  ,QRWSGI6H?$^D#Q+_8'V
MV'^T!#YK1^8 5R0 O^\>3CK@>XH BN_!VB7U\+R:UD$IMQ:N$N)$62(9PKJ&
M ?&3C<#26O@W0[.72Y+>VF1M+C:.S_TJ4B)2 ",;L$$ #G/05IV^J:?=W#6]
MM?6TTR EHXYE9E .#D YZ\5;H Y[4_ _A[6-8&K7EB6O-@21XYGC$RCHL@4@
M./9@?3I5FY\,:5>3W,LT,K+=%#<0^>XBEV@!=R9V]% Z<XYS3K75SJ.NWEE:
M;?(T\JES*1G=*R[A&OT4J2?]H#UQ:CU.PNKJ6RMM0M7O(P2T22JSIVR5!SUH
M H:?X?BL/$VJ:S'E'OUC61!*[!RHQN(/"G&  /?DYX6[TAX_$T&O6BAIOLYL
M[F+./,BW;E8'^\K9Z]0S>U2Z/K']H3W]C.JI?Z?*(KA%^Z0RAD=?]EE.<=B"
M.<9JY>:C8Z=&KWUY;VJ-D!IY50''U- &0?!/A_\ MZ36A8E;R5Q+)MF<1R..
MCM&#L9AUR1UYZU,FD-<^*?[;NU"FV@:ULX\Y*AF!D<^[;5 '8#W(%3Q'KMYI
MM]X;%B]L]IJ6H+:RDJ6)5HW<,C X_@]#UIVB:S?WOBWQ)I=T8#!IS6_V<Q(5
M)$B%CNR3D]!QCITH O:IX<TO6+ZTO;R!VN;3<(98YGB8*V-RDH1N4X&0<BJ4
M?@;P]#I]M8Q64D=M;77VR&-+F50DNXL&&&[$D@=!D\4WQ'XC?2]9T72(9;:W
MGU5Y0MS=*6C38 =H *Y9BP &1WZ]#>TJXU?[;?6VK):[(0C03VZLJRJ<Y)#$
M[2",8R?7// !+;Z%I]KK5SJ\44@OKE%CFD,[D,JYVC:3MXR>W<U#JGAG2]8U
M"TO[V*=KJS+&WDCNI8C$6&&(V,.HX-7;/4]/U$R"QOK:Z,1 D\B57V$],X/%
M1QZUI4OG^7J=F_D#,VV=3Y8Z9;GC\: (K'P_I>G7TE]!;%KR1=C7,\CS2E?[
MN]R6"^V<57D\):-)=74YM7 NY!+<PK,ZQ3N,?,\8.TG@9XYQSFM$:E8L]NBW
MML6N1N@ E7,HZY7GYA]*C_MC3&F$":E9^>Q=5C\Y2Q91EAC.> 02.PH S]7\
M&:%KFJ1:E?6;&\C3RO-BG>(NF<['V$;E]CFIK[PMI&HW]I>SVSK/:QF&-H9G
MB!C."8V"$!DR!\IR*HCQ78Z/I^CIK>L:?->W[^6LMNP2*0C)+#+'"@#!.>O'
M>M6TN)I=:OHS?V4ULD<1CMXO];$3NR7.>C8&.!T- &?;^!_#]I;:?;P6DJ1:
M?,9[55NI0(Y#G+#YO<^W)]:F?PGHSG52T$Q_M8;;W_2I?WPV[?[W'R\<8XXK
M0M=5TZ^EEBM+^UN)(?\ 6)#,KE/J >*6TU/3[]V2SOK:X9!EEAE5RH]\&@#%
MU#P'X=U*'3X[BSDW:>GE6TL=S*DJ)_=WA@Q'L2:N_P#",:0+ZPO$MFCFT^)H
M;4QS.JQH<9 4-CG SD=A5;Q'XD;2+O3-+LX%N-6U25HK6)VVHH4;GD<CG:HY
MP.3P/</FD\164MF6-A?0R3I'<&*!XFB0G!8 NV[G'I@<\XH 8?!6@G39[ VD
MOV>:Z^VN/M4NX3[MWF*V[<K9YR"*FD\*:1*\Q>&8QSF-IH3<2>7(4"JNY-V#
MPJ@\<XYS5]]4T^.^6R>^M5NVX6 S*)#QGA<YZ5BIK.I/\0+W02UL+9-+CO(&
M\H[E=I&3#?-\P^3/&.M %K3?#\6G>(]6U>+*-J C\Q!*[AF4$;R#PIP0,#TZ
MG/$UUX<TR\URVUF>*5K^U5EAE%Q(H0-]X!0VWGOQS6;X0\2MJG@FQUK6I[2V
MEF:19&SY<8(D90!N/HH[U=U3Q9HND:?:7UQJ%L;>[GC@@=95(D9F"Y!S@@9R
M3V - $4G@K09=/U&PDM9FM=2F,]W&;N;]ZYQDGYLC.!T]!4L_A72;AYS-'<.
MMR$%Q&UU(4FV@ ;E+8/  /KCG-79]9TNUCADN-2LX4G ,+23JHD!Z;23SU'3
MUI;K5]-L69;O4+2W95#L)IE0A20 3D],D#ZF@"G<>%M(N=2NM0DMI!=7<(@G
M>.>1!(H! R%8#(!(W8S@D9I'\*Z-)X9'AU[5FTM45%A:9R4"D%<,3N&"!C!X
MQ5XZKIPOA8F_M?M9.!;^<OF'C/W<YZ<UCZ/K-_>>,_$>DW)@-MIZVS6YC0JV
M)%<G<23D_*.F/I0 Z/P3H4<UQ-]GG::YM?LD\K7<I>6/GAFW9)Y/)Y[9Q4R^
M$M&0:4%MY@-)&++_ $J7]R-NW^]S\O'.>.*VZQK378[Z^U$QR11:?ILA@GGD
M.-TH + $\!5R 3W.1QMY (Y/!N@S6VJ6\UB9H=4??>)+-(XE;@!N6.TC P1C
M&!Z5#%X$\/1:'<Z/]DE>SN@!.)+J5GD Z*7+;MH[#..O'-8NG^+M6UO3_P"W
MM(ETVYLH))_M6FY/GB%&=496!/SMLR P .<9XR>UL+ZWU/3[>^M)!+;7$:RQ
M./XE89!_(T 4U\/::NKP:KY<QOH(#;QRM<R'$9()4@M@Y(!Y':J=KX+T.PMH
M(+.WGMTMY&E@\N[E!B)R"%.[A?F/R_=Y/%:IU73A?"Q-_:_;"<"W\Y?,SC/W
M<YZ<USD6OZM)KOBZPW6F-*@@EM&\EOXT=CO^;G[H'!% '2:?IUKI=K]FM(O+
MCWM(V6+%G8EF8D\DDDDDU:K'\)ZG<:UX1T?5+H(+B[LXIY @PNYE!.!Z<UL4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2!UK0\,:AX8U_6-.U>PU"\GOK*U>*2-T6(6<1'S)*%11P0  3U&1P":]$I
M,X &>M '&?"B6.7X=:<(W5BKSA@#G!\YSS^!!_&LNY%G?_'&>W>]>/\ XIY8
MLP7)C;?]H8E,J0<X.<=>]>D44 <!KD6A^$+GPMIUM:06$ N)_L]Y,SF.V<QG
M<6Y^>1]Q W'KD\XP>*1].?PKIL=X5>.V\9LDK7$>W8C32$AL@!01R1QP>0*]
MTK!\3>'Y]?\ [+\F]CMA8W\5[\\!D\PIG"_>7 .?>@#SWQ!IKKJ/BZ^\*VX>
MP;3;47,=DHVSS+,6D50.&;R001S]X ]:N7-UX5U_3-;UVPU*XU&?^Q)K>:69
M52.-<;D1P$4;]W0=1@^U>IJ J@  8]!B@ #H /I0!Q'AS4O#7ACP'H6IW#V=
MFMW:VML]RD?,DFSA791G@[NO3G.*WO&,%Q=>"=>M[0$W$FGSI$%ZEC&P %:-
M]91:C:M;3EO)?_6(,8D7NI]CWQ5F@#S'6KMHOA7X1O8D>32HI-.EU!8U+?Z*
MJ@MD#J 0I(] :NZ3JFE:A\8KJYTZZM[B.XT&'$L#!ED832?Q#@D#'Y8[5V>F
M:9%I,,EM;-BT+EXH2.(LDDJI_NY.0.W(Z8 M2QN866%Q$Y&%?;G;^% ''>!8
MY/[<\:3KD6TFLL(_0LL:!R/QX_"N>\=:C9-=^--. 6TO6T1<EE9Y;Y0DA41J
M<@(A)W$ GD\KC->F:=I]OI=BEI:J1&I+$L<L[,269CW))))]35K% 'FT.HVM
MSXS\ R)<HV[2;H9+8))6$#KZ[6QZX.*T_AS<0SCQ1Y4J/_Q/[IOE8'@E<'Z'
M'6NVHH \[\7ZG86/Q5\%R7=[;P)#%?>:TD@41[HT"[B>F<<9ZU9\8^((-9\*
MZS9>'+A=2N8;=9IA9.),1^8NY,C(+,@DP.>G3D5W=% 'F44_A_Q+#JNL:)J%
M[J=^=%FM7;8%6-",K&ZJBC?NZ#D\&J<.J6']D_#&_P#M"?8[9U@GFP=J2?8V
M7:3Z[OE^O'6O6  .@ ^E+B@#R&2ZTB\N_$?AKQ1>ZA#=W.I//!9QQ@-=Q$AH
M#$VPL2 JKP>-O85M:!9:/=?$_P 7+-;V<\T8L9(PZJ[*ZHQ9A_M!@N2.<XKT
M/ )!P,CH:6@#S'P9=36FM:-I]O>6NMZ/+:2FRN@-MU8( I,<P!P0<*N>#D<U
MM^/)I;.^\,7\P/\ 9%MJ8>_./EC!1EC=_15<@DG@'![5V0 !)  )ZTM 'GB&
M(>*_%NK6EQ%_8LNEQ+-,KCRI+H!\D'H2$V _4"MKX;RQ2_#CP^(W1BEA"C[3
MG:P0 @^A%=0  ,   =A2T ><Z;-%X-^)/B1M9D6VL-<:&XL[V4[8BZJ5>)G/
M"MGD ]16OXQU33=2\!^(EAEAN8%TV?\ ?J5:+?L(50W0MGL.G'3(SUS*&!#
M$'J#2@ # & * /*M1-CHOACP?K=M$(-,1X6U.ZLH59P/(94D?Y3N"NW.0<$Y
MZU7U=]*MM-37-'GN[[1I]=M;K5[DKF)T4'<P4* 5#",L0,''<@UZ[UI  !@
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MU'-;^F:IX7\5(EYH< FU"+39+;Y%9?LL9 _=.. #N  7KP2.,UW0 '0 ?2@
M#. !GF@#QK2-9TZ;1_AC;QW*/+9SK#<J 287%M(I1_[K9['FM_P)9Z!-_P )
M3<RV^G2&#6[MED=$/EQD 9!/12"W3CD^]>C!0.@%+0!XOHUU;VW@/X97<\J)
M;VU^%GD)^6,F*8 ,>W) Y]:T-4\R?7?B1!HN#?SZ5:F..+Y7D8++O '7=@@>
MN2*]8HH \NM;WPEXCBEU:WU'4KF:VTJ>"Y6-%C:T@*'<CA44;@1\HYY&1P":
MT_!=W?IXADTRZNK'68(]/5[;6+0;6,>_"Q3 $KNY)!'4 ^]=Z !G  SUH  S
M@ 9YXH X'QK!+I7C?PQXM>*233;$3VUZT:EC LBX63 YV@]3V%=7;>(M*OWB
M33KZWOWD(XM)5DVK_>8@X ]S]!SQ6I2*JH,*H&>>!0!X[O\ M?PJU?0;PC_A
M*X[V8^1G$[W1G+Q2(.I!!4AAQ@'G KJ+2ZCB^+]RMS=0^:GAV!96W #<LTC-
M^A!^AKNL#=NP,],TM 'C?AW6-/LO!O@GSS!&YOKH1WT['RK1\R_> (!9E;"A
MN.<]L&M%=01^#YF>5S%8^-%FGDEC*>5']JW;F& %XY(P,9Z"O;:,4 >5:GJN
MDCQ7XAT[Q)J-S9V&KP0_86$0,=U 8@K1J2A.X.6.!@_/D5-9:7HDGQ-L].N+
M6&:-?#4<8@OE61R1)P'!ZN%ZYYQFO3B <9 ..E+0!XMJ>L:?*;=H66Q6U\7Q
MR7%GAFDC/G$--*QSM#=0!@8..>W5:9K.G:?\0/'-[=721V\%K92R,<DJJ1R;
MC@<\9&1C/-=_@>E,E0R1,@=D+#&Y0,CZ9!'Z4 0Z??VNJ:?;W]E,LUK<()(I
M%Z,IZ'FN1^&F;7PWJ<=XP2:#5KT7+.<?-YI;)/T(/TKL;2UAL;2*VMUVQ1+M
M49R?Q/<^]5X=,CM=4N+VW;R_M6#<1X^61P,!_9L  GN /2@#E/A==6K_  Z@
M(FC812W1EPP.T&>0C/IQS]*G^%$,\'POT%+@,',!=0W78SLR?^.E:Z;4[ :G
M9/9R2,EO,-DP7AG0]5![9Z$]<9Q@\BU'&D4:QQHJ(@"JJC  '0 4 >,:EK.G
MS&V>%ELA:^+HY+BSPS21GSB&EE8YVANH P,''/;I+:^M1XR^():XB4?8;4_,
MP'2*0'KZ9&?3->BX'I10!S'PZD23X<>'=CJVW3X4;!SA@@!!]P:Z>BB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "N-^*KR0_#76KF"66&X@A#Q2Q2%&0[AR"#FNRKF?B!I%]X@\$
M:EH^FQ(]U>1B-"[A57Y@<D_AV% #9_$<6AWNDZ%%I=]<SWEL\EN8BA#[ I8%
MF8$'YARV!SUS5<_$"U3P_%J[Z9>K&+XZ?=1DQYM91)Y9WG=C;NQR">HIUQI>
MJ7'BWPUJGV(+!I]K<17 ,J[@T@0#:.X&SVZBH-'\*33^&O$>C:U;K'%JE]=3
MKM</A)F)4^S+_,#F@#=U#Q%:Z7->B[CD2WL[=9Y9\KM^8D*@&<[B5/&/3UK'
M_P"%B:5!=W]K>QM!):6+:A\DJ2K)"IPV"K$!@>H/KG)'-0'PCJM_\.+C2;^^
MC&NW2))+= 97SHRA0_3]V@/XGO5FU;Q;?:3=+J6BZ5;3K;M&+=;CS4NW..N5
M^1",C'S'GVY #Q!XNO=,\+ZSJ4&E,9;*S6YB<S(T4@8-@A@>=NW)'N,=<U*_
MB^2UO-)TZ?1K][[4;>26((8B&,8!89WX!^8'G YZ]JYX^ KM=&\3Z=I,;Z;I
MVI6'E6^G3S^8D=P=VYEP2$0Y48!]3@8 K7_LO6[GQ+X6U.XL(HDT^VN(KE$N
M Y4R*@&,@9QLYZ=>,T ,/Q'@32)M3DT34DM[.Z-IJ#'R_P#1'#A#GYOG&2#E
M<\'\*OZ[XWL-$>^7RS<-I\8ENE2:-&4$;L*&8%FV_-@=B.<G%<Y>>%-<N?!7
MBO25M(Q=:KJ<MU;YG7:$=U8;CV("G@9ZBM&33O$^D>+-1U'2M.LK^QUCRI98
M;FY\E[294$9.0K;E(5>!SD?F 7?^$ZAN-22QTS2;Z_EETY-1@:(QJDL3G"D%
MF&._WL'T!JE-X\EN_P#A$I](T^66UUN5]V]D5U"QNQ3!.-V5Y.<<<9S5R#2=
M5@\>_P!L2P+-;C1TLFD1E5GE$A<D+GA3G'7K[<UA:9X2U_3M"\'H+6V>\T2\
MF>:%KC:KI(LB[E8 ]-XXQV- &]\2F>/X<ZY<12213PVK2121N49&'0@@YKF;
M2ZF@\6^%4\-7EW>12VKMK$ N7GA5!&"K$LQ5'+9 P03WXKL/&^F7VM^"M3TJ
MPB22[O(#"NYPJJ3W)/;\ZU-*2>#1;2*> I/% J/&&!^8#'!Z=J .;LOB':W6
MG2ZI+I.HVNEPK/YMW,$VH\3["F Q)8GI@$$G&<YQI#Q0(M9MM*OM.N;2ZO(7
MELU9D83;!EH\AL!P#G!X]":YRW\%:E??#'4O#%Z4L[N>XFGAE5]Z@M.9DSCT
M. :U_P"RM3UW7- U+5;-+(Z2)97590_FS.FSY,?P %CDX/3CK0!1@^)UG+9Z
M;J4FBZI!I-]/]G^W2K'LBD+E & 8MC(^\!@9QDU<UGXA:5HHNII5,MI9SB"Z
ME25-T;9 )"$[F"DC.!ZXS@UROA72;WQ-\*=+T-K416DET9);HR CRDNC(0H^
M]O)7;R,#.<]JW;+2O%6A:SJEG86>GW>EZA>27D-Y-.4>T:0[G#)M.\!LD $>
MY'8 T3XT,FNWNDV>@ZE=S64D"3/&8@H64$JX)?E<8]^O'%9>G?$*Y3P=)X@U
M71[D0+>R0N8'C81J)VC!.6!PN%!./?I6OHNE:A9^-O$6HW$"BSU!;80.) 6_
M=(5.X#IG.1_2J?AS09M.\+ZAH'B"*T6QEGN55Q/GSXYI'?D$#;PV,9)X- '2
M?VF#K:Z8MO(S?9_M#R@KLC!8@ \YR2#CC^$^E7)I4@ADFD;;'&I9CZ <FN-\
M&V6IZ7X'DO6E34=2DA)MWF;RQ)%&NV %NP*@,3ZNU;^G33:_X7C>^MQ:RWEN
M5EC1MP7(()4]P>H/H10!A:)XDAC\#R^-=89U2XC:YV@9,4.XB.-1ZD;<^K$_
MAHIXC6X\1#PW=Z3<I<S6OVDG=&\0A)VG)W YW?*0 >H[<URT$?V;X+2:%?1V
MS7MO%_9+6]RQ5&FW;(QD<C=E&4^C \#FM#03JEGXEM9-:\/R1W-S#]BBOVU)
M+DJB!I-I4(A .TDM@DG&>V #6\,:K++JNNZ!<R-+-I%P@21SEG@E0/'N/<CY
MESWV@GDFFZUXTM]%_M*66PNI+33#$+N< *%\S&-@)^? 8$X]>,GBH/"MD\GB
MSQ7K^,6]_/#;VY_OK FTL/8NS@?[M8?BWPMXEUU?$UI]FL[N.[1/[-N)K@K]
MG4!=T83:<,6!.[/(/)X H UG3_B\B+ODV2^'Y"R^8V,^>@R!G@X]*?\ #'/_
M  AY!9VVZA>*"[%C@7$@')Y-3)IFK'X@V^N36<:VRZ0UG((Y@Q$ID5^,XRN%
MQGCGMBIO VDW^B:!)9:A"L<WVNXF&QPP*R2LXY]0&P: ,72&:'XI^+<"YGCM
M;2TDAMUE)"LZONV*S!03@>E7M-^(5MJ*:'<?V3?P6.LOY5O=2[-HDPS!"H;=
MR%/.,9_.C3])U:T\>^(M9>R!M-0MH(H-LR[]T2L#N'8$MQR:R+'PKKEMX4\%
MZ8]I&9]%OX[BZ(F7:459!\A[D[QUQT- &KI/C662/Q)=ZM9M:VFF:@UJC!T;
MHL05.O+,SY]/F SQ1/XML=9&LZ"R/!>QZ<]TOEW"NKQ<C*O&W!#8!''4=16=
M<^#M;N;#Q7IL;6T"W^I#4[&[,A;$@\IE5DQP T7)R>O -;-H?%&HZ1>KJNDV
M5C*;5X4AM[D2^=(PQNW%1L4>G)Y]N0#EK;<?#WPIF\R3>\ENC?O#A@;5SR,X
M/('-=+JWQ$TG2/.FE!>RMKD6MQ.DJ9C;<%)V$[BJL<$@=C@$"LZ'PWK,6B^!
M;0VB&70Y8FN\3+@A(6C^3UR6SSCI4FFZ5XJT+4M1TVTM+"YTJ\O);JWOY)]L
MEJ)6+NK1[3O(8DCD9[D=@#9U'Q?%91W\]OIUY?6VGS+#=R6RABKG;D*N<OM#
M MCIVR00*D/BN_;Q;X@T]M+D:TTRV@E4I(FYMPD8L<D=0H 'MSC-5+'2_%/A
M_7=8M]-MK*ZTO5+MKV.ZFN"C6CN!O#)M.\9&0 1Z$CM<BT'4X?&FMW82%]/U
M6R@B:<R8>-HUD4C9CG.\'J!UH L0>,[.X@\-SI:7(AU_'V=CM_=DQF3#C/HI
MZ9IO_":6ZW=FDEA=1VMY?OIT-PX S,N[JA.0I*, ?T&:YO3?#?BB.Q\&VD^G
MV48T"<+*_P!KSYR")X]XPO'4''7/IC)9)X7\57+:=-=V5A<:A8ZV+Q[V2[.Z
M>'+[54;#L55=1M']WIS0!N>%5,?CWQO$'<HMQ:%0[EMN8%)QGH,DG%9?B@V<
M?Q3T2*_O9+:QGT^X>9?M;PHSJ5VDX8#(R:Z#0=*O[+Q?XFU"Y@5+;49('MV$
M@)Q'$$.X=LD9'7CTJOJ.D:G/\2=(UJ*U5K"SM)K>1C* Q:0J00OH-O/2@#G?
M#7BR^T+1+ZYU.'4[_2GUK['I4\@W2M"[!4)+D,ZY/!Y)KKH/%,D\\-B='NX=
M5E667[%,\8*1(P7S&8,0 20!C).?0$U'XWTJ_P!8TNR@TZ!)98=0MKIM\@0;
M8Y Y&?4XP*BU+1]1@\<6?BBPA%RIL#87=H9 KA-_F*Z$_*2&R""1P: (Y/B'
MIR:=;78L+]VEU'^RY8%13);W&<%'&[GU&W.>/6G6GCZQ+ZM#JEC=Z3=Z8BRR
MV]SL+/&YPC(48JV3QUX)Q7+^(-%NM%M+"\>.-[[4O%UO>M K_*N?E5-V.NU1
MDXZD]JU]>\&7WB>YUG468:==7%C!:6*N0Q0Q2^<'DVY'+[1@$\#/?  +W_"P
MK!+O4+.6TF-S:6)U 1P2Q2^;"IPVU@V-P[J2/;-4-2^(&H?V/8WUCX>O8H;R
MXL4BGN&C"ND[#.T;LYQQR!U!Z=;HC\5ZOX>U*VU/2;"RGDLI+=([>Y\SSY77
M;OR5&Q!Z9)Y]N8=0\.ZO<_#W0M.B@A_M+3)+*1H7EPLA@9"P#X.,[3@D4 ;=
MIXE6X\3R:!-I]S:W26@NPTK(4="=IVE6.2#P?3\15S3=734=&&IF"6" AG4.
M02R#.&&">"!D>Q%<QXRTV;59-#DM+R.SUV.Y^SGRGWD12H1,O;H@+@D#E!ZU
MV<5O##:I;1QJL"((U0#@*!@#Z8H X?P(G_"9>'4\3ZUOGEU"61X+=I#Y=K$K
ME555!QG"Y+=23UX%;221^%$%I)<75]-J-\5L89)3)*<H"5+,?NJ%8Y)X '4]
M<SPQI&M>";1]#M[%=2T>.5WL9HYU26)&8MY<BO@'!)^8$Y'858U_0]8O[K1-
M;M_(;4=*NWF%KOPCQ.FQXPY'WL'() &?04 5O$.OP:MX3\7Z:\5Q9ZEINGRO
M+"7P0#$S)(C*?F4X_,$$"J&"->^&<@>3+VLRL-YVMBUR,C.,\]:NZCX9U#4A
MXJU/[.L=[JNF?V=:VS2#Y%VN-SL.,EG[9P%'4G ?_86K'4?!,_V1=FCPR)=_
MO5R"T/EC;Z\\]N/?B@"^/&EN+NR22PNH[6]OWT^"X< 9E7=U3.0I*, ?IP,U
M3TSQI*\GB:?5;-K6RTJ\,"OO1N D9"G!R68OQVY S6(_A?Q5</ILUW96%QJ%
MCK7VN2]DNSNGAR^T*-AV*JLHV_[/3FKEYX.UF\M_%VG(UM!%J=XE_9WGF$E9
M%$1563' #1<G/0]#0!I?\+"L$N]0M);28W-G8G4!'!+%+YL*G#;6#8W#NI(]
MLU):>-FN[.VN1H.IQQWAMULV=4VS&52V<ACM"A3DL!VQG(J'R_%>K^'=2MM3
MTFPLIY+*6W2.WN?,\^5UV[\E1L0>F2>?;F*YTCQ"G@[PW86L,;26)@CU&T-Q
ML%Q$D>UE#@=-VTX.,@8/H0#/\;:[%KWPN\3O%'/;7&G2M;3)YF"LJ,N<%3\R
MD,#^/(KT9?NCZ5YC/X-U]O"/C#1XK&QB;5KPSVBPS_(H98P0?E& -A[<YZ"N
MS&JZFOBBVTY]-C6PFM#*9Q.#(D@/(* 8V]!G/4T 5=<U-Y?%.C>&X791=I+=
M7;*<'R8P %![;G90?8$=ZYY-3DT#Q]XQFM].O+](K*SF,,,BX10LI8C>P ]E
M'7L.N-C6K)[3XB:!KQ_X]G@FTV9NR,Y5XR?8LI7ZLH[U&VBZJOB3Q7?"T5H-
M3L8;>V(E7)9%D!W#L#O'KTH 7Q#XABLO#NF^-+%W^QDV[3J>/,MIF5>1_>7>
M&'I@CH371ZSJD>BZ7+?2PSSJA51% FYW9F"J /J1R>!7#:SH5[)\)]'\&S1A
M=0N5M+!PC;@%C9#(^?[H5&/X@=375^+K36+WP[+#H<BI>&2-BIE,7F1AP70.
M.5++D9'3/;K0!F:KKL>KZ%XMTN2">UO=-LV,P$O'SQ,Z,KJ<]CZ=*PH=V[X5
M2^9)N>(*PWG##[$QY&<$Y[U:MO#&M077BUX]+L;>#6+"**WB@N/N2+&Z8/R@
M=7R3^6:L)X?U=4\" VB9T1<7G[Y?^>!B^3UY.>W'O0!<^(6NWFDZ;IECILOD
M7NL:C#I\<X )A#GYG /&0 <>YJ[>^$+.32I;>QFNK6[*86[6YD,C-_MMG+@]
MP<]:3QIX9?Q/I$$=M<+;:C8W4=[93.,JDR'(W ?PG)!^N>U3VM[K]U"L-QI$
M=C/C$D_VE98QZE /F;V#!: ([[Q5';MJ?V2PN;Y-+Q]L: K\AVARJ@D;F"D$
MCW R3Q5=O&]I+J&G6FGV%W?G4;)KVTDAV!)$&WC+,-I^89W8_$\53M=%UC0M
M6\1BRMH[VRUB4W4+-*$,$S(%82 ]4.T$%<GJ,57TCPA>:!K7A@6\8GL=)TN6
MSEFW@,[N4.X*>V4/?O0!.OQ&MSI4>IOHNHQV:7?V.]D;R_\ 1)?,\H@C=E@&
M(Y4$8/KD"Y>>-#!J>L:?;:'J%U<Z7%'-*$,2AT<,<J2_HO0\DGIU-<]<>%-=
MF\":UHZV<0N[W5VO8LSKL$9N5FY/KA<=.N*V8M)U5/$_B;4C9#R-2LH(;<>:
MN[?&K@[AG@9?WZ4 36?CNUO+G1=NFWT=CK*XL[R0(%9]A?:5W;AP#R1@D>F#
M4=W\1-)LYX6<%[*6\^Q?:4E0E9-Q3)3.[9N!&['OC'-9=KX9UJ#1/ UFUHAD
MT.9'NR)EP0L31_)Z_>SSCI4_A_2O%6@22:$EI83Z2+B22WU-I\211.Y<H8MI
MW.,D Y Z>F* -&W\<1W.HWMLNC:@D-A=-;7ET_EB.W"QA]['?RN#VSCOC(S:
MM/%/VJ]TZ+^R;Y(-2A>:TN-H*D*H;#X/[LL#D;NO0X/%9NF^&KV:+QE9ZA$(
M+?7)Y'BD20,51X5B.1V/RY_&I?"D?BVTL[/3-9L[**&PC$37<%QO:\"KM7"%
M1LSP22>V .> "/0_$6F6^@+<:9I5\@N=5FM%MG;>_GF1M[,=S!5R&.<X Z=A
M65XVUV+7OA=XH>..>VN-.D:VF3S,%9$*G@J?F4A@?QY%);^'?$]EX>CM8;>(
MG^VYKRZM1=;!<6TCNVS>!P067(Z'!&2#@P3^#=?;PEXQT>*PL(FU:[,]HL,_
MR*&6,$'Y1@#8?KGH* /0[^Q74M,DLWEEB24 ,T3E&VY&0&!!&1QD>M<%#HUK
M)\6;W2&DO38)HL4ZP_;I@!(964MG?G. !7HT)9H4+H8W*C*D@X/IQ7*P:1J:
M?%&ZUU[51I\NFI9*WFC?N60ON*_W3GUS[4 7(M4&F$:%807.J7>G6D;3_O%#
M!2"$W,QY=MK''MDD9&:+?$+3Y8-$FL+"^O5U@R);B)4!61%8M&P9AM;*D>@[
MG IPTC4]'\<:GK=C;B]L]6MX4GB$H1XI8@55ANX*E3SSD$=#639>#-2TF?PJ
M88HY_L%[=7M\RR!1NG5P0@/4*7[XR!ZF@#3TCQ7J>I^,I-*FT6>S@33X;EEE
M>,NC.S#+8/;;C R>YJ+Q5JEU=>,] \)VUQ+;0WRRW5[+"Q20Q1CA%8<KN;J1
M@X'!YJ\-)U.W^(TVL0PP2:?=:?%;2.TI5XFC=V^[CYLAQW'0_C'XI\.7M[K.
MD>(M&:'^U=+9U$,[%8[F%QAXRP!VGN#@X- %Z7PS;1W%E/ITDMFUO.LCI'*P
M2=<$$.N<,><@GG('/6N:\+ZFFAV?BN=X[JY"^(Y((HD)D<EQ$JC)/ RW4G %
M==:76K7CQ^=IW]GQJ<R&299&;V4+D8]R0?;G(X__ (1_Q/;Z7KR6421RWNN?
M;Q&+G89[8[ T6\<HQ"'D>O6@#6OO%%C=:)XG@U#3;IAI43)?VT3KEHVBWY1@
MPX*$]P1@T]?%=O8RZ)I5II-]*U_8&>T5&0C:BK\A9FZ@,O)X]R:PU\*ZVD/C
M6*+3+"WBUNT6.UC@GXC?R?+P1M QGDG\@:T;?0]637O"5X]HHATO3I;6YQ*I
M.]UC VCN/W9].HH /^%CP+I+:G)HFHI;6UV;2_9O+_T202",@_-EP"0<KG@_
MA6S-XF1=3O;*ULY;I[&2&*Z$;J&C,@4@[2<E0&!)^N,D&N2N_"FNW'@CQ-I*
MV<0NM3U62\@S.NT1O*KC<>Q 4C !Y(JWXB\+7VMZL]_;:?\ 8-6BEA-CJT$X
M5DCPA=)@#EQG> ,,"".E '?US"ZBVK^/+K1P3]CTFVBFG4?\M)I2=@/J%5"<
M>K ]A5[3=4U&Y\0ZMI]W8Q16UMY;6T\<V\R*P.0PQ\K<=/0CVSDV-D^D_%#5
M[B3_ %&MV<#Q.>GFP;E9/KM96'J WH: )M%?2]9N/$EM;V5W9S)?>7=N\OS-
M,(T(="&(7C;C&.G2K'@S7)M=T$O=D&^L[F6RNBHP#+$Y4MCMD -CMFH/#FG7
MFD:IXGO=0CC@MKV]^UQ.90<((D0[O0_(3]#4?P^TV:RT&ZN[B-HY=5U"XU'R
MV&"BRN2@([':%..V: )3XTMTN[59+"ZCM;K4&TV*X< 9F7<,[2<["48!OTQS
M7/"+_B;?$R'S)MBP0LO[YLJ3;%N#G(YYP*AG\+^*KI[*:ZLK"YO[+7!>&]DN
MSNG@#/M51L/EJJL!M_V>A)S6P-#U8:GXUN/LB%-7AC2TQ*O)6'RSN].>>_'O
MQ0!J^$;A8/ASH5S,Q*QZ3;R.>IP(5)K%\$(/%WAQ/$^M[[B6_>22&W+,8[:(
M,55$4<;L#);&XD]>!71>&=/GL?!^E:7?Q*)K:RBMIE#!E)5 IP>X.*Q/"VC:
MMX(LY-%AM3J>CQRN]C)%*JS1(Q+>6ZN0#@DX8'G/04 /TO7]$TC3]4E@U6>^
M@34!$%E=V>*5@BB#=)CD,#P3\H//3-17'Q+TZUL];EEL[AY]'1)9X;>2.0-&
M_P!UU;=@C/![CTK+7P/K@\/:H\,MK!JTWB!]<LXW8O&#E<1R$#N 0<>M7]<T
M[Q1XF\#ZO8W.EV5A=W< @AMH[H2#.<EW?:,#C@ 'WZ\ &Q;>+H'UV;2[VPNK
M!ELVOHIK@IMEA4@,W#$K@D<-@X/:JMO\0-.N-5T^Q$$G_$RC=[-UEC8N57=M
M8!LHQ'(W?0X/%5]5\.W^L>*8[F6W\JPET2XTV9O,4NC2E3D#N %/YT_PM#XN
MLK:UTW5[#3UBL(PAOK>?<UVJC"A8RHV$\9)/K@<Y  EE\0XKW2&U9- U<:>L
M<C>=L1B727R_+"AB=Q/?IUYX.+5SKD>K6WB/1IK::UO;&T$DH$O!61&*E64Y
M_A(/3IW%9%AX?\36'PNET6T\NVUA)9'1EGPKHTYD90X&5)1BN<<'GWHL/#FL
MVFM:_>)I-E;6VI:;%#'##<Y*2*)!@_* 2=X);^= &]X!9G^'GAQF)9CIMN22
M<DGRQ715B^$-/NM)\'Z1IM[&J7-G:1V\@5@P)10N0?0XK:H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ JGJ>JV.C6;7FHW*6ULOWI9.%7ZGM^-7*XSXL_\DL\0?\ 7N/_ $-: .NM
M[B*ZMTGA;?%(-RM@C(]>:EKCM4U;6K?Q/X?T;3Y[.*WU"SG=GE@9VC:-4P>&
M (^?IQTZGI7-ZAK^NZEX;TX27T4-U!XICTRXDAAPLX2X #8)^4< D \^N* /
M5:*X#Q=XGUGP_:ZQ<1W-JS:=;130PI"9#/\ \]&F _U2G&%Y'0\GI5V[U;Q!
M=>.9M!L+NRMK=M*6]CE>V,CHQD*8(W@-T]NO0T =E574M2M-(TZ?4+Z;R;6!
M=\DFTMM'T )KBM,\:ZCJ6A^#Y94BMI=;E>&YN57*1,BOPH/ 9V3 SGOP:J7?
MB[Q+;>"O%>K";3VDTBZEM[5S:-B98R 7)\S!/..  "IZ]  =W'K6G3:P^DQW
M2M?I +AH0#D1DX#$XQU-+J&L:?I4EI'?7*PO>3+;VZD$F21NBC%<9J<6J7/Q
M7*:5=V]I<MX>7,\\!E"C[0>BAER<^IX]#69>:[>Z]H7AR34H8H]0L_%D5E="
M'/EM)$[J67/.#P: /5**X6]\1>)-0&K2^'+'SWTZ\-K' RQ[)RFW>'9I 5/)
MQ@<8!YS@+>>+KF#Q6=(O+A=)F>: 6274.8;N)@AD EZ>8"74#(Z#@YH [FHK
MFYAM(?-GD")D*,\DDG  '4DG@ <FI:X^>\>]^+=IICG_ $?3](:^1>QFDD\L
M-^"A@/\ ?- '0'6].6[OK4W($UBB27*[&_=J^=I)QC& 3[8YQ5U@D\)&XE'7
MJC$9!]"/Z5SVCZQ?W?C;Q'I%TT#6MA':O;^7&5;$HD+;B2<GY1Z?2J?@"[<Q
MZ]I+',6E:M-;6_\ LPG#HOT7>5'L!0!T>EZ38Z+9+9:=;K;VRDE8E)VKDY.
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M9ST4>I]!ZGH*E!! (.0>AK"\-ZA/KUC_ &N;F"33;P;[2%$!*QX_C;."V<Y
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M^ISP =C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !6-XI\/IXI\/76C374EO!=*%E>-06QD' S
MP.GI6S10!S\GAIYM;T?59-1<S:9#)"BB(!9!(%#%O?"KTQ6>? ,3:3<67]J7
M*O)JO]K1SK&FZ*??OX!!!7/8C\:["B@#B]1^'D6HG6T;6]02#6842[B C.YU
M0('SMR. ,@8&?;BM*V\+R6WB$:U_:DTMR+ 6&)8EP5#%@QQCYMQ/3 QQBM^6
M6."%YIG5(HU+.[' 4#DDFD@FCN;>.>)MT<B!T.,9!&10!YGK.A#P[I.@:!_:
M&JQ:=;--+_:,5BMRH8_=CEC",#GS&(8@ ;?4Y&E::%?>)/#.J:)>ZS<W&DW4
M21PW+Z<MI*!D[U5, ;>$P=O<XSV[ZB@#G[CPU*^NP:U;:F\%^EG]BD)A5TDC
MW;L[3R&SSD''L:KW/@FUDT[3+*WNYH%L;\:CYA4.\\X8L6<GKEF8G&/; %=1
M10!R4O@<KK]YJ.G:[J&G0:@P>^LX-A29@ "RE@3&2  2N#[BK&I>$4U5+FTN
MKUGTR>>*<VK1*3$8]N%C?^$$H,\$\G!&:Z6N<T[Q+=:I%X@6VTDF[TJY:VCM
MVN /M#"-7'S8PN=P'?% %C2;/4[?7=8GN;^XN+"=D:VBF51Y+#=O"8YV_=Z\
MY!^IIZS8-IWBFU\5Q12S)%9265Y'$A=_*+"1651RQ5@1@<X?VKI(6D>"-I8_
M+D9063=NVG'(SWJ,WEN+Y;(RK]I:,RB/OL! )_,B@#E/#[>9XF\2>(TCG.GW
ML-FEN3"ZO(8T?=A" W60#IU!':M/PGHLND6-Y-= +>ZE>RWUPH.0C.>$SWVJ
M%7/J#6_10!QNK_#Z'5I-?4ZQ?06NMJOVFWC"$!U4*&!*E@,*.,]O3BM./PT\
M?B6VUPZE-)<06+6.V2-<.K,'+' 'S;E'3 QQBM^B@#&\-Z OAS3YK-+N2Y22
MXEN-TB@$-(Q9AQVR3BI5TAO[<NM1DN?,CN;=+9[=HQMV*7(YZY_>-GM[5J5D
M^)]:;P[X;O\ 6!:FZ%G"TK1!PF0!D\F@#$N?AUIK^!?^$1L[B:TTXN'=T :1
MB)!(.3[@=N@ K1NO#+2:[!KMK?M;:HEN;6:01!HYXL[@&3/4'D$$=3U'%:$-
M[>37EHJV ^Q36QE>Y\X?NWXPFS&3D$G/M[U9M+RWOH3-;2K+&)'C++TW(Q5A
M^#*1^% '.R>"+;R=+C@O)HC87[:D7*JS3SMNW,_UWMP,=L8Q4=YX"L]2.OB]
MO)Y$UIXI) @"- \0 1HV'((V@\YY'X5LZQK*:7-86J1B6\U"<P6T;/L4L$9R
M6;!P JGL>U4].UK6Y[6_FU+PVU@;9,Q+]L23SV!;=C &!P""<9W=!B@"O!;R
M>$-+GU/6=6U36WB58P_V<,Z(6 PJ1KR<X)8Y/'M3_!^BP:?'J6I16DEJVJW;
MW7DR@AHT)^4$'[N3N?;V,A%:/AO61XA\-Z=K @, O(%F$1;=LR,XS@9K4H Q
M/$'AT:Y-IMS'?SV5WIUP9X)HE5N2I1@58$$%6/TK&?X>1-87UF-9O3%=ZDNI
M-O2,E9596XPHX+*"?R&*[2B@#F+[P5:ZKJ>J7>H7+S1:E8K83P! JA%+$%3U
M#98G-5[3P1<17VB75WXBO[M]'\P6^Z*(%E9-F'.WYCMX)ZGV/)Z^B@#&\4^'
MT\4^'KK1IKJ2W@NE"RO&H+8!!P,\#IZ53OO" UFUBL]9U6[O+!"I>T"I%'-M
MY'F;1N89 XR >X-=+10!R^M>#OM^M6^LZ7J]WH^H10?9GDMD1EEASD*R."O!
M)P>V:Q-1LI+7XD^&X+.\D0V^GW2O/,GFAG=HSB0\<MAFX(Y'''%>AT4 <M/X
M%L9]/2,7,\=^E^=26_7;Y@N3U;&,;<?+MQC: />K#>%S(][=OJ,RZK=B%#>1
M(J^6D3;E5%.0%SDD'.=Q[8 VA>6YOFLA*IN5C$K1CJ$)(!/U(/Y&IZ .3O?
M\&HV>NQW%V4N=;CCANYX(@GR("!M4D\\G))/7V&+C^%P^NZ;K"ZC<1W-G:M:
M2>6J[9XBRM@Y!QR@Y&._2N@K.US6(-#T[[7,I<O+'!$@."\DCA%&>PRPR>PS
M0 W7-*?6;)+47CVT8E223:@;S K!MAS_  DCGU'%5O%?AJ/Q7H+Z5/=26RM(
MDGG0J-ZLC!@5)Z'(Z^F:33M5UVXU:>TOO#HM;:)6Q=I>K(DI^7:%7 ;D$Y)
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M@822PD%6!/!1B,^O.#@@BNMHH YS3- C\+W.IWEK<SM9W<IG.GQQ HDA')C
MY&X\D9QD]JE\):))HFD2BYV_;;VZEOKK:<@2RMN*@]PHPN>^VMZB@#B]3^'D
M6I+KD(UF^@M-8E6XEMT6,A95"C<"5)Q\B\9QQ6M'X;>/Q0->_M&62X%@+'9)
M&N&7=OW'&/FW<\8&.,5O44 8_AC0%\,Z,NF1W4ES$DDDBO(H#9=RY'''5C4;
MZ'>PZG?WMAK,T'VUU=X)85EC0A%3*#@@D*.I(]JW*J)<7C:K-;O9!;)8E>.Z
M\X'>Y)RFSJ,  Y[Y]J .>F\!VBZ)IMC8WUQ:W&GWAOHKO:KNTS;M[.",'=O;
M(P.HQTKF_''AC^R/!OBFXCU"]O+K5Y+=VC9%)+JT:Y4*N<X4GC@#L,5ZA4%O
M>6]T\ZP2K(8)/*EV_P +@ D?D10!@7.E18EUV^OA>30V,D-LX0(B(X!8@#.7
M;:H)]@ !DYQ/ F@-?^"/"XU&Z>2+3XXIDM6B",DRKP)#U.PG(&!T!.<5Z#10
M!RG_  @UNEOJ>GPWTT>CZG,TUS9!0<%_]8J/U56[CGJ<$9J_:^'%M/%5QKB7
M39GM8[4VPC 140DKCOG+'_"M6"\M[J2XC@E5VMI/*E _@?:K8/X,I_&IZ .2
MD\"Q-IOB#3DU2Z6TUJ6622/:A\HR_P"LVG&>>V<XJW'X7:/7=/U;^T',UE9-
M9(AB&UT8J23WSE5Z8%=%10!YIKVA'P_H=AI0OM4%E+J,MY-?6]F)_)+;GVR1
MA6#(7?C*X&!D]*W?!HU%7E4ZI-J.EB,>7)/IHLRKYZ( J[EQG)V]<8)YQUU8
MD'B!I?&5UX>:S*&&R2\6X,@(<,Y7&W''*GO0 _5_#UOJM[9:BDLEKJ5B6^SW
M46"0K##(P/#*>X/U!!YID?AT3:S;:MJMT;VZM%86JB,1Q0%AAF5<DEB.,DG
MZ8R<[=,FFCMX))YG6.*-2[NQP%4#))H Y@^"HMFK68U&X_LO5;E[F[M=B[F9
M\;U#]0C8P1R<$X(J]_PC@3Q6->BNS&ZV/V%+<1CRQ'NW ^N<_ACC'>FW/B98
M/$>AZ7':&2'5HI9([G?@*$0-]W&3D$>E;U 'F^N:$?#GA2PT5+W5#9-J#SS7
MUO:"8P L\OSQA6WJ7./NX'&>G+K'0;KQ%H]YH\VN7EUH\T09+AM,6S>&99%=
M-@VJ''!)^7' YY->C44 <K'X)5M2U"]O-8O;I]1L!8W2LL:AP-PW#:HQ@.<
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M<[#5+B.[?5&U2*[CC4202L &"=MA  (.<CKGM?U3PDVM07MGJ&HM-87KQO-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+LJHNU5+,6(4=@"QP,GCUH Y &V\2Z[XPTO5K^6TGL7C6U9)O+:UA,2L)D[
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M\'>&VDE=M"T\M+.+AR8%.Z0'.[IUS4Q\-:*T=Y&=-MRE\<W2E>)S_M_WOQH
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MY++I-FTEZ5-RQB&92I!4L>^"JGZ@>E7+/3[33UD%K"$,C;I&R2SG&,LQY/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !5+4M8T[1XXI-1O8+5)9%BC,KA=[DX 'J:NUQOQ*C:?P_91+;37!_M2
MTD:.*%I3L6968D*#P #0!M1>*M#N+$7MOJ,<\#.Z PAG)*??PH!)QW..*R-;
M\03&_P#"5QH^HQ2:=J=_Y,AC5765#$[<-VY4=*SO$\YTCQM9:O>6>I3:+<6!
MMC+I_FEK>;S-^76([MK @9P>5%5;RPMK)?!<>EZ1>6EE%K#W/DF.1VBC:.4;
MWSDIEG!P3QNYQS@ [9_$>D1WPLWOHQ,9A;C@[?-(R(]V-N_'\.<^U48/&&EW
MFK:QIJW'V=M-51+/*I50Q4L3DC& ,<GKFN!UB>YNM_\ Q*M0MGL_%$,\EI;6
M#^68EG4F<L%_>,PYX)Z].,UTFGR26?C'QJ+BSO%6\2WFA?[,Y1T%N%/S 8R&
M&,9SGM0!M6/B32;+2-*6_P#$5M=2W<.Z*Z?;$;D!2Q<*. , GTJ]:>(]'OM*
MFU2WU&![*%F668MM$;+U#9Z'IP?45YSH]O,FE?#".:QNPUDS?:5:U?\ <'R'
M4;^/E^8CK3=2M]^A>._,@OH@^LPW-L4M7)<CR K!<#>N]>0,D@''.* /2K7Q
M!I-YJ#:?#?Q?;E&6M7.R8#&<[&PV,<YQ2Z[K5KX>T.[U:]W_ &>UC,C!%+,<
M#H /\^M<IX6U72]4\9WNHF[F74[JTC@6U>RFMUV1EF)!D4;VRYZ= /J:W?'%
MK/?> ]?M;6)YIY=/G2.-!EG8H< #N30!9@\0Z?)IEI>R3;!<J/+C",SLV,D*
MH&YL<]!T&:NV&H6>J6:7=C<QW%N^0)(VR,@X(]B#P1VK@8+J>W\4^&]>EMKS
M^QVTA[!F>W=3;3$HVYD(W*K;-NXC' [$$[?@K3I[6Z\1WQC>&TU'4VN+6)U*
MG;L56?:>1N8,>>V#WH T=?\ %%CX>FTV&ZWF2_N1!&%0D#@DDD#L >._YXP;
M7QE%IOBGQ-!KNKQ1Z?:-:FT\Q NQ7C+-T&2,D<GIQTJSX\65)_#%XMO<30VF
MLQRS^1"TK(ABD7=M4$XRP'3O6'.CR:E\29#977^EV$209MG_ 'I%NRE5X^8A
MB!@9YH [V^UK3].A26YN5"NAD78I<E!C+84$[1D9/09%6;6ZM[ZTBNK2:.>W
MF4/'+&P974]"".M>66UQ)HM]H=_JUCK#Z7<Z#:VGFV:3A[:XCW%ED2/##=NZ
MD=5KT/PS8VFF^'K2UL-/DT^T0,8K:1B612Q(SDD@G.<'IG':@#,U7Q!=S^,;
M;PKI+)%<FU-[>73KO\B'=M4*O0NS>O  S@U?2WUNTU:S47PO--?>)S-$HF1M
MN5(90%VY!&-N<XYKG-5M;CP[\34\4FUGN-*OK 6-TUO$TCVSJVY7*J"2A'!P
M#CJ:Z"[U Z[I5Y:Z,9?,FMI46Z9&C2-BA"D$CYCDCITP<XX! +4/B'29[V.T
MCOHC-*6$0Y"RE?O!&/#D<Y )QBN6?7-94^/XQ?C?I"J]D_DI^[S;B7&,<\G'
M.:R(K:XUGP3X2T.*RN;76-,N[/ST>%E^S>1Q(^[&,%0<$'YMPQFK4BS?:/B:
M?LMUBZB46_\ H[_OL6@C^3CYOF&.,T =1IGB.VB\-:-<ZI=C[7=V$=PP5"SO
M\BEWVJ.@)Y.,#(I+_P ::18WFBP";SUU8L898@73RQ&S[\@$'. ,>^>QKE;.
MZE@D\+6LNG7L"G0EB-[!9.\QD&P&V)VGRQ\NXD@=!R,&LOP^EU9:%\-KFXT[
M4533I)X;I?LDA>-FA=5RH&<%B!G&* /3;OQ#I-C=+;75]'%(9%BRV=JNWW59
ML;58Y& 2"<BH)?%WAZ'4/[/?6+07?GI;>4),MYK?=3CO_B/6N"CAM?M6N>&O
M$>AZQ>3W6H37%JL9G-O=QO)OCRR'8FW@'.,;170:"C)X^\:3_8IF\W[(8&>%
ME6;9#@A788.&XZT =':^(M(OKR.TMKZ.2:4.T0 ($H4X8HQ&'QWVDXK,\%ZG
MJ&I#7TU"Y^T-9ZQ/:Q-Y:IB-53 P![GFN(T::>?6/ MY_9FHVZ6[7,4]JFGO
M%#8LT141J-O3/&XDCOD=*ZWP")$E\4>9!/%YNN7$T?FPLF^-E0!ER!D'!Y'I
M0!U%]J%KIL*S7<RQ(SB-,Y)=ST50.23Z#FJ+>*="33_MTFJ6\=OYWV<L[;2)
M<XV%3R&SVQFLSQQ=R6D6CN+%YHO[03S+J.V-P]F-K8D5 #\W.T'! W=#TK@;
MJ"Y;PAXLL3I^IR2S^(X;F,2V<A:6(R0-N^[SPC$XZ8YQP* /5M-\0:1J\US#
MI^H07$EKCSE1ON9Z'W!P<$<<5S>H>*_-\;^%;'2]25K._DN!/&(N)D6%V5D<
MCE=P'*G'3FL7Q58ZAJGB?Q+%I,-P);OPRMO!*(F5'D\R0E Y&-VUAW[TX:M'
MJVN> ;BVTS48A923)=1M82K]F)MF3:WRXQN(&1QT- 'IW09-95KXDT>]N%@M
M[^)G>-I8\Y59$4X9D8C#J.Y4D5>O6=+"X>.#[0ZQ,5AS_K#@X7\>E>5Z+<2R
MZ]X'OC8:C%'#;7,,\(T^2*&R=HT B4;<A001N).<=>P .^A\9^&[B:UBAUFT
MD>[D,4&U\AW!*X!Z9)! ]<<9J]:ZWIU]<WEM:W2RSV1VW,: EHCZ$8Z^W>O+
M(K>9/AO:PC3[P7*^)!<&/[))O"?;"^_&W.-F#GTKI/$^GZA:>+;6[T<$1^(8
MO[-O2IVF,JI=)Q_M+&)1_P!\T =O97MOJ-E%>6DHEMYE#QR+T93T(]JYV[UZ
M[U'QD_AG29$@-I;K<ZA=E YC#'Y(T!XW'DY.0 .A)XZ:&&.W@C@A0)%&H1$4
M<* , "N$EL[KPM\3M0U][:>?1]:MHHYY8(S(UM-$-JEE4$["O\0'!ZX'- '3
M0V^LVNL0*U^+S3&B<2>=$JS))QM.5 !7&X8VYSCD]I!XBT@Z@EC]NB%Q(66,
M'(61E^\JL?E8C!R <C!KD;JV36?BKIFHZ? TMM!ITXFNQ"1&LI($>6(P6 SC
MJ169X1CLY[+1M#UC0M8.NZ/-&6$S3_9T>/CSU?/ED$9('<G&,<T =N/&OAII
M8HUUJS9IIOLZ;9,@R9QMSTZ\#U/%7-1\0:5I#$7]['!M"EV8$K&"< N0,(">
MA; KS"[MYF^'/BB&/3[S[1/XC>XBC%I)OD0W:.' VY(V@G/H*T;M[:U\3>(=
M/\0Z5K-W9ZQ(DUG)9K.T5PAA2,Q,(R I!3^+'!Y(% ':W_C#P[IEQ);WFL6D
M,T>S>C2#*[SA<XZ9_P#KU.OB/2&OTLA?1^>\K0)P=K2*,L@;&TL,'*@YX-<O
MI%HL'Q.E']GRPP)H%M:H3&[QJR2.3&)",,0"O?FN:GN+FZ&C2G2=1M9+/Q-Y
ML]C;Z>XB@3=+\^0O[PMN#%@2/FZ#N =SX>U/4+KQ?XJTZ[N?.M[":W%LOEJN
MQ7B#D<#GD]_2KWB^]N],\(:MJ-C-Y5S9VDMQ&2H8$HI;!!['%9'AD2#Q_P",
MI'@G2.>6U,4CQ,JR!8 K;6(P<$8XK0\=AG\!:]#'%+++-83Q11Q1EV=V0@
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M5U\H*_3/S;S\H]>E3>*O%!;P9#KGAO5(GB:\MX_.B59 ZO,D;+ST.&/N*RH
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M.T,MX8Q"8P6N]H8-$ PR,-U(Z%<5@Z_I>H:1<^'=:T&P(NK>(:7-:ABX6&0
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MORR YQD#GL3CT&:Y#Q<UOJ/@*_GTK1KF(7FH6TRA;)UEN2)HF>4Q[=PX4\L
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M&",KKM 5OF' +#WH Z6BN5\)ZBXUKQ%X=D8N-)N(S;L3DB"9 Z+_ ,!.Y1[
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M/;]UBHQST8'U HCQ^LDMA/;6'VG3KR[^S"2&1FF0%BHE:,)C9D?WL@$''4
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M3.Z0Z>CQ1VCW+W5S/Y,.00!&&VM\YYXXX]:YK4M0MM>U?X<:[#;^6;R=Y%W
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M&.; @,DJJ"ORX8 G_9XKJKKQK#IVH>(;>^M#'%H\$$_F1R;S.)=P50I PV5
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M#F=>\*:QJ^IZW-;7M@]GJFF?8XFN%9GM258'RP.-K[@2<YX'!QBF:UHMY?\
MAWP]X6G>*6Y$]N]XT (1((2&)YYY*JH]2V<<''=(BQH$10J@8  P!33Y<6^0
M[4SRS'C\S0!B^,=#N/$?A>YTVUFCAN'>*2-Y02FZ.17 ..<';C\:IQ:+K \;
M)K\QL64:6;)HTD=3O,GF9&5/'\/Z^U;S:A&NK1Z<8;@R/"TPE$1\H $#!?H&
MYZ>E6E97&58,,D9!SR#@_K0!Y[IO@G6K#3/"]HTFGNVC7\MU(PE<"4/YG ^3
M@CS3^7OQMOH&HZ=XQOM>TEK65-2@CBN[:YD:/#QY"2*P5NQ(*X]\UU%4[K4H
MK62R3RIYA>2^6CP1%U7Y2VYB/NK@=3ZB@#D/^$&O=,M?#\ND7%K+?Z7>3W4O
MVG<D<YG5Q)]T$KR_'7H,UE:WI%YH?AS7H=4O]*SK^KQM"TT;")6;8"')/R#;
M&<$'(.,'.*]0J.>"&ZA>&XBCEB<89)%#*P]P: //M,35WGU#3G@T&>XU&T=6
MNK._FF=<+M7S2X)V?,<8/7/')(NVOA+5K>/P4A>R/_"/H4F(E?\ >_N3#E?E
MXX.[GZ>]=A9Z?9:="8;&TM[6(G)2",(,_0"K% '*^,=.D>^T#7H59SH]Z9)E
M49/D2(8Y"!WV@AOHIJ>\T>\O/&VD:] ]JUE:VLT)!D.]_-*'<,#&!L'?G-='
M31&BQ^6$4)C&T#C\J .6T6P:[\=:UXC(_P!':"+3[5O^>BH6:1A[;VV@_P"R
M>V*>^@:CIWC&^U[26M94U*WCBO+:YD:/#QY"2*P5NQ(*X]\UTX 50J@  8 '
M:L[1M=LM=2\:R,N+.Z>TE\V(QD2* 2,'G'S"@#EY_ ]Y!X>T;3=/FMGDL]53
M4[F68L@E<2&1@H . 2V!Z #K73Z]ICZYX9U+2MZPR7MI);[_ +P0NA7/;(&:
MTZ* .,B\-ZXVJ>%;VY?3B='BECF6-W&_?&(_ERO;&><9SCC&30N_!.LW/ACQ
M%I0EL%EU75?MZ/YKE8U+HVT_)R?W>/Q]N?0JS=1UVRTO4=.L;DRB?4)3#!MB
M)4L%+'+=!P#WS0!SGBGPC>^*5GAN8-.!RCV5Z)&6XL' &XH0OS?,"0,KGO[=
M+J]O>7&F&&R^S/*63<ET,QR)N&]6P#U7(Z'K6A10!YTWPXN(=.NQI-S!I5R-
M2CU+3[:(M);VTB)M(Y .U\MD  #(QTJ_K7A_Q1XB\'W^G:C=:6E]=>4JK;^8
M((E1PQ.2"S,<8[ <>^>VHH Y>;0-0N?&IUF0VJ6KZ2VGLBR,SAF??N'R@$=L
M?C[5AP^"?$5GX>\.K::CI\>LZ!F*V8HY@GA*[&63N"0 >!P1^->B44 <;JOA
M_P 0ZQI^F&[N-/:]M]3@OI50ND2+$<B-."3GNQQUZ=!5;5_ UYK=[XH-Q<06
M\&L06R021.S2020$LC$%0#\Q!QGM[UW=(64.$+#<02!GD@=?YB@#D'\/>(/$
M'AZ^TOQ1?6*_:+9K=3IRO@L<?O6W=P0,*..O)R,7?#MIXLB,:^(K[3ID@7:C
M62.&G/3?)NX''9>YSGC%='2,RHI9B%4#))/ % '*ZUX>U>^\4IJ-K=69LS8-
M:>5=*S&W<L298P."2"%.2. .>U9MAX.UJTL/!L$L^GR-H#$R%6=1(OE&( ?*
M><-G)QZ8[UT>G>)['5+^*T@CNAY]O]JMYGA(BGBR!N5NG<<'!P0<8K:H YW0
M=$OM-\1>(=0N6MS#J<\<T8C=BR;(UCP<J!SMS^./>H+C0-2E^(UIXB0VGV."
MQ>S,9D;S#N<,6^[CC&,9_&NIHH YWQ=HE]K<.EI8M;JUGJ,%Z_GNR[A&V=HP
MIZ^O;WJ*^T"_B\90^)M+:W:9[/[%=VMQ(R+(@;>K*X4D,"3U'(/:NGHH X"Y
M\ W\,-OJ6E7UM%X@AU.?4RTJL8)&F&UXCCYMNS:N>ORYQSQ=UCPWX@UC2K2Z
M?4[2WU^RNUN[8QQL;9"%*F,@_,596;+<'GIQBNBUO6;3P_H]SJE^91:VZ%Y#
M%&7('T'\^E78I%FB25<[74,,^AH X_5/#?B+7]"4WVI65KK5O<Q75F;1&:"&
M2/.,[OF;=N8'IQCCCEFJ^&/$7B;PW-;ZQJ%A;:FDD4]F;%',,4D;;@S;N6R>
M#Z#IGOVU% '$C0?%-SXD37+B?2K:Y72I;$) 9) )&8,'!8#C*CC''O5G0O";
MZ;XIGUS[/9:>UQ:^3<6UB[&.XEW!O-(*J 1@@<$G<<GUZVD#*6*A@67J,\B@
M#C=>\+:SJ6N:G<6]W9-:7VF&R07*LSVC$,&,8'&&W#)R#P.N,4S2_"VM6>K>
M'+RXDL)!I6F/8R"-W7>6V<C*GIY8^N>U=M10!YS'X#UJWM+.YMKJQCU;3]6N
M-0MBS.T4B3EM\;_*".&QN /3I6]H&AZO9>*=;UG49+()J26X$-N78QF-2OWB
M!D<^GY5U%% '!0OJ"_%K7_L$5K*?[+M RSRLF#NEP00K9[Y'OUJ2R\$7FE7G
MA4VDUM+#I#7,EPTC,C3/.#O*@ @ %B0"?;WKKX]-L8KU[V.RMDNGX:=8E#M]
M6QDU!J>LV^EM'$\<T]S*CR1VUNFZ1U3&X@9' R/Q( Y(H QH] U32/%&KZII
M#VDL&K+&\T%R[(89D7:'4JIW C&5..1UK*M/ 5]X;N]#O?#MS;2SV-D]A=17
MA9$N(V?S"P*@E6WDGH>N*ZG1/$5EK]A+?6L=U%;QMC?=6[0[AM#;AN RO/7V
M-:U 'GA\#:V=$OHC>:>;YM>&M6N%<1[A('V.>N#CL./>GWO@35-;N/$C:I>V
MD,>LV=O"!:JQ:"2(LRD$XR Q'UQVKT"B@#E[#3/$][IES:^(K[3\O:O;K]A1
M\.6&/,?=CG_9'')YZ8H6_A;5CX7TG0]4MM%U.SM;7[+/;REU5PJHL;JQ5B&&
MUL\#[W'3-=O37<1QL[!B%!)VJ6/X <F@#*\+Z/)X?\-6.E2W+7+VR%?,8D\9
M)"@GDA00HSV K7K.T/6K/Q#H\.J6!D-K,7"&1"C?*Q4Y!Y'*FM&@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "N;\7:W/I7]C6EL_E2ZIJ,=EY^T'RE(9F(!XW87 SD9.<'&*Z2L[6
M]#LO$&GBSOD<JLBS121MM>*13E71AT8&@#GK>^U.#QQ?>&)M0GEMY=-6_MKK
M9'YL!\S8R'Y=K \$$C/4<\4SX30R1_#717>ZEE$EN"J.%Q'R>!A0?S)KH+;0
M8K>6YN3=7,U_<1+"]Y(4\P(N2J@!0H +$\+U.3FG>']#MO#>C0:5923/:VZ[
M8A,P8J,YQD 9Z]Z ,;6-5U"Y\7'P]8R2P[-/%XSPO&KL6D9!@NK#"[<GCJP^
MAHQ7?B,1:-8:OJ<2ZBT$_P!IATM5::=U8!'!9=J* <MG:-Q [XK:\0>$-/\
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M+-@@ _>)/L>E9ESX3.B>%-4BTU]3UB\DM&MX4O;TLZQMP41B0%XY[$[1SP,
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MEVA2X?;G:,E0<<\UMZAX'TG4]&M]/G>\#V\WVB*]6X87*2_\]/,ZY[>F,#'
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MTVX\2:(EQ+K-QI_V2YMIQ'&D[P2,?,3  0N%1]O'/IVJAKFM?VYX)GGLM<U
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M427(BU'S197#1CR[@QY+;<$L. 2-P&<<56A^(6C3&Y<0ZBMM:O<)<W+6;B*
MPC+AS_">#@=3^(R = -*TY99)186HDDD$KN(5RSCHQ..2,]:?)I]E+>1WDEI
M ]U&,).T8+J/0-C(K(MO%UC/<S6TEO>6\\5FM\(I(MS20$D;E"%L\C&.OM5;
M3O'ND:G-I20PWR1:JI-I<2VY6-V"EMF[^]@$^G!&<\4 ="]G:RRM+);0O(T?
ME,[("2G]TGT]J2TL+.P5EL[2"W5CEA#&$!/OBN2M?B"G]G:]J=_I5]!9:7>R
M6[LB*Y54"@E@&SG))XZ#'H:Z4ZO"+RPM1%,TE[&TJ;=I"JH7)8@_[2C(SU%
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MHTK3@8R-/M1Y7^KQ"OR<YXXXYK,C\6V<I$8M-06XDN&M[>"6W,;W!"[RR;L
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M>75G_8]JXDLK6" JX;9M_>,3@@9)  '.#VJ:U\1VL^L)I,\%S97LL)G@BN5
M\Y!U*E21D9&5.",]*K^+_$<OAK3K6XALI+I[B\@M1LQA-[A<G)'8G'OCH.:
M.@JO+8VD\XGEM8))@AC$CQ@L%/5<]<'TK#75=/;QF(&.IQZBFEF=K8AO)$6]
M>=HR&DR<97/&156'XCZ)/:Z=>"'4%LM0E,,-RUJVSS,L A[Y)4XP#Z<'B@#H
MQI>GAT<6%J&10B-Y*Y5<8P..!CM2?V5IWV62U_L^U^SR?ZR'R5V/]1C!K,LO
M&&F70U03+<V4FF!6N8[J(HRJP)1@!G(;!QCG(QC-367B2TN];DT:2"YM-06
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MMXIL[C6+K2&MKV+4+:(320M 6PA!*D,N5.<$#G.1BM'3-035=,M[Z."X@2=
MXBN8S'(OLRGH: $_LG32)!_9]KB7F3]ROS]^>.:#I.FDH3I]IF,;4_<K\H]!
MQQ6;=>+]+M=2O=./VJ6\LX5GFABMG<A#G!&!R.#S_B*#XQT3&F,MR[IJ4#7%
MJZPN5= H).<=>0,=<D#&30!H_P!CZ9Y8C_LVS\L'<%\A< ^N,=:ECL+.&=YH
MK2!)7&'=8P&;ZG'-9EMXJTR]M[*2U:::2\@^T0VZQ$2F/IN*G&T>[8ST'-$7
MBW1YSI7EW#LNJNT=J_DN%9U#$J3C"M\C#!P<B@"+5=&U&Z\C3]-N+*QT5XWC
MO(5MSYI4GD1D$!<C(S@XSFM'5=(MM7TM].N(XS;2 *RF,-A?]G/ /H>W:LG6
M?$MG_9]Y;PWUU8W0NUTU)ULVD,=PX4IA2,$'>N">#FK]_KUAIHGBN)9)7MH/
M/N?)0L8H\'YVQ]WH<#J<' .#0!JJH50JC  P!2&-#(LA12Z@J&QR <9&?P'Y
M"N0\&Z@UGX1TN74KBYFU#52]W% [M-+M<EU49)(549!DG [GFMFW\3Z7=:?;
M7D,KN+J5X8(@A\R21"590OL5;)Z #.<<T :HAB$;1B- C$EE"C!R<G(]R3GZ
MU772M.2-(TL+541"BJ(5 53R0!C@'N*YOPI=2:OXG\2:FLUU]BBFCL8()I'V
MJ\:YE(0G .Y]O']RNOH J?V5IWV;[-]@M?(W;O*\E=N[UQC&:>]A9R+ LEI
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M=HD0-A6.4RO;GKP.,];I%KHFG7\]C977G:@B!IEGO'N)T0GC)=F8+GMTK:H
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M_.T$9!4'@]">*77/#>HRZS+?Z-976G:U"\$<-[:R*MM>1!4W":/=T7YQ@C.
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M6SAU*W:6>XN#O6&0 ;8U0,K.6.[&.R].:T(?#=_%XJN-=;5('EFT]+(QFT(
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M9VA)<*C,P8R%^3ECGBL)/A[J,=K96H\0KY-CJQU*W)L@7)+.Q$C;_G/[PX;
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M7)>31A(;"VD,1E CC D>56!15)Q@9R6'!Q5.TUC55^'GACQ5=:A=/]BN]NI
M3$":W\UHBS 8W%?E;/?!S0!ZM2$A022 !R2:\QT_5[M]:UK06O+W=JKQSZ/,
MUR[,+9F*.R'/ 78T@]0RYK=^*%S-IWPNUM[5W5Q;K#NW$L%9E1CD\_=8\T ;
MG]M^=IT-]96%S>033(D9BV@LC$#S1DCY #G/4CG&*UJX[QS)/I>AZ.=.NIK5
M4U.R@*PMM#QM*JE3[8[5D7T=_?\ B;QM:MK>J0P6=C;SVZ07'E^4[)*<@@9
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M>#C..] %>[\+:-?:;::?-:$6EI(LL,44SQA74Y#?*PR0><GOS6NBA$51D@#
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MK..WMW\J9Y)0OEO_ '6!Y!]NIIB>+_#CRF)==T\R"5X2OVA<[T&YAU[#D^E
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M:5-I$NM:9H;307.H6AFOI+*0$%6_U_EX#L(P%P>A)]C7HM% 'BNL&231OB5
ML>H3O>"W>W>:T96G_<QC@!0,Y!X S@=.*ZCQ;+%IFH>&M;6VNFT.(31W;Z>K
MAH2Z((Y"$^8@!2I] ?PKT*B@#BM*U;PYX;TTWMM;7]M9:MJ1*RRQS,9I7 S*
MP?YD4D=3CIGH<UV;R)%&SR,%11DL3@ 5%=6D5XB)."T:N'V9P&(.1GU&<'%3
MT >4366IPV7AKQ/X<M_.U*$-IMU RE=T4K':7'4!'*M]"36A:VD.E?%G2;:(
MR/!!H4ELT[*<-,TRM\S=-[8+$=>?>O1Z* /)?"RZ==6>E^'M=T[5Y/$.EW:R
M&%S.(O,1R1<!Q\FW!+<GG)&#D9SK^[EB^%WB'PYJ%K=MK\=[)))&+9W-QNN0
MZRJ0""""!GVQZ5[710!YUJR7&H?$#5%T\R1SW/A9K>WE9&3$QD<JN2!A@"#@
M\@4_PMK&FZGI6C6_]@7)UK1[4Q/#-:-&;-A%L<!V&WYL!0 22#[''H5% 'C^
MB7GGZUX#NDM;R&*%;J&2TCL9$BLF:+ B!*Y.",%B2.,\"F3+>#0-9N;:UGG@
MMO&'V^Z@CC)::U#JQ95_B&0#QP=IKV.B@#@=,U&VU/XM-?V23R6LVA)&MQ]F
MD5"PF8X+%0.GK[CK6GXYO191:,[V9DC.HINNQ"TOV/Y6Q(%7OSM!/ +9.>AZ
MNB@#Q2[#-X/\664EO?222^)8IT$]JP:6,O;MNQM /"L2 . .0*V?%5O>7_BC
MQ-#HH;[1<^&%A@:,8$D@DD)16Z;MC#'/<5ZE10!Y>-9LM6UWP!/96EVHM'FC
MGC^QR VI-N4V-\O&&P/UZ5U'Q%L-0U+P!JUII<;2W;QJ5B7K*H=2Z#_>4,,=
M\UU%% '"SR1>)?&?A/5-(W[+)+A[QRA4QQO&%$3YZ,6P=IY&TFN3C_Y)=I6E
M3VMP+FUUV,7$,EN_ %XSMU&" G)(R ",]:]FHH \J\26MY?Z]XWATJ)Y)KG2
M+01*@($[(TA= W0DJ<?\"%7+>\\/:[!=ZQ8V6K&_ATR:":6]$Z^0&'^I(?AV
M+=ESTZ],^DT4 <S\/H88O 6@A8%BF33X(I04VL&51N5AUR&+?B36)X]AMKOQ
MIX,BNH1/;1W,[7 *%D13$0I?L 6QC->@T4 </XOT/^RO!TJZ%82O%#J$%_-9
MVI(:1%D1I%3'.?EW8]:YW78+'Q#X7US5?"EAJEU>RVT4=Q+<>>K31I*K-"JR
M?>.T.#@=\9.:]:HH \SOM4A\0^-]#N]&6Z_>:5>PK/\ 99%$4C>7M#';\N"#
M]/QJ'PC)H^H6^@V5]IFK1Z]HH420W!G6.T9$VM)N/R;2 <#)SD#'<>I44 >4
M:6(K;X3:Y+_8BW\Z7=XS6LD#;G5YR0Q  8KMVMQU"U<TF\4^/M6O&EO;B"YT
M.$I=2V;1(Q5Y2<?*  ,C&>>>IKTNB@#E/AHK1_#C089$9)8K18Y$=2K(PZ@@
M\@UC:K;6E_\ &>P%U"9;9=&DB+E6V"4RJ0I8<;L \9KT2B@#S>WLX+/XQ7B:
M>A@BD\/B!9=K%!/YS';N/&X#!Q5'P@=+O[30=(U+2]7_ .$AT9X]T$QG$<,B
M#:9@_P#JRI&2!GG.,5ZM10!XW:7QN)O"%R+"]M!:ZQ,)M/BL9!'9[DF&"=N6
M8D@DYQST JSJMO/>^'OBC!;02RRSS[X46,YE40Q@E?[W*D<>E>MT4 <!<7EM
MJ'Q$\)WT:2&W33[O]Y+"R!&;R]N=P&TG:V,XS5WX;_+H^JQ[60#6+QT5E*_(
MTK,I /8@Y!KLJ* . U*&7PS\46\2SP32:1J5@MI//%&7^S2HV5+@ D(1QGL>
MN*Z*[URWOM*O6TVV;5(UMI'98P=DF%.(PV.68\8'3OVSNT4 >3:%?*_BKP??
M;+L6PTJX@918O%#:MB+]TN5R H4@EB>G6F:;I]S+\$V33["1]1@N7FDMU0QS
M2(+OS&0=#EHU&/7BO7** .,\+3:!K6N-K>E6NIM="T^S375[YZ[%W!A%B3AC
MG)R,XQUYJO\ %D>;X1A@5)))'O[9MD2LS;5E4L<+S@ =:[NB@#GI]'T?3]/U
M/4[:!3<7-JRO=/(TLCKM.%W,2<>@'%<.EE<1_"?PA<V=E(YTV>QFU&WCA/FM
M%&<NNW&20QW8]LUZS10!Y[?VD6N>,+[5K-YFTL^'Y;2ZGME.969LJJ?WG4;C
M[9 [UC^%M9TB^O\ PA]NU1(+G2;-K6",VLT7GNZ*@W%T"KPOW03EB,'@9]-U
M?3(=9TB[TRXDECANHFB=H7VN 1C@UG66@7J-&-3UZ[U*&)U=(I(8HP64@J6*
M*"2" >PR.E '%:6(H/A[XOF&BC4)AJ%_*+1XB#,CR'!Z9*E<'CJ!Q26MVDGC
M2[O#)>W-M<^&_+2X>R>*,L)')51M&  1C.3SC)->J44 >1V<,2>%_AA$]OA[
M6YB:=#$<PX@<,7&/E^<KR>^*LW$-I<ZMXWBNI;RU@GU&QDANK5#NC=4C E7@
M@A9%&X\@8.:]3HH X#1O$\^@:5JESXEF2ZMX;U(H]5LK5L7@,:_O&5<@;0-I
M8?+\N.U=Y*Q2%W5#(RJ2$'5CZ5'=VD5];FWG!:%OOH#@./[I]0>X[]#QFIZ
M/'M%O//U?P'=)9WEO% ]U%+9QV,B16+-"P$>2N2<\$DD<9^45K>%S=V.OZ5:
MZ;=MJ&AW!F<VEW#BYTEMI/W^"4).T!O48)%>ET4 <E\3;>:Y^'6KQV\,DTFR
M-MD:EF(616. .3P":H-=VUY\5M*U!5?[,-%G"RRPL@5C*A'W@-I*AB,X.*[R
MB@#Q_0KT:=HGAN*6REB U34!]M%J\CV09Y"@5 #@R*^ 2",=C4-NLT7A*,O:
MW^+'QB+J<R6KAEB^TEM^ O/!!.!QFO9J* &12":%)5#!74, ZE2 ?4'D'V->
M01F]MO!(C2PU"1])\12W5_;PQ.DC0&>0Y0\;B RN-I[5[%10!Y'XF31=3\"^
M*-3T*SU"674(8(I+B=9]URZ.,*J2<G:,Y(&/<X..B\5)9MX@\%R6\,9@&HM,
M[1Q_*J^0ZJS8' SM&3[>E=U10!Y5=QQ-:?%0+"2UTA$&(SF8_957Y>/F^?(X
M[UZ'X=??X:TMLG/V2('/4$* 0??-:5% 'E[0V=S/X]BO3>0VT^I6K)/:HP=<
M+"HE3@Y".,DC/W371>"+C5GFU:WU.XM]02"6,0:K!%Y?VM2O.X#@LO )7CMU
M!KKJ* .&UV\?1?B=IFJ:A',='DTV6TCG2-G6"X,BL=V =NY5 !]JY"*2YMM/
MFU--/U)]/L_%EW=744,$D<A@<.@D48!(4L"0.1CFO:** /,-8CT>X^'_ (PU
M#0[2^/\ :EJ5,TXFWW<H0J J2?-P,#('/X5H:W-'-JG@&6/+I'=%I&52?+4V
M[KEO[OS$#GO7?T4 >.ZG$LO@KXEQI;LT]UJ4C0*(CNF&R(*5XRPW!L8]#6E?
MWME9^+M63Q!#J;Z7K-K +.>T6=XY%"%7A81<YR20"/XC7J%% 'FNF2Q^%/&\
M:WME=6FE7&CV]MII*O,(#&S%H&(R0YRI]\8R<5K_  L!C\!VT+030-'<7/R2
MPM'@&>1A@$#(P1TKLZ* .*FECB^,/GR96)=!:-I2IVAO.#;=W3.W)QUQ7'Z5
M&MO\/? $7D/'-;ZU%).GE$-$ 9=S,,94889)]17LM% %'6;.[U#1KJTL;W[%
M<S1E$N-F_P O/4X!';/<5P$.B>)K/XEZ%YNIV4EM!ITR;X-+:*-8A)%F+_6$
M!B!P>V#P:]-HH \^N?&NBZAK*-=1:F\5C,3:VZ:9<-YTPR!(3LVX&2%R<<[C
MVQZ".G3%%% 'GWA&]@\*W?B/3-:<V<LFL7%Y;O*I"3PRD,I1L88]00.016FE
MZUAH>J:M/IUQ-;W^H*WV8V[-(86,<)8QXW?=4OMQG'4=JZZB@#R[2M$L=)\?
MZ>_@JXE72[L3'5[&,L;:(;/E8 \1ONP-O7'8 &K7@"YC\$:,WA/72]I+8SRB
MVN)$(BNHF<NK*^,9^;!7.17H]% %>SNOMD32K%)''NQ&9%*EQZ[3R!G/7TS7
M+^+$\/:S>2:%XGL UE]G2>*[DC8(CEG4@2CA& 52.1G)ZUV%% 'CJ6VN6/A!
MV#ZGJVCZ7KL<ULQW?:IK%1R5Z,VUCE3WV9'&*MZO%8ZAHU[XA\+Z=J5X?M5E
M<7K2B8/>QP2!C&J2<MM4=0,'ISR!ZO10!YWK]UIWBGP;XHOM!TR>6XN-+>)[
MEK5XGF(4[8P&4%R,GIQR!SV6^O8;WQ#\/[J%)O*1YRSO"R[ ;=E!;(RH+8 S
MC)Z5Z'10!Y)Y,S?#KQ-X5U"WE?7I+FZ\J,H=UT\DA>*5#W7)7)_AV\XQ6M8Q
M+;>/=:-\1(Z:#;0/<,AQ(ZF3S #CD\J2/<5Z+10!ROPV#I\.=!BE5TEBM$CD
M1U(9& P00>175444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4R:)9X7B9G57&"4<JWX$<C\*?39&
M9(V9$+L!PH(&?SH X_X<&>_^&.F">[N&FECE#7!D)D_UCC.XYY]ZS_#2Z79?
M$S5=.TG4+F*)+!&FT^ZDF;?-O.94\SJ N 2#@EAZ5J^$M,UGPW\/X-.>SMY=
M3M%?9%]HQ'(2[,/GVDC@^G6K,6EWFI>(;'7K^QBM)K&UEBBA682,[2;<[F
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7N >B$@=3BCK7EWCG5=4U#P+XUT[6-$-M]AMT:"[7+0W(;!RA('*G@_TK3\
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M(0?+4*=Q&<D':/0GMUNM^,'L;G4;;3K..\N-/B62:-Y60NS+N$:;4;+;<'G
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M8'6\.:RWB#0+74WLKBQDF!WVUPI#QL"01R!D9'![C!H TI)HH5#2R(@)P"S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% ''^._ D?B\:=>6UX;'6-+F$]G=;-P!!!VL.XRH/
MMCZ@ZEJOB:X\E+_^S+1493+):2/*TH!Y #JH0'ZMQG'/(W** /,]2^&5Z_\
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MD]?PJQ8:UI6JO(FGZE:73Q?ZQ(9E=D^H!R/QH O4444 %%%% !1110 4444
M%%)D9(R,CG%5=2U.QT>PDOM2NXK6UCQOFF8*JY.!S]2* +=%48-9TRYU*338
M+^WDO8XEF>!) 7"-T;'H<CGW'K5Z@ HHHH **** "BBB@ HJEJNK6&B:?)?Z
MG=1VMK']Z20\#_$^U70<C(Z4 %%5--U.SU>Q2]L+A9[9V95D7."58J>OH015
MN@ HJ*YNH+.'S;F9(H]RIN=L#+$*H_$D#\:EH **** "BBB@ HHHH **** "
MBBB@ HJE<ZOI]IJ5GIT]W&EY>%A;PD_-)M!8X'H #S5V@ HHJM?:C9Z9 )[Z
MZBMXRP4-*X7<QZ >I/H* +-%9L&OZ3<2-%%?P&94,C1%L.JC&25/('(YQWJJ
M/&?AEK<W U_3C /^6@N5V^G7.* -RBJE_JECIBQF]NXH#*=L:NWS2'T4=6/T
MIMGJ^G:A*\5I>PS2H-SQHXWH/]I>H_&@"[16;J'B#1])GB@U'4[2TEESY:3R
MA"^.N >M6;'4;+5+87-A>074!)'F02!UR.HR.] %FBBB@ HJGJFK6&B:?+?Z
MG=1VMK$/GDD. /\ &K8(8 CH>10 M%%% !1110 45%#=07#S)#,DC0/Y<H5L
M[&P#@^APP/XU+0 4444 %%%% !1110 4444 %%%,EEC@B>65U2- 69F. !ZF
M@!]%5=-U*SU?3X;_ $^X6XM9@3'*G1@#C(_$5:H **:[I%&TDC*B*"S,QP !
MU)-9EIXET6^N8K:VU.VDGFR8HPXW2#!.5'\0P"<C(H U:**I6^KZ?=ZG=:=;
MW<<MY:*K3Q*<F,-G&?K@T 7:*** "BBJB:G9R:K+IB7"F]BB69X><JC$@'\P
M: +=%%5[Z^MM,L+B^O)1#;6\9DED;HJ@9)XH L44R*5)X4FB8-'(H96'<'D&
MGT %%%% !145M=07MK%<VLR302J&21#E6![@U+0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\\<FH0+&&)9#DF-B?EW=\AO;%.U;X;6MQK>E:SHFI3Z+?Z=;K:(\$:R*\(&
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MHTCV1L,$_*,L_ ^8\\<8R<NT?PIJ.FVK6]WXEO-12*(Q6@N(4'D@C&6VX,C
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MI%UJ$JEU@C+!%ZNW\*CW)P![FL/PYX1N]!,,,WB*^U#3[0;;.UG1!Y0Q@;G
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MF5W.I;*$H%..QZ^@?>>#+@^)+G6-(U^\THWP07T$,<<BS%1M##>#L;'&1Z4
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MR(EC#!2/FY.';K[55M_ _P!EB\-"+59XY="A>VBD2)<RQ,JJ0P.<'"+R/RH
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M-IX)]L],]Z 'Q>(;S4M=MM#LY(;>?^RTU"XG:/?C>=JJJY'<,23VP.^1A_\
M"<ZY+86(BAL4OD\0?V'?*Z/L9AD[XSNR 1M.#GKUXS70MX2:/4M.U:SU#R-3
MM+3[#)*8=T=Q#G(5TW Y!&001R3VXJ&?P/$]K8Q07S1R6^J?VM+*T08W%QDD
MEN0 OS$8'8 9XH E\,ZQJ=SKNOZ-JLEM/+ILD)2>WB,0=)4W %2S8(((Z\\5
M8\77XM-(6U$KQ2ZA(+5712616R7<8!.50,1[XJ33- ;3_$>KZP;SS3J?E;XO
M*VA/+7:N#GT/.>_I4[Z5,_B2+57O 8HK=H([8Q<+N*EFW9^\2J_@,>] '(_#
M.\AL+G6O"*.YBTR<SV!=64M:2DLH&[D[6W*3]*2_\9ZR-+U'4K);57M-:&EK
M92PL[,ID6,-PP)8[MX XV\>]=#?>%WNO&5CXD@U V\]K;M;-$L((FC8Y*N<Y
MX/(QC!]:X2T>YGU6\O+?7+VQU:6ZED&GW6@B>:/YB%42;02NW !#8 .,X&:
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MG ]*N76O:58W0MKJ_@BE+JF'; 5F^ZI/0$]@>O:B^U[2M,D,=[?P0,H#/O;
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M&VMV\2/+/-!LBBC0LSL2. !R:Z#1M)72+(PFZGNYY&\R>YN"#),^ ,G  '
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M&=N&/.. _O7L]% 'CU_]KNY_&-YIFGW\\2ZKI]]Y4<$D37,,:1%PA(&6^7.
M<\ ]ZN:R=#UCPCXGU71+#4Y+JYTI[5[BZ6XW2-@[(E23[Q!)Y XZ9YX]5HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2+&(V1Q(1A2%!R#@<]:[JUC-EI$,?V:*-HH0/(M5PBD#[J#CCL.E &!!\1-
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M)-+*1\N,]%V]3QEN,X- #=1^)MA'H!U+3;#4+E76!HI&M62(B5P@.XX!P3R
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** (;RTM[^RGL[N%9K>=#'+&XR'4C
M!!_"LC3O".F:9)&8GOY4B(,4-S?S31QXZ;4=B..W'':MVB@ HHHH **** "B
MBB@ HHHH **** "L^_T+2=5E674-,M+J15VJ\T*N0.N,D5H44 8G_"'^&O\
MH :9_P" J?X4?\(?X:_Z &F?^ J?X5MT4 8G_"'^&O\ H :9_P" J?X4?\(?
MX:_Z &F?^ J?X5MT4 8G_"'^&O\ H :9_P" J?X4?\(?X:_Z &F?^ J?X5MT
M4 8G_"'^&O\ H :9_P" J?X4?\(?X:_Z &F?^ J?X5MT4 5[*QM-.MA;65M#
M;0 DB.) J@GKP*L444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !117/:AINO3>(IKBTO+./3Y=
M/:!3(C&:"?YL.G\.#E<YY^04 =#17AOQ@CU32O 'AQK][:'5%OQ#-)IQ=49,
M.0 2=QX )SU.:[?36\-3:G>ZW81RV$6@NZ7+E)(E=3#N?=&V.FX$$C/!QP:
M.[HKA])^)5CJ%YI4=S:_8X-6MYKFRE:8.2L7+"10/D.WYA@M^=>?_$+QE<>*
M/!6D:W8:?+96$FLK%;78N,2R*-X8,H V@E>F3]WG'&0#WBBN,U[XA6VD:GJM
MC;VGVM](LQ>7Q,PCV*>0J9!W/MRV.!TYYJMJ'Q,@MO$&DZ59:3<:@VK6'VVR
M:"109 59@I#8Q]WJ3@#\J .\HKA[CX@7-O':P2^'Y[?4Y=.EU&6VN92B1(A(
M*&0*1O.,@$#W(R!7&_$'Q3'XE\ >$/$6FB>U%WK$28W8=1^\5T)'4;D_' H
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M1DM\[IT9L*.N>I]!0![!17*7MK9>"4U3Q&GVMK&*S -A"6=4*L3F-"<+G(!
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MSO 7@C7?"!?2+B#1[K2XKDS6VH')N F<[-FW&??=QD]>*]+HH 1B0I*@%L<
MG&37G_@#P?K7AGQ-XIU#419&#6KO[3&()V9H_FD;!!09^^.<]JZ_4-?TO2;V
MSM+^[6WFO9!%;AU8"1ST4-C&?;-7;JY@LK2:ZN95B@A0R22,<!5 R2?H* .+
M\7^%-6USQQX4UFR^R?9='EDDF665E=]^WA0%(XV]SWJ;Q+X2NKSQQX?\6:<8
MI+C3!)%-;2OL\V-U895L'# L3@]?45T^EZK9:U81WVGS&:UE&8Y=C*''J,@9
M'O5R@#Q'6?"-SX5\%^3/96^JZOK'B!;LVT4I1D)W-M@?&=X /S$="W'%:&CS
M7>J_\)/X?D\(W.C:]K.G2S-=7MWYHN./*&YU7Y0N\8 &.O2O0;K4M U674]-
MNXDNVTI4GNH9K5G\O(8JR@K\QPK8VYJYH]MI:V<=[IEI%!'=QI(&6'RV=2,K
MN! /0]#TH YWP]X<UW1/A8GA^&YM;?68+62&&XC8O&KDDJV2H/?TX]ZYCP]\
M.O$NF^,/#FO7LFE2/96;V]Z8Y9#)*S;LR%F7YV.[G..F.E>M44 >,S?"[Q+-
MX-\5Z-OTP3ZSJ@O8G^T/MC7>&(;]WUX X]:Z*U\&ZVGQ+TCQ)*+%;.STE;"5
M%G8N6 ;+ ; ",MCJ/Z5Z)10 4C9"DJ,G' SC-+02!U- 'G'_  AVO_\ ""'1
M-EA]J.K?;MWVEMFS[3Y^,[,Y_AZ>]7M;\'7^OZ_K,LY@@L=1T9=.5TE+21R!
MV<-MV@$98=^U=S1D9QGF@#C[.V\=7FC7-GJ<^F65TEK)%#=VCLYFE*E5D(91
ML )W8&23Z 8.=H_ACQ!9:_HVJ26>E1?9=/EM+E([EV:1V*-YFXH-Q8ISGD9S
MENE>@UFZOK^EZ!'#+JMVMK%-((TD=6V;CT!8# /UH XJT\':];>#_"^DLE@;
MC2=32\F87#;617=L*=F<G?W Z5=G\(WEYXIM-:^RVMCJ%O?,\E_:S$&YM,MB
M*1-HW,5VJ<YQC(/:NY+!5+,0 !DD]JS]&UW3?$%E]LTJY%S:[BHF5&"L0<'!
M(&>1VH ON&:-@C;6((#8S@^M>;Z;X1\407?AN[NX]*>[TRXF:[N/M#M)=[XV
M3S"2G49^[SZ9 KTJL]=;L'UY]$$S?V@EO]I:(QL!Y>X+N#8P>3C@^M '$3>#
MM?D\&:GI 2P%S=ZPVH(WVEM@0W FP3LSGC'2KOBC3;77_$FB+:7T27ZO);:A
M#"X<M9E=TL;XY W", GH7]ZZ_3-2MM7TZ&_LS(;>8$H9(VC;@XY5@".G<46V
ME:?97ES=VMC;07-T0T\T<2J\I'=B!D_C0!;IKND:,\C*J*,LS'  ]35;4]2M
MM(T^6^NS(((L;C'&TC<D ?*H)/)':I+U+>6QGCNXEFMFC998VCWAU(Y!7!SD
M=L4 <ZEN^J?$AKTC-II%AY$9[>?,0SX]Q&D?_?=4/!GA?4] M8+&^M-.E:TE
MD,>HF9Y))%9V8D(5'EL=W.&QGG!KI]!OM,U/1;>]T<H;"8%HF2,H&&2"<$ ]
M0>M:- 'F:>#/$K>%;70IFT\QQ:K]IN'$[YO8S.927^3Y3T!7G/J,<ZI\+ZG'
MXRU?4'M-/U&RU-8&S<S.OD-&FW'E[65QGYAR""3SWKMZ* .?M=!N#XTN==O6
MA=4LHK2S"9^499I6(/0DE0,$\+6!J/AOQ0R^,8M/DL4;6#OMKQIF$BCREC$9
M7;A0,$[LG[W3)R._HH Y"#PYJ,/B#P[,J6:Z=I-A) J!V)CD;8HVC'S8C4KD
MD?>)QVKKZ** //1X(U1/#MI: V;WUSK(U/5F:1MD@\QI H^7) (C&.,A3TS5
MN'POJ5OXLUJ[DL]/O[/4IH[B.:YF?,#*BI@Q;2K8VY4Y!]Q7;T4 <->Z!XG7
M4/%DVGRV2MJMN@M;MI6$D3)#L";=I &[+9SQN/!J2U\+ZG;7?A!%6R6RT6VD
M210['$A144J,?,=F\9..6S['M:* .#F\*Z[/HOBVT\VSCN=;NW*S"1B1 VV,
M9.."(EP!S\W<5IVWAN>S\96-Y;QVT>CV&E_8[:/<2Z,SY? QCD)'SGL>.<CJ
M<C.,\T4 4-;L)-5T#4=.BF\B2[M98$E'\!92H;\,YK)TFQUZ/PO%I4\5E82P
M67V9)()FERP3:K#Y5VC.#W/;WKI001D'(HH \\LO"OB/[)X.M+A-.@M-%8&>
M".=G$CI$423.P9.XEMO'NQSQTGAW0IM-OM:U&],3WNI7K2EHR3MA4!(DY Z*
MH)]R>M:%_K6GZ;<16]Q.?M,H+1P11M+*RCJP1 6P/7&*K?\ "4Z-Y-[(;LC[
M#&LETAA</ IW8+IC<O"L>1T&>E '/^%/"^IZ(6M;RTTZ<17<T\6HO,\DC+)(
MS\1E<(_S$$AO?FNUFFCMX))Y6"1QJ7=CT  R36:?$FDKH/\ ;AN6&F;/,^T>
M2^W9C.[IG;C^+I5/4O$/AR;2[4:E)YECJ96*!9;:0I<%ONJ!MYW#H.XH Y?P
M]H^J>(?!$D4\<=I!X@GDOKV<2$R-#,VX(JXX)CVIDG@<C-=/I/AUK/Q5JFL3
MK#MDAAL[%(R3Y-O&N2.G!+LW SP!3CXC\.Z)/'HPD-M)%!YJ6J6LGRQ XW !
M>%!XST'2M>PU"SU6RBO;"ZBN;64926%PRM^(H Y6/PWK%G#XCL[*6W1M8O9+
MA;]F):%'15(V8Y90#MYQTSCI63-ILUMJ5E%X5TW[5#H-L=+N&2\%O.V5C8(&
M8%6&"&.=OS$8;AA7I-4+C1-+NKEKFXTZUDG< -(T2EF Z GN/K0!R=AH]KXA
MTOPS_9]A]@T6PNY9[BRG/[SS8RZ*IQD/^\+,6W<X!YS6IJ^DZO)XTTS6+%;2
M:W@M)K9DN)&4PN[(?,4!3NX3&,CZBNECCCAB6*)%2- %55& H] *=0!YW;>"
M-8G\-KI6IS6DGVK6?MVI,'8F>(2%\?= R=L2[>  #SVJ?5O!NJ7EIXOGADMO
M[1UHQVT&9&58[10JE2=IVD@R$X!Y(KO:* (;6(P6D,3"-2B!<1C"C Z#VJ:B
MB@#C_$&@ZWJ/B1IX!8W.FR:>UND=U(P^RS$G,JJ%(8D$#J",=1DYRE\%W]UX
M2TG0];TG3;Z.SL$@1X[EDD@F0;0Z/LR 0 3C&, 8;OZ+10!0T.SNM.T&PLKZ
M[-W=P6Z1S7!ZR.% +<^IKGY-$UO2_'5]KFDQVEU::K!%'=0W$S1-%)$"%=2%
M;*X)!'!S6KJ7BW1-)FN8KV\,36RAIR(9&6($9!9@I XYY--3Q?H<BRLMW(!%
M ;E]UM*I$0ZO@KRHR.10!QNF>#?%6A:3X>NK!]-?5M*2>WFMY)7\JY@E</C=
MMRK @=B..M;GB'1?$>N>';2!QI_VX7\%W(GG,L42QNK;%;82Q.WJ0.2>V!6M
M9^,- OY;2.#44W7@S:^:C1B?O\A8 -^&:LWOB#3-.U.UTVZN&2\N\_9XA"[&
M7 R=N 0<#D^G>@#*GTC57\?6FO)#:_98M,DM&0SD/O9U?(&W&/DQU[U@6O@[
M7[?P=X<TEDL#<Z9JJ7LS"X;8R+*SX4[,Y^;'('2NWOM;T_3[J.UGG8W4BEUM
MX8GEE*CC=L0%MOOC%.L-9T_5)IX;.X$DUOM\Z(J5>+=G 92 5)P>#S^= '*Z
M=HOBS0]3U"QT^33I=%O;N2ZBN)G836GF,6=0FTA\,25R1UY]*IW/A3Q%9VWB
M[2M.2QN=.UTW%Q%+-.T<EO+,FUU*A2&&>1R/>N[6_M'U&33UG0WD<2S/#GY@
MC$@-],J?RJIJGB+2]%GMH-0N&BEN6V0*(7?S&_NKM!R?;K0!+HEM<66A6%I=
MB(7$%ND4GE,67*J!P2 >WI61/H^I'XAQ:['';-91Z8]GAIB)"[2*X.-N,?+C
MKWK6T[7--U;[0+&[29[=ML\8R'B/HR'Y@?J*IP^+]%N)+B.">YF:VD,4PBLI
MG\MQU5L)P?:@#E+;P=K\'@WP_I!2P-SIVKI?2L+AMC(LS284[,YPV.1VKT<=
M.:@LKRWU"SBN[60202KN1P",CZ'FIZ //O$/PKT:^M;--+LDADCOH)I?,NIL
M&)7!< 9/)&<=/J*T=6L?%(U*WBTK3]'FTBS1/L\5W>RJQ=1PS 1MG;_",GGY
MCDXV]A3)95AB>5]VU 2=JECCV Y/X4 5],_M Z=$=4%N+T@F5;8DQJ<G 4GD
MX&!DXS[5;JEI&K66N:5!J>G3>=:7 +12;2NX9(S@X/:KM !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %<-\8?^26ZQ[-;G_P F(Z[FJ6K:59ZYI-UIFH0B6TN8S'(F<9!]#V/<&@"C
MXQ_Y$C7QZZ=<#_R&U;,BJT3JQPI!!.<<5@1>&)C;PVE]KFH7UE$5_<3"(>8%
MY D94!8<#N,]\\UI2Z:TNKB_^WW2Q_9F@-H&'DDDYWD8SN[9STH \S6ZU;X=
MZ3#I6OVJ:QX-0HD&J6W^MM4W IYJ=P#CYAZ#J<"NZ\=7MW8> M=O-/9A<Q6,
MKQNG5?E/S#Z#G\*KGP3'+HL.AW6L:A=:1&J(UM-Y9,B+C",X4,5X'?/;.*VE
MTO\ XFEU=R7EQ+!<0+";*0@P)C.2%QU.<'GM0!G^!K>VM? >@Q6@7R?L$+ K
M_$60$GZDDD^YK8L[2"QMEM[:,1PJ6*HO09))Q[9)K!TSPB=$B-II6M:A:Z:&
M)CL\1R+#DYVHSH6"^Q)QVQ6G_8X6]T^>"]NX(;-9 ;9)/W<Y<=9,@EB#D@YZ
MDDYH H>-GM?^$9EM;R0PPWLL=IY^[:(6=PJOGMM."/? [U6\)RZE;ZAJ>DZU
M!;OJ-N(IFU&WC""^C8,J.P[./+*D>PQQ6MXCA^T>'KV$Z8FIJ\>UK-VP)5)&
M1G!YQDCW%9O@W1Y=%M]0MC)<2V8N<64EUDS>0$7",6^;"MO"YYQ^9 *OQ4Y^
M&&O?]>X_]"6NKE4F(.D4<DJ#,8<X&[&.N#CKC..]9_B/08/$VA7.D75Q/!;W
M("R- 5#$9SC+ @=/2G7^EW5W:VT<&LWMG+ X8S0K&3*,$8<,A4CGL!0!S'@?
M]_<^)=-U72H[;4H]2%U=JDGF12EP&C=#@<811@CJN3U(%F>R:^\77?B2S08T
M_39;*&11_KY2VXCW5"H'^\S#M6O)X<C?3;^VCU"]AN;\YN+Z)D$[<!>#MVK\
MHP, 8ZCGFJNC>$3H]W!,?$&LWD5NA6*VN)(Q$O&!\J(O0=.U 'G[LT/P#\-W
M5NQ:\6XLYXG!^8S-< D_4EF_,UT6N^)]7TNZFGCO8I1%K$%K]F@B#PK [(N)
M'(!$OS$X#<?+QCFN@@\&Z?;FVB$L[6%K=&\M[$[?*BE)+ CC<0&8D G )]AB
MA=?#JRN4OX1JVJ16]Y?#4?)C>/;%/O#EERA)R5Z,2.>E &H?%.C7&M/H1>Y:
M[9FB9#9S!"<9(\S;MQCOFH-4C2]\3:)I$:JMO:!M0F11@ (-D2X_WF+#_KE7
M1(NR-4RS;0!ECDGZU3M],BM]6O=1WN\]VL:'=C"(@.%'MEF/U8T >;VY\06\
M?CK4=$U*VMC9:M-.8);;S!<%8(F*LV?E! QQSGO6OX8UM_%'CR2]D0QQ6VAV
MLL,).=C7.9'/UPJ+^'O6U)X,MFFU54U"]CL]6D,M[:*4VR,5"MAMNY0RJ 0#
M],4K:+_9?BZ+6K*#_1I[-;&YBB7[@1LQ. .H&64@=BIZ T 9'AVVN?\ A:'B
MXO?RNB)9;HV1,.#')@'C( SV_'-6?!]T\7BGQAHG_+O97T<\([*)XQ(RCVW;
MC_P(UK6F@0Z5KNJZZM[>RRWZQ^?"51EQ&I"A0J;NA/<YK%?PMJ$FC:W<175Y
M9:QK%V+G?:2JCPA0JQ1ECD8"J-V,]6QGC(!V<HD:%Q$ZI(0=K,NX ^I&1G\Z
M\UL_%GB*\\*>"[]+NU6YU>_^S71:WR"")2" ", ;!QU/J*]($<AM1&TQ\W9M
M,J@9SCJ <BN7MO %E:Z5HFG1ZGJ'DZ-<_:K8DQ%B_P W#?)R/G;TZT 8Y\7:
MMI U[3[RYAO+JTU2TL;6Z>(( +@(075>/DW'IC.!]:U]9M]9MM%\3)>WT5WI
MK:9(ULSJ%G5_+;>&VJ%*]"#UY.:EO/ 6F:@->6]N+N=-::-YU+(OEO& $:,A
M001M'4GI4UOX1":1>6-YK6IWTEU ULUU<.AD2,C!"@+M&>Y()/&2<# !AZ'J
MM[9R> =,BF'V/4-&9I8R@)#10Q%2#U_C.?H*BMO&.I_9C923(U[<^(YM(@G:
M,#RXD))<@<%MJD#MDCC'%;LO@J!K;0DM]4O[:XT6,PVUU'Y9<QE0C*P*%3D*
MO..V:JM\.=,;3+FS^W:B&DU$ZI#<>:OF6UP3G<C;??'S9S0!DVXU#3_'7C.1
M+X37$6D6LD,T\2DC'G$!@NT'D'ICM^+[?Q'X@O8_ (BO;>(ZY9M)=LUL&.\6
M_F;AR .>W\QQ6Y#X+1+[4;Z;6M1GNM0LUM)Y&\H95=V" $ !^8^WM2VW@FUM
M3X=,>HWQ&@QM%:@F/YE*;/G^3GY>.,4 8"^+=:LO"FM2W$L=S<Z9K7]G/>>2
M%"PEH\S,HXRJR'VXR>,ULZ%J>JW7C+6-/-]'=Z39Q0M'-Y*[B[@DH77"Y7 /
M"]&&??,\0^'3H^B7J6LFMW4>J:JEW>26BH\MMT)=$5,L/W:+MPW7.#R#<\)1
M:@NH!H=7UF]TORF#KJM@ML5?(V[/W:,>^>"/QH ;\1/#Z^)X-.TO?Y<TC3/;
MRYP8YEC+(V>V& _#-9(\0-XW\%6]G*NRY^SROJ\70Q-!PT9';=(%X[J&KN[W
M2?MFIV-\;RXB-F69(HPFQRP*G=E2>A[$53C\)Z;;?VVUF)+6;67WW4L6W=G9
MM^7(('<\@\L30!Q_A;6KBR\#^!=)M$E\_4;,DO"(RZI&FX[=Y"YR1USQGBM#
M^W_$FG_8=(U1$BO=1U1K:TNF"%OLP0N7=5)4284KCID@X[5>D^'FGOX:TS1T
MU#48VTI@UA>QR*L\! Q@$* 1C@@CD5->>!K2_P!)AM;G4=0DOH+E;N/4S(OV
MA)E& P^7:!CC;MQCMGF@#G;=M1TOQ7\0IXKX374&FVDT,T\(/1)B P7:#T/3
M';\=32O$=_K,OA[2OM7V>YO-#35+JYC12[$[%VH&!499B3P>  .N1>C\$QK<
M:O<S:SJ,UQJUJEK<R-Y0RJA@" $P#AF[8YZ9YJ*Y\ 6<MIHR6VJ:C9WNCP_9
M[6^@9!+Y6 NQP5VL, =1U'UH ;+=^(;.#1[35-2LX[F5YEN7L8R\TVW_ %?E
M(RD=""Y(P/8&L*#Q=XBO?"WA.]CN+:&YU'5GT^Y+6^<A6F7=C. ?W0) [G@B
MNHG\%VTEWIEY#J>HV]Y8"5?M"2(SSK)@N)-RD')4'@#';&!BI;_#RQM;#3K.
M+5=3$.GZ@VH6X+QMM<ES@DH<K^\?W.>3P, %7^TO$,E]>^'XKV:YO]/M(Y)+
MRVMX$\V20R%-R2-@* H!V\DD\COU6ARZE/HEG)K%O%;ZD8Q]HCB;<BN.#@^G
M>LK6_!L&K:W#K-MJFH:5J*1>1)/8NH\Z+.=KAE(."3@XXS4AT.ZM]?TF:QO[
MZ.RM8GCGMVE#13 AOF8'YFDW%3N] >YY &^,-8O-$LK2Z@@NWL_M&+Z6SA$L
ML$6UOG5"#D;MN>#@9X].6OM1N=7E\$7%EXC-S;7>I3CS[9$"R*(Y2A8%?O*
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MO);!RV<?+C(P* /4ZK17]M/?7%E%*KW%LJ-,@_@WYVY]_E)Q]/6O';>RAM_
M]EK"/-]OMO$OEPSM,S%$-Z4*C)Z%201W[UU_AFRT^#XG>,G6WMHY_-M#&0H#
M9:#+8[\\D^O- '>45QGB9M/O/%UCIL^R:<:?/.8;MP+5(]RJ9&7&6<=  1@%
MN1WY+PS>M<67PNNYKDR3,;B":9GR6Q!)M5CWZ# - 'J]_?VVF64MY>2K%!&,
MLS>YP!]22 ![UEC7YO\ A.CX=:T01?V<;Y;@2Y+8D";2N..I.<GM7F.L+977
M@[QN"()H;?Q+"8>C+&"UL#M]!RPX]374W.D:7J'Q4AL'@C>P'AYQY$;;8SBX
M P0O49SQZ_2@#T*BO'_#FHSS:;\/].OY&ETNZEOH93*VY9'B9U@C<GJ, X!Z
ME1Z5#XHAFL]&^(&GV\LL>DV<ME)9JDA58))-IE1<'[O*G;T&[I0!ZW>RWT3V
M@LK6*=7G"W!>79Y<>#EAP=QSCCCKUIT%_;7-W=6L,JO-:E5F4?P%AD ^^,'\
M17#>)M$L-"O_  N=/6:(W/B*-YLW$CB1FB?<2&8]=BGZCWIGAW1-'N_$_CNR
MGM+=3->I'A5"N%>WC8[3U!SELCOS0!Z+17F_A 2WTEEX8OX<S^&)G%U(4P)2
M!BW;WWJQ<_[2<]:]"MKJWO(C+:SQ3QABN^)PPR#@C([@C% $U%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 56O=/LM2B2*^M(+E$<2(LT8<*PSAAGH>3S[U9HH SY-"TB:VBMI=+
MLI((7\R.-X%94;.=P!'!SSFE.A:09;F4Z58F2Z7;</\ 9TS*/1CCYA]:OT4
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MC:<(;=_,AC%JFV-O[RC& ?<4I\/:(8KB(Z/IYCN6W3K]F3$I]6&/F/UK2HH
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M-V4#CY5(VC@\DN.G< Z&BO+?&'Q,U+1?"FA:[I,5I/'J5Q]G9+JUEC*M\V2
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ML_$-KH<U["E]<1-*J-(!@ J!G/=BW [X/I4VF7;NNHR7&I6-S%%<N%-O@"!
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MEU.SM?'.E6TX%I/+8SB*_=6<D%DS#$GW3(< \@G P <UVU% 'B/AI]/N=/\
MAA'<"%V@FNHI1,F-N(I  <CIN*CTSQUKH-(T6S\2:=X\T6.6*/S-8>6V:,C]
MU)Y4161<>CJ>GH:].K-UJQU*_M8H],U=M+E64,\JVZ3%TP<IAN!G(Y[8H P_
M!-U?:]"VNZK:-;7:QBQ$3#[K1DB9AZ!I 1](UJMX[O3IFN^%-0O<C0[>]D-[
M)C*1.8RL+OZ*&)Y/ .#77V%E#IUA!9P;O*A0(I8Y)QW)[D]2?6K&,C!H \<O
M]7TA+WQ_=+;QW]E+/ITF4+"(C:@\TLG5%.&.#R![T^:Y6]N?B3'#=-?2WFB1
M20O'"56;$,P)0 <KT .3G@9->P44 >4W'B*TLKWPKJUU?W%OH+Z4UJ+Z"/<D
M-P?+.&)4X!"E<^H(]:[;P;9:;8Z (]'%Q_9\DTDL+3Y&_<<EE! PI))' ]1P
M170$9&#10!YY;7=G9^*/&ECXF>.-;WRWMS.<+<6OE;=B9^]M;=E1SEO>LB 7
M.E:-\,;36YA'?0W0:59FPR)Y,H7=GIC<J_6O6L ]J* ,SQ$+Y_#&JC2R?M[6
M<HM2IY\S8=F/QQ7F*ZWHEYI?PYCM)(Q<V6H0Q7$&T^;;,()%=7&,J2P[]<9Y
MKV&C ]* /(=-GTJ_CG\-^(KK45UVWU62X6Q1-K3/YS/'+&P3.W!'S;L  YP*
MDU&2Y\GXD:=9)*^I274=PELBG?+!Y46[''(*JZCU/%>M8YSWHH \N^V>%O$-
MKJ6MV%]=7]RFCS6\SSH$2%",B.0;5&[=T')X-9^H6>C1_!OPU<);62W#_P!E
MI+($7>Q5XRX8]>/GR#TYKV' '2B@#SV&/1A\7=0W)8B'^PX<Y"[<B23/MD(1
M^!]*YC1Y[4>"_AFSR1>=#JH5BQ&Y%"S#![@<K^8KVFB@#QO4XM+?1_BH1':&
M0NPBX7)/V=,;?^!@].X]:GU_5K*YBUNT4K!=S>&DQ-M:62_79(0D8Y4*I)W$
M GYNVW->NT4 >8:7J-LGBCP1>22,()] DMXY"C?/+F'Y1QR>#^59$C./#OBE
MM/036MOXL6YO((!N+VBF$OA1U7Y3G'4!J]FHH \YU1K/5/&@U?3;BWGTY=$G
MCU&='#1."0858]"V=Y'<#ZUA:/\ 8+70_A;)']GBG68"5EP&&;=U;=W^]M!S
MWQ7L8 '044 9ND:_IFN_;/[-NA.;.X:VG 5E*2+U'(&?J.*X[QCJ5C9?%+P1
M+=7<$,<"W_G/)(%6/=$H7<3]W)X&>M=U;645K)/*I9I9WWR._4\8 XX  &,?
MCU)-6: .%\8:]#K?A;6;#PY.NI745J)9?L;B0;-ZY3(R"S() !STZ<BL@WGA
M;Q#9ZIK=A?75_<)H\UO-).@1(4(R(W&U1OW=!R>#7J-&,=* /)=*-A;2?"IX
M#;12?9I%E*X!R;0@AOJ^!SW]ZQY]7LS\)I-*U*15\1VNJ1O>VT@_?>:;Q6,F
M.I4J>&Z8(&>U>Y48&<XH \GOK[26U[Q/H7BJ\O;>/5)DEM42+*WEN8D55C(0
MMN5E(P"#D\<YK0TO3])F^*5]:W%K;RE=%M%$=R%D;>KN3NZY<#:2>O0UZ1BB
M@#F?B!=6UGX(U":\L3>VX\L/%N8#!D4;F*\[5^\<=@:\_P!1OK2XN?B$9+U+
MS[9H$,D,HAVQRL$F&4XP1DJ <GD@9)KV:B@#RL&U@UWP$=+-K'</I-V@*;1E
MS%'M#8]7!Z]P:QDUG3)? 'A.QFD"ZOI^M69OK:4'SX91-^\=UZC)+'=WW5[;
M1@9SB@#F/B'Y+_#CQ#YH0AM/F"!QU<H=N,]\XQ7/I>6]OXR\%74L@$$VC301
MR %@\A\DA1COP>/:O1Z* /,/#=U-9^(M)L[*]MM9T:YFG>%7&+S3&*NS!R#\
MR9)7+8.67KQGH?&R!Y=):#6UTC4HIGDL[B9 T#MLPT<@)'#*QP>OISP>NP,Y
M[T$9&#TH \G&K['\#:WJ]M;:9!#J%]'<2QL?LX=DD4.K'HCMR"?45GR:B8[+
M7[Z&&>:RMO%\=[?1K$VYK41QY;;C) 8!L?[->T8S10!YAXEO=+U+0-2U_P -
M6LE]$]U93:G-;HQ%W#%(-R '[VU!\V!T.#GD"3Q%?:7X@\-:YK/A."2^NI((
M!=7%LC?OHHY QB 889MGF9&,\@'J!7I8&!@4 8Z4 >7--X1\26VJ:Q;ZKJ5R
M)=+-I=WB+L^SQ%@0K#:H+@DG&"0 >Q&8S=7%WI^N:?KNJVLB1+8F+Q)IR@;C
MYW[KS%R5#(^&(!QM;G%>J@ =*  .E 'C]_?ZU+I,[7L5K>PZ=KEE-J-_IR$Q
MWULH!9BG/S)B/<!D<>@K4UO[+J/BC5M6L)[>;2SX=EBO9D8-#))NS$"1P7 W
M>X!'J*],  &!0  ,"@#RVST_2?\ A6OA2>WOX-&OVCM1%J*1(0LZPL=LV>JY
MW@@GJWK75^!KZ\O]'NGO[6UBN8[V6-YK,GR+HC&94SV))!]P:Z>B@#QCQ'JU
ME)!JZ18L7M/$MO+/:A&>1R)8@;AV.=J, -NW X')SBM"==)GUSXE2NEJ=^GP
M[2Z@'F!PV,\YSM![YQGFO5Z* /)]!UN#3->\+W>LW*0Z;-X9A@M+J9L1)<Y!
ME0L>%<@+U_NXKH/A;) WAS4([<;435KS:NPJ%4S,5X/MBNXQFB@#QCQ1JME)
M:Z]%%BQDM?$%M+/;!&>20K+"#<.QSM0@#;MP.!R<XK6U6]EL?$5W>Z3>V^HV
M]QJ5L;W0[I-LXE_=!98#][@!&P1CY&Z8./4:,#.>] 'F"74VG^*D&G7MMJNF
MW6M.L^FSC%U8SEF#RQD')08+8(^Z>#S6=<)9S>$OB7 ER+>/^TVE#0IOX"0_
MPCJI92I/IN]*]@P,Y[UEZ_I$FM:9]EAOYK*598YHYHU#89&# ,IX9<@9'>@#
MA]*U/PYXA\7WFMR:MHTEP-)%K]DBF\PX5F9Y"753QG:,#IG/7%8>C?8+7PA\
M,94^SQ7*Z@@E88#@&&56W'KUV@Y]J]-L=&O_ +5!=:QJ45]-;$M!Y-H(%5BI
M4L?F8DX8CJ!R>.F-N@#S#2KJ:P\46$-A>VVL:3<ZG<$6L@Q=Z9,WFEVR#\T>
M2X^8='&"<BO0M+U:QUFVDN+"?SHHYG@9MI7#H=K#D#H15W SG'-% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/:AJ.
MN0^(IK6UTN6>T_L]I;><,HB,XW?))GYAGY ,<<G\.AHH \M\1?$'6+*V\,:)
M:6<MEK^N3")C?*K-:IOV%RJ_*2>H'3 YJWX]U_6?AWI^G:XFHS:I8_:5M[VV
MNHXP65@3O1D5=K<=.1R.*9\2O"6I7WB#P[XLT>W-W<Z-<*T]HI >6$.&.S/&
M1\W'?/M4/Q)LK_XAZ5IWAW1K&]C26Z2>[N[NUD@2WC4'^^ 6;)Z+GIVH =<>
M.[NT^+,5@;RXGT*?1Q?1V\-IYKER>"NQ2YX&?SIGQ#^($D7PYM?$WA#5P%DO
M$A\P1*P(.[<K*ZD@@CV--?1KK0_C%::JFG7LFBVNB)8B>&!I<,"V%VJ"QX7J
M!@9&<9KC+_P-XAM/@P^GC2[J74;_ %K[>+.*,NT,>W&&QP#P#^./6@#U--<?
M_A:5UIS^(8UM8=-\UM+>U92A!&9?-(P1@^OX<9JS%\1O#,QLO+N[ADOW>.S=
M;.9EN"APVPA3D ]_Z5R5WI-Q>_&34]1N-+U!]&N= >T:9;=QO8@$H,C@XR/K
MQUKCO"&O>#;A_"%CJ.O3PG1YY&L[5[)T82R/E5EEY4[3@9 4'O0![)?>/?#F
MG3O'<WY5([H64LZQ.T44Y&=C.!@'\>.^*HZEX_MK'X@V7A5;6Z>1X&GGE6VD
M? Z(%"@DC.<MT&,9ZX\M\:Z'XEUNS\2P6_A.\M\:NDT*6D*K'.@+ RD@[I';
M(/0@#/0YKM[_ $[5(_C=I'B%=*O)-/ETC[,9(T!\J3<QVOSA>HY/% &IX:\4
M1&[\776I>)H;JRT^[/[M[5H/L"#=\C%E&X\8XST]\5NZ;XMT?5;A[:VGE%RM
MLMV()8'CD>%NCJI + ^W?BO()_!VO:QI/Q+M(+"Z@EU'44N[(31-&MRBRLV
M3@9(Q@'OBNFTW2=1U'XG:1XA6RO+73M+T%;><SV[QL\I#YC52,MC<#D C(H
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MGIBMJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV6YCN+5FDBFW-L$89E7$FXJ,=P0>* .SIDDT413S)$3>P1-S ;F]!ZFN:O\
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M:RK$9$$C LJ%AD@=2!^(I]>>:F;Z'XI:-<0:;:MJ<NCW2L@GQ&<218W2;-V
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M;=NT9! )SGJ#QT)M>(_$=QH5]H]M!IOVO^TKDVRGSPFQMC,.".1\I_\ K]*
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M5(O$VO:C:3V;6VK6L4;1RA@Z/&CJ,$<8.[.>O&,<YJA:>#]5MM/\&VQELB=
M8&5O,;]\!$T?R_+QPV>?3'O75ZUK%IH&CW.J7WF_9K9#)(8HRY 'L/\ ]56X
M)EN((YDSLD4.N>N",T <E9^'-9L1K[1MITC:GJ0O!'*69#&51'C?Y>ZH><'D
M]..;OA+PNOAHZGY*16UO>7 FCL;=RT5O\H!VD@?>(+'  &<#I7244 8E]I=U
MJ'B*SGN8K272[:-]L3DEC*V 'P5QPNY0,_QD^U9EUX6O(/'=AX@T9;&V@CM7
MM;R$Y4W"$AEP%7 *GG/.<XXKKJ* /(;>>>[N=2U6RN?"UQ9RZD]P(+RYF@<.
MC;5WQ*2N_P"0$$KD\$C/3MM%TK4AXKO?$-S%##!J-E;QFW+DRPLFXX/RX/WR
M/;%;O]E:=]N^W?8+7[7_ ,]_)7S/^^L9JW0!Q/AOPUXF\/;-&35+&3P]!*6M
MW,;_ &M8]VX1$YVX[;NN.PXP:)X:\2Z#<2Z7:ZI8MX=-P\T1>-_M4*.Q=HE.
M=N,D@,>1GITQVU175S'9VLMS*',<2EVV(7; ] .30!Q-QX.U:?0_&&G^;9!M
M>N))8W\Q\1!HU3!^7G 3/XU<O?"U]J6N:1=W/V46MKI\]E<1K*Q9Q*J@E?E[
M;._KVKHM'U6VUS1[35+,N;:ZB$L1=<':>F1VJ[0!QWAG1/%FC6]OI=]JFGW.
MEV*A+>2.-UN)D4819#]U0.,D9)Q]:SXO!.L1>$-.T;SK$S6FK#4#)YC[6 N#
M-MQMZ\[<^V?:O0:* .<TG0K_ $WQ9K>HF>V:QU-XIMFUO,1UB6,C/3'R@YZ]
ML4>)M%U/5+_1KO3Y[798SM)-:W88Q397 8X_B4\CW]*Z.LR]UZRL-:TW29_.
M^U:B7$&V(E/D4LV6Z#@=.M ''+X&UQ--^R->:?+M\0?VPK .F5\TR%3UY)./
M;'4]K.L^!+O7KSQ1]IN(8+?6;6VBB:)F9X7@+,K$$ $%F!QGM[UW=% '&0Z#
MXFO/$F@:OJMQI2MIL4\4PMQ(WG>8$&X9 V_=Z<X]\\;'B_0Y/$OA+4M'BF6&
M6ZBV)(XR%8$$9]LBM+4+Z'3-.N+ZYW^1;QF23RT+MM R< <FDTV_AU72[34;
M;=Y%U"D\>X8.UE##(]<&@#GQHFLR^+M,UVY>P)MK&6VECC9URTC*V5R#P-@'
M/7.>.E8D?@37+72K.2RO[*#6=/U*YO;9V#/#(DS,7B<8!QAL9'IGBO1&=44L
M[!5'4DX%+0!G:/%JJ6S2:S/;27DAR4M5811@= N[D]R2?7IQ65>:!?0>,U\2
M:4]N[S6@L[NUN'9%=5;<CJP5L,,D8Q@@]JZ:B@#AI_ UW'IMD;*ZMO[1BULZ
MU.TJL(Y)&WAE&.0 ' '^Z,]:G/AC5CJ'BNY,EDW]M6L4$?SLNPI&R;B-IX.[
M. >,8R>M=E10!P$?A#Q'I+Z+J&BWVG+J%IID6EWD-T':"XCC^ZX*@,K Y/3O
MCZZEQX?UB?Q#X<U.6ZM9FTT7!N"=R&0S+@A!@X5>V221U/>NKHH 1LA3M +8
MX!.!FN,\/:!XCT"/64B;2G;4M2GOUD:20B$R$?*5VC=C'J,^U=I10!P<OPW0
M^';F!-29];GOTU1M2DC^]<HV5.P'A!]T+G@&KM_X0E\2W4USKP@B9M-FT^.*
MTD9POFXWR;F5>>  ,<<\G/'2:AJ$6GZ?<WACFN%MU+/%;1F20\9P%')/(XJT
MC;T5@",C.",$4 <QX9TSQ18PVUIKFHV$]M9IY<3VL;K)< #:#)N.!QS@9R<'
M/&#@67@7Q#;:-X>TDWVF"WT/44N(9 DA::-=^-PXPV' P..^>Q]'HH X6X\'
MZK/HWC&Q\VR#:_,\D;>8V(@T:Q\_+S@+GCUJY=>&+^^US0[RX^R?9K&QGM+B
M,2,6?S5125^7ML[]<]JZZB@#C?#&@^*M$@M])N]4L+C2+$!+>5(W6YDC7[B.
M?N@#@$C)(&.^:H'P3K!\(/HWG6/G-JW]H>9YC[<?:/.VXV]<_+G\?:O0%=7&
M48,,D9!SR#@C\Z6@#DCX>UNV\0^(-3L+NRC&JV\6P2(S-%-'&47V*Y()/7C&
M.<U3@\,7NA7.LZWI2:7I5U=6BH+9&=[9I@Q)E8!5.2#C"C\\UTUQKME;>(+/
M1)/.^V7<<DL7[L["J8W?-TSR.!ZU8L=02_\ M.R"YB^SSM ?/B*;RN/F7/WE
M.>&'!H -*FN[C2+*:_A6&\D@1IXUSA'*C<!GT.:Q+[PC%>^,4UEY1]EDM/)N
M[0CY9W4GRF;UVAY/QV^E=-10!Q^E^#KC2/ =_H$5VMQ<W$4L$<TQ("QE3'$#
M@$_+&%X]0?7-,@\*ZFEUX.D=[,IH5N\,P$C9EW1"+*_+QTSS]/>NHLM02^DN
MT2"YB-M.86,T10.0 =R9^\O/4>AJN-=LF\2G0!YWVX6INSF,A/+W!>&/!.3V
MS0!SOAGPWXF\/+%HPU2QE\/VTF;=_+?[6(MV1$3G;@=-W)QV'44[_P #ZQ<>
M'_%.C0W=CY&L7DES"[APT?F,K$-C(XVD#'7/;&#Z#2*ZN,HP89(R#GD'!'YT
M <EJ/A:[U?Q.;^[^S+93:/-I<\22,7Q*RLS [<<;<?CGVH\-:3XMTN""PU34
M].NK*Q39!)#&Z37  P@E)R%QQG:"3@>^>NK,AUVRN/$-SH:>=]MMX%N) T95
M=C$@$$]>0>GI0!2\%:)>>'/#$&E7KP220R2L)(22&#R,_0@8QNQ^%)XCT2]U
M;4]!N;5K=4TV]^U2"5F!?Y&3:, _W\Y]JZ&B@#@+_P !7^I3ZY.]W;V\]UJ-
MOJ5A*A9_)FA557>"!D';S@]_:MZUT2[N?$T&OZJMM'<6UHUK!#;R-(HWL"[E
MF53D[5 &..>3GCH:* . F^&['2-6M;>_\J9[T7>E2;>+$B3S0 /^NC/GU! [
M5W%E:16%C!:0@B*"-8TR<G &.?>IZ* .-G\/>)-.\57^I>'K_3EL]4*/=6]]
M&[>5*JA/,CVD9RH&5)'3K4VO>%+GQ#:7%E?3J\$5LHL)!*RR)<C_ );L0N P
M(&,=/F_O<;-WKME9:YIVCS>=]KU 2&#$9V'8NYLMTZ=NM6+/4$O9KN-8+F(V
MLWDL9HB@<X!W(3]Y>>H[@T <U?:#X@U.U\-&]GL'O-+O4NKF56=5GVHR<#;\
MI.\GVQ^4=[X0NM4U^QU*Z2QBNK*_^T1:C;LRSM &)$+#: 05(4Y8C':NTHH
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M]CW!YH SM+DUW5/&^OVC:_-%9:5>VQCA6WB/F(T0=HV.W.,MU'/N:[FLK3M
MMM-UC4M3AGN'GU%E:X$C J2JA5( '&%&/YYK5H \I\2ZC>>)OASXTU$7\MO#
M:R75I%;1JFW9%\K;\@DEN3U& 1CH<]'IVH:@_C:XT?[?*+(:'!=1H$3,4C.Z
MDJ=N3PHX.:L7OP]TB\?5@)[^WMM6RU[:V]QMBE<C!?&.&/?!P>X-6IO!VG2Z
ME:WZ7%_#/;VPM&,5RP\Z$'(60]3@DG((/)H Y3P]XJUG6M,\+V4EP[7FH:=-
M>7$Z&.)Y"CJ@5<J5'WB3@9X'O79>%UUN/26AU^:">\BF=5EB()>/.4+X  ?!
M&<#'?O64WPWT(Z)IFF127\!TQF:SNX;IEGA+?>VOV![C&/:NCTS38-*LEM8&
ME< EFDFD,DDC'JS,>2?_ -704 9'C/7)]$TVP%LPCFU#4;>P68J"(?,?!?!X
M) !QGC.,UBZKJNL:+XDN]'349IK>YT>:]MIY(T,EM+$0"/NX*G<.H.#^G7:S
MHUCK^ERZ=J$1DMY,'ABK*P.592.000"#5,>&+9EN6N+N[N;JXMOLC74K)YBQ
M=U7"A1G/)QD\9/ P 4? PU:[T#3]8U/6);TW^GV\OD-"B+$Y3+$%0"<Y&<]P
M<8' L>._-7P#K\D%S-;RQV$TBR0D!@50GKCCIVY^E:>CZ7#HFD6NF6SRO;VL
M:Q1>:06"*, 9 &<#BIK^R@U/3KFPNDWV]S$T,JYQE6!!&?H: .)T_4;N.]\+
M^&4O[A5N=,:\EN"J>80JHJQK\N /F))QG '/-:OA+5M0N-4\0:+J,IN9-)NU
MCCNBH4RQR()%#  #< <$@#/'%3_\(9IPM=,C2XO5N=,)-I>^=NFC!7:1E@05
M*@ J1CCIFM73=*MM*CF$&]I+B4S3S2'+RN0!N8_0 8&     * ,;XB_\DW\2
M?]@Z;_T USSZCKGA?5O#TLVJR:CINIP2)+9M B^0R0&13$5&<84@AB?K7>ZE
MIUKJVF76G7L?F6MU$T4J;B-RL,$9'(JA8>&[6RGMYY;BYO9;6(PV[W3*WDH<
M @8 &2  6.3@8S0!S.CW_BC4;;0?$$5S$UC=1K-?022)Y91UR!$ FX,I( !;
MGH<FK7AV\UGQ#HNA>)(=92*.Z?S;JT=%,7E-D"-"!N#J=HR3R<^PJ]HW@/2-
M!O?.LIK\6RNTD-@]TS6T+'J4CZ#J<9SC/&*72O NDZ-J#7%G+?+;F4SI8&Y8
MVT4A.2RQ]!SSCD \@#B@#F)?%.L7/PVG\<VE\R20RR3"P9$\DPI,4,;<;MQ5
M<[LYW>W%6I+W7-2U[Q;:1:[=6=O96=K<VHC@BWQ,Z2L5)93D949SSP.1SGH5
M\%:7']IA1KA=/N;C[3-IX<>0TF0Q.,;@"P!*@A3Z<FI_^$8M1J6K7ZW5VL^J
M1)#<89<;5!"[1MXP&;\Z .1T[7=<8>!=6N-5>5-="QW5GY,:Q#= T@9<#<""
MO.6(.3P!Q4VFZIXH\0:?I^O:9<11PO>,9H)I4$/V<2,K)C9N#@#KNZ@]N!T$
M?@O3XK71+=+F\$6BL&LQO7Y<*5&?EY^4D<^M16G@+2+'69M0MI;^**:?[2]@
MMTPM6ESG?Y?3.><=,@<<4 =17%R:C>:_K7BC3H;^6RATB..%!"J$O(\>\NVX
M'(&0 .!PW7C':5S][X/T^[UR;5XY[VSNKB(0W7V6?8MR@X&\8Z@< C!]Z ..
M\&:E?VEG\.+"&[=;*_TN8SP;$()CC0J0<;@<L>^*L6WBO5UMI+22[::XG\33
MZ5#.PC1HXD5F &%V[CMV@D'[U= O@+28=.T>SMKC4+<Z1N%I/'<GS%5AM923
MGY2,<8[<8I'^'F@2:1?:;(ET\-Y=F]9FN&+Q3$Y#HV?E(]>I[YH M>'(M?M[
MS4X=8GCFM-Z/8EI%:94(.Y7VJHP&'RGKCKTKH*Y.]\&J/#-SIEKJ.K/=SLI^
MW27S>?E3E=TG78/[H'<\9)-=5&K)$BLY=E4 L>I/K0!SFOW5W_;EC8V^H2QK
M+;RN;6S13<2,"H5\L-JHN3DDC)*CGI7$V^HZEXF@^&E]/>>1J%T;KS+F.)20
M1 X+!3\N2!Z8![$<5Z#J/ABQU+6K;5WENX+R")H-]M.8_,B8@E&QU&1GC!]Z
MHVW@+2;'3=-L[2:^@.F2O+9SB?<\)8$,!N!4K@D8((_'F@#G(]9\56/_  D6
MCB6?6)])N[5DGC2-+B6VE&]U P$,B@'L,@^N*DA\9_:K;2[?3M5N)3J>L&S:
M6Y@5)[)5CWM$RE0-^5P,@\-GG%=8?#%F+=ECGNH[A[D7<EVD@\V24#:&8XP1
MCC;C;CC&.*AN/!FDW=G/#<":2::[6]:[WA9A.H 612H 4@* ,#&.QR<@&!?Z
MGJ%KJGBCPW=7#WEJ-$:_MII%4/&"'1HV*@!N1D'&>O6HM!U*_M#\.+"&[=;*
M^TAO/@V(0QCMXRI!QN!RQ[UUG_"-6K0:@LUQ<S7&H0B"XNW*^:T8! 484*H&
MYN@'+$]>:J2^"M/DL=&MTNKZ%]'&RSN(I@LB)MV%"<8(*@#IGCK0!Q&L:AJN
MI>&+Y;C5KK=:>+([)'18T)B$\856PN#C.>G)ZYKH;R^UW5-7UO1=*O98Y]+@
MA6.;?$K-*Z%P[@H05Z#  '#>V-+_ (0'11I5_IP:\$5[>"^=OM+%TF#!@RD]
M""H^O?-+J/@32]0U*#4ENM3L[V.$0/<6=X\3SQCG;(1RWUZ^_2@#;TE[U](M
M&U+R/MWE*+C[.V8_,Q\VT^F<UB:YK%POB[0_#T$S6RW\<\\LR ;BL8&$7((!
M);).,X''7-=';P16MM%;P($BB4(BCH !@"L_6- L]:DLYYFEAN[*0RVMU P6
M2)B,'&0001P000?2@#S_ %KQ-XAT[3_%%A'J3?:M&OK)8+QH4)EAN&3Y'&,9
M4,1D8)XKT72K*\L;>6.]U.;4'>5G626-$**<83"@ @<\]>:S+WP9INH:5=6%
MQ+=$7<Z7-U,' DFD4J5+''&-BX   V@5T"*515+ER!@LV,GW..* .?\ %&L3
M:?=:'I]O+Y#ZI?"V:XP"8U",YVYR-QVA1D'K61K.I:SX9ACM9=52Y_M/5[>S
MLYGC7S;6*7[Q;C#$;7"DCJ1G/2ND\0^'=/\ $VF"QU%)-BR+-%)$Y22&1?NN
MC#D,/6J;>#-+FT.;2KQ[N\69ED>YN;AGG+KRK!^JE<#&, >G)R 86J:MK&C^
M(M2T9-1FFAET674+6XDC0R6\L9P5^[AE.0>02#D?2KI&K:ZMWX$GNM9FN4UZ
MT874#0QJBL+;S0Z87(;(YR2#GH.!76_\(Q:NEV;BZN[BYNK;[))=2LGF"+GY
M5PH4=3D@9/<\#$,7@^QA_L/9<WF-$7;9#>ORC9LPWR_-\GR\_P ^: .%M+O5
MM)^&?B_5;36KS[9:W]\8GE6-\%)2,\IU('T] *Z2[NM8O/'UKH\.M3VEE<:*
M]RXBBB+K()$7*LRG!P>X(Z\="-&7P+I,FG:OI_FWJVFJRO+<1+.=H+G+[01\
MNX\G^E7%\-6Z:W!JXN[LWD-H;-&+)CRR03D;<9R <^WI0!Q]AXIUF3P9X=N[
MNY($^J266HWZHH*1I)(BL1C"[BB MC W'IP0O_"1ZYIUAK%U)?27-J=6AT_3
M9Y4C53'(Z*9-P7YMI9E#'()49SSF77?# TC3M(TZQMM;N-,@NYKJ2?3[@"YM
MY&#8*@8+*QD<GKCTP>+NE^&?[5T[4+#59-9N]&O(E3R-9E5I=X.=RE?F4#CJ
M<Y&0!CD IZY/XNT31O$MX=1$=K%IS7-DTC1R3Q3("6&-@4H>.N2#5BUO-9M_
M%NBV5QK,]Q!K&ES2NABC402((R&CPN?XSPQ:M.+P+IZ:)>:7-?ZI=QW<7V>2
M:ZNC+((NZ*2/E'T&3Z\"KJ^&+4:IIFHFYNVGTV!H(,LN-C8# C;SG:O/M0!B
M_"I9SX#LYY[VXN6EEG8^<5.T^?)DY !))Y.2>?2NUKC[KP-!;Z"=,TB]U*US
M=?:(6CO&40'<S?B@+$[>YQDXY'84 <=KG_)4O"7_ %Z7_P#**L>W\5ZK;Z=?
MPS7OG74OB@Z-;7$D:#R8R5P<  $A=V,CDD9]*[2\T&VO=?L-9DFN%N;%'2$*
MP" /C?D8YS@?EQBLV3P'H\^E:EIUPUU+#J%V;V1FD =)R0?,1@ 5.0/;CIUH
M R+Z^U?3_%>K:7'K-U);QZ U_"9$B+1S>85R#LY&%Z$'J?;#;+Q!J\P^'4KW
MS$:O 3?)Y:8E/V4R9^[E3N&?E('M3].T)K+XD3*Z:E>64FB"U>\O-\GF2>:S
M%2Y&/ND=,#\<UI67P^TFR;2BMUJ4O]E.6LQ+=L1$I4KL&,?* <>I'!)Q0!@?
M\)=JMAI>OB:\\^Y'B1=)M)I(U @1Q" 2  #MWL>>IZU--%<:9\4[B4ZH9"OA
MF:1);[;MB(F7EBH'RY&3Z<]N!OR>!M'GT[5["Y^T7%OJMQ]JN%D< B7CYU(
M*D;5QCTJ,> =+EN'N+ZZU*_EDL7T^1KFZ)WPOU!"X!^OMGKS0!C:)K&K3^*=
M/TN74;R:UO\ 1I+AIY(HTW3*T8\V(;054[SPP]./7*\)ZOJ%CX&\*6\=[<37
M&LW<L;22L@,8'FN=K%?O,5 RV[J<=J[+3_ ^FZ??Z=?+=:E-<V$#6\3S7;-F
M,[?E8="!M']<U"WP[T)_#YT1OMAM%G^T6Y^TMOM7#%@8F_AP6;\^<T 8]WJ_
MB70(TL=0NXB=3U>WL]/N"RO-!%(&+;P%"DC8P4X.<C.<59TFUEM/B_JJ27DU
MR#HMNR-,%W*/.E^7( SR">?6M67P-I-SH,FE7DM]=[Y%E-W<7+/<"1?N,).J
ME>V,#KQR<SZ;X3L].UMM8-YJ%U?M;+:M+<7!;<BDD94 #/S'M^N20#;ED$4+
MR$$A%+$#J<5YI+XIUE?AQ9>.XKUW9I(YIM/V(8FA>4(8UXW!@"/FSG(/8XKT
MZN=MO!>EVB?9HGN/[-%S]J73BX,"2;M^0,;L;OFVYVY[4 9&D2:[JGC/7K=]
M?GCL]*OX1' MO%^\C:%7:-CMSC+<$<^YXQW# E2 2I(ZCJ*R]-T"VTO5=2U&
M&>X>;4762X$C J650JD  8PH K5H \Q?Q+KB> ;C4O[4D-Y;Z\;,2F*+YXOM
M8BVL-N/NGJ #5J_O->N=<\:VD&OW%K#IEK!<6HB@B+(S1R-M)93E<J,\9/'(
MYSKW/P[T:ZCO87GU 6UW=B\:W2Y*QQR[PY90.F6&3]3C%7_^$3L_M>KW(NKP
M2:K"D%S^\4Y15*J!E>" Q&>O///- ',?VA-JVN_#'4K@*)KNTGGDVC W/:AC
MC\33!XLU6PL_$*S7?GSIX@BTNSEEC4"%)!$ 2% !V[V//4]:Z>#P?86\FANE
MS>9T2,Q68+KA5*["&^7YOE '/\^:CE\#:1<6.L6=T;B>#5IOM%RKR $2\8=2
M "I&U<8]!0!FRW&JV7CUM'&LW<MI)HDUV/,2(LDRRQJ&!"#L3P1CDUG6'B36
MI_#_ ,/K^34&,NJW"17H\J/$P:*1C_#\IRH^[BK6GZ%)I7Q,M7']J7MJNC2V
MSWMV7ES(948*7QC[JGIQZ\FM&V^'6CVL6GQ+<:DT.G7'VBSC:[;;#PPV+C'R
M_,??H,XXH P[SQ?JFCVWC*26Z%P]EJ5O:61EC4+")5CP3M R%,A//7&,U8NK
M:?3_ (JZ6\NIRW _L6[8/=A $8/%EB5"\'@D=L<8K?D\%:1<Q:U#=B:YAUE@
M]W'*XP6  4K@ J0%7&/0'K4$7@/3/M4%S=WFIWTL-M):*;JZ)W1/C<K8QGI^
M/?/% &'H^N:N_B+P[9R:E<75OJNGW#S7!B18Y)$"$20#:&"_,<;A@C!YZUF^
M&M6U#2? ^E[+^XGN-5UN>R#SLF8R9YR6#%>6;9CYLC)X':NNL/ 6E:?<:3.E
MSJ4DFE*T=J9;MCM0@#81TVC:./;G-#_#_0I-%O-)D6Z>SN9S<*AN&_T>0N7S
M$?X#N)/X]QQ0!BZCJ_B;PU;W4=[<PO'?7]I::9+(RO+;^:VUS)A5!"\E?R.:
ML6=I+:?&4K)>SW2MX?)4S!=R_P"D+D94#CO^?; &L? VDS:#<Z3?2WVH)<[?
M,N+RY:2?*G*$/_#M/(QCDGU.6Q>"[."];47O]7NKX6+60F>[^<QDYXQ@;LXP
M?4 ]>: .GHK+\.:9/H^@VUA<7,US)#N'F32&1]I8E5+'[VT$+GOBM2@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.)9#G;T+!=O/4#%8K2I=_#+Q'I6H$#Q/'?7#>5G$[W)E+0.@ZGCRPI'8>@H
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MT' /-1S>-M/BUNYTB.SU.XN[9H1*(+1F"K*2 ^?[HQR?RSS@ Z,*JJ%"@*.
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M*YRU\:Z??:Q+IEK9ZG++#=_9)G6T;9"VS<"Y[*0>M=%)(D4;2.P5$!9B>P%
M"X&",#GK1@>@K TSQAIVJ7EA;QQ747]HV[75E)*@"W$:XR5P21PRG# '!KH*
M $P/05R\GAS6HM5O;BTUFR>TO)O-:&^T_P ]XCM"[482+\N!P"#CWIFC^,Q?
M2:_)?6,]G:Z7>-;B1]ISM6/C"L26+.< #H0.O%6)O&VG6DVH6]];WMI=6-I]
MND@DB#.\&2"Z["P(!&#SD=\4 :^GZ7;:=80V<2!DB8N"R@?.S%BV ,#))/
M&>*N!5 P% 'H!7)_\+$TE;>"YDLM6CM[B2WC@F>R8)*9ONE6Z$#O^F<BI/\
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M4I^7]V0S,ORYSN ()XZC(/(OX;\0+\+M:T%-#(O)M0EDMXH[B+:R-<>8""6
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MH B'B;Q%?>)$T>ST^RM'ETA-0'VPNS0NS[2CJN,X.1@$>N>,')_X2K6M=M_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEO*;R]I8KC?C&[(Z9SBK=<1?>([_ $3Q;JT%S<M=:?8^'_[1$7EJKLZNP.6
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MY&TYV#/&/0"JFB^,-4UZP\-6H\U+O4-+>^N);41!R59$PHD^4 EB3P3P,=Z
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M/$EA<ZII>IQ6AM]3D@6UFC4Q&&*38^\[2^Y@"V01C*CU)B&M:OKEEXIO=-U
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MT%K/<!XK<MG)0;?<_>SU/>K?A/P?I_@[3KBPTZ:ZD@GF:=A<,K$.0 2"%'7
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M2._7UK5TR2_DL5;4X8(;K<VY()"Z ;CMP2 ?NXSQUJV"",@\4 <Y'X-LXAH
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MF%6 !(VJ,L0 -S9./J<[=&1G&>?2@#E!X!T\:2--_M#4/(&H?VB#NCW>=O\
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MD!G613%\L X,: $G.3DE^,<UT>GV^D2?%W6Y'BLB\^FVCPOA<N6,H9E/4DC
M)':NSET72IY9I9M,LY))T$<KO I,BCHK$CD<#@^E2OIUE)<+</9V[3+&8ED,
M2E@AZJ#C./;I0!Y'H=T;?P?X(MIS_P 2:XUF[AO"QRK'S9_*5_52^.O!(%2^
M+++['%\0;*S0)HZZ3'<^4GRQPW9#YV@< E0K$#U![UZFNCZ8EC)8IIUHMI)]
M^ 0*(V^JXP:!I&F"Q-B-.M!:$Y, @7RR?7;C% '#V=C9Z1\2- >RC6 WVC7#
M7;!N9RAB*LY/WB,GD\UWEAJ%GJEFEYI]W!=6TF=DT$@=&P<'!''45'_8^F++
M'*FG6:RQ+LB?R%R@] <<#V%,T;1[70[#[):11QH9&D98HPB;F.3M4< =@/0=
MSS0!S7Q+2.32M$25BL;:[8AV#E2!YHSR.1]:YC6;+3/"NL^*DLQ=6N@-HBO?
M0V$FTQW+R%4*$\(S)G/M@FO5[FVM[RW>WNH(IX'&'CE0,K#W!X-11:9I\%D]
ME#8VT=HX(:!(E",#URH&#F@#R^,VD7BKQ'8+)IT4,_AU)#;6+XCWJ9>X(W,%
M ^; XQQ3="L+2PD^%M_;1B.[O+7RKB8$[ID^R%MK'N 0,#H,<8KTU=#TE$"+
MI=DJ"+R0HMT $><[.GW<\XZ4?V'I.(1_9=EB#_5#[.G[O_=XX_"@#RG0;R&+
M7[JWUZWB?P_/XAOUMY3@HM[YS;1*#V*_=[9SG/&/6X-0L);V?3X+JW>ZME4R
MVZ2 O$"/EW*.0".E0_V#HWD-!_9-AY+OO:/[,FTMZD8QGD\TRVT.RM=:FU2*
M"".X>$0 Q1!#L&/O$<L?E &>@   YR 6[^"*YT^X@FB26-XV5HW4,&&.A!ZU
MXUI]GI<WP[^'0B6!9)-4M$N#"P5F+))D-MYR=HZ\\5[;6>=!T<QK&=)L2B.9
M%4VZ8#'JP&.I]: .*M]-T;PU\3[:RMX;:QT]M F 1B C'[0K,/FZ\$_0>U8?
MAV&YU'P-X>71[C3I[RVN;Z1=-ON8KI!,X*_[+*&!4X[GMFO5[K3;"^D@DN[*
MVN)+=M\+2Q*YB;U4D<'Z5$VAZ0\$<+Z79-%&Q9$-NA52>I QP30!YC&^BZCJ
M?@"]GTJ"QMR^H120781A$45\IN(P5#AMOYUZ[55]-L98H(I+*V>.W8-"C1*1
M$1T*C'!'M5J@#S S:%K.I^+]-\574=O>P7H\AWD$<L5L$0Q-"3R/F#'Y><GW
M%7K&.SUWQCXKT[Q# LBPP6_V2.Z RELT?S.F>AW[MS#D$#G@5VL^E:==7L-[
M<:?:S7<'^JGDA5I(_P#=8C(_"B\TK3M1DCDO=/M;EX\[&FA5RF?0D<4 >4Z)
M;SZI/\-CKH>XN+BTOEE,S',\04>7O'\64()SUR<]:I7^D:?!\/?'$\5NBR:1
MJ\XTY@3_ *'M,; 1?W.6/3'I7LTVG6-Q<Q7,UE;R7$7^KE>)2R?0D9%0?V%H
M_E2Q?V58^7*VZ1/LZ8<^I&.30!PTN@Z1KOQ/UVSU6!;BWDTBUE:&20[2=\@+
M8SU''/:L?PY/!-I?A;3M6E6>Y6VO9+9]2<&W-L)-J2.I_P!8^S;M&1\I8YKL
MXO" ?QK>ZI>6&F3:=+9Q6L,++N:/RRYSM*8&=^, \8KI;C3K&Z>![BRMYFMV
MW0-)$K&(^JY'!^E 'CNC"WU/PQ\-UFG\]AJ4UO)ME.=@2?"G!SC 7CTQ6S8^
M%;'6;;QYX7@CCM[6._1K)$&%MI6@C8,H[#=R0/4CO7H?]AZ3B,?V798B8O'_
M *.GR,3DD<<$GG-5-1TR[MK>27PU;Z3:ZA+(IEDN;<[77/S9V8)/IS0!S_A+
M45\1F/7]0M$LWTFV:RD$BA!%< _Z1C/15VJ ?=J[.SO+74+2*[LKB*XMI1NC
MEB<,K#U!'!JM8:6MEH_V%W2=W#M,\D>5ED<EG8KGH68\9Z<4[2-*MM%TR*PM
M$5(4+,%50HRS%FP!P!ECP.E ')_$FVLIG\*27D%NZ+KL",TR @(ROD$GL2!Q
M["J&F>']$U?XD>)TN+6*XMX8].N($W'8K;9"& !QV'X$CH37H=U9VM] 8+RV
MAN(203',@=<CD'!J.+3;""[>[ALK:.YD^_,D2AV^K 9- 'CWVBR@^&]I!)-
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M!6K110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !574-1M-+M#=7LPBB#*@."2S,0%4 <DDD  <G-6
MJY+XBQ>9X;@9(+F:YBO[::V%L TBR+("&"$C?@ DKW&>1U !JV_BG1[F[O+0
M731W%DF^Z2:)X_)7&<L6  &.<YY%+;>)]*NKR.S2:5+B6$SPQRV\D9F0=2FY
M1NQD<#)Y''->?WEF?%.G>*[2W@U.T\0:S9IL%[8M:QND. $0DL/XL'+?Q^@K
M?GBNO%.L^%+Q=/N[%]-E>YNS<0M'Y1,13RE)&'RQZKD84\],@&_:^*M'O='D
MU:WN)7LXY3"SBVE#!PVTKM*[B=W'3K1J7BK2-)\PWMP\<<3*DTH@=HX2V,"1
M@,)U'4C&03C-8-EH%_9>.=0MTB_XI^ZE35MW87(RK1X]V"2_5?>L@V<UAKVN
MZ7JWA2^UBWU*\:YM+B$;X'5P/W<I+ )M(ZD=/H,@'6W7C?0+/4IM/FO)/M<#
MQ))&EM(Y7S"0AX4\$CKT&1D\BHX_'_AN5H=E](5EN3:"3[-+L67=MV.VW"$M
MP-Q&:HZ%:SVGQ#\03R64T=M+96<4,H@81L8A)O"G';<N/7MFN8ETW46^'FI6
M0TR^^U2^(#=)%]F?<8OM@EW=.FP$_IUH [F]\;Z#87&H6\UU,9M."M=1Q6LL
MC1*P)#$*I^7 )+#@<9/(J6U\8:'>:E:6%O>%Y;Q"]LXA<13 +N(23&QB!R0#
MD5SJ07(\2^.+DV-YY-[96Z6S_9GQ,RQNK!>.H+ 50M+&^CTSX:Q-I]X)--V"
M\'V=_P!SBV:,[N/[Q _7I0!VDWBK1[>\AMI;ET,]Q]ECE,+^4TV2/+\S&W=D
M$8SU!'7BJ4WQ \-0"X:2_D"6US]EN'%K*5A?C[YVX4?,!N.![\&N4\.Z?-;(
MGAO6/"5W=WEK=L\5^Z[K21/,++,6+<, ?NXSD>_$6HZ;J$_@WXA6<>F7K7&H
MZA+):1_9WS,K)$H(XZ91NOI0!VP\50-XU?PV+>Y\R.U6X:7R'*G<Q"@$#&.&
MRQXSQG(-:U[J%MIZ1M<.P,C;(T1"[NV"<*J@D\ GV )[5RL$5Y%\3DU#^S[M
M[.[T6&W6<1X6-UE=F#YP5X8'GKVH\=VM]'J&A:S;:;<:G:V$LJW=G;']Z4D4
M .@R-Q4CIWR: --O''AU+**[DU#RXI+O[%\\+J4GSC8X(RAY_BQQS4-UX[T>
M'1-9U*#[5.=)0M<V_P!EDCE7Y=RY5E!"D<[NF,G/%<YJMA]HTO2[G3?#=W9+
M)KUK>2Q& F9D1@7ED S@^QYP/P!J^EZA?ZA\1([>QN3_ &EI$,%HS1,JS2+'
M*&4$C&<NH]\T ='_ &[97USX<:74;VRN;MF:*U$#HMR?+)96W)]T<D<C.!UJ
M&U^(.E20ZY<WD=W:VFE730/*]G*1A50ECA3CECQUP 2!67<K>7EYX#N!I=_&
MEG,S7 >W.8E^SM'E@,X^8@>O?I5WPSITR:AXNTO4M-G^S7VHRW D=1Y4L,D<
M:X!SR3ALCMCGM0!TQU>R$MC%ODWWP)MP(7^8 9.>/EX_O8J]7#> ]/U&UCN5
MU)OM":/YFF6$BG<TL2MDN?\ :($:$>L1]:Z7P_K::_I2WRV5W9-O:-[>[CV2
M1LIP01DT 0R>+-%BO1:M=-N^UBR\P0N8Q.>D9?&T-R!UZ\=>*=J/BG1]*:[%
MW<LHLU5KIDB=U@#?=WE00OK[#D\<UY]K,&M7WG>;H.HB>T\10W"QVL06!K=9
ME(D&"/-9E&23D@Y^Z*=K9;^W/%EBNFZV;'5EABNVL[$77S>2 ^QE?Y&VD*00
MW(R.N* /09O$NF0VT<_F3R+)$9E2&VDD?RQP6**I8#ZCGM55_&WAY#8A=0\T
MW\+3VHAA>3SD&,[=JG)Y'R]>>E<E<R?9/$=KK=OH>I:KH-[IL5H@M(V,]K)$
M[X5XR0P!WD'/0@YJ['IKVGBSP>UKHDMC8VEM?"2*&$E+;S2A16*Y&X[3G!(!
MSSC!H ZBU\4Z/>:/'JL%V6M7E,"YB<2&4-M,?ED;MV01MQFJTGCCP_!:37,U
MY)&D%R+28&VEW12G&%90N5SD8)&#G@UPB:?K=E -7MM)O)SI_BBZOWL_**R3
MVTH=0\8;&Y@'R!U^E=O]C@\7Z!JEO=Z1-I]IJ">61<1".=SC'F,H/!'RXSS\
MOIB@#:.I6JZG%IQ9_M4L1F5?*;&P$ DMC Y(X)S3;[5;33I(8IW<S3[O*ABC
M:1WP,DA5!.!QD]!D>M<_X"CU2XTHZGK91]0D46F]&R&CA)4/_P #;>_T8>E1
MZQ;WNG?$33/$ MI[G36T^6PG$$9D:W8NKJ^Q<L0=NTX!QQF@#3E\:>'X=+AU
M*34 MK-<"U#F-\K+NV['&,H0>N[&*OZ9K-EJ^GM?6;RF!7="9(7C8%3AAM8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHKGM0MO$3^(II+*2T&GR:>T<3R.V^"X^;#;,88'*Y
M)Y^7\P#H:*\?\9Z]KWA:V\*W?B'3Y)-'C,JZK%IT[LN_I&6<X+#!S@G!;/M7
M1Z%XI\-VV@ZOXIL]<ENM#2.-C#+([O:L,@H%;D;BRX![GCC% '>T5R4'Q TU
M9;V'5(9=.EM=/74V64AMUNW<;?X@>"OJ1C-0V7Q"@N[EX'TB^@=M+_M:WW;2
M)8/3(.%?V/YT =G17 V_Q6TJYT[PU?+I]\(=?NS:6^=F8W$FSYQNZ9YXS4NI
M?$NVL/$>JZ!#H>JWVI:? L_E6D:OYJD*<K@YZ,,Y'MR<9 .YHKS6SU^#_A:&
MLLJZX;^'15N#ITLJ"W"_(?E&?E?Y@.>GS>M5O#WQ1O7^'<_BW5M%NY;9;AR6
MM6C(2,R%0 "P.%X!)'O0!ZG16-IWB"/4Y=.%M;2-#>V0O1,'4K&IQ@-SG)W<
M8]&]*\\^+UW>67BWP-'9W][;1WVH>3<I!<R1K*F^(8(4@=&/YT >N45Q^K>/
M(-&\5KX7CTB_N[]K/[7"(63:Z#/!9F&#\IZ^G?-<YXE^*Y_X50GBG0;*4/=R
M&U4S%1]F?)!)&?F/'&..F?2@#U.BN9N_& M+ZQTLZ9<-K%W#)<"R\Q,QQIG+
M,P)7G&!C.2>W.,JY^*VB6]AX=OTMKR>TUUS';O$@+1N&"E67.<@G'&>E '=T
M5Q\?CZ,PV$=QHNHV>I:A>26EI872B.1]G+2$YP$ YSS[9JNWQ0T?[)I[K&ZW
M5Y>RV'D32+&(IH_OAW)P/X<8SG</P .XHKSGQ?X_U+2W\,066CW$4NK:BL$B
MS,@=524*T8&<;FZ9SMP>#W&S/X7GO[G6+N2XU&"/4[2-&M!?%=D@ ^Z5R(\8
MP2N<Y;VR =;16=;+-HWAV!+B2:^FL[55DD&#),RJ 6Y(Y.,\FN>M_B):3P:-
M=?V/JBV>L#;:SE$(:0J6$94-N!(!YQM]\<T =E17,VWC:R>VU-KVTN;"YTVX
MCMY[:<H7+R!?+VE6*G=N7'/'?'6H!\0-,235(+BWN4NM.A2=H(]DIF1SM4H4
M8@_-P<XP?;F@#K:*YB;QK;VD>NBZTZ\2?1;=;JYA78Q:)E9@RG=@\(V0<'CO
M2V'C.WO-6L;&73;ZT&H6K75I/.$V3*H4L  Q8$!@?F S0!TU%8FC>)(];^R2
MVUE<"SO+9KF"Z+(4905&#@DJQW9P1V/<$54UWQ'>Z9XLT#2+?3Y)XK\S-)(K
MH"0B$[0&([D$GT&!G/ !TU%>8:+XG7PO'XLN+FSU&[LK?7I!-<*X<6\96( D
MNVY@">BYP/3C/6:WXRL=%:]7R9+HV$0FNEBDC4HI&[ #,-S;><#MCU&0#HZ*
MSCKEA_PCAUX3;M.^R_;/,"GF+;OSCZ=JI+XH@CM+B\O;6:UM(;9;H3LR.DB-
MG 4J3EN!Q[C&<T ;U%<M'X]TI-2NK&_#64EO9M?;WD21&A4X8Y1F^8=U_+-6
M%\5$78MIM&U&)Y+1KN$LJ$.JXRI(;"OR#@D?6@#H:*YJ#QK8W%IX=NDM+OR=
M>(6V8A/D8H7 <;N.%/3-16'C4:I>W%K::#JT@M[J:TGDVQA8Y(UW8)W]^@Q[
M9QD4 =517G=KXLBL?#GA#_A'=*NFT[5+GR(UFE5I$3#MM^=SECM/4X []*Z:
MQ\4P7FJZOILEE=6MQI:))-]H,8#HP)5E(8Y'!Y.,8H WJ*IZ=?G4-(M]0%K/
M#Y\0E6"4*) ",@'!(!_&N2TSQ?HVE>%].O+/3-36SOM3>S2-B))$E:9E);+D
MX+!B ,^E '<T5QFH>/'@T3Q+-%H]U%J6B0B62UN6C&59"R/N5B"N <@'/!%7
MT\5+#8Z>EQ;2?VC<VWGBW:6)#M &6+%MH!+# SGGIP< '245QD7Q(TVZMM(F
ML]/U"Y.J22PQ1QHFY)8U8M&V6X/RXS]WG.<<U/=^.[6SL9;B33KL2VULMS=V
MS/$DL (+;2"XW/@9P,\8]0" =917-?\ ":65Q&[Z9;SZ@J6,=^P@*AO*D!*D
M*Q!)PIX_KQ267B.]NO'VIZ$VGR+:VEM!()@Z')<O\QYS@[0 !D]2<4 =-169
MJ>MP:;?:?8>6\U[J#NMO"F!D(NYF)/  '\QQ6 _Q&L8M*NM0DTK4UBM;Y=/G
M&R,E)BX0C <D@$CH.<C&: .RHKFD\6RO,MK_ &!J<=Z4FE^SRB-?W<94;MVX
MK\Q88&?7H.:A'CZPE30'M;#4+E=<B>2T\M$ZJA<JV6&#QCT]\#- '5T5PFI_
M$"5?#,FH6&E7"W4.J)IES!.R!H)#(JGHQ#<.,8..1FM;5?&=KI27(>TFDFM(
M!<74*RQ!XE()QRX#-@$X4GMSR,@'2T5SJ>*K+5$AATJ&?4&N;);PK PC*0OP
MI+,1AFP0!UX/3&:S_A7*\_PXTN61I69FG),K$O\ Z^3J3SF@#LJ*YD>-+3[7
M:(]C=I:W=^^G0W+*H!F7<.5SN"DHP!QV]#FJ5U\1K6UMM5NFT;5&M])NC;7T
M@6/$0 4E_O\ S#YQPN3@9('&0#LZ*P]0UR%[JZTNUM+F^GBMQ-<+;.$,:-G:
M-Q8?,V&P!Z<D9&<SX8322_#+0II&>61K;<2S99CN/<]Z .OHKR?Q'XCOM?\
MAIXAO+BTN+)K34?)C,<PP EPD97Y&RQZYR,<\9KMH/&%H=4U"PO[.ZTU[.T^
MW%[K9MDM\D&0;6.,$'(.#TXH Z*BN9LO&UA=:]9:3)!+!-?Q/+:,SQL) @!9
M3M8E6 .<'M[C%6=<\40Z'J>FZ>]A>W4^H&18/LR*P+(A8J<L,$XZ].<D@ T
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MIFF_\(OKO_"#'2?[/'VLZU]OQYZ;?+^T^=USUQQCUKM=+\+:'HLHET_388)
M,*PRQ0>BY)VCV&*UZ .(_L;5O[6\:77V!O+U:VBCM/WJ9++$4.[GCEL]^ >_
M%5[?P_K$4?@%6L>=$3;>?O4X_P!',7R\\\G/;CWXKOZ* .!\+Z1XGT!(_#\F
MFZ?+IUM,?(U;SQO\C<6"F+;DN =N<X[\XYI7_A;7;KP=XSTM+ "YUC49+BUS
M,FW8VS&XYX(V'CGJ/P]+HH Y6+3-5B^(<FM):1FQO--BMY"\P#PNCNQ&T [L
MAQT/:G^)M,O[[Q!X:NK2V\V'3[QYYVWJI"F)TX!/)RV?H*Z>B@#S^Y\/ZS-:
M>/8EL?FUP$6>94[P"+YN>.1GOQ[\56O_  [XEOK:XL)["WN;.714M;9)KD*E
MI<!&5V*@$.22I#=L8XR:])HH \ZTK0O$FAZSI6KQZ?!<A](ATV]M%N@&A:,D
MJZL0 PY(([=LU1M?"7BG3]-TZ_@LK&34=.U*\G^Q/<92Y@N'8L-^W"L,J0?;
MGTKU.B@#,T0ZB]HTVI6=O8RR-E;6&02"-<?Q. -S'D\# X'/4\%JOA;Q+)H/
MBK0[33[>2/4=2:^M[IKD*&5Y$<J5QD$;3R>,=,]*]0HH X^/3-63QEK6JOI_
M[B[TV&VCV3*<R(7)ZD<?/P?;H*P=%\+^(_#W_"+ZE!8QW-Q8:8VEWUGYZJ2A
M8,)(V/!Y7D''%>G44 >7GPEXG-C>W<5M91:C#XA?6+2"2?>DZ,FQHV.WY<J6
MP?Y5I^(--\1^(O!5]:MHUK97ER\'E6D=RK[ DJNS/)@#G&  #C ]3CO:* &Q
ML7C5F1D8C)5L9'MQQ3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
..**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>exhibit1061-loanandsecur003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNT9&\R6]DD$F&!*L&) # $9 &,\>E.O_ !=8V"W\OV>[N+;3FVWMQ;H&2W.
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M5SGBJW\0^)O .IVPT5K>[NO+6"R,\9=0'#,SMNVC..@)Z#UP)[FTU>U^(?\
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M&+9X).[;CI@$YS@ 'ID<BRQ)(ARC@,I]0:K66IV>HR7:6DXE:TG-O. "-D@
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M@$8.,G&<5K4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&TLLK*9)9#RS-M4<D\\*/8#H*YK0K%-9U[Q7J120Z7JT%M!$[(R&15B8/@,
M?X\=.H([5VE% '&6/@*:UDT"27Q!=SMH89+0&&-1L,?EA6 '/R\$]3VQ5_2_
M"K:7X=U#1TU!I$O))Y/-:( H922^ #@\L<>GO7244 <U:>%KFPTO3]/M]4#0
M6EB+%HY[821S1@ *67(^8 8ZX.3D53@^'\&F7&E76B:E<V%S868L&<HLHN(
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>/YGUKK?%FG/#8Z)K'A3^R;@:9IKRW.D21H8IX6 \UU'0L,8;'/3Z$ ]L!!
M(((/0BFB:(S&$2H90,E-PW ?2L;PQ>V]QX'TF\B@DM+9K")UB<[FB38,#/?
M[]Z\#L-7TXZSX"N=,OLP1ZQ.C3W,JF[9&D7+3E<8#9; .>,G/.  ?2KS11JS
M/*BJO4LP %+)+'%&9)'5$'5F. /QKYZU_3K"Y\7_ !8:>VAD,&G)+%N4$))Y
M:G<!_>SWZ\GU-6VNI+D?".#5G$FC2PYE\XYC>8( @?/!(XQGU- 'J'A+QG)X
MEUWQ%I<NGK:OHMPL!D2?S!+DOR/E&/N>_6I?$7B/5M%35;J#1H)[#3;+[4\\
MMV8S(0&)1%$;9("CDD?>%<5\(C9)XX^(45BT(MQ?Q^2L1&W8#+]W';Z<5W/C
M\@?#KQ+DX_XEEQ_Z+:@#-\*>--6\3Z7HNK+H,$6G:E))&SI>EY+?;O ++Y8!
M!*8X/\0KLA+&TC1B13(HRR@\@>XKSWX1/,OP5TMK4!KA8;CRQZOYLF!^>*Y#
MX8Q1ZY8>']0E\06UMK.GW]Q]KMS 3=7+2,=RR$OD@K@YVX&W_9H ]Q,L8 )D
M0 D*,L.2>U(\\*+N>5%&0,E@.?2O%?AGX4T;7=9\62ZA;><+'Q"\MJBR,BQ,
MK$A@%('H.>PKF=0TW3YK#XOSR6L+RVM[&8&*C]T3*^2OH>V1]* /I$2QF4Q!
MU,@&2F>0/7%"S1-(R+(A=3AE##(->&:/##9_$WX:3VX"37^A>9=R _-<,8&;
M+GJQSZ^@]*L>"5O= \>Z7IEY%;:KIVHO=76EZQ" )AE6:193U/7!#=&(P>,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF40B>.0,GF$@!<CC)) QZD47?B?0["[%K=ZI:PS&00[7D  <C(4GH&(Y /-
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M&0<X/(SCM7F.FO=6_@;PP?LUT8M%UMI-5A\A\QIYLN&QCY@I96(&<<&O9:*
M.,TJ$7OQ-U#6].D5]+DTJ*WFFC.8Y[@2,00>C%4X)'3<!27\HL_B[I]Q-'*(
M;C1I;:.18F93)YR-MR!QQD\]A7:44 >,WWE2?#[Q9"$WM+XG:2./9DNAN8VW
M =U*ACD<8!KK%-D/C";C]R(ET!5$N!M!$I. W3.PYQZ>U=U10!XGHUTVC^'/
M!VHWD=\ND6C7]O>-;*^^U9Y<Q.RJ-VW:".G ;WKTOP?;:5#IMU/H\%S':7EV
M]SYEP7S.[ ;I K\J"0>PSC(X.:Z&B@#Q75+WROAYXV\/ZG#/_;KW5S,(S S&
MY5W#1R(0.5V[1[;1TKJ3J,%A\2Y+NX2X2'4-"ACM3]G?,CK)(60#&0P#*<'L
M:]!HH \9\.>2VG_"U+F%A]G-QYJS1$;,PN%)R. 6VX/0GI76$VMI\7&P(X;>
M/P]Y60H5%(FW;?0$+SCTYKNJ* /&=(2&W\ ?#M!&(IH-8B>==FUHQB4,6'4#
ME<D^HI=8N])23Q;X:O\ 5/LEM?ZJMP\]Q;S>9%Q$S;<(58?(-I+#'H0!GV6N
M9M/"^HZ?--':>);U+"6:2;R'AB=T+L68+(5SC)/4$CUH T-8VW_A'4/L)6=+
MBPD\CROF$@:,[=N.N<C%>>V]S;7EA\,%*,5M719Q+$RB-EM2N3N'9\#/3/TK
MU.UMH;.TAM;=-D,*+'&N>B@8 _*I: /'KXW*)XIN+."XG@M_$MO?3P6H.^6!
M4CWL@'WL,N>.ZUV?A)M!U'4[[6]$6]F:YBCCN+RX\U1(5SM4!P,E03D@<9 S
MZ==10!Q'Q<R_PQUF! 7FFC18XT&6<^8IP .3Q5CQRUS=^!A=:9'+>+#/;7,D
M-L?GFBCE5G5<=\*>/;%=?10!Y3JTOA_6?"WBC6-&2_N;F?1I;62YN!*NYL$I
M$%<#<^2>@..F>:N>(H=/_P"$>\%&*"#8=4L7DVQC[B*02W'1<X.>E>E44 >;
M@6@\8?$&5UBQ+IUNBN5'SXBD#@'OSL! ]A6EX,\0V%GX;\(Z)<RR)J%UIL:Q
MH8FQNCC&Y6;&%88/!YXKMJ@ELXI[J"XDW,T!+1J3\JL01NQZX)'XF@#B?BWL
MD\(P6[ NSZA;,8U!+%%D!8X'. ,Y-96LVEJ?&GAN^\&QRR:B+H1WTJ*[PK9$
M?O-[-E5/3&,$UZE10!Y6I$7ASQSX?UB)FU.[NKN2WB9"6O$E7]R8_P"]C"KQ
M]W;SC%6]'L!'\0]/M-66.YN8O"\-M/)(H=7F$F7&3P6(YQUP<UZ310!YGH]B
M;^R^(,>GI&NIS7]RUE*5 ;)@54=6/;<6&1[U$I37?#W@:RTV-H=5TV]M6N(-
MA62S2)"LP<=5! *\_>R,9KU&B@#S'6/#5]>:WXB\+VZ/%IFMHNIK= ?+;S+P
MX'^T9%A;Z%CUITZ:]K_PQU/5);&5=9N;>*(V@X=DA8>8@'^VWG8]0RBO3**
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MS+M;,((!R%)(89&1[]36;JVCZ_=>++W5=,C6U:707L;>:5U)CN"Y=25&?E'
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MRIM.".HXKB/"NE7OB/X=^#+*6T\BUM&MKR2X:12'6+YE5 .<D[<Y  &<$\4
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MR,<9XY[8YKG]-\)^)]$TOPU?6=K;2ZGHYNH;BR>X"I<0S/N^5\'!&%ZCL?Q
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M?:[.?3$B#&.@=_6M'6_#.KW'A;2_L$MLVMZ=>)J)$N1%/,0_FJ?16\Q\>G%
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M*0I=1C9N8! ^Y/FP1M8=2#5JY\3QJ[PV-C<7US%:+>30Q%08XVSM!R>6;:V
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M>'-6UQM4@8:7K;6?V=;10L\0G6/#')(X;(QSGJ3VV-?\2ZA;:KXCM!>IIO\
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MB2TO]#N[[_BHH-36T618D ,3?.LH7&,>4'//=2,T =]437,*7,=L7_?2*65
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M/FR>#R,>] &/;^#K<:-?:=J&IZEJ@O+=K5Y[R53(L3 @JNU0!UR3C)(&2<#
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M.MVUQ9W-]?+87*1)-:AD9&$?0Y92P8XP6!R?KS74T4 -CC2&)(HU"HBA54=
M!T%8.L:4^NZ]I(D1EL=+N/MK,PQYDP4K&J^H&XL3TR%'/..@HH I:?I[6#WC
M-?7=U]IN&G N'#"$$ ;$X&$&.![FKIZ=<4URXC8QJK/CY0QP"?K@X_*L#PAX
MEF\4Z7+?O8)9QI<26X43^8248J3]T8&0: (K/P:-.O-3NK/7M6ADU*;S[C M
MS\^ ,C,1QP *:/ &AIX?72(5N(@ET+Y;I9<SBYSGSMYSE\^HQCC&*ZBB@#GY
M_"5M>6^I"[O;N:ZU&U^QS77[L.L/S?(@"[5'S,>F<GV&&WGA"VO=%TG2Y-1O
MUCTR:&:&13'O9HL;-V4P<8'0#/>NBK"TS7YK_P 5ZWHLMHD2Z:ENZ2K*6,HE
M#GD8&W&SIS]: 'ZCX;@OM8M-8BNKBSU*VB: 7$&W,D3')1PRD$9&1QP>E/B\
M-Z='H5YI#(\L%[YINGD(+S-)G>S'&,G/88'   %:]% &#%X/TF&?0YEB8R:+
M&\=JQ.20RA26_O'C.?7FJ^K>"K;4=?\ [:MM3U/2[UXQ#<-8S*@N$'0.&4C(
MYP1@BNFJ.X:9+:5K>-9)PA,:.VT,V. 3S@9[T 8\/A:TMO$5OK,-U=I)!9?8
M4@W(8_*R&P<KN)R <[LUN5S=[XBO].U'PU976GP"35G,4Y2X)\B01,Y"C;\P
MRI&<CZ5/H>OS:KK6NZ=/:) =+N$A#)*7\P-&'#=!CAAQ^M %6;P%H4^CZEI;
MP/\ 9]1O/MLV&Y$F\/\ *>PR.GN?6K^N>';?75T]9KFYMQ8W4=W$+?8,NGW<
M[E/'/08K8HH PT\,0QZWJFJI?WJSZE"D$JYCVJJ A=HV9!&YNI/6K6@:+!X=
MT.TTBUFGFM[5!'$TY4L%'0$J /TK2HH Y?4O ]IJ5]J]Q_:6H6T>KVX@O;>!
MT"2$(45LE2P(4]B <#((R#(W@Z+[$;-=6U 6SV":?+$QC8/&NX G*<-AR,CM
MCCBNDK"\8Z_-X8\+7NLP6B736RAC$\ICR"0,YP>F>GZT 4+SP!82:E;W^G:A
MJ6D3Q6Z6KFPF"B:).%5PP;) X!ZUT]M;16EK%;0J5BB0(H)).![GD_6I:* .
M-M/AQI]G#ID$>JZMY.EW1N+.,S)B$$,"@PF2I#GDY8=B*FF\ V-QHFL:3)J6
MHFWU:Z:[N"&BW!R02%/E\#Y1^5=97/>*_$DWAN/37CL$NA?7T5BNZ<Q['D)"
MD_*W''/?VH S]9MHO$^K6NA7.DW[Q:;=Q74E_<PA(7VKD>6PP'))"D 8P6]J
M[&LNVO-7_M"*"]TNWC@D1CY]O=-*%88P&!C7&<GGVK4H Y]O"EO-<0M=7UW<
MP0WYU"&"785CE+,PP0H;:"Q(&?;..*SKWX=6%[!JEJVJ:G%8ZC="\>UBD0)'
M-O5V93LW<E>A) R2!G!&IX>U^?6;[6[:>TCMVTV]^RC9*7#C8K[LD#'WNE:$
M\NI+J*1P6D#V9@=FE>8JPE!&U=NT\$9R>V.E &'=^!K6?79-7MM5U2PN+B-(
M[U;2946["C"E_E.&QQN7!QTQ5V/PO;P^(9-9@O+N&=K);%8D\ORTB4DKM!3.
M023R32^$=>?Q-X8L]7DMEMGN/,S"K[PNUV7K@9^[Z5=%U=0W=^U[%;P:= B/
M#<>=RPP2Y<$ *!@=SGVH @\.:#;^&=!MM'M)YYK>V!6-IRI8#.<94 =_2M6H
M;2ZBOK*"[@;=#/&LL9(QE6&1^AJ:@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L[7-1.EZ1-<QJKW
M!Q%;QL<"29R%C7\6(_"M&JUYIUCJ(C%]96]T(VWH)XE?:WJ,C@T >9ZS::AX
M+U#PWXEN8;6.VL2-.U*>*X9VEAF;F1\HO24[^O5C6Y)<6VJ?%&^TC64BDMH=
M,BEL+>< I)N9O-D /!8849[#/J:Z^]TVQU*W%O?V5M=0@Y$<\2NN?H1BJ]SX
M?T6]BMHKK2+":.U_X]UDMT81?[H(X_"@#RK2]/0_!_2]9L(UGNM!O9[Q$!W&
M6)+F0R1D]\IDCW -=)K%SI<_AFZUZY\Y8=9N[:*W,+")I8MZK&KL1Q&Y!9B1
M]Q\=A7=6NGV5C;&VM+.""!B28XHPJDGKD#UI)]-L;K3SI]Q96\UD5"?9Y(@T
M>T=!M(Q@8'Y4 >1:DR1Z7\3[$36\:06T4T4%G(4CB?R#NV@'U SP,D<@5M26
MO]B>,])FT>-A=7N@W3RJ7+?:)$$1C+9/)!)&?0XZ5W9\/:(4D0Z/IY62-8G4
MVR89%^ZIXY [#M4BZ-I:7$%PFFV:SP+LAD$"AHU]%.,@?2@#AO"+:!JND>&-
M:AOB=<$1$HCE EN9V3$JS#JP# MSTP".*S/"WV/7]/\ #^KSZY:VVMP7:_:E
MAAVW<LV2LD$F7)*G)XVX  (P!7I=KHFE6-_/?6FF6<%Y<?ZZ>*!5>3O\S 9-
M$6AZ3!JDFJ1:99QZA(,/=+ HE;ZMC)H X+16GTOQ1I2:A:6U];7UU.VGZW:-
MB1V99&,=PIY)"[AD' V#@<UJ>-+?4)-6@NM/MK'5A;6CFXT>[;8TD;,/WD3<
M@.-I'/8]LUU5KHNEV4_GVFFVD$W/SQ0JIYZ\@=^_K2WFD:;J,JRWNGVMS(JE
M5>:%6(4]1DCI[4 <#H-[9>(?%-E8W=NTFD/X>M[C3;:\4,'!.)&(/!<#8,]A
MTX)SE*]W_P (II$%S-)-;VWC*.WL99&+,]NEP53YCUQ@@'T KU2\TC3=02%+
MRPM;A83F(2Q*PCXQ\N1QQQQ1<:1IMW!!!<Z=:30P$&&.2%66,CIM!''X4 >:
MWIL_$.J>*M.UK6++3;RTNQY$DT>+BW@"(8Y(7+C:,Y/ ZDYZUM16\5Y\4I;:
M[!N$E\,1+()5VEP9WSD=C_*NMNM#TB]OH+VZTNRGN[?'DSRP*SQXZ;6(R*;=
MZ9"'N-0L;*P&L&%DAN9H1G=CY0S#YMN<9 /2@#@_#5LQN4\"WD!D_L2\:Y>9
MTR)K;[T!)_O$N ?7RG!ZUK?%6UMI_!RO<012,E]:!&=02H:XC#8SZCK6_H6G
MW]NL][K$EK)JEUL$QM581(JC"HN[D@$L<GNQJ]?:;8:G$L6H65M=QJ=RI<1+
M( ?7!% '&I!:7?Q)O= U&S@.GPZ5%)I]H\8\H@NPE<+TW [!GJ!]37*V\$]Y
MI_A2WOY[B:W3Q)<V=O*TS9FM568)DYY!VXSU( KUF[T;2[Y(4N].M)U@_P!4
M)8581]CMR./PHGT?3+H6XN--LYOLV/(\R!6\K'3;D?+^% &/K>BP6/@>71]+
MN8],B4)#;O*6=%)D7:C9.2K$[3ST8UP&MW)'@[Q+;WFBQ:3JVGW-C)/]E<-
M0TJ 2Q' *@J&R.W?J:]>NK2VOK9[:[MXKB!\;XID#JW.>0>#R*@32--CLYK-
M-/M1;3Y$L(B79)D8.X8P>..: //?$>HRV?CCQ%-HTJ-?1^%6EC6(@DS"1R#@
M=6 V^^,5L>&H_#%W-H>KZ3?9NY;(H4@E!-PI4%FG'5F4C[S=&;!Y-=19Z'I.
MGO$]EIEG;/%'Y4;0P*A1,D[00.!DDX]S3;30-&L#<FSTFQMS=?Z\Q6Z+YO\
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M Q2 #OO4)GKAP*M:A9V-A=>&]+NXXVU"[>YNVMY'5;1Y-N9&D!!W[-_R*/S
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M+)41B46SM?L\:@]MFYN<Y.<]ZT: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Q?%%Y<6VCM#:17
M37%VRVZR6\#2&$,0K2':#C:I+>Y % &)H'BZ[O\ QSJ&E7D:I97$ N=(<?\
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MPO+J&-I88!%MB8A=XV G..<$>U=1H/B@7OA#1]7U:(V=S?Q*1;JC,S.03A%
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M.,3NY8C;TVL#^-:K6;)>^.++4M$U&ZL]0N8IE,$38DB,4:$HPZNI!.!SQ^-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5F:Q:Z9<K;_VE.81O\N+%V\&YV( 7Y6&XDXP.?:M.N)^)BXTO
M1)EA66:/7+$Q@X!)\T< GIGI0!M_\(II7I??^#"X_P#BZU;6UBL[9+>'?Y:#
M"[Y&<^O+,23^)KCT\5^(8]4U31+K1K/^V(++[?9)!<LT5U%NVE=Q4%6!P.G.
M>PK0TKQ1)K-AX=N+*.!VU2,S3+N/[F-5^<CCDJY5,''+>U '3$X&3TJLNHV+
M,%6]MRQZ 2K_ (U9KRG0C:0ZWX^$WAN;58O[3)9(8(Y-P\I<KAF!)/\ 6@#U
M:BO,/ OB'^ROAYHT0N4OKR]OVL[: R-_HY9F;RG9AN'EH#GCL .QK;O_ !G>
MZ3/KNGW5A;R:AING'4X=DI2.Y@&03T)5@5(QSG(YYX .THK@[CQEXBL]-TS4
M)]#L3;ZE<V<%NJ7K;P)NNX;, @^^.>IQ6E;>(-8FU6/0I;2QAU@6SW<Y69I(
M8X_,*1XX!);!],8/7I0!U5%<)_PG]R=,M[TZ=%$(=7&DZJKRDBUDW!=ZG'S)
MEEY./O#WJW'XRN/[4\3:=+;VPN=(2-X%20DW(D7*]N#N^3'/)H ["BN/U/Q;
MJ%O+J%I86"W-]IT*//$L<SK)*R;_ "D*(<<8^9O[PXZU!)XPUZZUBWTS3-!A
M6>XTD:BBWUPT3(=ZJ8W79E2,D=^<=* .WHI!G:-P ..0#FN"A\6W^FZOXTO-
M8>$Z9HQCVI$6W!3$' 4'@L2V">.<=A0!WU%<O)XEO]-UC1K35[.".'5R8XI(
M)"WD3!=PC?(^8$ X88Y'3O744 017MI/)Y<5U#(_]U) 34]<'X'ABC\<>/&2
M-%8ZA",A0#_J5/\ ,D_C70:YX@_LV_LM-@CWWEXDDBDQO($1-NYBJ D\NHQQ
MU//'(!N45P;>.M8CL=,>7P\8KBZU8Z6Z3N\0)PQ66/<@)1@O4X(]#BIE\=3V
M%OKZ:Q8PK?:5<0P+':REDN&F"F( L 026 /'&,T =@;NV%VMH;B(7+(9!#O&
M\J#@MMZXY'/O4U>=7%Q<:?\ %>WOM62TC2+P_<S/+;YY59(RP(/)VXX/?/05
MIV7B_5+K4=+5=%EDL]1B9A(D,R_96V[D$K%-I5NFX=#ZCF@#LJ*XOP]XG\2^
M(M'.IP:+I\<317*Q*UXQ9IXY&15^Y]P[>O7@\#BNOM6G>TA:ZC2.X,:F5$;<
MJMCD ]QGO0!+16!XD\13:%<:1!;V O9=1O!:K&LNQE&TL7 VD$ *<Y([<UD7
MGCRXT^T\2FZTN'[5H9AS&EV2DPE4% '* ALD#!'<<\T =M17+3^+;FR8_;-'
M>-;B2&#30LP9[R5PQ8;<?(J@9);MS@'BEG\4WEO?:MIITV&34;&P6_2-+D[)
M4)<;=VS*ME#VYR#] #J**YVV\3O>VNC7=M:1M:ZC8->O(\^WR $1AD;3D?-@
MGMZ&LW0->MH]"TN>UTMH=0\0R/>1V7VAG^]\S2,[#Y4VE2<#@L !DT =8+ZT
M:]-D+J W83>8!(/,"\<[>N.1S[U8KSVQUE8O$OB+Q'J40S:/#HEI%;MO,L@.
MYE3(&2SR(.<8V\G S6P?&:VL^I?;[5%MK&&-GFM93,#,[%1;CY1F3[O _O#.
M.X!T5Q?6EH\*7-U!"\SA(EED"EV/ "YZGV%6*X:_EOM:\=>'M+O;.*".S1]7
ME1)O,((!CC5N!R&<GC(^4^F:[F@"*XN8+.!I[F>."%>6DE<*H^I-.BECGA26
M*19(G4,CH<A@>00>XKE/B3=B'P=-8^9Y;ZI-'IZL.H$K8<_@F\_A3+;QI!80
M:Z-0T_[%::*T,*"*3S6D+H"L84  /\R#:"1EASWH VM2\/6^JZI:WMS=WP2W
M&#:1W!6WE.0P,B#[Q! _KFM>N</B.\@UO3]*O-.AAN=1MI9K=1<EMK1[2R.=
MO'#CD9&01Z$U+/QW#<:;H4\MDT=QJEVUH85?<(&5G5B6P,C<A X&<^QH ZZB
MN<D\4-!<-:26:_:Y;R2WLT6;*S1HH9I6;'R*N2&X.",#)(K/;QQ<16,=\^EQ
MM8MJT>GFY2X.UD=E43)E/F7<VWMTR"10!V=%<]>>*#I]]>6\]D6VSPVUEY4H
M9KJ61=Q3! V%>IR3\O/M69?>.;BQTK6[[^S;>>/36BC22.[/E7$CG!17*=58
MJ#QCGL00 #M**S-+U#4+ZYNA<Z6;2U0(;:9I0QG!!+'9C*8XX/)SVZ5IT -D
MDCAC:25U2-1EF8X 'J338)XKF".>"5)89%#I)&P964C(((Z@UP<NH:KJ.M>.
M=.O1:R:?9VD:1Q\G:&B=P<$8))(R?8>E0^#?$.HZ?I7@;3+FQMQ8:GIL<4$R
M3$RJ\=N'RRXQ@A3C!)Z9]  >C45Q@\9WD&LZ5:7ME!!_:-Y+:_9?-S<6X <I
M(^."'"9QQ@,.3S4O@K5-8U2^\1_VDUNT5MJLMM&(RWR!4CPH![<DY]2>* .K
MEECAC,DLBQH.K,< ?C38;B"X!,$T<H'!*,&Q^50:LBR:-?(ZAE-O("",@_*:
MYOX5QI'\+_#^Q57-H"<#&22<F@#L**X_6?&%Y;S:M%I&G->R:60LD0BE8SR;
M YC0HI"G:R\GN<8'6FGQ7K=YK[Z1IVCVZ2MI<6H1M>SM&5#L1LD4)E6!4C'/
MU'2@#LJA@N[:Z,HM[B*8POY<@C<-L; .TXZ'!''O7*:7XX.N6'AX65JD=_K-
MN]P8Y6)2W1,!V..6^8@ <9SVQ6#X8UEO#\?BAKBUC%U<>)3:Q0P;BA=HHN1A
M2<8!; !/;F@#T^F--$DJ1-(BR."40L 6QUP.^,UP>I>.]7TK1M?NYM"+MI8C
M>*9UE@AN4?@E=Z9W*>"OZUIG3=2O-<M?$.K65O#)I*W0MH;64RM(DB)C.5&&
M^5AB@#K**YCPIXH?Q-'#=0/8S6<D&]S;R$O;RY7]U(IYS@GGC.#P._22^9Y3
M^4%,FT[ YXSVS[4 0'4[!=06P:^MA>L,K;F5?,(QG(7.>E333Q6T$D\\J10Q
MJ7>1V"JJCDDD]!7FGAB2^E\+2ZE<Z5::E=1:U</ S-S#(;AD:0DCA44GIS@8
MX[:LGC-KK0O%V^QL=0_L6,EPLO[B[B,/F=PW;((Y!QUYH [+[?9^9;Q_:X/,
MN1N@7S!F48SE1WXYX[58KS^^>.Y\8?#N\2WBA>6"Z(5%X0&V!"CV&>E3S^.K
MR#PGJNLG3X#)INJ-8/%YIQ(!,L6X'''WLXQ0!W-%<C+XDUV;Q=J.AZ?I-E(+
M)+:9II;MEW1R,P/ 3A@%.!TX//057B\<WETVG7ECI,]WIEY=" ^5!,9(XR2!
M,6V["O )&> >IZ4 =M117GUKXOU#3'\9ZEK)ADL=*NQ%''"3N_U<>Q%SQR7Y
M)[GTH ]!HKF6\17VF^(]+TK5[6W5=55Q;S6[DB.5%W&-LCG(SAAC..@KI6SM
M.T G' )Q0 M8%WX4AGUB?5+75-4T^XN0HN!:SKLEVC )5U8 XP,C%<V_Q UF
M/0)M<?1;3['::FUC<QK=$R$"80[H_E /)!YQGGIU.O#XGU6'7]2TB^TJ%[F#
M3O[1M4LYRYE7<R^6=RKA\@<].: .CM;6WTVT\N,D1KEG>1RS,3R69CR3[FI+
M>Y@NX$GMIHYH7Y62-@RM]".#7*Z3XHEU/Q&?#]_;V;O)IWVQ_(?>(B'"/"X/
M!(+#GCOP*Q/A9J\UUX*T#3M+6WF%M;?Z?*[G]P2254 =6(YQQ@=3R 0#TJBN
M)N?'-X4^VZ;I$]]8I>M:O'#!,TK*LAC>52%*8# G;GD#.0>*[:@ HKC/$?C.
M\\/M=SS64"6MM<PPI%++B:Z1R@:2,#H%+XY'.T\BG7WBG7!K^N:3I^EV3OIU
MK%=)+-=,!(K[^" F0?DQCIU.>U '8T5G>']637O#NG:ND1B6]MDG$9.2FY0<
M9[XS5/6_$!T_4K32[>/?>7,4DP)B>18XT*@DJ@).2Z@=!UYXP0#=HKA/^$YU
M@6NCF3PZ8+F^U)].>.XD>+#!682)N3)1@N<GD>AJAX@\9:['X.\6!8+6TU;1
MY5@>2*1G0I(JLKH2 =V'[]",^U 'I5%<?J?B3Q#:^(;;0K32M/GN[BQENDD:
MZ94W(RC!^3('S#UR?0<T^U\67<>HZ]8ZQ:VUG-IEJMW'Y<C.)HF4G>,@<!E*
MD>OU% '6T56T^2ZFTZWDOH4ANGC#2Q(VY48CE0>^.F:P==\5?V7KT&CH]I!<
MSVQGMVO7*)<.&QY2MT#=SUZC@]@#H1=VQNS:"XB-R$\PP[QO"YQNV]<9/6L_
MQ!X?@\16D%M<W-S D-Q'<+Y!4$NC!ESN4\ @&N2N&U%?BL9=.LK7[?-X=5G$
M\A1%;SS]XJ"3Z=/QK2T_QC=ZKX=T75(+*&UCOUD-S<7$O[FT*9&#T+;F&!T]
M?8@'5375O9I%]JN8XM[K&C2N%WN> !TR2>PJ"]^RZE#=Z4M^T4[PD/\ 9I]D
M\2MP&&.5/H?:O/M9UM?%/@OPQK$EJD,Q\0VL94'<%9+KRVVD@'!VY^AK<TV-
M(_B_KI1%7=I-HS8&,GS)>30!TFD:3!HUB+6"2>8EM\D]Q(9)96P!N=CU. !]
M  .!5^HYVE2"1H$224*2B.^T$^A.#C\C7":3X]U2^LO#&IW.DVL.G:Y,+8;+
M@M+'(RNRG&W&WY".N><^U '?T5QEUXTN_P"P]4U^PL8KC2]-GECD0R$2S)$<
M2NG&!@AL _>"]1FDL->U/4?B*]K!+;OI!TF&\A&6!*R.PW'U;Y1]!^- ':54
M.JZ<+26[-_:BVA;9),9EV(V<8+9P#DC\ZMD @@C(/:O*;/44T'X?>++P:7:7
M]O!K]X&M9SB,J;@ <;2#@D'''3K0!ZM17+7OB'5QXPG\.V&G6;.-/%[%//<,
M%.7V88!21R#TSGU%9-EX^U.YTG0-8DTBVBT_4;Q+"5?M):5)6<Q[E&W!4..Y
MR1Z4 =S'=6\MS-;QSQ//#M,L2N"T>[E=PZC/;-35PM_XBO+>;QU]BTVQMK_2
M;.*9;G.XW ,3NI?Y0?E"X Y^M='X6FO+GPOID]^R//):Q.75B=V4!R2>Y[T
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MG!>6VM]TD#DC.?:MF@##M-!<^))-?U"59;P0?9K>*,?N[>,G+8)Y9F(&6XX
M&/7(7P$(])CM(M0>.==6_M'SP@)0><\@C4'H '8<]R3CG%=G10!R6M>$);G7
M-)U73GL@;&"2V:VO83+&Z.5.X<Y#@J.><YJ_K_A^?7O#+Z5+?!)WEAE\]8@
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MT-^Z8 @'.>>"1@YZU9@\,:?!/!)FXE2WN&N8(99BZ12MNRP!_P!]L#H,\ 4
M5_'6NS^&O!6IZO:JIG@C C+#(5F8*&([@;L_A69?7%_H/B_P[:07]S=V6K^=
M;W*3.'(=8RZRH<?+T(('R\C %=;>6=OJ%E-9W<*36TZ&.6-QD,I&"#6=IWAJ
MPTV2WDC:XF>UB,-LUQ,TA@0XR%S] ,G)P,9H YWX=69AN?%$GVFXDVZY<Q[9
M'R#Q'\QX^][TGQ9#GPE:",J'_M6SVEAD ^:N,CO73Z/X?LM#>\:R,X^V3M<S
MB25G#2-C+<],X'3BFZ]X=L/$EK%;:B)FABE695BF:/YU.5.5(/!H XCQ:VH6
M'C?P?>Z^]O=:9]N^SVPLD,3I=2*0K.&+;EQGH1COGI4S:QJ>L^%_%.NVVHS6
MEYI5U=1VL2D>6BV_\+IT;?@DYY&[C&*ZQ?"FE'4[;4;A+B[NK7)MWNKF241$
M]2JL=H/OC/O39O"&D375]-Y<R)J!#7MO'*RQ7!QC+*.,D<'&-PZYH Y."[UC
MQ-XJMK4:U?Z9;7?A^WU'R;<1[H96DY )4\<<YR?<#BF6E_K$-KXMUN?6[^Y3
M0+^[\FTVQA)D2W5@CX7ID\8QCGUKN%\/V*>(?[<43"^^SBUR)3L\H'(7;TZ\
M],TFF>'=/TIM0-NLK#4)6GN5FD,BR.P )P>!D # XXH Y&XU/4],TWP?K4.H
MSW9U6YMK>^B<@QRK.OWT'\!4X(VX&,YSUK,U;5==L;+Q-HT&HWLNN6=VESIQ
M##=-:LOF;.F" L<RDXSD#N:[K3O"6E:9]E6!9V@LV+VD$LS/';D@C* ^Q(&<
MX!(&*OG2+%M;76#;J;];<VPF[^66W;?SH XS4O%C?\(UJ/BK2[IS8QVMM%;B
M1LH'D*[I3P?NB1/Q5LBI;ZV\2Z8NJW:ZND-@VERO'']I\^9+A 6$B%XP-I'5
M>1Z8KI[;PYI%KX?;08[*+^S&1T:W(RI5R2P_,FL[3O FBZ7I]S8P?;6AGA-N
M?.O))&CB/6-"Q.Q?ICH/04 -\$6]\^@6&JWVL7=[+?V%M(T4VW9&VS)*X /.
M><D],U'?:E-??$*'PT9Y;>U72VOW,+['E8RA -PY 7DG'4D=N#T&EZ;;Z1IE
MMIUIY@MK:,11*[ERJ@8 R>3@<56U/0+'5+RTOI1+%>VF[R+F!RCH&^\N>A4^
MAR* //)M?\0FP2S_ +6GCGLO%<6DFZ6-,W,#,I&_Y?O , <8SCGK7I6E6$NF
MZ>MK-?W-^ZLQ\^Y*ER"Q(!V@#C..G:L^Y\(:1=65M:/',L5M="]0I.RLT^[=
MYC-G+-G)YK< P ,DX[F@#S3Q!KFHV;WE_9:G<7#6^MV]MOBPEO#&SQHT#*3\
M[?,Q+ <$XR,8J34)=8N]<\<VRZ_?V\.FVD%Q:K"(U,;&*1L9V\KE1QU/<UT%
MU\/_  _=F^\V&Z"7MR+N6-+N54$P8-YBJ&PK$J,D<U;'A+2Q/J<R_:0^IQ+!
M='[0WSHJE5 YXP"1D<\T <R^MZE:P>#?$]Y?2C3+^"&+4H00(XY98P8Y>G W
MG:><?,#VKJ_#;SW6GR:A--*Z7LS3VZ.<B.$G]V!]5PWU;'85BZII$LFGP^"K
M7199=$>VCB>]FG5DBC#8*8)WE@JC:<=2#V-=BJJB*B*%51@ #  H X[5+[4-
M5\87OA^TF\A;;3XKA=MT8'9I&==X(1LA=B\<#+<YXQEB3Q+_ ,)!X5TC4=?(
MFNK*\6^:P";'DB* ,I*9#?,<Y& <X ZUU&O>#](\0WEM>W:7$5[; I%=6EP\
M$H0]5W(02/:I/^$6TM=0TZ^C26.;3HFAMMDK!45L;AC.#G R3D\4 <1I_B;5
M%LM/T6;4)7EG\176E&^?'F>1$SD<XQO8*%SCN3UJKJ6IW'@[6?B%J-K-)-+#
M9Z=Y+7!\SRMYD0$D\L%+;N?IFNVD\!Z%+IEQI\D,[137AO\ >;A_,CN"<F1'
MSE6R>U20>"M%AFOYI(KBZDU"!;>[-U<R2B9 " &!.#U//;/&* ,N_GU#0_&'
MAZRM]0NKFSU=9X)UF8.R2)'O69"1QT((^[R.*Q= /BC4/ 0UZ#6[N]U-A/"E
MK*T<<<F+HKP=O$A52H/0%AQQ7;6'AFPT]H71[F62WA,%N\\[2- AQD(3TZ#D
MY/ YJ.U\(Z59>'SHEN+E+'S?.51<OO1_,\S*OG</GYZT <>/&6--E2RGO[:[
MEU2UL9K35"5EL/,Z_,0V0VT[6^;EO;%.\3GQ3X?\,>*+O^V5AA6V6>P1)_/G
MA8<."SQ@E#D>X/0BNNN?"&C7]CJ%IJ%NUXNH!!=/.Q+R;/N<C&-O;&,'GJ35
M9/ FBC0KK1Y/ML]M=@+.\]Y)))(@Z)O)R%'H,#KZF@#4T?3[BQCG:YU2ZOVG
M<2CSPH$7R@%4"@87(S@YZUA)?3Z]XVU[1&N[BS@TRVMS$+=]C.\H9C)GN%PH
M Z9SD'C'5P0BW@CA5G8(H4%VW,?J>]9M[X<L;W54U3,]O?K$8#/;2F-GCSG8
MV.",\CN.Q% 'GUCK_B#6HO"$<VK3VLMU?7MA>/;QH!/Y*2@2#*G!.S/H#VXK
MT[3[62RTZWM9;N:[DB0(UQ/C?(1W;  S68_A+2&?2F2*6$:42UFL4K*(R002
M>?F)!.<YSD^M;E 'F-YJ?B&[M]02UO+R#7XM<%M#;PJ"GV3>HSM92FWRB7+D
M$AN,CI6I%>Z@OB+QEI[:C<O#9Z?;36Y9@&C=DE+," .I0''3VQQ6-:^';^2>
MZ$^E>)K'4Y[B69Y;#6 ED7=RP<?O.!R,C9GV-=C/X.T^^NQ?7KW#WLEHMK=/
M#.T27*@'[Z*<-R6QGUQTH YS3M4O]6T?PRLNIW,US=:&+F6UM<1RO(53]^TF
M0%0$L,=R>C8Q5"PUK7=:T_X>,VM7-N^KQS)>-"D8\PK [;N5X;(^F><<5U\/
M@/0;=M/:"*ZC-A;_ &6(I>2@M#G/EN=WS+D9P>*+/P)H=@FE);)=1KI3L]F/
MM4A\LL"&ZGD8.,'C% '*>*+[5-&TG7OLFNWU[=Z18PM&Z[4^SN%+%ICPLC/P
M=N#@8X&<G6N)-3U/XA_V4-:O;6QFT1;HQV^Q2DAEVDJQ4D<>N3Z$5KZEX&T+
M5;O4KFZAN"VI1"*[1+F1(YL+M5F4'!8#@''858M_"NFVFIIJ,+72W26GV-7-
MP[?NLYQR3DYYR><]Z //;:[OM?T[X<W=_J%R;B6^GBE>-]F\I',H<@<;L*.?
M<^M;L>HZCK^G^+;R#4KBRN=(O)[6S6,@*GDHI#.I&'WDDG=GC&,=:W$\#:''
MI5AIJ1W*V]A<&XM2MU(KQ.=V<.#NP=S9&>]3S^$=)GO+RY"3P_;D$=Y'#,R)
M< # W@=\<9&"1P<B@#CK/4M:\5Z[HT(UB]TN#4_#GVZ2*V5!Y<N^,90LI/\
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M;<_;6L FQI8F1=R$ID$Y.<C@YP!UJII?B?5'LM%T6XOY6FN];O-/DOFP)##
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M<DC&#L)./:@#U6.^M)KJ2UCNH'N(^7B60%U^HZBD^W68F$)NH/-+% GF#=N
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MUWY-Y6#>.,XPPR?RS67>RZ)JOQ.\/!'L;FS;2KMD4%6C8^9'@@=#T)'TSVH
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M>'/#6JL^GP&_027<;A@6!0G;%SUSCKG@&L :MIR>-_%UIK\]NGVBT@&G_:6
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M3I(T<:[6(,28[@$D@8/!S5C3O&>F:EJ5C91Q7D37]N;BTDG@*),H +!3W(#
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MH(;[PQU[<TKHLB%'4,K#!4C((KE8OB#I$SW'E6VJR16TD\4\R6$A2)HAE@Q
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M[66]MI;&]COK:S:]2UD10\\0X+(=V.#U!(([B@#H3#$Q8F-"6P&)4<XZ9IY
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MMAJ-AX]\2SRV#_8=1:WFANA(FWY(0A4C.[=D>F,=^QT?^$/\,?\ 0N:1_P"
M,?\ \31_PA_AC_H7-(_\ 8__ (F@#%\:V.IWFN^%[FPTNXO(M/OS<W#1/&NU
M=C+QO9<G)J"71-2U;XF:3XABTQ]*M;"WFCN999(_,O=XPJ;49OE4\Y8]>@[U
MT/\ PA_AC_H7-(_\ 8__ (FI(?"OAVVGCG@T'2XIHV#I(EG&K*PY!! X- %G
M2[R[O;5Y;S3Y+&1970122*Y90Q ?*\8(YQ5VBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHR
M!UH **16##*D$>HI001D<B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HI"P7&2!DX&:6@ HHHH ***16#*&4@@\@CO0 M%%% !1110
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MS["KFLZ#J$WB31_$>G?9_MEG%);W%M+(0DL3X)"N%."K $<<^U9&K>"-2O\
M3=9DB-F-3U?4+:ZE#RL(XD@,>U 0A+'$?)P.6/I0!I?\);J9UV\T1?#K_P!H
MQ6RW<"&\0))$S,N6;'R$%<8 ;KUQS6QX;UR'Q+X=LM8@B>%+E-WEOR4()# X
MZX((K.71]57Q]+K_ )=G]F;2ULA'Y[;]XD9\_<QCYL=??VJ3P/HM[X=\)6>D
MZ@;=I[<R9:W<LK!G9AU4'^+'3M0!5;6-3N/B-<>'WM+5M-335N#NE.7#N5)(
MVXXV$;<]#G/.!S'@+Q'+H?@SPS:RZ6YT^[O)+);L3+E9'FDV_)U*Y&,Y'/8]
M:ZV?1=4C\?G7K/[(]K+IJV<J32,KJRR,X*X4@@[L<D8Z\]*P+7P7KMOX0\.Z
M0?[.,^EZJE]*PN'VNBRL^%_=YS\V.1VH T]6^(5IIHN9XX(KJUM+K[-<".Y'
MVC(8*S)%@E@I.#R#P< @<]CN&W=D8QG-<38Z#XKT35M2MM,N=-?1;^[DNUEG
M+^?:-(=T@50-KC<21DCKS7:2Q+- \+Y*.I5OH1B@#S/QCK!\0:#H6I6^G(VG
M2:W:?9KII?WF!.!OV;>%;!Q\V<$9 [='J_C1M'DGEN-+D6QAOHK)I99/+DD9
M]HWQH5^= 7'.X=&XXKGH_!GBJ'PKI_AH-I4MMIE]!-;7CSNKRQ1RAPK($(5L
M#&03TZ=ZEUGP;XEU*'7(3)I<S7=]#=6UU/+)YBQH\;B C8=JC8<$$YS]W))
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MZL!ECN$!.T+%@,A'<\@U!:ZSKUO9^'FO-82:7Q$UND>+5$%I^Y:20J?XV;
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MGE B6-0-\[<[8Q^9]ADD\9-<MIG@>ZT?2?#2VDT#7FCQSJT<A(B<S@EP" 2
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MTQPUC>I.JSVX VA5(7&W;Q@@Y[YKH=)TM-)L_(6YN;J1FWRW%R^^25L 98X
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M8IX;A-\,J2)G&Y&!&?PH YO5/ UA?ZK;ZG9WVH:1=PP"V+Z=*(Q+".B,"I!
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M#HMOJ%C%;SK)=P0L9&.-LDBID8ZGYO6@#7U73;?6=(O-,NPQMKN%X)0IP=K
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MM*D <;>WN<]3)+'#&TDKJB+U9C@#\:S]=UNVT+P[>ZS-^\AM8&FVHP_>8&0
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MVA/+ \L8"YSM^F>U 'E>BV=A8S_"R[M8H(KFZM62:9<!YA]CSAFZL P7 /3
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MU.Q9T?1]*N';3D!YC:=5=D/IL#$#VEKJ?$4<LWAK5(8(GEFEM98XXT&2S,I
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M:?V?!<7=K''"5&9&&4=_F;9G)P/EP,=P#K-<U_3_  Y8K>ZG*\5N9%BWK&S
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M_#GU; ]ZI6OA_7=&LM-\/26%Q>646B>0)K.14!NB3N61BRMY8!&!T.3D$X
M-W6-6>Y\2>![K3=0F.GZC-*2D;%4GC-N[J2.I['!_*NJU+4;;2--N-0O&=;:
MWC,DK)&SE5 R3A037GFF:9J\=C\.4FTB[B;205O =I\H?9VB!.">K'H.<=0*
M[+QC_P B/K__ &#;C_T6U %2Q\>Z'J&IVMA"]TLUY"9K1I;9T2X 7<1&Y #$
M#K@U,/&>CG2(=4\R?[)+=_8PYA;*R^9Y>UAC(^;C/2N;L+&?Q'IW@3R[.>!-
M+$-Y<32IM "P%0BG^+<6!R,C YYP*R)M*UZ+PK<:#'H%Y+/!KPO!*K1B.6(W
M8E!0EN3M/0XQ@Y(XR =S)XUT=-:FTE1>R7D$T4,RQV<K",R?=+';PO\ M=.>
MM6+;Q/8W?EM!%=/'- UQ!*(25FC7&64_\"& <$CD"LO0+:]B\>>*;R>PGAMK
MU;7[/*X&US'&58<$]"?Q[5D>%]#O].UFT.F0ZA8:3<6\IU#2[SYHK24@;?(8
MYZL3D*2N/0X% '40^+](GM-&NXY93;ZPXCLY/*;#L02 >/EX4GGTI/\ A,-(
M^V)!YDI22].GK<",^4;@9S'GUR",XQD8SFN#TS3=>C\.^"=+?P]>K+HFI1_:
MV+1A2JQRKN0[N5^8')QU &3TDU"Q\1W[VLMUH-])=V7B*.Y/E21K ;=9"5,:
M[P"2I!+,,YSD]J .MO/B!H5D=1$AO6&FR".\*64I\C(!W-\O"X(.>_;.*E?Q
M8G_";6_A^.TGD22Q-V;A8R5.715P1_#RV3TZ>]<S>:7JDUA\1HUTRYWZLN+(
M;1^^/V98^.>/F!ZXXYK0L;'4[7QIHFHG3+A[9M#%A*P*CR)1(C'>">F >1G.
M* -[Q?X@_P"$6\*W^L?9I+AK:,LL:#.6[9]%SU-3/X@M8_L\?DW+W<\;2):K
M$?-V*0&8@]!DCDD9R,51\?Z9=ZSX"UK3K"+S;N>V98H\@;CP<9/':LKRM3M_
M'%GXG;2[PV%WI?V&> !6FM760NK%5)R&!(.W)'&: .KTG5['7-/6^T^;S869
MD.5*LK*<,K*>58$8(-<?XE\21:;XZM]-UV_NM+T>>T4VES$YCCDN-S;E>0="
M%"X!(')SGBMGP9HUQI,&KW%S&87U/5)[X0$@F)7P%!QQDA<G'<T:S(;F^O--
MU?09=0T22",K(L*S+YF6W*4SN_ND$ ]3R* +&GW$NC:3G5=1DOVDN66WFVJ7
MF5CF-0$ !.WT Z$\#-$'B[2)H+UVFDAEL9EM[BWEC(E21L;%V]6+9&W;G.>*
MX"'P?K.E^%;9K/37NX-/UR2^M-'NI%9Q9LC)Y622-PW,P!)QGUK3U32K_4=&
MCU?0_"B:9=6M_;7HLI4BAGO!%N#*Y0D#AOER<\'ID4 ;.N_$"RTO0==NX;:X
MDO\ 247SK-X\,C.,QENVP]<@]CWXJ]<:K83>)M#@DN=3MKR9)V@M/+=(I@%^
M8R9&"5P"!G(SGO6+XE35_%_@#7H;?0KBRFN+8)!!=%%GF<')SM8@#C R<DYZ
M<9LZ@E_J/C3PCJ:Z5=Q6]NEW]H\P+F'S$54W8)Y)';..^* -6X\7Z1;?O)9)
M19BX^RM>^63 LN[;M+=OF^7=]T'C.:AOO'.C6%WJ5HXO9;C3422YCALY'*JP
M)W=.5 4DGITYKD(?#NK_ /"MK[P'/83/=&62&&\(!ADB>4N)BV>" QRI^;(X
M!S6LFG7T'B+QC+]ANG@N].M[>UEV@^<\:2*P'/JZ\G ZT =O9W<%_907EK()
M;>XC66*0=&5AD'\0:X?QO:^(--TJ^\1V/B&ZCO+5PUM8(B&VD7>%6-E*[F9L
MCG/4\5T/@NVN++P1H=E=P/!<VUC#!+&_571 I''7D5B:GK6JR:ZPE\'ZS=V5
ME)FU\HP;)9!_RT;=(#Q_",<?>/.-H!K7&K2WGBVV\/Q,8O+L_MUZR'D MM2,
M'MDAB3UPOO4M]XOTG3G?[1)*+>*X6UFN5C)BBE8@!6;ZD D9 )Y(K&L(+BU^
M*DUW=Q>4-5T:(J-V0LL3G?&#WP'4^_/I570AKV@7>J:!+H,UY'/J$UU9Z@&0
MV^R5R^9<L&!4D\ $G''K0!OMJLFF>,[;1KB1GM]4@EFM"QR4DC(,B9[@JP8>
MF&'3 &OJ&H6^F6HGN6(5G2)%499W9@JJ!ZDD"N8URU?4/B=X5\D$C38;N[N#
M_=5T$2 _4EL?[A]*U/%MC!J6A-9W6FS:A;RRH)(X&VR(-V?,4Y!RI ;CGCO0
M!@^-->D_L2VN[.YO;![76;2VN5(\LD-(A93ZKM<=#@Y[UMP^,]&DBU6266>U
M&E()+M;JW>)DC()5PK#)!P<8YXKC;K1_$7_".FQ;^T-4@AURUGLI;E0+DVT;
M1NYDSC."& S\QQTZ5=UFUU]?$'BR_P!(TMY9+G2K>&T:9%V22(SEQANX#\;A
M@F@#J[?7;35I[S3(VNK2^CMUF,<B;'$;Y"NIY'4$>H(Y KA+'5M4E\!?#^_?
M4[LW%WJ=M%<OYAS.K%\ASU(X%:>CVFH0>.I]5.C:HEE<:,D1ENI4>3S%D=B&
M&\D$Y& ./85G6>C:O!X!\#V#Z5=?:]-U*WENX@H)B1"VYLYP?O#IDF@#TK4%
M9].N525XF,38>,X9>.HKAO _CNQD\.^&K+5+F\:_OK=$6[N()/*FF(R4$I&T
MO[9Z\=>*[VX0RVLJ+]YD(&?<5YOIF@ZE?^"O"_ANYTVXM;C3+FVENY9@ D8A
M;=\C G<6P ,= 23CI0!V%[XMTJPE47#S+;FY%H;L1$PI,3MV%NWS<9Z \$@T
MDWC#2(+MH6DE,:7BV$EPL9,:7#8Q&3Z_,HSC )P37'Z3I%WI]Q>:!J/@R'4B
MU[+-:ZK)'$\#1R2&0-*6.X,I8\ $G QZU!K]AXBU)-02;0[V6>WUN&XM_(DC
M6!K9)4(*KO&Z0J"26&1SR!@4 =F_C72$UJ;2%%[)>03Q02I'9RL(S)]TL=O"
M_P"UTYZUL:AJ%OIEH;FY<JF](P ,EG9@JJ!W)8@#ZUS?AZVO8O'?BB]N+">"
MWO5M#!*X&US'&5<<'L3^/:M/Q99PZAX>FM+C39=1@E>-9((FVOMWC+J<CE?O
M#!S\M %'Q!X@TP^&=2EOKC5=,AMY4@GEMXV6:)SL8;2H(P=RC=TYQFKE]XMT
MRQU>;2F6\FOXK<7)@@M)'9D)P"N!\W.>G QS7$ZEHGB%_ 'B/2$.H:K#)/$N
MEFZ4"Y>,%&;>3C@$, 6P3CZ5TBPW?_"SY-6-C<BP.BK;B;9QY@E+[<=<[3Z8
MSQ0!8MO'V@W@TQX);EK?476*"X^S.(O,;.(V<C ;((QZ\5%>_$;P]8&]\U[Y
MA83>3=M'8RL+<X!W/\ORKR.3UYQG%<K:Z-K$7P]\,Z>^DW8O+/6H[F>':,I$
MMPTA;.<'Y6' .:M6,TLM[\1-/AT^XNI;J[,<2JGR.S6T:[6;HHY!); P>,GB
M@#<N-0FD^)>AI;7\KZ?=Z7<3>4K_ +IR&BVN .O#'GWK3_X2W2A>V=NSS(E]
M(8;6Y:(B&:09^56]3@XSPV.":YNR\.WVE^(O"EJ(9Y;;3M$DL)KQ!\HD(C ]
M_P" ]N.*J^#]+N[*WTW0=4\%0?;=,=%&K-'$T#(A^656SO\ ,(' QD$Y)% '
M>ZS<V]IHE[<74T\%ND#F26W5FDC7'++M!.1UZ<8K&@\6Z-IUGH=HUS?W#W]F
M);1G@DEEG14!R2%Y<@@D=<GI6IXCCEG\,:K#!$\TTMI+''&@R69E( _,UQUA
MINI17_P]:33;E5TS3Y8+UBHQ"[0H@!YY^93TSZT :FH_$"QA\/V^J6%M=7'G
M:@FGM&T+*T,AD".'4X((R>.YQ]:UM0\46&FP2RS1W;""$7%R(H&9K>,Y^9P.
MG0G')X)Q7"S:)K#^']7V:5<M*/%*ZI'#\H:: 3(V5R<9PIX)!JY>6E]8^,-2
MOKSP?)K6GZQ'"Z!%ADDM9%0(T;AV VD '(.!SUH Z*\\?:#9W"P"2ZN9'LQ>
MQK:VDDOF0D@!EP/F'.>.F#FK-]XNTG3B7N7F6U6=;>2Z$1,44C$ *S=N2 3T
M!."0:QK#3;RT^(EE<C2A;V,>A_8RUL@$$4OFJ^Q1P< #KC'TK'L=(N["_P!4
MT34/!D.JI<WTUS::D\<3PE))#)^^W'<"I8] 2<<4 =PWB*R6[:!4N)%6Y6T>
M9(RT:RG'RD]NHYZ9.,YXJGX:\4CQ#>ZQ"+*X@6PO7ME:2,C<%5"<GL<L>.N,
M5SMUHM^GBG^T]#@U#3KZ344%["?FLKVW# -*0<A7V#@C#9'0YS6OX1L[_3=8
M\36]W831Q7.J27L-R64QR(Z1@ 8.<_*<\<8H W-1UJUTRYM;6022W=WO\BWB
M7<\@098^@ &.21U'K6%?^/;**QT*\T^"XO(-7NQ;HZ0M\F-VX$<'=\C#'J#Z
M5)XF.J_V]HZV^GW5UI9$PN6LF59E?"[ 6+*50\Y*D<@9XX/(Z=H>N67A#PS"
M^AW7GZ3K\EQ- CQEFB9Y_F3+8(_>+U(/7MS0!ZG),([9I_+D8*F[8JY8\9P!
MZ^U>;:CXRN-9\*^'->MWO--CFUNV25!E1)"TQ&TG^+Y0,XXSFO3$+,BEEVL0
M"5SG!]*\IL]'UN#P)X9TB71;M;G3-9@EGP48&..9G9UPW(P1CN<\"@#O++Q;
MI-ZFI-YD]L=-(^U)=0/$Z!AE6VL,D$=/6IK'Q'8WVKRZ3B>WOXX1<>1<1%&>
M(G =?49X/<'J!7$Z[X=U?5]3\:K:6;I]NMK$V4DX CFD@9G9#Z G"\X!R:WO
M"V+V\%ZW@Q="GCA,<LL\40D9B1\D90DE."23C/&!UP ;.M^(]-\/"T.HR2H+
MN=;>$I"[@N>@RH.#P?KVS6?_ ,)SI)M_-$5]O6V>[E@:U998858J7=6P0,JV
M!U.. :@\<6EY=GP]]CLYKG[-K$%U-Y0!V1)NW-R?<<#FJ'BFWUJ^UJ_LUTNZ
MN-/GTHQVLEJZ1@SG=D3,6#8 *X'(Y/!/0 U+GQE GB'1--M;:>XAU.W>Z2YC
MC)4Q@*1C_OM23V'UXM7/BW2K2XA29YE@FN?LB77E'R?.R1LW>N01GID8SFN4
MTS3M9M;CP#=OHMUBQTN2QNH]T>Z%RD0#-\WW<QMTR>G&>*AT#2+O3V?P]J7@
MR&]EBNW>WU=XXG@>,R%UD<D[@ZYQM )) Y'6@#TN:6.WA>::18XHU+.[' 4#
MDDGTK'MO%6F7-]9VI,\+WR&2S:>(HMP ,G:3WQS@X..<4_Q7I$NO>$M6TF"4
M137=K)"CGH&(P,^WK[5S36&I>(X?"4%SIMQ87&DW<=U>M* %4QQLNQ"#\X9B
M.1QM!S@X% #;*]N?%GB77+0W6K:?_9UW"EJ\&Z-4 C5V$@/RMN+$88'C&*W_
M !3XF'AS^RU%I/</?WT=J#&A8)N.23[X!P/6J/A2VO+?Q-XJGN;*X@AO;U)K
M:21>)$$2(3UXY4\'%2>.K&^NK?0[BQLY;LV.KP74L417>8U# D;B 3\P[T 7
MM2\5Z;I4,\UR+DPVRJUW)' S"V# $;\=.""0,D @D $5!=>-]&M;VXLU-W<W
M,%NMRT=M:22%HVSAEP,,.#R./?-<P]A>Z=XGUA;_ ,&?VW9ZO*MS!,JPOY3&
M-4:*7>>%&SJ,C![UIV5A>67CK4+MM-=+/^Q;>TC:WCQ&9$9R40=0,,,<8H Z
MW3M0M=6TVVU"RE$MK<QK+$X&-RD9'!Z5:KF?A[97>F> ='L+^VDM[NVMQ%+$
M^,JP^G!KIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ***S-<U"[TZSBDM+9)6>=(Y))'"QV\9SNE
M?D9"@=!UR.G6@#3JMJ%C#J>G7%C<&00SQF-S'(4;!]&'(-<1-\0KN+PKK.JQ
M6-K<RZ7J2V+[)BJ2JS1A9$X/_/4<$]CS6@WC&YTK6-7L]?M;>"*RTW^TTEM9
M6DS%N964Y ^8%>W!S0!NV%OI7A^WM=*@FCA,A(B2:?=),W5CECN=N"2>>E:$
MLT4$9DFD2.->K.P 'XFO.]5GU&]\6^ ;Z]MK2)+BYED58R3)#FV<A"3][@]1
MCD=#UKN=5T>PURT6TU*V2YM0X=H9!E'(Z;AT(SS@]P* )H+ZTNG*6]U!,P&2
ML<@8@>O%*M[:-<&W6ZA,X)'EB0;N/;K7(>&M!TZT\0>(=0T+3+"Q$:KI]N(8
M1&C.@WNQVCD;W"G_ *YUD^$[)_#WBZ#3O$&@:4NKW<4DEMK=BF3=L.9 Y8;E
MD(.X]CSB@#TGSH_.\GS$\W;OV9^;;G&<>E$<L<R[HI%=02N5.1D'!'X'BLC2
MXTU"[U6_E17BFE^R1AAD&*+*D$?]=#+]1BN)T&^ET'X&:I>6 $<MH-1,&T?<
M(GE"D?3C\J /2HKNVGFEAAN(I)8CB1$<%D/N!TH-W;"[%H;B(7++N$)<;R/7
M'7%>=7J#0+'X<SV0VRM=PV,C#K+'-$QDW>N64/SW&:Q5NYI_@9J/BEFVZM)=
MRZB)_P"))4N2J 'T"H$QZ<4 >RT5D:WJ\^E^%+W68;9)I+:T>Z\F20H"%0L1
MD ^GI7.VWC35X=4T$:OI5K!IFMH%MYX;@N\4NS>%D! && .,$X]: .YHKB;7
MQMJ%\VD7MEI$USIFI3"/]W;3!X(VSLF9BNPKTR!]W/4XJ"W\<ZK]DU;5;W3+
M.#2=(N;N"\=+EGE/E#Y3&-H!R<#G'7VY .]HKFGUS6--D>YU?3H5TM+&2[FN
M+>3)MF09,; \OD9PP Z=*J6?BG6+C5=.A_L:22UOX7<2K#,BVKA=RK([)@JW
M3<._8T =A17GVF^/=7NM,\/:M<Z59Q6&J7PL75+AFE1V=U5@-N-N5YYR<YXK
M3\*ZGK&H>)?$\-]);M;V=ZL$2IN!0>4C #/^\23Z^U '622)#&TDKJB*,LS'
M  ]S2-+&C(KR*ID.U 3C<<9P/7@&N5O[YK_XEZ?H+'_1K33WU.5>TDGF".//
MLOSM]=I["J_BVWA_X3OP/<^4GG_;9T\S;\VW[/(<9],T =?<W5O9Q>;=7$4$
M><;Y7"C/U-2@@@$'(/0BN+\YM0^,<EI< -;Z?HPEAC89 DED(9\>NU0OT)]:
M=\-;F231M6L6),.F:Q=V5OGM$CY5?H V![ 4 =5+J-C;R&.:\MXY!U5Y5!'X
M$T^2ZMXH%GDGB2)L8D9P%.>G-<3XT\(^'I-,NI#HUC/J^JSK;1W4\"R2B25M
MNX,PS\BY8#L$I?&GAW5;F#3ETS2-'U72M/A(.E7VX&4@ *4/W0P4$#=_>- '
M2ZU!HFKZ*8=4F@:PE92)#/Y8W@Y4JX((8$<$'/%,L-"L-'S=/=7DYB4D37][
M),(QCDC>2%XSSUQWKE%MDUO3?#FLZ#I6=)2PNX?[-0)&8GD4*/E)"\%70_[W
MIFK=BPL=#TC2=7N@]OID5M;W<B@O]JN]JA(5 &6 .&/'/RC^\* .CUW1[#Q#
M:KIM]-($#I/Y<4FUB48%6]<!@#6JH*H%+%B!C<>I]^*Y#QCJD4O@2X\1Z3,K
MS:<#=V\@!!!C;$B$'D9 =&!]3W%;UUJC)X<EU:TA68BU-S''(^P,-N[!(!QQ
M[4 :5%<!:>.M9"^&;_4M'M8M(U[R84DAN"\L,TB;DW*5QM)R!@DCOSQ5D>-K
MZY^QWVGZ3->:=<7GV=EBMIC(L>XKYV[;L(R,[?3OGB@#MJ*Y'1?$>O:SK-_;
MII=A%9Z?J3V=S(;IBQ41JP9!LY.6&<XZ]^36KKFJ7>GSV<<$<$<$V_SKVY;$
M5O@#:",@L6)P,'L?I0!+8:#:Z=J^H:I#).USJ!0W&]\JQ0;5P,<8'''XYK4K
M@HO']_<Z!X;U*WTJ!GU:_:P=&N"OENID&1\O*GRCSU&>AIM]X[U;3-#\4S7.
MF6;ZAH,B!TCG812(Z*ZL"5SD!N1QTZT =_534]/AU;3+G3[AI!!<QM%+Y;8)
M1A@C/;(-<_%XCU=?%,VB7EC9Q-)I[W]H\<K/@*ZJ4DX'/S Y''7K56T\;W5U
MHOA'4_L4*IKTZ021[SF$LCMD''/W,=NM '5Z=8Q:9IUO8P,[0V\8BC\PY(4#
M &>^!Q5JO/;SQWKD&D>(M332+'RM"O7@G0W3$RQJJ,=IV_>PQ//'0<]:VK3Q
M'J0\7VVCZA96T4%]9R75K)#*6==C*"K@@#.'!X]QSUH ZBBBB@ HHHH ****
M "BBB@ K*N?#6B7EP]Q<Z5:2S2'+N\0)8^YK5HH Q?\ A$?#O_0%L?\ OR*/
M^$1\._\ 0%L?^_(K:HH Q?\ A$?#O_0%L?\ OR*/^$1\._\ 0%L?^_(K:HH
MQ?\ A$?#O_0%L?\ OR*/^$1\._\ 0%L?^_(K:HH Q?\ A$?#O_0%L?\ OR*/
M^$1\._\ 0%L?^_(K:HH P9O!7AJ=0'T6SR#E66( J?8BI/\ A$?#O_0%L?\
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M\N-O1FQA3]30!TM%1V]Q!=V\=Q;31S02J&22-@RL#T((X(J2@ HHHH ****
M"BBB@ HHHH **:CI)&KHP9& *LIR"#W%.H **P)?&WAV!E6340-TQ@4^4Y#R
M D%%.W!.0>!Z4X>,=!+0*+[+3W:V2+Y3Y\X@$(>.#@@\XXH W:*** "BBB@
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MU>61/,M7&>4(4<<G@YZFLKXG>'[ZW^$^H:?'=:GK>H320*'>/S)&"R X"QJ
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MD;*8Z@8( --C^&]A;Z58VEMJ>HQ3Z==275C=AD,EN78ED&5PRG<<A@2?6@#
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MA6&-YMN[:HP =H Z#TJOJ/AZ/4=?TK6&O+B*73?,\J*/9L;S%VMNRI/3T(H
MY*U\9ZI#IWV&ZFAFU%O$3:)'=^5M4K][S"@.-VW(QTSBGZYKFL:=>^(- :_=
MG71)-4L;Y8U$L>PE61@!M)S@@@#@^HS6JW@#3Y+&_MI;Z]=KK4?[42?*![>Y
MXP\9"X&,#@@]_6M >%[>=KZ;4+B6\NKVT^Q23,%0K#SE5"C R6))Y)..P
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MA$:'H\4>J6-@VH1W,TPFA._EY&8')4$, VW/H.N*VKCPQH-W/=3W.BZ?--=
M+</);(S2@$$!B1ST'7T'I52T\:Z#?:1'J=O>EX)+D6BIY3B3S\X\O81N#>V.
MG/3FDF\;:#;:5/J4]S-';6]S]DG)M92T,N0-KJ%)7J.3QR.>: -2/2-,AOS?
MQ:?:I>%!&;A85$FP?P[L9Q[52B\(>&X)O-BT'34D$OG!EM4!#\_,..O)_.K5
MWKFGV-PL%U,T3M;R71+1-M6),;F9L87&1U(ZU03Q)I^KK/965U<07C6?VN(M
M 8V,1X$B[UP1G'TR,B@"WI&A6FCW&H3VT,,3WT_G2B&,(I/K@=2>22>23Z8
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M!4'YB 0!UYR.E/T34[&QEU2Q;5=1O)+;%X8KNVD\VWA<?*H)7<XRK>K#H>E
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M3]Y\I;)&W*C:"<G XKG9?&.GZ+X;N=3M;K4=51]4:V!EA;,,C2!2F-H(1"<
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MJ3Z=+-/)>K;BY$$%K)*SQDX!4*IW<^F<8.>E:6EZG9ZUI=OJ6GSB>TN$#Q2
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M=PL.]%8@]?,;<Q]05JKH]IJ4GC2QU%M)U989M"DM9)KL*NV8R(V"N["#@@
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M'@Y;@DBFZ;:ZI;:QX*OI-'O?+AT>2QG7:NZ&0B+&_G@'8W/]>*]&I&8*I9B
MH&23T% 'D>H:?K*>%/$>A1Z%J$UR^NF]C=(QY<D3722@JV>3CJ.V#G%=;HD-
MRGQ'\17DME<Q6]W:V:0RO$0K-&)-XSTXWCV/;-=A37D2,9=U4'^\<4 >5W>C
MZI<^"/&=M%IMT;BXUPWMO$T95IHO-B;*YQG(1N.OYUT'C.&^DLM(\3:3;F+5
M[&X58H+@A3+',PC:)L9QG<K>Q4=Z[1)$D^XZMC^Z<UC3:+IC>*(=2N+J=KUD
M_<VLEVWE948+K%G!8!NN.,^M &AI=@NEZ7;62N7\I &D/5VZLQ]R<D^YKD_'
M<%W/K/A66UL;NY2RU,7-P8(2P2,(RY]SDC@<UV]1BXA:X>W6:,SHH=HPPW*I
MS@D=0#@_E0!Q/B?3K_QQ=:9ID=A/::-;W<=W>75R C2A.5B1/O<GJ2 !CC-8
M.OVVN:A'J*2:%J!GM]=AN(4M558'MUE0B08(\QRHR2<D>P%>J27$,4D4<DT:
M/*=L:LP!<XS@#OP,U)0!YQJ.B:KJ&K>.+%+&XA&N:?"MM<G;Y:LL+(59@>#N
M(&!GKGI5WPP_]H7=G<77@NXTW4K*-A-<7*+M1BN&6!MQ+;CWX&!R>E=U02 "
M2< =30!3TF^?4]+@O)+*YLGE7)M[E0LD?.,, 35RHX9X;F%9H)4EB;[KQL&4
M_0BI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *XGXN11R?"S7BZ*VV ,NX9P=Z\BNVKG_&VA77B?
MPE?Z):RPPO>($,LN2$&0<X'7I[4 4KO7KS2-7T/0-.TFVE%]:2O"[7'E*AB"
MY! 0X'SCD9/M6+?^--9N_#^G7%I:VUK>?\)!'I5ZAF9E#+.%8(VW[K8Y)&0"
M>#6_-H.IW'B70-6=K11IEO-#)&'8^89 @)!V\8V X]_QK)/@;5#HUQ;B\LUN
MO[>_MJ!L,R9\WS/+;H<=LCKZ"@"_JOC&[M6U&&PTY;NZTR-3<0J9#YDA0.8X
MRJ'G:1@G&20,5#+XQUFYUI-,TKP_')-+ID>I1B[NC"P5GVE'782K#!XY_"EE
M\->);#Q)=:KH>K:>B:DD?V^&\MG91*BA/-B"L",J -I/;K5ZV\/W]OXW36FN
M8I;<:8NGD.3YK%7+^83C&23C'XY[4 4+KQW.J_;+#29;ZQ2]-JXA21IBJR&-
MI% 0J0&!XSR!G(Z5<L_%KZCKMWIUG%:M)9WGV:XMWG*W")Q^]V8Y4Y&/;G/:
MJ>F^%_$6BZA=V>GZQ:+X?N;E[D)) QN;?>Q9TC8$+@DG!()&>AJ34/"%SJVM
M65]>"R6>QU#[3!J$.Y;@0AB1 1C!!!VDYQCMGF@"3P5J^KZM-KS:DMOLM]4F
MMH_*D8[0@0!0".G?.>23P*N:_P")XM%U;3=.=[6&2_64Q37<ACB+)MQ'NP?F
M;=Q]#UZ4>'-!O=#U#63)=02V5]?27L2K&1(K2;<ACG&!CC YS4GB'1Y]8V6[
MVNGWVFO$Z3V=[D!F)&UU8 X(^;MWZC% '+ZG)?'XA^%KR+38$U6XTBZ,L+R[
M51OW)PSA22%)(X!^@S6MI_C"]U'0;:\32T2Y-]+97>9LPVIB+AY&? )7Y..!
MRP'%0:7X-O\ 2=2\.3)>17,.CV$MFQE9@\N_:<C@X V  <\=ZJ0^"-;M[>U\
MJ^L2]OK$^I&&57:&42ECM8<'*%LJ?4 \4 9_BO78_%/PKUBYDMH5ELM22U)1
M_,0LEQ&-Z-@<$']<5NM%&GQKAD6-5=_#\F]@,%L7$>,^M49_ FL2^&-?T@ZC
M9.VJ:G]N27R63R\R+(P(R<\I@#MG.370?V)?MX[@\0,UL($TUK)H0S%LLZN6
M!QC@KC'X^U &9\5HT;P%<2-")'BNK5DX&0?M$8X)Z'!Q^-*_CBZTC6+NQ\2Z
M7%8QI8RZA;SVUP9EDCC^^IRJD. 0<=#GKZ[/BW0I/$GANYTN*X6WED>*1)'3
M<H9)%< C(X)7'XUGWWA)_$5S/<Z\85+Z?+81PVK%EC67'F/N8 ECM7 QQCOF
M@ T_Q5?W&OV-A<:1(+:]A>1;B%9&6W=0#LE+( ,CH0>HQCO5WQ=XAF\,Z*NH
MPV(O!]HBA:/S=A'F.J C@Y.6'''UJKX:TKQ38""VUO6+*[M+-=D+V\#)+/QM
M!E)8C@=@.3@YXYI_%0L/!#;'1'-_9[6<9 /VB/J* '0^,=4M]=OM'U701'>)
M8/?V26=QYPND4X,>2JX?) QTY_.33_%U[>:[/HGV.R:_73OMJ+%=$JK;MK0R
M';E6!(YP>O04FK>%+_79[Z^N+R.QOI--DT^T:U9G\C><M(6(4DDA1@ 8 /)S
MQ6L?#^HZ+K5KXAU+4-*M[2RTEK.XC@@9$C16#[E);@?+R2.!QCO0!<TKQA<:
MOX?TN^AT^)+Z]NS:R6;3G,#*6\P%MO50C'&!GCGD5%=>-+FQU6QM[O3XH([S
M4S81PO/BX"Y8+/LQC8Q7UZ$'/:H_"NFZ?=>*M9\1Z7=>?IMRP\C808C,RKYT
MB$=<[8P3_>5QZU1/@77O)@A_M6P?[-K0U2.>2W=I9OF8XD.X9(#;1CL ,C%
M&=INJ:KX=F\;76CZ';WEI:ZN\]PAN/);8((BPC4*<MC)YQ[9)XU$O;*_^)F@
M:S;A5AO/#\]QYA4!BA>%AN^@-7QX6U6"3Q%;VUY:_9-<F:9YF5A+;EHUC8*O
M(?A<@DC!/(-2KX1:W\1Z5=6WD#3+#3'TT0,S;RC;.<XQP$ ]\T 06?CBYO+G
M1YH=(FFTW5'"K)$DAD@5AE))!LV[3QG!^7(Y-=%KNL6^@:-<:G<JS1P@81/O
M.S$*JCW+$#\:YWPQX;\2:"EOI$NLVD^A69'V9A PNC&#\L;-G;@<#(&2!CC-
M;7BO0%\3^&KS23<-;/,%:.91DQR(P=&QWPRCB@"B?$.K6_BBPT2[T^S#WUM-
M<1R17+,$,>W*$%!G[X^8>_%4;7QY/<^&_#FL?V9&JZO?I9/%]H),)9V3<#M^
M;[N<<=:H(NLQ_$OPLNNW%C+=_8+X8LXV5/\ EES\Q))/X8Q20> ]=@T?2=(7
M4]/%II.J+>V[^0Y>1 [. _(&?FQ@=>N>Q -35?&ESI-ZBW.GQ16[ZG'8)'+/
MMGE1V5?/5<<IN;&/09R.E.7Q/KMWXGU31[#1+20:;- LLTMZ5!CD7=N V'D#
MM['DUEWO@77;B/4(5U6P99M7CU.*66!S(=LBN(W.[[JA<#';'2N@T70[_3_%
M.N:K<RVSQ:GY&%CW!D,2;.<\'/7VZ<]: ,+PWXRU$>#[34-6CAENK[49[6V$
M3N=S":7@C:2JJJ'&-Q(7UI]_X_U+3='UJ[FT%F?3)85#EGCBN8Y2 &C+("2I
M.&7]>:C7P!JD?AF/3(=7@AN=/U%[_2[E("=K&21\2@GY@1(RD#''//2KFL>&
M_$GB#PE>Z=J6H:=]NNC$!Y$;K!"J.'R 269B1@G(XQZ<@%'Q*U_<:IX2GU73
MK:TN$\1".$PS>:6A,$A!+;1@D]1_LUL0>+YUNO$EKJ%C#;3Z/&)D59R_VB)E
M)5Q\@QD@K@9Y&/K8\0Z)?ZS<:#/$UM&=.OEO)59F.\A&7:#C_;)R?3I61?6^
MD>*O'FFW&FZ@DTVFB2/4EMW#*45U9(I,=")5# >BO0!VEF]Q)9PO=PI#<,@,
MD2/O"-W ; SCUQ7"S^,6TC0_%VK6^@6B3Z5?F.=(Y]OV@[(_WA8)RV&'!'0=
M:] K@;_P1JE[HGBS3Q<V:'7;O[0CY8^2-J+@C'S<1CTZ^U &U8>(K^3Q@^@Z
MCIT-OYED;ZVDBN#(2@<(RN-HPV64\$CW-:>M:A=:=9QR6ED;J229(B-VU8E8
M_-(Y[*HR3_DUFC1-0?QQ:Z^[6RQ1:<]D\*LQ8EG5RP..Q3&/?/M4GBW1+[7+
M"SCL+F&*2VO8KIH[A2T4ZIG]VX'.,D'ZJ* ,&X^(DT'AG7M4BT^VNI-'O%MG
M$-U^[F5MF'1MI_YZ#Y?8\U:OO%7B+3M3TVPN/#]GYNI74L%OMU D!5B+JS?N
M^.A!QG&#@'BL^_\  FMWFF>)[,ZE8'^VKF*X#>2Z^4RB//&3D?N\ >^<]JW]
M:T34=3UOP]J,;6L?]ES/-*C,QWEXVC(4XXP&)R?RH S[GQEJ<,%W#'I,4FIZ
M? DEW:I)(X,K+O\ *1E0Y.W')Q]X#U(=JOC6\LM+DU)-)^SVT>G+??\ $PD,
M#2.0Q-NHP?W@"G.>A(XYS3K[PYX@M/%=WK7AW4[&*/44C6]MKZ!I%#(-JR)M
M8'.W P>#C\J^I^#=8N]0U)XM6MY(+_2AI[/=PL\L)PP9DP0 'W9/N!UP!0!+
M=^,M3?4]-L=(T:&Y?4M,:_MVFN_+ QL^5OE./O\ 49YQT'(GL?%TVH:S<Z;!
M!9BZM+E(+JT:X(G12%)E5=OS*-W'J!G/:H=,\+:M9ZUX?OKBYLI5TS36L) @
M92^[9\PSG&-@^N3TZ4NJ>$+G6=5M+J\%D);._6ZMM0BW+<I$'W>2>,$$94G.
M,'H2,T =+JMQ=VFE75S8VJW=U%&SQV[2;/,(&=N[!P3]*Y>V\>FYNO"8^RVP
MM?$,+.LOVDYAD5 Q3;LY[C.1R*[2N"E^&R_V-J=G;Z@T4TE\+O39@O\ QX@2
M>:JJ/]]I/P8#M0!9UGQ"XL=.N;O1+.ZMI];BM(2\V[9^]V). 4ZY!(P?0YYJ
MK+J6J:GKWC72KV&TDTVSLXE1-Y. T<C9VE<$DXSR,8'7%;'B+PU-J.EZ/8::
MT$,6G7EO<@2D\K"00@P.^,9[>]0R^&=33Q!K^H6MU:>1J]K'&\4B-N1T1D&&
M'&WYL],\8[YH Q/!?B*_T_1? ^F7.G0K8ZEIZ0P7"W!,@=(-^63;@*0IQAB>
MF<=!-)XR;2?#WBK5[?P_:1S:;JC6\\44^WSVQ&/-+;.6^<<$=!UJU:^#]3M[
M;P;"9[0_\(\,.<M^_'E&+CCY>#GOZ>]5[WP/JMWX?\4:8+FS1M:U#[8LF6(A
M'[OY2,?-_JQSQU]N0#;T_P 17\OB^;0-1TZ&W8V?VVWDAN#)F/?L*N"HPP)!
MXR.>O%0^/M6U/1]#M9M,\D22W]M;R-(Q!"O*JD# /7.,]AGK4ZZ)?MX[B\0.
MULL*Z:;)H59BV2X?<#@#J,8_'VJ;Q=H4_B'0Q:6L\<%S%<PW,32J63='(K@,
M!S@XQ0!R\IU*V^*U^^FZ=9R7\N@0/(KSF.+=YTG)8*23P /E[<XJW'X_O+ZS
M\+3Z=H\<IU^.0HLMUL\F1(V8J?D.5R/O=<9XK3@T/58O&4^OR2V<OF::EEY8
M+)\RNS[NAP"6(QSP,Y-8^C^!]5TNV\(0FYLI!H!EWMEAYX=&3@8^7 ;/?.*
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MF1SQ[5.\''')88Y^[UJK?ZU(VOKH%C!#-=FU-U,9V(2./=M7. 22QR,>@)]
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MR6B1<G!R,9)8DD>@'.,T 9WPZU^37_!UL]TZMJ%FS65YAMW[V,[2<]\C#?\
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MLAOQ<8NYUMH##"TF^5L[4PN3DX--A\5:5)JD.F2R36E]."88;NW>$RXZ["P
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MW@<G'3'!S7&2>(=8@\"Z'XRCOY)I;F6W:[L\*8GCF<*8T&,J5+#!SGY><YH
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M7C7%CXB^QQQD)L:(*#AOERWYUV6JPW%U^T7I]L=1O8XAHYF14D "$LP(48P
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MY6=N[//H#@XX%7K7PY:V6K:CJ<%Q=+=:CM^T,9 0=J[5P",# ]/QS6FMS;O
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MM6&N6KW.G7"3PK*\6Y2""48J2/;*G![T 5?$6BMJJ6%U;[1?Z;=+=6Q8X#$
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M6TY\W.8U!"@9'& QYZ\GO5*Z^'VB7.GZ7:AKV!]*3R[*ZM[EHYXDQC8'')&
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M\BDV0S+YP# @-EE.#@LN#CCJ,VI]#U6[UCPH[6$T4%EIUQ:W<GFQYB:2-%&
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M7EWIZ3VZZE&S12W)+!H/,#*JE<+UY.\''&" =]4<D\,4D4<DJ(\K%8U9@"Y
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MDB,WSJ3)QP/E[KQR<5;L;Z\T7PIX$N&@TVY>[>RL1*UL5>&&2-3A3N//R]>
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M7&_"C/\ PK+1=P .R3('0?O7KLJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P_%&@2>(]/M[2.\6
MU\FZBN=YA\S)C<.HQN'&0,UN44 <QK_A2[U/5[+6M+UE]*U:VB-NTRP"6.:(
MG)1D)'?D<\>]32^'[YH8HO[5CN$:&2.[COK43)<LQ!W%0R@8P0!TP<5T-% '
MF$6EIH'Q \,:+IFHQ1FRT6> -<IYF[+QD*0&7!."0 >WI6Y>_#^.?3H_LNJ3
M6FLQW[ZDNI1Q@GSW&&RAX*%<+MST Y/.>SJIJFI6FC:7=:E?2^5:VT9EE?&<
M*!Z=S[4 <WJ/@JYU?18HK_7KA]8@N4N[?48X53R9$R%VQ]-N"V02<[CSTQ)?
M^$+O5_#%[IFJ:Y)<7MT8R;M;=46,QN'3;&#C&1DY))R>>F+T7B.7[=86MWHN
MH6GVYRD,DGELH(1GP^UR5.%/^-;M $5K'-%;1I<3^?,!\\FP+N/L!T'M^IKC
ME^'BC0CI9U:7;;Z@=0TZ585#6DOF-("?[_+L#G&0<<=:[:JFFW5Q>6?G7-C+
M92[W7R965C@,0&RI(Y !_&@"C8:$\6MR:UJ%S'<Z@UL+5&BA,21QAMQ 4LQR
M6P22>PZ=Y-5TN[O[B-H;R!+?R9(I[6YMO.BF#;<$C<O(VD?1C6K10!QL7@,Z
M<OA\Z1JK6LVCP26P>6 2B6.3:6&,C:<J"#SCI@U6/PW9=)%O%KMQ'?P:G+J=
MG>B!<PR.S$J5Z."&((XS[=*[.^O8--T^XOKIPEO;Q-+(Q[*HR3^0J'1M6M==
MT6SU6R8M;7<*RQYZ@$=#[CH?<4 8.H^$+_5=$2SO==,UV;J&YDN6M0%/E,&5
M%0, JY'/)/)Y]+]KX?FM_%]WK[WJ/]IM([5H! 5P$+,"&W'G+'MZ5>UK58]$
MT:[U2:":>&TB::58=N[8H))&X@'@>M8C>.K:#1;?6KW1]5M=+FC27[4Z12+&
MC $,RQNS 8(YQQWH U-4TN\N]1LKZQU+[)+:I(A1X?,24/MX89!P-@/!!]^Q
MR;CP-;ZK_;,NM7(N;G5;9+21[>+R5BC0DKL!9CN#'=DD\@= ,5NR:B[/IS65
MJUY:W9RUS#(NR)-I97.3\P/ &,]:OT <I9>%]:32[FTU3Q/)J+O;M;P.]HJ"
M,,,%F"MEWQQDD=^.:2\\&2W?P]@\)G4U58H88/M0M^2D94K\N[K\HR<^O%="
M;JX&KBT^PRFV,!E-YN78'W >7C.[..<XQQ5+7?$":%+I:26DTPU"]CLE="H6
M-GS@MDYQP>@/X4 96H^$-0D\1'7-'\0/I=W<0I#?(+59H[@)G:P5C\K#) .3
MQ^.9=6\)3:I8W6FR:DDFG7-HMO)%=VWG,&&[,JMN&'.[.<'E0:ZBB@"M%:FU
MTV.TM9-IBB$<3R@OC P"1D9_,53T?29=,T%=.FN([J0!]\S0[1(S$EF9=QR2
M22>1G/:M1B50D*6(&0HQD^W-9/AK7X_$NCC48K:6W4S2P^5*06!C=D.<$CJO
M8T 5?!OAN?PGH,>COJ/VVWA9O()AV-&I).W[QR 3QZ"HM1\,7MUXPM?$5MJD
M$,MM:O:I#):&12K$$DD2*<\#TKIJ* .?LO"R1^(#K^HWCW^J"(PP.R!(K9#U
M$:#IGN223TSBG>'O#C:);ZG!/=)>)?WLUXX\G8%,IRRXW'(K>HH P/#_ (7B
M\-^&FT>RN6;[^V:9=Q /"@C/(5 JCD<**QH?A[+9Z9X=2RUDP:EH*M%;79MM
MRR1,,,DD>[D$ =&&,9%=C+=1QRF '?<>695A4C<RC XR0.I Y(JAX9UZ+Q-X
M?MM7A@D@CN"^(I2"R[79><<?PT <[+\.S=VNLI>:U,T^HWD=]'/!"(S:SHJA
M73DYQM'!/3WYJQ>>#M4U;POJ&E:OXD:\N+V+R#<BS6-8TSD[8U;&X]R2>@X%
M=A37=8XVD=@J*"68] !WH YN[\)OJ&O6^HWEY%)$FG2Z?+;BW($J2;2QSOX^
MZ/UK*A^'^HQZ?HVFOXE:2RT>\CN;,&S7S0B!@J.V[#8#8!"C@=#VU8O&22V-
MIJ*:/J)TV\DB2"Z C(82,%1RN[<JG<#DCIU KIJ *.L6,FJ:->6$<ZP&YA>$
MR-'OVA@03C(YY]:A\.:0^@^'K'27N1<BSA6!)1'L+*H &1D\\5J54L[JXN)[
MQ)K&6V2&79$[LI$Z[0=XP>!DD<\\4 <>/AW=);6]JGB&46]IJIU.V!M5+*Q=
MF*NQ/S\N<'CW!XJ22/2?%_C73[NT^T.^AO-'=RF)XT9@5VQ'<!OPZB08R 4'
MJ*[>B@#"?P_.?&9\0I?1J?L!LA T!( W[]V[<.<^W3\ZQH_ ,\?A;3]#&KIM
MLM0%^LQM.683&8*1OZ;B?P_.NV)P,FLGP[XBT_Q1I7]HZ9+YEOYTD.3URC%?
MUP"/8B@#%'@N_M=<OKO2_$=Q8Z?J,OGWEDMNK[I" &:-R<QEL<\'^6+!\)3C
M4O$5W'J,:C6;:.W*&V)\D(K*"#OYX8^G.*Z65VCB9TB>5@,A$(RWL,D#]:Y3
M3O'T.J>'TUVVT#66TU@Q\T)"S *Q5CL60N<$'H">* "V\%36K>&I(=6*3:):
MM9[Q;C]_$RHO0D[6_=KSSWXK:\1:2^N^'K_24N5MQ>0O \ICWE58$' R.<&F
M1Z_#?Z)::KHL+:K;7+H$,#JOR,V&8[B/N\Y'7C%:] ')R>$+Z\\/0:!?:X?[
M,CA6WD6TMO)DFC4 ;6<LV 0,': 3SR*DN/!^W7+#4-*U Z?%;6!T\VRP*Z^3
MN!&S)^1A@<X.<#CBMVYNKB&^LX(K&6>*=F$LZLH6 !<@L"<G)XXS5+Q1X@C\
M+^'[G5Y;2:YC@V[DB*@C) SR1QDCID^U &!9?#^:PTOPY;0ZY)]HT*1S#.;9
M2&1T*%=N>N&X))Y[=JFB\$WMEK-]-IOB*XM-*U"=KBZL! K$R-]\QR'E-W?
M/4XQ78T4 0W43S6DL,3K&[H55F7<%R.N,C/YUR=EX%FLK3PO;KJJ,OA]F,9-
MKS,"A3GY^/E8]._Y5V58^B>((]:O-6MEM)K=]-NOLSB4J2QV*V1M)XPP[T 1
MZ%H$NC:CK-V]XLXU.Z^TL@AV>6VQ4P#N.1A1^M9^K>#)M2UC5;R'6)+:'5+
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M>*X@<20RH'1UZ,I&01^%24 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZU;AM2\4ZMXITZWU,V%WI\Z16S+<R1M;J8D=92BD!P6+?>Z@8Z5U$/A#0X!
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M^C$5T92TAF4#&&+$YX_.K&G:#IVE.'M('#K'Y*O+,\K)'_<4N257IP..!Z4
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M)KV*P\/W4\NLQZ/\N%O9%5A$?96X8^U)>^*-#TRYDM+S5;:.YBA\YXBV7"9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.&![C@C/% '4D@#DXHKS'QGK/]O>']'U"UL-VG/K5H+>[,OS$"=1OV8^XV"
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M72M/N+Z\D,=O;H9)6",Y51U.%!..M/L[N&_L;>\MV+07$:RQL1C*L,@X/L:
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M@!MXV<Y"CICI5>R\#V-E9P:<MW=2:1;W N(+"0J4C8-O5<[=Q56Y )[#J.*
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M ;O-&%/)VYR,"C2M3UWQ)ID&N:7>V\,1OWC:SG0>6;:.5HVRP!;S"%+#D 9
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M9?/)8L[;@0Q;>V01CGZ57?X?Z?/;:_!<7^H3KKBH+HO(N0RHJAEPO!^7/IV
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MMGJMM"8&OK>1!)/&3N*R KM(R21A1B@#'EU;QG+J?AO2;BXLM,O=1LKIKK9
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MD4,QMWC6.3IR2A(;';#5LZPFGZ?9Z*VHVR17NK:K]I(E81PK*4=E$QQ\P1<
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M.] ';JZ."596 .#@YP:IZC->"S+:7]DDN Z9%Q(50(6&XY4$YVYQ[XKS#7-
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M3A"!@H#D#V''&*Z"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "H+FSM;U EU;0SJ#D"5 P'YU/6=J
M^NV&A1VTFH221I<SI;QLD+N#(QPH.T'&3QDX% $]MIMA9N7M;*V@8C!:*)5/
MZ"EN=.L;R:*:ZLK>>6+F-Y8E9D^A(XJG#XCTV?4M1T]))OM6G1K)<HT#@*K
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MH>*]*":AYCSQRZ=&);J![=_-1",AP@&67@\KD<'TJ>'Q!IUQ9:9>0R2O!J9
MM66!SORI8$C&5&T$Y..E %HZ98&T6T-C;?9E.5A\I=@/J%QCO1)IMA,D22V5
MLZ1<1JT2D)]..*Q-)UW2(M-U;4!JMW/;0W\B3-=HP:&3*CR44J&P"0 N"23@
M9K,L=>EE^)^H6\EW=Q6$.C+</;W2>6D3^:06&0.-H'.3W&>H !UATG329"=/
MM"9?]9^Y7Y^<\\<\T2Z5IT\,,,VGVLD4)W1(\*E4/JH(X_"J5KXHTRZU2/3@
M\T-S-"9X%GA:,31CJR%@,XR,CKSG&*YKQ%XH%QJGA,Z5>7B6]YJR1,RQ%8;F
M+8Y.&(Y&0N.<$<C(YH [::QM9YDN)+2"6>/_ %;N@++Z8.,BN>\*^%3H[7\V
MH6]A+=3ZA/>13QKN=!*Y;;DJ#QDC(Z^U=37%:UK4VD_$G38I;N[:QFTNXD-G
M%&9-TBO& 511N8X)]<<]!F@#K)=.L9Y9)9;.WDDD3RW=XE)9/[I..1[4#3[(
M7"W L[?SU "R>6-P XP#C-9]OXJTB[T:UU6"Y9[>ZD\F!1&WF/)D@H$QNW J
MV1CC!)X&:@F\::);:;J%]<3S11Z<X2]C:WD,D!/(+( 3@@Y#8P1WH W)X(;J
M!X+B*.:)QAHY%#*P]P>M0-I>GLK*UC;%6548&%<%5^Z#QT'8=JK)XATY]=CT
M8/,+Z2W^U*A@< Q9 W;L;>I QG.33%\2:?);131?:)6F:18HDMW\Q]APQ"D9
MV@_Q=.1SR,@%P:5IP>-Q86H>(8C80KE![<<4L>F6$44L4=C;)',,2HL2@./<
M8Y_&LB+QOH,T6FR1W4K)J,QM[<BWDYE&<QM\OR,,'AL=#6A-KEA;RW<<TKH;
M38)28FQE_NJIQ\S'( 49/(XY% %JULK6RM_L]I;0P0_\\XHPB_D.*BATG3;=
M46#3[2)4W! D*J%W8W8P.,X&?7%9,WC?0[6WU*6ZFN+=M,57NXI+:3S(U895
MMH!)4^HX]<5H:3KMEK?V@V1G(@<*S20/&&R 05+ ;@0>HR* )?[&TORA'_9M
MGY8.X+Y"XSZXQUJPMK;I<&X6")9B@0R! &*CH,]<>U5M:U2/1-%O-3FBEECM
M86E9(5W,P SP/Z]JXF\\53S:EX%U(W%W;6M_YINK58F"R'[,S@!=NY_F(QC.
M>,<T >@S0Q7$+PSQI+$XPR.H96'H0>M0QZ=8PV9LXK.W2U/6%8E"'_@.,5E0
M>,M%N-)?45N)4C2Z%DT4D#K*+@L%$6PC=N)(XQWSTJCK?CRPTWPOJ^K6\,\\
MVFN89;8Q,K1RD J''9?F4[NF#QD\4 =-;VEM9Q^7;6\4"9SMB0*,_04V6QM)
MYQ/+:P23!#&)'C!8*>JYZX/I3[>=;JW69%D56S@21LC#ZJP!%>>Z3J<]QXB\
M6V>H^*[BSAT^Z2.V+20+Y:&,,3\Z'.">^: .\&E:<'1Q86H9%"(WDKE5Z8''
M K-U/2=25((/#LVGZ9"[,+MC:Y<J1@&/:0 PYZY'3TP<KP=XKGO/!4>KZ\ZH
M?M#P13K$5^UKOVQNJ#G+\8 ZGI6O_P )9I*QZBTTLT,FG1B6ZAD@?S(T(R'V
M@$LN >1D<'TH U;2UALK."TMT"0P1K'&H[*!@#\A236-I<S)-/:P2RQ_<=XP
MQ7Z$]*YP?$7PWY"3M<720.T"I,]G*(V,WW,-MQCKDYP,5>@\6:9=0Q-"+MI9
MC(([8VLBS$1G#G8P! !(Y.!R!U.* -2ZL+.]V_:[2"?;]WS8PV/ID4R;2]/N
M9(I)["UEDA7;&SPJQ0>@)' K+_X3/0C9V%TMU(T-]<_9(66"0XFSCRW&W*-D
M$8;'2IX_$^ERW.JVZRS"72E#7BM;NOE@KN!Y'S9 SQF@#3%M +;[,(8Q!MV>
M5M&W;Z8Z8I+FTMKV+RKJWBGCR&V2H&&1T.#67>>*--LK8SR?:F5(!<RK';2,
MT41SAG4#*]#P>>#QP:J7GCWP]921QM=33/+:?;8A;VTDOF0\?,NU3N^]GCH
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M /-(M%U6#P'KW@R?3YYKRXFN4M+G9F&9)G+B1GZ*5+'(//R\9XK5L=/NM/\
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MPGBK1[M_%6FW6EN$&L1-IFI(25)@ ,@D'^TH#KG_ *:"NZ1%C1410JJ,  8
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MMK33KJV\V-EN2\@?=C:5V@8QR#G\!G NZYK-[IUU%#!;P) T#RO>7<FR)6!
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M?/"A;<XEV[F!QQC;T]ZRHO!/B)=)T+29=8T][;1+Z&>WF-LYDDCC!"JXW 9
M(''7KQW +%QXJDTP^-KN'0[-;G1A')*RS;3=#R=X9FV9R%P "#Z9J]I_BG49
M/$FG:;J&FV\$.IV3W5K)%.7<%-FY7&T <.#P3T[U5OO!VHWB^,5%U:J/$,:Q
MH<-^X B\K)_O<<]N:LRZ#?0ZSH6L336_E:-8S02QHK,TN]4RR\=O+&!SG.*
M**^/KV?2]$U:TTRWEL]8OC96\<EPT;QG+A6<A6Z[#D ?+D<GFNNU>XN;31KV
MYM%B:XBA=XQ+G;D#/..<5Y3X?O;N*VM-1L=0\*:DS2O=0V>9$NC)(2654#LJ
M2X8J<*,<YXR:]=N[<7=E/;,Q431M&2.V1B@#B_#WBK4'\.>$X+I89]7UJV62
M)C(=NQ8@[R/QUY VCNPY')&WH/B*34M5U;1[VW6WU'2W02B-MR21R+N1U) /
M(!!'8CJ:PK7P/J=IIGAIAJ-JVJ>'@8K9Q"RQ2P%!&R.,DY( .X=".AKHM'T-
MK+5M4UBZ:-K_ %(QB019V1I&N$0$\GJQ)XSGH,4 9>OZKK%MX[\.:99_9_L=
MVES)(KLP+F-1P2 >!OR!W([8KE=-UV\\)Z=XPU&TTRVETZT\0S-<@S&-@A$0
M/EJ%()&<\D5V^N:!>:AXBT/5[*[A@DT[ST=)HBX=)54'&",$;1CMS6%=^!M2
MN_#/B?2#>6BMK=\]V)=K$0AMF5Q_%C8.>.OM0!HZUXNN;6ZU2VTJP-Y/IB*T
ML?ERL97*[Q&I1& .TKR>[#CO72:=>'4-,M;PV\UN9XED,,Z%9(\C.U@>A'0U
MRUSX;\0VOB:YUG0M4L;?^THXQ?VUW TJ!T7:)(RK*<[<#!X./RZVVB:"VBA:
M5Y61 ID?[SD#J?<T <'+XRETKPWXIU>WT&SCFTW5&MYHHYMHG.(P92P098[Q
MP0.!UK2?Q+KR^*9- &D6/VB6S-Y:R&[;8$5PC"3Y,YRR_=!ZXSWJA>>!M3N_
M#WB?2_MEHC:U?F\63:Q$(.SY2/XO]6.>.I]*VWT34'\;6_B#?;!(M.>R,&6R
M2SJ^[=CU4#&/?VH QXO'U[-H>@7T>D1&74M2;39HS<D>5*K2*2#M^9<QGG@C
M(X-#^,/$*_\ "0VPT;3S>Z(%EF/VQO*DB:/S%"G9G=@$<@#CK4=MX&U2WTO1
M[,WEFQT[67U0OAAYFYI&V8[?ZT\\]!Q6B_A?4#J'BNY$]KC7($AC4[OW.V,Q
MY/\ >R#GMTQ[T #>-#=K91Z9;;KBYTZ/42)4D=8TD^XI\M2<DAN>,8[]*33O
M&-SK TFSBTJ2RU6^MI+F>VO@R?98T8(21@%LL0%Z9'/&,&BG@O7M,;1K[1-5
MLHM1LM-CTRZ2YA9X+F)/NM@$,K Y/7OC/K=O/"NKKK6EZ_8:I ^K6T$EM=?:
M8CY5Q$[;R  <IM;[O7C .: .3TS46T3P1XINKG1;&Z2/Q)*DUH[_ +I2TL2@
MKE3NPQ! ('3L:ZWQ5XNO/#L>IW/V& 6MA LR-<3;#>$Y+I%C/*@#DYY/3O6=
M-X#U>;PQKFE/J5DTFJ:I]O\ ,$#*(OWB.1C<<YV =L9/)J;7/!>KZM=>(FCU
M.TC@UJQ2V(EA:1[<JA7:C9 V$G<>.I/% %@Z[JLOQ(MK&,VZZ4='-YM9V#<R
M("QXQD 8 ]SSS3+3QQ>7LVCW-MH]Q/IFIRA \4$Q>!&&4E<E-NT\9P?ESU-6
M8O"VI1^(M-U9K^T<QZ;_ &?>1F!L.N\/E/FXZ8YSZU!X:\+^(?#ZPZ2VMVTV
M@6KYMAY#"ZV Y6)GW;=HX&<9(&.,T 8FE:E=^&]$\<ZCI>FQ7?V/79Y7MM_E
M_NQ'$6*X!Y R<8YQ7;6^M/>:K8V]FL$]K-9_:Y9U<_(K$"/ QSO^8CIPAK(L
M(;?P9#K=YK^HV,-GJ>I-<J[L55#(JKY9+<'A.OUXI_P_T*+1= <QM,T=Q,[V
MXF^]';;CY,?/( 0YP>FXT 7/%?B&Y\.PZ;);V"WGVR_ALRIFV%3(< C@@_B1
M6%/X[U;3&\06>J:+:QZEI=@=2B2&[9HKB 9R0Q0$,",8*\GTJ?XELZV'A[RG
MC24Z_9>69/N[MYQGVJ75?"-YK(UR[N)K:*_U+33I<04LT=O"=Q)S@%F);/0=
M /4D 1/%VJ10V;7VEP0OJ;)]@6*5YB5\HR.TBJF1MQT7.20,@9-);>-KLQFW
MO-'E@U!]16PM0ZO'#<Y4N)%+J"%"JQ(P<$8YR*EU;PIJ-]HFB?8]1BL];T8J
M]O<!"\3D(4967@[64\]Q46J^%-;US1[>2\UBWBUVTNTO+6:W@86\3H" NPL2
M5(9LDG)SZ "@"U<>)]0TJ"Z&JZ7LE6\BM;-XG+1W9D PP !9=O.X8)^7C/2J
M;>.KBPCU7^T])G7[(85M)DBDCCO&E(544R*-K!B >N <U+J?A;6=?T!H]3UB
M&'5TGBN;6:SA(AMI(SE2%9B6SDYR>0<8XJ/4?"FM^)/#=S9:]J]LE\QC>VDL
M(&6.!XV#*Y5F)8D@9Z#' QR2 4E6_7XQ6KW5M9B=M!G*O"Y <^;%\K$C/'KS
MP>@Z4EAXSFMO".@W]CX?M(4U+5&L3:PS[%A8S2+N'R -DJ23QR<\UIVOA_Q"
M_BNRU_4;W33+;V$EH\,$+@/N96R&+<<J.QQ[]:H6W@;5+?PYH>E_;+-GTS5?
M[1,FU@)!YCOLQV^^1GGITYH LGQU/IUGXH?6=.C2?0425EM)C(LR2)N3!900
M>"#D>]78/$>ICQ?:Z!<6-HWVBQ-]]HBG8!%#!64+M.X@LN#D @]L8K&\2:?<
M:);^,-;N;NVB@U>""W0F(R"W(!B#.#P5^?+'L >M1>%)[RUUNTABNO#&I0RQ
MB%WTR25YH854E3EG?$8.!C(&6XYX(!T_C72M0UKP?J&GZ7)&EY*BF,2'"288
M,4;V8 J?9JYCPWKNB:SXILK>_P!&;P_XJL8W4VDL07S8RI!$;CAU'4?0XXR:
M[77+*\U#2V@T^\6TNO-BD29X]ZC9(K$%<C((4C&1UK)G\/7NK^(M(U35C91C
M26DDA6VW,TKNNW)+ ;5P2=HSDXYXY *$/CJZNWTR[LM(GNM,OKD0[HH9C)$A
M)"S,=FS9P,C/ .<GI4NC^)]?UJ\ODAT2Q6VL;Z>RG=[YLDHH*E?W?()(!R!C
M/0XIGA[PKX@\/LNE0ZU;/X=AE,D"&!OM2)NW"+?NV[<\9P3CCCC&CX<T*_T1
M-:\V6VE:_OY;V,+N 0N!\A]<8Z_I0!D:)XQ@?PMX=:RTN&SFU2*1X;2&-FC@
M1#\QPBY."5& !DMVI?\ A/Y;?3H)-6L#I,DFHO8-<7BNEN,*664%E4[&P ,X
MY)R>.:T'@'5K#P[X=BT_5K>'6=!\Q8)VB+0SQO\ ?1USD \=#QC\MZ32=<N+
M&)+^XTZ_>1V-[:R0LMO(A7 1 =Q4 @')W9.>.> #8TJYN;O3HY[N***9F?B&
M3>A4,0K*V!D%0&_&L+QQ-;W.FQ:!-?I8_P!K;XI)FD"%( ,R$9]<JG_ ZO>$
M_#Z^&-"734D#()I9512=D0=RPC3/.U<X'TSQTIUMIEV?$=[J-Z;:6&2)(;9%
M!W1*I).<\$L3DD8^ZHYQF@#(^&FNR:UX/ABNIDEO]-D:PNV1MP9X^ P/<,NU
ML^],^+,:2?"W7]Z*V+?(R,X.X<U:T[PU?:9XZU36K:>V33]2CC6:T"MN\Q!@
M2 ],XX(Q^-6O&FA7/B;PI?Z+;310->)Y9ED!(09!S@=>GJ* ,+Q;X9TQO =S
MJ%G;Q:?J6GV+75K>6J"*2)T3</F7'!Q@@\'--T7Q1-JEUX->[TJT:ZU32Y;A
M;QC\\3JB%U4;>%8L.AZ#I6EJGAO6-?T==&U#4K>VTYU6.Z%G$WFSH.J!V.$!
M[\$X[BI[GPU+_P )/H&H69MX;'2+>6W6WP<E755X[#:$'U]J *VG^+KZ\TW5
M3+86\6J6&H?8/LGG,0[$J$;=MR%8,&SC@9]#2/XEMM.\3^(/[0T^VMQINF17
M<M[$=TDL>7^4_*#QM; R>M7?^$5C'CEO$23E4DMU26V X>9=RI*?<([K^(]*
MI:AX-DU;7->N+R>+[#JVFK8&.//F1A=Y#YZ$_.>/8=: ,;5KB_OO%_@&_O+&
MU@6XN9738Y:2(&WD(1CCG@YXX!'?K6D/'5U.;*[L=(GO--N;O[.3##,TB)N*
M^=G9M*Y&2,\ YSGBHX/"?B227PV;_5M.D_L.8LLB6S[IT\MHP6&[ ;![<9Y]
MJFT/PKX@T&=]-M=:MCX=\]IHHVMV^U1*S%C$K[MNW)/)!.#QC@@ I7GC_6+7
M2]?U(:):&VT.^:WN1]L;<\:A"2GR<MA\\X'0<]M^YUJ;4=8U#1=,M;:Y:R@C
M>Z-RQ",T@)2,  ]0,DG@9'!SQBW?@C4KKP[XKTHW=HIUZ[>X63#'R0RHI!'\
M6 @YXZU>3PUK%AXKN=;TR]LT&I011W]O/&SJ'C&U9(R"#T."IQGUH 9\*?\
MDEWA_P#Z]O\ V8UV-8'@O0;GPQX2L-&NKJ*YDM4*>9%&4!&2>Y.>O7CZ5OT
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MJQ  SSC!R>:YU]4\3P_#M_%Z^(KJ:ZT^]F4VCQ1B*XB6Y:,JX"YW$="" ,
M9YH ]AHKS3Q5KNIV,.LZC8ZE/,]CJ%M$HA4+!;*S1*T4@/\ K'.\DXSC(Y7I
M6IJ>M7'A?QM*VIWMQ+H^H63R6B'&(IXAN>,8&267E<D\@@4 =O61KOB*Q\/Z
M8U_="66%9DA;R%WE69@HSS@<L.OK4VC6UY;Z);0ZA<R2WIC!FD)!(<\D#C&
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MEH Z\2(9&C#J74 LH/(!SC(_ _E3J\JGU2Y\-7GQ)UJ*>XN9;%X3#%*^Y,M
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MC)]*R](M;]IM'U0:^T]K<VN;B"501<2,H97CQC9CYN!P1],UP?A2?4=(\'>
M[ZWU2X\J[OULI;,A?),;F7MC=N!4'.?TH ]BJCK&J0:)H]WJ=TDK6]K$TL@B
M3<VU1DD#Z"N(CO?$OB*QO=4TB_M;2:TU*:%5N+HK$D<,I5DD01G[R+NSG(+#
M! XJOK-_<^)O"7C^X:]GMTTTW=C#!$0% BBRQ<8^;>2>O08Q@\T >C65U'?6
M-O=Q!A'/$LJAAR PR,_G5+6=>M-":P%U'.WVZ[CLXC$FX!W.!N/85RV@7MY_
MPE6D:5]KE^PS>&4N##D860/&@8'&0<$]\5AG4;S5? GA&[O[AKBY;Q-"C2N
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M(4WX((!(YZ@5J5G:[<2VVE226^H6=A-N0+/>#,8^89!&1R1D#GJ: +/V.)K
MV4VZ>%HS&_FG)92,$$]^*Y^T\!Z+IKZ;/ M])+I8868>]D;8I 'EC+8V\ 8Z
M<<UM7>M:58&47FIV=N85#2":=4V G )R> 35+4?%FBZ7?:9:7.H6Z2:B6,),
MJA=@0MO)SC:<  ]R10!3T*UN-4UM_$NI:*VF78M19PQ3.CRA-Q9RQ4D8)VX'
M7@GO5MO"FG-/K$Q>YWZP@2\Q,?G4+M ']WY>.,?G6A-JVFV]['93ZA:Q74I
M2!YE5V)Z *3DTU]:TJ.Y%L^IV:W!D$(B:=0V\]%QG.XXZ=: ,]/".FHVC,K7
M.=&7;9?OC^[&W9S_ 'OE^7G/%067@30]/UF34K6.ZB\R8W!M5N7^S>;U\SRL
M[=V>>G!Y%;,>K:;+?M81ZA:O>*"3;K,ID&.ORYSQ33K>E"62(ZG9^9$&:1//
M7*!?O$C/&._I0!DR>!]'FTK4M,D-TUKJ5P;FZ3SSF20D$G/49(' P.*O#PY8
M#7DUK]_]N6!;=G$S!9%4DKO4'#$%C@D=_I2^'_$6F^)M.%]IES'-"69?E8$@
M!B 2.HSC(SV-3WFM:5IYD%[J=G;&)0TGG3JFP$X!.3P": *VN^&['Q&EJE^U
MQMM9UN81%,8]LJ_=;(YR,TD7AC3$U*'49TFN[R 'R9;N=Y?*SU*!CM4^X -7
M9]4T^UM8[JXO[6*WEP8Y7F55?(SP2<'CFF-K.EI]FW:E9K]J&;?,ZCSA_L<_
M-^% &-?^ -!U*34VGCN@FILKW,4=U(D;2#&'V@X#?*.?:KX\,:8-9350D_VI
M;9;9LSN5E122N]2<.06/+9ZU;N-7TRT:9;G4;2%H%#RB295,:GH6R> ?>F-K
MVCJUVK:M8AK,9N0;A,P?[_/R_C0!EZ'X&T3P]>>?IZW2HK,T-M)=2/! 6SDQ
MQD[5)R1G'0D=ZTM:T*QU^V@@OEEQ!.EQ"\,K1O'(N<,&4@CJ1^-6!J=@=/74
M!>VQLF 9;@2KY9!Z$-G%,36=+DM8;I-2LVMYG$<4JSJ5=R<!5.<$YXP* *$_
MA/39;^>\B-S;37,*P7)MYV3[0BC"A_<#(###8[UK0PP6%DD%O"([>",)'%$O
M"JHP  /8=*SY_$^AV^E7NIMJMF]G99%Q)%,KA"/X3@_>]NM6M*U2UUG3(+^T
ME22*9 WR.&VD@':2.XS0!QO@/PL8_"EE;ZS!>1RV]W+<&RG;]V'\YG1L#KP5
M.,X!YQFNJL- L].U74=2@:<W&HLK7.^0LKE5"J<=!A0!QVK&U3QK9O8>(X]&
MOK.34M'MWD*R'>K.J%R-H8$@8 )!X)]JU/#^O6NJV%E&U]:OJ;V<5Q/;QR+O
M3<H))3.0,F@"EI/@;0_#]Z]Y81W:1JS2QVGVF1X(6.<M'%G:"<GH._&*Q_!'
MA8_\(Z(-9@O8RNH371LIV_=L3,SQMCOQM.W.,C)&:[&+6-,GNVM(=1M)+E-Q
M:%)E+C;P<C.>._I530_$^D^(FNQIEY#/]FF:%MC@D[<98#KMR2 >^* ,^]^'
M^@Z@VI><EV(]1E6>XBCNY$C,H(/F!0<!OE7GVJ.[LI]<UFUTRZT.2/3=*NH[
MJ.]N)5<3,B_)L&2V=QY+=E/K712:E817@LY+VV2Z*EQ"TJARH[[<YQP>:B36
M])DM#=IJEDUL'V&87"% WINSC/M0!?KF9? >ARV-Y8E;I;6[N?M4D2W+[0^_
MS/E&?E&_YL#&36TVKZ:E\+%M0M%NR=H@,RB0G&<;<YSCFEDU73H;P6<E_:I<
ML0HA:90Y)Z#;G.30!1;PSITNKS:G.)9[B>T^Q2B5\H\/)VE>G4D_C5?P_P""
M](\-2[[ WC*H*PQW%U)*ENIZK&K$A1].?>MV>XAM8'GN)HX84&6DD8*JCU)/
M2JUMJ^F7EV]I:ZC:3W*()&ABF5G53T8J#D Y'/O0 :KI%CK5G]EOX!+&'61"
M&*M&ZG*LK#!5AV(.:JQ>';3[=;WEW-<WT]L2;=KJ3<(B1C*J !NQQN()Y//)
MJV-6TYK_ .P#4+4WG(^SB9?,XY/RYS5/3_%&D:GK=]I-I>PR75D5651(,EB"
M2 .^!C/IG':@"MJ/@S2=3U&]O9OM2/?0"WNDBN&2.90"%+*#@D D#-/7P=HZ
M-I+(ERC:5$8;9A=29\LXRC'.67Y5X/''I6M<WUI9M&MU=00&0D()9 N[ R<9
MZ\ FHK?6-,N[![^VU&TFLTSNN(YU:-<=<L#@8H I6?A>PLYK-P]S,MDS/:QS
MREUA9@5)7//0D#). <#%43\/]!^Q+:HEW%'%=_;(#'=R P298_NSGY1EVX']
M[Z5K2ZI:W>DWEQIVJ6.8T91<&17CB?'&_![$@D9%.CU&"UT>UN;_ %&S^>),
MW.\)%*Q7.5R>AY(&3Q0!CR?#_09;74+8I=B'4)TN+A?M<AWNNW#<G@Y123U)
M S5^3PQIT^KRZG<"6>XEL_L,HE?*/#R2I7IU)/XU2\$Z]=>(+#4I[J6VE^SZ
ME/:Q26RX1XT("L.3U'/4]:VKS5M-TYU2^U"UMF<959IE0D9QQD^O% &%:?#_
M $2S;3MCZBZ:;(9+.-[Z4K!P1M7G[N"1CTXZ5+/X&T>XT_5+&4W36^J3_:+M
M?/(\R3CG/4?=7@8Z"MF\U73M.V_;K^UMMP)'G3*F0.IY-6P01D=* .?U'P^%
MN9];LA)<:S'8/:VXFG*QN.H1L=BP!)Z^]<CX?\.7< L(;&#Q;I<UL8PXO-25
M[5%4C<H3S&# @$  >GW>WH<&JZ==736MO?VLUPH):*.968 '!) .>"<4Q-5L
M;J>6SL]1LWO44DQ+(KLF.,E0<X!Z]* &:YHEIXATF;3+_P TVDXVRI&Y0N/0
MD<X^E4)/!FD7 M%O?M=[%:.KPPW-T[QJR_=)3.&([9!JGX*\6IK7A_39-5OK
M%-7O/.(MT<(SA)77*H26(POOTKH)]6TVUO([.XU"UBNI2!'#),JNY/0!2<F@
M#%U+P'H6JSZI+<QW.-415NXH[ETCD(&T.4!QN  Y]A5O_A%-,.IQZ@_VAYX[
M1K+]Y.SAH6.65L_>R0"2>?>D\4Z]%HFB7TJ7]C!?QVSS01W3#YRH) V[@3DC
M'!ZFG:!KL&H:+IDES=VPOY["*ZFA#@, R*2VW.0N30!1L_ &AV+Z:\/V[?IF
MX6A>]D;RE88V#)^[@#CIQSFG_P#"#:/_ &/_ &5F[^Q_:OMFSSVSYN_?NSU^
M]SCIFHO%/B2:QTC3M0T:ZLYX9]2M[61P/-#(\H1MK*V 1D^M;UYJVFZ?+'%>
MZA:VTDA 19IE0MDX& 3SS0!CW?@;1;W6Y-6=;J.XG55NEAN7CCN@HP/-12 _
M''/4<'(I=5\#Z-JVLC5I1=V]X4$4KV=U)!YZ#HLFPC<*U-4U.UTZW;SK^SM)
MG4^4;EP 2/;()'(Z&L_P3K%UX@\%Z5JUZ(Q<W4 DD$:X7))Z#TH VO(06WV>
M/]U&$V+Y?&T8P,>E8$'@?2+:PTJRA-TL&E3>?9KYY/EOSSGO]YN#GJ:V)-7T
MV&]6REU"T2[8A5@:90Y)Y "YSDU'=:[H]B9A=ZK8V_DE5E\VX1=A;.T-D\$X
M.,]<&@!FGZ#9Z9J>H:A;M,;C4'5[@O(6#,H"J0.V  .*9=>';"ZUV/6F\^._
M2#[/YD4S*&3)8!E!PV"21D=35V[U"SLK<375Y;V\;\))-(%4G&1R2,UA^"-=
MN_$&DWEU>26\KPZA<6R26Z[4=(W*J1R>H&>IZT $?@;1XM)L-,C-VMI870N[
M9//.4E#%@<]3AB3@\<T3> ]#FUV;5]EU%-<$-<PPW+I#<L.ADC!VM^/![YK8
M?6-,CFGA?4;19;==\R&=0T2^K#/ Y'6E35M-DBMY4U"U:.X;9 XF4B5O13GD
M^PH 9K6C67B#2)],U&,R6LX&X*Q4@@A@01R"" 1]*R?^$&T?SKN8M?-->6@L
M[B1[R1FECYZY/)PQ&>P/&*V8=7TVXO&LX=0M)+I<YA292XP<'Y0<\'K2IJNG
M27GV.._M6NLD>2LRE\CJ-N<\4 9J^$M-231G#W.[1U*67[X_NP5V'/\ >^7Y
M><\5&W@K19;74[:>*::+4IQ<W DE.?-&,.I'*L-JXQCH*W;BX@M('GN9HX84
M&6DD8*JCW)Z5%:ZA97MNUQ:7EO/"A*M)%(&52.H)!XQ0!4MM LH'GEE,MW//
M"+>2:Y?>S1#/R>@')Z#GOFLNS\ :)8R:;)&U^[Z86^QF2\D;R05V[5Y^Z!QC
MIZYJ.V\4M>_$2+1[.]L;K37TR2Z)@(9UD62-0"P8C&&)Q@=>]-\1>*_L.LZ%
M9:;?V$IN]26TNX,AY54JQ)&&^7!7!R#U[4 66\#:.^CW&E,;LV=Q=?;)4\]L
MM+OWEL]?O ''3(K0B\.V$.OR:V@G%[+$D4I$S!)-H(4L@.TD!B,X[U9DU;38
M;Y+&74+5+R0X2!IE$C'&>%SD\5C^-/$B>'_#>I7%M?V$6I6]J\\,-RP)<J"0
M-NX$YQ@?UH L^(?"FE^)A:M?+.EQ:.7MKFVF:&:$G@[74Y&>XJO>^"-%OK"Q
MM72YC>QD,MO=17+K<(Y^\WF9W$MWR3FMG3KAKC2;2YF(#20)(YZ#)4$UGZ-X
MJT?7HKR6POH)([65XY&$@Z+P6Z\+G.#T.,T <UH7A:*Z;Q?I6IV%TNFZA>(\
M32LVZ5!%&N_?G=NWH3D\]ZV?^$#T-YYI[E;NZFGLFL)GN+N1S+$220W/)Y_#
M QBMRRU*PU$2&QO;>Z$9PY@E5]I]#@\53UWQ)I?AQ+1M1NHX3=W"6\*NX!8L
MP!//8 Y)]!]* *5CX(TBPOK.]B>^:[M+=K:*:6\D=O+.#M.3@@;00.F><9K1
MT/0[/P]IPL+#S1;!WD59)"Y!9BS<GGDDG\:PK7Q:(O%FNVFJ:CIT&E6D%I+:
MSLPC!\WS.KLV&/RC&,?2NEN]2L;"V%S>7MO;P-TEEE5%/&>I..E %!O"NDOJ
MFHW[P.\FI1B.[B:5C%* NS)3.W.WC..E)IOA?3],>T:-KB862&.T6XF,@MU(
MP0N?;C)R<<9Q6O#-%<0I-!(DL4BAD=&#*P/0@CJ*HW.OZ-9LRW6K6$!601$2
MW*+ASR%Y/7VH -:T.RU^RCM;Y9-L<R3QO%(T;QR(<JRL#D$543PII\=]>WD;
MW2S7MNMM,WGDYC4$*.>F,GGKR>:OWFLZ7I[,M[J5G;,L?FL)IU0A,@;CD],D
M#/N*K0:BJZAJDEQJ^GO90K$R1H0KVP(.XR-NQAB,C@< ]: ,RY^'VA7.F:99
M;;N'^RQMLKB"Y>.:!<8VAP<XP,<UOV-C;Z581VEJC"&('&YB[,2<DDG)8DDD
MD\DFF6VL:9>7;6EKJ-I/<K&)6ABF5G"'&&*@YP<CGWIRZKIS7_V!;^U-YS_H
MXF7S..3\N<T <7X3\+FXMM<CU>WO8H+K6;F[^R2MB.9&EWQL1Z=,KD#CD5TU
MWX9L+G59=31KBUNYXA!<26TIC\]!T#8[C)PPPPSP:=9ZFD2:C/?ZQITEO'=%
M$:-@@@7"XCD)8C?DY[=1Q5RTU73K^:XAL[^UN);=MLR0S*[1'T8 \'ZT 4#X
M5TL7^E7<4<D+:5&T5FD3E4C1@ PV]#D #GTJ0^'+#^W9]9C\^*]N(EBE:.9@
MK!00I*YVE@&(!(XS5FVU;3]1>2*PU&TN)D7<5BE60KG@$@'.,UE>"-9O=>\.
M?;=0,)N1=7$+>2A5<1RN@P"2>BCO0 D?@C18=#LM)CCG6"PE\ZSD$S>;;ODG
M*OU[G@Y!S@\5+>>#]*U#2;[3KH3RQZ@RM>2&4B2<C &6'0# X&!Q]:TKS5M-
MTZ18[W4+2V=QE5FF5"1G'&3Z\476K:;8NZ7>H6MNR1F5EEF52J @%CD\#) S
MTY% %5?#UH->AUII+A[Z*W-JKM)P8R02".AR0#GKQ3]6T&RUE[26X$B7-G(9
M;:XA<I)$Q&#@^A'!!R#W%/77=':2TC75;$O>#=;*+A,SCU09^;\*DN]6TZPE
M2*\U"UMY'QM2:94+9.!@$^O% %&?PKIESHU]I<HF,%^2UX_FD23D@ [FZ] !
MQC   P.*T[*U2QLXK6-Y'CB4(ID;<<#@<]Z0W]FMVUH;N 7*IYC0F0;PG]XK
MG./>HEUC3'AAF74;1HIW\N)Q.I61\XVJ<\G/84 8,/P[\/V\=K'&EX(K.Y-U
M;1_;)=L#'=D(-W"G<<@=<U/+X'TB;2]4TV0W36NJ7!N;M///[R0XR<]1G:O
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M#/#<Q^9!+'*F<;D8,/S%24 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&.=H8<J!@8..:V+F[FL?$KS:7>P:E97>KQB[T:Z3;<V\NY5\Z$CG PKD,,
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MO83#<VEE#;RH6#?,B!3@@D$<5LT %%%% !1110 4444 %%%% !1110 4444
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M.0J"R!MVTXY&>] 'E_B?0Y?#'@:PTC^UQ+$NL6K6A>/#6\8F5MHRQW*@Z9Z
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M]OHWU&]L#IPGCMRJ0PG);:A8G))R26[+QQRR+PA-%<^&9O[24_V#"T*#[/\
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MHK9O9P2);%(XE<@NVS>26.%YW 8' '.;OAK1F\/>';'2#<_:5LXA"DOE["5
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MK6",'&^21PJ@GL,G)/H#P>E+I-YJ-VER-2TP6,L,QC39.)4F3 (=3@''.,$
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MW]K%<1!@ZK(N=K#HP]"/4<U7F\/Z/<::=.GTVUELF;>T#Q!D9LYW$'J<\Y-
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M?0=..E66T32WOK>];3[8W5LNR";RQNB7T4]A["@"W!"EK;1PIN\N) B[F+'
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M-5AU2\TBRGOX,>7<20JSKCIS[=O2K*Z3IZ:H^IK90"^=-C7 0>8R^A;KCVH
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MXS7,Z/-/JN@_#1KG4+QWGN)H9V6Z<&11%+@-@]?E'/7WKU2_T32M4N;:YO\
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MHS=^&M6T^YD:&[\0RPF]GF_?W,9\T,C*  (E*@*#G@*<+7KE8W_"(^'-[O\
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M&H*_+\PW!NE3SS#3?$UQ+K.F:U<Z7JUA;)!+9).=C(K*\,B1D$$[LC([GWH
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M+ 9QALGMD5<\,W6FZS?Z??/X?UFWU33XG$SZAY^VURN'5"Y(?) P%SQSQP*
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M6;1+E9EMVC+_ '9&Z*?3^G&>M%GXS\-ZA*([76;25C#)/D/QY:-M=LGC /\
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MC9923%YA&"0N._.* 'R:[>^(/$^LZ+IFKRZ9)8+!]GD%H)%D=@SOY@9?NX
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M)&AM]6N$U'P\L<%S=6C1B5QYN1@JH7[R@*0#SG!'- '41^)K/5M.\/7B:O\
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MC'(!VX(.<$''!]JR/$OA^+Q-I/\ 9T]U/;Q&6.4M"%W$HX=?O \945P?A_Q
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MA21F\H!]^] 2%<' X8#(]B/I6A0 4444 %%%% !1110 4444 %%%% !1110
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M 0,CGN.M!T/Q3HOB?4+S0IM.NK#5#').E^[H\$RHJ%UV A@0H)''(ZBNVHH
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M8KSS6\U;=I-Y0IMP7&2H.<=#VP?0ZJ:;J5OJUDMW:^;Y3,RCS8FC;*L5/RL
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N(^+__ "2K7O\
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M&C&63RM[%]P)V_,% 7!X)SR,77\ 6,F@WFCMJ>H_9[N]-]*V8M_F&02'!V8
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M',1&'4'Y6(!(!(QD#O6Q533=/CTRR2VCDFF(R7EG?=)(QZLQ[D_D.@P!BK=
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M$*R*I'0@$8%8&N^%YM3\2>';F.TT]],TOSA)!,2,AT"J%0(5^7 /4?A7644
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M -DCCEB:*1%>-E*LC#((/4$>E4(] T:$VQBTFP0VHQ;E;9!Y(]$X^7\*T:*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG4;4E@JA<#<W4%, ].AZ[[R2VOQ]TR^OK66VCNM"6-!L9AYNXY0$#DBO6J*
M*6FZM9:L+HV4QD%K</:S91EVR)]X<@9QGJ.*NT44 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5S^G:R=7UW51'+Y>GZ3*+9FS@23;
M SDG^ZH91]=V>@KH*X3PG!=Z8/'%BL"S7PU6XO(8I.%E6:-7CS[$@K_P$^E
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MF25Y$?.3\O8D]B:L:]8:GJ7PEU*1["636=8"7$EM"A=E9BFU/^ HJ@GU4^M
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M.W#J1@@_+U'O4S>.9[&W\1C5M-B@N=%\EG%O<-+&\<H^5MQ0$ <[OEX )&:
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MX[) &12P=7*@E7&-N0,Y/IR =O1533;BYNK!)KRW2WG)8-&DF]>&(!#8&00
M1P.M6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *Q?%'ARW\4:/\ 89I7@ECE2XMKA!EH)D.5< ]<
M>G<$UM44 <OJVC:YXBT=]&U*6RMK2<!+N>U=VDF3^)55E CW=,Y; )^M$WAR
M\LO%5MK.CBS,,6FC3C:3,T81 ^Y65@&Z=,8_&NHK!T_Q3#J=[:QVNGWSV=V)
M#!?K&&@;82#D@Y7.."P&: ,:Y\$72:7IEO:7$#W$.LC6+N:7*":3>78* #M!
M+8'7  ZT[4[.YT"_\5>*+J6W%I<Z?&BJJ&1HS$KX)4@!@2_3(''6NR>6.-XT
M=U5I&VH">6."<#\ 3^%9FAZ_;Z__ &DL-O/";"\:SE6<*"7558D8)X^84 <'
MX7^W:5<Z0J3>%]2C5$M8S8W<KSI$Q&YHU8LH48#,!M&%]@*NV7@;Q!;1Z(DN
MIZ=(^EZB]T9S"YDN0ZNI>0[OOX?ITXZ]J[RUT^RLF=K2SM[=G^^8HE0M]<#F
MK- '$-X/U5-*\7:;%=V;6^MR7$L)96#1M,@5MQY!"X. !SGJ*FB\+:E8ZQI.
MMV4MJU];Z<--NX)'81SQ@Y5E8*2K!LG[IR"1[UJVWBO3KCQ9<>&B)H=3AA\_
M9*H"R1Y RI!.>HXZT[Q'XITWPO#9OJ#2EKRX6V@BB7<[NW3C(X]_<4 <_<>!
M[S[-;&WGMC=-KJZU=LY959@?]6F 3C 49/IG'/%S_A'M:AU[Q#JEK-8J=3%J
M(DDW,%$)(97XY#J6''3WKK48LBL5*$C)4XR/;CBD=BD;,%9R 3M7J?89H X1
M?#NH^%=/UZ_T!=.L;J^DBDBL KRVZ,O#;5 4[WSC  ' ^M=L8OM=@8;J,#SH
MMLJ Y R,$9_.L?3/%46L:'I^K66G7\L-Y<FWV!%WP@.R%W&[ 4%3G!)Y'%;]
M '&^&/#_ (HT.&WTFYU>RN='L@%MG6)EN9$7[D;G.T < D D@8[TRZ\)ZM)J
M.GZ];W-K'K\-PYN92SF.:V;_ )88QG: %QZ,"W))SVM% '%Q>&?$6E^(=3N-
M%U.QBTW5I1<7$5Q$SR6\VT*S18(#9 !^;H1^%+-X:\0Z;XFO-2\.ZG8K:ZD(
M_M<&H1/(4D10@D0J1DE0,@GG'6NSHH \_1;^W^+D\5F8;F1/#UNCFZD*%L32
M?-E5//J,=^U6!X%N[*VT!M.O;<WNG7TU[/)/&=DS3!Q(0 <C!?@9Z  GO6KX
MEUC1/"$ UW4;#:I<1R7<,"LR%N!N/WL?3-;_ )\0M_M'F)Y.S?YF?EVXSG/I
MB@#.\1Z7=:SX:U#3+2]:SN;F!HTN%SE"1UXY]N/6N;M_"OB"'6CJD=YI5K+_
M &,=.2*WMW"1.&+(RY/0$Y/'08QWK?\ #/B>Q\6:6=2TQ)_L9=D225 N\J<'
M SGKZ@5M4 <KH7A0Z9XGN]<\BSL7NK989[:Q9C'-(&W>:P( #=NAZG)-3Z[X
M>N;OQ!I.OZ9-$E_IXDB:*<D1SPR ;E) )4@@$'!^AJ[_ &_;_P#"5CP\8+@7
M)LVO!*0OEE RJ0#G.<MZ=JMZ9>OJ.GQW4EG<V;.6!@N5 D7#$<@$CG&1ST(H
M Y/5/ UQJ6D:\?M,$6K:O=6]RSX+11^04\M.Q(PG)XY8G':K\6AZNOC1?$$S
MV4@&F?8FC1F7+>9YFX<' S\N/Q]JZBJFIWKZ=IT]W'9W%XT2Y%O;*#(_/102
M!^M '"6O@/7=,T70FT[4K*+6=&DN!&\B,T%Q%,VYD<<,/X>1G[OOQK:IX>U[
M5;;1WN;RQDO+34X]0FP'2+"*5$<8Y('.=Q/7)QS@=<[E(F<(S$#.Q<9/L,\5
MF^'==M_$NA6^K6D4T4$Y<*DP <;7*G(!(ZJ>] %+Q5X:/B.'3_+N6M+FSNEE
M69/O>604E0'MN1F'UQ3-(\)Q:/XJU35H)0+:[53%:J,+#(559& _VA'%^1]:
MZ2B@#C[/PYK-B=?>*73V;4]16\5)-S)LPBO&WR]U0\^IZ<5F/\-Y8]/N_P"R
MKF#2;K^TH]2L(( 9+>UD1-I&"!D/EL@  9&!QSZ'63I^OV^HZ]JND)!<1SZ:
M(C*T@4*XD#%2N"<C"]\=: #0X-;2*2;7KFSDN7 4162,L2 9Y&XDDG/)XZ 8
MZD\WJCW:_&'3?L26\D@T.?<DTA0%?.CZ$ X.<=CT-=U59["Q-W]M>TM_M*C_
M %YC7>!_O=: ..F\$7RV]@;>>U:Z77/[:O'<LJNYR-B  X&" "?[N<<UJ77A
M^^MO&)\1Z4]NSW%H+6[M;AF17"DE'5@"0PR1C&"#VJ]<^)+2VUS2-+\J:1M5
M61[>= IBPB;SDYSTQCCO6Q0!PS>![N"/2/LT]L\UOK,FL7CON7SI7W[E4 '
M_><9[**6^\'ZI=Q>,T$UFO\ PD**D9+-^YQ"(LGY>>!G]/>NXHH Y(^'=5M]
M<TG6;9[.2>TTUM/FMY7958%D;>KA2<Y0<%>_6JE[X(NWT1+6VN;=KR;6$U>[
MED#*KR+('VJ!G PJJ,]AGFMO4?%-OIVO6VBM8WLUY=1O+ (50JZKC=R6&,9'
M7%7=-U5=1EN8C:75K-;LH>.Y0*3D9!!!((Z\@]0: ,"[\'W%[KVOS2W,']F:
MY8QVMU%M/FH51T^0],8?.2.W2FZ1X>\2MIIT?Q%JME=:<ENUNKVL3)-<*4*
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MT]0&5_HZE(O^!$]J]#U'2;35?(^UB8^1*)H_+G>/#CH3M(S^-.&E60O[B^6
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M.01UJWI?AC3-'U&YU"U2X-Y=(B3S374DK2!1A<[F.2,GGKS0!G^,-7N-/N-
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MUG7[/6+NPMX[&^2UMFSY7F!HE<#YF.6^;MZ=*Z*\U&QTY%>^O;>U1CA6GE5
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M44 %%%% !1110 4444 %& ?PHHH :D:1@A$503DA1CFE"J&+!0&/4XY-+10
M@50Q8*-QZG')I<444 (R*XPZAAZ$9I:** "BBB@!&564JP!!Z@BE  & ,"BB
M@ I-HW;L#.,9I:* $V@YR!R,&EHHH 3:-V[ W8QFAD5B"R@D'(R.E+10!1U+
M3(=26!F)CN+:436\R_>C?!&?<$$@CN":NC=L )!;') XS]*6B@#-MM)^R1WD
MD,^+Z\??-=% 23@*,#H %& .<=3DYRBZ#8IH\6DHK+9I]Z/.?-&26#$\G<22
M3U.3ZFM.B@ HHHH 0@,"" 0>H-  4 *  .@%+10 4C(KXW*&P<C(S@TM%  0
M",'D48&<XYHHH 0JI8,5!(Z$CI2T44 %%%% "!5#%@HW'J<<FEHHH 155<[5
M R<G ZF@(JDE5 +<D@=:6B@#$T31;ZRN);O5M6.J7K*8XY?LZPK%'NSM"KGD
M\9.>=J^E;+KO1E#%<C&Y>H^E.HH Y"S\(ZI'IPTB^UNWO=+$9B(?3P+AT/4-
M)O*DGNVS)R3P>:ZX    8 I:* $V@= /6EHHH ,#TI%14SM4+DY.!CFEHH ,
M9I"BL064$KR"1TI:* "BBB@ (!!!&0>U(JA5"J  .@':EHH *:$13E54'D\#
MUIU% ";5W%MHW$8SCFEHHH 0@$8(R*7 'XT44 %%%% "$!A@@$'L: JA0H "
MCH .*6B@!&W%3M(#8X)&1FL'PGX=E\-Z9):3W<5VS7$TZR)!Y9'F.7*\LW0M
M6_10 4444 (J*B[44*!V Q2T44 1SI));R)#+Y4K(0DFW=L)'!QWQZ5F:%I%
MUIL4DNI:B=2U&8*)KHPK$"JYVJJ#@ 98]3RQ/L->B@ I%14SM4#)R<#J:6B@
M!%55SM4#)R<#J: JJ254#)R<#J:6B@!H10<A0#G/3OZTZBB@ QFL2#1;XZ_)
MJ&H:L;NVC=GLK06ZQBW)7:26'+G!8 G& QZ\8VZ* "BBB@ HP/3K110 BJJ*
M%50JCH ,4,JNI5@"#U!%+10 UD5EVLH*],$<4[ ]*** "BBB@ HQFBB@ I&5
M6QN4'!R,CO2T4 %->-)%VR(K+Z,,BG44  &!@=*145!A5"C.< 8I:* "DV@Y
MR!R,&EHH ,<YI JABP4 GJ0.M+10 $9&#2  = /2EHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K-U'2I[V\M[F#6-0L3"&4QVQC*2 X^\'1
MN1C@C%:5% %73]/M],M!;VRD+N9V9CEG=B69F/<DDFK5%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
' 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>exhibit1061-loanandsecur004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCY@K<Y! ;I@\]M?PEHD^E'6+RY3RIM4U"2\,.X'RE(55!(XW87)QD9.,G&:
M*I\17&H^)M?\/G3[J&"RM(F^TI*JG+B0[LJ^X [5 QSG.<5E^ _%\7_"->%;
M"_34&N-0M0D=[,A,<LH0L5+DY+8!.<8..M7_ .SM6LO'&OWT>FO<V6I6,"1S
M),@VO&) 5(8@Y.\8[>I%8UAX>URW\/> ;.32I1-H]RCW@$T6$41.F0=_/+ \
M=LT =3>>,]-L7B>:.Y%C)=?8_MP53"LNXKM/S;L;@5W;=N>]/\;>(_\ A$O!
MVI:V(Q*]M&/+0]&=F"KGVRPS[5RV@Z'K&CW$VB3^%K"\@%U));:T[1$")W+_
M #H?G+KN(P.#@<@<UUOB_P .Q>+/"FH:'-)Y0NH\+)C.QP0RG\& H KV'AV=
MM)B:_P!7U)]5DB#2W,=TZJLA'.V('RP >@*D<<YJ2#57TNWLM(F6XU/5XK))
M+A+?:6( "ER791\S XYR>>.#4.CZIX@2PAM-3\/3_P!H1((WGBGB-O*0,;PQ
M;> >N-N1Z&J1TW5])\=RZZEJVH6M_81VURMNRJT,L9)# .PRA#$=<@T 4_$F
MNP:QI7A75=(O;A89M=M87".\9(+D/'(F1G!7!!':I[74ETSQ_P"+YKR\G&GV
MFG6MRRR2,ZQ#]\7*KSCA>@]*RY?"6K6FBZ<L-DT]S)XE&LW44<J 0(92Y4%F
M )"D#COFM"]TWQ&GB/Q;J&EV7ERWFF0PV$\KQE3-&).HW$C[XQD8XYXH VK?
MQ=;W-Q+:+I]\EXMB+^*WD$8::(G&5(<J#G PQ!Y%5?#WC$ZKX7TS5+JQGBN-
M1_X][="A,I(+?+\V,!0<EMO3W%8^C:+K"^,[;59=$FM;>;1FLYY+F\2659O,
M5LN0Q+9P<8)_X#TK+M_#/B.U\)>%6_L*&YO= +13:=//&1=QLI5F1LE01\I7
M=COD#N =6_Q#T:&R:XFCO8WCOUTZ>#R-TD,Q( #;21CD$$$Y[9J9?&ELQ$0T
MK51=^3+<-:20+'*L4;;2Y#,!@DC&"2?2L/6-*U;4="L6M?#,=E(-5M;IK.&2
M$.D<3AF9VW!2QP< $]N>>-+Q#:Z[>>(HHTTY[S19+!D\M;A(UCN2W68$Y9-N
M, !AG/!X( *NM:LFI:IX$U/3;NX%I?WA.U9&198V@D8;DS@G('4<5W5>9Z9H
M&OP:+X!MY]'D631YLW:B>([%$+QY^]SDMG SQ[\5VFDZQ=W^J:K97>EO9?8I
M0(I#,L@GC;.U_E^Z?ESM/(!'K0!%J_BJSTBYN;9K>ZN9;6T^VW"VZJ?*AR1N
M.YAG[K<#)^4\=*AN/&FFPWUC9Q07UU-?VAN[46\!(E0;3P3CGYAUX'<BL?Q5
MIWB#4]5U2T73FO=+N-,,5F5N$CCBG(<,95)RW5=O! QVR34.CZ1K<.L^$+FY
MTB6*/3M'DL[DB>)MDA$0 ^]S_JSTSU% '06OC+2[S1+;4XEN/](N#:1VK1@3
M&<,5,>W. 05;/.  3G'-9/A*^N+KQ_XPBE%]%'$+/9;W4F[RBR.3M^9E /!^
M4XK!A\->)+*"QU2'2V>[T[7KR^^Q-/&#/!.7&58,5#A7Z$COS72^&[351XV\
M1:K>:5+9VFH16OD&66-FS&K!@P1C@_,.Y'O0!1\>7GV'Q3X2674[BRLKNZEB
MN]MX\*.HC++DAACYL<\4F@ZT\_Q'N=,T75)-4T&.Q\RY9YO/6VN-V%593DG*
MY)4DXQVZ5<\7:?JEUXJ\+7UCI<]W;Z;<RS7#1R1*<-&4  =UR<FJL_AS4M<^
M(EIKSV+Z39VUC-;2LTJ&:[,@P 0A8!5Z@DYSVH VCXTTQ4M;EX[E=.NY_L\&
MH%5\AW)*CON )! 8J%/'/(RS_A.+!M9NM+AT_5KB>TN$@N##9LRQ%UW*S=PN
M,<XKF8?"^M77P\M? ][8M&;>:&)M061#$T$<JN'4;M^XJH&".I].:Z'0+'4;
M+Q=XLOKC3I4MKZ:"6V?S(SY@2%8R,!L@Y7C../2@!+#XAZ1J%@VH+;:C#IZP
MO,;R:U(BRLFPID9RY/11UZ=<BM!/%%O_ &DVF3V5[;7YMS<PV\JINN$'780Q
M4D<9!(/(XQ7(6WA'6KKX0+H$D'V+5H)C/$DLBLCLMP9E!*$\$8'L:WO[.OM>
M\6:#K5UITVG)I4-P62:1&9Y)55=HV,?E #$DXS\N!UP 30^.M-N+#1;Z.WO#
M;ZQ-Y%LY11B3GY7^;Y3\K?ECKQ6A-XAM8)+J.2&<-!<);* %/G2LH8*G/)PP
M)S@#OT..*O\ P%J<]KXALX9%2VBN&U#0@&YCN6VR$GT"R*P'M(U:7B'PWJUS
MX4TN2UM[:[U>RO5U*>TE($=S(0_FQY/ '[Q@I/3 H O77Q"TBQLM5GO(;V"7
M2I(X[NV,0:2/S,;&^5BNTYX.ZMW2M575HIY%LKVU$4QBQ=P&(R8 .]0>JG/!
M^OI7$:YI6KZUX&U2"T\*1:;=71@6.T22$2-LD#,SL"%Q@8 R3U]>/1(V+QJS
M(T9(R4;&5]C@D?K0!YOI?BN+PW=^+Y=0&J7=I:ZOAI%W3"UB,47)+'A02>!D
MCTKL=4\26VF?: MM<WC6L N+A;4*3%&<X)W,,Y"L<#)XZ=,\;?\ A[7+CP[X
M^LTTF7SM8N7>S!FBPZF)$R3OXY0GGMBI;G2=8T[Q3+J:>%H=;L]2M8%DBDDA
M66SEC7;_ !G!4C&<$\C\P#;G^(6D)-;Q6EOJ.H/<V'V^ 6=J7,L65'R],GYN
MGL1UXJQJ/C73=+MY;NXANS802K#<W:HOEV[D@88%MW!8 E00"<'H<9]MI.IP
M>/\ 3-0;3$2RBTB2TE>W9!''(\B/A5)#%0%(SM].*RK71-8TK6]6L6\+6.JV
ME]>RW=KJ<KQ8A$IW,LJM\QVL3C;G(XXH (/$X\/>+_&9N(=7U"U@DMI%2W5K
M@6Z& ,QY.%7))P/? XKJ;?Q?IMWJNFV%NL\@U.V-U:7 4>5+& "<$G.1D9&,
M\UDPV.KZ3XI\3W46DO>0ZHL#6LB21A R0B,K(&8%1D9X!X]^*H:KX5GT'X=Z
M';V%Q&VL:$\#6<K A992P1H_7:^\KCW'I0!V^GZE'J)NO*AE1;>=H"S@8=E.
M#MP3D \?4'TK U#X@:9I]UJEL+#5KJ72]INEMK0ML5EW;^2/EQS[]LX..@TF
MP&EZ5;V8<R-$GSR'K(YY9S[EB2?K7%:?=74'Q \=);:9->LZV84(Z!=WD<!M
MS# /J,]_;(!9OM4CO_&_@B]TZ^F>PU"&[DVI*PCE41!D)3.,C)[9K6N/&>FV
MLUL98[D6=S=?8XK[:IA,V2H7[VX L"-VW;GO7.Z;X2U+0[SP':Q6[75OHUO<
M1W=PCH%5I$ X#,&(W9Z#IBH_#6AZQHSC0KKPM87$4%PQ@UMFB(:(N6!9/O\
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MI-*;2[6W$?VK4[Q;2)Y!E8_E9V8C(S\J' R.2* -NF331V\+S3.J1H"S,QP
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M;8+/(H5YG8NY4=%W,2<#TSBJ,7@KPS"04T.R&V?[2 8@0).<, >!]X\=.<T
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MJU@!9$W*8O3BVZ_O3C=Q^ )^@)KE-%M8K[QMXYM[JW=[2\^S)^\C8),@@V.
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M+VT@R5D(P?ER,'(Q@\XZUQ-])JUWHFG1:M$EZ\/B>V(O;:U*K>0(5)G9 "
M/E)Z?+QQ0!Z+:>)=$OK.[N[;5+62WLR1<2"0!8L#/S$]!CG-,DUJVO\ 3]17
M3+U!=VL19E9#NB)4E2R-@X..,\&N#UN:2WUCQ_<1Z0^HI+;6&R%[=WCFV[@Y
M 'W]@(8@'/&.*L:;<-_PF7B&Z;^TIX+O183%=3V;QB0J9<X&P =0 ,9.>_6@
M"Q;^)=:D\.> +]KQ?,U:X@BO?W*_O \3N<<?+RO85W=_J%GI=E)>7]U#;6T0
MR\LSA57\37F%JLL?@WX:0O;W EM+VW-PAA?,(6&16+C'R@%@,GUKM?'ZM)\/
M]?ACC>266PFCCC1"S.S(0  .2<T 7['Q'HVI:@]A9:E;3W:1^:T2/E@N<9_,
M@'T[TY?$&DO?)9K?PF>1VCC&>'=?O*K=&88.0#D8-<3<122^)?!XLDDA*Z/=
MP&40L%A=DB"!CCY3E6X/I6;%:W.I_#/1/#*6L]OX@L;JV1D:-@;=XI07FW8Q
MM*!B&!P=V!DG% '?:3XJT[6=:U/3+5R9;"01.2"-S;03CCH,@9[UH7NJ66G%
M!=3B-G5F"X+':,;FP/X1D9/09%<SX9,EKXY\76\UO<(UQ=PW$3F%O+>/R$7(
M?&W[P(QG/'2HO&5NSZS:W5CJMQI&K6]JY@N3"9;:92PS#(,8R2%(Y!ZXSB@#
MIX=<TRXN5MH;V)YWMA=I&IRS0\?.!W7D<CUKF_$/BP0/X;O]-U:V_LJ[U(VU
MU)A2I0)(6^8_=P8\'\:R;2]NK'Q7X8UC5]+GLEN- >T:*WMGD6*<O$XCPH)7
MA3@'TQVK&TZ&=/"OA::YT^\2.Q\2SSW0DM7/E1L]P5<\<K\Z_,,@9ZT >AR^
M)]&U3PW?WVF^(K."&)'C-]N5EMGQP65N,C@X/6KKZQ8Z?IMM->7Z.)(0XE"<
MR@ $N%7G'()[#-<'K5AYMM\1==MHC'I]YHAA5BA47$B0REI #U #*H;O@XIM
MQ=#1=;T34M4MM3?1KG0X+5;BQ\X^1,I+$.L1W88,O.#RM 'H3ZWIBV5O>"]B
M>WN1F!XCO\T8S\@7);CGBLJ]\<:):2Z,J7:3IJLC+#+$=R!55F+$CW7&.N3[
M&N2C^S^#==T'4H=&O[;PT;&XM418Y9WLW>82!W7YG4.!TZC@''2KFJI#:W?@
M[4;/1KBSTR'4YY&BAM&W()(I ':-5RNYFS@C(W#.#P #N=5DFCTB[EMI?*F2
M%G1]H;! R,@]161X$U.^UOP9IFK:C,LES>0B5PB!%7/8#_$UJ:S*L>A7SN&&
M;=QM"DDDJ<  =3]*XOP/XBM-$^'&CVUW;:B+RVM CVRV$Q<N/X1\N,_I[T =
MEJ.O:5I+8O[Z*WP 6+GA 3@%CT4$\9.!4%[XKT#3IIH;O5[2*6!!)*AD!95/
M3('//-<-=R6]GXG\0Z=XITS5IK?6#');-9_:)(IU,*1M"1$< @J>H'!SD5H:
M;!#9?$>4M9O;VT/AVWMEW*SJA61R8Q(1\Q"E>^30!V;ZSIR6-O>_;(FM[G;Y
M#H=WG9&1L R6)'/&>*YSP?XF?48/$5UJ&HPS6MEJKV\$VT1JL82,A?KN8CGG
M/'M7%^&);O0[3P)J.H6EX--MK*YL[C%NY:TG=AM9T W $#;G'&?>G2B]-GKM
M]:Z9J4L$'BE=1EAB@EBDGMO*528^ 2P;YL Y^6@#TMO%>@I8W%Y)JMM%!;2"
M*8ROL,;GHK*<$$]AC)JWINL:=K"SMIU[#=+;RF&4Q-N".,$J?S%>9>)8M(U/
MP+XFU'0M+U-Y=0B@B>:X2X,ERR.,*J298[1GY@,<]3@X]5M_),*O;JJQN PV
MKMSQQQ] * ,;2O%NF:OJ>JV4$N&TZ3RY'<%0<*&8C/89QG^E7K+7=+U&Z-M:
MWL4D_EB41\@LG3>H/WE_VAD5YOK&G:I>67Q'T>QM;D7]Y.EQ;@Q,$FB\J($!
M\;3NVLN,Y_6MVX=?$_BGPEJ6EQ31_83/+=L\3(88VBV^4V0/F+%?E_V2>U '
M=UG7^O:5I;LE[>Q0E%#R;CQ&I. SGHH)!Y.!Q3-!U^S\1Z>;VR6=$61HG2XA
M:)U88X*GD<$'Z$5R5G(=)UOQE9:W;S2)J,OVBU<0LXN8C$$\I< Y9=N-O7G/
M2@#JM1\4Z#I#E-0U:SMW$)G*O*,^6,?-CTY'UJQ?ZS8Z;HDVL3S9L8H?/,D8
MW;DQD$8ZYKSKP_I-WI6O>!;+587EGL]%N()W,9=(G;R]J%L8!P&7KV]Z[[Q/
M;2W/A#6;6WC+RRV$\<<:#EF,;  "@"G:^-M!ETRPN[G4K6T:\@\Y(I90&&$W
MMUZX&>?:K#>+M 6".<ZK;F&2-)1*&RJHYPC,>B@GH6QFN(AG2ZN?AHYM+KR[
M176<RVLB^4?LI0%LKP-^ ">XXJMXX:6XC\::7!IEU;R&QC\@6EDS?;P(_O-(
M%( 3[H4$'@]<@4 >B7WBC0M-N)K>\U6TAGAC$LD32#<JDX!(Z\U-_;FF&SMK
MM+R.6"Z7? T67\Q<9RH7)(QU/:N0L9XY?B?#?M!.D'_".K&)9;=U ;S2Q4DC
MAMO..N.U<[H=B3X,\,(+^^T+5K1+SR+LVY,<?[T$Q3(PQM8%2,X^[P: .S\2
M>,;6QBT1+.\3;JUTD:W*#=LA*LQ=<@@_<P,@]<XJW:ZS#H5H8M>U^"XD,FY+
MAXA%MB<_N_,V_*I[;OE!]*Y6\NK^YTWP#-J.GFVNTU,37,4$#[(D$<J[R,?(
MIW*<'IN]JBNFLK;Q%XCTCQ-IFL74&JW GM&M!<-%=1M$B>4?+. RE,?-CC'.
M* .YO/%OA[3[J2VN]9LH9XV17C:494N<*".Q.#6I<7$-I;R7%S,D,,:[GDD8
M*JCU)/2N(T6UBB^)NH*UDT<8T:T@C+(SH&1G+()",,1E>^> :O\ Q$M;^X\.
MV\UA!)<_8]0MKNXMHAN::*.0,R@=SP#COB@#;A\0:1,ETXOX4%HH:X$I\LQ*
M>C,&P0#V)X--TSQ)HVM3M!INI6UU*D23,D3Y(1ONM]#7):BJZMXP&O:?YAL;
M?1+B"YF$; 2L[ QQ@$9)&&)';('>MGX=0K!\/]"C-N89XK*.*5'C*.K ?,""
M >N?SH ORZA GB@6[:Y;IY5D\LNFD+N W+^^+=5 !QCH<Y[4VV\8>';RXM+>
MVUFSEENR1;JDH/F$$@@?D<>N.*Q[MO+^+UG<,D@@31)HFF\MM@8RQL%+8QG"
MDX]JX_3X7A^'7A"$V=PD\'B&.::/[.X>-!<.2[#&0-I!R>QH ]>N;F"SMI;F
MYFCA@B4O))(P554=22>@J@GB31GANY3J,$:6:AKGSCY9B4C(+!L$ ]CWJEXY
MF>'P5J<L>F+J9$8_T5HS('!89)4<L%'S8'7;7$23/)KOBN<+J=U%?>'46&XF
MLG02L/.& -@QRP &,G/?K0!Z#:>*="O[Q;2TU6VFN&A\]8T?+,F <@=^"..O
M-/@\1Z/<Z5+JD&HP26$1*O<*<HI!P>?8]:X6Q3R[OX8;;>51;6DB3XA8>23;
M!</Q\N7&.<<U=BTB\LO'-WH4,6=#U&5=88@\1.I_>1X]'D$3>F"] '<7=_:V
M%A)?7<ZPVL:[WE?@*OJ?0563Q!I+W-G;+?1&:]C\VV3)S,G7<OJ,=ZO3P17-
MO+;S('BE0HZ'HRD8(_*O(UTSQ%8:+9W:VL\MQX.O#;VJ ?-?6Y;:V/;R&C _
MVE;TH ].?7]+C1F:\3Y9S;[0"6,H&2@4#);&3@=JB;Q1H:VEK='4[?R+N7R8
M'W<229QL'^UG(V]<@US>M>9HG_",13VCLSW$KW.I06K3O:RNC%BB@'!=F902
M" .W3&7X?T&37? _B'1Y([NUO%U:ZGM9KB%D9)?-+Q2 D<\@$X]?>@#T<7]J
M=0-AYR_:A'YIB[[,XW?3/%0ZAK&GZ646\N5C=U9U3!9BJ_>; R<#(R>@R*QO
M!,U[JNE_\)!J=O\ 9[W4$C'E9SY<:#  /<%C(X]G%4?$5VT7C6SMVL[B))=/
ME5=0MK5I9)&+K_HX8*0@.-Q)'I@C!H M>*?%]MI>FZ5+9W43#5+N"&*=/G58
MG;YI%Z@_+G'49(X/2L<Z]?Q>(X?#4OB0M]JAFNHK]+5!*B_NQ%&05*,<NQ)V
MC( Z<UA6)E3X;> +>2TO$FM=4M#/&UM(&C5"VYB,9"C/7I767<H/Q<TN8)(8
M1I$\1F$;% [21LJEL8!(4G&: -FQUNUM19Z9J>K6LVJ-B%Y$3RTEF Y5>H#=
M]N<^U6;C7])M;Q;2>_ACF:18<,>!(PRJ%N@8]E)R<UYSX?BL98(?#6OZ/K$V
MMV5\TJ*6N!;R,)2ZW <'RPO.3GG.1@DXJYH%Y';1W_A77=$NKO4AJDUQ 'M&
M>&Y#RF1)O,P54#(R2<C;CD\4 =AI7BK3M8US4]+M7)EL'6-R01N;;N...@R.
M>]:=[J%IIZ(UU,L?F-MC7!+.<9PJCDG )X':N6\-&2U\>>+[>:WN$-S<P3PN
M86\MXQ BY#XV_>!&,Y]J;KS7&F_$71=9N4D?2/L4]F\BJ66VE9D8.V.@8)MW
M=!WQF@#?;Q-H:6$%\^JVBVL\@BBD,HP[YQM'^UGC'458TS5]/UFT-WIMY#=6
MX=HS)$V0&4X(KRS6=,F72]<NA:SM8ZEXCM+FVMQ S%HT:+S9=F,A6*L>1R!G
MN*]=C$83=&%"M\W QG/.: ,5O&?AI2@.MV/SS_9P1*"/,R!MSTZD#Z\5;L/$
M&D:I?7%E8ZC;W%S;@&6.-\E1G&?<9XR*\NU"!Y?AOX[@2SG:>ZUJ>2&,6[;Y
M5,J%648RPP"01Z5N^(+>XO\ QQ+'I8>-Y_#%U:P7"QLJ)*SJ8QNQ@'J<>U '
M:6_B#2;J]CM(;^%YY QB7/$NW[VP]'QWQG%<Y\1/%G]A^%-4ETS4HH-3M@N#
MY8D"L2/E.1M#$'(!Y]JQ$BDUWPQX+TRUM9[;5-,O;1[F)X60V@A7$NXD8 (!
M _O;AC-8VHS7,/PT\5>&KZQOGUPW<\NU;61Q=!YMZ2*P!!&"!UXQCTH ]0.H
M0CQ1+;_VW"?)LC))I@12Z?,/WQ8?,!@XQT[URMIXR&HM<:M)XB@TVQLM4EMI
M8)H5,4D"-L!+$!E=B,@[L<@8-74F$GQ<2[$4ZV[: 8_->%U4-YP;:21PVWG!
MYJMX0TVVUKPOXDTF_@E6&]U2^+)+&R,8Y)"5<;AZ$$&@#M6U&T2YMK9I@LUR
MI:%"""X R<?3(_.K5</X*?5)+*?4-?1FN-)CDTU'0;S,(F/F2J!R=^U!CKE#
M74:)K-KX@TB#4K(2B"7< LT91U*DJ0RGD$$&@!DGB'2(KX63W\*SF80 $\>:
M1D1[NF\CG;G/M5:[\8^&[!KA;G6K*-K=Q',#*#Y;'L<=/?T[UYUK=S-<K<J-
M-OK5[3Q/#-):6U@Y1HUF7_2&<*=[,.?E/?H<9K1NE$MY\3I/LLV;NRC2#,#9
MF(M=A5>/FPW&!GF@#T$:UIIU5=+%[$;YXO.6 '+&/^\!_=]^E3VM_:WQF%M,
MLA@D,4FW^%QU4^]>?ZG!=67A#PMXHT^W>74=(@A26W/R//"ZJDL1S_%G!&>Z
MUW&B6#Z;I$%O,P>X.9+AQT>5R6<CV+$_A0 E_K^E:9(T=[?10E &D+'B,$X!
M<]$![%L"N=U3Q2=%\?Q6^HZI!;Z(VD271$BJ )!+&H.[J>&/ ]:S;5VTN\\;
M:;K5M/*VHW#W-JPA9Q=0O"J"-2 <LNW;MZ\^G-4]#T^Y\,Z_X4?7%DQ;^'6L
MWN3&71)]\9V%@" =H8#UQ0!T/B;Q)(-%T35- U*"2UN]4M8&DC59%EBDE"L
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MA,+( '5&;!R1UV]>@[FLZ\\>)9VDS2Z>([VUMEN+NRFNXTDCR"=B\D.^!G'
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MJYMEV;[><L%P>?F'((*YSD=*Z72KRZOK$37NG2Z?/O93!+(KD $@'*DC!'-
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M+?V8OHDN9U@ B(&-S'/)S@  ]#T S0!T]%9/AKQ!:^)]"M]5M$DCCEW*T<H
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M7@C;GC/6I=1\.^(;V_0-%83V3:4+58IYVQ:7'(:15"D/D$ '@C';)SWE% '
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MC&[A/P!4"O2Z* .&\,:+XI\.)_8"_8)-%BN'DM[\RMYRPLY?RS'MP6Y(W;L
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M <7-X3O[KX7V.A.T,.KZ?;0?9ID?<J7$(&Q@< X)7TZ$U-XG\-7^H?#V;0;
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MY]*[FJFF:A%JNG17L,4\4<N<)<1-$XP2.5;D=* .=TOP[?#5/%IU".%+/6I
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M=MEG6'.Q,]%4GD@#C)Z]<#H+5%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<]XTU:]T;0DNK/Y
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MO:K-9RWLTZ*I=@K*JHNX$#EB2<9X'K6UI6G1Z1I5IIT,DDD-K$L,;2D%MJC
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MION)@&E(6($$9S@L2,!03D54O=5U;6/"FF-=:C=0SP>*X[!V18U:1$N=JEP
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M-Q;R7+VTL%J;UUN87B/D#K(-P&5&.?3O0!?32=-CMYK=-/M%@F_UL8A4*_\
MO#&#^-9L^E:K=ZVBSW%BN@0-'+#;10L)F=.0&;.W:& 88&?E ]<M/B2QU6&[
MLK*ZN+>]^Q?:X]T!C<Q'(61=ZX(S^7<"L+P3X[TZZT'PY8ZE?S-JE[:IB::%
MPDTNW)42$;"WL#[=>* .]JK)IFGRW#7$EC;/.Z[6D:)2Q&,8)QG&*YCP]J\T
M.K^,/[3U&22UL+Y%C:;'[M#"C;0 !W8XXR?<UNZ?X@T_4M1N-.A>6.]@19'M
MYX6B?8W1P& RN1C(Z'@XH F_L32O+CC_ +,LMD;;D7[.N%/J!C@U86SMDGEG
M6WA6:8 2R! &<#H&/4_C7-:Y>7MM\0?"EM%>3):78NQ/;C&QRD65)XSP3ZXJ
M_%XNT:>\M[:.Y<_:)WMH)?*?RI)4SN17Q@D;6[\X.,XH O0Z+I5O:RVL&F6<
M5O*=TD20*J.?4@#!-3#3[(61LA:6_P!D(*F#RQL(/;;C%8TGC?0(M,OM1DNI
MUM;"X^RW3FSFS%)QP1LS_$.<8Y'-:RZG;-J"6 ,OVAX?/"F%P F<9+8P#GL3
MGVH :-'TP6*V(TZT%FARMOY"^6I]EQCO3SIM@;+[$;*V-IU\@Q+LZY^[C'7F
MK+J61E#%"1@,N,CW&>*\Z\&>/+&#0+"WUW4[B2^GO+BW^TS0N4W>?(J(T@78
MK%0,#(XQ[4 >C  # &!55-,L(KZ2^CL;9+N4;9)UB42./0MC)J@_BG2(TU9W
MN)0-(P;X?9Y,Q KNSC;EAMYR,\53;QE:-XGTW2((+F5+ZR:\6X6W<KMR@7&!
M_MY)/ XSUH W+73[*Q+FTL[>WWG+^5&$W?7 YIMKI>GV+S/:6%K;M.<RF*%4
M,A]6P.?QK/\ %E]9V&@R27VI7>G0M)&OVFT4EU)<8'"M@,<+R.]37OB'3[">
M:*9IF, 4S&*!Y!%N^[N*@XS^@Y.!S0!9@TG3K4PFWT^UA\G<8O+A5=F[[VW
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MS^--FT;2[BS2SFTVSEM4.Y(7@5D4^H4C K"_X2ZUL]4\/Z/&M[=#4+0SK=M
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M"[%8J!@9'&/:M^77M.L=6\03_;M0N9=/M8I+FP6)BL0^<@QC:,EL')R1P.E
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M-I<EB;%]-LVLR=WV=H%,>?7;C%7:* &111P1)%%&L<: *J(,!0.@ [4^BB@
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MO=4NH80L1,;,\,:C<_W5P<$Y(XZ9KU2LG1M M]#EOY+>>XD-]<M=3"4J1YC
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIW.K1[3OPQ)&",]R.VKHFEZA9^-?$FHW%N%M-0^S^0XD!/[M"AW =,]1^N*
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M)L"2&5<JV""/U /X5-;6T%G;16UK#'#!$H2..-0JHHZ  =!7%WFI^+)?%_\
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M92.0>,=\TRUU;Q/_ ,(_I^JWE_I:PZ@+1CB$JUNKH2^W)/F.3M"@ <D\'&*
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M)15#2HM5BBG&K7=M<2-,6B-O"8PD9 PI!8Y(.>>_%7Z "BBB@ HHHH ****
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M7\!1:K=:](-7O;>WUN!8KJWC5""RIL5@2I(XQD \XK*BL[J#XJ1PVVI2;H=
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MVFHZ:XDM=0MP Z-C:<J<@@C@CH:EA\/7L$%LPUVZEOHYC-+<S1H1/\I78R*
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M5H:=X>;3M<UG54OG>35"C/&T8VQLB;%VXYZ#G/7VK:CD6:))4.4=0RGU!IU
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M70KX*\,HLBIH=DJR,6<"(#<3U)]34VH^%/#^K6%K8W^CV=Q:V@"V\3Q#$0
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M!KCZW%I%FFIODM=+$ Y)ZG/J?7K2CPOH0UTZV-(LQJ9ZW7E#?G&,Y]<<9ZT
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MKM 7;SD'!/-=ZOAG1$BLXDTRW6.R;=:J%X@/J@_A_"D/A703KO\ ;G]D6?\
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M!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:*7;MF\P! VPG<26//')8UD+I6F7OPUNX[:"V/BA=6F6T9 /M4<_VMBF/XE
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M K?KB?A)+!)\,])2!T81>:A"G.TB5^#Z<8KMJ "BBB@ HHHH **** "BBB@
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M"S!Y$BBCC&6ED<X55'J2?IW. ,T 7:*YW_A,;&%-4^W6UW92::8Q+'-&#O\
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M!I\KRVML\YMF= WR@DY()';)P3[9/% &J(T4DA%!/4@4V.WAAQY4,<>,@;5
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M2&# ]""""/:O/]:U*;7OA!KOB8SW$+W,$TEH(I6C,,*L0@&TCE@NYO4MCH
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M\F+SO.\M/-QMW[1NQZ9KS&SU"ST_P/XPEUD:E=Z?!K=U$X@G8S+&'4* Y8$
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MB,] >YZTP>'=:75=>NH-"CMX-2T5;5$%VK2"8>8/G)^\QW@ELG@=2>*]*HH
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M1/,C<*2"=K?NSUXY'->ET4 8*:SJJ^(K'3[C1EBM;JV:4W"W2NT<@)RA3&<
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M7FBVD !CC@-@D9&0,=,UR/\ PB&OIX8URQCTRUBD?74U.UABN!MDC$L;E!P
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M2"]\Z 2)<%,[)-H*[7 )'ICM6IHFCVN@Z/;Z;:;C#"#\SG+.Q)9F/N6))^M
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MX/L_]FR7VHA86W1E>-B_-\IW"0<Y_P!6:V-5\-6>K:UI.J3%UETUW*JO D#
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M[D2\\47WB?3XM9&G7.FW"Q6[^;('MHA$C)+@. P8EB2V<]"<"K&GW3^)-?\
M$FGZC>RO_9MI;);B"1H0WF0[VG !')8X&<X"X[G(!UWAS64\1>';#6(X6A2\
MA$JQL<E0>Q-1>'O$"Z^-3Q:26K6%\]DRR,"6*JIW<<#[WJ>E9OPR_P"29>'?
M^O&/^5<6^E"XT/Q_JJ:IJ%C=:?JUW/;26]TT:(Z0QMDJ#A\X .[/'3'- 'K]
M%>;W6JW7AO5=#\3ZM+=BQU.P$%];F5REO=; ZLL>< MADP!UV^M=KX?LI[#1
M8([N21[I\RS^9*TFUV.XJ"2?E7.T#T H ;K.O0:3I.J7RQM=-IL)FG@B8!@
MI;N0.@S5S3KP:AIEI>A"@N(4E"$YV[E!Q^M>8-8V\%G\5I$,H95F #3N0=UF
MK'()P3G/)YJ]I,,FE^(_! @O+UDU32YENHY+AV1]D4;(0A.U2,G[H'6@#O\
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MEPR-<VR"7&\@_,<KC=URN<YYH ]?HKS5_#J'Q]'X=&KZT-._L)I=HU&7?O\
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MD/\ M;!,>>A916_J*QQ?%7PXL:;8HM-NHB57Y4),6Q2>@R%.![5VM(64$ D
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MEE4%MA4D@@'G'6O9*Q]=T)]8-E-!J5SI]W92F6&6$*PR5*D,C AA@D>HSP:
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M!@:*YQ.^7)A\K*?)^/./3WH CT+QK>'0+S4];AMHB=3ELK=8[C@N)3&%)90
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MPW4;%FC7!*R2)M^5& X.X]1D#.!1/Q#M#/8R0P13V%Y=_95DAN0\R$DJ)&B
MXC)'7=D @D4GA+0_%6@VMKH=U=:=)I%B=L%W&7^T2Q _(C(1M4] 2">!C&3D
M,\-Z!XK\/!=$6ZTV308)2UO<DO\ :EB+;O**XVD\[=V>G:@"2\^(=I;,L\4$
M5Q8_;/L;M%<@SJ0Y0N(<9*!@><YQSC%9WC[63K'@7Q;%9:?'=6=C%+;S3R2[
M2)57+%%VG.PD9)(Y!QG'-W1M \5Z#=7.EVEWIKZ!)<R3PSR%_M-NDCEVC"XV
MMRQP2>,Y(/2J%UX-\10:7XKT/3VTZ;3=:>XG@FN)G22W>8?,A4(0RYZ'((R>
MO2@#8C\4FV*:396D5U?6VFPW1@>X\N256!XB7:=Y&PYZ8R/6NL=MB,Q!.T9P
MHR3]*X+7O!NHZ]IBV=Y::8T\-M&ME?QSNDUG,!@LI"9*Y 8#(ST/J.VE@G;3
M'MX[DK<&$HMP5R0^W ;'UYH YRP\9O<:OI>GW6E/:RZG:R7-O&9LS($ .V5"
M!L8@^I&01GBJ-O\ $2::PLM2DT&:+3Y]1.GRRM<*6B?S3$"% ^8;@,\C&>,U
M5TGPAXDM+_PS>7 T@2:4D\=TR32,UR9%4&4L4!+DKD@],YR>E(O@O7E\&0:/
MG3?M$>K_ -H%_M#["GV@S;?]7G/.WI[^U %SQAK)U7POXLL[+3X[RWL+66&Y
MEDEVXE\K<0@VG<5!4G)7G@<].B\*_P#(GZ)_UX0?^BUKEIO"GB&S'BJQTTZ=
M-IVO>=.#<3.DEM-)'L<8"$.I(!'*XKK] L[G3O#VG6-V8C<6UM'"YB)*DJH&
M1D ]J ,*[\<I;Z/<:]%IYGT.VN&AEN4E_>;5?8\BQX^9 P/\0. 2!TS'!K-_
MJOC;6-%EM;.72(;&"13YI8LLGF?,1MP<[0,9P ,Y.<52A\%:K;>%]4\(QRVC
M:1=RR^3=&1A+##*Q9T*;<,PRV#N .1G&,'3B\.ZEIWB^\U+3Q9-87.GPVOER
MR.KHT6_:!A2""''.<C'0T <W\/\ Q+-I?@_P98W&EN+&_46D=YYRY$N'8#9U
MVG:1G/4=,<UNWOQ#M+4B>*"*YL5O#:2-%<@SJ0^QG$.,E P/.<X&<8K/LO!F
MN6OAGP?IC'3FET.]2XF<3OMD55=<+^[ZG?GGTJYI&@>*]"O+K3+*ZTU]!FNI
M+B&>0O\ :;99'+N@7&UN6."3QG)!Z4 7;/Q;?:AX@O=+M?#\[)8WB6UU.US&
MHC5D#AP/XNHX'/\ *M/Q!K]OX?M;::?RQ]IN4MHVFD\N-68$@LV#M'RGG!YP
M.]4O#VBZCIOB'Q%?78M?L^IW*3P^5*S,NV-4PP*@?PYX)ZU>\0V-QJ5C%;16
MEC>6[RXNK:].$EBVMD [6^8-M(X[=10!0NO%%SI[Z6M[I7EF_P!1^P#9/NVD
MABKCY1N4A2>QY'%5-3\=?V9;^*)'TIY7T#RVD6.88E5TW@@D#& >>#^-9:^!
M-3L/#]C;:=+;F73]:&I6EG/<.8HH@"OD"3:6 PQ(.TX)QSUI-0\&^(M1M_&:
MN^EJ^OQ0I%B60"(K$$.3L.1[]\9P,X !L/XOOTUZ'26\/R":[M6N;)OM28D"
ME0P?CY,;@>-W'OQ4=OX^MY=)L[B>U2TNKC49=-:*YN L<4\>_<#( >#L('')
M(&/2>70]6E\7:'JY2R$%C936\J>>Y8M)LY7Y,$#9WQUK,LO">JPZ5>6%_8Z/
M?VMYJMS>7%M+*S*T4K,P )CX=6(_Q% '9:;<W%W9"6ZM#:S;W1HM^_&URH(.
M!D$ ,..A%6ZP?"&A3>'- 73I9S(J32-#'YC2""-F)2,,W+!1@9-;U !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9'!J2ULK2RMA;6EK#! ,XBBC"KSUX'% '$W%K;V/CKPG/X<2**WOH;@7:VP
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M]T4Y(&UP!\O4')X(Z9KBK71=>L_"/A&9_#CW4V@[H+O39FC+3HR;6>/D@[2
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M[ZU02)-$S%E# '*,,X.1CCK0!O6]S-H%JT6L7\E[-/>-'9G8/-F!&50*H R
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M,WR-)9R/"VRY"C<=A[G'('!(Y&:AO;R_UV&;28=)OK.*ZMY4EN[E458P4*@
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M#)'*Q#W#1J&D"$<+C) R#D@]!S63JFKW>L>*_ MYICP&RO8KBZ@6;<,DP=6
M[@.0/J: .Y&JZ<UK#="_M3;S#,4HF78X]5.<'\*L12QSQK)%(DD;=&0Y!_&O
M/_BIIMC8_"N]M;2T@@MUN;=EBC0*H+7*%B /4L?S->A !0   !V% "T5Q$'C
M>_O3IE[8:3-=Z9?7(A(BMIO,BB)(68OMV%> 2!T!ZG%4KGQ]K=OI&LZLVD6(
MM-'U-K.Y7[2Q=T5D4E/E S\^><>F.] '7:OHMCJ-U8ZA>32QMILAGA99-BHV
M""Q]>"1SQ6C;7,%Y;QW%M-'-!(-R21L&5AZ@C@USE_K-SJ=]K6DZ9!:R?V;
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M*C' '/ XZ@ ]/HKBD\;7MM#=Q:CI,\=PE[%:6DHMY4BN_,!(959=_P H#;E
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MY-ZHY#@''3(QD>E='K/A:+6->T;56G,4M@S+,J# N(SA@A]A(B-^!'>NAHH
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M_P#F$DB1&,. Q"ML/W25VDCMGMTK5HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE_'S:A:^&)=
M3TV>>.;3G6ZDBA;'GPJP,J'ZH&QCG(KJ*:Z)+&T<BAD8%64C((/:@#S8>*9(
M?%FHB.ZN+G3=5L_^),6E.QKA=JNB$<\M(G)Z;6Q@5KROJ%AX]T#2#JMW-:S:
M7<F57(^>1#&!)G&<_,>^!V K=@\,:/;6VD6\5DBQZ0=UD.3Y9V%,^_#'KWYZ
MU+/H5A<Z[;:S*LIOK:-HHG$S!55L;AM!P<X'4=A0!Y.+9H_@W<2"YN))'UP+
MF:0R8(U'&>>YZGUKN=&FO;'XB:KHTNI75[:-IT%ZGVEE8QR-)(C!< 8!"@XZ
M#M5U_ F@265S9FWN!;7%S]J>);N4*)-^_*C=\HW_ #8&!FM&'0+"#77UI5F-
M_) MNTC3.08P20-I..I)Z=Z .:\1+J5Y\0--T>#6[ZQL[O3;F21;;8"K(T8#
M*2IP?F[Y]L50$OB+Q##K2Z5J:6UYIE\;2"::[90@C"Y,D2QE7W\DD_WN,8KM
M)]!L+G7K;6I%F^W6T;11.)G"JC8W#:#M.<#J.PK/O? N@7^NOK$UK*MU*%%P
M(KAXX[@+T\Q%(5\>XY[YH YW5M=O=-\0DZRU[!ILUS;?8]3L9"]M&,)NAF0?
M=W-N&\@\..1BJDR:]J:^-6B\4:A;2:1=L;+RQ&%&($D"O\O*Y.,<=23D].WG
M\,:;<W%Q+,)WCN9DGG@,[&*1TV[25S@8V+P, XY!KG-$\-/=ZYXL?5+2^@M-
M1O Z(9ML=Q"(D7!"MQR&ST)!P<CB@"CIFNZSXQ<6:N+2<:-:785+MK=A+,K$
MR#:C%E4A1@\>H.1B[IM]JFH>(+?PSK&IK]HM](%S/+82&/[1,96C+!A@@+L&
M0,#+'(P!6[K/@O0]=N[6\NK>6*ZM4\J*>TG>!Q'_ ',H02OM^5)JG@G0M6%@
M9;:6"2P7R[::TG>"2-.A4,A!P?2@#E[S3[M?&/@:WOM:N+ZX6*]CFN(6\I9&
M1!SL!(#<D'\:U/BC$9?"UL1--'C4[,'RI"NX&=!SCKU_/![5N7/A71[H::'M
MG3^S23:F*9XR@888$J06!'4'.>]6M9T>RU[3)-/U")I+>0JQ"NR,&5@RD,I!
M!! .10!S=M<3:SXQUSP_)>WEO;Z5:VPA,4Q221Y0S&4MU;&% !XSG(/%7/ >
MKW^N>$8;C4V#7B2S6TDR+M$ICD9-X'09VY],YJ[-X6TR6]@O4%Q!=Q0_9_M$
M-PZR/'G.UVSEN><G)SDYR:T[*RMM.LH;.SA6&WA7:D:] /\ />@#QRXMC%\)
M/%3_ &FXD;^VI8QYTI?[MZH!Y[^I[UTFIZSJ?A7Q%X@1+ZYU"&+P^^J)%=$,
M%F1V7Y=H&%(QD#TKHI_ F@7%KJ%K);S_ &>_N/M-Q$MU*%,A8.2 &^7+ ,<8
MR0/2KQ\-Z:VL'59(Y9;MK7[&S23,RM#G.TJ3M///2@##T>WUTZMI&I+JD#Z7
M=6["YCDO&F-PQ3<CQ HH0\$D+@8[<50\5,R_%OP.;HXL=MV(B?N^>8^,^^.G
MXXKH-!\$Z'X;N#+IL$Z8R(HY+F21(0>HC5B0F?:M+5]%T_7K'['J5LL\.X.O
M)5D<=&5@058>H(- %J=8&11<!-@=2N_INW#;^.<8]Z\RD\0:I>_#*\\;6]_-
M#J-O--,MN6_<K'',4\EH^ARB\M][)R".!7?V.A6UE(DAGO+IX_\ 5M=W+R[.
M,9 )QG&1GKR>>:JCPAHRSW#K!(L-S.+F>U$S""27(.\IG&20"1T)&2#0!CV4
MAF^+UQ*R%"_AVW8H>JYGEXK!\)7+1^ O"5JE[-&;BYN0UI;#$UVH>4[5?(V
M'#%LC@8SS@]^?#]A_;LNM 3B_EMQ;-()W \L$D*%S@8))SC.36<G@+0([#3[
M.*"YBCTZ5Y;1H[R59(B^=X#AMV#DY&>] '!W=U?ZMX2T];^]NC):^+TL@PF(
M8QK=;5#$8W$ #!/< ]:Z*ZFUG7-7\0Z+IEZ;>;2DAAMI&O&C9':(.)74(WF
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MSQIJ,ZB1W^\3A^_>K4_A/19M)L],6R6"VL762T%NQC:!QT9&7D'DY]<G.<T
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M-G$JCHA4KG"X&#TK EU+7(/">IZZ=?OY+C3?$#6T<9*".2+[6L15P%Y^5CZ
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M&\"Z!H%^UWIUM+$=S-'";B1H86;.XI&3M4G)Y Z$@<5-;>%-,LHH%C6XE%K
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MGGD$4 >BW-U;V<#3W4\4$*_>DE<*H^I-,%]:-##,MU 8IB!$XD&V0GIM/?\
M"O/_ !'XILCKGAW67OY8?#A:ZM_[0A57B6?Y CDLK *=LJAL>O.#6/JEAX:M
M[+PS]AG%S8W/B@3++<E-LBO&YD\O  \HM@8 VYSVQ0!ZS;7MK>PF:UN89X@2
MI>*0,H(ZC([USL?BA[GQ_;:-:7%C<Z?+I\MPSPMO=9$=%P2&QC#],9K@-=F6
MS?XAV^E*AMX[O3Y+FWM<9\C8GGX5?500WXUJZCJNG:C\0;:X\.7MG-<S^&[N
M&VEMW4YDW(8UR.XY..HH ]*BU"RGNI+6&\MY+B+F2%)5+I]0#D40ZA97$PAA
MO+>25E+!$E4L0#M)P#T!X^M>9^%+GPQKR^'7.HW<FK:9"T;V#(B-;?)MF$P"
M [.#]XX)QU)K3^$MAI#>$K>^MK:S:\2>[C,Z*I=5,[X7/4# 4X],4 =W/?6E
MJ6%Q=00E4,A$D@7"#@MSV&1S[TP:GIY>W07UL6N1F "5<RCU7GYOPKBM1ATN
M3XT6:W*6C.VAS%Q(%R6$T>W(/4XSCV%<7$ND6_PNCNHOL:3P>(@(I5*[HU%]
MP%/4 (2>.Q- 'M4NHV,%VEK+>6\=S)C9"\JAVSTP,Y-*E]:2SO!'=0/-'G?&
ML@++CKD=17C_ (RUC39M/\6QV\T-I/#J=K)-$[%YYRK0XFY/R1!>!@=LY&<5
MU'B1KC0/$UGXFT6V^T+K,(TZ=47AI2";:4^V25)]&'I0!WD%Q!=1>;;S1S1D
MXWQL&'YBJ%E>RQQWTNHWVGM''=,D;0MM$<?&U9"2?GYYZ=1Q4^EZ?%I6E6UA
M%S'!&$W'JQ[L?<G)/N:\:U%M*_X5UXSC5K0)'XGS$%*C9F>'E<=.-W3MF@#V
MJ"]M;J2:.WN89GA;;*L<@8QGT8#H?K4::IITCSHE_:LT'^N F4F/_>YX_&O,
M]?1;?QAXAM/#7D0WDWA0F&*TVJ7D$C[2 O\ %M/'?D5M^&M2\)>(SI-SI*)+
MJ-K8-;^7%N!M(RHW)*O0?,H !YSR.,F@#M!?V9,(%W 3/_J@)!^\_P!WU_"D
M&HV1N! +RW\YG,8C\U=Q8 $KC.<@$''H:\;TG5]-_P"$.^&]H;N'[39ZK%'<
MQ[OFMV$<RE7_ +ASV.,X]JZGP!I^B7&M^*IH[:QEN;;7I7@944M$#%&,K_=R
M2XR/>@#O9+VUAN$MY;F%)G&5C:0!F'L.IJ-=4T]X9)EO[5HHR [B92JYZ9.>
M*YGX@0M9VFG>)X(B]QH=T+A]JY9K=ODF4?\  &W?\!K!T>RU"V\47N@75H5L
MM;D36V 0;8!G]]"W8G<(0?7>QH Z73/%#OXE\0V&J7%C!::?);+;2[MF_P V
M,OABS8)[#&*V[J:Z75[".*YLTMG$GG12Y\Z0@#;Y?...<Y!XKS35$TF[U?XH
MM="TF>.QB"&0JQ0_9B#C/0[L#COBK%G=6<OB;X97!G@:XETJ</)N&Y_W,> 3
MU/.[\<T =?X5UV\U9==_M'[,AT[5);-6B4JIC14()R3S\QS6W:7UI?Q&6SNH
M+F,':7AD#@'TR.]>1RZAY>@>*KFWE:6VM_%OGWPML2.+8>5N;;@Y QD\$$*?
M>NT\)G0+_7-1UK1-4GU*2[BC6ZG!7R<K]T?*JC?@G/<#&<9% '3W6HV-B4%Y
M>6]N7X032JF[Z9/-.N[VTL(?.O+J&WBSC?-($7/U->;>-]1T\ZOXFT\M%:WK
M:#M+S$N]VA$I"0H3C@YW, 3ST&,U7TKQ+IVGZWH-WKEW&FDW?AR&&TNYC^Y$
MX/[Y"QX#$;/KMQ0!Z%>^)=)T_4]/T^XO8%N+_<T*F0<J%)W'GIP /4FI+>[F
MCN=3>^O;#[+#(OE>6=K0IM&?-).,YR1TXQ7!W*:+H_B+P"UM%]CTE$OH;?[0
M6Z%%V#+9/S<E0>>0,=JQ=<.F?V)\5X5-IM$J.B#;@/\ 9TY ]=V?QS0![##?
M6EQ<26\-U!)-$ 9(TD!9,],@<C--&HV+7+6RWEN9U^]$)5W#ZC.:X&W&EVGQ
M,\."P:UA-QHEPKF$J#)\T17..I^\1GWKF_#\V@ZS8^%=&N]:T9I-*U"24M/.
MOG763( IB89#.6!8'G([D\ 'M,DD<,322NJ1H,LS'  ]2:BM;VUOHC+:7,-Q
M&#M+PR!QGTR*YWX@WME8^%&DU"W\ZW:ZMU.Z1DCC/FKAY".=BD GUQCO6/X)
MOH)O'_B]%OX;IYQ9SJ\*[4D'E$%U'/R]!G)[<F@#7U[7]4T_QAH.B68L_+U9
M;@^;-&S&(Q(&/ 8;LY]L>]2:9XENF\8W7A?4[:%;N.S6^AN+=B4EB+;#E3RC
M!NV3D=ZYWQS<:=_PLWP3%>WR6\:+?&1A=& IF)=N65@1DC'7GI6=9)+;_$36
MH_"%R=1MKK27>YNI)/M'D70R(D$[9)[?(6..3Q0!Z@FH64MX]I'>6[W*#+0K
M*I=?JN<B@ZC8K,(3>VXE+F,(95W;@,D8SUQSCTKRN*2'4_ 7@R#3&"^(+.]M
M5,><3Q2J<7.\?> QO+9ZYYZBM'PIIWAR[UCQI)<6NF3?9]69U,B(PB7R4!89
M^Z,[@3]: /0X=1L;ARL-Y;R,$\PA)5)"?WN#TX/--BU33Y[>2XAO[62",X>1
M)E*J?<@X%>.Z?9VL/P4T'5;&SAD9&MAJLL,8:5[59@TJ,1\Q' ROH#VKLG@M
M=7^)=M=:8\%S83:1+%J;1,'BD4LODJV.">7QWQGM0!V U33RT2B^MBTW^K'G
M+E^<<<\\\<4\WUF%F8W4&V#B8^8,1_[WI^->/M%JFF:-"RV[L_@.\8&0I\US
M;DCY5/M;MD^^VM_Q+++HVFZ#K%_Y]M9RZH;O59(HPS0;XW$9<$$$1DQKG!^Z
M#UQ0!W\>I6,MHMW'>V[VS':LRRJ4)SC ;..O%9.LZS?Q_P!G2Z&-/O89+U;>
MZ5I27VDX;R]N067DG/0*:\[\3P>&3X2U+4=/OS>PWNKV4SW,K((FE\U YBVA
M0#M'S%?SR#7K6GV%AI]L8].M;>W@D8RE;>-45F/5N."3ZT ++J-E!<I;37EO
M'.^-D3RJ&;)P, G)J>21(HVDD=411EF8X 'J37F6NW4VF>(]2O+"YM-4LWU*
MT%_H\XQ<13 1!)(&!R>!&VTC'RG'>NG^(5Y9V7@VZEU"V-Q;&6%74R,BKF5<
M,[+R$!P3Z@8[T :USX@TBUTBYU634;4V-LI,LR2JRKCMD'K[=>:I?\)EH?FZ
M5";^ 2ZDI:%/-7*@(6);GCICZFO.[F[AO9/B=%'>PWTMUHL4T30)A)<02@L@
M!.0/E&<GL,UI2ZCI)UCX=Z@+BV-EY%Q"9QC89# N%ST+$@@#KD$=: /2)-0L
MH;N.TEO+=+F3[D+2J';Z+G)HGU"RM7*7%Y;PL "1)*JD G ZGN>*\L>6&X\"
M^-=*U8J-?%Y=.L3']])(3FV:,=2/]6%(_NX[5<T[3-.OOB<UGK<%A=WI\.VI
MN8Y51P\XD?>Q4]6Z<]<4 >BMJFGI(L;WULKM)Y*J9E!+\?*!G[W(XZ\TZZU"
MRL6C6[O+>W,IVQB654WGT&3S7BNH1:,GP^\>W$2V0GAUV3R)%V[DQ)$5VGMS
MG&/>M_5M2T=O%GB72O$^JR65GJ<$/V)BJ&.YMS$%948HW(<N< YRV10!Z:+V
MT:Z-JMU";@=8A(-X_#K3H+F"Z5FMYXY55MI,;A@#Z<=Z\^UNV?PHWA_Q5IMG
M=W @MDTR\@D&9Y87"B(L?[ZR! ?]XUO_ -E^)-.TJRMM$N=)2;#R7KWL$C^9
M,YW,R[&7&6+GG/44 ;#370UY(OM-D+/[*S& Y\\N&'S#G&S!P>.I'-2IJ>GR
MS10QWUL\LH)C195+. <$@9YQ@_E7$N;1/C!"E\UE]HD\..MU@ *[>:F<@\XP
M#@'/ KCM'&DVWP_\!7D1M([G^WHE:8%0^/,D!!/7&T@8],4 >WNZQHSNP5%&
M69C@ >IKC],\4WNNW,MWIUWI*Z;:WTMO<PSL?,\F,E3*'#8&6&0"N"#UK5MD
M\3#5Y7O[G1FT?+D)%!(LP3G;EBY7TSQZ]*\ZL=3T>W^'NK2SQP7,!\1RJQ$N
MU(@;O*22%>?+'#'U''>@#UNUO;6^A,UI<PW$0)4O%(' ([9%59=?TB'3[J_?
M4[0VMH"9Y5F5A']<'K[5Y+J.H22-\0/L%R-0D<Z?<R+:ICSX %\XH!G*E 1G
M)R.YKJ-2O/#'B/0_$.I^']E[=R:%-!)/;[BJJ$8I&R] ^2<#&X =N* .WTO4
M[;6-,M[^TD5X9XU<88$KD X..XS5RL'P7=V=YX-TB2REBEB%I$I:(@C<$7(R
M.X/!]P1VK>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMH9 9+FY+"&(,JEMHRQ)8@ #(YSW'K7/O\2-,30)-8^PWS6]M>&RO0@C)M)
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MGIL8$>W>@#>"J#D  XQT[4;5P!M&!T&.E<S%XU@>^TFU;2[]6U:$SV9Q&0R
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M)%(H97!Z@@]10!YQH$.K:1<:&^M^&;PBRB6QMKDZC#,+?S-J\( K'.%&3N(
M^IJY9^$M3O/ 7B#0;I!97-[>7-Q;R%U=1OE,B9P3T. 1^6:ZC2_"NAZ-,)=/
MTZ*&11A&R6V#T7).W\,5L4 <*NE^(/$WA[4-*UK1[#1FGLY+=I[>82F5V7:&
M4 #:G?!.>@]<FGZ;XDUC1;C1]<TBPTTM:26TM];S+(;@LA3<BA04'.XY.>,8
MYR.ZHH \T31O%L^C^$]-N=(MEET._@:6X%XOES1QQN@=1C<,@C((!SV/;T'4
M[5KW2KRT0A7G@>-2>@+*1_6F-J^GIJ\>DF[C_M"2(S+;YRVP8!/L.11J6KZ?
MH\,<NH7<=NDDBQ(7/WG8X  [G)H X>TT'Q -*\#6\^F(CZ'+&+C9<HV42 Q;
MAG'))SCT[YXHNM$\412^)9].MC&;_4[>Y5!<K&TUNJHDD8<'Y&(4X/H>H->B
MT4 >8S>#=:N;3QQ:Q:;964.M6L7V14G!"NL6W:0%'4\D^I[]:]"TMKMM,MS>
MVRVUQL :)9/,V_\  @ #5RB@#@;SPO>W/BF'6+*P?3-32_4SWUO.HAN[0-RL
MJ Y9BG ^7K@Y],W5_"_B630O%VAVFG02IJ>H->V]TUR%4AVC)0KC(8%3UXQZ
M]#ZA10!PPL?%&B>,-3U+3M,M=0L]96%Y8VO/*-I,B!"<E3N0@#H,\=/6Y'IF
MJQ?$%-8FMC/;+HPLWFC9%+S>9O)"EN%/3Z^W-=;2,RHI9B H&22> * .;\ Z
M5?:'X-L]-U& 0W,#2[@'# AI&8$$>S#]:Z6LRP\0:5JEY+9V=XLEQ'&LK1E2
MI,;='7(&Y3_>&1[UIT %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5B>(M:DTIM,M;<1_:M2O%M(FD!
M*Q_*SLQ (SA4.!D9)%;=8GBCPU!XGTV*W>YFM+BVG2YM;J#&^"5<X89X/4@@
M]0: *%W?>)M,L+]KDZ84CNHEM[R1O+40,5#NZ$_>7)P 1NX_'*C\9ZHNG^)B
MMLUW)I%W!&CQVCK(T,@1F<Q$Y+(K,<#&=HZ5I7G@RYU'2HHKW7[J;4XKJ&[2
M^\E%"O$24'E@;=O)XZDGKTPL'@VYM;W5;V#Q!=BYU&6"9V:&/"O&%'0 9!"8
MQQP3WYH I1>-3)HT5W8W]IJ@OM12RLI8(R"H*!CYB%@=XVR<97/R],UL^'KS
M7YK_ %*VUBRV6L3(UG=[50S*1\RL@9L%3QG@$'I6=>_#VRU"VU(S73P7][=1
M7@NK-/*\B:,81T7)YZYR23N/MC;T/2;S38W?4M7GU2\<!3/)$D0"C. J( !U
M))Y)_   &)XN\0ZKH[:B]M):11VNG-=P(T;323R+N+!E4@I& J@MTRW7C%4]
M6\<S69TTSS0Z5!J&G)<6]Y<P-);M<-SY3N" @ P><9SU&.=/5?!7]I:MJMY'
MJ]S:Q:K9"SNX$C1MP4,%*LP)7AVR!U]J0^#[DZ0-+?6#/9OIZ6$T=S:JX8+N
M^=0" K8;'.1\HSDT =1"S-!&SE2Q4$E>F<=JXGX5C'AS4O\ L,WO_HTUU]G9
M)IVEV]A:';';PK#$9/FP%4 9Z9Z5S6B^#]2T"RN+2Q\1.L<]Q)<DO9HQ5Y#E
ML<],^N: )]6UV_?7[C1-*3;/;V:7,DODB7EV=4&"Z\?(2?J.E92^(_%DFI>&
M=/N+2QTV[U2UN6N8I4,I@DBV\@J^&4[LA<@^]7;WP-,][8:EIFOWFGZK;6WV
M6:[$:2_:DSN/F(PP3N+-GL6-76\*M_;6C:DNI2,^F1S(!+&&,QEQYC,01R2,
MC  'ICB@#"L?&VI/IUO97 M6UF;6YM'698R(CY98M+LW9^XOW=W4CG%4/[6N
M?#7C#QMJ-XT=W)!8Z>(MB>7O+-(J!N3_ !-R1V[5LR?#M);":(ZK-'=_VJ^K
MVUW%$ UO.Q)(P20R<D;3V/6I7\ QW]QK,NL:I/>C5K2.UN(UB2)1LW;67 )!
M!;(YZ]<T ,FU?Q99S:B7LXGLH]/>YBNY8 @CG7GRV02$LI'(((([YK0\'7NN
MZKI%IJNJS6)@O;&WGBBMXF5HV9,MN)8@@Y!' QTYQDP67A+4HM+N;/4/$UWJ
M3/;M;023PHOE(PP20N-[XXW,?YG.UH6EG1-!L=*\_P ];.!($D*;254!5R,]
M< 4 <_J_B74(]9UVPM7M[3^RM,2^C:X0L+@G?GN,(NP D<Y;J,<UX/$^ML?!
M4ES'9H-<8FYC$#*\68&D 7+G!&,'/Z5D^)&%SXUO#/J]WI+Q1Q0VZ3Z0MW',
M -Q>(E#CEMI .<ISVQT-OH6IZRN@ZCJ=_MNM,N))D/V3R_/!#(I="WR$HV<=
MB>W0 $$'B;5H;WQ+IE\UH=1L3$VGB.%E6=)>(B06.3YF4., 8IU_K^NS7FJZ
M;H\<<M[ID,>YOLX9)IV3>%(,@V)C;W)Y//'.U>>&K*]\4:?K\A<75E#)"%4_
M+(&((W>NT@D>YS6=J?@Z>?Q(^N:/KMWI%S<1K%>+%$DJ7"K]T[7! 8 X#>G:
M@#)U7QKJ-A<6UKJ(@T&YN;".6W:\B,D#W1W;X6E#!5VX7'/.[/L>UU-IUTJ[
M>UE6*=86,<C)O"G'!QGFL34_"3:C97>G'4"=-N[5;:6">$2D8!!D5B>'.>I!
MY .*WTLXDL%LE!\E8O* SD[<8Z_2@#S_ ,,>(M2B\,^"]/DN8IM0UR$NL\D1
M_=QI%YCDC=\[$X Z#YLXXP>BT#7;VX\2:SX?U(1/<Z>(I8KB)2JS0R XRN3A
M@5(/.#P1BJ-O\/TMM&T>T35[@W>BR!M/NVB3,2XV[&48W*5X/.3ZBM[2]%6P
MOK[49I?/U"^*>?*$V+M08557)PHR3R2<L>?0 P;JXU1OBY96<=\BV0T>6;R#
M#D?ZZ(-SN'S'L>WIR:Y?0]8UC0/#/]HVSV9T\>(I[>:W>)C)(LEVR%@^X!2"
MW P>G7M7?WWATW7BBSUZ"_EMKB"V>U=%1666-F5\'/3E1R.<>G6L?_A 6/AQ
M]&_M9O+;4?[0\W[.-V_S?-V_>QC=^E #-0\2>(+PZNWAVR6=]-NOLR0O&"+A
MU"EP7+KL^]@<'IDYS@=3?7=W!H-S>V]DTMZELTL=H3RT@7(3([YXXKGY?!5P
MFOW>I:9X@O=-BU J]_:PQHR2N %+H6!,;$#!(KH[RR^T:3/803/:^9 T*2Q_
M>BRN PSW'6@#D-+\876K:-JM[I5]I][-:VH86UPAM9+>?YMRS!F^51@8Z=#R
M>M6=%\1:AJ'B74M%%S!,L5C#=V]V;5T&79U(VDC>N5R"".#U/6C5/ ,.N+J,
MNHWQ^VWMFEF;BUA$1"JX<,1D[FW >V!@ 9JW9>%;JT\12:Y)KD]Q>2V2VD@>
M! C;68JV% ( W'@'\: .1\(:M=Z9\/O#S/Y-U=7]])!:?N,M$Y>9G8DO\Q*J
MV,;>N.:?XRO=>F\!^)K?6;+9;P2VIL[O:J&=#*A(9 S892,9[Y'%;J?#R'_A
M#+7P\^J7&;*?[397L2!)H)=S,&[@\L1T'!_&IK[P7=ZKX;NM+U/Q!<75Q=F/
MS;MK=%(6-@RJB+A5Y')Y)R?;  1>+7ET'5/%22P2:';0RR00I&?.?RP=Q9MV
M%RPP%VY'?!X$*^(/$=C=Q7E]8";1C9RW%U*D:QFV9$WC;^\)=6Y'3(.#TJW%
MX+BCU#6)#=9T_6(RM]IXBQ$[E=KR+SE6;OCK]>:;H?@VXTRW%EJ&OWFJZ=#&
MT-O:W$:*$0J5P[*-SG:2!DXYZ=, %;3M:\57MWI%PEA&^GW\)>X8QA1:$IN1
ME/F9D7/!X!/48Z5@Q^-_%<7@^P\7W*Z6^G"Y\F\M8H7$AC,YBWHQ; (./EP>
MYSS@=+H'A&?PVL<4WB2]NM(LP3:VEPJ*(5 XW2 ;G"CH"<#CT&,#P%H;:UX
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M2K''N5=S>K$*!^)('XU-7$?%"UBN-!TPRAOEUBRQM<KC,R@]#Z$\]J -V#Q
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M_A6M7'?"K_DEWA[_ *]1_,UAZ['<V?B37- 6\O0VOVB3:2XNI 8)U.R0(<Y
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M[P]917-MXQT&[U"\CTZVU+RXI#>.)(4:.-]JR$[@-Q/?N:] 4!5 &2 ,<G-
M"T5Y)<3:C=>!]9UJ#5=2-UJ.I/'H4,=W("O[P1QXY^8':7(.5VYXZUO+;ZCX
MB\8>(+2+5;^SL;6TALI);:<C_2&4N[1@Y"L T?(''3N: .]HKS:35Y[KPEXF
MUZ\OKR&WLWGL]-BBG9&S$3&KDJ07D>0=#D=!CDYM2:CJ.D>(_"=QJEU.'O\
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MJNT$GE2A?X6P&P??##\ZRY/$ C\90>'C9R S64EVMP7&TA652H'7^/OBN?\
MAO96]L_B9HMX8:[=Q@-*S#:"O8GK[]:9K^FPZM\5-+M+B2X2%]%N=X@F:)F'
MFQ<;E(8#Z$=/3(H [VBO(+#5=1L1:Z%=:G(=,_X2&ZT^*]NW9C)$D>Z.)W#
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MT+2S?VU]]CC%S:Q^5!(N1Y2?W5 X X''2G:7K>G:U%<2Z==+.EO,8)64$!7
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M^$?#VE:M-JEAI%I;WTV=\T<>#SUQV&>^.M0R>!_#$LTTLFB6C&>43R*4^5I
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M);3-?MA!J;#I&T1R&/\ OQEH_P CVKL;*SBL+80P[B,EF9V+,['DDD]2:L4
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M?PK7M8KO3(/&ND:AI]Y<OJ=U<75F\=N\B7,<T854W 84KC:0Q&!@].:]'HH
M\XT;2M0\.^*O"Z7EM=7*Q>'O[.DN(8FD19@\9(9APHP#@G&<>M9366KIHFI7
MMII5[*]EXM?5#:- \;W-ONZQA@-QYW#W6O7** ///$+7/B+PY=ZGHF@7<<T=
MQ:7+I/";:XOA#('*<X;@#@GOTK7\+/I^I:E+J]IH>IV<K0"&6YU-9$E;G(C
M<DD#DD],D8SSCK** . \5M>S>(KZR&E7GDSZ0R075E:EFN)"7_=/*!\BC@@9
M7)8\]CG:%%=#4/AR\NEZC$+'1Y;>Y:2SD BD,42@,<?+DHPYQT]Q7J%% 'CR
M6NJVL*:FFE:A+;6/BRZOI[46KB22"0N%E1" 7QNS@<UU7AN:2Y^(OB*_6QOH
MK.[L[,0SSVKQ*Y02;A\P!!&X<$9KM4=9$5T8,C#(93D$4Z@#CM1CE_X6KI%U
M]DNFMXM,N8WG6W=D5V>,J-P&,D*U<=;6NJ6&D:9J7]D:K-;V&MW\EU:0Q2Q3
MF&9GV2(OREL!@<#L3[U[%10!Y=JUD?[/L_$&B>'=4%O#JBW=W;$R)=W2>4\;
M2!2V_(WC )!.#VQENLV37FE+KV@^'M241ZI9WMW'<(XNKZ.$G(".2QVY4C/7
M:<#@9]3IK.B %V502 ,G&2>@H X?3+IM1^*DFIPV&H)8RZ''"L\]G)"N\3.Q
M4[P"#@]ZM>(HI7^(?A"=+2YDAM_M?FS1V[ND6^,*NY@,#)%=A2(ZR('1@RD9
M!!R#0!Y&=/U7R+N^@TZ^9++Q@VIR6YMG1Y[8C;OC! WD9+ #KCUQ6SJVE76N
MZ[K^KZ?;W MY?#<FG()(FB-Q,Q9AA6 )VC SC^/'8UZ)2.ZQH7=@JCDDG %
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M5BX=7&SHREAQG'O65+\.K@>'?$6G:<;73X]2E@FM;%97>W@>-E9CG:"N\CD
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MD7C.\C\1MHNHZ#-9SS6SW-@WVA'%RJ?>4XX1QD'&2/?UQ[KQK+JW@"\UN_\
M")FT233_ +04DNT/F\X*%<9  YSW]*W[C1-1U+7[36;V*TCET^UFBM8(YV8-
M)+M#,S%!@ (   >I-9:^#]6'PA/A R67V[[&;03"5_+Q_>^[G\,?C0!NR:\Q
MU-='TNSBGO([-;J1))O*CB1CM1=P5CDD' QT4^V<<_$1)-/TJXM=(N)9;W4&
MTR6!I51K>X4-E&ZY^X>>F,&K \/:K8^*H_$%@+.22>P2SOK269D4E#E'1PA.
M1D@@J.#5!O!&H01:4;5[-YXM<DUJ]:21D#.^\%$PIX < $X^[[\ '9:7<7EU
MIL,^H6/V&Z8'S+;SA+L.3_$.#QS^-<_J7BW4(/$EWH6F^'Y+Z[@LTNT+721(
MZLS+U(..5/\ @!S75UPDKWR?&2]-C!;S'^P(-RS3&/\ Y;RX((5OY4 7=.\;
MG6=(TR]T_2Y<W8F\_P"TN8H[-HN'65PK8.[@<<\GBJR?$/S]"T#4[;1Y9AJ]
MV;-8Q.H\N0%P>?XAF-N>..:@M_!.K:8^B&SN+&ZCMY;F>]@NMZQO-,V_S4 !
MR4)(4''!Z@\U7L?!/B"ST;P_8-+IDITK6'ORXDD7S$+2G'W3@_O?H-O4YX +
MUGXC\37/C>VTNXTFTLU.E/=26S7I<AO-5,EE0@XQP!V8Y.>*NZ?XREO_  _<
M7_\ 9BQ7T-^=/:Q:XRPE\P)@MMXZANA&WG-37FC7Z>.[;Q#;RV@M!I[6=RLQ
M8,B^8)-RX&#T(Y(QUYZ5EZ5I^GZI\0[O7-*U".YT[R(I9E@=7B:[PR*X89&X
M1$@C_:0T =P,X&0 >^#7+WGC"1+76+[3]-^VV6D2O%=.)]DC,@#2>6NTAMH/
M<KD@@>_4UQ,7A;5]-'B.PTZ2SDT_6II;E9)Y&62UDE7$GRA2'7/S 97T]Z )
M+CQS<3:K#8:)HCZFUSI@U*VD^U+"LL991CD<?>[]\#'<=BI)4$C!QR/2N0TO
MPG=:/XKTZ[M/LYTNRT8:6H:5O-.&5@V-N/X<=>^?:NPH Y*[\:R6.H6D5UI3
M06UUJ?\ 9L32S;9F;)42B,KS&6'4-T(.*J7_ (^O;0>(GA\//-'H+C[4S7:I
MNC\L2%EX.3M.=OMU'2J$_@KQ+* &N-*EEAUQ-32ZE:3S9XUD++&_R_+M4[0!
MD8 ^[5VY\):S/:^-H=UAN\0)MA;SG'E_N!%EAL]MW&?3WH V$\4%O%5AI#60
M2WU"S:ZM;MI?]9MQN3;M^\ P/7IS[5I:/J,FJV;W36ZPQ^=)'$5DW^8BL5#]
M!@'&1UXQ7'^)K.&\T71M$CU2WMO$]G-;&V%M*'DC;[KMM.#L\OS"<CH.^*[J
MTM8;*S@M+= D,$:QQJ.R@8 _(4 9^JZVMAJ.GZ9!")]0ORYAC9]BA4&79FP<
M 9 X!R6'N1RGB'QW?P^&==-G9Q6VL:5<16UU%+,6$:RLH22-@OS ALC(7H<C
MC!W/$.@7EYKVC:]IDD/VW33*AAG8JD\4@ 92P!*D8!!P>G-9.K^![W5=*\32
M>=;0ZKK4ENX&YFBC6 KL4M@$YVL2<?Q=..0"O=O>VWQ:@N+?2X)=1E\/2AXT
MGVH2+B/!:0KG&.,[2>1QWK4L_'MK>:'I-Z((X+K4C*J6]S.$6-HB5DW/@\ C
M (!)R..N)8]&UIO&]OX@G6PV)I;V3QI,^=[2*^1E.0-N,]^N!TK M? _B+3=
M&T66PN].36M(N;J2,2,[03Q3N6=&.T,IY7! /*^_ !H'XBL-.MY_[$F>9]67
M2I(TF!7>QX='(&]".AP/?%=9I5S?7>GI-J.GBPNBS!K<3"4* Q .X  Y&#^-
M<UJ^A>(]8L-):YETTWEMJD-_+&LCK$B1_P#+-#M)8GD[B!UZ5V0S@9ZT <OJ
MGBJ^M/$[:!I^A/>W9L3>1L;E8D8!PN"2#CKUQUQQW%2P^(=GJ&E6<PMUM;^X
MGFMGM+N81B"2+_6!WP>!QC ).X<#G$%\]XGQDA-E#!,_]@/N2:4Q\?:!R"%;
MOCM4$O@75[&&RU31KVT77H+^YOI1.&^SS?:#^\CX^8  * <?PYQSP 6#\16&
MG03_ -B3/,^K+I4D:3 IO8_*Z.0-ZD'@X'OBK?\ PF%\EXNF3Z/!;ZR;5KH6
M4M^,R*'95$;!2'8A,D<8W#/M%J^A>)-9L-*:YDTTWEMJD%_+&LCK$B1G/EH=
MI+$\_,0.O2I?%_ABX\3B:VGL=-N;4VP%M)-*T<UK<9;,B,J$XP4[C[OO0!?D
M\0W$^IW6FZ78)=7EG;QSW*37'E*ADSL0':V6(4GH !CGFLF+XAQWL?A]].TJ
M>X&L/-$H:58V@EC5BR,#W!0@^W(ST+['PSJ^@^(9=4L+B"_^VV4%O?+=RM$S
M2PKM64,%;J"<C'OGM5:T\#WNFS^&#:RVLJZ9=7-W=O([(99)E<-L 4\ N<9/
M0 >] &_X9\02:]#?K<67V*\L+Q[2XA$OF+N 5@5; R"&!Z"J_CR_M-,\'WMU
M?Z4NJ6BE!+;.P56!=0"<YZ'!Z4OAG1;_ $G4-?GO/LQ34;\W<7DR,Q4%$3:V
M5']S/'K3O&^B7GB/PE>:38- D]QL >=RJJ X8] 3_#C\: (;[Q3?P^*+CP_8
M:(;JYCL5O$=[I8D=2Y7!."1R#V/;C'(TO#6N1>)?#ECK$,3PI=1[_+<Y*'."
M,]\$'FLU=&U5?'DOB I9^0^EK9"+SVW;PY?/W,8RV/PS[5/X(T2\\.>$;'2+
MYH'GM@REX&+*P+%@>0#WH M:CK1MM5M=)M(%N-0N8GG5'D\M$C0J"S, 2.64
M  ')/L:SH?%LTD6F6\ND36VKZA+-%'97#[ OE9+N7Q]S &"%R=R\<\1^)= U
MB;Q!IOB'P]/:+?VD4EM+;WA813PN02-R@E2"H(XJ+4?#>LW=]H>NBZM'UK39
M96>$[D@DBE4*\8."PP I#$')!.!G  (=0^(7]FZ5KDT^DN=0T66-+JT2<$%9
M,;)%<@94@_W<\'BKT?BR[77;[2;O17AN(K$W]N%N5?SHPVTAN $8''&6'/6L
MG7/!&HZOIGB21&LX]3ULVZ$-*WE0QPXVC=MRQ/S'H/O =LG2N]"U>?QB^MHE
MB(FTA[#RVG?=O9P^?N=.,>O?VH K:7X]GOSX<GGT1K:QUT;8)S<AV2387 *
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MV,'EAP#5FXL+.[E@EN;2":2W;?"\D88QMZJ3T/N*Y29M_P 7M)?&-V@W!_\
M(T-=G0 56OM.LM3MS;W]G;W<!.?+GB61<_0C%6:* &QQI%&L<:*B*,*JC  ]
M *=110 4444 %5%TO3DU!M02PM5O6&UKD0J)"/3=C.*MT4 %%%% "$!@00"#
MP0>]0V=C::=;+;65K!;0+G;%!&$49] .*GHH **** "BBB@ HHHH KBPLUOV
MOQ:0"\9/+:X$8\PK_=W=<>U6*** "BBB@ HHHH **** *ATO3CJ/]HFPM?MP
M7;]I\E?,QZ;L9Q5NBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SY-!T:74!J$FDV
M#WH.1<M;(9 ?][&:T** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *BN;:WO+=[>Z@BG@D&'CE0,K#T(/!J6B@"&UM+:QMDMK2WBMX$&$BB0(J
MCV X%3444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5+5M)L=<
MTN?3=2MUN+2==LD;=^X((Y!!P01R#5VB@##L_#C6\*V]QK6J7UHHP(+EHR"/
M1F5 [#ZL<]\TRX\)VDFJWVH6UY>6,NH1K'>);,H6? P&.Y25;'&Y2#C\*WZ*
M ,)_"E@=0T6Z@>>V&C1M':00E1&JLH4@@J2?E '6J,_@'3;BTU"W>]U#_3;Y
M=1,BR(KQ7"[<.A"\?=7@Y'%=710!R_\ P@>ENVLF>YU"X_MBW6WO!+/D. I7
M<,#AL'Z#L!3+_P !6%_%IS'4M5@O]/4I#J,%R%N"AZJQV[2IP.,?S-=710!S
M[>$+,W>D7*WE\LNE-(\)\Q6+NX(=G+*2Q8$]^_&*JZIX!TO5KC6))KO4(H]8
MC5+R"&<+&[*NU7QC(8 #O@XY!KJJ* ,.'PO;0ZY9ZN+V]>YM;4VBAW5E9"06
MW97))*@]1TXP.*OZ3IO]E:>MH+R[N]KNWG7<OF2'<Q;!;T&<#T %7:* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJO?WUKIFGW%]>S+#;6Z&
M261CPJ@9)H L45D^&M?MO%'AZTUJSCECM[H,R+* & #%><$^E:U !1110 44
M44 %%%<WJOC.QT_7H= M;>YU+694\S[):!<Q)_?D9B%0?4YY''(H Z2BL6S\
M0BXUM='N--O;.[:W>Y'G!2C(K*IPZL03EQQU'<#(SM4 %%%% !1110 4444
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MW;1@GJQ(.!['D<9JP^+6O)5-CH]Y<6Z726ETR[0]O(RJQRF>0N\!B#P<\'%
M'2T444 %%1V]Q#=V\=Q;R+)#(H9'4Y# ]"*DH **** "BBB@ HHHH **** "
MBBB@ HHHH **BBN(9I)HXY%=X7"2 '[C;0V#^# _C4M !1110 4444 %%%5+
M"ZN+I;@W%C+:&.=XT$CJWF(#Q(-I. ?0\T 6Z*** "BBFNZQHSNP5%&68G
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MI-!>646]ZZDR"9!N!Z@\]?P/!(-:-M5\2V>M7-MK8TZ\TS4Y8A,T\G^CI"^
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M,% HZ9Y!ZUV:^$]$2UT^V6S80Z<XDM$$\F(6' *_-V!(_$U&?!?AP^(#KO\
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M#.-O*^:6'/<;AD=LU%X&O=-LOASX1AU.+=*S1V\*M 9#'<?-C/!V$#/)QC-
M'H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S]_P"'KZ37)-5T
MW79[*2:)(9H6A2:-E0L5(#<J?F;H<'/2N@HH IZ=8+812 S//-,_F332 !I'
MP%R0  .%48 Z 5<HHH **** "BBB@ HHHH KQ6<45W-=#<TTP569CT49PH]
M,G\ZL444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!EVJ=PX/(R!CG% &]1533-2M-9TRVU&PF$UI<QB2*0 C<I]CR/I5N@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHJ*.Y@EGF@CGC>:$@2QJX+1Y&1N'
M;(YYH EHHHH ***B:ZMUN4MFGB%PZEEB+C<P'4@=2* ):*** "N%\*6]YI9\
M;V$<227_ /:D][;QR<+(LR!H\^Q8,O\ P$^E=U4#V<#WL=YLQ<(I0.IP2I_A
M/J,\\]#0!YMHUIK$GB3PAJ5QHNJ(T-I<07K3;%2*1EC'RH&PD8VL!@#( ZFM
M[1[5[CXI>)-34'[/#:6UCN[-( TC#\ Z?G78L-RD9(R,9'45%:VD%E (;>,(
M@)8\Y)).223R22223R: )J*** "B@D $DX ZFJHU*Q-M'<B]MC!*XCCE\U=K
MN3M"@YP3GC'K0!8D<1QL[!B%&2%4L?P Y-<)\,_#Z6/AU/[3T5;?5(KJ>0//
M;KY@5Y&92'QZ$=#Q7>U$EU;R7,END\33Q@,\0<%E!Z$CJ,X/Y4 <KH]I=)\0
MO%-S):W$5M>0VJ07!C(5S&KA\'V+#KU[9KF8?#^JW'PN_P"$#N;&=-1CE6#[
M5L_<F-9@XG$G3[HSM^]NXQWKU"6Y@@DBCFGCC>9MD2NX!=L9PH/4X!/'I3/M
MUI_I'^E0?Z,,S_O!^ZXS\W]WCGF@#B&LKU=9\?2_8+HQW]K#':-Y1/GLL+(0
M/^!$#G'KTYJO;:?J")\-PVGW8.EQ[;W]T?W!^S&+GU^8XXSZ]*]$BECGB26)
MUDC=0R.AR&!Y!![BF)<07#SPPW$;21'9((V!:-B,@$=C@@\T >3V-K-K_P .
M_$7AVVLIWN;W5[R*-VB/E*#<DF0OT&W!.,[LKP#D5UFF6M[I/Q!UZ>2PNI+*
M]M+3RKI &7]TL@8'G.[)&  <YK>T+0;;P_:S6]I+.\<T[W#"9@QWN2S$8 ZD
MDUJ4 >;Z1X:N;KX,V^D7J2:=J5I&TL3S#:;>=',D;YZ8!QR.Q(KJO"$=W)H4
M>I:E$L6HZEB[N$7HA90%3_@*!1]0?6K&L^';'79K1[YKDK;%B(H[AXXY0V,K
M(JD!UXZ'CKV)K6H *Y'78+F3XA^&+R.SN9+6TBNUN)DC)6,R*@3ZY*GIG'>N
MNHH \FUS3-970O'VB0:)>W$^IW3W5K-&J^4Z.D8QNS]X%2,8S^'(Z>QAO'^)
MSZC)I]U#:R:+%;>8Z<+*)6<H2"1T8<].V<UV5% 'E.H:3JEQX&\=6,>F7ANM
M1U66:TC\H@RHWEX8=@/D;KCI[BM^[@NI?B'+J2:;<36;>'WMP7B(5Y3)O$9S
MZK^';KQ7;,RHC.[!549))P *9!/#<P1SP2I+#(H9)(V#*P/0@CJ* /-M,T?4
M=+6]MM*756T&72YA_9]_&6>SG. D4+'EE(W9 )4;0<\T^QT[4(H/ALCZ==AM
M+C*7O[H_N3]F,7/K\Q[9]>E>E44 %<M\0;&\O_"X6QM9+J:"]M;@PQ8WLL<R
M,VW/4X!XKJ:* .(LUU#1_'>K:M<Z?>2:?K-K;F,Q1^8]O)$&7RW5<D9#9STS
MG)K3\":)<>'_  K#9W2[)FFFG:($$1>9(SA... P!QQG-=)10 5Y_HDEYI?C
MOQ?J$^CZDUIJ$MLUM+'!D.(X0C<9R.?45W<=U;RSRP1SQ/-#CS(U<%DSTR.V
M<'\JEH \\\1C5[ZZT;Q&/#MQ=VME/<13:8P7[087"J) I."P9,@9SM8=.:CU
M33I+C3]&GT[PS+IZ'7[>^E@2!1*(T^]+*$)&[VR3C'?('H]% 'EGB/P_K.KW
M?CE;"SE#WB6$EFTJE$N# =SID],\#G&<^E7KP:EXE\6:/>1Z)J=E!_9MY;32
MW$:IY#R"/&?FR<8/(Z]L\X]%HH \W\(6LR6^F:9JG@DV^I:4%634)(D:#Y!C
MS(F!W%F Z <9.>G.CX/:^T'P3?O/I%Z]U#=W<ZVBIB257E9UVYX.017;TR6)
M)XFBD7<C###/4>E %?2]035=)M-0CCDB2YA654D&&4,,X/O5NH99;>QM&EED
MBM[:%,LSD(B*/4] !4JL&4,I!!&01WH \CBT[6X/">EZ$- OWN=-\0+<RN @
MC>+[4TH9"6^;Y6'H!SDCC.G97)_M_P"(=FNGW-S)<31I'&D6Y9&:U0;&;HO4
M<L0.>O6O2JRM,T"VTK4M1OX9KAYM0D62X$C @L%"@@ #&% % '&>'M U+P5K
MNGR7,4][8OHEO82S6R&4P31$G&T?-L;<<$#@CG%54\.:E81:*YL;@F3Q1-JT
MT,:[OLL+B0 ''&1N7(&>2>N*]2HH Y/PW;7,/C3Q=<S6L\5O>3V[V\CH0L@2
M%48CZ,#UZ]:ZRHYIXK:%IIY4BB099W8*JCW)J.&_L[BT6[@NX);9_NS)(&0_
M1@<4 <T;:Y'Q9%_]DG^Q_P!C?9?M'EG9YOG;]N?]WOT[9S7.Z?I=Q97>I:!J
MG@TZF9KZ:XM=0:.-[=XY)#(#*6.5*EN1@DXX[5Z5'<P3-MBGC<^BN#4M 'E&
MJ'5=#\/^/M*N]'O)HKP7M];W\6TPF*2,G#$G(9<8QCG Q6I:17VG^)?#NL1Z
M9=WEI+X?%D6ME5C')NC<;LD84@'GI7;:MID.LZ3=:;<O(MO=1-%+Y9 8HPP1
MG!QD&I;"S33["WLXW=XX(Q&C2$%MH&!G ':@#R>QT;7--\.^&KZ?PY<7G]F7
M5\MYI_R&1XIY699(P3R5XX."<GZUO7NC6&I:3;E_#-]I$,]Z9TEL5$=W:N$P
M)V$9/)Y7'S'!&>X'H5% 'FAL?$JV7A:[U"VN-2ET[5YF=HXU29[<I*D<CID
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MK7>44 <K\-[*ZTWP#I=C?6TMM=0*Z212K@J=[$>QX(Z5U5%% !1110 4444
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M+6VN88426;;+=(Y0-)&/12^.>NT\BK%QXM<^)[O0[1;3[9:M#_HUQ*4DN(W
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M'# EI 6)8D#&!@ $^O&</#-]H$6O:KHS6&FWU^L.VWAB:6!70G<^P8)=PV,
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MV=8]P<YV\D$!>@Y<57@\<W=V^EW=GH\]UIFH7 A#10S&2)&)"S,=FW9P,X/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@V(Q:D1C]P/]C^[^% 'F^GWR?VKX,U*PN9&MK^_NE:[GF_?WD925B9%& %!
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MVC6+Z?&VY+8PKL0^JCL>O3UJ6X\.:+=Z3%I4^EVCZ?#@Q6YB&R,CH5'8CU%
M'*^#A8Z/XC\;KYL=O:Q:C#S))A4S!'QDG@9. .W %=[7/7O@K0;C3+VRATC3
MHA>!1,WV93NVXVDCN1@8SQFMVW@2UMHK>//EQ($7)R< 8% '(:C<?;OBA:Z%
MJ"[M-.D/<PPO]R:;S0K9'1BJX(';<37'S-?G3X+*6^O?LUGXSCL;247#AFM]
MP^0G/S;22H)R1M]J]7O])L-4$7VZTBG,+;XF8?-&W3*GJ#CTJ*;0-(N+:VMI
MM-M7@M7$D$9B&V)AT91V/OUH YOPG"NG>.?%NEV[R_8HA9S1Q22M($=T?>06
M)/.T$UV4L:S0O$Q8*X()1BI_ CD?455M])T^UOY[^"SACN[@ 33J@#R =-QZ
MG%6Y(TEC:.10R,,,#W% 'C-A;Q:CX,^&D]]NN)7U7RVDE<EF!6<G)SGD@?E6
M[J4\^E>(6O;VU74-$GU*!8=1M)L3V#@HBQ.IZQ%@.G]\D@DBNV/AC0CI<>F'
M2+(V$4@ECMC OEHX[A<8!Z_F:D&@:2MV;I=/@$S2"5F"8W..CD="PP,'J,4
M:->:_P!@VGB#QMXUL=0O;X6T4=F\06]D40LT;G>,-Q@\@=/:O2JXVT\*-/XV
M\0:GJEA;RV=^D"0$R;FVQJ5977'W6R#C)''- '':-%=^(Y/ <>N75\QO]'O/
MM2K<R1^<%\L(QP1@E6SD8)SSFMO3[>'66\8V.HRS13:5*+:S8S,'M8%A4QR*
MV<AB=S%NIQR2!7=2Z-IDU_;WTEC;M=VPVPS&,;XQZ*>P^E,O- TG4+O[5=Z?
M;S3[/+:1T&63KM;^\OL<B@#S714NO$VN^%UUZ>\!OO#<DUU MS)&LK"2+!(4
MC!(.3C&>_'%5M/U&]TV.ST2\U'&C#Q#>6$5U>[I%>)$S%$[;@6&_<O)Y* 'C
MBNVU/PW<:C\0;#59;2&33K:PDMLF7;(KNZL&4 < !2.H/)K>N-"TF[TC^R;C
M3;673\8^S-$#&._3IUYH \XU[2I-)T9;:'7YIT;Q#9E8[9GB6T6210T0^=LC
M^(*?NYZ<BKUWX;TC2OB7X8AAB<1-:7\A,T[R'(:)A\S$G +,<9[FNR'A;05T
MR#31H]E]A@??%;^2NQ&Z[@/7/?K5J[TC3;^6TEO+&WN)+1M]N\L88Q-ZJ3TZ
M#\A0!YE<ZK=:/I7C*5+R=((_$4$,L\DCR&"W<0"0YW;@,,W0C&>"*U;C1);=
M=6.E>)[.%M1M(O)M88V6W23S%"R9#MM\S.PXQG.1DBNUBT+28%O%BTZU5;TD
MW0$0Q/G@[Q_%^-5K3PGX>L--GTZTT6QALKA@TT"PKMD(.1N'?&* ,?P3?&:_
MU>QNM(?2=3MO)-S:I()("&#;7B(XVMM.1@8(YYS6IXSO+>P\':K<W5Y<V<*V
MY#3VN/-3/ V9X#9( /OU'6M.STZTT\2"U@6,R$%V'+.0,#)/)P..:DN[2WO[
M26TNX(Y[>92DD4BAE<'L0>M 'FB^;:^)_$FF@K90-X?2X%M:W+820&0;MPQA
MR ,D8SQUZU#H<!LI?AE?Q7%T;G4;3RKMGN'82K]D+@$$XX901Q7?1>$_#T./
M*T2P3$!MP5@4'RB<E.G0Y.1WS4J^'-%3['MTNU'V+_CUQ$/W'^Y_=_"@#RJ_
MFAU_X02Z_?-NU=M2C^T,7(:%A>*OE8[*JX^7IT;KS7M-8EQX.\-W=S<7%QH=
MA++<L&F9X%/F$'()]3D#FME$6-%1%"HH 55& !Z"@#SGQO-!=77B6.&5Y;FP
MT7S&$TNR.S)$C*\6!DRG YXP%'/:JVJW&IS:5I^K?9TUNS71(6O[-9_+N8"P
M)-Q$>A8X8=C\@P:[Z\\.Z-J%\+Z]TJSN+H1&'SI859MA_AR1TY/YFH_^$6T$
M)$BZ3:(D4/V=52,*/*R3L..JY).T\<F@#@_$%]*D4NO+;'5O#K6$!E,4GEWF
MFKLW^:BG@@JRDX(/&#D"I;DCQ5K'BG3KK6;?3KBTD3[*\B,);:$Q(RS1GS%Q
M\Q<DX]B<8 [R?P_I%S<M<3:?;M*ZJKL4^^J_=##^(#L#D"F:CX8T+5[^"^U'
M2+*ZNH,>5--"K,N#D<GWYH XFQM+5/B/J-U-<CSQX>M9C>LA4ERTBF3;Z\#C
M\*G\)7,^E:_!I>NV*6U^NG.\>HVT^^VOXU9-TK9Y60?*23_>//2NVN=%TN\O
MTO[G3[:6\2,PI.\0+JASE0>N.3^9]:@3PYI,%I/;V^G6JI+ UN49,IY9'*8[
M)_LC H THIHYX4FAD22)P&5T8$,#T((ZT^J&BZ3;Z'I$&FVH"PPAL!5VJ,L6
M( [#).!V&!5^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "L?Q->PV.BN\NM+I!9T5+IE5R#N'RA6X
M)(R/QK8KD/B?%-<> KV"WMY[B:26WV100M(QQ,C'A03P 3^% &M?^+= TRYN
M+:[U2WCGMT$DL6=S*#G' R>QX]!FK#:[I@MK:X6Z$L5U'YL!@5I3(F 2P"@G
M:,C)Z#(]:YF-A_PM74;YK6Y^S-H<,2SFUDVLPED9E!V\G#*<5RVBZ;-_PAOA
M1?M&K:%K5E8RI%=_8W9$.Y=T,R%<$-A2 <9V\4 >G0:_I=U<06\%VKRW%M]J
MA0*<RQ<?.O'(Y'3UJNWBWP^EI!=/JULD,\YMXF=MNZ0'!7!YR"#GT[UQT%UJ
M-IKW@[6=9TJ>WW:3/:SQVEK)(L,K&,JI502H(4X!Z=.U8\$-R?#FDQ3:5J >
M/Q>UU)&UE(Q6+SY&W\ @J PY&10!Z,GC/P])9)>1:DDL#QO+NB1GVQHQ5G8
M$JH(().!Q4UUXHT*RD@CN-5M4>>'SXEWY+Q\?,,=0<C'KGBN5\52SOXBOK)-
M,NT2?1V6&ZL[-G>Z<E_W+2!2$49S@XR6Z]CFZ"LQU'X;O)I]\@LM&E@G:2SD
M412&*%0&)7Y<E& SUQZ$9 /0+?Q#I-WI":K;W\4EB[;%E4GYFW;=H'7=GC;C
M.>,4MOX@TJYLY[J*]3RK>3R9MP*M')P-C*0&#<C (R<CUKS"%-2L(%U>/2[^
M:VT_Q7>7D]JMLXD>WE\Q5E1" 6 W[N*VO$;MJ.CPZ[HN@WOD0ZI#>721PM;W
M-[&J,C,%^5R5W*1G!.T]L$@'<Z;K%AJWGBRN!(]N_ES1LI1XFQG#*P#+QSR*
MO5R_A0:7=W=]J^F:9?V_VI8UEN;X2K).5! &V0YPH.,].<#.*ZB@#@+KQ/-J
MNN:]8VNNG1DTKR#',]L&C<E=\AEWC[N,*,%?4$\5T=IXQ\.WR3/;:O;2+##'
M/(0V J/]P\^O3'7/%<S:LZ^(?B#(UI>".Y2'R&-I)B;;;[#L.WYOF&.*SS8:
M@OPN\&36NGW)DTF>QN+ZS$#+,R1C#@(0"2&.['?'% '?)XDT=X+R8WT<2V0!
MNA.#$T((R"RL 0#V)'/:JL?C3PW+-%$NL6V^:#[1'EB Z8!R">"<$''7VKF-
M8MGU3Q'JNO6,-PUDOAV6R9A X-Q*[%E55(RQ49Z#@MCUQ4MH)5@^%ZM878-E
M&!<@VDG[@_92GS_+\OSX'- 'H6DZSIVN6C7.FW27$22&)RN05<=5(/(/3@^M
M7B0 23@#O7'>#%D3Q#XO+V]Q$DVIB6)I8'19%\F-2RD@ C*D<>E=B3@9H P[
M;QCX=O+Z.RMM8M9;B1I%5$?.3&,OSTX /Y'T-2Q^*-$EEEC_ +1BC:*'[0WG
M9C!B_P">BE@-R?[0R/>N'L-*OM2\#>.K"SM9X+Z\U&_DMQ/ T/FJY^4@L!D,
M.,^]6M,N=,UY1?KH.L6^IVEG,DLFH^>HM=R$,BF0X<DXZ=ADXX! .GM/&OAN
M_P!0M["UUBUENKF/S88U;F1<;N/4XYQUQVJ=O%&BIITVH-?QK:03FWFE*L!%
M(" 5;CY3D@<]SBO.M&M$U[P'\/K*PMY/M5E<6EW))Y+((4C&Z1BQ&/FZ#^]N
MSSS4&LK=0^$O&^B#3-1EOY]8>ZB2*TD99(GEC965@-IZ$8!SD=* /18_%=A+
MXLNO#X\P3VT"2R2-&P7+%L#.,<!2<].W7-6+3Q!I>JS"TL;]3/+"9H3L(WQY
MQYB;AAUR1R,CD>M<M<2W%KX^UNZ32KN[2]T2'[*AMW\N9D,I,;,1A#\RC#8/
M/2LC0I+B;Q3X-O?L&IK&NG7%O*IT]X8;5R(L1*I4;57!&XYSC[Q(X -KP1X\
ML;[0M)MM:UJW?6[MI%VMA"["1@HP!M!P!@=3Q6EHVK7C^-?%=E>WH>QL$M9(
M ZJHB#H[-D@#(X')]*XRRTF?4/AA8^%18W,6LQWX9A);NGV;%R9#*6(QC9G!
M!YS@9JYK&G:EJ6I_$2WL+6X$UW:6@M6>)T2<QHV]%<@ Y^[P>] '?V.O:9J-
M[)9VUT&N4C$IB=&1C&3@.H8#<N?XAD>]:5<3X8N=+US5[?4X-#UBWU"W@:.6
M;4O/4P XS$#(<.2?3@8R2. >VH S-1\0:5I+,+Z\6+8H>0[2PB4G 9R 0BD@
M\M@<&G7VNZ;IV/M-T ?+\XB-&D*Q_P!\A0<+_M'CWKB_MC:+XL\3:?K>BWU_
M9ZS)'-:20V;7$<Z^4L;0M@$+@K_%@8))(JSIS3^'_'FLS:G9RQV.I6=H;1X(
M6ECB,2%7@^4'!RQ(&.<G% '3W'B;0[5K-9M5M%-ZADMOW@/FJ%+%EQU& 3FJ
M1\=^%Q9K=G6;80F4Q%CD;&! (<8RF"1RV!R*X?1M%O=&D\ 6UU9W.+>\OIW5
M8&=;6.5)/+5B 0N-RCGH?I3[VVGD\-?$R)-/O3+>W$AME%G)F<&!%!3Y?F^8
M-TH [S4O%_A[2)IH+_5[6&:%!))&6RRJ>G Y]>/0$U/_ ,)%I!LK.[COHYH;
MT$VQ@!E:; R=JJ"3@ YP..]<79W]K:_%"&:Z25=WA> !F@<E3YSY!&,@GT/7
M&*SM'L[SP[#H%O-I=U;VMQ=7\Z7$%FTTUBDC[HX0 K>7O4\DCC&.#R #T%_%
M>@1V=E=OJ]HMO>MMMW,@ D(SG'TP<^F.:K7'B;1]0\.ZE=V>O0VD=NKQ27A
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M)J%FEG>-;1F:V086)MHRH';'IVZ53\<(\O@/7X8HI9I9M/GBCCBC+L[-&P
M ).210 ]O$^BZ?':V]YK,#7$EL)P6X>5,#Y]HZ9R.,=\"M'3-3LM9T^*_P!.
MN4N;67.R1#P<'!^A!!&*X:U60^+O!4[6=V([?1IHY9&M9 (G81 *QV_*?E;@
MUJ?#J.6+2-4CEM[B G5[R5%FA:,E'E9E(# 9!!S0!V'09-9*>)=)D#%;HD+
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MG0":ZN_+C,8F8^6Q\N,]'? ^1>O+8'!J#4/&7AS2I&2]UFTB=81<%=^XB,D
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M.!P.3VK:KG? 2R1^ - AF@F@FAL(8I(YHFC965 ""& /45T5 !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %<5X=UE+J[\7^(+UCY6GWLM
MB@Z^7#;H"V/<L7)]>/05VM<EI.BQZ7JOB+2[F/=I^M7#WD1/1C(@6:,GL<KN
M'J&XZ' !8TO5/$%^^C7ILK1]+U&$S3!&*R68*!H\DMB3.=IPHP>>E5=!O6M/
M'_B'0!_Q[>5#J%NO:,R960#V++N^K-3_  WX6U/P]#!:77B-[S2;$8M8&MUC
M=4 PHDDS\X4=.!T&>F*FT+3'D\4ZUXDE4JMXL5M:JPP?)C!RV.VYV8CV />@
M#IJ*** "BBB@ KRGX>SS2^ X=-?09+JQN=0N()IF:/RA&T[ALKNW]\=/?I7J
MD@<QL(F57Q\I9=P!]QD9_.L#P;X;F\*:'_9<M^EXHFDE618#$1O<N01N;/)X
MZ4 4F\3:@E[XNLUCM<Z+;Q3V[E&^<-&SX8;O]G&0??VJ@WB[Q!>3^&[;3;/3
M1-K6DM>AKAWVQR*D;8('.W,F.Y^E:&I>#[VYUG6;RRU=+6#6+1;>[B:V\Q@R
M*RJR-N '#<@@].,=0W3_  9=V&H>&[DZM%*NBV+600VA!F5@@)SO^4XC7L>]
M &;<^+/%*/XGACM-(670H(IV+-(RRYB,C*.GI@'MZ'/&F/$TUSXA\)QK96WV
M;6+.:X$CDF6(B-'VCL =PSZXITOA"ZDN_%,XU2$#7H5AV_92?("QF,'._P";
M@^W/Y46_A"ZAO_"]RVJ1,-"MGMMHM2//#(J$YW_*<(/7G- $?ASQ=+X@U,VZ
M3622PR2I>:<Z,ES:A20I.6^8' Y"XY%<MX-US5="\'>&&6"S;2[O4WL'4EO.
M!DGD <'[H /&,'([CI771>$+B35]*U2_O[>XO=,618;E+4I)+N0H!(=YW* <
MXXR0#QSFC!X!NX/#.C:,-9A(TS45OUE-D?WA$C2!2/,XY8C.>E '<UQ^J7NK
MK\3=&T^WO(([&2QN)VB:$DEE:,$DAADX;CTYZYX["L'4_#TU[XHTO7+:_%M)
M9Q2P21F'?YL<A4D Y&T@H.<'Z4 8,_CF^'A&3QC:V]M+HT4S9M]K><\"R&,R
M!\[0>"VW;TXSFNZCD66))$.4<!E/J#7&Q> FAT6\\.IJ*_\ "/W,[2?9C ?-
MC1GWO$LF[&TG/)7(!(]".S50JA5   P .U '#?$M0S>#L@'_ (J:SZ_1Z[*_
MO(M.TZZOIR1#;1/-(0.=J@D_H*P_%OAFZ\2?V5]GU**S_LZ_COTWVQEWR)G
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M?9X_M 03;1Y@C)*[L<XSSC-<]_PB]R/$NDZO_:OF"PMI8&26#<\WF%2[%@P
M.5& %P.F.E6M-365\1ZJ;J\\_2V$9M8S;",PM@[E#=7'0Y/K@=#@ VFW;3M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP<$_)C=UXR#GFM"UBU1(/%>C:3>DM9ZO#]DAO;ER'4QQR/!YA)8!OF'7O[T
M>DW-U!9P^=<2K''N5-S?WF8*H_$D#\:B-S=_VN+86+&S,!D-YYJX$FX#R]G7
MISGIQBO*=7N+75_#:1S6-_87EKXDLDN;&XN&;[,S-$,(P."A7D$=-QQBNJ\K
M;\55TX7%TUE)X?<F W,C+D3(NX9/#8XR.: .QMKJ"\A\ZVE66/<R;EZ95BI_
M(@BI))$AB>65U2-%+,S' 4#J37C>A)_9_P -O!-Q:3W$,DNM6\<NRX<!D,[J
M5(SC:>A'0UH>)3]I;XHV<EQ-);P:3#,D)G8K&YBE8D#/&2%)'0XH ](EOIV?
M3VLK,W5K=-F2<2!!"A4L'P>6R<# YYJ]7G<\9L+SX>I:7-RD<LY26/[2[*X-
ML[?,"<'D CTKG]4CG7PKX]U)=3U,7.E:K(UDWVV3$)5(F'&[YAR1AL@#IC)R
M >R45PFLO=7'BV\MKH74]D^C!K6.S+%HIRS L0O*LW&US@#:V".:Z'PC8:AI
MWA73K?5II9M2$*FZ>2=I29"!N^9B>_IQZ4 ;5%>>>-)Q<7GB".VNKB6XL=&,
MK1^>88[,D2,LBE>6D.WCC "]1G!K0^=K'B;PC'=7]\8K[0))KJ.*Z>-9' AY
MPI&#\QY&"?I0!Z96#XA\3#P_=Z7;M83W+:E<"VA,3J,2$$X.XC P#S6?\.)Y
MY/#$T,T\LXM-0N[:-YG+OY:3,J@L>3@ #GTJA\1T>75/!:1S-"[:X@$B@$K^
M[?G!!% '56FIW4VH"TN=*N+4-$TJRLZ.AP5!7Y22#\P//OZ5IUA1Z=-'=W=O
MJ6KS74=_$L4"<12)M#E]IC QU!W=?TKE_",US>QP>&+ZXN7O]"O)!?3&9]TJ
M+S"Q.<D2!U;G@[&% 'HM%>7Z3]M\3:4FM_\ "01V%_::G)]H.)&>/;*R_9V3
M>%P5V@#;SD'DG)S=6AG_ .$>^(5\-3U,3Z5J#O9,+V7]R5BB88^;D9/0Y '0
M#)R >N&Z@%XMH95^T-&91'WV@@$_3)%35P%M:02_&-KE]XD;0(9B1*P!;SF'
M3.,=..E;_CG5+W1? ^LZEIRYN[>U=XCC.TX^]CVZ_A0!T%<[-XFG>_N8-,TN
M34(K*[CM+QHY0KQLRJQ*J1A@H=2>1WQG%85X'TK6O!UUHUU<31:E+]GND:=I
M%N8C"S^:<D_,NW.X<\XZ5)X!T^WM]<\7R1^;NCUAHUW3.PQY,1Y!."?<\T =
M+XFUU/#6@7>L36TMQ!:IOE2(@-M]1D@'\ZS+SQHFDV$.HZMHU_9Z=)M+78\N
M5(0V,%PC%@.>N"!47Q2_Y)AXB_Z\V_I2>++VSL?A9?O?,OER:8850]9'>/:J
M@=R20* .MCD26-9(W5T<!E93D$'H0:S]8UB+2([0,GF3WERMK;Q[MH:1@3R>
M< !6).#TZ&O.?#\.H-)H_A#5;E;>2'P];R1P3,ZEW)97P5=260*@[XY(J?5]
M)*VG@.WO]5EU:XCU?[-)>J[Q^:%2?L&^\, %LY..O- 'H6D7UY?6CO?:;)87
M$<K1F)I X8 \.K#JI[9 /M5^O)_&5Z\-AXFOM+O;J273;FVC$[W#(+1AY>8H
M@,[\[LL6P#OQ\V.-\2M_PGWBFUDNIQ:_V3;S",SL%1B90S+S\OW1DC'2@#?U
M?Q -(UC1M/:S>0:G<- )@X"QD(S\CJ>%/^-:D-U!<2SQ12J[V[B.51_ Q4-@
M_@RG\:\NTZYFO-#^%5Q<S23SR7 9Y)&+,Q^S2Y))Y)K<\ 6-M;ZUXPDC\P.-
M:D0!I6(P8HF/!."<]^M '0^)?$ \.6-O=-9O<K-=0VQVN%V&1P@8Y]SV%;5<
M9\3E+^%;90S(3JED RXR/](3D9KGM7O[SPIJ/C6/3+F[:.'2;>\C6:9YS%(S
M2*\B[R3T ..GRT >J45P TF2.5M3M?$0-G>:;*!;6TDI\\A=RS*YD)5AW8=<
M@$]*PK6232/ 'A?66U2\$NK_ &&VO[FYNI&1(RI.[&X;,G:I88.#UR2: /7*
M*\K\6:=?:!X6\3SQ:\[!EMKF"VMVD3[&=X5F5BY(5^?EZ<''>MR^D=_BC<62
MW=PL,OAZ25XH[AU <3* X /RMCC(P: .XK%\5^(!X7\-W>LFSDNUM@"T:.%.
M"0,Y/;GWKSO03<V^B_#C6/[0OY+V_G2WNFENG=98VAD)!0G;U4'.,Y&<DU6U
MV=?$?PC\3:S>S2G4([R:-D$S 6X2<*L6W. -@4D8Y)R>: /9Z*\\OQ<^)_%/
MB?0VU1;*6SBA%I\TBO$C1!O.3:ZY(<D9Y^Z!WJLFF/K/C>VTR]UO4+BWD\.1
MS22VUS) LTHE \U5#?+G .!Q]: /3**9')')N$<BOL.UL-G:?0^]<I\0DN+;
M0X=<M9+@/I%Q'=S10RLHF@4_O48 X(VY;GNM '745Y7!JDP\3:M813W)M/$L
M*OHTIN';;M;RY63)X !$PQ_#^0T7T9+_ .)=_I4M_JB6,6E6LZ11W\JXD$KC
M=G=GHHR.AZG)P: .S74I(8]1N-2M?L-I:,2L[RJPEB"AC)@?='48//%6GNX(
M[F&V>51-,&:-.[!<9/X9'YBO(O$2-<>!_B3#<3W,Z6VI?N1+.[[!Y<) !)Z
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MY6LH[FX=S';9^0;6)V\[N.#C;GIP ='<74%J(S/*L?F2+$F?XF/0#WK+TOQ
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MS7,I<)'',K%B@RV,>G/Y'TJ:TU_2;ZYDM[;4+>2:./SF0/@^7_?&>J_[0XH
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M+ZP#G[<8V(OHV7Y7W'.7 PA7)QM&.*R-/M2?!_@PPZK<Z'K%IIKI%<O#NA!
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MDK\OXTL<3ZUX,\':/:VTUOK&FWEGY\31E6M/)XE9N.%(# 'HVX8SFO5** .
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:RN8@03N(53\N!DMT''/-:-QKNGVXM_WS3/<QF:&.WC:5WC&,N%4$[>1STY
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M*::&ZA$8\Q"T+(K8SPNXXR<>O2@#T"_\5:/ILI2[N7C19E@>;R7,4<C8PK2
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M++PW?7-WJ$UA;"%MUW;J6>($?>7 /(^E<.;66RU[7=.U3PM>ZS:ZI=&ZL[F
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MUZ;FPN].-U$+=]T0A"^82,=!C\>V: .IO?'7A[3Y]0AGNY?-T_;]K2.UE<Q
MC.XA5/RX&2W0<<\U;O?%&D6.P27+2%[8W86WB>4^0,?O"$!PO/7OVKDY[6[.
MJ_$.06%X4O[.*.U;[.^)V6!D(7C^\0/UZ<U3CBU?[+I6G2Z+J @_X1V. 26T
M.R1K@##12R$AD48! R 23R>E '9W'C'0K9[!'OBS:A"9[01PN_G( &RNT')P
M1QU.1Q4MIXIT>]T<:I#=DVQE,&&B=9/-#;?+\LC=OSQMQFN&T"SU&.?X<^?I
M5_"--T^:"Z,D!_=,8HT7.,XR5/\ 7&:J_P!G:W;03ZK:Z3>3M8^*I]2-F8BC
MW%LZLFZ,-C+88D#KQ0!V&L>*M$G\-ZM*VLW6G)9MY-U/%"RSVK'!'RE21D8P
M<8.>*T]3\3:5H\DL5Y<2>9!;_:9Q'"\ABBR1O?:#@<'\CZ&N6\7&[\1?#KQ!
M]BT"\MYKV)8X89+?;<3OD9+*,D   #=@\'MC,7BD:IJ5]K=HFCW[6USHVRRE
MM(MAGD*R969SAAM)&$) .6X)(% &QJFIW(\>^$XK2_<Z=?PW3R0KMV2;8U9&
MSC/\7KCI71WVI6NG+%]ID8/,^R*-$+O(V"<*J@D\ GV R:X6SM[YM7^'LSZ9
M?1)96,T5T7A/[EFB1%W8SC)4_3OBM+Q@NI:?XD\/^(;/3[G4;2R^T07=O:KN
ME590N)%7^+!3D=<&@#;@\5:-<Z<+Z&\W1&X-KM\M_,\X'!C\O&[>,'C&>,]*
MBE\8Z%!IM_?S7C10Z>VV[5X)!)"<9&Y-NX9'(.,'M7.ZQ!J-Q=^'O$EKHL\-
MO8ZC)-/8B,"=HY8S&961<Y<$D[1EL'UR*S?$^B7VJ0^--6L[*[*:CI<5C;0>
M0RR7$B[B7*$9 &X*"P'0]L9 .YT_Q3I&IZJ^F6MR[72P^>%>%T$D><;T9@ Z
MY(&5)ZUS?B?Q4KWGAH:1J%TD=SK,5O(R0$0W$>6W 2%<'D#[IYYZ]HM6L+[4
M?%6FM:V]U"C:%=6AN3 ZK#+)Y>P$XX^Z3[8K'C_M:;PMX-TE_#FJ1WNC:E:+
M=J(/D"Q*REU?.UE/7(/?GMD ZNZ\4:=I">*=3%]?7YTX(]Q9"(XMB(\A4^4<
M,!N))(&<Y%3?V[97USX<:74+VRN;MF:*U$#HMR?+)96W)]T<D<C.!UKGK[2M
M1OG^)D4-A<[M2M46S+Q%1.PMO+(4GC[W'_UJL7*WEY>> [@:7?QI9S,UP'@.
M8E^SM'E@,X^8@>O?I0!U%YXKT:P>47-TR1PRB&:<0N8HG.,*\@&U3R.IXR,X
MS45_XRT33K^YL9[F8W=O$)Y((K:61]AR P"J=PX/3.,<XKCH],U.V\'>*?"=
MSIUU/>WDUW]CG$3-%.LY+*[28VH5+<AB"-O&>*T]*L+G2O'4SS07<MM#H%M9
M_:A Y662-G+ $#DX(/XT =I87]KJFGV]_93+-:W$8DBD7HRD9!JQ7*_#>TN;
M#X>Z-97MO-;W5O!Y<L4J%65@3ZUU5 !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8WB'71HL=A&D
M:R7>H7:6=LC'"[VR2S'T"JQ]\8[T ;-%<7?^,=0TBZUS3;JSMIK^PTQM4MG1
MVCCN(1D-D?,58,,8R<Y'(K7\,ZCK.JV2WVIVEG;VUQ!#-;""5G?YERP<$ #'
M&,$]?;D U8+ZTNIIX;>ZAFE@(69(Y QC)Z!@.A^M6*\SAN-=L?&7CJ7P_I]C
M</'+:RNEQ*T>_%LIVH%!^8\\G Z=<\;>B^-GUW5M(@MK>-+35-)?4(V;.^)E
M9%*$=#RQY&.E '8U!<7EK:-"MS<PPM/((H1(X4R.02%7/4X!X'I7$Q_$%ET"
MPO[];:P6YU&>QDNI S00>6SJ&;D?>* #) &>O'-W4M>N[=/#+W>GZ?<?;]4%
MMYJR;UCR)"DD?!SE%SG(QNH ["BO/]0\;:];P^*9K?2]/,?A^3,GF7#YEC$2
MR$+A?O8/?@=.>HT[[Q;<2W,]IH\&^X@LXKIO,MY90QD#%(_W8^4D*<L>F1@'
MG !UM%<-+X[G$FFVT]O#HU]>V/VF*'5 R"2;)4P!N &! .3DX886K.H^+Y[;
M76T5#96VH"UCG@@O"5^V,V=R1MD#*X [DD]@,T =A2,RHI9B%4#)). !5.-]
M2.LS))#;#3!"IBE5R93)D[@5Q@#&.<__ %N?\2WS3^+_  UX>S_H]X\UU=#^
M^D*@JA]B[*3Z[<=#0!TJ7]G)=K:I=P-</%YZQ"0%S'G&\#KMSQGI26VHV-XB
M/:WEO,LC,B-'*&#,IPP&#R00<^E89U:7_A8CZ1_9]KD:2;J.[W?O&_>A=A.W
MY5SSW]:R[&[;Q+\,[V[2T@TZZ1KMH5M>D,T4CA74X'.Y<DXYR?6@#N:KO90-
M?)>A2MPJ>674XW)UVMZC/(].<=3FAX7U@Z_X4TO5R@5[NUCF=1T#%1D#\<U@
M6/C+4'U_1]-O;2UCFU-9]ULDF9+)XUWA9&!(8E>N ,>AH [:J]M90VC3/&I,
MDS[Y9&.6<XQR?8< =!7!CQ[K:Z0^L2Z78I96VK'3[E%G9I"//$.Y/E X)!YZ
M\\#ON1^)KBW\5:MI.J+;6T%M9B^M9QN/G19(=CZ;" ".^0>* .HJO=7UI8K&
MUW=0VXD<1H99 NYB<!1GJ2>U0Z5=74VBVUWJ44=O</$))8USB/(S@Y[CO7G?
MBC5[SQ%X6T+68X;9--N=9LVA1@?.6/SU"N3TRV!\N. >IQ0!ZE56_P!2L=+@
M\_4+VWM(?^>D\JHOYDURFI^,M04:E-HVF/?+IUS]G:W6WE9[@KC?L=1M4C)
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M0@\R<I&(][M(JKDD<#"\<]0!F@#J8K*""[FN8E*//@RA3\KL  &(_O8 &>X
MSG P/90RWL5U(I>2$$1;CPA/!('J1QGTR.YSR4/C2_CMQ!J&E2V]_+J!LK9S
M;RB.==C2><J$;\!5;*\\@#.#D5K_ ,;ZYIFB:K=SZ("]A=00I-(DD$=S'*RJ
M'17&<@M@J3^- '?45QW_  D'B0^*;KP\+'3!<FS6]MYO.<QJA<H5<;<EL@=,
M#![=*AT[QX^IZ-H<B6HAU#5$G9D$;SK$(6V2':@W,-Q4#IP>O'(!V-W;K>6<
M]LSR1K-&T9>)RCJ",95AR#Z&JFBZ-;:'8_9;>2XF);=)/<S-++*V ,LQY)P
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MEW;7]K'=6=Q%<6\HW1RQ.&5AZ@C@U-7GNG^,[X^'_!T]AHUC&FMN8O)64QI
M=CL  %Z?+R?T-6#XZN['2=;DU6U@CN=)U".TGE@WO"L<FPB8C[V%5\D>W49X
M .Y90ZE6&01@BN;L/!-AIT2VL-]JC:<@VI827;-"J_W<?>*]MI)&.,8K$\1>
M(M9/ANTO-/O-.>.?5[6WCN[8ETGA=XQD88[<DLI&3P#ZYJ]<^(?$I\57'A^P
MT_3'G@LH;OSIIW5&#.RL,!20?E.!S[GM0!V5%<)<>.;^W\):WK'V.V:;2M3>
MQ:/+!95614W _P )^;..>F/>KMUXBUV7Q1JVAZ=8V&^SLXKF*:>9\.'+C# +
MP?DQ@?7/:@#KJ*X+3_'6IW=IX7U673;6+3-<E2VVB9FFCD9&8-TV[<H1CKC!
M]A-<>-=0DC-]I6E2WUFEZUJT$5M,TKHLAC>17 V<$$[>X'4'@ ';T5P&H^-=
M?MT\526VEZ>4\/N&D\RX?,L?E"0A<+][![\#WZBU'K.JWGQ)L;2":%=,ET8W
M@B93N.Z6,$DYQN Z>F3ZT =K17)>/-2U33K?1!IDT47VK5[6WE+J22K2#@8/
M .,'VR*F_M[4[_4-5T_28K-[C24C$YFW;9IF3?Y:X/RC&/F.?O=.* .GHK(\
M-:]#XH\,V6LVB-$MU&3LDY*,"593ZX8$?A7)W?Q U"P\.7FHW5M9QW&GZJ;"
M\@RQV)N'[Q>[?(?,QQ\N?2@#O+R]M-.M7NKVYAMK=.6EF<(J_4GBI@00"#D'
MH:\_^(UW->^"?%L&V![.UL5 D .XS$!B/3 4H<_[?MSK6'B#54\5)H5]96BK
M/IS7EHT4K$C8RJ4DR.OS Y'3GK0!TEI>6M_;BXL[F&XA)*B2%PZD@D$9'H01
M^%)=WUI8(CWEU#;J[B-#+($#,3@ 9ZD^E<=H7B]KGP_HP@TZUM;_ %6]N;:*
MWB/[J/RWD+N< $\(3VR6[9R*'C>XU6?PJXU73HHY[;6[-+>6)QMN4\^,AU&2
M4SD@@GM0!Z15:XU*QM'"7-[;PN1D++*JG'XFL31=>U&Y\3ZIH6J6UK'-:PPW
M,3VTC,K1R%A@[@.04//?/05A_$(A/%'@>06K7++J4F(DV[F_=-P-Q ]^3VH
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MAR:["B@#C=(\(ZGH^DKIXU*SO+<W-Q+-#<VIVS)*Y;8WS8R"<YQCJ,<U#%X
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M"J.@ P!2T <?JGA'5=8TBW:ZUT1Z[:W2W=M>06^V*%U!7:(RQRI#,#DY.?0
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MXR<\'\\"W^'6I:?H^BK8Z[&FJZ+-.UI<M:YC>*4DO'(F[G/'((QC@=Z]#HH
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MF]MM4M5?4KR.ZV-;,5"J@0QM\_S!E7KQ@\X-=2\L<;QH[JK2-M0$\L<$X'X
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MK;N$WY+$CDD^F ,<]G10 R(2")1*5,F/F*# )]A3Z** "BBB@ HHHH ****
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M1G\*[91M4*"3@8Y.36?JVB6.M+;_ &Q)/,MI?.@EBE:-XGP1E64@]"1CH0:
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ML4<:$ LS(0!DD#J?6LOPIX;AL]"T1[VWN5OK*S2)8[B<O]G?8%?9\Q [@$=
M<# XH XZ+5=9T[P7K_BF36M0N[G2[J^MX+=ROE,!*41G4+SMZ\$#C%=#J$U]
MH>O^%Q9ZE=75MJTC6ETDLGF;CY1=9DSD*1M.0/EP>E='I_AK2M,L+RQM[=FM
M;QWDN(II7E5V?._.\GKDY%,T_P -:9I'D26\5Q(;2-H[999WE\E".53<3C@
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M99?8GD5Q_B>S>_\ B7X<MDO+BTWZ??;I;<@2 9AX!(./KUKN8XTBC6.-%1$
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M<'J,]: //7O;GQ5I7PWU?4'GANKN^VRB&0HI(AF^=0.A.,Y]#BO6478BKDG
MQDG)-9-YX8TF];33+;N@TU@UFD,SQ+"0-HPJD#H<<]JUP,#% 'GOC34+R-O$
M;V.I73SZ?I0GCAMF\I;-P';?(V?G+;1A,'A>0,YI1<:GJWC/1[-]8O;>UO=
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M2KVSAU"QGL[@,8)T,<@5RI*G@C(((_"LI?".CHNDJL,X&D#%D/M4G[H;=O\
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M9/N0M*H=OHN<FBXU.PM'*7-];0N-N5DE52,G ZGN>!7E;2Q7'@'QCH^JD?\
M"0_;+IUA8XFEE9LVSQCJ1_JPI']W':M#3-.TZ\^*$]IK$%C=WG]@6OGI(B.'
MG$C[VP>K=#GKC% 'IKNL:,[L%51DL3@ 54AU;3;BWEN(=0M)((O]9(DRE4^I
M!P*QO']S:6?@759KZS>\M1$!) KLFX%@,EEY"C.3CL#7-^'-5LG^)>M2R:I:
MW,=SI-K*)HE"0N%:4$KR05' W$GGC/:@ ?XB70\,GQ9%<:5)IBQSE[!G*W"L
M"PA 8$@EBHR"!@$D9QSU%AJMS;_:+S5M7T:327"?9KF)O*P_.]6RQ4@8&"#G
MKD<9KS=;JS/[-$N)H-_V9TQN&=WG' ^M=%XAUNRTOQMIMWJ.I/9:'=:8T-M>
MQ*CPB;?EU8LK!=R[>>,[: ._FO[.WM!=S7<$=L0")GD 0@]/F/%9VH^*M%TM
MM.6XU"W']H2;+<B5<.,$ELYQM '7IR!WK@+>ZTGP=J_AB9Y;E/"OV:[BM;J[
MSLBG>165B<#:K*'"D@<$XX-6-7_L+35\'7>GQ+:Z*NMR.)I"1&=\4IW MT5G
M)QV/&."* .^ANY1JM_YU]8M9111O'&AQ+%D-N:0YQM.!C@=#5B#4["YN!;P7
MUM+.8Q*(XY59MAZ-@'.#D<]*\UO9-,/B'XDHQM@DFD6[,C8&6$<V20>X)7WR
M14.E?V9:ZA\+)+<VL4LMG*LK(5#/FU'#'O\ .._?WH ]0;4[!+HVKWULMP.L
M1E4/TSTSGI5A]S1GRF4,1\K,-P'X9&?SKQ:.ZT*]M_\ A'-0UW28_LWB*2\:
M6]F"3.%F9BIC8?>))3)."O/M7M!:."'<2D<2#J< *!_(4 <)H_BKQ'JGA"\\
M0+%I9-I)<*;0HZ;Q$Q!Q)N."=IZJ:Z?2/$5EJOAFRUYG%K:W4*3?Z0P79N[$
MGCKQ7D_AV+PMJ'PVU6'5-<>W>2[O"8XM1<$YD8KB$-M?/'R[3N]ZU=(U#6+=
M?A[?^*+=;.V$%Q%-F,11P3D;8&=> A* @=,%B.,XH ]1&HV1LUO!>6YM6Z3^
M:NP\X^]G%1_VQIFTM_:-I@,Z$^>O#(,L.O4 $GTKR'Q3;6Z:%XYN0T/]C3ZI
M8O8G(VF;=%]H:,^YSDCN&]#70^(],\.6_CKP7%'9:9%#<3W3NJ1HJRY@(4D#
MALD#KU.* .^EU?3((89IM1M(XIP#"[SJ%D!Z%23SU'3UJ22_LXKE;:2[@2=E
MW+$T@#$>H&<XX-<'IS:;I/C3Q1IFM):6EC-:VZV"2A4A:T6,J\:#IA6+94?W
MJR+2RU+0O 'A#Q%=PW$E]HLI$L94F4V4K%-F.I94:,X_V* /3UU?37MWN%U"
MT:!#M:03*54^A.<"G2ZE86]U%:S7MM'<38\N)Y5#O] 3DUY[X?T_4;/Q+>^&
MKVW_ -#NYTUTE5&R/<<O"#[3*A'JI:LV:YTB]N_$GAOQ1J-];WLVIO-#:1HH
M>ZCW P-$VPL2 JKPW&WL* /5)-3L(9_(EOK9)MZQ^6TJAMS9VKC/4X.!WQ5E
MF"*68@*!DDG@"O.] L-%O/BAXM6:VLIYXOL,L8D5'97",68>C!@,D<YQ6K\2
MS=)X2$L$;RVT5Y;RWT<:DE[99%,@P.HP.1Z9H Z:UU*QO8Y)+2]MKB.,X=HI
M5<+]2#Q2V^HV-Y(8[6\MYW""0K%*K$*>C8!Z'UK@]4-CJ7CB/4M.GM9]._L2
M==3E1E:%ERIA#'IG.\C/. :O?"NQTQ/ .AWMK;6HNWL8XYIXT7S"1R59NO![
M'I0!UUYJ-CIZJU[>6]LK?=,TJH#],FEEOK2W*":Z@CWJ77?(!N4#)(SU '-<
M+XMU&PC\73V$ACM;R71) MQ+ES<(SG]S$GW2V1DG!.,#!ZCG-#DTF_N?A9YQ
MM9F&F31R>9@Y*PQ@ YZX8''N#W% 'K']L:6+:&Y_M*S\B;/E2^>NV3_=.<'\
M*G^U6_VD6WGQ?:"N\1;QN*^N.N*\QT71;;Q)X2\6:782PI/;Z]<SZ>T9&+>5
M6#QL,=!NST[$UU7@N\G\06[>)+VT>UGN(DMDA<8,:QYW_G*7^H530!TUQ<06
MD+37,T<,2_>>1@JCZDUGZEX@T[3O#USK1NH9;2&%Y0Z2J1)M!.U3T).,5SWB
M^Z>P\8^$KR\.S1DFN$GE;_5Q3M&!"S]A_& 3T+5@7J1P6'Q.O(98QHMS:_Z.
M0P\M[C[.PE*=B22@..K CJ#0!V'AG4M6U<0ZA+=:9<:9<6B2;;8,)()S@E"<
MD,N#UX.>W/'25C^%)89O"6D/ \;H;.'E"",[!GI6Q0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !00
M#UHKG?&][I]AX7GFU6TNKJQ\V)9%MGV,"9%"G.Y3C=MS@_AB@#H<#T%(R(ZE
M64%3V(XKF&\472>/;O19+!ULK73UNFG#(<[F8;B,YP-A&!D^W2K^C^(5UDVK
MQ6,Z6UW;&Z@N"R,C+E1@[2<-\P./KSP: -D* "   :%144*JA5'0 8%<]JOB
MU--UY=%BTG4+V^DM6NHEMU3;(JLJD99A@_-_%@<=R0#GQ_$C39=)L+^/3]1;
M[7?_ -FM (U$D%P,YC<%N#P>F1TZ4 =@B*B[44*/0#%*54J5*@J>H(X-<];^
M*FNGBM8]'OEU-H&N);&1HU>% Y0%CNV_,5.W!.<=JIM\0],-EI=S!9ZA.-1N
M'M$CCB7?%.H8M&ZELAOE([COG'- '6[5V;-HVXQC'&*0(JC"J /85RUCX^TZ
M>WU/[;:7>G7FFRQPW%G<A/,W2$"+:0Q4AB< YQZX'-0S?$;3K9-86:SN?M&E
M6PNY88GBD+PG/SJP?!P1@@D$>] '88'H* BABP4!CU..37#:IXZOX1IGV7P]
M?QQWNHP6R33F-1(CKOR@W=2%(^;&.^#Q6C'K.DP^+M6:XM;JTO+338Y[JXGD
MS%Y&7(P Q&00^3@'ZT =.$16+!%!;J0.M"HJDE5 +')P.M<M#X^TPZK;V%S'
M+;&ZMY+BWD9T<.L:[G!",2K!><$=/?BM/2-?&KFW:.QGCM[FV^TP7!9&1ERO
M&5)PWS X_4\T ;! (((R#VI%544*JA5'0 8 H9E12S$*H&22> *YD>-[(0Z=
M>R6ES'I>HS+#;7S!=A9ON%AG<JMV)'<9QF@#IMHQC QG-#*KJ590RGJ",BN9
MM/&0OM;N=,MM$U-VM;P6ES-MCV0DH'#D[^5(/;)'<#(SHZEKGV'4(-/@L;B[
MNYH9)PL>%4(FT'+,0,DL !_(<T :K*K*5905/!!'% 4+G  SZ5RB^/["6VT"
M>VL-0N$UQ6-KY:)D,J%BK MP?EQZ>I YJ.3X@VL'A^_U:?2=10:==_9+ZW'E
MEX&^7YB=^TKAU.03P?8T =<Z*Z[74,OH1FLS6[#5+^*W33-8.F;9,S,+996D
M3!&T;ONGN#STZ&ICJJ_VQ!IJV\KO);FX:52I2-00 &YSDD\8!S@^E0:AKJ6E
M^VGVUI->WJ6_VEX82HV1Y(!)8@98@@#O@],9H T+.TAL;*"TMUVPP1K'&N<X
M4# J8@'J*X#4-2CU;Q7X U.V^UPQ7;W1,,VZ,X^SN<,F<9![_KBMG_A-+47=
MJCV-VEK=:@^FQ7+*H!F7</NYW!248 X[>G- '38Q3=BEPY4;@,!L<XKD/^$C
MTK2[WQ??IIFH"XTT12:@-ZMY@$6Y6C4OM "#/8GTS4J^.8SJ%C9MHFIA]1MF
MGL3MCQ<;0I91\_RD!@<OM'6@#K,#.<4  =!61X=U^'Q#8SSQVT]K+;7,EK<6
M\^W=%*AY&5)!Z@Y![U9UC58=%TJ:_GBFE2,J!'"FYW9F"J /<D=>!WH N*BJ
M6*J 6.20.M.P,YQS7.IXQL8SK27\4UG+HXC:Y5\/E9!E"A4G=G!&.N>*BO?%
MTUFFI1OH=\EW:6!OXT<ILE09!'F E0P(Y'7'(S0!TX  P!@"FJB(NU54#K@"
MN(7Q!!?:+X.N]<TR\^T7UQ;F"2.1519VB+!V"OG:07P"#TY XK6OO&%M:0ZE
M<PV5U=V>EN4O9X-I$9 #/@$@MM!!;'T&2"* -F^L(=0A6"?/DAPS(,8?'.#[
M?3KTZ9JU7,3>-;?^UX],L--O=0GFL!J%NUOY82:(L ,,S #K_%CVSD5J>'];
MMO$>A6NK6B2)#<*2$E&'0@E64CU!!'X4 2:9I<6DPR6ULV+/>7BA(_U6225!
M_NY.0.W(Z8 O8'H*H:OJ]MH]O#).'=YYDMX(8P-TLC=%&2!V)R2  ":R)_&M
MK9C5XKNPNXKS2K;[7-:C86D@P3YD9W88<$'D$$8QTR ;>I:>NIV,ED\ACMYA
MLG"##.AZJ#VST)ZX)Q@\BU'&D,21QHJ1H JJHP !T %9&@:^VO1/,-+O;.#R
MXI89;E5"SJZYRN"3QWR!U%8-U\2K6UMM1NO["UB2UTR[:VOI4CC(@VA27^_\
MP^;^') &3CC(!VVU>>!SUXHP/05RMUXYABU=M-LM'U+4)Q:1WJ&V6,K)"[;0
MZDN/0\'!] :DO/&UE9V5UJ7V2ZETFTN#;W%[&%*H5;:S!<[F56X) [' (&:
M+FH:+?:CK$4DFK;='0(SZ<MNN9)%;<&,F<[<A<KCG'N:VZP-1\5P6AOOLEE<
MZC_9\*SW7V7:=BL-P R1N8J-V!VQZC,.H^-+"RC=H89;EX[5;R2(.D3K&P)4
M8=ERQ /R^W.,C(!TF!Z"C ]!7,'QUI<]G;3Z<&O&N+1;U(Q(D1$9R!G>P^8D
M, /53G%/L?&NFZS9Z9)I,<UY)J4#W$4*X1DC4[69R3A<,0O?)Z9Y( .DVKSP
M.>O%+@9SWKR?1M3LK?P3J\VL66I36A\22Q^4)OWL)\]1&&;?G ;:#@G\178W
MWC,6NL:CI4&BZE=W=C;I<NL0C"O&V[D%G _A/!P3V!H Z4(JYVJ!N.3@=32X
M&,8%<_%XPL+NWT1[))9Y=:A,]I%PIV*H9BQ)P,9 [\D58\.^(X?$EO<S06=U
M;"VG:VD%P$!$B$AU&UCT(_EC- &QM&<X&>E&!Z#BN:NO&EK:7!$EC=_9%U%-
M,:YVJ )FP 0I.2F6 W8Z^HYK&U:637/B)<>'[_3;F?3ETD.J+(B[6>5E,P.\
M$'"@ _>'/ SR =^0",$9%( !T ]*\MT6:UNHM9O]>AU"-=$U79;WCW"^9&L2
MQ*L.5<EBQ)W#[K%SDYKJ(_'^DI?WUG?[K.6TL_MS%G217A!P2"A/S \%>O(Q
MF@#J5C13E44=>@]>M.P,YQS7-R^*Y89I[>30[^.X6Q:]A5]FV15."I<$A6&1
MD'L>,]*Q8O$L.I^%/">HZ[I=YYFH7=H86AD546=\%'.UP=F2>"#TY'2@#O2B
ME@Q4%AT)'(I<#.<5R-_X]BL[C7($T34[A]%"O=^6(@!&4+[P2XR-O./O>U:3
M^)[62[L;.QBDO+J\LS?11H0N(1M&XEB,9+* /7T )H V@B*Q954,>I Y-*$4
M,6"@,W4@<FLCPWXBM_$^CKJ=I;7,,#LRJ+@*&8J2K<*QQ@@CGTKF%\6G4_#/
MBVXUK1KS^S[&>XMY8[>5-WE(H##(<'=]YLCUP"<4 =_35147:J@*.P'%<C_P
MDUQ#XHT'1;/3)FL;O3VN=_F(6POE@#YFSA0W)ZGMFJ'A;5;?1+?Q=<7DTK11
M^(I(8P\A=F+)"%0%CW+8Y.!WP* .^VC(.!QT]J-H]!6#HGBRSUG5[[21&T-]
M9HDCH71U>-NC*RD@C(P1P0:JQ^)[H^.]1T:6Q:.QL[*.X-P73'S%\NW.0OR8
M&,GJ3B@#J,#T%&!Z"N:3QK9XTJXFL[J#3]5D6*SO'"['9AE-P!W+O'W<CTS@
MUJZOJ\>D16S-!-/)<W"6T,<2Y)=LXR3P  "23Z>O% &@0",$ CT-9FOZ1+K.
MEM:V]\]C-YD<JS(@<91@P#*?O*<<CC-<;XWUV+7/A?XGD@6ZM+G3I&MID\S:
MR2H5SRIPRD,#^/(K3O-R?%S1=LDNV32;HLAD8KD/%@[<X!Y/2@#5L-#OOMMO
M>:S>V=W/;,6@^RV7D ,5*ECEW).UB."!ST/&-T*HQ@ 8]JSM3UF'3KJSLQ&\
M][>LP@@C(!8*,LQ)( 4#&3[@#)-8=W\0=/LM'U*^GL;T2Z9<);7MJ%0R0LY
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M'2-276-+@OXX)8(YQNC67;DKV;Y21@CD<]#5Z@ HHHH **** "BBB@ HHHH
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MA<<Y$@QSVKLJ* //X/#6LW_AG0?#>J6T<2Z7<6[37B2J4FC@.4V#[P9MJ@Y
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MX]>G2J.A>'M<MO%>CZO<:5;6ZIILEI>.;SS96D+1MO9MN7)V'')]R.E>A44
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MVMG<03P3Z 8%>R5Q:?#X1:%;Z/'K-Q]DM;];V /$A*%93*J9&,C<>2>2 .E
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MYMR!*D@0G<-WWOWG4$#CI6YJ'@EKV+3KA-;O(M:L)GFCU/8C,Y<!7#)C;M(
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M $3RSL$,TBJHW!B-P5AEAD9S@5NQ^'B'L1/?RW4-N6DE2=%)N)6_C8C XSP
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M.2=Q!SSQGT'2M"F0K(D*+*X>0##,%VY/KCM3Z "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D9@JEF(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!G:%HMKX>TB+3+-I&@B:1E,K MEW9SR .[&M&BB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>exhibit1061-loanandsecur005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$$CN)TBG6\$L0E;RWVQ J2N<$C)YQ77URVNZ=J%SXZ\+W]O9/+9V(N?M$H=
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MY;G&[./DP !G.>,8)AT'Q#H\/A:SN[-[^6"ZNY8+:.Y8O<2R^8X*C<?56/)
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M65L%1C@J2"*J^)]*U%O$OA[Q!IT!N_[-::*XM5=59XI5 +(6(&Y2H."1D9H
M?=>/=(LM'U'4+F.[C.FS+!>6QBS+"S8VY .,'((8'!SUK8TK55U:.=ULKVU$
M,QB NX#$9, '>H/53GK['TK@O$7A35]2TWQ??6NGR&\ULVD<%H98PRI!CYG.
M[:"?FX!/ 7W ]+C8O&K-&T9(R4;&5]C@D?D: *>I:K;Z8+=90\D]S)Y5O!$
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MF+L22>23@9).!@<UQ6I^,O$&FZ/XG#/9OJVC7:>7$MLQ$]LX#*0N_.[;O/7
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M)92.0>,=\UAZOJ7BRY\(Z+JD^J64,6HW6F%8K>V8,OF.NX,Q;D$D'@#N.G4
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M//#I#ZK8W+0D A"0T<BAADYQ@@C@]..4TKQ)KQU;PF-0ELI;77K-Y#%#"RM
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M&.1D/(]=N: *UGX7DCETV34-2>_?2U869DB"D,5V;Y,'YV"Y&1M')XSR,Y?
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M0>JL#@C]16=J?@B+5M+UFWN;YOM>L(D=U<I$!B-!A41<G:!DGDDY8^V.KHH
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MK&]&FK:M'-&Y; 3 #IPI^Z!SU/;L=,OM1N;F\@U#2_L9@9?+E2<2QSJ1G*G
M((Z$$#VS6E0!Q\G@&*Y_X2$7>KWDXUVV2&Y!6-=K*FP.N%ZXZ#IZYJVWA6:2
M_P!!O9M6EFFT@N59X5'G%TV-NQ@ ;>F/J<UOS7<%O-;PRRJDEPYCA4]78*6(
M'X*3^%34 <D/ L$=GJ.EQ7TJ:)J$S3366P$J6.71'_A1CG(P3R<$5<'AAH]>
MU/58;X(U]:):&+R1MC1-VTCGK\Q]JZ&B@#+\.:,/#WA^RTA+AIX[.(11R,H5
MBHZ9QWK4HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"X22VAC:Z2>X$*-(P&TMD?>V=5!YXK/U#PCX>U74+>_U#1[2YN[< 1S2QAF
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M:S^R33&>2(1  R9SO]C[BK&G>'M'TBYFN=/TZWMYY@JR2H@WN , $]3_ )-
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MWGVI8;739GBEEE!483 +<C@;B1^'O7*Z?Y@N_AAOMKI/LUE(EQOMW7R6-L$
M?(^7+ @9Z]JN>'M0AT.P\7C4["^9(M7NKAXULW?S(I'&W;QA\@]L\9SB@#T"
M.1)8DDC8,C@,K Y!!Z&G5!97<%_86]Y;-NM[B)98FQC*L 0<=N#4] !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5'/"MQ \3LZJXP2C%3CZCD?A
M4E% #(HHX(4BB14C10J(HP% X  I]%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<Y
MI.KMK>O:PZRE-/TF?[&H#8$DP4-(S>H7<% Z9#'GC !T=%8$?BS3+B_LK%UN
M81J2,;*:1-J7( R=C Y!QR,@9'(S3="U:1]<U?P_=2&2?3C')%*WWI()!E<^
MI4AE)[X!ZDT =#1110 4444 %%1W$*W$#PL\B!AC=&Y1A]".17G?@CQ1J5O=
MQ>'O%$S227JO+I6H,<?:8\G=&Q&/WB_J/U /2**Y?2-2ATO19KF_NKF9Y-3N
M+6$.[2.Y%Q(D<: ]\*/R))X)IU]XUL[/2];G%K=&]TB S7%BZA9 NTL&SG:5
M(!^8$]#WXH Z:BL_0]0DU31;.]E@>&2:)'967')4$D<GCGBF:YKMIX?M(KJ]
M6;R9)D@W1IN"LY"KN] 20,].: -.BLF+Q%:3:U?Z2L<XN[*%9Y0ZA5*-G:5)
M.#G!^F.<5F_VYIE[X@T,^;JD5S<VDT]M;[62*6/"DEQT+ 8P.HW=LT =117E
M_B#Q?=ZS\.M6U6W2^TN2SU%84=7V':MRL3 E3R<;LCISWKM++Q7IMYJ%]9,+
MBTFLX1<2"[A,(,)S^\&[^'Y3Z8Q0!N45A0>+-/FN[&W:.Y@_M!"]C)-'M6YP
M-V%.>#CD!MI([5$WC724T:;5F%R+6"\-E,?*^:.4.(R"/3<0,C- '145SECX
MG>]\:ZIH(L)TCL88&\\J,,S^82>O"X0 >IS[4OB'Q.^B:SH>GI83W!U*=XR\
M:@A0L;-@<C+?*/PS[4 =%17G-EXKC\/Z]XR;4Y=2NK2TO(B-J/,+:(P(S$]E
M4%B<?7@X-=A?^(;2Q#;(KB\=(!<NEJ@<I$<X<Y(ZX. .3@X!P: -:BJ=AJEG
MJFDP:I93>?9SQ"6.1%)W+C/3KGVQFN;A^)?AZ9;*8&^6TO)S;I=O:.L*2;BH
M5V(PI)'?\<4 =A17-_\ ";:6VLSZ5%!J,US;W"6\XBLI&$1<95F..%QWZ>F>
M:BT7Q!H\.@/?07E_/!)?RP)]KW-,\QD(\M5/.-V0!V YP : .IHKGW\8Z7!#
MJC72W-O-I<7G7=N\):1(R"0X"Y#+@'D$@8.<59T/Q%:>(!*]G!>)$B1R++/;
MM&DJN,@HQX8>N/ZB@#7HKGYO&&G0?VT'BN\Z,%:\40Y*J5+!@,_,-H)XJS_P
MD5IY=E((KEDO+=KF,QQ;R(U ))"Y/\2],]10!KT5P][X[T'5O"U[=;M:@TUK
M(SF^MK:1"$)V_)(!PP/Y=^AK0D\5&#Q?9:!'874L<NGM=&? ).&11WS_ !')
M^F,\T =117*:!XTBU72;O4+NSGM(XKR2UC1DRSD2&-5&"<N2.@]?QI]UX]T:
MPM-5FO5N[>32MAN[=H"TB!Q\K?+D%3ZYQZXH ZBBL6P\4:?J.MRZ1&EU%=)!
M]H03P-&)HMVTNA/4 D#\15W4-4M].>WBD#R7%RQ2""(9>0@9.,X   R22 /7
MD4 7:*P;;QAI-UIZW43REVNVL1;&/$OVA<[H]OJ,$DYQ@9SCFH9_&^CVFFZK
M>77VF%M*(%[;F$M+%D94D+D%2.0P.WWH Z2BL&S\7Z7=ZK)IV+F"5;8W:-<0
M-&DL0(#,A/4 D?GGD<U+:^);*Y59'CGM[=[4WJ7$ZA8VA&,OD$XX8'!P<=10
M!LT5@+XNT[^T4L9XKRVGFMVN;=98#FXC7[Q0#)R,@E2 W/2JVG^/M%U.32A
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M(ZN-6L]8T;7(;+48[1;*Z$EH9(;F-22IV;P58$G!SWQ756-M):V4<,UP]S*
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M=X[@ZO#9Q/YQ\@6LC./+P,;BP'S9R..*T*9$)!$HE96DQ\Q5=H)]ADX_.GT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 445S_ (MNC!::?$M_-;-<7T<8BMUS+=#DF)#D;"<9+9&
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MTW7H8H]1M_,,+^9#(CM')$_]Y'4AE/T-#Z_H\=K:W+ZK9+!=L%MY#.NV8DX
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M"#[/YL<[IE,D@$*P!P22"1D'D52C\$:!%INGZ?':3K::?.+FUC%Y-^ZD!)#
M[\GJ>#QR:2SUX:KIVI:I'>P66FQ-+;V]S+C:60E6F8D@;0X( R,@9)Y&+=CK
M5@D&EVEUK=E<7]W;H\3!U0W7R@ET3/0]>,XH J2^!O#LVOOK36!%[(RO+LF=
M8Y67HSQ@[6(]P:T+'0=.T[5+[4K6*5;N_*FY=KB1Q(5&%^5F(& ,< <5#JNK
M>397MQILT-U<:<"]S:JP+$ ;BA[JQ'(S[9X-7K/4;2_TN#4K>96M)X5G24G
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M6^HVLERF=\ E'F+@9Y7J."#T[T66MZ7J-R]M9:A;3SHH=HXY 6VGHV.X]^E
M%67PKH\WAR/P_);.VFQ*BQQ&>3<@0@IM?=N&"!C!XQ6=?:?>:KJ,.B3:(B:'
M:30W O9;A9#,4PX4)RP;>!DMU ;KFNAO-0M-/C5[NYCA5SM7>V"QQG '<X!/
M%5VU_1TL[:[;5;(6UTX2"4SKME8G "G/)SQ@4 5M9\/Q:OJND7S;DETZ8RI*
MLSJ5!QE=HX;=C!W=!G'6G^(=%_MBWM7B94O;&Y2[M7;H'7/RG_992RGZY[5=
MT[4['5[07>G7D%W;EBHE@D#J2#@C(J*+6]+GOQ8Q:A;/='=B)9 6;;][ [X[
MXZ=Z (7T2QOM5L]:N;:9-1MXV2(_:''EAL;AM5MIS@=NPJH_@G0)-)O]+>TF
M:RU"<W%U&;N8^9(3DDG?D9/4 X-:/]N:4+];'^T;;[4SF-8O-&2XY*C_ &L<
MXZU6NO%?AZQ,PNM;T^$PR".4/<H-CGHIYX/'2@"._P!$.IZGI8G5A8:9*+E
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M26UU%HI[F:UD86$F9?FVXY8YVCJ!O!.>A]@HH \2N2K^$?$=G-'=22/XICF
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M7;[K*]@N!#<6EQEN0V0=OW>A/3H:ATW0==T#Q&-7.-5^VZ;;VVH;7"/]HB!
MD7=@%6W-D9!'7GI0!;_X6#ITMMHUQ:65]<IJLSV\01%#1RH&+1N"P(;*D>G?
M..:U/#WB%->6^0V<]E=6%R;:XMYRI96VA@05)!!# Y!KE+?P;J6G/X=:**.9
M[?5KC4[XI( JF42#:F<9QO [9VY[XJP(]>\-_P#"7:Q!IEO,]W=QW5O'-<A
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M,]ZEN;:]>TE@F$H95#!_E92K ]5.[V/H16!-X"M)-/:&*\EMKIM575S<01J
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M%7["2_D%S]OMH8"L[K!Y4I??$/NL>!ACW'./6K= ''-X!1O#L^BG59_)FO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0!7N=&T^Q\'W.DV]JGV&.U=$@?,@VX)Q\V<_C7FUG:V$G@CX900K$HEO[4W
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M>DV-O]J!%QY5NB>:#UW8'S=3UI8M"TB""6"'2[*.&90DD:P*%=1T!&,$<]*
M.8\%S30:]JFEZEHMMINJQ6\#R-8MFUN(\R!9$& 5.=P(// I/W.K_$W6-(UN
M".>VCTZ"2P@F7<C*Q<2N ?XMVU<]0 *Z^STZQTY66RL[>V5L;A#&$SC@9Q3+
M[2=.U,QF_L+6Z,1)C,\*OLSUQD<9H \DLH)M0M?!4.IS3SP_VS>6L,CS-F>U
M5)@FXYYR% SW&/6O2M1T>PLO!-YI,%JGV&*RDC2!\N H4X'S9)_&M"?2-,NF
MMVN-.M)FM\>09(%8Q8Z;<CC\*ND C!Y% 'D>BS6L6F_#73O+MUTF^MC]M5 -
MDMR+=3&LF.I/S'!ZE1Z"NI\(Q2V/C#Q9IUOD:-!+;O;1C[D,KQ[I43T'W&VC
M@;O>NC&A:0-..G#2K(6);<;86Z>7NSG.W&,YYS5JUM+:R@$%I;Q01 DA(D"J
M">O H XG5-,TZX^,.DF>RM9&DTFY=B\2DLRR1!2<CD@< UR>HSVUO\-_%<32
MQQRV_B658%+ -&/M*8"^GR9Z=L]J]<DTG39K];^33[1[Q!A;AH5,@'LV,U#+
MX=T2>YN+B;1["2>Y"B>1[9"TH4@C<<<X(!Y]!0!S@6*X^,%W&ZI+%)X=C#*0
M"&4SR=1W%<<FGV,7P4\63P6\44HGOQYD(V-A9WV@D=0...E>M#2-,%V;L:=:
M"Y*>69O(7>4QC;NQG&.U1+X?T5+22T31]/6VE.Z2$6R!'/J5Q@T <Q?$?\+'
M\%\_\PZ]_P#08:G^'QR/%'_8PW?\UKI!HVEB>"<:;9^=;KMAD\A=T0]%.,@?
M2GV>F6&G>;]AL;:U\UMTGD1*F]O4X')H XV>UAF^*VK6\J"6&?P[&TD4GSJQ
M,T@/RGCH!^5<YX=L&N/AOX170SI3WZ1"XDT^Z4".^PA5@Q'\8SD$YY'MQZJ-
M,L%U Z@MC;"]*[3<")?,(]-V,XJO_P (]H@@6$:/8")9#*J"V0 .>K 8X)]>
MM &?X(O;>^\+0R6]A+8!)IHY+21@QAD65@Z@C@J&R 1VQ715'!!#:P)!;Q)%
M"@PL<:A54>@ Z5)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !5>]OK;3K8W%W*(H@P7)!)+$X"@#D
MDD@ #DDU8KDO'EEJ$\.B:A80270TS5(KNXMHAEY(@&5MH_B8;L@=\>M "^(_
M$<4_A#Q)-H^H2V^HZ992S,IA*2Q,(RZY21<X..N.><&I/#WC+1]4^PZ4-2#Z
MJ]HDA5D9?,(4;BC$;7P<YVDXYK U[1;WQ!J7B75=.M;A8I_#,NF1)-$T+7$[
M%V&%< \9 R0/O>QJQ%92ZY/X,,-E=VYT8^==2W%L\)3$)C\M=P&XLQ'W<C"]
M>F0".PUV0>#_ !%-K?B&YLUMM7N;5-06-3)&B2 * H0CH,?=[UV5_KFGZ;-Y
M%S,WG"%IS'%$\K",<%B$!(&>]>:WNGZA-\-?&=DFF7[75WJ]Q+;P_97W2H\R
MLK 8Z8!/MWK6\17\FG>/%U*QL]3DDFT@0S-!ISW2@&1BF8U961@=YYX(.,9!
MH ZN/Q;H<]K:W$%]YZ7;,MN((GD:7:NX[54$D <YQBJ.H^.M+M+'1[RU\^\@
MU6[6VADA@D8#D[LX&0PVL-N,Y'3@XYFQDALK+PKI^CZ=JDNE6B36T]S]B;[9
M;R!5PC!ANB#Y)+ #^'D#FL^PT_5+7P;X<231M25]+\2O<7$1A+R>49)_F !)
M8?O%Y&>O>@#T*SU*RG\3W\4>KS/+%:Q-+8/'M2 $MA\E0<GH1GC;TJ6V\4:/
M=W=O;179$ETA>V,D3HLZ@9)C9@%?CGY2>.>E<?J^DZCK/B;Q5#;6]U;?VAX?
MCM()Y(F5/-S*2N_IQO7.#W.*<UM>>(M-\'6HTV\LKS2KV"YO/.MVC6$11L'5
M7(PX8X4;2<@Y[4 =#_PGOAG< -3!'VG[(SB&0JDN=NUVVX3DX!; )[UHW7B#
M3;.Y:WFFDWI)'$Y2"1U1WQM5F52%)W+U(^\/45YO>V%_+\/O%MHFEWYN;K7I
M+B"+[))NDC-PCA@,=-JD_A6EKMG?CQ%>ZKX=74[?4FGMQ+:RVKO9ZBFV/YF)
M7$;*"5W9!'E]* .]U35;/1=.FU#4)3#:PC=)($9@H]2%!./>HI-=TV+44T^2
MXVW,ENURB&-OFC7&6!Q@XR.,YYK/\=:?<ZKX#URPLXC+<SV4BQ1CJ[;> /<U
MSMM=W-]XX\/:HNC:K%9PZ5<0RR3VC(4<F(X*GD?=/;GMF@#H;/QUX;OY;&.U
MU(2?;G,=NXAD".XS\N\KM#?*<*2">W45G>/O%$>F>%-<-AJ$\&HV=N2)8(#(
M(I"N55VVLJDY'!P>1TR*Y>PL+^'X?^#;1]+OUN;/6XY[B+[))NBC$LC%B,=,
M,#^-%Y%JMEX5\<^';C1]2N+V^FN[FSG@M7DCN$E&5^<# 8="IP>!C- 'H,GB
M*PTS38)+^>4N+59Y?*@>4HF.78(IVC@\G X/H:@O?'/AO3R@N-4C_>6OVQ/+
MC>3?#Q\R[0<]0>.<<] :Y"5;K2_$;W6I>']9OM-U33[:-#9([/;R1JRM'(BL
M, [LY/')]\:-EIS67C[0&AT>:SLH-(G@VQPLT=NSR(RH7 *YPIS@XSWZ4 =/
MX@\0VV@>&+O79(Y9X((#*%BC+%N,CH.![G@=ZYS4O%$EOXN\,RM>W,.F7MI=
M/-:O;E2SH$VX4IYA.6.!SGC K:\=V-SJ?@+7;*SA::YFLI4CC7J[;3@#WK"=
M[B]\8^#K]=,U&.WM[.Z29I;5QY1=8PH;CY<E6Z^G/44 :VH^)M&O_#,6HP:]
M+96LUPD27441WAQ( 8RK*2"2-I! QFM6[\0:;8W$D,\TF^-D60I!(ZQE\;0S
M*I"DY'4]QZUYM=6&H/X%U^U73-0,\_B4W4,7V23<T1NDDW@8Z;03_P#7K4\2
M65^-=O\ 5/#JZG;ZMO@1[9[9Y+/4TVK]_*[4(!*[L@C;0!Z17$WOBZ[M/B+8
M:<\:C0[C?8>?_P!/NU9 ,^FWY1_M9':NIU:_?3-*N;R.UGNI8HRT<$$9=Y&Q
MPH ]3WZ"N$\0^#KBX^'LODZCJ4NHPC[? HA'-X&\S(39O&7)^FZ@#O;[4[33
MO)%U+M:>3RX452[R-@G"JH)/ )X' !-9+>.?#:6-Q>/J:I!;2B&8M$X,<A.W
M:P*Y!SQC'%<SKVJW%W;>$-<;2M4AU2"=W>".S:5X<PD2J8LAF7D ,#QD'/8Y
M.H)!?> O$5EI]GJT^JWFH17US;3Z;+"Y+S(<K&0?DVQ$9R>5/.30!Z';^+-&
MNK=YK:YDF"S/!LCMY&=G4 MM0+N8 $'(!'(YJ2#Q+I%UID&H6]WYUO.YCB\J
M-V=W&<J$ W;A@Y&,C!STKF?%XN[3Q+HVOII>HZEIBVLUK<0V(?SX2[(RN$4A
MB/DP1VK+U/3Y=.DT37=.\,Z@NF1SW)N["VW"[Q,$Q,45LEMR<KG.&YYS@ [$
M^-?#HL[>[;4T2&XN?LB%T92)@<%&4C*$=PP&*B;Q[X;6&[D:^E!M&VW$7V2;
MS8^,[C'LW;<<[L;?>N8U2Q233M&N-,\/7UI')XBM[Z6-H':8JOWYI0,E3['G
M 'T%Y89T\6^-KAK&\\FZL+>."06KD2LB2!@IQS@LM '5S:]IL-K;W G:9+F+
MSH1;1/,TD> =P5 25Y'.,<CU%4CXU\."/3Y!JD3)J*LUJ45F\T*"6 P.HP1@
M\YXQGBN T^WU'0X/"NH7NAZO=V2Z''IUU#9QR">UF0@[C&I#%3R,C/0&MDZ:
M+?7_  7)8Z%<V-E!<7<TD2PLWD+)$RJ9",@,S')&>,\T ;6I>/\ 2+7PTVM6
M9GNXA<K:;4MY R2EPNUU*Y3!(X(!/ ')%=/#,D\"S('"L,@2(48?4, 1^(KR
MJ^TW49O#/B](M,OFDD\1Q7T,?V=PTT*O 2R CYO]6_ YX]Z]%U.";6O#%];V
M_F6LUY:21Q&4;6C9E(4D=NH/K0!'!XHT:YN[:VCO#ONB1;.T3K'.1R?+<@*_
M'/!.1S4-MXT\/WFIKIUOJ DNFN'MMBQ/Q(J[BI.W X[DX.#C.#7(I8WVM^%/
M"6B-IMY9ZCI=W:/<F6!E2$6XPS+)C:VX# VD_>]CC<\#PS07WBDSVES!]HUB
M2XB::!D$D91 &!(&>5- &CKOBFVT/6-'TZ6WN9)-1E= T5N\@15C9B?E!R<@
M# YP2>@KG]/\90:/K?BF+7]6E:WM+^..!FA+>3&T2-\WEK\JY8_,V!ZFM#Q?
M#=)XC\)ZE#97-U!9WDWGBWCWL@>!T4D#MDCGH.]<[?V5[-I?Q+C33;XR:CD6
MB_97_??Z.L?R\<_,"/UZ4 =_J6O:=I2EKJ:3Y8O.80PO,5C_ +Y" D+P>3QP
M?2K=O<P:A8QW-I<+)!/&'BFB((92.&':O-I%NM)\0K>:AH6L:AIFI:;;0JUC
M'(7MY8PP9)(P00IW9R>,Y]Z[_1;:+3M"MH(K 6,,<>5M4^;REY.WC.3ZXSST
MS0!R/A.;7_$%MKKS>);N.6SU:YLH,6UN4"1D!2P\O)//."/PJ]X7\9/=VFLV
M_B$V]KJ&B7/V>[>+(CD!_P!6Z@Y(W=EY.?K6;X)O)=%M?$0N]*U82W.M7=U!
M&MA+F6-V!4@E=HSCN1[UCW'A#Q NFW_B.6TSJUUKEKJLNFQ.&;[/ WRQ9Z,^
M.>."0 * /2;/7]-OKFYMHK@I<6RAYH9XGA=$/1MK@';P>>G%5X?%>C7%RMO'
M=.9G@-Q$IMY!YT8ZM'E?W@Y'W<\$&N1\2Z%>^,-5O;W2X[FU4Z!<6(DN87@,
MLLI!5,. V!@Y.,?,/?&SX;U:?6X[)+GPS>6%[:0&.>:]M@BQ';@K$QY<$@<K
MQ@<\X% &O'XIT::WTRXCO=T&J.$LY!&^V5B"0,XX. >N.AJG/X]\,VR7,DFI
M?N[6?[/<.L$C+"_'WR%PH^8?,>/>N#TN'4X_"_@72VT+51<:/JL8O<VK!4"I
M,NX$\,O(.X9'3G) JY>V-]+X2^(ULFFWQGU"]F>T3[*^9@T4:@KQR-RF@#OK
M+Q-H^H:N^EVUWOO$C,H0Q.H= <%D8@*XR0,J338_%6C27T%F+PB6X5F@9XG5
M)PHRWEN1M? Y^4GCFN6U2SN]0\5Z ;>WO(XQH]W;/<&VD"PO(L83<<<'Y3],
M55\(QB6WTC3M4\)ZG#JNDA5>XN0[6T91=IDB<L0VX#@*._H,T =1!X\\-7+V
MJPZD'%U.;:)Q#)L,H8KL+;<*200 2,]LTEMXRL)]=UK3Y$G@CTE$,T\T#JG*
ML[$L1@*% P21GG&1S7#K87X^'4%I_9=^+I?$(N3%]DDW"/[89=^,=-G/Z=:V
M9K:6/Q%XX2\T2^O;+4[:!XQ%$=LZ+!L=0W9\\8Z\@^X .UL=7L]0N)K> S":
M%$>1)K>2(A7W;3AU&0=K=/2KI( ))P!U)KS_ $*;5O#3:JY&L:WHMO:QO:F:
MS87N_<P,(W!3* ,')Z9QZUV*S1Z[X=$UL72.^M-T1<890Z9&1V/- &+IOBRV
ME\.S>*]0N&@TF1F\@"-F"0ABHD;:"<MC=GH 0/4G<?5[)'M5:1P;I&DB_<OR
MH&23Q\O!'7'6N;\ V<5[\+-.TJ^AX6U>QNH6[,I:-U/X@T>!=/U:RL"-<1O-
MTQ&TZU<@DRPHW^M Z_.!&,?],\]Z !=9TP^$;6Y'BN[,$]]LBU#RAYDC>>1Y
M6-G3(V9QT[UJ7>K2:3XIL+"YDWVFJ^8D#,.8ID7=LSW5EW$9Y!4CH0!P2V&H
M#X4VUA_9E_\ :UUH3&#[+)O"?;3+NQCILY_3K73^,8'U'Q-X,M8 ?,346O7.
M,%8HXFW$^G+H/JPH M?$6_OM+\$WE_IUY):W,+PX=%4Y#2JI!R#V8],&M WU
MJWC-;$:M*+I;%I#IH3Y"N]?WI.WJ,@8SWZ5F?$NVN;SP'?VMI;3W-Q*\.R*"
M)G8XE1CP!Z FJ6J6MY>_$436L%U'%+X?GM4NC X1)GD1E!;'!P"?;'K0!OR>
M+M$BGMXGNW'VFX%M!*+>0Q2REMH59-NTG.>A['T-.?Q7HL5CJ-X]VRP:;(8K
MQC!)F%@ 3D;<XP0<XQS7G!OKH>%O!6C7FBZA87>FZQI]M.9X=L19#MRC]'!Q
MG*Y]_>SKEMJ4%C\1-)31]1N)]49I[1X;=FCD5H$7A^FX%2-O7T!H [MM1LY?
M%EG:IJ\JW#6;RKIZI\DJ97]X3MX(R!C/\72L#QCXK6*/25TG49XWDUFVM)&C
M@)BF4RA9$\PJ5R.?NMG@CL:9);WMQXWT.=+2\@1=$GMVF:!ML,KF,J&(& ?E
M)Z]JYR)=43P#X?\ #\V@:J-3TC4[3[2$M6:-DCF!,B28VL"!G@YYY]: /2+C
MQ5HMK=M;2WA#I<):NXB<QI*V-J,X&U6.Y>">X]14%GXLM;SQ5JFAB&X1M/CB
M9YG@<(2P<GYL8"@*,$D Y.,XKA/$D>K:C::W"="U))HM8@GABM+;$4L*RQ'S
MBR_ZUR%.1DD8' QFM2_TO4[W7_&MI'97<)US288[2X*?NU812J0S@X!!91CK
MSD<<T =C:>)=)O=1CL(;EA<RQ&:%9(7C$R#JT98 ..1]TG@@]*UJ\_\ #$T>
MH3Z?/=^$M5M-4TV)_-FO5<I"=FUA S,=^XX'R\8ZXX!ZW0-;C\0:3'?QVEW:
M;F9&M[R+RY8V4D$,O.#Q0!SOQ"\4QZ9X1UQM.U&>#4+.'_6P0&18Y" 0K-M*
MJ2"."0>1TR*UH-1MI/$]I:-K$HO!IQE;3]HV,NY,REMO4$@8SWZ5P%]!JUIX
M-\:^&KC1]2N+^ZN+J>TF@M7DCN4E.Y3O P&'0J2#P,9KH_+N7^(.F7ITV\^S
MKH$L#EX&VB1GC8(2!@$A30!TMOXETFY8".Y8*;=KI9)(72-HEQEU=@%*_,O(
M/0@]*?;^(--N6E59I(_*A%PYG@>$"/GY\N ,<'GVK@=(TZ]TX26UE;:I>^')
M=*N#+I>HV[K+:-M&((I& +!N5V@G&T'/2JMSX;U^\T'7?#^E7=_=:5/I?^AM
MJD#13P2[P?LX=@"ZLH(YSCCF@#T:T\1Z7?WJ64-RZW,L1FB26%XC*G=DWJ P
M&1TSU%<WX<\5+8:-JUWXAU*62.#6[FRCG>$MA5DVHI\M<#L.@Y-)<)<>*-:\
M)WL5A>V3Z;+)<W9N+=XC$#$4,0+ ;LL1]W(PI.>F8?#^@?VQX7\5Z/J5K<V\
M>H:I>.AFA9#LD?*2+N SV(]"* .TEU2S@NQ;2RF.0PM<?,C!5C7JQ;&!C/<U
M6L_$>EW^H_V?#<.+LQ>>L4T#Q%X\XW+O4;AGN,UR4>C>(M=^&^K)J48@U^\L
MC9A6;&?+!49/^VV]L^CCTJUX8F@UC4;2]E\*ZII^H6L;++/J(<"(D89(F9CO
M!/<<8'/.!0!UM]J5IIPB^TR%6F;9%&B,[R-@G"JH)/ )X' &:SI?&.@0Z2^J
M2ZBB6D<WV>1F1PT<F0-C+C<IR1P0.HK+\2V]]:^-?#NO1V\]UI]LEQ;7*01F
M1XO,"[9 BY+#*X. 2 :Y;Q%HE]<:7XQU"WL+QTU>^L6MK5;=S(RPM'YDA3&5
MSM;J 2%'J* /2M*UK3]:MYI]/G,L4,K0R,8V3#KC(^8#/4<C@UG6WC?PY>7X
MLH-25YS)+&1Y;A5:,;G!8C"X /4C.#CI6\CAXU<!@&&0"I!_(\BO.+#1M0U+
MP9XYTR&VN+6[U"_OGMC/"T0E63[AR0.#T]J .SM/$NE7VHBPAN76Z:+STCFA
M>+S(^FY"Z@,/<9ZTVW\4:/<W=M;179WW6?LS-$ZQSXY/EN0%?CGY2>.>E<;:
MVQ\5:;-$OAK4]+UE;">W-WJ(<+;/)&4(B9F.X%B.5&,#G!P*1;*^UWPUX0TA
MM-O+/4-*O+22Z,L#(D(@&&*R$;6#8P-I.=WL< '66WC7P]>:BMA;ZB)+DSO;
M[1$^!(B[F!.W X[DX.#C.#3T\8:$\]G"+X[KT$VI,,@6<#NC%<,.0<@]"#TK
M"\+6Q2U\9)?65U##=:G<SKYL31>;"T:C*LP YPW?BN=\,7D ;PDNKV^MVZZ3
M'Y-HTVDR1QAI$$:B28$J<*=H.%!)SQTH ]"C\5:++?16B7A,DT[VT3^4_EO*
MN=R+)C:6&T\9['T-5)_'WAFW^T&34P%MKC[-.PAD98GX^^0N%'S#YCA?>N&E
M75[O^PYYM U.*YLO$)FN+:WMMEO#'F4!D P'W;E8R<\ELE0<5-J-A?3>$OB-
M;1Z9?-/J%[(]HGV5\S*8HU!7CD95J .[DU&S7Q>MJ=7E6XCL'F;3PGR% Z_O
M2=O49 QGOTH7Q=HQNK&V::YCFOVVVJRV4R>:<9^4L@'3G/85A-YH^(UCJ+6%
MZUFF@2PO)]DD(WF2-PG3J0K<?AUJMX=>>\UF7Q%K&G:@FJW+"ULK1K.4+I]L
M6QRQ7;N/WV.>P H ZL^*-'%_!9-=E9+B5H87:)Q%)(,Y19,;"W!X!SP?2M>O
M+?"5D\=KIGA[6?"VI2:GI<Z8NYM[69V-\LZ.6V[MO( &<G' R1WNBZ[%K3WT
M:V5[:26=PT#I=P^67QT=>>5(Y!H K7WC30--NKRUN;XBXLT62>*."21D4YP<
M*I)'!R1T[XJY)KVF):V=P+GS4O4\RV$"-*TRXW;E5021@@YQQD5S'E3Q^//%
M%TUE=FWFTN"&*46SE9'7S=RJ0.3\RUA^&;'5-#F\':I=:??-:0Z(=+NHEMW:
M2UEW*P8Q@;B#LVY /0=J .YD\8^'X=,AU&34XTM)IQ;*Y5AB7=MV,,94@\$,
M!COBKVE:O8ZW9&[T^5I81(T9+1LA#*<$88 ]?:O-=3T.^2PU*\2PNWCU'Q+;
M7T5LENS,L,;1[Y&4#*EMC-@\XQWXKU<$,H(R 1GD8- ',Z;XG@N],O\ Q'<S
MM%HT$LL4)2,N#'&Q5I6V@GEE;'8* >YK776]/:&PF69S'J'_ ![,(7^?Y2WI
M\OR@GG' KF?AC9>1\.K?1KR,-+9R7%G=1L.I$KYS[$$'Z&E\#Z/J>F"6RU-&
M^S:,TEEITC<F:%B'#^^$\M![JPH =-K>ECPCJ5X?%EVEM]M>,Z@(1OMV\P?N
ME&SD#[O(/7K6Q+>6LGC!-/&L3I=?8'<Z>J_*5W*/-W;>&&0!SWZ5Y_>:?J$O
MPR\5V2:9?FZNM:GF@A^ROOD1KD.K 8Z;0375RI-)\5["^6TNOLG]C2PF<V[A
M [2QL%)(X.%/7^= &GH.L27>H:KH]VP:^TN5%=P,>;$Z[HWQV.,@XXRIQ@$"
MK&I^)-*T>5XKRX99(X#<R+'"\ICB!QO8(#M7@\GT/H:P=!MY)OB?XKU%0?LZ
M0VEGN[-(JEV_(.OYU1\6C4;G7-6L5TF]:"?1REM<64'-Q(=^8Y)1RJKD$+D
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MD7 /ES9 \O;C)XR=W3BM&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSF"^9&"6"LK!E."QYQGGK6C8:?%IT+)&\LCNVZ269R[R-C&2?H!P.!V%6Z*
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M37+G7-+_ -&M8]-NK$37,#;S<6\I&>3]W;T7& 2<GH#72444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%1O<11S1PO(HEESL3N0.IQZ#CGW'K0!)165=>)-&LK^*RN=0A
MBGED\E Y(4R8R$W?=#8(.W.>1Q6K0 4444 %%%% !139)$BC:21@J*,EB< "
ML>+QCX9F ,7B'2G!;:"+R/&?3KUH VJ*0$,H92"#R".]+0 4453N=6T^SO[2
MQN+N*.[O&*V\+-\TA ).![ &@"Y15.RU;3]1GNH;*[BN)+1Q'.(VSY;8S@^^
M*N4 %%%% !1110 453BU;3YM5FTN*[B>^AC$LL"MED4G )]*N4 %%%% !111
M0 4444 %%4YM6T^#5+?3);N);ZY5FBMRWSN%&2<>@]:N4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 455N=2L[.[M+6XN$CGO':.W1NLC!2Q
M_ $U:H **** "BJMCJ5GJ:3/97"3K!,]O(4_AD0X93[@U:H **** "BBB@ H
MHHH **** "BBB@ HHHH **IW6K:?8WEI9W-W%%<W;E+>)F^:0@$G ^@-7* "
MBBB@ HHHH **** "BBJ=SJVGV=_:6-Q=Q1W=VQ6WA9OFD(!)P/H#0!<HHHH
M**KWM_::=;FXO;F&VA!"[Y7"C)Z#)[^U06NMZ9?3B"VOX))R"?*#C?@=]O7%
M %^BBLL^)-%$-_,=3MO*T]MMW)Y@VPG&<,>F<4 :E%1V]Q%=VT5S X>&5!)&
MXZ,I&0?RJ2@ HHHH ***IZ=JUAJ\<TFGW<5S'#*T$CQ-D*XQE<^V10!<HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX3_Y'7QQ_P!?UO\ ^DT=2^*M>U329KK[*]G###I[W,/F1M-)/*I.5\M2&"
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M"0OAB.,C;SGCI6[I_AY['Q-J^L&\$HU-8E>#R<!!&I5<'/H3G/Z5F:#X(N-
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M!UDB)R8Y$/WESSU!!Y!%6TTF>[AD36;N.]5XVB,44)AB*L,-E2S$D@D<MWX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/'?%7K#4+35+&*]L9TGMI<F.5/NL <9'MQ6+X AMH/A[X>2TV^4=/A?*]V9
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M8VC '3.:T:\\U"WOXO'W@.6\U-KLR?:RZF)%57^SDDIM .WD\$D\#GKGT.@
MHKSN]\2:S;Z%X]F2^/G:),WV.0Q)D*(4DVL-N",L>V<5;?4M>O\ QI!H\&K)
M:6L^B"]W);(SI)YBJ2"V1W[C'7CH0 =1JFMV.CRV,=[(Z-?7"VT&V)F#2-T!
M(&!WZXZ&M&O+)M8O->\&>!M0U!D>[?Q! DKHNT,R22INQVSMS^-7_$GB76-*
M>_NX+])1:ZG;0"WMXE:%(7:-2LSLN1(2['"MP-G&": /1**X35=9U?3O$6N:
M9)J3H)M.%YI#"&,X<,5>/&WYSN,>!UPWKS4_A?7+WQ+8:.RWLT4RVCOJ8\N/
M<LP;R]A&WCYUD(QV3GK0!MS^*=*M]1BLGEE+27(M!(D+-&)B,B,N!@-S_3K6
MN[B.-G()"@D[5)/X <FO([6\U30/ /C'6++5;C[3:ZQ>;!)'$RL1. 21LSDC
MT('H!7<'5+Y/B9%I'G[K"72)+ORBB_+(LL: @XSC#'@F@"9?&FAOHMEJZW$I
MLKVY^RP2?9Y/FD\PQ@$8^7Y@1\V*Z"O';;_DCFA?]A^/_P!.#5U]UK]WH'C2
M\MM7OG;2KFP>ZT_$: J\?,L>0,LP!5E]L]30!V=%4-&2_31[4:G,9;XQAICA
M1ACR5&T 8'3\*R_$.M3VFO:!H=M)Y$NK2S;K@*&,:11EV"@@C<3M'(/&>* .
MCHKS'Q!XKU_1K#QC81WB/=Z/;PW=I>O I9XY,_*Z@!=P*GG&".U=[I%MJ5NE
MPVI:DMZ99-\06W$0A7 ^08/S#.3D\\T 3:GJ,&DZ=+?7(E,,6-PAB:1N2!PJ
M@D\GM5NN8^(.JZAHG@N^U+3)TAN8#&0S1A^"ZJ1@\=#[U3O;S7KOX@W6@VNK
MK9VG]DI=HZ6J.Z.963@MD'[O<8Z\=P =G17/>!M9NO$'@G2M4OMANIX?WI08
M#,"5)QVSC/XUT- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%->1(\;W5<]-QQ0 ZBHI9&\MUA:/
MS]A**YXSCC..<5!97$RZ3;SZE):+/Y2M.\#GR=V.=I;G;GIF@"Y17.^,_$%S
MX=\'WFM:?%;W#P*K 2L=I!8#/'7K[?6MZ6X@@*"6:.,N<*'8#<?0>M $E%4)
M=8L8=:@TAYT%[-"\ZQ9&=BE02?3E@!Z\^E.T^2^=KP7QM,+<,(/L[,<18!7?
MGH_)SCCI0!=HJ.&>&X0O#*DB@XW(P(S^%"7$+N$2:-F*[PH8$E?7Z4 2445'
M'<03(SQ31NJDAF5@0"/6@"2BN5TKQ!JFNW*7>FQ6+Z6M[-:SI(S"95C9D\U6
M!(.67[N.A'-=--<0V^WSIHX]QPN]@,GT&: )**:\L<?WW5>"?F..!UIHN(2B
MN)H]CC*MN&&'M0!)7,VFFW/AW4]=ELK5KFWU)S>Q1HV,7.P!D)[!]BD-TR6S
MCC/2;TW[-PW8SMSS0\B1C+NJ]3\QQTZT >6>'M/U**WM(M.U+Q?;WT87S+6_
MM5^S*<Y8,[Q_,O7[KEO3)KM;?27O/&+Z_<(42WM39VB,,$[FW22$=LX51WPI
M/<5NB:)HEE$J&-L;7##!STP::UU;K"9FGB$0."Y<;0<XZ_6@"6BF--$H4M(@
M#<@EAS4=S)(+>9;5H?M0C8QK*?EW8XW8YQG&: )Z*J6URR:=:R:A-:I/(B!S
M$_[MG(YV$\D9SCOBFS2WO]IV0@:S-@Z.9R['S2V!L\O'!'7.?;% %MU+QLJN
MR$C 9<9'OSD51TK2(M+TE--\^:Z@4%<W(4DJ>H.U0".3VJYY\/G^1YJ>=C=Y
M>X;L>N*)+B&+/F31IMQG<P&,]/SH YT^!=%7PW;:' DUO;6ER;JT>)\26TGF
M,X*$@]"Q R#QP<U:/A:RGBU(7TT]Y/J-M]DN)Y2H?R<,-B[0 H^9CP.I^E;E
M1F>$3B RH)2,B/<-Q'KB@"KH^F+H^EP6"75S<K"H19;A@SD 8&< #@ #@#\\
MFJ_B#0+?Q%816T\]Q;O!/'<P3V[ /%(ARK#((]>"".:IZMKURNOQZ!I;6JZ@
M]E)>>9= M& K*JH0I!RQ;KG@#H<U=N-:31_#JZGKOE6CI$IG1)-RB0X^12<;
MLG@>M &9'X'M8KG4KI=5U3[5J'D&:;S4W!H2"C#Y< Y'(QCG& *=>^!M*U.U
MU2+4&GN9=2\KSK@LJ2 Q?ZLJ4  *DD@X[\Y'%/;Q%/'X\71'2V6P;3'OA<;S
MNRLBI@]@/F/K6K?RWHBM7T]K,AKB,2M<,0#$3\VS'5^F,\4 5="\/KHD;[]2
MU#4IV 7[1?RAW"CHHP  /PR>Y.!5S5=,MM9TF[TR\5FMKN%H90IP=K#!P>QJ
MPUQ"LPA::,2D9"%AN(Z=*DH Y>S\$6]GJ5GJ(UC5I;RUM&LUEEF0EHR00" @
M'!4'ISWS3(/ 5A;Z/HNEQZAJ M]'N5N;7YH]VY<XW'9R!N;\ZGD\7VT?CV#P
MNT3!IK9Y%N/X3*N&,0_VMA#_ $(]:Z&26.&-I)75$7JS' 'XT <I!!%XG\6V
M>JS:+>V8T7SXHY;V(1M*[$+\@R=R8!.3W*X[UUU,\V/RA+YB>61G?NXQ]::U
MS;I$\K3Q+&A(9RX 4],$T 9NN^'+'Q ELUR9H;FTD\VUN[=]DL#]"5//4<$$
M$'N*DL](DADCDO-3N]0>/F/[0(U"GIG$:*"<>N?;%:#31)#YS2(L0&[>6 7'
MKF@31&-9!(A1\;6W#!STP: .;MO VG6ML;".XNSI'VG[2NFLR&%6W[\#Y=VW
M?\VW=C/MQ5Q/#4,>N:EJZ7UXMQJ$"02J#'M54SMVC9G(W-U)ZUJF[MA$93<1
M>6K;2^\8!],^M.FGBMXS)-*D:#JSL /S- '+6_P_L+2WT2.UU+4X7T='BMID
MD3>8GQN1ODP1\HYP",=:(_A]ID.CP:;#?:DB6VH?VA;2^<I>&3<S87*D$9=N
MH).>2:ZLR(NW+J-WW<GKQGC\*HZCK>G:5IRW]U=1K;LZQHP8'>S-M4+ZDDT
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M:W(3,[6SGR0W?:6YQ]: ,>_\%6&IZ5JEE=7=XSZKM%Y= H)9%4851\NU5 [
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M,EU;Q)9NUO#>IH.&:\;=YB-YA5((\CYL]6]=HP>U;38=+UKQ3X(>X6VO//\
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M<5TUII%C:6EC;I;QNMC$L5N\B LBA0O!QQP!TH \HT.Y@?P1\+@DT;;=41"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#)F\.:=<>((]:F29[N) B*T[^4,9PWEYV[AD\XK6HHH R]+T&UTB]U"[MY
M)VEOY?.N/,?(9\!<@8XX '''%:E%% !1110!!?6<6H6%Q9S[_*GC:-_+<HV"
M,'##D'W%0:3I%GHFGI962.L2G):21I'=N[,S$EC[D]@.U7J* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "@@$8/(HHH YNR\#Z-I^(K=
MK];,?=L3?3&W4>GEEL;?]GI[5TE%% !1110 4444 %%%% !1110 4444 %%%
M% $<T$5Q'Y<T:R)D':PR#CID5)110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBU0-]EECG61@0NX"5!RA(Z=?0X- '7T51UC4QH^E3WQMI[GR@,0VZ;G<DA0
M/J1SV'-<]>:Y'K%AXIT6YM?)N].M-TH27>C"2-F4JP .?E.00,8[T =?17EE
MO&O]E?":;G?^Y7.3T^QL?Y@5Z3J5S+9Z9<W,$(GEBB9UC+[0Q SC/:@"U17'
M>'_%>HWWACP_<W&FO+?:K&&4HV(A^[WEW8 [!Q@#!.<42^/XD\(-XCCTNXEM
MH)W@NT1U+0%'*,_'WD!&<CMSCK@ [&BL#_A*K5-)O]7FCV:9;-MBN5<,+GD#
M*>Q8[03@$^W-9A^(NG6]SJ5O>Q!7LK$W^ZVG6=)(@<$!AC#@XR#ZYR1S0!V5
M%9NEZG/?RRK+:+'&L<<L<\4PEBF5]WW6 '3;SQW%:5 !17+3^-$MKRW6?39X
M[2XU/^RXYG.UVER0&"$<QEAC<#[XQ5FW\3B]U"X@LK3[1#;7OV*X=91OB?NS
M)CA><9SD]<8YH Z"BN?TSQ.-6N$-G:>;9M=36K3K,"T+Q[\F1,?*"4XYSR,@
M9K-3XBZ9)>Z8J*CV>IW MK>>*='<.<["\8Y56QP>>HR!F@#LJ*Y_2_%"ZN\4
MUK:>98232P_:$E#-&T>[/F)C*YV\<GJ,XSBH]*\5G6+."_M-.>:QN+5[F&6&
M96)VE?W; X"N=W3) VD$\4 =)17$6WQ%%Q9:'?G0KY;'6&$5O*'C+>:59E3;
MG.#M(W' S[<U=@\<6R0:P=4LI;"XTJ6**:%Y$?<90/*VL#CYMP')&#U]: .J
MHKBY/B+:0'6(I;)I9]-LC?E;.X29)81G)#Y !!'*GGIC-6[+QDUUJUC82Z/<
MVW]HV;W5E))(A$VP*64@'*G# C/Z=* .IHKA= \<W,_A6UU35[:&&6]U"6TM
M\S@1EO.E55+8^4 )C..3VR:Z[3KN>\@D:XM'M94D:,HS!LX_B![@]1_2@"Y1
M4=Q<16MM+<3R".&)"\CMT50,DG\*P;7Q')J%SIT,FC7:V.JPO)!<#Y@JA0P$
MH'^KW*>.3Z<'B@#HJ*\N\">)3HGA#0;:?3;EK*ZU":S%YO7"R/<2[!M)W$9X
M)_G747_C1-.G9IM-G6R348].:=SL9I'V@,J$?,F6 SG/!P#B@#J:*Y8>+YYO
M$E]HMIH%[/)8S0)<2B2-55)03YG+<@ 9QUZ\#'->7Q_ MA9ZG#IEQ<Z=>WYT
M^WDBD0.\N]D!*L0 I92 2V>F0,T =C17'ZU\0M/T<7LOE+/#82K%=!;A!*"<
M9V1]7V[AGD=\9Q5X>*TN=2NK33[47?V2:"*XVRA9%$H1@X3'*!7!)R.AP#B@
M#HJ**R-:\06NC2VMO(T/VJ[W^2DTPB3"@%F9CT RHX!.6''7 !KT5Q$7Q)M)
MK"SN(M+NY7GU0Z5)'&R,(YQD\-NPP(&0PX.>2*NP>.+=8-8_M*PN+*YTJ:**
M6W++(TAE \K80<$L6 QV/7UH ZJBN7OO%MSI<.K/?:)<QG3K/[:61]T4L?.0
MKX WC:<J?;FK+>*(UU?2+#['*QU6TDN8'5EXV*K%2#CGYQCM]* -^BN&C^(Z
MOI5EJS:%?)I]Q>&R>4O&6B?S3$/E!RWS 9QTSWJ/Q#X@_M;P]XOT:]TR>QO+
M/2I+I5>56WQLC[6!0\$,AR/YT =[17">'_%[6<7A[2;_ $:\M8;ZTCCLKQF0
MI-(L0.T@-E"0#C=C/M4]GX_DO+"YU%/#>I_8;;[0LLBF-V$D3%=@0-EB<=1D
M>_7 !VE%<P/&'E7>JV5UILJWNG62WS102K)YD;;N 3MPPVG(..V":@TSQR-0
MO-"CETBZM;?6X#+:3NZ$%A'YA4J#D?+G!/7'2@#KJ*YJ/Q:;C[%<VNEW5SIE
MY=_9([J'YB#DKYA0#B+*D;L^AQ@YJE??$73+*19-J2V7VS[')+'<(9$;?L+^
M5U*!A@GKW (YH [*BN?M?$XO[^:&RM//@M[TV4[K*-\3CJS)CA<\ YR>#C'-
M:VIWZ:7I=U?R132I;Q-*8X4WNP SA1W- %JBN9B\7D:C>Z==:9*E[;6"Z@(H
MI5??&21C)VX<$<@\>A-5=+\>KJ,V@&31[JVM-;CS:W$CH1O\LR;2H.0, X/<
MCTYH ["BO,?B+K?]M?#_ %.>RLFET^*Z2!;L2@$NDZHS*O=-P9<Y]>".:]./
M(Q0 9HKRFUNM.TGP%XUEU'39=0TZ+7+M9;:-P"4WJ!R2#@<=.?:NRUOQ=:Z/
M<W%G$D,US;6XN)8I+E(?E.=JKN^\QVGCITR1D9 .DHKCX?'\-_=:;;Z9I-[=
M-J5@U[;DLD8(4J"K9;Y2"W.?3C-26?CJUO=+TNX2W,%UJ%S+:);W,H0)+'N#
MJSC(ZH0, YR/? !UE%5=.NI;VR6>>UDM92SJT+D$J58KU'!!QD>QJU0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^,-/M[32-6&FFSL5$8OH)&,ERBC"#RRN$. -QR>AP.<CH]/U:PU43?8;I)S
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MNH6AW-,#"H4*V?EP>>^:Z:N8/A^^LW\.6^GZK?K;Z8/*E!9!'-$% Q( !N;
MP,8P2373T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !50ZA#_:8T]-TEP$$D@7I$AR 6],D$ =3@]@:MUQ7@.62^NO&-U,[
M"X;79[?>.JI&B(@&?0<_C0!OIKR)817M]975A$\S1-]H508OGVJS8)PK'&#[
MC.*UJX#P]+/K7PEU$:I<R7;R+J$,DLQRS*))5&?H /RK?\"WUQJ7@+0;R[):
MXEL8FD9NK':/F_'K^- '04444 %%%% $=Q*T,#R)#),RC(CCQN;Z9('ZUE>'
M?$^F^*=+>_TMW=8Y&BEA==LD;KU5E/0_XULUY0FF7GAFPLO&V@0-+^ZVZQ81
M_P#+U"&/[Q1_ST0?F./J >D:3JJ:O;RS1VUQ L<TD)\X*"61BC8PQX#*15XD
M $D@ =2:\U@\3"3P_P"'SIMPRV6NZ_<Q&Z3Y2(FGF< 'JK-@+ZC)Q@U!XIFO
M;.3QAX?-W=S:=_PCSZE SSN7MY!O4IOSN*MMS@D]".G% 'HD^H['L/(M9[J*
M[?;YT&TI$NTL'8DCY3@#C/450U7Q/%IUQ=6]OI][J,]G%'-<Q6:*SQHY(7@D
M%B=K':,G ]QGF7DNM,7X?Q6M_=I!=3+'/$TI82#[,S8)/. 5&!G'M3]'TF.?
MXE>,D^U7T9\BRPT=TX(+)+[\X[ \"@#OU.Y0P!&1GD8-9/B7Q%:>%=&EU:_A
MN'M(2HD:!0Q3<P4<$@GD@<9KDO#FI7]_%:^&+R]N3K.G7TBZC,)6#R0Q_,LG
M7[L@>(8]VQ]VK?QA_P"25ZS_ -L/_1\= ':P2-- DCPR0LPR8Y,;E^N"1^M2
M4R25(5#2,%4L%R?4D #\20*\ZTBZU[Q)I6G^(;348;1Q>LUQYEXYC,2R,K0&
M'9M!Q@ YW9&<\T >D4R:0Q0/(L;RE5)")C<WL,D#/XUY)J=YK,7A?QMJJZ_J
M7VC1M5D^R 2 * JQ':P ^9?F(V].>F>:ZR&]E\0^-/$&DRW=S;0Z5!;K"EO*
M8R7E0N9"1]['  .1P<@YH W_  ]K=OXDT"SUBTCECM[M-Z+* & R1S@D=O6M
M.O(O!>I73^'O!7A^)@L5UI<]P?\ 2GMS*Z.H"AT!;@,S$#&<#G (.A?)XCTY
M?#>G7?B*5I9=::UD>V<%C T3NJNQ4$N !SCG@D$T >FT5S>MV]SHOP\U-+;5
M+U[FSL)I([R9U>8LJLP).W!].E<K$^M:7=>"M337;^[&LF.UO;69E9/G@+AT
M7'RE=N<\Y[YYR >G45Y''JFL:9X"UOQ6VM:C=7>GW%[;PP2,IB(\\QJSKMY*
M]>W3'2NDU"2\T/Q1X9CL=0N[FTU5I+:Y2:4RY(B+K,F[.TC:<@?*0>E '<45
MY!'>ZTO@6RUW^W]1-[%K9M1ND!1XS>&(AUQAOE/?I@8Q6KJ5SJ>CZMXNTZWU
MF_>.+01J,,DT@=X9LR@[21@ [!QC [8H ]*K&\0^)+3P]H%[K$L4MU!9_P"N
M6VVEE]>I XR,UQ,3ZSIDW@G5!KE_>+K)BM+VUF<%"'@+AT 'RE=IYZGN>N<:
M2U6'X)>,'$MP[&ZO4_>SN_"W# 'YB>?4]3WH ]G!R ?6EKBM?U"7PSXMTK6+
MN^G70KR-K.XC>4^5;SXW1R8]&"LI[9(/4UO^'([E='CGO'F,]RS7!29RQB#D
MLL?/3:I"_4&@#6K!U/Q1%87-U;V^GWVHRV2QO=)9HKM$LA.WY206. 3A<G'X
M5Q]MJ]^NJ^&+NVU.ZO;>_P!4GMYKMW*PW2%964)#DA578 &^4G;GD'-266F1
MMXN^('^DWJE(K?!6[D4\VY/4'MV].U 'H\,T=Q"DT+J\;C*LIR"*?7E7A^]G
MLO#'@'1[>5]FK61DD,EX\>XI"A$:N Q0').%Q]WW.;&K)XDTC3].M9O$#AY/
M$4$"&"7S'2WD(Q'(S*"Y'J>H(SF@#TVBL?[/_8'A>Z5]8N"+>&63[??L)6C'
M+;FX&X+Z>@Q7):%>ZB/&&F6!O-0^R7VAO,SW,NYY95>,"8(Q81Y#GY??E1B@
M#T6BO(M&U#6%\,>"==EUR_GNKW5$M+B.20&*2)WD4@KCD\ @]1VXXK9N-2OM
M \0:YH<]Y<SRZG$DVB/+,QP6(C:,'/\  [*W'.TY/2@#T2H+VY%E93W1BDE$
M2%RD>-S #/&2!G\:P_%6I7'A7P#J%]:N\]Q96N4DF)<EN!O;UQG)^E0OILEJ
MS7L.O7$]E<:<Z&VG<RB>3&X3*Q/R\9RJ@+R.F* -K0]6AU[0['5K=)$AO(5F
M19 -P##(!QD9J_7DOA=[W2M*^&]Q#J5VT6H1K:SVS./)*?9V9<+C@@J.>O6K
MCZO?QW^@WUIJ=U=PWFO/:2W1<I!-$?-'EI%DC"; -^ 25R,YS0!Z=17D>J76
ML+H'CO45\0:DLVC:@[68610J[8HGVL .5Y(V].3WYKI-7O[V3Q0UK=RWL.G2
M:/YUL;'?N^T;B&SLYR!LV@\'GJ: .XHKS:RO_$,8\*Z%K$\C:AJ-E/<W0ENC
M;L\J"/$:O&N1@,S$#GCKC(/6^%;;5;+39[35]0BO9X;EQ&ZN79(CAD1V(&Y@
M#UQR,&@#1LKV2[ENT>RN+86\QB5I@ )A@'>F"?EYQSCH:MUY/JVK:S!X,\>S
MQZS>"XT_5C';S;EW(FR'Y!QP/F/3%=+8O>Z=\3VTQM3O+JTNM(:[>.X<,%E6
M95R@  4$,>!QP* -C6O$]OH>HZ?8S6=Y/-J$ABMO("$,X&2"688X&>>*?8^)
M+*\UB31Y$GM-3CB\[[+<IM9H\XW*02K#/'!.*YGQ^L[>*? XMI(XYCJ4FUY(
MRZC]RW501G\Q5">6\TKXQZ=)KACOYKW3IXM->S0Q+#L&^0/&2Q)8  -NQVQZ
M 'IM%>5/KVJ-\+['QS;7UP^I&6.:6W$A,,JO,(V@\O[HP#@$#=E>O)K7T^UU
M'5_'?B6VE\0:I%;:==6DEO%#(BCYH0S*P*D%23T_//% '?45Y!:ZMK&F_#%O
M%LNNZA<7@:6TVRLK0QAKORQ*5V\LHR0>G;&.*ZF_-WH_CC0],MKR\FT_6(+F
M*XCEN&=HFC0,LJ,3E2<X(!QR.,T =M17CT_B'5-.T*W2>]OI]1\/ZFZZQB9@
M9K-7&9"/=)(V'3HW8$5T>KZW<VMG#?VUTWD:SK$5G"SW!5(X<$95L';O9#A@
M.D@QS@T =]65K^OV_AVSBN[JVO)H7F6)FM83)Y0.?G?'1!CDUPOBE/$?A_PI
MXGN!K;0H%AGLHH[EIYK?+!7!D=0Q1CR.XP0#7=66AK;0S175]>:B);C[1_I<
M@8(<#Y5  &T$9"G(!_"@#5HKSWQ;J][H^LW=QJ(OTT,I$D6HZ?,2+!_XO/B!
M&5.0=V#P1TK6^)5Y=V/P\U:]T^]FM+B&(.DL) /W@,9Q[]L&@#K**X.2YO-$
M\>75I)K=R;.;0YKV1[M@Z021R*/,5> H 8Y48'%5-#O]17Q7H5I]MOWM=0T>
M:226YDR9Y%,>)EC)819WDA?0X*C% 'H]%>/V=[K1\$>&];/B#43>RZRMG(6D
M!1XWNGB(9,88XQ@GI@8P.*T=3US4O"=YXQABU"ZNH;2QM;J!KM_,,#R,Z.P.
M/NC ;&,#'2@#T^BN5TFPUBT\1QW3:C%_95S;%3:O>O<L\H.1(C,HVC&00..A
MQ4=S?RZI\1)O#LL\\%I;Z6MV%@E:)I7>0KNW*0<*!C .,MSG H ZZBO)?[9U
M^XT_3+635[J.6W\5OH[W,84&Y@4/AFX^]P!Z9!R#7=W]G<:/X'OX(-4OI9[>
MTF=+R=U>;(#,,DK@XZ=.@_&@#?K)T+7X->_M$0V\\#6%Z]E*LX4$NJJQ(VDC
M'S"N"MIM;TVT\":ZNN7]XVK/:VM[:3L&B=982V]5QPR[<YZGO4MA=&UTWQAM
MU%[%Y?%)A5XH]\DA80#RT&1AG&5![9SQC- 'IU%>5W7BC5-#@\8HTTT,=G=V
M,<!N)?/:T2<('8LV<XW%@"2 >.16YXEEO/!^EZQJ]IK$TL/V)3%9W+&4Q2!P
MK3!V). '7*XQQGOB@#N**Y32;'5[7Q'%=-J,1TJYMBIM7O7N6>4<B1&91M&,
MY XZ'%,N;^74_B++X=EGG@M(-+6["P2M$TKM(4SN4@X4#H#C+<YP* .BU75+
M71M,FO[QRL$0&<#)))  'N20!]:SO^$D:.SU:XNM&U*W.FKO='1#YR;=VZ-@
MVUN <C.0>*\\UJZOM5^&FK0ZG<SS3:5KR6$=P'*&XC6ZB 9@N 3@XSZKGK7I
M&NP+;>#]5A5Y'5;&8!I'+L?D;J3R: +FDZC'J^CV.IPHZ17EO'<(KXW!74,
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M*CAU.PN;22Z@OK:6VCR'F2561<=<D' Q3K2^M+]&>SNH+A%.UFAD#@'T..]
M%BBJ=UJ^FV7F_:]1M+?R0&D\V94V \ G)X!I5U33FO(K1;^U-S*GF1PB9=[I
MUW!<Y(]Z +=%59=3T^"\2TFOK:.YDP$A>50[9Z84G)IMSJVG6<C1W6H6L#J
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M^!_&NB:N5_MY[NZ>.!O];.['-L\8ZL.$"D=-N.U7M,T^PNOB>;/68K*[O?\
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MWJ9Z=@1ZJ?>N3-KX9;Q7\0[?6(;'#" JDJKNPUNNXH#SN)Q]WG./:O50 H
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M95PRDCKOC!7\O2NVK&US1[_5Y((H-8>RL"KI>6Z0*S7"-@8#GE.,C(]>W!H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*2F<;EW !ES_ !+D5Y]XM%E=?#OQ)JMIH-]8&>.W2234$9)YRLJX!5B3A0<
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MUJLIA8F-U<2 [=A0@-NR0-N,G(XJ;3-;T_6&N4LIRTMJXCGBDC:.2)B,C<C
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MRFMK5+=RY2)HO,D*8RN[:YY . /6NH\3)<CQCX2U6&QN[FU@-TDI@B+,ADC
M3</X02,9. .^* *.A^,[?3;GQ#%X@U>1Q;ZT]M!))#D11[(]H8HN$7<Q&YL
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M8YRW)PQZD9XSZUKT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_)%(0FX(>. <XSD 8'6M[X@:OJ&@^!=6U/31%]J@@)5I&(V9XW# .2,\#@4
M=&9$618RZAV!*J3R<=<"G5YYJS7L7Q,\/74>FVSZG+I=XK(D^$.&BV[I"@.
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M+"XV9'][."#CM5:\^(5_:V.NWR^'PUMHEX8+MC> $H%1BR#:<MA\[3@8'7/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K \8:'=:_HB6UE+#'=0W<%U%YV=C&.17V
MG'(!QC-;]% '+0:)K$?C.YUZ3["ZS:9'9B-9'4[U=GS]TX!+X_#/M6!8>!O$
M6B:5X=ETJ^TY=7TBWDLY%FWFWNH'8,02!N4@J", UZ110!2TN*_CLP=3GBEN
MW.Z3R%(C3_97/.!CJ>IR>,X'.VGAS5?#FO:G>:";.?3]4F^TW%E=2-$8IR,,
MZ.JMPV!E2.HX/:NOHH Y;Q%X:O\ Q)HABGNXK;4(KB*[M#&"\4$L3;ESG!;/
M()P.,8'',L6BW]UXB@U_4H[1+JSLWM[:W@F9TW.078N4!'W0 -IP,GG/'244
M >>VW@G6;?P9X;T7S;!I])U"*[>3S7"R+'(7P/DR"<X]L=Z;K?@GQ!J<7B*W
M2\TUTU*YBN()YPYEC5&C80G P$!0D$9ZGC)R/1** ./G\)WUUXAU:YGN+5K#
M6-,CLKQ5#"12HD!V#I@B0]3QCO3O#6E^+]-@@L=5O],N;.R39#+ KK-<@#""
M3.0O8G;G) ]\]=10!P=OX.UNW^&7_"-1WMI%?)(665&<QRJ9C(4;@, 02IQG
MCZXJ2W\*ZW%J/B"[+Z6B:KIT5LL$0=1"Z*Z@ X^[A\YQSC&!7<44 97AG3KC
M1_"^EZ7=&)IK.UCMV:)B5;8H7(R ><9Q6#'X:UA'\7LWV'_B><PXF?\ =_N1
M%\WR<\#/'T]Z[.B@#B[GP??W/A'P[9+<6\.K:$]O+;R LT4C1+L(;@$*RYSW
M&>^*=J7A;4-7EUC4K@6D6HWFDMI4$22LT<2,6+,S[0222.-H^[[\=E10!QJ>
M&=56]\'SDV6W0X7CG E;,A:+RLK\GX\_3WK0\+Z)?:/=:[)>&W*ZCJ#WL?DN
MS%0RJNTY4?W,Y]ZZ*B@#BO$WA"[\1WLCRQ6"/%<12V&I([)=6BJ$W 87YLD.
M1\V/FYZ5!J_A#7+BX\716%QIXL_$%OC?.7\R&3R/*Q@#!4X!SG(YX-=Y10!P
M@\+>)-*U>TU;1KS3&N'T^*QU"WNA((G\O.R1"N3D9(P>"/2M&70-6?Q7HFK/
M/;3K86L\,S,S(TC2E22J@$  IP,G@]>.>JHH Y[PAHE[H5E?PWK6[-<ZA<7B
MF%V8 2N7VG('(SCWK+O_  5/J^J^*C>R0+8:Y90VJF-R9(C&'PV"N#R^<9[=
M\UVM% '(Q>'-5U(Z"FO/9LFCR"</;NS&YE5"BL05&P88L1EN<<XZP>%_#?B3
MP[%%HG]H6$F@VTI:WE"O]J\K=N$3?P^V[GCL.H[6B@#S@>"/$GE6<;WNER26
M>M?VE]JD60RW*Y?'F>A57V@#(P ,C%:J^%]6MW\6Q0S63VVM,\L.\NKH[Q+&
M0V 1M&W/&2?:NRHH X>T\(:IILWAO4[26T;4=+TX:9=0O(PBN(<+R&VDJ0RA
MONGKCWJ._P#!%_<6=Q)#):?VA>ZQ!J=R7=@BB(IMC4A23P@&2!R2<=J[RB@#
M@]?\%:AKEWXG>1[5(=6TR.TB D8LDD9=E8_*!@LP[]JT]EUX@\-:<GV.RG4@
M1ZE87_ )"$,A^5L,KX/3!Q[@UU--"*K,P4!FZD#DT <#<^';C0_AKJ'ANU<2
M7.HM-;V=N'9U@68D!%8\E$4DDGL#7;Z=91Z;I=I81$F.VA2%2>X50!_*I]B[
MP^T;P,!L<X]*=0!P5Y\.C<6GB2%+P+]NF:XTP$<64I*2,P/O,@;CL/<UI>(_
M"]WJ/@A-!L98/.WP.\]PQ4,4E61F. <EBI_[ZS75T4 <RVB:K#XWFUZV>S,-
MSI\=M-#*S;E=&=AM(&,'?C)Z8S@]*P[/P3K-KX5\+:09+!I=&U!+N1_-<+(J
ME^!\G!._]/?CT*B@#AX_!^J66F^(-#LY[0Z5J\LTB2RLPEM?.&)%"A2' ))7
MYEZ\YJQ_PBVHZ9XHM=0T22S%FNE1Z9)'<EMT:QL61UP,-PQ!!*]!S7844 >>
M:9X'UO3=$\(PI=Z>][H4LA;<'\MT=&0X/4D;L]LX[5U'B[0Y/$GA'4]&CF6*
M6[@,:R,/E#=L^V:VZ* .3_L36Y_%>C:W='3_ /0[.:":.*1QEI"I^7*]!L'7
MKGM6*G@77;?389K.^L;?6;+5KC4;5R7>%UF+;XI. 0,-C(]*]&HH S=&CU=;
M9I=:FM6NW(_=V@;RHP.P+<D]22<=ACCGDM.;4_\ A9'C9=-CM'9HK(9N)678
MWE-@X"G</;CIUKOZJPZ986UW+=P6-M%<R_ZR:.)5=_JP&30!R6F>";G1=5\,
M&RDMWL=&LIK5S(["24R[2S@!2!RN<9[]L5)?^#9]7UKQ*]Z\"Z?K.GQV0\MR
M98]F_#8*XZOG&>W>NSHH X^'PWJU]%H$&MO9NFBS+<+);NQ:ZD1"B$@J-@^;
M<0"W(]*O>$-%OM"M-1AOC;,;G4)[Q# [-@2N6VG*CD9QGO[5T5% &#XM\/R^
M(=+@BM;K[)?6MU%=6USC/E,K<G'?*EACWJIIG@V'2O%\^JVTNRQ>UB1;3J!.
MBF/S?KY>%]^<UU-% '-^'M%U'2=5\0W5Q]E9-2N_M4*QRL2N(U3:V5_V <CU
MZ5A0>"-8@\':3IBSV/V[3-6&HH2SF*0>:\FTG;D<.1T/3WKT&B@#CKCPC?7>
MO:U-<7%JVGZUIL=G=A582*RK(IV#I@^9GD\8[]:D\-Z;XPT^""SU>_TRYM;)
M-D,D"NLMSA=J^;G(7L3MSD@>^>MHH \]M?!6LVWA/PWI!DL&FTG4DO9)/-<+
M(JNS;1\G!._'X>]=+XO\/R>)?#\EC!=?9+M)8[BVN-NX1RQL&4D=QD8_&MVB
M@#C=0\-:[XJ\+W^F>)+RRMYIXU6'^SE<I&ZL'$A+X).Y5XXP,\G/%I=$U74M
M7TC5-86R6?28Y3$EM*S+-,Z;"Q)4;!C/&&^]UXYZBB@#SVV\%:U;^$= T<R6
M#3:9JBWSR>:X5U65I-H^3()W8_#WJ[>>$+O4_$%EJES%807EG?F=-1MG99WM
MPQ(A==H!!4A3EB,<XKM:* .)T+PYXGT":32K;4=/;P]]H>6%W1_M4*,Q8Q#^
M$\D@,>1GIT%5KOP9K%UH'C#3A)8J^NW+S1/YKXB#(B8;Y.2-F>/6N_HH Y>+
M0=4B\:6^N)+9B%]-2RN8B69E*N7RAP,YW$<XQUYZ5+XF\/W.IZAHVKZ=-%'J
M6DSM)$LQ(CE1UV2(Q )7(Z'!P1T-='10!R4OAB]G/B+4'^RKJ>KVBVB()&,4
M,:JP'S;<L<NS'Y1V';)V?#=A<Z5X:TW3;OR3-9VT=N6B8LK;%"YY QG'2M2B
M@#C+/0_$.F^,]?URWCTN:+55MU$4ES(C1^4I4'(C.<Y)]J35_#GB34H[+58K
M^QM]>L+MY[9,.]MY3)L:)N V".2V.O3MCM** .,U?0/$>MZ38K>7&G?;8M1M
M[QTC9UA18G#;%)!+$D<L<=>G%5M;\"WGB"^\3?:9X(+75[*WMXVC=F>)X69E
M8@J 1N8<9[>]=Y10!Q'_  CWB;4]=T#4=8DTD#3HKB&X%NTC>>)552PRHVYV
MGCG'J<\/\,:!XKT&"WT:?4M/GT6R(6VF5'%T\2_<C;^$8X!89R!TR<CM** .
M5\/Z/JOA[0M:2233Q<SW5U>V[F1C$ID8N!)P#@$\D=1Z5L>'[C4;O0K6?58H
MH[YE/FB$,$."0&4-R 1@X/(S@UI44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 445%/=6]L 9YXX@<X+L%S@9
M/7T'- $M%06=[:ZA:I=65Q%<6\F=DL3AE;!QP1P>14D4T4\?F0R+(F2-RG(R
M#@C\Z 'T444 %%%% !139)$BC:21U1%&69C@ >YK._X2/0O^@UIW_@4G^- &
MG115:74;*&^@L9;N!+N<$Q0-( \@ ))"]2  : +-%5K/4;+4/.^Q7<%QY$GE
M2^3('V/@$J<=#@CCWJS0 4457O;ZTTZV-S>W,5M I53)*X5020 ,GU) _&@"
MQ1110 4444 %%%% !15"?7-(MIFAGU2QBE4X9)+A%8?4$U8M;VUOHC+9W,-Q
M&#M+PR!QGTR* )Z*** "BBB@ HHIKND<;22,JHH)9F.  .Y- #J*IV.K:=J8
MF-C?6USY#;9?*E#;#UP<=.*B_P"$@T7S/+_M>PWYQM^TIG/YT :-%("& (((
M/(([TM !15&+6=,GU%M/BU"U>]4%C;K*I< '!.,YX/!]*O4 %%1SSPVT#SW$
MJ11(-SR2,%51ZDGI26MU!>VL5U:S1S6\JAXY8V#*ZGH01U% $M%%% !1110
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MG=@JJ,EB< #UJ"ROK34K5;JQN8;FW<D++"X=6()!P1P<$$?A0!8HHH)P,F@
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M+.T/+)'"J@GL,G)/H#6]-K^JV/B:+0+M+-[B^M))["Y1&5#)'C?&ZEB>A!W
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M'///:@"SX*O]7O\ 4O$W]HW4$L5MJLEO&J1%2H6.+ &6/&">/4DY[57\>MJ
MU?PE':SP)%)JZ#;(C'+B*4C.&&5XZ>N#FMC0_#UQHNL:S<K?K+9ZC=&[%OY&
M&CD955LONY'R# P.IY-'B+P_=:W?Z-<P7\5LNF7@N]CVYD,C!67&0ZX&'/8T
M 9%OK=Q83^,;2"ST^*328TO \4119WDC:1BX!Z_+C.??VJI/?MJWBCX;:G)&
ML<EW;7,[*O(4O;*Q ]N:TM1\'ZA<:QK=W9:M#;P:S:)!=1O:[W#(C(K(VX
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MQ[\Y*\9 )X#?2@#U^BO/-?TAM)U_PU#;:MJ^S4-5D%R'OI&# P.2 ,X RH(
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M&$DML<':YS\^"2,G/W:Z:SMUC\=GPG-=7[Z=;:7]K@6:[D+S.\S!B7SN8*,
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M<?</7\JV:X30+2#3?BEXH6-W$7]GV3_O92P3F7."QX'&<>YKN@00"#D'H10
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MC\07*@R.7;&U.I/)^IYJO=VL:?&.6Y59WE30/.5%G=0["? & <8/'R],]LT
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M>.X;V>X1M,!M[:".=H_*3R-PDP",EF+<G/ QTSGIO W/P^\.?]@NV_\ 12T
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M1( 3*J,N,\,-W?IZ5L2:A%'XE:%M;M52*R:273B%\Q<,O[XMG(4 XQC'.<T
M.;PUH[Z3!I;62FRMV5H(R[?N2OW2ASE".V",43^&M'N=,FTV>S$MK.^^='=B
M9FXY=B<N>!U)Z#T%2Q:_I$VFKJ46IVDEBSA%N5F4QEB<8#9QG/'UI;G7=*L[
MQ+2YU"VBN'<1JCR '<?NK[$]AU/:@!+G0M.O)+*2X@:1[)MULS2OF-L8R#GK
MCC/I4+>&-'<:@&M,C4>+P&5_W_&/FYYXX^G'2E?Q/H,=Z+)]9L1=&9;<1>>N
M[S6Z)C/WCZ5-'KNE2ZB-/34+9KMMVV$2#<Q7[P'J1W Z=Z +-K:065G%:6Z%
M((D"(NXG:HZ $\U5L-"TS2X+F"TM52&Y=I)T+%ED9OO$AB>3W]>]<]XY\6C1
M]+']F:E:I?+>00/&RAR=\BJRCG ;:Q..3CG'>NQ9E12S,%51DDG  H Q=%\(
M>'_#KSOI.E6]JTXQ(4!.1UVC/0>PXI=&\):!X?N9KC2=*M[26;(9HQT!.2!G
M[HSV&!Q5FTUO3=4>2#3]0MIIQ&) JMN^4\!\9Y7/<<'UKAH_%FO-\.=,UDW4
M'VR75A:SMY PT9NS%A1G"_+CU_K0!UVF^#?#NC:E-J.G:1;6UW-G=)&",9Z[
M1T7/MBKVF:/8:/'-'80>2DTC32 .QW.>2W)/)[GO5J:>*V@>:>5(HD&YWD8*
MJCU)/2LRU\5>'[V_AL+76K":[FC$L4,<ZEG4C((&>>.?IS0!=MM-LK.P^P6]
MK%':88>2%^3#$EACW)/YUG:-X0\/^'FG.E:3;VIG&V3:"<K_ '><X7V'%2P^
M)]!N;V.S@UFQEN99'B2))U9F=0"R@ \D C-36VNZ5>78M+;4+:6X*EEC60$N
M!P2O]X ]<=* ,ZV\"^&+22!X='MU^SRF:!3N98F.<E5)PHYZ#BK&@>'K70&U
M!K6)(1?737+Q1D[58@ GGN<9)XZX[59DUS2HK]+&34+9;IW\M8S( 2^,[/\
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MAN_^/>0SKME_W3GG\*I_\)MX6^S_ &C_ (2'3/*\HS;OM*8V!@N[KTW$#ZT
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MPLK '<&4X*\X;C(KT_2999M L9;BT-I,]K&TEMG_ %3%1E/P/'X5?HH \O\
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ME7)W<XQO%=1<6UB?B_9HUM"8/[#FBQY0*"1ID;;TQDKN..X)]:[NB@#RU/\
M1]!\=:!K$#MJ%Y=7<MK$4)-Y'*N(?+_O$8"X'W=HSBKE[IFM:#_PB6J6\1N]
M42R71[_'S!]Z K(Q_NK*N2?1C7HU% 'G_@K1[_2]3N- N4D;3="G>6QG<#]Z
MLRY0#'= TRGM\RXZ5B^&O[-NK2P\.Z]8ZM)XATZ^\WR#YXC,BR%A<!Q\FW!+
M9)YR1@Y&?6J* .'\ 16KWOBB0PIYQUV>:-V3!*%$ 921R#\PR..M2_$4J+;P
M]D$E-=LY3@9VHKY9CZ #J>U=G10!YA="W?6/B8[(I,]A%'&Q3_6_Z.RE5/\
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MUJ.)[)X8IRD\9A5&A*QC(8$,<$ _-VKT72K>.RT:RMHX&MXH;=$6*1]YC4*
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M@T 6?"_BT^*88+JWT>^M[">W\Z*ZGV!6(;:4P&)SWZ8X.#TRNN>+4T5M1/\
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MLW?&\,FT^8,\@ CT)':,Z!X@TK5?$L=C;6]_8:XOFK))<>4\$WEA&##:=RG
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M8=8U (!9V8*JC) Y)')( ZD@5S6HZ7K8^)-MX@L]/BGLX=->R*O<A'+-('W
M8/'&.?6CQ!I/B3Q)I=P%CM=.NK6>"YTY&E\U7EC;<3(0!@'A<#..3STH ;-\
M2=/MH-:,MG,]QI,"W,L5O+'()(C_ !JVX X(P0>1Z&M*R\717&NII=UIUU8F
M:T:\MYIRFV6-2 W1B5(W X8 X].E96K67BGQ)X+UBQO-,L;"ZNK1K:&WBNO,
M!9NKL^T8'HHSWSVP[4/#FHZIX@TN>6W$5G'I-Q87#"4;U:4(,J.X&P_G0!E^
M*=;.LKX0O[:SN4L;C7+8P7)DP)$)."R _=8#*YS[XS6WJ_Q$TG2//FE'F6=K
M<BUN9DE3=&VX*2(\[F56."0,\' .*P8O#OBT^'O#>B36%@QT*_MG%T+LA9X8
M<A2%VDJ=N <]_7MI:;I7BO0M3U'3K.UT^YTJ]O);N"]EG*R6GFL6=3'M/F88
MDCD9[D=@#3C\8M<>(KS1K70M1FDLKB&&YE4QA(UD7<)/O<KC!XYZ\"MO2[Z;
M4+5YI["XLF65XQ%/MW$*Q 88)X/45BZ'I6H6?C+Q+J-S JVFHM;M PD!;]W'
ML.X=LGD=?PJ]X;U/4=4M+MM4L8;2X@NG@ @F\U'4 $,&P/7:?0J: -FBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ICRQQ%1)(B%CA0QQDXSQ^
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M:RL+"VN+6)HY!.SS*SR!&P-H X.0<\>G8 'IOVRU^VBR^TP_:BAD\C>-^P$
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M;RK$J7$FXX09;!90!QUZBE\2ZK=ZWX2MY=2TJ2QNK3Q!:0 R1,JR@3IB2/>
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MD&II::OHQC>UO$BW(61"A#(3]UE)!&>];FBVNJP0/)K-]#=7DF,BVB,<* =
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MTGF+P2<@-[C(].M=U10!S7]@7]YJMMJ^IS6CWME:RP6J0HPC5I-N^0Y.>0H
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MZNQ)+,?<DD_C6G110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M41B4[0?.8$8Z8X'%=Q65=>'=.O-;BUB1)EOHH3 )(YW0%,[@& .&P>1D'!H
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M7-)]I,FE@BT87+CR\KM)//S';QSGB@#D-6\3:IH%_P"/9Q=272:;96DMI%,
M5A9Q)G@ 9&0"<\\=:WY[:YTI9=43Q04L6TZ3=]L E7S0-PG!SP ,DHH"D=A6
MD/#&E?VAJ=Z\#RRZG$L-XLLC,DJ $!2I.  "1P.YJEIW@/0-,L+FQBMYYK:X
M@:V,=S=22A(6ZQIN8[%^F.@]!0!@:)?:A)XNL]+DN]0-E>Z$]P[SOAY)5>-?
M.09)BR'/R\8X^4$5D>%-2N[#P-X,LX+F0OK-Q)'+)/<%,!1*^U7VL5+$ 9QG
MKC!.1W5AX)T73;ZRO84NVN;*$P12S7DLA\LX^4Y8Y4;1@'@=>M0M\/\ PX^@
MOHK6<C6)E\Z-&N)"87!)!C8ME,$G 7'4^IH Q[F+Q?I.FW<?G)J2K?1S16<-
MX?M7V4AM\8D95);*DJ>I 89S6[X,U:VUC1I;BUNKR95N9(WCO4*SVS#&8G!Y
MRN??C')ZU)!X1TRVL(;6)KP&&<7*W#7<C3&0*5W,Y)+?*2,'C'&,5I:=I=KI
M<4J6RMF:5IIG9MS22'&68^O 'L  .!0!A>)-6GB\4>&M!CE>"'5'N&FEC.UB
ML4>X(&_AW$CD<X4XQ7(^(]<US2M-\<:;;ZG<K_9*6US97?RM(JR]8F8@YP0<
M'[V#UKT;5]#L=;B@2]C8O;RB:"6-RDD4@Z,K#D']#WJG=^$-(O\ 2;S3KJ*:
M6&^</=N9V$DY& -S YP,#@8 Q0!=TK3I].2X$^IW=^TTIE!N-O[O( VKM PN
M03CWK$\6WM[9:YX4%K>2Q0W6I_9YX5"[9%\J1N>,]5'?%=1%&(8DC#,P48!=
MBQ/U)ZU0U/0K'5[FQN+M93)8S>?;E)60(^",X!YX)'/K0!YSJE]KBZ/X[OD\
M0WZ2:+>,UF%\L#"Q1OM8;>5Y(QQU.<FM/Q1KU_IUW)=WXOX=%EM(A%J&GMN%
MA,<EC-&.2IRG)! '3!.:Z63P9HTUKJUM)'<-#JSE[U?M+_O20 >_'  XQP*?
M-X2TR=)XY&NS#<0K!<1&Y<I-&HP%89]."1@D<$F@#FK&W>7XC^+IH=1NT*V%
MF\3)*&"[EFQ@,",#J!C&23WK$6ZUR'X567BM_$6HR7\\-F"A91$I:=%8@;>I
M5B#DGUXXQZ)-X7TN;5I=3\N:.ZEMQ;R&&=T5D&=N5!P2-S8.,C-,7PCHR^%3
MX9^SR-I6SRQ$TSL54'(PQ.1@@$<\8H Q=1OM03QWJVGP:A/#;C0!=HJ[6\N;
MS77<NX'LHXZ5@6-[K;:7X!U ^(+XS:P$M[M6V%"K0,^X K]\%<Y.>3Z<5V</
M@K1X;Q[S_37NY+3[')/)>2L[QY)(8EN3SU/3 QC%/3P;H\=KI-LB7 ATE@]D
MOVE_W1 *COSP2.<\&@#CI/$6J:$/$6F_VA+<+;:Q9VEO=7;C=#'.L9;<^T\#
M<V"0<9'7&*L^(D\3Z#H/B>[&L+!;#3VN+.-;DSSPRH/FPSH"4.1ZD'H1FNIE
M\&Z'<+JZW-J]PFK[3>I+*S+(5 "D GY2 !@C&,"H+?P)H<&BW>DE;R:VNT$4
MQGO)))&C'1 Y;(7D\# YH Q[:34K7QKI-C+K%[<V^K:5-+,DA4".1#'AH\ ;
M>'([]LY/-8GAEM7L_A;HMWIRWFHEKJ1[RU2YVS2PAYMPB8D'=NVL0""<$9YK
MT%?#6G+J=CJ.+@W5C"T%N[3N0J'&01G!S@=<]!56V\%Z/8VT4%F+NW6&X-S#
MY=U)^Z<[LA020%^=_EZ<]* '>#M4MM7\/K<VMW=7*B>5&^UH5FB8.?W3@\Y4
M$+^ /-9OC&;45\1^%K.RU2YLX;ZZE@G6$)\RB%VSR"<C'';O@UTNG:9:Z5;O
M#:H5$DC32,S%FDD8Y9F)ZDG_  Z5!J6@V.JW]A>W0F,]A(9+=DF9 C$$$X!P
M>"1SV- ''#^V]1U#6O#MEJLK7&DV\$4-U-=F*4R/'O$SA8R'Y.,'CY3QDYIJ
M#7M3\90:+=^(YX4?04N)VT[8%\[S=C-&Q3(!QGG)[#%=+K/@K1=<U6+5+J*X
MBO8T\HS6MS) TD><[&*$;A]:R)M!GD^)L-U%:W=KIL.C"SCN+=@BJXEW;,9Z
M;?;'XT <Y::UXCNK'P_:7&M7"3KX@N-(N+B)$'VF.-9,/ROWOE ],C)!K9 U
MB\U75/#-KJL\DNF6</E7,]X89F>0.?-;9&0X& N#QP<@D\=-)X1T>2+38A!+
M&FFR^?:B.=UVR'.7.#\Q.YLELYR<]:CUOP9HVOZE!J5W%<1WL*>4+BUN9(':
M/.=C%""5]J .4US5M>TFU@EUJ2XGLETX1W.HZ*^?LET"P:9XQ@LA 7L0"K<5
M<FU#5/$^K:UIND7R1?8K:W-K,EVT7S2Q[UF("-O7D#!X^4\<YKI;CPMIL[-M
M$\$;VJV<D4$S(CPKNPA4' ^\W(P>>M5=3\"Z#JE];7LEO-;W-O$+=9+.XDMR
MT0Z1ML(ROM0!@PMKE]XULM(O=?F1)= ,]Q]@*!#,)41FC8KD9YZ\CMBL.*ZO
MM<T+X?W-_J%T]PVLS6TDB2;/,">>H8@<%L1CGW/K7HZ^&M-CU>/5(HY8KJ*U
M^QQF.5E5(<@[0H.T<@'IVJFO@;0DTBTTQ(;E;:TNC=V^VZD#Q2DL25<-N&=[
M9&?XC0!AW&H:I'K_ (WM$U6Y$=GI<$]H<(3 Q64G;\N#G:.N3[U4T:^U:"_\
M W,VL7=T-:LV%W#+M\LD6WF!E &0<CDY).377OX3TI[O4;DI.)=1@6VN2MPX
M#1J" H&<+@$],'DTU/".DQ'1RB7 .CJ5L?\ 2'_= KMQU^;Y>.<\4 <;)J/B
M*_MBMO>7T&O+KIMY(85!C6T\S!(#*4VB/#;R"=W&<\5Z:BE452Q<@8+-C)]S
MCBO++'PSJ#K+')I/B/3M5EEDE>>SU@+9"1V+;U'FD[<G./+)]0:]2B5TB19'
MWN% 9L8W'UQ0!PD5_?\ B.#Q=/%J-Q8W&DW<MK9+$V%C,<:L'=>C[F)^]D8Q
MC!R:S;+5-:\6:OH$9U>]TR'5/#SWDL5J$&R0-&-R$J2,[L\YXZ8S7:W7A32K
MJ_N[PI/%)>H([Q89FC6Y4# W@'DXXR,''&<5-_PCFF_VU;:NL<B7=M ;:'9*
MRHD1QE=@.W' [=A0!IQJ4B1"[.5 !9L9;W.*\[CO/$?B.RO]3TK4+:SN++4Y
MH5,UVRQ1QPRE2DD0C(.Y!DDG(+9! XKT:N;D\":!)KTNL_9YDN)G$D\<=PZ0
MSN.C/&#M8_4?6@#'N=6O= \8ZMI]W=3W$.HV:SZ0DDA $H;RWA!'.2SQD'J
M?:K%Q-J.E>./"^FG5+JXMIK&Z-PC[?WKQB/#G SDECQG'H!73WFD6.H7MA>7
M5NLEQ82-+;N>J,RE3^A_0'M45SH5C=ZW9ZQ,LIO;-72!A*P50^-PV@X.<#J.
MU 'F6JWD_B3X7Z=XEGO9_.N]3MI# K_NE3[6JK'MZ?+@?-]XD'G!Q6]/<^(/
M$USXBBTB]CL[K3;W[-;,UTR"+:B-N>,1L'#$GJ>G P02=:3X=>'9([B#R;M+
M2>X%RUK'>2I"L@8-N5 P"DD \?ABIK_P)H.HZS_:LT%PETZ+'.8;J2-;E5X
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M1Y8M7B=+@IJYS?#[2_[WY=OKQ\H XQQ6Q:6T=E:0VL.[RHD")O8L<#@9)Y-
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M(HQ#$D89V"C +L6)^I/6GT %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/<K"T8,:D$]'8;FP"<#)Q]1FJ/'=E<7\%GIVGZA?RW.GC4;<P(@66(D 8+,
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M5W;PI8$!MN/P(-5KCXBV5M8ZG>G2-5:VTN[:UO9!''B' 4E^7^9?G'W<GC)
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M^ GGTY5&C6TD5YLG1MI, B&.F>1DXZ#H37H%% ',>$],O].U+Q)+>6IBCO\
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M"5;:,\9Q\HJ.V\,:[#X(T'2VTX_:['6DOIE$T>/+6X:7@YY.& QZY^M>FT4
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M'C<9 #C.<=^<<U[OPSK=QX2\;Z:NGD7&LWTL]IF9,;'1%&XYX(V$GZBO2:*
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MB:$/YI90C LW1E'.>AZ5,OP^:/0(M&CUF;[)!?K>P!X%)CVRF4+D8S\QY)[
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MWG9"R8^8[D."#T/?/:IY?!%MJ5W/=:W-'>S3:>^G.T<'DF2)B"2^"<ME1@C
M'.!S4MEX4EC_ +*74-2-_'I'S68>$*V[845Y"#\[!20,!>N<9Q@ YE?&7B9-
M";6YCIAM[763I\\"0/NE3[0(=RL7^0C(.,-GU[5?\5^+M6T ZG<J;/R[*:W$
M5J$:5Y8G*!FD93^ZY9@N1SM[YJPW@)G\-W.BG5CY=QJ!U!I?LXW!S*)=H^;&
M-P_+\Z9J7P\;48==M_[=N8;75YDN98EA0[)E"<ACD[?W:_+GC'6@"C)'KDGQ
M+\4+H4]C!<?V?9$O>1-(IQYV%PI&,]VR<>ASQ677I/$S_#O5IK<6\\NHW"31
M Y"R)#,C8/IE3BNJ/ABZ@UVXU:QU=XKB[MH[:Y,MNLF[R]VUUQM"M\S=B/:H
MV\%6\7_"/1V%R;>#1)6EB1DWF5F5E8L<CKN8_4YH H1>*=6M9_$VG:B;,ZE8
M['T]8H65;B.7Y8B07.29/D.,8/UKL[<3+;QBX='G"CS&C4JI;O@$G _$UQT4
M>F>+?&MEJUM;W0_L99X9II8'A5Y"P"QX8#> 0SY&0#M[FNUH Y&\UF_UB_\
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M'=HV614Y <!ASTXZ]3C!SM+\<:AJ.C:"C01KJFI-=)(88RZJ+=RCLJEAU.W
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3V\\_P!JD1BQS-G/F9SD-[CDUMT4 8R^$O#Z1WT:Z/9JE\@CN5$8Q*H  !_
M#\JCU#P9X;U6SM+2^T>UFAM/]0I7!CSUP1SSW]>];M% $<$$-K;QV]O$D4,2
MA$C10%51P  .@JF-"TH:I<:D+"#[;<H(YIBF3(H&,'UXX^G%:%% &9IWA[2M
M)=&LK-8C&I2(;F81*>2J DA%.!PN!P/2KMW:6]_:2VEW!'/;S*4DBD4,K*>H
M(-344 8FG^#_  _I=U;W5GI4"7%NACAE.6:-3V!8D@?RJ.+P1X9A*;-%M $N
M/M* ID+)SR >!]X\#CG.*WZ* ,.\TU](AO\ 4/#VF03ZK=,K2)-<-&LQR 2S
M<\A<XX[8JSH6FR:?9RM<"$7MW,US=&'[OF-V!P,@*%7.!G;GO6G10!2U32;#
M6K)K+4K=;BV8AFB<G:Q!R,@=<'!_"H-7\.:/KVGQV.K6$5Y;QD,BS98J1W#9
MR#[YK4HH Q[KPIH-[H<6BW&DVKZ;$08[?9A4([C'(/)Y'/)]:D/AO1CHJ:/_
M &;;C3T(*P!<!6!R&'<-GG/7/.:U** ,M_#NDR:=<6$EF)+>Y.;A7=F,W&/G
M8G+< #DG@4M[X=TG4=)CTN]L8Y[.(J8XY"3L*_=*G.01V(-:=% &9IOAW2-'
MNI[K3]/A@N+@*)95&7< 8&2>3T_KUJ;4M)L-7CB2^MEE\IQ)$V2K1N.C*PP5
M/N#5VB@#*N/#6CW6F_V=/8QR6GF>:T1)P[YSN;G+-GG)R<\UIHH1%09PHP,D
MD_F>M.HH R[OPYI%]>O>7%DCSRH(Y6!*^<@Z+( 0''LV14EYH>EW]Y:7=U8P
MRW%IG[/(R\QYQG'Y#\A6A10!B'PCH1L)+$Z>AM)9OM#PEVVM)G.\C/7/.?7F
MDU'P=X=U;48-0U#2+:YO( %2:5<M@= W][\<UN44 4(]%T^+5Y-62W OY$$;
MS[FRRCHIYQ@>E6/L5M]O^W>0GVKRO)\['S;,YVY],\U/10!1_L?3_P"R#I(M
M46P9#&8$RJE3U''8Y.?7-5O^$8T?9 JVA000_9XC',Z%8O[F0<[?;ITK7HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<Y+#CJ.XK1U#3[W3/&NKW%QX3_M_3=7$3Q21K$S02+&(V1Q(1A"%!ST&3UH
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M%%% !1110 4444 %%%% !1110 4444 %5-1U2PTBV^TZC>0VL)8('F<*"QZ
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M59(97D"%'())4 .21D_=X/-.L$OD^,MP+Z6WE;^P$V/!$8QM\]N""S<YSWH
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M7]U#:VT8R\LSA57\37)KXEUBWU7Q-:RZ=:W-SI>F07426BMOG=ED.S)Y(RG
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MIK@&3:Z\(L<08.^_E@!D@ @^M4(OB)*?"WA_6+Y8-/AU%Y8[F\>%Y(;=T8J
M0""H8@X)/&,'UH ]"HKDXO$E]<ZGI>BPR6!U"ZLY+Z6Y0&2 1*P52@# MN+#
M'S< &L>Z\>:O;Z==QBSLCJ>GZQ!IMRK%A'(LK*%D3DE<JXX).#ZT >B5#=7=
MO8VLEU=SQ06\2[I)97"JH]23P*Y*'Q'K\.I^(M+GM+&\OK"SCO+,0$PK('W@
M(Y=B 04^]D @]!5*3Q/=:@_B#1;B2TNHET,WD=S;1/&K;@Z,HW,P<97(93CM
MVH [NUN8+VTANK:598)D62.13PRD9!'U!J&PU2PU03M87D-RMO*896A<,$D
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M7Q!9Z8MO FFVXCF^U1L[22O%O*<,-H (!//)/''-WX=_\DX\-_\ 8-@_] %
M&UI^IV.JP/-I]W#=1)(T320N&4,.HR/2K=>2:?J_B'P_H/B?6--M].GT^QUR
M^FN8)B_FRH)27V$?*I YY!S[=^N@\57,7BM['4'M8=,N-.^WV$_ELK.J_P"L
M5B6QE05/ Y!SQB@#K:*S]#N+Z[T:UN=12..YF02-'&A4(#R%()/(&,\]<UH4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5B>+- ?Q-X?FTE;L6HE>-FE\KS"-CJX &1W4?AFMNLCQ
M-XAM_"NA7&L7EM<SVMN 91;A2R@D#.&89Y- %)O#-S;^)+C7=,U"*VNKV!(;
MV.2V,D<Q3(1P X*L 2.I&/SID'A%M/TVUT[3[R'[#'!)%<6][;>>ERSMN+L
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M.3]WDY7'/.",UJ1^%KM-<TG5&U5))-/LI+3:UMCS-^TEN&&.47 ].YZUT]%
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M<]MM&F^!6L]&L-"NM26ZT>QG6:*'[/LD?:^]%D?<0P#8/"KG ]\]C10!R_\
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M7<-J@(HQDG ZY.:UM)\46&JZG<Z7LN+34[90\MG=($D"'@.,$JRYXRI(K:H
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MLXH/-;?*RCYI&]68\L?<DUG:;X*\.:/JLNIZ?I4-O=R%F+H6PI;J57.U2?4
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M(E4E3T/((XH\1^(8AK.@>(I?MT?AU1=6SW4"-F)R4"RLN,A24=0<=#GO0!W
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ME<X51G@=R3V )K(F\9"QNM4L;[3I4U"PLC?B"&176X@&061FV]",$$ ],9H
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MB1-Y.<I]WY^O7CI6+I/@[Q%X?_X1G4+1;&XO=.TXZ7>6S7#*DL18,'1]G!#
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MIJ5O>/$)F$<21NK;%;9EB=O4@<GT%=G10!RWB;PM-K>K:1?VTRP/ 7M[T?\
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M-O&Y.[CY=VT-R%SC/K23> +*?0M6TA]4U'[/JEX;V=@8MX<L&(4^7@#*CL:
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MBWMK>73+-X;7BW0PKB+C'RC'R\<<4DNNZ;':VMP+GS8[M/,MQ C2M*N,[E5
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M=);W%K9K%,]NZI(R"3< Q&#C<M'B.*9_B!X0G2TN98;=KLS2QP.Z1;XMJ[F
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M@\]/3-.T&-=<M;*UG\.:O8ZW8V[Q-<W_ )OE6KF,H6B=F(;)QC;VY/2O2Z*
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MQ\*1MR<!1\O!-;L7G-XV\47KZ??K!<:3;QQ.UI(0[+YI900""1N7@?TKOJ*
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MT$J2Q2*&21&#*P/0@CJ*?0 4444 %%%% !1110 4444 %%%% !1110 4444
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M78Z,(V(;[B[,#'KVK>TC0M0L/%FLZQ<3VTD>HQ6\>Q%964Q*PSSZ[B<=O4T
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MS-MW*)24VX;ID$X/J.:HV7C_ %2XTO1]6GT6VBL+[4?[/EVW9:1&,S1*RC8
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M;&8O-.W"?>V]CP#W-5[GP)K<T=S$NK6)1M:358I9;9FD;;('"2'<,A0-HQV
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MF3A&R%*#C@?-SGBL^5_%+ZOX5T:_\0^3<WMG>I?2:>J%3)%M"NA9,AOFYR,
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MMX@:.>6%DLI&W1-M)P.F?0]ZIP7UQ)XJTSPM]MN4MQI#7\DH8"29MZHJ!@.
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MR>M3T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M</!*$/5=RD$J?2I/^$5TQ=1TR^C$\<NF(\=L%E.U5?&_(/WBV!DG)[]:VZ*
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MZ\YFLG66VN!(1+$Z\!@P[XX.>#WS6O10!1T_2K;36N)(M[SW+AYYY6W/*P
MR?0   # 'I5%/"&AQZ7;::EB@M;:\%]$G]V8.7#?F3^'%;E% &'XA\)Z7XE>
MUFO!<175HQ:WNK6=H9HL]0&4YP?2FMX1TLR:5(IN4;2W:2V(G8D.P(9F)R7+
M G);.<FMZB@"DFEP)K4NJB2?SY8%@9#*QC"@D@A.@//6KM%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 53U75K'1-.EU#4KA;>UBQOD8$XR0!P.3R1TJAIOBK3M6U.33[:+4%F0,2
M9[":).#@X=E"G\^:9XH\/W>O06AL=:N=*N;24S12Q1I("^TJ-RL.0 3QQUH
MNZ+KFG>(;#[=I=P9[;>4W^6R9(Z\, >]:-<]X.U74]3TFXCUF.)=2L;J2SN'
MA&(Y2F"'4=@0P./7-3/XJTY-=_L<Q:A]JWA-PL)C%DC/^LV[,>^: -NBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+U/1Y=0N[:YAUC4;!H P*VK
MILE!Q]]71@<8X.,C)K4HH KV-C!I]J+>W4A=Q8EB2S,3DL2>I)).:L444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
/ 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>exhibit1061-loanandsecur006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\H^+_BU=(O-,
MTIM7U?28G1KB:[TV$.PYVHK$LORGYR>IX'%>KUSNLZEK5OK,-G%X8.J:-/#B
M>>*XB#HY)^4QR%0RXQSGN?Q (?A\T$GA&WGMO$-QK\<S,_VVX)WGG&W!Y7&,
M8^OK745YY8:'K_@K28[?POI-I.M_K+W-U;RR[5M+=R!A>1R%5>F<'. :]#H
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MR+%<PK*BR+M8*P! (['FO.?"=EXP\'_"0Z=!HML=8L&?RDN;E/+E#2LS-D,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<T$5S"T4\
M22QM]Y'7(/U%2444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUX6O#*& (\O!C7/;=)M_!6K0T7Q?::CX B\4S K"EFT]RB#)1D!\Q0/4%6%
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M[F15+(X"_+PXP03] >* .MHKEO .LZIKWAS[?JD5NKO<3JIAE+<+-(NW!48
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M-M-I=U%)O<7'F-$1@>7+&5&UB">,G&#[5ROP_P#$ESI'@WP99SZ7_P 2^_\
M]#2[^T#<LI#LO[O'W3M(SNS[4 >I4T.A=D#*64 E<\@'I_(UR=WXUDL=0M(K
MK2C!;W6I_P!FQ&6?;,QSM$HC*\QENX;H0?:LFWL[9O%OQ'A-O$8I;2T9T*##
M$PR9)'<T >A(ZR(KHP9&&0RG((IU<W\/?^2<>&_^P;!_Z *Z2@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHI"< GT]* %HJIINH1:KIT%]#'/'',NY4GB,;CZJ>15HLJD
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M#;:?XG\'>$)K2P;2;F:*\DDMEE\S,T;RO(5P!Q(=VT 9'&2:[QPS1L%;:Q&
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M&0#SCI6S110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5X-15!;(H(W [E.X8R!M8GISWH [#Q;K4VC6%D+8?O[Z^ALD;CY-Y.2-W&<
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MHF2JX55'5F/3//L,5]3\,P:H]\)KV]2WOX1!<VR,GER)@@]5)4D$@E2#^0H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZSCY.O7YAQ[BKIU73Q=3VIOK;[1;IYDT7FC=&G]YAU ]Z +=%43K6E_V?%J
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M'T)[#OVJ&]\3:%ILTD-]K%A;RQ[=Z2W"J4W'"Y!/&:  ^'-*:ZO[G[,PFU!
METXF<&50, 'GH 2!Z D4Q?"NC)'IT:VA"::<V:B9\0<8^7YN../IQTI\/B70
MKF\CLX-8L);F61XXXDN%9F=0"R@ \D @GTJ6WUS2KNZ^RV^HVLL^TL(TE!)
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M]FNM(@E>](:X)SAV&,-C. W Y&#[U93PSI$=Q<W$=H8Y;F%8)625UW1J,*N
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M52T/S9^;H%;@<MD8Q@[VGZNS:]>:%>%3=P1)<Q.!CSH&)4-CLP92I[=#QG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** ([BXBM+:6YG<)#$AD=CV4#)/Y5QS:W%<_#R?Q%K%]?:?:WT'G*]
MF&,EK"W,>W:#AMI!+$=2>@ QTFOV$FJ^'-4TZ)MLEW:2P*3V+(5'\ZXFX@NM
M7^ D>GV=K++?/I26?V=%^83(H1E/IAE8'/I0!U$][8'Q7IEBVHWZ7CVDKQVR
MAA#,GRY=CMP67C&#D;CQS2:+J\AU_5?#]W(9+BQ$<T,K=98) =I/NK*RD]\
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M4)S.J/&X(W*>2".#ZUM>(M>MK2RU*UBFNOM<%J9I&M(B[6ZD':S<$#.#QR<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M @*,XW'D\5CVW@74K;PMX>T<7UJSZ1J*7IEV,!*%=F"XS\N=Y&<GITYKO:*
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M1UR,JP)!QS6Y=W*V=G-<NCND2%RL:[F('H*KZ+JMOKNBV6JVJR+;W<*S1B0
M,%89&0">: .=U3PUK^KZ5:&ZU>T.I0WT5VR+;L+5E3.(BFXL1D[LDYR!TP,<
MOXTT"_T3P9XMN[K4K:5=3O+6X7; 4V/YD*GJQR/DX'7U->L5%/;07*A9X(Y5
M!R!(@8#\Z ,1-%N[GQ!#KE\UL;BTM9+>TAB+% 7*EW9B,\[5 &.!GDYXP[;P
M)J-KX3\/Z7'J-K]LT6_%Y',T+&.4?O,@KN!'$A[]AZUW2(L:*B*%11@*HP *
M=0!Y]JO@/6=0M_$%JNLVAAU6>*Y$DMJS2HR;"$SNQL!3@8XW&M^#0;Y/&_\
M;\UU;NATU;%XU0J20Y?>.3CDXV^G>NBHH PM?T>XU<B!X;"\TZ2%HY[.\0D,
MQ(VN& .".>W.>HQ638^";O2KOPW-9ZHCG2K%[&8W$18RQL4.5^;Y2"F!G( /
M?'/9T4 <-#X#N8/#EWX4%["= GF9D)4^=%"S[VA'8\D@-V!Z&ISX5UK3?$M_
M?>']6M+6QU,H]U;W%L9#%(JA=\6& R0!PV1D=^E=E10!PNM_#]];UB]O)KI
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M/=>"-1NM"\5Z:;VU7^WKEIQ)L8^0&1%(Q_%P@YXZUVL=M!%*\L<$:2/]YE0
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M7[2^3/NW[LYS][G'3-1:]X:S;:QJ6FP/=:O>6)LRDUP525.<+Z#[S$'CD]:
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M:/'L",7"K,A+L%9MP7/ /7/!-9^HZEJ/A_4?&:Z:L%K-%H4-S%:6TF](I<R
ML 0!NV@$X S@9SUH ]7NYI+>SFFBB$KQH65"VW<0.F>U4/#.M?\ "1>&=.UC
MR/(^V0+-Y6_=LSVS@9_*L.PL]!,MIJNDZE(3<Z<ZB&.;<MRN WFR#DEQTWDY
MRV#UKC?#=JFG:%\,M2MI)UNKJ5;:9C,Q#Q-!(=FW., J"..HSUH ]CHKRG31
M_P ))8/J5QK]OI^KV.JR"9EA8W$169@L'^LY1EVJ%VX.>A.35PSW.E^+(9=3
MM$OM/O-79+/5K23]Y#(69!;S(>2@.5!' P#C- 'I5%<AXZU":TF\.6K.T>GW
MVJQV]XZG&5*L50GL&<*#ZCCO7,^)(I],O/&NG:?)-%I:^'#?A(961;:Y_> ;
M,$;0P3<5'!QTYH ]5K(\3ZT_AWPUJ&L):_:OL<+3&+S-FX 9/.#_ "JMX1T>
MTT[2(+R SM<7MM ]P\L[R;V"#D DA>O8 =/2O/\ 6)8/$/@'X@7FI?/J-E<W
M<"!F(:VCC&(U7T##DX^]N.<T >MVTWVBUAFV[?,17QG.,C-9^L:T-,N=.LHH
MEEO=1F:&WC=]BY5&=BS8.  IZ \D?6N'DD37/$=[H%_?6ELBZ5;/9)<QLV59
M6WRQD.N&#8&>2,#&.:2_TNVEUWX>1W5W_:K%KB)KUP5-PJV[X8\\YZYSSU[T
M >@:1=7UYIR3:CIYL+K<RO!YHE P2 0PZ@@9' //2KU>1^(KR+9?ZEIUP[26
MWB.WMS=SRXE1Q)&CP1*!Q$ 3G)YRW!ZUI7$T::I\28VF"P)8V\T0,F%0F!SN
M7G@E@#D=_>@#KM2U]]/\4Z+HWV/>FIB;%QYN/+,:;B-N.<\=ZU;:]M[QKA;>
M59#;RF&7;_"X )'X9%>=VDC3ZC\*Y)',CR6$S,S')8FT7))JEHFEC_A'/$UO
MI,MI9W[>(KB.$3DB.55G4B%L<[6'RG'][WH ]8JI%/>MJES#+9JEFD:&&Y$P
M)D8YW*4Q\N,#G/.:YWP-?+<)JUK)I4NE7]O=C[79F021QL8TP8F'&PJ <<<D
M\5C7BM_PE7CZ+[1<A!H]O*H%PX,;;9CE3GY>@X&* /1J@N[VWL8XWN95C625
M(4S_ !.[!5 ^I(KS'1+<6-[\-+V&:X^T:C9-'=L\[MYR_9-X!!.,!@"*W?B3
M9VURGA@W$2OC7K1 6[!B01^/% &YI_B![WQ9J^AO9^5_9\,$JS>;N\T2;^V.
M,;/4]:W*\QNM)L=3\9^,(9=YMX]'LS&L4S(.%FVGY2,XQQ572]7FU;_A$=-U
M:]MA#>^'TG0WT9D2YN/E#9^=<N%P1G/WB>M 'K%%87A"S.G>'HK+^UWU58)'
MC6Z8'D!C\N23G;]W.3T]JW: "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***HZGK.FZ,D+ZE>PVJSR
MK#$96QO=C@ 4 7J*Q]+\5:%K2W;:=J=O.+/_ (^,-M\H8SDYQQ@'GIQ1'XIT
M1WN$-^D3V\/VB19U:(B+IO&X#*Y_B&10!L45QVL?$71;;PWJFH:5>Q7MQ:67
MVE(T5F!W*3&3@< XY].^*GTK4)+79?WNO3W=K>1(L-I+98E$P&7*!%#,N.<;
M3C&<XH ZJBL=_%>@Q:=#J$FJVRVL\H@CD9\9DSMVXZ@@\$'IWQ5:+QSX8G*"
M+6;9F<R!5!.X[#AN,9Z\>_;- '0T5SR^.O##6]O.-8M_*GD\M&Y^5MVW#\?)
M\W'S8YJYJ'B32-+FEBO+U8FA"-,=K,L(8X4R, 0@)'!8B@#5HK&O_%>A:9=R
MVEWJ<,=S%$)GA&6<*3@' !/X=>]6!KVF-IUKJ$=XDMM=@?9VB!<S9&<(J@EC
M@$X SP?2@#1HK,A\0Z5<::E_!>)+;O(8E**68R D% @&[<,'Y<9X/%3Z9JUC
MK%JUQ87"S1J[1O@$%'7JK*<%6'H0#0!<HJE?:M9:<Z)<RL)'4NL4<;2.5&,M
MM4$X&1DXP,CUK \5^,+?3/"D.J:;<).+R6**WGB4R)AY%0MD C(#$@'J1CGI
M0!UE%9.B07D2W,L^JRW]M.X>V$]N(Y(5QRI( W<\C*@CIS2KXET=K]+,7J^=
M),UNAVML:502T8?&TL,'Y<YX/I0!JT5S\_CCPS;&;S=9MAY,WD2D$D(_'#$#
M@?,.3QSUK1CUO3I=9DT=+@'4(XQ*\&QLA#T;.,8[9]: +]%5K*_MM1B>6UD+
MHDC1,2A7#J<,.0.A!!]P15;4->TS2W=;RYV-''YL@5&?RDY^=]H.Q>#R<#@^
MAH TJ*Y/Q9XJ32UT6&UG;&J7D<7VB&,R;8BK,60@$$D+@=>N<5M:-!>6>GN+
M_5&O\NTD4\L*Q,L1Y56 P"0.^!GTH T2 001D'J#6'8>&K2VT=]"NK>WN](0
MG[/#,@;:A)(C92,$+T!], \C)RW\8Z?HWA\:@^JR:S'/J1MHI8H>%+2[=GR#
M&$!QGOCN36[/XBTNV&9KAE&Q78^2Y$8;[N_ ^3/8-B@"7^Q-*^UV]U_9UK]H
MMD\N"7RANB7T4]0/856FT*WM].N[31[>VT\WK-Y\L,84@L/F< #E_0GOR<XP
M=665((7FE8+'&I9F/8#DFN1\,ZCJOC/11KJ:A+IEI<N_V*"&*-F\M6*AI"ZM
MDG&<+@ $#D\T =386-OIFGV]C:1"*VMXUBB0=%51@"K%>8ZAXWU1_#6H?Z0E
MEJ^C:O!8WIB13'*CRHN\!L[596)ZY!!YKL[+Q+I'B!;ZVT?5HI+FW7Y_+Y:/
M(X8!AR/0\@T ;=%<)X>\0RZAX)\)7NIZ^+2_OY(F8^6A-X23F+;C@'CD 8Q7
M3W_B/2-,>9;R]2+R IG8@E80WW3(P&$SVW$4 6K_ $VQU6U:UU"T@N[=OO13
MQAU/U!XJI%X8T&"6&6+1K!)(&#1,MNH,9'0KQP13+CQ3HEK$LKWZ/&T)N-T*
MM+B('!D.T'"Y_B/'!JO>>,-.M->TK2@9)7U")YXY8XV9/+ &"& (.2PZ=!R<
M<9 +TOA_1IM/EL)=*LY+.60RR0-"I1W)R6*XP3GG/K4=_P"%]!U1K5K_ $>Q
MNFM0! 9H%;RQZ#(Z>U0:9JUDQUJZ.OQ7EM;7)$A8*J68"*2FX8R!UR?6K,'B
M+2KB2XC%XL<MO&)I8YT:)EC/1]K@';[]* %U;P[HNO+"NK:79WHA.8_M$*OL
M^F:Q-3\,S7_CK2M2:SM6TRRLI;;!DVNK.4(*@#@ *1U'6M&S\9>'=0N[2UM-
M5@EEO%+6X7.),#. <8SCG'7'-7%UW37OH[-;@F:25X4/EML>102RA\;20%;(
MSQM/I0 Z?0]*N=+73)]-M);!2"+9X5,8(.0=N,=>:GN+&TN[%[&XMH9;1T\M
MH'0%"OICIBI9IHK>"2>>1(HHU+N[L JJ.223T%9]MXATJ[GD@CNU6:.+SRDR
M-$3'_? 8#*_[0XH CC\*>'HEVQZ)IZC[.;8@6Z<Q$DE.GW22<COFKEEI=CIQ
M<V=K'"7 5F4<D#H,^@R<#H,U0TOQ;H.M7:6NFZI!<SO$TRI&2<HK;2>GK_,'
MH:T;W4+73T1KF7:9&V1HJEWD;&<*J@EC@$X Z T 17VC:;J<L4M[903RPY$;
MNF64'J >N#W'>B[T72K^T@M+O3;2>VMV5H89(59(RO *@C P.*BB\1:3/IB:
MA%?1R6TDGE(R@EFDSC8%QNWY!&W&>.E0R>*]#BTNXU*2_1+2VD\JX=D8&!_1
MUQE#R/O =1ZT 3-X=T5OM>[2;(_;?^/K,"_O_P#?X^;\:COO"OA_4[6VM;[1
MK&X@M?\ 41R0*RQ#T48X'MTJX=2M1/:P%V$MTI>%3&WS  $GIQC(ZXZU4B\3
M:-->+:+?QB5XVECWJR+*B_>9&("N!W*DT 6&T72WO;>];3K4W5LNR"8Q+OB7
MT4XR!["K,EM!+/%/)$C2PY\MRN2F1@X/;(K&MO&OAN\FLXK;5[>5KQS';[<X
M=@2-N<8!RIP#UQQFK,WB71X+W[)+>JLOGK;$[6*+*P!$9?&T.<CY2<\CUH O
MQV=M%',D<$:),S/(%7 =FZD^I-4$\,Z'';0VT6DV<4,#F2%(H@@B8]67&-I/
MJ*K7OC3PYI\MW%<ZO;I)9E1<*,L8\@GD 'TY].^*;=>+M/MO$FG:*/,DEO8&
MN%ECC9D"#:!@@$'.X?0=<9% %V\\.Z+J&EIIEYI=I/8H<K \(**?4#L>3S[F
MKEI9VVGV<=I96\4%O$NV.&)0JJ/0 <"JL.NZ;/>I:17!:61G6,^6P5RF=P5L
M;6Q@YP>U7+FY@L[:2YN9DA@B4L\DC!54#J230!R7A?PD;*YUBXU?3[-I;O5)
M;Z%E?S/E8@H&! ^92,CKC/!KIDTC3H]3?4TL;=;]UV-<B,"1E]"W7'M5>#Q%
MI,[W$8O%CDMHQ+-'.K1,B'HY5P#MXZ]*CTKQ5H>N7/V;3-2ANIO)%QMCS_JR
M<!NGK0!.=!TEM0:_.G6QNF97:7RQEF'1CZL.QZBKD]M!<F(SPI)Y3B2/>N=K
M#HP]#R:K:AK%AICQQW4Q66569(HXVD=E7[Q"J"<#(R<8&1ZTW^W=,-A:7R7D
M<EO>$"V:/+F8D9 0#)8X!. .@/I0!)=:5I]]=6]U=V5O/<6QS!+)&&:(^JD]
M/PJE=^$O#U]>3W=WHEA/<3@+-)) I,@'][CGT^E1GQIX;6TFN6UFT6.&012A
MGPT;DX"LO4-GC!&:D@\5:)=VSW%K?K<(D[6Y$"-(QD4995502V 0> >.: '7
M_A;0-4:U:_T6PN3:@"#S;=6\L>@XX'MTJ;4= TC5YH)M1TRUNI+?/E/-$&*9
MZ@$]O:FQ>(=*GTR'48+U)K:=BD31 NTC#.550"Q88.1C(P?2J_\ PE_A\6=M
M=-JULL-S/]GB+-M)E!P4(/((/4'&.^* -#3]+L-)M?LVG6<%K!DMY<,80$GJ
M3CO[U4/AC06M9[5M&L#;W$GFS1&W7;(_7<PQ@GW-5&\=>&5M[F<ZM$$MGV3+
MM;>AQG)7&[&.<XQCO6C<:WIUM:P7#7&^.=/,A\A&E:1, [E5 21@CD#'(H A
MU#PQH.JSVT^H:/8W4ML (7F@5B@'0 D=/:K0TC3AJG]IBQMQ?[/+^T^6/,V_
MW=W7'M5!O%_AU([)SK%IMOD:2V(DSYJJ"21],'\>.O%4M2\>:+9^&SK5O.UW
M;FX%JHBC8D2E@NUAC*X)YR!^9&0#4?PUH<FM+K+Z39-J:]+LPKY@XQG=C.<<
M9ITGA[1I9+R232K-GO5VW3-"I,X]'X^8?6F7'B/2K1"\]PZJ(Q*Y\ESY:$D
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MJ.@ '05)5>POK74[""^L9TGM9T#Q2H<AE/>K% !1110 4444 %%%% !1110
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M! # 8'7D=?9JY[Q'I%G<7%KJDNMW.CW-LK0QW4,R*"KD$HPD#(<E5/3/% '
M:D;*^^'OB2VTQ=0OM1O=2BO;FU_LV9'4O,A^6,KNV[8SSSDJ?I71^+I)M/\
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MEA#<WDS1F"23R1)$P5I#@["S'."<C/..:R[^SO9?#'C$1Z;?EF\217L:?9)
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M=K58["QDM)(U=B6+["6'R]M@X]Z -?7=9M?#VAWFK7N[[/:QEV"CENP4>Y)
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MPF,9Y*AMW?.VH_$]EH_B36](TFQOXAJ-A<%+F&W<,\=JT9$L<@ZJK#8OU*T
M=;HM]<:GH]K?7-JMK)<1B00B0OM4\C)*KSC&1CCI7">(K>P'QETA[G2UO ^D
M3[D6W$A)$BX)'MSS[UZ5TKD]1T#5YO'EIXBM&L3%;64EH(97<%][!BV0IQC
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M[0DP-N63YI?F.0#GM^'6NHU_7(M"LH)6C\V>YN8[2VAW;?,ED;"@GL.I)YP
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M!W;4#=),4=0%^T>?@CG))X]O>@":WFU"R^*:VD6FZ;;)>Z8UW>>3<-F1ED1
MY.P;BJD@# SDY/2IX/'LEU+I4]KI;W.FZC.(4DA+M+$K9V2NNS:$.!GYN,@\
M]!H7>@ZA-XSL-?AFM8U2R>RNH7#/\K.KY0C'/RXY]<\]*S_#7AKQ+X>6+1QJ
MUE+X?M9-UNWE,+H1@Y6(G.W Z;L$D<8'8 L^'_%&KZ[J-Q&-#AALK6^N+*YG
M^V;F5H^A5=@W GCMC/>IOB)#%-\.?$0EC1PNG3NH9<X8(2"/<5+X4T2]T-=6
M6\>W<7NHS7R>2S':)#G:<@=,=>_H*M>*=,N=;\+ZEI5HT22WMN]OYDI.$#*0
M3P#G&>E 'EFN2V-KX*\+MIVF2:1J3&S":PUOY$4'"[C)(.JL,C!X.:]+GU^Y
MN-9U#2M'M(+FXT^&.2X,\YC7=("4C!"MR0N2>@R.N>,35/"&M:[X-M_"MY=6
M%M8B*&&XGA#222)'M.%! "D[1R<X]*OQ^&KW1O%%YJ^BO;/#?V\4-S;7+LN'
MB&U)%8!L_*<%2.< YH H)\0Y;^+PZ^DZ1YYUDSQA)KCRF@EB1BR-\IXRI!([
M<@'@5+%XM\13:W+HR>&[;[=!:V]S,#J'RJLC%6 .SDC:<=C@\C@%EKX'N=,N
M/#!LI[>2/2)KBXN&ERK3R3JP<@ ':,N2.3V'O6M:Z)?0>.[_ %QWMS:W5G%;
M",,V]?+9F#=,<[R,>U &=<^.WB\/3>)H=/6;0H9VC>19CYQC60QM*J;<$!@3
MC.2HS[5//XONHM4UNP&FVY>QL%U"U9KPJ+N([LG.SY,%<'KU'UK/A\#7UOX:
MO_"27-N="N9G,<I+">&&1][Q!<88Y+ -N&,]#CG8UKPE%JFL:+?13?9UL=\4
M\:C_ %]N0#Y9]MZ)^&[UH 9IGB_^U-+T74([:!8;^U>[N#]H)^S1H!N_@^8A
MF"D?+W]*IV?CBYN[W2?+TAY++4P?+DB+LT!*[D,HV8 ;H2"<'UZU<T+P=!H_
M]MQ/,9;74)G,,7000OEFC'I\[R'Z$>E5?#.@^*=$@M]*N]6L;G2;$!;9TB9;
MF5%^XDASM '&2 20/K0 OA_Q#J7BZV?[1H$$6ER&YM9W:\WG<CE,;=HRK8//
M'?CH2/<6'P[T'2-+0P103W3P)+.YC@A+[Y,$G)"Y^503Z<U?\':)>>']'EL;
MR2"1FNIKA6A)QB21GP<@=-V/>K>NV%UJ,,,,4%C=6I8BZM;T'9,A' SM;!!P
M>AZ?C0!:TRYN;NP2:[MTMYBS@I')YBX#$*P; R& ##@=:N5A^$O#_P#PC.@K
MIHDW(LTLD<88LL*LY81J3R54'&3UZ\=*W* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y3Q_?ZE
MINBV4^F7S6LSZC:P,?+5PRR2JI!!'H>Q!]Z .KHKA9)M8@\1KX775KF[?[&]
M\UP[1PRL&DVJH(0C"X[ 9R.W!9IVIZ^VK:/X8UN_A2^>TN+BZN;,C,VQU5%&
M5PIVON; [<8!H [VJFH7ZZ=!'*UO<SAY4BVV\1D8;F W$#HHSDGL*Y">_P!<
MT^]T3PW<:DEY>7;73O=1[879(MI5#\I ?;("2!T4XQG-4]3O/%>B>'K<WVJ1
M_:%UVW@1XMCM):R2H LOR !\,1E0,\&@#T:FLZJRJS %CA03U.,\?@#7 R#Q
M%K?BWQ5I-KXDN+&*RCM7M#'!$2C.CG!)4Y7(Y[GCD<YQ]%U74?$VN> M3NKV
MXMYKO3KQYHH=H0O&44L%*G[V3^!XQ0!ZQ17-^,M;GT:RTR.V?RI=2U.WL!-M
M!\D2$Y8 \9P"!GC)'7I5**\U*S\?/X<>_N)K*\TUKR&9@AEMG1PC ';@J=P(
MW X/M0!K6_BFQNM2MK2&&[>*Z>6."[6+= [QY#KN!R,;6Y( .#@FMNN(^$T$
MD?P^L)'NII1(9<(^W"8FDZ8 //?)/X5!K&J:MIGB76M,DU:X1+[3A<Z.RQQ9
MCF5MC1KE?F)9XL!L\-^- '?57OKL6%A<7;0S3"&-I#' A>1\#.%4=2>PKC_"
MFLW_ (EL-*']H7$-S;6K_P!J +'N^T!C'M(*X'S)*>,?='8UAZ;?^)9OA5=>
M+)?$MR;M=+N9%B%O"$$B,Q5_N]<+@CISQC% 'I\5PDL4+G,9E4,J2#:W3."#
MW'<4]75BP5@2IPP!Z'&<'\"/SKSV07=Y\0/"4C:G=IYVCSRNJ%-NX>3DX*D<
M[CD]?3%9FD:I?:%H.M7":A<3S3^)I-/1[AD(CW3JF_.WJ%X&<J..,<4 >KT5
MYSX@F\7:%H7B:\.IK%;16!N;$LZ2SQ2H/G',8!0Y'7)!J_8WNK67CG2;*YU6
M:\MM3TR6XDBDC15BDC,>"FT @$.1@D_6@#MZ*Y+QK>ZG97OAN/3M0>U6]U1;
M6<"-'#(8W;N,Y!4=_KFN=N?%6K>'X?$UA)J$EY)9ZG9VEK=W*)NB6X6,DMM
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJD2"W5!&(\?*% QC'IBL33_!VF:<EK#$]R]E92F:TM)9-T5N_."O&3C)P&)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 <?\5?^27>(?\ KU/\Q7+^/X;W2?#F@ZS=W[:I8V5W;.VER1JAN'.
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MMW=64;SX^4EF49/'3/7VS7EZ64%O\&K@0EXW?6PG$A.T+J.!@'(&/I]:]K
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MD^6F-S>PR0/S(KB-(\7Z;IWACPN-+T.\6RU4F&TAC=3Y1PS!26;.3M/MZD4
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MH)Y^93N!!7.<]NVGHWB1M3UK4=(N=-GL+RS2.;9*Z.)(WW;6!4D9RI!';WH
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M_K5OXBT"RUBT5U@NXA(JN/F7U!]P<BM*@ HHHH **** "BBB@ HHHH ****
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M/<YH\3:%?7FM:%KNF&)[O299<V\K[5FBE4*X#8.&& 1VXKIJJ6NIVMY>7EI
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M:W$5RX<H2TI0_(N/NKLQR<X]ZJPZ3XKT+Q#JO]CIIUUI6J7'VH/=2LCVDK*
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M?:Z@6[2U,@\]U+A "2%'<^@[9/>H6U2S74/L FWW6 S11J7* ]"V =H/8G%
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MB'#M"L>UEVX !7.<GZ>E:P\*ZQI,OA;5($@EO-,TL:7>VWG8$L>%^:-B.H9
M<$#(/45WU% 'GFI>"]4N;*_GA2V.H:CK%MJ$R-,0D4<)3:@.WEL)Z8RQ[#G=
ML=)U&+X@:CK4L,*V5S8PVR8ERX9&=B2,8P=_KVKIJ* .;\=:/?Z_X4GTS3DA
M:XEEA<&:0HH"2HYY /9<=.]0)I6JIXZO]<^S0&VGTR*T1?/^?>CNW(Q@#Y\9
MSVKJZ* .>\#:1>Z!X+TS2-0$0N;2+RG,3[E;!Z@D#^55GTO5]/\ &VI:U9VU
MO=P7]G# %:<QM$\9<Y;Y3E3OZCD8Z&NJHH \_M/!VL:,^AVML;/4M.MH9OM4
M%S(T2?:9)/,\X*%;< 2P"GIGKGFJNC>#_$.GZ;X/M9X;%CHEY++,T=P?G1ED
M48RO7Y\X]NOIWFL:Q8:!I<VI:G/Y%I",R2;&; ^B@FKH(901T(R* /-]7\'Z
M]?Z7XNM(H+/=K-]#<6Y>X.%5!&"'^7@_N^V>M:>DZ#K>A+JNEV<%O)H4\;/8
MQ/<$/:.X.Z/[N#'N.1SD>AKMJ* ."E\)ZO-\)K+P[BV75+*.V"_O28I&A=&^
M]C(#;,=.,U!JNE:ZU_X@U^_MK*"VG\.O:F*.X9WC=?-;^Z WWN3QU[XS7<C4
M[4ZN=*WM]L$ N"GEMCR]VW.[&W.1TSFI;NT@OK62UNHEE@E4K)&W1@>H/J*
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MFQMX)Y/^$=?*S3&( ?:!SD*W.<<8KK]+T:'3;F\NS*\][>LK7$[@ MM7:J@
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M^JV.^4M&H\JX*ED5G[;@DO'JGH<5UVG:+'9:A<ZC-.]U?W*)').Z@81,[44
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MA"WA:WN[6>?SQ(2X:,H"NW&!]\=S^%:>FR7\EJQU**VCG\UP%MY"Z[-QVG)
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ML5 !!['G&#W%7+?Q/I5Q>W%FT[V]S;P?:9([J)H3Y/\ ST&\#*^I[=\4 :Y
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M,EN6C41#]XKA1AF0GH3Q[5-X5\0W=UXC\1:;<7Z:AIFF^4T6I%47!927C9E
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M@']*O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5Q_P 4;.[U/X=ZKIUA:SW5W<JBQ10H6)(=2?8<
M ]:["B@#S3Q7I$NNC2$\-Z)<6.JPW<4AU(V_V86T8/S@DX+@CC:,@UH64%]H
M.N>*X+S3KJ\M]5F^UV<L$1D$F8PAB8C[A&T %L#!ZUW=1SW$-K"TUQ-'#$@R
MSR,%4#W)H \X\/\ A[4- UOP7:7$$\ZZ=I,]M<W"1EHXY',9"[O3Y6&?89Q6
MOH]E=/XQ\:,\%S;17_V<6URT1"MMAV,0?9OS[5VE% 'ED.BZGJ'PVT[P9<:=
M<6^IVD]O%)/Y9\E$BE5O.63[IRB\ '=EL$#FMK6O#-Y=>,YE@B)T;7+(1:JP
M;!4Q'Y?Q='*'V&>U=S10!YWI?A?7+KX?ZQI6I.$U%K*72;25CP\,>]8W/IOS
MD^H J;PW*+V6TN+SP7=Z=J-A$XGN;B(,$8IM80$$E]Q]!C&<\XSWU1O<0QS1
M0O-&LLN?+1F 9\<G [XH YCX;6ESI_P_TBQO;6:VNK>(QRQ2H5*G<3^/7J*7
MQ[8W=YI&G/9VLERUIJMI=RQQ %_+CD#,0.YP.@YKJJA^UVW[[_2(OW'^M^<?
MN^,_-Z<>M ' :_8ZI?:GK/B72-+,SIHOV"WM[N#:;IS)O8F-\'"C@!@,DD=.
MM6*VOSXIU*_72=::VN_#WV=9KI0SF4/(2"H/RD[AA0 .^ .:]-CD26-9(W5X
MW 964Y# ]"#3J /,[*POX;+X;(^G7@;2TQ>CR&_<_P"C-'SQ_>('&?7I6?HM
MAKF@:[=>((=.O[B&?5[J*>Q:$[A;RR%TGBST/'S#N,9Y KURH_M$(N!;^='Y
MY0N(]PW;0<$XZXR1S[T <GH<4X^(_B.]>SN4M;NULU@FDA95<QB3>.1QC>O6
MN1GL-9B\)7>A)H6HRW4'B 76](QY<D1NQ*&1B?F^4_A@YQ7K4,\-S'YD$L<J
M9*[D8,,@X(R.X-24 >=6%\L'CGQY')I]U<&9+0+%%"9-Y^SXV$C(7.>I('O4
M&B>'=4\,:EX*26SGNTM-*GLKB2WPRQ2NT;#))&%^5AGVKL[31;/1M5U36C>3
M![[8UR9W41C8NU2.!C XZ_6M2WNK>[MEN+:>*:!AE98W#*1[$<4 -O(&N;&X
MMTD,;2QL@<=5)&,_A7FD.C:GJ/PYTKP?<:=<6VIV<]O%+,8SY2)#*K&99/NM
ME5X .[+8(')KTZ">&Y@2>"5)8G&Y)(V#*P]01UJ2@#D?"MO<0^+/%LTUI<0Q
M7=Y%+!))$5615A1"03_M*?YUM>(S>CPUJ9TZTBN[W[-)Y-O* 4E;:<*0>"#Z
M=ZU** /,=-M]0_X2^#4WTK5UMY= DMI)[P*NV7>K$%<X08!P ![#'-4] LI/
M$GPY\#Z=;VEPDEK/:7<LTD)5(DB.XL'/#%N@"DGYN<8->JW4'VJUE@\QXQ(I
M4NF-P!],@C]*IZ'HT&@:+;:5:23-;6R".+S2"RJ.@R ,X]Z /.;-7U'PWX_T
M2"PGN+J]U>]AAQ$3&6<*H8OC:NT\G)!XXSQ6_H6F7.G?$&7?!</;)HEK9+=M
M$0CR1LY89^C ^E='HF@6^A&^-O/<2_;;E[N7SBI_>-C<1@#&<#CIQ6K0!Y9%
MHNJI\.M9\$7&GW$M_)-/';7'EDPS)+*764R?=7&XD@G/R\ \5N>(M U2#5M#
MU'1&9[D0G2KV7.#]G=>)3[HZAAZ[B.]=O10!QWB#3Y(_$_@S[%93-9Z?<2F1
MHHRRPH8&C7)'N0*YC4M+U*X\"^/;*/3+UKG4-4EFM(_(;,J,(P&''3Y&ZXZ>
MXKUBHYYX;:%YIY4BB099Y&"JH]23TH \XU^ZFMO&>H7-AIVK2+>Z7%!<O:V0
MN!DE]N4WJT;J">N0=W08Y[#PB;!?"]A;:9'<Q6MK&+98KN,I*A3Y2'!Y!X_P
MXJ*Y\)65QJT^IV][J5E/<[3<?9+ID28J H)7D9P ,C!P*V;2TAL;9;>W4K&N
M3RQ8DDY))/)))))/)H XWQ0NJ7'B.>T72KR6QFTMDAGL@JF28ELI))D%5 P0
M,@')SGI7/Z5+/IFJ?#:*^T^\@FM](NH)8C"6="L<*D[5R<9'IGGI7K-9-WH%
MO>>(;'6I+BX6YLD>.%%*[ KXW@C;DYVCOVXQ0!YOK6FS:9;/JTMK+&FI>+[.
M[BM@OS[ 57)7LS%2V.O(SSQ5_P 6>%=0\6WOB"_TR*2W\[1H[& SH8C<2K-Y
MI^5@"%P F2!]X]A7;:OI%CXF2WC>]D L+M)Q]FD7Y9D(9=V0>1D''OS6P!@
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M67BF>*VAW:3]D>U+MN#,XDW9*],C&",X.3SQ6<G@?54\&VFA_:;(RV^IB_\
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MF7B"8QB:Y9 [JF%/."OS'')QCJ:O^)M$OM8O=#FM)+=$TV^6\82ELR85EVC
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ML2FWM8FED\I"[!5&2<#VKS73]:\0CPMX=UZ?7;F::;6_L,T+11B.6)KIXCN
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+:^L(+F&W</$DR;PC#@$9]B12Q:+IL-[=7D=E"MQ=J%N)-O,H' #>H X&>E
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MS7M%UB;7-/O?, 8W'V=F60LMPK@^6!@[O7.0 2: /1/^$BTC[>ME]NB\]IC
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MRM;G3]4;31.C;([E@1M*@DD-R,C)Q70P^*-$N;*.[MM1BGAD=XXS#EV=D^\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2,)*K#/N1C@\Y['B@#LZ*X/0OB+%/X6T.^U6TN$O]5=8X(45%$SD%OD+,!M
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M@#P?Q5X0\;^(+;5EDT!!(NM+<VP@N8HXW@&1D("-SG()=^>W;%=5J6@Z[/\
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MB@ HHHH **** "BBB@ HI%8,H92"#T(-+0 4444 %%%(S!1EB /4F@!:***
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M7EE)=)+OR-JE592N/]L=ZX'0]8U#0/A_I*Z5;P,+GQ%)9MOD*[$:\<8 VGJ
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M2076)WR^Z$1Y3Y.>F><5CKX*\4V_@Z#PK$VERVEC>0RVMY).ZN\23"0*Z!"
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MJ<+R:=/).I6=E7<48+DQG'(SGCMGBL)/%,NH?"Y]9\2:)#?6TMV5:".8%?\
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M)4?. ,9!ZBO.]'\3>))-"\'ZY=ZG%,NJ7ZV=S:K;*JE7,@#;NH8%1TP,=NY
M/4:3(R!D9/.*X"3Q'K&I>&?$/B'3;P0'2KBY2"T:)6CE2#[PD)&[+8;H1C*^
MARS2KV[UGXDV]Y'?W45M<>'8+V.V8(5C\R0Y7[N?X5R<YXZXP  =QIVHP:I
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M1D&.J\ C))]Z .MHKG=?O+V+5["TMK_[/%-%*S1VZ+)=2.-H7:K*5"#)W,<
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M(PI+-YF02.N2J\]O2@#O:*XB[UG6-$N?#-Q/?"]MM8G2SN(S"@$4DB%E>/:
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M=>0K1RCE3'Y9.5/((;)'!SUH ZDD#&2!G@>]+7$^,%NW\:^#(8-2N;6*:ZN
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MMU;$M%NW@DC<=G(^8_G707\E_']F^PV\,VZ=5G\V4ILBYW,O!RPXP.,^M6Z
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M\Y)N62.)DW9/."3CTSBL8R:9J/@+P;K<KPR:K)KEDUW<N0)3-YP\Q6/7 /\
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M8;8':%28AZ*<?+^% 'D%_96<?@CQ#9M!$;/3_%L<=LC@%;>,RP$JN?NCYV_
MFO85$<.FD:='"42,B&./ 3(Z 8X SQ4(T+2%@N(!I5B(;DYGC%NFV4_[0QAO
MQJ]'&D,211(J1H JHHP% Z #L* /'U9KKX4Z3XBLB3XI6\A!GQB:2Y:<))$_
M<C!8;#P !Q@"M[0M!TV_^(GBN6ZB:5[&_M)[8-*^(G\A6W 9]2>M=O'H^F17
M[7\>G6B7CG<TZPJ')QC);&<XXIUOIFGVEU-=6UC;0W$W^MECA57?_>(&3^-
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M5I;7UL]M=V\5Q!(,/%*@=6'N#P:K_P!C:6+!K'^S;/[&QW-!Y"^6Q]2N,$T
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M$@DW!?WA*_*-Q Y_E6,--U/7M(\):=<Z;<65UI%[;W-X\@&Q/(4CY&!P^\X
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MR:US)#$)I)'7 CC*')3/)+8'3CK@ Z/3O&6D:GJ-I90-<K)>P&XM7EMW1)E
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MWDVES6@\R&(3RR.N B%"?W>>26P.AQP: -Y/'FB/=6UOF\5[N SVI-I)BX
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M[.WB2\U3[ ML9,SHAW!)SC(VL5SMP.".30!UUO>6MV91;7,,QA?RY1&X;8V
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MJ&D6]Y=1)$\Z^8J)GA#RN<]\8)';.*OT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@>*M"O-<@TX
MV-Y%;S65['=A)XS)%-M!&UU!![Y'/! K?HH \_N_ .JW.D^(+ ZQ:D:MJ$5]
MO-JP\ME,9(QOY!,0 '8$Y)K1U7P;+KFO7]Y?7$0L[[2#I<D,:G>H+%MX8\9R
M>F.U=?10!PUOX1\1--X<-]K5A*-#F+)(MHX:=/+,?S?/@-@]N_//2G_%5]G@
MQ0LJ1.=0L]C/R ?M"'.,C..M=M4<MO#. )H8Y .F]0<?G0!RFJ^$;K7WU"[N
M[]+6\GTU]/MGM02(%<[F?)P220O'& ,9YS4%KH%]HFLP>)-4U;3X[:RTEK2Y
MCAM#&BQJP?<N6.,8YZ\< #K7:JH50J@  8 ':@@,I5@"#P0>] '&>%-/TZ\\
M3:QXFTN=I=/O"H@Q_JVD*KYTB?[VV,$^J-5+_A M9%O;VXUNT9+76?[4BD>T
M9I)"69B)3O\ F(#8!&. *[6XO/L=U8VB65S(EPS)YD,8,< 52<N<_*#C Z\D
M56\1Z];>&="N=7O(IY;>W +K H9L$XZ$@?K0!B_\(GJ,,GB"WMM1@6SUN8S2
MNT1\Z M&L;!>=K9"\$XP3T/2IAX1,/B32[VVDA33K#37TU;5E)8QMLYW9[!
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M &3@D\5U=% '!VO@74;7PSX;T@:A:LVBWR7?F^4P\X*6(7&?E^^><GI45WX
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MP JIE>/V>09]]F1P:W!KMI-XFE\.-!-]I6S^ULSH/+:,MLP#GDYSV[5J\(O
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M,5VYYY&,YZ5LKX<NW\7WNM37,/DW>G)8M"B'<NUF;=N)YY<\8]*Z2B@#A(?
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M(D:-G<;N$!4DG)X[5NA$5F954,WWB!R?K0 ZN"E\"ZH^F:E;IJELLMSK0U=
M86:,\J?)D7=\R_*.>/I7>T4 <SH?AN^T[7M<U&^O[>ZCU7RF>%+<IM98PAZL
M?EP.GOUK(3X96R^';+3#?RF2TOA,EQ_$(.4\D'LODDI]>:[VB@   & ,"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,H1MXR=N#Q\IXSS3]*U&_P!=\2W.B:A?^6VG:;;22M82%%GGE#;I%;@[5VC
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MVT'D]R*ZV*ZO=(^(UMHJ7,]SIM_I\EP$G<R-;R1LH)#'G:P<<$G!'&.E:/\
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MNQ971SP3R01G(Q5_QI?330:%JD$,TFD6>KQ2WC!#\T05@)<=2BL5.?;(X -
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MZ^WN/6@#J)]8TRVO%LY]1M(KEV"K"\RJY)Z#!.<GMZU'>:_HVGM,M[JUC;-
MH:437"(8P> 6R>,]LUYJ65O OC'P[JJYUZ6ZNVA@8?O+IW.Z"2,=6'W "/N[
M><8K2TR&W@^)$ZZJ]M)<1>&[:.XEDP0TH>3S.3WP03[&@#OIM3L+>S2\FO;:
M.UD *3-*H1@1D8.<'(YJ6UNK>^MH[FTGBN+>0;DEB<,K#U!'!KQG0-4&BZ#X
M'U'4YKN'2(].GLYKB!2WV6<NA7S!@D JI7IQ]#7IG@^STRTT5SH\=PMC/<23
MQM/N!D+'+.H;!52<X&!ZC@T :;:QIBWZV+:C:"[9MH@,R[RV,XVYSG'.*CEU
M_1H+DVTVK6,=P)$A,3W"!@[9VKC.=QP<#J<&O+%66]^$EQX9GR/%L5VP\@\3
M&Y-QO69>^T@[MXXQGGBNET&VT^X^*'BP3Q6TTHCL2A9%.656W%<]PVW..AQ0
M!VUUJ-C9211W=Y;P/+D1K+*JE\#)P">< $U1_P"$K\._8TO/[>TS[+)(8DF^
MUQ[&<=5!S@GVKGO'0M6\2>#1.(CMU-F;> <+Y,@R<]MQ7\<5SMXFGM'\5L+;
MEI8OW7 RY-JH.WU_>#''\7O0!ZA>ZG8:;&LE]>V]LC9VM-*$!QUQDTR;6-,M
MXH)9M1M(X[@9A9YE D&,_*<\\<\5P&A:BNG>+-/O=6G2/3KSP_;PV=W*V(ED
M0YEC+'@,<@\]=OM6(MA'8V'AN.\1$LW\637%G%*N/*LSYNS(/1<D'GCYA0!Z
MH_B/1([&&^?6+!;28%HIS<H$< X)#9P0*OM<0I;FX>:-8 N\R%@%V^N>F*\V
MU>ZTWP]XVO[76FN-/T?4;"&*RDMH?W)VF3S(CM4X)+[L=\_2NKM["TLO #6-
MM;S16<=BZQ0W)+.J;3M#9Y!QC@\CIVH T+?Q#HMW>)9V^KV$UR\0F2&.Y1G:
M,C(8 ')&.<^E/.NZ0+0W9U6Q^S"3RC-]H38'_N[LXS[=:\KTBRT[5/"7PZ31
MU@.K6MQ:3RM !YD42IF8OCD*1QSU)6J^L7T%MX+\<:/)YG]H'77N!;B)BWEO
M/&ROP/ND=#Z\=: .[B\6BQ\8Z_8ZYJ6GVFG6<5HUM)*1#S+YF0S,WS'Y!Z?2
MK6N:W>V?B3PO;6<MNUCJ=Q)'-\FYF A=U*MG&.!V_&L#?HT7Q'\13ZW';K;W
MFFV@MC=Q?ZY0)/,5 P^8\KE1STXK(TNSGT2T^&MCJ.Z&:&[N7,<I^:*-HY?+
M5O3 9%^O% 'I&GW9EOM4+ZK974,4JA8H0 UJ-HRLAW'G.3SC@U8LM6T[4FD6
MQO[6Z:+'F"&57*YZ9P>,UY9JJSRP_$5=+A-PXO[28V\(YGA1(O-51WR%=3Z\
MBNX\/ZMX>\1ZL^L:-"TTYM1#->>4Z;5#96([@ 3DL<#ICGJ* -R^U33],56O
M[ZVM58$@SRJF0.IY/:FW&L:9:+"USJ-I"LREXC).JAU W$KD\@ $Y'85R8O5
MTCXH:O)K<B0V5]I\"V%Q.0L6$+^9'N/ 8E@V.X^E<E8:<NGQ>!K?48U2$:S=
MRP13K@Q6S"7R@P/0<I@'ID"@#UL:KI[::-2%_;?8&3>+GS5\HKZ[LXQ45MKN
MD7EW-:6VJV4US"F^6&.X5G1?4@'('(YK&\>6MO!\,O$,$4$4<,>F3[(T0!5Q
M&<8 X%<U%9Z9?ZUX(N]%6V$EC#(]]+" !' 8<%9<="7(X;G.X]C0!VD_B/2)
M[6:.SU_2TN6MY)(G,Z.$ )7>1NY4-P>>H(S4UGJ]DL5A:W.KV$U_<0(Z[)%4
MW'R\NB9)VGDC&:\]\-6VF?\ "G=7E-O:_:%CU%&8H-XWR2;1Z\C9@=^/:K=]
M#)%\._"?B:QC,MYH-O;SLD8RSPF,)/']=N3CU04 =_)J^FQ+.TFH6BBW<1S$
MS*/+8]%;G@G(X-9VJ^+]$TG0FU>34+>6U\P1(T4JL'D)V[01WSU],'/2N>\0
MS)H^CZ+<ZE:(+BZU5+B:ZE#,EE*RL0S!2-VT8C&>.A/2N2N9-W@KQO$/M4KQ
M^((KIFDMV5C%YENQ<@*!T5CP.@)H ];N-=TBSMH[FYU2RAMY1NCEDG558#J0
M2<$5>$B-&)%=3&1N# \$>N:\SU76]/L_&E])KES>V^CZO80QV5S'$QCD"EP\
M1^4D$[MP]0?I74QV.G6/PZELO(O(=+CT^1/*8DSK#L/'/(;;T!Y'3M0!KV^L
MZ7=^;]FU*TF\I/,D\N96V+_>.#P.#S38=5L]3@N!I6HV<\T2\E'$H0D94L%(
M.#]1FO,I=0O+/1]=L[Y+;Q9IL.D!HKRW!21H]VWR9MG< ELC!PK''-:6B:G;
MM\2KJ[:_-S!<:!$5N1;F*$[99"=O'W0".23UQG/% '2^$?$AU+P'I6N:S<6\
M$ES"'E<D1IN)/ R:V%UG2WL([]=1M&LY3B.<3*4<^@;.">#^5>1Z/J!TCPAX
M U*[>ZBTFUAG@O9;=2QM96 ",XP2!PZDXXW^];<MEHPT^VNM#UBZTB2XU*:]
MM-1N4W0S3-'ARRO@!&!8=N1D=1D ])M;NWOK=+BTN(KB!\[9(G#*V#@X(X/(
M-1W>I6-@\*7E[;6[SMLA6:54,C>BY/)]A7*^&_%D%MI&E0:Y'#8W^HW<\$*V
MZ.8;AQ(<R(<<*Y.X9/.[C-:'CO2I]4\*W#60SJ-DRWUD<<^=$=Z@?7!7_@5
M&NFLZ7+)<I'J5F[VHS<*LZDPC_;Y^7\:YMO%Z6OC:XM;W4].CT(:3'?17!8(
MN6E*<R%L$?+QC'6N=C35;CQ'%J$=K-'9>,K81S1X -J(P"K,>S- 7]]V!VK7
M?^SQ\8I_/^S^7%H"1@R8VH1,Y*\\ [3G'H?2@#L9=3L(;%+V6]MDM) "D[2J
M$<$9&&S@Y%9FH^,M"TV'399-2M7CU&816SI,I1_5MV<;0 >?P[UYAH.I_P!C
M>'?!&I:A+=PZ/!:W5I<3P*6^RS,ZE"XP2 54KG'&[T-;.H0:3ING>'+_ $M+
MI=*/B47<D\RN<[XY 9 ",JA<X' '.1P10!T=EXO2W\3^(K76M4TZVT^S:U%I
M*["$'S49L%F;YCP.GITKIKW5-/TV!9KZ^MK6)NCS2J@/?@DUYO=/87&L_$N6
M00L9-.A2,R*,G_1V!49Y^]M!'K@'FJEIK,.CW?AZ]UJZN[?2;OP[;6T5W$I=
M([A23)&^%.TL"OU*8[4 >G7&O:/:)&]QJMC"LD9F1I+A%#(!DL,GE<<YZ5;C
MNK>6T6[CGC>V9!(LRN"A0C.X'IC'.:\O73=#LO$O@*QMK4I81QW_ )<5X"6"
MN 4W!N0&.=H;Z8R,5TOQ$M+K_A YX=+M6D2"2!Y+6!.7@212Z*H_V0>.XXH
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M9WF_0E5[I $RRF/S 4^;!^7GG%2?\)3;RI:K96ES>7%Q9K?"WCV!DB;H6+,
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MEDE9QT/HV#74U3U72K'6]-FT[4K9+FSF $D3]&P01^H!H Y7P)H4FESZE_I
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M$#L>.17::IJ^GZ)8M>ZG=Q6MNI"F20X&3T ]3[5;=TBC:21@B*"69C@ #N:
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M-K/%(CR-@NSN2QD/;=N.[ZT 4]3\37M@LTJ+%+'/J,>G6($1R7Z.S?-\V"'
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MY;[2]-_M.TG,3!)H?F!5U#<,&4C(.#G.!6W>^$$OM#TFR>]=+W27CDM+V.,
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M@=E\L@\D\GN>_%+X<MKC5[+PWXCB\2*!.@%TJ&1C>,Z?-&PWX5E;)& -N#C
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MFMYM_GW D51!@97*GEMQXXZ=ZMUYQ;:C'>:W\.Y].OM0>RNK6Y1EGF<&4)
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M06K21QM(SEV"[@,DD\FN!^VW:^ O"OBFPOKF;5KBXM/M'[YF6Z,K!98BF=N
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MEU<PZ;>V:VT+)<,FQ-I+N.<*X9BN>H\N@#KZ*ALX4MK*"".1Y(XHU17D?>S
M# )8]3[]ZFH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JEJFDV.M61L]1MUN+9F#-$Y.TD'(R!UP<
M'ZBKM9'B36QH6E+.J"2YGFCM;6(G DFD8*@/MDY/L#0!*- TT7\E^+=OM<D(
M@>;S7WM&.BDYZ=_KS5.?P7X<NM&@TB?2;>2PMWWPPG.(CZH<Y7\*R/%-_J^E
M:KX6LK?5I474;QK:Y<0Q$D;&;*Y4X.1COQ^=;5O;WHU&>W&O37,8@^=7CB\R
M%R?D8%4 ((#<$'H/6@"6Y\,:)>:3;Z5-IL!L;=E>&%5VB-AT*XP0>3R/4^M0
M/X,\./!=0'1[41794W"JN!+M "AL=0,#CIQFI/#FM'6+6Z2=42]L+I[.Z5/N
M[U_B7/9E*L/3..U1W/C+P]::C)I\^JPK=QRQ0O$ 25>0D(#@=R/PXSC(H N7
M.@Z;>36<US;F66R.;9VD;,1Z9!SUQQGK5;6?"7A_Q#=07.K:3;7<\ Q')(O(
M'H?4>QXJ4^)-(&H0V)O LT\C11%D81R2+G**^-I88/ .>#Z5'?\ BO1-,,IO
M+WRTA<1RRB)VCC<]%9P"H;D<$YY'K0!)J/AK1M5N;:YO=/AEGMAMADP59%/5
M<C'R^QXJQI6CZ=HEF+33+.&TMPQ;RXEP"3R2?4U$=>TT7%_!]H/G:>BO=1^6
M^Z-6S@XQR#M/(STJC-K6GWFH>'VMM>$2WI:6"W1 PO4\LD=1E0!\V>.F* +?
M_"-Z/]NDO!8QB:6432 $A'D'1V3.TL,#YB,\#FIH-&T^VU6?5(;<+>W"A9IM
MS9<#H#SR!V].U48/&?AVZU!+"#5H)+EYGMPBY/[Q%W,,XP,#GT.#Z&K%IXCT
MF^U!+&"[S<R1F:)'C9/-0=6C+ !QR.5)'- &1XUT2[URX\/K!9FX@LM22[N/
MWH0A CK\O(.[+ CITZUKS>&]'N--N=/N+".>VNF#SK,2YE88PS,222,#!)R,
M#TK%\?:KJ6D6VC2:;>M;&[U6VLI<1H^8Y&P2-P.&';M[5'<ZUJ6B^/-$T)KT
M:G;:I',762-5GMO+7(<E  4/3E1ST)Z4 ;,?A'P_"T[1:5;QM<0"WF9 0SQ\
M_*2.3G)SZ]\TMQX3T*[T^SL9].B>WLB#:KE@8,<#8P.5&., T^Z\2Z/93M%<
M7JQ[)5A>0HQCCD.,*TF-JL<C@D'D>HJ#4/&?AW2KR6TO=5@BN(=GF1\DKO.%
MS@>OY=Z +NEZ'I>B"<:9806OGR&27REP78]S44_AK1KF^FO);",S3[?/()"S
M8Z>8H.'Q_M U7MO&?AV\U!+&WU:"6Y>22-47/WHQEQG&!@9[]CZ&K%MXETB\
MNHK:&[S+-&98 T;J)T'5HR0!(,8/RYX(- %+5K/5M7U,:9-968T',4TEPTQ:
M20HV[R_+VXP2J\YZ9[GCHJPO^$QT'^STO_MQ^RO<?95D\F3!ESC9]WKGCZ\=
M:OR:O80W$\$T_EO;PBXE,BLJI&<@,6(QV/?L?2@"@?!N@&[GN_[.7[1<$--*
M)'W2$="QSD_C3[CPCX?N]#71KC2;:33E<R+ R\*Y))8'J#DGG.>31_PENAJE
MZTM^L'V%!+<K<1O$\:'HQ5P#@X/(&*FTGQ%I.NR7$>F7J7+6X0RA01M#C*]1
MSD _E0!$/"FA"PL[%=.B2VLI!-;QH2HCD'.\8/WLD_-UY/K4W_".Z3]HOYVL
M8WDU! EV9"6$Z@8 8$X( X'H*I:;XML=2US5]-1)HO[,95EEEA=%SMW,<D8
M (Y)YZCCFKEGXBTJ_O$M(+K]_)'YT221M'YJ?WDW ;UY'*Y'(]: *]AX.\/:
M9<VUS::5 D]JI2"0Y9HP<9"EB<#C\.U%AX.\.Z7JD^I6.D6UM>S[M\T2[3\W
M7']TGOC%:-_J=GID<3W<VSS9!%$H4LTCD$[5502QP"< = 35:'Q%I5QIZWL-
MWYD+3& !8V+^:"04V8W;A@Y7&1@T 3:7H]AHMN\&G6RV\+N9&16)&X\D\GJ3
MU]:2;1=/N-434Y+?-ZD9B2<.P94/51@\ U&OB#3'MHYTG=EDE:%$6!S(77.Y
M=FW=D8.>.,4O]OZ:;&&\6=GBG+"(1Q.[N5SN 0#<<8.>.,4 5QX1T);"&Q73
MT%I!-Y\4(=@J29SO SP<Y.?4DUI7EC:ZC8RV5[;QW%K*NR2*5=RL/<&LO_A,
M?#OV:RN/[6MO*O69+=BWWV&=PQU!&#G.,8J!O'OAA+.6Z;54$<,ACE!B??&1
MC.Y=NY0,CD@#D<T 3V7@[P]IVEOIMGI<,%I(ZR/'&2-S#D$G.3C QD\8JZVB
MZ<VLKK!ME_M!8O)%QN.[R^NWKTSSCUYKE]2\5+H_Q!BCO=6V:++H[W*Q; P,
M@E105VKN;*D\<]S3_$GB4SZ-X?U7P_JJM:7FKVEN[PA666)Y0K*<@D'J.,$<
MT ;&G>#O#NDZA<7^GZ1;6MU<!@\L*[3SUVX^[GVQ5JST#2M/TR73+:QB2QEW
M;[<Y9&W?>^4Y'.3GUS3-2\1Z3I#.+Z[$0CV^:_ELR1;ON^8P!"9_VB*LZIJ=
MOI&DW.I7/F-;V\1E?RD+L5 SP!UH HZ9X1T#1K&YLM.TR&VM[D;9ECR"X]"<
MYQR>,XY/K3U\+Z/'%:1Q6AB6TC:*W,4KH8D;&54J00IP..G KEKOQC+-=^"]
M2BNY;/3]29_MD$L6U3_H[2#EE#'!Q@J<&NKLO$FD:AI<NI6U\CVL4ABD8JRE
M) 0-A4@,&R0,8R<CUH <?#NDF>PF%E&LFGJ4M"A*B!2,$* <#(X/J.*@;PEH
M36%Q8MIZ-:W,WGSPEV*R29SN89Y.<'/J >U6]-UK3]6DN8[.<M-;,$GA>-HY
M(B1D;D8!AD<@XY[5A7FNWFI>-W\+Z7,+5;2U6ZO[L('==QPD:!@5#'[Q)!&.
MV>@!CZOX.EO_ !)>75_X8T[6(I=BVMT;UH)(HU4#8_RDM\VX[LDG/L*['0])
M&E:%#ISGS$3?\C.T@568G8"W)50=HSV Z=*A@MM8L]:A\S43=Z4;>3S/.C19
M$ERFT[E"@KC?QCKW/:2U\2:1>7D%K#> RW"E[?<C*LZCJ8V( <8Y^4GCGI0!
M6MO!/AJS:V:WT:UC:U=G@95YC)Z[3U'MZ=JD_P"$1T+[ +#^ST^R";[0(=[;
M?,SG?C/7/.?7FN1GUW6X_"OQ N%U67[3I-U.+.;RH\HJP(X7&W!&2><9KK?^
M$CT_3]/M#J%T?/:S%S(J1-(P0 ;G8(#A<GJ<"@"".RU74M?235+*TAT_39VE
MLF28RR3,5**[ J-N%9^,G)(].=^:%+B%X9 2C@JP#$9'U'-8%[XRTZUUG1M.
M033_ -J1O-%-#"[IY87(8%00<DKTZ Y..,W;CQ)I%K>QVL]X$DDF%NKE&\OS
M3TC\S&T-_LDYH 0>&=&&A'1!8I_99&/LNYMF/3&>GMTKE_$?A*2_UV*:;PY8
M:SIT=JD%LLETT,UN026R2#O!RO?C;TY.>@_X33PX=0%@-6@-S]H^S;!DXDV[
MMI.,#COTJQ8^)-(U2YCM;.]W330F:',;*)8P0"\98 ..1R,CD>M &;H_@S3[
M:QACN[11Y-R;FV@6YDD2T;:!A&8@]B<X'+''%:3>&=&?^T0]A&XU(8O Y+"?
MC W9/.!P/2LWP)J-]J6E:BVH737,L&J7=LLC*JG9'(5484 =!Z5I7GB;1["Z
MDM[F]"/$Z1RML8I$SXV*[@;4)R,;B.H]10!6'A+3(M<TS4K>TA@?3HFBA:,'
M<58,-I[;?F+=R3@Y&.:/BK0[K6/$GAJX2S,UGI]Q++<,)0C#=&R+MY!R&(/&
M.G'-:-]XQ\/Z;<W=M=:G$L]HJO/$JL[(#G!PH)['..F.:N2ZYIL=I:7/VH21
M7@!MO)4R-,"N[**H);CG@=*  :'IG]FSZ<UE%):7!)GCE&_S2>I<G)8].3SP
M*=8:18Z86:U@VNZA&D=V=RHZ+N8DX&3@9P,FL#P!K-UK5GK4MS>O>)!J\]O!
M(\80B)0NT$ #D9/;-7[SQIX=L)+V.XU2(/8E1<JBLYBR">0H/&!R>W?% &A+
MHVG307\$EE"T6H$F[4KQ,2H3+?\  5 _"EU71].US3GT_4[.&[M'QNBE7(XZ
M'V/N*J6_BK0[O5(=-M]1BENIT,D*KDK( ,G:V-K$#D@'(IT/B;1Y[Z*SCO0T
MLTCQ1'8P21TSO57QM8C!R <\'T- $2^#_#Z:3%I2:7"MC%()5@7(7>#D,>>6
M]SS6TJA5"C. ,<G)_.N-\-^(I(HO$,FM:A)-'::V]E YB!8+MCV)A%Y.6].2
M:W]1\1:7I49>]N&C58Q+(1"[>4AZ,^ =@X/+8'!]#0 EMX;T>SNOM%O8QQN)
M&F503L60YRZIG:K')R0 >3ZU-8Z-I^FW5U=6EN(IKMM\[AF)D;U.3R?>K0N8
M#:BY$R& IY@E##:5QG.?3%<BGC&PTC0-$E.HW.M#4;O[-#>K;']YEVR3L7'R
M@$  9;;WY- '27>C:??:A:W]S;B2ZM,_9Y=S Q9Z[<'C(X/J.*J:MX0\/:[?
MPWVJ:1:W5U",)+(F3CK@_P!X>QR*TKF^M;.PDOKJ98+6./S'DE^4*N,Y.>E9
MZ^*-(:*]D-RZ?8462Y22"1'B0@D,4*AMN ><8X/I0!8;0].;5)-3^SD7LD7D
M-.LC!C'_ '>#TSSCUYZU57PEH2V%M8KIZ+:VLOGP0AV"Q29R&49X(.2#V)/K
M5F/7-.FM;"ZCG9X;\@6KK$Y\S(+#'' (!.3V&:BM_$VCW5]#9PWH:6=I$A.Q
M@DK)G>$<C:Q&#D GH?2@"*Y\'^'KO7(]:N-(M9-23!%PR?,2.A/8D<8)Y&!2
MW_A'0-4OI;V]TN"6YFB\F60Y!D3&,-@_-CMGIVK#UC673PGXPO\ 2/$3W%Q8
MB5T*Q(1:.D0;RQE<,.^3G[W6MF/Q'8V.EV+:C=-]HDLEN75(FD;8%&YRJ D+
MD]3Q0!3OM&O)GA\/6NEZ?!X9$<?F2"3YL*V3$(MN,' &<]"3UKJ3P.F?:N(U
MSQ2NF^+O#<W]KJNAW]G<S. JLDFU8S&RD#<<[^@//'%)XK\5I<_#^77O#.K@
MA+B%!+$JG.Z9$96##*G#'T(XH ?X7\)^3/K<NL:=@W>K2WL2F;<CHQ!3>@;:
M6!&>0<<8-=-'HVGQ:Q)JR6X%_(@C>?<V60=%/.,#TIFIZ_IFCAS?7!C$:>9(
M5B=_*3IN?:#M7@\G X/H:M2WMO%I[7V\R6XC\T-"IDW+C.5"Y+<>G6@"D?#>
MCF^DO/L,8FED660 D))(.CLF=K,,##$9X%7KFRMKPP&Y@24P2B:+>,['&<,/
M<9-8NB^,-.U?PW;:TQDMX;@@(DD3!F+'Y548^<D?W<UJ:=J]CJRS&RG$A@?R
MYD*E'C;KAE8 J<<\B@!+S1["_O;6\NK<27%HQ:WD+$&,G@D8/!(X/MQ6?>>"
MO#=_<W5Q=:/;227>/M&00)2.A90<$^^,UF>(M3U2U\>^%M+M=0>&SU/[5]H0
M11L?W489=I*DC)//7\*ZZ66.WA>::18XHU+.[G 4#DDGL* ,74_!GAO6)K67
M4-%LYWM5"0EH\;5'\/'5?8\58U'PUHVJW=O=7NGPRW%LI6*3!5E4]5R,97V/
M%1KXKT0O=(]\(7M8?M$JW$;Q,(NF\!P"5SQD9&:;8>+] U.]MK.SU*.6>ZA\
M^!0K 2)@$[21@D @D9R.XH O:5I&G:)9+9:99PVELI+".)<#)ZGW-5XO#6C0
MWC745A&DCS>>R@G89?\ GILSMW_[6,^]<WX^\5C3M!F;2=2DAO8KR" M'!O0
MEI45XRY4J&VDG ((Q72ZEXCTG1RXOKORA&%,K^6S+$&. 9& (0'U8B@"BUGJ
MVJ^($_M*RLXM+T^X^T6KI,9))WV%5+*5 3;N8]2<@>G/15@W_C3PYIEU):W>
MK01SQA"Z#+%0YPO0'J:U+_4;33+=9[R81(SK&G!)=V.%50.6)/8#- &:O@[P
M\D"0)I4$<27'VE4CRH67.0XP>""21Z9.,9J=_#>DR3WTSVF9;^,173&1LS(.
M K<\C!(QZ$CO6=J_CC2=,\-W>LQ-+<I;3?9FC2%]R39 ".",IR1G('4>HST$
M5S%-:BX4LL1&[,B%"![A@"/QH SO^$8T<);HEH8Q;P_9XC',Z%(O[F00=O3C
MIP/2K[6%J=/^P"%4M/+\H11_(H3&-HQC QQ5*P\2:1J=U';6EWOEEA\^(-&R
M"6/(&]"P =>1RN1R/6I-4U_2=%>!-2OX;5IR1$)&QNP"3^@/- $]MIUK9Z<F
MGVT9BM43RTC5V^5>F <Y ';'2N2U[P5!'HEIINB:)I\^FQW7GW.FS2-&LHVG
M&QL$(P8AN@SC&>N9M;\6VFI> =?U7PUJP^T:?;2MYB(-T<B*6PR.O'3N/I6H
MOB.PL-,LCJ%TWVA[-;EU2)I&" #<Y" D+D]3Q0!BZ%X'L8OM)FT6+3;.Y@:"
M:PCO9)EG!(.7'"C&" !G(8Y]*Z2[\.Z1?Z(-&O+"*XTY5"K!+E@H'3&>1CMZ
M4^76].BMK6X^TB6.Z7?;^0C2M,N,Y54!+#!!R!WJ./Q%I,^FV^H07BSVUSD0
M&!&D:0C.0JJ"Q(P<C&1@YZ4 1IX5T&/0'T)=*M?[+?[UL4RK'KDYY)SCGKQ4
M47@WP[#HIT:+2H$TXN)&@7(5V&,%N<L1@=<]!Z"M+3-4LM8L4O=/N4N+=R0'
M7L0<$$'D$'@@\BLG2/&&G:M=:S&!+!%I<[1233Q/&F%169BS  8+'@G.!GI0
M!H?V%IW]I?VCY#?;?)^S^?YK[_+_ +N<],\_7GK5.7P;X=GT3^QIM)MY-.\P
MRBW;)57))++SE3DGD8ZGUJW9:_INH7ILX+@_:A&)A#+$\3-'G&]0P&Y<]QD5
MA^,-:N-$UOPS)_:'V:PN+UXKM&5=K((789)&1RHZ'F@#5'A30Q8V5DNG1);6
M4@FMHT)41R?WQ@_>Y/S=>3ZU*?#FD--J$KV*.^HIY=X7);SUQ@!@3@@ D#T'
M2H].\4Z'JVG7&H66HPR6UNQ29CE3&P[,K $'V(YJQIVMZ?JEQ<V]I.3<6Q43
M021M')'D9!*. <'L<8- $]A86FF645G90)!;Q#"1H.!5.U\-Z/97/VBVL8XW
M$C3*H)V)(V<NJ9VJQR<D 'D^M2ZCJUG8$03W$B3RHS(D,32R!1U?:JL<#(Y(
MQDCUKG? WB5KSP%IVJ:M?-<W%S-.BR+'EYMLT@4*B#GY5Z =!F@#H['1M/TR
MYNKFSMQ%-=/OG<,Q,C>IR>3[T:CHVGZLT#WMLLDMNQ:&4,4DB)X.UU(9<]\'
MFH(/$ND7-C'>6]X)HI)6@18XV:0R+G<FP#<& !)&,@ YJI?:YIUR-'DAUPV8
MN+T)&@C^:Z*EE:$AAE>0<G@C;0!/?Q:CI.GV\'AK2[*4F;$B3SF%44Y)?(4E
MCNY/<Y/>KFC:9'H^D6UA&0?*7YV"[=[DDLV.V6)/XU7O_$NCZ6\ZWEZL0M]O
MGOM8I#N^[O8#"9XZD=1ZU!-XR\/03>2^JPF8P?:!'&"[-'D#("@D\GH.: +\
M^C6%QJL&IRVX:]@4I%-N.44]0.>A[^M9T'@CPQ;&$PZ)9H8)C/%B/[C\\CT'
M)XZ<]*LKXET>33[*^BO5F@OO^/4PHTC3<$D*J@L< '/'&#FL_4_'.DV.FZ9?
M0/)=PZC>):0M#$[ ,7VMNP,@C#?*>21C% &_]BMOMYOO(3[48O)\W'S;,YVY
M],\U4N-$L)- ET9+*W^PO$8OL[ B/:>H..:CO_$VD:9'YEY=-$BHLDC&%R(E
M;H9"!^[!_P!K'0^E.U+6K"T0PR7K1RR0F56@C,K(G_/0@*V%]R,4 3Z1IL6C
MZ/9Z;"2T5K"L2D^@&/P^E7:YGX>ZI>:UX!T?4M0G,]W<0EY9-H&X[CV& *Z:
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N,^(D$AA\-WP!\BQUVUFN#V5"2FX^P+BNSJ&ZAM[FUD
MM[I(Y()5\MTD&58'C!^N<4 </\0K?[7KOA,/IMS>VMOJ#370CLGG1(_+9<MM
M4CJ1Q6WH[Z7!K$D&C:-/:K/'YES*;![:+Y>%'S*H9SN[=EY[9WK: 6UND(DD
MD"# :1MS8[9/?ZGGUR:=+&98F02/&6&-R8R/IF@#C_!-O(WB#QEJ(!%O<ZKY
M<7HQBC5'(_X$"/JII=%BE7XF>*IWM+F.*XM[-(;A[=PCE!)O"N1@X++WKK+2
MT@L;6.UMHQ'#&,*H_P \GOGO4U 'E7A.U7['I?A[6_#FKRZOI=PA$TS3&TRC
M<7".6V?=Y ZY)&*RM2O+O3_A5K'AS4M-U"/4;6Z+27#6[>3,KW8<2B7[ISN'
M&<Y[5[563XDT"#Q/HDVDW-S<6\$Q4NUN5#':P8#+*1U [4 <I?M<:9XY\2O)
MI]],FJ:7 EJ]O;-(C/&)0RE@-JGY@?F(K-TJWO([+X8+)INH(U@A6Z#6DG[C
M_1FC^?CY?F('->HHI2-59RY P6;&3[\<4H92Q4,"PZC/(H \ZTK2[V_\/_$"
MPAMKFUN]1OKLVKSP/$'5X55&#,!D9!J;PI+:ZO>Z7+<>&M8M=6TZ-EEEU#SO
M+MB4VL(V=BK[C@?+VY.,"O0** .$^*%N][INB6Z6%S>HFLVL\\<-J\X$*L2Y
M8*IXQV[UGWFDK+X[T"\\(Z3<:=Y<I.JW(LWM(9+?'W&5E7S&)Z8!Q[5Z702!
MC)Z]* /*TL;^/P)XG\)7NGW4VJ7$]V+9Q S1W/G.6CE\S&T8+#.2-NWGM6SH
MEG<6?Q)G\^"ZD1-#MK7[8UN_ER2([EP'(QGE3UKNZ 0>AS0!YII^D:AJ7@WQ
MWIMM;W-I>7^H7SVYG@>'S5D VD%@,@],]JL21S^)8_!BV]A=V=WIMY'<WGG6
M[Q?9T2)E>/<0 =S%0,$Y'/2O0Z* /,]4\(:EJ&I^)/#T(>#1]1VZI%<J<".Y
M((V#_MJB2\>A'>IKZP\0:Q\-)]0EL777KEK:[DL@Q1B(71O*!ZC(1FQV+D5Z
M-10!YG=&QUKP]K^HZ?X=UN*^DT:>S,M_%,9F+*=L**Q)8;B22. >_)QV_AA=
MGA724,,D+)9Q(T<D9C9"$ (*D C!%:M% 'EVLZ/JM_-\1=)M+2Z2XU1(I+28
MQ$12J($4KYGW<DJ5QG//IDUJ3K+XHU7PA=6ME=V<NG3M<79GMWB\A?**M%E@
M 26(&!G@9Z8KO:* .5\9W-Q;7.AM'8336YO#Y]W;VAN)K0>6P#(H5B"Q.TM@
MX!/J*X_3],\W1M1L=0LM?L6/B2>XMKR&)S+;[E8I-D!MR_PD\CY^37K5% 'F
M L]2U'2+*/6Y]1MM0M[VX-EK>GV;(Q  "R2Q!2 '!8$$ ':/7-5WDUZSD\/:
M[KFEWUU"D-W9W@TN.2.5"\JLDYB0A@'" L.V>1GBO5Z* /-+VPAC;PM+IF@W
M]K;'73>R(T$CNJF)U,L@Y*$L1P3GD$X.0%N+>X:Z^)I&GWI%];HML19R?OR+
M41D)\OS?-QQ_*O2J* /-M)6;3?$7AG4KRQODM5\."R9Q:2,8YPT9V,H4LIPI
MZ@ U0N-$O;#P_;NNGW6+OQ;'JB6T-NSM;V_G*V650=ORKN([;L=:]8HH \PG
MC%GXB\0Z9KN@ZUJ-KJMS]HM9+,2M#,C1HABD"L%4@IC+8&.IP*[?5K&63P9?
M:?;P 2MI\D,<*-D!O+("@GKZ5L44 >86OVBX3X;DZ7J2"P^6Y\RRD'E$6ICR
MWR\#><9/UZ<U2O;'5C#XBNK32]0E$'B6+4?LZQR0O=0+&BMY1XR<@D8/5?I7
MKE% '+>%/[.O;R[U:PT?4;-IXTCEN-1$B2S%<X7;(2<+Z].>,\UEW-I=>%_B
M7>>(C:7-UI.KVL<-S);1-*]M-'PI**"Q0KW .#UKO:* .:UN2X\3>&=6T_2$
MGC:YLIHDN)HWA =E(4 , 3UY/0>N:YPP7/B+2_!=I%87=G?:7>V\]V)K=XQ;
MK$C!UW$8(8X4;2<@YZ UZ.&4L5# E>H!Z4M 'EEQ;7C^%OB5 NG7YEOKF<VJ
M?9),SAH$12GR\C<I'%6M1EO);V&S_LC4$BFT$1QW-M9-YDTO(,$DA&8E'!P2
MN2>O8^DT4 >6:/'>VJ_#:[ETK4@EEI\UI<+]E??%(8HU&Y<94$HPW-@<9SCF
MFZ3:JGVGPSKWAW6+R\2_EF@ES,;.=6F:1)2P;8N-V2.N1P"3BO5:* .$T%+F
M'5/'<RZ7/))/<^;;)/;M&ER! J@!F !!8$?C6)HANY?$O@R_;2]61(["XM[A
M6L'ABM'*Q8C5,#:B[2 3U 'S,17JU% '(?#R*>'3-72XM;FW9]8O)D6>!XRR
M/*65AN R"#7)>,EU'4+/Q;9+HNHI.+J"2".SLF\NZC4Q$S-(!^\; (VYX"CY
M3C(]<HH X*$R-X]\17SZ??+;SZ/;QQNUG)AF!D+*#MY/S+P/Z5S_ (;74O#\
MG@S4K_3-1:QAT5M-G1+21Y+2<LC;FC W8(0+D ]*]=HH XWX?+,@\2&:RNK8
M3:W<7$7VB!H]\;;<,,CGH:SFAG'B#XA2&PO2EU9P) XM)")BL+J0AV_-R0.*
M]"W*6*AAN')&>10K*ZAE(92,@@Y!% 'F5I;W4=O\,5.GWRM8QA;H?9)/W!^R
MM&=_R_+\Y Y^O2LZ)]0NI/#%S+H6J6\UGK<C7-G!8LD%JK"8#;@ ."6!,F2,
MDY*YQ7K]% 'D%C'K&C>)=3\11Z=J-U9C6YA)8&RDW&*58U%S"-N2P*D'U7/3
MOIW\GV+QCK)U;1M;OM*UF.%K62R28KQ&(WAE12-N<9^88^8YKTRB@"CID$>G
MZ):0):_98H(%46Z$OY0"_<&,DXZ<>E>8:?9W]M\//!IDTS4 ^G:X)[J$6DGF
MQQ[YOFV8W$?.IX!ZUZX&5BP# E3@@'H:&=4 +,%!(&2<<GI0!S_C*:Y'@G4)
M;321J,YA4BREA\S=DC.4_B*C)V]R,5S_ (>CEE^(FHW,EIJLMG>Z3 JW5]:L
M@D*O)N!! "=0-N >^,<UZ#10!P_@K1]2TVXGTR^B86&B320Z9(QSYT<F&4_5
M$/EY]V':N8LGU"YNO"-W+H>J6TMIJ<WVJSAL6C@M-R2@!   P)()DY')R5SB
MO7@RL2%8$J<'!Z&EH \ON+:[?0/B9$NGWYDOI9C:K]DDS/NMT0;/E^;Y@1Q4
M]W+>/=V5H=(U!(I=!$:7-M9-YLLO0P.Y&8E& V#MR3UXP?2:* /*=$BNK.+X
M<WUWIFH10:?IT]K<EK1RT,C1Q*-R %@"589(QQZ$4W7-%O5\*>++JWT^[QJ^
MKV]Q:VD5N[2;$>'=(4 RI;8[<@'&,\G%>L44 >:ZDQT_QGK!U;1]:OM*UF*%
MK:2P69E&(]CQ2(A&,]?F&/F.:[K3K-;70+:SAM!:)';B-+8-N$0VX"9[XZ5?
MW+OV;ANQG&><4M 'D6C6VJ6?ASP%>/I>H"/096BU&U:V<2+NC:/S%3&7"%LY
M4'AN,X..OT&PEE\=Z]K\<<L5C=6]M GF1M&9G3<6?:P!P RJ"1SS7744 <%X
MN>6+XC>#KT65_-:V7VPW,MO92S+'OB"IG8IZGTJ?Q5=WGB?PWJVEZ)8WWG"V
M$@DN;:6V61PZD1*7"DE@K D<#(YYKM694&68 $@<GN>E+0!YS!-8ZU8WVI6_
MAO6X+^/39H'DU".<R(67_4H&)+Y//RC''O5>PMKJ*'X8*=.OE:QA*7?^AR#R
M#]E,?S_+\OS\<_7I7IU(S*BEF8*H&22< "@#QF0:E!\+)_"UWI&J2:U:7R-)
MY=G(Z7 ^UK)YJN!M8$$GKG.>*V+@"S\2Z_8ZWH6MZA9:Q*MQ:R6:RM%*K1(C
M12*K!4(V?Q8&.I %>GT4 <-H]H]M\3+AO[.G@MUT.VM8Y!"YB5D=RR"0C!P"
MO?FM'QQ<7-M8Z;)!I\ETG]H1>=+#:_:)+1,-^]1,'+ X&<'&[.#7444 >.W>
MG:C+X4\=VD6E:JTDVJ0WD(E@8O-&/()*_P!XX1C@<C&" >*]1NKJ2X\/7-U;
M6+SR-;NT5K<(4,IVG"LIY&[@8///(K1HH \KT(W<OBKPA?-IFJHBZ=<6\X>Q
M:"*UD(BQ&J8 1%VD GJ /F8BMWX@RQP:GX.EE1W1-;4D)&7/^IEY  )..O'I
M7;UCZUX>BUN\TRYEO+J!M.N/M,*P[,,^TK\VY22,,1QCK0!Q&M:3<7,7Q!U:
MSLKHPZGIB6EO&EN^^YE6-P6"8W8^=5!QS@]N:FO9;R2\M+0Z1J"0RZ"(TN;:
MR;S99>08)'(S$HP&P2N2>O8^DT4 >1Z#/J7AU?".KW>C:I+8)H0TNXCCM'::
MUE!1MQCQNVG;MSCL.V,Z6M+-I^HZ#KL7A_4(]&2.Z@GL]/5DGM_-9&64QQD'
MDH2P[;N>:])5U==R,&'3(.:6@##\*VMG!IDTMCID^GP75P]QY=QN$LC,!F1P
MQ)4D@\'GH3@DBN$U/2-8O-'\?:/:6%T+VYU%;ZW+1%8KB(+"=JN?E);8RX!^
MN*]7HH XB97\2^,?"VK6=M=V\>G)<2737%N\)421A!$=P&3NY(&<;?<9L>-8
M9AJOA:_6VGFMK+4C+<-#$TIC4PR*&*J"<;F'('%=<652H+ %C@ GJ>M+0!Y5
MKNA:I>7/B/Q#I=A<-'+<Z?-':#=#+>"V;=(0.&!.0%Z$[,CMGJ?"K:;J.HS:
MO9:+J=I*\ AEN=365)6P<A )"20.<GID\$\XZRB@#AII[K0OB?>7U[9WL^G:
MC80PVUQ;6SSB%XV<M&P0$KNWYSC%<CI=OJ>E>'O"VHSZ-J[VEA<7\5[:VZ21
MSHLTI9)%52"P  SCLU>ST4 >;W6DZ9=Z=;RVFGZWHAN+][N"_ACD:>.;R\&6
M5"&(5^5(;KQG&>(+G^W+G1?"1U.RFFN[?Q")99;:R==\*^:!.Z 'R]VY6(./
MO?EZ8LL;NR*ZLZ?>4')7ZT^@#R376@35O&&CRQ:M'I^J31BXEATN6Z ;RDWE
M'3(&5VC##((SR"!6_:30W/Q)L-4LX+J73/[ :*.Z%M(4W&56"[MOWMH/'7MU
MK8C\("VOKF>RUW5[2"YF:>6TBEC:,NQRQ!="RY.3\K#VQ6]:Q06T"VUN%5(0
M$"@Y*\=^^?K0!Y5H+W^FZ#X7MYM&U")%O+[S[E-.=[BUW2.4"@J2H<-@MC@<
M<9R(K2RU"W\(Z>KZ1JBG3_%?VJ:-K=WD\GSW;<H&2X 8$E<YSU/->OEE#!2P
M!;H">M+0!YA<G['XGUZUUO0=<O;#6FCGMFLQ*Z.IA2-H951@JD;?XN,$Y.*N
M:3]H\+^-]26]TJ\%AJ%E9I8O:P/<)#Y*%6@)4$KR203@').:]#HH Y'X7PW%
MK\.-&MKJUN+6>&$H\4\1C8'<3T/L:ZZBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N(^)J(-,T*
MX-OYTL.NV31A0-V?-&0I/0GIU%=O6!XNT2ZUS3+6.RDA6YM+ZWO468D(YB<-
MM) )&<8S@_2@#,C\:Z@+S5=,N?#LD.KV=I]MAM1=*XNH<X)1PO# \;2.I'/>
MM&P\3C4[+0+FSMHY1JR>:0)O]3&%W,WW><'"D<?,P%1QV/V37KCQ7KL]G9&.
MS6S11/F.*/?N9F=@O);:.@ P.N:H>!]%M[.]UB_L[GS]-DNI$TU1@I%&2'E"
M$?PF4L/H@H [&6*.>)HIHUDC889'&01[BN&^#L,2?#;3YE11++)/YDF/F?$S
M@9/4X  KN93((F,*(\F/E5V*@GW(!Q^5</X2T7Q;X5\(P:+'::)<2P&4I.U]
M*JDN[/ROD]MV.O..U &KK?B^/3+J\M+6*VN+FS@6::.:[$);=DA$^4[F(4G'
M Y'//%2+QU+?:E86.FZ'/-)?::=0A,\JPXPRJ4<$$K@MR>>1P#UJ&7P_XITO
MQ$VK:)=Z==?;K:&'4(;\N@,D8($J%0>H)RO^1=70=87QK8ZT\MI<10:9)9R,
MSLCO([JY8*%("Y3&,G@^W( VP\<1:CH^DW$-BRZAJ=Q+;163R@;9(BPE+.!]
MU=C'(!SQQDU@:'JT6@>)/'=]?VD5H1=V2>3%("K2/&JKAB%'S%@22!C)ST-.
MM? NOV%CHUU;3:?_ &MI&H75S&C2N89XKAF+HS;,J<,,'!Y'O4MWX(US59?$
ML]S<V5E/J4MI=6;V[M*;>:!5V[LJN1E>N/PH O3_ ! ^RIK0ETQ9I-,LC?AK
M.Y$L,T0SN D*KAACE<9Y!&:T;/Q!K=Y9I=)X8D$<LD'E9O8\M%(,O(1VV?W>
MIJE=Z7XOUOPIJVGZL^D175W926D26LDGE9==ID9F7/'90/7).>+>H3:]HGA3
M34L(=.DU"$Q0RPRR.5E4#!6(@ ES@8R,#DG@4 =/7)^%[M?$UUK>I72++!'?
M2V%K&XRJQ1X5C@]V?<2?0*.U=97(>$+*;09=>T<HID^WRWUH';:LD,I##G!^
MZQ93P<8'J* .*\"6V@7_ (#L;&_T66>ZN[J>V-X+)LH#-( WG[<#   YZ@"N
MYU&_.A^/-&@CXM-;6:&5.RSQJ'1Q[E=ZGUPOI3_ /A_4/#7A6'2-2^RO)#++
M(KV\C,K;Y&?^)1C&['?I4>L6#:SX^T QC,&CB:ZN&[!W39&GUP7;V 'J* .B
MU+4+;2=,NM1O'V6UK$TTK8SA5&3_ "KF[?QLTFL0Z<VG)(US;// ]I=+,-R#
M)CDX C;'3D@X/-;NO:1%KV@:AI$[LD=Y;O SKU7<,9'TZUBZ':^,X[9;?6Y]
M)E%M$4CDMFD#738P#)N7"#N=H.3Z 8(!3TOX@3:A#X>O)=#DMM/UM_)AG-RK
M,DI5F4% /ND(><]>V.:;I/C*^CM_$M_K4-M':Z?JC6<0AG).[$2H@W*!RSYW
M$CENF!FJUGX,UNU\->#],)T]I-#O$N)G$[XD55=<+^[ZG?GGTJ2X\#ZI<V/B
M?3_MMM!#J.H?VE97*;C+%,#&RAE(Q@-%V)R#VQ0!:E\?FV;5XY=-6:33[ Z@
MK6=T)8I8USN7>57:XQ]W'0@C-;7A[6;_ %JW-S<Z0UA;/%%+;2-.LAF#KD_*
M.5QQUZY^HK(FTWQAK'AC5+'5WT>.YN;*6TB2U>3RV9UVF1V9<C'90.YR>F.B
MT.UN+'0K"SNQ$)[>W2)_*<LI*J!D$@'MZ4 5]2UP6FK6>D6L*W&HW4<DRQO)
ML1(TP&9F )'+*!@')/L36!<_$-+;2KFX?29FO++48]/O+595_=N[*%8,?O*0
MP(.!GOBM#6] OI/%.E^(]*>!KJTBDM9[>=RBS0O@\, =K!@".,'IQ6-JG@C4
MKRQU*6%K(:CJ>J6U].'E81QI"4VHI"$L<1]2!RQ]* +MSXRU")?$5JVCQV^I
M:78B^A26YWQS1$/@DJO!!0Y7GZ]ZDTCQ/>-I'AVVN+>&?6-4M!,B"<A"BQJS
MR.VSY>6 P >2.V2&7GAC4[_Q'KE[(UI%:ZEHXTY=LK,Z,/,.XC:!C]YZ]JJ6
MWA/7;5?#&HJ^GG5-&MS9R0+*XAN("BJ?G*Y#94,/EQV]Z .BT#Q$FM3:C9RV
MYM=0TV?R+JW+[PI(W*RM@95E.0< ^PJ'Q'XE?0+O2K=-,FO'U&X-O'Y<BKM?
M8S <^NT^P]:?H.AR6&J:QJ]V8_MNJS1O(D3%DC2- B*"0"3@$DX'+>U8WCYI
MUUGP:;9(WF&L?*LC%5/[B7.2 <<>QH @G^),ECI.ORW^@S0:EHAC-Q9BX5@T
M<GW'63'(/TR*U_\ A*+U+VWT^XT8V]_>SR+90R72D21(@9I7*@[ ,[<8)R1V
MYK&U_P %:GK6G>)I5:SCU+6HX;=%:5O+@BBY&6"Y9B2Q/ '(';)U]<T#4;W5
MM"UZR-LFI:89%>WDD;RIHY% ==X7((P"#M[<B@"C??$--.TS5Y;C2I?MVD7,
M,%W:I*" )2HCD5B!N5MPQQG@\"ID\=_8]:O-.U_2I=*\JRDOX96F65984^_G
M;]UQW7GZ^O/>.M#GLO"7BG6K@PK?ZI<V&8T8LD:1S1*B[B 2<EB3@=<=LGH=
M5\(S>*+^6XU@0V\8TV>PACMY#(09L!Y"2J] H &/4GTH =:^-C/K-IIYT]'^
MVP/+;O:W0FVLHW>7+P!&Q'3D@D$9K U+XAZY=?#ZZ\1:9H M;9K,R174]VIV
MN9-F @7)(SD$X!Q],]%X>M/&=K!%;:S<:5-':1[(Y;9I ]V0,*9,KA/4XW9(
M[#KF0^"=4;X02>$)Y[-+X0&))D=FC)W[@3E01Z'@T ;C^([NT\4:;HM_IT4/
M]H12/%<1W)="Z<F, H#NP<]N,^E:6DZC)J<5Q,UNL44=Q)#$PDW>8$8J6Z#'
M(([]*Y;QBO\ :>BVFGRZA96OBF.X@N+*.VD#M%+OP&"MAF3;N!) & QQQBNQ
ML+*+3M/M[* $101K&F3DX QSZF@#+U'Q!+I_B?2](>R4QZBLODW)FP!(B[BA
M&T\D<CGL?3G/TSQG)JFE7-Q%I\0N[?4SIK6OVK)\P.%)W!>@!W=#\HS[5=\7
M:!/X@TJ&.RN5M=0M;J*ZM;AAD1NK<G'?*EACWJEIG@N/2O%\NJ6TVW3VMH@+
M4\_Z0BF/S<^OEG;[Y- ',6>M2^%+_P >7UIHWVFTM=16>X"3+%L3R(RQ48.Y
MNIQP/>NKU7QE!9S3P64=M<3V]LER\<]T(-RL"55/E.YB%/' Y'/-95WX0UJY
MTWQK:@Z>&U]R8&,[_NP8EC^;Y/\ 9SQGKCWI[>'O%.E:XFK:'+I;FZLX;>_M
M+R20('B!"R1NJYZ$@@@?X $C>/KBYN=/MM*\/75W-?Z<]] DLRP'Y2H*-G.T
M_-C)[^QS3M3^(,5A!=7$=E'<1V4P@NH4NA]H#<!_+C ._:3@\C.UL=LVAH.L
M?\)KI>LRRVD\-M82VL[%V1V:1E8LJ;2  4P 6Z'KQS3MM \5:-K>III%WIK:
M/J5TUV6N0_GVDC_?V #:X)Y )')_, [5&#HKJ<JPR#7*3>-7M=1L(;K2WM[>
M^U%M/A,LNV8L-P$GE%?]62IP0W0J<<UU:C:H&2<#&3WKSAO!?B=TM1)/I,L]
MKK8U'[7(\AEN8PSX5_E^4JKX !(P ,KCD OWOQ!NK6VUZY3P]+)!H=QY=VQN
MD4E JL648.3AL[?;KVK93Q*Q\7PZ')9B.*YLS=VUT9>)@" RA=OWAN!(ST.:
MP+OP?K=SH_C.R!T\/KTK/ WGOB,&-8_F^3_9SQGKCWIWBNSAU2TT;2H=3@MO
M$MI<0^4+68/)$K+ME.#@[3%O.2!T% '6Z+J,FK:?]L>W6%'D<1;9-XD0,0KY
MP.& R/8BN3U6Z?7_ (IV_A>=F_LJSTTZA<0 X6YD+A%5_5 .<=">N<5W%O!%
M:VT5O @2&) B(.BJ!@#\JYK7?#5[)XGLO%&B2VZ:I;P-:S0W)(BNH"=VPLH)
M4AN0<'W% %R3P[I5C?VNJVT45@MEYCR+"OEQNA0@[E&!D=0<9'([UG?\)P([
M'2=6N-.,6C:I*D4-UYV73S/]6TB;?E5N.0QQD9'7&M]FU+5K>6WU6&WM;:2)
MXY(;><RF0,I4Y8HN ,GH#DXY&,'F[7P=JTOAC2_"^IRV<FGZ?/"?M4;MYD\4
M+!HU*%<*?E4$[CP#CKP 4/L=L=4^*,!@C\IH869-HP2;7)./7//UK6\/ZQ<V
M'@WPM;6UAYV_1HIGN)I3#!$J11\-)M;#$MP,= 3VI_\ PC>KC4?&-P!8[-:B
M1+8>>^4*Q>7\_P G&>O&?3WJM:>%_$-HWAD;],G@TS3A9S6\TCE%E 4"=!M^
M9L*1@XP"<$9S0!')XWU#4T\&W>CV<*VVM3/YB7$Q5AMB=MF0K#&5SN]@,<Y%
MW5OB!;Z:MY/#:QW=O97'V>X2.Y N"00',<6T[PI/.2I^5L=!G,TWP3K^G:%X
M5@$^FR7FA7<CX+R".2-U=>NW.X;\XQCMGO5ZTT#Q7HNLZE%I5YICZ/J-R]V7
MN _GVLC\R;% VN,Y(!(QGGW +B>+KZZ\2W^CV/A^6X^PRVXFG-RB 12@G> >
MN ,[>IYZ<92T\:O+K&CV-WI;VG]K^=]G627$\?E@M^\B*C:&"DC!-3:5H>I6
M7B_Q!JDK6PM=22!82DK-(AB5ERP*@<[L]>,=ZY[3/!GB:VG\.3W4NDO/I5U-
M)<3AY&>[$D;(96)4?/\ ,/E.1_M#I0!I_#Z&*WNO%\4,:QQKK\V%48 _=1=J
MT/&E_9V&G6+7VE#4()=0MH@K, (G:10C\]<$@\4OA;1=0T>[UZ2]^S%-0U%[
MR+R9&8J&55VME1S\F>/6E\9:+?Z]I=I:V!M@\5];W3&>1E&(Y ^!A3R<8H 1
MO%)EUV]TNQM8KB:QGABN(S<;)@L@0^8J;3N0!\YR/NL.W/1UP_B'PA>^(-2^
MTR06$%U!<Q2V.J0RLMQ;QC:70@)\V2'P"V,-VQ7<4 ><>%=4M/#>F>(W\G_6
M>)Y[6VMXL+OD=D5%'8#)_  UOR^,X=,U*^L-=MUL9;6Q;4%DCE,L<L*\,5.U
M3N!ZKCN,9K$?P)JMQI.IQ27%G!?'73K=A(CM(BN&!59 5!QP0<9Z^W-_5?!L
M_BJZNKG6A!:M)I<NG11VTIEV>806D+%5R1M4 8]<]<  U(/$&H_;88[O0;F.
MWGM'N8YH'\[:5P?+D&T!7(/ !8$@C/%5+#QC/=ZQ9Z5<:8MM=WNGM>P1-<Y9
M,;?W<R[ 8V^<?WNA].8],TWQF^C2:?JNH:=!)%:O!!=V6]GE?8561PP 7'WB
M!G)[@#!S]%\):_9ZSX=OK@:1$-/M)K:Z6!Y':4OLS+DJ-S,4YSTSG+4 /\.>
M-KN3P?8ZIK,=JEQ?WDL%L%N-JLWF2\,2HVJJH>?F)"],G%6X/']N8;];BR*W
MEM=PVD4<$OF1W3R_ZORY, $'G/ VX.>E9,/@;Q!;>%K&QMK[3XM1T?4'O-.F
M^=DE#-(2LHP"H*RE2%SC&<\\:&L>'/$GB+0X9+VZT^UUBTO(;VRC@WO;H\1)
M =B QW;B#@<<8!P<@$&EBX_X7-?M=6,%K,VAQ$F&7S%D_?-\V=JG/;D=JZ_6
M=1DTO2Y+N&RGO959$2"!<LQ9@H^@&<D]@":P=-T?7F\<GQ#J,>G01/IBV;P6
M\[RLK"1GR"47(Y]/\:T/%^EZEK'AZ2STJXBAN3+&Y$S,J2HK@M&Q4$A6 (.!
MWH RI_'OV:R\322:<LMQH"+)-';W(=)%9"P(<@8(PP(QP1WJS9^,)9-=M=.U
M#2VL8KRR>\MIVN%?<J;=X8 ?*0'!ZGCTZ5AW7@O7[B/Q8B?V1"FN6$5M'%&\
M@6!EC9,?<Y4!LYP,XZ"M*[\+:E?ZSHEQ<"S6UM-.GLKE4G8NWFJBDI\F.-G?
M'7VH Q/%.JR:_:>#]4CTR-;"?7K1[6Y:7,NPOPQ3;\H8#/#$],CT]-;<$)0
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M8->0$,%CD3: 3RA)).-O'7A-*\(7UOXELM?EM["ROT@D34&L9FV:@Y7"EUV
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MFN?MR0^>T,=E-(1'G&_Y4(VYXSTI9?%VB1Z=8:@EZ)[2_N$MK>:!&D5I';:
M2!A>>.<=#7,WLEW'\;PUE;PSR_\ "-'Y)9C&/^/GU"M[=JQ[OPQ<>%O"&G6]
MY/%+=7GBJUO9A!GRXVDG7Y$SSM&!V'>@#UFHKB>.UMI+B7=Y<:EFV(7.!Z
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M3*RRHOW=Z.48CV)4D?6M^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "HYX(KFWD@F0/%*A1T/1E(P
M14E4-6UBQT2U2YOYUB229($R1EW=@J@>O)_($]J ,VW\%:+;6N@VZ0,5T-M]
MH6;)R5*DL>^2=W^\ :MW/A^"Z\26>N/<W*W-I$\,<:E?+VOC=D;<\[1W[50B
M\23#QO?:/<_9(["#3HKV.<.<G>[)\Q/ 'R_KUKH99X8(3-++''$!DN[ */QH
M Y=_A_IKZ5<Z8M_J26<]Y]L\I95(C?S/-PN5.!OYYR>V<<5>F\)6%UK%YJ-W
M+<7+7ED+">"79Y;PY)Q@*#G+-SGO6ZCK(BNC!E89# Y!%1R75O$2))XD(8+A
MG Y/0?4T 8NG>$[6P.GB2\O+V/30191W3(P@^7:""%!8A25!8DX)[\UG7'PZ
MTVY@O+8ZAJB6=S>"^^S),H2*;S!(2ORYP6'0D@9.,5U<]U;VVSSYXHMYPOF.
M%W'T&>M.>:*+_62(G!/S,!P.IH RK?PW:VWB2XUR*XNUGN(HXYXO,_=R; 0K
M$8SD!B.N/;/-8^M)/X@\2:+;P65Y"-)U3[3/-/ 4C=!"X!1^C99U&!SUXXKJ
MA=VQ$1%Q$1-_JOG'S_[OK^%++<P0/&DT\<;2':@=P"Q]!GK0!S&I> -.U.36
M=]]J,-MJXS=VL,JK&S[0N\?+D' '&<''(J>7P7:'5K?5;74-1LKV.W6UEE@D
M7-S&.@D#*02.Q&",]:Z6HEN8'G>!)XVF09:,."R_4=J .8M_ &G6ND:3ID5]
MJ(@TN[^V6Y,B,WF98\DJ<CYFX]Z?+X$TY]=NM3AO-1MDO6#WEE!<;8+E@,9=
M<9R1P<$9[]Z;>^(M1O-:U32?#_V!KO38H9&6[+8G:3<=BE3\N%3KAN6Z<5-X
MS\17OAK2[2\M;:WG::[AM6CE<K@R-M!! ['VH DOO!NGZCJ&J7=U/=2?VG9?
M8;B+<H3RANP!A<@C<QSGO4-CX)M+'4[+4O[4U6>[M+5K1))IU.^,D$!@% X*
M@\ 9[YKI8]XC7S"I?'S%1@9IBW,#7#6ZSQF=1EHPXW >I'6@#/\ #V@V_AO2
MAIUI/<2P+(\BF<J6!=BS<@#NQ/XURFE:/<:AXS\:&675;*TO9(%4K#Y:3H(%
M1MK.G!R",J0>_H1W9NK<.J&>+>S%57>,DCJ![U2UW4_[*TBZN8WM_M*0N\,<
M[[1(RC./4_A0!4C\*V,&MV&J6TL\#6-H;*"WC*")83CY<%<_PKW[5%-X.LGO
M-3F@N[RUBU3_ (_K:!U$<QQM+<J2K%>"5(S]>:MZ'K2W_A32M8OG@MVO+.&>
M3YMJ*SH&(&3TR:TWGAC4,\J*&!(+,!D 9/Z<T <[J?@?3K[4;34+2ZOM*N[:
M 6JR:=*(]\(Z1L"""H[<9%)JO@73=2ET^X@N]0TV]L8S%%=V4^V4QGDJY8-O
M!//.3GGN:Z9'61%=&#*PR&!R"*CCN8)97BCGC>2/[Z*X)7ZCM0!D#PU'"8#:
M:E?VQBA:%MKI)YH9MQ9]ZMELY.?<^M5U\%V,-D+&SO+VULOL"Z>UM&R,C1+N
MZ[E)W?.V2",UOBY@,HB$T9D)(";ADD=>/;(JO?R7R2V7V-K18VN MQ]H+ F/
M!XCQ_'G'7C&: ,R'09;3Q+975G=7D.G6UB+4V9FS;D#[FU.NX=V)Z #G)P_Q
M-HLFIII]Y:@&^TR[6[@!.-^ 5=,]MR,PSZXJ[9:WI^H7U]9VMRDDUBXCG"L/
ME8@-C\ 1GTJW!<P7*[K>>.5?6-PP_2@#*U3P_8>(&L;Z47%K?6I+VUU"?+FA
M)&&'(((/0J00?2F+X8ADURQUB^O[R^N[!9%M?-\M5C\P!7.$5<D@ <Y]L5LR
M3PPY\V5$PI<[F ^4=3].109XA!YYE3R=N[S-PVX]<^E &)INDO+XIOO$=RA2
M26W2RM8VX985)8L1V+,V<=@JYP<@6-0\/P:CKVF:O)=7,<^G>9Y*1E-AWC#;
M@5).0 .M:2W,#V_VA9HS!C=Y@8;<>N>E)]JM\RC[1%F(9D&\?(/?TH Y[4/
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M(GZDU%<:M)IE_80:B(A%?/Y$<T>0%FP2$(/9@#@^HQW%:S,J*68@*!DDG@4
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M'/RYSNYX(]!@<5KK<P-<-;K/&9U&6C#C<!ZD=:!<P-((Q-&9#G"AAGCKQ[4
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MK['#;3Z''2@#G=!\#6'AZ=?LM]J4EG"S-;6,]QO@MR<_<7&>YQN)QGCFEMO
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7$_%%+?_A&K*>Y6+RH=5LF=Y ,(GGIN))Z#'6NVILD:31M'*BNC<%6
M&0?PH \[-IHFK_%*]BGAL[JR'AZ HC!6CQYTO('3H1@^AXZUS.@:Q#:Z)X!D
MUK46M=(DTR:%;I@C1I<AE"ARZLJ_(' )QW&>M>RM96K.7:VA+$8+&,9-(UC:
M/;M;M:P- QR8S&"I/TZ4 8G@JPTO3M!:#1KR>\TXW$DD,LK*4.XY(C*@#RP2
M<8&.N.,5Y]JNEZ/-:_%9Y+6T=[<;X254^4_V53N7^ZQ<=1R2*]C5510JJ%51
M@ #  J V-F=V;6#YOO?NQS]: /*M=U33KR'4H))K=+YO"\>^6\??YZLKD+"F
M1EL_>;GG:,'J)=-32]7\3> Y)A:W9FT"43%L/YI58<!O[V#NX/0@]Q7J0L[8
M,C"WA!12JD(/E!Z@>@I/L5H"I^RPY0 *?+'R@= * /%+FRTJW^&GB2[AAMEF
ML/$,J6<P W6ZK>+M6,_PC!/ P.3ZUN:K<:)?>)/%>B^+-8.G_:?+-KYGE*);
M8Q*!Y3.A.X.'.%/WCD#->G?8+/:5^R0;2<D>6,9_*E>SM9&A9[:%FA_U19 2
MG^[Z?A0!GS)>0^#Y$TYKB2]2P(MC<X\UI!'\N_MNSC/O7G<7V>^\$^!KG1RH
MUN*]MD8K_KM_2Z$G?&-Y?/ID]J];J%+2VBN'N([>))Y/OR*@#-]3U- '%>'(
M+#_A:GC'RXK;SHX[(KM5=RDQR;B/3.>:;\6IX8/#.G--*D:C6+,Y=@!@2 G]
M 37;I:6T<OFI;Q+)R=X0 \^]+-;07!!F@CD(Z;T!Q^= &9<>(M-9H[2QU"UN
M+^XW+;PQ2J[$A2<D \  9)_J17G?A)O#VN67AMKG6;K_ (2*PE'G6*^4MQY^
M"LPD79O,9^8L2>1WS7JT5G:POOBMH8V_O(@!H6TMEGDG6WB$T@P\@0;F'H3U
M- 'BCV6E6_P\U3488;5+JU\3D6\Z@;H@+Y0 A_A&TG@<8)K>N-0T^74/B#9>
M()+9;TQXM4N2!OM?)^3R\]1OW$X_B/K7I?\ 9]EMV_9+?;G./+&/Y4LEE:2L
MC26L+M&I5"T8)4'@@>@H \BTG6-.A'A&/6=42STF?PU#%;7#^48?M  $J,75
ME5MNWKCH1[58_L+P]%K7P_TZ%S?Z<?M\<3WQ5FFB\LE1P!NCR?E&,8Q7JTUG
M;7$"P36\,D*XQ&Z J,=.#2O:V\CJ[P1,ZX"LR D8]* ,?7[:XT_P-J-KX?A$
M5Q!82)910C&Q@A"!1Z],5Q1%E>Z9\/;SP_Y0O1=0H_E8W_9_+/VA7[X&.<_Q
M8[FO4JABL[:&626*VACDE_UCJ@!?ZGO0!P/PZT?1I+K7;Z.RM&N[37KU()54
M%H5)QM4_P@@G@<<U=\?+;KK7@N9Q&)AKB*KG&[:8I<@'TSM_2NRAMH+?/DP1
MQ[NNQ ,_E1+;03D&:".0KT+H#C\Z /+EATC[=\0]/N;V#39IKJ,"8*N^*-H8
MAOVG^#<>>QYKH_!EU?G7-8L-6LK)=1@BMVDOK#(AND._82I^ZX .1Z8[8KKV
MMX79V:&,LX 8E02P'0'UI+>UM[2/R[:"*%,YVQH%&?7 H X74]/TN\^,MG'>
M6UM-YFA3%TE4$.1-'MW _>P,XSZ>U<MH%XMMI/@I9F7^P(]7OX9\G,:/OE%L
M&[;03QG@';[5[$]I;22&1[>)I#P69 3^=(+*U$+PBVA\I_OIY8VM]1WH \?\
M86<4>E_$CR5B.C^1;R1K@>6MYCYRG8-C83CN:Z"YTC1!\4]'A6SLS%<Z/<--
M'M4K.1)&5+C^,\L03GGFO0!9VHMUMQ;0B!?NQ[!M'T'2C[#:;@WV6#(& ?+'
M H \;Q9+\.[=1Y CL_%OEVW3$2?;>B^@VGMVK:N=+T:\\:^/EN[2TE"Z9;2%
M9%4@,8YLMC^]TYZ\^]>D?V?9;=OV2WQG./+'^%+]AM"6/V6#+<$^6.: /)=,
MUBUA7P:=?U,VFF7/AV-(+J7RS$;C"^8K-(K*&*8Y..A'>I@^C^&[OPQ;-J]V
MGA9H+J.TOKGRFC$Q=2N69-H39O"' XS@X->J/8V<MO\ 9Y+6!X<Y\MHP5SZX
MZ4^:V@N(#!/#'+$>L;H&7\C0!Q.CVO@W2M%TV![]+JQ;5#+I<MXZ%3.22/(*
M@#:"6 P,=<=JV_'%U:67@?69[Z&>:U6U<2QP.4=E/& PZ=>3V&:TK_2K;488
M()T7R(9%D"!!U4Y 'H/IVXZ9JZRJZE6 92,$$9!% 'DD=UITWC#6H'O-+G@N
M?#*_):X\EBC2<#D[RJ_Q>G85'HEKI]E;_"J]MXX(KN>/RYIEP'D!M&RK'J1D
M*,'I@"O6196H4*+:$*%V >6,!>N/I[4GV&S&W_1(/E^[^[''TH \4O\ 4M-N
M_A%J8U:6V7Q%#JF^]28@3),+H<X/.!'@#'&T8Z"O5?&)EN? 6NFP;?+)IL_D
MM&<[B8SC!'Z5K/8VDDS3/:P-*P 9S&"Q .1D^Q /X58(R,&@#S/Q7+ /V>79
M&58FT:W"<XSE4P*K_$NPMK?X17=TNH7<@:.V*"2[9D;,L?8G!XYKT#3=$M].
MM/L"I')8QL3;12(#Y())V@_W1GCT'':KILK5HUC:VA*+G:IC&!]!0!R'Q.+3
M>%K+[*VZY?5;+[,5.<OYRX(_#-7?B3#'-\-O$0EC5PMA*ZAAG#!20?J#6O-H
M\-S?V<\P7R+)C);P*N%60@C>?4@$@#MDGDXQ#XJTF?7O"^I:1;RQQ/>P/!YD
M@)"!A@G Z_2@#AUT32X_%7@N\T2"W66>VF.H-#@B>V,/+2G^+YRN"V<DUF^'
MM%T)_@IJ>H_8;)[I++4HO/*J65?,E(7/8<*0/Q'6O4]+TV*QT](6M[993&%G
M,2 "0@8R>.<^_K5@6=JL31"VA$;'+($&#]10!YSI-VJ^)?!T>H%#I<WAT+9M
M)@QFZ^3</3=Y8X]MV.IK OK*"/2/+F$7]DKXSA732QP$A,B^8(SV3=O'''!K
MV62RM);;[-):PO!U\IHP5_+I2O:6TJ(DEO$ZH,*K("%'MZ4 1:?I>GZ79?8]
M/LX+:UW,WDPH%3+')X'')->/)<6]EX,OD@6$1V_BA_[7CB WI9BZ)8.!R%QC
M@_PY[9KVL      = *:(8E,A6-!YAR^%'S=N?6@#BX(4'Q7BN-(:/['+I).H
M>01Y;-O'DDXXW8WX/7:#VJ/QX+"+Q-X-NM0%NENNH2I)+.%"@&WDP"3QU_6N
MVM[6WM(_+MH(H8\YVQH%&?7 ITD4<H DC5P"& 89P1T- 'D&LV>EW\/Q5N+B
M&WFD@C5H6D )B86BX*Y^Z=P'(YR/:K<VJ:=)XA2V\4:L+*ROM#MOL<\_E>3*
M"&\Y=\BD!B2A/() 'H*]/-C9G=FU@^;[W[L<_6EDL;26)(I+6!XXSN1&C!"G
MU [4 9_ABTM[#PO86EE/=7%K##L@ENR#(Z#[I) '&,8X'&*\CN-3TRZ^$D;Z
MG-;+X@@U>)[Y)F43QS_:UWD@\_<.!V"\=!7N=5VL;1IFF:U@,KXW.8QN;!R,
MGV(% 'GEV--;QQXT#72VMO/X>A>>X@(W*#YVZ08ZD+@Y^E8^K&Z7PUXLTK6;
M/3;JYCT#SX=4L5 CGB7>(]Z?P.#DC!QUQTKUTVEL9&D-O%O8$,VP9.>N361X
MA\/KJ7A75-'TY+:T:_A>%G\O"KN&"Q ZF@#B'T>TM_$'@W4/"\-NFH2VLS74
MD./WT)AX:4C[W[PI@GN:H1E;_P"%6ARV1 \4P7\*C/%P+OS@)@_?E3(6S_#R
M>*]4TC3DTZPBB\BW2<(JRO"F!(P&,GC)_&K*VELETURMO$+AAAI0@WD>A/6@
M#S>>6?3?$HN(S9ZSI%WKBQNA&V\L+HL$R#_$@QT."%/I6/K-O:GPM\588(H2
ML=WY@1%'RGR(R6 [<[N?K7KXLK5;G[2+:$7&"/-$8W?GUI4M+:/?LMXEWC#8
M0#</?UH X+4'TF3Q[X"N-/:S*.MZJ20;<,/)Z CJ,Y_'-<\6%_\ "G64NL#Q
M7;W\Q;'%PMYYQ,.WORI0+CC;P.*]>^QVN4/V:',8 0[!\H'3'I0;2V-T+HV\
M1N -HE*#>!Z9ZT >9?V7IEYXS\:)J5K932C2+225652HDV3;GQZ].>HS[UU_
MP^F-Q\._#LC2>8QTZ ,Q.22$ YK=:RM6=F:VA+-]XF,9/UJ2**.%-D4:1K_=
M50!0!X^6%_\ "G6DN\#Q7;W\Q;'%PMYYQ,.WORI0+CC;P.*Z3R+5OC%8+=QV
MK79T!WD^5<F031_-]>#@^@KN3:6QNA=&WB-P!M$I0;P/3/6@VELTWG&WB,N<
M[R@W9^M '(?%:.$^ [B69$*175HY9P"$'VB/)]AC.?:J#V^BZK\6(H7BLKJR
M_P"$>W)&0K1$?:#R%Z$>E>A21I+&T<B*Z,,,K#((^E1&RM6<N;:$L1C<8QG&
M,8_+B@#QG0]6@L?#?@234K]K;1,7L#7.$:.*828AWEU8 ; X!(XSVKTCP38Z
M38:3=+HE]/>V$MY),DKLC1Y;!81% %\L-GIQG=6\;&T-N]N;6$PO]Z,QC:WU
M'2I41(T5(U5$4855& !Z"@#SSPS+%X9^(?BG3]6E6W;5KE+ZPFE.U;A2N&12
M>-RGC;UP<]*T?B#JDTW@76UT5WN)X8E,S6QSMCWKYB@C^+R]YP.0/3(SUUS:
MV]Y%Y5U;Q3QYSLE0,/R-/BBC@B6*&-(XU&%1%  'L!0!PDZVDWC[PE>^'6@\
MB2UN/M9M<;&M=@\O=CL'*[?J?>N7FN(?^%,:HWFIC^WVYW#_ *""G^7/TKU^
M"SM;976"VAB$ARXCC"[C[XZTGV"SV;/LD&W.<>6,9H \G^(&H:;,OCFVC>""
M]BL(1*;EM\D^$+IY"Y&U5SDL,\YX&,UK)<V$GQ.M+M9+1Y;KPZIM97VD33>=
M@;3_ !'IT[5Z(;2V)R;>$G9Y>2@^Y_=^GM3_ "8MR-Y2;HQA#M&5'MZ4 >2^
M$F\/:Y9>'#=:S=#Q%83#SK%?)6X\_!682#9O,9^8L2>1WS46E67ART\!>+-7
MN--2X-G?ZE$&M2%E2)I&78C#[B[3VX ).*]<6TMEGDG6WB$T@VO($&YAZ$]3
M1':V\2NL=O$BN,,%0 -]?6@#SCP[?V2_%&18[_3G2?0(MHLB!$2DK\ Y.\JO
M?CCL*N_#?6],T[X;^%H;R^@ADO 8+=7<#S)-[?*/?_ZU=TMG;*H5;>$*$\L
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MD_@ <C\3H+*2+PP]ZL?EC7K9&=SC"L'!&[L#QFN4\3Z)8:<WQ 33+:WAT?\
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M>PLX[2W %O!%*P!E\E<!F]>@S^- 'D_A_4=+/B?P'):75C';3:=<PK!%)O=
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M2,GM0!<;QAI44.IM<_:+>73(_.N[=X6,B1D$AP%SN7 /*Y'!SC%3Z'XCLO$
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MC$>^/:O4Y//H#BN6O-$UJ;P'XIT]-(NC=WVMR75O%E,O$TZ.&SNP/E4\$YH
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M5<;FYP !D<D@9('4@5RG@?Q!G0]2N+ZZO+@MK=U;6J3AFF8!ODC"GD$ 'CC
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MZ73H/[)O[=IY723#V2[-Z;\GY\C@[0,'U'-9LGCFZ@\.:?XJEM(?[#NYHU9
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M9C%.'1%!W^65' (+9]>:VZ\GM-<U#PM9>-M5LK&TELK/79);A9)"K,FR$,$
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MM$ZNJB/=G;P<DMDY]@!+)X8NKGQ7%K%Y>6\T7]F2:?- ("OF!V5F8'<<#*X
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MG<$!7&_YN$'/'4UV\(D6%!*5,@4!BHP"?856TC4HM9T:QU2W1TAO+=+B-9
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M1NYWFN)"LMH[,%LG7AH=AZ,".2>I)(P"!5N?PGI%SI-AI<L4[6E@\;VR?:I
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTC#^ZH +-Z<=Z /5**\LN;2W\)OX:\/S:C UG<37 U"YO(R\,MV8T9%==R@
MAFVKG PO&14[:+=6NF)9Z)J]CJKQ:I+<1Z==*5MI%,>6MT.6P%W;E!R ?IP
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MP:;/'>JT.IL$LY C;9F() !Q@' )P<=#0!K45SI\=^&!=&V_M>$RK,\# *Q
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MT9T_4U*JK$C]XK!'YP,8*],\\U+HO@K2K2VG6[T7246=TD^Q00A[>)ESAE#
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M%&H5$10%4#H !T%/JIINI66L:?%?Z?<)<6LHRDB'@X.#]""""#TJW0 4444
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M9C@ >YH X737N-&\3^)SJFG7LUKJK175J\=LTV]?*"-"VT$*PVXP>"#]:VO
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MDCE=%?<@?&WN%Z]ZV/#$]IK6J6VH?\(WJ]E?VT3)+/J@E'DYZQQEV._)[CC
MR<' KKS>6HN&MS<PB95W-&9!N ]2.N*GH X[Q/#>VGC3PWKJV\]SIULMQ;W*
MP1F1H3(%VR;%!)&5P<#@'ZUAZEI-VVD_$748+2[,6M0"*RMEMW\R1EM]A?9C
M(W,<<@?=ST(KTVB@#/T)BV@:?NCEC9;>-626-D92%&00P!%>8W?]I7?]G22:
M%J<,]EXE6>:UMK(K!'%YC_O%( \TL"&+\\D_='7UZHGN8([B*W>:-9I03'&S
M@,X'7 ZG&1F@#@TCN1KWQ!E-A?!+JVA%NWV63$Q6 H0AQ\Q#''%='X(CE@\"
MZ#;SPS03P:?!#+%-&R,CK&H8$$ ]0:VKBXAM;=Y[B:.&&,;GDD8*JCU)/ IX
M((!!!!Z$4 >5)INHK\.]?\&W>GW4NJRSW*02^0QBN/-D+I+YF-H +9.2"-OT
MK?T*TN+3XDZD9H+IX_[)M+=;M[=PDCQE]^'(QGE3U_E7;T4 <SXXGNK?2+22
MUT][P"_@,K1VWVB2VC#9,R)@Y=<#'!QG.#C%<!JUCJ$F@?$*UATC6)&OYH)+
M4R6SNTP\N(9'7G*MQ_#C!V]*]D+*I4%@"QP 3U/7^E+0!QI623XL6EZEI=BT
M.B20&<VLBH',J,%+%< X!.#5/PUHUY8>*KS1&53H>E3M?6)#?=,X.V+'HA,Q
MQ_M(>U=O>VWVRQGM?.F@\Z-H_-@?;(F1C<I[$=C571M'AT2Q^SQ3W-P[-OEN
M+J4R2RM@#<S=S@ ?0"@#G?BN0/AKJI*E@&@^4#.?W\?%4==M;C5?$\>MZ5I<
MEP-/T>[C>.Y@:);IY /+@PX!8<,3V&0.]=7XCT"#Q-HLNE75S<002LC.;<J&
M.U@PY93W JW<7]GID,7V^_AA#857N)%3>?T&?I0!YSH;70\8^']4DTW6/(_L
M::WF>2Q:)(9-T1\L1@#8H"D#CG P6-16NDZA/^S[=:3'IMVFHBVF7[+) R2%
MO-9L!2 3D<\=:]6IJ.LB!T8,C#(8'((H K65S]OTV.=(YX/,3Y5GC*.ON5/(
M^AKR^/2-2N_A0/!,]C=QZW%,L'FF!_*XG#^>)<;<;?FZYSD8S7JT%S!<J6@F
MCE53M)C8, ?3BB.Y@EEDBCGC>2/[Z*X)7ZCM0!R42S#XNW%R;2[^S'18K87!
MMG\LR"9V*[\8Z,#Z5+\0;>YETK2I[>UGN19ZQ9W4R6\9D<1I("Q"CDX'85U!
MN8%N%MS/&)V&X1EQN(]<=:EH X.(S-X]\07SZ??I;SZ/!'&[6DA#.ID+(" 0
M2-R\#^E<SI4.I:%I_A#4;[1]9GLH=(.GW<-HDJSVLNY6#%%(8J=N#CT!]*]B
MHH Q_#-I;6FCC['ICZ;!+(TJP2Y\SYCDLX).&)YQG///.16Q110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7#?&*-'^%6N%T5MJ1D9&<'S4YKN:YWQQX?NO%7A*]T2UGAMVNPJM-
M*"=@#!N .O3'6@#G(M'>;XEZ5?Z%I<EAI<5G+'JLC6QMX[G(Q&FP@;R#SG&,
M<9[5%X-UJ+0?!EI!'"&FN]8O;>WC"MM&)I6)(4$X"H>@]!QU'HL/GBU02B/S
M@O(0G;GZXS7")X!U./PY;6T&J06^K6&I2ZC9W21EDW2,Y9'4]5(D93@^_M0!
M<C\<W,5O<QWND2Q7JW\5C9Y5XXKQI?N,K.H(  ;=P<;3UXK-ANY=(^)OB'4-
M1MX4%MX?CN'-KD^:JR2$G!_BX(QD]!SS@:>J^%-<U[186U'5K6/6K6[BO;22
MV@86\,D><#:S%F!W-DY[CCCFKJ%AJVCWFK^+M5O;(*-&^S/#:VKR;65G8,-S
M<C+=Q]<8S0!;MO%^HR:EX;MVTZU:/7K=KF)UN6!@555V4_(=YVL,'Y02"..#
M4</CJYNGTR[L])FNM,OKD0;H8I3)$A)"S'Y-NS@9&> 0<GD5A>%'N]-NM*CM
MKWPIJL81+9182RM.D1(W,@+L%4<,P 4';VXK?\/>%?$'A]ETJ'6K9_#L,ID@
M0P-]J1-VX1;]VW;GC."<<<<8 ,#X@:S-XB^&NMWMI:6TFF13^3')(Y\Q]DP1
MI%&, !@0!U(YR.E>EW\,USIUS!;S&":6)TCE'5&((#?@>:X"Y^'VM+X:UCPQ
M8ZI9+H]Y,TUNTT+&6WW2!V3@X(SD@]>?Q'=WMK<7>C7%IYRK<S6[1^:BE0&*
MD;@,DCGGK0!Y=HM_IUF^B^%?&&B+H^LV<\)L;]8PT%VZ,#E)1T9\<@]V]>*O
M?VA?Z#XL^(-]I.G6LXMEM;F999C$"%MRS!<*<L<'K@>]=!JWAK5O$6F6NDZS
M/826T4\4TMU"C"64QL&^5#Q&21@G<>"<#FFS>%-1DN_%\PN+4+KT"0Q@[LP[
M8C'D\?-P<]O3WH DU+Q==0V$-]:V<*6DFG"^6XO)=B.Q&5@7'\9&3GMQP>U6
M;QOJ-P_AM-*T>"9M>L)+N#S[HIY;+&K[6PIX^<<C/T'6HT\%:S'/:,FIV?EI
MHRZ5(LD+/Y>,@R1<C!88R#Z#KBGZ5X.U:PN/"4DU[92KH-I):N$1E\U71$R.
M3@@(#[Y/2@!;WQMJ,-M>O::0+JYT[8EU;1>:YDEV*[I&RH1\H8 $]3V'4V'\
M9M/K<NEV<,"7D<4,RVEXYAFG20!B4!'\(R".3D$''4LD\,^(-.\2ZA?:!J]G
M!8:HZRW5O=V[2&*4*%,D1##DA1PW&12>(O!MSXBBFLKI[62 /$]G>.&^U614
M+N*L!R25)ZCD\YZ4 ='KEY>:=HEY>V%HEW<V\32I;LY3S,#.T$ \GMQUKGK;
MQP;C6/#-L(;;[+KUHUQ%.)CN1P@;9MV]P3@DC[IXKL:X%OAI&- N-.AU&2*9
M=06ZL;A1S9QK(76-?8!Y1_P/TH M:EXAE^SZ#<W>C65S!>ZREO;NTFXQ EA'
M.H*=2%)&",!AR>:S+W4=4U23XA:?J$=I)8V-MY<:!B=H-N9 <$8)RW)XZ#TK
MI/$7AV?4XM#AT][>"+2[Z&["N#AEC! 08Z<'KVQT-4KGPIJ1U+Q3/;7MJ+?7
M8%4QR1MNC<0^5G(."N &Z9SQQUH H>%?$5_96_@_2;RP@2SU+3%%M.DY:0-%
M"K'>NW !&<8)Z<U8G\>R0^&HO%8L8WT!I@K,)#YRPF3RQ-C&",X.W.<'.<\5
M+#X3U".?P@[SVI708&AD'S?O]T7E9']W@9[^GO5:W\!W47A=_"$EW!)H!FW(
MY#>>(/,\SR2.AY^7?GIVS0!?E\774<GBR(6,)?08DF0^<<3JT1DP?E^4X&.]
M48_$FLW_ (N\-16\=M'8ZAI+WSQ-(V<_NLY..<!S@=^2<<5-J?A'59M5\1RZ
M??V<5IKMHL,RS1,SQ.L9C&W!Q@@CKT]#3[7PCJ=G?>&KN/4;4RZ58-87&ZW;
M$B'9\R#=PW[L=<CGIVH TO&'B"X\,Z&-1@LDN_\ 2(86C,NPCS)%0$<$$Y8<
M$CZU1D\3ZI;7::9>6%K#J<BRSJ(I))XUA5@JL=J;LL3C& ."<] ;WC'0[KQ%
MH7]G6DT,+FXAF,DH) \N17Q@>I7%5/$/AW5[O6=/U_0K^VL]5MH6MY8[F-I(
M)XF(8JV"",,,@B@"O9^-KF[M]#@ETB:QU/5+F:W\FZ#*D7E*S,_(!8$*-O S
MGM@UG:EXSNI?!WBF\O?#]A<Q:/.]I-;RW)9+@K@DX,>,892!SW'&.8_%[7,+
MZ!I][K6F1:DTTEX9[^)HK=F5=H6-@X9"-XV@-DA22?5(=,U+Q-X/USPVDFAJ
MDZ +?Z:9'B9G9C)NR26D& 2=QSO&?< W-6\6M9:V^BVB6@OA9+<V\-U*8OM9
M)8>7&<8R-HSU^\..IJO_ ,)!J<'Q UJVNVMUTC3]-BN3AVW*I,A9L8Y;Y.G&
M .]2>)/"MYXELKBPO4TV:VFMU2)I%;?9S8(,L9QSV(&5Z=>:>_@^=O$-U=&]
M22POM+CT^[CE0F5PF_Y@V<#(<YR#T]^ ".R\8ZC=:CID:Z+(]IJ4;,LJ)*/L
MS;=RB5BFW#=-PS@^HYJA:>,-9UCPC>ZU-X<L&TQ+2[:2&2]),C1.RE,>6059
M5;D]\\ 5H^&M!\4:/#!I]]K5I>:;8KLMBD#1SS*!A%E;)&!QT&3@9/4%-+\*
M:A8?#V]\-/<VSS3I<QI.H8*!,SL21UXWGZX[4 1+XJOHIO#&G:?HUIMU?3VG
MA'V@QI!LC0[,!#A1O&",].@HM_'DIT".XN;!(]1;6/[&,*2DQ"?S-F[=C.S'
M/3/:I;;PMJ,.I>%;II[4KHEE):NHW9FWHB[AQQC8#CGKCWKGM=TR70/#\^GW
MVHZ;"VL:ZUW'-<QL;=-S&4I(V1M^X &!!)(QCK0!UVB^(+Z_\3:QHMS96Z?V
M8(B]Q',Q\WS%W)A"O' .?F.".^:GOM<D'B*/0-/CB>^:T:\D>9B$CC#!%X')
M+-GTX!/H#C>#;F^&IW5M+)H5Y%*AFEO-*DD=A(-J@2ERV25Z?-D!.F*T=2\/
M71\6VOB72YH5NTM6LKB"?(2:$MO&&&2K*W.<'()% &/)\0[G^SK>6+2$:]&M
M+HUY;M<X\J4MC*G;\RD$$$XZUUVFSW[:8)M8M[>UNE+^8D$QD0*"<$,0.HP>
ME<K=>!KIK2#[/=6_VMM;76KJ1U8*[J1B-0.0, +DGMG'-=K)$L\#Q2KE9%*L
M,]B,&@#C;CQM?+I&E:W!IUN^F:E>06\(>9EE$<L@592-N.0<[?<<]JEN/&-W
M!:^+W^P0M)X>&_'G'$Z^2)>NWY3@X[\URFL:%K'AGPQHNE7FJ6ESI=IK5C'9
ML(2LY3SUVASG;\HXX'.!T[]'JW@W5KJZ\5+8ZA9Q6?B"VV2"6)C)%((?*X(.
M-I !)ZCF@"UJOBV^LM/%['8V\=N--%]YUU/M220@D0(0,EL G..XX.>,V^O(
M=7\8?#K6(X!&;R*YE&0"P5K;<%)]LU+)X*UHW.Y=6LWCET==,D,ELQ,1 (+Q
M#?QNR,Y_N@\XQ4UGX1U2VD\'M+>6<G]@0M%)M1E\T-%Y7')Q@#.>Y["@"'^V
M[F;1/&TECIEG87NGSS1O)%)_K6$"MYI8*"6P1U'8#-9^EW\N@Z%X-U6YT?3V
M6XMK;3GU!96WP12(A4M\G(+@ \X!(YY-;</A;4H;/Q7#]HM2VN2R21GYL0[H
MA'@_WL!0>U5M732]+\ 0>%/$%W;M<36'V2WBB;]Y<M&BJ#&IYW[MI YYQ0!9
M\3^(9;;0O$T[Z19ZA8:;$%>.>7 G.P,ZD%", ,OKDY'&*?<^)=33Q+:Z#I^E
M6CM<:8U[%+)<E%7:R+M8!"0!N[9SQTY(+KPI=W/PWF\-B[0WMU;-'<7<N3NE
M?F1\#KEB3BI8_#^HIXLL-;:6U*VVF-8M$"V6+,K;@<<#* 8QWH IV7CMKS0-
M$NC8K%?:I?-IXB,F8XI$9PY+8Y'[MB!U.0..2-+P[X@O=7U76+"ZL8(#I=P+
M=Y8YRWFL5#@A2HP"K#^(D'CWKB]6TR;PYX>T;P_=ZII4$\VJ37D=Q=QL(#\S
MR[2VY2C!G7:0P)V^F173>"KF\\Z\M93HMQ#_ *XW>DN[*TK'D2%RV7( .=Q.
M.N.,@$VL^+7L=?ET2U2T^WK:+<V\-W*8_MA)8>7&<8R-HSU^\..IJ8>([IO$
M.N:2+.'=IUI%=12&4XE#[_E8;?EQLZC/6J_BOPM<>)X;RQN$L)K*>$+ TZGS
M;.7G,J$#D\J<97IUYJ.;PKJD/B&>_P!.U&W$-YIT5E<_:HV>0&/=M=2" 20Y
MSGOSSTH =I/C&77+71([*TB2_P!2T_\ M!TED)2"/Y1R0,L2S  <=">V#B:Y
M=ZA>:MX&O[K15M-6_M"XB-N\H/2&4?ZP#[AP&Z9QV)J:U\!ZWI%GX>N=*U:R
M75])LS82&:W;R+F X.U@&W @@$$'\*V+WPWJMY?^'[R:_MYIM-NGNIV9&42%
MD9-J#G:H#<9)Z<\Y- %SPOKUSK7]J6]_:Q6U[IMXUK,L,A=&^57#*2 <$,."
M.U<MXEAT\_&#1'OK%;F-M)N=R"U,Y;#KCY0I)ZGMWKJ/#VAW>DZIKMW<2P.F
MIW8NE6/.8_D5-ISUX4'/O4-YX>O[CQ]I_B%)K86]I:R6IA;=O<.02V>@Q@<?
MK0!YY=:-?:=\,]:^W6CVUF^NPSZ5:3X+VUNUS$ ,<[,\_+VS[UWFM>+[FUNM
M4MM*L/MD^FHK2QE9"97*[_+4HC ':5Y/=@,=ZO>,="N?$?AY],M9HH7>:&0R
M2@D 1R+)C ]=N/QK-NO#?B"U\476LZ!JEC;KJ21B^MKR!I4#HNT21E64YVX&
M#@''Y %B#Q+-KET=.T[3T$RV,5W=QW^4\KS0=D++@G<=K9],#@YKFO 6NG2_
M ?A'3HK=1=ZI<7,$88_NXMKRNQ..N N !C)/:M__ (1;5=.\4MK6D:C QN[6
M*VOX[U&;S#'G9*"I'S8)!'0^U<K?Z7<>&M"\,^&KK6M)BNH[J>[CGO87C@."
MQ"APX97#2@C:02 ?3! .CM_'<XMM3:]TV*.2SU(:7&(IV?SYB5P<;,JNU@W&
MX\$8.!E6\=SV$>K'5-*F5;,1&VGCCD2.[:1@JHI=1A@Q /7@YK+M='O?$NAW
MFE"[TF"6VN(KVSU31RTB"Y#ECO#D[FR 3\Q)#\XXSJZAX4USQ+X9N[#Q!JUJ
MMX^PVTEA RQPNC!U<AF)8D@9Z#' ZDT 5%6]'QCTQ[ZWM(Y'T6X/F6[$[OWD
M7RG(!X['OGH*T?']AJ]S8Z;>Z19Q:BVGW@N9M-E;:+I K# )XW D,,]P#U H
MM/#_ (@E\5Z;KNJ7VF[[6SEM9(K:%_WF]E.02W'W/0X]^M;.KV6IW%Q8W&F7
M<,#VTC-)',A99E*D;#@C'.#GG&.AH XO2M2\,>(['Q-=V%F;+4GL/*U'3;FW
M\J1&0.59EZ'[V,^PJ3P;XAU"PTKP/I=UI\"V.IZ<D4$ZSDR*Z0!\LNW !"G&
M"3TSZ#7D\*WEYK&IZY<M9Q:A=::=-BCAW%$0DL6=B 6.<8X& ,=\U!:^$-1M
MXO!T9N;4CP\NUSAOWX\DQ<?W>#GOSQ0 _P#X32ZAUG2K.]L(;<:C>26JVYFS
M<0A0Y21UZ88)G';<.345KXUU25M7NKC2+6'2]&N[B"^G%V6<)'$'W(NP;LYZ
M''4=>:IVO@/78+?2(6UBQ?\ LS5'O5F:V8R3AA("9#NY?#_I6OIOA*5+#Q-8
M:G+#):ZY<S3,(<AHUE0(5YZX"]?TH CMO&&H-JMI!/HL[VMW;R3":WBE/V=D
M7=LD+(!\PX!!ZC&.]6O"WBA_$T4%W;_8I;*6#S&>WF+/!)E?W3J1P<$\\=#P
M.]?0]#\665FMCJ6O6D\%K"T5K+!;LDTAVE5:4EB.,YP!R0#GCE^E>%)+;Q4O
MB"X2RM[PVC6]S]B!5;QBRGS'! P1M.!R?FZ\"@"_J6O3:?XJT32/LR20ZIYX
M\WS"&C,:;_NXY!Z=16!=>/KVVT35+X:3#(^GZR-+=%N2-P+1J'&5ZYD'RG'3
MK6SXDT*_U'5=%U73+BVBO-,ED8)<HS1R)(A1A\IR"."*P)? >KR:/J]BVIV;
MMJ&L)J>\PLNS:T;;>ISGRQ],]30!H'QK+I=_KEMX@LX+5=-L4U!7MIC*'A8L
M,<JOSY3'H<UEZE)J%Q\0O EU?65K 93=,#$Y9X\V['8Q(&>O4<9SQW.CK'@F
M;7]8U>>]GA2SU+2ETYDCR7C*LSAP2,'ENGM3(/"_B6;4O#EWJ6J::[:,T@+1
MV[[KA6C\O)RV Q![< ^O2@!8?'5S=OIEW9Z3-=:9?W(A#112F2)&)"S-\FW9
MP,\\ @Y/2K.@>)M;US4[J,:/:0V5GJ$]E<S?;"S HHPR+L&X$GG.,9[XJOX=
M\*^(/#Q328M:M7\.P2E[=# WVI$W;A%OW;=N>,X)QQQVU/"VAWFAMJ_VJ6"4
M7^H2WR^5D;-^/E.>N,=?TH I^)]6UBS\7^%M/T_[/]GO9I_-$CLI<I [!20#
MA>_?) Z=^7M]8OO"\_CW4=.TRVGM++4A/<*\WE'8((BP0!3ENIYP/KGCM/$.
M@WFIZOH>IV%W!!<:9/(^)XRZNLD91N 1R <BL>Z\&:E<Z9XOL_M5H/[?D+*^
M&_<@QK'R/XN%SVZT 7M4\7RQW-W:Z3:"YN+6V2X<.DA#EP2L8V*V"0,Y/3(X
M/.-W1]0;5M'M+][2>T>XB5VM[A"LD1/56![@UR\WA;Q#9:VFKZ%J=C!/<6L5
MM?V]W"\D4AC!"R+M*D, 2,=#786D,EO:112SM/*J_/*PP7;N<=N>W:@#R!;B
MTT"RE\*^/=*$"SSR-;>(5CWQ3NS%E=WZI)DCKZ=A7=:SXMGM;S4;/2K,7=Q8
M0K)(K+(?,9@6$:E%;!( .3_>'!YQ6O/#&NZGX1;PSJ%YI]Q;S0B"6],;"0)Q
MT0Y!< <-N'/..U+<^%-:TWQ$^J>&-3M+>.Z@B@N[:_A:53Y8VI(I5@=P7C&<
M'% %FW\57FK-]FTK32E['81WL\-\3&8C)NV1$8SN)1LGH,#KFG6OBB_EU[2-
M+NM)^R2:AI\EV5DFR\#H4!1@!@\OU![=*J7GA77+3Q%%KF@ZM;"ZEM$M+Y-0
MA9TG"DE9!L((8;FXZ8..*L:AX:U5M9T75[#4;=[RRAFM[AKR)BLJRE26 4C!
M!7@=,'&1B@#.;Q_?_P!CV=ZFCPO)/K;:0\8NB-I$IC#@E><[3UQC/>K?]L:@
MGBCP]8ZQH6G)?W<=V8[B*X,I@\L#(4E 0&!3)_ CBL^/P)J\.E6UG_:-G(T&
MO'5P[1,N1YA?8<'J=W7C'H:Z#4]#O+[Q?H6LQRP)#IJ3J\;9W2>:J@X/08V_
MCGM0!R<?B?53X"\4:MK&G:?J45G=W436SR$(Z1N4*X*$;0!^/.<5TFH^*)+>
M[DT[3;5)+J"S2Y<.DA0;]P1!L5L$[&Y/3C@YXS9O ^IOX8\2Z$FH6GV?5;BX
MFA<Q,&B$S[FW<_-C) QBK-]X9U^'78-<T+4K*WO)+1+2^M[J)I(9E0DJXVD,
M&&YOP- $:^/6F.EP-9IIE]?V;7,=OJK-"6D#;3""1][/.2.A! .>.QMGDEM8
M9)H_+E9 SIG.TD<BN8UGPQ>ZO8/I]\UAJEI-;;)%O$*E)\L3*F,X^\ %X(VC
M##ONZ=8RZ7H-I81SFYFM;9(5FG)S(54#<WUQDT >>?$76'2__M6RU&)'\+S1
M7!M/.56N68?OEP3GB%A@_P"VP[5V^H^)+>UTS3;NT"W+:I-%#9#=M60R L"3
M@X4*"QX/2C1]%>TT)K344M;JZD,C3R!2%F9R68G.2 23QS@5RUK\/M6B\$V6
MAOK$*WFDW:W>EWB1L?+*EBJ.I/S* Q7KT(XXY )O%WB+Q+IGA/7Y180VD]F\
M20W@D)2:.0J"R#J&4MC![\@GI7;I+)%9>=>^5$R*6DV,650/<@'I[5R^J>&M
M;\0^$=2T[5M3M!?7:($-M"P@AV,&'RLQ8DD<G(XQQQSTL5O+-IWV?43%+)(A
M6;RE*H<]0 23C!QUH Y1_',\&AZ;XCFL(UT.^FC3<)#YT,<C;8Y6&,$$E<@'
M(W=355(KK5OB?KNG:A:V=QI_]EV\312.6'E,\N<#;C)P,CV')Q4]IX'O5\-V
MOA:\O()]&M)XW23:1-)%'('2)AT&"%!8'D#H"<UK6>AWUOXXU'77EMVMKRVB
MMA$-V]!&6(;/0YWGC]: +VMV5L_A>^M&A0VXM'41X^4 *<#%<+,;\? #23I\
M4LSC3K(S1P@EWA^3S0 .N4W?AFO1-3@FNM+NK: H)9HFC4R$[1D8R<?6L_P[
MIE[H/A+3]*)@GN+*W2W5@Q1) H R>"1P.G- ')Q:IIUU\4-%7P],C6U]I<XO
M?LXVKL0KY1.!PP)9?49QQ1):Z'I'Q7T2*#2Y=*D:VN(DN8X L5^[ '8S@\E0
MK-\W)./QZFPT"2UOK_6)KB.?6KN(1+,T9\N%!DI&JYSM!.3SECD\< 11:/J>
MI7.F7.OR6)?3I3/&EFK!7EV,@8ECD !V^7GG!SQB@#F?']GH>F7ND7]SIDT#
M_P!J0W$VM0PAC!ANCOG<%;A,= #[ 5Z17-7VC:QKMM=:9K$VG'3)I@<V\;B1
MX@P8(0Q(!X + GO@#J+2S:S_ ,)B\/F6\FC&TSM6)A)%*",9;.#D$\>WY@#]
M;U6ZTZ>TB@MXA%-O,UY</MAMPH&-WJ6) 'X_0\];_$2&;P_H>I3I;V']ISRV
MYEN)3Y$+QE@06P/O%.,XZ^V#K:]H6I7_ (@T?5+"]MHQ8B57@NHFD0[P '4
MCYUP0/9CTK+TGP?JNEZ!#I$\VF:G9++<&:VN(2J3))(7&3\V&!)[8QQCO0!U
MFF3W-UI\<UY!'#.V[<D<F]>"0"&P,@C!SCO5NL;PKH(\->';;2EF,BPLY7KA
M SE@BYYVKG:,]A6S0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7ATW6;BV2WV1!9(Q&F%?"]BV1C'3OFK7BB\NQJTEK;:A< IILDRVEF LB/G
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M ?F]?F'2M2O.;RTOKCQWX6M;C5B;P:1>1W%[:HJEV#0ABH.0I)'H<<XQVWO
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M$ET&V3=(S=68NX)ZD\\8KN!<0&;R1-'YH_@W#=^5.CFBF!,4B. <$JP.#Z4
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MTX:I8ZC%YT4UC UM;B.3"I&<9&WH<[1R?2IM%T*ST"VFM[(S>7-,\["20O\
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MA#IJ7JSEB&RTC)AB3@#Y?UH Z.--D:H69MHQN;J?K3J16#*&4@J1D$'@BEH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5F:IHEMJEQ97322P7EDY>WN(2-Z;AAAR""K#@@
MCT[@&M.B@"CIFE6^E)<>27>6YF,\\TA!>5R ,G  Z      "KU%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
, !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>exhibit1061-loanandsecur007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:T#P?=_:X;:>YUPV5TL<)*2-&TH#8+9QF(';GOUXH ]0DD2*-I)&"HH)9B<
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MPTY-6G5[#4FU&WN%B7<'9G+ @Y!'[QOT]*[*B@!J+LC52S,0 -S=3[FN5L?
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MLVLT0PC:ZMMR6YZ_(O3CK725BZOX@_LK6]%TXV;RKJD[PB8. (RJ,_3J>%H
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MNI'LM-LY+<2RM+Y1*R;F4,3C'WO3BM^32=(D@^VV6J7,EO?:7(GV87#.ETN
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MJAO(D,<<P)#(AZJ".@]JK)X5T2*)(XM/CB6.5IT,;,A21OO.I!R&.3DCDYH
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M,M[/2I[2PMK*]1(I$>3R/,*; ['.TL-W!/'(H [VYU:QM-&?5I)P;%(?/\U
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M4_,=H8$@8YQDY-;=Y?6/C#0-<N=(T>Y^VS://:FXN+-H9-Q4[8!N +<DDXR
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M^0,D$,Q';C.,UDVEE=7WP9TEK2UN4U?08H+F&.:!XV\^ ?,@# $Y7<O'!W4
M=_'XATB6*^DCOXF2P)%VP)_<D<D-Z8'-5/[9M!KT[?V["T,-@)I-/6,%XQNS
MYI(^;D$#;BN3M]*U@>+MTEO(+'Q- MS?J>EJT3#]V<<?-$4C/J036L59OB_<
M2"*3RVT%81+Y9V&03,VW=C&<$'&: *=_XZ-_H_AO6-(NUM[.]U6&WN5D0$^2
MQ;J3]WA0>.F>M=99^)-&U"RN;RTU*WEM[9]DSJ_$;>A_,8]<\5YA8[S\/? E
MA-8WBS6&K6PNHY+20>7L+[R<K]T9&6Z<]:U+VWMKG7O'<=[%J"6=RVG;)K2-
MPX9<*9(R <E&VDXSC;0!UFL^-='T?1;K4GF,@MY%A:((P82-C:K C*YR#R.A
MS5ZY\2Z-9QK)<7\2*8O.).3MCSC>W'RKG^(X%><ZLNO7/@;Q+9W3?VNMM<6;
MV^HV]L5>[C66-WRJ\,R!>2O7Z@U=\4:@VHW^N6\.G7T'VK0R+::&P<R7V1)^
M[9BIV*N1\IP3OZCI0!W-WXET2PG$-UJMI%*8?/"&4;C'Q\V/0Y&/7/%21:]I
M4^D1ZM%?P/82XV3JV58D[0!ZG/&.N>.M<%HCB3Q-X)GDMKA$M] DBD>6W=?+
MD(B !)'RD[7QGJ/K618F\TZTT;4GLKM],T_Q%?37<*6[EDCD,@BEV8R5&_.0
M#UH ZFP\4R7FK>,XIM=@MK&PC@%M<R1*@M&='+%@V,D,!PWI70KXDT>PMK.*
M^URT:>2U68.[*C2K@9DV]@<_K@5PT\XO+KXE3P6MX8K[3(EMW-I(HG;[.ZX7
M*\G)48ZG(QQ5JT ;Q)\/I&@EVVVDSI*[0MB%S'$ &./E.588..AH [F#7])N
M=(35H=0@DL'.%G5_E)W;=H]]W&.N>*6RUW2M1NY;2TU"WDNXLF6VW@2QXP#N
M0_,O4=1W%>6N!!X5O;EX[R%[7Q>][;@6LC@J9RRL4 W&,J3RH/.*ZOP7J&DZ
MAXBUV_MKYGU#4#%+):M;2PB..-!&"/,52_7E@.X'U .KO=4LM.*BZG$;,K.%
MP6.T8W,0.BC(R>@R*CAUS3+BY%M#>1/.UN+I8U.6:$X^<#N.1R/6N7\96[MK
M-O=V&JW&D:M;VKF&X,)EMIU+<PR+C&<@$8.[DXSBLZTO;FQ\6^&M7U;3)[(7
M/A]K5HK>W>18I]\;>5A02O . ?3':@#N(]>TJ;3(]1BOH9+.1RD<J-D.P)7:
MN.2<@C YXKG?$WBDQV&C7^BZG#]FEUFWL[HA0WRL^UU.?N$<YXR/:N,T::^T
M;1O"NKW&F:@;'3M1U$7T0MG+Q":23RY0N/F4 G)7/#&MSQ(UE>Z5I5SIVD2P
MVUQXCM;N3_1&1IU# R3.FW<![L!G&>A% '=:7KFEZVL[:9?070@?RY?*;.QL
M9Y_#IZU->ZC::<J&ZF"%R0B@%F<@9.U1DG YX%<OH&1\3?%LGER+%-!9>7(8
MR$D*+('PV,$C*@XJ#Q%J$OA[X@Z=K=[;74VCRZ=)9--;P/-]FE,BOEE4$X8*
M!D#J!0!MW6MV-V=%ELO$5K!'=W ,:KLD^VK@@QKGD<X)(Y&W%2CQ9X?:_2Q7
M6+-KIY_LRQ+*"3+C.SCOBN4UR.W6+P;]@TF2RM4UP7 @2W*F.(I+F1U ^3+.
M#SC&[G!R [2+.6\U/X@16T30W5U/FTG>(J&/V=4#*Q'(#[N1T_&@#KX_$6D2
MW@M([^)IV5V1!G]X$^]L/1\=]N<4B>(]&>TL[M-2MVMKR7R+>4-\LDF[;M!]
M=P(QZBN4\&:I9:CI^@Z=/H-U%K.D0B&47%FR"S*Q[&99"-IW8P I)(/H"1R\
M$LL'@O1-&:PU WVG>)$DNHTLY#Y:"\=]P.W# J01MSQ0!Z7=>,?#ED;@7&M6
M2?9W$<W[T'RV/8XZ>_IWJS;^(M&N]5.EV^I6TM\$+^2D@)('7'KC(SCI7"7"
MA[CXH-]FF/VNW18"8&_?8M F%X^;Y^,#O3[==NI_#0K;RJMO:RI.1"P$)-N%
M ?CY<L,<XY% '<+XATEI6C6]0L$>08!PRI]XJ<?,!T.,U1T;QGH^L:%#JZ7
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MF ['PQ#>ZD(2#UY'%-;QG:03:W%=6TL;Z5/# RJ0QG>4*8U3IR=RCG')].:
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M-#RY"L">GH"2"  =;15&XU:UMM#EUAF9K..V-T65<DQA=V0/7%<MXCU5]9\
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M>X^)-I:6>N22V#S3Z1$L\B6LZ2I+&W1E?(Z'@C&1Z&@#MZ*Y1_&-PFN1Z2=
MO/M%S;-<V7[V/$P4@,&Y^3&X'GM[\46OCNQN-&M[R6$VMU->2V/V6>55V31E
MMX9^FT;"<_3 R0* .KHKD+3X@6%S:71,#B]@O4L!;1R*XFE?E/+?H5(R<G&
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M*^F1UKMZ* /./$_A'Q'K)\1VO^@W<%]:)%87%S,0]L0F&4($(!9LDL".O.<
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M+&1,'QYK;F7#*05SSR,YYSF@"_X8U"+5?#UK>PZFNI12[RET$"%UWG&5 &&
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MC_0=7O!?R:6D7E7GE+&TL<H#@,%P-R],@#/%=]+X.TPV^E1VK7%E)I3,]I-
MXWH7!#YW!@V[)SN!ZDTE[X-TW4-"U#2IY;DIJ+^9>3AU\V<\=3C X51@   8
M&* *]UJ>H0_$G2],6Z_XE]SIT\SP>6OWT:, [L9Z,>*YJ/Q)X@U"TTQK?4&A
MUB?6'L[W35AC;[- '<%MI7<-J*K;B<'/N,=I-X>B;6[76S<W4M[9VSP1*60*
MZM@L&^7J2J\^U<%I.EZJ;41VL_C'3=6):1K>1D:SCF9BS?,X8-'N)Z,6(]Z
M-'Q'XCUC3&OKNVU(S_9=4MH/*MXD,$<3M&A25F7)D.]CA"<97I5S1X;R7XG>
M+1_:MV%CM[,1QL(V50RRD#!7("DDC!&2><U=N_AYI-XNI1O=ZE'!?W2WDD,5
MQM1)PRMO48ZDJ.#D>@%:4?ABT@UV;6(+F]BN9X$@E"S95]@(1F!!RP#'KQZ@
MF@#D-!\7:KJ6C^"K.XNRM]KC7+3W:QJ"%A#,0HQM!/RCH> >_-5_$7BCQ!HV
MG>,["+4"USH\,%W:7K0H6:.7(V.,;<@@X..1BNJA\!Z5;Z%IVEQ37BC3)O/L
MKD2+YT#9).#MP0<D$,""#SVJ6^\%Z=J6DZE874]TYU,K]LN-RB64* %7(7
M Z #OW)R 4[.]U:R^(W]CW>IM>VEUICW@1H43R9%E5<)M&=I#=&+'CK47Q+%
MQ_8NE^1>W%MNUBR1_)*_,#,HYR#TZXZ9'.>E;@\.P_\ "10:X]Y=O>0VIM!N
M*;6C)#'("]20#GVJ77M"M?$.F?8;MYHU$L<R20OM>-T8,K X/((]* ,*WO\
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MLR6E4$(IG0-R>@P<'VJBVDZ+K'Q2N+2:UM;K3QX=@V08!BQY\N/E''';T[4
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MNF*[GDM63;)]2H.\>FT^M 'KE<MJGB?4K/QC9^'K/2K2X:ZM9+E)IKUH@ A
M(($3>HJ[X8M$%G/JK0+%<ZK*;N3Y=K;2 (U/N$"Y]]WK7-Z]&T_QDT"*.\EM
M9#I-UAX@A;[Z=F4C].U #I_B-(WA?4-2M],6.]TW44T^^M9YO]4[2*F58#YQ
M\X(Z=Z[UF5<;F R<#)ZFO-_&7AVP\-?#;4H;1I7>YU&UN;FXG?=)-*UU%EF/
M [=@!4&M2:7J?C#Q-HOB74K6Q1K>'[$UVJ#]P8_F:)GX#"3>21SD#TX /397
M*1,5V%\?*';:">P)P<?D:Q?"&O2^(_"EIK%S#';23F3=&C$JNV1EZGK]VN1T
MF:QF\:S:3K\XN;>'1;8Z:=2 S,A#>=(0W&\D*&[X'UK T&[M;;P)X&D-Y:M9
MP:E<+-9RSHHFYFQRQ"Y3AP&(SQWQD ]J!! (.0>](K*XRK!AZ@YKR&Y@BT'P
MMJ>JPRVZV%[KT<MS]E99A;61=<HVPD8SDE1D8<CFEU\V&CZ#K^J^'M9%S'="
MU^WIIVP0P1>8%>1?+^ZYC+9(YP,]@: .^D\03IXZM=!%O";:>QENA.)"7W(Z
M*5*XP/O^I_"I_$FOIH%I:/Y2RSWEW'9VZ/)L0R/G&YL' P">AZ8QS7)PC0K?
MXNZ-)I9L(TGT2<#[,5"N/,BV<#@\9Q[#VKI?&$&@WVE0:7XBCC:RU"X6W4NV
MT+)M9E(;L<K@'U(]: 'PZGK2ZF]A=:9:AOLKSPSQW+&.1E91L.4RI^;W[>X"
M^$==?Q)X5TW5YHD@EO(O-,2-D+R1QGK7+^'H]:\+>,_^$6EU:76-'EL'NH)+
MGFXL]K!0KM_$ISP3Z<8P:YCP_865GX3^&FK6\,::A+J,=N]R/]8T;)-E"W7;
MP/EZ4 >U;EW[-PW8SC/.*-R@XR,^F:\9O]1TM[K3M2LY[>#'BP+))<2 W1_>
M,DFX\;(\?*%.?EVY(Z5L:7HEC=^)O&]W!9Q3WUC>1SV&3GRYOLRD,HSW8\^O
MX4 >G!E+%0P+#J,\B@,I) 8$CJ,]*\K\(C0=87PSJT&N(-8@3;+;P(BW$CE,
M2I./O, 06)/<9[BK'@_SM+U_1K2\MK._BN[.8Z;KEG\KS1?*["=?[Q^4[LD$
M^Y- '<^(];B\.^'[S5IHS(MN@(C!QO8D*HSVR2!FC3I]7%U>QZM!:);QE#;7
M$$AQ("#N#*>5*G'.><]JYSXM06TOPZU"2XBB<Q/"4:10=A,R X)Z<<5%)#:+
M\3X-%O+.W72O[(+Z?;-$ODM+YI\W"XQOV[??!/J: .\) ZFD!##(((]17B[6
M6_2='MKHE["+QFUKIS,YYM,N @;J5W!@/8#VKUW3=)L-(TV/3M/M8[>SCW;(
M5'RC<22,?4F@#!\1>,5T[PO=ZSI,<%ZEK=+;2;I"JY\Q8VQ@'."WMT/-=2&!
M) ()'!]J\1EATV#X4>)XH$M8;E=:D218PJNJ"_4*#CD #I6YK5N^@^+?$L7A
MN 6]S+X7:Y$< P9)UD<"3'\3X/4\F@#U(,K$@,"1U /2E)QUKSKPM%X<U'6=
M%UG1]:A>X-JZ-:V:(IDC*Y/G@?-\K <G^(^]7/B7;V\T7ADW!VJ=>M8RX<H0
MK;LC(/&>* .X#!AE2".G%"LK9VL#@X.#T->.Z[9/X4U'Q>OAJ)[?2ETZTGNX
M;8';%*9B)-@'0^0"QQCJ#Z5H75AX<N=/U[4])UBWN_/T*82VUBL:P;5!*2.J
M]'!X!.#@'TX /1M2EOEL6;2TM9;H,F%N)"J;2PW$D G[N2/?%7&95QN8#)P,
MGO7D6L:#I%C\'K/4[>UC2[N8M+>:XR2TA$D0!)SZ,P^AQ70P):ZM\0O%.F>(
M((9HDM;<V4=P 5^SE#YC)GI\^0Q'HOH* .\9@JEF( '4DU@^%]>N==&L"YMH
MH'L-2DL@(I"X8(J'=D@==WI7GGAG4;I[GP58^)Y?,T^:RNFMGN^5GE60"$OG
M@MY/(S_>SUKI_AG]AB_X2JVL6A$4>O7!2.)AA5*1XP!T'7';B@#NF95&68 9
MQR:RO$&MIH5A#,8_,EN+J&TA0G ,DKA!D^@SD^PKFP(-2^)^LZ7KD$4UN--@
M;3XKA0R-&2XF90>,[BH)ZX KDGM1<?#[PR=42.Y2/Q)#!:37*AV>U^TD)R>2
M"@'U % 'JVE2ZLZW2:O;VT;1S%89;=R5FCP"&VGE3R01D].M0G5I-3T,W_A\
MVMTQE*1M/(5C8+)L<[@#V5L>O%:2VMNMI]D6"(6VSR_)"#9MQC;MZ8QVKQ2*
M#2U^!&Z&.U6[BO8S*8PH=3]NVC=CG[N0,]LT >WEE4$LP&!GDT;AN"Y&3R!F
MO/Y=&TO4_BUJ]M?6<-S!)HMN\D,HW(S>;(,E3P3@#GM7+:-:6L7@KX=:RJ+_
M &D^JV]N;PG,IB/F(8]QYVX &WI[4 >TEE#!2PW'H,\FEKR%#I6O#6+;6M:2
MPURTU>1E"H@NUVRY@\DM\Q!38H '.2.]>C^*8HYO"6L)*H9/L4Q(/LA- &L&
M4G 8$XSP>U&Y=VW<-V,XSSBO)]$L++3[[X77MK"D5U>6+1W$R_?F7['N"L>K
M ,!@'I@8Q47ALZ5KUEI-UJ&M);>)+/4=T\$:(MV;@.0T;9^9D(/(Z;1V"\ '
MKNY0P7<-QY SS064,%+ ,>@SR:\N\/7&@:SI[#7;A8_$MIK,C2JL@2Z\Y9F\
MM5_B*%"J@#C&?0FJ>=*UYM=M-<UI-/UJTU:0IA$%VH63,'DEOF(*;0 !SDCO
M0!Z[N4-MW#=UQFC<N[;N&[TSS7F6H>=IOB5]0EM[/6-(N-8A1I5^6\T^XW(B
MC_;3(7@8.&[BBU,VE>*[*>XM[/5M,O-8N%M-1@^6ZM9V\T-'*/XT'SKD'@*,
MC@4 >FAE+%0PW#J,\T;ESC(SZ9KQBQU+2FU'P9J=C<6\$$^IW.6FE#73HZRE
MC,_&,L!\I!QA>>*W/!_A/0-7F\3/?:=!<M!KMY#'OR?+5D52 .V03^GH, 'I
ME5-3U*TT?3+G4;Z98K6W0R2.>P']>P'<UY_X2M'FGMO"-]:AAX7N&=Y6C&V9
M<?Z,WIDJ[,<<[HN>M;'Q8@BF^&.MF6))/+A#KN4':0PY'H<9YH [(LJKN8@#
MU)Q2UY^C:=<?$FTTN2&S?16TAWTZ)44P/-YI\[:/NEPN/< MZFK_ ,.4N(=(
MU2W9V>P@U:YBTXL<XME;"@'NH;>!["@#L"RK]Y@/J:&944LS!0.I)Q7F9\/:
M#K7Q#\:6NL012V_V2SE*2.0%RDFZ0#/!'][MGWK#T'4)4@\*6/BR]CAM+C1Y
M/L\NH1JT<DGF\!M_&_R=F">>2._(![02!U(%(70#)90,9SGM7DKZ#HZ:EX#T
MZ.Z?4]/-S?0I-,P(EB\ESL!'WHP<@=B..16C:>%]!/Q%UC2'TZW?3X]%M0+9
MQN08>49P>X &#U% 'I6X;MN1DC.*S)=1FTY=4O-6-I;Z;:@213+(2WEA<L7!
M& <YQC.:\JT:UMHO"'PUUI47^TY=1M[=[PG,K1E)%,98\[< #;TXJUK=I;-I
M?Q:A$,;(@215*@[6^RJVX>ASDYH ]<AE6>".5,[74,,^A&:?69X>%B-"M!IP
MMQ;^6N!;A=F<#/3C-:= !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %07=E:W\0BO+:&XC#;@DT8< ^
MN#WJ>L3Q9?6=AH$DM]J5WIT)DC7[3:*2ZDN,#A6P"<+R.] &@^E:=);16SV%
MJT$3;XXFA4JC>H&, TDFDZ;+&\<FGVCH\AE=6A4AG/5B,<GWK*_X2RW_ .$S
MG\/-;W"&"T6X>=H7V?,Q YQ@*-K98\9XSP:O6&OV.I7$4-N9]TT!N(F>!T62
M/*C<K$8/WEXZ\]* +%QI6G7;P/<V%K,UOS"TD*L8O]W(X_"B;2M.N+I;J>PM
M9;A<8E>%6<8Z<D9J#6M?TWP_;PSZG<&"*:98$?RV8;V. "0#CKU.!56'Q9I=
MQ:K/!]LD+&0" 6<OG?(<,?+*[@ <<D=P.M &V0&!! (/!!JG'H^EPI&D6FV:
M+&&"!8% 7=][''&>_K5.'Q3H]S8Z?=VMV+B/421:+$A9I2 2V%QD8P<YQC'.
M*RM4\6Z#?^&+^Y75[^RMH9%AFNK>VD62&3?C;\R'!R-IXXS@XR* -_\ L32?
M*6+^R[+RT;<J?9TPI]0,=:=<:-I=W<&XN=-LYIRAC,DD"LVP\%<D9Q[57O\
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MW/4D]ZT98HYHGBE19(W!5D<9# ]01WK"\1Z_:V5AJ-M'<W"7<-JTSM:PF5H
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M%51Z #I4E9N@:J-;T*RU#RGC:>%'9'C9,$J"<;@"1SP>AK2H **** "BBB@
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MRH\Q<3^9]T8!R03NRO3D5ZM10!P"65W!XC\:R-9WCPW6G6T%M+Y+'SW2.56
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M3M'J>I/'>H_&>EP:I<::LJ:I;RQ"5X-3TT,9+23Y0 0H.58$Y!!'R_C76T4
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M')$8FE*@X,@SPN<XZXZ"[XG2_P!;\*F_M-!N8#%J-K>"U:-1<S+'(A=BH/7
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M!+'@8!!!XR.O Q[T :6D^/[G4H;'3Y+**WUZ?49].EB+%HHG@4O(X/!9=NW
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MC&LY8J?,D&[DC;P,\9//3 !R;ZI<:Q#\-=5LK"SANKB6=H[<$I%'FWDXR 2
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MC13VYF1UD !( 9=KC;P>>I_'.T?P?J6C:/#IBZK:WEK')<&2"YL\I-'*Y?#
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M6,O'/"QW;3@@@AAD$>_%9NI>!'O?"FJZ3%J$<5UJUU]JN[IK<L"^Y3A4W#
M15&2>!W- '2VMEY'FW;P6AU*9 LLT4?E^;MSL!/)P,]\XR:\^E\3:O>>#_#M
M[81V6FM>:^MI/%$A*X%RR\$$<$IEO7)Z9KTM!,( '>,S8Y95(7/TSG]:XJ+P
M#=P^%+'2%U>'[38ZF-2@N#:'9N\UI-K)OR1EB.&':@"Q-XNN%\3SZ")K"&_@
M,&RWN59#>(P4N\3%@.,L-OS'*'/6MSQ#K2:%IBW)C,DDL\5M"@!.YY&"CH"<
M#.3@$X''-8VN>#[KQ#'+:ZC?6T]LTT,T,AMB)[4H$W>6V[ W%"<X&-Q^]6KX
MH\/Q^)M#DT]KF2UEWI-!<Q<M#*C!D<#O@CI0!S>JZOJ=]H/BW3M1T]C;1:5-
M+;WRVLD,<N8V!0I)R&!]R"#VJ73?$$MMI&@:-9 "Z;1H;IY&MI)U1=JJHVQ\
M\G/.1C'?-7AX>UZ\\/ZC8ZOKT-S=7=J]JDL5IY<<:L,%B@;YF/U &. .<TY_
M!.J0_P!BWNDZY'::MIMD+"25[7?#<PC'#)NR"",@AO6@"73/%FIZF=+TZ33/
M[.UB[AFGGCN48K"D3!-P7Y2VXLN!D<$YZ8-#6-8\5*WA>*>*VTVXNM5:VN(^
M9%E"K(RL"&X1M@.T\\@9X.;^J>#M2N9]+U6QUTPZ[8"16NIK??%<))C<C1@C
M"Y VX/&.YYJQJ?A6_P!0M=)D.L+_ &G87PO3<2VVZ.1MC(5$88;5VMQANW))
M)- %2;Q:NDZUXJ;4;*WCATBQ@N3/!S).K"3"G('=< <XSUJ>;Q-J>E7VA+JE
MO:FVUEQ C0;@;><H61&))W@X(W +R.G-%QX*^WZKK\^H7J3V>LV4=G)"L.UT
M"!@&#[L9^<G[HZ"GVOA6]D718]7U&&\CT=Q+;E("C2R*A1'D^8\@,>!U//'2
M@#$'CO75T>369=.T];*UU<Z?<HLKM(R^>(=R< <$@\]>>!W[#Q+K#:!X>N]4
M6%I?LX4L%4MM4L 7(')"@EB!V!KFI/ -])X5O=%.L6X-UJ9U S?8S\I,PFV[
M?,_O#&<]*ZW4K:]NM-,5G>):W>Z-A,8BZ_*P8@KD$A@"O7H: .;;QF8='6^2
M?3]22\O8++3IK1RL<SRD#Y^6*[3NR.3A?4XJ[:Z_>0>,/^$<U2.!I)K0W=K<
MVZE%D56"NC*2<,,@YR00>U9,_P -[:Y@U1Q/'97=Y=P7L+6<.V.VGA^ZX0GD
MDYW=,@^O-;MGH4[:^FN:I/!->Q6IM85@B*(BLP9SR2220OT QZF@"IK6OZM:
M>+=-T.PM+-Q?6T\JS3R,-C1[.H Z?/\ C[=:S]/\<W-UIMA#-:P)K-UJDVE[
M%8F$/$6WR>I4*F<=22!GO6S?Z!<WGB_2]<CO8HTL8)H?(: L7\S;D[MPQC8.
MWK6(GP^G2R'_ !-8QJ$&KRZM:7*6Q"QO(Q+1LN\[E(8C@@T 5_$/B[5['3_%
M6F?Z-!J^F:<;^WN41BDT)##<%)RK J1R2,X//2NPT<WC:!:F>6)[EH%(<*=N
M=O&022??FL:]\&_VM%KDNHW:?;M5L/[/\V&/"P1 -@*"22=SDDDC/ XQ6[H]
MI=6.E6]M>W4=S/$@1I(XO+4X&!A<DCIZGG\J .'\-^+=4A\':;=ZC+!=W^JZ
MI+9VH"L@#F>7);D_*JJ2 .P SSFNCT[Q!=#Q?<^&M3CA-RMHM];W$"E4EBW;
M&!4DE65L=SD$'BLB/X>3)X>BTLZNN^PU ZAIDZVV# _F.^'&[]X/G93C;Q[\
MUOV&ARIK\NNZA-%+?M:K:((8RB1QABQQDDDEL$GV QU) (KS6KR?7KK1=(6W
M%U:VBW,LEPI9<N6"( ".NQB3GCC@YXJP>(]3O-1T_1390V&L2Z>;Z[2=O.2W
M4,$"C:1O)8GN, ?A1K'A;49?$\?B'0M7CT^\:W%K=1SVWG131ABRG 92&!)P
M<^U.G\*7$>MZ?KECJ.-3MK9[6X>YCWK=1,V\A@"-I#_,,<#IC% &/)\0-1%A
M%LTRV-_%KL>C7L33,%#,P =#CD,&!&>F>^*L/XYNM('B9-<M;<RZ,D$L?V1F
MVS";(1/FZ-N&W/3D'%2W7@226TA6'48H[HZRFL74S6Y82R*P(4+O&U<*HZDX
M'K2:KX!_MJZ\2-?:@OV?6K>"'9%"5>!H22CABQSR<XP.E %*_35?^%H^%C>M
M9"1K"^*-#&V%;$658$_,!Q@\9R>!4UKXXO[CPMX<UDVELK:GJ:V,T0+84-*T
M>Y3GMMS@^M7+?PQKLNOZ)J^J:W9W$NF13PD1613SA($!)_>'#?)GCCVK.B^'
MVIQ:78:6FNVZV6G:FM_:#[$2^!(TFR0[_FY;&1MX]: -1_$6LZA#J%WH-A;W
M<5A?&S-M(VV2X*,%E*N2%3!+8!!SM[9%,T/4-7NOB'XFM+BY@:RLUM5BB6-@
M55D=A@[L9R>3CG Z8ID'@[5-.UG47TS7A;:3J<YN;FU-MND21OOF*3=\N[W!
MQVK3L_#UQ8^,=2UJ*^3[-J$<(FMC#E@\:E5(?=P,'D;<Y YH 9XAUG4--NEC
MMTM8;?[-)*+JY.X22@C;"J*P8DC)R,X Z&L>+QOJ=^/")L=.M0-?MI)3YTS?
MN66+?CA>1[]3Z#K6KJOAF]O/%,>LVFJ);H;%K&:&2W\W"EMVZ,[AM;L<@@X'
M'%9FD^!;_3?^$5#ZQ!,- CEC ^R%?.5TV?W_ )<#ZY/H.* *\GC76XO"FJ:H
M;&S:YT;47M+]4WE#&A7=*@SGA6#;3Z'FNJM]3FO-=-M;-!)8QVJ322J"26<G
M8%.<8V@GVROK6%%%I_@BTU63Q#JEN]KK6I22JOV9@-\B@&/ +;N$]JO^!=!'
MA[PM;6I\[S)/WK"<Y= 0 B-[H@1/^ T 5O$/BU]*UY='2:SM)Y;3S[1[X,([
MJ7<P\I7R K#"YSD_.,"K,.NW\OB[4-",=NODZ?%>12[2<%V==K#/.-G4$=:/
M$OANY\0QWEI+/9R:==6HA-O<VQD,,@+_ +U#N'.&'&/X0<U7_P"$1O;37[;4
M=,U58D&FQZ=<+<0>:[I&25=6W !_F/)!'M0!6T/QI=>(+#P^EO!!!J.JV4EZ
M^_+QP1H0IXR"Q+,H R.YSQ@YGB2YUBX/@Z;4-,AM]337C&(Q,"C@13!7##)"
ML #CDBIK7X=:CIFD^'AIVNQPZOHL3P1W+6F8IH7QN1TWY/(!!!'2MB_\*ZC?
MMHDLVL1O<:???;I9'MCB9]C)M4!QL4!N!ST&23DD L>&-=OM3O-9T[4X;=+S
M2[I86>V+>7(K1JZD!N0<-@CVK-N_$7B:X\2:WHNCZ=IC2Z?!!-')<SOB02;^
M" ."=F!V'.2>E:VBZ!<:7KVNZE+>13+JDT<OE+"4,12,(!G<<\*.PYKF[*6Z
ME^+'BF/3KVSCD^PV:LLR%SD>;R &'W<\COD<B@"SH?CR?6[GPN8[2.*#6[>Y
M=T;.^"2# 9<]&&XD=!T]ZQ?$6N7>MZ%;R2VT'VG3_%T%G&$)59#', #DYVY_
M''O70'P+)81>'#HFH1V\^BB9 UU 95F68?O"P5E(8L-W!QFH%\ 78TJ[M3K*
M/-)K0UB"5K7A) X<*X##<#@=-O>@!6\0:K)>ZYX:U^RLTN!I;WMM-:.S1RQ<
MH00PR&!Q]<]JI:'J\NF^$OAQ;BRMIXKZ*W@,LIR\+?9RVY1CKA2,Y[UT;>&K
MBYN=0U&[NX6U.ZLOL,;I"?+@BR2<+NRQ+').1T XQS0C\%7D>E^%+(:I 1X?
MD1P_V4_O]D9C QO^7ACZ\T 3#Q%K.I07-]H=A;W5M;7YLS;NVV694?9(ZN2%
M7!W8!!R%ZC.*U/%&M_\ "/:!/J?EEUB>,.VPL(D9PK2$#DA02Q [#MUK%L_!
MVJ:9JVH#3M>\C1=0N6NIK0VVZ6-WY<1R;OE#'V..W/-=+JEM>75F$L+M+6X$
MB.'>,R*0&!*E01D$9'7O0!A)XBOY=#;4+1],OH'NTCCO8)0L"VY"[IG!;^$E
M@5W9X'2N;\1>(9/$'PS\<17"0E].\VV$L2D)*-BNKA6R1PWJ>F0>:TI?AVZI
M--I]];V%S)JL.I^3';$VH:--NTQ[AG/WB<CG![4ZX\!7]QI?BFQ?6XB->?>S
M?8_]4Q14;C?R/E&!QCN6H O7?B.YCNFTG3$4W5K8Q7$CR6LLZDON")B/IG8Q
M+$\<8!YQ0D\>7"#28;^WAT*[O[1I575%8(9@VWR=V5"GOD]B,"K5_P"$M7_M
MFVUK1M<BL=0%JMI>"2T\V&X122IV;@58$G!SWQ5K4O#%[J%E)8SWUM>V<]KY
M,T5];>9F7+$RKA@ ?F^Z!V&",4 :M[JR:3X<GU?4E\M;:U-Q.B<XVKE@/7T%
M8,OBK4M.?P_<:E;6OV+6I4MU$.X/:S2*6C5B20X."I("X/8ULKX=M#X13PW<
M-)/9BR%D[.?G= FS)/KCGZUE6?A*\-MHMGJNHQ7EMHTJS6Y6 H\KHI6,R'<1
M\H.>!R0#QT( SPUX@\0:]J%R9+'3H+"SU"YLK@B9VD)CX4H,8(SUSCKTXYT;
MW6IY/$R>'M.\A;D6AO)YIU+K&A;8H"@C)8ANXP%[YH\+Z!<Z FIK/>Q7(O;^
M:]&R Q[#(<E>6;('KQ5?5?#-[)XLM_$>CZC%:7@MOL=Q'<0&6*:+=N' 92&!
M)(.?:@#E?!NNR:3X=BLS$@O[_6K^,".-Y4CVR.SMM4;F Q@#CJ.G-+XNU74=
M4^'.N)JFFM;2VM];1Q3>2\:7"?:(B)%5_F7N"#G&.IK07X=7T6E1I!KPAU2U
MU.;4;.\2UX0REBZ.I8[E(8@]*T=6\*:MKGA2XTN_UN)[VYEB>2X%H1&@C=7"
MI'OXY7DEB3D^P !'XM\6:EX>CU2X2WM$M[&V6XA6=BSWIY,BH%.4"@#YB",M
MV JVWB.\A\8:9IMQ%!'INIVCRVL^#O,J@$Q'G .TE@>^",<9K/UCP/J&J77B
M%DUJ**#6[)+>9&M-[Q,J%1L;?PAR25(/4X()S5;Q'!8:Q9V'@V346E\06\EO
M,'MHVC:%0?FE'4*-F\=3U SDT =;H-_<ZGIOVV<1".61S;F,$;H=Q".<D_>
M#?0BM.F111P0I#$@2.-0J*HP% X %/H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDLT<$9DE=40$
M#<QP,DX'ZD4^N)^)T FT'3<R3)C5[(?NY63(,RCG!&?;T//6@#H(-?@G\4W6
M@?9YTN;>U2Z,CA=CHS%1MP2>JGJ!TK6KSRYTHWOQ2O[)+^^M47P_;CS()B)3
M^^EQ\YRWOUY[U0T#Q+JFN6'A#3[F;=+J&E2W,SFZ:V:XD1D4 .BELX+,0,9]
M<#! /4J*Q/"MMJEEI+VFKZA%?7,,[JLJ,681G#(KD@98 @9QSP:Y?Q/K%[H^
MOW4VJ?;X]$9X5@U&PF)2R;Y=RSQ CAB<[B#PP''% 'H=9,.OP3>*;G0/L\Z7
M,%JET9&"['1F*C;@YZJ>H'2N&\4ZO?6T.L:EIVIW<[V6J6T0D1S'!; O$K0;
M,D2M\Y))'&[KE<5<UG4)=)^('B+4H8Q)+:>%EG1#T9EDF8#]* /0R,C!HZ5Q
M&B0:S-?:%K$>JQ'3[J _:HWO7G%V63<C(I4+&P()PN!C(QQ6AXZUFXT;1[,V
MTAA:]U&VLGN !F%)' 9QGC.,@'L2* .GK!MO%,5[?6\=IIU]/93SRVZW\2*T
M2O&6#;L'<JY5@&(P2/<$Y.^[T[XAPZ%'=7<VEZCILL[)).[O;R1LJ[ED)W ,
M' QGJ,C%1_"BU2#P/!*LDS-)<W0(>5F48N91P"<#WQUH [BF[$W;MJ[O7'-<
MCXFGEFUW[#!?W32+ILLPLK60PE"6 6=Y00<#!4+@Y.3@XXYZPU35]8'PZ:76
M+R+^U+*8W@A*KYK+ &W=.N2?IVP>: /4:*\OA&O7G@[Q%%8:G?S7^B:O.EH6
MG/F3Q1[7\EV'+9!90>O3FNI\.:M%XGOVUJPN9FTQ;6*.)/,.UY&&]B1G&55D
M7Z[@>E %_P 2>)+7POIZ7U[;W,L#2K%F!58AF(5<@D=20*BM/%=E=ZI/I+6]
MW;ZK#!]H^Q3H%>2/.-R'.UAGCAN#UQ6%\6]W_"#?*0&^WVF"1QGSDK2M_"US
M+XW7Q/J=Y%)-!:&TM;>WB*JBDY9F))+$].P ]: -3P[KEOXET"TUBTCEB@N5
M+(DH < ,1S@D=O6M2O(_"FJW,'A#P+H\#*B:D+K>3<- 7,98A Z@D9SGC!.W
M&>M:LUWK>B7.EZ!?ZJ)%U/5VC6:.9GEM[?RS((3(0"6) 4-UP?7!H ['3]?@
MU#Q!JNCI;SQ3Z:L32/(%VN) Q4K@GCY>^*UJ\O$>H:1X@^([Z-,\E['IUI);
M&YEW[&\N4_><\XY(W']*OVD^IG7;:^L)]7?2(M(:XNHKG> ]P,;%_>#.XC=E
M5P!@=,\@'H.!G..?6LGQ#K\'ARRAN[BWGFCEN(K?,(4[6D8*I.2.,D=,UR6@
MR:YJECX=\2Q:I$L$\:R7RF\>5+D.OW%B*A8V#' VGM@YK"U&ZE\1_#'2?$MQ
M>7#7-WJEK*\2S'RE4W2J(]GW?EP.<9RO)Y- 'L!( R3@5S0\:VC6,>HIIVHO
MIDSJD-ZD:F.3<VU6 #;PI)^\5 []*Z-]OEMO *X.0?2O)KB'6/AOHXU#3;A-
M=\#D+(UG/_K[2)R#F-OXU&0<'_$T >BVFOP7GB34-#%O/'<6,,4SNX78ZN6
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M.H7%F9]9MK>0PD?.CL00<@^G3IZYKF=4\0:GX4B\<Q0:A<W*6 L7MI+M_-:
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MD<985S_A76W\5/I<T<EQ#]@M3_:$/FMQ<D[/+?GG:4D)SSRA[U)\5 3\.M0
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M^UGFC&7CBF5F49QD@'(YXIB:WI4EQ#;IJ=DT\^?*C6X4M)@D':,Y.""#CT-
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MX#N/>@ LK*WTZSBM+2)8H(EVH@[#^I]SUJ>BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N%^*@L
MSX=T_P"U^3C^U;/'F8^[YR[\>VW.?:NZHH \VU^[T[PMXVL)[F;^R=!NK"2.
M&YM8$\E;AI-SAOD(!==ISWVU6MI="T&^\-6%CYUI;/#=M9:A>[C\K.I:.-.
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MPJ&4E< = 0<BJFH6FCWWQGBM[Z"RG\S0G5HID5@[><N 0>IVYZ]LUZ#10!Y
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M&MM@655VY'S,,'YAUQZ<GBEMO&[7>LW&F1>']4\ZTE@CNV;R@(%E7<'8[^0
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M9PA+(^Z,Y(60 ,NTX.,YR  =0OC!;BWLY+32KV1[JR>_5'**!"",$L&*[FW
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MDMG"\B0@Y9 V3@;L@G@=: -O3O$5_>>/-9T5[!DM+&"W990ZGE_,)8\YP=H
M STR<9K+^(BD:CX0*2S1^?K<-O+Y4K)YD95R5;!&1D#K6E8:/JMAX]U+4BD$
MUCJ%I;1O,9-KH\0<$;,<YW@]1CFH?&^D:KJUUX>DTRTCF&G:G'?2^9,(PRJK
M+M'7GYOI0!U,TT%C9R3S.L5O!&7=CT15&2?P KF;;Q]87&KV.G?9Y!)J,3RV
M926-S(47<48!OD;'(W<>X/%3:A;:SXBM;K2;NQCT_3[FTFBEF%P)78NA0 *
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M;5=%N+!8[#6KJXDMKB!G-P%CC++N##9P..#D^E;C>*]8UX7B^'K9UEMK."=
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M.+:(W-LQPISROUR>.O:NH\0W]Y9W&G1P7$-O;SRNL\A7?-PA*K%'@[F)Z\'
M!X[@ W*Q;WPEX>U'4#?W>CVDMVP >5HQE\=-W][\<UPMSXBUK6_#'AB[^UI:
MS3>(5LK@1PX$NR5PI()R/]6"5SU]N*[[7[N]T[P]-<6LMH+F,(#-=-LB4%@&
M<\]@20,\G H U(XTBC6.-%1$ 5548  Z "G5YS<^,=8@TWQK]GDBDDT.WCN;
M6:ZM&1G5HRY#IE><J<' ZC@]]"UUK7D\4:7IUY=6;PZOILMQ%Y5N5-M)'L[E
MOG!#^@Y';I0!VU%<+I'B;6+W2387$UNGB.+5383JL/[M0#O+A2<[3""P.>3Q
M6IXVUG4]"TRQN-,-L9)M0M[5UG0D,LD@4X(/RGGK@_2@#IJJ:EJ=GI%DUY?3
M>3;JR(7VEN68*HP 3R2!7#77B7Q/HFJ:YI-]/I]U/%H\FK6-TEJR( APT;IO
M)ZXP=WY]*2]U_P 5Z=X'B\137NFR?:5L6C@6T8&,2LJN-V_D_."#CL>* /1:
M*Y2ZUZ]TKQVNGZE<0)I%U8R7%K)Y>&$D9!D1FSSA#N' XSZ4R;4];BBTF.ZN
MH+8W<4LDI2#?<!_E*1I$,YP"=Q_V>V: .NHKRT>(=:\0V'P_OQ=QV;ZA=R+<
M11Q91G6.7G!.<?+G;GOWP*U[OQ%XEU!-3G\.V/VA]/O6M4@98PDYC($FYFD!
M4_>Q@<8&<YX .[HK$\3:I>Z3X=DO[2SFFE1H_,CBC\QXXRX$C!1]XJI8X]JQ
M+?Q/-?>'O[1TS6M.N[634(X1=LNQHH2%W Q]YMV0%P,Y7CL0#J=6U>PT/39=
M0U.Y6VM(AEY&!./P')JXK!E# Y!&17EFOZ[=ZU\+_'<-Y\S:?++:QR&(Q,Z;
M$=2RGHWSXZ#IT%=)?:YJEQJUWHVCQN)K*RAF:18XWS))OV@AW7Y1LYQDG/48
MY .PHK(TZ;6K[PO#+>6\6FZU)!\\1(E2*7\#RN><9Z'K7%P>/-2^P^%+NYF@
MC^UW36>KQ>1S!(K^62#GY5$I5><\,#0!Z701D8/2N3NM8U5;/[7'=6D=I/J7
MD))(GSI ,J2@Y\QV=?E '(8'!K(@\::K_P (UJ-[);RR_8-9>QGG@M29$MUP
M?-,77< P!&..3CC% '46G@[PY8WOVNUT6RAF#;P4B "M_> Z ^X%7=.UC3]6
M>[6PN5G-I,8)]H/R2  [>>O!'2JGAC55UG2#>Q:E;:C;O*WDW%NNT%.,!AV8
M="..>PZ5QUAK3Z#)XRN88A)<3>(HK6%3TWRI @)Y' W9QD9QC(ZT >C7%O#=
MVTMO<1K+#*A22-QD,I&""/0BH-,TNPT:PCL=-M(;2UC^[%"@51GK^-<G/J_C
M#3H]9=M(DN[:&V6:SE*1^:7W8=#&CG=@?,,8SC'6H4\937'AN_U;2+S^UX(9
MH480VQ^TVR%@)=\7!+J,D# ^AP<@'>U4U/4[+1]/FO\ 4+A;>UA7=)(V<*/P
MYK-\*:S'KNFS7MOJEOJ5J9RL$T2;&"[5^61>S@[L\#C' KA+R74KCPK\4&O;
M_P"T1PO<PJAB"X MHR,'/  .,?CG- 'JL,J3P1S1-NCD4,IQC((R*?7#:3JV
MLV'B'0M*NYK6>SU+2WFBCCB*- \0CXW$G<"'ZX'(Z#I4.F>*M7D\0:#8W,]K
M/_:D-SY_DPDPP2QJ& BDZ2 <J>3R.HZ4 =_17F,7B_Q,N@1:Y/<:>88M9-A-
M;I;,#+']I\G<&+G:1D$#GIR3G WOB?<7MKX!U":QNS;2!HD9@N2R-(J,OMD-
MUH Z(:QIYUO^QA=*=1$!N#  <B,$#=GIU8?G5ZO/[Z#4V^*EE#;7L"79\/SA
MKEX-P ^T1\A-PR>G?WYZ4FD^-=3U+1?#\30J=3U)[M)7MT7 %NY1F178#).T
M\DXR>#B@#T&BL/PS<Z]/9W2:_9K!/%<.D$@V_OX>-KE59@K=B,]O>N,N/%'C
M+^P/$&MV\^E&/0K^XB>V-LX^TQ1$;OFW_(=N3_%D^E 'I]5++4[/49;N.UF\
MQ[28P3C:1LD !QR.>&'3CFN/BUWQ'K/BNYT[3+NPMK1;&TOXVFM6=]LC-E#\
MXYPOWN,>G.0R/QIJ5O::W]J^RR74.OQZ19E8RD8\P1!6<;B3C>2>><8XH [Z
MBN1U75]=\,V>J7EZ;6]LU\A+%P-DAED<1E7' VAF4@Y'&1[U9T>Z\2_\)%/;
M:A9LVDM;"2*ZD$:.DV[!C*H[94CD''&"#F@#HW=8T9W8*J@DD]A572M5L=;T
MZ/4--N%N+24L$E4$!BK%3U]P17+F74G^,#6O]H?Z''HZSK 8@0-TVUAG/4[!
MS^E<OX5U;6-#\'>&KJ&>U.GW.LR6,EL827*RW4J[]^[@@]L=._H >N45P.N^
M*]6TF[EE\ZV98]6@M!:Q1F1?(D9%W22#[DA+DA<],<'.:M:!+J4WQ*\51SZA
MYEM;+:*D)B VJR.P .>,$DD\Y]J .THKDM2U76SX]@T&RN;."VN-,ENA(]N7
M>-UD1<_> ;AC@<>^<8KGHO%_B9?"MKKT\^GE;?4QI]U ENW^D#[1Y)<-N^0\
M@@8/3KS@ 'H<>IV<NJSZ8DV;R"-)98]I^5&)"G.,<[3W[5:) !). .IKE!XA
MU*+Q;XBL'CBN+?3].BN[:*&,K([-YF5)R<D[ !@#KTK+T[Q/K=]>>$/(NK.:
M+7+9[F[7[.6^S;$5B$PP(&6V9;.&Q]* .RTO5[#6K>6?3KE;B**5H'900 ZG
M##D=JO5Y'8ZMK&@:#KVL64]J+2W\3W"S6SPEFF5[D(WS[AMQNR.#T_"NHT:7
M4IOBCXFBEU#?:V]M9[(#$,!6$Q !SQSR3SGVP* .F;6-/36H]'-RO]H21-,L
M&#G8" 3Z#J/SI-/T;3]+FN9;*W\J2Z?S)VWL?,?^\<GD\#FN4U^.\E^*>B)8
MS103MI-V!++&9 @WQ<[<C)_$?CT+=,\4:O?>&M/N+B>S@F_M&:QO+A4.6$;2
M*##'R6=BJ_+SC)X- '>45YP_B[Q _@;4M9@\DSZ1J4T%R#;',MO%)AF"Y^5P
MGS8Z9!XK:UCQ3)IUGJFK6\D=QI]G:Q;% _UD\F"HW9X7:T9/^_[4 =;5%=8T
M]];?1EN5.H)!]H:  Y$>0-Q/3J16/I5UXG'B,P7UFSZ3);;_ +2ZQ1O%,#]T
M*LC94CIW&.2:QM7AU.?XM+'I5W;VEPWA\_OYX3*%'V@=%#+D_4_G0!W]%>=Z
M5XXU:_ALM+GM4766O+NSN7ME4K_H^-S1AV YW)U)QSP:M1^)/$EHEIINJ:=Y
M>HWFH2V]M*GEDR6Z1F3S-GF;0^!MP6QGGGH0#NJ*\\U/Q#XQTC19YKJTMHG3
M5+>WMYIT7-Q!*ZKDA'(1@203R#V%;6AZKJW_  F.K:#JEQ;7(@MH+N"6& Q8
M#EU*$%FS@IP<]Z .IJC<ZQI]GJEEIMQ=*E[>EA;PX),FU2S=.F #UK&?6+W5
M?%6J:%IUQ':?V9;0R2S-%YA>27<5&"<;0%R>YW<$8YXY]>U#Q/J'@>Z1+>TU
M5-0O[67<I>))8X)$9@,@D<9 R/3/>@#UBBO)?$7B'Q&/#/BK2+V]@6_TJ>T4
MWEM#L%S!.Z@#:2=IP6!P?IZUTWB76M9T<7:I?6P-MIKW46R R23RJ6SOC&=D
M0 4;LCENHQ0!U-QJ=G:ZA9V$TVRYO-_D)M)W[!EN0,# ]:MUQB^)]2GU?P8B
M"V2UUNTDFGC\LET981(,-NZ9;IC/'6L2;Q=XG@T#5=;>XTXQ:5K+64D"VK#S
MXQ,L?WB_R'#9[\_E0!Z=68VDZ/9ZI<:\UE;1W[Q;9KS8-Y0#H6Z] /R%<YJ6
MOZ_?76N0>';8O-I<BPQJR1E)Y?+60ARSJ54APHP.Q.3TJS9ZYJNNZU?Z9;&/
M39M-M;=[E9$$Q^T2H7"<'&Q0!DCDYX(QR =%IFIV>LZ=!J&GSB>TG&Z.500&
M&<9Y^E6ZX[X4_P#)+O#_ /U[?^S&NQH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K$\5^'4\5^'KG
M19KJ2VM[G:)7B4%\!@P SP.1Z5MT4 10QRQVRQO*))57'F;<9/KBN1;X=VK^
M'$TDZG=K)!>M?VM[$%26"9F9B1Q@C+,,$=#767EY;V%I+=74JQ01+N=VZ 5/
M0!R=YX'75-$-IJFLWUUJ FCN(]1PB20R1DE"BJH4 9/&.=QS574/#M]I1U3Q
M'_:.I:IJ9TLV@@MXXXR^"Q!4!<A@6R,?KP*[:B@#S'PM#=V]U9IHWB"^O8U:
M-;BWNM"%N/+! ;?)Y:$,!G&223V/)KH-)\"C1;UDM-;U :+YYN$TH[/+1RV[
M ;&_9NYVYQZYYSUU% '#77PVBFTW5=)M];O;;2-1E,[6:)&PB<L&;8Q&0I(S
MCL?R/4:GI7]J:,^G27EQ&7"9N8RHE!5@=PXP#D>F/:JN@>(&UNZUB![,VS:;
M>FT.9 ^_Y%?=P./O].:)O$#0^,K3P^;,XN;22Z6Y\P8^1E!7;C_;'.: (I/#
M<M]?Z?<:MJ3WL>GS>?;Q>2L>90I4.Y'WB QQC:,GITK.G\ QW&@:UI#ZI/Y.
MKWC7DSB)=R,S*Q"]L95>N>]=-I]Q>7$<QO;(6C).Z1J)A)YD8.%?(Z;ASCM5
MN@#C=4^'Z:H^N;]9O8H=:B1;N&-$VEU0(&!() P!\N>U:5GX8:U\2QZV^ISS
MS+8K8LDD: .@8ON. /FW$].,<8KH** .1@\"BRU>[FLM;U"WTN]G:XN=+388
MGD8Y;#$;E5CU"D9R:MW/A07T\(OK][BU@U :A#&\0WQR!BZJ'_N GIC/;..*
ML7OB!K/Q;I>A-9EEU"&>5;CS  OE!21MQS]\>E;= &-X@T :]_9VZ[>W^PWD
M=ZFQ VYTSM!SVY.<<^]5O^$5(U37;]=0</K$"02KY0Q&J*RJ5]\,>N>?RKHJ
M* ..L_ *6,VFR6VLWL1L].&EMM2/]] IRH.5.UO]H8JA?:5::-X/B\ B/4=4
MDN[1H+:1[8F-!T4LZ@*@7AN>>/4BO0** *VG6,.F:;;6,&?*MXEC4L<D@#&2
M>Y]37.3^"%N+7Q);OJ4H37R3<$1KF/Y GR?\! ZYKK** ..G\ I/->N-9O8D
MO]/2PO(XT3$JHK*K9()4X8YQUJ]=^#K34/!UOX<O+JXFC@6()<Y"RJ8R"K J
M!@\8X[5T=5=2NVL-,NKQ(3,T$32>6&"EL#.,GI0!E>(_"EMK]E9QQW,^GW5A
M*);*ZM<!X& Q@ C!4@X(/!%7M'TR73+9A=:A/J%W(<RW,X52WH J@*H'H!W)
MZDFC0-5&N>'M-U80^2+VVCN/*W;MF]0V,X&<9]*T: .6;P6G_$WMDU*X73=7
MG:>\MMB[BS@*ZJ_558* 1R>N"*;J'@D2:ZNKZ/K%YHMP\*6]PMJD;)-&GW<J
MZD!@. V.!75T4 <GJ/@=9M4M=4TC6;[2+Z&W%K)+#LD\^('(#AP06!).[KR>
MM6QX56/7=-U2._FWV%O+ B2*'\SS""[.>I8E0>,4>)?%<.@^'-2U>W@%_P#V
M>XCFB20)AOER,D'IN&<9KH: ,;PYH \.VES;I=/<+<74MT2Z@$-(Q9@,=LGB
MJJ^$Q+=Z=+?WSWB:;.]Q:[XE#JS!EVLXZJ QP,#H,DXKHZ* .3M? EK:Z:-%
M%[,^A+<"XCL&0?+A_,$>_J8PW..O;..*GN/!MI>ZGKES>3O/!K-LEK<6Y4!0
MB!@NTCD'YCS_ "KI&940N[!549))P *P+OQ3'!JOAVUM[8W%MK9;RKH2;0@$
M32 [<9.0/;K0!GVG@:>&ZT2>Y\1W]U_8S/\ 9=T40)5DV8<[?F^4XS_(\UIZ
MWX;_ +6U;2]3AU&YL;O3S($>%48,D@ 92&!'\(P>U;M% '&Q_#V"'1H].CU>
M^'D:G_:5M,1&6BDWLV,%<,/G;KGK^%;/B#P]'X@T-=.DO+B!XY(IH[E-I=9(
MV#*Q!&#R.1C%;-% '&W'@ 77]NF;6[YVUNU2WNRR1_PJ5W+A1@[21CI]3S5Z
M7PYY&IZ7K,M]-(VD6DD"1I"#YJ,%W9 Y+?(N,=^U=)10!R'AVTLM9\47?C"W
MLKJV$]I':Q_:8FB:0@DLY1N>A50?]D]L9A^)P:30-/AC>1)#JMHX:-=S(JRJ
M6?&#PHYR1BNUHH YNX\++J*ZC<75\9+S4+(V/VB.,*L4!SD(N3R2Q)))YQV&
M*;?^$%U#P=:^&Y-0F6&W$*B=8UWL(F5DSVZHN>/RKIJ* ,;7?#=GXBBL%ORQ
M:RN4N49/EW$ AE/^RP)!'<&HM3\-?;_$5EK=OJ5U97-O ]LXA5&$D3%6(^8'
M!RH.16O:7EO?VRW-K*LL+$A77H<$@X_$&IZ .,M?A[#9Z-H^GP:Q?*^DW;7-
MK/MC+*&# I@K@C#GD@G/Y5*W@7RM<N[[3]=U&PM;]Q)?64.PI,^ "P9@60L!
MR5()]17744 4=2L)+VSCAMKN2S>.1)$DB4'&TYVD'@@]"/0USMUX M[EWNTO
MY;;4GU&/4C<V\2JHE1/+ $9R,%2<YR223FNPHH XV;X?13:9X@L'UB]:+6Y/
M,N"ZQDJQ558KA1R=@]AV J?4_!DEYJUMK%AKEYIFJ1VXM9I[=$9;B('(#(X*
MY!)P>V:ZNB@""RM$L;..V1Y'"#EY&W,YZEB>Y)))^M<[<^ ])N;7Q' 3(HUU
MM\Q!_P!4P48*>AW#?]372SSQ6MO)<3R+'#$I=W8X"J!DD_A2Q2I-"DL9RCJ&
M4XZ@\B@#"U?PI#J%OH\=K>3V$FD2K):R1!6P A3:0P((*DBJMCX,DTM[J2SU
MV]$EQJ!U F1(V&\IM8$ #(;OTQ@8Q755D:MK9L+^QTVV@2XU"]65H8Y)3&FV
M, L68*Q'WE'0]: ':%H5OH<5YY)#2WMT]W<,JA%,C  [5'084>OJ22:QY? 5
MG=V6O6=Y=SRPZQ<BZD*@(T,H"A6C(Z8V*1G/2MZPU"6;1H[_ %*T;39/++SP
MS2*WDXSG+#@CC.?3TK/NO$RP>(M"TR.U,L.KQRR1W._ 4(F_[N,G((]* (+3
MPK?1:?)%=^)M1O+PA%ANW2-6A575L!0N"25&2V2:5?"92\O=1CU!H-3O)('E
MN((552(LA5V'.00S!B3DYXQ@8Z6B@#)T;0H='GU&Z5@]UJ,XN+AD38A8*%&U
M><#"]R2222:R;KP-%<1^(H4U2ZBMM=W&>$*A",R*C,IQG)51U) YX]-35?$$
M&G:C9Z7#"]WJ=X&:&VC(&$7[SNQX5!QSU). ":BC\1^1K<&CZK:?8[RZ1GM"
MLHDBN-O+*K8!W <X(''3/. "M-X06YU#2[N?4)6.GV<MFJ*@42)(JJQ)Z@X5
M<$8Q5+3_ (?_ &!]!?\ M^_E.B*\=J&CB \IEV[#A>> !GKQVK9\-:^?$-I>
MS-:&U:UOIK-D,@?)C;:3D =321^(&?QI-X=:S*>78K>K<>8"&!<IC;CCD'O0
M!DGP"A\.OHO]JS^2U_\ ;S)Y2[_,\WS<>F-_MTK<\0Z%%XD\/76D74TD27"K
MF6+ 965@P(!R.JCBK6F7%Y<V"2W]D+*Y+,&@$PEV@,0#N'!R #[9Q5N@#GHO
M#,L?B.#7&U6::ZALFLOWD2X=68.6.,<[E'3 QQ[UE?\ "N(%T.QL8-7O(+O3
MKJ6ZLK^(*)8FD9F<$8PRDL<@CIBNTDD2*-I)&5$0%F9C@ #J35%]0GE33IM.
MM!=VMTP,DOFA/*B*E@^",MS@8Z\^U !I.G/I=FRW-_/?7+G?-=3A0SG&.B@*
MH '  _4DGA?"VC-KEGXKL)[V2/3[S6KII8/*PTD3,/NL>B. 03@Y&<$5Z510
M!AVGAQ;3Q5<ZY'=-F>VCM3;",!%1"2N.^<L?\*S9O %G=Z;KEC>7EQ)'JUW]
MM9T 1X)@%PT9'3&Q<9ST]ZZZB@#ECX+6_P!"O-,U_5KS5S=1"$S2A(S&H.1L
M"  '(!R<DD#/  JWX?\ #]WI!WW^NWVKRHGE0O<JB^6G&?N@;F.!EFR>.W.=
MZB@##NO#@F\51>((+^>WN%M/LDD:JI21 ^]<Y&1AB>A&1Q65%X!2'P]INC+J
ML_DV%^+^*0Q+O9Q(9 #VQN8]LXQS78T4 <5=?#N.YAU"!=<OXK:[U :DL2K&
M1%/O5R02I)&5X!.![ULV?AM;+Q/=ZU%J%SF\BB2XMV"%9&C4JK$XR.#T! S6
MY0>E &+/X?,OBR'Q MXR30VCVBP^6"A1F#$GOG*BL@^ 4/AJ30SJL_D/??;C
M)Y2[]_F^;CTQO]NG%:MSX@ETOPS'JFKV!M+EF2,VBS"3$CN$1=XX.21SVS[5
M:TR]U*Y>\CU#2Q9O!)MB=;@2QSJ1D,IP"/0@J.?6@#'U+1KC3+K7/$EM)=7E
M[<:>(1:6ZA2WEABNP\D-ECZ_2N8\+P7MM/9IHWB&_N]K1I<6]WH0@'E@@/OD
M\M"& R1EB2?7FNQ\.>)6\0W>JPK8-;KIMV]G*[RAMTB@$[0!TP1R<?2N@H X
MZ7P"DOA[4M&;59_)O[\W\D@B7>KF02$#MC<HZCIFM6#PX+?Q3<:['?SJ]U!%
M%<VZJOERF/=M;D%AC>> ?2MRB@#%NO#YN?%5IKPO'26UMY+9(=@*%7*EB>^<
MJ*Q8?AZMM'8FWUJ[BN;*^GO89UC0D&;=YBE2""#N..,BME/$#-XU?PZUF5VV
M'VU;CS 0PW[-NW'KGG-;= &#H/A:#0X-3MS>7%[!J%S+<R1W 4@&3EQP!G))
MZU'9^"]*M?!3>%7$DVGO"T3F1OG8'OGU'&/3 ]*Z*B@#GO#WAJZT8J;W7[_5
MO)3R[<700>4OOM +M@8W-D^F,G,M_P"'6N/$4.NV=_):WJ6IM&!C61'B+;NA
MP00>A!_ UN44 <E?^ +&YTVRAL[Z[L;^RN'NX-1B*F;S9"3(S9&&#Y.1C'0<
M 8I=0\#IJ>CPP76L7[:I!<"[BU12JS)*!M!"@!0N.-N,8]^:ZRB@#E+OP9)J
M&CI9WVN7=S<_:8KF2[>- SF)@R*% "JH(Z =SSS6C;>'S;^*KK7FO&>6YMH[
M9X?+ 0*A8@COG+&MB61(8GEE=4C12S,QP% ZDFFV\\=U;17$+;HI4#HV,94C
M(- &+=>&@WB,Z]I]Z]E?2P"VN/W8>.9 <J2IQ\RY."#WP0:JOX)M(K?2!87<
MUM<Z5/)<03%5?S'D#"0R CYMV]B<8P3QBNHKG_$GBJ'0O#FJZM;P?;SIK;9H
M4D"8;"DC)!Z!AZ]: (+[P39ZCHNK65Q=3FYU21);F\4*'WH5*;1C 5=B@#ZY
MR234-UX&^U7]W=MKE^K7]B+*] 6/]^HW8;[OR'YV^[BNL4[E!]1FEH Y:V\&
M?9IO#DO]JW$C:%"\4/F1I^]#($.[ '10 ,8]\U7F\ I-X>U31GU6?R=2OC?2
MR")=ZN9!(0O;&Y1U!.,UTVJ:E;Z/I-YJ5VQ6VM(7FE(&3M4$G ]>*Q[76]>N
M-5MH'\-!;&95D-ZE\K+&A4G!4J&+ @# R.<YH K7?@J23Q!-K&G:]?Z7->(B
M7\=LJ%+C:,!@'!V-CC([5*W@U+?Q =7TG4[G39);>.VNHHU619T080_.#A@.
M W/':NGI'=8T9W8*JC)8G  ]: ,CPMX?C\+>'+31HKN:ZBME*I),%!QG./E
MXY]S[UL5%:W,-Y:0W5NX>&9%DC<?Q*1D'\C4M !1110 4444 %%%% !1110
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M>G7,SM%XG@MFNYIMK@^8B/!&H_Y9 9')YY.#UKU3[+ +PW?DI]I,8B,N/FV
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MOIM/@>YDV^8Y7_6;?N[AT;';.<=J?/HNFW6I0ZC/9Q/>P@K%.1\Z ]0I[ T
M9'Q$@CN/AQXC65=P73IW SW5"0?S -<Q=:=:RZ[\/;-3(L+VUT7$<K*3FW0D
M;@<C/L17I4T,5S!)!/&DL,BE'1QE64C!!'<$5F0>%]#MFLV@TJUB:R!%J4C
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M%@L($6]S]J 7_79&"6]21QS2VNAZ99*ZP642J\?DL"-W[O\ N<YPO)^7I[4
M4?!<$$'@S1U@& UE [?,3\QC4]ZWJJ:=IECI%DEGIUI#:VR?=BA0*H_ 5;H
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M1>Z3X!MH]*U**YTS4(([R V$N;?9!(C<[<$9P<CMS7I^I7$MII5Y<P1>;-#
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MM+&RJ6Q@$A2>M<YX<AM7M[;PWKVB:Q/K5C>F1=S3_9G(D++<*X/E@8.?7.0
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M\S3IYE4>8Q0X12RL/GRK 9!'0YH [%_&7AI(X)#KNGLD^[RF2=6#[5W-C![
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MA,;,C^]G!!QVH [2BN"O?B#J%K8Z]?+X?5K;0[PP71-Z 60*C%D&PY;#YVG
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MC.UPIR5.,X/IP13ZX>/Q98Z5#XJOWTB&S>POXH+F19!B=G$8$KL%X #KD\X
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M +=B\IW !,,#Y;$].3WJSJOCN;3+;Q5(=)65] \LLJW.!,KH'!R5^7 (XYH
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M/)MR0,D*">I% &#J?A;4-7.KW]P;2/4;S2WTNWB25FCA1\EF+[06))!^Z.%
M[DTS4?"FK7/AG08K.\MK77-$,;V\I#/"Y6,QLK< [64G..1776UPEW;)/&)
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M#4)_">A6%_#]DTV]ANI&R3L2!"(U/'5F*?@&/:O2:1452Q50"QRQ ZGIS^5
M 0&!! (/!![UYZ/AF\?AZ.PBU)H[NVU!9K*Y'WK>V5VVQ ]\1R2#ZMZ"NPU;
M7;+19;".\,H:_N4M8-D18&1N@)Z#\:TZ .:\1^'[K49/#ZZ<+6*'2[^.Z*2,
MRY5$9 BX4]FZ^U5E\.:HFL^*[T&S*:Q!%% ID;,92,IEOE[[L\=,8YZUUU%
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M@CBO[2]WLFY,[71E .0"1@@9_EUEI%+#:11SSF>8+\\NW;N;N0.PST':IJ*
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M@:V9KZY:5EB(P44\;1].3@9)P*TM&TF'0]*@T^WFN)HH5"*UQ)O;   &?0
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MJCY"N%P<X&3E>W!V+OP;IMWIBV+27*)]K6]DD1QYDLX8,'9B#DY X&!P!C
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M+G._R_7/.,XR!QQ5W0]'GTR_U:=[N[EAO+DS1Q7,_F^6><[?[JG(PHZ!1W)
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M%!;Q(8X0=NX3EARS9/"G(!4X&<UV6E:#;:1>ZC=037#R:A-Y\XE92-^T+D8
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MTZZU0KLED$I#$DX4GR]FT_W3Q][D ](NM5L[._L;&:91<WK,L$>>6VJ68_0
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M:\>^&>'4!.SG(P"H4 <9SR>1CFM?5I=,ATR9M8>T73R DINROE$$@ -NXY)
MYKA(]"@T;6]<'A$K'87&CS//:VS9ACN^/** <*S+OR!Z*>XH U];\9W-IX2O
M?$.F6L$]I#,L4)E<CS1Y@C9Q@=,DX'<#.>176N[-'((&C,J\ ,<@'T.*\KU'
MRC^S=8[" @TZRW$'&#OCW<_7-;,&B6.E?%+39/#T$<$4^GSOJBP'Y'7*^2[=
MBY8O@]2 WO0!U^CZM%J]I)*B&.:"5[>XA8Y,4JG#+GOV(/<$'O5YI$1@K.H8
MY(!/)Q7&>$A)_P )_P".RF?LGVNUV8Z>9]G7?^/W<UC>,/.L-6UC5TALM9TR
M(0)J-A+\MS:X *O"W?[P;:>I!P<YH ZW2O$%Q>^*/$&E74,$,6F&W$4BR$F0
M2J6YR!@\ 8_4UOO)'$ 9'5 3@%CC)KRO5=,T[5-<^)9OK:&X,%A;O&)1N\MO
MLSD, >C#'!ZBH9;_ $Z^M-,@O)8#?MX4CE>74'W1%' SY:$C=(S+RV1@8Z]*
M .]UK7KK3/$GA_38[>%[?4YY8I)6<[D*Q,XP,8_AZY_"C0->NM5UG7[&YMX8
M?[,ND@0QN6WAHU?)) Y^;TKA]*O4N[+X3R?:5F?!5VW[CN%FP()]<UTOA!@?
M&/C@ @XU&'I_U[QT :/_  D%PGCR3098($M%TW[:L_F'<3Y@3!&  .OK70%U
M5"[, H&22>,5P&KZ9IFK?%U+35K>"YMVT D0S\HY$_\ =/!P.?;K7*V%Q_8U
MGH-MJ%V;?PNVJW\5I<7 #Q+&#_HVXOD;2/,VD\?=/H: /:5974,I!4C((/!I
M#(@?874/C.W/.*YKP38:9I^GWT>D:B]]927CRJP*F&-FP62+:,; >PX!)'K7
M,7QFTWQ*U\\-EK.CW.M1HS@;;S3[G<J ?[: @<<':WI0!Z89$4@%U!)P 3U/
M7%#R)'MWNJ[C@9.,GTKQ:;0-#O/"/C^XE@C%]8ZK=M9R*3YD$@"&,1X^Z2^!
MQUX'85?GFM+_ %O5]%\:ZI!832Z=;"%KM8P&0Q#S3&SC 82[SQSP/3@ ]:>1
M(QEW503C+''-5;A[]=2LE@6U-DPD^TM(Y$@.!LV #!YSG..*\YMKK1XO$UQH
MWBB\#V+Z);IILVJLJ>;'AQ,V6P!(?DST. /2KDEM86WC?X?"R\PQ"SO(HI)B
M3))&L2;22>3QR,^M &[<Z_J][J.J6OA^ULYY-+GBAFCNG9/.+J'.UA]W:K#J
M#DYZ8YWK"6Z_LN"74_LT=UY8,_D.3$&[[2<''UK@= TO23K/Q 46-F!'<A!B
M)1L4VR9 XX&<_CFL?0]4M;'3/APFLR1)HDVENN^8CR1=!4V;R> =OF8SW)H
M]?:2-8_,9U"8SN)XQ]:P?%VOW/A_1X+ZT@AG$EW! _F.1A9)%3(P.?O>HKE+
MEO#&G2>'[#3I%>VEO[J6TDN9\V2L$)<^CJ-Y"*".0>1BN?ANH&^%<UNES#(+
M;Q*J!8R J)]N!4!<G:N,D#TH ],BUZZ;Q[<>'Y+>%;>/3DO4F5R6;=(4P1@
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MN+:.=XU/W2R@_7'->737-O'K'CBVAN=./VCPVKK%8X$9<)," ,_,0, GCC'
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M@92/<'BIJ* (X8(K:%(8(DBB085$4*JCT '2H1IMBMV;Q;&V%UR?.\I0^?\
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M*V%M)]^$1+L;ZC&#5H    8 HHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH ***QK+5VU37[^TM6 M=-98IWQDR3,NXH/0*I4GN2V.,'(!LT5G1Z
MYI=U>?8(-1@-TX;8B."S;>&V]FVGKC..]5]%UAKV]U+2[K:+_39%678,+(CK
MNCD [9&01V*MVQ0!LT444 %%%% !13)E=X76*3RY"/E?;G!]<=Z\J\'?$W59
MO%3>&O%\-O:7-W&LNFW4*%$F5AP.2>3VYZ@CKB@#UBBL#3=7:TT2[U'7M1MD
MAANIXO-*")%1)6C7.2<D[1^)X%32^*]#BTF^U-M0C^S6 /VK@[XCC.&3&X$]
M@1SF@#9HKS>]^(KZIX(L=8T/4=*T^YN+I%8:FQV(A+?*2/XR #C_ 'L5V>J^
M)-&T1PFI:C!;-L$A#M]U"0NYO[JY(&3@9H U:*S-0\0Z1I8C^VZA!%YD9E7+
M9_=C&7..B#(RQX&>M:*.LB*Z,&1@"K*<@CU% #J**Y3Q_K6I>']!AO\ 3)84
ME-W# PFBWJ5D<+GJ.1G- '5T5QT/B+5;#XA6OAB_:UO(;RR>ZBG@B,;PE3@A
MUW,"I[$8YXKH;G7=*LKQ+2YU"WBG=UC".X'S-]U3Z$]@>3VH T**SKC7M)M;
MP6D^H6\<^]8RC.!AV^ZI/0$]@>3VIUSK6FV=R+>XO88Y2RIM9NC,<*#Z$D\
M]>U %^BL^]UW2M.F\F\U"W@<;=PD<#;N.%W'^')Z9QFF7OB/1=-N)+>]U6S@
MFBB\YXY)E#*F0-Q'7&2 /7- &G16?_;NE?8+:^%_;M:W6!!(CAA*2"<+C[QP
M#P/0US_B7Q.UM;>'M0TG4K5M/O-5BMIY0 ZM&=V[#9PN-I!].>F* .PHKG+W
MQ/9ZAX3U?4?#NJV=S+9V\K"2,B54=5+8(!]JFTK7H5\)Z/J.JW<<<UU9Q2NQ
MXWN8PS84?B>.E &[14-I>6U_:17=G<17%O*NZ.6)@RL/4$=:S[[Q/H6FRSQ7
MNKV4$D"AY4>90R ],CJ,T :U%4GU?3H[&"]:]@^S3@&&0.")<C(VX^]D<\5F
M:MXRT;2?#YUDWD4]JT@AC,3[@\A;;MR.F#USTYH Z"BL4:I;W'B"V2WUVT,9
MM7D:P4*SR#*XEW9R%'(Z8.?:N6_X2FYU_P#MF;3?$]CI":;>M #/&DD;0*J;
MI6R0<[G."& X (.2: /0Z*RX=5M+31[&>]U.&;S84*W  7[0=N2RJ,]1\V!G
M I[:_I*V=M=C4+=K>Y!,#HX82X&3MQ][ !)QTH T:*Y_4O&>B:;%I4K7L,L>
MJ3+';21N"C @DMN'&  ?QXJS97T=SX@OXXM:MKF.*&+-C&J[[8G=EF8'/S<<
M$#&WWH UZ*SK77M)O;G[/;:C;23;#(%6099!U9?[P'J,BJR^+O#CS00IKFGM
M)<2F&%5N%.]P<;1SR<\?7B@#:HHK/?7=*COELGU"W6X:3R@A<<R8SLSTW8_A
MZT :%%<=J_B1KCQ?_P (Q8ZM%I\_V%I_M 5';SBX1(]K C'4D=3Q@BMZYU)=
M"\.MJ&MW$8-K;A[J6)"%+ ?,57D\GH* -.BN&NO&;/JOA&ZM[ZVATC4EF:[5
M]IV;8#( 7)XP<9Z=*ZFUUW2K[2SJ=KJ-M+8@D&=9!L!!P03V.>U &A15/3]5
ML-525K&[BG\I_+E"-S&WHPZ@^QJCKGBC3?#]UIUM>S*DM_/Y48)P  "2Q/8
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M6F:40+Z]A@.PR8=N0@ZL?11GDG@4 7Z*S+KQ%HMDZ)<ZK91/)$9D5YU!:/\
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M]O88"J>8V]L;5Z;F]!D$9/I3;W7M)TZ<PWFH6\$@VE@[@; QPI;^[D\#.,T
M:-%<S+JVH1_$NUT?SHSITVE2W/EB/YA(LD:@EOHQXXK6CUW2IM173X]0MVNV
MW;8@XRVW[P7U([@=.] &A12$@ DG '4FJ%GKNE7]S]GM-0MYIMGF!$<$LG3<
MO]Y?<<4 :%%</8^(KOQ/K6I0:/K-M;?V=?)"D)C61;F((C2,?XA]\@%2,;><
MYKH/$7B73_#5M:S7\@7[3=16T:^I=PN?8 ')/M[B@#8HKBO^$P2P\::I!JFJ
MVD6C1Z?;W-N[ ( 9&<'YLY;A,_TKJ)]7T^WLXKN6\A%O, T3ALB0$9!7'WN.
M>.U %VBH+.]M=1LXKNRN(KBVE&Z.6)PRL/8BIZ "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS[PO9WHL/'VFQ.8M1?5[N2
M%B<$>;&K1-GTP1^5>@U3.G0C5/[1C)CG9!'+MZ2J,E0P]02<'W- '%>"]5TS
M4]/\/Z?+HMPFM:/"(9$GM'3[$PCV.V\C;\V,  DG(]"1=TB&27XM^)+J/(@B
ML+2WD/8R?.^/J%(_[Z%=FP)4A3@XX.,XJM8:?!IT4B0[B\LAEED?EI'/5F/K
MP!Z   8  H M4444 %%%% #)94AB:21PB*,LQ/ %>:ZSX+L_B#\-M,2!_(U:
MR@4VEPRE'BE &4;N <#Z<&O3:* /#M8TOQ)?_"+PU-?P7,EY9:RUSJL(3+E1
M/*&8J.N"<\>N:N2Z7J6L>*/B9JFG123:;>Z1]DMV0';=3" #Y/[V"&&1W->R
MT4 ?/>NI<77P!\-:?#97C7=O>1"2'[,X8;?,W<8R0,C)''(KH+UX=.^+/B&/
MQ-87-WH/B&RA2VFCMY)D8*J_N_D!(YW=.<X/?->R44 >)ZQ:C2OB?.-4BU.R
M\.ZMHB6%N]K;>;Y:X ,# (Y7HW3G)%>FZ#-8:1!I?ANW2^5H[$20BXC)(B4A
M0&<# ;D<=:WZ* "N$^+($OA&&W59))'O[9MD2EFVK*I8X7G  ZUW=% 'GEA"
MG@OQK<2M$]SHVN_/#J&TS26TH',4DG+>41RI)P#D>]9"?V;-/KOAGQ-I^K7%
MW=:C+<6L41G\J]C>3?$RLGRKM^4$D@#;UX->M44 >.^+KIKFP\4VJ65U:3Q:
MI;2&V@M'?[2JO#_I#OM.<A> I&-O.<UJ:Y+<VWB"^U+0;J22>6YMOM>AWL!V
MWGRQ;9(<@,C*NW)Y *?-C%>G44 >9PO]BMO'>C:W#(]U?W5Q/:J8RWVR&2,+
M&L?'S,NW;@<C HT"RFTSQMX=AU4A[FS\,>1/.XRJS!X\KOZ;L!N^2,FO3**
M/'_#]Z-.T#PK#+92PXU#4%-Z+5Y'L]TDA0*F#@R*P )!&.QJ"VB?_A%+%9[.
M\:*Q\7M<77G6K_)$99#O8;<8PP)(&!GM7L]% 'FVHV:7&K>,-=T],:=<:$+4
MR(O%W< 2'<N/OX4HN1U)P.AK/2]&C-X1U/5(]0&CG0DLGFM!+FUN!L)$BQ_,
M =N.G517K-% &'X3LM/L-!CCTJRGM+%Y'EBCG+[R&8DL0_S+DDG!]>@Z5AYM
MU^+]]<3HHB70XXO-=/EW"5V9=W3.T@D>E=Q10!XYX3-UI=EX!U&]BF73;6TN
M;2Y+(?\ 1)G(VM(.J@A=N3P,]@:FUW3;DZ)XVU*T@F;3;S5+&YMHXXR=XC>$
MS2JH&2"58Y[[2>F*]=HH X>>ZBN?BIH=W&L@A.DW*[WC9<%GC*@Y'!(4D \U
ME:;*A\*_$2,AMTU]?/$I0@RJT2JI4?Q G@$=37IM% 'E=EJC>';_ ,)ZOJ,%
MR=(?P^EB9HX'D^RW'R,0ZJ"5W!0O3JM:%S=6.GZGX<BL]&FTNRE2Z,%W'9,T
MD6YE.Q4VG8TGWOF4G Q@$G'HE% 'C6DF6U\%>"WFM+U5T[Q!(;H-;2;HP3<
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MNM\2:*/$7AZ]T=K@V\=Y&8I)%3<0IZXYZU?M(7M[2&&202-&@4N%V[L=\9-
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MR<'ZX&:W:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR)-8:3ILMG-,T@5F=RAW!?3*'OW[T =7J6K?V7X>N-7FL[AEM[<W$ENFWS
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MZII\ADM+A2T3E2I89(S@\CI7(^%_$]WJ&NQZ9JUW<V6KI'(USIEU JK)R,/
MX7YT'/\ $3@\]*YSP??ZOHW@[P+<Q:@&LKV\%C+9>0NW:_F$-N^]N!7U QV[
MD ]?K(7Q+ICWFJVHDF\W2D1[M?L\F4#!B,#&6X4GY<UR6I>)=8L=2MI(]06X
M1]?CL)(H(E-O' [; I<J&,HZG:Q /!JS9_\ (]>/?^O&R_\ 1<M '8:7J5MK
M&E6NI63E[6ZB66)BI4E2,@X/2H=-URQU:YO[>S>1I+"807 >)DVOM#8^8#/!
M'/2LGX<_\DV\-_\ 8.A_]!%<K';ZZ^M>/;C1-7CL);>]255:V603,+:,[6+=
M%.,<<\YSVH ]1HKSS3O%NJ^*TBAL%N;.8Z1;7K&V$)(DF#8!\WJ@V=ADYZCO
MV6@R:I+H5FVM1P1ZGLQ<K VY-X."0??&<=LXH T:*X+3?%-VWBM-*U>[N=/O
MA<SE;.>W7R+NW ?88) N20/+)!;/#<>C=(UKQ/KMGH>NZ>&^R7DJO=6\Y@$*
MP-D?(0?,WKQU."<\#@  [^DR-VW(SC.*\LN/$GB>#PWK>MG6$/\ 9.MO:BW%
MJ@6>(3)'M8]1PW&,'/4GMO:2MV_Q8\1!]2NFAAL[-E@(38 WG?+]W( //!SZ
MDT =J2%&20!G'-+7%_$7[3Y/AU;>^N+59-<M(I!#MPX+Y&<@]"H('3U!I]OJ
M.IZ]K'B#3+'5)+,Z1Y5O')Y4;&65H]Y>0%3\O(&%V]&YY& #L:PAXOT9K^\L
M4ENY+FRV_:8X[&=C%N&5W83C(Y'K2>"]?E\3^#]-UB>$0SW$9\V->@=6*MCV
MRI(]JY?2)-4C^*/CS^S+6SG<K89^TW#1 'R3C[J-D=?2@#O-.U*RU>QCO=/N
MHKFVDSMDB;(.."/J#VJU7CWAGQ"_A_P[JML,QZ_=^)1;7JN@\JWGN' +( 3E
M H)&>I'(YKJK[5]8T?Q3)HIOC<PWFF37=K<30IO@EB(W A0H92&!&1D'UH [
M>BO*Y=:\6P?#:S\4G7HGFNX+(BW-D@5&DD16.[W#\C'!'&*Z 7VL6_BNS\+W
M&LM-+<PSW[W:6T<;I$K*J1*""IY8DL03@?C0!VE%>9WOB;Q%;Z-XC5;HO=^&
M[Y#-+'"F;JT(5SD$8#B,GD #(Z<U</C">W\7ZI:O>RW&G36'GZ9MCC >8!=\
M:MMRQ_>18SZD'.* /0**XB74M;FU6X\/07=TUY8Z?#-+=6T=N&DFD+C)63C8
M-G0#//)&.:4NH^,9M7\/:1<:C:Z;>7^GW+71@@681RQ% &7/7.[..@]Z /1*
M*HW3W-GH4S_:;=KN&V8_:+@>7$7"_>?'W5SR<=!7'Z)KVKW'BJWTI[^6X@NM
M%:[$\ULBCSE=%+1@!6*'><;AV!!H [ZL_6M:LO#^D7&J:B[I:0+ND9(F<@?1
M03^/2O/M&\2^))-#\&:Y=ZJDZZM>K9W-J+9%0AQ)APP&X,"@Z$#';N8?%>IW
MWB;X9>+M3COGM[:![BVBM5C0JT<3;"7)&[<Q#'@C'R\'G(!ZLK!T5AT(R*K7
M^GV.L:?-8W]O%=6DORR12*&5L'/(]B/TJ2-2]DBJ[(3& '7&5XZC.1^=>7^&
M]<O]+\$:+G4)Y[K6=:ELA-.J-Y.;B8NXPHRQ"GKD9(XQQ0!ZC;6T%G;1VUM#
M'#!$H2..-0JJHZ  =!5;4M'L-82%-0MEG6&02QAB<*XZ,,'J.Q[5A:?JNHV?
MC^X\-WEPU[;RZ>+^VN'15D3#['1MH (R00<#N#FK?B*]N[>_TNWM[X6T4[2"
M2.% ]S*0ORB-2K+@$Y8G  QR,T ;X 4 #H..32UYA;^*_$5WX6\+7:7D45U>
MZTVG7+/;JV]0\JY(!P#^[&=N.IP15^.\\4SKXPT:SU;SM3TMHGL;F2WC!DWQ
M!_+=0-N,Y&0 >10!Z!17*:#X@?Q++I%Q87<@M?L/VB\5E3)=CL5&XX(9)<XQ
M]SWJSXIUN;3)]%T^V813ZK?+:^<5!\I=K,Q /&["X&>,G.#C% '15FW&NV%K
MK-AI4LCB[OU=K<"-BKA%W-\V-O [9SR*X;Q-K.L62>+M DU&=C!H3ZI9WJ(B
M2H &5HVPNW[R\$ '!/.>:;<VUW_;/PZABOW\Y[>ZQ/)&C% ;=>@  X'3(/OF
M@#TVBO.+/Q=JT.G-87,[75]_PD,FCI=+'&CLBJ9 VTX3?M&WTS@X/0IK^J^,
M="\-Z[=O<*BP3VQL)KA(FF9)'5'614^08)X('(H ](K N/&F@VE]=V4US.MQ
M9J'N5%G,1$IY#,0F I]<XK0TJTU"TAF74=3^WR/,SQOY"Q>6AQA,#K@YY//-
M<1;OJ"?%?Q<-.M;:XF;3[,!;B8QJ#A\9PK9'K0!Z!:7=O?VD5W:3QSV\JAXY
M8V#*X/<$=:FKS70;*^\&V>A>![>XGEN#:7%Y/<6HC#9$B_*@E^7&9#V)^4<#
M)Q)=:IXRLH_#MI>WEO;W=WJKV4L@B1S)#Y;NCD#A7PHR!QGVXH ]&HKSG6->
MU?PW<K8ZWK%S! ULBVVM+91_9Y)R6R)P%;R_X ,8&,G-:T6J:EXBU?Q'9Z;J
M)L/[*=+> K&C^9(8PY9]P/RY(  QP"<\C !V%%>9Z9XMUSQ)<>$&M[N/3XM9
ML;I[F-8 Y22+:"5+>Y.,\=,YKIO ^J7^IZ3>IJ4XN;FQU&YLC.$"&41N0&*C
M@'&.E '345Q6IZOK6IZSKNEZ*]Q#/ID<2QM$("K2NF\&3S.=G*CY0#PW/3%=
M-0\47WB^UT6;48=/,VA_:YUMX4D,4XD5&V,V0><XR",=L\@ [PD+U('..:JP
MZC!/J=UIZ+,)K9$=RT3!"'SC:Q&&Z'..E>9+JVK:_I/@&\N=3FAN+C5);>X-
MNB*LC1B90Y!4\_N\XZ<GCIC:O]5U>34?'&G'4I(XK#3(9[1X8T5XF9)2W.#D
MG8.?RQ0!UFHZ[8:7/I\-U*ZOJ$XM[8K&S*[D$@;@,#@$\GM6E7ETD<D?A#X9
MF6YEG+ZE8N#(%RH-L_RC ' ]\GWK2GUKQ-K4>JW'AX.L]AJ+VL4+^3]GD$3!
M7$A;]X"?F(*XQE>O)(!VVH7UOIFGW%]=,ZV]NADD9(V<A1U.%!)_*EL+V#4M
M.M;^V8M;W,231$C!*L 1QVX-</J.JWWB32O&8M[UK*WTM);1(D1&\QQ"'=G+
M G!+;1M(X!.>>.D\%_\ (B>'O^P9;?\ HI: -L$$D @D'!]J6O*K#7+_ ,/Z
M%XGU!M0GN[AO$+V$/VD(45F>.-7;:H/RKVR!P!@5U#:GJ6C>.]+T:YNWO['5
M;:9HWEC19()8@I/**H*L&[C((Z]J .MHKEO'&IZII=MH[Z7=1P/<ZK;6LOF1
M!PR2/@CKQ^'/N*Y^^\7ZMX87QE'>7:ZB=*CM);226)8\&X++M8( "JL ?7&>
M: /2:IZCJ=OI=@][.)7B1E4B")I6R6"_=4$GD\^G-<U?:AJVB>+-$TR749;R
MTUE9H"[Q1K);S(F\.FU0"I /# XP.>HKE=,U36=)^#*ZS;:M-)=F\;<UQ&C_
M 'KQD;' Y.XG)SSTQ0!ZI>6D%_:2VMU'YD$JE9$)(#*>H..U)965MIMG%9V<
M0BMX5"1Q@G"*.@&>@'I7,S:CJFN:YXBTK2]0&GS:5'$D)\M'\R:2,N&?<I^3
M[HP,'[W/3%:?6-<U#4[S1K662*]L;""226Q$)5IY W.)O^68*<8&>3DCB@#M
MZ*S]$DU*;0[1M7CABU(Q@7"P-N0..#M/IWKA+KQ3K<'@;Q%J2WW^EZ;K4EI#
M(8D^:)9TC 88QT8\C'- 'I=!X%<'>W_B&[\6>)-+M=:%G;V=A!<VY2U1F1F\
MSC+9!'R#.1],4W0_%E_XCF\-Z<)_L<][HPU6[FB12QY5 J!@0,LQ)R#P .^:
M .MTC6['7(KF6P=W6VN'MI=\31E9$QN&& /&:T:\I\/:M>:-:WMBDCSW>H>*
M[NT,ZJ@;A2Y8!L)N.S'/&3T.,5>UW5?&.A^&]8NI+A$\F[MA8S3I$TSQR2*C
MK(J?*,$G! Y'O0!Z115#2K74+2WE34=2^WR-,SI)Y"Q;$.,)@=<<\]>:OT %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 5F:[H-GXAL%M+SS%\N5)X9HFVR0RJ<JZ'L16G574-1M=+M
MA<7DRQ1M(D2D_P 3NP50/<DB@"E;:!';W%S>/>7,VH7$*P->2"/>L:DD*H"A
M0,L3]WDGGH,.\.Z#;^&M$M])M)[B6VMUVQ>>5+*,YQD 9ZU6M]?GE\<7GA^6
MUC2*"QCO$G60L7#.RX(P,8VGN:WNE &-<>&[>;Q(-=CN[NWNS;"U=874)(@8
MLNX$'D%B?T.1Q6;#X"L(-%TK2H]0U 6^EW8N[<[H]V\$L,G9R,L>/>NKKG-4
M\2W6G>,-'T%-.BE74TF=+@W)78(E!;*[#_>&.?RH @/@'3AKEUJ,%]J=M#>R
M>;=V$-QMM[A^[,N,\]\$9[UU+*&4JP!4C!!'!%9>IZG=66IZ9:PV<4T=[,T1
MD><H8R$9\XVG/"'N.35*#Q)/JVJW]EHEG%<1Z?+Y%S=3S&.,2XR8TPK%B,C/
M0#/>@!NG>#X]&5H-)U?4K&P+%ELHS$\4>3DA-Z,RC)/ .!VQ5B^\*V-W<Z?=
MPRW%G>Z?N$%S P+[7^^K;PP<-U.03GG.>:K7'BY=)T_5;O7;)K)=/9%Q&_F_
M:-X&WR^ 3ECM ('(.<4MYK7B"RT6?4Y= @811&4VL=Z3, !G'W-I/J ?7!;N
M %[X+TZ_T&ZTF2XNU2\N!=74Z,@EFD#*P))4CJB\ #A0.E3W/A6TO-<;5;BZ
MNI)6L6T]XR4"/$QRV0%SDD9R"*W 01D'WI: .3T_P!8Z?/HTPU/59GT=6CM?
M-G7 C8 >60%&5 4>_')(XH?X>Z/+HM[I,DU\UI<7+74:^=@VLA<ONB( *G<2
M<G)[=.*ZRB@#E9O EI=^'KO2+W5M6NQ=A%FNIYU:9E4Y50=N  >> #SUJ[J?
MA>#4]0TW4'O[Z"]L%=$G@=5:1'QN5QMQ@[1T ([8K=HH Y*/X?:;#H]OI<5_
MJ2VUO?\ V^+,JL5D#F0#+*?E#$GU/<FNK92T102,K$8WC&1[\C'Z56^UR_VO
M]B^Q3^3Y'F_:_E\O=NQY?7.['/3&.]9WB+6[C1Y=(AM;>*>74+]+3:[D%006
M9@ #G"JQ[=* *^F^#8-'T[3[*PU3484L#)Y3[HR660Y96RF",\],^]:NCZ1:
MZ'IRV5F&\L.\C,V,L[L69CC Y8D\ #T %7ZSO$&J?V)X>U#52J,+.W>?:[%0
MVT9QD ^GI0!0D\':9-J&L7,S7$L.KH%N[1I!Y+D($W8 R#M '7'?&>:?IWA:
MWL9;"2:]O+XZ>A2S^U,A\D$;<Y506.WY<MDXSZG.GID]Q<Z5:7%W"L%S+"CR
MQ*<A&(!*Y[X/%-FU&WC:[B6:,S6L0EE5FP$4[L%CCC[I_*@"+7=$M/$.D2Z;
M>F589&1MT3;65E8,I!]05!JM'X9LWDN9=0EFU*>XMC:22703_4G[R (J@ GD
M\9/'H,/\+ZK<Z[X8T_5;NV6VEO(1-Y*L6"JW*\G'\.#^-:] '->'O!EKX<>/
MRM3U2\A@!6U@O+CS([8=,(,#MP"<D#@=35_7M @\00VD5Q<W,*VMU'=H8"H)
MD0Y7.Y3P#VJ^MW;O>R6:RJUQ$BR/&.JJQ(4GTSM;'T-3T 88\,0KK.HZJM_>
MBXO[=+>4 Q[0JYV[1LX(W-Z]:SK/X?Z?I[Z6]IJ.IPOIUJ;-&29098"0?+?"
M] 1P1AO>NAAFO1>WPNH8([*/8;:5)"SN-N7+KCY<'I@G(K'T'7]3UT:?J$.G
M0_V+?P-*DWG8EAY^3<I'.X<\=#QSUH I1?#C2[;3-*M+6^U*WFTJ1WLKQ)E,
MT0;[R<J5*D<$%34C_#S2)['5K2[N;^Y75)UN9GDF =)5"@2(5 VL-H/Z=.*Z
MW.** .5D\(O!X=O;*+6=<N;RX54%ZUX%N%"MD*KX 4=<D#)!/4XKH[**:"PM
MX;F;SYXXE627&-[  %OQ/-3T4 <]:>$K>VDT^234+ZYDTZ)XK-YS&6AW+M)R
M$&X[1CYL_C5:#P%86^C:/I<=_J M](N1=6V6C+;QG&X[.1\S?G7544 <?)\.
M=,>.2)=1U2. Z@-2BA2=0L$V_>2ORYP3GALXSQBM./PM;Q:GJU^E]>B;5(4A
MF&Y"%5 57;E<Y 8]2<YYS5;2?$.I:W+:WMAI\$FC37$\#RF;;+&(V9!)M(P0
MS(1@<@$'U W+O4;6RGM(+B54ENY?)@3N[;2Q _!2: (=#T>'0-%M-*MI9I;>
MUC$41F(+!1P 2 ,UFS>$+62^U.XCOKZ"/5,&]MXG79*0H3.2I9<J #M8?@>:
MDT/7Y]4US7]-N+6. Z7<1PJR2%_,#QAP3D#'##C]36]G% ',:KX&T[4;^SO[
M2[OM(N[2 6R3:;*(RT(Z1L"""H[<<5T%G:16%G%:P;O+C& 78LQ]22>22<DD
M]2:GK!O/$;?\)#_8&EVJWFH)")[@R2^7%;QDX7<P!.X]E [9.!0 D7A2V6>S
M>XO;RZCLKEKJVAG*%8Y"&'!"AB '; )../08IZ5X!T[1K]I;._U-;'SC.FF&
MXS:QR$[LJN,\'D#.,\XK4M-3U!M:&FWVFI#FW:=+B*?S(WPRJ5Y4$'Y@>1W&
M"><:V>#C!- '*R^ K";1-2TE]0U VVHWAO9SNCW>87#G!V<#< <>U:4?ANVB
M\2/KJ75V+F6!()T#@1S!-VUF '4;CT('/2N=NO'M_;^#/$&N?V7;F?2;Z6T,
M'V@[6",%W;MO/)SC ^M=WF@#*U_0;;Q#90V]Q-/ T%Q'=0S6[ /'(ARI&01^
M8-5'\)VZZK-J5E?WUE<W,"0730NI^T!!A6;>K?.!D;A@UK2:C:Q:G!IS2K]K
MGC>5(NY12 Q^F6 _&K7?% %;3M/M=*TZWT^RA$-K;QB.*,?PJ/Y_6L2'P@EM
MK>IZM:ZUJ<%UJ7E_:2OD$'8NU,!HSC ]*Z2FL6V,4"LX' )P"?<]J .:7P%H
M0T&]TEHII$O9OM-Q</*3.\V01)O[,"!C' QTJVGAF(R33W-_>75[):FT%U+Y
M8>.,G)"A4"C)P2<'.!Z"CPAKTOB7PY#JD]LEM(\T\9B1RX7RY7CZD#/W<]!6
ME/J-K;7UI92RJ+F[+"&/NVU=S'Z =_<>M &'+X(L9O!]MX8:^OQ8V_EA&#1^
M9B-@R G9C *CMGBKNJ>'+;5+O3[YKFYM]0L"WD7D)4/AAAE(*E2&[@CZ8J+P
MQK\^N_VN+FUCMGT_4I+$+'(7#!%0[LD#KN]*WJ ,VPT.SL+6[A :<WLC274D
MV"T[, I+8 'W0!@   "LZW\$:+;6.@VB0N8]$D\VT+-D[MI!+'ODG=VY ]*Z
M//.*,\XH YS7/!MGK6KV^KQW^HZ;J,,9A^TV$PC:2+.=CY!!&>>E2CPG9IK&
MF:E'=7B2:=%)#"F]65@^"Y<LI9BQ ).<YK4@U&UNKZZLX9E>>TV"=5YV%AD
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M3NI0QJ&"@?+NSAFYSWK9F:00NT"(\H!VJ[;03Z$@''Y&LCPCKK^)O"FG:U)
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MFDV+V.[=]F:W0QY]=N,9H S?!=A:Z9H36ECJ3:A:)<2>5+QL0$Y\M""<HI)
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MUIV=CH%[,=4TK6K247&F2H]KI\8C66/&0\H#$AE.!DX.3CO7H:V-HMZ]ZMK
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M*ZA2X78Q>)<.A'7#KN7!QU%=YH-G-9Z3']J %Y.S7%S@YQ(YW,,]P,[1[**
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M9B"ZO(S)P""0&7I7/^%]-U;1$\%ZI=:?>M;VFF2Z;>P"!FDMG9E8/L W,"4
M)4'M0!WO_"7:']@BOOMI^SR7(M-WDR928MMV.-N4;) PP'6C4/%>EZ?_ &HC
MO/)<:9;BYN(([=R^PYP1Q@@[3R#@8.<5PVK>'M2;3/$6KVUC<NEWK=I?PV2Q
MGS6BA:+>X0\[FVL=IYP!WXJY/!J.K^)?%%Q#I%_%!J&@);VTD\7EAG'F_*<G
M(/S#@\COB@#M?#^KKKN@V6I"*2(W$*2,CQLF"R@D#<!D<]1P:TZPO!CS'P?I
M,5Q9W-I+!:10O'<)L;<J*#QUQD$<^GIBMV@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL'Q7XAF
M\-:?:W<5A]L$UW#:L@E"%?,<*",C!Z]./K0!O45QQ\<G3I?$$>O6"69TBVCN
MR;>?SA+$^X*!E5PV5(QTR1S5N3Q/>V&LZ9IVJ:;# =45UM9([@NJS*N[RY/D
M&,C.",]",>H!T<TT5O$TLTB1QK]YW8 #ZDTD]Q#:PM-<31PQ+]YY&"J/J37F
MJ^*;^;X7:KK.O:/8ZG"EU,CVQF.UU6X9 "&0C"X7'7.,\&M7Q//J)^(OA:RC
MM[66U>*\D$<L[*'94098;#@@.V.N=QZ4 =I#=6]SN\B>*7;C=Y;AL9&1G'J"
M#4M<!I.KZ+X6B\3PVN@0:='I5S#"5M6!:Z>15,?88)+JHR3C/I6[+KNLV<FH
M)=>'I91;V?VJ![*7S5G;D&$952'X'8Y!_"@#HJ9)-%#M\V1$WL$7<P&YCT ]
M_:N13QC=R7^K:4+2R_M"STX7R&.Z,D>264HYV@JRE?3D'M69;>(;F7P;X-OM
M;TFTOY-1N[-5D:7)BDD *S8*<,"6X'3UH ]$K,UO1(M<MX8)KR_MEBE$F;*Y
M:%GX(VL5Y*G/2LJY\574@UJ32-.CO8='<Q7&^<QM)(J!W2,;2"0&'4C)X]ZJ
MIXYFU'5-,M-%TR.ZCU/36O[:>:Y\H  H-KC:2/O]LG/;N #KH((K:WC@@C6.
M*)0B(HP%4#  _"I*Q?"NO'Q)H,6HO:_99O,DAF@W[PDD;LC -@9&5X.*OZG>
M2:?I=U>16DUW)!$TBV\ R\I R%7W- %NF/-%&R+)(BM(=J!F +'K@>M<I;^.
M(HM5U*QU6*V@^P:<-0EEM[CSE1,L'1OE!#*5Z=\CI6'K-U>:EXH\!:A<:9;V
MZ3W<CQ.)MTJ V\A"/\HQD8)P2 1CGJ0#TJBN3LO%]S<6>N^=ID4.H:5="U%I
M]J+><S!?+(;8,!]PQP:9J_C6:Q;4H[+3X[R?3 OVB$2N&=R@<I'A#N(5AUQD
MG'T .OILDB11M)(ZI&@+,S' 4#J2:XZ7QGJMQK?]EZ5X?%Q(VGPZ@AN+KR#Y
M;MMVL"IVL,'CG\*S[;Q)JEQX?\:W>K:997MKI]S<Q&V$YVM''$F8\%,$$;CD
M]23P!0!Z$K*ZAE8,K#((.012UR'_  ET5L^DZ9:6MG#<7>G+=6\$]QY*/P (
MHSM()'Z#'![2:CXOEMI9K2ULHI+ZWM([F>&:5DPS@E8P51LM\IZ@ 9'7/ !U
M=%<9#XVOKW4=)LK/0F634M/>\C%W.83$R%04==A(P6ZC/TJFOQ"U :$NL3:#
M'':V]]]AU#_3,O&_G>43&-GSJ"0>2I]N] '?T5R&L^-GL7U,:=8+?'3'"3Q"
M1EDD;:KLL8","0K#J1D\>]-D\8ZG<:S=Z9IFAI+)%I\5_&US=&$,CEOE8;"5
M;Y3Q@^Y% '8USH\'6L6H7-U::EJMHEU*TT]M!=$1.[<LV""5SWVD5A'QEJ>J
MWW@F;2[:!+/68Y9Y(YIBK96$G82%/ )SG') Z5W] $=O;Q6MO'! @2*-=JJ.
MPJ2L6]UV1?$":%I\$4]]]E-W)YTI1(X]VU<D DDMG QT4GT!P'^(<ATVSGAT
M=GNGU?\ L>ZMC< &"?..#MPP[@\<$4 =S15+2I[^XTZ.74[*.SNR6#P1S>:J
MX8@$-@9R,'IWKF;GQXT/A]_$T>GK+H$<YC>99CYWEB3RS*$VX*[@3C=G;S[4
M =F2 "2< 4R*6.:)98I%DC895D.01[&N*35=1U;Q7XITFZ@LY=)MK*W*+YA/
MRNLK;MI7#%L#(R  !UK+\"^([S3/#7@BPN=,1;#4;9;:*Y%QF02"(N,Q[<;2
M%.#NSZ@4 >F45Q4OCX[H+FTTTW>GR7AM6:%G:95#E#+L"8*@C^]G'/M5G2_%
M.KZMKE]8PZ%$MO87YM+F<W@RJ^6'#JNWYOO $<8R.3S@ ZRBL#Q3XBF\.QZ:
M\6G_ &P7M_%9$"8(4,AP",C!_,?6LP>.VL(_$0UO3UM9M&$+,MM/YRS+,/W8
M4E5^8M\N",9[T =E3)9HK>,R32)&@(!9V &2<#D^]<[)XEO;+7[+1M1T^"&?
M489&LI([DO&TB+N:-SL!4XY! .<'CCGE[?Q3>W/PK76]>TBRU**2[ :(S?*<
MW113M9#@(VS R>!G(- 'I4L2S1-&^=K#!PQ!_,4L<:0Q)%&BI&@"JJC 4#H
M*Y^_\1WGVO5;31M-2_GTN)7G1YC&7=E+K$F%.6*X.3@?,OOBK?\ C*2)Y+>S
ML%:]ALX[J:WNI&C*EP2L7RJWS_*<]AQUSP =915#1=3&LZ+9ZB+:>V^T1!S!
M.A5XSW5@>X-<Y=>.GBT"?Q)!IRSZ%;SM')*LQ\XQH_EO*J;<$!@>-P) S[4
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MQU;/([8QWIT/A;Q3*?#*W][I3?V'<;O.C60M<((VC!*\!6PW(R1GG/:N]HH
MYN?PJLGCF'Q EQLA-N$N;8#B:1"?*<_[H=_QV^E49_#OB33O%.H:EX>U#3UL
M]4*/=6]]$[>5(JA/,CVD9RH&02.G6NRHH YFTT#4+?QPVM/-#+:G3([ [G/F
ML4=GWGY<<EL8_'VK//A'5H]-\7:=%=6;6^MR7$L)8,'C:9 AW=1A<'&.N>U=
M#K.OVVB3Z;%<0W#_ -H7:6D3QJ"JNV2-V2,# /3/2M6@#BM2\)7NJ:%!I%_:
M:5?6B6"6^V9V4PS*"/-C8(3R,<<'CKZPKX2\1Z+J=MJ&@:M:32/8P6=^FIHY
M$YB!"S J<AN3D=#ZUW=% '+'P_J?_"6Z5K#W-O.MG936TI<E6D:1E8L  0H!
M3 &3P>O%8\W@G5Y?!NIZ)YUB)KS5&OQ+O?:H,XFVXV\GC;GWS[5Z#10!Q9\.
M^)M-\1W]]H6H:;'8ZJZS75O>1NY@F"A6>(J1NR%'#8Z5;A\/ZE;^+;[5UDMY
M8I]-BLD$DC!R4+'>Q"XY+\X]*ZACM4G!.!G ZFJVFWC:AIT%VUI<6C2IN,%R
MH62/V8 G!_&@#BM.\$:OIVG>$$AN[+[5H/FQN7#LDJ.A0L.A!'!QT]ZZ31;G
M6)M4U>+4?LCVD4P%G+;JP^4YRCYZLN%R1QEB.QK;HH YK4?#]ZGC&W\3:5)
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MGAF>-[H7DC"=U>288(=F!!)&U<=A@<<5(?"^F&_O[[;<"XOX5@N7%S)\Z*"
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M9)\4W-Q<OY<; *\S,,-9ANA]"3CT'%>BZ3I5IHFF0:=8K(EK @2)'D9]B@8
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MV@<#&R-BN5 _X"/ISZFJC^%M+>]U.[*7 FU2-8KMA<R#>@!  &<+@$CC'4T
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M=I1-<"ZDF:1A*9A@+('!R& 4 $8P!CI2R^%=+N+"_M+A)IEU!!'=R/._F2H
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M +0, MS)]H?'E@[MNW.W&>>E '"6OB74K?2FM[G49G:Y\62Z3]KDV[HX0[8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&
M4,,, 1Z$4M% ";5Y^4<\GBC: <X&?I2T4 ,6*-6++&H).20._K3B >H!I:*
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M*Q4Y&1G!IU%% #5C179U10S?>8#D_6E"@'( S2T4 (0#C(!QS1M7^Z/RI:*
M$VK_ '1^5(L<:,S(BJ6Y8@8S]:=10 UXXY5VR(KCT89H9$?&Y5;!R,C.#ZTZ
MB@!NQ=I7:-ISD8X.:%1$0(J*$'10.!3J* &I&D:;8T55]%&!0D:1KMC157T4
M8%.HH :D:1KM1%49SA1BEVK@#:,#IQ2T4 -,:,ZN44NO1B.12[5)S@9^E+10
M W8N0=HR#D<=*=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)LDR 2I (R/7/M5_6]"\5>)/!NH:=?RZ5%?78C1(X7D\F(*X8L6*[F8XQC
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MS;W&'^U>5NW"(KC;_L[L].V>@!%<_$2ZM])U753X><V>DW[VEX3=J&"J5!=
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M>:=Y3D+.)5DCD#%6!P,'Y6!&.,=35_6-1FTVTCDM[&:]FEGCA6./.%W-C<Y
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M4R2P9SG;CD#!QSCS_#V]C\(ZYHVF&TM8M1NXIK>T:=VAM%4HS!3MS\S*3@
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MZI_9CQQ7"D))YA3*L<;P<9'3/&<51T_P9XAT[0?#%B)=,G&E2RFYM999/)N
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MO=6@L3>_9(S*\*R;&*#EB#@\@<X]JI>'8/%JF-?$=QIC+ NT-8[RUPW3<^X
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M\FTE7+;P"2HQM(]Y)/$UY;^,#I6J7=UICRWRK8[X$:TO(>/D63:2)#SP2.<
M=: .\HKGO&&NS:'IUB+8JMQJ&H6]A'*PR(C(^"^.^!G';.*H+J&IV7CI?#D]
M_-<6M_I[W-O<F.,36\B,%8<*%*D,",KP?6@#63Q3IDFIV]BC3,;B62&&=86,
M3R1YWIOQC(VMUX^4CJ*VJXCX402Q^!K>22[FF#SW.$D"80BXDR1A0>>IR3[8
MJEXV\1ZQHT'B&\L=1#-IT4,L-M;Q*ZQC@M]H++P6SP%;.,''>@#T2BN*O+K7
M;WX@W>A6VLFRL_[)CNT:.VC9XW,C)P6!!^Z.H/?IU&1;^*M;;P=X4\5W-]LL
MGD2/6(TB3!1F*"7)!*@/M+ =B<8Q0!Z9161HMQ<WUUJ5V]RSV1N##:QE5  3
MY7;(&3EPXY)X />N:\0>)KS2?$LMIJ%W=:592M"MA>B!'M9"<;TE8J2C$Y Y
M Q@_4 [RLZ+7+&;7Y]$1Y/MT$"W#HT3*-C$J"&(P>0>F>E<7XH\2:QI0U2]M
M=1$HL]0MHEM[>)6ACB=HE99F9<^8=['"-D H<#)J75=2&C?$C7M4,9D%GX56
MX*#^+9-,V/TH ] HKC=)N/%$^I:/>F4RZ5=0%KQ9S" K%0R-#L^;&>,,3QCO
M5[Q%K4]KX@\/Z%;2F!]6EFWW 4$HD4>\A001N)VCD'C/% '1LRHI9B%4#)).
M !6/IWB?3M4U!+.W,^^6W^U0.\+*D\60-Z,1@CD>_(/2N5O=3U.6+QKX=N[Z
M5S86(N;>\1$61XY(W.QQMVY!4C( )![$9KHO L,D/@;0]]S+/NL(&7S HV Q
M+\HVJ.![Y/O0!I:OK%EH>E76I7SNMM:J7E,<;2%1C/1035N"9+B".:/.R10Z
MY]",UY/<I='PA\49+C4KJY$<]U$$EV8P+>/!X4$8'  .,=L\UN6^L:KH6OZ7
M;W>H&\L+O1IKHV_DHGDO"(S\A W$$,1AB>?RH ] J&ZNK>QM9;JZGC@MXE+R
M2R,%50.I)/2N+T74?%.IC0-8B?=87L:R7L,QA$2HZY4PE?GR"0,,3D>]0_%)
MW)\)VDO&G7.O6R78/W6 )*JWL2!^0H Z1_%VD16ZW,SW4-NY 2::SF1&).!A
MF4#DD8]<\5N5#=VT%W:2V]RBO!(I5U;IBN-76-6UZ#Q3<:;J!LGTBZDM+:$1
M(RR/%&K$R;@20S,1\I& /6@#IKC7+&VUVTT:5Y!>W<;R0KY3;65,;OFQCC(X
MSGD4NCZY8Z['=O8O(RVMR]K+YD31D2*!N&& /&17$VVL'Q!XJ^'FKM#Y+7FF
MWLS1_P!TE(20/;-,T>\N+'2?%4MM>P6;MXHE0S2J6.UFB#"-0#ND(R%&#DD4
M >DDA5+,0 !DD]J"%=2K ,I&"#R"*\E\1ZUJ]WX+^(%G->WD9TS8()'6-)C'
M)$K%'VC&/F/3#8//.:ZF[U'4O^$@7PW:7=Z\D6G"\>YC%N)7+NRK]]0F%VGH
MO.1SUR =18Z98:8CI86-M:([;G6")8PQ]3@<FK5><R:AXR%]X4TJ]U*VL;W4
M([N.\:WA24;HTRCKGH<$''3/J.*B\3Z]K^@:7K$T>M"[N=+AMB%M[=-IX7S&
MN,KA2Y)PJ-D @X[T =T-<L3XB_L$/)]O^S&ZVF)@OEA@N0Q&#RPZ$UHUQLG/
MQEMC_P!2_+_Z41UV5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-+>4W"S26_VJ596C8Y0Y+*JCC/4D^F.NUGPAH'B 6O\ :>F0S&UX@8$HT8]
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MS2,WE(QRB $_+A=N0.^:S=0TB\G6'PQ;:3;+X;,,:RW,ER6945N81&02<@
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MRNRPANHC4DA,_P"R!0!R_@.QFO9K_4KO5M4GDLM6OK:**2[9HS&)"H#*?O8
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MJ6<"2J'1I)E 93T;.>A]>E,O?$FAZ=+)%>ZQ86\D85G66X12H)P"03QDGBN
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M6=K@R),O<KR&WC@ 'GBNJLYDA^+-^T\R_+H4"/*>%+K+(S#/3(!!(]#0!?\
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MVE>[#<&QCN#6QXAUJPTGQG>7,E[%Y>I:)'"QN8Y3$/FDVE&1&!ZMN4X[8/7
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M[1[A%9VB692P5>&.,] >OI38?$.B7,44L&L6$L<TOD1NERC!Y.NP$'EO;K7
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MJ X(8A@0W'OUQBMK5/&,>EI?-)I5\XT^T6\O-NP>4C;N 2V'8!&) ...N>*
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M)C*^6,;MWS<$;ER!GKQGFM/5M732C9Q_9YKB>\G$$,<0_BVELL3PH 4G/\Z
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M>$7%Q9R+'YC0D$B12'VL.#G!XJW'XTA,2//IE[:F=U2S%P8T^TAD+[E);Y0
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MRY"A@ ,DD]*K:]=2ZE\1++P_=:;/<Z8VFSRO$'0+(Q>-1)RP/R@L/4$Y [T
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MM)!( 8$GZXR00 #=HKC;_P"(4-G-J\46@ZO='2' O/)2/Y$*!]XR_P PVD'
MY]A6FGBNSO7M8])BDU":YLUOD2(JH$+<*S%B,$G( Z\'IC- #]$T"72-7UF_
M>]6?^TYUG=!#L\M@@0 '<<C"C\:W*YJU\;:;?VNGR6:2O<7TTENEM(5C=)(P
M?,1\G (QC SG(QQS4&I:S83W?AMM0TO4(YKF_9+;+A?(F57!\P*_/RAO[PH
MZRBN)MO%4^H1^+DU'2+K[#IDCP%89(]S1B)689W@[B&)XZ#C.:T--\06$6DZ
M!::9:SR27M@D]K:EP72 (O+LQ[;E&<DDGOR: .FHKDIOB#IT.E?;6LKXM'J"
MZ=<VX13);S%@H##=R/F!!7=D$8K1T;Q*FJZMJ&ERZ?=V%[9+'(T5QL.^-\[6
M!1F'\)&,Y% &Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^7M=&V[MP"9R=J]".E $OBF^U#3= FN],M9KF>-X]\<"!Y?*WCS"BGAF";B
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M$:O'$<DA %VC).22#GCT &AHNE1Z'HMGI<,\T\-I$L,;S;=^U1@ [0!T [4
M9%[K%S=>-X_#-K<-:!=.-_-.BJSG,GEJJ[@0!D,2<'MTKC=2U[6-6T^RM+B]
M>WN[#Q7#IEQ);HH6Y4,K(^"#C@J=O3(].*[[4_#D&H:Q::Q#<SV>I6L;0K/#
MM.^)N2CA@0RY ([@]#52Z\%:?<Z0EBMS=PRK?#4?MD;)YIN V[S#E2I],;<8
MX XH YN>+5!X\\5_V=J8M9X=)LW,[0+(S,HF(X/RC)'/'TQ5O3_%VHZ]#H=K
M D\5S>:,FI7#V:Q%@6*J HE.W;G=G@G[O2MU/"4$>IZEJ"ZGJ'G:A:I:RY,9
M 1 0I&4SGYFY)/6LZ7X<V/V#1X;35=4L[O2(O(M;Z&1!+Y7 */\ +M9>!U':
M@#-DU?QG%<>%M.O9K.QO=0FN;>Z*PK)D)&[)(,,0#@ [?7OCBN[L(KJWTZWB
MOKI;JZ2,"6=8_+$C8Y;:"<9]*Q7\'6SW>CW7]HZ@)M+D>6-RZ,9G=2KM(60D
MD@D<8 [8P*Z.@#R7Q'JE]XG^%O\ PD/VPQVES?P%+,1J5$0O$1<MC=OR Q.<
M=1CO753:UK:>,-?TRV\FY%MI"7=E;[-N96,@"LV><E!Z=:AE^&MBVF7>DPZO
MJ=OI-Q<+<K8Q-'LA<2"3Y"4+ ;AG;G')K5F\(V\^JZCJ+ZEJ GO[ 6$FUHP%
M0;L,N$R&!9CG/4]* .57QI=S^&?$-[8:K(-1TW3FGEL-2LPD]M,H9CE0%RIP
M #R![YQ5@Z_XBT76?#UQJ=]!>Z7K,;))#';!&MI!$9 58'+ A2#GZC'06O%W
MAP1>&?$%^9+O4=5GT>73X6$(9V4@D*%C49)8C)Q],<UI:!H,<MIHM_?7%W<R
MV=J%MX[F,)Y+,@5B5V@EL97)[$^I- '/S>+M7A\":?XX$ZO;RRQ27&G^6NP0
M22! %;&[>NY3DD@D'@<8NOXIN8O&#:1J-Y-I<[WJK91S0+]FO8.,A),$^8>>
M,CG QWK2M/ UA9V:::EU=/H\=R+F+3G*F-&#[PN=NXH'^8*3^G%6)_"<%W*%
MNKZZGM%OA?I;2;-J2AMX"MMW!0W.,_CC(H X[Q+K6LW'A7XB0/J'E-IC>7;R
M6\80B,PJY7G)YW$9Z^F*Z&XU'5-,\2^$=,%\)K2_%PMQYD*AV*0EUY&  #CH
M.W6K4G@BPG@\0P3W=[+'KW-TK,@V'8$!3"C& !USTJ4^$HGOM$O9M5U&6XTC
M?Y3.8OWI==K%QL_N\?+C\^: .;F\6:O<^!+[QI8W"K':S3.FGO&NQX(I"A#-
MC<'(4MD' ) P>\KZSX@U3Q!KME8ZI%9VUOIMO>VQ^R!G0R"0X.20?NC/Z =:
MV!X&L%BOK..ZNDTJ^G-Q<:>"GE%F(+ ';N56(Y4'UQC)JT?"L']M:GJB7]ZD
MVH6R6TB+Y>Q$7=MV@ID$;FZD]: )O">JS:[X1TC5;A56>[M(YI G0,R@G'MF
MIO$%U=67AZ_N;*:TAN8H6:.6\8K"A]7(["L6T\*W&D2^';73=5U(6.EHT3QR
M21^7+%MP ZA1N8<8.!CDYSP=KQ!HEKXCT*ZTB\:5(+E0&>%MKJ00P(/J" :
M.03Q+JZ:CXCL8KN25;324O[2>]M0CACY@.5 7*G9QD ]>HQ2:1X@U\7W@J:^
MOX;BWUZS)F@6W">6X@$H=6'.2001TYX K7/@:"2]NKV;6M5EN;NP^P3R,\7S
MIEL-@)@$;B.!COC/-31>"[6%O#Q74=0/]@H4M03%\P*>7\_R<_+QQC\Z .*\
M0ZI?>)_AE#XA^V&.UNM1MV2S$:[1$+M57+8W;^ 2<XZC'>O63G:=I /8D9KB
MG^&MB=-N=*AU?5+?29;E;E+*-H]D+B02?(2A8+N&=N2.37:*I$87>Q(&-QQD
M^_I0!YI)XL\1+X0FOEN[;[7%XA.G,QM_E:+[2(@ ,\<?4UT6A:EJJ>-=8T+4
M;U+R.&U@NX)!"(BF\NK)@=1E 1GGGDFF'X?V1TB733JFI^3)J/\ :3-F+=YO
MF>9_SSQMW<XQ6M;>'8;;Q-<Z\+V[DN;BW2V>-]GE[$)*X 4'.6/?O0!'XEO;
MJRBL!;WD5JDUTL<SE=\K)M8[84VMN<D#C!XW'M7+:?XSU.33TM9W O)O$,FC
MQW$L:AE107WLH^7?M!''&2#CM76:]X<AUV;3K@WEU97>GSF:WN+8KN4E2K A
MU92""1R*QY/AOI4VFW]E)>ZBPNK[^T4E\X>9;7']^-L<'/KF@#*\=IXAL?!6
MO?:-7#0">W^RRQ*JS-$[HCI+A0O5C@KC(Z]ZVXM0U*'X@C0)+]YK5]':ZWM&
M@=9!*$R"% Q@]"#S4L_@NVO?#E[I&HZEJ%X]X$$MY+(OG?(P9-N%"@ C(&WN
M<YS4ESX22?5+'4TU?48;ZVMVMI)T:/=<Q,P8J^4P/F&<J%QVQQ@ P-&\2:OJ
M7AC0;NYU"*%[NZN8KEXH@;B4(\BH(8]K GY5+$C@ GW&5J6LWNN?#6UN=0P;
MF+Q!#;,VT*6\N]" D#@' &<<9Z5TMK\.K*QM])2TU;5()=+EGDMYE>,L!,<R
M(=R$%2?49'K3A\/-/71I-*74]36V;4/[0'[Q&97\SS  60\;N><D]S0!7DCF
ME^+>HQV\Y@F;P["$E"AMA\^7!P>#]*CT#Q%JFK:7IUA-=>7KJ7TEOJ06-,1B
M+)D(&,;2#'M/_31>O-;=QH\.FZY=^*S/J-S<I8?9VM8E1P\:$N JA0Q8DGOR
M3BJWAG3X;K6M3\4_V;/8S:BL4:1W*;)=B+RS+_"2>,>B*: -O69KZWT2^FTR
M!9[^.W=K>)CP\@4[0?J<5P\/CU4T35M0@OYKF:V%M";"_MUAN+6>238?,4!0
M5^9#UQ\IYKO=1LEU'3;FR::6$3QF,RPD!TR.JD@X([<5AW7@K3=3^WMJTDM_
M)?6BV4LD@5#Y2L6&-@'S;CG/J!C% %1)/$B7>IQ7L<LFCOI[O'+=>2LT<XR"
MH$1P4*\Y(R".]<Q:?\B9\*?^ORU_])I*[/2_"']GV4\$^N:M?N\+6\<UW*C/
M#&>H7Y<$G R6!/ J-/ UG'IF@6"ZEJ(BT.59;4YBW,54JH?]WR K$<8ZT 9%
M_P")-<MV\?K'=6^[1;6.>S)M^%S"TA!&>3D 9S^%2Z=K6N0^)?#<%]?Q75MK
M5A+*T2VX3R9(TC;*D<G.X@Y_#'2M2Y\%6EU+XA=]1U ?V]"L-TJF+"J$*#9\
MG'RDCG-/;PI#%>:-?K>W\LVBV[PVT>8@)0R@$/\ (.2%49!% '+1^+-?OK#2
M+BUNXHM2O-7>QN=->!7^S1AW!.T8?*JJL23@[CP,BO0M1O4TS2KN_E!:.U@>
M9PO4A5)./RKR_1K751;C^S]2\566L.6D:RN].5K=)&8L5:9XL-'N)YWY(Y'/
M%>L21I-$\4B*\;J596&00>H- ' 2^)M9L?#GASQ/+<I/;ZE+;+=V0C4+$D^-
MIC8#=E2R_>)SSTJWX>O?$>L:_JXFU:V2STO5GMS"EF,S1^4C!<ELK@L#GD]?
M:M"P\$V5A;65C]LNY]-L)Q/:6<Q4K$P)*#=MW,%)RH).,#K@5>T7P[#HEYJ=
MS#>7<YU&X-S,DY3:KE0OR[5! PH')/2@"#Q;KDNB6-BMML%UJ-_#80.XRL;2
M'EB.^%#''<XKGK>WOK;XLZDAU SRGP_&899XERG[Y^"$V@\Y/;K75>(O#UEX
MFTEM/O3*BB198IH6VR0R*<JZ'L0:H6GA#R-:?6)M<U*YOGLA9-(XA *!BP.T
M1@9!/^.: .;M_&>J#P1X9US4/M0M+N%GU*]L;99&MS_ 2F#A.N2 <8'K5B37
M=<N]5\,6&FZY8RV^JV=S(][';!PQC"X=1G'\73C!ZYZ5N:;X/31M.TNRT_5]
M0C33HI(8B_E-O1RIPXV8.-HP1@_6N<O/#ZZ5XQ\':?I0OX;6Q@O0]S';EU5I
M-A&]MNP;CNXXQVQQ0!'9>--:MY&\/ZC+#)JRZXNEB^2(*K1-'YHDV= ^WC'3
M)'7D'1O?$&OZ7KFM:# IU2ZCTL:EI\A15D/SE&C8+A6(/*X ST/K6M<>"-,N
MM,>UEDN/M#WHU#[<K*)EN1C$@.-H( "@8Q@8Q4S^%HIC=SSW]V^H7,<<1O5V
M+)&B-N4( NT?,2>AR3SVP <T?&$USX/\2ZIH^LM-/IUH91!?6@2XM9%5F99$
M 7K@8.,<'KBK<VKZ]<^)]#TNWU"&W@O])DN9'^S!G5U\OD9./XS@8P/0UJ77
M@RTOX-76[O;IKC5K9;2YN$$:OY2A@% VX'WVYP3S[#$L7A."+5]-U(:E?F?3
M[1K.('RMK(VW)8;.ORKTQTH YFU\8:N/"6G3W4D?GOK;:7>7ZQA5CC65T\W;
M]U2=JCG@%L^U;GA;4M6O]<UZWN;N.ZTVQN%AM9Q" 9<HK-EE.TE22IP!^>:P
M]>\.#0M(LM/MIO$$MC+J4E[<7=FB2S6['<W^K5/F4NW]UL8^F-GPC%J,<\K'
M4]5O=,,6$_M2S6WD63/\ "(VW&<[E],=Z +6O:U/;^(]"T"VD\B34S.[SA0S
M)'$@)"@Y&XEEZ@X&>.E<UJNKZG<Z-X]T"[NF,VDV1EBO$C56FADA=@K#& P*
MD$@#/!&*['6_#UMK<MC</--;7MA*9K6Z@(WQDC##D$%6'!!'-5Y?"=K/INKV
MLMW=>=JZE+R[78)'79L"CY=H 7@#'J>I)H D\(PR0^$M)$MP\Y-I"0SJH*C8
MORC ' _.L.R^VR?%?7$?4IVMX=.MG2 JFP!FERO3/49SG)]<8%=9I>GKI6EV
MU@D\TZ6\:Q(\VW<54 #.T =O2L^;PS#)XDEUR&^O+:XFMEMI8XF38X4L58AE
M)R-QZ'![@T >?>#=2U?1O"/@*5+V)["_G6QDL_(' 99&#[\YW K],'IW.ZFO
M>)M9M#JFA02.L>H20BVD\@020QRF-LL6\P/A2P/ ' P>ITX/ -C;:1H>F1ZG
MJ7D:-<+<VQ+1;BP# !CY?(PS>G6B+P%9VVLW5Y:ZGJ=O9WDQN+G38Y@+>60_
M>)&-P#=P" >_'% '37;SQV<[VT:R7"QL8D8X#-C@$_6N$T7Q==:C::@$U-8=
M6M-/>2XT[5X1;FVG&,.2%&8<YYR<#'/-=W>6RWME<6KLZ)-&T;,APP!&,CWY
MKG+[P+8ZM%.NJWEW>R2V#Z>)GV(ZQ,02<JHRV54Y(QQTY.0#+TSQ#JTOB2XT
MH7K3Q-HPOHKBYM0F)0^TE5 4E#U&1GCJ16;9>)/%$FB>#-7?4[9_[;F2UFMV
MM!M4O&["0$$'(*=,@'./>NF@\$QQ:I'J<FMZK->K8FQ:61X_GC)R"0$QD'T'
M/?-)%X#LH=)T+34U+41!HDZSVIS%N+*K*-Q\OD ,PXQUH Q6\6ZMHS>(K"\N
M%O[BQO[.VM9S$L9(N=F-P!"G:6/<9P,D=:Z#1)/$2Z]=PZA'*^DM KV\UR81
M,LN<,A$1P5Q@@X!'(.:CN_ >EZ@^O&]N+RXCUL1_:(V9 $,8 1D*J"",#J3T
MJ[H/ATZ*"T^KZCJD^WRTFOI%9D3^Z-H YP,DY)P,G@4 9/C*Z=_$?A#1LXM[
M[4&EF]&$$9D53[;@I_X#3?%VLZII\VH_8[](A;:8UU!!;Q"65I1N):4,I"Q8
M4 '*DG=@Y K5\3Z-)J7]FW]HH:^TJ[6ZA7./,7!5X\GIN1CCMD#/%5;[P?9Z
MQJ-YJ8OM2M1J5F+2[MXRJ+*@#;<AE+*1N/0C^>0#'GOGU/Q7\.=0E55DNK2Z
MF95Z M;H2!^=7_ ?_']XQ_[&";_T3#5NV\%VUM/X?F&IZ@[Z'$T5ON:,AU90
MIW_)S\H XQTJ]HGAZ'0I]3EAN[J<ZC=-=RK.4PLA 4[=JC PJ\'/2@"GJ^LS
M_P#"6Z7X<M9C;M=V\UU-<!065$V@*FX$9);DD' 4\<Y'(^(M8U*_\%>/=&O;
MD_:=&C93<Q(J_:89(MZAAC .#@[<=.,9KNM9\.V^KWMA?B>:UU"P9FM[F#;N
M4,,,I# AE(QD$=N,55N_!ME>:'JNF2W5V#JK%KVZ0H)9<J%QRI4#: H ' 'K
MDT :>BPR0:/:K+</._E*=[JH.,#CY0!5^H+*V^QV<-MYTDWE($$DNW<0..=H
M _2IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG P=P^4]QVKI:\5TVVLF^&7P]CB$:/-JUF9S"=KDD2#)(YSP1GKQ5S4KE_#
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MX P/7CS]9)+KX4Z7XELF8^*%NX<SCB62X:X"21/W*\L-AX  XX%=+9Z;8?\
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M*73;-[Y0 +EH%,@QT^;&>*Y_Q5XPAL- TZ\TR<S+J5W;P17,$32J(WD568$
MC=M)P#U/8XQ6C:22:%H]_J-]J5[?V8)N8EDM3YT,>T'9@ ,W.3R 1G!Z9H T
MKC2M.N[@7%S8VTTP 7S)(E9L Y R1V/(J<VUN;H71@C^TA#&)M@WA"<E<]<9
M ./:N!O?&4MU#X+UB"ZFL;+4;D+=P21;596@:3&67)P0,%3@^]=;8^)M'U'3
MKB_MKT&WMY3#,71D:.08^4JP#!N1@8R<C'6@"1_#VBRZ?]@DTBQ:S\SSOL[6
MZ&/?G.[;C&<]ZD?1]/V7OEV-FKWJ;+AC I$PV[0''&X <8)Z<4S3M<T[5;BY
MM[2=C<6I43P2Q/%)'N&5)5P#@CH<8-<O?^*ET#XB7UMJNJ2+I8TF*YCA\K?M
MD,KJVT(NX\)GOCGM0!U>CZ5;Z+I4.GVBJL,6[ 50H!+%C@#@#). .!TJ6[TZ
MQOW@:\L[>X:W?S(3-$KF-_[RY'!]Q5$>)]&>RL;N&]6>*_!-K]G1I6F &3M5
M02<=^..]87B?Q$TNC>']4T+4R+:[U>U@=HU!$L;RA74[AD=".,$<@T =-)HN
ME37_ -ODTVT>\^4^>T*E_E^[SC/';TJU)!%,T;2Q([1/OC++G8V",CT."1^-
M9=YXIT;3[F6"YO-C0R1QS,(G9(F?&P.X&U"<CJ1U'J*BO_&6@:;=7=K<Z@!<
M6B+)/$D3R,BG.#A02>ASCICG% &S'!#%)+)'$BO,P:1E4 N0  3Z\ #\*SX?
M#6@VY4PZ+IT92;SUV6J#$G3>./O>_6GOKVFI:6ERMSYL=XGF6WD(TK3+C.55
M021@@YQQFHX?$FD7.F6^H6]V)[>Y)$)AC:1Y",Y 106R,'(QQ@YH M66E:=I
MR2I8V%K:K,VZ000J@<^IP.35.U\+>'[&5);70]-@D1S(C1VJ*58]Q@<&K>EZ
MM8ZU8K>:?<+/ 6*;@""K X*D'!4@]00"*J7GB?1["61+J\\M8I%BEE\MS%$[
M8PKR ;4/(ZD=1ZB@#695=2K %2,$$<$55L]*T[3H'@L;"UM89"2\<$*HK$]2
M0!S7->(O$+)XLTKP['+>V\=U#/+/-;6[L_RA @4[2,9?)(Z8 .,U:U76W\&>
M%[675;B?4[KS([<SI;$&1W<*&8("%Z_B>!R0* );WPO96_AO5]/T#3-.LIK^
MWDB/EQB%&9E*@L54GC/I3_"_AZ#0]&T^*2QLHK^"U2"66W7.X@ $ABH."1GI
MUK$N/%7]F_$&>*]U"X&DMHR7<=NUN=RR&5E.$5/,/RKG!!QSVKIE\0:6^FVF
MH177G6]VH:W,"-(THQGY54%CQR>..] "1^&M"B??'HNG(WGBYRMJ@/FC.'Z?
M>Y//7FJNDZ?K,FI-J.OO8&>%7AM([(/M6-F!+,6YW$*@XX&#ZUI:7JMCK5BM
M[I]PL\#$KN ((8'!4@\@@\$$9%<UHFL7WC#4=8DM;V6PTK3[MK&(P(ADGD0#
M>Y+JP"Y(  '8DGM0!T;:-I;W<MVVFV;7,R[)9C I=U]&;&2/8U$/#FAB"" :
M-IWDV[[X8_LJ;8V]5&.#[BN,U3Q3JMC#XNT&:]9=4TO2WU*QODC0--%M)&]2
M"NY6&TD  @Y %;WAWQEH^JBQTL:HDFJO:)(R%6'F':-Q5B-K8.<[2<<T ;$F
M@Z1+JR:M)I=D^HH,+=M IE';AL9I&T#1F^T[M(L#]J_X^,VR?OO]_CYOQKCK
M#7I1X1\23:UXBGLQ:ZO<VD>H"-"\:(X"@*%P3CC[O>NROM;T_39?)N9V\[RF
MF,<<32.(UX+D*"0/>@!PT;2Q):2#3;,/9@BU80+F 'KLX^7\*O5C1^+-#FM;
M:XM[];B.Z9E@$$;2-*0NX[54$D <D@8JCJ/CG2K2QTB[MC->0ZI=+;020PNP
M')W9P,@C:WR]<CIP< &S'HNE17[7\>FVB7;L7:=85#EB,%LXSG'&:<ND::FH
M-J":=:+>N,-<B%1(1[MC-9]GJ5I<>)[V*/6)))(K6-I+!H]JP EOGR5!R>A!
M/&.E2VWB?1[N[@MHKS]Y<H7MR\;HLZCDF-F 5^.?E)XYZ4 :Q (((!!Z@UF6
M_AK0;7ROL^BZ=%Y+M)'Y=JB[&888C X)'!-4/^$\\,[@HU5"#<_92PC<JDN=
MNUFVX7DX!. 3WK1NM?TVSN6MYIGWI(D3E(7=4=R JLR@A2=R\$CJ/44 -_X1
MO0OLOV7^Q=.^S;_,\G[*FS?_ 'L8QGWJQ'I.FQ7QOH]/M$NRFPSK"HD*^F[&
M<>U0>(;NWLO#]]/<ZBVG1+"V;M5!:'C[P!!R1UZ54D\5:)IQM;.ZU/?<R6HG
M0&-FDE0 ?,%5>IR. ,\\"@#0LM%TO396EL=.M+9VR"T,*H<$Y/0=SS4$GAG0
M9;BYGDT73WFN65IW:V0M*0006..<$ \]Q5G2M5L=;TV+4-.N%GM9<[) ".A(
M((."""""#Z5R.L>,S?:'XP32VO+.[T6"79.;8C+I%O\ XU*@9(&#R1R.,&@#
MJCH.CE[ESI-@7N5VSM]F3,H]&X^8?6E&AZ0%LU&EV06R;=:@6Z8@/JG'R_A6
M7X=\5:;J:66G_;O-U-K))W4HP\S@;BK$;6P3SM)Q5U/$VD/J,%B+O$UPS+ 6
MB=8YF7[P1R-K$8/ )Z&@"Q:Z+I5C/Y]IIMI!+S\\4*J1GKT'?OZU>JM>W]MI
MUOY]W*(T+!%X)+,3@*H'))/0#FLYO%FAI87UY)?+%%8'%T)8W1X>,C<A 89'
M(XY'2@"S!H&CVNH3ZA;Z5917MP")KA(%5Y >NY@,G-$F@:-+9164FD6#VD+;
MXH&MD*(WJJXP#R>E5+?QAH-U%<20:@LBP21Q/B-\EW&451C+D]MN:QO#OB1K
MKQ1XO%UJ,C:;IYMC$+F+ROLX9&9P054]?7G&.M $NG>$#_PEOB#5-5L--GMK
M]H#;C/F.@CC"$,&0#!V@\$UT6IZ+I6M1)%JFFVE['&VY%N85D"GU&1Q5(^+M
M#1+YIKTP&QC$UREQ#)$Z(>C;64$KP>0"*GTCQ'I.O27":9=BX:W"-)A&4 .,
MJ<D#.0#T]* )WT?3);FWN9-.M'GMEVP2M I:(>BG&5'TJ,>']%%G<V@TBP%M
M='=<0BV0)*?5AC#'ZU!-XIT:WO#:R7F'%PMJS"-S&LS $1EP-H8Y'!/<>M5[
MWQOX<T^:]AN=242V.W[2B1.YB!!.2%4\8')Z#C.,B@"_9:!H^FL6L=*LK9C'
MY9:&!4.S^[P.G)X]Z73="TC1A,-,TRSLA,=TOV>!8]Y]\#FDNM:T^WCMRUR6
M-TA> 6\;2O(N 2RJH)( (YQCD>M8GP\U>ZUKP[<7=U>/>$:A=11S.H4M&LA"
M<  #@#L* -6V\*^'K.99;;0]-AD63S5:.U12'_O# Z^]:]<[=>.O#5F+LS:F
MH%G+Y5P4B=Q$V ?FVJ<#D?-TYZU;M/$^C7VK_P!EVU\KW?EF55V,%D4$ E'(
MVOC(SM)Q0!8CT/28;]KZ+3+-+MFWM.L*ARV,;LXSG'&:H1Z?K-YX@\_57L/[
M-LYC+8QVX?S&8J5#2%N 0&?@=<@\8J:T\5:+>W<%M;WH9[A7:!C&ZI,$^^4<
MC:^/8GCFJJ>._#,CQ*FJ(WFW'V56$;[1+G;M9MN%R>!DC/:@#HJS[_0=&U65
M9=1TFPO)$&%>XMDD*_0L#6?>^-O#NG3WT%SJ0$UB%-RB1.[1A@2"0JGC .3T
M'?&15^YUW3K6WAG:=I4GC\V(6\3S,Z8!W!4!)7D<XQR/6@!UAH>D:6\CZ?I5
MC:-* LC6]ND9<>AP!FHK3PWH=A%<Q6>C:?;QW7^O2*V11+_O #G\:IS>-_#<
M$%E.^K0F.]B:6V*!G\Q5!+8P#R,=.N>.O%:UMJ-I=Z9%J4,ZFREA$ZS-\HV$
M9W'.,#'/- $"^']%5;95TC3P+4YMP+9/W1_V./E_"HKCPOH%W=S7=SHFG37$
MV!++);(S/@@C<2.>@_*N=N?$[77Q!\,V>GW]Q]BO(;F2:![<HD@5 4=6902.
M3T)'2NA_X2?1_M\-D;LB6=V2%C$XCE9<[E1\;688/ )/!]* );SP_HVH3VT]
MYI-C<2VV! \MNK&+'3:2./PJ<:5IRZB=1%A:B^*[3<B%?-(]-V,X_&L?1/&>
MGZS:ZE=;9[:"RNI+<M/ Z9V$*>H^\6R-OWNG&>*FD\9:!#;7]Q/?^0NGX-TL
M\+QO$",J2C*&P>QQS0!NUES>&]"N+FYN9]&T^6>Y"B>1[9"TH!! 8D<X('7T
M'I5 >//#!E\O^UH@QG%N-R. 7*[@ 2,$8YST]Z:WC[PREK<W#:BP6V<I.AMI
M?,BP 263;N"X(.XC'/6@#5_L+1_.EF_LJQ\V9/+E?[.F77^Z3CD>QJ.;PWH5
MQ816$VC:?)9PMOCMVMD,:-ZA<8!^E5KK5+%_$&BQ)K9B>>.66*TC 9+M-F=Q
M;!P%'(P1G/>H1X\\,LZ*NJH=US]EW"-RJRYV[6;;A<G@$X!/2@#330='CM+B
MT32K);:Y),\(MU"2G_:&,'\:C7PWH2Z8NF#1M/\ L"MN6V^S)Y8;UVXQGWI-
M3\2:5HWF?;KEHUB"M,ZQ.ZP@]"[*"$'NV*34];L+2-H6O9(YG@,P:VB,S1I_
MST("L ON1C@T :B(D4:QQJJ(HPJJ, #T IU<S\/=2O-8\ Z-J-_.9[NX@WRR
M$ ;CD\X'%=-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !65KM]-86UNZ6$M]#).(KB**+S&$15LMM
M[@'&1W' Y(K5K-UFTTZ>W6;4KB2WAA/^L6\>W4%B!R59<\X SZ^] ' V/A:.
M#QA<2>$(;S3=+O+"=-0CD@D@@\Y@!$8T<#YLDD[1@ =L\O\ "D O+32=+U#P
MSJUOK&EHL;7%T9#;0,J[?-B<L5.1T"^OH,UV7_"*:7_>U'_P9W/_ ,<I&\+:
M4BEFDU *!DDZI<X _P"_E '+^"+B[@T?2O#.J>&KL:EI3"-KB:VS; *2/.24
M\$E3QCG)],FL^:SU!/ GCS2#I6H&[N+R^D@"VS,)A*V8]A ^;.>W3'..*[2+
MP[HD[%8KF]D(&2$U:X/_ +4J7_A%-+_O:C_X,[G_ ..4 <Y;+>:5XXM=8N+2
M\DTR]T:*T#QVSNUM*C%MKH 64,&/..HP>U8O]AW]C;:2YL;MDG\7OJHA2W9S
M;6["0 L #MZJ<=1N]C7>_P#"*:7_ 'M1_P#!G<__ !RC_A%-+_O:C_X,[G_X
MY0!E^&XIT\>>,)Y+6YB@N9+5H99('1)-L(5MI(P<$8K2U36+7[7<:-=:1J-T
MLD/\-DTD$X;(*;Q\H/KO*CGK3%\/:&]R]LMS>M<1J&>(:M<%E!Z$CS,@&I?^
M$4TO^]J/_@SN?_CE &;ILX\$>'/#>C7MM>7+.8[,S6\1DC@8X"[V[+E@H-6?
M'$UW!X>#V>G&^874'F*MN)WBC\P%I4CP=SJ!D#'4 ]JTDTS3M.M5+LX@A?SM
MUU=/(%;CDEV/3 QGH>1S6D"" 0<@]Z /']2LM0ELOB)%#I6L2?VG:0&T>:W=
MFG/E;3[@Y[8&WN%Z5NZK9WM]XKTIK*WNX0="NK47)MI%6&5_+V!CC@_*3[8K
MT.B@#R.*:^F\*>"]*;0-6BOM&U*S6\C^QOM18E96=7QM93URI/6NS^(4=S=>
M$9;"V@N)?MTT-K,8(V=DA=P)&PN3C9N'XUU-16]U;W<7FVT\4T>XKOC<,,@X
M(R.X- '&7MA=7OC7^U)M/N!8:)I6;:WV<37$AW%5QPVT1H..Y%8UEIVH+X<\
M$Z9-IMZWFWQU'43Y!R)0&FP_]W,S#[V.%_"O4:CGN(;6!Y[B6.&%!EI)&"JH
M]23TH Y71M&>_P#%7B+6=4M6V22K8VD,\?!AC3!?!ZAF>3'L3ZUR$Z:S=^#-
M2L)=(U$:EJNK&'593;,=L#3;1Y?'S*(0 ",J!GD$UZN+RU,\< N83-*ADCCW
MC<Z#&6 ZD<CGW%34 8\.N0+XA30387L,OV43I,T.(" 0"BN#@L,C(K'\517,
M7C+PEJ4=E=7-M;2723&WB+E#)%A,@= 2,9/ [D5U0MH1=&ZV9FV; Y).%ZD#
MTS@9QUP,]*FH \PCLK^U\)^+_#%YIUW<7U[/>-9R+ SQW(GR48R ;5(+8.XC
M&*T=3T#6-,NO#-WI1,][':?V/>S#G]VR B8YZ['3=[[B.]=]44MS;P20QS3Q
M1O,VR)7< NV,X4'J< GCTH XKP9H%_HM_>Z9/$W]E:1-(-)9V)\Q)L/U/=,L
MF?\ :/I7.:?_ &G<7W@Z^GT'5+>6SOIQ=VT5F8H+3=%(H5%& 5R1^\Y'/+#.
M*]=HH \SL](U+4/!'CK3;6VN;6]O[^^DMO/A:+S5D^Z06 X8<>W>E%_<:MK/
M@6XCT+5K<V$LJWB2V3H+<FW9,9( (W$<C(Q7I=% '$_$J18;3PY(\;R*FOV;
M%40NQ += .2?85D>(;*^FU;Q'XCTO1FO(SI4%DMM<6I/VJ02EG<1, 7V(1C(
MY(P.E=KKF@V_B'[$LUY<P_8+M+I!;E/]:G*[MRGUZ<=:V!P.N: //O#L,TGQ
M"U*YEL=5DLK[2H$%S?0%1(5:3<&! "_> V8'7.,<U)X+TJ^L-3O-,N_GTWP_
M*\&G/NW%UE57 /\ M1HP0>S&NRU.Q_M/3;BR-U<VOG+M\^UD\N5/=6[&DTO3
M(-(L4M(&ED )9Y9G+R2,>2S,>I/^>* /+I[&^?X9:O9#2]0-U-KS3I#]CDW-
M&;P2!@-O38"?TZUJ>)]*O];\5ZW#8V]R@O?##6<-P\#I&9C(S!"Q& <$?GZU
MZ310!Y_X>N;?5)[2]N?"VLVFI6$+B:6_65A 2N&6$L3OW''W1T&3@X!Q=-L;
MZ#P1\.[5],OUN+#4HI+J/[))NA4)*&9OEX&77\Z]:HH X_P;%<V.M^*;2YLK
MJ+SM5DNXIFB(B>-DC"E6Z$Y!X'3'.*C N]#^).J:A=VUU-IVIV4"0SP0/-Y+
MQ%\QL$!(SOW XQU[UUZ75O)<R6R3Q-/$ TD2N"R YP2.HS@_E4M 'E$FAZAI
M?@C1[4V-V\C>(H]0^S0P-(;:#[29,':#C"\D>I(KTG58GO-"O8H%+236TBHI
M&"25( YZ=>]7J* /++2.\DT7X<Q-I.IQOIL\2W0DLY!Y6RV:,D\<#<0,GKU'
M'-0ZGINKS2^*[FQTV]D*:U::A%!L>$W<4:1AQ&QQSE3C!SD#VKUFB@#E?"IL
M;^^GU:TT+4K&22)8I+C4U=)I,'(0!R3A>>>G/&>:K77F:9\49=4N+.[:RGT:
M.VCF@MGF'F+,[%3L!(.&!YP#79T4 >6:;INI>'DT.VFTFY2VN;F^N))+.V$T
MUD)7W1P @'RPP.&8=QC(ZU3L['48? &AV$FD:FEQ:>(UFEC:V=V$8NFD+<9)
M 4@[NA[$UZTES;R7$MND\33Q!3)&K@L@;ID=1G!Q]*EH \D\8IJ>I67BNS71
M-16;[1!);)9VA$=S&IB)E=P/WC\$;<G 4?+P3700^<WCWQ!?OI]\EO/I%O'&
M[6CD,ZF0LH(!R?F7@?TKMH+FWN?,^SSQ2^6YC?RW#;''53CH1Z5+0!Y%H U;
MPQ#X0U:YT;4[BTBT9M,NX(;5VFM9-RL&\O&X@[<$@=A6KKJ75G?Z#KT/AZ_&
ME1K<PW%CIZLEQ")61EE*1D$DE"6 Y&[GG->D44 8?A:VM8=-FFL]*FTV*ZN&
MN/+N,B61F S(X))#$CH3G&,X)(KBX[&_MO"?B_PO>:==W%]>SWC6<BP,T=R)
M\E&,@&U2"V#N(QMKTM[JWCN(K=YXEGER8XV<!GQR<#J<5+0!P7V&ZL/&OA"*
M2&[N([#2I[:XNTMW:/>1$!E@,<[&_K6E\1K2ZN_"+"TMIKF2*\M9S%"A=RJ3
MHS84<D@ G KIKFZM[*W>XNIXH($&7DE<*JCW)X%!NK=;I;5IXA<.I=8BXWLH
MZD#KCF@#CH'ED^*4FJ-87\=HVA)$)7M'QO$S/MR!UVD''7MUXKD-(L]4T70/
M!^HW.C:O/;64%U9WUK;)*EQ!YDBLKA 0S#Y #CL:]@>ZMXKB*WDGB2>7/EQL
MX#/@9.!U.!4M &)X7MK6#39I;/2I=-BNKAI_+GR)9"P&9'!)(8D'@G.,9P<B
MN?\ "]G-X)U#7-.O+:Y?3[N_DO[*Z@@>88DQNC8("5*D<9&"#QZ5W=,EFC@B
M>6:1(XT&6=V "CU)- 'F^H>'=0UV[\8>(5LY8VO-$DTK3;>1=DLJ[6)9E/W=
MSD  X.!R!5J*RDUR7P7Y%G=6[:.1-=2W%L\)C A*&(;@-Q9B.F1A<^F>_CD2
M:))8G5XW4,KJ<A@>A![BF275O%/%!)/$DTQ(BC9P&? R=H[X )XH \HOK&_F
M^&OC6SCTS4&NKO5[B6WA^R2;I4>565E&.00"<]JV/$6H/IGCU-3LK74G>;2!
M#,T.FO=*%,C%,HI#(P.\\\$''4''?Q75O</,D,\4CPMLE5'!*-@'#8Z'!!P?
M6L6]\*Q7.L2ZI:ZKJ>G7,ZJL_P!EF79*%X7*NK $#C(Q0!Q]A+;V-CX4T_1[
M'4IM+M5FMI[P6#&\MY JX1@5W1!\G+8' '('-9]A8:E:^#?#R2:/J:OIGB5[
MBXB,#/((C),=P R7&'7D9Z]3S7J]E90V%OY46]LDL[R,6=V/4L3U/_U@.!5B
M@#SC5]+U'6?$_BJ&UMKJV.H>'H[2">2%E3S<RDKOQC(WKT/?CI2M;W?B+3/!
MMHFG7EE>Z7>V]Q>>=;O&L"Q1L'4,1AMQPHVDY!ST%>C5$]U;QW$5N\\2SRY\
MN-G 9\<G ZG% 'E%[8WTGP^\7VJ:7J!N;K7I+B"+[')NDC-PCAP-O3:I.?:M
M/7K2_7Q%?:KX=&I0:BT]N)K.:U=[/4DVQ_.25Q&R@[2V01Y?(KTFB@#G_',4
MMSX#UZVMX)9YY[":****,NSNR$   >IK MHI_P#A,_"MT;&]$%OHLT,LAM9
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M>R/$L#N+<2(0I<C(5F)R1G@GFNB\?Z7?ZUX#UG3M,YO)[<B-<XWX()7_ ($
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M8')YKT*B@#DOAE!<VGPYT6UO+2>UN(8-CQ3QE&!R>QYKK:** "BBB@ HHHH
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MVDCD=54L54812>2K<]L=^E9GA[PYXC\.V^HPP7NE2B\OIKW,D,GR-(<E>&Y
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M>O!XZ"M+PUH?B72+:WL=0UFTO+.PC\NU\N!HY9@%VKYS;B, >@Y(!SQS4M?
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MEK>6.CVMK?S0S7$4:HS0(43@ < DGM6A0 4444 %%%% !1110 4444 %%%%
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ME317!VLXQ:JP!R#G P,]<#KGFMB]EUC4?%FC:5#KUY96][HLL\GDK'N613&
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M23>1(VV,A@,*N, <'.<C'7Z0NHOH%M'J=U VI"+9//:8*&0<%ER,=1T(Z]J
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M5W%@<C(Y QG-:=OKFJ>(K^RTR.40N^AV^H/Y=P8&=Y2P+ A&R%VCC@9;G/%
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M:*Z7R?F)5 Y*C/3##DXK?M;A+NTAN8P0DJ+(H;K@C(S7F%U_R*WQ8_Z[W/\
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M,!AG[IQQQBK&A:'9^'-*BTS3_-6TAR(TDD+[ 23@$\]2:O+/"TS0K*AE499
MPW#ZBI* .?N?!NCW4VK2.EPO]K)LO$2X=4?Y0A.W. 2H )'./J:F3PMIZ7VE
MWFZX,VEQ-#:DS$A48 ,"/XL@ <^E;5% '-:5X$T/1=2:\L8[F-3(TJ6OVES;
MQN>K+%G:#R>W';%4O'6G76IWWAE;>VNY([75%N9Y+?@Q((W7=GZL..?IBNRH
MH P;OPAI5_IFH6-V)YDU%@;R4RD238  !88P  , 8'YFK&H^';#5+:SBNO.,
MEG();:X60K+$X&-P8>W!SP>^:UJ* ,2?PGH]YI5_IU[;&ZAU!@]VTS$O*P
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M!+&%5$9@95VMM49R/IGBO3** .5A\#V5RL=SJLEU/?O9"SNW2Z=1<(,X$@7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM<6D5^T4>55)MJ@)C!) QTSS38[4:YJ?@R>RMIX_[(5I+F:2W>+RE\DIY7S
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M[:&]0RRQF6$,"HF0=6C) #@>JDBJB^-O#3RQ1IK-JS2S_9T*L2#)G&W/09/
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MYD6'<RML61ONHSXVJQR, D$Y'K4$GC#P]%J0T]M7MOM9N%MO*#9/FMT7CO\
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M7DVGD;F!Z]0 >XKC?$SWEY:Z[ -(U""6#6[>9;>TL',<T2RQ?Z0SA?WC, >
M>,#Y>": /0;WQGX<T^6[BNM7MTDL]HN$!+&/.2,@ ^ASZ=\5;&OZ6VI6^G+>
M(UW<Q>=#&H)\R/\ O @8(]ZXLK(_B+Q]<-87@2ZTVW2%FM'_ 'I$4@95./F(
M+*"!FH;BSN[3X:^%=>MK:5=6\/VMNY@D4QO(GEJD\)##()&<>ZK0!Z':W]M>
M2W$=O)O>VD\J4;2-KX!QR/0@_B/6JESXBTFTO4M+B]2.1Y1 "RG9YAZ(7QM#
M'^Z3GFGZ%8RV&DQ1W&#=R%IKDCH97)9\>P)('L!7G6GV\(:_\,>(-!UB\O#J
M,T\#*TYM;E7F,J2%E;8F-PSGICN>* /0=1\2:1I32K>WJQ>2 TS;6980>A=@
M"$SVW8S4L6N:;/>&TBN0UR+<70B"-N,1Z.!CD9..._%>9:G?7&E>&/B%HNI6
M%_\ :[DWUW!<+;.T,T+QG:WF ;1M4!2"1]T 9/%;-O*^E^-=#U&>TNY+6X\/
M+:1R6]N\H\X.K;3M!VY'<X'!YH Z*\U_3;RTTBYL_$,5K%=WJ)"R*K_:\,5,
M(##(R>"1R,46_C#3;O6-8TP2O;G3%42SRQE5#%2QY(Q@#')ZYXK@=/@NT\ >
M#K>33=02>V\0+--&;20M'&)Y&+G ^[A@<].:Z>P,MCXX\9^?9WGEWB6\T$JV
MSM&ZK!M;# 8SN&-O7VH WM+U:T@\-Z?<SZN=16:,".[6'YKHX)RL:#DX!. .
M@J>'Q'I-Q80WMO>+/#.YCC\E6=F<9W*% +9&#D8R,'->8Z?'?:/X<\"ZC=Z9
MJTEE964MG?PVR2I/;N^S:Y1<,0"A!]CWK9N=)TN:QM)=.@UC0'FO)KRVU!(Y
M'D24JH9YD<$A7Y&'QG:.A- 'H-E>VVHVB75I*)8'SM< C."0>ON#5BL'P=-J
MD_AFW?6((XKW?*',<1C$H\QL2;#RI<8;!_O=JWJ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0D*,
MD@#IS2UQ'Q,5%TS0[@P&66'7+)D"@;C^]&0,]S0!V]%<?%X]CMKO5;/7M,FT
MJYL+7[:$:591/ 3MW*R\9W87![D<TQO';?;+NPCLK>2[6Q>\MVAO!+"^WJCN
MJ_(PZXP01T- '9T5P^C^,M030/"=UJMA&?[:\F(W*3_*CO'N!9=O&XY  SS@
M9YJ];^,FG'B",V"K=:-,L#0"XR9F8 IM.WC=N &>^0<4 =517(ZSXZATH7^R
MW@N)--"_:X1=JDFXJ'*Q*1F0A6!_ASG YR :CX]L[>&=[%(;EK>U2ZDCFN1
M[*Z[U5%()9]O.#@<@9YX .NHKD$\<O>ZI;6&EZ+<W,EUI@U&!I)4B!4LHVMG
M)7&>>.O8]:V?#6NQ>)?#UIJT,+P+.&#1.02C*Q5ER.N&4\T :U%><^-$LH_B
M;X/-W:F:">*]$\:6[3>;M1-NY%!+8)XXXIGA?5;=/B#XA6PGEM- M+%'FM+O
M=&R3@DM(D3X9(]G!. ">F: /2:*Y0>-5CAT>_N]/>#2M7D2*VN?-W,K2#,?F
M)CY0W8@G!(SBH[3QI?7][?PVGAF[DBT^\DM+F3[1$NW;&'# $\YR!@'C(/L
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M9+>970F1@%='XWJ=W89R""!75Z5=WM[:-+?Z:^GS"1E$+3+)E0>&RO'([=J
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M$,0O0 @@C(QWH ["D)"C)(';FN8LO&#S:[:Z=?:7)8QWMF]W:SO,K!U3;O#
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MQDUSH^L7;Z:8;O3+HVCV9G!=Y/E"@'&/GW+M]<CI0!U5%-0L8U+J%<@;@#D
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M89'?['<M:SAXF0K(H!(PP!Z,.:-:UNP\/Z<U_J,CQVRLJ%UB9\%B ,[0<9)
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MX2X@"JK0R$)D9V \ @]#Q6CHFE3>'M0\076N2Z3;Z;J<\;QJLI55/E+'Y9W
M#'RX'][/0=*[.JU_IUCJEM]FU"SM[N#<&\J>,.N1T.#QF@#F/AWHHTK1))!=
M/<PR2-'92/U6S1V\E<]Q@E@>X85O:[;75YI;P6MO9W)=U$L%Y_JY8\C>I^5N
MHSCCKBM$;5P@P,#A1Z"EH \V_P"%>ZC::7,-%N8;"6VU./4=+LY9&E@@*Q['
MC)QD*^Y^!TR,5JZSHGB7Q-X,U*QU%M.MK^X$7D00N[Q(4</EG*@DMC' X '7
MFNTJGIVIVVJ68N[<R"(R-'^]C:,Y5BIX8 ]1^- &7-X3TC6+F#4];T:QEU1%
M7,BY?9@Y #$ G'K@?05C1>%M8TZV\2:58M:2Z?K,TUQ%-+(RO;-,,2 J%.\
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M^V-65%PWR=1LSQGK5KQC9PZW)H]I;:C%:^(+>Z5-MO*'DCBD0B<'H0/+RP)
MY5:[JJL>F6$.HS:A'96Z7LRA);E8E$CJ.@+8R1P* )XHHX(4AB0)'&H5%48"
M@< "GT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5S/C_5=0T/PC<:CILZ13Q2PC+QA\JTJ(0,\
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M\D2E1]H3H"<9SCKGOQW'0^%HM1AT^87]Y>7<9ES;27T21S^7M'WPH ^]NQD
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M<,,.0000!D$=J@G\&6UQ%IBR:GJ)DL+L7HF+HSS3!2NYRR'/RDC P ,8' H
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MJPM(T5GI]SY7G.%28&0[A@]B./J?6M/XFQ+)H6FDO(A&KV2@I(5.#,H/0^E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH.E:%% %'4M&TO6(XX]3TVTO4C;<BW,"R!3Z@,#BKJJJ(J(H55&  , "EHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)_>(SD#WIJ:SI<MM%<QZE9O!,_EQ2K.I5W_NJ<X)]A0!>HK&M-6@@CU*YO\
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MC<6L4CR2N(U+,@8XR?K0!LT5'!/#<P)/!*DL,BADDC8,K ]"".HJ2@ HHHH
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M= P(RI[$9XH \B\*ZEH.IMX*LKK6=-CET=66&-MRRW#,GEHK*R@*<$$@,WS
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M122Z,;EFD#[A\I&.,?C1KVC^)/$>F3@_8].N[6>"YTU1,9E,L;;B9#M'!X7
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M1_\ D.,?4L>]=!J^D:A=^./#VJP11&ST^.Y28M)AB954#:,<XV\\CK0!P5_
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M]8DOY62X(#1LTIP 5^]^]Z9QQUH Z%/&,\AFMQHLR:C;6@N[BP>=/.526 "
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MANQ9?-'O9U*;=V",IG)R<<<YR(]+\4ZIK7AWPS?/<PV?]HVTCW MT\R=Y5
M$49#?+G<6)' QR.M '>T5YK:>,?$&H:#X-O(I+**;5KR2TNMT!(RHE^8?-Q_
MJ\X]^HJ[;^(=<BL_$MG/?6#7>E7\,"WLZ>4GE2+&Q)49RX#L .YQ^(!V&G:/
MIND>?_9UA;6GVB0RS>3&$\QSW..IJ[7GH\8ZM:6/C0I!)?R:+''+:":#RY)
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MYGL[;19EGMHX@IW.JE?F+ DY#-GIG.:Z6B@"O=V[W5C+;K.T32(4\Q "1GN
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M(@.FX$;E)[C.15FB@#FYO!UI?2:A-J=Q)=7%]IYTZ64(L9\DYST'WB3G/L,
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MVEA;VTES+<O%&J-/+C?(0,;FQQD]:L44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !5/5M-BUC2KG3IWD2&Y3RY#&0"4/WAS
MV(R#[&KE%      , 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>exhibit1061-loanandsecur008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF&B:(#<C+CKDXX/4&JLWQ D@TJ:].C/(T.L_V1)''<#[WF!-X) SRW P/J*
M.VHKBKSQGJ<-KXG@;28+;4]'LA>1J]T9(Y8V5R#D*""-C97'7'S<YK?\,W5[
M>^&M.N;]8Q<2VT;L4D+[LH#N.5&"?3]: -:FNZ1HSR,JHHR68X %<G'XUD&K
M:3:7FE&T35+B:"%9)\3ILWD,\1485@AP0QZCUKG/B-K+:_\ #?7IK33H9]-@
MF\E;F2;#ETD"LZ)M((#9&=P)P3CID ]1HK 3Q%*/&4GAZXLDA'V/[9!<&?(F
M4-M8;=O!!(SST(J#_A)K]K6QE32$ NH9+@S2W)2WBC7&W?)L.&;<"!CIGTH
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M/ES^-+XKUK5M-UOPW9Z=#;/%?WC12F69D)VQ.P7A3@?+G//3&.<T =0'1G9
MREEQN /(SZT&1!(L9=0[ E5)Y('7 _$5YA!JUSX8U_X@7]CHT=U!:S07-PBS
MB$*@ME9RORG<W4XP ?7-=/+K%C/XST"(Z4LDMY8SSVM^[#=&@"%E QGG<O<4
M =517-^'O%3>(Q!<6EK UC+O#2QW.^2!E/"2IM&UCSQDXQ]*V-4U"+2M*N;^
M8%D@C+[1U<]E'N3@#W- %RBO/? UU?:1XJUCPSJUX+J>X5=6MY0<AO,XF0>@
M63H/1JV-5\9-92^(%M-/%TN@PI->;I_+8[D,F$&TY(09Y(Y.* .JHKBY_&^H
M&[TRSLO#K7-SJ5A)>VZF\5 0NWY2<'&0PY]3C'>DU'Q_]BM[N>+3DN!8R+%=
M0)=?O]^%WB- I#[=V.2N2IQVR =K17'ZMX[CLEU!["TBO1I^WSXVN/+E<E%<
MK&FT[F"LIP2O)QUS3SXQO;K6Y=+TS0S/-_9T6H0M/<B$.CD@!OE)4_*>QY].
MM '6T5P]E\09KRS\/ZD=$>+3-8G2U$S7(,D4S9 &P#E=RD;MP/?;4NI?$"&R
M6>XM[-+RTMKLVLPBG_TC(?8[)$%.X*V?X@< G&,9 .SHKB=0\=7]M-XCCMO#
MQG&A!9)V>\5 \9C\PE?E/S;>@^O(XS(/$NIW?CK1[*R@MSI=WI3WV9)65R"\
M0R1M(R QP,\Y.2,4 =@\B1KND=4&0,L<<DX _.G5S?C;4+73M'MI;W2DU&W>
M]MXS&[ !&:10K\@YPQ!HE\5,^OWVD6-K!<7%C)"L\3W.R8JX4F1$VG<JA^N1
MRK#TR =$[K&C.[!4499F. !ZFG @@$'(/>L7Q?>0Z?X0U:[NM/74+:&UD>:U
M9@HD0*2P)/MFLM_%5Q;ZII>BZ?H8D:\TXW4'^DB.- NP;#\I( WCD#\#0!UU
M%>>WGCC5+S0]!O=.L(;>6\UE=.NX9K@YC=9&#*&"D$$H1NQT/3GC3U?QS_9P
MU#[/907<FF[5NH1=;9&?:KLL2[#O(5AUVY/% '7T5Q[^,[Z?6+C3-+T%KF5-
M/BOXFFN1"'1RP /RDJ?E/8\]<=:FL/&L.K66A-IUIYEYK%NUS'!++L$4:@;V
M=@#T+!1@')/89( .H5T<L%96*G# '.#UP?S%.KS+PAK$/A^S\2O<VL-M+-XE
MEMXK=9 (_,:.,_>P,+@,V<9P.F>*VX_'\,<6J"\L"D]E-##"+>7S8KMICB,1
MN57)W'!!'R_2@#L-Z"01[EWD$A<\D>N/Q%.K@+(7)^-1>[L+>VF?0&)>"7S!
M(//3J2JG(Z=.F.?34\0ZUJ]EXQ\-Z98PVSVU\UPTIDF9&8I&3MX4X'(/?) '
M'< ZN@D 9/ KDKSQJ\.F:GJ]IIOVO2M,F>*YE6?;(1&<2LB;2&"\]6&=I]LZ
M'B-K75/ NJ2J$GM9].DD0L,AE,9*GG\#0!N(ZR(KHP96&0P.01ZTM>=>&/%E
MWI>D>$+#4=%>#3K^TM[6VOQ<*^9?*!57C ^4-@X.3[@5I'X@0M+8S6]FESI]
MW=_91)#/NF3+%1(T07[F1UW9 (..P .SHK+UW6X=#M()'0RS7-Q':VT(./,E
M<X49[#J2>P!Z]*R)_&,MC?ZGIM]I@34+2Q.H0QPW&]+B$'#;7*KA@>"".XQF
M@#JZ*P/#&O:AX@LXKZXT8V-G<6L-Q;R&Y60R;UR5*@ KCCD]01TY%4+OQE<V
MDOB6%]*C\_1(%N0ANL?:865FW*2G'W2/J,9[T ==48GA,8D$J&,G ;<,$YQC
M/UXK%L?$4FI)I<EG:131WUD;QF6X_P!6N%VC[O.2V.<=&]*X?4+C3M6^'?AB
M_LM(ATZ$:];>3;+AO)/VLJV" .I!)QZT >J;T\SR]R[\9VYYQZXH+HKJI90S
M?=!/)^E<;IT,47QBUHQQJADT>U=RHQN;S91D^IP!^55?%9EM?B7X5NK'3UNK
MU[2^0+O$>_ BQN<] ,GL>O H [ZBN,LOB##-82"]L?L&JQ7_ /9TEE-.-JR[
M2X/F <IL!;=CMT/&=3PYXD;7;G4K66S^SSV$BJSQR&6&56&5:-]J[NA!&."*
M -WS$\PQ[UW@;BN><>N*=7*OJT$7CG4K9-$4ZA!I23B[$BAIHM[ 1].!N#'D
M_A5+2_'UQ?KX<N9]#-M8:Z?+AF^U!V238S@% OW2%/S9S[4 =O17":1XROX[
M3Q%?ZU#;)!9ZJUE"L,Y)W?NT1!E0,%FR6)ZD\ "I9_'TEJNM"725E?3;$WZO
M:W/F0S1C.X>847:XQ]W!X(- ';45Q$_CK4[2VT^YN?"\JP:C<V]O:E+Q&9_-
M0MDC VD8Q@_F*CE^(=S8V_B"/4M >WU+1K87AMENE=)X"#AUDVCT((QP?6@#
MNZ*Y/_A,;F%8!?Z5'9/>N!8^=>KME3R][,Y"DICIC!R2/PQM2\=ZI/I4#V&G
MQ6]RNN6^G3^9,QC96D7YHGV?,K XS@$<\$T >BT5R6K^-&TXW\,%G;7-UIT2
MO=0&[V,6*[]D7R$NVW!Y"YR!ZXGC\3C69A8Z7IRW3M8QW=Q'>2&$1I*#L1AM
M8[SALC& !R>E '2(Z2+N1E9<D94Y''!IU<7\)ACX9:. GE@>=\G]W]\_%=I0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !112,RJ,L0!ZDT +112$X!//'H* %HK.T;7++7K:>XL&D
M:.&X>V?S(V0AT.&&& /!]:T: "BBB@ HHJO?WD>GZ?<7DJ2O'!&TC+#&7<@#
M. HY)]J +%%,BD$T*2J&"NH8!E*D9]0>AI] !16;8:Y8ZEJNHZ;;-*;G3BBW
M"O$R!2X)7&0,\#.1Q6E0 4444 %<7H>E7&E7_BO1TG-O)J5U+J-E< ?\]4 8
MCU*2 DCT9?6NTIK(CE2RJ2IRI(S@],C\S0!P.C^#_$%GJ7AF[N9-)7^RH)H+
MGR3(S3^8$S+D@9=BF3GH3G+=*U="L&NO&^O>(B/]'ECAL;5O[ZQY+L/;>Q4?
M[I[$5U3*&4JP!4C!!Z&A5"J%4  #  [4 +12!E)(!!(Z@'I2T %%%% #9"XC
M8QJK/CY0S8!/N<''Y5SUIX:6]\&'P_X@M[::-XVCD6%RRD$Y!!*@@CJ/0BNC
MHH X%/ -_;>%=&LX=36;5=&U![VWN9\[9\R.=LAZC<CX)&<'GFM_3]$N#XIN
M/$6HK!'=O9I910P2&14C#%R2Q5<DL1V& HZYK?HH X[7O#6M:CXAN[JWN+%[
M*YTTV:+=;RUHYW;GC4#!W!@#R#P.H&*KZ7X4UNSO?",UP^GNNB6$EG-Y<C@O
MN1%!7*]O+SSC.>V.>YHH \\NO!6MW/@_Q)H^_3UGU;4I+R-_.<K&KR*^#\F<
MC;CWSVK7M]!UC2?$^JZOIHLI8M62)[BWGF=/)G1=NY&"'<I&,@@=/PKK*0LJ
MD D L<#)ZGK0!PD?@>^T2+PJVB36D\NBK<)*MVS1K,)P"[ J&P=PR!CH<9JJ
MW@C7SI%W:-<:;))-X@&K!MSH-@E63;C:>3MQ[9ZFO0Y98X(7FE=4CC4L[L<!
M0.22:R]-\26.J7[64"7*2^0MS&98&198F. ZD\'Z<'VH Q+WPKJ-_K?B2YDD
MM8K;5]*6P0K(S/&P$@W$;0"/WGKV]ZW?#EG?Z?X?LK+4C;&XMX4A/V8L4PJA
M<Y8 G.,]!UQVR=6B@#S>S\$^)85T3S[O2I9]-U)[N6Y/F&2[#*Z[WXX<!P-N
M2./O #%1W7@3Q$GA76O"EC<:8^EW<SRVD\[R++"'D\PHRA2& .<-N_"O3**
M.7\3>%IO$(TB<7*VUY9S'S9(\X>"12DT8_WE/![$ T[6=$U:Y\3Z5J-C)9/9
MVL,D;VMWNVQNQ7;,@48+  C!QP3@C-=-10!YUI/@G7=.T[PI:2S:=+_8EY+.
M[*[KYB,'4 ?*>?WF?PQ[T^_\"ZM?C7I!=VMK=76IPZGI\R,S^5+$JJH<%1D'
M9SC^]WQSZ%10!QVH>'O$/B7PU=VFLWUE9WS>6]J=/#O'#+&X=7)?!;+*.,#
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MD9D9FW-A,#)?MZ?A6#I7@;7M"MO#-W8SZ?)J6D6TEC/%+(XAN8&(/#A"48$
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MH1'N4\O@G&223@=*Z?1(];\EYM=DLOM+X ALMQBC SSN;!).>> . /4G5HH
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M,^W8OE_,2RG.\DXY1??&O-X?@F\2Q:]]IN4NX[9K554KL$;$,1@KURH.<]J
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MOR]0&EMJ!G9 Y:5E,K$@\'+$U9\=7T]IX'TG748F\L[NRN%8<%B[JCCZ,LC
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M;X>P^,I=.LI+0P_:)K6.5ED2,'!*L00Q &<'&?6NUU&6.'3+J25U1%B8LS'
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M=.K?*=_S1;3[\ X/H.* )K3Q/X@U2XO-.LET5=6TU8!<PO([1SNX+,L;@@J
MN.2K<G!Z9/4ZOK>GZ'%;O?W"1?:;B.VB!(!=W8*,?3.3Z $URGA1; _$CQL(
M1;F1)K3;L"Y7_1QNQ^.<U)\2Q;)I^@7-T(E@AURS:627&U$W\DD]!TSVH ["
M6^M(%B::Z@C$IQ&7D W_ $SUJ>O.]/N=-G\8>++373;"UGMK=K/S\".2R\OY
MMF?X0V[..Y'M6Y\.8]1B^'VC)JAE-T(/^6N=^S<?+W9YSLV]: "R\0:C=>/=
M2\/O%:K;V5M%<>< V]PY("XS@8P>>?I73/(D4;22.J(HRS,< #W->>66K:;9
M_&;Q%]JU"U@SIMJH\V95R07R.3UY'YT[QGXFL9H=+O8+TR:'9ZJD>HW=J%E1
M"8VVDY# JKM&2<'!QW' !WB7MK);"YCN87@/259 5/..O3K3HKF"=I%AFCD:
M-MKA&!*GT..AKR'Q/9^&O^$1UF_TO4C?Q7>J6,SSEX_)6;SD5_***H#;?O$?
MXU9\0*VE>)_%D'AB.*WNW\,1RI%: *6D$D@W!5ZL%/'?I0!V>I^)I+;QCH&D
M6CV<UO?RSQ7.'W21%(6<  ' Y7O[UT/VRV^U_9/M,/VG&[R=XWX]<=<5Y=_:
MGAJY\1_#:YTJYL=B>?&-CJ&C5K9@$;N#NXP>]5_#<NBZU9:59ZOJ]W%XFT_4
MC))8((DG^TASN/W-[1D$DG.-O4\4 >LB[MC,(1<1>:6*A-XW$@9(QZ@$&I'=
M(T9Y&54499F. !7GGP]TK1)M2\1W<=G9O=6FOW/D2*JEH054?+_=!RW2M'Q_
M<R6DWAN>?_D#KJJ?;V/W5&UA&7_V!(5))XR!0!UT5W;36WVB*XBD@ )\U'!7
MCKSTI8KB"<N(9HY"A 8(P.W(R,XZ<5Y1XMM8#<>/IK7R6TB300\^,&/[=A]I
M';?L"$XYY7VKO_"FF:79:):W.G6MM$UW;PO-+"HS,0@PS,/O'D\F@#6GO;6U
M>-+BYAB>0X19) I8^V>M.ENK>#/G3Q1X0N=[@84=3SVY'/O7E7C[4-.DF\;V
M0:"WO5T=!(;EB\ER DCH(4)X"DG<PSSV&,U:L$T;5_B1I$LZV=VLWA@NY?:X
MD82QX)S]['.,^GM0!Z2;VU C)N80)0#'F0?.#T(]:D$T33-"LJ&51ED##('N
M*\DT;2CJ7PCT^^TM(YM3T.]N+JQ P<^7<2?NOHR?+C_=]*[SPG(FJVTWB0PM
M&VJ[7A#KAUMU&(P?K\S_ / Z -Z>XAM83-<31PQ+U>1@H'XFLOQ%XBM?#WAB
M\UN0K-%! TL:JX'FG' !]ZPM<NC:_$_0?[2*KI4EE/';-)_JQ=EE/)/ 8QA@
M,^K =37':U;QVWPY^(./+_L?[:YTW.-H)">9Y?\ L^86 QWW4 >G://K$US.
MU])IT]BR(UO-:!E;=SO5E)8''&"#WZ50T[Q!J-YXZU;0)(K5;?3X89O.4-OD
M$F<#&<#&#SS7062VXLXOLHC$)4%?* VG/<8K@=,U?3;/XP^*_M6H6D&ZRLU'
MFS*N2 ^1R>V1^= 'H<DB11M)(ZHBC+,QP /<U$EY:R6RW*7,+0,<+*L@*GG'
M!Z=:X+QCXFL9?['OXKYFT&UU3RK^\M@LB(WE-L)R&!579,G! ..XK!\1V7AM
M?"][>Z9J)OX+K6[*9KAGC\D2F5 _E%%4 [?O$?GG- 'KL-S!<&00S1R&-MCA
M&!VMZ''0USNH>)I(/&>A:/:/9S6U\UPEP0^Z2)HXRX'!P,GU]ZXCQ"KZ5KOC
M6W\,1Q6]TWAZ"1(;0!27#R@L%7^((>,<]*MOJGAJZ\7?#RYT:YL?+$=S%'Y;
MKE%,'RHV.0<\8/.<]Z /31>6INS:BYA-R!N,.\;P/7'6D-Y 9/)2>%ISN"QF
M09+ 9(QUXR,_6O)_"TNAZW8Z';:IJ]VGB73K[?+8*(DG%R&(D+#9O:,@DL<X
MQU/%;?PYTK1);O7[R*SLWNK37[Q8)552T*G PI_A!!/ XY- '4>'=7OKS03>
MZY#:6<T<CH[0S;H64' 96;''^%;$,\-Q&)()4E0]&1@P_,5SOC:'S].L(XM5
MBTV\^W1M:2S('B:8*Q"."1E2 1ZYQCG%-\"WL][I-[]JTZWLKN"_EAN!:L6A
MED&"TD9/\))_ @YYH Z&>]M;:2..>YAB>0X19) I8^P/6L77O$8T[5]+T>":
MVBN]0:7$L_S)"J)N)*A@3D[0!D=2>V*X3Q_J&G2/XYLE>"WO4TN(2_:&+R7.
M$=T$*$_*JY.6&><\#&:T[^XTR^\:?#^9I+6?S[:[)=BK>9^Y7!]^<XH T+?Q
M-XAOKJ\T:W.BIKFGV\<DRLSO#.[M)A$.0R_+'DDAL%L8XR;.K^(=;T7PSI][
M.-+GO)=0BM;C[.7:(*\VSY<G.X C.>X/%4M%CTV3XJ^+HV2T9A:665(4]IM_
M\QGZ\UR=K/:Q?!?1%26%8UUZ, !@  +\G^7/TH ];62]_MR2)I;/[#]G5DC&
M?/\ ,W')/;9C&.^<U-'?V<WF^5=P/Y/^MVR [/\ >YX_&O/]2N;"Q^)'B2X9
M-ZCPRLL\=L0)9,/)G&.=VW'/TK,\.7^FR^-_#'DW5@UM/H,MO'!;G<J@-$5B
M9B?G<#.<@=S@4 >DZ3KVFZUIAU&RNHY+3<X\S<,85BN[V!VDCVJVM[:/:?:T
MNH6M@,^<) 4Q_O=*\8TG4[33OAWX6E:?RK&TU-UUAX$5F@R9A&9 01@.4/(X
MX/I6])8:'-9W=QH'B=DDOM3@GCO)!')9F[56(3"A5.X*-V/XBO>@#TR&>&YC
M$D$L<J'HR,&'YBI*XCPSXGM;+3;C^WH['2;MM6:R=H9"8+FX*J=T9/9N^>A!
MSS73>(/MW_"-ZI_9>?[0^R2_9L=?-V'9^N* +<=Y;2W$EO'<0O/']^-7!9?J
M.HH^UVQF$/VB+S2Q4)O&XD#)&/4 @UY<C6NH>&/ $VB,@U6&\ME8)_K44*1=
M+)WQ@-NSWQW(K2^'VDZ)-JGB6Z2SLGNK37[CR)%12T(*(/E_N@Y;I0!VNLZM
M!HNG-=S*78ND4,2_>EE=@J(/<D@>W7M37DU-+W34:73UB?S/M2'<'8[<J(N>
M<'.<]O2N<^("R?;_  ?(<_9TUZ'S?8E'"$_\"(_$BF>)?LL?Q2\$R-Y2W#+>
MKN. Q'E# ]<9S0!T!N=72#4I0+&Z>"<F"" L&:(*#L8DX$A.?;IZYJ[IFI6N
ML:7;:C92>9;7,8DC;&,@CN.Q]17)?#S[*E_XQAM?*5%UV4A(\8&8HNP]\_K3
M_A2LB^ X2V?):[NF@!_YYF=]OX=Z +I\0:C_ ,+%'AD16OV?^SO[0\\AM^WS
M-FS&<9[Y_2NG9@JEF("@9)/:O/+K5-/LOCJ&NKZV@7_A'-F9954;OM&<<GKC
MG%2>./$MG<:();"[-SI]C?VS:I-9[90D)8EAT(.W",PP>#SUH [B._LYK9KF
M*[@>W7.Z59 5&.N3TI\=S!++)%'-&\D6!(BN"4STR.U>0>+;?PS<^"?&&JZ5
MJIU,W5O"T\NZ(P+*I 3;L4 28/..<8SC(K5U2.+3/'LH\/1V\5]-X7NGA2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVLHW1R&-D#CU&X#(]ZJ^)1CPEJXSG_09N?7Y#5'X?<?#CPW_ -@VW_\ 18H
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M9[E(FEDCD=4=76,[003PP'([9KK[;2+N6RDM]:U$:@#<^<NR 0@(,%8R 3D
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M@)9"L1VE2,$$\@YSFNA\,+J\E@M[JFIQW8NX898XDMQ&("4RPR#\V2<\X_P
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M"121A@1MVD,.",8/M6U10!@3>$K2XTK5K*2ZNO,U<%;VZ!02R ILP/EV@!>
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MHW$%O);S2:A<0A8=B$,<., N0-A '\1[9KM:* "BBB@ HHHH **** "BBB@
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MMO =D:NK 1R +C:QRPR.H4^E8^@V4%C!\+]2@WK>7D8AN)C(Q,L9M6;:V3R
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M>DZG<P7-_IEG=3P',,D\"NT??Y21D5(-+T\:B=0%C:B^*[3<^2OF8]-V,XH
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MP7Z-+&Q:20S%"SC#@E/4@#C SEL6DVI\3^"K"749]5MFT^^C:>9SBY1#&%)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M![%)#Y;*A5HY8P00#URPQR??%S3K![+XBZ4T>D36EE#H+VH$<+-% YE1A'O
MQPH/.<<4 =)=^*M%L7*W-[L42)$\OE.8XW?&U7<#:I.Y>"1U'J*BAU;3X]?U
MHOK;M]BMXGN;610([1?G._=CN <\G[M<OI$M]I-WK?AW4O#EY?FZU.:[M+C[
M.)+69)'WJ9'/"E3U!YX&,\5+=VK2>+/&;W6D7MW8W6E00A$@<"YVB7>B-CDX
M<8P>_% '7PZ_ITOVK,SP_9(EFG^T0O#L1MV&^<#CY6_*DL-?TW4K^:PMYG%Y
M"@D>":%XGV'@,%< E<\9'&:\ZN=$\22Z'K>E:=<7NJ6*6]M/8R:C$T%QOCF#
MFW+L%9QM7[QZ%L9ZUU'A>2SU75/[4B\.:GI]REL89+C5%=9!E@?*7<Q++D$D
MCCIZG !HZGXIMM-\3:;H;P7+37J22>8EN[*JH!T(!R<L,^@ZXR*Y_P .>,[>
MR.L0:_JTDDD>N36<,DD)(1 56,.47:@). 6P"<U?\1174/Q \+ZE'8W5Q:Q0
MWD$CP1E_+9Q'LW>@.T\GCUKD[^QOYO 'C6UCTO4#<WFMR3V\7V23=*ADC(8#
M;TPI_*@#T?5/$>EZ-YIOKAT$*!YF2%Y!"IZ,Y4$(.#R<=#Z56;5;!_%,,2:T
M_F#3WG^PHH,;Q[E_?;L=1D <]#TKDKQ9+#Q=KB:IX?UC4],UKRI;:2R21E_U
M2QO%*FX!?N_Q<8)S6C#:2V/Q#T>1=-G@L[709+9C# [Q1/OC(C# <X"''T]Z
M -[2/&&@Z[=1VVF7XN)9(GE7;$X!56V-R1C(...O(/0YHU/Q?H.CWLEE?7XC
MNHX?/:%8W=]F<9 4$GZ#G@GH#69\,[>>S\#VMK=6EQ:W$<UP7CGA:-OFF=@<
M$#.0P-4[V\BLOC+#)+%.ZGP^P!A@:4K_ *0.H4$CZT ;A\;>&Q8:???VK"UM
MJ!*VLBJQ\PC.1P,@\'@X.1CK4D?BW19K."Z@N99HYXC.BQ6TKOY8."Q0*649
M!'(%<##H5[IL6@N=.N_+D\43ZH8([=G^RV[B0)NV@[?O*<=L^QKI0MWH?Q)U
M34;JVNI]-U.R@2&>"!YO)>(MF-E0$@'?N!QCKWH E\5>,(;'P_IMYI<[3)J=
MW;P17-O$TJB-Y%5F! (W;2< \D]CC%6+?5;7P[;W;ZEK-[=P-_I2"6S=I+2$
MCI)M7(7(8@N < C^$UQ\FA:AI7@G1[4V-V\K>(H]0-M#"TAMH/M)DP=H.,+@
MD>I(&:T-3$VF^-=5FU'0]7U+2M8AA,$E@LC>6RIL:*1 1@'KD\<GWP =A=>)
MM(LX3-)=%XEMQ=,\$3S*L)SAR4!PIP<$]<'T-27FOZ;8SO#/-)NC*+(4@=UC
M+_=#,H(4G(ZGN/6N#UW19K;]]H=MJ.CZM:Z;''!#;V[7%I=(-Q%M(,%?E)(W
M9&-^<XZ/UZRU8:I=:IH\>H6FO8MTGM/(::QU$;$R&)&U2N67=D$!: .QM-1L
MY/$NK1+K,DLEM#$9[-U CMA\WS!L#[V#GDXVU);>)](N[N&UBNB)9XS+!YL3
MQB=!R6C9@ X (/RD\'/2N,UK1=1UC7?'-I:07$+:AI$%M;7#Q,L<DBB7<N\C
M'\0'X^U69H;GQ*/!^S3[RRN=+NTNKTSV[QB%4B96C#$8?<Q4#:3D<T ;R>//
M#4CQ*FIAA+<?90XADVB7=MVLVW"DG@;B,]JMWOBK1M.N9H+J\V- \<<[")V2
M%GQL#N 54G(ZD=1ZBO.Y[&_;X=:S:+I>H?:IO$+7,<7V.3<T9O%D#@;>FP$_
MIUIWC&/5=5L?%EFFAZB)6E@DM%L[4K'<QCRR9'<8,C\%=A)( 7Y>": .P2_O
ME^*DFF->2/8-HPN5MRJ[4D\[;D$#)X'<GO6AX@O;6UETJ.XU>73WFOHTB6-
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M32[>^^R75IYR;O(NX]DJ>S+DX- %RBBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8V<UW<RK%;P1M)+(W1549)/T H FHKFX?&=G)K%OI;V5W%=7<#SVBN8_]("
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M/2H_'-W!*EW%?0:6)I)I)"+?R/,/(&[&<[LG&<#K0!TE%<[!XN@GN[&!=-U
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MD+C[-/;$NZ&*< .I5RIS@D=5R""<C%6Z "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KA?#^BF)O&WAVY8QF_O9KN-QWAN4
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M-/UZYTV6S_LVRN(X[=Y8VDEEE"@C*L5V@*>21DMT&*Z^D9@BEF("@9))X H
M\VL?#6N6WA?P-I[Z:WGZ->QS7>)H\!5CD0E3NY^^#^!K?\/Z5=VVN^*IM0LM
MEIJ=TDD)=T8.@B6,@@$XR5/'H:VK#7M+U2[FM;*]CEN(D61XQD-L;[K@'JI[
M,,@^M/U?1M/U[3GT_5+5+FT<JS1N2 2#D=.>HH YGX?:+-IMM=F:Y%S;VTTE
MAIS]UM8Y&P"?7)*D]Q&M:'CO2;W6O"LMKIT2RW27%O.D3.$W^7,CD9/ )"GK
M6_;V\-I;16UM$D4$2A(XT7"JHX  ["JVHZUI>CJC:GJ5G9+(=J&YG6,,?0;B
M,F@#FK?3M9TKQI?ZZFG-=6VKVL*W$$,R>9;RQ9"_?*@J5;G!X(Z$<UJ>#M!D
M\.^'Q:3LAN)9YKF8(<JKR.7*CV&0,]\9K4L-4T_58WDT^_M;M$.UFMYED"GT
M)!.#5N@#BWTG5[7Q9XGNX;!;BSU6SA6.19E4J\:.NW:>Y+ YZ8SSGBLZR\/:
MU!IO@"W?3FWZ(1]LQ+'@8@:+*_-SRV?I^5>BT4 >>>&]%\0Z&YT*70M/N+**
MX=K?66E3(A9RV&CQN,@!P.W3GCGJ_%>BOXB\*ZEI$4PAENH&2.0]%;JI/MD#
M-;%% ''Z"_B+RO-U'PK8V%Q;1'<;>>-C=28P F -BGK\QST&#R:J:9HFM:'X
MJCU6VM3-!K$>_68MZ*(9Q]QXQGG )4@=0 <D]>[HH \UN/".OSZ1XBL(H+:.
M9]9.K6$\LH:.8^8DBHRCD#Y2#GVZU<OK'7];\':U;2>&;72KJZL9+6.WCN(W
M:1W&-Q<8"H/J2<]!@9[*[U;3[&\M+2ZNXHKF[<I;Q,WS2$#)P/H*N4 <6-*U
M1_%/A2^.GNMOI]A/;W+&6/*.ZQ@8 ;D#8<X]15OP#IFIZ'X<&DZE:I$UM--Y
M<B2AQ,K2NX8 =!AAUYZ\>O4T4 <K?:;J<7Q&L];M;1;BS;37LI3YH1HCYJOG
M!ZY (&._7 YKFT\,Z\/ UOI9TQOM<>N"^*^='CROM1FZ[NNTXQZ_G7H5]JVG
MZ;):QWMW%!)=RB&!';!D<]%4=ZGNKJ"RM)KNYD6*""-I))&Z*JC))^@% 'FO
MB3P_XIUJWUR"73([N5KZ&?3IWNU54@5XV\M4_A?Y6R>,YZG %=!;6&MV'C?5
M]633HIX-0L+< BY"[)8A)E.1DY+C!QC^5=5;7$-Y:PW-O(LD$R+)&Z]&4C((
M_ U(RJZ%64,K#!!&010!F>'=3N=8T.WO;RR^Q7+EUD@$HD"LKE3AAPP.,@^A
MKAO%?A[Q1K<'B*T?3HKPRSQ2:9.]TJI'$I0E%0_=?*MECC.>N !7IBJJ*%4!
M5 P !@ 5';W$-W;1W%M*DL$JATD1LJP/0@T ,>)KS3WAN%\IIHBKJC9VY&#@
M]_K7(>#;;Q7I.FV7AW4-.MDMM/40C4TN0PGA7A0L>-P8@ '. .3STKMZ* /-
M(/"&LK\/KCP'-:[H#(T46I"1-AMS+OW%<[A( 2,;<9 YQS5W4-$URVUWQ2;#
M35NK76K"***8W"H(72-T*L#R<Y!!''J1UKOJ* //])T+6[75O!DMQIVV/2M*
M>RNG2=&"NRQ@$<@D?NSGCN,9K7TK3-3L/'WB"]:U1M/U(6[I<"494QQ["I7K
MG.#Z8[YXKJ:* .7\6:-?W>I:#K6F()[G2+II&MF<+YT4B%'"D\!@#D9P/<54
M?0[Z?4O$>NM9/'<7^GI8VUH9$WX4-EG(;:"6?U. OJ<#LZ* ,3P?9W>F^#M'
MTZ^MS!<V=G%;R*65@61 I(()XXK"-EXET#QGJ]YIFF0ZGIVL&*4EKH0FUE1!
M&=V02RD*#\N2,=*[BB@#C8-*UC1/&E[K,=L=2MM4LX([D0NB/%/$" P#L!L8
M,>AR#VK*M/!^J:6WA<1VPG:UU.YU"^,<BA8S,L@VKN()QO Z<X)]J]'HH \]
MN= UF:R^($2Z<^[6U9;/,L?S9MQ%\WS<<C/T]^*AL7O=/^)&FQMILTLT?A=(
MI88Y(]R$3 =2P4C(]>XKT&]O;;3K&>]O)EAMH(S)+(W15 R2:IQ:1I<^K1^(
M(D9[R2 1I<"9\&(_,%VYQC//3KS0!P<G@O6]+CT_6;&RM+_4([^\N[K39) J
M.ERP)1'(QN3:G)X)!K5UC2-;U+1=,N8M'M;>ZM=7M[XZ?%,H(C3@@O@*7Y)]
M.V3C)[JB@#SYM*\0Z3XIU.YM_#]AJUEJSQW!,ERJ-9S"-48,64ED.T$%1GVK
M2M=+U2U\>W&J/8F2U_L>*S$D31J'E1V8X4MP#NP/\FNOHH \RT?POX@TS1O
MQ_LY)+K1))DN8#<(N5DC= P;D$#<">_M7I4O^I?/]T_RI]4-3T73]8^SF^@\
MTV[^9$P=D*,1@X*D'D$C% 'G'A_2M3E\ ?#[4M/LOM<FF,)Y+;S%C9XWC=,J
M6(&1N!P2,BI=2\,^);S0_&5M_9<7G:O?0W%LJW2D8419R3C&/+/X]L<UZ)8W
MNGRRW&GV,L1>P*PRPQC'DY4%5QV^4BKM '*^*M/U'5+GPU-:6+N+/4TO+@&1
M 40(ZD<MR<N.GH>:RIO#%_)XLAUFPL)M*OQJ&;NYAN%^SWMH&/\ K(PV2Y3
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *R/$-_>:=8PRV9M4W7$<<TURV%AC)Y8#(W-T 4'DD=>E:]8?B
M7P^^OQZ>T-^]E<V%VMW#((Q(I8!EPRGJ,,?I0!R=QXZUF+PCKVHPQ6CW6E:J
MMB#+!)&)8V:(!BA.5;$OZ=.:V(M8\1CQ1J7A^633'N?[-6_LI5@<(A+LGER#
M?EAD#Y@5ZGCM5>Y^'DEQINM6)UV<QZM>QWDA>W0E'4QGC&.IC7V R,=ZTKS3
MAI/B"Y\7WM\3'#IOV:6&*U9OD5BY88).<D\8/'YT 4]"\5:AK>D:&4%K'J=S
M-)'J$)A;$'E9$P WY!#;%!)/WP<5V5<EX3TRRDU?6/$UI#-%%JDB&%949,J$
M4-($8 KO8<Y'.Q3WKK: .$;Q?JUKK6E6]T+(B]U22QFMH49_(7#F,F8$KOP@
M)4@'#=!BKEIKFO:W9G5-%BLGM4U![86TP(>2))#&[[]V%;*E@-IX]2:J0?#J
M6WM--M%\0W7D:;J)OK5?(CW+DOE6)^\?WC?-^AJW9^")M-U2\:QUZZ@T:\N&
MNIM-$2$;V.7"R'YE5CU4>IP10 SPM=:K<^,_%D=W?136]K=111QB$J54PJX
M.[  W'/!R><CI6YXFUV+PSX:U#69XS(EI"9/+!QO/0+GMDD#-0Z?X=.G>)M5
MU:*_D,6I,DDEJ8UP)%0)D-UQA1QZU>UC2;37='N]*OD+VMU$8I #@X/<'L1U
M% '/W6O:QHNMZ)::D;.>WU=FMP\,3(;><(64<L=R'!'8C&>_#/!NL^)/$$:W
M]ZVF)8I/<V\D<,3B1FCE**P)8@#Y3D'/KGG NVGA>X$NER:EJ8OVTI6^QDP;
M#O*[ \GS'>P4D<;1R3C.,6?"^@/X;TR2Q-X+I7N);@-Y6P@R.78=3D98XH L
M^(=0NM*\/WU_9VKW5Q!$72%%+%C_ +HY..N!R<8KF(?'2R:++J5G?V6J0RW%
MO:6I@B9'261]A65"V01D''RY''O77:G:37NGR06]V]I,2K).BABA# ]#UZ8Q
M[US5[\/K+5$UE[ZXVW>J"#?/91^1Y;PDM'(HRQWACDDGD "@"EJGB7Q5I.F>
M(;J2P@:"QLC=VEW+ 8U=@#NB9/,)SQD$$#%+JNO^*]$T6'7+M](;3S<6YG5+
M>0O!;O@.V=X!*D]<8(R<#&*O2^#]2OO#NH:9JWB2:_FO+=K7[0UJD8CC8?-A
M%(!8\?,2>@X'.=TZ3'<>'CH]^RW,4EL;:4A-H=2NT\9..* ,?7-;U.TTWQ)?
MV7V)[?3+1GB6:)COE5#(X)##*X*C@#DGTIEKXAOM4OK#2;-K>WNI-)CU&XFD
MB+JN\[555##N&))/  '?(M+X42+P(_A>*\<+):-:R74B[G;>"'?&>IR3UXS5
M"Z\#W!GTF_T[7)=/U73[06+7*6ZND\ Q\KQL<=1D'/!S^  ?\)%K@ETW2+NU
M@M]:FM)+JZ\A#<)&%<(-HW+]XL#R>,8YSFMGPS>ZO?Z,LFN6 LK]9'C=%^ZX
M!^5U&20",'!.165JO@J6[?3;VPUR[L=8L ZK?E%D,RR'+K(API!/( P!VKH=
M,LI+"R6*>[EO)R2TMQ* #(Q[X' '0 #H * ,/Q7K6KZ7JF@VFF"S(U*Z:V<W
M",VS]V[AA@CIMZ=^F1UK/D\0>)':^TRV6UEU;3;>,S/%:N\4T[J6"@%P47 7
MG).6/3'.YKGA^36-2T>\2]%N=,N3<HAAW[V*E,$[AQAC5'5/"%U/XD;7=&UV
MXTBZGB6&\5(4F2=5SM.UN PR0&YX[>H VQ\0:MK.HKI<5O%IE]!8175\)T\[
MRI)"P6-0& .-C$G/3''/&3IGC76;K3?#%U/'8[M3U6?3[E4B<;0C3 ,AW\?Z
MH=<]:UKKP<\&MP:UIFN7&GS):K;7C/&LHN8U)8,V[HX))W>_2N;\(:!_;W@#
M2EM]0:TOM-U:XNX9C&),-YTN-ZG&0R/GMU!H U=0\6ZO;V'CAECL'DT$!H-T
M3[9%, E(<;^3SC@CZ4^^\0>(Y==TK2M+.F1MJ&E278DN(G;RY%V=@PRIWXQV
MZ\XP9G\"226WB:*36II#KZ*D[/ O[O\ =B,D 8YP..P]#UJ[#X6GCU[2=5;4
M59M.LFLQ&+? D5MN23NX/R+^M &3<^*/$=S;ZA+HMC%=SZ?=?93;B [;ETVB
M7$A<;.2VW(/09SG DU'6]0UVU\46VG&WMX=,@:"3SXB[2RF+>R\,-H 8#//.
M3T&#8?P5=0:]?7VE>(;O3[+49/-O;*.)'#O@!F1SS&6 Y(_3C"S^"9$U;5;O
M2M7DL;?5H@EY;&!9%+!-@="2-K8X/4&@"[X"_P"2=^&O^P7;?^BEHOM;N)/%
MT/ANP>**?["U]-/+&7"IO"*JJ".2<G)/ 7ISQ?\ #^D?V#X?L-)%R]RMG D"
MRNH4E5  X'L*IZIX<-WX@L]>L;O[)J5M"UN6:+S(YH6.2CKD'@C(((P?6@#E
MIO'>M#3T2.VL1J-OX@CT:[5E?RY [+B1.<KE6!P=V.>N.>ZTI=32P5=7EM9;
MP,VY[6-D0KD[>&)(.,9YZUSUWX&6>RABBO\ RK@:JNKSSM#N,TZL".,C"\ 8
MY. .<Y)ZT9P,D$]\"@#DM9UK7D\:6N@:6=.2.ZT^6Y$US&[F-D=%Y 8;A\W3
MCZ\8.7I?CS4[JWBTV[M(4UP:G/ILQ@C9XOW2>89$4D$@J5P">,Y[8J;66E?X
MNZ.+6\A@E32KA29(_,4EI(R$(##D@$CD'Y?2K=[\/X+G3(UM]2N+35H[Y]13
M4HE&\7#\,=IX*%?EV^@ R: ,_4/%/BS2]'>:YTZU29=6@M(I)HRBW,,KJH8*
M')1AD@YR.^.U6I]7\66/B31M$N)M'=]12[?SX[>0!!'M*G:7YX<9&1TZU:OO
M!][J>CQ6M[KTD]VMW#=273VRC)B8,BJBD!5R.>I.3S6A?>'YK[Q-I&M&]5&T
MZ.6-8A#D2>:%#$G=Q]T8]/>@#D)O&?B>V\+:IK$G]E,=$U![2Z18)/\ 2U61
M5+)\_P"Z.U@>=_/I722ZQJ3>/;K0HS:1P_V3]LAF,19U<R;,-\P! QG QUJG
M/X"DN/#FN:,^K 1ZO>O>2R+;<QEF#%5&[IE1C/OU[:T?AZ8>+QX@EOD=S8"Q
M:!8-H*[M^X'<2#N/Y<>] ' 6>J^(IOA]X,O#JT/F:CJMNLS&V)9]TC-\QW\C
M<,D#;D<<=^GU#Q)KL\FL0:';Q7%UI3+#L-L66YF\M9"N=X\L$. ,YP><XI8?
MA\T'A?3]%36I_P#B6WD=U93- A\O8Q*J1_%]X@G/ITJ:X\%WB>()]6TGQ)=Z
M<UZB+?QK!'(+AD7:'&X81\#&0,>U #[;7]3UO5K[3;%(+";3[2"2Z6YC,I$T
MJEQ'\K 84#D\YSQC',?PJ_Y)AH&>OV<_^A-4[>#GM?$3ZOH^JRV+7%O';WD+
M1"99EC&$8%CD.!QGD>HJ_P"%/#__  B_AJST87DEVMLI5970*<9SC [<^] $
M6K:Y-#XDTSP_9&)+J\BEN'FE0L(XX\#A01EB6 '/&">:Y+Q%X@U/4/!7CK2K
MAK>'4='ADCFECB;9/"\19&4;LHQ4X/+ $=\\=AK?AP:IJFFZM;71M-3TYG\F
M;9O1D<8='7(W*<#H001D&J5YX-6\T37+)KW;=ZWG[;=B'J-@0!%SP H &2>Y
M.2: -70K9X]+LY;G[/)<_9T3S8H?+.S (7EF/Z_A577M2O[*_LH+:2VM[>=)
M-\\B&60N,;$2)2&8G+$D9P%]\UJV%O):6$%O+*LKQ($WJFW=@8SC)K)U3PW+
M?>)+'6[75);.>WMY+9U6)9 \;E6.-WW6RHYY^E #O!FNS>)?"&FZO<Q)%/<Q
MDR)'G:&#%3C/..,\U@_%)BFF^'65&<KXALB$7&6^<\#) _,UT'A3P]_PBWA^
M#2%O9+N.!F\MY$52%+$XX^O6HO%/AN3Q+%I\8OA:K97L5ZN(=Y9XSE0>1QZ]
M_>@#GUTK7(?&^N^+[?34M4_LG[-!9SSHINYE.X22%254 #;DG./2I['Q9J<^
MM7VF":RN2FDKJ$%RENZ(7W%67ECO3@$,I]>372Z_HJ>(?#=[H]S.\2W<!B>6
M$8(SW /\OPK%C\&WHUC^U9M?DFNVTTZ?)FU149=Q((4<C!).,]>^.* .6U77
M_%U_\,HM?>\TVUAO8;,B.W@<R R2JKC<7Q@AO3(Y'^U76S:WJVE^---TO4Y+
M%M-U"WD\F>.W=&^T)@E"3(0 5RP^A%-;P2LGP]B\)R:B^R".)(KI8@&7RV5D
M)4D@\J,^OM5+Q/#9>(A!X/N'O+G4XYH+F2X6!XQ$H;<T@D VCY=R@ Y^8#U-
M '2^'[V[U+2EOKLPXN':2W\J,I^Y)/EDY8\E<$].N,<52U[6[W2M?\.VD MV
MMM2NGMY@Z,77$3N"I# #[N.0:Z!$6-%1%"JHP !@ 5B>)/#SZY_9TUO?&RO=
M/NA<P3>4)!G:RE64D9!#'N* .7U?QKK=AHWBVYB33WFT6^B@BW1.%='6,_,-
M_P!X>9UZ<=*OS>*]1T/Q#JEIKAM);.WTA]51K6)D:-4;:T9W,=YZ8;"_04RZ
M^'CW>G:_:/KD[?VU/'-,[P(2A0(.,8Y.P>P';O6E?>$1JFO3:C?W22Q3Z8^F
M36RPE0\;G<Q!W$@Y_3WYH YO5Y]6OM3\ 7]]):".ZU 2^1%&P,3-;R$+N+'<
M "03@9(SQTK0C\5Z_J4%MJ>CZ<+JR>]:%K?R<,8%D*&02EP-PV[L;?;KS4EO
MX#OHXM#@N/$D\\&BW EM/]%0.4",@5VYW$*V,X'TSR)M/\$7&E:C<+9>(+N+
M0YYVN'TORD(#,=S*LA^94)ZJ/4\\T -T36?$NK^(=4M]VEQV6F:D;:7]U)YD
ML?E*PVG=@,"PY.0?;'/6W(E:VE$$BQS%3L=DW!3V)&1G\ZR-"\/R:-J.L7;7
MHG&IW/VED\G9Y;;57 .XY&%%;A&01ZT >.Q7>J7_ ,.O U_=W$-U=7&MVDJL
MR%/F+.3O.3GGN /I74?\)-KEM;^,K6Z.GSWNAP+<0RI Z1RHT32!60N3D;2,
MAO2GV_P_EM="T?24UMV@TF]CN[<R6RDX0DHAP1D?,<GJ>,8[W9_!\L]UXEG_
M +25?[=MTMY%^S_ZE51D!7YN3M8]>^/I0!FWOC>6PM=!>]GMM-@U'3UF^W3V
M[/;BX(4B,D,-@Y)Y//J,5VME)++86TD_EF9XE:3RSE=Q S@^F>E8'_"+W:Z7
M!IPU.&2U6P6QEAN+/S(Y N0'V[QAL'GJ#Z=,;.D:9!HNC66EVQ=H+.!((RYR
MQ50 ,GUXH S?%VH+9Z.MKYQAEU"46JR+G**V2[C'=4#$>^/6N<^&5[#92:SX
M124O'I5P9+%FSEK24ED'/)VG<I/TKKFTNX?Q+%JKWBM#%;M!';>3]W<5+-NW
M=257MT&/4U0OO#$MSXTLO$MOJ MY;>V:U>$0;A-&QW%6.X=#R,=#ZT 8%]XU
MU@:5?:G91V@^RZU_98LY8F9V'F+'NR&'S$L' QC;Q[U=76/%-WXQU+1+5])2
M.QBM)VEDAD)99"^]<!NN%.#VQT.<CE;.:>XU2\O;;7I+35I;J64:?>:")KB,
M[B%3?A6*[< $' '&<#-=]I6@W=MXCN]?N;J/S[^VABGMDB^6,Q@XVMNYY=NW
M/'2@#&L_%6OZK%I>JZ7IPN=.O+D+)#Y.UH[<DCS1(7P6& 2NWN0.F2+XJU_4
M8(M2T73A=VAOF@:V\G#-"LAC9Q*7 #?*6QMZ<=>:M:/X'N-$NV@M/$%V-!\\
MSQZ68DPA+;MHD^]LW<[?PSR<EEX(N-,U.Y^P^(+N'1;JX:XETP1(0'8Y8+(?
MF5">JCU.",T 9=_XJ\3QVGC"XMFTI!X?E+*'@D;SXQ"LI4_.-IP3\W/T'6M"
M+Q/JUMXCT>+4/L1T[5[*:YC2&-A);&-4?!<MAP0W]U>14\O@N6:U\3P'4U"^
M(,^:?L_,0,8C.WYN?E Z]^?:ISX4EDU/0+R6_1O[(MY(!']GXF5U56S\W'"C
M'OGKTH S=.\3>(]3&B:C:::LVFZCM::/R=C6T3KE)/,+X?'&X;><\8Q68?&G
MB6/0I];E&E_9K+66T^>!(9-TR?:!#N5B_P A&<\AL^W2MS0/!-UH#I:0^(KN
M71('+VNG21)^ZYRJF3[S(#R!QT )(XJ&3P%))X:O=%.K#9=ZB=0:46WS*YE$
MI4#=C&X#\/SH ?HESJL_Q+\36\]]$]G;16@2'R2"JLLC *=W!R>20<^V*Z?5
M7N(])O'M95BN%A9HY'3>%('7&1FLVU\.O:>++S7(]0<"]AB2YMA&-KM&&"L"
M<D##'CV'-;4T2SP20OG9(I5L>A&* //?#/B/4H_#?@S3Y+B";4=;@WK/)$V(
MXTB#N6&[YVR0.JCYLXXP>AT#7KRZ\0ZSH&I)";O3O*D2>%2J312 E3M).&!!
M!YP>H]*S[?P!]FT?1+9-8F-[HCYT^[:%?D3;L,;*,;E*\'D$]B*W]*T1;"_O
M]2GF$^H7Q3SI538H5!A%5<G &2>23ECST  (O%VI76C^$=6U.R6!Y[2UDG59
MU+(VU22" 0><>M8TWB#7)/$6B:7:'3XTU+3)+HRRPNQC=?+[!AD?/TX^M=#X
MATDZ[X?O])\_R%O('@>39N*JPP<#(YP:S(_"T\>MZ1J9U%&?3;)[-4^SX$BM
MMRQ^;@_(OZT <R?&GB:'PM-K<PTLKINIFPO(DA?-R!<"$NAW_N^H."&^HZ5I
M7&M>+;[Q'XCTC1_[(1M,2WD@>YBD;S/,5FV$!AUV@;NWH<\22^ 9)O#&I:(V
MK 1W]^;YY1;?,K&42E0-V,;@/P_.J.E+>7/Q*\7)9ZG!;N]O9H6,&_<P1PS)
M\PP5)_V@,C(H DTGQY=>)+/2UT^W^S75UIYO9\P&?RSO,>T+N7C<K\D] ..<
MA&\3^+C-X8LIM/L+"_U0W,5Q'.K.(WC1F5UVM]TX!VGGMGO5VY^'T=N-(E\/
M:K<:/>:9;&T298UF$T).2LBMPWS?-GU)-79?"<TFIZ%?G57>;2GED+30AFN'
MD4JY8@@ 8/  P..PQ0!EQ:QXNGU[4="\_1H[JTTZ"Y^T"VD9#(^\,-N\'&4X
M.1@=C5;3_&>NW-AX1UFXCT];'6YX[66UCC?S(W='(<2%L8RA^7;P#U/6ND7P
M[/'XGU'6X[] ]Y:I:^4T&0@0L5.=W)RYS^'2LN#P));Z#X=TI-5!CT.Z2YB<
MVW,A0, &^;IASG'MTH B?Q9JUN/&!^Q0W$FCW$*0K;0LS,CHC%F7=EBJL3@8
MSMQQ33XVD/ABZUNRO+75+%+B)!<6=N[-!$2/,:2+=NW+DG''&#CK6G'X5NX+
MS7+NWU@Q3ZI<0W&Y;?\ U31[ !][Y@50 @^II(?"4MK>WVI6NH1VVI7L\4TT
MD-MMB;RU*A3'NR<[CD[LGCI@4 9>I>+KV+P7)KNGWFDZE#]NABBFCC;8\3O&
MG*[_ )7!8]?3H*KRIK;_ !,\2KH4MA#<_P!G61+WL;NIP9L+A2.OKGCT/;1N
MO $5QHVI6,=ZEN^I7\=]</#;X0.A0@(F[Y03&I.2223Z\:,OAR[3Q%<ZU8:H
MMO<7EM';W*O;>8I";MK)\PVGYCUW#VH Y/\ M]_$_P#PKW5IK<6\\FJ3I-$#
MD+(D4R, ?3*G%;,?BK5;6X\3:?J(LO[1L DFGI%"RK<1R<1$@N<DR?(<$8/U
MJX_@J")?#T5A=&W@T69IHU>/S#*[*RL6.1UWL3[G\*I)'I?B[QM8ZI:PW7_$
ME$T,\LD+Q*[[E"Q_,!O (+\9 (7UH [&W$XMHQ<M&\X4>8T:E5+=\ DD#\37
M.W6LZKJ&L:UI>AFTCGTN"-B;F,N)9I%+*G##:N ,GD_-VQST]<KJ7A"YE\32
M:[H^N3Z5<W,2PWJI"DJSJOW3AONN 2 >>.WJ $.O:IJ.N?V'"MK97UOIT5W>
MLZF=4DD) C7#+D JQ)],?48:>.]9NK/1_(M;&*\EUF31KZ.0.565 Y+(0>GR
M X(/7'O712>$_(URWUG2KXVU[':"SF\^,S)<1@Y!<;E.\')W9[G.:K2>!XUB
MTI+:^,;6.HOJ<CO$&:XG;=N+8(P#O;@>WI0!G_\ "7ZU867B6*]@@N[O1;N"
M-IK.V?:895C<R>5N+$HKL2 W.VJ.O^)+_4/!#:CI6N6$\$FJ6T$=Q:PGYX7>
M)2K@OE6W,P(XR,<#-=&GA6\AU/6=0MM8\F?4KB"X)%OD1F)54+][E2JX/U."
M*K77@"WN].U:+[6+>[U*[AO'FMX J))$5*D1DGJ4R<G))- %AM7U6/QW;Z"[
M631RZ3+="=8&#"59$7IO/R_-G&<^]<OH/B77['P'HFISW5I=O?:P+67S;=@V
MV2Z=&((?&>>.,#I@UV*>')QXKM-=DU(RR06369C: #>&96+9!X.5&.,8_.LI
M?A]Y?A8Z''K,X2&\6\L93"A-LZRF49'\?S$@Y[8Z4 0Z[XDUF.3QI86\UM =
M+TI+RUG6$EP660D-EL$_N^#@=>AIVGZ[J,%CH&CI(DM[<Z8+MITMF?9&HC4#
M;OY8E_O9QQTYJXG@AI;W6KJ^UB>X;5[!;*X58D0  .-R]<??.!^>:@N/ =T]
MGHTEMXAN;;6-)C,,%^ENA#1$ &-H^C+\H/)Z\T ;?AF]U>^TCS-<L!9WR2O&
MRKPLB@_+(HR2H(P<$Y'-;-4M+L9+"S$4]Y+>7#$O+<2@ NQ[X'"C   '8=^M
M7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *Q/%OB'_A%?#=UK36ANH;4!I(UDVM@D#C(P>OM6W7$
M_%W_ ))5K_\ UQ7_ -&+0!V%I)--:QR3Q+%(R@E%?>%]LX%355>[@M+.&2:0
M*K%(U_VF8@*![DD5YGI?_%26!U*XU^WT_5[+59/.*PL;F-EF8+ ?WG*,NU0N
MW!ST)R: /5J;(76-C&@=P#M4G )],]J\=U>P1]!^(]XUQ>&?3KUY;-S=29A=
M8(V!7YNN?7H.!73V-U'K_C[5-+UD*\=MIEK+9V[G"N) QEE _O [5W?PXXQD
MT =)X4UX^)_#-GK!MOLQN=Y\G?OV[79>N!GIZ5LUXOX8OQ%X<\#:5<75O#IM
MY%? M=H9(I9EE^1'^9<\%R 3@G'&0*T=3TG^S[/P_8IKMS>Q'Q.L.89'C6*)
MT=C /G.0IQ@Y)'0$8H [_4]9N-.UK2K)=+FGMKYVC>[210(& RH*GDYP>1TQ
M6Q5#3-&L=(LK>TM(2(K<,(C([2,@8Y(#,2<9]^P]*X0S7.E^+8)=3M$OM/O-
M7=+/5[23][#(69!;S(>2@.5!!P-H.,T >E44UU#HR'.&&#@D'\QR*\2CTZ1?
MA7;>([.]OCK]GJ+K:2&[D8L3>LGE%2<,&!YR"3F@#V^BO.M.TNRN_'WBZ>_G
MO&BTRYM+F ?:I-L3>0')P#R,Y^4Y';'-96AW*P^(O ]S:3,MOJ%O=EI9I@;B
M\3R]ZO/C SGD#G'J.E 'K54)=2\VSU!M+1+V[M"T?D>9L#2A0P0M@@?>7GMF
MN$\)/IOB'P[HNN7VHRP:Y'>G[2T4@65YB[*;=P<GR^1\G&  1CK67;6-G:^!
M?B/);#[/<17FH^6T,A1U"HK#!!!P#C\Z /6X6D>"-IHQ'*5!= VX*<<C/?ZT
M^O.K:]M[WQ7I>AZRZFRD\/Q3VL4S82:4MB0\\,RJ%QW&215=Y;>#6M \./JZ
MW.E/I\XMY]4!F6[F20+@D,@9E7.WKQSR<&@#TVBL'P?9?V;H"V0U=M52"61$
MN&!X&[[@))W!?NYR>F.U9>L7)N?B7I.B7ZAM+FTZ>>.)_N3W"NHPPZ-M3<0#
MZY["@#H];U>VT'1+W5KO=]GM(6E<*,D@#H/<]*BTR^U6XO;F#4-*CM841'AN
M(KD2K+G.5(*J588],'(YKR_7H93\.O'UC<%Y[#3;QTT]Y6+&-2J,4!/)"EBH
M].G:O7;*U@L[2."VC6.(#(5>G/- $]%>=^-)+6\U36K=7,MS9Z(9'6XDVPVH
M)<K)&,9,I(QD$8"CGG!HVJ?VSK?@(7EU<S+>Z%*]THN7 E81P'Y@#U^8Y]<\
MY% 'J5%>36FDW>H_#_45L&EEO-"UJ[;3XWD9MZ0SDB!N<LK*-N#[>E=CX5O;
M?Q+/-XIMU86US%'!:;A@E%&78CUWL5/_ %S% &GXFUA_#_AO4-72U^U?8X&F
M,7F;-P49/.#_ "J2*^O9Y-,>&Q1K2YB,EQ,9L& [05 7'S9)([8Q67\0_P#D
MG'B3_L&S_P#H!K&GW1^-? 1264++8W0>/S&V-MBCP=N<9&3SCO0!WU%>:^%)
M-.\0^']*UK4-1EM]<AU$FY:*0+*9O,9?L[ Y/EX(&SC@ ^]4K#_BI+&XO[G7
M[?3M7L-6E$K"%C<PE)F"0_ZP91DVJ%VX.>A.30!ZO17CVKZ?'+IGQ*N7N+QI
M=.G,UFWVJ3]RXMT<,OS=<_ET&.:TO%$U]&D^L36L>L:4-,B%[%%+Y=U8?*S-
M-%G@Y#9/0G8.<"@#T^F2LZQ.T:!W .U2V 3Z9[5YG=2Q>*]>\3:9>:M;6+PI
M"UDT\;"2"%H5831'S%VD.6R<=@"<8%7-&FBUOQAJ.D:U<_;4LM+LVL_-!C\X
M.I,MP%[-NVC/5>V,F@#JO"FO?\)/X8L=9-M]F^U*S>3OW[,,1C.!GIZ5LUQO
MPHQ_PK#0P&W 1.,YSG]XU5?%-E%?_$?PS93SW(MKJTO1-#'<NBR;1'@8!&.I
MZ8)'!XH [RBO%I[:YLM)O-,COKW^S['Q9:VUE)]I?<L;/&7CSGY@I8@9S@YK
MJ(["SLOB':>&'B?^QFTR:\@@GE:1)KAIAOSO)W%5Y [;B: .PUW6;?P_H=WJ
MMT&:&V3<57JQ)P /<D@?C3=-O-5GO+R#4=+CM4BV&">*Y$J3@@YZJK*5(P<C
MN,&O+=:BEE^&/BVUO&>XM=-U@P:?+,Q9EB$L7R[CR0I9ER?3':NCU7[._CE?
M#,\ME:Z>=+$MI!=1,T<CF1Q(5PZ_. $QU(!)&.: /0J*\OGL=4L],TO['<P^
M+H;"TECN;:X<Q2S)YA FB))!=0A7).2!P?FJ#5KF2XTBWUFQM#K&@_V)#Y]I
M)+Y=[9QD.?/C)X+%<YY!)C&#0!Z9Y][_ &N(/L:?8/(WFZ\X;O,W8V;,=,<[
ML^V*MUYY<7\P^(,M]IIGF,GA5[J"!W8JS^8NWY"< G@<5EB5SX%\(>)-+G=]
M:N+FT6>8,2UVTC!9HY/[PR6X/W=O&,4 >KT5XUJUBC>'/B+>FYO#<:;J#R6;
MFZDS"RPQ,"OS=<^O;BO8+9S):PNQRS("?Q% $M%<):I#XC\9>+=,UD$BS6!+
M1"Q7RHFCR94/9BV[YAR-H&>*YC2EO/$1^'HURXNW>^LKY+D+</&+A%4"-C@C
MDJ0<C!.?2@#V*BH;2UBL;*"T@W>5!&L:;W+':HP,D\D\=37G2%-?L/'<FJ2/
M%J.G7D\=M)O*O9Q)$&A>,_PYY;(Z\YR* /2Z*\ITNUE\2^*]'AU][K=>>%DN
M+NV%S)&KR>8@)*J1CU(&.>M4-+U*\LX='T74-04Z.=8U"RANK\&1)DB.(4<[
MEW GS ,G!*#TH ]EHKR?6-)_LS3-.LX=>GNHCXGME MW>);99&!,*_.<J."
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M4 =%17EMY#;:!9^%W%R8+;6I8EU&YO)))8I'%NWEJP+@ ,V. 0#@ \<47_\
MQ3(M[ :Z)=+U#7(8[E808X[.-T9C$K;FVJS*N1D8#=@U 'J5%>5:M;V]MK7C
MNTL0$@B\/),D,3?+%+B8[E4<*W"GC'K5Z"Z5_$GPYVW&9+C39S-MDYD'D(5+
M<\\[B"?>@#O+">]G6X-[9I:E)W2(+,)/,C!^5SP-I/\ =[>M%W/>Q7-FEK9I
M/#)*5N)&F"&%-I.X#!W<@#''6O)K[S1\/O$VV\NU>#Q0T4<@N'W*OVF-,$D_
M,-I(P<UT>M:/:Z#XC\(1Z>]U''/J\K2H]U)('+02$Y#,>X!__70!Z#17C&K6
M2_\ "+?$._\ M-X;G3=3DDLY#=2$PLL4+ CYNN3W[<5T^M.]QXPF@OD-[:2Z
M*#!;1.NZ&8NV6P2-I;@*_;8>10!Z!16'X/TR]TGPGIUIJ5Q)<:@L*FYE>=I2
MTF.?F8G].*W* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *J:CI=AJ]J;;4;*WN[<G)BGC#J?P/%6Z
MY?XA:E?Z1X.N=0TV[:VN(98 &"*V5:5$(^8'LQH T;?PKX>M+B&XM]$TZ*:$
M[HI$MD#(>F0<<4\^&]$.M#63I-D=3'_+WY"^9TQG=C.<<9]*C%] _C#[$NL@
MS)9%WTP(IP-Z_O2V,CJ%QG'.<4^'Q)I%QJ$-C'>J9Y]_D JP6;9][8Q&UR.^
MTG% "MX;T-H[J-M(LBEVVZY4P+B8^KC'S'ZTEUX:T.^-J;K2+*8V@VV^^%3Y
M8]!QP/;I1_PDFD?VA%8F]59IF9(BRL$D9?O*KD;688.0"2,'TJHOCCPRTD2+
MK%NQDG^S*5R1YF<;2<8&3P">">E %F3PKX?ETC^R7T6P;3]V_P"S&W79N_O8
MQU]^M/;PYHCVMI:MI%D;>S(:VB,"[82.ZC'RGW%/N-=TVTNC;37!$@D2)B(V
M94=R BLP&%)W+@$CJ/6HG\3:/':W]R]X%BT]]EVQ1OW!QGYAC(X(.>F* -:L
M^+0M*@O#=Q:?;I.96F+K&!^\;.7_ -XY.6Z\U2U'QGX<TJ1H[[5[>%U@%PRD
MDD1D@!L >X_#GH*L77B71[.X2&XO5C+2+%O*MY8=L%59\;58Y& 2#R/6@#3<
ML$8JNY@.%SC)KD?!'A$:)HL,6J6%F=0BN9IA+$V\$O([!N0/F"MMSC.!UQ72
M:GJEEHU@]]J$X@M8\;Y64D+[G X'O4<NMZ;!J#6$UVD=RL!N2C@K^Z! +Y/!
M ) H ?;Z1IMI>W%Y;V%M%=7/^OF2(!Y?]X]3^-5+;PGX=LVA:VT/3H6AE,T1
M2V0%'/\ $..#45GXS\.ZA=6=M::K!++> FW"YQ)@$X!QC.!G'7'-8_Q#\5+H
M_A+6)--U)K?4K2,8DCA\Q8W."$8E2JD@C .#R/44 =%#X<T2WUF36(=)LH]2
MDSONEA42'/7YL9Y[TLGAW197O7DTFR9K[ NB8%)GQ_?X^;\:;?:_INDPAK^Y
M\O;$)9"L;/Y:?WWV@[5X/)P.#Z55U#QIX;TMREYK%K&PMQ<D!MW[HD -QG@Y
M'X<]* +%]X8T+4[*WLK[1[&XMK;_ %$4L"LL?^Z,<?A4NI:!H^KV$=CJ.F6E
MU:18\N&6%65,# VCMQQQ5B\U&TL+(WEU<)%;C;\Y[EB H'J22  .236?)XLT
M*&PN[Z?48H(+.3R[@S!HVB? (5E8!@2""!CGM0!J6UM!9VT=M:PQPP1*%CBC
M4*J =  . *AO]+L=4CC2^M(;A8W#Q^8N2C?WE/4'W%9]IXO\/7M[=V=OJUL]
MQ:(9)DW8VH."V3P0#W&145KXX\,WU]:65MK-M)<7:[H%!/[SO@'&,XYQUZ4
M:,VAZ5<Z8--GTVTDL0<_9GA4QYSG[N,=>?K5N""*VA2&"-8XD&%11@ >U<=9
M:W=+J?C>WU+6?L]IISQ+;W+H@^S*\ ?/3!P6[YZ"M^#6+*TTC3I)[]KLW$"M
M%*L):2Y&T$N(T&>1R<# S0!+>:#I&H7T=]>:79W%W&AC2:6%6=5/;)'3D_F:
M9!X;T.V>U>#2+&)[5"ENR0*#$IZA3C@'VIH\3:,]G9W<-\D\5X&-MY"M*TH7
M[VU5!8X[\<=ZY_Q#XJ2"[\*:C8:Q&NC7UVZ7#@*4DC$4C9W$9&"HZ8]* -:\
MTN_TN&.+PE8Z/:^?,6NFF1D R/OA4'S-GUQGU[UK:;80Z5IEM86^?*MXUC4G
MJ<#J?<]3]:Y?7_%MM??#[7=8\,ZLAFL8)6$D: M'(BYVLKCC\16V=<M+#3+2
M:_G;S)+<2L$B:1B !N;:@)VC/)Q@9H T+VQM=1M)+2]MHKFWD&'BE0,K#W!X
M-5AH6DB>TG&FVGG6:[;:3REW0CT0X^4?2K-K=V^H645W9W"36\R!XI8V#*P/
M0@UROA3Q%)_8NIW.N:AYA@UBYL8I&0!F"R[(U"H.6/' &30!O1>'-$AUE]8B
MTFR34G!W72PJ)#G@_-C.?>D;PWHCZTNLMI-D=37I=F!?,'&,[L9SCC-0OXLT
M.+3Y+^2_5+>*?[-*S1N#'+P-C+C*GD<$#J/45:CUO3Y=5ETM)R;Z*,2O#Y;;
ME0]&Z=#0 QO#FB.MVK:39%;PYN08%Q,?]OCYOQI&\-Z([ACI5ID1K%_J@,HO
M13ZJ.P/ JY97MOJ-G'=VDGF02#*/M*Y'XBLOQ%XGM/#AT];F.9WOKI+:,1Q,
MP!)Y)(!Z $@=3^> "QJ7AO1-8NX+K4M)LKNXM_\ 523P*[)SG@D=,]J?J&@:
M1JUS!<ZAIEI=3P?ZJ2:(,R#T!/;VKE8/&$>F>+_$T6M:KMTVVBLY;57BP8Q(
MLC/PJ[B.!DGIWQ75W6MZ?9V\4TEQN29#)'Y*-*SH "6"H"2HR.<8Y'K0!-I^
MF6.DVBVFG6<%I;J<B.",(N>YP._O7.Z]X=N=7\:Z%J+VMM+I]A%<))YDA#[I
M-F&48[;/4=:T7\7^'HTLV;5[7;>QM+;%7SYJ@9)&/\YXZU=TK5[#7+$7FFW*
MW$!9D+*""&4X((.""#V- #)O#^CW%E#9SZ79RVL+[XX7A4JC9SN (ZYYSUJ2
M^TG3]22%+VSAG$#;HBZY,9QC*GJ#CCBHYM=TVWN_LLEP1)YJ0$B-BJR-C:A8
M#:&.Y>"<\CUJ%_%&BQV%[?/?*MM8RF&Z<HP\EP 2&&,CJ.OK0!/<:'I-WIJZ
M=<:9:2V*XVVSPJ8QSG[N,=>:CU+PWHFL6L-MJ6E6=W# <Q)-"K!#[9Z4[4=>
MTS2E)O+G9B(S,$1G*1CJ[!0=J_[1P*YN\\4?8?']JDNJJ=#N-&DNT155E9Q)
M&%92HW-E6. ,]: .EN-!TFZ,1FTZV8PQ^3&?+ *1_P!P8Z+_ +/2DG\/Z/=2
MB6;3+5W$0@R8AS&.B'U49/RGCFK&G:C9ZMI\-_87"7%I.NZ.5#PPK&G\?>%+
M9]LNNVBXG-N3N)59!C() P!R.3Q[T :_]DZ=_:8U/[#;_;PGEBY\L>8$_N[N
MN/:HK;0=)L[QKNVTZVBG9V?>D8!#-]YAZ$]R.3WJIJ/C'P[I5U+:WVK6\,\0
M0R1DDE0QPN<#N:GN/$FD6ER8)[U4(E$#.5;RUD.,(SXVJQR."<\CUH 5O#6A
MM%=1-I%B8[MM]RA@7$S>KC'S'ZUHPPQ6\*0PQK'$@VJBC 4>@%4X=:T^?5KC
M2XKC=?6Z!Y8=C913T/3&#V]:SI];L+O4-&%OKGV8SSR!+;RN;S:K K\PR ""
M<C'W<4 :-]H>E:E<)<7NGV\\R(8Q))&"VP]5)[J?0\4LVC:9<7EM>3:?;27-
MJ,03-$"T0_V3U'X4Q=>TUKY+-;@F625H4/EML:102RA\;20%;(SQM/I5+2=8
ML39:K>MK\=]:PWDBM*P55ML!?W0( W8SUY)SB@#>K.NM!TF]O/MESIUM+<%0
MID>,$LH.0#Z@'H#TJ.+Q)I$BW9-ZL1LT#W"3JT3Q*>C%7 (!['&#4-CXOT#4
MKVUL[/4X9I[J+SH%4']XN-W!(P3@Y(Z@=J ,R]\-3ZA\1(M8N;2VETZ/33:
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M#L363>/;6UC:ZEI/AR_BMKS58Y+B[FM))[F/",/M"Q,&8'H@8CN3@C&?2J*
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MBZ/;V4$NJBV^U31FY*Q1(6*K\^PDEB#@;>QSVR>,]#N/$GA#4=)M98X[BXC
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M'4HTCO[.WNDC<2(L\2N%<=& (X(]:LT4 %%%% !1110 4444 %%%% !1110
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M>N"03SR*M5R'PRT2/1/ E@BVRVSW>Z]DB7^ RG<%_P" J57_ (#77T %%%%
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M')Z#T .XJM-J-E;WMO9S7D$=U<[O(A>0!Y<#)VJ>3CVKQ7Q-\0];UWX$QZ[
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M9^[@J3P3P<9XK1N?$'B[2X-(M]7MM,MYKHS"[U"$-);P$9\I50LK,S<#J>>
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M<Z?@F:TRP$;&0.0200<%1D=.,&I-#U/Q!J/QI\3V+ZC:_9]/MXHXXWMF90C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **R[+Q!IVH:YJ6CV\X:]TX1FX3^[O&1CUXZ^E:E !1110 4444 %9'B
M;16\1:#/I/VG[/%<,BS,$W%HPP+H.1C<H*Y[9K7HH P/$N@7VMIIJ:?KEUI
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M-74?NU..H' !Q70Z'X!6;PZFG>*Y;G5E@O7N+(7ERS2PI@! S*0&8<G/.-Q
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M^N.IK3K+B\.:1!XCG\01V,:ZK/"();G)W,@Q@8SCL.<9X%:E !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(-,BMH+".21BT%N8N)$8G.XMNR^<_*!GB@#T2BO(K2]O+;PMX+\::TS.8?\
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M/!(R#\P')(-94MI/::3+IBWEY_9]EXPM[6R?[0^Y8F=-T><_,%8D#.<$'TH
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MP/RH Z+PGKS>)O#5KJ[6OV5IVD4P^9OV[)&3K@9^[GI6U7BNC6D5IX,\&:O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %9,6C+::W=WUOL\G4 OVR%AP75=H<>Y7"
MD'J #Q@YUJ* ,BV\+Z#8>0]EHFG0R6S-) 4MT7RW88)! X)P!D>E2:3I"V$]
M]>2L)+Z_E$MQ(.G"A40?[*J /<Y/>M.B@ HHHH **** &R1I+&T<BAD88*D9
M!%8Z>#_#,:;$\/:4J9W;19QXSZXQUK:HH J7NF6&I6RVU[9P7$*,&1)$!"L.
MA'H1ZBH9M!TBXT];"?2[.6S5MX@>%63=G.<$8SGG-:-% %&;1M,N+FVN9]/M
M9)[48MY7B4M$/]DD97\*2]T32]2N$GO=/MKB9%*!Y(PS;3U7/=?;I5^B@"*:
MUM[BW-O-#')"<?NV4%>#D<?@*/L\(N3<^4GGE!&9-OS;0<XSZ9)J6B@#,G\.
MZ+=:O%JUQI-E+J,6-ET\"F1<=,-C/';TJ>WTG3K6^GOK>PMHKNX_UTZ1!7D_
MWF R?QJY10!3O]*T[5!$-0L;:Z$+[X_/B#[&]1GH?>HM5T#1]<BBCU73+2]2
M([HQ<0J^P^V1Q6C10!R.L>&)M1\9Z'?_ &.S?2]/MIH61G*L"^S!10N!MV>H
MZUNS:!H]Q9P6D^EV<EM V^*)X%*HW7(!& <]ZT:* ,[5-!TC6[>.#5=,M+V*
M([HTN(E<*?;/2EGT+2;GR?.TZU<P1^5$?* *)_='HO XZ5H44 9FH^'=%UBV
M@MM1TFRNX+?_ %,<T"LL?;Y01QT'2I7T;2Y+JWNGTZU:XMEV02F%=T2^BG'R
MCV%7J* ,O_A&]#-E<61T>P^RW+^9/#]G79(^<[F&,$Y[FG'P_H[7/V@Z7:>;
M\F6$*C.S 3/KMP,9Z8XK2HH AN[2VO[26UO((KBWE7;)%*@97'H0>#6>GA;P
M_&NU-$TY1Y'V; MD'[K.=G3[N23BM:B@#.7P_HR-:,NE60:S&+4B!?W _P!C
MCY?PJO-X2\.7-U/<SZ%ITDUPP:9WMD)D((()XY.0#^%;-% "*JH@55"JHP !
M@ 57.GV3020FUA,4LGFNA089\[MQ'<Y .?:K-% %+4='TS5_)_M+3[6\\A]\
M7GQ*^QO49'%5SX8T!E"G1=/*B<W(!MD_UIZOT^][]:U:* *;:1ISZDFI-86S
M7R+L6Y,2^8J^@;&<>U59O"WA^XFNII]$TZ22Z(:X=[9"92"""QQSR >?2M:B
M@#-/A_1B]VYTJR+7B[;D^0N9AZ/Q\P^M+_8&CXLA_9=E_H!S:?N%_P!'_P!S
MCY>@Z>E:-% &?::'I6GS":STZV@D&[:8XPNW=][&.F>^.O>IM0TVQU:V^S:C
M9V]W!N#>5/&'7(Z'![U:HH S[O0=)O[A)[O3;6:5$\L.\0)V?W?=?;I5\JI7
M:0-N,8]J6B@#$/@[PR7D<^'M*+2$L[?9(\L3U)XYJ>[\-Z'?Z7#IEUI%C-8P
MX\JW>!2D>.FU<8'X5J44 9[:%I#_ &3=IEF?L0Q:Y@7]P/\ 8X^7\*1= T=8
M[N,:59!+S_CY7R%Q/_O\?-^-:-% &58>&M"TN9)K#2+&VFC3RTDB@565?0'&
M<<T67AG0M-DN7L='L;9[H8G,5NJF0>AP.1[5JT4 5K#3K'2K46NGV<%I;J21
M%!&$4$]>!Q3+C2--O+V*]N;"VFNH49(YY(E9T4]0&(R :N44 90\,Z"MK%:C
M1M/%O#)YL40MDV(_7<!C /O39O"WA^XEN99M$TZ22Z(-PSVR$RD$$;N.>0#S
MZ5KT4 4CI&FF_:_.GVIO&B\DS^2N\Q_W=V,X]JFLK*UTVSBL[*WBM[:)=L<4
M2A54>@ J>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCJ"MI-^^G:E817$"LOG3N&BA?_II@C'YB@#3HJE-JEE8Q1&_U"T@9UR&DE5
M_J1D].:JCQ/I#>(VT%;V WZ0B5X_,&1D\+U^\>3CTY[B@#7HK*TW4"NGK)J.
MIZ=,\EP\22V[!8V)<A4&6.6Z C/6KEIJ%E?I(]G>6]RL;%':&4.%8=0<'@^U
M %FBJEOJNG7<A2VO[69QC*QS*QYZ=#5N@ HJI+JFGV]VEI-?6L=RY 2%YE#M
MGIA2<G-+/J=A:W*6]Q?6T4[XVQ22JK-DX& 3DY- %JBBJMYJ5CIRJU]>VUJK
M9VF>54!QUQDT 6J*165U#*0RD9!!R"*6@ HHHH **** "BBB@ HHHH ****
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MO92JL02H.#D9'2EH \WT+2]$E^)7BVVBLM.9X(K$VT1B0B-E1N57'!4A>G3
MK"1FU#X1VVCJX3Q=;7R 0L?](CO!<9:3'7E2S%NFTD]*]EI-J[MVT;L8SCF@
M#SKQ!I4T7C"^TV&W+V7BVR\F=PN5AEC^5W/89A8X]60>M,T%-=U+P?J(EB=-
M8TFPN-(M7Z&2=009%/HVV'!]=U>DXHQB@#R[PO=^%_$$NA7 OKN;4M,MGCDL
MY(TC%FICVR+, B_+QCD]<8[U)\/;?PU!\+$U*_M;!H8H;I+R9H5=A%YK%E;@
MDK@+\OH!QTKTP*H)( !/4XZT$ @@@$'M0!#9-;/8V[V806K1*80BX79CY<#L
M,8KD?B(DF[PI-SY$/B&U:;T .Y5)]MS+^8KM:K:AI]MJEA-97<?F03+AAG!]
M00>Q!P01T(% &!XHNTOKVP\-07MM%=7C^=*LHW?N8R&(*[@3N;:N,C*EO2N<
M^TOX.^*\;ZC?VC6_B6WVRF./R5CN(<!&(+-C<I*YSR0*]&MXY(K=(YIO.D48
M,A4*6]R!QGUQQ[#I4M '%:JDDOQ?\.F#/[G3+Q[C']PM&%S_ ,"_E7:U1M-,
MCM[^YOY&\V\N J-(1C;&N=J*.P&2?<DGT O4 >-:P-+N=(^*DLGV62?S#Y3-
MM+9%O&!M_P"!CMW'M4_B/6+"ZBU^U62."\F\-I^^;,DE^ICD(6)>5 4D[B 3
M\W;&:]>HP,YQ0!Y%?7Q.EV>IZ3J]DUTOAZ 7>FZ@/W-];_/PC9#!\AQD9!RN
M:]3TV8W.EVD[6[V[20HYA?[T9*@[3[CI5DJIQE0<=,CI2T <-X_2T_MKPA+J
M*Q?8(]2?SWG \I<P2!=Q/ RV!SWKE=5LWT]_%&JZ) X\/F_T^:5+) 5D$9S<
M/&N"K#[F>""5;/0U[$0&!! (/4&E  & ,"@#R76)-,U+0]=U_P +WM_J\\L5
MM]NEA5=LD4<JLR!0@#/Y>\$8)QP>HIVI3^%M<T+Q+KNG:G-J<SZ#-;RS2*JQ
M+P3&K (H\S)..XY]J]755484 #T H"JHPH '7@4 >76!TRV\2_#AK0VL3RZ=
M<+(8RH+YBC(#8ZY8'KWSWKU*BB@#RVXU6SM=3\?Z=K\L45[=1DV:W''VBV\C
M"+'G[V&WY [L:K:+J5CIU[\.]0O+F*WM&\/R6OGR':OF[8?DR?XOE; [X->M
M%58@E02/44%0<9 ..1[4 >*F^M?^%<7(,JH1XKW;7^0@?;0W(/(^7GVQ76^*
M%O/#_BFU\0Z-;B<ZO$-,N%09'G')MY3[ Y4G^Z1Z5WH  P!6*FBWTGB%K^^U
M9KFRB?S+.R%NJ"!MFTDN.7X+8SC&X]<# !HZ;81:7IEM8P9,<$8C!/5L#J?<
M]3[FN7^(\EQ!I&E72HSV%MJUM-J(49_T=6))([J&V,?85V5% 'E_B!;6]\1^
M(=3LIK>;2G\-R1WLJ,K123[B8LGH7"[O< KZBJUU:Z39_"/0-4MC:6LB#399
MIA'\L[(R'9,Z@G;N)R3G![$\5ZPJJJX4 #T K(\0:/=:O#:&RU)K"XM9Q.C>
M4)8W(4C#H2-P^;/48(![4 >=3ZAX<N[3QQXC6;3M7:[LXUDT^QN-TBQ(NPLS
M@!@&+#) X"CK0=1T^Y\6ZT\NH6EY!=>&%*R1Q[8'VO)PN<Y XY)/)QGL/1--
MT>ZAO5O]4N[>[O4C:)&M[7R$56(+<%F))VCJW;H.:V, =A0!Y!H_]F6MO\*)
M83:Q3F(K*ZE0QS:$,&/^]@<]\5;T?7M$\.Z5XSOITAFCM_$,KV]M&1F20QQ!
M HZ<L#ST&">U>JT4 >0WD7D>#M6O$O(=4\2WWE7NIBP=92ENDL>Z!!R-JH6
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M^!X_"NIHZ44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 50U75H-)A@:57DEN)EMX(8\;I9&SA1D@=
M 223@ $U?KF/&NBZGJEKIMYHS0_VEI=ZMY#%.VU)@%960GME6/- $G_"86T$
M%\;ZQO+6XM+F.U\ED!,\DF/+$39PV[<!U&.<XH;Q=#!?7NGWEA=0W]K:&]6
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M'*%L9VD\;L9 J/6_$?C'0_#GB&]FM($2R\I[&YN(US,K$!U9$D.&4GANA]*
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M8G:XO--:9G159D2/:#@,RC)+KW/ /%;$.L^*(M.M5UB"UT^4ZA);R7!VL\L
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M L<X_'( /1Z*S=!O'U#1;>[>\M;SS=S+<6O^KD7<=I')QQCC)P<UI4 %%%%
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MYCDG<NSJ,  Y[Y]JMT >;>*='AT=O"EG97$B2_VZ;VXN64.Q9DE+R. , %F
M[#!P,5T-[X(L=6LM7CU2:2:YU3R_.N(OW9C\OF/RQSMVG+#)/).<]*ZBB@#D
M_P#A#;NXT&_TW5/$=[J$EW;-:?:)8HU,43##!54 %CQEFR>!4]]X2:\M]"*:
MK<6]YH[9AN8XT.\%#&0RL".5/7L:Z6B@#C#\/8?[)U"Q_MB^/VK4AJ<<K+&6
MAF#A\CY<'+#G/X8J:]\$S2:X-8TWQ#J&FWLT*07KQ)&XNE7HS*RE0XR0"!P.
MU=;10!%;6Z6EK%;Q;MD:A5+$L3CN2>I]ZY5_ <,V@:UI,NHSE-4O3?M*J*&B
ME+J_R]05!1>#[\UU]!.!D]* .:U'PK/J=I>65UJ\LUI?6X@N8YH$8GKETQ@*
MQSZ$# XXK>"P6%@$W"."",*"QZ*!@<UB:-XENM;DL;FVTEFT>]C>2&]6<$KM
M/&^,@8W#D8+>^*Z*@#S;X>: ^I?#[P]!J5T[6UFRSFS:'8XE1RRK(?[H.& P
M#P,DCKU6F>%XK";6S/<&[AUB9IKB&2,!02@0@8[%5 P<UOU4U*XO+6Q:6PL?
MMMP&4"#S1'D%@&.X\< D^^,4 8-AX+CL[/3=/N-1FNM,TN99K."5 &4IGRP[
M_P 03/' Z#.<5SWAG27UN+QA827SQ6%[K-QYL(BP\D+!1E'[*X!&<'H<$'FO
M2J* .3O_  26UW^U]%UJ\T6:6%+>Z2V2-TF1.%^5U(# <!NPJ[!X72V\3V^M
M17D@\BQ^P+ RA@8]P;)8\ELCK_\ KK?HH YG_A$%2?7W@U.XCAUK+2PE$*QN
MT8C9U.,D[5& 3@'L:IW/@$-9Z)]AUF[L-2T>W%K;WT*(2\. -DB$%6'R@_7F
MNRHH P1X?NHA:M#J\KRQI*EPUU$LJW1DVY9U&W!&S VX !QC'%7=!T6U\/:)
M:Z39[O(MU*J6QDY))/''4G@<5HT4 <0?ATOD+;)KU^EM#JG]IVT82,^5)O+D
M9*DL,LV,^O>KDW@D36WB2!M2EVZ^,7!\H9C'EB/Y/^ @=<\\UU=% '*?\(6T
M&KVNJV&KW%G>QVB65RR1(RW,2_=W*P(##LP_+'%:7A;P\GA?0X]+CO)[J.-W
M=7F"@C>Y<@;0.,L>N:TY[NWMI+>.:54>XD\J)3U=MI; _!2?PJ*"XO)-1NX9
MK'RK6()Y%QYH;S\@[OE'*[3@<]<T <]-X)*^(+S4].UR_P!.AU$JU_:0!"LS
M 8W*6!,9(X)7GZ'FK3>%1;:Y=ZKI-\]A+>PI%=1B)71]@PCJ#]UP.,\C&,@U
MT5% ',0^"[6SOM FL;AX(=$BDB@AVA@XD #ESU).,Y&.23S5*7X>03V%U VI
MW"7,FJ'5[>ZC15>VN#U*CD%>V#V)Y].THH Y-/! EO=6NM1U>ZNWU2P%C<H(
MXXU* ,,C R#\YQS^=,LO \D%_H=Y=Z[>74FD120Q Q1JKQNJKM8!?1>3U/J*
MZ^L7Q3X@/AK1QJ'V-KI//BA91($V^8ZH#W[L.U &9H/@?^P)5MX-;OI-&AE,
MMMICA-D3$[@-^-Y4'D+G'3K6EH7AU=!N=2>&^GE@O;N2[$$@7;$\AW/@@9//
MJ>*V)6=8G:--[A253.-Q[#/:H;":YN-/MYKRT^R7+QAI;?S!)Y3$<KN'!QZB
M@#.U#0/M_B72=9-VT;::)1'"$!5_, #;CUZ 8QT]ZHVO@^33_MHL=:NX5N+]
MK]$*(5B=FW.O3+*3D<GH>/6NHJI87%Y<"Y^V6/V0QSO'%^]$GFQC[LG'W<_W
M3R* *FBZ##H\^HW*LKW.HW'VBX9$V)N"A?E7)QPN>2222<U6N?#<A\1SZW8:
ME):7%S;);3J8ED4JI8JRY^ZPW'GD>U;]% '+7'@BV6WT1-+O9]/FT=W:WF55
MD+>8")-P88);))/KS2:?X-ETH736>N7@EN-1;4&:5$92[+M92 !D$8SR.G&*
MZJB@#D9_ 5M-I<MFEXT#3ZFNJ3O%$ &F5E( 7HJ_(O')/KDU;/A9O[6UK41J
M#"35K:.WE7RAMC5 P4KSU^=NN:Z.L3Q1X@/AO2X[[[&URK7,,# 2!-OF.$![
M]V% &*_P]$5KHIT[7+RPU'2+86<-[%&C&2#CY)$8%6Z _7FM?_A'KF)8/(U6
M5BL4D=P+J)95N2Y!+.!MY&#C&  <8Q@5O5#=W4%C9S7=U*L5O ADDD;HJ@9)
M/X4 <W%X*2STE-)LM0=-.^PBQDMYX5E5ERQ+CIA_G/\ L]..!6_8Z=;Z?I-M
MID 86UO MO&"V3L5=HY]<#K5H$$ CH:6@#B=/^'8T]=#5=>OW3197:T4I$,1
MLI4H?EYX;&[KZ8/-:4'A3_3M*N;^_:\;2F=[1VB"R LI3#./O *3@8'0$YQ7
M25A0>(I)_$^J:&NGL)+*UCN4D,HQ-O+  #'R\IU)H D\3>'+;Q1I0LKB::WD
MBF2XM[F!L202H<JZ^XY_ FJ%QX..I>&[_2]7UB[OKB]15>\9$C9-AW)M10%&
M&YZ$GN>F.@L)KFXT^WFO+7[)<O&K2V_F"3RF(Y7<.#CU%6* .5B\'7 UIM8N
M->NI[Y]/-B[-#&J,I;=G:!Q@],'ZD]*9+X'27P';^$_[2F%M (E6<1KYA6-@
MRCTSE1SCI76U4N[B\AN;-+:Q^T12RE9Y/-">0FTD-@_>Y &!ZYH QO$/A,ZY
M/I]_!JEQINKV&X0WMLJG*L!N5D;(93@'!Z8IL_A%KA](EEU6XEN-.NC>&:5%
M+3RE2A+8P -I( 4#''I7344 <C=^!(+^U\1V]QJ$Q37'224HB@Q.@4*5]OD7
M@YJ[)X:DDUO2-7GU2::?3(I8QNB7][YF-Y.,8^Z,8Z>]=#10!QFC0V'B;Q<G
MBNWLKN!;>T^RH]U \)E<L>=C 'Y 6 ;_ *:,.U=9>V<&H6-Q9748DM[B-HI4
M/1E88(_(U.>!TS6+X;\0'Q#!J$C6;6K6=]-9,C2!\F,@$Y [T 4-!\&OI$"6
M=WK=[J>GV\9BM;6Y5 L2$%<,54%\*2HR< 'I26'@B&SL+'2Y;^:YTBPG6>UM
MI$&Y2IW(K/\ Q*IP0, \#)-=1(S+$[(F]PI*KG&X^F>U0:?-=7.G6\U[:?8[
MIXPTMOY@D\INZ[AP<>HH YJX\#+<:;XBL7U.41Z]*9;@B)<QDJJ$)[84=<U*
M?!SQ:ZFLV&L7%G=O;);7GEQ(R7*)]UBK [7'8_I74U4N[B\AN+-+:Q^T12RE
M9Y/-">0FTG=@_>Y &!ZY[4 <M;?#U++1-%L;36;N.YT>X>>UNVCC8C>&#J5Q
M@J0YZ\^]$OPXL[C3]6M;C5+^1M0O%OA-E%>WG4*%D0A>ORCV[ "NTK$\5>(#
MX9T1M3^QM=(LL4;*) F-[J@.3GNP[4 4IO!S:AX<U'2M9UF\U"6^A\A[ID2,
MHHZ;%4!1SR>I/<\ "'4?!,]W>6&IVOB&^L]:M83;O?1QQMY\1.[:\97:0#R.
M./>NC2XO#JTMNUCMLEA5TN_-!WN204V=1@ '/?/M5N@#EKSP4LEWIFHV6JW=
MKJM@KQ_;"%D,Z.<NLBD8.6YXQ@],53E\(ZCI>@ZM!H^O:@+^_OFO5E$<7$C$
M9'W<!3@9_0=CTD^IR2Z:MWI%LNH[IA'M681C ?:[!CP=N&/OCCK6C0!%+ +B
MT>"8DB1"CE>.HP<>E<AI_P /S8-H+?V_?2_V('CM0T<0'E,NW8<+SP ,]>.,
M=:[2B@#CCX!5O#DNBG59O)DU#^T#)Y2[]_F^;CTQN'ITI]UX&+W^KW%EK%S9
M0ZQ$5OK>.)&1WV;?,7<"4)'7U^O-=&EQ>'5I;=K';9+"KI=^:#O<D@ILZC
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MMTZ5TH\+:$MC;60TNW%K:R>=;PA<+$_4,H['/<>IJP-$TT:HVIBT07[)Y;7
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MZ^N[JZNM'LYI[I0L[O&"9 /7\!CZ<5*WAO1FF:7^SH 6"!U4;5<)]T,HX8#
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MP?X;N9KJ6?1+&22Z<23LT()D8$')]\@'WQS6M+;0S6S6TD8,++L*#@8]..U
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MK0LXKS1KSQCI^H:?>72:G</=V<L-NTJ3J\2IY1(!"E2H'S8&#GI0!TNH>,-
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MEW*S(T3PMQ@,K ,,Y&..<\9KBKVQU-/AQX/GMM,O)Y='-M)>:>@:*=U6%HY
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MV,R37&IZAJ,D>?*:\D4^7D8) 55&<$C)!.">>36O110 4444 %%%% !1110
M5F>(-$@\1Z'=:1=33Q6URNR4P%0Q7N,D'%:=% $=O$8+>.(RO*44+O?&YO<X
M 'Z5)110 4444 %%%% !61I_AZ'3M>U/5X[NZDGU'R_.CD*;!L&U=H"@C /K
M6O10 4444 9$GAZ"3Q3%X@-W="YBMFM5B!3R_+9@Q&-N>J@YSVK7HHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "LOQ%H-OXFT.XTB[GGAMK@!9# 5#$ YQE@<=*U** &1(8XE1I&D*C!=
M\9;W. !^0I]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9 \
M/P#Q4?$/VJY^TFU%IY64\ORPV[&-N<Y.<YK7HHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BJ[7UHE_'8M<Q+=R(TB0%QO900"P'4@9%6* "BBB@ HHHH
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M,?/F9-^P$$;  5&[YN2>..<:/Q[J6LGPW_85A9[=<M+B9#=RL/)DB W*VT=
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MBV?G"[\8;/!&:V=5T3[%XV\.:3!J^LK9WZW\EPAU&4E\*A !)R,9/(Y&3@T
M>C45Y!%JFJ:+-/X>;4+R;3!XF@T]+V69FE2"2(2&+S.OWB$W9R W7I6GKKWV
ME:WXFTJSO+Q=/;PY)J*8N'W6MPI91L;.5# 9QG&5/J: /3*BN;F&SMWN+B18
MXD&69CP*\[AM([/0/#LSZOJ\M[K#6A:W-TS"Y9868IDD"-#]YB.H0#!)P<'4
MS/>^ =?@OII6^P>*(X(%%T[^4GG0?*&."P&]L9Z=L8% 'KCW-TNK16JV+M:O
M"SO=B1=J." $V]22"3GIQ5NN'O))]-^)-C!:SW<L T.YD^S/<NZNZ21A3AB?
MFY(SUYKGSJ5^_P ,=&\8V=]<RZT]Q;O*HF8I<&281O"4SMVC<0 !QMXYS0!Z
MQ17DVKP7$T?Q)E.JZHITI1/9!+Z11"XM5DXP>1N_A.1[5Z;I,\EUHUC<2G,D
MMO&[GU)4$T 9NF>*$U/Q-JNAII]U%-IGE?:)9"FS]XI9-N&).0/3BMZN&\+_
M /)5?'OTT[_T2U7_ !+?6\^J:1IT=Y.UP]VZFQA?8+@K$6(D?(*HH97.,YX&
M#0!U5%>2Q2ZM-\.]0U"*]O6N]!UFXD6..\D/FV\,YW0LV0778& W>@J9->F7
MQ3J'V:ZNY-/\1VNW1I'NI&59D(1]BY^09</QV0D<4 >J45#:VZVEI%;H\KK$
M@0/+(7=L=RQY)]S7E[ZC>ZE\-=<\3_;KJVURQN;ITVS,%@,,A"PE,[2"H4$$
M<[L]: .^U77#97\&FV=M]KU*>"2XC@,GE@I'M!);!P264#CDGL 35VPO6N]+
M@O9[:6R:2,2/#<8#Q<<AL''%<0]HMY\5]%N+E;F*>70I9I(UN9%".)(?EP&X
M'J.A[@UT7CN%)_ 'B!'W8&G3M\K%>1&2.GN.G>@!]UXG@@UO0M/CMI)H]8$C
M0W2L BA8S)TZG( [=^M;M>7/I\37GPUM5FN426*8NRW#E^;3) 8DE1]",=L5
M6BUJ[TG2;W3_ .T)ELT\6'3!<7,[LT-N45PID)W ;B%SG(#=: /6JRM6UR/3
M+NQL8[>2ZO[XOY$"$+D( 78DD *,CWY& :H>'-+O-)U?5(YM6%S;S^7-#99=
MOLN002&9B=K$9QT!!Q4/C#P[9>)+C3[8:C<:;K5N);C3[RW/SQXV*_'\2G<F
M1WH U-.UT7DU_#<V5Q826(4S?:"NTA@3N5E)!7 Z_P L&M.&5)X8YHFW1R*&
M5O4'D&O)]2U+6;KPEXX\.^*(K>74M-TLS+?V>46YC*.4+ 8P05.5Z')XQUW%
MB@>XT+2+>ZO)Y3I;SM8F[=$VGRQYKRY+#!)"J >6S@8S0!W4US#;O"DLBHT[
M^7&"?OM@M@?@I/X5+7CFFF37=/\ A=>:E<W,US-).DDPN'5FQ!)SE2#G@9/4
M]ZU<ZAXHB\0RPZ\NF7FF:G)&DWF29M8XF&TE P4JR#)R.=Q]!@ ].HJO=3RP
M:=-/''YLL<+.J 8WL!D#\:\Q.H7Q^''A_P 765_<S:Q+<6S3#SF*7!EE"20E
M,[< L0 !\NWC'- '<:KXCDM+ZYL-.TY]1O;6V6ZF@20(WELQ"A<C#.=K8''3
MKR,Z5YJ=KIVDRZG?R?9;6&+S96EX\L8SSCOVP.]<AI6GP#XO>()-]QN6PM)
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MTNHS:BUHWVR<!99UGD#.!T!(;H/3I4O_  DFBBTN;M]4M(X+9@EP\DH00D]
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)&5GQ\Q48!/TR<4Z@#QWQK=F[L?&5I%9W-K.MQ;R>3!:.YO%7RCY[/M(V@#
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M<]O,+BUUV,7,,L## %XSMU&" O)QD $9ZUH^([>[OM>\;PZ3&99[C2+01HG
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MC"Y!XR1GM6O10!YSHWA+44\.ZAINDWWV'3&U4S6,5[ \P^S!5S'M+*P0R D
MGE1SD-3_  II_B*W^)7B.;4;ZVFB,%H)7CL6B$WRR;=A+G&WOUSD=*]#HH X
MOP]*A^)?B\@_++'9"-L<.51PVT]\$@''2N;.GW6G_#WQ'X-6%VU2>[N(;./:
M?WT<[[ED'^R YW'HNTYKUBB@#GM>TF]/P^O](TN0_;!IS6\# X)81[1SV)]?
M>N69D\16O@9=*C>&_P!.O(I+J,H4>SB2)EE1Q_#DX7!Z]L@5Z510!Q7A":-_
M&?C,AN);V%XB1@2*($4E3W ((XI?%+FU\>^$+Z2*9K:/[9$SQQ,^UWC3:#M!
MQG!Q]*[2B@#QK5427P)\2%CBW7-SJLC0!4)>48BV%>,L,AL$>AK6U*^T^T\8
MZW#XA346TO68(?L4]JLTD<R>7L>$B+)SDL0/]H_CZ?10!C0Z/!+X.718H9+.
MWDL?LJQ.Y=X4*;0"23D@'U[=:YGP+J4>@>%8/#?B79I]]IRM;M]H^6*XC!.U
MXW/#@KC(Z@YR!7?T4 >,6MMJ-CX0&JFQU&6V@\3274R('$SV0WJC(/O%5W*P
M ],U;\3)H>H>!_$>IZ);7LQU%K19+B=9LW+I(O"I)R=JCD@8^NTX]<HH \R\
M16\M]XSU:WT@J)KGPG+;6SQ\*92Y**&Z X.1Z YJ;PS?>'M:N]*O?L6J1ZKI
M<#K,MWYZ+8 IM=6+?(<D  #/KQ@X]'HH \CT<V^G?!+396T=+B:*2-)T>W8M
M!_I 8R.BX8A>'QWP.U2PS_Z;\1&9[V=;O3(7@GGM6C\[]PZ\?*!U( '4]L]:
M]7HH Q/![ ^"M#'=;"!&!X*L$ (([$$$8KDO -Q#X&TN;PIKC&S>TN93:7,J
MD174+L65E?INY(*YR*](HH X;QE<W5PF@ZM!:W#Z98:M'-=*(VW-%M9?-V8W
M;59@>G;., &L7Q) +Z]\8ZSI[>9IMQX;-H7C&5N;K]YMVX^^0I"Y']X#L:]3
MHH \O\1IIT7A#P/*T$(@_M2P$O[KLL; AACMR"#TYJEXJT2]U:\\7ZEX:A\V
MWGTVUBD$(^6\E24O(%QPQ\H;..I;'7->A>(M ?7FTPB\^SBPO8[U?W6_>Z9P
M#R/EY.>_N*VZ .#NI[?7_&GA?6=*D_T>Q@N7OI=I41Q/& L<F>C;L':>1M)K
M T<V]A\$TF;1DNYXI66:%X&+1@W6=[*,,0HVO@=0H^M>MT4 >22>=>7GQ#C@
M^WWCZAH4?V:62T9//(BG7Y<*!U8 =S[]:OW%[!=_\*YFB$FV&X'F%XF78/LS
M*2<C@;B!GIFO3** /* K+X-\9^&]5@D?6+FYO&MXBA+7GF\PO'_> .T<?=V\
MXQ6EI$(L_B,!J;I)-!X:M[>:X<95I5=S(-Q[X.2.N#7HM% ''_"T,GPUT2*1
M626*$HZ."&0ACP0>1QBN7N;Q+6R\=2MI_P!N1]:@D"/$SJ$Q"/.VKRZHRD\=
M=O6O6** /-M MH-7\7>,;*[-Y<VFJ65JHFGMC&)4V2*Q'R@ <@#N??K63%'X
MFMM.T77WLY9=0\/S_P!D/ !@WD98Q/)GJ03Y+#TV,>]>OT4 5-+LO[.TRWM=
M^]T7]Y)C_6.>68^Y8D_C7F.R0^ ?%GAC4H)'UV:YNS!$4.Z[:1BT,J?WADKR
M/N[><8KUFB@#@<O:_$CPU%=S>9-!HTT$\W.TRDQ8!/0%MK$ ]:O_ !-BDD\"
MW1BBDE,=Q:RLL:%FVK<1LQP.3@ G\*Z^B@#@TNK2Y^+<=\1B : 5666,J%;S
MMV/F'!V\XZXYKD-%N7T?PYX-U*]@OQI-I]NMKPVRR![5GDS&[*OS;<*1TZ-[
MU[710!S_ (0MM+@TZZGT>UN8;2\NGN=]P9-T[L!NDVR?,H)!XP,XSWKFO$]E
MX6\3378UKS=)U;3Y6CM-1C#0S$#E6B?'[SKC:,\@\"O1:* /+8)]9A3X<ZGX
MCAN3=0O<K=R+ S,"\+K'N502&8;<CU)K-UF^^T+,%LKJS:T\4PS36<-F[ J)
MUS.[[3N+#D;2!@XP<9KV2B@#RW5(+ZZU+XC:?907(O=2M8)+0&)E$JBV"D!L
M8&2"O)ZFM;PQ>>'_ !%K-CJ=G9:K_:EI \<OVL3H+,,/FC;?\K$D#@9Z9XQ7
M>44 <7XG>?3_ !UX:U:X5SH\27,$TH!*V\KA=COZ X*[N@SSC-<]J=I(F@?$
MN_@#?V=JD>+%%4_OI?L^UW0=]S\9'7;GIS7JM% %#0Y8YM"L'C8,OV>,<=CM
M&0?0U?HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KD/B'KMYH^E:=9Z;+Y-]K&HPZ=%/@'R?,/S
M. >,@ X]S77USOC3PRWBC1HH;>X6VO[.YCO;*=AE4FC.5R/0\@_6@!+WP?92
M:1-;64MS:W;1D+>+</YI;U=LY<'N#FH]7\:0:0U]++I]TUEI\\,%S<<* TFW
M!0'[X&]<D>O&<5;M+SQ#=0+#<Z3#97&,23BY66(>I08W-[!@OUKD/$_A7Q-K
M47B*V:VLKO[1-%)IUU-<E3#$I0F)4VG:<JV6!YW<] * -<9A^,=P4\U]WA\2
M>6'SEO/(X!. 2 !VK%U/7XX/@]+J'ANQN[."69H@'F'F0[KGRW))8G));&"<
M9'3%=)'IFJCXA?VY+:1BU.D"S81S GS1(9#C(&5YQGCGL!7/MX3U[_A5#^&Q
M:P?V@UT9?]>/+V_:?.^]C/3CIUH W;%K'1=8N+32=)F34[V$7=Q8K,JQ0JI*
M!NNU2QS]WKCGIFFO\0]/_LW3;R&POYOMM\=.,2J@>"X&[,;@MP?E/3(]P.:=
M/I.IV?CA?$ME;?:(;JQ%G=VAD59$*L61U).T]2",CL1GI6/)X-U2V@TYX(89
M;@^(VUR]42X5 V\;$)'S$!E'8'!Z9H UX_&]Q)J4>EGPSJB:G)9-=K;.\(X$
MFS&[?@>N3CC'4FJ]UXIT?6=#\-:G/IMY+!?:G%';C<$-O<!RHWX89 96Z9!Q
M5^72]0'Q'36UM@]BFE/9Y$@#F0R*_0]L#&<]?;FN<M?">NP>$?#VF-:0FYT[
M6Q?S8G&TQ"9Y,*>[8<#''(/- '1ZGXT@TQ[N273[HV5G=Q6<]SPN'DV %5/+
M*"ZY(]\ XJWXPUX^&?">H:NL8DE@C A0]&D8A4!]MS#-<?XB\+>)]8AUV![6
MQNY)KV&XL+J:Y(,<*/&WDJNT[#\C9(/.>]='X]T:\\0> =0LH(U-_P"6D\<:
M-D-)&RR!03C.2N.W6@"OK6J7_A6/P]96UN][-J%\D%S<LZAG?868X/=MA'8
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MP]_2@ O?B5]DUZ;15\/WTM_'IPU QB2-<)@$JQ)&".0>O([UA>+/&>E:_P"
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MG)Y&!D [&D8A5).< 9X&:H:%)J<NAV;ZS%#%J7E@7*0-N0..#@^G?VKE-/\
M$]V_C%-(U6[N-.O/MDXCM)X%$%Y;@/Y9AD"Y+?ZMB"V<AACL #J]'UJQUZS>
M[T^1Y(4F>$EXV0AT.UAA@#P0>U:%>0:;J&KZ'X9NM7L[]4MXO$LT4EH8%(F2
M2\V-ECR#\V1C'3G-;?BWQ+K&CKK%Y:WZ/]AN;81VUO$KQK&QC#"=F7(<[FP%
M;(&TXZT >@10Q0[_ "HU3>Q=MHQECU/UJ2N(EN_$6H>/M4T:UUF*SM+6VM;I
M,6:R-\SN&0Y/0A.O;C%5].USQ-KMEINN:4KFVFNSYUO-Y @^S!V4X;/F"0
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MBQ^;<"<C! [8/6M[4?&.I:)=^.);B2*X@TB*U>SC,>P*95;[Q')&=N?8<8H
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MI]R;S3K6Z90K30I(5';(!Q0!B7W@NPU#1=4TVXN;LG56#7MRI02RX 4#.W
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MY.?EX[?GS4.G> M/TO4Y+BTU#4TLGG-S_9?V@?95D)W9"XR!NYVYQGM75T4
M%5-4T^'5])O--N"X@NX'@D*'#!64J<>^#69XFU^?0!I316D<Z7NHP63EI2IC
M$C8W 8.[OQD46.O3W7C+5="EM(XTLK>&=)EE+&02%QR,#;C9[T 0S>#K>\M;
M6RU#4;^^T^VD21+6X9"&*'*[V"AF (!Y/..<U5NOAYIEWKNM:N]]J"W.L69L
MKD*\>T1%0N%!3@X4<\UUU% '$-\+=%.FZ#9"]U1%T.1Y+.6.=4D&X@D$A1D9
M';!]Z(OA;HD&@:SHD5WJ266KW'VB=?.5BIR"0I*G@X')R>.M=O10!AS>%--N
MO!P\+WGFW.G"V6V_>,-^U0-IR !D8&#CM6?8> K6R\-7.A/J^K75M-:M9J]Q
M,K/#"PP43Y<#CC)!-=#IDE_+IT+ZG;PV]X0?-B@D,B*<G&&(&>,=JMT <3!\
M,-(MSX=V7^I?\2 L;(%X_P")LG=\G/0#Z5+?_#;1=0DU16ENXK+59X[B^LXG
M41SR(<Y)V[ER0"=I&<5V-% '-/X(TU_&,'B;SKI;J"U^QI I3R1#S\NW;G')
M[U@R_!W09=).C_VAJR:4+O[9%9I.@2%^<A3LSCGH2<=NIKT.L&UUZ>?QK?Z!
M):1I';6<5TDRREBX=F7!&!C&T]S0!0U/X?V&H>)8/$,.HZE8:I'"()9[.54-
MP@[."I!_#'0>@Q/<>"-.N/%6E^(?M5ZEWID)@MT5U*;""#NW*6)(8Y.<UTU8
M/B/7Y]#GT9([6.:/4-0CLG=I2ICW@G<!@[ONGN* -ZLS2M&_LI;W;J%Y<O=S
M-.[S^665B .-JCC   .< "M.B@#S>Z^'D?A3PGXG'ANXU>:XU*%B;9)HQ^\.
M?F3"#:0">!U''7%4?#>G^.--UC2HH_$<NIZ:SA+N"?1#9B*((?F#LHRP(4 =
M3GGC->K44 <]X5\'6/A!+]+"YNYEOK@W,HN&0_O#U(VJ,9XXJCI/P[TO0]9N
M[[3K[4H+:[F^T2Z<LX%L9,YSMQNZ]LX['CBNOHH Y"T^'>F:?XBOM7L;[4K5
M+^3S;NQBG MYGSG)&,\DG(!'7'3BDF^'.ESZEX@OVOM1$VO0&WO 'CQLP%PO
MR<<#'?KZ\UV%8NK>((K+3M:FLEBN[K2H#-- 9-@!VEPI8 X.T9Z=QZT 8D?P
MQTB,>'0+_4L>'R39 O'QD@G=\G/0#Z5-%\.],M?$U]K5E?:E:?V@V^\LX)PL
M%PW7+#&>23G!'4^IKH=&OVU30]/U!T$;75M'.4!R%+*&Q^M7J ./NOASI=WJ
MVO:D]]J*SZY;?9;L*\>WR\!<*-G'"XSS^=-G^&NCSZ!HNDFZOU719UGLKA9$
M$L;*<CG;M(Z=1V%=E10 R*,10I&&9@BA=SMECCN3W-86N:2^O:MI4,B%;+3[
MI;Z5R,>9(@/EHOJ 6W$_[('<XU=0DOXX8CI]O#-(9D619I"@6,GYF! .2!T'
M>K= &)XQ627P5KD,,4LTLUA/%''%&SLS-&P   )ZD5G>&- 1M(\/W=_/>S36
M%J@@@ND">0YC"L=NU6+ 94%L\$^N:ZRJVHZA:Z5IUQ?WLJQ6UO&9)';H * .
M7E^'.GRP3VO]IZHEG)?"_CMDE0)#+YGF$K\N<%N<,2!GC%;&G^'(-.US4]52
M\NY9M1$8G24H4^1=JXPH(P/?FMD'(S10!@6/A2VM+G3YY[R[OGTZ%X+4W)0E
M%8 ')506. !DY_/FLVU^'-A:V^F6ZZKJK6^EW0N;*)IDQ#@,-@PG*_,>N3QC
M.,Y[&B@#CC\.=-\I8%U/54MX]0_M&WA6=0L$N\N=ORY())X8G&>,5:E\$64U
MOK\#:AJ&S7/^/OYH\CY GRG9Q\H YS^?-7]8UIK#4=-TNVC1[[46D$/F$A%$
M:;F8XY]!CWJWI,]_<Z9#+JEDEG>G(E@242*I!(R&'4$ 'UYYH S4\)VL>KZ=
MJ:7M\+FRM?L>0Z@3Q;@P#@+V(!^7'OD<5>U[1;7Q%H=UI-Z9!;W*A6:)MK+@
M@@@^H(!K1HH Y^7PG VHVFIQ:C?0ZG;P&W:\5D+SQD[BL@92I&[D8 QVP.*T
M]*TJVT>Q^RVH;:7>61W.6DD=BS.Q[DDD_P#UJNTR8RK!(855Y0I**S8!;' )
M[#- &?JF@6&L7NF7=Y&6ETVX^T0$''S;2,'VY!^JBFZ=X?L=*N]5NK)6BFU.
M?SYW&#AMH7C(]BW.>6-20ZGY$>EP:IY-OJ5\-H@C?>/,"%W"G ) "GG'IZU2
M\.Z_/K5YK=O<6L=NVFWQM!LE+AQL1]V2!C[W3% %&/P!81:'I^D)J6H_9["]
M%]"VZ+=Y@<R#)V<C<2<>]6W\&Z=/>:Y/=RW%TFM1)#=P2E=FU5*KMPH((!/.
M:Z&B@#F-,\%0Z=I\UHVLZM>!H&MHI+J97:",\$)\N,X Y8$\=:6'P39P1>'X
MDU"_VZ%_QZ F/D;"F&^3GY21V_.NFHH Q/#FEWFF+J NKZ]NHY[MIH!>2B1X
ME('RY' 7.<#G Q]!7U/P;9:GK%UJ+7M_;M>6@L[J*WE"I/&-V,Y4D$;CR"/Y
MUT=94FJ2Z;9ZG?:TMO:65J[-%(DI;?$%!W,"!AB<C SVH SK'P3:6%UHMQ'J
M.HN^D6S6MN)'C8%&"@[ODYX5>F.GUJ&7P#83:#J>COJ.HFVU*[:\G;=%N\QG
M#G!V< L <8[5>FU^>'QQ:: ;2/R+BQENEN!*2V49%V[<<??ZY-;U &!)X5A_
MMB?5;34+VSN[J%(;MX#'BX"C"LP9" P!(!7'%-3P=IT%]HMS:RW-LNC0O#:P
M1%=FUP V[*DDD <YKH:.E 'GWB#PV='T=H+1M<NK>^U;[=>3691I[=N7WHBJ
M-P+J@QAL#G'%:/A.WU"._:1-4UR[TPPD,NL6ZQ.),KMV#8CXQNSD8Y&.]=/I
M^H6NJ627EG*LMNY8)(O1MK%21ZC(/-6: ,G6O#UKK<MC<22S6UY82F6UNH"
M\1(PPY!!!'!!!!JG=^#=.O\ 2-5L+N6YE;5&5KJZW*)69<;""!@;=JX &..^
M3GHJ* ,&+PM%'KMOK!U/4)+R"T:T#.T9#(S!F)&SKN /& ,8  XK,?X<:6VA
M6VF"^U)&M+I[NUO(Y52>"1V+,58*!@ECD$'K]*[&JEY)?I/9BSMX98GFQ<M)
M(5,<>T\J,'<<X&..M &'<>";6ZT^TM9M4U-Y+:\COC<M(C2RS)C:6)0C P.
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M:)I,<D4B:79+)"GEQL+= 43^Z#C@>U T325LI;)=+LA:2G,D MTV.?4KC!H
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MX:!GVQ;YSOR,Y'[Q.>^>,\T =Z?''AY=*O=3>]D2UL91#=%[657A8X(W(5W
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M54@8.&('Z].:H0PW^BWNB:C>Z'J]]I\^AVUC*EFC^=:SQ;B=T8(.T[R,^HH
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MJ0Q-+(V%&YMJ@G )'.,9('<5F?#K5;K6?#$EW=WDEXWV^ZC2:10K,BRL%X
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M(TNK5[<LH^YN7&1]*Y[PCJUWH_AZQT/6]+U&'4-/A6UWP6<DT,ZH-JNLB*5
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M%Q;8'E!GR<%,-EC@8 /6HO"5Q=0:U;0VNH>&-5MY4\J5]+#F:&)58H2QD<!
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MA)^SRX"[64GYUQD'IG<>*ZKP]KMMXDT.#5K..:."<N%690KC:[(<@$]U-:=
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M6:2)!*>J!\;L?7:/UH X>#Q9->>$IO$]B\S+IFC/));LY*M=;22C]\IL.?\
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M,5U=BG\. &/3H* ,S^UM7BT[XA6ZW=Y:MI4 GLO,D666#-MYFTL=V1D>IQG
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M7VN2/[5)\TN_?NSNS]X XSC-.O?!6C7VHW%^Z745Q=0B"Z,%U)$+A0,#S I
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M&ZDCFA3&-HD!W8P ,$T <MKUAJO]D>"XM<U,7.HQZ[%!-/9R$(W$N&Z#YP
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ME=BO"(ROE@#Y>&(QSVSD\UTESX+T2Z.J^9!/MU7_ (_(TN9%23("D[0V 2%
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MJ,6"[5XZ9;D'C'2WW@?1-0OK^[DCN8GU"+RKQ;>ZDB2X&W:"ZJ0"0#C-,OO
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M4U,S&7=C&T"1]F.?FW ]L'.1OS^$=%NO"\?ARXM6FTR-%2..25F9 OW=KYW
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M0!%X,@%OX,T8"263=90MF1MQ&8UX'M[5NU1TC2+30]-BT^R$HMX@%02S-(P
M& -S$G    [ 5>H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ K'\4^(+?POX;OM7G"M]GB9TB+A3(P
M'"@^YK8KC/BP\"?#'73,T:YM\)O(Y8D8 ]Z -33]2O86N+K5M1T=]*94-O<P
ML8R'YWJVYBI P,$'UXXK9-W;"&.8W$0BE*B-RXVN6Z 'OGM7$7-]!:?$K19[
MF2%=%GTJ6.RFR/*%T74L,] QC''K@@=ZX_4+2T@TE?M'D#27\9PMIWF$!1 9
M%\SRSVCW;^G&,GI0![1;W,%W")K::.:(D@/&X93@X/(]ZCAU"RN+A[>"\MY9
MTSOC2569<<'(!R*2SL;'3;(P6%K#;6V6<1VZ!%R3DD <<DYKRO2;C5;2V@TW
M2KFTUJ.;1;K^Q-2A^6YM@%4K',!P?F"#=P=R\C- 'JT5_9S74EK%=P27$?WX
MDD!=?J,Y%8WCC6KWP[X,U/6-/6!KBTB\Q5G4LI_(@_K7$QR6NJ>%O (T5D75
M[6\ME>-#B6%54BY$@Z@8#;L]3CN173?%:1(_A?X@WNJ[K4J,G&22,"@#J+B_
MM+*!);RZ@MT; #32! 3Z9-2/<V\8C+SQJ)3B/<X&\XSQZ\5P\>H00_$VX;59
MH18W>D1#39I6'E, S&903QN.4)'< =A7(6]C;06GA"#4%A-HWB.Y%@L^,_8B
M)O+'/.P_+@=,%?:@#V6WO;6[MS<6US#-",@R1R!EXZ\CBDMKZSO 3:W4$X!P
M?*D#8/X5Y)J(L5TGXFV5K>06=O'=P2A8A\@_=Q%@57HK,"K'W.>E=%X;N-#\
M0?$&?Q!;:CHTMT-.CMDM;:X2:4%68M(2 ".&"C';KCI0!W5U>6MC%YMW<PV\
M><;Y7"#/U-)+?V<%JMU+=P1V[8VRO( ASTP>E<IXKU2PLO%_A^&Y>&UN7BN3
M!>W3'RH^$#(JY :1@1C/0 ]<X/&^&9#/X,\-)I>N6UCK-E<7PMTO$S!*1*P:
M*0<%3M92,<@9XH ]BBFBGB$L4B21MR'1@0?QKC/$7CR&+PCK>J^'KFSNI],D
M\MA(=ZM@J&("L#@%L9Z9!K6\$WIU'PC97+:>E@6\P-;QMN0$2,"4/="1D>Q%
M>9ZI=V$'PX^(5DTL,=VNKW):+(#A6F4KQV!'3UP<=#0![+#>6MQ-+##<PR2P
MD"5$<%HR>S =/QI(=0LKBYEMH+N"6>+_ %D22!F3Z@'(KS?5DAMO'UY!X>-M
M#>7'A2X\A;<JI>;S%,9XZGDD'ZT_PC<^&M>O/#MW::G=RZMIT#1?8E5$:V!3
M;(LRJ@.T$8&3][&* .Q\2^(T\/PV44<'VG4-0N%M;.WW;0[GNQP<*!R3@U1U
MOQ!J?A.TBU/639W.E^:D=U);1-&]J&(4/@LV]0Q /W2,YYZ5G?$"RGBUKPKX
MD2)Y;71[US=JBEBD4JA3)@=0N 3CL<]J;\1KNW\0^#)] T>X@OM0U8QQ6\<,
M@?"[U+2-C.$503NZ=!WH [7^T+(B4B[M\0_ZW]X/D_WN>/QJC>>)M(L=1T^Q
MFOH!/?[FA7S%Y4*3NZ].  >Y-<29['0?&_B.SOKF.)KC1+1+82'#7.P2J=HZ
ML>G R>:R=#N["*#X5W=Q+"L"V%Q TC8QYGDH F?[V00!USTH ]9_M&Q^UFT^
MV6_VD=8?-7>.,],YZ<U1TKQ-I&LVMS<V5] \%M(\<DGF+@;3@MU^[D'![XKA
M["YFL/$]E';W%GK6CW6KW(C0C%WI]PWF^9G'WT&7!S@@,.V*R[/5=(T_PA>V
M]Y'"\L7B>190[E$M6-T6CDFQR$& <'@]/< 'K*:E8R6;7D=[;-:IG=,LJE!C
MKELXJ2*\M9YY8(;F&2:$@2QHX+)GIN Z?C7B&OW=A/X>^)T,EY;7+,]O<1,%
M"JQ,,8WH/<]#DY]3UKIM6\BR\?NOAW[+'>S>&+KR%@*CS9=Z&/IU.<D?C0!T
MWB+Q0^FZOHEG87%C,;O4DL[J(MNDC5E=L@!N/N8Y'>M>WNYH[K4VO;RP^RPN
MIB\L[6A3:,^:2<9SDCIQBO+!K.@7/AWX<&WN;87=KJ=NEPC,!+"_E2"4.#R"
M7')/4\TS7#IG]B_%>%3:;1(CH@VX#_9TY ]=V?QS0![#%>VD\\D$-U#)-$ 9
M(TD!9 >F0.1FFKJ%DURULMY;F=/O1"4;A]1G-<#;C2[3XE^&Q8&UA-QHMPKF
M$J#)\T17./O'[QY]ZYO0)M!UFQ\*Z/=ZUHSR:5J$DI:>=?.NLF0!?*89#.6!
M8'N.YZ 'JOB?4KG1O#&IZK:+$\ME;27.R4$JX12Q7@C&<=:YR^\9:KHGA33O
M$VH6UG<:=<+ UQ'!N26%9=H!7)(?!8<?+6K\09HH?AWXC,LB(&TVX12QQEC&
MP 'N37FVNKI'_"MM!NM(U62[U^VBM)+*P%XUVLLV%!4P,S#@%N0!MQU% 'LE
MSJ%E9R1QW5Y;P/)PBRRJI;Z GFL:^UN^M?'FD:,JP&ROK6XF9BI\P-'L[YQ@
M[_3M7">-=3M)1XQLIA!9:F=#C\]929'NOW<C!85)P%0D[F /)[8S6K'J=I<^
M-_ TJ74<N_2+K!#@EB1#C'KG:<>N#0!W\>H64UV]I%>6[W*??A652Z_5<Y%(
MVIV"R)&U];"1Y#$BF5<LXZJ!GD\CBO']+UK2KB_\"75K/!;6B7UTGV,,7DMM
M\<OR3.229&;^'CGH#C-5KR+1HOAYXPNH5LEG@\1OY$J[=T8%RA7:>PQDC'O0
M![7<W]G9M&MU=P0-(<1B60*7/H,GFBZO[.Q"&\NX+?S#M3SI FX^@R>:\YEU
M;0E\4^+=(\6RQK'J2PFS,I.+FU,0 2(CDD/O.%YRV14&H7VE6GBG5]*\2WT^
ME6%_IUO'9"<(5DA"%7BWNK?.&)XSDY!YH ]5SQGM5:+4;*=]D-Y;R/L\S:DJ
MD[<XW<'ID$9JGI-K:6GA>TM3YILHK94'V[!<QA<#S,]\=<_C7E&D6EE;_!*P
MUC3K..2XA=!?36T:O.ULMR&E3.#D;5&5/&!TQ0![%!J=A<V\EQ!?6TL,61))
M'*K*F.N2#@4#4[!I)8Q?6Q>)!)(HE7*)UW$9X'O7EVNGPMJGAGQ;K>FZJ^IR
M3Z*\<TK>6(0RJ3$" JCS<DX[@=<<58:UT,^+_ *K%8D7&GW/F !?WOR1E=W]
M[Y@2,YYR>M 'I8U"R:R%Z+NW-H1GSQ(-F.F=V<54U&^:70;B[TF_T]7V$Q7-
MPVZ $'DL5(XZ]Z\MLM5TC3].NHG^S"!/&4JVTK2[;>S."RNX4@;?O87(!)'(
MQFJ.IW-C+\-_B1!+<PSR+JCS1[E"\LD.UU';<=V/7G&>: /:YKZTM0PN;N"$
MHGF/YD@7"YP6Y/ R1S[T2W]G!;)<S7<$=N^-DKR *V>1@DX-<'/'HEY\9%:=
M;&97\/F0[]C!CYPP3ZG;W]*Y_P -NTW@OPJVD:Y9V6JVQOA:QW>'MYT$I#1-
MSD':4((Y SVH ]ABECFC62)UDC895E.0?H:B:_LUO%LVNX!=,,B R#>1_NYS
M63X+O?[0\'Z==?V>MAO1A]F1MRIAB/E/=3C(]B*\XW_;?A-J>F73 >+8;^0F
M+.+C[89RT;KWY!7!'&WV% 'KIO[,"8F[@Q <2GS!^[_WN>/QJC=>)=(L]4L-
M.EOH!<WRL\*^8.4 SNZ]#P!ZD\=ZX6YOK72_%GC:WU.XABN;W2+4PHW!N"(Y
M5;8O5L'CBJ6C7=A%<?"ZZGEA$)T::#S&Q@R^5" G^]D$ =<B@#U/^TK'[4UM
M]MM_M"_>B\U=XXSR,YZ<U2TKQ-I&LV,][9WT#VT,CH\GF+@;6*ENOW20<'N*
MX?2+F:Q\1Z9!!<6>MZ-=ZC<F#C%WI\S"4R!L<.G+@DX(W#KQ65IVK:1I_@B*
MWNU@:>'Q(Z2[W*):/]JD:.2?&/E& <' /'3J #UM-1L9+,WB7MNUJN<S+*I0
M?\"SBGPWEK<330PW,,DL)Q*B."T9]& Z?C7A^N7=A+X6^(\,MW;W#_;H+B-M
MH4$LD/SH.V><$=0,Y/6NEUCRK'QY?Q>'!;17TOA2X-NEOM!DF$@,9P.K<G%
M'4:]XH>PUW0["QN+&87E^+2ZC+;I8P4=L@!N/N8Y'>M>VNYHYM2>_O;#[-#*
M/*\L[3"FT$B4DXW9R>W&*\O&L^'KK3?ANUG<VHGMK^*.9"P$L#&"0.''527
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_<7\J=10 QHHV9&9%)3[I(^[]/2E>..0KO16VG*[AG!]13J*  C(P>E(%"C
M 'TI:* &)#%&FQ(T5<YVA0!2[$X^5>/:G44 -,494J44@]1BC8O/RCDY/'6G
M44 -V)_=7\J:\$4B;'B1E]&4$5)10 =*9Y4?F^;Y:^9C&_'./3-/HH 8T4;L
M&:-68 @$C)P>HIVU>/E'R]..E+10 Q88UD,BQH'(P6"C)'UI3&C*RE%(;D@C
MK3J* &[$.<JO/7CK0$4'(49]<4ZB@!@AB5BRQH&)W$A1G/3-+Y:?W%_*G44
M5[NU%U9SP)(\#2QL@FBP'C)&-RGU'45S-GX3U+[)#I^JZCIUW80JJ#RM-\N9
MU7& 7,C =.2%!],5UU% "!54DJH!8Y.!U-+110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44R66
M."%YI7"1QJ69CT ')-<D=?%YX&G\07NKG1K6\B\RVFV*3;Q'[C8(.YV&"1VS
M@=,D ["BL26_MAXFT^T_MLI.;:1S8!%/GCY?WC'&5V_49W54M+V:\T;4[O1M
M:_M2:"[F:,.BA 5Y^SY ' Z;NN3G)QB@#IJ*H:+JUMKVB66JV9)M[N%94SU
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MV^12S;4!. 2,G&!D>M6%\0Z3)96=Y%>QS0WO_'J809#-P2=JJ"3@ D\<8.:
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M6&\M[:19+1S)*RLRE>497P<C'./IZQ10!@>#9-6D\.I_;2(+M9I5\Q8?)\]
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MQT=;KRH[2YG19A$H A9F(.#ECR1QSSDCOT,VN:=>^)O";'2O.DU"VFGLKUV
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M>Q(7)W[>!V7KSQ8M[+QE>Z->6VM2:/YS6KP1BT>0+,[#&]R5^4#GY0#R>O%
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M^0,0J^W7 Z4NKZIXRT;17:>ZBCD_M>VAMI98XWDDMY9%7$@3Y0021E<9'H:
M/1ZSKK7+&SUNPTB9Y!>7P<P+Y3;6"+N;YL;>!VSGD5S+WNMV^O+X:;4[J[N/
MLCWS75O#!'+M:38B@/\ )A><G&3E>G.<:\3Q'<Z]X&AU6XM[760U^DD\*"0
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MJ6D@LEC3RTC^TJ$7.-VX8!)SC.>,8QZ;K$D\.C7LMK*(IXX'>-RNX @$].]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9<0-%YD9) ==P&5R"*X[7M-NM8\#ZL-,\'G3;F\:W5+?RX4GEV2AF9]K;0H
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M?*RE2<A@Q'&[MD>@!Z3I]]%J5E'=P+(L;YP)$*,,$@@@\@Y!KE_B%K6KZ9I
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M(Q8,(]H/ ZGJ#P* .ATO4[36=+MM2L)?-M+F,21/@C*GV/(JW7*_#BQO],\
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M>6#MSM)R3QD<'G#++Q3?ZS+;V-GI_P!AU$Z>M[<Q7ZM^X+,56/:,$DE6YXP
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M.<XH [6H;B[MK1 ]S<10H3@-(X4$_C7-Z/XJGUO2O#US:I 9]2W-<Q$-^X5
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MPYV3 *K!P#R,AQQD].II)]>N[3QU9Z)<Q0)8WMK)-;7'.YY$QNC(Z [3NSZ
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MXU=HRT3A@&4X89'<$8(KAKI=27XK^'&ODLS(VFWA4P;E^;]UE23G('&&[Y/
MQRR#QK>6WA6WU&VT2QC>;7&T^6".4JJDW!C+@[?F).22<=<T >AT5QB^,KW3
MY?$\.LV,'F:+:)?+]CD9A+$RN=OS ?,"A&>G.>*DMO%&JGQ#HNFRV=E+'JMD
MUX)8Y67R0NW<N,-O^^N#\H//2@#KZ*R]=U"[TZTADM((WWSK'+-,X6.VC.=T
MK9(R!CH",DBN9C^(#+X9U;49;:*6:PU,::IB8K'*S-&$DYR57]X">O0X)XH
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MY=<Y;,:G+9[]<UMT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY-P"@DDY()&>.>:(_".M:=K>H2:1KZ6VDZE.;FXMI+;?)%(WWS$^X!=W7D$
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M]O';W5M'+#'(DJ(PX5D8,I'T(%.CL+6+4)[^.!%NIT2.64#EU3=M!^FYOSH
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MC>ZOX(\4^(/[1N[35=-NKSR!'.RK;^03LC,>=K A1NW YW'VQ-;Q7OB+QO\
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MYK"_A\ZUF&V2/<5#CT."./:JR^'=+2_AOU@D%U!!]FCE\^3<L?\ =^]TX!_
M4 9'PXN[J\\%P&\N9;F6&XN;<33-N=ECF=%W$]3M &:Y?4M3NUO+34=/U*\N
M(V\416CW+3M'&4:7RV@2($JR*,@L0,D9&>M>BZ5H]AHEH;73H## 7:0IO9AN
M8Y)^8GJ23]367+X%\,S23O)I$+&>X%T_S-CS0<[P,X4DCG&,]\T 8-K))XIC
M\3O+K=UIEYINIO!%)#,5%K%'M*L4R%8, Q)8'(8CH!A\+R>*]0\66<NKW>G7
M6G7*0VI@F:/[/'Y2.LI4$!MS%\[NPQ707/@OPY=ZTFL3Z3 U\H4>8,@-M^[N
M4':V,#&0<8'I2ZEX-\/:OJT>J7^EPS7J*%\TDC>HZ!P#AQ[,#0!A:?</XF\6
M>(M+N[Z[2&PM[5;4V\[P%A)&7:;Y2,DG@9R!MZ<G/-Z9J&L>(5\"+J&J7T+W
MWV^WNVMIC%]H6)7"O@="0,Y'KD8XKTJ^\/:9J%\M]/;L+M8S#YT,SQ.T9.=C
M%""RYYP<BDD\.Z3+<Z?<&T"R:<I6S\MV00 C!"JI '''3IQ0!QUF#JE]XJT:
MYO\ 4"FB6\-K;#[4ZR$&'<9G((WLQ[G(^7W.:/AI_M?AWPAIL5W=23'0?--C
M#,T"8^11,\JG<,<J% ;ELXXS7=:AX4T35-3_ +1N[$-=^5Y+2I(Z&1/[KA2
MX]FS4">"/#<8L0FDPJ+&,Q08+#:AZJ>?F7V;(H X72M0U/5]-^&LEQJU^KWX
MFCNVBG*F8+!(06QU/'7KW&#S3DUR\T:RU'36U&Z^QIXJCTW[3/.SR06SHCD>
M8Q+=25W$Y ;KP*[JU\&>'[%;%;73A"+!VDMA'*X\MFX8CGN..>W'2I&\)Z')
M:ZC:RZ>DL&HOYEW'*[.)6X^8Y)YX'(YX'I0!S?B:67PC8:C/;ZS<&"ZNK-6B
MN)6<6$3R".1PY)8!AGZ')%:^AZ9J&F^(;IYM5$EE=6ZO'8F:28QNIP9%=R2%
M((R.F>?6KUEX3T*PT>?2;?38?L-P,3129D\P8Q\Q8DGCID\=J?H/AC1O#,$D
M.CV*6R28WX9G8XZ#<Q)P,G S@9- '.^)[L^'O&&GZG=WEX-'U"WFLIXEN) D
M<X7?&RJ#PS!77COCN:SO!MUJ%XD'AO4[F]&JZ3>R27[M=R,\D0 :++9Y#>8G
M'0^6_%>@7EA::A'$EW DRQ2I.@<?==#E6'N"*6*PM8+ZXO8H$2YN519I0.7"
M9VY^FX_G0!Y)XA,UU\/_ (AQ75Y=SK::P5@\RX<[%VP$+U^[\QXZ=ZZ/5-+B
MG^)^C6'VB\2'^QKK<R7+B1AYL7'F9WCZ@@\8SBNH_P"$5T7[)J5JUB'@U)B]
MY&\CL)F(P2<GKP.1SP/2EA\,:1;WEO=PVK)<6\)@BD6:3*H3DC[W.3R<]3SU
MH ROAS=W5WX007=S+<R6]W<VPFF<L[)',ZKN)Y)P ,^U<OKS3W%E\5+2>[NY
M8+:T1X$:=L19MBY"X/ W<XZ'H:]&TK1[#1+9K;3X##"TC2%-[,-S'+'YB>IY
M-0KX<TE9]2F^R!GU--EYOD9A,N-N&!..G'TXH XV_&I:9I>BSV%K>ZIID-AF
M\LK:_D2Z4L%(E3+9? 5@%R,9XKK]$FM-7\)6$D%U/<VMQ9H%G=F2612H&XD'
M(8]^<YJ.+PEHMO';I;VLD'D1&&-H;F5&"'&5+!@2.!UST'I6M;6T%E:Q6MM$
MD,$*!(XT&%50,  >E 'D?AB]DTWP)X'LXKAX8M6G:*>26YD5<A9"B!LY3<P'
MW<9QCO6AXAM-9T/0KF/_ (2&XRVKV;6Z0SNSVT<LJJT;.Q)=3R0#ZXZ5V3>"
M?#3:--H[:1;G3YG\QH3D@-DG*G.5P2<8QC)QUI5\&>'UTA-*73PMDDHF$8E<
M9D&,,S;LL1@8))Z#TH YK4-)ET[QMX:TJ'6M9:SO5OGG22^=BV%0@;LY&-QP
M1R,\&N>O6O[3P'XIU"/6M6-QH.JS16#->.=J*Z$*_/[P88CY]W'3%>J3Z'I]
MUJ5GJ,T+O=V:E;>4S/E >&[XYP,YZXYJF_@_0I-/O;![)FM;Z4S7433R$2N>
MK-\W).!GUP/2@#EO%>I7NCZW>WFHI>R:"3"HO=/NF#:<P )$L0(W*202>>#@
M]J]$R"2,C(ZUDR>&-(FFEEEMY',VSSE:XD*2[  N]=V&P .H/2K5MI-C9ZG?
M:C!;A+N^\O[3*"<R;!A>,X& >U &/\0_^2<>)/\ L&S_ /H!JEJ7_)%[O_L7
MG_\ 2>NGU/3+36+"6QOXC+:RC;)'O90X]#@C(]JB;0]/?1#HS0LVGF+R3"97
MYCQC;G.<8XQGIQ0!PFGFYT77O!YM[R^G34=)G-Q;RW#/&YCBC9-J?=0C)'R@
M=><T[PV=4UW2O#?B>/74A,CHUZ//D=)]_P KP^63L4AC@8'&/K79IX;TI+G3
M[A;9_-TY#':,9Y#Y2D8(&6Z$ #GL .U5['P7X<TW6I-7L]*@AOI&+M(I. QX
M+!<[5)R>0 >30!F?$*6[BM] ^QW]U9M-K5K;NUO)MW([8(/8_0\5RVM:CJO@
MC5/$EI9ZG>W5@-,@O4>\F:=K1WG\IB&;)QMW/@YY7I77>/-'O-;M-(M[6R>Y
M2#5+>ZG"RJF(D.6P2P.>>,?F*VX-$TZ&"ZC^RB1;Q=MS]H8RM*,8VL6))&,C
M&<<F@#D+W3=2L8M3OX=>9+.XTB5H[:*[EF8R(-RSH[DE>" <<'([UA:[I);X
M'7>K7.IZI=7-WHUM+()[QR@8(.0N<<[N0<@X!//-=[IO@?PYI%E=6EAIBP0W
M2>7,%E<ED_N@ELA>>@(%6IO#.D3Z NA2VI?3%4(+<ROMVCHO7.T<<=.* .?E
ME)\?6/AAY[N/3AI4EZO^E2;YY?,"X,F[<0JY.,_Q>PKE[G4-9_L][$ZK?*MC
MXM@T^"Z68[Y(&9#L<_QE=V,G.<<YYKTJ[\/:9>I:"X@=GLR3;S">198LC!Q(
M&W#(X//-,N/#&CW5E;V<MGF"WF^T1JLCKB7.[>2#DMGG)R<G- ')W&DR6/CO
M0]%36=9>QN+&]DE22_D+,0\9'S9W#&\@$'('>N?EDU"U\!ZIJBZSJKW>BZX]
MK:.]VY'E+=JFV09Q)E21E\GZ5ZG-H>GW&JV^IRPNU[;QF.*7SG!53U'!QS@9
M]<"J;>#]"?3;C3FLF:TN9_M$T1GD(DDSN+'YNN>?J,T <1XXU.[AM/%5_IFI
M7DD^FM;X=9VABLF 0F-5!Q*S;LMD8PV,\8K5N[2;5/B5JNF2ZIJ<=B=&AG$-
MO=O$%D,DBY4J05X4=",XYS6]>>"/#=_-=S7>EQS27B*EP7=SY@48!//W@.-W
MWO>K47AK28+U[R&V:.X> 6Q=)G4^6.B\-T&2?J2: .#\+>(;S68_!>FZK>S!
M+[29KAY%E:-[J9&50I92#PI9B >3C-7[N>ZTK4M \,_VU+>174MV&GN)VC=F
M0*T<)D4[B0'/?)V<]Q717'@;PW=:-;:3-I:-96K[[>/S'!A/^PP.Y?P-3WWA
M'0-1T2+1KO2X)-/A(:*+E=C#^)6!R#R>0<G)]: (O"EC?:99WEG?:H-0,=VY
MBRS.T$; ,L3.Q)8C/4\X(KE!>W>N^'O&6IMJ%W::AI=Y=16OE3LBVX@4%,H#
MM8-C<=P.=V.@&.^TS2[+1K".RT^W6"W3.$7)Y/)))Y)/J>:J7/A?1KJ]N+N6
MSS+<A1<!9'5)P.GF("%?CCY@>.* .)F1M:\6?#W4+X7,-S>Z;<S3QQW,L81_
M*B)  8;>2<XQGOFNE\=:O-H^CV;13"!+K4(+6:<L4$<;MR2PY7. N>V[(P>:
MU[K0M.O=4M=2G@9KRU#+!*)77RPPPP !P,@#/KBI]1TZSU;3YK#4+:.YM)EV
MR12+E6% '#:E;7N@6NL?:O$DUO;7AM_LUO [SS0N9 I6-G;(\S[HY 4DD$8-
M95]XAU;P_'XZVRS0I9)8/ CW#7!M1-E9&!;T'S8Y ([UV\'@;PU;Z)/HT>DQ
M?8)RK2QL[,6*G*G<3NXQQSQVJ>W\(Z!;37,T>EP>9=0"WG+@OYJ#(PV2<]3D
MGD]S0!C:QID5EI^L75MK%U+;W.BS!;*6=IE8JI/G*S$D<, <<'(K!T!9]+O?
MATT%_>LFIZ<T5S#).S1,%ME=,1_=4@CJ ">^:[+3_!7AW2M/NK&QTU8;>Z3R
MYE$KDLG]W<3D+R> <<FK">%](C?372U8-IBE;/\ ?R?N01@@?-TQQ]..E '.
M_%[_ ))O??\ 7Q:_^E$=2?%F:V3X::Q!< .]S&L%O%C+23,PV!1W.<'CTKI=
M8T/3M?L_L>J6_P!HMMP8Q&1E4D'() (S@@'FHH?#>DP7D5Y]D\ZYA_U4US(\
MS1_[I<DK^&* .2T WFK:]?\ A[6;F[B;2]+L418+EXB[O&3)+E2"Q# *.PQ[
MUF^&O$>I:O<>&M'UJ[E"7$=\#.CF)KUX) B?,N#]W<Q ZD#MQ7H5]H&FZC?1
MWUQ XNXXS$L\,SQ/L)R5+(02N><'BH-3\)Z#K&F6VFWVF0R6EJ0;>-<IY)'
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M=/TVV2WM(1A(US@#\>35R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGZ4 >D:IJ]L8 EGK^G6<R7<<,C2LK_-N&8L;AAV!P._/2J<6K:F_Q"U#1#-
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M)&,Z@(AZ,3G@'UZ5PEC>>%_$D7]HQPZQ->6>G3Q7,3K)&UI&T9#QG("EL@
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MD;JK ?:%Y&X@'GW[UW54#HM@=:&L& _V@(O)$WF-GR\YVXSC&><8Z\T </\
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M=\JV_P#MQPQB,./8L&QZC![U:\::3?ZI9Z7)IT,<T]AJ=O>F)Y-GF*A.0">
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MQ9+:'^QYC;1I/$7^T3*@=@Q!&U?F"C'/!//2K&I>#VU[['%K>JS75G:S+/\
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M-K[UC9\_,@;! QG@ DCBM6\\-V5[XGT_7I-XN;*&2)54_*X8@C=Z[2"1[G-
M&(WC-O[$_MZ"2*?3;;1_[0N5$9#N[ E%4YPOW7R"#CBI+74?%K:O;1M9QO87
M%L[27#Q*HM90,K@"4ET;D8ZC@YJ]I?@W2M,T#4=%2-I+*_DG>6-C_#*3E!Z
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M;*YG\^ZBMT$\WF,_F2;1N8$\X)R: +<4M\VJW$4EK$EBL:&&<2Y9W.=P*XX
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M3DQQ2F%DCN'7[P1R-K'@\ GH?2HHO&?AZ;4UTZ+4XWNS<&U\M48_O0N[:3C
MX[]#0 _0=/U.-YM1UUK-M4G1(F%F&\J.-,D*I;DY+,2>.H';-:.I07-UI=W;
MV=P+:ZEA=(IRF\1N00&V]\'G%9GB#Q1;>'[O2[::"YEDU"Y\A#% [A?E+$G:
M#S@<#J>N, US]KXQATCQ3XJAUS59/L-I);&V#PY,2/$';(1<A03RS#CC)H B
MTSP%B6T^V>'/#-A);/&XOM/W&=BA!R,HI4G')+-U/6NS?1-*DU W[Z;:->$J
M3.85+DK]TYQG(['M3;[7-.T^)9)YV8-&90((GF8QCJ^$!.WD<].:M65[;:C9
M0WEG/'/;3('CEC.593T(- #YK>&X"":))-CATWJ#M8="/<57U/2--UJU^S:I
M86U[ &W".XB610?7!'6JK^)M(COX;)[O;+/*8(F,3B.209R@DQL+<$;<YR".
MU11^+=$E%SLNW9K6X2VF06\FY)6.%0KMSD_U% %N30M(E%J)-+LG%H +8-;J
M?)QTV<?+^%/?1M+DO)+Q].M&NI$\MYC"I=E_NEL9(]J@U/Q%I>CB0WUPR")!
M)*4A>01(<X9RH.P<'EL#@^AHOO$6E:=$))[K*F'[1F&-IL1?\]#L!PO^T>*
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M(K+3S#Y$[(@-LKP[B1A><$Y&0>@ZULV'B#3(HM%L7U.2ZN=0ME>UE>%@;H!
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MDCDOM/M;F2,$(TT2L5!Z@$CH?2J5OXMT.ZTZ\OX[]5M[)_+N3+&\;1-Q@%6
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M=06(! Y8"L:RLM0L?%<%QH@U%+2YU.;^T-+OK9C#$"7W7$,C* N?O8!(;?\
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MSR,\')[U@1:'J.B>$/ VFS6=W+/::PEU.D,+2BWB)E.&*@CY=ZK^''%>K44
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M9.=O ^4<A1GKC)KGI_ ]];^'='TVPEM9)K75DU2ZEF9D$CB4RL% 5L9)P,]
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MKR:[&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** (+NRM=0MVM[VVAN8&^]'-&'
M4_4'BGP00VT"06\211(,)'&H55'H .E244 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
..*** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>exhibit1061-loanandsecur009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8@.X+,.0I) ]<5S'C#P;(-"LKCPS:73ZOIMS#/8Q/>L43:0"I\Q]H4KD<>U
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M6]W;>3F6%R0!N .,'<"&!P<\&G'QK:#5;C2_[,U8WT<(N(H/LPW7$><;DR<
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M&1GK@GU-2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 <^G@CP_'=23Q63Q^:Y>2&.YE6!V)R28@VPY[Y7FM\ *
M   . !2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !67I7AS2=
M$N;RXTZS6&:\D,L\FYF+L22>23@9).!@<UJ44 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !6%XP\//XK\,7>B+>+:)= +)+Y/F$ ,#P-P]*W:*
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MT0F:X3)+JQ/0L3DMU%;]% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115>"]@NIIXX6
MW^2VR1@/E#=USW([^E %BBF32B"%Y2KL$&2$4L<>P')^@IMM<PWEM'<6\J2P
MR*&1T.0P/<4 2T444 %%%% !15#6=:L/#^F2ZCJ<KPVD0S)(L3N%'J0H) JK
M'XJT>2YM;=[B6WENSBW%U;2P"4XSA2Z@$^PYH V:*** "BBB@ HHHH ****
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M !1110 4444 %%%% !112*RL,J01DC(- "T444 %%%% !1110 4444 %%%%
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M#QQB@#FTO]3U&W\=V-SJ,FVPD,=N\<:*40P*^WE3GEB,GGW%9MA>ZIHOP[\
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M1[&NCH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0P.&((SGKT)XZ=^PQ<KGK7QEI5Y=6447G^5?2RPVER8_W<[Q[MZ@YR/NMC(
M..,U0G^)GAZWCFF<:A]FM[IK6YN/L4GEV[@A?WA(^49..>?;I0!UK0Q.X=HD
M9QT8J"12/;PRR)))#&\D9RC,H)7Z'M7.:AX\TC3[V^LO)U"YN;*-)98K6S>0
M[&SAAQRN%.3TZ<YK,U77$U+6? VHZ1J,S:?J%W("(Y"J3)Y$C ,O<@CH>A%
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MEC'!*;<[B.,K]X9'%0^'_&.F^)FC_LV&^:&2$S)<26K)$P#;2H<\;L]O\#@
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MO[V?PXUC8RW0M-7BNIS&R#9&JN"?F89^\.!67KNG:AI_CB;5U\-+K^FW]I%
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M<(" 1D_WBH(SFLB?0-<?P]KBKI,_GMXF35(83)'NFA$L;?+\V <*>"17J5%
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M(RW ;'<'&#FC2](OX?&WB2_N;;;8ZE%;QPN) 6_=JRMD=L[N/UQ6!!X.U=_
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M[N5]0AN+"ZENL;($DC81*NT[#\K9/&<]ZW(-/US2_%FMZI%I\-RNJ06PCV7
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M3XX[:[MKE8[BTN5!!*OD?(<*>,]/NGMV>F17MGH5G#?3?;+Z&V19Y%X\Z0*
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M2[AK:6V<IYCR#& N&P=VX;<D9S4::KI<?C:]2XL[BUU"#2DGFN99!Y7V?>W
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDFYE,TWSLV]SU8Y)^8\9/4XJ_10 4444 %%%% !1110 4444 %%%% !1110
M4444 %4+C1=/NM4MM3F@+7ML"(9?,8&,'J  <8.!GU[U?HH HZGHUAK"0I?P
M><L,@EC!=@%<<AN".1V/:KH&  ,\>IS2T4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJLJ88#<H(!(#-@XXS5FQT*TL;T7F^>XNEA^SI+<2%V2+.=H/N0"2<DX&2<4
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MWLJ"XEDW6=L,3705#PKY&Q5)#$Y'89YP;VFZ#9:5J-_?6QF\^_<27!>4L&8
M '!X'  X]*;K'AS3];NK&ZNQ.MS8LS036\[Q.NX8894@X( R/:@#B-/USQ%<
M>#+2[$-UJ36VJ7,%[#;R*MU+;QO(@V$8W,IV9Q@MCW-=CX0U.VU;PY#=VM]/
M>1M)*/,N$V2H=[?(XP,,O"_AFH;3P5I&GHJV)N[4I<O=(T=R_P COG=@$D;?
MF/RXQSG&:U]-TRUTJU-O:(55I'E=F.6=W8LS$]R22: //8YGT+Q5\0]826YG
M?3[2WN%A9\K(1 [ -QT';TJW<:GJFEV'@_6H=1GO/[5N;:VO87(,<HG7.]!_
M 5."-N!C.<]:ZNV\-Z?:ZKJ&I()FN-1"K="20LD@4%5!4\  $CBHM.\):5IG
MV58%G:"S8O:02S,\=N2"/D!] 2!G. 2!B@#B+K_D6OBS_P!=+C_TC2MG3]2F
MU#Q'IOAHSS6]K%H,5\QA?8\K,P0?,.0%QGCJ6&>E;;>#]*>VUBW87)BUABUZ
MOGM^\)4*>_RY4 <8XJ2;PKILK:?*IN(KK3XS%;W,<I$BQD8*$_Q+P.&STSUH
M X>37M>C\,WNH37T[GPWKC6UW(@ -Y9HR[F8 8W!7R2,?</K5F/Q%>)XEU_3
M!?7$D=_$K:'*S@KNW^3(%QU"R$-SGY<GI7=0Z)I\&D3:6EN/LDXD$RL2QDWY
MWEB>23DY)]:BB\-Z3"^D.EH@;2(VCLC_ ,\E*!"!^ % '(>)-8O= U.5=3FU
M*+1_*ACM]6MF$B6TG\7VA!S\Q(^8@C!&,'FNVALIDU>XOCJ$\D$T2(EH0OEQ
MD9RR\9R<^O:JE]X8T_4)KQKAK@Q7NT75N)CY4P4  %>W  .,9'!R*MPZ5;0:
MQ<:FC3?:+B)(G4RL4"KG&%S@'GJ* +U%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5C+K5Q?:5>7VCV2W@CW+:AIA&+EE)!P<'"Y! ;O@\8P3)XF
MEN(/"FL2VF1<I8SM%MZ[PA*X_'%<-JBK'^SI$]M+)$8]#AD1X9&0[O+4]01W
MSD4 =[)JJVVJ6ME=Q^2;L$6\F[*NX&YD/HV 2/4*?3%:-<+\16DC\-Z'- 3]
MJCU>Q,..I8R 8_$$BNZH **** "BBB@#'\4ZZ?#/AV\UDVIN8K1/,DC$FUBO
MMP03^57]/N9;S3X+F:%87E0/Y8??M!&<9P.:YKXI?\DP\0_]>;?S%;MK=P6>
MA6<T\@1/)B4'^\S !0/4DD #WH T:*\IM0?$MIJ%W<Z_;Z;JVGZM*'D$+&XM
MPDQ"1C]X,HR!1MVX;)X)YJOJ^G1W$'Q-EDN+QGT_$]H?M<G[EQ:K(&7YO[W3
MTZ#&30!ZXY8(Q1=S <*3C)^M8_A37CXF\.P:JUK]E,LDR&'S-^W9*T?7 SG;
MGIWKE]-OAK_C8:7K)$D4>B6]S;02'Y96<GS9<=R,* >W.,9-<SX<OQ:>&O!N
MERW<$.F7=WJ4<DETIDCDD69_+1_F7.<L<$\D#K0![117E&KZ2=-T[2[*+7I[
MJ,^*+= +=WB6W20Y,(^<Y4<$9)*YXQ7I6E:5::-IR6%DLBVZ%BJO*TA&YBQ^
M9B3U)[T .L)[V?[3]MLUMMD[I#MF$GFQC[KG@;2>?E[5;KRW3H-0NM \06EA
M>QFZ3Q/,L,5_*[)<*A5O)9N3@A2/PQ74^!K^.\L-1C_LV;3+JWO6CNK*20.L
M,FQ#B-AP4(*D8]>F,4 =317D?CZ\C-CXQOK&XD-WIQMP;B:7:;20!6"6X R,
MYRQ)&2<<XXW99K'7_&GB?0]9N1&D%I!]A!D"%(V1M\T>>-X?C=U&T>] '?T5
MY_I]S9ZIXQDT34KIKRRM='MI;);MO^/H-N$D[#@,WRISCC)(QDUSV@W$@T#P
M#<?:96,FNW4#3-*6,B;KG"LQ/S#Y1U]* /6;^6Z@T^XELK9;JZ2,M% TGEB1
ML<+N(.,^M2Q,[1(TB!)"H+*#G:>XSWKRG4YMVC?%-8+J54M6WP^3.R^6PME8
MXP>/FSD=,YS5^\TN#6/&^@V%Y-=FTN= E,T274B*Y#1 =",=>V,]Z ._@GO7
MU*[AFLUCM(U0P7 F#&8D'<"N/EQQW.<U;KS"ZA,&H_$FVCN;L1P:5;/%_I4A
M:,B&4_*V[(Y Z&C2+8:?KWP^N;>:X\W4M.E2\9YV;S@MNCKD$XX/3'2@#T^D
M9E1&=V"JHR23@ 5Y3:Z?J&N65M LDKZK%KTC76I07)19;596W*'5@VW9A @Z
M%>@ S7>^++:*?P9K,$J>9']AE^5CG.$)'UZ4 5[SQ4D.I>'(;:V%Q::VQ$=R
M)-NP>4T@.W'.0/;K715Y-%8VDFF_"^WCRB2E6E\J0J239,3R#D9]O6H9-1D\
M/Z9K]E#=-;Z7;^)H;9Y)&9UMK>1(V89W A-QP>1PQH ]?HKE?#.EQZ9KFI/;
MZQ!<074<<OV"UB*PVYY&]?G;;O\ 3C.W/K67K&FP:K\6+?3[R:Z-G/H4SR6Z
M74B(Y$T8' (QQZ8SCF@#OJ*\7A@NQI.D6$U_?/:VWC%]/M9?M+AI+4!\*2#\
MV&!7/4;>"*Z>PL+)/'EQX5N(G.EVFEI-8VT\K2!R\C^:^6))(.U02?E'3&:
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MA06(YY. 3UK$\%7C_P!KZKIU_HPTG58(H&FA@DWVTB$N%DB],D,"" >!U.:
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M)Y5AB\U\;W)P /\ /%9]MXT\.7EE?7EMJL,L%A_Q],H;,(ZY88R%P#STXZT
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M2[.*UGSYL"0J$DSUW+C!S2V^A:5:6TMM!I]ND,RA)$V AU'13Z@9.!TK0HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M O*V"3C)   !))(  KC_  OKGD:UXRGOGOD@@OX(HK>Z<R.C-$@V*,G[SMP
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M<'(Y.#D # Q571O&TUUX9\/R&U@M[[5I+@!(('DCB6)GW$(OS-T4=1RQ/;%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1152YU&*UO;.T>.=GNV94:.)F12JECN8#"\#C/4T 6Z*** "BBB@
MHHHH **** "BDW#=MR-V,XSSBEH **KQWD$UW+;1-ODA \W:.$)&0I/K@YQU
MQ@]QDO+V#3X//N7\N$$!I"/E3/=CV'OT'>@"Q1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?R(;>9HA T$<K(P8X,@?:N[.>O;%=S?7:V&GW-XZED@B:5E7J0H)P/RKGHO
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MLP63H5V$-\O/RG'_ -?F@#(TOQ->/XNBTC5[NZT^^-U/Y=K- GV>\@ ?889
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MQZ)92_"Y=7LH\>)(=4F6PGC<^:LIO& C7GH03E>F"3[T >X%@" 2 3T'K06
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M.;1;CQE=Z)J5WIMGI<FF1_V<LT2&!AND$WEDD*'SMSCG 'I0!Z<2!U('UH+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1^-(((0)0(DQ*<R#:/G.,<^O  _"I** *=MI.FV:R+:Z?:P"4;9!%"J[QZ'
MY')_.K$$$-K!'!;Q1PPQJ%2.-0JJ!T  X J2B@ HHHH **** "BBB@ HHHH
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M26]GJDMO%<1@)'Y2JA4YR?[QYSWH ZZBLL>)-#-B][_:]D+:.3RGE,Z@*_\
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M=S^SK&L2[F?1(8DC R2X11M ]<@_E7IU4[#38M-,R6Q*V\LAE$/\*,Q);;Z
MDDX]2: .1\5I<6;:!XMTFW:\GLV%M-##UGMYL*1[X?8P],&KOB>V72OA9KD$
M["1_[-N/-<#_ %DKHQ8X_P!IV/'O76U3OM.BU'R4N26MXY!(8?X792"N[U (
M!QZ@4 0>&[:>R\+:1:W6?M$-E#'+GKN" ']16G110 4444 <A\42#\-=<B&6
MEFMBD:*,L[$C@#J35BR\6:4FFZ?!!,;BZE6*%($C;=N.!\W'R@=23T -=/10
M!Y)9MIEQ_:/A?Q+;ZM)JO]IS3PVZ"4)=!IC)%*CJ, #*Y)(QMYIVHI;/;_%7
M$<;27$>V'Y>9?]%50%_O?.,<=_>O6:* /,])U9=)\:6UUJ[2+97VB6T-A<E&
M9 ZDF2+(!PY)!P>NT#M7/:/=-I/AKPIJ%Q;ZA%I%E>:C'>-!#(K6YDE8Q2;0
M,E0,@D=-_P"%>VT4 >3:Q;:&-*TFXTRWG^Q7GB>WO))+D.?._P">DNU^0G8G
M '?H03ZK#%##$$@C2./)8*B@#).2>/4G-244 <1.UL/C*DL_E[(M!9?,<#"/
MYP.,G@';DXZX]JY3PUJ$5AX?\&036[P,)KZ,7WD-(UH=[8C50" SJPQN!&!P
M#FO8J* /'=#BCD\)Z?;G5;S1=3M-6OGMKV:WQ&CF23Y958!2K*WMS@<'BO0O
M!5W?7OAF*;4;2"WN?.F#_9P1'-B1OWJ \[7^\/KFN@HH X?Q4MM)\1O!@G2-
MU0WF_>N0NZ(!<^F2,#/4UAWLFEZ?XE\1Z'XEAU&.SU-HS9"UBE:*XA\E(_)4
M1@X92IXXZYKU2B@#S&"^LO#?BC5M.\0V5U'IVIV%K#8[H7N T:1%'MR5#$MD
ML<=]Q/?EE[=6?A_Q5MUJVO\ 3]%OM*MK>S-NKLD)CWAH'V X.''MQUKU&B@#
MS;[)8Z9XG^'UK96TUK:6Z7BQQSEB\2-'A Y;E<]@>_':K0TN\L?'.H:+#;N=
M&UMEU.20#Y8F0@3H?7S"(N/1VKOZ* /+M2N=/M?%7B72/%*:F+;5F1[0P1RO
M'=1&%4,0\L'Y@5;CC[V:LZ3=Q>'/'.I6NL03V]M>:=9Q:895:8;(T(>'<,Y?
M<Q..K9SS7I%% '&_"HD?#/1(VCDC:.$JRR1LA!W'U'(]Z;XBU"*V\<Z9!+#)
M;-+8S!-1C@:5VRZ9@08*@G 8D@\# ZYKM** /&M'F"^ OAO#(LL<EKJ\?G+)
M&RE J3 DY'W0649Z9.*[+PY(I^)7C+G[XL]A[-MC8-CUP2 <=#79T4 <W\0;
M>:Z^'GB&"WB>65["4*B#+,=IX [USLU[9:CXU\"W*?/#'9W?SR1E0K%(PI^8
M<9(;'K@XKT:B@#QA)I;+39-02*ZDTVQ\67D]U': [U@?S%250.2H+AN/KVKO
M_"":+/+J6JZ(EV\5\Z/+=7'F 3NJD957P>!@$@8/X5U%% '&?%/:W@.Y3&Z1
MKFU**!DG$\;' ]@"?H#516L6^*FLW,OD-$=$A02L 5)WR%@#T/RE<CT(KOJ*
M /'K*98_AS\.8I21+!J=J9D8'=$JAPQ8?P@9&2>F171V=Y#I?CCQ4FO,JVNI
M1P264LHS'/"L>UHE/0D-N.WJ=^0.:[ZB@#R#0]+ETZZ^&UCK,>9[>WOA(DZ[
MC"K@>4CYZ'&% /=<5LPQV,/C;QONC@2(Z7:Q1_( I"I*&5>W&4! ]J]&HH \
MCT[R8/#GPN"JL<L$Z>< N#'_ *.ZMN]/F(!SW-59=2CN%T&5+6YL_LOB<O/I
MT5H["WRTV7=MI+.Q8'@@?-@#C->S44 >9PS);P_$BQN(Y4FFFFG16B;#(ULB
MJ0<8.6! &<DU#H]P^F:EX)U.^)72/^$?%EYS?<MKG$9.\_P9";<GN,5ZE10!
MXWJFG^7I6ISM'_Q+;[Q5;7-I$R9#1AX_-D _N$ASGH1ST-=?H[Q#XK^(#$5"
M2Z=: %?NNRF3.#T) *_3(KM:* ,KQ+*D7A?56=@H-I*!GN2AP!ZD^E<IX,\4
MZ7I/PYT2&XED-W;V,4;6JQ,92X4#;MQUSQ7H%% 'E5W/I\.O^)=#\6PZF%U2
M=9;9;=)7CNXC$B^6I0?>4J1SCJ#5^RALK?X@ZQYT21QQZ!;0CS3NVD&3<F\_
M>(!7/X5Z-10!XWX8OWT9/ >H:J)5TF/2);-I2A*VMT2O^L_NY52H)]348GFB
MT[5M0MK2_>RM?%[WMTD$#J[6YC"[U&!NPQ#8'/RYKVBB@#R'Q.F@W_@;Q+JF
MBQWEP=1:T$EQ.LO^DNDB\(C@$E5') _D<>KVD5K'#NLXX5BD^?,2@!N ,\=>
M /RJ>B@#A?$NJ?\ "._$+2]7U..;^Q7T^6T%PD32+;SEU;+!02-RJ!GVJA/]
MGTK7_"FJ6M@]EX:C-XAS&46"27!25U(R@;YP">F[G&<5Z310!XYXELBVC>.+
MV%=^F:CJ-BUF@7(F=&B\Z1!W!P>1UV$]*V=:&G2>.=9656;3Y?"IBE^RCEQO
M<E4QU;8<@=<'TKTJB@#S"SN-0CL?$5A>7]MK=@NCDP:LD860Y#A8)<<,_.1C
MGGD9-5M*U Z->^!=1U(2+HZZ +,3;"4MKLB/._'W254KD]\CUKUBB@#Q=9Y8
M--U'48+2_>PM?%\MY=)! Z.;=D*^8HP"VUB&('/&:M^)TT&^\#^(M3T:*\N!
MJ,MGYEQ.LG^DNDJ\(C@$[4') _\ 03CUVB@#A/%5M;1ZEIMUH^L0Z)J2P326
M]PT:FUN%/E[HY.W.U""#GY3C.*Z/PI<W%WX4TN>ZL%L)VMTW6J@@1\8P >0,
M= >16Q10!Q%Y]F'QDLIIA'B/1)E\QP,*YE0@9[';N/KC-<9I=TVD^'/#&H3Q
MW@TFQU#4$O/LJMOMO,D?RI"JC.W!(SCH_O7M5% 'E%\;#2DTKQ)I%GJ$VA+K
M+7FH.R2,TA>%D^T!&&[:K$=N2,@=#5OQ'<V<VD0^(-"TZ[;3EU>&\U"6VA=)
M+E C*TBJ0&8*3&<XYVGTS7IE% 'F4T'AG5-.U'5-.N]4MEOKBU+:QB08FC)\
MM@L@Y"X4,<8P>3P<0^9>:AI#1:OJD=E>V^LK]B\06$0$,\@MSB5U.5QMS&W.
MW/&>*]3HH \KBUN[1-!?6+"WAG_M.[B76+6!WB'R$>;&G/,NY@"<C()P<BL:
M,PGPM:6ES',3%XR\R1;B J?*^TLQ8@J!C:<G P,\XS7MM% '$^-K,Z3#IWBK
M2;4-<:1,7EA@4 W%M*<2J.Q/(<>Z^]=)H5C+8:3$ES@W<I:>Y(Y!E<EFQ[ G
M ]@*@OM"GU#6X;N;5KG^SXPA.FJB"-Y$;<KEL;N#@XSCY1VXK9H XSQB\]CX
MJ\)ZM*K'1[6>X6[<#*PO)'MCD;T4'<"W0;JX_P 669ETGXA:C:C?INHK9K;!
M!E;B= /,>,#[W&T9'4J?2O8Z* *]G%:) 'LHX5BD 8&%0 W  /'7@ ?A5BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKM,8:0_*>Y_>#CCH?;(!L6_C&_.K>*(Y=$NI;?1V152W:-G8>6)"<%ADD,"
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MY]J,6J1_$7P0^H7<$Y=+PLL4.P(_DC(4Y.5^O/'4YX] ;<5.T@-C@D9 /TH
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M!H:[H?A*"X.L:QI]HLLLD<+3F,YD9B%0-M^]R0.<UT<<:11K'&BHB *JJ,
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M9F?$H$RLJF)3G! R6/?&.G)H [&BN"T?Q/KVI>%]#U.]DL+7^T)G$S1PL'5
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M^X6XM)@3'*H.& )!QGW!JW7&_"G/_"LM$W8W>7)G'3/F/794 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5B>)_#<7B6P@A:ZFL[FUN%NK6Z@QOAE7.#@\$8)!!Z@UMU1UG5;;0M&O
M-5O"PMK2)I9-HR2 ,X ]3TH X?3=*^U>.O$VEZE>SWJWNCP6TMPR*GF$F4.%
MV@*" PX'3/-:]CX'EM[[0KNZUZ\NI-'CDAA!BC571E5=K #T7D]3ZBK]KK&O
M2ZW'97'AOR[-@&:^2]5T52I(^4@,6W#! '&0<FN@H Y'0_ S:#<""VUV_;1(
MY3-!I;A-D39W ;\;R@/(7/USWM0>%,WVE7-_?M>-I3N]H[1!9 64KAG!^8 ,
M>,#H"<XKI** .,;X?1GPG=^'%U>Z%C/<><F8T+0CS?-VJ<<_,>ISQQQ6E+X9
M=/$$FN6%^;2^N;=8+P>4'CG"_=;:3PPR0#D\'!!KH:J:A<7END!L['[6SSHD
MB^:(_+C)^9^>NT<XZF@#!C\$VUK/H#V=U)#'HKRR1HR!C,\BL'9SQR=S'C')
M_"EM/"5Q8S7T]KK,L<UWJ/\ :#'R5*ARFPIC/*$ <=>,YKJ*Q8_$!?QG-X=:
MS9#'8K>BX,@(8%]F OU!H DT+08-#2^,1#2WUTUW<%4V*9& !VKV&%'<G.23
MS4/B#P[_ &W<:9=17\]E=Z=.9H98E5Q\RE&!5@0<JQ^E;E% '%-\/$-C>68U
MJ[,=SJBZF3)&A*R!@^. ."R@G\ABKE_X)MM6U+5KG4+EIH=4L5L9X%0* BEB
MI4YR&!8G//:NIHH Y&T\%74>H:)>7GB.]NWT?S%@W0QJ75E"X<XY..I[^QZ]
M:V2I"D!L<$C.*QM?\0'0[G2(C9M.NHWR6?F"0*(BP)!(ZGA35M+^>.747OK5
M;2RM<-'<M,K"5-NYF('*8.1SZ9H QK/P19Q>%+_PY>W$EY97LDLCDJ$93(Q<
MX(]&.1Z>]-LO!;_V9<Z?KNN7NMV\MNUJBW*HFR-A@\J 6?&/F))],9.=R6\N
M3<6'V2R^T6MP29I_-">0NW*MM/+9.!@=,YJ]0!RVD>#GLK)K'5-;O=8LU@:V
MA@N510D;+M.2H!=MO&XGH3ZFD\/>#[G0?*A;Q#?WUC: K96MPJ8A&"!N8 ,^
M <#)P/3@8ZJB@#"T#PS%HFBW&E23F\MYY9I'\U ,^:Q9U..HRQJ&V\%:7!X'
M/A.3S9[!H3"[NW[QL\YSZCC'I@>E='6)JNO2VNI+I6G6:WNIM:27@A>;RE\M
M65?O8/S$L !C'!R10!%X?\.WND%3J'B"^U<Q)Y<'VE47RU]]H!9N -S9/TR<
MW]>T>#Q!H-]I%R\B0WD+0N\9PR@CJ*S=?\5MX=\(#Q#=Z7/Y:)&T]MO42Q%R
MJX]"06P>:6Y\5C2]0T^TUC3KBR74)A;V]P'22(RG[J,0<@G''&/>@"K!X,N(
MM6CU677[N>\73VL'9X8PKH3D': ,8//7D]\<4VW\#"VTSP[8)J<ACT*82V[&
M(9D(5E ?GT8],5UU% '-CPIYUYITU_?M=KIMR]S:EH@LBLP8;2X/*@-TP.BY
M)Q4TGA'2YM<U35)D9WU*S6TGB)^0K@ACCU*[0?916]10!S,G@C39O \/A626
MX^SQ1H%N%?$HD4[A*#V;=\U02>#+N\\/7^F:IXBO+^6\@-L;F6*-3'$>H55
M&3W8Y/ KK:* ,=](O!#IX@U,QRV:&-BT(9)U( PZY'H#P1S[<5)X?T.V\.Z2
MNGVF3&)))2< #<[EVP!P!EC@#H,5J44 8GB+P^?$ TX?;6MA8WD=ZFR,-N=#
ME0<_P\\]_>DMO#[V_BRYU]KTO)<VT=L\/E *%0L00<YSEC^=;E% '))X$MXK
M&^TF.^E70[V=IY;'8#MW-N=$?LC'.1@GDX(JZOAEHM?U35HKXK)J%M';&/R@
M5C5-VTCGK\QKH** .0A\#"#2/#NG)J<GE:%.L\#&(9D*JR@/STPQZ8KKZ**
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M$#$M&X=1SVR!FJMSX4\[7;[58M4NK=[ZR6TN(XE7#%0X5P2"01O/ /I71T4
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M2 <A'5P0V#R#ZDFI-2\#BYFTV^L-9O;'5K!707RA)&F5SEQ(K#:P+<XP #T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#:"#G@5+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 445AV&L-JNO:E!;R!++2W$$SX'[V8J&9<GHJJR^Y)[ <
M@&Y1659^(M)U2X6TL[X---$98<*5\Q <%XRPPX!(Y&1R*AT36'NM1U/1[LJ;
M[370.X&!+$Z[HWQV/4'W4XX(H VZ*** "BBB@ HHKC?%'C"?0?$NCVR0AM,:
M=(M2G/\ RQ,VY8?_ !Y23Z#;ZT =E17+_$#4K_1_"KW^G71MYX[FW0D(K;E>
M9$8?,#V8T+J5^OQ1?26NBVGG1_M2P%%&V3S@F<XR>/4]Z .HHILB,\;*LC1L
M1@.H&1],@BO)(O&_B2Q^&L'C.>^@O"EXT,]B]NJ"5!.8L1E<$/P#SD=>* /7
M:*Y73M4OG^(FM:=<79:P@L+>XBB9%7RB[2!N0,G[HZFM>S\0Z5?WWV*WO%:Y
M,?G)&RLOF1YQO3( =?=<B@#3HKB/$?BP)JWAN#2=2.R[U5;:=5ARD\>&W;7*
MX.&4 [3WKH;WQ-HVG/*MWJ$4*PNL<LC ^7$Y (5WQM4D$<$@\CU% &M165>>
M)-'L+=;BXO4\DQ"<R1JTBK&>CL5!VK_M' X/-27FM:?;11;KOYKB,R0^0AE9
MD &7"J#E1D<XQR/6@#1HKE_AWJ]WKO@FSU&^NA=3RRW ,P55#JLSJIPH ^Z!
M47C3Q*= NM$MY;P:=97]PT5QJ)0,(,(2J_,"JECQE@0 #QW !UM%<?JD^OZ=
MX?\ $=TNK+/%;Z?]ITZ[$*;MP61F#8&UNB\@ 8/3/-7?#7BG3M4MM/L6U&*;
M57LHYY8^A8[5W$<8.">0.GM0!T=%9-MXET>[O(K6"^1I9MYA)5@LNS[^QB-K
MX[[2<5#;>,O#EY?)9V^L6LMPYD"JK=?+&7YZ<8/Y'TH W**RK;Q)I%W<R6T5
MZ@FCA^T%9%:/,7_/1=P&Y/\ :&1[U-9:S8:C.T%M*QE6,2['B="4/ 8;@,@X
M."/2@"_15+5[F*TT>\GFOEL(TA;-TV,0\<-SP<=<&LV/Q/HUA9Z=#>ZW#+/<
M6JS1R. K7"A03)M XSG.,=3@4 ;]%4]+U:PUNP2^TVY2XMG)4.N>H.""#R""
M.AIM_K%AI<UI#>W BDNY/)@!4GS'[*,#K[?6@"]169'XATN9[]([K<VG_P#'
MV/+;,/&?FX].?IS7,R>+DT[QU>1W^J;=&_LB&\A1XL%6:1P< +O/RIG'..:
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MQ]5MXX6N/LN9"5839 V%3R&Y'!'%7M*U?3];LS=Z;=)<P!VC+IG&Y3@CGWH
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M#10!Y7J.IZGX@^#EN+S2]276%FM$N+=K*7S&:.>,LX&W)!52V1].M=$OF/\
M%Y;D6]S]F;0_)$Y@<1[_ #MVW=C&=O.,UV5% #9)%BC:1L[5&3M4L?R')KSK
MX8^'K*3PA9-JND.M_:W<\JI>V[J8V,KLCA7&,[2.0,UZ/10!YMKFFZAJGB?Q
MG:V4%PDE[H,=K;3-$RQO*/-RH<C;_$O?O4=D(/$]CFTT+6+/Q!;6,\*S:@9U
M6SD>(J0C.2K9;;]WL,G&!7IC,%&6( ]31D;MN1DC.* /)4O9+KP]X$L1H^J0
MW>DZC;)>PFPE_<^7$Z,V0N"N><@G@U#J4EBLOBC0+PZG!IE]JPN)95TN><@C
MRV?9)&"N"4XSROH>@]@!#="#VXKFK;PB;">1+3Q%J\%E-*\IL@\3+N=BS!79
M#( 22>&SSU% '+WMW!!XMU.XU+3]6O\ 1=<MH'LKG3A-)&R^7M:)UC/?.X9&
M/F-3Z<'\*^-UDN=*O(=)N])M[:R\B%[D6K1EB86V!B"=P.>AQUXKT."&*VMX
MX(4"11*$1!T50, 5)0!QWPPCF@\#6]O<6MQ;2QW%R3'/"T9PT[LI&1R,,.16
MEXCNK426VG:GI;WVEWD<HN"+9IUC*[=NX ' .3SC@@=.36_2$A02Q  Y)/:@
M#R6TT272-*\:V6A+J,GAJ;3&6RMI8Y&(N61PR0@C<4Y7GID]>#6G%'.FL_#Q
MX["[Q:Z?/'-_HSJ(F,**JN=N%RRD<^E>D4A(&,D#)P,T >0Z5+=S:GX)O7TC
M4[;[+<W*7-I'I[Q0V1:%U5%&T9&2/GR1W)'2M"PTF_U'P%XWT^TM)X+Z[U&^
MD@6>%H?-5VRN"P&0PXS[UZ?10!YO9S:1X@MIKZ3POKIO;:PGCN$OO/#1JR$/
M#&7)WLQX&WZ\' -WP;%J=CKDEB+VYU/0TL@UO=7ML8[BW;< (&8@%^,GD9&!
MGJ,]W10!C^*PS^$-91(Y)7>RF1$C0NS,4(   )))-<98Q3?VQ\-W>QO +/2Y
MH[AFM) (',,2@,=ORG*L.?2O2Z0$'."#@X.* .0^'Z2Q0^(1+;7$'F:Y=S1B
M:%H]\;ME6&X#(//(J]XXTF?5_"MTED/^)C:E;RR(ZB>([TQ]<;?HQKHJ* /,
MX])UN;Q+!?M:R):^*+8#5(3TM1&0R*?=HBT1_P!KFM?#1_%C4+M[6Y^S?V'%
M )_LSE"XED9E# 8)PRG KM-P+%<C(Y(I: /(M(MKR'PC\-X)=/OUFLM05KE#
M:29A41RKEAM^499>OK6II%R^GSZUX9UKP_=WUQ<:I-=6K-:&6WN4=]Z,TF"J
M[3C.>FT8R>*])I"0HR2!SCF@#S2\AF>^^)I%C>-]LLXX[<BTD/GD6Q0A#M^;
MYCCBNV\+[QX3T=9$DCD6RA5TE0HRL$ ((/(.16M10!YYXO@@N?B5X7EO-,N+
MRPM8+L7#"PDGC1G5-F<*1G(/TK.M] O9?%6OKX5M+G2=#N](DB<2PO;Q/>MD
M*\<; $8&,L !Q7JE% 'F"6USKGA/P?H\5C=6FJ:7>6C7*R0,@MA ,2-N(VD$
M A<$[MP]\:7A93#'XU>:SNHS-JD\\1>UD4RQF)%!7*_-R&'&?UKN]ZD*=PPW
MW>>OTI20H))  Y)- 'E<6FZD/A%X4-KI]R;C2;BSN;RQ,#)+(D39=0A ).?F
MQWQQFNABM!K?Q%AUNUBE_L^+27M9Y)86C$S/(&5,, 3@!B?3('K79[AD#(R1
MD"EH \A.A>(+#1 T-M.\G@^])TQ1]Z]@+9*_A P08[Y':MSQ-8W^DV7AS4FL
M[R^BLKJ2?4X;!G\W=,C!I$VD,0K.>!_"?2O0J* /*]=M+&Y\.?:](T/4TCO-
M8L[B4S03233A)%+R,C98*%&,G&<'C&,^IH5*AE& >>F*6DW#<5R-P&2* . \
M;6LYUJ:^TFZO['6(=/&QA:M/:WR;G/D.NT@L#G&"&Q)QFGZ:US_PLC[??:=/
M!GP[#%*4MW:-)1(SO&K 8) (X!KO:0L 0"0"3@9[T >1^&)+S3M!\%V=UI.H
M6X2WN8I;M-/=[B!]PQ$ 5)C#CJV/X1@CJ(K"WO(OA]X6LY-,U))[/Q&DDT;6
MDA9$6YD<L< Y4*0=W3GJ>:]BHH X[2EE'Q3\03M;W*P2V%HD<S0.(W9#(6 8
MC!(W#OWK7\8*[^"]<CCBDEDDL)XTCB0NS,R$   $DDD5M44 >;0PS_VK\.O+
ML[R,6VGSQ3O]ED @9H$4!_E^7YE/7'2J?A*&"2RT?0=9\/ZPVM:1,A+3-.;9
M6C.!.CEMF-N2 .23C&.:]3WKOV;ANQG;GG%.H \PL-)OM1\"^.-/M+6>"^O-
M0OI(!/"T/FJY^4@L!D,.,^]36EW9:S:RZE;>$]7EUBSL)U:'5//"JQ0@PJ9"
M0^XX'';DX. ?2-ZXSN&,XSGOTI: /+= DG?QGX;U V6J>2='FMY&>P>&*"3=
M$?+"[1L50IP3UQ@,QJ"2RO;WX:>/+.'3[W[5<ZA?3P0O;.C2HTFY2H8#=D=,
M5ZS10!YMJVH-:^+;/7;G3=;ET2]TU;97M(YTEMY5D9OGC3#A6##J.JCBA=.M
M['Q)X&2PT2[L["V-\_E&&206XD7Y"[8.PL23@G@G%>DTA8 @$@$\#WH 4
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M&W2M.;8-&W%PK[MF,9('4DXQ5C3]*OM2\%>/-/M+6>WO;W4+Y[?SX&A\T/\
M=(+ 9##C->G44 >;V$^E:] ;V7POKAO[2RG2X2]\\&(-&0\49<D.6. -O;G@
MX!KV-CK$=GK&CVES=ZMI#Z),MG+>VQCN;:0C:MN6(!?(YY&1M&>V?4** ,+P
M9,9O!ND*UO<P/#:10NEQ"T3!E10WRL >N1GOCCCFMVD!##(((Z<4M !1110
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M"E\+46/P0L: *BWUZJ@=@+F2JGBAY;/XG>&KJRT\W=X]A?*(T=4+X\K&YCP
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8.0P RIRO&.#Z5!H]UJFE^(_"ME)JDMU9ZKI<K/;O&BI"T21%2F!NZ.0<DT
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MNX93D'D'!S^&KX&75;KP_IVKZEK$UZU_IUM*86B15B<H"Q4J 3G(SGN#C'0
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M'O=U+@,D:X.9&&0.#0!MT5Y5JGB77K7PQXZ,5]=6]QH\T9M'F2)I41XT8HV
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M20<YSBDU34/$#/X^,/B"Y@70U6>S"0Q?\^XEVME#E<G'8^] 'IU%4]+NGO\
M1K*[DPKW%NDC;>Q90>/SKSRZ\1ZY#X"\0Z@NJ2_;-/UR2TAE,<>3$+E(PI&W
M!^5CSC- 'I]!.!FN O9];O?%GBC38=?N;2VL["WN;<10Q%HW82Y&2IRN5&<\
M].1W;H7BB_\ $=UX:TR2Y:VDN]"&JW<L( :5B50*N0=HR68XYX Z9H Z[1==
ML]?ANI;(3!;:YDM9/-C*'S$QNX//?O6G7DV@:I>Z/:W.FPW#27&H>++RT:Y<
MJC8"LY/W2H9M@'3')P.E7]?N_%^@^&]7GDU6-#'>VOV%\I+*(I)51TE^0# )
M.".??B@#TJBJ&DV-W86\L=YJ<^H.TK.LLR(I13T3Y !@<]N]7Z "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *R]<T*U\06L-M=R3I'%.EPOE,%.]#N4G@]" :U*I:IJUEHUJEQ?3+$
MCRI"F3RSNP50/4Y/\Z *$GA33I]2U"^NC+<MJ%L+2YCE(,<D0SA< #'WFY'K
M1I_A:ST]K1OM-W<FRC:*S^T2!_LZD8.WCDXXRVXXXSR<P0^(ISXXO=%N([:.
MS@T^.\2<.<G>[)SG 'W?UZUT$DL<49DDD5(QR68X _&@#FQX%TP:+'I(N+W[
M)'=_;5'F#(EW^9G.W/W^<47?@/2+O7)=6\V_MYKD*+N.VNFBBN]HP/-5>&XX
M[9KIE8,H92"I&01WILLL<$9>61(T'5G8 4 .VJ4V;1MQC&.,5S]CX,TO3TM[
M>)KEK"UG^T6UD\@,,,F205&-V 22 20#T P,&JZ]=6'B[0-*2&!K34A<;YBQ
MWJ8X]PP.F#QS6\)HC#YPE0Q8SO##;CUS0!F6OA^VL_$%[K4<]R;J]5$G5F!1
ME3.P8QQC<>GKSFK&I:8FI+;;KBXMY+:;SXI('"L&VLO.001ACP1BK2SQ-#YR
MRH8L9WAAMQ]:IW6MZ?9WUC93748N+V5XH4# DLB,[?@ OYD#O0!FW7@O2[K3
MOLC/<I)]M_M#[5%)MF^T?\],@8SCC&,8XQ4?_"!:$\>L1W$=Q<IJZHMVL]PS
MA]BA5(YX;@'/7/3%=&TT2RK$TJ"1^50L,GZ"AIHE<(TB!B0,%AG)Z?R- '.P
M>"-/BT6\TN6]U.ZCNX3;RS75T99/*(P44G[HP3T&??I5E/"UFNH:3>FXNFFT
MJ%H+;+K@(P 8$8YR%49]JW*Y[4M>NK#QEHND>3!]COX;B1YF8[U,2J>G0#YA
MSSTH T-<T:W\0:/<:7>/*MK<+LE$3!2RGJ,XX_"K%C9KI]A#9QRR2)"@C1I"
M"VT# R0!GBI1/$45Q*A1AE6W#!^E/WKNV[ANZXSS0!S3^!-&FT;4=*N1<7%K
M?W+7DOF2?,LS'<71@ 5.<'CC]:5? VD/H5WI-\][J,5T%$LU[<M+,0IRF'/W
M=IY&,<Y/<U+XRUV[\.>'SJ5I!#,RSPQ,LK$ "214R,=3\WJ*W'GAB=$DE1&<
MX168 L?;UH YA_",>G22:Q:3:AJ6LV]A);6_VN]8"0'Y@C$8') Y_'KS7-^'
MM#O84L(;!_&%C-;>4KQW]RC6J*I&Y<$MN7 ( 7VY'4>FF6,$@NH(ZC/2D\V,
M@'>N"< YZT <W'X"T>#7)]3@>^A%Q-]HGLH[IEMI9>N]HQP3G!/8]Q3+WX?Z
M/>RZJ1-?6\.K _;;:WN"D4K$8+[>S$=<<'N#73+/$TC1K*AD7AE##(_"I* (
M;.UCL;.&UA+F.% B[W+M@>I/)K"/@RR%C-IZ7^I)ITY<SV@GRDF\DN,D%E!)
M.0K <FN@DFBA"F61$W':-S 9/I6 _B&XC\>)H;QVZV+Z8]\+C>=V5D1<'L!\
MQ]: +/\ PC5DFN0ZO#)/#<0VALHEC*B-(<@[0N/4 _AZ<5FQ?#_2((-.CAGO
MXVT^:6:VECN"KKYIS(N0.58G)_3%=.\\4</G/*BQ8SO+ +CZT[S(]BOO7:V-
MK9X.>E '+K\/]'CM4MHIK^.*/4/[111<%MLVXL"-V> 23COGG-6M>\':=K][
M:7\TU[::A:J4CO+&X,,NP]4)'53Z?E6VUS;I")FGB$1. Y<8S]:P]2U^ZL?&
M>BZ.(8#::A#<2-,6.]3$JG&.@'S#GF@"8^&;5#&;6[O;39;FW(BE#>8A))W;
MPV6R2=WWN3SR:T["PMM+TZVL+.(16MM&L448_A51@"IEDC>(2*ZM&1D,#D8]
M<U1U34&MM!O=0LA#</! \J OA&*@G&1GTH PD^'6B1Q00I+J*P6UY]MMHEO'
M"P.2Q(0 \ [F]^>M:NF^'++3)=3>-YIAJ4IFN4F8,KN5"DXQQP ,=.*?H.K'
M4_"NF:O=^5"UU9Q7$@!PBET#$ GMDU3\*Z_<ZY'K#7<4$)L-2ELU\ERRLJ*I
M#$GUW'L* (] \#Z5X<N!)93:@T,98V]K/=O)#;9SGRT)P."1GDX)]36MK.C6
M.OZ9)I^H1&2!R&&UBK(P.596'(((!!%6UGA>'SDEC:+^^&!7\Z1KF!%+-/&J
MAMA)< ;O3ZT 90\,VK)=F>YNKBYNK?[+)=2LOF"+GY%PH4#DY(&3W/ Q=TC3
M(=%TFUTVV>5K>UC6*+S6RRHHP!G'. ,5<!# $$$'H13))X8G1))41G.%#, 6
M/MZT 4]7T6PUVW@@U" 2QPW$=R@/9T.0?Z'U!-%OHMA:ZU>ZO#"%O;U(XYY/
M[P3(7]#^@]*NRS10*&EE2-2< NP&3Z4K.J8W,%R<#)QF@#GV\&:<]CK5FT]V
M8=9=I+P>8,L64*V./ERH X]*G/ABT;4-(OFN+II]*C:*V)=<;6 #;ACG( 'X
M>O-:S7,"QI(T\81R C%QAL],'O3I9HH%W32)&I.,NP S^- %;5M*L];TJYTR
M_B,MI<H8Y4#%<CZCD55L_#]M;7*W5Q/<7]RD)@CENV5BD9QE0  .<#)QDX&2
M<5J-(B8W.JYR1DXZ=::+B B,B:,B3_5G</G^GK0!SNA^!=)\/78EL9;_ ,A&
M9H+.6[=[>W)SDHAX'4^N,G%;.IZ;'J=O'$\T\)CE65)('VLK+T]?R/![U:DF
MBB*"25$+G"AF W'T'K1)-%$"9)$0 ;CN8# ]: ,&[\&:7?:?>6MPUPTMY<)=
M2W:R!9O.3;L<%0 I4(H&!CCIR:9'X'T=9M1FF-Y<OJ5J+2[,]RY\V, CG!'.
M&//;MBM:\UBQL+RPM;BX19[Z1H[=,C+%4+D_0!>ON/6KU '-/I-OX>@MK_R=
M4UB2R406R9622!&PI*CY<X&,DY; QZUGZ9X+M]0\,:II^N6[&/4=4N;]4#;9
M(=\I:,@C[K 8/MG%=EYT7G>3YB>;C=LW#=CUQ0TT2-M:1 V0,%AG)Z?G@T <
M\/ ^D2:#=:1?->:C%=A1-->W+2S-M.5PYY&T\C&,')[FG0>#--CT2]TNYFOK
M^.]A,$\U[<M+*R8("ACT R<8[G-=%3%FB>1XTD1G3[RA@2OU':@"#3K%--L8
MK2.6>58QCS)Y"[M]2:RV\':/)<:O)+%++%JP_P!+MGE8Q,2H4L%[,0HY]N,5
MG^)?&B:?X2UG6-%^S7DFF2&*02.=FX%0V,=<%L=N0>:ZQ98W=T5U9DX8 Y*_
M7TH R-.\-VMA/;3O<75Y+:1&&V:Z<.84.,@8 R2 !N.6P.O6I=>T"S\16,5K
M>&9/)G2XAE@D*/%(ARK*?7K^=:*S1/(\:2HSI]Y0P)7ZCM0LT3OL61&;!. P
M)QG'\^* .7G^'VC7,.K122WY35@@O ;IF\S: ,\YP3M&3UXP,#BKUUHD5KJ?
M_"1*;V[U"TLG@CB1DS*G#%,8 RS*.<CGT%;I( ))P!U)ID<T4T?F1R(\?]Y6
M!'YT <[X=L3<ZK?>)KG2GTZ[OXXH1#-M\T1H#R^TD!B6/&>BKGG@;M_8VNIZ
M?<6-["LUK<1F.6-NC*1@BI!/"P8K*A"C+$,.!C//X4L<L<L8DC=70]&4Y!_&
M@# T?P9IFCVLEL);V^A>$VX2_N6G$<)ZQJ#P%.!]<#/05)IWA*PTT62+-=3P
MZ?G[#%<2!UML@K\O&3A20"Q8@' K:BGAG0O#*DB@X+(P(!_"E6:)WV)*C-M#
M8# G!Z'Z4 <V_@73)-&O-)>XO3:7EV;R8>8,M*7#DYVY W ' ]*MR>%K*35[
MC51/=QW=S;K;SM'-M60*"%9EQ@L S8XQSTZ5>L9;W%V=1:S7;<,L/D.3^ZXV
M[\]']0..E6Q+&V<2*<#)P>E '/-X(TI_#-EH)DNQ:V,B2VDBS8E@9#E2K =N
M>N>M,;P#H4J:NEQ'<W,>K(BW:3W+N&*@ ,,GAOE4YZC'&*V[K5;"RTR?4I[N
M);.!"\DV\%5 Z\U"UW=W+Z9/8&U-G.2UQY[$2;"A*[ ."V<9SVS0!0L_!NFV
MNDWFG3SW]_'>0&VEDOKII9/*((V G[HY/3\:9+X*TZ6VTN/[5J*3:82;>Z6Y
M/G ,NUE+'J" !CV&,5T+31+*L32H)&&50L,D>PHDFBB!,DJ(%&3N8# ]: .7
M/P\T06[11O?1,=0.I)*ETV^.<Y!*D],@D'U[Y/-.D\ :-)8:O9&2^^SZLX>[
M4W+-N. #@MG!.T9/7CK72RSQ01^9+*D:?WG8 ?G6'XFUZZT6;0Q;002Q:AJ4
M5G(SL<HKY.5 Z_=]?SH W(HC% D7F.Y5=N]L;C[G Q61IWA;3M/L-2L?WMS:
MZC++-<Q7#!@[2??[# .>G3TQ6W5&SEO0]\=0:S6..<B PN21%M!'F9Z-G/3C
M&* ,33? .DZ98W%E'<ZG-;RV[VT:7%X\@MHV&"L6?N\=^OO5T^%;"<79OI+B
M^DNK,V,DD[#=Y!SE 5 ZYR3UZ<\5M++&[NBNK,APP!R5^OI4$VHV5O:SW4UW
M"D$"LTLA<80#J3Z8H QH/!MA!/I$ZW=^TFDAA;-)/N/S+M;=D<Y4 >V.,'FK
M;>'+*3Q!/K,C2R7$]K]CDC<@QM#DG;MQZDGUY]*NV>HVU]I]M>Q2 0W$:R1[
MB <%=WYXJ=9HG7<LJ,N,Y# C% '/Z!X*TOPY*K64U_)%%G[-;W%T\D5L#U$:
MG@<$C/)P2,\FH?\ A =(&@R:(LM\M@\XG\H7!.PB3S JYSA0_/'XYKIS(@VY
M=1N^[SU[\4P7,!2-Q-&5D.$;>,,?0>M &3<>&+6;5FU6&YN[2^DA$$\UNZJ9
MT'0."",C)PP (SP:;_PB6F)=Z//;^=;C2$9+..)@$4,-K9!!W9'&3]>O-;4D
MT4.WS943<=J[F R?04/+''G?(JX4L=QQP.I^E ')ZAX(C.D7]IIU_J,$]]>_
M;6F2YV%)CU<D $KP/D'!P.G)KKF4,I5@"",$'O5&^UFPTY[)+FX17O9A#;KD
M9D8C/'L "2:OT <]8>#=,T]+:")[EK&TF^T6ME)(&B@?)(*\;L DD D@'H!@
M8N:3H%MH]YJ%U;S7#OJ$WGSB1@09, 9 P,< #TXK2,T0F$)D02L,A"PW$>N*
MP=6UVX37H= TPVRZA+9RW8DN06C4(RJ%(4@Y8OUSP >#0!;UWP]9^((K5;I[
MB*2TG%Q;S6\AC>-P",@^X)!'O65)\/M&DM-0M?-OUAU"Y2ZG7[4S;I%VD'YL
M]T4D]3CTXKH+.2^ETN&2[@A@OFB!DB5RZ(^.0&P,C-<]X(\9GQ9'J,5S9BRO
M["?RY8!)O!1AE) <#AN>W:@"[>:5'INHW/B>*._OM12R^S^1$R9EC4E@H7 &
M=Q)SD=?PIOAK30MWJ>O3:<;"\U:1&>%]OF*B(%0/M)&[[QX/&0.U4QXRDG^(
M_P#PBEK9HT<=J9YKMY",,"N450.2 Z\Y[D=JZKSHO.\GS4\W&[9N&['KB@"E
MKFCVWB#1[G2KQI1:W*[)1&VTLO<9QQ5'6?"6G:]I=K97SW)>T=9+>[BE\N>)
MP,!E=<8.*OV.LV&I&]^RW*2+9SM!,P88#JH+<^V[!]P:N>=%M=O-3:G#G<,+
M]?2@#%B\*VMO;6L<-[J"36\IF^U-<;Y9'*[27+@AOEXP1@8& ,"HIO!>DS6E
MK#_I,;V]XU\L\4Q24S/NWL6'][<V0,#GC&!6^)8VB\U9$,9&=X/&/7-"2QR,
MZI(K,APP!R5/OZ4 9>G>'K72]4U'4+>>Y,^H%3/O<$950JD#'&% 'OWS6<_@
M'19= ET:;[5);/=&\1S+B2&<L6,B. "IR2?Q/:NE6:)Y'C61&D3[RA@2OU%<
MUI6OZKJI\3V\=O917FF7+6UKO=C&Q\I74N<9QEN<"@"=_!FF3^'KG1[J6^N8
M[DJTMS/<L\[,I#*=YZ8*@@#CVY-3KX9M%UJSU7[1=M=6D#6\9>7<"C$%MV1D
MDD Y]N,58&LVT-[8:;=3PC4;J$RB.-LC"@;F&>=N2 /6KPGA,QA$J&4#)0,-
MP'KB@#!M?!>E6:+;Q-<?V<EQ]JCT\N# DF[<"!C. WS!<[0><4Z7P?83'7-]
MQ=_\3M0MZ-Z_,-FS ^7Y?D^7C^?-;C3Q*0&E0$MLP6'WNN/K4E %>PLTT_3[
M>RB=WC@C$:&0@MM P,GZ5S=Y\/-%OEU**66_%MJ%P+F:V2Y98Q+N5BZ@="2H
MS^F#74O-%&Z(\B*[\*K, 6^GK1)-%$/WDB)QGYF X]?U% &,OA:S34=0OTN;
MQ9[^W2VF/F!LHH(4#(/(W-SUYYJE_P (%I*VVDQP37MO-I*&*SNH9MLJ1D8,
M9.,,O X(-=34:SPM,T*RH95&60,-P'N* .8?X>:#+I%[ILJW<D5W>&^:1[ES
M)'.3G>C9^4CU'7OFI9? VFSZ')I5Q=ZE<1RR)+-/-=&2:0H0R9<Y( (! &!^
M9ST1GB5@IE0,6V@%ADGKCZTX2(6*AU+#J,\T "*515+%R!@LV,GW.*=2*RN,
MJP8>H.:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "N(^*,5LWANQFNHXC'%JUD7>51A%,Z!B2>@Q
MUKMZ9+#%<1-%-&DD;##(Z@@_4&@#SPZ?HNL?%&]@FM[.ZL1X>@,<3*K1;?.E
MY"].AX/;/'6N:T'5XH-$\ G6]0^S:3-IDT27,H1HEN0RA0Y<%0=@< GW'K7L
M3:=8M(TC6=N788+&)<D=,9Q2-IM@]J;5K*V:W8Y,)B4H3ZXQB@#&\$V&FZ;H
M+6^CWTU[I_VB1X9792F"<E8RH V D@8]ZQM=U6PL?B;:P>(9((M+FTIA9O=D
M"'S_ ##Y@RW&[9LZ]LCOSW2(D:*B*JHHPJJ, #T%1W5G:WL8CN[:&>,'<%E0
M. ?7![T >:SZ=HG]N_#[3+-3-I(%^L*7#EQ)&(^.I^9#VSP1CM6=:7.E:;I-
M]8S1QK:IXR>"TC\SR[>!L!UWXX\L'<=O<X''4>M265K-*DLMM"\B8VNT8)7'
M3![5'_9>G^4\7V&U\MR"Z>2N&QTR,<T >+:E+83>!_'ENUS9S&+7(9HC#A54
M,;?+H,G:"2W(///-=5XCT3P[H?C#PA(MAI]I9S7EV]PS(JHS&V;!8GC)('X^
M]>@R:?92[O,L[=]Y#-NB!W$# )XZXXJ1K6W:..-H(BD1#1J4&$(Z$#MB@#R4
MMHNM/K^F>(=:EL-8AU9WCB01)<L!(&MS 64L<IL "^X[UM:%H>C7OQ+\7O<6
M5M++:7-C<0[E'[J3R0=X'9L\D]Z[Y[*TDNTNWM86N4&$F:,%U'H&ZBB.RM89
MFFBMH8Y6SN=8P&.?4T 1:7JVGZU9+>Z9>0W=LS%1+"X9<@X(R*Y#QA:6-[\0
MO!]OJ44,MK)%?*T<V"CG9&0I!X;IT/I76Z7I5OI-M)%;HJ^;(99"J!06.!P!
MP!@ #V'<\U8NK2VO8?)N[>*>+.=DJ!ES]#0!Y;:>#8]5T/Q9INF1QI8P:G]H
MT)F *13HBLVS/ 3S0RX''WJZ'P[>7GB:RG\56EC!!J$ENEI:1WBE0A7F7) W
M >867_MF#WKHM8M=7>TMX=!O+.Q9) )#/;&5?+P1A5#+@],=N*N:?91:;I]O
M90EC'"@0,QRS>I)[DGDGU- '!^.9-97X<WAU\:='-]NL]GV)W*;?M$77> <]
M?PK$^(5[ILR>.8(W@AOH+*$2-=/NDD(0N@@7(V@9R6&><\#&:];GMK>Z0)<0
M13*#D"1 P!_&F-86;,6:T@+&/RB3&,[/[O3I[=* //M=-OIVO:+XGM;6+4(=
M6M&TJY5%#B9V&Z$DCL64H3TPP]*;X&TV6&=?"E];HZ^&;IY5F\K"RAQF!AGO
MM>3/<%%KTCRH]B)Y:[4QM&.%QTQZ4H1%=F"J&;[Q Y/UH \R\.23:9X@T6&=
M;+5--O&N7T[5H?DN(LJSNDX[]P6!^\!D9KT/3-5L-:L4OM,O(;NU<D++"P92
M0<'GZT^'3[*VE>6WM+>&5QAG2( M]2.M1:5I=MI%H;>V15#2-(^U0H+'K@#@
M#H /0"@#D_&<%Z^M1W6ERZ==75M82>?I.HCY+B!F&XHW\+#;@G!'(S63IR:7
MK_CCP[YU@OV.7PL9$L[H!]H,L6T,#PV!ZCMFO2+G3[*]*FZM+><K]TRQAL?3
M(H>PLY)C-):0-*1@NT8+8QCK]* /)/#NH:;!X;\'6ER\2R"^U!;26ZEQ;0B-
MY%^<9^8A6 5<CZC%4+?^SKOP?HEO++;R_9_&/DC:0OEQM<2?*!G*J1V]*]H&
MFV C6,65L$5Q(%\I<!AT;IU]Z'TVQD&)+*W8;B_S1*?F/4].I]: /.M3BT+0
MO&RZ+J$EKI&B3:9FQ5XXQ;F0RN9U^<%58@IQQQ4,>DZ4FO\ P_TE)Y=2TY+7
M45B:](<S1@)MR  &7'W>,%0*].N;&TO(EBNK6">-2"J2QA@".A -$EE:2S++
M):PO*N-KM&"1CT- 'CUM<+I^E16P")H%OXRN+>Z1?]7%#O;RU8=!'YA4^G2N
M@O+?[)XK\7?V?M32GT$2W:Q\1K='> ?0,8P"?;:3VKT!+"SBBDBCM($CE&)$
M6, ./<8YHCL+.&T^R1VD"6W_ #Q6,!/^^<8H \OT?48(+OX>6^K/&FD2:"#;
MM*1Y3782,#)/&X)NQG^\<5DPZC8:;I.J?9YXXM&C\8N;XVX5UBMVC&UBN"/+
M\S9VQQ7LDFFV,MJ+62RMGMP=PB:)2F?7&,5(MI;+%)$MO$(Y,ET"##9ZY'?-
M 'D7BK3_  ZO@GQ3?:7JHU"*XN+.:1XVC-O#+YJ*3&4 "N5Y;'/(]:Z/7O#T
M>G:E8_\ "+)I,%[LN9VTR[CQ#>JWE"1LC[KC:GS<]3G@FNV&F6"VJ6HLK86Z
M'*Q")=BGV&,"B?3;"YCCCN+*VECC&$62)6"_0$<4 9W@Z\@O_!ND7-K9O90-
M:H([=SDQJ!@#/<<<'N,&O//B#>Z;-_PG%NCV\5]!IT(D:[;<\A",Z"!,C:!G
M)89Y[<9KUT *    . !4,EG:RRM+);0O(R&-G:,$E#U7/I[4 ><ZCK.F0^+=
M.O+Z_L+RSNM!:,6]Q=1H Q<9<&0A6#X*G!S\G3%90\.:7IVE?#JPF?3[UFU!
MDGN("K)/F&3<-P^^,A5.>N!GTKMM5\-ZG/K;WEI)I-Q:20I$+34;,R"#;GF,
MJ1C.>01V'/%:6E>&K#3K5D>TLGEDE,SF.V6.,,0!\B<[1\H[GG))R: .#OH?
M#UEXIU?PWK5W;Z/IC:?$FG)*L2Q&$AO,"-(I 8.<G')X]!AC3:59^((-'UW5
MY8=+DT2&/3KG4UBQ,H+B7<TBX#D&//0D 9KU*YLK2\,9NK6&<QMN3S8PVT^H
MST-%U96MZBI=VT-PJMN42QAP#ZC/>@#S&#1='C\6>![%&?4+3^S;Z-9;T*SW
M$:F/R]W #+C.W(Z8K#O-.TRW^&WBN[BM[=9M-UZ9+*4 9M56Y0A8S_ .3P,=
M:]JDLK6699I+:%Y5Z.T8+#\:C_LK3@A3[!:["02ODK@D=^GN: /-M7FT74/%
M'BK1?%6K)IXF2+[(9_*4/;&)>8G=3\PDWGCO4]GHFD7?Q+-I>6RWD1\,VS2"
M^0%Y&$KKOE7&"^,9)''M7HDFGV4S0-+9V[F#_4EHE/E_[O''X4KV%G)*TKVD
M#2,,,YC!)&,<G'I0!XWHIL'T'X776IFV:!7N87FN=I7:(I0JDGMD# KVO.5R
MOIQFH%L+-(UC6T@6-7$BJ(P &'\6,=?>K% 'C(+7_P ('N<!?%]O?G+\"X2^
M^T8 ]>5.,=-A]!70Z/H>CZA\4/%IN[*UFEMVT^XC!4?NY=C'>!V;('/7\Z[W
M[#9_;/MGV6#[5C'G^6-^/3=UI8[.UBG:>.VA29L[I%C 8YZY- %#Q2^H1^$]
M7?2@QU!;.4VP3[WF;#MQ[YZ>]<&4L[G3/A]?^'A&+U[J%)&BQO>W,9-PLG<X
MQSG^+'<UZE5>&QL[:>6>"U@BFE.9)$C"L_U(ZT >,:@--M_AM\1((EM8KM-4
MN@40*KK'YR;1@<A>1CM71:M:#2?'NH)X>@C@O+CPM<RHL( ,TZR#RV/]YLD\
MG).:]%DL+.4N9+2!_,8,^Z,'<0, GCDXH2PLXY5E2T@611A76, @8QP<>E '
MFWA6/PKKL_A[4+/6#-?PVSQ/8QB(,59,2+<*%W%01U;^+')SS?\ A)H^E)X-
MTW5H+2#[<5N(#<J,OL\]ODSZ<#BNY33[*-YWCL[='G_US+$H,G^]QS^-206M
MO:H4MX(H5)R1&@4$_A0!R/Q$NI+6VT)Y?^04=6@742?NB(YQO_V-^S.>.E<[
MXGL8H]6\:K:1Q?V3)X:::[C4#RQ=_/Y;8Z!]@SZ\*?2O4Y(TEC:.1%=&&&5A
MD$>A%0)IUC%:?98[.W2VSGR5B4)GZ8Q0!YIJ6FZ3I'@'0-4M?L=H9[C39KQI
M'"+?!0#L=SQW+9;CY>:@NUT"'3/&_B21[2XM+X0IY&GW49EC0A4;=(A(0._+
M8R,#)R<BN[\0:#=7]K91Z5-9VPM9C*;6XMO,MYQM(VNH(/!.X'U .#3-'\,K
M;73WM]:Z4MP\+0&.QM/*0HQ!(;))?E1UP!SQS0!P4T]A+K?C:V>YTR:.X\/1
MR>7:@")F43=!D[BH ^;V' JSI%E86&K?#&YM888;B\L)4GE0 /.OV56PQZL
M0,9Z=J]._LZRV;/L=OMV"/'E+C:#D+TZ9YQ2#3; %"+*V!C^X?*7Y><\<<<T
M >::1>Z%HOAOQ1<ZA:PW%M;>)+K[/9JH;S9CA4C5>A))X';KVJ":PTCP[X3O
M[O7%MY=7U>:"2\BM)!%' IE0)$6 (6%20&.#N^;K7J/]E:=L*?8+7:2"5\E<
M$^O3W/YTJZ98)')&MC;*D@VNHB4!AZ$8YH \@OY;6>W^*-J+BQN2VFQ7$:6R
M@(6$#AG1<GD84%O4#I6[<#2FUOX<3V M,>=,@D@"X/\ HKY&1[X_&O1DM+:,
MDI;Q*60(2J 94=!]!Z4S^SK$B(?8[?\ =#$?[I?D'MQQ0!Y4YBU#X>>+SJ0"
M^(K6]N6W=)TG#9MMA^]C'EA<=1P*OVNCV6H_$+4H=;LK2>=O#UK)=1R(I4S;
MI S$=,^_45Z.]C9R7:7;VL#7*#"S&,%U'LW6D;3[)Y6E>SMVD<89S$"6^IQ0
M!Y/X;U/3Y=%\"V][- +LZ1,T=Q?R9MU0%$8;"1ODP  ,C"[OI4.D7D,OPY^'
MRBY1VBU^&)OFY4AI<*?3 QQZ8KUY=.LE$86SMP(FWQXB7Y&]1QP?>D;3;%T5
M&LK=D4DJIB4@$G)(X[F@"U7B>LV]DOP_^)$8CA6.+7BR   (V(.1Z'.?UKVR
MJG]EZ?M9?L%KACDCR5Y/Y4 <!?V6F:5\0]0AMRFG6UQX7GEN9+8!6)$H_>G'
MWG +'<>:S6CN8-+U_1=5T_3;J=?#DLMKJ=@@$=S"H(0.G\+@G(P2#SCI7J7]
MFV(??]BM]VW;N\I<XQC'3ICBG6UC:68<6MK! '.7$487<??'6@#RH6>@ZC<?
M#2-8;&:&6.6*8(%Q(?LF2K8Z\XR#Z\UH1PZ+X?\ ''B/3REI96LFB6JP0-A1
M(%,JX4'[QZ#N>E>A_P!F6'[O_0;;]V,)^Z7Y><\<<<U)+9VL\\<\UM#)+&"$
MD= 64'K@GIF@#Q[0+?3=13X5"5+>??8W,,@.#N"P#*-Z@'L?>H-0TG2H_ 7Q
M#DCM+8/I^J3_ &,A1_HN%B8>7_<^8D_+BO9?[.LLQ'[';YB $9\I?D Z <<4
MW^R]/"LHL+7:QRP\E<'Z\4 >;ZM=Z1>^+=<TKQ1JL5C;W5A!]B>X\H)) 4/F
M;&D4@,'R>#GIZ</L=$TB?XC:79SQ&^A_X1GDWZ!I)PLR!6E7 #''J/U%>CR:
M=8S+"LMG;R+ <Q!HE(C/JO''X4KV-G+,9I+6!Y2,%VC!8C&.OTH \:TY=/\
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MB#1HKBQE@ ^Y#<%D\[9_=."I..Y/O6MKNCG1_%[7'@NW2&[FT&\>Z2V'RNX
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M48 R3[<]*ZL^(M/:TL[BV:2[%[#]HMTMXR[R1X!W8[#YEZXY('4XKFX[:_\
M^$Q\27\FFW207>EV\,)V!MTBB3<G!ZC>!GIUYKG;'1]6T2S\*ZA=>&IM5@MM
M(&FWUBJ(TUNX((D16.&'!!P>F* .T/C_ ,/?9M-G2YGE342XMA%:R,69 2R8
M"\.-I&WKGM4\OC+2XM-^WE+QH4MUN9PMJY:"(Y.Z1<9' )QUP,XQ7/7&F7"Z
MQX0N;3P[]@M;:\N+B>WMHD MU>)D!?:<%B6!.W./?&3'J5C=:9XVU:XNO"CZ
M_INKK$T4D*1.T$BH(V1Q(1A2 #G..30!UTOB33E\D6[2WKS6XND2TC,A,)Z/
MQV/;N>< X-8/BGQE"GA73M0T::2>'4KNW@2X@C9MJ-*JOV^5\%@ >0?<5#I^
MG7WAKQE-J!TPMIE_IMO 4L(]RVDL.[$80<["&."!C(YQ63/X:U2P\&65JEC-
M+=3>($U22WBPWV>+[1YA7.<9"XX!Y.<9ZT =YHFGFQBG=;V_N(+B3S8HKUBS
M0 @90%OFQG)PQ.,U+K.M66@V0O+]G2W,B1%UC+[69@JYQTR2!GWJNNNL?$Z:
M.VFW:1R6IN([Q@!&Q! *8SN!&1U'?Z9H?$+3;S5?!=Y;V%NUQ<K)!,L*D!G$
M<R.0,]\*<4 7[KQ/I=E?WME<23)/96HO)E$#MB')&X;0=W(/3G@U0L/'V@:C
MJ%A90S7"OJ$0DM));9TBG^7<55R-I8 \@'VZ\5SVHKJ5YXDUO6'T:\M;";PR
MUNLD^P%7#RMA@&)!P>@SVSC-1Z38S^)/"OP_@BLYX1IOV2]GGE3:JK'#@!3_
M !;R1TS@9S@\4 =?<>+](MB7EED%H+C[*UYY1,"R[MNTOT'S?+G[H/&<U!?>
M.-&L+O4K1_MLEQIR))<QPV<KE58,=W"\J I);ITYR:Y"+P]JX^&VH>!)["9[
MMI9(8+P@&&2)Y2XF+9X(#'*GYLC@'-:T>G7MOXD\82_8KIX+O3;:WM9=F?.>
M-)58?FZ\G /- ';V=W!?V4%Y:R"6WN(UEBD'1E89!_$&N3N_%3ZA=^*='MXK
MRTDTRV&VY6,@[S&SY!(( P%QGKS[5J>"K:XLO!&AV=W \%S;6,,$L;CE75 I
M'OR*P9;'4[7Q+XT;^R[F6#5+2$VT\>TJ2L+(5ZYW;L=NASTH L>#/%]I=Z-X
M:TZ[GNGU*]TV*19IH7V7$BQ*T@$A&&8<D\^OH:V)?%NDP7=M#+)*L=S<?9(;
MDQ-Y+S9(V!^F<@@'H2,9S7)V.F:E%#\-D?3KH-I,.R^^3_4G[*8N?7YCVSQS
M4/AC2;K3XX/#NJ>#([FZL[@F+5WBB>W>,.664L3N$@!Z 9SW'4 'HNH7J:=I
MUQ>R1RR)!&9"D2[F; S@#UKF;#X@:;)X?T34=1CN;6755011BUD8,[)OVJ0.
M>,X[GMFNFU&%[G3+N"/&^6%T7/J00*\XM+#5_P#A'/ %K+HE[%+I%U#]K5@I
MVJD#QL_#'(W,,=R,G'J =4WCO1EM'N<7FV*U^V7"&U</;PY8;I%(R/NMQR<
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M+-' S8P'8=/O+GTR,XJMXG\06]MI6K6]M-=?:K:T:622TC+FW!4E6)P<9QG
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MP>">S#KBNLH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&KI-.2\BTZVCU":.>\6-1-+$FQ7?') [#-60 !@# %% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%5;K4;6S<)/+M<HS[54L=HZG !..G/J0.IH M454TO4[/6=
M,M]1T^;SK2X7?%)M*[AZX(!J6VNX+M7,$@;RW*.,8*,.Q!Y!Y!^A![T 3444
M4 %%%% !115>:]M;>ZMK66=$GN2PAC)YD*C)Q]!S0!8HJAJ^M:?H5FMUJ4_D
M0-(L8;8S?,Q 4< ]20*%UK3WUQ]%6?.H)!]H:'8W$>0N[.,=3CK0!?HHHH *
M*** "BJ=GJEG?->""4G[',8)RR,@5P 2,D#(P1R.*RE\;^'WU.VTX7LGVJZV
M&W0VTH$JMG:ZG;@KQ]X''3GD4 =#1110 44=Z* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **J:=J=KJMN\]G(SQI*\+%HV3YD8JPPP!Z@\]*
MMT %%'2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***.E !153^T[
M7^UQI7F-]L,'VG9Y;8\O=MSNQC.>V<U;H **** "BBB@ HHHH **J:GJ5KH^
MG37][(T=M" 7949R,D#HH)/)["K,DBQ1-(Y(5022!GCZ4 .HJEI.K66N:9#J
M6G3^?:39,<@4KNP2#P0#U!J[0 445'<3QVMM+<2DB.)"[D G  R>!R: )**@
MLKR#4+&WO;9BT%Q&LL;%2I*L,@X/(X/0U/0 444A(49)P* %HJAI6LV&MV\L
M^GS^='#,\#G8RXD4X88('0U?H **CFF2WA>63=L09.U2QQ]!S6-8^,_#FI/;
MK:ZO;N;EBMN22HF([(2 &/L* -VBJ%IK6GWVJ7VFV\^^[L0AN(]C#9OSMY(P
M<[3TJ_0 450O=:T_3KZQLKJ?R[B^D,=NFQCO8 DC(&!P#UJ_0 444V218HFD
M<D*H)) SQ]!0 ZBJ6DZM9:YID.I:=/Y]I."8Y I7< 2#P0#U!J[0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<9X-NWU74
M/%^HSG,J:K+8)G^&*!0J@?\  F=OJQKLZYS2-)?0]?UA$C9K#5KC[:C*,^7,
M5"R*WH#M# ],EAQQD X'PQJGB#P[\/?"6K)=6LVD.T%K/8_9R'5)'V!Q)NY8
M$@XP!CCMD]A=73Z=\6M/@C_U.K:9*)D'0O"P*M]=KL/R]*LZ9X(M=/L=/TY[
MZYNM-TZ436MM*$ 5E)*;F !;:3D9[@$YP*F@TI[[QJVOS(R0VEH;.T5Q@L6;
M=))CL/E51ZX8]"* .BHHHH **** "O)?'5T]Y/<^([*.]>]\/72-8".UF:.1
M(R?M/SA2N&RR'G_ED.F:]6GC>6WDCCF:%V4@2( 2I]1D$?F*HZ9I":9H,.DI
M<23)%%Y0EE52[#'5L#!/<\<T <O\0;ZWU3X8B_M7WV]S-8S1-ZJUQ$1_.K/_
M #6?_N7O_;BFP?#NV@\%IX5&L:B]A'*DD;/Y9D3;() H.S&-P';VZ5LKX=0>
M*U\0F]N&N!9_8C%A/+*;MV>F<[N>M $.KZO.OB;2_#]K*()+R&:XDGVAF5(]
MHPH/&XEQR0< 'CGC,GUC7].?2]&OO*FU*^N+@+/9A=Q@C&X-MD*J)""N1R!R
M0#6IXD\*P^(9;&[2]NM/U&P=GM;RU*[TW##*0P(92,9!':JNI^![74],M89-
M2U!-1M9_M,6J)(HN!*1@L>-N"."N,8 &.* ,34-=\9:7IEI]JCM8)Y==@LHI
M)HU8SV\C@!F".0C<D''7MBG&+7X/B-H-E?Z\+C-E=RGRK58T.)(\?+D\[6QG
M/;CJ<[-UX*2]TZTM[K6=0EN(+R*^:[;R_,EEC(*9&W:%&/NJ!^9)-_4?#D6H
M:[INL"]NK>ZL4DB_<[<2QOM+*V0<<J.1@]>: .5N=6U;5O!7CY+J[C633I[N
MVB>&':#$MNK 8)//S'G-/BU'5-$T#P.L5U#+'?7%M:3;X!N$;0EL*0<#&ST)
M.:VT\&0QZ;K]B-2O/+UR626X;$>Y#(@1MGR\#: .<TZX\'Q7-AH=H^I7871I
MHYH&"QY=HU*KO^7D8)Z8ZT 48M5U[7X-5N]#N;6&2PU)[.*VN%_=RB)@LAD8
M L"?FV[<8XSG-4?%?BG5]%&K7<-U WV&XMUBM88_,4Q.4#&=L?(Q+-M (X .
M#6J? L$>MWM]::MJ%I::A)YU[I\++Y,[XP3DJ67=_%M(S4&H_#NUU!-:A_M;
M48+35IEN9;>,Q[5F&WYU)4M_ O!...E %&34;S3_ (A>)[RXOI9++3M(ANA;
M!%QM_?$J/3[N<]3] *N:7J7BNZO=(O!:&;3;R O=B0PHL)*;D,15RQ&>"&R<
M'/'2M0^$K9M>DU1[V[<W%FMG=0,4*7*KNP7^7.?G;.T@'TQ530O Z:$%@76]
M4NM/@!%I97$BE+<$$<$*&; . &) ],@&@"EX/\53ZWJ:VEY>O!J45LS7^DW5
MN(I(9<KAHSCYH_O#.6ZKS7<5S4?A,1RVUW<:E=W5W8V<MK:W!1!*@< %B0,,
M_P HQGCKQGFM#PY9WUAH%M:ZE=S7=U'O!FG(,C+N)3>1P6"[02.X/7K0!RC>
M*=7MM8T=9;J&=;W5I;&XA@BW01)B0IMEP"9 $&X9(R6&!Q4&L>+]:BL/$5W9
MR10WVEZDEG;:=)$'^T(QC 8C(8E][%=I ^4#GDUI0_#BV@MK"U36]4%OI]\;
MVSCW1_N2=Q*YV98'>W)R1V(KGU2[EUW49QJ?B72M2ENY&6T725N4P/E4I*T3
M+M*JI^^ ,XXQF@#<N;[Q3<>-I_#]KJMA L>F0WGG_82WS&5E8;2_0[#WXSWZ
MU'!X@\3:S:P:OHEF\L!OGB-L_DK$]NDC1L=Q?>),*6Z8[8/4[>F>'IX];B\0
MWU[*VIR:?':7,**@A^4ECCC/WF;OWJI:^ X+'5KF>TU?4H=-NIS<3:6KKY#2
M$Y;&5W!2>2H(!^G% &?-X@\3:K!>WWAZS>9K34)+5+9_)$4R12;)-S,X=6.&
M((  X&#UJ.]UOQ++J'C*WMM1M+==&BBFMS]DW%@83)M;+>V"?RQ6I_P@<$>M
MWE[::OJ5I9W\IFO=.B=?)F<_>/*EEW?Q;2,U:;PC$UWX@N!J-V&UN-8YP F(
MPJ;!L^7^Z3US0!BV'B/7&U7PA/=7%L]GXA@9GM8X-OD,(/-!5\DGH0<^M&F^
M(/$^MVVD:UI=F\EE=W \^"3R5C6V)(W*V_?O48)!&#R,"M>/P;#$?#A&HW9_
ML%-EMD1_./+\OY_EY^7CC'K4&E^ X-'OW-IJ^I+I1G-PNE%U\A)"V[@[=P7=
MSMSC/7/2@#F[SQ7XHM_#WB/6?MUEMT75GMQ MIQ/&K1C:26)7ACR,G/?'%:\
M<NJ?\+1UM(KQYHX-*@E@M650I+-+\N>V2HR>OX 5<G\ 6MQH>M:3)JE]Y&KW
M;7=PP$>Y68J2%^7 'RCJ#5VY\)Q7&MS:K_:5Y%-<6(LKA(]@651N*L?ER""Y
MZ$#I^(!F>#?%#Z]>F":_<7D-MF^TRZMQ#/;S97E1@9CZ@'GMR<UH7^LW%QXT
M@\,VDYM6_L]K^:=4#/MWB-54,".N220>@'?(L67AQ(-8@U6[O);V]M[5K2*6
M1%5O+8AB6V@;F)4<\#K@#)IVJ>'(M0UFRUF"YEL]2M$:)9HP&#Q-U1U(Y7(!
M'0@]Z .-G\:>(!I_D(]FNH6?B*+2+B1H24G1V7:X&[Y"589'/?&*[[3(-2M]
M.\K4;Z*\NPS_ +](/*4@D[?EW'H,#KS6+=>![.YL(;87MW$ZZBNJ2SILWS7"
ML&#-E2,< 8 '  KI\'9C=SC&['ZT >:_\)?XB/A*TOUGL_M;>(/[-D)MSM:/
M[28A@;OEX'N:OC7O$EE?>*M-S%JMWI]I#=V?E0>6S>9ORFW/S8V9'.3G&:NC
MP!;+H\>F#5;[RH]2_M,/B/=YOF>9C[F-N[G&/QJW/X16;5M2U)=5O8;B_AAB
M8QB,>6(F+(5^7KDGKD<]* .-\0^)I-7^&_B:[TK7Y)!!"BLDD BN8&)(DCD7
M QG(P0/7'3-;VJWOB6/Q7I_A^QU6UC6ZTZ>?[1+9[F1T9 #@, ?OXQQZ\UH7
MO@>QU2WUE;^XEDN-7MX[:XGC58R$3.W  QD%B<G.>.P J>+PMMUW3M8FU:]G
MNK*W>W'F"/$JN06+ *.<J.F,8H P9?$>M6VF^.@]W%)<:#$'MY1  &/V82D,
MOIN)'TJ9=;U^^\4:5I<%[:V\%[HAO6?[-N9) T8)&6P?OG Z#OFKNI^!8=1O
M-<E75;ZV@UJ#RKRWBV;781^6'!*EA\N. <''/&15FT\(QV>KV&I)J=X\UE8&
MPC$@C(:,E3EL*/FRJ\C'2@#DHO%?B9/"=KKT][9M]FU06%S EM@7*_:?)+YW
M?(<$$ <<=\X&M?:]XCU1]:_X1RW=IM-N_LL,;"'RIG549Q(6<,,[L#;C& ><
MX%L^ +8^''T,ZI??9WO?MQ?$>_S/-\W'W,8W\]/:GW'@:-M>N-5LM:U/3_MN
MW[=;VKJ([@J,;N5)1B!@E<'Z'F@#.FU?Q/>^(]<TR"]M+%;33H+N+-MYC1LX
MDRI.[#<IU].@YS5"+6-4U_5_AY>_;FM5U&RGN9H(T!3S!"N3SS_&P'IFNL3P
MI#%K&HZE#?7$;WUJEHT2JFR-$W;=HVYR-QZDU4@\"6MK:^'X8-3OXWT-7CMY
M5,>YXV4*R-\N.@'( /O0!1TWQ5<7/BX:/?W;:??K=S#[!<P!4N;<!_+>"3'S
M'[C'G^]P,5H^-=7U72(=&;2Y;=&N]4M[.7SHB^5D;'&",?YZ5/\ \(I'+<V;
MWE_/=Q65X][;)*JY20[L#<!DJ-YP/89)Q5GQ!X>C\0I8I)>7%M]CNX[Q#"%^
M:1#E<[@>* , ZGX@75)/#OVM[F^MK074MY:6T2%O,D<1C9(^  $YQDG(Y7O4
M_MKQG)J?AO2KLV&FWNHV=RUTOE>=Y4D14!E(?!!#9 SQGDG&*W==\'IJ^KVN
ML6FJWVE:I!$8#<VA7][$3G8ZL"I&<D<<$UAZMILEMX^\)064]XJVMM>"2Z:(
MR@O)Y9'F-C&6(8]1STQ0!GMXQ\46^F3VDTUBVIV&OP:9-/Y!V7$4C)M8#=\A
MP_(Y]JVVU+7XM8_X1Q[Q[J]2T:]DN[2VB1MK2,L:[)'VX&TY/)/'3K5V[\#6
MEUIXMC?7<<K:@NI37"!-\TZL"I.5( &U0 !T %2Z_P"$(]9U*SU6VU2]TS5;
M6,Q+=VA7+QDY*.K JPSR..#0!@WGBK7=&TS2)?%$$FE1R1RK?7MG$LZ0RA@(
MR^-VU&7)/7G R*N?\)!J>H7D&D6,YEN$TJ&\FO+%8G61Y"R@J)& V91CQDG<
M.1WV?^$<>(0_9M4NDV0O%*)E247&XY+N".6SG&, 9(QCBLJ;X=6,0TJ31]3O
M])N]-MA9QW%LRLTD.<[7#*5;G)Z<$T 41K?C ZGX5TV^%CIUYJ5O=?;(Q%YO
MEO$%PRD/@@ALX[=R>E9&I:WK>H>%HHY]1\NZM/%,6FS30Q!?M"+<* 2O..Q(
M'7'IQ7;'PE!_:NCZ@M_>"32TF6,,5;S3+CS&<E<DG&>"*I/X!M7TJ]L3J=[F
MYU(:HLP\O?#/O#Y7Y<8R!P0: 'KJFKI\0#H)NH&MCHQND9H/F\T2A,MAN1U.
M!CK7.:1XL\23:)X1UR\O+22'5KY;.XM4MMO#^8 X?.<@H.,8QZ]:[!?#(7Q&
MFN#4KLW2V/V'#!"I7=NW'Y?O;AGT[8K/@\ 6MOH>BZ3'JE]Y&D7:W=NQ$>YF
M4L0&^7!'S'H!0!CZUXOUF&Q\37-G)%!>Z3?1VUKI\D0?[0C;,,1PQ+EVV[2!
M\HZ\UV.K:HV@>%[S5;W;.]E:O/((UV"0JN< $G&2/4XK@"EU+XAU*?\ M/Q+
MI.HR7;E+9-)6YC*C"*R2F)AM95!^^ ,X[9/HD-I)?>'H[/6HXYI9[417B 85
MRRX<8'8Y- '+W&OZQI"^&+^ZN(KJVUFXBM;B%8@H@DE4E&C(YV@C!#$D@YR*
M?X3U#Q)K6H7T]WJ-F+.PU2ZLW@CM"#,J<*0Q;Y<'G'.>>?31T_P?#9Q:9;SZ
MA=7EKI3;[**<+^[(4JI8@ L54D#/U.2 :M^'_#T?A\7XBO+BX%[=R7C^<%^6
M1SEL;0./8YH HZQK5ZWB5- T]9UD%D;R26!8F< OL4 2,%QD'/4].G6LB?7?
M%.E6'AW4-<2"TC>\%IJL<:JP4,2L4H8$[06V!ADXW<8K;\0^$8M;U&SU2VU*
M\TO5+16CCNK0KEHVY*,K AER,\C@U9N_#-G?>%KG0+J2:>"YB9)9I6#2,S<E
MR<8W9Y'&!@8  Q0!@^*-?UC3/".O:YI]U"!;SA+42PAAL5E1SP1SOWX)R, <
M'-:)U:\U?Q;JFB6-T+--+MX9)91&KL\LNXJ,'C: N3W);@C'-K6?"UIK'A,^
M'#//;69C2(M$5+[5P0,L".PYQ4%SX1$GB%=<L]5O+&^>!;>Z:%8RMRB_=W*R
MD!AS@CZ4 <=X(UJ\MO!_A31+5)#<7D%W/)) (RRK'+@A1(0N27'7/ /'.1I7
M6N>,M/L]&CO4L[:ZNM;_ +/+21AS- RLR2$(Y"G"X*_D15Q?AK91:'I5C;:O
MJ4%UI4DDEE?HR"6+><NOW<,ISR"#]:T;CP;'=0:8LVK7\DUC>K?F=MA>>8*5
M!?Y< 8.,*!QB@#";QAJVC_\ "16-]-;WEU8WUI:VMP8O+4_:0FW>H/1"Q/!Y
M [5N7C>)-+M]9G-]:7%K%9&:TEFB_>+*H)965=H*<#!SD9YS3+SP%IVI-K_V
MZYNIH];\HSIE5\IHP C1D#((P#SGD5/:>%)8M+N[2]UW4=0FN(&MA<W'E[XH
MR,$* H&3W)!)P,]!0!@Q>(_$%VW@:*"[M(_[<L'EN6>WW$2"!7W#Y@,9;IQ]
M2.*C3QAK%IX6U&6Z:&:ZL=<_LN6]$6U4B\Q 9V4' PK_ $R/2MZV\%P6TWAV
M1-2O#_8,+06P(CPZL@0[_EY.T <8K$\0^'VT30[J&"XUF>'4]66\NY[2)9)+
M7.&+"-4RZY15VX;KDYQ@@&OH6IZM=>,=;TV6ZAN=,L%A,4WD?O&>122A=2%R
MN <!>C#/O5U=K]OBKH5O'J$D=JVGW,ODA%*Y5HP3[D@XSV[=32^$$U!+[]SK
M&HZAI/E-N%_IBVA23(V[/W:%N-V>".G.:VM3\.1:CKVG:PMY<VMS9))$/)*X
MEC?:65MP/=1R,'KS0!YY9ZIK&@Z!K^LV5U MM;>)[A9;5H-QG5[E4;Y\_+PW
M&!VYSGCIM1UWQ!J5UKL'AZ%_/TN800KMA,<TOEK(1(7<,%.\*-N,8)R>@L2^
M +:70-1T=]4OO(O[XW\K@1[Q(9!(0/DQC<!VJ2\\$+-K\NL6.MZGIL]TB)?)
M:,@6YVC 8AE.UL<;EP<>E '26DDTMC!)<PB&=XU:2(,&V,1RN1P<'C->-^&M
M U/Q=\'/#>C6UO';P"Z\^2_DE&8U2=SF-1SO[<X'O7LGV8)9"VMG,"J@2-E
M)0 8&,Y_6LSPKX;A\)Z!!HUK=7%Q;6^[RVGV[@"Q8C*@9Y)H Y*ZUD>'O%GC
M_5S&)#:Z?8R*A. S;90 3V&<5H7&M^(]!ENM2U"UEN-$@T^6XG>40H\<J#<
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MO/O6O0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[8Q7!:WI<.F^$O'#6VKP7$-SI3R_8;6+;#;GRV&Y1O;;OQG'&<9K0N 5\9^
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M0T45JQ<*2N';AQDE>G&<5Z7I6C66BQW"62R@7$QGE,LSR%G( )RQ.,X' XH
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M#A+5E6YE2%WC@) (WLH(7@@G/0$$X!H U#;0&Z6Z,2&X5#&LNWY@I()&?0D
M_A5&_P##FB:K?07NH:3975U;X\J::!79,'(P2/7FL'Q-XC$/B30=%1[Q;:_\
M^2>6UAE9F58\J$9%/=@25Y&!G /.W"9/#OAMFO[RZU(VD;N\YB!ED4$D#:HY
M(&!GOC)H M)I.FIJ;:FEA;+?NNQKD1*)"OH6QG'M4'_".:)_;7]L_P!DV7]I
MX_X^_(7S.F/O8SG'&?2L:P\?Z1-H.CZC?M/:/J:)Y4;6TIW.4W[5.WYN.A'7
M'&:LGQUH LS=_:)S$EO]JEQ:REH8LD;W7;E1E6Z\\$]!0!<O/"OA_4+R6\O-
M%L)[F9-DDLD"LSKTP21SQQ]*U(88K:%(8(DBB0;41%"JH] !TK&O/%^BV5_'
M8R7,KW4MN;J**&WDE:6/(&4VJ=QY' R>I[4^V\4Z1>Z997]I<//#>LRVZQQ,
M7<KG<-N,C&TYR!C% $R>'-$CTV33DTBQ2RE?S'MUMU",^<[B,8SD#GVJW9V-
MII\)BM+>.!"VY@BXW'U/J?<URGBGQA';:3I,NGM=;=1U&&T:1;67<B&3;)@;
M<A_E8 'YN<@<5:@U:Q\,VEV;[5=1O(%/VK,UM)(]G PX$A"[@!AC\_S8SGI0
M!K7_ (=T35;E+C4=(L+N=!A)+BW21E'L2.*=9:#H^F^?]ATJRM?M"A9O)MU3
MS ,X#8'(Y/7UK-O_ !WX=TZX,$]Z[2?9EN@L-O)+NB8@!UVJ=PYZC/0UT+R)
M%$TLCJD:J69F.  .I/I0!E6?A7P_IUK=6MGHMA!;W7_'Q%';J%E'HPQR/:I5
M\/:*C6C+I-B#9#%J1;K^X'^QQ\OX5!;>*=)NKRVM4GD22ZC,MKYL#QK<*!DE
M"P ;CG YQSTYJ'3O&FAZMJ"6-C<RRSM)+%_Q[2!5>/[ZLQ7"D>AQ0!-/X1\.
M7-S/<SZ%ITLUPP:9WME)D((()XY.0/RJ6\\-:%J%[;7MYH]C/=6P AED@5FC
M Z $CMV]*GU'5K/2A!]JD(>XE\F"-$+O(^"<*H&3P"?8"JD'B?2;FP2\AG=T
M>X:U6,1-YAF7.Z/9C<&&UL\< $].: +B:3IL6I/J4=A;+?2+M>Y6)1(P]"V,
MD4[4--L=5M3:ZC9V]W;D@F*XC#H2.G!XJFOB/3G@BE1IV,TKPQQ?9W$C.F=X
MV$9XP>2,?F*HWFN:7=3Z$XU2]M?M5VRV\:0LHN64,#')N7Y1P3@[3\M &H-#
MTD79NQIEG]I:+R3-Y*[S'_=SC.WVZ5/8:=8Z5:+:Z?9P6ENI)6*",(@)ZX X
MK-U#Q;HNE_:FNKIEBLW6.YE2%W2%FP55F4$ \K],C.,BHKCQKH=O=FT::Y:Z
M%N+H01V<S2-&3@$*%R>_3I@YQB@"R?"GAYI)I&T/3B\TPGE8VR9>0'(8\<G/
M.?>K][8VFHVK6M[;17-NQ!:*5 RD@Y!P?0@'\*R&\:: +;2[@7VZ+5 39LL+
ML)<*6QP.#@'@\YXQFJS?$+PXEE<737-T$M9#'<J;&;?;D8R9%V91<$'+ "@#
M9;0]+?3Y[!]/MWM+CF:)XPRRGCEL]3P.3Z#TJ&#PSH5M_J-'L8SY/V?*VZC]
MWDG9TZ9)./>G7_B#3].3=+)++B'SRMM"\Q$?]\A <#KCUP<9Q5*3QMX?22TC
M6]:9[RW-S;+!!)(9HQCE-JG<>1\HY]J +K>'-$>P@L&T>P-G;N)(;<VZ>7&P
MZ%5Q@'D]*CG\+>'[F:ZFGT33I9;L@W#O;(3+@@C<2.>0#SZ"LJ_\?:9!I&E:
MC9+<7<.HWR6:%+>3*$OM?<N,AAAOEQDD=.M=2DBO"LH#!67=\RD''N#R#[4
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M../KTK*L[:37?A[XG\/6UE/)=7NL7L4;&%O*&;@GS"^-H"X)P3GY> <C/KK
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MB2K+"%"$_P ++MQ@]1TSQGO/#:31>&-*BN()+>:.TB1XI,;E8* 0<$^E:E%
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M^P2YB?3;K>GV0SEB"F,J%).,GMWKGKS2+VR^&7B(WMI+;V#:U%-I-K<CY[>
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MO)).<GITJ[I.H>)_$.FZ7XAT^\MX8I+HM<0S3CRC;AV5H]HCR'  YW=0<\'
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MF4*9 HW$#MGKBI** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>?WXQC#^HQQSVXZ4?\(YHQ-@3IMLQT\8LRR F <<+GH.!Q[#TH \RU.6YC\
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M110 4444 %%%% !1110 4444 %%%% !1110 5!=WMO8PB6YD"*S!%&"2S'H
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M8@JSX6>-$5VEE(XSDCYB"V6QW- '7:;I3V<AGNK^XU"[*[//G"+M7.2JJBJ
M"0,\9.!D\"M*N-O/B%;6&CZG=SZ;=?:M+NH[6\M%92T9<J$<'/S(VX$$#/L*
MZ/2;Z\OX)I+S2YM/=)F1(Y9$<N@QA\J2!G/3KP: +]%<M!XT5]1TJ"?39[:'
M59YH+5Y6Q)NCW'+QD JK!#@@GMG&:Y&XMHAX:^*\87Y8Y9Y%&3PPM$8'\^:
M/5Z*S-%=D\,:<ZQM(RV<1"+C+?(.!D@?F:Y:V^)L<UAI6JS:#?V^CZA,+?[:
M[H1%(S%5W*#G;D8+=,^O< [RBN4N/&R6^D^([Y]/D)T&5H[B,2#]X BN2A^C
M#@XI+_QI/;ZU_9-CH%[?79L%OD"2QH'0L%P"S<8R>N/;UH ZRBN%NOB/)!::
MK>1^&=2EM=)NG@OG$D68E4*2X&[YN&S@= ,DBMK_ (2A+VZDMM$MAJ,L5K'=
MR?O1&H20$Q@$@Y9@"0.!CJ1D4 =!17*VOCJPU.'2#IJAYM429X8KF3R<&(A7
M0G!^<%L;1Z$YP,U+=>+XK9+.%H(X=0N+0736MW<K#Y2]-K,<_-G(  /0\@4
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M(".K\;E.[' R#D$5=?QC<)<ZQ8OHTL%_8V/VZ&*:9-L\1+#)9<[2"I!'/XT
M=916'X/U.]UCPCI6HW\2I<7-K%*Q5@0^Y%.[ Z9)/%5O'>N7WA[PO+?Z? DL
MWG10Y=L; \BIN'')^;I_^J@#I:*\\N;B[M/BS]HM]+>XO9?#Y)MTF4#=YXY+
M-@#@ 9^G%;%OX\T^[T32;^)5BFU17,,-U,L00QG$FYCD  X' ))(X] #JZ*Q
M/#'B6W\3Z?/<P1-#);7#VL\;,&"R)UVL.&4@@@CJ#5*]\9QVUEJ6I6]A+=:9
MI<S0W<\;@."F/,*)_$$YSR.AP#B@"]8>'Q8^)M4UH7DDCZBD220E %41@A=I
MZ_Q'.>OM6U7(1^([O4?'8T:&VBETF32EO%F67F19'VAL8Z *<#WS7.^ _$K:
M)X/\/VLVF7#65UJ$UD+P2+A97N)=@VYW$9X)]?6@#MX_#XC\7S>(?MDAEEM%
MM#!L&P(K%A@]<Y8\_I6U7':Q\0].T@74VQ)[6RN!;W)2X43!L@,4BZL%)P>A
MX. <5.GC&>X\1WNCV6@WEPUE-;I/,)8U58Y03Y@RW( YQUZ\#N =517"?%B-
M3X4MI!E9!J-J@=&*L%:50PR.<$'!J#Q]8-X5\-S>)?#TTME=Z:4E>!96,%S'
MN 9'0G;T/!QD>M 'H5%<XOBHWCSQZ3I[WLUK;17%PGFB,KYB[EC7(.YRO.#@
M<CGFDLO&5EK%OIC:+&;N;4;=[F*-V\L1QH0K&0X.W#$+@ \^P) !TE%<O;>,
MO.GT**?2;RT?5I9H DXVO#)&K,VX'JI"'!'7(JM?>/HK#2=;OI-+N'_LB]6R
MF2-U.2VS# G'R_O%[9]J -_7-&BUW3?L<MS<VQ$B31S6SA71T8,I&00<$#@@
MBH=/T2XMYHY]1UB[U.6$DQ>>D2+&2""0(U7)P2,G/4XQFLT^+[P:]<:(/#UU
M]O%L+JV0SQ[98MVTEFSA"#CCGJ*2V\>:?=Z'I=^J""?46D2*"ZF6,(T9*R;G
MY  (QD9SD<<T =717$)\2;22PM[A-+NI)'U4:5+'$Z,$E)X(;/SJ1R".O?%-
MU3QU>6^@>*9(M(:WU71(1(T$TRLI5T+(^Y<YX!^7U&,]Z .YHKF8_$\R2:?I
MSVD;:I<V9NA"]R$WJN!\IQ\S'.<< <Y(KH+2=KJR@N&B>%I8U<QO]Y"1G!]Q
M0!-167JFM)I]]8Z?%%Y]_?%_(AW;1M099F;G"C(' )RPXK!O?B%;6&CZK=SZ
M;=?:M)N8[>\M$928RY4(X.?F1MP((&?:@#LJ*H:5?7=_#,]YI<VGLDS(B2R(
MYD08P_RD@9STZC%7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *YCX@Z'J'B7P5J&BZ:(/M%V%4//
M(45<.K9. 3VKIZ* (H#-]E0RQJDVWYD5\@'TS@?RKSN'P9XCM?#EC]DDL8M:
MTS59]0MPTC-#,DK2;HV.T$960C..HKTFB@#A];T+Q/XBT:TNIS86>KV%]#?6
MEHDC20YCW J\FT$[@QZ# P/<U6O[?5;+5M8\4ZU:Z9:V#:&+62)[EI@K*SMA
MAL&Y3N /3KWKT&F2Q1SPO#-&DD3J5='4$,#U!!ZB@#S?P];:QH<VA'5-"M)H
MH8TL;6YBU8S-"K[02D;(,C@9P20H.#@8K3\+Z-XL\/11>'V;3I-%M9#]GO\
MS&\_R-V1&8]N-V/EW9P!S@FNCTSPSH6BSM-IFC6%G*PP7@MU1L>F0.GM3M2U
M^PTJXT^&Y>3?J%P+:W*1EE,A!."PX'0]3V- '!7/@SQ/#X-UGPA:1Z?-8SSO
M+97DMRR,B/+YA1T"')!)Y!Z?E7H.I1ZA<:#=QV;10:E);.L+;R424J=IS@'
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MW@@J",@9[XKN** //-;\%ZKJ6F>(IX$M5U/6KJTD,;S$1Q1P%-H+!22QVMG
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M6))%^ZZAAGT- '&:GHWBCQ/X;F2^>PTO4HI89[%()&FC26)PX9V*@D$@# '
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MJCQWK&E+?E;6/1H[N!?*3]U(TCJ3G&3]P=:ZFPLUT_3[>S2625((Q&KR8W$
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M("$P N1@$]^<\YH B\47EQ9:9"]O?Q63/=11M(R%W92PW+$N#F0C@#!KD?\
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M$>AR3>0FPKQ/&& !4_>P,GKP,$5T&B>&K30KO4+J"XNYIK^42SM<2[LL%"Y
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MQNN^6X#;@[$J<\@<# X Q@ 4 :NE6=Y96 @OM2DU"<,Q^T/$D;$$D@84 <#
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MPDGGN$O;!_,MKV)E66-B,-_#M(8<$$8/I5G3M(MM-^U.A>:>[D\RYGFP7E;
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M@U.P6&,_9(UW[C@KN79M49)YW>XKHX/!-II<UEJ-M<ZE>7VFVKP6RSW>!(I
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I"0!DD >]+7$?%""&;0--,HY&L605@Q4KF90<$<CB@#M@RMG:
M0<'!P>AH#JQ(5@2IP<'I7D6NQ3>']0\?0>&(!:R?V-;7"Q6J[<.6D#R*!_%L
M&<CG(%;5W:V'_"0^"[OPW' L5XLB7"P@;9[/RB29 /O -LP3W;WH [C3=3M-
M6MFN;&99H5E>+>IR"R,5;'J,@U<R,]:X/X4QZ?#X;N(K:.V2Z6^NUF6-5#@"
MXDVAL<X Z9IGBE5\+>---\56]EYJ7L;:9=)&GS-(WS0,/<L-A/\ M#TH [XL
MJJ6+ *.I)X%5-2U2STFP:]O)EC@4JH8G[S,0% ]220!7#W5G'H_BSPEHU['"
M=+FBN6?Y (IKX@-EATR09"H/<\=!7->(+*.#0?&%OY43:)::Y8FRWJ"D+-)"
M9U3/"J"Q&!P,L/6@#V=G5 "S  G R<<TZO+=3GT2[\7ZEHVK7]A9:;+IT0T[
MSDC\EH_G$OEEOE5@V,XYX'I7>^'K:&'PS8VJ7,]];I (TGN@"\R8P"WKD8^H
MH R=?\8K8^&)-:TE(+V**\2T<M(0,F81,5P#NPQ]1TKJ@RL2 0<'!P>E>(^5
MIL/PAU:&!;:*Y&M[)EBPLBJ-1&T''(P.GZ5LZY ^@>)_%L/AN 6T\GAE;H1V
MPP6F$DJ^9@=7QWZDXH ]45U8L%8$J<$ ]*Y[QCXDNO#&GVEU;V,-YY]W%:[9
M)S%M,C;0<A6R,]:Y_P +Q>&[_7=+UG1=;BEG:T:,VMFD:[XR,_OU7GY6Q@GH
M3CO4_P 6"/\ A&M,!D\O.LV8##&1^\'(SQ0!I6_BVZ_X26Z\-WVFQ6^JI9_;
M;;9<EX9X\[3\^P%2#U&VK_A/77\0^$=-UJXB2!KN 2LBG*IGMDU';>&+.RUF
M[UZ:XN;S4I;;[/\ :+EE_=Q YV*%55 SR>,^]>;:/J,5GX2^'46HW4=MH\]K
M,DLTR*T(G 7R@^[@<>9C/?Z4 >S[EV[LC;C.<\8K T77[C4_$VOZ7+;PQQZ:
M8/*DCD+^8)$+9/ QVX_4UPDHTS0Y= LH=3-WX7NM;G:YD8K]F1S&6CA4CY?*
M\SMT# CM45X+*"X^*-OI6H6NG$VUM(LD;X5#Y1W'Y>1D\$CNWK0!Z^KJX)5@
MV#@X.>:0.I8J&!8=1GD5YG96UOJ/B&;7=&CTZ&:VT1H8;."XAE9KGJK 1L1A
M1\N3R=W3 JKX7_L35;?P[J]CK2/KEO"RFTA5%GED*?O$G'WB P));OSG)&0#
MN/%?B"?0+>PDMX()_M%_;VL@DD(*+)($W  <]?45I:SJD&AZ)?:K<AS!9P/.
MX098A03@>_%>/F[TB^^'/AG4[F6V.L#6K5KV64J)UG\\>:'SR,>AX  [ 5Z]
MK5W96F@7UW?HLMA';N\ZD;E:/;\V1W&,T 9=OKFM,-+GFTRS>SU!U!EMKLN8
M RE@3E &' &0>I'&.:D\.^(+C5[W7+>[MX;<Z=?_ &1/+D+;QY:.#D@<_-TQ
M7%C2KCP%J^B3>%M6>ZT#5;Z.W;2)9/-5%?),D#=0%&6(Z8Y)K,US3K&ZT#XF
MWTT$<EU:7S26\K<M"ZP1$,G]ULCJ.3C% 'LK.B$!F +' R>II6=5^\P'&>37
MDGC.\TV]C\4HSVXOH-"C,DEZX;DI(Z"W3C#$\E\]0O!JQ'IVD^)?&^@I?I#?
M0W?AES,"^X2L)(AS@\D'/T(SU% 'J1=0P4L S= 3R:"ZAMI8!CSC/->0NFC:
MQ)XBTS7-933=2M-3;R5"(MTD2L#;F!F^8Y4* %ZDG^]SHZL9],\03ZG)!::S
MI,FJVRS<!;W3[@&-%VGHR9VG:,'#GL30!Z3=FX6RG-FL370C8PK*Q"%\?*&(
MY SC-%L\IM(&NO*6X:-3((VRF['.TGDC.:Q_&\4<O@37UE4,HT^=N>Q$;$'\
M"*XI-/L;_7_AU'<P1S)-HLXD1N1(HBAP&'\0Y/!XH ]25@RAE((/0CO2%T5E
M4L S= 3R:XWX:I'!I&L6< "VUIK=[!!&OW8XQ(<*!V STKCOB%>Z?+:^-7MY
M(8KZT^S!Y+I]TOF*JL@@7@HH!SNR<G=QWH ]C9U4$LP&!DY/:G9'K7G3Z7HN
MN?%?44N;>VO;2;0H)&5B'CD/G2#<1T)P!@]JP]/M';X5>$O%T4(NM1T&-9SD
M;FEM@2LB9]0F2/0K0![#FD9U7.Y@,#/)[5A>%X8I[>YUP0A)=6E^T [-K>3@
M+$#W^X Q!Z%C7.W&CZ9J7Q?O[>]LX+B&30HGDAE7<CMY[C)4\$X Z^@H [_<
MNX+N&2,@9ZTF]0X3<-Q&0N>:\5TFSLX? G@+5TC7^T/[:M[<79.9/*\UT\O<
M>=FT8V]/:I==U#3'EEOK2>WAD@\5PK+)<R!KDNLJ(^#QY<8&0 <Y4]LT >RE
MU7[S =.I]:4LJ]2!QGDUY)J.D:1J&H?$YYK:"=8K2&>+=\RHYM2V]1T#9YW#
MG\ZLV5C9:QXP\)'488[K[3X89YUE^83',.-XZ-U)YS^E 'J6Y=N[<-N,YSQB
M@.I4,&!4]#G@UXOIVH1Z;X<\.6]W<K;Z"FM7]M+)(H>*+:\@@5\\;<],\ A3
MV%6=;TC1;;0K<:?J7VVTD\36<F^-E$4#/(N](BG &.2 >"?7- 'KX8,,@@CU
M%<KXC\8KIOA74-9TE(+W[%<"WD#R%5W;U1L8!S@MTXZ'FM[3-'T[1K'[#IUG
M%;6NYG\F,87+')X^IKQVYBTVW^%OC.&!+6*Y769T=8PJNJ"\7:#CD 9&* /;
M@RDD @D<$ ]*02(0Q#J=OWN>GUKS34H],\-^.M;,,3VMF_AB2ZNUL_EDD996
M'F#UDP3\QY]353PX^FCQYI%O&^F"TN_#K1FVA97##?%L61NDCX+<[1U/% 'I
MNFZE::O8)?6,HEMI"P21>C88KD>V1Q2(]_\ VO*CQVPT_P E3&X<^:9,G<"N
M,;<8P<]<UR/PB6Q7X=Z8+9;<7'EG[0(P V[>P&_'.>#UJI?1VT?Q$\4AKDV2
M2>&XWFN(_O1_/,#(/<  _@* /0U=6^ZP...#56[>_6[LA:QVS6[2$71E<AE7
M:<; !@G=CKCC-<;X,-U8>)9=(U33;!;U=.22+4M-^6&[@5MJ[D_A?)]P<G'
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MG&8-.@A^)\<&G00_V;=Z0[:C;H@\EB' B8J.-Q!<>X4^E+\)K6SB\"6\]O!
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MDYH ]+#J6*A@67J >13N@R:\P\(IX>U6Z\-ZO8:XC:E' R/:VZHLLFY/WBW
M'S$*1G+?Q8.<D9W/'MT]M=>&DN.-'FU1([\G[A!5O+#]MI?;G/&0* .KN[^U
ML=/FO[F>..UA0R22LWRJH&2<UB77B6:+Q1X?TV*VB:SU:&:7SF<[T\M V-N,
M<[ASGUKAO%>G+!+X_M+*",Z1_8(N9850>7%>8DY4=%;8JL<>QJ[/::/?>(O
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MF7)*H^,$X!QSSCC-1:;XTT35]02RL9[B69I)8L_99557C^^K,5 4CT.#^8H
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M8V$YZED*D8[YZ5Z910!QOA=X]2OX;U_!T^D7<$12:>\C4,">J1,"2RD\YX&
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M2.W,8C8(J<98\?+T_4T 9WBWQ;J7AV/5+E;>T2WL;=9X4F8L][U,@0*V4"@
M;B",GT%27/B/6IO%PT/3;2P"RZ6+^*>XD<X)<+AE _0'WR.A@UOP+>ZK=^(S
M%K206NN6J02QO:^8\15"HV-N "G.2N.YP1G-7K/PQJ%MXE@UJ35()7BTL:>8
M_LA4-\V_?G?QR.GIWSS0!1TGQQ/K&F>'$AMH8=4UCSLJY+1PB$D2-@8+#(
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MUMY\4Z*25.W<I##<><]\4 9S^+_$ES>:)8VNB6UG>:G83W!BOY'!@ECV@JP
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MG\J2-#AD8D9# XY Y]J=;>+];&F:3=WUGIR'6S:QZ?'%(Y*O(A>0R9&-J@9
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M ]AI" 1@@$>]>:^.-3O8(/%-SIVIW;W&FVD4B+!(88[%@I?YL'$K/P=I4@#
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M/!?<I'I@@<5V.EV4UCH]M:3W4L]Q'$%DN'8LSOCELG/?/% %VBO);34-5L/
MFJ>*9=<U&>YLKF[MHXY9 8@GV@QAV7;R4'(/;&,8XK6UBYUSPI9ZGX@AO8I+
M%=,D>.RDO)+K?,O*RJS*"%P>0.,>E 'HE%<#=BXL?$W@Q8-6OIX]1>9;LM<L
MR7&+=G#;<X7GD!<#IZ#&/)J^II\.[V]&HW?VJU\0FVCE,S;O*^V"/:3_ !#8
M2.<T >K8&<]Z*\]N)M9\4:AXFL]/OA97>FW2P6KB\>+R!Y:.':-5(D#$M]XX
M(&!C&37US6M0TN]:[UB2[;2)([<)JFE3L8[.3:I;S8@1E&)SN(/RL!QQ0!Z.
M)HVG>$.IE10S(#R <X)^NT_E535=5M](MHYKC<3+-';Q1IC=)([!549XZGOP
M!DURGAFSC7XF>,I?-N6*/:%0UP[+\T))^4G!&3P.W;%+\1[2.X/AAG>=2==M
M8_W<SH,$MS@$<^_44 =1I&IR:G%<&;3KNQE@F:%H[E0-V #N0@D,I!X(]QVK
M0KB;.277_%'B719+Z]M8M)2W@M?)N'1P7CWF5B#ESGCYLCY>G)KF]-U?7/$J
M^!A=ZM>6;:E%?17GV1A'YIB!59!QP3C=Z#/&.#0!ZU6+?^);2QOM&MO*FG35
MI?*M[B+:8P=A?DYSR%., TFL67D^"KVS:ZNI3%8.GVAI2)7*H?F++@[CCDC%
M>?PV6/#7PNBBN+B,S30N9/,+LI-F^=N[.T>@' ]* /6Z*\L;Q!J.AV^O:=_:
M$\T4&OVUE%<W<Y+PPS+&S R$$@#<P#$'&[VKKM!L-6T[7;X7=^CV%Q&KV]FU
MT]Q)"PX<AW ;:<C@YP>E '2T5PVKQWVH?$R'1UUG4+6PFT:6=XK:0(0PFC7*
MG&0>>O7J!C-<_IVKZW##HUM=:G<S26OBR32&N&<@W5NJ2$;P."<@#.,_+]:
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M=J!A@C[Q8X(/ [9SRNM37DOAGXCZ'>7-S<6VDP%[2=I6WE9+<OY;,#EPI/\
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M9ZDT .^QPBQ^Q@.L.S9A9&#8_P!X'.??.:S8_"FB1^&CX=^PA](*;/LTLCR
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M)XO+E='24$GS X(;=DDELY.3GK69X>\5FXN-8M];OM/@DM]7>PM>1#YH"1L
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MHW!!\Q4?4Y!K0UNXTK3_ !MKOD6D5S;'PH=]G:,$,^'?Y1MZ'8>HY .:]2
M& ,"B@#R?0M2M;GQYILMO>17$5QX:DAA%M$PB!$D9$:'DL5&<Y)(YSCI6=HV
MG:=?^!O!5MI<5M_PD-K>6SR>2H$T&QOWQEQRHV@@ANI*CN*]II, $D 9/6@#
MRRXN+*6/XK))+ ZE<@,P.2+15&/^!#'UXZTEL=+N?$?PW,IM)#_9$P;=M//E
MP[0??(;'N#7JM% 'BXN;*W\':C.EY##!I_C!IXTY,)47&55]H.V,YSNP1P,
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M9([X]*]"H  & ,"@#QZ&]U^&#0_%4MC*]YI+_P!AW< 7#766,;/GNOFB+'_
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M!P.3G%>SJJHBHBA548  P *6@#SG0[;2=0^)'C%E@LI;@"REM_,C4E7$9)8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !56]TRPU((+ZQMKH)G9Y\2OMSU
MQD<=!5JB@#*_X1CP_P#] /3/_ 2/_"F+X3\.H[NNA::"YRW^BIC.,=,5L44
M8[^$_#LC(6T+324.X?Z*F,_ES6C:65I80^39VL-M%G=LAC"+GUP*GHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JGJ-@=1@,!
MN[B")@1((&"EP>HW8R/JI!]ZN44 06=G;:=90V=G D%M"H2.*,850.P%3T44
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>exhibit1061-loanandsecur010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHP=AP0 01G'(-8Z>$=5T?PYX+TJVLVO'TO4EO+MXI$54!$I8+N8$X,O''04
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MO>Z?(L=U;3A0\>X;E/RD@@CD$$U=U'4+72M/FOKR7R[>$99L$GK@  <DDD
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M8)UF^U?Q%K&DZ9/#;#2X8C))+%YADEE4NJXR,*% SW.[@C'-?X5_\DO\/_\
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M$C;SR !C-8?C'6+_ ,3?"S6]7MYH(M/,YAB@,66>..<(6+9X8LI(XP!@<]:
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MT%R )71 S8#!N,\#D>AK;K-US6H-#LHYYD>62:>.V@ACQNEE<[54$D <]ST
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MS*0<YSEC_A67I_@9M+U&?['KM]%HTT[7#:5M0QAV.Y@'(W*A/)4'U[$UU]%
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M$M_84+0Q+Y(_>JR",[N>NT#ICGGVJOHG@9M"N1#;:[?'1(YC-#I;*FR-MVX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?5O"<4=Y=VR7&J>1+]GN&CWH89#@X..H'/4=B*YN8_\ "/7_ (KT3^U-332
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MENF?E;#<J2,<9./6O,HTECL?A>GB'RSJ)F(F%SC>5^SR;0V><\J#GO[UZV
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MBDZI\,/$)=@N;1@,G&2>@H ZBWNX;@E$FB:9%4R(K E,C/([4D=_9RO*D=W
M[0_ZT+("4_WO3\:\ZNCI6C_$"TFM8HTCD\-W4DR6F \^UXV'3EF^]@]>M9GA
M[4M,?Q7X'>UNK%;:72;BWC@@?=Y8Q$5B=R<N_7.0.<G'>@#UD7MJ83,+F$Q
MX+^8-H/IFB2\M8IXX)+F%)I?]7&S@,_T'>O/M#TY[#Q!J'@@VO\ Q+([L:M
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M.IH ]+%U;L\:+/$6D7<BAQEAZCU%(+NV,32BXB,:G#.'& ?0FO-;M=!T;4?
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M (2:T;3R2 J9>+S_ "SV7<7'''#>] 'M$4\5PA>&5)%!*[D8$9'!'%$D\,)
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M[^[$QC4G?--MD;))8C  QR2 .!W K1/Q T%;*UN2]UBXO&L!&+9R\=P,YC<
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M,+>*-Y)8HHDFD'S.% +'MD]ZK:;I<6G?:9 WF7-U+YUQ,1@R/@ <=@% 4#L
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M=1N+G3E1[B.WLI'*JP)W=.5 7D].G6@#I%@A0L5B0%N"0HYI(;6WMP!#!%&
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M:J77CW1K"SU::]6[MY-*V&[MV@+2(KC*M\N05/J#CUQ0!TR(L:!$4*H& JC
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MY)#)F4-\^Y2QX .<#&.M>F44 <5I>C7\VK^-H[FTFM+?5G7[-<,R$,OD+$2
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M)CVCHN0><@\8HZ!HVNVJ?#U;G1;F/^R(9HKP^9$?+W1;%/#<Y/IGC\J]0HH
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MDX Z\X'+0:/K&F:3XMT Z;+=C5+BZGLKE67RV%P.5D).5*DG/'(Z9/%>B44
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M8[S[-N"RI"8L@L6Y&YO7UJ"3PW=VOBJ\U[2+V&%[^%(KR"XA+H[)D)(,,""
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M3UN]MM9L"=5N?M#+)I[GRR%"@#$PSP!0!R>G:['X"\1^,]+A1I=(LEMKFRM
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ME24--*Y\U#%YF. ,$CCT'OVGLO%VIS:QX<6YLK2/3M?@>2W"2,TL++%YHWG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBN?\ %MT8+33XEOYK9KB^CC$5NN9;H<DQ(<C83C);(P >: .@HKR2
M]UC6X?!'BMEU*[M[C3==CM[=O-\QTB9H/D+D98#S&YSGW-=##!>Q^/=3\/\
M]LZC):W6CI=AY)LO#-YK)NC( VC !VCCCI0!W5%>>^%]5O=6ATW0KJZN%U;2
MKB5=6<3-E_*X4DYZ2%T8=L!@.E;'BG59[?Q#X9T5)7@M]4N95GFC;:VV.(N$
M##E2S8Y'. <4 =/++'!"\LKJD:*6=F. H'))K+F\000>)[/0FMY_.NX)+B*8
M!?+*IMW#.<Y^8=J\W\:7%]%HWC[09;JZGL;2PAO+61IF+Q^9N#1,^<NN5) 8
MG@D'(K>U?30_Q"\+64=W=Q(=-OLRK,3+@F$D!VR1]>H[8H ]!HKRS3/$>IC3
MM)TF:\>8SZY>Z<UU/.8WDCB,A13( 2&;:HR!DXQP3FI=?3Q'H6A7"-KSH3JU
MI]F6*8RR0PRRJIC=W4,PSNQGGL2: /3J*R[6S_L31[E9-5NIU7S)C<WSAS&#
MD]0!\J^GI7%Z%J6HQ^*?"T7VV]N+34]-N'FEN7.+ID$;"98R3Y0.\D 8X."!
M@4 >D45Y=;7'B+5+'2O+N]2AUHZS)#J7E$^2EL)'#;<@Q@!0F".21CDYJ]:#
M4;CQ7XK>76]4:#1KF":WMHY%59!Y <QL-O*DG&!C\Z /0Z" 001D&O/= ?7-
M5LO#GB2+5(5AN$5[Y6O'D2Y#K]Q8RH6-@QP-I[8.:AT"XUWQ%I&@^);?4X;;
MSIU>\#WCO')&S%6A$6W:K D $'.1R3DT >D45Y!?WNLQ>#/%6L+K^H_:](UF
M9+7]X NQ9$ 5E  88)&#QZ#K6YJ&HZAX8\7Z@L5_>7T)\/7&HF"Y?</.B=0-
MH &T$,00,#I0!Z'17":/;ZU>2Z'K$6L(EE=VY^U WC3?:2Z95HU9 L; Y.%X
MQD8XKG=*O]83PMX1UR77-0GNKG65LYDDD'ER1//(A#+CDX ()Y&.,#B@#UI9
MHWE>)74O'C>H/*YZ9I]<-X+LUC\8>,Y/.N7*:BB@23NPP8(ST)QWX]!P.*9J
M=OJ&J?$NXT<:[J=G9-HZ702UD5"DGG%<@[3V49Z_7'% '>5DZ=K\&I:[JVDI
M;SQ3Z88A*T@7:_F LI7!/&!WQUKC;2YU[Q+IL^KV&I165S::E,CM)>/Y<<44
MI4Q20A=O* $DG.6SD<"B>[^P^(OB/<_VBNFE+6RVWAB\SR3Y3 ,%_B.3P.YH
M ](JC<ZD(H;.:VMIKV.YF2,-;;6"*W_+1LD?(.Y&3STK@_M%]_;GB#2)9=0A
MLFT!;M(I[MGE23=(I8,&)0G:. Q'';)%5K.2ZTOP!\.Y+*_NXA<W6GQSIYI8
M2(Z#*\Y(7@< @=>* /4Z*\OU1]5GN?B%C7M3B728DGLUBE">6WV?S,<#E<]N
M_?/&-0ZM?7>J>'QJ$MS'I=[HS7#M9EU8W/[L_-L^8*%8X[9/KB@#O*8DT<K2
M+&ZLT;;' .=IP#@^^"#^-<]X&BUE?"5J^OSW,FHR[F?[0%#*NXA!@ 8.T*2#
MR"37"65_-X<\+>(+JTN;E99?$\MAY\LS2""-IU0R88D;@O<]\9S0!Z_17'&>
M\T3XBZ9I<%S<W&FZG93O)%/*TI@DB*_.&8D@,'P1G&<5%XTU#4=,U!+HVU_=
M:*EJPN/[,G*W%JY/$Q0$%UP#QSC!X- ';45PVDZB]YXZ@M8=2GN=,NO#D=TI
M\Q@)&,FWS!SE25QT_G6/X9\17VHV'@S3+^_G/]J+?///YA628PN0L>\<C@Y.
M,'Y /6@#N]:U^#0YM,CGM[B0:A>)9QO&%*H[9QNR0<8!Z ]*UJ\V\46%U9V7
MA^QEUF6\=?%$/ES,H,D",'94).=Q4$?,W7(R*V?"<UW!XJ\4Z-+?7-W;64MN
M]N;F3S'3S(MS+N/.,C@=LT ;E_KUK8ZC#IJ1S7>HS(95M;< N(P<%V+$*JYX
MR2,G@9IEGXBMKN\N; V]Q;ZE;Q"9K*8*)&0\!E(8JP)XR&X/!Q7+>&@\7QD\
M:I>9\Z:WLI+3=W@",&V^V_K[TOB-))?C'X,^QY\V*VO7N]O: JH7=[;^GO0!
MU?AW7;?Q+H-MJ]K%-%!<;BB3 !QM8KR 2.WK45GXCAO=6UK38[.Z%QI2QF0,
M%_>[U9EV8;GA>^.M>7:0FIZ/\+M%\2:=K%\)[>Z5/L&X&":-[HQE-F.IW9W9
MSG\,=7 91XO^(;0SO!*MK9LDD>-RD0N<C((H [>PN7O=/M[J2VFM7EC5S!,
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MJ%EI-](8[YK*2!53S RR;&8_-C:#D]>@KHJ\>LYKW2O -R]GJ-S'+'XK>%Y
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M/[J[=V 0,_+R3DYBU:;5GM?B%<+K^IQMHS^=9B.0*$(MUDP<#E<DC'3GG)H
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M[K5+EH)_.U2,1WC"ZE'F* 0!@-A< D<8ZUC>,?%@TP:?%IFI68NGU2WM9XB
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ML81-$9HR]PHWQ@;BXYY7'.>E4M-\9Z'JVO3:38W\$\L<$4P=) 5DW[B G][
M7)QZB@!(?!.AVXF\F"Y1YKD7;R"\FWF4#:'W;LYQP?7OFM;3],M=,29;9"#/
M(9IG=BS2.0!N8GDG  ]@ .@JS)(D4;22.J(@+,S'  '4DU2M=<TJ],PMM0MI
M3"@DD"R#*(>C'_9.#STH R&^'_AIR^;&3:UV+T(+J4+'-G=N10V$)/7;C-67
M\':&\.J1-:S&/5?^/U?M<V)>-O\ >XX '&..*QM"\0WOBF_FN-,U>TCAM-1E
MMY;(JLGFVZ';O!'S!B>0<[<$#'<[NO\ B;3?#8LOM\Z1M>7*6\09L<D\L3V
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M7\UG<V$DC@J7MPO#@<@$K[\?E0!:2YN9OC#IPN+.XM"VC3ML>8.C?O(L8 )
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M1M;9'F\S:Z/$'!&S'.=X/48YJ3Q]I-]KO@V^TO3HEDNK@QA0[A%&'5B2?HM
M"W_BTVOB&?0[;1K^\OHK07:B(QJLB%BO#,P Y!ZX/H#6GH.M6WB+0K/5[,.M
MO=1B15D&&7L0?<$$?A6,FGZD/B'-KIL3]C;2$M /-3?Y@D:3IG&/FQG/7VYJ
M;P%I-]H7@O3]*U&)8[JV5E?8X93EB00?H: '3>+8XM3UG3_[,O&N-+MENBH,
M?^D1MNP8_FY^Z1SCGBGV/BF+4K#1[NSL;B9=4@:XC16CW1H%!RV6QW4<$X)
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MF]K::9?O;(597/RB,!, Y+LS?3Y@,UT^D6]Y:Z+8V^H7(N;V*W1)YP/]9(%
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MJ.I:OXOMY!"FFZ_:Q(MR)/GB9(BF-F.><'KTS0!LQ^+H1?:7!>V-S9QZJ/\
M0II2I5FV[@C8)V,1R >N",YXK4UF-9=%O5;<!Y#G*L5(.#@@CD&N770]8UJ#
MPU;:Q:QVQT:YCNIYDE#K/)&C(OE@<@$MN.X C&.<YKJ]46:32KJ.WB,LSQ,B
M)N"Y)&!R>@H YSX8EY?ASHES-++-<3VPDEEED9V=B3R2234VN^.+#1#?YB:X
M&G*'NQ'+&K("H;"JS LP4AL#L1WXK-\,6_BGP[X)T_1ET2VEO+2W\H2->@1D
M\X)^7./:@:5XHT'Q/J-QIEG8ZMI^JM',YN;CR'MIEC6-F.%.Y2%4X'- %]_'
M,4NI-8:;I%_?S&PCU"$Q>6JS0N2%(+,,=#UP?0&K%KXRL=1T[1KFPAFGFU>,
MR6UN<*P51ERY)PH7@$\\D 9S56#2M5M_'L^L26XGMCH\5EYB.JL\J.[D[<\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M10>/X6)//8#KD '1)XHT.XTN._2^22RGN?L:2!&(:4OLVXQ_>XSTK8 "J
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MMX3"3O9U\L@LW\2C!]Z9J,6II\0_ TFH7<,YD%X62.+8$?R.0IR<K]>>.O/
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M),4$L84@129Q(HR0>3R.HZ4 =]5>_OK73+&:]O9EAMH5+R2-T4#O7G5OXO\
M$W]@6>N7$^GF$:R=/GMX[9@9$-R8=P8O\I'! P>G)YP+NN:O?>(/#_C06-Q%
M;VNEQW%EM:+>9G6'=(6.>!\VT8[@DYZ4 =U:W4-[9P7=N^^">-9(WP1N5AD'
MGV-8'BG3O"<4)UOQ':6BB!0ANI$.X#/"Y7DCVYJ[X3_Y$W0_^P?;_P#HM:X#
MQEJ]]XE^%OB+5;>XBAL%ED@B@,63)''*$+,V<AB5)&. , @]: /4K:V@M+:.
MWM88X8(QA(XU"JH]@.E2URHUC4-9\0ZWI&EW,-H=)CA4R21>9YDTB%P",C"
M;>G))/(QSF>'_&]UXJ&CV=NB6%W=6D]S=L5W^68I1"50'@Y<DY.< >IR #O:
M*XM]9\2:;J'A>SU3[!YVH7DUM<^0K%654=T=23\I(5<CGJ:S=7\8Z[8Z%XON
M8'LS/HVH1V\)> X:-EB/.&^\/,//3CI0!Z-17%/J/B8>-I/#WV_3PESIYO8I
M_LC9M]L@0KMW_/G<.21WX[53TKQKJ>HZ/H4#0J=4U":[BE>W1< 6[LC,JNP&
M3A3@GC)ZXH ]!HKSV]\1>,=-TZR^V6EI!/+KD5@CS(#]HMY& 5\(Y"-U!'/J
M,56UK7O$$.C^/-.FU"#[5I-DES;WEO;^6=LD;MMVEC@@H0#GOZT >ET5P%_X
MEN?#=EHD6HWAM=/GM,MJ8M"\4<OR[$DP3M4@GGC..HKM=.EEGTNTEFEAEE>%
M&>2$YC9BHR5/<$]/:@"U17F&F^)-3T31O$^I7=VE[,->>QMTDCVC>6CC0D@\
M* 1QZ#KDUTIUG4M)\;:;H=_+'=VVJ6\KV\RQ;'CEB +*0#@J5.1W&,'- '55
M1BUC3YM8FTF.Z1K^&(320@'*H3@$GIUKG?B1/?6_A^S:QO#;%]2M(I"$W;U:
M91CKP.>?7I6;<P:M)\5;N*QO;>"[_P"$=@W7$MN7&?/EZ)N'4^_'O0!Z%17"
M:9XKU/6/#GAK4&EMK,:C [7+1H9)3(H "Q1\E@3N)ZX _&L=_$6M:_HG@:_^
MUQVDE]JK07,<<.5=D$P!()SC,8.W/4]>* /4Z*I:IJ":/HE[J4X,B6=L\[A>
M"P12QQ^5<UI^I^+;G4-,E%DKZ=>P,US(Z1J+5RNY&3$A9U)X(//?(Z4 =E53
M4]3LM&TZ:_U"X2WM85W22-G 'X5Y]IGB_P 2S:'X9UN[FL&@U'4A83VT=NP.
M&D= X<L<8*CC!X[T>*M7OO$7@+QI<VEQ%!960NK)8FBW&41KB1F.>,G<%QTP
M"<YP #TF*5)H4EC;<CJ&4^H/(I]5-*_Y ]C_ ->\?_H(K$\;:SJ>AZ=87&F?
M9C)/J-O:NMPA(*R2!>"#\IYZX/TH Z:BO.[OQ-XGT34]=TF^GT^ZG@T>35K&
MZ2U9$PAPT;IO)ZXP=W3UZ5+#XDU^WLM#DO;JQDF\0/;1VJQV[*+;,9>5F.[Y
M^ ,=.3Z4 =_17%2:UK\>NZQX:BEMI=1BT]=0TZY>'Y9%+%-DB@@9W#&1C@].
M.;/A_P 177B+3]!GM9HU>XMFGOPT7W"OR%,9^4^9D<]D;O0!T.GZG9ZK%++9
M3"5(IG@<[2,.APPY'8BF0:QI]SJUSI<-TCWMLBR31 '**Q(!)Z=C7&6GC74V
MT9!<?96U*ZU^71X'6,K&H5V&\KN).%1CC/)P,U1NM4N/#'C?Q7J=Y*MX;71+
M9XOE$9;]Y*%5L<?>/4 <8XH ]/JC=ZQI]A?V5C<W21W5ZY2WB(),A )/3V!Z
MUR]QX@\1:%->7^J6#S:)!827,LQ6.-XY4&=BA9&RK#@9Y!ZDUF:HVJ7.N_#^
M^OKJ!Q<WC2O#'%@1.UM(0%;.2 "0<]2 >.E 'I-49M8T^WU>VTJ6Z1;ZZ5GA
MAP26"C+'VQ[UE>/KB\M/ .NW5A<FVN(;*61957)&%)X]#[]JYF_BU#_A)_ ,
M<5U!]J:TO=LSPG:H\J/^$-R0/<4 >DT5P>G^)]9N- F-Q/8I=6>M2:;<W94H
M&C1B-Z1Y.9#\H"\\GOTK%UKQ+K&I> =?=;OR)K#6DT_S1;E&FA+P_>4_=)$N
M#TZ=LT >K53L]4LM0:[6UG#FSF-O/P1LD !(Y'/!'(XJQ LJ0(LT@DD ^9U7
M:"?IDXK@+O6-6U;P3X\6XN+>.73I;NVC>&$@&-8%;H6)#'<><_A0!U]AXCTG
M4[]K&TNP]R(1<!"C+OB)P)$) #KG^)<CFM2L+PA!)'X5TE[B2.63[%$$=8MA
M5"B_+U/I6[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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METT?3U8SBX)%L@)E&</T^]R>>O-31:1ID#7#0Z=:1M<Y$Y2%09<]=V!\WXT
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MNKZS:*YEWDF9/L9<*V3R R@@=NU>D6OAW1+*WN+>UT?3X(+G_7QQ6R*LO^\
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M;>SMH;:!?NQ0QA%'T XJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG! 91D<'GH.^!7,6,EKK=I-=W'@K5H[VWL9DG6_#@G<A#0PLS$OO/&5XQZ'
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M^8@9([\YJ#7O#]_=:9XUU2RT^Y*:E>6,EO;"(K+(L#1F1PAY!.&P",G;GN*
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M-E;:Q&#@D=^>U8?A"T86FDZ#K'A74CJFDR1C[5/O:T'E\":-RVW.WH ,Y.,
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M?.UG,CRF17=MVU"I;D8SQQDUUWQ @GN_ &N6EK!-<7$]I)%%%#&79F(P!@4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<WX[T&]\4>#[[1+%[>*2["J99V(" ,&S@ YZ8[5TE%
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M/<D#:IE)R%]2%!R<>F#U=% ')^']$U[P[\/;?1K273FU6TC\N&64NT#?-G+
M ,.">!WKJQG:-V,]\4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY5BK%3@_4$4 6Z*** "BJL&I6=S?W=C#<(]U9[/M$0ZQ[QE<_4<U:H ****
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M5M/LKVTL[F[BBN;MBEO$S?-(0"3@?0&KE !113998X8FEE=4C0%F9C@ >I-
M#J*JZ=J-GJUA%?:?<)<6LH)CEC.58 D<?B#5J@ HHHH **** "BBB@ HHHH
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MXM#GG:X;2_*0A68[F59#\RH3U4>IYY-7],\++9R:\+JY6[M]9F::>$Q; NY
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MXU!;/['YD5OY6]"P8E^3N;*C'0#GCF@"YX@O+S3]#N;JP6V-Q'MP;J0)&@+
M,S$D<*"3C(SC'>N0F\:ZK%8>,C";6:70[:.ZMYI;:2,2JT;/AD+ ]4."#@@B
MNJ\3Z"/$FBMI_P!KDM'$L<T<R*&VO&X=<J>&&0.#6'<> Y[IM?>779G;7+-+
M6YS;I@;59=R@8QPQP/SS0 VV\3ZO9^(-+@U=K%K'4M.FNU\B)E>W:((S L6.
M\$/Z#I6'KVIZGKWA[PEK4C6T=G>ZW8S);",[XXVE!3Y]V"V,9XQSQTYZQ_"3
M3:IHMY/?)(NF6LEKY7D8$R2*JMGYN#A!^M9,7PYN(=*LM(3Q%<?V9I]['=V<
M9MT,D01MRH7/W@#TX_.@#O*\YO\ QGK=GX6\7:C''IYNM'U(VT8\I]CIMBY(
MW9W?/USCCI7HH& !G/N:XR[\!/=Z-X@TU]5VQZW=_:I76WYC/RY"_-T^1>OO
M^  \:_KUEXJOM(NX;2\)TI]1M([6-D8,K[?*)+'=G*X;"]^*S(O&%YK/A36K
MW3=7LOM%IILDKQ_96CGM)U4DJ\;-G'! ..H/WJZ"\\+W%YK[ZN=4\J9M,?3L
M108VAB&+@[N&# $>WYU&W@V.\O;R^U*Z2:[NM-?37EMX!"6C;JS<G<W P> .
M>.: ,.WUKQ'8V/@G3[:?3Y6U:W*-+- ^4VV^]2</\W3GIGVSFM/3M<UXZUJ^
MCZA)IS7-CIL%RLT$#A3(^\,""_*Y3CH>:?;^#+F%_#COK33/H>[RB]LH\P&/
MRL'!&!M_'//M5F_\*S7/B2?5[/59;/[5:+:742PJ_F*I8J58_=/SD=^/0\T
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MIL50^:#&Z@C.[!!!/857T_7/$]W?Z5(-/233[Z%FG?R=GV1BNY"&+_O%)X/
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M!)%\F1L,H.#R!UKC-52Z'AOQ_J U75!<:3J4CV)%[(!"5BB8<9^8<D8;( Z
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MSZ9/ SUH K:!8741N]2U."WAU*_9&FC@?>L:JNU4WX&[')SCJQ[ 5LD9&#5
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M.VZ:>UBED8#&69 2<?4UE0:W<ZOIFJZGI\J16ML9H;5BFX2M&2&<_P"SN5E
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M;_;6F?V?#?B_MVM)\>3*D@99/9<?>/!X'H: *Z>&M(CDT^1;3#:<I6S/F/\
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MWE26&10Z21L&5E/0@CJ*DH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF/&]O;W.GZ>LNH7.FS+>J
MUM?P*&%O*(WPS@\%"-RG/'S=173T4 >4W5UJDNB:!>ZK;(QLO$RF6ZLH&V7$
M0611<!!D@,6 XXSR."*I>,;TWVF^+[:*QN[2<75M*+>*S=FNU'E'SW?:>,#
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M/>>K!2,\Y(YKG_#S/9:'\,[N>"Y$5E-<Q7&V!V:)FAD50R@$C)( X[BO8Z*
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MS@\C..U:]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEPNW!.?;D<W/I&L:WX8U_P ,1Z=I-I?7)2=[F+4))HW9FR3(Q3=OP@P,=,=
M *Z'Q+HFNW=_I&NZ)+91:K8+)');W+L89XI-N]=P&0044@X[<T 16?Q!L[O3
MX7:!+:]DNY;/R;B<)%OC&682XP8\8PP!SN''I!_PL91IZS_V1,\HU6/3)4BF
M5D#.P"R(YQO4YXX'H<4_5] \3WT6EZQ;WFGQ^(-/G>58&W_96C=0CQ;L;N@!
MW8Z]@,8=K&A^)=<TG3Q=-IHO(=3M[UXDE<11I$P;8K;"68X/) Z]..0!P\8Z
MHVH:KIB>&V.HV$:3^7]L7RY(G#8._'#?*1MP>>^.:EC\=V-WI^DSV@@6;4K/
M[9''>7(@5$X!W-AN<L   <X/I3H]#U:/Q?K6KA+(P7UC%;1)Y[A@R;SEODP
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M3..GX4 <%IOC"RTWPEI-YIWAV2&WO]5>R%K#*G[J1IW0L<]26!..G/4=:O\
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M-KX,URV\+>$-*)TYIM$O8[B9_M#[9%177"_N^IW]_2@"[\6D4_##7)"H\R*
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MKW0ITG-SJVG6RR-&0X\HNA4[5V[PV%R&4=._9Z'<_;-!T^Y-[%>M);QLUU"
M$F;:,L .@)R<4 7ZCEF2&-G?=A5+$*I9L#T Y/X5Y]+XGUB]\%:OXMT^\$0L
M)KAHK%HT,;PP.58.<;MS!6.0PQD<<',^BW%SJ/Q.O+D7]VML^C6ES';,$VJ'
M:3*_=R.@/7.>^,  '8:/J]GKVDV^J:?(9+2X!:)RI4L 2,X/(Z5>KR#P?J&K
MZ-X.\"W,6H*UE>W@L9;+R%V[7,I#[_O;@5]0,=NYZ :WXFUNSGU+0E?=;ZA)
M MO+Y(MWBBE*,'8_O Q"ELC &0,8Y(!W]%<+83^)-8\6^(+!=>6TM-,O(%58
M[-&9XWA#E<MG'+=>>GX5B3>,]9L?#UE<7FH2&^T_5GM-:6."/'D*X#2@;?E
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MTRZU"Y)$%K"\TA49(506.!]!0!S,OPZTM]!TG3([[48)-()^PWL,JI<0@C!
M8+@@C@@@YK2B\,);I:F#5=22X@9V>Y:1'><L #YFY2#]U<  8P,8Q56V\1ZM
M+::9?OHUN;'4'B"O#>;WA60C:SC8 >H^Z3R>XYJSHFOSZIKFO:=<6L<!TN>.
M)624OY@>,."<@8X8<?J: &6OA*WT]+<:??WMH8A-N\ORR)C*^]V=60C.[D8
MQD@<<5J:1I5IH>DVVF6*%+:V0(@)R?J?<GFKN<44 <RW@C3L:C!'<W<6G:E,
M9KNP1E\F1VQOZKN4-CD!@#[9-6YO#-L_B(ZW#=W=M<M:K:ND#J(W122I(*GD
M%CCMZ@UMYHS0!RD'@&PM]&T?2X]0U$6^D70NK8EH]V\9QN.SD#<WYTH\!:='
MK=UJ%O?ZG;P7DOGW6GPW&VVGD/5F7&>>X! /?BNJK!O=?GM/&>E:']EC:"_@
MGE$_FG<IBVY&W'^V.<_A0!/IGAZ'2]9U34X[NZEEU)T>=)2FP%5"KMPH(^4
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MUG%:W2R,FV*7S$=0>'!X(!'.#R* ,F;P593^$K/PVU]?"RM/*\MPT?F8B(*
MG9C *KVR<<U;'AR(>))-=%_>?;'LQ9D?N]@0,6!QLZ[B3_\ 6XK:J*YN8;.U
MEN;F58H(4+R2.<!5 R230!S-OX!L+;2M'TV/4=1\C2;K[7;9:/=O^;[QV<CY
MV_/Z5;?PAI[W^M7+3W?EZQ'Y=W;"0"(GR_+W 8R#MXZX[XS3+KQ-)%XC\.Z?
M#:H]IK$<L@G,A#ILCW@;,=\CG/KQ71T <C=?#ZPN=.TNW_M/58KO2^+34(YU
M6X12H4KG;M*D  C;SCU))L7O@>PO+6P7[;J$5_83&>#4DE!N [##%BP(8,,
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MK(64MI ]H%""!HP4"CH-O3 JO<Z%I%[:P6MUI5C/;P',,4MNC)&?]D$8'X4
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MU%7*I'42-;33?L5V5:W,_P!K$?[@88#86S]_G.,=*NT %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<SH>J'7M>UJY9
MR++2KHV$"9P#(J@RN?4Y;:/0*?4T =-17*+X]L7BTJXCL+Z2UU:4Q64R*F)6
M&2,@L"N0I(SU ['BI8-2;3/'?]@.S-:WUFUY:[CGRW1@LB#_ &2&5@.WS=L
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MLHF0L'0_-M&-C'.<8'X5:\/^)K/Q$;Z.!)(;FPG\BY@D*DHV,@@J2"I'((-
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M);&417"E&78Y&0.0,\$'BK] '$R^']3N==\:2&W$=OK%A%;6LK2*1N2.126
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MSR0+/&T;21!=P!&#C(([^E5O#^BQ^'="M-)@N9[B"UC$43S[=P4< ': #^5
M'#IK3>']3\?7\<8>7^T[.&-6Z;Y(H8P3R. 6SU'3J*O:IXC\0^%;;6=3U&UD
MN-(M[$3027)A247&X+Y9$9(*'<#G&1SUK5F\"Z==IX@CO;BZN8=<97N8W*@(
MRJ%4H54$$!5QDGD9IMMX&MVTF[T[6-5U'6HKB VVZ]D7,<9QPNU1SD [CDY
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MGB@BW6\:8D*;9, F0!!N&2 =P('%7/ QOI=9\6/=:C+<K%J[PJCJH  BBQC
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M:R>U2W'EA)5)#'/R]2RCG(% ')0>+=?O]/T*[M;F".^U'5)+*ZTZ2W#_ &5
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MS6A3(D:.)$>1I&48+L "WN< "GT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445QOQ';RM)TFX#;&
MCUFRS(#C:IF4-SZ$<&@#LJ*\NUN2-M<^(L,5PRB/0HI=L,I79($F)/RG@\+G
M\,T:?;+I6O\ @2ZL_.-QJ&ESBZW3,WVC; CJ#DXX/3TH [7Q1K\OAVRM+I+-
M;E9KR"U?,NS9YCA-W0YQGIQ6Y7BTDEGK'PS\/Z_<LDNK2ZS:M=3L<2"7[2 T
M9[@*.B]  ..*U;GR?$E[XHM-2UNTTR^L;XB*62,_:+6%54QO$WF#:IY/ Y).
M<YH ]4JO>WUMI\"S74JQ1M(D0)[N[!5'U)(%<#IVBVFK_$CQ!'J$EU.D%OIU
MS&IGD0"7]X=VT-QR.G09(Q5_XGVMM<:/H[7$,<@36K( N,[09E#?F.* -NVU
M^6?QG?>'Y+-8UMK..Z2<2[O,#LRXVX&,;3W-;E><SZ-INJ_$K5;*>,/9KH%N
M%BCD*I@2S ?=(SCMZ5B:'K,M[IW@>QUB]MA:7ND2$/J$9ECN+A2@"M\RY8)N
M(R3R3WQ@ ]AK#T37Y=5UK7=.ELU@;2YXX=RR[_,#QAP>@QPPXYJ/P=8IIFAM
M91:LVIQ0SR".8CA!G/EJ<G(4DKU.,8[5QM]=VME/\29;RYNK> W=G&9+1@LN
M6AB4 $\#)(!)Z F@#U*BO,]+T^._\6^+O#TQM[6WN-/M2+:SD.R"5A*"R=/G
MP%.0!T''>L.#6Y;6'P[X@N;?8OAZ3^R]<(4D;R3%NP.I0JC^N)1CO0![117G
MVIZ3J<5AI3V%O8W%^TD]]<Z1>-M2YWXW*&Y :/>JKD8KHO!EY:ZCX2LY[2WN
M+:$^8GD3MEXF5V5E)[X8$ ^@% &_39"ZQ,8U#N =JLV 3Z9P<5Y#:V1L_"/B
M[Q!:&ZEU;3-0U..SD-Q(YA3<5.%SAL+SSDY ]!73>'K+3GU_3]8TS7;-X[FT
M93:V,15;E>")),NQW*>-QYRV">: .@\)Z\WB?PQ9:RUM]F-R&/D[]^S#E>N!
MGIZ5I7E];6$4<EU*L:R2QPH3_$[L%4#ZDBO*_#$MI)X+\#:?-OFGN9KEH;1W
M"V\VSS-WFY!R%!R !RV/3(SU6WOO"&DQ730W2VGC%8(R3N5(3=$ +DG"8X'/
M3B@#V'SK[^US!]DC^P>1O%SYOS>;NQLV8Z8YW9]L5;KA$@A_X6K/;122"UD\
M.J0D<S!1^^*Y7!^7@#ICI7)Z!;K;>%_AQK,<LYU"XU".WFG:9F+Q.DNY""<8
MX!QZ\]: /9Z0D $DX ZDUY3J5G>ZROB?3HI1+K#:NGV+4$N%7[-%^[.S.X,N
MQ=P*@<ECU)./1M3LK=O#MW9/'YEN+9H]DA+[@%Z$G)/XT 6;*]M]1LH;RTE$
MMO,H>.1>C*>A%6*\@T">&VT'X:Z=MC33-1C_ -.V\++,(,Q(_KN;/!ZE176>
M%XYK'QOXHTNW+?V/"+:6"+/RP2NI+HGH" K;1P-WO0!U,E_ M\+!9$:]:%IU
MA)P2H(&3Z#+ ?GZ5G>$]>?Q-X=AU22U%JTDLT9A$F_;LE9/O8&<[<].]<\]E
M8?\ "[#-+! )#H:2!V R7%QM!SZ]!^5<CIEG%:^"O#6L0M*M\OB3R1*)6XC>
M\D5D SC:03D=Z /:J*\IF\KQ)/XF@U'7+73-0T_46$<S1'[3:Q+M,31MO&%9
M1V&"2<YS78>.M0OM+^'VJWUBT@NHK;=YB+AE&0&8#L0I8^V* .FHKSW5?[,T
MW2=1U[PG>%K]]%E:"WMI \<H4;A,RX)9QG&XG)SCFJ\\<5M'X%U70'8SW]S%
M!<LCDFZ@>%FD:0_Q,-N[<>0?K0!Z517D>GZ):3^$O&&J2R7C7MA=ZK';2_;)
M08E&X <-ST'7-2VVE#39/A]K&E37+:C?^5!> W#.+B VY=BP)(PNT8P !D>U
M 'J]%>._:+B^^$7_  D\3,OBN&Z+&8']Z+C[1L\@]]I!";.F".*W=/T>RU'X
MC^*FU!KB1+)K"ZB3[3)MCD",V0 ?4=.G7CF@#T6J]K?6UZ9Q;2K)Y$IAD*]
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M\5L+DV5N\YB,FS<%!)YP>P]*R/&FH:>NFQVLT\V^2_MK?RX'""61G!6*1B"
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M** "BBB@ HHHH **** "J]]8VFIV4MG?6T5S;2C$D,R!E8=>0:L44 9*>&-
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MEI=G;2I$(%>&!498\YV@@=,G.*G;3[-H9H6M83%,_F2H4&';CDCN>!^56:*
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MLR?3;22P_P"?9X5,?7/W<8Z\U'_PC>AA)T_L;3]MPBQS+]F3$B*,*K#'( X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB*79C)5=^> >M=9X3G%SX_\ %MW';726]TMFT,TMK)&LFV(@X+*.1D?_ *J
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MB;C@9)<G.!P,8SCG?T!_$L^9?$$.GVI5-BPV4K2!VXRY+ 8Z<*,]3D],;E%
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MV[;X7D3)C;U7T/N* ./U7PKKEZVMZK9RP6^I:@]JBVYF95-O"V6C:11D%]S
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M5(ETX0!'GNIF01DM_"N6(P!TY.3P.HG\)Z;=:7?V-QYTHU%E:\F9_P!Y-@C
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M5'QCECG)!(&1UYK,OM8\3I;^,-+L[^1[_0O)NK6Y\F,M<0NA<Q.-NW< K $
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M.Z%QM #@*,[<#\ZRO$]_JX\(_$#2KG6+J<Z6T7DW.V-)'CEC1C&VU0,?,1P
M<5W4G@ZQE@TV-KN^+6%T+Q)6F#R23 %=[LP)8X)&.F.,<#"7'@K3+P:ZMS+=
M2IK:JMVI< ?*H52N ,$ #\N<T /\1:M+X4\$:AJA>2]FLK9I%,P4%V_AW;0!
MC)'0#@5D7VI:OH6I^&7;4I+^UU>86=PCQH-DC1EUDCVJ, %3D'(Q[\UU*Z3;
M'1FTJY,EY;21-%+]I?>TJD8.X^^?\*S]/\*6>GFRS=7ETNGJ5LEN75A;@KM^
M7"@DA?E!8L0,^IH X=-?\21>&/[=DUR21K7739-;_9X@DT/VKR<-\N<X/!4C
MIWZUW?BB\GLM-@:WOX[)I+N*-G*;Y'4M\R1+@YD(X'![GM5(^!--.B2:0;N^
M^RR7GVUOG3=YOF>9G.WIOYQ_2M+7?#UIX@L[:"[FN(WM9TN8)X'V21R+G# X
MQT)&,8YH RO!>K:AJ%UX@L[]YG^P:AY,)G5!((S&CA6V?*<%CSZ8S52VO]:\
M2VVLW>EZNEA-8:G):1121JT.V)@'\S(W$L-QX(P"ON3NZ-X9L=#O]0O+66[>
M6^=9)A-.S@L%"[@#W(4?TP.*HR^!-*?7;G5(Y[^W^V,'N[2"Y*6]RPXW.@ZD
M]\$ ]\Y- %"+5-4\17'BA;#4I+!M*N#:VJ)&C!G6-7+R;E)(+-C (X'KS65I
M?B76_$VI>%_)U!].M]7TB:YGBBA1BDB-&,H6!_O'&<C':NMN/"=E+J=[?P7-
MW9R7\:QWJVSJ%N !@%L@D-@XW*5.._2GCPM81ZMI^H6[S6[Z?;&TMHHBHC2(
MXRN"I_NK^5 'GVMWVI:Q\'KZ2^U&5[FTU/[(\J(B^>([Q45F&W . #\N.?RK
MKKV^U+3?'7AS3/[2FGLKNVNWG62./<[1A"IRJC^^>!@<"I9/ >FR>'[G1&N[
M_P"QW-T;N4"10QD+^8>=O WC./Z<5I7'AZ"ZUO3M7FNKIKK3TD2'E I#XW[@
M%YS@?EQB@#SK7-1O?$WPPM?$<E_*D5WJ-NZV:HGEK']K557.-VX8!)SUSVXK
M?N]3\1Z]/K\>@3FWN--N_LMNI:/RRRHC$RAE+$,6(X(XQCG-7)/AMH[6=S8)
M=ZE#IL]PMS]BBN-L4<@</E!C(!89QG'/ !P:LWG@/2[O7)-6CNM3LYYT5+M+
M2[:-+H*,#S .2<<9!!]Z ,9[SQ#J/BC6=,77'LHH=*M[N,6T,3^7(_F9"LRG
M*Y4=021T(K-M=1U'Q!J7PWU"?4;B"2^L[B69( @0R"$98*5(R=Q'L#QBNX'A
M>T35[W4HKFYBGN[9;5U0IL6-<[0HV\8W'\ZJ1>!=+AL]%MHY[U!HVX6DBS;7
M",NUD) &01QZ^] &,VNZO')XXA?6((?[.GA2TN+F(;(%>)&/"C+'+$#())P.
M:=I^KZA<:OXJTFYENI+6WT^*XM_M:(LJ^8L@;[@'!V @,,CGITK7O/ NEW\>
MM)<S7CC5Y(Y;C$@4J\>W8R$ ;2-J_ESFG0^"[&"^N[X7NI/=7=JMK/(]QNWJ
M-V&((QGYCVP.P% "?#S_ ))QX;_[!L'_ * *Z6J&BZ3!H6CVNEVKRO;VL8BB
M\T@L% P!D 9P*OT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5@>*M=NM ATR2WMH9EN]1M[.0R.04
M61PNX #D\^H_&M^N*^)JQ/HFDB=ML)UNQ\QMQ7"^<,G(Z?6@#M%=7!*L&P<'
M!SS2)(D@)1U8 X.TYP:\FUNQTKPQK7BAK&WFM]!.A ZC!IS>6!<-)M3;V5RF
M<^V">O*1S6$?BW7K3^U-/L;:Y\,*6?3F&R(AI1N'/SLB<[L#@#@4 >K32NUK
M,;,Q23A&\L.WR[\<!B.0,]:9:33?V?;/?F!+EXU\T1/F/>1R%)Y(SG%>;6ZS
MP6OB31];TK3EO!HGFB_T\8@NH%#A"R?P."3ZCTX%-BMKZX\,^$;C2FTZ]NK?
M0(S)I.H#Y+F%DCW,C?PN"H&2"/FYQ0!ZB\L<<32R.JQJI9G8X 'J3Z57T_4K
M75-,@U&UD#6L\8EC<\94C(/Y5B:=+9ZQ\-K:2&R9+.?3%,=M.-Q5?+X4^O;G
MOUK@M!N;*+1?AK !;?V1.NW4-@78UUY \D2XZDMG@]POH* /8E974,I#*>00
M<@U2,UY'JDWG?9$TQ+<.LAD(E#Y.[<",!0,<Y]:YGPI;/9>-_%EM9@)HZO;O
M'&G^KCN&0F4*.@S\A(]6]ZI3VEM)\3_$4)@B<3>'X6DC*@AV\R4<COP%_2@#
MM;#5+/4],@U&VF5K2= \<A. 5/0_C5L$$9!!%>1:!:+=^ O!X\/W.DC5(K?S
MC9W* PW;B(*ZOMY$@#9!Y(Y[9KO/!-U!J'A"UDBTW[!'NEC>S+!EC99&5E4C
M@KD''MB@"I)XAUO4Y-0/ARSL)UL+YK&2.[E:,NP52T@89P%+ 8P20#R.!736
MLDIL[=KOR5N&C4R")LINQ\VTGDC.<>U>7:;INE_\(=\2&2SM 8[W48PRQJ"B
MK$I"@CH 1G'J*?'I]A?ZY\-X[F"*9)M%G$B-R)%$,) 8?Q#D\'CK0!ZGYB>7
MYF]=F,[L\8^M ="@<.I0\[L\5Y!IUQIECHZZ9,JB!/%US;V432B.VBVEV59.
MVP<D)W;;TZC.N'LI_ OB6W^T6LIM_%,30_9SL5%::#)0 DJIR^,'N>: /<5=
M6)"L"5.#@]#2*Z.S*KJ2IPP!Z?6O*-?@DT#Q#XPA\,P+:SOX;CN1';+M)E$D
MH,@ ZOM[]<XKH] '@S5KW3[_ $22"6>33S"T-M("/)."?.4=P>/FYR3[X .I
MTV:]_LR.35A:170W>:+>0M$/F.,%@#TQGWS69XOU^Y\/:$NI6EO#< W$$3"1
MR %DD5,C Y^]ZBO/?#=WIL7@GP+:W)C\R6ZNFMS<2[;92IER9!_$0#\J\9;N
M,566Z@;X4ZK;)=02"V\2!%6(@*B?;E*[5R=JXR0/2@#VNFI(DB[HW5QG&5.:
MYWQ]=65GX(U.741.;0HL<@@D\MCN=5 +?PKDC)],UYWJ.J7&FWOCLZ-=67VQ
MM'MI8H].X4,/,#L@!.65/XACH.!0!Z/J7B&>R\7Z'H\<,$EOJ/GB27S#OC:.
M/=C;C'/'.?PKH-RXSD8^M>7S-X9/C7P!<:2UAY,T%T@:-ERZ&'Y0WJ<D]><D
M^]2:5I<>GZ_JO@4V2?8)[M=5A/EC9]E8[G3TXE4)CKM?VH ]!A>_.JW*2I:B
MQ$:&!D<F4MSNW#& .F,'UJTDB2#*.K >AS7FUS;6:^+_ !] ;H:=%+HUMYMQ
M&.8<K,"^/88-8^K7NM:3H/B>RDTNUAUB+3[:5[[2/ECN;02LI8*.4<(9/P''
M % 'L*NCYV.K8.#@YP:!(A. ZY SUK@KNSLAXZ\+2Z#';BTO+2X6^2W4>7-:
MB,&-F X(#E0#_M$5SWACP[I5Q\)[:_BFM['492ULFH2+O S>?+&P)Y1F55(]
M"?4Y /7D=)%W(RL#W!S09$#A"ZASR%)Y-<CX'N9S=:W8W^DVVGZG;7$9NFLF
MS;SLT8VNG&1E0,@\CCUKB?%VH:;);>(KJUF@ANK77+57>ZD#7)D22$$Q<@QQ
MA<XZY^?I0![(TB)G<ZKCKDXQ1(ZQH79E4#NQP/SKR^XTG1M6\7^.S<6UM=0G
M2[690V&3<8YCO Z9Z$-U&>#S4'A[5([C5/!-MKLJ/83>&DEMC<D%);OY V<\
M%PG3/]YO6@#NO"FO7.OVFH2W5O%!)::A/9[8G+ B-MN<D#.?H*W?,3S/+WKO
MQG;GG'TKAOA<UDNEZ[;V+PF&+7+P(D3 A4W_ "XQVQTKD]3U+2WN+2_M)[:W
M*>+4$K7$@:Z)$NR0DY'EQXX"G/RXR1TH ]6&N::9M1C^UQ#^S@#=N6 6+(W8
M)[8')^HJQ9WUO?:=!?PO_H\\2S(S<?*P!&?3@UY=+9Z0U]\3HC;61N&B#PH8
MTWD&S5LJ.OWAG([\U)I=Q8B[\ 6FVU.BW%BP<1A?*>]\F,J'QQOV[L9YR?44
M >J[UV;]PVXSG/%('0]'7J1U[^E>+^([);?0?&EN@"Z-;ZS8FPP<+#(SPF<1
MG^$!F/ X!+#UKH=;\,:#8^/?"%I;:;;0P74M\\T2C E)AR=P[@]QTZ^M 'I"
MNK('5@5/((/%(LB.@=75E/0@Y!KQK[5'HNA:E C"VT.V\8/!=!$#1V]N4! *
M] @D9<CIS6\O@[0/$6E^)+/3=5CO5OQ'*&A$9M[6X"G:Z;!@,<*6'<8SUY /
M2,C.,CFD61'SL=6QP<'->=:5=+XIT.]UO5(FTQ]/TV;3WE$>'MIMI^T.GLNU
M0N/1O6K7@QKNP\23:3JFG6 O5T^.2+4M-&V*Z@5BJ[D_A?)/J#DXX% '=NZ1
M@%W503@$G'-*6"XR0,^M<,OD7_Q/UO3==ABF@_LZ!M.BN%#(T7S^>5!XSN*@
M]\ 5R&GV(O+?P%#JH^T0MJE[!;O,V6EM DOEAB?O*5"]>H(]: /:%8,H92""
M,@CO2)(D@)1U8 XRISS7+>+(M)\/?#?4+=H)H=+@MO)\JT?8RJ2% #=AD\GL
M,UQRRV/_  E'BFR;5M/L(+O0(MTFGD!(FS*"PY^8JN,GC@#@4 >M)(D@RCJP
M]CFAG1,;W5<G R<9-<1X,EN[7Q'J.EZKI=C!J2V<$AO=.X@NH0SA"5_@;.[C
MG/;@"HX%M=3^(?BK3?$$,,L2VEN;*.Y *FV*'S&7/3Y\[B/1?04 =C=:I9V=
M_964\RK<WKLL$>>6VJ68X] !U]2/6LKPYX@N-7NM;@O((+=M/U$V:".0MO&Q
M&!R0.?F]*\XTF-&'PXN/$0AD)%\GGWJJ2\(1C#N+=?EVD9^O6DUS3[&Y\-?$
MR_E@CDN[347DMYFY:%Q#"0R'^$Y'48)QCM0![.\B1XWNJY.!DXR:&=$^\RKQ
MGDXXKR_5;K3-1\7:QI7B;4[:R@N-.@-DUVL>QXF5O,,;/P&#]<<\+_=X9%X>
MT?4/'>CZ=>J^HVK^&G4M>??N%66,*SCC)QR,\\ ]10!ZIN7^\/SI">#M(+8X
M!->4ZUX<@AU[7/"-O91+;>)H$N;1_*^2WEC^29N.F!L<?[38[UM^#RGB;2UU
M35-/CCFL[,Z8\;Q ;95XN,?[)*J!Z;6]: .PTZ:[_LN"35?LL=V5_?"W<F(-
MGHI;!_.K;2(B%V=54=6)P*\CT"UO;SX?^"&TJXL'U"&SEDCL-07,-VO"N,_P
MN,C!YZGMFBWUS3Y[KPRFH)'HNBW.G3I;PW:I)#'<K+M9"6&W[H.UNX)Q]Z@#
MU[.1D4WS$W!=ZY)( SU(ZUS_ (-TZPL/#$=EI]]+J&GJ\@AFE(960L?E0C@H
M"2![#CC%>8+I>FI\,HM02"-;RW\0E(+E3B2)?MQ7"-U4;2>!CKF@#W!75B0K
M [3@X/0TBRQN"4=6"G!P<X->6:NND^&O%7BR.*W>UTY_#27%S#I^(W9O,E4N
MN.CXQ\WXFET)=,F^(?\ 9[/I3V=[X=5&M;5@T;XDX4G/[Q@I/.!P>@H ]3W#
M&<C'UK!\3:[=:'/HJP6T,L=_J,5E(SN08P^3D #G[I[_ )UR7A:P;[7'X)O+
M0/#X>NC<^:\8*S0GFV.?[V6.?>$YZUJ_$F.&6W\-1W) @;7K99,MM&"''7M0
M!VRNKC*,&&<9!S2)(DF=CJV#@X.<&O']=LF\,WGB\^&8&M](2QM)+R&T'R1R
MF7][L4<!O(Y('J#Z5U7A:V\/R^)FU;0];BNWGL0DL%D(UAV!@5=U0</R0,\X
MR.QP =LSHGWF5>,\G%!D0.$+J'/(4GDUY[JNA:1K/Q?:TU*SAN(9M +21/T<
MB< $CN1V/; ]*PX_[(UL:Q9:WK0T_6[35Y&5$2-;H;9<P>26&X@IL4 9R"1W
MH ]>9T0J&=06X )ZTH93T8'C/6O(]2U#2[W1OB'#K;VO]LV\EREO'<E?,6$1
M P&,'D#^(;?XB35_2Y+&Q\;Z!/>/;V\5QX4V,\Q55D(>(D$GKA?TH ]"U"2^
M2. Z>MJY,Z";[0Y4"(GYBN <MCH#QFK1=%."R@\<$^M>+:<;.3X<^$60Q%[?
MQ6BKC&8\WLAQCM\N#CTQ72:;H6EZA\2O&#364$\]J]C<VZOTCF\MF#@=CD#G
MZ^IH ]%\Q#(8PZ[P,E<\X^E8'C+Q#/X:T"34+6&">2.2)6CED*X5Y%3( '."
MWM]:X/PG_8VN6?AV\N=;\KQ%9W(\^VC2-+IY^5E208WE#\Q;V&>U95]>:;J/
MPBO+S5&MO^$ACU53>&8@31S"[ QSR (^ .FT4 >I^--=NO#/A.^UBTMH;B2V
M4-LE<J,$@9X!SUZ<?6MT.A+ ,I*_> /3ZUQ_Q2=9/A;KCHP9&MU8,IR"-Z\Y
MK,F\.Z7;?$?2/[&M81!>V-S_ &O''\R3PD+Y;2=F8N3ACR?FZX- 'HFX8SD8
M^M#,%4LQ  Y)/:O,O#FG>5?'P%<V@>TT>\-\LCQY66U)WP GNV\X/J(F]:Z+
MQU=V$$.BP7RY,^IQK"))?+A\P*S#S3CE1@G;W8+TZ@ ZH.C('#*5/(8'BA75
ML[6!VG!P>AKPVZDLI/!7B:%KJU=;;Q3$\9MVV+'&TD&60!CM4Y?D'N>:W=:\
M/V.E>*=;AT>V2&PG\-W$NH01?ZOS0?W3D?WSA^>IVDT >JB1&;:KJ6QG /;U
MKF-)\0:OK.F^(3!:645_IU_-9P))*WE-L5""[8SSN/05Q5CHEC;6GPVU;18U
M35[AK=+B6)LM/;_9R9MY[A<*!G[O &.*9J20S?#KXG^8$;9JUVPSV81Q8/US
M0!Z[Y@2)6F9$.!D[N,^Q-.>1(QEW503C+'%>=7.HZ5_PG3Z=XGDMDL)]%B.G
MF[8+"V2PFP6XWD;/? JK>-X?CO=/TF"166'0I/(FU63S(C;EPH*J<;W;:.<C
M"XZYQ0!V6IZ]<V'C#0]'%O";744N&:8N=Z&) V,8Q@Y'.?PI/&7B"X\.>%+G
M6+*""Y:$I\LDA"X9PN1@'/WNG'UKSK1A8ZW;?"Z&_>*[A>QNHIDD?<&80I\C
M<\_[IIFK6*:5X%\?6MC\FA1ZA +%<_(C;HO-5/\ 9$F1@< @B@#V9Y$CQO=5
MR<#)QDTDID$3&%4:3'RAS@$^Y ->:Z[/IE[XWUS1_$NI6UC;S6,/V(W:Q['B
M(82%&?@,&ZXYX7^[QW?A^&.V\.Z?#'=7%S%' JI/<_ZR10.&;IR1@T 9W@CQ
M)<^+?#4&M3V,5FD[2*D23F4C8[(<G:O=370M(B%0[JI8X&3C)KSWX3:II]K\
M+-.:XOK:)8WN2YDE5=H^T2'G)XXYK'\9ZEI.J1^*VC,*7*:"C[K\Y.&21XQ
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M"S10,V,!V POWE^F1G&:-4\5:3HXN&NII-EJJO<O%$TBP*W0N5!QZ^N.>G-
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M 2M*+&V\QEV%_*7)7&,9QTQQ4,^F)!9.-)MK*VO(X7CM7: ;(R>0,+@[<X)
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M@8,D6\DEW(4DG)R6P,@ UWG_  B.@_\ 0-B_[Z;_ !H_X1'0?^@;%_WTW^-
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MUU%Y>V6CZ=)=WD\=M9VZ9>20X5%Z<F@#!TKQ7)K.E>'KNTMX6DU0%IHS(?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4@ 4    < "EHH 3 R3@9/&:22-)8VCD171AAE89!'N*=
M10 BJ%4*H 4#  [4M%% !1110 4444 %%%% !1110 4444 %13VT%U'Y=Q#'
M,F<[9%##\C4M% #418T"(H55& JC  IU%% !1110 4444 0"RM!<_:1:PBX_
MYZB,;OSZU/110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$4M>8ZK>ZYX*TW3M#AO$2SM-%?R[U=LD\]U&O"B(Y/EX&20. >6&.<Z_\?\
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M?'W>HSR._O6:OQ.UW_A5N@>)I[=RDUXT.J7-I"K-%$K,NY5;*@G Y/';C(H
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M$?-Z^N<#@8YKUNQD::PMI7.7>)68^Y JDWAK1'CO(VTNU*7IW72F,8G/J_\
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M5I/=20F!Y7B!9D((()^A(_&G_P#"/:-NL6_LJR!L,_9,0*/(_P!SCY>@Z>E
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M%MPZ,NIS+IK:0U\;<1Q\R"8)C=MW8P>F?QKK+N[@L;9KBYD$<2X!)&<DG
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M^[N0KN&<C!Q@T'QMH N[BT^US&Y@02>2+64O(A. T:[<R#@\ID5QWB&T75O
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M5P'@/Q]I]WX;T"VUC52^L7R;=\D3!9)-Q^7>%V;L8^7.>G%>A5Y1IFB7U_\
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M,2>2)"^T'D9) YQC(QQ5?7==AT2.T#*KSWD_D0(S%5+;68DD D *K'H>P[T
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M[G  ]233STXKR#Q)J>I:]\,O'+:O;6A6SO)H8?+D+^68V10 "H]SNSDDG@4
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M#;01M)+(W15 R2?PJEINNP:E?7-D+6\M[BW1)&6XAVAD?.UE(R#T/&<C'(%
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MO+R*&Y65IH+NVRVQ_.,R-@@=&P,=P.U==:Z?IVEJWV2TM;02, WE1K'N/;.
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MCKZ* ,SP]87&E^'--TZZ,336EM' S1$E6V*%R,@=<9Q5+QWQ\//$O_8*NO\
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M>F5Q^.?:LW2?">J:=X3LM#NHM*U"WCEG-U!.6\N9)'9QC*'!4MZ'IVSQW%%
M&'X2T%O#7A^+3#+O5))'C0,66%&<LL:D\E5!"@GKCMTK<HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JKJ5_%I>FW-],"8X(RY5>K8' 'J2> /4U:K/U;2(]8A@BFN+B)(9DG A
M8#<Z,&7.0<@$ XZ<4 >:VSS>%O&NAZS<6EU;KK*FPU>25-J&Y=C)&P.>S%D&
M>BX%=9K>KW,'C"#3+F^;3=+DTV2>.Z7:-\X< KN8$?*I# =\]\8K7\1^'+/Q
M1I#:7J#SBV9U=O)<*Q*D$<XR.0#QBN2\0Z9=-XGC>XB\3""*S2"WO](G&Z0[
MB7$JC&,?+@[>><GI@ J1ZIXM.A^#)+W5)[6^U:^\F[1K6(%4,<C#"[>#\@(S
MW.#G&*T!<>(;K4-3\.VFJSRW>EVD.+O]U&\DL@=@[J4(*C"C  Z-G.1C0L/"
MLM[:V+ZK?ZJ[V-X;JQ^TRQM-'\NT>857#'E_7A@#DBKFM>"]-UK5X=6-Q?V.
MH1Q^2UQ87+0M+'G.Q\=1G\?>@#%BU7Q%J6I?V#-,D&H6VF13W,EC*@#S.SH2
MN]3\JF/ICJV#TJ$7GBI=;\)Z7J.KQP7%]:WBW_V.-'0R1;<.A9>&^;D$8![<
M5NZKX%TG4Y[&YCDO=/N[&+R(;FPN&BD\K^XS<[E[\]_K5K_A%; :EI=]'+<Q
MR:9')';J) 1B3&\MN!+%L#))SGGK0!P5SK?B2T\&:]JO]OSO/H&J2VT0,$6+
MF-)%'[[Y>3M;'R[?7FN@U#4=>UO5_$6FZ+<M:SZ7Y<4!5T \QHA(&<,C$J2V
MW QPI[]-*7P+IDVC:II4ES>M:ZG<M=70\Q06=B"V#MX!(' ]..]&H^!M-U'6
M$U8W>I6M\8EAGFL[HP&Y0=!)MQGZC!_2@#(2Y\1:CXSCT:?6VLTDT*.[F%E'
M&XCG,FUC&S*?EX_B!X].V';ZEJGB&R^'-[=:I<17-Q=SQS- $4.R13#?M*D9
M.WTP,G %>@)X9LX=<&KP37$-PMF+%%0KL2$'(4*5['G/].*HQ> ])ATG3-.C
MFO5CTRX:XM9%GVR1LV[<-P )!WM^?7I0!4UJXDL/BGX5\DG&HVMY:W _O+&J
MR(3]#N_[Z/K5O4]6N)_'5CX:AN'M8GL);Z66,#>^'5%1200.I)[\#WJTNCM>
M^+8M9N$*16%N]M9HW4LY'F2'TX55'?[Q[BK&J^'[35KRROF>:WO[(L;>ZMV
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M&*"^NFFC@C/!1%/ &..YQQG% &?IG_"4W-]I-Z-01M,N[9OM?F21D[F3=&\
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M>0\[8PX4E9.Y!(.1CH0*[ZL/_A%K-IT::YNYX([PWT=M*ZF-)BQ;<.-V Q)
MSC/:@"MXDUFXM=?\.Z';RFW.K3S"2X4 LB11ERJY!&6.!G'3/?%<1XTU34%T
M'QUX=O)VNXK.UM[FUN74!PDC<H^T '!4X.,D=?6O2=:T&RUV&W6Z\Q);683V
M\\+;9(9!T93]"00000>156;PEI=WIVI6=Z);K^TP!=S2/B27:,+RH 4#'
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MRE,!B!C)7'.>30!REMJ.I^(S\,]0N=3N()[T3M-Y 0*7%N_S[2I&3R.F!DX
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M>/Y97XZ$(RR#U8>IK5\#K_PD%C!=:KI\23Z5;-I3H\0QYRG;.1Q]T[4Q]6%
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M--&OVD<5M%((88V=86^<@$+'N!+<=,B@#U*^U:QT[2;C5+FYC2SMXS))+N!
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M7F)Y@Y*[AG\J?7F-HT^E^*K&:2*RU?2KO6;A;6\C&V[L[AO-#H_]]!\ZYX(
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MQBC6**.6SC?]V!@*V0=V,=?3\SU5% '.1Z!JUI:"WL-=2W13\J)81*JC/.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9P@R,L>!GK3+_P 3:+ICJEYJ,,9,/VCJ6"Q?WR1G:ON<"@#6HI 00".0:6@
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M#0HK('BK0C#=3?VK;*EF%-R6?;Y&[.-X/W<X/7%6SJVG"]2S-[ +F2(S)$7
M9HQU8#N!D<T 7**Y[3O$&G6^F+<7OB6QO(Y[QXH+@%(U8E\+$N#ABO"Y'7&:
MM1^*-"ET];Z+5+:6U9G59(WWABOWL8Y.._I0!KT50;6M,6P@O1?0-;7&/(D1
M]PE)&0$Q]XX!X'I6'X&UVZUZ'79+B\BNH[75I;:WDB0*OE*D9 X]V/7F@#JZ
M*J7NIV6G!#=W"1%\[%/+-CDX Y.._I5>3Q'HD-K:74FK62P79"V\AG7;*?\
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M# @C;,H:&-5*#'S D$9'I7INDNLFCV3*<@P)_(5:21)%#(ZL" 00<Y!Z&G4
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M"1U.63> 0,]-V#CD5N?#UPT_BHB"XB6;7)IXS+;O&'1DC 8;@,\@^_K7;44
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MNV9XR>,]:]%HH \GO8T?0_BBBP,9+IY! !$<S?Z.BKLX^;YP1QWK4W1+XO\
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MIXF29RG[YF;YB4!&-W8'.*K0^$]:M;;P6\,E@;K08&MIE=WV2*T(C+*0N<C
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MNVHK;3N;Y6[ =.>15(^/[BZETN'2_#US<S:E827D$<TRP$%"H9&SG:<MC/\
M/K4^JZ'XBM/%LFO>&YM/=;RW2WO;2_+JI*%MDB,H)R Q!&,?TE;0=8;QAHVK
MRS6DT=G:307#%F1G:4JQ*+M( &S !;.#UXY *NI?$&.PM[N>.RBG^PR+%=6Z
MW:_:-^%+B., ^9MW8ZKD@X]Y=<UT:MI^O:?IVGQ7\5I:?Z49I?+&YX]X11M.
MY@N"<[0,@9ZXBAT'Q3HVOZF=%N],;2-3N#=-]K#^;:RL '* ##@XR 2.?U8W
MAC7=-UG7I-*DL;C3];0-(+N5TDMYA'L+#:I#@@ X^7GO0!J> #CX<^&SC/\
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M7#!!G 7'\'KWJ/POH/BO0(8-$EO=-ET2S;%O<@/]J:('*QLN-H[*6R>.V>0
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M/+3S/,V+OQMW8YQZ9IU8WBBZU.P\/37&E6\MS=1M&3'"%,C1[U\PH&X+[-Q
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M# XZG)YZT >GT5Q"ZQJVO1>*)]-U V3Z1=26EM$(D99'CC5B9-P)PS-CY2,
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M%Y+=SQZM,L\X9U!210 KH54%2-J_E]:Z?(P3D8%+0!CZ%X?CT.-\ZCJ&HSN
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MC:5Y2HP7?&YO<X 'Z4^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.CM!- VDV)BF8-+&;=-LA'(+#')^M+)HFDS+(LFEV3B4J9 UNAWE1A<\<X'
M]* .+\2:9I?AO4?#[6RV\5C-J4L]Y923!?M3F$@29D;:2I ;!(R>?O8SB7$
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M/6+3Q\FN)&M_8W4HA=^'MK=8E,#QGJ@X+ COFI=-FOY_$_P\DU;(U%]%NFN
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M90)]HAE*OF.,!)5D( 53UVX_&MRVTNPMK5X(M/M((Y1^]BBB4(W&.>!GTY%
M'E&G)&?AM\,I3]]=5M%!SV._(_0?E6G'-H.M7/BRQ\472V^I6VIGRF,@2XB@
M788#">HSC^'J2?6O0/["TCR(H?[*L?*B;?&GV=-J-Z@8X-23:3IUQ?Q7\VGV
MLEY",1W#PJ9$'LQ&1^% 'DWCN\L)K/Q?=6TD<=[9SVJM+=R S)(HC(6 <%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>exhibit1061-loanandsecur011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%%  <X..M<[IGA_P R:_NM>L-.N+NYN#(K
MJ/-"QX"HF648PH'3@DD\9KHJS_[<TW^W5T3[4IU%H6G\@ DA 0"2<8'+#C.:
M .3T;PIKFCZ%XAT6,:=]AO9+A]/C$[_Z,)<Y0_)]T$DC'J1[UT7A+2[O1/"F
MF:3>F!IK*W2W+PN65PJ@9Y (SCI5^_U2STQ(VNY@AE?RXD"EGD;T50"6/4X
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M3B>!V+W+0@B/*E0$YPQY;I@=>%L/#&MV^@^*+$7EO:76JW5S<VMQ;R,QA,H
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M[0[?5([XVY-WJ5Q>IY#LV!*^[:<J.1T]ZZ*BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*XZ]_P"2P:1_V!;K_P!&PUV-9$WA^";Q-!KQN;D74$#6Z("OE[&(+#&W/)4'
M.>U ''1QZSK'Q)\4W-E=6L5QI%O!:6*74!D5?,C\QCPRXW' )Y.![5FV^N7_
M (]U_P '$".RB^P3:H\4L9D1KA'$0XR,[22R\\9!YKT.Z\/6\VJRZE!<W-E=
M3PB"=[9E'G(,[=P93R,G##!YZTR3PMIOEZ6MHKV3Z6I2SEMR T:$;67Y@000
M!D$'D ]1F@#B=1U6[\0>&[_3M3E%KKVF:W':6-S9IA9;D8:%PK$X!5OF!)P
MWM6OX'O+J;7M;AU^V\CQ.BPBX*?ZB2W&X1-#_LY+DYYW$Y[ ;K^%--DTXVA$
MH<W0O?M(8>;]H!SYN<8SVQC&.,8XJ[9Z3#:7L]\TLMQ>3(D3SS;=VQ22J@*
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M<*&(+%F]@JL<=^!QG-<AX8N#X6^(VK^&;Z[MBFK :K:>4OEJ)6.V5 I9B"2
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MRKTY6#*&4@@\@CO0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !UID<4<0(CC1,]=J@9I]<7\0]:U?3-+ T%0]Y;#^T+A?6VB92Z
M_5LX]P&H ZX6MN,X@BYX/R#FE%K;@@B"+*]/D'%8FL>*K>P\#S^)[2%[RW6S
M^U1+'CYE*[@3Z#UJC)XSFCU?P_IQTJ[W:G#)*[E!P$49 &[U93]/KP =1]EM
M]A3[/%M)!*[!@XZ4YK>%\[H8SN.XY4<GIFN7E^(NAQ17,Q6_^SVEW]CN9OLC
MA('RHRY(X&6 ]?;'-;_]IQ?VV=)\FY\X6WVGS?)/E;=VW&_INSSCKCF@"Q]F
M@SGR(\XQG8.F,4&UMVA:%H(C$WWD*#:?J*Y?QEKUY9:CH.@:9*(+[6KEHQ<;
M0QAAC7=(R@\%L8 SQS5ZYT"YB6V?3-5OXY8[B)YA-<-*L\8<%U(?.W*Y^[M]
M.G% &V;>$Q+$88S&OW5VC ^@H,$3! 8D(C.4RH^4^WI7GFB^+H= ?Q0VKSZC
M<V]MKCQ><4>9;:(QQ8W-_"H)/ ]SBNI-_IY\=BR-U?+?IIS2F EA;&+S%&_!
M^4OD@9'09% &A>Z5;7RP1RHOE13"?8JCEP=P.<<<\\8S],@WJP8_%^F27]A:
MLMQ&NHAC8W#QXBN<#.%.<C(Y&X#(Z9KGM%N;GQ=K>L&>?5[%M.U4);M!(8T6
M-$C)C=<E6+%FSD'@C!X% '<"SM5N3<K;0B<\&4(-Q_'K4@AB$GF"- Y_BVC/
MYUPWC>_>P\6^$XGU6>QL;V:>.[(N3$C*L19<G/R_-CD8SFM;3+RP274+W3=6
MNM5MK:,)-#'-]IVN/F^0YY;:>1GTQS0!T1@A:3S&BC+]=Q49_.EEABF"B6))
M K;EWJ#@^H]ZQM'\6:;KPLFTX3S)=P-<(X3A$#%?GY^4D@@ \G!]#AC^+],B
MN[.*03I;WMQ]EMKPQ_N99><(#G/)!P2 #C@F@#?J.."&(DQQ(A/4JH%8EQXP
MTNVFB#^>;:6\%BMVJ9A\\G;LSG/W@5SC:#QG--E\9Z7!I6K:C(MRL&DSM!>#
MROFC8!6/&>1AAR,]: -T6\ G,XAC$Q&#)M&XCTSUI7ABDD21XT9T^XQ4$K]#
MVKG3XK)\;_V MA<&-;$7;3A,@[GVC SG PV>.N/QIV/BS1=,\/OJ*3ZI<V4F
MHR6YEN59FCE:7;M.[!5 QVC/ X!H ZZ2*.4 21HX'3<N:<JA5"J  . !VK/N
M=:M+*YGAN=\2P6WVJ:5@-B)DCDYZ\'CO@U7L_$MG=:T=(DBN;6^,'VF.*YCV
M^;%G!92">AQD'!&>10!LT5R'B;7+O_A+-#\*Z?,;:341+/<W*@%XX(QG"9X#
M,>,]AGOBJOBR^G\#1Z?K-M=74VGM=QVU];7,[3 QN<>8K.2RLIQP#@@GCO0!
MW-%<%J=_<:WXYO\ P])_:UM:P::DD<EE(8G65I''F94C(P@QG(ZY'-8]O??V
MSH^O7VKZEXBL8])O9XS<V<C(?(B55*LJ97<?F8G;D$Y!&!0!ZK16)%KEG;V6
MG06XN[V:>T$\,*X>9H@!\[$D#N.2>2>,TEKXLTS4=-L;W3O.O1?1O);PPIB1
ME0X<D,0%VD@')') ZD4 ;E%<M_PL'03::?<(]U(+^9[>%$MG+"5 =T;#'#?*
M1MZGMZUOZ;?IJ>G07L<-Q"DR[A'<1&.1?9E/(- %JBBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO*7R$:)TR^& 9\L"=N?3G&3W]%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ****  YP<=:Q]%TNYLS?2ZB]O/<75
MRTQDC0C"X"JN#G[JJH]^O>MBLPZ_8#Q&F@[I?M[V[7(4Q,%V*0"=Q&#RPX&:
M //]>\.7OACX;^-XI;NV?3KM;BZMX$0J;8OR4!)P5STX')/K741>'I=;GTF]
MUA[:2&RM72&.#.)6ECV,[$]!L) 49^\3D\5LZOJ&FVBP07ZK-)</M@MA'YCR
ML!_"OL.IZ =2*?/J%EI&E"ZNPMC;H -C 9!)P% 7.22< #.2>* .8M/!%XOA
M^Q\-7U]#<:/8SQR1OL(FECC??'&PZ#!"@L.H'09S5L>&+]=5\4W@N;;;K4,<
M<:E6S#LC,8)_O9!SV]/>MB?7+>TT]+RZAN(!)(L4,3H/,E=B H"@GDD]#C'.
M< 5)8:O!?W5S9A)8+RV"--;S !E5L[6X)!!P>03T([4 <Q:^"KW3T\-7=I>6
M_P#:>BV?V!]RL(KJ#: 0>ZG*A@><'L:W="T/^RI]2O9I%DOM2N!/<,@PHPH1
M47V"J.>YR>,X$^HZW;Z?>060BGN;V=6>.VMU!<HN-S') 502!DD<D 4NDZS:
MZRERULLZ-:SFWFCGB,;(X56(P?9AR.#VS0!5DT66ZUG4YKP6\NGW]E'9O!@[
MMJF4DD]#GS2,=L=37-77PXE'PX7PE9:BNYI(WEO;E2[-L=67@'LJ*@YX"BO0
M*Q8_$UM=S3IIUK=ZA';N8Y9K9%\M7'50S,-Q'?;G!XZT 96I^&]='B1?$&@Z
MG9VEW/;K;7UO=0M+#*%)*N,%6##<PZ\Y_,N?"FJP>(K'7],U2%M02T-E>B\B
M)2XC+E\C:04(8G Y&#CM71:5JMKK-@+VS,AA+O'^\C:-@R,48%6 (P5/45=H
M X#_ (0/5?\ A&I]*;4[-WEUC^T_,%NRA?WWF[,;CG)'7M[]:O2>%]=L?$]_
MJFA:M:6UOJNQKVWN;=I?+D50OF1$,O) '#<9&>>E=)J>J6^E01RW!8F:5((8
MTQNDD8X51G S]2  "35'1O$8UB^N;3^R-5LGMP1(]Y;A$W!L;58$ACT.1D8(
MYH P-7\#ZI?W.O+!J\/V75M.6R)N86DEAVH5^5MP&UB=QXZYJ_#X9U)=>\/Z
ME->6LG]EV4EK(JQLOF[]F2.3C&P<<Y]JZIFVJ6P3@9P!DUF:!KMKXCTO^T+.
M.9(O-DAVS*%8,CE&X!/=30!0\<>';KQ7X7N-%MKF&V\]HV::12VW8ZN, 8SD
MKCK4?C#P[?\ BC0K>PCN+:VD6XBN)'96<9C8, !QU(ZUI66OVM]K^I:-'%.M
MSIZ1/*TB85A)NV[3G)^Z>U:I( ))P!0!S#>'K^T\5S^(-,FMEEOK9(+ZVFW;
M&9,[)%8<Y )&".1Z51D\#2PZ;H5I97<6[3]4_M.>25#FXD)<L  ?E!,AQUP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME70@O;E;J=!=R?-*I4AOO<'*J2>Y SG% &!XOT6>T?PO'-K6I7;2>(HB'F=
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M)"^P>@)YQ3+#0K+3M6U#4[?SOM.H,K7)>4L&*C:N >!@<<4 :=%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPRY[,.JYXSUZY$&OZ1?>,VT^PNK"6PTJ"Z2ZNC<21M)/LY6-0C, "<$DD=.
M<Y'844 <K;:?J,?Q)U#5FL'^P3:=#:I*)$R71W8G;NS@[_TK(M=#UI?"'C/3
MY--=;G5;F^EM5\Z,AEF7"9.[@C//]:]!HH \\&D^)-%U71=<T[2UOF72(],O
MK!KE(W0H=RR*Q)4\E@1GIC\)]<TGQ&-7TGQ%;Z99:G<QP2VUYIK2JH$;L'4Q
MNXP64J 20,^V:[RB@#A]1TK6;N[\,70TB&+['J#7=Q!;RIMA0Q,@7)QO;Y@3
M@8Z@=!GN*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **8DT
M4DDD:2HSQD!U5@2N>F1VI] !1110 44R&:*XC$D,J2(20&1@1D'!Y'N"*?0
M4444 %%%% !1110 4444 %%1R3Q0F,2RHAD;8@9@-S=<#U/!X]JDH **** "
MBBD9E12S,%4#)). !0 M%-CD2:))8G5XW 964Y# ]"#W%)%-%.I:&5) K%24
M8'!'4<=Z 'T444 %%%% !1110 4444 %%%% !13(9HKB,20RI)&20&1@0<'!
MY'O3R0!DG H **0,K?=8'Z&EH **** "BBB@ HHHH **** "BBF)-$\LD22H
MTD>-Z!@2N>F1VH ?113)9HX(7FFD2.) 69W8 *!W)/2@!]%("& (((/((I:
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MB>XL]0CT^);:??'<R2;/+*MC@'>,]<8/6M/Q=HM]KFF6L.GW$,<D%Y%</%<
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M !1110 5$UM ]Q'</#&TT8(20J"R@]<'J,U+10 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYB.5E8#!8?7&:AUGPIH/B&>"?5M)M;R:#_5O*F64=<9]/;I6LB)%&L<:JB*
MJJHP !T % &'XIN)#8Q:9;0RSSW[^6T<+*'\D<RL"Q 'R_+G/!=:\Q\ SR>!
M_BSJWA.XMI;+3M9!O-/AF*_(W)VC:2.@9>O\"UZ_+I-A-J<6I26RM>Q*4CFR
M=RJ>2![' R.]5;_POH>J:E%J-]IL%Q>PX\J>0$O'@Y&T_P ///% 'DNKZ5XE
MU,^-;6/[9=ZY)J<*Z7=6TAV6\.X,4W@XBPA^9203D=<@U?U^PN#\8?"F@KJ%
MY;6T^DR+<BWN7'F;4DSR3G/&-QYQWJ74/A.U_K&LWUQ#<K=WMW)/!-8ZB8(@
M#]TNI4D-ZXW9/3T'>:5X2LK:+2KK4D2_UJPMD@_M&0'S"0N"0<Y .3]<G/4T
M >>:G%-IWQ$T3P,L\D^EKI$AMEO[ME\Z=F<;F8*=S* =HQQVQQ45U>ZW8^*O
M!/A;6[^VU*%K:<32-<-'#=SJ710[;26*@*,$?>/KBO4];\,:)XC$(UC3+>\\
M@[HC*N2A[X/7L./:FZIX4T#6;"WL=0TFTGM;;'D1M& (L#'RXZ# '2@#R7Q7
M:ZSHVE> ]-O];DN+L:T+2:ZM+APSQEQA&;@D@<<^E9UU;%;CXIV"W=\+33(E
MN+2'[7)MCD*D[OO9)X[U[7<^%=!O(+*"?2K9XK$YM4V8$)]5 Z'CK3'\(>'W
MDOI&TFW+WXQ=L0<SC.</_>_&@#RD>)-2N9OACI]]*LUEJ%B9)Q<S&-+J81[4
M$C $G!VG&#DL,TWQA::SH?AWPCI]YK3S72Z\MLUQ:7#AA"QR(V;@D@8'/H*]
M7N_!WAV_TBWTFZT>UEL+<Y@A9.(O]WN/PJ2X\*:!=VEG:3Z3:O;V1W6T6S"Q
M'U4=C[]: /)].5TN_BWHOGW+V%M;&2")YW?8QCD)().>2!GGG'-=#\+;_0_#
M?PJT2]O[V&R-Y^[9YYB [^8X4 $X'0],=#Z5W=KX<T>RO;R]M].@CN;T$7,@
M7F8'^]Z_C54>"?# TU-.&A6/V-)Q<+#Y0VB09PV/Q/YT ;U%%% ')_$W_DF7
MB+_KRD_E4'BK_DCFJ?\ 8$?_ -%5U&HZ99:O9/9ZA;I<6S_?B?[K>Q'<4R71
MM.GTDZ5+:H]@4\LP,25*_P!WZ>W2@#B;"V.E^./#<4%U=F/4](G-TLEP[*[(
M(BK $X4C<P^4#@U0TK^V;KP4@T^=;RZAUZ['V6]N6'VV)))1Y/F')S@!AGCY
M.>*] 'A_2ENK6Y%FOGVL9BMY-S;HD/55.>!_A42>%M$CM5MH]/CCB2<W*!"R
ME)2""X(.0WS'D<\T 4_!&HV^HZ#(T-O>6SPW4T4]M>-ND@E#99-V3E1GCVQ6
MIK>H-I>D3W,2"2XP([>,G DE8A47\6(%6;.RMK"#R+6%8H]Q8@=2Q.2Q/4DG
MDD\FHK_2K+4_(^VVZS>1()8LDC8XZ,,=QZT >;75M?>"_$WAO7+FUAALY%&D
M:E,EP9#(9&W)*XVKC][DD_[=;^N--)XX:UO%N+G3'TAC%!:EBT<_F$%RJ\@D
M8"N> 5;D<UU&JZ-IVN6GV35+.*[MLAO*E&5)'0D=ZXWQ!X/EO_$!N+CPWI6M
M6 MXX;7SKEH9;8+DL"=IW DYSGC'2@#*?2=5L[;P#8:OJ.HB^N;F2/4-NH2M
MYA,#DJ3N/H!D=.=N.M6?L!U#7M:\)KJK6RZ?9P+8_:))7E5&0DS*PD4E@QQD
MYQM XSSTVD>#=.M+*V2ZLXB]M,T]M&LKR):$_P ,;-S^/'4\ <5>UGPIH'B"
MX@GU?2;6\E@_U;S1@D#T]Q['B@#BX7N=:UYO#E[KD4YCT>WDMIW1T^U%MXDG
M0+(OS<)SDXZC&3DBLIV\5>$]-N]>O-2CDTR\2XGCFDB6Y,;1A6P&X/)RP.3Z
MD&NTUGPKH/B!;<:MI-K=_9_]3YB<I[ ^GMTJPVA:8U[;7GV*,7%K'Y4$BY4Q
M)TVKCH.!P/2@#RB>.:U^'^M:C'J&H&ZT77)+>P=KR0^5&MTJA2,X<;6(^;)Q
MQT KH+Q;CQ3KWBO29-8CT^YL7C6U)WB2WC,2LLR;9%'WRV3CL 3CBNN;PIH3
M6,]BVFPFTN)?.FA.2LDF<[F&>3GG/J!3=2\(>'M8O+:[U+2+2[N+8!8I9DW,
M .@)/WA['- ')0:?_:WCV73[[5+ZZM9/#MM._E7,D*2R&1U,@4-\F0H.T''K
MFL321_;5O\+KS4I9I[B5;F.29IF#,%@?&2#UX&3U/>O4VT336U&343:K]LEB
M\EY@Q#%/[N0>GM5?_A%- ^P6M@=)M3:6DGFV\+)E8F]5';J>.G- &QU&17GD
M+0^*+OQ?:ZEJD]A=Z=>B.&2*<QM9P*B,DBCH-QWDD]1QT KT.L>^\*:!J>K0
MZK>Z1:3W\.-D\D8+#'(SZX[9Z4 <W8,OB?Q7XHTW49KD)91VR6BK(T3(CQ;C
M*,8PY8GGMM XYKGM%NM2UZ3X?/JM[>B2]MKY;D17#QBX6,81R%(P2O.1@_-U
MKTN^T#2]2NUNKNS1[A8S%YH)5F0\E&((W+_LG(ITNB:9->6EV]G'Y]FI6V<9
M!A!&"%QT!'!QU% 'GFG+J\GAV_L=+G6Y?3_$EQ!!9WMRP^U0("WD>8<GH21G
M(^3!XJK>26.M6/A9_LM]:RP^)_LT]M=3,7MW*2,T88'D?=VD=L 8Z5Z*/"NB
M+&R+I\:AKC[62K,#YV"/,R#D/@GYNM23^'-&NM/6PN-.@FMEF\\)(N[]YG.\
MD\ELD\]3DT <?=1"7Q=XOL6GN);,Z% ZQ-<.RJ3YH.W)XSM&<=:S-'46&A?"
M]K6>>+[2T*S@3OM<&T8[2,XQE00.G'%>D1:)ID.H2W\=G$MU+&(I) .60=%/
ML.P[53/A#P\=(32O[(M18I*)DA5,!7'1ACD'MGTXZ4 >:^*<77ACXCPR3RRP
MVFHP>2C3,RQ_)"2!SP,EN.F:Z:_Q?>-Y?"[7<<%JFF)-:Q3/(QE9I)!(P8.I
M++A,9)(YQBNH3PKH$<-["FD68COE"7*B(8E4   ^P &!46H>#O#FJV5K9WVC
M6<\%I_J$:/\ U?K@]>>_KWH XV\AUO3M-TYQ<GQ9;6-G)%>I%*;>X/SD">/D
M[F 1EZY.,@\FN]T"ZM[[P[IMU:2R2VTUK&\4DHP[*5&"WOZTV?P]I-PT3-9(
MIBA^SIY1,>(O[GRD?+_L]*T(HHX(4BB18XT4*B(,!0.  .PH X?7[&VE^+/A
MF64,"UC>$L)67[IB(Z'IR?ZUR5Y ;;PGXNUN"YNHKVQ\2RO;M'<.BH?/C!RH
M(#9!(.X'BO6K[1M-U.XM;B^LH+B:T8O \B F,GKC\A^0JHWA30GLKFS;386M
MKJ7SIXCDK+)G.YAGDYP<GT'I0!R5ZMQXH\1^*M'DU9+">R\I;4G>'@C:)6$R
M;9%&=Y;)P>@!XXKN]*+G2+(R70NY# FZY";!,=HR^WMGKCWJAJ?A#P]K-U;7
M6I:1:W<]LH6*29-S #H"3U'L<UM 8&!0!Q=Y<QZI\1KGP]J,KI;+I23VL*R%
M/-9G=9'XZE0$QZ9)JA:2[_%^B^&;G4KB_P!,32)9HYYI,&\G64(=Q&-^U<GW
MSGG@UUVM>&=$\1"#^V-,MKPP'=$94R4SUP?0]QT-2W>AZ9?0VT4]E$5M"#;%
M!L:'C'R%<%>..,<4 >7W5QJ2:9-9-J%]Y%AXNM[.TG%PP9H&DC)C8Y^<+N(^
M;/3VK8BT2"7QKXET5KO4?[.%A;W0@^W2\2L9%+!MV[^$<9QGG' QVL_AW2+B
MR@LY;"%K:"3S8H\8"OG._P#WLY.>N3FG?V#IGVVXO/LB_:;B,132[FW.@Z*3
MGD4 >9:3+=:ZOPX6]U+4,:AIMR+L1W;IY^R-,$X/7D_,,'D\U7U5+JQ\#>.-
M':YN+K3]/U.VCLY9Y#(RJSPNT>X\D*6QSSS77ZEX/4^)?#)L-,2/2-+6Y#K'
M+Y9C,BJ%,8!R,%3G!'7C-=)-X=TBYTHZ9-80R6+/O:%AE7;.[<W]XYYR<\\]
M: .0U'S_ !'XP\0:!+J4=FUM:PFT5MX95=23,FUUY#<9YQM'3)S5TZQC_P"%
MEZ3+<7K:C<+X;+F\#-&+AEFC ? ;&#UQT.<UV6K>$O#^NR6TFJZ3:WDEL,1/
M,FYE'ID\D>QJW<:)IEU?6E[/86\ES9@BWE9!F,<<#\A^5 'GWAI;KQ#H^@>)
M?^$BBMKL72F\"HY:5F8J]LX,F ,G ^7Y< @5ZA6-;^$O#]IKDFMV^CVD>I2$
MEKE8P&)/4^Q/.3U.36S0!Y1JE^_VJVU/3[RXE4^*H;5KN6<JQ!E$;P(@X,0&
M1SC)!.#UJYKD>JZC>^,+.$W<U]L@&CRVDA MV,8(7<#B-MWS-G&58=1@5UTO
M@SPU/+<RRZ)9.]S*)IBT0.]P0=WUR 3Z]ZY6^\$RWNOW]QJ/A31=4^T3[H+T
MW;0,D0 54=0A.5 Z@G/M0 EYHANO'NFZ)=ZAJ7V:309FG2/4)OFD$L8W EL@
M\]>^ #D<556.Y\20>(/^*A32[W2M1DC69A(TMI'&PV''F %609.1\VXYS7;:
M7X7L-/%E/)$)K^TA\E+EF8LJ==@)).WM@D]!G)I]WX2\/WVMQ:S=:/:2ZC%@
MK</&"V1T)]2.Q/3% '&2K=>*[WQ19R:Y'IEYI]T$A<AUDM8A&C+*H$B@!CN)
M)'/()P !+%I_]K^.-;L;V_OI[8Z/:3;4N98E,C&0%E4-E,X!VCCVXKKM1\)>
M']6U2'4]0T>TN;V'&R:2,%ACD9]<=LU9.AZ:;^XOOLJBZN(_*FF#$,Z=E)ST
M]J /,=)ENE\._#O7FU"^DU&]O8;6YDDN7998FBDRI3.W^%3G&<C.<\U=LA=^
M)]/O=3/B&/3=1T_59A*^QV>W$<Q"Q%?,"E60*,;><YY-=ROA;1%M;.U73HA;
MV4GFVT8R%A?LR#/RGKT]322>$O#\NO+KDFCVC:HI!%R8QNR.A^H]>M 'GFKV
MCS6GQ*G;4-2#Z8WGV6V]E'DN+99 1AN?F['('8"M>R@AN_BMIM[<;C/+X;6=
MF$C+E_.3' .,<].GM77MX9T9UOE:PC*W_P#Q]@DXG[?/SSQQSVXI_P#PCVD&
MXL;@Z? TUBNRUD9<M$O' )[<#Z8H TZ\G^WO]L\-ZK87EQ+!>>()8&O9IR'N
M8SYP*>6.!&I4!<\_*#@9KUBL+_A"_#.YF_L.Q):X^TG,(_UG/S?J?SH \XU6
M"4>&?B#J U'4A<Z5J4CV3?;9?W)6*)ACYN1SC!R .F,G/66EROB'Q[KFE:E)
M((K&RM6M8%D9-WF*QDE&",D':H/\..,9-="WA;1'M[RW;3HFAO7\RZ0Y(F;U
M<9^8].OI1=^%M#OI[6>ZTV"::U3RX9'&65/[N>Z^QR* ,3X4\?##0AG.(6&?
M^!M7953TO2=/T6Q2RTRSAM+9,D1Q+M&3U/N?>KE !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5+W4
M[+3?(^VW,< GE6&(R' 9V. H/J3T%6ZY#XCQRGPY:7,<,LJ6>IV=U,(D+L(T
MF4LP4<G YXH W9O$&D6[WJ3ZE;0M8J'NA)(%\E3G!;/0'!QZTRR\2Z)J5_\
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MW5VVI6\<%H=MRTK[/).,X<-@J<>M>8QQ7T<,M_#:W,EI9>,9KZYA6%MS6[9
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MK'&&:/&-Q##/!ZK7:>$_[$OM0O=9T>ROU-S'''/=WGG*92N<*%EY.T'J!CG
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M;0=:;4K"SF2>*Z-POV8-&5>,%SM8M@  9]>,4 =Y9:UIVH3^1:W222^7YH4
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M01DMDB0=<\C -7+>PL].\8>"X;+3)[.QM;*]5(Y%=_(#E"@9CG:Q ;@GCD4
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M\ZNU#:^0;='MD58W (VKMR,8''T 'X5-0 4444 %%%% !1110 4444 %%%%
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M<DA1U)]LGZ5=U3Q9IFI^"9[[4]$N988=06SN[/S%S#.DZJ,L&&0'VG(S].M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!5E89# ]010!YAX=MM8T1- DU/P_:S6]L$MK:>'5O-\CS<*3'&4&1S_>)"Y
M..NM9>$KQ?%=CKBVD&F7J22?VE-:3GR[^,JP4-&  6R58DCC!Y/&.ETWPMH&
MCW)N--T:PM)CD>9# JD ]0"!P/I6M0!B^&-2U/4],DEU:UMK>YCG>+_193)$
MZC&&5B!GJ0?=37'ZYX2\3:HFLQM%IUS)+J,5U97<]PP=8$DC<0!=AV ;#R#R
M3T).:]) "@   #@ 4M 'F.HVVJ:KXGUY],TVPOX'ABL-0CCU-K8NRH2R/\C;
MN'P&&TXX]:UK*TU#5]?\,Z[!IMO:6-C:W-K+!]H!*;F51LP,,H\K@Y&01707
MWA3P]J5_]NOM$T^XNN 9I;=69L=,DCG\:UU544*JA548  P * .)BTKQ7H7B
M+5?['33KK2M4N/M6ZZF9'M)2H#G 4[U.T$#(],CK0=(\5:'XHU"[T9;#4+#5
M3'),MY,T+V\RHL9<;5(92%4D<<CM7;T4 <I#H^K0>/6UJ189[?\ LA+$OYFU
MWE5V<MMQ@ YQUK"MO"&O0>"O#ND&&T-UINJQWDQ%P=C(LS284[<Y(;'('2O2
M** .&L-(\6Z%JVIV>G#3I](U"[DNX[F:5EELVD.YQL"D2?,25Y'7DTZ;P[K#
M:AXUF6&W*:U;1PVI,_(*Q&/+_+P,G/&:[>B@#AK'PWK=EJ7A2]2*S8Z?I;:=
M=HT[#;GR_G3"_-_JSP<=1S3=-\)7D7BNPUQ;.#2[M?,_M1[28F*_!4A<I@#=
MN(8D@8P1ENH[NB@#F?%.A7M_J6AZSIC1&^TBX>1896*K-'(A21<X.&P>#C&1
M6)X@\':GK=EXHNTB@CU#6+.*R@A>;Y8HTR=SL!U)8\ '@#GK7H-% $-IYOV2
M$3QB.4( ZJVX ^Q[URNE^&KTMXOMM22*.UUN=WC:*7<RHT2Q$$8&#\N>_6NP
MHH Y'PK;>,+.&TTS65TT6MB@C^VV\K,]TJC"_(5PAZ$G)Z8 YR.6\)Z1>^)O
MA7I>BR0116,ET9);GS<DQ)<L^U5QG<2NWT .<GI7JLB++&R.,JPP1G%5M-TN
MQT>T%IIUK%:VRDD11#"@GDX';F@#G=+\/7PU;Q:VH1Q)9ZS(IB:*7<X40K$0
M1@8/&>IJ+PI9>,--MK31M4&FFQL%$2W\,K&2XC480>65PIP!N.3WP.<CLJ*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***8\L<;HCR*K2'"*3@L<9X]>* 'T4C,J*68@*!
MDD] *1'26-9(V5T8 JRG((]0: '4444 %%%% !1136=%959E!8X4$]3C/'X
MT .HHHH **** "BBJ]U?V=EL^UW<%OOX7S9 F[Z9ZT 6**** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7%^'=82]O_%NO7K$0Z=>2V$8Z^7# H+D>
M[.6)]<+Z"NTKD=(T:/2]5\1Z3=)FQUFY>]A8]',B!9H\_P!X%2V.X;CH< #-
M.\5ZM>:CI!_LJ273]20L[QVLR&SRNY2[L-K@],C&#ZBGZ#>M:>//$'A[_EV6
M.'4+9>T?F9$BCVWKN^K&CPWX:UO08X+*]\1B[T>Q&+:,VPCE* 859)-V"%'H
M!G R<<&?0=->;Q7K?B212([M8K6T!&"8HP27^C.S8]0H/>@#IZ*** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJR!8C(/DQSD =_PK8U.6^ATZ:33;:*YO%'[J&67RU8Y[M@XXSVH MT4=N:*
M"BL'Q#XLL?#E_H]I=ABVIW7V=6'2,$8WM[;BB_\  JWJ "BBB@ HHHH ****
M "BBFR2)%&TDCJB("S,QP !U)- #J*@LKR#4+"WO;9]\%Q$LL;8QN5AD'\C4
M] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:TGD@8&[ 7);A0 <?,1QBN?MHKRSU/QY#-IM]B]83V\B0%DD4VR)@$=6W C
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M]:VMDNIQ;R&.W?[LK;3A3[$\?C0!2LO%6C:A.D-O>$N]N;J/?"Z"2(8RZ%E
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M&<\^W6:@+[^S9UTXP_;2A$+3DA V."< DXZX[^U6J* .2O/!-C>>"IM'?3;
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M*WM;@P,K0#>^&VAU&<%"2,'(JV=?M5\4)X?,<XNWM&NP^S]V45E4\YZY8=J
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MCC257N(@$D1LX*LI(SQR#@CTK5H **** "BBB@ HHHH **** "BBB@ HHHH
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M_LYF_P">GE9V[L\YQP>>M &"NH^(9)/&]M8W3W=U97D"6<<K)&0C1QNT:G
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M6(+!YC@%VR!C<> QZ GC)%9ND6UUK.OQZ_JFAMIDUI ]K;I-(CR-O8%V)4D
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MU*QGLKV!)[:=#'+$XR&4]16?8^&K&P:)TDNII((3!;R3S&1H(SC(4GZ#DY/
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M-\@.Z5LMTJW45K;K:VT<"N[K&NT&1MS8]SWJ6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HYIXK:
M%IIY4BB7[SNP4#ZDU)7,>-X3-9:8L.K1Z9?"_1K.69 \3S!'(1P2/E(W>^<8
MYH WTO[.7R_+NX'\S[FV0'=]/6I([B&;?Y4T;[#AMK [3[^E>3W.I[]+\.WV
MI65IIILO%)CNY87S;EML@:5&/1&9N_0Y!JGJ^J1//X^N-.<7-N+[3I[F.#EI
M;0)'YI4#[RE0V2."">QH ])\0^(/L/A+5M7TB:SNI;&WDFP7WIE%+$':>O'K
M6AI>I17]G;DS0FZ:".66)&&4W*#TSD#GO7">(K[PKJ7A7Q;J^AW$%Q-/HDD5
MQ<V\A,6 C>6A&=H?YCQC< .<<9CL8],LO&_@5K$6T3W6DW*S-$5#3?+"R[B.
M6YW'GOF@#TR21(8VDE=4C499F. !ZDUG7U[*\<7]FWFGAUNHXY_M#Y 0D;E&
MT\.01C/K6'\45MV^&?B#[0L9 M'*>8!P^/EQGOGI6!XJT[0=/T/PQ>6=M80-
M-K6GR&=%4&0[@"Q;OQU/YT >CS7EK;21QSW,,3R'"*[A2WT!ZUA7OB&YLO'%
MAI+_ &5=.N+&>Y:5LAU,90=<X ^?T[5Q/B>]TV/Q!XTTB]U72T;5[*"*(W]R
ML(MCY; #YOO*,A\K_$2.O(N_8=%3QSX0TU7L;JSBT:YV;0GERG=$0^T<')#-
M]>: .YU+Q%I6E6]G-<WL(2]F2"W(<'S&8@ CGD ')/H*TU974,I#*1D$'((K
MQ.WDT^+P?HS.]LME9>,70L2OEPP^?+@$]%7D>W2O6[+7=)O=2GTNSO89+RVC
M226W7AD1@"IQZ$$?F* +\DL<0!D=4#,%!8XR3P!]33+>[MKM6:VN(IE5BK&-
MPP!'4''>N*^*,5F^G:!+>K%Y2:[9AI'XV(7^;YNPQUKEO$^DSV&H>,)/!MNL
M5LVB0BYBL1M0S^:<A0O&_P G=TY^8>M 'KD5_93^;Y-W!)Y/^MV2 [/][!X_
M&D_M&Q"JQO+?:Q(4^:N#].:X>Y:QU/Q?X-OO#CP-&89A<?9\;?L9CX5P.V_8
M #T.?>N;O=(U"WL=5\-Z;:#S/#=\=:TZ0QY4Q$F2.%?<L95^B>] 'L N(#))
M&)H]\8RZ[AE1[CM4<6H64]J]U%>6\ENF=TJ2J47'7)S@5YYX@O))/!(\4>3/
M';7]_;75X$C#2)8JP"Y4@Y&T!R"#]YNU9'BJ+PS>>#/&&KZ7JK:FUU8IY\I,
M9@$B_P"KQM51YN"?<#&<9% 'K\5Q#.9!#-'(8VVN$8':WH<=#3+F\M;)%>ZN
M88%8[0TKA03Z<U4T33M+L;,2Z7:VT27(61W@4#S3M #$C[QQWKEQ=10_%+5[
M?7#$MM<:9"-.-Q@1M&"WGJ,\9R5)'7 '84 =M)<00A3+-&@?[I9@,\9X_ $T
ML4L<\22PR))&XRKHP(8>H(ZUXM96-LD'@6#55A> ZO=I:"XQN-F5E\I3GDJ?
MEP#P05%>RV=E:Z?9QV=G;Q06T2[8X8U"JH] !0 C7]FDJ1/=P+([F-5,@!9A
M_"!GD\CBEEO;6!]DUS#&WR_*\@!Y.!U]3P*\8DT?0+KP7X[C-K:G4X=8O$L@
MBCSHY=P\E8\<KEL !>O-=#I6DZ7??$[4K;5K:QNKL:19/*DBJV9PS[GQ_>&%
MYZX/O0!W=K>S1/?-J5YIXB6Y*0>4Q4JFT$+)N/W^IX[8J[]IM]\:>?%OD&Y%
MWC+#U'K7F^@:'IGB/2?B!H/[@0W&L3*HC Q&3#%M< >C#/U!K8\'74_B.P34
M];M5CFLK=M.E291@RJ<7#<\%244#_=:@";5O$&LZ/HFBW$C:7<W%UJ<-G<O
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MMKB12,TM\D:W0!=K;8_DJV>2-NS /M7LMK:6UE9Q6EK!'#;1($CBC4!54<
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M<?Q9[@T =<]U;Q3+#)/$DK?=1G 8_04Q=0LFC>1;N QIC<PD&%STR<\5RWQ
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M./;FO-I[JW.E_%K]_%TE_C'_ #YJO\QCZUZ!X9D27PKI#QNKJ;*'#*<@_(*
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M'S9ZC! -<+XUT*;P[X.\037&M12_VIJMK=(&@$>R3S80W\7S !,@<8&<D]:
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M'FQ[FW&-9=W"9)[9P<9'6NEU2VO;JU1;"\2UG617WR1>8K*#RI7(X(XZ\=:
M.4U#QCJ-GH=KJ5HNEZI#=:G!:0SV\Q5)(Y"@W 9;#;BPP3QC//2HI/'6HZ%J
M>KZ?XDL;42VMB-0M7L78I-&7\O8=PR&#E1GWSBL7Q=H%OX9T9'BN;2TFU+Q%
M97(1(]D,+!T!*IGG[NYCD9R>E=9?^#(=??4KC6;A99+ZQ%@AMEV"&+=ORN2<
ML6P<]/E48ZD@%:;QAJ.D7%Y+JFGO+I4%@]V;R&TEA$;IR8B)/O$CHPQ[@5J6
M=[XC:^M?/L+.2RN;5I6DBD*FVEX*QL227!SC<%&,=*HVGA/5KK2;G2_$VO\
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M"+/^L^;Y1GMS^51/X*U6TU.RU31]=AM+Y+*.QO/,L_,BN$3[K;-X*L,G^(T
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M,1K(0, 8;#'D\#I@]:D_X5]J0MX;9?$$?DVVL?VK 6LMTA8NS%9&W_/]X@$
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M0[>YANXS)!(LB!VC+*>-RL58?@01^%2UP_PGM(;?P+;M&9<O/<@AIF8 +<2
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M&!VN"^PILR-I[#-=OXKCU"7PY<1Z5<10WK/'Y7FR%%D_>+F/<.5WC*Y'(W4
M;5%>2:AK4C^%M2:)-6T?5+/5K(7-I+=NWD;Y(EPCAL-$RY..G)XK0\3ZYJ.B
M>)/%L^GW$SM:^'8[J*!I6>..7S) 7"$X' !.!VH ]%NIFMK26=8GF,:%A&A
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M*XO&U>S2WMFV3R/,%$3=0&ST)[ ]: "\\,:)?W-I<7.FP/+9IY<! VA4X^3
MX*\#Y3D57E\$^&I]$31I-'MCI\<GFI%M(VO_ '@PY#<]<YJ<^*O#ZRW<1UJP
M$EHNZX4SKF,9QSSZ\?7BIDU[29-,@U)-1MGLIR%AF60%9">,+CJ>#P.>#0!"
MWA;16L[*T%@BV]C();:-&91&_/SC!'S<GGKR?4U9M-'L++4;N_MX-EU=[?M$
MF]B9,<+G)[#@>@XJ+_A(M%^QP79U6S%O/+Y,4AF4!Y,[=@YY;/&.M2:=KFE:
MN+@Z;J-K=BW;;-Y,H;8??'2@!E[H&F:CJ-MJ%W;&2[M23;R^8P,1(P=N#QD=
M<=:EU72+#6[!K'4K6.YMF(8H_J#D$$<@@]Q7-77BSSO'?A[3-,U*UGLKV.X:
M>-%#,=B91@V?NDYY'7'6NJO+ZUT^$37=Q'"A8(I=L;F/11ZD^@H R6\%>&V6
M[7^R+<"\18[C;D>:J] V#S[^O?-7+S0-+U'3[>PO+-+BVMW62))"6*,OW2#G
M.1DCKTXI\>MZ9+I_V^._@>UW^7YBN"-^<;?][/&.N:GL[ZUU& S6=Q'/$&*%
MHVR PX(^H/!':@#$2QU/4M>B_M'3K.VTS3)S+9-'-YCS-L**Q7: @ 9N,GG'
MIST=8MUXP\-V3%;G7M-B(E\@A[E!B3 .T\\$9&?3(J6_\3Z%I<LD5_K%C;21
MQB5TEG52J$@!B,\ E@/QH 1/#6CQ7KW:62+))-]H90S>69?^>ACSMW]]V,^]
M3VVBZ?9ZG=:E!!LO+O'GR[V)DQ]W.3CCH/3M3;G7M)LYUAN-2M8G)48>0#!;
M[N3VSVSU[5*NK:<VJ-I:WUN=05/,:U$@\P+_ 'MO7'O0 :GI=CK-@]CJ-LEQ
M;.06C?ID'(/L00#FJT?AO28;QKN*T\NX: 6Y>.1U/E#HG!X ]/7FH+[6;2=]
M/6S\06-L6OA$RG;(;G;D-"O(PV<<C)&.E5?&GB6+0_#FJRVVHVL&I6]H\T2R
MC=@A25!&1C<1@9ZGUH GN/!7AN[T6#1[C28)-/MVWPPL6_='_8.<K^!K6L+"
MTTNQBLK&WCM[:(82.,8 _P GFLZ#7[.TT'3[S5;Z&!YK5)G9V"Y^4%FQV SR
M>@S5VXU;3[:UAGDO8%CG&8'W;A)QG*X^]QSQVH 9::)I]C>7EW;0&.XO"#<2
M"1LR$# )YZ@< ]A7-^(O"$9T6VT_2-'L[O3UO/M-U83S,GF\-RCG.UMY#'IG
M!&>3FYX#URZU_1;N[N[F&Y,>H7,$<L*A4:-'*J1C/! SU-74U:UAU?5GN/$%
MBUK:QQ&2V)139GYLM(^?XL=#C&WWH P]"\$64?VGSM&&FV5S;M!-8+?R3+/D
M@Y<9VC !'&<ACGTKHT\.Z4EU8W*VQ\ZP0QVKF5R8E/! YZ$  ^H ]*+/Q)HF
MH7RV5GJMG/=/$)UACF4L4(!#8],$'\14?B'Q)I_AFTMY[^4+]HN8[:-<XRSL
M%S[  Y)]J +.FZ+INCFX.G6<5M]HD,LOEC&YB22?S)..G)]:9?:!IFHWJWES
M;9NEC,7G1R-&[1DY*,5(++G^$Y%<Z?&"6'C74;?4]5LXM%CTV"Z@D;"#+NX^
M\3\W"9_I6W>ZE ]WHXMM=L[=;F7>L1VN;V,H2%0Y^C;AGI[T 37GA_2K^.SC
MN+-3'9,KVJ(Q186484J%( (' /:M'8ICV$;EQ@AN<CWSUJG_ &SIHOELOMT'
MVEG,:Q[QEG R5'JP )(Z@5>H PH?!OA^W@M8(--CBBM)?/@6-V41R?WA@]<<
M#T' XJQ_PC>C[M09K&.3^T1B\$A+B?C W D@X' ]!6-HGC%]2\;ZIH<T B@2
M(3:?+_S\(C&.4_@XP/4<]*Z.]U.QT[;]KNHX2P9E5CR0OWCCK@=ST% %70O#
M6C>&H)(='T^*T20@OLR2V.F223@<X';-/O\ 0=,U2]M;R\MC+<6K;K>3S&!B
M)ZE<'@^]1'Q5X>$4<O\ ;FFF.1BJ,+I"&(&2!SV')]!2MXHT)=/AU ZM9_9)
MD,D<PE!5E!P6SZ \$]!WH M:II5AK6GR6&I6L=S:R8W1R#@X.0?8@@'-9O\
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M.KV]SY$:G=<PHL/F!?[V=C#CK@CO7K]% '"7,MOK7CO0=<TN8-9V=C=?;[@
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M.GW36\2G-S%&D?FA/[W*D$#KC'>O7Z* .&E$>O\ Q!T76-&D\RVM]/N8[V=
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M)MY/RR;Y6QT!9LD],M6%>WQLM&^(NC:M#.-2O)+NXM?W#N+F!H0(MI (.T*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZJ:T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=AXG^%>HWZ(DUI=Z7).@< XS&2/H0?R(H ZJ6:*",R2R)'&.K.P 'XUF7O\
M8=Z=]U/:/YD30DF8#S(VX93S\R^WK7%:=?W7A@7G@?7YFGB>UE.C7TO/VF$*
M<PN?^>B#CW'ZM\0VMO)=_#2.2")T^TA=K(",?9SQC\!^5 '5:3X5T>T6-K2[
MOKFUB(\J"74)9H8\= %+$''& <XP,5N6]I#:^:8DPTK[Y')RSMTR3WX 'L
M.!7GOQ M8?"VH:#XET:)+2];4X;.Y2!=BW<,F05=1PQ&,@GD5Z30 55?4K&*
M0QR7MLCJ<%6E4$'Z9JU7 36=M<?'8B>WAE'_  C>[YT#<_:<9Y]J .\\V/RO
M-\Q?+QNWYXQZYJM_:VF_]!"U_P"_R_XUPDD*>%?B_H]EI*B#3]>M;@W5G'Q$
MLL2[A*%Z*3T..OUK-\'W*6.@>)I!X:EU!8M8OR'1(2F YX(9@V!WPIXZ9H ]
M3%Y:F5(A<PF1QE4WC+#KD#O4K,J(SNP55&22< "O-?B'X>E<:'_8B>7?Z+:3
M76GJ.YA,.(_<%<KCWJ7Q9KL/BSX=D:;(PAU#2YKZ<J>8X8T)*$^IDVH1W ?T
MH ]"AGAN(_,@E25,XW(P8?I3E=7SM8-@D'!S@CM7)>']2@T+X2:-J,H41V^C
MV[[<A=S&)<#/3)8@?C6#X!U!=)\8ZMX;EU>'4A?1KJL,\4H<&5L+<+P>/G&X
M#L#0!Z1%=6]PSK#/%(R<,$<$K]<=*8]]9QRF*2Z@611DHT@!'?I7G?B?2M4M
M/'=[XF\-INU"PL+9KBQ486_A9YMZG_; 12I]L5NZ%K&F^)?$-IK.G,LD4^ED
M!BH#I^]&4;T(/!% '31ZE8RN$CO;=W/15E4D_K5FO-OAMH6DZGX+OH+W3;2X
MCDU*\5EDA4Y'FL!V[=O2KGPQO+H0^(-#GN);F'1M4DM+6:5BS>3P54D]2O3\
MJ .]HHHH B2ZMY)V@2>)IEY:,."P^HI)+NVBF6&2XB25ONHS@,?H*X3QSH%]
MJ'BO2M0T&9;;7+*RN)X'( 6?:\(\J3U4AV'L3FK&C^(K+Q9J6@7Z0>3>0-<P
MW-M*/WEK,$ 9#_CW% '87>HV5@$-Y>6]L'.%\Z54W'VR:EDN(8H?.DFC2+@[
MV8!>>G-<'\+)/[>\/77B74%$NH:E=S>8SC)CC5RJ1#T4 =/<GO5?P[:P/X[\
M5>%)H$FT:SDMK^UMW&4A9UW,@!XV[OF"]!0!WG]K:;_T$+7_ +_+_C4@OK-I
M_(%U 9LX\L2#=GTQ7G^@:)I=]\0OB#97.GVLEN39)Y;1*0 UOSCCBIU6*T^-
M=],L08Q>&8VX'S'$[?K@"@#N+K4;&Q*"\O+>W+\()I53=],GFG2WUI" 9;J"
M,$X&^0#T/]1^=<5\*U&K>#X_$E\%GU/5Y)9;B9AD[1(RK&,]$4  +TZ^M9_Q
M)T2QT7X=WT=E;JL,NJ6UP(54 (S31A@HZ#."?^!'M0!Z)%J%E<2".&[@D<]%
M20$_D#5BN;M?(N?$-I&_AN6Q>"*2XBN)5B'S<(5!C9NSG(..W7MTE !5>[OK
M.PC$EY=06R$X#32! 3]35BN ^'DQU_4O$VNWX$EVFJS6$ <9\B"+:%1?3)))
MQU/6@#NC<P"W%P9XQ 0")-XVX/0YZ5"NJ:>S!5O[4L3@ 3+D_K7"6<ATOXG^
M(/#ENH&EW>D#4O( ^2*7?Y;;1T&[J1Z\^M9_PZ6VO? /A?3;KPW))#<H5:]=
M(MBE0[A@0Q<'*@ D#G\* /5J*** *SZC8QR&.2\MUD!P5:500?IFGS7=M;!3
M/<11!ONEW"Y^F:\]U=;$?&M3>V'VN-O#;9C6V,Q)^T?W0#VR,^]<SJ6BZAH_
MP>G@U6V>*-M<BFLK.0AVMK=ITV1\$C.-W /\6* /:H;B&Y3?!-'*O3*,&'Z4
MRZO;2PB\V\NH;>/.-\T@09^IKSW18H]9^*LNJZ+;?V=9Z9;O9:DC*(GN93R@
M,8YPHY#G&>@R!5KP),VO^)?%FL7X$EQ::I)IEJKC/D0Q <*.VXG)]<#TH [H
M7,#6XN%FC,!&X2AQMQZYZ8J#^UM-_P"@A:_]_E_QKA%MX;?XLW_A@0JVC:KI
M*ZC-:8_=K,LNTD+T 8 ;AW-/@TK3F^-5_;M86I@_L"(^685VY\]QG&,=* .Z
M;4[!" ]];*2 <&51P>0>M2P75O<AC!/%*%ZF-PV/RKSG6[.VTSXF^$K6VTMK
MJ&#2KF&.WC$>0B[ OWR!@#WK6O\ 29?$/AGQ);:98'1=0N1]E E"KOVJ&!;8
M2,-O9<@GY2/3% '5VVI6-X2+6]MYRK;2(I5;!ZXX/7@_E2'5=.!(-_:@CJ#,
MO^-<#H.OZ9J7B?2=.U[0SH'BBP#_ &>)HQY<Z>6RL(9!PRX.<>W?!H\5Z'I>
MG^(_ =I;6%LD(U!T($2_.!"WWN.?7GO0!Z+#/#<1[X)4E3.-R,&&?PJ2JECI
MEGI@G6RMXX$GE,SI&H5=Q !( Z9VC\:MT %57U*PCD,;WMLKJ<%6E4$'Z9JU
M7GXL[6X^.5Z)[:&4?\(_$WSH&Y\]AGGVXH [TRQB+S3(OE@;M^>,>N:K?VMI
MO_00M?\ O\O^-<+%$GA;XPV.F:4HATS6[&66>R3B*.:/GS%7HI(X..M9?@B>
M.T\'ZJQ\,R7Z)J5X/,"0E,>:1@AFW8'?"GCIF@#U07=L9EA%Q$96&53>-Q&,
MY ^E2.ZQHSNP5%&2S'  KS3XB:',MSH=UHJ$7^A6-Q>6:CJXB>W!C/<@H7&/
M>I/'.LP^*/AU<#393]FNM(FU*9E/*Q)&2J'T)DVC'<(XH ]%AGBN(_,AE21.
MFY&!'YBG*ZN"48, 2"0<\@X(_.N7T[4X=!^%^FW["-5ATRWV*S!59RBA%ST&
M6(&?>N?^'M^FE>*=9\+/JT6I+,JZI;7*2J^\OQ..#QB3Y@/1J /18;JWN"P@
MGBE*<-L<-M^N*8]_9QRM$]W LB\E6D (_"O.?$6FZGIGCC4?%/AV,R75G;6_
MVW3T&!?0DR;O^V@V@J?;'/2NAT'5=-\1>(AK.G.DT%QI415\?,!YKY4^A!X(
M]10!TD>HV,SA(KRW=ST595)/ZU9KS7X9Z!I&J_#=;>^TRTN(Y;J[5@\0)(\]
MP.>H(['M5_X6WUW+IFMZ3=7$ETNC:M/86\\K;F:)2-H8]R,X_*@#NZ**"0 2
M3@"@!H=2Y0,-X )7/(!S@_H?RIGVJW^T?9_/B\_KY>\;ORZUY3!XD@MOB'I?
MB-=6@FL]>9M-DMEG5C H.;9MH.1N(8G/0R8KHOB!X>DUZ^T,6-S]AU6&666T
MO% RCK&2 ?5"1@CTH [.:[MK9E6>XBB+= [A<_G49U/3PY4WUL&!QCS5SG\Z
MXC3O$J>)CHL.H6JVNMZ=JHBO[-QDQ2"";#+ZJW53_A1H=A9W7Q:\;_:+2"7]
MQ8?ZR,-UC?/7UP/RH ] !# $$$'H12UYUH*_\(Y\7=0\-:?E-'N]+74TM5/R
M6TOF;&"#^$-UP.,UZ+0 C,J(7=@JJ,DDX %5DU*PE<)'>VSL>BK*I)_6K5>;
M_#K1-*U'P]KL-[IMI<1OK5ZC+)"K97S#@<B@#T.>X@MD#SS1Q*3@&1@HS^-,
MDU"RBM#=R7<"6PZS-( G_?6<5XW+/.GPY^(_AV::2YM-&EDBLY)FWLL1&Y4)
M/7;ZUU7B"SUFVM/"VN:/IL>J0Z7 ?/TS(5G5XU >/MO4 X'HQ ZT =T+ZS,
MG%W!Y) (D\P;<'IS1]OL_(\_[7!Y.[;YGF#;GTSZUP.GZEX<UWPCXNO]$A-O
M)/;2?;[&6'RY(9A$P^=.Q('4<$@]\UGI?-_PS^;;^Q[SR_\ A'2/-VQ[,^1]
M_P"]G&>>F: /4H[B":$S131O$,Y=6!''O45IJ-E?[_L=Y;W.PX;R95?:??!X
MKS'SFO=0^&_AB0 :7<:=]KN8>BSF.%2B,.Z@_,1T/&:U_BDYT+0[+Q+IZ"+4
M-.O(0C(,&6)V"O$?52#T]0#0!W<-U;W!803Q2E.&V.&V_7%(+NV-Q]G%Q%Y_
M_//>-WY=:\W\1:;J>F>.-1\4^'8S)=6=M;_;=/08%]"3)N_[:#:"I]L<]*O2
M^)[*ZBU3Q9HQCN GAXW$+%><JTIVMZ$$8(]J .VGU*PM;A+>XO;:&:3[D<DJ
MJS?0$Y-2SW5O:@&XGBB#=#(X7/YURG@+2[6X^'VG37D<=Y-JEJMS?2SJ'-P\
M@W-OSUZX [  5YWJEY//\'O&>E7+M<1:+K/V&UDD.YO*6>/:"3U(!Q],4 >W
MP7,%RI:":.51U,;AL?E4M>:6446M_%BWO-$M/[-BT6&2#50Z"%[GS%S$GECD
MJ/O!B,>G2O2Z "@G R:*YWQC?P6^E1Z?+>QVC:G+]E\YY FQ""9&!/0A V#_
M 'BM &_YL8A\[S$\K;NW[AMQZY]*2&>*XC\R&5)$/&Y&!'YBN)^%NJBX\.W&
MA2W4=U<Z%<-8F5'#"6$<Q.".Q3 _X":YZT>Z\ ZE?>(8 TGAF]U*XCU*V1?^
M/)Q,RK.@'\.  P'L>>P!ZC_:=AAC]NML*<$^:O'ZTZ.[L[P-%%<PRY&"(Y 3
MC\#7":Z+:;P/\1)H!$\4JRR*Z8(?_0H2&![^N:FD\+Z5JOPPLMUM#;W46EQS
M6]W"H26"01 AU<<@YZ^M '=111P1)%$BQQH-JHHP%'H!3ZYKX>ZS=>(/ .C:
MI?<W4]O^];&-S*2N[\<9_&NEH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KGO&_AZX\5^%+S1+>YB
MMOM856FD0OM 8-P 1GIZUT-9/B'Q#9^&--;4M0CN/L2$"6:*/>(@2 "P'..>
MH!H T(A<+:*)/+-P%P=N0I/\\5QEA\/L^%]6T/5KJ*=+Z]EOHY[=#&]O*[;@
M5R3RK<@YKJ+[6K6QT.36/GN+)(?/+V^'S'C=N'/(QSQ3+[7K33S:13I-]LO"
M1;V:*&F<@9/ .  .I) '<T 8]SX4O]6T?3DU74HFUG3)EGM=2@@*_.HQED)Y
M##A@" ?;BIM4\/7WB6.WM-<FM1IL4J336]LK'[2R'*ABWW4R 2H!)P.?6_:^
M(;:?46TV:"XM-1$1F6UN H:1!U*,"5;GKAN,C.,TW1?%&FZ[>:A96S21WNGR
M".YMITV21DC(..X/8CB@"KXW\.W7BOPW)I%M=0VOFR1NTLD9?&QU<  $=2OK
M5CQ-H]WX@\)WVCI/!!->P-"\I4LJ!A@D#C-+-XD@@75&>RO-NF+NN6"+P-H?
MY?F^;Y3GCZ=>*J6/CK1KV33%;[5:C5%#6+W,!1+C(R K=,D= 2": '6^E^(8
MM,L]/_M&PCBA6.*26*!Q(T:X#!27PI(!&><9H_LS7[=+^"&]T^XM[J:5XUN8
M&S KDG;P<2#DG!V]2,XK3UG6[#0+%;S4IQ# TT<(8_WG8*/YY/H 34^H7HTZ
MPFNV@GF2%2[) FYR!UP._P!!S0!E:=X;&B>"HO#NG3 B&V,"2S#.20<L0/<D
MX_"G^$=$G\.>%K#1KB>.X:SB$2RQJ5#@="02<'\:=I/B:QUOPT-?LEF>Q9&=
M"P 9E7()QGCD'KCI5"]\>:5IFC6&KZA!>VEA?2)'%+-#C!894L,Y4$ G)':@
M#J*1]VQMF-V.,],U'<7$-I:RW,\BQPQ(9)';HJ@9)/X5S(^(.CGP>?%8BO?[
M'!_UWE#.-^S.W.[&[CI^E &IH6F76G6,Z7TL%Q=SSR3R31H5#ECD @D]!A1S
MT45SNE>"]5TKP=JWAQ-1LVMKMIQ:GR6 M8Y<DIC=\P&XXZ5T0U\"Y@@ETS48
M3.Y1&>)=N[:6P2&.,X/7C.*;HWBC3=<OM0L+=I([[3Y!'<VTZ;)$R,@X[J>Q
M'% $/B?PO;>+O#CZ9J6$E.'BN(<[H)1]UT/7C^616?K'A34;^?PU+:WMK%_8
MCB3$L3/YK>7LQP1@8)/>M2?Q/;V[WR/97[-9R1Q.$B#%FD*A H!YSN!]AUQ5
M%?'=B]Y?VB:;JSW.GHCW42VN6C# E> ><@'IF@!T_A:XUC6[#4==OH[B+3I/
M.M+*WA,<2RXP)')8EV';H!Z5T]11W$4EJMR' A9!)N;@!<9R?3BL,>,+)[!M
M3AM+^;2E!8W\<(,>T=6"YWLO^T%(QR..: .AKE+CPYJQ\>MXFM;VR4?V?]@$
M$L+-\OF;]VX,.<\8Q5[5O%FFZ19Z?>2":XMM0EC@MI;8"17>3[@Z]_7I[U9M
M-;2ZU(6#V-];3-"TRF>(!652H.&!(SEAQ0!GV'A>2+Q#/XBU*]6^U8P?9[?$
M7E0V\><[47+')/5B23[#BJ7AWPWKWARTOX(-0TV;[7>S7FY[=_E:0Y(X?D"N
MQK/T76[#Q!I::EIDPGM79U5QW*L5/ZB@"A!I&J)J6E7<U]!.;6"6.X9D8-*T
MA0LR\X4 IP.>#CM67;> (=+T/Q'I^F7 1M8,JHTJDK;1N&^10#T#.[ <?>K9
MTOQ1IVJZS?Z-&98=2L0K36TZ;6VMT9>2&7IR">H]:DEU^.*\OK46%])+91+-
M((T4[D;=M*_-\V=C<#GCITH RK+PWJ=MI?AO39+NTDM=)6,3+Y3 W'EIL0]?
MEP<-CGE14GBCPS>:QJNAZEIMW;V=WI5PTHDDB+[T9=KQ\$8##K]*O:#XEL?$
M>@C6=.29[1M^S>H5FVD@\$\<@CG%6M&U:+7-+AU&W@N(K>=0\7GIL9E/1L9R
M ?>@""UT^^B\17FHS2VYAN+>& 1HIW+Y9D.<]\^8>PQBL_3O!UKHOBO5-=TU
MA'_:$($ML>(Q-G)D'INXS[C-:VM:W8>'M+DU+4YQ#:QLBLY[%F"C]2*M75Q]
MFM)+CRI)1&NXI& 6(]LD4 <CX>\+>(/#VBSZ;;:OIX,MQ+.)S9NS(9&+'"^8
M <9XS^1I9/#][X3\)_9/"]RIU%[K[1-+=Q&5[R1CE]V,8+' W=% ]LUO>'/$
M>F^*M%BU;2IC):R%E!9=K*5."".QJ&W\4Z;=^*;OP[;&66_LXUDN-J_)$&Z9
M8GKR.!F@#;HK$'B>VG>X_L^SO-1BMG,<TUJBE%<=5!9AO([A-W/'7BH;_P :
M:-8>%SXD\V2XTI<;YH$W%/FV_,IPP(8X(QD'KB@"Y-I]Y)XFMM266 6T-M);
M^45.\[VC8MGIQY>,8[]:H-X.LD\=1>*K9C#<M T-U&H^6?@!7/\ M 9&>X/M
M6I?:M'I^B3:K<6UPL,,332H%4NB $DD9[ 9P#FJ,WB[3[36=.TN_CN;*YU$'
M[*;A $D(QE=P) ;D<'!H K:=X<O/#ES?C0YK8V%Y.US]DN0P\B5OO%&7^$GG
M:1P<X/.*N:!X=31IM0O9I_M6IZE*);NYV; V!M157)PJC@#)/7).:N7NJI8W
M]E:/;7$CWCE(FC"E=P4L022,?*I/_P!>L27Q[IT+6*OI^JC[?)Y=H3:X\YL$
M\9/H,\]J )-$\.WVF>+-?UJ>ZMY(]7:%C$B$&+RDV#DGYLCV%$?AV^7XA3>)
M6NK<P26"V/V?RSN"ARX;=G&<D\8K8TO5(M5BF>."Y@:&4PR1W$>Q@P /3TPP
M.:K3^(;9-2FTZT@N+^]@56GBM0O[D'IN9F503U"YSCG&* ,C1_#&J>%6GM-#
MN[1]'EE::*TNHVW6I8Y9493RF22 1QGK3_%?A;4/$?ALZ6NI1)-)<1W$L\D1
M*@HZL%5 W ^4#J?Q)S6E%XGL+C2[Z^@6>0V!875L(\30E1D@H<'..1CJ.F:H
M3^/-)M_#NGZ\\5X=/OW5(9%B!Y8X7<,_+D^OXXH T!;:]-=VQN+ZRCM8Y-\R
M6\+AY  <+N+<#.">.0,=ZV*S[W5DL;BP@DMKAY+V3RHQ&JG#;2Q#<\8"L<].
M/I6?:^+K6]N=4MK>PU"2?2V"74:Q+E6(W #YOF..?ES0!T%<U;^'+G1-:U+4
M-$F@$.I2>?<V=P"%$V,&1&'3<,9!!R1G(K0T/Q#IWB30XM7TB4W-M(#M"\,&
M'52#C!^M1IXGT[^P7UJY:2SL5)&ZX7#$AMN H)));@#J3T% %2R\,S6MQJNJ
M2W,5QK6HH(VF,96.*-1A41<D[1DD\Y8\\< 2^#-!N/"_A6QT2XN(KDV:%%FC
M0IN&2>02<'GUITWBB*T@CN+W3-2M;:1T1)9(5(RQ 7(5BR9)'+ 8[XK6O+D6
M=G+<F*218E+E8P"Q ZXR10!/165H>O6WB'1(M7L(9S:S*6A\Q0K2#U )XZ=\
M5FW7CO2K#28-5OH+VVTZ:?R/M,D0VHVXK\^"2HR#R1B@!6\.WQ^(:^)A=6_D
MKIYL/L^QMVTR;]V[/7/&,4_QKX=N_%&B)IMK=0VW^D13M))&7_U;A@  1U(]
M:U-4U:'2K 7LD4TT)9%S  QR[!5[C()(Z>M9USXMM;77H]$>QU!]0DM_M2Q1
MQ*V8\[2V0V.#Q0!!?^&;M_$MIXBTN[AL]0$?D7T;1EXKN+J 0""&4]&]\<CB
MG0^'+G2=>O\ 5=&F@4:D5>\LYP=C2@8\Q&'*DCJ,'. >.]W3/$VFZM=W5E;/
M*M_:KNFLYXFBF4'H=K8R#_>&1[U4L/&-KJ@NS9:;J4XL[A[6?;"OR2I]Y?O<
MXR.G% $VD>'3::U>Z[?SK<ZK=QK"71-J0PKR(T!).,DDDGD^G JM#X=O8_B#
M<>)6NK<PRV*V7V<(=P57+AMV<9Y/&*DO/&5A9+I!>VOF_M8#[($AR68KNVD9
MRI ]:N:3XDT[6;R\LK=Y8[VR*BXM9XS')'N&5.#U!'0C(H S-6\.:G>>--.\
M06EY:1K8V\L"PRQ,V_S,9)(88Q@5/=Z3KU_!=B75[>"5A$+4V\#;82KAV9@6
M^<G &.  /<UHZEK$>FS6\)M;NYEGW%$MHMY 7&2>P'(Z^M9&G^.M.U.-);:R
MU-H&NOLAE-M\JR[MF&.>/FXSTH 6[\.W^M:MI%UJ\UEY>E7'VF/[-&P:63:5
M&2Q^1><E1G) YXY=XC\.WNLZYH5_;W5O"FE7#7&R1"QE)4KC((V\$\\U;T?Q
M+:ZW<ZC;VEM="33YC!<>8BJ!(!G:#GDX(Y''O5:U\9V%YIVJWT-K>F#2I9(;
MLF-04>,9< ;N<#T_#- %C77UE+W2?[*FA$9N5%W"\)<R1$@,0V<)M&3D]3@=
M\';K!C\6Z?+HVG:E'%<LNI%18P!!YMQN7<-JYX&T$Y8C '.*M:;KL&I7UU8B
MVNK:\M422:&XBVD!RP4A@2K?<;E21Q0!J5R<GAS5U\=W'B2VO;)1+8K8B"2%
MVPJN7W9##G)Z8KK*S]%UNP\0:<+_ $V<3VQD>,./5&*G]1Q[$4 9>F^%Y+;7
MKKQ#J%XM_K$L/V>)O+\N&WBSG8BY)&3R222?:J/AOPUK_AK2KBRM]0TV;S;F
M:Y#R6TGRF1BV,!^0":W+OQ!:V^I_V9!%/>Z@$$KV]LH)C0]&=F(5<]LD$X.,
MT6OB""ZN+VU6TO$O+.-))K>2(*V'+;=ISM;[C<J2..N>* *\&D:E'JNF7DU[
M#.+6TEMYBZ$-,TC1LSCG"C,?"\\'':L:'X>Q:;X5\0:+IER$_M8S(KS*6%M%
M)NQ&H!Z*7<@<<L:M6OQ%T*XTRSU1Q>6VFWD@BAO)[<B(L25 )&=O((RV!6IK
M7B6TT*[L+:ZM[IWOY?)M_)0,'DP3MZ\' )YXH HVOA_4XK;P[:2W5H]KI2H)
M5$;9G98]BMUXQG=CGG'I2>)/#-YJNO:%J^FW=O:7.ERNVZ2(OYJ.-K1G!& 1
MWYP:TX-<$]VUJ=.OXI_*,RK+&JAU! .#NQGYAP3WK-L/&]EJFC_VK8Z;JD]E
M\_[Q+<<["0WR[L\$$=.U &C9:?>PZ_?W\TMNT-S'%&L:*0R;-W))ZYW>@QCO
M6?I7@ZVT#Q)K&L:6PC74D0O:G/EI*"2SC'3=D9'J/>K%QXNTNTU_3=&N3+%<
MZFA>T=D_=RX&2-V>#['%6]?U[3_#.BW&K:I*8K2 #>0NXG)   [G)H Y[P[X
M5\0^'?#?]C6VLV"_O)9!<_8V9E\QRYPI?&06.,\>H-;OAOP[9>%]'73K(R.-
M[2RS2MF2:1CEG8]R356]\865A'I3SV=\/[48):JL:DNQ&X*?FX.!GG^=64U\
M-.\!TS44F6$S*C1*-Z@@':=V"1N'&<T ;%9GB"PO=4T6XL;&YBMY+A?+>612
MV$/#8P0<D9&<\9S3- \2:;XFT@:GI4K3P[F1D*[71UZJRGH?KZBJR>++>2*)
MX].U*1I998EC2 ,V8F*N2 > &&,GJ>F<T ,\6>&3XE\(SZ+&\-K)(J;)0A(A
M92"&4#!X(&.E/&F:Q+=:-<7-W9R26(;SV6-E\YF7:2!GY?7'-5]/\=:=J2A[
M>RU(P_:_L33&V^5)=X3#<\88@9Z5NZCJ-GI.GS7U_<);VL*[I)'/ ']3V [T
M 8NI^#K*_P#&&D^)HV,%]8EEE*CBXC*,H5O<%L@_4?2K:^&]:L?%VMZ[;WUA
M_P 31($\F2!V\L1*5!R&&<Y.>E:,GBJUM1!+J%G>V%K.ZI'<W486,LW"AL,3
M'D\?.%Y..M+J?BFTTO7+71Y;6]EN[M'DMUAC#"14 +<YXQD=<4 1Z%X772]4
MO]9O;MK[5[X*LUP4V*D:_=CC3)VJ/J23R2:Z"LO1?$.G:^ER;&5S):RF&XAE
MC:.2%QV96 (^O0]JU* &ONV-LQOQQNZ9KCO#_A?Q!X?T^^M+?5=.S=WDUWYS
M6;L8S(VX@+Y@!QVKH](UNPUR*YET^<3);7,EK*1_#(APP_K]#56U\4Z=<>))
M_#SF6WU2*(3B"==OF1DXW(02&'';_&@#$N? ")X%U/P[I]Y_I&J%WO+^Z7>\
MLCGYG(&.>P' %:?]DZW"^E36U_:*]G:O;S0O$QCN,[,$'.4(V'^]]XU?FUE(
MM5DTX65W).D'VC**NUDSC@ENN>,=:@\.>*+'Q183WFG1W'E02M XF0(WF+]Y
M=I.01QUQUH RAX1NG/B.]DN+5=3UR!;=S'&?*A1495[Y=OF)).,\#C%/7PM?
M+\-#X3^V6_F_V>=/^T^6VW9Y>S=MSUQVS6UHNLPZY9F[M[>YBAWE%:= N\@D
M$CGD9'7H>V:K-XGMAXEE\/K:7CZA';_:B@5=IBW;0P8MCD\8Z^U &;)X-DFT
MGP^#>1PZQH2J+2\CC)4@($960G)5U&",Y]#5B_\ #UYXAN;'^VY;86-G.MR+
M2V#$32K]TNS?P@\[0.3C).,5=T#Q-IOB-;P6,CB:RG-O<P3)LDB<=F4_H>AP
M:8WBBQAM-1NKJ.XMH=/D$,S2H#ER%(50I)8G>N,=20.M $UII]Y#XAO[^66!
MH+F.*-(U4ADV;N2>ASO]L8[UFZ7X(T[2?$6M:C; "UU:)5GLR/W8?+;V [!@
M>1ZCWJ[!XD@?48-/N;&^L[F=&DB6XB&UE49)W*2HQD<$YYZ5G_\ ">Z>+C3H
M&T[5EFU)6:T1K7!E"KN; )XP.><4 .TC0-7\.:4-'TJ]M9+&+(M'NT9I+="<
MA2 <2 9XY7C .>M9VJ_#WS_ -SX8TZ]6)[R87%U>W";WEE\Q9&<@$<DKCV%:
M=UXXT^SALY)[+44^UW?V*)#;X?S^<(1G(R 2#T([U>TWQ-IVJ:C=Z;$9HM1M
M%#S6D\9CD"GHPSPP/J"10!0U3PS>7.N:?X@TZ\@LM6@0PW),9>*Z@/.QAD'@
M\@YXYZUTR[MB[\;L<XZ9K'T7Q)::[=ZA;VL%RCZ?.;>X,J!0L@QE1SSP0<CC
MWIL_B>WMUU5Y+*]V:6NZY8(I &T/\OS?-\ISQ_/B@#;K(73;QO%#ZG<36[VJ
MVWD6\00AX\MN=LYP=V$[<;1[U/HFM6/B'1K;5M-E\VTN5W1L1@]<$$=B""#]
M*I6/BS3]3UG5=*T])[JYTLJMT8U 56(.%!8C)X(XZ$&@"F?#5]!\0)?$EE=V
MT5O<6BVMS:F-LS%22K[@>&&<=#Q6CI.DS6UA>V>HFVN8KF>:4JJ':5E=F*,#
MG/WL>_I5"Q\<66IZ*-8LM.U2>P(=A*EN.0A(;Y=V>"I'3M5M_%FF0^(;31+D
MRV]W>QF2T,J82<#J%8'&>>AP: ,2W^'XTSP5KGAK3+P+;ZD\OE/."_V>.2-4
MV]?FVXP.>F/2K$GA?6KSPS!X>N=9M[>R6W6VGDM+9A-+&%"D!F8A,@8)P>O&
M*W[K5H[35+6P>WN&DN0S1N@78 N-V3GC&1]>V:Q/^$^T\3:;"=.U99=2#-9H
MUK@RA5W' )XPO/.* .BT^PMM+T^WL+*)8;:WC6**->BJ!@"K-4M+U.+5;9IH
MX;B$I(T3QW$91U8=<C]1Z@U=H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#\7QI-X=>*5%>-[FV5
MD89# SQY!'I6Y5+5-+MM7M/LMT9?*WJ^(I6C.58,O*D'@@'\* /+M;,WPZTS
M6- G+R>&-4M+A=+F.6^QSLC?Z.Q_NL?NG\/>MZ#>OQZN_M></H*_8BW3:)1O
M ]\]?:NSU+2++6-*ETW4(1<6LJA75^2<=#GU! .?6F:GHMCJS6\ES&PGMF+V
M\\3E)(B1@[6'.".".A[@T <AX^61_&7@,6F?MHU-V^7KY 3][^&,9JEJ?AV]
MDU+4_%'AP*OB#3[]P(R<+>P[(RT#_7JI['\QW-EH5E9WSW_[VXOG3RS<W$A=
MPF<[5SPHSSA0,]ZET_2;;3'N7MVF)N93-+YDK/ER "1D\< <#CB@#B--U^T\
M3>$_&6JV8=$EA</%(,/$XM5#(P[$$$56\/\ AB]\3>$/ ;7EQ;PZ=I<5K?JD
M0+2S2)&-@). H&3G&<^U=Q)X;TM[?5(%@,4>J,7O!"Y3S&*A"<CH2 ,X^O6K
M.DZ5:Z)I<&FV0D6UMT$<2/(7**!@ $DG H Y'Q=8_P#"5WE[H[Z9=7MC;6K1
M%H&B 2ZD7AOG=?F1"",9_P!9[5H_#S6[C6_"%O\ ;P5U2Q9K&_1CEEFC.TY]
MR,-^-;>F:1:Z0MP+4S'[1*9I#+,TA+GJ<L3CZ=*K:7X9TW1M3O\ 4+)9TN+]
M_,N2T[LLC?WMI. ?H* .)@TE],^(MWX2MI570-5A.K26V/\ 5D.%DB7T1V*D
MCTW#O73^,]+MM;ATG2[Q-UM=7DD+CV-K.,CW'45HR>&].D\1QZ^PG_M&.(P+
M()W"B,G)7;G;C//2K%_I-MJ4]I-.TP>TD\V'RY60*^TKD@'GAF'/K0!P/A?4
M[K6M*MO!NHL6U'3+AK?5"?XX(2"C?23,8YZCS/2N9/\ R:I)_P!<V_\ 2PU[
M(NCV*7E]>10^5=7RHMQ-&2KN$!"\^P)K'_X0'0/^$6/AGR+C^QR<FV^U28^]
MOQNW9QNYQF@"Y'%K4.K02W]_8R:>(G5EBMVA/FED"'+2-G^(=N37':IX<O9]
M5U7Q-X=VIXATZ_8*I.%O(?*B+0/]>Q['TZCLQX;LO/MY9)K^8V\@DC2:]E=-
MPZ$J6P<=1G/.#5K3])MM,DNI+=IBUU+YTOF2L^7P!D9/'  P..* .<\#:_9^
M*)=7U2U1T5YHE>&5</#(L2AD8=B""*K^&O\ DK'CK_KEIW_HIZZVSTJRT^ZO
M;BTMUBDO91-<%> [[0N['K@"JMCX;T[3];O=8MQ.+V^""Y=IW82!1A?E)P,
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M>_R)?XE####Z$=O855U7PYIVLWUC>7BSM-82>;;%)W0(^,9P" 3CCG- &J
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M=1\-Z=JNK6&IW0G-W8%FMG2=T$9888X!P<CCG- &E!!%;6\<$$:QPQ*$1%&
MJ@8 %<5'_P EUN/^Q;C_ /2EZ[FL@>&M.'B)]> N!J+P?9S+Y[X\O.[;MSMQ
MGGI0!PL^AW]@)?&7AN+?JMM?7J7MFO U"W%S)E#_ +:]5/MCG@5>L6T7Q]X2
MUUC=RQ:?J6H1^5.AVR1R;(-F/1A( /J*[;3-*MM)AEBM3-LDE>9A)*S_ #NQ
M9B,DXR23BJ<OA71I=.O+ VFRUN[D7<R1.R9E#*VX%2"IW(#QCF@#E-)U3Q'H
M/B?3/#OBU+?4X;LR+IVL0+M9F5"2LJ=F*YY''UY(M^*0!\3_    , /?_P#H
M@5T=OX=LH-1AOY)+FZN;=66![F=I/)#<':#W(XW')QQFC4/#>G:GK%AJMR)S
M>6!<VSI.ZB/<,-\H.#D<<T <S\2U<2^#_(""4^)+8C<.,^7)UQ4'@Q&U#QWK
MVJ:TPA\26L8L&LXQB..UW;T=">7#GG<<8.1@5UNL^'-.UZ:REOUF9K*=;BW\
MN=T"2+G#84C)&3UHN_#FFWNL6NKR1RKJ%K&8H[B*9HV*$Y*MM(W#/.#D4 <Y
M\/\ Y=<\;QGAQKCL1[&-,&I]2YTSQZ1T$3+^/V-#_45L7/A>PGU6;4X7NK.]
MG54GEM)VC\X+PN\="0. <9QWJ8^'M..BSZ2$E%K<!A-B9]\N[ABSYW$GN<YH
M X.ROY? WB/6/#\* QZLHO\ 14;[OGR$))%] Y5\#HI)JYX#T^/2OB#XUL8V
M+B&/3@7;J[>2Q9C[DDD^YKM3HM@\^GW$L/G3Z?N^S32L6>/<NUN3UR..:JVO
MA?3K+5=0U.W-REYJ 074GVASOVC"\$X&!P,8H XCX:6^NR_#72C87MFD'VN0
MM$]LQD,8NFWC?YF,D;OX?\:V?%?AVP\7:Q:6<LFP_P!G336EU"?F@E$D)21"
M.X_45IV7@?1]-TH:99/J-O9#=B*/4)U W$EL'=D9))_&M*+0K*#4+>]B$J26
M\'V:)5E;8L?'R[<X_A7MGB@#BO#GB*]O_%>GZ%K\8BU_3(IUN=H^2XC(39,G
M^RV.1V.>E7O%8 ^)?@  8 EOL ?]>]=;+I5E-JUOJCVZF^MXWBCF'#!&P2ON
M,@&JNH^&].U35[#5+H3F[L"QMG2=U$988;@'!R..<T :H !)  R<GWI:** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *QO$_B.W\,:0+V:)YY994M[:W0X:>9SA4!/3/KV -;-</\
M3=,N[K3-&U.S@DN#HVK6^H2P1KN9XD)W;1W(!SCV- %_6=9USPWI#ZUJ$5E=
M6< #W<%JCK)"F?F969B)-O7&U<@'ITJ'5/$^H)XH\/Z9I9L9;76H)IXKB1'.
MP1HK9X8;@P88Z8J/QIKEAJ/@74;33+F&_N]5M'M;."W<.\K2*5! '89R2>
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M%.KZ=IOA:Y2.Q=]:N[>UD4QN!$95+;A\W.,8QQGVKF;ZRTT? +[8+ZY+'0D
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M^XOY4H 48  'M2T4 )M7;MP-OIBA55?NJ!]!2T4 ! (P1D4BJJ_=4#Z"EHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !116!::I+K>M:I:V<[0VFFN+9Y44%I)RH9AR",(&7ZDGL.0
M#?HKA? ?C:UU+PYH<.K:HDFLWR/G*;=[AF.,@;0VT9V\'':MVTU>2#Q3/X?N
MWWR-;_;+24@ O'NVNAQQE3CGN&'<$D W:*** "BBB@ HJ*ZCEFM98X)S!,RD
M)*%#;#V.#P:\G\(>,?$NM^&O%UGJ.II;>)=%D?!\F,1A54XR-O(+*P)],?B
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M K*5$GV65U'*[H/WICB0*S#OCDC/3-=-I2^+;6RBL;Z/2[B2)1'_ &@)W!D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[]J;X453X'T)BH)&FP8..G[I:\ELBX^%'PS$F?[/.M0"[_NX\U]N[_9SC]*
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MA+5(3_Q*+_5[%[W)X$)8DJ_L& !]Q7IES%!/:30W*JT$B,LBOT*D8(/MB@#
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M<",QE(2SD2$!/E'/)9?S%<%>[M"\9>)/#2 "'Q1"ES9 C($SD0S\=R 1(1Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)0/DC^$8.._^.?9>/YI_ VCZ_<6MM#/K%REM;Q&4B.)G9@"[D=,*3P/0=\T
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MNK<$6[W3 B'(P2JJ H)'&[&<<9JM::AKT]I879M=/:&Y,3.B2N'5'QDC(P2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!:(D<J2.,B@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRLJ@$X QG=P<CVSZ4DOCE8CHEJ;%?[2UEI#:P&XPGE("QD=]O"E<$<$G(]\
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M:2&9%DC=2&5AD&@"6BO+/ _B)?#OPF\.7\UG<WLE]<BWDD1@7W/,R*6+')[
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M[1J%XKO%$7V*J)C<[-@X'*C@$DD<=2.7\0^,9Y_ ?B>?3X)+75=+CE@N8GD
M:W;82)%(^\,$%3QGVQB@#O00>AHKGO#6AV5D@U.+3DLKRYMXXYA%(2L@4<,0
M, MSUQGWKH: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%](.@>%=*TEF#/9VL<+L.A8*,D?CFM-HHWD21D5G3.QB,E<\''I3Z "BBB@
MHH!!&0<BB@!LA=8V**&<#A2<9/UKR[P+X*\2^$K?6$NK'2;TWMZ+R("^= C
MY )\H]#CFO4Z,@YYZ4 <=J&AZYKOA--%UA+.0WK2'49(IC^[4LS*L6Y.<?(,
MG& #WQ7*-\-_$VJ?"9?">K7MDM_83++I]U%*[*0N=JOE01@$@$9XQZ<^N44
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M,ABRH9$N(]Q4'T7.,XS79S>#+=[W3+V#4]1M[RQ65#.CHSSK(07#[E(Y*@Y
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M=O\ VD-3AA1X]L$V_>2N4)(+9X8D#-;-CX;@T_Q%?ZQ!>7>Z^$9FMV93&71
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M!]IET#5)[O1O-^9I;))#B,$\E63=M_X"1VKO?"OD:FMUXF2 (VJE6A9DVO\
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M)P<\C/:@#N?%FOW/A_3;2\M;>&=9KV"V?>Y&U9)%3< !R>?45NLZ*5#, 6.
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MX@87_@-= Z+(C(ZAE88*D9!'I0!RNO>,5LO#3:SI"07L*7J6CLTA R9A"Q7
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M,;K;N5CZ+Y@:(GT7/3%=!J&D66B^,_A[:6T<:&$W<6X*%+XMV))QW))/U)H
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M>73ZG;J;*>>!V:Y 3=N9@NT-MY.<4 ;#Z5ITC3,^GVK--M\TF%29-O3=QSC
MQFGG3K$I.AL[<K.=TP,2XD/JW'/XU6DU[3XFNU>213:RI#(/)?F1@"JKQ\Y(
M9>%SU%5X/%FCS0:C(]RT!TY@MW'/&R/$6&5RI&3N[8SGMF@"\-)TU6B8:?:
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MKT. >3@X!P:KR^,]!C33)!?&2/5 39O%"[K+A2Q (!YP#\O7/&,T )X@\/\
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MYXSU[ T 3ZKI%MK$<$5W'&\<4RS -&&.5.1@G[ON1SC(XK0KA/ 7BN*;PEH
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M\] A7<R^X!K.U'QKX>U+0+B5-5U*RM@EO+]LMK652!(P*;6*$')&T^F2#@T
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M([1I*T,BR1M&\<BG#*RL 01Z&@#01%C1410J*,*H& !Z4M%% !1110 4444
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M_"T9-4^QW8L3HBP";R&QY@E9]N,9SM([>W7BNQHH \?LK6^T?PKX*+Z3J/\
M:^G75PWE0PJ\D:$/NS&67>I#H,@C&1SG@]EX&EM-NJ1QVNI6U]/=&^NTO[8P
MEFDX!09(VX3 P2?EYZUHZIH>E^(+Z.?[7/#J%B#&)K&Z,<L8;!*-M/0X!PP[
M5H:=I<&F1L(WGED?'F37$K22/CIECV&3@# &3QS0 :SN.B7RI&\CM ZJB*69
MB5(  %<!-H^KGX6^%DM]+DFOM&:UEN-.E&QIA&A21!GC/S$CL<5Z945Q<P6D
M)FN9HX8AU>1@JC\30!YQJNF76KZ%+JN@^%7TZ\M[NTNQ!=HD4]Z87W%&P3@
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M#D[2/Y=>*Y6WTK5(_ACH6G-I=Z+VVUF.>6#R3N6-;HREO3&T@\?3K7K%% "
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MU2B@""SN&N[2.=K>:W+C/E3 !U'N 3@^U<UXZM+RXBT"YL[.:[%CK$%U-'"
M7\L*ZD@$C."PKK** //C;7K:[XYN&TZ\5+_3[>.V_<D^8ZQ2*RC'H7 ]#U''
M-9%K8:EHK>&]2N_#EYJ=F-"@TVZMH8P9[6:/)W;"1E3N()![ ^F?5V944LQ
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M0KNZEA&  ?X<$D\#(X/..9\)ZFEEX7^'%K+IEM<B\C$<=S(WSVSB%FRHVGJ
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M7KLE_9:P89&>WE :VO<$'S(''& /X>.&Y!(S5KXB0R23>%0EW<0!]<@C81.
M""KG)XY(*C&: .BL-?M-1UO5-)A2=;G31$9C(FU3Y@8KM/?[IJ[/9VMTR-<6
MT,K)RID0,5^F>E>;W5K>-XL\>O::K=64EMI]G(LD(3>[K%*5W%@>,CD #/K5
MRQ\0ZKXBFT;3DE$4MQH$&IS&.?R&=Y."5.QN%(SCC[PSGI0!Z'161X935XM
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M]CBG*I<!5VC<.WRC&5QD=:H^(;.36,>%!H#'2)4B,EVQ00)&K@E N=V["@#
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MHE @G2YA>&5HWCD7.&##D=2/QK2HH PAX2TY;G4[A9+I9-3A2"Y_?$[D4%5
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M;(MU'*6L9P6W@[F^S*#]3G(^N:]-:&)Y!(T2,Z@@,5!(!ZC--^RV^4/D190
M)\@^4#ICTH YCQ]?6-CIFEF_12DFJ6Z1/+(4ABD!+*\I[H-N<'J<#CJ/-M7N
M+";P;\1()+JTN&75(;B,H J_,(/G09. 3G!SSSR:]REBCGC,<L:R(>JN,@_A
M36MK=]VZ"-MQ!.4!R0,#]* //Y=*T,?%ZVMA9V/DS:')))%L7;(PF3:S+T8X
M+8)S7-Z!>K;:7X,\UT_L"'6=0AGY!CC??*+8-V"@GC/ .WVKV/[);;MWV>+.
M,9V#ITH^RV_E/%]GB\M_O)L&&^H[T >0^+;)O[-^))L4#Z2T%M*%C&8Q<CF4
MKCC.T(6QW_&MV74]$U/XKP.EW97-M/X>GC9PZLDG[Z,[<]#QDX]*]#C@BBA$
M,<2)$!@(J@*!Z8IJ6=K&@1+:%5"[ JH -O7'TH \8T*WTVT\&_#+4(4MX[Z3
M4XHGN!@2,ICF#*6ZD?=&/H*[+P";"#7?%UH@MTO5UF5Q$H <1&.+!QU"D_A7
M:?8[7 'V:' Y \L<5*(T5V=44.V-S <G'3- '#:BUA:_&73I;S[/'YVC2I$T
MH WRB>/ 7/5L>G.*XH0Z:G@$ZJJVWVV+Q3F.YXWH/MW9NH&TDX'')/>O;7BC
MD96>-6*YP2,XSUJ/[%:[<?9H<=<>6* /++Z?0]1U?Q7H?BO6);"XFNU>"/$8
M::WV)Y1A9D+$@@\*<[L\9)J=-,T>Y\;^+8KVV@FVZ-:NXNE1FW[90S,.F_&,
MGW]Z].:UMWDCD>")I(O]6Q0$I]#VI#:V[,S-;Q%F^\2@R: .%\*3>*+CP#X9
MDT2;2'B_LV$2M?>:S[PN."AZ8QUYJ&UDL;C7_'-AXH\E6<(R>?@ V7E  IGL
M&WDXZ,?6O1(XXXEVQHJ+Z*,"F2VMO.\;S012/&<HSH"5/J,]* /*-"N)]*U7
MP#=^)ITMKA]$N8I9KI@A+9B*JS-_%M['GK69%-IK^$[*9VM_(MO&K&4R  0Q
MFY8_-G[H(QUQ7M<L$,^SSHDDV,&7>H.TCN,]#1]GA,1B\F/RR<E-HP3G.<?7
MF@#S'7KEK#5M1U33GL=7THW-G]MTQQMG@?;'Y3P,.HP48*1USCJ:AOKO1]+U
M;XF?;H Y\N)_L\#!)GC-JH8J1R!G.6Z"O4FM+9KA;AK>(S+]V0H-P^AZT\Q1
MEV<QH69=K';R1Z'VH \GM;S3)O&M[$][I<]M<^& H2VP86V.V%!).\JO?T["
MJNAV^FV>D_"R]@2WBO)I!'+.N [@VS@JS=2,A1@], 5Z^+2V"A1;Q!0NP (,
M!?3Z4?8[7C_1H>.GR#B@#Q/4]3TZY^$NOPZO+;KXBBU)WO(IB!,)!<C:0#S@
M1;0".-HQTKL6_LR;XN7^?LCQ7'AM&E^Z5D'G-R?7Y<<^F*[M[.UDE:5[:%I&
M !<H"2 <@9^M*UK;NY=H(F<]6* DT >,:#;Z;:>$/ACJ$*6\=[)J,<;W P)&
M4QRAE+=2.@Q]!4VK/I5^GBKPU>ZUI*3W>M+.MS>74:/"H,9*E&.XE0I1<<'U
M S7K_P!CM< ?9H<#D#RQQ7*0^%-8CEGAFO\ 2;RTEFDD\Z[TWS+D!V)VEM^T
MXS@$KP ..,4 =!J-K"WAN[M+:"/R3:/'%%&HVXV$  #C'3 KRW2M6TJ:Q^%2
MK>VKR6X$4V'!,3?977:W]TEN,'J1[5Z[96<.GV%M96X(AMXEBC![*H 'Z"E2
MTMHCF.WB0[B^50#YCU/U- 'B=Y9Z1#\/O%]]%#:+<6OB.3[/,H7=#BYCP$/\
M(QG@8[UTSZEI[>*O&UEX@EMDEDMHQ9+<D!9+4Q=(\]1O+9QW(]!7HOV*UVE?
MLT.#SCRQ2O:6TC1L]O$QC&(RR [![>E 'CFA:S8VEGX*.K:F+/2)-!$$-R1&
MT2W(V[T<NK*IVC'..A'<U;DT7PY;ZIX"LK:3[;IK7EXL4EX4/FQ-#(=JX S'
MN. ,8/&,@C/K$EK;S0""6WB>$8Q&R J,=..E*]M!(RL\,;%1A25!Q0!G:AIM
MK;>%;O3[6TB2VCM'CB@1!M "G  KS&UETB\\(_#&W22TDC-W;I<(K#!<6KAE
M;'4Y(!!]<'K7LE0FTMB%!MXL+T&P<=Z /(=5ATZ'P[\5;&*.V2UA<210*%"(
MYMD.5'0'<.W>M3Q*TR!M0TVZTZ\\O0H_M^D7QPMQ:Y<[HW_A;AQT(/RY[5Z5
M]CM>?]&A^;K\@YI'L;20QE[6!C'RA:,';]/2@"*TO86T:"^E!M86MUE83G:8
M@5!PV>F.]>?ZIH6H^+_!NIZC;7]E'_:3+?V;- QDB\O!@ DW@+PH)^7@NU>E
M.BR(4=0RGJ&&0:00Q+$8EB01GJ@48_*@#S+5?%=IXD^&_A_Q#]NMH NH6DMS
M#+(%C=U?YXG;HHR"P+<?*/6L_4[30;_P_P#$77X+C1[EKZR+1QP2Q3/!MAQE
MF4G#,X!P#U4'.:]!U_0+F_CM&TJZMK.2VF\TQ36PEAG^4KMD4%2<9R#G@@&D
MTKPYY%V;[48]->[\HP@6=GY*!203G)8L<J.2>/3K0!Q>K1Z5X>T[PGJ<:1V6
MD7,L;:E>V\:-E_((A>0E6##<?O,#@D'KBJ^IMH^C:=%J6E:K=W6@3ZXD^IW4
M0CDAC)C8;D"IM*B3RRW!&<=P<>L&"$P& Q1F$C!CVC:1]*%@A2#R%B00[=OE
MA1MQZ8Z8H \@\4V?AO\ X0KQ)J.EZF=0CNKRRF>;?&8$F$J*3$44 .5^]CU'
MO6]_9.A?\+>:T^Q6/D2:$)7@V+L=Q-@,R]"0">3S@UWXL[98%@%M"(D^[&$&
MT?04?9+;=N^SQ9QC.P=,8Q^5 'C&B:M!I_AKP5+?7S6VAI<7\$MRH1HX)?-8
M0;MP8 ;=X!(XR.E7=5TOPY!IVA?V==F]LKCQ5%(LTS(8R7!\Q82H \O/4#C.
M:]:-I;&%H3;Q&)_O)L&UOJ*&M;=D1&@B*(,*I084>WI0!Y#KMK906WQ5L+*"
M!(8[*WF2WA4!4?R&W,%'0\#)KTC2=:T3[-I=G:7MIOO(F:VCB88EV %RN.#C
M//XUKK;0*S,L,89LAB%&3GKFE$$*F,K%&#&"J$*/E![#TZ4 24444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116/K?B6PT!X
M4O8[YS,"5^S64LXXQUV*<=>] &Q5"PUO3=4N[VUL;M)YK)E2X5,D(S#(&>AX
M]*N0RK/#'*@8*ZAAN4J<$9Y!Y%<CX9_Y*'XX_P"NUE_Z3K0!T7]MZ:=<&BB[
M0ZCY)G\@9)" @$GL.6'6K]<==?\ )8M,_P"P'<_^CHJZF_O8M.L9KR<2F*)=
MS"*)I&Q[*H)/X"@"Q16;HNNV>O6\D]FEVB1OL(N;62 YQG@.H)'N*TJ "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "L?3?#T.F:WJ>JQWEU+-J3(TZ2E-
MF47:N,*", 8ZUL44 8\OAZ&7Q1!KYO+I;F&W:V6(%/+\MB&((VYY*@YSVK8H
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
3"BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>exhibit1061-loanandsecur012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#,^T\8XSGW?HGAO4-(OKA]*L+ZPTF>PE\_29KB.2-+DD;?(^<[1]_/('3CT
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M<>=]FE^S[/.V'R]_W=V.,^V: .?L/&NFZA<:?''!>)'J4,DUC,\8VW"I@MM
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MC SG..V,]MVVL=5T;QOJFLQZ;/>6.L6T&^..2,26TT2E=I#, 5(/4$X(].:
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MC9$D/L0W3L0:MW7BO4] \07,6LR6L]A_8\VJ*+>$H\1B90R9+'?D-UP.1T%
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M)-;O/,T:826D_EQY5 A381MP?E8\GG//M72SZAFVO_[/C6\O+,%3;+($+2;
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M-.PA&8RRJI"<],*.N>]=A7/ZSXK@TNVT^YMX#>PW>I)IQ>.0*(W,OEDG/7#
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M2-X=#LE,4OG1CR@1&_/*@\#J>E3)X2\/Q:ZVMQZ/:+J;9)N5C ?)X)^OOUH
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MM--M4MK922L4?"+DY.!T'))XJ&_\.Z1JEY#>7UC%<7$((BD?)://7;Z9[XH
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M#$WF1(\$:#JF"V<XR2>#UJ>]G3Q)HWQ$?4)9/M&G-<6]O$LI7R(E@#(X /\
M&2Q)[CCH,5VUSX.\.7DUW-<:+92R7;!KAFB!,A!!!/OD#GOBEO/"'A[4+IKF
MZT>TDF:'R&;9C='C 4XZ@#IGIVH X[PM<KK.M6NB:@S?9K3P]936MN)"HE+K
MAY.",E<*H/;G')K&T#S+7P9X!,%U<+GQ!+ X$S 2)YEP<.,X;E0>:]*G\(^'
MKA+)9-'L]MDNVV"QA?+7NHQV/<=#1'X2\/PP6\$.DVL<5M+Y\*HFT))_?&/X
MO?K0!Y_%90VGA[XH7%M)<6]Q!<W;1217,B,I%M&X/#==PSG^E:^DW;:MXJL-
M$U)I&LT\/074,1<@32,VUW.#\Q4!0/3)/>NNF\,Z)<3WT\NF6S2WZ;+I]F#,
MN,8;U&  ?7 S2S>'=)GAM(WLDQ9C;;,I*O",8(5@<@8XP#C% 'F5M-J5S)H5
MG=:CJ!B@\3W>FQS+<NK7%LB2;=Q!^8@@KNZ_+USS77>"%:TUKQ7I233/9V>H
M(+=)I6D,8>&-R S$G&XDXSWKH9/#^DRK9JUA#MLCNM0HVB$^JXZ'WJ6STBPT
M^ZN;JUMDBGNF#3R+G,I'0MZGMF@#D?$]C;3?%#PA),&RUO?!F$C+PJQD=#QU
M-<^]_=ZC\+-3\4_:KB'Q%:7,\@99&S"\<Q"P;<XV[0J[2.=V>IS7IU_H^FZI
M+;2W]C!<R6K^9 TJ!C&W0D5"?#ND&_DO?L$/GR2++(0/E=QT=EZ%A@88C(QU
MH NQAKBR07"%'DC'F("1M)'(R*\9L+*"+X7^'5A+QO+XEC4E9"2H%](!@'(&
M![5[96*?"/AXAP-(M5#W'VI@J8S+G(?CN"20>V3ZT >?ZMJ%QX5N_&D%C=W,
M=G"NFR[I9I)C;B:0I,X+,6^Z,\'J,\5UVA:2]AXE>[BUV&:TO+(,NGP(WEEE
M8?OU9I&QD, <=>#U%;8T'2OM5W<FQB::[C\JY=QN\Y,8VMG[PP3P?6H]$\-:
M+X<CECT;3+:R69MTGDI@L>V3[9/';- '._%*UAN/#-H\@;*ZG9J,.R\-/&#T
M/_ZJ99I%JWCGQ!H-^9A::?:6PLH?.=<K(&+R@YR6W87=U&WC&3GK=3TC3]9@
M2#4;6.YB1PZI)RH8=#CU'8]JBN] TN_FAGN;19)X4,:3;F#A#U4L#DJ>X)P:
M /+M)?4->F\$P:MJ%^PN1J5O,\=R\?VJ.+*QN=I')'\0Y.>O-:,5E+KC>(M)
M_M_^S;C1YU@MY9FD::UA2-"DH;S%R&^8DD<\@DC 'H,F@Z5)=65RUC#YUBNV
MU91CR!C&$Q]T8XX[<57U#PGX?U;5(=3U#1[.YO8<;)Y(@6&.F?7';/2@#C=3
M74[_ %#Q+:/)=7MPVF6YTJ2TW(89BC9) /[IR^&R<?+@9P,59TV.=_&-KX7U
MF:::*WT-+@*]Q(XGG:0K*Y8G+;3@ $_+GC'%)J_@V;4O$E]=ZCX7T;64G=3;
MW4ETT$D,84 (X"'.""=P)//3@"NDLO"FGQZ586MW LTED7,$H=]\(8DE$?.X
M* 0O7D 9H X%+S4_[+TJ*>^O'6R\9#3X)C.V;BV60@"3GY\$%<G/W?K1J]H\
MME\2;AK_ %'S-,D\ZRQ>RCR7%LD@(PW/S=CD#L!S7I<_A_2;FVM+:6PA,%HX
MDMXPN%B<=&4#H1Z]>34;>&=&=+Y&T^(K?\W8.<3]OGY^;CCGM0!R=U/=7WB!
M8[X7%W:3Z"DD,5J26BG+'+D+RK-QM<\#:V".:Z/PC:W>D^&=+L=9NVDU9X0T
M_G7+2L\F!NP6))Q[<>E<YK?@MKO7FEF\,:1K&GB"."T\ZX:&6U5<Y4_*VY22
M2,'CIBM33_ UG;G299(($DTZ:2> (SOY&[_EE&S<[.A.>O. H.* .@UO_D Z
MC_UZR_\ H)KG_AS-'!\+= FFD6.*/3T9W8X"@#DDUU%U:P7MK);7,?F0R+M=
M"2 P/4'VK&3P3X92!8%T6T$"_=BV?(.<].E '(2>?XNNO$\#:ZFEW5A= 0NR
MN);2$(C)(H\Q0 WS$Y'/(/  $,MB=2UCQQ'=:CJ$J6^G6L\6RZEB59##(V]5
M#97D9V]!Z5W>H>$_#^JZK#JE_H]G<WT.-D\D0+#'3/KCMGI4S>']*>XO;AK)
M/-OE"73Y.9E' #<\@#C'H<4 <-X;U67Q%K>BZ;K$SR1GPS;7ZQLY47$TF \A
MQ]XK@8]"Q/I6+X<O&M-/\/Z*;Q(+&\U/5$>2X+.LLB3-Y:.0RD[LL>3R0.M>
MF3^$M N8+*";2K=H['BU&WF$=-JGJ%]NE-D\&^&Y=)DTI]$L38R2&5X?) !?
M^]]>3S0!PVJ:5=:4-$T\^(KNZ1_$JPD0221>1"\3OY!.]MP& 02<@$8Q7I.E
MZ;!I&FPV%LTS0Q A3-*TCX))Y9B2>OK5,>%="6SLK--+MTM[)_,MHT7:(G_O
M+CHW)YZ\FMB@#QC48IH_ WC'5%U'4?MNEZW/]CE-Y(3$%DC '+?,,''S9XK?
MU1HO#?C:^5=3OK:RF\.W-U=2M,\Q61)% E56)&X!CP!CH,5V#>%=#:RNK)M-
MA:UNY?.N(3DK*_4LPSR>G)]!Z5+-X=TBXN?M,]A%--Y!MM\F6)B(P4.>JGN.
MAH X71HW;QI9Z8[3PV-]X=:1X_M;-)*1)&%E<CA92&/*D_4U)X8EN;E[?P=>
MS7#WVBWCO>3F1MTT"\PN6SGY]Z9!/.QQ74_\(KI.E6ZW.BZ'IZZA:0N+/>NT
M!B.A;!(!P!GG J;0;"]C:YU+5HK:/4[W8)4MV+)&B#"H&(!;!+'..K$=!0!7
M\>:I=Z+X&U?4;$LMQ!!E749* D L!Z@$G\*Y[Q(T7A_0=0\0^'=3N)+A]'=H
M+993+'+@@_:2#DEE!^]WR,UZ#)&DL;1R(KQN"K*PR&!Z@BLK1_"VA: LZZ3I
M5K:"X_UOE1@;QZ'VY/'3F@#EKL-I>K^#+S1+F>5-2F^SW2-,SBYA:%G\ULDY
M9=N=W7G'2N=O/^29>)?^QJ?_ -."5Z?I_A[2=+<-8V,4!52B;<XC4G)5!_ "
M<<+@<"H3X4T)K*6R.F0&UEF\^2$YVO)G.\C/+9YSZT <#X[OF%EXNO\ 3KNX
M>YTUK<>>\YC%DX"'9"!RQ.<L3@'=CG&!-J9_LSQKXWU:Q0M?6VAPW,'SL090
M)L<9P>@&*[>Z\(>'KVXN+BZT>TGFN8Q%-))'N:10,#)/4XXSUJPGA_1X[^"^
M33;5;JWA\B*58@&2/LH]!R?S/K0!QVEZ8+QM(UJU\3 VUW:21R0V_FAKW,>X
M$MYIVNA!.X#/4<5BZ';V\?P^\-:M=ZGJSZAJAM;8J+MB+IMY81$,=J@@$,PP
M< ]23GT'3_!WAS2I[J;3]&M+66Z4K,\,>TLIZCCH#Z# J5_"VA2:,FCOI=LV
MG(P=+8K\B,#D%1_#SZ>IH \RU>>X'@3XEV,S@1VL^(8%E,B0AHHV*J2 <;B>
M,  D\"NMO(4N/BQ80R9V2>'[A6VL5.#-%T(Y'X5NMX0\.M'=1_V-9A+L*MPJ
MQ "4* %# =0,#CVJ6?1+2*7^T;2RA?5(+=HK:25V&!CA"W)"DXSU^E '$^'W
MN6F_X0:\GN9+S3;XSS7+2OOFLP?,C<OG)+%DC(ST#UVOB>\AL/"VJ75Q>2V4
M4=K(6N85W/%\I^91W8=O>H=!L=0$UQJVLPVL6IW21Q-';,76*-,E5W$ D[G<
MGCN!SC)U[JU@O;66UNH4FMYD*21R+E74C!!'<4 >90->VWB:^T^"\.EQS^&&
MF5GN3+Y<H?:L[]@^#SC.<=31!/J<D6K:)):_V'XC^RVY3=<M)9W*B7;N1@=R
MERVQN WS#J17:Q>"_#4*JL>AV(VP/;C]T,^6PPRY]"./I5C_ (1K1VMI;=[&
M.2*541Q*2Y*H=R+DDD!3R . >E 'FNM:I))X$\4Q_9-0T35[&6V:>U6[8I'N
M90#$ZG!C90W'3.>,UT6NB[N/%FL6<ZW-U;MI"&QCM&.Z"8LX).#\CL0NUS@?
M*>1S743>&M'N+&:SN+&.>"=@\RS$N92,8+DDEL8&,YQ@>E<GKG@Z;4?$=Q=7
MGAG2-:M72..UEGN6AEMT5>5;Y&W#<6.<YYQCB@"BND7UMKW@?2]4U#4&GGT^
MZ_M!5U"9A+(J1D\EN.6;D8Z^G%;_ ,.WE&E:M9O-++%8ZQ=VL!ED+LL2O\J[
MCDG&<<U>T;PCI^G6]DTMM&UU:&0V["1V^S*Y)*1LQSM[=LXZ <#5T[2;#21,
M+"V2 3R&64)GYW/5C[GN>] ',ZL'/Q2T2W\^X\BYTV\\V$3.$)!C .W. <,>
M1S7*>&+"\3X;:(VB)!/<B]N))=.N+AHUO(UDG7RP>0I&0PXP2O->HRZ183ZI
M#J<MLC7L*E(ISG<BGJ!Z ]QWJFOA/08P?*TNWA8SFXW0CRV$ISE@RX(/S-T]
M3ZT 5O!.H6VH^'%>WAO(#%<3QRV]XQ:2&02,6C)R<A2<#GH!715!:6=O86XM
M[6%8H@2VU1U).23ZDDDDGDDU/0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5/4=6T[2(XGU&]@M5E
MD$49E<+O<G  ]35RN,^):>=X>LHO(DG_ .)I:.T:1&0[%F4L2 #P%!S0!H0>
M(]+U?6-,&E^);1XV,ZM9Q[7:Y*C&<]5"$$\=<U=N?$^AV<A6ZU2U@ D,)DE?
M9'Y@ZIO/R[A_=SFL'70O_"Q_!\L4+F)%O3)(D1*H710NX@8&X@]>M<9:W^CP
M6L.BZC?75G9:?KLE\DDVGS[_ ))W<*T@0H!N)._=]WC .2 #KM/\9P6'B#Q)
M;Z_K-K':6MU#':,X5 %>)7/3J,MU/M6X_BS35\6+X>\P_:OLWVAFP=HRP"@'
M&"3DGVQ[UQ%_'YT/Q2*VTKM>0!;8B!CY_P#HH0!./F^?CC/-6+5VM_%=C<W-
ME>36]SX62V&R!R&D5R60D#Y3@]\4 =[9ZWIVH7 @M;I))3'YJJ 1O3(&]<CY
MER1R.*;J.NZ9I+;;Z\CA81F5@<DK&."[8Z*/[QXKC?!B7]AKMMI]M>RZKH0L
M7,$MW 4N=/P4Q [8&<CL1N&ST'*>+KB63Q!JUB+"ZB:;12D-S:VC2O>$[_W1
M<*0BKG.."=V<@#D ZZZ\3Z%93"*XU:SCD,/V@(9028\@!L#L=PQZYXJ6/7M*
METJ'5(K^&2RG($,R-N$A)P N.2<\8'.:\^\,,&\1>#9I;6XC6V\--!(\ULZ"
M.7]U\I)'!PK_ %'L><K1WNM)/AO4[BSO/[*LM5U,72K;N6@\YV\F4IC.W!/(
M' :@#NO"&O7.M:YXFADO%N;6RO(XK8K&$V*8E9E/?(8D'//%4[?QK;Z3XJ\2
MV?B+6K6"TM9[=+/S0L> \0=AZGEAR>G'2G>#)1-XN\8SI;W,<%Q=P2PR2VSQ
MK(/(0$@L!GD?7O513;6'C'QL-3L9I(]1CM_(3[,S_:T$ 5D0@88[LC% '97N
MN:9IT"375Y&D;H9%(RV4'5^,_*,C+=!D57G\5^'[=E676+(,T'VE0)@28N &
M&.H.X8]<\5YKI%G<>"KC3K;Q1;ZI+9SZ-;6JW%B9G6"6-I"T+"$Y.1(,'!''
M%;.EV%GIGCOP^EIID]C86VC7*1I*KOY!:5&56<YPQ4,<$Y'(H [B/7=+FTN#
M4HKZ&6SN/]3+&=WF'GA0.2>#P.>#Z5A^)?&UCIWA4:IIMW!.9YX[>%U^8*S2
M*C$CU7<3@]QBN#T]KC2M/T/4KFPU-M+L]1U)+N.V25)85FE+12[5PQ7 /3L]
M:^OV^G)X'FET73+^**^UFVN\2),\MP1-&TDI1\NHPIZ@9QGN,@'1:9?RVWB*
MZ%UXQBO[06K7,6GM;1K-''E<R,R $@'( VC.[N15_1?&6DZUHEOJD4Q2*X<K
M'&58NW+8PH&2=J[L#..?2LR1Q)\7K*X1)&@.ARQ><(VV;S-&P7=C&<*3BN4T
M*U$O@3PQ8RW.J:'JVG>:L=]]E8)!*,@I(&7:R$'J>. ,YH ]6MKN#4K$7-C<
M))%(#Y<J_,,@D9]\$5R7@CQI;ZAH.EQ:SJULVLW<DZ*AVH7VRR*H"C@':HP.
MIQWK7\(75_-X5@N-8MXK>Z#2F3RD*+(!(V) IY&\?-@_WJ\[L(7B^'7A2(VE
MPEQ#XC2>:/[.X=$%T[%V&,@;"#D]C0!ZC<^(-)L[U+2XOX8IGD$0#' \PC(0
MMT#'C )R<U OBWP\U^EBNLV373SFW6)9029 ,E>.^"*\_M8[%WU7PQXDT?6+
MJ]EU&:>W6-KCR+M'E,D;AT.Q,9&2<8V_A6A96$^H-\1K:TA:.]O97^QRO$4W
M$VRHK*Q'(#;AD=.?6@#M(_$VBRSO FH0M*L1FVC/S1CJR_WE'<KD4]?$&D/'
M8R+J$!CO^+1PWRS'&<*>AX!/X5Q'AF32-=ETH_V+J\6MZ;"\;B]-PJ61,>QP
M"YV,&P  ,\<X&*P]*N7'ACX?6!L-1^T:7J4:7J_8Y?W)6*53GY>>3U&0!UQD
M4 >D_P#"9^&O,CC&MV):2?[.FV8$&3.-N1[G'UXIOBC7[?2=(OPE_';WT5JT
MR$IO\O@[68= "1C)P*\ZOH7?X>>-(H[.X-Q<:_)-$BV[[Y5,\;*ZC&2,*3D>
ME:C7SZ=?^.++4K:Z>35%:XL)DMGD2XA, 0("H."I!R#CKF@#J]&\20)X-T34
M=8O$6XNM.AN96V\L3&K.^U1P 3R<8&:LW?C#PY8HKW.MV**T'VE3YP.8N/G&
M.QR,'OFO.=)N?[$?0KG6[#65TRY\/V=F);>*X4V\\0;?&Z1X;YMW!P<XXK6T
M_3;&P\;>%[>STF>TT^#3+N..*5'?R?,D0JK,V=K,NX[2<C)% '8>(/%&G^'M
M!&K7$GF02%%A\OGS"Y 7D=!R.:L7/B#2K2%)9[V-5>,RC@DA!U<@#(4>IXK$
M^)=O--X#NUMX)9FCGM93'"A9MJ7$;,0HY.%!/'I5"POCIWQ UN_U**X73M6M
M+9K&=X'P!&&#1$8RK$MN"D G<>] '=0S17,$<\$J2PR*&21&#*P/0@CJ*H+X
M@TE[Y+-;^'SY':.,9X=U^\JMT9A@Y .1@UA>!M&U#2_A[%I\FZVN6$[0(_6!
M7=VC4^A 9>.W3M7)Q6ESJ?PRT;PPMK/;^(;*ZMHV1HV!@>*4%IMV,;2H9@P.
M#NP,DXH [Z;QGX:@+"37+%=D_P!G8^<"%DX^4GMC<,^F15S4M=TO2,_;[V*
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M44 %%%% !1110 4444 %%%% !116=K.LP:-!;O*K237,Z6UO"F,R2-T'/ &
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MUU*PTV69HM^Y70QL4D1AC(R,<@$$<BJT<:KXP^'L@!#/I5R&.>H$46/YG\Z
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M?_L:;3]:@CO+&-[>YE^QG;>P%BRHZ^9P5).&S^G%:\>G-JOC]-;/-IIMD]K
M_:2:1@9"/4*JJ,^I([4 =11110 4444 %?+^D;F^&GCJW70WO$;46S=80I:
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MX/BI?VOAGQA?:EIMO+>^'KW[+MM2RQS9?8I^;) SR?:KK?#&Z:#P9%_;</\
MQ3+[U/V(_P"D<KU_>?+PN._7\*SM7\*7W@WPKXZU*+58;B;6I?/"FR^6%G<@
M@Y9@5PY!) QU- &OI7C+6Y_'.F^';N+3W2[TI-3>:"-UV@Y!3!8]QU/7T%8W
M[1 !^&\!QTU&+'_?$E,\%ZAK^F^*+"QGT;PQ);WB&*2XT:=I)88T0E2Y+-^[
M&  .F3Q[]9\1O!$WC[08M)74TL(DG6=G-N96) 8 #YUQ]Z@!GAY(->U'[5=Z
M.]C<:-,BVK2H@D8-!ACE2<J?,/&?X1WXKAO#FFW6M_$OQ\FH+874EM+;2IY\
M3,J2HK^4RC=P!SQ7HQT+79IM/6?6K%;6WDCDG2WT]D>XV<JI<RM@9 /3MBJ6
MB>";O1?$_B36QJL$K:WM)B-H0(2H(7G?\W7GI^% 'E_@/6K?PQ\+;7Q3>6=M
M>:F;^2ST^60$.KRL=^]LGC@G@9X([UW.H_%"70M+\1SW]DMP^F-"MI/#&T4-
MYYH& -Q.-IR&Y/3\*B@^#Z+\-6\(7&L^8T=U]KMKR.WV&*3W7><]2.HZUMZG
MX(OO$_@RZT/Q-K*W4\RH$N+>V\H1,AR'V[CN8GKR!C@ =: *&O>(_&6DZ#XH
MEGLK*/[!:)/9:C&A\N7*Y==A8G<IR 2<="1VJ'0M2\90_"C1;W2K.SU?4IHX
M"$E<H?*899F9F^9L]\CKG!QBMBW\(:O=>#+SP]K^OK>B:T-HDT-J(RJXP';)
M)9NGH/YUEZGX4\1:9\-;/1=+\231:A8E%MY;.TVF954A8B-QQDX)8G''(QF@
M#T09*C(P<<BOE[1]S?"KQI;KH;W<;:FV;O"&.T VY<C._@<_*IKZ<1;@6:*T
MB?:=@#.5RN[')QD<9KS72/A5JND>&M;T*'Q-;_9]8D9[B3^S3YBAAAE7][@9
M'&2#0 W2O&<&A^'O!.A6.J6^HS:E"R_VE,K&-(XE)8E<AB<C8 2#QSZ4W5/B
MAK%CX4TK5$TF!;NXU4Z9/!.KHK'DB1#U"D 'D'KWQS;N_A+!;:;X<3P[JDFG
MZAH+N]O<S1B42[SEPXR.IST[$BM'Q7X%U'Q9I.E6UWKL27-G>K>R2BS)5V4$
M!57>-J\GJ2?>@"CI_P 1KRVU/QC9Z]:VP_X1Z);@/9[L2H5W;?F/WN@SP.>@
MJ3P]X[U76KW3;8VML1JNG&[AFABD*6DN-PBE.?F^4CD;>01CFIH_AL)-?\5:
MA?ZDL]MXAMQ!+;QVY1H@%V@ARYR<>W6KO@[PMKOAG2XM,NO$$5]9VB%+-1:;
M& [>8=QW =@,?6@#Q?1H+9O@IK/B'5]+L-6>TU%_+%RL@<F1XUD.]6!&25((
M]#ZUW5]KNN/\0_ NCZ;)9VEC-IQNX[<HQ0-Y#C#88$@#.T?B<U>M_A-<P?#3
M4?!O]O1,E[="X-U]B(*#<K%=OF<\H.<^M:MQ\/KE]?\ #.M0:PD5YHMH;-\V
MNY9D*%<@;_E;#'J6&<=<8(!W55[RRM]0MC;742RPLRLR,,@[6##([C(%9.A:
M+JNF:MK5U?Z[-J%O>SB2UMY$VBT3GY0<\]0.WW<]2:WJ //].LK23XP^(89+
M6%HCI-K\C1@KRSYXJMY-]I?Q%U>WT"WLP\&@VBH+EF"*JO* /EY)X [?T/2V
M?AJ[M?'.H>(VU"%X[RVCMS;"V(*!"2#OWG)Y/:E/AR\7Q9J6N1ZA !=V*6:P
MM;$[-A8ABV_GESQ@=J ,F+QA)J-OX)OAIEL8]:D&6D;<]N_DNQV<?[)&<]#T
MJWI?BZ35?$4^FPRV4<UK>2P7-A*&2X2)=VV9<G#JQ"G@8 ?KQ5:R\"7EGIOA
M2R&KP,- E\P,;0CS_D9,?ZSY>&/KS5NX\(3ZAJ^GWNHW5M+)I]\]U;W$=N4G
M"$L5A+;C\HW 'U"C@=: .DOKV#3=/N+ZZ?9;V\;2R-Z*HR?Y5YCX5U=-+^(@
MCEU2WNU\3VWVF1(KA9/L]XG)CX/ \LA1Z^77H&NZ7=ZM#;06]W#!"EQ'-.LD
M!D\U48,$X9< D#/7/2J7C'PS/XGL;&.TOX["ZLKR.\AN6@,I1TZ8&Y>N2#[&
M@!NH>(;S_A)+K1-/CMUGM=.%\TER"5DRS*J  C ^4Y;G&1P:PX/'6MWUEX5G
MMM)L4;7_ #-BR7+GRL1,ZY^0<<<]>.G7-9WBJZ2?QD\-UX@T739K6R2'9JUG
M^ZGWDLYB)D7*GY01ENF/KMV>CZMKK^']4N+NP@.D7$K1B"S<1W*%#&"H+@H-
MK''7H"."* "X\5ZVL=]:065O)JVFP1FYAAMYYHYIV3?Y:,H^08*X9L\MTXR9
M)O&%]=>9;Z?8/!?06,5U-!<VDTI620,5A/ECY3\IRQ]1@'G$M_X5U:/Q3<ZW
MH&N1V!OT1+Z">U\]'*#:LB_,-K!>/0X%,O?"&JPZ['K&@:]]CN9+9+6\6[M_
MM"7*IG:Y 92'&3ST.>U $47BW7+O5]'T^/1H;.;4=.DNF2\D8/!(A0%64#H-
MWX\=*H#QYKJ>'&UJ?3M/6&QU$V%^BRN6<B<0EHN.!D@_-G/(XQD]!_PC%V/$
M^EZQ_:BR?8K26V9)8"SRF0JS.6# #E1P%P.GI65+X!O9?">I:&=8MP;[4FOS
M.+,_(3,)BNWS.>1C.>E %C5O%VH+)JZZ)8F[DTN01- ;:9S<R;%=D5T&U" P
M )SDYX Y+7\4:_=^(+O2=/TVRA>/38;Z-KR1P1O+#:Z@<'*XP.G7/:GR^$M:
MM?$5YJ6B>(([*#4BCWUO):"4>8JA3)%EAM) '7(XR<]*N0^&;NW\47>L1:C$
M5FT^.Q2*2!F90A8AF??\QRQSP* .>7Q7K&N7G@*ZL'@M+?5TFFF@=6;YU@8X
M)!&5&3CW /;%=1XQUF^\/>'+C5K*"*<6I5YTD!.(L@.PP>JC+8[@&L2Q\!7F
MG:;X6@@UF+[3H!D5)FM"5EC="A&W?PV#P<D9[5VEQ;Q7=K+;3H)(9D,<B'HR
MD8(_*@#EO^$O,7C&[T>YEM%M$TW^T(+A58[E'W@><94%6P.H8'BD.MZA'XB\
M*V6HZ;9";48+B1Y1G?;LJ!BB@].H!.><'BJ\'PXM8M+T"UDOII9M*N/->X8?
M-<)LV&-O]DJ(U^B"MG5- N-0\5:)K*7L44>F"8&!H"QE\Q0I^;<-N /0T <#
M>HG_  K_ .*2[5P-2NR!COY,5>I6A<:7 8U5G\E=H8X!.WC)P<?E7*2^!KR;
M0/%.EMJT &O7,DYD%H?W&]54C'F?-PHYXKK;6&:#3XH'EC>9(PF\(0I(&,[<
M]/;- '!V?C74$\)>'M0M='L$;4M5:Q>!)"B1DRR+E<+SG823ZG.#TJ6]\;:Q
MINF>+#=6EBU]H"QS#RBYCFC=-P'/(88(S^E2V_@&^M_#VB:4-9MV_LO5/[1$
MOV(_O/G=]F/,XY<\Y/0<59OO \NHS>*S<ZDGDZ_;QP;$MR&@V(54Y+G=USC
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ML53TRUN+2R6.[NVN[DDM+,5V!F/]U>=JCH!STY).2;E !1110 4444 %%%%
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M 87C(';)J_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&FOIL>I)?V[64H!CG60%'STP>]9VHZY97.BQW6G^(;"T22=(TNG*R(Q#C=&
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M,)]I4ACL<#Y=Z=RO]X5V5% ''>+-0CL_$_AY9;=XO,%P%U)(&E: [5_=H "
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MR.GW6GR7/RS0D)RLFW"L&C!Z'@U;U;1O$EQ?Z!XCAMK-M1TZ6;S--6;"&&5
MI59"!EQM!R0 22.@&0!? TLLOBKQH)89X"M]"/*FDWE/W"DX.3P3DCV/0=*T
M];\9V^B?VG))87<MKI8B:\G4 !0_38"1OP""<>O<\5%X8TS5[3Q+XDU'4;2"
MW@U*:&6%4N/,8;850@C:!V]?S'-8/B[POXDU[_A)K3[+9W<%Y @TV::XV_9@
M%&Y FTX8MD[L\@\G@"@#J[SQ/'!?WMG:V<MY-8PI-<)$ZA@KYQM4D%N 2?TR
M>*5_$T;:G=V=K9RW1L[F&VN3&Z[HVDV$-M)R5 <$GV.,X-<WXD\+:CK[-.=,
M2TUF*-/[.U6SN@K6[8&5D/!9 <\8.<G@=:?KOA2^U36SJ%M9BSU>"XA^S:Q;
M3!-\ V;UF0'+=' 7!'W>1S0!IVVN:-9ZYXLN9+6YM)M.BAEU">5MRR((V92B
MAB  H/0 G/(S4D?C%6U73=/DTB]6;4K<W5MM:(@H,;MV7&&&Y<@9Z\$\UCZE
M97&F77CK5M0MK4:?J-I%'!]HDRCLD;1[9 .0&9@!CG![&J^A1:MH^HZ2^L^&
MY2881I]M=?VI'<&(,!P$VH3G:,MR0!R< T :=M\1;:YM;&]_L;48K&ZOC8-<
M2","*7S#& P#9(+#J 0,]>N-=/$T<]_<06EG+<1VUXMG/)&ZYC<[>2N<[1N'
M/Z8YKD8_"NNIX'L])-E']KAUH7[?OUV^6+DS8!]<'&,=:NZCX6O;_P 20ZO;
M6']FZK%>HQU&WG"K/:A@2DR Y9BN5 P>QW#I0!UVKZLFD6\#FWFN)+B=+>*.
M)<DNQP,GHJCDDGT_"L&Y\?VEGH6J:E-IUYG2[P65U#'L8HY*@,#NY4[UZ<\]
M*N^+[/6;RPLUT<+($O(WN[<S>4;B 9W('[<[3[@$=\'CKKP;X@;P_P"*M-@T
MVPB&IZA#=6RPW&$0#RB5(VC 'ED9QR3T YH ZV+Q<9-4O],?1=0CO;:T%Y%
MQC+7,18KE,-@'(QAB#R*DL/%MMJ6B:/JEK:7#IJL@CABRF]"0Q.[YL?*$8D
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M4J[)A"X5BSYSA>O3U(Q4.B>%;G1]6O+W3=/?3+&XLG6?2UN%:%[HD8>,9P@
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M,Y,BJ=IC=,*#U/S9[=*9I6C7T?B[Q1>7=MLL=46!8764%L)&4;('3.<CK^%
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M)QAL#/&#5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9S@;>F??M0!Z/#J=G<:G=:=%,&N[54>:/:1L#YVG.,'.#TJW7"WWC2\T2_\
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M9//:OJFKS,AGCC/E1*L;2,5&?F.%VCGDG..U &YJVL:?H=B;W4[I+>W#!2[
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MF8"J [*,9W9Z]NF<UT?ANYUB[T&VEUZQ2SU/YEFBC8,N02 PP3@$8.,G&<4
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M/+>6%RTK,7 5U+N9#@CT8Y'IQ74T4 8-EX<=+ZPO=2U"34+C3XWCM7>,)MW
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M#4=)M1917L2(3+  !LD1@5;H#]>:ZG3['^S[%+<3RSN,EYYB"\C$Y+'&!U[
M #H, 5;HH P= \-?V#J&K7:WTEP=3N#<RH\8 5\ ?+CM@#@Y^M5]4\')J.MW
MFHIJEW:B^LA974,00B1!NP06!*GYVZ5TU% '*:?X*_L^[T"X&K7$QT6U:TB$
MD:?O$8*#NP!V1<8].<\U=3PUY'B/4M9MM1GB;4(HUF@VJR;T4JK=,]#TSC(K
M>HH XH_#J!/#^BZ?:ZO>6MYHI;[#J$2KYB*W#*P(VL".HQS@?CKQ>'[RWCMG
MCUNYDO(W9YYYXU87)8 89!M 4!1@+C&![YWJ* ,S0-#MO#VEBQM<E#+),QP
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MDCVKJ+'POH6FSPSV>DVD,T,9BCD6(;E4G) /7FC2_"^A:)=SW>EZ39V=Q/\
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MF/&0ORXZ=JL^,]3L-/UOPTMV88)GN96M[RZD*P6["(@EAD!F(8A02.23GC!
M.K%W;&&.87$1BE($;AQM<G@ 'OFF+J-BT+S+>VYB1]C.)5VJWH3G@^U>*12Z
M9/X5TZVGEMY&M_&FS#@*41KEB1C^$$<D<<5UNF:3H^H^-/'>@&*V6QN;2R5[
M>(* "4D#, .A'R\]L"@#T'[7;?NO](B_??ZOYQ\_T]?PJ:N"\$G4-2FAM=7@
M(F\-![%I&7"S3]!(O_;':?\ ML?2M'XDR74/@6^EMHI)5C>)[B.(99X!(IE
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MVJ*AA208=+=1\@/U)=_^!T =!)-%#M\V1$W'"[F R<9P/P!J)-0LI;0W<=W
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0D $DX
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M"%)7>X0$@D<98=*@NO%%K::S>:7):79N+6Q^WDHJE9(MQ7Y?FSG(/! H VR
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M;3=(M-,T6RTJ*,/;6<,<,8D 8X0  GWXK&NO$5VGC^W\.+ITSVTFGR7+SHZ
MY\R- 1E@0J[FSW)(P.,US7@_Q4FBZ&L5];ZE/!)K5S:&^8ATB9KAEC#LS;R.
M@R 0.YH ])\J/!'EI@G/W1U]:4QH<913CIQTKESKNC6/B3Q%/-'>PW&GV,4]
MY)(Q,1A'F%2B[CSPV>!GBMC3M6-_<20M8W-L4BCF5Y"C)(K[L;2C$$C;S]1U
MS0!>6"%9C,L48E(P7"C)'UH-O"9#(88R[8RQ49..1S[57U74$TO2[F]="_E(
M2L:]9&Z*H]R2 /<URO@#4]4%QK/AW7[@3ZMIUSYOFCI+#-\ZD9[ EE]L 4 =
MH$0-N"+N]<<TB0Q1,[1QHA<[F*J!N/J?6N<U/QOI^F0ZK<&VN[BUTF18[V:!
M5(B8@'&"P)P&4G XS['$=[XZ@M-2&G)HNL7-X;(7JPP0HS-'N"\?/U!/Z<9)
M&0#I_*CQCRTQG.,=Z1X(92ADB1RARA90=I]1Z5S>I>/-+TM'N)XK@V,5R+6>
M[0ILB?=M.1NW$!CM)"G!^AIVL>.--T6.[GFAN);2RE6*[N(MA6%CC/RE@S8W
M#.T'&?4' !TAC1FW%%)]2*%1$SM55SZ#%<Q<^.+:&]U6SM])U.\FTR*.>40)
M'AXW#$,I9P",*>.ISP#SA;/QU87MWI$:65^EIJZYL[V2-5BD;9OV8W;@< \E
M<''!- '3&-&;<44GU(I/*CV,GEIM88(QP:YJ[\=Z79RP-+'.;*:[^Q"]4H8Q
M+N*\C=OV[@5W;<9]N:K77Q%L+2#5)VTG57@TJY^SWLBQ)B'A3OY?E<,.F3WQ
MC% '7)#%'$(DC18QT0* !^%(\$,D8C>*-D!R%901GZ5SH\373_$#^P$TZ5K5
M; 71G5TPVY]H;!;(4;6'J2>F.3?U_P 00>'8+6>ZMKF6&XN8[;?"%Q&SL%4O
MN887) SS0!IM!"\9C>*-D))*E002>O%/551 B*%4#  & !6''XJM6U;6-->U
MNHIM*@6XF:3RPKHP)!0[N1\IZXQCG%5%U73[SQ=I4,]EJ5OJ,^GRS0^8^U%C
MRFY657(WY*]CCUH Z8QHS;F12V-N2.<>E)Y4?'[M.!@?*.E>0WTDZ?"GQ<XO
M+L26VN7"12?:7WA1<JH4MG)&WC!S7K\C;(V<*SE03M7J?84 9&M:7J=_]GBT
MS54TVW)9;L+;!WD0C'R-D;&'/.#UZ<5JP016MO%;P($BB0(B#HJ@8 _*N5T[
MXA:?J5@-073M3@T\QNPNIH5"%UE\OR^&)WEB,#H<]<@@/E\>Z?;2ZI!<V=Y%
M=:?9_;W@'ENTD R"Z%7(.",$$@T 6O$/A^YUK5=$NX[B".+3;EIVCEC+>;E&
M0KU&!ACZUO+#$L:QK$@C7[JA1@?A7+)X\M6O-/MCI&JJ=2MS/8L8DQ<$*&*#
MY\J0#U8*."<XYJ:V\;V-QI;7?V*^CG34/[->S=%\U;C(&TD,5Q@@[MV,=Z .
MC>*.2(Q/&K1D8*D9!'TIR(J($10J@8  P *X_5_%6DW?A+Q#+?V>HK!IS/;7
M]O$0LRX4,2K*^,%6!R&J[<^+;>RU>'18=,U*ZNY+'[7"D2J0Z JN-S, #\W5
MB!QUR1D Z/8NTKM&#G(Q4;VT$L?ER01NG]UD!'Y51T#7+7Q'HEOJMFLJ0S;A
MLF7:Z,K%65AD\AE(_"LC^VM,M/$VON+343?6-E#+<_-E'B^<KY:EL9X;/ H
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MI0U"Q\Q4\QXI(Y0 \<BG#*P!(R#Z$BM6@ HHHH **** "BBB@ HHHH ****
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M&6=(GMY(\@,"P(*D'D#G(_/J!=Z1HLUCI"RVUK+<%EM;5< O@%FP!]"2:TJ
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MW:W'FHJQ/,N&24$@X!&05#9!]>*[+3M2L]7T^&_T^X2XM9ANCE3HPSC^E6J
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M;!Z\*1@=_0<US1\,Z\? SZ7_ &8WVLZY]N"^='CROM7G==W7;QCU]N:].HH
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MG$;*CD$*S+N /TR,UQ]MX":UT'P_I*:KF/1;M;J%S;_-(5W85OFZ?.W3V_$
MKR>*_$%] ^H:%IHN[>*^>W^RF'!EC24QNPE+@*WRLP&WIQUJI)KD/AKQ7\0M
M9N$+QVEG82;%."YV2 +GMDX%:UOX'N+'5[R2P\07=MI%].US<::L2,"['+[)
M#\R*QZ@>IP14UUX(M]1O?$<E]=&:VUV".":!8]IC$8(4JV3S\Q/(Z@4 9&HI
MJH^(O@=]1GM9-ZWA*P1%/+?R>0"6.1^1X]^.^F\WR7\ED67:=A<$J#[@$9KD
MK7P9J"ZEH=[?^(YKM]'\Q8<6J(9%= GSGG)QU(QGV/-==(':)A&RJY'RLRY
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MD<4"1R+QU&T'>_ ^8Y[X')R 5K+Q1KEUJ'A2..33YH==LWNI"L+_ .C[55B
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MU' P&) /X<]\T >UT5Y=K-_>^$]9\7)IES=RI'H,>H(EQ.\_ES;Y%+KO)QP
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MO;[,=C D,S$[6(SCID''>KUI>'4_&EIH%W)(EG!H45W'"DC)YSLVTL2I!(4
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MPZK/=_:[EYF\R4Q[RD9?.?F;'?G;CH:Z+P;:1V7CKQO;PM(8UN+0@22%R,P
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M.;>-GF1=HE.T9<+V!/.*N4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJRVJ"_-N+8SC[WE!MVWZ9YJY110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 445F0ZL+S7+G3K4*RV07
M[7*?X7896,>^,,3V!7KG@ TZ*C%Q SJ@FC+MDJH89..N/I4,\\CVDLFGF&>5
M"<(7X8CJN1T/;/;TH M452TC5+;6M*M]1M"QAF7(###*0<,I'8@@@CU!J[0
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M<0NZHLT;.R[@H8$D>OTKG_&_B.;PSX8O-1LUM9;N!0XAG<C*E@"<#D]?;ZT
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MM&L;9U0Z4GC98]-WGA;<G#*A_N;@XXZXKKH++3]*^)D>CRV5M;:2VDLVFP%
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MMCXIC%Q&R)A8G7"7()[90AA_M'WKO_[-L=H7[%;X!R!Y2\'\JL%%+ARH+*"
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M^T>>(XC&Z GY<X8D'IP*76M)N-<\#:X=+\)?V5<W*0[('CBCN+@QR!CNVDC
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MXY(/4?GK1:7=6WC/PY<1:*+2QM=/NHI4M8U$5NTC(RH .OW3D@8S]: +5_\
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MJEVVKN.-Q]![\4Q[B".>.!YHUFER8XV8!GQUP.^*P].N4\4Z5=QS365YITR
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MY'4@94^FVI;[QY>PZ5>ZO:6%O+:VFJ_V8T$LC)(Q\P1;]P!Q\[#Y=I..<]J
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MI#+W4JQ!'O7044 <XFD^(9]+:*_U>V>[G=%G:WA:.-80?F2,;B0S D%R<\\
M8%4;;P=>:8^OVVF7=K!I.J(QBLC"<6LK+M9E(/0]2N!STQS78UC^'_$$>OKJ
M)CM9K8V-[)9.DQ7)9 I)^4D8^;UH Q;;P??VX\'C[=;$>'HS&?W3?OQY)B]?
MEX.>_-02^!+NYT#Q%IDVHPJVK:D-1CD2$D0L&C8*06^8?NASD=37<T4 8$.B
M7DVM1ZWJ,MN]];VKV]K'$K"./>078D\DG:H[8 [YS6';> [^T\*>'M+BU2V^
MUZ)?"ZBG:W8I(/G!!3<".)#T/85V&FW<][9">XL9K*0NZF&9E+ !B <J2.0
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MHB3<(6W#D$8(/0X-<)::@]Q?WNI66M^%WEEOY)UL-1MY!=*ZL50&-9!^\"@
M'86^IKTWPUKT7B71(]4AMY;='DEC\N7&Y2DC(<X)'5?6M/R8O.\[RD\W&-^T
M9Q]: .=T?1=0A\4W_B"YDA1=1M+>)[0*2T)C#'[V<'ER.G850T#PEKF@2C3;
M?78F\.QS&6& VY^T1J6W>4)-V-F3UQG'''6NTK'USQ!'H=QI44MK-*-1O$LT
MD0KMC=@2"V3G&%/0'I0!AZ7X2US1;ZXM+'78D\/3W#W MVMR9X=[%FCCDW8"
MDD\D$C/'/-$_@V_FL?%UM]NMA_PD!;#>4W[@-$(O7YN!GMS7:44 <G)X5O)]
M6\.W<UU;-%I5K+;2Q"-OWPD14)!S\O"CCGK4/AOPMK^@)#I;:_%<:':'-K&;
M<K<; <K&\F[&T<=%R0,<#BNRHH X.3P)J,GA2]T4ZE:AKG5#J/G>0V%S.)MF
MW=SR,9STK8@\/:A:>*]5UFWO[=(]2MXEDA> L5DC5E4AMP^7YLD8SQU%=)39
M&*1LRHTA )"+C+>PR0/S- %?38[V'3;:/4;B.XO5C FEB38KMW(7M5JLGPUK
MT/B;P_;:O!!+!%<;]L<N-R[79><9'\-:U !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<1\7O^25:]
M_P!<D_\ 1B5V]9^LZ)I^OZ>]AJD!N+1\;XO,95;!R,[2,\@'F@#B(HYKCXK6
M,7BB5#-:6[RZ";=/+AFW*!-N!+$RJ,<9QCG%.G?5?%-]XGM+34_L%WIUV(;=
MQ=R1FW41HRN8U^5PQ+'YLY'':NQO_#NEZG:6MM>VQFCM)!+ S2OOC<=&#YW
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MRSHLKB*5QC#/&#L8\#DCL/2K$>AZ?%K<NL)"XOY8Q$\OFN=R#HNW.,#)[=Z
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MB'0QIH+QW3RK_I); P).2=F<XXSCOFI=3\%VFG^#[W2?#FE6S"Y*":"XF?\
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M:[.J&CZ+IV@:>EAI=JMM:H2RQJ20"3D]3GK5^@ HHHH **** "BBB@ HHHH
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M-UV-]?NKR'2]4T:UBM;J%2\;,H<21,0IPQ+Y]Z /2+G7=(LSBYU2RA/E>?\
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MUW-%%,K,!G&< YQGC-<1+J>E>,-#O;CPS:2?VVFD3VL<GDO$UH63B(D@ -N
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M/W>5W;1N8;FV_-@=B.Y H W:*X^7QH;GQ#X>M-+M)+O3M5M9;I;F-D&Y5"\
M,P(QO!.>>P!YK!\/>*$\-VOB"2\M=2N;*+Q#/#)=AA(MNC.B+N+MN8 D?=#8
M'6@#TZBN<UOQG8Z+]NW037(T]!)=^2T8,2D;NC,"QV_-@9X([D"JL_CZS&H+
M96.E:GJ,KV4=_$;6-")8'; 9<L/?@X/UH ZVBBN#\>Z^MSX,\40Z?;WLWV&W
MDBENK:0((I0F<9W!FVY4MC(YQS@@ '>45SEIKZ0V]GIUM:W%_?)817$L4)0%
M$(PI)=@,L0V!['IUIUKXRTS4+#3KBP6:YEU!G2"V"A9 R9\P,&("[<8.3UQC
M.1D E\2:!+KZZ:([Q;;[#?17HS#YF]HSD+]X8'/-;@SCGK7,)XWLS'8M+I^H
MPM=:D=+*R1J#%.,_>^;E?E)#+D4E_P".;'3H?$$DUC?DZ$$-TJJA+*Z[@R?/
MR,>N#[4 =117+'QM&NKQZ8=$U3[3<6YN+,;(\72J0&"G?\A&X'Y]O\JDM/&V
MG7>CPWWDSQ32W3V0LY=BRB="V]"=VW@*QSNQ@?A0!TM%<:_Q(TJ*PN[B2TO?
M,L[V.RN8$5':)Y" C?*Q#*=PP5R?;-33>-Q'#KL?]CWT5_I5J+O[+.8U,T1#
M;75@Q 'RG.>1CIGB@#K**R?#&I7&K^&M.O[NW>&>>VCD<-MPQ9 2PVDX!)XS
MS[5)JFLQZ9<6-L+>>XN;V1HX8X@.JJ6)9B0   ?Z4 :5%<W;>-+"[T^SN(H)
MQ-=WDEC';2;%<31[]ZD[MO&QN03GC'6MG3;TZA9"X:VGMFWNABG W*4<J>A(
MP=N00>010!A6/A?5-/5[2'Q+<-IS2.XCDMHVF&]BS#S>_)/)4GWKI+>WBM+:
M*V@0)#$@C1!T50, ?E5/5-8M]*^RI(KRW%W-Y-O!%C?*^"QQD@ !0223@ 5D
MOXN22SUN."RN4U32H]TMF^S< 5)1P=VUD(!.0<\$8SQ0!TU%<5X!L4O=%T?Q
M%/%>PZC/IT8N'DF!6[+JKF1E5B"<YP3@@$C&,5TFK:Q%I*V@:":>:[N!;PQQ
M 99R">22   I))]/6@#1HK+T+7;?7K:YEAAFADM;F2TGBE W)(AP1D$@CD$$
M'O4NM:Q::#I,^I7K,((<9"#+,20JJ!ZDD ?6@"_17/P^*DD\03:&^EWR7T5N
M+DK^[*F,Y (._N05^OMS61H_BW1]-\*^'I['3]3&F:E<?9;9I&5VB=G8#S&>
M3(R0><GL/04 =O16/>^([33Y+X7$4ZQVGE!IOEVO)(0%C7YL[B2O4 ?,.>:R
M)_B'IMJNKK<6=VMQI=L+R6!#&Y>$Y^="K[3@@@@D$4 =?5>]LXK^V:VGW&%^
M)$!P'7NI]CWK%T_Q?!?:W;Z7)IU]:/=VINK26X5 DZ+MW8PQ8$;APP%=%0 4
M5YMXY\0#4_#=M<Z?!??9/[6MHH[V*4)&^+A5;(#99#AE!(P3[8-=)J7C6STR
M2]:6SO'M+&XBMKJY55"QO)MQ@$@L!O7) []\&@#I:*Y:'Q5<-XVU?2;BQ>&Q
MT^TBG:Y+I@!O,)=OFR%P@ P">"3BG6OCC3KG6=.TYX9X3J:,]E*Y0K+M&X@A
M6)0[>0& _/B@#IZ*1CM4G!.!G ZFN,_X618C3EU)M(U5; 7ILI[@QIB"02>7
M\RA]Q&[^Z&Z^O% ':45SEOXRLS?ZE9ZA:7>F26%J+US=A,/;Y8>8-C-P"IR#
M@^U1Q>.=..K1Z==07%K+-;/=0,Y1Q(B#+CY&8A@.<$=* .GHKG-/\86]_?6E
MH=/O8)+VQ-_:"0)^]C&W(X8[6^9>#CKUZU1L?B+8WT&DW2Z7J<5CJ=S]DBNI
M40(DVYE56&_=R5/(!'(&<YP =C16'#XFANKQXK:SN9X8[PV4EPA0K'(.NX;M
MP&>,XZ^Q!K<H **\TUSQ'?:WX2\?0RV5U9#3!/%!-',J[2D*L,E&W9)8G&",
M<$UT.A^*H7NM/T:YLKRUEEL!<6]Q<!0DZH%#D88L"-P.& .* .JHKEH?'FER
MZAIEN8YD@U1BMG<ED*2-C< 0&++N'(R![X-=30 45SC^,+4/!)'97L]C->_8
M5O(D5D\S<4SC.[9N!7=C&?;FDOO&=E96U_>BTN[C3]/F,-W=PJI6)EQO."VY
M@N?F(!Q@]<' !TE%<S=>,X(]8ETJSTO4+^Z6S6]C^SB/9+$Q(!5F<#L>N/;-
M9\WCQKF;PG)I.G7%S9ZVTC%LHK@+$[;,,P^8$#)SC ."<T =M17+0^-X+C5[
MO3XM'U5S97(M[J81(4ARF\.<-DK@]@3Z@<9FTWQC::A?:=:M97=K_:=J]W9R
M3!<21KMSD!B5.&4X(Z'UXH Z.BN<A\8VUQ-IQBL+Y[+47:.TO%13'(0"02 =
MRJP!P2 #[4WP=XCN_$<&H376GR6H@OIK=,LC+B-MFW(8DG@D\8YX)H Z6BBN
M<O;_ $^/QUI]I+:7C:B;*>2WE5\1% 4WKC=@MG;C(_&@#HZ*XVV^(MC<V]E=
M_P!E:G'975Z; W,B1A8IO,,8##?D@L.J@@9&3GBM8>)H9;V>"VL[FXCM[M;.
M>:,H1'(VWJ"V[:-PR<?IS0!N45P]MX^FBLO%&HZCH]XEIH]W)%^Y,3$(D<9(
M/SC+98MZ '&215]/&\(NK**XT;5;:.^NTM;:>6.,)(SH7#??W8P#VR.X% '4
MT5RVH>.[#3;;Q!--8WY_L)D%TBJA+!T#JR_/R,$=<'VI6\:(FL_V4=$U7[7+
M;FXM%V1@7* @':2_R8R/O[?Z4 =117-6GC;3KS1K:_6*>.6XN9+1;278L@F0
MMO4DMM&-C'.<8'J0*I-\2-*2QFN'M+W?;WZ:?<0HJ.T4CD!3\K$,IR""N3[9
MXH [*BN2N/' BL_$&-'O8K_1[8736MPT:F2,JQ5PRL1CY6SW&.F>*V?#FH7&
MJ^'K"]NK=X9IK>-W#[?F)4$L-I/!SQW]J -2BL[4]8@TR:SMV22:[O)#';V\
M6-SD*68\D   9))_4@'#O/B!IUAI&K7MQ9WJS:1(L=[:!4,L6[&QOO8*MD$$
M'^1H ZVBL_2M3?4TN&?3KRR$4IC472!3*, AUP3\ISWP>#D"C5-8M]+:TB=)
M)KF\E\FVMXL;Y&"ECU(  4$DD]O7 H T**XG7O'PL?#7B&YM+"8:KHZ 36DY
M0&/<,I)D$AD/7@DG&,#M4U34;F#XB>'KD66HM)/IMWFQ612696CV\;_+7@GG
M(Z\G/% 'H-%<W:>-=.O-%M=06*>.2YN'M4M)=BR"9"P=3EMHQL8YSC ]2!5%
MOB1I4=A/<O:7N^VOTL+F%%1VBD<@*>&(93D$%<_3- '9451TK4)-2LS/+I]W
M8.)&3R;H*'X.-WRDC![<U>H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG?%]MK5S9V(T=/.1+Q&O
M;=9O)::#!RJOVYVDCC(!&>:Z*B@#D?!.BZCHEWX@6[L+6UMKS4#=6XMY0P"M
M&B[0 HQC:?3Z5=\;:'>:_P"&I+73IHXM0AFBNK5I?N>9&X=0WL<8_&M2#5]/
MNM3N=-@NXI+RU57GA4Y,8;.,^F<&KM '#ZOI7B+QMX/U+3=2LX-%EFA40QBX
M$Y,JLKAF91@+E0,<G!.>@JR^FZGKNM:!J>HZ<UDVD"6:2/S4<S3-'L"H0?N\
ML<MM/W>.N.OHH \SMO"^NP^!]!TIM/\ ]+L=:6]F F3;Y8N&EX.>3A@,>H/U
MJ_=:#K:W/CB.&QCE@UN'-M*)U!#&W$6TJ>F&&<YZ>IXKO:* .)N].\1)X5\-
MVEI:[C:&&/4K,7*QM-&L94A7!QC=@XR,@8/4BL(>#/$<6G:@;.SL;:ZMO$ U
MFPB6?,4HV!3$<*-HQN&<=>P'->IT4 <3X@T_Q'XK\#:O:7&GV]A=W$:"WLS<
MB0[E8,2S@8&<8 &<8R3S@:ZZSJZ:_IMC<:-'';7D+M),ET':&09.TKCD8"@L
M.,L!]=^F^6@D,FQ=Y 4MCDCTS^)H =7F5UX8UV;PGXAT]=._TB_UW[?"#,F/
M*\Z.3DYX.$(QZD?AZ;10!Q6H:5J\OC'4=6@TN.:WFT,64<=Q(FV24.[[7&3\
MI#;<\]^W-92>![Z/2?$NG:3%/IVEZCIC0V^G75P)$BN6#99,%MB8(&,]<\#
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M7174;B\@W7@C$L<DN\GI\I52>#U(XKO:H:GJ>F:=]E74;B&(W,Z0VZR=7E)
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MR<'<<9';M717OB#5/#^N:+;ZJ]K<6>J%X6D@B*&WF5"XQ\QW(0&'J,9R:1O
M27]YJEQK.J2WPU.Q2RN(EA2)"JEB&&,D$%LCGKZ]KUGX7D$VF2:KJ)U#^RU8
M6NZ$(22NS?)R=S;<C("CDG&<8 *>CZOXAURPT;6[);$Z??MOEMG4AX(&!*,'
MS\SCY<C ') QC-94WC36HO!>IZOBQ-U8:RU@1Y+[)(Q<+#G&_(;!SU(]JU=
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MR10 \RN%)"_B<#\:Y.?PGJFG6.NSZ=X@O1J6J3QSAX[>+Y7557 !& "%QDG
M'KU/57-K/>:/-9O<M#<36[1&>$8*,5QN7/H>10!Q$/C>ZO/"VMZOINI6%S)I
MU@T[6\UJ\<L$RAF9)(RX('  /L>36JWB+4_[?\,62_9!#K%C//)F)MT<B)&P
MP=WW27Z8SQUJ:7P9!?W.HW6IW"S7-]IS:;+)!"(<Q-G)/)R_OT&.!5>T\&S6
M=_HFI7WB&>=M%AEB0F&.-&C95'S=<<)R>_M0!SB^-_%<7@VT\7W":4^GQW30
MWEK%$XD:/[0T6]&+8!''RD'N<\X&E<Z_XPNKOQ3!I;:0IT25?+$L$C&X4Q+)
ML.'&T\XW<_0=:I^ ]$;7/ -I97MX&T];Z6:6S\G#G;<NZJS9^X2%;&W)!ZX-
M3Z-:W&J>+O'4%MJ:V\%U<0HV(@[%?LZ(S1MD '.1DA@"!QZ@"P:PFO\ C#P'
MK"QF);S2KR<H3G9E821GOBK6G^*/$>KQ:/JNFZ;Y^G7TX$T)C"F*W;.)!(7Y
M9>"1MYR0.F3L#PE##K.AWMI.(+?1[5[6"V$>08V"@Y.<YPBX_'.:IZ+X'ET*
MY\BUU^]_L-)C/#I;1IMC;=NVB3&[8&YV\>Y(SD P;SQEXGM_#?B#6@^EE=$U
M.2V:'[._^D1HR#KO^0X8G/S<^G?9G\3ZIH?B>[L]8>TGLAI$VJ)]FA9&B\I@
M&0DL=_##G"\CH*6?P$;GP[KNC/JA\K6+M[N:00#=&7(+*OS8Q\HQG/?KVT;K
MPM]O\0QZK>7:2J-/DT^6W$.%DCD(+\[L@DJ/P_.@#.T_6?%-W?Z5(+!'T^^@
M9IW,046C%=R$'S,R*3P> >_'2L?3O&7B2;0_#NMW9TTV]_J8T^>WB@<-AIGC
M#JY?C&T?+@YYYYP-_P /^#[W05BMSXCO;W3[0$65K<1)B+@A=[ !I H/ ) _
M(8@A\!-!X<TK1EU4F/3K\7\<AMQN=Q(9 K?-C&YCT[8^M &5!XAU/1[_ ,<Z
ME?74=W!IUS''#!Y10Y:)"BAMQVKE^>">2?:M*Y\3:]H4M_>ZM8&;1;>P>Y:X
M6(0NDJ?\L]N]LAAT/8]<U<N/ UK>77B#[3>3R6.MJOVFT"J KA FY6QGHH('
M8BFV7@R<Z7<:;KVO7FM6LENUM&DT:1[$88))499\<;B?7U- &)J;:K/XJ\ 7
M6H3VK+/<32-%%$5\IS;.<!BQW#!QR.HSWP.P\17]YI^GQ36C6L>ZXCCFFN6P
ML49.&8#(W-V"YY)'7I6':^!;R.70C=>)+JX319"UKFWC5F4H4"NV#N.TXS@?
MGS6QXE\/GQ!!8B.^DLKBQNTO()40.-Z@C#*>",,: .1NO'.M0^$O$=_ MJ]U
MI&I):(TUN\8EC8Q8)0D%6 D^G'3FM*?Q9J.@:]J]KKC6MQ:6VD'58VM8FC9
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M5!#?=8#&/NBN8OSK6J?!4^(+_P 1WTLMU9P^9;HL:1Y,R@GA=W(.",X/TXH
M]HHKB]8O+[PSXIT2YNM6N)="N]UG.LVP"*<\Q.6"@X."O7&2M;OAQ[JXTD7M
MU/+(;MVGB20 &*)B3&O '1=N<\Y)H UZ*Y'QM>:I:7WAN'3=2DLQ?:D+6;;&
MC@H8Y&S\PZ@J,<X]0:P?[5UO1KWQ/H=UXA9TM4M)[/4;J%7EC69RK1D(H#N=
MI"?+U(X- 'IE-=TC4,[*H)"Y8XY)P!^)(%>9W.NZU;VGCZ"*\O+8Z58Q7=D9
MQ&\L1:)V()PP()0'G)&3T[1Z]8:G_9WA:[NO$6H3F^U>P+1@1HD9*DG: O(R
M 0&SR.YYH ]'6_#:M)I_V:Z!2%9OM!B_<G)(VAN[#&2/0BK=<%J?B#4=!\4>
M( UU+>6FG^'AJ$5O(JC]X&D!Y4 G.P=?4UJ:3;ZI.='U,>(&EMKNT)N8712)
MG= R-%Q\F/FXY!'7.,T ;VG7XU&U,XM;JVQ(\?EW,7EO\K%<X]#C(/<$5;KR
MJ+7_ !!+X0T2Y7695NY_$AL)9FAC/F1?:'0 C:.@4?=Q5JXU/7/#VL^(=%G\
M1F2 :4NH6FHW\*LUJS2&,J0B@-DC*C'H,&@#TNFHZ2QK)&RNC ,K*<@@]"#7
MG$NIZF][XKTDW6HPVT6BI>6YG91/&Y\P$AAD@'8.#R.<8I-&O[ZWT?P3H-M<
MR,=0TG[2SR3"-B(XHL1HP0X'SD],_+UH ]*K+T[7K/5-5U/3H%G6?371)_,C
MVC+KN&W/48[^]<BFI>(M/O=$\-:MJ$+7.HZA<*+N!@TBVT<?F*C$JH$AR%)
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M+G?Y$\<NP[6V.&VGT.* ):*YK4O$LMKXPT+2+7[)-;W[SQW#!R9(FCB+@8'
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M>E=U]AL\$?98,-R?W8YK*DT;4;G7%DGO[?\ L2%DE@L8[?:WF*.-SYY4-\P
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MN<9('3U(K*\2^%-7U;3_ !?>VVGL+S6(K:VMK5I8PP2(Y+N=VT9)/ )X ]2
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MB2T:[MO.B5!<HN =A+<$%APVWKGIS1X*\17'BCPY#JEQ8R6IF>0J&92"HD8
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M5 [DY)P,#-F33]2UWQ#H&KWFES6']D)/*\3RQLTLLD>S8A5B-OWCDX_AXZX
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M$>)5EE+J>3\H /.<'T!H [2_\06^G%X8K6ZO9H;<7$L5OL+)&<@$[V7).UL
M$D[356'QIIM[;P3:9'<:@)K/[<$MPNX19(SAF7G((P,G(/M6#J>DZS9^+/[:
MMO#<&M6E_9PP7%K++$DMK)&6PP+G:5(;! /49H\0^&;G5$@W:-)!?6]INLK_
M $BX2%[68LQ,>2R[D^YVP?F.!F@#O8)EN+>*9 0LB!P#UP1FN?M_&NG7-U8Q
MK!=K;WUS+:6UVR+Y<DL>[*_>W#[CX)4 X^E;6F)>1:39QZC*DM\L"+<2(,*\
M@4;B/8G->;C1/%=U/H5YJ&CB;4[#5VFNKEKQ-LD1$BJ8AD[4 9<K@'CHQR:
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MVW%N=R@;O?.!5^ZU[5]'US1K'4_L4L.KEX$E@B9?L\X3< 07.]2 1D;3Q[\
M'6U6EU&S@U"VL);F-+NY5VAA+?-($QN('MD5S'PXO-4U#PY+=ZG>17+O>W2@
MK"4(VSNO7<1C@8  P!CGK5S4]9O+3QSH>DI!:M;W]O=/YC ^8C1A#@'H =X_
M*@"WJ?A71M7ODOKNT;[8J>6+B&:2&0KG.TLC D>QK2L[*VT^V6WM(5BB7D*O
M<GJ2>Y/J>37GJ^-_$:Z(=:F@TL6MOK!T^XA1)-\B?:/)W*=V%(R#R#GVKT>0
M.8G$3*LA!VLR[@#V)&1D>V10!0DU[2H=2CTZ2_@2[E;8D1;!9\9VCMNQSCKB
MM&O,?#$NJ0^$M5OF&FWDL6MW3H;F/RUA;[2RO,69\852Q &#@8S6K;^*=<OH
M/%-MI\=G<W^D>6]LS6\B)<J\>\+L+9!X(# X/!Q0!W-%<K9>*C?Z=IFI0S6[
M63Z<U_>N(FRB # 7YOE.=W!S]QJSY/&6J6F@Z)XEN8;0Z5J4L*R0(C"6WCF(
M$;;]Q#$97<-HZ\=.0#NJ*X[1M<\2ZOXAU2U6/2H[+3-1^S3$B0R21F)7&WG
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M;!YYM@PC+=]N[G'UKCK'QAJI\1:'IU]'99U-[B.:"!68VCQHSA3*&*.<+@@
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MN.@. /45@^)]9U#Q)X#L-:C-K'IEUJEJT4)C;S1&+E0K%]V,G )&W@'&>,D
M]4HJ"]\\64YMI$CG"'8[IO53C@D9&?ID5Y_X6\3ZFOA3PE!<7$%SJFO;C%+)
M$P$:JC22,_S?.>, #;RP]* /1Z*YO1-?NY_$VJ^'M32'[79)'<13P*52:%\X
M.TDE6!!!Y.>OM4/B77-:L/$FAZ3I4=B1J8N%\RY#GRVCCW _*1QTX[]..H .
MJJK?:C9Z9!YUY<)"AR!NZG ). .3P">.P-<?<>*/$+Q:E;V%M;3ZGI:QQS1Q
MVLLD=S<&-9&1&##RU^8 %L\]>!S!J,VK7?Q%\)2;X;3SM.NIOLTT!=H3B'<K
M$. 6YP",8YZT =U9WMMJ-G%>65Q'<6TR[HY8F#*P]014]<#!XGU1[*&Z\/:1
M'-IRWK6_V**S=28EE9&D63(0'(+;=O3C.:NZ5KGB75?$NJV21Z5'9Z9J"P3,
MPD,DD31*_P O. P+#D\'VQR =C17(_$6\U*Q\.V\FFW:6[2:A:PR%HRQ97F5
M2!\PQUY]1D<9S4R:UJFH:[J6B:=-8I<Z7;PM<3S6[LDDLH8JJH'!50%R3D_>
M]J .HHK#\(^(?^$G\.0:DUO]GF+/%/#NSLD1BK 'N,CCVK<H **** "BBB@
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MIC78NE26659/*\L_O'9R",GNQ_"N:$D\WQCU-;#4+6&3^QH(R)8O-#,))"0
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MM23G5-.%C<HENL8X#@,O)P,.>.3GN>E='J5U/9:=/<VME)>SQKE+:)E5I#Z
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M2!X2Y=7"[BS[LY^0=O7K715G:]JRZ#H-]JTEO+<1V<+SO'$5#%5!)^\0.@H
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M.U&5LD;0,8(Z5@VDVH1>#])UPZSJDEY'XA^R_O+MRC0F\:,HRYPPV]SDCC!
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MAC6.-!A548 %/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV=Q;VZ6SL61&B\V78!D!BKG)'(&>XH ])A\5:'<6(O+?48IX"[Q@P@N2R?>
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MXO$6D2I=-]NBC^R*'N%FS$T2GHS!L$ ]CT-5[7Q?X>O5F:VUBTD6"!+B5@^
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MQ'>PVUVMK=6=GY4\EK)&DA3S-W+*.?F'7K0!V=W=V]C;-<74R0PKC+N<#).
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MR=[%NR@@8ZC(R =,GCKPM)]W7;(\1''F<GS/N8]<T\^-?#82Z;^V+8_92!,
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MKDL!PF3N+8X';/%;$_CLP:/KUX-*>>?0YO+O(()@V5VA]Z-@9 !R00",'TY
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MU (SS^=<[_P@U@L>H6<=W=1Z5J$QGN=/!7RV9CEP#MW*K8Y /<XQFNG "@
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M8XP,D'G/S]* /96D1 2[JH R<G&*7(SC(S7F<NE:+K'C[Q9]HMK6[MWTBUF
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M") [[RJEB 5!&<#IU.1@5':>+='O-(FU-+AXX()S;2K+"Z2)-D+Y90C=N)(
M&,G(Q0!H-I>GN\CM86K/*,2,85)<>_'-)_9.FCR_^)?:?NO]7^Y7Y.<\<<<U
MFR^+M-B@U,E;G[3IT/GSVA@83;,'#*I^\#@\C@=R,59\-:S_ &_X=L-4,+PM
M<V\<K(R,H!9 QV[AR.>".#0!8.D:80X.G6A$ARX\A?F/J>.:F%E:!H6%M"&@
M!$)\L9C!X.WT_"N4\/ZM+;ZYXR_M/4)9+2PO8Q&9CD1H84;: !ZL> ,GW-;,
M'BG2IKJ\M9)GM;BS@^TS1W4;1%8>?WGS#E>#DCICG% &@FGV4=Z]ZEG;K=N-
MKSK$H=AZ%L9-,ETC39KB2XET^TDGD #R-"I9@"" 3C)P0#^%9T'B[29]0M+$
M-<I<7D0FME>UD_>QG^,';@#D9W8QD9QFBR\7Z/J%Y9V]O/(?MWF?9)3$PCN/
M+^_L;&#C!/N!D9% &U+#%/"T,T221,,,CJ"#]0:K?V3IV(Q_9]KB+F,>2OR=
M^..*Y_P1=WEU-XGCO+R:Z^S:W+!$TI&5C$<1"C   !)_.M?5?$5AI F^T&=S
M!%Y\X@A:4Q1\_,VT' X/N<' X- %LZ98,\KFQMBTK*\C&)<NPZ$\<D=C1+IM
MC/=QW<UE;27,?W)GB4NOT8C(K(E\;:%'=Q6J7$]Q/-:?;84MK:24S1$@ IM4
M[OO#IG'.<8JG?>/M.CL]!N[&.>[M]8NA!%+' Y" ;BV1C.[Y&&W&<@^E '2O
M8VDMRMS):P/.OW96C!8?0]:B&D:8(GB&G6GEN0S)Y"X8CH2,<]36*VOZ=:ZQ
MKMP+S4[B:QLXI;BP\IMD:_.08U*C+-@Y.2.!G&*J1>*+'5]"\,:A=W6H:;+J
M%Q;M&D,3JLTK)N\IF*D&,[CSD9V\'B@#J7LH,1M%;VZS0H5@<Q ^5D8X]![#
M%9N@Z9J=NTM[KEW;76IRHL1:UB,<2(I) 4$DY)8DGOP,<"C4_%>DZ1YS7DLJ
MPP2+'<3K"S1P,V,!V P/O+],C.,U+/XBT^"Z> F9S'/';2210LZ1RR;=BL0.
M,[U/H-PSB@#595=2K ,I&"",@BH+2QM+"#R+.U@MH<D^7#&$7)ZG JQ6=?:W
M9V%R+5Q--<F(S>1;Q-(XC!QN( X&>!Z\XSB@":VTO3[-)4M;&V@6;_6"*%5#
M_7 YZTW^Q]+\H1?V;9^6#N">0N ?7&.M9<WC?P_#::;=_;6D@U)BMH\4$CB1
M@"2O"\-P1M/.1C&:T[+5K2^T=-5C9X[1XS+NGC,151U+!@",8/6@#/\ $7AZ
M+5- U2SL;:SAO+ZUDMO/9 I4.I7)(&3C/2K6A:1#I.FV\7V2TBNEA2.:2W0#
MS"HQDG )SUY]:KV/BW2=0N(X(7G$DUK]M@#V[CSX>/G3CGJ..O(XJK9>/_#V
MH-I_V>YG:+4)3#;SM:R+$T@) 0N5P&.TX4\_G0!MII>GQXV6-LN)#*-L*C#G
M@MTZ^]-_L;2_+,?]FV?EL=Q7R%P3ZXQUJK9^)M+OCJ8@EFSI;%+L/ Z&,@;N
MA SQSQFM"TNXKVRANX=XAE02(70H=I&1D$ C\: ,B+2=4FUWSK^[LVTJUD\R
MQM8("KJVS;F1B2#@%L  <D'L*OW6DVU[JEE?S(C2699HCL&X,05^]UQ@G@=^
M>PK-'C71"]D/.G*7[,MG*EM(ZW!7KL*@^YR<9 R,CFIKWQ;I%@9VN)Y!;V\H
M@N+E8F:*%SCAW P.HR>@SSB@"#6-#U#6]1BANYK0:1!=07<2HC";?$=VUCG:
M06 .>.,C!SFMFYTZQO98I;JRMYY(CF-Y8E8I]"1Q56+7]/FU^30TDE_M". 7
M#1F%POEDX#!B-I&>.#3!XCT][:*:+[1(9FD2*)8'\QRAPQ"D9V@_Q=.1SR,@
M%Z:QM+B=)YK6"26/[DCQ@LOT)Z5%_8^E^6T?]FV>QB&9?(7!/J1CW-9!\>>'
M19V-U]LE,=[,T$(6VD+&5<[HR N0XVGY3R>P-1Q^/]"E=8HS?M<M;?:EMAI\
MWFF/=MR%VY/(/3I@YH Z);.U26.5;:%9(T\M'" %5_N@]A[5))&DL;1R(KHP
M*LK#((/4$5@'QMH'V;2K@7CO%JH)LV2"1A)A2Q'"\-P?E/.>,56;XA^'TLKF
MZ:2]"VDACNT^PS;[;&"6D7;E%P0<G@]NAH Z>2*.6)HI(U>-AM9&&01Z$567
M2=-2S6S73[1;53N6$0J$!]0N,57O_$%A8)N8S3D0_:"MM$TI6+^^0H/'!QZX
M.,X-47\<: )+...ZEG>]MC=6H@MI)/.C&,[<+R>1P.1W H V4TZQCG6=+*W6
M91M618E# 8Q@'&>G%-;2]/>S:S>QMFM7.YH3"I1CG.2N,9SS7.7_ (_TZ'2-
M)U&QBN+J+4;]+)=L#YC;?M<.N,AAA@%QDD=,5?OO&6C:<UP+B:95M1$;IQ Y
M%MYF-GF<?+G(..P.3B@#4;2]/='1[&U99"I<&%2&(&!GCG &![4^2PLYK/['
M+:0/:XQY#1@ICTV]*YMKN\3XLPV/VR8V4FBR3_9B1L$@F1=P '7!/7/6NBOM
M1M]/6,S%R\K[(HXT+/(V"< #KP"?8#)H K7^A6.H65O926\*VL,BNL8B7"[>
M@7^[Z9'."1Q5^>"&Z@>"XBCEB<8:.10RL/<'K7/MX[\/I91W4EW)&CWGV!@\
M#AHY\@;'&/D//? QTS45UX\TN'1=;U"&*\EDTB/?<6KVSQ2C*EE.UP"%(&=W
M3 - &^=-L"K*;*VVNBQL/*7#*O13QT'84U=*TY;0VBZ?:BV8Y,(A783Z[<8K
M".NV5[<^&FN+S4+.ZO&9H;=(72.X;RB65]R_= R1R.@/-0VOQ!TYH=>NKV"\
MM;/2;IH'E-I*WRJJ$L=JG'+'CK@ D"@#ITL;2*T-I':P);$$&%8P$(/7Y>E+
M:V5K8P>19VT-O"#GRX8PB_D*KG6;,2V$6Z4O?J6@ B8Y &XD\?+P1UQ5^@"I
M!I>GVL,L-O8VT44Q)D2.%55R>I( Y_&C^RM.\J.+[!:^7&_F(GDKA6_O 8X/
MO6;)XOT>*\^SM/)C[8+ S")C&+@XQ&6QC/('IGC.>*?J7BO2=*:]^TS2;;%5
M:\>.)G6W#<J7P/3GC.!R<#F@#1;3[)H'@:SMS#(_F/&8EVLV<[B,<G/.:5;&
MT6Z-TMK +@\&41C>?QZU0E\2Z?';1S(+J;S(C.(HK:0R",'&XIC('ID<]LU3
M/CGP_G3Q'>23_P!HP-/:>1;R/YR+C.W"\L,CY>H]* -J#3;&VN9;FWLK>*>7
M_62QQ*K/]2!DU'_8^E^6T?\ 9MGL8AF7R%P2.Y&/<U2M/%>D7NCQZI#</Y#S
M&W5&B82^<&*F/RR-V[(/&.V>G-59?'6@V]G<7,]Q/&MM<K:7"FVD+0RMC:&
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MT<BAE8>X/6H?[,L/L:V?V&V^RJ<K#Y2[ ?9<8JU10 R**.&)8HHUCC4854&
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M9)'*?+GG##IQGC-<EI>CZOHFC>$;^Y\.W.HQ6-C-87]@J S0EG5ED120&^Z
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MWRM%&@(].5/7%=Y8ZA,][#8'3KM(A9K-]J=0(PV=OE]<[^_3&*U:* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUXW",R.KHQR,KZ]N16=X)^(2VOASPG::]%J/FZLGE0ZE.5=)I=V-I.XN"<@
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MR_$#2(M+@OS#>E9+\:=)$L.9+><L%V.,\8)[9SVSFFZKI6I6GCVR\36-LU[
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M@BL_P]X@T>+PGI<^G)?/!>22QVD%Q)NG=@[ELEVX VL<EN!@=<"LOPUX;O\
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MS7LJP+MAX4[SEAE?F'3)[XQBMB_\26UG?RV,5O<7EU#:_;)8[<*2D>2 ?F8
MDD-@#G@UQM]X<URY\,>.[!-,?S]9O));0&:/#*T<: D[N.4)_$4[5UU23Q=)
M<:1H]S/,FEQVMZ;2]@CD0L68(XD!7('(*G/S'/!% '<:%K5KXATB#5+)91:S
MKNB,J;2R]CCTK1K#\(O;CP[;VEMILVFI9?Z+]DF96:,IQC<I(;USGZ\YK<H
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MZ=!J%C*9;6==T;E2N1]" 17):,^K3_$/Q='_ &DK);QVJPQR0[E0,CL!@$'
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MW]N+BUE66$LR!UZ$JQ4X_$&@#,\.^'8_#D5U!!>W$UM+<23QPR[<0[W+L 0
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M&1FC4JKGY<YP>F<9K.M/ ,%EIGA^PBU.Y,6AS^=;%D3+G###\<C#MTQ77T4
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M,BFP^#K2TU31[NRGDMXM)M7M+:W504V-MSN)Y)^5><UNWMY;Z?93WEW*L5O
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M?#;/<S6TD%S%=0S0A2R21L&4X8$'Z$5!JNOW%MJ;Z5I=BE]J269O3#)/Y*E
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MJ4E RIR/?@^Q-1W_ (1TB\TVPTY+"TAM+*=9H42$#RBIS\F/ND\\^Y[\UO4
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M]J /-Q/*WP^\+>)]-N))-<FN;432AR6NFD<)-$X[KDMQ_#MXQBH]5G-OX/\
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M:M)Y(WKI5M*#D\.99<FM'Q5+;R:WH&GR&2:XN)9GBLF<+!.%C.XRG!R%W @
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M60Q3R!&Q&X."IXZ@]1V[UY]IVGZ@GPF\,ZC;:?=C5_#[1S+;20M'+(J_)+&
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M)2JR[E4[?F/S+P*Q="NKWPS)X3U6_P!,U*33O^$?CTV;RK21Y+2=2K'=&!N
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MH..1SC/4<5S%]%-=?$>_>"UN3#/X;-NDOV=UC:3S&8)N(QG!SC/>M;X>R.?
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M2*&R9HL"-5VCY01C<<@XZ]AIZ'8W$_PS\66:6%REY<2ZF8HI;=HWD\POL(#
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MG@)D,8;9MY3( )R#D].A.I#XPU*XUO5+)=%B6UTJZ6*\NGO0-D1C$GF!=O)
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M(SF 2)YH4.8]PW!3P#CTX-<Q\/M8U37?"L6H:HD DEEFVM%(3D"9QC!4;0,
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M68_NU) 3 V_-N^;!R.$- &M1110 4444 %%%% !1110 4444 %%%% !1110
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MU.^GLUM;RWFAC27%Q#M#HV=K*PR#T/'4=P*U: "BBB@ HHHH **** "BBB@
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M9%2[^R730K=A1@>8%QGCCC'% &I?7=Q!X8N+QKBSM;I+-I//D8F"-]F=Q/=
M>?I7'Z;K.KMXF?3#?WC6\N@F]2:YAC5C,KA?,1<9"D-]U@.G05VVHZ59ZKH]
MQI-U"&LKB$P/&OR_(1C QTK!_P"$.T_3)%U5)]4N;VVL7M5:2X>5I$."%*CK
M@@< >YYYH Y*SUOQ1;^&_"'BB;7'NUU">VM[RQ:WC5&68[=RD#<'!(/7!] .
M*=<:AXKF\.^*]7M_$DD<NA:A=""$VT6R:.(*VR3Y<GC(&,<G)SQC<\">&?*\
M'>'DU7[=YVG1JZV=R,+#, 1D#:"V,G&20,\=!BOX9\-M?CQ-!J:ZC#:7NL3S
MFUD39'<PMMVDY7.#@@@$9 Y'/( EM?:]X@\72V<&MSZ=:/I-IJ"1I!$S1N[M
MN3++R"%P<\^XY!KR>)M8O/AY?^-+._:*:UFGECL61#%Y,4K(8WXW9*KG.003
MQQQ7:P^'[6#Q)-KJ37'VJ6!;9DW#R_+4DJN,=B2<]>:I_P#"%Z6&O(T:X2QO
M9_M%S8!QY$DF02<8R 2 2H(![CDT <]'/XA\1>*->TZT\07&FV\-G:7-L$MH
MF>)I%D.TEE.5R!GOP,$<YS=,\1^(_$2>#%_M5]/?5K:]2\\F&-OWD/RB1=RG
M!)R<=/:MNUTFZN?B1XCN2^I65M<6EM#%/$FU)=@?>,LI'&5P1@\G!K<'A'38
M[W1[FW,UO_9$;16<43 (BL &!!!)R .I]^O- &)%J6KV'BK6-,N-:66&TT**
MY2:[C1$27,BM(^T#Y?D!(SQSBJ^BZOJL_BNSTJ74+V2UO=$>Y,\L4:%I5=%\
MR(;<J#O/# =!Q71WGA'3;_4M0O;IIY6U"S^PW$9<!&AY^4 #(^\QSG/-0Z?X
M)TW3]1L-06YU&:ZLH&MHWFNV;=&2#M8="!M''YYH XSPGJ^H67@?PA:QWL\M
MQK,\B-+*R H%$CD*Q7[S%1RVX\G'.*[CPU%KUO)J$&M7$4\0F#V3;PTHB(^[
M)A5'!!P<<CKTJDWP[T%O#PT0_;/LL<PGMF^TMOM7!)4Q-_#@L<?7G-;>C:+!
MHMJT,4]U<R.=TEQ=S&660]!ECV Z 8% '):UXCO=+\526NJ7%[IUC+=0"POH
MXE>U=?DWQ2G!*.S;P"<<$8(P<T[*6]L=4^(=VFN&![:9!%+>[6AB)MT8%L+G
M"D\ ?D3777?A:SOIKO[1<7;VMW-'//:%P8G9-N.VX#Y%) (!QSU-5[_P-HVI
M3:Q)<BY*ZLBK=1+.P1F50H< =& 4<^U '/+JVJOK&N:0U]J*6PT);V&6=(TF
M1]SJ67 RH.T<, 0<\"J_A_4[^U\->!M&@NIGDU33?/,C.BLJQPQGRT.W'\><
MD$X4\]QU=KX+TVVU3^TGGO[FZ-I]CD>XNF?S8\D_,.A/)]N<XSS567X>:++H
M-EI)EOU6P</9W*W3">V(& $?L .,=/QYH T/"\>N0V5U!KUQ#<31W+BWD1@7
M,!P4$F%4;QD@X&#P:Q+>]UGQ-!KEQIFKC3[C3]3>S@C:-6B"Q%=WF C)W#=T
M(P"N.A)ZG2=*@T>R^S0R3RDMODFN)3))*W3<S'DG  ]@ !P*QY_ ND3:[<:J
MLE] UV0UW;07+)!=$# ,B#KQP>Q[YR: *$&I:EXEOO$\5EJ4E@VES"UM1&B$
M%Q&'\Q]P.X$MC' P/7FL_P -^+=4U_5_"\LDS06^JZ//<SVP1=HE1HU#*2-P
M'S,<9(Y%=1<^%;*;5+O4()[NSFO8UBO!;2!1<*HP-V0<$ D;EPV.])>^$-,N
MY-+DA-Q8OID;0VQLI?*Q$0 8S_LD*ON,<$4 <5_PD7B&7P]ILR:PZW$GBAM,
M>1H(SOA\]T (VCD!1TQFK\6G:C:?%#1K6Z\07]X5TJYD+NL2[AY\?!4)CH0"
M0,G Y%;2?#_2(K*&TAFOHXH=0.I(!/G$^XL#R#P"3QT/?-:E]X=LK_6K'5I7
MN$O+-&C1HI2@=&()5P.HRH./:@"CXNUN?2WT6RMI/)DU744LS/@'RE*LS$9R
M-Q"X&0>N>U<[K>MZUHNH>)=(CU&600:$^KV5T\:%X64LIC;Y<,"0",C/49KM
M=;T.QU^P%I?(Q5)%FBDC8J\4BG*NC#HP-4YO"MG<VFH175Q=3S:A +:YNG91
M(T6"-@PH51\S= .I/7F@!OA.'4CI<5_J.KRWQO;:"41/$B+"VSYMNT D$D=<
M]*YYHY;?XNZI<F^NF2'0H9S&!'AE$TOR?=SCCZ\]:[;3K%--TZWL8I))(K>,
M1HTA!;:!@ D 9XJDGAZV3Q++KPN+DW<L"VSJ6788P2P7&/4DYZ\]: .8T6^\
M4:K;>']?ANX?L=VJ2WT,LJ>68W7.(P$W!E) &6YZ')K UK4+SQ-\,+/Q)+?R
MJEWJ5NXM%5/+6/[6JJG3.1@$G.<Y[<5VVC^ ](T*_,]E+?K;B0RQ6#73&VA<
M\EDCZ#J2.H';%5I/AOHKVMQ9)/J,.GSW"W/V**Z*Q1R!P^4&,J"PSC..> #@
MT 4KK4/$?B"?7X]!NA;7&FWGV6V#.@3<J(Q,BE&)#%B.".,8YR:2&;Q!JWC>
M_P!,&OO9V\%E9W82WAB<!F9]ZAF7E#MZGGIR.0=:]\!Z3>:V^JK/J-K/,BI=
M+:WCQI=*HP/- /S<<9R#BM&V\.VEIX@N-:BEG%Q/"D#IE?+\M,[0%QQC)_.@
M#CE\0ZM#JN@2KJ;WD-]J\MG/)'&@M63$I58\@.2NQ?F&02&Y-:_A+_D<_''_
M &$(/_2:.I(?ASHD$5I#'-J(AL[LW=K$+QPL#'=E5 Z*=S>_/6MC3-!MM+U/
M4K^&:X>;49%EN!(P*E@H4$  8PH _"@#*DU.YU;QS>Z!#>2V<%A8QSNT(7?+
M)(S <L#\JA?Q+<\#!XWP]?ZEI7P]\)FUOF0S>(6M+G$:XF1[N4,#D<9QVQUK
MT#4_"MCJ6MP:R)KNSU"*(P&>TEV&2+.=C\$$9Y]1V-4HO .DP:59:;#/?);V
M=[]NBS/N(FW%@26!X!)..ASSF@#*O?$=[8>+C8:M<7NG0SWT2Z?<K$KV=Q'\
MN86;!*R$AQSCG&#CBL9+C5--T#XD:G:ZS>"ZLKZ=HFD6-QE8(B#RGI\N.@';
MO7=S>%K.XDD$]S=RVTETMVUH[J8C*K!@>FX#<H. <9'3DYKW7@C2[H:RIEO(
MXM8S]KBCG(1B5"L0IX!(4 GKZ8H P=7N-?T;1M*U#_A(9YVOM3L4>-K>(*L<
MC*KHORYP<^N1Z]ZO+>:OXFN?$D&F:J=.N-,NQ:6J^6K+N"(Y>0$$D,6*X&.!
MZULZAX8M-3TJQT^XN;LQ64L<T3*ZAB\9!0D[><$#Z]\U5O? VE7NN2:OYU_;
M7%PBI=K:W31)=A1@>8J]>..,<<4 96EI<R_%G4V?4YY(UTJUD$:E3$=SR@@
M@D+QG@Y]2:UM=U:>/Q1H6@PSM;#45N)9)D WD1*IV+D$ DODG'13ZY%T^'+#
M_A(DUQ#/%="W6W98Y2L;HI)7<HX."QQ]:9XB\,:?XFAMEO#<0SVLGFVUU:RF
M.:%NA*L/4<$=* ,"ZU+6=(OM%\/W6JK/-J>HSQB]2-1)';HAD5&&-OF$;5SC
MH<XSS61XC\1Z[H<'C#3HM1E:33;&+4+&\,<9=5<LIC?*[6&5.#C..I[UV,_@
M_2[C2H+*5KIGMYQ=17;3EKA9A_RTWG))QQSQCC&.*D?PMIMQ8ZG:W@ENSJ<?
ME7DTK#?(H7:!\H 4 $X  P23U)- &;<:CJ/_  L'3]+2_D2SNM(FG:,(AVR*
M\8# E<]&/!)'M7"WTWB#5O@I=^(+_P 27;M/8.KV\44<:$^=C.0N[E<@@'!S
M7H5IX)L+34+74?MVIS7UK;O;1W$UR6;8V.HQ@XVCC&.Y!/-20>#-*@\'R^%B
M;B72W1H]DDF656.>& !ZG(S0!M6T+PVB1/<RS.!_K9 NX_\ ?( _2O,W\1>(
M!X->\35W%Y%XD-AYK01D/%]I$04@ =O3!]Z]+L[-;*RCM4FGDV+CS9I"[L?4
MD]37/GP)IATMM.^TWWV=K[^T#^\7/G;]^[.WINYQTH AT&[U*W\<ZUH=YJ4U
M_;Q6MO=PO.B*T9<R*R_(J@K\@(R.*K:[%<2?%7PTB:A=11/97;&-"NW*F+L5
M/7<03U],5T-MH%O;>(;C6UGN'N[B%() S+M**25& .,%C^=&I^'K+5=4T_49
MFN([JQWB)X92F5?&Y6QU!VC\J /-!=ZIH_AWQ7KFGZG+ ;+Q+,WV98T*3!IH
MU8.6!/1CC:5Q[UT]]J&OZ[J7B*PT2Z^RW&F.D%N=Z!?,,2R!I R,2I+;<#'"
MGO6E)X$TR;1]2TJ2YO6M=1NC=W(\Q06D+!B0=O )4' ]/K3M1\#:9J.LC5C=
M:E:WK1K%<26=TT'VI5Z"3;C/U&#0!-K=QJ:_#[4+F/R_[5&ER./LS%E$WE$_
M(>I&[I^%5OAJMLOPU\._9=OEFQC9MO\ ?(R_X[MV:Z:**."%(8D5(T4*JJ,!
M0. !6!:>#[33)9?[*OK_ $ZUF<R/9V\B^3N)R=H924R?[A6@"IJ&HF+Q?I7A
MBPD-G!=17-[/+$!N8AAE%)! )9V8]^.V:YO4/$^O6%OK5@=0<W.D:S96Z77E
M1YG@G:,[7&W&X*Y!*@=C7<7_ (8TZ^^P2+YUM<Z>[/:W,#XDC+##<MG<&[A@
M<]3S45UX0TN]T2]TR<3,M[*+B>X$F)GE!4K)N'0@JN,# "@8QQ0!AZMK&K0>
M)?$UC!J,D<-MH:7UL/+C/E2[I02,KR/D'!SWJEI.JZXE_P"!Y;G69KF/7;)O
MM,+11JB,+<2!TPN0V0<Y)!ST'2NA'@;3?M-W=/=ZC)<W=E]BGF>Y)9X\MG(Q
MC/S$=..V*FB\(6,3Z&RW-Y_Q)$*68+K\JE-A#?+\WR_+S_/F@#B]$M_$)\ :
M]<Z-K-Z=3@U*\:)9%BD\WRYFROS(3E@,>QQC XKK="UO_A)K^VO]-O9#I26*
M/(FU"))9.0K'&0R*.0"/OCTH:QA\&P75WI>F:IJ)O;PR/:6\H?RVD)9F578
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<<C\NA6;4)O$^HV(O0EM#9P3Q 1*6#R/*IR>X'ECCW/- &Y17 >$M5\6^)?
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MB[Q-JW]GVTL&JRP/"OVO:R"./9\WRXYQG@UHA?$\8LIX[:Q&V63SK(3D(L.
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MIDL4=[ I*\F10)8R.=CCN/4CZ]?XAM;V\M;6*R@25DO()GWR; %CD5SC@Y)
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M[F>&UCCLA;1PRR*RN\;;A$$/#,<=.]=K;)XABTO3[)=-LHI(5BC>X:ZW^6
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MN+EWC$F\,DLSR+S@88;A]",BD\$^'KSPSH\^GWMZUZPN7:*X<Y=XL*$W?[0
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M_P"6@QU'IZCTP/2N:\'?VG?W=QX5UF19X_#,Z*\^<F\! >W+#MM7#'U95]Z
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MM*AB.0I;N,D=L_5OB+;V/AC3O$]C9&_T6Z=5EDCD*S0@YW'R]IW;=IR,CH:
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MN[K4Y=C,TOEK ISM+?*<YVO@?[)H/B?4Y/&=YX<MM*M&>WM4N_.DO64,C,5
MP(C@Y!H O>*?#47BK3([">\N+:%9DF)@"[BR,&7[P/&14GB'0%\2>';G1KF\
MFBAN4\N:2$*'8=\9! _*LS6O$VLZ'X>O-4FT&*9[28(\$-XQ,J': T9,?S'+
M8VD#D'DU:D\5V]SX*D\3Z,L=];K;-<JC2^7D*"64G!PPP1C'6@!Z^';DP6UO
M-KM]);0LA:+RXE$H4@A6(0'!P,XQGIT--T[PK#8:_K&K->37#ZN(Q<P2HGEX
M12B@ #.,'G).:JZ]XDUO0]-U/43HEI)::?!YTC-?,C2$+N8(/*.0.F21SGTJ
M[HNK:OJ$EJ]YI-O;VES:?:$G@NVEVGY<(P,:X)#$\$_=- %6Q\#:=:>'[SP]
M-/<7FBW&X)9W!4B!2<[48 -@'IDDCCFK%CX>O;2V6SE\0W]S9H-JK(L8E*_W
M6D"@GCC/#>];]<W8>)+O7VNY=!L[>:QMYF@%U<SF-9W7AM@56^4'C<>X. 1S
M0 E]X0^U>)[?7H-6N[.YM[4VD4<,<101DY(PR'N!^5+<^%)KVSOX+K7M0E:]
M18GD*1 I$,Y10$  ;)R<$GUX%5G\;JWAC6]3AL?].T02_;K":;849%+'#!3D
M$#*G&"#VYJ%?'-Q:GP])JVDQV]IKK1Q6\]O=&;RY9%W(CJ47&>F1GF@#<\1>
M'X?$OANYT2\GD2&Y0)))&J[N"#D9! .0#TK/OO!QU&/1!<ZS?.^CS+/#(5CW
M2NH(!?Y>>">F*Z>B@#*31!_:M]>SW4DZ7D"6\ENZ+LV+OP!QG^-LY)K&N?A[
MIDO@VT\+6MS<V>GV[K(#%M+LROO!)8'^+GI5WPMXML_%)U-;5&1K"Z,!#=73
M *2#_98'(JI+XW33_'4?AG5K1;7[5$LEG=K,7CE9BP$;94;'.QL#)SB@#JHU
M98U5WWL!RQ&,U@6GA8Z0D]OHNI3V%E-(TGV98T=868Y8Q;A\N3DX.0"> *M3
MZG?IX@&F0V5NZ-:M<+,]R5.0P7:5"''+=<_A6=X4\63^(&U>"^T^+3;[2[@P
M3VQN?,(XR')VK\K#H><XH 6^\#:==>#[CPU#-<6UI=$M<2H0TLK,VYF9F!RS
M'J<?E4VI^$H-3CTJ1[ZY@U'2WW6]_ $64#&&4@J5*L.HQ@XJWX>U.^UC3OMM
MW816D<C$P!)S(9(\G:YRJXW#! YX(SCI6M0!5N;::XTZ2V6\EAE>/9]IC"[U
M/]X @C/X55BT2*/PRNA^<S0"U^R[V1<E-NWD8QT]JIZEXML],\7Z5X>E1C+J
M".1+_#&P!**?=MLF/]VK?B#7[7P[IRW5RLDKRRI!;V\0!>>5SA47/<_H 30!
MF6/@W^S_  ]IVBQZS?/;Z?+')"\BQER$8,J$[<;1C'3..]:.O>&]/\1VUK%J
M$>Y[2XCN8)5X:.1&!!'L<8(]#5:\U3Q!8:>U[-H]I*J@&2&WNV9T'<\H V.I
MZ=#C-5]1\3:C;>,[?P[::7:S/<6;W:3RWC1@*K!2"!&W.2* -K6=-&L:->::
MT\D$=U"T,CQ@%@K @XR",X/I3=$TM=$T2STM+B2>*TA2"-Y0-VQ0%&< #.!Z
M5F^'/%/_  D4&I1I9&VU+3;EK6YMI9,J''0AP.5(Z'&?:L_0/%NN>(_"L>NV
M.A60242%+=]18.2CLN/]3C)*\?6@#HM;T2Q\0:9)I^H1EX6(=65MKQNIRKJP
MY# \@UG77AAM4ABM=9U.>_L8W5S;M&B"<J<KYI4?, 0#@;02.0:@U+Q1?V?B
MO3-"M]+MY7U"WDGCEENVCV>6!N# 1M_>JQ>:SK&GZ9JUW<Z1:YL;?[1&([QF
M28 ,67<8P58;?0_>'- %GQ+H,7B;0+K1I[F:WM[I=DK0A=VW.<#(('3TI]UH
MYN_#DFC/>S!9;<V[SJJ[RI7:3TQG'M4'A+Q)%XK\/0:I' UM(S-'/;.V6@E4
MD,AX'0CTZ$5FZ#XTD\1^(=?TRQT^,0Z2T:"XEN"//+!L$*$.%^4\Y.1@]Z +
M9\)1'P/_ ,(I_:%S]D^R_8_.VIYGE;=N.F,X[XJO?>"$O],T.Q?5KQ$T::*>
MW=$CW,\8VH6RI!X/8"J^@>+-<\2>%H]=LM"L0D@DV0/J+!R4=DQ_J<<E>/K4
MFK>.5T#Q/IFF:O9+;V6I(?)OA,2(Y,@!9%*C9DD#.3S0!K)HMU]NBNKC6KNX
M\E6\J)HXU17(QO(5020"0,G')XK,L/ 6G6OA:^\.W-Q/?6%Y))(_GA0RL[;B
M5*@8(;D>AK6O=3N[76["QCM(I(;E)':4S%639C.%VG.=WJ*Y^?Q?X@M-4T'3
MKGP]8Q7.LB3RE.I/^Z*1[V#_ +GKCCC/- '3Z183:9IT5I-J%Q?F)0HGN0OF
M$#IDJ "??&:O51TNYOKJV<ZC9)9W"2,ACCE,J,!T96*KD$'TXZ5>H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K-U[4CI6D2SQA6N7*PVR,<!YG(6-?H6(S[9-:55[NPL[\(+RT@N
M AW()HP^T^HR.* /,M=L[[P5>>&_$UP+5;73F&GZA+%(Q:6"9@#(^0.DA#_5
MC6C*ZZ+\;!J%^ZQV6KZ4MM:7#G">:C[C%GH"1\P]>U=Y=V%G?PB&\M(+B('(
M2:,.H/T--ETRPGL/L,UC;26>,?9WB4QX]-I&* 'M=P+=QVN\&=P6"#DA1W/H
M.V?6N,NV'_"\=-&1G^P9N/\ MLM=A8Z;8:7"8=/LK:TB)R4MXEC!/T I&TO3
MWO1>M86K70Z3F%2X_P"!8S0!R'C!@/B-X!!(!-S>?^B#4/@.)]'\7>,=(O?D
MNKG4FU*W+<>=!(!@KZA2-I]#7:W&E:==SI/<V%K-,GW9)859E^A(R*6]TVQU
M%$6^LK>Z5#E1/$KA3ZC(XH XN"!M5^-DNJ6AW6>F:1]BN)E^Z9VD+^7GN0O)
M],BL[^P;U/#7A[Q?X956UNRT^)98 <+?V^T;HF_VAU4^OX8](CL;2&S%G%:P
M):@;1"L8"8]-O2EM;2VLH1#:6\4$0.0D2!%'X"@#!\!WR:GX0MK^.-XTNI[F
M94D&&4-/(0"/7FM;6B!H6H$G %M)D_\  35R...)=L:*BY+848&2<D_B2339
M[>"ZA:&XACFB;ADD4,I^H- 'BDVG1G]G_3[V?7)T2"QCF6SF=?(N'7D0LH 9
M@2 ,;NN*[V[O+W6]&T'3%M8;>^OX([R[M)"56*) C.AP"<%RB8QR"WI70P:!
MHUM*LL&D6$4BG*O';(I!]B!5DZ?9&]%Z;2W-V!M$YC&\#TW8S0!P6AR7/ACX
MGWVEWXMXK;Q'&;ZV6%R4%R@"RJ,@'++M8_2JVL:%;7$FK>+_  ?K9T?5[629
M+Y-P:WG>(D,)D/ )VYW>ASCG->AW&EZ==W"7%S86LTZ8V220JS+]"1D5#-H&
MC7,XGGTFPEE#;A(]LC-G.<Y(ZYYH \^UR^FUV7X9WMVKV%Q>7!E=(SM:-F@)
M.,].3W]:[;3X+?2]:N(&U2>[N+R,2K'.X9HT3@GC&%RP_$FM"[TC3=0=7O=.
MM+EU& TT*N0/Q%,@T32;99%@TNRB65=L@CMT4./0X'(H XKX7:I8:3\&])O;
M^[AM[:%)B\DC  ?O7_7VJU\*=.N[+PO>7=W;R6W]IZE<7\,$@PT<4A&T$=N!
MG'O74P:!HUM*LMOI-A%(IRKQVR*1]"!6C0!F>([>6\\,:M;0(7EFLIHT4=2Q
M0@#\ZQ? NJV,?PPT2\DNHHX+73XHYW9@!&R(%8'T(((Q76UG'P_HIO\ [<=(
ML#>;M_VC[,GF;O7=C.?>@#SWQ-!+!X+^'5M,7MIUU?34;@!HVV'/!!&0?45H
M^,? /VOPUXGN;.:[OM<U"S$0EG9=VQ"&$2!550#CTY)Y-=Q=Z987[(UY8VUR
M4^Z9HE?;],CBK*J%4*H 4#  ' % &!H&O:=)X(LM6:XCAM(K13,SG'DE5 96
M]""""/45QG@S2[C3/!&@)J$)A:\UEKE;>48*))YA52/7'./>O1'T329+S[9)
MI=DUUN#><UNA?(Z'=C.:GNK"SO2AN[2"<QG*&6,-M/J,CB@#S#4=/O? VJ6N
MD6L,D_A?5=4M&M0O/]GS_:8W9/\ KFP!(]#QWY]7IDD4<JA9$5U!# ,,C(.0
M?J" ?PI] ' >)HGTWXK>&-=N>-->WFL&F/W897Y3<>VX_*#ZTOQ1@;6++1M
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M-8M%%[,8V<17"'",2!T*_*<=.":TXM'L_$ECXCTO5;&?[)>7A9?-A:,E?+C
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M7*JNCWT,D6FR?WYX&(F_/)Q[1C'6NB\17UU8:'<2V%O/->.NR!8HC(59N Q
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M$T:EN".QQ@CN"<UR^HWEOK/BKX<ZQ>:2MS)?Z9<S30)"KEB8HF'!Z@$G&>E
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M?VR* DPVY1RO3<ISSUP<=* /0%8,,J01Z@T@=&.%921V!KR>VDN?A_K6I:Y
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M?QKHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS>7HL(T:)0PG)("D%N,X)!Z8[T :NGQ:G#8RM>R6\UX\C.$C)6)!T502"<8
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ME_K=GK%Q%,U_9AA;R+<R*(PPPV%#!>0!GCF@#DIDOT^,VA_;KBVF8Z3=;3!
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MMY%N9%$888;"A@O( SQS5BRTBTT^[N[JW$PENW$DQ>=W#,%"@X8D#A0.,=*
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MX! &3ZT >>Z5#K!^ Z,M[8BV_L%SY9LW+[?)/&[S<9QWV_A7;>"/^1!\.?\
M8+MO_12U+%X6TB#PV?#T<,RZ68C#Y/VJ7.PC!7=NW8QQC-7M,TRUT?38-/LD
M=+6W01Q(\K2;5 P!EB3@ >M ',^)XEU_5/[&ETRYU#3[>W=KI(&C'[R12B [
MW7HAD;'."4/I3/AEJ=S<>&#I&I!EU31)387*OC<0O^K;@GJFWG)R0:Z73]'L
M],GO)K59A)>2^=.9)Y)-SX"YPQ..% XQP!5>S\,Z58:[>ZU;0S)?WNW[3(;F
M1EDVC"Y0MMX' XXH H?$3_DG'B0?]0Z?_P! -<UJ8,>I?"YW&U5<H2>S&U(
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MM9T6QU2%'2*\MX[A%<?,H=0P!]^:Q-+U_4KSQ[K.A3"T%KI\,,RND;!W\P'
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MOQMIVKB[N[N(Q&,7[7.U$RY<[G;8HYYX!)%<7X5'AC4=/\7PZGK<=M]HUN^
MQJ;0@QL1A@H<*1[X(/O0!U/B7QAJ_A./1KW4;&":RG&-12W1C):X4%G4Y(9
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M^OKUNHZA;:3IEUJ%Y)Y=M;1-+*_HJC)KR35X=)MK2+QAX#U,6&N73Q,^D0R
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M3>'+SQ+XW&I:Q' LNI87;J;6X=?*4$C:X!Y!&?:@#T[3);N;3HGOA"+@YW&
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M*=110 TQH7#E%+C@-CD4ZBB@ HHHH **** "D9%<$,H((P01UI:* $50JA5
M '  [4CQI(I5T5@>H(SFG44 '08%%%% #7C208D17 .<,,TZBB@ HHHH :T:
M,ZNR*67H2.13J** #K1110 4444 %%%%    , 8 HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***Q];\2V&@/"E['?.9@2OV:REG'&.NQ3CKWH V*H6&MZ;JEW>VMC=I
M/-9,J7"IDA&89 ST/'I5R&59X8Y4#!74,-RE3@C/(/(KD?#/_)0_''_7:R_]
M)UH T#XX\.#7$T<ZFBWKRF% 8W"-(."@DQL+9XP#G/'6NAKE/$VDV^M)IWAZ
MVB54AN8+N9E'_'O%&VX8]&8KM'L6/:NCO[V+3K&:\G$IBB7<PBB:1L>RJ"3^
M H L45FZ+KMGKUO)/9I=HD;["+FUD@.<9X#J"1[BM*@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K'TWP]#IFM:GJL=Y=2SZD4:=)"FS*+M7: H(P!CK
M6Q10!QZ^ $$L[_\ "3^(\3RF69!=HHD)ZYVH#C  XQ@  8Q78 8&!110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>exhibit1061-loanandsecur013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC9T3/\#;,@= <].X!3\%6,VMVWB(W>KZOYMMK5U:6\BW\N8HT8!0 25.,_Q
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M-2^W7TT3(B[V)+D!V' R .^!4FD>$;K2/&.JWRMYFBO*;^SM%QE;J12LIY(
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MD$4!%TY,*%%=PF3P3DC/;-,MM/>;XG:GHC:IK L8=+AGC0:E/E9&=@6SNR>
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M5GLOK;,;7<<B-'= ' D !W*2.2"!B@#G_&UU]E\;>$89M3N;.PO)+I;L)>O
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ME.23&5/H0.V*NVOA"]T_P_XVBTS2I+6WUJ-DL-*$L8\IC"49S\VU0S'. 3@
M?0=EX4LYK#PMI=M=6?V:[@LXH9D)4G<J 'E201D>M '%Z1J.G+XF\76^NZ]=
M0PV5ZJVR2:K-%LC,:L< ."1DGUJ]J>L7<$OA3PSI>H7'F:V\LK7TIW31VJ*9
M" 6S\Y4A0QST)ZU-X>MM8TCQ%XHO+CP_>O!J5XLT!CFMSE1&%Y!E&.13-7T#
M6;]]!\1V-A%;:KHT\ODZ=)*H#VSC88RX)4.5 (/0$X]Z -^X\/21&U?3=2U"
M%XKB-Y5EO))EFC##<IWEL<9Y&/0\9KE/$>G7&D:MX2M$UG5W-_J!@O'^WRCS
M5\MFP &PHR!TQ79VNI:C?&-?['N; 9!E>\>(X'<*(W;)[=AWYQ@XGC'3=3O_
M !!X6N+'3Y+B#3[\W%PZR1KM78R\!F!)YS0!E^.;2[T#PW"UGK&I@RZQ;*CF
M\D+I%(R*T>[.2.I&>1FK'BQKCP[XL\.:Q]NOAHTMQ]BO8#=2&-7<8BD(STW<
M'/'(J[\1-,U+6-#L[73+"2ZE2_M[APLD:;4C<,?O,.>.U;/B/1(?%'A>^TBY
M4QK=P%1NP3&_56X[A@#^% %:\B;4?&%K%'<W4<-A;F:Y6*=T21G.(U8 X/W7
M8_\  >QKC]%U/3%U?Q;'K^OW44=CJ+);I)JLT92((K8 #@D9)]:Z_P &Z=J6
MG^'87UMA)K-P!+>LI!RX4*!Z<*JCTSD]ZQ?#5KK&CZKXGFN_#U[)#J6HM<P>
M7+;G*;%7D&48/R]/>@#K='B\K2+9?M$UPI3<LLYS(5/*[CW(! S[5>JCH[73
MZ;&UY:"SDR0ML&#>4@.%!()!.T G!QDXJ]0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,RHA=V"J
MHR23@ 4M<#\5KB3^R]!TTL5L]4UNUL[T@XS"Q)92?0X ^E '3#Q7H)C\W^U+
M80G[LS-B-_\ =<_*WX$U<OM5L=-,8N[F.)Y21'&3EY".NU1RWX"EOM-M-1TR
M;3KF%6M98_+9 , #MCTQV],5Q?@Z5]0^)/C>ZO/FN;26"S@#?\LH-A8!?0,?
MF/J: .SM-6L+ZVDN+6ZCFBB)60H<E&'4,.H/L>:;INLZ;K-LUSIM[#=P*<&2
M%MRY[C([UQU_))8?'#25M,A-2TN5;U%Z,(SF-R/4$[<^AQ4WPCX\ 0CTO+O/
M_?\ >@#H9/%>@0P-/+JUI' DODM*\@55DSC:2> V>U:%[?VFG6;W=Y<)!;(,
MO*YPJCU)[#WKC+^T@O\ P-J]I<QA[>XU>2.1>FY3> $5@W&H7?A+1-:\%:Y.
MTL#Z=<'1;^3_ );Q",_N7/\ ST0?F,>V0#TFZUS3+)(&N+M$\\$Q+@EG ZD*
M.2!D9..,U&?$FB#3'U/^U+0V$;;7N1*#&IXX+=!U%<YXKT_Q%8^)H/%'AN.W
MU"6*S^RW>ES/L:2+>7#1M_"V<]>#COBL/6=<TO7_ (0^+[S3K6>SF*R_;K.X
M39)!/M4,"/? .>^3WR* .^B\3:)/-#%%JELTDS!(E#CYR>@'J:DMM=TJ\U&;
M3K>_AEO8<>; K9>/(R-PZC\:R=,GU6>#1;:ZTFW%BT:,\RW!D*E4W)\NT8^8
M YSVQWK-\,_\E7\>?[FG?^BGH [FBBB@!DTT=O!)/,ZQQ1J7=V. H R2:;]I
MA-J+D2*8"@<.O(*]<USOC*XMIK>UT.Y,ODZBY%SY2.S?9TY<?*"<,2J?1S69
M\+=29]!N?#]Q([W6A3FSW2*59X.L+D$ C*8'_ : .OT[5+#5[3[5IUY!=V^X
MIYD+AUW#J,CO55_$NBQ6MQ=2:E;I;VS^7/*S86)O1CV/U]:\ZBBN_!-U>>,+
M!99](NM1O%UJS7+% MS(JW"#U4 !@.H'XB_XBN;>]^%OC:ZM94FMYC-)'(AR
MKJ8T((- ':VWBC0;N>&"#6+%Y9O]5&)UW2?[HSS^%:U<?XBTVRU3X57$5^BF
M./2_.1VZQ.D6Y7![$$9J]X"O[S4_ .A7M^6:ZFLXVD=NKG'WC]1@_C0!I:AK
MFE:5-'#?ZA;VTLJED21P"P&,D#T&1^=5;7Q=X>OI(8[36;*=YMWE+'*&,FT$
MG;CK@ GCTK4>"+S'N-@\TQ[-_?;UQ^=<5\)((IOA7X<:1 QB1W0G^%M[C(_
MD?C0!U5CKNE:G;S3V%_#=0PL5D>%MP4CJ"1W'I4"^*] ?3)-375[1K"-MKW(
MD'EJ>F"W3K7'_#:ZU"'1M62VTT3Q_P!LWOS^>J<^:>Q%<[;9/[-6KDC!_P!+
MR/3_ $EJ /58?$NBSSPPQ:G;-+,VV)0XRYZX'J:6[\2:-8W,EO=:E;PR18\W
M>^%BSR-[=%S[D50L9]5G;2K>[TFW6R*!VF2X,A5E4%.-HQSSGVQWKE+^77/
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MF[O[B[BMXFW+:1RE3Y:GI_",XXJI\,H(KCPWJ:3('4:Y=N >S+-N4_@0#^%
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M)Y4:IO<\M@8R?>IJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN]T<T85HRQ48W$<Y!X_6@!]SX5*>()M<T?4'TZ]N45+M?+$L-R%X4NAP=P'
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M/PMX;/ABRNK1+UKI)[F2Z+21A2KN<MT/3/\ ^NK^LZS8Z!I4VHZA+Y=O%C.
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M1 2<D  DYSZXK3/A?1&L+BQ.FP&UN7WSQ$<2M@#+?WN .OI1'X6T.)X&338
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MOAY>)!;S37Z2PRV8@1FE619%^9-O((4MSZ9KM+(6ZV,"6BJELJ!8E5<!5 P
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MRSJ1Y@'R-@*1R,Y-5_AS:W^GZ9J=K/=7=SI,-XRZ7->@^:T&T=<@$J&R 3U
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M94FR $V]R2RXQUW"I[+Q+97NMSZ-Y5W#J-NBR2PR0'"JPRK;URF#@X^;J"*
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M3!L93DD<G!Z 9H ]*HKGK'QGI5_=6$,/VCR]0\T64YC_ '=P8\E]N#D< D9
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M63;(N<-QUQD]>.:NV]K#:B3R4VF1]\C$Y9VZ9)/)X 'T '04 34444 %%%%
M$=Q*T%O)*D,DS(I(BCQN<^@R0,_4BO-O$/@F\\3_  [OX[Q;]-5NPUV;(M$5
M6YQE5!_NCA =WW1^%>FT4 >-:UX=\8>)?@=#H5[I+QZ[9/$OEO-&?/1#@,&#
M$9VXSDCD'UK:\5:-KNI>+?!/B*VT:9X]/>7[5;":+S8@P 4G+;3TYP3BO2Z*
M /'M3\':[8WOQ CMM/DO5\30QFTDB==J/\P=7+$;0-^0>A ]>*EF\$:S8>(/
MARD5D]Y:Z% R7MRCH%5B . S D CTZ8KURF3316T+S3RI%$@RSNP55'J2>E
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MZ]/<0VL#SW$T<,*#+R2,%51ZDGI26]Q#=VT5S;2I-!*@>.2-MRNI&001U!%
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MX&O$3S&@$@+JO3)7J!R.: +"G*@X(R.A[5PUU=M:?&5F%K/.I\/J#Y*ABO\
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M(=6'C"RT.:"QFCN; WQN8F=-@#!2H7YMW+ @Y7/-9WQ5"_V3H!:/S -?LCM
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M0F/(9R_3<W=CWK<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ IDLT<$9DE=40$#<QP,DX'ZD4^N)^
M)T FT'3<R3)C5[(?NY63(,RCG!&?;T//6@#H(-?@G\4W6@?9[A+FWMDNC(X7
M8Z,Q4;<'/53U Z5K5YY<Z4;WXI7]DE_>VJ+X?MQYD$Q$I_?2X^<Y/O[]^^:/
MA_Q-JFNV'A#3[F;=+J&E2W,SFZ:V:XD1D4 .BDYP68@8SZX&" >HUDZEK\&E
MZSI.FS6\[/J<KQ12H%V*RH7.[G/13T!J+PM;:I9:4]IJ^H17US#.ZK*C%F$9
MP45R0,L 1SCG@UD^+O\ D</!'_81F_\ 2:2@#L:*\R?5M1U;P1XD\20ZC<VN
MHZ;<W9@C60B.)8"<1O']UMP7DL"?FX(P,&L^(M1M674]6AU"WT>YM;=DO=/F
M)&G2E0SB>($$J2P^8@\8'% 'H4=[(^JS61LKA(XXDD%TP'E.22-H.<Y&.>.X
MJW7"7%[J'_"9>*;1-3N1!'HT-Q;@%<0N3+DJ,8_A'7)K)T2]U6$?#S4)=8OK
ME]7A\J\BFDS&X-L9 =N.&#*#NZGG- 'J-%>87-UXBO[>^CM[C48M=CUWR8U@
MW>2+7>!Z&/;Y1)+'D-[\5Z;&I2-$+LY4 ;FZM[G'>@#G)_&MK!K&H:6-,U.:
MXL(EFN/)B5PJ-DJPPV6S@\ $\=*V-(U>QUW2K?4],N%N+.X7='(N>1T/!Y!!
M!!!Z8KA[=-1?XM>*ETV6VBF.G68WW",X4_/@X!&<>E.L?#\7A2V\/^%K/4[N
MX*QW$LEK 3#)<L2"96D5AY:*6/ )SN'4B@#T.F&:,3K"742LI=4SR0" 3CT&
M1^=>4V6K:WJ/A;P++)K-W%/>ZG)9W3QE<RHOG $G')Q&O/KSBM.QT-;7XJ"R
MDU+5+KR] 5O.GO'\QCYY')4@= .@[9Z\T >C45YQI%_?[KGP;=ZA=R:S!J0S
M=&8^9)9D^:)<CI\@,7' ;'K7HX& !0 5SW_"66IFU^(V-X7T,(\Z[4RX9"X*
M?-@_+SR17)7&KW\=]H]_9ZG=7<5SXB-G)<ERD$D3&1?*2+)!";<;\#)7()R:
MM+_R'?B;_P!>T'_I(: .XTG48M8T:QU.%'2*\MXYT5\;@KJ& .._-7*P? __
M "(/AW_L&6W_ **6L/7XK_4/B+9Z/'K>H65E=:3<2.MJZH599(P&4XX/S=>?
M3O0!W5%>;K+KOB*VUMM.U1;.\TS4'MHIY;QU6)8B/]9$$VN'&6);^]QC JMX
MMUG4+>RU_4].U2YFFL+FV56A<QP6AS'NB*YQ*S;R3E> P&01B@#U&BO//$^L
M7NCZ_=3:I]OCT5GA6WU*PF)2R;Y=RSQ CAB?O$'A@.*EAO+SQ(OB]_[0NK&Y
MTN[DM;(0RE!$$C5@[+T?<Q)^8$8&!0!WU%>8:1JFK>)]<\-_:=2O;.'4_#SW
M5Q;V[A!Y@>(;E.,C.XG.<@'@BGZ)J][>>'="MKO5KN:Y;4KNV,,7$]\D+2J
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M@?A794 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<<DG'O5FZOK.QC$EW=06Z-P&FD" \9ZGVJ2&XAN4WP31RI_>C8,/TH R=?\
M"FC^)A;'5+5GEM6+0312O%)&3UVNA!&>XS4]MX?TRTDLI(('C-DC) HF?:H;
M[Q*YPS'^\03R>>:9;ZO]OUZ\L+7;Y.G[5NI3SF1EW"-?<*5)/^T!ZX73-0VZ
M;')J.J:=-)).\236[!(W.\A4&6.6' (SU!H Y7Q9X+BB\+S:=X>TNYE-WJ4-
MW/$EV<<3*\C#S) %) /W<<UUEMH>GQ&>5X'FENHA#,UU(96:/GY"6)^7D\#@
MY)YJU::C9:A'))97EO<I&Q1VAE5PK#J"0>#[55EU>WNM/O9-)O[*XGMXRWRN
M)51L$C<%8'MZB@#/TCP+X?T))TT^TEB65&CP;J5O+0\E8\M\@/\ LX[>E21^
M#-"BM-,M8[698-+D\RR07<W[IL$ CY^>"1SG@FD\)^(1K'AG1+N^GMDU#4+1
M)S"K!2Q*Y.U2<XZ^M;$5_9SPRS0W<$D41(D=) 50CD@D=,4 9]MX8TNUGAE2
M*9A!,T\,<MP\B1R-G+*K$@'YF^F3C&:JV/@;P[INLR:K9V!BN))#*4$S^4)#
MU<1YV!O<"JMEXHDOO'=YI-O>6$^FQZ8MVDL/S%7,A4AF#$$ #/;K6OIFHJFD
MV+:EJFGS7,RX\ZW8)',PR3L!)SP/4]#0 RS\,:7936\D44S?969[=);AY%A9
M@02H8G!P2/8$@8S6M)&DT3QR*&1P592,@@]14%MJ-C>VAN[6]MY[89S-%*K(
M,=?F!QQ26VIV%ZQ6UOK:=@<$12JQZ9['TH P[+PK;GPL_A74XFN=+B7RHB)F
M0R09^5&*D-E1A3V( /<@:"^&M+358]4$=Q]MCMOLBR_:Y21%G.W&[!Y .>N1
MFKUY?V>GQ"6]NX+:,G >:0(">N,FD.HV*QP2->6X2X_U+&5<2<9^4YYXYXH
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MN2TM[ZVFN8AF2&.96=.<<J#D<T0:II]W<R6UM?VLUP@):*.969<''(!R.>*
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M@8^H4E1U(K%DN;%_AW<L[1K)'XL+*)%VL@-Z&/!Y'RYS[9S7MA .,@''(I0
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M)B9\Y;H<#'Y>U<WI']FS>%OA:ES]E<K<E)!)M) \J4$'/;<5X/<BO:PJK]T
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MXW;\D=\*?2NT\6^'Y/$WAFZT:&[2S%QM!E,/F;0K!N%W+Z>M;42,D:ARA?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1X-1AM[FV67<##=1[)8V5BK*R]B"I%:- !1110 4444 %%%% !1110 4444
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M*U#3%\Z_MS97#^5N6=0DQ)V^7NSSD\8')Z>U:2JJ*%4!5 P !@ 5XW:0Q_\
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M<B[O85@G<3-\R+G: .@QD\CU-9UQ\/?#]QI.G:=Y5S&FF9^Q317+I- #U"R
M[L>V: -#PO#J]MHJVVN7MO>7T,C(TT+9RN<KN^5?FVD9X'KWKC/&.MZC8P>(
M-0T_4[B:73[BW6,086&T!,>Z.0$XD9MQ)X. 1]VO0M/T^VTNQCL[1&6&/.-S
MEV))R2S$DDDDDDG)K#O_  #H&I2ZFUQ#<[=2*O<Q)=2)&[C&'V X#?*.<=J
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M#<O&ER%& )54@/\ CUZ'-7&\+Z<=0U*^!N%GU&%8+DK,P#(H(4 =%P&/3U-
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MT'!Z@]:TO$EGK=CX-\:QZC>P36$NFR26<!N&FFA_=L'!9E4E2<$9R1R*Z,^
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MW_"0Q7=LS2P8\Y57_7^81SM"@@@\=!Z"@#T?6-5U73-&\1WZ2:;,UA"\]K$
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MD(,<H92W7'W1CZ"M<1Z9)-\0[3^THM-B;4K3%Q$%(A<K#AF7H5\S[V>/O9H
M]1MKRVO8S):W,,Z#C=$X8?F*;?7D.G6%Q>W#%8;>-I7(&3@#)KF/!-]?SWVM
MVNJ6MD+^WEB\Z]L2?)N\I\K8/W7"@ CW';%3^([D:EJ]AX<M+VUBNF/VV=95
M\S]W$RE5*!E)W.5/7HK4 6?!WB3_ (2GP['J#VYM;I9'@NK8GF&5&(93^A_&
MMAKVT2Z6V>ZA6X89$1D <CZ=:\]TNY;PC\5+O3-0OK0P>(X1=Q>4GE*ERGRL
M-I9L%UP<YY(K U";1[Z/Q%X9O]<TB.2?Q!]I^T7MRJ/&H=&*[&Y) 4QKV([@
M=0#V&6^M('V374$;?+\KR 'YCA>OJ>!ZT?;K07@LS=0?:B-PA\P;\>NWK7GU
MEI'AZ\^+.LVDEEITJ)IEF\<!C0J&5Y.0O3( 3GJ!CUK'T&;1M7M;33-;U:\B
M\26.JM,U@@C68W D8AU^3<R%3DG.-O4X% 'K+WUI'=I:/=0+<N,K"9 '8>H7
MJ:;-J%E;EA->6\95@AWRJ,,>@Y/4^E>46DVC:JE_HGB+5KRWUV#6))A9QB-9
MI7\TM"\1*;B-FP YX [+27UGHLL7Q6WPV3&)"T>0IV,;13E?0[QU'<>M 'K:
MW=L]T]JEQ$UP@#/$'!=0>A(Z@4BWUHUXUFMU ;I1N:$2#>!ZE>M>9P"PMO$G
MP\FLC:QW5U87(DD4@-,3 A&\]6R_//?-5/"DVA:U8^'[;4M5O1XCTRZ#2Z>%
MC69;@$B4O\FXQG+,Q)P0>3F@#U4ZA9+(D9O+<2.YC53*N68=5 SR?:JL&OZ9
M<Z[=Z-#=1M>VL<;RQAAD;]V%^N$)([ CUKQ^Y@T:'X=^)KV%+)+BW\2MY$R[
M=T0%VFT(?X1C/ [9KM-.O=,T_P"*GBB2[FMX6EL+.>$M@%T59B[KZ@#J10!W
M]%5-+U2QUK38-1TVY2YLYQNCE3HPS@_J"*MT %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4UD5_O*&
M^HS3JS]7UB'1X;=Y8IIGN;A+:&*%06=VZ#D@ <$DDCI0!=\J/.?+3/\ NT>3
M%\O[M/E.5^4<'UKE[CQ]IUIH=_JDUE?*NGWHL;J$(K/'(2H'1L%3O3D$]:MV
MGB^SFU/4+"\M;O3I;*V%XS7BJJO 21Y@*L< %3D-@CTH W?)BP!Y:8&3C:._
M6E$:!MP10WKCFO/M6UF34?&/@>>&UU&UMKJXF9&D<+',GV=R-R!C@]"-P!Q^
M('<ZEJ-MI5A+>W;[88\ X&222 JCU)) 'N: ++*KC#*",YY%((T5BP103W K
MF&\>Z7;SZG;WL-S:W&GVGVUXF"2&2'.-R>6S \\$<')].:M0^+;(7FH6M_!/
MITMA:+>S?:=A'DG=\P*,PX*L"/;O0!N"&)<8C08)884=3U-'DQ8QY:8_W16
M/$,.H70TJ:PU*S:\M'N()7 4.@QGYD8E&&0<'!Y]>*YKP!XM6#PKX3L;^UU
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M5=.OVOQ<![.XM9()?*9)]N2=JMD%201AAW]:S-9\66VCS7T1LKRZ-A:"]NC
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MDQ\H#?>W9YP#QUK#\":U'IW@'3VNY9[BXGOKN"%6DW22L+B8XW.>RJ3DGH*
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M;/,NVXBE>0LH8$@-MDXSQD>G->G55U'4K/2;)KR_N$M[=656D?H"S!1^9(%
M'$Z]X:U+6G\2:JEB\-U?:(=)M+5Y$W<EV+N0Q4#+@#!/"GUQ5M=)U5O$OA"]
M.GNL&FV,\%TQEC^1I%C P W(!0YQZBNUHH YSQWI%[KGA"[L=.C22[,D,L<;
MOM#^7*CD9/3(4BL^+3M9TWQK<>((].:XM]4LHHKFVBF3S+>6,MM(+%592K$'
M!X/J*Z*37M*B;41+?P1_V;M-X7; AW+N&XGU'-6[6Z@OK."[MI!)!/&LL;CH
MRL,@_B#0!C>#]!ET#1I8;@K]INKN>\F5#E4:5RVT'N "!GOC-;]%% !1110
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M<T2)L&,99EY=L<9/J>,\U9\3^'W\1V%O:+>?95AN8KG<(MY+1L&4=1QD#/\
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M6M6\+6$\5S#:SIXECTV=EMV E5+@*#M+;D!P"5SGJ,BO2Y&N8;!V"I/=)$2
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M"SN3E$4D$*H/+<+QP =Q17C]I>:A>>#O!SR:I?+._B)[*22.Z;+Q"2<!6/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?XO>LB61#\-OBMAU.=;!'/7-PN*^BH;&TMY998+6"*27F1TC"E_J1UIO]F6
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MG/;0E!MC95?# =B,+SU_.L0%K_X0+.N%\7V]^!NX%PM]]HP1Z\J>G38?05[
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M\#U)K5U*31-2UWQ9HOBO6#ITTDZ-;AQ$K/;^6GEF%G4DD,&X4_>)XR37I_\
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MI7DD9=1DQ2D[6&#Z'IUK,A\.ZC>^$_#'ARYL9(+O1[RV>6XQ^[5(#_K$;N7
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M#*P8;4+#T._VH B\ :W=:WX6C743_P 3:PE>QOQW\Z,X)_$8;\:XV_U75(/
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MGL!S0!OP_$3P_/%ITZRW0MM0)6VN&M)!&[X)";L?>(4X'7MUXK)\8>*H]0\
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M ';Z9KEIJEW>V<0EBN[)D%Q!,FUDW#*GT(([@GH:O7$\=K;2W$K;8HD+N?0
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MOB/Q#J-U/!-;:OY68%C(*!(_+P3GG(]A4Z^*]/98Y]DXL9+G[*EZ5'E-+OV
M==V"_P H;&">_(IVH>*-/TZXNX76>46,:RWLD*;EM4;)!?G/0$X ) &2,8H
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M9]6QC'2NCHH X&R\":MI^D^'K:#5[5I]'NIIQYMLS0S"3?U3>"&7>=IS2_\
M" ZB-%O+/^V(&F?6AJ]M(UJ=JN)1(5<!N03QQC%=[10!QL_A;7[7Q'/K&B:Y
M:P/J$<:ZA#<VAD1G1=HEC <%3MXP21P,YJ[;^'+R#QG#K?VY)88]-&GF.1"9
M'^??YA;.,Y[8KI:* //YO 6L/%) FMVOEKK2ZM"\EHS2,PDW[)&WC< .!C'
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MY@P6VAAAER<<]S7=44 <!%X!U2#3+.R&KVKK:ZV=51FMB"P\QGV'#=27//;
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M07]Q$8HY$B;RX >K ;LLW/4D=!P.<QZ]X9CUKP3<^'56W@6:V$"'82D6 -I
MSGY2 1SVKH** *&C6U_9Z1;6VI74=W=Q1A'N$0IYF!C<02<$]^:OT44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA8VLQB;RW"[\2>62IP01N_,<UMZS:0OX:OK0Q*8/LCH(\<8VG KP*SMK*/\
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MG-M*DD+I(DN0/+,9&[=DC QDY%3Z7KUAJ]Q=VUM(XNK-E6X@FC:.2/<,J2K
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M6@!LGA[19M835Y-*LGU)/NW;0*9!V'S8S0WA[17^U[M(L#]L_P"/G-NG[_\
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ME[X>2T@N)(F6-IA)(^PDCC(8#/N:])J.&XAN/,\F:.3RW,;[&!VL.JG'0^U
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MWD/A79XV53QUPIKF!IFICP6EK_9=]]H'B;[;Y?D-GR?M7F[^G3;SZ]J]9HH
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MGZ]J]WH]]:FSUB)1<Q7BLS12JFS>A!^;(QD''(Z]JAL/!FJ65OX-B:[LY?\
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MR_B+Q$FN^%O'6CW$-I*^FZ6THFMY/,C??%(1C(X960^O:M%/!^HR_#%-"_M
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M<<\UT%<Y#:>+?['NGGU'2_[8D55@$<#_ &:( \D@MN8D$\Y';C@YZ,9P,]:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8HEW,(HFD;'LJ@D_@* +%%9NBZ[9Z];R3V:7:)&^PBYM9(#G&> Z@D>XK2H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q]-\/0Z9K>IZK'>74LVI,C3
MI*4V91=JXPH(P!CK6Q10!AP>&@K*+W5M1U&!)Q/'!=M&51P=R\J@9@IY 8G&
M!Z"MRBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>exhibit1061-loanandsecur014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCJT:I?2IB4(SF0D,"Q)(Z\?+6CXSTJYO? 6IZ/I-F99I[1K:")65 N5P,EB
M *?);7S> 6L18R_;3IYM_L^],[_+V]=VW&>^: ,?P=H[ZKX1T#5)]6U8SW-B
MCW0-_,1*7CY/WOE(;!!7'<5F^ _$NI6QL_#OBF=Y9;^W%SI>H,Q!N8R,M$S?
M\]$S^(P?KU7@VTO=(\#:387ME)'>6=I'!)"'1BS*H'!#8P?<BL[_ (1(:_\
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M96]S%/+YD>,R!<84MD@;>>/SH RO!_BZXAM-374+BXU*R&L&PT>Y"@R78/(
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MW#=:9/-%^]BFDW!D8DJ&&U>N.XH ZT_$/11IT%X8[W]YJ']FO$(-SPW&<%'
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MK0M,\0V:6FJVJW,"2K*J%F7#CH>"/4U>BBC@B2*)%CC10J(HP% X  ["GT4
M%%%% !1110!ES>'=)N-?BUR:RC?4H8_*CG8DE5R3P,XSR><9YK4HHH ****
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ML?BKQ9%*K0JQD>.'#3)NVJX3CKD>@[\"NYTV_@U73+34+8L;>ZA2:/>NT[6
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MG/4DXS0!Z[17D7A3Q+<WWQ@\363:W-=Z%I]I]HMT6??&/]7D[A]X#+=2:O\
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MS?\ VVX!&1Y5NN[!]BY056\8(FD^,O!]WI<20W]YJ!M)Q$NWS[8H2^\#[P7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "FK%&C%E10QZD"G44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M (1/0/\ H%6W_?-'_")Z!_T"K;_OFMFB@#&_X1/0/^@5;?\ ?-'_  B>@?\
M0*MO^^:V:* ,;_A$] _Z!5M_WS1_PB>@?] JV_[YK9HH QO^$3T#_H%6W_?-
M'_")Z!_T"K;_ +YK9HH QO\ A$] _P"@5;?]\T?\(GH'_0*MO^^:V:* ,;_A
M$] _Z!5M_P!\T?\ ")Z!_P! JV_[YK9HH QO^$3T#_H%6W_?-'_")Z!_T"K;
M_OFMFB@#&_X1/0/^@5;?]\T?\(GH'_0*MO\ OFMFB@#&_P"$3T#_ *!5M_WS
M1_PB>@?] JV_[YK9HH QO^$3T#_H%6W_ 'S1_P (GH'_ $"K;_OFMFB@#&_X
M1/0/^@5;?]\UIVMK!96R6]M$L4*?=1>@YS4U% !1110 4444 %%%% !1110
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M_P#$T?\ "5:1_P ]I_\ P$E_^)K8)"J68@ <DGM5.?41%<6,<=M<W"7C%1-
M@:.(!2P9SG@'& >>2* *?_"5:1_SVG_\!)?_ (FC_A*M(_Y[3_\ @)+_ /$U
MLT4 8W_"5:1_SVG_ / 27_XFC_A*M(_Y[3_^ DO_ ,36S6&/%%K.;@Z?:7NH
M0VSF.:>UC#(K#[P&2"Y'?8&YXZ\4 /\ ^$JTC_GM/_X"2_\ Q-'_  E6D?\
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M)H_X2K2/^>T__@)+_P#$ULT4 8W_  E6D?\ /:?_ ,!)?_B:/^$JTC_GM/\
M^ DO_P 36S10!C?\)5I'_/:?_P !)?\ XFC_ (2K2/\ GM/_ . DO_Q-;-%
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M[MV<=NE<]\&F#?#:S$A/VT7%P+W=]_SO-;=N]\8_2NE^WZ__ - .W_\  _\
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M/+-O!J1C!7KC*H#R>OK27NCWNH?V<;G0RYTZ02VQ_MAP4< @,<+\QP2.<]:
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MK_\ T [?_P #_P#["@#9HK&^WZ__ - .W_\  _\ ^PH^WZ__ - .W_\  _\
M^PH V:*QOM^O_P#0#M__  /_ /L*U;=I7MT:>(12D99%?<%/IG S0!)1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\U6*>2>Q;?;-'.T9B;(.1M(YRH_*@#S[QJ;D?M">#_LBQ-/]ADV"4D+TFZD
MFMO1=!E^&=KJ^M36VH:_J6M7PEN8]+ML[,[V&U"WW06;G/<<5TMYX*T>_P#$
M=IX@N!=-JEFFR"<7##8O/& <?Q'J.]=%0!S#^*9KCPG)J4>EZCI]W*YM[>UO
M+<^=YA. VQ<D@<MQSA37FW@FY3P/\8+_ ,/;KL:3KJ">T>[C>-O. )YW@'D[
MQGO\M>P7VC6VH:A97LSW FLF+PB.9E4,05)*C@G!(Y]36;X@\$Z+XFU&QO\
M4XIWN;%MUL\<[1F)L@Y&TCG*C\J .+^+/AEO$5AK<MLI^WZ99VM[;LOWOE>X
MW ?5<_B!7*^-M9F\7_!-O$UU$R,4M[6,,,9<2#SG'LS@#_MG[U[A!H]O!JD^
MH"6X>>>-8I \I9"JYVC;T&-S=/6LW4_ ^@ZMX<@\/7%JZZ3!MV6T4K(O'3)!
MR>>>M 'F/QB_Y(9X=_ZZ6G_HAZC^,J:JNF>%#J$]E)'_ &C'L%O"R$';W)8Y
MKT[5_ 6A:[H5IHNI1W,^GVFTPQ&X<8V@JN2#DX!(Y-+KG@71?$=O90:LMU<1
MV1W0#[2ZE6_O9!&3[F@#HY(TEC:.1%>-P596&0P/4$5Y[<6-CXA^*5EK[S0Q
MV6AHUI#(6 -S<N2I4>JIG'^\2.QKOI+99;)[5I)=KH4+JY5\$8R&'(/N*XW2
M/A%X-T/6+?5;'394O+=_,C=[F1\-ZX)P>M '0>)E5](164,K7MH"",@C[1'7
MDG@^UO/#'C?Q'\-UCE-A?R"[M9!TCMVQYG/NGR9_O+7LNJ:5!J]JMM<O.L:R
M))^YE,9W*P93D<\$ _A2_P!E6?\ :']H>4/MWV?[+]H_C\O.[&?KS0!Y7\&P
M%\<?$A5  &J8 ';]Y/6)\(4UEAJAT]H?L(\0*;U=K>:4Y^Z0<8SMSQTS7K.B
M^"-&\/7NH7FF"YAN-1;?=.;AF\QLD[CN)P<LW3UJMI?P[T+1(KJ+2VU&T2Z;
M?-Y-_*I=O7.[@^XH X3X\M;'PEH"VFSR8]7$8"=%*AU(_ @C\*7XV+*?%?@/
M^S\_VK]N;R=GWL;H^OMG^M=UJ'PX\.:IHUCI-W;W#V-BQ>"(7+C:Q))8D')/
M)Y)[UI6GA72+35QJWD27&I*GEI=74SS.B^BEB=HY/3'4T ><W?\ R=#8?]@H
M_P#H+U%\)GE?XH?$ ZGG^U/M*[=_7RP[]/\ 9QY?X8KT.3P3HTGBM/$S+<_V
MLB[%G\]L!<$;=N=N,$]J?J7@[2-2UF/6?+FM=51=GVRTF:*1E_NMCAAT^\#T
MH V6BMQ=+<,J"=8V0.>H0D$CZ9 KPCX@7US9:QH_Q'LH[XRVEWMD1[>18_L9
M.U &*A<,-Q//6;VKV1O#-A)87=K*]U(;R/R[B=KAS*Z<_+OSE1R>%P.3ZFG:
MEX;T_5_#S:%?":6P9 CH92&91R 6Z]A^5 ' ?'"\@U#X0?;;6026]Q-;RQ..
MC*W(/Y&N_P!)NH;/PGID\[A(Q:0#)]2J@#ZDD#\:R[CX=>'KKPQ!X;GBNGTF
M!]\=N;I^#V&[.<#)P,XJR?!6E-'8Q22ZA+#8R1RP0R7TK(&C(*97=AL$#KGI
M0!SGQQ:]7X6:C]CW[3)$+@IU\K<,_AG&?;-=+X%-L? /A\VFWR/[/@V[?]P9
M_'.<^];D\$-U;R6]Q$DL,JE'C=0RLIX((/45SMAX%TG2H&M=/FU&VL"Q;[%%
M>R"(9Y.T9RH)[ @4 >=_$" 6WQA^'T90)HZR 0*/N";S.<=L_P"KJ[^T-SX*
MTM8=QO#JL?D!/OYV/T[]<?I7H^J^&=&UK2HM,OK")[2$J843*&$K]TH5P5([
M8Q5=?"&F/J=IJ5ZUSJ%U9Y^RO>2F00D]U7@;N!\Q!/'6@#S#Q6^I1?'?P8\,
M,4^I+I#GRY9-B/)LGR"P!QSGG%6_A)+#K_C7Q1XFU&0V_B)W^RW&F[=HMXQM
M /)RWW ">,$'U%>@WO@K1]0\3VWB.X6X.J6J[()EG8>6O/ 4'&/F;MWH;P5H
MG_"5-XFB@E@U9TV230S,@D&,?,H.T\ =1V'I0!Y'X5T;4O$6O_%71K"XMK9+
MW4/)GGF5G**9)L[5&,G&>I&*=XB\/KX5^(?PRT8R22Z1:$)%)+T:<RY8^@))
M3CZ5ZWH?@S1_#FIW^H::EQ'<Z@_F7;/.SB5LDY()QG+-T]:O:YX?TOQ'8BSU
M6T6XB5Q(AR5:-QT96&"I'J#0!YI^T-SX)TM8MQO#JL?D!/OYV2=,<^GZ50\7
MMJ,?QN\$-'%%-J*Z:QV2OL1I-LN06 ..<]J].7PAICZG::C>M<ZA=6>?LKWD
MID$)/=5X&[@?,03QUIFH>"]'U/Q+:^(;E;@ZG:+MMYEG91&.> H./XCU'>@#
MSWX42Q>(/'WBCQ+J;FU\1Y^R3:9MVB"(;1G.<L<Q@$\8(/J*B^+MO-X@TV\U
M*Q^W"YT&=7LFBMY#&2AS.^\+MX.!R>#"?6O1IO!.B2^*&\2)!-;ZLT?EO<03
MLF]<8^8 X/&.H[#TJ]9:!9V&BOI,+7!M&# B28NV&)+?,<GG)_.@"IX/U^W\
M7>$]+UM%0O+&&9<9\N4 JX'ISN'T/O7GWP^_Y+CX]_X#_P"A"O0_#'A#2/!]
ME+9Z+'-!;2OYAC>=I &QC(W$XZ#\JCTKP5HVC:_>:Y9)<+J%[G[3(T[,)><\
M@G'Y4 >?>,XTB^/O@6.-%1$MV5548  \S  IO@SSA^T3XP_M#/VDVO[C?_SR
MW1[<>VW;7H6I>"M&U7Q'::_=K<-J5H,6\JSLHC'/ 4''<]1WJSJ?A?3-5U*V
MU26.2'4K92L-Y;N8Y54]5)'WEY/# CF@#S7Q>)V_:-\)?V?G[0+/-QL_YY;I
M<[OPS^E)XO\  ]Y>6?\ PF/A?,/B33+Z[?$8YN4%Q)\I'=@,_497TKTO3?"^
MF:7J%UJ44<DNI7:A9KV>0O*RCHH)^Z.!P !QTJWI>DP:1#+%;R3LDDKS,)I3
M)AF8LQ!/3))..E '*?#CQ9#XF\.:AXAG1;-9;O\ ?"1@%C988E;D]L@XSVKN
M%974,I!4C((/!%<YJO@[1[SP]JNE#35DM]1F^TS6ZRF)6E)4[MPY494$X]^#
MG%:7A_21H7AW3M)$IE%G;I#YA_BV@#/TH TJ*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!=6R3B*6,/R%E3:V,\9!Y&>N#SZXJ:BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP254PJQ.6.6ZD\G Z\]*ZU?%,5Y/8VNE0?:KJ\L1J"I))Y:I"<!2QP<$DX
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M:U#_ *%?5O\ O[:?_'Z/[:U#_H5]6_[^VG_Q^MFB@#&_MK4/^A7U;_O[:?\
MQ^C^VM0_Z%?5O^_MI_\ 'ZV:* ,;^VM0_P"A7U;_ +^VG_Q^C^VM0_Z%?5O^
M_MI_\?K9HH QO[:U#_H5]6_[^VG_ ,?H_MK4/^A7U;_O[:?_ !^MFB@#&_MK
M4/\ H5]6_P"_MI_\?H_MK4/^A7U;_O[:?_'ZV:* ,;^VM0_Z%?5O^_MI_P#'
MZT[6:2XMDEEMI;9VZPRE2R\]]K,/R)J:B@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:TMFBD"7#*\<@(V/&Y0$'&[.,8R,9[];_9FL_P#0P-_X"1T?V9K/_0P-_P"
MD= $OAS3[S2?#FGV%_>->7=O"L<L[$DN1[GD^F3R<5S&L>']?\0^#'\.:M9Z
M9/++&(S?-.S"/TDVE,^8!SP<$]P#71?V9K/_ $,#?^ D=']F:S_T,#?^ D=
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M_P!# W_@)'1_9FL_]# W_@)'0!LT5C?V9K/_ $,#?^ D=']F:S_T,#?^ D=
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M\:V:* ,;_A$]#_Z!Z?\ ?3?XT?\ ")Z'_P! ]/\ OIO\:V:* ,;_ (1/0_\
MH'I_WTW^-'_")Z'_ - ]/^^F_P :V:* ,;_A%-#_ .@>G_?3?XT?\(GH?_0/
M3_OIO\:V:* ,;_A$]#_Z!Z?]]-_C1_PB>A_] ]/^^F_QK9HH QO^$3T/_H'I
M_P!]-_C1_P (GH?_ $#T_P"^F_QK9HH QO\ A%-#_P"@>G_?3?XT?\(GH?\
MT#T_[Z;_ !K9HH QO^$3T/\ Z!Z?]]-_C1_PB>A_] ]/^^F_QK9HH QO^$3T
M/_H'I_WTW^-'_")Z'_T#T_[Z;_&MFB@#&_X130_^@>G_ 'TW^-'_  B>A_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#'VM:3<K;2:7!96SK&02?WAER2",$G:,]L 4G@2..&RUJ.)%2-=:O JJ,
M#S.@% '5T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDN)@"6GE R[$Y)(& !D]!@ <5:HH P_#7AY_#T>H(;S[2+R]EO6)BV%7D.6
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M7 )(8' .*I:E\.X;R+4[6UU2>SL;^RAM&MTB5_+$0*IM8\A<'E>YYR,UVM%
M',3>$YIKW5[I]4+/J=@EC(6@'RJH?YA@@9_>-VQT].=&+0U7PFN@27,A067V
M,SQC8^W9LW#KAL?K6M10!QUKX&N+>:*=]<EDE32VTS'V9%0Q_P )P.A'UY/H
M.*EA\%*BZ!'+?":#1[*2Q$9AQY\;HJ'<=W!VH.G?/T'644 <98^!)[-=$@;7
M[B6TT6<R6:- F\)L9 C-_%A6P#@<?F.BU739[][.6VOGM)K68RJ0@=7^1EVL
M#U7YL\$'@<BM&B@#D[WP-;ZNFJR:I=O)>ZC%%$9[9/)\D1,7C*#+'(<[LDG/
M';BBX\&W&J:#/I^M:]=WMRYC:&[2-(6@:-MR,JJ,;MP!)/7IQ7644 <Q=^$[
MK4_#EWINJ:Y/=75P8F%V(401F-PZ;8QQ]X9.>3ZXQBG>> YM0CUS[5K<KRZS
M9QVEPPMU"J$W<J!T^^<<_7-=G10!AW^@2W]]H=V]ZJR:5*90!#Q*QC:,Y^;@
M88_C6>UE;>$[;4?/%_J5GJM[(XM(+3S2C399@=HSM)R,G &0#ZUUE% &+X2T
M,>'?#%CIOS&2.,&0N^\[CU&[OC[H]@*L0Z;,FOW&IRW2R+)"L,</E8\H DG#
M9[D\\<[5]*TJ* ..OM!O-$D\4:WI]Q<3OJ4.XV-M" PD5-BNA)/S8P3P<XZ5
ME>%+.]@N(8=,U S6IB,4_P!H\/M9F-0C;3N(3<0V/EYZGIUKT:B@#D#X$7_A
M$=)T6/59X;G2'22QOXHP'C905!*G(8%6((Z$&I;_ ,'W.HZ?:&;7KL:S:7'V
MF#4DB0%'V[2HCQMV%205[YSFNJHH YJX\+7-VFE-<ZQ)/<V-Z+YYI(1^]<(4
M V@@*NUCP/KG.<U;SP0UYINOV3:GM36;I;F1A!S&0$&%^;TC7K[_ (=?10!R
MK^#[E-<N[^QUZZL[?4"KW]I%$I65PH4LA.3&2  <9Z>O-,U'P2=1A\30OJ6Q
M->""7$',05!&-OS<_*HZ]_RKK:* ,!-$.G^(+CQ ;Z8^;:1PW,$4&X2>7O*L
M ,L/OMP,YX_&#P5%,EEJLDMO/")]6NIHQ/$T;,C/E6VL <$>U=-10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>exhibit1061-loanandsecur015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D+ 8R0,\#
MWI:\5\7:]+X.^(^HW_BOP^VJ^';^.&.TNO+$@M J_,JAN!EB21D$X!YZ4 >U
M4FY22-PR.O/2O$?&WBI=-\!^'-*\):M*;;7;N5$OPS>9'$9,E<GY@P,@4D\_
M*?6O0[GX=>'7\.RZ5:6$5H[0M&EY$N)U8C&\R#YF.>N3ST/% '645XEXX6UM
M?V@/"IEM3)"]F7FCB@,AD8>;@E%!+'@=NWM35>SO_P!I6R,=H\<+6#2-'/;-
M$2X1_F*L!STYQ0![?17SW=76EZ+\:_&\]YI*7UK:Z9YL5J+3SD$FV [BH!"C
M).6. ,GGFNZ\?>&].T+X3^)HK&!$A<FZBC"\0L2@.STY!/'3.* /2J*\$U&P
M72?@+HOBS2'.GZS9102FZM_D:8,X0K)C[X^8'YL]/K1\0-07Q ?A9J\MO&DN
MI3QM<*%X;+0Y4^JY)P#ZT >]T5SNN:=92ZYX:>2T@9H[MT0F,?*HMY2 /;(!
MQZ@5YWX6M;<?M)>*81!&(H;%9(DVC:C$098#L>3S[F@#V:BN.^*D4<GPRUYG
M16:.U9T)&2K#&"/0UQ'P\L-"\1>&M#TF321'?Q6(OFU!K0QN9%F&W;)@;QUS
MR1T% 'M%%8OB_69/#WA#5M7A0/-:6SR1J>FX#C/MG%<3\+]!L?$?P]BUC7X$
MU/4=6:5[BYN5#O@.R!58\J %R ,8/2@#U"BO /#^NWNL_";QUHVJRM>OH:2)
M;W,WS/MP^WD]P4.#UYK1^'EGX?U[PAH&AW.C_P#$QGLY[DZBUF496CEPI64@
M;SEAP"1@8- 'MU%<W\0(8YOA[XA\R-7V:=<.NX9VL(V((]"/6L#X(Q1K\*-(
MF"*)93,9'Q\SD32 9/? &* /0Z*\B\0:G/XE^.FG>$+IV_L2S@^TS6N<+<R;
M"PWC^)1E>#QP?6H_B+=_\(!XT\*ZMH4:VD5],UM?6L"[([A 4P2HXW ,V&Z]
M* /8:*X/XKSZK+X-OM.T-B+Y[=[F1E)#+!&07QC^(Y  [C=Z5I^"]>M?'7@*
MRO[B.*;[1#Y5W$R@KYB\."/0D9'L10!U-%?/GA^\OOA)J>G?VG))=^#O$$$<
MAD<;A;2L@)R/QY'=>>2N*Z;Q/97]O\/-/NO#.F17ME;:M)=7EA ORW4"RR8!
M"_>7[O'/ '! H ]<#!@"""#TQ2UYM\.O$_A7Q7J\M[HL3:;J$=L8[K3&4(/O
M*?,4#Y3@C!(&3D9Q@5Z30 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!9VEP;/[*L-HY?S"6R9'8JN3C"@8Z#KTQV%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2"*0@=(PS!L].A[5H>)+*74I/'M]H_\ I&G76AI&Q@^9)[I0^2N.&(3:#CU
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M^$JTW_GEJG_@INO_ (W1_P )5IO_ #RU3_P4W7_QNMNB@#$_X2K3?^>6J?\
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M_GEJG_@INO\ XW1_PE6F_P#/+5/_  4W7_QNMNB@#$_X2K3?^>6J?^"FZ_\
MC='_  E6F_\ /+5/_!3=?_&ZVZ* ,JU\0V-Y<I;Q1WXD?H9=.N(UZ9Y9D 'X
MFM6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB@#F/^$_T#^]J?\ X*;K_P"-T?\ "?Z!_>U/_P %-U_\;KIZ* .8_P"$_P!
M_O:G_P""FZ_^-U#=^)=&\1V4^BP7.IP27\;6XE_LRX39O&,[FC"CKU)XKK:*
M ,;4-<TKPU';6EPMRB>6!$MO933 *O&,QJV/QJC_ ,)_H'][4_\ P4W7_P ;
MKIZ* .8_X3_0/[VI_P#@INO_ (W1_P )_H'][4__  4W7_QNNGHH YC_ (3_
M $#^]J?_ (*;K_XW6]I]_!J=C%>6WF>3)G;YL31-P2.58 CIW%6:* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ***YN'QI87%T5AMKN2RW(BWJ1AHRS2-
M&. =VW<I&[&.^<<T =)1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M534]1M](TJ[U&[)%O:Q--)M&3A1DX'<U9C?S(D<HR;E!VMU'L?>@!U%%% !1
M110 452M-4M[W4+^SA#E[%TCF<CY=S('V@]R%92?J*NT %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4?\ "5:G_P!"5K__ 'U:_P#QZ@#IZ*YC_A*M3_Z$K7_^^K7_ ./4?\)5J?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HK,\1:L=#\/WNHK&)988_W,1/^LD)
MVHOXL5'XUHQ^9Y2>;M\S:-VWIGOCVH =1110 4444 %%9.DZM)J>HZO&(T%K
M97(MHI!G,CA%9S] 6V_536M0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %>0ZBUII^N?\)9X,NXXIKP6K3Z?&04U!I)65E* _+(!SD=,-GJ
M37KU54TVRCOWODM(5NG4(TP0!B!D]?Q- %JBN;DA\;&5_*OO#XCW':&LYB<=
ML_O>M,\GQU_S_P#AS_P"G_\ CM '3T5S'D^.O^?_ ,.?^ 4__P =H\GQU_S_
M /AS_P  I_\ X[0!T]%<QY/CK_G_ /#G_@%/_P#':/)\=?\ /_X=_P# *?\
M^.T =/17,>3XZ_Y__#O_ (!3_P#QVCR?'7_/_P"'/_ *?_X[0!T]%<QY/CK_
M )__  Y_X!3_ /QVCR?'7_/_ .'/_ *?_P".T =/17,>3XZ_Y_\ PY_X!3__
M !VCR?'7_/\ ^'/_  "G_P#CM '3T5S'D^.O^?\ \._^ 4__ ,=H\GQU_P _
M_AS_ , I_P#X[0!T]%<QY/CK_G_\.?\ @%/_ /':/)\=?\__ (<_\ I__CM
M'3T5S'D^.O\ G_\ #G_@%/\ _':/)\=?\_\ X<_\ I__ ([0!T]%<QY/CK_G
M_P##O_@%/_\ ':/)\=?\_P#X<_\  *?_ ..T =/17,>3XZ_Y_P#PY_X!3_\
MQVCR?'7_ #_^'/\ P"G_ /CM '3T5S'D^.O^?_PY_P" 4_\ \=H\GQU_S_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXRH&,YXSWK(\(^)]9\07<MI>0V=M<Z8SPZK$L;'][N.P1'?]TJ-VX@YR .^
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MCZM;Z[H-GJMH<P7<"S)[9&<'W'0_2L3X9_\ )-?#_P#UYI0!U=%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>exhibit1061-loanandsecur016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML=?\R,226\IC+*S, 6"G&2NTGT/I3] \*^)M+M_'D5SX9DN/[?FD>U5KF#8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD\5[GH6B6OA[3?[/L05MA+))&G]P.Q;:/89XH TJ*** "BBB@ HHHH ****
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MA>Q%KIUNUOY#RN'D!$@W<)@?ZSISTZUT'C71KSQ%X0U'1[%H$FO(C%OG<JJ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]2NC;*X=A(A$3R9(Q@_<(Z]ZZ"N2\7<^(?!G_86;_P!)IJZV@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>exhibit1061-loanandsecur017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD*6(&<#J:\Q^'?AS7O#_ (P\::EJ6DRQ6VKWAN;4K-$QV[Y6P0'X.''MUYH
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M:V<-P2.K>V:7A+P-'HOQ"U/Q!I^G/I&EW%FL LF9?WDI8,SA5)"J   ,]2>
M* /1*\N^*,7BNTU"WU;PIJ-TLME ;JYL1(S1W"*R@X3.. >0.H]^OJ-8SB\_
MX2Z*0:?,;-;1HS<[X]NXLIQMW;N@/.* .:\->*K'QT^@ZO8W-S"2LJW5FERX
M5)%4':R@X(YR#CD'\*R? .O7OQ(UW7]3N[RZATBRF%M8V=M.\(QSEW9"&9B
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M=QB\\LR"#/SE!U;'I[UY7XG'_&3/A#_L&O\ RN*](E'_ !6MF>_]G3_^C(J
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MJ-M:6K$!999  Q/0#U_"N!^*.DW4GPSNI$T&#4+^2WC:]G)420A I9UR"3@
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M==36I])5> K^?*_1C7&Z?XD?QK\%[NVG+--I&EW/V_</O2)&RP@^N1\_LT=
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M;@2J"=L)D?>P$&#]3WH Z*JSW]I&)R]S$HM\"8EAA">@)['IQ[CU%6:\SN_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@E611'L^?)/<?<;L:VYM5GCUY-+2P+^9;O<+.90%PI4$$=<Y8=L8H YSP_\
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M.2?F/0BNL@>1X4::,12$9*;MVW\:RO$GB?3?"MA!>:G+Y<4]S';(?]ISC/T
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ML_%FD>'3I=P]UJL"SV\@D4(%()^;N"-I[&@#:@T6^CO].NY=6,S6=N]NVZ
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M@'M5JR\=37VAZ?K4/A^\:PO63:ZS1%HU9@NYEW9P"1G&<5V#,%4LQ 4#))/
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ME>12F,@#;CDYSZ"IK'QK#KFIZA9:!8R:@FGMY=Q=>8L</F?W$8Y+'CTQ[\T
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M6,101@*D8)PH'  ST'M2W5K;WUK):W<$4]O*NV2*5 RL/0@\&@#SKXZS1?\
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M&'AC1!K/]L?V=#_:7_/WSYGIC=UQCC'3%!\,Z(=6EU4:; FH3+MDNHUV2.,
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M+$<MN9!]UY<CH>^-K?\ ?0]:F\:^%M0\/2:?\1O"28OK:!#J-JH^6XBVC<Q
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M U0 .@Q2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6FRA(6B82[VC("%,9W9XQBL#X*Q36/PRL[2\@FMKF"28RQ3QLC*#(Q!P0.U
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MK+$?+8KC;C:-P *L-PR.>M=;7C.G>"K+1?B;HVH^!9KJ.RF,AU6W^?R8H\<
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M\RUDE@=%F423'*DC!X8'\: -'4_%7B&W^+FC>$H[N&*TU"Q-S(Q@5GC<+*2
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M6_;]W?C'MUI_@;2YOAUXV\3V>J1R)I>IRK<V-_L)B(!<E&8<*V''7&=IQU%
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M-D^W^69/M6\^;N^T[<[^OW>.O3BO3?ATH_X5WH$IR9)K**21R<L[%022>YH
MZ>BO'M8R/VE-$L0[BTFT]II+<,?+=]LWS%>A/RC\A5#XTZ6OAGP;87%A<W27
MEQJV9K@3N'<.LC%>O"YQ@=.!0![A17*:CX#T^[M-6@MYI[47]ND:^7*W[B1-
MVV1.>#\PR!C('N:X+X<>(KQ] U+P'J29\1VER]L#(-V]&)S*Q/W@@!.>XV#/
M(H ]HHJKIVGP:7I\%C;!A#"@1=[%F..Y)Y)/<U:H **S]:OI-/TN66W57NGQ
M%;HW1I6.U ?;)&?0 GM7"_!OQ->ZMH5_HNLR,VM:/=/#<>8<LREC@GZ$,O\
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MOKG5O,>X$SAL/YC;!SPHX&!Z4 >TT5A:+X?M-.NEU&T,D9GM4CEBWL4)'(8
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M7VL?E) Y&/3TKQ?POK6F1_#/Q*=5U2Y&M&[ECTPK<2>>7"+L5"#G&XC(Z<T
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M:9+>1K>-99@IV([[0Q[ G!Q^1KA-4\!-KG@*\T^_@!UFZC9Y&6]D,/VD_-O
MZ!=W.-O3BNRN-7L[74(;&4S_ &F>)Y8T2WD?*KC<<A2!C<O!.>1ZUFZ+XV\/
M>((KR73=0,L5EG[3(\$D218Y.YG4 8 - &!X?T3Q9IO@/3M#U"&PN;VQN(-L
MJW3!6ACE5P.4SN"KM'&.AS4_Q"^']OXUL[.Z0)!J]BZR02G^)<@M&Q[@]O0_
M4YVX/%^CS_9");B-+UU2UDEM9$2<M]W:Q4 YZCU'/2HI?'/A^'7I-":YN6U2
M-=[6L=C.[[<9S\J'(Y'(H YOQQX/UW7O'7AG6].CLS;:/+YCK/<%&E^93@84
MX^[WJW#X(O-4^(T/C'7Y+=6LH?)L+&V8NJ?>^=W(7)^9C@#CCGBNJTC7=/UU
M+EK"65C;3>1,LL$D+1O@-@JZ@]&!Z=ZT: "D8D*2!DXX'K6!J/C;0-*UV'1+
MRZG34IEWQ6Z6<TC2#GE=J$'[IZ>E7-*\1Z1K:W']G7JSO;-MGBVLLL1]&C(#
M \'J* .2\0^!+GQ?X*GT;4D@M+H:C)=V\T<ID"!YF<_PCG8[#'K5;QAX%U;5
M?%7A"]TB&S2P\/RJQ2:<JSJ&0X4!3T"8Y-=9H_C/0=>U"]L--O))KFQ8K=(U
MM*@A()&&+* #E3W[&D3QGHDD,-P+B86L\@BAN3;2"*5BVT!7VX.3P#G![9H
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M4@O9-IMPN%1@-HZER>OWSS5^'Q7I,^IVFG![N.ZO-WV=9[">(2;5+'#.@7@
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M'+;!,GWX8V/'NO7H<C. "*]-MOAWI-IXAU/6X;J_6[U.-X[L"1 DBL,'Y=N
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M+EU62TYPV9(RS@3;CUW@%R3WZ]Z[C3_#\=@VHM]MN[E[]R\S7)1SG:%X^48
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M6S6TBH4;(.<[2>JCOVK5M]'^SZQ+J1O[N666%(7C<IL*H6*\!1@Y=CG/?Z4
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MYNOL?2@#?\6?$N3PAXLL-*O]'5M.NVC5M16ZXAWLP&Y"G^R3UZ U?^(?CP>
M]'CO5TXZA(S9:+SO*"ID*6SM/\3*,8[^U9/CSPNGBVQ\1:1&1+>PZ;:36_.6
M$J-<%?IN&5_X%7!>)Y-1U']GM=9UD;;VY%K!'NZF*-\*3_M,2S'V(]* /=M&
MOI=3T6ROYH$@>YA2;RTD+A0R@XR0,]?2KU<?I/BW1-)T_P *:->WJQ7^HV,/
MV:/8Q#_(H'(&!D\#/6NPH X_3?&[^(_$.IZ9X>LHKB#3&$=S?7$Q2,RG/R(
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M&X<54NOB!K%GX_T[P?+H%C]NO;4W*RKJ3F-  YP3Y.<_NSV[BN>\+6<NM_M
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M5$=\Q2=&."0QB&"".A'\ZY#XZ,!>>"\D#_B: \^F4KKOBT0/A7X@R<?Z./\
MT-: *5_\1[NQ^%\/C9M%A>.14<VHO2"%=PH^;R^3D],?C4?B;XEW?AKP%I/B
MF31(9X]0\K_1UO2#'YD9<<^7SP,'@5P>NZ>4_9GM;O\ M*\93;V^+=G7RO\
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M;4O\YN#QU;GYS@#\NU<OX^TS6?!NH>'?';6MJMQ8S^7J#VUPSFX\QBS$@HN
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M$7\WP7H4F,;M.MVQ]8UK9H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHZ%RNDV(+@AB+=!N'H>.:\T^*>J>*?!GA%]8M/$=R+N;5#&D?DPF..%O,**
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M?7=C->?:#K^N77QSU[PW<:O/)I5C:"XA@,<8^8B$X+!<D?O&[UU7Q#O[W2O
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M"J/H!4E% #8XTAB2*)%2-%"JBC 4#H .PIU%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45
MYO\ $'QI_P (SXLT*SU.:ZLO#]U'(T]U; [C*,!5) R%'4[>3D=@:NW=[=KX
M&\1ZM8>(FO[9+22YTV[B9"T>R(G:2!AL,.XS@X/(H [NBO(/!.KZKXL\%:?C
MQ9>)XEN;>XN JF(J!'+L&]-G .5';N:U_%'BW4[WXCZ;X$T.Z^Q/+&9[^^5
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MFN)T;P1=^'_#?CV#3+2]73=5A:+2K"3)DW&)E+$'[H+, -V#A1FO7Z* /(_
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MEC!VD/*021D@$,N0>H/J*]ZHH XWX;WGB,^&TT[Q1IDUKJ%B/*$S89;A!PK
M@GGL?7KWXYGPQX?O['XY>(==DT>X@TF]@V6\YBP#(?+W''49(<Y([^]>L44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q_ANWA?QYXSF
M:&-I4O+8*Y4%E_T6+H>U=A7&^';JWB\=^,X9)XDE>\MBJ,X!(^RQ=!77?:(?
M^>T?_?0H DHJ/[1#_P ]H_\ OH4?:(?^>T?_ 'T* .3^*5O#+\-]=DDAC=X[
M1RC,H)7IT/:NPKC/BA>6R_#;78VN(0\EHX12XRQXZ#O6R+G6!XQ-MFTDT<VF
MX[5;S8I0P^\WW<$$X'7@GZ@$NL>']+UTQ?VO;1W=O"&(@G&Z+)Q\Q4\$@#@G
MIDUYHT5SHO@.UTRVEFCTS6?$J6EFI<YCL)).%!/(5E5L?[+UW_BFPU_4D@@T
MB;34MLDW*7JR,)AV3Y"/E]1GGH>,@T[OP[K.O:#+;:Y>V"WT=S%<V4EE"PC@
M>,AD)#$DDD$'GITQUH H2QK9_$]M$M,VMCJFB-)+';_)MDCD"AUQ]UMC%<CT
M7T%)!X5T[2?B3I<OARTCL8X;.8ZHMN-J2(V!"''0MNW,#UPISVK7&AZDVM7G
MB%S9KJS6(LK2+<SPPKN+$L< L2V"< <*![U7T+2_&%E<Q)J%[HC6K2&2ZDMX
M)?/G;'7+-M&2 .G &!C P ,^']O"+76IQ#&)CK=^IDVC<1Y[<9ZUV-<;X!N[
M9;36X#<1"4:W?L8RXW >>W.*Z[[1#_SVC_[Z% $E%1_:(?\ GM'_ -]"C[1#
M_P ]H_\ OH4 <E\0+>$VVB3F&,S#6[!1)M&X#SUXSUKL:XWQ]=VS6NB0BXB,
MIUNP81AQN(\]><5V5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 116MO;LS0P1
M1ENI1 ,_E4M%% !1110 4444 %%%% !1110 4444 1S6\%P )X8Y0.0'4-C\
MZ> %4*H  & !VI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"M/IUE<ES/9V\I<88R1*VX8Q@Y'/%4_P#A&- _Z >F
M?^ D?^%:M% &5_PC&@?] /3/_ 2/_"C_ (1C0/\ H!Z9_P" D?\ A6K10!1A
MT72K="D&F642DYVI JC/KP*O444 %%%% !1110!3GTK3KD.+C3[64.<N)(5;
M<<YYR.>:K?\ ",:!_P! /3/_  $C_P *U:* ,K_A&- _Z >F?^ D?^%'_",:
M!_T ],_\!(_\*U:* *<&E:=:A!;Z?:Q!#E1'"J[3G/&!QS5RBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ***XOQ9J>I67C+PMI]MJTMG9ZE)
M<)<A8XCC9%O4@NAP<T =I17#ZWXDG\)Z%JNKC5&UJ/=%;6<,BQJ1<EBI4M&J
M@K\R$]QM:KVIVOB'3?#T^HPZW)<ZG;0F=H'AC%O,5&2@ 7<H." =V1QDF@#J
MJ*\YOO%=[K!\$7FCZC<6-GKLK)/&L<3E0(RV 70\AE(]*T_#&NZE<>-/$/A^
MYN5U&TTY8GBO1&JLK.,F)]H"EAUX ]Z .SHKB_B'J6KZ#8V.MV.HRP:?;W<2
MZE$D4;_Z.S89P64D$9'X9K7UV>[FN-)LM,U"2VFN9][O$D;_ +A1ES\RD=U4
M$=W% &[17.>-=4U/3/#LJZ&@EUF<,EHC#/S*I=B1[*K8[9*CO5[0M7A\3>&;
M+5;.1HX[R!9 4P3&2.1R",@Y'3M0!JT5R'PUU34M;\'0ZGJM\]U<S33(28T0
M*$E9!@*H[*.N:;J.I:I%\4=(TF+494T^ZLIKB6 1QG+(5 PQ7<!\W//:@#L:
M*P]3DO%\2:/##?S0V\WF^="J1D/M7(Y*DCGT-<YH6I:CJ.L^*+>_\37-O!IE
M_P"3#M2V7$>Q6^8M&<XR>: ._HJAI:W#:/")[XW,CH2+H(JEU))5L8 !VD=L
M9KS,>)_$%OX#UWQ%)XA8W6FZC/;PP3V\/E3K')M5"%0-N8<<-UH ];HKAO&>
MNZM9>%]$U*TN)=-N+N\M(KB+8C;%E(#J=ZG!&>OM6U"9+?5(_P#BI);N..)Y
M+BWF6'A,</F.-2,'U.",^E &_17&^%=0U+QGI/\ ;[:A<:?8W,CBRMK=(\B)
M6*AY"ZL2Q()P, #'7K5#Q=J'B3P]X5:Y;5BMTNJ10I.D,6)()'51E2I (!(S
MQR,]* /0:*P8(YUU>WBB\2SW7RN\UM*D!RF,!@4C!!#%>IP>:PO#5WKNN+XM
MMVUR99[+4I;.RD\B'$855921L^;EN<]OSH [NBN+\'>)9K[X?RZCK%W+_:%C
MYT.HG8@>*6,D, H7'H0,'J.M4/$%]XCT'PWX9>?6YEO[S5+6UO9/)@P%E/SJ
M/DP-O8^W- 'H=%85I'/_ &MY47B2>[5(29H)$@)7<<(X*1C!RK#!R#^%<YX0
MF\0>(M)U.XE\2W4=Q;ZC<VL/^C6YC"QOM4LOE@GWPP_"@#T"BN6\$^)KK7[;
M4;34X8H=6TJ[:TNUASY;D?==<\A6'8UU- !17$Q>+KL?$E=*GC5=&O(I+>RF
M_OW4)S*,^F&*_6,U)XUU'5+'6?#-MI^IS6D6HW_V6<1QQ,=NQFR-Z-@Y% '9
M45QOA?7M3F\9^(O#=].M]%IHADBO0BH^)%SY<@7"[AZ@#CM78NZQHSNP55&2
M2< "@!:*XOP=XLO=8U[6--U.(0N/+OM/7&"]G( %/U!!SZ%L=JI^(/$VJ^'?
MB)8)+=>9X=G2&&Y1XT_<2S-*L;A@ =N8P#D_Q4 >@45P?Q4\4ZGX<\-.VB2K
M%?\ RRO*R!_*A\Q$)P01DLZ@9[;CVJQKM_JMAX[\):5!JTXM-1%T+E3%$2_E
M1AE(.SC)/./TH [2BN.U;4M3@^)NA:5#J,L>GWEK<330".,Y:/;C#%2P!W<\
M_E6[K5IJE]'%;Z;J/]G*23+<I$LD@ Z*H8%1G)R2#TQCG( -2BN5\$:AK%U#
MJ]CK-PEW-IM^]JEZL8C^T(%5@2HX##=@XXR*R;GQ-JNC?%&+3[VZ\[0+[;;1
M;XT!M[EEW(-P )#!6 !SS0!Z!17!?$7Q/JFD2:79:-.()9;R 7DVQ7,<4DGE
MJH# C+'<0<?\LS74:CK^FZ)&XOKF4^3$)9F2!Y#&G(WOL4A1P>3@<'T- &K1
M67=:[IT4<2B[=VN83-#]DB:=S'@?O %5OEY')&.17'^&/$7V_P $^';O5?$-
MQ%=7FI.D<R1@F[(GD58F 7 5@!T Z=10!Z)16/J7BC1](:47MWY:P%%GD$3L
MD);&WS' *IG(^\1U!Z&DO_%6BZ9//%=WFPVYC$[+$[)#O^YO8 A<Y'4CJ#WH
M V:*Y4W]\OQ6333>2-8/HKW MR%VK()D7<"!GH3U)ZTFO:_=GQ9I?A72Y%@N
MKN%[JYNBH8P0*<953P69N 3D#DX- '5T5B'3]8M=2T]X-6FN;+S6%Y%<I'N*
M^6VTJRJN/GVY'/X8Y?\ \)3HPN88#>8\Z8V\4IB<1/*"1L$F-A;((QGJ".HH
M V**Y^;QQX=@U&2PDU$?:HYUMWC$,C;7894$A< $=^GO4-M\0?"UW<V4$&K(
MS7S^7;MY3A'?)&W<5VACC@$@GCU% '345D7_ (GT?37G6[NBBV[*MQ(L3M'
M6P1YC@%4X(/)& 0>AJ#5/&GA_1;J2UO]0$<Z0?:&18G<^7D#<-H.>O;MD] :
M -ZBL5O%>BK>+;&\.YKD6@<1/Y?GD9$>_&T-[9Z\=:J6_C"RO-8US32MU;+I
MBJLEPUNX&2I8D$K@ #;C/7MD8H Z6BL'2]:TZW\-Z5.=5FU!+F-5M[AHB9;H
MX)R$5<DX!)P. ,FG2^,= ATF35)=06.TBF^SRLT;AHY<@;&7&Y3DC@@=10!N
M45E:9XDTK5[ZYLK*Z+W-LJM)&T3H=K9PR[@-RG!^9<CWK3=UC1G=@J*,LQ.
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MO<Q-#(OJK#!_G7)?#O2-9L=/;^WQFYL5.FVK'^."-CB3V+_+]0BFNT5U;[K
MX]#3J .62WFUSQ1>7+2ZE8I81BVMF$/EB3=AI'!="""0B\?W">AK(\$QW/AC
M6-?\/R6FHMI,=R;K3[IK5RK!QNDC!"XX?.,#!R<5Z!10!YO\/=2D\/>!H+'4
M=(UI+N*6X<PKILS$AI7=<$+CD,.]7=8AU&'Q;X9\4R:?</;QVDUM?0V\9EDM
MS(%93M7)8 C!P">^*[NB@#GHKAM9\0V5U;VUW'9V44I:6XMWA+N^T!55P&.
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M5BN8)I$@DLKEX711/&"597(QPV!QV)KO*BAN;>X:189XI&C;:X1P2I]#CH:
M/+M=T[6KGP;I5U?Z?<3:Y>:I9WM[%;0-)Y*(1\O . J@<?WBV.M7M2$VG>--
M6EU#0=7U/2M8BA:"2Q1V"%4V-%*@(V@]<MQR<]\>D4 @C(.0: /.["&[\+>-
MC<3:-=#2[W2[>VMQ90M.MF\1;]R0H) ._P"]TS6-8V.I1>!?"EK+I&HQSVOB
M$7,T1MF+)$)Y'+D ' PP_IFO7:* /.K&:^T76?$6C:CX<O=3@U._>\M)HX!)
M;RJZJ-DC'A-I7'S=NG;.7XUM]7U.S\7Z<-$OC*R1&T^PV^([H!5R[N.78$%0
MA/  P#UKU=I(T=$9U5G)"*3@M@9X]>*$DCD9U1U8H=K '.TXS@^G!% ''1BX
MF^*EIJ'V&\CM6T-X#*\#!5D:9'"EL8!V@GK[=>*B\2:9?:;X]TOQC96<U[!'
M:/I]]! -TJQ%MRR(O\6&Z@<XZ UW%% &3%JO]K)Y5C!>1JZD//<6TD'E\<8$
MB@L<^@P.<GH#Y]%H^I7WPMM?!4VGW4&L6\\,!E,+>4HCG5_/67&TC8">#G)Q
MBO5Z* ./\-131^//&$\EI<Q0W4ULT$TD#*DH2%4;#$8.&!'ZBN,T.S;Q'\(=
M'T*TM+C[6UZKB8P,L<*I=%VDWXV_=!'!R2<>M>PR*7C95=D)& RXR/<9!%96
M@:+9^%=$M]*@NI7MHV(B-RR[LLQ.W( SR3[T <=!:W^FZ=XTT.]TZ[NI=2N;
MJXLI(H&>.X2=,*I<#:A4_*=Q&!@]*ET#2+S1_&^BP7$-S,EGX:2PDO! YC,P
M=#C?C'12?_KUZ LL;R/&LBLZ8#J#DKD9&1VI] 'DFKIJUZ6,FA:DDUGXEAN#
M#:VVV$P+,#YH(QYK,HR3R0<_=%=%8I=V7B_QB\^FWHBOT@F@E6$LC!8 A&1G
M+!AC:,GOTYKN:;')',@>)U=#D!E.1QQ0!Y7H6GZKI-EX!U.;3[UK?3K*6ROK
M<0.9;=G50'\O&YAE<' /!S3?$6B7]QIGC+4;:QO'35[VP-K;+;N9&$)CWR%,
M97.&Z@'"CU%>L44 <3-+-;_$RZU9=/OY;1- "!H[5_GD65I/+7( W;3P/4XZ
MUNP:NVL^$Y=2L;"5II()=EE>)L8R+N4QN.WS J:UW02(R$D!A@[6(/X$<BHX
M5M[58K2+RXP%^2($#Y1Z#\1^= 'F>AQZA+XH\(:A)I&K(L=A<6]SYEMY,5O(
M1%A%3@(@VD XY '+&MOQ3I5]9>--%\7V%I+>I:PR6=[;0C,ODOR'0?Q%6ZCJ
M1TKM9)(X@#(ZH"0H+'&23@#ZYI%EC:1XUD4R)@LH/*YZ9':@#.M=:747065I
M>;>LCW-K);A!])%!)/3@?7W\WL5U:YO?"-[<:!J<$]GJ$WVNVBMO+@MMT<B@
M1J, KE@?,YZ\MSBO7** /,+BSO7\._$F!=.OC+J$\QM$^ROF8-;H@*\<_,I'
MZ]*T-12X;5/ ,RV-\T=FSO<E;60^2#;L@W<<?,0,5W]% 'G=K!>Z1_PF>E7V
MG7EU_:=S-=64D4#2).DL841E@,(5*[?F(&,'I3/#VC7NB>+O#5M=07,RV/AT
MV,MTL+M$)M\9V[\8Z*W/M7H]% 'E]_9WDNF?$R)-.OF?4<BT'V63]_\ Z,L8
MV\<_,"/UZ5I1QW9\:>&+I+"\,<&C30R.]NZJDC>5M5B1P3L;KTKOJ* /)-+3
M5)]5\%W\^A:I!):7%PEY EKY4%J7B=0J(,#9DCY^<YY;M72>-ITMO%_@B:2.
M215OY\K'&7;_ (]WY"C)..O'I7;UD:IX?@U75M+U&6ZN8I=-D:2!8BFTLRE3
MNRI)^4D=: //?$NAWEUIOC?4K73KMUU>:Q2VMEMW\R7R2N^0IC*@\CG&=F>X
MSTVOQ7D'C3P[XBBMKFYTV*">VN$BA9I(/,"E9/+ W$97!P,BNSHH \QU31KU
M]!^(5_!9W177$"65JL#>8Y6 1[RF,KN;/4#@ GK4VK_;+'5?#^N'2-4OM-73
MFLKF"T219[=R48/Y8(8CY<'Z ^E>D44 ><WVAV4]IIIM-.U?0)2]Q<VMW91,
M\MN[;,B9%#9\SDE3_= .#5:>QU:_TW2KN_.IZ3XDM[)S'?Z=:,\;DN?W<L2J
M1\P"/M.,$GIC!]-:2-9%C9U#OG:I/+8ZX%.H \^CBU:?Q5X,N;_3Y8)XM*N(
M[QH(&,4$LBQ87(&!RK=\#%8\6BZG=?"K_A![BPNDUB*98/.,+>20)PXG$N-N
M-OS==V>,9KUFB@#SFXMKK^T_B,WV"]9;VSBCMF%JY$[+;LA"G'/S$#]>E4XU
MU,VVEZ?)HNH)$?#D< FM[8K*\X&&AED.#&HP"!D DGD]*]2HH \MTNVOULOA
MFLNEZA$=.4K=AK9_W7^C-'EL#@;CCGZ].:Z#QJNHV6L>'=?L["XU"VTV>475
MM;+OEV21[-ZK_$5]!S@FNRHH \]UV*^OXM'U_3]#N(;>RU=;R>S,(2XGC*%&
ME,8Y+C=PI^8@?056\1:7=:I=^*]:L[2\\BY\/'388C;.LES.3(<A"-V &5<D
M=SV%>ET4 >;^)Y!;^%_ CR6TZ^5JUB'A,+"12L;@C9C.1CICZ54\5>&-3\1W
M7B?4](MY(O.L+6WACF0Q&[DBF\UN& (&T*@)QGGM7>:YX?@UYK!I[JYA^PW2
M7<0@*#,BYP3N4Y')XK7H XBX23Q#XM\-:U!9WUM#I<5S+=&XMGC8>9&$$0!&
M7.<GY<CY>O(K'TF/5-.^#$=M%HDTU]#,?,M)[0LX4W)8NL;##L%.X#GD#TQ7
MI]% 'E3:;J-W<>/HX--U5EU;1(TM)KM"#*XBF4@Y/RDEE^7 QGH!6A<?:KL>
M 95TO44%G<!K@/:N#$HMV3+ #Y1N('/UZ<UZ+3'ECC9%>15:0[4#'!8XS@>O
M - 'FD=AJ-KX4\7>%[O3;NXO;V>\:SE6!FBN%GR48R ;5(+<[B,8K0T>PN=)
M\>H;B&[E@MO#EO9-=BW=DDEC=BP! Y."#^/K7?44 <G\,[:YL?AYI%G>6T]M
M<P1LDD4T91E.XGH?8BNLHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF/&^K3Z=INGV=K(T5QJV
MH0:>LJG#1JYR[#W"*V#V.*Z>N7\<Z5/?Z;IU[:QM+/I.HP:@(D&6D5#AU [G
M8S8'<@"@":?0=07Q!!<V%]!;::MDUJUOY&7C;YMKQMGY>2N?78/P\J^,NE7>
ME_"O1(M3EM+G4(-26(W%O!Y>4*2D#DD^F?4\U[G#-%<P)/#(LD4BAD=3D,#T
M(KB?BCX*U'QWH5II=C<6ML(;I;EI9V;G"LNT #_:ZY[4 <A9&"/X^6::1&?#
MUF+/%Q9SI]G%^Q#\QQ]&_AYX^X:WYOBU"FF7VO1Z<'T"RU,:=)/YQ\UN!F54
MVXV@L.,Y(YXZ5;O_  )J/B/QYI'B36KJU@ATD V]I9[G+N#NRSL!QG' ':L:
M;X2W9T"_\+0WELNB7FK#4#,2WGQQX&8@N-I/RC#;OPH VM5^(>H6OC:?POIO
MA\:C=?8/MELZ7802>S97"CKSD]O7B.^^(FKV/BC3/#A\,>;J=_I@O%B2] V2
M8;,;$KMP"A^;/3MGBKD/@V^@^*G_  E*2VHL1IXL5@W-Y@ P=W3';&,_C3K[
MPCJ%S\5].\6I-:BTM+(VAA9F\QL[R6Z8_CZ>W6@"%?'>HR:SI_A]=&BBUV;3
MVOKN":Y_=VP' 3<JG<Q/Y ]ZS+GXO1KX1T;Q-:Z2)-.O;H6EV9+C:UF^<$D!
M3N7@G/';UK9U;P?>?\)Y'XMTB2V:Y:P>RGM[EV16!Y5PRJW(. 1CD#J*S[7X
M6P6OPDN?!9N5FGG1I#<,N%\\G<K8Z@ A1ZX'O0 ^#XE23>*=>T#^RX5N=.A,
MMJWVHXO#N"!5^3@[B%[\^N,TNO?$V'1]2U:QCMK:671[6.XO!)=>679L'RXO
ME^8A<G/'88YXG'PWLX_$WAC5HY>-&M&MY0V=UP0 48^N&+,<]\5#-X,U[3?B
M+?>)O#]YI_V?5(DCO;:^5SM90 '3;U/'0D=3Z\ #=0^)<\?BG2]%TO0SJ)U7
M3!J%FXN1&6!5B%8%<+]WDY_ GBM*U\-)K<XU[5])CL]0O-,:SO+3SV;>&QE&
M8'& !V&?F/H*KW7@[4Y_BCI/BK[3;/;V5A]C=&)$DA._+X"X'+]/:NWH X+6
M[:/P!X6TF_LV.S3+B*"?&</;R2;63DDX4N"N22-HYY.>]KE/'=@VOZ;:>'HA
MEKV[A>?'_+."-Q(['_OD*/=A6AIMWK$OB/5K>[%F^FQ",VDD ;>I(.Y)">"W
M&>.@(SUH ;XK\1/X9TR&]6P:\$EU%;E%D"$>8X4$9Z\GI^HK'_X3F^M=0U73
M=3T'[-?6E@VHVZ)=B1+F%3AOFVC:P/48-+\43(/"EOY102?VI9;-_3/GIC/M
M4VH>&=0U6^U#4[@6D=Y+I<FFVL22LR('.7=FV@DYVX 7^'KSP 16GC>]DTVP
MO;O1%MTU3[,FFK]K#&>252Q#?+\@4 G/.1VSQ4MWXTFTZ?6K&\TQ1J.FV!U%
M(H[C*7, SEE8J""""""/3KFH;GP??7/A'P]9+<V\.K:$]O+;RC<T4CQ+L(;@
M$*RYSW&>^*?J/A:_U:76-2N/LD6HWFDMI<$:2LT<2,6+,7*@DDL.-HX7WH C
MC\;:FU[HD+: @36[9I;-A>@D.J!RL@VX5<$G(+' Z9XJGJOC!+GP)KUWJOAZ
M"Y;3+LV=[8-.'B<@H0P8IR/G0\J#^57T\,:JMYX/F+6>W0X7CG E;,A:+RLK
M\OX\_3WJA?>"=8O/#GBO3!+8H^MW_P!KC<R.1$"(P0?EY/[L?G[<@&WJ/BMK
M;7;K1K*VMY[ZWM4N5MYKGRGG#;N(AM.[&WGW('O5?6_&W]GR:FEA91WKZ9@3
MQ&<I)(VT.4C4(VY@K+U(R3BH?%7A.]\4PW%O=6VFD,BFSNC(XGL)<<LA"98
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M#E(_E.2%(ZD#)QZD<EX:T>^\1^"-5T9C;1Z==ZM>++.)&\T1_:6+*$VXR<$
M[N,YP<<]+;^'-4T76]:N=&>S>TU8K,T5P[*;>8+L++A3O4@ [3MY'7F@#)N=
M1L-?\9?#W7+%08[R*\9)&4!]I@SM/T.>/7-1^']5L_#$?C2Y,(V#Q#Y4,$0"
M^9))'"JJ.PRS=?J:TK;P3-I5WX033I(&LM!BEC?S6(>4R)L)  ('.6Z]\<=:
MJW'@.^O].\0VT]U;P2W^J+JEE/$6<P2($VA@0,C]WSC^\?2@#?@\1S1>*(M
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MAE21!C. 5'F9SQG'05._AK7)XO"GGR:>9-&F$DH1W <"(QX7*GGYB<G'I[T
M37GC26/2]4UBRTT7>EZ7-)%<.)]LKB/B5D7:00O/5AG:?;))XQO;G7FTK1](
MBO&?38]1MYY+ORHY(W8@9^4E>A['MTZU5C\'ZI9:;K^AV=Q:'2M7EFD261F$
MMJ)AB10H4AQR2N67KSFKMEX9N]+\6C4K1;7[!#I$6F00M*P<>6Q92?E(QSC\
M,^U &MX9UR/Q+X;L-9BA:%;N(/Y3')0]",]\$'FM6L#P5HEUX;\(V&CWCPR3
M6JLGF0DE6!8G/(&.M;] !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %,FFCMX9)II%CBC4L[N<!0.22
M>PI]<;\1+EUMO#^G@D0:CK=K;7 _O1Y+E?H2@'T)H Z2WU&S<K'&#&6C,Y5H
MRNU"3\S?W<G)&<$\^AQF:WXW\/\ AS3;;4=6O);:TN6"Q2FUE8,2"0/E4XR
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MSQ@ [VST^RTY&2RL[>V1CN98(E0$^IP*K:OKMEHC6*WAE!O;I+2'9$6'F.<
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M3X8HM3D:&WN;:X,@$H&=KJ44C(Z$9]\4 $/@?3H-.T:QCNKT0:/*)K,;URK
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MQ)ST_=15UMO:6UI$8K:WBAC)R4B0*,_04RWT^RM&=K:TMX6?[QCC"EOK@<T
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MH<#FIH+>&UA6&WACAB3A4C4*H^@% &-XR6)? FOK(%$7]FW&X=L>6U2>$/M
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M6FW;Z+K-H,2R?)OVSKW8G;\P/)Z\DUZW56UTRPLI&DM+*V@=QAFBB5"?J0*
M/-?"D7AK7/\ A&]1M]9634XH6CELXEC$LFY,2I<+C<R@@DEN^#DDC.S\)DL(
M_!RQVRVR72W-P+A8PH<8N)0H?'/3IGM790:?96US-<P6=O%<3?ZV6.)59_\
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M /0"G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD:WC.SCG.?E( QG/MS0!W=UXSTNTN)T=;AH+:\CL;BZ1 8XIGV[5/.[^-,D
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MN;FSNXFAO(YHA%<1"Y67=\SA@V,Y!';K0!ZI?7D6GV,]Y/O\J!#(^Q"[8'7
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M>3N&.2,=QTH Z33O'6DZE=:7#%#?1KJD)EM)I;<K'+A-Y0'^\%Y].#@FH/\
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M;;R9$!=Y&"E0FTD-G<.0<=<XP:3Q39KJ'AZXM)-*_M2&9HUEM P4NF]=Q!)
M#*,L.1RHKA+GPGXC&B316OG:C;:=J<%[IEEJLBM)-$J$21,YSQ\QV[N1CGM0
M!OZ[\08--T'7+BWL;DZEI6Q9K.55#1F3[CL0Q!0YZJ3Z5U]O,T]NLK0R0EO^
M6<N-P^N"1^M>?ZQHVH:_X$UR&R\*P:/=7,*+%;$Q++,RL&.YD.T#C R?7.*[
MZSFEN+2.:>U>UD<9,,C*S)[$J2,_0GZT <!!J3:]J_B.74[C5=+MM(NXS%<1
M3B);>-(DD8. Q#;LMG(/! [5U4/BJR?4+6QG@N[2:\B:6T\^+ N%49.W!)W
M$':<-CM7)3^%M6UK3?'FFRVDMC_;$_FV<TCH58")%&=K$C+)Z=#6G+8ZIXCO
M?#-Q>Z7-8/I,QNKK>Z'=((R@2,JQR"6SG@8'J<4 +<?$K3SH][J%AIFJW:6T
M-Q(S"U*1AH20RL[8"GC.#SCMGBL^^U^Z;Q!X'U"47\*W<5R9[2,DB8B#<N(U
M)!Y)QGIWQBI=)T'5F^&?B'19[![:^NS?^0DLB$/YS2,G*L0/O#.>E+%8:U/J
MW@>ZDT2YACTV*9+O=+$3%NA$8SA^?F!Z9XQWX !U>A:]:>(;&2YM$FC,,[V\
MT,Z;)(I$.&5AZ]/SKE+S7I-#^)FJ+(NJWMN=)@F2SM4>?:QDD#,J=%X4>GYF
MM7P587]A+XB-]926PN]7FNX"[(V^-E0 _*QQ]T\&H[BUU'3_ (BW.LIIMQ=V
M5SI<5JK6[)E9$D=L,&88!#C!Z>N* -*T\6:9J.F6%]IK2WHOT9[>&%0'<+P^
M0Q 7:>#DCD@=2*YKQ#XCAUC3/#VH:3>74(_X2&VM+B,,T3 ^9MDBD4'GD=#D
M?@:RSX.U?P^FBZG%H]OK31-=_;].#)\HN)!)F(OA24*@=L_C6MK&DZE=Z/HI
ML_#B6C)K=O?2V=LT2F*)&!8N=P5G.,_+GL.<9H Z/4/%-EI[7W[FZN4T]0U[
M);QAA;@C=\W().WYB%!(!!QR*5/%6GS:M:Z=;K--)=V9O;:2,+Y<T0QRK$\G
MYEX]P>G-8%EIVKZ#J7BB!=,EO[75YVO+66-TP'>,(T<FYAM *C!Y&/?BH)_!
MFJ:5X3\*PZ1+')K.AO&@E?[K(X\N;K_" V['^P.] '16/BVQU'1X=3MK>[:&
M:Z^R(A11)O#E#E2>,,"#GI@GIS6_7$^'?"-UH7BJ]1&SH2E;RU#-EOM+IY<A
M)^BEO<RUU.GW=W=/>"ZT][,0W#10EY%?SXP!B08Z Y/!YXH LSJ[V\B1OLD9
M2%;^Z<<&O/=4LKG3_'7A/1DUK5WMKZ&[-T6O'W2M&BE3D'CDD\8KT:N-U[3]
M2N?B/X7U*WTZ:6QT^.Z6XG5XP%,J*%P"P)Y'/% &?JC77ASQEX5@;4M3O(9?
MMY:+S&D:8!0T:E1PQ7<0">W4\9K0U3Q9HFH^#;C4)Y-5M;5+I;:<0*T=Q#,L
MJC8Q7[OS8!YP0>O-6-=L+^X\>>%[^WL99;.R6Z%Q,KH GF(JKP6!/(["N6O?
M#^O3>"_%-@FC3FZO]<-Y;QF6+YXC-&^[._ X0\'GI0!W=[XCM;.YNH1;W-P;
M,(URT"JPAW?=R"03QSP#@<FM*ZMUN[9X&DEC#C&^*0HP]P1R*X+Q1H.HZCJM
MSJ>CV-]IVNQK&MG?P3((KA< E+A=V"JDMG(Z8QGI7H$CM'"7$;2,!G:F,GZ9
M('ZT ><^ O%&I+]D\.^*9F>[O;876FWQ./M<3+DH2,?O$S@]R.?<]!HVJ0Z7
MH,<EY<7-Q/<7\]M KR&225A-(JHN3V5?884DGJ:IGPE_PD'P]TS2M1AFT[4K
M*&(P3AE,EK.B@!U*DCJ/7D5F+X=\1V^C^%M1FA6ZU;2+^>>\MHG51.LK2!V3
M) SA]P!QUQP: -S5O'5M8Z!KMY#9W#W^CQ[KBQD"JZ97*L><%".=RD\ XYXK
M1C\0C[):[K&[DOIX3,+2-4\S:,9;EMH&2,9.3GBN6USPMJ.O#Q;J4-JT$VHZ
M0NGVEO*RAI"N]BS8) R6"C)['.*CU+3]936-)\0'PJ-2A.GBQN]-E>$S0$-N
M61<DH>200&Z8_  [C1-:L?$.DP:GITIDMILX+*592"05(/0@@@CVK0K.T.!K
M?2XU?3[?3V8E_LL 7;%D\ E>"WJ1QG/7K6C0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>]O[33;
M1KJ^N8K:W0@-+*X5020!DGU) _&K%<YXYU>;0O"L^H0V=M=".6%7CN,[<-(J
MYQCD@L#VZ4 ='17'ZIXNEM?$\^AQ365K=K%'):Q7JL/MV[.X1ON"@CICDY]!
M6UXBUM="TV.X\LR2SW$5M"F"<O(P49 !) R3@<G'% &M17 ZGXQ\0:3I7B&Y
MDTJ.9-.MA<VUV\$MO%,/XD*-E@R^QP0>U:%MX@UL^*8='O(;"-;[3Y+NTDBW
MN8F0J"L@)&X?.#QCH1[T ==17G'A;Q9J2^"]!GOYX[G4-8GE2)EMW;9@R.[,
MJDE@ N %QU X'(GO_&GB'3=&O;F;1HC);:A!;1S2))!'<Q2NJAT1OF!!;!!.
M!C.30!Z!17(/XAUJVU!-'O$LDU)XY+GS+:WGN8TA#!4R@PVXDG)R -OOBH[#
MQ=JEZ='TV?3!I^M7WGM*EPK%(HXB 9 O#,&RN 2.IR>.0#J;/4;'43-]BNX+
MGR)/*E\F0/L? .TXZ'!'%.BO[2:]N+**YB>ZMPK30JX+1AL[2P[9P<5Q_P /
M1<+J/C$77E>>-;;<800I_<Q<@')&>N,G'J:DG\37UMJ?C-(]/LO,T>SAN(GW
M,#."DC8<X[;.![GF@#M**XC3?%>MS:GX;BOK6P2WUZS>6'R2Y>&18ED^;/!4
M@G@=/4]:SM \6:I:>&/MFI3P7EY?:U)IUJHC:,>89W09.X_(%7.!SA<9)YH
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M8 KQC!"G.<'/I0!Z+17%)XHUJ"/3_P"T+>Q235BGV$6RRS-&OE&20R*!DD8
M 4]^3QFJMYXS\0Z?I4DT^C1"6/5(+-)95DA2XBE=5$B*V64\X()XQGF@#OZJ
MW&HV5I<V]M<W<$4]RVR")Y &D/HHZG\*XR_\3Z_;Q>++"46$-_IFFB_M9X49
MT*,K_*RL1\P,9YZ'(..U4KQKJ73_ (;S7LR33OJ$#>8J$$@VLAYR3D^I[^E
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MD'H<KTS74W]]!IFG7-]=/L@MXFED;T51DT -NH;;4[6ZLI)-R,#%,L<A5ER
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MBO'O%OB[4O%/AOQ];64=G%I6CJ;1O-1C+.X)#L&!PH!' VG/J*[KP&I;X7:
MJR^43I<0$G]S]V.?PH V_P"V])^U26O]J67VB/.^'[0F]<=<C.1BK]?/UGXA
MO/!.F)X)^(>A,=),A%MJ\"[EW%BPD]&()W9^\.X-=YKOQ%NH?$&M:7HT,$LF
MD627+"2-Y&NI& 81IL(V_*?O'/)'''(!Z+17GD_CW5=5U=](\.6$*:A%HHU1
MXKY&W%VV[8,;EVGYAEB>/2GS>-];MO&?A30KK3K:V.LVCRW,;Y9[>149BH(;
M!&0.U 'H%17-S!9VTES=31P01KN>65@JJ/4D\ 5Y=:?$_6+CX:>(O$K6EB+O
M2;]K98PK^7(H,8R?FR#\Y[]J->U_Q'?_  ZU36-8T;1WT6?2X;B*W9Y&>1FV
MEE?!&WKD8/'')YH ]3BECGA2:&19(G4,CH<A@>001U%/KQB]U[66U/X8Z=I3
MV=A8ZA:)<"V6)F166$$*?F!9!NX&1R,DGC'3+XYU.P^(&I>&M;6Q@ACT]KVR
MN8XG_?@#)R"_;#<#KM/(H ]!IID19%1G4.V=JD\G'7%5]-:]?3+9M16);UHU
M,RP@A%<CD#))P.G6O'?B9XCOM*\5Z)XMM+I7TS2+Y[&6V1@6<, )7QGV9.>A
M0'O0![917&^,O&DNA6V@#2XH;A];O8;6"XER8HU?'SD @G@\#(SSSQ6-'X]U
MW9XX#PZ>S>&D)1UA<+.<%AGY^.%((SP2#[4 >ET5YKIOCWQ$WA4>+]5TS3XM
M"&F-<E89&\]I@P"K@\!6[=>Q)[4[3_B1>1H+G5+-9;%]&.J&>T@D587 W&!B
MQ(8[<8;C)[<T >D45YYX9\>:KK=_H\4MG$UOJ]G).LL$$A6SD W*DC$X8%>X
MV\CWXY:/XO\ B4^"[3Q0^G:5]F;5?L$MNOF;W&,[E.<+TQSNZ^W(![917GEE
MX_U&S\8^)=%UZ"S\G2=._M%9;,,#L"JS*=QY/S=>.G3GAOAKX@:GK=[H>^RB
M:UUF"9PUO!(18LO*"1R<,&'&1MY% 'HM%>*1?%[Q'_PBT'B&73]*^R#6O[,F
MB02;W&W=N7G"_CG.>V.=V\U?7Y_CO;Z-%>6R65OIC7"1/"Q&&8!B<,,OQP>@
M';KD ] 36M*DC@DCU.R:.>4PPLLZD22#^!3GEN#P.:MPS17$8DAD61#D!E.1
MQP?UKG%\"Z,MFEJ+*T6-;\7^([95"2#;CRQ_!]Q02.3\W<YJNEZVF_%,Z8G%
MKJNG&Z*=A/$X4L/]Y&7/^X* .NHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#\7:!+XG\.S:3
M%>):><\;-*T/F8V.KX W#J5'>MRB@#E/$/A&Y\2VMY8W][;265R490UJ3);,
M  S1-OX)QD<<$GKTK2\3^'HO$NA/IS7,MK*KI-;W,7+PRHP9'&>N"/YTZTU^
M&[\37^A"VGCGLH8YVD?;L=7+ ;<$G^$]<5KT <=>>$];U?POJ.EZOXBCN+F\
M@-N)H[+RXXT/4[ _+'U)P,< <YO#PW=GQ/I6LR:A"?L-G):-"ML1Y@<J2V=_
M'W!Q@]ZZ"&:*Y@2:&19(I%#(ZG(8'H13Z ."C^'5U#X8L=+AUYHKK2KDW&F7
MD=L 8>6^5U+'?D.0>@(QQUS=U/PEJ^L^'S97^OQR7KW$,[SBSQ&HB<.JI&'&
M.1R223GZ8V=.U^'4M>U?2%MIXIM,\KS&DV[7\P$J5P3Q@=\'GI6O0!R_B#PO
M?ZCJMAK6D:N--U>UB:!Y#;^;%/$Q!*,A8'&1D<\5!?\ @^^N+K2=6MM;V:YI
MYDW7,UOOBG23&]&C##"\#&#QCN>:Z^B@#GO#7AZ[T.\UBYN=0CNFU*Z^U,J6
M_EA&V*I ^8\?*/\ $U4N?"%W/J'B>Z74X5&N6B6NPVI/D!590<[_ )N'/IVK
MK*P)_%"+?2P6FFWM]';W:6=U+;*K"&1@IY7.2 '4L0.,^QP 4H?"%W%=>%9C
MJ<)&@PM#M^RD>>&C$9.=_P O SWYJF?AXS:+<Z:^KD*NI-J6G2I;@/:S&0R
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MJI ^]MC7/<QGUK=UW2[O5HK6&"\A@ACN(YIDD@,GFA&#!>&7 R!GKT^M:M%
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M63#7C*?$5OY4OF6@S&VUE+?*P!'S-@8';DXYJVWPJGMH_"$8UV-AX;DD>/\
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MVBVY3"%5!(?>>?E].]2>#/!VK^$K%-,;Q%]LTRV+FTA-H$=<Y(#ON.Y023@
M<]\<5V=,$T33O )%,J*KLF>0K$@$_7:WY&@#RO\ X4S-_P (;_PCO_"0IL_M
M7^T_.^PG.[;MV8\SIWS74W7@J67XA6OBZWU003+9_9+B V^X2+G.5.[Y3]0U
M==10 5R+Z;/J?C"\U^&7R8K336L;*8Q[\RLVYY O\0&$ ]3NKKJ* ,OPZ-4&
M@VHUF83WX#"241"/S!N.UB@^Z2NTD=CFM2BB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N6\:ZO/
MIPT.RAF:W75-3BLY9U.&1"&8A3V9MNT'J,G'.*ZFJ&L:+IVOZ<^GZI;+<6SD
M-M)((8'(((P5(]0<T >>W8CT/Q=XTE75Y[%%T6V=;R<M<M;DM* 0&)+<\@9Z
MG'M4XFO1K^O:/-)J$-D_AY;M89[UWE1]\BEMP8E"0HRJL1Q[FNG_ .$$\.N+
MOSK&2X:\MQ;7#W%S+*TL8R0"68G(SP>H]>*FL_!V@V-\E]#9$W2V_P!E\V6>
M21FCYX8LQW=2,G)QQTH XG0[R:R\/> -&MI'6/5=/,LADO9(R[I#&1&KC)0'
M<3M7'W?3(-M[K6=&O-'\.:AJ_FIJ.K2IY\<S-+!;B(R+ 9#ABQ.!N^]M/KS7
M22^ O#4^@Q:+)INZQA<21*9I"T3#H5?=N7 X&#P.*FF\&Z!/H<>CR6 :SCD$
MR?O7\Q9!TD$F=^__ &LYH Q/"5HME\1?&D*2S2)BQ93-(9&&8WXW,22/J:I>
M-K^Z0>*)+#4KQ[C3=,69(X)3!'8N%=]S$']XSX&%*D +SC=SU^E^&=*T>_N;
MZS@E%W<JBSS2W$DK2!1A=Q=CDCUZU#J'@W0-5OKN\O+#S)KR#[/<XF=5F0 @
M;E#!20"<$C([$4 <GXEU?5+6*/4;I+^71I-+C,MQI<Y6:PF(8M,T2D;U(*GO
MC8>.3GI/&/B"71OA_J6NZ81-)':>; ^,CYL /CN!G=^%6/\ A#]$$?E+;SI&
M;9;5T2ZE"R1#.%8!OF^\W)R3D\\UKR6MO+9M:201M;-'Y;1%05*8QMQTQCC%
M '&7TEUH?B3PJ;"_N[NUU61[6ZBFG:42#RBZRKDG81M.=N 0>G2F_#VPA@U/
MQ;(DER637)8P)+F1P1Y4)R06()_VCS[UTNF^&M*TIX6M8)<V\9B@\V>240H<
M95-[':. ..P Z"I-+T#3M&FNYK&*6-[N4S3EIY'#N<98AF(SP/RH YCXG?/I
MF@HOS-_;]CP.O^LK)\=:K?6MIXJOM,U.[DN-,2%D\J0Q163 !BA .)F;.2"N
M "!D5VY\+:,VO2:VUIF^D:-G<R-M9D4JC%,[=P!(!QD56U#P/X=U2YO[B\T[
MS'U! ET/.D5)<# )4,%W =&QD>M &+=P7FI_$R^TE]8U*"Q;1HK@16\_E[7,
MKKE2!D<*.G/OCBLCPYKNJ7T?PWN;B_G>2_CN8[OYSMGV0N5++T)R <UW</AC
M2;?4#?PP3)=&W%J9!<RY\H9(7[WJ2<]<DGK54^"/#_\ 9-EIBV<L=K8R^;:^
M7=2J\+<YVN&W ')XSCF@#E;?5;G['KMO/K%Y&$\3"SMU0F265-L;?9T8L"N[
M+?-D;1DYK-U75M9MO"/CQ$U"\M9=,O(OLI%P9)(E=(F*>8>2,L>_&< XKNG\
M!^&GM;BW_LW;'/<K=OLGD4B9>CJ0P*MQU7%$G@/PU+#?Q/IQV:AL^U 7$H\W
M: !G#>PSZD9.30!A^)M/OO#%E#X@@UG5[N&SO5N=0@EN2RM;D!9 JK@ +]\#
MV8=.*Z/P_,=1FO\ 5TN))+2YFV6B^863RT&TNHSCYF#'(ZC;4>O+JWV>+2-+
MTM;FVNX7@FO)[H8M@1@%E;+2<$\>V#US6S8V<&G6%O96J".WMXEBC0?PJHP!
M^0H YSXA6>IW?A"]_LZ>T40QF>:"ZA+K<(GS&,D,-H.,'K^%9OC^\;4/@QJ5
MZ\)A:XT^.4Q'JA;:=OX9Q722^%]*GO[F\ECN'>Y(,\1NY?)DP !NBW;#P!VY
MJSJ^C6&O:;+IVI0M-:2X$D0D9 P]"5(./:@"\.@ILK1QQM),45(QN+.0 H'?
M/:L7Q#X9MM=TNUL) ^+>=)HI6GD#Q,N<."#EF&3C<<9Y.<8J_J^D66NZ=)I^
MHQ/+:R8WHLKQ[L<\E2#CVH Y?4M-FU*/7_$$2-'=7&DR6&FIC#LF&?<1URS$
M8'8*#U) YR\Q-\+OAU'9\RM>Z6(]O4,JY;\@&S^-=WI'@W0="OS>Z?9NESL,
M>^2YEEPI() #L0.@Z59M?#FE65W'<P6NUXF=XE,C,D3/G<40G:A.3T ZGU-
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MDXN)#Y:MR0F6^3/^SBGQ^#-"BL-.L8[25;;3IA/:1BZEQ$XS@CYNV3U]3ZT
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M\)'IVHF8V 3:WGB1B)@P3)0ABQ;=C!/M7:?$J6./X;^( [JIDL98T!/+,5.
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MZS87^H7EA;3%KJR$9N(S&RE-Z[EZ@=1Z=.]7Z "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%-DC66-HV+!6&"58J?P(Y% '(?
M"O\ Y)KH_P#NR_\ HUZ[&LBR\,Z5IWA^30K2"2/3I(WC,1N)&(5\[@&+%AU/
M0UHV=I#864%G;J5A@C6*,,Q8A5&!DGD\#J: )J*** "BBB@ KAO%W_)1_ /_
M %\WG_I.:[FN5\0>'Y]6UFVO?[*MKAK+)M9VUFYMGC++AL+&A STZG(H QOB
M8/.UGP1;V?.J_P!N12Q!?O"!03,?]W&W-16EUK_B739M8L-1ALKBUU*97:6\
M?RXXHI64Q20A-O* ').<G.1T&W8Z/J>GWTE]!H&DM>NNQKF?6)YI=O\ =#O"
M2%]@<50/@^4Z_)K0\-:2MY(XEE":S<+'(XZ.T8AVLPZY(Z\]: (X3*OBWXB-
M!/)!*MK:,DL>-RD0.01D$52?4]1M/!7@KQ7-J%V\$45J=67S6VRQ2(%,C#N5
M=E8^HSG(K<_L'4?MFIW8T+3Q/JB".\8:[<CS% P!CRL+@$CY<=:?'H^IQ>'#
MX?70-).EF VWD/K$[XC(QMW- 3TZ<\4 4=8UF[L[.VO8;AQ%K6L1VL1DN&58
MX,, 5;!V^84R"!TD&,$ C,\4IXDT#PKXFG&MM"@\B:RBCN6GFMP7"N#(ZABC
M'D=Q@C-=)J6E:EJ^BMH]]X<T2;3V14\@ZG*  .F"(,@C P1TK-7P=,-"GT9_
M#VGR6=P5:82:]=%Y-OW0S^5N('89P/2@!/$ME?\ A6VMM?CUO5KRUM;X3ZC!
M-/E3;MA6VJH& AP^/3<.F!71^'Y6OY=0U47$DEK<3E+53(601H-NY1T^9@Q!
M'4;:Q]8E\7RV?]C6_AO3Y8;R!X'NVU8R) "N,N'B#/U[9SWK2LE\0:?8V]E;
M:+H\=O;QK%&@U.3Y548 _P"/?T% &/;W-WXGU'Q; =0NK&73)Q:V8@E*>5B(
M,)6 X?<Q/#9&% QUS@-=S>*(/AKJ]^9X;J]F;S1#,T8S]GE.Y0#QGKD=CBNF
MN] U*]U&>_?0]-CN+B(0W#0:W<1>>@Z!PL(#8R0"><<9Q3KS0]1OI].FFT#2
MPVG'-H(=:N(EAXV\*D('3CITXH O>.UV_#GQ(H).-*N1R<G_ %35@:5X6N]?
MT_P9?:A>PI9Z5;0W,$$$1WR2>4H4LQ. !Z <UMZI::WK.FSZ=?:+I<EK.A25
M%UB=-ZD8()6 '!'O3M/M]=TO3H;"TT?3$MH4$<:MK$[E5 P!N: G@>] '.^&
MK?5-1T_6=1N/$>JF6RO]0MHD#IL**Q52P*\D8XZ8]*I6.HZO?Z?\-BVLWL9U
M.%Q=E&7,I^S,^XD@\Y']<9KH[#0]2TVRO;.TT/3XX+V1Y9U.NW+%G?[Q!,1*
MDYYP15>'PM=6ZZ4L7A_3U72<_80-?NOW.1M./W7/!(YSQQ0!B1>(=0TJSOM,
MDU*XDB7Q1'I27D[[I88'1'/S'OR5#'IN'I6UXEMM0T+PQXLN;3Q!=X6R-U:0
MLV^2U*HV<2.68JQ&>>F#BB3PI/-9ZG:3>&M*E@U.3SKM)=;N'$C\?,,PG:>!
MRN.@]*6'PM=PZ'=:/_8.GR6EVNRX\S7;EI)5QC:9##NQCC&<<F@"I*=2U/QC
MHVF?VWJ%M:76@O<2K ZJQ</$-P;&03N//)ZXQFJ.C:KJ;VB:/J&L7=Q/::]<
M6$8B&+C488XRP!<%=FW(+-D?<QU/+[G0_$S>-]+N(M!B2SLM.DM(YHM:D"J6
M92,N4\PX"D8*D<]>*U[CPO=W-K96[^'M,064S3P20ZW<1RI(V=S>8L(8ELG.
M3SGF@#F=2O[Z]^%&OQW\SRR6>NBT0R/O8(E[&%4L>6P.,GDXKUQF"J68@*!D
MD]JX,^#9#IUYI_\ PC6EK:7EP+J>)-<N5#2!@P/$0Q\P!P.,\UL7UMKNHZ9+
MIUUH^FM;2Q^6ZKK,Z,RXP1N6$-S]>: .&\2F_>PC\<6VC7IO+&]&H13[HMK6
M(7:8\;]X#19<C;PS&NH\5:E<7%SX/GTK5;B"TU*_6-C 5Q+$T+N#R#_=&.WM
M6A)::Y+I#:6^C:8UFT7DLO\ ;,^XIC&-_D[NGO67#X2N+>TTVUB\/V"P:9+Y
MMFG_  D%V?);!&1F+T)&#QR: ,:X34TA\>6:^(-6$>B*+BR?S_G5FMQ+AGQE
ME#=%)Q@G.>,:NE:U=>)/$=II5Y<3PQ#08+]A;RM"TTLIP6W*0<+C& <98YS@
M5:;PY?.^K,V@Z>3JRA;W_B?77[T;=N/]5Q\O'&..*1O#=_C3S'H>G0R:?%Y%
MM-%KEPLB1]-A?R<LO X)/2@# M->UIDT6*XOIVEMO%4NCR3AMHNX$60@NHX)
MRJ@G'532>)-6U6UTWXD"UU6[A.FF![5EDR8MT*LP!.2 22>/PQ70WGAV^O='
M@TN3P_I26T$PGA,6LSI)'*"3O#B$-NR22V<G)SUJJ_@R22'4H7\.::T>I!!>
M#^WKH>=M  W$19)XY/4Y.<YH DC6\M?B%'I4FJW]Q::CH\L\J238V2)(BAH]
MN-G#D<8['KS4OPGA$?PVT:7S)G::'<WF2,V#N/3)X_"IUT;5%U>WU7^Q-/-[
M;P&WBE;7;DXC."5(,.#D@'D'H*?H_@^S@L(K.YTN*SAM;M+NVCMM2GF"NI)'
MWE7"@D_(,KR>* .KKAOBX /AY<X&/]+M?_2B.NYK,USP_IOB2P^PZK#)/;;@
M_EK/)&"0003L89P0#0!S_P 5%S\/+_;@,9[0 X_Z>8JR-6UC4O">O>)4@OKJ
M^BA\/_VG''=OOV3!W7(P!A2 "5'''&*[C5=!T[6]*_LS48I9K3<K%/M$BDE2
M"N65@3@@'D]J9_PC>E'5WU1[=Y+R2V^R.\D\CJT.2=A4L5(R2>G>@##TBTUA
M=:TS4DU2)M+N;<K-%)>O<?:6*[DDCW(H0\$D+P1VXJI\1?-_M?P5Y)02?VVN
MW>"1GRGZXK=T'P7H/AJ=I=+M'B8@JH>>218@3DA S$("?3%6M5\.:7K=U97-
M_#+)+92":W*7,D8C<?Q85@"?K0!Q7B30-0T32/&/BYM69-8N;'$36B;%@2-?
ME4;LDDGDMQ[8J;7(=2T72]&O(M?U.62]UBP$RRR*5VNRJR+A<A3Z9[UV^JZ3
M9:UI<VFZA&\MI.NR6,2LFY?0E2#C\:K7OAK2]1L+.RNH9I(+*1)8!]JE!5TY
M4E@V6(]R: .+U#^T[S6_'<']NZE##I]I!/:K#($\MS%(W! Z9 X[]\U9T;7+
MGQ'JND:5?7<T(F\.P:D_V>0PM-+(=K'<I!PN.@./GYS@5U#>%=(:YU.X,$_F
MZI&(KQA=RCS5 ( ^]\N 2.,=:J7G@/P[>VFG6TEG,HTU/+M)(KJ5)8DQC:)
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M;F0N\:DD)NW9VY8\9YR<YH YR"XN]%\:6%N^L7+V=[HLUQ,+E@T<3QF/#JO
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MYIJ^JVG_  K[QYI&L2QIKQN[F5K>;_63+N!A= >64(% (Z!>U 'KTNK6%FL
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBJ6JZK::-9&[O'<1[@JK'&TCNQZ*J
MJ"6)] * +M%9&@>)M+\2PSOITSE[:3R[B&:)HI86]&1@"*UZ "BBB@ HHHH
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MB!=$1)[,)!%U^SB7:Q*G*YX]?>K%M-=ZE\2M"NWO[F)9O#K7301E=@)DA+*
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M>/')-'G.V1A]X9R?6KL?ABQAUNTU6%YXYK2U-I%&KC8(B02I!&3DJ#G.>.M
M'*G4?%.NVNJ7&B7D<5SI^H/:QB:1%A81,%<2KL+?, 3D$8R,8QS+?>)+VP\5
M_8]6N+S3K>>]A&GW<<:R6<T?R;H7;!*N3O&3CM@XZ[$_@+1YM=N-522_MVNB
M&N[:WNFC@NB.,R(.&XZ^O?.35N?PM9W4LWGW%U):S7*74EH[@Q&12&4]-P&5
M4X!P2.1R<@&)X&AN/^$A\822ZA=3A-6,824J1_J8B#PN1CH #C':F^-->O\
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MG1V>"RDNF:WMV;.2B=!U/7.,G&*KR_#O1IHYH6GU 6TEX+U;=;IECBEW[R4
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M<[5Y]J ,3X5+.WP]TVXGO)[AYA(Y\XJ=I\Q\X( )R>3DFNTKG+7P7IUCHO\
M9-I=:C!:B=9D$=VP,>'W[%/9<DY'<'Z5T= !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1T&315/5+"TU*Q:WOX3/:_>D
MAP2) /X64?>'MWP* +:L& *D$'H12UP7PT;3(W\1VFF+/:1Q:B6&ESQ-&;-2
M@ PIZ!RK.,<<X[5WM !1110 4444 %%%>;?$W3+F34]*UC24 U72K>XOXMHP
M9A&T.Z-CU(*,XQ[T >DT5Y]XTUR/Q!\/)!I,["/4=,FO7D4\I;I'N8'W+%$(
M_P!IO2K7AS4)-(\$^%+>RTU&6XTV.6:X=O*@AVQ*2TCA3@L3QQSSSQ0!V]%>
M>7/CC4M2T;PKJ.DVEO&FJZG]EF26X.05,F5#!3\I,1^;'3''/&RWB^X1O$\3
MZ;'Y^@Q)*RBY)68-&9.#LRIP,=#S0!U5,$L;2-&KJ9$ +*#R >F1^!KCIO&]
M^]UI-KIV@?:KC4],.H0JUV(P" A*$E>/O@9]>W<1/X@D@U#Q=);:#:VVKZ=I
M]O<23239\_*2,JL57.%VG'KGMUH [FBN&L/%VJ6>B^$I=3L()(M76"&2\6[/
M[N1XPREE\L<L<C . 2!GFNHL-2EO=2U&#[.BV]I(L2S"7)D?:&8;<#&-P'4\
MY]* -&BO.M4TG3KWXVV"7=A:W"/HDLC++"K@L)5 8@CJ 2,^]%VO_"'?$[P_
M::6S1Z5KR3Q3V"L?*CDC4,LD:]%)S@@8'M0!Z+17(6?C6>;6M(TZ[TH6DFJI
M,T,4D_[^'8I8"6,J-NY0>A.#QSUJCH?C._71=1U#6H;4%=6EL+=8IS@N)?+5
M>4&%&,EN3C)QVH [VBN=T'Q-)J^K:AIL]D(9+54D2>&0RPS(W]URJ_,",$8]
M.M=%0 45F:CX?TK6+RWN=2L8+QK='2);B,.J[RI8X(QGY1S7!_"WPSHU_P"
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M!)F6)FVY]"Q ]JZJX^*CVEYIAN-%>"TO]3;356>0I<*00!+Y97!0D]C^.>*
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M=<&EK@]9@3P%X>T2]M'/EZ?<0VEQR<26\C["N"3PI8,N22-N,\G/>4 %%%%
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M':1OJ17844 <V-%U!/'\^OK]E-J^FK9+&9&#[E=G#'Y<8.['Z^U8,/@G68?
M^D:%YM@;BPU)+QI/-?8ZK.9<#Y,@G./U]J]"HH S=?L;C5/#>HZ?;^4L]W:R
M0*9&(52ZE<D@$\9]*Y^/PQJJW?@Z8FRVZ'"\<X$K9D+0^5E?D_'GZ>]=E10!
MY[/X,U]H-3$-QIX-WKBZH8'D<QS1!54PR?+T.T'.",\$4EWX$UF]TOQ=9RWN
MGI_;4D<\!C1P(W58QAO]G]WCC.<YXZ5Z'10!R5WH>OOXETO7[>333=1V<MG=
MQ2&0(JNZN&0@98@KC!QGVK(M/!&NVNBZ)8FXTZ5].UI]29MSJ'4O(VW[IY_>
M'GMCO7HE% '(:MH/B&W\6-K_ (;NK &[MTM[VUOP^QMA8HZLG.X;B,="*Z6W
MMI!IRV][,+B1D(F<+M#$]<#L.< 9.!CDU:HH X&V\#ZB/",7@Z[GM9=&AG3;
M<AV\]X%D$BQE-NT-P%W;NG.,U8N/"NK32>-"&L@-?B6.#,K_ +K$/E9;Y/\
M@7'T]Z[:B@"CHMI-8:'86=SY?G6]ND3F-B5)50,@D ]O2N=^&,T3?#[2D$B%
MU1]RAAD?O&ZUV%9TV@:-<(4FTBPD4MNVO;(1GUY'7D_G0!H;E_O#\Z-R_P!X
M?G61_P (GX;_ .A?TK_P"C_PH_X1/PW_ -"_I7_@%'_A0!K[E_O#\ZY'Q9-&
MWB?P;&LB%QJKDJ&&0/LTW:M?_A$_#?\ T+^E?^ 4?^%7+?2--M'1[;3K2%HQ
MA#'"JE1[8'% %RN3U^P:U\:Z#XD'_'O#'-8W;?W$DP4<^P=0">V[/0&NLI"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.4:9#*&)<#"X+ \D=14/@^32-5&@VUQH^KQZ]I"A'BN3<+'9L$V,P8G85(&
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MF,+MX^8;@W3OFMG3M3.D>/KZXU2*Y:SU/3K1=/N%@>11Y8;?%\H)#%FW8[T
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MD#)'!*@G!YQ7(:4\^D^&_">HW5GJ)TVQN=0BO4MDD66W\V5C%(57#;0/3L]
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M20;?+DB8@8XWYY4\CK7HE% &1X7TZ^TGPU8V&I7;7=W!'M>9F+$\G +'EL#
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M"Q:VT-E:0VMN@2&&-8XT'\*@8 _(5+110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>^O8=.T^XO
M;ABL-O&TKD#)P!DXJQ6;K6D'6;:& WLUM''/',PB53YFQ@P5MP/RY R!UH \
MVTR[/A[Q]I6J3I>QCQ&AM=3\^UFB2.[)+PX9U . 3$,=E%=GJNM7:^,(M#6Y
M73[=]-DNUNV53YDBN%V#=QA1\Q'7!'(P:N>*O#,'BO1?[,N;J>V3S4E$MOM$
MBLA# J2#@Y%<EXGAF;Q/"E[J&O626]FD<-Y;:<+N*Y8L2V5$3A&&%[#/T H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7& N#CYMPV\\Y%1W'C.2/4M3TV#0=0N+S3[>*XDC5X@&5PQX8MCC:1ZD]N]
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M.MLI^SDIYK %8RX7:&(((4D$Y'K5S4-!TC5;-[._TVUN+=R"T<D0(.#D?RH
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M3Y+_ $Z\E>]NVNRSW0>-TWYV< ;AA/P& *]'M+2"QM(K6V3RX(E"1IDD*HZ
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MD8&>HYKI(=,U _$=];:V"6+Z4EGDR*7$@D9^0.V&QG/7VYKIZ* .8_LO4/\
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MQP(-1\10B". R#;"BP^6F]O7EB<9Z@#.,UUNC13P:+907,7E310)&Z[@PR%
M.".HJ]10!YE:>$_$5MX.\/:+):6K2:3JD-PSQW.1)%'(SD\@8)!&!]<D5JW&
M@ZO)J_C.Y2T0QZO816UKF90=Z)(IW>@RX/?@'Z5W%% 'GUUX3GU#PWHVE:KH
MB7/V+3XXDG@N5CGMKE%"[HWX^4X!SGL/E/;J]-MM2L/"MK:WLOV_4H;58Y9
MV/-D"X)R??N:U20H))P!R35+2]8L-:MI+C3K@3PQRM"S!2,.IPPY'8T 8$_A
M%-=\!6&B:HC6MY:P1"*XB8%K>>-0%D1AZ$>V16:OA/6K2S\(WZ/#<ZKH?F)<
M1%]JW*2KMDVG'#<!AG ['%=_6?\ VWIO]L2:3]J7[=%;_:7AP<K'D#<3C'4T
M <=KG@O4-;T[Q;=*L4&H:S!!#! [Y"+#R-[#C<Q+=,@#')YJS?6'BNT\2P^)
M-,T^QN7NK-;2^TV2[*;-CLR.DFWDC>P(Q],]:ZO2M6L=;T]+_3;@7%J[.JR
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M]_;V[B:,ME9)%0X((P>>N#735C^)- 7Q'80VDEU);I%<Q7.Z-026C8,HY[9
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M0]/U!T"/=6T<S*.BEE#8_6L&\\"6]Q?7DUOJ=]:07M@MA<P1E&$B*&"G<P+
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M^7NQN^1L=>O?&*OIJ/BF7Q%KF@C5+ /:VL-Y#=_8CD!]XV;-^,93KG./7J+
M^'D*63VBZQ>F-M6&K#>J$K*'\S'W>1NY.>?I6JOAMD\0:AK*ZA()[ZU2V=/+
M7:BIN*D=\_,>I- '/:7XSU'7K'0(;:W9+R_TLZA<-;JC%,%4PHD8#!9B><X
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MVS75>/-8O_#_ (*U+5M-: 7-K&'7SHRZD9 / (YYZ_I4,'@I+>/PW&NHSE=
M&VVRB_O!Y9C^?_@)[8YYJ'XHJTOPVUJ"-'DFFA"1QQJ69VW#@ <D]: (H]9\
M0Z5XZTS2M6FL[JQUB*9H#;PF-K:2-0Q4DL=ZE3UX.>PZ5D>$;Z[L?AYI)MIX
M+>.75;N.>63YG5#<3'$28.]R0 !@]2<'%==9Z*+B^M-7N;XWD]O;M%:.8PJQ
MA\;G('5SM )X&!P!DUDP?#Z.UT[2[:VUF\BFTR\EN[:X"1E@92_F*05VD'S&
M[9% %'3_ !MJ$VG);RB/[=-K\FCQ3O$4 5<MYC)G[VP$8X^;'TK1U'6->\/P
M3)>?9[O[3?P6FF2H '828W>8N57*D-C! /'2HI/AO93:;?VCZIJ!>XU'^TX)
MPR"2UN/[Z$*.<^O&#QBKEUX)BU30+C3M8U6^OKF=D?[>=D4L3(<QF,( J[3D
M].<G.: )] N/$3:MJ%OJUFPT]0CV=U(8ED8G[R,J,PX.,' X-+K^H7]OJEG:
MV]U%;030RL62/SKAY!MVJD>#E>26/; Y&<U9T+1+G2T9[_6+O5KI@$$]PJ+M
M0?PJJ  >YY)XR>!B'4O#(OO$=KK<&I7=E<PV[6L@A"$2Q,P;'S X.0.1S0!R
MT7C^[/A/PUK>HJ]E9:A [7U];6YE2WD& FX<[48[N><8 R,YKN=&N)+O1;*X
MEN;>YDDA5FGMO]7(2/O+R>#VK"TCP9)H.F:?86&M7+1644L(2YB21)$<J<,H
M ^[MX.>YSG.*V]"T:U\/:):Z59;OL]LFU2V,G)))XXZD].* .8L/%D]SXO;1
MKR[%A>I>2J+"Y@VBXMANV20R?Q$_*QY/\0P,9KFM.U76- \/:OJ]G/;"S@\3
MW$<UL\)9IEDNQ&?GR-I&_(X/3WP.YD\)BYNK5[V_DN8;2^>_ME>-=\<A+$+O
M'5!N.!C/ !)'%49/ ,4GAZ^T9M4N?)O+\ZA)((TWB0RB4@<8QN [=* */B[Q
M7JV@KK%U#/;D6#VY@M8XS+OC8KO,S#_5DY8+R/NYYJ\?^2SC_L7C_P"E IFI
M?#R+4DUN%M9OH;;6'2:>"-8]HE4*-X)4MCY%^7..*UH_#;1^)TUW^T9Y+A;'
M[#MD1=K+NW;C@#YMW/&!VQ0!F?"__D1H?^OV]_\ 2F6LV[@U>X^*>LQZ->VU
ME.='M29IX#,/]9-@!=PZ^O/T].K\,Z GAK2!IL5U+<1"6256E4!@7<NPXXZL
M:ANO#;OXBDUNRU*:TN9K9;69?+5U9%9F4@$<,"QYY'J#0!S.C>.-4UVVTJR6
MT,6ISQ73WAM@C;#!*(CL$C 8+'/.< 8P<Y'5^&+C7+C2#_PD-FEM?1S/'\C*
M1*@/ROA68*2.HSP0:RK[P!92V>E+I=]=Z5>:67^S7D!#/\_,@<,"'#'DY[UT
M.EZ>=-LQ"]U-=S,=\MQ/C?*Q[D  #H     !0!RNI:O?:['XLM;"YCMH-*C:
MV^:+>9I?*WMNST4!@.,'.3GM6=X:UJ^/A_PSH.FI*)5\/6UW)+$D;, 5"* '
M91C*MGKVZ9S6]=^"E?6-3O[#5KNP758@E]!&B.DK!=H<;@=K8X..OUYJH_P[
M2&VT8Z=KNHV.H:5;"SBO4$;-)!Q^[=2NU@, C(X]Z *=UXNUS1]-T>3Q3;-H
MZS)*MY>01"XCAE5E$>[:6"(ZDD^AP,CK6C_;^J1^(?"%D;FRN+;5+69[B2!"
M0[I$K;D;=C82V1QVZUI?\([-$L(M]5G.V%XIQ<QK*MP7.2[CCYLYQC  )&,8
M%5;7P3:6%SX=DM+N>.+0H9(;>(A6$@=0K%SCK@=L8/Y4 8-WXPUQ]-GO[)[>
M.ZCUS^RQI\L&\[/,"!B P8O@^9U V]N]6+O6?%$NM>*-/M[_ $^$:59P7$,G
MV-B6+)(Q4@OW*=<\#MWK!L/M\MY=7-KK&N6&L33RR'3Y]$68HS,2$\XQ\IC
MSOV@=P*[:+PK(;W5]0EOW6YU>UCM[A$12D>Q2 4SS_$W7- &:/$VIZAI6BWD
M<\%FE_I/VS;%&9IFG*H0JQX/[L;CEOIR*R8]=U?Q!>?#J^6\6T&I13S30QQ;
MD\P6['/)SCDX&>,]ZWK3P#'8S:;+;:S?1&RTX:8VU8_WT"G*@Y4X;_:&#26G
MP_ALM.T"VAUB_671&?[//B/<49"C(1MQC;WQGO0!3E\1^)]3M[G4/#^GFY6V
MOWMEMF\E4FCCD,;DNT@96X9AQCH,'K4'B#5[[Q#X5\;M9W,=O::9'=6(C,6X
MS,D.92Q[#YBJXZ8R<YQ6LG@1;?6;VYLM:U"UTZ_F,]YIL>PQ2R'[Q#%2R!N^
MTC/J*2\\!)+<:Y]BU>[LK36T?[;:QHCHTC)M+J6!*DCKCK[4 ;?AK_D5='_Z
M\8?_ $ 5Q>I>,-?M/"WC*_26R-UHVHFW@)MVVF/;$>1N^]\YYR1[5WNE6 TK
M2;33UGEG6VB6)9)=NY@HP,[0!T]JYJZ\ Q7>E:_ITFJ7 BUNY^TW#*B;D;"C
M"<<#"+US0!+8:KK$'C]M#U&XMKBWGTTWT1BA,9A99%0IDL=PPP.>.E3>-M6U
M#0='AU:S>,6UM<Q?;E>/<?L[,%=EYX*@Y[\ U:7P\?\ A*H/$#WTC3Q61LO*
M$:A&0L&)]<[E'?\ "M._LH-2T^YL;I-]O<Q-%(OJK#!'Y&@#C/\ A+KR'Q/X
MBTN6>.1;>U2;3-D6/-8X5DSG#$2,B\8^]SS3KO4/%<GC ^';34M.B8:2EY]H
M>S9OWGF[&&W?T.#CI@'N>:TX/ ^EP#P\<RN^B!O*=FR92R_,7]26 ?\ W@#5
MS_A'Q_PF!\1?;)/--F+/R-B[-F[?G/7.3US^% ''>(?$&MR^'_B%!]LB@DTE
M0MO+!#M.QH Y')//S8S^6*V7U75M,U?P=IOVFWEMM1\U)R8,/\D#.N#NP!P.
MW;K5J7P5;7"^)8[B]GDCU]=MPH55\O$8C!0X_N@=<\BGGPDSW6@W4VK7,TVC
MEVC9XT_>ED*'<   -IP,8]>: .5O/%OBBWT#Q#K/VK3]FB:J]L85M6_TB)6C
M&,E_EX8G///M6[K/B*_CUW6M.AGBL1IVEK?0R3(&%PQWYSG^!=H!Q@Y;J*=/
MX!BN=!UO2)-4N/)UB[:[G<1IN1F*DA>, ?*O7/>L'Q LLOC&Y-UJFL:9)%%#
M%;O'I O(;C +%TS&X0[FP0"#\H//& #M_"][J&I>&=.O]32..[NH$F>..(QB
M/< =N"S'(SCK^ K7K+\/?VC_ &-%_:DQFN=S8E:$1,Z;CM+(.%8KC(_0=*U*
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ2 EY 3'V5L;3GWR:?8BU@\::C8*]C!;W'AM7:VLI?EWAVQEAC<^W^( <>U
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M (7K<C(S_P (Y'Q_V\-46H:78ZQ\79;34(%N+<^'E+0N3M;_ $ANH[_CWYH
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M&!3:60@[L%3P<9(.#6_J&O:?IDK0W$DC2I%YSQP0/,R1]-S! 2!P>O7!QT-
M$D.BZ7;6<EG!IMG':RC$D*0*$?ZKC!IXTK3ET]M/6PM19,"K6PA7RR#VVXQ6
M;=^,O#]FE@\NI(4OT:2U:)&D$RA2QV[0<G Z=2>!S6G9ZE:7^EPZE!,#:31"
M9)'!3Y",Y(;!''K0!7M_#^BVB,EMI%A"C1>2RQVR*#'S\AP/N\GCIR:6/0-&
MB1$CTBP14C,*JML@"H3DJ./ND\XZ5#9^)](OK^.QAN6%Q+";B%9(7C$L8ZLA
M8 ,.1TSU!Z4D'BG1KFZM;>.[.Z[R+9VB=8YR.3L<C:W'/!.1R,B@"P-!T=5@
M4:38A;<YA MTQ&?5>./PIXT?3%U0ZH-.M!J!7:;H0KYI'3&_&?UK'D\?^&8A
M,7U$[8+G[+,XMY"L,G'WR%PHRP&XX&>_!K2O?$&FZ?-+%/+)NA"F4QP/((]W
MW=Q4$+GW^M $LFC:7+J::G)IMF]^@PETT"F51[-C(J]61J?B?2-',OVZY:-(
M2HFD6%W2'=T\QE!"=1U(X(/0U6O?&N@6%U=VLUZYN+2-99HHK>25E1LX;"J<
MC@Y(R!WQ0!M?8[8Q&+[/%Y9D\TIL&"^[=NQZ[N<^O-1W>FV-^\3WEE;7#1'=
M&9HE<H?49'!K$O/&NGP:KH5G D]S'JZ/-%/# [IY83<""H.225X[ Y..*WKR
M]MM/M)+N[F6&",99VZ#L/J2> .YH AFT?3+F:>:?3;.66=!',[P*S2*.BL2.
M1[&D71=*22WD33+)7MAB!A H,0]%./E_"H;;Q%IMU<7-O'),+FVC$LMN]O(D
MNP]&"%0S X(R >>.M<UX1U&]\5K#K0U*^MC'=W"RVAMR()81(Z(@+*!N&U22
M#G.0?0 '97=G:W]LUM>VT-S ^-T4T8=6P<C(/%0'1=*,TDQTRR\V5-DC^0NY
MU]"<<CVKFKO4-4'Q7LM'35)DTV73)+M[<11'+K(% W%-V,'U[5UMU=P6-L]Q
M<R".).K'W. !ZDD@ #DDT 5)= T:?3ET^;2;"2R5MRVS6Z&,'U"XQFKT,,5O
M"D,,:1Q(H5$10%4#H !T%8<GC308+?4)KB\> :<%:Z2:WD22-6&0Q0KN(/8@
M8J?3_%.CZIJC:;:79>Z$/GJK0N@DCR!N1F #C) RI- %]=/LDN9[E+.W6XN%
M"S2B)0T@' #'&2/K5:W\/Z+:6<UI;:180VTYS+#';(J2'U90,'\:Y;Q3XK4W
M7AU=(U&X1;C6H;:1HX#Y-PFXAU$A7!Y'\+<\]<''1WWBC1]-F\N[NFC F6!Y
M?)<Q1R-C"M(!M4\CJ1U'J* +3Z+I4EK#:R:99/;PG,436ZE(SZJ,8'X4'1M+
M,\LYTVS,TJ[))/(7<Z^A..1[5G/XTT"/5FTLWQ-ZEQ';-$L$AVR/]T$A< 'U
MZ<CFM^@#-/AW1#''&='T_P N($1K]F3" ]<#'&:T5541410JJ,  8 %8\_BO
M1;:[:VENR&6Y6T=Q$YC29L;49P-H8Y'!/<>M33^(--M[LVSRR%UGCMW9('9$
MD?;M5F *@G<O4_Q#UH FCT?3(K]K^/3K1+QSN:X6%1(3C&2V,YQ3ETK3DOFO
MDL+5;QOO7 A42'ZMC-1ZQK.GZ!ILFH:G<"WM8\;I"I;&>!P 35"S\9^'[^_N
MK&WU -<VL7G21F)U+1YQO3(^=<]UR* ->\L;34+<V][:PW,!()CFC#J2.0<'
MBH#HFE-+/*VF61DN%VS,;=<R#T8XY'UK+LO'7AO48WEMM2#1);BY,C1.J>7N
MVY#%0"<X&!SD]*MQ>)M*EENH1-,L]K$)Y8)+:1)1&?XPA7<PXQD \\=: )I]
M T:ZL(["XTFPELXSNCMWMD:-#ZA2,"K\<:11K'&BI&@"JJC  '0 5F6_B/2K
MO2[/4K>X>6SO75+>18)#O)X'&W('N1BJFF:QI@.NW?\ ;<EQ!:W)^T?:!L2T
M(1244[1D8Y[]: +4GA;P]+(TDF@Z6[L<LS6<9)/N<59;1],;3AIQTZT-B.EM
MY"^6.<_=QCKS7+0>(9;OXI6VGPW=V+%M(EN'M9[<P@.)(PKC<H8\$]R.O2MZ
MW\4:1=:C;V$=TPGND:2VWPNB7"KR3&Y 5\#GY2>.>E %QM(TU].;3FT^T:Q;
M[UL85,9YSRN,=>:C;0='9)$;2; K(BQN#;)AE7[H/'('8=JY/Q=XK53HBZ3J
M-Q'YNM6]K(T<!\J=3(%=/,*X/0_=;L>N#CJ]>NK>RT&^GNKV2QA6!]]U&N6A
M&#\X&#R.O0]* )$T?3([B*X33K19X5VQ2"!0R+Z*<9 ^E27VG6.IPK#?V=O=
MQ*P<)/$LBAAT.".OO6/_ ,)7HNG1Z?:7&I22W%Q:B:#,+M)<(%'S85>6.0=H
M&>>E:>D:Q8Z[IT=_IT_G6SEE#;2I#*2""K $$$$8(H ;)H.CS"02:38N))/-
M<-;H=S]-QXY/OUJ6/2M.BNVNX["U2Y==C3+"H=E]"V,XKF;WQ:+Z3Q1I=C]L
MM+K2K;*W/V9O]9Y;/G+*5 P%QGKDX[&G^#_%]AJ.DZ#8W-\\FK76G13$O$X6
M9A&IDVOC:S GD Y% &W:^'-#L95EM-&T^WD1BZM%;(I5CU(('!/K5VZL[:]B
M\J[MXIX\YV2H&&<$=#[$_G6:_BC1X[Z"T>Z97N)C;PR&%Q%)*,Y028V%L@C&
M>H(ZBJGCR^O=+\#ZOJ6G7;VUW:6S31NJ(W*C."&!&* ->QTG3=,,AL+"UM3)
MC>8(53=CIG YIMMHVEV5]-?6NFV<%W/_ *V>*!5>3O\ ,P&3^--T-IY-"L9;
MFYDN9I($D>1U5225!/"@#]*KWOBG1].>875V42"18YYA$[10L<8#N!M4\CJ1
MC(SU% %N#1],MM0FU"#3K2*]F&);A(561_JP&34<GA_1I9[B>32+!YKDJ9Y&
MMT+2[2"NXXYP0",^@J#4O%&CZ1)/'=W3!K>$3S^7"\@AC)(#N5!VC@]?0GH#
M3+SQ;HEA?BQFO";MK?[2D,4+R,\>0,J%4[OO#@9/4]C0!H0Z7IUO>27<-A:Q
MW,@P\R0J'8>[ 9-,31-)CMKBV33+)8+GF>);=0LO^\,8;\:=I6JV6MZ9!J.G
M3B>TG&8Y ",X.#P>00000>A%4I?%>BPWOV5[LA_M0LRXB<QB<XQ&7 VAN1QG
MJ<=: *]SI.J76JQ6K-IT/AR#RI$@BB83LZ'(4\[0FX*>!T&.]=#7.WOCKP[I
M\M]%<7S^98$"Z5+>5S$",[FVJ?EQR6Z#(YYK0N];L+=8$-P[R7,9DA6VB:9V
M0 9<*H/ R.<8Y [B@"S::=8V#2M9V5O;M*VZ0PQ*A<^IP.369JOANVN+#4/[
M+AL]/U.ZA>,7R6REP6'))&"?SK/^'.JW6L^%#>7=Y)>.;VY19I%"ED69E7@
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MV;&/,+@BX!(,;#;\C<'AL4MUXMT.R35'N;TQC2]OVS="^8MPRIQMY! SD9H
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M7#7$5Q#Y\7V6)YR\?'S@("=O(Y]\56;QIX> L"NI))_:$32VGE1N_G*HR=N
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M]N*YV*QU&R\.>,/#=WIMW<W5_<7<EE*D+/%<+.#M)D VH5)P=Q&,9&:],HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* /4J*\G%W<M\.?#?BK3[N>76YKBU\YQ(3]J:20)+$RYP5!9L#'R[1C&*U=
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M5Q7PTTU!X2TC69+F\GO;S3H1,\]R[J<#(PI. ><9 ^O))+O'JR?;O"@CNKJ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ&[M+>^M9+6[@CGMY5VO'(H96'H0:FJ"[O;>QA$MS($4L$48)+,>@ ')/L*
M*ZZ+IJV=U:&T1X;M#'<!\N95(VX8G)(QQR>E6K6V@LK2&UMHEB@A18XXU& J
M@8 'L!51=;TU['[:MVA@\PQ!AG)<$@H!U+9!&,9X-)#K^DW&FG4(;^![57\L
MR!NCYQL(ZAL\;>N>U &C162OB?1&M_/_ +1A6/SQ;,6)79*2 $8'E6Y'!P>:
MEFU[2;::[BN-0MX7LXQ+<"5POE(>C'/0'!YH T:*Q[7Q7H%\L[6NK6LH@2-Y
M-CYVB3[GXGL.N>.M3V^OZ3=65S>17\'D6K%;AV;;Y)'4.#@J?8XH T:P->T>
M^UI7M9%TB>P)#+%>6CR,&'?(<<YZ$ $5G:;XCGU#XE7>E0WHET^/2TN/(,.Q
MHY3(5YR-WW0#SQS5CQQJU]HMCI=S9W:6ZR:I:V]P616#1/(%89/3C/- !8:#
MK&F$FTET9'(VEVM9G;'IN:4G'MFH8/#&H6MX;N!=!CE,AF^6REVB0\%POFX#
M')RP&3DUI6WC'PY>65Y>6^LV<MM9'%S(LF1%Z%O0>_2K_P#:^GF*RE^U)Y=\
MP6V;G$I(R-OKP"?H": .?/AK4C<7MQ_Q(_.OEV73_9)<S*. &_>\@#CZ<5"_
M@VXDBLHWM?#KI8Y%JK6$A$(/4+F7@<#CIQ70Z]K=IX=T.[U:^+""VC+L%4DM
M@= !ZUS-_P"+GA\3>&I!J$4.CW]M<R7".@ #1JA'S$9ZOCC&>* )?^$-G_L]
M;#['X:^R+/\ :5A_LY]HE_OX\SKR?PXZ47O@V?4=6@U2\M/#<U]!CRYWTZ0L
M,=/^6G..V>E=%;:]I5YI*ZI;W\$MBQVK,K9!;.W;ZYSQCKGBI=.U6PU:*26P
MN4G6)S'(%X:-QU5@>5/L: ,.'0=7M]4GU.%]$2]G 66<6<NYP.@)\WD#MZ50
MB\#-"R-'8>&5*3_:%QIK_+)S\P_><=3QTYKJK_5[#2RBWERL;NK,J %F*K]Y
M@H!.!D9/09IC:WIJVMM<B\CDAN4\R!HLR>8N,EE"Y) !&3T&: ,>RT+6-.N+
MF>S?1(9;I]\[K:2YD;U;][R?>EO]%UK4S ;V719C _F1;K27Y'[,/WO!]ZU)
M/$&E16L%RU[&8)X?/C= 6!BP#OX'"\CYCQS2WNOZ7I]ND]U>1QQ/'YH;!/[O
M^^0!PO(Y/ H R-5T#5M<M!:ZH="N[<,&\J6RE9<CH<>;4$GA74)96DD&B,S(
ML;YM9L2*OW5<>;AP.P;-:,WC#2HO$5AHRSB26]MVN4D3)39E0N&'!W;N,=A[
MBK\.MZ;<7JVD5TK3.6"#!PY7[VTXPV.^#Q0!A/X:U.2]DNW_ +$,TLBRR'[)
M-MD=<;69?-PQ&!@D<8&.E5M1\+:Y-;:J]F^@I?:C"8IY&M)1YPQC#DR-Q@D#
M@XSP*[*>>*V@DGGE2*&-2SR.P55 ZDD]!5*VUW3+QYXX+Q&D@02RQD%75#T;
M:0#M.#@]#0!YSH?@'6H-0CNQHGAK0Y8&#)-8O.[MZK@,HVD9!S^7<=(/!UT+
M%;(0Z!]E67SUA^QR[!)G.['F]<\Y]:C\.ZY?^*[N2]LM76"&UU&:&2Q-NK)+
M;HQ0'=@,')&[.['.,5:\<ZOJ>C-H!TZZ6+[?JT%A,'B#@))NRP]&&/I[4 -_
MX1;4-]Z^-#W7RA;MOLDV9P!@!_WOS<<<]N*%\+:@IL2JZ&#8#%I_HDO[@8Q\
MG[WCCCCMQTKKD4JBJ6+D#!8XR??BLR+Q'H\UY]D348/.*-(H+8#JOWF4GA@.
MY&<=Z ,"+P=<0:Z^MQ6OAQ-3<DM<KI\@<D]3_K.I]>M#>#[M[.ZM&AT%K:[E
M\ZXB-G*5E?KN8>;R>G)]!Z5L6_C'PY=SVD-OK5G+)>,RVX24'S""00#]5./7
M'&:H^-O$L6B^&M8DM-0C@U*UM'F3,?F;&VDH&[+N(P-W7MF@"2V\/79UJVU&
M]BT666&+R1,EFXF$?/RAVD/J>N>I]:V].TVRTC3X;#3[:.VM(01'%&,*H)R<
M?B36=#X@L[/0K"ZU2\1));5)G.W)QM!9R%'"@GD]!FEO/%WAW3U5KK6K*,/!
M]I7,P.8N/G&.W(P>^>* )]0\/:1JMW#=7]A%<3P9\J23),>>NWTS[5)8:)I>
MES2S6-A;V\TV/-E2,!WQTW-U/XU<AFBN((YX75XI%#HZG(92,@BLZU\1Z/>W
M @M]0A>1D:5.<"1%.&9">& [D9 H 6W\.Z1:7ANK?3X8Y3(9?E'RB0]7"] Q
MR<D#)R:?;Z'IEI-=S6]HD4MX<W#H2#*?5CGD^]4XO&7AN>:VAAUJRD>ZD,4
M64'S'!(P#TZ@@>N.,U!XN\10:/H6J&#4([?4(+1YD)3?Y9P=A8=%!(P-V,T
M:=KH6E66E-I5O80)I[!E:UV9C(/4;3Q@^E+I^C:=I6?L5JD1*A-V2S;1T7)R
M0HR<#H*9X>NIK[PSI5Y<OOGGLX99&P!N9D!)P.!R:=KEU'9Z)>32:G%I@$3
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M]>U  _A/0)-+DTQ]*MFLGD\XP%<KYF<[AZ-GN.:GT[P]H^D7$UQI^G6UO/,
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MA)$MPUI*B%A,S8)91CCU]Q5[XC6TEQH-@Z6TEQ';ZK:3SK'$9"(EE!=MH!)
M&2>*ZT2(93$'4R* Q7/(!Z''X'\J=0!Q5KID.L_$*\UF&#=I<FCBQG=D*K=.
MTF[ S]X*HP3_ +6.QQ7\$:?J,-]+I>H O:^&W>TLIF;/G!P&1CZ,D3*G_ S7
M8ZI92:CID]I#>W%C)*N%N+<@21G.<C((_2DTO38]*L5MHY99FW%Y)IF!DE<G
M)9B !D^P '   % &7X\M9[WP!K]M:Q/-/+83+'&@RS'8< #N:YQ[E+_Q=X$N
MTMKKR(;2Z#O+:NHC+1QA=V1\N2& SC..*]$HH \<V7MMI\^HII^H3VEEXLNK
MNXM[=)(Y6MY%=1*@&"P!?=QUYKO?"4>D32ZAJND6-["EZT9EN;OS@]PR@C.V
M7Y@ ,#.!G\*Z0R()%C+J'8$A2>2!UXH21)-VQU;:=IP<X/I0!QWB*\:'QKIT
M#6=Q%'+8RJNH6UJTTC,77]P"%(0$#<21V&".37(:%:2-X,\)JM[J6@:S8VD\
M<5W):MY0.Y-\4JL,%6^4CIRAP>*]BIDLL<,;22NL<:C+,QP!]30!Y=<_VE<:
M?IFIB:;P_P"(X=+'[H6S/:7*[F_<,A'!^4$#.X;^AQ0UW)INOK<^)M)U.&SU
M72;5$&GB=TMY45M]NRQ'/5^,CU]Z]0,\(@\\RQB'&?,+#;CUS4E 'G5O9QZ)
MXR\*M;Z5>6NG#2[FUAB5'F,+-)&RHYYVG )^8X&#SQ47AM+VP\0Z7!I=Q/=Z
M)</,\MA?0$3:4VUCE7(!V%CM ;J&X)'->E44 <I\1K+4+[P;<)IL+W$T4T,[
MVZ?>GC2179!ZD@'COT[U3DV:YX_T'6]-\P6EE97(O)FC9 0^S9$<@98$,Q';
M'.,BNU$B&1HPZF10"5SR >AQ^!_*G4 <;\-RRZ+J,<D4T3G5;R4++$R$H\S,
MK ,!P01S5;XF.V/"Y2"XF^SZ]:W,H@@>0I$N[<Q"@\#-=RDB2;MCJVT[6P<X
M/H:=0!S.HZVNL6UQI.D+=F[N;:8+,]M+$D/R$!BS*!G<5&.O.>U<SX2ETG41
MHD5UHFL0ZWH\>V1;LW BLR$VNP9CL((& !G((X !(],ILDB0QF21U1%Y+,<
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M?-A^.,\TQ;H:1K-E=ZU::N^EZAHMK;QSVBSGR98]^Z.1(_F&=_<=0?>O5J*
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M&LD@<@_)G(QCWSVJ#Q$]WJ/C=TL)M%2\L].6*XBN[N:W?]XQ8A7CPSKA1U&
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M[E(DS/HUUN;:,L-\6,^O4U)\-8HX-*UN*)%2-->OE1%& H$IP /2K$6@:O\
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M1U9K]'\YRJ*9EEVGY,Y^7'XY]JV5T;5['Q;JVN6TU@L%_90HZSE\QRQ!\<@
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M+<SV-K'=!Y+P1K(K%N/ND@_(<<'/?%/LO&<6K6^B#3;02W>K69O5AFEV+#$
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M=YP%Q/Y4:HI )+!6.26   ]?2M9?#VNZ?XKU/5M-?3WM]8BB%Y!<2.#!*B;
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M*"!AL9&>G:M/6- \2:[H=O%>3Z;]M6^M[IHXF=88TB</M4E2S$D<D@=1QQR
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MLDL13+184,$.XX##T(]]K09-<U*S\/Z[_;$36MY )KVU>-=G[Q 4$1 W JQ
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M6"](=[0NEU;D<_)G<I((YZCB@!=1U^PTNZTZWN'DWZA.+>W*1LRL^"<%AP.
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M %^/QGH\FFZ-?K).;?6)DALV\AOF9LXW<87H3SZ5T%>0:;_R3/X:?]A6S_\
M:E;/B/Q'J^FO?WEMJ1F%KJMM (;>)#!%$[1J8Y689,AWL?D)QE>E 'HNY2Q7
M(W  D9Y /_ZC2UYN^H76C>,/'VK/>W5Q'ING6UPELVS8P$<S!/NY !ST(ZG.
M:U=//BJ;4M-N!>!M,NK9OM)F,)*N5W1O"$7/7.0Q/&/>@#LZJZEJ%OI6FW&H
M79<6]O&9)"D;.0H&2<*"37GFAZIXDN_ %MXDO/%$,4ES"(RDMH@1&,X7>NU2
MS2%<JJX(+%>/6?\ M?4+RR\?Z9>27#P6-B'M_M*(LH62!R0=F!C*Y&>1G!H
M[ZPO8=2TZUOK<DP7,231EA@[6 (R/H:L5B^$/^1)T'_L'6__ *+6MJ@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)P /4DD ?6K3.J %F"@G ).* ,.[\*6E\]TMQ=7;V=U/'/+9ED\HLFW&/EW
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MM2C@O[I;R2&*YVHDX96WJ,=25&0<CT KK%=7SM8'!P<'.#0'4L5# L.HSR*
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MW,B$KCA2?ER<=.3FK>CV^F7_ (_US1KAM+>TO]'M]]K9X$1;=("!S\S!<?,
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M[Q]XLGFM(I9+/4K>:V)/^J<VZ'<OH22<^OX5L^.+JPB.A6UZ,M<:BH@$LFR
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M71M[25M(@DCG"*)5/[X.Z=RV!U'I4O@P7.F>)(=(U*PL'N/[,+VNK:=\L=W
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MER'2M=_MBUUO6EL-<M-7D955$%VNV7,'DEOF(*;% '7)'>O0O&O/@/Q"._\
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M P+-*)'(QC[S 8_2O2X]-L8;1[2*RMDMI,AX5B4(V>#E<8-%MIMA9E#:V5M
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MCIGFM*YU^S#V]O;":\GNH#<1Q6H&[RN/GR2 !R,9.2>F<&N3GTG699_B"_\
M9,__ !-K5([/$D?[UA;^61][CYO7'%1Z5IVN^'_$&EZHVCW-W;3Z);Z?<PPR
M1^;:S1$D<%@I0Y/(/6@#7^&5]/J/@Q+FXN+FX<WETH>Y9C)M$[A0=W/  &.V
M*Z/4-4M]-\A)=[SW,GEP01C+RM@D@#IP 222  .36#\/;#4-,\-R6NI6+VDW
MVVYE"NZMN5YF<$;2>S=\5'XQLM7CU?0?$&D69U!M,DE6>R5U1Y(I5"DH6(&Y
M< X/7F@#0M_&&E7-B]RK3+(EZ=/:V:/][]I'_+,#H3WR#C'.< FF2^-=)MK/
M59[I;J"32E#WELT):6-2,AL+D%2 ?F!(X//%8^N66O:LNB:]%I;13Z;J(N?[
M-:1/->%D*-D@[/,^8D#.,<9S5/Q#X>U+66\4ZM;:?.LM]HG]EVEJS(KRL2[%
MVRV%&64#)SP?;(!T]CXPTR_U6/3U2Z@DFMC=0/<0&-)HQC<4)ZXW#\\C(YJ:
MR\365[Y3B*XAMIK5KR&YE4"-X1MRV03CAU.&P<=JYZ73M6?Q+X6O%TF8PV6F
MW$%P7>/"2.L852-V3RASC/:LBT\&ZB\-YI^EQWVDZ5J6EW$-WI]W*)(;6X=0
M%\G!) R6)P=N ._  .RC\7Z<=1M[&:&\@ENX7GLS+ ?])11EM@&3D @[2 V.
MU5+#X@Z+J/\ 9;PI>BWU.0PVUS);,L1D^;"%C_$=IQ^7!XK.\*Q:AFT&H>"+
M;3KVQC(FO%$+"5@I7]R5.[+<$YP ,C)K'L- UVW\#^#-/DT>X%WINK1W%U&)
M(OW<:M(2V=^#PXX'- '3:=XWBN)O$#7EE<6EKI5U]G$CJ#N.U#C@GYBS\#TQ
MG!K?L=36]GN(#:W%M-;[=Z3J!]X9!!4D$<=C[5QB:1J$+^,;.[\.OJ-EJ5\M
MR@\V,+/$R1(RC+ AQM8\X' YK4\%Z3J6CW&IV\EQ?2:-F+^STU!P\T?!\Q=W
M4H#M"YYZ]N2 7_&7B%_"_ABZU6.T>Y>/:BJN,*S,%!;D< D=.:GF\00Q31VR
MVEW+?/"9S:1JOF)&#C<V6 '/ &<GG&<'%'X@:7>ZSX'U*QT^'S[MQ&T<6X+O
MVR*Y )XSA3UK.2VU6Q\=/XB.EW,EEJ6GI;S0*R-+:R1LQ7(W8((8YVDX/MS0
M!U&D:O9:[ID6H:?-YMO+D E2I!!P5(/(((((-,U/6K;3+BSMG26:[O79+>WB
M W2%5+-U(   )R2*S?!FASZ)I=[]J7RYK_4+B^:$,#Y/F.2$R.,@8SCC.<5'
MXJ&L'4]%^Q6-Q=Z9YDGVY+25(YA\H\O#,RX7.=V"#T[9! '-X[T1-+L-09KK
MR;V[^Q1@6[%EF#%2K #@@J1[XXS33XZTM=/U:[DM[^/^R2/MD+VQ$L:D;@^W
MNI'.1Z'TKC[/P]K]OH.EV)T*96L_$YOF"31$>1YKON&6'&&&!U//%=3I.EW?
M_";^*[B]TYUT_48K:.*21D*RA$97& Q(^]W'- &Z-:MVETV-8YF;4$+Q;0"
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M!'(@DSMX^[F,\]<'H:;-XN\316GB9?L6E&Z\/DR3/OD"3Q^4)0%'4-M)!).
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MD,88F<!I-HRVT=3@$9Q5BN/'B:2[UWPBJ:?;>3K-G+<I-(2TL)$2OM'' .X
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M&C$?]_Y<*!Z\_E78T44 8'B70+O69])NK+4([2XTZZ^T*)H#-%)E64AE#+R
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M*[ S'T7^$#H![<DG)-NBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "N8\9ZO<::NC6T#K&-1U%+2
M21I3%A2CL ' )4L5"Y SSQ@X(Z>J&LZ)IWB'3)=-U6U2YM)<;D;(Y'0@CD$>
MHYH \_\ $T?B+0/#&O2_VX\:BYM);.*.X::6W1Y5C=6D=0S*3N([CD9XK9L4
MNK7XC:AHCZG?W-E<Z0EV1-.2T<OFLA*$8V C'"X&1Q6H/ _A_P#L-]':TF>S
MDD620-=2EY&4@J6?=N."!@$X&*NCP[IHU@ZMY<_VYK?[*9OM4N?*SG;C=CKS
MG&<\T >:>'[Z70_ASX?%K<7$9U76S833&5F\F-KF7)4$D*2%VY'=L]:W-7N]
M2T?Q'J^D6E_>?8IM!EU")GE,DEK-&VWY7?)VL".#G!!QBNGA\':#!H$FA+8E
MM-D)8P23R. Q;=E2S$J=QSD$<\U,OAK3/L]W"\<\OVN(03RRW,C2O&,X7>6W
M <G@$=3ZF@#A[:[OM-\/^$KNXUS496\1/96]U)-*"L0,+.?+XRK.0%)SGOUY
MK3UZXO/"L$D<>LR3PW^I6L4:7,AW644APP\T[FPQ4@$CY<\=*Z*?PGHEUX;3
MP]<67FZ7&BHD,DKL4"_=VL3N&,<$'BF)X.T)=!N-%>Q$]C<_Z];B1Y6D/&"S
ML2Q(P,'/&!C% ''^*8O$.@>%O%5TNM/!%]D6XLX8[IYYK=EX?$CKNVMQQV/0
MU>N+:^C^(%AI@US4_LFI:9--<)Y_1XWCP4X_=\.0=N/SYK<A\">'H=#N='%G
M*]G= "</=2L\BCHI<MNVCL,XZ\<U>/AO3#JEKJ1CG-Y:PF"&4W4IVH<9&-V#
MG Z^@H X#2_$6IC3](TB:\>;S];O=/-S/<&-Y(X3)Y:&0 D,<*,@9.,=3FIM
M=C\1:'HSQOKTBEM9M/LZQ3F62*&655,;NZ@N/O8SSV.:ZN7P)X<GT:XTF73S
M)9SW!NG1[B1B)B<EU8MN5LD\@CJ:?_PA6@_V3%IC6DK6T<ZW/-U+O:52"KL^
M[<Q&!C).,#TH Y#5A=6TOCO1I-3O[BTCT1;V(S7!+QR%90VUA@A3L4[>G48P
M<5VG@^W6W\'Z.J-*P:SA8^9(SG)1>F2<#VZ5(?#.DMJ%Y?/;.]Q>6_V:X+SR
M,)(N1M*EL8Y/;N:M:3I-GHFG16%A&\=O$,*KRM(0 , ;F)/   YX  [4 >=2
M:WJ6H?#75/&$.H7%OJEI/<2I")#Y4:Q2LHA:/.TY1>21G+9R.*T3:K>?%O2[
MF4W4,DN@R3M&+AQL;S8OEP#T]1T/<5TQ\):*;JXG^RL!<S">>!9G$,L@P=[1
MYVD\#/'.!G-6)/#^FRZ]'K;Q2_VA'$85E%Q( $)!*[0VW!(!Z=J *7C!]6CT
MJ!](A-Q*MRK36J7'DR7$0#%DC?C#=#U&0I%<B-?^TVGARYTR^U2/S/$8LKJW
MO&82Q I(S02 DYP0N#R<8YZUZ#J.EVNJI MR)<P2B:)HIFC9' *Y!4@]&(QT
M.:HW7A'1;S3#836SF(W(N_,6=UE\_.?,\P'<&]\]..E '%ZOXEO]%N_&FR]E
M6"WO=/@B>1MXM$F""1QNSTW$C/&<=N*UO%6F2:=X;\5.NKW$UI<:).4L;AVE
M*.L;;I%=F)P0R@KTSSWK;B\%^'XAJ2_V>'74D6.\665W$P50!NW$\\?>ZYR<
MYJ.S\#Z!8Z1=:7#:3&UNX_)F#W4K.T>"-F\MN"X)^4$#D^M '.:0UYI7B7P=
M"FI7DUOJFER_:()I,Q@QQQ,A1<87&XCCJ.N3S6]XIU62UUKPYI/G-;V^J7<D
M<TR-M;"1LRH&ZJ68 9'. 0.M7T\+Z1'=Z;=+!-YVF1F*T8W4I\M2 ",%L'(
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M;_V=;NKP1_:)-T3*<J4?=N4@],&F#P1X?"ZDOV)\:G$(KP_:9<S*%V\G=G)
MY/4]\T :&AL$\-::S$*HLXB2>@&P5P6DZKJ \0>$'BU*\O+74VNEGNIG*I>
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M9FBWR 8Q\WW@F=O(7/;-0ZY)X@L/!GC74DU75(+>"0G2VD;#B,!<D%AOQN+
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ J.>>&VB:6>6.*->KR,% _$U)5'5-'T_6[9+;4[
M6.ZME<2>3*NY&(!QN4\'&<X/?![4 2VVHV-XY2UO+>=P,E8I58@>O!JS7'^$
MM%TJU\1:]J6EZ;:64 D33XA;0K&&\K)D;Y0.=[E?^V8KL* "BBB@ HHHH *K
M3:C8V\XAFO+>.4]$>50WY$U9KA/%*(WQ6\ L5!(_M#DC_I@* .TGOK2VD2.X
MNH(G?[JR2!2WT!ZU/6%KT:/K'ADLJDKJ3D$CI_HMQ6=I/BV76=;FL+:2R26W
MNYK>YLI=RW$")O"2X)^=6(0\# #]3B@#KJ*X4>.;[_A$HM:-G;^8-5_L^6(,
MV"/M'D[E/8]\&K*^(O$5]XKU;1M/T[31'ITEMOFGN'^:.0$D@!?O #ITXZG/
M !V-%<;IWBW4+S1+LRVUK%K5OJ7]GM9@L5#[@ <]2I0^9G'3/I78C.!D@GOB
M@"*:\M;>2..>YAB>0X17<*6/L#UI;BZM[2/S+F>*%,XW2.%&?J:YOX@Z1;:Y
MX4.GW0(CGO;2/>N-\>ZXC4LI['!/-<N-<O(]"U?P=XG97UBS@#07##Y=0MPP
MVRC/\0Z,/7GUP >GI(DJ*\;JZ,,AE.013JYZ77+R]U_4=&T=;83Z=!%)/)<A
MBI>3<4C 4@CA<EN<9'![<Q_PF6IZ]=>#9M,$5G'?7=S#=VTP+%98HI-R$@C*
M@KGW^4\=* /2*0D $DX ZDUPVH>,]5T^V\5*]I9F]T3RY(H<L!<PNN5(/4,3
ME0!GYEQWK:M=<N=2:V;3A:W,$FG+>.S%D!+_ .K /. V'[$C;WSP ;5I=VU_
M:QW5G<17%O*-T<L3AU8>H(X--@OK2ZFGAM[J&:6W(69(Y QC)Z!@.A^M>=1>
M)=5OM%\!W.EQ66GV^JW.V6V1#M4".1@HQC"_+SZG'3O&VI:IH?B'XAZCIEI9
MRBS-O<S+.[(&5;5695"@\D \GVZYX /4:*XO4?''EWUM96S6EK<7>G)>V8OR
M56[=L_N5?("L,+GJ?G&!3H]4UI_B;>Z>7A:QM]+BN$@52&)=W!YS@ME!R> /
MQ) .RHKB].\8W\VOZ7I=Y;68GU&UFF,,4A+6<L84F*1AD,<-R0 01TYJA:^/
M-:ETC3=8GTNQCL9]4_LZ=$G9I 3.80R\ 8! SGKSTH [ZXN8+.W>XN9HX84&
M7DE8*JCU)/ J(:E8M+:Q"\MS)=(9+=!(,S* "64?Q  @Y'K7%^*-9NM;\+>,
M8M.BM39Z;!<6DIG!+32"+=)MQPNT, "0<D'H.:DTO5I+:]\%Z9_9]K(+O26>
M.Z=OWD92*/*CC@'<,G)Z=* .ZHKSM/'NMC2!K$VEV*64.K'3KE%G9I,>?Y.Y
M/E X)!YZ\\#OJ:MXON[:?Q,MC;0,/#ULEQ,LY(-QNC,A"D?=&T8R0<G/ QR
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M:YO)#%;P1XW2,%+G&2  %4DDGMZD4 5_"FBS>'?"^G://=)<M9PK")4C,88
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M .1T^[\0>)-,37;'4(+.6'4)?-\V\?RUACE96A>'9M!V@?-G=DYSVKT=@2I
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MM$Z!4$CY RPX45NW7@#P[>F^$]K.T=[.+F:$74HC\T,&+JH;"L2HR1@]?4T
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M(H^S>*/^@MH__@LE_P#DB@#;HK$^S>*/^@MH_P#X+)?_ )(H^S>*/^@MH_\
MX+)?_DB@#;HK$^S>*/\ H+:/_P""R7_Y(H^S>*/^@MH__@LE_P#DB@#;HK$^
MS>*/^@MH_P#X+)?_ )(H^S>*/^@MH_\ X+)?_DB@#;HK$^S>*/\ H+:/_P""
MR7_Y(H^S>*/^@MH__@LE_P#DB@#;HK$^S>*/^@MH_P#X+)?_ )(H^S>*/^@M
MH_\ X+)?_DB@#;HK$^S>*/\ H+:/_P""R7_Y(H^S>*/^@MH__@LE_P#DB@#;
MHK$^S>*/^@MH_P#X+)?_ )(H^S>*/^@MH_\ X+)?_DB@#;HK$^S>*/\ H+:/
M_P""R7_Y(H^S>*/^@MH__@LE_P#DB@#;HK$^S>*/^@MH_P#X+)?_ )(H^S>*
M/^@MH_\ X+)?_DB@#;HK$^S>*/\ H+:/_P""R7_Y(H^S>*/^@MH__@LE_P#D
MB@#;HK$^S>*/^@MH_P#X+)?_ )(H^S>*/^@MH_\ X+)?_DB@#;HK$^S>*/\
MH+:/_P""R7_Y(H^S>*/^@MH__@LE_P#DB@#;HK$^S>*/^@MH_P#X+)?_ )(H
M^S>*/^@MH_\ X+)?_DB@#;HK$^S>*/\ H+:/_P""R7_Y(H^S>*/^@MH__@LE
M_P#DB@#;HJCI\6K1L_\ :5Y97"D#8+:T>$@]\[I'S^E7J "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>exhibit1061-loanandsecur018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK74(X+XQ3WHT^1&B"O;7!(4)*"1L.2.>G(YY%;Z:E&^LRZ8L,IEB@6=Y,#8
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M<Z1(AT=9EO,3Q'9NB9%_BYY(Z9XJ6[T#7)_#OCZS329?.UBXD>S!FB^=6B1
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIS1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<YXXO=0T[PT]W81SR+#-$]VMM_K?LP8>;L_VMN>G.,XP<5T=8/BZPOM
M0TJ".R3S1'>0RW%L&"FXA5P7CR<#D=B0#C!X- %'PAJ0UB\O[[3+N6Z\.R1Q
M"TDFD9V,PW>;M+G<%QL&#W#8KK*XW2]&FT?7M?UO2],EAM;JU5QIV]4^T72[
MB7 R0FX;5R<9.21QD]99RS3V4$UQ;M;321JTD#,&,;$9*DC@X/&10!-1110
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M8K^-I93M')VY23^(#!'2NB@O[[2]"O\ 6K?P5'92JB8L5EACFE /S,SK\H4
MY )SP>F: .OGFCMK>2>9PD4:EW8]  ,DUAZ?XPT_4+JV@6&[B:[LS?6IDB&+
MB$8RRA23GYE.T@'GI6C=37=SH$\^G1A;V6U9[9)Q@"0KE0P^N,UP>D:7KZ^)
MO#NKW.@W:O#I\]O?23W432>:WEG/#D;"5;:%QUZ*.: -^R^(>C7R:9+%#?K;
M:C<&VAN9+8K&)=S*$8GH25..OO@\54\>^(D7PAXDCT_[>9K&V=9+NS;:+>;9
MN4%@P8D94G:#@'G%8EIX>U^'P)X9TY]%G^V6.MI=W$8GA^6);AY"<[\'Y6'
M.<TMSH_B*QT/QMX?CT:>]35I+NYLKN*:()^^7[CAF!#*>. 0?:@#T+3IG7P_
M:3E9)I!:HY52"SG:#QD]3[FO/-0\676M^$/#FO!+W3A+KELK+'(0)(3.05(0
MG?\ *H!!')Z"O1='2:/1;&.XA:&9($1XV8$J0 ",@D'\*\XM- \10^!_#VCO
MH<QN-+UB">4K<0X>-)V<NN7'&TC /.<\#J0#M;/Q?IET-5\U;FS?2]IN8[J(
MHRJPRC #.0V#C'.1C&:FLO$EI=ZW)HTL%S9Z@L N5AN%4&2+.W<I4D'!X(R"
M/2N/USPOK6LZGXR$-F8$U"ULQ93S/&4DD@9G*L Q8 D@<CIFMWPLMW<7 N;K
MP?;:#)'$4D?,3/(QQPAC_@X/)QGCCK0!N:AK$%A<V]IY<MQ>7(8PVT(&]E7&
MYOF(  R.21R0.IKC/%OB:WO] T[4=.O+RW-MKMK;7<2ETD0B51)'(B]>.W(.
M1C.:UM:TW4;7QUI?B2SMGO+9+26QNH(V4.BLRNLBAB >5P1G..F:P=0\):K)
M:ZEJD-FS7-WKUKJ0LA(@<0PE!C.=N\A2<9QR!F@#H%\56.NV^LZ9$NH6&HVM
MLTK0W$;02["#MD0^F1U'3OBLK0]6MCX2\!'5+O4C>7:P&*2)WQ-*8B2)6Z,"
M,G!/)%7I])OM1\17_B'[!-#C1VT^WMG9!+,S-O)/S;5 (4#)_O=.,Y$&A:Y'
MX:\ 6;:1/Y^D7,+WJB:']VJ0O&3G?\W+ \9XH Z?4O&FE:7'J$\JW$EKILBQ
M7MQ#&&2!R <'G<<!ESM!QGGO@OO&>G6(N";>]E-K:"]NE2'#00G.&8,0?X6.
M!D\=.E<7?VMS<ZEXFM8O#VJWNB:A>CS_ .SI[<I,R*@D^^P9264JP']W (.3
M5W7(M;\31:HMMI-Q<Z5J&C :9B9(4BE9'W"92P);)7;PRC';DT =#-XN/_"7
MZ9H]K8SSVUY9/>"Y3;@KN0 @$@X&_)X],9YPW2?$.BP6&M7Z75^88=3>&87>
M\L)SL'EQJ>0I+* H'4FLJPTO6[;7O"FHOI$A2#2'L+E!/'FW<F(AF^;D?(?N
M[C6;-X5U^YTG6FCL&@O$\2C6;**::/;<HA0A258[2=IZXYQ^ !VB^*[%;N\L
M[J"[M;VUM_M36TL89WASC>FPL&&>#@Y!ZXJKIOCO2=3N=)BBAOHTU6,O:3S6
MY6.0A=Y3/][;D^G!YJA>Z7?ZSXB77O[-N;=;32I[:."5HQ+-+*1QPQ "A>I(
MR3QP*S+'0M<@TGX>V[Z1.)-'=?MH\Z']V! T>?O_ #<L#QGB@#L;3Q':WMQ;
MI!;W+07$LD,-T%4Q.T>[<.#D?<8#(&<<58U76+;2%M?/$CRW<XM[>*, M)(0
M3@9( X4G)('%<;I7A_4;/Q39ZEIEE>:2D\\K:O9M,KVDH*MB1%#'#EMIXQP3
MGWWO%PUDC2_[,M9KJU%V/M\5M*L<YBVMC8S,H'S;<X(.._6@!LOCO1[?1WU*
M9;M(XKW[!-'Y!+Q3;@NUL9 Y(YS@YXS5BR\7:;=W.I6\JW-E)IT2SSB\B\K]
MR02)!G^'Y6ZX(QR!7"MX:\0)X;UG3HM =6G\0QW\*QW$6#")(W."6'0(1SW_
M #K1\3>%M8\0ZUXE2*TDMK?4-#CLX+F22/;YJN[[2 Q8 [@,X]: +%_KDM[\
M0?!@@34[6UNQ=.5E)2*X00,5)0,>02#A@#ST].IU_P 16'ANTANM0\_RI9T@
M4Q1%\,Y &<=!DUR@'B'5O$'@^_N?#=U:'36G%[OGA*J7AV93#DLN3['':M?Q
M[I^H:EHUE!IMC)=RQZC:W#JDB)A(Y5=CEV Z"@!O_"0Z;J.O:#'-%K5E=S37
M*6T$L3PI(41MQD'1A@97KV-6+[QOI-A#<W,BW3V=M="SFNHHMZ)-D#;@'<?F
M(7(!&3C/6H-?L-1N_&7A.^MM/EEM;&6X>YD$D8\H/"4'!8$\GG -<@8+B5]8
M@/AO5KW0+G5GO,6$]N\4Q1P21N8/@NFXJ._ ..H!L?\ "0MI7Q UV21=5N[;
M^R[6Y2SC5Y#'EI-Q"$@)P!D<=,=:U;GQLAU7PU!IUE/=VNM1/<).@4?NUCW8
M )!SRI.>@SWZ5+2#4+KQ=K&MP:9</IVH:1;QVLN^(&1AO;&TN".''4#O65I.
M@:]IMGX E?1Y'ETB":VO(1/%F,O&%#9W8*Y'."3CL>E ':P>([6YNXH8;>YD
MAEN9+5;E54Q^;'NW@\[A@HPR1@D>XJYJ>J6NDVJSW3$!Y%AC11EI)&.%51W)
M/^)P!7$VWA_48/%L.J:597FDR2W\AU.'SE:TNH?FQ*%W'$C?(> #DG([UL^-
M]'U#4K;2;S3(Q-=:5J,5\+8N%\]5#*R G@-AC@GC(H T+7Q);75W>V(M;J/4
M;-%DDLI%42%&^ZRG=M93@\AN",'!KG/ #7'B/2=+\37=QJ<-XZ2-*AG_ -'N
M [-@>7D@!>,8"GZUH6VG7=QXWG\4O87$*1Z6+&*W<H)9B9/,8XW8 &% R>I;
MM@E_PZT[4-'\":7IFIV;VEW:QE)$9T?G<3D%&([T 5YO$D^I:UXET(65W;QZ
M?:QD72.%.YUD;=D-D#Y5QCGKG%5/ _B^"30/"VG7WV]KR_L4\N[GC)CFE6/<
MR[SR6P"<]#@\YJ9].U:T\8>*+F/2Y;BUU2R@$,T<L8 >-)%*$,P.26&.,8SR
M*S+'0M<@TKX>V\FD3B31W'VT>=#^[ @://W_ )N6!XSQ0!U-SXPTVTEMS,EP
MMG/=?8TOM@,/G9*[2<[A\P*[L;<]ZN^(->LO#6CS:IJ'F_9H<;C%&7(R<#IT
MY/4X%<1X=T/5-)D.A7GA*RNEBN7>#6G\HHT1<L&=3\^\ XP!R0.0.:V/BL2/
MAEK1 R=D>!Z_O4H O6GC?2;G5[C3)5O+.XA@:Z7[9;M$LT*]73/4#\#[5)I_
MC#3]0NK:W6&[B:[LS?6IDB&)X1C+*%).?F4[2 >1Q65J^FZMK7B&SUFSL6LY
MM+T^[6W^UE?WMQ*JA5(4GY5VY)Z'(QGFLG2-+U]/$_AW6+G0;Q7AT^>WOI)[
MJ)Y/-;RSGAR-A*MM"XZ]%'- %^_^)]D/#%YK&EZ7J=U'%:RSI(UL4BRC["K.
M3@$'G'7&>XQ6K-J]E-KWAN*\&IVM_<B9K>$$K$^(R6\S:2K<#(&202#7/6?A
MK6I/@K?^'9=/:WU1X;E$ADEC(<O([KAE8CD,!R1S6E=VFL7_ (D\&ZC_ &+<
M10V1N#=!IH28=\11<X?DYY^7/'Y4 :UUXPTVSE@,R7 LYKK[&M\$!A\[<5VD
MYW?>!7=C;GO5B+Q':W%XD,-O<R1-=/:"Y55,8E3=N4\[A@HPR1C(]Q7&^'M#
MU3297T*[\)65VD=T[V^M/Y10Q,Y<,ZGY]ZYQ@#D@<@<U8C\/ZC%XNCU72;*\
MTJ:749#J,?G*UI=V^6Q+LW'$C +T .2<CO0!I?$NXFLO"B7<%U<6[Q7UJ"T,
MC)E6G16!QU!!/%:5IXOTRYN-3@F6YLI-.B$\XO(C'^Y(.)!ZK\K>XQR*J?$#
M3M0U7PTMIIMD]W.;RVE*(Z+A4F1V.78#HIK$\0^&-6U_Q!XB$=I);6VH:''9
MP74DD97SE=WP5#%L?,!G'K0!TG_"7V$>H-87=M>VER;9KN*.6')GB7[Q0*2<
MC(RIPPSTJ#3?'>E:I:)=P6^H+;2Q1R0S26K*DQD;:J(>A?/&.WTS69HL>IW%
ML[W7@BVTJ\AMW222,P%IG*XVQ%3P#U)8CTYZC//AC7'^%.@6"Z;'_:^CO;S&
MPN9$*7!CX9"P)7# G!/?&<4 =#=>/=*L;;59+R"\@ETK8;RW9%,D:/\ =<88
MAE/JI/O6G/XAL[?77T>2.X^U+:->+MCW!XU8*<8R2<L!C%<AJNBZAXB\#:[;
MVOA:WT2ZNK81Q0,8A+,X.[!9/E"\8&3W)..]N%=;O/'MKKTGAZ[M[0:/+:LD
MDT/F+(9$< @/CG:<8)[9Q0!H:=\0-'U-M),,-\EOJI*6MS+;E8F?!.S=_>(4
M^W&,YXK'^)/B0?\ ""^(#IC:@)+,&)KVS;8L4P(RNX,&.,@' (&<$C!Q1T_P
M]K]MX-\":?)HT_VG2=0CFO$$T/R(JR*2#OP?OC@<]:K7N@^);?P3XH\)1Z+-
M>/=3SRV5['-$(Y$E??A]S!@P)(Z$>^.: ._U/Q):Z5'<%K>ZNOLD(GNOLR!O
M)0@G+9(SP"<#)P.G2L^Z^(&C0W$4%O%J%_)-8B_A6SM&D\V$D %?7[V?P]>*
MP[O3-5L?%U[J3>$H];L=6AA)1GA\VSE1-A5MYP5( .03@@UIV>E:G;_$*QOC
MI2QV$>BFS>6W:,11RF17VJNX-M !&=M '9*VY0V",C.",&LC4?$=KIT]W#]G
MN;E[.!;BY%NJL8D;=@D%@3G8W R>/I2Z5K%S?ZOJMA<Z7+9_8G7RI&E5UN(V
MW8<8^[]T\'G&/6N8\9>'[S4]3N+W3;&^M=9@ME&GZI93HHD;D^5,I;E <$Y&
M,$XYX( V37GT3XB>(_._M.]MX].M9TM8 TNSF7>RJ3A1@#TS[UT1\6Z=(FG&
MR2>^DU"U-Y;Q6ZC<T("DL=Q 'WE&,YR>G6L:#3=9C\7:]?SZ;))%=:5!;QRQ
MR1!994\S< "^0,N,9 K+T73/$UAIWA?3;S1IY+"WTPV]U!%<Q*5N 5 ,C!_F
MBV@\+GW4\"@"_K^MQZI#X)U?2;VX6TOM6A7Y'9!+&T<A*NO?E1P?2KOAV:<_
M$+QA;/<W$L$0LVBCDE9ECW1N6"@G@$\X%<WIGA[Q#;^#_!&GRZ+*+C2=32:Z
M59X3MC42#=RXSG>, 9.!VZ5U.AZ?J%MX]\47]Q82165ZMJ+><R1D/Y:,K<!B
MPY/<"@"AXCU672/B/HCAM0F@FT^[+6=MOD$CJ8]I$8XS\QY_6MG3O&6E:KI2
M7UKYY9KDV?V1XMLXG&28BIZ, "3DX &<XYJIKME?Q^-]#UNWL9;NTMK:YMYA
M"R;T,AC*G#$9'R'IS[5S6H^#]82-]>MM-@N[YM:;4GTF9TP\+1>3LR<KYFWY
ML\C)QDXY .[T;Q!9ZV][#"LT-U8R^3=6TZ@/$V,C."000<@@D&N2?Q"VA?$+
MQ*)DU:_MUL[26.UMD>?R\^;O95SA1P/3/O72^&HI/(GN7T"'1!,5Q;J(_,;&
M?F<I\O?@9.,>^!F?9M2TKQ]J^JII=Q>6M_96\436[Q\/&9,JP9@1G>,'D=:
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MK8,2LJJ2Q R7P21R3G@<4 =7_P (AX9_Z%W2?_ */_XFC_A$/#/_ $+ND_\
M@%'_ /$UG3>(=3TC7M%L=7CM7M]7+1));*RF"<+N"-DG>" 0&&.1TYXUO$MU
M=V7AC5+NPDCCNH+626-Y$WJ"JD],C/2@"A/H7@NVO;>RGTG0H[JY)$$+6T0>
M3 ).U<9. #5K_A$/#/\ T+ND_P#@%'_\37"RRZG*OPRN))(+F^D+,CL&0'=9
MM]XY8D]22.OM6U:^-[R+3[Z+4;>#^TK;5QI2&V1S'(S*KJ^WEN%8DJ,DE<9Y
MX .@'A'PT""/#VD@CH191_X5?N=2L;.XM[>YO((9KEMD$<D@#2MZ*.I_"LCP
M_J^K7NIZC9ZC8E8(-C6UZMO) DZL.5V.20RD>I!SVK*^(9F6Z\(M;1QO<#7(
M_+$C%5SY,W4@$@?A0!VU%<"OCK4=*N-7TW7[*V_M&S-L;=K,N8KA9W\M#@Y8
M$-P>OMFI;WQ7X@TZVUV5],CN(;'3VO;>\:WEMHW*@[HF5\G<,9!!P0>V* .Y
MHKB[/Q7JL>N:/;ZK;V*6>K6$MU$T!<O"T:HS!B>""'[#C&.>M-T_Q=J^HR:)
M>VVF-<:;J94R(EI*CVL;KE)#(WR..F0 ,9X) H Z:_U[2=*E2/4-2M+5W("B
M:54ZYQU/?!QZXJU:7=O?VD5W:3QSV\RAXY8VW*ZGH0:\\T>._N-2\=-?)IU^
MD5XI,$\!V.R6\;)U+8 P.,'GG(H37]9U _#N6RDL[&'54>26W6!B@(MG8+PP
M^4=AZ@'/&* /2:*9-,EO!)-*P6.-2[MZ #)-<1+XWO[?PUIOBN6VMSHMY+&)
M(0&\Z"*1MJ2%LX8\J2NT=>"<<@'6ZCK&FZ1&LFHW]O:(W0S2!1C(&>>W(Y]Z
MDO);%;,RWLEN+488O,P">H.3Q7%V\-Y>_%;7+:ZDM)[/^R[='AD@+!HF>;Y>
M6QGU)!!]!73>(HHX_"&K1(BK&MA,JH!@ >6> /2@"Q;:WI-[,L5KJEE/*W1(
MKA&)_ &K]>(ZM<S3? O0[=]&N8(Q:VF-6?8R6>-I\X"-FD[=E'7G%>D+K\^H
M:V=%T>>V>2"QCNY;N=#(C"0D1@*K+G(4L3G@8X.> #IJ*\]'C_4[FQTAK73;
M5;NXU:32+R*65L0SH'R5('*_)G/7!Z5.VO\ C+_A(%\/K9Z%_:']F?;3*99?
M)W>;LQTW8Q_/KQ@@'=T5Q-QXPU*70=8\0:;;VLMAI<\R- X;S+A(3B5E<'"]
M&P"ISM'3/$J^++N775M4:SBL;W2?[2TZXF1AOQC<K_-V#*>.S>W(!V-%<=X;
M\67GB'1M#ND6VCN;MY?ML)C8>0L61(,%L@AMB\_WLX[5!9^,=5U$:/J%AIK7
M6FZA,JO$MK*KP1-G;*93\C#H2 .,\$XH [BBN/\ #6O^(M=U&[,EIID-A9:C
M<V5P1(YE;R^%*<8Z]<XZ]L<]A0!3DU;38KP6<FH6B71Z0M,H<_\  <YJY7"W
MZJ?C=HYP,_V)<<X_Z:I_C72>(M:30=+%T8S)))/%;PH 3EY'"+T!.!G)P,X'
M'- %7_A"M"%[-=1V]S"T\AEFB@O9HX9'/)+1JX0Y[Y'/>MY$2*-8XU5$4!55
M1@ #H *X;4/%WB#2]/\ $$[Z9'/'I]E]LMKQ[>6VBEP#NC9'RVX8SP<$'MBK
M-OXJU.V\0V-IK$%E'97^G2WL3P%B\)CV%@^>""'SP!C&.>M '47>I6-@\"7E
MW!;M<2"*%99 ID<G 50>IYZ"K5>7^(-4U'7='\':PZ6L=A>:[8S10;&\V-&?
M*$MG!)&,C QGJ<<[-]XQU1X[VZT73C?)97K6IM%M96DG"/LD*RCY%(.[ (.=
MO49P #MZ*XZW\0>(M0\7:KI-G9Z8EMILUJ9))I)-SQ2*6;  ^_CIGCCOG([&
M@ HKG?$.LZCIUVD5LMI!;FVDD%S<@R>9*"-L*QJP8DC)R,X Z5BP^-M5U!?!
M[6-A9J-?MI)&\Z5OW++%OP,#D?SZ<=: .\JK%J5C/?S6$5W!)=PJ'E@20%XP
M>A8=1GWKC[7QS>C2Y8KRVMCJXULZ+&(BPADDX82<Y(4(22,D\8SS2:,MZGQ=
MUH7SV[R?V1;;7@C*!E\V7JI)P<Y'4]!]* .[JJNI6+ZB^G)>0->I'YCVZR R
M*F0-Q7J!R*YWXC7^I:;X2:XTRY2"0W5O$[,A8E'E1"!@C'WNOIGIU&5=KJR_
M%?;9&R:_/AT!I9E81#_2#SM!)/TS^/8@'H-<K+X6\*Z/()Y0UG!<3A!;F_E2
MVDD<\+Y._P LEB>FWGTJAIOCN75='T%T@6"_U2&:5P()+A(A$P1R$3YFRQ&.
M1P3SQ@QW/BO68]%L)]0T2".9M<AT]_/1U5T:10L\2L,C(.0&.01WH [T
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M>5&#()6 W8R07!).> ..*Z >);JT\6:OI.J?9H;>WL1?VDR(V9(LD.6^;JA
M! Z[@>* .HC011J@+$*, LQ8_B3UIU<C+XDU-;F#2BD,.J_8%O+@BSFGCC+L
M55-J'/56RQ/;@'/&UX<U&]U;0+2]U+3I-.O9%/G6LG5&!(_(XR/8B@"U%J5C
M/?S6$5Y!)=PJ&E@20%XP>A8=1GWJU7GMVVJ1_%+6FTA+/[3_ &);-NNMVP8E
MF[+R<].HQ[]*N6'CF35]/T/[+"(+S4M/-\^;>2X6%054C:F"<LW!R!@'O@4
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MIZ->6,,Z0/<PO%YCQ[PH8$$XR,]?6KU% '$'P/J<W@N#PG/KT TU+=+61X+
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M&W#$]/85H4 <A/X4US4_#6I:9K'B-+JXO+9K59DLA&D:,,,VP/\ ,Y]<X&.
M.<RS>$9[K5]'O;G4()(K"RELY(1:D><L@4,<[_E^X.Q[UTT,T5PA>&174,R$
MJ<C<I*L/P((_"I* . B^'VJPZ1IFCCQ%$VGZ5?175F7LLRA8VW+&[;\,!TR
M#5V+P9JEAK-_+I?B)[72=1G:XN;,VP=UD;[YBDS\F[KT.#TKLJ* ,#2_#]QI
MWBC6M8:^CECU,0_N!;E3%Y:E1\V\YR#SP*E\+KK*:7(NMW@O)Q._E3_9O(+Q
M\8RG\/.1] ">36U10!S>J>&;R]\4QZS::J+8&Q:QFA>W\SY"V[=&=PV-VR0P
M.!QQ69I/@2\TP>%@=:BF70$E10;/'FJZ;,??^7 ^O/MQ7;T4 <)/\.YKBROU
M;60EY+K']LVEQ%:X^S3X P5+G>N!C''4UJZ7X<U*V\5SZ_?ZK;W$L]E':20P
M6AB7Y&9@02[$?>Z'/]*Z:LB[U^&S\3:;H<EM.9=0CEDBF&WRP(P"P/.<_,.W
M?K0 WQ5H)\2^'I],6Z^RR.\4L<WE[PK1R*ZY7(R,J.,BJD/AS4$\6C7Y-5@D
ME_L[["8OLA )W[]V?,]>WIWSS6MJVJVVC6'VNZ+;3(D2(OWG=V"HH]RQ IFE
M:G-J)NDN--NK&6VE\LB<#;(, AD8$AEY_ Y!H Y&'X<WMEHFBPV&O_9]6T=Y
MC;7JVGR/'*V7C>,N<@\<Y&,"M34O">HZKI-E;7.MJ]W#?PW\MPUKE7:-@554
M#C8ORCN3U[G-=710!@:9X?N;#Q7K&M/?Q2IJ20J8%MRIC\H$#YMYSG<<\>E:
M6L6,FIZ->V$4RPM<P/#YC)O"[@03C(SU]:NT4 <C>>"9;SP?I&CC5F@O](\E
M[/4(8,;'C7:K%"QR"I((S@YJW!HNOK9JUQX@CFU'S49Y/LFV QJ&'E^6'[[B
M2=V<X] *Z.B@#RGQ3H5MX7L-,2"[M+6:_P#%%K>;5CV0Q-P#M3=]WY03R,DG
MIQCJM0\$P:\NK2ZO<^9<:A:):+);IY8@C1BZ[<DY;>=V3Z 8XYZS&:* .1A\
M(ZE?Z+>:7XHU]M5AGMFME\JV%O@'^-L$[GX&#P!SQS5G0O#VL65NMOK/B ZG
M%#$880EL(3@C&Z0[CO;''8<DX)Y&UJ=Y+8:=-=064][)& 5MX-N]^0.-Q ]^
MO:K= '#Q^ []/"VBZ(=<B9=)NX+B*4V7WEA;<BD>9UXY.?H!6UKOA>WUW4]&
MOYI6CETZ9G.P?ZY"O,9_V2P0GK]W'>MZB@#EM?\ "U_>^(+;7M$UG^S-2C@-
MK*9+<3Q3P[MP5ER.022"#W-=!I]K)9V4<,UR]S*,F29P 78G).!P!D\#L,"K
M-% '.GPY=CQ9J&NQZC"/M5DEFL+6I.P*S,&W;QGESQ@=JPX?AW?:?IF@C2_$
M MM5T>%K9+O[)NCGA8@E)(R_/(!R&ZUWU% '*ZEX4O\ 4K32%EUI6N;'4$U"
M6:2UW"9U! 4*' 1<'&.>@ZG)-G3?#EU8:YK^I-J,;C5V1A&EN4,)2,1C#;SG
M@ ]!S5K7_$$/A^*RDGMIYDN[R*S5HMN$:1@H+9(.,GMFM>@#D8_"=S'JD>MW
M-_;G5;:PEM5N[>R*M,6"X>1=QW[=N0OJ3]!M>'1JBZ#;+K,XGOQN$DPB$7F#
M<=K%!PI*[21V.:U** .7\2>$Y_$MOJ%A=7EL^G7@7;'+:[Y+9@,%XWW<'N..
M#SSR##>^#[V36=4O+#5TMH-4LH[6ZCDM_,?**RJR/N '#\Y!_P .NJAK6J)H
MFB7NJ2P33Q6D+32)#MW%5&3C<0.@/>@#DU\ ZA8IH=SI6OK;:II=B-.>=[3?
M'<VXQA6CW#!!&00W7-7-4\&WUS<:7J>GZZ]MK=@)$:[F@$J7"2'+H\8(XR!C
M!XQ73V%VNH:=:WJ*52XB255;J P!P?SJ'6=331=%O-3E@FGBM(6F=(=NXJHR
M<;B!T![T <]JW@Z^OXM-O+?7I8->T^1Y$OS &1]X =#%D#80% &<C:#DG)-X
M:)K'V:#S=9BN9RSF[$]IF&=64+L"!OD P".3WSG)K8TZ\34=,M+Z-61+F%)E
M5NH# '!_.K- '(V'@R72=+@TVSN[1K'_ $DW%E<6A>"3S7#@*N_Y53D <\$_
M6H;#P#_8DFBW6D:AY5YIMJ]D[3Q%TN(6;>4*A@5PW*X/'0YJU)XZM8M"U_56
MTZ^\O1;A[>XB_=[R456+#YL8PP[Y]JZ:"43V\<P! D4, >V1F@#D+OP))/91
MI#J4<5VVKIJ]S.UJ7$LJ,"%"[QM4!5'4G ZYYK2U_P /W6N)<VTEU:/875J(
M)+:YM#(%<%OWBG>,'YAQ_LCD5T-% %73+%-,TJST^-WDCM8$A5Y#EF"J "3Z
M\5QMW\/K^XAU"WCU]4M[C55U6(/9[W202*^UFWC>ORX& I'') Q7<>=%Y_D>
M8OF[=^S/.W.,_3-9EYK\-EXETS1)+:<RZ@DKQ3#;Y8\L L#SG/([8YZT 9+>
M#[QKGQ/,=6B)UVW2 YM#F';&8\\.-V02>@Y_*J\'@B_TV^TG4=,UF&*_L]/3
M3;@RVA>*YA3[I*"0%6!YR&_2NUHH P?"?AZ;PWID]G-?"\\VZFN0XA\O;YCE
MR.ISR?:N?UR=S\7M"BM;RUBN!I=T"LPW;LO'A<!@03C(^E=]1@4 <5>?#_SM
M/5[357M-;347U-=12$$><XVL#&3RFS"[<] .3SF;4O"6K:OH<=I?:_')>_:X
M;EY_L?[L>4X=42,.,#(Y)))R?;'7T4 8&H>'[F^\4Z+K0OXHQIL<R&'[.3YO
MFA0QW;_E^Z,<'\:QKGP#=W/AGQ#HS:S"!K-Z]VTHLC^ZWE25 \SG[HYSZUUN
MH7DME!')#93WC-*D92';E0S %SDC@=33M0O!I^G7-XT,DRP1M(8XL;F &3C)
M S^- &1'X>NAXT7Q#+J$+#^S_L+6ZVQ7/S[]P;><<]L'C\ZQH/A_=V_A/3M$
M36T+:7>Q75E,UIPHC<L%==_S?>()!7MP.<]7HNIQZWH=AJL*/'%>6\=PB/C<
MH=0P!QWYJ]0!QTWA#5[?Q#<:KHWB,V7V]8Q?PR6BRK(Z*%$B9("-@ ="/8U-
M_P (C>6'B:36=%U9;;[7;Q6][#=0&<3>6,)(#N4AP.,G(/I75TV1S'$SK&TC
M*"0BXRWL,D#\S0!B^$- D\+^%[+1I+P7?V52HE$7EY!)/3)]:W*R_#FNP>)=
M M=8MH988;D,527&X ,5YP2.WK6I0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/>+;GR+73X1?3V
MSW%]'&(K8?O;KJ3$K;EV9 R6R, 'UKH:SM9T+3M?MX8-2MS*L,RSQ,DC1O'(
M.C*RD$'D]#WH X.PO?$<^B>(;6S=KBZLM=\J&UEO2))( D<C0K,><X+8)^F<
M5)'K%_J.@M-H<.I33VVJ$7VD7MTT-TJB+YH4D+9."5D&#R.,]:ZJ/P5X?A,[
M0V+0M/.MP[13R(?,48# AN#P,XQGOFIV\+Z4R*/)F5UN#=><MQ(LAEV[-Q<-
MN/R_+@G&..E '%3:X;G0/#5UI>HZI&K>(H[6YANF*S*&E8M#+G).WA>O('>I
M_$%SK<U]XMM8I-26\A@A;119;]NXIGYMORY,F<[_ .'';FNLF\)Z+<6UO;R6
MKF.WN?MD>)Y%;S\Y\PL&RS9).3FN0O\ PM->>)=3NM0\,75T]S.##>Z?JQMU
M\L*%02*)$.X <G#>W&!0!8DMM3?QSI&CW6M:DL,VBS27*13[=TBR1C(8 $'Y
MCR.<=ZS]-U+Q%/X,TV:#[3J[6=_=Q74"W1BNKF".1XU97!!9E^0D9&[BNQTS
MPM:VS65Y>-//J=M;M;K<&ZE8B,G.S.1NQP-Q&3M!/-/M_!^BVD4,=M!<0B&6
M2:,QW<P*N_WSG=GGN.E !X0U&UU3PU;W5I<7<\3/(,W@(F0AV!1\\[E^[^%;
MM9*>&=(C?3W2TVMI\LDUN1(WRNX.]CS\Q.XDEL\G-:U '#?$GAO!V/\ H9K/
M^4E2_$:,R0>&D21HF;7[0!U RO+<C.1GZUT.K^'M,UU[1]1@DE-I,L\&V>1
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M.HWH!N+#GD8&<]*JCQIX8(0C7].(?RPN+A3GS/N=^^#BO/M$TJ?29OAS9ZE
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MT(DC&C3PEFCW(':1"%)Q@$J&X],T =+<>(='M9XX9]2MHWD957=(,$M]T9Z
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MYPQR,'MG'&>H%%IX_P!.N-:L=/E00C4(GEMI1.CCY%W,L@4_(VWGG(X/.>*
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ML_8Y8=1NK"ZLI3+!-!M;!*E2&5@5888CIGG@UFP>.K/48H&TFWDO))M/&HK
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MPKN$B-G#KC)['@\5J6GBVQNM/O=4 VZ3:0B8WP8-'(-@=@N.3M!P>.O'4$
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M%Y9I'-LF9&\R)]P5@4)'52"*EU77'L+Y+*WL)KJ<VTETS9V1JB$ @N>-Q+#
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M[/EESD)G_97:G_ : (KC6+J_\8S^';*X%H+6Q6ZFG$8=BSL550&XP-I)XYR
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MMW8)SCY0.,D^_O6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\X]:Y?7--LKS2?B=>S1+)<6ER9K:0DYA=;:,AT_NMD=1SVH ]:>2_&K0QI#
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M&Y$A )QTX/!X.#D8ZTP^.?#RZ-=ZM)>R1VEG-Y%P9+:5'BDX^5D*[AU'4=Z
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M&B:4+2>T&F60MISF:'[.NR3_ 'EQ@_C5"PU.PD\0ZVJ:O/(]K'";FUF79%:
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M[1I9AME<PJ6D'HQQR/K3K;4;:\N[NV@9VEM'$<P,;*%8J& !(P>"#P3U%6J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N2^(=M<7>@V<5K:SW$BZE:2E88BY"),K,3CT -=;10!QL*S1_
M$[4]1:SNQ9OI$,*S?9GVLZR2,5'')PP_E7->&H=8TW1?"&GW6B:@D$5I/%<R
M6]OBXCEW#;&6.#&C#DL",D+R #7J]% 'D>B:=J=OH'@>TN-'U"*73M7FDN0T
M);8A\X!LC/&77Z]>G-.\0Z=J-SIOQ!A@TR^D?4+NV:T5;9_WP5(E8CCL4;\O
M>O6J* //?$.EWNM>,;Y;6"YCBO/#,]C'=- ZHLSN"H)QQQS^G6E\+.MW)IS7
M_@^_LM3TR-A-<W499(CLVMY#9)?=Q]T=,Y[9]!HH Y+X:6MQ8^ =.L[RUGM;
MF'S!)%-&4()D9AUZ\$'BM'QI_P B)XA_[!ES_P"BFK<JEJVFQZQI-UIL\LL<
M-U$T,AB(#;&&" 2#C()H X6UM'U^T\!O;VES$-*$=W<320,@1! 5V*2/G+,5
M^[D87/IFK;^'M4U7X3^(=%AMIK74+B[NI8DN(S'Y@:<R*,GLRX'MGFO1]-L4
MTS3;:QCEDDCMXUB1I,;MH&!G  Z>U6J .(GBN/%'B'PKJ$=A>61TUY;B[-S
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M;JVTRYE^U00KN?9+&4\Q5'+;<]!S@G%<SXIT._U*R\<:I9V5VPU6RM[2UMQ
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M5EC/ 8=U()!^M,MM%O9/$3>(KY+47T=E]CM[>*5FC4%M[,7*@Y)"C[O '?-
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M)A<1R^;&&'!B<%1\W0@C(//I5._\$7&KWGBP7T\,=IKMO!$AB8F2%HE(5CD
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M+#X9U%-8\3W<36?E:O:16T*%V!B\M&4%OE[[\X'3&/>LZ'P;XATE="O=&O\
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M3>W$$\L+2'?"A489V?')Y^][5T- !1110 4444 %%%% !1110 4444 %%%%
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M,< =?6K'B/7M2ET/6M3M;^Z%Y::5!=+!;MY2:?(4,A\PD_O"W'RD'  SC.2
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MO[-M[J*"\F\V1'+R*3G)QG:/ER1QVSB@#K=0O[;2M.N=0O91%:VT;2RN?X5
MR35/3=:;4+ZXM)-+O[-X420/<1KLE5LXVLK$9&#D=16#\5X1+\,M=)>1?+MB
MPV.5S[''4>U)JBR1ZI:Z5;ZE?2G[!++]CAF99,EE"S/-N!"+RH7G)/0XX .T
MHKS7PWXEOM>C\'Z=J%Y(AU#2)+R>6-O+>XD0HH4,N".&9CMP>!VR#=U3^W]$
MT^QC%Q=^(8+::;[<EI)Y-V8^#'C# N4# $ @ME30!V5W>M:W5G MG<SBYD*-
M)$H*PX4G<Y)X!QCC/)%6Z\[36Y+F;P)<:;K5W<V%]=312^8 IF"Q2'$@QG<K
M+@C.,CI63J-YK0\,^.M17Q!J*SZ-J,IM"K*  D43!6 7!7DC'3D]Z /6JY[4
M/%D.EZ&-5O=,U"&,W0MC&T:AP3)Y:L1NQM)((.>A'%8\,VH6/Q TJU.JW<\&
MJZ;/--'*5*QR(8]K1C&%X<C'3IG)YKG+V]O+_P"#TTU_=2W4ZZVL7FRXW%4U
M!57I@= .E 'KE%<%?7.L>(M=\2Z3IUV+6?3?*CMG%XT1C9X@XE9%0B0%B1AC
MC"= <FNRTMKA])LVNYH9KDP(998/]6[[1EE_V2>10!;JAK6K1:%HMYJMQ%-+
M!:1--(L(!;:HR2 2!T'K65XUUB?1M)M#;NL;W=_!:&5GVB-7;!.[!QQQG!QG
M-<_KMCK.G^%_&:WU[%)I\^D3R6MJUR\\L+")@_SNH)4Y'!S@T =[9W27MC;W
M<894GC610W4!AD9_.IZ\^@O[V^U+2_#L#[(UT&&[ 6\>V=V8[,AE4D[=HXX'
MS\YXI=,O=7;6]'\*Z[JJ2S#3Y[B>YLY#&;ETE"*NX8(*J26QC)'ID$ [UY8X
MB@=U4NVU03C<>N!^1I]>::OIEU%K7@BROM<NK^:/4;B)YXW,1(\F5EW!3C>!
M@;NIY]34UJ^IR^(O%D\VMZF]OHEU'-!:QL@$J_9U<QM\O*DG&!@^Y- 'HM0W
M-I;7L)AN[>*>(G)25 R_D:\XDUG5+?P/X<\70:A//>7<UJ;NW+DQ3+.P5HU3
MHI4L,$8/R\YYJIJEWK0TGQ[>KX@U%)-%NF>S",@ VPQOM8!>5R2,=.3G)H ]
M)CFCL]0@TNWTV6. PM()HHU6"/! V'!X8YR!CL:OUQ%SK%_#X]L!]IF>TET*
M>[:S& AD5H\$<9S\Q')/6CPTU[K6B^'/$PUZ2-[E1+>PD[H9MXQY2KG"%7(
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MKC<N" ,LQ"XSD=ABG:Y;75E%X)M+W5/[3N8=?5'NB@0M^[FP" 3R!@$]\9H
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MEL+5I/M4I)C!) ^]ZDG/7))S5&?X?>&Y]$L=)-G*MM8,7LV2YD$L!/79)NW
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M^&[FMXW 9=Z*Q(7.0N30!E:CHTLUK#X/MM#+: 8HA)>SW(=0BOEH]K$N6PH
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M3I4NIZ1<K8Z5XU\*;)]4M;.-+BWC;Y=0MPHS&<?QCJI]1CTKT55"J%4 *.
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M (6^(?") ;6&O+BU@ML_//YTNZ-U'4J5?.>@VMGH:]>"J"2  3U..M&U=P;
MW 8SCF@#'TK5-,BO!X:COHY-3L+6-IH,'<$P &]/3\QZUSWCAAI_B_P;KES\
MFG65S<17,Y^[#YL6U&8]EW#&3P,UV L(O[2-^Q9IA&8DSC"*2"P'U*KG.>@J
MR0""",@]0: .<N]1LM7U_1+?3KJ&[>UN7NIS X<11^1*@+$< EI%P#R><=#7
MF6J1:+_P@_Q+EC6Q\Z/5)?)9=NY?DB*[?3Y@>G<&O;HXHX5VQ1JB]<*,"GT
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M?%"W\VCM9Z?9S3M=.L,S12(ABB8@2,"S#G;NQCOB@#FO#_B;49/'LUKJ+_\
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M;"V=H<@ENN.0,UN:-;ZM-\0K_6;G1Y[*RNM-@@0SRQ%U='D)!5&;^\.F?Z4
M:FK^++'2+B\A>"ZN'LK47EU]G53Y,)+88[F&?NL<+D_+TZ5'<^,].@U*UL(H
M+ZZN+NT-Y;K;P%A(@V]"<#/S#V'<BL/Q9IGB'5;_ %NR&FM>:=<Z68K!EN$C
MBCF*N&,JD@L<E=IP0,=N31I&E:U#XC\-7MSI$L4-EHCV<Y$T3;)"8\#[W/\
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MP9:Z?JEI]FNHI)B4\Q7R&E=P<J?1A74T %%%% !1110 4444 %%%% !1110
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MMG&",'T/./0UCZ9J$MK+X;TJ-+!M7O-.+B[-L0(;9%3Y2-V6)9AQN ZG'&"
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MY!8\8(/K78Z5/<76E6T]T;=II$W,ULVZ-O0J<G((P: +E%%% !1110 4444
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MUK1T<M;1VMQ ;83Q2QQC"$ D;64'&>>/U=J'@R^_MBUU?1-?EL-02V%K<O/
M+A;J,$L"RY7# ECD>N,8KKZ* .:;PM<GQ!HVJ_VKO;3H)HBLT&YIC*5+L6#
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M?]D%GQ_O&J7AWPEJ^@I#92>)I;S2K08L[:2V574#[BR2 Y=5[ !>@[<5UU%
M'(6G@2-?!%YX7U"^-Q;W$DL@FAB\IXV>0R9'S-RKG(^@HC\'7^H:)>:7XGU^
M35HI[=K93';+!M4X^<X)W/P,'H.>.377T4 <9;>#]8_M'0+S4/$4=TVBF01E
M;'8TRNFSYSO/S8[@#Z5K>)?#\^N'3)K34!9W.GW8NHV>'S8W(5E(9,KGAC@Y
M&#6[10!PDWP]NY=,U>Q_M[*:CJ2:BS/9@E'4QL1PPSDQKZ8&?K5_4_!*ZUK.
MI7FH7J/;:AI8TV6WC@*D*&9@X;<><L>W85UE% '%VW@S6!>>'Y[_ ,11W/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M65_=6*6^HWEU;P)<-%:6C2%HVSAE[$<'GIVSGBLG6->AU>X\#ZMH^H3FRO\
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MGM[A0&,;' =2I((R".#P>N*XB^\+ZYJ%GXN2*P$4]QJT&HV(N70QW B$7R,
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MTMQ:Q*'6)T**S>8.A8#&!R034"_$316C$PAU 6PO38RW#6K+'#+OV .3TRQ
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M1.C7]EIC7.FZE(H:-;65'MHV!*2F0_(PZ;@!QG@G&: -W_A#_#'_ $+FD?\
M@#'_ /$T?\(?X8_Z%S2/_ &/_P")KFK3Q9XIO;#5]1CT_2%M=+N+R"5'FDWN
M80=I7"XP2.<X_#O/I7B[69]1\+#4+2Q6TU^T:1! S[XI%A$O)/!4C/';CDT
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M9;=M.T@-C@D9&:\?U.^U;4OA/KUUJES#<NNK^6FR(H1LO54 98X& ,#MW)H
M]AHKBYO&-[HNKZU:Z[;VOE66E_VI$UH6),>YE*'=U;*\$8!ST%6M/U[6I?$%
MI:7&G&6QNH&=KB*UEB%K(!D(QDX<$9 8 <CIS0!T5S?VEG+;Q7-S%#)<R>5
MKN 9'P3M7U. :L5SGB35YM-UKPY;K:6TT-]?>0TDN2\1\MVRHQUPI&<]ZYZ_
M\;>(K?3_ !/?16&F>5H%T4D5I')FC"(Y .!AL,>3QT&.] 'HE%<2VL:F?B6\
M#7D*:5%HJWOE&$Y :3#9(;EODX., <8ZDK8>+=8OY=&N[;2VN-.U, NJVTJ/
M:*R[D=I&^5QT!P!C/&X4 =K17GEOXP\4W/A[5=<73](%KIWVU)(VFDWNT!8
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M8R>:%!^;<,8VC'!J?1/$$.N3:I%';3V[Z==FTE6;;DL%5LC:2,885J&:(3K
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MSR,-W!Y /8CBJ;_#[43!]G3Q @ABU@:M!NLMS[_,WE9&W_..< C:?KTKO:*
M.0N? JWMUXC2YU OIVNHGG0"$"1)%C"!@^<8^4-C;U'7'%7?#VBZ[IY3^VO$
M/]J+"FR$+:B$GMND(8[FQQV').">1I:IJ\.EM:1,C2W-Y*8;:%" 9'"LQY/
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M+'/)+>G'%=;6!:^*$OKZW2TTV]N+&>>6W%]$JM&LD98-N&=P7*LH;&"1[@D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2>IR22>22222>23FLV+PGHL%P\T=HRJ]Q]J: 3/Y)ESG?Y6=F[(!SCJ,]>:
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M<?0_E6)XHUZYT3Q)X;0WL%OIEW-.MYYJ@?*D+N#O)^4 J/\ &JD3PGXOQR0
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MD,6@^#[ZVMF-O;ZI9RSM! 6*(L;IDA1G@D#IQTH [.TUO2[^YN+:TO[>>>V
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ME)E88VLK#KCH,'D9NS7=]=V?@:?4[..WNTUF22<01L$V;9E\[!Y57)5N?[U
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M9$U4PNS78EP;D.3G> ?F XP&Z<8Q0!Z!17*_V[?7/Q NO#KV)^PQZ>DYD64
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M01Q[9KA[++>!/A=.7?S#J-JK'>?F!BD)R._('Y4 >@Z+H#:/J>KWIO//.IW
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MWKF=1\>6EA9:EJ"V-Q<Z?IMX+*YEB90PERH.U6(RH9U!)([\$#-8S:A<Z?\
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M!QQU(R,@&_17)?#!F?X9^'W=BS&T4DDY).376T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S7C'0
M;S6;?3+K37C%_I=]'>PQRL527:"&0D XRK'G'!Q72T4 <O;Z1>3>*KGQ/<6@
MBG&G"PM[7S06(WEV9F' R=H&,\ GO@2> ])OM!\%Z;I&HQHES9Q>6QC?<K<D
MY!Z]^XKI** .7ETG5+?XAR:Y;00364^FI:R;I=KHR2._ Q@Y#XZC%<]9^$M=
MM_!OA?2GMH#<Z5JJ7DY$XVF-9';Y3CDX<<$#H>:])HH XH:'J\>L^+;P6%G<
M0ZH;;R(9Y 5D2- CJXP<;AG'7WJSX.\,R>';S5/L\<MGI%P8VM=.DF\SR' ;
MS"O)"JV5PH)Z9XSBNLHH Q[^WO9/$FEW4-L'MH$E65S( 1OVXP._W>>GXUC7
M/@GR_B%I_B739O(B:1VU*UZ),_DR(DH']\;\'U!SVY[&LG5/$VD:*Y6_N_*V
ME/,81NRQ;SA2[*"$!(P"Q% '*Q>%=9L= \0^&((X);'4Y;AK6\:3'D)/G>'7
MJ2I9B,9W<9VU:_X1&[MO$X-LD3Z1-H<>DR.\I62((S\@8.[*OZCD5VU4-7UG
M3]!T][_4[D6]LA"LY4M@DX P 3UH YSPG:^,--MK/1-4@T_['8*L0U&&8L]Q
M&HP@\HK\IP!DEO7 YR-OQ'92:CI?V4:=;:C!)(HN+6X("R1<YP2/O X(]QU'
M6M>B@#S7_A"M7M=%M["R5FM(-=@O[6UN;G<UK;1E6,>[G))#$#) SUJYJOA_
MQ+-JGBR]TIHK6;4K2UAM)3-A@T1;>#@?+N#D C)'7BN^HH X/3/#VL6?B>_U
M-=*L+6UN]*2W\B&Y+,DBLYP3L 8G>,M_.J]OX5UN#PGX+TPVT)N-%O89[HB8
M;66-'4[#CDG>#SCH:]$HH H:Y82:IX?U+3XG5)+JUE@5FZ LA4$^W-<S:>'=
M2U"T\,6>J6T5K#H;1S.4F$AGECB,:;,#A?F+$G!X QWKM:* .&\*Z7XM\/PP
M>'9(;"32;23$&IB<^:8 V0ABV_?Q\N=P '/..=WQEHMQXB\':KI%J\:3W<!C
MC:0D*#VS@$XK<HH Y4Z7J&JZ[I&KWUDMJ-)BF,5N)@[2S2*$/(X"A<X[DGH,
M<XEOX(U6;X4VOAR9X+75;*19X) Y>(R)+YBY(&<'H>./>NZTS4[36+".^L93
M+;2%@KE&7.UBIX8 ]0:MT <J=&OM;\2Z7K.I6JV/]FVL\21+*)&>28*&.1QM
M 7CN=W(&.>;T_P *^*8-&\):9)9V"KH%^CO)]K/[^-4D7<!L^7AAQR<GMCGT
MZB@#RD6^H7T^M75GH5GJ>@W6I-<,(]6$$<K1$ LR-&>=T>3\P#$9((Z])86F
MHW?BVX\2I8[;.^T>""*-Y ) X9GPPZ#[^.IY%:Y\'^'&U%M0.AV'VIWWM)Y"
MY9O[Q'0GWZUMT >;Z5X2U_3-,\$[8+22ZT+SHKB-K@JK+)&4W*P4YQD'&,UW
M>KPS7.BWMO;H'FE@>-%+;025(&3V'-7:* .!T_PUK-JW@,26T.-"MGANR)AR
M3#Y0*<<C(SSCBDA3Q#X3TOQ%?PZ;:W$UWJ[WL4+W.W=$ZHNW@?ZSY,!><EAU
MZ5W](55B"0"0<C(Z&@"OJ$=U-IEU'92K!=O"ZPR,,A'*G:2.^#BN"TCPUXAM
MM<\.ZI<:;8I)96D\%\XO#)+.[B/]X6*_,24/!/&>M>C44 >;6_A+78?!6AZ2
MUK ;JPUA;Z7$XV&,7#2X!QDG#8Z#D=:6Y\,>)+33/%^B65K:W5EK;7-S;W$E
MSY;0O,OS(R[3G!Z$'ZXKTBB@"CI%O<6VB65M=K&L\4"1R")RRY  X) )_*N4
M\*:7XM\/P0>'98K"32K1\0:F)SYI@#9"&+;]_'RYW  <\XY[FB@#S*3PKXJG
M;3I;JUTZXO[+6Q>/>R73;[B'+[5 V'8%5U&T<?+TK3T;2/%7A^_U#2[2*QFT
MB[O);J"^><K):B1MSH8]IWD$G'('//I7=5DOXFTB/5(=.:[Q<32M#'^[?8TB
MC+('QMW#GY<YX- ',W7AS6)G\>;;:+&NP+%:$S#@BW\G+\<<\\9XKK=#MY[/
M0-/M;E D\%M'%(JMN&Y5 .#W'%7ZH-J^GG6O[$-S_P 3!X&G\D!@?+! +9'
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M-ENT1+Y+?RRMSM& Q#*=KXXW+CVQ712Z=:3Z6^FRPJ]F\)@:(\@QD;2OY<4
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M"/6M1N=,MF)L["<H4@SG W!=S 9X#$@?4 @ K?#.6_N/"\ES?WS73O>W0RZ
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M.,9-;FC>!(]#N]EKK6H_V.LQGBTIBABC?=NP&V[]H;D+G&>N: ,+3]:?0O\
MA,+B&(27$_B6.UA4XQOD2! 3DCIG.,C.,9'6M2?5?&.G1:S(VE2W=M%;I+9R
M,L7G%]V)$V1N=V%^9>F<8JW+X"L;JPUVRO+NYFAUBY^UR$;4:&4!0K1D#C&Q
M<9STJ:U\*7<6GR0W7B34KR\.P17D@C#0JKJP"J%VG)49+ D]Z '>$=>A\007
M5Q:ZLE_;(ZJH:+RIH6Q\R2K@8.?8<?3)Z2N;/A0XU:XBU.>UU/5!");VUC5&
M41_=VJ<CH2"3D\]L#'2#I0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX8#.": /2:*XKX<2ZK-8:I)>27<NEM?.=)DO2QF>V.-I);YBO]TMSC\*[6@
MHKAH[Z7Q-\2]7T2:21-+T2W@+P(Y47$THW N1R551C;TR<G/&&7UT_A;XA:%
MIEN\C:3KT<\+VSN66"6-0P=,GY0P."HX[XS0!WE%>2^&[S2<^);?5Y]3ED3Q
M!<6=N$FN3LC+HB*&4X4 MZC%>IV5O]CL;>V,LDQAB6/S)#EGP,9)]3B@">BF
MNBR1LCC*L,$5XC/+<)\#->U%;V]%]#J$JQW/VJ3S$47(0 -G.-O&* /<**P/
M%=ND/@36%A:2/R+"9XG21@R,L;$$,#G.>^:Y;QA]BTWQUX.BN;R6TTV6*]^T
MC[7)&CA(U*%B&&<$]30!Z117!^ GO;^Z\19FO+CPQ+,G]DRW;NSNI3]YM9OF
M,>[&TD].E9^E:A)X"\0ZIX?U-[N]COB;K1IIIFD>?.%-MN8GYE)&/8Y- 'IE
M%9'AW1?[%TT12S2SW4K&2>1Y7<;R22%W$X09P!Z =ZUZ "BO,_$.B1:5XA\%
MV$5YJ+)=7<D5TS7TV9P(F//S\<C/%.\>:=%H.EZ-Y%]>Q03>(;59&:\ERL+G
M#H7+9V'!.">,T >E45Y[X:NI[GXB7AT&[NKOPLMEMFDEF>6$78?&(F<D_=^\
M%./QJ?PJK?\ "S/&L333O#;&S\B)YF9(M\)9MJDX&3SQ0!W=%>=^,-?U'3/$
M5EK4$Q70M(NDM-20='\\89S[1YB/U9O2KGQ;>2'X=WMU;SS07$4MOY<L$K1L
MNZ>-3RI'4$B@#N**9#"EO"L48(11@ DG]33Z "BBO+=&N--C\5>,HM5GU%X+
M6]3R%1[AUB0Q*Q V9 &23B@#U*BL6PN;32?"27WFW#6<<#7(,SF20(<N%R22
M2 0HYSP*YWP1J6KVWB/6?#WB&7??,%U2V.>/*E^_&OM&X*_C0!WE%<)IUW)X
MO\=>(+6ZDD&DZ(T=M%:HY59I64L[R8^]C@ 'COC-:>I: EE;:K=6]S<K:OI[
MH+;SWVQ.N2'CY^7KSC'0>] '445Y5I>N6+?!(>;?W#:@VD/*92\ID\[RR0V_
MKG..]=MX'!/@7097>222;3X)9))'+L[M&I))/))- &_15/5]032=%OM2=2Z6
MEO).RCN$4MC]*Y7P?IH\1^$;+6M<EFN;_4HOM+.LSH( W*K$%(V +@9')/))
MH [:BO%]:\0:C<_"OQ?;W-Y/_:?A^_-G'?1R&.21!*FUR5Q\Q4D'UQ[UWFE+
MHEYK\/\ 9LNHI<6:><XD>=4=7#(%*R'#<\]."HH ZRBBO/?&TL5O\0_!JSW%
MS%:7/VQ;F.&60++MB!3<J'G!- 'H5%>:Z+X@6#QMXA_LR\N;GP]I^F>=<17$
MKLT=T"3B,2?.%*#G^'/2M'P59_\ "4^$[77M=>2XO=2#3X69U6W0L=J1 $;<
M+CD<D\DT =S17CNJ:[J$WP[\<:=<WEPU_P"'KAH;>]60I*T>08V9EQ\V,@GO
M^)K4M;MI?&WA^'PI?W=U!'&PUM?M,DUO&A0%-Q8D"0G.-O/KQ0!Z=17F6O76
MF6/Q9E36-2EM-+_L'[0RF]DBC\WS]NX!6'S;>.*-(\0ZWX<^%^OZWJ2W4Z6L
M\[Z5]NSYSVY($)DS\W4]^<4 >FT5R>D^&8[[PS:RZA=W<NJW-NLLM^L[+(DC
M+DE,'"J">% Q@<@\UQ5UK.J^(OA,GB%I)O[7T&\+78MY&C6Z6%\2!@I PR?,
M1ZB@#V&BO,]3U>WM/BCX:U"VN+F33-3MA#*/.;R$DE!:W<+G&YMCKTZ5M7-L
MEUI_BO51).%9)8;?;,X"^4A#,HS\K>8'&1_=% '945YAX5FTB^\'^'%N;G53
MJE[# //\RY&9=NXL6)VD<$^AZ=Z-:N]*L?BM?)K6IRVFF#0TN"IO9(D$IF92
MP"L/FP,<4 >GT5R'PW;6W\,RG6C=,/MDOV%KP'SVM<_NS)GG=UZ\XQ77T %%
M<[XQ:]N='.C:7<?9]1U,-!%,/^6*[27?CD8 P#_>9:C\&:Q_PE7@NUFOE(NP
MIMKZ/)5DGC.UQQR.1G\10!TU%>6^$=<U#PU?0:/K]S)<:1JLTHTN_F<L8Y [
M V\C,2<G&5)//3Z)XN5[+X3^)KRVN+J*ZAO)S%,MPX=-MSM #9R %XQTQ0!Z
MG17#>+M'GT?PI=:UH&H7MG?Z; ;I0]U)+%,J#<R.CL000#SU![UU&@:JNN>'
M=-U94\L7MM'/L_N[E!Q^&: -&BLGQ0N[PKJQW.K+9RNK(Q5E8(2"".00:H?#
MX%OA_H4\DDDLT]C#++)+(79W9 2222>M '2T5YMJ$EK'\8KFTO9K[[$VB1SB
M"&28KYIF92VU#P<#%6=5L;/4? &I7&DWVHVXFN&:VF-Q*LD#!UB.W+;MN4)V
MGU/% 'H%%>;1>([R]\)^(O#^ODV_B72K"5W:)BGVA AV7$1&#@\9QT/ITJ;Q
M-9H/'W@>P26ZCM;D7BSQ1W,B"4)"&7=AAG!YYH ]#HKS[7Y[KP3XH\/7-G>W
M4NE:M?+IUS97$[3*CN#LDC+DE<$'(!P1VJAIDVGIX\\9VVIS:@UO;36QMXXW
MN'6(-"&; 3.,DYQ0!ZA17F'C$P6W@3P]=6E[>Q6\^IVKB5[J17$$TA8HS;LD
M!6QR>@'I5SP]=37/Q'G_ .$?O+J[\,I9%+MY)GE@6Z#<+$SD_-M^\%./7F@#
MT.BBH+V[AL+&>\N&V001M+(WHH&30!/17!>"]4U>V\5:OH7B"0FYND35K,'^
M"-P%>(?]<V 'OG-26MY)XM^(&MZ;/+*NDZ$L,7V>-R@N)I%+%GQ@E5 P%Z9R
M3GB@#N:*Y6!-&L_&2V-O?S1SO9NKZ66D*%2RXE53PH^5E)'!SZUYM#?H/"6M
MPVNK:DWBC^UKJ'2X;>\E>9BDGRKLW$% .NX8QF@#W.BO._B'+>V_@S0[F\FE
M@OOMUE'=-:R,F=S 2*-AR0>>*V].31;C7TBT]]06>"%I)4E:<(R-\N"LAP>>
M<@<8]Z .IHKR7P[?Z5;VOBV;6IM3F%EK-XD>V2Y8)"F-J J<#'/?BM;QC/-X
M:.@27T&H:AX8M(7BOFA9G=7PHCEE .74 -G/<Y.3B@#T2BN<\('39[2ZO]&U
M5M0TV[E$D!-PTODX0 H-Q)49&=IZ9[5T= !17FWCO2$TNWT::"\U 37OB&W2
M=Q>RC='+(Q9,!L!<'  QP*/B5I2:!\/-;O=/O+^%]]LZ$7DI:(^:BMM8MD J
M<$=/SH ])HKS3XC:OI[>%;6+3;V>*=;ZVC0PO+&VQI5##=QD$$]37::[<R6&
MC>18D)=W#+:VG?;(W ;W"C+GV4T :]%<?\.M3N[KP[+I.I2E]5T:=]/N7;DO
ML^Y)SR0R%3GOS6'K.APZ7XQ\$:7%=ZBT%RUTEUOOYB9]D&06^?UYXH ],HJC
MI>F1Z3;26\,T\D1E:1!-*TC(#_#N8DD9SCTSBKU !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-D9D
MC9DC,C 9"*0"?SXIU4=3UG3M&A2;4[R&TB=@HDF;:N3T&3P* .4T7P?<3?"E
MO"6L(()G@EA9XV#J"S,RL/7&0><=*M1:'J>JZOX>N]6AC@718W9ML@<7%PR!
M RXZ(!N/.#DCCBNFOK^TTVS>\O)TAMHQEY7^ZH]2>P]ZIW/B71K*>""ZU"*&
M:=2T4<F5:0#J5!'./:@"QI<VHSVC/J=I%:SB5U$<4OF H&.ULX')&#BKM9D7
MB'2)X[F2*_B=;55>?:>8U.<%AV'RGGV-0CQ9H!M+>[&JVQM[DD02!_EE(Z[3
MWQ[4 ;-%8=OXQ\.74D:6^LVDC22>4@63.Y\XVCWSVJW8Z[I>IRW,5C>1W$EJ
M2LZQY)C8=5;T/MUH T:Y[Q;'I&L^']3T&^U"SA>ZMVCVRS*I1B,JV">QP?PJ
MU%XHT.>UNKJ+4H'M[1BMS*I)6$CJ&/\ "1WSTJO_ &_X7O&BE-Y82^>46.1@
M"'+8"@$CG.0!0!Q6H^'[34/"7A^U;Q%8KK%G<+-=W0NDW.)<K<@'/<.V/]T5
MU/B35;.YT8:=I]Y821SLD5QB]C39;Y'F!<GJ4RH^N<\5:N=:\)V=Y-9W-QIT
M-S"NZ6*155D7U((X'OTK2M8-)O;:.YM(K*>"0;DEB565AZ@C@T <'XOTK1I;
M"PNO#$FCPZQ87D5S;O\ :HXU 4_,K'/W2I(P/:K.KW:ZAXW\+:S'-8+;::ER
M+E6OXMV94"C;\W.".>E==?-HFFK&UY'9Q&1ML:F,%I&ZX50,L?8"FV4NA:BD
MS6B6DI@.)4$0#QG&<,I&0<=B* .>\=1V/B'0XO[,UO3H-7L;F.[L9GN$PDBG
MOST*EABMBVU+1M)T2*SM=2LY_L\(1 ;J,-(0.I)/4GDGZU"OB#P>R3.MWII6
M%F25@@Q&PZAN.".^:T)WT.UTS^TIQ8QV6U7\]D4)M;&TY]\C\Z .'\(7USX9
M\!V.B2PZ5<WEHC!2=4B$3-O+*<]1@D=NU3W7E77C_3]3N;O3+G3XM+DL+EFN
MXAYC.P).S/W>.GOTK?/B3P8KR(;[2PT:[G!"Y4>IXX%6H]1\-2ZA%I\;V+7D
ML8ECA$8+/&>C@8Y7WZ4 8'A2=?#$]QHK:II]SH,;[M.G-\AD@0\^4X)Y"GA2
M">,5UG]OZ-_T%K#_ ,"4_P :J?;?#IU1]+'V,WZ)YC6PB!D"_P![;C./?I5>
M/7?",HD,=SISB)RDFU =C#J#QP1Z4 8T_P!BTOQM<>)M+U+3[A+^W2"_M/M<
M:.Q3[DB$G!('RE21QSFE+V6L>+['Q#J=]86\.E12K8VGVR-I&DD #NY!VC@8
M !/4DGM6^VH^&4EL(VETY6U !K,%5'G@C(V''S<$=/6KUS;:79VTMS<P6D4$
M*&221T4*B@9))[ "@#CO!,EOI7]OIJEWIJ+?ZO/?Q8O(W&R0KA3SPPQ]/>NO
M_M_1O^@M8?\ @2G^-1V3:+J-@M]916D]JPW++'$"K#U''/X4W39M UB*633O
ML%TD4ABD,2JVQQU4^A]J *>M>)H[:SCETBZTN\F$R>;%)>HA,6?F*DG&['3/
M%<HOA_3)OA=J'AB;7].CNKYIIS(+A"L<CRF11UY .T'Z&NXM6T2]N+BWMHK6
M26W;;,@A&8S@'!XX."#CT-5!J_A8R*HEL-K/Y8E\L>47SC:),;<YXQG.>* ,
M6YUZ?6]$?2+L:;9R74)@N[DZC$\2JPPYC .YB1G 8+UYJ+7YX+[QYX:U2WNM
M.DL=,6Z6<F]B!;S8PHVJ3SC'.<5TNI7OAW1Y(4U%K&U:<[8A+&!O/H..3[5)
MI\V@:LLIT]M/NO*;;((@C&-O1@.0?K0!RWAQX?"NKW>G6FHZ;/X:F?SK4?;4
M#V3,<O&%)YCSR,'(R1@TOBFXAU'Q1X8OK.\T^6WTRYDFG)O8E)#1E,*">3SG
MG%=K_9UC_P ^=O\ ]^E_PJ&"'2;IIU@AM)#!)Y4H5%.Q\ [3[X(_.@!O]OZ-
M_P!!:P_\"4_QI?[?T;_H+6'_ ($I_C4$%QX?N=4FTR+["U_"N^2VV*)%7.-V
MW&<>]+--H=O?"RECM5NC&91%Y(+%!C+ 8Y R.?>@#E_%5Q#J/B;PQ?65YI\M
MOIET\\Y-[$I(9"F%!/)YSSBE\=3PZU!HL>G7NG2FSU6WOI2][&@V1L20.>6/
MY>]='I5YX<UR.632VL+R.)MCO"BL%;T) Z^U2:?-H.J^=]@6SN/(<QR[(P=C
MCJIXX(]* .4C>'0O%TNJ:+?Z;)I>J#?J-BU[&C13C&)8^<$L.&&1G .:9I%Y
M_9OC#Q9K#2Z>\.IBW-J@U"($F*,H0_/RY/IGBNNOI="TUXX[J.T267/EQ"$-
M(^.NU0"3CV%%K+H5]:275JEG-%&2LACC!*,.H(QD$>AYH Y)-)\,7_A&:VU9
MM,DU*[@<W;"YB+-,^2S*V['WB2OH,>E8VI#4]6^$4?AN[NM*?6$$$;2_VC'Y
M;K%(C!B<YR53'3K7:KXC\&O:FZ6]TLVXSF8!=@P<'YL8ZUIZ@=$TJV%S?I96
M\)8('D10"QZ#IU- &1'XHN;R]M+>-=-MT>5?-E.I1R,%'.%4?>+'"]L9SVK>
MTV;49H[@ZC:16S+<.L(CE\S?$#\KG@8)';M6*/$_@Q&D8:AI:F$C>?E'EGMG
MCBM>'7=,N-5ETN&\C>_B&Z2W&=Z#U([#WH T*XC0=/UW1_$/B6_?21+#JEVD
M\(6Y0,JJ@7YAZ\9XS720^(-)N+VYLH;V.2ZM0#/"@)>('D;AC(S[U63QEX<E
MM3=1ZQ:O;@$F57R@ Z\].,&@#/NK'5]4M=.L;[3(%L7N?,O((IE*QPIGRHQT
MW<A&;IW S5'7O"D]KXCT'6_#&FP)<V<SK=CS!&LMNZX9?=LX([9KJ9]?TJVU
M"WL)KZ)+NY&Z"$GYI1C)*C^+CTJK+XO\/6]Q<03ZQ:12VV//223:8L\C=G[O
MXT 8ZZ'JOA_Q?J.N:1:I>66KK&U[9&41RQ2H,!T)^4@CJ"1SR#VK8O/[5OM(
MOP;,1-+;O%#;>8I8LP(R[=!] 3W//0;$,T5Q"DT,B212*&1T8%6!Z$$=13+J
MZ@L;2:[NI4AMX4,DDCG"HH&22?I0!Q^GZ'JUK\)/^$<DM%_M)=->Q"B5=A8H
M5#;O[O/IGVK>\*6=UIOA/2=/O8A%<V=I%;R ,&!*(%)!'8XK7!! (.0>A%9
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M@_N1C/S<<<<\]N: .;7PM?:OX_\ ^$CU.WM[2TBT][%;:.7S)+@.<DR$  *
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M6Q^-%C%I]FDHC\-NBQ>9L"J+A0.<'I@"NELO#1L_%VH>(?M[O)?11PR0&,!
MJ9VX/7/)SG-#^&6?QK'XF^WN)DM#9"#RQL,1<.>>N[('/Z4 <[IDMS+\;KUK
MJV6WD_X1^(!%DWY'GMSG JAX/N];M-.\:OI.FV]VZ:_J#)ON2C%\C@+L.>W<
M9]J[!?#+IXRF\2KJ#>?+:"S\DQ#8(PQ8=\YR3SG\*JZ/X1N]#74%LM=F O[R
M6]EWVT;8DD(+8]N.G- &7\0O#?\ ;<&EZ;8X@NK>*::P9>/*FC"-'CTY&/H:
MI:AXA3QQX BCB789[":ZU*/H8O*!!C/IF4 8/55:NN@\/307&ES#4Y9#8K(&
M,D8)G:3EV8\8)/(Q@#/IQ4$?@S3[2VU^+3V-L^MR/)<R!0Q7<NTA1]2S<YY8
MT )\//\ DG'AO_L&P?\ H KCKFRU#PUK&J>-=&CEN(Q?2QZQ8(<^? IXD0?W
MTR3[C/X^A^']'_L#0+/24N6GCM(EABD=0&VJ,#.."?RI=(TN73!=B2[-P+BX
M>?F,+M+=0,=OU]Z /-/&7B 3_#CQCJVB7>ZWN[VV47,1Z1/#;*Q]N"0?3->D
MWNDZ>_A>?23#&NG?9#!Y>/E6/;C]!5'3O!.B:;IFL:7%:JVG:K<//-:M]Q2Z
M*K*OH/ER/0GCH*8?"UT^C_V+)KER^F>7Y)'EJ+AHL8V&7TQQD*&QWSS0!YO8
MZE?W_@#X7WMXLEQ=_P!L(HRP#2!1,J\GN5 Y-=5X)5M=\;:]XKD"V4NP:9)I
MN<RQM&V=\O;<>-N,C:>M;VK^#X-1_L..VN38V^C3I/;0PQ KN0%5!S_#@XP,
M?6II?"Z#Q2OB"RO9;2[DA$-W&B QW2C[I=3_ !#D @YP<=* -#6M331]&NM0
M=&D,*92-1DR.>%0>[,0![FO._"<Z>&OB$VFF>XEM_$%L+EI9H)(P;^,?O=N\
M#[Z_-QZ8KT#5=)EU.YL)!>-#%:3B<Q",,LK $#=GL,Y&.X![53\4>&%\2KIW
M^G2V4NGW:W<,L**7#J" .>W)R.] '.>+?#MYK'BU]1T>X^S:[I=A#-8R$_(Y
M,DVZ)QW5P,'TXJUX;\3V_BG7]-NEB:VO(+"\@O;.3[]M,)+?<A_H>XKI(-*G
MCUV35'O=YDMTMVA$0"X4L00<YSES^%11>&=.M_%LWB2"/R[Z>U^S3[>DHW*0
MQ_VAMQGT^@H X[54OO!/C=7T=(VLO%,AB,+'"V]]CB;'=64$L!R2OTKO]-T^
M'2]/BM(-Q5,EG;[TC$Y9V/=F)))]367K_AHZ[J.DWAOGMSIEQ]IB1(PP=\$?
M-GM@G@8^M;XSCGK0!P'@65[_ ,;^.+V\^:[AOTLX]W6.!%R@'H#DGW/-$KR6
M7QUMXK3(BU#16DO47H3')A)#[\[<^E='/X<5-=FUO3+HV5]<1K'<_NP\5P%^
MZ77(.Y<D @C@X.:=8>'DLKV\U-[EKC5KM%C>[E0?(B_=1%& J DG'4DY)- '
M#_#:75'\!V-HFEVT^G37UQ%/*TY+>6T\@;]WMY]/O=#GVKTZ2"*5HF= QB;>
MF?X3@C/Y$_G6-X3\-KX4T5=*BO)+J!)'D1I4 8%V+-G'!Y)[5NT <'X2ACN?
M&7Q @F0/%)>0HZ-T93 H(-06DUW#\8_$9M+-;@G3;3<&EV8Y?V.:Z31/#1T;
M6M7U/[>\[ZI*LLT;1A0K*NT;<=L>N:+/PR;3Q??>(?M[O)>PI!) 8P$"IG;@
M]<\GUH Y_P 'O/)\3_'3W$ @E*:?E ^_'[I^^!69\.+G68OAM9I9Z7;7%NUW
M.C,UP=VPW3ASLV8. 6XW<XKL+#PQ+I_B/6-;BU)FGU58A+&T(V)Y:E4V\YZ$
MYR3FJNA^#KSP]H2Z1I_B&X2!6D97:VC9U+L6)R1CJQ[4 4/$*+'\5O B(H"K
M!J(4#L!''7/WNOR^'/&?Q%OUTMKZ)4T\2\C9&IA(W2#EB@SD[03@&NUG\("7
M7-#U1-1E5M&A>&"-D#!PZA7+D\DG:#GCFI-/\*K9>(M:U>2\-S_:ZQK<V\D2
M[,1J44#\"<YSF@!G@#0?^$9\#Z7I7VY;WRHR_GH?D;>Q?Y?]GYL#VJMXV:TU
M-;?PY=FX^RWJM)>&")W81+T'R D;G*]>H5A6EX:\.?\ ",6CV%M?SS:<'9K>
MWF )MU)SL5NI4=@<GWJS8Z3+::SJ&HRWC3M=A%"-&!Y2IG:JD=OF8\]V- '-
M?#G5'U7P5)I=_*ZWVE,^G73L"C$(,))AN1E"IR>^:YZ"_P!1\#:?8^'?&&GK
M>>'8988[/6[0?+'L<&+SD_A((7YA^O6NTB\(^3XHU;6XM1E7^U(5AN+81KL.
MU=JMZ[@#US^%13>#I;W1H=#U#69[S24\L/'+$GFS*A!"O(,9&5&<*"?6@#)U
MR#Q+X:\57_B30K2/6K"\2);_ $X-MGC,:X#1'O\ *<[>O/'6LCQ3J>DZQ\'X
M;W15=+*348"(I%VM$YN@70KV(8D8KO'T2]BU.^OK#6)(#>,K/!+"LL2E45,J
M."&PH[D>U95]\/[2Z\*IH$5_/#";G[7-/L5I)IO,\PL>,#+<X ] ,4 9XG;4
M/CHUG><Q:=HWGV43=-[N%>0>^/ESZ9K8UO6([7QIX<TN73%FGO&G>UN?.V^5
MLC_>9&,\JW '4XSC%6M6\+PZK>6&I_:9;76+$$0WMN "5/WD93D,A]#^!%,/
MAF2[\1:;K>IZ@9[G35E6V2&$11CS%"L6!+$G ]0/:@#C+_3]1T'7]8\:Z'')
M</%>M%JFGJ<_:K<(AW*/^>B9)'J,CZ[5MJEEK>@>+]2TZ=9[2Y@WQR+W'V5?
MR(Z$=C74:3I<NFR7KR79N/M4YG(,878Q &!CMA1UY]ZS+;P78:;IVN66EN;.
M'5Y7EE55!$1= C;!VSC/H"?3B@#$\%3:O)X!\*VQTJVDL);2".:7[0681^7]
MXIL'< =>,TVXDO(_CA,;*VAG<^'4W++,8P!]H;G(5LULV7A.]L/#UMH<'B"Y
M2S@A6W4K!&)/+ QC=C@XXR.:?+X3F/BV3Q%;ZK)!<-9BR$2P*46(/O'7G.3U
MH J:QHNI>)?"$L3&'2=9>]^T1\[X_,AES%NX&X%8TYQ[XXQ5+P]XGGN_%EMI
M/BK13I?B2.WE6VEC.^WNXR5+F-NO\"G:>F*W)_#%Q=0R_:-<O3=/<13)<1JB
M&(1\JBK@KC)).0<[B*EB\.R3:[9ZOJE]]LN+%)$M%2$1)'O #,1DDL0,=<8S
MQ0!SOBZ5[GXH^"-+N,_V>[75T8S]V2:./*9]USD>]'Q?>2S\&PZK:974;"_M
MY;-E^]O+A2H]BK$$=ZZG7?#]IKT5MYS20W-I,)[6ZA($D,@[C((((X((((JO
M+X<?4KRSN-:OOMJ64HF@MTA$47FC[KL,DLP[<@ \XSC !QNLZS-H'Q2UW4H=
M,GU#[/X>AD:&%E#8$KY//;Z GVKH/AIHZZ1X/C*7L%TM]-)?*UMGR4$AR$3/
M.T>X'.>!6C#X9,7C.X\2&_=I9[9;1K<QC8(U8L,'KG)//OTI?#_AA/#4UW'8
M7DHTV>5IH[%U!2W9N6$9ZA2<G;R!GC% &#XCL_$FB^*9O%'ARWAU:*6WCM[_
M $QWV2X0LRM$W8X<_*>OOGC \4:OI.N?!ZYO-)AEMXCJ<7GV\R;'@F-TC2*P
M['<Q/XUZ#/HMX-7N=2L=6DMWN$1'@DB62'Y<X8#A@W)YW8Z<<54_X0C2Y?#&
MH:'=&:>/497N+N<D+)),S!BXP,*00N,# VCK0!:\8?\ (GZL/6V<?I7-VDK:
MA\<=1CN^5TS2H_L2-T7S&_>2 >O 7/IQ6^OA^_GBAMM4UN2\M(F5C&+=8VF*
MD$>8PZC(!(4+GOQD4[6?"\6I:M:ZS:7<VGZO:H8DNH0&WQDY,<BD89<\XX(/
M((H /%:_8]#U#7+:('4M/L+EK9P.0=F<>X)53CV%4OAK;PP?#G0GB.YKBU2X
MFD)R7ED&YV8]SN)K:M=.G#^;J-Z;R0*5"^6(XU!ZX7G)/3))]L9.<G2O"4^@
M(UIHVLS6VEEV9+.6%91!DY(C8X(&3T;=B@#!^(-E'I=AX2@T^! !XHMY$B+;
M5W.TKD9 .!N8]N*ZJU;4;S4KQ=4T^&UBBMD$$\,YD)+E_,&XJN,;4_2JNN^$
M5UJ#2XAJ,]N-.O4OD<(KM),N2"Q/;YCP /PJX-%O)KN.:\UB:>.-'"0K"B+N
M8;=QQR2 3@9QS]* //8;[4? FF6GA[Q=8+>^&8I(X[36[0<1!7!C\Y/X2"%^
M8>W4UN:[;^)?#OBF]\2Z!:Q:S97<<4=_IN_;.AC!VM$>_#9V]\\=>-27P9+=
MZ'#H-]K,]WI"*BO'+$GG2JA!"-(,?+P,X4$COWK0?1+V+5+V_L-7D@-V5+P2
MPK)$I50NY1P0V!USCIQQ0!YYJFLZ9KUOX&M]*62/0]0UJ1KJWE7:1*K&3RG7
MI]\GY>G KJ/BTBCX;:K=AS'<6?EW-M,IPT4JNNUE/8]OQK0_X0;26\._V1(9
MW/VHWWVL,%F%R6+^<"!@-N/IC'&,5+=^&I=76"#6]1-[9PR++]F6$1+,RG*F
M7D[@" <#:,CD'I0!R&HZI>VOQ'T?4O[-FO+H>&999+: J')WH2!DCOQCK5SP
M)HT-]X-UR_:_B6'Q++/=D6K'9:"1=I4$@?,O.XX'(Z<5TLWAEIO&=OXD^WNL
ML%LUHL C&PQLP8Y/7.0.?;I5:/P7#:RZTME?SV]CJZN9[,*I2.1U*M)'W4GJ
M1TSVH Y2SU?4_#!TGPUXWTQ)+&.>"+3M;LQF(NA'EB1>L;< 9Z')[9->A:]I
M$&O:!?Z3<?ZJ\@>$G'W<C /U!P?PK+N?"LVHP6MEJFKS7MA;2QS>6\*K),R$
M,OF..",@'A5SCGO72T >'W^LZCJG@+0[R&(-K7A21KJ_!Y8&V81.A/;>I9OH
MAKU#1+J'7-6NM:MW$EHL4=M:OV8$"1V'U+(I]XZET_PMIFG7NN7,<(8ZS*)+
MI6'!^0*1]#\Q^K&IO#^@V_AKPW::+I[$16L6Q'<9)/)+$>Y)- 'G.D_\D:\<
M?]=M6_F]>B>%./!VB?\ 8/@_]%K6-:^!!:^%=6\/KJLS6^IO,\LK1+O7S<[P
MO;OQD<59@\+7\.EVNEGQ%=-90)'$4%O$K21K@;"V,\@8)&#S0!FZ/_R63Q/_
M -@VS_F]=S7+_P#")7,?BF_U^VUN:"XO8DADC$",@1,[<9R<\GG/>MC2M-FT
M];AKF_FOKB>3>TTJJN!@ * H "C'YDGO0!S_ (#O'U:3Q%JTYS+)JTULF?X8
M8<(B_P#H3?5S7*^.KUI[N;Q+9_:WN_#ETALT2"0I*B<77S!=OS E3SQY/O79
M:/I$^AWVMV,#-%;ZC=/?6MPJ;A&\@'F(1TR&!89X(;V-:NFZ1_9WAZ+2?/\
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M 3 %E.=B _PX]0._%8&C6=]I&OWGPW5BVE21_;[:??\ /%9,Q$D'KG?\H/\
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M Y&48@$_KCW]Z;H]E<VFC:#J,^NW!L[>W1Y8)4C"D-%M4 J@8D%A@$G/N<4
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M".1['M7%>)-*2U^*.CQ6LS0VWB:*:'5(%'RS"! ZGV)&4)_ND]^:](
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M$?G7;4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM[-H^H7-I;Q+$%79&5 =@.21DDX(X':MW2+O4+Y]*O\ 3=>@UC2+EF^TOY*
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M;6LL\;;0PW*I(!![<5AZ+<ZWJ7AC1-5?6HUN;Z&"8PO;H$<LH=D&.1QNP>U
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M;NRO&L-*MKI[6W>*-&DN&3AI"7! 3/  &>"2>U &TGAK18X;J)--MU2[4)<
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M]G%B]M(KI*4VX?(PJ@]6/&.<UVE% &!XDB-MX#U.V >1QITD*+&A9G;RRH
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M';KQ/X-N;*PV_;HI([FW5S@.Z,&"D^XR/QKJZ,T <IJ'BA+OPW.MG97CZM/
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M?^V=:7Q:M;>X\-Z<9H8Y"-6M%!90>&D (^A'!K2NO!=E=^"I='DTZQ:[DLS
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M#_#<L'V(C^J@_-MZ'C.:A\;B+PA>:!KFCP1VKR:G#8W<,*!$N(9,@AE'!92
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MVZHE@UAY)"^4"3YA('.[U4D#'J<]J *?_"=Z%]HM+<G41/>(TEO&=,N0TJJ
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M]G"%6F*;MXQ'E#\W& 0/?./>L+2/[1_X6OXW_L\6N?*T_=]HW?\ /)\8Q^-
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MD^P74@BAF2WD<,Q;:!A5)&2,#-68?$-C-=Q6NR]CEE#>6)K&:,-M&2 64#.
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MSV\D8#KPR_,HR12:EXDTS2-1LK"\DF2YOF*6R);R.)& R0"JD<#GFN<^%O\
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M&UEX?2P@,-U8&^%R9R"JA@I79MZ\CO0!N:3:SV.CV5I=7#7-Q# D<DS')D8
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MZ@LX)A< 12#<\H;?O9B"2=Q)]S5Y=!)O+>YN-5U"Y-NQ:-)6C"!BI7<0J#)
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M,D$MR5_<AOO;%154$]SC..,XK7JAK6L67A_1KK5=1E\NTMDWR,!D^@ '<DD
M#U-9BZGXC;2CJ*Z+;9,1D2Q-R1,1C(!;;M#_ .STS_%WH +/P?;:7+-_9.HZ
MAIUK,YD>SMW0PAB<DJ'1BF3V4@5=O_#FF:CIT-E/"VR"0302*Y$D4H.1(K]=
MV223WR<YR:?<:Q':>'6UB:-MBVPG,:C+$E<A0.Y)( 'J:A\-:]'XF\+66LVJ
M!3<P[C&Q^Y(.&0GV8$=.U "+X<@DOK:\U"\NM1EM&WVXNB@6)\8W!4506QG!
M()&3C&:LV^E);ZQ=:D+JX>2Y1$>-RNP*N[:  N1C<W?OS6'X9\;QZWKFIZ%?
M6JV.JV,C 1"0NEQ&&V^9&Q5<C(((QQ3K_P 2:M9Z;XAO(]+M)?[&9LH;ME,R
MK"DI(/EG!P^,<\CK0!JGP[IO]JW^I)#Y=W?VXMKB1./,49P3[C)&?3'I5'_A
M#;1[&WTZ>_U"XTN H4L9I5:,[""H9MN]@" <%B..>*=HWBJ#Q#X6;6-,C!E1
M6$MK.Q1H95^]&_!((^GH:@E\7-%;:' +-)=8UE-]O9I,=B*%#,SN5X50>NW)
M. !0!I7WA^UO-4CU2*6>SU%(_)^U6Q4,T><[&# JPSR,@X[8I;#0;:PN;F]$
ML\VH7*A);R8JTFT=%' 55&2<  9Y()JA=>([G1-3T^UURW@CM]1F%O!=V\A*
MK,1E8W4@$;L'!!.2.0*S];\6Z[HBV4DNAV1BOM473[<-?.'^=V5'8>5@ A<X
M!.,T 7-.\$0:3!<06&LZO!'<3//(JS)S(YRS9*9&3Z5-/X-L9YM&E^UWJ/H^
M3:D2*3N*[69B5)8D9R3ZFM'3+G4YI+F/4[&"V:-E\MH)S*DBD=<E5P0<C&/3
MUK*UWQ+?:5XHT/1;;3[>?^UC,J2R7#1^68DWG("'.1TH E;PE /$%UK<6IZC
M#>W4:PRM&T>THN=J@%#C&3SU]ZL6/AG3],AO19&>*ZOCFXO3(7GD., EVST'
M0=!V JI8^)YI/%-QX;O[%+;4EM/MD#1S^;%-%NVYW;5*D-P01]":J:!XHUOQ
M#;ZC+;Z5I\0LKZ:R82WSC<T9P3Q$< T =!8Z3%I^B0Z5#-,8881 COM+A0,#
MM@\>H^N:J^'?#=MX7T1-(T^YNS:QY\H3.':+))PIQTR<\YK2L9IKBPMIKF#[
M//)$KR0[MWEL0"5SWP>,UBMXCEOO$-YHNC6\4TU@J&\N)G*QPLXRJ  $LV!D
MC@ =\\4 6/#_ (;M?#=O<P6=Q<R1W,[W+B9E;]XYRQ& .I[=*JVG@^+3[[4+
MRSU?4X9M0E\ZY(:(AWQ@'!0XXP.*=I_B22XUN\T"\MH[;6+>$7,:"0M%/"3@
M.K8!X/!!'!]>M<Y#\2=07P6?%EUH, TR.9HYUAO2\T:K*8RP4Q@-R.FX<4 =
MQIFG1:79"VBDFE^9G:6=]SNS$DDGOR?P&!5RF12I-"DL9RCJ&4^H/(I] !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %9FOZF=*TB6>,H;J1E@M4<X#S.0J#Z;B,^V36G4%S96EZ%%U
M:PSA#E1+&&VGVS0!YCK]C?>";GPWXFGDM?LNF,+"^DBW!I+>8@%WSU(DP_U)
MKK]8L[#6/$MEI]['%<6MUI-XKQL<AU,EM_G(K?N;*UO(Q'=6T,\:G(66,, ?
MH:C32]/CECE2PM5DC&$=85!4>QQQ0!YYH*:OH'C/2?">I^;=6EL)IM,U!N3)
M!L(\MS_?3('N,=*M_%.UCA70-7AGDM-0CU**R6YB;:WDS'9(N?IR/0C(KT%D
M1F5F12R'*DCD=N*ANM/LK[;]KM+>XV_=\V,/CZ9% $EO;PVEM%;6\:QPQ($C
M11@*H& !^%<]XQM/#^K6EGHOB%$,-_,4MW9]A295+*5;LV <?ESG%=(B+&BH
MBA548"@8 'I4=Q:V]VFRY@BF3!&V1 PP>O6@#A/"@UO1?%U_X3N]5?6=-BL!
M=6]U/S-;Y?:(I&'WB1D@GG I_P *KRWL_AE8V]U/'!-IWFP7B2N%,#K(V0^>
MG&#SV-=I9Z?9:=$8K&SM[6,G<4@B" GUP!4,^B:3=7@O+C2[*6Z&")I+=&<8
MZ?,1F@#S7Q#!-;:-X2\1O%(=/L-9EO;H!3F.":5RLI'7"A@3Z9KTUM5L?LT5
MPEU%+'/@0F)@_FD] N.O^3TJV0""" 0>H-4[/1M+T^9YK+3;.VE?[SPP*C-]
M2!S0!Q%A:_;/C'XH1+ZXMV2PL\^0R@GA^N0?;\ZD\&1B#XG>/(?M$D[+_9^7
ME8%C^Y;K@"NVCTVPAN3<QV5LEP<DRK$H;GKSC-$.FV%O.9X+*VBF/61(E5C^
M(&: *^O:H-(TB:Z78TY*Q6\;G DF<A8U_%B!7GGB*PU#P7_PCWB>>2U:'2)!
M;7TD08/-!.P$CMGJ=Y#_ %)KTZYLK2]55NK:&=5.5$L88 ^V:+BRM;N(17-M
M#-&IR$DC# 'Z&@#@;R6/1?C-;:U?2JFF:KI'V*VNF;]VLRR!]A;H-R\CU/2N
M]-[;B[CM5D#S."VQ>2J_WCZ#MGU-#6%F]E]B:T@:UQCR#&"F/3;C%)9:=8Z;
M$8K"SM[6,G)2")4!/T H X[4G4?&S0U+#=_8]SQGG[Z?X'\J/&SJOCGP&"P!
M-_/C)_Z8M_B*[!]-L)+H73V5LUP"")3$I<'ZXS1<:;87<JRW-E;32+T>2)6(
M_$B@#BO!<3:)XY\7Z7??)/?7O]HVC-QY\3#!V^NPC!';(I5@;6/C0NI69WV>
MDZ6UK<3K]TS.^1%GN0OS'TR/6NVN["SU"(17MI!<Q@Y"31AP#ZX(I8[.UBM!
M:QVT*6P&T0J@"8],=* /.6\/W<_AK0_%7AHH-?L+8 )G"7L.<M _U_A/8_F.
MG\ WXU7PA#J AD@%S=7<WE2C#INN93M/N,XKH+:TMK.+RK6WB@CSG9$@49^@
MJ1$2-=J*J@DMA1CDG)/XDDT <I\2-+GU'P9<SV0_XF&FNFHV9[B2([N/J-P_
M&N,U";4+.[T+XA6-G(;O5Y'M)+<]?*F4"U!] &2,GW<U[ 0",$9!J/R(?*2+
MRD\M-NU-HPN.F!VQ@8H X+XF64>E_!75;%'RD%I%$&;JQ#H,GW)Y^IKIO$SK
M_P (-K#[AM_LV8YSQCRS6I<V=K>H$NK:&= <A98PP!_&D:PLVM!:-:0&V'2$
MQC8/PZ4 8?@-E_X5QX<;<,#2[?)SZ1+7(?#C3S-\'+*X&J7L2?9[@E(Y$"+B
M23U7^M>EI86<=JUJEI MNW6)8P$/X8Q3$TO3X[=[>.QM5@D^_&L*A6^HQ@T
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MD@0Y6-XP57Z C J9X8GA,+QHT17:4*@J1Z8]* //-3T.^\<:%K5Q;R67D:F
MME*Y;>B0D^4RD<<N&<>SXK'UW5[CQ?\ "S0/$,4333:3J5O=ZG;QC+ PDK*-
MH]SNQZ<UZO#9VMO;FW@MH8H#G,:(%4YZ\#BDM=/LK'=]DM(+??\ >\J,)N^N
M!0!7CUO3)M-CU&"]AFM90#')$P;S,] N.I/3 YS7*?%YU7X<W18A<W-KU/\
MTWCKK;?1=*M+MKNVTRSAN6SNFC@57.>N6 S4UU8VE\JK=VL%P%Y42QA\?3-
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M0VUI;649CM;>*",G)6) HSZX%34 %%%% !1110 4444 %%%% !1110 4444
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M(-/U.TU9/BC8ZU!HUU<V$&F2VKRQ20CYV=6& S@XP*EUU-5U7PQXEL;7P_/
M;JSDA@C>2'?/-(C*6XD*JH^7J<G)XXY *L>G:Q)X!LM7TK7+]-7_ +/CNO\
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M9I+>:,!CB0G<593T))!Z$#BIO[&O=#\=WOB.RM)+JRU>WBCOH(RHEAEC&$<
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M,YZ^M>,Z8%UKX6^'/"5M9FVU2_N9I++49MJ1Q&.Y9F9&!W;PH("X!//:@#Z
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M2WU@[6%VRL&#/'QNSW#+M;/O7(Z!//\ #H6U_([/X3U69O/STTVX+D!O:)N
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MP^8NY/,G5=P]1D\BO.-0O+SP3>ZY%XCT5M4\*ZM=27#ZA;IYC0!\ I,G4JH
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MT(@6,JZKC=RSC&,CK5.?XA:+#X9O->5+N6UL93#>1K$!+;N"%*NC$'.2.F:
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M[RRSRXW2R,<LQ X'T'857\-^&KK0M5UN\FU&&Y75+K[48TMC&8VVA<9WMD8
M[4R[\;6ECH>I:Q<:;J*6>G3-%,VV,DE6VL5&_D \9_P-7)_$D,/V");*[EO;
MY&EALT">9L7&YF)8* -R]6ZD#K0!8\0:9+K7A^_TN&Y2V-Y \!E>(R;5=2I(
M&Y>>?6LFR\/Z]9Z!9:,FNV:P6\$=N98]/=96C4!3@^<0K$#K@XSG%6D\4P-I
M^J7;:??QMIF?M,#QJ'7"!SCYMK#:0<@D'MFB+Q?IC>&;77YA/;VEV$-LDB R
MS%\; JJ226SP.M %C3M+N[76-2U"ZO(;C[7L6-4MS&88T!VIDN=PR6/0<L?I
M69I_A&:Q\4:[J1OX)=.UC:9]/-J0 P3;NW;SR1][Y>:NOXGAM;FUAU.PO--6
M[D$4$MSY91I#T0E';:3VW8ST'/%(/%FGKXL'AJY2>UU&2$SP"8*$G0$@[""<
MG@\'!XZ4 4M$\-:OX:M1IFEZO;/I,9/V:.\M6DEMU)SL#JZ[E';(R/4TNO\
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MM%U$003H-28O=XNYOWK'@G[W!QQD8XJ&+P1H4.F+ID<-XM@J[!;#4;CR]O\
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M47?A Q_;(\<R2AMERI^D:AO^!FO4O#KK?6-WK2G*ZE*983_TQ V1$>Q5=_\
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M3J+N"2[??<&WO)8A*<8R0K 9P ,]<"@#A=5UN'Q!H?PZUF&U-G!+KD*F%O\
MEDP65-N?3<"!Z\5W/B8YM].0?>?4K;:/7$@8_HI/X58N/#VD76B)HTUA"=.1
M55(%&T)M^Z5(Y4C'!'--L_#UA974=T#=7$\0(B>[NI)S'D8.W>QP2.,CDCO0
M!R(COY/C3JPL+FV@?^Q8,F>W:4']X^, .N/SIOP[E>T\4>,=+U'$NLQ7<4]W
M>H<13K(G[L*O\&%&-I)/N:ZJ7PEI$NL3:L8[M+^9!')-%?3QED'(7Y7 P/2H
MY/!7AZ32+C3#IX%O<S+/,RRN)'D!!#F3.\L"!R30!P%LI'PL^)1((!U'52/>
MNQT*'5X='\/W4^J6HTZ&V1YXUMS&=GDD#+%SG!([#U[5KS>&])N-#ET:2V;[
M!-N,L2RNID+$EBS AFW$DG)YSS42>$M(CBMX=MXT-LR-%#)J%P\8*$%<J7((
M! X((XH YGX;%DUSQQ!=G_B8C7))'#?>\AE7R3]-H.*[P"#[4^-GVC8N[&-V
MW+;<^V=V/QK-U#PSI6I:BFHRPRQ7Z)Y8N;:=X)"G]UF0@L/8Y%7K.PM[")D@
M5OF.7>21G=SZLS$D^G)H X_P:,^//'H/3[;;_P#HA:[FLO3O#NF:3J%[?V<,
MJ7-ZP>X=KB1_,(& 2&8C@<5J4 17('V:8]]A_E7 > HKF;X%6,=EG[6VFS+
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M#Z[;-;!?O KN+-] N<FF:YX6DU[5]8OM,F%IK^G7,4MA=>C>2F8W]48<$?\
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M(3]Y2&'(Z$$'%8-]9R+X9^)7B6X5K>#7(C'91RC8TB1Q%%;:>?G)) ZXQZT
M=,WB_5]+N?"YU..RN;77G2$&UC>*2"1UW+PS-N7L3QCK7;RB0Q,(F59,?*SK
MN /N,C/YUY19QP>&[[PYXIG=]0T2>RAM7EFD:<Z7,5 $B$D[4;[K8Z'';BO5
M!=VQM?M0N(C;E=WF[QLQZYZ8H \UB^(6OP?#F/QK>0:9-:K,4N+.&-XW""8Q
M91R[ G(!P0/K72^+O$.I:-)H']G?9=FJ:A%8M]IA9C'O5FW##KTV]/UKS+P[
MIQ'P]T/Q#;K)J<6DW=Q+J&D/(TB/&9G(D6,G D08<<#(S75?$#6M&U>V\&SP
MZA#):/KMO*[I-L*1['RQ((*XR,YQC- ';V_]N+J)AN+K3IH# S;HK9HVCDW
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MAU"&WOM0@CL48N,Q$C#MC/!5=Q'^UM'>@#I?"OC%?$>KZU8-!Y#64J-;$_\
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MC/8# [8XKG-8NDM_BK966HZI>6]A+HSS/$E]-%&9A*H!&UAV)H ]&I  HP
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M='4H;A+?[1%^[BC=3\S;L%FVD\9QNQVKHX]2UBZOK:%=#N+.W+YGN+B:$[5
M)PJH[$DG [8!)K;HH QO$L-W<6%O%9V<ERXO;:9@CHNU8YD=C\Q'93CWK!\;
M>"YM;GMM9T>3[+J\6V*<9 %U;E@6C?MD=5/8C\1V]% '(W.A7NE>.Y?$^FP?
M:XKZU6VO[5759,H?DD0L0IP/E()''(]*671;SQ#XPTO6=0M6LK+2%D:VMY'5
MI)9G 4NVTE0J@<#)))YQCGK:* ./\0Z9J=W\0/"NIVVGR2V6F?:OM$@DC'^M
MC"KM!8$X(Y_K78'I110!PF@6NM:/KGBB[F\/W,L6IWHGM]D\'W0@7YLR<=/>
ML.3P+KEK\*O$&AQ6T<E_J]W)<Q6D$JB&T5W4B,,Q' "GH.I_&O5Z* ,#[9JL
MS64<7A^>&0.JO<7$L)6).-Y&UR2<# &.N,U%X^TZ^UCP/JNEZ=;&XNKN Q1K
MO50">Y+$<5TE% %'2H773;(W%L8;F* 1E7*EEX&1E21C*COV%<QH5CJWA/4-
M=@&DSZC97^HRZA;S6LL0*&3!9'61UQ@@X(SD'M7:T4 <=JVCZI<^!_$5NMH)
M-3UE)B((Y5VQEXQ&@+,0#A57)'?.,U)IEUX@L_#NFZ9'X=N([J*"&W>>2X@,
M4> %9^'+,!R<8YQCBNMHH X:WM-:T_XC:WK0T*YN+&\M8((FCGA#9CW9)#..
M#N_3I74:5<:C=+<3:A9&R_>;88#(KML 'S,5)&2<\ G  K1HH X[PKI>I6/B
M[Q5?7>GO;VVI7$4MNYDC;(6,*<A6)!R,_C77R,4C9E1G(&0JXR?89(%.HH X
M#P=9ZSH'A>?3+_PW=3RO<W$VU)[<HRR.6 ),@]<'BMV./5G\0:/=W5@WR6,T
M=S)'(FR.21H6P 6W$#RV&<>GK7144 <1'X*FTOX@P:SI4NS2KAY)KVRSA4N#
M&5$J#MN!PP'?!^DGA?2-0MO$GBN?4=-:*SU6Y26$O)&P9!&$(8*Q(SC\C79T
M4 <GK.@7D7C2P\6:7&)YXK9K&\M=P5IH"VX%">-RMS@D CN*9JNCWOBS6M&>
M]LI+'2]*NA?%)G1I)YU!$8 1F 5<DDDY/ QWKKZ* /.T\'SZSK_C-=8TZ6#3
M]9:V:UG$L9>-HHMN\88E6# $?K4E[X=\0>*?!#:)K:K;ZQ92K+:ZDKJT4\D;
M?)(5!W+N'4$<9./2O0** ,"RU77KBW6&Y\/26M[C#RM<1/;AN[ A]Y'H-H/;
MCK61>V&KQ?$VUUV+29[JQATI[)GCEA5FD:0/D*SCC _6NVHH XW7X-9UGPMX
MBL(-$>W-W:O!;1--%ODD=6#.Q#%0O*]R>M,D@\2W'@NWT&RTO[#=M9I:2WEW
M-&4A&P*S*$9BQZX!P.F37:T4 9N@:+;^'/#UCI%GN:&SA$:D]6QU)]R<G\:Y
M?P]I>L:=+XPDN-)F']I7LES:@31$NI14 /S\'C//:NZHH X_4?"1\0^#-.L[
M@2:=J]A%&]I<@J7MIT4#(*D@J2,$=Q6SX6LKO3O"NEV5^%%Y!;)'/L.1O YQ
M[9K7HH YBRT=]5U?4M0UBPN;>0NL-J!=8_<*./\ 5OU+%R<^H':LKPGI.L>&
MHM?TD:3,=)-Q)/I>)XB0K\M&07X ;)&>Q.>:[RB@#@/!Z^(_#'@33]'D\,W$
MU_:0E,B[@$3-DD?-OR!R/X:EO;#7(?B-I^MII,U[;6^E/9RR12Q(7D9U;*JS
MCCY>^.M=U10!F:9=ZG>75P]YIKV%LBJL*22H[R'G<QV$@ < #/K[5A:SIFIW
M'Q)\/ZK!I\DEA807,4THDC',@7&%+9(&WGC\Z["B@#GK'3WO)_$5OJFF,++4
M+@,JS,C++'Y$49!"L2.4;\,5AZ!X6UWPII_B&ULKG[9^[5=&:=QE456VQN?]
MDG&?3'T'>T4 <%K?A^Y\2ZYH-^-!?3-1L+R.>;4'EB/[I<[HE*,6<-T^8 8)
M/'0WO'6EZGJLOAP:=8O<"QUB"^G82(H$:!@0-S#+?,./UKKZ* ,+Q/#>W^G0
MZ?;V$L\%W*J7A61%*09RXY89+#Y>.Q)[#.!XL\*7,-SHFK^&K*:?5-.O!)A[
MLX: @K*A,C<;@>W<5WE% &%&M[)XL2[;3IX[4V/E&5GC^5RV[! 8GIW%8ND^
M"9=!\>2WUA(!H%S;3L;(]+>X=HRVP?W6"9QT!'O7;T4 <-X5TW6/ ]G)H"Z5
M-J>DQ3.]A<VLL0=(W8MY<BR,O()/()R/2G^/=+UOQ!X(N-/M; 2WEQ/#(D2R
MH!$B2(^&9B,DA3T[G';)[:B@#$-[J=S?V@BT&>W^;;+<W,L)$<?!8 ([$EBJ
MC]>U<WXATK4_$_A*YT;6/# NK]E=+:Z\Z+RXF.0DA;<'4@8)"J>A'-=_10!C
MZ<-3L)-/TJ6V-S:PV*B;4FF +3+A=I3J=PRV<UL444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYA!4AF4#;R HJ[XC\4:5,_@SQ3'J4"68GE8).Y6,[X"#N8 A77. ".I(XY(
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M4O&6E4;U R2.>0!SGTK.U/Q9HFE:1%JDVHVS6LTBQ0R1RJPE9FV@*<X//7T
M)[5P":9X?L?$7P_LK5=]D#?>3]MP79"I*'! ^4L<J"/3%9UQ-:)X/\2F&2$6
MUKXOCF;81MBB\Z$EN.B_>.>G6@#V>*:.>))89$DC<95T8$,/4$=:?6=;:[IE
MWJ0TZWNT>Z-L+L1A3S"6VAP<8P2*T: .%U+Q!XJTR_\ #UI<#25EUB=H2H@D
M/V<A"_)\SYNF.U3WVO>(-)UC1+2__L[R;W4'MI)(XW&Z,0F0.,L=IRI!!STJ
MGX\O+:#QGX&66XB0KJ$C,&<# ,3 $^@R0*E\>M9OXB\&07;0E&U1F9)2,$>3
M(.0>V2!^- '2WNIQW/A^ZO=)U33@0C>7=RN'@1AW8@C@?6K,^IV-C'%]NO[2
M!G7(,DJH&]2,GI7D>LOIP\+?%*U1K;RENO,AB4K@.8(QE1ZE@>G<&M?Q5<F*
M>XU'2M5L)I?[&B%YI-]CRKZVS(1Y; Y#\N.,@Y7- 'I=R+AK9Q:21)/CY&E0
MLN?< @_K7*>!?&Y\6V$T%W MCK5NH::V.2I1AE)4SRR$$?3IZ5U$%VK:;#=W
M"_95:)9'64X\O(SAC[=*\\309=8\&>'?$7AJ>%?$&F648@<,-MPNT;[>3V/O
MT/I0!V>B:I/<:-)?:I-:Q!)YHV9 8T41RLF268]=N?QJ2_\ $NCZ=H5QK4VH
M6[6$"DM-'(K*2/X00>6SQCUKST:C<_V'X-UF]MI+72QK%S-J,4@_X]V=YO+,
MGH$=ADG@$ U'XFM7NA\0[W2R)M,N-&0.8?F22Z"ON*XX)";<X]1Z4 >EKKFE
M_P!F1ZC)J%I':2#B9YU"9]-V<9Z_E5Z.6.:))8G5XW 974Y# ]"#7F%_XDT^
MS\1Z)J5WJDEKH-SI1@M[^)%:%9]P+*696 W*!S_LD>M=%X<U#PWX:TO1]&M;
MR:*'4))1IJW0.Z;YMQV\ !<M\N<9!&.M &WKWB#3O#>G?;=2N$AC+K&@9@"[
ML< #/^0,GM5B;5]-MK:.YGU&TB@E_P!7*\RJK_0DX-<S\42$\"S2O_JXKNTD
M=L<*JW$98GV R:I6VJVD/Q(U2;59X5T^_P!,@_LR>8A8GC4OYJJQXR2RL1W&
M#T% '<S7=O;P">:XBCA./WCN O/3D\<TV'4+*X@:>&[@DA5=QD20%0/7(/2O
M(K9SX;\.^$;_ %&\6VM;75[IK2&\+)&;9EE$>YL':0ARN1W XZATC6-OX6U/
M6=*O[6_CFU^/4-3&EE9F@MRP.WIEL;0Y!&,[N,<T >DZCXKT33=!N]:DU*UD
MLK8'>\4JN"P'W!@\L>@%9MSXJ:+QAI=HEW8-HUW8W%R\^>5,10??W;<?,>W;
MK7'>(ET/5O!?C+6- OKK5);O3U%S< #RV*?=&%507"YSQD#&>HK7OK[1M6^)
M'A219[2YMCIUVR$D%228MI&>O1L?0^E '?#4+)K$7RW=N;,KN%P)!Y9'KNSC
M%,35=.EM$NX[^U>VD8(DRS*49B< !LX)SQBO'K'4XM+T/3[P7$D>AV/B6^%T
M]JJN+9&:41.5PPV L#T[@CG%6?$<'AEO#,U_I]V;NWOM<LYY+F<J(Y'\U!(8
M\!1]T?,5&/?(- 'KD%]:75NUQ;W4$T"DAI(Y R@CKDCCCO4']MZ2(4F_M.R\
MIV*H_P!H7:S#J <\GD5+8V=E8V_EV%M;V\#L9-L"!58GDMQQD^M>5ZCH6IG^
MWO">F0%/L-T->TV?9\J;LND2^A\Y7'^[F@#TS4[]4LKV*TU"Q@OHH2ZFX8%8
MB1\K.,@[>E5)/$^F6NK6.C7&H6O]I7-N90 X"X&T9P3_ !%OE&><'TKD=<GB
MUCX2^(?$%[;K"^J:>TD,<P&Z-!&1$HSW))8>[T\7UG;>.?!]U--&L$^B30Q2
M9R)),PD*#W. >/:@#=\*^*3J-O<IJ]W8PWBZG<V4"(?+\T1/M&U68DGOQFN@
MU'4;/2-.GO[^XCM[6!"\DLAP%'^>U>,W3Z9_PK[Q'>JUJ;M?%#/',"N\?Z8I
M!!ZXV[CQVR?6O5?%RFY\#ZZL(\TR:;<! G.XF-L8]: ,B?QBTNL>%6L9[1M*
MU83&X+<O%L@,@&X-@8XR".U=3#J%E<V7VV"\MY;3!/GQRJR8'4[@<<5YB+[2
M=2N_ABGGVT\ 20,&(*EA:X[]?FP/J,=16:]ZECIFO36CM_9UEXO$]XMHJN8[
M;8F7"X(*B3#=#]T^E 'L-G?6>H0F:RNX+F(,5+PR!UR.HR.]<]J.O:G;>/\
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MTAAD+DG!)KF]%NM U*Q\.Z#>Z[I(;2M6DG+W,N)[CYY $:-APSEQNR3T[D\
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M1"3^ !- $DOBIHO&\%BUY8?V++I4M[]HSC:R2(G+[MNWYCV%=(;^S6Q%Z;N
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MG;M4!20Q;>N,$YS6):ZI</\ %FX26#4K>)="\TVLS[U+><!N159ER0,<<\4
M=%_85]_T-&K_ /?NU_\ C-(V@7K##>)]7(]#':__ !FL;2O%^AZ;X8T"2V75
M9K/4I3!:-*C32ELL<.22<G:V!DG':M&#QMI3Z9JU[=)=6(TF3R[N&YC D0D
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M=Q@;L##%E.WD!@N?KQ4$OCS2X[>TNA;WLEE>736EM<Q1!DFE!(P #NY*L 2
M#CW&0#I]J[MV!NQC..:-J[@V!N'&<<USMSXUTVUGF5H;MK>"^33YKI47RXYW
MVX4Y;=C+J"0I&3UZTDGC2R&O76C0Z?JEQ=6LL,<WDVI94$N<.3G[HQR?RS@X
M .C**3DJ"<8Y':EQ7G7C;Q&+W1;"?3%U%8#K%M"E]#)LADQ.JN#AMS*<,,E=
MIQP>1GI?&OB"?PQX4O-5M[1KF6(!54%0%+$*&;)&0"1P.?Y@ Z#%8FM:+?:O
M<PQIJS6VEE&2\LUMU8W"G'&\\H,9!P.03TZT^;Q D5S%9K87DNH/";@V<9C,
MD<8.W<Q+[!D\#YLGGT.+&C:U9:_I::A8.SQ,64JR[71U.&1@>C @@B@#0Z#
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MBG8C*@88LI8#(W 9^M6M?\1V/AN&TEOEN"EU<I;(88B^'<X&<=OU] : -<
M  8 [48KE(/B#H[1ZN;N&^T^;2HA/<P7<&V3RST=0"=P/3COUQ5L>+[-)=2A
MN;.]MKG3[9;N6!XU9FB;.&78S \JPZ\8H W]BYSM&<YSCO2X'I7!ZC\2 -#A
MU#3-#U22*X>T$4\\2QQLL[ #!+?,1G&!W(YP<UT5KXD@N/$3:%)97EM>K:BZ
MQ,$VF,G;D%6.<'@XZ?E0!M452TO4H]6L_M44,L4?F.B^:!EMK%2PP3P2#@]^
MO2KM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %<[XO36Y+.Q_L>"2X07B&]AAF6*62#!W!'8@ YV]
MP<9 -=%10!Y1<^%O$'_"->*M-@T((=0U:&\M5CN8L% 821R1@CRFSGN1C(YK
M7\1^&=4\0>(]7*6LEM:7WAYM.2Y>1,+,79L%0Q;'(!('K797VL:?IMQ9V]Y=
M)%->2B&W0Y)D<]ABKU 'G*6WB?4+KP<]UX=DMI-(G;[8YN82C#R6CWIAB2N3
MG! /L>M:_CC1]2O)M'U72["WU*;3)W:33YV51<1NFU@"W 8<$9KJ+V]MM.LI
MKR\F6&WA4O)(YX4#O5)?$>D,^EH+Z/?JJA[)<',R[=^0,<?+SSB@#DM7TG5]
M3T.Q-OX;BL9!JUK=-9PR0ADCBD#,SL"%+'!P 3VYY.'ZEH&K:AK/C)DL6CAU
M71DL[65Y$P9%648(#$@9D'..QKL-3UC3]&ABEU"Z2W26588RV3N=C@  >Y%7
MJ .!ETS7+JW\$E]&EB?2[E7ND\^(F-1 T>?O8/+9P,\>_%3Z7X?U">+QK97M
MK)9Q:S<RM;S%T;Y'A6/.%8D'*DX/M7;U1N]8T^QOK.QN;I([J]<I;Q'),A )
M.,>P/6@#D_"%GK4 LK/5/"EA8362!)=2C>)Q/M7 ,87Y@6X)W8P,U?\ %=AJ
M3:]X;UG3[![]=-N)O/MXI$1RDD13<N\A3@XXS706VIV=Y>WEG;SA[BR94N$P
M1L+*& YZY!!XIVH:A::5837U].D%K"I>21^B@=Z /-;KPYXCG\/>)+0Z.?/O
M]>COX52YC(,8:$GDD=HC^8K0\2^%M5\1:_KOEVSVUKJ&@+817+R)@3"1WP0&
M+8^8#./6N^M[B*ZM8KF%PT,J"1'Z94C(//M5?3-7L-9AFFTZY2XCAF:"1DS@
M.O4?AF@#B5@\3:GJW@^ZN_#LEJVE22B]9KF$J=T)CW)M8DKDYY /M47A30]:
MT58=!N_"]A-%:3'RM;+Q$/#NR"4^_P"9CCTSSGU](HH XK0M-U6RTSQ<EQHX
M:2]OKFZM8)Y(V2X5T4*C88XR5P<]C65;>#M2@T[Q#INE17EEH]]I,D-OIU]<
M+((;E@P_=D,VU,'D9QD\5Z5574=2L](T^:_O[A+>UA7=)(_110!Q:6_B=SX>
MAN-$D;3(K(PW5FMY&I68! K2$-AH\!OE4MU!(/09>B>&_$-EI'@JTN-'9&T>
M_FDN=EQ$P"%9%!'S#/WP<#L/PKTZ":.Y@CGB;='(H=&QU!&0:DH \OU/PKX@
MO'\075K8^7<?VW:ZK8I-,@6Y$*H"A(8[<E3C/M^&S9Q:W=?$!-?FT"XM;3^Q
MS:E)9X3()/-WXPKD=!US]<5V]% 'E^F>&]>M?"O@FQETF47&E:E]HNU$T1"H
M!*,@[^?]8.!Z&GZ[I-X(?';7FE[H=8DMDL5DN$7SI B1J 58D-O (SCMG%>F
MUBSMH'BQ+_1YO(OUM9%6YA(/[M_O+SV/?(.10!SV@37<?BJ*YUO0=6M[^ZM_
ML4-[=3VTJ;4#2%,0G@G#,21R0!QP*O\ B"VUNY\36BQV!OM#:T='C6X6(+<%
MAAI03EDV\8 ;G)*GBMC2_#NF:.Y>TAE,F-HDGN))V4>@:1F('3@>E:E 'F'A
M_P .^(+*V\ Q76D.AT8SK=E;B)MH:)HU/WN>6S@9X]^*9>>%_$4L.J7=MI^V
MZA\2IK5I!+-&!=1JBH4R&.TG#'GV_#U*B@#C-+M]8N?B++KESHTUE8S:3';9
MFFB9UD65V((1F[-V/^ C\4:?K^HZU>VRZ>;W29]-,5OBX2..*X.[)E4G+<%<
M<,!CH,YKMZ* /*_LNM6*>#HH-$FDUG2]+:.XBM;R 2QIM2/#;_D*,RD]<Y48
M_BJ4Z?=W>@:9INF^'M0M[G3M<M[V\AN9H2[#S/->3>'VL6R>!WXP!BNWU7PO
MH^M7D5Y>VK&[B3RTN()Y(9 N<[=\;*2,\XSBK]C86NFVPM[2(1QYR>22Q]23
MR3[GF@#C?$FE:K;^,H-?LM @URTGLEL[BT>2-)(2KLZNID^4CYV!&?2JNJZ'
MK-IJVE:Y:^'+#446UDM;O28WC3R59]ZM&7PI8=&Z9[>W;W>L:?87]G8W-TD=
MU>N4MXCDF0@$G&/8'K5Z@#AKO2=5FU3PI=QZ)%;QV=[+<7,-L\86!6B9 .HW
M-E@3@8ZXS@9J76A:U-IWQ!A72Y=^L[OL698OGS;K%S\_R\C//;\J]$HH \T;
M1=;TK6[?4T\,0ZS;7FG6]M<VTDL*RVLL0(!!<[2I#<X/;-:ZZ3JD?C70]0_L
MM$M;73[B&;[,\8CC>1D8*H)!(&TC.!GKCGCM** /+X_#>OQ^';11I+FYM/$S
M:I]G\^(-)"97;Y3NVYPXX)'0UUOC72;[Q#X#U33+6.,7MU;;51G^7=P<;OPQ
MFNCHH XK4]!O/%NJ6%S=6<VEP65G=1?OGC:1I)X_+XV,PVJ-QSGDXQ5?P=I^
MMVB6.G:IX4T^TEL%$;ZHCQ,LX48#1J/G#-QG=C'/TKO:J7VIV>F?9OMDXB^T
MSK;0Y!.^1L[5X]<&@#CM"\+7L_@+5/"NL6?V=))+I8YQ*KB022NZ2* <C&Y3
MS@Y'2J2>#M>NIM#U6\DC&IW4;6FO -E6MF0':/H8P..\C&O2:* .#U[2=5LO
M&SZU9^'[?7K&]M([>>W:2-)+=XV8JZF3@J0Y! YXS5;5-#UFQU[3];M_#=AJ
ML+V7V.ZTV)XT^SGS&D5HR^%.-Y4],]<>GHM% '#S:1JK^(_"5ZNCQ0P6373W
M*6SQA(!*A55Y(+$=R!ZXJ_X-T[4-.F\0F^LGMQ>:M+=P%G1MT;*@'W6.#\IX
M/M74T4 <!=Z+K<=WX[BATQIX=9A#6LRSQ@,WV81;2"00=PSS@8[YXI8M$U<Z
MAX%=]-F6/2[.6&];S8OW3-"L8Q\W/()XSQ^5=]10!YSX/T76M'BL]"OO"^GE
M;!U5-:#Q%98E.58)]\2$ #G@'G/8Z'Q%DDB?PG)%"TSKK\!$:D M^[EX&2!G
MZD5VU9VJ:%I^M26CW\4DC6<PG@V3R1[)!D!OE89/)Z^M ''ZOHOB*>]U_P 0
M:1:FWO[BVMK.VMWD19'C20M(V[)56(8JN3QC)Q5)_#VM_:/&#V^@/%#K.CQV
M]N&NXV?S0DJD.2W+9D!)R1C^(GBO3J* .&U?1M7N?!7AN*#3V>^TRZLKB:T,
ML89A$1O"MNVYX)'-&H:#J>K^,+^>:S>WLKWP\=.:X$J,(Y6=F/&=Q #=<=17
M<U1O=8T_3KJSMKNZ2*>\D\JWC.29&QG Q]#0!Q_A2RUVW@M;+4?"6G6=Q8Q[
M'U%'B=;C:N 8P/F!;@G=C S1X5\-WVD>(+>ZL+*ZTC3)K=S?Z;+<)) LY*[3
M %9MO.[/08QQV'?44 <SXST;4-2M].O=&,:ZMIUXDUNTGW2K?)(I]MC$_P#
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MLLB&3Y<@Y!&1_AWVIZ!INL3P37T#2O"KHN)G0%7 #*P4@,I &0V16B %
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M+G!&T<8/?)YXW+#P++97>BW;:_>33:3;O;0[XHPK1L% 4@*.FQ<G.3ZBFQ>
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MNX^7EADG.<X)P1IPM)H^L>'/#.HZZVHZ=<3WBF9@R!G4*8[=F+,6"[FZGDJ
M>F* /0M0N+RVAC:RL?MDC3(CIYHCV(3AGR>NT<X[UGZKKTMKJ8TK3K);W4C:
M/>>2\WE+Y:L%QNP?F); &,<')%<EXCLTT?0;*"QU>^G6+Q';+\UPW[I7F0F'
MC&Y &P V<=.U7)-.M9/C4'97W?V'YW$K#YA< 9Z]/;I0!U6B7^H:C8&XU'29
M-+E+D)!),LC%,##';P#R>.V*TJ\C36;C2]#U!9;VY6S?QB]E<W$D[,T-L6'&
M\G*CA5SG@-70:];:9H5EJRQZSJ$*7TUH%L[:0'RF9PH6,G[@EP0<D=S0!UVM
M:B=(T2]U(6[7'V6!YC$K!2P4$D9/L*QE\7[KCPK%_9[!=?C+B3S1B B$RXZ9
M;ICM_2N6AEGB_P"%DZ=(4B@@L4>*UCF,D<+/;.6"Y QG:"0 .:FC_P!=\*?^
MN3?^D+4 >E45YG(;C1-?UGPEYMRQUTK/I<[RLS1HV%G4,3QY0!D4>AKN=7@:
M+PS?6]I>?866TD2*Z8D^0=A <GKQU_"@#3I&8*I9B H&23VKR2Z\07^A:1K\
M-UILVD:W;V,#R&"4S6\D/F['N(N<A@'8D'!X&2<5IZEH<:6.KW<>NP3V-]HD
MQ^P6Z/Y<Q49$X8R-SR 3T;(SF@#T2UN8;VTAN[:0203QK)&XZ,K#(/Y&L+4/
M$MS'?W]GI.E-J4^G+"UU&LXC;$F2 F1AF"C<02HY'.:7P+!#!X%T,0_QV%N[
M?.6^8Q+ZGCZ5QQ0Z/K_Q)U/3H7>^L;:&:W!=F^?[,3R,\\]C^% 'J5(2%!)(
M '))KS:=GL['P-K&CW4\L^H75O;W1,S-]KBEC+2,XSRR[=P/;![53TW0[?4M
M"\77E[=:A<265_J4,"R7LI41A2 I&[##_>ST% ';7OBJ&WOO#T5O;FYMM:DV
M17*R *H\MI <=3D+[=:Z"O)8;&W;0?A=!&\B+,\;2&.5@V39-G!SE<^V,=L5
MU'@0-:ZCXITM)9GM++5-MNDLK2&-6AC<J"Q)QDDX]Z ->W\0&?QA>>'VLVC-
MO:1W8G,@(=69EP .G*GO6W7GU]I5OK'Q5U6UNVG\DZ#!E8IFCR?.EQDJ0>/3
M./TK$T#6[S5K#P1IVI:A&L5_I,LF^Z5G6ZG1D4*V'4E@I8\DY)S@G! !ZY17
ME=[I5Q8/X5TN3Q%>7Z'6I;9Y(I9(OW1BD;RC\YW;>F[.X=,@BK']GK>>(M6\
M(C4_LL5E8P_85N6EDDV,&+3(WF*2RMQDYQM'3G(!Z#-<7B:G;016/F6DB.9K
MGS0/*88VC;U;=D\CICWJW7GD(N(?&7@R!]8N-0$NF7:S7 =D2Y*",+)LW$ G
M<3N'7.<]*YN..6#P6NM+?Z@U_:>)###(]W(V(S>^65()PP*D@YR3Z\"@#V>B
MF++&\CQK(I=,;U!Y7/3([4^@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "J6J:/IVMVJVVIV4-W"KB14E7(5AT8>A]ZNT4 <CXA\'V\ND3PZ)I&DA[
MF>*2\MYX]B74:8^0LJG;T7!P>GOFJF@>!K.VNS<MX=L-&C:-HI;>TNGE^T*P
MQM<;57:.O0D^W(/<T4 9PT'2AHQT?^S[<Z:5V?960&/;Z;3QBHK#PQH6F:1+
MI-GI-I#I\V?-MUB&R3/!W ]?QK6HH Q+3P=X=L-)GTNUT:TAL;@YF@6/"R_[
MWK^-6?[ TL75K=?8H_/M4,=O)SNB4]0I[#VK2HH R#X7T)M/N]/;2K5K2[<R
M7$+)E9')R6(/\6><]:9%X2\/PZ0FDQZ1:)IZ/Y@MPF$WYSN([G@<GTK:HH S
MUT33%OWOOL<1NY(O)>9AEGC_ +I)ZCV-5HO"FA6\%O#;Z9!;I;;O)\C,9CW8
MW8*D$9P,_05LT4 16UM!9VT=O;0I#!&H5(XUPJ@=@*S(?"F@6^NOK<.CV<>I
MODM<K$ Y)ZG/J>YZFMBB@#*F\-Z-<:9_9LVG0267FF;R'7*;R=Q;'KDD_7FH
M]1\)^']6N[:[U'2+2ZN+8!8I)HPS*!T&3U'L<ULT4 9&L^%M!\0RP2:OI-I>
MR0?ZMIHPQ7V^GMTK&O/#<UY\1+?5);)3IL.F-9HZ3;'20R!LJ%((7:"O7OTQ
M7844 9MSX?TB\TV'3KC3;62R@97B@:(;$9>A ['K^9JU=V%I?V$EC=VT4UI*
MFQX74%67TQ5BB@#$3P?X<CSLT2Q&;<VI/DC)B.<J?4')_.K]EI5EIS.]K $=
MU56<L68J,[5R23@9.!T&35RB@#.O-!TO4+IKFZLTDF>,0R-DCS(P2=C8/S+D
MG@Y')KGAX8DN?B!J.JWEBIL)K&*UA=9MK#8SE@0I!VMN QWQR*[*B@#+U/PW
MHNLZ;%IVHZ7:W%G%CRH7C&V/ P-O]WCCBFW?AC0K[18M&N=)M)--BQY=L8AL
M3'0J.QZ\CU-:U% &4_AO17TVVTXZ9;?8K5@\$ 3"1L#D, .^><]<U-_8FF_V
MJ-4^R)]O">5]HYW[,YVY],\XZ5?HH RT\-Z*EE>60TVV-K>L7N863*S,>K,#
MU)]>O%0P^$/#MOHDFBQ:-9KILIW26XB&UVXY/J>!SUX%;5% &.GA30(OM'EZ
M19I]HA%O,4B ,D8_A..H]?7O4@\.Z0/L.+"'_0!BTX/[CC'R?W>...W%:E%
M'/:79:O=ZO\ VEKMO8PO:K)#9QVLC2?*[#+L6 P2%48'OZX&Y=6T%[:S6MS$
MDUO,ACDC<95U(P01Z$5+10!0MM$TVT258K2/$L8BD\S+[HQG"?-GY1D_+TY/
M%5](\*Z#H,=Q'I6D6EHES_KA%$!Y@]#[<GCIS6O10!4TW2[#1[);/3;2&UME
M.1'$H4 U';:+IMG?W%];VD<=U<X\^5<[I<# W'O@=,]*OT4 9ECX>TC391+9
M6$,#+NV!!Q'N^]L'1<]]N,U)8Z+INFI<)9V44*7+F2=5'$C'JS#N3W/>K]%
M&-#X3T"VCM8X-)M8DM',EN$3;Y3'JRXZ''&?3BKEGI-AI]Q<W%I:QPS7+;YW
M7K(WJWJ?>KM% &>VAZ:^H37YM$^US1^5),,AV3^Z3Z>U5+CP?X=N]&CTBXT>
MTDTZ)MT5NT?RQGU7^[WZ>IK;HH RCX:T4PV,/]F6XBL#FT14P(#ZH!T/N*;K
M/A;0?$,L$NKZ3:7LD'^K::,,5]OI[=*UZ* *$NBZ;/?6]])9QFZMT*0RXPT:
MGJ%(Z ^U5O\ A%="^PFR_LNW^RF7SS#M^0R9SNQTSGG/K6Q10!3MM+L;2^NK
MZWM8X[JZ"">8#YI @PNX]\#BKE%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K)USQ+I/AR*.35+HQ>9G8B1/*[ =3M0$X&1D
MXP,BM:JE[-:Z?'+J$R?.$"95<N_/RHH[DDX [DT &F:G9:SIT&H:=<QW-I.N
MZ.6,Y##_ #QCM5NL#P;H;Z!X?%M*JI///+=2Q(<K$TCE]B^RY"_AFM^@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P->\++KU[:W3:SJMDUL#Y
M:64R(H)X+<J3NQQG/3..ISOT4 9NBZ.NC6CP?;KZ^9Y#(TU[+YDA. ,9P
M.@%:5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>exhibit1061-loanandsecur019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'&9IY8-D'&UW^60L<*6P .?:@#F#KUJ?&&KZ-XGU/4=(U"2X/]DS"Y>&W>#
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M:2/$+:]]C4ZFR"/SV9C@ 8& 3@'!(R!G!K4HHH **** "BBB@ HHHH ****
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M%74J1L7G<:+CP' ]I;R6]Z\.KP:@VI+?&,-NG;APR9&4*_+M!' '.1FNOHH
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MM4_QKP1WKK5='W;&5MIVG!S@^E #J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** .%^,9 ^$VO9./W<?_HU*\JU
M@_V'H'PXUK3[@ZMJAAACBTJY(F0 HIW1IU0@@#/T]*^B+JRM+Z,1W=K#<(#D
M+-&' /T-16NDZ;92>9::?:6\F,;HH50_F!0!Y3H=I-X=_:*UA]2!CBUNS9K&
M9_NR-F,E ?4;6&/8>HI?%MG+XC^/?AF#3LR?V/$MQ?2IRL(WE@K'L3@#'^U7
MK-Y8V>H0>1>VL%S%G/ES1AUSZX-)9Z?9:="8;*SM[:(G)2")44GUP!0!X3:6
MNNWOQ.^(Z^&M2-GJBQAH<*C"4@C*_,#@GH",8.*V?A[?Z++\&-?L[&V^QZE:
MVER-3AD8ES-Y;#><\X./PP1VKUF#1],MKC[1;Z=:13<_O(X%5OS S2/HNE22
M22/IEDSRY\QF@4E\\G)QS0!\UPVVKQ_!30;\S37WAB.\?^U=,3:AVB8D,'4!
ML?4\'!Z=.Q^(J6DTWP^\8Z2!)X:T^>(.8A\MO'O0J2.P 4J?0@"O9H=+T^W@
ME@@L+6*&48DC2%55Q[@#!I\%A9VMNUO;VD$,#YW1QQA5.>N0!B@#S7XY3+?^
M!;72;("ZOM4O(EM(8CN:3'S%ACMC'/3D5#\3/!]R_P (M.,3%M5\.00S)*G4
M^6@63!^@W?\  17I-GHFDZ=,9K'2[*UE(P7@MT1B/3(%79(TEC:.1%='!5E8
M9!!Z@B@#PCQMIVLOH/AGXD):D:['=0RS0)GB)PHC3Z9 R/65J]!\96;Z?\'M
M<AG93<&PFDG8=&E?+.1[;F.*[5X8I(Q&\:,@((5E! (.1Q[$ _A3+FTMKV+R
MKJWBGCSG9*@89^AH \D^&9M-!\$:/XHU#6F6QBTN>%X)I%VQ-YP8>6  <G:0
M1R20*@\=K-=?';P9'#<O97$ED^V555FB8B7'# @\UZL/#NA@Y&C:?G_KU3_"
MI9M'TRXN/M$VFV<D^<^8\"EOS(S0!Y-\+KD:?\0_$6F>*4SXRE;(OG.!=0 #
M 0= ,!3@#D8_NUV?@"/PI'-X@_X1BYFF=M0=K[S"QVS=PNX#CKR,_6NJETZQ
MN+I+J:RMY+B/&R5XE+KCD8)&13[>SM;0RFVMH83*YDD\M N]SU8XZGWH FHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_A(=$_Z#&G_^!*?XT?\ "0Z)_P!!C3__  )3_&@#2HK-_P"$AT3_ *#&G_\
M@2G^-'_"0Z)_T&-/_P# E/\ &@#2HK-_X2'1/^@QI_\ X$I_C1_PD.B?]!C3
M_P#P)3_&@#2HK-_X2'1/^@QI_P#X$I_C1_PD.B?]!C3_ /P)3_&@#2HK-_X2
M'1/^@QI__@2G^-'_  D.B?\ 08T__P "4_QH TJ*S?\ A(=$_P"@QI__ ($I
M_C1_PD.B?]!C3_\ P)3_ !H TJ*S?^$AT3_H,:?_ .!*?XT?\)#HG_08T_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFB@"M_9]E_SYV_\ WZ7_  H_L^R_Y\[?_OTO^%6:* *W]GV7_/G;_P#?I?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O-/%.CC2=3\(6T.H:HWVS5!#=N=0G'G*8W8@C?
M@#(S@8Q7I=<CXPTG4M3UKPU<6-IYT6FWXNIV,BK\NUEPH)Y/S9[#WH 9J]OI
M?AU-.@O(]3O(+S68/LQ^U._V>9MJKN9GW%,@MCD<D8Z4^TU^[U?Q)XET2?3Y
MX;6Q2*-94E4'YD9]Q*MN&05QC.,<XS4_C/3+_58=%%C;>:;75;>\E!=5Q'&V
M2!D\D]A^HJ"TTK5K#QCXDOELXYK+4XX'C<3 .&CB*%-I[DX.<XQ0!G^"O$,.
MG_#KPLMR[3WMY:9C1I%4OM&68LQ P,C)SW%;&G>-+;5M*%[8:??7#I?_ -GW
M%O&JL]O(&PQ;#8*C(.03P17+6?A7Q)I&@>$KFSL;6YU+1+>2TN;":8*EQ$^W
M)1^0""BD9'K^/8PS:_#IL,PTFS%U/=)YMHEP MO"<!COV_.P SC ZX&<9(!O
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 45B^*_$4?A3P]<ZU/:R7%O; &5(F ;!8+D9X/)]:<FK7XN;9
M)]%GCBF?89EF1Q'D$@L <XR,<>HH V**** "BBH+R6>"RGEMK?[3.D;-' '"
M>8P'"[CP,GC)H GHK N?$<MGKF@:7<::Z2ZLLFY_-4B!DC+E3C[QXQD8%;]
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH P
MM6O[Z/Q%I&F6DT427<=Q)([Q[S^[V8 Y']XU13Q!?:CKFL:98W5C;WFGL%BL
M[F-B\XV!M^0PPI)P, XQDYSBK&J_\CYX=_Z]KS^459/B;3;/7HKL7^CW\>IV
MKL-.O;.%O,/=2KK]WDXPY [^] '1Q7[OJ=A;RW]M%.]JTDUB4_>L?E^8<Y4
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MR+SV9E5,_>8#)4>K <XZUQVE6$RW9TC5="U"XG@U)[J"\,K?9B#*TBRYW8#
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MN 1]W&Y0!GN3NS^'N*R#%<Z=XJUZ6[LKB[LM3MX?L[0Q&091"K1-C[N2<@G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
)110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>exhibit1061-loanandsecur020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'&9IY8-D'&UW^60L<*6P .?:@#F#KUJ?&&KZ-XGU/4=(U"2X/]DS"Y>&W>#
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M:2/$+:]]C4ZFR"/SV9C@ 8& 3@'!(R!G!K4HHH **** "BBB@ HHHH ****
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M%74J1L7G<:+CP' ]I;R6]Z\.KP:@VI+?&,-NG;APR9&4*_+M!' '.1FNOHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,T+HJD\*H) W$\\#T]Q7+_#_ ,1V&A_#32+>^6[2ZMK8B2W%G*9-P8\ ;>M
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M&H:-)&%\+6UR-8M92?ER^2(?3:L@:3VPOK0!#8^,?$4_PJUCQ-<26D>I6;W
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MQIDEU+I-G)?(([QX$:= .%D*C</SS6)I'C*POK&'[0EQ:ZD$ FT^2!Q,CXY
M7'S#/<<8YS6K'J\1U6'2Y8IH[R2U^TE?++(J@A2"X&W.3TS0!H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!!;VD5LTSH"9)GWR.QR6.,?H !BIZ** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M Z>GI6O0 445'<)*]O(L$JQ2D81V3<%/KC(S^= $E%8OV#Q#_P!!VU_\%_\
M]LH^P>(?^@[:_P#@O_\ ME &U16+]@\0_P#0=M?_  7_ /VRC[!XA_Z#MK_X
M+_\ [90!M45B_8/$/_0=M?\ P7__ &RC[!XA_P"@[:_^"_\ ^V4 ;5%8OV#Q
M#_T';7_P7_\ VRC[!XA_Z#MK_P""_P#^V4 ;5%8OV#Q#_P!!VU_\%_\ ]LH^
MP>(?^@[:_P#@O_\ ME &U16+]@\0_P#0=M?_  7_ /VRC[!XA_Z#MK_X+_\
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M_8/$/_0=M?\ P7__ &RC[!XA_P"@[:_^"_\ ^V4 ;5%8OV#Q#_T';7_P7_\
MVRC[!XA_Z#MK_P""_P#^V4 ;5%8OV#Q#_P!!VU_\%_\ ]LH^P>(?^@[:_P#@
MO_\ ME &U16+]@\0_P#0=M?_  7_ /VRC[!XA_Z#MK_X+_\ [90!M45B_8/$
M/_0=M?\ P7__ &RC[!XA_P"@[:_^"_\ ^V4 ;5%8OV#Q#_T';7_P7_\ VRC[
M!XA_Z#MK_P""_P#^V4 ;5%8OV#Q#_P!!VU_\%_\ ]LH^P>(?^@[:_P#@O_\
MME &U16+]@\0_P#0=M?_  7_ /VRC[!XA_Z#MK_X+_\ [90!M45B_8/$/_0=
MM?\ P7__ &RI[*TU>*Y#WFJP7$.#F-+3RR3]=Y_E0!IT444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?/\ _%T ;5%8O_"*:3_<O/\ P/G_ /BZ/^$4TG^Y>?\ @?/_ /%T ;5%8O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6=J,&J3WX/\ 8UXGV;7X[C9;Q*(GB!_UN<@NS#KZ>W4@';W6NZ592,EUJ%O
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MA5HFQ]W).03@?,>:RM'T'5M'O-$MYHYI&707L'N(OF6&4NC#)SP  <'OMXH
M[--7L+JY:RMKZ'[649D7.<XX)']X ]<53\.ZA>7SZO#>/'(UE?M;(Z)LW*(T
M;D9/.7-8'A.U=O[)M]0\/W\&HZ3$8FN9Y6:%/DV$Q'<0V[C@#@9]!G7\*_\
M']XF_P"PNW_HF&@#HZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** *%]H]GJ-U;75PLOGVP<1213O&5#8W#Y2,YVCKZ
M5?HHH 9+$D\+Q2H'C=2K*>A!X(K*L/#.GZ:8Q"UX\46/*AFO)9(X\=,*S$<=
MO3'%;%% !1110 4444 %%%% !1110!B1>%=,AGD>+[6D4CM(]LMW*("S'+?N
M]VW!).1C!STK;HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *S].T6RTJ6YEMEE,EPY>1Y9FD/4G +$X7)/ XYK0HH **** "BBB@!L
MB"2-D)8!@02K%3^!'(JIIVE6FE).MHCK]HE,TK22M(SN0!DEB3T4?E5VB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
2**** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>exhibit1061-loanandsecur021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7;@B1'56P>.A'.3R,UW%% '$6/@JZN?'\GC/7)+=KV*#[/86ENS-' N#DER
M68[F_A &X]>*I^$_ FJ:-XQ\3ZMJ+6$UGKKEFACE<M&-S'!R@#9#8[5Z'10
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MQ=H&NI$$3!BP_P"61W8)![=*[S0;?4[;2476)X9]09Y))7@SY8W.2%7/. I
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M7+QXV8/* '[G3CK7H-% 'G_C+P5K'B'QQX<URTDL4M]&E\PQS2N'E^921PA
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7*1#:86@8\\@# 7N3QEN>Z\97=K8^ ]4GU![L6ZVA64VS!)N1MX/13D]>@H
MWWFB2)Y7E18T!+N6 "@=23VK.3Q#IDEGI=TMP/+U0H+0'@R[EW# _P!T$UYS
M$++_ (2[7M/#:68+GPVC_9;/!B,BM+@?[;!0/FP.,<"J5O:Z"WACX92M;Z:8
M_/A2Z<HF-QM&)#GU)"YSZ"@#V8LH8*6&X]!GDT%E4@$@9X&3UKQGQ3?Z7+::
MW>V$UO%-:ZY:J9;B0-<;U>%2(>GEQ!<XZYR_05L-=^'M9USQ=IOBF[MXGWQ-
M9R2RJA6T,2E'@8_[>XDKW(]J .PM]?N)/&]]H,UO#'!;V,5VDPD)9][LN",
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVPNK$6-Q96TUH  ()(E:, =!M(QQ3!H^F"WEMQIMF()MOFQ^0NU]N ,C&#C
MQGT%7:* .?U;1;[5-?T>Z\ZVCL]-NC<A<,9')B=,>@Y?/X5T%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>exhibit1061-loanandsecur022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur022.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 5[5=JM_OM_.K%06_W3_OFIZ "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH K6F=C9_OM_.K-06_W3_OFIZ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@""V^YCT<U/5>V/RG_?/\\58H **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@"K:<HW^^W\ZM57MONM_OFK%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[;E6(_OFK%5[
M481A_MFK% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 06_
MW3_OFIZ@M_NG_?-3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!!;_ '6_WS4]06_W6_WS4] !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 45FZAXAT;2IU@O]4M+:9L8CEF56P>^.P]^E
M(WB'1EM3=G5;+[,K;&G\]?+5L X+9P#@CKZB@#3HK)@\4>'[J:.&WUS39996
M"QHETC,Y/0  \FEN/$V@V=R]M<ZUIT,Z'#Q27**R_4$Y% &K156UU.PO;1KN
MUO;>>V7.Z:*5608ZY(..*S_^$P\,\?\ %0Z5ST_TR/G]: -JBLQO$FAI9+>-
MK%@+5F*"8W*;"PZC=G&?:EG\0Z+;6D-W/JUC%;3_ .JF>X54D_W23@_A0!I4
M5EV_B70KN=8+;6M/FE8$B..Y1F( R3@'L!FI+'7=(U29X=/U2RNY4&YD@G5R
MHZ9(!H T**SKW7]'TV;R;[5;&VEQG9-<*C8^A-7+>ZM[R$36T\4\1.-\3AAG
MZB@"6BFK(CE@K*Q4X8 ]#C.#^!'YUF77B;0;&YDM[O6M.@GC.'CEND5E^H)R
M* -6BLNV\2:'>NR6NLZ?.ZH9&6*Y1B%'5C@].>M0CQAX9()'B'2L#K_ID?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JNI7$EKI=W<
M0KNEBA=T!&<D*2*M4A (P>10!P7PE"W7A)]7F(EU&^N97NIVP7<AL $^@ &!
M[T_Q[I-GI?P\\2M9Q"(7;+<2(H 7>3&I( Z9V@_4FM.Q\'MH;W(\/ZI)8V]S
M+YSVTD2S1JQZ[!P5S]3TJQJWAAM7\/W.D3ZE.R79S<3.H9ST.$'"H/E'&#W[
M\T 8?@AFU;0M/T^^L#';65A87-L[%27?+G>""<<H!@\]?6L_7)AI_P ;+"Z2
MTGN#_9#,Z08+G#/R Q&>!T'-=.GA6=- MM$&KRBRAB2$XA4/(BG[I/N!@X X
MITWA4S^,8/$K7[BX@A-ND(B&SRR2<'OGYCSF@#E_ %M;>(M0\2>(%D5;#5',
M!TX-RH P6<#&&89/']X\T>,$AM_B=X'C6(+$AD5$3Y0O0#'L..*Z?3O!]OI/
MBJ]UNPNY85OL?:+0*OE,W]X=P<Y/XGUINL>$!K/B33M:EU"2.73FS!$D:[>N
M3NSR?TH R?BA96UI\-->:WA6,SRQ328_B<RQ@M]3@5E?$S8/A)8% I0&V*XZ
M8V]J[?Q1X>7Q1HDNDRW3V]M,5,IC0%CM8, ">G(':L[7/!9U[PW:Z#<ZDR6D
M"H"\<($CE!@9.< 8Z@#J.W2@";2;B;6]6FEU'3/LHL6CEL=S*S /&P9LKZY(
MQ[5Q?@ZZ?3]9^)MW %$EO.\J CC*F<C^5>HVUO);6$5OYWF21QA!(R8R0, D
M"L'P_P"#HM!U/5[T7KW1U63S+E)8UQNRQXQT'SG@YH S/A5;PR>"8=2=O/O;
M^262ZG<9>1M[#!/4X KI#'I_AC2;^Z11#;*TEU(!T!/)Q]3_ #K/TKPF_ATS
MQ:%J)M[.>0R&UN(O.2)CU\O#*5'L<U;GT*>>"T@?4YI(XI_/G\Y YG8,& /9
M5![ >GIR <3X1UB?3_B-J&E7NHP78UB%;Z-HI X28+AHP03@ *0,]D6MOXAV
M%M:_#_Q%+%$JR7 665L<LVY!G\@*O>(_!T?B'4=.O!>O92:>WF0/;QC?NSSE
MCQC@<8]>:O\ B/0W\1:-+I;W?D6\Z[9F6/+D9!&TDX'([@_A0!0\%65M)X2\
M.WK0H;F+3HXTEQ\P5E4D?3@?E7%_#K4)TOM3TN&Q+P7&N3_:)V"E$3RV(4C.
M<DICICG\*](TG2I='T"WTN"Y5S;1"**62+/RC@;@",G'H16+H?@R?PY]N_L[
M5N;Z<SS-/;!R&.?N88 =3U!H Z6QLH-.L8+*U39! @2-<YP!T%<!\.)I=5\2
M^*]4OF,MXEX;6-V_Y9Q*6PBCL.GY5WFFV)T^PCMFN)+AEW%I9,!G8DL2<<=2
M:RO^$76SUZZUG2+K['=7@ NHWC\R&4CHVT%2&]P>YXH YNQEEL/C=J%E;!A:
MWNGK<3Q@_*)!@;\>O&/QK!\(ZI>:?K?BB*RTT3++XACBN)RPQ'$\Y0_+U/4]
M/7/;GT;3?#BZ=<WVI?:?M&L7H DNYH^  ,*JH",(,#C.3W-0>&_"47AS4-5N
MX[R2=M3F\^970 *^2?EQV^8\<]J -RSM+>PM8[6UB6&"/(2->BC.<"O/?A[8
MVMUJ'CB*X@26.;5Y8Y$<9#+N;C'XFO1I1(87$+JDA!VLZ[@#V)&1G\Q7*Z5X
M,N-(;4S:ZW,IU.9I[EA NY7;.3&?X>O<-VH X?PU=W<WP8\46MU+),MF9X(I
M'.?E"@X'L"3^=;WP_8ZIX8TK2;W3BEG'9+/'*^T^8XE)RN"2,8'7!YKHW\'6
M4/A%_#6FO]DLI59)&*^8[*V=Q!)^\3W.?3'I'9^%;VPT&+0[?6=EA'&8MPM\
M3%3G(W[L#KU"YH R?BC8VUK\.->EAB59+B6&65N[-YD:Y_( 5O\ AK3[9]!\
M/WQC N(=-BC5QP=K(I*GU&0#]13_ !/X<'B70WT=[HV]I+M\TJFYR%(9=I)P
M.0,Y!S[5=L;"73M#M]/@N%+V\*PQRR1Y&%& 2H(SP/44 >7?"N\EBL9;!;(R
MVM[K,\4\C %%46Y;:1G/)4=L8SZUK?%"SATWP=H-G;1GR;;4K:*)<Y.U4< 9
M/TK<\/\ @NY\,6=Q:Z7K)$=S.9Y6FM@[!C@';A@!P.X--U;P*=7TFPTR75YU
MM[.07&\1*999LL2[,>,?,> /QH P)YT\5?%G3_L2O87&B*QO1. LDH)X5=I.
MY??.,/3?B-ITBW=SXCL4 U#1OLMPK!>63<X8'VZ'Z UU.L>#$U75=.UF._DL
M]8LDV_:H(QB7CHRGJ.O&>A(S6C'H\[WVH2WMU!<6]Y"(6@6WV[5&[')8YX8Y
MX].E 'F/Q'OX?$W@N77+=BUE&8(K<'IO;#2'ZCY4^H85I?%Z)HO FB1R+ATO
MH%8=<'RGR*Z;5_ EOJ?A2R\-1WC6VG6RJ&*QAI'*]#NS@9.2>#GVI/$/@J3Q
M+I%AIE]JFR"T*2;H;?#O(JE0<EB ,'ICKW[4 5O'/AB+Q3?65D=T=REG<RVT
MZMCRI5>#:3[<D?C6+X9\0WFJ^(M'T37(Q'KND33"?<-WFKY+ .#V/(R1UZ]^
M.Z_LO4'UFSU";4("MO"\+1);%?,W["QSO..4&...>M.N/#]E/XCL]=P4O;:)
MXMR]'5NS?3M]30!RGQ,NIKO2[C2;.]AM9X(!?,SS*C.5<;$4$\YVNWU11WK<
MT#4;/QMX.L[J7+),J>>@)'[Q""RGU&X?B#[U>TK1YK'[=)=W<=Y<74YF,A@V
M[?E"A<;CP !CFL[PEX0_X13[6D.H//!=2&9H#$%1')ZIR<#'&#GH/Q .8>&*
M3X^A'C1E_LS[I4$=*A^+NE6UOX2TFPLTCMXI-6&,\*ID$C,?898FNJ'@^;_A
M-!XG.IK]J"^3Y0M_W?E>GWL[O]K./:I/%_A-_%L5I!)J'V6"VE$ZA( S&0 @
M').,<],?C0!SGBF>:]^+7AC1)]YTSRFN3#_!)(H<@D=\;!U]Z?\ %F232K'1
M]<L $U*VOTCC91AG0AB4)')4D#BNIU;PU'K!T^ZGG,6J6#^9!=P)MVMW&TDY
M4]P3^-1W'AF35-4LKS6KU+I+)O,@MHK?RXQ)V=@68L1VY % '+^,?"EQKWB*
M^O\ 2Y6@UK3;:UFM'4XW'=-E3]<#\O2K_@KQ7#XKU3SGB,.HVUEY5Y"4(\M]
M_;/8XSCMWKIK73+F#7KW49+N.2.YB2(0K"5*!"Q7YMQS]]L\>G3'++/PY8V'
MB*^UJV4QSWL:I,B@!6*D_-]3GGZ4 :]%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% $%O\ =/\ OFIZ@MB"K8_OFIZ "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\=K]I \I0^<#Y2<=.?K52U\2:JWC?7](O-8$-EID22I(MLF\A@IYXQQNQ[T
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M=T2YU2&"UTQ8F2X%NOF.9 " V3MZMC@#/% '2CPIH(0(-(M/+5MPB\L; ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF^X!G*CCWZT ;OA[3H;*S>X@5XEO=EPUOOW)"Q1053VXS6Q3418XU1%"JH
M'8"G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%O\ =/\
MOFIZK6A)1L_WV_G5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@CJ-N-V?;%8FG:_%XF^&DVIH?G>QE69>ZR*A##\^1[$5R>K:=<?#/6E\1Z/
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M@"K9_P"I/^^W\ZM5!;$>7C_:-3T %%%% !1110 4444 %%%% !1110 4444
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MRU&YN+I)[$[K8PLJ;"<9.<9.<#@\?F:WAP*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K6O
M*M_OM_.K-5;/_5$_[;?SJU0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$;9)\H X)SG;G\16>F@:S%X5L@--E:YL]?\ [0-L)$WO%YK-\IW;<X8=2.]
M'7^(M<DT3PQ=:M'933/%"9!%@90XSEN>@[XS[9H7Q"BV-I)+9W?VJY!,=HL8
M,C8 W-C. HR.2>X[D"E\2V-SJ_@_4[."+%U<VCHD;,/O%>%STZ\>E9"V^JKJ
M.C:Z-+F5H[5[.[LC+&9$4E2'4[MIY7GD'!'IB@#HM,U:UU:&22V9@T3F*:*1
M=KQ..JL.Q_0]1D5RNJ:VEIXUGL=>NKNPL)(H_P"SITE,4+-CYPS*?O9Z!N,#
MWYVO#^FSV^HZQJ=Q";<ZC.KK Q!951 @+$$C)QG /'%,U-I[J:]L-1\/-J.G
M,0T#(8F#?*,AE9@00V[!H ECOVT'1K2/4KN34+R1BB-$H+S\D@@<#A>IX'%+
M'XIT^6R-Q'YS2^>;;[*$S*9@-Q3'3..<YQCG.*Y63PMJMGH'A]_[/@U:736F
M$NG7#JP,4F2JAVXW( H!QS@U:NM&U7[-IVKZ;HEE975A=-.FEHRKYB,AC?+K
M\N\@Y![8% %_5/&\=GHCWUMIUW+-'<I;3V[J%:W=BH^?G_:&"N021SU(T#J-
MG)XET^"1KZ&^FM))4MR2(]F5SO .TL#]<<^M9>O0:[KGA*X#Z6L-P9[>6&S6
M96DVI(CMN;(7/!P,_C4TUC?WOC72M3:RE@MTT^:.4LZ$QNY7"\$Y/!Z9'O0!
M<;Q;IR'S'6Y6R\WR?MQBQ!OSM^]Z;N-V-N>])?>+K"QNKZV\B^GFL51YT@MF
M8JK!B&]P IR?ZUSG]BZS<>!O^$0N--<.&6V^VK*AB,(<'S.N[.T?=QUK273-
M2CUSQA.;21X;RUA6T8.O[PK$P*CGCYCWP.: .KM[B*ZMHKF%P\,J"1''1E(R
M#^5<J=8O+WQCI'D2/'IDIN8U4'BXV*/WGTSD#UQGN*U='T^9_!EEIMZDEM-]
M@2WF5'&Z,[ IPPXS[UA?\(9<VGB'09;?5-4FL[,2!O-ECQ$NU0J@!1P<8/L.
MU %6_P!9OKC0_$/B&&[FA?2[MXK:%7/EE(2 P=>AW'=]!C!XK<\17\YTS1;Z
MRNY84GU"S#+&5Q)')(@()QG&#V(K'O\ P_J<>DZ]H%K9M+#JUV\T5R'4)"LI
M!?<"=V5(8C .<BMGQ%ITYTC2[33[5YQ;7UH^U"HVQQ2*Q/) Z+0!TE8A\4Z>
M)%8K<?9&E\D7HC_<;]VW&[TW<9QC/>MKJ*X"#P_J*^!W\&3:?*R_- M\'3RC
M&7+"3&[=D#^''4=<<T 7+N^EU?QO/HLL6JPVT5F"K6\QBPS.P\PE6!QA1C.>
M_%:6M>()/#\^D62V5W?-=RB$RKM)X4GU&6.W/0#K]*;;6EX/B%>WS6DBV4FG
M10K.67:761B1C.>C]<=C3O$]E=W%UH=W:6SW(LK\2RQQLH;88W7(W$ X+#O0
M!13Q,FE:WXDCO?MTUO:30/F.)I5AC>$,3QT4%6)^O&:V[W7K:T:!8XKB\>:/
MS52UCWD1_P!\^WIW/;-8EUI^IS+XVB%@VR]A LVWKF9C;^61C/&"HZXZUEC0
MM4LI=(O9-$&JPC2X;.XLV>-9+:1!]Y2QP0<D$ ]@: .ZLM1M-0T^._M9UDM9
M%WK)TX[YSTQSD'IBN>\.O/XJTTZU>7-U%!<R-]DMX)FB$<08@$E#EF;&3GIT
M '?<TJW>+2XHIK2WM203]F@ V1@DG;QP3SR1P3FL+P];ZGX7L#HTNGS7MI;L
M?LES;%,M&22%=68889QQD&@#0:_/AZR1=4NY;R2:Y,-J%C!DDSRJ8  R #S[
M9)K/U[6!J7@J_N].N+JTFB<1$@&.6&0. P/Y_2I-7_MZXMK"06!V&[S<P6TR
MB9(=I PY(&<XW;2#@D ]SD1Z5JJ>#M>M!H\T=Q-?-+!!YZ.9$+H<ABWH#G)%
M '5RW5JGB$0_:;AKT63R"T4G8T8< MCINS@#G/)KEM#UC^U)]:U35)]1L4T[
M49%5S*5B6) H\MER5).3GC//!K<DL;O_ (6#!J(@8V?]F/;F4$85S*K $9ST
M![5A)H.K77A;Q):&S$-Q<:K)>6J3%<2IYB2+D@G&=I'/2@#J+7Q#:7%T]I)'
M<VUR(S*D,\15Y(QU9 ,[OIU'<#(JE'XWT26RDOTEN?L"0K-]J^RR>606VX!V
M\D'&1V_ XC>&ZU?Q!I6I-IUQ:QZ=%,["4J&>1UV>6 #R!R<].F,UBQZ!J@^#
M:Z(-/=-26 )]F,BDEA)D_-G'/7KWH ZZWUVTN=8N-+"W$=W"GF[9864.F<%E
M)'(R<?\ UN:HV&LZ;9:%;317=Y=I-,\4'GAC/,^YLJ P!X((YP !Z5(UO<MX
MTMKS[(XMAITD3397 <R(0I&<]%/;%8%M9:[:^']+MQIUPJ_VC/)>10RIYRQ,
M\C*58M@9RN=ISC."* .LTG6+76K5Y[4N/*E:&6.1"KQ2+U5AV(R*R+.[D\2Z
MUJL:W<L6GZ;/]E"6\A1I90H+EF'( +   CD'/I3/!&FWNF1:TM[926OVG4Y;
MF%7E$A,;*N.03SP<YIMM97GAC7-4FMK"6]TS4IOM;?9]OF03$ ,"I(W*V <C
MH<\=Z -2(3:)]ON+[43)I:(CPF8[I(CR&4G&6!^7&2222/3+K;Q#:3W4EI)%
M=6URD9F6&>$AI(QU9<9W?0<^U9^L0ZMKFA7T4=@MNZ20RVL4[J6E:.19"&P2
M%#;0HY/<GTI);6[U77]*U66QN;1=-MYG,3LA:2210NP8;M@\\#.* )QXTT(Z
M9)J7VJ464<:2F<VTH0JY"C!V_-R0"!G'?%7+?Q!IMS?R6*S/'<QQ><8YX7B)
MCSC<-P&1GN*XG7+&XTOX&K97-L8;F""W22(N&PPF3/(XY//XUKZGHUUXIU4W
M!AN-.CBTVXM-TN S23 #  )RJXZ]"3Q0!LP>)]/GNK>$BXB2Z.+6::%DCG.,
MX4GOCIG&>HS36\6Z2MPT*RS.(YY()I$@<I \:[F#G'R\=#T-8_V'5-:TS0M/
MO+&6SN+"ZAGNI"RE/W73:1][<0..P)S[V[&#5;?3O$SQ:=LO)KJ>6T28J5F^
M0!"<'H2O0XH O6?BBROI&BBBNEF,!N88Y(MK7$73<@/7MP<'D9 K*@\56>M>
M$(]4O3?Z3;S3(BRQ@[CF3"X(!X. "<=S]:J:1IFJCQCI>I7.G7D<:Z:]O/-<
M31L1*2K?=5B%7@@!1CVQ4$>CZJGPO313I4S7UM)&JH6C_>!9@VY3NQC SS@T
M =A?:Y;6,[P>7<7,\:"62.VB,C1H<_,<?0X'4X. :@?Q3I"P6$PNFDCOPWV9
MHH7<2$ D@8!YP#P>>,525+[2/%.J7;6DUW8W\<3QM" S1R(NPH1GH1@@].N:
MR+'PYJ>ECPHB0-+]FO+BXN@KJ$A$JOQZG&_ QZ&@#IX_$>FS:?->12R,D,_V
M9T\IA()<@!-I .XEE_,58TW5(=3CE,<<\3PR>7+'/$49&P#CG@\$<@D>]<VF
MF3^3XCBU#1YKFUNM42>)(Y0KNFV)=ZX((*E-PY!..*T_"L.I6]I=PWTMS-;I
M<$64EWCSC#M7[_N&W#GG H IZ->3>++C4+MKN>#3K:Y>T@@@<QERAYD9QAN2
M>%!P .<DUJPM+HL%Y+J>HF:T$@-NT@!=5( V' ^8[LXZDY Y-8VBV5YX2NM1
MM/L,]UIES=/=P3P89HM^,QLGWC@YP1GCKBI-?M-6UK2%FCLS%):7L-W!:M(-
M\ZQ,&*L0=JENW)Q@9]@#6L?$%E>S30-YMI<PQ^;)!=)Y;B/^_P \%?<'CH<&
MN?O_ !,)_%/AI;*2]6VN9Y$(*%(KF,Q-AP2/F .".F>#R"#4FJZ;=>)Y[B6&
MVFL<:7<6:27";6:2;;Q@'.%V=?\ :XS5:VBU>[O?"<4NB7=N-,9A=RO*@12(
M2@VD-E@2>P]J -]_%.FQ70B=IEA,WV<79B/D^;G&S?ZYXSTSQG/%2^)-:&A:
M,]VJ*\[.D,$;' :1V"KGVR<GV!KD]*T6^M)I--O?"MK=E+IG@U)F3RV3?N#N
MI);</0#DXZ=:V/'UM+)H=I>QJ&73;^"^E4C/[M&^8_@"3]!0!)>Z^_A_4-$T
MBY2[OI[YG$ERL6?NJS'"K[XX X7/I5>#Q!'I&K>)6U2[N6L[>ZCV,8FD6%6A
M1C]T':N6[U/XBLKN7Q#X;U2UM9+J*RFF,R1%=P5XBH8;B ><5FZGI.K75CXX
MCBL7$FH;1:?.N)AY*QG'/'W3UQUH Z>]URTLI%C(GGD*"4K;0M*53.-QV@X'
M7'<X.,XITUW)?Z#)=:--'+)- 7M9.JEB/E//OZUR=[IE];ZW;WTGAO\ M:UN
M-/A@EC#QB6VDCW'^)@"#OQP>WY]?I-LMII5M ME#9!4_X]H<;(L\[1CCOU]:
M ,JQO=7-]8-<:?=163VA\PR2H6AD!.3)@\Y 7&WU;/MB^%]4O_'GV_4VO+FQ
MTE)_)LX;9E1WV\EW;!.>1P#CKUKNG4.C*>C#!K@_"&EZEX%6^TF>RGN]+:=I
MK2ZM@';! ^5T^\#QUY'TH WDN)_#<&IW>NZL)=-1U:VDD0!T4CE#M W'=TZD
M\5;M/$6G7:7),K6\EJ@DGBN4,3QH1D,0>V._X=17.^,],UCQ3X4=+>P:">"\
MCGAMGF7?,B]0W.U2<D@9/0=#TS-3\,:GXCUCQ)J<,4MK%=Z4+*WBN%VF23(;
M.,\ ;<9/][VH MW?BPW7CCPLFDW=W)9:@LQFMWA,:N@3*2#>H)'4Y!Y"_GTU
MQXJT:VOWLY;P"5)4A<B-BB2/G:K.!M!..A/IZUQMO9:_<ZQX)G3P_+:KI,;P
M7;RO'M4,@C.T!LD8!(/O5.P\*7EGX@UVWU70;K5H+V\^UVLRW/EPL2QYD 8
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MD=!0!87Q -/\8Z_'?7%P]I!;6LD44<3R^7D2;V"H"0.!D_2NJ@N(KJVBN()
M\,J!T<=&4C(/Y5R1M+T:]XJF>TF*W.G01Q.L9VR.JR!@OXN*T]#L)SX"T_3I
M1):W(TU+=]PPT;B,*?R- $L7BK1YIK>-+E]MS(8X)6A=8I6]%D(VG.#C!Y[5
MCOJ$NN^*-3TM+K4[);6*);>2")U"R'<S.Q*X(X4 -P<<=:J06%_?>#M*\.7.
MF7%O>6CVT<DQ V(L+J3(K]#E4P .?F]C6OH\=R/&WB"9[:XCMIDMQ#(\>%<H
MK!L'\1_2@";4_$T>E^(-,T=[>YE>[21S*L+. %';:.3DC.!@#KCBLC0O%4=G
M+KB:Q>W#K'K4MM#(T#.L:8C"JS*NU1EN^.M:&MV=V?&OAO48[666UMUN8IGC
M&?++JH4D=<<'GM7-:AH^J2>"_&=M'87'VF]U>26VC"_-(F8L,/;Y3S[4 =S?
MZ_I^FRR1W$LA>*/S91%"\OE)_>?:#M'!Z^A]*LS:A:PZ:^HF4/:+%YQDC!<%
M,9R-N<C'/%<5J5E>V7B[4+R30+K5[#4XXMGV>4*8V5-A212P!4]>>!D^IKKH
M;20>'DL_L\-O)]E\OR8?]7&=N-J^PZ4 10^(]+GDTN..X8MJD;26?[IP)%"[
MCSCCCG!Q57_A--").+N0JLYMG<6TA2.3(7:[;<+R0.<9KG-*M=4>Z\$)+HEW
M#_94,D%S+(5 0^3Y? SR"0#G_P"OBI>:5JDO@KQ7;1Z;=_:;[66GMX]F&9"\
M;!OIA30!V.O:[9V=K?6HNYX[N.V:1FMH&E:$8.&.%(7IW]*@T7Q'!_PBVAW%
M]<23W=W91R$11-(\C! 7;:@)X)Y.,9(K.GCU'3=?\1AM(N;RVU5$>WDAVLNX
M1!"C@D;>1G/3FL@Z3J=C9^%[R;P_<7L5IIBVES;0S!)H) %PZX89R0<C/>@#
ML7\6:*EO8S_;"T=\7%L4A=C(5!W+@#((P1@\YXZTW_A+]&,(F%Q,8O+25I!:
MRE45_N[CM^7/H<&L Z;=G4O"LT6BM90PWL\TD,8SY*,A4&0@D;B3D\GK^-2>
M)K2__M.XO=$@O[?5U\M%:--]M>+Q\LH/R@#+#/4#IZ4 ;T5U:_\ "5W<7]K3
M&=+16>P88CC7/^L!QU.<=>WY-M_%NCW4]I#%<3%KPG[,3;2A9L=2IVX('4GH
M!STK*O+>6/QW?ZE<6LAL%T'R7EQM1F$C,R@_[IK&\-2?9K70)=4LM4MX=.C*
M6WF6F%C\P!!YC@G=@'&=JCG)'' !UT?B_1)9%1+QCFX-J6\B0*DH.-CMMPIR
M0!G&<\5/?>(]+TV66.YN&7R=OG,L3ND.[IO8 A/Q(XYKDY;>_P#^$9U6$Z1<
MM,==-Q BQ?-+']H67?ST^4,.?2DNM,NK7Q+K,5UX=N-5LM1D6>"2&?;'NV*I
M252P&/ESD@_C0!TVNZ_:V-C>Q13RF[2U:4"VA:4Q@@[6.U2 ,COZ4[PC=3WO
M@_1[JYE:6>6SB>21CRS%0236&;74=.U774ETZ>YAU*TB6%[0#8KK%L*8)^7G
MD$\<UN>$+6XLO!^D6MW T%Q#:QQR1L1E2!CM0!M4444 %%%% !1110 4444
M%%%% !1110 4444 06_^KQ_M&IZ@MQ\K?[YJ>@ HHHH **** "BBB@ HHHH
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M'&H.XG"DL21\OIDYJ.S\3:C=^'Y[Q=.A^UPWC6;!928E*OL>5B0"$&">YP*
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M5L:%/>W.BVLVHHJ7;IF0*A09SP=IY&1@X-:-% !1110 4444 %%%% !1110
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MT'!R*ZP^&]'.F6^G'3X?L=L_F0Q<XC;GD>GWC^=2'0M,/V[-G'_IX NNO[T
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M[M$)6"[O-5=P /!QQD<URNG-_8O@6^U"VGN(I)]3DMI9VN780QM=%"X5B5#
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MKJRC&DSNR3R*48"2+#85B 1D@]_PQ0!U]%<_:>+;"ZO+.#9)$E[D6LKLF)"
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M)9+9W=G%((MA5F=61FX(!8C!_P#U=A10!REY8ZV^J>'M4EM(KB>T^T"XBMY
MH3S% 7!8C(& ">_7':LZPT'5--U2ZMAX?TJZADNI)H-5?8'C5V+$,N-S,-Q
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MEHSRK(GF1A#M;'(RR<G!ZGK6M=IXAUW1-5M;G38; 3Z?+!'$UPLC/,ZX!RO
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M3:OX9M]6U"#4%O;ZPO84,0GLY0C.A.=K @@C//3K3CX:MEN=+N(;J[ADT[S
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MIQ87FI6\)5%<[GZ*QPI^AP?RH U**RX_$>C2WB6D>I6[SO,\"HKY)D0 LOU
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M4 %%%% !1110 4444 %%%% !1110 4444 11_P!34M1Q<BI* "BBB@ HHHH
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M1F8P/A57))VG@ =37"V.F:A%IOP_1[&Y#V3G[2OEG,/[LK\WIR17HA(4$D@
M=2:4$$ @Y!Z$4 >9:GINHQ>&_%NE1:9=7%S>:FUU !"2CQN\9R&Z9&#QG/&<
M8K;^RW3>,-=OC:7"V\NDQ1HQC/S.-Y*C'4C(Z5V#R)']]U7/J<4;TW;=PW=<
M9YH \^T[2[N+P]X$1[&Z%Q972B=/*(\I?+=6+>@R5_\ KUH&*ZLM9\7&73;F
M=+\1-;!(]R3_ +E8RN<87YA@[B!CGUKLE8,,J00>XI: /-[;0[W0+W2OMMGJ
M5_;#2H;.22QN'#02H6)!52I*'=P>V*UX;%H_$WAIX-'DM((+6Y5U1<I &VE%
M9AP#\IX]3WKL:* *&N64NHZ!J-C X2:YM9848G[K,I /YFN9G2XUU?#UM%97
M%G<Z=>17%TKQ%%A5$8%0W0AB0 %)XKM:0L ,D@#WH YCPM;7$.O^)YIK>:**
MXO4>%I(RHD41A<C/7D&G^*8[<SV,[R:A:W,(D:"^M(#*(C\N4=0#E6XX(YV]
M1Q72T4 <=IBZK<:_X?O-1LO)E73)TG,2'RT9GC*C.."0A..W2J-G#>6?A^QM
MQIUS&C:K<LTD=IOEMD9Y61T0CC(8#=@X#'BN^/ R> *%(8 @@@]"* /,YM+O
M5\-:K9-IU[)))X@6X5'B+EXO-1MV>A&U3GG^=;?BBQND\3Z3JHL[R[T^.&6"
M=+*1DEC9RI#X4@L/E (S7944 <+?:?816=H\5AJ>C2":6>"[@B,KQN=H)E W
M$^9Z'.=O.#72^&Y]1N?#]I-JT21WK ^8J(4!&X[3M/()7!([$FM,,"Q&1D=1
M3J //UM+R/POK7ANZM;J6_N9KD02B,[)Q*Q99-_(7&X9R<C'?BMQ8;BW\8:4
M&BN9XDTV:W>ZV$KO+1D;CV)"-^E=)10!SGCRTO+WP;?06$4DMUNB=$C&6.V5
M&./P!-5WBFF^(=GJ:VUP+-=(D5I6B90K&12%((SG /'6NKI,@$#(R>@H \NT
M_3=5LO#N@73Z7?SQP75U]IMH9'AF6.60E9  03@=O]JNY\.VUO#;W,MMIL]D
MD\WF'[0[-+*< %F#$D=,<GH,ULT4 <=J>EC4OB-8R7%E-+91Z?+$\AC8('+J
M0-W3H#5SQ!IT-O9:/!9:;FVAU*%S#;0 K&HR=VT#@ XKI:* .(UJTN+7QO\
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M;6STZXBN':V=&<OMV( 0"W()X!Q^-=Q2,P4$D@ =2: //(4;3/A?HC0Z0&G
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M HHHH YJ;Q1<_8M1U&TTQ+C3K%Y%>7[3MDD\OB0HFT@@$$<L,XK.U34[F_\
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M!*DV\.@8 [A@;3R/7ZT:[>V=MK.@P76GK<O<73+!,2/W$@0G=CZ9IBZ%=_\
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MZW-YRP[L[-F,$X^7=N'KCB@!ET7U3XBW.F75C#<V*:6H999>%$DAW,%V]2%
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MT>Z:4HDMBQ;[.8QDL0Q0DL21U&,+Z\U9\+Z+)H6GSVS;4B>X:6&W25I$MT(
MV*S $C()Z#&['O0!F^-GU.^M_P"RM$F6*]2(WS-GG$; H@'JS@<],*:W="U:
M+7-"LM3A^Y<PK)C^Z>X_ Y'X5FVWAF"^NKV]\0Z=IUY<RS$0ET$XBA  5070
M8_B) [L3GGAGA+0[_P /OJEK(EG'ILMTT]E';R,3$K=5(*@ =QCU- &#K<6D
M/\58XM3MU:)M',A'E,X=_-P#P." .OO4VAZYJ.AZ!IR:E9W<YO\ 49+:S$KX
MD2(EC$'W<YP#U[8R:V9-&U-_B'#K>;7^SH]/:TV>8WF[B^\MC;CL!C/O[5)X
MET>]U:YT-[3[.$L=1CNYC+(5)50PPH"G)^8]<=/?@ I7?CB.R\N"[LTM;\Q>
M;+:W-Y&A3DA5#9(9FVD@#\2*H>(=8N-3D\*?9;-)+'4;@2/#<-M+D1LP1A@X
MP<'OR/QK6U+1]9@\1G6=#FLB;B%8+JWO"P4A22KJ5!.1N88Z<U%J6AZS=W?A
MV<36EQ)I]R]Q<O([1;MP(P@"MP-QQD]AZYH ICQ+HOA=;RTLK6);:UGQ<11W
M0WB1L%A'&QR0-PX&!UP.*V)O$L@UNXTNTTFYNI(%@D9T=%!CD+ L,GMMZ=3^
MM48]$\1:7J^H'2;K3VTZ_F:X/VD/YMM(P^8H!D,,C."1S5S3M'U"T\8:OJ<K
MP/9WD$$<?[PF0-&".1MP =Q/!H K0^-D>TN+Z72+ZWL;4S)<SRE!Y3QD@KC=
MELD8R.^!ZXDL?&=G<7;V]R(8<6S7/FQ7*S(JK]X.R\*P'/H><$XIEKX;OKCP
MCJ6DZG+!%<WDUQ*)+5F98S)(9%(R <@G]*2'1_$6I:+/IFNWEBB26LEL\MF&
M9IBRE=[!@ N <X&<GN.E &1K&HSZIK'@V];3'MX)K[?#,TH+;#$QPRCH6&#U
M/2MSQQ#J<V@J=+@>Y,5Q')<6J/M:XA!.^,'WX^H!%48/#^ORP^'[>];31'I%
MPDADAD<M,JHR#Y2H"G#9QD\UT6K0ZE(MI)IDD*R0S[Y(YF95E38P*D@'')!Z
M'I0!S.@WNB30WNK>&HF2YBMBLVEN3$4<'(RG(4\$9 YJWH_B>Z?PYHD]];K)
MJ.IH@@CC?_6DIO9CQ\@ R3UQ[U/:Z->77B*76[RSM;*9K)[/9%*96D!<$,QV
M@8&WCJ?FY]*S[/PSK=OI7AT-)9+?:(=BJDSF*XC,>PACLRI_ CC\@#57Q5!$
M-0BO+66"\L6C5[<$,9?,.(_+/ ;<WR\XYZXJCXAU"6^\.^(M/OM,FMWBTV2=
M9,[XF^5B,.,?,"O3^=.U/PM>ZRNJ3RW4=E>W*P);-!\XB\F0R(Q) R2QYXX'
MK3I].\4:GHVHVVH2Z:DDUC):QQ0.^QW<8\QF*Y7'.% /4\GC !8\/:H\]KIU
ME:VWG0Q6<7VBYWX6-C&"$ Q\QP0>.@(S2^*9].B?18]1LI+D3:G$EN5?:(IN
M=K'!&0!NXY%9V@^%]3\.:G;/I_V)-.GMHUU"U$C*%G50#)$ F#D#G.,^U:?B
M;1[S5Y=%-J8 MEJ45Y+YKE254,"%PIR?F[XZ4 20^(#<ZG<VMO9F6.VN%MYG
M64%T8X.XH.=O/4D=#Q6CJ42S:;<QLTB@QGF.1D88&>&4@BN8O/#^HWGB.WOO
ML5C;SQ70D_M*VN&222W# ^5(@7YR5&WDD<9]CU5XDLEE,D"HTK(54.Q49/J0
M#_*@#$\!3S7/@31IIY7EE:V7<[MDGZDU2U'9KGCU=#O(_,T^UTXW;1EB \K/
MM4D#K@!L>A.>N*ETVWO_  G\/[>VEDTX7EE"$+S3,L!Y_O;<]#TQUXIZ:??7
M.H:?XFM[2"+4)=.\BYM;AF3;NVN!N"DY5AC!'0GTP0#F[+6[C5;;1=#ED>1)
M-6N;.Y>3K+%!N8*3WR-@)[X.>IJ35-5N- T_Q5I^GR/%':2VHM2",P"<J&"Y
M' !R1Z9]JV$\*W%EI6ERVYAFU73[J2\.2525I2WFH#@X!#D X["FS^$;G5M,
MUPZA-%!?:I)'(HC.]8!%@Q*3@;L$9/UQ[T .LXHM!\>PZ79 Q6%[I[R^0"2%
MEC=1NY/&5;GU(!KKZYF*POSJ<_B*_CM+>[AL&MH86G)B7G<SL^. 2!VR%&3R
M<#4T&_N-3T:WN[J.))I-V1"Q9& 8@,I(!*D $9'0T :5%%% !1110 4444 %
M%%% !1110 4444 %%%% $,'W?JQJ:H8/NCZFIJ "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HKS74M:UI-"\5WR:M.LNCZ@PM@L<84IA"$<;?F W'WY
MZ]*Z;SKG6/$%YIYOIK6"UM8) MLP5W>0L=Q)!.!M  Z<G.>, '1TM>>C7M>E
MT_15^UE+A]:DTRXDCB0^=&OF#S,8(##9GCC(/&.*ENM8U+2=)U6T^WR3R1:O
M#8074[(KQQR)$V2VW!(WM@D>GIB@#O:*P-!AUFUOKF'4)XVLV4-;1R7'FSH1
M][+;1E<D=<D?3%1W<T^I>*KC1OMLUK;PV,=Q_H[!9)&=V&<XR NP=,?>YS0!
MLZCJ-MI=FUU=/MC#*H ZLS$*JCW)('XTVPOVO1+OLKJT>)]C)<(!G@'*E258
M<]037G&NS76J^%(UOKR:2XT_74L6FB;8)@LR@.5'&[&/H<UZ2;/_ (EYM!<7
M RA03;\R#WW>M %JJ>HZE!I=LEQ<"0QM-'#E%SAG8(N?;)%<"_B?6X-%@\V]
MD;4])O'_ +75(HP);:-QN;&WC*.A&,?Q>E7M;,^I:#J&HI>/Y$^IV:V.3N1%
M2>--X'?+;C[C:: .\JIIM\-2T^*[%K=6OF _N;J/RY%P<<KVZ5AVM]?0^-;W
M0Y;Z:X@;34O(I)%C#1,9'0@;5 (X!YST]ZQ-&\07^KZ%X3@O-1DAN-6$S3W$
M:JCOY>?D7 PI.1R!G"G')S0!V.J:U;:1)8I<K+_IMRMK$R+D"1N@/IW_ "K1
MK@/$UM=6]IH-K<ZB;IT\16ZQRX'F(AW%0W8L 1R1SP:V?#-W=+K6OZ/<WLMV
M+">(Q23 ;]DD8?!( !YSVXH Z:LZ'6;:?7;K1U$HNK:))GW+A2K="#WZ'\JY
M_P 67U]IM\;N>>^MM(2W %W9;7^S39.6EC(.]2-N."!@YZYJFD5Q>_$'4VL=
M1DB=M'MV2:%4.\EGP?F!&#UZ4 =[25PL&K7^K^'?#;S7TZ7%]"7FAL559IR
M.5)X10>6/ Y [UGVWB+7KWPKX3N$U$PW5_J3VES)Y,;;D#2#.",!L(.G&: /
M2J6N*N)M8DUE]!BU*>66VM$G,X>.&25G=\,1L((7:HP  <\YS4>I7>O66F:;
M<ZM-<^1#!)]ON-)*DI*" KE2,LN V0!C/48' !W#':I;!.!G ZU2TG5;?6=-
MBO[42"&0L )$VL"K%3D=N0:DTR9;G2[2=+H7:R0HPN NT2Y ^;';/7'O7 Z-
M=WUIX9T&^L=1<6]QJQ@DMS&A1XWN)02#MW \@]>W2@#TBBO/M?UK4[.[O+NU
MOKB86NH00A8506\2,T:M')D9=SN)^7.W(Y'.=34=?G\.^)Y4U&Y>73;NS::U
M4HH,<L?+Q@@ G<I!&<G(H ZVBN(EU#6_[6TWP\\[R73:<;NYE61(6D?=MVJP
M7& <\  X R>N>BT ZI_9@36)8);R.1E9X2#E<_+NP  V,9P * )]-U6VU471
MMB_^C7#VTF]=OSKC./;FKU>;VPU2VT?Q7J>G:JUJUGJ=Y,(3%&8Y=NUB'+ G
M! QP1UJW_;&M>(;V\M].?[--;6L$D:QW*IB26/?N8,C;E!.,=.#WZ '>T5P[
MWVN:EJRZ6+D1W%K80RSK:SK'OF8G+@LC;E&W&, <G.>*L"?7Y-0\/65QJ:12
MSVTYOC:*C*7CV#*EE.#EN1TZT =A5:.]$FHS6?V>X4Q(K^:T1$;9[*W0D=Q6
M5X4U"YO["\2\F,\UG?SVIF954N$<@$A0!G&.@JB-3U>;Q-XFTVUG5FMK&&2R
MCD50J2NK]3C)&0O6@#K**XNRU/6+W3]3@MKF[77(+- +&^AB0I+\WSJR@*P;
M'!Y7('3-5+SQ#+:^%?$5Q;:I?P7]G"KBVO($,UJY&?3#JQ(YY YP<<  [^BN
M9U;5KO3/$#$3M):KH]S=FUV+_K(FCP0<;N0Y&,XJGHE]XDNH-*U2:6)[": S
M72ET.0R;E\L*@((/&"QX]3S0!TFIZK;:1##+=%]LT\=NFQ<_.[;5SZ#)ZU>K
MSC5+JYUCPGHFL2WTQ6ZU6UE%OLC"*IG&U?N[N!C^+KGZ5Z/0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% #61'&'4, 0<$9Y'2G444 %%%% ",BNI5E#*1@
M@C((I>E%% !1110 4444 %%%% !1110 4444 %%%% !1110!%""%_$U+4<?2
MI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@##?PGI4MCJ5F\4K0ZG+Y
MMT#,V7;CG.>.@Z8Z5-<^'K.XNK>[5[B"[@B\E)X92',?]ULY##OSWK6HH S!
MH&GJFGHD+1KI\ADMPDC##$%23S\Q(9LYSG)]:A?POI,T6J13V[31ZFX>Z621
MF#$# QD_+C QC&,#TK9HH S-(T"PT-'6R27+@!GFG>5B!G RQ. ,G@4M_H=I
MJ%[!>N9H;R!2D<\$A1@IZJ>Q!QT(-:5% &/<^&=,NM,@TYX76VAE$RJDC*2X
M.X,2#DG/.3U/)K8HHH SSHNGM+J,AME+ZB@2Z/\ ST4+M /X<5'=^']/O-)M
M]+DC=+.W\ORXXI&3;LQLY!SQ@?E6I10!031[1-:DU?:YO9(!;ERY($8.[:!T
M'))_&L]O!FB-H%MHIM7^QVK^9!^^??$VXME7SN')/>M^B@#&_P"$6TK[/9P&
M*5DM+D7<9:9V9IAT=F)RQ^I-6K/2+2QU&^OX4?[3?,C3NSD[MHPN >F!QQ5^
MB@#*U#0+349II)I+E?M$0@G2.8JLL8W?*1_P(\C!]Z6+0+&#4YM0A22.XEMU
MMB4D( C7[H"]!CVK4HH P%\':0D.G11I<QC3D=+9H[J1657(+ D')' Z^E$'
M@[1[:&RAAAF6*RNC=VZ?:'(20DG/)Z<GCIR:WZ* ,;5_"^EZW>6]Y=QS+=6Z
ME8IX)WA=5/490@XI3X:LE6(6SW-J(X!;@03LN8\DX.<Y/)^;KSUK8HH @MK2
M&SL8K.W3RH(HQ%&JG[J@8 'X5F0>%=+MM+L]-BBE6ULYQ<0IYS9#ABP).<GD
MDX-;5% &!<^#='NC=>;'<%;F<7,B+=2!?-!!W !L Y K0O=(M-0%D+J,R?8Y
MUN(=QR0Z@@$^O4U?HH R=9\-Z9KKV\E]"_G6S%H9H96BD3/7#*0<>U6]/TZV
MTNR2TM(RD29/+%B2>I)/))]35NB@##?PIIKW%P_^D+#=2^?<6PE/E2OZLOOQ
MD# ..0:74O"FD:KJ,6H7$$J7<2>6)K>=X6*?W24(R*VZ* ,+4/"&C:E/:SRV
M\D4UI%Y,,MM.\+(G]W*$<5;BT+3X+BPFAA:,V$30VZK(P558 $$9YZ#D^E:5
M% %#2-'M=%M9(+3S")96FD:1R[.[<LQ)]:AE\/:?->ZA=M')YVH6XMK@B5AN
M0 @  '@\GD<\UJT4 8O_  C-HZ7 FN+N9YXEA,KS'>J*25"L,$8))SU]33D\
M.612]%TTUXU[#]GG>=LLT>#\@QC ^8]/6MBB@#'M?#5A;7\5\6N9[J.!K82S
MSLY,9.2ISP1GUJ'3/!^C:1=+/9P3)Y;,T437#M%$S9R50G:IY/0=S6]10!SJ
M^"M'0JJK<K;K<BZ2V%RXB24-NR%SCKSCI[5L0V,<-_<7BR3E[@(&1I2R+MR!
MM4\+G/..N*M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 1Q]*DJ./I4E !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 444E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%)2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD!_U9&=VXGVP#SSQ4%CI^N67ASQ&MO8PI?W-]<SVD<A0B17(*EN2,]1SZ#-
M&K#XILIVN8U@NUN8+87?V=XPKR1'HZY."..Y!!X.*SHM>M]9\+:/JE[+?:<+
MNYA$8ML@L[-A58@'Y">#G /XBJ6FZ!J \63WSV5W%;W.D?9'FNKA)'\[>220
MKG (Q@+Q["FVFCZP/ 6A:9)I<B7EE=VIFC,T9^2.169P0V",#IUH Z:]\06E
MC-/&8[B<VRJ]R;>,OY*GH6QST&<#)QSC%)-XFTR*>T@666:2\@-Q;B"%G$J
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MY#SRW4MO(-I682+\H7G.?P_&@#<BUFQT_3-.037EXT]N'AQ$TLTJ #+L /\
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MT2R\0R6L']DW3Q[HN1-#$[!5D)R0W525 '7J<4 =#*VFZNEUI\DEO=*F$N8
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M)419C&#YBJI4*R]",8_(&IM%T=-'@N5$OFR7-PUQ(P0(-Q '"CH,*/UK3HH
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MSOK9'C#^6)%DC;!*LIQGD C!&"*J_P#"+'^R;FR;4IFDFOA?+,8US'()%D
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M&Y,XE%MGR@=ORXW?-]WKD?2EO/"]RVMOJVF:U/I]Q<(B7:K$LB3[1@-M;[K
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MT8P<[OEX)]:X^QNU2[N+M-<TMM6>XEEBL9]-W7 8L0J9#!LXPN['3OBO5*3
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 R/I3ZCCZ5)0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17,<LMM+'#,896
M4A)0H;8>QP>#4M% 'G/A[Q+KFKZ5X@M;Z_ALM:TB5LD1*(MH!QN!R=I(.2"#
MTY]5\/\ C#4/$/PXO;];AXM:BD, \J-!B8L!& &5A@[E!R.YZ<$/UCPE>3?$
MN"_M-RZ;J-N5U/ ^5A&5PI_WL*/7 ;WI=-\)7MI\4=4O<E=&G"7VP#Y7N/F
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M^$KC7K-!<1I9FZB4G&\;=PKF]!\0ZAKVDVFH:-K%OJ%RSQ?;K&:)$\A20'V
M%6&!D@L6SCBL?P7J^NZ/X)OM-ETB_ENM-8_8]]E*JW,1<<#('/)P.N,>AI-3
M\-Z==Z[8:GX2MKK3M:CN5\^,6[PQ*G._?E=HXXX/S9XSUH ]4K%U7Q+::5K%
MAITR2F2[WMO\MRJJJDD@A2">G'8')[9L6&M6^H:C>V*0W44]FP#B>%D#J20&
M0G[RDJ1D>E9VNRO;>)-!N?LMU-"IG1VMX&DV%E 7=M!P"1C)H JZ;XFCL[[6
MXM<U>V2.#4##;&4+'M3RXVY([ OU/Y] -S4==TS275+V[2)RADVX+$(" 6.
M<*,CYCQ7&ZG;74OACQY$+"\,EQ=OY""W<F7,42 H /F&Y3R/2G:I$\'BN6ZU
M+3]:N+*^LHE2;36G4QLN[<DB1MD [LC.<9/O0!WT4L<\22Q.LD;J&1T.0P/0
M@]Q6#XPUR[T32#)IUN+B](,BQD](T&Z1OP48^K"M+1;6&QT:TMK>U>TACC"Q
MP.VYHU[ G)Y]>3]36)%97.NZKJ-^+F_T\1-]B@S;JI>( ,[ 2H>&8XSCH@H
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M4=2XAW%2BL1D#"@CG^[QVJ#Q@QN8_%=A'8W-NWE0A$MK1G-WM4$.SX*A%^Z
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M %%%% $< Q$ >M24R/I3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MI-REBN1N SC/-81\074C>?::4]S8"Z^RF5)<R$A]C.J8P4#9R=P. 3C'7.L3
M%9?$#Q/<+"QQ86LKK$F6<CS>@'4X % '7T5SFF^*7N]7.FW5BMO/]B^V[4G$
MC(N0"CK@%7^8<<CKS26WBIYM#EUAK*)[-;1[I6MKD2GY0#L;Y1M;D],C@\T
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M[)!XTANK!9(;-Y+Q[PV4<$<@*2R<G<LG0Q[03NQV/&>* .GW*7*AAN !(SR
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MF^6)(ROR@X^8X7T')-2:EX4OM7O?$ZR.EM#J,=J+:8'>0\)+ LOIG'X5VE%
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M9S6DR*Z,CJ&5A@J1D$4JJ%4*H  & !VH 6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH :GW:=34^[3J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ;']VG4R/[M/H **** "BBB@ HHHH
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M2;;RVW[P/1MG7^*L/2-1TXZAX:O;&>UC674KA'@=A]IPZRY,TA(YSM.S']T
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MFE0W%I'<'Y5#%C(XSQN'RC=U ';FM/X=%#X TCRY!(HB*[@<YPS"@#J****
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M88F9&:-"4^Z2/N_3TK&O_%NE:=+?13-<L]AL-RL5L[^4K L'.!]W ))]O6K
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MMGTSTJ6""&VA6&WB2*)>%2-0JCZ 5C/XMTQ;:]D47336<?F2VIM9%FVGH=A
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M;2ZU!91?1Z5^[%G#?2!Y8S@[P""3M^[C)SUJ+Q>UX+_1SI=O)/J$,LDX2&1
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M-O<K--?:A>>6^^)+JX+I&>V!QG'8MD^^: (_&=C<ZEX-U:RLXC+<36[)'&"
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M5 )'M6PS!5+,0 !DDGI4=M<P7D"SVTT<T+9VR1.&4\XX(XZT 2T444 %%%%
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M/(.>^.: .8\/:]/H_ABPM0L<FH7VIW<0*Q/(J[9)&=@B_,P&.![C)'6M"_\
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MA&KB>( 85U/N,@]LFK+^&FEO=%N9M1FF?3)992TB@M,T@(.2,  ;C@ >@[4
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MCT:WN$0W3P-*S#!(*J20H4<>_?M=:37+?2M,EN)WUE(5FCOFTV;RY&(8!74
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M.M,GO=2L?L&D7FJ1;KK4_L[RPREY8HRC2+&6(!W' 7=C.&!Z\T =N6"J68@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME1NVY)^4]A][VYU-?TG4-0U?3IX([2YLX%D$MO=2,J;SC:^T A]N&X/KV/-
M&?J'BV_>Q\.WFE64;PZG=+$PEF (X8[1@$<[3\WMTYXO'6=+L_$NK&XM#;SV
M=A'<7%WG(:+YCC YXP>U90\-:['X>T6V1-/-WI6H?:%7SG6.6,*X'.PE3\_3
M!Z=:OW7A>XU'7M<GNGC2SU'3$L08V)<'YMQP1C^+CGM0!<3Q#-#>646I::]E
M#?/Y5O(TH<^806".!]TD ^HXQGI50>,F,4MP-(G%M;W[6-S(94S$P=4#8SR"
M6'2I?[*U34SI4>L+:!=/G6Y,L$A8S2("%PI4;1SD\GTZ'-4KWPWJEWX4U;3
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MGQWUFS-!(652Z%3E6*G(/(Y!K!&K7>J^(X=(BN'LT33TO99854L[.VT*-P(
M&"3QD\>^7^ !(/!MJ)6#2":YWD="?/DS0!O7EY%9)&\HD(DE2)?+0L=S' SC
MH/4]!4X-8/BO4;S3+73I;.58S+J5O!*"@;=&[A6'/0\]:J:)%<?\)OXA9[^\
MDCC$ $4JILP58@+\H.!GC!ZYSF@#J68(C,02 ,X R:K:??Q:G817D"RK%*,J
M)8RC=<<J>1TJ>97>%UB<1R%2%<KNVGL<=ZX6WU_6Y/!VA:G=?:'2X5VOKBPA
M5I(EYV,$(/'K@9XH [VBL[0;K[9H=I<?VA%J&],_:HDV++R>=O;Z5B:_#=2>
M./#7E7\\$)%R6C0*02$&#R#V)'X\8H W=,UBSU@79LW=OLEPUM+OC*%9% )&
M"/<<U?KS*&[O],T'QIJFGW9BFL]:N)?+9%9),+%D-D9Z9Z$=:Z#4]1UB\UO4
M=.TMI8S:01E3%Y63(X)!;?U7@#  [\], '6TC,%4L<X SP,G\JIZ5+=SZ5;2
M7RQ+=F,><L+[E#]#@_6LF>^N-3\4W&C6M_-9+96\<\KPHA>1G8X7YU8;0%YP
M,_,.1B@#6TK5;76M-BO[)V>WE+!2R%3\K%3P>1R#5RO,M U:_M/#OAK2;+)F
MOY[YI)$V!]L<KDA=YV@DL/7 !XK;GO\ Q)8:.KWD%VX2]999+18Y;C[-M)5M
MH&W<&V@X'0$@4 =3>W\.GQQ/,)")95A7RXR_S,<#..@]^@JS7$7?B"[A\.Z/
M>Z?K$=\ESJD5N]P80"\3R8VD8&U@.#Q^ J6VO]=O?%^NVBZG%#I^E36[B,6H
M=Y4:,.R9R,<<9Z_U .SHKAM'U;Q'J\>G:S KBSNI098)6A6)(22/E(^?>..I
MY(/ KN* %JEJ&J6VFF%)O,>68D1Q11EW; R2 .P'?W'J*YM=3U?4-!U#7+2^
M6)[6>?R[/8K1ND+%2CG&X%MA.0>-PXJOJ FO_''A6[CO;B!;BSN9%C58SY8V
MQ$@97G.><YZ<8H Z_3M0M]4L(;VU9C!,NY2Z%#Z<@C(I-3U.UT?3+C4+QV6W
MMUWR,B%R!]!S5NO+&ENH_!?CZXN+ZXNMMW=VVR38 ?E1 V0N<@8&.F!TH ]1
M1Q(BNOW6 (IU<E;W^IZ=XEMK:ZODN-/N;"6Y2(0!6A\LQX .?FX?O^E5M UC
MQ%J\&F:LD.ZSO&W31R-$L<<39P4(RY8<=>O/ XP =M6"OC+16>X4371^S.8Y
MV^PS[8F'4,VS"X'/)Z<UO5P7AR35DU'Q<--M;*;.JR8-Q<-'AO+3L$;(Z=Q0
M!V-I#I\TIU2TCMWDN8US=1J"9$[?,.HJY7G/AG45T_PIH>CZ=+/%<3W\EE-+
M,@+0NF]Y,#D=5PO7 /.<8K6N=:U73=4UC3);NV?R[#[;9WET!&L>6*;9"HP0
M&&0< XX]Z .PHKB-.US5)-2UJS^U3O'#IZ7-K+>6@C8,2X)V@+N7*Y&0#4=C
MK>NIX;TW4+_4;=KC6?LT%K&MKA;=W'+D@G<<9;' R,=Z .NCU2UEU>;2U=OM
M<,2S.A0@!6) .>AY!Z5=KCM(M[BW^)6J)<7DEV3ID!5Y$56 \R3CY0 ><G..
M]=C0 45SOB"\U>'7-%LM-FABBO&F29Y(]VTJFY2.>O4X]A7/WGB77=,TWQ#;
M3SQRWFDSVQCN_("K/'*R\%>@(!(XH ]"HKF[G5;Z/Q9>Z;'*HA72?M<>Y =D
MF]E]LC@'!K,M-3\1W7A&UUT3^:;FW@=K6TM TD>6&]T)/S':3\I!_'N =O17
M&RZ[<?V38W=AK"WD;ZO!;.SPJK^6[JC1NN!M<%B>@/3BK<NL7\.J>)K<7-JJ
M6=K#/:M<_(D;.KYWL.JY0'/N: .GHKA[?Q#J27>K6*W3W ATH7UO=7-L(R6R
MZG"#&4)4$9P>O48--TSQ#K,ESX4FN[F"2'7+<[X8X-OE,(O,W!LDG)[=* .Z
MHKEO ZW?V'47N]0FNV&HW48\Q5&-LK+G@#KCZ#L!3_B )/\ A#+YDO);0#8'
M>( DH6"L#D'C![8/% '345S;WMY<>(?[ M]1DB:VM!<7%R8D:1RS$(!QM&,'
M/'/'3K4_AC5[C4X+^WO-K76G7CV<DJ+M67;@AP.V589'KF@#1U+4[72;=)[Q
MV2-Y%B!5&?YF.!P >]6ZY_Q=JM[I-IITMG(B&;4;>WEW)NRCO@@>AK(M&U%?
M'GBHPWD\[V]G UO;N$V$LLA5>@. ?<'GDF@#N**YCPMJ\FI7%PDFIS2R1Q(9
M;*[M1#<6[G.<@  J>,<'ZG-;&M7,]GHUW<6TEM'-'&2CW+%8U/JV.<#T[]*
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M&"X5I3-ILUN8I40$[&1B3O'3GT.?:NP% !1110 4444 %%%% !1110 4444
M%%%% !1110 U/NTZFI]VG4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&=@8X.N.<9;&2!DG'U -)I/@RWTB<+#J5_)IT<GFP:?)(#%$V<C'&X@'D G
M//)KILT9H YT>')([F.\N-3NKI[2.46S-&ADC+C&=P +$#( /XY/-7?#D%];
M:#;0ZE+-+=+NW/.RF0C<=NXKQG;C./S/6M2E% !1110 4444 %%%% !1110
M4444 %%%% !1110 U/NTZFI]VG4 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'E4FE:&^C^,O,6+^T(;^<VK$YEA<JK1^4.JDM@#;UP!SBM>VLX;[X@F
MQU*"&Y4Z#!)<PS*'4S+(1N8'(+ =^N*Z#0] .GW.H7-X+6>>ZO'N4D2'!C#
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MP21^'2O64C2-%2-51%&%51@ >@JFVC:6T$T!TVS,,S^9+&8%VNW]YACD^YH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@!*6DI: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,>7PS8/<SSQO>6
MS3MOE6VNI(E=CU8JI R>YK4@@BMH$@@C6.*-0J(HP% ["I** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW3^24428",P60L =P[=ZM3>)K0:U)I%G#/?7T*AIXK<+B%3T+,S*.XX!)]J
M-NBL73_$MIJ4U[:113IJ5D,SV$FU95R,C'S;2#D<AL<C)%9.G?$&VU2._EMM
M%U4Q:>Y2Z?$/[LC.>!)EL8/W0: .PHKG;CQCIR>%?^$CM([B^T\*69K<*&4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !39?]4_^Z:=45S;QW5N\$N_RW&&V.R'\U((H \JU'P]>
MZ?H&@^-/#B[=2M-/@-W "<7,0C7.0.N .G<>X%9_C&&\U#X,:7>VRL(6N#=W
M,8.=JR.[#Z@,X%>Q6=E;V%I':VL0BMXQM2,=%'H/:ECL[:*U^RQP1K;X*^4%
M&W!ZC'IS0!B^)+NV7P!J5R\BFW?3W*MU!W)A<?4D5RVB^%9]5^"<&C7T+)=-
M!)+"KCYD;>SQ]>G! ^AKL$\)Z*CI_H9>-#N2WDF=X4(Z%8BQ12.V!Q6UB@#Q
M&4:OXT^&R:HYEBGT*$&!C]Z::-OWCGUP@7'^T6KT/PG?/>Z--XJU,BW^VPI(
M58_+##&O\L[W^C5T<5C:P6K6L-O'';MN)C5<*=Q);CW)/YTV2QA_LI["*WA\
MCR#"D#+^[V[<!2/[N.,>E #K&^M=2LHKRRG2>WE&Y)$.0PKSWXW #P)$ ,?Z
M='_Z"]=OX?TA=#T2WT]3&?*W,?+3:@+,6(4=ERQP/2EU7P_I>MF/^T[4721_
M=CD=C'GUV9VD^^,T 0>)U7_A#M8; W#3IQG'./+->>>'(=1/P(G>.]@6V^P7
MA\IK8EL;I,C=O'7GG'&:]/N=)L[S3A83I(UKP#&)77</[I(.2O;!X([543PM
MHT5@UA%:&.R8Y:VCF=8SUR"H;&#DY&,'OG H \^MO^3<F_Z]7_\ 1QK9\"BY
MM/#=AJ&K31G35TA-C 82(*Q)W#<=S%=ASCL1QWZ<^%-%.GC3_L9%B#G[*LSB
M(]3@H&VD9.<8QGGK3!X/T(1K#]A)MEQMMFFD,"\YR(BVP'/<"@#DO$2W;?&C
M1/L,L,<XTR0J9HRZG_6<$ @_CFF_#^>/4?&&OWNL(8/%"D0RVW1(X1@#R_4<
M#)^GK7;/X;TF35!J<EH'O@VY9W=F=/923\H]A@<GUI\^@:7<ZB=1DLT%\4\O
M[3&2DFWIC<I!H \QT*TU"Z\=>+O[.G5735K1YXBF2\*S$MAL@#@$]#D#'>NI
M^)EQ;S_#77EMW1O*9(Y G\+^:A(/OS^M;*^#-"C=Y(;6:"67_6RP7<T3R^[L
MK@N?=B>I]:GG\+Z+<6*6,E@AM%<R& ,P1V)R2Z@X<YY^;/- '/\ @FRU,6ND
MW%W,L^GOHELL*J@58V !P02<G!'.!T[5E?#"W:Q\0^+[6\\W^TA>*\A?&&C)
M8JP^N2?Q%>AV&GVVF6B6EHAC@3[B%V8*/09)P!V X'057OM"T[4+A;F>!EN5
M78+B"5X9=O\ =WH0V/;.* .&@MY;CX]74]H7$5MIZB\/\)++\J^W53_P$URF
MBWNNZ=H7C>\T5;=S'?R>:LD9+JI+ NISC('."/\ "O9K;1K&RLYK6VA,239\
MUTD82.3P6,F=Y;_:SGWJ+3/#NE:.TC:?9K 91B7:S?O/=LGYC[GGD^IH XJ2
M/2(O@==IH<K2V7V)R&=LON)RV[T.2>*/AO%?V^@V%]>W$?\ 8JZ7\@/"QL)6
M+%LGDXYSZ?KUP\(Z"ME)91Z='%:2OYDD$3,D<A_VE4@,/8\=/04Q?!NA*B1"
MTD^SQG<EJ;F4P*?:(ML]^G7F@#5BU&RFOIK&.[@>[A :6!9 70'H2O4=:Y'X
MN?\ )-=4_P!Z'_T:E;<'AZ*/Q?<:]Y-M&[6_D*T2D/+G:6:0]\;% 'IGGGBY
MJFB:?K2)'J,!N(DS^Z:1A&W^\@.UL8XR#CM0!YOX@<Z7XD\%WVLD:C$V([6&
M%?*\A_D_>8^8OU7N/NCUJ+4K?4+KXP^((-+F6*]?12L;,N>=J<#D8/H>W6O1
M[/PUI-C=1W45J7N(@5BEGE>9H@>,(7)VCV&*@_X0[1/M4EV+:87DA^:Z6[F$
MQ]O,#[L<=,XH V(GB,DD:,ID0CS .H)'&?PQ7G/QG_Y 6C?]A2/_ -!:N^TW
M2;+2(I([*)D$KF21GD:1W8]V9B6/XFH-4\.:3K4JR:E:?:M@PJ22,44^H7.T
M-_M8S[T 4O'( \":Z<<FRES_ -\FJOPV /P[T3(Z0G'_ 'TU;MYH]G?Z<NGW
M22R6J@ H9G&\ 8PQ!RX]0Q(/?-.TW2[/2+3[+80^1;ABPC#$JN?[H)X'L..O
MK0!C_$#_ )$#7/\ KT>O.-0GGD\-^"M*\0JD?ANZB@9KJVW!]P3Y4?/0<C)'
M7!(QBO7]3TJSUBT^RW\32V^X,T?F,JOCLP4C</8Y'M50>&-&&C#2'L4ET]6W
M+!,S2*I[;=Q. .P' H Y+XG"1M0\'B%T60ZQ%L9EW*#D8)&1D>V176Z<UQ:Z
M=%'K<T;WLDLZA@N Z[W8;1DX&P XSVJ"]\&:%J*62W5K-(+$?Z+_ *7,OE<Y
M!&'ZCC!ZC '858MO#6F6M\+U4N9;D1M$LEQ>33E5;&0-['&<#I0!YM<V>N?#
MW2VU70KR+5O"LG[U[*Y',:.1@J?3G]>0:T$$@^.MO>7.Y8;O3,VGFKC;\O*C
MW^\3]:[.#PAHUM%'!%;R+:H5(M?M$AAR.03'NVGD9Y'7GKS6AJ.E66JQ)'>P
M"3RVWQN"5>-O[R,,%3[@@T <)\34EGU[P;;VP8W3:CO0+P=JE=QSV %-NUQ\
M?;!MRG=I9X'4??ZUVUAH-AI]R;I%EFNRNPW-S*TLFW^Z&8G:/88%5;GPAHEU
MJ;ZE-;SF^8_\?"W<RR*.>%8."J\G@8'M0!I275K+>MICL&F> RM&1G,>=O/U
M)_G7E_AJ&[TK5-7^'8#M"UP)XYB3A;1L&0>Q(PH]W)[5Z3INA6&DSW$]JDWG
M7 42R37$DS,%S@9=B>-Q_.K*V%JNHOJ A47;Q+"TO<H"2!^9/^0* //OC4BG
MP98H6$:'48@6QPHV/S77Z4+FVEO1JSH99+\_9Y#PKJ8UV[%).W RN.Y5CWIV
MN>%='\2"-=6MY+E(^5C^T2(@//.U6 SR><9I8O#&EQ7D-V1>2SP[O*:XOIYO
M++#!*AW(!P>HYH XSP5_R57QI_O)_,T[X3*Y?Q--"I&FRZFYM2>_)S[=-E=+
M#X"\.V]Q<3PVMS'+<G]^RWTX\[_?^?YAR>#5O5M"M[OPY)I%I:6R0D*$ART4
M:88'/[O!XQG QG&,C.: -@C(Q7FEI D'PZ\02>9,S-?7"$RSN_2X('WB<'U/
M4]\UZ3#&(8(X@S,$4+N8Y)P.IK(D\*:-+9WMFUM)]FO9O/GB%Q(%+[MV0 WR
M_-S\N,T 4)[B;2]=U")M4D6V;37N_,N<.MNZN1N &/EP>F?X15/19;M?$=G9
M/<WTEG>:0\SFYF)>217C'F  GR\ASP"/H,<]'<Z#IMY=O<W-MYLKVIM&+2,0
MT1.2I&<'ZXS[U!8^%=&TVYMKFTM72>W5DCD,\C-M;&5)+'<.!@'(';% &9\.
M(H8_!-FT+R.)'F9S)(S?-YK!L9/'(/3OD]\TQ8L_%V4EYMHT5'"^:VT,9B#Q
MG'0#C\:Z'2]'LM&MWM[")HH6=I/+\QF523D[0Q.T9).!@<TZ;3+2?4X-1='^
MU0(R(ZRLORGJ" <,. <$'F@#CK9KBUT.UOK:\GB8:])"T2L/+D22_9&R,>C'
MFF27?B+6[W7&TZ>VM7L+LV\+S7KQB)5 )9HA&RN&!/+'ITVXR>I_X1G2?[-3
M3Q;.+1+C[2L0GD \S=OS][)&[G'3/:DN_"VBWVI_VC<6"/=$ .P9E$F.F]0<
M/C_:!H UU)*@D@G';I7GGARRU:^\*:Y;Z?>6L#2ZE>H/.MV?@LPQD.,<]\''
MH:]#(!4KS@C'!Q6#%X,T6".2.)+Y(I&9Y(UU&X".6Y8E?,P<]\]: .8T#6(K
MG0_"&E6,=S86=[YT4A$GSCR0<J) !]Y@3D ' .,5H7=]>:<^O:8=3N(X(8[>
M2VNVB,\L9F<IY0YRYRH"D\@MR3BNDFT'3)].@L/LJ1V]N5: 0YC,+#H4*X*G
MZ>I]343^&M+FTNXT^X@>>&Y8/.TDKF21@002^=V1@8YXQ0!RRWVJV\'C&W$E
M[:QV=DES:&:8321,4D)&\[O[@X).,G!JTLU];Z;H8?6+EI-;DACEEE90(?W+
M.PBPHP6*[>2>O'-;@\)Z,JW@%O-_IL(@N6^U2YE0=-QW9)ZC/4Y//-6;G0M-
MN](BTNXMO,LX501H7;<FS[I#9W C'7.?>@#"\.V"V/CKQ(@GFF_<6A1IW+LB
MGS?EW'DC([U-XL;=J_A:%93'(^I%@0,G @ES[=Q^=:UAH.G:9>S7EK"XN9T6
M.6:29Y&=5^[DL3G&>O6IKS2K._N;.YN8B\UG(98&#LNQB,$\$9XXP: .+N=7
MU+3-+UZV6^:5K?5(;2&XN'VF..58B<MM.,;S@[3CT/2K&J#Q#IOA[Q!=37T=
ML$LC-;I#<FXDC=%Y(=XU^4X&1@X.<$9XZ0^'M*>/4(Y+02QZB_F722NSK(V
M <,2!P!TQC ]!4$7A'1(=+N--CLW%M<((Y0;B0LR#^'>6W;?;..3ZF@#&UYM
M2T^]TW3H=1DF.I73NYN+DVX^51^Y1T1BH8G(&,\$9JKJ,&L1Z#]EO+VW-R-9
MM?(\N8S-;HTJ%5=V4%B,G&5Z8SFNNU/0].UBP6RU"V$\"%60,Q#*1T(8'(/N
M#FH1X:TE=*;35MBMLSB0XE??O!!#[\[MP('.<\"@#">TU/\ M;4] @UR\/G6
M"75O<R,#);R;BN,A0"IP#CV:K'AW6[CQ FGJ"\,EFC'45SR)QF/RS[9#M_P%
M/6M0V/\ 8=A<SZ;93:A>.5++)<?O)L8&"[G@ 9P.G7N:- TQ]/MKF:>**.[O
M;A[JX6(Y4,V  #WP !GN<GO0!4\87%[;V.GFQO7M'DU*VA=T56W*\@4@Y'3G
M/&.E<_J,^M:-)XATV#6+FY5-(-_;SSE#+#("P(R%Q@[<C(]<5T'C+2I]9TJU
MLX8)95-] \OE2"-DC5P68$D8( XQSFK0\,Z:UE>6LR33K>J$N9)9W,DBCHI?
M.0!D\ @<GU- '.O-J-DFA6\NKW<S:W+&LTS;5\@"(N1'@<;B .<G&>_-3SVF
MK-=:SH-GJ]TI%K'=65PS[I(7+.-C,1\RG8.O.">:Z*ZT/3[S28M,FA8VL(01
M!9&#1[,;2K@[@1@<YS3]/TJVTWS6A,KRRD&2:>5I'?'0%F).!DX'09/J: ,/
MP]K4WB5K.YC:2*&"T_TI1QBY8[2AS_=VL?\ @2UB:=K]_/X?T"VEU"6274M3
MN+:2]("OY:/)C'& 2%4>W:NZL-,M-,29+2(1K-,\\@'=V.2:H'PGHIT<:5]C
M(M$F,\:B5]T<FXMO1L[E.23P>YH X>6XN?#FM>-I+6YDED TZ..:YDR8ED++
MEG(/"ACAB#CC.:W;>S\36D6HP"_M_,N;-FLHY+\W$@F!.6#-$N%^9>,$ X[&
MMJV\):+;17Z?9GF_M!%2[:YGDF:8*"%R78],GI_04EEX0T6PTZ>PAM7\B=/+
M??.[-L_NAB<J/8$4 4_"DY>YOK>6?5%N8EC,UGJ#!VA)W'<CCAE;D#!Q\G05
M0\=V7GZMX7;[5<Q;]32/$;X"_(YW#C[W;-=/IVCVVF/+)$\\LTH57FN)6D<J
MN=JY/89)Q[GUINH:'8ZI>6EU>+*[VCB2 +,Z*KCHV%(R>HY[$T 8L?VC7-3U
MFU75KJS.FNEO$L! ZQJ_F.2#N)+$8Z#;[UBVNK:QK^H^'(FU*6R34-.G>X%I
MMQO0@!T)!ZYSSD8Z>M=??^&M.U"[DNI!/%--&(IS;SO%YR#H'VD;L<C/7!ZT
MX^'=._M:QU%(Y(YK&$P6Z1R%8T0C!&T<>GY#TH M3VIDTMK62XN"?*VM-&=L
MAP.2".A/M7G4$,EMX%\'".XN'-UJ=F2TS;S%U/&>@R!U]:]0KGT\':7'8VUD
MKWOV>VN%N8D-W(=K+]T D\*.RCB@#G+[6=2\.IXEMO[0FNEMA:_9[B\92T;3
M$JV2J@ #&02"!Z&MOP_;:U8ZO)'J%[ UI/ 7B@:^:YEWAAEE)C3"X8 CG!QC
M&:TSX<TU[K4[B:%ICJ2+'<I*Y9&500 %/ ZGI3-%\,:3X?+G3K=D9E";I)7D
M*H.B@L3A1Z"@"KXIO+JRET(VUP\0GU2*"55QAT8,2#D9[#I65J%Y>V/B%FU2
M\OK.TDO(Q:74!5[8IQ^ZD&,JS$,,GCYNHQ74:GH]IJ[69NQ(?LEPMS$$<J/,
M7H3CK]*J/X5TM[QK@I/AK@730>>_E-*#G>4SC.0#Z9&: ,"2\O;'Q,D6KWFI
M6PN-0VV<L>U[29#]R(@<JW8Y[C.><55N]3U"#PEK5U'J5RTMMKGDPN3@I']H
M2/9ZD88CG/K75)X9TZ.]%P/M) N#="%KAVB$I)8L$)QG))] >:CO/"&CZ@]Z
M;B.X,=XRM/"EU(D;,K*V[8& #95>1SQ]: .>O+SQ#KNN:W:Z3<P6SZ=(D40>
M\,>TE V]T\I]X))'4<#''4]K!,QT^.>4H[&(.QA.Y6.,G:>X]*R=3\&:'J^H
M+?7EJ[7 C\IF29T\Q/[K[2-P^M;JHJ($10JJ,  8 % 'GRZKJ<G@6'Q?#J-P
M]T2)WM!M,++YFTQ!<9!QQG.<BK5KI^/BW?-]LNSC38I<&3@YE?Y3Q]T>E;T7
MA/289M\<<RP^=]H%L)W\D29SNV9QUYQTSVJS#H=I#K\^M*9C>3Q"%RTA*[!R
M %Z#GGCU/K0!E>.K3[3H$9^T7$/EWEM_J7VYS.B\^N,Y'OBLNXTZ2?XDR64>
MH7<#CP^@%PC R9$[<DD<UU^JZ7;:SILMA>*Y@EVEMCE&!5@P((Y!! -4H?#-
MA!J+WZ27ANFM/L?F/=.S"/KP22<YYSUR: .8@US6-4@\,6D3Q&:\TS[9,S71
MMS*X"# 8(Y_B+8 '3K@8/5^'O[132Q!JUQ;3WT+E)'@<L,=5#$A?FVE<\#UQ
M5.?P3HEQHUCI<D$I@L3FV<3,)(OHX.?;\JV+"PMM-LTM;2+RX4S@9+$D\DDG
M))/J>: +-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 <>VMW6N:]JVEZ3J\5G/8>6L0,2RK*S+N
M8L#R0 0!@CD$G/2MK3=06'2;5]2UBPN9920MQ$1''*<GA1N.<>QK*\,HX\7>
M+G:-U1[J HS*0&Q$ <'OR"*PD3/AOPG&MO*/+UK<R&%@40-+R1C@?,O/3D4
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M4)P#*Y. !G )(''2JUS<V:^)](\31S)_9]S8RVCW+9"*"R2(3G[N2K#GZ>E
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M<9!'Z4VUM8;*TBMK=-D,2A47K@#^=344 %%%% !1110 4444 %%%% !1110
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M10 45ER>(]&AN)8)-3M5FA.)4,@RA]QVK0@GANH$GMY4EB<91XV#*P]01UH
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M&8*I9B  ,DGM5>QO[74[-+NRG2>WDSLDC.0V"0?U!% %FBBB@ HHHH ****
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M+%M2TV>R%P]NLZ&-WC4%MI&#C((H \R^&9N[SPUH^DSV8?1KFVO?/8G(D;S
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M!J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK6$M-/U"=H+EY#+9R12;)5D4=4/J >E %NPU&:YN+BUNK)[6>!58_.'1U8L
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M;R_E<L%V'!!/R-UP.G/-<=HT-QK,C7UUK5G9ZG#J!67Y&$R,),+"09 NUEP
M-O.<\GFK=I9K!X[\9W=G;*U[#:6\EOQG]XT<A/'N<4 =^#D D8/I2YK@?#,,
M%TVBZQ'KL)GE!%Q%&C;[F0I\R/ESRIR?NC&.,"JUG:I<^ ]9U0WU\\\(U!8)
M!>2C:BR2;/XN<8&">>W2@#T?-&:X37(HM-M-(,EWY-MJ5T@U"XN979&(A;:&
M&X;0S*H."!T!XXI+Q)-#TJ:*/68Y+&XU"WCE$*[%LXG8!P&W,5#>I/&[C&10
M!U::H6\02:4UN5VVPN%EW@A@6*XQVZ4V^U<P:E#IEK;_ &B]EA:?:S[$6-2
M26P>[   '\*P],L++3OB)<Q63A5;2T8P"0L$/FGD DXSD<#'KWJUK^C6>MZG
M$L&HR6&NV</FV\\)^948D'*GAU)7D?RS0!K6FJ)/;RRW,,ED8I?)=;@J/FXQ
M@@D$'<,5?KSC6Y9]8\(7-OKT5M+<Z?J]M;/-#D)(#)%EQZ$K(01V.:V!!'?^
M+[O0[V,C3[:QADLX0Y7.2P=P0<DC"CV_&@#KZRM9UK^R)=-5K9I4O;M+7<'
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ML;JQ:3/[B[39(N"1R,\=*O5XWI^NWP\!>"4N+UVBO[^2*\EFF8&11*^%9^2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >?:!O7XR>)83+*\:6<)19)&?;D(Q
M R3@9)XKT&N8LO#^H6_C:Z\023VK1W4 MV@4,"BJ<J0W\1/<8%:6E6FKV]]J
M,FHZDEU;2R[K.)80GD)S\I('S'D=?3WH U:*** "BBB@ K%\7ZO/H7A+4]3M
MHC)/!"3& ,X8\!C[#.3[ UM57OK*WU*PN+*ZC$EO/&T<BGNI&#0!QW@+1-.O
M?!=K?:A:Q7MYJ*&6ZN+A [RDD\$GL!P!6%\5-"M=*^&5O:V\0:.TO 8F=CNC
M5B_ ZY^\!R??J*ZW0=!UCPUI2:3:7UK=VD1(MY+F-EDB4G."%.'P2?[OI4/B
MSPIJ7B?P[%HK:G$%+"2:ZDAR[$$D (N !T[]!WZT 2:)9:5JFHR7\.DK8SZ7
M<M;1-Y(C=T,*Y#C&<'S"1] >YKC(I_#^B_$GQ@=6M(ETY(8/E%F98UW(N<A5
M(7)/4XR37H*6FMR7-J96L+>%91+=&VW[YR%P!R!@9"YSG@8K,T_PE=1>*M8U
M>_EM)H-7A$,]LJM\@50H )^]D#G@=: ,;P%X=EU/P.]OJ[,^FW-X+JS@\T-M
MA#!E4]>"1RN>YZ&LVVT'1V^-EYIATNR-@NG!Q:F!?+#?)SMQC/)YKL?!_A>_
M\)BXL!J2W>D%F>VB>,B2 D_=SG!&/IS]35>'PIJ47Q$D\4_:;0I+%]G:WPV1
M'\N&#=VXZ8Q[T ;$OD>%O#J06<>\(PAM8G; +N^$3..%!8#V ]JYGX::M=AM
M7\.:M,)-2TZZ=LCH\;'.1[9)/T85TNJZ-+JVKV1NXK.?28 [/;S*6+R$8#8(
MVG SU_O9["L9_ YMO&UKKVBO9:;##!Y,EO%;_+."3G(4J%/(P>>@^E &4;"U
M7X\1;8$4?V7Y^ , R;BN['KBL[Q!I.H^'==U#QAX=7_CTNO+O;-0 CP>5&Q(
M'UR3]<]JZL>%M1'Q"/BC[7;[#"+;[*0Q(C]0W8YYQC'7GO6UI-G?02Z@U_\
M9B+F?S5$)8X&Q5(.1_LC\S0!A^"[_2M=U/5];TR.,?:1!O8* X.S)5L=P>M8
MOQ>LXW@\/W1AA+?VG' [E?G*L"=ONORG(/M[UUOAWPO:>&KG5&L2%M[V<3K
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M_P 2V<\>8/[3"E0!RB,&"'(/R\8(]":[C0_"]OX;O=6FTU4$-](DJP'Y5C8
M@@$#@'KTJCX&\*7WA;^U!=W%O/\ ;;@W&80PVD]1@]J .4CT32C\;Y=..FVG
MV(:=O%OY*^7NXYVXQFE^*^DV6G>'M @MX0JI?I"&Q\WED,=N?2NIC\*WZ_$A
M_%#36WD-;_9_(!8L!@?-G&,\=/UH\=^%;[Q9;V%O:W%O!':W N"TNXEB 1C
M'3GK0!E>)+F34/B1H/A(,8=+%N;J>).%F W;4('\(V=.G/2E^(KCPI;:;X@T
M>);:XCO$AF2!0HN(F#$HP'!Z<9Z9XKH->\+C5-4T[6K29+;5M/;,<C+N21#G
M,;8P<<GGMDTS4O#MSXEN[ ZTMO'964WGBV@E:3SI ,*68JN .>,'.>M '->+
M_#]]=Z]/X@\/N]MK%A9P7"1(@_?[FE#*P[MM4#WQCZ7O"VOZ9XN\16>JP01Q
MWL>GRI<1D?/#)OC!'KC!.#Z$^XKK(+6[37KN\D$/V>6".)0K$N-C.<GC'/F'
M\JSK'PC::;XNOM=LR(C>V_ES0A>#)NW%\Y[\<8]Z . MM2L]&:;0/&>E36MU
M-<R-#K0&X.SLV'\SJ, X[\#D#FO858.H92"I&00>#7)77A_6-2\+?\(_J3Z=
M=(T"PO>MOWC QO$9!&\=0VX<\X[5JV>GZK::ZSC4(SHBVRQ0V7E#>CC W;^I
MX![]Z -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BL_7-3_L?29KXJA$>T$NQ"KE@-S$
M G SD\=JKVFOV]WKITU)8@WV99XU.=TJG!WKVV\X]<_3D V**P=2\5V6F>*-
M*T*4@SZ@KD-N_P!7C[H(Q_$<@?2G^*_$47A;PY=:M+'YIA "1!@"[$@ ?3)Y
M]J -NBN'D\::E9R:;:WME9K<:G<JEM(D_P AB*AMY7J.N,9Y/I5RQU_Q"VFZ
MM<ZII-E:/90M)&L=V)=[*"2K ?=Z?_6H ZRBN2TOQ7J&K^']"U*UTV OJ$VV
M>-[D+Y,88J67(RQX' ]:ZA[B&.18WEC5V^ZK, 3]!0!+16;J6NZ?I5S9VUW<
MHD]W)Y<,98 GU/T'K5YIXD=$>1%9_NJ6 +?3UH DHK$NM6O8;O4H$33\6\ F
MA:2Y9>W/F_+A!G.#D\=JT[&>2YL+>>:'R9)(U=H]V=A(R1GO0!8HJ.2>*$$R
MRH@&,EF QGI2^='YOE>8GF8SLSSCUQ0 ^BHS-$LJQ&1!(PR$+#)'TH>>*-T1
MY$5GX568 M]/6@"2BHWFCB#&21$"C)+'&!227$,*AI98XU/0LP - $M%(K!U
M#*05(R"#P10S!022 !R2>U "T5'Y\7[O]ZG[S[GS#YOIZU#>/<FUG73VMS>*
MOR"<G8#VW8YQ0!:HJDFIVIOO[.-S#]O$0D:$-R ?_P!1]ZJ>'M9;6-'M[JX6
M*&XE>5/*1\@F.1D.,\G[N?QH V***:SJI4,P!8X4$]3[4 .HJ-9HFE:)9$,B
M_>0,,CZBA9XGE:)94:1?O*&!(^HH DHIN]=^S<-^,[<\X]:1IHUD6-I$#M]U
M2>3]!0 ^BF-*B.J,ZJS_ '03@GZ57CU.RFU*;3X[F-KN%%>2('E0V['_ *"?
M\F@"W13)IHK>%YII$CB099W; 4>I)J&UU"UO+&.]@G1[:1 ZR9P,$9Y]* +-
M%-1TE0.C*RGHRG(-*S!5+,0% R23P!0 M%,CECF0/$ZNAZ,IR*4.K%@&!*G!
M /2@!U%(6"C+$ 9 YI: "BN33Q;?M;ZW,-(BD72)VBF$=R=\BJH8LB[.N#T)
M]>:Z*VU"VN["VO8I5$%RB21,WR[@PRO7O@]* +5%)FF^:GF"/>N\C.W/./7%
M #Z*8945U1G4.^=JD\G'7 I7=8T+NRJHY)8X H =10#D9'2B@ HIN]?,\O<N
M_&=N><>N*7- "T444 %%-=UC0N[*JCJS' %5[S4K/3X$FNKB.*.1UC1F/WF8
M@*!ZY)% %JBLD:M*?%;:.;=1$+(70FW<D[RI7'Y'/O6HSJBEF8*H&22< "@!
MU%("& (((/0BEH **P=:UZ[TS6])TVVL(;@ZB9%622Y,81D4L<@(V00*FT;7
M1JEUJ%E+!]GOM/D6.XB#[U^9=RLK8&01[ \=* -BBFHZR*&1@RGH0<BB21(E
MW2.J+TRQP* '44UY$B0O(RHHZLQP!3J "BBJM_J%KIEHUU>3+%$I W,>I)P
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M+W7]7TR2W2,6'D[9%DW>8)%)Y&!C&/>@#7HHHH **** "BBB@ HHHH ****
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MS1XSN3:2&';@\'@U%XITFYU2PM'LR#<V-Y%>1QL<"4H>4)[9!./?%4;VRO\
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MYL89D\Y6!SNVC@$]:O76DWLWBZ_F\E_L5]I:VGGJRD1N&D/S*6!/#C& ?PH
MOVOB6RN;RW@,5Q"MV";2::/:EQCGY3G.<<@$ D<C(J*+Q;ID]K-=1"Z:VA29
MY9A;MM3RB0X)QPW' /)K$\+Z+<64EG#<^$=-LKFT78^I)Y3>;A=NY OS@MWW
M8QD]>E3V>DZDG@+6["2P9+VY:^,4/F(2_FLY3D' X8=3VH U%\6:<\T,2I=E
MKB#S[;_1V_TA<*3L_O'# X[#/I4\'B/3[C2FU",R^6LQMVC,1$@E#[-FWKNW
M?XU2^QWKZ]X=NFL&$4%E/'.Q=/W#N(\#KD_<897(YK _X1;59M!U5&L;=KAM
M=EU&"UNV5H[B,MPK8R!D$]>A H ZL>)+!;6]FN?-M&L<&XAF7YT!^Z<*3N![
M$$Y/'6LJVU66Z^($4!%[;Q_V2\K6LV0,^:@5]H)&<;AZCH<53GT2^O?#=W'8
M>'K/1)UF@GAMLQYE>-U<[C'E0#M '7WQ5ZQ&K7WC:'4KC1)[&TCTYX"\\\3$
MNSHV $9N/E/- $VF:WIEEX<LIXKF_NX[F=H;<7)+SRR;FROS8Z;6ZXP!UJY_
MPDNGKI)U*4RPPI.+:17C.^.0N(]I S_$1R,CO7.6ECXALO#>DVJZ?<*!>3M?
M003Q+-Y;/(R['+@#DKG# XZ5"FAZR=!U/3Y=)8!];CN8(UG0AH/-C=CN+9S\
MK=>>1UH Z&;5+.\U'2O,;5+25KJ2*&-HWA65E0DAP1AEP"0>F1QWJ6Y\4Z?:
MR,9%G^RI<"VDO G[F.4G;M)SGJ0"0" >"12ZW;7=QJF@O;VS2Q6]ZTT[AE'E
MKY,B X)!/+CIGH:YC3_#=SI.J7=NWA;3]066ZDGM]4D:/**[%L2!OG)7)^[G
M/'3K0!U_]M0F^>V2VNG6.98'G2/<BN0#@X.<8(R<8&>M:5<9=V5\/$0NM*T^
M^L;M[N/[3*)$-M=0 @,S#<<-MZ<!LX[<UT]E=W-S+=)<:?+:K%(5C=Y$83+_
M 'AM)(^AP: ,[Q3J\VEV5K#:21I>W]U':6[2#<$+'EL9YPN3CUQ2SZ%=16K/
MIVJWJ7Y*DRW$[2(^#R"C9501G[BBCQ/HLNL6=K+:>5]OL+F.[MO-)"EE/*DC
MD C(S21ZSJET(X(]!N[:Y;_6/<M'Y47J=RL2WL .>^* +%YKUM9SS1>3<W!M
MU#7#6\>\0@C(W=\XP<#)P<XQS1)XBTU)+:..5IVNK=KBW$"%_-1<9VD<$_,.
M*SHDO]%U35MNGW%_#?S?:8&A*85O+53&^XC'W<@\C![8JKI/AVZTO4/#430^
M=%I^GW$,MPK *LCF,C SDCY7'3TH N7OBZ"'3M/O[6QN[F&[NA;';'M:)MQ5
M@RGYL@J1C'45:F\4Z=!?RV+K=FXB,(D1+61MHDSM;@?=X(+= >,YXKGWTG65
MT6R*V$WFVNO27K6R21[I86FD<<E@HX<'&>U;MA;W7_"6ZG?2V4D4$UG;11R.
MR'+*92PP&)&/,7\C0!++XETZ'?)(THM8YO(>Z\L^2KYP06] ?E)Z \9S6<NH
MS0_$>_MY;J06,>D1W!C9OD5O,8%@/H*S(]*U2W\)7OA'[#-+)-YT45\74Q&.
M5V;>QSD,H8Y7')''!S6E)IE\/&^HZG]@\^S;2%MD#2(!-('9BF,Y ((&2,4
M;5AJ\.H.%2"ZBW1+,C30E0RGI@],].#S[5H5Q^B6M]I4UU_9]AJ,>FQ6A\O3
MKN5#B<'(2)MQPN,@Y.T9&.^.ETR\.H:;;W;0M TJ9:)F#%3W&1P>>XZT 4Y9
M;0^*[:!KJ\6\%I)(MNI80,FY06(QM+ D#KD9J2QUN&_GCCCMKM$E0R0S/%B.
M11CD,,XZ\ X)'(XJI<V=X?'%E?);,UI'I\T+R[U #L\; 8SGHA[8Y%9>@65]
M:Z[$UI87NFZ?)$[7EE<.KQ1RG!!A(8XR2<X^7 Z T ;WB+68_#_A^]U610XM
MHRP0G&YNBC/N2!5=-&OI; O/J]U'JCQ\S0O^ZB<@<+&?E*@CC<"<=^34_B31
MD\0>';[2G8+]IB*JQ&0K#E3^! -5;36-66WCM[S0KDZ@ %=HG3R&/=@Y.0O?
MD9[8/&0"S)JXTV&UM;P2W6H&$/+':0ESQ@,^!T7=TS_0TG_"3Z08+&=;EW2^
M++;E()&+LH)*X"G##!^4X.01C-49EU#2_$LFIFRDO+>[LXH91:@%HI(V<@X8
M@E3YAZ=,<U0T[0KZSGTB=X9&+:K=7T\>Y3]G65)<+UP<%E!QGDG% %Z_\:6=
MKX:N]9AM+N86LGE26[1&*1'XX8,,J/F4Y]"*O3^)+.U:..6"^^T2P-<) MH[
M2%58*> .N6''7!STKG-6T'5+C1/&,"6H+WMRLUJ 5S*JI'GOZH0 <5KR0WUS
MXSTG419SI9K83QR;V4>4[,A&X;NI"=L]J +ESXEL;9F4QWDOEJK3&&V=_(!&
M1OP.#@Y(Z@=1R*S=4U&7_A-/"L=I=L;.\CNF=8WRDH6-2I]^N13;5-0T#5];
MVZ9<WT5_<"ZMY(70C<8U4H^YAMP5&#C&#[8JO;^&[^RU+P6 BRPZ5;3Q74JL
M %9HE48!.2"0>@^N* +>DZP+:X\3S7MS,UO;:D(XE=BY&8H\(@'JS<*.YQR:
MU(?$%A))>12N]K+9QB6=+E=A6,@X?G@KP1D=P:Y>^\,:G>6GB*-;2%GEU:*_
MMH[AE,5RB+'E&P20#L(Y'>IQH<M]HFHPVGA>RT*XEB54R8MTK!@V"8LC;QC)
M.>3QZ@$[:XUYXYT2W@-_!#+:SR/%-&T:2 !=K8/<9/!Y&1Q74W@8V4X1VC;R
MVPZXRIQU&:Y=)-4U;Q;HUZ^A7=G;6D5PD\D\D7RNZK@ *Q+#*XR!CFNJG0R6
M\B+U92!^5 ',>'/%ME=Z;HEO<W$SWEW:1?OVA812R[ 6428VEL@Y /8CKQ6K
M9^)-.OM)O-2@:8PV9=;A7A971D7<R[2,Y ]*Y^PL+Z^T/PWI4^G7%K)ILEN]
MS),%V@PC&%()W;F QCMG..AL7&D3CQNR6\R#3]0A6YO8.^^)E ([?/E0<]0A
MH ZN*3S84D"LH=0VUQ@C/8CL:R[WQ)I]A/-'(9W%OC[1)%"SI!D9^=@,#CD^
M@Y. 16O7'PIJ.DS:[9'2KFZ2^N)+BVF@*;6WJ!M;<PVD$=3QB@#7O?%.E6$[
M6[RS2SBV%V([>WDE+1%@NY2JD'DCH??I6PK!T##.",C(Q7&:'H.H:3XGTI6A
M,MI::$ME)=97'FAP<#)W8PI[>E=I0!A6FJZ;;0:K=+?W,\<%ZT4RRAB8IOE'
MEH" 2"67 &02W!K1T_4H=163RXKB)XFVND\+1D$C(ZCG@CIFN8L]+D73/$\>
MH:3/<P7>K/(MNI >6(B(;UY'3:6'(/R\<UH^%%U6-;]+YKMK19@+(WNWS]FT
M9#$$Y / )Y/.: ->\U*VL+BTAN&=6NY?)B(0D%\$@$CID ]?2J-SXITBSMM2
MN+FX>*/39%CNB87/EEL8X .00P.1GK3/$L-P\6FW%O;2W'V6^CGDCBP6V ,"
M0"1G[PKD=;TC5[_0_&HCTNX$FHRV[VL9*[G 2,'H>,;3G],T =Q;:[8W6JW&
MF*TT=W GF&.:%H]R9QO4L &7/&17.ZOXH$VK>'HM->[$%SJ C:<1E89H]K9
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M!&1CD$<$$<]*ZNN)&D7]MIEJZV<C27.NK?/ A!-O&S[CN.<<#DX[DXSUKMJ
M,)O%^D+IEWJ!DN!;V<Q@NC]FDW0, "=R[<X&1R 1S5NZU>SCNC9/)*KM:M<^
M8B$A8QP3N (!]*PK[PY>7/BN]48_L/5($>^!/)D3Y=JC_:7;D^BX[U8\*Z7?
MZ3I<KZD#/=PJ;6'&-SP1%A'WZMRWXC/2@"NOBRVT]O#UC ;_ %./4HVD2[,)
M+.@4MG  YR5R,# J'2?%":?-X@?6KRX:WM]5>"*0P,ZQ)M3 8HN%&6ZMCZU2
ML]-U.SB\#WCZ9<M_9L$T-U"FTR1EXPH.,XQE?7TJ"_T75)O#7CBU2PG,U]?,
M]JN!^]4A!D<]/E/6@#TG((S63<>(K"VU$V3BY9UE2&1TMG:.-WQL5F P,[E^
MF1G%:,!)MHBR,A*#*MU''0UQVI07:^(9;O2K74K/47NH4D.TO:WD0V@L_9=J
MY&>&XXS0!T,WB/2K>UU*YENBD.FOLNV,3_NS@'IC)X8=,]:-1\1:?IAQ.T[!
M8Q-(88'D$49SAWV@[1P?R/H:Y'Q#INJ2V7C&P@TNYF;4V26VECVE& BC4@Y.
M0<H1C'<5HR_VMHFOW4R:-/JECJ-O$,0,FZ*1%V[6#$#:01SGCGB@!]WX@>T\
M=I'YL\^FG13<B*VB:;>_G* P" D\'KTYKI[&]MM2L8;RTE$MO,H=''<5SD5E
M?#XA0:C+:%+=-$,+O'R@E,JML7N> >U7/!5M<V?A#3[>\MWM[B-6#Q/C(^=L
M=/48/XT ;]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%<QH7B"[U;4&B:6R1HG=;FQ*,D]O@D
M*<EL.#@<@ <\5GMXLUJ#0;37;BRLS9FX\FYAC+&0 RF,.K=,?=X(]>10!V]%
M<I-XCU.X>^ETJU2XBL[DVWV=H)-\[*0'(D'RK@DXR#G;U&>+$FKZK>SZI_8\
M5K*NG3" PRYW7#[5=@&R F P )#9.>E &V;VU^W_ &#[1%]K,7G>1N&_9G&[
M'7&>,US5Y;>#M+O2EY>0VA9B6@DOWCAR?F(*%PF3G.".A]*U7O9SXFDTY(H$
M)L/.CN&!9@V_;@CCY>AQG\JYC29+W2O ^N:M<FTOV2YO+I(GB*C*2.&R26ZA
M>!CCID]: .\B>.2)'B96C90493D$'H1[4^N8O?$4Z:BFGV<6PI:I<22?8Y;A
M5+$A4VQ],[6.2>W0]B'Q!J-[-IFGQVL=AJES;O=7$5T#(((U8*>%(W$LPQR.
M,D^E '06]W;7BR-:W$4XCD,3F-PVUQU4XZ$>E5[K6M+L)?*O-2L[>3(&R:=4
M.3TX)K)\%),NG:B;D1?:&U.Y,IB4A6;>1D Y/8=2:HZC*UO\3HY5M6ND;1F$
MD<:!G4"7C&2!SDC\* .Q1UD0.C!E(R"#D$4ZN"T5K[PM9"PDA$%QJNHW%Q;6
MQ0SBT@V[B-L?WL$#Y5.,OUXJ_<^)M5L-#-W<Z>AF%_%;(=CQK/'(R@.J-\RG
MYL%3W!H ZZBN6U+7-2TJ6T@U&YTVR-R\P6Z:*22'@KY:'E=K,&/)./EXZ\6_
M[2U*XOX=,A6U@NULDNKJ5U:6-"Q*A5 *ELE7YR. ..: -ZBN0@\6WEREE''9
MP_:6U632[I=Q*HZ(S%U/=<+GGU]JU- U:[OKG5+'4%MQ=Z?<+$S6X8(ZLBNI
MPW(.&P1D]* -NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M#%1QP10[_*C1-[%VVJ!N8]2?4U)10 48HHH ,48HHH ,48HHH **** &2Q1S
MQ/%*@>-U*LI'!!ZBG(BQHJ(H55&  , "EHH ,4444 %%%% !1BBB@ Q1BBB@
M Q1BBB@ HQ110 4444 %9^EZ)8:,C+91R+N !:69Y6P,X&YR3@9/'3DUH44
M%%%% !1110 8HHHH *,444 &*,444 &*,444 %&*** #%&*** #%)@>E+10
M8HQ110 4444 %&*** #%&*** #%&*** #%%%% !1BBB@ Q1110 48HHH ,44
M44 &**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** ,&/P_/+JUAJ&H7L5S+8;_)>.V\MVW*5
M(=MQ!&#G  &0#6)X7TN76O"]M'<:A#/I;7,DODQPX9MLS,%+AL%<@$_+D],U
MW-% '.+X8FMM3O;C3]7N;2VO7\VXM516&\XW,A/*$\YZ\G-.G\-SKJUU>Z;J
M]Q8K>X-U"L:NK, %WIG[C8 !/(.!QQ70T4 9XTP_\)!_:IFX^R_9A%M_V]Q;
M.?H,8K-7PS+_ ,(KJ6AR:@&%XUQB408\M96+$8SS@LW.>X]*Z*B@#G;OPU</
MJ-KJ5AJKV=]%;"UE;R0\<Z#D90G@@DD'/&>]27/A^=K^QU*VU%DU"VA:W>::
M%9!/&Q#$,HV]U!&",<UO44 9FBZ3)I$5VCWC7/VBZDN 6C"[=YR1QUJ(:++_
M ,):=<-X-OV/[)]G$74;MV2V>N<]A6Q10!D:]H?]M16S17DUE=VDOG6]Q" 2
MC8*G(/!!!.15/4/#5WJ6BI97.L227 N(KAKEX5ZHP8 *I  R![]:Z.B@#,U+
M3[R]?;%=P+;/"\4MO<6WFH^>A^\#QZ<@YJC:^%_[,>PETZ]>.:ULULF,Z>:L
MT2\KN&1@@DD$$=2.E=#10!SJ^%E3^SS'=E)+?4&U&=Q'S/*RL&[_ "C#D8YX
M _&:+0;BWN=;NK;4?*N=3D219!""(=J!!P2=W"\]*W** $4$( S;F Y.,9I:
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH R_$-]<Z=HLUS:0RRRJ4&(HC*X4L S!!]X@
M$G'M4$6HW5YK5U9!;FWC^RK)!*;4A<G&27/&X$XV8[$_3;-17$\=K \\S%8T
M&20"?T')H \TT[QEX@N? 5_XHEO+,2VDS1BV-M^[D"[1UW;MQR>^/:NWTOQ%
M:7FGZ7+>2165Y?P)+':RR ,2PZ+G&[\.:\IT;1XHOA[J-I<:+?IXB-P\MF4L
M9%G5N#&ROM^501SR .?6MW7K76[<> KS6(IKFYLKDF^DMXC*5)VD9" DG [#
MJ* /0TUO2Y+.>\34;5K> [9I!*,1GT;T/L>:S]5UZ.3P]<7FC:KI*3*ZQK-?
M2[84?(RKX.0=N>.O2O/-*L8YO#_B>SU:UU6VAO-<++)#;N)(P3N63&.0"O.*
MEUR+7IOAGXBT_4%%_<BY@CM[NWMR&O #&=Q &20!@G_9QDXH ]*;7=,M7BM[
MW4[**Z:%9=K3! X.?F7)Y'!JS;ZE875HUW;WMM-;)G=-'*K(,=<L#CBO/=:M
MY+KQCX!"VLTB6T323-Y+%8\HNTDXP#E3[C'TK#AT_5;[P!XQM[.RNBLFK-/;
MP>44,D6]6.U2.<@=,>V.U 'K$&NZ5=64UY#J-L]M!_K91(-J?4]N.1ZBB+7=
M*GL9KV+4+=K>'B5PX_=GT8=0?8\UP-U;Z1K6BW][/%XB N[>WM;@_9=GD8<%
M<($7=L/)(!&#C/.*@BL;F[\-:CIFNW4]Q MY EKK-C ?-<@95WQRVW"@GGJ>
M>,@ ],LM0L]1A,MG<Q3HIVL8V!VGK@CL>>AYKE?B/XBU7PIH46JZ887(F6&2
M*>/<N&!.[((.<@#\:M^"1JB6%['JQAGFCNC&E['%L-VH50';U/&W/^SWZUA?
M&:":[\'06MM:S7,[7B.J1(S$ *V3@#W _&@#5UGQ/?\ A75M*BU3[/=6&H3>
M1Y\$1C>%^V5+-N!R/3&#UKHKW6--TZ18[R^MX'8@!9) #ST)]!QU/%<-XUT]
M_'E[HFGZ=!,]I#/]HN[F2-HTC3IM^;!+'G@<CVK/\3^;=7_C*TL-+NX7FLU,
M\CP22&\9  OED#:BJ"?=L^QH ]+GU;3K:\BL[C4+6*ZEQY<,DRJ[Y.!A2<G)
MK/US5;B.SD&BW-C+?03(DL$F7)W=$PIRK'C!/ Y)XYKD-?T:\O?A=H>HVD;C
M6='MK:ZB+)^\#(B[U.>>Q..Y45W>D6[QV?GS(4NKHB>=2<[7*@;<^B@!1["@
M!FGW%_+JNI17+VSVL3H(#$CAER,D.3\I/3[OKS5RXO;6T:-;FYAA:3(022!2
MV!DXSUXJ>N6\5V\LVN^%7CA=UBU$L[*I(0>6W)]!0!K'Q%H8C60ZSIVQF*JW
MVI,$C&0#GKR/S%6;W4;/38U>\N8X%<[5+G&3_G\J\]O[&XDT7XA[+28O-.?)
M B.9/W:#Y>.>1V]*O:H[VGB/3M2ODU06$VF+!]IM$=S'+NW$.J@L,C'..H]J
M .RN-5T^TM$NY[V!+>0920R##C&>#WXYX[4\ZA9""&<WEN(9_P#52&5=LG!;
MY3G!X!/'8&N-2.WL9O#UG8V-U8VBP3F.YGMWDEC#,/W8!R%9LY^8' &, ]*6
MBQ3IX=\%0R0W!FAU)S+N@92HV3#+#'R\LO7UH [Q-6TV2R>]CU"U>U0[7G69
M2BGC@MG&>1^=/LM0L]2A,MG<QSHK;6*-G:V,X(['!'!]:XTVMJ)O%"WAN[6!
MM4@FBGAC8E'$<1$@X((#J<G!'!S6WX5N[VZAO1=R6]RL=QLBOH(]BW2[1\Q'
M<C[I(XXXZ4 ;%Y?6MA#YMW/'"A. 7.,G&<#U/!X%(NH636\,ZWEN89B!%()5
MVR$] IS@_A6+K[O_ ,)!HD21>66,I%]Y+2&$X V+CY59@>K<84\9-<Y:6C2>
M&?#L;6UP1%X@>1EE@*N@\Z9E9EP-O53T YH [?\ MS239O>?VI9?98VV/-]H
M38K>A;. >1Q5MIX4>-'E17E)$:E@"Y R<>O )KCK+2(]1\4>-+*\MG^P7<=K
M'RI56_=$,5/3(XY'3 JUX3CU&YVMJH/FZ6'L$;/$S _-+CW4(!W!W^O(!U3$
M*"2< =2:YR3Q(DOB_2M,L;RTN+:YMYY)A&P=E*;-IR#P#EORJ?QG!?7/@_4X
MM.!:Y:+A%Y+J""ZCU)7<![FL62^@U#QCX?N=/MKAH;>QNBZ_9GCV;A'M7D
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M$=G575F0X< Y*G&<'TX(/XU'<W=M90F:ZN(H(@<%Y7"K^9JKI%O)%:O/<?\
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MR0 #SUYKOH+:"UC*6\,<2$EBL:A1D]3Q0!5U34K:PMG$E]:VUPZ-Y/VAP 6
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYGW2,2RG^+&>2#6GXEM+J[2S%HEM<-%*9)+*XD*+<)C! /J"01D$9Q0!9O\
M6/L.NZ3IOV9G&H&4><&P(RB;N1CG//ITK5KSV9K>]\0>"4CAN88'^WHT,TA+
MH1&5*E@3T.0,'I3=+NUCT+5+*>2Y>*+Q ]E:0I+@LH92L19NB=<^V0.PH ]$
MHKS/4WN;3P?XI@L[O[,;;5(5B\B8X@#"W9T0GMEGXX')X'2M7Q!##8ZSI=@;
MI;>ROI)I7:]:2:*2?Y-J$%Q@$;R!G;D=,T =O17#R:7=#1X+*RU.TU)[>_=S
M:3NT<<R[23 IRQ(7<",[@, 'IQT'AJX@N=&5H+>>W"32QO!-)O,;K(RNH.3\
MH8$#'&,=* -BLO4]3FM;NUL;.".:[N5D=%ED**%0#.2 >[*/Q]JY1V2Z\,^(
M=6N)F35;*XN@DP<JT!C)\I!Z KLXZ-N.<YJ>6&*[^(6@_;;.'[2VERSR''/F
M!H_Y8.* .OT^:YN+&*:\M#:7##+P&0/L/IN'!JS7.>,+TV5EI_F2&*RFOXHK
MR0$C;$=W5NP+!03Z$UF:NUII&DWBZ3?N+62\MA>*D_R6<+NJR%".4RN2>>,[
MAB@#MJ*Y"XMDT_Q-'8Z>7BL[G39WNH(W(6,J5$;C'W6.YQD=<>U9VG6H:W\$
MW1NKDW%];K'=2&=B9D^RLV#SZ@<CG\: /0**X*[DDMO"?C"&&ZG3[)=.(3YS
M%XQY438#$YQDG\ZUI;.+_A,_LF^?[/=6$DLL?VA\%UE3!'/'WCTQUH Z>BO/
MK2_OE\.:%;3RRM;W&JR6TTYF(*PK)($4MUY*JO7)Z=ZFU@7.FW7B"SL6E33Q
MHCW)"RD?9YQN"[.<J& )P./E^N0#NZ*XNR9H=7\)2+<S>9?6,GVA&D9A+B)#
MN()P"#C\S6UXFM;F[L($M)+<RK.&^S7+;8[H!6S$2/;YAP>5'&* -6>Y@MO+
M\^9(_-<1IN;&YCT ]34M>9ZL+#5+;PPO]G/"8->^S303_/Y;8<NBMT9,XQCC
M@#C&!NQ)'K5UXBM]3GDA>SG"0F.0HT$0C5ED7!ZDECGVQT&* .OK.N]3-IJ^
MFV/D;UO3(OF;\;"J%NF.<X-<GIU\^LZEI5IK[D1W&BI<(C-Y:RS%CO. 1E@N
MT@?PY)XJ757N++_A&AI4QU>>)KA(WFN K38B<'YPI!;C'(Y(Y/>@#N**Q] U
M'3[K0;:\MKMW@F8_O+A_G,A8A@<]#NR,#CTXQ6A?6JWUC/:L[HLT93?&Q5ER
M.H(Z$4 6*JZA<75M:F2SL_M<VY1Y7FB/@D G)XX&3[XKSHZM?IINF:B_G;_#
M<QM]6)E<"51^[8[1G><8DR?ZUMZU+/!X.N-2,LD$]Y?VTY.XJ41IXE5>O'[L
M*"/7=ZT =<;B/SF@5U,ZIYGEYYP20#],@U5T34SK&D07Q@,!EW QEMVTABO7
MOTKG=,@B7XJZ[($ ?[!;G/U+9_D*HZ:C6N@>'KN&>993J1A8B0[61Y9 5*]"
M.?3/ ]* /0**XJUSK47B26_N)(+JQO9HK>1)-K6T:JI1AZ9Y;)Z]\BI=(OKJ
MX\6:8UX[I/<Z LTL&XA?,WJ6.WH"-Q'K0!U<MQ# T2RR*AE?RXPQQN;!.![X
M!_*I:\OMHDNK'P))<M+-*-0GC\R1BQ*XEX+$Y_A7ZXKM?&+R1>"]:EBEDBEC
MLI71XW*LK!2001SU% &W17#2'^QM3T*\BU2Y:*YM)FOR\K2*\:Q%_.VDG:0V
M!P,88#TJOH=Q=+XIT+:TXM+W2Y6W371=YP"C"1T'"N=QZ$\'&>P /0:*X[X?
M6YG\.6.J3WEU<W3)-"S2SNZD"=R,JQQN&,9Z_A4GB&^_X1OQ%8ZU(\[6-TC6
M=Q&I+*KXW1,%SP25*Y]Q0!UM9/B#6UT"PBNWMVF5[B* A6 QO8+G\,UA7*3Q
M2:%ITTES-J$PFN9;-9RL3,W+EY.2$0N0H&>W''&1=FXN_AGI:23&>4:I%$'>
M3=N"W14?,>O ')ZT >E45Q>J32QW'C4/<.J)I\4D0$C#8?+DY'/!RHZ8[5FV
M]U=ZIJFGZ;/J<<"MH<$\8G60^:[9$C K(F6&%[DC)QCF@#T:BLO0O]'TBRM9
MM5349Q&0+G@&8*<9QDYQP"<GU[U1\67$T8TJT#2Q6EY?)#=3QR%"J$$A<CD;
MF"KD>N.] '15A:3KMWJ[P3Q:8!IEQO\ +N1."PVD@%DP,9P<8)]\511);;Q?
M?:9$))-,ETT7,BNY<13;RH R>-P!./\ 8^M,^&5O'#\/])= P:6'<V6)YR>F
M>GX4 ;]WJD-O'?",B:XLX1-) K , 0Q'TSM/Y4:-J::SHUGJ44;1I=0K*J,>
M5!&<&N4MX+4>)?'+I'B=8(B6!."&@/;H3D'\ZS- 9M/M_ ,MO+,#?1&*=#,Y
M1E%OQ\N<#!4'@=<GN: /3:AN[J"QM9;JZE2&")2\DCG 4#O7G^DF[U6&349]
M>MK6^MM1<7"^2[2Q[9-HA_U@!4KM&-N#G.">:V_B/;S7/@F[$,;2")XII8U7
M):-)%9N/H"?PH N3>(+Z"Q?46T.X-BB&0XE3S]@&=WEGC&.V[/M6ZCB2-7'1
M@",U M]:2:?]N6>-K0Q^9YH.5*XSFN=0G6/&&L:9>O*EK;6D!M$CE:/<)-^]
MQ@@D@A1GM[9H ZNBO-S<7DR^%[:34+UDDU&[L9)$N'0W$*>8JLQ4C)(13N_$
M5I/I44GB^/1)+_4#9IHX81_;9%9B)L;RP8$GL?J,]J .VHKS?2]0O9?[%TG4
M+NXDLGU&]M5NO-*M<K#D1!F')S\W?G8.>:B\2W%]INC^,[*UNKI;2UAMYK>3
MSVWPNYRZ!L[L< XSP&QT- 'IM137$4&SS75/,<(F?XF/0"N2U.SBM-4L+6UN
M;V>ZNY9;K[#+>.L4GR $LYR51<YV@'DCCCC%LK==3\,^%IM1=I[A-7E@$IG9
MCM#S* 'X)X50#UXH ]!6XNCJCV[61%H(@ZW7FKAGSRFWJ,#G/2K8KC-2N[O3
M_$^N26;S2O;Z$D\-L9"R>9OE&0I.,_(O3^M02/\ 8;+PQJ>G7ES<S7MW!',S
MSL1<)*I+L5/''WA@#&,<4 =U17E%Y/<P^&?$FL+>WOVS3=>D2V8W4FU5\V(;
M2N[##!(P0>M>I+.C2^4)%+X!*AAD#UQUH EHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ,4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!3N=(TR\G$]UIUI/,.!)+ K,/Q(J
M::UM[F V]Q!%+"1@QR(&4_@>*FHH K+IUBMF+-;.W%J.D B79US]W&.M(FF6
M$<T<R6-LLL:A4<1*&4#H <<#D_G5JB@"FND::EJ;5=/M%MR03$(5"$CH<8QQ
M@4[^S;'?&_V*VWQ +&WE+E .@'' JU10!7@L;2U1TM[6")'^^L<84-]<=:2T
MTZQL-_V.RM[?><OY,2IN/O@<U9HH IG2=-:(Q'3[0QEM^TPKC=ZXQU]ZM-&C
MQF-D5D(VE2,@CTQ3J* *2:1ID=W]K33K1;G.?.$"A\_[V,U/):6TL\<\EO$\
MT?W)&0%E^A[5-10!5.FV#7?VLV5L;G(/G&)=^0, [L9[G\Z;=Z3INH2QRWNG
MVMS)']QYH5<K]"1Q5RB@"$VEL;D7)MX?/48$NP;@/3/6B"SMK5I&M[>&)I#E
MS&@4L?4XZ]34U% !4!L[4RRRFVA,DR[)7\L9=>F&/<?6IZ* *BZ5IR);(MA:
MJMJ<VX$*@0G_ &./E_"EETRPGO([R6QMI+J/A)WB4NOT;&15JB@"E-H^EW$L
MTL^FV<LDZ[)7>!6,B^C$CD?6IQ:VZLS""(%D$9(0<J.B_3VJ:B@"G+I&FSQ1
M13:?:21P@K$CPJ0@(QA01QQZ5:CC2*-8XT5(T 5548  [ 4ZB@"DVCZ8R3(V
MG6A6>032@P+B1P<AFXY;/<\U.+.U6\:\6VA%TZ"-I@@WE1R%+=<>U344 5+7
M2]/L9I);.PM;>67_ %CPPJA?ZD#FG7FG6.HJBWME;W(0Y03Q*^T^V1Q5FB@"
MJNF6"26SI96RO:J5MV$2@P@C!"<?*"/2HVT;2WMI;9]-LV@ED,TD1@4J[G^(
MC&"WOUJ]10!0?0])DBFB?2[)HYPHE5K=") OW=PQSC QGI4]W8VFH6YM[VU@
MN82<F.:,.I/T/%6** *3:1ICP6\#Z=:-%;G,$9@4K$?51CY?PJQ!;P6L*PV\
M,<,2_=2-0JCOP!4M% %.32--FNQ=RZ=:27(((F:%2_'3YL9J1K&T>]2]>U@:
M[C4HDYC!D53U ;J!R>*L44 ,FABN(7AFC22)QM9'4$,/0@]:AM].L;6S-G;V
M5O#:D$&&.)50YZ_*!BK-% %2VTK3K.&6&UL+6"*48D2*%55QC'( YXI5TRP1
M;55L;91:?\>X$2CR>,?)Q\O''%6J* *9TG36AN(6T^U,5RV^=#"NV5O5ACYC
MP.3Z5*;.U-RMR;:'SUC\H2[!N"==N>N/:IZ* *@TK3EL#8+86HLSG-N(5\LY
M.3\N,=>:2#2K"VM9+:*TB$,H(E0KN\P8Q\V?O<<<]JN44 5_L%GYEM)]D@WV
MH*V[>6,Q C!"'^'(XX[4MU96E\B)=VL-PJ.)$6:,.%8=&&>AY//O4]% %1]+
MT^2R%F]A:M:AMP@:%2@.<YVXQG/-,N]'TV_E26ZL8)I$&U6= 3C^Z?4=\'BK
MU% %6^TRPU.)8M0L;:[C4[E2XB60 ^H!!YI6T^R>2WD>SMV>VSY#&,$Q9&#M
MX^7CTJS10!D:AH%E=VLEO%8Z>BSS"6<R6J/N/.6P1@O[G/XUK      #@ 4M
M% $?D0[)$\I-LF=XVC#9X.?6F75E:WT'D7=M#<0Y#>7+&'7(Z'!]*GHH JOI
MMC+?+?265L]VJ;%G:)3(%YX#8SCD\>YIBZ/IB06\"Z=:+#;R>;!&(%"Q/G.Y
M1C .23D=ZNT4 4+O1-,O[I;FZLH99E&W<R_>'8-_> [ YQ4UQI]E=RPRW-G;
MS20G,3RQ*Q0\?=)''0=/2K-% %.32=-FM8[673[1[>-]Z1-"I16YY Q@'D\^
MYJOXDL)]5\,ZGI]ML\^ZMI(4WMA064CDX/K6I10!D:'X?LM(LH52TA2Y\A(I
MG49S@<@$_P .<G'2K%MH>DV4L<MKI=E!)$"(WBMT4H#UP0.,U?HH AMK6WLK
M=8+6"*"%22L<2!5&3DX XY))_&G2P17"!)HDD4,& =00&!R#SW! (^E244 5
M;O3+"_>)[RQMKEX23&TT2N4SUQD<=!42:)I4=K]F73;00><9Q&85*B3.=V,=
M<]ZOT4 4+S1-+U"Z^TW=C!-/Y30^8Z9;8>HS^?YGUI;K1=*OX(8+S3+*XB@&
M(HYH%=8QC&%!'' '2KU% &3<:%;W&LZ;?>5#&-/5A"43##<-NW/0+CMZXZ#.
M="ZM;>]MI+:ZACF@D&'CD4,K#W!J:B@"C;:/86=I-:P6X2*?/FC<27R,<G.>
MG'6K%I9VUA:QVMG;Q6]O&,)%$@55YSP![U-10!2.D:<=0EOS90&[EC$4DQ0%
MF3T/YXIW]EZ>%M5^P6N+3_CV'DK^Y[?)Q\OX5;HH I'1M+.H?V@=-LS>]?M/
MD+YGI][&:ND9&#110!EIX<T>.[%S'IT"2!MXVKA=W][;TS[XS4]]I&GZDR/>
M6L<KIPKGA@#U&1S@]QT.*NT4 5#I=@9;64V4!>T!6W/EC]R#Q\O]W@8XK$N_
M#PU/QD][>V<;V26"P1R%\/OWECC'(&..O-=-10!2N-(TZ[L$L;BRA>UCV^7$
M4X3'0KZ$=B*A;P]I+:5-IC6,1LYCNEBY_>'(.6/4G@=3VK3HH HW^CZ;JA@-
M]8P7!MVW1&1 2AXZ?7 R.^.:K_\ ",Z)_9YL/[+M?LAF\\Q%!M\S.=WU_P#U
M=*UJ* *D>EV,6I/J,=M&MV\0A:4#DH#D+]*AMM TFSO/M=O80QS\E65?NYZ[
M1T7/?&,UHT4 9;^'-(DLI[)[&,VUQ.;B:/)P\A(.X\\\@'\*LQV-M'J$EXL*
MBYD0(\N/F('8U;HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **1F"C+$ #N:3<-VW(W 9QWH =15:?4+*UE2*XN[>&1_N))(%+?
M0$\U9H **** "BBB@ HHJ(7$)#D2QX3[YW#Y?KZ4 2T4T2(S;0ZEL9P#SCUI
MU !1110 4444 %%%% !1110 4444 %%%% !1110 445')/%%GS)43&,[F QG
MI0!)12 YY'2EH **** "BBB@ HHJ.2>*$H)943>P5=S ;B>@'J: )**** "B
MBB@ HHHH **** "BBB@ HHIKR)&A=V55'4L< 4 .HIGFIYHBWKYA7=LSSCUQ
MZ4^@ HHHH **** "BBB@ HHHH **** "BBB@ HI%974,I!4]"#2T %%%-\Q<
ML-RY4989Z?6@!U%-5U=0RL&4C((.0:=0 4444 %%(KJ^=K!L'!P<X/I2T %%
M%% !114,-U!<,ZPSQ2&,[7".#M/H<=* )J*:SJ@R[*HSC).*=0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'(^V-D4GY01T.X9/7(Z4_P .>-]2\0:19ZJFB)%8EY!>3M<@"%5S\R@C+?\
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MV*L3(51>_2,#)[DG SBI;S2;Z#7]3UZ&]@BWZ<MM"KQLP5E9FW, >?O'@<T
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M9;6!) B1A45MA..!ANOM45]XW^S2W,<5I')+9*OVFW,W[UI"H8QQ@ AB 1Z
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M;MH6F@B6,M#G:P48!YY[4 7J*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ I" <9 ..>:6B@ HHHH **** "BBB@ HHHH **** "BBB@"
M);6W2Z>Y6");AUVM*$ =AZ$]2*EHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** (+NSMKZ PW=O%<1==DJ!AGZ&BTL[:Q@$
M-K;QP1 YV1J%&?H*GHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
)HHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>exhibit1061-loanandsecur023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur023.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U/NTZFI]VG4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U/NTZFI]VG4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U/NTZFI]VG4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U/NTZFI]VG4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U/NTZFI]VG4 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 U>.*=34Y&33J "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :GW:=34&!S3J "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M) I(?=N5=^['0C /4UH>%;/4K'2&M]3GGF99W\@W+J\PB_A$C*2"W7D$\8H
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M"EP<$^7*I."H/=L=>#VH Z*^\1:=I\DJW#R[8-OGR)"S)#GD;V P."#[ @G
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M #KZB>YMXW='GB5T3S&5G *I_>/H/>I:Q+WP^UW=ZC(-0GC@OK;RG@"*0LG
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MRI/KR./>L8:OK.FWNE-J1M;FTU.80C[- R-;.RY49+-O!(()PN.O3@8.K?\
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M4,<X4\C@^M<U;>++PZYI]G<I9XOIY(#!"2TEL45F&]LE22 /EP",]ZRY0/\
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M;:?X>M#=LZZ,P=6V8,I"%!GG@88_I7244 <S+X2::RUZQ;4I?LFK.TFSRQF
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MZU<H **** "BBB@ HHHH **** "BBB@ HHHH **** $!R,TM-3[M.H ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% " 8X%+2
M4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 8HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8:A+&MQ<8!6,!<9P!D\^F<FNHM?$VFW=[<V4;3B\MXA,]N\#K(4/0@$<CZ4
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ME+P1":?RH7D$*<_,Y4''0GZ"G7OB'3K *99)'!A-P3#$TFV(?QG:#@?SY]*
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M#Y1R.3Q[\5N@A@"""#R"* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUCINGI%J"G4+"ZFN8;DP84^:6+H5W9VD-C[W8'MBI=0\*2ZK8:PMS>Q)>ZG
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M&\N7' 6385C3/K\Q8CT ]10!L:M=W%CIDUQ:6C7=PNT1PJV-Q+ 9)[ 9R3Z
MUF>'?$J:Y>ZI9@6[2:?(B--;3>9%)N7<-IP.1R"/459\2:1/K>D_8X+E8&\Z
M.0[UW)(%8,489&5.,&JNAZ#>:9KVKZE<7-M(NHB$^7#"4\LQIL &6.1C_(H
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M/#DD]W [Z4KK*5C(\W,?E@CG@]S5:X\(W=QI^IQ)J0M[J?4SJ%I<11G,+8
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MIJ^GZ<UO,[WOF;9$QL38,G=DY[]@:P[O[;>^*M8L#J=U!:16$$\:0,$97+2
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M63D0VJ@_*RIG,@]V8D?15JBUU-JWC'4='DN)[>WLK6&6/R)"C.[ELL2.2!M
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MF"4P2I+&49' !((/L1R.*OUSOB'45L196]I*L,E_J,=K/+$%W(64G)ST8A5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%&: "BBB@ HHHH **** "BBB@ HHS1F@ HHS10 4444 %%%% !111F@ HH
MS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHY%PQ4GC<,#@]>:R;[1]2U"Q\6W:V)BGU6T2TMK8LN\[5=0[G.!DR>O 7\*
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M0!D:[HC:VMHOVMK<6MPERFQ Q,B'*YS_  ^W?UJYJ%E_:&F7%D\K1B>)HF=
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M;Z=J+O)<VPB5CN<8?8Y^Z&[@@]\8JWJGAO3]6M+"UF0K!93)+$B<#"@KM/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA'+;N =K8W*<@@@[1[\5 /#,$-KY-I?7UHWVN2\$L4BE@[DEAAE*E3N/!!H
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MM+.\MRIG>S;,$KD+AT'\)P!E>H/KG-;3"QN/&ODZTD<EN=+C-D+G!A/S'S<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@!GDQF42^6GF ;0^WG'IFE5%3.U0,G)
MP,<TZB@!,9HP*6B@"I?V]U)8SIIT\5K=O@K,\6\ \<E<C/ QUJ+1]-;3;1UF
MG-S=32&:XG*[?,<@#..P "@#T K0HH 1E#J58 J1@@C@U&+>%8EB6*,1J<A
MHP#G/3ZU+10 QXDD7:Z*RY!PPR,BA8T4L5106.6('4^]/HH 8(8Q*91&HD(P
M7V\D>F:3R(L2#RTQ)]\;1\W;GUJ2B@"-H(G=':)&:/[A*@E?IZ56L=-6REN9
MO,,DMQ)O<[0H'H !_P#7)R<FKM% #'B20J716*G<N1G!]11)$DL9CD170]58
M9!_"GT4 8'B;0I]<;2%C, BL[^.[E$N?G501M QWW'KZ5M+;0)"84AC6(Y!0
M* ISUXJ6B@"$VEN5VF"(KMV8*#&WT^GM3C;PF#R#%&8L8\LJ-N/I4E% $7V:
M#>7\F/>R["VT9*^GTIHL[8","WB B.8_D'R'V]*GHH :8T9U<JI9<[6(Y'TJ
M/[+;[I&\B+,@Q(=@^<>_K4U% $7V:#9&GDQ[8R"@VC"GV]*JV.EQV=U=W1?S
M+BY8;Y-H7Y03M7 ]-QYZG/TQ?HH B>WADD$CQ1LX!4,R@G!ZC-8^H:'<SZM#
M>6TMF88[?R!:W-OO1?FSN7!&#T!^@K=HH RM)T<6"7;3FWDENY-\@AA$<8
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M@W#\:<D,<18QQJI<[FVC&X^II]% !1110 4444 %%%% !1110 4444 %%%%
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MJEO+-(7?#1JY0L>3M+8!/...U<UXUN+J*/Q!J5C=W;RZ>D6UA<-#%:, "54
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MA\;>XEC66:WAE5'P)$,#DAO7E14>JZC>"YN=3T^]GG^S:S%;/,S&..-"Z1M
ML>2'P6.6(')R.@H ]"2XA>>2!94,T85G0'E0V<$CWP?R-25YQNDTKQ%\0=1L
M_--S;6L,D2F5BNXPLV2I.#@C(XXY QFM#PU:7T5]I]^-:MYK2\A;>INY9FNC
MM!#*'.%(QSM X)XX% '6W=S-;O;B*SEN!+*$=HRH\I3_ !')&1],FK5<WXLN
M;BTDT)[:XDB,FJPP2!&P'1LY!'?H*YRZ-[>VGC:3^UK^&339W>U:.X91'B)7
MQ@$9&0>#QR>* /1Z*J"YQI(NII!'B#S'DQD+\N2<5QFBW=]%X@\.QFYO9;>^
MT^<N]U,Q,Y7RV$GEY(C^\<#.<'! P* .^HKS2RN[Z/0-"U=M3OI+DZO]B=7N
M&*21M=.AW+T)VG /; ]*UKJ_NO#OB2^LWFN+F/5HO-TU992P2<':T0R>!\RM
M[ -V% ':TC$A20,GT]:JP6TEGI*6RW,CR10[!/,Q=BP'WF)Z\\US&ARSPZA)
MI^HC4K;4UL&)#W;3P3JI4&6-CT8%AD8!&[H>M '4V%Q-=V,,]Q:/:3.N6@D8
M,R'T)'%6*\QTN_U"^TSP'YNI7H:_^T)<NL[!I/W;D$GN0>15B.ZU=/"?BNUL
MKRZFN+'43;V\DDK/-Y?[LLH8\EL,VW'.2,4 >BL2JDA2Q SM&,G\ZS?#VM1>
M(=%AU.&&2&.5I%"2$;AL=DYQQ_#6;HD,\OB.^O(YM4&F^3$(8KLR*#*=V_"R
M?-C'E^V=V*XO1;Z[C\*>%M+@G6WBO[N]$DK3/""5E<JF].06)[$$XQW- 'K5
M,$T9F:$.IE10S)GD Y /X[3^1K%\-6VI6<-W;ZA?177ESGR@KN[1 @-L9GY;
M&003S@UR]O9K#XK\>W<4]U'-!#$T;+<R8!:W)R1G!P3QD'';% 'HM%>?6[3K
MX'T_4[G7-4^UZK#:1D(V\L[8RL0RH1F!(+9'KUJM?ZCJ5OH?BV/[?<VK6%W
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M_L]Y[>%+Y[J5'1<[UDD4':> 1@@'H1FF:S)?Z9X7LM1AUB\EN+R\LWD8R H
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M@"[=Z#I=]';QW%C"RVPQ!M&TQ#&,*1@@8[#BEGT/3+FQM[*:RB:VMG62&/&
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M#V_')D.>YZ<#I5J#4["ZN7MK>^MIKA%#O%'*K,JGH2 <@<B@#.D\(Z#+K?\
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M3T/)'M0!7U7PMHNMW45UJ%BLL\:%%D#LAVG^$E2,CV.:UT18T5$4*BC"JHP
M/055N=6TZS2)[J_M8$E&8VEF50_TR>:MJRNH92&4C((.010 M%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4C E"%."1P<=*6B@#SB2WN[CX?3>&YK:==;\PH,PL0[^=N$P?&W'\1.>.
M>]:\1*_%=W993'_8R0>;Y;;#()68KNQC."#UKL*:[I& 795!. 2<9/I0!SGB
MB;RK[2%\B5=TLF+Z*W,S6IV8^50" S9(!((&#P:Y'2_-LO#6EFXM+]39^('E
MG#6DA94)EPV O(^8=/6O4Z* ,/Q:QE\%:OY?F[I;*1458R7)92 -N,Y)('3O
M7*7ZR66OZ;J5[#K']G2Z5%"DE@),QR*22KHG."&'4=17H]% 'G$R+9WEA8VN
MDWFFVYL)1!<1P27$V#*2(<D-LW##'<,C.,C&:CT>';X4\-%+J^TO5K:TD1)6
MLV9."N^.12.A(4CIG;P:]+HH X&TFN8=:\+:C?:9)9K)ITT#Q6\#LL4C-&54
M@#*@@'KTZ=JV?%\TD4.FJMLSHUZA:Y6 S&TP"1($'4YX!/ SD@XQ72T4 <;\
M/TE@'B&.<79=]6DF5[J QM(C(@#?=4<[3T ^@K/O[=I&^(O^B2L9K95A_<,?
M,/V;;\O'/S =.XKT*B@#AX ]OKGA!K>UE"C2[A)0L) &5B95)(P"2IZXY^M8
M6ER?:-8\+7DMI?6ZP7$ZM8I82+%9;T;"YV98EL9;..O %>JU5U"UFN[*2&WO
M);.5L%9XE5F7!!Z,""#C!^M 'G%U87=]IOC6&QA::1=9CE:!.LJJ(F9<=\@'
MCO6])=6>L>*]+U/3C*T.GPW O9A"ZKL*X$1R!E@V&VX)&.V:Z+2=(BTI+DJ[
M2SW4[7$\K  NYP.@Z    >U:- 'G/A[3EM_@S,C6!CO'L+I&0P$2,Q+X&,9.
M>/TJQIXDLM4\'7,]O<"'^QFMF986;9(1%A6 &5Z'KZ5WU(PRI&2,C&1VH X*
M^T:XM/%=QI5FA_LOQ$#-<X.!"R8\W _Z:*57ZG-;WC6PO+[P5J=GI@;[2\&(
MTC."P!!*C'J 1CWJQHNA-I3R2W&I7>HW##8LMT5)C3.=HP![9]<#T%;% ''/
M<P:[K/A^;2UDBDLW:2Y_<E?(B,9!B?(&&)*?+UXSZ5/X.;-YXDRLB^9JSRH7
M0KO0QQ@,,CD94\CTKJJ* .5=C;?$QIY8Y1#+I*1)((V*EQ*Y(R!@'!!YKF+9
M'M?AUI7E6,K7J:PLPB\A]VX7);<1C.-G<]J]1HH \REM(?[4\1:3K]CJTRWE
MT;B'[*LC1749QL7*@X*[0.2!QVKJ?%UIJ%SX,G@TZ$M<*L;-;AMQD16!= 3U
MRH(]ZZ2B@#CYI8->\6Z%>:2Y(L1-]L<(5*(R8$39'!W8.T\C:361%<R)X?T[
M3QI]V;NWUQ2T7V=P%3[2S;\[<8VG.:]'HH X<((/$'C1-0AO)+>[AA*^3 Q+
MQ^458(0,$C./6L^:34)M#\3V$,R:NJZ4Z1WX@V2DX8>0^!\SJ"3V/S<C)KTB
MB@#CM0U%)[[27CAN8%:TE(O%LGDD490-$J[2 S8')!^[@#G-<WH5E</HOP^B
MFLYR]M<S><LD+?NQM?[V1P.5Z^U>JT4 >8W-O>?9/$^VPN;B :]%/);+$Q,\
M(,>_:/XA\ISC.<5LZ?)%?_$^:^MK>;[*=&6)I7MVC4OYN=OS 9.W%=K10!Y;
M8V4H\(>!X8[.Y#V^M*S+)"P>.,-+RW' Y7GITJW?6PED^(HG^TP6LT<6)4B8
MY @PQ4?Q<@@XKT>J6K:8FK:=)9O-+"'*L)(B RE2&'4$'D#@C!H Y/0;^SNO
M$MO=7LT,5\;);*"/R)D\W!W,0947\%&>,\U<UZRFL_&.D^)$@EGM8()+6Z6%
M"[QJW*N%') /!QD\YQ6O#I%RUW!/?ZD]T(.8XA$L:;L$;F ZGGCG ]*UJ ,N
MTU^QU&>*/3W:[5B=\L2G9$ ,_,QXST&.O/3@XXB*1E\#3^'+LR?\)(9I L>P
M[VF,I9)@<<H.#OZ#&/:O2Z* .+N+59M4\:;[5G62QB528B0Y\IP0..3R!Q4=
MI;%;WP*WV9U>.TD$A\HC9F!0=W'&2!U]*[BB@#RNXT^Y;P)XC6.RF\Z3Q TL
M2B([F3[2A# 8SC&3GZUO7=I=OX\U=;%'A:30%BAF"$()0[[>>F1E:[:B@#SV
MW,>H>&_#VE6L;0:S8S6WF0F,B2VV$"5F] 5#<GAL\9S5#5+&Z_X0_P ?1K:3
MF2?4V>%%B),F1%@J,<\]QZ5ZC10!6FN#!IDERD,DQCA,@B099\+G:!ZGI7"-
MI^FP^(;"\\'W+6]U)=1C4+"#*QM"3\[21G[C ="<<\8R:]$HH \XO+6^>X\>
MVUM;W!N;KRG@4*R^<HB4,%;&.>1P:T;F:SU[6?#=QHF!/93EI\1[6MX/+8-&
MXXVDG: I]R.E=M10!P?AR>%-,TW1M5TNZFUBRNMS%K5]GF;CF<28VXPQ.<Y.
M<=:R[ 3Z;K5YK;13W>F/K<RR6X@9O+9@H6X3 RP&,=#P217J%% '/^,HS>^!
M-9%MB7S+&1DV'.X;<\>O%91U2"+Q!H^L3RDZ,^G/#'<E#Y<4Q922Q(^4,HP"
M>#C%=K10!S7A"U\A=8EBB,5C<ZB\UHO0%"J@LH[*7#$>N<]ZY*[N;:XN8EC%
MQ:&W\0^;+;V]L[LF&;=*[[2?F&#Q@ -CFO4J* .=\;7D=MX,U&1IA%YD6Q23
M@MGL/J,\5F>*=(O(%N/$7AQ5DN98"M[:KG%]%MP",?QJ#D''/3VKM:* .)><
MZ5K7AV]U%633ETQH!*R?+;SG8<N?X<J"N3[CO65=V,9AU"\DB+Z3=:]:3VR^
M62-N4$D@&. QW<]^O0UZ710!Q=K;W,7C[78=.\NS#V%L49H"T6\,V3M!7<<'
M'6KVL7]YI6A?9M0U*V:_OYA:VTT,!A"%\#=@NWW1ELY'0"NFHH \Z\203^$Y
MO#^MO=6S06$RV;1PP&)C;N,,/O'=MP&QCMFM'5+RVF^)7A;RIT?=:73#:<\,
MJE3^(4X^E=I10!Q^CWMK+\2?$D23HS_9;88!SRAD#C\"RY^M<MYEHGPQ@DC)
M*OKN\$< ?Z43D#'(V#->LT4 <'J%RD'Q'U:5(&NFC\.@F"(_/(1(QVC'.2"/
MS%9?AZ\27QAX:F@N0T$NFS0+'# R11!0A$09AER,'.2>1T&:]0HH \FM9S_P
MA&CD2W"6VEZE,VI^1$&E@&Z7:VUE((!96(VDC@\8S7;>$TTYH;N\TV6\N(KJ
M02O<W*>7YSXY94VJ!QC)"C/N<FNCHH \YU9H#J7Q#C\E-W]E1;GV]6\J3 Z<
MGE?TIUBL2:]\/W@55>33)A,R#!8>3'C=CKR#U]*]$HH Y7Q=>1VNH:)O'D,T
M\@2^96<6[;,8"#AG8$@;N!SP:XZPFLHM#\-V[2Y>W\2S(QG38VW=-R00.NY,
M^Y KUNB@#A-/T[3M9UCQQH[I$UM++"FQ5!5"8%7('3(93]"M7O"8U._=;K5U
MQ/IR/IX;'$KA\/*/8A$Q[[JZ#4[2YO+9([34)+&19%<RQHKD@?PX8$8-/TZP
MBTRQCM8F=PN2TDAR[L22S,>Y)))^M '+>,)X[34%N;?4K>VU!+)P+:]4&WO(
MB?FC)/0Y'8YY&014 $,_C'P=*]G]BG.FW!-N%YCRD>(V..@&\?A7=44 >.6X
MLK7P/I%PD<,4[>(0\3A &VBX;D=\!?TK5UVYTU-1\4Z/>:G:PKJ31>8]RL@D
MB&Q1\ORD.H RO(P<_6O3JPCHFHPW5R]EK)B@N96ED22W61P2 /E8D8 QQD'%
M &)J4UL_CCP8+&:%X_LMX8F4@J5,:;3QV.#^1K \.&REDT_3+^YU;^W+&\\Q
MK 0*BA]WS2>8(\["&+'+_,.#G//IUA91:=8PVD)8QQ+@%CDMZD^Y/-6: .3\
M?3?9M,TJX)"QQ:M:O([ %43?R3GH,=^U9NE6ND:G\2_$9FM[:X/DV<T6^,-@
MA22PST(RGOR*[ZB@#R.WO[6XN/#\\#1V2QZVVZP,3,UOO\T,99&R0[$<#('/
M0XS2:K%IRZ-\1':*W$HNMD1*#<&**,+W^\#T[@UZ[10!YMXBNX;61KRVU.UE
MNYM.A2?2KT I?1_,0$/WM_+],YXXK)\:W7VJS\30Q(+&Z6.W,MN(S+-<@*C
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M\+".61]KO(<894(YCR<;L_A3-1T'5=2CT0W%S;M-9ZFM]<-E@H4!@$08YP&
MR<=/>LNY\):U-<-.S:=/<+JJ7Z7,KN)'C1@4B.$.T 9'!/TH T;;Q+>1ZKXF
M.H0PII^D;6+1R%F">5YA(&T9)R.,C'OU+K/QO8SWJVUP8(R]N]R'ANEG5%0
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M)CM_/LM16YF_>G;Y8=F.#CDX;IQ79, RE2 0>"#WH P8O%EE+<Z%"+>Z4:U
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MQKN7@C:'(*9^4CKQR,0:KK>KZ39^)K$7YFN=/L%O;6[DA3?AMV5< !204X(
MX/3CD [JBN.O;W6]+TF"\N=626.]NH%>9;=8ULHG^\5SG/.T9;.,U7@U76CI
M_B*>'6+:6VMI1%97MQ$ IZ%S\@PY4DJ,#!*@4 =S17GR^)-7@L?%\7VF9Y-*
MM(KFUFO($67YXV8AU4!<93C@'GFK^G:MJD/B31K:ZOFN[?5K%YRCQ(GD.BH?
ME*@$@[CG.>V,4 =-I^I0:FD[P+,HAF:!Q+$R'<O7&>H]QQ5RN.L;[4;C1M5N
M=0UYK2.RU*X5[B*WC!6",%0H#*PZ\Y()[54L]1\00^#K_6+S51";ET-A]OB3
M=!"6 !81H-TC Y"X/.T>M '>54N[^&S>U6196^TRB*,QH6 )!.3CH, \FO/=
M2U?5+K0/&=A)?7R?V;;QRPS21QQSLKQEBC[5  X[ -@]:W;^]U'1H?"T$.HR
MS+=WT<$[31Q[G0HS;?E4  8[#/O0!V%%<;#J&LZXFMWECJ/V,Z=>2VMO;>4C
M1RF+&3(2"V&.1\I7 ]34,.N:IKNN:=:VMZ^GP7^B"^&R%':*3>G0N#G@D<C'
M.: .WQ2XQ6!X*U:[UOPI:7U\R-<LTD;NB[0Q21DW8[$[<GMS6\V2I"G!QP?2
M@ =5=&1U#*PP01D$4B1K&BHBJJ* %51@ >@KSRR\0^(8_ __  D5[?PM.ADM
MFM5MUV>9YYC5]V0>/3(! YQR:O7.L>(/#MGJ.HWL<]UI\-H9$-\T"S"8= !"
M-I0\=>1@T =D+:!;EKD0QB=U"-*%&XJ,D GK@9/YU+6!90ZU!,EW+K$=U926
MQ>2.>)$V2=049 ,)U^]N/ Y-8VA:UJ\VM:;%/>O=VU_:2R/(8%2%9$VX\D[5
M<I\QY;.>"#0!W%54OHI-1FL563S8HUD8E#MPQ(&&Z$_*>*X.UU[Q+-X+MO%!
MU"!O*F8368MU5)8Q,8SECDAL#(QCZ&MVXO[^X\0Z[I/VMH8(K"*>"2% )(RQ
M<'DY!^YZ=Z .@L].LM/61;*T@MED8NXAC";F/4G'4^]1ZGJMGI%O'/?2M'$\
MJPJPC9_F8X4':#C)XR>*XW2+FZLO!OAJ.'69]MY$K,WEH]R?W6?+A7800&')
M<' SD]*H7NM7VL?#>WFOSB[35HK:8@ ;MER!R!QV&<<9% 'HHO8CJ)L<2><(
M1-GRVV;<X^]C&<]LYJS7-R:IJ$GCBZT..>.. Z2+F)_*RR2&0IDY/(&,XXJG
MHEWJ=WXGN;6#6+F]TZP'E7<US!$ \^/]7&41<8SEB<]0/>@#L*I:M]B_LJY;
M4;=+BS2,O+&\7F!E S]W!STZ5Q^F>(-7FU[286NVNK?4?M"3-'&HMXF09!@<
MJ&<#&"6W ]CQ570KS5+'X>:]JZZG-/=0RW<L?VA$95,;MZ 'G'K@=@,8H [?
M2M(TO3(2=,T^WM%E +>5$$+=QGC/?OTK0KEAJ5_JVL1:5#?-8;=.BO))H51I
M'9R5  =6 4;23QGD=*H/XDU>(Z9:O)#Y[:R^FW$GE<2*%+*X&>"1MR/7/2@#
MN**YSPSJ5]<ZGKNFWUP+DZ?<I''-Y81F5D#X(''&<=.E7-;OIX;G3;"VE$$E
M_.T1GP"8U6-G)4'C<=N!D$<]#0!KT5Q=_KFK:.NOV#3BXFL=,.H6MW-$N6'S
M95U7"D@KU '7IZ]-IZ7^9);RYBD20(T<:1;?*./F&[/S#.,<"@"]16#?7MU=
M^)!H=M=2602T%W)/$BL[9<J%7>"HZ$G@]NE<OJNK:EJ-K:VKZA-;7-IX@BL)
MI+5543*2&5\,IP<$<=,YR",4 =S%JEG-JT^EI*3>01K+)&4885LX.2,'H>AJ
M[7".MU'X]UPVUV8YXM(@;S7C#%L&3J.!S[46GBK4=;BT>WMX[F*>ZTT7TS67
MDE_O!<+YQVA<YSP3R!QUH [NBN,DUGQ##-X;LKW[-:W=_)/#<[%$FTK&S*PY
MP#P"1776R31VT:7$JS3*H#R*FP,?7&3B@"6J]M>P74MQ'"S%K>3RI,HRX; /
M!(YX(Y&17-0ZM>CQ.UIJ%]/8R27#):VTENAM[F$=T<#/F8YP6X_NU5N_$>L0
MZ)XLN8I+<W&EW1CM\PD@IL1@"-W)^8\Y_"@#MZJZA?V^F6;W=T9!"A )CB:1
MN3@?*H)/)]*P)K[6/^$OCTA;V)(+FQ:Z5C;@M$5D52HYP00W?TJDGB/5I? <
M&KH8#>+>""4^7\K(+CRB0,\''/>@#J7U6R35X]*:;%[)"9TBVGE <$YQCKVS
MFKM<G?1NWQ-TQT (CTJX8Y. /GC'\R*IZ5XAU.3Q-I=G+=BYAU"VFE<B#;"C
MIMQY+;0S)\W5LYX(- '<45R_@S4=6UO2X=3OKN HQFB:".WVY9)64-NW'L!Q
MBH_'3W")H(@O)K<2ZO;Q,(PI#9)(SD9X*CC(SSG- '645S(OM7N?%E]I,-[!
M%%;6]O.CM;[BVXN&#?,.NT<C&/2J,'B'4%U>P\V]AGBNM0DLY$A0&WB 61D"
MR$ M)\H#=1G(X/4 [2BN'NM?UR'0]?U*2>VA;2K^5$C\G<LD*["-W.<E2>0>
M_M4_B#7;S3]69;B]?2].,49M;S[,)(7E.[<LQ.2H^[C&WOSVH [&BN-\3>(=
M1TM-7GMKFVQ:6J7%M"D32[AR6,QQA0<$* 03@GVJ\U]J&LWMU;Z=>BQ:U@AD
M'[M7WO("P#9'W, #C!Z\B@#I,U6M+ZWO7N%@9R;>4PR;HV7##&0,@9'/49%<
MQ)_:#_$#1X[B\EB)TN62:"$ P[PT8.TE<GD]^< =,FD?Q3>6UGJ)D,,DXUI=
M,MF\HJJ[_+P6&<G&YCU&<=LT =C56/3;2'4)K^.!1=S*$DEYRRCH/H*P;C4]
M1T768].N+L7B7EK/-;RR0@-')$%)5M@ *$-QT/&,G-9VD^(]9FLO"]_=7%I)
M'JS>7+"L6PKE&8,IW$D@KSVP?QH [C%5)-3LXDO':;*V2EKC8C-L^7=C@')Q
MS@<\CCD5)?3M:Z?<W" %HHF< ]"0":Y>SN;G2?A;_:<!3[<NG-?N\HWAY2GF
M,3@C.23WXX]* .MBD6:))$)*.H9201P?8T^N7_M'5[G5--M(;JWA2]TM[@.8
M"Y256BR?O#(Q(<#CGUZ56M/$6IW=CHUM(88;Z]N[FUEF"Y5?(,@)"YZMY8[X
M&30!TNIZG9Z/8O>W\WDVZ%59RI."2 .@/<BKE<'XW75$^'>L+JDEM(RW$0@D
M@!!:+SH]I<'HW7..*U9-;OO^$FUS35>,0VNGQW,+;/F5SNSGU'RB@#IZS%U_
M37T^YO4G9X+65H9BD+L5<$ C:!D\D=!6!H_B6^URVT.T2:*"^O-/-_<R"/(5
M 57"@G&2S?@%/J*R['4K_0?!?BO48)(9KRUU6Z?=+&=KD,N<J",9^M 'HBL&
M4,.A&1Q3JYC^U-5NO$\NCQ7%M!$VG1WD<H@+.K%RI4Y;!''H.OXU7L?%-Q>Z
M)X9NI&CM_P"U&\N>;;PC!&.%SD#<RX&<_G0!U]%8'A34]0U6SO9[XPM''>2P
M6TD4942Q(VT29R0<D'I@<5)KVHW%E<V$,<\<,=PSJ2J^9,[!?E6-,<]R3V ]
M\@ VZ*Q?"FK3:WX;M;^X4"9C)')A=N61V0G&3C.W/6L_Q/KEWI-\JM<&PL7@
MREZUMYL(FW$;92/N#[N#QG)YH ZJBN%AO+R'Q_K-Q-J#26EKID4XB5 5VG>2
M%_+.>IJ8Z_K%EH>D:[=36T\-[+ LUM%%@1I*0 4;.21E<YZ\]* .TJG9ZI9W
MUU>6UM-OFLY!'.NTC8Q&0.1SP>U8=GJ&LZRDM]IUQ;1Q17[6_P!FFBX:-)-C
MDL#G<0"P[=!SUK&&JM8>-M:TRT_<7.HWL"I<O&3%&1 K-GL6(! '<_2@#T&B
MF1AEC56<NP&"Q !/OQ7)ZGK][:^)#827::>'FB6S-S;DPW2';O D!X?)8 <?
MP^M '7U2BU6RFU:?2TFS>P1K+)%L885NASC!_ URNL>)=3TR[N)FGA\FWOX8
M#!';M(HA=D7=)(#\C_.2![#@YS3M3O\ ^R?&VMZCY?F?9/#JS[,XW;9)6QG\
M* .RED6*)I&SM49.U23^0Y-,M;F"\MH[BVE66&095U.017.:3?\ B2:_L6N;
M426%Q$6GE98T$3;<KY861F*GD8(ST.>M+HDWV3QGK^DH/W!$5\B@8"-("KC\
M2F[ZD^M &_?7UOI\ GN698RZH"L;.<L<#A03U/6K-<_XPU:\T71XKNR,0<W<
M,3^8A;*NX4XY&#SUYJC?:EK\FL:]965U9Q1V-I#<0EK<LQ+"3Y3\V.2G7MZ=
MZ .NHKC5\2:B8_"NK.T(TO4TCBNT$1S'-(F4(.>A?"_EZU,_B"^6TAF5XL:E
MJGV2R9H^(XOF^8C/S9V.1R.H^E '3W-Q%:V\EQ,VV*-2SM@G '7@4VSNX-0L
M;>\M7\RWN(UEB?!&Y6&0<'D<'O7.G4=2AUN_T2]:*XA.G-=P7*IL;@[61AG!
MY(((QP:S-/U2_P!'\.^"+A&4Z7/;V]M>*4&4+Q 1MN[#=@'\* .PU+4[32+)
MKR]D,<"LJE@C.<L0HX4$]2*MUR&HZUJL/AF_U6WF@VB]"6WF0[OW/F+'G@CG
M.2">V.*?>:IK$GBO5=)M;JW@BM]/2ZA8P;B&)8$-EN>5]N./>@#K:*XZU\47
M>I:9X8G,D5C_ &LI,LI7< P7(1<\ L<XSGICFM'PAJ6HZMI4MU?S6LH%Q+##
M);Q%!(B.4W_>;.[&>,?C0!O+&B9V*J[CDX&,GUJK9:G9:A-=0VLXDDM)/*G4
M @H_H<US7B=-0?QGX62VOI8H7EG+QJBE05B;YCW/7'/%8L]WJFDOXWU?39H$
M^R7JRO'+'N$H6%"5SGY>#UQ0!Z717)ZAK6L7&L:C8Z1;NS6"(#M2)@\C+O&[
M?(I"X(' ]>>U=+92SS6,$MU (+AXU,D08-L;'(R.#S0!/1110 4444 %%%%
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M>G65_M^V6=O<;.5\Z)7Q],BI'MX9;<P211O"5VF-E!4CTQTQ0!YWK=G:P?\
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M[>2>/[DKQ*67Z$C(H \_AL(]5\;:3;Z];137$OAW=>1.<@N)$^\/J/T]JUO
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M54Q'"$PHR>2.68D]3Z# '.0"IXUB>;P3K2Q'#BSD92#@@JN?Z5B07*3>,_#
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M"XUBW6WM[1F3<-D94,3G:,ECWZ ?2NKT:.2'1+&*:)HI8[=$=&QE2% (XXH
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MLK.$S7,]NT<<8(&XGW) JM;6%Y'XLTZY:U?[/#I#V[R[EP)"\9VXSGHA[8H
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MUU:U-S:,[1ARA\R)HR".HPP!KBY]%U.6VO[^WM)@=0UFUN_LQ*JZP1,F2P)
M!.PMC.>F><BO0* ,6UU";4O$5Y!!(%LM.(BDQUEF90Q!] JD=.I;VYQO&'BB
MVM]* M+V\BE6^@A\ZWA;8Q\U0Z;RNW[N[OU&/:KF@1&U\0>)K.1BDLUTMW&1
MCF-XE4$?1D8?A7/V]CJT/A&S\.RZ%<S7MA=02>>OEB%U6</O5BW)*YR,9R3Q
M0!U5Q?RZ1XBM89Y7DLM4=HXRY_U$X7(4'^ZP5N.<,/0\;M<OXI@-]KGAFSBR
M9([_ .V/A20L<<; D^G+J/J:UM'U?^UA=@V5U:/;3F%DN4"EL $,,$Y!!!H
MH:IJ\LOB.V\-V<K07$UNUU-<* 6CB#;<*#QN)XR0< &IK;2]0TZ\M?(U6ZNK
M0LXN([LJ[8*D@JV ?O8&/0^U4-9TJ\MO%UEXGL;<W7EVS6=U;HP#F,MN#)G
M)!ZC(R*UK74I=2?RXM/NX8"AWS7*>40>P"GDGGKP/<]* (QXGTLW:0&60+)+
MY*3F%A"\F2-@DQM)R".O7CK4-YXRT.QN+R":[?S;+'VE$@D<Q C.3M4\8[]*
MY^TL=0/@^/PE-IUP+N!DA^T%!Y#1K(")0_3.T9Q][/;O3[S3;_[9X_E%E.RW
MUE$EKM7/G$0.A"X]S0!N7/BFVA\1Z=I*0SR_;86F69(F9-O&,$#GKR>@[FIK
M3Q5HU].(;:\\QCYF2(G"J4^\"Q& 1Z$YKG;33]0L]8\'73:?</%!I9M9RBC,
M+E8_O D8'RG\J;I>BWE_X!U_2Q:RV-Q=W%YY2S KD.Q*GGG!! S]: .FLO$N
ME7]S!;PSN)+A"\ EA>,3*.24+ !N.>.W-4/!U[=WC>($N[F2?[-K$T$1?&5C
M"H0O'89-5F^U^(IM"5]/N[&;3[I;FZ:9-H7:C*41AP^XL.AQM!SV!F\&6US;
M3>(_M-M-!YVL331>8A7>A5 &'J#M- &]?:G:Z>8EG=O,E)$<<<;2.^!DX502
M<#K6%XC\66]CX*U#6=/=Y6C1HT*QG,<O0;P1\N#USBI-7AN[/Q5I^M1V\ES9
MI:RVLZ0KODCW,K*P7J1E<''/X9QSOB'2;^Y\'^*Y8;&Z,VK7*/;VJIE]H6-=
MQ4?=)V$G/MGF@#K=%L7@>2Z34M2GMYE 6"^!RC#@L-P##/H>/2LJ[\5"\7Q-
M86L=U;7&F6[%9S$1\_EEL\C [8SU[5UB-OC5MI7(SAA@CZUPTMG?0:MXWC.G
MW3IJ-LLEM+&FY'Q!LVY_O;NU &KX:\3VM[I^C65U=.VJ7-A%,V^)E$K&-6;:
MV I/.2 >*T8_$6F27B6JSON>4PHYB<1O(,Y4/C:3P> >QKF[#3KD'X?[[&X6
M2QMF6X8QD"'_ $;80WH2V *BT*SNK6WL]"OO#+3SV,Z[+Z3:;<HK?+*#G._'
M8#.?3F@#LM5U&+2-)O-1G!,5K"TK =2%&<#W-8]A9:MJFFPZC<ZO=6=W<1B5
M8(!&8H<C(7!4EL=SGGGI6GKFEIK6A7^F.VT74#Q;O[I(X/X'!K(TC5[^PTRW
MT_4M'OFO[>-8B;:+?%,0,!E?A0#C/S8Q0!HQZHVFV%A#J\ADU&6/#+;PLYD9
M1\S!5!('Z#-,E\6:'!86U]+?HEM<R^1&[*W^LY!4C&5(P>N*I7?VZP\2VVL3
M6DT]O+9?99H[53*T#AMX. ,E3R"0.H'%<]-I5]"EO<?8+O\ TWQ(FH^2L>XP
MQ# )<#A2<9(]_K0!TR^.?#[&)5O)&DEA,\<:VTI=D#;3A=N2<@\8SQGI5V/Q
M)I4^FV^H077G6]PVR$QHS-(W.0% W9X/&.U<YJU\NG_%2PE:WN9PVD2J1;Q&
M0K^]4Y('..,?B*K6VD:CIEQIVM?8)O*74+NXFLHCNDB2<84[1P2,9(&?O'&>
M: .HD\5:/#I\U]+=F.""7R9MT3AHG]&7&5_$8Z4U?%FC/D1W+R/YYMU1()&9
MW"[CM4+EAMYR.,<YKEM;T^\N].\5:E%IEU)'J<=K!%:^61-((R0[%?X1AO;[
MN>]:_B22\^TZ.+>PO#9.LGG36D(:Y@^4;5!/*!N02.>!R.M %B]\::?!:Z7<
MVJ3W46H7(MT>.!R%/.X$8SN&UAMQG(Z<&K-O>6LOBR:-=5N#.MDK-ISH51%W
M9\SD=>0.O_UN'L=/U.RT.T+:/J1%AXC>[:(KOE:$^8 5^8[L;QDYYY.36_?:
M?>ZAXXNY([:>*&X\/M;+/(A"+*TA.TD=P#0!N6WBG2+NY@@ANF)N&9()&B=8
MYF7J$<C:QX/0\XXJ*X\9Z#;-.);QP+><V\S""0K$X )W$+@#D<GCWKG!%?:M
MX<T;P^VDW=K?V<MJ9Y#&8XH!$06=''RMD+@!<_>[8JO?Z=J$VB^/HX]/NV>\
MG_T9?*.9AL5<KZC(/X4 >D@@C(.16!:ZMI\-SK=V=6GGC@F2.:%T)6V< #8@
M"Y)8D'C.21BM>P!&G6P965O*3*L,$<#@BN+>V9I/%YO-(U&>TNKV#8L*,KNH
M1$+Q]"=I4MQZ4 =A8ZE;ZB)?(\T-"VR1)8FC920".& /0BFW^KVFG2P0W#2F
M6<,8XXH7D8A<;CA0< 9'/N*S/#"ZDCW\=W-<SV22*+.:[BV3LNWY@W ) /0D
M9/-5/%D*SWMFP&KVUS;QN]M?:?$T@1B5RCH =P;"\$8XZB@#8@\0Z9<WEI:Q
M7.Z6[@^T6X\M@)$[D$C''<=1D5S^N>)[=XM"U'3]2>.R?51:W.5* @(Y96##
M<""HXJLXU>/5?">KZAIUS+)#8S1W8MHMQ21E3&5'3.#[#VJA9:5JL6CV=Q-I
M=RC6_B26^DAP&D$)\P;@ ?FY8=.O;- '9VGBK1[VTN[F&[.VT($Z/$Z21D]
M4(#<]N.>U4]6\9V.GZ5<W<,=S+)!+'"\1MI%9&<@+N! ('(^O:LF[TT7]WKN
MLW6E7LEE=V]O:K:JA2>3:^3(%Z@KD$9P?E],51O+37KCPEK-JR7M];QW-JUB
MUQ#MNI$61&<,."V ."0"<'VH ZZ]\6:1IR,UU+/'LB$T@^RRDQ(25#. OR@D
M'KCI3[[Q3I&G7OV.XN6^T^5YRQ1PO(SID#*A0=W7H,G&3T!KD_%"7^K1ZM&N
ME:HJ76F?Z,EO$$,LFU^)F!S\O&$)P<G@DXJ_I8NU\4Z7-+87OE0Z%Y<D\D)&
M)"R':?\ :PIX&>M %^]\:V,4.CSV<<]Y;ZE/Y:310.R@?-GH,[OE(V]>M68-
M0LEU[59#J\Y^S6\;W%K*-L5NN"=_([@'//:N+TNPU.T\'^$VDTR_#Z;J3O<V
MXA/F;3YF&"]Q\P_.M6XAU-/$'B^ZM-+DF:?3H5MA/%^[F=5;*\\-]X<=#S0!
MT^GZ]IVL2/;V=Q()3"LRAX6C)C;(#KO R..HR*XT:UJC?#K0;_[?-]JFU"&.
M:7(S(K3E2#QTQZ8J70!>1^+X-1FTS6%AETKR))+F+A)%;<0$4X1<#   R>@.
M<U2^PZ@GPRT.U.F7INK?4(I)(! 2X59BY./3% '=V?B#3K_4;ZP@E?[588^T
M1O"Z% <X/(&0<=LU;T^_M]4L(+ZT9GMYU#QLR%21ZX(!%<IXGTFZ_P"$DL;S
M36"2:I&VF7G)!$6TOYHQ_$H5@#_M 5V4<:0Q)'&H5$4*JCH .@H =1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%(>AQUH 6BN/7Q==GP];ZDUM#O;5/L,B G!'GF+</0]\<TM[XFU
MB.]\00VMC9%-'B28O+,W[Q2A?& O!P/H/?/ !U]1SW$-K \UQ*D42#+.[  ?
M4FN;U#Q-<Q16L]O%;PVEQ9?:4N;I_E:0C*Q!1\Q.,DG!P!TK-UG4+O6M*\(:
MA D$2W=[;S>5*"VUS&[#D8R!_,"@#9T^7P[HL%WJ$&IVZP7]P\\DTET"C2=&
MP2<#&,$#TK?1UD171@RL,A@<@CUKBTMKH?$>:#R-.$;Z;YDN("/,#RX?//+'
M8.3[9J;2O$=S,FEM9:5_Q++E@D<<-K*OD0G(1]VW9C !(XP#QG'(!V%%<S8:
M]JNJQP:AIUC!/ILMXT'^MVR+$KLAFR>",J3M'.*R].\1ZG96GB.^U.2&Y2UU
M%K:&*)&!+XB5%7D\$MTP3DD\]* .ZJ&2\MH;F&VDN(DGFSY43. SX&3M'4X'
M-<XGBFXM([^;4K.46MK:&Y^TK;2PJ2O6/$@!+=",=>>F*R;V?4KGQIX*N+^*
MUB65KEUCB9BT9,!.TD\-]1CZ4 =_16?KFKP:%HMWJER"8K:,N0.K'H!^)(%4
M!JVIV>HV%KJ5K;8O]R1/ [$1RA"^QLCD$*WS#TZ4 ;]%<UX6U[5/$$/VN:QM
M+>T5YH6VSL[[T<J,#:!MP#U(/M4WB#7;O2=0TFSM;**X;49F@5GF*>6P4L"1
MM.1P<\YH WZ*XR?Q;J*3WEC':P/J&GQ(;F..*>5'E9=P1&5.!C')'4].*N/X
MCU"76;32[?38XIKO3OMJ&ZE*F-@R@HZA3TW=CU&..M '3T5PUKXVU&72],U.
M73;9+6YOEL)56=B^\N8]R_+C;D'KS5OQ+XMN= >\D:WMUAM421%FD_>78ZOY
M8'0*.,D=?0<T =.]Y;1W<=H]Q$MS*I:.$N [ =2!U(%3US5YJB+XPT.V&G6S
MF]MIWCNG_P!;&%"DJ.. <CO6=%XRU Z9!JDUA:K8_P!H-93,DY)'[WRPZD@#
M;G&<X/L* .VHKEY/$=W)XBFTNV2S$T%Q&C6TTA2:6%MI:5,\$ %N.?N'OQ74
M4 %5!JFGM;S7 OK8P0/Y<LGFKM1N.&.< \CCWJGJ.JS1:M::38I&]Y<1O,S2
MD[8HT(!8@<G)8 #Z^G/$Z7>MI7@OQE>7=A:7C0ZO<M+;-_JG^YD<@\?44 >E
MHZR(KHP96&0P.01ZTZN5N/$.J'Q&-$TZPM&E;35O4DFF94Y<+M.%)'?IGMTJ
MM/XQOFGO#8:>MU':7'D-%&DKO,1C?M94VC!) !ZXYQ0!V=%<[/K>IS'49-*T
M^.XCL'$9C=RKW#[0S*G]W 8#)ZG/3J6PW>KR^.)+9I8%L4L8YO)*MN!9V'7.
M,_+_ )YH W[>ZM[N,R6T\4R E2T;AAD=1D5+7FNBZQ<>'?#VIW\5K'-91:[<
MK=#)5HHS*!O7 .0N<D>G>NWAU">XU^:TBCB:RAMT=YLG=YC$X4=B-H!/^\*
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M5+9/5N2>_:N@^UR?VI]C^QS^7Y/F_:OE\O.<;.N=W?IC'>K5 #8PRQJ'8,X
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M]JMA-)=FX\W#;0#/YV,=<YX_6NTHH XO6_!NH:K+K86_M/+U*$1I)/;EI8
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M73ZMIL.L:1=Z=<9$5S$T;%>HR.H]QUJY10!R]GX?UF>S-AKNKPW=D+=[?9!
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MBBB@ HHHH *;(@DC:-L[6!!P2#@^XY%.HH \AGL(+;X1ZU)$9@S:@T?S3.X
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M*DJ(@1@X ..G'TH X7Q-<WEG;:TVGZC>W$FDVL?ER^>46V8#)WX_USMP2"N
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&GPPZE+)I6H^7IMR+:[<"/$9+;0?O9(R.PK>O/$=D-:@T*.*6ZNKFW-PRQ$
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MGG(&!='#$YRH(SU!_&FWGBJWM/MD@LKR>TL9/+NKF)5*1G&6P,[F"Y^; X_
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MZC<Z>DES)=VI FBBLYG*9Z9VH>#V/>K,6MZ=+I<VI+<8M82XD=T9"A4X8%2
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MZLP*L!M 7:!]U>.!ZFO4J#0!PNJZ+8Z]XVTK4]/O8F'ES07ZQ$,LT2$?(W_
MB ?_ *U7-9\/ZEJ7C[0]8@6W6STQ)-YDE(:0N",* #TXZXZUIV*Z!I^OW&G6
M-O;V^IRQ?:I5C@*%TW8W%L8/S'UK:H \IN/A]X@E\*:QH@%CYNHZH;U9A.WE
MQH><'Y<DY4#@=ZV]:\%W5QXU@UZ.RTW4[=[46L]I?<!<'AU)5A^F?SX[)-0M
M9-1FT])0;J&-97CP>%8D YZ<[3^56J .+U;PKJ6H:OX6NHAIT,.DRM+,D99
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M4;KPQ;W%Y?7,5[>VGVZ/9=1P.H27Y=N[#*<-CC(Q[T 8D&I7EKX=T6"WNXX
M=(26-(T\V:6147 V$8$8'5LCD@9%3CQ%J8M_"NJR_9TTS48HQ??+S'))&#&5
M.> 7(!Z]JNKX-LX6B-K?W]N4LEL6\N1#YD2],[E.#SU&*IZG80Q:!%X+AM;Z
M[26T$$=S)%F.- =H+N  &4#(&,G ]: -W2;NXOFOIY.+;[2T=L,#)10%+<>K
MA\>V*HW.H7E[XHET:TN5M$M[1;B60(K.Q=B% !XP-ISQW'2MNUMHK.TAMH%V
MQ0H$1?0 8%9U]H27.J1ZI;W<]G?+%Y)DBVD21YSM96!!P<X/!&: .4UJZOM=
M\(W,%U<>1/9ZK%97/DQ@)/\ OX@&&<D<,IP#UR*[Z-65 &<NPZL1C/Y5C77A
M>VNM)&G&\O(XS<"YE>-UWRN'#Y8E3CY@#\N.@'2MR@#A[#7?$FJQQZC863S6
MSWC1K'^Z6$P+(4+%B_F;^"?NX[8[U-?>(=1L]8C1IHW#:G':-;Q1%HTB<@!F
MDP,2\YVY/&..]:-OX.L;2^GGM[R_BMIY_M$MDLP\EI,YSC&X<\D!@#CD8XJ*
M3P5:R))&-4U*.)KXZ@B(\>(YB^_*_)G&>Q)H <E[K.IR7D^G3V\8M;TVPMY4
MRKJI&\LW4,03C' XSFL>\N-3LM:\97NG2P*]K;P3!)(B_F%86.WJ,#CK6U-X
M.LY=2O+N._U&WCOB&NK6"8+%,<8)(VY!(X)4C-66\.0-)K,C7=T6U9!'-RG[
MM0I4;/EXX/?- &AIUT;W3+2[90IGA20J#TW ''ZUSNF:Y=7'B%["[O!;7*SR
M@V-Q;[/,A&[8\+_Q_P )/)[\#OT=C:)86%M9QN[I!$L2LY&Y@H R< #/'I6;
M#X>"75K)<:A=7<=I,TUND^TE&*LO+  D ,< ^V<XH YP^+M5_P"$334LV_VA
M=7^Q-^[.UH_.\OIG@XJV(M3D\;^(AIEQ;0/]CM#NFB+Y;$NT<$8'7)YJXW@B
MP:WDM?ME\+1[S[:( R;4DWA^#LW8R.A)ZU;G\.AM8NM3M=1N[66\C6*X5-K*
MP7A2NX':1D\CUZ4 8C>*;QM(TJ\O)#I\,\4@N+J*#SHHYE;:-Y_A0D-S^HZU
M:NM8U:XOO[.L TKPV4-Q)<VJ1,'>3<!@22*-GR$\9)SU'?2_X1X6]O#;:=?W
M-G;10B#R0$D0KSS\X)W<]<\]P:JOX+L5FL)[&]O]/GLK46B2VTBY>(=%<,K!
ML=>G>@".#5M8O;S3M*N(DTV^DM&NKS:5D*88( G5>2<\YP..O-4QK^LQ:0LT
MTEL;B/6UL)2L9VO$9@F0,\-A@:UIO"EF]S975O=7EI=VD;Q)<0NI9U8Y8/O5
M@V3\W(Z\UF:+HT6IZ+J5G<B]@4:O+/'(X*R!ED#JXW#D9 (X(H EU/Q/=:9?
M^(8RL,JV%G!<6\7W6+.74Y.>1E5].M2V^H>)$FF%Q8%;86C.MQ*L0V3 =-J2
ML2I_ CUJ:3P=I]S/J,UY/=73ZA:K:W!E91E!G! 51@\]N..E2:?X8CL+4VYU
M74[E1 T$1N)58Q*1CC"@$\#EMW3ZT 9.F^)-6G7PQ=7+6IAUH8>&.(KY1\HN
M"&+'/*GC'?VYD\"RW\YUY[V]-SLU:>$%HP#\FU0>.V !C%:L'ABQM[?1(4DN
M"NC_ /'N2PRWR%/FXYX)Z8YI^D:#'HUWJ$L%W.\-[<O<M X7:DCD%B"!NZCN
M: ,+QK'=MK_A80W2Q(VH853'NPWEO\W7GCC%:4NIZM#JVM6<4<%R]MIL5S9Q
MJI4O(WFC:QSCEHQZ8!_&KVJ:'#JU_IMU+<3QG3YC/&L>W#-C'S9!XP2.,=:)
MM$CEO[^\%Y=1RWEJMJ3&RCRE7<0R';D,"['))Z^U '.VWC"5="OM2:[M[F2W
M6*-K62%K>6"=WVXD4DD+EEY]C6WNU^S%XTDEC=QK:EX7(,)$PS\K#)&SH<YR
M.?K33X7MKG[8=3FDOFN[=;:0NH3]VI)'W0.<L3GZ=*8/"4#Z?<V=WJ>I7J3V
MS6NZXE7='&PP=NU0">!R03Q0!4T'Q!=WGB-]-FF2YA-BMTL\=LT2[M^TA23\
MR],'O@\FG_#H*/ >F! H&)#\K;AGS&S^.>W;I5FS\,?9M=BUB35;RXNTM#:'
M>L85D+!APJC&".U7= T6#P]HEOI=M)++%!NP\N-Q+,6.< #J30!F2:Q>W^I:
MW;V$\4$>EHJ%GB+EY2F_U'R@$#U)SS531_$>IW]WX9\X0"#5-->XF"H01(H0
M\<\#YZNZEX=BCN=2U2UN[NV>Z@/VJ&#!$Y52%.,%@V./EP35'0?#TMSX9\+W
M#7-WI]]860C^5%R ZJ'5E=3S\H[<4 16/B75;KPXE[)+9Q,NI26T\S(>(D=A
M\B#)9S@  =ST-2-XCU;_ (1Z:\B^SO/!JJ69\Z%H_,C:54'RYRK?..N>G2KZ
M^#[:WLK>"SO[NWEM[R2]BG&QF#ON# @K@C#L.GI3O^$3B:UN[:34[YHKF]6]
M/^K!5U8/@'9T+*#^  QSD R[@ZS#XYT.TN-96020W$C1Q6OEH0NSMN.3R1DG
MCTJ>#6_$%Z4N['3C-;->/%LQ&JB%9#&Q+&0-N^4M]W';WK:U#1$OM8T[4UN9
M;>>R#J/+53YBOC*G<#Q\HZ>]9T/@RUM[ZYDAU"^2RNIFN)]/WJ87<G)ZKN /
M=0<'Z<4 1:3J'B+4]9U)'DL(+.PU$VY7R69Y8MBL.=^ V&7MW/ QBM'Q1J-]
MI6@RWNGK \\;Q@).I*L&<+C@C!YZT_1M"CT:;4Y([B27[?=M=LK@ (S  @8[
M8 _*IM;T>'7M)ETZXEFBAE*[S"5#$ @XR0>X% &+=ZSJK^)-7TNVFM88[2RC
MNHW: NQ)W9!^8#JHY]/SK6\-ZI)K7AK3=3E14EN;=)'5>@8CG'MFH9/#J-K6
MHZHMU(LM[:+:E-H*H!G!'OR:M:)I4>AZ)::7%*\L=K&(U=P,D#IG% '-7?B+
M5;.3Q!ITL\(U&V5)].Q;DB>-_E12,\G?\A(QC(-6;#Q"^O6%M);2(8FTQI[L
M>601(WRJHYXPRRYZ]!6Q=Z!8WFOV.LRJWVJSC>./!X(;'7UQ@X^IJ.R\-V6E
MV.HVVG;K<W\LDTC_ 'BKOU(SV'84 <KX=U/5=)TOP9#/<6\]CJ-O' (EA*R1
M?N=RG=NP>@!X'XUIW/B:[L/^$B\Q+=GL[R"VML(0"95CVE^3G!<9Z9QVJU#X
M/BAM?#]O]ON&317W1%@I,G!4!OHI(XJ9O"MK/_;:WD\MQ%JSH\B<+Y950J[2
M.<@*O/J* ,SQ4NL1>%/$4=[+:W%F=-D,<J(8Y ^#E2N2,8P0<^M2:9J.I6FL
M:'I[F.73[W3RZXB*M$R(G&[)#9R>PJ=O!OGZ3=65YK6H7<D]NUJ)YRA:.-B-
MP "@$G:,DY/%7DT#9?:1<&^E*Z; 85CV+B7*A2S''L#@8Z4 6=;NKJRTF:>S
M^SB52OSW#;8XU)&YCR,X&3CO7+1^+M1&E^*95:&672(UF@>6UDB\Q2F_YD8@
M]B 1@'KS73ZYHT>N6"6SSRV[QS1SQ2Q8W(Z-N4X((/(Z&LAO!:2-K;3:K=RO
MK%LEO<,ZQ\;5*AAA1@X)XZ<T 16VN:JVN:=9SSVIBU:P>X@\NW(,$BA#@Y<[
MA\Q].E0:;XDUBZT:2SN!;Q^(8M1^PNOEGR_O;MX7.<>4&8<\XK4N-"@L[O3M
M7,UPXT>SDB2&.,,95*C/'4M\HP!W^M0:';VVK>(;GQ*-.NK1FMTM8_M41C=\
M$EG*GZJH)YX/:@#=U2:ZM])O)K&$37<<+M#$?XW )4=NIQ7$ZGK)UCP)XF?^
MT8;E8[%E,)@,,]N^UMRR(2<=L?0UW=W;FZLYK<320&5"@EB.'3(QD$]Q6#=^
M$EO[34H[K49GN-0MEM9+@1HI$:DG  &,G<W)]>,8H 99ZGJ\/B=-,NS:SP7&
MGM=PF-"AC9652A.X[A\X^; ^E9^D>*K^XU_2]/N)K>=;VVF,C0P,$BGCVDA'
MSB10&QD9Y'7L-MO#43:E;W;7<VR'3VL!$ N"C8RV<9S\J_E5.Q\&+9WFDW3:
MO?3R:7$\%NKK&%\ME"X("CL!SUH Q;#Q;XA?P=%XCG6QE6=?)BMHXF4^<T_E
MHQ);&WU''UK5.J>*;:+4WFTN22**U\VVD*1^89 >4\M)&W<<CD="/2K5KX-T
M^'P</#-S)+<V8#?.Q"N"7+@@CN"<CZ4MKX5>"%O.UW5+BY$8CBN)'3=$H<-P
M N#DJN=V<@4 2>&-8_MF*XF34H+R)2H"+"8I86YW+(A)(/I^/UI;W5;F7Q/'
MH-E(D$@LS>2S/'O^7?L50,CONS]!ZU9TS1DT^_O;]YS/=W@C660HJ A,[> .
MOS'D\]/04S4= BO=6M=6AN);6_MT:)98P"'C;JK C!&>1Z&@#D_$6H:EJ/@7
M4TNS#%=V.H1VUPL2928"6,J5RW *NIP3ZBN]MHY8X0)Y%EF_BD5-F[GCCFL#
M4O!T.H^'Y](-_<1K<S^?=3@*7F?(/.1@#(7@#@*!TKI%!"@,<G')QC- "T44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1T&312,JNA5@&4C!!&010!SVM^++?3O#EUJ]@(KY+:=89$$F
MWGS1&><'H3^E=%7D=Q!:0_"/6O)BACD;4F5_+4*2!>X4''H.E;FL%M(U/Q+:
MZ(&ANVT2*YBCB!)+AYE9_P#>QMYZF@#OPZL2%8$J<'!Z5DZCK;6NL6FDVL,4
MU[<Q/,HFF,2!$P#R%8DY88&.Q_'FO#(TB?5K"]TO6;61I(&#VME"%WKC.9AN
M."I[G!R<9YK9\1:9I6O7EOIMS-);:E&AN;2Y@<)+%@@$H?Q&1TH TM*O[J^%
MTMY8-9RV\YBQOWK(-JMO1L#*G=CIV-:%>8ZCK6MQ:#<V>H74=Q#I^K16M[J4
M<7RO;E=S%T4]B55@#W(]:76(+/\ X1'Q.VGZZMRC1PS$61V10MD_=PQ + #(
M^G'- 'HMV]X@@^R0Q2YF42^9(5VQ_P 3#@Y([#CZU9KA?%6FVNE1Z!]C#QF7
M7[9G/FL2Y8X8G)[X&?\ Z]9EW)8W^J:[#J>LP6%];W?[KS(L7"Q@*8S"Q8$@
MXX"CDYX.>0#TVBO/]=!L=9U#4Y+>WU6P>>W%Q$'V7-BP5 NW)Y!R&VC!RQZU
MU^M:@VF:5+<1()+@XCMXB<>9*Q"HOYD?AF@"O9^)+.^\2W^B1_Z^TB23=GA\
MDA@/]T@ ^YQVK3NY98;.66&-)940LJ.^P,1VS@X_*O/-8MKWPK_8OB"ZM[14
MTZ3R;R:.X9FF28X=F!0<[SOZGG->A7#JUA*ZL"AB)# \$8ZT <O8>-99M)TK
M5;W3%M[#4I%BC>*X,K1LQ(7>NQ< D8R">M=?7G?@GPXFJ^#/#L]]J%U/;6X6
MXBL\(L8=2=I)"AC@\X)ZTMO9M+=^,KR!I9[ZQNGEL8_-=O+E^SJ1A<X.2<8Z
M<8Q0!Z'7.1^(+Z_OKU-*L(;F"QO!:3[YS&Y;"EV7(QA=PX)YP?;//>&SH]]=
MZ1>VNN6\D\L;)-:0Q_O)RT9+B;+$G!!.6'7C/-58X[;3?"WC.^TB"&*[M[^X
MC\VVC&^-!LW 8Y&!D^U 'IU%>=VBZ.PN+C3-<M)3+ILVZVL(_+#* "'<!CM9
M2< G!^8BJ$UG%%\(8]7$UQ_:%S:6OFW)N'W-^\3W[9(^E 'J=)7 :Y%IFB>)
M-*M;B2.VTN]$\KFZ+2PRW/R8+[FP/ER1GC)/?FJ[26T#Z)ISZHU]H,^I3*\[
M'$0Q'F* -D[DW$XR3RN.U '8Z9K$E_K6L:>\"Q_V?)&@=7W>8'0/GH,=>G-:
M]<;X1@L[;Q5XLAL%B6 7%N56(Y4$P@G'XYK!\7W<#?\ "2WD$JQ361@07-R^
M6AE 4A8$X(R#DMGD] <&@#U"BN,&G6NI_$/4DN=[Q165K*B+<L5+[WP^ ?E(
MV@8].>]<Q8R)J3W4M]XCMK'58-0D$D26I-XK"0[$1B^74KM&%7&./4T >M45
MS/C*\%K%I*SOY>GS:A'%=ON( 0AL!B/X2X4'MV/!K#UJU-EJGB"PTZ/98/X?
MDGDMX_NI/E@C*O\ "2 W3KM'I0!Z%5>SO[74(Y)+682I'(T3,H.-RG! /?!X
MX[@UPEO-%<ZI\/P["5YK"99B7SO'V=,AAWY/?W]:-+TRQ'A34[&RFL+.[?5)
MH QC&UBMRQ2-U!SM8#;CT:@#N[R^MM/@$UU*(XVD2,$]V9@JC\215BO*=8CM
M+C1X[>;1(K"YMM?M4N(@PDCRVS)0]E90O&![BK_BT6HEU](-BR6.E!D>:4!;
M9@K%! @P0QX^;/8#GI0!Z-2UQ,4']J^)M,%U(\UO<Z$6N(S*P61M\9!V@XSR
M>?>LC3=3=M)\+65[)G3+G4+JVF>1R0^QI!#&23R"0.#UV@=.* .OM=?N;V]U
M^Q@L%-SI;*D:F?B<LF]><?+V'>MN%I&A1I4"2%064'(4]QGO7F'DV]C;?$M-
M/(A2%%>/R7V[&$&[@CIAL\?A6P(OM^O>%[>X>:2&?1Y6GC\Y@'P(L%AGG[Q_
M.@#NJ*\TM[BXD\&&+SLQ6VNO;^5)<;#/")S^ZW,>>#@ G! Q71^&=--MK&M7
MJHT-M<2H+>W,X<( OS$*I*J&;)Q_+.* -B?4]FKP:;!"9IF3S9CNPL,?0,?<
MD$ =\'IBM"N6\/&0^,O%AF/SB6V"9/(C\K*_ADM^M<W=3M;^#-=2/4)(WM]<
M*H?-^95\]/D'/ PV,>AH ]-K,U#5FL-6TFR^SB1-0E>(R;\&,K&SCC'.=I'4
M8KGKNRBU#Q9XAMKJ25[4:=;R>3YK!0^9?F SP?E'3Z]:KV=S+=6GP[N+F5I)
MI?G=W.2S&TDR3[Y- '>45YKIKIJ4MQ<WNLVMGJ-MJCB1?*8W4>)CY<0;?AE9
M<  )@@GODUJ.&T_Q$MY<V\%]9W>H".*^AE(FMG)VB)QW3<".#QW% '8F,-)&
MQ+Y0DC#$#D8Y'>I*XK2P^DZ_;QW=O'>+?W$OV;5;>3+/D,VR5>^T @') P.!
M5_Q39SW%Q:S006VH&"*4OIMQ)L$JDK^\4] R] 2/XSTSF@#IZ*X;2;Z&]\1^
M'+BR%Q'8W6C3%$G8DMM:/&XDG<0">>>N>]9>F:@J:;HD&I3D:5)J5[#.96_=
MY5W\J-R>B^@/' % '<ZYJ[:-:6]P+8SB6ZAMV ?;L$CA-W0YP2.*U*X+5DTV
MUT%[;3[YKB,:[:C8S[EA<S1L8D.,8 YP,XR:U-$A2P\:ZW8P22"V^S6UP(6<
ML%=C(&(SZ[030!U#' )K+\-:T/$7AVSU80& 7*%O*+[MO)'7 ST]*PIC;:MX
MWU?2M8VM!!90R6<$C85E;<)) /4':N>HQQC-<WX=EMY?"/@ZQ8^;/)%.ZVTL
MFRW< D%I>#NVY&%'4G\: /5J*\[@MKZ]^'EGJ%C<--J.F7,DT.V5L3)',X\L
MG.2I08 )/05T^@31ZO++X@C5O*NHXX[8LI4^2!NR0?5F;\ * --)[QM3E@>S
M5;-8U9+GS@2[$\KLQD8]<]ZM5R-PYD\9:]:?V@]J7T>)DD,A*P$M*#( 3@8P
MI[=*?X7DDM-3N]*O--2UO8X(Y#+;REH;A,L Z@\JV<YSR?4T =52UQ5S +OQ
M=XBM9I;@P?V9!*J"=P$;,HRN#\O0=/2H=+NFU75= L=48S6TVA)<HDIRL\WR
M[RP_B(&#S_>)H [:XNH+5$>XF2-7=8U+'&68@*![DD"I:\UU9(AI30W#M=V%
MEXBMH[668[V$>Z/>H8\G:S2)ZX&*[#Q3-#:^%[TRSSV\918@]NP5P68*H4G@
M9) SVSF@#:K"U#7Y[7Q%;Z-!8">:XMWG1S-L "D @\'GD5F^'(Y+3Q=J]G^Y
MBB^R6TWV6"5G2%V:4'KT8A5)P!GCCN8M9MY+GXFZ1'%=S6K?V;<?O(@I/WE_
MO C].U &YIFOQWVJ76E3P/:ZC;*)'A9@P:,]'5AU';L0>U:]<3HT+V'C[4-+
MF=]2DGL$GDU&7 EC&[8(3M  '&X8 ZGKUJCI5\\OA[P YO)&GFN%63]Z29%\
MF7=NYY^8#KWH ]%JI9SW<QN?M5F+8),R0D2A_-08P_ ^7//'M7)*6T[Q/;2W
MELEQ;W=_(MKJ5M.=P=M^(94[J/F P<#:. :H7]Q-'X1\52->SJ8=8*PL)F#(
M-\8"YSG&2>.G- 'H]%<3J+7.E>(-933IYQNT)[E(V<R#SE9\, V>>?QP*BT3
M[.7TO4(_$MJT<]M(H2%),S?+N+.6E;!0@DL0.>"1D"@#NZ*X/3EGL'NM,OT%
MA?/ITACU."<M!.%VJ92I.5=2R=?7@UI>&6>UU>[TZ[T]K*\6"-R(9S);S)N8
M>8N>58G.0>3QG/6@"W=>(+F+Q.-#@TT33&U^UB3SPJ[-VWG(ZYJ?3]?CN]4F
MTNYMI;/4(D\SR92")$SC>C#AAGCL1W K*/\ R5U?^P"?_1XJOJLR7OQ$TYK0
MY&DVMP]].F3Y0=,(A[$D_-CKQ0!VM%><Z&EPFM: B#-G?V5P99);DO-<KA2)
M) . W(Q@D@$CC&!;TN6ZAO)O!S^<S077G"=I6+&R+%P2Q.2=W[KKG!SVH [N
MJRRW)U"2$VP%LL2LMQY@^9R3E=O48 !S[^U217$$SRI%-'(\3;9%5@2AQG!]
M#BN0N[B2'Q_K$1GN#;_V$LS1+,P 8.XRO/RG ZC'K0!VE%>?:3)+#+X"G2><
MR:A:;;HM*S"4"UW#()QU4'ZY]36UXR1[2TL]<B>1?[,N$FG578!X"<2 @<'
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MC2M.N[E+FYL+6>=!M666%691Z D9Q5RB@"M::?9Z>C)96EO;(QRRPQA 3ZG
MJ&'0])MYQ/#I=E',&WB1+= P;GG('7D\^YJ_10!1CT;38;O[7'86R3[B_F+&
M =QZM]3DY/7FG-I.G/!/ ^GVC0W$GFS1F%2LKY!W,,8)R!R?2KE% $ LK87A
MO!;0BZ*>69M@W[,YV[NN,]JKV^B:5:-,UMIEE"TZE93' JF0'J&P.1]:OT4
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M3^=JM[<-#<<&'9*  [-GC [8SQ[UZ#10!Y_>:1-9^)+X77AZ;6;.]5'BE@D
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MT>6UGW0V"%K@*/*#*%79G/WN^/05KT44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!6O;V.RCC9U=C)(L:(@R68G_]9/L#4+ZO:1+?22N8
MX+$9GF880?+N(![X&,_7'6G:KI%CK=BUEJ$'G0,P;;O92".A!4@C\#61KFAZ
M"EGJUU>(;?\ M-$M;F=7;^,A%.,X')7G'UH L0>*+>22S2XL;^R%Z^RW:XA
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MV:%1%'))M_>G'.0#]"3V!P.B6UODT^_O%UEK[29],S"D@#-OV'+[O0CMT]J
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MN((YH9%DBD4.CJ<AE(R"#Z4^N8^'?FCX?:)YV[?]F&-W7;D[?TQ73T %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-I8)G"%)%4@'E6.T\CAL'GI7,^%_#NLZ1I$5M-X=TI=0LK>5(K]I%8RDJ0H
M R,Y 8DC@'UXL^$O"MSHWB26_MK*;2K"XMO])L6F22/S\C!CVD\ ;NN.H_
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M4(I))EU)@EG#&O[R9CV )&,=R2 .YK+\1>(4O/!.OS6,MQ:7^GHRRH6V2P2
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M#>./Q%;ZE C6^HZA+*J%@0\31HO..GW30!M&]B%W!;#<[S1M(K*,J%7')/\
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M$@95CZ\@?6I=6TG5;OP9K,%EX;LM.NKJ)(H[6V:,N_S?,68;5Q@G Z\$]\4
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MJ23)& WN00">#V/(S5TC2;RR\8ZU?2PHMK=6]JD3H1C,:L&&W.1]X8K%\/\
MAZ_T@V^FR>'-+D%M-A-6.S<T8;(8IC=OQQUP#SF@"[XJUL3Z-<16)OUV744#
M7=ME55O-56&X'/<J<<9X[5V!KS?4M#\0#P3J?A:#2C<,]P[07@N$".CS^9D@
MG<&&2,8QQG->D4 <U:>(=&L-+O+XW=XULNH/!*\ZR2%)2V"H&"57<0!V%3?\
M)99O#JODVUVUSIL7FRVSPF-V4@E2-V.#@US%YH&K2>$-6L8M,D%Q=ZX;F./S
M4.(O.5]Y.[&,*>.O(XK:N=+OY_%FN3)9%;>ZTE;:*Y9UPT@+\8!S_&.2/X:
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M'"J/<DU8KS^%M1F\&6D^H7PNS)K%L4)CVLO^G+P3D@]L8 P!BM.X\3WND_\
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M+76I'N(I48M(NV(84@C:>3R0?I6]J_B/4AJUW8Z4F6M(T+9L9+CS'8;@I*L
M@QCDYZ^W(!UU9VM:=I>HV&-7CC>T@;SR97*JI4'DG(XP3UXJ2&[N9-'2[>R>
M.Z,'F&U9AD/C.S(XZ\9KG=.UJYUC2;]I;VSEVVCF:V%NT%Q;28X5T9FXZ\\=
M.,T =19O;264#V31-:E!Y)AQLV8XVXXQCTJ>N*T#5+ZPM_"EI,ULUAJ%C''$
MH4K)&ZP!\ELX8'!& !U'-3OXCU*#7;6&;[&;>XOFM#;1*SR0C:2KM("5!.,[
M" <-UXH Z34-.M-4M&M;V!)H6(.UNQ'0@]01V(Y%16.C66G3-- LS2LNWS)[
MB29@O' +L2!P.!6':>)-0N1K-RT5JMGI-]/#,,,7>*.-6!7G&[)[\4W1M>UN
M\O[0SV326ER"9-MG)#]FR,J=[G$@[' '8XH ZVBN9\.ZW?:I>.EU=62R(K>?
MI_DM'/;G.!R6.]>OS8 /!%7-3U*\_MBUT?3G@BN)87N))IT,BHBE1@*&4DDM
MZ\8- &P[JB,[L%51DDG  JE8:UIVIRR1V=VDLD8!=.0P!Z-@\X/8]#7'^)=4
MU*\\#>)+:<PV][8$PSNB$I-&5# K\V5R&'4G'(YKM+"&5+6)KF2WFN=F&E@B
MV*1G( &20,>_O0 TZQI@NS:'4+47 .TQ&5=V?3&>OM5VO.(7N?"%C_8?B*R^
MVZ!)*?*U. 9V;G+?OQU7YC]X<=*V-7\3:B-6OK#2(&:2Q5-^ZRDF$LC+O";E
M("#!7DYZGCCD Z^H([NWFN9[>*>-YH-OFQJP+1[AD9';(KF)?$.NW'B*#2;.
MRL[>273%OF%XS%HVWA60[>.,_P">E3:EXIETW^VV>T#BQDMX8=F29'E"@ XR
M>&8=!T]Z .HHKDK77M>6WU1IM,DN1!;-/;3+:O;^8X',1C8EL]P1U''45H>&
M]6EU:&65M0L+V(!=K6R-'(C'.Y9(RS;2.,<YZ\"@#<9@JEF(  R2>U)'(DL:
MR1NKHX#*RG((/0@U@^*;ZW2WM],FG$0OW,<C9((A',G3D9'RY[%P:I> ;W.E
M7.BR2K)+I$QME8'.^'K$_P"*\?530!TEYJ-CI^S[;>06V_.SSI F['7&>O44
MMI?6FH0>?9W,-Q%G&^)PPSZ9%<SX^)6#P\0I8C7;0A1C)^8\<U5>+4;'4_$/
MBR&S^R1_V< EM<D;II(]S;V"DX&/E'.?I0!W%(S*BEF("@9))X KDKSQ'JME
M;V7F1V[2:FR_93!!)(8UV%W+H#EB.@ (]3BLSQ%JNM7GPZ\0/<6C6DD*,BRM
M 4^T1'@L$+9C/)ZY_7@ [&QUK3=4EDBLKR*:6,99 <,%[-@\E3V/0]C6A7%W
MNLZGI]Y8:9&(9+Y[0SS7<6GR2C8&PJB-6SU/)+8]N>%7Q/KTQT*W72X+6\U)
M+@21W6\>6T?1L==IZXZ\_C0!V=%<G%K/B.?7)](CMM,\^V@MIII"TGED/N$@
M!QG.5^7(Z Y]J=EXNU;4+N"YM+%I]/FNS (TLY,K%N*>;YV=AQC)&.G&<T =
MC>7MKI]J]U>7$5O;QXWRRL%5<G')/N14AD3R_,W#9C=NSQCUKSWQCJM]K/@O
MQ'/9-;+I]L9+5DD1C)(4(#,&!PO/08.<=1GCM][Q:)YL:JSI;;E5^A(7H?:@
M"Q;74%Y;1W-M-'-!(-R21L&5AZ@CK4U<3:>*[V32/"DT-I:1G6&,;J VV([&
M8;0#TR*V?#FM76ISZK:7L<(N-/NO(+P@A) 5# X))'7UH W:S;#0-+TR_NKZ
MSM%CNKIBTTNXL6).3U)P,\X&!69/J^K7USJB:&EH_P#9D@A:*<$FXDVARH8,
M @PP&2#SG(&.9I=3U&_U6ZT[2WM+>6RBC>X:XC:7YW!*H &7C R6R>HXH WZ
M*XV+QE<W<>B+!;0QSWUW/9W"R$L(I(U;.",9&Y?R-*_BC58=%UV62UM&O]*N
MEAX+".52$8'&21\K^IYH [&BN>FUZYTW4M1BU&.%K:WL&OXV@!W!%+!E.3R<
M <C'>L[3_%.K/<PRW>GR/830/*[QV<L7V;"[AEG.) 0,9&#G'&#P =E5:_U"
MTTNRDO+ZXCM[:/&^60X5<G _4@5CZ=>>(+O[)=/'9&SO83( BD-:Y&Y-Q+?O
M.N#@+S7/Z?KNI6'P^O\ 6=0F@OF@NIMPDB(R!<%3W(Z=  ,8 H ]!SD9'2BN
M?FU2_P!0U>\T[1YK2%[&.-IGN(FDW.X)5,!EQP 2>?O#BLJ+QAJ%^^A+8V]K
M&VH27%M.L^XF&:)6)QC&5RI^H]* .UHK&\/:M<:G#?)=B'[397CVLAA!",5
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M[7UZ]V24"[-P4;?? 4<T7V@6E_KEAJLV[SK-755!P'R5(W>NTKD#UY[5JT4
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MC"#_ -^Q7$75M;6WPGU-;=%0"_E4JIX7%\0!CMQBO2HHHX(4AB18XHU"HB#
M4#@ #L*I-H6DLDR'3+,I/()95,"XD<'.YN.3DDY- ',ZI>76D:[KT6G>?+,=
M%^V11-*TBB4/(,@$G&>.!Z4>&[:-[C2M3@UZ"5)X&3RXE?-W\N<OND;YEQG.
M,C)%=<+&U6\>\%M"+IT$;3!!O91_"3UQ[5#9:-I>G3RS6.G6EM++_K'AA5&?
MOR0.: ,KQ-&\VI>'[=;JX@2>\DBE\F4IO0V\I(X/^R,'J.HP:P;RU-QXGN?#
MYU)((;>PC:T6\:21SN+[Y%;>I++M7DDD=L<UW,]C:W4L$MQ;0RR0/OA:1 QC
M;U4GH?<5%?Z/INJ^7_:&GVEWY9RGGPJ^WZ9'% '(:I;W(TVTO&G_ +<LK?3P
M+AH9S%/W(N(P#M+$ ]2#QP>H-BW$6L^+)H/MEVUA)I%M/$B7$D9&6D^8X(Y(
MQ^0STKI+O0],OC&;BRA<HH1>,?(/X#CJO^R>/:LJ7PQ'=^+;G4;N"&2S>QBM
MXUR0RLKN3TZ###OSTH Y&UU#4+QO#6FZE>(D,JW822[W,MTT<FV/?AER=F6Y
M."<'DUL,5TYM#TO4=7:[L9[JX1YE=E4N!E(6;<20,L,%CDJ >F*Z^ZTK3[ZS
M6SN[&VN+9<;898E9!CI@$8XHDTK3Y=/&GR6-L]D %%NT2F, =!MQB@#C/$%E
MI<46B0K.UY%%X@CC >3>86<$^6#V )7CMT[5ML7?X@R6K7#FW;2 3 '( /FD
M;L>I'&>O%:K:+I;6$=@VFVALXR&2W,*^6I'0A<8!J9=/LDO!>+:0+="/RA,(
MP'"?W<]<>U ''>'[B\-P/"MW/<276FW322SM(2TEN/FB);/5BR@CN%:L^U\[
M65U*\N-;@L;VRU%Q,Q1S+ J2_*@_> %60 8VX.X]37HRV\23O.L2++( KN%&
MY@,X!/?&3^=57T72Y-174'TVS:]7&+AH%,@QT^;&: *7B^9K?P;K,R2R1.EE
M*RR1'#*0IP0?6N=U2&73? D%[#>WC7=U)8--*UPYR3)&#M!.%!R<@8!S7;W5
MI;WML]M=01SP2##QRJ&5A[@]:BDTRQFM8;66SMWMX2IBB:,%$V_=P.@QV]*
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M!U9CDD^Y-6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 57OQ>&QF%@85NRN(FFSL!]3CD_2K%% '%>%_#GBG2
M+V$:AK%E-8JTDLT<$&UYY&S\SL1SR<]NWI71:';:M:VDR:S?17D[3,T;QQA
ML9QM4X R1SS6G10 4444 %%%% !6)XLTN^UOPY=Z78-;QO=IY3R3EL(IZD
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG\*Z7+J887KVR&;<,'=CO[^OO0!KT444 %%%% !1110 4444 %%%% !1110
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M.<6S (Q)D.,* !ECR.F?T- %N:WAN8_+GB25,YVNH8?D:<B+&BHBA44855&
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M(RL.H*L 0?J* 'R65K-"D,MM"\2?<1HP0O;@=J6&TM[>)HH8(HXV.2B(%!_
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MRQ1-(P7 RQ"@X&3^/.,XH O7FGV6H1"*]M(+F,<[)HPX_(BG&SM6MA;&VA,
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MFCQGX?,#SKJ*M"D'VEI%C<J(]^S=D#^]QCJ*T_[2M/[02P\X?:I(3.D>#\R
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M% !1110 4444 %%%% !1110 4V1BD;.%9RH)VKU/L*=37941G=@JJ,DDX %
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MV2O;/%&2KD0LA4GH&R!QU.1BNXHH Y(6]VNN^$R;.X AL9TF;9E8F*1X5F'
M.5(K'L5U"?4= N;K2-2@GM;^47$:1!;: -%*OR*I^9<L/GP>IYYQ7>W5_9V*
MHUY=P6ZN=JF:0(&/H,FIU974,I#*1D$'((H \W32=4;P_KEI#87#7<.NM?QP
MN#&MS'YP<!7. <@'H>H%=+X:,%U/-?1:%?V#,FQIM1)\Y^<[0"S':,GK@<\"
MNDHH YKQ1+=QZGHRQ:?/-:M)*)[FVA$DT'RX4*>JALD%AT ZC.:YW3+2ZA\-
M:39S:5?K<0:\9"K0,Q1?.=MY;D;=K?>SCKS7H],\Z,S>3YB^:%W;,C=MZ9QZ
M4 <)KNF:AK4?C"UL;:=)9HK987E1HUF*9+*K$<],9Z<CM5Z.\;6?&6BW*Z3J
M4"6MK<^9)<6S1K&[^6 N3P3A6Z9'(_#L*C6>)Y)(TD1I(\!U# E<C(R.W% &
M5XJDN8O#5XUI8B^GPH$!B\S(+@$[?XB!E@/:N+&BZC?W?BNWABU#.JZ="+:Y
MOT*[V4.&#$ !3E@-N!QVQ7IM% '%S3ZAXJTN[M$T"YTV\:SEMVO+Q%CV,R@;
M8R"692V.>!@=S5O0]8O+XVR77AN[LY[:,K<S31@(F!C$1Y+@D#IQC\,]310!
MP5CI-Y>?""YTU+&:WO9K>X"V\R;'W%W(!!Z9_K5DB;5/$>F7$&G7T2-I=S;2
M33P-&$8F,J"#R.5;MS].:[2B@#S_ ,(Z>8(["SN] U%-1TX+$T]U<.]L,#:9
M(]SE<D9P%'&<<"NE\6V%WJ?A>^M;%5>Y959(V.!)M8,4/^\ 1^-;=% ')L[:
M_KVC7\-O?6R:>LLMP)H&C.63:(^1\QSSQD<#GD5AQ66H3^&O"*-8W?GQ:X+B
M=7MV1HTWRDLP_A'S#\Z](HH J:JURND7K6<"7%T(',,,GW9'VG"GV)XKB-!A
MOAXRTN]-KJH@?3'@FDN;?RT63*,$5!Q&HQ@< ''5NM>A44 <[XRLKV[TJTEL
MH6N'L[Z"Z>W7&9D1LE1GOW'N*PI7U"Y\2Z[JUIHMU)$VB"*!+NW*+/(&<["K
M<G.>AZ_B">_HH X7P\ERGB73[B6SU7;+IC0O+<6_EQQN&4[ @XC P0.!GCD]
M:A:VNC\.[>%=-O!<#4HY&A\@A\"[#EBO7&T9S7H%% ''>(]*NQXEL[C395C.
MJQMI]Z"V#Y8!?S%Q_$H#*#_M"NOCC6*-8T4*B *H'8"LNVT:PTN]N-3>>=I'
MWDO<W#,L08AF"[CA02!^0K6!! (.0: "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#THHH X/0]7U/
M1_"VC3FQMY=.>5+=V28^8@>38'QMQC<PXS^-:-[XINM.U1(KN*TBA>^2T6'S
M"TNQ^%E)&0H)Z*1^-36WA>9+2RTZXODETZSF69(UA*O(5;<H=MQ& V#P!G _
M&K-X-OI%=$UP)&=3_M%<VF7W;MP1FW_,HX Z' QTP* +7_"0W,OB&?3(6LDE
MAF1/LDY9)98B%+2HQX( )^4 _=ZCI3)]=>SN/$CII\(EL/)/F1@LTH9<AF &
M3M'89X%3ZGX<GU:\A:[NX6MX+I;F$K 5FBVX.Q7#< XY.,X)'O4_]BW4-]JU
M[::@L5Q?/"R%X-RQB, $$9&[< ?3&: )="U";4K5[AKJPNX"1Y-Q9,=KC'.5
M).T^V36'X@^W-\0/#*PRVZQB.[=%D+?,0B Y ZD!CC\:U]$T'^RKW4;UF@$M
M^Z.\=O%Y<:E1C(&3DG))/?BI;O1WNO$>FZK]J")91S)Y(CR7\P+G+9XQM';U
MH R--UN:"'43%I5E9Z3I=S/%,4F((5%WEE0)CDGG)'4]>IL+KNI6PTNYO[:V
M^R:E+'$JPL=]NS@E=Q/#CH"0!@GN*MV7A^."TU>UN91<0ZE<2RNH3;M60 %>
MISP.O'TJO;^'KLQ:?:W^H)<VNGR++"1#LDD*<)O.2./8#) Z<@@%*]\67MKI
M&H:HMC"8+"_:UD1I"&D02*FY>, _,>OI6I::O>'Q++I%Y;1+_H@NHY(F)&-Y
M4J<@9(X.1ZU2F\)RW7AO4-*GU!=U[=M<M*L'"9D#[0-W/(QG/?I6I_9<O_"2
MC5C<IY8M3;B#RN>6#;MV[VZ8H ?K-[<6%AYULD);S%5WGD")$I/+L>X [=ZP
MCXNN8O#M_J'V6"YFLKY;,A':-9=S( X!!(_U@X/H>:VM:TN758K417*0O;W"
MS@21>8CX! 5ER,C)!Z\%0:R)/"=Y-IVJ6DNK1O\ ;KR.\W_9<&-E9#MP'Y'[
MM1Z]>30!9D\1R6&J:K;:E#$D%E9"^$L3$DQDN""".HV?K6;>3ZG<>*?"$MY;
MP0QRR7#E%)WQ,8'PISUX/7 Y'2M:^\-1ZCJM_=7-R3;WNG?8)(%3!QN8[MV>
MOSGC%5+/PSJ<=UH\EYK,4\>DLPA"VNUI5,93YSN/S 'J ![4 ;.LWMQI^FR7
M%K;K/*&50KR!%4$@%F8] !R?I61:Z_=:E:ZW#;_9?/L2!'/&S&.160.&Z9!P
M>Q(SWK0\1:1)K>F+;13I$Z31S#S8_,C?:V=KKD94^F?2JUMH5_!/JT\FHPRO
MJ$8&/LQ41L$VC'S\K[=?>@#B[.XU>T\)>#);>:P837,$*S%6\PJ^69<GGDKA
ML=<>E=-?^*[V'4=0LK.P:XET]$$F()G$TC('VJ45@O!7[WK[5(WA&6+POH^D
MVM]&)M+FAFCGE@W!BA/50PZY]:?<^&M277)]3TO6OL3WB(MY&UL)$=E7:'0%
MOE;  [CCG- $<GB35KC6(]-T_281+)IR7P^US-&4RV"C@*2".1WK4\37%]:>
M&-1NM/EBANH;=Y5:1=P&U23QZ\<5#9Z!-;>(UU1[TRJE@ED$="78!MV]GSU)
MSVK2U.R&I:5>6)?RQ<P/#OQG;N4C.._6@#D[L:B^N^$KF1;>2[\BZ&02J%C$
MI7)Y/.#GBK;^+IK;2O,N;$?;AJ)T[RX2TB%^N\87<5V\XQGM5NUT*_\ M6C7
M%]J$,K:;'(I$,!02EE"@G+'&!^>>U5KKPC+=Z;=0MJ30WCZ@=0M[F"/'D28
M P2=PQD'IG- %_0]7N]2FNX;NQE@\@KY<QADC292.PD4'(((/7MSS3[S59_[
M972=/BA>Y$'VB9YG(6-"=JC Y))!]@%/L#+I5EJ%L))-3U$7D[@#$<7E1H!G
M[JY)R<\DGTZ55O\ 0[EO$$6M:;>1V]SY'V:=)HC(DL>=R\!@002>?>@#GO#&
MJ7-KX8>>WLX5,^KW0D+R[8;93*Y+%L#(&,#@9)'2H]3\8ZC=>$;N^TXVT4]M
MJ:V,DBDLK@N@W)TQD..OO6G'X0OK>TMEAU:*2X@U"6^)FM<Q2&3<2&0,.06)
M!SP<4K^#99M)UFRFOXW>_OQ?QR>00(G!0@$;OF&4'<4 27WB:\M;Z73X+19[
MNV@66?RXIG0LV=J#8C;<@=6]1@'MO:9>/?Z9;7<EK-:R2QAF@F&'C/<&L2Y\
M.:E_;(U?3]6AM;R:%8;T&U+Q3;3\K!2^5(R1U/!KH+:%X+6.*29II%4!I6&"
MY[G Z?2@#GI?$UVND7&MQV"/ID#/D>8?.>-6*M(!C'8G;UP.H/%07#W=Q\1K
M((;:2U_LR1T#[C\IDB#''3<>GTJ9?"]VFEWNC+J*_P!F74SL 8V\V*)V)>,-
MNZ<D XX!/6KXT:<>*X=66XB6UBLFM%MQ&=W+*V=V?]D#&* $UXVFB^$+UTTR
MWGM+2W9OL1PD;(O)7H0./:HM7UV>PU6+3K=+,2R0&6);J8Q^>P./+0X(!P/?
MKTX-7=?TV36?#]_IL4RPO=0M#YC)N"AA@G&1VS577M%GUN"YM'>T>SG@"+'/
M!O,4F3^\!!'."..,%00: *M_XDNX-:;2[>"R%VL,<L<%S<&,W.XG<L9QCC&/
MJ>@J1_$<\=UXD@-O&QTB!)HSN(\P-&SX/IC;C/O4>J^%Y]4TQM,FNH9;;RXT
MAEFA+30,HP75LCYNX/8D]1Q3[GPU.]_J\UO>1K%JEHL$RRQEF5E1D#*0P_O#
M.0>GO0 V?Q)=MI]C=6]G#"ES9BZ,MU+B(,5!$0(&68Y)Z=%/TJ&+QE)=P>'9
M+33U8:TDA3S)BODNJ%@#\IR,@C/XX-*OA6^MKZPFM=3B,=KIRV(CGMRX4CK(
MGS#:Q'!Z]!UI+'PG=6L7A=&U",C15=7V1%?/!38O\7''7KD^E $EGXJEFL[A
M9;2'^T(-0&G>2DQV/)P<ABN0-I+=#]TU)?>(KS1;"[GU2PC4QS10VSQRY2X,
MA &!@LN">>#TR,]*J2>"GEL]7C_M$Q7%YJ7]HVUQ%'S;.-NW@GYONX/3()JW
M?>'+W6='EM-5U13<%XY();6#RQ Z'(8 LQ)SUR<>@% %C1M9NM0O;BVN+-E2
M-%>.ZC1UBDSP5^< AACISQ@^U3WVI3QZG!IEE#&]S+$\[/*Q"1HI [#))+8
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M(//XT 0W'C1[2RE:?3@+VVU&*QN8!/POF$;75MOS AE."!W'&*L7GBJ2TO\
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M(0=_KF@"/4=7&L^#O%4,R6SO9VTT9>"3S(Y,P[U8$CC[PX[$=:ZRT_X\H/\
MKFO\JYH^&]4>U\0V[W5CMU6((GEPL@BS&(CQN.0%&0.Y]*Z>WC:*VBC8@LB!
M20, D"@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ***CN(([JVEMY=QCE0HVUBIP1@X(P1]1S0 L<
ML<R!XG5T/1E.0:?7G&D :;X6\-6%O-<06^IW7DW$@GD)48<A4.[]WN*A?EQU
M)Z\UT.DM/I_B^^T:.2YGL/L<5VKW$[2M#(SNA3<Q+$$(#@GC!]: .FHKD+U+
MO4/%FKZ>VHW<-E'IT$RI!*8V60M(,JPY PG(SS5/2-4N]=@\,6=[-<+'>Z6]
MU/+%,8FFE7RP!N0@C[S,0".V>A% '=U1M=4CN]3O[!89DELRF]G"[7#C(*X)
M/8]<5F>&Y[E;_6=,FG>XAL+E8X)9&+/M:-7VLQY8KNQD\XQG/6L;7-5FT>;Q
M;?6KHDT26:AV/";B5)/!Z!L]#]* .ZI*Y*RLM7ABO%MM3AC%Q8LUJDE\]X1+
M_#*'=00O(R.1TQCO7L)KJ>RU?2[0:E9:O%#&3!?W;2KR6^:.4ECAN1GL0. 0
M: .VJO/=QPI/M/FRPQ^8T*,-^.<<$C&=IQG X-87A:_@GFO[(+J<%U:L@FM+
M^4RF+(."DA)+*V#SN/3M6?INFV\?B[Q;=*;CS1Y76YD*G=#D@J6P0"3C(XSQ
MB@#I]'U.+6='M-2A1TBNHEE17QN /KBKU>;>'FEL-/\  MQ#=7.+V);:: S,
M8BHA9@0G0'*@YZ_A4S7]T^IV6HVE_>3Q2:S]D><RLD,D9+ QI#DJ0N,;\ D@
MD4 >AU7O[ZWTRPGOKN3R[>!#)(^"<*.3P*X+5]0U!-!\3ZHNHW GTG4G-JL<
MA50H2+Y'4?>7EN#G[WY=UJ=O9WFFSVE_L-K<+Y,@9L A_EQGU)( ]\4 9>E^
M*8]2OI+5M.O;8K<M;!Y0A4NJ!R#M8X.WGFKR:S;OK[Z-LG6Y2#[1N:,A&3('
M#=SDBN+\(W=[H>NW>C2@W6GS:C+;PW3?ZY94B5_WF!A@4& W7*\]:W2Y/Q21
M/FP-%8CCCF8=_P /Y4 7-2\46VF/<&6SOI+>U(%S<10YCBR <G)!8 $9V@X[
MUN5SGC5+[_A&;J:TEMA';H9YXIXV83QH-Q3((VYQCOZ5OPR>;!')MV[U#8],
MB@"C<ZS##?BQ@AFN[O;N>*WVDQ*>A<L0%SVR<G!Q1J6L1:;)%#]GNKJ>0%A%
M;1[V"C +$9&!D@?C7G]K<ZEIGA#6_$]M>2+J"ZC-+<6LD:,KA9 @C;C<,*!C
M!'6NQUK0%OICK-K?7&G:I%;>7'.DGR!1EL.A^5ER3G(_D* -2?4[>TTT7UWO
MMXRJG9(/G!/1<#.6R<8&<GBIK2X>Z@$KVTUN2>$FV[L>O!/^-<7)<W6N>(O"
M9N=]M%+I\MZ%"CB?8HXSD94.2.#BMOPMJ%[>1:I;W\HGEL+^2U6?8%,BA58$
M@<9^;''I0!9U'Q#;:?<RVX@N;F6"#[1.MNJDQ1\_,<D9Z' &2<'BI)M<LX[.
MSN(2UT+T@6J08+394MQD@ ;03DD"L71"(?'_ (N>8A 4LW4L<?((B"?ID']:
MYOP]'<K?_#]V4K:-:WAC7;C;N7<H/_ ,8^AH ]#TK5;?5[9YH Z-'(T,L4@P
M\3J<%6'K^A!!%7JYCPR"?$7BN2/_ (]VOXU7'3>((P_'KGJ:H1#4-4\5^*K(
MZQ>P0VB6YMEB*@1L\9)/3GD=#0!VU%>;Z9K6K^)#IEI<'RIWTR*\VK>O:&9V
M+ N"B$L  IV]!NY![:TQUH7OAK3+K6&$LZ7*7DMH%'F%%XP2O!![X'(/ [ '
M95GZWK%MH.ER:C>+(;>-E5S& 2-S!0<9]2*BU6VU%?#LMOI<[/?*BB.29P&?
M!&<MC )&1G'4YKB?$MY!/\/-<MXUU&*:WN+=9;:_D,CQ$RQD88DEE/4')H ]
M+HKCI]2GTSQ-J^GOJ<BP#2!?I-<@.L#[Y%)P,<8V\>U,\/W5[!XKATYY;Q[:
MXTHW;?;)"SM()%7< 2?+!!SL' ] : .THKSRSUC4U^'^FZ]+JDC75VL$$AF=
M$B3=*%,F=AVG!/)R/8UTVDV^LP:K.UY/;BQDA4QP"X:=UD!P6#,BG:1CCGGT
MSB@#=JGJ.HPZ9;I+-DF25(8T7J[NP55'XFL02R:UXJU?3);FZMX;"&W,0@E,
M19GW,7R.6 P!@\=<@UA7<EUK&B^'6O[B<7,6N?9FGB/E^;Y;2KO ' SM'Z]J
M .QBUE5TVZOM0M9]/CM-QF\\ \*,EE*D[E]._M447B&(W%G%<6-]:_;7*6[3
M1KASM+8.UCM) )PV#Q5K4K2SN]'N;.^;_1)83%*7?'RD8.3_ %KF;)M<\*ZA
MI^FWTPU;1[B46]O=%<7%NV/E#]F7@C=U]: .TH-<'I\VOZ^9K^RNHH)H+^6
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M^H1WUQ$D.NR6S0(%*2(]VP;<",YPQP<C&* /0$N2][+;?9YE$:*PF91L?.>
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MAACT+QI/:/#%HTP@\K8<1M.&_>E<=^%!QP3[@UZA@8VX&.F*-B[=NT;?3'%
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MT/J.E:CKH-[IEQ<6.M2V\$]_#-%=RHOV=K@*<+LPHVX4;N@)(YS7H"JJC 4
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MGYY(<OC:-OR !@-H/8\<T :-M$XUOQ@OGRF$QQ;4\UOD)B8L5Y^7.>V.E6_
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MHT^"_P!*6S#><LC(X>0\@<8^<'K_ /6L>&['4[4&"[T+2[ JFR6YM6'^D,.
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M[[0]7E\->*;.*S#7%]?-+;+YJ@.AV $G/'W3[T ;EY=V"^+]-LYA=B]:"62
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MKK<]CK^CZ9#8O,M\\F^4%<(J(2<9(YSM_#/>L^'6QI,_B.YNX[J:VAU$!FC
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MU:'3)K6%=/D$ 6:%G,LFP.<D,-H^8#H>A- &U>7UO81H]Q)M$CB- %+,['L
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MKJZMH)0\UJP290#\C%0P'Y$'\:Y\:GKU[XGN-,MS9VD,5I!<EI83*Z%RP,9
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M7&W5XMYXW\(SK&%$]E=3 D?, 4C./UKJ[S[5]CE^Q&(7.T^5YP)3=VS@@XH
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M+Y(A;9MS&S-/Y@^5@1A=O4Y!)S[53UO65T:*SD:!I1<WD-K\K ;3(VT-[XH
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MB6)D! **54@_CTK85@RAAT(R*6@#F8_"(MM-TB&UOY$O=)5EMKET# AA@JZ
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M&X[9)KJ[BV@N[>2WN88YH9!M>.10RL/0@]:+:UM[*W2WM8(X((QA(XE"JH]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!AWWBJPT]
MY3+%=M;0/LGNXX2T43=PQZ\=\ @=ZVP0R@@Y!Y!K%UQ5U*&708E;==QD3NJ_
M+%$QPQ)_O-R /7GH#6TJA$"KT P* %HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,2Y\(:%=W4MS<6 DGE;<[M*^2?S_ /U5LQQK%$D:#"(H
M51Z 4ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>exhibit1061-loanandsecur024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur024.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M*EG_ *I_^NC?SJW52S_U3_\ 71OYU;H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"K9_ZIO^NC?SJU56S_ -4W_71OYU:H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"K9_ZIO\ KHW\ZM55L_\ 5-_U
MT;^=6J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JV?^J;
M_KHW\ZM55L_]4W_71OYU:H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBFOOXVX]\T .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@"K9_P"K;_KHW\ZM55L_N-_O-_.K5 !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 5;/_5L?]MA^IJU56S^XW^^W\ZM4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!5L_N-_O-_.K5
M5;/[C'_;8?K5J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+@A7@<J%8-\IW+D \'/6M'3M+OK?QC=W\T2?9I+""W61" "Z%B<+G@?-Q]*
M+MIKL=[=B&&RNVA,TD'VG"&/>F[<#AMPY4C)4<X]16M7'6VD7\?B.VO[;3I=
M.D>9FU Q7"&VN$*M\VP$G?NV\[1WR378T 8=UXIL[19YWM[IK*VE,,]XBJ8H
MV!PV?FW8!X)"D#GT-9FI7\M]XWM=$EL;N2Q-E).?+F5 Y+QJ),AP=J@M[Y/
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M&XCC0*<H;A7WCG &T&K]S'?:?K7B*-M*O+V#545K>2$*R9$(0HV3\O([\'-
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M\\J1Q:E;.SPM.NUP08U.UFSTP#Q6#;"XA\;:1=W4-P5GT7[.9?*9@)=Z,0Q
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MLSQJT@C;<H8CG![C/>N2\;SPZBDNAG48[$I;&Z:9YA'^\Z0IDD=6!;_@ ]:
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MSC(SUQ7-ZMXL&DRS/-9%;.">.!YI9/+9RY4$QH1\ZKN&3D=\9J18D7XAF15
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M895E$LC[=@1N!SO'7&.<T =-16#_ ,)$UK'?_P!IZ?-:O:*C#8?,2;?PH1\
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M,^5)'9$+=,;E$=3QD(A.7(!!.,>@R>*ZF*6.>%)HF#QR*&5AT(/(- #Z***
M"BBB@ HHHH **** "BBB@ HHHH **** *MF#L;_>;^=6JK69^1O]YOYU9H *
M*** "BBB@ HHHH **** "BBB@ HHHH *#R*** .<T_P?:Z9=E[>_U$6?GF=;
M S P(^<\#&[&><9QGM59_ T1-JL>M:FD-K>F]@A)B98W)8D#*9(^8]2<5UF:
MKWTUS!932VEL+FX528X3((PY]-Q!Q]: ,N?PK87,NM-</-)'JZHMQ$2-J[%V
M@K@9!P >2>145KX2@BM9[>]U'4-366W:U!O9%8I&PPP&U1R<#).3P*V/ML2S
MV]M,RQW4\;.L6<DA<;N?;<*K:)JKZO9RS26OV9XKF6W:,R!^4<KG('?% &98
M>$?LEYI=Y<:S?W4VFQO#$&\M4*, ,%0OH!SG/'6FOX,B^Q7<,.I74,MQJ/\
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M%KJ(CU/PQ8)(^I:==?;].N)&8E83\Z@L3SE@8\9[^U:&JWK:IX$U_P 31+)
M]Q8B.V;E&6-!G/J#O9^?0"N_$48E:41J)&4*S@<D#. 3Z#)_,U$]C:261LGM
M8&M"NPP&,%"OIMZ8H X>2QMKCXC>'9I8@93I+R%P2"S*4VDD=<9[U0OE^S:4
MNI033+<+XG9%996"A6N2&&T'!!'7(KT6;3-/N);>6>QMI9+8Y@=XE8Q'_9)'
MR]!T]*@FT#2)[3[+)IMK]G\[S_*6(*OF?W\#O[T :%<K\.I$'@'34+ /;H\4
MRG@QNKL&!]"*ZNLJY\-:)=W+W%QI=K)+(0TA:,?O#ZL.C?C0!1\)%-/\*VAN
M9HHUGGFDC9FP&$LSNF,]20PK.U/1$O=7O]8\,ZH+#7+<B*[5OFAFPH(65#T^
M7&&&.IKK+JPL[Y(DN[6&=(I%DC61 P5QT8 ]Q5:]T#2-1E,MYIMM-*1@NT8W
M,/0GN/8\4 5O#6LMK'AO3=0NEB@GNH\M&K?*6R0=O/(XSWI/%\EQ#X1U22UG
M$$RP-MD+[,?1NQ(X!]2*T)=-L9VM6EM(7-HV^WR@_='&,KZ<54\2Z9<:QH<U
MC;_9RTCH62X!V2*KABAP#@,!C.#C/2@#F[.VG&J7.L:7:WT5E!I>(;:6=U26
MX ./DW88[>"Q[\\GFJWA+=>3:1JT>OVS+<1LLT222/)=L4)(<,Y",I!/ XP0
M,"M?1_"\=GJ\5]'H>FZ28RQ)LYF9I<@C:0%4!>0W?H.!6U9>']'TV^FOK+3+
M6WNILB26*(*S9.3R/4_G0!P=C%=)H?A[5CJ5[)=C6OLQ>2YD<- UPZ%""V#Q
MCDC/ ]!4TGVO6]7UM_[:M[&YTZZ(61S)OMHEP5(CW!65N<DYSGV KM5\/:.E
ME!9+IUN+:"87$46WY4DR3N'ODFEG\/:/=:I'J<^F6LE]&05N&C&\$=.?;M0!
M@6%@=1\6:O\ :;V[>.+[%<1(D\D85]K9^7/"MQE3QU[UBVMS,NL>'M2M9KJ2
M&^U":%KFXN&WW2%9#S$/E505&WH?E' KO[?2K"TO[F^M[6..ZNL>?*H^:3'3
M/TJA'X/\.1$&/1+%2)A."(1]\=#^I_.@#FG_ ./+XC_63_TD6HW\_1]"\)^)
M(99_LMM:P1:A")F"-"\84.5S@E"V?I]..T.B:81?#[%%B_\ ^/KC_7<8^;UX
MXK.OM,U"95T6TMK*'0FA2)W$C"14SAD5-N,%< '(QDGG&* )O#L!>.ZU5VD+
M:E+YZ(SDA(@,1@ \#*@,?=CZ5ROCJYDVZ]/9W%R]QIUE&V1<M#':.2S!E"_?
M=@1U&, #/.*]%  & , 5EWGAO1=1NI+F\TRUN)I$".\L88L ,#.?J: .>DEC
MUKQ.-(U2XF6)M*CN+=(Y&BWNQ82/E2,D +CTR3BH4DM-2UO3M"N]3N+NQ&FF
M2WN!<&/[9*'*.2RD;V4 $8_O$\\&NFNO#6B7UC;65UI=K-;6W^IC>,$1]N*D
MO] TC5+2&TOM.MI[> @Q1O&-J8&.!VXH Y&^>;[3H.A1:REU;R0S_O[R5@;J
M2-E4*60@L0"W&>=N3FH+A=0M['0[%]?DG;^W/L<DEI(RD1&-V\IF))8C &3S
M^/-=K>:#I&H:?%87>FVLMI#CRH6B&V/' VCMQQQ6/K_A>.^AT'3[.R@33[*^
M6XEC&$545'& !WR^?P- '&^+;*:#1_%VE27EU=:=;06US"]U</(T$C-@J226
M887=@YQFM_4I+S_A+;/PW:W7DVJZ>9XOM%U,&GD+D$!PP=BHYQN/7/88ZS^P
M],.G3V#VB26UP=TR2DN93QRQ))8\#DGL*CN_#>C7]C!97>FV\]M <Q1R)D(?
M:@#G+%[BZN=(T+4-9>Z'V>XDEN+65HC</'(JA=ZD-\H8YP>2.:L?#Z!+:TUZ
M"-W=(];NE#2,68X*]2223[GK6]/H.DW-G;VDNGVYM[<YAC" "/C'RXZ<$]*F
MT_3+'2H7AL+6*VB>0R,D2[06/4XH X[Q:[W-SK9MKR\,NG:>)0([DP1VCX9@
MV5Y=V '!&  1D;JMM<?VSXE31[V[NH$&F17,2V]PT#2NQ8.VY""=H"\=.<D=
M*V;[PKH6I7LMY>Z7;SSS((Y&D7(<#ID="1V/4=J;=^$= O["UL;K2X);>U&(
M%8',8] >N/;/- &2\GFZIHVA7NKW$\3VTSFYBF,#74T;*NW=&0<@%B5!Y[]*
M2]DFL;GPYX?;4;FXMKN>>.>[\TK(P1&*QF13D'.!G.X[>O)K;U#PSHFJ:9#I
MUYIMO)9P8\F+;M$>.!MQ@C\*E;0M+;38=.%E$EI P>*.,;/+8'(92N"ISSD<
MT <;KUUJ6D:?XEL;2\O&BM(+6ZM9VF+20EI"&3>V2P^3/.3@D$\BMV7SS\0C
M;I=SI;S:2[O$)&*AQ(JAE!.%.">0.:UDT/35T^YL3;![>ZW>>)&9S+D8)9F)
M).,#)/84D&A:=;RQRQVY,L<#6Z222N[+&3DKEB3C/\J .(TNZOH]+\&ZS-J=
M_-<ZA<);7*M*3&Z.DC?<^Z""J_-C.!UI='M%L?\ A/9[6>ZCFAFD$;FX=]O[
ME6SAB06SW(SVSBNRC\.:3%:Z?;1V86'3Y/-M5WM^Z;GD<\]3USUI?^$<TG[5
M?W(LPLU_&8[EE=AYBD8/0\' ZCF@#E[*_O[YO!<<M]=A=1TMWNBC;=[")&W9
M[-DGI44.H:P_A&[6TNKBZ-IK+6C2*"T[6RR@,!_$S!3C/4XSUKKXM!TR&?3Y
MH[;:^G0F"U(=L1(1M(QG!X ZYZ"LC6_#5L-*:WL-'CNX9;[[9=6OGF-I6(.6
M1B<!MVT]0, ]* )?#B7']J:JXGOWTU75;1;HL1DJ"Y!?YR-W0DD#D#BF^();
M_P#X2?P]9VMY+!;71N!<K&5!*K'D$9'7..GJ:9X;T:2SO#=1Z;<Z3;^6RM:R
M7YG\QR1ABN648 Z@YYYZ5-KNCOJOB/0Y'M)I+6V\YGGBF$9A8J IR&#=B. >
MO- '.WFKZQIECK]F-0GE-AJ=FEO=2!2WERM&6C)QS@,1R.AKH;Y;K3-1T&%-
M2NYDN-0D243%3O4P2MCA1P"@(_\ U8T)?#NF3Z9_9TT#O;>8)F!F?<[@YW,V
M=Q.<'D]AZ"K%WI=E?75I=7, DFLW,D#Y(V,1@G@^GK0!Q-[J&IC1/$&HIJMR
MLMCJK1P(I7:J!XQM(QR,$]?6M:5WUO7M<T]M3N;.;3UB-MY,A0)NCW"4@8W_
M #;@0Q*X7H.M:S^&M(DL;VR>TS;WTQGN5\Q_WCG').<_PCIZ4FI^%]$UBZ2Z
MO].BFG5=GF<J67^ZV"-P]CD4 9YU"Y;QEI%HE[YMK/I<TS&/&V5@T8#C\&./
MK6$]YJMKX.'B!=9N9;JWNROE2E?+D07!CV$!>20>#USCZ5W)TVS%Y#>K;+]H
M@A:&)EXVH<$J!T_A'Y5SWAGPO!;Z?!-?V4\-VMU+<^1)<%D#F1BK[58INVD?
M3ZT 4=8N[C0]:\7:G;;6G32;6:,$< AIEY_+-:-G#KHN(Y([VU%M-:,J!KLW
M'F28!21<QKCWP2"#P!6]_9EE]KNKHVZ&:ZC6*=FY$B+G (/&/F/YU0T_PEH6
MEB866GI$)8VB;#L<(>JC)^4'VQT'I0!G^&+RX^W/8ZB=1@U*.W5I;>Y8212<
M@>9&X'(SQCCJ,BG:BYN/B+HMK*^V*"SN+J-6'$DF53CW"LQ^AK7LM$L["Z-S
M%]HDG,?E!Y[AY2$SG W$XY_E5;6]*DN+RPU:S0-?Z>SE(RVT3(RX://;/!!/
M&0* ,C1YI5^)_B."\P'>UM6L@>IA ;?CVWMSCVJ[-JM]'\0+72-EH]G)8R7.
M\QL)4PP7 ;=@@DCL*UK[2;+4S#)<PD30G=%,CE)(R>N'4@C/0C.#4=MH-C;7
MIO56:2[\HPB::=Y&5"<E06)P,C/% '(^([.?Q2VJB&PN[E((S;Z?/ T06.92
M&9\LX.=ZJO X"''4UT&A>)(M0\&0Z[<_N]L#-<KC[CID.,?4''X5JZ9IEMI&
MGQV-FKK!&6*AY&<\DDY+$D\DUGP^%-*MK2XM84N$AN)A<2J+F3YI <[OO<9.
M"<=>] '%SK<Z/J.E>*;C2KRTD:Y8:G-*\94Q3D* <2%L(=@'':NB\6&4:_X4
M,"HTGV^3:'8J#^XD[@''Y5T&JZ5::WID^G7\9DM9P!(BN5) (/4$'M59_#FG
MR2Z9(XN"VF#_ $7-P_R\;<GGYCCC)SU- %?1M#N;36=5UB^GB>YU#RE,4*G9
M$D8(4 GECR<GCZ"JW@5BFCWMEN)BL=1N;6+/78LAVC\ <?A6]?RW,-H[6=M]
MHN#A43>% )[L2?NCJ<9..@-8$/A,0:;I-HDSM-9S_:)+D3/'ND+;G;8IPVXD
MC!X /?H0#I9E9X)$21HV92 ZXRIQU&01D>XKBK#4]6O=%\&7#:E/%)J.8[HB
M*/,A:WD<-]T@8* C'8\YKMI(Q+$\;%@'4J2K%3SZ$<@^]9D'AS3;:#2X8HI%
MCTPDVJ^<^$.TKSS\W!(YSU- ',7FOZGI.E:Q')?^?+;ZO#917,D2 Q12")LL
M  N5$C '&,XR*V[NSN;+3]9$NJ/<V\MH[0P3*-\9"'<=W4@Y'&./QJX_AS2I
M4U*.:T69-2</=+*Q82$  =3Q@ 8QC&!3+3PSI=E9W%M%',RSP_9W>6XDDD\O
M! 0.S%E R< $8H PM.U"ZMI? UG%<.L%W8-YT.P%7V0*0<XR"">QYJO8:]JD
M]A=6\E^PFD\12Z9%<E$W11*21@8P6PI )!Y/>NG;PWIC6NGVXCFC33EVVK1W
M#HT8V[<;@<GCCFH1X0T0:;=Z>+0_9[NY-U*/-?=YI(.]6SE3D#H10!GZ;:36
M?C'7H_MT\Y.G6K1/-@M&-T_&<<X()YYYJI!K&J75MX'4WSQMJMLQNW2-,NWV
M4N&&5(!#<\#'MCBNBL_#NGV5]<WL8N&NKF(0R2RW,DC%!G &XG'4]*(/#FF6
MPTH1Q28TI66TW3.WEAEV'J>?E.!G..U '/KK>JCPWX@,<TDUSIVHM;+.44N(
MLQEGV@!251V[<[15_0I;Z7Q'J:KJ,UWI$21>0SJI'F,"74/C+ 84]>-Q';A-
M=T5(=(NH[#3Y9UO+Y+J]2&<I*<%26C.X8;Y$XR._?@TK33+R62>* :ZEB]M+
M'+'?W@9G+C"B,DLRD<G<2,<=>P!VE<'?:MK5LFMZ-#?32ZS#,D^G$11[IH6&
MX(1C&!MD4MUXSUXKL-)M)+#2K>UEE>5XDVEW<N3[%CR<=,GKBE.F69U==5,(
M-ZL!MQ+DY$9;=C\Z ,)-=GU?3+[4].F:*UBL-\3;5/[XKO.01_"-H]/F/IQB
M7#WFH^)O EQ)J%S&UW9332+'M"AQ"A) *D<[B.>W3%=E#H=A;:/-I5M"8+29
M9 RQL01O)+$'URQJ$>'+(+I(5IU;2EVVSB3YMNT*0WJ" ,T <*U_>Z/H_C/5
M[*[DADLM:DD,05"LPVQ#:VY20,$]"#76K=7NL>(-5L(;Z>QBL(X54Q(A+NZE
MBQW*<@#:,#'0^O$LW@_3+C3M6L)#<&#59S<7($G.XD9P<<#Y0/PJW<Z#;3WS
MWT4MS:W4D8BDDMY-ID49P&'()&3@XR,GF@#!TG7]3U&Y\-RR.L<=VEU#>1 #
M#21':&7C(!*L>O0BL/6-0U#4=!437\ZM#XH6S#Q[5+1K-A0W&#C@].H&<UW$
MOAVP:"PB@$MJ+ G[.UN^TKD8(]\]\]:CE\+:9+IUQ9%9%2>\-\7#_.LV\/N4
M]N1^5 &O&I2)$9V<J "[8RWN<8&:X/\ M6[T?P%;W-FZI*VJO$25!^5[QU;K
M[&N]1=D:KN+;0!N;J?K6*WA33GT>/2W:X:V2Y^U#=+EM^_?U]-QSB@#)U#5M
M4:\\61P7S6ZZ5;QS6^R-#DF%F(;<#D$@>]/L=8U'^UO#GGW1EBUBTDE>'RU5
M8F5$<;2!NQR1R36U)X?LI)-7D8R[M5C6.Y(?^$(4&WTX)H'AZR6XTF=3,&TN
M-HK<!^-I4*=WKP!0!R^O7FH7NC>+;9[^6(65W&D+P*JG8R1MM.0<CYS]?TK3
MUR[U"QDCMH-3G9UM'D"PPQO/(X/#."NQ8\=3\O/&:T9O#-A/%JT4AG*ZHP>X
MQ*000H4%?3A1^5)-X:M9[E;A[N^\W[.+:1EG*F6,$D!L=\L>1@\T <JEWJ.M
MZSX#OGO)8OM=E-<31PJFQ6$:_, P)YWXY)]L=:U]2\27&DIXEGE99$L?)%LI
M3@-(H !QR1N(_"M"'PG801Z2L4MTC:4K1VKB3Y@C  J>,$8 'X59;0+&675'
MG$DRZFBQW$<C?(5"E< =N#0!GWM]J&BZSH\,MR;RTU"5K:3>BJT<FPLK+M R
M#M((/MSZY<&JZZ-(L=1EU&-S_:_V&6,6ZA9(S=-#GU#8P1@]N<UT-KX?B@N[
M:YFO;R\>U5EMA<NK"+(P2,*"6QQEB3@GU-1?\(Q:_P!DP:<+F[\N*[%X)-Z[
MVD$GF\_+C!<YQC\J -RN/UDW;?$C0(([^XBMWMKB0Q(%VDKM]0>H./Y8YK9T
MFQNK75=5GEGO7@N)%:*.YG5PA&<^6!]U#E< G/';N_4-"M]0U6PU(S3P75EN
M"/"P&Y6QN5@0>#@=,'WH XE-0O\ 1](\3:M9W(06NN2M) T883 F(8)/(X)Z
M5KW>KZ]?ZWK5GI*L/[.,<<07RMK.T8?]X&.[;\P'RXZ&M'_A#K)M)U#39+N\
MDAU"Z-U.S,FXL2"0"%&!\H]_>GWWA&PO=8;5%N+ZTN)$$=Q]DG,0N%'0.!UQ
MZC!H U8[B:/2UN;R(),L(DFC0Y"MMRP![\YK&T>76KZ#2M4%]#+:WB>=<6[(
M (D9-RB,@9)!P#N)SR>.E;\$$5M;QV\$:QPQ($1%'"J!@ ?A7/Z=X)TW2YU,
M%Q?M:QR&2&RDN"8(6.>57\3U)P>10!EZ?K^JC7]'MKF[CN5OIKF*<0QCR(RB
MLZB)\!F("@-G(R3W%-.M2:4WB,0(PGFUN"VBD9,H&EC@3/OM&3CZ#O6E8>!K
M+3GTTPZCJ173)&>U1Y$*QA@59<;.003UY]ZNR^%K&YM-6M;J2XG@U2;SYE=@
M-C *!L*@$8V+C.3\HH S==N=?T/0=:O/MT4T=O$DMG*\:^9D??60 !2.F,8/
M)J^M]>Q^-H]->=7M)--:?9Y8!619%7(/7!#=#Z4Q/!]B=+O;&[N[^^^V0?9Y
M)[J??($YX4XP.3GIS@9S4^G^&X;#4HM0-]>W-Q%:FU4SNI&PMNZ*H&>!S["@
M#GM$O+FT\%Z9]GN$@62]N%E8(7E*^;*<1)@[G) [< $UF7^K:OJ?AS1WN+NX
MM+@>(HK.78BHTBB;"E@0<$8!P.,]175P^#;.WMM-CAOK])-/FEF@G#H7S(3O
M!RNT@[CVI)?!EG+9M;&^O\?;QJ*/O0M',#G()4Y&><'- #;O6KO2=9U%+F9)
MK&STH7@3R]LC,"P.6SCG9V ZU7?5]4L+/1-5GNTGAU&>"*>W$0"Q^=PIC88/
M!(SNSD9Z5LOX?M)=8EU*>2:>26S^Q/'(5V&/.3P .2>O./:H++PS;6<-E;_:
M[N:ULGWV]O,RLJ8&%&=NXA>V2<?@, '/:KXBUVTT/6]3BN+<MI.I&$1"WXFB
M_=\'YLC <\CTKO:YZ?PC:7&FZM8->7JQ:G<FXG*NFX$XRJDJ<+\H]3[UT"C"
M@9)P.I[T +1110 4444 %%%% !1110 4444 %%%% !1110!5L_N-_OM_.K55
M;/[C?[[?SJU0 4444 %%%% !1110 4444 %%%% !1110 444V12\3H&*E@1N
M'4>] &;_ ,)#I?VN.V^TL&DE,*.8G$;2#.5$F-I.01C/48ZUA:CJ=UJ?C1]
MM[J_LH8[ RB>&W;_ %Q<JI)*XV@*<<[3DC)(K/BT^^G\#KX4GL;H:A&ZP^=)
M&6B*B0-YPD^[]WG&=V>,5KPK=-\3[B<072V1TE(#*8F$;2K*S8SC!(5NON:
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MOH+K4=(EM];CABG61TM,)F]7;U7=\WR_>^7\:Q_'?BH:-X;OI].OXX[^V=$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@"K9_<;_ 'V_G5JJMG]QO]]OYU:H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<DQ.Y5L@Y!('H?>KMIK=SK>IV-G;W+6J2:5'J$CQ(I9C(<*!N!  PQ]>GOD
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M%,=4^4C#9/0YK'B\2ZZVAC63<V;Q0ZH+.6%;8KYB?:/*W EB0<,N!SC!ZYX
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M5M/$VF"TUJ"SF>&>!MT-S&-K/Y9/.?E!VGD8H [6HYYX[:WDGE;;%$I=VQG
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH @M_NM_OFIZKVQ^4_[Y_G5B@
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M> &Z]#RFCVHOOA1IVI6Q674]#GEN8NFX;)6)C.>0"G&/]WTKU8@'J!1C'84
M<)JDD,W@K4];O8W,>J20,J-*8=D)=%C5FP<+SN;CH["F:5+9M=>+[>WN+*4&
MV1W2U39&6\M@Q"Y.>@!/TKOL C&!BFB- Y<(H<@*6 Y('0?J: //[6\2TT+X
M;$C<SO"@7.#\UJZ9_#<*Q]>U&U6\-Q%<6L+1>(XE)E</=9#[78MG]W'@8 Y^
M7N,XKU@HI925&5Z''2FB"%)'D6) [XWL%&6QTR>] 'GIL]!N/&7C1M?BM#$J
MVSJUR!E%\C!9,\@CU'--L#<V]S\.+?4MS7QCN"PE8EU_<'D^^,"O0Y;:WFD2
M26"*1TY1F0$K]#VI_EH9!(47>!@-CD#TS0!Y7ID>DWT\UIJNKW-KK\6I2,T*
M11BX+"0E"C;"Y4IM'!QMR.!7?>+8(+CPAK"7 C\O[',=SKD(=APWU'6MC:,Y
MP,^M(RJZ[64,.N",T >>H+>WTSP/YD,(T:6,?:R%'EF5H0(RXZ'+9Y/?%9_B
M:&TATGQ>+=HH]'86NPI@)'<;L/Y?8'&PG'<_6O47C22,QNBLC#!4C((^E,:T
MMW@$#6\1A'2,H-H_#I0!!I^EV.F1R+8VL4"S/YDGEKC>Q'+'U)QUKA;R+38/
M"GCY4BMDD5[A2%0 C,*;1QVW'CWKT>H6M;=C*6@B)E $A*#YP.F?6@#D9K2*
MR\:QOIB0PW%[H]S)(L**IED5XMCL?XC\S<GWK&\'?V3>_P!AW*:MMU6,%9;>
M" ),\FW,JSGEF7/.3@9QSG%>D^1$'63RDWH-JMM&0/0>U(D$,<KR)$BR/]]E
M4 M]3WH YSQHELT>BF[D\J'^TXE9_,,?!5N-P(X/ K U"*QTJY\30P%TTB2.
MU1X;>01JER[[=H/105\O=[,>*Z[7]*FU7^SD1;=H[>\2>59LX90&& ,'GYN_
MI6A'86<-K]EBM($M_P#GDL8"?EC% '$:18V>J:QXIT*7[(;62"W/EVF!'$Y5
M@S(N>&!"G< .0.]6_"XGU(6=CJ4'[_P_N@E8K\KR[=B,N>O[L[O^!BNCO[.Y
MCLW;18[""^P%1YX24VY&0=I!Z>]/TVP:SLFCN)%N)YF:2XDVX#LW7 YPH& !
MSP!UH X2U_L^/PMX<U%5C65M66"*<+ARC3N-F>NT@GCI5J_#Z='XUM=$_<2P
MVT$T<-L /+8HV2JCH2%SQZ5W*VELL21+;Q"-&W*H084^H'8U(L,:R/(L:!WQ
MN8#EL=,GO0!P>D0Z+.TESIVM03I+IDBFULXQ$NSCYW .0PZ9.#R:KZ3';Q?\
M*]N5(6YN[4Q3MGF9/LA.&]0&5?H?K7H"6=M&LBI;Q*LGWP$ #?7UI1:P 1 0
M1 1?ZOY!\GT]* .:\"0:=#I=X+."WBG6_NTF\J,*V!<2;0<=0%(Q[4CQV&I>
M,M4L=8CCG$5K%):PW"@HL9SYCKGC.[ )ZC KI8;.VMY9I8+:&*28[I71 I<^
MK$=3]:;=Z=97^S[99V]QY9RGG1!]I]1D<4 >:,J7/AKPE<:K;07COK2V\4EP
MH=GMR90F2>2,;3SUP":[WQ%)/8>$M3DTY-L\%G(8%C&-I"'& /3L/:M%[6"0
M1AX(F$9RFY =OT]*FH \Z']AQ^)_!,VEBUE:99U\V-@793"3N;N3G/)YR326
M.CGQ!I'C2P60B?\ MF9K:1G/[N4(A4Y[#/'T)%=W#IEA;RB6&QMHY 2P9(E!
MR>"<@=34L%I;VOF_9[>*'S7,DGEH%WN>K''4GUH YGPU<_\ "331:]*C)Y=F
M+7805VRDYF_(A5!]FKE]'N_+\)^$;6^N7_LZZU*YBNI2[$28>;8C'NK-MSG@
M]Z]0CABAC*1QHB$DE54 9)R3^))JNNE:>MB;%;"U%FW6W$*^6><_=QCK0!YK
M=&+1;[Q]_982VCC.G[_(4D1H>)2%4@\*6. 1^%:$RV-OH&OW6EZQ9R%]&F86
M^F1&*)<(2LA =MK\XSD$C_=KO+;3;&S#BULK: . K^5$J[@!@ X'/%,BTC38
M+::WBT^TC@F_UL20J%D_WAC!_&@#BM-ABL=?\%-#+*LUYILBW&7)\\+%&1N]
M<'I]36+=BSO?!VBZQ<M'+JK:U#]HN'&)$?SCNC.>0JC@#I@ XKU%-+L(Y;>5
M+&V62W79 XB4&)>F%..!R>!3?['TTW+W/]G6GVASEY?(7<Q]SC)H Y#6%^R^
M(9M4DM(=0L?M<"M/!(5N;&0;%"X)^9"<$@8^^<@UO^+I8D\/2QRO,HFEBA40
MR!&<M(H"[C]T'H3Z$U??1M,DOOMKZ?:M=9#><8EWY'0YQU&.#VJQ<VEO>P-!
M=013PMC='*@93CD9!XH \NFFNK?2?B#9K*ENEI!#)##9RL$MW:(E@AX(Y'/0
M$YX&<5MVV^Q\9Z(MO+-BZTB62=6E9A(XV$$@GKR:ZY=%TM X73;,!X_*<"!?
MF3^Z>.1[5*-/LEGAG6SMQ-"GEQ2",;HU_NJ<<#V% 'F,D=E=>'/!FKA_.U"[
MUFU:YG<G>TA8^8ASV5@0!T '%>@^)M,EU?PY?6=N[1W+Q$P.IP5D'*X/;GCZ
M$U.=#TDW?VLZ79&Y#^9YWV=-^[.=V[&<^]7Z /,5\0W:7>F^*X+!_)NX187,
M00J9;DK\I SVD41;B/7L!5TZ$D7C7PY87#NZ0Z1,K[)"OF,&3.<'."3G_P#5
M7>"V@6-8Q#&(U;<JA1@'.<@>N>:8]C:R72W3VT+7*H468H"X4]0&Z@<GB@#S
M*UU>9O#N@07UXD5G+J-U;237:O,C%6<1))\X)'U./E'859UFRM8K+3();J'4
MEC\0VT:K'&42W#@9C0EF.!D-UXSCC%=['HFEQ:<-.33K460)/V?RE,><YSMQ
MCKS3VTG3FL5L6T^T-HIRL!A7RP<YX7&* .(O],MKWQAXCMG,\?EZ/ 8FBF9-
MI'F8/!&<<'DXXJC%JDFHQ^$['5;VWC2]TGS!]KC:6.XEPH^;#K\VWD9/4GOB
MO0SHVF&.9/[/M0LT8BE B4;T P%.!R .U-FT+2;C3XK";3;22SA $<#PJR)C
MI@$<4 <.T+&?PQ8KKUS>0G4+FVEFBD>(.JQN?+/S'=@C;NR3QP<\UWVG6$.F
M6,5G TIBB!"F60R-R<\L22>M1MH^FO):R-86^ZT_X]SY8_=?[OI^%7J "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@"O;#Y3_ +Y_G5BH+?[I_P!\U/0
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M.CVB32J7>:9+>")2 9)'.%49X_'L :Y>'44TWQQXEU"^MOLR6VEV\DI1M_F
M&0[AP.V!^%;GBG1)]<L+9;6X2"[L[N*\@:1<H70Y ;O@Y[5ER^&]4U>[UB;5
M)+2V34=.6R"6SM(8BI<YRRKG[Y[#^M %NP\8VUS=/#<+;QA;9[GS(+I9PJKC
M<'V_=89]P<'!XJ>PU^ZO+JQ#:/<)9W\1E@N5;>$&-P$HQ\A(Z<GTJK#I/B#4
MM,FT[Q!=V9@>WDMW>S#;I]R[=S9 "]2<#OCD#BG>'].\2:?%9V%_=6#V5D@C
M$L*MYMPH4JH8'A>Q.">GO0!C^%M0.DZ%K$D5G-=.=>N88X81DY:7 SZ*.Y[
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MUZ4 ==7'I]IN?B%J>FOJ-^ELME#<Q1HVQ4)9E;!QE@< ^@Y':NN1BR*S(4)
M)4XR/;CBN3D-];>/;[5'TF\>R&GQVD4D05C*ZNSG"YR!\V,G'2@!]GJMYIWB
MBX\/:E=27<<MH;RTN1'B14!VLC;1\Q'!! R>_-6=,UW3K33]$@6ZOKE-1!6U
MN;E2S.<%@'; P<9QGTJ.QTZ]N_$<GB/4;9[9HK9K6TLMZNP4G<SL5.W<<
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MR1N!C<K#(//L:XSPY?ZQ]A\5WEQ?)/):7UQ'$KPX4&-%QP&Z8'3ZG/-7-/\
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MT-% '(^)7ND\:^%_L7V=IL7?[N>0H'78N1D D'OT[5'>>%=3F@:>*>S>\GU
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M9;[1[)EDGGGF=H[0R^7#,%7YC*<'*KN!P,DG'%;R65I'>27B6L*W4JA9)UC
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M_P#"$Z.=#L-)=;AHK EK:;SBLT9R>CK@CKCCL!Z4 9;ZEKFG:';)K%]#"_\
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M1110 4444 %%%% !1110 4444 %%%% $%M_J_P#@1J>H+?[A'HQJ>@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI?"S(9&*@<KN& >3SCCWQ62/&.M6/@;Q$3=RRSV>K-817D@#/%&6 WMT!('
MXZD4 >BGQ-9+XJ7P[)%<1WKPF>-F0;'0=P0?8]1VK:KS.2+[+\:-$#74DZC1
M6/FRMDGE\DGWZT[PKKNJ-XMATO7Y;RWU!DE=$W^9;7B')#ICA< <=B/>@#TJ
ML75/$L.ESW,;6-]<+:P">>2"-2D:_-U)8<X4G [8]:VJR?%'_(I:S_UXS_\
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M.7VOYN>OF;VW9SWSFI]9U%HM8T?1[&40)J%U,MS-!C<FR,R%?9FXYZXR>O-
M'345P&NZIK.C6?B2RMKV5OLEG%>VEW(%9XM[LIC;(^;[AP2"<$Y/2K>NOJ^C
MS:/##K5PS:CJR1RM)'&VQ#&V47Y1QE<C_.0#M**\[N-?U3P_>:MH\EW/>1I)
M:+;7LRJ7@$[;"7( !VD$C(] ?;:FEO=)\2V>F)>W5Q;ZG;S8:4JS6TD8!W@D
M<@[L;3QG&.,B@#JJ:[K&C.[!4499F. !ZFN"TO4=3F\$V&MWOB*:.2]BAC*&
MW1L,6 /EJJ;B[ $ <C)SCBLCQ%J.HW/@GQE;37%Y"+">-81(Z^9Y;HA*.RYR
M#N/?/.": /2[B_6WO[6T-O=.;G=B6.$M''M&?G8<+GMGK5NN9O;F^T_Q7X<L
M%OYI;>YCN1.LBIF0H@*L2%&#D]L#VK)BUK4;SP9-XPBNYDDB\V9;(E?),4;L
MI0\9)*KG=G.[IQQ0!WE%<;//K-[JNNV\.K2VL$-E!<6Y2*,M$[+)P<J=PRH)
M[]LBNCT.[EO] TZ\G(,T]K%*^!@;F4$_J: +]5;/4(+Z6\CAW[K2?[/+N7'S
M[5;CU&''-<MJFIWUCXHV:AJ%WI]C+<P)92)#');S A=\;G:65R=X!R!@@]N<
MR]34;%?&NM:?J,EO);7BR"((I639!$Q#;@>""1Q@^] 'HU9]SK-I:ZU9:3)Y
MGVJ\21XL(=N$ +9/XBN7\5ZSJEE)K,NGWS,]A9I/';6\081D99FF9AC!"X"@
MYQDXS@U+J<IG\?>#96 !>UO&('ND9H Z33=7M-6:]6T9V^QW+6LNY2N)% )
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M. ":F@F2YMXYXCF.10ZG&,@C(KDO$=OJ-KX#\30W]\MXHM93!(4"R!"AX?
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M6=W#>):N]W%$85GEG=W*$$8))Y&">O\ 2IK'PUIFG7,-Q!'*6MXS';B69I!
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M;P3"99+9E!) (VD,""ISTQZ5B3^ ]+GL&@::Z2Y-T]X+Z)UCG65L;F4JH R
M!C&,"MC0M3.KZ#I^HNBQO=6T<YC!SMW*#BK^]=^W<-V,XSS0!SL_@RQN-&^P
M27E^9/M"77VUI@T_FIC:VX@CC &,8]JZ"WC,-O'$TKRLB!3))C<^!U. !D^P
MIY(&,D#/2EH **** "BBB@ HHHH **** "BBB@ HHHH **** (8/N#ZFIJ@M
M_P#5CZFIZ "BBB@ HHHH **** "BBB@ HHHH **** "HKHR+:3&&,2RA&*1L
M<!FQP"?>I:* /.='L[[^V/#%W/I&H1R6\<T=R615AMRZ*-B(#@(".N.@Y)-7
M?#\5[:Z[:I80ZG!IDRRR7EG?0G;;2'D&.0CG+'&T$C&3Q79SW5O;-$L\\432
ML$C#N%+L>@&>I]J5+B"2>6".:-I8L>9&K LF1D9';- 'G=EI^IVVCZ7?II-R
M3:ZW/=S6C+B22*0R 2!3W4.#CVJ.^TG5];NO%UU;:?<P+<?87MXKE=GVGR2S
M,G7(R0.>.U>F5%;W5O=J[6T\4RHY1C&X8*PZ@XZ$>E '->&;>V?47O8?#EUI
MDGV?RY)KQLNV2#L7YFRHP23QSCWJ;Q=+=1G2_)L[J:W^TDSS6D(EF@&Q@"@[
M9W8+ < GUS6_'=6\ES);QSQ//$ 9(U<%D!Z9'49P:FH \G&GZB/#-[ =*U)9
M'\3BY5'A9W\HRAMQQG( ')YY[UU=G9RS?$#Q!]HM)OL-Q8V\6]XR(Y<;MP!Z
M'AL?G76XK/UF"VN=->&ZOIK*)V4>=#<&!P<Y #@C&: .:\':9>6]Y-:7;B:T
MT1Y+2QE+;C(&PV3[HFU/^^JUO&ME=ZAX2O;>R@%Q<9CD6!C@2A)%<K^(4C\:
MU=/T^WTRRCM+8/Y2$G,CEV8DEB2Q))))))/K5J@#A8KJ?6?'NAZC'H^I6T$5
MG<1RR75J8PC':0I)^A_IWIFBZ!+J?@?6M+NH)K:6>^NI(3-&R%6,A:-QD9QG
M:<UWN*,4 <EI*7S^&;[5]4LY8]3O+8"2!49G540JJA0,\L7;&/X\5E:=%>Z7
M/X0U"XTR\EMH=(^Q3*D#-):2XC^8H 6P=I7@5Z%BD8JJEF("@9))X% 'E:V>
MJS>'=4OX=)U'*>(GU$6;*\$T\) 'RX^8'G/'/RU<U6W6_P#"NMR67AW4T%PM
MON^V+))<SNL@XV,68JH[_7'3->CQNDL:R1NKHPRK*<@CU!IV* .)U73]0G\<
M7S6,$T8G\.R0+<%"(Q-YGR+NZ C).*R8WO+NP\$6']C:E!<:?=Q?:@]JX2(1
MQLA;?C:0201@UZ9BC% '"*D]GXEC?2#>K'<:@_VW3KJU8Q_>(:>-R,*.K=<-
MD=^*Z3Q18W6I>%M4LK%MMS/;/''\V,DCIGWZ5KT4 <1,9->@\-PVUK>6MU8W
M<5Q<>=;NGD*B$.I)&#NSM &<[L]!FJGE3R>#[QO[*O5GEUW[0(C;-YFW[4K[
M\8SC8.M>@U"MU;O<M;K/$9U&6C#C<![CKW% $_:O/]#^TV5[;6NG+>3Z,+.1
MGAOK5A/IY &V-6P"V>FWYC\G6O0*,4 ><V5E>V_A_P  PR6-UYMK<H;A!"Q:
M$>4ZY<8^4 L,DUGZBEY=.Z)I=];_ &?Q!%<M:6]DY3RED&9RP7+EN3P>G;C-
M>K8HQ0!Q>BV[3^,?&3>1(GGM;>3+)$R@XAVY!(['/2LKPQ:PK#I>DWNAZR=4
MT^12[S3S?9E9209E8ML((R0 .2<=.:])Q1B@#A]'DFM==M+?36NI=/FFF:>S
MO;=@]DV&)='(^Z3QM.?O<'FMGQI97FH>$K^VL$\RX8(PC#$>8JNK,O'JH(QW
MS6_10!RDSQZUXET*_LDN$6R$SW#R0M'M1DQY9W <EMIQVV'VI? C[K'504E0
MG5;J0"2-DRKR%E89 R"*ZK%% '+^*93'K&A_Z.ZIYDI-\ENTS6QV  * " S9
M(R01@'BN3TV&YB\*:5!)979E3Q,K2>; RLB^<S;R-O3'4CCFO5*,4 <?;Z=!
M?^+/%MG<VLGV>\MK5'=HR%D^1P<$\$@%>E+X,M]2>()JI5WTG?80R@Y\[#<R
M$=OE"#USN]:Z'5;"34;/R(M0NK%MX;SK4J'X[?,",?A4MA91:=91VL.XHN26
M<Y9F))9B>Y)))^M &/XU@O)_#;?8X&N&BN()I8$&6EC21690.Y('3OTJJLD6
MK>,K+4--#M#!8S1W,^PA6W,FR/G^($,2.H[]:ZNC% 'E.EV\Y\'>!;=K6X$M
MIJJ"XC:%@8^)/O C@?,.>G-:FIV=Q,_C,65M.[--9S!(P5,P0(9%0XY)"%>.
M]>A8HQ0!Y[<QV.J:-KE[I]IJTUS)HT\+2WB2*02N5B"L!N;.3QG'KS75^&H$
MB\.:8WDB.9K*%9"4VL<(.#WXR>M:^*2@#D;^\32?&5U+J5E<26-]8QQ17,4#
MS!"C/NC8("1G>#[XJ69D_M3PDL5I+;1KYNV!DYB3R2H#8SCJ!S7548H \P\Z
M:>Z\.3PP7=MMUEY)+06KA;96\P,7<KDDEB2<X^;@8&:U[6X>T\4Q0:?=_:[6
M:_F\^PN(L2VCG>6E1NH0DGKQA^#SBNXQ24 <+HTYM?$%C9V%PM]I\DDS?9[B
M';<:<Q#,3NQ]PG*\X/S#!-;7C.&XET%3!!)<)%=02SPQ\M)"LBLXQW^4'CO7
M0XHH XV[EM]4\3PWMA+')9QZ9<QWLX&8R"4V(Q'<8<XZ@9Z9JU\/[6"'P/HS
MI B2_9%5VV8;/<'OUS748HH Y+Q2J0ZK:WUOJJZ;J<5O(D4ES%NMY4)4E'/8
MY4$8(/7@UC#4FL=;TN^U2QNM.L+O1XH!Y$.^*WD#,3&PVG:""N..P!Z5Z-1B
M@#@(+72[7Q)X5LHK5XK=;2[6**X0E@K%=H;/3(#84_3M5G5H'D\1:O8Z9&L=
MW)H!2$JFU0VY@HR/J,5VV*,4 >>>&I-,O$TEI7U:6_L;9XGAD@\L68\O#AMJ
MKD'  R3S@CH2)O"=Z$UV#2[6XM-8L8+-A!?QJ!-:("N(9<<9.%]"=IR.*[W%
M)@"@#F/&OGK:Z5.$9[*#4H9;X*N[$(S\Q'=0VTGTQGM4%K);7'CB[U33IXFL
M!INR\FC8&)Y0^4^8<%@N[/< BNOQ2  =* .4^&8*_#O1U*E66-@01@@[VS3-
M8U&#2?'5O<ZG!(+&73S%#=&,M'%)O)93CH67;SWQBNOHH X&[N--L9_#L-C
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M0ETATM;6[^QZ@_GJ3;R>8(SM&/W@R5.>.#Z@BI8/#6HQWWA&=WM=NC6LD%P
M[$N6C5 5^7G[N><=:H7/@[5I_"FNZ6)+(7&HZJU\C&5]J(9$DP3LSGY<=.]
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MCZWJ]CJUR)@(!=Z?MB"ETSM*<=6#%1]"/>@#K:*KV"W*6%NMY()+D1KYK@
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MDTH>4HORQ2$@84DY_"MB7QB\BZ2MI8R/)?V0O6)CDD$2$+@'RU8Y);V'!]J
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MWHVIZ5+=7IM]2N6N9CYB[@6()5<KPN0./KS70T4 9;Z% _B(ZY]HN%NOLAM
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M;BWN,VXECG49()4L,$$G!S4R^';@:YI6H-J;2K8P2QLDL66E:3!9MP("\@<
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MR\%O/NTJ57FF"MEU2(@%CW!W^X.?>N[T_0K&PLK6W^S02FW!V.T0RN22=O\
M=&2<#M5K^SK'RXH_L5OLB.Z-?*7"'U QQ0!YQ%)9:A>ZJ]_J\5GJEEJ;MC[/
M_I0 D/E+&Q;YE9 H"A<')X).3Z#K-S96>CW4^I*&LE3$P9005/!R#VYYJRUG
M:O<K<M;0FX4864H-P'UZU*0&4@@$'@@T </8V-UX5UK2;72=1-WH-\[1_9)G
M\QX/D9@T;==@V@$'(&?>L?2GM]4=KJ^U>&RUFUU)A,B0;;K=YA"Q@EOF1EP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %&*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** &1_=I],C^[3Z "BBB@ HHHH **** "BBB@
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MV% 'M<MU;P6QN9KB*.W #&5W 4 ]#D\54BU_1IY5CAU>PDD;HJ7*$G\ :OD
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #(_NT^F1_=I] !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %8^O:R=--G:6X1]0U";R+9'/ ."6=AU*J!G Z\#C.:V*XCQ
M2K0?$7P9?2*5ME>YMVD/0221X1?J2#B@#IKO6=/TI4CU"_ACD"!F+'''3>0/
MNKGN>*IZYK3Z(MMJCO')I#,D=P1UB#L LH/=02,CT.0>,'A_&$5Q=ZUXD@LM
M%OX)9--*/?)!)(+PA01&I(*(H[D<DC P:=J1F?X )!+;RPW'V:" 12(58L)%
M4<$#KQ^= 'J0(90RD$$9!'>EJII4,MMI%E!.<S1P(DASG+!0#S]:MT %%%%
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M/ ,VUO+2R=&?:<*S1$*#Z$F@#I/&WBF7P[H5SJ&GS64T]F\9GM9<LQ5F5>S
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M!. >A)Q7 _$31;?1_"/VO1K9UBN;R"34YH@7::%0WS/Z\D$^I.3UIUXND?\
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M<8'?:?2N"FL/#SZ3XZBNX[07JZA/]D7"^:KE$V>6.H)? ^7KT[4 >NS7$%N
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M_P"*KN"W5V33K>8H#MWD;R>?7BM6#Q;'-_PCC"RD6/6T+(Q<9B(3?@COQW%
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MTRXU2XNC!/+>7[W<9"?ZH,JC&3W^6M/4=2BTV*)G2262:40PQ1 %I'.3@9(
MX!.20.*YWQ)J$SKX?N8&O+0MK,<$L18H67Y@RL%.&&5]P>U '52P0W"A9HDD
M4'(#J",_C0\$4CH[QHS(<HS*"5^GI61_PE>EI::E<7#RVRZ<0+E)XRK)N *\
M=\Y&,=:?%K<5\NHVJQ7%K>VD0>2*8 ,H9258%200<'H>W.* -5(HXMWEHJ[F
M+-M&,D]S[T^N"6YO9O#7@*<7]RLT\]J)W$K9F4P,S!^?FR5[UJ^-[J6RL](N
M(KBXAQJUJDGDLPWH9!N4A?O CMWH Z)[2WE=G>WB9F&UF9 21Z&G""%6+")
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MK59M'TQ[)+-M.M&M4;<L!@4HIYY"XQGD_G1IVJ6VJ12O;&0&&4PRI+&R,C@
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MDZ&,J$++E<9'(QZ5?H XS4?"NJ7^FZPPELX]1U2X@=^6,44<17:N<98_*<G
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M+,NKLC2X 7R]BA4V^XVJ<G/(JU::(\=[;W=]?R7TUK&T<#21JNW=@,W Y8@
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MUW81W[!KJ!(T<,P &Y"P^0D#KS5\Z%(?%<.M&].R&T:U%OY?4$@EBV>3D>E
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M3RV,2/("DK%W92P0;$..,'<?7&.N+">(9=0O8+"PME2Z>S2\F2[RGE(_W4(
MSN)R#Z8[]*BNO#FIQ^(KC5]'U>.T-W$D=U!-;><KLHPKCYEPP''<4YO#5W;:
MY%JVG:F%G^Q+9SB[B\T3!3E7.&4ALDY['/2@"E\,-W_"#P;HQ$WVFXS&#D*?
M.?C\*B@\0ZC8:QXLNM4FMY-.TM4*Q19WK^[#C /'S;L$GN/2MSPKH<GAW0DT
M^6Z6Z<2R2&58_+!+L6/&3W)[U2N?"+7E[X@\Z\4V.M(BRPB(AXRL80%7W8[
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M7S9"7W*% . =YP<G&!UKM1G SUH **** "BBB@ HHHH **** "BBB@ HHHH
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M<0& QK@KN4[@Q]<CVQTJW=:G*=>M])M%0R>7]HN9'Y$<6<  =V8Y ] "?0$
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MT2(09H5,;/L_O<*W ZXKTBB@#CM+O$U3XBW%];0W(MAI,<1DEMGB&_S6;'S
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH 0J&Z@'ZBEQ110 4444 %%%% !BBBB@ HQ110 4444 %%%% !BBB
MB@ HHHH **** "BBB@!I12X<J-P! ..0#U_D*=110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR3T '<FF27MZNN06<>FL]D\1>2]\U0(V[+MZG/'/O0!HT49&<9YHH **0TM
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MZ4 +1110 4444 %%%% !1110 444F: %KAM:CDA^+OANZD4_9I;2>"-MO D
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MWH.&BC 42A_3+9X/4XK!U*WLY;7XDS201//]KC%N[)D\R-G8?7@]*]W"@$D
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M;ZZ98I>)>+9VXN4C$23",;E3^Z#U ]A3[NSM;^W:WO+:&XA;[T<R!U/U!XH
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MUE86FFVPMK*VBMX 21'$@502<G ' H Y5M/M3\6C,8SYC:2)20[#+"7 /7T
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M,\5-I/B.YT&SU&YOHKZ?2'U-+736<$OL;C.7.XIGH>36SJ6BZE<^/]*UJ*.
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M]_K$NE_9KNWN$A^T)YZ!1+%G;N7DG&>Q /M4%CXMLK^ZLXDMKN**^:1;2>5
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MY5+FW.X[.<J"=FT,03DCH>M &U)XFM$6V"P74D\]O]I^SJ@$D<>."X)&"3D
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MN)EFMTM(KJ)O+"LA9W4KQU'RB@#H:*YO7[Z_35;6QM;U;5)87<>3&);AW!
M"$$;!GYF./3(SFL2R\7:MJ.D>$KI#;0OJ\LD-Q^Z+8(5\,OS<<KG'ZT =_17
MGMSXDUVVTWQ!<F\MS_85R5;_ $;)N4PK8/S *<,1D?6M^35+O4O$)TNQN%M(
MXK-+J21H@[MO+!5&3@ ;23P>HZ4 ='17#1>*=3>+3UD\E;A-<.DW>U/DE 5C
MO7/(Z*>IQDCFKVHZUJ=E;^*WBE@9M,A%Q;>9$2,>67*M@C/W2 >,9[XH ZDH
MC,K,H++]TD<CZ4ZN3M]7U3^W=*MI[F%H-6L99D5(-IMW18SG))W [SU]!3_
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MLXUU"[NWAC\D-(K1H"QD" [N5'W<\$\G%:6AW]_?1W/VZU,)BFVQ2>6T8F3
M(;:W(ZD'D]* +T5]:3WEQ:0W,4ES;!3-$K M'N&5W#MD"K%<% VKK\0_%?\
M9*6;2""S+?:BV#A'PH"^O/)/&.ASQ<MO&<VJ0Z=]AM2LL]I]IN/W#S^2=Q0*
M N,_,K\Y'"].: .QHKC&U/7[V_\ #4A*Z;]HEF2YM)82Q8JCG.=P.T@9 ]2"
M<XQ4M[XGU"UB\16X6T.HZ:4>VC*-MGCD V#KG>6W)QWQZT ==17+?\)?&^E_
MVE!Y<UO#IAOK@*#G)'R*#GC)5^H/2G_\)!J&GF>;5+/?91V;W4DUO Z>24&Y
MD.\_-D=",<@Y H Z:BN5TKQ#J][J%M')IVZVN86?S!;31"W?&55F<8<$<;E
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M)K<13&-3(5_>J,?.N">#GO@\=* ,FU\(:9::)J>DQJZVVHO*TNTX*A\_*OH
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M]1S6.OA#4T\-VFF"[L_-M]4^W"0JVT@2F7;CUR<=>E=IN4,%W#<02!GD@?\
MZQ10!R@\-ZW8:GJ+:/K$$%AJ$IGDCG@,CP2-]]HSN YZX/ ]*ZF*,0PI&&9@
MBA=SL23CN2>IK/US7;3P]8+>WJS&%I5BS$FX@L<#/H,\9]ZTZ "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ^QKM3I]D;5;4VEN;=""L/E#8I!SP,8ZT\VEL9GF-O$99$V.^P;F7T)[CVH
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M*2S_ &;SC%$P7:-[L.?ESP!GDY[9'*6-]?WNA>!Q-?W>ZYO989VCG93(BB0
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M[<5ZO7-S>!M#GBD@,5REM)/]I:WCNI%C\S.<[0V!SSCIFNDH **** "BBB@
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M$!5D(W$# *D=>X]Z=H%A/H6AZA=S6LKW=W<SW\EK$0SAG.1&.<$@ #KC.>:
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M-U D]O+'-$XRLD;!E8>Q'6L/7]>ET[5]'TJW>VAGU)Y L]R"R*$ . H(RQ+
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M2Z?>Q:EIMK?0',5S$DR?1@"/YT 6:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!"JMC< <'(S2T44 %(0&!!&0>H-+10 BJ%4*H  ["AE# A
M@"#V-+10 4444 %4]3TZ'5+)K:;<OS*Z2+]Z-U.5=?<$ U<HH BBC80QB=EE
ME5<-(%QD]R!VSZ4\QH<953MZ9'2G44 )@$@X&1TI:** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** (KE)I+:1+>80RLI"2%-VT^N.]<Y?>#+>]\(MHA>W$KQ"*2\:V#.QSR^,
M_>/7.>O-=110!Q<W@*2;PUI6F/K,C76DW"3V5XT )39]U67.& ^HZ"IK/P.J
M:KKU]J&H&[_MJ 03QK"(PJ[0OR\GMG].O?KJ* .%M_A_>1V^AV\NN^9%HL_F
MVP%I@L!T#G><XY&1CBM.W\*31>/+WQ+)J*NMS:?9!;"#:47*G._=R<KZ=ZZ>
MB@#@!\-YX_ =WX3CUE/LLTXDCE:TRZ)O#[3AQDY YX[\5K?\(A)!JL&KV5]'
M%J*Z<-/F>2W+QR*,$,%# @Y [GCCWKJ:* .%O/AM#)X-T[PW9:B8(;2X%P\T
MD/F-*P)/9@!RQ]>,5<7P9=1:WXDU.'6##)K, B3RX"&MV"[58-NYQ]!^%==1
M0!PNE^ +S3M5T.^;6XI#I2R)L%EM\[?G>S'>3N.>ISTZ=<[7ACPY-X?EU:2:
M^2Z;4;U[P[8/+V%NH^\<CI7044 8LFE:A!K-UJ5A>0A;E(UDMIXB5)7(#!@<
M@X//!Z"L&^^&]IJ&@W=H]T8+^YOO[0-U F%CGY VKG[H!(QG/.<UW%% '-:C
MX>U76/#6H:5J&L0R2W<8B$T=GL5 #R=N\DD_[V.G'K)-X<G?P(OAN.^C5Q8K
M9&Y: D%0FPG9N'./?K70T4 <*?A[/%'X?GL]9,&IZ-%Y*W)M]R31_P!UDW\<
M$CANY]L:M_X?U*_@2.[O;*_C:-UN+:YM,12,Q&&7#93: 0/O=3SGFNEHH R/
M#6AIX<\.VNDQS&40*?G.>222< DX'/ STJI;>%XC]NFU2#3]2O)Y6D2::U'R
M@C"IR6(4  <'WZUT5% ')^"/"-WX/M+BR;5$N[.20RQQ?9RAB8]0&WG(X]/>
ME\3^%[_Q!JVE7D5[;VRZ7.+F%6A:0R-QPWS# X[9ZUU=% $3"8VY"LB3E.&*
MEE#8ZXR,C/N*P/#OA*/1?!O_  CES.EW"5D1Y%A\O>KDDY&3SSC/TKI** .3
M\)^&-6\,6$.F?VO;W&G6[.85^R[9&#9.&;<1@,Q/ R?7M5"'X?SR1^*([[4(
MF77MK-Y,1'D."Q&,GYAR/3/M7=T4 <UH^B:UI^C+I]WJEM<+!;&V@$=L8]PP
M K.=QY '08ZGK4?A3PF^A^##X=OYX[J,B5&:(%=R/G(Z]>374T4 <IX3\-ZQ
MX<L8=,EU6WN-/MG)AVVQ65E))VL2Q &3V%<_-\-=1F\+ZQI!U&U!U+4?MN_R
MV_=C.2OOT'ZUZ71B@#D-1\(WS^)['Q'I.HQVM]%;BVN8Y8R\4T?X$$<_R'3'
M)J_A/4KS7=+\06>IV\6JV49AEW6Y\J="3QC=D=3W-=?10!7LTN4M(UNY8Y;C
M&7:--JYST R>!TZ]JY"R\*:U9>-]3\31W%AYE_"L36[;V$> @X;C/W/0=:[>
MB@#D+3P0MAHNO0I=_:-3UE9/M%W*N!EP1@ 9(4;C@9/UJH_@FZ'@^RT"6/3]
M1A@MS$PN-T>)-V1(C@,5P#T[^HKNJ* .)F\#7*GPI+;:BCS:"K(3.A(F!4 ]
M#D=.*NVWAJ\3XB7/B:2: 0R6?V185R6QE3N)X .1T_6NIHH YBU\,W$'Q"O?
M$K7$1AN+,6PA .X8*G.?^ ]*YZV^'>I1>%?^$6DO;8Z=-=?:+FY0LLA7<&\L
M)@CJH^;=^%>D44 <?X@\+:K?>*#J^FWEK$LVER:=-'.I. 6+!ACKR?4=!US6
M9<_#R]E^&EIX82^MS=6DXE24J0C_ #LV#U(^\?7I7H=% '-2>'[ZY\<6&O32
MVZPVEDT'EIN+.[9W'G@ <8Z]ZQ8? 5Y%I&G^'3/;G1[.^^UBX#-Y[@,7$>S&
M!RWWMQX'2N_HH XK4?"&HWFJ>)[U)[4#5K#['%&2WR87:&8X]R< >G-=#X;T
ME]"\.6&ER2K*]K"(RZC ;'?%:E% &-XHNG@T&YM[<%[V[C:WM8UZM(RD#\!R
MQ] #4FF6-YIBV%A%]F.FVUFL);YO-,B@ 8'3;@?7-:9C1I%D**74$*Q'(!QD
M _@/RIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI,-S!%() LSN"9&7:ZY9<+CDD9)]Z /1*S=>UJU\/:+<ZI>;C# N2J_>8YP
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M@\1>%VO)#';R7$L<Q\UD5E$9(#8(_B J+3]??0I/$=ZRW=QX9L1"UJV"[9(
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MB58K>--[R-P /6@!+BSMKO9]IMXIMC;D\Q VT^HST-"6=M&DB);Q*DGWU5
MW&.?7BJ5GKUI=W?V4I<6\[(9(TN86C,J#J5SU]QU'<"FZ;XCTS5YUBL)99PR
MNWF"!P@VMM(+$ !LYXZ\9H N+IMBGE;+.W7RAB/$2C8,YXXXYYITEA:2W*W,
MEK \Z_=E:,%A]#UJGJ&O6>FSM%,MPYCC$LQA@:01(<X9MH)YVMTR>#5@:G:&
M[N;42$SVT2S2IL;A&W;2..<[6Z9Z4 /DT^RENA=26EN]P%*B5H@7 P1C.,XP
M3^=1#1M+%N+<:;9B /Y@C\A=N[&-V,8SCO5=_$NE);V4YN6,=]"9[;;"[&5
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M9:6$^U22 N&95CA>1B%^\<("<#(R>G(]:GL[NWO[.&[M91+;S('C=>C*>AH
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M9+&]6>VUB.26+[,^Y%#R9+#'RC# Y-=AX\AFN/ VL06\,LTTEN42.*,NS$]
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MND?!"$H0JD8 .[ P!7I$2[(D4+MPH&W.<>U/HH **** "BBB@ HHHH ****
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M0C"!<(4#.>=S!21D8')XS45CX133Y98[?5K]-->8S?8 R[%).XJ&V[PN>P-
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M*G$ENI@4,RA&0*[=SAL9 ' Z9YK8UW3#K.A7VF"?R/M4+0F39NVAA@\9&>*
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M>6\:E/,!>51E>/FY/3D<^]5=0\0Z5ID%M/<WUNL=S(L<+>:H#ECC()/('7-
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MKBS\'65O=02PS(TNZ.5"K#,KD<'V(KE_&,&H:A;^)K0:3?;I1&+:.T@++=X
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M^&X[&0PBT,\LGRY.6 4CYN%'.>^>W'-;1?$VD6>F:_J4^IZB\%I?.MP+[YC
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M<?<.<;O7''.0 =%1110 4444 %%%<9<>*-:C\<_\(S#8V#,]L;I)WG<#9D@
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MU8ZM/?PV<N][&<V\WLP /'MSCZ@UHT %%9$.OP3>(YM#%K<K<PQB9W(39L/
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M(UT%R8U.Y3;2MC/<$A3[D"LRX2?6=4UT7.M6.FW-E=XB>:%O/MX5"E7C/F*
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M<E#AOE52V >"<8Y%/;Q!I2Q6DAO8MMVK-;XR3(%&6P/4#MUK'UZ"YM_$MMJ
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M-=\VWG5+E;=H9?*8QOM0AOFQ@$'L30!;T[48+?0HKJZUB.^C9RHO-BJ)"7(
M 7@G/R\=<5,VOZ2NGS7[ZA EK"_ERR.VT(^<;3GH<D<=>:X^VM-0LK#PQJ5Q
M;7'D6-Y=R7D*0G>HD\T*^SK@;LXY.#GFG^(;2?4]-\47ME:W$L5W96\$*+"V
MZ:12Q+!2,XPZC./X?:@#L;36-.OKN:TM;R&:>$9DC1LD#)&?ID$?458NKN"R
MB$MQ*L:%@@)_B8G  '<D]A6$T,I^(=O="VF\DZ4\9G\L[0QE4A2WK@$XH\7W
M4MK#IK);,T?VP>9=);&=K4;6&]4 /S'.T'!QNZ&@#4_MK3?L0O#?0+;F3R0[
M. /,SMV<_P 6>,=:?::K8WUQ-!:W44LL'^L13RO)&?ID$9]C7 :=;7;>'O$]
MJ(+Z69]=66,2PL'>,O"0^,#^ZQ.!QWQ6YK&G:G=>*-0>QDF@,NA-!#*$.SSO
M,;'S= PST_VB>U $VL>(@VI:+::5J,0>XU'R9EV;A)&H8R $C&05QQT)K:UK
M5[;0M)N-1N]WE0J3A%)+'L!CUKD+?4([RV\+V5OIU^D^GW<2W4;64BBWQ"Z'
M+8VXR1R"171>,8I9_!VK1PQ/+(UL^U$7+,<= .] %+4O$3VVOZ*T5U&FD3P7
M4UV\JA0JQA &R<$?,^*VH]:TV72UU..]A>R;I.K94G.W ]\\8]>*P;V2'4/&
MOA2\C2X,7V:[D1O*90I98\;\CY<@-[Y KFXX=16PGU#R;V6TL?$MU<R01!A(
MT#%OF0<$@%BV!UYH ](LM0M-1A:6SN(YD5BC%#G:PZ@CL?8UE7VL7,OB./0=
M.\M)Q;_:;FXD0L(H]VT!1D9<G.,G  )P>E/T V-Q+>7]C9W<2W)0O/<AU:8A
M<#"N=P &!G S^%9MW ^B^.)=>DBEDT^[LEMYI(T:0PNC$J2HR=I!QD#@CGK0
M!LVD>K6U\D5Q<QWEHT;LTQB"2(X*[1P<$$%NW&*F@UC3KF]:SAO(7N%W9C#<
MG:<-CUP>#CH>M4I]1.LV%Y;:4)][VT@2Y:-D5),84#<!DY.>.!CGM7-VS'4=
M'\+Z7 )(]5TZ>W:ZC9"&@6(;9=Q[!@"H.?FW<9% '7+K^CO,D*ZM8F620PH@
MN$W,XQE0,\D9''7FI;35M.U 2FRO[6Y$)Q*89E?8??!XZ=Z\\N+9'\%^(8FM
M9LS>(68*8VRX^T1G<H'.-@Z^QKI/+B_X6!JKO$YB;2(EE(0X8AY,C/<[2O ]
M: -E/$&C2.$35K!G,7G!1<(28\9W]?NXYSTJ>VU2PO;-KRUO;:>U7.Z:*560
M8ZY8''%<%ID3+X>^'JO:RB:&X4.3$<QCR9%(;C(^8K^56+FWFDB\9"UMI9/^
M)C;S>6B8,J*L)D"YP&SL<8[GCO0!V5MK&G7@F-O?6\@A7?)AQ\J\X8_[)P<'
MH<4EOKFDW<\4%MJ=E--,GF1QQSJS.O\ > !Y'!Y]JP8KFVUWQ=I=]I9\R*UM
MITNY-I7:&V[(VSWR"=O;'..,XVB030>%/ D;PS1RQWV7'E$E!Y<PY&.!E@,G
MUH [C6;FXL]#OKJU,8G@@>5/-0LN5!." 0>WK7,VGBG5(+'PU?:@+.:#6VAB
MV6\31O"\B;@>7;<HZ'I_2N@\1N$\,ZH3GFUD4  DDE2  !W)(K+\(:/:#PYH
M5[-!(;R*PA0>>[GR6\M5;:K'"'C!P!0!N)JVG27:VB7]JURY8+")E+DK][ S
MGCOZ40ZMIUQYODW]K)Y2;Y-DRG8O/)P>!P>?8UQ\&F&]\*>*%L+<+?R75]Y#
MF/#;F! VDXQN&!D>M.\+)I-U>6%Q"NM&]LK=HF2[CD1+<$ ,IW *>5& ">GM
M0!>T7Q VOM/J%GK-HEM;74B36Y".H@4E0VX$%2VTL"21@].];]MK&F7MK)=6
MNHVD]O$<22Q3*R(>O)!P*X!8[NX^']S-#%=R!-9ENIHX4,<LL/V@N=JGN5(8
M"I;Z/3[KPOXEOM+AU6[FN-.,+RWJ2#<0#A0K $L-V<@$>] '<OK6EQQW$CZE
M9K';,$G8SJ!$QZ!CG@^QI\6IV$]M%<Q7MM)!,P2.595*NQXP#G!/M7'^)4BM
MTT'68X9QIZN7O)K)/WBAXMJ2$ 9.,GGJ :S=0CTV'1+:[T\7OV6XUVTG,]X6
M'FMO&YPK8(&!R2!G!/O0!Z)9:C9:C&\EC>6]TB,49H)0X5O0D'K4=GJ^FZC)
M)'8ZA:73Q?ZQ8)E<I]<'BN+O;.ZFU?QQ:Z2@2X?3[58E3Y<MME) ]R./Q%:%
MM?:3X@M[B71+21-4CT^2W5Q T)MN.(BQ  .[H!TQG@8H Z6WU;3KN\EL[:_M
M9KJ'/FPQS*SI@X.5!R.>*SO%^LW/A[PS=ZM:I%(]N%/ER@D-E@O4$8ZUR?A'
M^R-1ET8^9JKZI8*5^RRQ+']C^7:^XJB@J>F"3G(XZXV_B>RCX>ZHA(W.(U5>
M['S%.!Z\ T 7-4U#7-!TU]1G6TU&" ;[B*WA:&0)_$RY=@<=<<9]:MQ7TEYJ
M6GSVNHVOV">U,OV=E_>R[L%77G@ >W_ULS6_$EEJ&C75CHLB:E?W430Q0P$L
M 6&,NPX0#.<G'2LU+ :;XX\)V0^=[32)87D"]0H0#/Y&@#JQKVCF2XC&JV)>
MV4M.HN$)C ZEAGC'O46F>)M'U>Q6\M-0MVA9_+!,B@AN< C/!(&0#SBN<\,W
M*P:CIEG97=OJFF3PS26\C1A;BS&02K>JDD+T!SZU@)=6\G@SP; '!EMM:MUG
MCQ\T9#/D,.U 'HSWAN;S3WLM2LC:R&3>G#M/@<;"#V/)ZUF^&/$C:I:S#49K
M.*Z6^GMHT0[/,"/M!"LQ)-4-<A@M?'?@V*"*.&-7O#MC4*HS%Z#U)_.N82VM
M)_"NOZ6(8AKLVK3"WC,?[X.TN8WZ9 QD[N@ /- 'JC7=LAF#7$2F%0TH+@>6
M.N6]!P>M9L_BC1K?5[/3)-0@%S>)YD*^8,,.,<Y_BSQZ]JY#49X[#Q'XQBO'
M EOM+@%NH4DS$1RAL >A_*G:6ZV=]\/S<GR1_8SP_.,?.4A 7ZGTH [2QN)M
M^H-<WUG-%%,VSR>#"@'W9#D_,.?2I[34K&_A>:SO+>XB1BKO#*KA2.H)!XKS
MZ10MGXFEMHM\,?B"*:]1$+>9;*(C( .C='R.^#6Q/+9ZCXBDO]-EAFLETJ5;
M]XR&1\E3$#CJ0!)] ?>@#JHK^SGF\F&[@DEV!]B2 MM.,' /3D<^]6:X#2H;
M.WC\ /%'''.\!#E1@L/LI!SZ_,%Z^@KL-*UK3];AFETZY$RPRF&3Y64JXZC!
M /<4 0CQ!ITVM3Z+!>PG4(HPY0L#@G/&,Y)&,D>E5?"GB ZWH5A<7DMJE_<(
MSF&,[<@.RY"DDX^6LB&>TM?BQJ1NGBB>7383"9, MM+EBN?0=:P])"+X0\$R
MQ*HN/[5"E@OS["TH8>N.>?K0!Z0VI6*7Z6+WMNMXXRMN95$C#U"YS5JO*8([
M&XFU+2=8OM7BU,:E),EI!$FZ8^86B>-_+S]W SNX ["O5J "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH ***Q?%FKW.A>&KK4K2.*2:$IA)<[3EU4]/K0!M45R-_K6NV%S::=.MJ;N[
M,TRR6MN\PCAC"\;,@LV7 SD#VSQ3EUW74L]*%S8P0W5U?M:/Y@(#)L=ED5<Y
M&0H^4G/44 =917#S:WXHMK377D?2V;16,DDBQ./M"")9=@7=\AP<;LM]*T/$
M.MZC8E#:/9P1FU:=#,C3/-(.?+5%(;&.2V#U% '07%]:6DL$5Q<Q1/</Y<*N
MX!D;T'J:L5RDGB625/"4ZVD.-8968/\ ,80T)?Y3QSVS52]\6:M;V6O7T=K:
M"#1[LQ.K[R9HP$/!'W6^8\X(Z#'>@#KC?6BWZV)N8A=M&91!O&\IG&['7&>,
MU8K!?5I/^$R@TQ8K8Q2Z<]RDK9$F0ZC ]N<UDVGBG5Y+'1=1G@LOLU]>?8Y8
MTW;U8NZ!E).,94<8]>E ':4V2-)HGBD4,CJ593W!ZBN-UCQ7J-M_;\UE';>7
MHC1AX)48O<!D5C@@C9UP#ALXKKK6226TADF4)(Z!F5>@)'2@!\44<$210QK'
M&@PJ(, #T I]<IXH\2ZAH;W,D45IY-O;>>B2DM+=$$[U0*?E"J.6((^84:GX
MFN8=5M[.W:SM!-:K/%)?AMEP[$_NE8$!6&!UR?F&!Q0!U=%<O=>(KJ/Q*=*#
MV-JZ^44CN]RFZ5L;O*?(&5Y&,$\=LU5O_%FIK?7@TS2Y+J"SE\DHMO(S3L,;
MMKCY4QG R#DCM0!V5%<K;7VM-XLU2-I89+*&S@N([7R")/F\W"YW8W909.,=
M!@8R9O"^NW>M+YDMQITL?E!I(X R36\A_P"6<B,2?7GCITH Z2BJ.L:DFD:1
M<W[HT@A3<(UZNW0*/J2!^-91UC5-,U+3[;6(K1H]1<PQ/:[AY4NTL$;<?F!
M/S #D=.: .CHKFO#NM:QKI2Z:SL;>P5YH9<3L\ID1RH*C:!M^7OSS[<Z>OZC
M+I&A7=_!;/<R0)N$2@DGG&<#G ZG'84 :5%<I+XDN[?P\^J)-INH1+/ BRVK
M$*ZO(J,,9.UAN'<_059N/$-Q;^);[2?LT3B'3?[0B?>5S\Q78W![J3D=CTH
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M9" J'G"D# 8< \D]L<R1ZWIVGZCXFF.EM!)9/#]HFB +73,@* ?[7(&">XH
MZF@\#-8B:W<P:K:6&HV"V[7@?[/)%/YBEE&XHV57#8R1C(X//%9ECXX^UV6C
MW\NFM#8ZG<?94D\X,R2EG4 KCD$IUSWZ4 =8K*P!4@@]"*6A5"C & .E<;9:
MA;:%J'C"\>/]VFH0_(N!N=X80.O RS<GWS0!V=%<[;^*XC_:7VJ&,"PMS<O)
M:3>?&RC.Y0V%PXV\J?44VU\3W$NM:=IUQI@B:_MVN8Y$N-X5 !]X;1AOF' R
M/>@#HZ,USMIXJ,VK6-C=6#6GV_S?LPDD_>Y3)_>1X&S(!(Y/X5@MIL,>G?$6
M15012LZ>6JX (M48G\2] 'H%%<W8ZZ+&;0=*GMG5+ZT7R;G<-A=4!*'T..1Z
MULV-]]N>ZVQ,L4$QA60GB0@#<1[!LK]5- %RBJ.I7\MDL"P6DES+/)Y:XRJ)
MP26=L':O'7!Y(%8Q\9PKH?\ :K64GDQ7OV2YVR*PAP^POD<%0<'/'% '3TAK
M-NM92VEO42WFG-G:_:)!$-S'.=J*.[$*?T]:JZ9XA>]U273KBR-O=+:I=*@E
M#DHQQAN 58'@@\>A- &Y2]JX.]^POX$TE].LOL=K_:=J8X,YV'[4H/<]\_G6
MYJWBE=(>Y>>QF%G:R11R7#,J!B^/N _?QN&<>X&2#0!OT5PGVRZL?B1KSVFG
M37SFPMF:..15Q@OS\QZ^PJSJ6I0ZO=^#-1MDD$4U^Y!D^5D_<2@J5]<@Y^GO
M0!V8HKE[GQQ86TS$QE[5+G[,TJ2*6W[MI(3.XJ&X)^O&*ZB@!,TM<*GD7VL>
M(;K7M/B-OITJ.DYEW-;JD22 *0 1R2W![XYK=B\1,+JQCO=.GM(K_BWE=@PW
MXW!' ^ZQ&<=1P1F@#=HK$TKQ"=7G58-,NTA$DT,TTA0"*2-BI4@,2<XZC(_7
M%_5=3M]'TR:_N=YBB RJ#+,20  /4D@?C0!<HKD;6YN9_B/']HLY;5CH[$JT
M@93^^7'0XR,G/U[U+I>NZ?;Z%I?]F64L:WLLD5O;3RA2&4N6W,6/]UL8)ZC\
M #J:0US5_P"(=1@UO0;*+3&5;]YA-YK@%/+4G'&1SPP.>0/RN6OB%;S4[JQ@
MT^\9[2Y^SSOA J94,'^]DJ01T&?4"@#:HKS;4-2TU_#VAWNFVE['&?$"*(2Y
M+F02/O'WB"#AL#..1TKI9?&=E;1:M]KM+NVN-+A$\UO($+M&1PR$,58=1UZB
M@#I**S)=91-3AT]+>9YKBU>YA;@(P0J"N<Y!^=>V.:YR;Q%!J'PXN=7U_3;A
M;5BXF@MWP^T2E1@A@<C SR.] ';"BLJYUDPWDEG:6,][-#$LLHB9 $!)P,L1
M\Q ) ]N<9%5/^$OL7CTR2WMKRX347>.(Q1C*2(K$HX)!5OE8?@<\<T =!16=
MI.L0ZL;N-8I8+BTF\F>"4KN1MH8'Y21@AA@Y]?2M&@ -)6']KL5\87,"6MXV
MJ+8"0MN/EO%OX"Y;;NW9[#H>:P_!L,.OK+K-Y97*7:W\[QW)FQD"1E5/E;D*
MH P1@X[T =S15+4M233(H7:":9IIEA1(5!)9NF<D #U)K+E\8V,.DW5_+;W*
MBTNA:7$(",\;E@HSAL8^93G/>@#H:3:-V[ STS6"GBE6EU"W.DZBMW9PB<6Q
M6,R3QEF4-& _/*G@X/3UJ:U\1VM[I6E:A;0S21ZDR+$B[=RY!)W<X^4*<X)Z
M=Z -FBBL[4]7CTR2TA,$D\]W(8XHXV122%+'EV Z#US0!H4!0HP !]*X_5[V
M1M>\,WPM+U)";H-:$@.V(F^7;NVDY'!SWZX-:,/BZSGTG[:EK=F079LC:;5\
MT3AL%#\VWWSG&.] &_5>RLQ9I+^^FF>60R/)*P))P!V     P *Y/Q/K*:Q\
M/]?GLA=6]Q9%XI%\P1R12QD$_,I(Z8/!Y''>KM\SK\2-'4.X1]/N=R;CM)#1
MX..F>3S[T =/@;LX&>F:6H+R-9K*>-Q(5>-E(B8JY!'\)&"#Z5Q?A3Q3%:Z%
MX?L[RRU)%NHTA2]EC!C:0]%+9W9)X!(P3WH [NBN=NO&>FVC22.DQLHIQ;R7
MBE/+5]VT]6W$!N"0" <^AKHJ "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S/$.CC7]$GTQIS LQ0E
MU7<1M8-T_"M.B@##\0>'!K<MG=07\]AJ%DS&WN80&*AAAE*G@@X'Y4U_#LDD
M6F"35+F66SNQ=R2R %IFVE2,<!1ACP!BK*:T&\42Z&ULZNEJ+I9MP*NI;;C'
M4'.:N6$\]U9137-HUI,P.Z!G#%.?4<&@#)N/#)N(?$,9OY -97:W[L?N1Y8C
M./7@"H[OPO-/J+WD.K2P-+9+93*(@VY02<KG[I^8^M;\D\44D4;R*KRL5C4G
MEB 20/P!/X5)0!S4/A/9!X<BDOV<:(?D/E >: FQ0>>,#\Z+KPD;G1M=T\Z@
MRC5K@SM(L0S%D*, 9YX0<^]33>)6LH-)>^TNZMI=1NQ:")F1O*<YQN(;H0I/
M&?PK?H QSH0?Q-;:VUTQ>"S:U$>T8;<P8L3^ XK/7P<@T?1M/-^Y.F7XO1+Y
M8S(P9S@C/ ^<_E73TR*:*X3S(9%D3<5W*<C()!'X$$?A0!P%XJ7'B'4+J?5X
M+*ZAN-L%O>:8LK84 (R'AG!.6&#WKN=.>YDTVW>[*&X9 7*(5!/KM/(SZ'IT
MJU5%-4B;7)-)\J431VZW&\@;"I8J,<YSD'MVH Q=7\*WFH7FJ36VLFUCU&U%
MM*C6PD*  @;26X'S'(QSGJ*DU#PYJ&H:>VGRZG:O926:6\D,UCO^< @R*=XP
M3Q@'."!7244 <SJ'A>ZU*,VEQJ4,FGK+%)"DEINF@V!?NR[QR2I.2I(W&D?P
MK=PZQ>76G:W-9V=^XDNK58@Q+X +1OG*$@<G!]>N,=(94$JQ%U$C LJ9Y(&,
MD#T&1^8IQ.!0!D-HMPNMW.H6]_Y27%FEL\9BW,"A<JX?=U_>'@@YQ45EX?GB
MU]=9O;N":Z6U-MF"V,.\$@Y?YVW$8XZ8R:M:'K<.NVD]Q!%)&L-Q);LLF,[D
M.#T)[T+K<+>)WT(PRB=;078D.-A3?MP.<YS[4 3ZKID&L:3<Z=<Y\FXC*,5Z
MCT(]P>:HPZ-=RSZ;-JE_'=O89=#';^5OD*E=[?,?X2W P,DGTQM4UW6-&=V"
MHHRS,< #U- &5X;T630=+:SENEN2UQ+-YBQ>7]]RY&-QZ$GFKU_#=3V;QV5T
MMK<$@I*T7F 8()RN1G(R.HZU9HH XZ;P-]KL];#W<=K=:J\4A:UB(2)HV#*V
MTMRQ(R3QGIVS5T^&;R76Y]6GU.)[B;3#8%4M2J#YV8/C>3QG&,]NM;D]Y% L
MX!\R6&/S6A1AOV\XX)'7!QGT-,TS4(=6TJTU&W#B&ZB69 XPP5AD9]^: .3\
M2V;>'_A<FG?:E+6RVMN+GRPH!$J*'*YQQUQG\:W+31[EM:_M;49X);F*W-O;
M^3$55 3EV.2>6(7CL!U.:V6174JZAE/8C(JGK&J0:)I-QJ5RLK0P %Q$N6P2
M!P/QH Q(?"5Q!H&C6*ZE&UWI5QYT=RUK\K_?&TH''\+X^]VS5F'0]4MKK5+N
M'5X?.OI8)0#:?*FQ0K+]_)#!1W^7WKH** ,70M".DW6HW;&%9+^59&AMT*QH
M0N.!W)Y)/'7VS4GB329M<T*XTV&X2W:?:#*Z%]H!!^[D9/'J*FLM9MK_ %34
MM.B643Z>R+-O7 )==PQSSQ1<:S;6NMV6DR"3[1>)(\1"_+A,;LGUY% %75](
MO;O4],U&QNH(KBS\Q")XBZ.D@ ;@$'(VC'/K69<^#9KC2I[ ZBFV;5CJ)?R#
ME5\SS-F-W)SQGT/2NMHH YO5/"@UG4-5EN[H?9KZP2R$21X9 K,P?=GDY<\8
M["HH?#>K3:MHM_J6K6T\FE&4*8[4J9P\80EB7(![\#%=310!S<?AZ[EUS3]4
MO9K4W-F9 ;F",I)<(P(".,XP,@]^5&,<UOW%O'=VTMO,NZ*5"CKZJ1@BF7U[
M;Z;8SWMW(([>%"[N1G '\ZBLM1-W/+"]E=VSQ@-^_C 5@>A# D'ITSD=P* ,
M>W\-WG]E:;I-Y>136EA-'(L@C*O*L1!C4C.!@A<D$YQT&:NZ;I5S::_K&HS2
MQ-'>F+RXT4Y0(I7DGKG-6M5U6WT?3Y+VX$C0HRJWE)O.20HX'N15W- %75+$
M:EI%[8%]@N8'AWXSMW*1G]:RXM$OM_AYYKBW8Z8&\[:A'F$QF,;>>.I/-;]0
M7M[;Z?:275U*(X4^\Q]S@ #J23@ #DDT <W>>$[N\L=107Z6]U+J0U"TFC0G
MR64* &!(W<*0?K6UI<.JQK(VJW=M,[;0B6\)1%QG)Y)))S].![TS^WK99XHI
MX;JV\Z01PO- RK(QZ#/8_P"]BM2@#.UO1X=<TN2RF=XR2'BF3[T4BG*NON"
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M.[.,9QNYVYV@\@<5-+H-E,NJ!A)_Q-%"W)#GY@$V8'I\O'% %RRG:YT^VN'
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ME:UC:/#R_++G',@  8C'!^OK6A0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"NHM3NX8KV<-:B%2HN#M)V/E3A<9.#CI[5G>-_%$5EX=UB*QN+M+V"/9Y]O
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M(>+CY'!'S#(!]<\U%=>$;:ZM[=&N[A98M0347G 7=+*O3/& .@P!T H @O\
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M'1L#CG>KC]9\.ZEK.II))!IL/DW*26^HPRNES'&I!*%0N&S@C[X'(..*["@
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M>]<;XF9D\3>%'@&)&O9$..\9C.?PX!K;UFYU6WCC.FZ9'?%L[U:Y$6WTY(-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKD8JK%H6JVT4D=O>Z;%')RRK8<$^I^?G\:FD\8^'X_,WZG$!%,8)&VMMC<$
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M:9H]]I=Y^XNM0M4WH 1)$[@$<CC(/L:  Z'JS7$<[7FFF6,81S9$L@/4 [N
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MDD\DFI8Y4FC62)U=&&0RG(/XT^@#%M_">C6DEF\-M(ILG+VV;F4B$D$$*"V
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44QPYQL..>:?0
M4444 %%%% !6)XIMKB[TZUCMK9KAEU"UE=5(X1)E=CR1V4UMT4 <UK<.H7&M
MP1"RN9=-:V<,]K*L;F7/"NVY6"8Y^4\GK6%8:1JMHG@>>339LZ7%/#=QJR%D
M+1[0?O<C(]<UZ%10!YQJ^F:WJ,]K)-I-VT]MK4=S^YD18!;I)D,%W_,Q7!)(
MSG/08J_Y-]I^O^*\Z7=7 U7RS:&- 4?$(0AFZ)@_WL<=,UW%% '&VFBWFE7W
M@RU\J2XCL;6:WN+A>51C$N,]\$J0./04T:-<1>-KFTMRATB\\O4;J,M@I,IP
M !Z.50G/]QO6NQEC66)XWSM=2IP2#@^XY%4-'T.RT.!XK-927(+R32M([XZ9
M9B3@>G2@!;/56NM6O;!K"\@^S;2)Y4 CF!_N'/.*H>*X+B==&6WMI9RNJV\C
M^6,[$4DECZ 8_45MQ6T,,LLL: 22D%VZEL<#_P#54M '#?8KQ=1\?S_8KADN
MH8Q;XC.9RMOM(3UYXKJM#BD@\/Z;#*C))':Q*ZL,%2$ (-7Z* /-K"5+G3/&
MNDPV-S/<W6J7,2XA9HRSHJ@EL;5QP3D\=>]2^(+749;?Q!IPTZ[;=IB16S6D
M6!=,(SDO(.3@\!,C(SP<UV>DZ-;Z-]N-N\KF]NGNY3(0?G8 '& ,#Y16C0!R
MMK')+XYM;HV=VD:Z-Y9DDB(C5C(IV@]FP.1[#TJO%'<VT7C2)[&[9II7F@V1
M$B96MT4!#T)RI&*[*B@#@X3?P?\ ",V\FF7L< TP)+<06P,R2X0>46/,:GG)
MXY Y&#B"TM+R/P+X;M?L&H>=;ZG;F:.2(EXU67<S'_9 Z'Z5Z'10!5U JNFW
M3- ]PHA<F&,?-(,'Y1[GI7$6\NI6FFZI::5#>:II\.GMY%OJ=HRNLO0198 R
M*5SQR> ,\UZ#10!Q>B/<?\)+8226>HB)M.:'SIK7RU5]RMMP -@ ! R!VP36
M9=VE[<_"JSTV/3KP7L$EM$\+0,&RDB%B..5P#R.*]'HH X;7FO;77+BZT1=1
MCU,R0QM"]N\EI>)A><XPA 8C=D?=.<UIQI>#X@ZC<?8I3!_9<4<4N,)(RN[%
M=W3/SBNFHH \RT=+E]3\)S3:5?6\EK-<1S0I9F."TW1,-J@#E<X^;D=>1TK9
M\-375M966@ZIH-S)>6,F/M7D+]G;!.)E<]\'/3.217:44 <)I]O=I:^.-/DM
M;D33W%Q-;@Q-MD1XE"[6Q@DD'@'-+I_VS2+CP]J%W:W)L5T=;*55MW>2WF^0
M\H 6 .W!..JC-=U10!Y[?:>S6-[<"UNA:ZEKMI/%"L+[U16CWN5QE02CMR!U
M&>M;EBDW_"P]8E\J86YL;9-Y0A&<-(2 >A(##IZUTU% '-^)%NH-8T+4U6:6
MQLYI?M4<,9=AOC**^T<D DYQG[V>U1Q1E=5\0:PJ2BSEM8X@HB;=))&'W,%Q
MD\,J@XYV\9&*ZBB@##\&H\7@K18I8I(I8[*)'21"K*P4 @@\CD5$KF'X@7&^
M*;9<:; D<@B8H6228L"P& <,.I'6NAHH \^MDN7\)^%%2WNDE75(V=#;MN10
M[[BP(RHQW/K5:+38AK&KZ7K]EK5P+W4&G@-NTIMIHV(VAMAVJ5P =V.@KTJB
M@"IJ;M%I-XZ6WVED@<K!_P ]2%/R_CT_&N/T3S9M?\/7!CNPG]G3Q,ALFAAM
MV_=8C4%<@?*WWB<XX-=W24 >:VL]KJW@JUTRQ#M?R:@6MR(#^ZVW1?S,D8"A
M0>>A^[U-:3W>F6NM>+HKRU:4S-"IC2 NT^8%&P8')SGCMG-=5I&F)H^FI91S
M23*KN^^3&XEG+'H .K&BRTQ+*^U"[$TDCWLJR.'QA=JA0!@=, =<T <[86EU
M8:KX2L[F.5YK72Y89Y51F0/MB'+8QSL:LV2WG?2-7N[2TN)EB\0B\EB5&#7$
M:&/.P'[_  H(QP2O'->A4HH Y&_U2TOM'O[VQT>XD<O DK7-A(I<;Q\VP@/(
M$!W8'T!ZXQ[B"XNK3QG#&;^[FO-,C:#SK8H9?W;K\H"CG/&.M>BT4 <=:K8Z
MAK/AQ]+MMHL8G:9UB*"*,Q%!$>.#N93M[;#6#!;7UCI$5W+87SP6WB*YGFAA
MB/F^6Q=5D48RP!8'CKU[5ZA10!A^'8["0WNH64-]&UW*&E:\21&D95"@A7P0
M, #H.E5]7RWC?PV CD*EV68*<#Y%')[5TE% 'F"Q3QZ+X@F:QGN;5?$[3SP(
MA)E@!CR0/X@",\==IK;MKV'5O&MY+9K(T;Z*BH9(FCW?O7Z!@#CWKM*S$TG;
MXEFU@W!;S+1+80[!A0K%LY[YW4 </I;[]-\"6ZQ72RV$XBNE:!V,3^3(A#<<
M#=Q[ @\#%)/;7+0>-#!:23(=4@D>%$.9HE\LRJ!_%E0PP.M>F44 <2-1MKOQ
MO'>V-M// FBS+OC@8!CYB,(P<=< \=LUEZ)<1/K?A28>:B_9I4$"6Q6*UW(,
M1;R"Q?CG+<XS@9KTFEH \OM5"_!_6].E!%U";I'B*DL&:5RN!WSP1BNB6XAT
MKQ?++J;K'9W&G0QVMQ-Q&"C-YB9/W2=R''?'M7744 >=65J]I:Z*DD;"&;Q!
M-/9Q^40(K=O-V#I\H((.#C[P':N@\-+&GB#Q.L4;HAO4;# @$^4@)'MD'\JZ
M6B@#D/$QTZ+QIX=EU(PI"(+L;I@-F<1XW$\ <G\:YN\ME@TVZN+) =.O/$MM
M+;((LJ$!0O(AQP"RMR.,#C@UZ!<:7)<>(+'4_M(5+6&6+R?+SOW[<G=GC[B]
MO6M.@#A?$44.C^)M+NW2>STD031^;8P!O*G9E.YE"G&Y01D#\>:;<PZ=9>&+
M"6Q%V]K+K$%P#/&=[9F!8JF 57@G&!ZXKO** .!UV2WT_P ;32ZI+?V]G=V*
M103V\7F1_*S;XV&QL$Y!J>TTS3H/$V@V4=O-);1:3.B"Y4LP!DB*A\^P; /I
M[5V])0!YY=/IXU/7=$UK[?"MW,IA^SVNY9XBBA51E0D%2N.V#TJ_;V]JGC;7
MA*L;01Z7;*[3GC@29W-Z[2,GK@^]=K10!YKI=ZNB0>%+[6(V333I(MA,ZEA!
M.=I^8=LJ,;L<8QWJW?3:;HY\-7D$%Y9Z&GVE PBSY+.05=E?)52!)SC@-VS7
M?TE '-:5J6AZ/8Q!+F>."_OG6!KA"/-E=LG:,?*I.<< 5H>)YX[;PMJLTUO)
M<1+:2;X8R5+C:01D<CZCI5ZXM5NFBWR2!$<.44X#D<C=WP#SC//?(XJQ0!YM
MIU[;CQ3)%Y]E+9R^',L;:/$7R.0%4]6PK'/?V'2BVL[.:X^'2RVT#O+8L) R
M EU%J"-WJ 0.O?%>DTE 'FJ%U\,>(%MHB]G!X@/FQ0*,?9@\;2J .HQNR/K6
MO>FUN?%4%WIEQ!]D_LRX_M*6 AE*?+Y62."<[R,]@U=I24 >7Z9':VVE?#NX
M6/;.TPC$P 4E3$XPW&3G@8S3[T:+=G4-'N]8TV)I-;^TR/-)LE0*02N&'7Y=
M@.<;3GVKTVN?M]$U:V5[1=7BDT]W9BLUIOFPQ)*[]VT]>I4T =  I48P5(_#
M%>::=-;_ /" ^$462,-'JEM%(H(RL@<DJ1V;VZUZ6JA$"J % P .U+0!YOJ\
M2PS>-[>PC92J63R0VBC<5Q\^%Z$E >.];GA?^Q;W49-2TS5I[Z;[*D3J41%1
M,Y4,$11N&",'D GIFNLHH Y7Q6%?7_"D; -NU!\J><CR),\>G/ZUSUR)X;/Q
M)#;QA;"#7('N8HTX%MMB:4 #MC)/MFO2J* .3@2UD\;6$^A-:_9OL<WV\VV"
MK E/)SMXW9WD>P:L&*[MK7PWX>FN"/[&.J7'VU@ 8^7EV%_]G?M)/3@&O2$B
MCB7;&BHN<X48%*R*ZE74,I&"",@T >;7CP.GC8>'2N]8[5G%E@$C!\S;CC.P
M,.._O4D7_"-W.GZE>:1JKW<AT::.6-$B2,)C(\Q41<,,X&?]KCK7HRJJ*%50
MJ@8  P!3?)BV,GEIM<DL-HP2?6@#SZQTC37^'>BSQW%K8WEQ;6A^U2H&2:15
M#*DN?O+G(P3QQCH*W?!5XEU97ZBQM[6:&\9)S:-N@ED"KEXSZ$8R.QSWYKI#
M#$8O*,2&/^YM&/RI4C2) D:*BCHJC % ')N;23QUJD.MI;F$V4)LA<@;2@W^
M;MSQG.W/?&.U<O<VT:>&O":W0WQ_\)"B6[7/+FV\R3RP2>2-NW\,5ZG)#%,H
M66-'4'.&4&D>"*1E9XD9E^Z64''TH #%&8O*,:F/;MV8XQTQCTKRJUNM-/PN
MT=;:6V65=1M4F5"H8.+C.&'7. 3SVYKUFHOLT!!!@CP6W$;!R?7ZT ><ZS'-
M877C6T\/VR12_P!FV\JQ6J;3O)D#$!<?-M_'I6IX7_L&ZU>VO]+U7[3.UH4,
M-K$L:+'D']ZJCA@>!N(/7 ZUVJQ1J[.J*';[S <GZT)%''NV(J[CD[1C)]:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "H[BXBM;>2XGD$<4:EG8] !4E(0",$9H HVNLV-Y>M
M9122+<K'YOE2PO&Q3.-P# 9&>.*OUSRS7,/CGR[JW@9+BT;[)-'G<BHR[U8'
MU+*<CT%=#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %17, NK=
MX6>5 XQNB<HP^A'(J6B@"G:Z9!:W#7&Z66X9-GFS.68+G.T>@SSQU_ 5<HHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
1BB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>exhibit1061-loanandsecur025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur025.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD=%R0&P,;L_A6Q:V&IP:_=W4FIB33)(E6"R\H#R6 &3NZG.#P?7VH U:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMJ7CF.XU%;6W:2V5F5=WDLT*C>1T.3@'/]TYK*U"^G.GZ@GE6XCL[VT:_O\
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M7&1%WPPSP3CTSWI[ZU?RVNL7>E1VBV^ES2Q&"2)MT[(H9_F! 7)) X;U[XH
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MY"HZS*O0D."-P'&<=*LP^'5MM;M]2@NY1Y&G_84BD^<8W!MQ)Y)X&?7%;5%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%% !1110 4444 %%%% !1110 445!;WMI>-*MM=0SF%MD@BD#;&]#CH?8T
M3T5 ]Y;1WD=H\\:W$JL\<1;#,JXR0.^,C\ZGH **@M;VUOHVDM+F&X16*%HI
M X##J,CO[5/0 457NKVUL_*^TW$4)FD6*,.P&]R<!1ZD^E6* "BBB@ HJN]_
M:1WT=B]S$+N1"Z0%QO91U..N/>K% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;>1$R+E\!G8%CDD <=!SR>U&U\'/;:+X>T[[>K#2+I;EG\G'G8#C &[Y?O\
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M&ZC@^56D)W(4+'*X)'6NBTJPN[-99+_4'O;F9@68)LC0 8 1,G:.YY))[],
M%2YU74VUV[TNSM+9FAM8[F.269@&W,RD$!>#\AQC-9VG^*K^X@T*]NK&V@L]
M6=8DVSEI$=HV<$C;C!*$=<\CW V5TN=/$ESJPNEV2V:6RPF+[I5F8,6SS]\\
M8'UK+@\)2Q:/X=T]]0#_ -CW"3F3R<&7:K*% W?+PWOTH AUOQ7>:-J 66"V
M$!O(K=(&?,TL;E09A@_*H8D8(YQU&:J_VIKS>)O%L$-Q:^386T)A$B-A"4=Q
M\H/))ZG(Z#BI[WP9?3QZG#!J\,<5[>I>[I;0R2!E=&"EMXR@V8  &!@9]=&+
MPY-'KVL7_P!MC,&JP1QS0^2=RE$*@JV[&.2<$'ZT 8=AXJO++PWX9AN"TVH:
ME;>:\SPR2E%502Q1 68G<!V'/45?7Q5J3:;93_V.1-/J!L2DI>+/7;(H9<[3
MC/(!'/6H8O!=_!I>CQPZTD.HZ0#';74=K\K1%5!21"YW9QU!';CBM"]\.ZA>
MVVGK)JX:XMKY+V65X#ARO\"*&&Q?Q/X\T 4[CQ)JUI>6VG7L>G6=_);-,#*[
M&"=PY B1^,' !).?O=#761F1H4+J$D*@L.H!Q6)X@T:]UE)K7SK%]/GA$;V]
MS;%RC9/[Q6##G!'!'49R*V+2V6SLH+5&=UAC6,,YRQ &,D^O% '*Z?XLOKWP
MOHFL?98 UY>K;7" D!5:4Q;E]\@'!]33I/$6O3ZUKFG:=I=E*VEB-AYERRF7
M>FY0!MP#^./K4T?A2ZCMH[/^U%^QPZDM]"BVP#8\TRF-FW<C)X( (QWZ5D6<
M.JW/C[Q>FE7UI; _9$D>6 RLO[DX*X8 $>A!_P 0#7L?%+Z\;"'25BBFN;(7
MTC7 +B)"=H7:I!+;LCJ ,=^E53XUN%M+,FPC%T=872;R,RD"-R<;D.WYE(P1
MG'!J]'X373KW3[S2+H6\UI9BQ<31F1)H1R,@%<,&YR/4\<U!=>#YKBVLE_M!
M!<1ZHFJ7$IM\B613]U5##:N,#J3@#J<F@"]HFMW5_JVK:7>V\,5SIS19:!RR
M.LB[AU (/!I^J:S<:;K^D6C01FROW>$SEB&CE"EE&.^[&/PHTW0Y;#Q)K.K/
M=)(NH^2!$(BIC\M2H^;<<YSZ"I]?T9-=TIK)IWMW$B2Q3Q_?B=6#!E]^/UH
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M$S&(8DVF'R\[<8^7.-V><YK4:PAF^)4<KO=*QTOS2HNI%&[S5XP&Z?[/0^E
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M'E,R*9"J>8%.W)55^49YP,=1LR6OB*#3;ZTANX[B=)X[A+1+QFF%N<AH_.8
M_,5;#<'J,\ T =I39)$AB>21@J("S,>@ ZFL/PIJ-OJ%E=>3+>[XK@I);WV?
M-MC@?NR3G([@Y/7J:9XHN)95MM)M[6:[>[;=/%"5!\A2"W+,  Q*KUZ,<=*
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M;A0$P ,9 Q@&@#NJ*X017DOB"Y\/+JEVYLK*-X&N+TQR3%V?=(3& 7VX5<'
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MIY99TUR*U,L4K1B4+<F/?A2!DA0<CIGC%>B11K#$D2EBJ *"[ECQZDY)/N:
M',Q520I8@9VCJ?SK/\/ZU#XAT*UU6WCDCBN5+*DF-P )'./I7/Z3=7-IXAAL
MM774(;R:2;R9OM#36UVN"W SB-@!G;@=.IKF_#$EQIOA'P5>VU[.AN;Q;26!
MI"8GC8RYPG3=P#GVH ]6K,BUJ.77+[2A;S":T@CG+';MD#YQMYSU4CG%<O>W
M=XFHB\MKZ[E5=9AMGE,A2$(SK&T*Q\A\9.6P#GH>,5LVTF[XA:DN\';IEL,
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MN2PWY\J4A"WJ P3/7\:UO"KW"7FOV<UU-<16NH;(#,Y=D1HHWV[B23@L>IH
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M83*N\@+G( 7W8YS@<X'TJIX9\1QZAI%H=1OK0:A-),@CR(V<+*Z A"<]%]Z
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MR./O?,H *^G&?<T ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,.@)]JO7^M^5=_8+.QN;^Y,2RRQP,J>7&Q(#%F8#)P< '/!KG+SPIJMSX?\
M%]BJPB75;MIK8F3@J0@^;CC[OZUJFQUG3_$<VI6<$%U;7=I''+ TOEM'+'G:
M0<$$$,0?I0!#\-IY+CP+92RO*SF6?F5BS8\YP 2?0<5I:5XA.K1QSPZ=="UF
MB:6";*$.!@8.&^5B3P#Z'.,8J#P;I-]H?A*WL+Q8A>(TSL$;<N6D9AS_ ,"%
M4M#T.[M=;BOETX:67B<7\,,X:WGD.-K(@Z$'.20IYQSUH NP>,M.N-,T;4$A
MNOL^K3BW@)5<JYW8W#=P/E/3-/NO%=M;>;,EM<3V-O/]GN+J)05C?(&-OWF
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M/H='PU9:AI_AVRM=4N3<WL:8DD+;CU) )_BP,#/?&: -6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "L_4M9L=*V_:I'WLK,L<43RN57JVU 3@9&3C R*YF[\1:K!X9E\5I/ U
MDC>9]@\KDQ!]I'F9SOQSTQGCWJ.XBO9?BQ9M'?E$;2GD53"#A/-3*?CZT =K
M;7$-W;17%O(LD,J!T=>C*1D$5 VI6BZJFF&8?;'B,RQ8/* @$YZ=2*Y_XD37
M=MX&OIK.Z:W=3&KE5!W(SA"O/3[W4>E5KRWOAXZTZ!+]/MG]D7(%R\ (!\V/
MG8".WO0!VF*6N%M_%NI76D:5"D>[4+R:YB:6&-3\L#$,RHS $M@<9XR>N,5T
M7AVZU:ZLYO[7M##(DQ6)V"J9H^S%0S;3U&,]L\9Q0!?O;^TT^-9+N=(E9MJ[
MCRQ] .I/L*BL]8T^_G:WMKN-YT7>T.<.JYQDJ>0/?%<[9,EU\5-6^T29ELK"
M%+6,@\(Y)=AVSG:#^'I6]JAMM/AN-;DB9Y;.TE/RG!9,!R/_ !P8].?6@#2H
MKDIM6UK2IM&N;Z>UGM=2N$MY88X2I@>0$J4;/S '@Y'OQTK'NO%GB&'1M6U?
MS+#R=*U5K,P"!@;A!(J<L6.P_-G@&@#T6BN6M=3UA/%=]H5Q<6LKM8"^MY1
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M.&W#;@-GH: /4*IOJ=FFJQZ8TX%Y)$94BP<E <$^G>N3\7>)-5T5]1FMKFV
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MFHZ;IBWEI-']F_M^>"XA:,$LLEZZ9W9XQN'04 =W52XU&TM;ZSLII@EQ>%Q
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ME_K6J)IVF3)9.-.COFD>+S,F3(5,=@,9)_R0#J(H8X(DBAC2.) %5$& H'0
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M&[!,:?Q.<* O\^Y)XMU5?#&L7,<D?VK3-12V,DUL5\V-F0#Y,C:V''7TZ<\
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M4UQ"/MUI.UP5BY65%4Y!SC&6Z8[>_ !NZKK%CHMJMSJ$QBB9UC#!&;YF. .
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MLT,C7UM';R"5U14DWAD!^5L^I':K= '.WGA-)M1O;NSU.]T_[>@6\CM]A$I
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MQR1Q2[+FQ"XP8\=B""1P3GN.*W?&=Y+:Z39LDC16TM_!%=R*2I2%F^;D=,\
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M6IV_B/2K)OLFNP_98HR",W.T-&Y&> 3O4G X3.>17I44,<$2Q0QI'&@PJ(N
MH] !2);0)%%$L,8CAQY:A1A,# QZ<4 <C):C3?'/ABR@G=88].N(RA<XD"[
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MFPH;^)07VGC).,G'6O1$L+2.S-HEK ML0085C 0@]?EZ4DVGV=S;I;SVEO+
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MF\:I;[-L;9).,2?<_.L"WB-]8SSKX>U*VO1831R->322%"R_<CW$[\D#D8X
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M6$\L-Q.ZM"H:8K"[K$#T+LH(7UY(XYJ"X\36L'B&ST@13R/<PM,)8X790 5
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MN%1U+[B6P<@>6V..>.E7]#UJYU2[U*VN;!;5K"?R&99O,#G:&R/E'&UE/XT
M6+31K>SUO4-5225KB^6-9 Q&U0@(7: /<]2:T161<ZQ,=7DTO3K6*XNH85FG
M,TQB1%8D*,A6R3M;C'0=:S#XS)LK2>#2Y)I);]M.G@$H#0S D8YX8<=>..:
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MP0^T?+@Y)QP >#0?$&I6]W<:9>65O%J(M)+NWDCD9X)%4@$'(# C(R._J,\
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MZC>>&.6.)Y8UDESY:,P!?'7 [XKF]4\726 M6ATTW,=UJ8TZ$B;:6.#E_N]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG;"T0*&\N&,!AUZL?G8]!V'O7444 4-$LIM-T.QL)V1WM8$AWIG#!1M!YZ9
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MXF;.V-L_*%&>6_\ K5M>(M,N=8T2>RM;E8)9"IRZ[E=0P)1@/X6 (/L:U:*
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M38XTB39&BHHR<*,#GF@!V*Y!_ 5I)::[ 9C_ ,3"5I+<_P#/J3M?*^_FC=^
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M\2 Q0-=2[BJ]0H/8$@9/4X&2<"@#D]$U36-2N-#*ZC=&YF>;^UK8QQXMPN>
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M+?58)O/E35)/,N=TA!)P!@%<8&% JP-&MQK46JF6X:XBMC;*#)E=A()R.Y)
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MP02RETBD;.6 /.?F;&3@9XQ5&+P#HL+VC1M?JMG+YMM']LDV1'T5<X Y/YT
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M=O%Y*-%*R#R\YVE0<$9 X-0KX8TY9Y'43""2;SWM1*?):3.=VSZ\XZ$\D9H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUCQ/X6_LN6^M1<27 F>3851%'1%')/U)_P   4H=6TOP;=RZ19V]M'?RV_\
M:%W'-?>7"KG *H6!^8G.  !CGBKMQ\0K2.V\/75O933P:W)Y41# -&V0""._
M)]>U-NO"6K0^+K?Q'I%]:0SFT6VN[>9&,<@'H1R.@_*I-<\*ZIJ]_P"'+EK^
MW=]+N?M$SNA4RG()"J. ,# R?KGK0 :OXWGT+3;6\U'0KF+S[_[&(A*&?OAP
M .0<'C@]/6GZAXU.D1(-2TQK.>>^%I;+-.H20<?O2X!VH,\\&I/&WAJ]\30:
M9%:3V\0L[Q+MC+GYMH.%&![FI/%_AFYU]-/N-/O5M-1TZX$]O(Z;T)[@C\OR
MH SV^(MF-(DN5MA+=KJ TY8(I@R22GH5DQRF.<X_"LS16D_X7AJJR0+ W]DA
MF5&RK,6CRP.!GKC) /%;/B#PMJGB'1X%N;ZV34K:\CN[=DB(BC*C&WGDYY.3
M^5.TWPOJ4'CJ\\37=Y;,;BS%L+>)&PGW3]X]>5]._:@#K:X_Q\(D30)WMO.9
M-6A7:J!F92&RH^N!Q[5TVGK>K8Q#47@>[P?,:!2J$YXP"2>F*S?$6DWFK2Z4
M;9X%2SO8[N3S206V9PHP.^3S0!2CO=(TRTO]>72;FQ-L/L[QF#RVE^Z5PHX.
M2P /UJZ-;N[?5+;3]0L8H9;Q'-LT-QYBNR+N*-E5P<9/<<&K6O:0NN:)=::T
MS0^<HVRIU1@0RG\" :I+I>HW6H:??:BUHTVGQN8Q$6Q)*R[2QR/E&,\#/7KQ
MR )X9\0W7B.TAOO[*:ULIHBZ2M.K$L&*[=H&>V<U>UW5DT329+^1 RHR+\S;
M57<P7+-@X49R3@X -5_">D7&@^&;/2[J9)I;<,ID3.""Q(Z^@('X5?U&.[EL
MREGY!E++E9P=C+D;E.,]1D4 4'UJ>WL8Y;FSB$\\ZP6R0W =)RP!#!\# ^]U
M&?E/!XRZRUIY=;ET>]M1;WJ0"Y3RY/,CDC)VY#$ Y!X((]*PK?P5/!I\JV\E
MM93KJ2ZA:0Q;I(;<A0I09 X8;^@&-W XK;M-)N'\0'6[\0)<+:BUCBA8NJJ6
MW,=Q )).!TZ#WH /&"*_@K70ZAA_9\YP1GD1DBJ&D:M)#I&A:9901W%\^F13
ME))?+1(PJC)(#'DG  ![]*VM;L9-3T'4-/B95DNK:2!6?HI92N3],UB0^'-1
MT^71[ZREMI+RSL5L+F*5F6.:,8.0P!*D,,]#G.* '#QE&4MP;&03-J?]F3QE
MQ^YEQG.?XE(P0>.#VIP\7+;6FN2ZG9&WET?:TR0R>:'5EW*5)"\D=B.*@F\*
MW<HM9C/!]I.KIJ=T<G:=J[0B<=E"C)ZXSWJ#7M/FTJV\5ZH\]OY6I1P)&'C#
M",A1$=X;Y=N2#[#- &I9:]>SZ]#I=SIT47FVANUECN2XV9"XP4!SDCV]ZW+B
M;[/;2S>7))Y:%]D:[F; S@#N?:N-T%C8ZU;1!]'N6N%,.^VNY)9HHT5F &_=
M\F>,9 RPZUUNHV\UUIEW;V\Q@FEA=(Y1U1BI ;\#S0!AZ9XK^V:S%I=W:Q6U
MS-:FY2-;CS'3!&4D7:"C@$''(Z\\58T'7YM<2&=+6#['-"9%F@NO-V-\O[MQ
MM&UL$\<]#6=IWAS5M/N+.6*33HA;V$MH%C5_O,5829/4ED!.?4\FIM)\.WEM
MXC&KS1V-H[6[17*V3-B[<D$.ZD  C!QU/S'F@#?O[HV.GW%TMO-<-$A80PKN
M=R.@ ]36!:^+FDN]2M+BSA%S96?VPI;70E&.<HQVKM<$=,=ZUM>L+K4]!O;&
MRO#9W,\91)P.4/\ ]?I^-8$'A.^CU:[NMVGP6]QI?V!;>W1E6'!8@CU'S'L/
M\0"Q:>+Y+FXT$-IP2WUJ+?;R"?+*PC\PAEV\#'&03]*DB\6%K'79);!HKS2I
M3$;7S-QF)4&,J0.CD@#BJMMX4OX+?PE&;FU+:+D2N%;,B^7LPOX'G/H*2.WT
MS7_&=OJ>F7B3PPV_^F>0X*2.K9A#8ZLIWG'48&>U '6QES$AD4*Y +*IR >X
M!XS6'+X@N&UJYT^SL8K@VTD:2J;D)+M8*3(J%<,@#==PY##MSOUR>O\ AF^U
MVZC\W[$H@NXY[6^4E;BV12I90 N&SAAR0.1P<4 8]MJ<OA_5O&VH06,<\%O=
MQRSKYOED+Y*EBORG<W4XXSZUO:WXL;2K:2[CL5DM([,7;33S^2K YQ&GRG=(
M0"=O'4>M5KKPG>W%KXLC$\ ?6R!%G.(QL"9;CK@9XJ"^\'ZG=22D7-E(LNE"
MQ07",WV9MI5VC'<-QG.#P.PQ0!>G\67#7]E96&DFYFO;#[;!ON!&",KE3P<?
M>Z\U5OO'D=I+=%+2.:*TF$$R"X_?EN VR/:=VTGU&<''O8T_PW?VVM:-?3S6
MQ6PTTV3JA;+,=OS#(Z?*/SJ+_A'/$%EJ>I'2=9MXM/U"4S,D\!>2WD;&XQD$
M YQQGI[]P#1_X2"2;7)].M+:"4V[1"57N-DNUPIWJFWE0&ZY'(([<[U<CK?A
MB^UJX1)A8[(9TEMKX,Z7-NJ[<@8'S$X;G<.HXXKKJ .8NO%<Z:??ZI::9]IT
MRQDD2203[9'$9(D9$VX(!!ZL,X/MFAJM]<W_ (U\/QVL5I<VCVD]U"LD[*'R
MJ .?D(X#,!UZGI4P\+ZI:V&J:-:7-JVE:@TI#2[O-MEESO51R'Y)(R1C/>KA
M\/W,7B/1;NT:W2QTVU>UV/GS&5@H'..VP?K0!M6&GVFEV4=G8P)!;1YV1H,!
M<DDX_$FO.[\V>EWVL:?XLTTI:ZE<R/;:V$#JH?[BLW)0IP!VXZ=SZ=7,WVC:
MW>Z9J6E2W-E/:WAF"S2JV^))&8A=O(8J#@'(Z#TH -2\4_8;PZ?9Q1WUS%;+
M/(S.R@[LA0-B/R=I/.!C'K4<OBR[DGTR"RT26274;.2YC2XE\DHR;=R."I*_
M>'/KCZU!-X3U33=2M;WPWJ5O;%;2*SN(KN$R)*L8(1^"#N )'6K@T'4QXDT?
M4'OXYH;*WFBF+@[Y6DP20.@ *K@9X% %<Z_9Z?KVO27.E1V\UEI\5U<7,;!G
MF7#$+T'3!'6GV_B^1I[A)M/22**S>Z\ZQG,ZY3DQD[%PQ'0<YIE]X1?5=7UZ
M:\EB^QZG91VJ*H)="N2&.>.IS^ J73M+\5QV<L>H:Y:S310NEJ\5N5W2%<*\
MN20<>@&._- %_0M9GUB)9S!:_9I(@\<]K=&9"<X*G*+@BMFN?T?09;+7+O59
M8[6WEN8E26*T9MDK@Y\Q@0/F[#ZG)-:&N6]_>:-=6VF3107<T91)9,X3(QGC
MO0!PLNLM!XTT_P 2M=H+&[F?26M_,!*1Y_=R8_VI%8D]E9?>O2JYG7_"=OJ?
MA*?1[*VM+>5XECC<KQ'M(P<@9XQ6UI4=]%ID$>I20R7:(%DDASM<COSTS0!<
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "@G S110!SQ\9Z4HO6<7BQV,ACNI/LKE8F')R0#V(/%;T,
MT=Q#'-"ZR12*&1U.0P(R"#Z5YSI=CJU_?^-K.R-HMM=WSP/)/(^Z+,8#,J 8
M;AO[PZ5H-I^I:?JFA^&=.UF:VLUTN0/(L:%]T9C <9!Y)8#!R,9[\T =S5"_
MU>"PN([;RY9[F2-Y5@@ +E$QN."1W*CU)-<C//XFU"\U-=-NHPVFS+!&\ET(
MU)"*Q:1/+.[.X]Q[8QFK4MM)/\1=/E.H3J9=,>79%(I3AX\JOR\J>O7- '66
M=TE[9PW4:2(DR!PLJ%& (S@@\@U/7G^@ZAXEU>#3M>AFMUM+J8&9);L&/R2V
M-BH(QM<< '<<G@YR,2:3<:S?IK]Y-KMRD>FZA=0QQQPQ?,BH,9RO4'!'3OG.
M> #O*,UYX=4UJT\):1JKZJ9+G5H[2 ++M2.%G7)<,%R&('<$!CTQQ4]YJOB+
MPWI-_+?R6\@=X4L]\XEE0NZHQ;"("H+ CCO@F@#K_P"U+?\ MK^RMLHN# 9P
M2A"%05!PW0G+#BKM<I;6,UE\0H/,U"YNT?290HGVDJ1+%D@@#KQ^56O&-_>Z
M=I%M+I\XAGDOK>'<R!@5>0*01Z<]L&@#H:*X?4)=<@UZUT"UU&6Y9H);QI9)
MDAE8;PJJ"(V! R?X03D<\<RQ2Z^)M"L;[4TCN)6N8;@VNU]P6-BC$E>''RD\
M8SVYH [.BO-VU36+7P]?:DVL74KZ3JK6@1EC N8_/1?WGR]<,1E=O;BK_B_6
M-3T]M6GM+QC]BLUFB@MU7$9R26F+=C@ *.<9..] '7R7HCU"&S^SW#&5&;S5
MC)C7'9F[$]JM=:Y0ZM?2>,M#M1.4MKK399Y8E48+C9@YZ\9/>N?CU[6AHEGK
M;ZI,[IJWV%[?RXQ%*AF,>6PN=V/0@9'2@#TE$2- J*JJ.RC I!&@D:0(H=@
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M\*X^VUJ]@NM2\,7%[*^J"Z5+2X8#>T$@W;^!C**K]L94>M '<4TNJD D L<
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M8IH_V2=HO/U2""7 !W(Q.1R*Q;N77FUU_#]CJ$\OV:T6=IY9XX9I&=V /$3
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MBB;U4'TYQDD#/&*U$N[:6XDMX[B)YH_OQJX++]1U%.$\32F)94,@ZH&&1^%
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M9M1^R.DT[AYUCG=(YF]7C!VM[Y'/>MTJ&4JP!!&"#WJ.6Y@@A\Z::..+^^[
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MQD5/?W,CZ?<?V=<V@NQ&6B:=LQ@]BV.<57F\1Z99:A!IU[?VL5V\!F;,BJH
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MO'VBC6$MS9O97" 7./+=]T9"G/!.,G!],]JR;3PRVJ>&M96PC1?L^J/=:$^
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M4G)' XZ<5M;%V[=HQZ8IU !1110 4444 %%%% !1110 4444 %%%% !1110
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M,D+]X-RVW)';-8>N>&KC3M8TC6?#UC<W5[!/LN?-O6;=;$$,N97ZY((QWZT
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M(LE\L8$SKT+?D*YGQ#I>N:E?ZM"+)+JSELRECNG5(XY"C*Q=>K')X."![=:
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M-0;4H[B,!6BF)SD#H0.1@]C7344 <K<>"4O3K+WFJ74DNJVR6\K(JH$"YQM
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M+33;2RO)H[6S+EX@JXGW9//' #$D 8].E;-%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!HHH 0#%+1
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM !1110 4444 %%%% !1110 45!'>6TMY-:1S(UQ JM+&#R@;.TGZX/Y5/0
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M+K%U<7]M*S3%C!/+9W<D99DXVML89(]^E #_  P]J-%CL[.TN;2*Q/V7R;D
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MT241&>-H]^W=M!&#QD=J .8/B36X]/TZXFL[42:H(A;0Q)([PDQEW+C^+ '
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%!X%-1MXSB@!U%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 449HS0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS!1P. .>_2NT0ED!9=I(Y![5R\MK?:;XWO=62PFN[>[LXH(_(*Y5U9B0VXC
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:3+(]O=I".1(Q+*R$\@Y'?M79T4 4M,L9K*"07-Y)=W$KF225EVC. ,*HX4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=)6?3;H?;6\N1G* P-QC<-W.3G[N>AK;J*2V@EGBGDA1Y8<^6[#)3(P<>G%
M&5XH-^-(!T^"2:43Q;Q"J-((]PW% _R[@.F:Y#4-%U.;3_&:0:9=_P#$QMX/
MLHDD#/(0FT@DL><\G->DT4 <5=Z1?WOB:QD2"2&'^PY;9ISC$<CE<#KG(P36
M:MCK<NE^%=&DT2Y671[VV:XN-\?DLD:L-R'=D\8Z@5Z/10 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN.^\<YH U**,T9H **,UC7^LSZ-X<FU+4X(5GBZQ0RDJ26VH Q ZY7/'KUH
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M%2SMU6W),($2@1$_W>./PH X(1VU[X8\0:IJ>V+6[2YN0MQNVS6[J3Y*HW4
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M#Q/IDPO=SS0O90B>>.:%E98R"0X&.1@'IGT/-2>)#?CP]>_V7 D]X4 2-E#
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M7AA.'(W#E3D<C[W7M0!F:EXTL[&P-S%9ZC,5N(H'C^Q2HREV49(90?XN/4X
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MK;:^@O))TA+GR'\MV,;!2W< D8;'0XS@\4V^U*WL/*64LTLQ*Q0QKN>0@9.
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MVL[.PBN#/-=S6HF$4,32.R@#<Q ''7OU/ R>*QK_ $RZU"P\4ZA%9W$<FHV
MMK> X61]J/AB,\9+XP><+[XJKJ.E7<.I:;J$^B2:I9-I\=M-;1LHFMY%RP8
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M5H26'/\ L-C- '8Q:W8RZQ_9(:5;WR#<"-X77,8(4D$C!Y(XSFK5K=PWB2/
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M>-@RGZ$5SND>(M1UJ">=-*MTMX9;B"0M=$G?&2  -G(..O;T-4=+\66Z>']
M:STN.V_M"-Y$MH58I!&A&X@(ASRR\8'6@#M**Y7_ (3$QZ?;7%W8M9&2^-F[
MW.Z.)."5?<R@E6P .!R<'&*W].GN[BT$E[;QP3;F&V*7S%*@G:P; ZC!Z=Z
M+1(52S$ #DD]J6N:\5LFHQ)X=%Z+5K^-S/(& 9( ,'&?[S%5^A;TIW@?5IM6
M\,PF[<-?6CM:79!S^]C."<CCD8/XT ;\LT, !EE2,'H78#-+'+%,NZ*1'7.,
MJV17+?$6.)_"F98U<"\M>"N[_EN@/Z<5#;V\\'BR2^TC3GM=+CL76X5HS;I/
M,#E,(1G(&?FV]^IH [*BN17Q?>#2;/4I-("07T<'V4"8LSR2#<P*A20% )R
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS3OL#1JN&4;F)8-GK\W''&*W:JV=VUV;C=:W%OY,S1 S*!Y@'\2X)^4]B<4
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M74X6;2+J"<2_9S^]6(8"D;^"><G/X5>BT*ZT_4]0NM+O888K]_.EAF@,@6;
M!=2&'4 9![BM[-&: .>T_P +KI>JZ;<6EPJ6ECI[6(@,?S/EE8L6SZH.W<U;
M\.:1+H>D"QFNEN6$TLF]8]@&]V?&,GH6/>M;-% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MGMW/JT7A?6-;77+L7&GW=T8(V">6R1RE0C#;\V0N/;/%:T<M[JGBS5=.;4;J
MVMX;>TN(U@V@JS%]PR5/!VC(--T#PW#-!>S:E:7<;S:E/<>1+<OY; RED)C#
M%#QM[=1710Z79V^IW6I1Q$7=TB)*Y=CN5,[0 3@8R>@[T <EHEUK>M6]OJ\5
M[!&/M;"X5[@E%C5RK1>7MPK8 ().<^QQ5:-WT[Q=XVU!);F62QL[>:.,RDAC
MY<K8(S@C/0=JZF/PGH<.KOJD=@BW3MYC$.P0O_>V9V[N,YQG-68-$T^VU.]U
M&.%OM5ZJK<,TK,'"\ ;2<# )Z#O0!SV@MK,LFE7L]_"+6\@_>J]UYIG<IN5H
MQL 4C#$@'&,\<5FR:KJUCX$AUZ74[B:Z;%NP/EK&%:XV^8?DX<+QGI[&NIT[
MPIHNDONLK,Q$!@@\YV$6[[WE@DA,_P"SBK$.@Z9#HG]C"U$FG[64PS,TF022
M<EB2>3Z\4 8,J:YI]IJTKWR10_8))8$^T^?*DJ@G>I9!\O(X.<'ZU+:W%];Z
MOHK27TTXO[)WGB<+LWHB$,H RN23W[_2M"W\):-:V,]G#;2B*>+R7+7,C/Y?
M]P.6W*OL"!5P:/9"XL)Q&_F6$;16Y\U_E5@ 01G#< <G- &#X<EN]7TG2=>.
ML%'N/GN(2 T3!B1Y2C(VE3@ \G(.<YJEIM[K>I0)JZ7EO!$+MO.,UV=D<2R$
M&,Q[  VWC);.><XXKHK7PMHUGJ#7MO9[)6D,NWS',:N1@NL>=JMR>0 >338_
M"FBQ:G+J$=F5GFE\Z0"5_+>3.0YCSM+9YSC.>: -JN<\1:C<:)JNE:B]TRZ7
M+-]DNXB%VH7!V29QD8; /.,-[5=TG2FT^^U*X(V)=2AQ&)WE]<M\WW2<_=7@
M8'6KNH:?::K8RV5] LUM* 'C;H<'(_4"@#F)=4O=FBPM+/"-:O9"9&(#0Q;&
M=$&>C$*H]LMCG%97BQ;N'1_%6ERWUS-:Q:<EW;LSX=-QD5D9ARPRF>>QQ7=W
MVG6NI6ZP7419$<.A5BC(PZ%6!!!'J#53_A'-+-E>VCV[R17R[;DRS.[R#&,%
MR2W Z<\4 4KR:YL?$7AVRANIOLT_GK,CD-YFV/<I)(SD'WKGKS4=:7P_K>HK
MJ<BW.G:Q)'"JA=AA\Q $8;><(Q'U-=FVB6,ESI]Q(DKS:?N^SN\[DKN&TYR?
MF./[V:K/X7TE]-O=.:"4VU[.;BX7[1)EY"02=V[(Y4< @4 9FM76H#6=0@::
MYAM4TX269ME)+3[FR3A3SPH"G(.3P><;7A]-0B\/V"ZM(TFH>2IN&;&=Y&2/
ME '!XX]*Y_6;"63Q!-<3Z)J=VCI'%!/IE^8#L&21(/-3D,S8//!KH]'MI;73
M(HIC-N!)"S3><R GA2_5L#US]3UH P;:6\\0W&OB/4KBSDL;IK6V\H@+&513
MO88^?)8Y!XQQCO6?:ZSJFK:IX:B:^EM$U/2I)IT@5.)%VD,I93C[QZY&,5U5
MQH&FW-U<7+PNDMP@2<Q3/&)0.FX*0"<<9/...E/.B:>=3M-1\@K<6D1A@*NR
MJB'J H.WT[=AZ4 2SRMI^DRREGN&MX"V7QND*KGG  R<=A7GMXEQJ.C^"M8N
M+ZXFN+O5+6:1&D B!8,V O0;>@[^N2:],(!!! (/!!K"3P;H<8ME6UD$=K,)
MX(OM,NR)QT*KNP.O0#% $$,E]?Z_XCTT:A-$D<5N;9U5<P,RMDCCGE0<'-4_
M#NMWFNKIMM([I=6(?^U2O&)4S&$(_P!H[GZ=%[&NE@TNTMM2N]0BC87-V$$S
M&1B&"#"X4G QD] *6TTRSL;B[GMH%CENY!+.P)^=L!<_D!TH X9O$FIVFE^(
M6:[>25=>%A;RN%_<1OY8R!C!VAB1GOUS3KXMH7CZXN8I)[EK?PU/,HG<N25E
M4XSUYQ75CPQHXMM0MFLQ)#J$QN+E))&</(<'=R>.@Z8Q@8Z4ZU\.:99W_P!N
MCAE>Z^SFV\V>>25C$2#M.]CQD"@##T4:S<'2M1;4X#;7"?O\W7FB?<F08QL4
M(0>PXQG(.*RX=4U1- T_5I=2NI)UU?[$R-M"21FY,?S +R=N!GVKJM,\(Z%H
M]T;BPL!$^XLJ^8[)&3U**250GI\H'%/;POI+:9#IQ@E^RPS_ &A%^T29$FXO
MG=NR?F.>N* .:U.>7Q#HOC"22[NK=-/,]I%%#)L!"1!BS#^+<6(YXP!C!R:<
M\^HV>D:+=M'>2:.FF1^;]@?$T4FT'S"O\:@#H,]^#70ZAX4T?4YKF6XMY%>Z
M0)<>1<20B91TWA& ;\>W%3-X>TYG5U2:,K;+:CRKF1!Y0SA2%89QD\]>>M %
MRPGCN=/MIX;@7$4D2LDP_P"6@(X;\>M9WBC4I=+T=9(6,;S7,-MYP /DB214
M+\\< G&>,XHCT*&#7+:]MHE@BM[;R%5)GP5'11'G8 .N<$].F.=&^L;74K*:
MRO8$GMIEVR1N.&% '.W%Q>:-XJT_3XKFXN+2_M;AV$S;S$\80A@<9P=V,=,X
MJ?P<]]?>']-U6^U.6YENK.-GCVHL88C.X *#N['G'7BM.'1;*"5IE25YFA\C
MS)9WD<)Z!F)(SP3CK@9Z"I=-TVUTC3H-/LHS';0+MC0NS;1Z98DT 8/B6ZG&
MH>1!?W"F.QEF^S6H"LK#&V5W)^X,$!<<D]#CC,M-=U/4'\%1O=M$-6L9WNS$
MJ@LPB1@PR#@@DGCUKJ+WP]IFH7_VZXAD^T&'R&>.=X]\><[6"D!AGUI+7PWI
M5F=,,%LP.F(Z6A,KMY:N,,.3SP .<X[4 <TM[K4WA._N+*^EEO-)U"=%4%7:
MYBBE/[M_E^\4&..3P<\UT&CZDNMW3:C:3,VG^0BQ@'AW8!V)]P"H]B6';ACV
MTGA^)TT/1GNS=W$D\^;H*%D;&68N2<$^F<8Z5>T;3(M'TBVL8DC41)\WEH%5
MF/+$ =,G)H R_%^I7>FQ:*;28Q&XU>VMY< '=&S89>?6LS4+O53/XO,6K3PK
MIT*2VJK&A"'R2Y!RO()QQ^M=7?Z99ZHMN+R+S!;7"7,7S$;9$.5/!YQZ'BH'
MT#3I&U-FA<G5$"7?[Y_G 7: .?EX./EQ0!D0W<VM:E#I\MY-; Z7#=_Z,P1G
M>0L"<]<+M''3YN<\5'<OJRZ[H&EG679;BTN?M4T,2(9&C\O:R@A@IRWN*U;C
MPOI%U%8I);.#8H([:2.9TDC4 #&]6#$8 ZGFIH]!TV&ZL;B*W*26,30V^V1@
MJ(V,C;G!S@=<]* .:9]<U6\U6VL+LQ3V$JV\4DMT%*D(K!WC6,APV2>2..!M
M-1^*=3U&RAU:X@OKAYK*R641VH"Q6T@4L3(3]_=QA>>.H&0:Z.[\+:->ZH=2
MFM"+MD"2/',\?FKZ.%(#C_>!HN_"VD7TMW)/;2'[9&(KA$GD1)%"[1E58#('
M&<9H QM<U"]L[I+V\:\ATIK=-MU9L"MM(<[FE3J5Y7GD#!X'6H6O=6\0:OK5
MMIUW'"+,I';.EUMV;HU<2,FQMX);')QA>.Y/0S>&],N$E26.=DEA2"5#<R8D
M1<X##=SU(.>HZYIE[X5T;4-0^W3VA%SY?E,\4SQ[T_NL%(##V.: -6!F:WC9
MV1G* LR?=)QU'M7!ZIKVK6GA'Q-=QWL@N;35O(@D:)04C,L0VXQ@C#D GJ.:
M[]55%"J % P .PK(N/"^D75C?64UO(]O?7'VFX4W$GS29!SG=D#*KP,#CI0!
MGV-U=6OQ N]':[GN+5].2]43$$HYE9"%P!Q@#CVJ+Q]")K'1P9)D_P")Q:*?
M+D*Y!D [?IZ'FNA&EV:ZN=5$1^VFW%L9=Y_U88L!C..I)SC-+J.FVNJVGV:\
MC9X]ZR#:[(RLK!E(92""" >#0!STD O?&][8I=75NR:5!F6%@'_ULG<@^E9U
MCKFHZEH'AJ*2X$=Q?B7S':;RGF,>< ,JG:6QDX&< CBNNBT:RAU5]31)/MCP
M"W:0S.<Q@Y P3C.<\XSR>>:IGPEH9T6WT@V(-E;N9(5\Q]T;$D[E?.X')/.>
M] $NA0:C;07$6H7*3XF)AQ)YC1H0#M9MHR0<\XZ$5A^*+ZZ%QJ*65Y</+:6#
M3""T(3[.^"0\K$\@[>%P>AR.]=/IVFVNE6OV>TC94+%B7D9V9CU)9B23]352
M]\-:3J%Y-=7%LQFGB\F8I*Z"5!T#A2 V,\9Z4 8T&J:A)XB\+QFZ_<WNFRS7
M,9P [*L9!''7+GIV^E<QJ%S=ZKX<MS>7EQ(T/BE;9&#[3Y8FVJ#C&<#H?7FN
M_?PSI4D=@AAF!L$,=LZW,BNBD $;@VXC '4GI1)X8TB33Y+$VF+>2Y^U$+(Z
ML)=V[>&!R#GG@T <W/9R77Q#U>WBN;F%QH\&V2%P')$CX&2*71=:O]<M_#5G
M>7$D+7FGR75Q-"=C2NA1=H/;[Q8XQT';(KJ5T2P34IM16.47<UN+9Y?.?)C'
M0=>#[CGGK5<>%='73[&R6V=8K%BUJRSR"2(G.</NW=R.O3B@#G+G6=4L[?7[
M);JX=M-OK1(+DJI8QRF,E&)'. Q!/7!%:.KF]T:^T)(-4NY4N]5\N99MC!D:
M-FV_=! !08QZGKQC6G\-Z7<Z7)ITL,IMY)1-)B>0.[@@ABX;<3D#J>P]*LWN
ME6>H7%G/<QL\EG+YT'[Q@%?&,X!P>">N>M ',7R7-QXGCTG2]3OQ.C_:KZY,
MNY+>,L2L07&W<W0 \A1GD]4:;5M9N]=:SOOLEQ877D0![C"(%16W.@4[@Q+<
MD].F,5LIX3TJ)[IXOML;7<ADG*7\Z[V(P2</Z "G7GA31-0U,ZC<V*O=, '<
M.RB0#@!U! ;CCD&@#(EEN=8U#Q!$]_+"FG0K%%% V 6>(.9&'\0^; !X^4^M
M:O@__D2=!_[!UO\ ^BUJ:[\-Z7>WSWLUNXN)%"2/%.\?FJ 0 X4@,!D]<U=L
M;*WTZQ@LK2/R[>!!'&F2=JC@#)YH Y9+N^UC3=;OX[Z>SN+"ZGBMQ']U1%TW
MH>&S@YSV/&*@M-4U+6O$]I9F^N+&"ZT&.^,<*Q[HI3( <%E;MQSFNDN/#VFW
M4T\LD4H-Q_KTCN)$27C'S*K!6XXY'(J==(LDUDZLL1^VF#[-YF]L"/.[:%S@
M<\]* *_B/4I=&\,ZCJ,*>9+;6[.@/3('!/MW-<Q?V+6GC[P>[WUS=NZ7>YY7
MRK$1#YE4<+G/0<=*[B>"*Y@D@GC62&12KHXR&!Z@BLFU\*:/97-G<0P3>99!
MA;;[F5Q"",$*&8@#'&* ,#0;G7M9@L-92ZBBBEN"9U>Y+*8BQ'E^7LPK#@ [
MLY'.<XJW9WUY;^)EM=6:^MY)KF7[-)N5[:YCPQ1 !]Q@N#R 24/)S6M:^%]'
MLM2DO[:T,4\CF1PLK^6SG^+R\[=W/7&:?;^'=/MKE)HQ,1'*T\43S,T<<C9R
MRJ3@?>/'09X H P7U/5H_#^H2QSS3R0:L8&D6-3(MN)5#;0!R0I.."?K2-/J
M<<GBFYAO+U;"WLPUB95&!+L9G*EAE@"%ZDCDBK7B#0!_8Z6UA8RW$+Z@MW=1
M1W)25OF+DH[,,-N"]QQG&.*;I.C"[$RRV6L6=E- \,T%]J+2F7=@<#S'VX /
M((/S4 4])U&^-]X0GGU*>3^U]/+W$+[=C.L*/E0 ,')8G%16NKWK:QH,L5[<
MSV]_=30RRR#;%.@C=U,:=0HP &XS@]0<UU4?A[3(I=+D2W8-I41BL_WKXB4I
ML(QG!^7C)R:K0>$=%MFLVBMY@;*0RVP-S*1$3D$*"W"X)^7I[4 <7IUW<:)X
M>\1W=K<2"4^()+3S;B8LL2&9$WDG/(!^\0>V<]*W+^ZUGP[IVHWLUU&8# GD
MPO.9WBD+A#)N*J2F&4D'."/0UT"^'M*5-0C^R@Q:BQ:ZB9V,;L1@G:3@$]R
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MM<J1Q*2H4D_@!5Q5"*%48 & !VH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *HU*Q:^-BMY
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M4ZXO+6TQ]IN88=W3S'"Y_.N>\):A<7MQJL5P+*X:"5%&HV:@)=@KD$XS\P&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,4M% !1
M110 F*6BB@!,48I:* $Q1BEHH 3%+110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 45GPZ]H]Q=BT@U:QEN22HA2Y1G)'4;0<]C6A0 4444 %%%% !11
M56]U*QTU%>^O(+5'.%>>0(I/ID\4 6J*B@NK>ZMUN+>>*:!QE98W#*1Z@CBJ
M<.OZ/<1326^J6<ZPH7D,,ZR;5]2%)H T:*I66KZ;J2NUCJ%K<A!EC#,K[?K@
M\5':Z_I-Y/Y-OJ-M)(?NJ)!\_P#N_P!X>XS0!HT55OM2LM,@\Z^NHK>,G ,C
M 9/H/4^PJ.VUG3+Q&:WO[>0*,L!(,K]1U'4=?6@"]164/$_A\YQKFF''7%W'
MQ^M2SZ[I-K'#)<:E:113IOBEDF54<>H8G!_.@#0HID,T5Q"LT$J2Q.,JZ,&!
M'L16?%XAT>:Y6VCU*V:Y9M@@\P>9G./N=?TH TZ**;YL?FF+>OF!=VS/./7'
MI0 ZBJ=YJVFZ<Z)>ZA:VS/\ <6>94+?3)YJ2ZO[.Q$9N[N"W$C;4\V0)N/H,
MGDT 6**S+CQ'HEF[QW.K64,B9W1R3JKC!(/RDY[&I[#5M.U6,OI]];W2J 6\
MF0,5SR,@=/QH N45F77B+1[.X-O<:E;QRKC>I?[F?[Q_A_'%6Y[ZTM;7[5<7
M4$5O@'S9) J8^IXH L454CU73I;%KZ._M7M%SF=9E,8QU^;.*2YU;3[2UCN9
M[R%890#&^\'S._RX^]QSQ0!<HJ"UO+6^A\VTN(IX\XW1.&&?3BIZ "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBEUKP*=<\,PZ'<:K((4E,TDWD@R22%F8D\X&2QXQ0!U%LR1:?$[LJ(L2DDG
M Q7 0-M^/MR!&&WZ2 3C[O*G/Z8_&NBN?#>HWUM!:7>OR-:QR1N\<=LB&0(P
M8*3Z' SBJS>#;O\ X2Z;Q)%KCQ7DL/D%!;*4$?'&"<]0#UZT =898U;:SJ&"
M[L$\X]?I7D#^+(HOB+I/B :M!-8ZCOL);>.4$VR!CY98#IDD,<],M7<7/A2^
MO(]0^T:_*\M[$L#/]F0".(;LHH[;MW)Z\"IO$OA./Q+X;31I[D0H"C/+'$,D
MKZ#/'ZT 5_&6@67B<Z=IE]N\J1Y2K(V"K",X(KC=%US4M.O[+P3XB#/J-K?6
M[6=P%)6:$$'KCL,\GW!Y%=ZOA^],NCR2ZN96TTDAFMQF8E2A+'/]TXX[\U;U
M'0++4]3T[490R7EA+OBFC.&P004)[J<\B@#S[Q5+-!\=O#TL%LUS*NG,5B5@
MI8XGXR2 *ZB[O+B#P#=^)8(ECU:XTB.:1E4\,(RP./8NWY#/2EU/P7+J/C"U
M\2C5C!=VD1AA1;<%0IW]<GD_.>>*UK/1[A+R>XU'4#?B2'R5B:%41%SEN!US
MQG/I0!C?#.UAA^'VFLHW/<JTTSMR9'9CDD]_3\*Y#0I9D\$_$/3%8MI]C)=Q
MVA+9VKM?*CVX!_$UW5AX6N-#MY+/0]3%I82.T@AF@\XPD]1&VX8'LP:KFG>&
M-+TS0Y](BA:2UN-_VCS6W-,7X8L?4T <IX8;;\"]VT-C3+HX/0_ZRI_%-KXA
M@NM'USPZD-W<6%LR3V,GWGC<#D#U^3MSQQGD5IZ;X.FTW2_[$35Y'T4!E$!A
M EV,<E#)G[IR>B@\]16E?:/=RZN-3L=3>UG$(A,3Q"2)P"QRRY!)RW!!&.?6
M@#,\$>(=.\0Q:C/;64MCJ F4ZA;2@@I+M"Y_),=CP<BNKKF)?"4DFGZDJZO<
MV^IZC(DD]_:J(F&S "J >%P".23R>37211F*)(R[.54#<W5L=S[T /HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK&:X"^=%"?ERN<' ^7.#U ]/2JS^(F?5+RQL]/DNVLY8X[@)*@9=X5MP4GD
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MU.2O![YZ5HR:;JEEKSZM9BWNC<VJ074+N8AO0DJZ'#8'S,"#ZCDXJK/X=O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[)GNO*U^&^%K/)&B_=!WF0*1C:8^G'4CO79T 5--U*TU>QCO;"836TF=D@!
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M@^5&,C+#)&<<GBNBR/44M '.:CX,L=3N-3DEO+](]255N8(I@J,50*#C&0<
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M>XMPIE13DINSC/OP>/\ &@#*M/"EI:"U@%S<R6-I)YMO9R%3'&V<KSC<0N>
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M],>]:M[?VNGQ))=S+$LDJ1)N/WG9@J@?B: ,:Y\&:;=KJ\<LMUY&JL'N(1(
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MD6\8CC#N6(4=!D^G2IY)8X8S)+(B1CJS, !^-*CK(BNC!E89#*<@B@!U%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4C ,I! (/!!I:* /)+O[+%\)]<BC\E)QJC"15P&'^F#&1UZ#C/
M85T5_$MCXRU6/2%2&[GT%YO*@ !>4.=C[1U;+'FNV\I.?D7DY/'4TNQ=V[:-
MV,9QS0!P'A"/0;NZTJ]T_6 ][';LCVL:1I( 1\RS!5W8#<Y;^+')SSW=W$T]
MG/"I :2-E!/3)&*>L:*25103U('6GT <CX'O+>P\+6VE7LL-K?::AAN8'<*4
MVD_/@_PL/F!Z'--UW4X+ZZT%F DT&:[=+F5Q^[=@I\K.>"A?H>A(7KFNGN-/
MLKN6.6YM+>:2(YC>2,,4^A(XJ66&*>%H9HTDB<;61U!4CT(- 'G&N1PV5GXU
MAM1'%HZZ<DBB-MJ)=$-@+C@$_NR0.Y'K6AXGT71K2;1)O(C@6]UB,W+K(4\P
MF*3J0>YQ]:['^S+'[#]B^Q6WV3_GAY2^7US]W&.O-9FNZ#_:S:/"L5J;*SNQ
M/+%(N055&4*%QC^+OZ4 <=<VZZ1_PDT.E!DT1)+(RQP<)$I;_2 O8?N\$XZ9
MK=-O8V_C/2FT=8D@FM)A>K; >48@%\LMC@<Y /4C/4"NKM[6WM(%M[:"*&%<
MXCC0*HSUX'%,BT^R@BFBBM+>..8DRJD8 ?/7<,<Y]Z /--*T[1;7X86NK7EN
MQGGC2VDF6;8S*TX 5F.<)G&>.!FDO!8OHGC6%?[.G6."*<0V:CRT(C^8J,GI
MW88_"O3#I]F;+[$;2#[+C'D>6-F,Y^[C'6GBU@6+RE@B$>S9L"#&WTQZ>U '
M,S2Z</$?A86;6R0O'="%(BH4_("0H''8]/0USY@BO/!D]S/';+XL@NG(9<"5
M;OS3L4'KM(*@#H5/I7HB6-K&82EK"I@4K"5C \L'J%]!P.E*;.U:\6[:VA-R
MJ[1,8QO ]-W7% '#ZGI>F:CJGC WR13K#:P2;)&RL3B*3#X[''?V%=?H,WVG
MP]ID^_S/,M8GWYSNR@.:MM:V[+,K01$3?ZT%!^\XQ\WKP .:D "@ # '0"@#
ME-9:.7QQIMKJL<#:2UE*T0G */<[EXYX+!-V/JU<_J=O$FCWEK#/Y6FQ:[:Q
MZ>ZRD! 6C$H4@YVAFD&!TP0.E>C7-I;WL)ANH(IXB<E)4#*?P-,?3[.6*&&2
MT@>*$AHD:,$(1T*C'&/:@!FG:58Z1;O;Z?;K!$\C2LBYQN/4\USGB>XL#XCT
MRUN6@6X$$TD;7SXM0ORJQ*G[[\\#(X).:Z^H9K6WN&C>>"*5HFW1ET#%#ZC/
M0T >4Z7.+OPCX'\R5)FCUPPY'("@S +CTVA>/3%;MIH>EZQJ'C30!$B6C208
MB4 +$[1 [U7H.>?J*[4:=8KLVV5N/+D,J8B7Y7/5AQP?>H-2M;UK-UT>:VM+
MIW#&66'>I'?(!&3^- &!X9GO-<N;>;5("MUHP>VE8J0'N?NLZ^HV 'T_>^U=
M>P!4@].]5=.LVL;)(9)C-+DO)*1C>[$ECCL,DX'8<5:(!!!Y!H \JT^Q0?#K
M5-5M(6.HV\EW%%/'S(D/FG<J_P# <X_2KT,>FM8:AJ'A;6A<7W]ER[8;1(U'
M0%2ZHO#@_=SSU]#7H5M:6]G"(;6"*"('(2) JC\!1;VEM:!Q;6\4(=B[^6@7
M<QZDXZGWH Y3PY>>%+FYT^?1'C^URVYC>&!@71<!B9U'.05QN;N?>LR&XM#X
M8CAOBDYNM>N%0>9MAD?[1(PWM@_)QTQSP.]=]%:P02221011O*=TC(@!<^I/
M<U&=.L39FS-E;FU)R83$NPG.?NXQUYH \_TR*UNM!\0Z<FJ:=;AM: A=8U-O
MNVQ,$V9(VL0PQGGGO5B.*'4-(N+(P:9I-]#J:KY3XDL[J58@0 O'RE.<#D$9
MY(KN7T^S=95>TMV68 2@Q@AP!@;N.<#UI%TZQ6S^QK9VXM>?W B79SU^7&*
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M7"A9420';$7R", !QGM7;^$X;"'39_[-N[BZM9+AY1++C82V&;R\  )DG@<
MYK<\M-FS8NW^[CBG 8&!TH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:[K&C.QPJC)/H*=39$62-
MD895@01[4 <KH4D_B[3VUF74+J&SN&=;2WMG\K8BL5#LPY9CC.,[1P,&M6":
M?1+"4ZO?M=_ORL$@BS(ZMC:I5!\S=1P.<9K)\-P7OA33O[$FTV>>TMY'^QW%
MMA]\;,6"N"0589QG[OO4VM6VJ7B:7J4=F?,L+W[0;-9!O>(HR'OMWC=G&<>]
M &H=?T](+Z:25XQ8+ON5>)U9%P3NQC)& >1D<&J]SXMT:S@\^ZN)8(-\:+-+
M;2*C%QE=K%<$8[C@=ZQM6TZ]U;^W[^WL9E^TZ.UA;Q/A'F<[SD@D8 W <GU[
M8RWQ(9K'PAH!EM)7F@O+'=;K@N65ERHYP3QCK0!OV?B;2KT7NRY:(V(#7*W,
M3PM$I&0Q#@'& >>E26FOZ?>7:6J/+'/)&98XYX'B,BCJ5W ;L9'3UKF=4T>_
MU^[UJ_M;5[=GL8;6W2Z&WSW20R$D=0O1<G'?M6G,+C6M6T6X&G3VJV,KW$SW
M" $$QLGEK@\Y+Y)&1\GTH M+XPT)HVE^W;8EC>1I7B=4 1MK L1C(/&WKR..
M:>_B;3Q;7LJ"Y>2TC$DMO]G<2[2,@A2 <'GGIP?2N>LK?5+/X;7<=MHQDU S
MSN+6XC4EP\Y;=M)P2$.0#W %+8Z?>'6]8D2RU+R;G2DBCFO'#-)(&E)!Y^7[
MXP. /0"@#236+;5-*\/WUS>7FGR7<L3I'$K*)I"N?+;*G*')],XR#6C>>)-,
ML9KB.:67-J ;AHX)'6$$9^9E! XYY[<U@"SOY?#G@^!-/N!+:7-M]I1@%,0C
MC*LQR>F?SJ6QMK[1Y=?LYK&>Z2_NI;FUEC 96$B@;&/\.",<\8QR>: -RX\0
MZ9;3B!IGEF:W%TD=O"\K/%D+N4(#GDCIZYZ5;L+ZVU.QAO;23S+>5=R-@C/X
M'D'V-<EHN@WNE>*M&5XWD@L] ^R27 Y4R;TX!_X"3]*T? 5G=Z?X0M;:]@D@
MG66=C'(.0&E<C]"* -.VUFRU)DAMI)P9XFDBE\AU5E! +*Q&#U!'J.>E8G@_
MQ-!=Z!H45[=2R7]Y;Y$CQ-ME< E@'QM)&#QGM3= LKG2]1":=:ZA;Z6T<CSV
M5V0RPR<%1"V3U.[(!*_2JVGZ%J,&A>"K:2R(GT^=7NOF4^4HAD4\YYY9>F:
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M4&.5)&#U& <'G/3FN8T[2=5_X230=1FT^\58+29+HS2QD)(RIA456PJY4@8
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M"2/%YDY!XR58C SQD]SQZWY+"^D\?:?J0MF2TCTV2*1]ZX5V=2%QG)Z'G&*
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M77>,L<GD$]\=: .HHKE'\5W%MJ]G;7=M;Q)=WK6BP";=<1_>V2,HXPVW.,\
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ML""WFE$K[2T8!$?'5LD<?3-9]]KJ6ES-;P65U>RVZH\Z6RJS1JY(7@D$G@G
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MQ+\2#3Y[5&6TM%?SHV?!PV#PPZ#)QWXY%=LB)&NU%55]%&!0L:*[.J*&;[Q
MY/UH YRU\*?8;_0IK:\VPZ7%/&\;19,YEP6)(( ^9<]#5E](O[75[Z]TRZMX
MUOPAF2>(MLD5=OF*01GY0HVG^[U%;E% '/W7A2VE\+0Z)!/)#]G*O!<]7256
MW"3MDYR3]34FK^'1?:=90:?=-IT]A(LMI*B[PA"E<,I/S*5)!&:W*0G Z9H
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MMD5 YE.Y<G "]^G 'M73G1;RWU&_N-/U!(8K[#R12P;]DNT+O4AAC*@9!SR
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M<YI7_@J:\LM<T^/48H;'59_M)7[,6DCES&2=V\ J=G3 //7BNPIK,J*68A5
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MU(@W8DD9Q+@;1PQ( QQ@8[>E1Z-X:TG0-_\ 9MJ8BRA<M*\A"]=H+$X'L.*
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MGM-"U]1-JUOJEG8M,T-R1)M;#XEC8@AE)'3.!MZ#FNTN;:*\M9K:=2T4R%'
M8J2",'D<C\*IQZ'I\?VC,+RFXA%O*9Y7E+1C.%RQ/'S'ZY- &&-7OQXG\/6O
MV@F"ZTR6>9-H^=P$P>GN>GK2^'FFU32M(\0'6I%END5[B(L&A;=UB5<X4AN
M1\W'.<ULVOA_3;.>UGBAD,MI&T4#R3O(41L97YF/'RCZ=JCM?"^C66I/J%O9
M*EP[F3.]BBN>"RH3M4GN0!0!Q'G7.GZ!K6K6EW/#-:>()@L:M^[D#W"(P=?X
MN"?IUKTU@2I )!QU':LQO#VE/8W-DUKFWNKG[5,GF-\TN\/NSG(^8 X'%:E
M'G,.JZI'\-[?Q0^JW#7LEI'&XD*"%2TH4R8V\, 2<]/4&M.<:YH%CJ>J172S
MV,.GR2QPS7+W+-,HRKABHPI'50<>F*Z.ST33K#15T>"U7^SU0QB"1BXVDDD$
ML22.346D>&])T*)XM.M?*1QM(:1I/E_NC<3@<G@<<T 9YADT>REU>VU>ZO8A
M9R2^3-)YHN'"[U9.?EX!X7 (/M6<+B_AT#2/$$&HSS7%V]J;F%WW12K*RJ51
M>BD;N-O/'.>:WM(\*Z)H4TDNFV"0/("I.YFP#V&XG:.!P,"G6OAK2;)X6M[4
MHL#M)%$)7,<;'J50G:/P'&3ZT 8%G>:JMWXFO[S4[F6WTFZD,-I"D8#H(ED"
M,=N3]X8P0<YR36;>P274/@O6I[^ZFN+O4+>22,R_N07B=OE3H,=!CG&<Y/-=
MW9Z59V$]Y/;1%9+R7S9R79M[XQG!) X '&.E9L?@W08I('CLW403_:(4%Q)L
MCDYY5-VT=3P!B@#7O2PL;@HY1Q$VUEQE3CJ,UPMI?:UJ/A+P]JDWVV\MVMGD
MOUL9?*G9N-K*%QN ^;*@C.1UQ7?30I<020R F.12C $C((P>1R*RAX8TI+2S
MMHH9H8K.)H(1#<RQE4;&5)5@3]T=<]* +.BW4-[HUI<6]W)=Q/&"L\JA7?U+
M  8.>HP*XF":30-'\67]K<3><NK>2'GE:14#&)2^&.,@.3GV Z"N^L[2"PLX
M;2UC$<$*!(T!)P!TZU4&@:8!J*FVW)J)+74;R,R2$C!.TG R,= .E &88[G1
MO$FEPPWMU<6M_P";'-%<2F0JRH7$BD\@<%2!Q\PXJ+QU,T>GZ2@_Y:ZQ9H3Z
M?O0?Z5LV.B6.G21R6\<F^.+R4:69Y2B<':"Q.!P/R'I4^H:;::K:_9KV$2QA
M@XY*E6!R&!&""#T(YH XO5=4U+PQ/K4$5_<7<"6*74<EQM=K>1Y-F,X^[U;D
M8&T]JW='M-5MM3+O=1OILD1.Q[IKB1WR,.K%1M&.JCCIC%:<>D6$4=V@@WB[
M&+@R,7,@QMP2Q)QCC%5]&\-:1X?,G]F6GD;Q@YD=\#.<+N)VC/.!@4 9OBNR
M2[U/PX6FN8\Z@8SY,[Q\>1*?X2.<J.?J.]9FOZG=0WM]>65U>.UG>VL&0VRW
MC5VC5HRN<2,=Y)..-PYRM=?J.FV^I11K/&6:&030D2,A1P" 0RD$<$CZ$UFC
MPOI]W%>MJ%FOFW[*UTL-S*(W92"K 9&&&U>0 >* .?U+4O[/\8:W'(T]O;W4
M=C!)>PJ#]GW>: 3S\N>F[D*2,UJZS-<3>(;'18IWCB:U>< 7;0-,RLJXW@%C
M@$D@8SQU&:V'T+39)[^:2V#O?Q+#<[G8B1 " ,$X'!/3'6H+WPOHVHV-I9W-
MD&AL\?9MLCHT6!CY6!##H._:@#'DN-6TZ^\-Z;>ZDSSW-S<1R-$ 1+$L3LI8
ME?O@A.1@'GBM3P]/<O<:S:W%U)<BSOO)B>4+NVF&)\': #RY[=*M?V#IGGZ=
M,+;#Z=O^RX=@(]PVMQG!R/7-3V6FVFG/=-:Q%&NYS<3$N6W2$ $\GCA1P..*
M ,'5[!)_'6ARM-<J?(N#A)V5?E,9' ..<\^O&>E4Y;B[U+1]<U==0NK:ZL)K
ME+>*.3"1^23@,@X;=MR=V?O<8KJ)=*LY]6M]3D1S=VZ-'$WFN%4-][Y<[>>.
M<=AZ5!+X<TJ:YN9VM2'N\?: DKJLV.F]00&].1TXH Y^RU'4=;UZ&U:]N;**
MYT."]*0A T4K.0<;E/;C!S6EXZBAD\#:QYYFVI:NP\IV4E@IQG!&1G&1TQ6N
MNF6::JVIK%B[: 6Y?><>6"2%"YP.2>U375M#>VDUK<)O@FC:.1,D;E(P1Q[&
M@#C;O3R-;\)VT=S<K&;:[4R^<6D!9$.0S9/K@]JK2:KJMII,5C]L,KOKKZ:)
MI9?+<PX9E!DP2&P N[&>?7FNPCT2PBET^586,FGQM%;,TKL45@ 023\W"CDY
MZ5#)X9TB;3+G3IK,2VMS,9Y4ED9RTA.2VXG(.?0\4 -T*SU6S-TE_<)+;LRF
MV0RM*\0V_,K2, 6^;D$C/-95_+>7WCY]$_M"ZM[*32/M&+=@C+()@NX-C(XX
MK>TG1K#0[/[)IT'DP[MQ!=G)/J2Q)/YU@WWAZ34/B-%J,T4XLH]*,2S0W#1$
M2^;G;E&!^Z3[4 96F:YJ[/H<-Q<NS+K%SITDA'_'S%&KX9ATSE!R.X/J:-3U
MG4[71?&,T%]*DECJ"+;L<-Y:D1$J,@\?,WYUUMSX=TN\TNWTV:W;[+;L&B6.
M9T9& (R&4ALX)YSSDYH?PWI,EI=6KVF8;N199U\QOWC*% )Y]%7CIQ0!CZM%
M?Z?J>CVUMK-Z%U#4)!,9-CD+Y+MM7Y> "@QZ9/6LZXU/5/#TNK6!OYKBV2>R
M6"ZN<,]NL\FQ]S< [<$@GID9R*W?$FC/K.HZ$K0M);6UVT\S"0H4 B<*000<
M[F7&/2M!-"TU;"XL6M5EM[DDSK,QD,I/=F8DGH.I["@#%F-_I'BFRL+.[GGM
M[^VN7*73F00R1[-K[C\VT[L%<X]*QUUR[T/3M0CNWOH=;M[!IVBNIO.@F.0#
M-&W. #_#\N >E=E;:%I]KYQ2*21IHO)=YYWE8IS\H+DD#D\"F6GAW2[-F:.W
M=RT/V?\ ?S/*!%_< <G ]A0!0TBQU"UU*&9-2\_3YK<ETENVG:1\@B1"5&!@
MG(''(P!3_$%Y,-4T;2DDD@AU":199XVVL B%PH;J"Q'4<X!Q@\U:T?PSH^@-
M(VEV2VYD&&(9FX]!DG ]A5K4=+L]6ME@O8O,1761,.49'!R&#*001Z@T <E=
M+=(GB?0IKN[GLX;!;J"5Y3YD>\29C+CEAE.YSC(.:VO!=LMKX-T@)),_F6<,
MA\V5GP3&O R>![#@5=&A:>+*ZM/+E,=W_KV,\ADDXQRY;=T&.O2K=E9P:?8P
M6=LA2""-8XU+%MJ@8 R>3Q0!RFI7%SIWB,SZG+J,5E+=1+:75M-F% =H,<L?
M;+;AN(/WAR,"JNHWE['HGCM5O[H-92-);.)2&B_<))A3U W$\>G%=1)X>TV2
M\>Y:*7>\JSNHN)!&TBXPQ3=M)X';L*CN_"NC7US>3W-H7>]0)<CSG"R +M!*
M@XR < XS0!ER2-K6NW&DRZC<VI@L8IHEMYC&SL^X,Y(Y;;M7CIR<]L5M1M7O
M/$OAB!M3E=_L5ZKW5L0C2'$2DC&0.>>.A%;FI>%-$U?[+]NL$E-JNR%@[*RK
MZ9!!(XZ&IQH&F"_L;U;4+-81-#:[78+$A&" H.WIQT["@"AX.GGETFZBN+J6
MY:UU"YMEEF;<Y1)65=Q[G '-4YI9-;\3ZYI<MU=6T5A;0^2+>8Q%FD5BS\'Y
ML8 &>.OK70Z;I5EI$$D-C#Y222M,^79BSMRS$L2235;4_#>D:Q<K<7MIOF5#
M'O21HRR'^%BI&Y?8Y% '+:'>7%IX;\!+#<-'%<;()DXQ(OD.P!R/51TJ22[O
MM*UG5/#RWMS+/J(6?3))I"Q16.V10Q_YYX+@>E=,GAS28X=/A2S58M.?S+5
MS8B;GG&>>IZYZU=DLK:6]@O)(4:Y@5EBD(Y0-C<!]<#\J .8O-0NK'QY%;)/
M*]M'H<L_DLY(=UD4!C[XXS[UC2H]YIGA#66U"6>>\U&WDGS(WEL65CA4/"[3
MQQC@<YKO3IMF=5&IF!3>B'R!+DY$>=VWTZ\U1C\*Z)#/%-'I\:O%+YT7S-MC
M?).57.%ZGH* .85]<UBYU2YL]3M[=[2_>(%[QPL*QL0 T0&TAE&3GDYSD<8M
MW=O?WNM^)89=7O8H8;6"6V2WD,?E,8Y 3QR?F7..AXSTK=F\+Z)<:L=4ETV%
M[TE6,IS\Q7H2.A(]Q5EM'T]YKZ5K8&2_C$5R=Q_>*%*@'GC@D<4 <O8W\^OZ
MQI>G7L\Z0G1HM0<0RM$9I6(!.5(.!Z=,L,]JG^&Z[/"\J[BV+^Z&6.2?WK=:
MVI_#>D7$5G'+9*19)LMV5F5HUQC 8'., <9JWI^FV>E6OV:PMT@@W,^Q.F6.
M2?SH M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 8WB+5I=-TRZ-F%:\2VEG7<,JBHI)8_C@#W/H#6M$Q>%&/
M5E!-<QX@T;4FTS6YK:_#&YMY,PBVW.X\L@1@[OKC ZL3SFNBLDFBL8$N)!)*
MJ ,P3;D_3)Q0!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>exhibit1061-loanandsecur026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur026.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (;?[
MK?[YJ:HH!\I^N:EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@"&#_5CZFIJA@^Z/J:FH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** $/4=:;&7(;> .>,'M3Z* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** (H1A?Q-2U''TJ2@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** (X^E25#!]T?4U-0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% $4((7\34M,B^[3Z "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH 9%]VGTR/I3Z "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M--%;PO--(D<2*6=W;"J!U))Z4RUNK>]MDN;6>.>"0922)@RL/8C@T 34444
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M.IQ0 M%%% !110"",@YH **** "BBB@ HHHH **** "BC(HH **** "BBB@
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M:+4]1U"XU&6>YO;5;8DQJH11G! '?YCUH R8O&4D7A[P_?W/V:QAU&%FEN#
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M/>K70*E0'4\8&<]3R!C% &?I'BK68/"EMJNJV<-R;F^$"_9YB&"O,R#Y2O\
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MX[@IVDED)VD^RA3CW;/85=MKW49/$][9R+:OI\<*NCQAA)&YQ\KYX)/S$8Z
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M?:W;W*7%U/"\+QN%0S%"06VM]T\X!_$5JWOBFWLQ>R)97=S:V!*W=Q"%*PD
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M5K'(Z[EC+L!N(]AG\<4 ;%%<?<7^JZ/JLFE2:DUV;JPGN;:XF@7?#)'C@A0
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M%%% !1110 4444 %%%% !1110 R/[M/ID?W:?0 4444 %%%% !1110 4444
M%%%% !1110 4444 9<GAS1Y;F6Y?3H#<2G=),%P[GW;J>G2K=EI]IIT+0V=M
M%!&S%V6-0-S'J3ZGWJM=Z_I=C=K:W-XD4I*J<@[4+?=#-C"D]@2,]J+O7]+L
M;X6=S=I'.=N002$W$A=S 87)'&2,T 7+>U@M;5+:WACB@1=JQHN% ],53L]
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M_A$M"%E%:#3T$$,AEB4.V8V(P=ISD#'& <5:UW6(- T6ZU.Y5FC@7.Q>KL2
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M&G-J$6HVK6:??G\U0B?[QSP>1P:1]<TI()9SJ5IY4+^5(PF4[7_NG!^][=:
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M6:X\G%IJ4UI$8@0&1-N">3SS0!KV=E;:?:):VD*0P)G:B#@9.2?J22<U6O\
M1;#4IXI[B%A<0@B.>*1HI%!Z@,I!P?3.*;;Z]IEUJ]SI<-W$]Y;!?,C##()R
M<#U("Y/ID5;BO;6:9X8KF&25/O(L@++]1VH KPZ-80I,IA,WGIY<K7#M*SIS
M\I+DG;R>.G-0V7A[3=/E@D@BD)MU*0"2=Y%A!&,(&)"\<<=N.E1>*-6N=&TN
M*ZM5B9FNX(6$BDC:\@0XP1@\YK5AN8+C?Y,T<FQMK;&!VGT..AH PK[0H-,\
M%ZKIFD6LK>=!,(X1(7)>0'NQ]3GKZU8T?0;2RBL[CR[DW$5N$47%R\IBR!D
M,Q /&#CTK3@O+:Z+BWN(9BAPWEN&V_7'2B"]M;EW2"YAE9.'6.0,5^N.E %"
M/PUI46T1V[+$DPN%@$KB)9 <Y"9VCGG&,9YZU+#H>GP7FHW:0$RZB%%T7D9A
M(%7:!@G X..*M1WMK+</!'<PO,GWHU<%E^HZBAKVU5PC7,(<OY84R#);@[?K
MR./>@#)LO"&CZ?/9S6\5R&LBWV??=RN(PPVD ,Q&,=NE3'PUI9LM0L_*F^S:
M@SM<1?:)-K%R2V!N^7))SC'6M..XAF>1(IHW>,X=58$J?0^E-2[MY+A[=)XF
MG09:,."RCW'4=: *%WH%G=3PW ,]O<PQ^4MQ!*4<Q_W&/\0^N<=1@\TI\/:8
MR6"&W8BPE\^W_>MQ)SECS\Q.3R<]36E)(D4;22.J(HRS,< #W-9^J:U:Z9H-
MUJY=)K>"%I1L<8DP"< ],G&* );32K.QO[V]MXV6>]97G8NQ#%1@'!.!QZ8I
M-3TJUU:W6*Y5P8W\R*6-RDD3CHRL.0>3]>AXKGY?$>H6EA;7TUUI4MM>M#'$
MR,1Y4CN P8[B&55).0021V'-;=C<W4"E=5N[!C))BVDA)3S5(SRK$\_0G/6@
M!C>'-.ETZ\LKB.2X2]7;=/+*Q>7C'+ Y'T& .P%:D<:Q1)&N=J@*,DDX'N>M
M1SW5O:H'N)XX5)P#(X4$^G-5Y]7L;;4[;3I;A%N[D,T46>2%&2: (;[P]IVH
MWLEW<)/YTMN+:0QW$D8>/+':0K 'EF_.F6OAG2K.73988'#:;$T-H6F=O+1A
M@CD\\ #GT%6K>6[%U>&[-H+9746YC8[\8YWYX!STQVJWO4$ D9/3GK0!@SV[
M^'K8P:)HLEX;RXDEE'G@*LC\EG+G."?3\JT-$TN'1=&M-.@1$2",*0@P"W5B
M![DD_C5M+B&25XDFC:1/O(K E?J.U2T 9^KZ/!K,=M'<2W$:V]PEPHADV[F0
MY7/J,\X]JKZSX9TW7+BWN;I9H[JWXBN+:9H9%!.2NY2#@_UXQ6H\\4<B1O*B
MR/\ =4L 6^@[TYI$3.YE&.3DT 8EYX1TB\T^UM##+#]D):WG@F9)HV/WB) =
MV3WR3GO4D_AC3I[6PML3+'97:7D>)2S/*I)!=FR6Y/.3FM=G55W,P"^I/%9>
MA:I<:F-1%PD*FUO'MU\EBP90JD')[_-0!0O?!&F7SWYDGOUCO7666&.Z98Q(
M"IWA>F<J/6K5[X9M]0N)7N;R^>WEDCDDM#,#$Q3;CC&<?*"0#R<^M6CJH?7?
M[+@C$CQQ>=<ONP(5;(0=.68@\<8 )],TH]8U#59ICHUO;-:02-";BZ=E$CJ<
M,$ !RH.1N/4@XZ9H ED\.P37ZW,MW>R1K<"Y6V>7,0D'0@8R #SC.,TG_",V
M@765$]T/[7.;@[P2/EVX7(X^7C\*A?7M0ATR:]N-)>+['.4NX]Q),8 )EB./
MG SG& 3@]Q@[L<T<L*S(ZM&RAE8'@@\YH RI/#EI+I^EV32W'E:;+%+"1)AB
M8QA0QQR*AN/".G3ZK-?A[N(W!!N8(;ADBN".,NHZ\8!]<<YJ#5/%D<%AI5]I
MHAN[:]U&*S9RY7:&<J6 QS@CVKI P/0@]N* .:O/ VEWHOT>6\C@OIA<3013
M;4\T;<.!CK\HXZ>W2M)-#@BUMM6CGN%N)(5AE4.-DH7=M+#'4;CS6FK!LX(.
M#@X/>AF"C)('U.* .?A\':;;Z%;Z3&]R([64SV\^\>;#(6+;E;'JQZC!!(.1
M4K>%K2:PU"VN;BZN)=001W%S(RB1D P%& %4#)X  Y)ZFE\,:[+KND27EQ!'
M;O'<2PLJ.64;&*YR0/3TK1O-1M+"W2>ZF6.-W2-23]YF8*H'U)% %=-&B768
MM4-Q<O/%;FV56<%=A()R,<DE0<Y[5-JFF6NL:?)97B%H9,'Y6*LI!R&!'0@@
M$'VJV6"XR0,G R>M+0!C0^'8E69KJ]O+RXEMVMA<3L@=(SU"[54#L<XR<#)X
M%:&GV4>FZ=;6,+2-%;QK&AD;+8 P,FFWLE]&UL+*"&56F43F20J4C[LO!R?;
MBLF\UN_FUJ[TK1X+:2XLH(YYOM+LH?>3M12!P<*3N.>HXZX +UYHEO>ZWI^K
M22SK<6(=855@$PXPV1CG( []JI7WA#3[W5Y=32>^M)YU5+@6ERT2S@=-X'4X
MXR,'%;B2'R5>51&VT%ANR%/<9I^: ,"]\(:?=WL%Y#+>6%Q# +</93F(M&.B
MMZ@=J+CPA8S:@EW%<WMJ1:BS>.";:LD0S@$D%LC/4$&N@S1F@#@KKP_<6?B'
MPIIEE?:M':V5K<QB[CC5MO";%<E"G12!D=AWK<O/"%E?>'[W2);BYQ>R"6YN
M5*>;*^0<D[=O\(' P ,#%=#67?:W#!:ZJUH$N;K38M\L)8H,[=X4M@C)'UZB
M@!&T*%M<_M47-PLKVPMIHQLV3("2-WRYR"QZ$5F6O@>VM)-,<:MJCG3&/V4/
M*F$0KM\O 3E<#'K[UO:;=F_TJSO&0(;B!)2H.<;E!Q^M6LT <\WA&S?1-7TM
MKN[,6J3R3SR%DW@OC(7Y< 8&.0:6[\*K=:W%JR:O?P7$,/DPJ@A9(U[E0\;8
M)QR>O;IQ6Q:WMM>-.MO*LAMY3#+M_A< $C\B*9++?+J5O'%;1-9,C&:8RX=&
M_A 7'(ZYYH R)O"4=Q>QWDFKZGY_V<VTSK(B^?&6+88!,#!8X*[2!3(_!EM#
M8Z1;Q:E?I)I.Y;6Y!C\P(R[2A^3!&,=L\#FNEJO<7MM:S6T,\JI)<R&.%3U=
M@I8@?@I- &7_ ,(M9-<:U)/)/.FL;?M$4A7:NU=HV8 (X YR>@-+8^'VM[J&
MYO=4N]1DM@PMC<+&/*R,$_*HW-C(W'L3ZG.WFHYG>."1XT#NJDJI; )QP,\X
MH P$\&VD>C:=IBWUZ(K&\^VH^8]\DGF&3YODQC<QZ 5T,D:31/%(BO&ZE65A
MD$'J#69X:UK_ (2'P[9:M]G^S_:DW^5OW[>2.N!GIZ5JT <]I_A2*Q6U@>_N
MKFQLY/,M;6?85B('R\[=S!>=N3Q[X&+VFZ+'IVHZE>BZN9I+]TDD65EVH57:
M-H &. ,]>@JY>7<5C8W%Y-D101M*Y R=JC)_05A66K^([BYLF?0K;[!=(DC3
M)>X: $9PR,@+$#'3% &GK6CPZYIXM)IIH0LL<R20E=RLC!E(W CJ.XID.BB'
M4Y=1^W73W,MHEJS-LQA"Q#X"XW99CZ<]*U,T9H YB3P/8G3M)MH;_4+>?2T\
MNWO(95$VPC!5CMVE3QQCM]:W--T]--M?)6::=RQ>2:=MSR,>[$ #T'     J
MTQ(4[1DXX!.*RO#.MCQ'H%OJHMS;B9I!Y1?=C:[)UP.NW/XT :U%%% !1110
M 4444 %%%% !1110 4444 %%%% #8_NTZF1]*?0 4444 %%%% !1110 4444
M %%%% !1110 4444 <-:SW&GW.L:/J'AVYOQ<WTEQ;R+;[X)U=@RB1SD*5X&
M3T"C'2LCQFNI:E9^)K&/2[Z.23RE@2ULF9;O&TEWEV\XZ!<C&.^>/4** .,N
M-1M+3XDQW$XG5)=%&W_1V./WI.& &Y3[''?/-8[Z9<VWA_PS"+&>+?XB2Z%O
MM+&")I'8;L=,!AG.,9KMUT<KXGDUHW3G=:"U$&P;0 V[.>N<Y_.M2@#SN83V
MEQX\B;29;V2?;/#;M$WEW">4JG# 8//\(.>#5CP_<M/XSGDVZ@\+Z3&J336+
MVX+*[EE7*@  ,N/YFN\HH YWP+N'@G25>.:-UAVLDR%7!!(.0>>U8MLTMCX@
MMXM(2[DM)]1D^UV%Y:G_ $=CN+3QR$<*3SC)!W\8KO*0$,,@@CVH \SBCO3H
M%_;06UT9K'7S>W-O]G8&>#[07PA(PV0,X4GICO5_7;:7Q5?2S:#)*-NE75O+
M+AHED=\"-"2!G!#GVX]:[ZB@#DM&UBRU.XL6.A7EO>6EN\<TD]HT:VJ@#<H8
MC#9(& N> >E<UX(^UZ ND2W-O<2Z?>PO;1E[9O-LG61B%(QD1L.YYSC)Q7J5
M% '/^,(9WT6*:&*29;:[@N9H8P2TD:2!F '\7 SCOBJ221ZEXYM=3T^7_1;:
MPE2\E"D*^YE*)D]2,.3Z=\9KK:* .6^'NX>#X(GCECDCGG#++&R$9E9AP0,C
M# YJO//+;>--=62)UMYM*C*R^4Q!9/,R-V,=#T^E=CD#K10!Y?IT,L.C_#N-
MH)EFBGS*GE-N0>6RDL,9 R5&3QR*DMDMG>^T;5+'7'NUU*66&.,2B&?,QDC8
M.!M4 %<DD=*],I 0<X.<4 <YXZT2XU_PE=6=GS=*4FA4G =D8-M_'!%20^+]
M/FLE?9<"]/RFP,3"??\ W=I_]"^[WSBN@XSCO10!QR7+Z7X\OKO5E,%M>6,"
MV\S<QHREM\9;& 26SCOBL+^S7A@\.Q2VDOV=O$$MS;QLC;H+<ERF1U R5//3
M(!KTZB@#AM2FTK3?B;I_VT6\,)TF58BZ#:KF53Z87C=S[^]8]C:7FG)8:L()
MO[%_MZYO/*2-B4@D0K&Y3&0H;+>P8&NY?196\71:X+L!([-K0V_E?>!8-G=G
MU [5L4 >7>, )+7Q3JFG,K6=UIT5J2JY6XGWG)7^\50@9'?Z<;_B)K&PBT(P
M6:P1/<!EO%@+"VQ&0&*CJQ!VC<"!GIT%=BK*PRI!'J*6@#R=03HIG)N/*L_%
M:7<OG0-&T<)D^]MVCUS@#C-=%=R)<_$S3I;5AN?1IMK[2/O,I7/'L3CZUVU%
M 'F\7^E>!-*T5%==?MYH%\DC;)'*D@+R'/1<!CNZ$'OFG:C#$8_B0QB7:T*B
M,E.K_90./4[N/K7HU% &=H,JS>'M-E7.UK6(C<"#]T=0>:X:P^Q-X5N#-?2:
M=')KUQ+:7<<8*1L)&=&;(QL('? Y'/->DTM ',^"KVYOM.O9;J"UWB[9?M=H
M,1WF%7]Z![C /)&17-7;6Z:OX@TC7Y=41;V;SHH[: .EW"0H558(6W#&,9&,
M9'<UZ710!Y_XJ@>YN3<Z7$WVK2[9?[05I,&XMG!+6Y;G+$*3G/';[W%?7-1T
M&Y\1^![Z86R:9,ETJ?:(PJ+\B!5((PN#Q[&O1S6/J&AF_P#$>D:M]I"#3A,/
M*\O/F>8H4\YXQ@=C0!Y_+%):2W6IV@GC\-C6_./V*,-A/*VF55*D,@DP> 1P
M2*T[LV46D7>IZ8FH:E:G48)[TM",3!3\Q1 JAL?*20.<=3@X]&HH X#Q%+IN
MK>%?%-SH]G+(\]D#-<K&P65E'  /4JO4@>@SQPW4[ZW@\365U/>7%OI%QIH@
M@N;6))(Q*'8NK$HVW(V^F=OM7H-% 'GL3Z9HVI>'VNA)'H*6MPMM->IA8YBX
M*LQ( 0%-P7@<''%:7P_5!;:^T2;(7UJY>/Y=H*G;@@>E=A10!PH;R?&/BVVA
M=(M2NK.%[)3@,Y$3@LOT;&:I"6POM+\)0:,D4.I07<!D@C&)8$4$3!P.0,9!
MW=21WQ7H^*,#.<4 <K\0HUD\+8D7=$MY;-+GH$$REB?0 9R:P-:LOM,FMW'A
M,1>4^D%)C8X"RR;\@*5XWA W0$_,/:O2:, =!0!YN9-.US3[NY\-75V=733)
M;=8UB$0A'!V/A!AL\*.O4CC)K2TS4-!U>(3:'"8]:BTYX4C2-T-OP/D<?=!#
M;<9Y]*[;%)B@#SBS:RN?"GAJVM73^W[::UW1)@3QN& G\P?> V^9N)X.1ZU1
MUM=/'@_QW="*$M#JK^5(@ *2;( 2I['=UQUQ7JN!G..:,#'2@#D?+M8OB./L
M B26;199)!$0-Y\U-K$#ORV#]:P_"']C7\>CQ27]W!K%@P62S\I$D64+^\+%
M4W%&(8DDX.1GFO2L<TN!Z4 <CX[F-K#I-U.\Z:=#>AKIX8P_EC8P5V!4C:K8
M)R..#U K*U!='7P-XLN+*^DO(9[>1VN)0@A:4QD#R]JA<],X[GUS7H=(0,8Q
MQ0!QNN3:>-$\-%EBC$]]9F)64 \D'^59NM-IW_"5:O8:]?26-M=6\8M7>*(Q
MR1A<,BLZ'#!\G:#GD$5Z)@>E&,T <$]SINF^((H-<+IIEQI$4%G-?\ $;O,1
MFZ"1@4)Z$[:EF71[37O"$ROY=N(+B&V>Z)#'Y4VY+\YXXSZUW! /:C /44 <
M78Z=I^L:MXWTF54,$\\2RK'@$;H$RWUW G/J*3PT;_5+42W*#[?H\$NGH[#"
MO< [6?W&%CY']YJ[; ]** /-/!BZ/>IHCKJEP=7LLB:R$42R))M*R^9A-^W<
M2<D\G')-=_INK6&LVGVK3;N*Z@W%/,B;(R.HJW@9SBJUA9?8H65IGGED<R22
MN "S8 Z   8  'H* /-?%%[8SS^)]DD%O/;RVXD^TG?,SJ4VF(9'EH 3SSDL
M3QWW$M-.U+QOKWG06US;2Z9;298*RMGS1NR>.G?TKMC&F\OL7>1@MCG'I2X%
M 'F>F7R+:^!GU*9/[(:P8-).08OM 10FXG@$ /C/OCFNB\#-IWE:XFEM ;9=
M5E*B$@J,JA.,=LY]O2NH>*.6,QR1JZ'JK#(/X4X*JYVJ!DY.!U- '*>'2Y\8
M^+TD.'\^W*YZ[3",'Z9!_(U6\ SQ:-H)T#4KI8]1L)YEE$[!6E5I&=9%R>5(
M8<^N:Z633?\ B<1ZC!+Y4A3RKA=N1,@R5!YX*DG!]"PQSQ:FM;>YV^?!%+MZ
M;T#8_.@"L+ZVU#2[F>WD\R *ZB3'RO@=5/<>XXK*\#1S/X T:.]0%C9HI5@3
ME,?*#G_9Q6GK&FG5K V)F,5M*=MP%'S/'@Y4'^'/ )],_47XXTBB2.-0J( J
MJ!@ #H* /(=.6WC^&7A!56)7_MJV6<  '>)F!#>^!WK2O=VEW?CNUTJ 100Q
M64AAMH\;58'SBJC'.P$\8KT;[%:XQ]FAP7WX\L?>]?K[U(L,4;NZ1(KO]]@H
M!;Z^M '(>%XM(?6?MVEZM%<F>T!>"SB5(@N1M:11G#]AG!X/7'$VK36K^/;*
MUU4I]B-@[VZ7 'E-/O&X\\%PG3N 3ZUU$-O#;J5ABCC!.2$4#)]>*)[>&X0)
M/#'*H.0'4,,_C0!Y7H]S8IX1T^UQ&ZW.N3BV$DVRW;#NP\PX(9<#(7^(XQZB
MO,D#^&GBGDL;B&V\4QJK0J!$D9=<@*2VU<EAC.,5ZR;*T, @-M#Y0.1'Y8V@
M^N*4VELRR*UO$5D.7!088^_K0!YQJYT^\\6ZWIFLZA9V%JUI";!KB-<&'8=S
M1L2 I#YZ<\#TKNM)O+-+6RT];_S[D6J.%G8"=TQC>R\$9QSQUJ\]I;2",/;Q
M,(_N H#M^GI59M,CDUI-2D*EXHC%$ F"-Q^8D]^@P.W/7/ !S_CK E\,,#A_
M[<MUX..#NR/T%0Z3:6C?%3Q%*;> S):VK*^P;E)#@D'J"1C/X5V3PQRE3)&C
ME#N4LH.T^H]Z9#9VMO+))!;0Q22DM(R(%+D]22.IH YSQ4]G)JVBV5PL+S2O
M+)$ETZB#"J S.I^^0'^51ZDY&,UR^EO#+X.\.>;/O>/7O)B>)RH $[X7@_=V
MCH<\8KTN:V@N0!/!'*!T$B!L?G2+9VL:!$MH54-O"B, !O7Z^] '(0Z%IE]J
M7BGP^(UCM9$MY1#'\HB=D8;U ^Z<J#QZ4OA:XNM5-G;W]L8GT)6@N"PX:X V
M*5SU'EY;/_30>E=+J-O>"TG;1_L<-_(5/F7$19&P>=VT@GC..:73+"2RLF2>
M87%S*[23S;-H=S[=@!A0,]% S0!/97UIJ-LMS97,-S Q(62%PZG'!Y%<*L&F
M0ZKX^V06L=VB!@1&H8*UJI.#CNVXGW.3UKLM'TJ'2+$V\2Q*7=I)/)B$:%CU
MPHZ#VY]R3S4LNEZ?/---+86LDLT?DRN\*EI$_NL<<K['B@#B=-M;2PU;P1-"
M2L]W8O'*^\DS!8$(#>N-N:S=/OK<ZSX:O;*>%$O+Z96DDE5[JY0K)S*5P ,@
M )@XP.0>*]'72M.26UE73[59+1/+MW$*@PKC&U#CY1CC IHT32@VX:99 ^<+
MC/V=?]:/X^GWO?K0!S?@2TL+6Y\1+;6]M%*NK3(!&BJPC 3 X_ASGCI3]<E\
MCXC>&&$S(DEO>></,(4JJ*5)&<<9;FNGAL;2WN9KF&U@CN)\>;*D8#28Z;B.
M3^-$EA9RW<=W):0/<QJ429HP753U ;J : .+\-"'2]<L;26*WN7NX)GM-5LW
M^6ZC!!/FC/+]#NY')QCFK7C"TL)O$_A62\M[9P;N5&:9%.5\ER 2>V<''K72
M6FC:787,ES9Z;9VT\F=\L,"HS9.3D@9/-37EA9:A&L=[:07*(P=5FC#@,.A
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MS '! XZ&NJT#6(]?T.UU.*,QK.I)0D$JP)5AD=<$&@#2HHHH **** "BBB@
MHHHH **** "BBB@ HHHH :GW:=34^[3J "BBB@ HHHH **** "BBB@ HHHH
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M0!@V7A>&TEM!)?7=U;V1S:6\Y4K$<8!R "Q ) +$XS4(\)(-'CTXZI>D+?\
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M2<P2VTXD\Q%Y9""LB#T#*2/RK>HH P-?T"YU&ZT_4-,OA9:A8%A&SQ^8CHP
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M;>%(A$D2+&. @4 #\* .(N[O3G\:Z[;ZX(1Y=C']B%SMV-$5;>5!_BW'!QV
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M/7IT KLE\.Z2FGQV"V2"TCF\]8MQP'SNW=>>>?K27OAK1=1U!+^\TRVGND
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M6K#:7]M/XQ@DT^X*WC//;RJ RR PJ@48.=V5/&* ->WUJPLM"T^6.YO+];B
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MQ)I5E-+'-<M^X($\B1.Z0G&?G< JO'/)%37NLV-@46:1V9T,BI#$TK;!U;"
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MA86,3,DYDD9UD#XP -P)R001]* .NN/$&DVEP\$^HV\<J2)$R%^5=QE01VR
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M%% !69KNAV_B#3Q974D\<0E27,+!6)4Y')![X/X5IT4 %%%% !1110 4444
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M5)-8VDHN0(;6YA</<6^ 3)')NVL?O' 7C&#ZU*/"#+H>D::-2<_V;=+="8Q
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M.(PK<+B4R(<$AP^=W(SSW-.;PK_Q,-)NAJ,S?8)I)W$BAFGD=2K,QXQP3@
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M,TN H\LC<!TR.?FZC-8-JSM<:38^*M3CL]VBH8FU"%&0N6<."9. ^WRP>_\
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MA/YRVVT16^8\*,9!/)QP.O/%=-4-O=V]V)#;SQ3"-S&YC<-M8=0<=#R.* .
MT7P[=Z= -)O?#$%[-%<EXM3D:-HF0N6WN"=^X9Z <D=16MI"ZQI/VC2)-%DN
MXS?R307OFQ^44DE,FY\G<&7<> IR0,>M=?10!P=QI^KQ:AXW2VL9C)J,"O92
MC;L<B'9MR3P=W8UHW5A?P:)X<N+>Q:273#&\UD"H8KY+1L%YV[EW9'...#72
MR7=O#/#!+/$DTY(BC9P&DP,G:.^!SQ4V: .(U6PN=6.O:I;6-P@GT9["&.2/
M9+,YWG.T\@#('.._;DNBTG4$UCP.QM)-FG6,L=VV1B)FB10"<\\J1QFNUHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8G'7'&#GKD=!T_\ 8"6_B.VUK[6$@M+%K1863@)D$L7)_P!D=JY'X?Z*VL^
M=)AN]02;3XIS,;98L.&20L$9]WW<X., ].<4 ;U[XJN=+G\3275O ]OIB0&
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MD311V_EJNS."/F8]SW[U8UG1?[3EL;J&X-O>V,IE@EV[EY&&5AD94@\X([4
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M+=#VP1U[4 +?^(KFWUDZ9;QV?VL0),EM/,8VN-Q((1L8XQ[YSVZUT3.$0LQ
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MS30/&GF,57+*0,D X'/I7-6?AC4H9?!GF&UV:) \=R5D8EB8?+&P;>1GGG%
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M/J;1&*:4EN!(&5L'#89?>@#T2BO*]5M"]EXYO&N+SS-.N3-9N+J0>4_E(QP
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M/%_BE=FWR9;>/KG/[H'/ZUTU !17+ZS>ZM_PEUAI-C>);P7=G/(SF(.T;)M
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MAC<*Y4E2,$9!!'X52@\/:7;#3?+MO^08A2TW2,WE KM.,GGCCG-6=0U*RTR
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M"PG>W2UAB=U>0(&+$LR\#)8<?[.>_'05Q^I^.+5_#FMW^@3VMW<:8V"CME7
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M/- '._$[_DG.L?\ 7-/_ $8M4=2B?Q-JT4NBQSVQ@TRYB:YEMVA&Z50L:?,
M3@@MZ#'O73^(M$C\1Z'<:5-/)##/@.T8&[ (..1["M.@#@$$FM:1X<TV&QN;
M/4;"Y@DG5X606XCX?#$;6!'  )SN^N':3)/;^(+6+26O9;":ZF>ZL[ZU8?8R
M0^7BD( "ECC;DYW<=3CO:6@#S*TNI[#P5;Z<;"Y-W::H5GD:Q>3[,&GD83("
M,/@8^[G&X9]*J72YT+QG'=#53;R75K/#)/;GS)"1$ V, $;E'RC!P,8!XKU<
M52U33(]5MDADEFA*2+*DD+ ,CJ<@C((_,8H XF.>TUV\U:>*6>/6K_2GL[>&
M6SEME.T,>"XP6W-V/  ]":=X5%M>WFFE]%UF/4+%2K_;GD\JT^4JVPGALX
M'8]L5UMGH\D-U'<7VJ75_-$#Y7G"-%3/!(5%4$X.,G/!/3-:M &3XI /A'6L
MC/\ H,__ * :Y#1Y['5X?!IT^W/VC3XEEN'6%D6"/R"K*21_$Q7 YSC/3FN[
MU.R74]+N[!I&C2YA:%G4#(##!QGO@TNG62:;I=I81,S1VT*0JS=2%4 $^_%
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MU'4(9;MS&28[/<%0%>N-H4D>KM63XBBTR+P?XEN-+U:.Y66W@=DM$6."-BX
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M.J:AIUQJ\=C/<PF-%\NXDMWV^7*5R/G^3E?0\@<T =L?$6E_V:;\7), E\G
MC;?YF<;-F-V[/;&:Q_#&MSZMXJ\1QM+<?98!:F"">(QM"61BP*D @Y]:S;NQ
MO((]*UG3O#TD45MJ#7$VG_+Y[HT1C,C#)!<9R!D\8K1\-1WC^+_$>I3:==6M
MK?+;&!YU52VQ"IXR2.O0_I0!I^(_$<?A[^S@]K/<->W:6RB)"VW)^9B "3A0
M2 !DXJ:[\1:?9%1+]I8[5=_+M9'\I2"0TF%^3H>N#53Q8MS]ETV:VM);DP:C
M!+(D2Y8("0QQ[ YJA:FZT;6M<ENK&[N[?42ES;O%"78G8%,+8^[C P3@?,>>
MM '60S17$"30R+)%(H9'0Y# ]"#6=>>(-,L+AX;FX9&C*K(XB=DC+= [@;5Z
MCJ1P0>]1>%-*FT/PMIVFSR%YH(@KG=N ).< ^@S@>P%<C/87%GKNLVE]X8NM
M7AU"X,UK<Q,#$=R@;)06&U5(QGGCM0!V=YXBTK3YWAN;K:T>SS2L;,L6XX7>
MP!"9_P!HBG:CK^FZ5N^V3LNR/S7V1/)Y:?WFV@[1P>3CH?2N$\666J7T?B>R
MCTB\_>01"U^QQ!8[C"C<SN""[#E0I[#@&M-9]1TK7+Z:?1+[4M.U6VA*+%&K
M-"R1[6BD5B, ]?3)/O0!:N=?-IX]1)+V1]*;1C<A(D\Q2WG*H8!06/!]^M=1
M8WUMJ5E#>6<RS6\R[DD7H17*6T-TGQ"L[N339;>!=#-N_E1EHHI/,5_+# 8.
M #T^E6_AY:W%EX*LK:[MY8)XWFW1RH589E=AP?8B@#J**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH S]-UBUU66^BMO,W65P;>;>FWYP 3CU'(YJQ:V5K8QLEI;0VZ.Q=EAC"!F
M/4G'?@<UYM->7VE:9XWU6PO9+>6SU1W"*B,LGRQ<-N4G&,]".M=<9KK6-=O+
M!;^:RAM;:&3%OMWN[ECDE@>!MQCH<G.>E &GJFL6NCI:M=%P+JYCM8]BY^=S
MA<^@]ZEU/48-)TRYU"YW^1;QF238NXA1UXK@+_5;K5_#.@RWH4W,/B2"V=U7
M:)#',5W =LX_/-7O$-Y>:IX;\82B]:&"Q2:V2"-(V#;8@S%]RDY)8C (XQWY
MH [:UN$N[6&YBSY<J+(N1@X(R*6XMX+N!X+F&.:%QAHY%#*WU!X-<4EWJ=W+
MIVCV$SPK%I-O=$PS)&[$DK_$C9 V#@==W/I33?>)I=5T/1Y=4M[:[N+.X-Y)
M;Q+*NZ,A0R[A][).1T&* .ZC1(HUCC5411A548 'H!2UC^(-4F\/^%+O4,K/
M<6T(PTGRJS\ ,V.@R<G%9UW=ZCHNL:/;R:C/>PZD[6S^9'&#$^PL'4J@XX((
M.>H_$ TI]?LUO#9F&XF3SUM9)4A+QI(P!"L1_O#)Q@9Y(JU:Z/I=C-YUIIMG
M;RXQOB@5&Q]0*YSP+;S1RZ^[WMQ,!JUPA20)@D;?FX4'/XX]JGU>]U.3QC:Z
M+:7[6<-SI\LWF)$CLCJZ@$;@1T/0T =517"?VKXEU,ZFNE.?/L;HVD9<PB!B
MFW<TH.7!.2?EQ@8J\MWK.N2ZQ_9VI1V4UC*L,$6U)(W;8CDR$J6P2Q VXXYH
M ZVBN96]OM9US4]/MM2^Q+810%6@1'+M(I;<V\'Y>  !@GGGTQ8_$VN:E-X7
MAAF@M)-1:[ANOW6]0T((W)GG&5) /MF@#O)YEMX'F<,512Q"*6./8#DU#INH
M6VK:;;W]FY>WN$#QL5(R#[&N;BNM4U.\U;3EU3RI-*BBB9XX4'GRM'O+,&#8
M0Y P,'KSTK3\'#'@C0<?] ZW_P#1:T ;=-=$EC:-U5T8%65AD$'L17!0>(]5
MCUS2DDOOM<5[?2VLOE1 6P 5BOEL5#LPVC)R5SN%:/@I;MKC7Y;C4;BY"ZI-
M$$E"?PA0#D*#T &.GM0!TME86>FVPMK&UAMH021'"@5<]S@5%I>KV>LP2SV4
MC.D4SP/NC9"'4X888 \5CS07#_$6!EO[A(AIK,8 %*']XH/49&>,G.>!7,:5
M<:KI.F7>H6MRB6[>(Y8I+=X@WFK)<B,G=G(QGCZ4 >FT5Q5UJ^O:EJ6M0:.L
MP.GR""%5$.QY/+#9D+G=MRV/EQP.IZ5U*SW)T@3LL"77D;RID_=A]N<%O[N>
M_I0!<JEJ&J6FF?9OM;LGVF=+>+"%LNQP <#CZFN-TOQ1J,.LZ?'=W4E[:7EA
M+/(_V<(HDB +& X!9#G@L.>""<U!J%Q>ZKI'AC6;B]8QWFK6DJ6JQJ$C5GRH
MSC<6 QDDXSG@4 =YJ%_;Z7I\]]=LRV\"%Y&5"Q"CJ< $U):745[907<#%H9X
MUDC8C&589''T-<3JFKWFM:-XNFM[LVMMI8GM%B:-2)62/+LY(SC+8&TCIGG-
M%G>ZXVJZ3H%M?PVR-H*7+RF 2%9 43(R1GKT]S[4 =C?Z98:I$D6H6<%U'&X
MD5)HPX##O@_4U8:*-HC$R*8R-I0CC'IBN,;5O$MV;Z?3H3(;6[:!(V,2PN(V
MVL6).\$@$\8 XZ]2Z\UW4+;Q&UI>7;Z='+<1+8[X UO<)A2ZF3!P^=P&2.V,
MT =H!@8'2BN-.O7T7B<V%_=MI\CW@2UAEM_W%U!Q]V3!_>=>,CG Q6QXFUE]
M%TV&2%5-Q<W,5I"7^XKR,%W-[ 9/OC% &U6/+XFTN&]2U>67<]P+42+ YC\W
M^YO QG\:HR7FHZ=X@LM)N;U[B'4H9?*N!"HDAE0 GH-NT@DC(X(ZG-5?A]!/
M'IVHM-=R3/\ VG=K(A10N\2MEA@9Y_R* .PHKD?%&NW>D:G%')=/I]A)!F.]
M-MYL(GW'Y93U5<8QT[\\58MM8OY/&*Z,\MN\#:0MYYD:?\M#)L)!SRO<"@#I
MJI7NJ66GW%I!=3B.2\D\J %2=[XSC(''XUROA_Q+J?B#3-!C::*UNK^WGN9I
MDC!PL<BIM13D9.\')SP#47B0:GGPHFH/;B]&L[1)$I*,-DFUBN>"1@D9_&@#
MO*H+K%@VMMHXN/\ 3UA^T&':W^KSC=G&.I]:S_#NK7=[?ZUI]Z\<LNG7*QB6
M./8'5HU8<9/.2?TJE=BZ?XD+':ND1.CG,K)OVGSA@8R.O- '655U'4+72K":
M^O91#;0KNDD()VCZ#FN4TWQ7>ZSIFA11-%;WVIM<*\WE[E00DABJYZD@8R>,
M]\5!KNIWLOAWQEI%]LDDL+#>EPB;!*DD;$97)P058?E0!W$,T=Q!'-$VZ.10
MZMZ@C(-0Z=J-IJUC'>V,PFMI"P60 @'!*GK[@US]A=WUT^GZ597"6RPZ9!<S
M2M%O9MV511DX ^1L]^F,=:Q= U._TKPKH>F6T#27UU=7:,453L$<LA; 9U!.
M<#[WKU[@'HE%<7/KGBBRTZ%KNP@@G?5HK5#*%/FP.P ;".0K#.#R>E=3IR7T
M=DJ:C/#/<@MNDAC**1DX^4DXXQWH MT5Q%KXLU'_ (2#2;.=K:5;Z>>&:.&-
MBD!12RA9<[7( PP'0YZ=*J-XI\2C1=:UA?[.:+2+Z>"2W$3 S1QL 6#%_E(&
M3C!SB@#T*BN7DO\ 7[W6]5L+"6P@CM8H9(9)86<L7#'8P##N/O#H.QK,T_QI
M>Z]]BCL;<PN]E]IN2L7FLC^88]BKN'&Y&YSTQ0!W=%<O<:OK,6FZ>]W##IMQ
M+O%P"GVE]P^Z(XXR2^[[W!.T Y]14M_%&K7.C>&KI(+9)]3N&MKA71L(0KG<
MHR",&,G:>><9'6@#J'U*S35(],:X07LD1F2'N4! )_,_YQ5NN8CU74[?Q9IN
MC7GV*4SV$DTD\<3*V]6 XRW"G(X]NM9UCXHUF?3=+U.9K$Q3:C_9]Q!%$P.3
M*T8=6+'&, [<'OSZ '<45QNL>)M2@@\12V7V=)-(9%C@FC+&?*!NS \EL+CN
M.^<#J899(]/6:[93(L>^4HA49QDX!)(_,T 6:*XS_A)=37P[;>*-]O)ILKH[
MV@A(D2%W"@A]W+#()XP>1Q3K_P 0:RK^)TMFLHSHRI-&7A9_-0QF0J?F&#QC
M(_*@#L:JW^HV6EVXGOKF.WB9Q&&D; +'@ >])8737^DVMV (WN($EQU"EE!_
M'K7GT5[=WGPPU&[U.X6X+W[*/W>"#]J"CN>,XQP,?A0!Z917+7WB.]T2ZU0:
MDMM-!:Z<;Z,P(R,2&8>6<DYZ+\W'4\4_2-3U^;5+>&\LBUI+"SRR^1Y/D.,8
M49<[P<D<<\9^@!N7&HV=I=6UK/<QQSW3%8(V/S2$#)P/I3?[*LO[9_M;R3]N
M^S_9O-WM_J]V[;MSCJ,YQFN=\9FY&J>%_LBQ-<?VBVP3$A<^3)UP"?\ /:H5
M\7W]A)JUAJL%L^HV;0+ UMN6*8SG:@(.2N&Z^U ':45R\^O7VA:Q;VNM26TU
MK=0RR17%O"R%'C7<RLI+<;<D'/;!J"7Q/J-IH-EXCN%M3I=R8F>!8V$T44I
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M\>BN&E#W# R1>6),K\OWL'H>!ZF@#LZ*CAF2X@CFC.4D4.I]01D5)0 4444
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MV+;2LA19 VX8.S> #R!N_3BK^KZ3:ZWILMA>*QBDP<HVUD8$%64]B" :O44
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M=VY<8(.>N16#8Z#J^D6\>GZ=K,*Z;&NV);FT\R:)>RJX=00!T+*<<9S7244
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD\3>/7&DW96\TP0VDR6KD3,(P" V.3DX]\>U '?P^*=#N+^VLH=3MY+BZ3?
MJMD2#&>#TSCMG-17/C#0+.ZN+6XU*..XMO\ 6PE6WJ..=N,XY!STQS7FUOI6
MHII?P[0:)>PW%C=EKK;;/^Y3S<$L<<;L;B/>M1+E+;XM^+@]I<7(?38QLAB,
MA;]VGRX&3STH [^X\0:5;6EM<O>(T=T-UN(@9&F&,Y15!9L#DX'%9FM>(8)?
M"O\ :>DZY86B2.JQWEPNZ,<\@CL>".:XO3]-UC1-&\%6#Z)<274'GM+>0Q>:
M]F'8G: 3M#$$#+9 P>#6*VAZTOPDU/2&T?4?MYU7>L7V=F+KD'<-N01P>>E
M'L5SKVE6-VEG=ZA;PW+1F4)(^TE #EAGMP?RJN/%OA]A 1K%GBX0O"?,'[P
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MKUA?V<.=0LVNQ;I-/$DR[H\J"25SD#ZU'XO@EN?!NM001O+-)93*B(,LQ*'
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M-:B!2Y:7F*4IN6-EVXY['/8\4 =16!9^%+>Q\67WB)+V[>YO$$<L3E/+VC&
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ML/LES#"MS$1,)!+$S%<\ 8.1TY^M &Y115/5KJ>QTB[N[:*.66")I%21RBG
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M>00C9$P&<L<]#D=,GGI6[0 4444 %%%% !1110 4444 %%%% !1110 4444
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MC@CK5V@#G_"FAWFA0:C'=W$4WVJ^ENT\M2 @<@E>>N#GGWKH*** .>NM#O\
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MRK_PE9S1Z9;V=K;V\-G=?:1("V^,YW'9CNW())_ ]M^XMX[JVEMYE+12H4<
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M*CR3N_[O.2"">23U)YH YGP_=Z[=6FD:O+J5L\%T!]H\ZX79)OZ"-53Y64X
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MY,D4Q_B1_O \=<DT 8?C6'6+/P?J2W.LR2@7D'D/&J)(87D12DF% /);H!G
MSW%;MY>W]AXI\/Z<+LS6UVEP)O,C7>Y10P.0 !U[ 4-X+TZ70[G2Y[F_G%RR
M-+=3W!>=BC!E^8^A' QCKZU>.@V[ZAIM]+<7,L^GK(L9=P=V\88MQR>.V,4
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MG]FR3>2T61_K$##.1R<#DYQZ<UM:+X?CT:ZU"Z^V7-U/?R+),\^WJJ[1@*
M,4E[H N?$=IK<5]/;SP0FW=$5662,L&(.X''('(H X?2=5U+0_#TU_;2VYM?
M[=EAE@>(EG#W&TD/NXX/H:V=0\1ZY=:KJT&B6LLPTV18E1(D99I-@8J[,ZE1
MS@$#WYZ5?_X0BU.@R:2;^[,<E]]N,N$W;]X? ^7&-PSTJ2[\'0SZU=ZG:ZKJ
M-@]ZJK=1VLBA)<# /*D@XXR"#0!KRZA]DT-]2O86@\JV-Q-%G<8\+N9<CKCD
M<5S1UW6+&QTO7+R:WFT_4)($DM4BVFV67&U@^?FP64'(&>HQ76+9VZV(LO*4
MVPB\KRVY!3&,'/7BL.S\*"VBL[.;49KK3K*19;>WF1<J5^X"X^\%ZCC.0,DX
MH YR&?7+,^,+[2);(+:ZC),\5Q&S&;;#&2H((V\#KSR>U6KCQ5>S:A92"^AT
MJSN[:">T^UVQ:.X9QED,F?E89'&/?FME_"A-QJ8BU2>.SU.7S;J (N22H5@K
M]5!  /4^A%+J?A4ZF+JWDU"3^S;H1J]F\:LL84 ?NS_!G'OSR,&@#'O_ !+X
M@N]0U-="L'G33K@6XC$:%9V 4N&8N"GWL# /3/.<"[_:/B6^\175A:?8;6&&
MWMK@F>)G==Y8-&<-@GY3R...ASD37G@V.?6+F_M-5U"P2]Q]M@MG 6? QGD$
MH<8!*X./3K5^PT)K'7KO45NRT4\$<"VPC 6-8\[<'.3]YOSH P;/Q!K4UG>:
M?+);KKD.J"S3$!V-&<,)-N[IY>YNO\-)KWBC5-'U20YMOL\=W!"MJ(R[O&Y4
M%V=3B,Y;@,.=O>M]?#EFOBM_$//VEK86^S'R\$_/_O8.W/I61J'@5KY[]1K=
MU#;7=TMX(5B1MDJ[>=Q!)'RCC.* *^H:_KW]K>);:REL8H='@AN%:6%G9PT;
ML5P&'7:.>V.ASQ<MO$-YK4NG6EB\%G<7.EQZE(TL9E"A\ *!E<\YYSVZ<U8/
MA0FZUVX.HR,^KVL=O)NB7Y=J%-W&,D[B>PYJK-X(_<:2UEJ]S9:AIMJ+-+N*
M-"9(@ -K*00>F?K0!#-XBUI+C3])G@CM=3DM6NKIH86N50!MH"JN#R3G.>,8
MYR*Z#0+O4+W1X9M4LOLEYR'CSUP<!L9.,CG';.*Q[[P2LS6-S9ZQ?V>HVBNO
MVQ2KM*';<V\$8/.3@8 STZ5T&FV/]GV:P&XFN9,EI)IB"SL>I., ?0  4 6Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH RI_$FD6U\;.:^C28.(VR#M5CT5FQM!/8$YI;WQ)HN
MG3217FJ6L,D>T.KR %=V=N?3.#7)3;QX0UKP[=Z?<R:A+)<I"BPLPN/-D9HY
M ^,8&X9)/R[><<5=TRVN8OB."\%RT<&A16K7+0N(VD60D@.1@G!!Z^OH: .N
MNKJ"RM9;JYE2*")2\DCG 4#J35.QU_2=2O9;.RU&VN+F$9>..0$J/6JOC)$D
M\$:ZK@$?8)SSZA"1^M<U=QIXHGT7^Q(Y8&M;.<M,T+Q"(21%%3.!SN(; Z;,
M^E '86NNZ7>SF&WOH9),,P ;[P4X8@]P#P2*KGQ7H0 *ZI;.3&TJA'W%E#%"
M1CMN!%<EX4L[9UTB.[T'7(M3TY<.UU+/Y$)"[69"S%&![*H/7T&:T_!5O'I?
M@EY+FSEM9EFN7E\V!E<DR-@@$9.5V=.N* %\-^()-2TVWU^YUR-;-T)N+22)
M0L3,?D", #D=,'=FNAAU[2I[&2]34;7[-&VR25I JHWH2>AY'7UKB-+2\LO"
MG@N]DM+MH-.D9;VW$#&1"4>/<4QG"L>>.G-)XC@^U0>+=5M(Y/L=SI:6B@1'
M-Q."WS 8R<!E7/3.?2@#LSXGT(2O&=7L@Z2&-E,R\,!DC\A42>,/#DELERNM
M67DO+Y*N9@ 7XX_4?G7/ZY;P[/!1M;0A!J%N_P D!&U!$0,\?+C*CG%9FH6^
MZ'XDLMN2\R*L1$9S)^Y"X7CGYN..] 'H.HZMI^DQ)+?W<5NCYVESUP,G]*63
M5M.A6)I=0M(Q*ADC+3*-Z@9+#GD8YS7#W5Z(=3T..2WNK9)-(53>PV;S2/DK
M^X"[6"] 267T'%9OAN#?I'P_CGM)<V]Q<+*LL##8=CXSD?WBN#TS]* /2(=9
MTVXTTZC#?V[V0ZSB0;!SCK]:6VU?3[NR>]@O(7MHR0\N\!4QUW9Z8]Z\]N/M
ML27^HQ6]Q<V5IXF^TS11)N+PB)064?Q ,<\=QGMFK^KSVNHZ-J&J:+I-_@7=
MM<73) T4EV$(SL5ADE0!VQD>U ':V&IV6IQ-)9744ZJ=K>6V2I]".H_&G7NH
M6FG0B:\N(X(R=H+MC)]!ZFL#PO\ V?=:A>ZE8KJ;M/'&LL]ZKQ[BN<*%8#)&
M>3COUJ+5IWTSQ[I^I7P8:4UB]LLY^Y!,7#9;^Z&50,GCB@"YXC\5V>B^%YM7
M@GAFW1DVV&W+(W;D=L]:LZ#+<7,,EY_;,.IV,^#;2)"$*XR&RRG##/3@$8Y)
MKB-9B,7@GQ4\22"UU&^S80JA)?[FXJO7!97;Z#/0UZ:C*Z*ZD%6&01W% %-=
M8TY]1;3EOK<WB]8!(-_3)&/7'.*'UG2XW*/J5FKB3RBK3J#O_N]>O/2O.%NU
M$^D3_8[JW":Y([6B6K;;=69PSRN03N.=W! QQCC-/U:U_P"))\0V:U8M/<A8
M3Y1)D.Q -O'/S>G>@#TI+ZTDO'LTNH&ND7<\*R NH]2O4#D?G4D<T<N_RY$?
M8Q1MK [6'8^AKB_$<-SI1T;Q390-->6ZQ6=U$6P9H9"% Y_B#LI'ZUU6D6!T
MW38X'?S)R3)/)_?D8Y8_F3CVP* "]UC3=-DCCO;ZWMWD("K)(%)R<9^F>,UE
M>)_$T&C'3K5;VV@N+ZX6,/(P/EQD$F3!(XXQGIDBLBTGM]'U_P 4KXA*^7>2
M+) 98\K<0[,>6@YWD'(V#GGIS6>L4NF:!X&L+Z1A<P:@DKQR_?BAVRA=_IM#
M(I/3- ':6EU/IVD7%WK>H6DD,;-(MS&NQ?)_A)Y//TZ\5A7OC07%GX?U#2+F
MV:SO]1CM;A9!N=%8,>H;Y3A>A'?M75WRE]/N552S&)@ !DDX->66]S:77@KP
M'9EE=XM5MXYHG7[I57# @^A8#\10!ZE;ZC97ENUQ;7EO/"N=TD4H91CKD@XI
M+/4;+4%9K*\M[E4.&,,JN%/O@UYOJ2S3W7CN.P226-+NRE>&W^\Z*J>:%&.2
M=K ^I&*W_"L^CZEK,NI:7)J-Y*UOY4]S=(4$8#96/!5=QY/3. .3R* -S5O$
MVEZ+>V5I?7<44UVY5%=PNT $[FR>%XQGU-7'U.PBN8[:2]MDN)0#'$TJAG!Z
M8&<FN=\87$5GJ_ABZN&\N"+4&WR$<+F&0#/XFN8FFMQJ&OZ/XBGU99;R^>:V
MM;>V#"[B.#$%<1E@1M ^\,8[<T >E3ZE8VI(N+VVB(8*?,E5<$]!R>IIO]K:
M=OB3^T+7=,Q2-?.7+L.H'/)Y%<9I]AIM_P#$S5TN;2&<IIUME9D5\."<Y[%A
M\O-<]J?V*7X7^*<(GFIJUPL/R8;=YX=0GX$'B@#UF"]M;IY4M[F&9X6VR+'(
M&*'T..AIL&HV5U,\-O>6\TL9(=(Y59E(]0#Q7)QK:6GQ606R11PG0FXA4 $^
M<".GMG\*H>&+M8M=TJRM)K+5M/>WD:VN%0)<V*8!VR <8)P.0#GK0!Z!-/%;
M0M-/*D42#+.[!54>I)Z55FU>QBTJ74A=0R6D:,YEC<,I ]".IK%\62_9]1T"
MYNDW:5%>$W)(XC8H1&[=@H8\D]#BLBYCB>Z\87EJT1TF;3E#,IS&]P%?)7L3
MC8"1WQW% &[X<U'4]7@L]2:XLI;"[MA*T2*1);NP!5,Y(;@\YP<CWP+$_B.S
MD?5+2QNH'OK&'>RDAE#88[< @DC;R.V14?@J../P3HFQ%4FQ@W[1C+;%!S[U
MC1&VB\7^+TN @EFMX6B0D!Y$$)#;,_3G% '0^'M8&K:'IMU/) MW<VD<\D49
MQ@LH)P"2<<U?%Y;&Z-J+B'[2%W&'>-X'KCKBN TH6,-C\/9@(DNV54=EX9A]
MD=2#CK\P0<]" *SM#^R7-O;V6MW>J?V[::F96LDBCW--YA(=7V9*;2,L7Q@>
MF* /2=9U--&T2]U.2-I$M86E*+U; SBLK3-1UVZ.G7;KIUSI]Z SM;;@UN"A
M8'))$@SQG"XR./36U:[CL=)NKF:![B*.,EXD3<77N,=^.U<+;VECHGB'3)/"
M&I!K74+G%WI4;^9&$():0#K'M[C@=!QTH ]"-S +@0&:,3$9$>X;C^'6E:>%
M7"&5 Y.T*6&2>N*\JLWL)9M4L-<O]1BUF+4GF6UABC$DQW[HC$Q0N1C:/O
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.F&)KV]:"19)5SA0QP#@C# 9SZ4 =;15+5)$31;J2XM)+B/R&\V"(C<RX^8
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M>QP<$U5T[6%M)M>-U<33B/5##;Q+\[G,,3;$4=<%F^G)/ )H Z955%VJ !Z
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M2RN9?,,.X1.8_, R4WXV[L=LU9OM0M=-MOM%W*(TW!%X)+,3@*H'))/  Y-
M$KP0R2QRO$C21YV.R@E<]<'M4?V"S\N6/[)!LE.Z1?+&'/J1WJG#XATR>TN;
ME+A@EM)Y4RO$RNCG&%*D9R<C QSD8J?3]6M-3,ZVS2;X&"2I)$T;(2,@$, >
MG- %Q$6-%1%"JHP% P /2L]] T>25Y7TNR:2259G8P*2SKT8\<D>M177B;2+
M.YNK>>[Q/:J'GC6-V9%()W$ 'Y< Y/0=ZDM=>TR]N8H+:[61YD+Q$*=L@&"=
MK8VL1D9 .10!8CTVQAOYK^*S@2\F 66=8P'<#H"W4]!^5%WIMA?R027EG;W#
MP-NB:6,,8SZC/2JI\1Z2MZMH;Q?-:?[,#M;89<9V;\;=WMG/:IK+5[#4+F[M
M[:??-9L$N$*,IC)&1G('I0 PZ#H_V=(/[+L_)2;[0L?DKM$O]\#'WO>K$6GV
M4%[/>PVL,=U< ":94 >3' W'J<4MO<Q:C81W-K*WDSQ[HY N#@C@@,/QY%<A
MX*\96EYX=TQ-5U5'U.X=XV+C&7WMM4D#:&P!@<$\>M '6WVFV.IQ+%?V<%U&
MCAU2:,. PZ$ ]ZC.BZ69+N0Z?:E[Q-ERWE+F9<8PWJ,>M17/B#2[2X>&>Y*%
M'5)'\MBD;-C 9P-JGD=2.H]:MWU];:;92WEY*L-O"NZ21NBCUH @71-*26TE
M33K59+-=ELPB7,*^BG' ^E+;:-IEG;3VUMI]K#!.29HTB 60D8)8=ZBLO$.D
MZC="UM+V.29HQ*BX(WH0#E21\PY'3.,T1>(=*GO8[2.Z!EE9EB)1@LI7[P1R
M-K$8/0GI0 Y- T>/37TZ/2[-;%V#/;K HC8@@Y*XP3D _A4]CIUEID)AL;2"
MVB+;BD*!03ZX'>JP\0Z4UY':B\7S))#%&2K!'<9RBOC:6&", YX-$FOZ9%>B
MU>ZVR&40!BC;/,(X3?C;N]LYH GGTG3KF]6]GL;>2Z6,Q"9HP7"'.5SUQR>/
M<U"OA_1DM8K5-*LUMX9?.BB$*[4D_O 8X/O2MKFGK>_9#,WF^8(21$Y0.?X2
M^-H/(XS3(O$6ES7R6<=R3-)(\29B<*[IDLH<C:2-IZ'L: )-;LKC4=%N[.UF
M2&6:,H'==PP>H/U&1GMG-<YI_A/;J=I=?V#H^CFUE\SS=/E+22C!&S_5IA3G
MG.?3'<;UIXCTB_NEM[:]5Y'1I$RK*)%!P60D88#U!-4Y/&_AN.,2'58F0J[9
MC1G 53M8G . #ZT :,>AZ7%J+:@EA;K=LQ8RA!G<1@GZD<9ZFB?0]+N=06_F
ML('NUQB4KR<<C/K@\C/3M4K:G9J+,^>"+TXMRH+>9\I;C'; )S3KW4+73H5E
MNYA&K,$48)9V/15 Y)]AS0!#J&BZ7JS(VHZ=:W;1@A#/$KE0>H&1[58L[*UT
M^T2ULK>*WMX\[(HD"JN3DX ]R35%O$FC)8/?2:C!%;QR>5(TIV%'_NL#@J?8
MBK.G:K8ZM%++87*3I%(8G9.@8=10!<HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#EH/#^JPWOB
MF>*Z@MWU7:;65"6:%ECV L" .P/!JKI/AC4K#7M-OWM]+2*WM'MYO+D=I)'<
MJ6E+%/F)V]#SR>379T4 <,G@W45T$6IFM3=0ZU_:D0#ML8>9OV,=N0>2,@>E
M:8T&_;Q'JFJ.;95O-/2V6,2,2KKN/)V]/FZ]>.G/'34E &3X7TNXT3PQI^F7
M3Q/-:Q"-FBSM..F,\],5S*>$]:>XT^::+33<6>I?:I;IIG:6Z0!PN3M.W ?&
MWD<<8KO*6@#D)/#U_<>*+?41;VUC)%<L\E[:2G-S!SMCDC(P21M!))Q@D=J-
M,\/7UOX@BU-K*TL)%C<7?V*8^7>L1P2A VD'G)Y[<UU]5+[48-.^S>>)3]HG
M6!/+C9_F;.,X' XZGB@#EK'0-2B\-RVE[I>GWAN+^>XGM)I=R[)&9@%;;C<"
M1R1V/2JW_")ZQ:6&E/;M'<2V&I-=Q6DURV(X64J(A(02=N<YQ[>]=[10!2U-
M+F71[F."%)+F2%E6,R87<1C[V.GOBN8TSP_JMM/X/\Z&$)I-G)#<L)<_,8P@
MVC'/W<_C7:55U+4;;2;"6]O'9+>+&YEC9R,D <*"3R1VH RO"NFWNFPZI]NB
MCC:ZU*:ZC5)-_P CD$9X'/6L^31=5AU[Q/<0V\,MOJUO&L3F;:R.D13!&.A)
MZYKK@<@$=#2T <1:>&]5A3P4C10_\2=&6Z(E]8O+&WCGUIN@^'_$6CR+II32
MVL8I2T6H[?WXCW9V;<8W8R,YXSWQSW-% &%XIT:YUC38/L,L4=]9W4=W;&49
M0NF>&QV()&?>J=_!XJU/1+T;;2QN75%AMX;AFR P+YEV@J67(&!QG/7IOZCJ
M-KI.GSWU[(8[:!=\CA"VT>N ":L1NLD:NIRK $'V- '!6OA?5+;_ (2C[/IU
ME;1ZO8I'#$EP3Y<BHR$,=HSG=DM_.KVJ:'JUYX3\/V"QQ/>6<]I)<EI<#]U@
ML0<<DD?K78TE '+>-[>WO](\J*[CBU:UFBN++!!<3;L(,=<,<KZ<GTI=>\.7
M$W@&ZT+3L2W$T6S?*^W>Y;<SL?4G)_&MIM&TQM6&JM86[:@%V"Y,8+@>QJ_0
M!SL=AJ \:W&L/;(+<Z8ELH$H+-('+D8QT^;&?:N6.E:CIV@^%=#6&W.MVIED
M3R[H(Z*H(+(Y1A@AE!!4YSCMD>EU2O\ 2=/U,Q&]LX9VB.8V= 60_P"R>HZ#
MI0!B^%!+9RWFFW.F/:W>1=33&Y$XG9R06+ +@_+TV@<<<"DET_4M(\4W^KV%
MH+^#4HHUFA618WCDC!"L"QP5(.#W&.];UEIUGIL31V=M' KL7?8N"S'N3W/U
MJU0!P;^&=4L8=#O;:WBN;NTOKB\N;=9=H)F#Y"L>,*6 [9QFJ]UX6URZ\.>*
MK5[>W6XU'4$O+=5FR& :,E22!C_5]??M7HE% %4++>Z9LN8C;2S1%717#&,D
M=,C@D5QBZ!K5WX1@\)7MHJPPO%$=025=C0QNK A?O!BJ@8(QGG-=[10!S%C8
M:A%\0M3U&2S*V,]G%#'-YBG+(23\N<X.[]*F\50:S-'8G2HVFA2?-W;I.(6E
MCVG #]N<9Y&:U+_5K'3)+6.\G$37<RP0#:3O<]!P*NT ><OX:U;_ (1+Q7ID
M6CPV\NH7!EM4BN%*D,%!'.,8VYYZYK;FTS4IO%OAR_-H!!:6<T=R_F+A'=5P
M ,Y/*X_&NKHH P?$]F;^VMK=](_M*V\W=*$E$<D. =KH21\P)[$'FL==*UZ+
M3-#FDBEO;C3]0DF,4TZ><8"LB*"_W68*ZD\\^M=;-?6MO>6UI+,%N+G=Y*'.
M7VC+8^@JS0!P9T+7KBTUN9;:"UO9-4BU"T1I0ROL6/Y6(Z9V8S[U:UJ'Q)X@
M\*:M:3:5#:23VWE0VPN%D9G)Y8OPH4#MUZ_2NGMM3LKR\NK.WN$DN+0J)XUZ
MQELX!_(U;H Y1-*U#_A,=&U VV+:#37MYF,B_(Y*D#&<G[N.*M^)[&[NO[(N
M+*T^TR65^EP\8=58H$=3@M@9^85T%% 'GO\ PCNI66N:NX\-Z9JL.H3_ &F"
MYNF3= S* 5<$$E01QM]_7CH=-TJYMO&.K:A+ ODW-K;1I,&'+)OW +U4?,OY
M5T-9A\0:4-473C>(+IG,:H0<%P,E0V,%L=LYH Y)-%UT>")K1K#??/JWVORS
M,@+)]H$V<YQG QBMJ2SU!?%&LW\=@LL$FFQP0B210LTB&1MN,Y .\#)]#735
M4L-1L]4@:>QN(YXE=HRZ'(W*<$4 <[X8TF\TW5YO(@O;+1VMP!8W,JR+%-N_
MY989B%QG(R!R,#T/$MKJUQJX6'3IK[3FLV41Q7"1*9B3_K-Q!9<8P.F<Y!XK
MK::[K&C.[!549)/0"@#A-)T#5H+KP2)[/RTTFTGCNF,BG:S1A !@\Y(SQ58^
M'M<&G374=D!=6OB.74XK5G4&XA)/&X' 8ACC/H*[ZSO+;4+2.ZM)DGMY!E)$
M.58>QJQ0!RFA6FI2^,=3UF\TZ2R@N+2"*-)9$9MRELYVDXZBKFLVMY-XF\.W
M$%JTMO;RSM/(&4>6&B*KD$Y.2>WI6J^H6D>H1V#7,2W<B&1(2WS,HZD#TI]S
M>6]FL;7,R1"218D+G&YV.%4>Y- '$WFDZP?!VK6\6FN]Y<:NUS%#YB<I]H60
M,3G&,+]?:NOUFVDO=#U"TA ,L]M)&@)P-S*0/YU>HH XNPL]3D3P@)]'EB^P
M!DN/,DC/E8AV!N&.<GICGUQ5"Z\.:Q=0ZW*MKF5-:CU&R@FE4)<*@7*G!. V
M#UQSC->AT4 <]X<BG9GN9O#MOHV4";-R/*YSD_,G&T=NY]N\-U8WL7Q$L]5C
MM))K-M.>T=XV7]VYD5@2"0<8!Z9KIZH?VUIAU#[!]N@^U%B@BWC)8#)'UP>E
M '!/I.OW-SHMW=:/=->6NJ>?=.+B,1"/+@>6@?&,$$\ ]<YS4@T+7-/U75=>
ML+*9KV/5'DBMVF39>6T@C5@,MA&!3=N.#QCGMZ15>UO;6^1WM;B.=$<QLT;!
M@&'4<=Q0!CNE[)XNT^_%A*+?^SI8Y6+)^[=FC8*1GD_(1QQ[USMIHFK1^$/#
MMH^G2BYM-86XFBWIE8Q*[[L[L'AAT.:]"HH \WU&&\OM;\0066G:A+IEY*D%
MX]MY+"4JBARI=P5./D( /W3C!Z=K;2P:OH'^AF2&*:%HDW*5:,C*D$=B"#^5
M9=UI?AZ/4I8SJ;V4\[;Y;6#46A#L3N+% PY/<CK7210QP0I%"BI&@PJJ, "@
M#AH]+U*X\&6?A62RFBNH&AA>Z&/*"1.K>8K9YR%&!U!/.,9K<M(;[_A.M1NI
M;61;)[*&"&8E<%E9V;@'/\8ZBN@J WMJ+X6)N(Q=&/S1#N&\IG&['IGB@#$\
M31:C->:4MK9RS6@E=KJ2V9%GC&S"A"Q& 2<$J0<?6N7;0=8N?A_KFGC2)8+N
MYU0W,,,DR,SQF='R6W$9"@@Y.?EKTJB@#!\FZ;QU]H^RR"TCTXQ_:"1M,AD!
MV@=>@SGI4?B>RCNY;)GM+\O'YABOK!\2VK8';JP;D$8(XY%=%30RLS*&!*\,
M >GUH XI[36AJ'A+5[^VEN)K2&>*\$*KO#2*H4E0<?P\XX!/I6;:Z5K]A8/J
M$&FR/<6WB"YO?L9=0T\+AERISC.&)&?3Z5Z34"7EK(X1+F%G/15D!)H XOQ&
MNJ:WX:9ET.>UD>^MG2W(5I6575F=MI(' P!UX]P!JV5G=+\1-5O6@D6T>Q@B
M64C"LZLQ('K@,*Z:B@#D_$2W\NN)%'IUU+:FR<+-:;59Y2?]6[D@JO /! .3
MG/2L31X-9T*+P[J(T:YN8X],73KNV0 30L"#O )PRDC'Y&N]N]1L;%XTN[N"
M!I#A!)(%+'VS5D4 <;=P7S7OA?4CHKVT=K<W#3VMOM=H5>-U4D+P<Y!.,X)/
M7K5+4O#^I:I?^.(8H'B&H06JVLLG"R%$.X _7C\:] HH Y.5+G7]>T"]6RNK
M,:>TLUR+B,H5+1E1&#_%R>JY&!U[5BV>EZC'X-\-6S6%P)[;6%FFCV?,B"61
MMQ]L$5Z-4:30RR21QRH[QD!U5@2I]QVH XB.&]B\3+/I-OJ5HTU^1?6EQ$6M
M98\D-.KGA6( (P>3C(ZFMOQ:+\Z?:"QM///VR/SF6)9)(8^29(U;C<.,'MG-
M=!10!YS9:;*LWBD7ND:K)97EQ;/$&<F9E55!D5MQ.58!L9R, 8XQ71>$UU2,
M7T5[<7-U9I(HL[B[A\J=UVC<'& 3@\ D GGVKI*;)(D,;R2.J1H"S,QP% ZD
MGTH Y&6TNX]=\771M)S#/8010,J%O-8))D*!R<%@*I:?8WD+^ (#97*-96[K
M=?NFVQ'[,4^9L8&6]^:[J.2.:)98G5XW 964Y# ]P:?0!Y?JT&JW&V0Z5J$<
MT.N13M;VL6(4B$F3(" #*S#DGG&>@Q6WX@T^Z3Q79R:>RQKK<)LKY<X(5 6\
MT8_B"[DS_M+STKM:R[#0K:PO[F]$]W<3S,Q#7,[2>4K')2,'[JY X'H/04 :
M,420Q)%$@2-%"JH'  Z"O-++1[^?P!I_AAM/N8=0BO5:5WA(CB43F0N'^ZWR
M]@<\UZ8\B1[=[JNX[5R<9/H*8+B!GE431EH?]8 PRG&>?3CF@#S^2PEAU36-
M/O\ PW>7XO+EY[:>*5OL\@;!"R?, F#UR.@XS74>+8)9_!6L6\$+RS264D:1
MQ*6+,5(  ')YK:CDCFB62)U>-QE64Y!'J#3Z .$CM+IO$?@]EM+J..'2Y8Y9
M/(8"!FC3 8D84_*>#69X9T8PPV&FWOAK41J=C(@^T3W,CVJA"/WR$L5#8SA0
M.IQP,UZ49HA,L)D02L"P0L-Q [XJ2@#@/#3ZA::;:>';_P -W$MW8W(*74R
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M4YNZKHEOK#V#7$LR_8KE;J,1D#+KD#.0>.3^= '*ZOXDU.PU":6.\,J0:C#
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MVD:(0SD8+(Q&4)QR1U]N,7K70OLWB:]UG[06-Q;QVZP[,;%3)SG/)))H SM
M\07FL:@T3RV<+QLXN-/DC>.XA4$A6&3\X/'. .>O:M76]4;3+>V$2*UQ=W"6
MT._[H=L\M[  GWQCO5*S\/WJZG9WFI:E%>O9!Q#*+41RMN&"'8-@C'8*.<'M
M5[7-&BUNQ2"21X9894N+>=,%HI4.58 \'Z'UH IV^IZC!K_]C7[6[R36S7%M
M<11,JG:P#*RECR-RGKSFLCX:I=3>&/-O7@F_TVX>,B,AE?S7#$DD]23C&.#W
MK>M=(NEO3J%]=Q7%\D+00.D!1(U)!/R[B220N>1T&,4>&=#;P[H_]GFZ^T@2
MR2A_+V??8L1C)[DT 4M3EU=?&VD06UY EE+!.[PO$3G:8\G(89.&X].>M8>G
MZE?:1IFLW]C' ]M%KMP+B*7.]@9E5BA! &,DX(-=;J&DS7>L:=J,%X(&M%D1
MD,6\2(Y3(ZC!^0<\]:S!X2D&A:GIHU$;K^]>[:4P?<W.&*@;O4=?>@"KK'BK
M4HM4U&RTJR:9]/5,@VDLHFD90^P,G"<$<G/)Z8%=59SO<V4$\D#P/)&KM%)]
MY"1G:?<=*Q+SPU='7;C5=+UB73Y+M$2Z00I*LA7A6&[[K <9Y[<5NP0BWMXX
M59V"*%#.V6..Y/<T >=W+3>$HM5LO$>G_;/#NH7,LOV^!=[1>:>1,N,\9X89
M[>U;NK^*KF+5UTW2H#,WV1;II_LTDZ%6)" "/D9VDY/IT-69?#VHG39M*CU9
M#I\RNC^=;;Y@CYR%<,%XR0,J<>]17GA*5;VRO=#U1],N+>V6S<M$)EEA7[JE
M21R.Q]Z *<WBO7';0K6WT:&"_P!5AG)CO9&00O$!G("DE3G([XQTJ[)K$VGZ
MO,VJ6EF#;Z1]KEFM\L^5/SJ"0/ESG'K[5++X:N9-?T34CJ;2)IB3!EECW/,T
MHPQ+ @+T& %P.G3&'W/ALWOB2ZU&YN$>SN=..GR6HC(8J6))W[O]HC@4 9NC
M>+-3U#5+6"32YI+:XC+M-':31+;G;N 9G #YY&5QR/>K/ACQ%>:^ZS,]AY6U
MO.MDW+<6K@@!'5CSW!.!TXR#4FA^'-4TM(;>[\037MI;#%M&81&PXP-[ _/@
M=.GOG I-/\-WJ:W9ZKJFH6UU=6MN\ E@M#"TN[;S(=[!L8X  &2: -V_O8=.
MT^YO;@XAMXVE<^P&37 ^'-3CL?'&V34K>Y.OV_G2)%.L@@N8_P" 8/ \L@#U
MV5V>LZ;<ZHMI%%=1PV\=S'-<(T.\S*C!@@.1MY R<&JGBG0+C7K>Q%I>QV=Q
M9W:74<SPF3#+G@#<.N>?:@#>KR>*TCOK'QGI=II,MQJ%QJ\XMY8X<+$Y5"&,
MIP%PWS=<^QS7JRA@@#$%L<D# S6'X9T"XT$:H9[U;IK^^DO25B*;"X V\L<@
M;1B@"FFL:S%K2>'X(+2YN[>P@N)IYYF0.2Q5\84_W<CZU4MO&US>7EO+;:?+
M/I\]QY($=K.9 N[:)=^WR]N>2,\ ]<\5MQ:'+'XQN-=:Z0QRV:VH@$1!7:Q;
M=NSSU/&/3\:&E>%=0T>>2WM=<9=&,QECL_LXWQ MN*+)G[I)],XZ$=: ,PWX
M_P"$F\9/J\=M+IEE;6ZS1LA8M%Y;OC!."<L:N:+XJU+4-1M;>336,5U TBR)
M;SQK P (1V= "",X8=QTZ$W$\*"74O$<U[<I-;:U&D3PK$5,:JA3[VXY.#Z#
MFG:'H>MZ:L$-[X@%[;VT92%!:B-FXPID;<=V!Z8R>30!DQ>--7;PC<>)'T>W
M2TCM7D5#<G>9%DVD$;?NX!(/?CIFM&\\27NGRPV]W9Q)<71=X!!YL^V%=N6<
M(F0V6 P,CGKZQGPC<GX?/X8.HQF5XVC:Z-OQAG+<)N]#CK[^U6M;\.W>I2:9
M>66I_8M2L"0LXAWI(K !U9,C@[1WXQ0!3A\6W=U8VL<>FR0ZK=73VL4=Q&\<
M1*#<TF2H;9MY' )/''6H/!GVC_A*/%WVM8EG^UP;Q"3M/[H<C///7';/?K5Z
M\\-ZE<PV-TNL ZO9W!N$F>']RV5V&/8#E4*\<'.<G))JQX?T&[TJ_P!6OKV]
MBN;C494E810&-4VKMP 68G@"@!^NZM>:?+#%;):QHZ,[75Y(5B4C&$XY+-GC
MV!//2L^U\7OJNF:%+I]NJ7.L*[1^>3LBV ELXY//0<9]15O5]$U.ZU^UU33]
M0MH3#;O 8[FW:51N(.]0'7#< ?2N3O=%DT+2_#WAV36K"(VHFGBN;R I&[*1
MM /F AQO8\'D \<4 ='9^)=4NM%O[DZ3%]JM+HV>Q+@E&=6"NY)48C&<YY.
M>.*CM_%:WNC>(9)K6UN1I:MYBQ2[X;A/+W\$KW4XZ$9]JS8=.U+7-'?2[:[T
ME8;.XAGBEM(G>WGPS,T3@L=W(!)#'KS6A'X5U00>)$GU&UF.L0; 5@9!$YC\
MOCYC\H&,#K[T 2)XDFB_X1RRLM-MPVK63S1*9=D<12-6V<*>/F X'X5$/&K)
MX?:]N8((+J/46TZ;=*WD12*Q!9GVYV<=<=QG'46(_#%U'J7A>X^TPF/1K5X)
M%VG,A:-4R/0?+1IF@:II-E>I!<6<LMWJ<UY*LD;;&CDSE/7.<<^U %/Q!KNO
MVMMHC6L=C$UYJ<=J["4R+(I^8%2!PIVD'C([>M==+.MM9O<7+*BQ1EY",D
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MWD0[]I\Z2)&#)$1C Z*"V>0.@SF@!;_Q=J%L=;,&DPNFBL&NF>ZQOC\L2?(
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M1W5M*R[@LB'(R.X/(/UJF^AWVI7=Q>ZC);Q3/8/90Q0$NL>_EW+$*23A>,#
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M&FP.T=E&$BP&D# \D-@$<\<$<#%<[IL%I>:5\.(KK8Z2M<1N&/WU*-E3Z@G
M(_"@#U^BO/SI.C-\3FL&L[0V<&A F J-B'SCR1T!P:QO#L-K%X;\":H=JWLN
MH&!I\_.Z%9E"D]2/E0 =* /5S(@=4+ .P)"D\D#K_,4[->3&32[N]UJ'6-7%
MEJT.ILZ1)$OVE@&_<^4Q^9LK@87U]ZM:C9V5]J?Q$\^*-A#9V\J9QF.002'(
M]&S0!Z'+J=G#J=OISS*+NX5GCB'4JO4^PJY7F=NMI<>)? ]YJ"6[S3:.SO-.
MJDNX2,J23U()./K7H=KJ%I>M<+:W,4S6\IAF"-G8XZJ?0\T 6:*** "BBB@
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MH **** "BBB@ HHHH **** "N3^(6KW&F:#!!:2^3/J-W%9+*#AHPY.YE]\
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M=G]GVWVOSHI"_F)Q@;< [N?4UAW'PVE;X??\([;WRQS"\^U(SEGC3YN$&><
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M2B]M#<%%E;/[LDX.Y1U*D?@<5)IOAC6+71O#=C+;VX?3-3:XE:.;*F(^9R.
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MV19=.212VP!BS!\ ;\E<#MCKSQ?\*:;?:7974%T]Q]F,Y:SAN91++#%@?*S
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M._-0Z_\ \BWJG_7I+_Z :X?1UOM*T3P5=V^J7<JWJV]M-92,I1HWBZJ  5V
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MM<,L]H+9566-9C&?FY(;'3&!6LVLZF]QXU@6[*_V8B/:.(U)CS!OQTP1GUH
M[.BN$CUS6]0D\+VT-]%;-K&DM/)*+<.4E"(VX G&,MTJXD^NZN-2BT[5HX+K
M3)5M5#PILN) B,SR#!*JV[ "XQ@]>P!T2:O8OK,FD"8_;DA\\Q&-A^[R!N!(
MP1DXX-7:XN]M;ZZ^(\BVMRMI-_8B@W*QB0H?// 5N.<'J.U5[#Q'J.K^&/#U
MRVH)9SWGF"?R(1)/,4W+^[0J0,D9)(P* .\HK@H?$6M7/A'3-0(GVFYEAO[F
MT@626-$=T#B,@@Y*C=@' )P*DE\2W5PFCV6F7LFI->QSSM=V*0K(R(P"A5E(
M0'YANZD;3P,\ '<T5D^'I=6ETS_B<PK'=I(RC!7+)GY68*2JL1U )&>E9(OM
M7UA]8GTZ^6U73;EK>&W:%669D56;S"><$G V[2!SS0!UE%<-:>)M4\076D1Z
M=-!91ZEICW67A\TQ.KH".HW#YB.WK70^(=7?0/#=QJ#!)9HE51D%59V8*/7
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MW*<#'3Z\>CT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M);:F^I0Z= EV[F0R*/XSU;'3/7G&>34=SX1T*\EN))]/5_M#;YDWL$=N/F*
M[=W ^;&?>MNB@!DL23Q/%*@>-U*LK#((/!!K,L_#FEZ;)%-:6K>9 A2W$DSN
M(@>H0,2$';Y0...E:U% '/:1:W]_JIUK6-+AL+J.$VT$2SB9@A.YF+  <D#
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M'/')JMK7A32]=N[>[NTFCN[<;8[BWG:*0+G)7*D<'^IQ6W10!@2>#M),UG+
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M(Q?>R-WVYZ'MBKOB+1-7\9VEKI=Y;+ING&19;UA.))),<A$P,8S_ !''0<4
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M=1!<E A=2!]X _>W$C@#/&!6#H8E\%/JUI?6EU)82WCW5M=6T#395\91E3+
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M#P#I$4T,D,J0E6CE0HRD,>H/- '3T444 %%%% !1110 4444 %%%% !1110
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MA4\@_3J.XH U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[X<:PMUMN+>TU80Z?--\["$3QC 8\D#YESW KTZ\L+/4(U2]M(+E%.0LT8<
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MJ5[%>WNF6MQ<Q#"2R1@D#T]_QIU_HFG:G,DMU;[I44H)$=D;:>JDJ02OL>*
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M#]-N;\S/=B=;X^6@$K+"6&,*, -TQC@<YKH=0TBSU22S>[B\PV=P+F'GHX!
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M;2W%I:0VZN\BQ($#2'+$ 8Y/<T 34444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0G I:0C(H 6B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHI'=8T9W8*JC)8G  H 6BJT-_;7
M$\L,<@+QMM((QD[0W'KPPZ>M6: "BH9;N"&1$DD 9VV@=<':6Y].%/6I5974
M,K!E89!!R"* %HIKR)& 7=5!(4;CC)/05#9WUM?P+-;2AT8;AV.,D=#R.AH
ML4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !4<\9E@>-2 64@$C./P[U)10!SNA^
M&GTF_EN&NBXR50%5P4*J>, ;/GWG XY%=%110!SNM>&FU34(KA+@Q*S!90BJ
M,H%;KD'?\VS@\8'2M^*,10I&,810O  ''L.E/HH IZG8KJ5BULS! Q&6*!\<
M]@>,^_:L[PSH3Z+:L)) SR*H==H)!&?X\98?7IVK=HH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ***0F@!:*1=VT;L%N^*6@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBC- !11UHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D(R*6
MB@! ,"EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ IK-MQ3J* (X91-"L@! /8U)110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!@IJ^H7NKR0Z=:6DUA!-Y-Q.]T5=
M6'WL($.<=.2,FMZN-U!-&?5]/OM#>S.J-?*DK6;KNDC+?O?,"GYL+N.6Z''>
MNRH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!B0Q1LS)$B
MLW4JH!-/HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
9HHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>86
<FILENAME>exhibit1061-loanandsecur027.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1061-loanandsecur027.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :IR,TZD QP*6@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &IRM.IJ?=IU !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -48&*=24M !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 -0Y&33J:GW:=0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% #4&!S3J2EH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@!*6D'-+0 4444 %%%% !1110 4444
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M>WM7Z)'.X\O_ '#G*^O'<FH-(\+:3H5R\^FP20O(N)?WSL)#_>8$X+>_7DT
M<IKOA"#Q;>^)(PWDZA;W,,EI<#@H_P!GCX)ZX/'Z&H_AKJFJ:GKVN+K4)CU*
MSM[:TN"?XV5IOF_$$=.#U[UVNGZ!9Z;J%S?0279FNO\ 6^;<NZL> #M)(R
M/IQ4KZ/9-<7EPD;0W%XB)--"Y1V"9V\CH1D\T >0_#%-3FN;F2VD)M1K :["
M@[R-CX.<_=W8R,>E=AXIT&T\1WFF0Z+J1TW5;".26SEA7]WL5@CKQZ-@<>O0
MYK8MO NB6,;QV*WEFL@'F"VO98_,([MAN3SUJP_A#1FBLT6&6,V49BMY(IW1
MT!()^8'.21R>_/K0!Q=EK%W<VVN:#XYM(K6XCM8HI;^W W2Q.^Q&./\ :;/I
MR<@<U7B?Q/X"U/3--U5X]:T":ZC@MKB08D@<G"]R1CG@Y&!@$5Z"/"^DFRNK
M6:V-S'=LK7#7#M(\NT@J&9B20,# H@\,:9!<0S;9Y?(;=!'/</(D1[%58D @
M< ]J -BO,_B"K^&O%NA>,XD8P1M]DO@G=#G!QWX+?B%KTRJFI:;9ZM9&TOH%
MF@+*Y1NA*L&'Z@4 >2W[ZMX5\<Z?XC\B2>;7X'CDMP  LK?ZJ/MT_= D]<,>
M];OQ&TY-)^$,UBAW>480S_WV\Q2S'W))/XUWUWI]K?26LES"LC6LPFA)_A<
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M0:9=:OIMC.L%WJ%I;S. 5CEF5&()P, GUXKGO"Y5?&'BZ*)0L N8'3"X!8Q
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M6)+FX:.%L>=,S,3 8P>6X" 8Z8]J .CUSQ&+37M/T6WO+2WGN5D>26?#",*
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M ,I5BO8D8.,@@]"*S[;Q%'>7AA@L+N2(74EHUPOEE%D3<&R VX#*D9*^GJ*
M-FBN6A\?://<6B+Y@AO)O(MYRT>UWYP-N[>N<'!*C]15CPSK]YK4NIBYT^2V
M6VO)($)9" %VC:<,3NY)Z8]S0!=\1Z-_PD'AZ\TGS_(%R@0R[-VT9!Z9'IZU
MH6Z/%;11R.))%0*SA=H8@<G';Z5GWFMQV]^;"WM;B]O%B\YX;?8"B$X!)=E'
M)!P,YX-58?%NGW#Z8(8YV74)GMU;:!Y4J ED<$Y!^4C@'I0!O45R&N>-FL=
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MW$*JA2!T )/7)/-:<5P?#5A;6-S-<ZE<RS2"#+ RNFXM\S.P'RJ0"21T'TH
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M#UI;3E4\G3XY45G()R7D V]#P.>G7FND&2H)&#CI2T4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  "#THIJ
MC Q3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EIJG(R
M:=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9'
MB36I/#^C2:FMH+F& @S+YNQ@I.,KP03DC@X^M:]<O\12!X U?)Q^Z7_T-: )
MKKQ'>Z/;&[US2!;6:[=\]K<B<19.,N"JG /<!JZ".1)8UDC8,C ,K \$'O7/
M>.+RWM_!VIP2.#-=VTEO;Q#EY9'4JJJ.I.2.E<;J]NT&C+IDY62_T_P\OFBZ
MEQ% =I^:, ;C*2A&<C  ^E 'I<^HVEM>VMG+,JW%T6$,?=]JEC^  ZU:S7F4
M,%EJ7B3P/=ZA%#<27&D.TDLJAO,D$:'D]R,L>?>J=F9-634+VXURUT_4K/4I
M&E+1.;J(*Y"QK^\ *%,*%"X.>A/- 'H^O:H^BZ%>ZFEN+C[+$TIC,FS<%&3S
M@]O:K5C<_;+"VNMFSSHEDVYSC(!QG\:\XUY+'6_#_C2?4]K:A8R310JTA4PQ
MJH,6T9X#<G/\62.<8'8Z/:V;)I%VT["]33D1(A,0"A"Y)3//..<4 :6JWD]A
MIEQ=V]LMP\*&0Q&39N4<G!P><=/YCK46AZG)K&C6NI/;?9END$L<9DWGRVY4
MG X)&#CG&>M0^(+^TMM+NK>>YBBFGM9S$CL 7"H2V/7 (S7'@I+HG@_3'"RW
M)TQ919W,GE6YVQ*NZ4X+':3PH!Y.>,9 !Z/FC->2:7-<W^C>"_M5[<;Y+^>T
ME:&Y<"2-?, &<\_= SU]ZDOY#IWA;QI;6\DRPZ=J$36\:R,6B7,;'!)R!G<>
MOK0!ZO1FN'N=8BMO'L\[W@ALO[!^TR@N25(<_,$&<D+C\,5D>'@\7BS0DB9D
MMK[2Y7<_:&,MPORE99<8 <[B>,D=,\< 'I^:,UYIX5\-)KW@AKF74=1^WS_:
M84F-Y(?+Q*P3 W=MH/J<D9P:U?#5]+XHN[&YO;66&XT>-XKI6!4?:CA2!ZX4
M%O\ MHO<&@#I-4U9M/>WA@L;B]NK@MY<,.!PN-S,S$*H&1U/)(J#1/$,.L"]
M1[>:SN;&7RKF"XQE#C(.02"".<U;U35+;2;3S[@DEF"1QKC=*YZ*H/<_D.IP
M 37%>([:6#P'XHG@GBDUB\07%VENX;RXSA0O'.!&A&>Y#&@#J=*UV76YA-8V
M6=*)8"]DEVF0@D91,$E<CJ2OMFMJN&LH[C2/$GAR#3]2N)]/O[5Q-;2R;U14
MC!1T'\(SM'''(]:[2WN8+J(2V\T<T9. \;!@?Q% '.ZIXNFTXW%PFAWEQIEH
M[+<WBLJ[-O#%4)W.%.<GCH<9Q5N]\1HMS86>FVXO+R^A-Q"C2>6@B&"69L$C
MJ ."<^G6J_B"[AU(W'A^.>)!)&!?RNX40PMU'^^RY ]!R>V:$+VUO\2;*2)U
M:TN]%\NS=,%#L?<0I'7Y2#0!HQ>+8[S2[:YT[3[F\NIW>/[(A56C=.'#L3M4
M*>,]\C&<U8T#Q"-;^V0RV,]C>V4@BN;>;!VL1D$,.&!'0US?@Z^CTCP_K.IW
M+,T%YK-S+:*G+2JS!5"@^I!]N_2M&)+VWL-4ELI+2X\07[K-+'!*O[E<"-<;
MNNU5[\%L^M &C:>)K6]\57.A01NSV]OY[S=%)W[2H]<'OZY':MRO/M'0V/Q+
MCM(=+GMXH]#2,(\D;%1Y['>2&.<G.>I)YKT&@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #5YYIU(H
MP,4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )2TE+0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !15>\OK33K5[F]N8K>!/O22N%4?B:H:+XIT3Q%)
M.FDZA'=-;D>8%!&,]#R!D<=10!KT444 %%%% !1110 4444 %%%5-0U2QTJ*
M*6_N8[>.65849SPSMT% %NBBB@ HHHH **** "BBB@ HJ&ZNK>QM9+JZF2&"
M)2SR.<!1ZDUA^']5U;79SJ36\=IHSH1:QR F:?GB0] JD=!R3G- '14444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 )2TE+0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,75]<N-,N8XHM+N+I67<6CZ#V^M9_\ PE]WW\/7PK:OY-3%S;Q:?#;F
M-E=I9IR<(1MV@ =2<GZ;:Q-"UW6]<L(M0CL[%8#=-!)%YK;U57*,P;&#T)QC
MIWS0 [_A+[G_ * %]2?\);>G[OAZ](^H%7O#.NG6M&M[JZ$,%U+),GE(^<^7
M(R$C/)^[FM>2X@A=$EFC1W.$5G +?3UH YO_ (2R]_Z %Y2GQ7>@9_X1V]_[
MZ'^%=,[I&I9V50!DDG&!48NK<^5B>(^;_J\./G^GK0!S?_"77??P]?"C_A+K
MG_H 7U=++<V\#(LT\<;.<*'< M],]:)+B"%T26:-'?A%9P"WT]: .:_X2ZY_
MZ %]2_\ "77/_0 OJZ.YF6VMIKAP2L2%R%ZD 9KG-/\ $6J:AI-AJ\-E:S65
MY+$/+AF8R0H[A=Q^7#%<_,.,8//% !_PEMS_ - "^-'_  EUU_T+U_\ I74G
MI7.ZMK=_I_B;2-*AMK>6+4F<"1Y&5HEC 9SC!W$@\=.>M &1K/B;6+S39;73
M](O;6XF&P3%<E%_B(]#CI46@ZI!X=TF/3M/\/:B(4)8NPRTC'JS'N37>X'O^
M=1Q3P3JS0S1R!3M8HP.#Z'% ',_\)E..N@ZA_P!\TA\:R 9_L#43]$KJMRC/
MS#@9/-".DL:O&P=&&0RG((^M '*#QM(?^9?U(?5*RSK"?\)3_;XT75S<_8_L
M?EX&S9OWYQC.<CUKT# I<4 <%K&L6&NV?V;5O"=Y=1=5#)\R'U5ARI]P16&^
ME^&'LI[8^!K\K-C=*S,\JX.1M=B67\",UZQ@48'^30!QEGXLCL+*&TM?#6I1
M00((XXU0850, =:F_P"$XD_Z%[5/^^!76[1G.*-H]* .1_X3B7=C_A'=3Q_N
M"G?\)K+_ -"]J7_?%=9@#M1M'O\ G0!R?_":S#G_ (1[4O\ OBA?&TK'_D7]
M3'_ *ZS _P FC H Y)?'$C-C_A'M4X]4%.;QM(#C_A']3/\ P 5U>U2>E&!0
M!R/_  G+Y_Y%[5/^_8I?^$XD_P"A>U3_ +X%=;@>E&T>E ')'QS(/^9>U3_O
M@4#QQ(?^9>U3_O@5UNT>E&!Z4 <B?'; X/A[5<^T0I?^$VF(R/#NI8_W*ZW
MHP/?\Z .1_X3B7_H7=3_ .^*/^$XE_Z%[4_^^*Z[%&!0!R!\=2C_ )ES5/\
MO@4G_"=R?]"YJO\ WP*[' ]*,#TH X__ (3J0_\ ,N:I_P!\"E_X3B;_ *%W
M4_\ O@5U^*,"@#D/^$YF_P"A=U/_ +XH_P"$YDW(&\/:FH9@I.SIGO77XI,"
M@!$;<BM@C(S@TZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ]*[&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!J?=IU(.>E+0 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_(C\JZRWD$L0<$$'D$>G:NC$2511J+T^[_@6(I^[>)+1117,:!1110 4444
M&:,TS>/\FJEYJ=II\)FO+B*",=6D<+_.A:Z(3=M67LT#FN=TOQAI^LZ@+6PB
MN9HR"?M(B(BX_P!HUT(Z54X2@[25@33V%HHHJ1A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M);Q6=O)>S3P^>L<9QA.Q.?6K.C:Q;ZU;F: ,IC=HI8WX:-P>0: ,DZ%KS?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** $I:0=:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,4M% #0B@Y Y
MIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% "4M)BEH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***8DFX [2.2* '
MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 )2TE+0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4F*6B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH 2EI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** #%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )2T9HH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** #-%(5!/-*.!0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !32P4X-.HH  <C-%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%)2T %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-8L,;0
M/>G44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M(:!0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% #7#$#:V#GKBG=Z** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBDH 6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@!*6BB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BFMNP=N,]LTJYVC=C..<4 +1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 !&:*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***8REBN"1@\T /HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>87
<FILENAME>exhibit1062-securedpromi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1062-securedpromi001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M HHHH *S-7TF359+)1?75K!#*9)EMIFB:8;2 I92#C)!X/:M.D8E5)"EB!G
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M@<A2N<,#C!R"<5WOP_\ " \!^#8=*#?:;G<T]PT? >1L9"YQP  !G'3M7/\
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M!G&<>]85[X \0Z=#X6\3>&K$0>(].M8;34+-YHU6Z14"G+!MIZ8ZY(P>"HH
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M@MNQQGD>F>,K3?!$FF>/;WQ1H&C?V7"--DB%E(ZHMU<$Y'RHQ")PN>G/0=Z
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M;1T;'F ;R4^O&0?7CH:O_#7QL/&UY)/<0&WU2SLUM[Z$J1MD#GD>Q].QR.U
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M7C/AZ232/VDM?TK3\K87EL)[B!?N+)L1M^/7<Q_[[->S4 5;W4['3EW7EW#
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M#2$C59?NE7B 93['C/TI++X;:/9-HI2VM@VF3/<),D>'W,[/L7^Z@9LXR3@
M=R2 =A;7,%Y;I/;3)-"_*NC9!_&I:\\T#4)+#XS>)/#R$_8[FTCU-(^T<GRH
MY'^]D$^XKT.@!&8*I9B H&23T%8\?BWP]*8]FL69223RHY/-'EN_]U7^Z3[
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M,Q=@HY8@ #.22>@-<O;_ !$>[\7W_A:#P_>/JEC +B5//B"E2$(PQ;!/[Q:
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ML_VP=.A_M+_G[Y\WIC&[KC'&/2HCX-\.MJ$NH'2+<WLO^LN,'S'^K=3T'Y4
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M?P)FB_X5A;V_W)K6YGCN$;@H^\M@CMP17#>#[>>7PE\6=8C!&EWJ7(M6_A?
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M)^\/P[JO+OAWX9U,^/?$OC74;26QBU%FBL[>==LABW [V7JO"+P>>OMGU&@
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M,V[G.>!]]J /1_$\VOV46J:C97L%O866FM/&C0!VEF4.Q!)/"X"=N<GTKG_
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MXJ^&>M:V\4-KJ6F"==\*[HI6CCW@@-G@Y (S^/-<;:^$[CQ/XX^(%L6O]/\
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MZ\T[PK<ZK>? GQ-=:CJ7VP1QSRV#&Y$LUNHCRH9@258'D G(H ]QHKPM7?\
MX9>_M+S9/M_E^9]JWGS=WVG;G?U^[QUZ<5Z;\.E'_"N] E.3)-9122.3EG8J
M"23W- '3T5X]K&1^TIHEB'<6DVGM-);ACY;OMF^8KT)^4?D*H?&G2U\,^#;"
MXL+FZ2\N-6S-<"=P[AUD8KUX7.,#IP* /<**Y34? >GW=IJT%O-/:B_MTC7R
MY6_<2)NVR)SP?F&0,9 ]S7!?#CQ%>/H&I> ]23/B.TN7M@9!NWHQ.96)^\$
M)SW&P9Y% 'M%%5=.T^#2]/@LK8,(84"+N8LQQW)/))[FK5 !16?K5])I^ERR
MVZJ]T^(K=&Z-*QVH#[9(SZ $]JX7X-^)KW5M"O\ 1=9D9M:T>Z>&X\PY9E+'
M!/T(9?\ @(H ]*HKPWQ2->\!^+[SQIH\D]SH<5W]FO\ 3MY*1H4C.Y1T );@
M]CCL<5V=K<:/KVE^(]9TTI-;W5@LL;@_=/EL3@?PMN'.,'(]10!W]%>!^$+.
MXU#X$7^NQZC?0ZS9?:+B*\2Y</\ N_FVGG#*0",'(YKT_P"&GB>Y\7> ].U:
M] ^UL&BG*C 9D8KNQ[X!_&@#K:**\C^/TTEEX9TBZMII()SJ21-)$Y1BA1R5
M)'49 .* /7**\=.H&[^,&D0^!KN::PAC(UJ.*1VMD7) W _*'X/3G('O5'Q)
M?6FF_'P)J#3_ -DKIC7$UO$'=2P1CNV+WX'.* /<**\\O=*U&#X<ZQ?>%&N(
M[[5+.*Z@MQ*SF)BHWB,DD@E<X []*PO GBWPQXDU/2K2WCGT'7K)SY]B[,JW
M9$;*P/9R"=WS#<"/K0![!17G/Q?UG6=/\+R#0"1<VICOKJ13S'"DBX'XMS_N
MH]= NKVGBGX<OJ\ !AN]/>4#/*-L.1GU5@1]10!TU%>8_ B22Z^':W=Q(\US
M)=2JTTK%G(&,#)YQ[5E_&F8V?B3P2\<DL27%^4N1"6!E0-%\K!>6X)XYZT >
MQ45Q_A.UTK4;YO$>D+-!!BXLC"S.%DVRJ Y1C\I!1NP.&YKL* "BBO*/B;XP
MU3PYXCT+4[8-_8>G7HAU$J?OO(F=I'^S&<CW8>E 'J]%<KX[TR+Q!X1,$-T\
M#W$UND%W Q#1^9*B[E(/(PW3O7FV@^)[VTTC6_A[XR9AJ]A;2O873.<SJJDK
MM;KD#D'J1D'D'(![G17CGQ)C6V^*'@2SMRT-M=3>7/%$Q195#H & Z\$BI[K
M5KSP3\:M+T.VNKB70]:@!-I-*T@MY"67,98DJ,J.,X^8^@P >N444A 92K $
M$8(/>@!:*\+2]N_ WQ7T[4)+J<Z#KES=V3QO(3' ZW#HN 3A0,1GZ%J=X^O+
MNZ^*'@R874ZV-YJ)ME@60A)(HY8U)90<'<QDY[KMH ]RHKE_'ESJ$'A*[L=#
M3.J7<$D5LJ\;0$)8C'3"@@?[14=ZI?#+Q,GC3X?6=S<D2W,:&UO%;G+J,$G_
M 'AAOQH [6BO$]"U)_AE\4M4T'6)[B?2]3B^T:;/*S2.,9(B!/))Y7'<A?6O
M5/#VD_V;:2S31A+R\D,\ZJV0A/1%]E'''4Y/>@#8HHKEOB#HXUOPJ]FMQ):S
MR7%O'%<Q,0\1>9$)&".Q/'>@#J:*\,T#Q/>V^D:S\/O&18:S86[M8W+.<W"*
MI*[6ZD@<@]2/<'.UXCUBYU?XQ:+X$BEDM=%AA^T744#&,SD(S!"1SLX48[Y.
M>U 'K-%>1_$74I/AWXE\-:MHQ-O9W<[6U]8H<0S)\N&"= X!;YASTJE\:=*7
MP[X$>_L;FY2^N=6\R2X$SAL/YC;!SPHX&!Z4 >TT5A:+X?M-.NEU&T,D9GM4
MCDAWL4)'(8 G /)!QUX]*W: "BN8^(@'_"N]?D&1)%8RR1N#@HX4D,#V(KQ
M:I<?\(3X).C7][9>))[AO,OKF62"WD0,_#N^$D_AX&XX!'M0!]+45XQ\2)TL
M_B]X12629;.X0F[BAWD2@$]47EOR)KO/!UGI]PA\1:7YT-KJ,.T6[NY4!7;:
MX5C\I*D9 ]* .KHHJAK&EQZSI<MA++)%%*R;VB8JQ4,&(!!!&0,9'K0!?HKQ
M:.Q@/[0LNB'S/[,&F[Q:^:VS=M'.,]?>H_BG9+X;_P"$)M+>[N%A_M%HI9#*
MVYX2ZD*YSE@ <<_UH ]MHKR#1M0EOOC1$/!UW/<>&X[3&JA9&:V27#XV[C@-
MPGW??WK?^+FJ:Q9^$+F+0&9;V-!>32(<&*"-U+$>Y...X#^E 'H%%<UI.L6?
MC/X?PZH$5HKRT+2(#]QP"&&>H(8'GVS7EOAG6]3^&WB&#0O%-U+>^&];C66S
MOKEBPB9@,JQ/;D CH.&X!- 'N]%>0^+)=2T3P'X?OM-L);[2K>Z\[5;:-V+3
M1\XW'DE<]<Y'"YXK=\"ZQX6\637=[H-PZPM;K'<:3-D"!LYW+'DJ >A*\' [
MYH ]!HKY\^%.HZ7>^&Y;37?M=[?7NL?8[=F>7*J43/[P?=P-QQG/YUI^/(5T
M+Q[X T][FY>U$2PW94N3<A-JY=5Y8X^IH ]PHKD/">GZ5J,3:_I\<B66H1/"
M;:1G*,$E8*^UC\I('(QZ>E>+>%];TR/X9^)3JNJ7(UHW<L>F%;B3SRX1=BH0
M<XW'D=.: /IBBO&O%K:_!^SJMWKSS1:] D1:4L5E3,Z@9(Y#%" ?QS6/>:F]
MPG@>V\%7MQ)XE\J!]0B@E<IY?EH7,XSMQD]3ZGVH ]]HKQKXI3K:?%'P6&>9
M+6YD(NXXM^)E#+]Y5Y;@GL:[;PII^E:E$VOZ?'(EE?Q20M;2,Y1@DK!7V,?E
M) Y&/3TH Z^BO!/A=IDGB/X?>))9KZ]348+N5;2\2ZD62$K&I7!!Z9[=#S7=
M_!WQ=?>,? RW6I-YE[:W#6LLN,>;A58,<=\, ?I0!Z!1110 45XA?WNFV'Q]
MU2#6+L0:,NFB5HY)66)7*I\V < \GGWK=^$KZIJ4?B-KI[JY\+RW9_L=KUF=
MGBW/G:6^8KC9U[Y[YH ]2HKY[^$M]IVJ:&=,UK[7>7NH:K);0RL\N8XQ '.)
M < C:>,YYSBNJ^(5WJ7@^/PK/<V5QK/AO3X3#J,:G.]PBJLD@Z'N1NXSUYP:
M /6J*\FD\;Z/IW@#Q%XL\*7KSH(X4CLYRQ^QREM@&PGY5^<-@?+D'%:/A+PU
M%K7PQMKW4+B>?6-1M3<MJ+2MY\<C E2C9R@7C &!QTH ](HKY\/C'4?%'[.^
MKZA?3/\ VKIEQ';K=H=KL/,BPV1W*L5/KCWKV'P$H'@#0).KRZ?!)(Q.2[M&
MI+$]R3WH Z*BO&KN!+G]HT:7*TAL)-.,KVXD94+[3\V >OO5WP=KNHZ/\7M<
M\#7%Y<7FFI']ILFN)#(\&51]FX\E<.1R3]T>IH ]8HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M I&)"$J-S <#.,TM9^M:YI_A[3)-1U29X;.+'F2K$\@7)QDA02!DT <7\/?!
M^M^&/%'BG4=12T,&M77VB/R)RS1_/(V&!4?WQT]*9JG@S6+_ .,%CXJ,%E)I
M5O9M9R0R3'?("L@)V[<8^?H3VKI=/\=>&]3N[.UM]1VS7L?FVJSP20^>OJA=
M0&_#-/L_&F@ZAXAGT"VNY7U2W&Z:W-K,IC''))4 #YASGN* .5\)>#/$'@/Q
M#JT.DM:7?AB[8S6]K+<,DD$F.@^4C'8\] #U'-S4/ K:WX'O['4[<'5[Q'>0
MI>R&'SV.0X'3 ;&!MZ**Z[6=9L- TR74=2E>&TA&9)%B>3:/4A03CWK)B\>^
M'IK.UO$N;LVEVZQP7!T^X$3LQVK\YCP,GCDT 87AS0?%NE> ++0K^*PN;RRN
M(3%*MTP5H8Y5< DID$!=HX]*M?$7X?V_CG28)%"0:O:$26TQ_,QL>ZG]#SZ@
MZ]_XWT#3=>CT.ZNIUU25-\=LEE/(TB\\KM0Y'RMT]#5[1_$.DZ\DQTR]CG:!
M]DT>"LD3>CHP#*>#U H HWD&MIK]W(MK:W^BW%M'&;:27;() 7W$ C:5(*@@
MD=/SY"+X;WEAX,\5Z=IT-I!<:]*S1VHE(AM4/ &=O)ZDX&.@' S7:S^+-(BU
M:72HYI;J_A4--!:0/,8@>F\J"%^A(-+;>*]&NX[]X+F1CIZJUW']GD$D.<X#
M)MW X4G&,X^M &?X"\.W7A_PGI6G:G%!]NT^%X1+#(74JS;C@D#KA>W:N;7P
M9X@C^+.K>*S9Z?/I]]9_9/LSW3*^-J*2?D(YV'CWKI+?XC^&+O29-5MKR[FT
M^/.^YCTZY:-<=<L(\#%6M7\;>']"GL(-1O)(9-0P+0"UE?SB<8"[5.3\R\=>
M: ,C5](\4:WX7\0Z?/!80O>P"TLH$NF9(DVD%W8H"6)/8= /K7*W'PHU:?P%
MH-O!-:V7BK0FS:WD<I*.-Y;:3MSCG(X/(/8FO2],\3:/J]]/8V=X#>P#,MK+
M&T4R#U*. V.1SC'-:U ')M8:]J\^D)K=G:);VZ&2Z-K>NI:XP K+A0=H!<XS
MG)'ISSLG@/6-)^*\'BGP\MLMA) (;^&XNW+S9X)!(;T0C)ZK7IU07MY;Z=8W
M%[=RB*WMXVEED;HJJ,D_D* //(?"?B6R^+>J^,8+73YK:ZLQ;1P/>,C@@1C<
M2(R.J?K5'1OACJ^C^$?%UNUQ:3ZKXB#AHXW9+>WW!\8)&3]\]NPKU6*:.>!)
MXG5XI%#HZGA@1D$5A?\ ":Z&;;[5]HF^QE_+6[^S2>2[9VX5]NT\\ YP3T)H
M XP>!/$ ^"/_  A.RR_M#;L\[[0?*QYWF9SMSTXQBM>PTSQAIO@&S\/6EIIL
M=Y#:):&[^VOA !M+J/+SG'(&>M=/=^(=/L]1.GLT\UVL8EDAMK=YFC0G 9M@
M.,X.,\G!QFJEYXW\/6&@+KMS?E=,:1H_M"P2.H8,4(.U21\P(Y[T <SJ/@_7
M+GXRZ;XOBCM/[/L[4VQC:<B5LB0;@-N/XQQGM4GQ;\&ZQXXT.QTW21:H8+M;
MEY+B4J.%9< !3_>KKO\ A(M)&@#79+Q8-,,8E%Q.K1#:>0<, ><C''.:H2>.
M=#@T_P#M&Y>\MK KN6ZGL9HXR.QW%>,]LXSD8H Z"%I'A5I8Q'(1\R!MP!^O
M>O/-+\'ZY:?&35/&$L5F+"]M1;B-9R9$P(QN(VX_Y9GC/>NFU7QOX=T/4[33
MM4U#[)<WF/(\V"0(^<#A]NWN,\\9YK2NM7L[/4+6QF,PN+K/DA+>1U;')RRJ
M5'XD4 7J*YJ+Q[X>N-5N]+@N;N:_M/\ CXMXM/N'>/Z@1^]22^./#\'A^379
M;R5--BD,4DS6DP,;AMI#+LW+\W'(H 75-,O=5\0V8N($.D6R.X9+IXY?/. &
MPH' 4N/O<[NG%<E;^!-9T/XLMXET)+9=)NH!#>P3W3F20]V&0><A3R>QZ9KJ
M[3QSX<O);*--0,1OU#6AN;>2!;@'IL:10&ZCH>]=%0!AZ;874O\ ;$.K65M]
MFO9V94$OF!XRBH0P*CGY3QR.:YKPY\/Y?"&C^)],TMDFM]1=GLDDD*^6&CV[
M6.#T/?G(]Z]!K"/C'13<7D,%Q-=-9'%R;2VEG6(]P612,CTZCTH X'0/ /BW
M3/AC<^#"VEPM=O(LMZ+AWV1/C<%38,G&1R0.:]#\+>';3PGX;LM$LBS0VR8W
MMU=B268_4DFE/BC1?^$=;7TOEFTI4,C7,"-* HZDA02,8.>..]9L?Q&\*R6-
MK?G4GCL;I]D-W-:31PNV2,>8R!>H/4]C0!U->??%CP?K'C71]/L-)%HIM[M;
MEWN)2@X5AM "G^]7H ((!!!!Z$4M 'FNK>!M:M?']EXR\+FTM[B9=FJV4\I6
M.=>,D$*>3].H!]:2[\(^(G^+T/C&&UL'LX[3[-Y#W3*Y^4C/W".IKL9?%6D1
MZG/IL<\MS>VZAIX;2WDG,0/3?L4A2>P/)]*2/Q=H4N@RZW%J"2Z?"VR22-&9
MD;(7:4 W!LD#&,\T 9$EAXNDL;R*U33M/$(M(],@2X>1%6.0-(9#M!Y4!< '
M@'GFJFK^#9O$OBK0=8NM,M=/N-+N!<37,4V]Y]OW8P0HRN<'+8( P!R:UA\0
M/#AU8Z4+B]_M$1^:;7^S;GS0F,YV^7G%)>?$/PO86>GW=UJ$D<&H$BU?[',?
M-(.,#"<'/8\T ,@\-R:H=6G\06:F6[8HL<%])L: +M5"!M'3).0>7:N;\"^#
MO%/A3PGK7A^Z%E<6LWF&P*W+9CW@@JV4X'0\9YS78:KXUT'1-0L;#4;N:"ZO
MB%M8S:3$RDD# PAYRPX]Z;?>-] T[7(-%NKJX34IT\R*V6RG=I%YY7:AS]T_
MD: .8^'_ (=\6>!_!C:,;#3+JY6622.3[<ZH=V,9_=YJGXM\#^*/$'_"&S(U
MC+=:-(MQ>/+<,HFES&S!<(>,J>3ZCBNZM?%6DWG]H"&2ZWZ>JM=1R64R/&&R
M5.QD#'.T] >E9L'Q+\)W&E_VI%J4ITX2>6UV;*<1*W'!<I@=1U/>@"S:0Z^=
M<M\V5C8Z4K233^5=-))-(PP!C8 %R23SR0*Z.L#7?&WAWPW9VEYJNHB&UN_]
M1,D,DJ2<9&&12.1R/6DU7QMH&B:E9:=J-Y+;W=\5%M&UI,?-)(  (3&<D#'4
M9YH V[AIDMY&MXUEF"G8COM#'L"<' _ UPFJ> FUOP%>:??P ZS=1L\C+>R&
M'[2?FW@= N[G&WIQ797&L6=KJ$-C*9_M,\3S1HEO(^57&XY"D#&Y>"<\CUK-
MT7QMX>\017DNFZ@98K+/VF1X)(DBP,G<SJ , &@# \/Z)XLTWP'INB:A#87-
M[8W$&V5;I@K0QRJX'*9W!5VCC'0YJ?X@_#^W\:V=G=($@U>Q=9()3_$N06C8
M]P>WH?J<[<'B_1Y_LA$MQ&EZZI:R2VLB).6^[M8J <]1ZCGI44OCKP_#KTFA
M-<W+:I&N]K6.QG=]N,Y^5#D<CD4 <WXX\'Z[KWCKPUK>G1V9MM'E\QUFN"C2
M_,IP,*<?=[U;A\$7FJ?$:+QCK\ENK64/DV%C;,75/O?.[D+D_,QP!QQSQ75:
M1KNGZZERUA+*WV:;R)EE@DA:-\!L%74'HP/3O6C0 4C$A20,G' ]:P-1\;:!
MI6NPZ)>74Z:E,N^*W2SFD:1>>5VH0?NGIZ5<TKQ'I&MK<'3KU9WMFVSQ;666
M(^C1D!@>#U% ')>(? ESXO\ !4^C:BD%I=+J,EW;S1RF0('F9S_".=CD8]:K
M>,/ NK:KXJ\(7ND0V:6'A^16*33E6=0R'"@*>@3')KK-'\9Z#KVH7MCIMY)-
M<V+%;I&MI4$)!(PQ90 <J>_8TB>,]$DAAN!<3"UGD$4-R;:012L6V@*^W!R>
M <X/;- $1TB[U/Q)<7>JVX2TCA6*R,%[(KKDYD+!=OWB$[G[@KF?!'@G6_!W
MC;6Y[=+0>'-2?S$@^T,TL+#D'!7!'+#KTQSQ74W_ (WT#3-=31+JZN!J<B&1
M+:.RGD9U&22NU#D?*W3T-7-+\2Z+K6ER:GI^I6\UG%D2R[MHCP,G?G!7 YYQ
M0!Q_C_P=K?B7Q=X6U33X[,6^BW7GR>=.5:4;XVPH"G^X>OK7HB%BBEEVL1R,
MYP:YS_A._#WV!=1-Y*NG,^P7K6LH@SG&?,*[=N>-V<>]:FH:YI^F06TMQ/D7
M3B.W2)3(TS$9 15!+<<\=N>E &A63XAM[^ZL8(M/@AE<74$K^;*8P%CE1SC
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M=]BWKVLJP$YQGS"NW&>-V<>]6M?\6Z)X8L(K_5[TV]I*P5)EADD0DC(Y13U
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MVDC"N.J[F4 GD=">M '%IX/UQ?C,_B\QVG]G-:_9O+\\^;]T#=C;CJ.F:?\
M$GPAK7BO4O#LVF+:"/2[L7,AGF*%^5.T *?[IKH8?&VAW5Q<0V4US>BW8I-+
M9VDL\2-Z%T4J3[ FHK[X@>&--T6#6;O4]FFW$C117*P2.C."P(RJG'*MU]*
M.<?P-K.B?$A?%/A@VD=I?KC5M/FE*!F[LA"D9SSVYSV8UT$'A^;4KS5;K7K1
M=]PWEPI!>R;3;A<*C ;1U+D]?OGFK\/BO29]3M-.#W<=U=[OLZSV$\0DVJ6.
M&= O !/6J,WQ$\,0:A?6$E]<"ZL4\RZC%C<$PIQ\S83A>1STYH YGP!X/\3^
M#-+UO29$LKC3YY'ET]1=-NC+<;7RG0C:>.X/!S71ZMX/@\5^!(M!UR!(YE@1
M5DB;?Y,JK@.I('],@D5>_P"$QT)DL7@O'NEOXWDMC9V\EQO5" Q_=JV,%@#G
M')JE8?$?PMJ=LMS97\\UN;A;;SUL;CRQ*Q "EMF 267J>XH JZ5HGB/0='\,
MVEFUG.-.M&M[Z*25D$PP@!0[3SE21D>HXSFH='\&-8>.]1\6P:=;V#3V0MDL
M89!^]<L&:1R!M4G"C ST)/)KNJS]:UO3_#VF2ZCJ<SPVD7,DJQ/(%&<9(4$@
M4 <1\+/ VI^$=!O=,UR.TE\V^%[&]O*6 ("8'*C!!3-+XU\'Z]KGC_PWKVG1
M61MM(?>Z3W#(TN6!(&$..E='I_COPWJ=W9VMOJ.V:]3S+59X)(?/7U0NH#?A
MFI;/QGH.H>(;C0+:[E?5+<;IK<VLJF,<<DE< ?,.<]Q0!#8Q>((]6)>PL;32
MXX976"&[9WFG=PV6R@"KR_KRU>>Z#\'[UO >L^'-?%F)KJ[:]L[JWE+^3)M
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M%:/=_;6.U54*SJ/+SNP#CD8/TKN:JW^I6>F0QRWMPD,<DR0(7/WG=@JC\2:
M. NO"/B(?& >,;>WL9+-+7[,L,ETR.?E(W<(0.34^E>!M4T_6_$7B^XNK-_$
MNHP-':J-QM[4!0$!) +?=3)P. >.:[?4]2M=(TZ:_O6=+:!2\CI$TA51U.%!
M.!]*HZ3XHT3Q'HDFJ:7=B^L061S'$[-D=5*8W9YZ8Y!H K>"+W6=0\*V\^O>
M0U_OD1I;<8CE57(5U]B "#W'(ZUT55=-U"VU73H+ZS9WMIT#Q,\31EE(R#A@
M#@CVJU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7%?%S_DE7B#_K@/\ T-:[6LKQ'H%MXGT2?2+V
M6=+2X $HA8*6 (.,D''('2@#S#P[X)U+Q9I7P]U.\FM+33=$MHYXEA=GFG;Y
M&&[*@(/D7H6[T_PG_P G)^,?^O!/Y05ZAH6C0>']&MM*M99I+:V01Q><0651
MT&0!G'OS6'!\/K"U\47OB2VU/4X=4O4V3RJ\9#+\O&TH0/NKV[4 0?%*>)OA
MOXE@5P98[+>Z]P&/!_':?RKG_A@=1E\*Z+#J<-LNA+I#/$RR$[G$H),F0 I
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MN40G$_4@$C\J] UWP+IWB+5]+U2_O+XW6EN)+5HW10CY4[B-O.2HZ\<4S4_
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M]\D?A6E63I&@0Z1=7MV+R]N[F\*&66ZD#$!0=JJ  % R> .YK6H \?\ %_\
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M(_2N?\(>"M,\$V<]GI,UT;::0RM'.ZN-Y !(.T'H!WQ0!TE<9\6?^26>(/\
MKV'_ *$M=G65XBT&V\3:+<:3>RSQVMP LHA8*6&<XR0<=.U 'EWAWP3J7B[1
MOA]J%W-:6FFZ+ EQ&(79YIV^0@'*@(/D'0GO4WA3C]I3QC_UX)_*"O3]!T:#
MP]HUMI5K+-);6R!(O.(+*HZ#( S^-9.H>!]/O/$X\26MW>Z;JQB\F2XLW0><
MG'#JZLIZ#MV'H* "YYF\6$=!;(/Q\D_XBO =/UR\LO@;:Z-+9)'I>K7[P2ZH
M7+BVPZL=T8'7 )'/8]Z^D%T&!-*N[%;BY#7>XW%R6!ED) 4DDC&< #@8
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M#*D?I5/X(RWLWPKTLWA<[6E6$OU\L.0/P'('L!6L?A]I[Z$N@R:EJCZ(N +
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M/O@59H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K \9^(I?"?A:\UR.R2\6T 9X6F,1(+!>#M;UK?
MKB/C 0/A1K^3C]RG_HQ: 'Z=XPUK4=%T?5HM!LS;:@86:--18S0QR.JE]IB
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MF5R "8VS$-IP0<\YKEOV@2!\,6&>M[#C_P >KL;IA_PKB9LC;_9#'/;_ %-
M&-X<^)=MJO@"Y\8:K:)IEA"S#8LYF8[3C'W5Y)( 'O4J>,]9?P:?%:^'XOL'
MDFZ%L;L_:#;XSOQLVYV_-MST[YKRC2=$OM?_ &9);?3D::X@O7N#"G+.JOR
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M+<?G_=J!&V3A,YR.HK&\*>.]7\5:'IVM0>'K>.QN[DP28OV:2'!*[ROE $9
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MEO.L2JZ;]RAN'!X(8$>F>] 'IUWX:TZ[N-.8VUO'#8RB:*..!00XY&#V&<'
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M>:".2!AM,3H"I'I@\8KR;X9>.]3U;P_XDAU[4)KK5M-D^4JB1ET8838 HY+
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF=0H9/FX'<9Z=\UU%% 'D6M>!K'4_%>@ZUX8TB]TC5HK])K]S T,21#)?/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN;^#[QR,<J"1@>N:XG1O!%WX?\-^/8-,M+U=-U6%HM*L),F3<8F4L0?N@LP
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MI.?X6YQ7I&@7U]>2W:3Z9<V-E;B.&V^TA1)+@'<^ 3@?= 'L?6MNB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBHX;B&X#&"9) C%&*,#A@
M<$'W% $E%)N&[;D9QG%!8 @$@$\#WH 6BF/+'%M\QU3<<#<<9/I3Z "BF&6-
M95B,B"1AD*6&3^%*\B1@%W5<G W'&3Z4 .HI'=8T+NP50,DDX H!# $$$'D$
M4 +137D2/;O=5W'"Y.,GT%#ND:%W954=68X H =129&,YX]:1)$E0/&ZNIZ,
MIR#0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHIH=2<!@3Z9H =1110 4444 %%%% !113$ECD9E1U9D.& .<'WH
M?12;@" 2,GH*6@ HILDD<*%Y'5%'5F.!3LC&<\4 %%-21)4#QNKJ>C*<@TD<
ML<N[RY%?:<':<X/I0 ^BD9U4J&8 L<#)ZFEH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* ,7Q=IU_J_A/4K#2YQ!>SPE8G8D GKM)'(!&1GWKE/A_?Z/?ZC+$^GII'B.
MR,ZW%@%"GRVDS\I Q(@( !'3GIGGN=4BO9K!TTZ>.&[#(R/*I*G# E3CG! (
M_&N<TSPU?3^(;/6=4CMK9[![OR8X)#(TGG/R68@?*!T7'4Y.,8H ATJ".#XO
M:_Y8(\S2[1VR2<L9)1GGZ"CQ%!&OQ/\ !DX!\QA>J3D]!",?Y]ZT[31+^'QW
M?ZX[6WV6ZM(K4(KMO7RV=@WW<<[^F>,=31K&B7]]XMT'5H&MA!IGG[T=V#2>
M8FWC"D#'7W]J ,[XC:7I,_AG4;R_T635+@6S1PB.$RO"<'YE_N8/)(YX[X K
M=\,3V]SX5TF6TO6OH#:1!+IP0TH"@;CGH3CGWHN_^$A_M%ULQIAL&C 5IC()
M8W[D@<..G&5^M97V'4/#%CX<TC03;26<,BPW,<Z,99(\C<Z%>%(RS'/'0#J
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M\3Z?XBU&6VCTF;2ULT^:>*]21O.;L"%(^4=<9Y/7C@P7?A[6-:T>(:Q>6/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI&0^U<CDJ2.?0USFA:EJ.HZSXHM[_P 37-O!IE_Y,.U+9<1[%;YBT9SC)YH
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MB2>[5829H)$@)7<<(X*1C!RK#!R#^%<YX0F\0>(M(U.XE\2W4=Q;ZC<VL/\
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MJP)4<!ANP<<9%9-SXFU71OBC%I][=>=H%]MMHM\: V]RR[D&X $A@K  YYH
M] HK@OB+XGU32)-+LM&G$$LMY;B[FV*YCBDD\M5 8$98[B#C_EF:ZC4=?TW1
M(W%]<RGR8A+,R0/(8TY^=]BD*.#R<#@^AH U:*R[K7=.BCB47;NUS"9H?LD3
M3N8\#]X JM\O(Y(QR*X_PQXB^W^"?#MWJOB&XBNKS4G2.9(P3=D3R*L3 +@*
MP Z =.HH ]$HK'U+Q1H^DM*+V[\M8"BSR")V2$MC;YC@%4SD?>(Z@]#27_BK
M1=,GGBN[S8;<QB=EB=DAW_<WL 57.1U(Z@]Z -FBN5-_?+\5DTTWDC6#Z*]P
M+<A=JR"9%W @9Z$]2>M)KVOW9\6:7X5TN18+J[A>[N;HJ&,$"G&54\%F;@$Y
M Y.#0!U=%8AT_6+74M/>#5IKFR\UA>17*1[BOEMM*LJKCY]N1S^&.7_\)3HP
MN88#>8\Z8V\4IB<1/*"1L$F-A;((QGJ".HH V**Y^;QQX=@U&2PDU$?:HYUM
MWC$,C;7894$A< $=^GO4-M\0?"UW<V4$&K(S7S[+=O*<([Y(V[BNT,<< D$\
M>HH Z:BLB_\ $^CZ:\ZW5T46W95N)%B=HX"V"/,< JG!!Y(P"#T-0:IXT\/Z
M+=26M_J CG2#[0R+$[GR\@;AM!SU[=LGH#0!O45BMXKT5;Q;8WAW-<BT#B)_
M+\\C(CWXV[O;/7CK52W\865YK&N::5NK9=+55DN&MW R5+$@E<  ;<9Z]LC%
M '2T5@Z7K6G6_AO2ISJLVH)<QJMO<-$3+='!.0BKDG ).!P!DTLOC'0(=)DU
M274%CM(IOL\K-&X:.7(&QEQN4Y(X('44 ;M%96F>)-*U>^N;*RNB]S;*K21M
M$Z':V<,NX#<IP?F7(]ZTW=8T9W8*BC+,3@ >M #J*R-/\3Z1JEW#;6ETS2SP
M&X@#PN@FBR!O0L &'(Z9Z@]#69XB\07<?B72/#&ENL5[J"R3S7+*&^SP(.2%
M/!9CP,Y Y)!H ZJBL-]/UBUOK"2VU>>YMA-B[BN8XR60JP!5E5<$,5)]AQCN
M^V\5:->7MO:07A:2Y:1+=O*<1S-'G>$<C:Q&#T/8^E &S17!6.M3+8>-O[7U
MRXM[>ROW@BO BE[:/R8V&T*N#@L3T-6O$/B7[#=^&M+AFO&CU*3]]=16SL[1
M"%W^7:N-S%5S@9 SP.H .SHKF;;6K+P[8RVNK:W/>O:MF:Z>V;]RC'*"5D7:
MI"D9+8XY.,U8U3QGX?T:Y:WOM15)A;FZV)&\A,0(&X;0<]1T[9/0&@#>HKFI
M_B!X8MUN6DU/Y;601SE8)&$1(!!;"_*N"/F/'/6K4M_9MXNLK0:O*MR;6206
M"KF.5<K^\+;>H[<_Q4 ;=%8UGXJT:_O+:UMKPO)=>9]G8Q.J3[/O['(VMCV)
MXYJ35?$FD:)<6UOJ5ZEO+<[O)0JQ+[5+'& >P/UZ#F@#5HKG(_'GAJ719M77
M5%%E!-Y$S-$ZM')D#:R%=P/(ZCO5F#Q;HMU"TD%VTN+AK8(L$A=Y%7<0J[<L
M-ISD C'.: -JBN8UOQE96G@O5==TUS<M:12J$\ER4F12=LBXW)@@9W8Q^-0Z
M1?&T6+4;K6-1N8KRW7;8RV3F3S5&7D10@?;R.,;1Q@\T =;161!XGT>ZLK6[
MM;LW$5UN\D01/([;>&^0 L-IX.1P< \FE/B32_L]O.LTLB7$)GC$5O([&,8R
MQ4*2!R.H% &M16 =6L+KQ'I4<.L3+)/:23162I\EPA"G>Q*Y&T8P,C[U3MXI
MT9+F.%KS;YLYMDE,3^4TH.-@DQLW9!&,]01UXH V**YV]\<^'-/FOHKC4")+
M C[4B02.8@1G)"J?EQR6Z#C)YJY>^)M)L-OG718M;FZ @B>8^2.LA" X7GK0
M!K45R&LZQ.?$_@Q].U%CIVI32^8D84I,GV=W1LXSU /!Q72WVH6NG1))=2;!
M(XCC55+,['^%5 )8X!. .@)[4 6J*R(/$^CW&GRWL=Z##%.;60%&#K-G'EE"
M-V_)'RXR<BF'Q9HBV=_=27OE1Z?_ ,?:RQ.CPC&060C=@CD''/:@#:HKF1\0
M?"V<'5D0&1(@SQ.JEG4LN"5P00"<]!@U;TSQ?H.KVU]<6FHIY=A_Q]^<K1&$
M8SEE< @8!.<8XH VZ*RK?Q)I5S=O:+.\=PD/G^5/!)$S1_WU#J"P^F<5GV_Q
M \+W432PZJC1+ TY?RG"[ X0\E<$[B!MZG(P.10!TM%<_>>,M)M-*U>^!N)3
MI4?F75N+>194!7<,JP! ('WNG!YX-5QX@L]0;PY))J5S83WC[TM1 RBY/EDE
M#N3.T=0>,XZT =116/>>*=&T^25;F[*+#(L4TWE.8HG.,*\@&U3R.I&,CU%1
MW_C#0]-OI[&YO3]K@B$SP1PR2/L)QD!5)/0],XP: -RBJ]A?VNJ:?!?V4ZSV
MMP@DBD7HRGH:L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%('5AE6!Y(X/<=:7K0 4444
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MGJ!P 3UJ;6/MECJOA_7#I&J7VFKIS65S!:)(L]NY*,'\L$,1\N#] ?2O2**
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MLC2*6DV[W+,JD<* !@]3S6KK5K<7VB7MI:^5YUQ \2F5BJC<I&3@$]Z .&\
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MF,R^4Q P 2>0#CVJOXC?3]4^*'@;_0) ?,O-YN;-H]X$&5^^HS@C/M72>)]
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M.#&4C=-S?+WWDX'ICOF@"73?&5Y=:MH=M>:.MK;ZU:M/:RK<^8P945V5UV@
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MFB+J-P]NR(S,2J_+O!  ))(QW7MG(!Z)65J_B/3-"GLX=0EFC>]F$%OLMI)
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MC$JL&+F'S?GZ\9QG\/>N@75=0'Q+FTU+KSM/.BB\B@VJ )/-VY# 9(('<]Z
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MK=;>3R9<(X7=M)4@@D;CCMSTJE#X&TZWTW1M/CNKT6^CS">T&]<JP! R=O(
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M0DN)[2_:9YTF<$DRY\S! &,Y/T[50NOA]I5UIFFVC7>I1SZ:?]$OH[HK<1#
M4@-C&" !C&./6IH/$E[-X]NO#9L(%BM[1+LW/V@DLK,5 V;>O![UTI.!D]*
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MOTU)$D&4=6'JIS0!R!^&VC?9)+&.ZU*+3FN5NDLH[G;%#('#Y3C(&X9QG'/
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MEOI]E:,[6UI;PL_WC'&%W?7 YH XW6U:X\4^&]=T+6FN6FN?L[VT<RRP26S
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M97*)@"63&06]22 <GFCX6KX?UW3='GU>]:+Q5I6HW)DC,H2>>21CG>N-SC&
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M05,/EC80>HV]*6UM+:Q@$%I;Q6\(Y$<2!%'X"@#QRWU2YMV\/^+YM+ ?2/\
MB2:HB0_O'D.8R5]E=8\8_P">C#M6YK*6WAS5/#%EJLUO9:;<I<O<SM$I@-\Q
M1LON&T9S+MS_ $KTG[/#L*>3'L+;RNT8W9W9^N><^M-NK2VOK=K>[MXKB%OO
M1S('4_4'B@#R?4=%T.VL?"]O97AO[&3Q0!'(Q7RPCQR%XHBN!Y6[C XSD=J]
M4TW3++1]/BL-.MH[:TBSY<48PJY))Q^)-))I>GRQQ1R6-JZ0C$2M"I"#T QQ
M^%6Z /%[O4]*>XT?4;.XMK=?^$K/F&>0&[^^ZR%VR-B=@I!^7;D]JVBTVF^*
M(;MX;+6-(O-;9(KJ,;;NQN2Q0JW]]!@CL0OL!7HG]F6&^1_L-MNDD$KGRERS
MCHQXY(]:$TRPCNS=I8VRW)))F6)0YSU^;&: */BN**X\*ZE!-?&PCE@:,W6,
MB+=QN(].>?;->;ZEJ6IZ7I/B"VO]+MK6_MEL9;V[TH9BN;,S$,P3&5;8) 0<
M\>PKUV6*.>)HI8UDC8897&0?J*BMK"SLH6AM;2"")CEDBC"@]N0* /+]6T[P
M[=:!XKU'1]5AU W&@R^;;VJQ&!2JDQR,J#B3J!GG /I7?>$C8'PMIW]G_9_)
M^SQ[OL^W;NV#/3OZUHVNG65C T%I9V]O$Y):.&)45B>I( J6""&VA6&WB2*)
M!A4C4*J_0"@#A9+&R;XSSLEG:-<C05G3=&N?-\]L/]>G/6N87-]\([+4[< >
M+8;]!YN,7'VW[0%=&[\@L"IXV^PKUS^SK+[5]J^QV_VCKYOE+O\ SQFA=-L5
MOFOELK<7;#!G$2^81_O8S0!P6C>'M%U/XC>,!>6%O<&VNK*:)'&1&YA!+ >I
M.<^M<M:1Z:OPBL((1;QW/]NQ)<B(A9!_I[;=Q'(XSCVZ5[/%86=O<//#:01S
M/]^1(P&;ZD<FHWTK3I599-/M7#.9&#0J<N>K'CK[T <CX>L[32OBCXAL=/@B
MMK>33[2=H85"J9-TH+8'<@#)[T_XD103+X5BNL>0^OP+)EMH(,<HP3[]/QKK
MX]/LH;@W$5I DY&#(L8#$?7&:?<6T%W \%S#'-"XPT<BAE;Z@T >0ZW9GPS<
M^,#X<A:WT2."R>[AM5^2.0R_OPBC@'R,%@.Q%;UE;^'GGU?5M$UN*[:?1W2:
M&S\L0!1DH[A!P_) SS@$=J] @M;>UMQ;V\$4,"C CC0*H_ <5##I6G6UM);0
M6%K%!*<R11PJJN?4@#!H \RT&X_Y)M:7X5M)GT;$8<9C:[$:;0V>,[=^W/<G
M'-$GAF75=*\:Z=8Q(UI9:@MQHH*AECN$19'1/1?,RN!QRP]:]-?2]/DL_L;V
M-LUKG/D&%2F?]W&*L0PQ6\*PP1I%$@PJ(H55'L!0!Y)#JDLGB*U\4:?IZQVW
MBNT^P0@P_,EP%#)(_L<R@^HC!KTFQET?1Y+/PY;7%M#/';!H+/> YC7C<%ZG
MD'GZUHBWA58E6&,+%_JP%&$XQQZ<$C\:J3Z1;7.L6NIRHAFM5(B8(-P)!!RW
M4C#$ =.2>>, '-?%F&*;X9ZP98D?RT1U+*#M(=>1Z<9YJG')I]Q\2X=.EBM)
M-'?2"VFQJJF!Y/-(FVC[I?&W..<9]37?21QS1-%*BO&X*LC#(8'L15>?3+"Z
MMH[:XL;::"/&R*2)65<=, C H \GC>73_"]H;B]B72+7Q5(EE#<3!4N;16;:
M@=CMPI#,NX@'RQSTJ2]AATWP]XJ\0:=);&WNM0@DDCLG29X+3?&)L["1\P$C
M%02,$^]=YXET*^U-=/.G2V(CM'9FLKVW\R"8%=HR 005YQU'/3I2Z#X;33KJ
M6^GM-,@N98O):/3K;RH]N<_-W<^YQCL.3D XC5M.\.W6@>+-1T?58=0-QH$W
MFV]JL1@4JC&.1E0<2=0,\X4^E2M;:1?:M\.;6&.TEM)(;KS(XMNQS]F4D$#@
M^X/7O7I5KIUE8P-!9V=O;Q.26CAB5%8GJ2 *8-)TY3"1I]J#",1$0K^[&<_+
MQQSZ4 >2"[BT70K^%6%MH=MXPD@N@B!H[>W*Y *] @D921TYJ3Q5IF@Q>"?%
M5WI>JI?13S6<S^08_L\$OF*I,93A7*\MSGD'O7K,>F6$4<L<=C;)',,2JL2@
M./\ :&.?QIHTC35LULUT^T%JARL(A78I]0N,4 -TO1M.T6&:+3;2*VCGE,TB
MQCAW( +'W.!5ZFQQI%&L<:*B*,*JC  ] *=0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !67KFO6N@
M0VTUY%.T5Q<);*\2@A7<A5W9(P"3C/2M2LKQ+HL?B+PUJ&DR-M^TPE4?^X_5
M&_!@#^% $<7B6TEU75--\FX2XTV)9I]X55*L"5*DGG.T\]!CG%41K6G77B;2
M@?[5BO9K"6>&V(9(WC^0G>N=I<?+CN,G.*YU/">OW5[HNKW9C6^U"%K77T#9
M40%58*/ILV<=Y&-;^HV%_+\2-$U&*QD>QMK*YAEG#( K2&,KP6W'[AZ#TH Y
M?6_%MWK?P\EUE(KW2W@U6.)667;N078B*G:QS\H.1TR>,UW.E>);/5M4O--2
M&[M[NT5)&CNH3&7C;(5USU!*D=B,<@5PDF@>(%\ 76@C19GN(]8^T(ZS1;98
M_MGG;ER_ V^N#GM74VMCJ'_"S;S57L)8["72HK99V=,>8LCL1@-GHPYQZT ;
M.I:W;Z9=V=FT<T]Y>E_L]O"!N<(,L<L0H &.I[BJEMXLTR]TFQU"V,THOI&A
MMX F)7D4L&7!Q@KL;))P,=:J>)TUE]:T<6EC/>:3^]%XEK,D<FX@>7DLRG9]
M[(!YXSD<'C=-\/>)]%TC0+V#1=]UHE_>^98+<(#<03N_S1G.,@%2 <$\\#N
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M9?ESG=@@].HR#Q]IX=U^WT'3;$Z%(K6GB?[>PCGB*^1YSON7+#C#  <'KP*
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M>O6M&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MESYEM;SW,:0A@J908;<23DY &WWQ4=AXNU2].CZ;/I@T_6K[SVE2X5BD4<1
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M(;Q_J1L+7RM-M?MZ:ZNBWL;RL$5\_>0X^Z00>>F>AQ0!Z#17#?\ ";WVF?\
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M0<'R>7D /NJ[?HQJ/5;S5HOB1H>F6MU;Q:?)97$QA,).2AC')##LW'''/7L
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MFR#\Y[]J->U_Q'?_  ZU36-8T;1WT6?2X;B*W9Y&>1F*EE?!&WKD8/'')YH
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MMO\ F/SG/ K/LO =U86/A>*#64%QH(DC64VF1+&Z;"-N_AL8P<D9['I7;44
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M23@ 4 <?X-\(ZSX5TZ/3)O$0O;"U#"SC-IL90<X#MN.X#/ &/KT%<R/@U,/
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M&X\13-))XA%J6MY=S+;NC.L<C,,LP&.3U&"0:ZJ?P%X:N=#M]'ET[=9VSB2
M&>3?$P& 5DW;Q@ #@] !TJPW@_0VL["U^R.(;";[1;A;B12LO/SDALLW)Y;)
MY- ',"*^FU^^\)PZE>2BQL(I8)KC49(IW,C29D+(N7VX10#P.^<T_2[W4;WQ
M38^&-7U0SM:Z1]JGFLY&A^U3>:8LY4@X4*<@$#+>PKI-<\'Z%XCNK:ZU.R,E
MS; K%-',\3A3U7<A!(]CQ2WWA+1-0:P>6S,4E@NRUDM9G@>)<8VAHR#MQVSB
M@#%^&$1@\-7T1D>0IJ]\N]SEFQ.W)/K6)JVHZI!9_$P1ZM>JVG)'):.)!F'-
ML)"%XX&X]N:[_1M!TW0+>6#3+?R(I96F==[-EV.2?F)QR:J3>$-$N/[5\VUE
M8:J +T&YE_? # !^;CCCC''% '-VOVRT\9Z%:OJNH7,&KZ3.UU'-.<!T$6&3
M&-A^<C*X_/FN?\-7TND^ O"5O!/<Q+K&KM:7$YG=BJ>;,<*23L+;0N1@\D]<
M&O2E\-Z6M_8WPAE-S81&&V<W,AV(<9&"V#G SG/0573P7X?CTRXTU=.'V2>7
MSFC,KG:^XL"ASE,,21MQ@DD4 9NEW%[IWQ(OM!%Q/<:9)IL=_'Y\C2-;R>88
MRH9B6*MC."3C!Q5#5M,.K?%IK7[=>6:GP_EGLY?+D/\ I!XW8R/7C'3TR*[*
MPTFSTUY9+=',TVT232RM+(X7H"S$G R<#IR?4U!?>'].U'48M0FCF2\CC,*S
MP7$D+F,G)4E&&1GG![\T >=QW^O1>#1K,VHWMT?#NK30W+)(5-]9Q2%69@."
MRCG/?8<YS7=^'[C^U+F_UB*YDELIY!%:+YA,91!AG S@;GW<CJ%![FHM6AU"
MPL;;1_#^B6\EI/')"\SS*D=H".&*$$R Y)('7'/7-;&G6%OI6F6NGVB;+>UB
M6&-?15&!_*@#SKQUJM[;6GBJ]TS4[R2XTR.%D\J0PQ63 !BI .)6;.2"I !
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M+7$C"1L8SR2!Q@9':H_#&@P^&]#BTRWRL,;NR1^8SB,,Q.T%CD@9ZGKUXZ4
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M1295!RH56+;B 2=W48S6AI,VEWOCGPM<2&W<?\(V^7E4#YPT6,Y[X#8]@2*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 '2BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBF32K!"\K!RJC)"(78_0 $G\* 'T5G:#K=IXBT6VU:Q\S[+<!C
M'YB[6P&*\CMR*T: "BBB@ HHHH ***PM9\46VBZKI^FRV5[/<ZB76V$"H0Y1
M=S#)88P.>: -VBL2T\5:?<:R-'G6XLM2=#)';7<>PRJ.I1AE7QWP216W0 45
MC6GB.&]U76M-BL[H7&DB,R A?WN]2R[/FYR!WQUK1L;EKRPM[E[::V:6-7,$
MP >,D9VM@D9% %BBBB@ HHHH ***H:IJT&E"V617DGNYA!;PIC=(^"V!D@#
M5B23VH OT5A-XGCA\,W6N7>F:C:QV@D-Q!+$HE01YW,!NPRX&003D=*@LO&V
MEW=YIUK-%=V4FIQ^98FZB"K<# ;"L"1G!!P2#[4 =)139',<3N$9RH)VKU;V
M%0:?=/?:?;W4EK/:O+&',$X >,GLP!(S0!9HHJO?W+66GW%TEM-=/%&SB"
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MF56Z@,H(!]^:M4 %%%9-EK\%]XBU/15M[B.XT^.*21Y NQQ)NVE<$G^$]0*
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MU_\ 2B.NYK,USP_IOB2P^PZK#)/;;@_EK/)&"0003L89P0#0!S_Q47/P\O\
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MU>0K!/)]KERZ+G ^]QC)Y'/)JNG@S0H[+3+-+686^ER"6S07<W[I@" 1\_.
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MCK@%B3C\:OT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,H8$,
M0>QI:* "D*J3DJ"<8SBEHH 3 SG%+BBB@!-HW;L#)XSBEHHH *0*%S@ 9.3@
M=:6B@ I%4*,* !Z"EHH 1551A0 .O H(!&",BEHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\M?M*(I1Y&=-IV*N4R%/J!GFNA_X5]HXMI[9)K](IK\:@R_:2W[X,&!&[/\
M$,^YZYJY/X1TR[O]1N[PS7)U&U6TN8I&&QXQG P ,8W'D<\T <YJ%E<VGQ(\
M%-/J<]Z7BO=WFJ@&[RERR[0, ^G3@>^=[QEH/_"0Z9:VT.I-IVHPW2W%A<J
MVV=%8C*G[PV[LCTJ*R\":=9WFEW37VJ7,FEAUM//NR0BL "O&,C QS^.>*U]
M6T:VUE+9;B2XC:UG%Q#)!*8V5PK*#D=>&/!X/?(H X>S\8ZOI5WJ-EXKT>%-
M;T_2Y[RVN[1B8;V),%@.ZG(7@_IWNVM[XFA73M=:ZCN-*>S>:]BDE0^9F/>C
M0A4!!SQ@D\'N>:Z2V\.6D=_+?W<T^H7<D!MO-N]IVQ$Y*!555 )QGC)P,GBJ
M.A>!=*\/3!K2:_D@CW?9[2XNFD@M]V0?+0\#@D<YX)]30!4T)]9U?3- UX:Z
MJPWL EO;=HUV$2)E5B.,J58@#).>^36%'XEUL^ M/U,ZG(;S^W19R2>5'^\B
M^UF+:1MQ]WN,&NIT3P-I/A^[$MC+??9T=G@LI+IFM[=FSDHG0=3USC)QBJ\O
MP[T:6.:%I]0%M)>"]6W6Z81Q2[]Y* =,MS[9.,9H I6+:[JGCKQ!8CQ!<06>
MF7%I)%$EO$=R/'O:,DKT/KUZ<\5SNJ:AJNI^!9WNM5N3-!XH%H)(PB%XUNU1
M00%QP.?KUS7HMAX>MM.UC4=4AGN3<:@$\\.X93L7:F!CC X]^^:HGP-I3:)>
M:2\MVUO=7?VUF\W#I-O$F]6 &#N /I0!GZAJM[X7\961U35YI=!O;62-&F2,
M"&YC&_YF50<,@8CW4^HKHO#XOO[%@EU*:62ZFS,RR*H,08Y$?R@#Y00,]R#6
M'JUD==O8?#<^BW;Z?:3P7+ZA=,K1R!,/A3N+,Q8!3D="WMGKZ .!\:V,?BR>
M]T22TNI[6UM6 >! P2[=<HQY'*+@_P#;7VJ71/%.J:G\*Y]4MK8R^(+*VE@F
MMF&3]JB!5@1ZD@''OBNITK2(M(2Y6*XN)OM$S3N9V#'>W4Y 'MQVP ,5S6K>
M$1INA^))-(BO+VYU@,;FU-PJB0OA79.@5MI.,$ X - %;2M1U34_$FF1Z?K=
MS<Z7-IGVB[D$<1\N;*A03L^4MEOD[;>@YSDZ;K_B"V\ )XJO-<DN)&D>S\AX
M(TC#->>2LI(7.5&?;&..N=30-+O3J-M+8WGBZWB0D3KJ\R-'LVD8"MDELXP1
MP,<GL>AM/!VDVWA>?PXZ2W.ES;]T5P^[[[%FP0 ?O$GV/2@#GM6U/Q-X5M]8
MU2YGBFTU+(/ ES*KRQW&\+GY47,>&!.>A'& :M2Q^*K.YNYSJ(&G/82%3-)'
M)*EPHW*R8C *D Y4Y]16EIO@C2K#3KFQGEOM2AN(3;L-0N6FVQ'JBY^Z.G3G
M@<\##-*\#:?I%G-:PWNJ3(\)MXS<W9E^SQ'JL8;A1P.V>!SQ0!RUGJGB)K+P
M)?-K\S-KD:0W4;6\6P;K<R;U&W(?*]R1D],<5+_PD^K:.NN:9+?O>2V^LVMA
M;7=PJ*Z).L;'=A0N1N8 D8R1D$<5U*>#-/CMM$MTN;P1Z*0;(;U^7"E!GY?F
M^4D<TVX\#Z/>1ZS%>">YBUAE>Z21Q@LH 5EP 5("KC'I0!SGB&X\7:%X?\37
MIU(1V\5E]HL69HY)XY%^^I^0 H<@Y/(-7[>YUBW\;6.F3ZS<7%MJFE33LIBC
M7[/*C1@&/"Y PYX;=TK03P)IW]A7FDW%]JEW'>1B&::ZNS+*8_[@8_=7Z 5?
M7PU;#6;'56N;I[JRMVMHBS+C8V-P("\YVKS[4 8GPJ6=OA[IL\]Y/</,'<^<
M5.T^8^<$ $Y/)R37:5SEKX+TZQT7^R;2ZU&"U$ZS(([M@T>'W[%/9<DY'<'Z
M5T= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7=NY.?F!]CQ[];10!S":'J8UG4?$1^Q#6););.TA+N\,2*Q?YFP&.YCDX P
M.M2IHEUJNJ6>I:[!9I):6\L,<%M(TJDRA0[%F53C"X"X[GD\8Z*B@#@=6^$_
MAN[O=)DLM'TZWAMKKS;I/+/[Z/8PV\?[14_A71>,-"/B7P?JNC(P62ZMV2,G
MH'ZKGVR!6Y10!QVI6-YXL\+:--9M%!J%E>6UV\-SD!98C\\;8R0<Y&<'\C3X
M_#^L+XBUS5':Q<:A80VJ*)'7#H'^8C:< ESQDXQWKK BJS,% 9OO$#D_6G4
M>=VO@OQ'HMKX?N]'O-.&J:;8#3;F*X+F"YA!!!R!N5@1GIW_ #[G38KV*R0:
MA/'-=L2TC1*50$_PJ#S@=.>3U[U;HH *Y34/#%QKFG>)=,U-+5;35CNB:.1F
M:,B-$4D%0,@QAN#[>]=710!Y?XO^%UWK/P^T3PGI%Q:6\.G.DK3SELNRHRGY
M0#U+ELYK3\3>#_$/B'Q+I]^NI6,-A#9R0R6<R/,J2L&'FH!M#-@@ G&,>]=[
M10!Y*WPIU>3X6Z5X7;4;$7NF:A]MBD"OY;C<YVL>O_+0\@=A]:WM=\'ZY?\
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M HSQR>@Z5Z110!Y0_P +-7N/ACI_AJ74K**_TFZ%S87$2L5+!G;Y\^N_L.,
M\]*]"T*+6DM-^NO8?:B #'8JWEC'4Y;DD_IC\:U:* (;NZAL;26YG;;%$I9B
M!D_0#N3T [UR?A+1=;T3PYI<,8M(YKB[EN]32?<65969RJ;>-P)4<\<&NP9%
M?;N4-M.1D9P?6G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=9Q;M*\31^9>8/$+Q;1*<>DD9"9_O8-=FFJ6[:U)I(287$=NMP6\IA'M+%0
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M73[A8'D4>6&WQ?*"0Q9MV.] &_X U>\U[P/IFIZA,LUU<*Y=U4*#AV P!QT
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M,&8'G)!;G&*\VTO3/[1^&?AWP[#:21ZY:WT,CHT+(]FR3;WD;(&WY 0#_%D
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M+A]$:/\ A63(VS?C*K1Y]%'K78ZKKD6FWVFZ>L9EO=1D>.WCW;5^12[,S=@
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MXP>-Q"YVC"\]1FFO\0K29=$;2]-O-1&LPRRVAB**"8URR-N8;6!X.>!SR>E
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MQ8GDX!8X+8&!GOC-<[X9TCQ9X?5= V:?+H\$S&WU$RMYRPEBVPQ[<%^=N[(
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M"Y)QU)K(;2_%.B>*M4N=%@T^]TS5I%G=;J=HFM9@BHS<*=ZD*IQP?IUKMJ*
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M"1R[!DQDN-S 8X/'(KT2B@#C(?#^I6OB+Q#=PVT)M+W3H+2U'G?-F,./F&.
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MNSU76KM?&$6AK<KI]N^FR7:W;*I\R17"[!NXPH^8CK@CD8-7/%7AF#Q7HO\
M9ES=3VR>:DHEM]HD5D(8%20<'(KDO$\,S>)X4O=0UZR2WLTCAO+;3A=Q7+%B
M6RHB<(PPO89^@% #;;Q5XLN=!\(WDDNGV]QK=YY,J?8W 1#&[*PS(<_<W=L@
MCI6B=5\2S7%_HEM<&XU+3+:)I+J"WB599I S+N1W^5,!?N\DYY&,&>T\.ZAK
M5MIMQJNKWK/IU\;JSE>VCADE79M'FIMX^\XP IQC(!JYK'@U-0U]=;L-7O\
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M\LO-,HV@M\N N#C"@<8H SO[3\1-?76@1W37&H6-HDTMY;6T2"1Y&DV I(^
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M#L,9R,=CWH T**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]#GD8J>]UQ8-6&DVEL]W?_9S<M$KA D>=H+,>Y.0!['H!0!K45Y[XJ\8M?\
MP]DU'1HKE&DNXK.X#,J26[>>D<D;#/#')7(SUSGO6VR:?X-T+5M=BTNYAC*&
MZN;.!U(38O)1=P1>!DXZ^YH Z>BN2M/'<4VLV&GW.C:A9KJ4+26$\P39<%5W
M%1ALJ<= V,^U58O&\6MZ#>79\-ZJ^EBWNO/DW1+_ *MBCI]\') )R#CL#D'
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M&T@#KTR>IJ7Q%HE_+XFT3Q%IBI--IXEAGM7?9YL,@&=I/ 8%00#@'GD5U%%
M'"7_ (5U&ZTOQG<I @U'Q%"((X#(-L*+#Y:;V]>6)QGJ ,XS76Z/%/!HUG!<
MQ>5-%"D;KN##(4 X(ZBKU% 'F5IX3\16W@[P]HLEI:M)I.J0W#/'<Y$D4<C,
M3R!@D$8'UR16K<Z#J\FK^,[E+1#'J]A%;6N9E!WHDB'=Z#+@]^ ?I7<44 >?
M77A.?4/#>CZ5JNB)<_8M/CB2>"Y6.>VN44+NC?CY3@'.>P^4]NKTVVU*P\*V
MMK>2_;]2AM5CED#8\V0+@G)]^YK5)"@DG ')-4M+UBPUJVDN-.N!/#'*T+,
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MV,C(XY'6M*#2/$#^)M:U>XL;6.._TN*VCB2YW.LBF3@G: ?O\GC';/6NWHH
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MC@J5SN"AG(4D#<<#TK0LO#8AUFWU:]O&O+VVM6M(I3$J,48J27Q]YLJ/0#G
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M8_,=(BP#NJ?Q$+DX_GTKF9?&%PVB6&J:5J]IJ-K<ZU;V0D$.#Y,C(K*Z\%9
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M.,8W =NE %'Q=XKU;05U>[AGMR+![<PVL<9EWQL5WF9A_JR<L%Y'W<\U>/\
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M54! ."=K<G@<>O'GZLUU\*M(\0V1/_"4K>0@SXQ-)<M.$EB?N006!4\  <8
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M!Z18:A:ZG \]G*LL22O$77IN1BK#\""/PHU&XGM-/FGM;4W5PJ_NX ^W>Q.
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M29;S 2@0;?G)P>%SC!S0!N@!0   !P *IV>CZ9ITA>RTZTMG(*[H850X/)'
M]:S&\;>'H[.2ZFU$0QQ7(M)1+$Z/'*2 %92,KU')&.<YIUAXT\/:D=0%OJ*@
MZ>GFW0FC>(QIC._#@97 ^\.* +D?A[18G9X](L$9IOM#,ML@)EP1O/'WN3SU
MY-2MH^F/JBZFVG6AU!1M%T85\T#IC?C/ZU6L_$NE7\\L$,\@FC@6Y,<L$D;&
M(YPX#*"PX(XJGHNMZ9#X5L;W^V9]1MIG,<-W-&3+<,78 !%4$G@@ +T7/O0!
MI'0M(;[1G2K$_:?]?FW3][_O<?-^-6DA6TM!#9P0HL:XCB7Y$'H.!P/PKE/"
M.LW&J>+/%D#WEQ/:VD]NMND\7EM%NCRR[=JG[V>HSTY/6MY_$&FQZM/I32R_
M;H+?[2\*V\A/EYQN!"X;GCC//% &/X&\)+X;\/65K?6FGMJ5L'!NK==Q;))S
MN*@@X./PK;N-"TB[NI+JYTNRFN)8_*DEDMU9W3^Z21DCVJ"U\3:3?:=9:A;7
M$DMK?2>5;R+!)^\;GMMR!P>3QP:P;KQAI^B>'=>UF&^O-66WOFA,9A.()2$
MB&%&$!8')SU/)/% '4)I&F17:W<>G6B7*+L6985#JO3 ;&0/:N?\.>$C8:AK
M-YJMEILTMYJ3WL$J?O'C!"@*2R#!!7.1ZU3O?$K6/Q#M%FO;L:7-I$TXM#;-
MN,JRHH*QA/,)P3Q@\9/2NCA\3:1<Z1::K!>"2TNVV6[(C%I6Y^54QN+<'(QD
M8.>AH M7NDZ=J31M?V%K=&/.PSPJ^W/7&1Q1=:3IM]Y7VO3[6X\D$1^;"K;
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M)9*VY;9K=#&#ZA<8S5Z&&*WA2&&-(XD4*B(H"J!T  Z"L.3QIH,%OJ$UQ>/
M-."M=)-;R))&I&0Q0KN(/8@8J?3_ !3H^J:HVFVEV7NA#YZJT3H)(\@;D9@
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MWAC#?C3M*U6RUO3(-1TZ<3VDXS'( 1G!P>#R""""#T(JE)XKT6*]^RO=G?\
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M"UI^CZ7I)E.G:=:69F.Z3[/ L>\^IP!FF6VA:19-<M:Z58P-=?Z\Q6Z+YO\
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MK'451;VSM[E8VW()XE<*?49'!IL6EZ?#=2745C:QW,HVR3)"H=QZ$XR:MT4
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M59EDV*2H(&"X!Q[]N:[OQ=I=SK7@_6-,LW"7-U:211$G +%2 ">P/3\:VJ*
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M">O-6K:QDM[S6/#^L^%=0U/[5?S7-K< %[26.20R+YIW;4*D\Y';C)Q7J5%
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MD?3PSM!)&7RKHI'RL'SGIG\:[JQL8=/@,4)D8LVYY)7+O(W3+,>2< #V  '
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *KWU[:Z;8SWM[.D%M A>25S@*HZFK%<
M-\4(9+G2]"M6=X[*?7+2.\=<<1ECC.01C?LZ\=* .JTO4)M3@%R;&2UMY!NB
M\\XE8=B4_A!'/)SZ@5?KC=,FO]+^(FH:0]]/<Z0VF)? W+[S;2>84*[CSM8*
M3@GC:<5V*LKH'1@RL,@@Y!% "T444 %%%% !61K'B"VTBYL[(12W6H7S,MM:
M0XW/M&68DD!5 ZD_J>*UZ\]OR;'X[:9=WIVVE[HLEI9NWW?/$N]E'N5_.@#J
M!K5W#J=C8WVE21->.RI/#*)(E*HSX8\$'"G^''O6U534;I;6W+*BR7.UVMXL
M9+N%)P/\]Z\Q^V73_#30/%EC=SR:[)<VQE82,?M+R2B.2%ES@K\Q 7'R[1C&
M* .U3Q6SZCXDLQILF_18XY/]:N9PZ,PQV7A>Y[UIZ!JHUWP]IVK+"81>VT=P
M(RV[9O4-C/&<9KD8/^1N^(O_ %YVG_HB2L_0WANM!\"Z;ODGG;1!-]A:3RX&
M41QKYDC<GY<X4 'EL\8R #TFXNX+4PB>54,T@BC!_B<YP!^1_*IJ\9T\?VQX
M=^&UQJ$TES.=3EA:5IF+%0LX'.<_P+SUXK799?%,GB:%M?BTN[TV^*12D/YE
MI$@4HZ_O%&UADDD<Y.<X& #T^BO.]/TM=7^(GB"&]O\ 4'AMH-.N8T2ZEC42
M'S"2%W< [?N].3QG%9>GW[?VMX-U"QNYY+74+^Z1KN><^;>1E)6^=!\H0%1M
M&<@ <+TH [[0?$!UN\UBW-FULVFWGV4[G#;_ )%?=QT^]TYK:KCO!7_(P>-/
M^PP/_1$5=!KNH/IFCSW$"*]R<16T;'AYG(5%/L6(SZ#)H K:1XGT_6M9UC2[
M5R;C2I5BFST;<N<CV!#*?=36U7E=S;7O@KQ3X<UNXMH(+*5!H^H31W)D,A<[
MHY7RBX/F9RW/WZO>-;B]T[4M0U*XMGU'0TMT2=K2<I<Z80"S2*O 8$,"<'/'
M.0* /1JJ07%Y)J-Y!-8^5:Q!/(N?-#>?D'=\HY7:<#GKFN UV^N=-U^?4[ZW
M>^T&2\MBE]9SE9M.8>7^[>/C,;'!..SG(/%3B6_CU_XC1V5^\4T5E;O:O<SD
MQV[F&0Y&XD*N>?04 >AT5YWHFEW>HZQX?OH$U*TL8]-)U%7N98A+.0FS(##S
M&'SDMR"".3Q7.VB30>"]*UH:AJ#W\/B+R$DDNY&'E&]:,H03A@5/.<GWX% '
MLU%>6W]@+W5/B-'/>7Y2SAAFME6\E40O]G+Y7#?WN0.@]*DT\S0:S\/=1%Y>
M/<ZO:N+XR7#LLW^B^8,J3M&& (P!0!Z=17EOAT7'B31]'\1-XACL[^.^!NPJ
M.9&8N5:V<>9C!R !MXX(%96H12Q>#?&.K+J&HF\TO79?L<C7LI\H*\6!C=\P
MP2/FSQ0!["+N WILQ*IN%C$IC[A"2 ?S!_(U-7":?8VJ_&/7)BI$G]FVD@/F
M-RQ>5>F>> !BNXCECFC62)UD1N0RG(/XT 8.M>)VT?7])T@:=)<S:H95MW21
M5 ,:[FW9Z<=,9J33_$\%WX@GT&ZM+BRU.* 7(BFVLLL1.W>C*2" >"#@^U<]
MXUBDF^(G@..&X>WD,U[B1%4D?N/1@1[=*RVDOM!^+DZS/_;=[>:-(]M*5"26
MJ1DMY95?EVLP'S8!R<4 >I45Y.+NY;X<^&_%6GW<\NMS7%KYSB0G[4TD@26)
MES@J"S8&/EVC&,5JZ!HL6K>+/%!N[W4W6PU1#;(M_,H3,"$CALD?,>#T[8YR
M >AT5XO823Z7\)=-\3"_U%KVZ$5I=W4EW(PC@>Y =P"<!@.-P&1DG-==>636
M/Q!TW2[%YAIFJZ?<_;;=96VQF/9ME7G*L2^W(QGCN* .ZHKQ8ZG>V&D6!EDN
M9KOPC?LFL,9G_?6V_:K,,_.61Q*">GEMZUT>LZB]G9Z5?-=?9;/7M7'G32LQ
M1(3&_DKPPVARL9.".6;/6@#T:BO*?%.EW6A^%M=$/B&9\WME+#!;,\8LP\R(
MR@EVRK<G:>!Z<UZ/I6D6VC6\L%J]PR2RM,WVB=YCN;&<%R2!QT^M %^BO-_&
M\ZW$WB@6UQ/+<Z=HWFL&G,4=DQ61E>/')D; ]  HYYQ38HWUGQCX<BN[V\:&
M\\.O-<11W4B+(X:'G"D8/S'.,9[\<4 >E5BZ5X@.I^(-;TIK-H&TMXE+LX;S
M?,3<" .G&.]>>:-K%R-/\*:+=W<YL+K6+ZTFF>5MSI"TGDQ,^<D$A1UY"XZ$
MUTG@^T@L?'_C:WMP1&)+-@I8MMS#G ST'H.W:@#>\6>(T\)^'KC6IK22YM[?
M;YB1, ^&8*,9X/)'>M>W>62!'FB$4A&2@;=M_&N+^,'_ "2O6_I#_P"CDKLI
MKF&UB1YG"*SK&N>[,0 /Q)% $U%>6Z*+GQ+I-KKK>(8['4+;4F^TXC=I%(E*
M_9F7S,;2, +M]"!DY.9JD$J^%/'VHC4-1^U:7JTC63_;9?W)5(6&/FYZXP<@
M#ICF@#V*9WCA=TC,CJI(0$#<?3)K+\+ZZOB;PU8ZREN;=;N/>(F;<5Y(ZX]J
MYVVN$\0>//$.E:D[B*PM+;[)"LA3B12SRC!'S!L*&_AQQC)SRGA*^=]"\"Z)
M-=0P65YIUPZ^>&*3S*Z@(<,N2%+G&<9[9 P >R45Y9?Z7<:>/#&F/XBO+U#K
MSVSO#-)%B%HI'\DG>=VW  ;.1T!!%>D:9IT&DZ;!86S3-#"NU#-*TC8SGEF)
M)_&@"W17D_BF_86^M:IIUW/)+9ZU;0?:I9RA@8/"K01(.J88[LXR6/#=:UU:
MW\3ZUXOT[4M1FLY[&2-+5XI_+:UA,2LLR<XR6+$MZ #I0!T\'B S>,;OP\UF
MT9@LTNQ.7!#JSLN !TY4]36U7D?B;59],\=7%S'Y\M@^A6B7UX@_?06[32AI
M0N.O3/\ =!)P<8K<URSMSXI\$6MC>W:V%R;E6\B]DVS(+=F4D[N3_M=>>M '
MH%%>0IJEWI&EWFFQW5RNGKXP337E:9BT%JP1BH<G< 6.W.<@-UK?GTZ4>/+[
MP[:SW$6DZAHK3R)'*P^S3B38KQG/R$@G@8R4SZT =_6+XC\0'P^FFN;-KA;V
M_@LB0X41F1PH8^N,]!^E>9P:_<VUOX=U>Z:91X?E_L_Q!F9]@)8PAV&<,0RB
M0D\@./6M_P 1V[Q>'= N)A(LUYXCLKETD8DQ[YP53GIM7 P.,@^M 'H]0W<[
M6UG-.D1F:-"PC4@%L#ID\5YU<+-XIU+Q58S:W'IEYI]T%@<AQ):1"-&25<2*
M "=Q)(YZ$XP!/8W \1:]XGL-4N9)3IUI;I;!2T/RO#O:=5!X8L>O5=H''.0#
ML/#>LKXB\-Z?K"P&!;R!9A$6W%<]LX&:U*\G\.RSKX:^',;EI=+DLY!=6L>6
M9V$0V,4'+HISD<X+*<=,/D_M/PUH5BNHWMQ;6^IZ\T+27ES)+Y%H?,,*-\_R
M9P@.".#@T >JU#<W<%HL9N)5C$LBQ)G^)V. !6!X9TJ32-3U:(ZPMU!,T<T=
MDB,%M,@@[2SL<,1G;P!SCK67\0[."YO_  >TRDG^W(X\ARORF*0D<'V% &_I
M?B ZEXCUK1VLV@;2_)_>,X/FB168$ =.!Z]^U;5>5ZAID%[KWQ$9IKE!;V%K
M)"8+AX\.+=RK94@DC QG(J5[W^V;'35FN9KJ^/AE+N:&2;RH8MZC]_D<F3((
M&.F#RN>0#TF:[@@GMX)9566X8I$AZN0I8X_ $U*VX*2H!;' )QDUY-8*FKZA
M\,+[4)'FN9],G,TK2L&8B!&R2#UR23Z]Z]:H P/#/B;_ (23^T2EA);)87DE
ME(9)%):6,@-@#^'GK^E;]<-\,O\ 4>*O^QEOO_0EIFK:FFL>.;;1#>P)8S:?
M)+ LH;9<2B4HX&UURRA01R>I(]: .\HKR[^S;BWUGP1I4_B*]U%#)?6\UQ'-
M)%YRI&Q"G#')7E=V<\=<U235KC2=+N=+6\N$T\^,!IC2M,Q:"V95<H')R 2=
MN<Y ;K0!Z);^(#/XPO/#[6;1FVM([H3EP1(KLRX '3E3U-;5>3Z\[>&/%/C"
M[T=6CFB\.0S( 2PC/F2@LH/0 #=CIG)[FMF#2D-Q'JEGXC4VEYI\B_9[0RC[
M3\NY9=YE)#+_ 'AR<X)Y% '?T5Q7PTTU!X2TC69+F\GO;S3H1,T]R[J<#((4
MG /.,@?7DDEWCU9/MWA01W5U )M9C@D$,[('0QR$@@'!Y4<]1VQ0!V=%>43:
M3%YWQ T_[7J M-.BCN+.,7LO[F1K?>6!W9/S '!) YXYJ>6].L6%D);F:YOO
M^$92[FBDF\J&'>N?/R.3(2"!CH >5SR >H45Y:UU=6WA'P9XVFNKB86EM;_V
MJIE8K)#)&%:5ES@LC,&SCIFNW\,H9K2XU5C)G4IC<(K,2$BZ1@ _=RH#$>K&
M@#0O;B\@EM%M;'[2DLP2=O-">3'@DO@_>Y &!SS[5;KC_&SRPZOX0DBGGC\S
M6DAD5)6570Q2'#*#@\J.HKD-7M'DTSXD7+7^H^;IDYFLB+V4>2XMT<$?-SSV
M.0.V.: /7Z*\_M[M/$?BS4=%U>YDC"Z1;36D:2&//F!_-F7'5@=H!_AQQU-+
M8GR/'^AVB:G<WMK+H,P::60XN622)1(1T+8)^8#D&@#OZ*\<MYKB[\)>&6&I
M7P\SQ3):M)'=OEX?.F 4G/(PJX],<8KU?2M,M]'TZ*PM6F:&+=M,TS2MR2>6
M8DGKW/2@!4N+QM6EMVL=MFL*NEWYH.]R3E-G48 !ST.?:K=<#<>:?'_B>V^U
M78A.APRJHN7'EN6E!*<_)]T?=Q6'H2RVMK\-=36]O7NM040W32W+NLJ&V9L%
M2=O!4$<9SSR<F@#T#Q7X@/ACP_/JWV-KI8616C5PGWF"YR?<CM6U7B^K31^(
MOA!JNNWTDAU3[>5E'FD>1MN@BQ8S@*$V_+W)SUYKH;U9O%'B'Q5H\VKQV%Q9
M&-;4G>)((S$K"9,2*,[RV3CL 3CB@#K;;Q 9_%][X?:S:,VUI'="<N")%=F7
M  Z<J>]:DUW!;RV\4TJI)<2&.%3U=@I; _X"K'\*\XAT:#7_ !_<6NHWMS<H
M?#MF7FMY7MO.;S)?G.P@CUVYQSWP*QM+BEU*?P ^K337;I?ZA;1W4DC!YH4C
ME",2".2%'/? ZT >S51UG43I&BWNHBW:X^RP/,8E8*6"@DC)]A7G@$_BB'Q!
M,WB&+2[_ $W4Y5$VQS):QQO\F!Y@!1D R,8;<>IIUU,GB/3?B%_:4DGVG33-
M;V\0D9/(B6 ,KJ >"[%B3W''08H ]#TB_&JZ+8ZB(_*%W;QS^7NSMW*&QGOC
M-7*\LTJT%]KG@ZSENKP6EQX8+2P1W4B(Y40@< C'7MC/?BJFEZS=0Z-X=TNY
MU I93:Q?633W3,X81M((8G;<"0< =>=H!R,B@#UZBO.;C1M8TW3Y;+3-8MM4
MD74Q.NF3LT2-&8V+6H<LQ_VP#P,#(P:KQ7E[JFA64FB6$DLMG>W/VW0=1N2D
MCD'YD5^0=A==N?EP1TP, 'IU%8/@V_M=2\+6ES9K=I$6D4QWA)EC99&#(Q).
M2I!&<]JWJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *AN[2WOK62UNX(Y[>5=KQR*&5AZ$&IJ@N[V
MWL81+<R!%+!%&"2S'H !R3["@"NNBZ:MG=6AM$>&[0QW ?+F52-N&)R2,<<G
MI5JUMH+*TAM;:)8H(46..-1@*H& ![ 5476]->Q^VK=H8#(8@PSDN"04 ZEL
M@C&,\&DAU_2;C33J$-_ ]JK^69 W1\XV$=0V>-O7/:@#1HK)7Q/HC6_G_P!H
MPK'YXMF+$KLE) ",#RK<C@X/-2S:]I-M-=Q7&H6\+V<8EN!*X7RD/1CGH#@\
MT :-%8]KXKT"^6=K75K640)&\FQ\[1)]S\3V'7/'6I[?7])NK*YO(K^#R+5B
MMP[-M\DCJ'!P5/L<4 :-8&O:/?:TKVLBZ1/8$AEBO+1Y&##OD..<]" "*SM-
M\1SZA\2KO2H;T2Z?'I:7'D&'8T<ID*\Y&[[H!YXYJQXXU:^T6QTNYL[M+=9-
M4M;>X+(K;HGD"L,GIQGF@ L-!UC3"3:2Z,CD;2[6LSMCTW-*3CVS4,'AC4+6
M\-W N@QRF0S?+92[1(>"X7S<!CDY8#)R:TK;QCX<O+*\O+?6;.6VLCBYD63(
MB]"WH/?I5_\ M?3S%92_:D\N^8+;-SB4D9&WUX!/T!- '/GPUJ1N+VX_XD?G
M7R[+I_LDN9E' #?O>0!Q].*A?P;<2164;VOAUTL<BU5K"0B$'J%S+P.!QTXK
MH=>UNT\.Z'=ZM?%A!;1EV"J26P.@ ]:YF_\ %SP^)O#4@U"*'1[^VN9+A'0
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M,'TI=/T;3M*S]BM4B)4)NR6;:.BY.2%&3@=!3/#UU-?>&M*O+E]\\]G#+(V
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M6\]W$GF/$CY8+G&??G@^AX-+%X@TF?44L([^%KJ0,8TSCS-OWMAZ-COC..]
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M?#VCZLUJU_IUM<&T),&] ?+R,$#V.!QTXI]YK>FV$QBNKI8W7;NX)";CA=Q
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M"#W%/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>$=(U""]AN[JW\@!K9PL;KCY7)'RDY &>M=/XM!/@[6D",[/8S(J(I8L2A
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M:I!':0I:A!;JBK$$^Z% XQ[8H Y/XF[W\(B***::5KVT8)#$TC86=&8X4'@
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M%L8!U)4$%7&"".#C!-3Z+XKN[.;P]I.J:(UK9ZC;+%9W@N%DWR+&&VN@'R9
M..3_ (6=0\(W6NS:S>Z@]O:WE]H[Z3"L#-*D*/N+.20I8EF'&!@+[U+:^'-1
MNY- .KBSCCT4;XTMI6D\Z41F-6)95V@ L<<\D<\<@')V=W9:)\//%\UQHT.H
MV$.NW:O9,0B%?. '4$8!QQCM7=7WB&6+7Y-$T^R2YO8K'[:XEF\I=I8JJ@A6
MR20>V!CWKF[GP3K5QX+\1Z)YE@L^JZA+=QR>:Y6-9) Y!^3)(QCWSVJ#Q$]W
MJ/CATL)M%2\L].6*XBN[N:W?]XQ8A7CPSKA1U& >1R3@ V]-\:7&KZ+I.I6F
MCLL6HK)())Y]L4$:KG=(X4[23P!CL>:R[KQSJ.HZ%X8U'2;2WC74]5%E.DMP
M<J59P55@I!4F(_-CH>G/"VFG:SJRZ#=6<&D06VE/+ ]DDKO:2#"A)8B%&2F"
M "!SNY'6F6_@?7+;PYI=B+O3I+K3-:;4HB0ZI(A>1B&/)!Q*>@.,=3F@#6_M
M^PL?%>N&^TR*TFL-,BNKB_5PQDBR_P O0' *M]?2I/\ A+YK:;16U+3!;6>L
MNL5M,EQO9)67<B2+M 4L 1D%AGCWJM>>#[O5=>UR;4'MOL&J:4FG/Y+L)%(W
MDN 1@??/&3C ZT6_AC5KRR\/V.M26;PZ+/'<":!V+W+Q*5C)4J G4,<%N1@=
M: *LGQ$O(M.O=2?P_ML=/U-K"[<W@W+B18]Z*%^;ELD$CCH3VV)?%;/X@O=(
MLK6">XLI(5FB>Y\N8HX4F1$VG<JANN1RK#TS@W/@K6[CPCK^C[]/6;4]5>^1
M_.?:BM*LFT_)DD;<?CFKGB+PA?>)+MI+B#3XIHIX9;'48I6%S:* A=1A!N^8
M/C+ ?-R.* .WKE/$OC&?P[%J=RVE;K/3XHY'FGG\GSRV25A^4AV4#D9') ]Z
MT=+O-7F\0:O;WJV3:?$8S9RV^[<,YW))G@L, \= P]:YOQ'X.UW6+OQ((;O3
MVMM5LEM[=[D.9+3"$,B@#&UC\Q(.<]C@4 37:02?%S1+E(ES/HUUN;:,L-\6
M,^O4U)\-8HX-*UN*)%2-->OU1%& H$IP /2K$6@:O_PE6C:O,UBR66GR6DRH
M[@EG*'*@J>!L Y/.<\=*M>$-$OM#MM2BOC;L;K4;B]0P.S8$KEMIRHY&<>]
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M<_+C\<^U;*Z-J]CXMU;7+::P6"_LH4=9R^8Y8@^.0 "AW\G@\=* .I;<$8H
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M*(JW06XBVN00<'# X&!D'MQ0!Z5IFMV^J7-Y:QPW,%Q9LJS17$10C<,J0>C
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MO+"4J.<\,#ZUUK_:;'0G,M[%)=0VY+75R B%POWWVX 7/)QVH OTC,$4L<X
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MGAD4F=!R-^]6!().&P#SUQQ6IING6NDZ=!8640BMH%VHN2?Q)/)).22>I-6
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MEN6@>5Y%BEEW+%N8L50=AEB?7GKP*K7'A*REU*^OK>ZO+-]00)>I;.H6XP,
MG*DJV.-RE3COQ6_3=ZY W#)S@9ZXZT 8R^%K"+6=/U*!YX&T^V-I;P1E1$L1
MQE<;<_PKW[58U_0K3Q'I,FG7IF6)G219(7V/&ZL&5E/8@@5I!E;.T@X.#@]Z
M171QE65@#C(.: .7D\!:;*VJO)>ZF[ZK:K:WC-<9\Q0&&<$8!PQ'' SP!5I_
M#-M#=Z7J/VB^FFTBW>*V0%/F5E 8$;1DD*HZCIVKH,T4 <KH%J-6\03^*Y]&
MN--GDM$LXH[M568J&+,6 ) &2H'?Y3V(K>U/3DU2S^SM//!B1)%E@8*ZLK!A
MC((ZCH1@CBK:NKC*L&'J#F@.K$@,"5Z@'I0!S=]X&TC4['4+>_\ /GEOY8YY
MKHN$E$D8 C92H 4J ,8'KG.32'P-I<^@76DZC/?ZDET%$EQ>7!>;Y3E,-QMV
MGD8 Y)ZY-=*'4L5# L.HSR*7- '.P^#+ :)?:7>W6H:DE["8)I[VX,DI3!
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MQ/:!IE;8R@JHY7H%8C'OSDTM[X#TS4'U1Y[F^\S49X;B1TD56CEBQY;H0O!
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MVT2Q1F0@MM48 ) &> *MT@(.<$'!QQ2T %%%% !1110 4444 %%%% !1110
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M4\7]F67ENVYD\A<,?4C')H X66'2;?XG>)Y+HV]I*VD021SA%$JG]\'=.Y8
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M@L,H*@CJH(X/<8]:I:E!;:L/$VBRW^G/J,VMK)!?S74:M;H#&2A#,'RBADP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 52U'4X-,2
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MMF3][]I'_+,#H3WR#C'.< FF2^-=)MK/59[H74$FE*'O+9H2TL:D9#87(*D
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MS+$9/FPA8_Q':<?EP>*S?"L6H9M!J'@BVTZ]L8R)KQ1"PE8*5_<E3NRW4YP
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M:FX3IN(^7+CH#\HQF@#T2N2MO&\)U'Q(E]:3V=CHI DN)%!&/+#EC@D\@C
MS^)Q76UY[=V'B>QOO'#:3IN^?4?+GL;AWC,;$0JA7!.=V5.,C;ZGL0#=N/$-
MOJ5OJFFHMY8W\5A]J"/A'\M@P5U921U4CKD8Z55\%Z\9?"WAFVG^U7E_<Z9#
M/+(/G*C:,M(Q/&3G&>N#C.#6);Z7JZ^*+S4H] OTMKO0?LN;BZC>7S@[G#_.
M>3N&,'&/3I3/ NC>(O"']F6[:;<SV%[9QB_C::-GLKF-%3<I+_-&P X&<8XQ
MTH ZZX\8:9:SVPF$ZVMS=?8XKW8/),V2NS.<]01G&W/>J,_Q%T.WAO9VCU P
M6-U]ENY1:.%@;Y?F;/1?F'O[8YK!\-:+J6E%= OO"%I=&WN6:'67$31M$7+!
MV!^?S #C&.H'('-0ZAH&N7/@[QYI\>CS_:=5OY);-#)%^\1EC4'._ ^X>N#T
MH ]1KS^?Q"VA?$77EG_M6]MET^VFCM+:-Y]A+2;F51PHP!GI7>0,SP1LT;1L
M5!*-C*^QP2*Y1[?4-+^(6I:L-,N;NTO-/@AB>W*'$D;2$JP9AC.\8/3U(H N
MV_C71[R;15M7FFCUE6-G,D?[MMH)8$G[K  \'G@XR:UK34HKR]O;6..4-9R+
M'(S ;2Q4-@'//#*?QKA;OPE-I/PJ%NTT<6JZ;(^JP2)RL5P)&E"#U'S%/<$\
M<UVF@V4UCI$2W6W[9*3/<E>GFN=S >P)P/8"@";4=3@TR.%I@[//*((8DQND
M<@D*,D#H">2.E9S^*[&)K);B"[@-W>&Q021CB;D[3@G@A20>AQUZ5'XPTV'5
MM+M[.YTN;4+9[E3+Y$FR6 !6(E0Y!R&V]#G!/!Z5RDVB>)8?#^E/.EYJK:7K
MZW<*2LGVJ2S"LHW$D!G&XGD@D8S@\4 =E_PE6EI)JZ3R20-I+(MUYB="XRFW
M&=V01@#G) Z\5B>)_$D5UX;\36,#7VG:M8Z7)>*I/ER!=C%'5E)&-RXZY]16
M#J7AWQ'J\_B^>#3&M)[N>PO;#SYD*R/ J$QMM8X)*X],]^,UO:G<Z]XD\&ZW
M WARXL9KC3IK:.WFFB:265T*C!#;0@SU)!.>@QR 6_#GBNSNO[*TF47BWD]@
MLT4L\+*EQM5=Y1C]X@L"?7.1D5U1( ))P!7"1Z9JI\0^"+DZ7.L.G6,\-VY>
M/]TSQQJ!][)Y0],]J[B;S?(D\@*9=IV;^F['&?;- &%IWC+2]3N]/@A%PJ:D
MDDEC,Z )<*GWMN#D<<_,!D=*CN?'&D6L0N'%T]FUV;%;J*$R(TX)78 N6/S
MKG;C(QFN2TO3/$<NM>$=3O\ 0KL75DUPFHRRW$1 9X]H9%#D+&#V !]B>32M
M=\-K(MQX<UJ?0(M5DU*$V;02PD+*S*P)<.4S\^,=3P2." >@:IXNT[28;FXF
MCNGMK3;]LGBBRMMN (WC.>C D $@$$XJO=^.=)MKV]LXX;^ZN+2!+B1+:U9]
MT;9(93T(PIYZ>A)XKG!IM_I_B35P_A*#7M/U:<7=K>-Y0\HLBJR2A^0HVY!
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M2"#4-.^P3Q26WF,@&[YHVW +G=R"#G'Y=+9W*WMC;W2*56>-9 #U 89_K4]
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M<?='-='10!S+^&+U/$NJ:M:ZG%$FI6D<$T+VI?#QAPK!MXX^<Y&,\#D50M?
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M218MP(8J&8XX)'L"0, TZR\,Z78&$PQSDP0M;P&2YD<PQG&50LQ*_='(YX%
M'#:3K6LR_#SPE>2W=U.MS?\ EZC.A)F:+?(!C'S?>"9V\A<]LU#KDGB"P\&>
M-=235=4@MX)"=+:1L.(P%R06&_&XL 2<D#Z&MGQ!X0BM=*T?2]*T*6^T:TN'
MFDM8=0>.>-BI"F-W<<99R1N'4>XJ72O!=M=V5[:7]GJ<&DW<:H^G7NIR3LS
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@HQC"_+SZG'3O&VI:IH?B'XAZCIEI9RBS-O<S+.[(&5;5695"@\D \GVZYX
M/4:*XO4?''EWUM96S6EK<7>G)>V8OR56[=L_N5?("L,+GJ?G&!3H]4UI_B;>
MZ>7A:QM]+BN$@52&)=W!YS@ME!R> /Q) .RHKB].\8W\VOZ7I=Y;68GU&UFF
M,,4A+6<L84F*1AD,<-R0 01TYJA:^/-:ETC3=8GTNQCL9]4_LZ=$G9I 3.T(
M9> , @9SUYZ4 =]<7,%G;O<7,T<,*#+R2L%51ZDG@5$NI6+2VL2WEN9+I#);
MH)!F90 2RC^( $'(]:XOQ3K-UKGA;QC%IT5JUGIL$]I*9P2TT@BW2;<<+M#
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M&$SR"*(2.%\QSDA5SU)P>!Z5S=MXLEN/%&E6?EPC2M6T\WEC<G(>1@%)C(Z
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M]Y<-L@@C:61O15&2?R%<@WC.^M=,T/7+RS@&DZM+#'M0GS;43?ZIF/1AR P
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MX-\@MR1);2Y'[J12<YP3S@9QT'< ZBBN?\9:_=>&O#YU*UM(KEEGAB9))"N
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MTH O>(GFB\-:G+;7$EO/':R.DL>-RL%)!&01VK@;2;5_^* G_M_42VMVHCO
MSJ5(^S>9N4$8#97[W7DYKTJ]LX=0L9[.X#&"=#'(%<J2IX(R""/PK*7PCHZ+
MI*K#.!I Q8C[5)^Z&W;_ 'N?EXYSQ0!R%MJ=[:V6OZ9-KMTJVFNPVEM+(/-N
M)8W$;F!3P=S;F4,>@.<\9%O2'U#4I/&6D3ZE>:>ME/&;2=KC?):AX%?ER3N
M))P21U&>AK=N/ V@727BRVTY-W<I=RN+J4,)EQMD4[LJP  RN.*<O@C04DO9
M%M[@-?>7]I(NY<R[  "?FY)P,G^+OF@#%^'^IWNNV]V^I7<\6IV<<=I-:AFP
MORY$^UQUDSN&1C  ZYK"M=7UJ?P+X3NCK-VMS<Z_]DN)?E)EC-Q*N#D=@HX'
M'L17H;>'=-;7WUP1RIJ#P"W:5)W4-&,D J#M."2<XS5*/P1H,6FV>GI;W"VM
ME=?:[=/M<OR2[BV[.[)Y).#QR: .8%OJ4FM>,-(_X2'51;6%M!=6["8>8CR(
MY(WXSMR@.WISZ5)HFN:E?ZKX%DGNY2-5T66>[C#82214B(;'8Y=NF.M=;_PC
M&E_;M1O?+G%QJ,:Q73BYD&]5! &-V!@$],=359_!.B-9Z7;+#<Q)I8*V;Q7<
MJ21*0 5#AMVT@ 8SV% '$OK&LGP_&\>KW<<B>+_[/W9#%H/M.P(21D@#\^^:
MTX[349?%?B30SXAU46<-G!=Q,)AYB2/Y@.'QD+\@.T<?AQ70+X$\/):_94M)
MDA^V_P!H!$NI5 GW;@P ;C![#CBKP\-Z:-3O-1"7 N[R%8)Y!<R#<@S@8W8&
M,GICJ: *O@;4[K6/ NB:C>R>9=7%G&\KXQN;')_&N@JCI&DV>A:7!INGQM':
M0+MBC:1GVCTRQ)Q5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "HYIX;=5::6.(,P12[!<L3@ 9[D
M]JDKA?BG':'0](EO$C\J/6;,L[C[JF4;N>PQUH [*TO[._61K.[@N!&VQS#(
M'VMZ'!X/M3+?5-/N_.^S7]K-Y'^M\N96\O\ WL'C\:\L\0Z4R:UXGNO"$"?9
MVT!8[E+  ))-YN0H"\%_*#CCG#+ZU>ANO"7B&.ZUFRU2>_GCTF6"82)&D<$1
M&0DH"* 0V, \\'' - 'H:ZSI;!BNI69"JC$B=> _W3UZ'MZTAUG2UCN9#J5F
M$MFVSL9UQ$?1CGY3]:\DO;'0H_@=HEZEM8+=/'IJ/<!5$A(EC+ MUXR^1VYK
MI$MM"'Q?N(O*T\0_V#&Y3:FS<)7YQTR$/7^Z?2@#L[^ZF(TZ2ROK&.*:X3>T
MYW>=$0?EC((^8\8/(Z\52/C7P\L^JQ/JEL@TL#[2S2KA3C) YYQP#CN<=:\R
MTNYL/^$$^'+M-;^9#KJH&+#<B!IAC/8?<_3VK;F>#^T/B?I^%-[/#YD, 7+N
MGV-1N ]-PQGUXZT =]9^(-,O-$@U<7MO'9RHK^9)*H"$@':QS@'GI5LWUF+(
M7INX!:%0PG,@V8/0[NF*\K'B"RLHO!.I3ZB]OH7]F-;/>P(K1PW12+&\LK <
M!USC@[AD<TYI-)\/WWA6ZMKB=O";:C=S275SCR5G=/W;] %CWF3:<  G(XP:
M .S\,>(;C6M:\0VLDMI-;:?<11V\ML#AT>)7R3N.3\V./2C4?$-QIOCBQTRX
MEM(M+GL)[F220%61HV0<L6QM^?TK*\#W=A/XT\;?89H7CDO+>53$05<&!,L,
M=<MGGWI/$\>G?\+-\.R:NMM]C-A=HK707RS)NB('S<9P"0/:@#L6U?34A@F;
M4+18I^87,RA9/]TYY_"I_M5N;HVHGB^T!=YBWC?M]<=<5YCIWA)]0\(^((M+
M18(TUA]0\/G&%C9-I5D]$9U<#MM;(X-=9X-NY->M7\37%J]M+?QQQQ0R##11
M(#P?K(TA]P5]* -^[OK2PB$MY=06T9. \T@09],FAKZT6.*1KJ ),,Q,9!A^
M,_*>_'/%<GXIU2QLO&>@P7+16EP]O<>3?7!)10=@:-%R TC<8ST Z'.*\_T<
MZ5-X:^'?VWR&CAU2YMYC.H 48FPC9Z#[OR].G% 'M,6JZ=-9&]BO[62T!P9T
MF4IG_>SBECO[:\-S#8WMM+<0_*ZJX?RF[!E!R/IQ7C?B?2K*VTCQ_=6,,*Z*
M\U@T/E*/+%PKJ)FCQP#@J"1WR.QKK(K#2XOB=IFH>'UM(K6+2YQJ4EKM$6PE
M/)#%>,YW$=\+0!I>'O$.J:YX)TC5I+G3;2[NK@+-YJD1LHE92B#=G<0 !DGF
MNGN=1L;.6.*ZO;>"24XC2655+GIP">:\<L[BQ/PH\%RR2V^^+78,,S#*?Z4Q
M;GMQR?:MW^U-#77?%^@>+_\ 6:A<H]NCALW=L8T$:1%>20P;A>=Q/?- 'HMS
MJ=A9SQP75];02R8V1RRJK-DX& 3SS6!)XFELO'=YI6HW%E!ID.FQWB3/^[*L
MTK)AF9L?P^@ZUP?CG4;%[/QOI\:K8WBZ? 98I29)KK;'N4H"2%1,X) /.22.
MIVI)-"O/B6EWJYL9+*?P[%Y$EX%\N0B:3=M+\$[3GCL?0T =-XEUZ[TN?P\U
MBUM);:CJ45I*64L2CJS;D(./X?0]:VYM2L;:ZBM9[VVBN)?]7$\JJ[_0$Y->
M30P?V/X8\'6]R_V>W/B@RV<4[;62U+3>7D'D#:5Z]-PJ:>YTB\O?$OAOQ3J-
M];7D^I--#:1HH>ZB)4P-$VPL2 JKP>-O:@#UN0.8V$957P=I89 /N,C-<WX1
M\2OJW@JSUK6);2VDE>59&!\N,%9608W'T4=ZZ,,(H TC;0JY9G/3 Y)->/>'
MM9TVS\%^"_M#VZ,=1N_*O9Y#Y-H^Z;EP" 696PH)'7/;D ]8.K::(89CJ%H(
MI^(7\Y=LG^Z<\_A3EU.P>2:-;VV9X 3*HE4F,#J6&>/QKRO2; ZWX#\36UA(
M9-3T[7;F]LRR;665)?,CXP-N[!&,#AJGBN=2N/$,&LVEK+%:>,K46VP+AK<H
MH*2L?4Q&9A]%% 'I\5_9S21QQ7<$CRH9(U20$N@."P&>1DCFI9IHK>%YIY4B
MB099W8*JCU)/2L;[3X<M/%%EIF+2/6A9G[*GEXD%N#R%;' RO3/:J'Q O[/3
M]!M9;Z!9(3J%L!)*[+% WF K+(01\BD D=#P.,YH Z!-4T^2R>]2_M6M4R'G
M692BXZY;.!0-4T]GN$%_:EK;F<"9<Q?[W/R_C7BVNW=C-H/Q-ADNX;EG>WGB
M8H%#DPQ@.@]ST(SD#J>M=E$FDP_%G3X;06:Q7&@3(Z1;<2_O8RH('7C<?IF@
M#N/[3L/LRW/VZV^SLVU9?-7:3Z YQFIY98X(FEFD6.-!EG<X 'J2:\\\-:?=
M6FM/X,F@8Z9HUS]OMYB,J\#$F"/ZK)OY_P"F(K?^(T4<WPW\1B2-7"Z?.P##
M."$)!^HH WH-2L;JYDMK>]MY9XU#/%'*K,H/0D Y IL>J:?-<26\5_:O/$"9
M(UF4L@'!)&<C%><)8Z6VO>"M0\/10-<P6\LEZUF 6: P\B3'4F3:!NYW$^]9
M6A:QID^L_#Z>TGAAM5:[A6TB+.;4M$<12.<EI"V,@XR>@[T >N)JFG26KW27
M]JUO&</*LRE%/N<X%-FUC3+='>?4;.)4"EV>=5"[ONYR>,X./7%<)'IEQIOB
MN^\(Q6Q.C:O,-41U7Y(HP1]HB/LSB,8])3Z57:'1I/&GQ"%Q'8MBPMR0X7@^
M7)O//?D9_"@#T==0LFO?L:WEN;K9YGD"5=^W^]MSG'O2'4K%;X6)O;87C#(M
MS*OF$8S]W.:\HTQM-MM+^%=S$UK'<LRK+(I4.<VK*P8]?O8!SWP*=HEQI&J6
M\6AZ]J-^GB*RU5YSIZ(BR-.)699$;9N*D$$MNP!G)P* /4Y-7TV%PDFH6B,9
M?)"M,H/F8!V=?O8(XZ\U5/B72O\ A(_[!^V0_P!H"'S6CWC*@D #_>/)QZ#Z
M5Y-J<.CGP;\39$2R\Y-1D\D@+N7]W$5V^GS ].XKK&O[&+XI--/.NR[\-Q"%
MD/,Q$TA;8>Y (/'0<]* .YM]2L;J=X+>]MIIDR6CCE5F7!P<@'(YJ'5YKF"U
MB:UN[.VD,\:E[L$JREAN48(^8C@>]<-X*N;FSUS3-,^U66MZ;_9K_P!GZE -
ML\$(,?[N91QSA0#P25/'6M'XHM:QZ%IDEP8E=-7LV1GP"N)EW$$^V<^U '67
M.JZ=9^;]JU"U@\K;YGFS*NS=G;G)XS@X]<5;!# $$$'D$5Y=+#HDWC7Q^9TL
M7_XEEL?G"GDI-N/UY7)]Q77?#^<7'P\\.N)!(1IT"L0<_,$ (/N#0!M2:E8Q
M7J64E[;)=2?<@:50[?1<Y--_M?3!YV=1M/W/^M_?+^[YQ\W/'/'->66]QI&H
M_P!J>'/$FHW\.LIJ\LZ64:(LDY\TO#)$VS<1MVC.[@#G"U:\626-GXEG\3VB
MI-I-K+%:^(8XY!B<@@HVW^)HB5)]0=O."* /2[G4K&R@2>ZO;:"%_N22RJJM
MWX)/-+=:A96-N+B[O+>W@;I)+*J*?Q)Q7!7OB/2;#X@74NNW4(TC4])B33KM
MSF!AN?S8PPXW-E#[@#VJE=W^F>&_$FD)=3W6C>')-(^S6$LB!D1Q(2R.9%8J
M63RSS@_+@],4 >E3ZC8VL,<UQ>V\,4GW'DE55;C/!)YIL^JZ=:QQ27%_:Q),
M-T;23*H<>H)//4?G7FS6-OI%GHX\+ZTEI/:V=P;6WUH PWELT@9@3P5Y"D$?
MPD<8Z5[^^D;3;35--DL["Z'A^(W7A_4O]5/:_/A4;A@PPXSCG*YH ];!# $$
M$'D$56&I6)OOL(O;8W>,^1YJ^9Z_=SFF64TMSHEO/' UM-+;*ZPR]8F*Y"M]
M#P?I7D\;G4?A+I^F0OL\6VM]$!"Q_P!(CO!."[D=>5+L6Z;23TH [;5/%$\_
MB6X\.Z-?:;#?PV8G#W7SJ\I<JL6 P(^Z<]2,CBNG%Q]FL$GU"2"!E13,V_$:
MMWP3CC/3-<=:7-F?C1J<8FA,G]C6Z[=PSN$LA(^N"/S%:?C>.*72;-&U;^RK
MC[;&UK=LH:-9@&90X. 5."/J10!M)JVG2B(QZA:N)6V1[9E.]O0<\GFIHKNV
MN'E2&XBD>$XD5'!*'T..G3O7E%]J<\N@Z=?:M;6=JVG^*X#>7=JQ^S2@#!G4
MG[JDL ?0@Y[U7UK4/MMU\0Y='8W9>+39=D')G@7_ %NW^\"FX9'!!]Z /2=7
MUZ-/#>K7^C7EC<W%C;238WB50RJ6PP5@1G'K4N@:W!JNEV!DNK8ZA+9Q7$T$
M;C<N] <[<Y R:Y'4M7\*:WH6OZUHTL4\YT.6WENHRRHB;24B8'@/EC@8R,?2
ML[3#IEKK?PR>U-K%)-83+(T94%\P)PQ'7YAW[^] 'J5Q<06L+37$T<,2_>>1
M@JCZDU6.KZ8OVG.HV@^R_P#'QF=?W/\ O\_+^-<K\7!;GX:ZH;CR^#$8R^.&
M\Q>GOC/3WJC);Z&/C!:(L5AY1T%VV@)M)$RE3CIG:6(]LT =X^HV,5FEY)>V
MZ6K@%9VE4(V>F&SCFF/JVFQV\-P^H6BPS?ZJ1IE"O_NG.#^%>2^'=8TNQT'P
MM%));0E=5U!;>]FD/D6F'EP"H(!9D;"@D#G(]#/HPTG5/A_JF@W4HDNI]:NX
M+1&/E2+.9F:-AP-A7[YP.!VY (!ZE<7L3V]XEI>V@NH8SDNX98FP<%P#D#\J
M;:ZA%'I]F;Z_LC<2P!VDC<+'*0N69,G[O4]3Q7 :?JEI/X$\5Z1K#VYURQBN
M%U,R,I^T/L.R8>H(VX'\. O&!5.S_LNYU/X6>=]DD9M+D5MVTYQ;I@'_ ($#
M@>H]: /3!K6E&*WE&IV9CN6V0.)UQ*W3"G/S'Z5*=0L@\R&\MPT S*/-7,8]
M6YX_&O&-0BT@?#WXBO$MGYL>K3^0R[<I_JV79Z?-N(QWS76OJFGV'Q.OYKNZ
MBC2_T.W%L2<_:"))<A,??;YAP,GD4 =T=1L@D+F\M]LP)B/FKAP!DE>>< $\
M=A4(UO23!#.-4LC#._EPR?:$VR-_=4YP3["O(O#C:7<V?PI$YM781W$;B3:3
MQ V <]MV./6EOX-&/A+XG[4LBZ7DQAP%RI,,9&WT^<'IW% 'M=4O[1M;B26U
ML[^T:\4$>7O#E2/500>#]*?ILRW&E6DRR"17A1MX.0W YS7G'A.^?3]6T>T6
M^LM8T22VG>RO>$N;", ,R3X."OW5SP=PYH ZKP5XI'B#PUI-U?W%G'JE["TI
MMHW"D@,1E5))QQ6Z=3L!?"R-[;"[/2 RKYAXS]W.>G->,Z(=,MO GPYND-K'
M=?VS&))05#X/FA@3UQ@J#^'M4^JZSILIB>&6*R%KXOCDN+1B6E1O.PTTK$G8
MK=@,#!QD]  =[#K^JR^(/%>G?Z)MTNW@EM&\IN?,5V(?YN?N@<8K3\):K<:Y
MX0TC5;I8UN+RTCFD$8PH9E!. <\5RMI?6@\<>/B;F)<6%H3N8#&(Y<]?3(SZ
M9K:^&TB2?#;P[L=6VV$2MM.<$* 0?>@!ND^*6;7O$%CK%W86\=A>16]LY/E>
M8'B63!W,<M\V./3I717FH66G1"6^O+>VC)P'GE" GTR37FEQ:^'Y?$/Q!AUV
M"T>25HC"DZ@RNAMD'[H'DDL,#;_$!WJE97DGAN^TJS\9ZC/I\5QX?M[>.X=4
M:/S%+>=$S.C ,04STSM'7B@#V!65U#*0RD9!!R"*K#4[ W"VXOK8SLYC$?FK
MN+@ E<9SD @X]#5#PI8V>F^%["ST\W1LHD*P&Z.9"F3M)R <8Q@$# Q7!:'I
MUE>6OQ ?2;>SDUB'4;IK!T52\3FW0(R'^'YBPR.^: /2XM4T^:>:"*_M9)H
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M#(!$SGH,C>H/JQ]:XGQ5;VZ:'X[NE:'^Q[C4;%[(Y&PS;H_/:,^YZD=PWH:
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M&^M7V(DH=0RY#!B!DJ< KGCL<=UJM\=,TF[OA;R7!MXFE\J,J&? S@%B!^M
M%H*%S@ 9]*1T61=KJ&'H1FN9T;Q<+SPWHE[>6<R7VJ1(T-K'L+3,8P[,GS8"
M@9.6(Z<\D9U-'UZTUIKN*%98;JRE\FZMIU"R0MC(S@D$$$$$$@CO0 FMZ?JF
MH);IINLG3%5SYY6W65I$(QA2WW3W!Y^E7[6UALK.&TMT"0PQK'&H[*!@#\JP
M=2\:V.G:U-I'V#5+J]A@2X:.UM2Y,;-MW#U (.3[4Z]\9Z;8-')/'<_87NOL
M?VY54PK+NV[3\V[&X%=VW;GO0!T) .,@''2L#7O#UQK&K:)>17D,":9<-<&-
MX"_FED9",[A@88]CS6'\0/$2GP9XD33EU!I+&%TDO+-]@@FVY +!@QQE<[00
M,\]#C>T[Q! ]Y'HQAN6OH].CO.0N)$/RY!W==P(YQ0 >+?#TOB3PU/HUO=1V
M8F:,F1H?,"A75\!0R_W0.M;4,?EQ ,$W'EBB[03W.*P[/QAIVHZ5IM]9QW$S
M:D7^RVP4"5]F=QP2  ,<DD#D=R!2VGB[3[ZQ2>"*Y,[W,EH+0H%E\Y,[UY.W
M@ G.<>_- &]@>@H**6#%067H2.E9>A^(+/7XKHVRRQ36D[6US;S* \4@Z@X)
M!X((()!SUK(U#X@Z9I]SJEN+#5KF72ROVL6]H6\M67=OY(^7'/OVS@X .K*@
MG) Y&.G:D9$?&Y0V#D9&<&N8NO'^D0R6<=M!?W[WMFU[;"SMB_G1C&0O3+88
M<?GS4<'B+28=6\0WFW51/96D$UW%*C[50JY7RXR>#@-NP.PYH ZT@'J*0HI8
M,5!8=#CD5S>F^-].U*_TRU2VOX1JEN9[.:>#;'* H9E!SG< <],'!P34G_"8
MZ=Y]D!%=&TO;HV=O>A 87EY&.#NP2K -MVG'7&* .AI-JD8P/7I7&KXLT/1[
M3Q+JS'5&BL[T)>+(K/MDV)_JU)^5,%?09-7[7QOI=QK4VE30WME.D#7,37=N
M8UGB7[SQGOCT(!]J .D  Z"DVCC@<=/:L#3?%MAJUY96BP7<!U"T-Y9O*J@3
MQ#;DJ58D'#*<-@\U0^'4T\VA:@)[B>=H]6O(E>:1I&VK,P498D\  4 =++81
M3W\%W(69X ?*4XPK$$%O7."1UZ$^M62 1@@$>AKSU?$#:#XZ\8//'JE];06]
MG,((=TODKMD+LH9L*.^ >>P-=4WB2T>"TDL8I[][JV%W%%;A=QA(&&.]E SD
M  G)[#@X -C ]!4-W%-+9SQVTPM[AXV6*;8'\MB.&VGK@\X[US(^(NB26^E2
MVT=]=?VHLIMD@MBS%HP2R$=F!!&/Z<U9N?&EG:Z;+?M8:BT5M MQ>*(5#VBL
MN[$BLP.X+R57) [<C(!?T/2KC3;>1[^_.H:A.09[HQ",-@8 51PJCTR>23WH
M\2Z1+K_AK4=(BN$MS>P/ 96C+[0P()QD<\^M0VOBBQOM3DL+6.>:8627\94+
MMFA<D*RG/<@]<50C\?Z/+:Z)<10WTBZR'-H$MR22JL2#CH?E/'\AS0!OZ99M
M8Z=;V\C1O+'&J/)&FP.0,9QD^GJ:M;1C@ =^G>N>M/&>EW.D7>H.ES;?9+K[
M'-;3QXF$^5"QA03DMN7&"<Y%8=KK+1_%'4VO#>V-G!H:7$L-W+F-")6S(H#,
MH&T#)'H: .CT+1KZP>6ZU?5CJE^ZB,3_ &=852,$D*%&><GDYYP/2MK ]!7/
MKXPLEU./3[FTOK6XGMWN;998@?M"+C=L"DG< 0=K 'GI2^'?%UGXG6.2PLM1
M6VEMQ/'<S6^R)QNQM#9^\/2@#?P/04;%W[]HW8QNQSBEHH 3 ]!1@>@I:* &
MJBJ254 MR2!UIQ /4444 )@>@I<8HHH 38I</M&X# ..<48'I2T4 -9%8 ,H
M.#D9'0TK(KKAU##T(S2T4 -9$<8=58=>1FAD1R"RJ2#D9'0TZB@ INQ0Y?:-
MY&-V.<4ZB@!,#.<"@J&!# $'L:6B@!OEIY?E[%V8QMQQCZ4H4#. !GKBEHH
M:J*HPJ@#.< 4N!Z"EHH ",]:3 ]!2T4 )M4]AZ]*,#T%+10 F!Z"C ]!2T4
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MH,4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,=<9JM=Z1J^E^,]6NH_#%KKVGZLT<R2-)$CVTBQK&ROOY*$*#E<XYX->A44
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-** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>88
<FILENAME>exhibit1062-securedpromi002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1062-securedpromi002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^FC21--*LLL;%Y7CV;$V,<KRQ)..@XY..9MM#\1V_AK0M$_L5BVD:VES)/\
M:H@LT0F=]R#=G[K#(;:<^O8 []?$EM+=M##:W4L2W?V-[F,*8TE'4'YMPP>,
MXQFMFO/)= OSXKBU?2[.YTJ^;41]M>.X0VM[:ACEG3<3O*8P=H.[VY';:==7
MMTUX+S3C9B*X:. F57\^,8Q)Q]W.3\IY&* .)^)EM=Z1X,\0Z]:ZMJ45ZHC>
MW\J[D1(1E$P$!VG/S'D'EJ3X@:5+H_@77+^QU;58RMH,*U_*VUPX^96+9&02
M",X/'I6O\2]*U'7? .IZ3I=HUS>72JB*'1 ,.I))8CL#3_'5AJ.O?#W4M/L+
M"1[Z[A") TD:E3D'DEMO;L30!=LO%5G=ZS/I)M;Z"ZBMOM2":#:)XL[2R<DG
M!(&" >1Q5#P_XATE/#>E/IW]HW,=]/-':Q7+[IY&5I"^2[=!M;&3TP/:D>RU
M)OB/::R-,G%DFCR6KN9(LB1I$<+C?GHI&>F<?6N?TWPM=/X%TK1-<\.W$WE7
M-Q)(8+F-9K9FD=XY8W#CG#8.#GV(Z@'H6GWJ:G8BX6&:$,SH8YAM=2K%2#@G
MN#T->>-K^I>#O&6IS:A<3W/A.6]2T,DTC2-I\IAB<,6.3Y;&3'L0/Q[+PC9Z
MM8>'8;;6;F6XN8Y) DDS!I3%O/E^81P7V[<D=^YZU#9:<U[/XCM=5TMA8ZA<
MAE$S(RRQ^1%&1A6)'*-U[8H CBNK?3M>UZ^N[Z9;&VMH9R9;AVBC!#EB%)P/
MNCH.W%68O%-JVI6VGW%G>6ES>1-+9K<*H^T!1E@I#'# $':VT_D:XZ/X=:LO
MACQ3X;?4#+;7,,46E7$K998TW,L;]_E)VY_NX^@VWT_5/$>J>&KO4-,DTYM*
MD:YN"\D;;Y/+*!$VL<KEB<G' '<\ $WAWQH=4T%]3OM/GM=UY);01Y1C*PE9
M%1<,?F^7G.!U.<#-:VD>(K36+V_L$BGMKZP95N+:<+N0,,JV5)4@C."#VK@_
M^$5\1+X12Q32H'N]*UJ34((IYD,5^C2R-M'7;E)#]['(Z=ZZ&&_U32] O]8A
M\&P6<R(FVP6XACDD /SL\B_(% .0,D\'IF@#KIYX[:WDGF8)%$A=V/8 9)K"
MT_QC8:A=6MNMM>0M>61OK4RQC$\(QDKM)(/S*=I //2M*ZEO+G0)IM.017TM
MJS6ZSC 60KE0P]CC-<)I&D^($\3>'M8NM"G22&PGM[^2:\B>0RMY9W<,1M)5
MMH'3.,** -VR^(>DWT>F3QVNHI:ZC<&UAN9+?;&LNYE",<YR2IQ@$=B0>*I^
M/?$*'P?XECT]=0>6QMI%DN[-]@MYMFX L&#'&5)V@@ \]ZR+3PYKT/@7PUIK
MZ1+]KL-:2\GC$T/RQ+.\A(._!X8<>M+<Z)XCLM$\:>'X='DOHM7DN[FRO(YX
ME4&93F.0,P8$'@$ @^U 'H&G2R+X?M)MDD\@M4;8I&YSM' )(&3[D5YWJ'BJ
M[USP?X;UYH;W3_,UVV!6.7B2(SD%2J,2_  ((Y/05Z-H\<\6BV,5S#Y,Z0(C
MQ[@VT@ $9'!KSFU\.^(H/!'A_1GT:0SZ7K$$\A6XB(>))RY=<L."I& ><YR!
MU(!V=GXQTVY&JB>.ZL9-+VFYCNHMK!7!*, I.0V#@#G(QC-36/B:UN]=DT66
MWN;/4%MQ<I%<!?WD6=I92K,.#P02"/2N2USPKK.M:EXQ$5K]G34;6S%G/,Z%
M&D@9GPP#$@$D#D=,UN>%EU"><3WWA*TT)XXRKLKQ.TKG'W"G1.#UY/'% &UJ
M&L06%W;68CEN+VY#-%;0[=[*N-S?,0 !D<DCD@=ZXSQ;XEM]1T#3M0L+F]MW
MM=>M;:ZA4NDB$3*'C=%/S<=N0<C&<UL:UI>HV_CG2_$MC;->PQVDMC=6Z.JN
MJ,P=73<0#AEP1G..F:PM0\(ZK+:ZEJ<-IF[N]=M=3^Q>8@810E!MSG;O(4GK
MCD#- &ZOBJRUV'6=*6+4=/U&UM6E,-PA@E*$';(A4],CJ#D'K65H>JVG_"(^
M ?[4GU%[N[6#R9(G?$DIB)_>MGY@1N.#G.*T)M(OM0\0W_B%K"6 C2&T^VMG
M=/-E+-O9CABH&0H&3_>Z<5D0:!K<?AOP#9MI4OGZ/<PO>*)HOD5(7C)!W\\L
M#QVH Z74O&NEZ7%J5Q)'=2VNF2+%>W$*!DA<@'!&=QP&7.T'&?8X+_QG86 N
M<VE],;2S%]=+'$ T$)W8+!F!S\K' R>.G3/&7UG=WFI>)8+?P[J-_HE_>CSQ
MI]Y;B.9D55?(D(8,64JVTX^7 P<DW=;@UWQ/%J?V?2I;G2=0T<#30TZ1)!*R
M-N\U"<ELE=IPP&.HR30!T$OBV0^,-+TBUT^:>UO+%[P7*L@!7<@! + X&_)X
MSTP#S3=)\0Z+;V&MW\<M^(H=4>"9;K<S&X.P;(U)) )90%XY)XK,L-)URUUW
MPKJ+Z22MOI#V%T@N(\V[DQD,W/(^0_=S6=-X3UZZTG6C'9F"]3Q(-:L8Y94V
MW"J4(4E6.TG:>O?'X '8CQ99)>7EE=6UW:WMK;?:S;21AGDBSC>FPL&&>#SD
M=\55TWQYIFIW.D1QVNH11:M&7L[B:#;&[!-Y3.<[MH)Z8.#@FJ5[I5_K/B%=
M=;3;BV^R:7/;16\CQ^9-+*1Q\K%0JA>YY)]N<VRT'6X-)^']N^E2^9HSK]MQ
M-%\@$#1Y'S_-RP/':@#KK/Q);7]Q;K;VMT]O<320Q70"F)FCW;NC;A]Q@,@9
MQ5C5M9MM'6U$R2R2W<XM[>*( M)(03@9( X5CDD#BN/TOPYJ-IXIL]4TZQNM
M'$T\C:O;>>C6EP"K8D1 Q(<MM/ '&<^^[XM36G&F?V5;2W5J+L&_AMYEBF>+
M:V-K,5 ^;:3@@D<=S0!'-X\TFWT>34IHKU$AOO[/FB\G<\4V\)AL$C&2.02#
MGC-6;/Q?IUS=:G;W$=S82:=$MQ.+V,1_N3G$@Y/R_*>N",<@5P[>&/$">'-9
MTZ/0MAG\0QZA L5S%M,(DC<XR1C 0CG!S^=:/B;PKJWB+6O$BQVSVUOJ.B1V
M<%P\B8\U7=\$!BP!W 9QZT 3:AK4U[\0O!9AAU.TM[H73;97VQ3H(&*DH&."
M,Y^8 \^W'5>(/$5EX:LX;J_6X,4LZ0 PQ%\,[!1GT&3_ (9KE1'XDU7Q!X0O
M[OP[-:'36G%Z6N82H+P[-R;6)*Y.>0#[5K^/-.U#4]'LX-.LGNI8]1MKAE5T
M7"1RJ[<LP[#B@",^(-.U#7] CN+36K*\FFN4MHIHVA1BB-N,@SAA@97KU!XJ
MQ?>.-+L(+FZ>*[DLK6[%E-=11AD2;(&W&=Q^8A<@8R>O6HM?T_4+OQCX4O[:
MQDDM;&6X>Y<2(/+#PE!P6R>3SC/%<A]FNIGU>-?#6I7V@7.K/>8L;NV,,Q1P
M2V'(?!=-Q .,CCCJ :W]OOI7Q!UV5H=6O+?^R[6X6SB#2&/+2;B%8@)P!D<?
MB:U;GQMOU7PS#IEA/=VFM127"3J4&46/=@!F!!Y4G/;@9/2K:6]_=>+-8UR'
M39VT_4-(MX[:3?&"[#>V-I;(X<=<=ZS-*\/:_IMGX!E.E,\VCP36UY#Y\8*%
MXPH?.[!7(YQDX/0]* .RM_$EM=W<<4%K=20R7,EHMTH4Q^9'NW _-N&"C#)7
M&1[BKFJ:I;:1:I/<LW[R588HT&6ED8X55'J3^ Y)P 37%V_AS48?%L&K:98W
M6D32W\AU-%G1K2[@^;$FP,2)&^0Y !!)SZUL^-M&U#4[72KS3$66[TK48KY;
M=G"B=5#*R G@$JQP3QD4 7K7Q+;W5Y>Z>+.[CU*S19'LI @D9&^ZZG=L93@C
M.[@C!P:YSX?"?Q#I&E>)KR34H;UDD:3-P/(N0[-@;-QX7C'"D>]:5MIMW<>-
M9_%,MA/ L>EBQAMG:/S929/,8G#%0!A0,G^]TXR_X>:;?Z-X&TO2]3M&MKNU
MC*2*71P3N)R"I/K0!6F\1W.I:WXFT+[!=V\.GVL9%RDJJ0SK(V[*ON .U<8Y
MZYQ5/P/XNA;0/"FFWT=^;F_L4$=Y-&3'-*L>YEW$Y+8!.2,'!P35A],U>T\7
M^)[J/37N+35+*!8IDFC&'C1U*$,0<DL,=L9Y[5F6.@:W!I?P^MWTJ42:,P^V
M_OHL(! T>1\_S<L#QVH Z:Z\9Z;9RV[31W(LI[K[&E\%4P^=N*[3\VX#<"N[
M;MSWJ]XAU^S\,Z--JM^)C;0XW^3&7(R<#Z<GJ>*XOPYH>L:-*VAW/A:QNH8K
MEV@UIFB(,3.6!=#\_F '&,8) Y YK6^*Q(^&6M$#)V1X'K^]2@"[:^.-+N-8
MN-+GAOK&>*W:Z0WEN8UGA7[SIW('H0#[5)I_C"PU"ZMK=;:\A:\LC?6IEC!$
M\(QDKM).?F4[2 >>E9FK:7J^M>(+36;2R-C/I=A=K;?:F0^9<2JH4$*Q^1=N
M23UR,=ZR=(TGQ!'XF\/:Q<Z#.LD-A/;W\DUY$\IE;RSNX8C:2K;0#QGHHH N
M7_Q/MSX6O-9TK1]4N8XK66=)9( D(9'V$,Q;KGG R<9[@@:TVK6<NO\ AJ&^
MAU*VU"Y$S6\0;$1(C);S-K%6X&0.2"1TK L_#.LR?!>_\-RV)@U-X;E$B>5"
M&+R.Z_,K$<A@.>]:5W9ZQ?\ B/P=J+:/-#%8F<W:F>(F'?$47.&Y.>3MSQ^5
M &G=>,]-LY(&FCN19377V-;X*IA\[<5VGYMV-P*[MNW/>K,/B2VN;Q88+6ZD
MA:ZDL_M*A3&)4W;@?FW#!1ADKC(]Q7(>'M#UC1YGT.Y\+6%U#'<N]OK3M$1Y
M3.7!=#\^\ XP!@D#D#FIT\.:C'XNBU?2[&ZTFX?47.H;9T-I>6^6Q(4W$^8R
M[>< @DY]: -#XF3RVGA1+J&YN('BO[3YH9&7*M.BL"%/S @G@YK1M/&&FSW.
MJ07$=U82:;"MQ.+R/9F$YQ(N"<K\I]",<BJ_C[3;_5O#:V>G6CW,YO+:4JKH
MN%CE5V.6([*:Q/$'A?5=?U_Q#LMGMK;4-$CLH;F1T($RN[X*ABV/F SCUH Z
M'_A,;&/43I]U:7UK<FV:[A26($SQK][9M8\C(RIP>>E0:;X\TW5+..\AL]22
MUFBCD@FEMMJ3M(VU8T.>7SU'0=<XYJAHL>L3VKF\\&6FE74,#H\D+PL9W*XQ
M%M/RJ>N6(].>HSCX7UN3X5Z!IZ6,0U?1W@F^QW+H8[@Q<%"P)&&!.">^,XH
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MG?B7<WUIX/>6PN_LSF[MHW.S<61YD0KUX'S<_E6;=PZJ_P 5O*L[RVBO#X=
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M=X>O[^\%VMA;*;:,1! KF/86?D[F ++T4#)XSTZVB@#D;7P);VNEC0_MTCZ
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MEYHX(D'5Y)'"(/;EAD]AFC2KV_NS=)J&F&QD@EV*5F$J3+@$.K8!QSC! Y%
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MX5N=+A6"_P!>O=5AAB,-LDZ(OE(1CDJ 7;'&X]L^IK:U.XN[73II["Q^W7*
M;+<2B/?R/XCP.,G\*MT <;'X",7AS2=%&LW#PZ9=0W$#R0H2/*;,:'&./4]3
MZBMG6?#5EKFH:1>W183:9<&>,IQNRN"I_P!DG:<?[(K9HH YK7_"3ZKK-KK6
MG:O<Z3JL$1MS/ BR"6(G.QT8$'!Y'H36YI]F+"RCM_.EG9<EI92"\C$Y+'&!
MDDG@  =@!5FB@# /AR0>)K[7([_;+=6:VGE&$%452Q!'.2<L:QE^'*V^E:)#
MI^MW=EJ&C1M#:WT4:EFB;JDB'*L.!^5=Q10!S-[X1>]M-+BDU6=YK&^2_>XE
MC5FGE4$#<!@!<'& !P!C&*L:?X;:QUC7-0-\TAU<HTD?EA1&40(NTY_N@9SW
M]*D\2>(/^$>AL)39O<+=WT-F2KA1&9'"ACGKC/0?I6U0!S"^%9%NH-1N]2>:
M_L[&6TM[J.W"R@.!EWZ[V&T8& ,D\<UI^'+?4;30;6#5;I[J\3<&FD"AV7<=
MN[;QNV[0<=\]:U** .=USPNVNQ:C9W%^3IVH(J36SPARF  3&V?E8X')!P0"
M #5>]\&>?J]_>VFJW%G%J-HEK=P(BL) @8(0Q&5.&(..OL>:ZJL[7M4.B:!?
MZJ+9KD6<#SM$K!2P52QY/L* .;/P]\B'19-,UV]LM2TJU%DEX(XW,L''R.A&
MT@8!'I[U9U/P0+PZ9=V>L7EEJ^GE_+U !)'D$G,@D4C:P)YQ@ =L#BNBTV\_
MM#2[2]">6+B%)=F<[=R@XSWZU#KNIG1="OM4%NUP+2!YVB5@I8*"3R?84 8F
MJ^"!J-I8.FL7UOK%C*TT.J*%,A=QA]RXVE2 !MP!@ =JN1:!?016SIKD\MXC
ML\\T\2LMQN4+AD7: H & N.G?G.KIE[_ &EI-G?"/RQ<P)-LSG;N4'&>_6K5
M ',6/A Z3;00Z9?"&-3<--#);AX9C,X=OD!&T @A0#P#@YJ"U\!6FE'2)M'N
MY+2\TR![9)60.LT3MN9'7C(W?,,$8/M39?'9B\/^)-5.DRYT.YD@>'SES($1
M6+9Z#[W3GI766\OGVT4VW;YB!L9Z9&: .7N_ \-Q8Q01WTD4PU-=5GG\L,TT
MZL",CH%X QZ <]SH:OH-QJCW*G4%6VNK06L]M);B1",M\Z@GAOF(YR.!D'%;
ME% %;3K&'3-,M=/MMP@M84ACW')VJ !D]^!7)7/P[$\5] FNWL5M<:D-3CB$
M<9\J;S YY*Y89' /3WKL!=P&]-F)5-P(Q*8^X0G /Y@_D:R[[Q!]A\5:3HC6
M;L-129UN-X 3RU!(QU/4>E %%O![FX\13?VFY.N0)!-NA&8PJ&,%>>NTG.>_
M. .*KQ^!6M+K2;[3]8FM;^PLET]YEA5EN;=?NJZ'C((R",<YXQQ7844 8GAC
MPZOAK3Y[1;Z>[$MS+<EIE4;3(Q8@;0.Y_P#U=*Y_6Q-)\6-$-K=+ \>FW*,[
MQ;TW,\>$;D<D D#(/%=W10!R%]X L[O2EACOKJVU)+YM134HL"07#<%L8QMQ
M\NWIM 'O3[WP9<:EHR6=]KMS<77VF*YDNWA0,QB8,BJH 55!'3'.3SS7644
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MMA$T5O-Y\2G/RRYSYG^_DD[NN2>>:XW4O!<VH>(=0NM2\*Z+J_VB;=#>O=-
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M*VM?A7\0?)!5A>:G& 9&/RK(<<$_3GK707$TFK^+1X=N+R*WA&CPS6L4H?\
M>LQ<2.NUU^9=J8ZD<D8YKK'\+Z%(M^K:5:D:@VZ[ 3'GG_:]?ZTS4_"7A_6K
M:VM]3TFVNXK7_4"5=QC'H#UQP..G% '%7L.M:=IVGN+D^++6QLGBO4CE-O<'
MYR!<1\D,P"%>N3MR#R:ZXW%OJ'P\^TV<LTD$VF>9#(Q*R$>7E6)'(;H?K5Z?
MP]I-P\;/91J8H?LZ&,F/$7_//Y2/E_V>E:$<4<4*PQQHD2J%5%4!0HX  ]*
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M)V@A2I4_>P.<Y%6M.DDT#QWKCZO;-!9:C:6ALG2,R1J(T*O!D#J&)('?<<4
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MJ$XP&.1@$YY%><>78B]U_P -^)='UB[FO-0EGM4A-P8+R)V#1C<AV*5P 2V
M-HYJWJ$=[8>))[O0KB>1YM1A6^T2[A+QSG*#SX7(RNU0&+9*Y0YZ8H ZVX\;
M^%K5ML^OZ>A\\V_,ZX$@ )4GMC<,^F:OZCKFF:2NZ^O(X0%WG.3M3^\<=%]S
MQ7FT1L;C3?B3IDEL9[N[U&>.*%8BS3,8(P@4XY(;G_9SDXZT10_\(SK#6/BF
MVU6YM+S2K2VBNK+SY$9XXRDD3B(YR22PR/XC0!Z5=ZWIEC!'-<7D8CE0RH5.
M_<@ )<!<Y4 C)Z#(K-N?&>CP:SI>FI<K*^HQ-/%+&=R>6 ,$,.#DD8_/Z\G;
MS1>#/%43W>D7T.@WFD0VEH(X9+K[*R.Y\EPH9@6#CU&1C)Q5RYB73O%O@RY@
MTB>ST]+6\@2&"W+"$OY9C5@HPA(4]> <\\9H W[?Q#IMG%JU]>>)+6XLH;OR
MR^%5+/Y5_=,PZG/.3_>Q6P=1M!/;0&8"6Y4O"A!RX R2/ID?G7%^'M,@U>;Q
MWIM[!(+74-0<?/&5$D;01H64D<\@\CN*;H%AK^I>$=0BU!6AU:UL9M(MI&.-
M[+E3,#Z.1'_WQGO0!UUMK^DW=^+&"_A>Y9"Z(#CS%'!*'HP'<C.*O3SQ6T#S
MSRI%%&I9W=L*H'<DUYUX1DTC5Y=#271-8BUS24V2+=FX6.S;9L<AF.Q@V, #
M.01P ..@^(5O?3^%&?3[>:ZDMKJWNI+:!BLDT<<JNRJ1SG R,<\4 :0\4:(;
M>\G.HPJEEC[3ORIA!&06!&0".YXJ:+7M*G:,1W\+>9;_ &I#NX,/]_/3;[UR
MFF7_ (<F-_XBL])U64FS^SW$MW'<%Y1G(A"29W').2!@9ZX)Q7\$6\_A/7;G
MPY>0,\-Q&ES97<:N\<:<_P"BEST"'.W.,AB< G% '3V_C3PU=7MK9V^N6,MQ
M=@F!%F!,G)''Y''KVJW=^(-)L;I;:ZOX8I6=8_F. ';[JEN@)XP"03FO*-&M
M(-=^$6@Z/80DZJ-0CEC*Q$& K<EFE)QP-@;YN^<#GBM%8[$WFO>&O$NCZQ=S
MW>HS7%JD1N/(O(W??'\R'8NW@$M@#:.: .]O/&/ARP>X2ZUJRC:V<),#*"8V
M/8XZ>_IWJW>ZWINGJ&NKN-%\OSBPRP6/^^2.B^YXK@KF,'5/B63;2G[18Q1P
MMY+'SB+=D*H<?-\Q XSS5.YBN$TC2[W3;^ZT_6K?0;=&AN+5I+>^4!LV[H1G
M>&##@[OGZ&@#TB_U[2]+C$E[>QPH4\PDY.U/[QQT7W/%)>:_I5A&)+B]B6/R
MO/+C+*L?9R1D!3@\G@XKSZ>Z%AXEO&\4Z5JJ6>L6%L(?L/GR1QL(RLENPB.<
MY8XR.YI-:TXZ8@D\/O<Z3?VVDQQ+IMS$UQ;WT(+E;<YR3(,D?*Q(W]QS0!ZH
M#D9K,B\0Z1/?)91W\+3R,Z1J#Q(R??56Z,5P<@$D8.:NVCRRV4$D\/DS-&K2
M19SL8CE<]\'BO([>[FN9?"ER=,O[0VNM2^?I\-@ZQ6>Y9@!G;EB202V2.?X0
M: /16\9^&E=5.N6.3/\ 9AB8$>9Q\N1]0/J<59UG6;/3K>6.6^CMK@PM(I*[
MRBC^-@.B@]S@5YAJ4#R> /B#%'9SM<76L2R0(MNV^928]K*,98?*Q!'H:Z&#
M43I7CSQ(=2M[I[;5H+=].GCMGE21$C*M%\H."&).#_>)H Z'P-JEWK7@?1]3
MOY!)=W-LLDKA0N6/L.!70UR?PR62/X;Z%#-#-#+%:JCQS1-&P(]F X]ZZR@
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M<6,]O>0:A_9ALMRLSW)(VJK X((8'/&!D]J .JHK@M&:=OC!J_VBT^S2?V/
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG/'6CWVO^$[G3-.6$W$TD+
MS2%% 257/(!_NXZ=ZZ.B@#BKG2_%&E>+;W5]$AT^[M=5CB^U6UW.T1@E1=@=
M6"MN7;C(QGBL_6H]7N/&4(TI+*^U*QTP17C"\-I+^];..$<%?D) ZKG.<D5Z
M+67J?AK0]:GCGU/2+*\FC&$DG@5V ],D9Q[4 <=;V&KWUKHL.GZ-8VVGZ5-+
M;7FDR7I:&3Y%V.) AWA23D,/O9SR,U#'X-\0Q^$8](,>GM+%K8OU99V56B%P
M9O[O!/0#GZUZ/!!#:P)!;Q)%#&-J1QJ%51Z #I3PRL2 02IP<'H>M #)&D6
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M76,\5S+.RM&QB1"A0+ZIUST/0]*VK'1=7C\=0ZQ<06JVHTA;%_+G+,)!)OR
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MWKH=!T.:SUK6];NPB76JR19B1MPCCB38@)P,M]XGMSCG&3T%% '+R:1JMO\
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M2R/A%3RY/ERN0#R,]17I59NLZ[8Z#!;RWS2JD\\=O&4B9_G=@J@D# &3U.*
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M$#&9%ZDD<'!&>_4U)>^"-/NM4O[^&[O[)M1B\J]BM90L=P NT%@5.& XRI%
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MGMF484HZ@=!QR#4DW@FRN-*AL9M0U*4QW,=VUS).'FDD0@H68J> 0,  #VH
MQ+\>)[3Q1H^@)XID9;^VO9&N6LH=Z%"A3 Q@D;\>AQTI&U'Q3K$.KQ:+=M]M
MTNZ%G$S"%8I71$+-*I!;YBQ^[C QCFNKNO#T%WX@T_6I+JZ%S8QO'$JE0A5\
M;\C;SG:._;C%9U[X$TR[U^?5X[O4K*6Z"B\AL[HQ176T8'F =\<9!!Q0!G#5
M=0\1W/B6TCOFL$TN!(0L"H^^5XO,9F+*<J,A0!C."<\C%KP1=K8?"71;QU++
M;Z2DI5>I"QYP/RJW=>"]/GUF?4[:ZO;":ZA6"[2TD")<(HPNX$'! X!7!QWK
M2T31+70=#MM(M6EDM;>,1)Y[[V*CC!H XN7Q)K5IX/\ #_BXWQG2]EMC=V/E
MIY8CG8#$9 W!D+#!).<'/M3U/6O$J:9XVO8==:(Z#<EK9%M8B'41))L?(.5^
M8CC!]^U=?8^"M-L(;:UCFNWTZUG^T6UC(ZF*%P25Q\NX@$Y +$ X]!ALW@FP
MGM-<M7O+XQ:TY>\&Y.25"G;\O'R@#\* ,R=VN_BEHL@9HFET"Y(9<$J3)#R,
M@CCW%5M)US69K6Y\/7FIR'Q';ZH+9IQ%&,P']X)0NW: 80W4'YABNC_X1NWM
M]5M-9%S>S75C9M:QH"F'C."01M&22J\Y'2J>@6JZOX@F\5SZ-<:;.]HEG%'>
M*%F*ABS%@"0!DJ!W^4]B* '?$/4M0T7P%JNI:9=?9[RUAWI(8U?N!T(QW]*I
MW]SK5U\13H=MK,EG8R:0;K]U!&SH_FA,J6![>H(Z\=".A\0:';>)-$N=)O))
MDMKD!9?)8!B,YQD@XJ >&X1X@76_MUX;U;/[%DE-OEYW=-O7=SG^G% %7P)J
MU[KO@BPOK^4/>.)(Y)44+N*2,F['0$[<^E>=W271^$?B:6?4;FZ?^V7C'G[#
MC;>J V0H.3@=\>@%>J>']"MO#>D1Z99RSR6\;.R><P+#<Q8\@#N2?QK(G\ :
M7/INI:=]JU!+34+HW4L2S#:KEQ(=N5. 7 /_ -;B@#)U#Q'JOA?7M>BN[UM3
MM[?0SJL221(GER*[*44J =AP.N2/4UIZ6WB<ZWIUP]QY^DW$#?:A<-$"'V[D
M:'8,X/((8GC!]:TI?"UE<:W+JMU-<7$LUB;"6*39Y<D)))! 4=22?Q].*K^'
MO!5CX<D3[-?:G<PP@K;6]W=&2.V!XPB]N.,G) R!U- %7Q%?:M%XV\.Z79:D
M;6TU".Z\X+"C,#&BD$%@<'YCZC@9!Z5RUUKOB:U\'>(M4_MYWG\/ZC+;QYMH
MO]*1&0XE^7^ZV/DV],\UZ#?:!;W^O:;K$EQ<)<:>)! J%=GS@!L@J2<@#OVX
MK-E\":?/H^KZ7)>7S6VK7#7-U\Z;B[8W8.S@':./;ZT 8OC37]7TR'Q!<V&I
M'?I]E'<06]K$C^4<,S&X+KC#8 "J<XR0.]6I[[6]1\>)I$&L/964^BB\Q%!&
MSQR>8%RI8']0>_'0B[?^ -,U&;5))[S40-4MUAO8XYPBS%4V*Y 'W@,=.#CD
M&KEKX4MK35XM4BOKXW,5E]A4O(K#R\[N<KR=W.?PZ<4 <=8^)O$.H:)X)G&I
M)%/J5Y-9WC"W0B38)1NQV/[L'CC)].*G3Q5J^EPZSIUQ>->W%OK=OIUM=R)&
MCA)EC;+  )N&Y@#@#.,BN@M/ >G65MI-O%>W_EZ5</<VH+H<.^[=GY.1\[?G
M]*?<>!=(O8-:@O'N;B+5Y%FN%=P-KJ %9"H!4@*N/I0!S^OWWC#0_#_B:]-[
ML@@M/M%A+,(GG1U^^I"J%*]"#C(KL=%M=2AMYI=0U4WK7!62,&!8Q!E1E1CJ
M,Y///N:R_P#A!+)]!O-)NM3U:\2\C\F6XNKD22^7_<!*X ^@R>YKH[>'[)9Q
MPF2241(%WN 68#UP!S]!0!Y9<:YXO7PAK7B.'7D+Z-J%RGV5K2,)<112E2KG
M&0=HXVX_'/&[:WNOZSXUU>QAUM[.RM(;&[CC%K&S8DWEXR2.A"X)Z],8Y!K^
M$?#9U#3=9M]4&I16MQK-S<M931>7',C2ET/S+NVD8) ..Q')SUUIX?M[/Q%?
M:W'<W)N+V-(YHV*^7M3.S VY&-Q[]^: .(E\6ZQ)\-AX\MKP_+(9SIQC3RF@
M$Q0QYQN#[>=V?O=L<5KSZ_?:)XSOK74KV:73[O3C=Z;'Y<:E9$.)(@0N6;YD
M*YSU[UI1>"=,@CFM8Y;H:9+<_:FT[<OD>9NW\?+N"EANV[MN>V"16EJFA6&L
M76FW-Y#OETZX^TVYSC#[2.?;G./4#TH YZ>]UO3/%'@_3;G4C.M['<B^!B0>
M8Z1;@00HP 3T&.@KEO$FI7OBCX3WOB W\D4$UXHCLU1-@B2Z6,!CC=N^7<3G
MKQC%>C7^@6^H:YIFK27%PD^G>9Y"H5"?.-K9!!)R..OTK$N/AOI$]KJ%BE[J
M<&G7TPN)+&&<")9-P<LORY7)'3./;I@ K7^J>(-:O_$-GH4TEO<:9*L%O@Q;
M&D,2R9D#@MM)?;\N. 3UZ3Z=JVJ>(=?U/2C>_P!G2:7:6QF^RA)-\\R%R<NI
MRBX &,9R<GI5N^\":=>:V=6BOM4L;J2-8KDV=V8Q=*HPOF=R0.,@@^]3S^#=
M/?6TU:SN+S3KD0+;2BSD"+/$OW5<$'IT!&"/6@#/^%/_ "2_0,_\^Y_]":NQ
MK+\.Z!:>&-#M](L7G>VMP0AGDWMR<]?\*U* "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IZF]_'I\
MCZ9';278*[5N7*1XW#=D@$_=SCCKBKE<5\5XXF^'MZ\@&8Y[9D8_PGSXQ_(D
M?C0!VA95!+,!@9Y-+7GESHFE:I\6=6MK^SAN8)-#@>2*4;D9O-E&XKT)  P>
MW&*UOAA/)<?#/P_)+(TC_9%7<QR< D#]!0!J:EX@BM[36?L/E7-YI=OYTL+2
M;5!*E@I8 X.%ST[CUJQH&I-J_A[3-1D5(Y;NSBN&C4\*70-@>W->?>1IEOXD
M^)7[JTBNOLZ-%\JA\-:98KWY.2<>]0Z)86>GZA\+[RTA2*YO;!X[F9?OSK]D
M# ,>K $# /3'&* /5]R[MNX;L9QGG%5M3NI;+3+FZ@A2:2&)I!&[E V!G&0#
MC\J\K\,G2M>L=&NK_6DMO$EGJ&ZX@B1%NS<!R'C;/S,A!.1TVCL%X]0UHA=!
MU$D@ 6TA)/\ NF@"GX3UR?Q)X9L=9FLX[07D0E2))C)M4],G:O/X5LEE7&Y@
M,G R>M<1\/=6TZP^%6A7%U>V\44-@AD9I -N!S^/M5.R6RUWQ1XQLO$<$>8X
MX3;I<@9BM#%G<A/3Y]Q)'1@.>!0!Z&S*@RS!1ZDXI20,9/7I7CVD7BWVG>'K
M3Q"\;:L=!EE=]4;,(A9PJML."\I55R<C )SG.*AT)+/6;7X6?:G2Z9H+B&;+
MY+!;<_(W/(Z9!['!X- 'LP8, 5((/<4,RKC<P&3@9/>N+^',4-HOBBQMD6.U
MM=>GC@A3A8D*1MM4=AEF.!ZUE^-I]+N=>U6SF, NXM"8LU\P,2HS/CRHSC,A
M(P6R,87K0!Z02!U(% 8%=P((/.:\ETZ"PUO5?APUUY5Y]HT*=;G<V\2E8H/E
M<?Q<EL@^^:I6MY'IFE66GRLL7AY/%UW:7 )_=QQ!W,4;=A'OVY!XXQT- 'I&
ME>(+C4/%NN:/);PI#I\5M)%+'(6,HEW]>!C&SH,_6I==U\Z7?Z5IMO%%)?:G
M*\< FD\N-0B[F)(!/3& !R3VZUSGA5=,MOBEXOAL#;1B2VL7\N$J 6 EW$ ?
M49^OO6MXQTWP_KYL-"UWY)+IGDLIED\N2.5,?<;LV&)'K@T :6EZCJ-QJ5[8
MZC816S6R1.DL,QD28.7&1E01C9T/_P!<ZH96SM8'!P<'H:\DN+_Q3H.E^+O#
M[ZE+K T[3X[FVU!5Q<1HY(:-R.KA S ]>_<8ENETW^S]1U[P?K44^IMHLRQV
MVG1HJE0,J[HO(=3PN><G'K0!ZL&4D@,"1U /2EK@=$B\&ZP-,OM)D@FNI=.>
M(P0.&WQD MYZCJ0PQEOXF]37*:7?:=_PB/PO+7-M]IBOXD<EQO0>7*"#W W8
MX/<4 >T;ESC(STQFLF'5I++3[$ZZ;6"_NIA;K%;2%T:0L<!20">!D\<8-<?X
M+\.:->ZOXGN;BRBEFM-?N%@+$GR@T,8( SQD$@^O'H,<S86]A)\//AS+>16[
MQ+K/EL\RJ0$)GR"3V) _(4 >VT5YMJT2^$?%S7^D643VWB:W%HGEQ@HEXH/E
M$XZ(ZDY_W,UWNDZ9;:-I-KIMH@2"VC6-0!C.!U/N>I]S0!F>,/%5MX/T/^T[
MF%YAYJ1B./[Q!.7;_@*!F_X#6['(DL221L'1P&5E.00>A%<C>V]QXEUO4! M
MG/I]I"^G,DY;#22 &7&WT78OL=XK"\+W]TOPX\0>&[O4DM-5\/PSV3W98_)&
M$)BFXY VX]_E- 'I@96SM8'!P<'I1N4G (SZ9KR_PW8:=K>N>';Z%-.A6RTL
MQ7,,=S%(T\A"[<!&.0N'.YL'YNG)QD:?IMK8?"K4]?L+4G4[:XO(A<1$F2.W
M-V?,5>>!L#'VY/<T >SJRMG:P.#@X/0T!E8D!@2#@X/2O*+]-.BTW6-=\(ZU
M'<W\FBN/L^F(BIL!R)&5.1( 2%S@]1V.+VF6?A?4[N+5-*UBWG,VFR1R6EFB
M(KQ8SF95Y!4X )P03B@#TD,I( 89(SC- 8,,J01[5XMINDZ</"GPSOEMT6\N
M;F&WFN%)$DD302;HRW4KP/EZ58U&1?#I\=6VF1BUTNUU#3I)X;:/Y8H'6,SE
M4'8KG(';- 'L*NK E6! XR#0&4D@,#@9/->3:WIWA]_#?BW4-*U>"\%QHCM+
M!9!!;JRJ3'(0G20\@>H!]*OVFF:?8>./"/V6VB0ZCH]RMX<9-R L)'F9^_U/
M7- 'H&FZE::O9"\L91-;L[HLB]&*.4)'J,J>:MUYY\,;O1-)\ 6\LD]A:2?:
M)8YV+(AW&XD5 Q]>PS^%>A]* .>\0^+K/P[JVB6%RC,=3N?(,@Z0@C"LWU<J
MO;J?2NA) &2<"O.M4T.^\<:)K<]NUD;?4@([*5V;?&D+'RV4CCE]S@^C 5EZ
MWKD/BWX.V&I7&!>)>VD-P V&BG6X1)!QTSR?H10!ZP&!S@@X.#CM2UYW;Z!I
M(^(^O:&EE#'IU]HD$MQ;HH"NYEE4N1_>QCYNN>>M1>#K>2[FL_#6H6JEO"DK
M+)(T0"RG&+=U^L;,Q[AE!H [_4M1M=(TRYU&^F6&UMHS)(['H!_6K'F*$#LP
M53W)Q7(?%6".?X8Z_P"9$LFRU+KN7.TCN/0CUK"U*\T5?&%CIEU<Z;:Z'-I9
M-D9(HVMGF\QO-49^4-MV>_)]3D ]-) ZD#ZTA=0,E@!C.<UY,= T<ZQX"TS[
M3)JE@R:A"LUPV3/$$)"Y'WD&<#L1CJ#5NW\,Z$_C/Q9IDFGV[V,.DV02W<;D
M7"S '![@ 8/4?C0!Z?N&[;D;L9Q2UX[I-K;0:)\,=81%&IW-Q%!-=DYEDC:W
MDRC,>2O X/ QQ7=?$6YU"S^'VM7&E^8+I(,@Q??5-PWE?0A-QS[4 =.&5L[6
M!P<'!Z5S4.OZIJ=_=?V19VTUI8ZD+"Z$TA20@*I>1#T^7?\ =/7!Y'%8MU:V
M47C+PA<^'(X$M[R&=;I;< )-:>5E6<#J Q7!/=L=ZE^'%AI\%SXJEMK2VCDC
MUVYA#QQJ"J 1G9D#@9[4 =A=:G:6=Y96D\RK<7LC1P1]W*H7/'H IY^GK65X
M?U^XU;4M=M+JWAMSIMZ+5/+D+;P8U<$D@<_-TQ6%XWM]-;QOX+FU&&T,/GW2
M2/<*NW'V=R 2W;/('K7+ZYIMA>:1\3[V>".6XM+DRV\C<F%UMHR&3^ZV1U'/
M&* /69'OQJT*)';'3S"QD=G(E$F1M 7&"N,Y.?2K8922 P)'4 ]*X$F-OBCH
M5RQ'FS:!.TCCJWSQ<_SJEX-\_2M?TBQO;:RODN;"7^SM;LOE:XA&QF$Z]=Q^
M4[LD$GU)H ZWQ?K]YX9T-]5MM,&H1Q.@EA68I(0S!1L&T[CEAQQ23>*8)_!C
M>)=&6*_M_(,Z*TICW #D$A6PPQC&.M2^*V5-%C+$ ?;[+DG_ *>8JX+QAIEY
MX(75;O2H&F\/:TK1WEHG_+G<N,+,@[(Q(##L<'VH ]45V$2M/L1SU ;(!]B0
M,_E4%YJ=I83V<%Q,J2WDODP)W=MI8X^@!-<B?)U'XHZKI>N0136_]F0OIT,Z
MAD9"6$Y /&[)0'O@"N.M;>)K#P4^LK#/9QZW=P6UQ> -OM0DPBW,W4' QGJ
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MC%\B+=)&K P- Q^;E< !>Y/'S<@'IVMW\FEZ+>WL,<<LT$#RI%))L#E5)QD
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M28K"=570[Y);2SE_O74)S)D]@<LOUCKJ[[5K33YK:"9V-Q<EA!#&I9Y-HRV
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M=@09'R"-IS@!<#J:Z"V6Z/Q#U35)=.O8K6;1X859H2<R*\C,GRYYPP]JZO\
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M0$Y^;;QN/4X[G&3UK5J"SO;74+5+JRN8KFW?.V6%PZM@D'!'!Y!%3T %%%%
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MD>^+>6D"@;BNU"<=<D#('(NIX7U-]:T#4[G5K:232H)8F1+,J)?,"@D?.=N
M@]><_09LGP\NVTVX2/6Q!J(U>35[.[AML>1(Y.Y&4L=ZX8CJ.M #=0\;:_IF
MB:E=3:*C26=[!!'-(DD$=U'*ZJ&17&0P+8()P,9R:[#2FU5K:0ZQ'9I/YK>6
M+1V9?+_AR6 .[U[5SNJ>$]:UOPW)8:AKT#WLTT,KS+9D1((G#JJQ[^Y'))).
M?88Z]-P1=Y!?'S%1@$^U '):+XMDUO6I+**2R62"ZF@N["0,ES B[@LG)^<,
M0AX& 'ZG%<MX9UW4_#WABVN(K6T?2WUZ>TF#.WFXDNW0,H P I(X/7GI75MX
M0N+O5],U&_N[66YTV=Y8;J.W*3.K*P$;MN.5&[GUVCIS5(> ;X>%DT7^V+?*
M:G_:/G?8SU\[SMFWS/[W&<]* )/$7C'4-!DNII;:U2"WNX(4MW;=-<1.R*9@
M5/R ,Y #+SM/(R*D@5?^%RWWRCYM!ASQU_?R54U+P!J5];Z[:IKT26^J7D=\
M-]GODCD4H=I;>,Q_NQ@8!'KZ[</AZ^B\82Z^VH0.9-.2R\HVQ'*LS;\[_5CQ
MCIWH S_A4 /AOI0 P 9^/^VTE3S^(=8ODU:;P_8V]V-,NOLIMY6VO=.NTR!6
MR%3&[ )!R0>E7O"&@3>&/#=OI$UVEV8&<K*D1CR&<MR-Q[L>]98\(:K8Z_J-
MUH^O"ST[5)?/N[5K82.DF &>)]PVE@!U#8/- %IM?U'4M1UFST2*U+Z3L207
M(8^=,R;_ "P5(V@ J-WS<GIQSDVOCV^UF;PU_8]A;>3K=K/,K7,K PO%@,I
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M+/',X9$D0Q[61<87[Y&!QZYKG+R\N[[X/32WMU+=3+K:Q>;*<L574%5?R %
M'KE%<#?3ZMXCU_Q+I%C=_99].$4=JZWKPF(O$'$I15(D!8D88XPF,#))[/2V
MN'TBS:ZGAGN# AEFA^Y(VT99?8GD4 6ZH:WJT>A:)>ZK-!--#:0M-(D(!;:H
MR2,D#H/6LGQMK$^C:1:- ZQF[OX+1Y6?8(U=L$[L';D<9QQG-8&NV&KZ=X8\
M:+>7T;V$^D3R6UHUR]Q) PB8.0[@,5/'!S@]* .]LKI;VQM[M%*I/$LBANH#
M#//YU/7GL%_=WVJ:7X<B;9$-!ANU5;U[9G9CL)#(I)VA1QP/GYSQA=,N]5.N
MZ-X5US5A/(+"XGFN;21HS=2)*$5=PP054DMC&2/3(H [Z2:.(H)'53(VQ 3C
M<V"<#WP#^5/KS/5]*FBUKP197NM76H2QZC<1/<+*T3$>3*R@A6^\HPN[J>?4
MU-:G49?$?BV>76=4DAT2ZCFM[6.5560?9U<QL-O*DGIQ^= 'HU(0&!! (/8U
MYB^KZG!X&\-^+K;4+B>^NIK4W<!D+13K,P5HUC^ZI4MP5 /R\YYJIJMQJ_\
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MAWQ)J^H3^'O#NIWLK-)<ZA%/>(WEO=K;-M4!AR,YR2.?DZ\F@#NK#Q197O\
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MB099W8 */4D]* ,J+PQI4&I/J$44ZW;VXM6D%U+DQC)"_>]23GKDDYS5&X\
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MK;:A:37*H)#%',K.%/1BH.<'(Y]Z ,^V\(:)9S:;-;VTR/IL)@M#]JE(BC(
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M-%Y#S6\[PM)'G.UMA&X#MGIVI'\,:0]YIET+4QR:8A2S$4SQK"I&" JD+@@
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MT-0Z*;>7PU9QV&NP:3>VNMW[:?(X5X/OR?NW4GA61SC&/;W]BI" PP0"/0T
M<]X(OI]0\,13W-C!9S>?,KK;DF&1A*V9(R>2C'+#ZUT5%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %(S!5+,0% R2>U+6-XF@O[W238V-OYHN76.X/F!"L!(\S&?XBNX#W.<\4
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MQG@8/S8[UTU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBV#(*OA@=V0,\=R>E;?@O6+[6='N3J1B>[L[ZXLI)(DV+)Y4A4,%R<9 '&:
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ME>.GWN<U>U'Q1XA\,V^LZAJNG--I5O9K-;3R>7&YG+A/*8([?*2RD-CCG.:
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M!!)>1CA5&/<U>KRS6]0U+7?#W@[7)IXDM[[7+"86@C_U:-*"F&SDMC&>QR<
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MY&!UH [MF5$9W8*JC)). !69I_B+2M4OI+*TNM]RD2SF-HV0M&W1UW ;E/\
M>&16;\0_/_X5YX@:"81,NGSECMSE?+;(Z\?6LVQU2[AN_#OA^.>+[7=Z>US)
M=>0 8X4" (HS@DLW4\8!XYH [BBO-=2\;:]8Z9K=N!9G4]'U.VM9)&B;9/%.
MR;& W?(VU^?O#C@<\=WI4.IPVTBZK=V]U.96*/! 8E"'H""S<CUS0!?K(/BC
M1!;:E<'4(O)TQMEX^#B(XW8/'/!SQFN83Q7JT&MZ+#<36THO]1FLKB&",M%"
M )"FV7H7 0;ASR2,+BLZ?_D&_%GZ2?\ I$M 'I5M<17=K%<P/OAF02(V",J1
MD'GVJK'HVGQ:O)JJ6^+Z1!&\V]LL@Z*><8&>!VJ'PZ&/A/2@A ;[##@D9 .P
M=J\_/C+Q;!X*C\7RRZ9)9VMW)%=V<=LP:6);AHBRN7.T@ 87!Z9).<4 >JT5
MP]QXEU:)?'2++!NT*)9;1C%US!YN'&>>>.,<5!)K_B;4-9T?3=/NM/MCJ.B-
M?&26V9S'*#'VW\CY^G&,YYQB@#OZ*\XDUOQI='Q.EE>:2LNAS (&M'(N1Y*R
M;/O_ "=3SD]NF.=#1/%]SXNNX+73G6P_XE4%_,[1^8P>;.U #Q@;3D]\C&*
M.WHKS=?B#>#0[:[U&%[..WO[BPU6\M8#*EN\7 8+R0C'')!QT]ZTU\37UW-I
MFF64\5Y<75G+>O>6*HRM&KA%*!W YW<Y)QC'?( .UHKS^Y\6:]HVD:;-XFLW
MTR-Y9HKR^MX1,L07'E.54ML5\G/7!&.,Y'8Z+<R7FBVES+=6UT\L88SVW^KD
M_P!I>3P?J: +]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#XZ#@L 3^F.]R_\ !%IJNH:O<:A<O-%JMFEG/ %"A40L5*GJ&!8G//:NHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+>.-7
MFTN#1H(Y6@BU'58;.>=#M,<;;B<-_"25"Y[;N,'!KJ:H:Q;6UYIDMM>::-1@
MDX:V*(P?N.'(';J30!SVE7\]A\1]1\-_:)KBR;3H]0A\Z5I&@8NT;)N8DD'
M8 GCG'%=A7':!X9D\/?VSKJZ? ^JWD?[JQMF"I'&BGRX0YXW$\LQXR?05U=G
M+-/9037%N;:=XU:2 N&,;$9*Y'!P>,B@":BBB@ HHHH *HZQJ']EZ3<783S)
M$4+%'G_62,0J)^+%1^-7JYS6K6?5=>T^RGM+@:5 &N)+B*Y6/,P $:_*X? R
MQR!U"T 4?A]JVH7-EJ.C:W/YVLZ/=M!<2?\ /5&^>.0#T*GC_=I+GXF:+:PW
M=P]IJK6UE=-:W<ZV;;+=AC+/W"\^F?;IFG)HE[H?Q'L]7T:RNKK3[NT:VU-I
M+T.00<Q./-DW$CD'T'2LG34N]2T3Q]HMK8-*]_JUY;QSLZ")-Z*I9LMN^7.>
M <]N>@!UE]X[TVSU"ZL(;/4KZZMX$N3'9VID+QMG#*<@$<'GIZ9/%9.KZ[!K
M-QX&U?1[Z<V=]J6PA)&19$\J4E73."0R]QP15;2RVA_$B]L[>UGO8X-!LH0T
M3(#\C2 9W,.OZ5%;^%=2TO3?"%K%:BX>RU62_O?*EC"Q"02DJ-S#.#(!P.<$
MT =)::[HUMJGB>X:XO8FL6B-]]I+>6G[OY?*4],C!X')(ZU.WC'3K>XO;?4(
M;NPDM+(Z@XN(P<P D%P4+=",;3@^U<KJWAC5]8F\<QQ0BU.I-:2V$\LJ%7>!
M4X(5B0"R=QT/X5L2:GXOU7PWJ!AT:+2-26T=84GN8Y?,G(XV[20%'/+=21Q@
M'(!;G\1VVJ0:AIGE7UC>_P!G&]C#D(S1'(#JR,<$$8QD'VK%\&>-[1/#_A73
M]234EGOK.&..^N(6\F>;8"4\PG)8\\D8/8FH+#1M6?Q6=0.CR6MO=:&UG))=
M7L<LJS;]V9"&8G/;&>/3H'Z=H.I7WACPGH-[8/9G1I[::YGDEC96, X$>UB3
MN8#D@8&<\\4 7O#>IC3[_P 927UW<26]MJJQQ"61I2NZ*+:B9)/+-@ =S70:
M=XCM;_6;K1W@N+34;>)9VM[@+EHF) =2K,",@CKD'K7$WWAC6=0LO%J1VD<,
M]SJL.HV'VF2-HY_*$7RL%8X!,9'([BNE\+FXED:ZN?#%IH!$>QD#Q/)(V03@
MQ\!!COR<]!CD H2R7!^,\-A]MO!9'16NS;"Y<1F43!0VW..AQCI[5U.KZO:Z
M)8?:[O>5,B0HB#+/([!54>Y) YP/6N4OH-5@^*D>O0Z-<W6GII#61>&> ,9#
M*'R%>1>,"IM=O?%%_ILS:?I4UJJ7, -NUS"+B:'=F8HRN50XP!\P/4\'% %Z
MY\<:=9Z=J]Y<6E\ATB14O8/+5I(@RA@W#$%<$'()_0U>3Q';/XBBT,P7"W4M
MJ;M'(7RVC! )#!N2"0,#USTYKF_#FA7":WXKCU#25MM*U=82@:X1RR^2(W5L
M$G=UR>F3P6ZUCQ>#?$4>DZ/=?;(QKNFSBQCF#C_CQ^:(D\X+;3YOKD =10!W
M<'B**X&G,FGZ@4OY7C1Q"&6,*"=SD$A5..#WR*S/B+9:G<>$+NZT:[N[?4+)
M?M$8MYF3S57ED(!YRH..^<5>U#5'T"71K*STLW%A-(MK)+'.J_95X5#M/+CG
MMT )K<WI_>7\Z .5OM2A\0>$](_LJ[N83J[0BWEAF99(TQO<E@<Y"*_7^+ /
M6K^I>(K31(;E!;7MVFGPB6Z,&)#"F"06+,"QP"<#+8YQR,XG@OPK<^'=6U-)
MYHVTRWGD&CQ@C]U%*5DD'T#84?[I]:IZCIFHZ;XWU+4(_#5IK^GZJL3!FDB5
M[65$"$'S.J$ 'CISQ0!O/XZTMKZ.RLX+^^GFL5OX1:VY82Q,0 5)('?O@=LY
MP*DM/&NE7L.AS0+<&+669+9S&  ZABRN,Y!&QNV,BLRUT[4+7Q_;ZBVGI]CB
MT/[&SV[QK&)?,#[54L"%P, X%8&GZ%KFF^&?";MI,DEWH^ISSW%HD\.]HY/.
M&Y#OVDCS%X)'>@#N(O%>G2#4MRSQOI]RMI+&Z#<TK!=BK@G.[>N/K4FF>(K7
M4]5O=+,-Q:ZA9JCRV]P%W;&^ZZE2RD'!'!X[XK@[SPUK^H0^))ETZWBN)=6M
M]3LX;B='CN!&D8,;X/&=I'/&>^.:Z32KC4HM.O-1@\&6]A=1PXCL4FA$MP_I
MO7Y57TSR<]!@9 .DU2Q?4;!K5+J>U+NA,L#E'"A@2 1R,@$9]ZX73-/DOOB#
MXGT:35M86SL[:T:W"ZC-F-I%?<<[N>@ZY%>B1LSQ(SIL<J"R9SM/IFN0T73=
M3M_B5XCU2?3I8K"^@MHX)S)&<F-6#94,6'WN.* ,FUUJ;PYXS\2I=MJFIQV^
MGV4ACAW2[3B7S' 9L*#@$@'GMFN@N-<T>]U?PM(LU\SZ@'GL&A++#(#"6/F<
M@'Y>0#D@XJ@VF:JOBSQ9>C3)FMK_ $^""V<2Q?O'02 C!?(^^.N.AK/TW0=;
MMHOAXDNE2@Z-$R7Q\Z(^63;F(8^?YN3GC/'Y4 =;:^)+:]NH(X+:Z>">XEMH
M[H!3$7CW[A][<.8V&2,$CW%8?C^+787T>[\-74B:E]K*_9GE;R;E%ADD,;+G
M&3LP#QC/7N*=AX=U&V\5VVJZ;8W>D--=R-JT'GHUI<QX;$@0,2)"=AX ZMGW
MZ?6H[R35M#>WL99XK>[:::1'0!%,,J#AF!/+CH.F: ,-?$-KXLT/1]2L9[NV
M8ZA'!<VZS/$\3YP\4@!'(/K]>]:]_P"++'3UOW$%W<V^FD"]GMT#K;G:&.<D
M,V%()VAL \UBZOX+N$\:V'B#19!%%/<QG5K7("S!<[90/[XZ'U!_..VTC6=&
M/BO3H].>^M]7N9KNTN%D0*K2H%:.0,P("D=0#D'UXH U3XM:7QI8Z-:64EQ9
MW.GF]%W&R%64NBJP^;.T!CGC/(P#4[^,M-BN;!9(KE+34+C[+:WI5?)EEYPH
MYW#.#@E0#C@\BL+3/"^I>'O$7APV]LU[9VNB'2YIUE5/+??&V\ACDJ0IQ@$]
M/K53PAH>KZ-'::%>^%+!_L,@5-;W1%9(E;*MM^^),<?7G- ';ZGK=OIEU96C
M133W=ZSK;P0A=S[5W,<L0H 'J:R6\>Z.NE:;J)2\,.H79LXU6W+,DP9E*L!T
M(*L.,YQQFE\41ZU)JNC_ &*SFO-*W2B_AMYUBD)*CRSEF7*9W;@#D\<$<'D;
M'PUXAM= T2P;1"K6'B-KYQ%<1%?(\R1MRY8<8=<#KP>!QD [2U\9Z7/;:M-<
MK<V!TI@+N*[CVN@9=RD $Y# \8Y/3&:Q1J=S<?%C2H3#J5G%)I5Q(]O<2?NW
M(>,*P56*Y&6!Z'UK-U_PIKNKW7C(VUH8#>M8SV,DLJ;)FM\$JP#$@$C R*U8
M$US4_'>BZU/X?N;&VAL+BWN!-/"Q1W:,C&USE?E.#U]A0!OZIXDM=+O39?9[
MFZNEM7O'BMU7*PJ<%CN8#KP "2?2N?UC55O]?\!ZAIUY<?8]0GD;:LC*DL9M
MW==R9P3T/(R*G\26>NWOB(P)I[WNC2Z>T:*EPD:)<ECS,"063;C  8 YXZ$8
M^F:%KT.G?#Z*?1Y$?1B1> 3Q'8/(:+/WN>3G SQ[\4 ;?A*68^+/&5O)<SRQ
M07T(B665G\L- C$+DG R2<"I?%6O1+I&N6=I'?33V=HSSRV3;3;$H67+;@<X
M^;"Y.,<<C*^&M/U"T\5>*KN[LI(+>_NHI;:1G1@ZK"J'A6)'*GJ.E8KZ7KVD
MZAXNM(=)EU"SULO<6US%-&OE2-$$*2!V! &T8*@\4 6=!U.S:V\!07L^HMJ5
MSIHDA97;RI#]G4N93G#''(SD@G-;]MXGM;N2$PVMV]M/)+'%=*BM&[1[MP #
M%OX&QD<XKE]/T36X;CX?&;2I%72+22&]831$1L8!&/XLMR,\9XIVD>'=1L_%
M-GJ>G6-WI"32RMJ]J9T:TG!5L.B!CARVT\ <9S[@%Z'XFZ'-%87/V?4H[&]G
M-NM[):E88Y-Y0*[9XR1].><<UI2^,+"&UUR=X+H#1#B\38NY1L#Y7YL$;2#U
MS7">'M-O/$WPEM/#\=C*D<]ZY>[9D\M(UNVD9A\V[=\I4#'7VYK3UG1=>67Q
MW9VFCO=1Z[;[K6Y6>-4#?9Q&48%MP;*\<$'/)'6@#H%\6R3>-+'18--N'MKC
M33?>?E!P7C53@MG #-GODC -6'\9:;'<V"R17*6NH7'V:TO2J^3++SA0<[AG
M!P2H!QP>16-::3K-MXKT+4FTQFA&B'3KG;.@-N^^-LGGD84_=SSCZU1\(:)J
M^CQVFA7WA2P;[!(%36]T166)6RK;?OB3''UYSVH Z^S\26U_<6ZV]M=-;W$L
MD,5T IB9DW;NC;A]QL9 SBK%_K$%C=V]D(I;F]N%9XK:#;O*KC<V6(  R!DD
M<D"N/TKP[J-GXIL]3TZQN](6::1M7M3.C6DX*MB1$#'#EMIX XSGWU-8TS4;
M7QYIWB6RMGO;<64EA=6\;J'16<.LBAB >5P1G..F: )9O'VBP:2FH.+O9]M%
MA+$("9()RP4JX[8)'USQFM:RUJ"ZTF;4I[>ZT^"$R>8+Z+RF14SEB/[N!D'T
MKA-1\*:NUG>WEOITDEUJ'B"VU)K998P888F3[Q+!2Q"$\$\D#MFNV\3:2_B'
MPIJ>DH_DR7MJ\*LW\#,N!G';/6@""V\66,^I6]E+!=VCW-LUU;R7"!4EC7&X
MY!)4@$'#!3@]*9%XQTZ2332\5U#:ZFX2QNY4 BG8C*@8.Y2P&5W 9[5F6 \2
M^(/#TVBZSH_]DEK*2UN+K[0D@E9D*9B"G('.[+8QC&#U%"+0=9U7PSX;T#4=
M.:UETJYMGN+KS$:-UM^ACP=Q+X7J!C)ST&0#4G^(VCV\%]<-::F;?3[LVMY,
M+4A8#\OS-DCY?F'3)[XQS5D^*9QXXN=!_LRY,%O9+<M,FUMVYB 0-V<?*1TR
M3VQ@GEM0\.:]<^#O'6G1Z1+]IU;4))K13-#AT98U!)W\?</!]JWUL]5M_B(^
MLII4LMG=:3%;LPFC!AD21V*L"W.0PQC(SU('- $FG_$/1]0L#J*V^HPZ>(&F
M^US6I$1P^S8",Y<DC"CK]<BM"/Q/;MJ;Z9-97EOJ MS<Q6TJINGC!P2A#%20
M<9!((R.,5Q]MX1UNX^#]MH36XL]8LYA<1QRR(R.Z3^:H)4D8(X]C6_\ V=>Z
M[XOT37+G3YM.CTNWN 4G=&>224*NT;&(VJ%;D]21CO0!?L/%EEJ>@6>L6EO=
M26]W,(8DVJ)-Q8KRI;C!!SW !)Z&F7_C+3=-'G3Q7/V 70M)+]54PQR[MF#S
MNP&^4L%(!X)X-4-"\,WFE^+-39BG]B>>;ZR3/*SRKB4>P&&(_P"NI]*QM)T+
M5](O[W2)O"MA?V\MY+/:ZQ(T1"1R.7Q(I^<LI8].O R!S0!T8\<:<^KW.G1V
M>IR26EPMO<R+:G9!N7<'<]DQWJY9>)+>_6)DLKU89[4W<$I16$L8V_=VL3D[
MU." >:RM$T_5+3Q!XONY=-9(K^:.6T:1XV67;"J8(#$C)7OC@UG^&?#]_H>M
M"XTVQOM/TB2T=KK29KA)(TN,J5\CYCM_CSR%Z?@ :_A_7=+7PKH\FFG4+N*\
M5A9QSOON)0"22Q=NV#RQ Z#J0*EM/&FF7T"&WCN&NVO)+$V155E6=%+.ARVW
MA03G=@C&"<UQ-KX5\0:=X5\(SG0H;Z\T59X;O2YY8CYL<A&61LE=PVJ1D^M;
MU_H?]KZ-;P7_ (16&VFN3*;>RECCGLR%PLN]64%\Y^Z3P1UP: .PL-0CO[#[
M6(IH%#.K).H5E*,5;."1U4]ZQ]/\::;J-SI\4<-W&FI027%C+)&-MPB8+;0"
M6!P0<, 2#2^&;/7;#PHUM?W+W%^C3"VDNF#/LW'RO-*\%L;<D5R>F:1XE;6_
M">JWVAS_ &NR2XCU*:6\B9F=T W* Q CR#A1C&?NCJ0#>C\=Z7JUA=-%9:S]
MD6.X66YCM6 C,9*LNX'(;N/Z5<TO7["/1]$@L(KZ\-UIRW5O$S*TQ@"I\SEV
M&3\Z@\DDGZUE^'=*U:R\":QI]SIDL=Y-->O#%YL1,@E=V7!#8'##.2*SF\+3
MW?A?PUIVI:+?QW>G::D27UA<QI<6<ZHJD*P< JV/<<#(] #HI=:TNZ\0^'"_
M]I1W5Y;2SVL8#+&RE%9A(N<%@,8')!-0#XBZ0T/VC[+J0M5O38S7#6V$@EW[
M!O).0"QQP#COC(JC#I7B,ZUX)N]2MC=S:?:7":C<QO& ))$51P6!/*G.!BLJ
MX\.Z_+X"US3%T>;[9=ZXU[%&9X>8C=+-G._ .U3QZT =IJ7BNPTV748S%<W!
MTV!9[TP(&\A&!()R02<*6PN3@>XS>M-8L[O15U<.T5DT1G\R92F(P,[B#T&.
M<^E<!K,-_<>*/$)T[1-0NK.]MH;.^:PNK<%G"'*L)#\KA' ^7L?7&.FFL(/%
M'PXN=)LH9=-CN+.2RCBF&&MRN8]K8)R 5QP3D=Z +,/BVQDN["WEM[NV&HJ6
ML99T54N,#=M&&)5BO(#A2?P-0MXWTQ-#FU=H;L6T%Z;&8;%W1RB01G(W<C<0
M,C-9/]DZOK]KX5M=1TU[&32+N*[NIFD1D=HD90(]K$D,Q!Y P,YYXK$O] \2
M?\(UK^A6^B/,TVM&_AN/M$2QRQ-<I+@9;(8 '(( XZG@$ [+3_$MQ?>-M7T(
MZ;.D%A%;MYY*8)D\PY/S9VD*H'&<YSCBM"]UR&TO_L$-O<7EZ(?/:"W"[ECS
M@,2S*!DY &<G!P.#6/IUAJEG\1-8U!]/8V&IVEJ!.)4Q$T0D#*RYW$_.,8&.
MO-,FT[4])^(-SKEO9RWUAJ-E';S)"Z"2"2-F*G#L 5(8]#D'VH I^*/&(F\%
MVFI:%]HEBOKN"V,L>$>(-,J.A#$%7Y9?8]QP:W+2*Q\,:7?ZG<W5]!9N?M$D
M-Y,9?LW&"J<DC)YV@GD\>E<G=^$]7MO!XM+:Q:XO;K7AJLT,<L8$"FX$I3+,
M 2% ''?/;FNH\;:'=>)_!=]IMHX@NY0DD/FGC>CJX5L9X)7!Z]: +$7B>U.J
M)IEU:WEG>2P-<013H"9T7[VS86RPR,J<-STJ#P]XQL?$S1&PLM2%O+$\BW,M
ML5BRK["F[/WL\X]/<$"A+8ZCKWB/P_K%UI4]A_9$<\KQ221LTDLD>S8A5B"/
MO')(_A]\6?AYIU_H_@NST[4[-[6Z@>7<C.CY#2,P(*DCHPH D/C6P.O7.CPV
M.ISW5M/##.8K4E8_,^Z['LGJ?YX.'_\ "8Z<+O3HY(KF.VU*7R;*]95\F=\$
M@ @[AD X) ![$\53TC2]03QIXKN;FREALM16W6WG\R,[MD91N Q(Y/&16-X.
MT;6-*AL=$U#PGIZOIY5!K0,166-#\K*H^<2$ #G&#SGL0"QX:UR/1[/Q3<:C
M<W4\4/B"2V@5Y&E?YA$J1KN/]YL#G SVJ_K7CJ.P\.^(;VWT^Y:^T9<3VDNP
M%"R!E8D,05P0>"3UXS6,FF>*K'2_$)L=-F2:[U_[8$6>(236A\L.$;=A'(0]
M<8SP<U5N/"FMW5GX\M8-'^RQZQ:Q&SWW*,6=8@I5B"?F)'))QD]3UH ZJ?5[
M*77O#<5[%J=M?W(F:WB4XB;$9+>9M8JW R!R02.E0/\ $;2$@GN#:ZE]EMKT
MV5S.;;"0/N"Y;)SC+ <9([@#%0W=GK%_XB\':B=&FBBL3<&Z4SQ$P[XBB@_-
MR<\_+GC\JP[WPYK\_@?Q9IJ:/-]KU'6)+JV0S0_-&TJ,"3OP.%/!]J .VU'Q
M19:?<WMN(;FYDL+<7-V+=0?)C.<$Y(R2%8X&3@=.1F>VUV"^\.C6K*"XG@>$
MS1)LV/*N,C 8@<CH2:XC6TU";Q;K$NF:+J%Q#<V,-I?-875NK;\,=KB0X#JC
MC!7/#<]1CL-!:WN_"<-O964UA%%"UHEM/C=#Y>8]I()!P5Z@G- '%7_B>[U7
M0/!&O/'>V1N]5@$L44A*S1O'(VW:A.\9"XR,\=*["R\8:;=VVHRRQ75I+I\R
MP7%O<QXD#N%V  $YW;EVX/.:Y"ST/Q"GA3P3ITNARI-HVH0/<XN(3\D:.I8?
M/R#N! Z]<@=WZSX4US5+SQA)!8K&UU=6-W8&Y=&CG:W5,HP#$@$H1R.] '2W
M'CG3;$ZI'?6U]:W.FVPNYK=X@SM"<_O%V,P*\$'GCOBI;3QA9WJ!H['4E,CH
MELLMOL^U%D+_ +LDX("@DDD 8^E<_<V&JZOX0UR&+P;!I%W=:=+:) DD!DED
M=<?>4A0@/J<GT&.9/$&B:O<:+X9O[328KR\TD@SZ7<NF)D:/8X#9*[AU!SC^
M5 %C5?B%%!I;36&GW4EW%J<.G7-O($5[=W=1\WS8.0WRE2021SC.-VX\1Q0S
MR6T5C>W-W# MQ<6\"HSP*V=N[+ $G:V I).*Y?6-'U34_"HEL_#<&GW":A:W
M2Z=$\0D=8I59MS A-Q .!GMUR<"[9V6KZ-XUU;6/[,FNK/68(&:.&6/S+::)
M2NP[F (((Y!."#VYH ZC2M4LM;TNWU+3YUGM+A-\<@XR/H>A!X([$5<KG_!6
M@R^&_"UMI]PRF??)-*$.55I'9RH]ANQ[XKH* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***P/%OB
M'_A&M,@O6 2![E(I[EHFD2V0@_O&52"1D!>HQN![4 :EWJ=A8SVT%U>00S7+
M^7!'(X#2MZ*.I_"K=>;^)K^ZU"P\(7BRV%W(_B*/[/-;/B&5-DNULY8CCKUP
M<UIV_B?7?*\2V<MI83ZGI$T*J\;&&%XY%5][;VXVJ6)^;G;QC- '7W5U;V-K
M)<W<\4%O&-SRRN%51ZDG@56&MZ6SV"#4+;?J"[[1/,&Z==N[*CJ1CG-<E_PD
MD^L6'C/2YS;S+I]B&CN8(FC65)87/W6)Z%3R"0016; /]#^$Q[[4_P#2)J /
M0[[4['3$B:^O(+82R"*/S7"[W)P%&>I/H*MUQGQ/W#PI;F-59QJED55C@$_:
M$[]JJW/C?5/#FJ:G9^)+6S=8=.?4K66Q+ 2*C!6C8-GYLLO/3!Z"@#O:S;OP
M]HE_<M<WFCZ?<SMC=+-;([' P,DC-9.FZUKDOB*&SN;'SM/G@9S=1VDL'V>0
M?P-YA^<$9PPQR.1S5K6=<GL_$.BZ+;+&LNI>>WGS*65!$H8@ $98Y'?H": )
M3X1\-$8_X1[2?_ */_"J=A\/?".FF<V_A^R/GN9'\Y/.^8^F_.WZ# K&L?'6
MHRZ<GVJUM%O;C6&T>V\LMY;.C,'E(/.W"$@ ]>,]ZO/XAUN+7-3\.^592ZK'
M8?VA82B-EBG3=M*.NXE6#8&0QX8''&* +4?P\\(Q:G)J*Z!9?:)%VL&3='CV
MC/R#\!5W_A$?#7_0O:3_ . 4?_Q-9NB>*+C7-)T"\@:W#7D+SWJF)OW2H,.!
M\W#"0A><]SVQ5*Q\7ZQJ7]C:A8Z:;G3M1D421"TE1[>)P2LIE/R,!QN '?@G
M&2 ;_P#PB/AK_H7M)_\  */_ .)H_P"$1\-?]"]I/_@%'_\ $US%GXJ\57NG
MZQJ*6FCK;:7<7L$B,TF^0P@[2IZ8)'.?T[SZ5XLUN;4?"HU"WL!::_:-(JP;
M]\,BPB7))."I&>,<<<F@#H/^$1\-?]"]I/\ X!1__$U5U'1/!FDVANM1TK0K
M6W! ,DUM$HR>@Y'7VK)L_&.K:FNDZCIVG&ZTV^N CPK:2J\,+$@3>:?D;& 2
MH'?@G&3B>-M:OO$?PPUK4[3[*FE_:/)C1T8R2)'.$+[MV!EE) VG@=<G@ [2
M]\/^#]-M)+N^T?0[:VC&7EFM8D51[DBI8O"WA>>%)HM TAXY%#*PLH\$'D'[
MM0^/ #\/?$F?^@7<_P#HMJP-.\0:_I,_AJRU"VT_^S-5A6WMI8"[202B+<OF
M9P&!"GIC'ZD Z?\ X1'PU_T+VD_^ 4?_ ,31_P (CX:_Z%[2?_ */_XFL/3O
M%>JW>D7D,\=E'K]MJ8T\VZQMLR6!5L;LE3&3)GC@'TKM!G:-Q!..2!B@#'_X
M1'PU_P!"]I/_ (!1_P#Q-'_"(^&O^A>TG_P"C_\ B:RO%GB35-#_ +0D@2RC
M@M;!KJ$S@R/=2+N+(J*P90H49<@CYQZ&H7\4ZS>:_I.G:=;6,<>I:4U\LEP7
M8QL#'P0,9'S].,^HH V_^$1\-9S_ ,([I.?^O*/_ .)JK:Z)X,O;JYMK72M"
MGGM2%G2.VB8Q$YP&P.#P>*R-,\<7FH:9HT#6]M'K6HWMQ9$#<84,!?S) ,Y(
MPG"YSEASWI?!ZW2_$#QL+QH7F\RRR\*%58>2<'!)(./<T =!_P (CX:_Z%[2
M?_ */_XFC_A$?#7_ $+VD_\ @%'_ /$U2N];U.\U76--T)+7[1I<$;/]I4L)
MI74LL8PR[1@#+'/WNG%,B\0:GJ.LC1;:&VLM0@T^*[O//!G6)Y,@1#:RYP5;
M+9]..> #0_X1'PU_T+VD_P#@%'_\31_PB/AK_H7M)_\  */_ .)KED\?:I=6
MFCFWT^T2[GU>32+V*61L1S(')*D#[OR9R?7I4Q\:ZI8:?XB&I6UO)=:->00R
M36D3M'Y,H1O-,>2QV*Y) /.WM0!T?_"(^&O^A>TG_P  H_\ XFK5CH>D:9,T
MVGZ796DK+M9[>W2-B.N,@=.!7$>(?$>J77@T:AI>KZ;+#+JEM!%=6D982PN\
M8((WG:VYF!&>@[9R-*\USQ2?%LWA[3XM(::/3H[T7$XD523(4(*@DC[IQR<>
MIZ4 =I17 7?C;5;;PAXDU80V;7&C:E):!=C;)45D&<;L@_/ZGI5_5_%&H_;=
M7LM%@62YTQ$!C>TEF$\K)O"!D("<%1N.>6Z8'(!UTDB11M)(ZHB@EF8X 'J3
M4-C?VFJ6<=Y87,5S;29V31,&5L$@X(Z\@USEGXDU'6M3?3;&WBL;JVL8;J\6
M\C,ABDE!*Q85EY&UB6SZ<<\5_A1N_P"%:Z3O 5LSY"] ?/DZ4 =5:ZA9WLMS
M':W,4SVTGDSJC F-\ [3Z'!%6:\\O?&FJV'ASQAJ45AIXN='U P*HW;9%V1G
M<QZEOG]NE;=AKNK+XW?0=3BLO+FT\WUN]MNR@60(R,6/S?>!R ._% '445A:
M[J>H6-Y9PVWV6"WF63S+JX'F8<8V1K$K*SLV2>,X"GCFL71?&USKNF^'%A@@
M@U'5X9IG+AGCA6([7(7()RQ4 9'4G/&" =O17)CQ!K5O+IVE:A9VL&KW]W/#
M#(I+0F&-2WG;0V1D8&S=G)Y--N/$>LZ8EO9ZE9VJ:C>ZF;&RDC)\J6/;N\XK
MDE<*&^3.20.0#D '745PNI^,=5T:;Q#IUQ;V<U_IVEG5;650R1SPC<&#+DE6
M#+CKSD'BI(_$^NQ1Z6EY#IHN=;DB73TBWGRAY1DE:7)YV@<!2,D@9[T =9;:
MG8WEY=6EM>037%KM%Q%&X9HBV<!@.A.#P?2K5>;Z?<ZOI_B_Q]<)!:WNH16]
MB8E4^1&XV28+;F.W Z\]NV:NCQK?@^)X8Q8WCZ38)?6]PD;Q1S*RN2,$MGF,
MX8'!S[4 =W17$:=XLUDZKX<34X+!;/6[)YD\C?OA=(UD.23@@@G@#CU/6K>E
M:[KNLVFD:Q8V=I+I=_)EX22LL$!!VR%RV&/ RH7^+&3C) .LHKAHO&.K7Z66
MHZ7IQN[">[\E[=;242+#O*^:)3\AQC=MQT.,Y%;/C/6-0\/^')M6L(X)%M65
M[A)49OW.X!V7!'*@EO?!H Z"JES>V27<&GSW21W-VK^3%YFUY H&XKCG@$=.
ME<R?&,D'C#4M*N9K3['#IWV^WFCB8E@.74G=@E04; ZAQTI[:UJ]OXE\,Z;?
MVMAYVH6MQ)-(BMNAD15)5<GI\P!YYQVH T[:WT'P3HJP+-'I^GJYV_:+EF 9
MB20"[$Y)).!W-;=>.ZK>:MJ'PI\43ZG=PW3)JS0KLA*$>7=HHZL0%PHP,<>I
MKN]-US5?^$UNM U2.S(-BM];R6P8;5+E"C;C\Q!Q\P ^E '3U4U#4['2K<7&
MH7D%K$6"!YG"@L>@&>I/I5IMVT[2 V."1D9KQ[4KW5M0^$^OW.IW<-TXU?RU
MVQ%""EZJCDL?EP!@8X]30![%17%3^,;_ $/5];M=<AM'ALM+_M6)K0,#LW,I
MC;<>6RHPPP#GH*MZ=KFN2^(+2UGL/.T^Y@9GN([26#[+(!D*QD^^#R 0!R.1
MS0!T-SJ%G92VT5S<Q0R74GE0*[ &1\$[1ZG -6:YSQ'K%SIFM>'+>.VMI8;^
M^^SN\H)>,^6[97L#\I&?>N<U#QIXDM]/\47T-II?E:!=E'1S(3-&$1R <C#8
M8\\CMCO0!Z-17$-JVI_\+,>)KZ%-*BT5;WR3 20&DPW(;EODZXP!QCJ2NG^+
M-;U"31;RUTW[1IVI -(@M98VM%9=R.9&^5QT!P!UR,B@#MJ*\[MO%WBNY\.Z
MKKBVFCK;:;]N22,M+O=H"P4KVP=I!S^E:&F^*-:;7/#UMJ,%A]EUNR>:(6^_
M?"Z(CG<2<$$,> !CU/6@#M*JV.IV.IK,UA>072P2F&1H7#A7 !*DCN,BN1LO
M&&J'Q#HFG7\-FK:D]Q'-;PY9K-XU9U5I Q1SA>0 ",U/X"&+SQ?C_H8)_P#T
M7%0!TZ:G8R:E)IL=Y ][''YCVZN"Z+G&2.H'/>K5<5(SQ_&"ZDBB\V1?#BE4
M! WD7#X&3TS3=+\6ZI=>(-/TFY^P&6^T^6<F!&9;6="FZ,MO*R@;\':1RO;-
M ';T5YP_Q U.V\/:?J-VMA#.-7.FZG%Y3D6^'*EU^;H!M.3QAA]#M:UXHN](
ML]2U!DB;3[:[BMA,L#N8E^7S97"MEE4DCC'*F@#K:*R?#VI2:MI[W9N[&[@:
M0_9[BR/R21X'.-S8.=P(SVK#G\4ZI=V&OZEH\5H]OHUQ+ 8)U8O<M$H,F&!
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MII<T210)"RGF)610=QQR^"<').>.E;FEZSK<OB,6-U9>=I\EN9!>1VDMN(I
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M=2ZNX+*W:XN95BB4@%FZ9)P!^)('XUEQ>(/,\93^'6LW1H[%;P7!<$.I<I@
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M8)NV,CJZG&1D94<9JOJGB.>VO[O3]+TTZE>V=LEU/")A&=C,P4*2""QV,<'
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M+#R##>Q1^6Z&(C:5&3@[01G)ZGZ5IV_B#S_&%YX?:S>-K>TCNQ.7!#J[,H
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M)$97520BD L?3)XH Y.[\"B32(H;34/)U*/5?[7-V\&]7N,G.4W#Y<':!G(
M')[Q2^ IKR/Q0M[K+2_V_!'%(4M@GE,L>P,O/(]O3')/-;_AG7%\2>&K#64@
M,"7D0E$3-N*CTS6M0!4TVWN;33X8+RZ6ZG10'E6+RPWT7)Q^9JW110 4444
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M-/F?R#&QV[71@I&  1MXZYYP, &3':7.DZ$5U2]U2-M1UX1V%L;IF>2#>3%
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M;'%/L?#>BZ9>"[LM,M8+D1"'S4C ;8"3C/U)H \PMO$TT*^&M?NFGCM]*/\
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MCO'IVH37'V@JQ42,D>8XR1V))..^W'3(K;T/3I;"UFENA#]NO)FN+HP_=WD
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MV5[NU!$$Q)W1YZ[?3/?UJHWA70VL[NS;3HFMKR3S;F(Y*S/W9AGD].3Z#TH
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M^4C*GN#UI-6\)>']<BM8]3T>TN4M1B /&/W8]!CH.!QTXH 9I)N[#P;'F_\
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M:1ADR1_W&SU7D\=.:K67A'P]ITUK-9Z/9PRVH80.L8W(#C.#^ _*@#S&XO\
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M3[DDDD]R:FH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"&J6-Y';:=J5R$O(Y%'RJ8&EP6/3&!G'YUUNHV[OX<N[:*,^8;1XUC#%N=A
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MO&7AJS:47&N6,9AD$4F9A\C\<'TQD9],\UD^/LFY\*[8Y'\K7(9G*1EMB!)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD9&0#>HKC_A6Q;X8: S$DFVR2>I^8UV% !1110 4444 %%%% !1110 4444
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MVYLTCBE\QB\ZA7;. -H5>.YSSC'/76MS%>VD-U V^&>-9(VP1E6&0<'V-2T
M<?X>@\:V]E%IVJKIB)9Q&-;R"5G:ZPI5,H5 3L2<GI@#GB#P]X3GTSQ.FKP6
M<.D1RVSKJ%I:SEH+F<E=KHF %QAN< G(&.IKM9)$BC:21U2- 69F. H'4DUC
M'Q=H2VWVI[[R[3&5NI(G6%_3;(5VMGM@G/:@"KXNTC4-6ET%K&.%A8:I%>S>
M9)LRB*P(7@Y/S>W2L+5/!FL:I>^*IHY;>T>_FL[G3YMY?9+;A<;UQP"5[9X-
M>A44 <7>6GB[7_"6L6.I6FFVES=6$MI%#!<,ZN[J5\QF*@J!V49ZG)Z4FK>'
M]=ET;P[=Z8;6/6]%*L(9G)AF4QF.1-P&1D'(.*[6B@#C-9TCQ)X@T&W>ZBL(
M+^#4+:\CLTG9HPL3ABIDVY+-@\[<#CW)O6^G2#Q/-XIU;R;(1V(LHHC*"$0O
MO9G;@9)"@ = .O.!TO6J]]86FIV4ME?6T5S:RC$D,JAE8=>0: .2\#Z&EAJ&
ML7%O<B?3([J2'3%'W88V(>95/<>;E?\ MG6WX9U+4]3L+A]5M;:WN(KEX@;6
M4R1R*,$,K$#U*GW4UJV]M!9VT=M;0QPP1*%CCC4*J@=  . *BO+ZUTV!'N'V
M*S".-54LSL>BJH!)/!X [&@#CO%?A*\\07\T\5G!;W\3QG3-8@G,<UN %W!P
M!EAG?@<@YQ\O6FZKX;U\ZIXM^P0V<MKKUFJ+-+.4:%UA,>-NT[L\$'(QS746
MGB/2KW1I-6M[EFLXBZR.8G#1E#A@RD;E(P<Y'%6-+U6RUFR2]T^;S[:3E)0C
M!7'J"0,CW% ')V7A[7-,U3P_J?V>TN'LM'.F7,,=P1ALQD.I90"/W?(..O>J
M]QX,U2.WL7@%M+=/XA&M7O[TJB]1L0[<G"[1DXS@GC.*]!HH XW^PM777?%U
MX(+<Q:M:PPVW[_D,B.OS?+P#OSQGI52P\,:U;/X$\R&VVZ#;O#=D3GYB8?*!
M3Y>>F><5WM5Y[ZUMKBVMYYTCFNG,<",>9&"EB!^"D_A0!@^%='U/1;W7([I;
M8VEWJ,U[!+'(2Y$A!VLI4 8P>YS[4:UH^IS^,="UJP6VDCM(KBWG2:0H5639
MAEPIW8V'CCJ.:Z:B@#SR'P;J]MX0U/P8OV=]-N991;WID^:*"5RS!DQRXW-C
M!P>,XKOX(4MK>.",8CC0(H] !@5)10!YI:>$/$=MX0\.Z*\-@SZ/J<-P76Y;
M$D4;LV>4X8@C ]NM6]6\&ZKK&H>+&\R&T35([,V4PDW-'+;DLI9<="V.A/&:
M['3-:T_6&O%L)_--G.;>?Y&79( "5Y SPPY'%7Z ,'P_)XGN#O\ $%MI]IY:
M;/+LYFE\Y^/GR5&P<'"\GGD\5F^.?](N?"T<)#NGB"W+*IR5Q'(QS^'/TKL*
MHQ:+ID&IS:G%I]LE]-CS+A8P'; QR?IQ]* .+UCPOX@DE\:6MA#926OB"#,<
M\LY5HG\@1%2FWG) (.1C/?&#H:;H6LV_B_2]3N(+06]OHW]GR^7.6/F;U;<H
M*C*_+CG!YKLJ* .+70M9BUOQ9>I:6$T6J&V\B*>7*R+&H1UD&TX##/K6+-\.
M+W^S-4@TAUTR%KBVO-.L)9C+%!<1,68\9VJYP,#.,9]AZ=10!QEIIWB.?QO;
M>(;S3K&WB32I+.2%+PNV\R*^0=@&/EQ^.?:L6S\&>)-,\.>');3[%_;6A7-P
MXA>8F&XBF9MZ[MN5.&&#CJ*]-HH XW7='\1:[H%L\L=C'J,&HVUZEH)F\I5B
M<-L\S;DDX/.W'08XR2\\-ZCJGBZXO;V*!+"[T-M,F,4Q+J[,6) *\C!QGK[5
MV5% '!6WA76+OPWHGAS54MA;Z7<0,]W%*3Y\<!S&%7&58X4-D\<X)J2X\.:S
M+<^.76"VVZY L5IF<\$0>5\_R\<\\9XKN:* ,[0+6XL?#VFV=TJ+/;VT<,@1
MMRY50#@X''%<&GA+Q2YTF6ZATR>^L-8-W->O<N7NH\2 ?P?(%#@!,D<<8KTV
MB@#SF^\(Z[=>%O&>F+#:+-K=[)<6S&<[55E1?G^7@C9GC/6M*#1]?TGQEJ&L
M6-M:7-KK$, N89;@QM;2Q+M!!"G<I'T.:[2B@#F_ 6CW_A_P3IFDZDL N;6/
M8WD2%U(R2.2!SS_]>NDHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO=<\,176HM&UW'//;RO&NU7,<K)NQVR%!Q7(SM?RVOQ0^TZC)/'!#+$D;(H
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MJ(_NA1@CH2"3D_,?;'1]J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)>>'[AHK:]WD2F,D&,EASN R">_?O6K:7'G^-] B\)W=U-!!&PUQ?.=[=$*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=6OM(OE:UCB>:W>*&V\T$[F!&YVQ@?09[\G.!K03PW,$<]O*DL,BADDC8,K
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MR#F-CG'##CKP/7M0!QVK^ =0/PYUK1K-H;G6-:N3=W<[-Y<0E:16..IV@+M
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M2"$^CE00GK\V* *!T5M5\27=UK.FV\MK%$L-CO82;1DEV*D?*6.WUX0=*S=
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M;;R ,D@! <'D$9ZCWH X[Q+HOB'7-"T^!;.TCG@U2&[\E9\1Q0Q-D(&V\L0
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M Y&0"0-N<<Y&13M9\+P:IJEKJ]O=3Z?JUJACCNX-I+1GDQNK AESS@]#R"*
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M<]P<58@\*7<.F6NF'Q%?M90)'$8_*A!DC7 V,P3."!@XP<&@#,T?_DLGB?\
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MN1T#%#\N?7V]QZU%I5G%8Z+X?U6YUJ[,-O!&1!(ZE)"\6Q5  !+98 <GT[T
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M^-6\-6^E6DDHL!?B:2^9%*>9LVX$1.<_I6#X[LIK34/!KS:M>70/B*V 2<1
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MS=@ =": .I?2]/EL5L9+"U>T7[L#0J8Q]%QBH(O#NB02QRPZ-I\<D;!D=+5
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MY4)$V(W#%N74X(QUK7L5E?5Y(H?$L]ZD=O\ OH'6 F,N?W;@I&.?DD&#D>U
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M-+LKB;&/,FMT=L?4BN5:^URV^(NA:+/K$CV\VEO/=1K#$%DE0JI(.S< 22<
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MDYQQFJ'BG3SJ'Q)\*RRZ9-=6%I%=K<R&U:2)#(B!,\$'E3].^*[O(]:,CU%
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M\??IGI5KPS:7G@K5;CP[]CN9_#\C&XTZZBB:3[/N/S028R>#RK'L<$\5W-%
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M]<C-9?AO3->T73?$=KK;RWS1QK#9W4<99[J((0A(&27YVGW&?<]_D>HI<YH
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ME974,K!E(R"#D&ER#T- &1X4@GMO!VB6]U$T-Q%I\"2QL.4<1J"#]#6O110
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M%8L&)"]3D\?K5B^TOQ'J6FW%O=2Z<?M,Z+)$CN(Q;*06C!VDEG^8$X'!''%
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M,S9^[C'S8_#/M6;9>"[73/'=UXBLI/+BO+62.XM/X#,S(3(HZ L$PWK@'UH
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MXB]MHT-Q\J ,2-Y.#ZG:*Z"QT[Q3:Z)8Z2)-+B2"**WDN8WD+[% 5BJ[0 Q
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M>D\4.K_$[P"R,&'F:@,@YY$&#0!TFG>)=+U35KS2K>=UU"S"M/;S1-&ZJ>C
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M7</A36);#=]L2RF:#;UWA#MQ[YQ0!&OB;3YIYX[1;J\6W<QS2VMNTB(PZKN
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MQ]4\0W_A>XL)-::TGTZ\N%M6N;:)HC;R-]PLK,V5)XSD8XX/:H_C:;2O'O\
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MN;FXCB 5&N'WN !P"V,GZG)K-.D/8>+Y=:M4+1W\"6]XB]0R$^7(/7AF4_\
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M,HDWKN;HJL.A/&:[FWUFPO;A8;*YBNV(R[6[AUC&.K$' ST ZGZ D7BJE2I
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M2R(RECARJJ/EZG)YX]0"G%I>J2^ ++5M*UO4(M8_L^.Z#3W#3QS/Y88JZ/D
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M +&F_*@NP+$!@!Z@4 :]MJ5QXE\>ZQHHN)[?2M#BA618)6C>XFD4L"7!#!5
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MZE.56*(QW+NQ1@2WF8! 7 SSSB@#W^F--$DD<;R(KR9"*6P6P,G [\4Y050
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MWMNMIC/GF51'CUW9Q7BNJS20^ ?B;H2Y.GZ9=@6:GI$CLKF-?0*>@[9KUCQ
M!_P@VJ# V_V;+QV_U1H O0:SI=U<);V^I6<L[KO2..=69E]0 <D>]27&HV-I
M-%#<WEO#+*<1I)*JL_T!/-<3XR\.2:_?:!'8W1L=3M;:>XL;E?\ EG*OE8!]
M5.2"/0T:3XH'B2ZT&*]MQ::WI^IO#J%FW6*3[+/\R^J-U!]/I0!V%QKFDV=X
M+2YU2RAN3C$,DZJ_/3@G/-%SKFD67E?:M4LH/-7='YMPB;QZC)Y%>>7]W?\
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M,M*22XLA?&+6-/3G?$(T/G(/[Z[B3Z@F@#TAM;TI#.&U.R!M_P#7 W"_N_\
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M6X^S- Q198W,IC&X9Q]X<X/% %R3PY,^B7=JNIR)?W=PES+?+&,^8K(053H
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M<_$6 ?#X>,_[*NO[///E;T\W;OV9QG'7WZ5V%O))+;I)+#Y4C#)CW!MOMD4
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M#N@WFKR6[W$-I&994C8!MH')&>#0!6\*>%[3PCH\FG6+$QO<2SY(Z;F)5?\
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MK:71IX7\DRQNTJ,CX(!7()P?F!Y% #=!T>YT+PO9:.MY%-)9VZ013F @$*
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MW5ON[W/0G!P ">,X YH SK#P+:Z-I6OZ=H\ZVL&K2/($:+>MOO0*P4;AQG)
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M"!%)4!1QCCM0!XL?^355_P"N _\ 2JO:9;B*VA1YG"*S*@)[LQ  _$D"LO\
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M5;6TU+3;J6"+39H0VY5X5Y.0Q#]05( !'7O3MHYO"?Q5D#3W=Y8Z_;!KB8P
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M;7=*T.QN?L\96&VC$#AI&,BNPC3;DJN[KTX/IFMGQ=JTFL^%+O1=!L[J\O\
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MSJ^HSZB\#$9@1S\JMCC( R?K[4 4_"VJ>)]?M[ZX.I6@^Q:Q+9-%]DP)(8Y
M&.=W#%<^V:O^%M7U34_$/B:RO;I'@TR[6W@V1!204#98]SSCC JG\,24L-?6
M2.6)GUR\G198V0M&SY5@"!D$=ZH^%=-T^_\ &'C*:^LMXDODD@DFC90Z"-02
MI/!&0>10!;TC7]:OM-\8SS7L?F:/>7%M:[8  1&@<%_4G.#C%6M"OM?U;PAI
M.LMJ]LES>P13>2UJ C,P!* YR,\@'M7/^&1%9:!\0(%@EA274+N2VC,+#S(V
MB55*#'S D$#&:?X53P[IW@GP_/<:5(-8L;:)]D5BXG,P7:5SMZG)!SQSG/>@
M#<GU37)OB1<^'K;488;5=+6^1GM@[!C(4VGD97C/K[U;\!^)KOQ1HES<7L,*
M7%I>S6;R09\J8QD#S$R2=ISZGH:Y?6M&@\2?%'4;.Z-U!!/X?6U%U 754F\Y
MCM#C ) (.#U]*Z/P+J,\>G?\(_J=@++4M,/D,(K<QP3J/NRQ$ +AAR0.ASP*
M +/B>;7;&QU74[*^MX+6SL&FBB:W\QI)%5V.3N&!PHQCUJOH$WB/4]$TK5)M
M3MS%>V"SR(EJ%,3LBL"#N.0#D8([]:T?&;8\$ZX@#,\EA/&B*I9G8QL  !R2
M35;PC.EO\.M&,VZ,P:;#'*KJ0R,L:@J1USGC% &?X3UW5M<^&$6OW5S&NH3V
M\LP,<0"(5+ #;W'RC//Y5J>"-4O-:\%Z7JVH2H]S>0"9]B!%7/8#T^M<5X(T
M33$^#T#7VG;+Z*TF65)8F$@?+X&T\Y/&..:M:%<M'\*/#^ADW%M=WL*6,I\I
M@]LI_P!8S9'RD+D G^(K0!N^$?&$NOZWK.GW4 @,+)<V/_3:S=<))[Y*D^VX
M"JGCO5O$GAOPWK.O6U]:B.V>/[-;-;;OE+(AW-NY.68]/2L_Q/87'A;Q-X<\
M207-[?>7)_9UU MNI/V5QG($2 X1@&K0^+1-W\,-3AM8Y)YK@0^3'"A=GQ*C
M'  ST!- '3:?;ZQ;WTHOKZ&[M&C'E[8/+9'!YSR<@C'TP:Y_QMJ/B+0=!US7
M+2^M4ALXP]M;M;;]P 7)9MW]XMQCH!78PRQSQ++$P9&&01WKDOBBKR_#;6[>
M*.26>:#9%%&A9G8D< #DT /O)O$=CH5[J3:G;S)'ILERG^BA2DJKN /S'<I&
M?0C'7FJ[:]JP^$/_  DOVF/^TO[*&H_ZH>7N\K?LV_W>W7-:&LSQR?#F^9-S
M>9IDB(JJ2S,8R H7KG/&.M<<VB:;_P *,R-._P")C_8@AV>4WF_:/)QMV]=V
M[VH U]6\0ZW9:%X.NX;V+S]9O+6VN2T *J)4+$J.Q!'&2:ZBTCU.+5_+GU.&
MZMQ 6DB\@(Z,6&QL@]"%D'3M7 >)?*NO"7P_@>WEG2'4+&2ZB^SLYCC6)E<N
MN,@ G!S77Z1)H-KKS)HE@R37D8^T-%;-%&B1[L,25 W9?&.IS[4 0^.]9U/1
M+;2)-,N(XGO-4M[&3S8@X"R,06'(Y'UQ5:U\0ZNGC74?"=Y-!+(FG#4+6^@A
MVE5W;2DB$D9SW&.*A^**^=I^@0B.:0KK=I-(L*,S+&K'<QV\@ =ZZ.+2](T:
MWO=0MH%22X3=-<DM))* /ERQ)9O89^E '!1>.O$5G\.]%\87,UG=B[FCCGL1
M;E&8.Y3$3!OO#&<$'/-=AKGB*XB\3:9X9TL1C4+V-[B6:5=RV\"\%MN1N8GY
M0,X[GI@^;^&]#N=*\%>%_%%II\]S>Z0CI?Z9-&S.8RYRT:-]V51A@1C(R*Z[
M4D*^/-%\;V<4]QIKV+Z?>;86\R!2V]'*8W8W<-QD=?6@#2U;7+[PGJNDKJ-T
M+W2]2NELC,\:I+;S,"4)VX5D.".@(X.33-,UK58?B/J'A[5;F)K9K1;O32L(
M4RIG;(&.>64XX&.#FJ?BR%?&UWH>E:9F:UMM1BO[R[53Y4:1Y(0-T+L2!@9Q
MR3BK'Q$T^]2VTSQ+I-LUQJ>B7(E6%/O30O\ )+&/JI!_X#0!KV\VI7VOZK'%
M?*FGVRI"@$(+"<KN;D]5"E.W4D9XKD+'QYJ:?"O3/$VH30+/?72P33B#]U:(
M9F0R%0<D #N>I%=SI5M_8VA1K>2+YP#374@Z-*Y+.1[;B<#TP*X3P)=KI?PG
MT*SU#2[B=&EDMKVU:T=WC1GE;+1XR5^Z3QT)H [#3FU9]2BQJD&H://:.\=T
MD2AQ)N3;\R_*RD%B, =#G-<S8>.[K3_"/B37M;D6X&F:E/8P0PQA/,V.$0=_
MF8D9/0>E0>&M(M="\=C_ (12XG_X1N:UEEU"W)8VUO*"-AC+=&/S94'@#G'%
M8]OX>N_$_P //%VEVJ/%?OKMQ>VB3H8_, E5T/S <, 0#TYH [RZ'BBUT&34
M_MMO+J,4)F>P$($#8&3&K??![!B2,\[<<5A:QX[U%= T#Q3H,!O=-O6)N; Q
M@RB,(S.48'[R[&XYSBMRY\6P3^'I&@M;EM6DA*KIAA83"4C&U@1P,]6/RXYS
MBL?0-&'A#1_!.A7$F^>UED:=D4E59XI2<G' WOM!.,T ;MUK?]HZ?HFHZ)J"
M&SO[F-/,"!@T;!B<9Z,,8YZ<Y%9UMXAN]9\5ZWHL&K0:;>:=(J6]I+ ':=2B
MMYK9(+*22,(1C')Y%9<WAG4?#7C/3QH\?F>&M0OQ<3VX'_'C.%;++Z(_<= <
M=,XJ;Q/9>&?$[W<>O6UQI^HV$S)::A%%)'*0.5:%P/GY.-HSR#QTH [;2'O9
M=&LGU)$2_:!#<*@PHDP-P'MG-7:P/!)U@^#-*.O[SJGD_OC(,.>3M+#LVW;G
MWS6_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !117'?$36[W2M-TJQT^8V]UK&IP:<MPOWH5<G<R^
M^!@?7/:@#L:*XKQ=HD&B^#]0U;1=UGJ6FV[74=RK$O)Y8W%9"3^\# $'=GKG
MK7.ZIJMKJGBGP#JEQ!<+;:KIUQ/<6\"22;SY4;+E4!+;2QYQ0!ZO16#X8ATY
MX+C4-,2YB@N9&0PS[UVM&[(2%?E<XZ<=!QG-<K\4M(@T_P #ZWJ\$EPNH230
MN)A.X* RQIA0#@#;QQZGUH ](HKA?&>@66E>"O$M]8^=#)_9KL )G(1T5BKK
MD_*W)Y'6L/Q1JUDOP5E6W-W'=QZ=$Z2BWF0B3"Y;S-O4\\YYS0!ZM17G'BFU
MAAU#P#'$I1);]8I55B!(GE,VUO[PR,\U7U_5;30O&]\WC*QG;1+M8ETS45#-
M#:X4!D.WF-B^3N')XYP. #T^BLSP];QVN@VD,-Z;Z$*3'=&7S#*I)*L6_B)!
M'/>O-YQI:^-/'\.H7-S"D$-HUFMO/(KQNT+%O*53]XM@X Y- 'K=%<AX;U36
M=/\ AE8W_B&*1]86V^>)QAY)"VV)3Z,V4!]S57P!>:C97^M>%M;NC<ZC83_:
M8YSQYT$V7!'T<N/;@4 =S17D]Y=:%8?$3Q:-=N)8;*.UM&A1))!M=PP;8$/#
M$[>G)-=A\/(]=B\%6*^(S,=0&_\ X^#F41[CLWG^]MQGOZ\YH ZBBO.3KNH6
M?Q#L-6GG)\/ZRTFE0)_#')&28W]_,82@>Q6M#Q/J=Q?>.=#\(PSRV]M<PR7M
M\\3E'DC3A8PPY +=<<X&,\T =M17(ZS:^'=$O=)_>/I=P]T@A6VCD"W+9_U;
M!!AR1G&>01FN5O;K0K#XB^*_[=N)8;%+.T:)4DD7:[A@=@0\,3MZ<DT >L45
MRWP[CUV/P59+XB,QOP7Q]H.91'N.SS#_ 'MN,]_7G-8+:[J%G\0]/U:><GP_
MJ[R:3"G\*2(28Y/<NXE /IMH ]'HKS_XDB!-5\(O-(8HI=56&=A(4#1[')5B
M",C(!K*M1=O+XZBM9+N7PS%9;[*2=W8)<",E_)=N=H//!P#TH ]5HKRE-6LO
M^%%;2;O[9_8AF\[[/-GS_)SO\S;US_%G\:[SPBBKX-T8@<O8PNY)R68H"23W
M)/>@#:HKS6UAM-'\9^+=#U-W&G7UD-3MG+G,40!655.?EVMA@!TS53PA>2ZA
M\,#H%XLJ:PEXVE3AV/FARV3)G.=PB)?.?X* /5:*X#6+2"#XK>$K:)"D#V=V
M7B#':Y14V%AT)&3@FG>%8$'Q/\;I@E+9K+R$+$K%O@RVT=%R>3B@#O:*X7XK
MKCPM:RHSI(-2M4WQN5;:TH##(YP0>E=Q'&D,:QQHJ(HP%48 H =17)_$+2GU
M/PXJVMU)97_VNVCM[R)B&A9YD7/!&1\QX/%8:^(I==\):KI&N0BV\1Z7L6[B
M4E=WS#;-&1SL8>G3./J >D45P:7)\0?$S4/#\N4TC1;.)S:H=JSS2\@OC[RJ
MO 4\9.3VIFKS-X4\=>'[/3V:+3-<\ZUGM5/R12JH9)(UZ*>2"!@'KUH [^BO
M,]9T"QT[Q[X(TN 3_9;A+U;A6N)#YVR%2I;+<D'FN^TO2X-)LVM+=I#!YC.J
MR.7*[CDC)).,DX].E %ZBO*-)FT:WU_QNFK)>M!;7P\HP1W#^2GE*2%,8.SD
MD\$52N[[4;S]GF_U*\O7FN$#/:70F#3+%YH";G4_?V\'G/8\YH ]DHKC[%-!
MFU?38+2UO[>\"FX61H)X5(4 ,"7 #9W].?7M3_B=E?AOKDR,R2PVS21R(2K(
MPZ$$<@T =;17$:)#H6H76F0V]M?17D5M]I9Y(9HE<8",IW@!P=YZ9Z9]*C^&
M*#[/XD9BSM'KUY C.Q8K&K *@)Z*/2@#NZ*\[UVT@@\)?$"6)"DD!F:%U8@Q
M$6L;C:?X<,2>.Y-=7X2B2+PAH^T<O90N[$Y+,4!))[D^M &S17!:-"G_  N'
MQ&A!,<-C:R1QEB51FW;F"] 3@<BM[QCX;'BCP[<V$=S+:7>TFVN8G*-&_;D=
M5/0CT_"@#?HKSK1]4_X3?1K70+BU>SO;*4)K$<9*&W:(_=1A_P ]"."#]S?S
MG%>@BWA6W%N(D\D+MV8XQZ8H DHKR'P;<:+_ ,(?<R:M;:A<SB]N8O,6&X;C
MS651YH&T8X&<\5L>+M*UBQUS1;SPS,[:C9V4\TEN[G;?I&85,;C.-Q#MAL9S
MC\ #T:BN*MM8TOQ;/X8U>S!*R3RQRQOPT;+$Y,<B^JL.A^HKF["ZTBQ\2>./
M[4MKVXAM+I#!'%#-(L:^2&*@H"J9)[D#O0!ZS17GLI>7Q_IG@:.XN!I5EIC:
MA< RMON/WGEI&S9R5&<GGYN^:?XIE'@K6O#FH:4OD6=_J4>FWEG'Q$XE!VN%
MZ!E*]1C(.#F@#OZ*\@GN=#LO&/CJ'5[BYCC1[2.QCMY) ZR/!G;$$/#%B,8[
MUH7FN>*/#GP@T@:G(4\2WLL5B)I,,8FD<A6;L6"#_OKK0!Z?17.7/@O3)=&F
MLHC/%=20F/\ M!9F^T[B,;C)G<>><$X[8Q7,:R+6+XN6,%\EQ+;2:(\DD4$<
ML@:42J Y1 3G&1G% 'I5%>>ZW'IS_#?Q5?Z6EU!&+>X9%E\Q&CEB5EW*&PR<
MCVZ9[T]O#BR_#RUO]+O+NPU:/3DN(KJ*X?YI!&&^=22KJ3U# ]: ._HK \%Z
MZ_BCP7I6L31JDMU #*H'&\$JV/;(-<GX9L+>\D\?0W"M(D6I2Q19=LQ((E8!
M#G*\DGC% 'I=%>:^!]:OM,-GX2\4R_:6NK99M+OI>1=Q%03$Q/\ RT3/XCGZ
M];X-B2+PAI>T'+P*[,2268CDDGDF@#=HKCOB!_:U_I;:1H$[0ZD8FO=Z]0L1
M#*OL7DV#Z!JT])U:U\6>";?5$0&&\M=[)_<;'S+]58$?44 ;U%<7\)QO^&FB
MW,C-)//"7EE=BS.=S<DGDU6O84;XUZ=$0?*;1Y9FCW'8T@E4!BO0D GF@#O:
M**X/Q!"C?%OPK&0?+GM;QI8\G;(45-I9>A(R<9H [RBO*YK^_P#!'B[6=75I
M9O"K7L=M>VX+.;$F&)Q.@.?DW2$,!TXKH;BWGN;CQ3+H$D8OY]/B:RF#942.
MDF&4]!D[3GOP30!V=%>7^%-2\/ZO?Z=8*EUH7B6P=7NK"Y=T>YPI#;B3B8?Q
M G)XSQ4GC?0[32SX8\A[CS+SQ%!%<R&=\RH_F,RGG[I../84 >F45EV>G6/A
MV"^GCD>*U8^?())&98\* 2,DX&%SCZUR/A75=5L_'-Y8:U(^S7;<:I8(_'DE
M0%>#_>5!&3]">] 'H5%><>+X-9TOQA%KGAP/+):V9FO=.#';>Q;\, .@D Y!
MQDXQSTK6M=4TGQ#K6A:Y8N);6;3[J8-[JT(^8?WERPYZ9- '8T5P'@)$\:>'
MAXHUN,74NH32M;P2_-':Q*Y141>@/RY+8R2>O2J7Q$TK^POAWJTL-W=.?M\$
MT$C3.TD*M)$C(&SNQPPQZ$"@#TRBN4L$T*7Q'9Q6-K?6]U#')<AG@FA5E $9
M4[P W^L!XS@J*XDWU@EUJGA[QE]ITK7KN:?[%K+R,D<R,Q\ORY0?D"@J-G X
MYY)% 'L-%(HPH'M2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5S_ (P\-#Q/H\5O'.+:]M+B.\LYRNX1S1G*DCN.
MH/UKH** .4UNRU[Q+H,VB36L&GI=IY-Y=+/Y@$9^^(A@$DC(RVW&<\XQ5:]\
M-7T?C'PM>:=:P+I6B6TUL5:;#E7157:,=MHZD5VE% "*JJ,*H ))X'<URWQ#
MT34?$G@V[T?3$A-Q<-&0TTFQ5"R*_. 3_#CI7544 8'BS3[_ %OP7J>FVD$8
MO+VU> +)+A4+*1DD \#Z5E:_X?U?5?A8_AV&"W74)+..U.^;]VI4*"V[&2.#
MVKM** .*UW0]:U*Z\)SPVEN/[*NEN+E7N,9PA3"?+SUSSBM.X36_M6JPW&EV
MFI:9<NOV>)IP&5?+0,CJR[=NX,<@GKTKHJ* .?\ !/AU_"WA2TTF217>)I'(
MC)*)O=GV+GG:-V 3UQGBJ6@Z-JECX[\2ZO=00K9ZJ+;R=DVYT\J,J=PQWSV)
MKK:* ,'6]-N=6U73K>:SMY]'B=IKA97R7<#"#81@J"2W)ZA?2L74O"=S8>--
M&USPSIUA D,<D&H(&$/GQ-@@ *IR5(W#./2NXHH X=/"=S?^+O$UQJUE;RZ/
MK-I!;;/.RX$88$D8XR6X(.1@4^QL?&.F^%KO1=UM>7,2M!8Z@UR5=HNBM(-I
MPZCTSD@5VM% '#^)_ -A?^#I+'1M)L;34T2-K2955&AD0@JV\ G@CGUYJ35/
M#>L:G<:%XCB^R6OB32U*R1&0M!<(PP\98#(!Y*G!P>QKM** ..UO2=8\2ZCX
M>D>RCL8M,U!+V9I)PY?:K#:@4<_>ZG'3I4*^%+F^\8^)+G5K*WET;6+2&UV>
M=EP(PV21CC.[C!R,"NWHH XJPL/&&E^%KO10UK>7$*M!8:@]P5<Q=%:0;3\Z
MCTSD@?6F>)O &GW_ (-EL-'TFRM-25$-I,%5&AD0@JV\#/!')[\UW%% '#ZW
MI'B+6G\*7$EG9K<:9>)=W@%R=K$(5(3Y>?O9YQ73:_;7-]X=U"TM(T:XN;:2
M%%=]J@LI')P>.:TJ* .+7P_JX^$G_",F"W_M'^R_[/SYW[O/E[-^[&<=\8S7
M0^'+6YL/#>FV5Y&B7%M;1P.$?<I*J%R#@<<>E:=% '*>+?")\1:OH%]'+Y36
M-RPN/^FMLZG?&?7)5!]":+7PB;;XCWWB-9?]$N;:/-O_ -/(!0R?]^_E_P"!
M&NKHH Y+5M&U2Z^(>A:U!! UCI\%Q%*6FP[&4+RJXQQM[D55TW2_$6E^-/$N
ML)IMG-;:LUN8E-Z4=/*CV'=\A'/7K7;T4 <+XJT7Q-XC\,I;&VL4O3J$5R(O
MM)\N*.-P0N_9EB=N>G&X^E;\<_B*XOK:.33[.TM-^Z>5;LRO@ X55V <G&23
MTS^&W10!C^(K6]O+&WAL8(Y76\MYW\R38 L<J2'L<DA2!6-XT\%?\)(UGJ5E
M+]CU>U*@2@X$T)8%X7QU!Y(]#78T4 <M>>'KNR\:'Q/I*QRO<VPM;ZTD?9YJ
MJ<I(C8/SCI@\$=QB@Z#=ZUXLT_7=5BCMX=+2065JK[V,D@ :20C@8 P%&>I.
M>U=310!R>O:+JE]XZ\,ZO:P0M9Z5]I\[?-M=_-C"C:,=L=R*ZP]*** .(T/2
MO$6C:UXDO1IUE,FJ7@N(0;TJ5 0+AOD/IGC-8\WP]U>'X:Z_H4,EI+J>MWDE
MW(%<I;VY=E)5>,D +Z=:]/HH P?,\02FTB&FV=N%=!+.;KS"B<;MJ[.20,=1
MUSVQ3/'.DWVO>#-3TC3TB:YO(3$IE?8JY[DX/\JZ&B@"EI<,L6F6B7,*1W$4
M*QL%;<!@ '!].*YO2-)UGPMJ.M):64.H6&HWTE_$PN!&\3R8WHP(P5R,@@D\
M]*[&B@#DM4T#5+KP5KUBJV[ZIK"S;P)"(HV=-@&XC)"JJC..2,X&<!=.3Q59
MZ!I^EKIMA%)##%;R7/VTL$  5G5?+Y. 2 2.<5UE% '$PZ5X@L?'^LZ[!I]G
M/:7MM!!&K7A1QY>>2-A'.[U[5TNE-JLB7$NJPP0.TF(8()3($0 <EBHRQ.3T
MX&![G1HH Y/PSHNJ:;XJ\3:C>P0I;ZI/%+#Y<VYE"1A,,,#DXSQFNJD++&Q1
M-[ <+G&:=10!POA+2?$?AOPY-IL^E6%S(]Q/,,7I"$2.6"G,?OBMF*TU@ZYI
M-Y=102"&RFANI$DQ^\D:)OD7'*CRR.3GIUKH:* .//@D6GQ!@\1Z;-Y-M-O:
M_M,X5Y=A595'9L$@^O!IWAG0]3T_Q'XFO-0M[<6NJW*31!)=Y"J@0AA@=<9X
MS7744 <QK7AVY;Q7I_BC2C$;^V@:TN()6*K<0,=VW< =K*W(XP>AQU$=_H=[
MXFUO2;G5($M-.TN?[7%;^8'DFG (1FQPJKDD8)))[8YZNB@#@X?!L^HZYXP.
MMV<!TO7OL_EB.;<\?E1[,GC@Y 8$$XHG\)ZWK_@J3P]X@N8?M=LZM9:K"Y9F
M:-LQR.A PV/O#)SSS7>44 8-E=>)Y+=;>]TVR@N@-KW4=R7B)_O*NT-[[3CT
MSWK+O='UM?B-;>(+:UMY[2'3'L2)+G8[,T@?=@*1CC]:[*B@#D==T_Q!K?AO
M7]/^Q65NU[:M;6T:W&1N96#2.VP>H  !Z=>>(I=+\47?A"#P_$ECIY-HMI/>
M_:&E9%"A6,:;!DD9QDC'O79T4 4-&TFUT'1+/2K%"+>TA6*,$\D =2?4]3]:
MYC0=#UK3)/%DD]K;DZK=O<VP2XS@% @5_EXZ9XS7;44 <K?^$D\0>"K/2-2'
MV:]MHHS#<0/EK>=% 61&X[CVR*U?#.GW.E>&-,T^]D22ZMK9(I73HS 8)'XU
MJT4 <U9Z -0U/4K_ ,0:38RS2R*EL7Q-L@4?*O*\'<78^[=>*S/#.@:SX;/B
M"QBL[7^R;FX>XTZ)+C!AWCYD(VX5<\C&<9-=Q10!PGA33_%GACP38Z(FE:;/
M=6D)C64W[!"<D@D>7G'/2I;S1O$">/['7;:VM;J"VTQK)S+<^4\CLX8O@(0!
M\OZUVU% &9ICZQ-=W$FIVUM:PA56"*&<RDGDLS$JN.P 'H>>>,75]&U2[^(6
MA:U!!"UCI\%Q%*6FP[&4*,JN,<;>Y%=;10!AZ;I]R;O75U&SA^RW]P)$7>'#
M)Y,<15ACOL/J,&L'1/!>I>%]/\0VFDWP=+A!_9/GN3]F #8C8]=JLW'L:[JB
M@#BM:\/ZAXGU#0Y;W3+6RFTV]CNWO4G\QL)R8X_E#$,<9W8X[$U9\;:+J>MR
MZ!_9\,#+I^K07\QEEV95 P*KP>3N]A7644 8?B2TO]3L;>QM[6*6VGF3[:LD
MNW,((+(!@[MV-I' P36'XJ\&,[Z1J'A;3=.MM5T^]6<28$*M'@AXV*J20P.*
M[BB@#$CM]1;Q2E]):1I:_8O)8^=E@^[=TQR.V<_A65IW@E='\?SZWI\PCTV[
MMI?/LOX4N':,F1!VW!.?<#UX["B@#BO#>B:UX*AFT>QM(-0T43/+9-Y_ERVZ
MNQ8QL",, 2<,#GVI_C?0M<\1^#;C3(%M6O+B>*3#2E8XE21'V[MN6^[UP.3V
MZ5V5% &*9==N+RU']G6EM$'_ 'TYN?,=4ZE578,[B #R,#GJ!6#J^CZ]KGA*
M[T#5-+L+N2X1XXKIKC*1@YV.P*[@Z@C[N<D=1GCN** ,?3K;4M-ET_3%6&;3
M+>Q6-[IY#YS2KA1\N,8(!).>M;%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %,F,HA<P*C2X^4.Q52?<@'^5/ILDL<,;22N
MJ1J,LS'  ]S0!A>"]<N?$GA"PU>[BBBN+D.62+.U<.R@#//0"F>&==OM8OM>
MMKZ"WB.G7_V:,0L6ROEH^23U/S>@K-^%$L<GPWTI4=69!(' /*GS'.#Z4WP-
M<P3>(?&0BFC<MJP=0K Y7R8AD>V01GU% ';452TO5K'6K1KK3Y_.A65X2VTK
M\Z,588('0@U=H **** "N4\2Z[JNF>)O#VEV+60CU:6:)GG@9S&4C+Y&'7.<
M8KJZ\Y^(,UA_PF_@F.]NDBA2YN6F8SF/8IA(!+ @J"<#.10!V%M/J5K=S_VI
M=Z=)9I$'\V*,PF-L\APSMP1R#QT-6(=:TJYN#;P:G9RSB(3&-)U9O+(R'P#G
M;@CGIS7&ZE<>&XM#\2VFFWD=Y]IL);BX/VCSTC(CV+EB3@DXPN>QK(TPZ=;7
M_P +6@-M&YLY5E*8!.;8 AOJX[]_>@#L%\6Z?K>@:C=:)K6GP26[O&MS<L&C
M0JV-[#</E)!P<\]:V;K6-,L"5OM2L[=T02.)9E3"Y W8)X&2!GW%>27T]H?A
M!XRT^7;]K@O[S=$Z_,C-<,4Z]R#D>HKI)H=&U/XO6Z7$=C=1S>'R-LBJZNQE
M7 P>"=N?PS0!W,NK:;!>1V<VH6L=U+@1PO,H=\],+G)JY7D$<^E7CZSX7\2W
M6HQZDVJ2SPV448#7(,F^!XG"9X 49W?*%YP*]0UK5[70M'NM2O'"PV\9<C/+
M$#A1ZD] * ,23QBL?Q#A\-/!BWF@<)='HURH5S%^$;!OQKI+FZM[.+S;J>*"
M/(7=*X49/09->8^*=#U6V\"1ZRNJ6,EYIDXUB-DAQOFR7=1)O.00S*!CD;15
MSQ)XGTN5_!GBF._BCMA-*VR<L(OG@(8.P!V.O0 CJ2..2 #NAK.EM;_:!J5F
M8,@>8)UVY/3G..>U(=<TD6CW9U2R^S)(8FF^T+L5QU4G.,CTKR/5$\/M\-M;
MN;74=,O9;W7(KN3[,X;R=]S&WE@D!N$#'.!U8XQ72>)+JP\+^+M(OY9#IF@3
MVLT?VNSA3RX[AV0[G^4@;E7&[';KC- '>OJ=A'8K?/>VRV; %9S*HC(/0ALX
MIJZMIKV]O<+J%J8;E@L$@F7;*3V4Y^8_2O,+B73?"\GAR_M;C4;;PMYMYNO#
M&&$4LNPI)M9#M0D2 ':/O9'!Y;JMIX>AT_P])8,TMG=^*([GS;K&)0RMYCH"
M!B,M[ 9YZ$4 >D_\))H0LVO/[:T[[*LGE&;[4FP/_=W9QGVJU>:E8Z?;BXO;
MVWMH3TDFE5%/?J37F[1:0?$WQ'WI9X^PP8W!<9\EP^/Q"@^^,UG:=KD.D'PI
M>:QJ-Q9Z3<>'(+6.\1%=$N%YD1R5;:6&WTSLQVH ]8DU73HA$9+^U03(9(RT
MRC>H&XL.>0!SGTK.U/Q?H>EZ-#JLFI6TEI/*L,,D4RLLK,VW"D'!QW] #Z5P
MB:;H-CXB\ 6=I$?L*&^,(O!ERA4E"0PR%+<J"/2LZXEMD\(^)FA:/[/;>+HY
MV\OE8XO.A); Z+]XYZ=: /989HKB%)H)$EB<;E=&#*P]01UI]9UMKNF7>IC3
M8+G?=FV%V(]C#,1;:&R1C!(]??I6C0!PFI:]XKTO4/#UG/)I"RZQ.T+*+20_
M9R$+]?-^?ICM4^H:YXATC5]#M=0DTWR+S47MY)(H67=$(6D##+G;RI!!STZU
M4\=W=O#XS\#B2>-"FH2.^Y@-JF)@"?09(%3>.VM'\1>#(;HPLAU1F9)",8\F
M0 D'MD@?4B@#HKW5K>Z\.W5]I.LZ:@",([V219($8?WB& X^M6KC5;#3XX_M
M^HVD#,NX&658PWJ1D]*\FUE[$^&/BE;H8-ANM\,:XP7,$8RH]2P(X[@UJ^*K
MGRKB?4=)U:R:X_L>(76E7H!AU"WS)@1L#N#\N.,_>7(YH ]+N1<-;.+22*.<
MCY&E0NH/N 03^=<EX$\;OXKL9;:^@2QURW17EM\':T;#*2IDY*$$=^#QZ5U4
M%T#IL-W<I]E#1+(Z2MCRLC)!/MTKSU= DUKP7X=U_P .7$4?B'2[.,6\@/RS
M *-]O)_LGWZ'GCF@#L=%U6>;19+[5I[2,)/-&713$BA)6C!)9CUVYZ]Z??\
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MYF+G:>.5_>-[\]> * */]M>*WL/%MC:7%I<ZOHLR&WD^S86X1HEDV%-W#<D
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M-@*20!T!YQFMGP9=RQZ[J.F:EH_]EZM';0O)';R[[6>,,X$L?H22001G@=:
M.WHKSSQW]NM]0O+\6:ZMI,>GA;NUBF\NZLAF0F>'/!)&<\@_NQ@U!'IMEXI\
M?:O;7-U?OIT^D6ES'"MW+& 7,GS !AC@#CIGDC.* /2J*\=\.ZO?WL'A;2-;
MU"(V]S:W@AFOD+K>/',$CW?,NX^7R,DYSGDX(TX7&C:OX;\.7^MG4=)GN+Q3
M+)E4:10IC@9BQW*NYP 2<E0.JXH ]$U">\MX8FL;(7<C3(CH9A'M0G#/D@YP
M.<=ZSM5UZ:UU0:3IMDE[J1M'O!#)/Y*[%8*!NVM\Q)P.,<')'?DO$=E!I/A^
MRAT[5;V:.+Q);#YKAL1!YD)A&,!D4' !SCIVJ[)IMG)\:@[19;^P_.SN/WQ<
M  ]: .JT2^U'4+ SZGI)TR8N0D#3K*VS P25X!Y/'.,=:TJ\B75YM*T+41+>
M7"V+^,7L[J=YF+16Q8 @N3D+PJDYX!-;^NV^CZ)8:LL&JWT4=]-:#[':2J%B
M9G"A4[(),8;GIDT =?K6HMI&AWVHI;FX-K \WE!]NX*"2,]N!6,GB]FN/"D?
M]GD)K\9??YW^H(A,N,8^;IC/']*Y:&66$_$G3W,,,,-BCQVL$A:*%GMGW!<@
M8SM!. .>U31_Z[X4_P#7)O\ TA:@#TNBO,Y$ET/Q!K'A)3,RZ^5N--F9F8QJ
MV%G4,>GE@&11_M5W.L0>5X8O[>VNQI^VSD2.YR?W'R$!_7CK^% &G2,RHI9F
M"JHR23@ 5Y'=ZYJ&@Z1X@@N=*;2=;M[&!Y'LY#);2P>;L>>/&"K ,Q.<-P.>
M*T]0T6T^Q:O>0:U:W%G>Z)-G3[6-A%-M&1/GS&YY )[YYS0!Z):74-]9P7=M
M()()XUEC<=&5AD'\C6%J'B6[34-0LM'TK^TI].6%KJ/[0(F_>9("9!#,%&<$
MJ.1S2^!(((/ NAB *-UA;N^#GYC$N37'F/\ LG7_ (DZEIEMNO[*VAEM@"6P
MYMB>G?GM0!ZE2,P52S$  9)/:O-9O]%L? NL:+/*]SJ%U;P73"0L;N&2-FD:
M3GYF7;NR>1@U3TS0;34M"\77E[+>7,MEJ&IPP"6[D953:1M*[L,/][)X'H*
M.VO?%4=O?>'8[:W%S::W)LBN1)M"#RVD!QC)R%]NM=#7DD%C:OH7POMXRR+-
M)&TOE2%6)-DV>0<C/MCVKJ/ B_9-2\5:9&\AM+/5-MO')(S^6K0QL5!))QN)
M./>@#8M_$#3>,KSP^]F8_L]G'=K/YF=X=F7&W''*GO6W7GU]I-KK/Q5U6UO/
M-: Z#!E(Y6CR?.EZE2"<?E^0K"T#6KG4M.\#Z?JM]"L%]I,K[[Q6D2YG5D4*
MWS+E@FXC).2<X)P0 >O45Y5>:2UD_A33#K]W?PG6Y;=I(YI(P(C%(WE??.[:
M?EW9R.F015AK"WN?$>K>$7OX[2WL["'[ EV9)'",&+2QL9%.X-QNY(VCH* /
M0II[Q-3MH(K(26<B.9KGS@#$PQM&S&6W9/.>,>]6Z\[A26'QGX+A;5KC4%DT
MR[22XWLJW&P1A9-N< G).X=<YS7-QP-!X*765O+UK^T\2&*&5[J1ML9O?+*D
M$X(*D@YR3^ H ]HHJ-9XGFDB25&ECQO0,"5STR.V:DH **** "BBB@ HHHH
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M1B<1Z-8H)X1;R[8%&^,?P'CD>U/'AW1A]BQIMM_H(Q:?NQ^X_P!S^[^%:=%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *R=<\2Z3X<BCDU2Z,7F9V(D3RNP'4[4!.!D9.,#(K6JI>S6NGQRZA,GSA F
M57+OS\J*.Y). .Y- !IFIV6LZ=!J&G7,=S:3KNCEC.0P_P \8[5;K \&Z&^@
M>'Q;2JJ3SSRW4L2'*Q-(Y?8OLN0OX9K?H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "L#7O"RZ]>VMTVLZK9-; ^6EE,B*">"W*D[L<9STSCJ<[
M]% &;HNCKHUH\'VZ^OF>0R-->R^9(3@#&<   #H!6E110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>89
<FILENAME>exhibit1062-securedpromi003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1062-securedpromi003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[OM,NYT6X8E(]\<+<XY;&>G&?45;M/'NH+&^EZC9VL>OIJR:7B(L8&+IY@E
M/S;=F3MSG( R,Y !W]%<>WB'6X]=U3P[Y5E+JL5@-0L)5C98ITW;2C+N)5@V
M!G<>&!QQBI=$\47&N:5H%W UNK7D+SWJF)OW2H,.!\W#"0A><]SVQ0!U=%</
M8>+]9U,Z+?V6FFXTS49%$D:VLB/;Q."5E,I.Q@.-P [\$XS7<4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% #9(HYHVCE171AAE89!'N*=THHH ****
M"LZ]T/3]1U*RU"ZBD:ZL2S6[K,Z>66&"<*0#D$CD=*T:* "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,NX\.Z1=Z[;ZW<64<FHV\?
MEQ3,2=BY)X&<9R3SC/-:E%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6-XKT)_$WAJ]T9;L6JW:>6\IB\P
MA>^!D<ULT4 <]J/AVZU'4M!OGU&))-)E:4@6QQ,60H?X_EX8^O/Y5'I7AB[T
MRSU^%=5!DU6YFNEECM]C6\DBA<CYCG& 1TKI:* .3?P2EY>ZE?7]S"UW?Z8^
MFRR6EMY.Y6ZNP+-N;ICT&:VM TVXTC1+73[F]%X]O&L0E$0C!50 /ER>P]3S
MGZ#2HH YZ;PA87'B:\UF8LXO+,6LUL?N,1N&\_[6QBGT)]:JCP2L7P[D\(P7
M[A9+9K>2[ECWLP88)QD<XX'/  ]*ZNB@#F]:\,W.L:!I^FMJ,<3VD\$[3"V)
M#F)@RC;OX!*C/)I?^$6<>)-4U0:B5@U.VC@NK80C)**RAE?/ PYXQU Y[5T=
M% '"_P#"OKV/1=#@MO$4D&J:(/+LKY;5=HB*A#&\9;Y@0HSSU&1BM"_\)WVH
MV&G17.M^;=6NH1:A+.]L,2/'C:JH& 1>!QDGWR2:ZJB@##TW0)K#Q3J^M/>I
M*-22%#"("OE^4&"X;<<YW'/'I5/5O"5QJ'B"YU.WU=K:.[T_[!<0F 2';EB&
M1B?D/S'/!!_6NHHH XZV\%75G;^&F@UA6O-"MWMHY);7,<L;(J$% P(.$7!W
M=<]:?>> [>\L7)O735FU!=3%^L8^6X4!5PF?N!1MVYZ=\\UUU% &-8:&\.MS
M:U?W$=SJ$ELMJK10F)(X@Q; 4LQR6.22>PZ8YCT+PO::#>ZO<0.SKJ-R9_+;
M[L0(R57V+EV_X%[5NT4 <?X?\%ZAX?D2SB\1SRZ#!)YEO8-;J'C&=P0S9R4!
M[8![9QP>CTZVOK8W9O=0^V"6X:2 >2(_)B.-L?'WL<_,>3FKM% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 45S_C77[CPMX3OM;M[>*X-HH=H9&*[P
M6 X(SCKZ5R,OQ3O=-L_"^HZKH\ T[7]H1[:X+20,V/O*5&X<]CV/X@'IU%<?
M?>-C+XY3PAHMM'<ZBD/GWD\KE8K5.,9 &68[EXX^\.:(?&K6GCA?".M6\5O>
MW$/GV-S"Q,5PO.00>48;3QDYQUY% '845Y[H_CK7-;\5^(= M-+L!/HYQODN
M'59LD@=%.WI[U/X>^(P\3^ M3\0V5@(+K31+Y]I,^Y=R)OP' Z$8YQ^% '=T
M5Y;%\4]5_P"%<0^-Y=$M'T\R[)H$NF$J+YGE[AE,-SCCCK70>(_B+IVA^'M)
MU*""6\N-9\L:=:*0C3%P",DYV@;ER>>HH [*BN*\1^,M1\%6MCJ&OV=M)IL\
MRP7$MF[;K5F!P<,/G7@\C!]JKZW\0+G1?'NA:'+96S:9K('V?4?-/4\;=N,$
MY*\Y_C% '>T5P<7CR^C^*G_"%ZA86T"R0&>VNED8^>N,X"XX/#=S]TU?UOQ/
MJ.E:+XBU6.UM98-*8^4"[ SA5#/SCC!.WORIZ4 =;17!Z/XQ\0:SX6T[7;;2
M]/9;M?--J+E_-6(.%=A\N&(R#CBEUGQQJ6G?$S3/!\%A:2'4+=KB.YDE9=@
MD."H!S_J^N>] '=T5QOAGQR^L>+M8\+:AIZVFJ:8!(3%-YD4L9Q\P)4$'YEX
M([UUT-Q!<;_)FCD\MRC[&!VL.H..A]J )**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:2">&YA6:"5)8FY5XV#*?H1574]'L=9CBBU&W2YMXW\SR)0&C=L8!93PV,Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW/?H: "BBB@ HHK*\0RWL&G0R6#[9OMMJI!QAD:=%<<^JEJ -6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT$;3_O\ K_C1_:^F?]!&T_[_ *_XT 45A\30@,;[2KO P8_LDD&[WW^8^/\
MODUJ6@N1;K]L:)I^2WE*0HYX R23@8&>_7 Z5#_:^F?]!&T_[_K_ (T?VOIG
M_01M/^_Z_P"- %RBJ?\ :^F?]!&T_P"_Z_XT?VOIG_01M/\ O^O^- %RBJ?]
MKZ9_T$;3_O\ K_C1_:^F?]!&T_[_ *_XT 7**I_VOIG_ $$;3_O^O^-']KZ9
M_P!!&T_[_K_C0!<HJG_:^F?]!&T_[_K_ (T?VOIG_01M/^_Z_P"- %RBJ?\
M:^F?]!&T_P"_Z_XT?VOIG_01M/\ O^O^- %RBJ?]KZ9_T$;3_O\ K_C1_:^F
M?]!&T_[_ *_XT 7**I_VOIG_ $$;3_O^O^-']KZ9_P!!&T_[_K_C0!<HJG_:
M^F?]!&T_[_K_ (T?VOIG_01M/^_Z_P"- %RBJ?\ :^F?]!&T_P"_Z_XT?VOI
MG_01M/\ O^O^- %RBJ?]KZ9_T$;3_O\ K_C1_:^F?]!&T_[_ *_XT 7**I_V
MOIG_ $$;3_O^O^-']KZ9_P!!&T_[_K_C0!<HJG_:^F?]!&T_[_K_ (T?VOIG
M_01M/^_Z_P"- %RBJ?\ :^F?]!&T_P"_Z_XT?VOIG_01M/\ O^O^- %RBJ?]
MKZ9_T$;3_O\ K_C1_:^F?]!&T_[_ *_XT 7**I_VOIG_ $$;3_O^O^-']KZ9
M_P!!&T_[_K_C0!<HJG_:^F?]!&T_[_K_ (T?VOIG_01M/^_Z_P"- %RBJ?\
M:^F?]!&T_P"_Z_XTZ+4K">18XKVVDD;HJ2J2?PS0!:HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **#G!QU[5Q&G^-KJW\=7GAG7HH(U:41Z??0QLD<[^6CM$P+-AP'
M7'.#0!V]%8UI?WK>(-4MKF:U%E:QQ2(5B97 ;=G<Q8CC;Z"KEKK.EWJ3/:ZE
M:3K" TIBG5@@(R"<'@8H NT5FQ>(=%FN(K>+5[!YY8S+'&MRA9T'\0&<D<'G
MVJ:RU?3=1M'N['4+2ZMHR0\T$RNBD=02#@8H N452MM8TN]AGFM=1M)XK?\
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M.IP<'D<=:Y:T\1:EK>LZY9:5<:;!)I4_D?9;J)VEE.T-O)#C8A)P#M;H3[4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH/'S9[8+M*:WFT*[@&MRZ7>P>*;J2TO)H $60^85\U6"KM92W''+#IQ7L5%
M'->!KZ[O]!E>]M+:"X2[F1Y+0DPW!#$F6//.UB2?KFN7\367A3Q#=7E_-J8\
M/^(].DDACOXYO)E.TX4X./-4C P,]US7IM&!Z4 <OX9\0SG0?#D'B-C;Z[J<
M!(A,1!=D7<Q( PIVX)!QR<51^+<B+\+]<C+ /+"%C7/+'>O '<UVU% '.P>,
M-",%E!;:G:W5S.8XHX()0[EC@<@<@#J2>@!KSFZUBQG_ +*DAS9+;>+-\]BL
M;N\)+R!I)6.2"Y.0!@8; SBO:** /'KV+2WTGXJ8CM2S%_*^5<D_9DQM_P"!
MCM_$/6M>%["'QEX >U:W0R:==+(T9 W92(@''JP;&>IS7I5% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M='M9+*\TZ>9 )HWVG=&YRH(* \]1FNUMI=9L])BEBT*U6XGNDWV45PJ"WB.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+%&CEUC16/4A0":?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "H8;6&"262-,/*VYV))+'Z
MGL.PZ"IJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
8@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>90
<FILENAME>exhibit1062-securedpromi004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1062-securedpromi004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[OM,NYT6X8E(]\<+<XY;&>G&?45;M/'NH+&^EZC9VL>OIJR:7B(L8&+IY@E
M/S;=F3MSG( R,Y !W]%<>WB'6X]=U3P[Y5E+JL5@-0L)5C98ITW;2C+N)5@V
M!G<>&!QQBI=$\47&N:5H%W UNK7D+SWJF)OW2H,.!\W#"0A><]SVQ0!U=%</
M8>+]9U,Z+?V6FFXTS49%$D:VLB/;Q."5E,I.Q@.-P [\$XS7<4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% #9(HYHVCE171AAE89!'N*=THHH ****
M"LZ]T/3]1U*RU"ZBD:ZL2S6[K,Z>66&"<*0#D$CD=*T:* "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,NX\.Z1=Z[;ZW<64<FHV\?
MEQ3,2=BY)X&<9R3SC/-:E%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:UISVUN0LTRW2%(R>S'.!^->4>*+FXM?VD-&N+.R>^G72'9((W53(=L_&6(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@&0,1SN.XJ"!D*W/ S8TWQ];ZC;BY>QEM(%NYK>;[0PW1K'"9MQ SC(QQU%
M'853L-3M=2>\6U<O]DN#;2G'&\!20/IN ^N:K6^OVDWAV/6Y%EM[=H]Y29<2
M*<XVD GYL\8&<GI7#^'==DT#X=#6EL9+G4M9U*66*U4C,DCR-SG. -B%SSC
M/- 'IM%<KI/CFQU2;3XA#*&U&YGBMBHR-D:E@[?W=P' ]:Z'4K>:[TN[MK:<
MV\\L+QQS#K&Q4@-^!YH LT5Q5G+H&F^&[N]CT.WMKVUB%O?6L2!9D9L J7')
M!SD-GD<U)I_Q%T6YU9]*V30R1SQVJ$KD,[,Z@<= -@Y/]\#K0!V-%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#0:TO_ ,%;_P#Q^C['XG_Z#6E_^"M__C] &W16)]C\3_\ 0:TO_P %;_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#5!);OYS0K$^X,D*-N)958X R?3M6_+X;T.;21I4FCV#:<#N%J;=/+!]0N,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD9@JEF("@9))X KDK;Q=J3QZ[;3:&)-5TJ:&/[-:7!D242A2C!BH( #$M\O
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M78Z6DJ6-I#;K*_F2"-0-[8 R?4X 'X4 6Z*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*/\ A$])_P"G_P#\&5Q_\<H VZ*Q/^$3TG_I_P#_  97'_QRC_A$])_Z?_\
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M$%QI4\\.U?M448E <\=?D ],@G%>G:99'3=-@LVN[F[,2[?/NG#R/[L0!DT
M6Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#64C;WMSH3;&;.=Q7S\9SWKKJ* ..'@VY$,L0C\*^5,%$B?V </M "Y'G\X
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MMW+%&2>I"JP"Y[[<4DO@W0);?3(!8^2FF9^Q_9YGB,0888!D8'![@GGO6[D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"FQ9-I)*ALD@$YQ@]Z[&XL[:[""YMX9@AW+YB!MI]1FI6574JP#*1@@C((H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ,35M2OH-=TG3;)K>,7B3L\DT328V!2  &7
MKN-45\07^HZGK-GIC6*W.F/L%G<!O-F^0,&R&&U26P#M;IGVJ;5O^1Y\.?\
M7&\_]!CK%\3Z;8ZT+N>;3M2M-<LV=;&^LK>3S'Q]PAU&"">"&([]!S0!U45]
M))JEM;M=6:%K4RRVA_U^[*_,!GA1D@Y'4CFI?[;TKSA"=2M!*20$,R@D@X('
M///'UKF[6#4?^$LT2?4H93.NB20W<\<9\L3,T1(W 8'W6-8?AF6V5O#:7T6I
M0)IJ/%:M+IT@60R *@>0 ITP..&;!SVH [Z'7M'N;B&W@U6REFG#&*-)U9I-
MI(.T \X(/Y'TJ5=5T][S[&M];FYRP\H2C=E>HQZCOZ5Y_96%Q#H&@I_9MVDT
M7B"2XE'V5PRQF24ASQTVLO/O[4Z)+^35]%F.D7UO]EUFY::".V(BB5UF <-_
M'N+ EL[1GM0!V%AXJT745D:'4;8*ER;8;Y54NX.W !/<Y ]<<5<EUC2X!.9=
M1M$%NP2;=,H\MCT#<\$^AKA)K.^C\.ZE#_9UXTEMXB^W%5A),D/VH2;H_P"_
M\O/&?3K4.NP7>HV_C)HM*U!EODL_LP:U?,NT#.!C/'H<$=\4 =\=>T@6S7/]
MJ6?D*[1M)YZ[0R_>&<]1W]*NK()H!)!(C*Z[D<?,I!Z'@\BN-UM#I_B6UOSI
M>H7&E7%FT##3T</#(6#99$PV&& >."HS71Z+:6^F:#;6UO:26EO#'^[MV8R-
M&N20#R23CMD^@S0!R<'CC5(=!M=<O;:TDLY;\V4L4 99$_>F,.,DAN1G;QUZ
MUV8U33S>BR%[;FZ)*B'S!NR!DC'J!SCTKDO ^@V[Z'"^IZ?<"ZM[V>>..[60
M*A:5V1U1OES@@Y R,UGRI?RZGI\G]D7T/V;Q!)+)##;'RPA64"7=CYRVX$D'
M S@X[@'=SZSIEK*8KC4;6%PVTK),JX.,XY/7'./2G2ZII\-W':RWMNEQ(0J1
M-* S$\@ >IKSMY+:.[N[6]CU*/3H=<?4/M T^25<J^2/,4%0NX'GLO!]1>2S
MWZIJ6DZOHNJ7;S:B;NUGB>06SJ6#(6=6 0I@ YYPHQGI0!V&LZU8Z#8B[OYE
MCC:1(ER<;F8@ ?K^ J2?6-,MEC:?4+6-9%#(7F4!E/0CGH?6LKQQ;SW/AEA;
M02SO'=6TQCB0LQ5)T9L <G !.!64R7$>J>)UOM/NY[?5K>-K3; S[E\K88FP
M#L(;)^; ^8GUH [*ZG%M:37!1G$4;/M09+8&<#WKG-$UW4M9L=+U.W?3[FRO
M&'G) &W6P*DX+;B&(.%/"^N.U7](M[[1_!MG;S?Z1?VEBJL/O;Y%3I[\C%<L
MVD1+XCTS5O#=E?Z9?3W*'4K<P/' \/)DW@C86'8J>2>_4 ';_P!J6 OA8_;;
M?[6V0(?,&\D#)&.O3FC^U=/%Y]D-];?:>?W7FC=P,GC/8<FN)T6SW7$&EZOH
MNJ2:A9:@]S'<EY!;-^\9A,&#;<[6/R]2<C'6K/A83);66CZIH=TVI:=<2/\
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M1110 UUWQLA+#<",J<$?0U3TW2K72EN1;>86N9C/*TDA=F?:JYR?91^57J*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
4@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385147392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Feb. 22, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Astrana Health, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4472349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1668 S. Garfield Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alhambra<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">282-0288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASTH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,423,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s definitive Proxy Statement for the 2024 annual meeting of the stockholders of the registrant are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. Such Proxy Statement will be filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) within 120 days of the registrant&#8217;s fiscal year ended December&#160;31, 2023.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001083446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387465696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Los Angeles, California<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696382136352">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 293,807<span></span>
</td>
<td class="nump">$ 288,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,498<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,657<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,335<span></span>
</td>
<td class="nump">1,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,450<span></span>
</td>
<td class="nump">14,798<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">461,507<span></span>
</td>
<td class="nump">428,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Land, property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,171<span></span>
</td>
<td class="nump">108,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,648<span></span>
</td>
<td class="nump">76,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">278,831<span></span>
</td>
<td class="nump">269,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,943<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loans receivable, non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26,473<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,774<span></span>
</td>
<td class="nump">40,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue', window );">Investments in privately held entities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,396<span></span>
</td>
<td class="nump">2,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">345<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">37,396<span></span>
</td>
<td class="nump">20,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,877<span></span>
</td>
<td class="nump">4,556<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">471,854<span></span>
</td>
<td class="nump">538,088<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">933,361<span></span>
</td>
<td class="nump">966,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">59,949<span></span>
</td>
<td class="nump">49,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,737<span></span>
</td>
<td class="nump">8,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">106,657<span></span>
</td>
<td class="nump">81,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">638<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">646<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,607<span></span>
</td>
<td class="nump">3,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,500<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,940<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">218,674<span></span>
</td>
<td class="nump">148,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,072<span></span>
</td>
<td class="nump">14,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">36,289<span></span>
</td>
<td class="nump">19,915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion and deferred financing costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">258,939<span></span>
</td>
<td class="nump">203,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,586<span></span>
</td>
<td class="nump">20,260<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">303,919<span></span>
</td>
<td class="nump">259,056<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">522,593<span></span>
</td>
<td class="nump">407,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 14)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_MezzanineEquityAbstract', window );"><strong>Mezzanine (deficit) equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (&#8220;APC&#8221;)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(205,883)<span></span>
</td>
<td class="nump">14,237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001; 100,000,000 shares authorized, 46,843,743 and 46,575,699 shares outstanding, excluding 10,584,340 and 10,299,259 treasury shares, at December&#160;31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">371,037<span></span>
</td>
<td class="nump">360,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">243,134<span></span>
</td>
<td class="nump">182,417<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity attributable to parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">614,218<span></span>
</td>
<td class="nump">542,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,433<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">616,651<span></span>
</td>
<td class="nump">544,310<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, mezzanine equity (deficit), and stockholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">933,361<span></span>
</td>
<td class="nump">966,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76,780<span></span>
</td>
<td class="nump">49,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">996<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58,980<span></span>
</td>
<td class="nump">65,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,125<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company&#8217;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling $540.8&#160;million and $579.8&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $146.0&#160;million and $149.6&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively. These VIE balances do not include $273.2&#160;million of investment in affiliates and $107.3&#160;million of amounts due to affiliates as of December&#160;31, 2023 and $304.8&#160;million of investment in affiliates and $11.6&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; for further detail.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FiduciaryAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FiduciaryAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of Investment in privately held entity that does not report net asset value per share .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_MezzanineEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_MezzanineEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity (Deficit), Carrying Amount, Including Portion Attributable to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387325792">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,843,743<span></span>
</td>
<td class="nump">46,575,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,584,340<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 933,361<span></span>
</td>
<td class="nump">$ 966,213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">522,593<span></span>
</td>
<td class="nump">407,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">540,800<span></span>
</td>
<td class="nump">579,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">146,000<span></span>
</td>
<td class="nump">149,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">273,200<span></span>
</td>
<td class="nump">304,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Amount due to affiliate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 107,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Due from affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,111,111<span></span>
</td>
<td class="nump">1,111,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">555,555<span></span>
</td>
<td class="nump">555,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company&#8217;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling $540.8&#160;million and $579.8&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $146.0&#160;million and $149.6&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively. These VIE balances do not include $273.2&#160;million of investment in affiliates and $107.3&#160;million of amounts due to affiliates as of December&#160;31, 2023 and $304.8&#160;million of investment in affiliates and $11.6&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; for further detail.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385512000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,386,661<span></span>
</td>
<td class="nump">$ 1,144,163<span></span>
</td>
<td class="nump">$ 773,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services, excluding depreciation and amortization</a></td>
<td class="nump">1,171,703<span></span>
</td>
<td class="nump">944,685<span></span>
</td>
<td class="nump">596,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">112,597<span></span>
</td>
<td class="nump">77,670<span></span>
</td>
<td class="nump">62,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">17,748<span></span>
</td>
<td class="nump">17,543<span></span>
</td>
<td class="nump">17,517<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">1,302,048<span></span>
</td>
<td class="nump">1,039,898<span></span>
</td>
<td class="nump">675,736<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">84,613<span></span>
</td>
<td class="nump">104,265<span></span>
</td>
<td class="nump">98,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (loss) from equity method investments</a></td>
<td class="nump">5,579<span></span>
</td>
<td class="nump">5,622<span></span>
</td>
<td class="num">(4,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on sale of equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(16,102)<span></span>
</td>
<td class="num">(7,920)<span></span>
</td>
<td class="num">(5,394)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">14,208<span></span>
</td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">1,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on investments</a></td>
<td class="num">(4,581)<span></span>
</td>
<td class="num">(21,271)<span></span>
</td>
<td class="num">(10,745)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="nump">6,121<span></span>
</td>
<td class="nump">3,944<span></span>
</td>
<td class="num">(3,750)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">5,225<span></span>
</td>
<td class="num">(17,649)<span></span>
</td>
<td class="num">(20,431)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">89,838<span></span>
</td>
<td class="nump">86,616<span></span>
</td>
<td class="nump">77,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">31,989<span></span>
</td>
<td class="nump">40,875<span></span>
</td>
<td class="nump">31,693<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">57,849<span></span>
</td>
<td class="nump">45,741<span></span>
</td>
<td class="nump">46,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (loss) income attributable to noncontrolling interests</a></td>
<td class="num">(2,868)<span></span>
</td>
<td class="nump">570<span></span>
</td>
<td class="num">(22,868)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Astrana Health, Inc.</a></td>
<td class="nump">$ 60,717<span></span>
</td>
<td class="nump">$ 45,171<span></span>
</td>
<td class="nump">$ 68,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share &#8211; basic (in dollars per share)</a></td>
<td class="nump">$ 1.30<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share &#8211; diluted (in dollars per share)</a></td>
<td class="nump">$ 1.29<span></span>
</td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="nump">$ 1.52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=asth_HealthCareCapitationRevenueMember', window );">Capitation, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,215,614<span></span>
</td>
<td class="nump">$ 930,131<span></span>
</td>
<td class="nump">$ 593,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Risk pool settlements and incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">63,468<span></span>
</td>
<td class="nump">117,254<span></span>
</td>
<td class="nump">111,627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember', window );">Management fee income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">38,677<span></span>
</td>
<td class="nump">41,094<span></span>
</td>
<td class="nump">35,959<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Fee-for-service, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">59,658<span></span>
</td>
<td class="nump">49,517<span></span>
</td>
<td class="nump">26,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 9,244<span></span>
</td>
<td class="nump">$ 6,167<span></span>
</td>
<td class="nump">$ 6,541<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=asth_HealthCareCapitationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=asth_HealthCareCapitationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696386846592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock&#160;Outstanding</div></th>
<th class="th"><div>Additional Paid-in&#160;Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
<th class="th">
<div>Noncontrolling Interest </div>
<div>Mezzanine</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, beginning balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,635)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">$ (75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (75)<span></span>
</td>
<td class="num">(1,546)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of non-controlling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Purchase of treasury shares</a></td>
<td class="num">(5,738)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,738)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,535<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,249,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning at Dec. 31, 2020</a></td>
<td class="nump">329,463<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">261,011<span></span>
</td>
<td class="nump">$ 68,323<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity', window );">Net (loss) income</a></td>
<td class="nump">71,690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,923<span></span>
</td>
<td class="nump">2,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="num">(1,546)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of non-controlling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest', window );">Sale of shares by noncontrolling interest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,638,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringPeriodValueNoncontrollingInterest', window );">Sale of shares by non-controlling interest</a></td>
<td class="nump">40,134<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">40,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">898,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants</a></td>
<td class="nump">9,061<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">9,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(174,158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Purchase of treasury shares</a></td>
<td class="num">(5,738)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,738)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">6,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Investment in non-controlling interest</a></td>
<td class="nump">3,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition of non-controlling interest</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Cancellation of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,707)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Cancellation of restricted stock awards</a></td>
<td class="num">(334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncontrollingInterestIncreaseFromCapitalCharge', window );">Non-controlling interest capital change</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares', window );">Dividends</a></td>
<td class="num">(1,156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,630,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at ending at Dec. 31, 2021</a></td>
<td class="nump">454,107<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">310,876<span></span>
</td>
<td class="nump">137,246<span></span>
</td>
<td class="nump">5,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">(4,338)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,338)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of non-controlling interest</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Share buy back</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(708)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TemporaryEquityTaxImpactOnAcquisition', window );">Tax impact of acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(448)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Purchase of treasury shares</a></td>
<td class="num">(9,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37,947)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity', window );">Net (loss) income</a></td>
<td class="nump">48,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,171<span></span>
</td>
<td class="nump">3,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">(4,338)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,338)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of non-controlling interest</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards</a></td>
<td class="num">(321)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(321)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants</a></td>
<td class="nump">8,633<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">8,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Purchase of treasury shares</a></td>
<td class="num">(9,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">16,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of shares for business acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of shares for business acquisition</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Investment in non-controlling interest</a></td>
<td class="nump">371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Cancellation of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,084)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures', window );">Cancellation of restricted stock awards</a></td>
<td class="num">(457)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(457)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AAMGEquityContingentConsideration', window );">AAMG stock contingent consideration (see Note 21)</a></td>
<td class="nump">5,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares', window );">Dividends (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">984,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares', window );">Dividends</a></td>
<td class="nump">$ 23,893<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">27,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,055)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending (in shares) at Dec. 31, 2022</a></td>
<td class="nump">46,575,699<span></span>
</td>
<td class="nump">46,575,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at ending at Dec. 31, 2022</a></td>
<td class="nump">$ 544,310<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">360,097<span></span>
</td>
<td class="nump">182,417<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,428)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of non-controlling interest</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Purchase of treasury shares</a></td>
<td class="num">(10,042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(210,873)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TemporaryEquityTransferOfCommonControlEntities', window );">Transfer of common control entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TaxImpactFromDividends', window );">Tax impact from dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,076)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TaxImpactFromInvestments', window );">Tax impact from investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(205,883)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity', window );">Net (loss) income</a></td>
<td class="nump">65,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,717<span></span>
</td>
<td class="nump">4,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of non-controlling interest</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards</a></td>
<td class="num">(933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants', window );">Shares issued for exercise of options and warrants</a></td>
<td class="nump">$ 1,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury shares (in shares)</a></td>
<td class="num">(3,451,642)<span></span>
</td>
<td class="num">(285,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Purchase of treasury shares</a></td>
<td class="num">$ (10,042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of shares for business acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of shares for business acquisition</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares', window );">Dividends</a></td>
<td class="num">(3,904)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,904)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockholdersEquityTransferOfCommonControlEntities', window );">Transfer of common control entities</a></td>
<td class="num">$ (2,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at ending (in shares) at Dec. 31, 2023</a></td>
<td class="nump">46,843,743<span></span>
</td>
<td class="nump">46,843,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at ending at Dec. 31, 2023</a></td>
<td class="nump">$ 616,651<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 371,037<span></span>
</td>
<td class="nump">$ 243,134<span></span>
</td>
<td class="nump">$ 2,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_AAMGEquityContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>AAMG Equity Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_AAMGEquityContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NoncontrollingInterestIncreaseFromCapitalCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase From Capital Charge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NoncontrollingInterestIncreaseFromCapitalCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_StockIssuedDuringPeriodSharesNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_StockIssuedDuringPeriodSharesNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_StockIssuedDuringPeriodValueNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_StockIssuedDuringPeriodValueNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents number of share issued exercise of option and warrants during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>It represents value of stock issued during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_StockholdersEquityTransferOfCommonControlEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity, Transfer Of Common Control Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_StockholdersEquityTransferOfCommonControlEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_TaxImpactFromDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Impact From Dividends</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_TaxImpactFromDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_TaxImpactFromInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Impact From Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_TaxImpactFromInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_TemporaryEquityTaxImpactOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Tax Impact on Acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_TemporaryEquityTaxImpactOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_TemporaryEquityTransferOfCommonControlEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Transfer Of Common Control Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_TemporaryEquityTransferOfCommonControlEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity during the period due to unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696381776080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 57,849<span></span>
</td>
<td class="nump">$ 45,741<span></span>
</td>
<td class="nump">$ 46,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">17,748<span></span>
</td>
<td class="nump">17,543<span></span>
</td>
<td class="nump">17,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance cost</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">939<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">22,040<span></span>
</td>
<td class="nump">16,101<span></span>
</td>
<td class="nump">6,745<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">7,183<span></span>
</td>
<td class="nump">3,759<span></span>
</td>
<td class="nump">3,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) loss from equity method investments, net</a></td>
<td class="num">(5,579)<span></span>
</td>
<td class="num">(5,622)<span></span>
</td>
<td class="nump">4,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_UnrealizedGainLossFromInvestmentInEquitySecurities', window );">Unrealized loss on investments</a></td>
<td class="nump">4,782<span></span>
</td>
<td class="nump">25,506<span></span>
</td>
<td class="nump">10,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized (gain) loss on interest rate swaps</a></td>
<td class="num">(201)<span></span>
</td>
<td class="num">(4,235)<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on sale or distribution of investments</a></td>
<td class="num">(1,246)<span></span>
</td>
<td class="num">(2,272)<span></span>
</td>
<td class="num">(2,193)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred tax</a></td>
<td class="num">(12,444)<span></span>
</td>
<td class="num">(14,278)<span></span>
</td>
<td class="nump">7,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GainLossOnConsolidationOfEquityMethodInvestment', window );">Loss (gain) on consolidation of equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">901<span></span>
</td>
<td class="num">(2,752)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GainLossOnEquityReceivable', window );">Gain on contingent equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,270)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Gain from investment in warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetImpairmentCharges', window );">Impairment of beneficial interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherOperatingActivities', window );">Other</a></td>
<td class="nump">422<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of acquisition amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Receivable, net</a></td>
<td class="num">(26,735)<span></span>
</td>
<td class="num">(38,194)<span></span>
</td>
<td class="num">(1,518)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties', window );">Receivable, net &#8211; related parties</a></td>
<td class="nump">6,167<span></span>
</td>
<td class="nump">4,229<span></span>
</td>
<td class="num">(20,116)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivable</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">8,196<span></span>
</td>
<td class="num">(5,351)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(2,956)<span></span>
</td>
<td class="nump">818<span></span>
</td>
<td class="nump">2,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">2,864<span></span>
</td>
<td class="num">(243)<span></span>
</td>
<td class="num">(1,529)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(170)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="nump">3,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Fiduciary accounts payable</a></td>
<td class="num">(328)<span></span>
</td>
<td class="num">(2,470)<span></span>
</td>
<td class="nump">892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_IncreaseDecreaseInMedicalLiabilities', window );">Medical liabilities</a></td>
<td class="nump">18,610<span></span>
</td>
<td class="nump">22,786<span></span>
</td>
<td class="nump">5,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable/receivable</a></td>
<td class="num">(14,477)<span></span>
</td>
<td class="nump">6,917<span></span>
</td>
<td class="num">(14,005)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(6,674)<span></span>
</td>
<td class="num">(3,945)<span></span>
</td>
<td class="num">(3,215)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">68,227<span></span>
</td>
<td class="nump">82,128<span></span>
</td>
<td class="nump">70,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for business and asset acquisition, net of cash acquired</a></td>
<td class="num">(6,512)<span></span>
</td>
<td class="num">(16,352)<span></span>
</td>
<td class="num">(2,585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties', window );">Proceeds from repayment of loans receivable - related parties</a></td>
<td class="nump">2,676<span></span>
</td>
<td class="nump">4,067<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(2,151)<span></span>
</td>
<td class="num">(1,854)<span></span>
</td>
<td class="num">(28,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of marketable securities</a></td>
<td class="nump">491<span></span>
</td>
<td class="nump">31,671<span></span>
</td>
<td class="nump">67,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Issuance of loans receivable</a></td>
<td class="num">(26,473)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment', window );">Purchases of investments &#8211;privately held</a></td>
<td class="num">(4,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(28,529)<span></span>
</td>
<td class="num">(22,940)<span></span>
</td>
<td class="num">(19,223)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchases of investments &#8211; equity method</a></td>
<td class="num">(325)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,622)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments', window );">Proceeds from sale of equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Distribution from investment - equity method</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PaymentsToEquityMethodInvestments', window );">Contribution to investment - equity method</a></td>
<td class="num">(700)<span></span>
</td>
<td class="num">(2,105)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity', window );">Cash recorded from consolidation of VIE</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,927<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(65,523)<span></span>
</td>
<td class="num">(7,113)<span></span>
</td>
<td class="nump">16,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(62,074)<span></span>
</td>
<td class="num">(14,030)<span></span>
</td>
<td class="num">(31,089)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayments on long-term debt</a></td>
<td class="num">(204,681)<span></span>
</td>
<td class="num">(3,865)<span></span>
</td>
<td class="num">(238,326)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Borrowings on long-term debt</a></td>
<td class="nump">284,527<span></span>
</td>
<td class="nump">3,598<span></span>
</td>
<td class="nump">180,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Payment of finance lease obligations</a></td>
<td class="num">(675)<span></span>
</td>
<td class="num">(561)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of stock options and warrants</a></td>
<td class="nump">1,522<span></span>
</td>
<td class="nump">8,633<span></span>
</td>
<td class="nump">9,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of shares</a></td>
<td class="num">(10,192)<span></span>
</td>
<td class="num">(9,250)<span></span>
</td>
<td class="num">(5,739)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Purchase of non-controlling interest</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(5,046)<span></span>
</td>
<td class="num">(1,471)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Proceeds from sale of noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts', window );">Cost of debt issuances</a></td>
<td class="num">(3,928)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration liabilities</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">3,421<span></span>
</td>
<td class="num">(20,085)<span></span>
</td>
<td class="num">(47,748)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">6,125<span></span>
</td>
<td class="nump">54,930<span></span>
</td>
<td class="nump">39,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, beginning of year</a></td>
<td class="nump">288,027<span></span>
</td>
<td class="nump">233,097<span></span>
</td>
<td class="nump">193,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of year</a></td>
<td class="nump">294,152<span></span>
</td>
<td class="nump">288,027<span></span>
</td>
<td class="nump">233,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">56,567<span></span>
</td>
<td class="nump">47,311<span></span>
</td>
<td class="nump">37,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">14,251<span></span>
</td>
<td class="nump">6,672<span></span>
</td>
<td class="nump">4,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">25,124<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TemporaryEquityDividendsImpact', window );">Tax impact from APC dividends to APC Shareholders</a></td>
<td class="nump">3,076<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet', window );">Distribution of real estate investments</a></td>
<td class="nump">152,767<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividend declared included in dividend payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_IssuanceOfFinancingObligationForBusinessCombination', window );">Issuance of financing obligation for business combinations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">12,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CashlessExerciseOfStockOptions', window );">Cashless exercise of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities', window );">Fixed asset obtained in exchange for finance lease liabilities</a></td>
<td class="nump">486<span></span>
</td>
<td class="nump">971<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued in business combination</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoanRelatedToPropertySales1', window );">Mortgage loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,275<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CancellationOfRestrictedStockAwards', window );">Cancellation of Restricted Stock Awards</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract', window );"><strong>Reconciliation of cash, cash equivalents, and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">293,807<span></span>
</td>
<td class="nump">288,027<span></span>
</td>
<td class="nump">233,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</a></td>
<td class="nump">$ 294,152<span></span>
</td>
<td class="nump">$ 288,027<span></span>
</td>
<td class="nump">$ 233,097<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_CancellationOfRestrictedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cancellation of Restricted Stock Awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_CancellationOfRestrictedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_CashlessExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cashless Exercise Of Stock Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_CashlessExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed Asset Obtained in Exchange for Finance Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_GainLossOnConsolidationOfEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Consolidation of Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_GainLossOnConsolidationOfEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_GainLossOnEquityReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Equity Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_GainLossOnEquityReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_IncreaseDecreaseInMedicalLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of medical liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_IncreaseDecreaseInMedicalLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_IssuanceOfFinancingObligationForBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Financing Obligation for Business Combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_IssuanceOfFinancingObligationForBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_PaymentsToEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_PaymentsToEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Cash Received from Consolidation of Variable Interest Entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_TemporaryEquityDividendsImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Dividends Impact</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_TemporaryEquityDividendsImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_UnrealizedGainLossFromInvestmentInEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized (Gain) Loss From Investment In Equity Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_UnrealizedGainLossFromInvestmentInEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480191/946-405-45-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoanRelatedToPropertySales1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage loan related to property sales in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoanRelatedToPropertySales1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentOfFinancingAndStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentOfFinancingAndStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow from the sale or purchase of and distributions from real estate partnership investment during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from operating activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480602/954-210-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-5<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385144816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Business</a></td>
<td class="text">Description of Business<div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 26, 2024, Apollo Medical Holdings, Inc. rebranded as Astrana Health, Inc (&#8220;Astrana&#8221;). Unless the context dictates otherwise, references in these notes to the financial statements, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar words are references to Astrana and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headquartered in Alhambra, California, Astrana is a leading provider-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. Together with Astrana&#8217;s affiliated physician groups and consolidated subsidiaries and VIEs, the Company provides value-based care enablement services and care delivery with its consolidated care partners to serve patients in California, Nevada, and Texas, the majority of whom are covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (&#8220;HMOs&#8221;), with a small portion of our revenue coming from non-insured patients. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company&#8217;s physician network consists of primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments changed from one to three in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#8217;s chief operating decision maker when reviewing the Company&#8217;s performance as well as an effort to provide additional transparency to investors and other financial statement users. The three segments identified by the Company are Care Partners, Care Delivery and Care Enablement, which are described as follows:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Partners</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners aligned on a shared vision for coordinated care delivery. By leveraging the Company&#8217;s unique care enablement platform and ability to recruit, empower, and incentivize physicians to effectively manage total cost of care, the Company is able to organize partnered providers into successful multi-payer risk-bearing organizations that take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare fee for service (&#8220;FFS&#8221;), Medicare Advantage, Medicaid, Commercial, and Exchange. Through the Company&#8217;s network of &#8220;independent practice associations&#8221; (&#8220;IPAs&#8221;), &#8220;accountable care organizations&#8221; (&#8220;ACOs&#8221;), and Restricted Knox-Keene licensed health plan, the Company&#8217;s healthcare delivery entities are responsible for coordinating and delivering high-quality care to the Company&#8217;s patients and ensuring continuity of care in Astrana&#8217;s ecosystem across age, stage of life, or life circumstance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the Company&#8217;s Accountable Care Organizations (&#8220;ACO&#8221;) began participating in the Next Generation Accountable Care Organization (&#8220;NGACO&#8221;) Model of CMS in January 2017. The NGACO Model was a Center for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) program that allowed provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participating in this new attribution-based risk-sharing model. With the termination of the NGACO Model on December 31, 2021, the Company&#8217;s ACO participated as a Direct Contracting Entity (&#8220;DCE&#8221;) in the standard track of CMS&#8217;s Global and Professional Direct Contracting (&#8220;GPDC&#8221;) Model for Performance Year 2022 (&#8220;PY22&#8221;), beginning January 1, 2022. CMS has since redesigned the GPDC Model in response to the current Administration&#8217;s health care priorities, including their commitment to advancing health equity, stakeholder feedback, and participant experience, and renamed the GPDC Model to ACO Realizing Equity, Access, and Community Health (&#8220;ACO REACH&#8221;) Model. The Company began participation in the ACO REACH Model on January 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Delivery</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. The Company&#8217;s care delivery organization includes primary care, multi-specialty care, and ancillary care services. This segment includes the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Primary care clinics, including post-acute care services; </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Multi-specialty care clinics and medical groups, including hospitalist, intensivist, and physician advisory services, cardiac care and diagnostic testing, and specialized care for women&#8217;s health; and</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ancillary service providers, such as urgent care centers, outpatient imaging centers, ambulatory surgery centers, and full-service labs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Care Enablement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Enablement segment is an integrated, end-to-end clinical, operational, financial, and administrative platform, powered by the Company&#8217;s proprietary technology suite, that enhances delivery of high-quality, value-based care to patients and leading to superior clinical and financial outcomes. The Company provides solutions to providers, including independent physicians, provider and medical groups, accountable care organizations, and payers, including health plans and other risk-bearing organizations. The Company&#8217;s platform meets providers and payers where they are, with a wide spectrum of solutions across the total cost of care risk spectrum, ranging from solutions for fee-for-service entities to full risk-bearing entities, and across patient types, including Medicare, Medicaid, Commercial, and Exchange patients. This segment includes the Company&#8217;s wholly owned subsidiaries which operate as management services organizations (&#8220;MSOs&#8221;), which enter into long-term management and/or administrative services agreements with Independent Practice Associations (&#8220;IPAs&#8221;), ACOs, or clinics. By leveraging the Company&#8217;s care enablement platform, providers and payers can improve their ability to deliver high-quality care to their patients and achieve better patient outcomes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Affiliates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other affiliates are not included as a reportable segment and primarily consist of the real estate operations and other entities that are individually immaterial. The real estate operations are deemed Excluded Assets that are solely for the benefit of Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (&#8220;APC&#8221;) and its shareholders. Excluded Assets means (i) assets received from the sale of shares of APC&#8217;s Series A Preferred equal to the Series A purchase price, (ii) the assets of APC that are not Healthcare Services Assets (as defined in the Series A Preferred purchase agreement), including APC&#8217;s equity interests in Astrana Health, Inc., and any entity that is primarily engaged in the business of owning, leasing, developing, or otherwise operating real estate, (iii) any assets acquired with the proceeds of the sale, assignment, or other disposition of any of the assets described in clauses (i) or (ii), and (iv) any proceeds of the assets described in clauses (i), (ii), and (iii). As such, any income pertaining to Excluded Assets have no impact on the Series A Preferred dividend payable by APC to Astrana Health Medical Corporation (&#8220;Astrana Medical&#8221;), formerly known as AP-AMH Medical Corporation, and consequently will not affect net income attributable to Astrana. APC and Astrana Medical are consolidated variable interest entities of the Company. See Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; to the consolidated financial statements for information on the Company&#8217;s entities that qualify as consolidated VIEs. </span></div>On December 26, 2023, APC completed a restructuring transaction to spin-off its real estate investments, a component of Excluded Assets (&#8220;the Spin-Off&#8221;). To effect the restructuring, APC contributed its real estate investments to a wholly owned subsidiary in exchange for 100% of the subsidiary&#8217;s membership interest units, which membership interests were then distributed to holders of APC&#8217;s outstanding common stock as a dividend, with each such stockholder receiving one membership interest unit for each share of outstanding APC common stock held. Dr. Thomas Lam, the Company&#8217;s Vice Chairman, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder of APC; Dr. Kenneth Sim, the Company&#8217;s Executive Chairman, is Chairman and a director and stockholder of APC; and Dr. Albert Young, the Company&#8217;s Chief Administrative Officer, is Senor Executive Vice President and a director and stockholder of APC. The Company leases certain properties that were spun-off and will continue to lease from these properties. After the distribution, the real estate investments became related parties since the chief executive officer of the real estate investments is also a board member of the Company. See Note 15 &#8211; &#8220;Related-Party Transactions&#8221; to the consolidated financial statements for information on related party transactions. The dividend was $190.3&#160;million and recorded at fair value of the investments&#8217; net assets on the date of distribution, December 26, 2023. The fair value of the dividend was measured using Level 3 inputs by applying market data of similar real estate comparables. The gain, representing the difference between the fair value and the carrying value of the net assets, was $5.3&#160;million and is presented within other income in the accompanying consolidated statement of income. As a result of the distribution, the real estate investments are no longer included within the consolidated financial statements after December 26, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391832336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared by management in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets as of December&#160;31, 2023 and 2022 and consolidated statements of income for the years ended December&#160;31, 2023, 2022 and 2021 include Astrana&#8217;s wholly owned subsidiaries and consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts disclosed in prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications were made between other assets and investments in privately held entities on the accompanying consolidated balance sheet as of December 31, 2022. The reclassification had no effect on net income, earnings per share, retained earnings, cash flows or total assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combinations and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including constraints, completion factors, and historical margins), income tax valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#8217;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#8217;s net assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A legal entity is determined to be a VIE if it has any of the following three characteristics:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity does not have sufficient equity to finance its activities without additional subordinated financial support;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:</span></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#8217;s economic performance, as evidenced by:</span></div><div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Substantive participating rights in day-to-day management of the entity&#8217;s activities; or</span></div><div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Substantive kick-out rights over the party responsible for significant decisions;</span></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb the entity&#8217;s expected losses; or</span></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The right to receive the entity&#8217;s expected residual returns.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company determines that any of the three characteristics of a VIE are met, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable interest model</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company &#8211; that is, the Company has:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power to direct the activities of a VIE that most significantly influence the VIE&#8217;s economic performance (power), and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; to the consolidated financial statements for information on the Company&#8217;s consolidated VIEs. If there are variable interests in a VIE but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting, refer to Note 6 &#8211; &#8220;Investments in Other Entities&#8221; for entities that qualify as VIEs but the Company is not the primary beneficiary.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as three reportable segments: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Delivery; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Enablement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 1 &#8212; &#8220;Description of Business&#8221; and Note 20 &#8212; &#8220;Segments&#8221; to the consolidated financial statements for information on the Company&#8217;s segments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company believes it is not exposed to any significant credit risk with respect to its cash, cash equivalents, and restricted cash. As of December&#160;31, 2023 and 2022, the Company&#8217;s deposit accounts with banks exceeded the FDIC&#8217;s insured limit by approximately $318.9 million and $324.7 million, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#8217;s concentration of risk exposure.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists of cash held as collateral in the event of default as required by certain health plan contracts.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase and such designation is reevaluated at each balance sheet date. Certificates of deposit in investments in marketable securities are reported at par value, plus accrued interest, with maturity dates greater than ninety days. Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, the Company classifies such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted-average share prices from observable market data.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables, Receivables &#8211; Related Parties, Other Receivables, Loan Receivable, and Loan Receivable - Related Party</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivables are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s loan receivable and loan receivable - related party consists of promissory notes that accrue interest per annum. As of December&#160;31, 2023, promissory notes are expected to be collected by their maturity date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation receivables relate to each health plan&#8217;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s hospital shared-risk pool receivable that is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately 18 months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#8220;FFS&#8221;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables, and the Company&#8217;s expectation is that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts. The consolidated statements of income present disaggregated revenue by service type. The following table presents disaggregated revenue generated by each payer type (in thousands):</span></div><div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,322</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633,463</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,286</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,093</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,083</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,311</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third parties</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,198</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,894</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,985</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386,661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144,163&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,915&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Less than 10% of total net revenues</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payers that contributed to the following percentages of net receivables and receivables - related parties:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer E</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Land, Property, and Equipment, Net</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land is carried at cost and is not depreciated as it is considered to have an indefinite useful life.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, including leasehold improvements, are carried at cost less accumulated depreciation and amortization. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets ranging from <span style="-sec-ix-hidden:f-642">three</span> to thirty-nine years. Leasehold improvements are amortized on a straight-line basis over the shorter of the terms of the respective leases or the expected useful lives of those improvements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maintenance and repairs are charged to expense as incurred. Upon sale or retirement, the asset cost and related accumulated depreciation and amortization are removed from the accounts, and any related gain or loss is included in the determination of consolidated net income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, long-term debt, and certain other liabilities. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 820&#8221;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This hierarchy prioritizes the inputs into three broad levels as follows:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#8217;s own data.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for these assets and liabilities for the years ended December&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Long-Lived Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives include network-payer relationships, management contracts, member relationships, subscriber relationships, and developed technology and are stated at cost, less accumulated amortization, and impairment losses. These intangible assets are amortized using the accelerated method based on the discounted cash flow rate or using the straight-line method.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives also include a patient management platform, as well as trade names and trademarks, whose valuations were determined using the cost to recreate method and the relief from royalty method, respectively. These assets are stated at cost, less accumulated amortization, and impairment losses, and are amortized using the straight-line method.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangibles and other long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may&#160;not be recoverable. If the expected future cash flows from the use of such assets (undiscounted and without interest charges) are less than the carrying value, a write-down would be recorded to reduce the carrying value of the asset to its estimated fair value. Fair value is determined based on appropriate valuation techniques. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> goodwill and indefinite-lived intangible assets are reviewed at least annually for impairment under a two step process. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Step 1&#8212;  Under a qualitative assessment, determine if there are indicators of impairment. If so, proceed to Step 2. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Step 2 &#8212; Under a quantitative assessment, if the fair value of each reporting unit is less than its carrying value, there is an impairment. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also elect to skip the qualitative testing and proceed directly to quantitative testing. The Company&#8217;s four reporting units consist of the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners &#8211; IPA;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners &#8211; ACO;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Delivery; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Enablement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An impairment loss is recognized if the carrying value of a reporting unit exceeds its fair value. If this event arises, the impairment loss recorded is equal to the excess of the carrying value of the reporting unit over its fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At least annually, indefinite-lived intangible assets are tested for impairment. Impairment for intangible assets with indefinite lives exists if the carrying value of the intangible asset exceeds its fair value. The fair values of indefinite-lived intangible assets are determined using valuation techniques based on estimates, judgments, and assumptions management believes are appropriate in the circumstances.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no impairment of its goodwill or indefinite-lived intangible assets during the years ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Other Entities &#8211; Equity Method</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for certain investments using the equity method of accounting when it is determined that the investment provides the Company with the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee&#8217;s board of directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize the Company&#8217;s share of net earnings or losses of the investee and is recognized in the accompanying consolidated statements of income under &#8220;Income (loss) from equity method investments&#8221; and also is adjusted by contributions to and distributions from the investee. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Privately Held Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for certain investments using the cost method of accounting when it is determined that the investment provides the Company with little or no influence over the investee. Under the cost method of accounting, the investment is measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. The investments in privately held entities that do not report net asset value are subject to qualitative assessment for indicators of impairments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Liabilities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Partners segment is responsible for integrated care that the associated physicians and contracted hospitals provide to their enrollees. The Company&#8217;s Care Partners segment provides integrated care to HMOs, Medicare, and Medi-Cal enrollees through a network of contracted providers under sub-capitation and direct patient service arrangements. Medical costs for professional and institutional services rendered by contracted providers are recorded as cost of services, excluding depreciation and amortization, in the accompanying consolidated statements of income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An estimate of amounts due to contracted physicians, hospitals, and other professional providers is included in medical liabilities in the accompanying consolidated balance sheets. Medical liabilities include claims reported as of the balance sheet date and estimated IBNR claims. Such estimates are developed using actuarial methods and are based on numerous variables, including the utilization of healthcare services, historical payment patterns, cost trends, product mix, seasonality, changes in membership, and other factors. The estimation methods and the resulting reserves are periodically reviewed and updated. Many of the medical contracts are complex in nature and may&#160;be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations may&#160;not come to light until a substantial period of time has passed following the contract implementation. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiduciary Cash and Payable</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Partner segment collects cash from health plans on behalf of their sub-IPAs and providers and passes the money through to them. The fiduciary cash balance of $7.7 million and $8.1 million as of December&#160;31, 2023 and 2022, respectively, is presented within prepaid expenses and other current assets and the related payable is presented as fiduciary payable in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives payments from the following sources for services rendered: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Commercial insurers;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal government under the Medicare program administered by CMS;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">State governments under Medicaid and other programs;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other third-party payers (e.g., hospitals and IPAs); and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Individual patients and clients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Capitation revenue;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk pool settlements and incentives;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">GPDC/ACO REACH capitation revenue;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management fee income; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FFS revenue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nature of Services and Revenue Streams</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH capitation revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. The following is a summary of the principal forms of the Company&#8217;s billing arrangements and how revenue is recognized for each.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitation, Net</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed care revenues of the Company consist primarily of capitated fees for medical services provided by the Company under a capitated arrangement directly made with various managed care providers, including HMOs. Capitation revenue is </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">typically prepaid monthly to the Company based on the number of enrollees selecting the Company as their healthcare provider. Capitation revenue is recognized in the month in which the Company is obligated to provide services to plan enrollees under contracts with various health plans. Minor ongoing adjustments to prior months&#8217; capitation, primarily arising from contracted HMOs finalizing their monthly patient eligibility data for additions or subtractions of enrollees, are recognized in the month they are communicated to the Company. Additionally, Medicare pays capitation using a &#8220;Risk Adjustment&#8221; model, which compensates managed care organizations and providers based on the health status (acuity) of each individual enrollee. Health plans and providers with higher acuity enrollees will receive more and those with lower acuity enrollees will receive less. Under Risk Adjustment, capitation is determined based on health severity, measured using patient encounter data. Capitation is paid on a monthly basis based on data submitted for the enrollee for the preceding year and is adjusted in subsequent periods after the final data is compiled. Positive or negative capitation adjustments are made for Medicare enrollees with conditions requiring more or fewer healthcare services than assumed in the interim payments. Since the Company cannot reliably predict these adjustments, periodic changes in capitation amounts earned as a result of Risk Adjustment are recognized when those changes are communicated by the health plans to the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Per member per month (&#8220;PMPM&#8221;) managed care contracts generally have a term of one year or longer. The Company assesses the profitability of its managed care contracts to identify contracts where current operating results or forecasts indicate probable future losses. If anticipated future variable costs exceed anticipated future revenues, a premium deficiency reserve is recognized. No premium deficiency reserves were recorded as of December&#160;31, 2023. All managed care contracts have a single performance obligation that constitutes a series for the provision of managed healthcare services for a population of enrolled members for the duration of the contract. The transaction price for PMPM contracts is variable as it primarily includes PMPM fees associated with unspecified membership that fluctuates throughout the contract. In certain contracts, PMPM fees also include adjustments for items such as performance incentives, performance guarantees, and risk sharing. The Company generally estimates the transaction price using the most likely amount methodology and amounts are only included in the net transaction price to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The majority of the Company&#8217;s net PMPM transaction price relates specifically to the Company&#8217;s efforts to transfer the service for a distinct increment of the series (e.g., day or month) and is recognized as revenue in the month in which members are entitled to service.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GPDC/ACO REACH Capitation Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS contracts with ACOs, which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC/ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, ACOs and providers. By entering into a contract with CMS, an ACO voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each ACO bears the economic costs, and reaps the economic rewards, of fulfilling its responsibilities and managing its risks as an ACO. APAACO has participated in ACO REACH, and its predecessor model, Global and Professional Direct Contracting Model (&#8220;GPDC Model&#8221;), since January 1, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the ACO&#8217;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#8217;s performance. ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties. ACO REACH capitation revenue is recognized in the accompanying consolidated statements of income under capitation, net.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Pool Settlements and Incentives</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain IPAs enter into hospital shared-risk capitation arrangements with certain health plans and local hospitals, where the hospital is responsible for providing, arranging and paying for institutional risk and the IPA is responsible for providing, arranging, and paying for professional risk. Under a hospital shared-risk pool-sharing agreement, the IPA generally receives a percentage of the net surplus from the affiliated hospital&#8217;s risk pools with HMOs after deductions for the affiliated hospital&#8217;s costs. Advance settlement payments are typically made quarterly in arrears if there is a surplus. The Company&#8217;s risk pool settlements under arrangements with health plans and hospitals are recognized using the most likely amount methodology and amounts are only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The assumptions for historical margin, IBNR completion factors, and constraint percentages were used by management in applying the most likely amount methodology.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitated arrangements with certain HMOs, certain IPAs participate in one or more health plan shared-risk arrangements relating to the provision of institutional services to enrollees and thus can earn additional revenue or incur losses based upon the enrollee utilization of institutional services. Health plan shared-risk arrangements are entered into with certain health plans, which are administered by the health plan, where the IPA is responsible for rendering professional services, but the health plan does not enter into a capitation arrangement with a hospital and therefore the health plan retains the institutional risk. Health plan shared-risk deficits, if any, are not payable until and unless (and only to the extent) risk-sharing surpluses are generated. At the termination of the HMO contract, any accumulated deficit will be extinguished.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's risk pool settlements under arrangements with HMOs are recognized, using the most likely methodology, and only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur. Given the lack of access to the health plans&#8217; data and control over the members assigned to the IPA, the adjustments and/or the withheld amounts are unpredictable and as such, the IPA&#8217;s risk-share revenues are deemed to be fully constrained until they are notified of the amount by the health plan. Final settlement of risk pools for prior contract years generally occur in the third or fourth quarter of the following year.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to risk-sharing revenues, the Company also receives incentives under &#8220;pay-for-performance&#8221; programs for quality medical care, based on various criteria. As an incentive to promote quality care, certain HMOs have designed quality incentive programs and commercial generic pharmacy incentive programs to compensate the Company for its efforts to improve the quality of services and efficient and effective use of pharmacy supplemental benefits provided to HMO members. The incentive programs track specific performance measures and calculate payments to the Company based on the performance measures. The Company&#8217;s incentives under &#8220;pay-for-performance&#8221; programs are recognized using the most likely methodology. However, as the Company does not have sufficient insight from the health plans on the amount and timing of the health plan shared-risk pool and incentive payments, these amounts are considered to be fully constrained and only recorded when such payments are known and/or received.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, for the foregoing arrangements, the final settlement is dependent on each distinct day&#8217;s performance within the annual measurement period but cannot be allocated to specific days until the full measurement period has occurred and performance can be assessed. As such, this is a form of variable consideration estimated at contract inception and updated through the measurement period (i.e., the contract year), to the extent the risk of reversal does not exist and the consideration is not constrained.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NGACO AIPBP Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the NGACO Model, CMS aligned beneficiaries to the Company to manage direct care and pay providers based on a budgetary benchmark established with CMS. The Company was responsible for managing medical costs for these beneficiaries. The beneficiaries received services from physicians and other medical service providers that were both in-network and out-of-network. The Company received capitation-like All Inclusive Population Based Payment (&#8220;AIPBP&#8221;) payments from CMS on a monthly basis to pay claims from in-network providers. The Company recorded such AIPBPs received from CMS as revenue as the Company was primarily responsible and liable for managing the patient care and for satisfying provider obligations, was assuming the credit risk for the services provided by in-network providers through its arrangement with CMS, and had control of the funds, the services provided and the process by which the providers were ultimately paid. Claims from out-of-network providers were processed and paid by CMS, while claims from APAACO&#8217;s in-network contracted providers were paid by APAACO. The Company&#8217;s shared savings or losses in managing the services provided by out-of-network providers were generally determined on an annual basis after reconciliation with CMS. Pursuant to the Company&#8217;s risk share agreement with CMS, the Company was eligible to receive the savings or was liable for the deficit according to the budget established by CMS based on the Company&#8217;s efficiency in managing how the beneficiaries aligned to the Company by CMS were served by in-network and out-of-network providers. The Company&#8217;s savings or losses on providing such services were both capped by CMS, </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and were subject to significant estimation risk, whereby payments would vary significantly depending upon certain patient characteristics and other variable factors. Accordingly, the Company recognized such surplus or deficit upon substantial completion of reconciliation and determination of the amounts. The Company recorded NGACO AIPBP revenues monthly. Excess AIPBPs over claims paid, plus an estimate for the related IBNR claims were deferred and recorded as a liability until actual claims were paid or incurred. CMS determined if there were any excess AIPBPs for the performance year and the excess was refunded to CMS. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each performance year, CMS paid the Company in accordance with the alternative payment mechanism, if any, for which CMS had approved the Company; the risk arrangement for which the Company has been approved by CMS, and was otherwise provided in an NGACO Participation Agreement between APAACO and CMS (the &#8220;Participation Agreement&#8221;). Following the end of each performance year and at such other times as would be required under the Participation Agreement, CMS would issue a settlement report to the Company setting forth the amount of any shared savings or shared losses and the amount of other monies. If CMS owed the Company shared savings or other monies, CMS would pay the Company in full within 30 days after the date on which the relevant settlement report was deemed final, except as provided in the Participation Agreement. If the Company owed CMS shared losses or other monies owed as a result of a final settlement, the Company would pay CMS in full within 30 days after the relevant settlement report was deemed final. If the Company failed to pay the amounts due to CMS in full within 30 days after the date of a demand letter or settlement report, CMS would assess simple interest on the unpaid balance at the rate applicable to other Medicare debts under current provisions of law and applicable regulations. In addition, CMS and the U.S. Department of the Treasury would use any applicable debt collection tools available to collect any amounts owed by the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participated in the AIPBP track of the NGACO Model. Under the AIPBP track, CMS estimated the total annual expenditures for APAACO&#8217;s assigned patients and paid that projected amount to the Company in monthly installments, and the Company was responsible for all Part A and Part B costs for in-network participating providers and preferred providers contracted by the Company to provide services to the assigned patients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As APAACO did not have sufficient insight into the financial performance of the shared risk pool with CMS because of unknown factors related to IBNR claims, risk adjustment factors, and stop-loss provisions, among other factors, an estimate couldn&#8217;t be developed. Due to these limitations, APAACO could not determine the amount of surplus or deficit that would likely be recognized in the future and therefore this shared risk pool revenue was considered fully constrained. With the ending of the NGACO Model on December 31, 2021, the Company no longer received AIPBPs but remained eligible to recognize any shared savings or loss for performance year 2021 upon issuance of the settlement report from CMS. Pursuant to the Participation Agreement, the Company recognized $48.8 million related to savings from the 2021 performance year as revenue in risk pool settlements and incentives in the accompanying consolidated statements of income for the year ended December 31, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Fee Income</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management fee income encompasses fees paid for management, physician advisory, healthcare staffing, administrative, and other non-medical services provided by the Company to IPAs, hospitals, and other healthcare providers. Such fees may be in the form of billings at agreed-upon hourly rates, percentages of gross revenue or fee collections, or amounts fixed on a monthly, quarterly, or annual basis. The revenue may include variable arrangements measuring factors, such as hours staffed, patient visits, or collections per visit, against benchmarks, and, in certain cases, may be subject to achieving quality metrics or fee collections. The Company recognizes such variable supplemental revenues in the period when such amounts are determined to be fixed and therefore contractually obligated as payable by the customer under the terms of the applicable agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a significant service of integrating the services selected by the Company&#8217;s clients into one overall output for which the client has contracted. Therefore, such management contracts generally contain a single performance obligation. The nature of the Company&#8217;s performance obligation is to stand ready to provide services over the contractual period. Also, the Company&#8217;s performance obligation forms a series of distinct periods of time over which the Company stands ready to perform. The Company&#8217;s performance obligation is satisfied as the Company completes each period&#8217;s obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration from management contracts is variable in nature because the majority of the fees are generally based on revenue or collections, which can vary from period to period. The Company has control over pricing. Contractual fees are invoiced to the Company&#8217;s clients generally monthly and payment terms are typically due within 30 days. The variable consideration in the Company&#8217;s management contracts meets the criteria to be allocated to the distinct period of time to which it relates because (i) </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">it is due to the activities performed to satisfy the performance obligation during that period and (ii) it represents the consideration to which the Company expects to be entitled.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management contracts generally have terms ranging from <span style="-sec-ix-hidden:f-665">one</span> to thirty years, although they may be terminated earlier under the terms of the applicable contracts. Since the remaining variable consideration will be allocated to a wholly unsatisfied promise that forms part of a single performance obligation recognized under the series guidance, the Company has applied the optional exemption to exclude disclosure of the allocation of the transaction price to remaining performance obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fee-for-Service Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FFS revenue represents revenue earned under contracts in which the professional component of charges for medical services rendered by the Company&#8217;s affiliated physician-owned medical groups are billed and collected from third-party payers, hospitals, and patients. FFS revenue related to patient care services is reported net of contractual allowances and policy discounts and is recognized in the period in which the services are rendered to specific patients. All services provided are expected to result in cash flows and are therefore reflected as net revenue in the consolidated financial statements. The recognition of net revenue (gross charges, less contractual allowances) from such services is dependent on such factors as proper completion of medical charts following a patient visit, the forwarding of such charts to the Company&#8217;s billing center for medical coding and entering into the Company&#8217;s billing system and the verification of each patient&#8217;s submission or representation at the time services are rendered as to the payer(s) responsible for payment of such services. Revenue is recorded based on the information known at the time of entering such information into the Company&#8217;s billing systems, as well as an estimate of the revenue associated with medical services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is responsible for confirming member eligibility, performing program utilization review, potentially directing payment to the provider and accepting the financial risk of loss associated with services rendered, as specified within the Company&#8217;s client contracts. The Company has the ability to adjust contractual fees with clients and possesses the financial risk of loss in certain contractual obligations. These factors indicate the Company is the principal and, as such, the Company records gross fees contracted with clients in revenues.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration from FFS arrangements is variable in nature because fees are based on patient encounters, credits due to clients, and reimbursement of provider costs, all of which can vary from period to period.&#160;Patient encounters and related episodes of care and procedures qualify as distinct goods and services, provided simultaneously together with other readily available resources, in a single instance of service, and thereby constitute a single performance obligation for each patient encounter and, in most instances, occur at readily determinable transaction prices. As a practical expedient, the Company adopted a portfolio approach for the FFS revenue stream to group together contracts with similar characteristics and analyze historical cash collection trends. The contracts within the portfolio share the characteristics conducive to ensuring that the results do not materially differ under the new standard if it were to be applied to individual patient contracts related to each patient encounter. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating net FFS revenue is a complex process, largely due to the volume of transactions, the number and complexity of contracts with payers, the limited availability at times of certain patient and payer information at the time services are provided, and the length of time it takes for collections to fully mature. These expected collections are based on fees and negotiated payment rates in the case of third-party payers, the specific benefits provided for under each patient&#8217;s healthcare plans, mandated payment rates in the case of Medicare and Medicaid programs, and historical cash collections (net of recoveries) in combination with expected collections from third-party payers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The relationship between gross charges and the transaction price recognized is significantly influenced by payer mix, as collections on gross charges may vary significantly, depending on whether the patients, to whom services are provided, in the period are insured and the contractual relationships with those payers. Payer mix is subject to change as additional patient and payer information is obtained after the period services are provided. The Company periodically assesses the estimates of unbilled revenue, contractual adjustments and discounts, and payer mix by analyzing actual results, including cash collections, against estimates. Changes in these estimates are charged or credited to the consolidated statements of income in the period that the assessment is made. Significant changes in payer mix, contractual arrangements with payers, specialty mix, acuity, general economic conditions, and healthcare coverage provided by federal or state governments or private insurers may have a significant impact on estimates and significantly affect the results of operations and cash flows.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues and receivables are recognized once the Company has satisfied its performance obligation. Accordingly, contract assets are comprised of receivables and receivables - related parties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#211d1e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billing and accounting systems provide historical trends of cash collections and contractual write-offs, accounts receivable aging, and established fee adjustments from third-party payers. These estimates are recorded and monitored monthly as revenues are recognized.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The principal exposure for uncollectible fees for service visits is from self-pay patients and, to a lesser extent, for co-payments and deductibles from patients with insurance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities (Deferred Revenue)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities are recorded when cash payments are received in advance of the Company&#8217;s performance. As of December&#160;31, 2023, the Company&#8217;s contract liability balance was $0.7 million. The Company&#8217;s contract liability was $0.5&#160;million as of December&#160;31, 2022. Approximately $0.5 million of the Company&#8217;s contract liability accrued in 2022 has been recognized as revenue during the year ended December&#160;31, 2023. Contract liability is presented within accounts payable and accrued expenses in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period of enactment. The Company records a valuation allowance to reduce deferred tax assets to an amount for which realization is more likely than not. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained upon examination by the tax authorities, based on the merits of the position. The Company&#8217;s policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. To date, there have been no interest or penalties incurred in relation to the unrecognized tax benefits.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a stock-based compensation program for employees, non-employees, directors, and consultants. From time to time, the Company issues shares of its common stock to its employees, directors, and consultants, which shares may be subject to the Company&#8217;s repurchase right (but not obligation), that vests based on time-based and/or performance-based vesting schedules. The value of share-based awards is recognized as compensation expense and adjusted for forfeitures as they occur. Compensation expenses for time-based awards are recognized on a cumulative straight-line basis over the vesting period of the awards. Share-based awards with performance conditions are recognized to the extent the performance conditions are probable of being achieved. Compensation expenses for performance-based awards are recognized on an accelerated attribution method. The grant date fair value of the restricted stock awards is the grant date&#8217;s closing market price of the Company&#8217;s common stock. The fair value of options granted is determined using the Black-Scholes option pricing model and includes several assumptions, including expected term, expected volatility, expected dividends, and risk-free rates. The expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. The expected stock price volatility is determined based on an average of historical volatility. The expected dividend yield is based on the Company&#8217;s expected dividend payouts. The risk-free interest rate is based on the U.S. Constant Maturity curve over the expected term of the option at the time of grant.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basic and Diluted Earnings Per Share</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) is computed by dividing net income attributable to holders of the Company&#8217;s common stock by the weighted-average number of shares of common stock outstanding during the periods presented. Diluted earnings per share is computed using the weighted-average number of shares of common stock outstanding, plus the effect of dilutive securities outstanding during the periods presented, using the treasury stock method. Refer to Note 17 &#8212; &#8220;Earnings Per Share&#8221; for a discussion of shares treated as treasury shares for accounting purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-controlling Interests</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates entities in which the Company has a controlling financial interest. The Company consolidates subsidiaries in which the Company holds, directly or indirectly, more than 50% of the voting rights, and VIEs in which the Company is the primary beneficiary. Non-controlling interests represent third-party equity ownership interests (including equity ownership interests held by certain VIEs) in the Company&#8217;s consolidated entities. Net income attributable to non-controlling interests is disclosed in the consolidated statements of income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mezzanine Equity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to APC&#8217;s shareholder agreements, in the event of a disqualifying event, as defined in the agreements, APC could be required to repurchase its shares from the respective shareholders based on certain triggers outlined in the shareholder agreements. As the redemption feature of the shares is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as mezzanine or temporary equity. Accordingly, the Company recognizes non-controlling interests in APC as mezzanine equity in the consolidated financial statements. As of December&#160;31, 2023 and 2022, APC&#8217;s shares were not redeemable nor was it probable the shares would become redeemable.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at its inception. The expected term of the lease used for computing the lease liability and right-of-use asset and determining the classification of the lease as operating or financing may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company elected practical expedients for ongoing accounting that is provided by the standard comprised of the following: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The election for classes of underlying assets to not separate non-lease components from lease components, and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The election for short-term lease recognition exemption for all leases under twelve-month terms.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The present value of the lease payments is calculated using a rate implicit in the lease, when readily determinable. However, as most of the Company&#8217;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to determine the present value of the lease payments for the majority of its leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Interest</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, APC received a beneficial interest as a result of selling one of its equity method investments, pursuant to the terms of the stock purchase agreement. The estimated fair value of such interest in April 2020 was&#160;$15.7&#160;million. In 2021, the beneficial interest was determined to not be collectible and the $15.7&#160;million was written off and expensed in other income (expense) in the accompanying consolidated statements of income for the year ended December 31, 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Standards Accounting Board (FASB) issued Accounting Standards Update (ASU) 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for the Company&#8217;s annual periods beginning January 1, 2024, and for interim periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09 "Income Taxes (Topics 740): Improvements to Income Tax Disclosures" to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#8217;s annual periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696479595824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Asset Acquisitions, and Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations, Asset Acquisitions, and Goodwill</a></td>
<td class="text">Business Combinations, Asset Acquisitions, and Goodwill<div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Texas Independent Providers, LLC (&#8220;TIP&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;1, 2023, the Company acquired certain assets relating to TIP. The acquired assets allow the Company to provide high-quality care services to Medicare Advantage patients in Texas. The purchase price consisted of cash funded on September 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For Your Benefit, Inc. (&#8220;FYB&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;1, 2023, the Company acquired 100% of the equity interest in FYB. FYB is licensed by the California Department of Managed Health Care as a full-service Restricted Knox-Keene licensed health plan to serve Medicare Advantage members only in designated California counties. As a Restricted Knox-Keene licensed health plan, FYB is not permitted to market directly to Medicare beneficiaries, but rather, contracts with &#8220;upstream&#8221; Medicare Advantage payer plans on a &#8220;global capitation&#8221; basis, which enables FYB to assume full financial responsibility, including both professional and institutional risk, for the medical costs of its Medicare Advantage members under the Knox-Keene Health Care Service Plan Act of 1975.</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Chinese Community Health Care Association (&#8220;CCHCA&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;1, 2023, the Company acquired certain healthcare assets from CCHCA. The acquired assets allow the Company to provide high-quality care to more patients in the San Francisco Community. The purchase price consisted of cash funded on May&#160;1, 2023. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">All American Medical Group (&#8220;AAMG&#8221;) </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2022, Astrana Care Partners Medical Corporation (&#8220;Astrana Care Partners Medical&#8221;), formerly known as AP-AMH 2 Medical Corporation, a consolidated VIE of the Company, acquired 100% of the equity interest in AAMG. AAMG is an IPA operating in Northern California. The purchase price consisted of cash funded upon close of the transaction and additional consideration (&#8220;AAMG contingent consideration&#8221;) and stock consideration (&#8220;AAMG stock contingent consideration&#8221;) contingent on AAMG meeting revenue and capitated member metrics for fiscal year 2023 and 2024. The fair value of the AAMG contingent consideration and AAMG stock contingent consideration on the date of acquisition was $5.9 million and $5.6 million, respectively. Refer to Note 21 - &#8220;Fair Value Measurements of Financial Instruments&#8221; for additional information on contingent considerations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valley Oaks Medical Group (&#8220;VOMG&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 14, 2022, one of the Company&#8217;s key personnel acquired 100% of the equity interest in VOMG, resulting in the Company consolidating VOMG as a VIE. VOMG owns primary care clinics in Nevada and Texas. The purchase price consists of cash funded upon the close of transaction and additional cash consideration (&#8220;VOMG contingent consideration&#8221;) contingent on VOMG meeting financial metrics for fiscal years 2023 and 2024. Refer to Note 21 - &#8220;Fair Value Measurements of Financial Instruments&#8221; for additional information on contingent considerations. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jade Health Care Medical Group, Inc. (&#8220;Jade&#8221;)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 19, 2022, the Company acquired 100% of the capital stock of Jade. The purchase was paid in cash. Jade is a primary and specialty care physicians&#8217; group focused on providing high-quality care to its patients in the San Francisco Bay Area in Northern California.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Orma Health, Inc., and Provider Growth Solutions LLC (together, &#8220;Orma Health&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 27, 2022, the Company acquired 100% of the capital stock of Orma Health, Inc., and Provider Growth Solutions, LLC (together, &#8220;Orma Health&#8221;). The purchase was paid in cash and in the Company&#8217;s capital stock. Orma Health&#8217;s real-time Clinical AI platform ingests data from multiple sources and utilizes advanced risk-stratification models to identify patients for various clinical programs, including remote patient monitoring (&#8220;RPM&#8221;), mental health support, chronic care management, and more. Its clinical platform is also deeply integrated with Orma Health&#8217;s proprietary RPM ecosystem, which consists of smart health devices and a suite of technology tools to manage patient health.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisitions were accounted for under the acquisition method of accounting. The fair value of the consideration for the acquired companies were allocated to acquired tangible and intangible assets and liabilities based upon their fair values. The </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excess of the purchase consideration over the fair value of the net tangible and identifiable intangible assets acquired was recorded as goodwill. The determination of the fair value of assets and liabilities acquired requires the Company to make estimates and use valuation techniques when market value is not readily available. The results of operations of the acquisitions have been included in the Company&#8217;s consolidated financial statements from the date of acquisition. Transaction costs associated with business acquisitions are expensed as they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of acquisition, the Company estimates the amount of the identifiable intangible assets based on a valuation and the facts and circumstances available at the time. The Company determines the final value of the identifiable intangible assets as soon as information is available, but not more than one year from the date of acquisition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not deductible for tax purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying value of goodwill for the years ended December&#160;31, 2023 and 2022 was as follows (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391736960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Land, Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock', window );">Land, Property and Equipment, Net</a></td>
<td class="text">Land, Property, and Equipment, Net<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land, property, and equipment, net consisted of (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life (Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 39</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 39</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,876)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,047)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,171&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,536&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Certain land, property, and equipment, net that were deemed Excluded Assets that are solely for the benefit of APC and its common shareholders were spun-off as part of the Spin-Off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the Company had finance leases totaling $1.7 million and $1.8 million, respectively, included in land, property, and equipment, net in the accompanying consolidated balance sheets.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span> $3.7 million and $2.1 million for the years ended December&#160;31, 2023, 2022 and 2021, respectively, which is included in depreciation and amortization in the accompanying consolidated statements of income.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property, Plant And Equipment And Asset Acquisition Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391736960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text">Intangible Assets, Net<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful<br/>Life<br/>(Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>January 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment/<br/>Disposal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104,859)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-14</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(131,268)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful<br/>Life<br/>(Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross January 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment/<br/>Disposal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite Lived Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename/trademarks</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,611)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,861&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, network relationships, management contracts, member relationships, tradename/trademarks, and developed technology had weighted-average remaining useful lives of 9.4 years, 6.5 years, 11.1 years, 13.9 years, and 4.1 years respectively. Total weighted-average remaining useful lives for all amortized intangible assets as of December&#160;31, 2023 was 9.6 years. Amortization expense was $12.7 million, $13.7 million and $15.4 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively, which is included in depreciation and amortization in the accompanying consolidated statements of income. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no impairment loss recorded related to intangibles for the years ended December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):</span></div><div style="margin-top:17pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391740480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investments in Other Entities</a></td>
<td class="text">Investments in Other Entities<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2023 and 2022, the Company&#8217;s equity method investment balance consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Initial Investment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustment of Fair Value*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(508)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,916)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other **</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,579&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,351&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,480)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,774&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-Off. On the date of distribution, the investments were recorded at fair value. The gain, representing the difference between the fair value and the carrying value of the investment, was $3.4 million and is presented within other income in the accompanying consolidated statement of net income. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Other consists of smaller equity method investments. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funding Reclassified to Loan Receivable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Entity Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tag-6 Medical Investment Group, LLC*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,622&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,418)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity method investments are subject to impairment evaluation. There was no impairment loss recorded related to equity method investments for the years ended December&#160;31, 2023, 2022, and 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in privately held entities that do not report net asset value</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MediPortal, LLC</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, APC purchased 270,000 membership interests of MediPortal LLC, a New York limited liability company, for $0.4 million or $1.50 per membership interest, which represented approximately 2.8% ownership interest. In connection with </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the initial purchase, APC received a five-year warrant to purchase an additional 270,000 membership interests. A five-year option to purchase an additional 380,000 membership interests and a <span style="-sec-ix-hidden:f-980">five</span>-year warrant to purchase 480,000 membership interests were contingent upon the portal completion date. These warrants and options were not exercised and are expired as of December&#160;31, 2023. As APC does not have the ability to exercise significant influence, and lacks control over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the years ended December&#160;31, 2023 and 2022, there were no observable price changes to APC&#8217;s investment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AchievaMed</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, Astrana Health Management, Inc. (&#8220;AHM&#8221;), formerly known as Network Medical Management Inc., and AchievaMed, Inc., a California corporation (&#8220;AchievaMed&#8221;), entered into an agreement in which AHM would purchase 50% of the aggregate shares of capital stock of AchievaMed over a period of time not to exceed five years. As a result of this transaction, AHM invested $0.5 million for a 10% interest. The related investment balance of $0.5&#160;million is included in investments in privately held entities in the accompanying consolidated balance sheets as of December&#160;31, 2023. As AHM does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the years ended December&#160;31, 2023 and 2022, there were no observable price changes to AHM&#8217;s investment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third Way Health, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the Company entered into a Simple Agreement for Future Equity (&#8220;SAFE&#8221;) with Third Way Health, Inc. (&#8220;Third Way Health&#8221;). Based on certain triggering events defined in the SAFE, the Company has rights to Third Way Health&#8217;s shares. The number of shares to be acquired will be calculated when the triggered event occurs.  As of December&#160;31, 2023 and 2022, the related investment balance of $3.5&#160;million and $1.5&#160;million, respectively, is included in investments in privately held entities in the accompanying consolidated balance sheets. As the Company does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the years ended December&#160;31, 2023 and 2022, there were no observable price changes to the Third Way Health investment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Seen Health, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2023, the Company entered into a SAFE with Seen Health, Inc. (&#8220;Seen Health&#8221;). Based on certain triggering events defined in the SAFE, the Company has rights to Seen Health&#8217;s shares. The number of shares to be acquired will be calculated when the triggering event occurs. As of December&#160;31, 2023, the related investment balance of $2.0&#160;million is included in investments in privately held entities in the accompanying consolidated balance sheets. As the Company does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the year ended December&#160;31, 2023, there were no observable price changes to the Seen Health investment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 323<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481543/323-740-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 323<br> -Publisher FASB<br> -URI https://asc.fasb.org//323/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696479403232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan Receivable and Loan Receivable &#8211; Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LoanReceivableAbstract', window );"><strong>Loan Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LoanReceivableTextBlock', window );">Loan Receivable and Loan Receivable &#8211; Related Parties</a></td>
<td class="text">Loan Receivable and Loan Receivable &#8211; Related Parties<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loans receivable</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pacific6</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, AHM received a promissory note from 6 Founder LLC, a California limited liability company doing business as Pacific6 Enterprises totaling $0.5&#160;million as a result of the sale of the Company&#8217;s interest in MWN. Interest accrues at a rate of 5% per annum and is payable monthly through the maturity date of December 1, 2023. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IntraCare </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;27, 2023, the Company entered into a five-year convertible promissory note with IntraCare as the borrower. The principal on the note is $25.0 million, with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to 8.81%, compounded annually. In the event that the convertible promissory note remains outstanding on or after the maturity date of July&#160;27, 2028, the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into IntraCare preferred shares. As of December&#160;31, 2023, the related note balance of $26.0 million is included in loan receivable, non-current in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the outstanding loan receivable under the CECL model by assessing the party&#8217;s ability to pay by reviewing their interest payment history quarterly, financial history annually, and reassessing any identified insolvency risk.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan receivable &#8212; related party</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LaSalle Medical Associates Loan (&#8220;LMA Loan&#8221;)</span></div>LaSalle Medical Associates (&#8220;LMA&#8221;) issued a promissory note to APC-LSMA for a principal amount of $2.1&#160;million with an August 2023 maturity date. The contractual interest rate on the LMA Loan is 1.0% above the prime rate of interest for commercial customers. In March 2023, LMA paid off the full balance of the promissory note and all interest. APC&#8217;s investment in LMA is accounted for under the equity method based on the 25% equity ownership interest held by APC-LSMA in LMA&#8217;s IPA line of business (see Note 6 &#8212; &#8220;Investments in Other Entities &#8212; Equity Method&#8221;).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LoanReceivableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LoanReceivableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LoanReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loan Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LoanReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391583840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="text">Accounts Payable and Accrued Expenses<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts payable and accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor IPA payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to related parties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other provider payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued expenses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391575664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">Medical Liabilities</a></td>
<td class="text">Medical Liabilities<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s medical liabilities consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired (see Note 3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852,935&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,831&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(559,751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(836,050)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(626,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,657&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//944-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391613408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Credit Facility, Bank Loans, and Lines of Credit</a></td>
<td class="text">Credit Facility, Bank Loans, and Lines of Credit<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt balance consists of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Loans*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction Loan *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note Payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Long-term debt </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,389&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*These loans are a component of Excluded Assets that are solely for the benefit of APC and its common shareholders. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using Level 2 inputs primarily related to comparable market prices. As of December&#160;31, 2023 and 2022, the carrying value was not materially different from fair value, as the interest rates on the Company&#8217;s debt approximated rates currently available to the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the future commitments of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amended Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2021, the Company entered into an amended and restated credit agreement (as subsequently amended as described below, the &#8220;Amended Credit Agreement&#8221;) with Truist Bank, in its capacity as administrative agent for the lenders, issuing bank, swingline lender and lender, and the banks and other financial institutions from time to time party thereto, to, among other things, amend and restate that certain credit agreement, dated September 11, 2019, by and among the Company, Truist Bank, and certain lenders thereto, in its entirety. The Amended Credit Agreement provides for a five-year revolving credit facility to the Company of $400.0 million (&#8220;Revolver Loan&#8221;), which includes a letter of credit sub-facility of up to $25.0 million and a swingline loan sub-facility of $25.0 million. As of December&#160;31, 2023, the Company did not have any outstanding borrowings under the Revolver Loan. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2022, the Company entered into the First Amendment to the Amended Credit Agreement in which all amounts borrowed under the Amended Credit Agreement as of the effective date were automatically converted from LIBOR Loans to SOFR Loans with an initial interest period of one month on and as of the amendment effective date. Amounts borrowed under the Revolver Loan bear interest at an annual rate equal to either, at the Company&#8217;s option, (a) the Term SOFR Reference Rate (as defined in the Amended Credit Agreement), adjusted for any Term SOFR Adjustment (as defined in the Amended Credit Agreement) plus a spread ranging from  1.25% to 2.50%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio (as defined in the Amended Credit Agreement), or (b) a base rate, plus a spread ranging from 0.25% to 1.50%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 8, 2023, a Second Amendment to the Amended Credit Agreement was entered into which, among other things, (i) increased the letter of credit sub-facility from $25.0 million to $50.0 million; (ii) revised the form of compliance certificate required to be submitted by the Company to the lenders on a quarterly basis; and (iii) waived the Specified Events of Default (as defined in the amendment) that occurred under the Amended Credit Agreement, relating to the Company&#8217;s calculation of Consolidated Total Net Leverage Ratio  and payment of certain interest and letter of credit fees, in each case, for the periods from the quarter ended September 30, 2021 through the quarter ended March 31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;3, 2023, the Company entered into a Third Amendment to the Amended Credit Agreement (&#8220;Third Amendment&#8221;) with Truist Bank and the other financial institutions party thereto. The Third Amendment provided a new term loan to the Company in an aggregate amount of up to $300.0&#160;million, with $180.0&#160;million funded at the closing of the Third Amendment, and $120.0&#160;million available to be drawn by the Company as delayed draw loans during the six months subsequent to the closing of the Third Amendment (collectively, the &#8220;Term Loan&#8221;).  The Term Loan matures on November&#160;3, 2028 (or such earlier date on which it is terminated in accordance with the provisions of the Amended Credit Agreement) and amortizes quarterly at 5% per annum for each of the first two years, 7.5% per annum for years three and four, and 10% per annum for year five. As of December&#160;31, 2023, the Company made total drawdowns under the Term Loan of $280.0&#160;million, of which $180.0&#160;million was used to pay down outstanding amounts borrowed on the Revolver Loan as of the Third Amendment closing date.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will pay a quarterly ticking fee on the delayed draw portion of the Term Loan, during the draw period, in an amount equal to 0.375% per annum multiplied by the average daily unused portion of the delayed draw maximum amount. The </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Loan will be secured by substantially all assets of the Company and subsidiaries of the Company that are not designated as excluded subsidiaries pursuant to the terms of the Amended Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan bears interest at an annual rate equal to either, at the Company&#8217;s option, (a) the Term SOFR Reference Rate, adjusted for any Term SOFR Adjustment, plus a spread from 1.50% to 2.75%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio, or (b) a base rate, plus a spread of 0.50% to 1.75%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio. As of December&#160;31, 2023, the interest rate on the Term Loan was 7.69%. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the Company is required to pay an annual agent fee of $50,000 and an annual facility fee of 0.175% to 0.35% on the available commitments under the Amended Credit Agreement, regardless of usage, with the applicable fee determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio. The Company will pay fees for standby letters of credit at an annual rate equal to 1.25% to 2.50%, as determined on a quarterly basis based on the Company&#8217;s Consolidated Total Net Leverage Ratio, plus fronting fees and standard fees payable to the issuing bank on the respective letter of credit. The Company is also required to pay customary fees between the Company and Truist Bank, the lead arranger of the Amended Credit Agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement requires the Company to comply with two key financial ratios, each calculated on a consolidated basis. The Company must maintain a maximum consolidated total net leverage ratio of not greater than 3.75 to 1.00 as of the last day of each fiscal quarter, provided that for any fiscal quarter during which the Company or certain subsidiaries consummate a permitted acquisition or investment, the aggregate purchase price is greater than $75.0&#160;million, the maximum consolidated total net leverage ratio may temporarily increase by 0.25 to 1.00 to 4.00 to 1.00. The Company must maintain a minimum consolidated interest coverage ratio of not less than 3.25 to 1.00 as of the last day of each fiscal quarter. The Third Amendment also revised certain negative covenants in the Credit Agreement, providing the Company with additional baskets and increased flexibility with respect to restrictions on indebtedness, liens, investments, acquisitions and restricted payments. The Third Amendment also updates the definition of Consolidated EBITDA to include additional addbacks and to clarify certain components of the calculation thereof. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the terms and conditions of the Guaranty and Security Agreement (the &#8220;Guaranty and Security Agreement&#8221;) between the Company, AHM and Truist Bank remain in effect. Pursuant to the Guaranty and Security Agreement, the Company and AHM have granted the lenders under the Amended Credit Agreement a security interest in substantially all of their assets to secure obligations under the Amended Credit Agreement, including, without limitation, all stock and other equity issued by their subsidiaries (including AHM) and all rights with respect to the $545.0&#160;million loan from the Company to Astrana Medical. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, certain of the lenders under the Amended Credit Agreement and their affiliates have provided to the Company and its subsidiaries and the associated practices, and may in the future provide, (i) investment banking, commercial banking, cash management, foreign exchange or other financial services, and (ii) services as a bond trustee and other trust and fiduciary services, for which they have received compensation and may receive compensation in the future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferred Financing Costs</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, unamortized deferred financing costs were $6.1 million and $3.3 million, respectively. During the year ended December 31, 2023, the Company recorded additional deferred financing costs of $3.9 million related to the Third Amendment. As of December&#160;31, 2023, $2.6 million of unamortized deferred financing costs was recognized in prepaid expenses and other current assets in the accompanying consolidated balance sheets and consisted of unamortized deferred financing costs related to unborrowed amounts available on the Term Loan and the unamortized deferred financing costs for the Revolver Loan. As of December&#160;31, 2023, $3.6 million of unamortized deferred financing costs was recorded as a direct reduction against the amounts borrowed on the Term Loan. The remaining unamortized deferred financing costs related to the Revolver Loan are amortized over the life of the Revolver Loan using the straight-line method. The remaining unamortized deferred financing costs related to the Term Loan are amortized over the life of the Term Loan using the effective interest rate method. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Real Estate Loans (Excluded Assets for the benefit of APC and its subsidiaries)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate - East West Bank</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, APC purchased three entities, each of which was included in Excluded Assets and had entered into real estate loan with East West Bank. As of December 31, 2022, the principal on each loan was $5.9 million, $0.6 million and $0.6 million, respectively,  and had a variable interest rate of 0.50%, 0.50% and 0.30% less than the independent index, which is the daily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Prime Rate&#8221;, respectively. The maturity date of each loan was August 5, 2030. These loans are a component of Excluded Assets that are solely for the benefit of APC and its shareholders. These loans were spun off on December 26, 2023 as part of the Spin-Off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate - MUFG Union Bank N.A.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, a subsidiary of APC, which was included in Excluded Assets, entered into a loan agreement with MUFG Union Bank N.A. with the principal on the loan of $16.3 million and a maturity date of March&#160;1, 2032. The loan was used to purchase property in Monterey Park, California. The variable interest rate was 2.0% in excess of Daily Simple SOFR (as defined in the loan agreement). As of December 31, 2022, the principal on the loan was $16.0 million. On December 14, 2023, APC paid off the outstanding loan balance of $15.6 million. This loan was a component of Excluded Assets that are solely for the benefit of APC and its shareholders. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction Loan (Excluded Assets for the benefit of APC and its subsidiaries)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, an entity included in Excluded Assets entered into a construction loan agreement with MUFG Union Bank N.A. (&#8220;Construction Loan&#8221;). The Construction Loan has a borrowing capacity of $10.7&#160;million with a maturity date of March&#160;1, 2024 or, upon completion of the construction and certain other requirements defined in the loan agreement, March&#160;1, 2034. The loan balance as of December 31, 2022 was $4.2 million. On December 14, 2023, APC paid off the outstanding loan balance of $8.5 million. This loan was a component of Excluded Assets that are solely for the benefit of APC and its shareholders. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Promissory Note Payable</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FYB Promissory Note Agreement with CCHCA</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, FYB entered into a promissory note agreement with CCHCA. The principal on the promissory note is $2.0&#160;million, with a maturity date of May&#160;9, 2024. The interest rate is the prime rate plus 1.0%. The prime rate is updated annually on the effective date of the note and published by the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wall Street Journal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s average effective interest rate on its total debt during the years ended December&#160;31, 2023, 2022 and 2021, was 6.19%, 3.22% and 2.06%, respectively. Interest expense in the consolidated statements of income included amortization of deferred debt issuance costs for the years ended December&#160;31, 2023, 2022 and 2021, of $1.1 million, $0.9 million and $1.2 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lines of Credit </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">APC Business Loan</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the APC Business Loan Agreement with Preferred Bank (the &#8220;APC Business Loan Agreement&#8221;) was amended to, among other things, decrease loan availability to $4.1 million, limit the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and include as a permitted lien, the security interest in all of its assets that APC granted to AHM under a Security Agreement dated on or about September 11, 2019, securing APC&#8217;s obligations to AHM under their management services agreement dated as of July 1, 1999, as amended.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Letters of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established irrevocable standby letters of credit with Truist Bank under the Amended Credit Agreement for a total of $36.5 million for the benefit of CMS and certain health plans as of December&#160;31, 2023. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional one-year periods from the present, or any future expiration date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of $3.9 million for the benefit of certain health plans as of December&#160;31, 2023. The standby letters of credit are automatically extended without amendment for additional one-year periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391639936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,638)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,444)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,278)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,671&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes differs from the amount computed by applying the federal income tax rate as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at U.S. federal statutory rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible permanent items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable interest entities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of investment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOL adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undistributed dividend</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off transaction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate differs from the Federal statutory rate of 21% due to increases from state taxes, non-deductible permanent items, stock-based compensation, gain on sale of investment, and a one-time gain in connection with the December 26, 2023 Spin-Off transaction. This is offset by variable interest entities, change in valuation allowance, and a benefit related to the reversal on deferred taxes on undistributed dividends. The Company had previously recorded deferred tax liabilities related to undistributed dividends for taxpaying groups that could not consolidate under US federal tax law. As a result of the spinoff transaction that occurred on December 26, 2023, the separate taxpaying groups now have the ability to consolidate under US federal tax law, resulting in tax benefits on the future payment of the dividends. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the Company&#8217;s deferred tax assets (liabilities) as of December&#160;31, 2023 and 2022, are shown below (in thousands).</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for bad debts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in other entities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,904)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,936)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(725)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undistributed dividend</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,454)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,214)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,919)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,072)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,217)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A valuation allowance of $5.9 million and $8.3 million as of December&#160;31, 2023 and 2022, respectively, has been established against the Company&#8217;s deferred tax assets related to loss entities the Company cannot consolidate under the federal consolidation rules, as realization of these assets is uncertain. Valuation allowance decreased by $2.4 million in 2023 and increased by $4.3&#160;million in 2022.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company had federal and California net operating loss carryforwards of approximately $21.0 million and $44.8 million, respectively. The federal and California net operating loss carryforwards will expire at various dates from 2027 through 2043; however, $5.3 million of the federal net operating loss carryforwards do not expire and can be carried forward indefinitely. The Company has determined certain NOLs are limited pursuant to Internal Revenue Code Sections 382 and 383, but does not anticipate these NOLs will expire before utilization. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the Company does not have any unrecognized tax benefits related to various federal and state income tax matters. The Company will recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to U.S. federal income tax, as well as income tax in California. The Company&#8217;s and its subsidiaries&#8217; state&#160;and federal income tax returns are open to audit under the statute of limitations for the years ended December&#160;31, 2019 through December&#160;31, 2022 and for the years ended December&#160;31, 2020 through December&#160;31, 2022, respectively. The Company is currently under audit for federal and California amended tax years ended December&#160;31, 2019, 2020 and 2021. The Company does not anticipate any significant changes to unrecognized tax benefits over the next 12 months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391548800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mezzanine and Stockholders&#8217; Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Mezzanine and Stockholders&#8217; Equity (Deficit)</a></td>
<td class="text">Mezzanine and Stockholders&#8217; Equity (Deficit)<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Mezzanine Equity (Deficit)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">APC</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the redemption feature (see Note 2 &#8212; &#8220;Basis of Presentation and Summary of Significant Accounting Policies&#8221;) of APC&#8217;s shares of common stock is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as non-controlling interests in mezzanine or temporary equity. APC&#8217;s shares were not redeemable, and it was not probable that the shares would become redeemable as of December&#160;31, 2023, 2022 and 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Stockholders&#8217; Equity</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock &#8211; Series A</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2015, Astrana entered into an agreement with AHM, a wholly owned subsidiary of Astrana, pursuant to which Astrana sold to AHM, and AHM purchased from Astrana, in a private offering of securities, 1,111,111 units, each unit consisting of one share of Astrana&#8217;s Series A Preferred Stock and a common stock warrant to purchase one share of Astrana&#8217;s common stock at an exercise price of $9.00 per share. AHM paid Astrana an aggregate of $10.0 million for the units. Holders of the Company&#8217;s shares of Series A preferred stock are entitled to receive dividends out of legally available assets, on parity with the holders of the Company&#8217;s shares of common stock. The Series A preferred stock has a liquidation preference in the amount of $9.00 per share plus any declared and unpaid dividends, and is convertible into common stock, at the option of the holder thereof, at any time after issuance, at an initial conversion rate of one-for-one, in each case, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock &#8211; Series B</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2016, Astrana entered into an agreement with AHM pursuant to which Astrana sold to AHM, and AHM purchased from Astrana, in a private offering of securities, 555,555 units, each unit consisting of one share of Astrana&#8217;s Series B Preferred Stock and a common stock warrant to purchase one share of Astrana&#8217;s common stock at an exercise price of $10.00 per share. AHM paid Astrana an aggregate $5.0 million for the units. Holders of the Company&#8217;s shares of Series B preferred stock are entitled to receive dividends out of legally available assets, on parity with the holders of the Company&#8217;s shares of common stock. The Series B preferred stock has a liquidation preference in the amount of $9.00 per share plus any declared and unpaid dividends, and is convertible into common stock, at the option of the holder thereof, at any time after issuance, at an initial conversion rate of one-for-one, in each case, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the rights of preferred stockholders, if any, holders of the Company&#8217;s common stock are entitled to receive such dividends, if any, as may be declared from time to time by the Company&#8217;s board of directors, at its discretion, from legally available funds. In the event of a liquidation, dissolution or winding up, the holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of the Company&#8217;s known debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2017 Share Issuances and Repurchases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, Astrana completed its business combination with AHM following the satisfaction or waiver of the conditions set forth in the Agreement and Plan of Merger, dated December 21, 2016, as amended, pursuant to which the merger subsidiary of Astrana merged with and into AHM, with AHM surviving as a wholly owned subsidiary of Astrana (&#8220;2017 Merger&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2017 Merger, former AHM shareholders received Astrana common stock subject to a 10% holdback. As of December&#160;31, 2023, 41,048 holdback shares have not been issued to certain former AHM shareholders who were AHM shareholders at the time of closing of the 2017 Merger, as they have yet to submit properly completed letters of transmittal to Astrana in order to receive their pro rata portion of Astrana common stock as contemplated under the Merger Agreement. Pending such receipt, such former AHM shareholders have the right to receive, without interest, their pro rata share of dividends or distributions with a record date after the effectiveness of the 2017 Merger. The consolidated financial statements </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered perfunctory and the Company is legally obligated to issue these shares in connection with the 2017 Merger.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC declared dividends of $58.0 million, $58.3 million and $57.9 million, respectively, to their Series A Preferred shareholders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC declared dividends of $210.9 million, $37.9 million and $29.9 million, respectively, to their common shareholders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, certain consolidated subsidiaries of the Company paid distributions of $3.9 million, $4.1 million and $1.2 million, respectively, to the shareholders who own the non-controlling interests in the entities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, APC owned 7,132,698 and 10,299,259 shares of Astrana&#8217;s common stock, respectively. While such shares of Astrana&#8217;s common stock are legally issued and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the consolidated financial statements. APC's ownership in Astrana was 13.22% and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.12%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of December&#160;31, 2023 and 2022, respectively.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, Astrana bought back 3,451,642 shares of its common stock, which included 3,166,561 shares of common stock purchased from APC for $100.0 million on November 14, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the total treasury stock, including the Company&#8217;s stock held by APC, was 10,584,340 and 10,299,259, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391610976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2017 Merger, the Company assumed the 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;), pursuant to which 500,000 shares of the Company&#8217;s common stock were reserved for issuance thereunder. The Company issued new shares to satisfy stock options and warrant exercises under the 2013 Plan. As of December&#160;31, 2023, there were no shares available for future grants under the 2013 Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2017 Merger, the Company assumed the 2015 Equity Incentive Plan (as amended, the &#8220;2015 Plan&#8221;), pursuant to which 1,500,000 shares of the Company&#8217;s common stock were reserved for issuance thereunder. The Company&#8217;s stockholders approved an amendment to the 2015 Plan at the 2021 annual meeting of stockholders to increase the maximum number of shares authorized for issuance thereunder by 2,000,000 shares, from 1,500,000 shares to 3,500,000 shares. In addition, shares that are subject to outstanding grants under the Company&#8217;s 2013 Plan, but that ordinarily would have been restored to such plans reserve due to award forfeitures and terminations, were rolled into and became available for awards under the 2015 Plan. The 2015 Plan provides for awards, including incentive stock options, non-qualified options, restricted common stock, and stock appreciation rights. The 2015 Plan was approved by Astrana&#8217;s stockholders at Astrana&#8217;s 2016 annual meeting of stockholders that was held in September 2016. As of December&#160;31, 2023, 2022 and 2021, there were approximately 0.4 million, 1.1 million and 1.7 million shares available for future grants under the 2015 Plan, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2023, the Company adopted the Employment Inducement Award Plan (the &#8220;Inducement Plan&#8221;), pursuant to which the Company may from time to time grant equity-based awards to new employees as a material inducement to their employment. Awards granted under the Inducement Plan may be in the form of non-qualified stock options, stock appreciation rights, restricted stock awards, restricted stock units, and other stock-based awards. A total of 500,000 shares of the Company&#8217;s common stock, par value $0.001 per share, have been reserved for issuance pursuant to awards granted under the Inducement Plan (subject to adjustment as provided in the Inducement Plan). As of December&#160;31, 2023, there were approximately 0.5 million shares available for future grants in the Inducement Plan.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock-based compensation expense recognized under all of the Company&#8217;s stock plans in 2023, 2022 and 2021, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income recognized (in thousands): </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,745&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized compensation expense related to total share-based payments outstanding as of December&#160;31, 2023 was $32.2&#160;million and is expected to be recognized over a weighted-average period of 2.1 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding stock options consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at January 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options canceled, forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215,609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023 and 2022, stock options were exercised for 140,000 and 41,603 shares, respectively, of the Company&#8217;s common stock, which resulted in proceeds of approximately $1.5 million and $0.7 million, respectively. The exercise prices ranged from $10.00 to $18.11 per share for the exercises during the year ended December&#160;31, 2023 and $15.35 to $23.24 per share for the exercises during the year ended December&#160;31, 2022. The total intrinsic value of stock options exercised was $3.5 million, $1.0 million and $2.8 million during the years ended December&#160;31, 2023, 2022 and 2021, respectively. The intrinsic value of stock options is defined as the difference between the Company&#8217;s stock price on the exercise date and the grant date exercise price. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, no options were granted. The weighted-average grant-date fair value of options granted during the years ended December&#160;31, 2022 and 2021 was $22.32, and $32.63, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unvested restricted stock award activity for the year ended December&#160;31, 2023 consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Based Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average <br/>Grant-Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average <br/>Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,632</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$72.58</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,635</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$41.14</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,228</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.90</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561,386</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.61</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260,637)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.39</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158,421)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.94</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,939)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.57</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,267)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.66</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713,284</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60.98</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,333</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35.05</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants restricted stock awards to employees and executives, which are earned based on service conditions. The awards will vest over a period of one month to four years in accordance with the terms of those plans. The grant date fair value of the restricted stock awards is the grant date&#8217;s closing market price of the Company&#8217;s common stock. During the year ended December&#160;31, 2023, the Company granted 561,386 shares of restricted stock awards with performance based conditions and 480,228 shares of restricted stock without performance conditions. During the year ended December&#160;31, 2023, the weighted average grant date fair value of restricted stock with and without performance based conditions was $33.61 and $33.90, respectively. Shares of restricted stock with performance conditions are recognized to the extent the performance conditions are probable of being achieved. The total fair value of restricted stock awards, as of their respective vesting dates during the years ended December&#160;31, 2023, 2022 and 2021, was $14.3 million, $10.8 million and $1.1 million, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants</span></div>All warrants issued by the Company expired as of December 31, 2022. As a result, there were no outstanding warrants as of December&#160;31, 2023 and December&#160;31, 2022. During the twelve months ended December&#160;31, 2022, common stock warrants were exercised for 0.9 million shares of the Company&#8217;s common stock, which resulted in proceeds of approximately $9.0 million. The exercise price ranged from $10.00 to $11.00 per share for the exercises during the twelve months ended December&#160;31, 2022. Of the 0.9 million warrants exercised during the year ended December&#160;31, 2022, 0.1 million of the common stock warrants were exercised by APC and are treated as treasury shares (see Note 12 &#8212; &#8220;Mezzanine and Stockholders&#8217; Equity&#8221;).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391543024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Matters</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws and regulations governing the Medicare program and healthcare generally are complex and subject to interpretation. The Company believes it complies with all applicable laws and regulations and is unaware of any pending or threatened investigations involving allegations of potential wrongdoing. While no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medi-Cal programs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a risk-bearing organization, the Company is required to follow regulations of the Department of Managed Health Care (&#8220;DMHC&#8221;). The Company must comply with a minimum working capital requirement, tangible net equity (&#8220;TNE&#8221;) requirement, cash-to-claims ratio, and claims payment requirements prescribed by the DMHC. TNE is defined as net assets less intangibles, less non-allowable assets (which include amounts due from affiliates), plus subordinated obligations.  At December&#160;31, 2023 and 2022, the consolidated IPAs were in compliance with these regulations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the Company&#8217;s payer and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services. Such differing interpretations may not come to light until a substantial period of time has passed following contract implementation. Liabilities for claims disputes are recorded when the loss is probable and can be estimated. Any adjustments to reserves are reflected in current operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standby Letters of Credit</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established irrevocable standby letters of credit with Truist Bank for a total of $36.5 million for the benefit of CMS and certain health plans as of December&#160;31, 2023 (see Note 10 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank for a total of $3.9 million, for the benefit of certain health plans as of December&#160;31, 2023 (see Note 10 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of its business. The resolution of any claim or litigation is subject to inherent uncertainty and could have a material adverse effect on the Company&#8217;s financial condition, cash flows, or results of operations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability Insurance</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its insurance coverage is appropriate based upon the Company&#8217;s claims experience and the nature and risks of the Company&#8217;s business. In addition to the known incidents that have resulted in the assertion of claims, the Company cannot be certain that its insurance coverage will be adequate to cover liabilities arising out of claims asserted against the Company, the Company&#8217;s affiliated professional organizations or the Company&#8217;s affiliated hospitalists in the future where the outcomes of such claims are unfavorable. The Company believes that the ultimate resolution of all pending claims, including liabilities in excess of the Company&#8217;s insurance coverage, will not have a material adverse effect on the Company&#8217;s financial position, results of operations, or cash flows; however, there can be no assurance that future claims will not have such a material adverse effect on the Company&#8217;s business. Contracted physicians are required to obtain their own insurance coverage.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contracted physicians are required to carry first-dollar coverage with limits of liability equal to not less than $1.0&#160;million for claims based on occurrence up to an aggregate of $3.0&#160;million per year. The Company&#8217;s IPAs purchase stop-loss insurance, which will reimburse them for claims from service providers on a per enrollee basis. The specific retention amount per enrollee per policy period is $45,000 to $90,000 for professional coverage.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company currently maintains liability insurance policies on a claims-made basis, which are intended to cover malpractice liability and certain other claims, the coverage must be renewed annually, and may&#160;not continue to be available to the Company in future years at acceptable costs, and on favorable terms.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391534352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related-Party Transactions</a></td>
<td class="text">Related-Party Transactions<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Method Investments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022, and 2021, AHM recognized approximately $16.7 million, $21.2 million, and $18.7 million, respectively, in management fee income, from LMA. On August 31, 2023, the management service agreement between LMA&#8217;s IPA and AHM was terminated. LMA is accounted for under the equity method based on 25% equity ownership interest held by APC (see Note 6 &#8212; &#8220;Investments in Other Entities&#8221;). </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC paid approximately $2.7 million, $2.7 million and $2.4 million, respectively, to Pacific Medical Imaging and Oncology Center, Inc. (&#8220;PMIOC&#8221;) for provider services. APC and PMIOC have an Ancillary Service Contract together whereby PMIOC provides covered services on behalf of APC to enrollees of the plans of APC. PMIOC is accounted for under the equity method based on 40% equity ownership interest held by APC (see Note 6 &#8212; &#8220;Investments in Other Entities&#8221;).</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company paid approximately $1.1 million, to James Song, M.D., a Professional Corporation (&#8220;Song PC&#8221;) for provider services. Song PC is accounted for under the equity method accounting based on 25% equity ownership interest held by a subsidiary of the Company (see Note 6 &#8212; &#8220;Investments in Other Entities&#8221;).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Astrana Board Members and Officers</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, AHM recognized approximately $2.1 million, $1.8 million and $1.6 million, respectively, in management fee income from Arroyo Vista Family Health Center (&#8220;Arroyo Vista&#8221;). Arroyo Vista&#8217;s chief executive officer is a member of the Company&#8217;s board of directors. The Company has a managed service agreement with Arroyo Vista. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023 2022 and 2021, the Company paid approximately $0.3 million, $0.3&#160;million and $0.4&#160;million respectively, to Arroyo Vista for services as a provider. The Company has provider contracts with Arroyo Vista. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023, the Company recognized $14.1 million in operating lease right-of-use assets and $14.5 million in operating lease liabilities from certain lease agreements with properties that were spun-off as part of the Spin-Off. The chief executive officer of the real estate business managing these properties is also a member of the Company&#8217;s board of directors. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC paid approximately $0.3 million, $0.6 million and $0.7 million, respectively, to Advanced Diagnostic Surgery Center for services as a provider. Advanced Diagnostic Surgery Center shares common ownership with certain board members of Astrana. The Company has provider contracts with Advanced Diagnostic Surgery Center.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC recognized approximately $0.6 million, $0.6 million and $0.6 million respectively, in rental income from Advanced Diagnostic Surgery Center. Advanced Diagnostic Surgery Center is leasing from a property that is a component of Excluded Assets. The property was spun-off on December 26, 2023, as part of the Spin-Off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, APC paid approximately $10,000, $0.6 million and $2.0 million respectively, to Fulgent Genetics, Inc. for services as a provider. One of the Company&#8217;s board members is a board member of Fulgent Genetics, Inc. The Company has provider contracts with Fulgent Genetics, Inc.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company incurred approximately $1.3 million in expenses payable to Third Way Health for call center services. One of Astrana&#8217;s officers is a board member of Third Way Health in 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022 and 2021, the Company paid approximately $2.6 million, $1.9 million and $1.3 million, respectively, to Sunny Village Care Center for services as a provider. Sunny Village Care Center shares common ownership with certain Astrana board members and officers. The Company has provider contracts with Sunny Village Care Center. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023 and 2022, APC recognized approximately $1.1 million and $0.3 million, respectively, in rental income from Sunny Village Care Center. Sunny Village Care Center is leasing from a property that is a component of Excluded Assets. The property was spun-off on December 26, 2023 as part of the Spin-Off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Company entered into a three-year promissory note with Sunny Village Care Center as the borrower for a principal amount of $0.5 million. The loan balance is presented within long-term debt, net of current portion and deferred financing costs in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, the Company incurred rent expense of approximately $0.1 million from First Commonwealth Property, LLC for office leases. First Commonwealth Property, LLC shares common ownership with certain board members of Astrana. The Company has lease arrangements with First Commonwealth Property, LLC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, Astrana paid approximately $9.8 million, to purchase Astrana&#8217;s stock from certain board members. During the year ended December&#160;31, 2022, APC paid approximately $9.3 million to purchase Astrana&#8217;s stock from a board member. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, AHM paid approximately $44,000 to an Astrana board member for consulting services. The Company did not incur any similar expenses for the years ended December&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements with Health Source MSO Inc., a California corporation (&#8220;HSMSO&#8221;), Aurion Corporation (&#8220;Aurion&#8221;), and AHMC for services provided to the Company. One of the Company&#8217;s board members is an officer of AHMC, HSMSO, and Aurion. Aurion is also partially owned by one of the Company&#8217;s board members. Revenue with AHMC and HSMSO consists of capitation, risk pool, and miscellaneous fees and expenses consist of claims expense, management fees, and consulting fees. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth fees incurred and income received related to AHMC, HSMSO, and Aurion (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AHMC</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HSMSO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AURION</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AHMC</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HSMSO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AURION</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,634&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,587&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. Under this agreement, during the years ended December&#160;31, 2023, 2022 and 2021, the Company has recognized risk pool revenue of $43.8 million, $50.5 million and $60.1 million, respectively, of which $54.0 million and $58.7 million, remained outstanding as of December&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">APC Board Members</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022, and 2021, the Company paid an aggregate of approximately $23.1 million, $34.5 million, and $32.5 million, respectively, to board members for provider services which included approximately $4.2 million, $3.7 million and $3.4 million, respectively, to Astrana board members and officers who are also board members and officers of APC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 6, 2023, the Company entered into a stock repurchase agreement with APC, pursuant to which the Company agreed to repurchase approximately $100.0 million, or 3,166,561 shares, of the Company&#8217;s common stock from APC. APC is a consolidated affiliate of the Company of which Dr. Thomas Lam, the Company&#8217;s Co-Chief Executive Officer and President and a director, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder; Dr. Kenneth Sim, the Company&#8217;s Executive Chairman, is Chairman and a director and stockholder; and Dr. Albert Young, the Company&#8217;s Chief Administrative Officer, is Senor Executive Vice President and a stockholder. The Company&#8217;s Board of Directors and the Audit Committee of the Board of Directors approved the proposed repurchase.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, affiliates wholly owned by the Company&#8217;s key personnel, are reported in the accompanying consolidated statements of income on a consolidated basis, together with the Company&#8217;s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company&#8217;s subsidiaries as related-party transactions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intercompany Transactions</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of corporate practice of medicine laws, the Company uses designated shareholder professional corporations, of which the sole shareholder is a member of the Company&#8217;s key personnel, to engage in certain transactions and make intercompany loans from time to time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For equity method investments, loans receivable and line of credits from related parties, see Note 6 &#8212; &#8220;Investments in Other Entities,&#8221; and Note 7 &#8212; &#8220;Loans Receivable and Loan Receivable &#8212; Related Parties,&#8221; respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391543024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text">Employee Benefit PlanAHM has a qualified 401(k) plan that covers substantially all employees who have completed at least six months of service and meet minimum age requirements. Participants may&#160;contribute a portion of their compensation to the plan, up to the maximum amount permitted under Section 401(k) of the Internal Revenue Code. Participants become fully vested after six years of service. AHM matches a portion of the participants&#8217; contributions. AHM&#8217;s matching contributions for the years ended December&#160;31, 2023, 2022, and 2021 were approximately $0.7 million, $0.5 million and $0.4 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387443488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated using the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to Astrana by the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants. The non-controlling interests in APC are allocated their share of Astrana&#8217;s income from APC&#8217;s ownership of Astrana common stock and this is included in the net income attributable to non-controlling interests on the consolidated statements of income. Therefore, none of the shares of Astrana held by APC are considered outstanding for the purposes of basic or diluted earnings per share computation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, 2022 and 2021, APC held 7,132,698, 10,299,259 and 10,925,702 shares of Astrana's common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, restricted stock of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186,290, 133,480</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 9,137, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being anti-dilutive. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023 and 2022, restricted stock with performance conditions of 782,484 and 245,478, respectively, were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of December&#160;31, 2023 or 2022, as applicable.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the earnings per share computations:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share &#8211; basic</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share &#8211; diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,553,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,971,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,828,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,943,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,602,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,403,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the shares included in the diluted earnings per share computations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:64.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,553,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,971,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,828,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,943,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,602,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,403,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391633824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (VIEs)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities (VIEs)</a></td>
<td class="text">Variable Interest Entities (VIEs)<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated financial statements include its subsidiaries and consolidated VIEs. A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity&#8217;s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states have laws that prohibit business entities with non-physician owners, such as Astrana and its subsidiaries, from practicing medicine, employing physicians to practice medicine, or exercising control over medical decisions by physicians. These laws are generally referred to as corporate practice of medicine laws. States that have corporate practice of medicine laws permit only physicians to practice medicine, exercise control over medical decisions, or engage in certain arrangements, such as fee-splitting, with physicians. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to these laws, the Company operates by maintaining long-term MSAs with its affiliated IPAs and medical groups, each of which is owned and operated by physicians only, and employs or contracts with additional physicians to provide medical services. AHM  is a wholly owned subsidiary of the Company and has entered into MSAs with several affiliated IPAs, including APC. APC contracts with various HMOs or licensed healthcare service plans, each of which pays a fixed payment (&#8220;capitation&#8221;). In return, APC arranges for the delivery of healthcare services by contracting with physicians or professional medical corporations for primary care and specialty care services. APC assumes the financial risk of the cost of delivering healthcare services in excess of the fixed amounts received. The risk is subject to stop-loss provisions in contracts with HMOs. Some risk is transferred to the contracted physicians or professional corporations. The physicians in the IPA are exclusively in control of, and responsible for, all aspects of the practice of medicine for enrolled patients. In accordance with relevant accounting guidance, APC has been determined to be a VIE of AHM, as AHM is its primary beneficiary with the ability, through majority representation on the APC Joint Planning Board and otherwise, to direct the activities (excluding clinical decisions) that most significantly affect APC&#8217;s economic performance. Therefore, APC and its wholly owned subsidiaries and VIEs are consolidated in the accompanying financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain state laws prohibit a professional corporation that has more than one shareholder from being a shareholder in another professional corporation. As a result, the Company cannot directly own shares in other professional corporations. However, an exception to this regulation permits a professional corporation that has only one shareholder to own shares in another professional corporation. In reliance on this exception, the Company designated certain key personnel as the nominee shareholder of professional corporations which hold controlling and non-controlling ownership interests in several medical corporations. Via a Physician Shareholder Agreement with the nominee shareholder. the Company has the ability to designate another person to be the equity holder of the professional corporation. In addition these entities are managed by the Company&#8217;s wholly owned MSOs via MSA. In accordance with relevant accounting guidance, the professional corporations, and their consolidated medical corporations are consolidated by the Company in the accompanying financial statements. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana Medical and Astrana Health Care Partners were formed in May 2019 and July 2021, respectively, as a designated shareholder professional corporation. The Company&#8217;s Vice Chairman is the sole shareholder of Astrana Medical and Astrana Health Care Partners via a Physician Shareholder Agreement, Astrana makes all the decisions on behalf of Astrana Medical and </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana Health Care Partners. Astrana has the obligation to absorb losses of, or the right to receive benefits from, Astrana Medical and Astrana Health Care Partners. Therefore, Astrana Medical and Astrana Health Care Partners are controlled by and consolidated by Astrana as the primary beneficiary of the VIEs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2023, Astrana Health Care Partners purchased 100% of certain Care Delivery companies (AMG, a Professional Medical Corporation, 1 World Medicine Urgent Care Corporation, and Eleanor Leung M.D., a Professional Medical Corporation) from APC. As a result, these entities are now consolidated by Astrana Health Care Partners instead of APC. On May 1, 2023, Astrana Health Care Partners sold 25% of Eleanor Leung M.D. to two of its physicians. As a result, Astrana Health Care Partners now owns 75% of Eleanor Leung M.D.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes assets that can only be used to settle the liabilities of the Company&#8217;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#8217;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to, or from, affiliates, which are eliminated upon consolidation, are included in the accompanying consolidated balance sheets (in thousands). </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net &#8211; related party</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable &#8212; related parties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts due from affiliates*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable, non-current </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other entities &#8211; equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in a privately held entity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount due to affiliates*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> *</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investment in affiliates represents APC&#8217;s investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#8217;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#8217;s consolidated balance sheets as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2023 and 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391593472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for corporate offices, physicians&#8217; offices, and certain equipment. This includes leases with properties that were spun-off as part of the Spin-Off. These leases have remaining lease terms ranging from one month to seventeen years, some of which may include options to extend the leases for up to ten years, and some of which may include options to terminate the leases within one year. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as Consumer Price Index.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, assets recorded under finance leases were $1.7 million and $1.8 million, respectively, and accumulated depreciation associated with finance leases was $1.6 million and $1.0 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company has entered into a lease arrangement for seven years with an option to extend an additional five years. The tentative move date is March 2024, once the unit is made available. Base rent during the initial seven-year term of the 2024 lease agreement will total $2.3 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,025)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,524&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/>Other information related to leases was as follows (dollars in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flows Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.73 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.66 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.00 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.41 years</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,896&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,033&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating and finance leases for corporate offices, physicians&#8217; offices, and certain equipment. This includes leases with properties that were spun-off as part of the Spin-Off. These leases have remaining lease terms ranging from one month to seventeen years, some of which may include options to extend the leases for up to ten years, and some of which may include options to terminate the leases within one year. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as Consumer Price Index.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, assets recorded under finance leases were $1.7 million and $1.8 million, respectively, and accumulated depreciation associated with finance leases was $1.6 million and $1.0 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company has entered into a lease arrangement for seven years with an option to extend an additional five years. The tentative move date is March 2024, once the unit is made available. Base rent during the initial seven-year term of the 2024 lease agreement will total $2.3 million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,025)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,524&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/>Other information related to leases was as follows (dollars in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flows Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.73 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.66 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.00 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.41 years</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,896&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,033&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391519264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segments<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its operating segments in accordance with ASC 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;). The Company currently has three reportable segments consisting of: 1) Care Partners; 2) Care Delivery; and 3) Care Enablement (See Note 1 &#8211; Description of Business). The Company&#8217;s reportable segments changed from one to three in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#8217;s chief operating decision maker when reviewing the Company&#8217;s performance as well as an effort to provide additional transparency to investors and other financial statement users which the Company believes will assist in the evaluation of changes in the operating results of the Company&#8217;s segments separate from non-operational factors that affect net income, thus providing insight into both operations and other factors impacting reported results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the performance of its operating segments based on segment revenue growth as well as operating income. Management uses revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors. The Company&#8217;s operations are based in the United States. All revenues of the Company are derived from the United States. The Company&#8217;s segments are not evaluated using asset information.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners with a shared vision for coordinated care delivery. Under relevant accounting guidance, while the Company&#8217;s Care Partners &#8211; IPAs and Care Partners &#8211; ACO are two operating segments, they share similar economic characteristics and meet other criteria, which permits the Company to aggregate them into a single reportable segment, which the Company has done. Revenue for this segment is primarily comprised of capitation and risk pool settlements and incentives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. The care delivery organization includes primary care, multi-specialty care, and ancillary care services. Revenue is primarily earned based on fee-for-service reimbursements, capitation, and performance-based incentives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Enablement segment is an integrated, end-to-end clinical and administrative platform powered by the Company&#8217;s proprietary technology suite, which provides operational, clinical, financial, technology, management, and strategic services to enable success in the delivering of high-quality, value-based care for providers and payers. Revenue for this segment is primarily comprised of management and software fees, charged as a percentage of gross revenue or on a per-member-per-month basis.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other is not a reportable segment and primarily consists of real estate operations and other entities that are individually immaterial. Revenue is primarily comprised of equipment sales and real estate revenue is presented in other income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company&#8217;s reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate costs are unallocated and primarily include corporate initiatives, corporate infrastructure costs and corporate shared costs, such as finance, human resources, legal, and executives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,284,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,386,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(170,116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(170,116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,386,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,182,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(166,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,208,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174,340)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,111)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,171)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,051,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,144,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,051,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,144,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">944,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125,823)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">944,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">966,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128,973)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,039,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,222&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,041&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,954)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,298&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,313)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,543)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">637,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(92,888)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">675,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,578&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,279)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,424)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance includes general and administrative expenses and depreciation and amortization. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span> Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391508496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements of Financial Instruments</a></td>
<td class="text">Fair Value Measurements of Financial Instruments<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of December&#160;31, 2023 are presented below (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAMG contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VOMG contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DMG remaining equity interest purchase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sun Labs remaining equity interest purchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate collar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,088&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Included in cash and cash equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of December&#160;31, 2022 are presented below (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,866&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAMG contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOMG contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG remaining equity interest purchase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun Labs remaining equity interest purchase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Included in cash and cash equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of existing Level 3 liabilities is recognized in <span style="-sec-ix-hidden:f-1895">unrealized loss on investments and general and administrative expenses</span> in the accompanying consolidated statements of income. As of December&#160;31, 2023, the reconciliation of our Level 3 liabilities was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of existing Level 3 liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,836&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, certificates of deposit amounted to approximately $2.2 million and $0, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, equity securities held by the Company are primarily comprised of common stock of Nutex Health, Inc. (formerly known as Clinigence Holdings, Inc.) (&#8220;Nutex&#8221;). In September 2021, Astrana and Nutex entered into a stock purchase agreement in which Astrana purchased shares of common stock, warrants, and potentially additional shares of common stock if certain metrics were not met (such additional shares &#8220;contingent equity securities&#8221;) for $3.0 million. The common stock is included in investments in marketable securities in the accompanying consolidated balance sheets. In May 2022, the Company exercised the warrants and subsequently recognized the shares within investments in marketable securities in the accompanying consolidated balance sheet. In March 2023, the contingent equity securities were settled and the Company received additional Nutex common stock. The additional common stock received from the contingent equity securities is included in investments in marketable securities in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the equity securities were approximately $0.3 million and $5.6 million, respectively, in the accompanying consolidated balance sheets. In December 2023, APC sold all of its common stock in a payer partner. The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total losses recognized on equity securities  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,629)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less (loss) gains recognized on equity securities sold  </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,052)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized losses recognized on equity securities held at end of period  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,577)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,441)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Swap Agreements and Collar Agreements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to interest rate risk on its floating-rate debt. APC&#8217;s Excluded Assets entered into interest rate swap agreements to effectively convert its floating-rate debt to a fixed-rate basis. The principal objective of these contracts was to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 10 - &#8220;Credit Facility, Bank Loans, and Lines of Credit,&#8221; for further information on the Company&#8217;s debt. Interest rate swap agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps. The estimated fair value of the interest rate swap agreements was determined using Level 2 inputs. On December 1, 2023, APC&#8217;s Excluded Assets ended the interest rate swap agreements. As of December&#160;31, 2022, the fair value was $3.2 million and was presented within other long-term assets in the accompanying consolidated balance sheets. For the years ended December&#160;31, 2023 and 2022, APC recognized unrealized gains of $0.2 million and $4.2&#160;million, respectively. The interest rate swaps were deemed Excluded Assets that were solely for the benefit of APC and its common shareholders.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s collar agreement is designed to limit the interest rate risk associated with the Company&#8217;s Revolver Loan. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 10 - &#8220;Credit Facility, Bank Loans, and Lines of Credit,&#8221; for further information on the Company&#8217;s </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt. Under the terms of the agreement, the ceiling is 5.0% and the floor is 2.34%. The collar agreement is not designated as a hedging instrument. Changes in the fair value on this contract is recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized loss on investments. The estimated fair value of the collar was determined using Level 2 inputs. As of December&#160;31, 2023 the fair value of the collar was $0.3&#160;million and was presented within other long-term liabilities in the accompanying consolidated balance sheets. For the year ended December&#160;31, 2023, the Company recognized an unrealized loss of $0.3&#160;million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent Equity Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Astrana was entitled to additional common stock if Nutex did not pay AHM management fees exceeding a threshold by the end of December 31, 2022. The contingent equity securities are considered to be derivatives but are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and accompanying consolidated statements of cash flows. The Company determined the fair value of the contingent equity security using a probability-weighted model, which includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of recognizing management fees and assigned probabilities to each such scenario in determining fair value. During the year ended December 31, 2023, the metric was not achieved. Subsequently, the common stock received from the contingent equity securities were accounted for as investments in marketable securities (refer to the subsection above on investments in marketable securities and Note 2 - &#8220;Basis of Presentation and Summary of Significant Accounting Policies&#8221; for further information on the Company&#8217;s investments in marketable securities). As of December&#160;31, 2022, the contingent equity securities were valued at $1.9 million and were presented within prepaid and other current assets in the accompanying consolidated balance sheets. For the year ended December&#160;31, 2022, when the equity securities were still contingent, the Company recognized unrealized losses of $2.4&#160;million.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining equity interest purchase</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the Company entered into a financing obligation to purchase the remaining equity interest in Diagnostic Medical Group of Southern California (&#8220;DMG&#8221;) and Sun Clinical Laboratories (&#8220;Sun Labs&#8221;) within three years from the date the Company consolidated DMG and Sun Labs. The purchase of the remaining DMG equity value is considered a financing obligation with a carrying value of $8.5 million as of both December&#160;31, 2023 and December&#160;31, 2022. Changes in the fair value of the remaining equity purchase are presented in unrealized loss on investments in the accompanying consolidated statements of income. The purchase of the remaining Sun Labs equity value is considered a financing obligation with a carrying value of $7.8 million and $5.8 million as of December&#160;31, 2023 and December&#160;31, 2022, respectively. For the years ended December&#160;31, 2023 and 2022, the change in the fair value of Sun Labs equity value obligation was $2.0&#160;million and $1.7&#160;million, respectively, and is presented in unrealized loss on investments in the accompanying consolidated statements of income. As the financing obligations are embedded in the non-controlling interest, the non-controlling interests are recognized in other liabilities as of December&#160;31, 2023 and other long-term liabilities as of December&#160;31, 2022 in the accompanying consolidated balance sheets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent considerations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VOMG</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon consolidating VOMG as a VIE, the purchase price consisted of cash funded upon the close of transaction and additional cash consideration (&#8220;VOMG contingent consideration&#8221;) contingent on VOMG meeting financial metrics for fiscal years 2023 and 2024. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). The contingent consideration is included within other long-term liabilities in the accompanying consolidated balance sheets. The contingent consideration was valued at $17,000 as of both December&#160;31, 2023 and December&#160;31, 2022. Changes in the VOMG contingent consideration are presented in general and administrative expenses in the accompanying consolidated statements of income.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AAMG </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon acquiring 100% of the equity interest in AAMG, the purchase price consisted of cash funded upon close of the transaction and additional consideration (&#8220;AAMG contingent consideration&#8221;) and stock consideration (&#8220;AAMG stock contingent consideration&#8221;) contingent on AAMG meeting revenue and capitated member metrics for fiscal years 2023 (&#8220;2023 metric&#8221;) and 2024 (&#8220;2024 metric&#8221;). If the contingent considerations are met, the settlement will be paid in the Company&#8217;s common stock. The total amount of stock that can be issued for the 2023 and 2024 metrics is 157,048 and 184,361, respectively. The Company determined the fair value of the contingent considerations using a probability-weighted model that includes significant </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AAMG contingent consideration for the 2023 metric was valued at $2.6&#160;million and presented within other liabilities in the accompanying consolidated balance sheets as of December&#160;31, 2023. The AAMG contingent consideration for the 2024 metric was valued at $2.9&#160;million and presented within other long-term liabilities in the accompanying consolidated balance sheets as of December&#160;31, 2023. As of December&#160;31, 2022, for capitated member metrics for fiscal years 2023 and 2024, the AAMG contingent consideration was valued at $5.9 million and was presented within other long-term liabilities in the accompanying consolidated balance sheets. Changes in the AAMG contingent consideration are presented in general and administrative expenses in the accompanying consolidated statements of income. The AAMG stock contingent consideration was valued at $5.6&#160;million as of December&#160;31, 2023 and 2022 and is included in additional paid-in capital in the accompanying consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391543024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drawdown on Term Loan and Revolver Loan</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2023, the Company drew down $20&#160;million on its Term Loan and $90&#160;million on its Revolver Loan. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Closing of Acquiring Community Family Care Medical Group IPA, Inc. (&#8220;CFC&#8221;) Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Company entered into an Asset and Equity Purchase Agreement (the &#8220;Purchase Agreement&#8221;) to acquire the partnership interests of Advanced Health Management Systems, L.P. (&#8220;AHMS&#8221;) and certain assets of Community Family Care Medical Group IPA, Inc. (&#8220;CFC&#8221;), which acquisitions the Company expected would occur in two separate closings. In November 2023, AHM also entered into a Stock Purchase Agreement (the &#8220;I Health Purchase Agreement&#8221;) to purchase 25% of the outstanding shares of common stock of I Health, Inc. (&#8220;I Health&#8221;). On January 31, 2024, the first closing under the Purchase Agreement occurred, and the Company completed its acquisition of CFC&#8217;s assets. The Company expects to complete the second closing under the Purchase Agreement and acquire the outstanding general and limited partnership interests of AHMS during the first quarter of 2024, subject to obtaining required regulatory approvals. It is currently expected that the I Health Purchase Agreement closing will occur during the first quarter of 2024. The purchase price consisted of $93.8&#160;million cash and 631,712 shares of common stock of the Company. In addition, the Purchase Agreement contains earnout payments of up to $15.0&#160;million cash. The Company is in the process of finalizing its purchase price allocation of CFC.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bass Medical Group</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 29, 2024, the Company announced its strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. Together, the two organizations will aim to bring high-quality care via value-based arrangements to patients of all insurance types, including Medicare, Medicaid, ACA Marketplace, and Commercial. Astrana has provided BASS Medical Group with a $20&#160;million senior secured promissory note (&#8220;BASS secured promissory note&#8221;),which is intended to be used, in partnership with Astrana, to continue to grow their footprint and invest in high-quality, high-value, and accessible primary and multi-specialty care for communities across California. The BASS secured promissory note matures on January 11, 2031 and has an interest rate per annum equal to 2.9% plus the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator) compounded annually.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advanced Diagnostic and Surgical Center, Inc.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 18, 2023, the Company acquired 95% of the equity interest of Advanced Diagnostic and Surgical Center, Inc. (&#8220;ADSC&#8221;). ADSC is a diagnostic and surgical center that also provides ambulatory surgery services. Certain Astrana board members previously owned ADSC. The transaction was funded with cash. In addition, the arrangement contains earnout payments. The Company is in the process of finalizing its purchase price allocation.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2024, the Company&#8217;s ESPP came into effect. The Company&#8217;s ESPP allows eligible employees to contribute a portion of their eligible earnings toward the semi-annual purchase of the Company&#8217;s common stock at a discounted price, subject to an annual maximum dollar amount. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Shared Savings Program (&#8220;MSSP&#8221;)</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2024, in addition to participating in the ACO REACH Model, one of the Company&#8217;s ACOs will participate in the Medicare Shared Savings Program (&#8220;MSSP&#8221;). The MSSP was created to promote accountability and improve coordination of care for Medicare beneficiaries. The MSSP has multiple risk tracks, and the Company is currently participating in the ENHANCED risk track. Much like the ACO REACH Model, under the MSSP Model, the Company recruits a group of Participant and Preferred (in-network) Providers. Based on the Participant Providers that join the Company&#8217;s ACO, CMS grants the Company a pool of Traditional Medicare patients (beneficiaries) to manage (the &#8220;MSSP Aligned Beneficiaries&#8221;). MSSP Aligned Beneficiaries will receive services from physicians and other medical service providers that are both in-network and out-of-network. Unlike the ACO REACH Program, CMS continues to pay participant and preferred providers on a fee-for-service basis for Medicare covered services provided to MSSP Aligned Beneficiaries. However, the Company continues to bear risk on all Medicare expenditures (both in-network and out-of-network), excluding drug expenditures covered by Medicare Part D, based on a budgetary benchmark established with CMS. The Company&#8217;s shared savings or losses in managing its beneficiaries are generally determined on an annual basis after reconciliation with CMS.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696378796672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 60,717<span></span>
</td>
<td class="nump">$ 45,171<span></span>
</td>
<td class="nump">$ 68,923<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387467216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387326528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared by management in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheets as of December&#160;31, 2023 and 2022 and consolidated statements of income for the years ended December&#160;31, 2023, 2022 and 2021 include Astrana&#8217;s wholly owned subsidiaries and consolidated variable interest entities (&#8220;VIEs&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts disclosed in prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications were made between other assets and investments in privately held entities on the accompanying consolidated balance sheet as of December 31, 2022. The reclassification had no effect on net income, earnings per share, retained earnings, cash flows or total assets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combinations and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including constraints, completion factors, and historical margins), income tax valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#8217;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#8217;s net assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A legal entity is determined to be a VIE if it has any of the following three characteristics:</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity does not have sufficient equity to finance its activities without additional subordinated financial support;</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or</span></div><div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:</span></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#8217;s economic performance, as evidenced by:</span></div><div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Substantive participating rights in day-to-day management of the entity&#8217;s activities; or</span></div><div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">Substantive kick-out rights over the party responsible for significant decisions;</span></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb the entity&#8217;s expected losses; or</span></div><div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The right to receive the entity&#8217;s expected residual returns.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company determines that any of the three characteristics of a VIE are met, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable interest model</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company &#8211; that is, the Company has:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The power to direct the activities of a VIE that most significantly influence the VIE&#8217;s economic performance (power), and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; to the consolidated financial statements for information on the Company&#8217;s consolidated VIEs. If there are variable interests in a VIE but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting, refer to Note 6 &#8211; &#8220;Investments in Other Entities&#8221; for entities that qualify as VIEs but the Company is not the primary beneficiary.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Reportable Segments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reportable Segments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as three reportable segments: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Delivery; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Enablement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 1 &#8212; &#8220;Description of Business&#8221; and Note 20 &#8212; &#8220;Segments&#8221; to the consolidated financial statements for information on the Company&#8217;s segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.</span></div>The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company believes it is not exposed to any significant credit risk with respect to its cash, cash equivalents, and restricted cash.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div>Restricted cash consists of cash held as collateral in the event of default as required by certain health plan contracts<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investments in Marketable Securities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase and such designation is reevaluated at each balance sheet date. Certificates of deposit in investments in marketable securities are reported at par value, plus accrued interest, with maturity dates greater than ninety days. Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, the Company classifies such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted-average share prices from observable market data.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Marketable Securities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, certificates of deposit amounted to approximately $2.2 million and $0, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock', window );">Receivables, Receivables &#8211; Related Parties, Other Receivables, Loan Receivable, and Loan Receivable - Related Party</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables, Receivables &#8211; Related Parties, Other Receivables, Loan Receivable, and Loan Receivable - Related Party</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivables are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated at the amount expected to be collected.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s loan receivable and loan receivable - related party consists of promissory notes that accrue interest per annum. As of December&#160;31, 2023, promissory notes are expected to be collected by their maturity date.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitation receivables relate to each health plan&#8217;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s hospital shared-risk pool receivable that is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately 18 months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#8220;FFS&#8221;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.</span></div>Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables, and the Company&#8217;s expectation is that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Risks</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div>The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Land, Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Land, Property, and Equipment, Net</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land is carried at cost and is not depreciated as it is considered to have an indefinite useful life.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, including leasehold improvements, are carried at cost less accumulated depreciation and amortization. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets ranging from <span style="-sec-ix-hidden:f-642">three</span> to thirty-nine years. Leasehold improvements are amortized on a straight-line basis over the shorter of the terms of the respective leases or the expected useful lives of those improvements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maintenance and repairs are charged to expense as incurred. Upon sale or retirement, the asset cost and related accumulated depreciation and amortization are removed from the accounts, and any related gain or loss is included in the determination of consolidated net income.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements of Financial Instruments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements of Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, long-term debt, and certain other liabilities. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 820&#8221;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This hierarchy prioritizes the inputs into three broad levels as follows:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212;Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#8217;s own data.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for these assets and liabilities for the years ended December&#160;31, 2023 and 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Intangible Assets and Long-Lived Assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Long-Lived Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives include network-payer relationships, management contracts, member relationships, subscriber relationships, and developed technology and are stated at cost, less accumulated amortization, and impairment losses. These intangible assets are amortized using the accelerated method based on the discounted cash flow rate or using the straight-line method.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite lives also include a patient management platform, as well as trade names and trademarks, whose valuations were determined using the cost to recreate method and the relief from royalty method, respectively. These assets are stated at cost, less accumulated amortization, and impairment losses, and are amortized using the straight-line method.</span></div>Finite-lived intangibles and other long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may&#160;not be recoverable. If the expected future cash flows from the use of such assets (undiscounted and without interest charges) are less than the carrying value, a write-down would be recorded to reduce the carrying value of the asset to its estimated fair value. Fair value is determined based on appropriate valuation techniques.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Indefinite-Lived Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under ASC 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles &#8211; Goodwill and Other,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> goodwill and indefinite-lived intangible assets are reviewed at least annually for impairment under a two step process. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Step 1&#8212;  Under a qualitative assessment, determine if there are indicators of impairment. If so, proceed to Step 2. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Step 2 &#8212; Under a quantitative assessment, if the fair value of each reporting unit is less than its carrying value, there is an impairment. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also elect to skip the qualitative testing and proceed directly to quantitative testing. The Company&#8217;s four reporting units consist of the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners &#8211; IPA;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Partners &#8211; ACO;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Delivery; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Care Enablement. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An impairment loss is recognized if the carrying value of a reporting unit exceeds its fair value. If this event arises, the impairment loss recorded is equal to the excess of the carrying value of the reporting unit over its fair value.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At least annually, indefinite-lived intangible assets are tested for impairment. Impairment for intangible assets with indefinite lives exists if the carrying value of the intangible asset exceeds its fair value. The fair values of indefinite-lived intangible assets are determined using valuation techniques based on estimates, judgments, and assumptions management believes are appropriate in the circumstances.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Investments in Other Entities - Equity Method and Investments in Privately Held Entities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Other Entities &#8211; Equity Method</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for certain investments using the equity method of accounting when it is determined that the investment provides the Company with the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee&#8217;s board of directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize the Company&#8217;s share of net earnings or losses of the investee and is recognized in the accompanying consolidated statements of income under &#8220;Income (loss) from equity method investments&#8221; and also is adjusted by contributions to and distributions from the investee. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Privately Held Entities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for certain investments using the cost method of accounting when it is determined that the investment provides the Company with little or no influence over the investee. Under the cost method of accounting, the investment is measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. The investments in privately held entities that do not report net asset value are subject to qualitative assessment for indicators of impairments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareCostsPolicyPolicyTextBlock', window );">Medical Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Liabilities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Care Partners segment is responsible for integrated care that the associated physicians and contracted hospitals provide to their enrollees. The Company&#8217;s Care Partners segment provides integrated care to HMOs, Medicare, and Medi-Cal enrollees through a network of contracted providers under sub-capitation and direct patient service arrangements. Medical costs for professional and institutional services rendered by contracted providers are recorded as cost of services, excluding depreciation and amortization, in the accompanying consolidated statements of income.</span></div>An estimate of amounts due to contracted physicians, hospitals, and other professional providers is included in medical liabilities in the accompanying consolidated balance sheets. Medical liabilities include claims reported as of the balance sheet date and estimated IBNR claims. Such estimates are developed using actuarial methods and are based on numerous variables, including the utilization of healthcare services, historical payment patterns, cost trends, product mix, seasonality, changes in membership, and other factors. The estimation methods and the resulting reserves are periodically reviewed and updated. Many of the medical contracts are complex in nature and may&#160;be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations may&#160;not come to light until a substantial period of time has passed following the contract implementation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiduciaryCashAndPayablePolicyTextBlock', window );">Fiduciary Cash and Payable</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiduciary Cash and Payable</span></div>The Company&#8217;s Care Partner segment collects cash from health plans on behalf of their sub-IPAs and providers and passes the money through to them.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives payments from the following sources for services rendered: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Commercial insurers;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal government under the Medicare program administered by CMS;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">State governments under Medicaid and other programs;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other third-party payers (e.g., hospitals and IPAs); and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Individual patients and clients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of the following:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Capitation revenue;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk pool settlements and incentives;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">GPDC/ACO REACH capitation revenue;</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management fee income; and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FFS revenue.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nature of Services and Revenue Streams</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH capitation revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. The following is a summary of the principal forms of the Company&#8217;s billing arrangements and how revenue is recognized for each.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capitation, Net</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed care revenues of the Company consist primarily of capitated fees for medical services provided by the Company under a capitated arrangement directly made with various managed care providers, including HMOs. Capitation revenue is </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">typically prepaid monthly to the Company based on the number of enrollees selecting the Company as their healthcare provider. Capitation revenue is recognized in the month in which the Company is obligated to provide services to plan enrollees under contracts with various health plans. Minor ongoing adjustments to prior months&#8217; capitation, primarily arising from contracted HMOs finalizing their monthly patient eligibility data for additions or subtractions of enrollees, are recognized in the month they are communicated to the Company. Additionally, Medicare pays capitation using a &#8220;Risk Adjustment&#8221; model, which compensates managed care organizations and providers based on the health status (acuity) of each individual enrollee. Health plans and providers with higher acuity enrollees will receive more and those with lower acuity enrollees will receive less. Under Risk Adjustment, capitation is determined based on health severity, measured using patient encounter data. Capitation is paid on a monthly basis based on data submitted for the enrollee for the preceding year and is adjusted in subsequent periods after the final data is compiled. Positive or negative capitation adjustments are made for Medicare enrollees with conditions requiring more or fewer healthcare services than assumed in the interim payments. Since the Company cannot reliably predict these adjustments, periodic changes in capitation amounts earned as a result of Risk Adjustment are recognized when those changes are communicated by the health plans to the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Per member per month (&#8220;PMPM&#8221;) managed care contracts generally have a term of one year or longer. The Company assesses the profitability of its managed care contracts to identify contracts where current operating results or forecasts indicate probable future losses. If anticipated future variable costs exceed anticipated future revenues, a premium deficiency reserve is recognized. No premium deficiency reserves were recorded as of December&#160;31, 2023. All managed care contracts have a single performance obligation that constitutes a series for the provision of managed healthcare services for a population of enrolled members for the duration of the contract. The transaction price for PMPM contracts is variable as it primarily includes PMPM fees associated with unspecified membership that fluctuates throughout the contract. In certain contracts, PMPM fees also include adjustments for items such as performance incentives, performance guarantees, and risk sharing. The Company generally estimates the transaction price using the most likely amount methodology and amounts are only included in the net transaction price to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The majority of the Company&#8217;s net PMPM transaction price relates specifically to the Company&#8217;s efforts to transfer the service for a distinct increment of the series (e.g., day or month) and is recognized as revenue in the month in which members are entitled to service.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">GPDC/ACO REACH Capitation Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS contracts with ACOs, which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC/ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, ACOs and providers. By entering into a contract with CMS, an ACO voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each ACO bears the economic costs, and reaps the economic rewards, of fulfilling its responsibilities and managing its risks as an ACO. APAACO has participated in ACO REACH, and its predecessor model, Global and Professional Direct Contracting Model (&#8220;GPDC Model&#8221;), since January 1, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the ACO&#8217;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#8217;s performance. ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties. ACO REACH capitation revenue is recognized in the accompanying consolidated statements of income under capitation, net.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Pool Settlements and Incentives</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain IPAs enter into hospital shared-risk capitation arrangements with certain health plans and local hospitals, where the hospital is responsible for providing, arranging and paying for institutional risk and the IPA is responsible for providing, arranging, and paying for professional risk. Under a hospital shared-risk pool-sharing agreement, the IPA generally receives a percentage of the net surplus from the affiliated hospital&#8217;s risk pools with HMOs after deductions for the affiliated hospital&#8217;s costs. Advance settlement payments are typically made quarterly in arrears if there is a surplus. The Company&#8217;s risk pool settlements under arrangements with health plans and hospitals are recognized using the most likely amount methodology and amounts are only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The assumptions for historical margin, IBNR completion factors, and constraint percentages were used by management in applying the most likely amount methodology.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitated arrangements with certain HMOs, certain IPAs participate in one or more health plan shared-risk arrangements relating to the provision of institutional services to enrollees and thus can earn additional revenue or incur losses based upon the enrollee utilization of institutional services. Health plan shared-risk arrangements are entered into with certain health plans, which are administered by the health plan, where the IPA is responsible for rendering professional services, but the health plan does not enter into a capitation arrangement with a hospital and therefore the health plan retains the institutional risk. Health plan shared-risk deficits, if any, are not payable until and unless (and only to the extent) risk-sharing surpluses are generated. At the termination of the HMO contract, any accumulated deficit will be extinguished.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's risk pool settlements under arrangements with HMOs are recognized, using the most likely methodology, and only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur. Given the lack of access to the health plans&#8217; data and control over the members assigned to the IPA, the adjustments and/or the withheld amounts are unpredictable and as such, the IPA&#8217;s risk-share revenues are deemed to be fully constrained until they are notified of the amount by the health plan. Final settlement of risk pools for prior contract years generally occur in the third or fourth quarter of the following year.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to risk-sharing revenues, the Company also receives incentives under &#8220;pay-for-performance&#8221; programs for quality medical care, based on various criteria. As an incentive to promote quality care, certain HMOs have designed quality incentive programs and commercial generic pharmacy incentive programs to compensate the Company for its efforts to improve the quality of services and efficient and effective use of pharmacy supplemental benefits provided to HMO members. The incentive programs track specific performance measures and calculate payments to the Company based on the performance measures. The Company&#8217;s incentives under &#8220;pay-for-performance&#8221; programs are recognized using the most likely methodology. However, as the Company does not have sufficient insight from the health plans on the amount and timing of the health plan shared-risk pool and incentive payments, these amounts are considered to be fully constrained and only recorded when such payments are known and/or received.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, for the foregoing arrangements, the final settlement is dependent on each distinct day&#8217;s performance within the annual measurement period but cannot be allocated to specific days until the full measurement period has occurred and performance can be assessed. As such, this is a form of variable consideration estimated at contract inception and updated through the measurement period (i.e., the contract year), to the extent the risk of reversal does not exist and the consideration is not constrained.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NGACO AIPBP Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the NGACO Model, CMS aligned beneficiaries to the Company to manage direct care and pay providers based on a budgetary benchmark established with CMS. The Company was responsible for managing medical costs for these beneficiaries. The beneficiaries received services from physicians and other medical service providers that were both in-network and out-of-network. The Company received capitation-like All Inclusive Population Based Payment (&#8220;AIPBP&#8221;) payments from CMS on a monthly basis to pay claims from in-network providers. The Company recorded such AIPBPs received from CMS as revenue as the Company was primarily responsible and liable for managing the patient care and for satisfying provider obligations, was assuming the credit risk for the services provided by in-network providers through its arrangement with CMS, and had control of the funds, the services provided and the process by which the providers were ultimately paid. Claims from out-of-network providers were processed and paid by CMS, while claims from APAACO&#8217;s in-network contracted providers were paid by APAACO. The Company&#8217;s shared savings or losses in managing the services provided by out-of-network providers were generally determined on an annual basis after reconciliation with CMS. Pursuant to the Company&#8217;s risk share agreement with CMS, the Company was eligible to receive the savings or was liable for the deficit according to the budget established by CMS based on the Company&#8217;s efficiency in managing how the beneficiaries aligned to the Company by CMS were served by in-network and out-of-network providers. The Company&#8217;s savings or losses on providing such services were both capped by CMS, </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and were subject to significant estimation risk, whereby payments would vary significantly depending upon certain patient characteristics and other variable factors. Accordingly, the Company recognized such surplus or deficit upon substantial completion of reconciliation and determination of the amounts. The Company recorded NGACO AIPBP revenues monthly. Excess AIPBPs over claims paid, plus an estimate for the related IBNR claims were deferred and recorded as a liability until actual claims were paid or incurred. CMS determined if there were any excess AIPBPs for the performance year and the excess was refunded to CMS. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each performance year, CMS paid the Company in accordance with the alternative payment mechanism, if any, for which CMS had approved the Company; the risk arrangement for which the Company has been approved by CMS, and was otherwise provided in an NGACO Participation Agreement between APAACO and CMS (the &#8220;Participation Agreement&#8221;). Following the end of each performance year and at such other times as would be required under the Participation Agreement, CMS would issue a settlement report to the Company setting forth the amount of any shared savings or shared losses and the amount of other monies. If CMS owed the Company shared savings or other monies, CMS would pay the Company in full within 30 days after the date on which the relevant settlement report was deemed final, except as provided in the Participation Agreement. If the Company owed CMS shared losses or other monies owed as a result of a final settlement, the Company would pay CMS in full within 30 days after the relevant settlement report was deemed final. If the Company failed to pay the amounts due to CMS in full within 30 days after the date of a demand letter or settlement report, CMS would assess simple interest on the unpaid balance at the rate applicable to other Medicare debts under current provisions of law and applicable regulations. In addition, CMS and the U.S. Department of the Treasury would use any applicable debt collection tools available to collect any amounts owed by the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company participated in the AIPBP track of the NGACO Model. Under the AIPBP track, CMS estimated the total annual expenditures for APAACO&#8217;s assigned patients and paid that projected amount to the Company in monthly installments, and the Company was responsible for all Part A and Part B costs for in-network participating providers and preferred providers contracted by the Company to provide services to the assigned patients.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As APAACO did not have sufficient insight into the financial performance of the shared risk pool with CMS because of unknown factors related to IBNR claims, risk adjustment factors, and stop-loss provisions, among other factors, an estimate couldn&#8217;t be developed. Due to these limitations, APAACO could not determine the amount of surplus or deficit that would likely be recognized in the future and therefore this shared risk pool revenue was considered fully constrained. With the ending of the NGACO Model on December 31, 2021, the Company no longer received AIPBPs but remained eligible to recognize any shared savings or loss for performance year 2021 upon issuance of the settlement report from CMS. Pursuant to the Participation Agreement, the Company recognized $48.8 million related to savings from the 2021 performance year as revenue in risk pool settlements and incentives in the accompanying consolidated statements of income for the year ended December 31, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Fee Income</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management fee income encompasses fees paid for management, physician advisory, healthcare staffing, administrative, and other non-medical services provided by the Company to IPAs, hospitals, and other healthcare providers. Such fees may be in the form of billings at agreed-upon hourly rates, percentages of gross revenue or fee collections, or amounts fixed on a monthly, quarterly, or annual basis. The revenue may include variable arrangements measuring factors, such as hours staffed, patient visits, or collections per visit, against benchmarks, and, in certain cases, may be subject to achieving quality metrics or fee collections. The Company recognizes such variable supplemental revenues in the period when such amounts are determined to be fixed and therefore contractually obligated as payable by the customer under the terms of the applicable agreement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides a significant service of integrating the services selected by the Company&#8217;s clients into one overall output for which the client has contracted. Therefore, such management contracts generally contain a single performance obligation. The nature of the Company&#8217;s performance obligation is to stand ready to provide services over the contractual period. Also, the Company&#8217;s performance obligation forms a series of distinct periods of time over which the Company stands ready to perform. The Company&#8217;s performance obligation is satisfied as the Company completes each period&#8217;s obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration from management contracts is variable in nature because the majority of the fees are generally based on revenue or collections, which can vary from period to period. The Company has control over pricing. Contractual fees are invoiced to the Company&#8217;s clients generally monthly and payment terms are typically due within 30 days. The variable consideration in the Company&#8217;s management contracts meets the criteria to be allocated to the distinct period of time to which it relates because (i) </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">it is due to the activities performed to satisfy the performance obligation during that period and (ii) it represents the consideration to which the Company expects to be entitled.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management contracts generally have terms ranging from <span style="-sec-ix-hidden:f-665">one</span> to thirty years, although they may be terminated earlier under the terms of the applicable contracts. Since the remaining variable consideration will be allocated to a wholly unsatisfied promise that forms part of a single performance obligation recognized under the series guidance, the Company has applied the optional exemption to exclude disclosure of the allocation of the transaction price to remaining performance obligations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fee-for-Service Revenue</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FFS revenue represents revenue earned under contracts in which the professional component of charges for medical services rendered by the Company&#8217;s affiliated physician-owned medical groups are billed and collected from third-party payers, hospitals, and patients. FFS revenue related to patient care services is reported net of contractual allowances and policy discounts and is recognized in the period in which the services are rendered to specific patients. All services provided are expected to result in cash flows and are therefore reflected as net revenue in the consolidated financial statements. The recognition of net revenue (gross charges, less contractual allowances) from such services is dependent on such factors as proper completion of medical charts following a patient visit, the forwarding of such charts to the Company&#8217;s billing center for medical coding and entering into the Company&#8217;s billing system and the verification of each patient&#8217;s submission or representation at the time services are rendered as to the payer(s) responsible for payment of such services. Revenue is recorded based on the information known at the time of entering such information into the Company&#8217;s billing systems, as well as an estimate of the revenue associated with medical services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is responsible for confirming member eligibility, performing program utilization review, potentially directing payment to the provider and accepting the financial risk of loss associated with services rendered, as specified within the Company&#8217;s client contracts. The Company has the ability to adjust contractual fees with clients and possesses the financial risk of loss in certain contractual obligations. These factors indicate the Company is the principal and, as such, the Company records gross fees contracted with clients in revenues.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consideration from FFS arrangements is variable in nature because fees are based on patient encounters, credits due to clients, and reimbursement of provider costs, all of which can vary from period to period.&#160;Patient encounters and related episodes of care and procedures qualify as distinct goods and services, provided simultaneously together with other readily available resources, in a single instance of service, and thereby constitute a single performance obligation for each patient encounter and, in most instances, occur at readily determinable transaction prices. As a practical expedient, the Company adopted a portfolio approach for the FFS revenue stream to group together contracts with similar characteristics and analyze historical cash collection trends. The contracts within the portfolio share the characteristics conducive to ensuring that the results do not materially differ under the new standard if it were to be applied to individual patient contracts related to each patient encounter. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating net FFS revenue is a complex process, largely due to the volume of transactions, the number and complexity of contracts with payers, the limited availability at times of certain patient and payer information at the time services are provided, and the length of time it takes for collections to fully mature. These expected collections are based on fees and negotiated payment rates in the case of third-party payers, the specific benefits provided for under each patient&#8217;s healthcare plans, mandated payment rates in the case of Medicare and Medicaid programs, and historical cash collections (net of recoveries) in combination with expected collections from third-party payers.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The relationship between gross charges and the transaction price recognized is significantly influenced by payer mix, as collections on gross charges may vary significantly, depending on whether the patients, to whom services are provided, in the period are insured and the contractual relationships with those payers. Payer mix is subject to change as additional patient and payer information is obtained after the period services are provided. The Company periodically assesses the estimates of unbilled revenue, contractual adjustments and discounts, and payer mix by analyzing actual results, including cash collections, against estimates. Changes in these estimates are charged or credited to the consolidated statements of income in the period that the assessment is made. Significant changes in payer mix, contractual arrangements with payers, specialty mix, acuity, general economic conditions, and healthcare coverage provided by federal or state governments or private insurers may have a significant impact on estimates and significantly affect the results of operations and cash flows.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues and receivables are recognized once the Company has satisfied its performance obligation. Accordingly, contract assets are comprised of receivables and receivables - related parties.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#211d1e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billing and accounting systems provide historical trends of cash collections and contractual write-offs, accounts receivable aging, and established fee adjustments from third-party payers. These estimates are recorded and monitored monthly as revenues are recognized.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The principal exposure for uncollectible fees for service visits is from self-pay patients and, to a lesser extent, for co-payments and deductibles from patients with insurance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities (Deferred Revenue)</span></div>Contract liabilities are recorded when cash payments are received in advance of the Company&#8217;s performance.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period of enactment. The Company records a valuation allowance to reduce deferred tax assets to an amount for which realization is more likely than not. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained upon examination by the tax authorities, based on the merits of the position. The Company&#8217;s policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. To date, there have been no interest or penalties incurred in relation to the unrecognized tax benefits.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a stock-based compensation program for employees, non-employees, directors, and consultants. From time to time, the Company issues shares of its common stock to its employees, directors, and consultants, which shares may be subject to the Company&#8217;s repurchase right (but not obligation), that vests based on time-based and/or performance-based vesting schedules. The value of share-based awards is recognized as compensation expense and adjusted for forfeitures as they occur. Compensation expenses for time-based awards are recognized on a cumulative straight-line basis over the vesting period of the awards. Share-based awards with performance conditions are recognized to the extent the performance conditions are probable of being achieved. Compensation expenses for performance-based awards are recognized on an accelerated attribution method. The grant date fair value of the restricted stock awards is the grant date&#8217;s closing market price of the Company&#8217;s common stock. The fair value of options granted is determined using the Black-Scholes option pricing model and includes several assumptions, including expected term, expected volatility, expected dividends, and risk-free rates. The expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. The expected stock price volatility is determined based on an average of historical volatility. The expected dividend yield is based on the Company&#8217;s expected dividend payouts. The risk-free interest rate is based on the U.S. Constant Maturity curve over the expected term of the option at the time of grant.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basic and Diluted Earnings Per Share</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) is computed by dividing net income attributable to holders of the Company&#8217;s common stock by the weighted-average number of shares of common stock outstanding during the periods presented. Diluted earnings per share is computed using the weighted-average number of shares of common stock outstanding, plus the effect of dilutive securities outstanding during the periods presented, using the treasury stock method. Refer to Note 17 &#8212; &#8220;Earnings Per Share&#8221; for a discussion of shares treated as treasury shares for accounting purposes.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_MinorityInterestPolicyPolicyTextBlock', window );">Noncontrolling Interests</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-controlling Interests</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consolidates entities in which the Company has a controlling financial interest. The Company consolidates subsidiaries in which the Company holds, directly or indirectly, more than 50% of the voting rights, and VIEs in which the Company is the primary beneficiary. Non-controlling interests represent third-party equity ownership interests (including equity ownership interests held by certain VIEs) in the Company&#8217;s consolidated entities. Net income attributable to non-controlling interests is disclosed in the consolidated statements of income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TemporaryEquityPolicyPolicyTextBlock', window );">Mezzanine Equity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mezzanine Equity</span></div>Pursuant to APC&#8217;s shareholder agreements, in the event of a disqualifying event, as defined in the agreements, APC could be required to repurchase its shares from the respective shareholders based on certain triggers outlined in the shareholder agreements. As the redemption feature of the shares is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as mezzanine or temporary equity. Accordingly, the Company recognizes non-controlling interests in APC as mezzanine equity in the consolidated financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at its inception. The expected term of the lease used for computing the lease liability and right-of-use asset and determining the classification of the lease as operating or financing may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company elected practical expedients for ongoing accounting that is provided by the standard comprised of the following: </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The election for classes of underlying assets to not separate non-lease components from lease components, and</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The election for short-term lease recognition exemption for all leases under twelve-month terms.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The present value of the lease payments is calculated using a rate implicit in the lease, when readily determinable. However, as most of the Company&#8217;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to determine the present value of the lease payments for the majority of its leases.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BeneficialInterestPolicyTextBlock', window );">Beneficial Interest</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Interest</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, APC received a beneficial interest as a result of selling one of its equity method investments, pursuant to the terms of the stock purchase agreement. The estimated fair value of such interest in April 2020 was&#160;$15.7&#160;million. In 2021, the beneficial interest was determined to not be collectible and the $15.7&#160;million was written off and expensed in other income (expense) in the accompanying consolidated statements of income for the year ended December 31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Standards Accounting Board (FASB) issued Accounting Standards Update (ASU) 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for the Company&#8217;s annual periods beginning January 1, 2024, and for interim periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09 "Income Taxes (Topics 740): Improvements to Income Tax Disclosures" to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#8217;s annual periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Swap Agreements and Collar Agreements</span></div>The Company is exposed to interest rate risk on its floating-rate debt. APC&#8217;s Excluded Assets entered into interest rate swap agreements to effectively convert its floating-rate debt to a fixed-rate basis. The principal objective of these contracts was to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 10 - &#8220;Credit Facility, Bank Loans, and Lines of Credit,&#8221; for further information on the Company&#8217;s debt. Interest rate swap agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps. The estimated fair value of the interest rate swap agreements was determined using Level 2 inputs. On December 1, 2023, APC&#8217;s Excluded Assets ended the interest rate swap agreements. As of December&#160;31, 2022, the fair value was $3.2 million and was presented within other long-term assets in the accompanying consolidated balance sheets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BeneficialInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Beneficial Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BeneficialInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FiduciaryCashAndPayablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiduciary Cash and Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FiduciaryCashAndPayablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_MinorityInterestPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minority Interest Policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_MinorityInterestPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Receivables and receivables from related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_TemporaryEquityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_TemporaryEquityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-2AA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accruing health care costs for a prepaid health care service provider.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480292/954-405-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 720<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480409/954-720-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391604416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregated Revenue by Payor Type</a></td>
<td class="text">The following table presents disaggregated revenue generated by each payer type (in thousands):<div style="margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171,723&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,322</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633,463</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,286</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,093</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,083</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,311</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third parties</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,198</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,894</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,985</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386,661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,144,163&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773,915&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Revenue by Major Customers by Reporting Segments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Less than 10% of total net revenues</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had major payers that contributed to the following percentages of net receivables and receivables - related parties:</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payer E</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391594032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Asset Acquisitions, and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Summary of Goodwill Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying value of goodwill for the years ended December&#160;31, 2023 and 2022 was as follows (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,831&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385318624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Land, Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Land, Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land, property, and equipment, net consisted of (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful Life (Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 39</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 7</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 39</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,876)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,047)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property, and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,171&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,536&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Certain land, property, and equipment, net that were deemed Excluded Assets that are solely for the benefit of APC and its common shareholders were spun-off as part of the Spin-Off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696381694080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful<br/>Life<br/>(Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>January 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment/<br/>Disposal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104,859)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-14</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(131,268)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful<br/>Life<br/>(Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross January 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment/<br/>Disposal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite Lived Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename/trademarks</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,611)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,861&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2023, intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful<br/>Life<br/>(Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>January 1, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment/<br/>Disposal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net<br/>December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite lived assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104,859)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-14</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename/trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202,916&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(131,268)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.819%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Useful<br/>Life<br/>(Years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross January 1, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment/<br/>Disposal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross<br/>December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net<br/>December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite Lived Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortized intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Network relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11-21</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(95,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management contracts</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Member relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient management platform</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,060)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tradename/trademarks</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Developed technology</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,729&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,743&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(118,611)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76,861&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Amortization Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):</span></div><div style="margin-top:17pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,818&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391752816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments, Financial Statement Information</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2023 and 2022, the Company&#8217;s equity method investment balance consisted of the following (in thousands):</span></div><div style="margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2022</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Initial Investment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjustment of Fair Value*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(187)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(508)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,916)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other **</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,579&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,351&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,480)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,774&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-Off. On the date of distribution, the investments were recorded at fair value. The gain, representing the difference between the fair value and the carrying value of the investment, was $3.4 million and is presented within other income in the accompanying consolidated statement of net income. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Other consists of smaller equity method investments. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Ownership</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Allocation of Net Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funding Reclassified to Loan Receivable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Funding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Entity Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LaSalle Medical Associates &#8211; IPA Line of Business</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,775&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,684&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531 W. College, LLC *</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One MSO, LLC *</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tag-6 Medical Investment Group, LLC*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CAIPA MSO, LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,715&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,622&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,418)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(600)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,299&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-off. Refer to Note 1 &#8212; &#8220;Description of Business&#8221; to the consolidated financial statements for information on the Spin-Off.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391654432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Expenses</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts payable and accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accruals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitation payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subcontractor IPA payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to related parties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other provider payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accounts payable and accrued expenses</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,949&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,562&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391650576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Medical Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s medical liabilities consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities, beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired (see Note 3)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">866,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,566)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical care costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852,935&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651,831&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for medical care costs related to claims incurred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(559,751)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior periods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(836,050)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(626,900)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities, end of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,657&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387404752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Credit Facility</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s debt balance consists of the following (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real Estate Loans*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction Loan *</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note Payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unamortized financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Long-term debt </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,389&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>*These loans are a component of Excluded Assets that are solely for the benefit of APC and its common shareholders.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Commitments of Credit Facility</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the future commitments of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385145168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.184%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,638)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,552)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,444)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,278)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,671&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,989&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,875&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation for Provision for Income Taxes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes differs from the amount computed by applying the federal income tax rate as follows:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax provision at U.S. federal statutory rates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes net of federal benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible permanent items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable interest entities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of investment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOL adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undistributed dividend</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off transaction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Deferred Tax Assets (Liabilities)</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the Company&#8217;s deferred tax assets (liabilities) as of December&#160;31, 2023 and 2022, are shown below (in thousands).</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax assets </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for bad debts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in other entities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets before valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,904)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,936)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(648)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(725)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Undistributed dividend</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,454)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,214)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,919)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,072)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,217)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696388139456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the stock-based compensation expense recognized under all of the Company&#8217;s stock plans in 2023, 2022 and 2021, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income recognized (in thousands): </span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,792&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,040&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,101&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,745&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Transactions Under Stock Option Plans</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s outstanding stock options consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate<br/>Intrinsic<br/>Value<br/>(in millions)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at January 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options canceled, forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215,609)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.03&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466,411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.36&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Share-based Payment Arrangement, Restricted Stock Activity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unvested restricted stock award activity for the year ended December&#160;31, 2023 consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.278%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Based Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average <br/>Grant-Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average <br/>Grant-Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539,632</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$72.58</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,635</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$41.14</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,228</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.90</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561,386</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.61</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260,637)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.39</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158,421)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.94</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,939)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.57</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,267)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.66</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713,284</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60.98</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627,333</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35.05</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391650576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Fees Incurred and Revenue Earned from Related Party Transactions</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth fees incurred and income received related to AHMC, HSMSO, and Aurion (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AHMC</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HSMSO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AURION</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AHMC</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HSMSO</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AURION</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,634&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,587&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696386816848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share Computations</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the earnings per share computations:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share &#8211; basic</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share &#8211; diluted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,553,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,971,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,828,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,943,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,602,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,403,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Shares Included in the Diluted Earnings Per Share Computations</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the shares included in the diluted earnings per share computations:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:64.589%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,553,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,971,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,828,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently issuable shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares of common stock outstanding &#8211; diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,943,140&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,602,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,403,085&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391825808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (VIEs) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Assets and Liabilities, Variable Interest Entities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table includes assets that can only be used to settle the liabilities of the Company&#8217;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#8217;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to, or from, affiliates, which are eliminated upon consolidation, are included in the accompanying consolidated balance sheets (in thousands). </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net &#8211; related party</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable &#8212; related parties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts due from affiliates*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land, property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,951&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes receivable, non-current </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in other entities &#8211; equity method</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in a privately held entity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in affiliates*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,707&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiduciary accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount due to affiliates*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,072&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,563&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> *</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investment in affiliates represents APC&#8217;s investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#8217;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#8217;s consolidated balance sheets as of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2023 and 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391587856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Expense and Other Information Related to Lease Costs</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">564&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,025)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,524&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,607&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/>Other information related to leases was as follows (dollars in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Cash Flows Information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">486&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.73 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.66 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.00 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.41 years</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted-Average Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Leases, Future Minimum Lease Payments After Adoption of 842</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,896&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,033&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Finance Lease, Future Minimum Lease Payments After Adoption of 842</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancellable leases as of December&#160;31, 2023 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Years ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,749&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,844&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,896&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,033&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391800320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Information about our Segments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,284,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,386,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(170,116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,300,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(170,116)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,386,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,182,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(166,417)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,171,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,208,391&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174,340)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,302,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,111)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33,171)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,051,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,806&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,144,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,675)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,051,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(124,675)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,144,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">944,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(125,823)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">944,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">966,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(128,973)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,039,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,222&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,971&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,041&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,954)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,298&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,313)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Partners</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Delivery</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Care Enablement</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment Elimination</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Costs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third Party</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intersegment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,543)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,691&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90,543)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">773,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">607,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(89,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">596,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,097)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">637,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(92,888)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">675,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,578&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,499&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,279)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,424)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98,179&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance includes general and administrative expenses and depreciation and amortization. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span> Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696391536736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Carrying Amounts and Fair Values of Financial Instruments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of December&#160;31, 2023 are presented below (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AAMG contingent consideration</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VOMG contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DMG remaining equity interest purchase</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sun Labs remaining equity interest purchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,802&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate collar</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,836&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,088&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Included in cash and cash equivalents</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and fair values of the Company&#8217;s financial instruments as of December&#160;31, 2022 are presented below (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair&#160;Value&#160;Measurements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market accounts*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities &#8211; equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,164&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,866&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AAMG contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOMG contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DMG remaining equity interest purchase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun Labs remaining equity interest purchase</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Included in cash and cash equivalents</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Change in Fair Value of Level 3 Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of existing Level 3 liabilities is recognized in <span style="-sec-ix-hidden:f-1895">unrealized loss on investments and general and administrative expenses</span> in the accompanying consolidated statements of income. As of December&#160;31, 2023, the reconciliation of our Level 3 liabilities was as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of existing Level 3 liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APCMG contingent consideration paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,836&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of Gain (Loss) on Equity Securities</a></td>
<td class="text">The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:<div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total losses recognized on equity securities  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,629)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less (loss) gains recognized on equity securities sold  </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,052)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized losses recognized on equity securities held at end of period  </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,577)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,441)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2C<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696382071296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 26, 2023 </div>
<div>USD ($) </div>
<div>unit</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_RestructuringSpinoffTransactionPercentage', window );">Spinoff transaction, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits', window );">Spinoff transaction, number of membership units per common share | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_RestructuringSpinoffTransactionDividendRealEstateOperations', window );">Spinoff transaction, dividend, real estate operations portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 190.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Fair value, net asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_RestructuringSpinoffTransactionDividendRealEstateOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Spinoff Transaction, Dividend, Real Estate Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_RestructuringSpinoffTransactionDividendRealEstateOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_RestructuringSpinoffTransactionNumberOfMembershipUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Spinoff Transaction, Number Of Membership Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_RestructuringSpinoffTransactionNumberOfMembershipUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_RestructuringSpinoffTransactionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Spinoff Transaction, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_RestructuringSpinoffTransactionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696379553744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>unit </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Amount deposit accounts exceeded FDIC insured limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 318,900,000<span></span>
</td>
<td class="nump">$ 324,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear', window );">Risk pool surplus or deficits, settlement period after performance year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of main reporting units | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,737,000<span></span>
</td>
<td class="nump">8,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,386,661,000<span></span>
</td>
<td class="nump">1,144,163,000<span></span>
</td>
<td class="nump">773,915,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 744,000<span></span>
</td>
<td class="nump">531,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Voting rights held (more than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_UniversalCareIncMember', window );">Universal Care Inc | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet', window );">Additional proceeds to be received from sale of equity method investments, if circumstances met</a></td>
<td class="nump">$ 15,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=asth_AccountsPayableAndAccruedExpensesMember', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_CMSMember', window );">CMS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport', window );">Expected period of payment upon termination of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=asth_PerMemberPerMonthManagedCareContractMember', window );">PMPM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming', window );">Contract term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=asth_RiskPoolSettlementsAndIncentivesMember', window );">Risk Pool Settlements and Incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember', window );">Management fee income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,677,000<span></span>
</td>
<td class="nump">$ 41,094,000<span></span>
</td>
<td class="nump">$ 35,959,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Management fee income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_RevenuePaymentTerms', window );">Revenue, payment terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Management fee income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_RevenuePaymentTerms', window );">Revenue, payment terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_MarketableSecuritiesCurrentMaturityPeriod', window );">Marketable securities, current, maturity period (greater than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Proceeds To Be Received From Sale Of Equity Method Investments, If Circumstances Met</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FiduciaryAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FiduciaryAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_MarketableSecuritiesCurrentMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Current, Maturity Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_MarketableSecuritiesCurrentMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_RevenuePaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Payment Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_RevenuePaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Expected Timing Of Satisfaction, Period Of Payment Upon Finalization Of Settlement Report</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risk Pool Surplus Or Deficits, Settlement Period After Performance Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfTiming</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_UniversalCareIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_UniversalCareIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=asth_AccountsPayableAndAccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=asth_AccountsPayableAndAccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_CMSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_CMSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=asth_PerMemberPerMonthManagedCareContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=asth_PerMemberPerMonthManagedCareContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=asth_RiskPoolSettlementsAndIncentivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=asth_RiskPoolSettlementsAndIncentivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696388179440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Disaggregation of Revenue by Payor Type (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,386,661<span></span>
</td>
<td class="nump">$ 1,144,163<span></span>
</td>
<td class="nump">$ 773,915<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=asth_CommercialMember', window );">Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">167,048<span></span>
</td>
<td class="nump">171,723<span></span>
</td>
<td class="nump">138,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=asth_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">901,322<span></span>
</td>
<td class="nump">633,463<span></span>
</td>
<td class="nump">307,286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=asth_MedicaidMember', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">266,093<span></span>
</td>
<td class="nump">280,083<span></span>
</td>
<td class="nump">283,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=asth_OtherThirdPartiesMember', window );">Other third parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 52,198<span></span>
</td>
<td class="nump">$ 58,894<span></span>
</td>
<td class="nump">$ 44,985<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_CommercialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_CommercialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_OtherThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_OtherThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385513280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Contributions to Revenue and Receivables by Payor (Details) - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net revenue | Payer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net revenue | Payer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">38.80%<span></span>
</td>
<td class="nump">34.20%<span></span>
</td>
<td class="nump">11.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net revenue | Payer C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">10.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net revenue | Payer D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Gross receivables | Payer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Gross receivables | Payer E</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">52.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696379478624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Oct. 14, 2022</div></th>
<th class="th"><div>Apr. 19, 2022</div></th>
<th class="th"><div>Jan. 27, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_ForYourBenefitIncMember', window );">For Your Benefit Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember', window );">AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">$ 5,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,849<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationStockContingentConsiderationLiability', window );">Business combination, stock contingent consideration, liability</a></td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_ValleyOaksMedicalGroupMember', window );">Valley Oaks Medical Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_JadeHealthCareMedicalGroupIncMember', window );">Jade Health Care Medical Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember', window );">Orma Health, Inc., and Provider Growth Solutions LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationStockContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Stock Contingent Consideration, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationStockContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_ForYourBenefitIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_ForYourBenefitIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_AAMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_ValleyOaksMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_ValleyOaksMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_JadeHealthCareMedicalGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_JadeHealthCareMedicalGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696392051584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Asset Acquisitions, and Goodwill - Goodwill Roll Forward (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning Balance</a></td>
<td class="nump">$ 269,053<span></span>
</td>
<td class="nump">$ 246,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">7,866<span></span>
</td>
<td class="nump">21,486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="nump">1,912<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending Balance</a></td>
<td class="nump">$ 278,831<span></span>
</td>
<td class="nump">$ 269,053<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 16<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696381945424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Land, Property and Equipment, Net - Schedule of Land, Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Land, property and equipment, gross</a></td>
<td class="nump">$ 30,047<span></span>
</td>
<td class="nump">$ 132,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(22,876)<span></span>
</td>
<td class="num">(24,047)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Land, property, and equipment, net</a></td>
<td class="nump">$ 7,171<span></span>
</td>
<td class="nump">108,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Land, property and equipment, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">32,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Land, property and equipment, gross</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">58,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Land, property and equipment, gross</a></td>
<td class="nump">$ 4,923<span></span>
</td>
<td class="nump">4,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Land, property and equipment, gross</a></td>
<td class="nump">$ 18,854<span></span>
</td>
<td class="nump">17,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Land, property and equipment, gross</a></td>
<td class="nump">$ 340<span></span>
</td>
<td class="nump">12,801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Land, property and equipment, gross</a></td>
<td class="nump">$ 5,930<span></span>
</td>
<td class="nump">$ 7,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696378934128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Land, Property and Equipment, Net - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Assets recorded under finance leases</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation expense</a></td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696386990544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite-lived Intangible Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(131,268,000)<span></span>
</td>
<td class="num">(118,611,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">69,498,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross</a></td>
<td class="nump">202,916,000<span></span>
</td>
<td class="nump">195,472,000<span></span>
</td>
<td class="nump">187,729,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired', window );">Additions</a></td>
<td class="nump">7,444,000<span></span>
</td>
<td class="nump">7,743,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment/ Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">71,648,000<span></span>
</td>
<td class="nump">76,861,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember', window );">Network relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Beginning Balance, Gross</a></td>
<td class="nump">150,679,000<span></span>
</td>
<td class="nump">150,679,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment/ Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(104,859,000)<span></span>
</td>
<td class="num">(95,451,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Ending Balance, Gross</a></td>
<td class="nump">150,679,000<span></span>
</td>
<td class="nump">150,679,000<span></span>
</td>
<td class="nump">150,679,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 45,820,000<span></span>
</td>
<td class="nump">$ 55,228,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember', window );">Network relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember', window );">Network relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_ManagementContractsMember', window );">Management contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Beginning Balance, Gross</a></td>
<td class="nump">$ 22,832,000<span></span>
</td>
<td class="nump">$ 22,832,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment/ Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(16,662,000)<span></span>
</td>
<td class="num">(15,208,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Ending Balance, Gross</a></td>
<td class="nump">22,832,000<span></span>
</td>
<td class="nump">22,832,000<span></span>
</td>
<td class="nump">22,832,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">6,170,000<span></span>
</td>
<td class="nump">$ 7,624,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember', window );">Member relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Beginning Balance, Gross</a></td>
<td class="nump">16,633,000<span></span>
</td>
<td class="nump">$ 8,997,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Additions</a></td>
<td class="nump">7,444,000<span></span>
</td>
<td class="nump">7,636,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment/ Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(7,345,000)<span></span>
</td>
<td class="num">(5,619,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Ending Balance, Gross</a></td>
<td class="nump">24,077,000<span></span>
</td>
<td class="nump">16,633,000<span></span>
</td>
<td class="nump">8,997,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 16,732,000<span></span>
</td>
<td class="nump">$ 11,014,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember', window );">Member relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember', window );">Member relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_PatientManagementPlatformMember', window );">Patient management platform</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Beginning Balance, Gross</a></td>
<td class="nump">$ 2,060,000<span></span>
</td>
<td class="nump">$ 2,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment/ Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,060,000)<span></span>
</td>
<td class="num">(2,060,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Ending Balance, Gross</a></td>
<td class="nump">2,060,000<span></span>
</td>
<td class="nump">2,060,000<span></span>
</td>
<td class="nump">2,060,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Tradename/trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Beginning Balance, Gross</a></td>
<td class="nump">$ 1,011,000<span></span>
</td>
<td class="nump">$ 1,011,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment/ Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(308,000)<span></span>
</td>
<td class="num">(257,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Ending Balance, Gross</a></td>
<td class="nump">1,011,000<span></span>
</td>
<td class="nump">1,011,000<span></span>
</td>
<td class="nump">1,011,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 703,000<span></span>
</td>
<td class="nump">$ 754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRollForward', window );"><strong>Amortized intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Beginning Balance, Gross</a></td>
<td class="nump">$ 107,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment/ Disposal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(34,000)<span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Ending Balance, Gross</a></td>
<td class="nump">107,000<span></span>
</td>
<td class="nump">107,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">73,000<span></span>
</td>
<td class="nump">91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward', window );"><strong>Indefinite-lived Intangible Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Beginning Balance</a></td>
<td class="nump">2,150,000<span></span>
</td>
<td class="nump">2,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Ending Balance</a></td>
<td class="nump">$ 2,150,000<span></span>
</td>
<td class="nump">$ 2,150,000<span></span>
</td>
<td class="nump">$ 2,150,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite and Indefinite Lived Intangible Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_PatientManagementPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_PatientManagementPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696378942880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 12.7<span></span>
</td>
<td class="nump">$ 13.7<span></span>
</td>
<td class="nump">$ 15.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember', window );">Network relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_ManagementContractsMember', window );">Management contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember', window );">Member relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">11 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Tradename/trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">13 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntangibleAssetsAmortizationPeriodMember', window );">Amortized Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntangibleAssetsAmortizationPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntangibleAssetsAmortizationPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696392802560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Future Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 12,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">11,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">10,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">8,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">7,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">18,390<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 69,498<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696386552720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities - Schedule of Equity Method Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 40,299<span></span>
</td>
<td class="nump">$ 41,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="nump">5,579<span></span>
</td>
<td class="nump">5,622<span></span>
</td>
<td class="num">$ (4,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified to Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">2,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdjustmentToFairValue', window );">Adjustment to fair value</a></td>
<td class="nump">3,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsConsolidated', window );">Entity Consolidated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,418)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="num">(24,480)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 25,774<span></span>
</td>
<td class="nump">$ 40,299<span></span>
</td>
<td class="nump">41,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember', window );">LaSalle Medical Associates &#8211; IPA Line of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 5,684<span></span>
</td>
<td class="nump">$ 3,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="nump">4,182<span></span>
</td>
<td class="nump">4,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified to Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdjustmentToFairValue', window );">Adjustment to fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsConsolidated', window );">Entity Consolidated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 9,866<span></span>
</td>
<td class="nump">$ 5,684<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PacificMedicalImagingAndOncologyCenterIncMember', window );">Pacific Medical Imaging &amp; Oncology Center, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 1,878<span></span>
</td>
<td class="nump">$ 1,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="num">(187)<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified to Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdjustmentToFairValue', window );">Adjustment to fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsConsolidated', window );">Entity Consolidated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 1,691<span></span>
</td>
<td class="nump">$ 1,878<span></span>
</td>
<td class="nump">1,719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_FiveThreeOneW.CollegeLLCMember', window );">531 W. College, LLC *</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 17,281<span></span>
</td>
<td class="nump">$ 17,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="num">(508)<span></span>
</td>
<td class="num">(619)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified to Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdjustmentToFairValue', window );">Adjustment to fair value</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsConsolidated', window );">Entity Consolidated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="num">(17,564)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17,281<span></span>
</td>
<td class="nump">17,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_OneMSOLLCMember', window );">One MSO, LLC *</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 2,718<span></span>
</td>
<td class="nump">$ 2,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="nump">938<span></span>
</td>
<td class="nump">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified to Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdjustmentToFairValue', window );">Adjustment to fair value</a></td>
<td class="nump">3,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsConsolidated', window );">Entity Consolidated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="num">(6,916)<span></span>
</td>
<td class="num">(600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,718<span></span>
</td>
<td class="nump">2,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CAIPAMSOMember', window );">CAIPA MSO, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 12,738<span></span>
</td>
<td class="nump">$ 11,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="nump">922<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified to Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdjustmentToFairValue', window );">Adjustment to fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsConsolidated', window );">Entity Consolidated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">13,660<span></span>
</td>
<td class="nump">$ 12,738<span></span>
</td>
<td class="nump">11,992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_Tag6MedicalInvestmentGroupLLCMember', window );">Tag-6 Medical Investment Group, LLC*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable', window );">Funding Reclassified to Loan Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsConsolidated', window );">Entity Consolidated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,418)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 4,830<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_OtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsContribution', window );">Funding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdjustmentToFairValue', window );">Adjustment to fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 557<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentAdditionalInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Additional Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentAdditionalInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentAdjustmentToFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Adjustment To Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentAdjustmentToFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Funding Reclassified to Loan Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentsConsolidated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Consolidated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentsConsolidated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentsContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Contribution</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentsContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the entity's equity method investment which has been sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSoldCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PacificMedicalImagingAndOncologyCenterIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PacificMedicalImagingAndOncologyCenterIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_FiveThreeOneW.CollegeLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_FiveThreeOneW.CollegeLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_OneMSOLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_OneMSOLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CAIPAMSOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CAIPAMSOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_Tag6MedicalInvestmentGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_Tag6MedicalInvestmentGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696381616752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 01, 2019</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=asth_MediPortalLLCMember', window );">MediPortal LLC | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares', window );">Membership interests purchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments', window );">Payments to purchase membership interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest', window );">Membership interests acquired (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Term of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption', window );">Term of option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests', window );">Options to purchase additional membership interests (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet', window );">Number of warrants available to purchase, contingent upon the portal completion date (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=asth_AchievaMedInc.Member', window );">AchievaMed, Inc. | Network Medical Management, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears', window );">Percentage of voting common stock, within five years</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment', window );">Duration of investment</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost', window );">Investment amount</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=asth_ThirdWayHealthIncMember', window );">Third Way Health, Inc | Network Medical Management, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=asth_SeenHealthIncMember', window );">Seen Health, Inc | Network Medical Management, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost', window );">Investment amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Options Issued, Option To Purchase Additional Interests, If Circumstances Met</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value Investments, Options Issued, Term Of Option</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value Investments, Aggregate Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value Investments, Duration Of Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value Investments, Membership Interest Acquired, Per Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value Investments, Options Issued, Option To Purchase Additional Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value Investments, Proportion of Ownership Interest in Voting Common Stock, Within Five Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value Investments, Purchase Of Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Equity Securities Without Readily Determinable Fair Value Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=asth_MediPortalLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=asth_MediPortalLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=asth_AchievaMedInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=asth_AchievaMedInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_NetworkMedicalManagementIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_NetworkMedicalManagementIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=asth_ThirdWayHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=asth_ThirdWayHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=asth_SeenHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=asth_SeenHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696379527504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loan Receivable and Loan Receivable &#8211; Related Parties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 27, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loans receivable, non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,473<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_IntraCareConvertiblePromissoryNoteReceivableMember', window );">IntraCare Convertible Promissory Note Receivable | Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt</a></td>
<td class="nump">8.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Revolving credit facility term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loans receivable, non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_NetworkMedicalManagementMember', window );">NMM | LMA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable | Pacific6 | NMM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable | APC LSMA | LMA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Amount of loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FinanceReceivableInterestRateStatedPercentage', window );">Note receivable, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FinanceReceivableInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Receivable, Interest Rate, Stated Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FinanceReceivableInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_IntraCareConvertiblePromissoryNoteReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_IntraCareConvertiblePromissoryNoteReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_NetworkMedicalManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_NetworkMedicalManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_Pacific6EnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_Pacific6EnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_ApcLsmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_ApcLsmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_LmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_LmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385571408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other accruals</a></td>
<td class="nump">$ 9,075<span></span>
</td>
<td class="nump">$ 10,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SpecialtyCapitationPayableCurrent', window );">Capitation payable</a></td>
<td class="nump">4,503<span></span>
</td>
<td class="nump">4,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SubcontractorIpaRiskPoolPayable', window );">Subcontractor IPA payable</a></td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">2,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">4,407<span></span>
</td>
<td class="nump">2,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyDepositLiabilities', window );">Due to related parties</a></td>
<td class="nump">9,271<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">744<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">20,098<span></span>
</td>
<td class="nump">15,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other provider payable</a></td>
<td class="nump">9,322<span></span>
</td>
<td class="nump">10,600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued expenses</a></td>
<td class="nump">$ 59,949<span></span>
</td>
<td class="nump">$ 49,562<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_SpecialtyCapitationPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of specialty capitation payable current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_SpecialtyCapitationPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_SubcontractorIpaRiskPoolPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of subcontractor IPA risk pool payable current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_SubcontractorIpaRiskPoolPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyDepositLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deposits held by the entity for a related party (entity, shareholder, employee).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyDepositLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696388147312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Medical Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities, beginning of year</a></td>
<td class="nump">$ 81,255<span></span>
</td>
<td class="nump">$ 55,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquired (see Note 3)</a></td>
<td class="nump">6,157<span></span>
</td>
<td class="nump">2,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_MedicalCareCostsAbstract', window );"><strong>Components of medical care costs related to claims incurred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current period</a></td>
<td class="nump">866,501<span></span>
</td>
<td class="nump">646,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior periods</a></td>
<td class="num">(13,566)<span></span>
</td>
<td class="nump">5,152<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total medical care costs</a></td>
<td class="nump">852,935<span></span>
</td>
<td class="nump">651,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PaymentsForMedicalCareCostsAbstract', window );"><strong>Payments for medical care costs related to claims incurred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current period</a></td>
<td class="num">(759,354)<span></span>
</td>
<td class="num">(559,751)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior periods</a></td>
<td class="num">(76,696)<span></span>
</td>
<td class="num">(67,149)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="num">(836,050)<span></span>
</td>
<td class="num">(626,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease', window );">Adjustments</a></td>
<td class="nump">2,360<span></span>
</td>
<td class="num">(2,415)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities, end of year</a></td>
<td class="nump">$ 106,657<span></span>
</td>
<td class="nump">$ 81,255<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_MedicalCareCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medical Care Costs [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_MedicalCareCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_PaymentsForMedicalCareCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Medical Care Costs [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_PaymentsForMedicalCareCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 40<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 40<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of increase (decrease) in the liability for unpaid claims and claims adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 40<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387348528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 282,000<span></span>
</td>
<td class="nump">$ 207,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of debt</a></td>
<td class="num">(19,500)<span></span>
</td>
<td class="num">(619)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Unamortized financing costs</a></td>
<td class="num">(3,561)<span></span>
</td>
<td class="num">(3,319)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">258,939<span></span>
</td>
<td class="nump">203,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=asth_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">280,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RealEstateLoanMember', window );">Real Estate Loans*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=asth_ConstructionLoanMember', window );">Construction Loan *</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Promissory Note Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolver Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=asth_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=asth_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RealEstateLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RealEstateLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=asth_ConstructionLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=asth_ConstructionLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385146640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 19,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2025</a></td>
<td class="nump">15,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2026</a></td>
<td class="nump">21,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2027</a></td>
<td class="nump">22,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2028</a></td>
<td class="nump">203,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total</a></td>
<td class="nump">$ 282,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696380062128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Credit Facility (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 03, 2023</div></th>
<th class="th"><div>Jun. 16, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Sep. 08, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_UnamortizedDeferredFinancingCosts', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,561,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,319,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Astrana Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolver Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts', window );">Proceeds from (repayments of) bank overdrafts</a></td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=asth_NewTermLoanMember', window );">New Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Required annual facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Revolver Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.69%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Revolver Loan | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Letter of Credit | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtInstrumentCovenantLeverageRatioMaximum', window );">Maximum consolidated leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtCovenantAggregatePurchasePriceMaximum', window );">Debt covenant, aggregate purchase price, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange', window );">Consolidated leverage ratio, annual change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum', window );">Maximum adjusted consolidated leverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum', window );">Minimum consolidated interest coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedAndRestatedCreditAgreementMember', window );">Amended and Restated Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedAndRestatedCreditAgreementMember', window );">Amended and Restated Credit Agreement | Line of Credit | Truist Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LineOfCreditFacilityAmountFundedAtClosing', window );">Line of credit facility, amount funded at closing</a></td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedAndRestatedCreditAgreementMember', window );">Amended and Restated Credit Agreement | Secured Debt | Truist Bank | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedAndRestatedCreditAgreementMember', window );">Amended and Restated Credit Agreement | Secured Debt | Truist Bank | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedAndRestatedCreditAgreementMember', window );">Amended and Restated Credit Agreement | Secured Debt | Truist Bank | Debt Instrument, Redemption, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedAndRestatedCreditAgreementMember', window );">Amended and Restated Credit Agreement | Revolver Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Required annual facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Amended Credit Agreement | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Required annual facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Amended Credit Agreement | Secured Overnight Financing Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Amended Credit Agreement | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Required annual facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Amended Credit Agreement | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Required annual facility fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Amended Credit Agreement | Secured Overnight Financing Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Amended Credit Agreement | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DebtCovenantAggregatePurchasePriceMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant, Aggregate Purchase Price, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DebtCovenantAggregatePurchasePriceMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DebtInstrumentCovenantInterestCoverageRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DebtInstrumentCovenantLeverageRatioIncrementalChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Incremental Change</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DebtInstrumentCovenantLeverageRatioIncrementalChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LineOfCreditFacilityAmountFundedAtClosing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Amount Funded At Closing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LineOfCreditFacilityAmountFundedAtClosing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_UnamortizedDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unamortized Deferred Financing Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_UnamortizedDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 835<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479359/835-30-S45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfBankOverdrafts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow from the excess drawing from an existing cash balance, which will be honored by the bank but reflected as a loan to the drawer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfBankOverdrafts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_AstranaMedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_AstranaMedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=asth_NewTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=asth_NewTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_AmendedAndRestatedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_AmendedAndRestatedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=asth_SecuredOvernightFinancingRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=asth_SecuredOvernightFinancingRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696386567584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Lines of Credit (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 25, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 14, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 10, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NumberOfRealEstateLoans', window );">Number of real estate loans | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,102,000<span></span>
</td>
<td class="nump">$ 7,920,000<span></span>
</td>
<td class="nump">$ 5,394,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_A120HellmanLLCMember', window );">120 Hellman LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_A120HellmanLLCMember', window );">120 Hellman LLC | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_RealEstateLoanOneMember', window );">Real Estate Loan One | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_RealEstateLoanOneMember', window );">Real Estate Loan One | APC | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_RealEstateLoanTwoMember', window );">Real Estate Loan Two | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_RealEstateLoanTwoMember', window );">Real Estate Loan Two | APC | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_RealEstateLoanThreeMember', window );">Real Estate Loan Three | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_RealEstateLoanThreeMember', window );">Real Estate Loan Three | APC | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_ConstructionLoanMember', window );">Construction Loan * | Tag-8 Medical Investment Group, LLC &#8212; related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500,000<span></span>
</td>
<td class="nump">$ 10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_SubordinatedLoanAgreementMember', window );">Subordinated Loan Agreement | Subordinated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_SubordinatedLoanAgreementMember', window );">Subordinated Loan Agreement | Prime Rate | Subordinated Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.19%<span></span>
</td>
<td class="nump">3.22%<span></span>
</td>
<td class="nump">2.06%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_ApcBusinessLoanAgreementMember', window );">APC Business Loan Agreement | APC | Line of Credit | Preferred Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_ApcBusinessLoanAgreementMember', window );">APC Business Loan Agreement | APC | Standby Letters of Credit | Truist Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Truist Bank | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NumberOfRealEstateLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Real Estate Loans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NumberOfRealEstateLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_A120HellmanLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_A120HellmanLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_RealEstateLoanOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_RealEstateLoanOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_RealEstateLoanTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_RealEstateLoanTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_RealEstateLoanThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_RealEstateLoanThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_ConstructionLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_ConstructionLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_Tag8MedicalInvestmentGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_Tag8MedicalInvestmentGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_SubordinatedLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_SubordinatedLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SubordinatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SubordinatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_ApcBusinessLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_ApcBusinessLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=asth_PreferredBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=asth_PreferredBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696389003760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Benefit) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 35,434<span></span>
</td>
<td class="nump">$ 35,365<span></span>
</td>
<td class="nump">$ 15,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">8,999<span></span>
</td>
<td class="nump">19,788<span></span>
</td>
<td class="nump">8,399<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax expense (benefit)</a></td>
<td class="nump">44,433<span></span>
</td>
<td class="nump">55,153<span></span>
</td>
<td class="nump">24,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(3,638)<span></span>
</td>
<td class="num">(11,552)<span></span>
</td>
<td class="nump">3,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(8,806)<span></span>
</td>
<td class="num">(2,726)<span></span>
</td>
<td class="nump">3,793<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax expense (benefit)</a></td>
<td class="num">(12,444)<span></span>
</td>
<td class="num">(14,278)<span></span>
</td>
<td class="nump">7,671<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 31,989<span></span>
</td>
<td class="nump">$ 40,875<span></span>
</td>
<td class="nump">$ 31,693<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696388937984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Provision for Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax provision at U.S. federal statutory rates</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes net of federal benefit</a></td>
<td class="nump">11.60%<span></span>
</td>
<td class="nump">12.10%<span></span>
</td>
<td class="nump">12.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment', window );">Non-deductible permanent items</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary', window );">Variable interest entities</a></td>
<td class="num">(2.10%)<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="num">(1.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(2.60%)<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent', window );">Gain on sale of investment</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="num">(2.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent', window );">NOL adjustment</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent', window );">Undistributed dividend</a></td>
<td class="num">(11.50%)<span></span>
</td>
<td class="nump">7.20%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent', window );">Spin-off transaction</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Effective income tax rate</a></td>
<td class="nump">35.50%<span></span>
</td>
<td class="nump">47.10%<span></span>
</td>
<td class="nump">41.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the effective income tax rate reconciliation of federal rate adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Net Operating Loss Adjustment, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Spin-off Transaction, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Credit, Change In Investment, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Undistributed Dividend, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696379468832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal corporate tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 5,904<span></span>
</td>
<td class="nump">$ 8,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance, increase (decrease)</a></td>
<td class="num">(2,400)<span></span>
</td>
<td class="num">$ (4,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_OperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards, not subject to expiration</a></td>
<td class="nump">5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember', window );">California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 44,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_OperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Not Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_OperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696386762608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets (Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsStateTaxes', window );">State taxes</a></td>
<td class="nump">$ 2,831<span></span>
</td>
<td class="nump">$ 2,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">1,747<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for bad debts</a></td>
<td class="nump">1,718<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DeferredTaxAssetsInvestment', window );">Investment in other entities</a></td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">2,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">7,551<span></span>
</td>
<td class="nump">9,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">10,897<span></span>
</td>
<td class="nump">6,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities', window );">Unrealized gain</a></td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">8,971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock options</a></td>
<td class="nump">663<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets before valuation allowance</a></td>
<td class="nump">28,046<span></span>
</td>
<td class="nump">31,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(5,904)<span></span>
</td>
<td class="num">(8,292)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">22,142<span></span>
</td>
<td class="nump">23,702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(329)<span></span>
</td>
<td class="num">(1,840)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Acquired intangible assets</a></td>
<td class="num">(15,301)<span></span>
</td>
<td class="num">(21,268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right-of-use assets</a></td>
<td class="num">(9,936)<span></span>
</td>
<td class="num">(5,632)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts', window );">Debt issuance cost</a></td>
<td class="num">(648)<span></span>
</td>
<td class="num">(725)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend', window );">Undistributed dividend</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,454)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(26,214)<span></span>
</td>
<td class="num">(37,919)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (4,072)<span></span>
</td>
<td class="num">$ (14,217)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DeferredTaxAssetsInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DeferredTaxAssetsInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Deferred Expense, Undistributed Dividend</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696381864368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mezzanine and Stockholders&#8217; Equity (Deficit) - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 14, 2023</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Oct. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringPeriodSharesMerger', window );">Holdback shares not issued to former shareholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of ordinary dividends common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,074<span></span>
</td>
<td class="nump">$ 14,030<span></span>
</td>
<td class="nump">$ 31,089<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,584,340<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,451,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,192<span></span>
</td>
<td class="nump">$ 9,250<span></span>
</td>
<td class="nump">5,739<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of ordinary dividends common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 210,900<span></span>
</td>
<td class="nump">$ 37,900<span></span>
</td>
<td class="nump">29,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,132,698<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC | AP-AMH | Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions of preferred returns</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,000<span></span>
</td>
<td class="nump">$ 58,300<span></span>
</td>
<td class="nump">57,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC | ApolloMed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.22%<span></span>
</td>
<td class="nump">18.12%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_CDSCMember', window );">CDSC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of ordinary dividends common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_CompanyAndAPCMember', window );">Company and APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,584,340<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AstranaMember', window );">Astrana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,166,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock, liquidation preference (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares purchased by related party (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">555,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of warrant, number of securities called by each warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise&#160;Price&#160;Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Purchase of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred stock, liquidation preference (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares purchased by related party (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,111,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of warrant, number of securities called by each warrant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise&#160;Price&#160;Per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Purchase of treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_StockIssuedDuringPeriodSharesMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_StockIssuedDuringPeriodSharesMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_APAMHMedicalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_APAMHMedicalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_ApolloMedicalHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_ApolloMedicalHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_CDSCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_CDSCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_CompanyAndAPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_CompanyAndAPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AstranaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AstranaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696386494752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 15, 2023</div></th>
<th class="th"><div>Dec. 08, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares issued for exercise of options and warrants (in shares)</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="nump">41,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.32<span></span>
</td>
<td class="nump">$ 32.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod', window );">Warrants exercises in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised', window );">Warrant issued during period value stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod', window );">Warrants exercises in period (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock awards granted (in shares)</a></td>
<td class="nump">561,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance', window );">Contingent on performance (in shares)</a></td>
<td class="nump">480,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value granted (in dollars per share)</a></td>
<td class="nump">$ 33.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of awards</a></td>
<td class="nump">$ 14.3<span></span>
</td>
<td class="nump">$ 10.8<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=asth_PerformanceBasedRestrictedStockMember', window );">Performance Based Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value granted (in dollars per share)</a></td>
<td class="nump">$ 33.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 15.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice', window );">Share-based compensation arrangement by share based payment award, warrant exercised, exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 18.11<span></span>
</td>
<td class="nump">23.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice', window );">Share-based compensation arrangement by share based payment award, warrant exercised, exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=asth_ApcStockOptionMember', window );">APC Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Proceeds for exercise of options and warrants</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=asth_EquityIncentivePlanTwentyThirteenMember', window );">2013 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=asth_EquityIncentivePlanTwentyFifteenMember', window );">Equity Incentive Plan Twenty Fifteen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of share available for grant (in shares)</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 32.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, weighted-average period</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other Than Options, Contingent On Performance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_WarrantIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Issued During Period Value Stock Options Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_WarrantIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=asth_PerformanceBasedRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=asth_PerformanceBasedRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=asth_ApcStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=asth_ApcStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=asth_EquityIncentivePlanTwentyThirteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=asth_EquityIncentivePlanTwentyThirteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=asth_EquityIncentivePlanTwentyFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=asth_EquityIncentivePlanTwentyFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696379231712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Share-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 22,040<span></span>
</td>
<td class="nump">$ 16,101<span></span>
</td>
<td class="nump">$ 6,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">1,790<span></span>
</td>
<td class="nump">3,792<span></span>
</td>
<td class="nump">2,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=asth_StockAwardsAndUnitsMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 20,250<span></span>
</td>
<td class="nump">$ 12,309<span></span>
</td>
<td class="nump">$ 4,265<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=asth_StockAwardsAndUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=asth_StockAwardsAndUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696381687664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">504,241<span></span>
</td>
<td class="nump">859,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(140,000)<span></span>
</td>
<td class="num">(41,603)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options canceled, forfeited or expired (in shares)</a></td>
<td class="num">(215,609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">504,241<span></span>
</td>
<td class="nump">859,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable (in shares)</a></td>
<td class="nump">466,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 25.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share)</a></td>
<td class="nump">10.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options canceled, forfeited or expired (in dollars per share)</a></td>
<td class="nump">16.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">34.03<span></span>
</td>
<td class="nump">$ 25.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options exercisable (in dollars per share)</a></td>
<td class="nump">$ 28.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted-Average Remaining Contractual Term (Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">2 years 2 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable</a></td>
<td class="text">1 year 10 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value (in millions)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding</a></td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="nump">$ 10.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable</a></td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385125232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares) | shares</a></td>
<td class="nump">539,632<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock awards granted (in shares) | shares</a></td>
<td class="nump">480,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(260,637)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(45,939)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, ending balance (in shares) | shares</a></td>
<td class="nump">713,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 72.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value granted (in dollars per share) | $ / shares</a></td>
<td class="nump">33.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">39.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">36.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 60.98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=asth_PerformanceBasedRestrictedStockUnitsMember', window );">Performance Based Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, beginning balance (in shares) | shares</a></td>
<td class="nump">289,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock awards granted (in shares) | shares</a></td>
<td class="nump">561,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(158,421)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(65,267)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, ending balance (in shares) | shares</a></td>
<td class="nump">627,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 41.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value granted (in dollars per share) | $ / shares</a></td>
<td class="nump">33.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">37.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">42.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 35.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=asth_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=asth_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385117760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 10, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Insurance liabilities</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ClaimsBasedOnOccurrenceAnAggregateAmount', window );">Claims based on occurrence an aggregate amount</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional coverage</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional coverage</a></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | APC Business Loan Agreement | Truist Bank | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ClaimsBasedOnOccurrenceAnAggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Claims Based On Occurrence An Aggregate Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ClaimsBasedOnOccurrenceAnAggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_ApcBusinessLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_ApcBusinessLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696381512928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 14, 2023</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,386,661<span></span>
</td>
<td class="nump">$ 1,144,163<span></span>
</td>
<td class="nump">$ 773,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,396<span></span>
</td>
<td class="nump">20,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,192<span></span>
</td>
<td class="nump">$ 9,250<span></span>
</td>
<td class="nump">5,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,584,340<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_Tag2PromissoryNoteMember', window );">Tag-2 Promissory Note | Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=asth_SpinOffTransactionMember', window );">Spin-Off Transaction | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=asth_CallCenterServicesMember', window );">Call Center Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember', window );">LaSalle Medical Associates &#8211; IPA Line of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_SongPCMember', window );">Song PC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AHMCMember', window );">AHMC | LaSalle Medical Associates &#8211; IPA Line of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,132,698<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC | PMIOC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_NetworkMedicalManagementMember', window );">NMM | Consulting Services | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PaymentMadeToRelatedParty', window );">Payments to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AstranaMember', window );">Astrana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,166,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_ApolloMedOfficerMember', window );">ApolloMed Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PaymentMadeToRelatedParty', window );">Payments to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="nump">$ 9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_AHMCMember', window );">AHMC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceServicesRevenue', window );">Risk pool revenue recognized under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,800<span></span>
</td>
<td class="nump">50,500<span></span>
</td>
<td class="nump">60,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCreditsAndOtherLiabilities', window );">Remaining outstanding under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="nump">58,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_ApcShareholdersMember', window );">APC | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PaymentMadeToRelatedParty', window );">Payments to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,100<span></span>
</td>
<td class="nump">34,500<span></span>
</td>
<td class="nump">32,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_ApcShareholdersMember', window );">APC | APC | Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PaymentMadeToRelatedParty', window );">Payments to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200<span></span>
</td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_LmaMember', window );">LMA | Related Party | AHMC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,700<span></span>
</td>
<td class="nump">21,200<span></span>
</td>
<td class="nump">18,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_PmiocMember', window );">PMIOC | APC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_SongPCMember', window );">Song PC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_ArroyoVistaMember', window );">Arroyo Vista | AHMC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_ArroyoVistaMember', window );">Arroyo Vista | Related Party | AHMC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AdvanceDiagnosticSurgeryCenterMember', window );">Advance Diagnostic Surgery Center | APC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AdvanceDiagnosticSurgeryCenterMember', window );">Advance Diagnostic Surgery Center | MPP | Rent Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_FulgentGeneticsIncMember', window );">Fulgent Genetics, Inc. | APC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_SunnyVillageCareCenterMember', window );">Sunny Village Care Center | APC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_SunnyVillageCareCenterMember', window );">Sunny Village Care Center | Tag-6 Medical Investment Group, LLC* | Rent Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_FirstCommonwealthPropertyLLCMember', window );">First Commonwealth Property, LLC | Professional Medical Corporation | Office Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_PaymentMadeToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount paid to related party in relation to providing services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_PaymentMadeToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCreditsAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income in future periods and obligations not separately disclosed in the balance sheet (other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCreditsAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceServicesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from insurance services, including net premiums earned, gain on sale of insurance block, agency management fees and insurance contract fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceServicesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_Tag2PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_Tag2PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_SpinOffTransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_SpinOffTransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_CallCenterServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_CallCenterServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_SongPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_SongPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_ProviderServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_ProviderServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AHMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AHMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PmiocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PmiocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_NetworkMedicalManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_NetworkMedicalManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_ConsultingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_ConsultingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AstranaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AstranaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_ApolloMedOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_ApolloMedOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_AHMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_AHMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_ApcShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=asth_ApcShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_LmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_LmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_PmiocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_PmiocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_SongPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_SongPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_ArroyoVistaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_ArroyoVistaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_AdvanceDiagnosticSurgeryCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_AdvanceDiagnosticSurgeryCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_MedicalPropertyPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_MedicalPropertyPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_RentPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_RentPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_FulgentGeneticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_FulgentGeneticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_SunnyVillageCareCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_SunnyVillageCareCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_Tag6MedicalInvestmentGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_Tag6MedicalInvestmentGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_FirstCommonwealthPropertyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_FirstCommonwealthPropertyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_ProfessionalMedicalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_ProfessionalMedicalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_OfficeLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_OfficeLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387348288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AHMCMember', window );">AHMC | Related Party Transaction, Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">$ 49,634<span></span>
</td>
<td class="nump">$ 56,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AHMCMember', window );">AHMC | Related Party Transaction, Expenses Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">21,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AHMCMember', window );">AHMC | Related Party Transaction, Revenue (Expense), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">29,634<span></span>
</td>
<td class="nump">34,587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_HSMSOMember', window );">HSMSO | Related Party Transaction, Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">1,242<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_HSMSOMember', window );">HSMSO | Related Party Transaction, Expenses Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">822<span></span>
</td>
<td class="nump">1,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_HSMSOMember', window );">HSMSO | Related Party Transaction, Revenue (Expense), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">420<span></span>
</td>
<td class="num">(465)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AurionMember', window );">AURION | Related Party Transaction, Revenue Recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AurionMember', window );">AURION | Related Party Transaction, Expenses Incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AurionMember', window );">AURION | Related Party Transaction, Revenue (Expense), Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="num">$ (300)<span></span>
</td>
<td class="num">$ (300)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_AHMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_AHMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionRevenueRecognizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionRevenueRecognizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionExpensesIncurredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionExpensesIncurredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionRevenueExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionRevenueExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_HSMSOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_HSMSOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_AurionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_AurionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696378796672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DefinedContributionPlanServicePeriod', window );">Defined contribution plan, service period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DefinedContributionPlanVestingPeriod', window );">Employee benefit vested estimated year</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer discretionary contribution amount</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DefinedContributionPlanServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Service Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DefinedContributionPlanServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DefinedContributionPlanVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Vesting Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DefinedContributionPlanVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387508096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Additional Information (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">186,290<span></span>
</td>
<td class="nump">133,480<span></span>
</td>
<td class="nump">9,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">782,484<span></span>
</td>
<td class="nump">245,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">7,132,698<span></span>
</td>
<td class="nump">10,299,259<span></span>
</td>
<td class="nump">10,925,702<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696389194000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Basic Net Income (loss) Per Share is Calculated Using Weighted Average Number of Shares (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share &#8211; basic (in dollars per share)</a></td>
<td class="nump">$ 1.30<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share &#8211; diluted (in dollars per share)</a></td>
<td class="nump">$ 1.29<span></span>
</td>
<td class="nump">$ 0.99<span></span>
</td>
<td class="nump">$ 1.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding &#8211; basic (in shares)</a></td>
<td class="nump">46,553,256<span></span>
</td>
<td class="nump">44,971,143<span></span>
</td>
<td class="nump">43,828,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding - diluted (in shares)</a></td>
<td class="nump">46,943,140<span></span>
</td>
<td class="nump">45,602,415<span></span>
</td>
<td class="nump">45,403,085<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696388175424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Summary of Shares Included in Diluted Earnings Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding &#8211; basic (in shares)</a></td>
<td class="nump">46,553,256<span></span>
</td>
<td class="nump">44,971,143<span></span>
</td>
<td class="nump">43,828,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Contingently issuable shares (in shares)</a></td>
<td class="nump">169,125<span></span>
</td>
<td class="nump">30,315<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</a></td>
<td class="nump">46,943,140<span></span>
</td>
<td class="nump">45,602,415<span></span>
</td>
<td class="nump">45,403,085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Adjustments to weighted average shares of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">819,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Adjustments to weighted average shares of common stock (in shares)</a></td>
<td class="nump">169,577<span></span>
</td>
<td class="nump">439,309<span></span>
</td>
<td class="nump">495,618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Adjustments to weighted average shares of common stock (in shares)</a></td>
<td class="nump">51,182<span></span>
</td>
<td class="nump">161,648<span></span>
</td>
<td class="nump">259,652<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-26<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 44<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-44<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-51<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-52<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-53<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 54<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-54<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-48<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696381171696">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (VIEs) - Eliminated Upon Consolidation Included In Accompanying Consolidated Balance Sheets (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 01, 2023 </div>
<div>physician</div>
</th>
<th class="th"><div>Feb. 23, 2023</div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 293,807<span></span>
</td>
<td class="nump">$ 288,027<span></span>
</td>
<td class="nump">$ 233,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,498<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,657<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,335<span></span>
</td>
<td class="nump">1,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,450<span></span>
</td>
<td class="nump">14,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">461,507<span></span>
</td>
<td class="nump">428,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,648<span></span>
</td>
<td class="nump">76,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278,831<span></span>
</td>
<td class="nump">269,053<span></span>
</td>
<td class="nump">246,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,774<span></span>
</td>
<td class="nump">40,299<span></span>
</td>
<td class="nump">41,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,396<span></span>
</td>
<td class="nump">20,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,877<span></span>
</td>
<td class="nump">4,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471,854<span></span>
</td>
<td class="nump">538,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">933,361<span></span>
</td>
<td class="nump">966,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,949<span></span>
</td>
<td class="nump">49,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,737<span></span>
</td>
<td class="nump">8,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,657<span></span>
</td>
<td class="nump">81,255<span></span>
</td>
<td class="nump">$ 55,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="nump">664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,607<span></span>
</td>
<td class="nump">3,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,500<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218,674<span></span>
</td>
<td class="nump">148,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,072<span></span>
</td>
<td class="nump">14,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,289<span></span>
</td>
<td class="nump">19,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258,939<span></span>
</td>
<td class="nump">203,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,586<span></span>
</td>
<td class="nump">20,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,919<span></span>
</td>
<td class="nump">259,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 522,593<span></span>
</td>
<td class="nump">407,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Voting rights held (more than)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,780<span></span>
</td>
<td class="nump">49,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,980<span></span>
</td>
<td class="nump">65,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,078<span></span>
</td>
<td class="nump">113,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">8,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="nump">1,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,991<span></span>
</td>
<td class="nump">9,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Amounts due from affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,950<span></span>
</td>
<td class="nump">228,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Land, property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,306<span></span>
</td>
<td class="nump">106,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,906<span></span>
</td>
<td class="nump">62,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,157<span></span>
</td>
<td class="nump">133,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,114<span></span>
</td>
<td class="nump">27,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investment in a privately held entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Investment in affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,182<span></span>
</td>
<td class="nump">304,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,796<span></span>
</td>
<td class="nump">11,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,149<span></span>
</td>
<td class="nump">4,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">537,998<span></span>
</td>
<td class="nump">667,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">813,948<span></span>
</td>
<td class="nump">896,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,707<span></span>
</td>
<td class="nump">27,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,737<span></span>
</td>
<td class="nump">8,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,157<span></span>
</td>
<td class="nump">55,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="nump">594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,305<span></span>
</td>
<td class="nump">2,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,542<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Amount due to affiliate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,340<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216,072<span></span>
</td>
<td class="nump">94,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,284<span></span>
</td>
<td class="nump">6,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,675<span></span>
</td>
<td class="nump">12,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="nump">8,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,222<span></span>
</td>
<td class="nump">55,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 253,294<span></span>
</td>
<td class="nump">149,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Voting rights held (more than)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_VariableInterestEntityNumberOfPhysicians', window );">Number of physicians | physician</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | Nonrelated Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,120<span></span>
</td>
<td class="nump">14,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,707<span></span>
</td>
<td class="nump">62,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company&#8217;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling $540.8&#160;million and $579.8&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $146.0&#160;million and $149.6&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively. These VIE balances do not include $273.2&#160;million of investment in affiliates and $107.3&#160;million of amounts due to affiliates as of December&#160;31, 2023 and $304.8&#160;million of investment in affiliates and $11.6&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 18 &#8211; &#8220;Variable Interest Entities (VIEs)&#8221; for further detail.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FiduciaryAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FiduciaryAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_VariableInterestEntityNumberOfPhysicians">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Number Of Physicians</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_VariableInterestEntityNumberOfPhysicians</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385509856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Remaining lease terms, operating</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease option to extend (up to)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRenewalTerm1', window );">Finance lease option to extend (up to)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable', window );">Operating lease, termination period, if applicable</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable', window );">Finance lease, termination period, if applicable</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Assets recorded under finance leases</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated amortization associated with finance leases</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LesseeOperatingLeaseOptionToExtendPeriod', window );">Option to extend, period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLeasingCosts', window );">Lease agreement</a></td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Remaining lease terms, operating</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Remaining lease terms, financing</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Remaining lease terms, operating</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Remaining lease terms, financing</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LesseeFinanceLeaseTerminationPeriodIfApplicable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Finance Lease, Termination Period, If Applicable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LesseeFinanceLeaseTerminationPeriodIfApplicable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LesseeOperatingLeaseOptionToExtendPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Option To Extend, Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LesseeOperatingLeaseOptionToExtendPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LesseeOperatingLeaseTerminationPeriodIfApplicable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Termination Period, If Applicable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LesseeOperatingLeaseTerminationPeriodIfApplicable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLeasingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for costs that are essential to originate the lease and would not otherwise have been incurred without the lease agreement. Amount includes, but is not limited to, cash outflows to evaluate the lessee's credit condition, guarantees, and collateral and cash outflows for costs incurred in negotiating, processing, and executing the lease agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLeasingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696392919776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 7,771<span></span>
</td>
<td class="nump">$ 6,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract', window );"><strong>Finance lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of lease expense</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(1,025)<span></span>
</td>
<td class="num">(649)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 7,524<span></span>
</td>
<td class="nump">$ 6,607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696386752560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Other Information Related to Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CashPaidForLeaseLiabilitiesAbstractAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 7,783<span></span>
</td>
<td class="nump">$ 6,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract', window );"><strong>Right-of-use assets obtained in exchange for lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">25,124<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">$ 486<span></span>
</td>
<td class="nump">$ 971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LeaseWeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted-Average Remaining Lease Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">8 years 8 months 23 days<span></span>
</td>
<td class="text">6 years 7 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years 4 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LeaseWeightedAverageDiscountRateAbstract', window );"><strong>Weighted-Average Discount Rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">6.02%<span></span>
</td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">5.24%<span></span>
</td>
<td class="nump">4.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_CashPaidForLeaseLiabilitiesAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_CashPaidForLeaseLiabilitiesAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LeaseWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LeaseWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LeaseWeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LeaseWeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696386539504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Minimum Payments Under Non-cancelable Leases After Adoption of 842 (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 6,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">6,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">6,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">6,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">5,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">21,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">53,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">12,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease obligations</a></td>
<td class="nump">40,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">4,607<span></span>
</td>
<td class="nump">$ 3,572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease obligations</a></td>
<td class="nump">36,289<span></span>
</td>
<td class="nump">19,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">1,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease obligations</a></td>
<td class="nump">1,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">646<span></span>
</td>
<td class="nump">594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term lease obligations</a></td>
<td class="nump">$ 1,033<span></span>
</td>
<td class="nump">$ 1,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696382064288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Narrative (Details) - segment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics', window );">Number of operating segments that share similar characteristics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Operating Segments That Share Similar Characteristics</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696381343232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Schedule of Information about our Segments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,386,661<span></span>
</td>
<td class="nump">$ 1,144,163<span></span>
</td>
<td class="nump">$ 773,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">1,171,703<span></span>
</td>
<td class="nump">944,685<span></span>
</td>
<td class="nump">596,142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">130,345<span></span>
</td>
<td class="nump">95,213<span></span>
</td>
<td class="nump">79,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Costs and expenses</a></td>
<td class="nump">1,302,048<span></span>
</td>
<td class="nump">1,039,898<span></span>
</td>
<td class="nump">675,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">84,613<span></span>
</td>
<td class="nump">104,265<span></span>
</td>
<td class="nump">98,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=asth_ThirdPartyMember', window );">Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,386,661<span></span>
</td>
<td class="nump">1,144,163<span></span>
</td>
<td class="nump">773,915<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=asth_IntersegmentMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="num">(170,116)<span></span>
</td>
<td class="num">(124,675)<span></span>
</td>
<td class="num">(90,543)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="num">(166,417)<span></span>
</td>
<td class="num">(125,823)<span></span>
</td>
<td class="num">(89,791)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="num">(7,923)<span></span>
</td>
<td class="num">(3,150)<span></span>
</td>
<td class="num">(3,097)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Costs and expenses</a></td>
<td class="num">(174,340)<span></span>
</td>
<td class="num">(128,973)<span></span>
</td>
<td class="num">(92,888)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">4,224<span></span>
</td>
<td class="nump">4,298<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="num">(170,116)<span></span>
</td>
<td class="num">(124,675)<span></span>
</td>
<td class="num">(90,543)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">33,171<span></span>
</td>
<td class="nump">19,313<span></span>
</td>
<td class="nump">12,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Costs and expenses</a></td>
<td class="nump">33,171<span></span>
</td>
<td class="nump">19,313<span></span>
</td>
<td class="nump">12,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(33,171)<span></span>
</td>
<td class="num">(19,313)<span></span>
</td>
<td class="num">(12,424)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Costs | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Costs | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember', window );">Care Enablement | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">135,824<span></span>
</td>
<td class="nump">120,200<span></span>
</td>
<td class="nump">107,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">59,075<span></span>
</td>
<td class="nump">51,531<span></span>
</td>
<td class="nump">41,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">57,672<span></span>
</td>
<td class="nump">41,628<span></span>
</td>
<td class="nump">28,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Costs and expenses</a></td>
<td class="nump">116,747<span></span>
</td>
<td class="nump">93,159<span></span>
</td>
<td class="nump">70,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">19,077<span></span>
</td>
<td class="nump">27,041<span></span>
</td>
<td class="nump">37,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember', window );">Care Enablement | Operating Segments | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">40,227<span></span>
</td>
<td class="nump">42,023<span></span>
</td>
<td class="nump">35,851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember', window );">Care Enablement | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">95,597<span></span>
</td>
<td class="nump">78,177<span></span>
</td>
<td class="nump">71,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember', window );">Care Partners | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,300,112<span></span>
</td>
<td class="nump">1,051,521<span></span>
</td>
<td class="nump">709,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">1,182,484<span></span>
</td>
<td class="nump">944,792<span></span>
</td>
<td class="nump">607,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">25,907<span></span>
</td>
<td class="nump">21,507<span></span>
</td>
<td class="nump">30,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Costs and expenses</a></td>
<td class="nump">1,208,391<span></span>
</td>
<td class="nump">966,299<span></span>
</td>
<td class="nump">637,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">91,721<span></span>
</td>
<td class="nump">85,222<span></span>
</td>
<td class="nump">72,578<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember', window );">Care Partners | Operating Segments | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,284,081<span></span>
</td>
<td class="nump">1,051,464<span></span>
</td>
<td class="nump">709,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember', window );">Care Partners | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">16,031<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember', window );">Care Delivery | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">119,904<span></span>
</td>
<td class="nump">96,132<span></span>
</td>
<td class="nump">46,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">96,265<span></span>
</td>
<td class="nump">73,927<span></span>
</td>
<td class="nump">37,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">17,766<span></span>
</td>
<td class="nump">13,234<span></span>
</td>
<td class="nump">9,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Costs and expenses</a></td>
<td class="nump">114,031<span></span>
</td>
<td class="nump">87,161<span></span>
</td>
<td class="nump">47,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">5,873<span></span>
</td>
<td class="nump">8,971<span></span>
</td>
<td class="num">(540)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember', window );">Care Delivery | Operating Segments | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">61,600<span></span>
</td>
<td class="nump">49,806<span></span>
</td>
<td class="nump">28,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember', window );">Care Delivery | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">58,304<span></span>
</td>
<td class="nump">46,326<span></span>
</td>
<td class="nump">18,627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_OtherMember', window );">Other | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">937<span></span>
</td>
<td class="nump">985<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="num">(242)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">3,752<span></span>
</td>
<td class="nump">2,681<span></span>
</td>
<td class="nump">1,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Costs and expenses</a></td>
<td class="nump">4,048<span></span>
</td>
<td class="nump">2,939<span></span>
</td>
<td class="nump">1,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(3,111)<span></span>
</td>
<td class="num">(1,954)<span></span>
</td>
<td class="num">(1,279)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_OtherMember', window );">Other | Operating Segments | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">753<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_OtherMember', window );">Other | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 184<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General and Administrative Expenses and Depreciation and Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=asth_ThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=asth_ThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=asth_IntersegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=asth_IntersegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=asth_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=asth_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696378187056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market accounts</a></td>
<td class="nump">$ 4,842<span></span>
</td>
<td class="nump">$ 135,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">2,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">7,340<span></span>
</td>
<td class="nump">145,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">22,088<span></span>
</td>
<td class="nump">21,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=asth_InterestRateCollarMember', window );">Interest Rate Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=asth_ContingentEquitySecuritiesMember', window );">Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AAMGMember', window );">AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_APCMGMember', window );">APCMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_VOMGMember', window );">VOMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_DmgMember', window );">DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">8,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_ApolloSunLabsManagementLLCMember', window );">Apollo-Sun Labs Management, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">7,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market accounts</a></td>
<td class="nump">4,842<span></span>
</td>
<td class="nump">135,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">2,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">5,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">7,340<span></span>
</td>
<td class="nump">140,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Interest Rate Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | APCMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | VOMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Apollo-Sun Labs Management, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Interest Rate Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | APCMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | VOMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Apollo-Sun Labs Management, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Liabilities</a></td>
<td class="nump">21,836<span></span>
</td>
<td class="nump">21,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Interest Rate Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">5,475<span></span>
</td>
<td class="nump">5,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | APCMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | VOMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">8,542<span></span>
</td>
<td class="nump">8,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Apollo-Sun Labs Management, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">$ 7,802<span></span>
</td>
<td class="nump">$ 5,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Purchase Obligation, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=asth_InterestRateCollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=asth_InterestRateCollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=asth_ContingentEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=asth_ContingentEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AAMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AAMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_APCMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_APCMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_VOMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_VOMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_DmgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_DmgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_ApolloSunLabsManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_ApolloSunLabsManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696479583184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at January 1, 2023</a></td>
<td class="nump">$ 21,259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of existing Level 3 liabilities</a></td>
<td class="nump">1,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid', window );">APCMG contingent consideration paid</a></td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31, 2023</a></td>
<td class="nump">$ 21,836<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696378905424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">$ 2,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">348,000<span></span>
</td>
<td class="nump">$ 5,567,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss', window );">Equity securities, FV-NI, unrealized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="nump">25,774,000<span></span>
</td>
<td class="nump">40,299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,715,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001; 100,000,000 shares authorized, 46,843,743 and 46,575,699 shares outstanding, excluding 10,584,340 and 10,299,259 treasury shares, at December&#160;31, 2023 and 2022, respectively</a></td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">General and Administrative Expense<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_ApolloSunLabsManagementLLCMember', window );">Apollo-Sun Labs Management, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation', window );">Business combination, change in fair value of equity interest purchase obligation</a></td>
<td class="num">$ (2,000,000)<span></span>
</td>
<td class="num">(1,700,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember', window );">AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001; 100,000,000 shares authorized, 46,843,743 and 46,575,699 shares outstanding, excluding 10,584,340 and 10,299,259 treasury shares, at December&#160;31, 2023 and 2022, respectively</a></td>
<td class="nump">$ 157,048<span></span>
</td>
<td class="nump">184,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">5,475,000<span></span>
</td>
<td class="nump">5,849,000<span></span>
</td>
<td class="nump">$ 5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationStockContingentConsiderationLiability', window );">Business combination, stock contingent consideration, liability</a></td>
<td class="nump">5,600,000<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
<td class="nump">$ 5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_ApolloSunLabsManagementLLCMember', window );">Apollo-Sun Labs Management, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">$ 7,802,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AAMGMember', window );">AAMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,851,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_DMGAndSunLabsMember', window );">DMG And Sun Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase', window );">Business combination, equity interest purchase obligation, period to purchase</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_DmgMember', window );">DMG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,542,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities | AAMG | 2024 Metric</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember', window );">Other Liabilities | AAMG | 2023 Metric</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=asth_ContingentEquitySecuritiesMember', window );">Contingent equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,164,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Cash Flow Hedging | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Unrealized loss</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other Noncurrent Assets | Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Other Noncurrent Assets | Cash Flow Hedging | Designated as Hedging Instrument | APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=asth_CollarMember', window );">Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DerivativeCeilingInterestRate', window );">Derivative ceiling interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFloorInterestRate', window );">Derivative, floor interest rate</a></td>
<td class="nump">2.34%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue', window );">Fair value of the collar</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Purchase Obligation, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Purchase Obligation, Period to Purchase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationStockContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Stock Contingent Consideration, Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationStockContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DerivativeCeilingInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Ceiling Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DerivativeCeilingInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFloorInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFloorInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4CC<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4CC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgeLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative liabilities designated as fair value hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueHedgeLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_ApolloSunLabsManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_ApolloSunLabsManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_AAMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_ApolloSunLabsManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_ApolloSunLabsManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AAMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AAMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_DMGAndSunLabsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_DMGAndSunLabsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_DmgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_DmgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_A2024MetricMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_A2024MetricMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_A2023MetricMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_A2023MetricMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=asth_ContingentEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=asth_ContingentEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_APCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_APCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=asth_CollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=asth_CollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696385278256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments - Schedule of Gain (Loss) on Equity Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Total losses recognized on equity securities</a></td>
<td class="num">$ (6,629)<span></span>
</td>
<td class="num">$ (19,169)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Less (loss) gains recognized on equity securities sold</a></td>
<td class="num">(4,052)<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized losses recognized on equity securities held at end of period</a></td>
<td class="num">$ (2,577)<span></span>
</td>
<td class="num">$ (21,441)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140696387185408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Jan. 29, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Jan. 18, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupMember', window );">Community Family Care Medical Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedDiagnosticAndSurgicalCenterMember', window );">Advanced Diagnostic and Surgical Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Draws on lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Revolver Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Draws on lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Community Family Care Medical Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire business</a></td>
<td class="nump">$ 93.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of shares of the combined company that would be owned by pre-Merger ApolloMed stockholders</a></td>
<td class="nump">631,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedDiagnosticAndSurgicalCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_AdvancedDiagnosticAndSurgicalCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_RevolverLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_RevolverLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>188
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !4AEU8;GOQ_5$(  ",,@  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+6;T7*C-A2&7T7C[G1V9V(;A.,XNXEG'#ONNMUNW3AM9]OIA0QR8!:0*T2<
MO'V/P :S%3)TY)O$V)P?]"&)\XO#S8[QKXE/J4 O41@GMQU?B.W[?C]Q?1J1
MI,>V-(9?-HQ'1, F?^HG6TZ)EP5%81];UK ?D2#NC&^R[Y9\?,-2$08Q77*4
MI%%$^.L=#=GNMF-W#E\\!$^^D%_TQS=;\D175/RV77+8ZA<J7A#1. E8C#C=
MW'8F]ON9<RT#LCU^#^@N.?J,9%/6C'V5&POOMF/),Z(A=864(/#OF4YI&$HE
M.(]_]J*=XI@R\/CS07V>-1X:LR8)G;+PC\ 3_FUGU$$>W9 T% ]L]Y'N&W0I
M]5P6)ME?M,OWO70ZR$T3P:)],)Q!%,3Y?_*R!W$4,+)J O ^ '\38 ]J IQ]
M@-,T8+ /&&1D\J9D'&9$D/$-9SO$Y=Z@)C]D,+-H:'X0R^N^$AQ^#2!.C*?L
MF7+41;^M9NCMFW?H#0IB=!>$(5R4Y*8OX!!RQ[Z[E[O+Y7"-G(W1SRP6?H+N
M8X]Z58$^G%MQ@OAP@G=8JSBC;@\Y]@7"%G84)S35A\_INH<PSL('BO"9/OS'
M-(:C6ZJC5UKC%+B=3,_1XOYKLDX$AR[_MXIPKC!0*\AYX'VR)2Z][<! 3RA_
MIIWQ]]_90^N#BHY)L9DAL0JY04%NH%,?SYB;PGPCT./KEJJPZ<-MJ_N3BH\V
MJBT?0V(5/I<%G\MF?"9QG)(0/= MXT(%2J\C>*K".]5&M05E2*P":EB &C8#
MM:0\8)Z<J!!,G<H^=4+I,#75SDW:^+;0#(E5H%T5T*ZT39VFG$MF\R!QH7-]
MH81KP>G5NET;=QU;14P;V):8(;$*L5%!;-1PON($LJ0LR:D?DWJM#0D3Y:#4
MAK6E94BL0NNZH'6M;>%]+ +Q"MTKI.AS&JTI5U'2:UB6W76NG&NL(J4-;4O*
MD%B%E&V5&9O5A-4#?0ID%@%=[#.)E*/PA- D"R?H(R6A\"_0(G9[*G9ZF;;P
M3*E5Z1WENW83>M!6QF$T$CDP+]!*P$2&&$=3EL:"O\)_3XU4KSZ[5P+4!K4&
M:$BM"A"7 '$3@(_D!2T\F.""3>!F%#4#]X3D]65W,+C"SN!:24\;W)J>(;4J
MO3+_M[5)\H'>Q/- /;DX?$"?8#_T2ZSN<WI)>S@<H54/_4#X)J"AAR;/-%8G
M<7JEUBC/X0?LTA#8^I1>B_)QQY0H]9(84IIYR)BJ$T_UL:WAG<,LV*5;L/5I
M_K?PIG(+YK]'MHN5X/1RD] GT9H3)3>CUL&46I5;:1YL?<[_+;?BQK'D[#F(
M7?4 UFM.)TIL1LV#*;4JMM(^V/J,_UML2Y8(\!%_!MOZ.ZU>\=H>64H'H8]K
MS>T<'L(N382MS_RS83GAE-1CT@L,\5 )R:AS,*56A51Z!UN?^']BTI,N?1;K
MS,,)$3S"70N/1DI:1MV#*;7J<FII'[ ^ZW\,!)@LMD$V?KM^AU;433GT,A6R
M$TI3%D60]JT$<[]>H#=6#QP8VA*.GDF84K2E'"4^X<I,1"_=%JDIM2K2TE-@
M?=8/%M\+XB>T>HW6+%22U M,5H\?E92,&@=3:E5*I7' ^BS_T-/0_8OKD_B)
MUOK6$T*?)ZO9Y%<E+Z-6P91:E5=I%7 CJ_ '#</NUQCR,ABK)(%)SD.+)$G5
ML]P)S2]4]5!GJH]JS>T<O@"7O@ W\@6_LQ"L/.'YJA)7/LPZH?19Y2&F^J#6
ML,[A W#I W C'W!8W\U7*+.Y#!+;5 U-KUC7Q8RZ %-J56JE"\"-7, B%I3G
M3Z[E2C@Y8%12TRO643-J DRI5:F5)@ W,@'9<$13\$U/C*OS#KW.)\+AYC%Q
M70I"(./EDDI^1LV *;4JO](,8'TNO^>WBD@8HKLT@9\3]0C]GX\3]'&M:9W#
M%>#2%>!&CQ3N(\J?Y(3V R@('WQ4M"6QNMOI!>NQ&;4'IM2J]0FE/7#T2?UB
M.G] D]0+!.-H(@0%HYZM[LY#\J0L5]#KU3U/UH>UKDPXAP%P2@/@G%CV/SSL
MFP<QB=T [&BV,)1]=\]Y]F !;@UYK=-?$J6Z]$-_F-H>J(]K#?,</L$I?8+3
MZ '#RH?$5S=<3\C4PS)J$DRI56$=U1,U,@G+=!T&KER[)LKL0Z_2NJC(;%51
MKG:9J<DZQ>>QW7-N^L\J,*4+<!JY@.H:Q4HN1R3HEU3 K!9GGOUM$.>K%,D[
M)3B3R?YTKS8\:NKEY0 [ VM4M'</Y1RVP"EM@=.LFB@Y>E *>=9:/G;>4,AQ
MU0O=)U27TENP.)&K3\*GB!>/L+__;H3MJP^)+-D,XB#+J)><O;P>S:,;F$5E
ME*SD0R2O<HHHS=S*7C"1E]EGH0=^[[\'07"547#<'A^: M<?FL4/S9+UCTO"
M!5HL%KE$D%1KJI"\&3(>(5E3A@3+CD)?A#Q'>;,L='MHE;K^?]JQ"V!>6U.T
M@:35@RU(2J3"?GDD@/X)7;-<))$].$BR.MNW<C^)"EL?5O?3[)/]X5VF :=M
M8PMYY%6'=Y/7[[S*^ATJ*S31C+I4+ID6-9;*$@#]A6T]XL_AWIS2O3EZKS6!
MR^#EM^NZG$8O4']K,6K73*E5,95VS=';K*.DIBSZFL.72L]Q0JRN0DX?UIK8
M.0R:4QHTIV'-UY[8OL*PGIE>;OY%2<RH23.E5B56FC2GD4F; C0.P!8P);V@
MGZ@ZWSM5_F79UL@9#)0/O/3!K:D9]6C]H_)]Z5:SUR 2Y,I2I+R2O_BV>-5B
MDKU@T"]WS]_3^)E(LYN@D&X@U.I=P4S+\U<?\@W!MMG+ &LF!(NRCSXE<+^4
M.\#O&\;$84,>H'@!9?PO4$L#!!0    ( %2&75AX1NF2/0(  +\%   8
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MQO3R8D4?V!V3OZ]NA?HUW6F9E4M6-R6O@6#S=R=7\9L;DNH&1N*/DCTU>]=
MFW+/^7?]X^/LW4FD$;&*%5*KH.K/([MF5:4U*1Q_;Y2>[-ZI&^Y?;[7_8HQ7
MQMS3AEWSZG_E3"[>G60G8,;F=%W)K_SI5[8Q*-'Z"EXUYG_PM)&-3D"Q;B1?
M;AHK!,NR;O_2'YN.V&L0(T\#N&D ^PVPIP':-$"'-L";!MCT3&N*Z8<;*NGE
MA>!/0&AII4U?F,XTK97Y9:W'_4X*];14[>3E]9?/=U\^?;RY^O;A!KR_^G3U
M^?H#N/OUPX=O=^ ,_'YW UZ=O@:GH*S!MP5?-[2>-1=3J=ZLVT^+S5NNV[=
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MQIRA5(QA[%G^1);;4)C;O#'/+&/HZ5IT9[#3!!?SH7Z%ZY*"J8?VD*4]-+)
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M<=VYL2^FN*\5C,1W1M=RZSO25.:<_] _[H/KCJ41T8CZ2IL@\.^93F@4:4N
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M+I];4!12?=C84,37]YVG!\?1UKRXKX_UE6 AMKELSG;MK^Z/#KZO#\QIUS_
M=U%S +"C:<XC7L7%?9J7(.-+1>F=,E7SB^:(7_-#BDU]Z.U.2"G6]=<5CQ->
M5 #U_Z40\O%'=8/]0<O9OU!+ P04    " !4AEU8;S@P D00  !#L0  &
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MD!TKA)L50F6%,-ZQ MFL0-05TATK1)L5(G63LATKQ)L58C5"M&.%9+-"HJQ
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MBARK"*R!!_N!Q[ 2_/)3C!'Z72ZX2\DYRV"3-:YA%]MTPA#CID%;)3N0B>.
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M730Y&3YUJYF$SAP8'IX!:/H)NZAZYR\'_VJY>"\[8G_ 5LUPJNLU1:XRPDH
MN@9VN9"5W !4-$HLQ 1D)$&N$&8:6)@?6!;'>WP9W(B[HJI4>\N(?Q(9>+2)
MV?B!XSBT2 W2$1(F9B8<T*&$)*X3=$P##?,##6P==B[4N0B/9^!X<1(A<RMC
M >F NDDAW;1NIIXUV3#_%MKU=K,IA1JTLE(=T,W+NMTV0P8OWR]%9>P/CS^Z
M'LPXZ7[:24M+3U7:M'XU:K&9G%,_6*HC-6I#K1AMH8,5:<,19=0ZZP3((FX=
M)4H!&>'C0^)33QJUV!&)II$G-W<P&XA0A*V=(D#&F'6"&U#)'N48Y)F&*^9_
M LS7 ZK]$R.C))/L^,=.<^RD#WZ=M+3T5*5-:WWT[)<?^OJGG\_KVW/)#ON3
MI/5-ETF90@FYG,S[,Z=]B-7/.Y_!;+B3,8?-9 X@,R=9KV3J7#,B\S/B]^PQ
M*-:R:KL!YZ^^+F38[3-47=U_T#]VM:I+28VP19OM2&CM+ ,JR^'1D,@T)#(_
M)*;&<Q[J49= =A_U0,O,,Q\,.G>-N3T"SF_@>2539QH(F1\(]YE$N5;)RZSI
M0S4OM\LA9O>MZ#NSQF:/<"_F)2D@<:TRN28_[B>_\6:R'N%TGFIZ)$1.9#=2
MY$Q@\=D]NL6\) 4DDG%=CY5QC7I\'O5*96.<MO(EJ?C\IAT@8=;Y:F\Y4S.:
MX;@_._6^>!3[\SG.,72:?9P903FP16<>,UP HL0Z^0"(7'XU4_&Y?3R=J.H3
M!H-=*#1!<\ ):VM]#8CL57@*J%SN-%UQ/UU]JION+I.MI@YT@/<_OUD'2!##
M9OHX]98TO7V-4]R?JUJH*"O+PX[C-[URNNX;[$IV,_BU%GP^2S4O20$)<:47
MN>85[M^6^[9[,4!Q,/9_)@/X2??K3EI:>JK2IG4]>HK>3TC]^D)5HUFY8#W:
M (,3$H<F,4 Z:*4-Z3PK;:ZIB,]MW<W'!)06,_-#@,CJ D>C#]?HP_WH\[U6
MZZ-G!'W0KNH']3QST*U$T-/?(3=ZV.,&:V&X$3YI42!W NG %@5T4(M>C%[Q
MLQ;-7?^J)#6;;*MN>%?.X=/#ZYBN^I<0&9^_1:_2X:5*NICA'4^?LN:NJ%HY
M"=_*(L/?U%C5#*]-&G[IZDW_(J&;NNOJ=?_C2F1R%: $\N^W==WM?U%?<'AY
MU>7_ %!+ P04    " !4AEU837I=,U0.  "V)@  &    'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;)5:;6_;.!+^*T066+2 [21NM[OH&^ FZ;:WES9H]@6+
MPWV@)=KF51)54K+K_OI[9O@BRG%RO2^)+5'#X;P\\\S(+W?&?G8;I3KQM:X:
M]^IDTW7M\]-35VQ4+=W,M*K!G96QM>SPU:Y/76N5+/FANCJ=GYT].ZVE;DY>
MO^1K-_;U2]-WE6[4C16NKVMI]V]497:O3LY/XH5/>KWIZ,+IZY>M7*M;U?W1
MWEA\.TU22EVKQFG3"*M6KTX6Y\_?/*7UO.!/K78N^RSH)$MC/M.7]^6KDS-2
M2%6JZ$B"Q+^MNE!518*@QI<@\R1M20_FGZ/TMWQVG&4IG;HPU5^Z[#:O3GXY
M$:5:R;[J/IG=.Q7.\Q/)*TSE^*_8A;5G)Z+H76?J\# TJ'7C_\NOP0[?\\ \
M/#!GO?U&K.6E[.3KE];LA*75D$8?^*C\-)33#3GEMK.XJ_%<]_I2N<+JEBUD
M5N)-[[# N9>G'833DM,B"'KC!<WO$70^%]>FZ39.7#6E*L<"3J%54FT>57LS
M?U#BI2IFXLGY1,S/YD\>D/<D'?4)RWMRC[R/=BT;_4W262?BPC3.5+J4/CB:
M4MQ8Y533R6B+M[J13:%E)6YQ42$2.R?^M5BZSB*6_GW,1%Z!I\<5H/QZ[EI9
MJ%<G+>UEM^KD]8\_G#\[>_' \9ZFXSU]2/K_X\D'!1U7\Q[IXN,6]RGY/C;B
MK5K:'IDMYL_8:4\G8M&:JC+B6I6Z@"'?F:K4S=I-Q/L&SK5X0%*T".G$@NS:
M2/%.R:K;\ KQZ,<??IG/SUZ$>_SM_,7CF?BCJ6CW;J-$@:A37SN!'<A-3AA<
MM3OMU(100UG5%+BJ&UKME&@,+>H,/[Q*/G;)QQ.^$W:^,'4KF_TD;!TO[]3A
ME=X=7C&]39<HOIRN=24MP53IA+0J5P_Z1 /06HU0*U*$PD"N7SI=:FDU%M,*
MN5KI2O,]**T[7)^0&67;6M-:NC/!H8NJ)XO?%;B%*+FL%-9T4,)U24RR^I_O
MK]Q@<OBE_ +WTNJ2S+FH-K*& Y%+LM*H#XW&YW@*#55$A6=H=ZBTU:6RTP*;
M6%W Q*K8-*8RZ_VT-3L2"6]I]WFZ5% ,CVPX# HR4^%],!/_5(@VN8[G\0=5
M'86<:LII9Z;XEXD6.&Y/(>L&O5#.+(>);/CH:\OFR+8K585" 9EM)3LJ>X@'
M2>8A<[ET%O:9ZPMXSZWZJL)Z&$<7NH5 LL]65KV:4LDH!0N6%AJLAR#KG5 U
MGYY.A*"K2638'O6*)&OL.1$;U)8IC%_I;N]E82'VT8Q)V$O"2*Z;JM5*<9E#
MB6@:96?B=[-6E \H*]U&9'ET_O,+EP=1N]D[* ^KK*WI6Q]D#X<@Q8=/EI E
MT3;N[MF]]>CH@A!%%T'&V.*LY)U0Y35DW"9:G3!I=/X\ C^HK2SQG\3_KK[*
MH&,M_V,LV0_PM=N86OC0VG(X+TEWO27/&2O:?EGI G)=#W,5*IX+L;6!<=:;
M &@6KO&?=.GW\V$DB UUJN%G359VAMQZ=_TQY=;$GUL*5\NJ$JVQ$68!(0")
MK6IZS@(*DY6%ZHUIIJP=.2Z8 ;X^YHF00< <0!W+3?:')94L-MXR;'( 0$\N
MPM9DLF-)X?8..)E#2U1@(E82",= !&,2QPNNBZ&%&ZY5!+?:T7I9]# XK]D8
MU^I.5G2U L20KO"QTXSH*VP7MA'>[(?A.C(_$K<9VR-%_/!<HSHBC'QN4H=V
M^0ZU1Y<':0SPPR(4)$ 1PC7H%4Y'^\S$K5I[,G%,0:O(_XS,+JXK-H0;I?>]
M:92O7E:I4-50QBPV#>A,!R'*Q-4 \AP(*ETK%.3B 2\ME4#=>&KO6?:Z1XFJ
M]EG$FSS#DYK%1JM5 %,*@A)'9Z)>R\^$-AM%TH@9!&R[ZPEE>6/*$6BZ S%G
MC1L!%(,)&.*\%D*6I28%4:<)P,!.J&SN:8ENMBA>QGHXX=I_K*J+'F$?8L*;
M+ED7&Z#RK;2'@1S.* HNZ,]- )^)_WH9DX&VY"M7"=Z0S!N-I/))0Z1IZ?G-
MBIC0SCT?2_0Q,+H2%*,*NC)H ? X[+KL-7,GWA-6\V5P5!@XTNA";MI8KF*\
M.\8ZOQ=)(.B99'7(!ZRW*A=: $9G35;$!RC&MNO&JP?PVDB"HZT/@Q4C2D =
M=8#S,_%F#VZ0BOFQ\.@;_:57=XI'JLG,@9::#XXPL*JPO>[22>(QB'#HK?Z6
MIS,#7ZR4B'6V)B45,I3K*&<+PTP>#<1H*"WQ=,#T5)4(AA,M /3GQ$#4R#\]
M;>4>IAM1G'%E8)+1(7O(G&!G>UI"1JH8FNA)X0LJ[M_5%6!J#2AQK>HEM-CH
MEGD!DHKX/8M8!M*>@W<L9&*%E""GA>J0"M7;M[=#G4JK%^56HE5:CPH@#%4K
M2WGGK7_UU4,-99TOF\<<'7$8"H8M-9"S)?@D?U.OI1DBG(%HME5DU5'']S>+
MK)B&B^!/IF\\DK+.(W,?BEA<Y/68M/^$! !5I>#]K3%?I[\I!>0%+U"-4Z-2
M,SEZKF/%,U%LS_Y=2[6'%!RE2\SR\-B=/(\$\"BJ1E)$ A11!'J<>B3=](']
M\/-$X _8H$(\<76/L<3^=>1F>@P,"U^A*'T0A;9%7^,F4FR&[D]%TG"HT2+S
M P/=QZ.$" Z(]A=+A149G0XX1-(_4*OW*SQA?<5Z4'H2_N'77/RU@65)W8OK
M6Y+[#]GXMO7L_&=?(7A]6+?C,GJAJ$UB/Z4D^%'6[8L4_RCK@5?%72$^[0EX
M0*<16@E)E2##C$BYX5.$>5\K]C>N#^D_E#0& O)NBT86;I74>DBJQ^!+,CYI
MU4[:P!B.&%)3WNV$[!#B2VZ1 EEG@"(HIZ4U&6 F_B)V2L:'!>K((H.W<TOA
MZJ4J&'_BW.;\>&[0,UFW5'JJ<JF!XAU-9GC"0AI<4<+LDT4O+ZZ214- 4 26
M=%1ZYG/P:MKHU\HL83,_WC$K:JB811S9*N[QZ\WEQ4&HD-=OLIKZ-P"<3C=/
M#]W\/9\/\('XU4U#0F-H>6O,9QQR&YS646F"ET 1? VEL]#684O=1'Q(J5[T
MUA(D+DHX05/NDB,.\"905ZNIUV$J/F ]A&B"F;K6'1=3BC<"\F)HN(7Z0C#!
M:?]9;4Q%X8G:4"YA70^,R7$-\5QP#4TC#'\/"LKZ[FEHN@&7?\(6^AO[->RR
MX"KIGZ7R@:H/=_L14 X-XM/5XN+=V"WCAN<.9I@FADAZ?HC3L5^>S YXW3%B
M/EZ1D30907>8;J!OE=,2#258\+@"Y$4HIW?W83W3G#0)2-#/?>*QQF\@Z/=O
MZR."1QE#NS,)/"4T,5V\R@H@0JHJ-4:Q@:2-=<97HUCN2)CMXCC/?3U^]@()
MF#57!5B)+D;AV=($(VL)XS8ODH3K(QI&29X7ASEC[ D'X5D'-N&Y#PKOEK]P
M2 ]]7(FKAAWL=Y_0+J6616!95)>U7#=05A= 1&;)DU'_]RWR7<*-G8%Q#I+4
MSP/CJ1;)NI%[)2XY(1ZY(73L[3HVOZ+@6H2;IN]B5PS3,I5.]V2]1"O7\5'H
M83)\NH?=:60UC1M6<NEFAYW,_5EPE0]SACS(!VJ3?"+G742T,#2,A,&3H::%
M*,MPC<8[@>FCR_8#PH/N;* \V1@PG_T!89C!\^QN(WG,.B3$:I1GD[L3JWS"
M1NK%62:3>T(]HFSA8-ZBJ43#+T!9==]()DTELQ;7CJ)UQ(#S>4,D#,>"_6'"
M&[%[?[!5/C+)6NC[&Y5[YBJQ+ZN5ZO(AZ; K#07(KAO%G76:>NVHPZ?<Z6Q?
MDV,&^P0>RMSC;L?#3"@^.!$T7$T3LD$&)2$*V!3_4[PG'@X'4"*,CYO-TQE]
M68>8:-V^54<[J._IA$:8?1]T'IIVARH,BF=VS>$0UD\:PD2;4,)WLN,IZ_'Y
MX_7M:/[(@CS%Y?:U0L,_);J7B\1)3F',@SP=QKEKJ\);,O;L^RR(;V(;M\C:
MN'OZ-VK%N,\(R/X]TX+[Q@23XY%8$%;5=$L%5I2-$N( _KZ>2]LQ,$3NO51=
MI]*]# 0^<D8MXJS]^-S/IYT<%M&&C4FQ4<9QWN%XT)^+:ZM&F(1Q9N3G%NDM
M%(_!!O#-$WU(!>Y,N#,L41K+GAL+7==XU"*2?=[?)X_)AB+JAUCW^L+5! 5)
M+E*2IBV4CZ39$DW<2K.BBZJBZ=O-,*$A&I^-].68O<?7B1?&PAJ>U)2SY4S.
MDBA9Z!7J\TB.0)P-I/)F8/GQC1N/L#SGA=L.#U(KTNR1?DQ-&EU "Z$0*:'+
MXF9$5MP'LR ^1=B&77RK.&L7]*9YI2R5-$7Q%0E^NM_V%GCAF,<3LWZDL2FM
M"!M[N8-E*4S>#>.&U(@&Q1])*GPH3_Z]W6BK096T:<KCQSG,Y0?Q/4)Z<^BR
M84+^^G86V6,8?.R]QMIEX:J:M5P/>L41%;_\V#5,K5!X'7\HJ1LV+7]&$*7W
MO-D8.@M/-ALYBP:YWA"R@.)TUEWL: $!!9H;%].%'$BO4:DI\]/<N!%8']HQ
MIV/S2V+#0T'Z,.VE(7LE0>U]N$ $>=!;XY'>>IT.M_X?4B8C&?B(6'=,#R<L
M#IX"VM!4G8;\@:@<AO!&;BE:"/N QSQ(/!X,C #* R:##;@7AYPY</317#QX
M;1_7#!!/T*SH-</G!E[FM_\WT\7UNV/2)NE-),(.+JGH-2%*-@6]Y"DNC1#C
M^>-$(TYJ@PHSUIX$'>@4W@)^WXOQ\82+7N0H\<$ "<]_839_/KS\_S-*>1^E
M7*77Z_3>]'$<0,;F/E?AV*\2&#?S=S7!>8=U9(SG7+Y6E #C'4B%F3CVJY/3
M[+=$\-&:?S%%3X-:^I\5I:OI1UD+_UND8;G_1=>UM"C8#@F\PJ-GLY]_.@'1
MXE])^2^=:?F724O3=:;FCZ"C0%]:@/LK ^.&+[1!^JG:Z_\"4$L#!!0    (
M %2&75AA[*H&M2D   "(   8    >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M[7UI<]M(EN!?07BZ9NT)B-;A0RZ['"'+=I<FRET*NZHW-C;V T@D*;1!@(4$
M)'-^_;PS\R4 RG8?L?MA(V:Z+!+(?/GRW1=?W;7=9W_C7)]]V=:-_^G!3=_O
M?GS\V*]NW+;PBW;G&OAFW7;;HH<_N\UCO^M<4=)+V_KQZ?'QL\?;HFH>O'Y%
MGUUWKU^U0U]7C;ON,C]LMT6W?^/J]NZG!R</](./U>:FQP\>OWZU*S;ND^M_
MWUUW\-?CL$I9;5WCJ[;).K?^Z<'%R8]OGN#S],!?*W?GS;\S/,FR;3_C'U?E
M3P^.$2!7NU6/*Q3PGUMWZ>H:%P(P_I U'X0M\47[;UW]/9T=SK(LO+MLZ_]9
ME?W-3P_.'V2E6Q=#W7]L[WYV<IZGN-ZJK3W];W;'SSY[\2!;#;YOM_(R0+"M
M&OYO\47P8%XX/S[PPJF\<$IP\T8$Y=NB+UZ_ZMJ[K,.G837\!QV5W@;@J@8O
MY5/?P;<5O->_?E/XRF?M.KONG'=-7S"NFC+[Q->$WWVJ-DVUKE9%TV<7JU4[
M-'W5;++KMJY6E?.O'O< ":[W>"6[ON%=3P_L>G*:?6B;_L9G[YK2E>D"C^$(
MX1RG>HXWI_>N^-:M%MG929Z='I^>W;/>6<#+&:UW=F"]F6-F__MBZ?L.Z.C_
MS)V8UWLROQ[RUH]^5ZS<3P]VB.GNUCUX_>__=O+L^.4]T#X)T#ZY;_5_V2W^
MZW?-YA?Y[<8!PZ[:[:YH]OC\JFT\O%(6O2NS==44S:HJZLS#\PYD1.^SF^+6
M94OGF@P0O"LZ>&ZY!U9I0+;@$UG5T))=">\Z8+/^)MNXQG5%7>_Q&[?#M8L(
MXZZK8)==#5#"NSV ]'M3X3.?<%<"^F+K.CA;]O#?_^W\]/3XY>^+3XOLSQ<7
MU_3WR<M'"SA76 5>N SGT&,F)UL6-4%'#.VS@MX!VG;;I>L"?1..X1^G](]D
M 8,0>!-V;K<N ]E-X.]=T?G,(<M-%\WCBO"/$WRW'DJ772#--P4>Z.3Y2Y_=
MW;2(L/:NP>V&I:_*JNCP*B? W,+GQ;)VL%;OX'I[V+NO>GQ6$?;7JW<^XNJC
M6]6%]T0OB""?7;JN+_#FMG@K/BLKOZI;#XM7>-$5G&P'5]!^E2BZL#2\V[<(
M**HT_">B9C5T'1*)++8SQ+C :_+.K*# W<&A@,)*W**_PUU:6*N#:_-T>PU"
M>0OG9F 8XEL #O!WX^HRHJ-E^CI,\@EA'*"+4X)T B<@H<R:-G/K-:A"W*IQ
MO9!&G@%)-+";QY/#ZL W.:R .(==]<L\6Q7^)EN#"H>=@9C:'O#,QUQDOP-R
M )QWOJ^VQ!@(!3,A P!?]F-*G[TNQ%CG:GI ;GKHF/WDOJI^SZP;. U>^&.H
M\"G#ZW"KV^*SRUR "9<&@(?MCN^NORD CXR2GK"V:SL2 $)I +2YQQH(N:KY
MLO#O"!T^","AQ,"=#[W#N^#9OP\=AV#KW*UK!H'&?0$CS<,?Y= AZ<272(X1
M32\240QR;.N1??]&"&CAGZN;>]"ET@#L#32H^&![!F3E@*B!S3U2SJJ]!9$:
MOZ[;9G-4@^55"C_T1;.I4"@PIO)L.7@@-N]A[>T2T, ;XL.;MBWOJKH&05(/
M4;M4P")5ARC*D6.Z ; &.VU="6>K$[0_!+B1LX&!AAZ8H(^X5 ET]>8O'U4"
M9< YU=8_RL&P XFU%6AP]9O6[RJD>N*1\JBK_&>"YL85-=#C#O@S^4XN2&@Z
MX(A  E0JAX-P!9P@AP'GUXZV6X.-T7;P&:U?@1'8T<E IVZJ!L$3P=X77RQN
M:N!/E!(Y W*$YFI)"P-UT#.\9(>FZE&[/AJ\2PC6P0L6?XOL0^0IQSLA.\+S
MATF%;@G^=]/B&9>DW_&*-_8H2+&@-%"DX?LL-\.Y(XJL; ;::MIMM0*Q>5MU
M;2,4 *\CKP,@Y=\&E;5W-X[Q*&JIZE;#%E@+-D0ELD(F6X!NR]9#CTR,EQ4Y
MKNI$6@)1%@V2S=(%D@"4D@0"";>J/"-UU2,1@A "9P )>:A11, 2789( C6(
M.G/=M:!P@)+N$4R+[*^J-:]4:[Y3-?'K%+4Y*H/T>%6#C ""!I'7.)0N(+.1
M-<&7*ETGE(#?7K*Z,7?K"I #M=O@'>&V>Y:4<(>(AD3Y+_?)&C/V52KFD$8W
M0T7?LZIRD7@5.(]DK")2E@ZVQ\2@2&@%]4#/P'7^IMH1:N[ X</_&N6 UG>%
MB"HVG6-1"^"T0"YU37"+M>=7X/M.I;4]!I*?XFD+Q =""'3K$LA9WUNWR)7$
M[5U%E/!C1N+FV4M& ;]\ R 6@G>0"<.*J))0CU^1"0/GA<-78 *H!5/"<U%^
MDH<;510\ K=5"H._% G/VP%5(TG+0<D00GV7@<KN _;J:DOFK@J$?2;628XV
M -PT2%*5*EL@2N9BV EWMV=4"N%#3JU" <-2W<NL6KA%/G/CHKD[NA)RQX#U
M<CX=K#\E H!5Q$O0L:/%5C>@DX1D^=_!XE^#IB$1&PB!X0LDV;@^&$)7:T,.
M9>N89R))* 5DQ1*T9,J!Q6Y7DR7(%F3T0B*IZ1&9' %O<#(Y[M:!6"GI#L.;
M<_!\&RQ1&EB:6=.E6RX8P), $"H"&1>87NVV+1W@>SVY8 (%"74_PRF@O>!>
M 3R0DBN/E/P'7'*UWF=$0> TT+7R_K1Q2[CBW1!0$B($E]D4\1NH!Z\&O0_0
M BE@(.J,J(>]@5%H3SQ&Q?PX"W9_ ^)D#/PLMP?:(/_$#^LU.L.HXO@Z85,F
M5D>ZUC VTF@+IDQ1EA7> 8J+80E"%TV5U(X<=FCIO)S;O_*),"'";]KF"-TY
M4"(8*%.4DJV 5@NQ(ZC5SADV $RA2^.8*+?%WT"]PZ=!4P<Z0$GDNH?^$:(M
M6?K12[S*!$A& K_""J[(-ET[H$PJ5I^9 48T0N*+) +<!ZX^Y?9%]BY9F;D!
MQ+U7;@":9E+=\T9SUYQ>Z*X%)Q"Y!\#;W(R0!N?R($/KHI-/<KS9$IP5<3K,
MQ2;2A:ETBSSNH]%>HXY=@RA"NI@110'K8%I1N)85%'QQ"YH5_D"5'<'_9"X;
MY3Z0X*ZPX(,(+(O]4=\>P7^L IV7A/$PR8W:;3Y7J\]'2+Z*H%OA7]Q_C_;3
M#LT E"!K0EYT6$HQMGQ*T"W0\(:E$:"V6/JV6\[B!NS-%2FS%H2UG] < 81+
ML*D^CU]= ^"L2C;X0$TW+/FM  WR0^5-I*-9(<'4BR(&)1,(\U0>DP\$E\LN
M&*W8)\PL[Z(G**(;!=4A@7V/I#;6YTB$)[KDH(@\I$= ;@0E$>Q%%AH@/RA6
MN'2-0S$(_UY(!&'R!8!0U'MT*.C0I!0P2'/KXC?L],!AB349*<(8?I&8(\8!
M]U'"DW:,[_+N/9I@Z,IJO$C7(.(X>:E&<GI^T!0STN)>&<!@?!O[PY/W\G[V
MD/9[E$\,LEFN8<X ($BW]G-,$9"!GDRN0(@114[/KNV11LC= :*P'"R8PQ<>
MAAMY=,^5H'8F1\ZAF*CZ,=DI'WP+07UT:\;\7P# [.0\7)S&(0\[70\1CD<2
M(@CQPJ\&;Y#[JH;39A1#:&9=FF0AMD=8F( @0&$P8P"CHT5HQ)C&" %H5!Q
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M?H.P*)K/03B@EJJVE)\ D^C+RKE2I"VR>,EAEB CWKN2EG@K&USA4Z3-+V/
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M"PG[A_%]=]2JPS_A )>1$_I3>W>1O4%#M0^A[5:GK6/\F>Z,W@0K".'#,5F
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M&3LJ;33\35JQVB(0PF^'#")2!TGU3T!KKAD](\ F<XFF$BC(_W3.)\7U$^=
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MXW;6!#._D2]A3\.7]<G[##G<4W;\'Z'N%YYO'M ;T'O2E]+B+@ GR)#"\=W
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M.N.P, :)I%=PN39*H'@$&AHD0UBBQ)I;UQV+FPL/S4F]5&U+3$Q#)BYCJ,T
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MT60<@![&[+"QJO.C;:DL#4J_;.C/!+53H.^UHN[8;)R#W;_._&]02P,$%
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MEL@6H*TC9KV*B]"S-"<J6_/\]M4/TS"8[(/*<<X<9]EH@4I+>1X)%BG4ORG
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M\%AHVH#G2X73?'5# IHOMD?_!5!+ P04    " !4AEU8&)W[X)8$  "Y"@
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M* D:MW-O&4WO1\Z^,?A;X-%<R. RV2CUQ2W^*.9>Z AAB;EU")Q^WW"%9>F
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M9P8^-G6[=V%[6&;AR_TA3NZ+"W3KM,PW+$Z.$K7S<IR;ZMZ8;"/H]CIH4JW
M9;6C"E,V_7K W E\/4WEL"KBNFKM+0Y@X[-9=U NM3IS8 ]?!4CU$706=]7
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MB^\WLGJIED@ZS:%_TYDB;'3*=+\?  G-G%/I?&?>+T"4:V+?8"1*H,<+%L]
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MEYG<N$[CH.B.&3JPK;&UE1UN3Z)GD)M#&/6'N>Y/*W5%0Q#:\3]M^O7-?)"
M7=B&*#!/[C8,X(+E3P8NIWY_ N-ML^PG0Y*$OLF+;Z>M4WJYD;4_M6V[AZ<B
M>TV]^ L^)U$'][8]JZL!6P']N!E*A/P]PL=';P NLZT[Q,A<PCO"M)NM7XCB
MV&548#*J&O#0.T%2C]<Y9MU]V6JN#*XL.WSQ!CANS,3V[O3U-9CWB?04$ WH
M?D!&Z)^6<:PP#%R>-6\OBEUK3&,8G7FB>O"R48$\\ZQ9K6(MIH/#DX\E$*V;
MX9#IKAWF>6"IAS8"E7C$C3QDI7LM-S[V1FHR>%M8"KUR[T3IG5!=V>;%8;_:
MOW:]:=XV[LF;=[:_<;U"9V2%6(+5'\^2$=/->]#FP:J->_>X4-:JTOU="PZ/
M$@'VETK9[H$.Z%]&7_\/4$L#!!0    ( %2&75@_"^0(?0D  )@=   9
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M6'[3.KQ2/D;B(8A8$0"\U;. @*3T7!1Y27)JN5FU&I3E,5=]JM!,PM*SR*'
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M>&]6?+E4$EF!!N#]W!C?WM "W<?8JW\#4$L#!!0    ( %2&75C=>^%2^0D
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MW;IL1WVCUTQ0S.DM->L4Z6%&[Z3[T=0=I'PSJJFBO1=U(6D"A5]1UMC' Q_
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M56XNEX)C.TX#\'ZNE&YO:('N"^[-7U!+ P04    " !4AEU88S9%\-\(  "
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M@K)-\X2VB"^QJ7*R+H1*40&B@O=2#M?,X4H1)!$(1]')7^I79I&KPL[T'!*
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M][.:4(@S+O!TUP//A;)QH><<5;'PW#/C'8S6T490MC6I3K@NGJ"F0:*$!"R
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M44EV]O*=T(UL[@W<HH:[4F@\7UC"Y=%%/F!<]QCA"QA!"!]48TL#[YH"BWV
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M/\,'\'ZIM=LNV,#NF]75?P!02P,$%     @ 5(9=6*6Z!;,)"P  6AP  !D
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M5R?:@.<;K=UT0PKFSXFW_P-02P,$%     @ 5(9=6!ABRRG8#0  2#<  !D
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M: ">3Y(D*[[0 N6/YT[^ U!+ P04    " !4AEU82%'>3WH)   E&   &0
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MI^W<J#5+#9-#[6,=W)4]+50B,J,7AY[;2)M/:X4(7HZFTUTU7;05JK'+I%V
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M!M4I%^F?$A])E*Y,:HIX#(R<\Y1@^6R=H%;%JM18M>_K8+_UZ1;C^B)\H&9
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MSP*$"=#/<\[5<6(V&'X_R1M02P,$%     @ 5(9=6%&@[B]C/   BM8  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL[7UI;QM7MN!?*?AUOY$!BK;D
M+$Z<!)!EN]L/<2)823\,!O.A2%Y*U2Y6,;5(9O_Z.?L]MQ9:3O(P;X#YD%@D
MJ^YR[MFW^]U]W7QH;T/HLH^[LFJ_?W3;=?MOGSQIU[=AE[?+>A\J^&5;-[N\
M@X_-S9-VWX1\0R_MRB?G3Y]^]627%]6C'[ZC[ZZ:'[ZK^ZXLJG#59&V_V^7-
MX64HZ_OO'YT]TB_>%S>W'7[QY(?O]OE-N [=K_NK!CX]L5$VQ2Y4;5%761.V
MWS^Z./OVY;-S?(&>^$<1[EOW=X9;6=7U!_SP=O/]HZ>XHE"&=8=#Y/#/7;@,
M98DCP3I^DT$?V9SXHO];1W]#FX?-K/(V7-;E?Q:;[O;[1\\?99NPS?NR>U_?
M_SW(AK[$\=9UV=+_LWMY]NFC;-VW7;V3EV$%NZ+B?_./ HB'O' N+Q @GO!$
MM,I7>9?_\%U3WV<-/@VCX1^T57H;%E=4>"K770._%O!>]\/+O"W:K-YF5TUH
M0]7E#*MJDUWS.>%OU\5-56R+=5YUV<5Z7?=55U0WV55=%NLBM-F)_O7XNR<=
M+ J'?K*6!;SD!9S/+.#L/'M75]UMF[VN-F&3#O $=F-;.M<MO3P_.N*KL%YF
MS\X6V?G3\V='QGMF('I&XSV;&6]JQ__K8M5V#:#4_Y[:,8_WQ?1X2&??MOM\
M';Y_M$>@-W?AT0___F]G7SU]<62U7]AJOS@V^O2!3BWR=PR3_7(;@([6]6Z?
M5P<$R+JN6H#))N_")ML655ZMB[S,6G@^ .UV;7:;WX5L%4*5P6;W>0//K0Z
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M0X[N*SNZKXY"^WU8EWG;$D]#$+=3!_:90V27H>ERQ.8=8FJ;;8IV7=8M[+!
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M6PGPUH>\M-3 85SOEX0"_Z3S7!AV3)W=)-"/46],!SP[GLCW-ZV+Q>G?FN=
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MP\_$13E:P!'@F#P4[VFGJD1I2^3-4QR:;!?GG"T2]J'&J(5IXL^</MA2Z%(
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M5$1^%47D5T?E&DBT8DTG]:HH>YS^M5ZKB.W6B;U,BLL_/FS&#]DUCAB7YR"
M5I^_OKJVVG-IS-]+WA^=B+K716<9&B#8L3(TLY>U)")1=+;[@'PX;$X5L>(-
M(U&>)B\B.F!$@;!>(Q/!TN,DSD[Y\P*)B0W[S44N\8<6([63G;,5,'L/ED 2
M)ZS[1FR#!V[ MY3JM'B&IU7N_#Y0-\XZ^PF;ZYQ];7=TZWF.<$#;LUC7SG7?
M:E\WV6-'M]AS"H)-RS_16]'O CH']G$^KCQ^'2GCZZ,H_%-=2;8=^7C>"HE/
MF^^?'.IT<JQ$>W1V<1OOC)R\;.96]/8X9+2CE1<MYP?'FE^@'J[+GIX 2,?4
M0FZ C"$Q_K1@>XD,I2^?_E7I2^[ )85/A,L_WKZ>F2 &WG?2L4-*Q0]XMT *
MKL+ 97DKB4=+;E\=W\Z+;5ZCD)Q_BKI_8>Q7C$1<]N.YO,7$?:''M*0;FV;X
M4#6[GX)"X*B!Q(2O/W;=X?.(WL\_<3/GO_Z55ZAO\K70DVC]1X9(U_5-7-<W
M1P?],:##9G(U#WDQ07I3&EHN>DXJF"D.BU>T4YDB>2"UY\Z4$B1(SB]0/TWV
M/B+75K;(/T9G&^M7J-C7VU.J,#2/G+^.F4Z]Q/HSG\85!\Q]!WHT2IC626>-
M51&J>](=UAWI7(UU*0QN.'>++_+3NJ*[8<Q!HEX/J]U#AX==PTT_U_N1KR+3
MG/R)5 5FU'9Y5638W%5P7.9B(?K$84^^Q_'MB'14_B8X J5&MS986^+\AATG
M";18#XI@0=IDL)@71/S&PV^9H\W.VM[637=*J,)O^B1' !^K[5;Y6#*V2FK"
M?2COPJE<AH4YN^I/9V:76#@\NOF\4770/FL;N_R*]= =%F$4=DDYO;G@\Y_*
M/TE;G>WD+H(I'BBKEXP+C7-@ESV=LE$G4;Q8CAJR,)DUUH.N;AI.M:05H]<X
M*1U\" 34+^VS\G$>7N0Q;OGLJ7$E^/.H/JORJ33A/<6B/G\4K%N^ !POL3;M
M*9927L8ZPCS*Q=)Y^]+*]#:P5*%"%][Y['7D"]21DE+ I&I'S"]UW0PJ=V*A
M<6KT2DZFK*[P^Z$:S+^<?;G\6JL'J5 [%E%.[8\+X'VYDK1Q\U$DM2V3P>E5
MC)L!^X.5;3DXQMX(DJ^<+"9B^D1^,4G_YQ<;GAW%OG@7][/CMVB_#Y@Z#-1Z
M(6E>%Y&'7C5U5:-_.X; ^/$C#X%ZGOU/$$0RW"0F/V1%#Y\"3_TG,'4).'CW
M$Q__&]-:KX7EMW[,ES4*@9,W%]<O'[-;,]EZ?.=7ZH^7G5Q<__J8AC]]^G7V
MZ%INZ7Y/>?GXQLDO]1Y,SO/G3Q]_F[WEQIK6F)(?(Z5-WWS%RAFZ_QZ)$@M(
M0Q5-4JK(;AJ^BFUC3VMSD,B@FCBX7![>^HL9M0=8J&YS2I")8\%4*[R)(JV2
MX_6IIVV9P<YMXT7K6H JEHXJ*GC]:N:MPDU1D3:27M#QQ<+ZHMF-<Y]XY<N%
M9![E6#=*F8GDWD*"[KIAG@K*+V[X@%<^211);5#-@E83UI03;8AHF@)I*12-
MP+A.UTX&%AU0B0\9N3J,!%PS5#.8?I,]2D*PC$=M]O474X@4'TT1B#2SO7*N
M8]CB8S2+].*F072'Q.9$IZ8DRL--W?QV_DP4^7_CO(\QXGA'_+/CU[J_"I14
M@T"+K.LM=A3HZ? F.>D?&S)J"N_QJ*_O\WVLV&=^?PER$410_'9JKT_:VQ"Z
M5WF7__#=+C0WX1+T!K1F@9E^_PA%D7V+93X B[-O+\X?/8$WX^,_?+?/;\([
MNHX %:PMO/IT^?67C]C,T0]=O<<AL:U:5^_HSUO0-T.##\#OVQH.6C[@!-CD
M@Y;WP_\!4$L#!!0    ( %2&75BIPIVOW@,  -X(   9    >&PO=V]R:W-H
M965T<R]S:&5E=#,S+GAM;(U6;8_B-A#^*Z.T6]U5*>0%0M@"$K!7M5)71<NV
M557U@TF&Q+W$3FVS'/^^8R>DK,JBE5!LC^?EF9G'-K.C5)]UB6C@2UT)/?=*
M8YK[X5!G)=9,#V2#@G;V4M7,T%(50]TH9+DSJJMA% 3)L&9<>(N9DVW48B8/
MIN("-PKTH:Z9.JVPDL>Y%WIGP1,O2F,%P\6L805NT?S:;!2MAKV7G-<H-)<"
M%.[GWC*\7XVMOE/XC>-17\S!9K*3\K-=_)3/O< "P@HS8STP&EYPC55E'1&,
M?SJ?7A_2&E[.S]Y_<+E3+CNF<2VKWWENRKF7>I#CGATJ\R2//V*7CP.8R4J[
M+QQ;W0DI9P=M9-T9$X*:BW9D7[HZ7!BDP1L&46<0.=QM((?R@1FVF"EY!&6U
MR9N=N%2=-8'CPC9E:Q3M<K(SBQ737(/<PT:A1F%86RN1P[9MD]W;\D+P/<^8
M,+#,,GD0AHL"-K+B&4<-'Y[9KD+]<38T!,DZ'F9=^%4;/GHC?!C!HQ2FU/!)
MY)B_=C"D7/J$HG-"J^BFQP?,!A"'/D1!%-_P%_<%BIV_^ U_U_+]<[G31A&A
M_KJ6<>MO=-V?/63WNF$9SKW&EER]H+?XYJLP";Z_@7;4HQW=\K[8TJ'-#Q7:
MKCUPS8I"8<$,YO"$+R@."+L3;-A)*G@^-7@-_LT U^$_EPA[6=$!MV4RE@S0
MM'S2D+^"H3H8!0I43D* D&4E-.R$"@RA@@]<@"GE01,/]<=[^ .9ZA@"U%^L
M=Z1Y[K']1/83PEK6-:J,LPJ^AC"9^,$HM;-)Z$](D69QZL=Q#(^8$YL5PC0(
M_9C,DSCV1TD,<3#QHS3I%'@.49+XP92"I($?I':,_3@,X1=36K0E5SDA5\;2
M8ASYX32%<>JGTQ&,1OXT'?=UI^!^G"9^DH1N'M)^F%A0DTGL3\,QW&C_N&__
M^-WMOVCX(_N;&KYVMPE2)4GTA(U4CM5;+&K;J&M<N!W-MIU*WC!Q@I+E="W9
M,*Z/&O9*UL"I_VM;YPV52%BQ;J-1Y9B!C(Z^XKN#I8%YQ:&&VFAOHP+=Y23H
M=>J8\WXV;!RAEO#MG?V%XT$,=YUP!7$Z2&D9CP81[86#:;^WAC 8A'#7V;7"
MA[.7:#"V6_ S:FV3$*1]9R$::8AV%T UW*S/_PL@WU.##/F+NVS='7VY_HY6
ME3M1'1_O8>D,WZA17XED$%!*43NTTD\P"MUR'-GA&C.'%V\.D:IP+ZL&=UFV
MST\O[1_O9?MF_:?>OOR/3!5<:*AP3Z;!8$*T4^UKVBZ,;-P+MI.&&.RF)?T!
M0645:'\OI3DO;(#^+\WB7U!+ P04    " !4AEU8+\NE[< "   S!@  &0
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M<FMS:&5E=',O<VAE970S-2YX;6R-56UOVS80_BL'M2B20(E>;2N);<!.6G1
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M%[,\ #T,SF%C5>>'U499&GU^N:-_#6KG0.>U4O:P<0FFO]?R7U!+ P04
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M3Z5UFNZU,$-N"+MFF?UU4E$,[K$)QSY-KB=;"Q89[YTV=]Z 91&?A.S)@]M
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M2 #K<ZW=YH4,;/_0SOX#4$L#!!0    ( %2&75A1IS /!@4  %\,   9
M>&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;(U7:V_;-A3]*X0;% F@RA(IT7*:
M&'#ZV /H%B1IBV'8!UJB9:&2Z)%4G.S7[U[2UNS$%O;%?!^><WDN15]ME/YA
M5E):\M34K;D>K:Q=7X[')E_)1IA0K64+(TNE&V&AJ<NQ66LI"K>HJ<<TBOBX
M$54[FEVYOEL]NU*=K:M6WFIBNJ81^OE&UFIS/8I'NXZ[JEQ9[!C/KM:BE/?2
M?EW?:FB->Y2B:F1K*M42+9?7HWE\><-QOIOPK9(;LU<GJ&2AU ]L_%)<CR(D
M)&N96T004#S*#[*N$0AH_+W%'/5;XL+]^@[]L],.6A;"R ^J_EX5=G4]RD:D
MD$O1U?9.;7Z66STIXN6J-NZ7;/Q<SD8D[XQ5S78Q,&BJUI?B:1N'O059=&(!
MW2Z@CK??R+'\**R876FU(1IG QI6G%2W&LA5+1[*O=4P6L$Z.[NW*O_Q[@9T
M%>2#:N"LC7#A.G\0BUJ:BZNQA6UP\CC?0MYX2'H",J;DBVKMRI!/;2&+0X Q
M\.M)TAW)&SJ(^%'F(6%Q0&A$V0 >ZT4SA\=.B5X)+;>B;\4S>,R2N=:B+:6K
M_SE?&*O!,'\=4^^QD^/8F$279BUR>3V"+#%2/\K1[.V;F$?O!Y@G/?-D"'UV
M#TE9=+4D:DGV51P<W:<GK,MCW ?1CW-_6$FR5#5D;]66Q*(KMBE<_2,-L3!L
MG(D6CDF^ST1Z)I"]N2I;F%^0#CRAB:AKE("+D;IHG]^^R6@\>6\\&%G7HC6D
M:MV1NX.G1+0%5L '6!/&J+P2%C WE5TYK,J83K2Y"P\(L+K*<=Q@I QV KL&
M>/D]$.419J$N&/.=:HW,49>P!)8!A[SNP,=(II2MU*+V^Q>0CA7Z!.^5G53'
M&:F(//?"$#T'1%57A6-K+!3H,\<(X%5S$*%SAZ Z [N8BTORAQ3:$(FY1" 3
M9+.  .ZRP4<&HT+N#_B?D3B83",H&9042AHD643N]L+BH[ 1NC  $= T(C$-
M6#0E24!Y2AZ4!;$N>D.G"] TB!+<*^9!',50X<$D2<F X]/>\>G_=[PC_+M3
M2!X@7XW(O=JOSE4'X[?HH&,Y,+C?Z1QXZ5/XPL%)M@6>[Z%U\+3!&!"NK<7[
M]+GT26O(=_>UD,6[^2,8JI2O.^9EJ64)3MGJ.=P0O/FK:#OXC)*=$;)T&F0I
M'@)-PRPC-(RG>")1R'J($F*&O)P(^OYDN9LOGZ3.*SSX\SB)@BB*+A PF_0S
M69CVLW-,O5H6 0C62UFY"&BT2:41@L9IP*,I0/ PY2<W?:'SM>73".R9H,M8
M$D8,E:+L))R\).XNJZ,8">=!$B,&S4+&28RB/,: :7EO6CYLVKV4.?*!"?:S
MT)MVCJ^3RCX?,^SP7L>\V;5XKP&X/IKM_BT$N^%!.8<^PQUS\HH9\O-K(?XZ
MN97:O1CQ,O:?J%,S?^O<;@"]RP&RRX&!H:\[A<+=HB^3(673@#.X]28T3"$7
M,FRFY"R)PS@A/VW3 .[#@-*,,!;"39GR.& 9QQ:/R3</?TYY!$LG%X1-0S:%
M/$BS(*$QM"?A-"&?>Z>?)VDP9>!N!NZ>D'.>PAT*ZQ(:<OZ2[^L@3V(6T"PA
M9SP*IQGA=!(PQL@92\,H/6;)\=ZCKY&Z=$];O'RZUOKW7]_;OY[G_M'XWW3_
M]/XB=%E!UM1R"4NC< )7I/;/6=^P:NV>D MEX4'JJBOX!R U3H#QI5)VU\ -
M^O\4LW\!4$L#!!0    ( %2&75B^=Z*(X@(  $\&   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0S+GAM;'U5;6_:,!#^*Z=TJEHI:Q(G4-H!$GU3^X&N@F[3
M-.V#22XD:F(SVRGMO]_9@8Q)E"_QO3[WG/$=P[54+[I -/!65T*/O,*8U640
MZ+3 FNLSN4)!GERJFAM2U3+0*X4\<TEU%; P[ <U+X4W'CK;DQH/96.J4N"3
M MW4-5?O5UC)]<B+O*UA5BX+8PW!>+CB2YRC^;9Z4J0%'4I6UBAT*04HS$?>
M)+J\2FR\"_A>XEKOR& [64CY8I6';.2%EA!6F!J+P.EXQ6NL*@M$-/YL,+VN
MI$W<E;?H=ZYWZF7!-5[+ZD>9F6+D#3S(,.=-969R?8^;?GH6+Y65=E]8M['G
MYQZDC3:RWB03@[H4[<G?-O>PDS (/TA@FP3F>+>%',L;;OAXJ.0:E(TF-"NX
M5ETVD2N%_5'F1I&WI#PSGF'%#6:?G[@R[_"LN-#<W9>&DV>^J%"?#@-#A6QX
MD&Y KUI0]@%HQ& JA2DTW(H,L_\! F+8T61;FE?L(.(-IF<01SZPD,4'\.*N
M[=CAQ8?;ACUM_YHLM%&D_=[7> N;[(>U$W2I5SS%D4<CHE&]HC<^/HKZX9<#
MI)..='((?3RGB<R:"D'F<(>HX4&DC5+4!A<9S/ 518-PRY4@4ZYD#1^WN:^W
MP]6?"X1<5C3%I5B"L6\#-!I-1F4*R"VA<I<0*;)&FMP4:? R$EHR1L+D?GKM
MP_U\.O_JN]A)H^R,GI0"3"$;339]>@D_D:OV#0&] *P7J+I7<,C)7(6V $R^
MS1Z^/NZQ;&_L$R07?C].2(A\EC ZCX\&+&)?2.KU_?CBW+G"P<6.Z_:-%J.F
MIEGHAV$( ZH:T\DB?Q"%%-[K)<[P2*OU$[!MB82%]#TASRF=<>+W!A;^).GW
M3K>.?8\EV!GR&M72K3(-J6R$:>>]LW;;<M(NB7_A[:J=<K4LZ:E7F%-J>';>
M\T"UZZM5C%RYE;&0AA:0$PO:^*AL /ES*<U6L06Z_Y#Q7U!+ P04    " !4
MAEU8?VT FU@#   H"0  &0   'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6S%
M5MN.VS80_96!$@0MH*Y$ZF)IUS:PEP3-0X#%NNVB*/I 2V-;6$E426J=_'V'
ME*5U L=(+VA?Q(MFSCE##CF<[Z5ZTCM$ Q^;NM4+;V=,=QD$NMAA(_2%[+"E
M/QNI&F%HJ+:![A2*TCDU=<##, T:4;7><N[F[M5R+GM35RW>*]!]TPCUZ09K
MN5]XS!LG'JKMSMB)8#GOQ!97:'[N[A6-@@FEK!IL=25;4+A9>-?L\B:Q]L[@
MEPKW^J@/-I*UE$]V\+Y<>*$5A#46QB((:I[Q%NO: I&,/PZ8WD1I'8_[(_H[
M%SO%LA8:;V7]6)5FM_ R#TK<B+XV#W+_(Q[B<0(+66OWA?U@.TL\*'IM9'-P
M)@5-U0ZM^'A8AR.'+/R* S\X<*=[('(J[X01R[F2>U#6FM!LQX7JO$E<U=I-
M61E%?ROR,\NW0K55N]5PCPI6.Z$0OOM)K&O4W\\#0P36+"@.8#<#&/\*&./P
M0;9FI^%M6V+Y.4! RB9Y?)1WP\\BWF%Q 1'S@8<\.H,73>%&#B_Z]G!_NUYK
MHR@[?C\5\  7GX:S)^92=Z+ A4='0J-Z1F_YYA5+PZLS8N-);'P.?;FB$UCV
M-8+<P GAM[+I>B-L<NM3TL^"GY;N#BE4&L1X2BVWV2'@R-\1OW;\Q1'_)?Q*
M%AK0[CO0KF&S)L-QY^R'VP][">0%Z,VKC#-V94]75<!K8!=1Z)IP:)+9.:^R
MJGM#I-:2Y]2$%WD^^'%X=*<2RQ_$,RJZ9 9?;:,B^0U="W3"BB>@ZTH;T9;$
M\86<./63)/)YDD(<^_F,^2R.(([\C&=^FL;_B&+43B0Y0;(XA#CQTY#[,4ML
M-PXC/\P2.)--R91-R3=GTVJ0^+XMZMYN6-6Z3;X[R/D;R7:6^Z\FVV$%JR_D
MC:OUK^7B?Y =JP&@<\J I;F?S&9DD/M1F$.<TVZS#!Z%4J(U>D#G5U.;L=QG
M"8,'I#NJ*FST@R2Q%ZK4D!!AQ@F7^6F< 4]R/Z6TOZ5;F,1B:^I/M,*ZMS?Z
M&)T5P7@"4>A'E&4CU?^6Q\%1]6I0;5V-UD3:MV8H9-/L] RX'JK?B_GPAO@@
MU+:B=:YQ0Z[AA:VZ:JC+P\#(SM7"M31465UW1T\95-: _F^D-./ $DR/H^6?
M4$L#!!0    ( %2&75@2'R-3L08  . /   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;(U7;6_;.!+^*P-OL=@NU%COMMLD0)KN[A5HMT';ZWTXW =:
MHFVB,NDEJ3BY7[_/4+(B)W7N/MB6Q7EY9N:9(7F^-_:[VTCIZ6[;:'<QV7B_
M>SV=NFHCM\*=F9W46%D9NQ4>?^UZZG96BCHH;9MI&L?E="N4GER>AW<W]O+<
MM+Y16MY8<NUV*^S]6]F8_<4DF1Q>?%;KC><7T\OSG5C++]+_<W=C\6\Z6*G5
M5FJGC"8K5Q>3J^3UVYSE@\ W)?=N]$P<R=*8[_SG?7TQB1F0;&3EV8+ SZV\
MEDW#A@#CK][F9'#)BN/G@_7?0^R(92F<O#;-OU3M-Q>3^81JN1)MXS^;_3]D
M'T_!]BK3N/!-^UXVGE#5.F^VO3(0;)7N?L5=GX?_1R'M%=* NW,44+X37ER>
M6[,GR]*PQ@\AU* -<$IS4;YXBU4%/7_Y35@EEHVD]]I+*YVGW[177DE'OWQ[
M_YM[2;]\Y77W\GSJX8^UIE5O^VUG.SUA.TGIH]%^XV"SEO6Q@2F #FC3 ]JW
MZ;,6W\GJC+(DHC1.LV?L94/T6;"7G;#WR:Z%5O\53)"(KHUVIE&UZ/BB:[I!
M1J3VW0NSHM^5%KI2HJ$O>"E!3N_HWU=+YRWH]9\?I:@#D/\8 +?<:[<3E;R8
M[-B7O963RY]_2LKXS3/AY4-X^7/6+[^@A>L6Q07T*^<DP')4'U!QU80B1W2:
M #^*YGE_7S>25J9!HRN])A_,*ETU;0TZB0Z WPA/E4 Z=7-/2TFMDS5Y0UCU
MD/>PT3P 9.C\ZMIL=T+?__S3/$UF;QPQ-Z,0#53W&U5M@EAE9:V\L:X+&671
M@C;B5I(VF"&5::V3G=[8R6D;IWP_,<HV6'@MM;0@2&=E! ->79#86<7S#[%K
MN5)@$YY[3VSYC)!&V!,/!6O&!=LKW^&4=Y7<'9C)+Y2^1?V8E'@DP8YNP5*D
M>2.;FB37];XK0&T0M38>\'?&>M(8_\$AW8JF!4:)P;T15@;_8FM:9GK=<I@1
M&4LK:[:(:+4"+OA@7"&!K"(;A4F%MS6U.\"KQGT5!9&>%34#9>BBJKHD,W$>
MY"&P% U:3E(8<1A*0<&T#KC<RS/"1)#;)= >I@)_I0>V7[?6<CKZ7%X+MPD!
M5?P@_VJ1GR;T\ M*YGD4S^;\E&11/(_1$.-THF3?94=I)ZO6=L0)G$C?4!X5
M>4:? 08F>5Q&(:5I$B5I3 F6R_3I<M!.WJ (38AU)RP*5,RC63RC,HWRE%$@
M,TB[N(,[.UB@)"KCF%@TI4](H1TM.LJ+'!+I/.,1MA,*U;_#/NYD1R@3%*KC
M["RBQ2+A[VQ.'XS01^X.@19)>7IQ',<X.RFR4-#5B$5,GQ%[?AU$$XYK05^-
MYQXZ!IC.BFA1Q)2F"!NE^M/H5X]$/B"Z",3'H853R;%RF7=<Q2[G193%)25Q
M&95IR4-/Z+7B(#H+G5 91PM(H02+(J$_C*GWJFE0QSA*BADE61;E^?Q4;6!C
MA"P!:'"C_WD@E6-6=860ARWW0 C&#/A;":K7E"!_28[PP:+D$2U/=7D>%^'S
M2'J4\7261<D\I2S.HUE1@)V84ZKB^H7VR..A*)^0330O6K.1. &1Y:/.*[-Z
MU3[,*:[)HN3ZY?&\9V2_A";(%VB1#'3N"JN?5J[(9N#?G,IR%N7)K!?L%U_0
M'$VYR+D]YXLR2A;%T-OC.7Z%,1(XMA/W@9EA>E65;>6H UY0EH86>\$YS<H8
M^WK==H-8/+8PBV;9#'T6EP5]Q$BO@&KLLB@")? 3%RF]4[>JEKH>U$LT$W^Z
MDX/L$S@V4.8E%8O\29+',AE(6W ;(4&'N'EN]\._,7K]"KOW%N?1I0?8(D^I
M3!9]R_5S^ZCZ28S(1R4^;KBQ[S0I,1A36F"(H6/&33<6>R=7$F]K[H9AX1[I
M2^<YE4 4G\Y!UW0(I'H46Q+%6<:#;%8\EY^3^B!E"54T4)P5F%OC-)U4&J86
M1D1>]%1^2/%1;K*XS_937A_5#VG KL0DR0[4'J^#B$46I6 !MI]\@3[/Z->3
MO<N;=G<P!>-OKH=SR?'^/QP[NHU9L=J*+T.H$9]$<(5S+1@?MOEN6WAVXSX[
M&N GC@%A<Q]O1.&TTD,9@+IVZ52-?D/L, LMZ#C<HR(^#*"V_:;O_O=QHNMP
M*_O#S"% HY\X?>Y4(<)9[^E9@HWS>>+L1X?QZ>C6M95V'>Z6[ =)ZBY@P]OA
M^GK5W=H>Q+N[[T=AUPI[:B-74(W/9L6D&[*'/][LPAUN:3QNA.%Q@RNXM"R
M]94Q_O"''0R7^LN_ 5!+ P04    " !4AEU8@. 3J:H$  #3#0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T-BYX;6SM5]MNXS80_96!]X($<&S=)6=M TZR
M01=HL$&2=E$4?:"ED2VL)&I)*D[Z]1U2LF+'J>J'OK4O$B_#,V>N$J<;+K[+
M-:*"IR(OY6RP5JHZ'X]EO,:"R1&OL*2=E(N"*9J*U5A6 EEB#A7YV+&L8%RP
MK!S,IV;M5LRGO%9Y5N*M %D7!1//%YCSS6Q@#[8+=]EJK?3">#ZMV KO4?U2
MW0J:C3N4)"NPE!DO06 Z&RSL\XM RQN!7S/<R)TQ:$N6G'_7DR_);&!I0IAC
MK#0"H]<C7F*>:R"B\:/%''0J]<'=\1;]VMA.MBR9Q$N>?\L2M9X-H@$DF+(Z
M5W=\\Q.V]O@:+^:Y-$_8M++6 .):*EZTAXE!D97-FSVU?CCF@-,>< SO1I%A
M><44FT\%WX#0TH2F!\94<YK(9:4.RKT2M)O1.37_&<DD"2</;)FC/)V.%8'J
MK7'< EPT ,[? -@.W/!2K25\+A-,]@'&Q*:CY&PI73B]B%<8C\"UA^!8CMN#
MYW8FN@;/[3?Q]\52*D%9\,=;1C80WML0NC+.9<5BG TH]26*1QS,/[ZS ^M3
M#T&O(^CUH<_OJ=*2.D?@*1BR\/F)BH[>K$S@JUJC@"]E4X ZD^\P9PH34+P5
MO^12R;>LZM?[L$:(>5'Q$DLEM?;<P&&K?8."*$A(>4ZU2TF2E:#6O)9$2YZ>
M P4*BR61VP;K8,6!KQ4*8EVN6NR8J,)["(=A:-,[& 8D=)V5K(QQ5V11<*&R
M/QN##Y@%H0]^X)%7%'$D<1)J)/*,+;,\4QE%W+9<""VXKY?-7E:2M0@G]M!R
M_%,X";S)*3QPQ?+7Y'S':\A9X5%6WM=5E2/U*HUUR>0:KHW'=J-FEBN6)>1/
M :S@M78Z<<IKJALPOD4HB$@M#-2+V3M&G>]X--:(J5&4"EX W_>U;/P<N<:4
M,+)[CJ:[$>@\U\3E"/EM/$Q//^/I6:V35TK4:;54]&UH+,2G>,W*%1H7]-K6
M CO^T*98?'P7.;;S:3]1)'A1 !/*HV-"],WT9TS.%H^D@RC<H?YF:5U-$3V@
M* X)1*/0A6=D@HP<!4$[?,7#'5E6N^../+L='FB\RF2LHPYW5+Z'JH*1Y< '
M\$>^1:]7*OP1N>$#>*,)R?3T'+_K.?[1/>>%2=,JAW!=*TI"N"'_%'71.NB6
M/1>F42Q2JCI8)+S:5F?D.6^UGUX*;S?55G/1:FYRI-IJKND3(Z#DY5FLG9/G
M^JNU=1$S+>PP%_ZIC?UFHH5EHCVP=_RU8[J@M%.";_K$Q EUL=D3O>3K:O,F
MX/N!G@8T=3T'7(HN34.:6FX$CN?J:03^,/(\"("Z,?U5&=<Z-B&Z7=8W+2KM
M]8SO#B,Z8M,S('J2BBDKJEJ9NFN;I.T8HK87[G4]OLRSE>E15%'6,)H$!!.$
MDQ8FKH70W:C2#9G"[9FN&'BDAI>K,Z7+YA#H/;C!T(DF-*!VZ[K0D[-!E[/!
MT3F[%XE_+6%[]?^?L/_YA!WO_&@7*%;F.B'!=/7FG[M;[6XLB^9'_46\N>[<
M,+'*2&^.*1VU1B$U2]%<(9J)XI7Y;5]R19< ,US3K0N%%J#]E'.UG6@%W3UN
M_A=02P,$%     @ 5(9=6&L98W&2!0  =0T  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#<N>&ULQ5=1;]LV$/XKA%L4"4#$(BF)8IL8:-)NZT.QH,DV#,,>
M9(NVA<JB1]))NU^_[RC;2=K$V5M?K"-%?O?=W7<4?7KK_.>PM#:R+ZNN#V>C
M98SKU^-QF"WMJ@XG;FU[O)D[OZHCAGXQ#FMOZR9M6G5CF67E>%6W_6ARFN8N
M_>34;6+7]O;2L[!9K6K_]=QV[O9L)$:[B4_M8AEI8CPY7=<+>V7C;^M+C]%X
MC]*T*]N'UO7,V_G9Z*UX?9[3^K3@]];>AGLVHTBFSGVFP8?F;)01(=O9622$
M&H\;>V&[CH! XY\MYFCODC;>MW?H/Z78$<NT#O;"=7^T35R>C:H1:^R\WG3Q
MD[O]Q6[C*0AOYKJ0?MGML#97(S;;A.A6V\U@L&K[X5E_V>;AWH8J>V*#W&Z0
MB??@*+%\5\=Z<NK=+?.T&FADI%#3;I!K>RK*5?1XVV)?G%S9!5(< SNZKJ>=
M#<>GXPA8>CF>;2'.!PCY!(20[*/KXS*P]WUCFX< 8_#9DY([4N?R(.([.SMA
M2G F,ZD.X*E]D"KAJ<-!LD]V[7QL^P7[Z^TT1 ])_/U8O -:_C@:M<GKL*YG
M]FR$/@C6W]C1Y-4+469O#G#-]USS0^B3*[1=L^DL<W/VH1^Z+LEWBI9B;N/9
MKF2/,3^,?;VT;.XZ-"+E(%+!60J!!- ^ZBSL]%'W#=:VSK.UQ:,);%G?6#:U
MEIIS5H?(HF,SEU#(C' VVWA/B=\Z&<"/VAXOW28 ,AR_9G_:V@_282B\74VM
MWQ>?7=3>LLO:Q][Z,(S>V0Z-[+\.H_<]A9'*^RM<>B0M8NFVXN^[%DTS^+UP
M'N6OHX45$-&%ZX/KV@8S#;MVL>[8];+U37+WE;UD@LLJYUDE8)>"EUD&(\^X
ME!J&+A1^7[VHI)!O'EB"JZKD92D><A$ESY1@1<55EC-3\,)H)JJ<'0F=<2'*
MXSW&[CFP\O;&]AL;"#BCE9()8;@!BE %KR30E'X$YHX(14R*(K6VLP0E*LES
M>#<EEV7!"L,S73!I2@"5)<^%O@\DM. Z4^QGBT* $\FA;I#;EOJ(3E9L.V:R
M "U$I;DN2U9H7FK)%->%9$>:&ZF.F5($!N895WFQ#=%^P5<F)%XR0X(,%H@\
MY0L1<9UKAE%>49 Y]F5W.,B)3*\^]#.W HW.A7#,YMZM&+Y=/A4_H"P&$4BJ
M)5*FJ7:"0J92'@%*@#VJB^*B(/(XS28/9$(&I5"'E"I_L%*S0O"\S"D$PZNL
M) -ID11GI;,GE2KRG(M2/>12(-LE5[)DND(*4$]1(/,26=#%_U ID2F0:DA+
M*(A5HF?0/*9Z#.6.PW<B-7BAC61:03J:$2H$(0N2@23AJSL86EO"P7,"!08)
M5'&I<I:CJV7%)':*I(("PH(L%(J-!I5X?*-/@]:0QB"GH(P(:8\!@%&&2%7<
M:+6'0"84JF&>UV8%9] 0# "01J6&ILDX$MP4^5:;0-IJ<_! ILCRU, 'Q"E^
MJ#AU9K@6)$VD)TL:I5.K2&%6Y1/2U%1TR.X!C[UF*M1-,YQ)50YYH&--QHM<
M/:O-'1?(NZ0S)L,)91139?8]Q([!=[(LL8N^"DI#CYI$5*!CCF2.TAQ5<&#$
M'4I!30"2S^@2IV%6%,R 3DYY*@&,Z 999@9GL<!QC;-)&WPW\F]EB>5HM9+E
M&KH6C#X$6 1UDRR-!%"U1T#W<8VUSVE22U[HBL16T'G[DN+-(?VD2:D-3<ET
MAN\TF?#)-'1LF!38>=W5_<SB>C'K-@VH+IY.Q#X<>M=8W!IF[?9"0HM7='G[
M-TV<D,_';EOC>U?AE?6+=.$/N)=L^CC<BO>S^_\4;X>K]-WRX0_)Q]HO6F2B
MLW-LS4YT,6)^N.0/@^C6Z6(]=1'7]&0N\;_(>EJ ]W/GXFY #O;_M";_ 5!+
M P04    " !4AEU8<92A!4X%   >$   &0   'AL+W=O<FMS:&5E=',O<VAE
M970T."YX;6S56%MOVS84_BN$&Q1Q(=02+=G.S8"3M%V'! N:M'L8]D!+QS91
M2E1)*F[VZW=(RK(2.VJZAPT##/'P=J[?.21]NI;JJUX!&/(]%X4^ZZV,*8\'
M YVN(&?ZK2RAP)F%5#DSV%7+@2X5L,QMRL6 AN%HD#->]*:G;NQ&34]E900O
MX$817>4Y4P_G(.3ZK!?U-@.?^')E[,!@>EJR)=R"^5S>*.P-&BX9SZ'07!9$
MP>*L-XN.ST=VO5OPA<-:MVAB+9E+^=5V/F9GO= J! )28SDP;.[A H2PC%"-
M;S7/7B/2;FS3&^[OG>UHRYQIN)#B=YZ9U5EOTB,9+%@ES">Y_@5J>Q+++Y5"
MNR]9^[7CL$?22AN9UYM1@YP7OF7?:S^T-DR>VT#K#=3I[04Y+2^98=-3)==$
MV=7(S1+.5+<;E>.%#<JM43C+<9^9OF=<D2],5$"N@>E* 7K<:"(7Y#TO6)%R
M)LC'0AM5^8G#.S87H/NG X/B+9-!6HLZ]Z+H,Z(B2JYE85::O"LRR!XS&*#>
MC?)TH_PY[>1X">E;,HP"0D,Z[. W;)PQ=/R&/W;&)=>ID-8?FOPQFZ/]B)\_
M]QGM6<;[6=J<.M8E2^&LATFC0=U#;_KZ530*3SH4CAN%XR[NTUO,T:P28,-U
MP91ZX,62S')9V4BQ(B-;BYX/Z3ZCNL7>K8"D&W&L)6YAQ=TWX@RNNY!YR8J'
MUZ\F-!J?:+)H5. M5#&W'N,)^1Q4$U/"%!#GM\) 1N:VAI!#7B!G66F4J/O'
MY#D(7\$]"!+5+:W;(;F3!J7/M 9<A(B$!TPH]14+($M39\L;<D#B8!)3;)WB
M].01Y>>NW2:;#41#6BEN.)KM5D4G) 5E^(*GS'A?9%!*S0VA092$#:]-ZT>[
M.<*WBIN']LPPGNQPLF/>0N8M/"#C8!B'SYCBYZXXFW/AF<YFUQ](BHF*P44_
M6E+S#!1S570_ER2(QTG3?OFMB\-3A:.Q_5WB%@P<GB(64[6I'*..P3>DK%2Z
MPMJ[LWD2)!@)_[VM"G+%YOJ?\!D'DY#6WX^;U:@PXEP*P=0V4 E]1'M7BY;_
MVGZQ*_ ;!9/AR!(T""<3\@9%I*+"&HB:82+IE4L>1UB-,8$<@/^M-*/_89I%
MPR2@P^097&UF?S8QDB 9C7>"[$<OML#<W;@#SN H#.OO8USH-2NWZX=!-(J?
M])YD812'#EX']?1!S=;.),%D-'J<A3<7/Y^&41!ZAJ[M3N1=YTR2J/[^#Q,8
M%8^/ZF]W3K:R,PIH<K0E7IB7'>=VTIS;R<O/[15#+UN)K0S#\4T>M5"Q[Z3N
M%+3_^N'J2B/55H]M0;&2X3O7-O2-"FU7<AN>5"X+_I?W4U7@8T"X'EZ8L, 4
M.'J/P:I+#GH0083@$8YF&=YBN;U/V>LXRL+GA;: =_6-G#.!=0L(,^175E3X
M3B";NT 3IZW'?D+O*$C&XQ^E5<EX1@Y=^O3;JNQ>3)JJWH&&48.&T8O1\ &!
M3PZOT)%]Z\EW'O^W387:!X%N[B[:>#I@!;;QL*3BVKK)N#Q9HD0?)AL^< '<
M+8SVA,#38X&GH5SK)X<##BN'HQ(4EYE&Q^OF(#DF=VL0&.KVY=\[T9T]=;9Z
MV2UH[57C@!R.@A$]ZELJ.L)"BN05(.P.A?.9M^9';+04&.<X"!/:Q[L7'5/R
M^3&,7Z#+"I )@@/0=1@Y;[O5BUJH.0T1(W$<]?=A9-!ZL^6@ENYE:L.#6>"?
M;\UH\_B=^3??=KE_.>/IN+16"UC@UO#M&&N"\J]1WS&R="_ N33XGG3D"A_P
MH.P"G%](:38=*Z#Y2V#Z-U!+ P04    " !4AEU80&QX%Y #   J#@  &0
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MWN 6<R6KR:3::%':J_=::+S(VV6&PQQ((X#O-T+HX\88:,;#\ =02P,$%
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M%U"_+XI"OF_H'6Q7$[[^+U!+ P04    " !4AEU8R&B?W^X#   6%   &0
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M>^ ;4,[ WM]*:=Y/W /*+:/YOU!+ P04    " !4AEU8(>Y1F20%  "A+@
M&0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6RUFFM/VT@4AO_**%NMJ,1B
M.W?8$"G$-ZJBHK+M:K7:#X,]$ O;D\Y,2/GW'3NN$[/.-*G>?@'?WF?&^(F/
M.?%DS<637#"FR-<LS>5E9Z'4\L*R9+1@&95G?,ERO>>!BXPJO2H>+;D4C,9E
M*$NMKFT/K8PF>6<Z*;?=BNF$KU2:Y.Q6$+G*,BI>KEC*UY<=I_-]P\?D<:&*
M#=9TLJ2/[(ZI3\M;H=>LFA(G&<MEPG,BV,-E9^9<A,ZX")1'?$[86NXLD^)4
M[CE_*E:NX\N.7<R(I2Q2!8+J7\]LSM*T(.EY?*F@G7K,(KB[_)WNER>O3^:>
M2C;GZ=])K!:7G7&'Q.R!KE+UD:]#5IW0H.!%/)7E3[*NCK4[)%I)Q;,JK&>0
M)?GF-_U:_2%V DY_3Z!;!;JO [T]@5X5Z!TZ0K\*] \-#*K X-# L H,#PV,
MJL#HT,"X"I2Z6)O+45Y+ERHZG0B^)J(X6M.*A5*(,JTO89(7[MXIH?<F.J>F
M5RNIMTA)YCR[3W):""5/R4Q*_;F915]6B4RJ;32/2<!YO$[2E/Q!9G%<[J$I
MN<XW'Z)"QA.7*9JD\JT^Y-.=2T[>O"5O2)*3OQ9\)35#3BRE)UX,;T75)*\V
MD^SNF:3+HC/2<TY)U^[V6N)S<_R&OA![?]H]?/!N2]PSQS]$RACW#X@[_;WQ
MP!R?+86.G^^-A^;X.YJ?D>ZH+6YIT6K;NK5MW9+7W\/3MQOR#U\)<L5R]I H
M;4YTUN:#$5/<SR_DDD;LLJ-OV)*)9]:9_OZ;,[3_;+,#"7.1, \)\Y&P  D+
M0;"&<KU:N5Y)[_WH!K=S,R/_OM?;R+5BF?RO3;\>4C\DS$7"/"3,1\(")"P$
MP1KZ]6O]^L8[WG6NF*8J_9"F]1,L)B=+)B*6J[=MXAEAQXJW@3EV22L>8I^G
MSL1ZWM4).9Z'A/E(6("$A2!80Z=!K=/ J--L=A.T>6-,'>L-$N8B81X2YB-A
M 1(6@F -PX:U84-\O1PB]4/"7"3,0\)\)"Q PD(0K*'?J-9OA*R7HQ^6N+EQ
MO&-U0L*\'T_>1XX7(&$A"-:09%Q+,C9*4M^CHFW3XE2OY"K)'[4JQ:),8B:J
M/6E"[Y,T42]M"FV&&NU<A$%_-'@ED7$^QTK4,N*X?]X<T6LYZ-RV7^F!G%:
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MYOW+IH$V$RW*NFFMA38ML![FYIL#T@:8_4P(_3FQ?;#[BL7_ %!+ P04
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M*(U":0Q*XU":0-'L\!@Y';HW<3B\D+4[)&S?>+A3R:">&4IC4!J'T@2*9N?
M>.;0[9G_O$IV5W1O#^(^P-ZG(ZBWAM(8E,:A-(&BV3$T:CL\/TXM@ZIK*(U"
M:0Q*XU":0-'L[VTPZCIR[\![<"UK.5L?RKRM2N;NK6\*H#0&I7$H3:!H=@J,
M@X[<#OK02O;LUC/N?OJ>4Z T"J4Q*(U#:0)%L]-D5'7D'Z4@15#%#*51*(U!
M:1Q*$RB:'1ZCF"/W6N1>7R4$U<I0&H726+2[!W!PWG%UCT.[%2B:G05CC".W
M,7Y:8?J=[+M[NS,52%MZ#:51*(U!:1Q*$RB:'9V-+R2+CE.#L%]/AOU^,J@=
MAM(XE"90-#L\Q@Y'[K7+?7=I=>-ZA^:1MK.OJK?M#2FT7P:E<2A-H&AV((SQ
MC=S&]_E"5&N^2G]\NOW6;B=2NK</<7?8.S)0@0RE,2B-0VD"1;-C901R=)SO
M3HN@VA=*HU :@](XE"90-#L\1OM&[A7-O8L45/>VM.U+6][V+5(4VBV#TCB4
M)E T^RM:C<F-W2;WL!K57HKZ_5X563*_TR>=]<?L&UEU!L?=;]_@0&D42F-0
M&H?2!(IFI\L8XO@XW\$60X4PE$:A- :E<2A-H&AV>(P0CMUKE]_(,BE)J=ER
M6E]CNI=%(F]3]7C1Z84LB:RWEI[H<]3+SA!!Q7!+>[YT[7OA]EW T,/C4)I
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MN,*&-59-"I_'WEG_>3.AR-4Q),:1F$!B$H09"0W6"0VL"95)H4JU(.I'^==
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M3:(T\[Y/NO7S!D>99'C0R@^JA5"-0C4&U3A4$U!-HC0SV+KR\ZS-RP&G+>Q
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MI_W:?![(KZQ/,L6WA7=8+ F3B,)"2SH7(YUFBN*Z7E04S_(+[#U7^CJ<%U>
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M&LO3-EN>=US$JDFX)+>[.YUW!Z4 M4&A- ]*8U":#Z4%*)J^ZZZQ01VH#>I
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M?D\-:^6'JH&$,1!,$^U\)]JY5;1_M;)LI8I,.C2(::>!_?&T)T*3YKRK54^
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M9J*/\SOC4W7AT8?P9YKBMG1%V#+).4IA(2FMT[[\4+'B E)T!%WI(_F<"GG
MU\U87MJ J0#Y?$&I>.JH":IKH/\?4$L#!!0    ( %2&75BA@BP/)04  )X<
M   9    >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;+5976^C.!3]*Q8[6G6D
M-F '2-)-(K5A5CL/U5;M=D;[Z(*3H +.VD[3_OLU'X% B .1IP\-'[Z'>P[7
M]C&>[BA[XVM"!/B(HX3/C+40FUO3Y/Z:Q)@/Z(8D\LZ2LA@+><I6)M\P@H,L
M*(Y,9%FN&>,P,>;3[-HCFT_I5D1A0AX9X-LXQNSSGD1T-S.@L;_P%*[6(KU@
MSJ<;O"+/1+QL'ID\,TN4((Q)PD.: $:6,^,.WGIHF 9D+7Z$9,</CD%*Y972
MM_3D>S SK#0C$A%?I!!8_KR3!8FB%$GF\5\!:I3/3 ,/C_?H?V;D)9E7S,F"
M1C_#0*QGQM@  5GB;22>Z.XO4A!R4CR?1CS[#W9%6\L _I8+&A?!,H,X3/)?
M_%$(<1" G!,!J A S0#[1,"P"!@V N"I +L(L#-E<BJ9#AX6>#YE= =8VEJB
MI0>9F%FTI!\FZ7M_%DS>#66<F#\+ZK_=W$OE K"@L2PGCK,7<@.>\U( = FR
M5N#O37;G+GU5H?@$5QX1.(SX5]GXY=D#5U^^@B_ !'R-&>$@3,!+$@I^+2_*
MXX<PBF0XGYI"YIT^W?2+'._S'-&)'"$"#S01:PZ^)0$)Z@"F)%RR1GO6]TB)
MZ!%_ (;P&B +#5L26G0/1RWA7O=PJ& S+-_A,,,;GGJ'F=YMNN9Q=GM<.J3<
M\@WVR<R08P8G[)T8\]]_@Z[U1YLF.L$\36 UO>Q2+UN%/K\GJS!)PF0E1XP(
M)SX!5[(^\ZK]VB9C#N=F<.E ^CYW+!O9\MV]'PITW&SL3,:.56_F*9.[D+I3
M4G>4U/,NS,&*X43(+G^&N'/$J$%FH7Q<WZ+0!%93QBV5<3LI0SX(\T-^7AOW
M2)L;:%ORKZ%02SM;YCQL5(4RNPNYCTKNHT[<_;0S1"2X!M)0+$F85@AE4I)-
MR,X+,CHFBJ#C6I.&(,I<^I:,)K":;.-2MK%2-CD;]1A$QMT&D>-FK8.(,K,+
M>4]*WI,^706_1F?)3XY8V:YKPR9YY7/[EH8FL)I$T*I\E:6<E']FCI,$-W?O
MA$D'#;X5 PMX9*%/6EV0I7.ZUHKFZ4*KJWG@4N$%4W9 HP@S#C:$Y<776GL%
M].2@^) S&(\;M:?.H+=>FM#J>J%*+]1[GN^H%CH[YZN?W5LI36AUI2KO#)56
M\\2\WU&K'!K:!V)!:S >-073:IUUH=4%J\PS5+OG'F:AHXIVBXKNP'&;*FHR
MSH6*O\*&P\J'0[41;_$.'=5RCM4:VH.FGUP4[<Z,>IXZS4MEJ$PW[.6Z2RO1
M40OWF.-X,#PJ'$W>NE#L5SAU6%EU..KG*YY(^GDO+:8%303#OMCB"/Q#6 RN
M_B52Q';I=+KPA58T3Q=:7>'*U4.UK=_7)-T*+G#63UL55*,@\)F*#R"(TV]7
MP 4!_FS[2+/H"(1R( [&IY \-=*EPE7+ MA[7= JG!H%9GP!M/9\X?"T=%H7
M#+K0ZI\DJQ4#4J\8[E8K1E98$/!=]N,PX:$/?N!HFX^(<?'YM+4W(ZTK!ZUH
MGBZTNJK5R@&I5PX=>W.!XARN4 =-']?22-J]YI<<=4*7$JZL/^IF_4M#VTHW
MQX#HT$4,G";?O-7HD&^3+#J2! TJDU'G4)ERU,N4GQI)"I0S+TVK^=:%E@MC
M'FS<Q(2ML@TP::WI-A'Y;D9YM=QDN\NVEAK7[^&MEV^553#YSMT#9G+IS$%$
MEA+2&HRD6BS?#,M/!-UDVT.O5 @:9X=K@@/"T@;R_I)2L3])'U!N2<[_!U!+
M P04    " !4AEU89E6BYF $  #&$P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970W-RYX;6R]F&UOVS80Q[\*H0U#"S222#U8SFP#2;IV>]$A2-#T-2.=;2&2
MZ)&TW0+[\",I1;)CB7#L9F^L)_+XXY%W_S,G6\:?Q!) HN]E48FILY1R=>EY
M(EU"287+5E"I+W/&2RK5(U]X8L6!9J9367C$]V.OI'GES";FW2V?3=A:%GD%
MMQR)=5E2_N,:"K:=.MAY?G&7+Y92O_!FDQ5=P#W(KZM;KIZ\UDJ6EU")G%6(
MPWSJ7.'+:Y+H#J;%0PY;L7./]%0>&7O2#W]E4\?71%! *K4)JBX;N(&BT)84
MQS^-4:<=4W?<O7^V_LE,7DWFD0JX8<6W/)/+J9,X*(,Y71?RCFW_A&9"D;:7
MLD*87[1MVOH.2M="LK+IK C*O*JO]'OCB)T. 1GH0)H.Q'#7 QG*CU32V82S
M+>*ZM;*F;\Q436\%EU=Z5>XE5U]SU4_.[B5+GRZNU;PR=,-*M=B"&G==H/MZ
MH1";HSL0DN>I5(U,!W2EG9G+'^C=1Y T+\3[B2<5CC;JI<W0U_709&!H3- 7
M5LFE0']4&63[!CPUCW8RY'DRU\1J\2.D+@KP!T1\$J!?D8?$DG(0S<4R0M"Z
M*S CA ,C'#IB2WDF^B9O-:2#[5*L: I31T63 +X!9_;;+SCV?[=@ABUF:*P'
M YA_K\M'X'KE[GMF7O.%;\ 7M7R1U8U?JXUR)&0?T",L\JK*JX6*K8)6*:!W
M>=6LUWOT;^_*U?SU"+$90>>>S2P*QG% )MZFARQNR>)C%UB8!:9F@=&"TTJ_
M/)8N/J +$Y^0I)]NU-*-K'0/QFM'0XP.("Y([,?!J)\B:2D2*X5*AW/(7P.2
M'(*$T3@8]W.,6X[QD;L(JNR4+30^P!KA@"1A/Q;VNYSJ6\/OF]$"Y9^K#7"E
M;>BSWCT7*D$#^D1SCAYHL8;>C.F_053B'3' 1WG4>#!C14&Y0"N528P/M3.[
MI-J+7YL?[WJ4N-' KL>DXR)6KM:AM'&H"4>4:8?.M4,WVJ%[07H*?0V!PQW\
M(' '=BGN- /;1>/A/)\&/51C=RAX<*<1V)KB7X3Q*61A#UGL1@/I!7?J@(^3
MAY/!HH-M&/ON>&@;=MJ [>)P"]S4P3K'U"73*^H!N^U30[M3#CPZNR3 5O4Y
M%;&3%6S7E9]1%>!#J2&)*@NB@;7OM ;;Q>9G%0;X4'2B& =)W ](.M$A5FUX
M;6W06-O39!PE(<$#()V($+N(O+X\: SNL<01B0<2">ET@]AUX^P*H;&_2Q:3
M41 $ V2=)I#@C4H$\A9_+$BG&L2N&N?FYL;\;FX.L8L':B[2:0:Q:\;_4R(T
M$"]+A'@H:#II(79I.:]&:(SO8XW<\9!7.]4@]C\<9]<(C?T]LI"X\5"ZZ\2"
M'"<6)X,E!_LPB%S_I4YX.T<K)?"%.4 2*&7K2M:G+.W;]I#JJCZ:Z9K7)UQ?
M*%>J)E !<]75=T=J+_'ZT*A^D&QE#FH>F92L-+=+H!EPW4!]GS,FGQ_T .W1
MW>P_4$L#!!0    ( %2&75BQB(/FU ,  !T2   9    >&PO=V]R:W-H965T
M<R]S:&5E=#<X+GAM;+5876_;-A3]*X16#"VP1J+\%6>V =M9L0 )8-1M]S#L
M@9:N;2(BZ9&4G0#[\2,E199BA5L,^<46)9[#>RXOJ2..#D(^JBV 1D\LX6KL
M;;7>W?B^BK; B+H2.^#FR5I(1K1IRHVO=A)(G(%8XH=!T/<9H=R;C+)["SD9
MB50GE,-"(I4R1N3S#!)Q&'O8>[GQE6ZVVM[P)Z,=V< 2]/?=0IJ67[+$E %7
M5' D83WVIOAFC@<6D/7X0>&@*M?(2ED)\6@;=_'8"VQ$D$"D+04Q?WN80Y)8
M)A/'WP6I5XYI@=7K%_8OF7@C9D44S$7R!XWU=NQ=>RB&-4D3_54<?H="4,_R
M12)1V2\Z%'T##T6ITH(58!,!HSS_)T]%(BH W'\#$!: \#6@^P:@4P ZF= \
MLDS6+=%D,I+B@*3M;=CL19:;#&W44&ZG<:FE>4H-3D_F@C&JS;QHA0B/T5QP
M3?D&>$1!H<]H&L?4YILDZ([G56.S__$6-*&)^F2Z?%_>HH\?/J$/B'+T;2M2
M98C4R-<F/#N('Q6AS/)0PC="P2%Z,*-O%?J-QQ#7"7RCJQ07OHB;A4[&6XBN
M4 ?_@L(@[#0$-'?#E["[0CBP<#QTA-,I<]W)^#K_(]?3DUS_>6^ZHSL-3/W5
ME+R<N]O,;5?[C=J1",:>6<X*Y!Z\R<\_X7[P:Y/PELAJ:>B6:>BZV"=W7*62
M\ A00LF*)J:^H+%<<II!1F.WH_T$!T$P\O=5)<ZQSE32*Y7TG$KF":%,9=M(
MC,RJ$%&42@E6&C$[U&8C84.T:3"1<MTD,>?O5R1V3B4Z@SA38K^4V'=*?"!/
ME*6L*78G\+T%V1)93>.@U#BXX+H<M)F&ELAJ:;@NTW#MG.J%%&M0*M_L([$'
M:=[C38JO3XIV^+IDG2.=J6-8ZABZ2Y;RMTK6"7SO7+5$5M.(@^-[.[A@T1;D
M+66B+;9Z*BH6!K=3N 5/M7*[O5>5ZQ[K7"WA44OHU++4QCRMGM$]: U2(;%&
M<PG&@Z%_T'0Q;U3E9'SW7+;$5M=_M$CXDAX)MVJ2VF*KI^)HD[#;)Q6O7I0(
M:R;VQF[G;NFY4?FI6>H,3YR$>\1S%1WM$G;[I?\H;C1+E4$HA>ZMY*FQ3V K
MP3S])E.J-)H1_NA8""T9I2)7E[!=^.B[</^2"Z%5<]866ST51WN&G;;GG0NA
M53]6L-665;]765>Y)+_R <Y ;K)S"67>1<;VY]_BY=WR[&.:??'[Q^[YP<D#
MD1O*%4I@;:#!U<"4H<S/(O*&%KOL<WXEM!8LN]P"B4':#N;Y6@C]TK #E"="
MDW\!4$L#!!0    ( %2&75B'8NE%N@T  %&?   9    >&PO=V]R:W-H965T
M<R]S:&5E=#<Y+GAM;+6=[W/:.!Z'_Q4-N[>SO6D*_@GI)IE)D72;F6:;:;I[
M+V[NA0L"/#4V9YMD<],__F1P$,)"X-N/^Z(A1'KLZ&.^B">R??6<Y=^*A1 E
M^7.9I,5U;U&6J_?]?C%9B&54O,M6(I4_F67Y,BKEM_F\7ZQR$4TWG99)WQT,
MPOXRBM/>S=7FN8?\YBI;ETF<BH><%.OE,LI?/H@D>[[N.;W7)S['\T59/=&_
MN5I%<_$HRM]7#[G\KK^C3..E2(LX2TDN9M>]6^<]'PVK#IL6?\3BN=A[3*I?
MY6N6?:N^N9M>]P;5'HE$3,H*$<DO3V(LDJ0BR?WX3PWM[;99==Q__$KGFU]>
M_C)?HT*,L^2?\;1<7/=&/3(5LVB=E)^SYU]%_0L%%6^2)<7F?_)<MQWTR&1=
ME-FR[BSW8!FGVZ_1G_5 ['5P_",=W+J#>]@A.-+!JSMXAQW"(QW\NH-_[BX%
M=8?@W YAW2'<C/UVL#8C3:,RNKG*LV>25ZTEK7JPB6O36PYPG%9'UF.9RY_&
MLE]Y\UDD42FF%P]17KZ0+WF4%M$F\X)<D-OI-*X>1PFY2[='<74T_$Q%&<5)
M\48V^?V1DI]_?$-^)'%*OBRR=1&ET^*J7\I]J[;0G]3[,=[NAWMD/QQRGZ7E
MHB LG8JIH3\]T=^U /IR4'8CX[Z.S ?72OPM>WI''/\M<0>N9_J%SNCN#8YV
MI_;N5$QD=^=H=W9^=]?0G9_?W;&,I;<[RKP-S[,?9:1QE)%_?91-R5TIEL6_
M#?OY8<OUS=RJ[+XO5M%$7/=D72U$_B1Z-S_]X(2#7TR)(6$4"6-(& ?!M*3]
M7=*^C7[S)2MEM<C%DTC7PA2HM7O;0)$PNH4--[#J#?GIQO%&81C*%\#3?E:&
M=H[O.Z&GM^/-=L.A=^D$NV;:  >[ 0ZL _QI)7)9AM,Y281\1R5Y]=9YD<TN
MUO*;J"A$::J^'ZS0ML..A-$M+-P;)D\.4W@PZ,U6[L#W_8,A!^V8%DRX"R9L
M%4P21U_C1+Y_"F,@5EC;0) P&C:&VA^,&H$@-\E!,"VWX2ZWH36WSV*USB>+
M*K)L1B;9<BG?EN2\:_+-%)N5U38V)(P.FV5IX%RZ![$U6UVZP>#@931L' &!
M?$F:Z]9H-\PC^QN#_-Q3K/.7[="^K0?Z+2D6D?SER,]R^KA]^,8T[%9VVV%'
MPNBH,5;.(!CYGG\PJ,S4T+V4HW]Y,/J@W=-2NMRE=&E/*9I?N.0ASY9Q460R
MK=^R4I#OFR\%^2PF(GZ*OB;&=W8KN6U&2!A%PA@2QD$P+6MGH#[[#3J:EM=@
M4-A0&H72&)3&430]\+T/^X[UY<TEFD3+;)V6U9O=5'PMC>E:*:W3=1KO.<'@
MH#I2Z"89E,91-#TT5X7FGIB@/&7)4S6QG.1B&I=D%DVJB>4+*46^-.9G!;;.
MS[Y['GD146Z:XU+H?C HC:-H>JA*B#C63^$WCZLXO?@TFVE5]SL9+V(Q(^Q/
M,5E7QI7(%O%$Y,:0H6H$2J-0&H/2.(JF!Z_\B.-W]9X+52=0&H72&)3&430]
M<.5KG$Z$C9W:.FVHLJEIVF=-WSE\3V?0C7(438]1V1T'JG?LM-;Q006/TS0\
MCM^8DC'H1CF*IL>G)(]CMSSC*$G(6*1RRD0>)5V^JYIS@PH>*(U":0Q*XRB:
M'J^22\ZHJW=5J%J"TBB4QJ TCJ+I@2M/Y=A%U6O@JTW@I0K\[=[GV[VGC=%#
MC1641FN:_M>H9HF&RB@43?]SN[)1KE5^W'R,'F61%N1>?LB=1 FY+8IL$D>5
M>/SIAY'K.+^0NX=;LGD]RW _K OYJ#!6<?N6VB8+I5$HC4%I'$73CP"EIURG
MHRKN0HT5E$:A- :E<11-#URI+=?NCOY6O9 _/:<B+Q;QRA@L5&5!:;2F54YW
M5Z0'[]S@H$B?UXRC]DV/0@DI]X20RN1'FX<Q^5[]]><IGIZ8)]MIK7.!VB<H
MC4%I'$734U;VR>W*/KE0^P2E42B-06D<1=,#5_;)M=NG,RHL5#1!:;2FG:RP
M4-&$HNF)*='DVD73[:_W515&SH:A+@I*HU :@](XBJ8?"$I9N<.N:C548D%I
M%$IC4!I'T?3 E<1R[4NDSJC54%D%I=&:=K)60RT4BJ8GIBR4:[=0MP]C8TQ0
ML02E42B-06D<1=//45 "RNMJ.90']4U0&H72&)3&430]<.6;//MRJ+^V)M4.
M;QTZU#G5M/T_\0T=SPTO1P?EV-#PR+)4U [J62E5Y-E5T>W63=S??3*67'OO
MUF% /1&4QJ TCJ+IJ>Z=%];9B6'8,\.PIX9ASPW#GAS6A8#RE(#RK+[CC#FN
M'= Z6*AH@M)833N8,1^>TX3:IAZ8$DB>72#]=G]?K4O,TF*=;):_O%IA^2R-
M<S$I,^/R1#NV=8Q0K02E,2B-HVAZW,H^>6%7!1EJF: T"J4Q*(VC:'K@RC)Y
M]H51#]'+4J1E0<J,Y/N+*HP90\42E$:A- :E<:]Y1MW>N:MZ<DH7>79==%M4
MZULB8TY03P2E42B-06D<1=,353K)N^RJ^$*-$Y1&H30&I7$43;]6@C).OGW)
M4[MSCVN8?HIO]4^?,8[M&VT;'Y3&H#2.HNGQ*7_D=^F/[/"VKUDHC?I-+>0Y
M81@T+X8!78Z$HNEY*L?DGW!,JRQ)LGM9@2WG7=D9K6.#FB8HC4%I'$73LU6F
MR>_*-/E0TP2E42B-06D<1=,#W[L0D=TTM?I@8V>USA@JG6J:=LV.46,IN*E5
M8\$X1^V9GHF22;Y=)E5K6XS##Y5%4!J%TAB4QE$T/4XEB_RN9)$/E450&H72
M&)3&430]<"6+_!/72HJ+;V259;LKO,FODVR>QO^51\$ZK18-1_-<B*KP&F.'
M^B,HC?H&1^,9ZJSAXDB#QLF3W- L'.R?(JLGH*2/;Y<^GT5UN=C*PV?KLBBC
M=%H]/F?HH4H(2J-^\]I(@=_X7,M,S4;#YM!W(7%\)7'\DVN"R'=R9&60O6_K
M%*">!DIC4!I'T?1++BI/$W2U,BB K@R"TBB4QJ TCJ+I@2NS$]C-3JL/#W96
MZXRA(B=HBAS7:UZJP=#,:UX2@)N:N<&Q=[5 B9?@G,4]V_\MZL5.:3W04/4"
MI3$HC:-H>KI*O01=J9< JEZ@- JE,2B-HVAZX$J]!$#U8F>USABJ7FJ:]IG
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MSV=95KY^4VW@.<N_;7;[YG]02P,$%     @ 5(9=6*?$A Z(!   \!T  !D
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M:T.;Z=0Y-02FD *=RC,X'0F[ #;$@BDTE8::=8*=B[M(H>BV9;UN"7.]WN#
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M 6%I@'R_H%2\WZ0)RD/>R7]02P,$%     @ 5(9=6!K,,][A @  +PD  !D
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M3+9 MA-S-[]B\]. //KQUZ>KX.6+GRPPL^DPV %33(=!=ABEL\G3]4=&7'(
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M?],JU(@ <DHA(GDB(G$2\<>P9-T> ]:[P0GA2P$D6)Z8%! 2:PQ8C%(2:20
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MR/_@?&Y<;Q;#UEP=R:QIMZ J "A:3LSP'H5$7XRS6>%$CVZ@/%.YDAH <6L
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M<V-Z<P.J"21FM)_&D:Y@6JS,NGA0CJG42$D@<4L"VYRG,>5I:*6J;"4$5!$
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ML?=G$_6)Q(YJ,*QJ,+2I!W>@]Q":;E"LJX D\$3TD-I^N'JQTDT3O%UQ@GX
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M%*+W[SZ@=XCDZ%M"=QSG,9^:0@:EH,VH#."A","Y$(#MH"\T%PE'?^<QQ.<
MIF1347)>*3TXG8@A1+=H9/^%',L9M02TZ._NM+B'_=WM#C:C*D$CC3>Z@+?
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MPG\#(D O@!E' <J*^=$9H1B_M$$MWH#R2BB_@@HN087=4-<*YQR%<WZSZ-X
M&!5<6U7JY8G</BIU0EVKTG%FMKN'YD;)AH1':G)&2_E)TZK:H,/PH&CA4&CG
M8A[G8;OO0-RQZ H(VSY]O=Q:GN74VOT%PW%M1 J[8[J6\W'^M;L'X!YE-FXG
MTG@S7S!T)TZ=\J CKWFR)Y !V^B]%8YT%13?TM75:O_F7N]:U*X_J'T=O==P
MA"DVA;Y@MB$YER*M):1UZTL"K-AG*4X$W>J=AQ45@F;Z, $< U,&\OZ:4O%Z
MHAY0[7;-_P=02P,$%     @ 5(9=6& XG+E4!   WA4  !D   !X;"]W;W)K
M<VAE971S+W-H965T.#DN>&ULM9AK;]LV%(;_"J$50PLLD4C=,]M FB#8@+0-
MFF;[S$BT+502-9*.VW\_4E8D1Z1I1VB^V+KP'+XO*?$YXFQ+V7>^)D2 'U59
M\[FS%J*Y<%V>K4F%^3EM2"WO+"FKL)"G;.7RAA&<MT%5Z2+/B]P*%[6SF+77
M[MAB1C>B+&IRQP#?5!5F/S^2DF[G#G2>+WPM5FNA+KB+68-7Y)Z(A^:.R3.W
MSY(7%:EY06O R'+N7,*+*Q2J@+;%/P79\KUCH*P\4OI=G?R=SQU/*2(ER81*
M@>7?$[DB9:DR21W_=4F=OD\5N'_\G/VF-2_-/&).KFCY;Y&+]=Q)')"3)=Z4
MXBO=_D4Z0ZW C):\_07;KJWG@&S#!:VZ8*F@*NK=/_[1#<1>  P.!* N )T:
MX'<!?FMTIZRU=8T%7LP8W0*F6LMLZJ =FS9:NBEJ-8WW@LF[A8P3BULBQX"#
M,W"S$1M&P*>B+JI-!>[P3SE9@H.'.B<,?*;U68;KC)3XL22@B[I<"GGO,J=-
M.R5T"9( @??71."BY!]DUH?[:_#^W0?P#A0U^+:F&X[KG,]<(:4K 6[6R?RX
MDXD.R+PFV3GPX1\ ><@WA%^='HY>AKMRP/I10_VHH3:??R#?EX8P+(IZU8V$
MR= N0V#.H-[."][@C,P=^?IQPIZ(L_C]-QAY?YKL_:)D+\SZO5G?EGTAQRPP
M&=Q%Q6V46BV>%E&*XIG[M"_<FGJB\* 7'AP3'IJ$[Z*B?>%QD(Z$6U-/%![V
MPL-CPB.3\% 7[@=H)-R:>J+PJ!<>'1,>FX1'NG#/3T;"K:DG"H][X?$QX8E)
M>*P)#Y,@& FWIIXH/.F%)U;AW]9$TENMPR;YB28?P50MH"_T6WN8J#_M]:=V
M_53@$BQW\*DZ^)1J405-AR"3L52?%S_1C%F[GF@,>@-9/:NU6\+Y!2BJ9B-(
M+ODGYXAP862?I]F!2%]+[?U-];-7*< 3IFHW-_2Q+%984=\,<Z@9"KPDC<:&
MK!U.-31 '%JQV4U0MF%,/F:@H4SY,=I!NIW(TZ8':4#TPWA8GE^J'.@+[?B]
MI?7J3#X[U8E#[VM:_0@E8[P9FL$TA>$!M0-R86"MC&Z*6I6)EKH(_B*R=C[>
M@M-P #4\2FIC;01U5,=0FX.W0#4<6 V/PMI8'D&=UF&HO;IO06LXX!H>Y;6Q
M0H(ZL'UO7"'9<T_5/A ;VI%]J$B"!EH'8Z39<T_5/M :VG%]J$Z".I"U)^8M
M:(P&&B,[C>V%$M()[(WTV_-/U3_0%YU"WU<72D@G,4S0>&[L?4_UMO<U?0J(
M3ZF4D$YB&(Q!;.]MJIL!V,@.[%?42<A X2@><\+>WU0_ ]*1_3/ZY#()&3ZL
M ^U1TQN%:6 N.]# 863G\"N+I"[;?JD&/7^\UII:H7A<(KE[FV]JY_,39JNB
MYE+(4H9YY[',PG:;B;L309MV/^Z1"D&K]G!-<$Z8:B#O+RD5SR=JBZ_?TEW\
M#U!+ P04    " !4AEU8L!PCT[("   /"0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970Y,"YX;6RM5M%NTS 4_14K2 @D6-JD#6BTD;8&! ^;IDW  ^+!36X3
M"R<.]FT[_IYK)PU=EV4;ZDMB._<<^YQK^V:V5?J7*0"0W9:R,G.O0*Q/?=^D
M!93<G*@:*OJR4KKD2%V=^Z;6P#,'*J4?C$:17W)1>?',C5WI>*;6*$4%5YJ9
M=5ER_><<I-K.O;&W&[@6>8%VP(]G-<_A!O!K?:6IYW<LF2BA,D)53,-J[IV-
M3Y/(QKN ;P*V9J_-K)*E4K]LYTLV]T9V02 A1<O Z;6!!4AIB6@9OUM.KYO2
M O?;._9/3CMI67(#"R6_BPR+N??>8QFL^%KBM=I^AE;/U/*E2AKW9-LF-IIX
M+%T;5&4+IA64HFK>_+;U80] //V H 4$AX#H 4#8 L)#P$-+FK2 B7.FD>)\
M2#CR>*;5EFD;36RVX<QT:)(O*IOV&]3T51 .XQO(*8EHV%MVR;7F-@OL50+(
MA32O:=0T 3,?:3:+\=.6^;QA#AY@#MF%JK P[&.50=:#7PSCQ\$ @4\R.ZW!
M3NMY,,AXP?4)"\=O6# *PKX%#<,32 ?AR=/AP8":L,M<Z/C"X<RQ:ZB51E'E
M[,?9TJ"FD_2S+UL-VZ2?S=XNIZ;F*<P]NCX,Z UX\<L7XVCTH<^I8Y(E1R*[
MX^*D<W$RQ!Y?KLLE:*96=(=9'_E2PF[/FSX;&[K(T=D[=1/37MCL>_-H1'(_
M8MQ%W%$Q[51,GZB"ZH$]Q+0;AD0,LCUW+TP?U7NDZ>Y8$W761/]M#<."(S,%
MUY1S40K)-4NI1T<(M# HTE[W!B=\KGO1/?>" _>.-%WCGK]7*DK0N2NYAJ5J
M76%SDW:C754_<\7L8'Q!U;XISO]HFE\%NF9S41DF8464HY-WE'[=E-^F@ZIV
M!6FID,J;:Q;TQP+:!M#WE5*XZ]@)NG^@^"]02P,$%     @ 5(9=6(-)LOAY
M"P  &V(  !D   !X;"]W;W)K<VAE971S+W-H965T.3$N>&ULM9U=;]LX%H;_
MBN =+#K IA&_R6X28&K.[A;8P13MS.[%8B_41$F,L:VLI#0M,#]^)=LU3?*(
MLL;'-VT^7K[F.2+%YTB4<O52U;\UCV799E]6RW5S/7MLVZ<WEY?-[6.Y*IK7
MU5.Y[GYS7]6KHNV^K1\NFZ>Z+.XVC5;+2YKG\G)5+-:SFZO-S][7-U?5<[M<
MK,OW==8\KU9%_?5MN:Q>KF=D]NT''Q8/CVW_@\N;JZ?BH?Q8MK\^O:^[[R[W
M+G>+5;EN%M4ZJ\O[Z]D/Y(TUM&^P4?QK4;XT!U]G?2B?JNJW_IMW=]>SO.]1
MN2QOV]ZBZ/[[7,[+Y;)WZOKQOYWI;/^9?</#K[^Y_VT3?!?,IZ(IY]7RWXN[
M]O%ZIF?977E?/"_;#]7+/\I=0*+WNZV6S>;?[&6GS6?9[7/35JM=XZX'J\5Z
M^W_Q99>(@P9$#C2@NP8T;, '&K!= W9L [YKP#>9V8:RR8,MVN+FJJY>LKI7
M=V[]%YMD;EIWX2_6_7'_V-;=;Q==N_;F8_G0'<6VR2ZRC]V8NGM>EEEUG[U;
M;X?4YM!\ZL9+5CW7V5[\RI9ML5@VWW?-?OUHLU???9]]ERW6V2^/U7-3K.^:
MJ\NVZUW_&9>WNYZ\W?:$#O2$T.RG:MT^-MF/Z[ORSC>X[,+:QT:_Q?:6)AUM
M>?LZ8^0O&<TI SHT/[XY!9K;XYN31#1L?Z38QH^ECU3VH7RJZG:Q?O .TG_^
MV<FS=VVY:OX+Y7[KS6'O_N3RIGDJ;LOK67?V:,KZ<SF[^?.?B,S_"N4-T\PB
MF7DYY?N<\I3[S2]56RR[T]?G<OU<0FG;-E>;YOTI]/,-85I*V1W0SX<9 72$
M<R*9K[.Q3BEFB-C+O##$/@R1#&->-6T_:_OT+&Y+</)M':370T54'O1P'NL,
MYU*+()!8)HPDG,*!R'T@,AG(W\MU67='I#N#9,5==[I;-&U=]"L#%)*,0V(Y
MXT%7Y[',"$K"(Q.KE!&&P_&H?3QJ], TFVC*+]U*W<"'1D%QT)SK(!! ES.C
M3:"SL4XJH9B$8]'[6'0REG?KVVI59J^65=.=]^_K:I5U]%%O3C]@6#KJAN8R
MS/L\5I&<4QF.MUAF-%$&#LGL0S+IZ?^XJ.^R]T7=?H4"2#:>>L[$-+-(9E[2
M2.Z0(3_C2K0S1THKJIO%<O,3>\!BY+3E:-=>CJY'D!!<D !A:D4BU,5"1TX7
M;5DWVY$"AI)L/GD88+I9+#<_=0[TR#E)CZ"B'JJ;Q7+S$^MHCYR(>[OVA[,A
M#V?6J,0F)7[7'>&1-.(=3J?LQ^6B8Z/-< "C2%I-'@&8;A;+S4^CXTLBSSFU
MDO0Z.;&8;A;+S4^L UV2)MWQJ153Z457?A BPPD&"2GO$#:<9H#0Y(*S@;GF
M0)>D2?>8<HK$0'I!I.1$A>% 0BHTC59B0*B-,F0@' >Y)$VYTXJJG9G7#67"
MWLXA&2,B.A5"LMPH.";J$)0F2>S(PFIG$HPYSGAX4@>%M,M^>) @H:%:ZX&
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M5%)!T1@*338%EU0!O>,T+-4F4$^U*&ZL;<+HH0V<>L@E3$A+F'; ;IY-1U_
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M>G#]AF?T.UKLR*:JT"DZJ.$$2HM!:0DH#4/1W.'1FE/A!#A_@WI5H+08E):
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M]?8">GOJ[07T]I/-;@&]/?7V GI[ZNT%]/;4VPOH[:FW%]#;4V\OH'>@WD%
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MNAM?\K/E;VFW/P%02P$"% ,4    " !4AEU8!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( %2&75B&
M:F1.[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( %2&75B97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 5(9=6&Y[\?U1"
MC#(  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( %2&75AX1NF2/0(  +\%   8              " @940
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !4AEU8T(#>
MF=H+  "X.0  &               @($($P  >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ 5(9=6'PQ%=1%!@  ^QD  !@
M ("!&!\  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( %2&
M75A%L+,2H0<  '0I   8              " @9,E  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    " !4AEU8;S@P D00  !#L0  &
M        @(%J+0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ 5(9=6 A4H'0T#@  R$H  !@              ("!Y#T  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( %2&75A->ETS5 X  +8F   8
M              " @4Y,  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    " !4AEU88>RJ!K4I    B   &               @('86@  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ 5(9=6/R8AN[4"0
MA1L  !D              ("!PX0  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    " !4AEU8,"N=614$  #W"   &0              @('.
MC@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( %2&75B;
MHDRY404  %(.   9              " @1J3  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ 5(9=6'RO^-!Y"0  O1T  !D
M     ("!HI@  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %2&75A(YA I^0@  )@6   9              "
M@5_!  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ 5(9=
M6#\+Y A]"0  F!T  !D              ("!C\H  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    " !4AEU8W7OA4OD)  #-'0  &0
M        @(%#U   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( %2&75AC-D7PWP@  ( 6   9              " @7/>  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ 5(9=6%8RH<U##   $BH
M !D              ("!B><  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    " !4AEU8T$XT.C4#   5!P  &0              @($#]
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( %2&75BQXCZ5
MEP4  #@0   9              " @6_W  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ 5(9=6!24+_@,#0  %B0  !D
M ("!/?T  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " !4
MAEU8.-4^K+$&  "_&@  &0              @(& "@$ >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( %2&75BEN@6S"0L  %H<   9
M          " @6@1 0!X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#
M%     @ 5(9=6!ABRRG8#0  2#<  !D              ("!J!P! 'AL+W=O
M<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !4AEU82%'>3WH)   E
M&   &0              @(&W*@$ >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM
M;%!+ 0(4 Q0    ( %2&75B8'<_+8P(  (4&   9              " @6@T
M 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ 5(9=6&0Z
MHFM# @  B@8  !D              ("! C<! 'AL+W=O<FMS:&5E=',O<VAE
M970S,2YX;6Q02P$"% ,4    " !4AEU84:#N+V,\  "*U@  &0
M    @(%\.0$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M %2&75BIPIVOW@,  -X(   9              " @19V 0!X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ 5(9=6"_+I>W  @  ,P8  !D
M             ("!*WH! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    " !4AEU8Q^-NQ\$#  #J!P  &0              @($B?0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( %2&75B'% E7L 0
M *L2   9              " @1J! 0!X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ 5(9=6$6*\4?4!0  % \  !D              ("!
M 88! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " !4AEU8
M($$A6!4#  #)!@  &0              @($,C $ >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    ( %2&75CH_O:>50,  %H'   9
M      " @5B/ 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ 5(9=6)6H];.( P  '@@  !D              ("!Y)(! 'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !4AEU86X(=+/$%  "M#0
M&0              @(&CE@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    ( %2&75A1IS /!@4  %\,   9              " @<N< 0!X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ 5(9=6+YWHHCB
M @  3P8  !D              ("!"*(! 'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    " !4AEU8?VT FU@#   H"0  &0
M@($AI0$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( %2&
M75@2'R-3L08  . /   9              " @;"H 0!X;"]W;W)K<VAE971S
M+W-H965T-#4N>&UL4$L! A0#%     @ 5(9=6(#@$ZFJ!   TPT  !D
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M=#4P+GAM;%!+ 0(4 Q0    ( %2&75C(:)_?[@,  !84   9
M  " @5#- 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @
M5(9=6)E;/ML7!   /AH  !D              ("!==$! 'AL+W=O<FMS:&5E
M=',O<VAE970U,BYX;6Q02P$"% ,4    " !4AEU8(>Y1F20%  "A+@  &0
M            @('#U0$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4
M Q0    ( %2&75CA+4"<P@(  )P'   9              " @1[; 0!X;"]W
M;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ 5(9=6->;%:Y !@
MP3,  !D              ("!%]X! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX
M;6Q02P$"% ,4    " !4AEU8+A<O5KH"  "O!P  &0              @(&.
MY $ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( %2&75AJ
MEZ7V40H  !!@   9              " @7_G 0!X;"]W;W)K<VAE971S+W-H
M965T-3<N>&UL4$L! A0#%     @ 5(9=6"\;\'-N!   ]!T  !D
M     ("!!_(! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %2&75CAB0 83P,  %(*   9              "
M@1H1 @!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ 5(9=
M6*M9,236 P  L0T  !D              ("!H!0" 'AL+W=O<FMS:&5E=',O
M<VAE970V-"YX;6Q02P$"% ,4    " !4AEU8>YS%BP0$   #%   &0
M        @(&M& ( >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0
M   ( %2&75C8@QTBB@(  -$&   9              " @>@< @!X;"]W;W)K
M<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ 5(9=6(TXGG8I#0  WZ@
M !D              ("!J1\" 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q0
M2P$"% ,4    " !4AEU8-EEJN84+   /G   &0              @($)+0(
M>&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( %2&75CO6F.+
M;@,  '(,   9              " @<4X @!X;"]W;W)K<VAE971S+W-H965T
M-CDN>&UL4$L! A0#%     @ 5(9=6,[NU(!3!   ?Q   !D
M ("!:CP" 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " !4
MAEU8+!53H*\#  ! $0  &0              @('T0 ( >&PO=V]R:W-H965T
M<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( %2&75AD:MJMEP0  *\1   9
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M970W-BYX;6Q02P$"% ,4    " !4AEU89E6BYF $  #&$P  &0
M    @('290( >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    (
M %2&75BQB(/FU ,  !T2   9              " @6EJ @!X;"]W;W)K<VAE
M971S+W-H965T-S@N>&UL4$L! A0#%     @ 5(9=6(=BZ46Z#0  49\  !D
M             ("!=&X" 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"
M% ,4    " !4AEU8I\2$#H@$  #P'0  &0              @(%E? ( >&PO
M=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( %2&75@:S#/>X0(
M "\)   9              " @22! @!X;"]W;W)K<VAE971S+W-H965T.#$N
M>&UL4$L! A0#%     @ 5(9=6.'M<?9H P  9@\  !D              ("!
M/(0" 'AL+W=O<FMS:&5E=',O<VAE970X,BYX;6Q02P$"% ,4    " !4AEU8
M2MROV3D#  #N"0  &0              @(';AP( >&PO=V]R:W-H965T<R]S
M:&5E=#@S+GAM;%!+ 0(4 Q0    ( %2&75AGC)Z?)@0  #04   9
M      " @4N+ @!X;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%
M  @ 5(9=6+8*O]@*$@  OZ$  !D              ("!J(\" 'AL+W=O<FMS
M:&5E=',O<VAE970X-2YX;6Q02P$"% ,4    " !4AEU8?9QY0!($  !R%
M&0              @('IH0( >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+
M 0(4 Q0    ( %2&75@M07J]  ,  " )   9              " @3*F @!X
M;"]W;W)K<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @ 5(9=6.Z-6+(A
M!   ^1(  !D              ("!::D" 'AL+W=O<FMS:&5E=',O<VAE970X
M."YX;6Q02P$"% ,4    " !4AEU88#B<N50$  #>%0  &0
M@('!K0( >&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( %2&
M75BP'"/3L@(   \)   9              " @4RR @!X;"]W;W)K<VAE971S
M+W-H965T.3 N>&UL4$L! A0#%     @ 5(9=6(-)LOAY"P  &V(  !D
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M=#DU+GAM;%!+ 0(4 Q0    ( %2&75AGASVR[P4  !XP   9
M  " @;7@ @!X;"]W;W)K<VAE971S+W-H965T.38N>&UL4$L! A0#%     @
M5(9=6*/HCC!3 P  KA4   T              ( !V^8" 'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " !4AEU8EXJ[',     3 @  "P              @ %9
MZ@( 7W)E;',O+G)E;'-02P$"% ,4    " !4AEU8A:P 2A '   I/P  #P
M            @ %"ZP( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 5(9=
M6!0V !R^ @  =S@  !H              ( !?_(" 'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ 5(9=6$;]('I, @  GC8  !,
M         ( !=?4" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     &@ : "/
)'   \O<"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>190
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>192
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>565</ContextCount>
  <ElementCount>591</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>204</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS??? EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS??? EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill</Role>
      <ShortName>Business Combinations, Asset Acquisitions, and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Land, Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LandPropertyandEquipmentNet</Role>
      <ShortName>Land, Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Investments in Other Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/InvestmentsinOtherEntities</Role>
      <ShortName>Investments in Other Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Loan Receivable and Loan Receivable ??? Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties</Role>
      <ShortName>Loan Receivable and Loan Receivable ??? Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Accounts Payable and Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/AccountsPayableandAccruedExpenses</Role>
      <ShortName>Accounts Payable and Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Medical Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MedicalLiabilities</Role>
      <ShortName>Medical Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Mezzanine and Stockholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficit</Role>
      <ShortName>Mezzanine and Stockholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Related-Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/RelatedPartyTransactions</Role>
      <ShortName>Related-Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Variable Interest Entities (VIEs)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/VariableInterestEntitiesVIEs</Role>
      <ShortName>Variable Interest Entities (VIEs)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/Segments</Role>
      <ShortName>Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Fair Value Measurements of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstruments</Role>
      <ShortName>Fair Value Measurements of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables</Role>
      <ShortName>Business Combinations, Asset Acquisitions, and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Land, Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LandPropertyandEquipmentNetTables</Role>
      <ShortName>Land, Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/LandPropertyandEquipmentNet</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/IntangibleAssetsNet</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Investments in Other Entities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables</Role>
      <ShortName>Investments in Other Entities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/InvestmentsinOtherEntities</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/AccountsPayableandAccruedExpenses</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Medical Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MedicalLiabilitiesTables</Role>
      <ShortName>Medical Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/MedicalLiabilities</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/StockBasedCompensation</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Related-Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related-Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/RelatedPartyTransactions</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/EarningsPerShare</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Variable Interest Entities (VIEs) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables</Role>
      <ShortName>Variable Interest Entities (VIEs) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/VariableInterestEntitiesVIEs</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/Leases</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SegmentsTables</Role>
      <ShortName>Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/Segments</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Fair Value Measurements of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value Measurements of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstruments</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Description of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/DescriptionofBusinessDetails</Role>
      <ShortName>Description of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/DescriptionofBusiness</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Disaggregation of Revenue by Payor Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Disaggregation of Revenue by Payor Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Contributions to Revenue and Receivables by Payor (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Contributions to Revenue and Receivables by Payor (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails</Role>
      <ShortName>Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Goodwill Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails</Role>
      <ShortName>Business Combinations, Asset Acquisitions, and Goodwill - Goodwill Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Land, Property and Equipment, Net - Schedule of Land, Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails</Role>
      <ShortName>Land, Property and Equipment, Net - Schedule of Land, Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Land, Property and Equipment, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LandPropertyandEquipmentNetAdditionalInformationDetails</Role>
      <ShortName>Land, Property and Equipment, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Intangible Assets, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails</Role>
      <ShortName>Intangible Assets, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule of Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Investments in Other Entities - Schedule of Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails</Role>
      <ShortName>Investments in Other Entities - Schedule of Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Investments in Other Entities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails</Role>
      <ShortName>Investments in Other Entities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Loan Receivable and Loan Receivable ??? Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails</Role>
      <ShortName>Loan Receivable and Loan Receivable ??? Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Accounts Payable and Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Medical Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MedicalLiabilitiesDetails</Role>
      <ShortName>Medical Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/MedicalLiabilitiesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Credit Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Credit Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Lines of Credit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Lines of Credit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Income Taxes - Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Income Taxes - Deferred Tax Assets (Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets (Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Mezzanine and Stockholders??? Equity (Deficit) - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails</Role>
      <ShortName>Mezzanine and Stockholders??? Equity (Deficit) - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficit</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Stock-Based Compensation - Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954518 - Disclosure - Related-Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related-Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954519 - Disclosure - Related-Party Transactions - Schedule of Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails</Role>
      <ShortName>Related-Party Transactions - Schedule of Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9954520 - Disclosure - Employee Benefit Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EmployeeBenefitPlanAdditionalInformationDetails</Role>
      <ShortName>Employee Benefit Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9954521 - Disclosure - Earnings Per Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails</Role>
      <ShortName>Earnings Per Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9954522 - Disclosure - Earnings Per Share - Basic Net Income (loss) Per Share is Calculated Using Weighted Average Number of Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails</Role>
      <ShortName>Earnings Per Share - Basic Net Income (loss) Per Share is Calculated Using Weighted Average Number of Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9954523 - Disclosure - Earnings Per Share - Summary of Shares Included in Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share - Summary of Shares Included in Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9954524 - Disclosure - Variable Interest Entities (VIEs) - Eliminated Upon Consolidation Included In Accompanying Consolidated Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails</Role>
      <ShortName>Variable Interest Entities (VIEs) - Eliminated Upon Consolidation Included In Accompanying Consolidated Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9954525 - Disclosure - Leases - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesAdditionalinformationDetails</Role>
      <ShortName>Leases - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9954526 - Disclosure - Leases - Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails</Role>
      <ShortName>Leases - Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9954527 - Disclosure - Leases - Other Information Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails</Role>
      <ShortName>Leases - Other Information Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9954528 - Disclosure - Leases - Future Minimum Payments Under Non-cancelable Leases After Adoption of 842 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details</Role>
      <ShortName>Leases - Future Minimum Payments Under Non-cancelable Leases After Adoption of 842 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9954529 - Disclosure - Segments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SegmentsNarrativeDetails</Role>
      <ShortName>Segments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9954530 - Disclosure - Segments - Schedule of Information about our Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails</Role>
      <ShortName>Segments - Schedule of Information about our Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9954531 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails</Role>
      <ShortName>Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9954532 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails</Role>
      <ShortName>Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9954533 - Disclosure - Fair Value Measurements of Financial Instruments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements of Financial Instruments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9954534 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Gain (Loss) on Equity Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails</Role>
      <ShortName>Fair Value Measurements of Financial Instruments - Schedule of Gain (Loss) on Equity Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="asth-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9954535 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.apollomed.net/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.apollomed.net/role/SubsequentEvents</ParentRole>
      <Position>96</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="asth-20231231.htm">asth-20231231.htm</File>
    <File>asth-20231231.xsd</File>
    <File>asth-20231231_cal.xml</File>
    <File>asth-20231231_def.xml</File>
    <File>asth-20231231_lab.xml</File>
    <File>asth-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>asth-20231231_g1.jpg</File>
    <File>asth-20231231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1630">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>195
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "asth-20231231.htm": {
   "nsprefix": "asth",
   "nsuri": "http://www.apollomed.net/20231231",
   "dts": {
    "inline": {
     "local": [
      "asth-20231231.htm"
     ]
    },
    "schema": {
     "local": [
      "asth-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "asth-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "asth-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "asth-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asth-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 489,
   "keyCustom": 102,
   "axisStandard": 43,
   "axisCustom": 0,
   "memberStandard": 72,
   "memberCustom": 114,
   "hidden": {
    "total": 8,
    "http://fasb.org/us-gaap/2023": 3,
    "http://www.apollomed.net/20231231": 1,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 565,
   "entityCount": 1,
   "segmentCount": 204,
   "elementCount": 1063,
   "unitCount": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1630,
    "http://xbrl.sec.gov/dei/2023": 39,
    "http://xbrl.sec.gov/ecd/2023": 4
   },
   "report": {
    "R1": {
     "role": "http://www.apollomed.net/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.apollomed.net/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "shortName": "CONSOLIDATED STATEMENTS OF MEZZANINE AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-33",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-33",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.apollomed.net/role/DescriptionofBusiness",
     "longName": "0000008 - Disclosure - Description of Business",
     "shortName": "Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "longName": "0000009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill",
     "longName": "0000010 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill",
     "shortName": "Business Combinations, Asset Acquisitions, and Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.apollomed.net/role/LandPropertyandEquipmentNet",
     "longName": "0000011 - Disclosure - Land, Property and Equipment, Net",
     "shortName": "Land, Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "asth:PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "asth:PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.apollomed.net/role/IntangibleAssetsNet",
     "longName": "0000012 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.apollomed.net/role/InvestmentsinOtherEntities",
     "longName": "0000013 - Disclosure - Investments in Other Entities",
     "shortName": "Investments in Other Entities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties",
     "longName": "0000014 - Disclosure - Loan Receivable and Loan Receivable \u2013 Related Parties",
     "shortName": "Loan Receivable and Loan Receivable \u2013 Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "asth:LoanReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "asth:LoanReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.apollomed.net/role/AccountsPayableandAccruedExpenses",
     "longName": "0000015 - Disclosure - Accounts Payable and Accrued Expenses",
     "shortName": "Accounts Payable and Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.apollomed.net/role/MedicalLiabilities",
     "longName": "0000016 - Disclosure - Medical Liabilities",
     "shortName": "Medical Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit",
     "longName": "0000017 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.apollomed.net/role/IncomeTaxes",
     "longName": "0000018 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficit",
     "longName": "0000019 - Disclosure - Mezzanine and Stockholders\u2019 Equity (Deficit)",
     "shortName": "Mezzanine and Stockholders\u2019 Equity (Deficit)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.apollomed.net/role/StockBasedCompensation",
     "longName": "0000020 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.apollomed.net/role/CommitmentsandContingencies",
     "longName": "0000021 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.apollomed.net/role/RelatedPartyTransactions",
     "longName": "0000022 - Disclosure - Related-Party Transactions",
     "shortName": "Related-Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.apollomed.net/role/EmployeeBenefitPlan",
     "longName": "0000023 - Disclosure - Employee Benefit Plan",
     "shortName": "Employee Benefit Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.apollomed.net/role/EarningsPerShare",
     "longName": "0000024 - Disclosure - Earnings Per Share",
     "shortName": "Earnings Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.apollomed.net/role/VariableInterestEntitiesVIEs",
     "longName": "0000025 - Disclosure - Variable Interest Entities (VIEs)",
     "shortName": "Variable Interest Entities (VIEs)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.apollomed.net/role/Leases",
     "longName": "0000026 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.apollomed.net/role/Segments",
     "longName": "0000027 - Disclosure - Segments",
     "shortName": "Segments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstruments",
     "longName": "0000028 - Disclosure - Fair Value Measurements of Financial Instruments",
     "shortName": "Fair Value Measurements of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.apollomed.net/role/SubsequentEvents",
     "longName": "0000029 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R31": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-565",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-565",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "longName": "9954472 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables",
     "longName": "9954473 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill (Tables)",
     "shortName": "Business Combinations, Asset Acquisitions, and Goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.apollomed.net/role/LandPropertyandEquipmentNetTables",
     "longName": "9954474 - Disclosure - Land, Property and Equipment, Net (Tables)",
     "shortName": "Land, Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.apollomed.net/role/IntangibleAssetsNetTables",
     "longName": "9954475 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables",
     "longName": "9954476 - Disclosure - Investments in Other Entities (Tables)",
     "shortName": "Investments in Other Entities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables",
     "longName": "9954477 - Disclosure - Accounts Payable and Accrued Expenses (Tables)",
     "shortName": "Accounts Payable and Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.apollomed.net/role/MedicalLiabilitiesTables",
     "longName": "9954478 - Disclosure - Medical Liabilities (Tables)",
     "shortName": "Medical Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables",
     "longName": "9954479 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit (Tables)",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.apollomed.net/role/IncomeTaxesTables",
     "longName": "9954480 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.apollomed.net/role/StockBasedCompensationTables",
     "longName": "9954481 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.apollomed.net/role/RelatedPartyTransactionsTables",
     "longName": "9954482 - Disclosure - Related-Party Transactions (Tables)",
     "shortName": "Related-Party Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.apollomed.net/role/EarningsPerShareTables",
     "longName": "9954483 - Disclosure - Earnings Per Share (Tables)",
     "shortName": "Earnings Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables",
     "longName": "9954484 - Disclosure - Variable Interest Entities (VIEs) (Tables)",
     "shortName": "Variable Interest Entities (VIEs) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.apollomed.net/role/LeasesTables",
     "longName": "9954485 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.apollomed.net/role/SegmentsTables",
     "longName": "9954486 - Disclosure - Segments (Tables)",
     "shortName": "Segments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsTables",
     "longName": "9954487 - Disclosure - Fair Value Measurements of Financial Instruments (Tables)",
     "shortName": "Fair Value Measurements of Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.apollomed.net/role/DescriptionofBusinessDetails",
     "longName": "9954488 - Disclosure - Description of Business (Details)",
     "shortName": "Description of Business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-70",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-71",
      "name": "asth:RestructuringSpinoffTransactionPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "9954489 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-70",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashUninsuredAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails",
     "longName": "9954490 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Disaggregation of Revenue by Payor Type (Details)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Disaggregation of Revenue by Payor Type (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-73",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails",
     "longName": "9954491 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Contributions to Revenue and Receivables by Payor (Details)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Contributions to Revenue and Receivables by Payor (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-85",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-85",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
     "longName": "9954492 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)",
     "shortName": "Business Combinations, Asset Acquisitions, and Goodwill - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-104",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-104",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails",
     "longName": "9954493 - Disclosure - Business Combinations, Asset Acquisitions, and Goodwill - Goodwill Roll Forward (Details)",
     "shortName": "Business Combinations, Asset Acquisitions, and Goodwill - Goodwill Roll Forward (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails",
     "longName": "9954494 - Disclosure - Land, Property and Equipment, Net - Schedule of Land, Property and Equipment, Net (Details)",
     "shortName": "Land, Property and Equipment, Net - Schedule of Land, Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.apollomed.net/role/LandPropertyandEquipmentNetAdditionalInformationDetails",
     "longName": "9954495 - Disclosure - Land, Property and Equipment, Net - Additional Information (Details)",
     "shortName": "Land, Property and Equipment, Net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
     "longName": "9954496 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "shortName": "Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
     "longName": "9954497 - Disclosure - Intangible Assets, Net - Additional Information (Details)",
     "shortName": "Intangible Assets, Net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails",
     "longName": "9954498 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization Expense (Details)",
     "shortName": "Intangible Assets, Net - Schedule of Future Amortization Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
     "longName": "9954499 - Disclosure - Investments in Other Entities - Schedule of Equity Method Investments (Details)",
     "shortName": "Investments in Other Entities - Schedule of Equity Method Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "asth:EquityMethodInvestmentAdditionalInvestment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails",
     "longName": "9954500 - Disclosure - Investments in Other Entities - Narrative (Details)",
     "shortName": "Investments in Other Entities - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-203",
      "name": "asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-203",
      "name": "asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
     "longName": "9954501 - Disclosure - Loan Receivable and Loan Receivable \u2013 Related Parties (Details)",
     "shortName": "Loan Receivable and Loan Receivable \u2013 Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:NotesAndLoansReceivableNetNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-214",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails",
     "longName": "9954502 - Disclosure - Accounts Payable and Accrued Expenses (Details)",
     "shortName": "Accounts Payable and Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.apollomed.net/role/MedicalLiabilitiesDetails",
     "longName": "9954503 - Disclosure - Medical Liabilities (Details)",
     "shortName": "Medical Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails",
     "longName": "9954504 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails",
     "longName": "9954505 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
     "longName": "9954506 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Credit Facility (Details)",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Credit Facility (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LineOfCredit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "asth:UnamortizedDeferredFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
     "longName": "9954507 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Lines of Credit (Details)",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Lines of Credit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "asth:NumberOfRealEstateLoans",
      "unitRef": "loan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "asth:NumberOfRealEstateLoans",
      "unitRef": "loan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails",
     "longName": "9954508 - Disclosure - Income Taxes - Income Tax Provision (Benefit) (Details)",
     "shortName": "Income Taxes - Income Tax Provision (Benefit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails",
     "longName": "9954509 - Disclosure - Income Taxes - Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails",
     "longName": "9954510 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails",
     "longName": "9954511 - Disclosure - Income Taxes - Deferred Tax Assets (Liabilities) (Details)",
     "shortName": "Income Taxes - Deferred Tax Assets (Liabilities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsStateTaxes",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsStateTaxes",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
     "longName": "9954512 - Disclosure - Mezzanine and Stockholders\u2019 Equity (Deficit) - Additional Information (Details)",
     "shortName": "Mezzanine and Stockholders\u2019 Equity (Deficit) - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "asth:StockIssuedDuringPeriodSharesMerger",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "asth:StockIssuedDuringPeriodSharesMerger",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
     "longName": "9954513 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-312",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-312",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails",
     "longName": "9954514 - Disclosure - Stock-Based Compensation - Share-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Share-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails",
     "longName": "9954515 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "shortName": "Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails",
     "longName": "9954516 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Activity (Details)",
     "shortName": "Stock-Based Compensation - Summary of Restricted Stock Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-325",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-325",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
     "longName": "9954517 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncreaseDecreaseInInsuranceLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncreaseDecreaseInInsuranceLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
     "longName": "9954518 - Disclosure - Related-Party Transactions - Additional Information (Details)",
     "shortName": "Related-Party Transactions - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-374",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails",
     "longName": "9954519 - Disclosure - Related-Party Transactions - Schedule of Related Party Transactions (Details)",
     "shortName": "Related-Party Transactions - Schedule of Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-379",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-379",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.apollomed.net/role/EmployeeBenefitPlanAdditionalInformationDetails",
     "longName": "9954520 - Disclosure - Employee Benefit Plan - Additional Information (Details)",
     "shortName": "Employee Benefit Plan - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "asth:DefinedContributionPlanServicePeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "asth:DefinedContributionPlanServicePeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
     "longName": "9954521 - Disclosure - Earnings Per Share - Additional Information (Details)",
     "shortName": "Earnings Per Share - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-408",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-408",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.apollomed.net/role/EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails",
     "longName": "9954522 - Disclosure - Earnings Per Share - Basic Net Income (loss) Per Share is Calculated Using Weighted Average Number of Shares (Details)",
     "shortName": "Earnings Per Share - Basic Net Income (loss) Per Share is Calculated Using Weighted Average Number of Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareBasic",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R84": {
     "role": "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails",
     "longName": "9954523 - Disclosure - Earnings Per Share - Summary of Shares Included in Diluted Earnings Per Share (Details)",
     "shortName": "Earnings Per Share - Summary of Shares Included in Diluted Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails",
     "longName": "9954524 - Disclosure - Variable Interest Entities (VIEs) - Eliminated Upon Consolidation Included In Accompanying Consolidated Balance Sheets (Details)",
     "shortName": "Variable Interest Entities (VIEs) - Eliminated Upon Consolidation Included In Accompanying Consolidated Balance Sheets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-423",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
     "longName": "9954525 - Disclosure - Leases - Additional information (Details)",
     "shortName": "Leases - Additional information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails",
     "longName": "9954526 - Disclosure - Leases - Components of Lease Expense (Details)",
     "shortName": "Leases - Components of Lease Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails",
     "longName": "9954527 - Disclosure - Leases - Other Information Related to Leases (Details)",
     "shortName": "Leases - Other Information Related to Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details",
     "longName": "9954528 - Disclosure - Leases - Future Minimum Payments Under Non-cancelable Leases After Adoption of 842 (Details)",
     "shortName": "Leases - Future Minimum Payments Under Non-cancelable Leases After Adoption of 842 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.apollomed.net/role/SegmentsNarrativeDetails",
     "longName": "9954529 - Disclosure - Segments - Narrative (Details)",
     "shortName": "Segments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-70",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "asth:NumberOfOperatingSegmentsThatShareSimilarCharacteristics",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails",
     "longName": "9954530 - Disclosure - Segments - Schedule of Information about our Segments (Details)",
     "shortName": "Segments - Schedule of Information about our Segments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails",
     "longName": "9954531 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) (Details)",
     "shortName": "Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails",
     "longName": "9954532 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details) (Details)",
     "shortName": "Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
     "longName": "9954533 - Disclosure - Fair Value Measurements of Financial Instruments - Additional Information (Details)",
     "shortName": "Fair Value Measurements of Financial Instruments - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails",
     "longName": "9954534 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Gain (Loss) on Equity Securities (Details)",
     "shortName": "Fair Value Measurements of Financial Instruments - Schedule of Gain (Loss) on Equity Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.apollomed.net/role/SubsequentEventsDetails",
     "longName": "9954535 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-559",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-559",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20231231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "asth_A120HellmanLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "A120HellmanLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "120 Hellman LLC",
        "label": "120 Hellman LLC [Member]",
        "documentation": "120 Hellman LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_A2023MetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "A2023MetricMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Metric",
        "label": "2023 Metric [Member]",
        "documentation": "2023 Metric"
       }
      }
     },
     "auth_ref": []
    },
    "asth_A2024MetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "A2024MetricMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Metric",
        "label": "2024 Metric [Member]",
        "documentation": "2024 Metric"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AAMGEquityContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AAMGEquityContingentConsideration",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AAMG stock contingent consideration (see Note 21)",
        "label": "AAMG Equity Contingent Consideration",
        "documentation": "AAMG Equity Contingent Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AAMGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AAMGMember",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AAMG",
        "label": "AAMG [Member]",
        "documentation": "AAMG"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AHMCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AHMCMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AHMC",
        "label": "AHMC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_APAMHMedicalCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "APAMHMedicalCorporationMember",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AP-AMH",
        "label": "AP-AMH Medical Corporation [Member]",
        "documentation": "AP-AMH Medical Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_APCMGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "APCMGMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "APCMG",
        "label": "APCMG [Member]",
        "documentation": "APCMG"
       }
      }
     },
     "auth_ref": []
    },
    "asth_APCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "APCMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "APC",
        "label": "APC [Member]",
        "documentation": "APC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable Type [Axis]",
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "asth_AccountsPayableAndAccruedExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AccountsPayableAndAccruedExpensesMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Payable and Accrued Expenses",
        "label": "Accounts Payable And Accrued Expenses [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued expenses",
        "totalLabel": "Total accounts payable and accrued expenses",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Payable and Accrued Expenses",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other accruals",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross receivables",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Receivables, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income taxes payable",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r221"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Professional fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "asth_AchievaMedInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AchievaMedInc.Member",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AchievaMed, Inc.",
        "label": "AchievaMed, Inc. [Member]",
        "documentation": "AchievaMed, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average useful life",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r974",
      "r1239"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additional Paid-in\u00a0Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r593",
      "r594",
      "r595",
      "r820",
      "r1126",
      "r1127",
      "r1128",
      "r1209",
      "r1243"
     ]
    },
    "asth_AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional proceeds to be received from sale of equity method investments, if circumstances met",
        "label": "Additional Proceeds To Be Received From Sale Of Equity Method Investments, If Circumstances Met",
        "documentation": "Additional Proceeds To Be Received From Sale Of Equity Method Investments, If Circumstances Met"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AdvanceDiagnosticSurgeryCenterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AdvanceDiagnosticSurgeryCenterMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advance Diagnostic Surgery Center",
        "label": "Advance Diagnostic Surgery Center [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AdvancedDiagnosticAndSurgicalCenterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AdvancedDiagnosticAndSurgicalCenterMember",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advanced Diagnostic and Surgical Center",
        "label": "Advanced Diagnostic and Surgical Center [Member]",
        "documentation": "Advanced Diagnostic and Surgical Center"
       }
      }
     },
     "auth_ref": []
    },
    "srt_AffiliatedEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AffiliatedEntityMember",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliated Entity",
        "label": "Affiliated Entity [Member]"
       }
      }
     },
     "auth_ref": [
      "r871",
      "r931",
      "r980",
      "r1175",
      "r1215",
      "r1216",
      "r1218"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1013",
      "r1023",
      "r1049"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1016",
      "r1026",
      "r1052"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1017",
      "r1027",
      "r1044",
      "r1053",
      "r1057",
      "r1065"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "asth_AlliedPacificOfCaliforniaIPAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AlliedPacificOfCaliforniaIPAMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "APC",
        "label": "Allied Pacific Of California IPA [Member]",
        "documentation": "Allied Pacific Of California IPA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r588",
      "r600"
     ]
    },
    "asth_AmendedAndRestatedCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AmendedAndRestatedCreditAgreementMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended and Restated Credit Agreement",
        "label": "Amended and Restated Credit Agreement [Member]",
        "documentation": "Amended and Restated Credit Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AmendedCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AmendedCreditAgreementMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended Credit Agreement",
        "label": "Amended Credit Agreement [Member]",
        "documentation": "Amended Credit Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt issuance cost",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r494",
      "r668",
      "r1117"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization expense",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r81",
      "r86"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "asth_ApcBusinessLoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ApcBusinessLoanAgreementMember",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "APC Business Loan Agreement",
        "label": "APC Business Loan Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ApcLsmaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ApcLsmaMember",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "APC LSMA",
        "label": "APC LSMA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ApcShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ApcShareholdersMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "APC",
        "label": "APC Shareholders [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ApcStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ApcStockOptionMember",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "APC Stock Option",
        "label": "APC Stock Option [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ApolloMedOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ApolloMedOfficerMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ApolloMed Officer",
        "label": "ApolloMed Officer [Member]",
        "documentation": "ApolloMed Officer"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ApolloMedicalHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ApolloMedicalHoldingsIncMember",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ApolloMed",
        "label": "Apollo Medical Holdings, Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ApolloSunLabsManagementLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ApolloSunLabsManagementLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Apollo-Sun Labs Management, LLC",
        "label": "Apollo-Sun Labs Management, LLC [Member]",
        "documentation": "Apollo-Sun Labs Management, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ArroyoVistaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ArroyoVistaMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arroyo Vista",
        "label": "Arroyo Vista [Member]",
        "documentation": "Arroyo Vista"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "verboseLabel": "Assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r261",
      "r291",
      "r341",
      "r362",
      "r368",
      "r416",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r466",
      "r468",
      "r470",
      "r471",
      "r634",
      "r638",
      "r659",
      "r758",
      "r864",
      "r974",
      "r990",
      "r1165",
      "r1166",
      "r1219"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "verboseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r270",
      "r291",
      "r416",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r466",
      "r468",
      "r470",
      "r471",
      "r634",
      "r638",
      "r659",
      "r974",
      "r1165",
      "r1166",
      "r1219"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current assets",
        "netLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r416",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r466",
      "r468",
      "r470",
      "r471",
      "r634",
      "r638",
      "r659",
      "r1165",
      "r1166",
      "r1219"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current assets",
        "terseLabel": "Non-current assets",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AstranaMedicalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AstranaMedicalMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Astrana Medical",
        "label": "Astrana Medical [Member]",
        "documentation": "Astrana Medical"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AstranaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AstranaMember",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Astrana",
        "label": "Astrana [Member]",
        "documentation": "Astrana"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.apollomed.net/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r995",
      "r996",
      "r1009"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.apollomed.net/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r995",
      "r996",
      "r1009"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.apollomed.net/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r995",
      "r996",
      "r1009"
     ]
    },
    "asth_AurionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "AurionMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AURION",
        "label": "Aurion [Member]",
        "documentation": "xxx_Aurion Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities \u2013 certificates of deposit",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r426",
      "r751",
      "r1134"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails",
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r559",
      "r560",
      "r561",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1058"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Balance Sheet Location [Domain]",
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r137"
     ]
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base Rate",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "asth_BeneficialInterestPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "BeneficialInterestPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Beneficial Interest",
        "label": "Beneficial Interest [Policy Text Block]",
        "documentation": "Beneficial Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r629",
      "r966",
      "r967"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r109",
      "r629",
      "r966",
      "r967"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares of the combined company that would be owned by pre-Merger ApolloMed stockholders",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r212"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest acquired (percent)",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, change in fair value of equity interest purchase obligation",
        "label": "Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation",
        "documentation": "Business Combination, Change in Fair Value Of Equity Interest Purchase Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, contingent consideration, liability",
        "label": "Business Combination, Contingent Consideration, Liability",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r113",
      "r632"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations, Asset Acquisitions, and Goodwill",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r630"
     ]
    },
    "asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "BusinessCombinationEquityInterestPurchaseObligationNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining equity interest purchase",
        "label": "Business Combination, Equity Interest Purchase Obligation, Noncurrent",
        "documentation": "Business Combination, Equity Interest Purchase Obligation, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, equity interest purchase obligation, period to purchase",
        "label": "Business Combination, Equity Interest Purchase Obligation, Period to Purchase",
        "documentation": "Business Combination, Equity Interest Purchase Obligation, Period to Purchase"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationStockContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "BusinessCombinationStockContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination, stock contingent consideration, liability",
        "label": "Business Combination, Stock Contingent Consideration, Liability",
        "documentation": "Business Combination, Stock Contingent Consideration, Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Business Combinations",
        "label": "Business Combinations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r190",
      "r191"
     ]
    },
    "asth_CAIPAMSOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CAIPAMSOMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CAIPA MSO, LLC",
        "label": "CAIPA MSO [Member]",
        "documentation": "CAIPA MSO"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CDSCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CDSCMember",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CDSC",
        "label": "CDSC [Member]",
        "documentation": "CDSC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CMSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CMSMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CMS",
        "label": "CMS [Member]",
        "documentation": "CMS [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "California",
        "label": "California Franchise Tax Board [Member]",
        "documentation": "Designated tax department of the government of the state of California."
       }
      }
     },
     "auth_ref": []
    },
    "asth_CallCenterServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CallCenterServicesMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Call Center Services",
        "label": "Call Center Services [Member]",
        "documentation": "Call Center Services"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CancellationOfRestrictedStockAwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CancellationOfRestrictedStockAwards",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cancellation of Restricted Stock Awards",
        "label": "Cancellation of Restricted Stock Awards",
        "documentation": "Cancellation of Restricted Stock Awards"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CareDeliveryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CareDeliveryMember",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Care Delivery",
        "label": "Care Delivery [Member]",
        "documentation": "Care Delivery"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CareEnablementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CareEnablementMember",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Care Enablement",
        "label": "Care Enablement [Member]",
        "documentation": "Care Enablement"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CarePartnersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CarePartnersMember",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Care Partners",
        "label": "Care Partners [Member]",
        "documentation": "Care Partners"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r257",
      "r937"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market accounts",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r218"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of year",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of year",
        "totalLabel": "Total cash, cash equivalents, and restricted cash shown in the statement of cash flows",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r187",
      "r288"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r187"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flow Hedging",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Supplemental disclosures of non-cash investing and financing activities",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CashPaidForLeaseLiabilitiesAbstractAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CashPaidForLeaseLiabilitiesAbstractAbstract",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:",
        "label": "Cash Paid For Lease Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashUninsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashUninsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount deposit accounts exceeded FDIC insured limit",
        "label": "Cash, Uninsured Amount",
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "asth_CashlessExerciseOfStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CashlessExerciseOfStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cashless exercise of warrants",
        "label": "Cashless Exercise Of Stock Options",
        "documentation": "Cashless Exercise Of Stock Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CertificatesOfDepositMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certificates of Deposit",
        "label": "Certificates of Deposit [Member]",
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r981",
      "r982",
      "r983",
      "r986"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer",
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ClaimsBasedOnOccurrenceAnAggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ClaimsBasedOnOccurrenceAnAggregateAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Claims based on occurrence an aggregate amount",
        "label": "Claims Based On Occurrence An Aggregate Amount",
        "documentation": "Claims Based On Occurrence An Aggregate Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r265",
      "r266",
      "r267",
      "r291",
      "r315",
      "r318",
      "r327",
      "r329",
      "r335",
      "r336",
      "r416",
      "r459",
      "r462",
      "r463",
      "r464",
      "r470",
      "r471",
      "r503",
      "r504",
      "r507",
      "r510",
      "r517",
      "r659",
      "r807",
      "r808",
      "r809",
      "r810",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r850",
      "r873",
      "r896",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r1072",
      "r1120",
      "r1129"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r335",
      "r503",
      "r504",
      "r505",
      "r507",
      "r510",
      "r515",
      "r517",
      "r807",
      "r808",
      "r809",
      "r810",
      "r955",
      "r1072",
      "r1120"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise\u00a0Price\u00a0Per Share (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of warrant, number of securities called by each warrant (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants outstanding (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "asth_CollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CollarMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collar",
        "label": "Collar [Member]",
        "documentation": "Collar"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CommercialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CommercialMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial",
        "label": "Commercial [Member]",
        "documentation": "ameh:CommercialMember"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and contingencies (Note 14)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r155",
      "r760",
      "r849"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r453",
      "r454",
      "r929",
      "r1160"
     ]
    },
    "asth_CommitmentsAndContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CommitmentsAndContingenciesLineItems",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments And Contingencies [Line Items]",
        "label": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CommitmentsAndContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CommitmentsAndContingenciesTable",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments And Contingencies [Table]",
        "label": "Commitments And Contingencies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common\u00a0Stock\u00a0Outstanding",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r977",
      "r978",
      "r979",
      "r981",
      "r982",
      "r983",
      "r986",
      "r1126",
      "r1127",
      "r1209",
      "r1236",
      "r1243"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r850"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock, Shares (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r170",
      "r850",
      "r870",
      "r1243",
      "r1244"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value $0.001; 100,000,000 shares authorized, 46,843,743 and 46,575,699 shares outstanding, excluding 10,584,340 and 10,299,259 treasury shares, at December\u00a031, 2023 and 2022, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r762",
      "r974"
     ]
    },
    "asth_CommunityFamilyCareMedicalGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CommunityFamilyCareMedicalGroupMember",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Community Family Care Medical Group",
        "label": "Community Family Care Medical Group [Member]",
        "documentation": "Community Family Care Medical Group"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "asth_CompanyAndAPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CompanyAndAPCMember",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company and APC",
        "label": "Company and APC [Member]",
        "documentation": "Company and APC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax assets",
        "label": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "label": "Components of Deferred Tax Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer software",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r145",
      "r146",
      "r375",
      "r927"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r145",
      "r146",
      "r375",
      "r804",
      "r927"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r145",
      "r146",
      "r375",
      "r927",
      "r1077"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentrations of Risks",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r240"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r145",
      "r146",
      "r375"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r71",
      "r72",
      "r145",
      "r217",
      "r927"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r71",
      "r145",
      "r146",
      "r375",
      "r927"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r634",
      "r635",
      "r638",
      "r639",
      "r697",
      "r931",
      "r1164",
      "r1167",
      "r1168"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r634",
      "r635",
      "r638",
      "r639",
      "r697",
      "r931",
      "r1164",
      "r1167",
      "r1168"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r343",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r370",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r465",
      "r467",
      "r469",
      "r470",
      "r1165",
      "r1166"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r343",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r370",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r465",
      "r467",
      "r469",
      "r470",
      "r1165",
      "r1166"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r942"
     ]
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investments in Other Entities - Equity Method and Investments in Privately Held Entities",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Variable Interest Entities",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r121",
      "r123"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in Progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "asth_ConstructionLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ConstructionLoanMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction Loan *",
        "label": "Construction Loan [Member]",
        "documentation": "Construction Loan"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ConsultingServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ConsultingServicesMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting Services",
        "label": "Consulting Services [Member]",
        "documentation": "Consulting Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContingentConsiderationByTypeAxis",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration by Type [Axis]",
        "label": "Contingent Consideration by Type [Axis]",
        "documentation": "Information by type of contingent consideration."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContingentConsiderationTypeDomain",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Consideration Type [Domain]",
        "label": "Contingent Consideration Type [Domain]",
        "documentation": "Description of contingent payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "asth_ContingentEquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ContingentEquitySecuritiesMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent equity securities",
        "label": "Contingent Equity Securities [Member]",
        "documentation": "Contingent Equity Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contract liabilities",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r520",
      "r521",
      "r533"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate Costs",
        "label": "Corporate, Non-Segment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r361",
      "r362",
      "r363",
      "r364",
      "r370",
      "r1132"
     ]
    },
    "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of services, excluding depreciation and amortization",
        "verboseLabel": "Cost of services",
        "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization",
        "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization."
       }
      }
     },
     "auth_ref": [
      "r1083",
      "r1084"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Cost, Depreciation and Amortization",
        "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service."
       }
      }
     },
     "auth_ref": [
      "r1106"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total expenses",
        "terseLabel": "Costs and expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r476",
      "r505",
      "r695",
      "r939",
      "r941"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "asth_CreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "CreditAgreementMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Agreement",
        "label": "Credit Agreement [Member]",
        "documentation": "Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1082",
      "r1123",
      "r1206"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Current income tax expense (benefit)",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r618",
      "r624",
      "r1123"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1082",
      "r1123",
      "r1206"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r375"
     ]
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "asth_DMGAndSunLabsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DMGAndSunLabsMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DMG And Sun Labs",
        "label": "DMG And Sun Labs [Member]",
        "documentation": "DMG And Sun Labs"
       }
      }
     },
     "auth_ref": []
    },
    "asth_DebtCovenantAggregatePurchasePriceMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DebtCovenantAggregatePurchasePriceMaximum",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt covenant, aggregate purchase price, maximum",
        "label": "Debt Covenant, Aggregate Purchase Price, Maximum",
        "documentation": "Debt Covenant, Aggregate Purchase Price, Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCredit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility, Bank Loans, and Lines of Credit",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r289",
      "r472",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r488",
      "r495",
      "r496",
      "r498"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r163",
      "r164",
      "r220",
      "r224",
      "r298",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r484",
      "r485",
      "r486",
      "r487",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r669",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r1121"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate (as a percent)",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total debt",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r224",
      "r499"
     ]
    },
    "asth_DebtInstrumentCovenantInterestCoverageRatioMinimum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DebtInstrumentCovenantInterestCoverageRatioMinimum",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum consolidated interest coverage ratio",
        "label": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum",
        "documentation": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DebtInstrumentCovenantLeverageRatioAdjustedMaximum",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum adjusted consolidated leverage ratio",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum",
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "asth_DebtInstrumentCovenantLeverageRatioIncrementalChange": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DebtInstrumentCovenantLeverageRatioIncrementalChange",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated leverage ratio, annual change",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Incremental Change",
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Incremental Change"
       }
      }
     },
     "auth_ref": []
    },
    "asth_DebtInstrumentCovenantLeverageRatioMaximum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum consolidated leverage ratio",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Face amount of debt",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r149",
      "r473",
      "r669",
      "r951",
      "r952"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate during period",
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r147",
      "r491"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate on debt",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r474"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r298",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r479",
      "r484",
      "r485",
      "r486",
      "r487",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r669",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r1121"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period One",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period Three",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Redemption, Period Two",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving credit facility term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Unamortized financing costs",
        "terseLabel": "Unamortized deferred financing costs",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r484",
      "r500",
      "r951",
      "r952"
     ]
    },
    "us-gaap_DebtIssuanceCostsLineOfCreditArrangementsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtIssuanceCostsLineOfCreditArrangementsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred financing costs",
        "label": "Debt Issuance Costs, Line of Credit Arrangements, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs related to line of credit arrangements. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_DeferredCreditsAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredCreditsAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining outstanding under agreement",
        "label": "Deferred Credits and Other Liabilities",
        "documentation": "Total carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income in future periods and obligations not separately disclosed in the balance sheet (other liabilities)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1123",
      "r1205",
      "r1206"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred income tax expense (benefit)",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r209",
      "r245",
      "r623",
      "r624",
      "r1123"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r168",
      "r222",
      "r612"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liability",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r605",
      "r759"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax",
        "label": "Deferred Income Taxes and Tax Credits",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1123",
      "r1205",
      "r1206"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets before valuation allowance",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "asth_DeferredTaxAssetsInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DeferredTaxAssetsInvestment",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment in other entities",
        "label": "Deferred Tax Assets Investment",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments)."
       }
      }
     },
     "auth_ref": []
    },
    "asth_DeferredTaxAssetsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DeferredTaxAssetsLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability",
        "label": "Deferred Tax Assets, Lease Liability",
        "documentation": "Deferred Tax Assets, Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1203"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforward",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1204"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1204"
     ]
    },
    "us-gaap_DeferredTaxAssetsStateTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsStateTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State taxes",
        "label": "Deferred Tax Assets, State Taxes",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1204"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1204"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allowance for bad debts",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1204"
     ]
    },
    "us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsUnrealizedLossesOnTradingSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain",
        "label": "Deferred Tax Asset, Debt Securities, Trading, Unrealized Loss",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in net income (trading)."
       }
      }
     },
     "auth_ref": [
      "r1204"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance",
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r1203"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Debt issuance cost",
        "label": "Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1204"
     ]
    },
    "asth_DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Undistributed dividend",
        "label": "Deferred Tax Liabilities, Deferred Expense, Undistributed Dividend",
        "documentation": "Deferred Tax Liabilities, Deferred Expense, Undistributed Dividend"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquired intangible assets",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1204"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Right-of-use assets",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1204"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesDeferredTaxAssetsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Property and equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r1204"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/EmployeeBenefitPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer discretionary contribution amount",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "asth_DefinedContributionPlanServicePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DefinedContributionPlanServicePeriod",
     "presentation": [
      "http://www.apollomed.net/role/EmployeeBenefitPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined contribution plan, service period",
        "label": "Defined Contribution Plan, Service Period",
        "documentation": "Defined Contribution Plan, Service Period"
       }
      }
     },
     "auth_ref": []
    },
    "asth_DefinedContributionPlanVestingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DefinedContributionPlanVestingPeriod",
     "presentation": [
      "http://www.apollomed.net/role/EmployeeBenefitPlanAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee benefit vested estimated year",
        "label": "Defined Contribution Plan, Vesting Period",
        "documentation": "Defined Contribution Plan, Vesting Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r87"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r346"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative asset",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r658",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r856",
      "r857",
      "r908",
      "r911",
      "r913",
      "r914",
      "r915",
      "r916",
      "r941",
      "r979",
      "r1237"
     ]
    },
    "asth_DerivativeCeilingInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DerivativeCeilingInterestRate",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative ceiling interest rate",
        "label": "Derivative Ceiling Interest Rate",
        "documentation": "Derivative Ceiling Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r839",
      "r841",
      "r855",
      "r856",
      "r857",
      "r860",
      "r861",
      "r862",
      "r863",
      "r865",
      "r866",
      "r867",
      "r868",
      "r884",
      "r885",
      "r886",
      "r887",
      "r890",
      "r891",
      "r892",
      "r893",
      "r908",
      "r909",
      "r913",
      "r915",
      "r977",
      "r979"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative asset, fair value",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r135",
      "r176",
      "r271",
      "r941"
     ]
    },
    "us-gaap_DerivativeFloorInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFloorInterestRate",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative, floor interest rate",
        "label": "Derivative, Floor Interest Rate",
        "documentation": "Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r136",
      "r138",
      "r140",
      "r839",
      "r841",
      "r855",
      "r856",
      "r857",
      "r860",
      "r861",
      "r862",
      "r863",
      "r865",
      "r866",
      "r867",
      "r868",
      "r884",
      "r885",
      "r886",
      "r887",
      "r890",
      "r891",
      "r892",
      "r893",
      "r908",
      "r909",
      "r913",
      "r915",
      "r941",
      "r977",
      "r979"
     ]
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r134",
      "r138"
     ]
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized loss",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r1080"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Derivative liability",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r273",
      "r658",
      "r832",
      "r833",
      "r834",
      "r835",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r865",
      "r867",
      "r868",
      "r909",
      "r910",
      "r911",
      "r913",
      "r914",
      "r915",
      "r916",
      "r941",
      "r1237"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Financial Instruments",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r129",
      "r130",
      "r132",
      "r141",
      "r297"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as Hedging Instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DevelopedTechnologyRightsMember",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Developed technology",
        "label": "Developed Technology Rights [Member]",
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r211"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Director",
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r1133",
      "r1238"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregated Revenue by Payor Type",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r558",
      "r589",
      "r590",
      "r592",
      "r969"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend payable",
        "verboseLabel": "Dividend payable",
        "label": "Dividends Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend declared included in dividend payable",
        "label": "Dividends Payable",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r166",
      "r223",
      "r987",
      "r1229"
     ]
    },
    "asth_DmgMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "DmgMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DMG",
        "label": "DMG [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r995",
      "r996",
      "r1009"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r995",
      "r996",
      "r1009",
      "r1045"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r993"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Earnings per share \u2013 basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r313",
      "r315",
      "r327",
      "r328",
      "r329",
      "r333",
      "r650",
      "r651",
      "r753",
      "r774",
      "r943"
     ]
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicLineItems",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r318",
      "r327"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Earnings per share \u2013 diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r315",
      "r327",
      "r328",
      "r329",
      "r333",
      "r650",
      "r651",
      "r753",
      "r774",
      "r943"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic and Diluted Earnings Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Earnings Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r330",
      "r331",
      "r332"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Tax provision at U.S. federal statutory rates",
        "terseLabel": "Federal corporate tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r607",
      "r625"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1202",
      "r1207"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable interest entities",
        "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes."
       }
      }
     },
     "auth_ref": [
      "r1202",
      "r1207"
     ]
    },
    "asth_EffectiveIncomeTaxRateReconciliationFederalRateAdjustment": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationFederalRateAdjustment",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-deductible permanent items",
        "label": "Effective Income Tax Rate Reconciliation, Federal Rate Adjustment",
        "documentation": "Represents the effective income tax rate reconciliation of federal rate adjustment."
       }
      }
     },
     "auth_ref": []
    },
    "asth_EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOL adjustment",
        "label": "Effective Income Tax Rate Reconciliation, Net Operating Loss Adjustment, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Net Operating Loss Adjustment, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1202",
      "r1207"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1202",
      "r1207"
     ]
    },
    "asth_EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spin-off transaction",
        "label": "Effective Income Tax Rate Reconciliation, Spin-off Transaction, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Spin-off Transaction, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "State income taxes net of federal benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1202",
      "r1207"
     ]
    },
    "asth_EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sale of investment",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Change In Investment, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Credit, Change In Investment, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r1202",
      "r1207"
     ]
    },
    "asth_EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent",
     "calculation": {
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undistributed dividend",
        "label": "Effective Income Tax Rate Reconciliation, Undistributed Dividend, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Undistributed Dividend, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense, weighted-average period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails",
      "http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r251",
      "r277",
      "r278",
      "r279",
      "r299",
      "r300",
      "r301",
      "r303",
      "r309",
      "r311",
      "r334",
      "r418",
      "r419",
      "r519",
      "r593",
      "r594",
      "r595",
      "r619",
      "r620",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r649",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r688",
      "r799",
      "r800",
      "r801",
      "r820",
      "r896"
     ]
    },
    "asth_EquityIncentivePlanTwentyFifteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquityIncentivePlanTwentyFifteenMember",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Incentive Plan Twenty Fifteen",
        "label": "Equity Incentive Plan Twenty Fifteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquityIncentivePlanTwentyThirteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquityIncentivePlanTwentyThirteenMember",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2013 Equity Incentive Plan",
        "label": "Equity Incentive Plan Twenty Thirteen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r412",
      "r413",
      "r415"
     ]
    },
    "asth_EquityMethodInvestmentAdditionalInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquityMethodInvestmentAdditionalInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Investment",
        "label": "Equity Method Investment, Additional Investment",
        "documentation": "Equity Method Investment, Additional Investment"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquityMethodInvestmentAdjustmentToFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquityMethodInvestmentAdjustmentToFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to fair value",
        "label": "Equity Method Investment, Adjustment To Fair Value",
        "documentation": "Equity Method Investment, Adjustment To Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquityMethodInvestmentFundingReclassifiedToLoanReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquityMethodInvestmentFundingReclassifiedToLoanReceivable",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Funding Reclassified to Loan Receivable",
        "label": "Equity Method Investment, Funding Reclassified to Loan Receivable",
        "documentation": "Equity Method Investment, Funding Reclassified to Loan Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants available to purchase, contingent upon the portal completion date (in shares)",
        "label": "Equity Method Investment, Options Issued, Option To Purchase Additional Interests, If Circumstances Met",
        "documentation": "Equity Method Investment, Options Issued, Option To Purchase Additional Interests, If Circumstances Met"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "% of Ownership",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sale of equity method investment",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment."
       }
      }
     },
     "auth_ref": [
      "r1107",
      "r1108",
      "r1117"
     ]
    },
    "us-gaap_EquityMethodInvestmentSoldCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentSoldCarryingAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Distribution",
        "label": "Equity Method Investment, Amount Sold",
        "documentation": "Amount of the entity's equity method investment which has been sold."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investments in other entities \u2013 equity method",
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "terseLabel": "Investments in other entities \u2013 equity method",
        "label": "Equity Method Investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r410",
      "r1094",
      "r1141"
     ]
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]",
        "label": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquityMethodInvestmentsConsolidated": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquityMethodInvestmentsConsolidated",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Entity Consolidated",
        "label": "Equity Method Investments, Consolidated",
        "documentation": "Equity Method Investments, Consolidated"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquityMethodInvestmentsContribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquityMethodInvestmentsContribution",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Funding",
        "label": "Equity Method Investments, Contribution",
        "documentation": "Equity Method Investments, Contribution"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investments in Other Entities",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r414",
      "r417",
      "r1073"
     ]
    },
    "asth_EquityMethodInvestmentsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquityMethodInvestmentsRollForward",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investments [Roll Forward]",
        "label": "Equity Method Investments [Roll Forward]",
        "documentation": "Equity Method Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Equity Method Investments, Financial Statement Information",
        "label": "Equity Method Investments [Table Text Block]",
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNi",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities \u2013 equity securities",
        "label": "Equity Securities, FV-NI, Current",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r657",
      "r938"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in a privately held entity",
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNiGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Total losses recognized on equity securities",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r777",
      "r1140"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less (loss) gains recognized on equity securities sold",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r775",
      "r1140"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofGainLossonEquitySecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized losses recognized on equity securities held at end of period",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r776",
      "r1140"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesFvNiUnrealizedLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity securities, FV-NI, unrealized loss",
        "label": "Equity Securities, FV-NI, Unrealized Loss",
        "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of option",
        "label": "Equity Securities Without Readily Determinable Fair Value Investment, Options Issued, Term Of Option",
        "documentation": "Equity Securities Without Readily Determinable Fair Value Investments, Options Issued, Term Of Option"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment amount",
        "label": "Equity Securities Without Readily Determinable Fair Value Investments, Aggregate Cost",
        "documentation": "Equity Securities Without Readily Determinable Fair Value Investments, Aggregate Cost"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Duration of investment",
        "label": "Equity Securities Without Readily Determinable Fair Value Investments, Duration Of Investment",
        "documentation": "Equity Securities Without Readily Determinable Fair Value Investments, Duration Of Investment"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Membership interests acquired (in dollars per share)",
        "label": "Equity Securities Without Readily Determinable Fair Value Investments, Membership Interest Acquired, Per Interest",
        "documentation": "Equity Securities Without Readily Determinable Fair Value Investments, Membership Interest Acquired, Per Interest"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options to purchase additional membership interests (in shares)",
        "label": "Equity Securities Without Readily Determinable Fair Value Investments, Options Issued, Option To Purchase Additional Interests",
        "documentation": "Equity Securities Without Readily Determinable Fair Value Investments, Options Issued, Option To Purchase Additional Interests"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of voting common stock, within five years",
        "label": "Equity Securities Without Readily Determinable Fair Value Investments, Proportion of Ownership Interest in Voting Common Stock, Within Five Years",
        "documentation": "Equity Securities Without Readily Determinable Fair Value Investments, Proportion of Ownership Interest in Voting Common Stock, Within Five Years"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Membership interests purchased (in shares)",
        "label": "Equity Securities Without Readily Determinable Fair Value Investments, Purchase Of Shares",
        "documentation": "Equity Securities Without Readily Determinable Fair Value Investments, Purchase Of Shares"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership percentage",
        "label": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage",
        "documentation": "Equity Securities without Readily Determinable Fair Value, Ownership Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1013",
      "r1023",
      "r1049"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r998",
      "r1010",
      "r1020",
      "r1046"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain from investment in warrants",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r12"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r654",
      "r656"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r654",
      "r656"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Carrying Amounts and Fair Values of Financial Instruments",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r143",
      "r144",
      "r216"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r654",
      "r704",
      "r705",
      "r706",
      "r951",
      "r952",
      "r963",
      "r964",
      "r965"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements of Financial Instruments",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "us-gaap_FairValueHedgeLiabilitiesAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueHedgeLiabilitiesAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of the collar",
        "label": "Fair Value Hedge Liabilities",
        "documentation": "Fair value of all derivative liabilities designated as fair value hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a01",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r538",
      "r543",
      "r654",
      "r704",
      "r963",
      "r964",
      "r965"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a02",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r538",
      "r543",
      "r654",
      "r705",
      "r951",
      "r952",
      "r963",
      "r964",
      "r965"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a03",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r654",
      "r706",
      "r951",
      "r952",
      "r963",
      "r964",
      "r965"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Change in Fair Value of Level 3 Liabilities",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r144"
     ]
    },
    "asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "APCMG contingent consideration paid",
        "label": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration Paid",
        "documentation": "Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of existing Level 3 liabilities",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at January 1, 2023",
        "periodEndLabel": "Balance at December 31, 2023",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r704",
      "r705",
      "r706",
      "r951",
      "r952",
      "r963",
      "r964",
      "r965"
     ]
    },
    "us-gaap_FairValueNetAssetLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueNetAssetLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value, net asset",
        "label": "Fair Value, Net Asset (Liability)",
        "documentation": "Fair value of asset after deduction of liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r32"
     ]
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "asth_FiduciaryAccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "FiduciaryAccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiduciary accounts payable",
        "label": "Fiduciary Accounts Payable Current",
        "documentation": "Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "asth_FiduciaryCashAndPayablePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "FiduciaryCashAndPayablePolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiduciary Cash and Payable",
        "label": "Fiduciary Cash and Payable [Policy Text Block]",
        "documentation": "Fiduciary Cash and Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on lease liabilities",
        "label": "Finance Lease, Interest Expense",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r680",
      "r973"
     ]
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from finance leases",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r683"
     ]
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Leases",
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease obligations",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r672",
      "r687"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finance lease liabilities",
        "terseLabel": "Less: current portion",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finance Lease, Future Minimum Lease Payments After Adoption of 842",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Finance lease liabilities, net of current portion",
        "terseLabel": "Long-term lease obligations",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2024",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: imputed interest",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing cash flows from finance leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r683"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetAdditionalInformationDetails",
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets recorded under finance leases",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated amortization associated with finance leases",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r1075",
      "r1078"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationAbstract",
     "presentation": [
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease cost",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of lease expense",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r680",
      "r973"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance leases",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r686",
      "r973"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance leases",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r685",
      "r973"
     ]
    },
    "asth_FinanceReceivableInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "FinanceReceivableInterestRateStatedPercentage",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Note receivable, interest rate",
        "label": "Finance Receivable, Interest Rate, Stated Percentage",
        "documentation": "Finance Receivable, Interest Rate, Stated Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r427",
      "r428",
      "r429",
      "r497",
      "r515",
      "r647",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r773",
      "r948",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1136",
      "r1137",
      "r1138",
      "r1139"
     ]
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities",
        "label": "Financial Liabilities Fair Value Disclosure",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialSupportToNonconsolidatedLegalEntityAxis",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Support to Nonconsolidated Legal Entity [Axis]",
        "label": "Financial Support to Nonconsolidated Legal Entity [Axis]",
        "documentation": "Information by financial support arrangement provided to a nonconsolidated legal entity that is required to comply with or operate in accordance with requirements that are similar to those included in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r813",
      "r814"
     ]
    },
    "us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialSupportToNonconsolidatedLegalEntityDomain",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Support to Nonconsolidated Legal Entity [Domain]",
        "label": "Financial Support to Nonconsolidated Legal Entity [Domain]",
        "documentation": "Financial support arrangement provided to a nonconsolidated legal entity that is required to comply with or operate in accordance with requirements that are similar to those included in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r813",
      "r814"
     ]
    },
    "asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "FiniteAndIndefiniteLivedIntangibleAssetsAcquired",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Additions",
        "label": "Finite and Indefinite Lived Intangible Assets Acquired",
        "documentation": "Finite and Indefinite Lived Intangible Assets Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful Life (Years)",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r447"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r446",
      "r447",
      "r449",
      "r736",
      "r737"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance, Gross",
        "periodEndLabel": "Ending Balance, Gross",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r737"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r85"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r736"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsRollForward",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized intangible assets:",
        "label": "Finite-Lived Intangible Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Finite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "asth_FirstCommonwealthPropertyLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "FirstCommonwealthPropertyLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Commonwealth Property, LLC",
        "label": "First Commonwealth Property, LLC [Member]",
        "documentation": "First Commonwealth Property, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_FiveThreeOneW.CollegeLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "FiveThreeOneW.CollegeLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "531 W. College, LLC *",
        "label": "Five Three One W. College LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_FixedAssetObtainedInExchangeForFinanceLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "FixedAssetObtainedInExchangeForFinanceLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fixed asset obtained in exchange for finance lease liabilities",
        "label": "Fixed Asset Obtained in Exchange for Finance Lease Liabilities",
        "documentation": "Fixed Asset Obtained in Exchange for Finance Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ForYourBenefitIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ForYourBenefitIncMember",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "For Your Benefit Inc.",
        "label": "For Your Benefit Inc. [Member]",
        "documentation": "For Your Benefit Inc."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1017",
      "r1027",
      "r1053"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1017",
      "r1027",
      "r1053"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1017",
      "r1027",
      "r1053"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1017",
      "r1027",
      "r1053"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1017",
      "r1027",
      "r1053"
     ]
    },
    "asth_FulgentGeneticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "FulgentGeneticsIncMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fulgent Genetics, Inc.",
        "label": "Fulgent Genetics, Inc. [Member]",
        "documentation": "Fulgent Genetics, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and equipment",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "asth_GainLossOnConsolidationOfEquityMethodInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "GainLossOnConsolidationOfEquityMethodInvestment",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss (gain) on consolidation of equity method investment",
        "label": "Gain (Loss) on Consolidation of Equity Method Investment",
        "documentation": "Gain (Loss) on Consolidation of Equity Method Investment"
       }
      }
     },
     "auth_ref": []
    },
    "asth_GainLossOnEquityReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "GainLossOnEquityReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on contingent equity securities",
        "label": "Gain (Loss) on Equity Receivable",
        "documentation": "Gain (Loss) on Equity Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnInvestmentsTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Gain (Loss) on Equity Securities",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security."
       }
      }
     },
     "auth_ref": [
      "r1104",
      "r1105"
     ]
    },
    "us-gaap_GainOnSaleOfInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainOnSaleOfInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on sale or distribution of investments",
        "label": "Gain on Sale of Investments",
        "documentation": "The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale."
       }
      }
     },
     "auth_ref": [
      "r1107",
      "r1108",
      "r1117",
      "r1228"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative expenses",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r875"
     ]
    },
    "asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "GeneralAndAdministrativeExpensesAndDepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expenses and Depreciation and Amortization",
        "documentation": "General and Administrative Expenses and Depreciation and Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r430",
      "r750",
      "r949",
      "r974",
      "r1144",
      "r1151"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Acquisitions",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r949"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill and Indefinite-Lived Intangible Assets",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r79"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of goodwill",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r431",
      "r437",
      "r441",
      "r949"
     ]
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r1150"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillGoodwillRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "asth_HSMSOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "HSMSOMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HSMSO",
        "label": "HSMSO [Member]",
        "documentation": "xxx_HSMSO Member"
       }
      }
     },
     "auth_ref": []
    },
    "asth_HealthCareCapitationRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "HealthCareCapitationRevenueMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Capitation, net",
        "label": "Health Care Capitation Revenue [Member]",
        "documentation": "ameh_HealthCareCapitationRevenueMember"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareCostsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCareCostsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Medical Liabilities",
        "label": "Health Care Costs, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accruing health care costs for a prepaid health care service provider."
       }
      }
     },
     "auth_ref": [
      "r928",
      "r930"
     ]
    },
    "us-gaap_HealthCareOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCareOtherMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk pool settlements and incentives",
        "label": "Health Care, Other [Member]",
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCarePatientServiceMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fee-for-service, net",
        "label": "Health Care, Patient Service [Member]",
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility."
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r640"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r995",
      "r996",
      "r1009"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Impairment/ Disposal",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r26"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment/ Disposal",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r1117",
      "r1154"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of intangible assets",
        "label": "Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)",
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value."
       }
      }
     },
     "auth_ref": [
      "r1117",
      "r1154"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible Assets and Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r198"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before provision for income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r177",
      "r228",
      "r341",
      "r361",
      "r367",
      "r370",
      "r754",
      "r769",
      "r945"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income (loss) from equity method investments",
        "negatedLabel": "(Income) loss from equity method investments, net",
        "verboseLabel": "Allocation of Net Income (Loss)",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r178",
      "r227",
      "r348",
      "r410",
      "r768"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameAxis",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Axis]",
        "label": "Income Tax Authority, Name [Axis]",
        "documentation": "Information by name of taxing authority."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityNameDomain",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority, Name [Domain]",
        "label": "Income Tax Authority, Name [Domain]",
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r601",
      "r608",
      "r609",
      "r616",
      "r621",
      "r626",
      "r627",
      "r628",
      "r812"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/IncomeTaxesIncomeTaxProvisionBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r246",
      "r310",
      "r311",
      "r349",
      "r606",
      "r622",
      "r778"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r602",
      "r603",
      "r609",
      "r610",
      "r615",
      "r617",
      "r806"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes",
        "label": "Income Taxes Paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r59"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes receivable",
        "label": "Income Taxes Receivable, Current",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r1101"
     ]
    },
    "us-gaap_IncomeTaxesReceivableNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesReceivableNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes receivable",
        "label": "Income Taxes Receivable, Noncurrent",
        "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r1096"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued expenses",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Receivable, net",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income taxes payable/receivable",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInDueFromRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInDueFromRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Receivable, net \u2013 related parties",
        "label": "Increase (Decrease) in Due from Related Parties",
        "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance liabilities",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "documentation": "The increase (decrease) in insurance liability balances during the period."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "asth_IncreaseDecreaseInMedicalLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "IncreaseDecreaseInMedicalLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Medical liabilities",
        "label": "Increase (Decrease) In Medical Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of medical liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities, net of acquisition amounts:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1116"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fiduciary accounts payable",
        "label": "Increase (Decrease) in Other Accounts Payable",
        "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other receivable",
        "label": "Increase (Decrease) in Other Receivables",
        "documentation": "Amount of increase (decrease) in receivables classified as other."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) In Prepaid Expenses And Other Current Assets",
        "documentation": "The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingently issuable shares (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r317",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r329"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r448"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r196"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r196"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsRollForward",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Roll Forward]",
        "label": "Indefinite-Lived Intangible Assets [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "asth_FiniteAndIndefiniteLivedIntangibleAssetsAcquired",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Indefinite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1017",
      "r1027",
      "r1044",
      "r1053",
      "r1057",
      "r1065"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1069"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1069"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1069"
     ]
    },
    "us-gaap_InsuranceServicesRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InsuranceServicesRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk pool revenue recognized under agreement",
        "label": "Insurance Services Revenue",
        "documentation": "Revenue from insurance services, including net premiums earned, gain on sale of insurance block, agency management fees and insurance contract fees and commissions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsAmortizationPeriodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsAmortizationPeriodMember",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized Intangible Assets",
        "label": "Intangible Assets, Amortization Period [Member]",
        "documentation": "A revision in the estimated economic useful life of a finite-lived intangible asset (the period of time over which the asset is projected to benefit operations)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, Net",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r442"
     ]
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Intangible Assets, Gross",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible Assets, Net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r84"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r230",
      "r280",
      "r345",
      "r667",
      "r881",
      "r988",
      "r1240"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r286",
      "r287"
     ]
    },
    "asth_InterestRateCollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "InterestRateCollarMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Collar",
        "label": "Interest Rate Collar [Member]",
        "documentation": "Interest Rate Collar"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r935",
      "r984",
      "r985"
     ]
    },
    "us-gaap_IntersegmentEliminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntersegmentEliminationMember",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intersegment Elimination",
        "label": "Intersegment Eliminations [Member]",
        "documentation": "Eliminating entries used in operating segment consolidation."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r370"
     ]
    },
    "asth_IntersegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "IntersegmentMember",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intersegment",
        "label": "Intersegment [Member]",
        "documentation": "Intersegment"
       }
      }
     },
     "auth_ref": []
    },
    "asth_IntraCareConvertiblePromissoryNoteReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "IntraCareConvertiblePromissoryNoteReceivableMember",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IntraCare Convertible Promissory Note Receivable",
        "label": "IntraCare Convertible Promissory Note Receivable [Member]",
        "documentation": "IntraCare Convertible Promissory Note Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in privately held entities",
        "label": "Investment In Privately Held Entity That Does Not Report Net Asset Value",
        "documentation": "Total of Investment in privately held entity that does not report net asset value per share ."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r344"
     ]
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in affiliates",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r1097"
     ]
    },
    "asth_IssuanceOfFinancingObligationForBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "IssuanceOfFinancingObligationForBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of financing obligation for business combinations",
        "label": "Issuance of Financing Obligation for Business Combination",
        "documentation": "Issuance of Financing Obligation for Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "asth_JadeHealthCareMedicalGroupIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "JadeHealthCareMedicalGroupIncMember",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jade Health Care Medical Group, Inc.",
        "label": "Jade Health Care Medical Group, Inc. [Member]",
        "documentation": "Jade Health Care Medical Group, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandMember",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land",
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "asth_LasalleMedicalAssociatesIpaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LasalleMedicalAssociatesIpaMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LaSalle Medical Associates \u2013 IPA Line of Business",
        "label": "LaSalle Medical Associates IPA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r679",
      "r973"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease Expense and Other Information Related to Lease Costs",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1213"
     ]
    },
    "asth_LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LeaseRightOfUseAssetsObtainedInExchangeForLeaseObligationsAbstract",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities:",
        "label": "Lease Right Of Use Assets Obtained In Exchange For Lease Obligations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_LeaseWeightedAverageDiscountRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LeaseWeightedAverageDiscountRateAbstract",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Discount Rate",
        "label": "Lease Weighted Average Discount Rate [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_LeaseWeightedAverageRemainingLeaseTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LeaseWeightedAverageRemainingLeaseTermAbstract",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Remaining Lease Term",
        "label": "Lease Weighted Average Remaining Lease Term [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeaseRenewalTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeaseRenewalTerm1",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease option to extend (up to)",
        "label": "Lessee, Finance Lease, Renewal Term",
        "documentation": "Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1212"
     ]
    },
    "us-gaap_LesseeFinanceLeaseTermOfContract1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeaseTermOfContract1",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining lease terms, financing",
        "label": "Lessee, Finance Lease, Term of Contract",
        "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1212"
     ]
    },
    "asth_LesseeFinanceLeaseTerminationPeriodIfApplicable": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LesseeFinanceLeaseTerminationPeriodIfApplicable",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease, termination period, if applicable",
        "label": "Lessee, Finance Lease, Termination Period, If Applicable",
        "documentation": "Lessee, Finance Lease, Termination Period, If Applicable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeasesTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Finance Leases [Text Block]",
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r670"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Leases, Future Minimum Lease Payments After Adoption of 842",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "asth_LesseeOperatingLeaseOptionToExtendPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LesseeOperatingLeaseOptionToExtendPeriod",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option to extend, period",
        "label": "Lessee, Operating Lease, Option To Extend, Period",
        "documentation": "Lessee, Operating Lease, Option To Extend, Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease option to extend (up to)",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1212"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining lease terms, operating",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1212"
     ]
    },
    "asth_LesseeOperatingLeaseTerminationPeriodIfApplicable": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LesseeOperatingLeaseTerminationPeriodIfApplicable",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, termination period, if applicable",
        "label": "Lessee, Operating Lease, Termination Period, If Applicable",
        "documentation": "Lessee, Operating Lease, Termination Period, If Applicable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r670"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "verboseLabel": "Liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r291",
      "r416",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r466",
      "r468",
      "r470",
      "r471",
      "r635",
      "r638",
      "r639",
      "r659",
      "r848",
      "r944",
      "r990",
      "r1165",
      "r1219",
      "r1220"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, mezzanine equity (deficit), and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r226",
      "r765",
      "r974",
      "r1122",
      "r1142",
      "r1211"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities, Mezzanine Equity (Deficit), and Stockholders\u2019 Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r256",
      "r291",
      "r416",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r466",
      "r468",
      "r470",
      "r471",
      "r635",
      "r638",
      "r639",
      "r659",
      "r974",
      "r1165",
      "r1219",
      "r1220"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Current liabilities",
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r160",
      "r161",
      "r162",
      "r165",
      "r291",
      "r416",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r466",
      "r468",
      "r470",
      "r471",
      "r635",
      "r638",
      "r639",
      "r659",
      "r1165",
      "r1219",
      "r1220"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Non-current liabilities",
        "terseLabel": "Non-current liabilities",
        "label": "Liabilities, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical liabilities",
        "periodStartLabel": "Medical liabilities, beginning of year",
        "periodEndLabel": "Medical liabilities, end of year",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r233"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical Liabilities",
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments."
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired (see Note 3)",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current period",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prior periods",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total medical care costs",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical Liabilities [Roll Forward]",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease)",
        "documentation": "Amount, after effects of reinsurance, of increase (decrease) in the liability for unpaid claims and claims adjustment expense."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Long-term line of credit",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r224",
      "r1230"
     ]
    },
    "asth_LineOfCreditFacilityAmountFundedAtClosing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LineOfCreditFacilityAmountFundedAtClosing",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, amount funded at closing",
        "label": "Line Of Credit Facility, Amount Funded At Closing",
        "documentation": "Line Of Credit Facility, Amount Funded At Closing"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityAxis",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lender Name [Axis]",
        "label": "Lender Name [Axis]",
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r1121"
     ]
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitment fee",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Required annual facility fee",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityExpirationPeriod",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of facility",
        "label": "Line of Credit Facility, Expiration Period",
        "documentation": "Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate at end of period",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "documentation": "The effective interest rate at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLenderDomain",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility, Lender [Domain]",
        "label": "Line of Credit Facility, Lender [Domain]",
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r1121"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum loan availability",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r1121"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "asth_LmaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LmaMember",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LMA",
        "label": "LMA [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_LoanReceivableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LoanReceivableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan Receivable [Abstract]",
        "label": "Loan Receivable [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_LoanReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "LoanReceivableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loan Receivable and Loan Receivable \u2013 Related Parties",
        "label": "Loan Receivable [Text Block]",
        "documentation": "Loan Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r224",
      "r485",
      "r501",
      "r951",
      "r952",
      "r1230"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of long-term debt",
        "negatedLabel": "Less: Current portion of debt",
        "verboseLabel": "Current portion of long-term debt",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r263"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r298",
      "r1170"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r298",
      "r490"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r298",
      "r490"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r298",
      "r490"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r298",
      "r490"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r298",
      "r490"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, net of current portion and deferred financing costs",
        "netLabel": "Long-term debt",
        "verboseLabel": "Long-term debt, net of current portion",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r88"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r375",
      "r958",
      "r1173",
      "r1232",
      "r1233"
     ]
    },
    "asth_ManagementContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ManagementContractsMember",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Management contracts",
        "label": "Management Contracts [Member]",
        "documentation": "Management Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManagementServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ManagementServiceMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fee income",
        "label": "Management Service [Member]",
        "documentation": "Contractually stipulated right to receive compensation for operating and managing business."
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investment in marketable securities",
        "label": "Marketable Securities, Current",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1098"
     ]
    },
    "asth_MarketableSecuritiesCurrentMaturityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MarketableSecuritiesCurrentMaturityPeriod",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable securities, current, maturity period (greater than)",
        "label": "Marketable Securities, Current, Maturity Period",
        "documentation": "Marketable Securities, Current, Maturity Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in Marketable Securities",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails",
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r457",
      "r458",
      "r554",
      "r734",
      "r798",
      "r840",
      "r841",
      "r904",
      "r905",
      "r906",
      "r907",
      "r917",
      "r932",
      "r933",
      "r947",
      "r955",
      "r968",
      "r976",
      "r1169",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "asth_MediPortalLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MediPortalLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MediPortal LLC",
        "label": "MediPortal LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MedicaidMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MedicaidMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medicaid",
        "label": "Medicaid [Member]",
        "documentation": "ameh:MedicaidMember"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MedicalCareCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MedicalCareCostsAbstract",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of medical care costs related to claims incurred:",
        "label": "Medical Care Costs [Abstract]",
        "documentation": "Medical Care Costs [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MedicalPropertyPartnersLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MedicalPropertyPartnersLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MPP",
        "label": "Medical Property Partners LLC [Member]",
        "documentation": "Medical Property Partners LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MedicareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MedicareMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medicare",
        "label": "Medicare [Member]",
        "documentation": "ameh:MedicareMember"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MemberRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MemberRelationshipsMember",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Member relationships",
        "label": "Member Relationships [Member]",
        "documentation": "Member Relationships"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MezzanineEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MezzanineEquityAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Mezzanine (deficit) equity",
        "label": "MEZZANINE EQUITY [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MezzanineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MezzanineMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mezzanine",
        "label": "Mezzanine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails",
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "verboseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r457",
      "r458",
      "r554",
      "r734",
      "r798",
      "r840",
      "r841",
      "r904",
      "r905",
      "r906",
      "r907",
      "r917",
      "r932",
      "r933",
      "r947",
      "r955",
      "r968",
      "r976",
      "r1169",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r225",
      "r291",
      "r416",
      "r459",
      "r462",
      "r463",
      "r464",
      "r470",
      "r471",
      "r659",
      "r764",
      "r852"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributions of preferred returns",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of non-controlling interest",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r204",
      "r214"
     ]
    },
    "asth_MinorityInterestPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "MinorityInterestPolicyPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interests",
        "label": "Minority Interest Policy [Policy Text Block]",
        "documentation": "Minority Interest Policy."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "us-gaap_MortgageLoanRelatedToPropertySales1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MortgageLoanRelatedToPropertySales1",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage loan",
        "label": "Mortgage Loan Related to Property Sales",
        "documentation": "Mortgage loan related to property sales in noncash investing and financing activities."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r375",
      "r958",
      "r1173",
      "r1232",
      "r1233"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business",
        "label": "Nature of Operations [Text Block]",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r247"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r285"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r188",
      "r189"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash flows from operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income attributable to Astrana Health, Inc.",
        "terseLabel": "Net Income (Loss)",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r189",
      "r229",
      "r254",
      "r274",
      "r275",
      "r279",
      "r291",
      "r302",
      "r304",
      "r305",
      "r306",
      "r307",
      "r310",
      "r311",
      "r326",
      "r341",
      "r361",
      "r367",
      "r370",
      "r416",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r466",
      "r468",
      "r470",
      "r471",
      "r651",
      "r659",
      "r772",
      "r872",
      "r894",
      "r895",
      "r945",
      "r988",
      "r1165"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net (loss) income attributable to noncontrolling interests",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r215",
      "r274",
      "r275",
      "r310",
      "r311",
      "r771",
      "r1103"
     ]
    },
    "asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income",
        "label": "Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity",
        "documentation": "Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NetworkMedicalManagementIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NetworkMedicalManagementIncMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Network Medical Management, Inc.",
        "label": "Network Medical Management, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NetworkMedicalManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NetworkMedicalManagementMember",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NMM",
        "label": "Network Medical Management [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NetworkRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NetworkRelationshipsMember",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Network relationships",
        "label": "Network Relationships [Member]",
        "documentation": "Network Relationships"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "asth_NewTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NewTermLoanMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Term Loan",
        "label": "New Term Loan [Member]",
        "documentation": "New Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1017",
      "r1027",
      "r1044",
      "r1053"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "asth_NoncashLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NoncashLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash lease expense",
        "label": "Noncash Lease Expense",
        "documentation": "Noncash Lease Expense"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends (in shares)",
        "label": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares",
        "documentation": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends",
        "label": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares",
        "documentation": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition of non-controlling interest",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "documentation": "Amount of increase in noncontrolling interest from a business combination."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r96",
      "r110"
     ]
    },
    "asth_NoncontrollingInterestIncreaseFromCapitalCharge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NoncontrollingInterestIncreaseFromCapitalCharge",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest capital change",
        "label": "Noncontrolling Interest, Increase From Capital Charge",
        "documentation": "Noncontrolling Interest, Increase From Capital Charge"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of non-controlling interest",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r96",
      "r214"
     ]
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in non-controlling interest",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r96",
      "r214"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Noncontrolling Interest",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r519",
      "r1126",
      "r1127",
      "r1128",
      "r1243"
     ]
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Not Designated as Hedging Instrument",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income (expense), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense)",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonrelated Party",
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r1124",
      "r1125"
     ]
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesAndLoansReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans receivable, net",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r752"
     ]
    },
    "us-gaap_NotesAndLoansReceivableNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesAndLoansReceivableNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans receivable, non-current",
        "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableToBanksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableToBanksMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory Note Payable",
        "label": "Notes Payable to Banks [Member]",
        "documentation": "A written promise to pay a note to a bank."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesReceivableMember",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes Receivable",
        "label": "Notes Receivable [Member]",
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of loan",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement and net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r425",
      "r859"
     ]
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/SegmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r1131"
     ]
    },
    "asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NumberOfOperatingSegmentsThatShareSimilarCharacteristics",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments that share similar characteristics",
        "label": "Number Of Operating Segments That Share Similar Characteristics",
        "documentation": "Number Of Operating Segments That Share Similar Characteristics"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NumberOfRealEstateLoans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "NumberOfRealEstateLoans",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of real estate loans",
        "label": "Number Of Real Estate Loans",
        "documentation": "Number Of Real Estate Loans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/DescriptionofBusinessDetails",
      "http://www.apollomed.net/role/SegmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r1131"
     ]
    },
    "us-gaap_NumberOfReportingUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportingUnits",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of main reporting units",
        "label": "Number of Reporting Units",
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment."
       }
      }
     },
     "auth_ref": []
    },
    "asth_OfficeLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "OfficeLeaseMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office Lease",
        "label": "Office Lease [Member]",
        "documentation": "Office Lease"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OfficerMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Officer",
        "label": "Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r376",
      "r1238"
     ]
    },
    "asth_OneMSOLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "OneMSOLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One MSO, LLC *",
        "label": "One MSO, LLC [Member]",
        "documentation": "One MSO, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income from operations",
        "verboseLabel": "Income (loss) from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r361",
      "r367",
      "r370",
      "r945"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r681",
      "r973"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "totalLabel": "Total lease obligations",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liabilities",
        "terseLabel": "Less: current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LeasesFutureMinimumPaymentsUnderNoncancelableLeasesAfterAdoptionof842Details",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Operating lease liabilities, net of current portion",
        "verboseLabel": "Operating lease liabilities, net of current portion",
        "terseLabel": "Long-term lease obligations",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r676",
      "r683"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r686",
      "r973"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r685",
      "r973"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "asth_OperatingLossCarryforwardsNotSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "OperatingLossCarryforwardsNotSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards, not subject to expiration",
        "label": "Operating Loss Carryforwards, Not Subject To Expiration",
        "documentation": "Operating Loss Carryforwards, Not Subject To Expiration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r370"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_OrmaHealthIncAndProviderGrowthSolutionsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "OrmaHealthIncAndProviderGrowthSolutionsLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Orma Health, Inc., and Provider Growth Solutions LLC",
        "label": "Orma Health, Inc., and Provider Growth Solutions LLC [Member]",
        "documentation": "Orma Health, Inc., and Provider Growth Solutions LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other provider payable",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_OtherAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of beneficial interest",
        "label": "Other Asset Impairment Charges",
        "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value."
       }
      }
     },
     "auth_ref": [
      "r1117",
      "r1158"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amounts due from affiliates",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r974"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets",
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amount due to affiliate",
        "label": "Other Liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r756",
      "r844",
      "r845",
      "r990",
      "r1238"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r974"
     ]
    },
    "us-gaap_OtherLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Liabilities",
        "label": "Other Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other liabilities."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r142"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_OtherLongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLongTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in affiliates",
        "label": "Other Long-Term Investments",
        "documentation": "Amount of long-term investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r1095"
     ]
    },
    "asth_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "OtherMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other [Member]",
        "documentation": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncurrentAssetsMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Noncurrent Assets",
        "label": "Other Noncurrent Assets [Member]",
        "documentation": "Primary financial statement caption encompassing other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncurrentLiabilitiesMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Noncurrent Liabilities",
        "label": "Other Noncurrent Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income (loss)",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due from affiliates",
        "label": "Other Receivables",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r268",
      "r858"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "verboseLabel": "Other receivables",
        "label": "Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "asth_OtherThirdPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "OtherThirdPartiesMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other third parties",
        "label": "Other Third Parties [Member]",
        "documentation": "ameh:OtherThirdPartiesMember"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1015",
      "r1025",
      "r1051"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1006",
      "r1018",
      "r1028",
      "r1054"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1006",
      "r1018",
      "r1028",
      "r1054"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Axis]",
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Domain]",
        "label": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_Pacific6EnterprisesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "Pacific6EnterprisesMember",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pacific6",
        "label": "Pacific6 Enterprises [Member]",
        "documentation": "Pacific6 Enterprises [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PacificMedicalImagingAndOncologyCenterIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PacificMedicalImagingAndOncologyCenterIncMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pacific Medical Imaging &amp; Oncology Center, Inc.",
        "label": "Pacific Medical Imaging and Oncology Center, Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PatientManagementPlatformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PatientManagementPlatformMember",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Patient management platform",
        "label": "Patient Management Platform [Member]",
        "documentation": "Patient Management Platform"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PayerDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PayerDMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payer D",
        "label": "Payer D [Member]",
        "documentation": "Payer D"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of contingent consideration liabilities",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "asth_PaymentMadeToRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PaymentMadeToRelatedParty",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to related party",
        "label": "Payment Made To Related Party",
        "documentation": "Amount paid to related party in relation to providing services"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentOfFinancingAndStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cost of debt issuances",
        "label": "Payment of Financing and Stock Issuance Costs",
        "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_PaymentsForLeasingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForLeasingCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease agreement",
        "label": "Payments for Leasing Costs",
        "documentation": "Amount of cash outflow for costs that are essential to originate the lease and would not otherwise have been incurred without the lease agreement. Amount includes, but is not limited to, cash outflows to evaluate the lessee's credit condition, guarantees, and collateral and cash outflows for costs incurred in negotiating, processing, and executing the lease agreement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total paid",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r28"
     ]
    },
    "asth_PaymentsForMedicalCareCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PaymentsForMedicalCareCostsAbstract",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for medical care costs related to claims incurred:",
        "label": "Payments For Medical Care Costs [Abstract]",
        "documentation": "Payments For Medical Care Costs [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForProceedsFromRealEstatePartnershipInvestmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForProceedsFromRealEstatePartnershipInvestmentNet",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution of real estate investments",
        "label": "Payments for (Proceeds from) Real Estate Partnership Investment, Net",
        "documentation": "The net cash inflow or outflow from the sale or purchase of and distributions from real estate partnership investment during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of shares",
        "terseLabel": "Repurchase of common stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid",
        "terseLabel": "Payments of ordinary dividends common stock",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsMinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of non-controlling interest",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to acquire business",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r631"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments for business and asset acquisition, net of cash acquired",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of investments \u2013 equity method",
        "label": "Payments to Acquire Equity Method Investments",
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "asth_PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to purchase membership interests",
        "label": "Payments To Acquire Equity Securities Without Readily Determinable Fair Value Investments",
        "documentation": "Payments To Acquire Equity Securities Without Readily Determinable Fair Value Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_PaymentsToAcquireTradingSecuritiesHeldforinvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireTradingSecuritiesHeldforinvestment",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of investments \u2013privately held",
        "label": "Payment for Acquisition, Trading Security, Held-for-Investment",
        "documentation": "The cash outflow to acquire securities classified as trading securities and held for investment purposes. Excludes payments for trading securities purchased and held principally for the purpose of selling them in the near term (thus held for only a short period of time)."
       }
      }
     },
     "auth_ref": [
      "r1111"
     ]
    },
    "asth_PaymentsToEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PaymentsToEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Contribution to investment - equity method",
        "label": "Payments to Equity Method Investments",
        "documentation": "Payments to Equity Method Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Issuance of loans receivable",
        "label": "Payments to Fund Long-Term Loans to Related Parties",
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates."
       }
      }
     },
     "auth_ref": [
      "r1112",
      "r1215"
     ]
    },
    "asth_PayorAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PayorAMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payer A",
        "label": "Payor A [Member]",
        "documentation": "Payor A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PayorBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PayorBMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payer B",
        "label": "Payor B [Member]",
        "documentation": "Payor B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PayorCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PayorCMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payer C",
        "label": "Payor C [Member]",
        "documentation": "Payor C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PayorEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PayorEMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payer E",
        "label": "Payor E [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/EmployeeBenefitPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefit Plan",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r536",
      "r537",
      "r543",
      "r544",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r965"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "asth_PerMemberPerMonthManagedCareContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PerMemberPerMonthManagedCareContractMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PMPM",
        "label": "Per-Member-Per-Month Managed Care Contract [Member]",
        "documentation": "Per-Member-Per-Month Managed Care Contract [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PerformanceBasedRestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PerformanceBasedRestrictedStockMember",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Based Restricted Stock",
        "label": "Performance Based Restricted Stock [Member]",
        "documentation": "Performance Based Restricted Stock"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PerformanceBasedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PerformanceBasedRestrictedStockUnitsMember",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Based Restricted Stock Awards",
        "label": "Performance Based Restricted Stock Units [Member]",
        "documentation": "Performance Based Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Shares",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199",
      "r1200",
      "r1201"
     ]
    },
    "asth_PmiocMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PmiocMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PMIOC",
        "label": "PMIOC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PreferredBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PreferredBankMember",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Bank",
        "label": "Preferred Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, liquidation preference (in dollar per share)",
        "label": "Preferred Stock, Liquidation Preference Per Share",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r93",
      "r169",
      "r1120",
      "r1171"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r503"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r850"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r503"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r850",
      "r870",
      "r1243",
      "r1244"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r761",
      "r974"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1102"
     ]
    },
    "us-gaap_PrimeRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrimeRateMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prime Rate",
        "label": "Prime Rate [Member]",
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassifications",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r1092"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "asth_ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash recorded from consolidation of VIE",
        "label": "Proceeds from Cash Received from Consolidation of Variable Interest Entity",
        "documentation": "Proceeds from Cash Received from Consolidation of Variable Interest Entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromCollectionOfLongtermLoansToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromCollectionOfLongtermLoansToRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from repayment of loans receivable - related parties",
        "label": "Proceeds from Collection of Long-Term Loans to Related Parties",
        "documentation": "The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates."
       }
      }
     },
     "auth_ref": [
      "r1109",
      "r1215"
     ]
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution from investment - equity method",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r1110"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds from sale of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of debt",
        "label": "Proceeds from Issuance of Debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Borrowings on long-term debt",
        "label": "Proceeds from Issuance of Other Long-Term Debt",
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Draws on lines of credit",
        "label": "Proceeds from Lines of Credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r1121"
     ]
    },
    "us-gaap_ProceedsFromOtherOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromOtherOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Proceeds from Other Operating Activities",
        "documentation": "Amount of cash inflow from operating activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds from sale of noncontrolling interest",
        "label": "Proceeds from (Payments to) Noncontrolling Interests",
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRepaymentsOfBankOverdrafts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepaymentsOfBankOverdrafts",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from (repayments of) bank overdrafts",
        "label": "Proceeds from (Repayments of) Bank Overdrafts",
        "documentation": "The net cash inflow or outflow from the excess drawing from an existing cash balance, which will be honored by the bank but reflected as a loan to the drawer."
       }
      }
     },
     "auth_ref": [
      "r1114",
      "r1115",
      "r1118"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of marketable securities",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfEquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of equity method investment",
        "label": "Proceeds from Sale of Equity Method Investments",
        "documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options and warrants",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductAndServiceOtherMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other revenue",
        "label": "Product and Service, Other [Member]",
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r372",
      "r735",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r936",
      "r956",
      "r975",
      "r1081",
      "r1161",
      "r1162",
      "r1173",
      "r1232"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r372",
      "r735",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r936",
      "r956",
      "r975",
      "r1081",
      "r1161",
      "r1162",
      "r1173",
      "r1232"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional coverage",
        "label": "Professional Fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r988",
      "r1241",
      "r1242"
     ]
    },
    "asth_ProfessionalMedicalCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ProfessionalMedicalCorporationMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional Medical Corporation",
        "label": "Professional Medical Corporation [Member]",
        "documentation": "Professional Medical Corporation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r274",
      "r275",
      "r283",
      "r291",
      "r302",
      "r310",
      "r311",
      "r341",
      "r361",
      "r367",
      "r370",
      "r416",
      "r459",
      "r460",
      "r462",
      "r463",
      "r464",
      "r466",
      "r468",
      "r470",
      "r471",
      "r633",
      "r636",
      "r637",
      "r651",
      "r659",
      "r754",
      "r770",
      "r819",
      "r872",
      "r894",
      "r895",
      "r945",
      "r971",
      "r972",
      "r989",
      "r1103",
      "r1165"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation and amortization",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r1075",
      "r1078",
      "r1157"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land, property and equipment, net",
        "totalLabel": "Land, property, and equipment, net",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r1078",
      "r1155"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land, property and equipment, gross",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r1074",
      "r1097",
      "r1156"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "asth_PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land, Property and Equipment, Net",
        "label": "Property, Plant And Equipment Disclosure And Asset Acquisition [Text Block]",
        "documentation": "Property, Plant And Equipment And Asset Acquisition Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land, property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r755",
      "r767",
      "r974"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Land, Property and Equipment, Net",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r241",
      "r244",
      "r766"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Land, Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r197"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful Life (Years)",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "asth_ProviderServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ProviderServicesMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provider Services",
        "label": "Provider Services [Member]",
        "documentation": "Provider Services"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails",
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r457",
      "r458",
      "r536",
      "r554",
      "r584",
      "r585",
      "r586",
      "r707",
      "r734",
      "r798",
      "r840",
      "r841",
      "r904",
      "r905",
      "r906",
      "r907",
      "r917",
      "r932",
      "r933",
      "r947",
      "r955",
      "r968",
      "r976",
      "r979",
      "r1159",
      "r1169",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails",
      "http://www.apollomed.net/role/LeasesAdditionalinformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r456",
      "r457",
      "r458",
      "r536",
      "r554",
      "r584",
      "r585",
      "r586",
      "r707",
      "r734",
      "r798",
      "r840",
      "r841",
      "r904",
      "r905",
      "r906",
      "r907",
      "r917",
      "r932",
      "r933",
      "r947",
      "r955",
      "r968",
      "r976",
      "r979",
      "r1159",
      "r1169",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226"
     ]
    },
    "us-gaap_RealEstateLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstateLoanMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Loans*",
        "label": "Real Estate Loan [Member]",
        "documentation": "Loan to finance the purchase of real estate, including but not limited to, land or building."
       }
      }
     },
     "auth_ref": []
    },
    "asth_RealEstateLoanOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RealEstateLoanOneMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Loan One",
        "label": "Real Estate Loan One [Member]",
        "documentation": "Real Estate Loan One"
       }
      }
     },
     "auth_ref": []
    },
    "asth_RealEstateLoanThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RealEstateLoanThreeMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Loan Three",
        "label": "Real Estate Loan Three [Member]",
        "documentation": "Real Estate Loan Three"
       }
      }
     },
     "auth_ref": []
    },
    "asth_RealEstateLoanTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RealEstateLoanTwoMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Loan Two",
        "label": "Real Estate Loan Two [Member]",
        "documentation": "Real Estate Loan Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable [Domain]",
        "label": "Receivable [Domain]",
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "asth_ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Receivables, Receivables \u2013 Related Parties, Other Receivables, Loan Receivable, and Loan Receivable - Related Party",
        "label": "Receivables And Related parties Receivables Policy Text Block [Policy Text Block]",
        "documentation": "The Receivables and receivables from related parties."
       }
      }
     },
     "auth_ref": []
    },
    "asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reconciliation of cash, cash equivalents, and restricted cash",
        "label": "Reconciliation Of Cash Cash Equivalents And Restricted Cash [Abstract]",
        "documentation": "ameh_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r998",
      "r1010",
      "r1020",
      "r1046"
     ]
    },
    "us-gaap_RelatedPartyDepositLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDepositLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Due to related parties",
        "label": "Related Party Deposit Liabilities",
        "documentation": "Amount of deposits held by the entity for a related party (entity, shareholder, employee)."
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Domain]",
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r692",
      "r693",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r869",
      "r871",
      "r903"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r294",
      "r692",
      "r693",
      "r694",
      "r695",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r869",
      "r871",
      "r903"
     ]
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related party transaction, amount of transaction",
        "label": "Related Party Transaction, Amounts of Transaction",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r692"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r692",
      "r693",
      "r1218"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "asth_RelatedPartyTransactionExpensesIncurredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RelatedPartyTransactionExpensesIncurredMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction, Expenses Incurred",
        "label": "Related Party Transaction, Expenses Incurred [Member]",
        "documentation": "Related Party Transaction, Expenses Incurred"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r876",
      "r877",
      "r880"
     ]
    },
    "asth_RelatedPartyTransactionRevenueExpenseNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RelatedPartyTransactionRevenueExpenseNetMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction, Revenue (Expense), Net",
        "label": "Related Party Transaction, Revenue (Expense), Net [Member]",
        "documentation": "Related Party Transaction, Revenue (Expense), Net"
       }
      }
     },
     "auth_ref": []
    },
    "asth_RelatedPartyTransactionRevenueRecognizedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RelatedPartyTransactionRevenueRecognizedMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction, Revenue Recognized",
        "label": "Related Party Transaction, Revenue Recognized [Member]",
        "documentation": "Related Party Transaction, Revenue Recognized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions [Abstract]",
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party [Axis]",
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r692",
      "r693",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r869",
      "r871",
      "r903",
      "r1218"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Related-Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r689",
      "r690",
      "r691",
      "r693",
      "r696",
      "r815",
      "r816",
      "r817",
      "r878",
      "r879",
      "r880",
      "r900",
      "r902"
     ]
    },
    "asth_RentPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RentPaymentMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent Payment",
        "label": "Rent Payment [Member]",
        "documentation": "Rent Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayments of debt",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r1115"
     ]
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of finance lease obligations",
        "label": "Repayments of Debt and Lease Obligation",
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfOtherLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments on long-term debt",
        "label": "Repayments of Other Long-Term Debt",
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r295",
      "r296",
      "r476",
      "r505",
      "r695",
      "r940",
      "r941"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1011",
      "r1021",
      "r1047"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1012",
      "r1022",
      "r1048"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1019",
      "r1029",
      "r1055"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1093",
      "r1119",
      "r1227",
      "r1231"
     ]
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash Equivalents, Noncurrent",
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r925",
      "r926",
      "r1096",
      "r1119"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r1096",
      "r1119"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock awards",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Awards",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "asth_RestructuringSpinoffTransactionDividendRealEstateOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RestructuringSpinoffTransactionDividendRealEstateOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spinoff transaction, dividend, real estate operations portion",
        "label": "Restructuring, Spinoff Transaction, Dividend, Real Estate Operations",
        "documentation": "Restructuring, Spinoff Transaction, Dividend, Real Estate Operations"
       }
      }
     },
     "auth_ref": []
    },
    "asth_RestructuringSpinoffTransactionNumberOfMembershipUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RestructuringSpinoffTransactionNumberOfMembershipUnits",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spinoff transaction, number of membership units per common share",
        "label": "Restructuring, Spinoff Transaction, Number Of Membership Units",
        "documentation": "Restructuring, Spinoff Transaction, Number Of Membership Units"
       }
      }
     },
     "auth_ref": []
    },
    "asth_RestructuringSpinoffTransactionPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RestructuringSpinoffTransactionPercentage",
     "presentation": [
      "http://www.apollomed.net/role/DescriptionofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spinoff transaction, ownership percentage",
        "label": "Restructuring, Spinoff Transaction, Percentage",
        "documentation": "Restructuring, Spinoff Transaction, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r204",
      "r763",
      "r802",
      "r803",
      "r811",
      "r851",
      "r974"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r299",
      "r300",
      "r301",
      "r303",
      "r309",
      "r311",
      "r418",
      "r419",
      "r593",
      "r594",
      "r595",
      "r619",
      "r620",
      "r641",
      "r643",
      "r644",
      "r646",
      "r649",
      "r799",
      "r801",
      "r820",
      "r1243"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDisaggregationofRevenuebyPayorTypeDetails",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total revenue",
        "verboseLabel": "Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r360",
      "r365",
      "r366",
      "r372",
      "r374",
      "r375",
      "r531",
      "r532",
      "r735"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r934"
     ]
    },
    "asth_RevenuePaymentTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RevenuePaymentTerms",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, payment terms",
        "label": "Revenue, Payment Terms",
        "documentation": "Revenue, Payment Terms"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuePerformanceObligationDescriptionOfTiming",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract term",
        "label": "Revenue, Performance Obligation, Description of Timing",
        "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "asth_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected period of payment upon termination of agreement",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing Of Satisfaction, Period Of Payment Upon Finalization Of Settlement Report",
        "documentation": "Revenue, Remaining Performance Obligation, Expected Timing Of Satisfaction, Period Of Payment Upon Finalization Of Settlement Report"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_RevolverLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RevolverLoanMember",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolver Loan",
        "label": "Revolver Loan [Member]",
        "documentation": "Revolver Loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolver Loan",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance leases",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r684",
      "r973"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.apollomed.net/role/LeasesOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities",
        "verboseLabel": "Operating leases",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r684",
      "r973"
     ]
    },
    "asth_RiskPoolSettlementsAndIncentivesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RiskPoolSettlementsAndIncentivesMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk Pool Settlements and Incentives",
        "label": "Risk Pool Settlements and Incentives [Member]",
        "documentation": "Risk Pool Settlements and Incentives"
       }
      }
     },
     "auth_ref": []
    },
    "asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk pool surplus or deficits, settlement period after performance year",
        "label": "Risk Pool Surplus Or Deficits, Settlement Period After Performance Year",
        "documentation": "Risk Pool Surplus Or Deficits, Settlement Period After Performance Year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesContributionstoRevenueandReceivablesbyPayorDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net revenue",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r1076"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Payable and Accrued Expenses",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r109",
      "r629"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Provision for Income Taxes",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r208"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Components of Deferred Tax Assets (Liabilities)",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings Per Share Computations",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r67",
      "r315",
      "r318",
      "r327"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Effective Income Tax Rate Reconciliation for Provision for Income Taxes",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r206"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/LoanReceivableandLoanReceivableRelatedPartiesDetails",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r412",
      "r413",
      "r415"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Equity Method Investments [Line Items]",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r412",
      "r413",
      "r415",
      "r416",
      "r659"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails",
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Equity Method Investments [Table]",
        "label": "Schedule of Equity Method Investments [Table]",
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r291",
      "r412",
      "r413",
      "r415",
      "r416",
      "r659"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r85",
      "r736"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Net",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r85"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Goodwill Activity",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r949",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets, Net",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r196"
     ]
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Medical Liabilities",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Credit Facility",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Commitments of Credit Facility",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.apollomed.net/role/LandPropertyandEquipmentNetScheduleofLandPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsScheduleofRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r151",
      "r876",
      "r877",
      "r880"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Fees Incurred and Revenue Earned from Related Party Transactions",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue by Major Customers by Reporting Segments",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r78",
      "r79"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Information about our Segments",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r78",
      "r79"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails",
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Transactions Under Stock Option Plans",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r99"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Restricted Stock Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90",
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r202",
      "r203",
      "r204",
      "r265",
      "r266",
      "r267",
      "r335",
      "r503",
      "r504",
      "r505",
      "r507",
      "r510",
      "r515",
      "r517",
      "r807",
      "r808",
      "r809",
      "r810",
      "r955",
      "r1072",
      "r1120"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Schedule of Variable Interest Entities [Table]",
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r120",
      "r122",
      "r125",
      "r126",
      "r634",
      "r635",
      "r638",
      "r639",
      "r715",
      "r716",
      "r717"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Assets and Liabilities, Variable Interest Entities",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r120",
      "r122",
      "r125",
      "r126"
     ]
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Shares Included in the Diluted Earnings Per Share Computations",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Future Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_SecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredDebtMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Debt",
        "label": "Secured Debt [Member]",
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SecuredOvernightFinancingRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SecuredOvernightFinancingRateMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate",
        "label": "Secured Overnight Financing Rate [Member]",
        "documentation": "Secured Overnight Financing Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg."
       }
      }
     },
     "auth_ref": [
      "r1208"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "asth_SeenHealthIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SeenHealthIncMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Seen Health, Inc",
        "label": "Seen Health, Inc [Member]",
        "documentation": "Seen Health, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r375",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r451",
      "r452",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r949",
      "r1081",
      "r1232"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/Segments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r353",
      "r364",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reportable Segments",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r374",
      "r946"
     ]
    },
    "us-gaap_SeniorNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior notes",
        "label": "Senior Notes",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r1230"
     ]
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Series A Preferred Stock",
        "terseLabel": "Series A Preferred Stock",
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1099",
      "r1100",
      "r1172"
     ]
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B Preferred Stock",
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1099",
      "r1100",
      "r1172"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r969"
     ]
    },
    "asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent on performance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other Than Options, Contingent On Performance",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other Than Options, Contingent On Performance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock awards granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested, beginning balance (in shares)",
        "periodEndLabel": "Unvested, ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r572"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested (in dollars per share)",
        "periodEndLabel": "Unvested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r572"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant-Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of awards",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails",
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r556",
      "r557",
      "r559",
      "r560",
      "r561",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of additional shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value (in millions)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised",
        "verboseLabel": "Options exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options canceled, forfeited or expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r1182"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options canceled, forfeited or expired (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r1182"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r1183"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r563",
      "r564"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in dollars per share)",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r563",
      "r564"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted-Average Exercise Price",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants exercises in period (in shares)",
        "label": "Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period",
        "documentation": "Share based Compensation Arrangement By Share based Payment Award Warrants Exercises In Period"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation arrangement by share based payment award, warrant exercised, exercise price",
        "label": "Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price",
        "documentation": "Share-Based Compensation Arrangement By Share based Payment Award, Warrant Exercised, Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails",
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofRestrictedStockActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Award [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r559",
      "r560",
      "r561",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r562",
      "r581",
      "r582",
      "r583",
      "r584",
      "r587",
      "r596",
      "r597",
      "r598",
      "r599"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Balance at beginning (in shares)",
        "periodEndLabel": "Balance at ending (in shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SongPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SongPCMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Song PC",
        "label": "Song PC [Member]",
        "documentation": "Song PC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_SpecialtyCapitationPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SpecialtyCapitationPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Capitation payable",
        "label": "Specialty Capitation Payable Current",
        "documentation": "Represents the amount of specialty capitation payable current."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SpinOffTransactionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SpinOffTransactionMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spin-Off Transaction",
        "label": "Spin-Off Transaction [Member]",
        "documentation": "Spin-Off Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StandbyLettersOfCreditMember",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standby Letters of Credit",
        "label": "Standby Letters of Credit [Member]",
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r1163",
      "r1234",
      "r1235"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r338",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r375",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r450",
      "r451",
      "r452",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r949",
      "r1081",
      "r1232"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r265",
      "r266",
      "r267",
      "r291",
      "r315",
      "r318",
      "r327",
      "r329",
      "r335",
      "r336",
      "r416",
      "r459",
      "r462",
      "r463",
      "r464",
      "r470",
      "r471",
      "r503",
      "r504",
      "r507",
      "r510",
      "r517",
      "r659",
      "r807",
      "r808",
      "r809",
      "r810",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r850",
      "r873",
      "r896",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r1072",
      "r1120",
      "r1129"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r46",
      "r251",
      "r277",
      "r278",
      "r279",
      "r299",
      "r300",
      "r301",
      "r303",
      "r309",
      "r311",
      "r334",
      "r418",
      "r419",
      "r519",
      "r593",
      "r594",
      "r595",
      "r619",
      "r620",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r649",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r688",
      "r799",
      "r800",
      "r801",
      "r820",
      "r896"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r334",
      "r735",
      "r805",
      "r831",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r850",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r860",
      "r861",
      "r862",
      "r863",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r871",
      "r874",
      "r875",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r896",
      "r980"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r334",
      "r735",
      "r805",
      "r831",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r850",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r860",
      "r861",
      "r862",
      "r863",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r871",
      "r874",
      "r875",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r896",
      "r980"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1002",
      "r1014",
      "r1024",
      "r1050"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "asth_StockAwardsAndUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "StockAwardsAndUnitsMember",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationShareBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock awards",
        "label": "Stock Awards And Units [Member]",
        "documentation": "Stock Awards And Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued in business combination",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares for business acquisition (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170",
      "r204"
     ]
    },
    "asth_StockIssuedDuringPeriodSharesMerger": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "StockIssuedDuringPeriodSharesMerger",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Holdback shares not issued to former shareholders (in shares)",
        "label": "Stock Issued During Period, Shares, Merger",
        "documentation": "Number of shares of stock issued during the period pursuant to merger."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares purchased by related party (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r169",
      "r170",
      "r204",
      "r807",
      "r896",
      "r919"
     ]
    },
    "asth_StockIssuedDuringPeriodSharesNoncontrollingInterest": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "StockIssuedDuringPeriodSharesNoncontrollingInterest",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of shares by noncontrolling interest (in shares)",
        "label": "Stock Issued During Period, Shares, Noncontrolling Interest",
        "documentation": "Stock Issued During Period, Shares, Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancellation of restricted stock awards (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r169",
      "r170",
      "r204"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for vesting of restricted stock awards (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r204"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for exercise of options and warrants (in shares)",
        "negatedTerseLabel": "Options exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r169",
      "r170",
      "r204",
      "r568"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares for business acquisition",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r46",
      "r204"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of treasury shares",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r169",
      "r170",
      "r204",
      "r820",
      "r896",
      "r919",
      "r989"
     ]
    },
    "asth_StockIssuedDuringPeriodValueNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "StockIssuedDuringPeriodValueNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of shares by non-controlling interest",
        "label": "Stock Issued During Period, Value, Noncontrolling Interest",
        "documentation": "Stock Issued During Period, Value, Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cancellation of restricted stock awards",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r169",
      "r170",
      "r204"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for vesting of restricted stock awards",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r169",
      "r170",
      "r204"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r169",
      "r170",
      "r204"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds for exercise of options and warrants",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r46",
      "r204"
     ]
    },
    "asth_StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for exercise of options and warrants (in shares)",
        "label": "Stock Issued During the Period Shares of Exercise of Option and Warrants",
        "documentation": "It represents number of share issued exercise of option and warrants during the period"
       }
      }
     },
     "auth_ref": []
    },
    "asth_StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for exercise of options and warrants",
        "label": "Stock Issued During the Period Value of Exercise of Option and Warrants",
        "documentation": "It represents value of stock issued during the period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Share buy back",
        "label": "Stock Repurchased During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r169",
      "r170",
      "r204",
      "r820",
      "r896",
      "r921",
      "r989"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Stockholders' equity attributable to parent",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r173",
      "r174",
      "r192",
      "r852",
      "r870",
      "r897",
      "r898",
      "r974",
      "r990",
      "r1122",
      "r1142",
      "r1211",
      "r1243"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Balance at beginning",
        "periodEndLabel": "Balance at ending",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115",
      "r127",
      "r251",
      "r252",
      "r278",
      "r299",
      "r300",
      "r301",
      "r303",
      "r309",
      "r418",
      "r419",
      "r519",
      "r593",
      "r594",
      "r595",
      "r619",
      "r620",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r649",
      "r660",
      "r661",
      "r665",
      "r688",
      "r800",
      "r801",
      "r818",
      "r852",
      "r870",
      "r897",
      "r898",
      "r923",
      "r989",
      "r1122",
      "r1142",
      "r1211",
      "r1243"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders\u2019 equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mezzanine and Stockholders\u2019 Equity (Deficit)",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r290",
      "r502",
      "r504",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r516",
      "r519",
      "r648",
      "r899",
      "r901",
      "r924"
     ]
    },
    "asth_StockholdersEquityTransferOfCommonControlEntities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "StockholdersEquityTransferOfCommonControlEntities",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Transfer of common control entities",
        "label": "Stockholders' Equity, Transfer Of Common Control Entities",
        "documentation": "Stockholders' Equity, Transfer Of Common Control Entities"
       }
      }
     },
     "auth_ref": []
    },
    "asth_SubcontractorIpaRiskPoolPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SubcontractorIpaRiskPoolPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Subcontractor IPA payable",
        "label": "Subcontractor IPA Risk Pool Payable",
        "documentation": "Represents the amount of subcontractor IPA risk pool payable current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r682",
      "r973"
     ]
    },
    "us-gaap_SubordinatedDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubordinatedDebtMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subordinated Debt",
        "label": "Subordinated Debt [Member]",
        "documentation": "This element represents domestic or foreign subordinated debt. Subordinated debt has a lower priority of repayment in liquidation of the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SubordinatedLoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SubordinatedLoanAgreementMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subordinated Loan Agreement",
        "label": "Subordinated Loan Agreement [Member]",
        "documentation": "Subordinated Loan Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsegmentsAxis",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsegments [Axis]",
        "label": "Subsegments [Axis]",
        "documentation": "Information by business subsegments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsegmentsDomain",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsegments [Domain]",
        "label": "Subsegments [Domain]",
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r699"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r699"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r699"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r699"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r699"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r698",
      "r700"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "documentation": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_SummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "documentation": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_SunnyVillageCareCenterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "SunnyVillageCareCenterMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sunny Village Care Center",
        "label": "Sunny Village Care Center [Member]",
        "documentation": "Sunny Village Care Center"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of cash flow information",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current period",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails": {
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior periods",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "asth_Tag2PromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "Tag2PromissoryNoteMember",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tag-2 Promissory Note",
        "label": "Tag-2 Promissory Note [Member]",
        "documentation": "Tag-2 Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "asth_Tag6MedicalInvestmentGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "Tag6MedicalInvestmentGroupLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesScheduleofEquityMethodInvestmentsDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tag-6 Medical Investment Group, LLC*",
        "label": "Tag-6 Medical Investment Group, LLC [Member]",
        "documentation": "Tag-6 Medical Investment Group, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_Tag8MedicalInvestmentGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "Tag8MedicalInvestmentGroupLLCMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tag-8 Medical Investment Group, LLC \u2014 related party",
        "label": "Tag-8 Medical Investment Group, LLC [Member]",
        "documentation": "Tag-8 Medical Investment Group, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_TaxImpactFromDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "TaxImpactFromDividends",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax impact from dividends",
        "label": "Tax Impact From Dividends",
        "documentation": "Tax Impact From Dividends"
       }
      }
     },
     "auth_ref": []
    },
    "asth_TaxImpactFromInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "TaxImpactFromInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax impact from investments",
        "label": "Tax Impact From Investments",
        "documentation": "Tax Impact From Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAccretionOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityAccretionOfDividends",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends",
        "label": "Temporary Equity, Accretion of Dividends",
        "documentation": "Value of accretion of temporary equity during the period due to unpaid dividends."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Temporary equity, carrying amount, beginning balance",
        "periodEndLabel": "Temporary equity, carrying amount, ending balance",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r291",
      "r416",
      "r659"
     ]
    },
    "asth_TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (\u201cAPC\u201d)",
        "label": "Temporary Equity (Deficit), Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "documentation": "Temporary Equity (Deficit), Carrying Amount, Including Portion Attributable to Noncontrolling Interests"
       }
      }
     },
     "auth_ref": []
    },
    "asth_TemporaryEquityDividendsImpact": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "TemporaryEquityDividendsImpact",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax impact from APC dividends to APC Shareholders",
        "label": "Temporary Equity, Dividends Impact",
        "documentation": "Temporary Equity, Dividends Impact"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityNetIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (loss) income",
        "label": "Temporary Equity, Net Income",
        "documentation": "The portion of net income or loss attributable to temporary equity interest."
       }
      }
     },
     "auth_ref": []
    },
    "asth_TemporaryEquityPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "TemporaryEquityPolicyPolicyTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Mezzanine Equity",
        "label": "Temporary Equity, Policy [Policy Text Block]",
        "documentation": "Temporary Equity, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "asth_TemporaryEquityTaxImpactOnAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "TemporaryEquityTaxImpactOnAcquisition",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax impact of acquisition",
        "label": "Temporary Equity, Tax Impact on Acquisition",
        "documentation": "Temporary Equity, Tax Impact on Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "asth_TemporaryEquityTransferOfCommonControlEntities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "TemporaryEquityTransferOfCommonControlEntities",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Transfer of common control entities",
        "label": "Temporary Equity, Transfer Of Common Control Entities",
        "documentation": "Temporary Equity, Transfer Of Common Control Entities"
       }
      }
     },
     "auth_ref": []
    },
    "asth_TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "TermLoanMember",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditScheduleofCreditFacilityInformationDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan",
        "label": "Term Loan [Member]",
        "documentation": "Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ThirdPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ThirdPartyMember",
     "presentation": [
      "http://www.apollomed.net/role/SegmentsScheduleofInformationaboutourSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Party",
        "label": "Third Party [Member]",
        "documentation": "Third Party"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ThirdWayHealthIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ThirdWayHealthIncMember",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Way Health, Inc",
        "label": "Third Way Health, Inc [Member]",
        "documentation": "Third Way Health, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1133",
      "r1217"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TrademarksAndTradeNamesMember",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetAdditionalInformationDetails",
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tradename/trademarks",
        "label": "Trademarks and Trade Names [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TrademarksMember",
     "presentation": [
      "http://www.apollomed.net/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks",
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.apollomed.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r497",
      "r515",
      "r647",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r773",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1136",
      "r1137",
      "r1138",
      "r1139"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails",
      "http://www.apollomed.net/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, common, shares (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.apollomed.net/role/MezzanineandStockholdersEquityDeficitAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of treasury shares (in shares)",
        "terseLabel": "Purchase of treasury shares (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r170",
      "r204"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFMEZZANINEANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of treasury shares",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r97",
      "r204"
     ]
    },
    "asth_TruistBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "TruistBankMember",
     "presentation": [
      "http://www.apollomed.net/role/CommitmentsandContingenciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Truist Bank",
        "label": "Truist Bank [Member]",
        "documentation": "Truist Bank"
       }
      }
     },
     "auth_ref": []
    },
    "asth_UnamortizedDeferredFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "UnamortizedDeferredFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred financing costs",
        "label": "Unamortized Deferred Financing Costs",
        "documentation": "Unamortized Deferred Financing Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "asth_UniversalCareIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "UniversalCareIncMember",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Universal Care Inc",
        "label": "Universal Care Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_UnrealizedGainLossFromInvestmentInEquitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "UnrealizedGainLossFromInvestmentInEquitySecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized loss on investments",
        "label": "Unrealized (Gain) Loss From Investment In Equity Securities",
        "documentation": "Unrealized (Gain) Loss From Investment In Equity Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossOnDerivatives",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized (gain) loss on interest rate swaps",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r890",
      "r891",
      "r892",
      "r893",
      "r912"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized loss on investments",
        "label": "Unrealized Gain (Loss) on Investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r238",
      "r239",
      "r242",
      "r243"
     ]
    },
    "asth_VOMGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "VOMGMember",
     "presentation": [
      "http://www.apollomed.net/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetailsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VOMG",
        "label": "VOMG [Member]",
        "documentation": "VOMG"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ValleyOaksMedicalGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "ValleyOaksMedicalGroupMember",
     "presentation": [
      "http://www.apollomed.net/role/BusinessCombinationsAssetAcquisitionsandGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valley Oaks Medical Group",
        "label": "Valley Oaks Medical Group [Member]",
        "documentation": "Valley Oaks Medical Group"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance, increase (decrease)",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEs"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Variable Interest Entities (VIEs)",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss."
       }
      }
     },
     "auth_ref": [
      "r213"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r635",
      "r638",
      "r639",
      "r715",
      "r716",
      "r717"
     ]
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.apollomed.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "asth_VariableInterestEntityNumberOfPhysicians": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "VariableInterestEntityNumberOfPhysicians",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of physicians",
        "label": "Variable Interest Entity, Number Of Physicians",
        "documentation": "Variable Interest Entity, Number Of Physicians"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityOwnershipPercentage",
     "presentation": [
      "http://www.apollomed.net/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Voting rights held (more than)",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.apollomed.net/role/VariableInterestEntitiesVIEsEliminatedUponConsolidationIncludedInAccompanyingConsolidatedBalanceSheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Primary Beneficiary",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r634",
      "r635",
      "r638",
      "r639"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditCreditFacilityDetails",
      "http://www.apollomed.net/role/CreditFacilityBankLoansandLinesofCreditLinesofCreditDetails",
      "http://www.apollomed.net/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "asth_WarrantIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.apollomed.net/20231231",
     "localname": "WarrantIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.apollomed.net/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant issued during period value stock options exercised",
        "label": "Warrant Issued During Period Value Stock Options Exercised",
        "documentation": "Warrant Issued During Period Value Stock Options Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r977",
      "r978",
      "r981",
      "r982",
      "r983",
      "r986"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.apollomed.net/role/InvestmentsinOtherEntitiesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of warrant",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1210"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "calculation": {
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to weighted average shares of common stock (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails",
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average shares of common stock outstanding - diluted (in shares)",
        "totalLabel": "Weighted average shares of common stock outstanding \u2013 diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r329"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.apollomed.net/role/EarningsPerShareBasicNetIncomelossPerShareisCalculatedUsingWeightedAverageNumberofSharesDetails",
      "http://www.apollomed.net/role/EarningsPerShareSummaryofSharesIncludedinDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average shares of common stock outstanding \u2013 basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r329"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "12",
   "Subparagraph": "(f)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481410/810-10-15-12"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "12",
   "Subparagraph": "(f)(2)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481410/810-10-15-12"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(f)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481047/942-405-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(2)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2C",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b),(d)",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "SubTopic": "470",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "835",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479359/835-30-S45-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)-(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-24"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2AA",
   "Subparagraph": "a",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-2AA"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a),(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.16)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r200": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r201": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r202": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r203": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r204": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r205": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r206": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r207": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r208": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r209": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r210": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r211": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38"
  },
  "r212": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r213": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r214": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23"
  },
  "r215": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r216": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r217": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r218": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r219": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r220": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r221": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r222": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r223": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r224": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r225": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r226": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r227": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r228": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r229": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r230": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r231": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r232": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r233": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(cc)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-5"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//323/tableOfContent"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-26"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "44",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-44"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "48",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-48"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "48",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-48"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "51",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-51"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-52"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-53"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "54",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-54"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//280/tableOfContent"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-30/tableOfContent"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//944-40/tableOfContent"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-15"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-16"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-4"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480602/954-210-50-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480292/954-405-50-2"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "720",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480409/954-720-50-4"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "323",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4CC",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CC"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-15"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-16"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>196
<FILENAME>0001628280-24-008024-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-008024-xbrl.zip
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MEZ2P/@JPIQUVH3D=M%" %4(C7OKPY"K$*@1&7,/^PQB)$7D-%!EY?HE42H5
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M>C!E09;:@7;QA$*9<G/VN('QKMD<%[6[DR!3$($5@:CA'*?C<C\X/Z]HE.%
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MS8LEU]':XHE]>(-E.W0_WX";D6^'-@].'TPGLKCUQ?>F)]YT%H74=N1J=,J
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M:1[_^0W>R'QS,C_G=]S)DBQ^Z,R=16% 3[3S)YKM FG@V>5.N.J;'Z+#L;8
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MR3KAL$#WYPD';;&SG.F>PY8G^O!Y6ZXM9E;44?N-^>#M.!Q## L#8G89MZ[
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MH;UB/UWFS -@+-B^.]LB3HLO@%1%/'%.ZY [-K_#AP+@ 8??,?@0.  6Q8(
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MXG+YV LEM(K5-)2N:_A48SH"^0K<2O5HOOR-G_X%R 441[8$QU(P+9Y.0CY
M9'$:)C[PV9.^$C!;@,-0,WK8",*)Q72,&R1P!LY #BOV7VP_YE]YX&?CKJ:2
M"!?.;X+_HM4@DHD9EM>-DEH\GFXPEQ(/Z397LOC/N(97)'GRA_L-D94D2)7
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MC;\^O7UW<MLP\/_<R,0LEQ10'3G WP%H1:L![QM3#/U_FSZ8*0UCB"Z&A:N
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M!$BFK:M5$@4E=,4<V5ZHM6,FC1^+3^2*"#@V90GC-HHK0^3W\L8^%YD[W:)
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M1Q%OR*WFM$[9<W-X^^AWK*W/SCR (19-!5Z)QV;SZ*D\0&R#WV'0XON5Z*J
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M$A4OQAVT^2GS]V +\\=\.JS";YL-UV(YU5E56F"-=,O(38YA9FYO6Y'#>W#
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M6M=EUPY;+6C[\2.EK;:@)\JHC0VB*J.'+D[+3F>T]2/@=@:U9K:B8\;<&>]
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MGW1![H/['CD"!B&N&5'94N6V70V;<]A=/[!VB"=E&IJZL" N[=MU&4!O6VC
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M'3WNF%N?DEKCI<JG%%5U9/-XC)P1_@>O1V1&M5HTRG<T\^*,/RM]H?$*KF<
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MI7UF)@ED[6],/W,R7>B) )T5S0"=>=0^Q;B(_>3U"$])#^#2&28F^;#3,,4
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M1^J5JF8.!0/A3.LTDHF(R0B))R"6DM!?\@Q*T6T/@MCM'.2;1DD81J!D-/_
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M.9JR>=A4?9<Z-,/$]!=%F&A:O/GJK"Q @%H7S*=#TI1$+Y"WIGR0[^"ZDC)
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M((<KSIL3L#]A<<UTS)+1O>R5;#W,Z71<-@!J#F0)S;2#+G?0'2=/00!VPOM
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M; (Z1Z$NN.5!PBL&(;FMX%S.2%X&\),!:9EF99/%^0I4&L(O?PE'4+<N5TZ
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MR%3,>MKLI 0G6WT9[,_4V^[4W>92GKKOZ!B@0H4\V&B[[19&]XN&HU/0^H)
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MMMG!T@LF3J*_)OU8V3JG:\%Z)]C']X\DXO\AS?^)@!NE0HQ2FK/TX5Z$'>9
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MINROAM<LEI24!NX8,\C-H@H%PQ*1GST (#:AQ.B+7T=T-Q)_HB]*PS(14D7
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MF++&9UL&74<P1H%^#SL$FM\E;2O_0S@U5944%0;]4-'$LP;U-:L4K_!"T/;
M<:&'?'@EBI@(P'!K.NGH^!<>!!/,4]Y#6C-116^3M*9*<HZ':#0YM/&\+'1_
M9I_OR'%8V UP'8R'=EZ=.+4/,@H58:14-UV2]#3OP&F$]MTR;RTTCW/?B=)I
MZH<H?<ZR$.)/%BE_C7"*V&B#GR>X0FJ#75"S/0(+^AVY6#U1TC>[]$I&L J5
MIG4Q8VVGX*FPW'B%B+0$(=1"I'^1SWJG5-JX5&?!G5@37H@\VGI[X9888B*G
M'",;A]"E8./8LFD,^5@.=Z(,</JT'#$-NBO4P6?52C]6!B-(3XLA=!32-,KJ
MER<5/'7T'/@$@<ZYJV\V2U]Z0IW&\"O"T,,;3;@57.T04<LVPO]/?\2[42OK
MFAF>ET-YV"$>J7X/6,)+)' .(B\)(5,8L=N2$=OJB9ZO31H\$YV9F%;44OL6
M)BR!^Q5G-%Z#D"OE_>KZ\81*K"@I,B[X$'-6Y-@;,,AC<4C)3(2P+P'F&DK%
M/PWSS"CYE7E4!P>(KC,C58#&NB19;L?T=['Q3:L9 D*!G2GY+F-SAZ1\^U4D
M/VSZQ)RU8;4!8S*+/>M>EU=;$K?U_^E1CC@IN4_ES/3+*%-?"W_4\[='X]@M
MG0TU*B+"E'"=X$D99S +T%;V.S-Y0!0B#T<57C&,9';27TG;WB!,+NE0Y+4?
M)^4ZZUQ(Z*G(JT[HC\&/&6FTF$'8/IIVD4]"G(RW?QM[L2ET)2/KFIC.B# H
MX>F:5I#9LZ*IURL=H,2TO(\%LQH03]@^*-OOHB6R*'+Z83LO6D^/Y_P1*8#A
MZ0""<J\]YOF2XX XLF4VBQQE_0)!7M=5F8?0@<0A&4!>B8(WY!J%:35F/K:Q
MU7%O/(>5:L=\2$7Y,E6:YJ]0,D*!%+;"1>4CO.B$\1Y[7,:,L'S0UP7_  )9
MQ6'4%G!$M+YD4"V],S@(8N\J>=75PW;@:\6L<B@:WWP9G,#\HA/_WI)]X+J5
M$49?-8*-P9K:Q C6<;F^PUHD/(M2=61B!H[.C-H I+(R-"OR%:_+?4N&>.M6
M^VD'E*"8@H?GYH[RI#UM)$MQL9EP2/(S3K-,UJ-1</&.A).)</&+VH,M9B^O
M*]2 G14Q<A!QY7AKXO'%!=II-WX#(1/R8KTFE12R'7GH^DC:#=A9I3N"&*HO
MOF.0IM5)B1R8RBHV]NJ;VG<XB14QM^8\A6X<CQ7&A#HS"0BD>YA[>XY <NC$
M6>P@:3E*[:X4X>ZFV]>&-KRA-,'QQ/+0J8(DN$3.E(':91!B"HJ^Q+M61-N7
MDE3>>N>N45+C'C+5HO2ASZ 9# 6Q*'/"X!VGF0@VA55<9RQI%R: #5[MG3'V
M#*C+Z-#9[MG-131\]'\O&P&A*"XODKY7,T0JVB-,9$K9R-+")-7T]$)W?"&Z
M8LP&IR?:ER_?Z<Q:'TTA0*^H54([73?T;$]S9Y9R-+UL0CD<.]7XX))6@@1S
MGAR8*2OA#_M\OI:C.RLMKA 0N+W=NS9/$T*_UQ(J.BI X$&2+H:E$MUWY/:%
M4X/31*:DZ)@YV)-VFS%A"%/UMIN<U_[H;ST?"#)5'-&3]4A:&71-FIODW+$4
M],M /BXZJ#[W)64T=<FDXI&2V^UX<[[8=+H.(T\=80+YB$YXDOM4@/GNB=QP
MST(8"L-LD5KF/]I+?UO@EL.+_EN,H/XCPE,0L*7\?@AJS1E@?;1AM#BD=L&^
MM9G;XIJ#]9=:@L.9!?F,Q<(<VO[H:$'Q\LEIG^U^$%LAK,AB "732VM]29(Q
M/72$C]Y]$GM7^/:%[X.OL_#]A89;H.BB;-U,@XUJ?L(%2'IFD_1C)Q"IC60(
MS0Z#8)'Q-;!B:K1C=T;[*K!B4?151L_!+!6#:;P=4HUD$>*2(QBC\+X=PW-I
M">.Z,%,JSZTHAIJIY)3#E3*.]J?\I&@662O[BDI0^ \FFRZW52!_TVCZG+9
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MN)0? E.9V*'Y('=7:&EO&#690%D,4X6J>Z9);(.H4HI6E=&(/9Z0('9]0JM
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M,Q_6#+Q[>!*2=L,]2R8N6N2S$VFL"+\YSRY4H1 G)CT=^:-HVMD*%@R^.3C
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MOW3XX*%&>S95"ID_E@5,G_LI.]<(+^*3A=I4UG1F*[X0TA=:0S'/2T'JYLB
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M.J\6S;I14 <Q;RF?291U2[A@H\Y/@J!KXX(##W"X6TZ@O+D[J*<R2Y+H947
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MP(-!R>?5@,=&N?E5:>#9D4U!H[2!9[;=IP6"R0DFV@WPQX3SB,][>.(7<)4
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M4A]79-P22*""(QK$X94?\#%9ZI$5/R<05"K/I)(S"M2/F2MX+#H$?XR'KA?
M$CXZ"5[$CQHXA]$2+#Q,HI06N"ID?-*#]O6':\T 4BWM*]^L5KS/G%'7XT,O
M@ 4H4Q$/26"U<R<,?5@;YJOD]HW.+X7QR"3"$!1Q%#A$MK, _U",QJ [G5![
M8_;R@:W$]167JEY%^AP1C:/POK? TX;D/IR*H>'9 4XCH($><XVA6$!L#5M#
MXZW.(QZQL,\P#\9=5MT4*R;MC__\N1K[VJ:+OEC+7;20&AD"I*,F2 @#V #
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M35,?#@Z<!M;@M;QXO3(Z^R>2-.4@-:E5';.I'S!M$?B/3HCMU^"C-%XBZ_G
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M!:\%H#PZ-D#KR8(W+Q:!_^S,8<7N4FNW1AK T\7T7%I3JR,_9U?5TK[3"^R
M62$#KUV;$ZS"F;/0G%!;!/#( #"C36)RX $*G^YN-.9-*' -J_YR?Z,].=&,
MEGKKSP'/]%B'+VQA@6"R7!=7/PU9I(V7?'-XOZEY@.D5 ,,R$$6M:I#@GDSW
MC3TR+V9K]R8N[IJ\.=["#QT<8_@N8*Z%2'O_Y$RBF0C4JC<*!=-.;['&H$OB
M:/TM"MQ0]K'@7)E)W5P02/EWEIPJ+H CKL= J3^NK2DL]IWE/EG+$&T7E3:
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M$WCU!+YWF2?P9P)WP.:6@_Y/ 4W/F#M1$FC2M!D+F5_EW/7\F..G57Z86D[
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MB..UV6_0Z4=:63(K",'FF  5;0I69+QW5 ;P(GA[C $$(%W05O" C++"$$.
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M?SK%!TB?<<P\-G7(L4PMBNQ)Q,0)Y0$KV=!/GC@?;DYTU1/=89U.='=__)G
MG?<D@3#![?S/_QB:QN#])H^2$D?0,\4@_: P]+G1J2SD&,IZ\L2I)=QZ0Y%*
M>*#%?YN@&3[!/$3,B)+OXD^*Q-I)RJ,WC*=2Z/ZC[$<M -P&SF^HA;$]TW.<
M/'$F:!=A4"AV"1B6M]0<D"]VA&K*VZ]@B)]1D 3! S?+=3'1:PJ;07WF^=XU
MF%]Q$/ J8V$%VOZ#1[IQ%QARX8+W\PA%YJPC";O9OD<YF_Q*@.PZ?.KHKG4*
MGZ'HVSBP9R@:K=0?<J(95ZFZB(-GK 0IPX'"Y[$; TYFS/X1H@VL8?8H/V?%
M-]RB+ >0*V"P<%_IFAZ*PSDA I+.]"\X\)#M RJ,@N^9/J"EWNZ!34ZY6=!M
MKZ3#F:M^6L?8Q7X=95/FS-%;E9?79L99N2/&@%W# G-&S,J:^!(4RV(*TL8/
M4,R%-CP?>6#L/];40<,:S.QIS4T.JK]GVS%\*F['4%9P[-J+HJ )Q75A%PH1
MGUZ)-ZP2ED7Z*CG* :FW0[ZHV5&#%'G7;8,"7-,UH]B SNJ^1 &'A^D_OMU-
M-GBQF5+ 4<[D__[%&0^M<7_0M]L#V^A.>VPT8-:H;]BV90^&;-3[?X/^7\II
MW17SV#U[(#7],3GUNF,!@!<>#)YS#?CH9P8+]3C9<1'J!(#U/V,PNW@F/A!+
M)VMBC-F#Y?%I'_R<D&'2!_[%"0]L&_$=47C(81B2,>6$="$\]Q;3I.YXP"'4
M^<=?9)HAFD+TS0</GX'W<Y:2:V"8=86A:5K90D&*..$1V23PKN3]/$4++2"!
M59DV*1)4+*QB<%W\?WHWY]F6]H5J#^BVF&?)9>_%2"&E@LN'YQ^!C[7 <+3"
M.*!5%BP\O6<<AX"K$-\4,I!+&*$4P4?O.KU,*+R6]A$@/\?$:,>C!_(DC+$?
M1W36)&& J1)3%G#E (\T-/)4S/?T?[/]_A?2G OI8_\LED&_&N]Y  AO--O:
MM;Q',$ERD3A_3FUG%$D) X41?,$1$@/Y@[4%'[4AIS\P%&X\+X;+OA$!(;9@
M:W/-:%__G<A+6KTDHY*MOD3#GTFT(%]I$G2<KE.SQDQ^J8&,^:Z6/6A2*/#:
M'DS_ EI)$IB!OE889[Q,F&J#9N-EST*]=594^BYWF2^IR< V<7QK,H1$I7\
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M]]I__L?0-,SWVL1!53PAV@:R2]YGA6$\7_!95BB%N87L>^JPM_\*-?;LA,0
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M<Y!KUNHO/NQ+B\B]#KA[W5H[BZ&4B#./<;QT8L31E ?M%A9F 5;PX'[N>'Z
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MCU)$AVQ"A.Z_6%1;#;$4! LX>Z:"A9:"D%G?_RE9CM+1'>\H]OP%;-I9=LZ
M0'3[$C&)M-N[U F#-3JAD%QVIC]._2KMRM961;Z+Q$86&4;&PMR&C%':3BXK
M\GFS6S!/P5UUJ'FS',, =_5RK\B13@Y_!X"WOR/9;F8(R0H4%R.W4<!HF+Y
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MMVX^P4=MR <O L/< )'!9=\8IODB-WWT@2.-]O7?N74,;C;*3I*D\,7<XKG
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MAW>T6YWV6\UE(<8$+2[D$$\+1LBBOY^3<\20C[P'$V?YVD['GH3[#SQ8NX\
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MD+  3,F)EILX*,] M@J7G;E)'ABO0#5[WKAJ>W)5S=UO<M5E>A;18;LUV#7
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MN=F?4Y$A181(X 2G8'$-KC3ZF,"5Q$I@7,^=>)Y[1!VTD!IU1R&. $6YBII
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M YE1KRQ':#$@*@M_P2LI&,K+SOC.@/I [%V)2S,/XZNH2J;0KO38$?3XAZ=
M2@5XP*;HW67S/4DC/>'/ E)DZ2 NZ(B<'*J8-R%#^I"'$ZN$0)9!F+PQ<<42
M9Y>7)5#%8>KU)GFL^0/]O 'O/U'NOE41I.WIC"7EG[=I=DL=7+%_,"(>[@&
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M0C8*;_,C)-6<+J$'.7/L3\")]9.DJYU=1<D!!A-1Z+[FWTLG::2>[?3%V':
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M9DXMY)!3Y1#[ !RB4PYIMU7-D(5#&M*KCN5@O0M^D#CAC5 "* +]G8AX1=;
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M.80Q7KEJO7T8$16C!L*(T(4UIDS%R++>F;C*:K6MQJQ65+$E1-*:..(&2%I
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MJ$*8ID+' "A5F7B1\L,;38GRIU7GQU<2/;YX$9D_1W2M>)#<W7^<-[&S!S(
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M\?Y+O3>W#/C^G)]Q4-DNW:9#1E4QZFA@RSJJ8S=L4&Q$Y2,XI<\<M)4MVKV
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MGI @]F"W,9:*GCDD#Y('R7/\Y&G2#EN54\7.D@]PE%P73I*J&H"CM;J&034
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M]\FNJ?;,204973#XA7=P^,*H-#,$IB(#VJVNK=KNHOC&29;'C:9U%OUNX.0
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M.V"?:98$R=<(ID.7[=4%DZ%!Z-%R)4@206-?'/B-G?>H8#=L]^=-D5.^>X3
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M2B4X^0$P*E>>>MUJ/%>3P6!<(^RUR:>H;^,&/7+15"Z/U>A<&[V-<E<;@KB
M0K,('Q?_IUA\]#PZ+2H6L )\(HM&XQ+=;X[7C(^!50E_PD;Q'\$@R@;E!+X$
M$MM,-?X>-Z/2EET5A!<.XA!G_MAHM0+&:(0)^@I^X?@\A''BZG^@3_%70!WV
MAB]>W2S^QZ_N\A]20 7<[N6'S[CN/\.$_:/[W1-6>NCW\KL[T@PO*?Y#B&6H
M]G^%D^EK0[#!9VW\ZK?"\N:=P,]NLE#\/2&J"PZ3TWX10$*@RW*B"$'A<\NO
MK)9&G O1<9H62  A^H="5#'!J WUDYG"ECML8C0 ,D)&<1>$!=!DG_Q8XE$A
MCHJR!W\Z00!T@O]!%P)UY%#91)OZ<MLNI.!3MYH?]>IN,S'C,XY+:\C:]]L(
MQ$X!/TX*8E.P@W=(X3,#T;>7[PQ$;7IC,L2CXC-?Y5;-BWZ-TSXV$0%P76?I
M"+U>I!@WO$J_X]?KMY<55,%;OW:4 .Q?@*?KF8>N_]7K67X'^!LE"2ZJ48NA
MT>L0RHWAM#G*4K@ET"-9Z.-9\-7RRBC1#,WP)LG7!6$!EQ AL\&+J#!(\2]D
M$3JDR%]BA1,L$B%?G$RB@J0_XAM*GH'UBE)R:3$C/O55C=,8T1.$V1!CY<S)
MS<4EZ(P Y2A"7[G.1$5MOW8:=*/#E7^"5T3_H7N5MUR06.=G4=ZA=3&36(/+
M&H)/[RXN?_.OQ?=*U7A&:C)@S?,63_U[.=A,COL]FKNV7S;R0"M[3WR3S-'D
M0RV9K=M_&!9A>YC!3Y.*Z]?55%P;8)Y"0+JP<9$;_8 <J$T>46OGSW\M4R'Y
M^*T?L"7*K'CW"OTI;0!;+\7&8Z@]J_CBR#%J]+*%V\NI8HC^4@GF-N93_#S)
M%,<_I#?9HZ=%S(_0]QHC] <K1.AQ _=MLMT]?83LBN8[)$%P;-*Z'G\+/KBZ
MAQWJ!';M^O@'\$PT\ 3P% -I3F1"$_7K8+UA7.^>=M=4O:8/#4Q77Q?[@R0O
M0L=_[ TZT986Q7C!X+RE/T@SLC&;(7R:DLSB*\;2'3!'PX%X%] >C<*;!# B
M&H!B3=ZAEA?K^8_V\Z#Z>9<"OZ_H>I2_L,.<1\2<"R.4M5_'^*E:Z*,:HR%3
M9C<ZF!BPI(,OT[+044;@$>2F,]^%DWX)\I;0!1]&#F*^ X3 %("V?F$,@O;Y
MJ*O6N;Z11_H^A?6=FY!@558W*:3E9I4PZT$W7ZJS_/ /8_*+0NB8?9BB()[;
M5B!)+I4(AW5A.:DL;OX*&&#DD:7\DW%(Z4Y6=QUY*G&KGG7A9HG@]G0^#CEK
MT2A$%YP<C+'8>#" %L (5?/2"DQFC1/4RCPN['DTW9BY]J<T,?'%#DQMVLXJ
MKW+#_D[0;+[C>4YN@/:S3ZC5J?5NV[=B&!#A.E84G3*9&W<8TT.94&3E!"_&
MPD?\BK99JN?!)D>1?K 58(*0R?*P:] T7J7:\+^&QQB_*EP ,A__N$Y>&QE*
MM ?-W(K95#5ZQ)?Q;'OFU3PKIPK:NW&*'K#T+JDF$G&T3K*RD#-S9,+/%&K.
MH?GPV<NAH878 TCAB#@%R8#>,'=).,DO ,P*G=J4I)M,2=]9NMDK!XFOM5O^
MPG'+S_''HVN=_,:BL2P3_9D7]FDU8^( >=4$OU+B-')"0SJ);)X//<I\QJ!=
MDWU5%,I\9YG 1C+^%6791V(*%SKE;5OCIA6L859G$ODXS)*DAAZ'.FFBFN+"
MN$3&$.Q4IT%IES$8U7&@*-G "CR7N5KV0\YRBJX #*-A2;[N:#*!1S/@'LQK
MYZU'OAB%WDC@+[Q?FB[KK ML$".6R -Q9WV5J%%$&[V(8\P:N+913O0L.ZF
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M!( MR7'QGOL]A:/83QA)*A\&;6^IV?;)P"9GD-O&C9MU3 #3B11&UBC-'-
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M*0/#* ]O;I"B"[*%>= #:=R6G?1GVF8-BME4LA?"&>(U_(FB$"@G)A\\Q9)
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M=Y_^S@_PS@]:!]WNFN72=MI+'V721)29.J6=Z=2$NKVG1]W#O?.C7JM[5O?
M[[3H'W'E3Q]UZ1W!E9^V3L\.=U?^*%?^]/[]WO'>^>%AZ^ST:&<W46D[0?P[
M7:F2]78P+8)A6F(.G=[Q+FBP-@ ]'_+? /44@PJM@]/CUO%Q74%]4%AA#5>]
MV0' ';'OB'T%8C_8 &H_16KO@KCO-KC&=]2^H_8=M:^+VC? ?C_;.S\Y.6B=
M=>NJ_3;2.ED@OU"5R9HZL'\>C-6PC)4I 'HS^Q#^.\WT+>1O9F;:DNXQ/Z=&
MZ&!_4\OSEJY-'X?8-N3?U$"">L91)1H6;'I#-W0W?#V0$9 WZI>%M$RV]4]3
ME6$"N*ZA3I2I'5MN["J/G-^62J2#WO&ZZFM676I!T<]!\TN^HQ+I\'!ME4CK
MVA1\<;!X4[M*I.^L1/KIBD*6*3CZZ8"RJRO:J+JBC;,4KJE4^>(AH>M5%,;-
M-@[^OW\\90A_!\<EX-A;(QP;;?G-@^9<DS6AJ9NU>)27YEXS6FO=2ZZ-CM\U
M!FB[9XVB[MYY]ZBS^?GJ3W,Y__C1"2 ;*C'>S*7P113:<-QG2H3'ZR7"WM[Y
MP6GGP664S>BV?72V.7KLYD%J54P]62^F'@"F'G;JA1H_[@)W# >O\72]UW@(
M4K_;,'GL)V4X/X\I>/E=@KWAN,^4SL[62V?8(F&_LZZTC:VGLUW6_*9Z)[89
M5#^/6?;VITG$_TYJ^!DM@A\(JIWN#3K!V?YZ=0+LUM+K/#CAXUGIWG[.R#:D
M99@6TVM]^7'G:(FW-PS:0 "U#SH-*138W1P7 $;Q0[:\++Q^5WG.HRR[^_^@
MEOTICL1QDDZV<'[JPN2<>O9-NDP"CM,(G^:LV[_](5B1RC<W3>?LK'.R?[)J
MEL[)0>=TC:DU!^M*K3E>,2'F439U<K*X7_!Z$D@6_NQL2Q-P_ %P/RCUYJ=+
MK]BU!/[^U)V?QP,Y/[3XE,D#/X,=TUVO'7.R=WYPW-G_T9D#VV_A['#\\7"\
MMUX</\460#L<WZ7&6/GU;N=M^Z$4?+!>"C[;.S_L/IR"GXNW;8>OZ\;7P[7B
MZ^$^=O39X>L"[W!UQM9*]83768K3U6;7<9@4%\GPW=]E-*4AU"",![-ZU>!A
MPV3;P^ZS&?7W>Y@,6X&&"H^5-#!IP7N+[7/*_DXCXG$N?99%.-<2O;!Y$<C'
M25H Q4XS(%KRI88X\I*'@"=Y! H:>VK'X2V.\@MPIO(H B:@]*B^.!JIW<CL
M549F=RO0>G8CLX\:1V8?SQ\U22QD.\A),P>B'V5Y0Y1( 7P0JS!7XS0&\IK@
M7$L]MQYKDJM$&&,8*!P,RDG)H0Q#B@@=FLP[P7+N_] 'G>"M^S40J9G+.\U@
M ]&49M&F/"(X!SF+&V_C(8*)*L;I,(#M\(!99^BLIN-;.SPZS'.%@V_#Y :/
M1(75'K@!?(-V]*T]CH: ,:_P#GM[Y\4X4[H5%7*-A=+H['AI<?0G;?%WX#1>
M3P'<Q*MAF=V!)9FKQ$JI ]Q*!"NU$SS[#"M,JURI$_S>>%%T3P)U'H0<5D!)
M4Z@M)/,Q_!;^+:##(<P&CIG"4=;(R1@MX L!OY[K6X=^FBMO0YWMDSD?<&J\
M2D+0]B1L-PVCC$$[&,.N6:@@$))<D<Q):.+QL!/\.060YZ )(J@R54298@HS
M>&GEEPX +DU!,DU[ K =,E;3JC):O273YF=FX1N<JP[[H.G042Y4#E]$3&-Z
MYG:H1]A[<V(Q@LG38>^=6;Z2VO8>@/E7&)?JX^A]A%".PO@J 20M"6%8>;/4
M</A,M#,\=D#G#CX ,969G<%KP! X<-@^NOG2,,)\9(X6V:.Q=@94@"@7YF.>
MRX[_0)%T"]1#Z#R*AB4\FLWH.Q12P&4*:H8!" Q@^*HD$*Z _"(,HK?\P>IQ
M"L=Q/FH98L&X/G\RX '-^ V@UU"3-;V?>0#QOB#M XAYBC8NG-RTD7B AOH%
M4YY>**6>NW$4]J.8-M7A&<P@/&<HCFX1!PR/G0.@&'A%-(I8I=7CU(5L\0P$
M95S-(]E^&-..\[%2(@M\1;BO IXA#[@X0H3DS;2"(:"EI#201,#I\ C3F>P3
MN;K=7^5$P*-*0>6Y,",0^6 +PBG(B6\DR)W=X(GAC3/8;)@%R(I!#A6X;YZ4
M3:D8[J,:/(P1\BL0M/R2NZ@8FP'W<JI($C)D+/W?)9!/,=M"464YQP4C-E['
MYP+.%H)2$;Q)X7^"%TB-O?W7[R\^OZ%_=E^_;/[]93JDP>,D#_1C%Y\OS5.G
MO?W6C\F66H*OS@%!(U]]TO0H!W((,0V]%F)MC+@'E :ZKD/[HK$B3MH/'18B
M2)^A)DQG'&K-!+4WT?,<$F(ECW\"+!4("">B#T 1@&=Y,: I8( 1L(H<G\U
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M 6*4X$>U=2-0I$ G:07]LJ D8LIP2N.6+9;FMRG0OSXW/8J;O%%@SE.88ZA
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MXFA+6\%K36Z:@>60P?JZA"G?U3 ]<=F "=[(Q/$=/WY,^./XJV":IACAPCR
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M MFF*!/L$4JINSI=8>)NU\19W=P2S!;L!'7;$+%PE]ZV0GK;X7-.;Y-08T,
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MAM^0B)HJX:=F_-[UA^L/9G*AQW6L1+#ENCPCG@8@(\07#W\^F9,(!?NAS#/
MDX]F]N5;A7,0J%/*QQ$<'U#29$(=[^^=IS+DN:J4<A$JW&;F5=-(_9BD%6(&
M.N"0" UI%3#GL-CAFZ9,C6:N4*2^C#K[#&=8ASK3&;"/I Z<20U"ZEZCFZC#
M>_L\+HE[G^NA"U?80YV'V#B=T74FN!3.<%>;IA]J*P3[F@,Q3:(29X6.X&?
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M(;<P1J=H;L+.+KWJK!I*$3#]!@%"QLM@'.]Y[CDX@619)?)R!9+A+Z*?D \
MNW>Z$KE,)%+/P2Z:9D'1(Z-=>=I$FYL$FQ1);HREVSOWT3D;2Z(S24'RZ" A
MF;P;  M'QO3(999R=6[4"=Y'S%N,KH0^5JN2L289I3:O2?J[6W60);^8[E0S
MRT'<,H.7B'95JU]DO\WVD=:5E4[4[-EE2S::[&6J82#1J,S61>*W9 :.V 98
MMQV/D$YMTB7@=!?:U>(ZZUO6'Z2SS08XI#N+0F")/ %1OU8<>I.TL'XK7L-5
M$3CX/%2"^S7_CMT3$X]I_T!8$0V"*8!D$@X:'Z&F=SI!RP,5AU:](%PT07U"
M>7XVITTEMY<;<1"^T'^)LU*&H9N]Y.54-_Z*Q;M8Y)YC$J6$4+[NT%O??H;L
M1<<2/4>A)$T)5,)X0.+%6A^+4A^;UFDV.!Z"0DO9&*XR'/R6WB$?;DG&I=F\
MT3<(5?+2W %H"-2JS1A_U896#D,BO8-25#2#F*=RDOSRBC0,6%LZ_\GAN$[G
M^'DLTP@LDZI!>4T4U/?LQ:\)SKH7'B^$O(U:P:^:8ULO/:I[DH+J* (M)XG.
M$0R4.CA5Y*2B64TA=?$3%_(PG#6YM74G*KITFHBEL7MB<_=(H97D-K@KV&-J
M4D8-H0TQ+]3(.;K0IJ4P[D02*9,[=C<C7GE):1H2=]1R.,K9V-=%,DX2$>,2
MZY/6VQX63DO!!..ONO&8M&,,3/NUL6K:JGC7W;P4$HLO6S6%29GZ'*,5686?
MYCV8RAMOMU&N9TMHO-],Q%W1+_['KQA4N+BZ?G.]O4D"ME$]'^<#AS\Q&-<<
M JN(#_B3G1RZF33%V<0+V)38' *=#6_ F,/:+1,L X0&-.=8OXYZ^QE)=V'=
M1C4QX$FM1S5S8V_K)D#GG$9S4B<##25&I1$X=\&I5/LXAR.[@1P__9029]JZ
M)3<]71;M=*0_\D]EWF]MY#8*0,K)NT(C)D<I<VUCDV\(D-?2'E9'G0D+3>*G
MW[(,[[(A'QIU,+@BZ:-+OW0V[F0H5/;+8HHD%+W5 :)YG9-25)'8>(TVQ<Z]
M4')P,[/S[I;T$LG\-LA%58'P83Z:B8N"=NMD):([),S9RV>:KZ(!5# 7T]*G
ML7:K"1"&D48DDBM^#,G2&-(T/&/(B;U14L_>YK=IEDD3LL%0A+?;.A G>9_<
MBC&S?2J?B$!R7#J7YZ-9]5%97HLCS)'GP#-YC6+EX4$E0.Q H[&-.[] EN1G
MFY5&UJ7@XFXK V>P6;%[WXV7LOB [A BDV- HE"+?$9[=NHC'B<#<N(C45F6
M<UUF.<XEGY>:9U(FE0U/.!A0176N;HF5S.2A*@DZH 4!_LS!>THW$D\0AJ"Y
MO['LAEFGQRTE<\)3XQOR"76"L MIK%DM:BRQDDQE[ 1^#\&:<HRKA%)G=7.8
MB$6'&AY0RH"$E2I5OY:] JN<*HN^N]#S2J'GX^<>>CYH##T?+@P]=_>;8\_=
M+8D](^TQ9=J,*=>+Z;1Y1P8F[O_^S&H*=VD9#P.JJ'<>)&Z*UA9E@&*<0SMH
MC$0&5HCR($,3;."J2\9T,0WG+S0[0^NOJ&@5X@Q@HI?0;9H95D@O=QNN.V$Y
M,D@\?D[#352#!U[,\SE*C:O1&\>G:$V=X!U/DQ:EAYRT(C11]K4"VG+HS%G0
M[%QW-W#F#O!MP>&4,1'=8HW0C#R8Z? $UA+$WM-<Z"8AJ0P-2630CO0S\6/Z
M.9Y4>4<PU1F5-#.CD\C/6?5&+8;% @G*[3-U[LE>)'"Z6(D16\)8XT)@%(IQ
M($/H>G_ -,!LX2B?V"@3 I<5.5P<M4*: 7BKO)>\MF:UJU+:A]T-H5>AC^,/
MS4I:!A+]H\\![_L.YSP:Q2DB%8@Q^]I$69$D+HS^HL<J2M8LKH:;?H$OUX5E
MS8]JDZ,3O/?&'"S*8N380\&DSKRBH'L.-1OJ*ZEDI*""-E#G;$%R3^G!"+1]
MJE>R#B.955;19O 'DJ.BKY6=@2E=7X.F*I^(HJ(IQ#XE-F*:1%(21F;7G7_=
M#>NZS[E'0=NL@HWD;1)7UN):O5.O<[PX)SZI24B#*QLK]MY]P_1:->1BO8^C
MSV1=<1[G-;F*/H[$ZOP3>/%[KNL.N<+/)@9^(G![S>B!7@>OAB70D9UQ>PR2
M]6"_5OU'[C5;0DNS6U*W,!Y8J;H-:595]881_R5 15Y#&AZ%]0AA[E'# E2B
M>W.!3O>'=^+??N7:^&>5\M6PYKNL6 ?FEB7Q^3G=;F^9VUWA+FL7,PHC*4+2
M=%*9:/0,@7JP/,D@^@UA[U0!4E#H,ZN#V64W[(T&W0^U*CN75PS*,F'S7H8H
MR.2\C$8K81K[(!0;E\G"E.H,5=]$^76UK4G-H>SI.+QC>6"7R=2-.+MRJI#4
MH4[Q2@KG_;,#2LA;A8E#;L[XEXQ<W)J^,/I&\4^[/.[);3!54(@YO 6,TJ>0
M;_E)P2NB<;^MSV9ZL9>><% MC,&3L>[+T46!J.,7=N>:.K_DBW$J '3IA?:\
MT.0/N$0*2Z)N4W$PF?P&KX6R*&0AH<R_B=*TO*U(<W1JB&\34X/".)80DD:6
M14YDK$1#>1!<R' @^.<;QY/L^@*MV'"<CKJD2ROS]G/'6U9I"#6GETO!>8D^
M,+80S2YRK4L.X0X7!6@I14Q'^KAJT*LRETH0%K\V"*L];J J#D()L9<)!TG%
MWC1F%[S L;RD]Y[-G/&S.G, 9AO%O,.G6E+#5YDO[IIZ ^0VB2 TQ0_-$#G@
M4B;Y"#8:@[ HM(=:@$1/$YB,]5;1+ALL8@XZT),2,N\W-<.1)@/5Y+HHKP/5
M)#71*$X3NZY%K3O!_VAC2%P#=5:!DD/W&PBDU4#7UX"25%H]V ""&*88B<U(
M],)G%1>JC#5O5J;IXBA;J&ISX.O9B8 V@H=;->U#AS'JWN"Y)L@<;\9*PY_.
MSIJG/RTY>.B='I5Z(8'E+^&W58="'1_NG1^>=D[G3X5RB$K#W>18$(SKUIY7
M7KY,X\OOK,#2[@QZJR)G114#>QOJMU@Q\NPT6GZO%,8)X?P;>;!ECV%[EU)W
MIXD,D:,F&*0'F)"@$)R)T&+!:)2GV:SE-10IL$:#"E(D$SHCCXT["!/PN[UT
M!T<4(M<7\V:B-M7.RX1).L(D).ZL6;+? 35'?9J"2<,V<:AQ6F(E"*K7W,##
M%!? 0S<9\C@G(QU!9]79G M#16D=1=^4WPRK94M-^)=.;(R]HGIIW+-N/6)[
MI+BINIQ-0FX4+1-U-Q(\0LZW@*F[VEN, K7@+3I;ICY&]!7 ] :SO N;&L!P
MI@'/IE5*F"-@!*B.RSL<C".%3,G)4"PR=$O7X51W 1//EH8JYL!>NI[Q"?N=
M<VW*EIO]Y3AB)?N++L,7Q%I#E&)[T^N/ZM8Y/5T043>S=1QBN+[I7>I8."8P
MN86:HV>@Z"'I?DJVSK\@SL_3TVMQ8^[76"-C6Z7%XUE8_:1J$^E)D9;%M*PZ
M8/G7Y'^U*CTA$%^CX+U3[=/4;0L_0_2]IYT2(V9B6F4W;7].(R;.ZL 0";58
M&#;;&4X1NT$^067L!96GK57>R>V23<<GV+#)QM,]\?107'IQW:U-^\V=#?.+
MFF/&\T_.Z2 1$X^[OD2*5&[<T; KLZ"3,;*%Y'+I)=J1)M:(A6Z?*SMT61M/
ME!I8:6W$_:>\Q J38^!('T_R2./+,.% (J=2,8_D>R44<TG<D)0N>\". =2-
MZM)!3K.7*+E- 8>KR0DULK9[UGX!R4@CL##?]*LPAZ7)$CW8)Z<:;W1. F;4
MG&C1"/L)3AR5_"-.B!>!X*68DO/.IQQ#.%CU1:"-"M-'2M_=B^CE+@5BM12(
MD^>> G'8F )QM#@%HMX>FC[N;4D*!)=R#6V=%UJNM]PO2(2&-ELI;; 6^7:D
MR9"U6O8],BDB_W@1 :T1"<HTXKPAV=G0JBN"%$4*<J%[W4-M"^5-DTB^1^TA
MSQ^S7-U[@ 2#MW\,>+2C;^UQ- 0">(6NB"/J$BH@0L@M'M.\WVT*X$CXY0N^
MOC'"<I=F0[A*ZP$YWCO'\C$0A%1B5HVWM##^/]8)]3-MA.A4$_17A1E(H67T
M= ,MM\UNID-.\T2/+@_UI$<(2)<BM,O$ZD%88A7E4M;(>AIZL#D\M+BEIUN>
M8\XA*MY-&5%*A._U0DFN6QKAY^E4RG/5-\5E]E1P_8T-2I!T@SC-'157CN/D
MZC0V$K+@:=[YABIQ*SIXWBM%550R)F=[RPN<&30NV]0?26>J:L]ZKQ>^5WY.
M#0L3B?=A[MG-O%$<9G#-' O0Z>%A?$GM]"ZA3JZ\UDV6EE-6%-%5(\:[:+PZ
MW;T^G[7F(S*!G, 'A_&D>NGMY@14E(\.:=OCRK78D&#N$/LE_D1SYXFPQ =1
M:Y0U9]Z/9SA[,W_<RB=[""Q-:,ACQSX%$A!G0J5,"';7C(,1;);W%')QOSA
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M_ 4WRSC?J'&[60;<\ TS?._?B4G'Q>WS']'0M&.1LN6YK" /7HCUB>+_EGQ
M+TGY<%KK$P8T G&.D;R%2@';F9*9C&->=-F,9V :C&P: 6)-\;Q29@=H'Y?
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M93DAL23L/^)F;HW4D!; J@<\*JBI\*M$3DQ1YEMN-8H(G3$5F5E7]FP1X,N
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MVCW+%P_WSH_V:Z&R?VBY?)L2]R;+6[3\OZ[>S3F_K=6:R/PT&=P#NG.50VF
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M!>1RW=Y@Y<\D_,63N,J"7Z/N@E^6"IJ8)W$=59@=)S?5PN[?BF@T]Q5[D.W
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MBXCN91<ES-F/?KP] ,NY(&GP(9T?KC660L - \SU!P+Y"UH+@9X5#B;SV"[
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M\*9.& 7.(ZT9!3ZX,R5>>9M%;N-6"-57YH\-XG^,:;^3-31Z5"XO>OF^:>]
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MOL9@;(B:=D8!< ZL@TW?-H%E#L:6J)K<Y'T;F'S%?-@T _.56[GM6+F4K$F
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M"7ONPH,A4Y"4E;:-VBG..B !QB6GE+_Q,$YX/T^$+0\ZDN]1'0!8E5 ;'$1
MQ0F4G%-N>@)4VZ[1<ACZN"0+K.DI6+ &XU.8,+9[WC+CQ;YMQM-)'Z?<"74J
M8G,I[6A5Y]*2NB]-(\0&D#?)HR457YH>_A"K7Q0D.]=@T9*]ZJ9G, )GL)\O
MTG:80_-!%@RN4U#_T)D5\NY%T9EVLG-%M^ '&C,;\* ZNB]VY'E^- %X*+?J
M/O&X;)\XIB 14 !9/*IB.-$>]R9#53-TU1X71!1Q-I5'/WJUT0\'F!2CZN.Q
MJEL%\G ;$CB4$;1[R/R?"W?)=F,*AU.*L#2&\/U%F)5VR])Q!PJ&XH5QT (#
MI#$GB/?@_IVS/7RWW@1K/Q3[0>SG=+F9Q=N=>X(=Z7VS[8F[PR$_.O;V?T+"
M:A NW#7>&<=/\8C;7@!XE)F0!T#&ES-WEY^?^/K"HH4_^^P],9Y$<!^__1L+
M,,CG/&[32&[TU)*#/Z89?3TO?/^3HU6(D[1@V%M7][4D1D4*&H/!.2D(3IXV
MZFL%%"PBWJM5X#NAQ%M?Z6 YF!W[ML2\C1GQ :MD1 IM[S2T1U4HC[DDCOOW
M5I?(V,I;-2U-M<T"^V@KMG#W-RN$^;:JZPDQ5W&2QJ#2-.NI'70R5<VV5<LN
M,&/WR.;=;&XP#U#>5RMA-SC2G?[D!]L$@OMY'6-W2)FG!\\CP?^_^D]\_UPS
M.73;::HV5:@I\FE[,M'?',(<O#%WYW(^>1(G6U+I0CK^?E"][@-ZV4G5!H%N
MDWUEC4S5*&BC?HIY: S*#@ U./SA0?-P1Y<T5V\'8')$O9WWF<9CEEF^MW>#
M%UVJ3(_15YJIT[.MR$-R"<N"$87_X$7%J%<=+?AO*"QC@590O6<X*JBR,ASE
MJ_<0DF[H<4KZC8=K].S;).5O*'IQB_9.*[KDHIK+9P\-1\RLP"2I#F[;'9-0
ME [^.>"LK=@LOLA0"@FA_(+?;S.O#/HTSKLJ2@ZK+!3+3IQN&2(-X%1CW=]>
M<CQSB\4>D^QQ;M=MP&<(L 99=6$Z[DVLP4 =%.7P;TV>TH1?2BS"0C3!$R])
MN>TP2UGYE)2S6^F-7&H/,")>A+E$E [X$CN^:QZZ18T4GWJ*C_B$J42?9/7*
M\L!H+'RPE1>S]"3=>1>SH%5A:AU'@][$\_<N83:9>+ZAXD*4L5M,QC<G(ZQ]
M,B*=+IJ5%U;S\J(L0GAY>3'"0(UZ&8F1-;F3Y$6L%OU$L3F^4I02+&+SR3+%
M.8ZXG017@O9?*BO&XB.GF2=B=H\H1\[S@9V?[FJS4GA8ARX77)70<=_XT26H
MC(*R2&MM%-S.>%*ULZR/![".=,3"(3R(PQ?7R [&,>P @*H\]W'[YT[QDI*Y
MT\D:1^!-30B"%=4P:IY*Z$X'N7.::5<"))J*%Y^FY_D!W.L$+I:FHPIME$Q(
M2=*XZ^8'XOP-[@"LT1".I8\RV] A(X?*: ,5YLQ%!2F.P5#9;%Y05Q52R\>3
M>G%) "H%Y^!)PXR2=7CY[HQVM821\B,CFE!^N;-XHX!N2P<=W$0C98PBE?87
M>3D]+)*7?(R3!;\'-P9VCDYZR>%8D)FPL*)E!9T VQT4QC 2T8J!C9V=DJP,
MCG+?XV&+4D&+RX8OHNB)ZRG?V3I*CI?89<;<3HY RK;+=A"HRGM:22)74ZP7
MP^63'_P5 5\YAC>R>I/!@0X;E<\]&%I)8E)[IHXQK+)L@WI"M\VSQQ!8/]^$
M*IE]5;/?$L+T0.BL"T[ ?3IB;16U)G%F(">%V?]QM5[Z_+SD9V^VF?+#9+1@
M^0!!ZHHRLS_]/CS5FC_)^L@]6?(X;AXH@B74!5R!#C&CH3%<0CQ"AH(L<*DL
M?#**)#^,)=/H\\&'R5G,[1KO##\^;2MVDQ%^*&FS&F5'W>Q5'1F5(ZX26BSW
MA2C]LCUU2A]G: "S$('XZH?Q#4TO.XR_W3/AW'B_M3NJFT"C1J(G*M:9H$YE
M)=4\]M5WJ#3M;TYP'WS'1 %>U6/[T(()CE'## 8%@C8I\*!F#:T"?R[-(LZQ
M"/VEN"H!U@WF]M(L1N_.G;]6" +5-!3*"@FV15^,![B,!968*NB+8F(?M;_R
M=D^66==]LHQV1PHW38PD/>;8/@_3!9MMENQ^_E'HON\@2=PIV\-$RZ4_I=_N
MYW\D+3CX25S::RK861KGMI Z8=10WZWMF7EBSY!*O,-#0M'^9:M$IRDJQ?UY
ME%27$M%397]U")'70!ZR:-&7\[6H*ED8^F@(Q*?A\5F)R(=GIW7_GD-\\!3,
M<TK[ADG,/XD1)+DC,)A'YB4-8)P9L 1F>)/\B*>:""K,N*.)X=.S>>/;<[&8
MLN*).NX)A7ZA)_@;6+19^.N[FLE(8L%B848]70$Z2V<=LG?Q+^]G;@@4?WGG
M>@0 NNF]>+Z0@"@V=_JYT@OYUUMY .J:9()H)"_>++[NPU=_R7]NZ?V1.2S\
M:M#7*GYN&<4OV7?'OD%I1M_2QG)0QPU*MPX^BAK^"D@4]/ N:M6=7*:-<M<5
MM-;FJO9"+:1S&^#$ _]=<-)$ 4,PTZNY#F5.OJP;]$/9O]O7^@W-77_#<]>J
M\,C>)N<'IHWY4:WJ-_\];7X<L?*EDTY#HNR>O<W>,R0<*%T@Y'_L$J^AR1_;
MWOXRLZ[6LSI[M-#8]8:$>\-FQ=[/1V[K'A<',%(>$!X24(?C?+1*I/R=9>'P
MJTH+N%>*2I:3+'<RRUF783DZ.C$<YX]-2):3+'?E+&=?AN5,S$DR1^W7<I7-
M:G'"L4MF]1_%>X,G&=@[TR_TN?1JY"L4-EWGN^%E^ Y+G Q4W:K->,4P/YM&
MD[ Z#E:CR\ *4WUTU1CDSWI)6%T#K,:7@176JU%U.[\K?AE4E=@"\081#)3M
M!^%U776&J&.\!=XF;OE!R4ZT1WI@#_="$4FQ^6@ HF?^!K<RR?*5GEQ=TER/
M!-<N([]'8&WJZJ#@!'LM-Z_6JK8[[B)Y6?)RJ35V&6;&YLBVJA4DFDIFELPL
MF?DT9M8OP<Q8YVQBJT.SMF=U85XF]^,OE(J7SF].EQ;I0O[HW[U4;N.>[-!E
MW-8@RODBHJ58IM_"X:IN>**O6OVKLA-W1Z4$?_6I:!Z;\4,PY%6EO\>TX*]^
M]-\LVB8,5\VDQWID$T,O*!++:9 ^?>:&1."IH.Q#)L?4QR97CL(7CLUN'/C;
M>61XJL+U9ZF3+\7ITX8^>#4:\:1J*CU&'^%U6KXEY6P38.&[%*GP:/CVB%[,
M,[S\\]&'RUI33.=^)S$H3HP_)<6]>'$H 4F\YA8/X;G1RP^4/OE<=BH7=G0N
M^P43UW>3RS,M #/YWJ('.)O%>>E)SON["ECI1+:U:?5'>K4<XKV9OUK?;E\Z
MLAQ4A4'IYMD2M]N??[HG%9/.BUQ_]FWQ[/\9&P6WW"B@8UEQ=WF%VLM+TJ1(
M\P=;.:X'DZ"_[N A:)1MG"7]_8,%*_KE%SH-\.M;)=WMXV/ L'T9$>,S$,D%
MA3NEO^@<,">2Z\6'0G=()>10/.SXV;QV92TZ[O7@TDY<,\<OY*O>1BZ_L**S
M/FND_)?C;;#UKO!4]XJ"0[OR!=3H^JY\\?'VLQ6O%(N3*KSP513,KU9^ 8L.
M3T;66!W5SS@JQG@;P[]O((Q[)>'8?=4Z,HREGY&M8FM)&$NQ"4D69"$_80(?
M^*;YEC&=Y::&%%QK@;<G/)B//2%D'LI1]5 958GUG3*\T>;6CPD1VA0B'.\M
MV?U*N2Y2IK9I;E6V#DIZW#4H3!./B9REPKT!:DQ0T%3V,M+S+1PNB.U\44[J
M)(/^"M-L3^L85)=9J#95^-GC&T85JI=CR>,);1'H[UN2C2MSO,]A^6KU+-^P
M$@ /6[\5P#F6X.P:.,5ZR>61RU/?+NIP_#-NEG*:9=3=4.<O39M&F*KPF1K6
M\$:/7,7P?<ITWD:L92J7T\<<J(EF%M>2S6U:=2GR<IT(:Z'Y$V/O2 NH ((:
M.;"C?&'Q[L?_KA.%IRE2N3PM$!*'3U$U'LG*"0?*_2P/:FEZ;V(4E(Z6,:US
MVVY3+*2[Q+YCHB4-ID8&F%.,/9S?6*BK<8.N)CM]VG8)NO5F'W%->(N@XO#7
M,?:?T9OHFJ7:!74.CK?_I O; M%^)ONO+B0KFX,F'LKK6[8,>W4$E#+L)9='
MAKUR:7_ITM^U$_^.2K;L$"@K&E9FZ[,"-0N;,IFJ;C9\F+Q\R5N:,E@/LJWC
M\N8J;^;FWU%6/6!SFFU--M3LWL0P^X.FTF7:SJ15[J\RETY ]M@3LJW,4M2&
ME*4XN'26HA3CUR_&#XKO"^<W:J/>Q"SH.MM">7W"8;73'-4C[D]-=*=V27JF
MISY=CJXSHWM+'KA(/*%J#&?RP(OK 4DOO,'=0ER^4[WP,2@+VU9-[55*NK7$
MR#\_=%O'\<T6:;LB4^XR'OD_>'DGV@"BVE,_?/RHAJ.N#\#]&?6-VMM '>+C
M$YSUH^?3"42_DL.^!ZTI]7.D'W],03(=T]M2V6T7]N.E$G@#2N 4?[X&/Z48
M)^O/:T4.O:Z?P:$_GUR_DGJ</(&<2MR]%/0GWBFF*7JNZZJ2+9?WS *V3>]'
MX:=T+^==-_;GO-/,*T[):,.<3& J3;4+-C9X7=505> 'JCOWB2U?U+C>X6ZI
MQ*F_6OD>7W95>5ZXTP7>N%EB(J#K*>O !\:;42569PU__80A1?#$BL57];+,
MTV*:D5BI0;*T'+)0,>=S3.-*5 2%BI/2+SXINS<9% C7>%)9%/05K)89\S.L
M+1CCH4)B'Y@[\%>'Y[_/UQB?M];(?CNMW*O@A^6+&#_R3YRLW=K)CF"RHWY!
M* 0+_G*Q0"(\2H$@5&9935&N*$XB&TKAMM(-VP)8?:- -)P*$I3/+9VM@8ZV
MT=?-LZ%$YV*&%_EV8P-1>4*IAVHD:V)LK8O*%;U;<9BAHL VM.*3#EN!7;&H
M>1=I@ W"^P4RN88F[B(9,!>_GR^#E9!A5L6&YZP76_):D>(OY447^)S-P9>8
M8>U]?._,G<_!!_"F3'E@T3-C7J$5R1]#]H3B>QG1H<S 7*1AX:=40H5_E#5#
M^LJQ];=;ZV.5+(_G9]TJ44V&+TVN1#]]>T.$FCMNL%VQ^!GB]DH@V<*C7-CN
M56WG/5]PL+H&??D!:/()2)+-($AK..S,K/>-?/L$M8[]TOII6]0TPLY[A+NR
MH'-=$5+=G<EM4FZSW9UK=TG(!<.V;Z07WGJSG4_^#I@I[9]@V!Q&K@<>X&T4
M?XC#Z6);A8UHZX%P*NBVK3B"'(GY6.Y/'-V/(1=-A[\%:6G!,B3<JR$F5'YZ
M+_X%!4QLR[#V0VI"\H[ZU@#G;+LQ_&=VP40L<K"]Q7D(_>4FVG]+KHCWA599
MT^P=,J=^+I+,IC4(H9N'@#E_WCAS&.T[9_GLO(08+DT#%U KGFX;\/I]DR_7
MY_PC%X#C1>\,.V&"HN5+F#^-AJ3EVW"$#:EV>1 _-GM[[^(L6HZH3K0!,;2^
M-=";Z2-A]?7AX3X2%VANT>2@C%&U)W5O4*.SM0$9M[YE0<ZX&!QC7)S8P:&K
MY  +E/Q8=/G(6E6.(5 S_6..[K+7&AH6[]7R;#;JKX8*Z^A&,^7S?R,$C!T@
M17A G([D!]V@(Z2@)Z3PAB*-=5JY%N))]%T(?6\A]?KOL0_(FW,>V^NDSG&T
M3J:V'9U,H)^M \K'?VW &?_L@?;>4&6W>W"P@Q\+QQ-!IZ1/YXG9U\:P-[&,
ML6H7A-J:3G=[@T@Z,4YYILWXX]%T6O1RU)L,];Z5WPZ12'I]F61W5R:-,8\<
M95)^CU4BZ5(RZ4PY,V>62>8 D^SZ6CY5HI[9U\%R@7\5NXTGL5#Y?-L'],HB
M<W@QD7FH(\81$M/4 .6C@:KK#>G>ALZ]7@=<#HK%X87$8@.[S296;#7ZXWP6
MC\3,N43,J+,BQ@!'T=948Y0_WB?A<E81,^JPB#%)Q-CY?.8W%W7C)QB;\%\Z
M ?6J=9@O:7WQI3E=-&(W5'L _FK^$,<Q7>1EG]+NF5]9R)PF&[&NW;AOY*MX
M2\R<3<A<SOZJ*V3P&)0U4DT]KTNED+E. ZP)(3,"(3/LCV7\:_(I;H[Q9@)@
M7;+!DM4Y74)B(2E+'1<HU-,$I/10VVZ%I3I9G"0=K0%(1[MOY>UV"9@K-,'J
MRQA+ZTUL2]7MICR]MPB9;AEAM64,UL[1^W9)V'1/(5JK4B':5]OHKNLLR)&U
M<F1OP0W8R7X\ON#L\75^BRM;78F0WJ?6QYW--[*,WF2H&:H^*O&2+U,U^AK0
M=&+.T;B3.4>6"4;BH#]N5R[&%:&IJFPR!MV5319@21^JAI&O"2#1=$'9E,54
M=V03;CI9_4%)9NV>"II[3^NWMKY+J@8"+[<2[JE\$&*A,+9:+_T7!J_'(B/L
M)YMNL&Q &%=5Q+I:S FPN Z5F\!".3"P)ZR9 [294>F D)>#$4]]=I=+!1=,
M\6&=% <K=+D^U4HX6.X"JTPUA2GZ@9L)2?G"XBK(S\#4(?-2:!GV)K['E!4,
M;;%;OP$)5C*%YMCB]"F,>I.YOPEX99W<'%Q/<:93N(D.RSZ[T8)*6$0L6(6\
MGH6/Y8V63KRLJ>I'V:(^>-L^:+GA3N6D;>W.I1]B[1]@H#]9%)=?*J_SV5>J
M52Z*=OF 5:^9:AA=35ZSQON3UT2M523ZON4C6*Q3AZHY\V\Y_J02M%ER#F)B
M.F&T.",E[TB$/\)7]U[JG'AEDMJ#_2G'ATB*M/0W48:<:=%9'=9QW2TE4W>K
MB$4+!T-K5S2JW"*?7F_+.%,IR==(X;.U?2E\-2IQ9;'?,8+L39O>+=+U_3 ;
M[.$!LC("-O4?/3!T9JAF>3&^""9$OQZX;QWX#U32!E[ZP*BM\73ALJ>X2!VO
MZ%G"%ESLJ2)"!F^$J[<S(VL&GXP<EJLJ6K'"8>6"H3O0:;!.9,5T#"H?F0)*
MQ<J1-E4T[Q?4_CZQBJAA70==3"KW?*"D9O7*HH9]':2AZN<%<GA/H?!65N.D
M)QY?-O"?3D 2.U])KGN^Z*$*9X#Z6W 4G\5TP6/ BO/*PTO&<F<_UVZP=^M"
M[RNWH 5$[7\RC@+&"Y56M$W+ZAG<+9TPO)^+Q;D/_L!9ICI'9:$]=W^RV<V_
M6> 7JE.[\:9VC0X/7&#/+XB6[#*AOWW^=AFS"U50B'U?]>V4&1P]L^63\,$/
MEX95,R[B=A3U6X#LJU%=SUF)F3M7FKFZ:!QA#X5\XE>B-+8>R24[:!RBHB#&
M65M-V. 'CP]4[2YJ+E&_MP06&2FR]BN!)]?(2- K(49IU?SAH/%&$ECRH@TS
MPWYE6N',CNP'<+R,Z2OWG(>N3((,]1()DDC3K2"MTE!!K4HP?=QVBAE(L?WF
M:"QLC]))8.C<?KLCE8A@C0+FB!P-_#7<!"^Q"/\E9$SYZD=,T72%)+C^GO[5
M!^^_L'__V_' \*('D<Q<^,L9"T(AZA5NL=/EVOM?^WE+LL!JQ@F[#R/GP1[:
MT\%PJIESBXV'S!G;VG3J3(<C-K;^1Q^ #BJWM<76V WFQ;RSS-@^%85R;RSS
M%<I%%YO:X(URR.9_5BO,#8A<N1'Y0[?>+ DX3ET6?G!#C'AO@J)2VT.SH-3V
MT,R7VDZ]@!8Z\XJ]31L/%1D6KREZNUZU\G%K?*<_V.-FZ40^\,X7)XI8$+;2
M(SSH,_WN//,U#OAD*-#UB%MI7BQZO["9.Q6QK\? 6='E"^8LHP5]#+A@@;,$
M8PW_ FFT7K*?=%&X>?A?<)=1_;M8P7 =L(A>P>V@V.MZ8$N,H(%3%O'; 64B
M= PN&]B#L!P4<UL6#1;_=K'P.D;5*-Z&SP2139X"*642=AZ9FA1;>Q2WPI_^
M\HF">,LEBS^%)ZQ]C 6Z#CB,@>\]SGRXIJ_\<^'"(#P_?CTNO.N!P MPP OG
M"1N ,$]9.3.FBIELM[W"#1B]A3.8PK(_L#2UYAO,AQ7K@'P(US^YL.(TV0PI
M*8H(UL42_PT!4.X<J$5W)(/DBD.%.Z?+#9$%&YB$*E()EM'%7_F&+'P?(MN2
M,9I9?/P>_[BY ZH()(3]"F&#-U@X?GC5A>-;)KP/K@6/V[CAGS</8$ARP? (
MELR_!0^E@T NIC @5_.] =YM(<.PPO#ZP-9.0&H2/_GB> [Z<7\CR:C<(=/\
M(NRF#U_^=I?81!G9MP*R<%'Q(D0>F'>>N]JLE&<_^!-'"IH955(\*'P?#!CL
M4!=EHL<BA9'1E;SMQ]>/\<NR-TV=< &+<S-=.NX*FQK"=#CGBT_6W)!-WP4?
M@E4X#=R';;@,IP/3^/IQIQL2CL4)0P8W+5F(\C4>)@@8^@3L!L #T)/DN;CV
M%QX0X-()/EWY&WSO;,.X''+F<Q<D:<3"7T%D@81"4>D'(,C(AO4?EK%$[RO*
M;53>P)5;S1YE:M,C/G^[%1:SZ^4$-UP=LO3Z][NGYK\@UO8$9V#1,7$&J -B
M_<D%:Y[L-'0WPHQ*!]H Q3="&:R<EQVMQ1MA(62S*@KYZ=$)2/%D%E=XS/3:
M4'@T*U(XRSCM!Y;T.RK._<_&<7@^,1%NORE+G#:8 Y$+*A&'AU%#TN7;S* (
M: L*&^<>\HB=Z*B2S%QQ<<[( ,)@^=UU'@"%J"QIX()CL'/%!K?IXDW% %W4
MYX5H @:V.&6G)-N&Q&Q<WZ,E@E&N65^YA=5Q9@@1SG(1VAA(@>3!\R5U92=\
M;H* 9 [,I\V K&A-?\?@+@B8WQF9TKA,=R""W:B5DSLZ*0Y6&1;>#1>X>+!P
M3_Y4M$3ATUUNISNEZ7*A\R/8N* 9?G.\/PENCMA9ALLJA43UX?#PWMSO,/K[
M.:?T)V>*$'_YXOQ$#?2;'P3$%7?.&KZ)7JJ',"Q^_G-_#".6 0]@G\]=4J1W
M7[YS-F%!Y #>N:O!<\0.!_Q3H8O!;NB"SU")IZARTO[NPT.Y"D1"I%"7W+\7
MEZD@1]< >B=(2WHOHPEW-\1.0^\W$%@L0 .J 0"/+PE@3.<]$+54BP L@?N*
M:N-W-_;G6SF;@VSXB;QLE]LM^&_.$>$1"J[WG\!Q\3=H6C]R%QRWS #</*#@
MXVXT&$-\K>'2D!M+]$0/4;\$SMH$(85(7# R'L#5!^2(O%NP-]"M%E88OIXL
M' R@+!,2XY R01W< ??0VA*8!R^$1+>_6<YX1,3!,0%YX/7.[(GA^QF8<O
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M;T\YX*8I@6&+?CX7]&3PO4YU6!/]R0.:XA3HO4YU5@L3, OZK!]JL5K:[ 2
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M:!:&!"9G"N.;D85!,P_8DCVAKL<O-K2_H#QN7+J"0X[,(,8\6"J4)&2> D'
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M  80-WMC[Q>XY($MG.5\WR!VJK'*\KKIX'2J>%W7R^ON"T#KQ0%H8^^*M$-
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M#(U[D[&I6GKMW5%I773?NFBU@2%MC)85&_B:JE I"PY4N;^#^.SVILL'-F<
MU)D2.3\3K+XH<JOE@AF\8DD^>U-_Q7XX/U/6S-<3&C0,!WC"4!^U.W-'PNE<
MB;Y-PTGK36S5JA^RE3LTU[1#LS<?6%4\%N%F_C2[OR]W;EJ6)URC]/)0Q^X@
M \-HM:\LX?2:F<1UX&0@G/1AN],-6Z)B_A+A\9TD8@T$P]5SO8U#%"OX!"[<
MB=:8J%W6?NCB!>\"MH0KG]C[9W<6+6+ I.[BE'DWV-[B/(3^<A/MOR5%["E
M@@6OCWL=QZ3IYDZ(/_5SD42QULXCNWD(F//GC3.'T;YSEL_.2XA$3TUJY7KQ
MTVT#7K]O\BLG>(1+*7*C9R4#'LEUYR_\(]>; 6W>&3;%SO@H'P)<Z/R(=U8U
MX9V!=:/W#GP]N#$/#@Z#=E1Y+EEKBCK!^BR==<C>Q;^\C\'H>D1ENNF]>)@
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M^;L>-C 0ZM$)T"=A%&)%PM2WRDZQ>\<C8?<6FV9<#@%]N<V5LF?A,XR;X*<
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M+U%8XD!=@9(" @>^YCG5W<BB)LKP=A"NQV4ISH3PRV9X8B1U?"V=33W#O.<
MRP'(K&J955TFOKN= 7Q,\O2;($1A*O2K5:&]1!&?[YOU>DDGKIRE<N>$"^43
MR;_/6V%9I]C]&?HP7"Q#NU[,K*U)2RU)>FH)DQ0;$<07:\<59X1%<4!1\&/&
M302FK*C,(#^]F&1#I;;RW]5AI$NSR[EBI9W)TMB>7Y@B&N8D):E>T^Z!<7FJ
MX:VD<5?*XHY/'E</Z?"3#:,KRDVY*I:H6/ZZ4RQ1N;IUM9,-I_,$G6X8CMIR
MVN>MI7[OUX;9JD R"[S)]$7!+O=>TG^]D#>L1C(991)X"T%S2B;CD:BQFTAJ
ME"G@-0Y&G4F<=C=)ZTSB]%L KKN[=I9;\Z. 'X:-'*5IC\U]O5AIW$BM#I91
M(P=H9(Y?9^)6;<_QHQ-@-_[\9H-5U7@55O\!*R/R@"7[.5U@@3^*:#84JKSR
M$'5GK(G[DH#D]=K3E35!B2+8.4=Y+QCHL_=1L,\G/\A&-%(V=M60QA@[Y:E:
M_7Q(Z;FUT#XMLSD:@QJ5/K_Y-PO\(I3I@]Z$VF'H[UL"L[?IZTF/[C5D<]J0
M/QC]T+7>Q!SE*X%+;Z]U.&K<VVL62'IO,FY-$3+I"9[1$WR;U4)EH=7V9A=>
M-A!1G&#X3_H#+-);&)7SR)0_D@YH)$T5+"XO4PQEBN';3C$\.F93;]ZMLN32
M'L&1W2FR'G L6X1H221+TK2BN.T<-J1(66Q&;S+J#XU<BPK1L^/R.9MM7\=!
MZ3KFVG"<8QTQ):AOVT>LXULH"W-DF*'>K%L%PQ/$2=JM:P:$5F]B] >#!H7)
M^4WG5JWB"<*D^56T<15-[7A1(CWL-['7>J2+\\$-J:F<\H<3[2_(U6%37,+]
M3<#]C-O+G0P]']["\#88[#G8Y;2:/Q.+$90BWUB $:XDY'RCI]05IJKU!ZVH
M]'^9-?G/LPG9J\/PX>V38@Q;KX!AS*#K6ZVHJGJ9-?G/ZXX.GVTS_ K31T[1
M) ><H*-Y<(P\V([\HR[ID3>9 -6\'FD P<:@-S'[X]J64"<1O$^+Y N"9<M]
M56K"6Y@(\<6)-@'\NZ\QKZ'G.O!6[/R;[TE]_,N[V?[WTP:FQ925Z[FKS4JD
M:*_%&01@M!D+%*#@S1278TE]P.-25LZ!]N^R;; L<'5LP:8VQMK^&R.P"O-P
MS$HZP>),.QSM2BO9B;_\WMC>SM4GY&2\C0*ZO84< Y#_9E43Z*@NRYTHTU&Q
M<DWE^;?6+JR<>&V6%2<^8(W%IR0_;-A7>.*/9[9\8E_@\8OJ13X, XM\C/7:
MM8RKKN6%3LM(7I2\6)$7"]VQ@SQ8P&9F;S+4\KU)6LAD;R%Q1Z<.0G)+[;S*
M"?V('\]^=9UD4>&I@E8^\JC0U8.K3-HFH"K #;98M=IRP.R->#NVW%!Z%3FZ
M"%CU=GD&9BVHAMF*8+T\[MY"2<IA58"<46]BU$]W:=?Y];;+TJ&T25]#EG[R
M-T%U43I&43HP1BTQ+Z11VC)1RE&5!XXY -XVVU)8^HU8I2-IE;Z*)'6?JANE
MI@9NFCHR6Y$#)8W2%DI20E4!<+#O8DM \T;.(?Q8L(!1ZSUIFIY;H-XBF4^7
MJ@8H/DT=ZVVQ-*2!VB*Q>@!;AVO9F69CM>R:M6!;<3SNJ(VXUI5&*1Q<DR4"
MA[P):YM]A!\^-N.;'TH E1KOW!JONI*SP'4PU)%4<F\15F5*KCJ<[-Y$ S1=
M\99A&YT*% _O%'>UWD14*)VW4)$1F[.(V[][,W&PA\T^_IS"I;?46[,ZLPRQ
M;7N#J8(R;M,AC!7*WOW8*H#/".!CM@4[;]+:Y>:M_P#CH6-IM2S<>HFR5\TK
M374K,,>]B3E01^.F[)-6)&<W9 I+_%63U9719PW0.+:'365AMBMIN<N6\W03
M!-@ ?>T'N![2<&Y84-]Q^E;G&&QPH-J#MA@YTD"^M-!-D%0 %MS,-*]L.[,S
M#6)^][W'FX@%JW*C^$B])L[9&T"$F;_!4_OQ+-[LD;+F"?1FI,D>S?35]Z:G
M*B>C-S%L51\U;,\UL*P7\C8D8TO&;H>94(>M3?32!D93&V*7Y>H]M912Y:$+
M_\[66LI_DBJQ(];5U'G0;NV'+E[S+F!+N/B)B4HXHO16ZD9!D<'V%N<!)K^)
M]M^2*]1Q(?AJJ8,%G*:IGSA>!)/[,'(>[*$]'0RGFCFWV'C(G+&M3:?.=#AB
M8^M_=#R7*>Y:)/D7:^>1W3P$S/GSAO+$WCG+9^<EQ-5,5S9RO9L=TN^C6GFU
M*/Z1Z\V J.\,FQ(_^/0> @11?JH':RQ=HDJ*/NAS_LS_K%:VZSM[Q.W//Q@%
M [Q'K.*V],--4%2FR[*XM +.8+/;*/[P)E>]2SPUS'-;FK8[?)9Z#3ZQZ$5Z
M1PJ#_5@PY<Y?P9M?0)JCG\![.F.#YZ0R4"B(A*V>G>D4Y"(5OGEVHX5R^_U.
MT4<#5<'<*7WP7A!42=:)/M?>*[^("\0-XN-?^TIZ"$(Y+%^4A1,J>[61&-#!
M'H^?OW[:A=!7JB-X/^=C0]D;+W^^C#]HI&>8:,B\1!D-4OBR>Y,(3Y3EE)$2
M) _?T@V&&;HAT=*?OU.T7Y4[)V#*-R>(/!:$[Q5=?/*!+4$T!R_O%<>;*8;X
M]*.'CR.R_O*=,>6K'S%%(XIK0-D/ .G 71.)_+GRVR:$-0S#+&GIXN'[L'A\
MU)EPILP#?U69ZL8KDGW8F_A> =$CO_*PAX/7&_9H+UJH7AY3YFX01LJ_-@ (
M%N B4G4]8 $'UBO<+"/\; K&A ,W\-4*<=)XK^OQT>"D _:X63H!\,\Z\)_<
M&:RIN&H7!M.%R^8I'D=2A/B(E?,G#.%YP?!I3RY[QF^+G@"WTHM1%,!(G]ER
M22/V%#:'+R)\LQB%@M82#M!9*E$ XFH-L/:F+WB)ZSVQ,/*#D"#OPYL"( ?:
MCBY<'49.Q)&_ 0D';UFXTT5Z.,H#L R#1X XH@$@H\5D94_.4HALI)^@F_AR
M.W=.8JIS6#31A$U"!N.&\7 ^P7J)XADTL3FL*4XC6CB1XLSG;!HI'L.Q3/T5
M4^'S32@(@B]U022 ',:L$%\!FVNA) _+D$(\U84Q3<5H$8^PLF+8_6.K++93
MZX@U0CS#IVE0P7+LT4,/X%, @;SX$T0J PVL@*7_#)1,P7%[-U^'OO+%\<"2
MBS$5YN[UD&=P%SE^^.XC.%^NP+'!E$H!FIV!;^]Y$.*8'< /7";6N5AFIY$!
MK^33%S#^.\@Y^.L[,@K<?@O3%C/:!33="RX-:!@AZ@ON+WI]0G=\@.='R9K-
M%)S<(W(= 3T11-W&9#+QC)9.\.!BO=/I1D#P8>,NB:$1."O$%OZQ@"??@#Q'
MIY>^H0_2(!&B,4 9 ;KC3T U2&W^+GP"6E>JPE9K_YD^4.DQ7%IR+ *% A]^
M2YZTCD=*EIFCA L8_TQYXH(=W@PJ$+04"%=<NBF' S<X^H #? 1XA["X,$FT
M\S8>O>EQXY+!IZ+T!;.A2$9F*15;)I^_W7)95OSU[=T]0:HI.\\)P<^*U782
M6(RU]@^0R]^1(M]=@(\3W,'O\$(@+A!T6EVICT&I/_MYE9Z75RC[V0M?#B7D
M;U<8S,E?H=^3'0?'$0-^X@H 3#O\SE&%[ENCC1Z%&<8&#>(\/H+R1^$"7ZRX
M5@$$P#!@Q?(VGUJ@2='DGH%YU0?CG8M$A$RT<#/07P= ^ #X#Q9E!7\0&X!R
M==9NQ%4M3@ ^_U-9^SY*T2CBQFLH$(PA @!=QQ57%OJQX9ZFE ,,&;GPQPW.
M&+Q*59DYD7,S0PGL9?E/\8-'QW/_S2F8$B_B@D*9 CP*BL7%9:6'X9*#^!=O
M%<+\P&M@*9:;&8O7](6N59456!7N3;AF:(%%\:?T0C#*ELOX2IAK\.1.46O$
M@,G@@SD!^I*)LIXS=@.(NA&W 2K=U<,F")E@DBV$^-M2TO(F5GG7B)V4>Y=&
MCT<)PX]H,,Q4+%(,<[J!?Y0I/!N#BGQ)9GBF S0!!?64]=*)D&@*J0VD_DNQ
M\1[XL% LPK6,V'3A 1$> ;T;$#:)I.%Z)65^.$LU>;NZM=+5U"-4K@,9%S(X
M0AH;>P1)%^,%@<H\+HXVA.'8F$FA'61*&O"J@C9'# 2"'TJG6/=QV;)V7E@0
MGB2_MJ/F@_;GT3.]A#&$)LAH=)#)\EOSG@'8FPUN!+,QW!J1\$*4@'C-S8K*
M2=_0KX".!7*"VT7DWI,B MJA[><4:!-._!1A*=Q!]F?  *B,W+AB!P<9&N15
M[#<%Z- "4=P9K#L\RUV!3D;]M]PC93*KR/ZU<=><DT!?\]>D1Q"DG\!"C%63
M(<V'(CR$[BW09\X]'DK+)5 $A2J2(_8]U$(94!0)HN@]MQ[(4>=&C; HF0-2
M@4C55_Y)IB =:8A!D+F!]!&0'@F\=/]$L\0-9C=HHKYDKX17)9''!% IV<\'
MG_@T 1A.CZ#"N&QS,A!D/]?,"\G%ITAB(OYXZG; WXY# SFS$G8P1E1@'+B]
ML[5?9CX'.W?CM]]WVNV^\P-8<>2#J1\*=VX#0GWI3VEF62X6U@%<&]\%@C]R
M2<^@2$Q]/ _ ] XV4SIC*)Z-BBJY1'@B])6*0I]\=*Y 8($7&Y@;$A:0.\6'
M+\&47:IB3=ET4Z3SJ^T>3!=LMEFR^_GN/L+GK=?ZVXOXLF!'P1X4!/KM07Y'
MH1-(0%N$]^R@Z![) "$0PTQ T7GP-^");()4$("C!)4OO-R?A> X@.7QP"AB
M. 4D($L#K<@.$>'')).3OX0__&"WD/+MSU,(7;1S]N8W34?[-TT[MOVY;Z..
M,VH1_^J]@]M[>O'VGG$"G[]NAQN@=W_ :5ZEQ8UF]NW1N*&^-,;(;*8OS:!O
MFFT;U+AO#:NUW>G6F$85VQ/M&].H/S*KOKM#@-*!Y,.V#:I92EF'!W5D2ZB2
MXAZ'+QL?TV'J-7L$C<N27P9Q?RGEHX?;L.GN4K2[6Z5AT+$%4O9EK!U=8:7T
M 573.X]3DN>Q?XY;H\S6Q(Y-<: 'UD5(W3Z$9X+?Q_0.DQ ]D<C;*+$$:47Z
M4?RRM>!L'[T^IZ-Z'T6D[-#Y2TG"',LFH:\[C'E)RE6@7"K62N4<SM%:D=>S
MN-0YE5U*%'=?_H$1<S)-CM*LK](<KDVG?8ZC8G.-X5IQD.>X25<ZQZ./#Y_D
M$=MNGP)_!<P9X3/_Z4:+NTT(\V/!QY^X3P!TN<4DMY#-?C@_*Y_NL34\W:./
M3'4PTL[=/*X-Y\TE!TH.3#C0&+2  _&8OJ;:@X%D/\E^;XO]M!:PGT$EL/3S
M]R>6["?9KUWLIY^!_0HX##L36[6/CTOV:A72)'N5LI=Q9NUVN*^";3765T&R
M7JM0*%FOE/5*:J2<F_5LR7J2]=XHZUDM\.FPD+QJC&S5MML?U&RT4GB[V2>]
MP7G2ULH5=CDY!P_:+>!!K,:/[8QK,Z!LI--&B U; +%Q;V*-5&-0N\^KA%@;
M(3:Z/,2&@]YD;*G6N'9T6$*LC1 [QPY\ 8IPDWTDI51'(/1+)0R9N3WD$"8
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MB5-9Y*P>O.YP02YY0V23;DUC8E@T]4^ ,#_)VL[4!BN92#0!7D"N .0LNG2
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M^-^0OA>VVJ#ETB]3H,WAD_4';6]F$NS*(R>K]UIR(.Q/TM2<,9OJA0/DZ9T
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M#@&+T5JA1Z2RD0Q7=G4),R'DYD18E.\4],%6HS.Z*7P1Q?PV*I[-F\C8F!P
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M<-VT0K=S^7LD-(()%7#YD+>9H#[J#]V@_G@']Z&S((L;V?H"$ $=IS:+TM.
M>12#$8E#8$G<]PU_XFPAQR^M"T9&AYVO:26)WR%[A''P/A^FF$1_F.$7A-^"
M[01;2=)U\DH;[1BDC9PJ;4(1@U@&!M$:WIO*,A4A3#86)GG)I',,9**DD@G/
MYYM+3Q_^S&ET0?"4@V! DLF_IUSM(1[-_LY3E"/5+]C@ K#A&#R*@MQV26YM
M^1C(34V?"L,)B](,NE^ X-P8%;U&\F1J?+H0T_LB173"*A*4592RFL= 6<U4
MRGH.FKY'JTD)SZM[X;, !=D(LA$N8;5;BDNX7=6Y@M5R"?^Q-L_N),[(@]4,
M+F&'&&7\S$9PS9<&,%>=D6LK#/>QT3=X-FZ80Q]RJ)?!F RQ1FG3T%4U.PF=
MZ\'D[7UW$FK5NY@Y1T5.R,K]#CLLJ91) ]VE#9\9>U_9T#&];=C*4VNWZMHB
M$BL*?K8O)EJ9?D\R!<)U5K_14JEEC[I/=F-59!RL7IK6.8/6$FI!7#F@!9JN
M9&(AYG#)03XD/U'7B8$T@1,%3FUX(!W.?'=7H]H78V2='-20/\I1;6I0*D8-
MNY,;^RK1,LTDY)=<?Y-A1TS)9M,]:Y)KL'*<2(7Q@B)MQ5(I,-# /\32:=84
M7M(G:%ZYT39J0"Q^22N=>>GZ415:%,N71$,P?BV!EV;%1)L$^U6':U!\@5[)
MQT*#:L5H,%#DHA8JU?Y:#7DY66S- J'(&6DIJO]N*T2ZW7J[T2Y:(-*MMQIJ
MH?J0M,^5NM)52JDTZ6BP$VV32A,.; X^T"4E2LB2CXXK*E'8Z>VI%F7)<FFP
MEH(4H:5'.\35 M4GIP"B&]HQ<1H+M2*(.)XL>%T8GU@-&,I\4Z&2 =QB9Y#S
M5>M75R4?&+QV3\552EVF*FSS2WGXO&YQV9JE2Z/1UN##EC[$,F4JI#[3Q!.\
M"I:C)WIC".,07_:^0&GL8#+\V/.F[N=/GS"5!]99?[/?/_6<P1@G87\BPS?=
M^01:E?Y);G349K/U"=8KR\VFTFC*P/F[<K?[R7MOMKMJ0_YG4VGVU?K8@\/J
M885G$/_%VA$4YP_$><,)34Q/B_MO%>J_E5LUU!ZM-^F_/^FG#L-8KSL!CYH
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MQE]X)I*@Z..AZ%;C\L<,[$46B)UDS^+V$Z 5=2$!VB]P34W,?23O^E"GU][
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MC'>!2]L^)B/H1C"MB4?06-J!.P BG)DX)M5F-2S\:VFL SON8^L0>V)XF%<
MC] ' ]L9TD $$BW6ROD>K)?+WZ4[CTRD5D,^UR_.M8NZ]!H9#J5C(R/ZFA$C
M?DD'<$_GN"S=-(.WK%H>D5YNKZ79%%Z'5SCDWS/B>G5I^7R,X?^<&?V.WF^U
M6X-&>R W1QKIMHG>;<F#@3YH=TA7^Z?24<^R3]7OG7R)0O2SUO0EJT'K!3]?
MXB>[[Y-,3YX"7&[54_FL7W\DO3!NEA>3DS3<Z*;5UMZP_=&V2+T2XJ(ZDJ&=
M+AF*4$/KK!KR9/> 32:OE[M?'GNO?_M^^Y**;T62Z;:*!-&L+^24R!P-AXHO
MVJ<@3!=#X29KY\.+(".,-9O#A@:W/P=CE'I^6IC<59LU_CPLBW;P#6/=E88X
MBGN@SS!G@LH-AQ4]PMO[K$"2E4LBG^Z3L6Z.L$\=/HBF=+ +:FPX]\R"N^@#
M]9DWMAW8]3"=PN.3&@YD+D-3KBOMU3,0\CY*ENO=9K>41S75>K/=VF0RPTK+
MM+6OK-5M,07*RWHOK]][CSWIU]O>_>NO->GN\7H!65=Y3IJ'Z#FIG/?@1O?(
MYTBN5I?E:A5PI1R()^_K_/-FFZHP>27O^)/[B<V=!N'Q>UUZ,28UZ:'^LH+$
M=D-.7+!0!;G(=)6U\T"WBU<5A/#! ?%Z;)!10E$TR^<GV+IMT7=P.%#=!T#/
M5Y1))'ARJR==B_F63]MF[91CLW8K8K.N<*#LU89]?OK[[7?IZ9O4>WU]^OYX
M^X_JF[*_/S[]7>K=WTO/M]]?GAY?I*__D%Y_O7VYE9[!%+]]?'U!PU'W)*(/
MQM(4K$F09!]CVXUTYI'TZ93H#AJ?IOV!CEW8D0>4P1R+\*UM@&5<D_Z%_YJL
MA;I+@!OJICFO28DZB-_-V' DSYD1>H^I?XQFIJ3S9D'N)2#!"%W(]#5OA+Z$
M.DOA,E.:^MV%W%F?K0B-<KP6!$;DHYHT C-];$SH=X8EH8UMZ1-20U?U@+#>
MRZY'=+"BT3-KL2V@*W6@3_4!M>=K:(\C3&+?PU.L(7,,^%[?],Y%[$7HML6H
M'.U^1%=!MX1/"QRVU);W;':#C7\%83@7EPAG8'$GA.>'??AS%KP0^(# $W%M
M3[#5-87)&_H?L \;=1FX.JA@JP&/OU,L8:X..,?(*= +F<?!F^,6AS;]## *
MA^JP&^D3:+V(_VP,.+XQ_PIP788%L#'BNFB+, <(8 Y)WS-@$2Z#7HP@! RD
M0*(OGSG S1$(%*)S:8*4P>(5,W.(:X3G,J2OT? 9#C#6D5QQ6?@(>.G(<";T
M3W@Z)94<L,*8AS4/(05_,URGB.B&&$OPD_ ON'6BSSDAP*9@A;A:] U%H0'+
M?#<<#\@&%VV/<GEX4GS1%?6QY7"FQ9QEZ$BC(1;N+V.\BOO)1M@[] ,/D1VV
MBV3)76G\71&?'.<2-&@>D#^C1/8I-HA',L16I%Z5_6N-NM)H%O:OU95FIQ2?
MF-*N-Y5BGKKT5VB=<D:HJMVZHJUVU.U^4=@!&3VA6_(>;EB"N@_78! OV$E.
MS_X:'23O_O7N]?XT=W[3>[W-8YXJ^S-/A<>YXH[8RGM;=\_"J^+88[D4B=X]
M*9_+:OM0K%K7F]6QF7+T@FVYY*OD$"GBK3\ 42 DHI"(E=T1"L-KL-B'\.JO
MNCNV]S?=I1(",.Q$A3+O:4K0S62]!7&N\Q5-JX3LJZ;L2TERV!^P8@2WQ0HW
M(<Z$.#L]<?:;/;:D/VSK;<^2;']"+#*\)T%N+7][<>0>+"&R-@;6%HE*B"LA
MKBH@KO;JC_R=6!;QQNCJV/\HJOUQF="=""JRX4RP/O'&<,C LQTAHPY#1NV5
M143H"%V&-T):'=9E0EI5>$<HJ%['\!Q7NM<GI^HG_ ,LIE7B2?C^A)!:#:^0
MAJB,JN//Y_JO=2&L#NLR(:P.P;2BGHOKL:%'?!<G:%H),^JP)-2>77T+!",D
MTD%<)B32(4BDOQ/#-*0;W1#R2,@C(8^R@+5,+D(:'<1E0AH=@C3ZK2[=VXZC
M8Q_96ZRL&^JN$$Q", G!E&DHK:(<(:,.XC(AHPY!1CT8WF!,3%/ZW?#TN3[1
MA8"RG1T.Q!%BZH#%5#KQ"!EU$)<)&74(,NK>L(:Z]* [[EA()V$^";F4!:PD
M@A$2Z2 N$Q+I$"32@^YY8WC<@_Z?X5QW+1%O$G*I>G*I<APAG6R$=#J(RX1T
M.@3I=*._ X-X&8PGQC"I8[B03$(R"8MI801($LD(J700EXEF^06;Y7?3F^5_
MZMO#.?PS]B;FU?\'4$L#!!0    ( %6&75AB(+3IB2(  ,>: 0 1    87-T
M:"TR,#(S,3(S,2YX<V3M75ES&SF2?N]?4:N-V'!'-*W#LMOVM'N"HB2;NY+(
M%6GW]+QT@%4@B7&QBEV')/:OWTR@3M8!% \1.Z6)F3%%(A/'EP 2B<S$+W]_
M6MC& _5\YCJ?CDY?GQP9U#%=BSFS3T=?Q]>=]T=___6''W[YCT[G'Q?W-\:E
M:X8+Z@1&SZ,DH);QR(*Y$<RI\9OK?6</Q!C:))BZWJ+3^963]=SERF.S>6"<
MG9R=Q\7B7[V/)^>F1<[-:><-?7_6.7]S>M*93,AYY_V)2<G9A\G/$XO^-/OX
M]L//;]X2>MZ9O+-(YWPZ>=?Y,'UG=<ZFY^3\W>3#!_+NE#-]\C_ZYIPNB %=
M<_R/3_ZGHWD0+#\>'S\^/KY^?//:]6;'9R<GI\?_N+T9\:)'45F;.=]SI9\F
MGAV7?W.,/T^(3^/BQ _FN>)DZ=JVNZ#6:X<&0'/VYA3^&Q='9JR&/7/\@#AF
MPMX*O$ZP6E+_M)P(?C_&W[&BD\[):>?LM$ JISSKG+SIY!MI!0E9MH5OC\6/
M1P8) H]-PH!> ]"7=$I"&TA"Y\^0V&S*J 529%.4DUR!S,\!\68TN",+ZB^)
M255&\=<?# /198NEZP6&4Z"=$G_"V^I[@NS($))PXYHDX *.)?VX6X7RQ]0.
M?/RK@W^]?O*MHV/U6D._,R-DV:CF+(VH/?JF20LR8GWZX<.'XR>4T_(6E,H=
M+]_!CYW3,Q"%!M56";!ZW?!7)Z;;11O2.=JL#3'=EFTHG9-5LB"CY'_[VS8C
MF>"-FQ%1-FI&^8*AB$5,@""\;5*A3\W7,_?AV*),9?ZM%\</369<C@DUK29U
MQL7Q0TF=Q''<@-/C-]%WRR5SIJ[X KY"6?T8"^P]G<9+=V'[*ED5^#\?B6=Z
MKBU90HZ7GKND7L"HG]WZ.(.Y1Z>?CG #[,0+]!]+C[Z&EL1%"A7D9QW^##50
M'W8)WM^;M$,Q"Q2\3T<^X&!3,40Z]]^BTZ;]!Q+FL'^+WMMDTK3W0$+M__<=
M-XG=M.- 8H;V)E*/Y&/XW6#6IZ.>"YK[D8'??;WOU^A0O%)1.F87,TPE\-<3
M_I]3HY-J^1V#4_URO%YVC4OH4VO@_,H_K\_IB#@J4D.X-BK*=/E)5$H6?1F/
M7LV8=D.+!7T'3S"\)<K#6R"4CO19?J0Y R/#H46CWAO<C08W_<ON^.KRHGO3
MO>M=C;Y<78U'ZM)=R4&*PQL8_!&,'(U%/L/*B'@9@MD+)./1D'C0JSD-&+1S
M>WSR[*1@G:N#9;S*\?ZQI>"-QO#_MU=WX]'@NG_7&]Q>;01:"1LI6&_KP$H9
M&H-K0[!\@>CZ]NJ?_^S>]>^NNG?P_:#W/U\&-Y=7]Z.K__W:'_]^>77=[_7'
M6R.H5HL4X'?J "<U&E"ED:WSO_[S_=GISW\S1-W&JZCVE_DZN.YU1U^N;P:_
M;;8/EG.2@OJS.JC(U>!L6P36)?5-CRV1FSN]"'WF4-]7!JB<6@K*>U06F6_:
MKA]Z%/](^1CNU(@YM0B'"^(SWYT.,YT@CC4*%POBK=SIB,T<-H6=WPFZINF&
M3L"<V="UF0DG.V6XMJI$BNJ'=51Y=8AGMD(#:C2B*O&W3*5&6JL15]LF$8BD
MON<N)LSAC?&[OD\!C#]#YO-J?!B]SZYK/3);75UMS%@&]>E) >JH"B-;QT\&
MK\7(5O,3QS^NJ47HWD"_A\(8LX*/5S D2]R3[FB@#&0=#REFI^N8(;>?C)@?
MQR7A^),!/%N$3A]:[LS8Q*9<9/TFJ)312M$X6T<CY2)FC=\^"!ZH'Z#PP5(R
M@(.N=P5;0=!D?ZMA(07D31&0A)G!'(.S,V)^+<+EQB7./34I>R @G+!*Y+^X
MIS;Z3@R)UPBJ9EREZ)T7%C=@9Z3\^.JV_AT_JYW^S8@J,Z+:6H1MI'#Y0[**
M8(!OO)!:5T]+ZO@-\)1SDF+X=AW#F*<1,>4@1FR-F&^+T+JE%MK^;AB9,+O9
MREA"*L7CW3H>$1,CPZ5%H]_SH/O!-3&QZZL+XGS']03UYAM4?=VI**!NW%#D
M)\7IYW6<!*$1L_[)0.9\]8O4;UX!'KY$R1:!V'=,0&%,GAII%2F-%(R":4-0
M&YR\10-]2__ZBS@@9VA@"%SS^]RU+>KY>,((5I=0E=E@KJAQDX)3L% D?(55
M(L,YL>/R&HQ741UMLN/RX;@@0 V'>MQLF]TA5Y#+0#HKV!8XHP[G9&19M0@*
MZ/:"B;,("&K/Y38RZC0R_M7QD()2,!YDN/&YD^/7(F0R!Y75V,/]V^1V+F58
M*AE(,2F8$")6'<[+R#)K$2!7BZ7MKBB]H ZP#88V45^RRFBE,!0,!S$7(V*#
M401M6JRNB =;ZLP?4F\T)QY5'_YU0NG8%X[],0L#>!B<28L&_AOQ&)Z3^TY
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M4(E2[H\]24)I'5)!V#I[-1X#UJ,!6R@(F:"^Y./0<Q^8#_RC3)3-3^?J/*5
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M)LM[T82#%F*IDG+FJV/%T:_4BI,&["(18SUC/5+:]&Y'DK4F+: %HA6AMM]
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MP$0:@FXW?H3/JVLV#2B5K">JU,^+["_'T%/?G-,%^?6'_P-02P,$%     @
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M<([+7C\&QQXBL$>DUN:LBE5>;YK;Z1CPI!M,B"* :HE(H6J.[!T:'H9T3/5
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MY$]QV=/ELA?DGYP"(3Q2]RO!9.Z%>]4KB+(::"(+FII"JV? K:R[P8UQK^I
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MM)_WQO21@$S3141&/\5QI7A#C)L^?7_,EY_%,A:X&,T;(K[]V4WQ3LYAV%+
MMSZZ =K%![%S/(\X;0GUF\^]AG,-\B;"^I'P:3(:3<XQ_S3&^<\+?,_.7K\[
M>WGZ_.3]B^>_G+P\>?WLQ;N_OGCQ_MW]6&$V_TB I!)R^4[_]^T?=@T@,6$X
M'M;-Y25]N_K$BJ415/PRQW'&Y0ZS?NAHDK[YI5'=WR:7"AE!Q-'BIX.+&?L
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MFKR"Z6\XK\[M.TP74Q(RKH4PX"H"<$MF;HITVJD*+=93266E@E:9>]N8''?
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M$QAO/KXX!H/)!):2=#47FP Z(\B4T2"X=E&EUN;"O:".@1QM)7^;&J[I)<-
M<<_!&,V,YH)<&T(4,Y?,)I6XCBY%T\\5TA&I_.$2O:U>WT:]KR?C=&.%(7!M
MLRO,VWJ!G>J5:-&&&9M\22$46W(OFKZ-Y0ANDO84< _.X9OIY!-.YU_?C(!
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M&=9;A%$MQOL+2;$NX&S\?#C[-)G!:,!]C*(HQWQ SK30))$<@ E)Y@[Y561
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MR$)!QW@Q61@E:9G-K\XW ?GN=;V_>'OH6703U//AZ&)>N^ NQJT88%$4,D/
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M7'(C>.NZC[Z#"BVB? NC\>-D1(J;W696,!IS"9&<3R*#I@.?WG<I&4ITQ(+
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M9.HFAT'6^UM9VV<K>N4BO6/,2;)(<K8F0.N^MIW!_2%IM:>.-K!I[_$'=[T
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M! 5,AP(LVNA8]BXY=-Z6;A."'UN!6\[[]OK;16"-]?:*)'5^<;X"8IQT6H9
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M"X:.T<*+2KDD*WCK./<V+$=I#C150,/QP7?A6K&^"[*>DL2VHWJ<E*\VVNM
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M\E$>@RQWW%$\1:[LHHG6MLS?QL//.)W!J,;D3L=IG;(8I B2]E:I4=1YV<"
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MXP4#)FJ;U)0-$)8 )4A7R=Y%DJW9B]8".7STV%]'D]8"'J!1\8/XYMO'*:V
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M9O-:M_^=I(_\7R8-%+?HA)<]S;04""IZ(Y@6BG=+P%S]Y!,AI-A;\)-64AO
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M1087:JJ>BD9J:4I,NK'M[(KQ_ QI4"T-D+BP61Z76@MM%J_HHA+Z>NUK;Y(
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M71P@''ER+DA(V5,<)*6BE1\0C'98$D,F#T4J\F/X_*UUTC#LWP)MN2(Z@#M
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M=W$7*VDA+.=> S=6@I*\)J]+!IK)4GFFC5Q-_]WT,K9UK"/VM=])"9/A)#@
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M Z*4J%T(6MO6"2([ 3RYA[<^=\[#J>90=G3W8O0$\47^OS>W+; N@_ 8#*>
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MW]K9VXWFO(H+&DF]CZ*296+CQ_"C+IX<3?K.Y KS7<@#<BR"C$1=835!M=E
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MZ-Q\$A0/6"L(,$,HS@/W7,HD8Y"Y]:3*(_/E$7<A)Z/+(=KHJ;'(VXOQGTN
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M"HSHZ=3H,'QS#O$;T8$29J-!'%]_P&9!O7M4/"6R;RH+H'-[5T:>[X"WFK9
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M2Z[T5QJYU<R5(QT]69SLR+/E[6@DVG?Q=B_M0!!'@-, 5I"S5E8O&O+X8:F
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M(7'ZIZ)M^  GV.\>(DYIN3B=_W1KEFF1(O[JN;6]8ONRGS<^P=^V2,.^&Z)
M.&\0YMSX5 V*L8OFA&^6@T@7E@C 79/)F+7"]P2 'L,BX=!5,=.Q$"[.DV:3
M/GYO\RF-J/"C$II/RSCU@[(2_KSC5)T7I-RD"18I"S3!F7=0=+RNMZO]S'.C
MPH4T5"VW7S)@O\+-T!>1)7-JP^5-*HL7/9.-,N[7(KOK&8I\*4!S"H$-GGW^
MGI:RM4/<<1$_IJT7'OQ6]*O$I>ZTDL(6-<P;WSJ=>X5.DL&6YB/#OC8+M2ER
M?AH3//2?6*E*^/%DAH[_A9HT9OR3KK%L?*".XI/-/2V9\P$9IVIHU"$!N"KY
MJK ']OE@G)]KN'TXA@G'F,AVVERZ#HNPX"0 K_6_IE:41)WO45DA4JIQHQ.C
M/6[P7<<%-5LO@>4JD>^<RPDFNK&3<J(-5%JCR5JOB[>=[@C]OEG]^8W&KNV+
MN([K*QFQ=\\K01[A^]C.Q6H/4434\"BU-)$9OP%M?MSXXE^'#XG5-]4V*UDK
M#6\74%#T B\D?PV4>QA\@P PE4 VR<@9?'\(GTH=]^/EMOW&:R>GE*#.[TR4
MZ:ZPMZI=.V_ ]O4%GPE_O)[;]$GJZ)KQ['-B*$V@?8V::^V_A&YE9EOM$S@D
M9S:=,J \.;0<)!*E0$KX>\5;:%I#Y!WXD9866=*>]=1,)]A;-':YK>'HF$GB
MV,#29ZKUB$T(N3.64)PMTB/&\M+FX[O <8@K)BKF,(]/>M=[060X9\3Z-^V\
M []:NXG"7-AA[PR_KE:R8?R'=.HP5LHC#C+_ZS\KJC9HM<Q9I=IH3GCPC$1:
MF(' 1YF<MK;0H(E.<!O42@".:(EIYV DQ,=(PFEPP7:.)?!<RPUT%_&N<COB
M$#TWU+(,?X,7(:8WCU!"N""I@YR8Q1Y8N)!R=$[$+Z17F%1X@&Z!_=%R6%.&
ME0"YEY"ARS<E<*A'YG9J1*,"_SRL57\1ZRB+C%>X#'KN6CPY_E!V_DAI(.Z[
M//5RH&[>1I*L0I27GWD>0U)EE,"C; -0,LS/*]G2*1]:6\MPE;+<*?=)CA*6
MC_R\285,W_<LP? .G:O\S0U$Z.:CMNII$0K@' XPMG2%Y4YUV"V2Z6VB7I:Z
MP1J6"G1LM[8Z D+$]93$XQY&LU16JJDR\:F17=V"Y'BB^G=8/Q9$HR0WGUSA
M-(G2\ %8R&6,L!,:6$<_,=A%A;(J6JX97K!R[]8F?,*N/;;81W-?Y4O@T(;;
MFTCN++Z'[\#DET\B3@R;PXY,$8XN;_>F[)8;/\=1'NN5T2S3K)D\-@J?BBTH
MO&=ADF4RJ&(PZI(]=-#8>%H[Y>)XL?_F@0%9UH#1S?T+D/L^.CLR2UW5=3H7
MH&Z)21[7YAHR[X$:04LCIU:5$OM:4)^$)_4H\F98J47ZM/F/H4\_O9:1N;\N
MD6SS2S9:LAE8;0F/T%,Y7%QE]3,:@%S D^%J9UE-.TLY7:5I&-+S<H6WK174
M3G.S]&0-7;:'YWD.R_5TKCE\"OO\*<&F^KET?%!C2P0E5OT 7ES*ERB8([\=
M)/LHJ"?MT$:00V/XP%&B>NAY^?9.<MX+U2N!/IN!FSMT1C*+M5.-5*M-EO,N
M-#X-,PFFPY9)>L)U/)(/L]18\!0<DPTFO 5C;5'Y%#Z-8DN@2!!5#>B<UE&1
M,;Q:XX:#66B;JH[*.R_%L(]'\D9IX^O.A9:.)=!C!MG7%Q3R6YE6HCN5>>%O
M%7E]9%W(?%JV'CSK=YAKJ4E$Q'"DVTT_#=GE+\C0=F(^8+KD6%;/C1)J7[;/
MB1@YT!EHYL8K&4(.OX$/KAIN%B00 /92(<Q\%H:RU/-K@.,TT2/)SN:TZ$\F
MI#!K!,!G?#TCR$L+7T\ 9B6:J0NKW@<BDC=%F_D7LCK*E;^:L':FV!1,SJA)
M])HEIWRXHEFR%#,GM&7AJ.(\Y"<V7JPM8=4KX>&/P(K'U!##L* <'J\ 0@[)
MCN. ZM^GZ,,%NL>GTD<R^-PPO/X, 5C(\X1C2*!SQZAU O F;@RQ?KX0-M<%
MI\R)M6/[=L@"WLO\30 N<Y3#!BYJ$P!$K-K?%^RC0N<O?413M$  WA_#T%!6
M1_Q+$V\<U@]>'#2 Z3C*\K3'<&66NM+>?Z)^0O**&>?8SI,[T?5IC#QX_#U1
M\:HBS/X1T=GC+;(.3Z3PO18U%@_^M%JM@A?[\.0A!+6VR2&L(M#.]RI>XRL]
M2JTSED5CR8512T 4M)TF:EFEW>'^(\N0 _R0>O3 9>?"HBKRN"VR_=61^::
M0"[['NDY,P(PQQY;3(_*=U(%VQ]\+J'Z676@9!&-]%[(&(_U9$Q=R)RZ7_N4
M.T/MQ\YX[\/C+OU?H!<TY_-_]1=O&B8Q0%M6-PW>W#ZT9:<9&9_-I$;B"D.;
MI"QS?_'LE>=2F3*)@@W==[6U##3VRJG+@G@'0G,;00M9U% VYN&Q7N7*-T.
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MP.O:?;1:QF2&8(,YW^"_;M9M @>C+H30E*FZ*#!,AS/M2_=F*R;(=.6L2$\
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MXNX#YJ5*2)CL$&$=]?4S[!FB<4-$]$0\6'%:(UQ#BRLG:[A-@U6D^$JUVE8
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MWOOT;PCR5SK@"'@ZE02EU;O2 ;O2L#6V^I+Y]<+_C5:T%UH@17$GH6@5QG3
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M,N[]X-]-O4[R^D0ZC!VL/(K>U?@H]Z9YEA!W]/3ZR$NE\\M@1<?X\" ,)R)
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M0>#6Y9RK7PT/>G\AWW,W7U8VL,>Q6H"M^BTXV^J<WS,K[":;P"M@BY[-A,#
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MF$,]2=GW2_R6D5CT=,6'%FXCMK;;6%]!RJ4>;Q8?-Y?4T<7C6DZ\P4W]074
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MG?M]OW/?<_;9=^]]]SO^UI*0M=8\_?D_L]; _<RE )L/6]M9 SP;>("SR#^
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M- @<MY+ZJ_VYQK,H",M,<HZ-L@Z HY@<+F!CA>N2!KU)?ZG@+Q7\EVG_@57
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M>*C$'AZ&)0O/M-PW\G!W>]5\)>?L@M!F-8-[KJT7^7-B/9:X@* $V'H0#%R
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MS.9E",84OTI(L,!0>]QWZKA;REQ?/%=8&Z'N?5;8^\+*/MD-45J<(4P]=G:
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M-R;)>0N3U_9H<W:4\JZP.&*F7.!.,7$$9"+QH>3MKY4U$@!2!O"KA[WGPK@
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MI^!_9F</A4L?)P-:?Z+]C^)"^9]9XGY0$-XW<,7Y9.'Q0W%3&=8BI0\],[
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MIOC/#H_?XQH-_7T*!OSQ#\,NT-'5'\PB 'PI ,1O" J0:88?D1G^\+4_("E
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M!2>%K%WFYTVQI2M<WZK$@V=0>%'G-M0HH9%V.B@<?@9;@[9NN>C\%,545(M
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MTT!GFW!O5* ,^ B^O=D+$5JK4+&MX)MSE_5+>-.U<V+GDUWO+!L\)MHOEE(
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M[*%KPEE'1W:D9DED Z2/=5/1E-P3F14G_F9@1HT"B#0>I  Z2^(WKN]HG:
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M_(,$HGLY>/\D&^_WO,$_D>)O9_^/C"^J=.H'KC" 1/XMMBYJ /X6A/_A*W^
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MI?$37;7)!Q.5IT7=D&Q@AYX0)!MB.A6,7=$>A;28&#[.AIDVW&V=8E/TSEX
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M =%' S0X\'(5^A(4 R1R'R-HP&U[SWI*@P%PVH^*P-R)9-+(@/,'9+8JV]>
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M/>]1/E'MD]"K*5ZWL,Z#49*+0?0K=5[W]\R0^ASY+BZFV"#PT]%<4>S5G)Y
M++:DKS![H$)EI*BH:/8ZU%/U%:<<B_"'6-"!@92]Q19T%88JXD_K:4*-8/!%
MP\WKOJQ;Q;O?8#]_R[72=X:C0Q)8%HZ!<:"09T2C-8@- Q2!+>=>4Q>EU2(E
M*JN>E1XK:N"'ZYA+[*C8G+KYX17GY-==FVM>"M=3]OD;D:<)N<RO[8J''@+<
MVN[U2_3;%:-SQK*N-3=$A(&XU[8\IK2)V&(3JW-RCAI[G=J#.[%EL4[: B*0
M,P[H)ICAY_T&<]/XK=AZ_>2$Y/)D^"TTQ!'V%1N!E%X]2U>FU32(=<\6_+0[
M8PY(ZT@[X=?5* >.-CWZ2J>^_XD/-NWENQ+R&>Z@7?5;52%S;)ET-BYL_5FA
MZ]#5)[=Z'W*!,D?8*C3\E#)>?+"GEC1#)V*;CF;S:%&O17^NFRS>K^RQ%?]9
MVH5.,8,'; &Y5^8-4#-I&)&YU-*E>+:KG^L2AO_+/+G,?XA?_G52]/^;6^E_
M/+>2:1N68,*^]Q:U(<X 5?H0UU$03VP,=L6=R^8Z:HW9T[5J)N)UZ40Z:J+8
M2Y.*NETGUU&""[("@OMOKANI)2M(5BQ4+JL54M!%&?\P<0>0-1"YU/N+-!W4
M%I8!\E3$#C% ^YX,4 **E+LFK(%"V6:/=GY9>5%B:=D8LI#A=U#(6?F=[7>!
MA3J4(2W?1_H"KA./&8W%KP]';F1ZGQ_;_>GB>F6P=N/#5SM!2D%4S.L^,WJG
M/P/4;/FS[A;E 4+C&_'NEYE[=0JYLA;+9[M'_%S>O(_I&A'RN(7!9;=(7TO(
MC>N%)U>58X4/KYKT9$SF:68NK07*M@:8/E/UHY)B<</TR?O)EK3"2T3-/ 6F
M-#FPLTS!%PVC*_6^W$1$2_76/ZUVXQ\^3@[5[/:&<-+/P*,0*L/(Z\AA!H@S
M:TB.B9N6%?C2,MA_/PW0DSPD4QYT0Y!37_O1P>;S:=[6E,^.%M)ORK\]AYY:
M/CMTUG>U\KBNXEG%68%71B#QQ4U ] )M,P+)!X>17'YO6$DWB,+[VC03FSV(
M9D)! 7FAI86._*/=_E2U[]LS49OL=\+$:WXG)B0IYK)Q!)%S)LZXY4H8NH]U
M//2MB8+RASD/=F[I #6Q&9Z1<S&]WL@U0;>JU ARJL6:"^J' OV",YA),9ZZ
MG[1VZ5T?1#PHA0<;7?*-)CMT11VFG_[J)UI5V>795S_TJ7]-HKS@J%R]\NBE
MJLH0FR">5FZ.FVQ_CECIP;3>VSR);C/&'+VJ:>"J*7JU12'+P$*8^VE\K_!3
M_U%-V/E<L4]!D=BRU[;(XHYN[(U=Y!]&-JMV^K]5J6P,/*&)?K9_W(0H5>7T
MY!G:/Z S)%K]@XT2J7!E,/MV:IZ!CHQ%Y62\M>N:T27E^(=!M8$<[%%4\RS@
M7&-*:)1\NR_3.!7)?5.M9&53&\%K57,3!!$F1%V$,0,44C?,.\  51S>-*S:
M1!4P0-[N[;$;1.LJRF-Z7P8_$)DU1H4 +_+:O1^7[>VG3X?'7;'#"UI]/_O
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M^X+CQT!/4PBH"%156U,]2\MUA"C @2^Z,Q,;<\24PMKX5*T^TX&WIG;A*I?
ML4YNU6L77%+!957KIA03<!6=B8$X>H)5114$\<DO-]GJB.CIAH;S[4OM @]V
M#Y\,P#;V!&./TX\"%I##5!'"C?2/RR73J0%'#W[@.>$>]\O"E %R:K==M=X<
MA <(#W-#BDQ@-JG.\2A<?@4Z)?OIOK$J>Q%1P"^'$VS,I%+S\W?33;#5VLOL
M(B;K/EEP(UCIBW46BKY.3<]Z+=%PK>;,5SC]+'!V?GWMQNXQ/R_V#UZ!1A<^
MO3$N:0D\,,T>JGX0,,:_5^4EX!KYD.'9X^P3(\N5!5R/R39<B"[/SO,) PF6
M1J8?/BR.QCCI/4Q]D'W!5O_XNS3$@$DT.1$C,G1_]WH#N-,K/[Y(3VGH77R>
M0H^!M3[4J%;S1M R%Q-]PMLJ_W78E^U#J H)#OI0O%41P#04;O<=N\8;[A]A
M61= KZ(B*4D[- 2:C?A.KX4!LMA_C=GUC\^55G&5IXVZ=.R/9@QYQMF60FUW
MD]R=#@O/!_9O6\ &_AQH;6KY7QZE33R&R+I^G"#=B#ZWPSY*:8:=4U5SFD5S
MM:@V"!!>UQ3"QDQ[[QSOELAS1U]K+6E=>Q2=Z28;?]A7#O30FG^Z!Q#%4L_D
MSD":5:1?H]BQ;JC78XL1/I)WUOA>A#Y'@\T>64],NHG/M9WP2G[Q4]#Q$-'Z
M%1%-"@&$*:I.9Y5QK9AP?UCHYT%I9%N61B!D<Y<_/;LNU=&(UTUHC#="L_"'
M40G/H=^L=AK>#-#Q!@F$+# Y'0D)AQQ%^&7#$VYAIR3E7?EV14)&>3)SYD5.
MQ11&A9XHS#8[>+0XZ/]G0>>\Z2H AC",C\X=5T7-1BOH&-3&26TD/7V+^HKV
M8_J0B\-IZ+%.$V+O#5S9X@_P::!0IMF_?@XV.L8D.HYZUSIMBR<_TGVF%U3U
MXNQ\ZD/\EP<9(+2GO@\X6U%4C_D $?E']GQ1U7:2 9*PB6(&B.4G\V8A>/LB
M S3!5/9GJ[-C^Q Z&^NY-C\(GG-0_<8D''FCFH(BV2?C=]X6I<26N6\+)23;
M=SR?=E5<A2F:$D*C>*IBB.?X8:,=:(52LGV1L+/<4/[&\*1(44J-_C+2/:-G
MS+Y"V+ZR=Y/PD8E$MN_\A,">3\KJ]3Z[W%<>J'Y<U^RTT-FA7@G/ULS2_)<@
M$K<:E^E^$4\KQ\.(4JVU9:'"H :W2+HTE,K5H0T96D8=J3M]^@7'RGZNT+ZW
MX[?=CN%>BXSL)YE.57RM><_?6HS=W'[4?:FQC2_/WG8-=*4!P50O5Z>J*4'
M< 8RIF!=X;@+CD#*8H=O=ZC#"U_G\)NA)HVB(RAJ@=9:]);$V3+6FJ!,=J))
M33+=(-J(2?<:4.)H5)4]<*+ZV<(JE"KW;)8!2LK6QA#*EO+_G?@_7U7=B5#\
M8E. >SDPWE+I"Y8RX16:%(\EV3ZJ18*&F=[B>.9,;#/[!)4'T/601&^X3(G9
MNKC&;DK<(<=+?VOK:PB0F8E*EFP.M#!66D7UU#@-Y&V_/N,)FTK*G,SL;YSG
MH1I+.V=V0O?F!IB0^)5..U;XQ9Q_Y/7\=S8@%J&,P1] &2D.L,+7,D5?4M8
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ML@*3]#GR"Q<[MZ@]D3M,*&B)>C8F/TR5ADH_ZQ'  9JRZ;F\S#&/,X7@^YD
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M1^:^WW/IIV3,[C@#]!39#^'T&ZKHAGRO<=DM[P?58<67^M!Q[!3MGSL8P0B
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M/.M=<KD9!V-=\!/)UO$L@"/FCBD+D-$$/WF\9JK.-M"MCH#TG>I*M6MS\M]
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M7@6EIHA\AQ0?@I9PMM?%*?1"0>TF)^5&+RT8&=<;2)NJQBGD)+][9Q,Y_B=
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MJ4<T_%B$UTW_$,.CE/<XCM0T=90CU=@23A$B^0[* ,T</6SI]P#[ET"6BRU
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MRJ1%[\<>5LJ2.?D$W>T!)$-D8'?H0>_HJ##+"*<E*;8?;Y!4K;DXQH?4^G;
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M!BN&\M17#,X%'ZVZ-9NF7%M_UONPQID.1/RUMX?@BF Y7Z@.O&TXB9J9EB#
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M1 2&.&5$(D_2,+8Z<AM R*E1VCME<ZFWL!(8?*UEM&2P0=;2\#3OE5=HZ/.
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MMP[:I@R4% Q'V/.@2 F#*.$Q5%L2'_IIBFF2AK[/L=V1RJFIIG>FHF2$C9"
M5%);NC).@<J9"+"/ RA\22&2,H'$XPD,PEBR1' OBJQV=BX@'2E#?!A #?U"
M#F :W![4(NX6CQRD4-DY)%SY>TY-,ZZOYXRR!WZ><]?;42P7V?PN)SQ;WG]Y
M?J2KQ3R002*"$$$/QQBBR \A32(&19!@'$84!YB8O/X'(T_M?6^$ [5T9N_Z
M(5S=+_=%( S\-AOJ;_SZGM3UR/M:"/;G^]6W7]0]]:NJ?MB^H8<CC?)*GE2@
M?0=/7W!9V-_=ZHK]]SK+A:[Z6CY_%.7#BN\>3*HO<LQTOD_"=+8P2@E,@S"
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M?GSY3I[T;YHC3"12'(8H@90C77W)4S3*/ 0]*;A,) T3W\BKZ42:J6T$&F7
M1F:P40=HJ<%/7V[>?_YYY_>54D!K55U@N4>X:"4-K?ZQUF=H._[2I1G@J-L)
MMJZL[(MD&==N=@';@27L9- >(8.-4?V1<'&W^BP6VNE[2_+R>>XA$B1!**%.
M38>(^QAB7Z:022\-(WV>'!NE47=/,S4.W767YK6<X$D+:A$L=QK3;M)SA]0X
M/F6@A01W*]"("6Z= 6416N@$L+'B"^O>#;KDP<$#IOTRU3]H]X[ZY5.^^I95
M)WM%7<36@7?>#+#.F,33=X\7F'A6@[WHQ/-7]_0)D"ROZHV^S0JV6!55R1&[
M8)&N(2;TOFLQZVJV8$?008)&3!!QM?_KFFK<#9Z!T@<[.)-[^A; Y4*>WB#6
MW9,7I"@^J6>FR7X)@I#Z*8JA']-45T4(8:J[&Y,PX#2,<)2&OEU97&L9IF9*
M;%6 BZ/.EV(&*CU I0C0FO1,2.JS8F8,-? Z#$Q<.TMPW/_5:PEZ%.;M#:*S
M<KWV$HQ<Q+<W1(>E??L/U;MB^-X4O^6KHGCW@RW6VG[[;;7BW[/%8DZE)+AJ
M'\Q"Q9$I9C"5$85AC$D2$5U QIN7JY(L3#G29%HK6MQ,/N0[>? *5H);UQ W
M@=R4Y%P#.3BO'<<0_+21&K1B.^P1:H>3NTKC)I..77+< H@CM<=M[N[AU:GC
M@ZZ5+LM2<>"M>GCNOJN?G^\>LKP4HJVUGR2,D=0+84(YUFU",4R#B,$P] 4F
M$0G"@!K[> PGG9J9%GA^V$;$;80'6GH+3X8IX 8.H %@')B-CH(':J%!*[5#
M!W8?F#I]&J9CC>?AL-1NS]]A>V_/<SSV(/AZ(6[DB6#$.YW7/A>,)$(D'L2Q
M+R'RB0>)2)A.1H^BU%=;Q"BP.K SFG9J'--*K2.<3P;?@J^5[+;=$,S6P?"X
MS3FZ0Y^K.0'6_NC,"B=79V1FDXY[&&8%Q,&IE]W=%Q/5B\)_OY(B8U=+WA0
MK";;-BRE*9*(8PS5_WV(HD37R D%3,/89W% /2[[,I>-').FLH-"EE60ZKH^
M1K'<T?5=)VMF&PK],:GN2 712H^J'4"C24-[1EU]+V' /GBZIT0K*5Z+(_M
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MJ7:^88*]!+,XI-8[7Z.I)[G73:WWNF8P&^]NG4,W_'Y6BPPJF6=@(_4,E"M
M17-P6>]?E>1.]Z]66+G;L9I-._8>U0J,([M2N_M[GAJ*LM11?V]RP3=Y#<3S
ML2\0AR@. HB\ $&*(@*3R&,Q3UD4VO7A.#;)Y SH2D;]P:ZEM#P!/ :CX0G?
MA> ,;4Z_P&6 A) N!%P=S!V;8MR#MPXE#P[6NJ[MX6_:)JC>YBLF!"_N5K\*
M9?,([?1ZKV3]0G3/\+J<TT=1/NB6>6VMU>):OLERMGXL2LU(A?K]/ JBQ ]C
M"66L=M4HD!(20A(H$941I41$H5%ED&'$FQJW[&1K/S4:-M_BO%$2Z <&%*2N
M2BGJ:F>/E:8@VZHZ YD$;%=;?9&%1\W]DV#@EGO5]1V8'G>6ME4.W*W KP*T
M^@&M(- :@AO9-MBNE037NTM[K2AV;VD_OO+26D0UO^H2CQ0#_5I+;><5'FPE
M.EW+[F<=SS\]&&)[3N[A9NEA$%1!Y&NF0W:6]U^>LN5*RJH2#F%:QEN1Z]X[
MY%[,61 3$6(!4T'4?H!R K$O.601Q\AGD12Q>5J.\;13^X WLH)R*^P,K+XO
MU=2ZDL+31G +OC9? X-/["#(#NXDW9%Y!EJ,[W8QOAT668LOW" (C_3E<H2T
MW8?(&K#.#XSY:.-].*PUW/L@V-_=S\-SQ=AJK;X@]:=&IW2VS6J2T(MY(*"'
M0U]7!F&01L*'G$:Q%Z- !#ZU\?*<FFAJ9/Y;OBJ*9N>EI;3L&7(23S-WCPN4
MAM[3-"*"K8P#>'W. >'(\W-RFE&]/^>4?>D!.GM]GRSLJ^O;JX]?;MK"0)A)
MD28<^CR0$$D>0D+4ZQ\*$5),@BB61D[>(V-/[8VOI -*O!GX\.&-3>[O/F0&
MAEA_( 9^J3<8]&ET]@('FW3GWGB,E=G<XN(J=_FHPMUIRONWC)B1?%36_>3C
MXY?T,T5>Y"[_OLP4PWWYO7FJ/(:]Q(\E3 +LZV*&#*:!%# BC" 4(N''1H&0
M1K--C:(NJE-@AJ^9?>(,M3%VC[N 59*"GY2LQ<\#F"M&N#BR6;KG&M5P,5+[
MI?5B=E//ZF5-]ZZF4 U]6>GF97V$)3\FS97:8WW+RN>J-]6V2#"/) T"'D/?
M4_LBQ3BZ VPL(/4(#PE+DS2U2H<=4MBI,5A=WHKNE[?:EAV:':D9TNAE6=!L
MR ? C".GLJP#4^S1@F6=*ZHK)QPEYMEFL0?M!S?&PKBJ;C:DJ.-6.!L!](,J
M9V/,:1_M_%YAN%J*-IKT[5K<K?Z6K=K:/7]=/8HW>E^?/W\@WZ\>2].J_K;C
M3NW;T,@/-G'1?"UT!,1&!QWUH+4 C1I Z3'3&7?KCL*'E\/?3?=#(S\P?0\#
MNE7T>5_T>D6B6T\V6E1Z7QAV(]1[C]'#4]C1H+@MX'%;5:V:(^[Y,1<A1#)0
M?R0\A10%/A0Q3TCD1Z''S9V(QM-.C=X^'NM$/@.LEGT&'AOIFUI?X*?[7! =
M55D^D*5A/5_+A3%P50X"]\"<UMW(?%M?!MQ:5%6SA-;"^SD(Q",Y1EU!;><^
MM4:LT[-J/MIX3E=K#??\L?9W]^XCR,6CFJQHCXO2-$5^JG;X:1I#Y),4IL3W
M8$)(Z#$B$T&D92_ O0FFQNE;^:Q[]^T#9^92N 2.@3EW*]H ;M53>KMK?K<_
M_-@-[(XJ=Z0)W?'K>K:#V2W\K7>^9997'IMM4N,55;MAPLIYXJ>!J+I[TD1"
MA"B!J<\1#"(6)P)1:EA]HL?<4WOCM[*"7\52R*SJ,MX(:]E4RF8)S AB(& '
M/Z7IA:E]3QE[=%SUF+&8>=R>,_:0'/2@Z3%$GW(XC]F*-5]+AA/$8H&@0,*#
M*$@)Q!'W(?;B)/9B$4=Q:%X-9SOPU,CF]N/UC4TDRBY&!GN[GIH/S :5TL[+
MX!RJVET%9^?Z$8O@'$JY7P/GR._[%G-?BC9U\#UA5=YPY>">\P3[D1\(]48A
M'R*/8T@"E, @2'2,A><3WZ[8[ZF9IO:R:4%W,EA;69NC*,M/^VE\S3[D3E ;
M^$7M"UB/0N=GP'!6N?S4/".7(C^C[F%M\7,W]".)$UE&VX/P0":1]$0(%56H
MS4$H*,2Q]&" 8YS0($Q]EMH5(3DWI<WC/T[QD?:0L:KB<SJ9;]MC_DM)RMK8
MO5[*5?Y8&4YV[')V8<Q(QB78 W/-260'C10P!<@1_YR=;E0:,E7^)1L9W]?3
M;T&*A]^7V5+O*WA]##D7%+.$L @&C.DDE3"%F.,4*CN&1RC$$@DKF^7('%.S
M5FJI &\:L)(V&T/\T&FC.LOX[?4;T*@ %MFC=4O;(S@;.B$N0V]@)M'2S<!&
M/F<GV0;:NW(F')EA7*?!:14/G ,=E_;U6RZ+U2+CU6?S;R3/-/U?+]4[IYBF
M+DQ^JW[/GN>1Q)A[/H>^3&*=NY)"&B(,&9(IBX*(!%YD9YT8SST],Z65%K3B
M@DK>S#:QS1Q^4X_E ) .32&[,L_ "6B?9Z"6''QM_CN(C6(-H#.7INF\(SLT
M+>$X=&?:#M [XS9?ZV+B;/4H[LB/S0GM/,)J^Y2B"$9>K'95)(Q@&B<1)#S"
M81Q0(I'EKNKD7-/CJ5I&4&HAP1-YUNA;I]Z> -:,D9R -3 #-3*"!JU*RDW4
MA=/LVVXHW*7?GIAG[/S;;G6/).">N:%/V96L^.-VM5I\6>=/BW5QD[\5,F-9
M67P19;FH/ =U\,:55*2D?JR<"$I!7>QQCE,OI*&?0"\2B3)ZO!BF ?&A3&,F
MF? II;%Y*99+1)G:CDDK YZ4-J"HU5%+HO9/M4(S4&Q4:@/PB%9*_Z75"CQW
M]6]TO9(&!SBCK<_0!\!Z:;0BH-$$W.3@[69IMMHT862@T@?L*-3=6M/UTMA4
MA!EKB<:J$C/P4EF6CW&!;G=)F8MF&+',C LD]DO/.!GQTOS-ML;%;6T*7BUY
M\]%MRQVK'>R+]#PJ!!:<Q# 1N&KKD4(2Q#X,1(IB%H<(>T;1 2Z$F=I'</>T
M8E/!I5&G2LQK+<NFD9&E=^"B=3,SS\=:C8$_><8+L:/,2%F1_7%UGO780Y17
MRFKL#]KIK,4+QNP38)6OE*U;/M^JY[14<^ESG*<7<5Q* MWR[(JIWQ55I<KM
MZTLB7T:Z.UGLL0@BRB2D-,303Z@7T8 $24C,@[(N$V9JM/M!O=$ST"I5O=\;
MC6;@DU4)WTO7R6!?,2+Z ]-LJXD"7^L"KG:1WVVJHW]1*01V-%*$:T"U[I?(
M8G\QXE*-M,/H7K+CZ[15UE6\H!M8NV,,+YQCQ+A$-VCLQS(Z&M,^__XNYU=Y
MOLV,NKJ_O_I&LH5%JGW'$%/[]"C1<G%/2D5Q6D)S?_HYJ+J_(PY1&O@3H?-J
MLN7]?M&2K=#@"(!.T]\-4.J5Z=XU[FA)[0;*[>:OFUQN_\)?+XM,7:D&KT[N
MU+BZNOJG57G%5T^EX-L/K^'K;SS@U,B@$1RTSWPK?F615B7GN>+= BA50*.+
M.5F8PWR>.@9!>& BZ0&NF8%I12?6R/4B%_-91J,::\5WB<?^YCX=EM2WA0M>
M!VI?J:]*];%I\G6B."9^3'T8!R*&*%0_I1Z)8<!)['FQ""B)S)LE=<PT-4YJ
M9&W3"#;2VG2UZ0+68+_K"JZA3_U/(-6G6&\G9#8]?1Q!-U9['MN'S;*OC@$:
MW2URN@88L=N-@1[[C6M,;N@9*+4L,YXMUF7V;:><Q;L?;+'F=4\<G8&Z+IL:
M1^](OE1?W^)6Y%75MR9TF3!,,4X"J/-#(4H(@FF8Q##F*:6,>((%1BUJG$HU
M.2K>46JG2!'X*5N"0HM=&-8A<KMV9@=#HZ_(T&R_NQ@[^]%6H[H;X(Y.5092
MHY4^< >57NYJM0T"M*L(,B<RC1MMYA+&@\@TIX/W)&Y=G/Q.W7OU(ROFC*9,
MF; <XD!B?3P4P%1O*Y! 48#CA/N1D7U[=/3)$:D6#FCIP%<MGV7V\#YRAO37
M%X^A:<P8"GLB.J:R*T+9&WM<8CBFUL$+?O2BGM$V^I7_]65UW!U_Z*_/VTN:
M&L_5_'6JG]H[EWEEO!<WY8/:1#^0Y<V3'J+X30U1%M?+IBB>SSP9X0!!F7@!
M1#[%D.(T@(&0/N:<I7%J51YL+,&G1B\[U;.+NJ1VU0<"W&NIU3_VMM=&>Q+,
M.&V*ZSLP7>Z64]]5>O=X M!G<+3LNE9]UF:A[V@/*O6K0J*@ 6 &:@B >E1<
MU69\K65S%78TEMCCABB-O!@'X4QCS]_',;M89'IRELF,W<@W9)')E;*(B6YK
M5+O$1,J%AU(=5!I3B%+$(,%I""D-6(12K!VVYN[9L_--[8MS=6M3A\H 3Q.O
MK%.4AC9S*V%!(ZWN[+V5%^CF87U\M.=AM/'4.H5S+'_M&5A=^6V-L>GVWIX?
M9D0?KK%.^YY<\]OZ[3;>DRS_&UFLQ4=!=)1/Q>V;?_QK)G(UY,/SV]4CR9;S
M4 A&F? A\3"'" E%N0R'D*6)2&-!XU!8E1ZUFGUJ+*SE!)6@8"-I=;K\Z>IO
MX&LMLZ6KP6XUS,SVP3 >F,,O@]?:3.X%DR-;UV[N40W67K"\M#K[#=*/T!JC
MM7B_RC^LBD(45TNN?[CB_[6NBQ\UR33S@.(X#@B"W%=_(,88Q"F*(?8\)K!$
M,D9HOJR"S?C=JB0+,TXS%L#H7</UNW8@QH 1>'H.\$0RPV C>^#->,LMCF,5
M8:Q309Z!^DJ#WY<:1?!F0;+'.NZH^7&K0IO9-6M_==N%NS6I66/HB-#,YQV5
MS*SA>$ED]@/8D1@7V?R:R?QJS3.ULE=E*8K:J'^_(/?S" =$_P^2B,?*_$K4
MMI<G :0BQ7[BI=)#1N97]S13L[.NW[S_#!I1P8ZL0 MKQE%G<.TF)'=H#<P^
M_8 R)A4S'#H"&-4 -7FH'[:<<6;840C"3+66#0RO[F>__%7P^VQY_U84V?VR
M]L[I8T>:D)!AG$#$0V6L\(C -, 8XB26@D2II$%BL_,Z/LW47OU&2K C9J\C
MW!.@FADBET,U\'O? R5K2Z(;!$=FPXE)1K41NA5]:1"<N;H?!7S.[A_*&_E[
M(:J$JQM:JFV1+FST[@=[T(YZ97[</*E-4ZFF_J"V5&)C=\YI1",24PECY$O%
M$XF )&$($L&1AW B!<<V/'&!+%,CDTH5N))P70A M#8%6#7ZZ(,WT6A4V>ZK
M5B>PT$J!Q3;)VXYZ+EI,+XRD[P<PI=4Q1Q*KGY2]%V$4,#_D$8JD7>VYD99S
MG.IT-_MK-.+"F'TX1@)[X*_+YK51>C3)OC<[;\V[W;=FNR*5.IMR&:?[Q5M_
MB!R ZNAK=8DDHW[2'$#V\KOG8LB>'T>QT)ZP6Y*7SW<Y61:$5>?/VT3E;6:;
MQU@LDBJDB?@0848A]GT"0Z$(-4ZQH"BTY$_SV:?'EXWPL)(>[(IOR9P62V#(
ME,/ .C0SUE*#0SQW:UFX32J\ #%7M&<Q\[@T9P_) :WU&*)GRR>A>%.<H,C?
MEUQ-J(.^!5>$JBYM<B]H0&D44@Y3$280:59+221ARGP1AFF >&KE!>@EQ=3L
M>JW$7T"F ^@KDZ0N#FW9(:K7<IB1V^ @#WVH4<D_>VG<S;;6G>[@L%4#U'HX
MSW2Y"$=73:EZR3!NPZI+8#IH9G718/;%(6[%ZHJ5:[)8/.N3,!VD:%$(YOC=
M4^.KVW<WH!6S.N][$5K<_=J80M;-36[0&IAX+@/*JDY#-Q:]BC*<&'*T"@S=
M*NV66SASY24&3MUH352\L=,1C;(0L9APW:J.0L2" *:!CV#H8T1DZ,6<616%
M[9IL:J__AQZ^JDXP;:R0RR$:R=AH!*U-C6*@390))DX-AQ-3O8)]T*WT<3/@
MS#V7%I?6O+-:5KD%<M/$H8FG:#J1OZA1[).0ISB44%(D(?*3!*9>$L(X0BD3
M813'MCVE+I!F>OZ>W:K&M_GJ6U;HSZ;VT^YV*NE;4]I^N<R(:J0E&)C'=K'?
MZJ'_ML6^#?X"/S7:_#Q23>G>P#HO*6TOR2M5E.X-V>F"TOV'[,>TVUW<JBC>
MD#Q_5E10I:I^R);BNA2/Q3Q*PB#"A&D>32'RTABF))'0#Z.(I%',8FJ5$VPP
MY]3LLQTWAY(9[ D-OFJQ026W90B*"?IF!.D8TX&)\'(XK8G. B!'A&8RXZC$
M90'!2X*RN;4?$5WK!J3:DOPB\F\9$\5G\4TLUV*N$[B0%)XRX+BRYV2:0!P%
M& KJ"2E0E 2"VK#/J8FF1CG;9EAY+:#Z+UO=+[-_"@[62UW&DM@5XCL+M1G5
MN !P8'[9B A:&4$CI#M".0>#(Q8Y.<VHU'%.V9=\<?;Z2ZV5/9]SVSV2)P)A
MD480Q2)0A@JB$(M([?^")*:^)$D<6![M=T\XO=W=C:L(M3-(4\QIA*4'PU23
M<B@(3*F?P(![:4B]1,;<J).(>YS'.UQDM7"*HW/M>G:*KZW1=REJX]E[!Z>$
MSENBFJ'BW,@[.MDKV7==BI\V[3KOZIE)ON,=W'1H;C+^$.4^%R2%?A+[VK +
M((U"!H,H(4%"U1]!8)4W?GJNJ1'(I@WY:GDI47<A;,8BCG ;F$+V?/^SG4;N
MM:0.<[[/P^$JP[MCIG'SN<^K?)"];7!+GS(_3ZPJ-?2P6J@[BK;P.L4!CX@/
M?:8+KQ,<04R\$/I$HC@@BD,"H_R%TU-,C2 LB_D<1:W[[7>#Q< OO8(![ IX
MOD2/95&9+OV[Z\@<O7/$TC%=DN]7B^F\<H! Q38?^NVZZC-[IW 4<RFE\!.$
MH! "J?T9#6 :I2%,29@@*HG@L5'3\]X23.T-5X]4[# <\2CH9M__0:$<F"!,
MPA#+%:"B"A6:58VM0:7$2"&(7?B-$7YX=/[IA!YVP6,5=M@Y4.^]2U:J&;[I
M%)92/769[O!:I0A^$N7<QR3T=)%<3D-==T'&,)5$P@"CV&.<*5Y3VQ?S$C'=
MTUG1UU@%8:QW*EUX&F]6'*$T_'Y%"0HK2<%6U#I9KNCN*-MGSV* BKMM2]=D
M8^]<#!0_LGDQN:MGK:E373,W)V5SAACB5>(9BB1$GA20(&4;)5$D(IP*Z@?(
MQA@Z/^74K)^7'63WVBU?<*!N +X9S[B%=&"N<8"F?14I8X!<E8\Z/^&X=:.,
M 3@H&&5^9S\*^B2^-XWIE9VD9ENJ'UE=8*_JG?=<_[D-PD,R\;G$' H>*%L&
MZ\YV2:*I*>3,#U(9<LN825L1IG>4]EDP)>WB>=,(<JL/V%>H>M_JRSLNTCTE
M_R$LFW;V7E$SEAMRE0;F/"7Z:;!G=6?/9_"U^>\@L9-]T7-$B-;3CTJ/?<%Y
M29:]Q^GA?;XC/ZX?U?-6ZNY+U\MOHB[?5\R#0+$CBQE,>405/WHA3!F3D$?J
M%P&.!,9&1U6=LTS-1M/!R%DE:-W'+-N*:N&;/HFI@7O:!5(#TY &J981:"'!
MM5N0+(K'NP!KI)+Q?4"S<^R? Z/3MW_RYO'<^^?DW_/PG[W8C@J+O)Q_%D]J
ML1]((3:=0M]4.;WYDRZ#\$DM;E-O7'HXYH0B2!C&$#&:PC0,D"))P5$<>4Q0
M(VJTFG5J5+DK)=!B6I9ZMX.\FSD' W)@)NV!H3$G],*DRTQ3 ^Z8:.IO6_/,
M;JY1**67^BW%]+O9N<M=&8'KQW55B>7J44?<_;/^)C))0AK2&'JQ[T$4!3XD
M,8F@Y#Y%H>\E$H5MP?:+'?$GA#!ZB_:+M@],2#N"@EU)G7GL3RW'Q5[\2R">
MAF??&GN7[OXS\ U_!'!*@*D<"YP!R.*HX-Q(/3:@OZZ+;"F*XLWJD69UZ=@O
MNGODFU6U_:UH=UEDO#H"72VWM2>)D"@*_12RD/FZ=WH$21IX,.(X2+F7"":8
M\0:UKQ13L\I:/0#;*C)KVG&RC2[ZQZTRLTTDYNGRE [7S6 3/,9J#,R8FX5X
ML[L0E19@JP9XL[\0Y^N$.EP(BXWV& LRTD9\J(6QVZQ?"FCG9K[WX.-M]B_5
M?\\9</%@(T0$?E_-:1Q[OB\BF&"10D1"'=+K8QB%!'DR0D$LK'+*+>>?VJ=*
M/;?1@-& "G SPWQ & ?^QO2+!/R^>J4XP"UVKQ$%J&:?;@S@%IJ+(@!WANEA
MB:O15GG;PC7DH1>CE"ASFE+=9T7"- U3*&*:8N[Q0'A&*>@'(T^-AI1L(@>G
M6[:>P<G FNVK_<#L48D%>K4 WD/ PHSLB\1(IJ$Q(G:VWC&M.^VWO1O&L\F.
MR;EG9QV]H&_$8/:-E.)V0>J#[>99\CW**2$A#!,90"1U-CL/)111*GPL&/-"
MJ\(7QZ>9' 754H*-F+8!@$>Q-+-^+D=H:)IZ"8[#U],,!&?!?$<G&3F KTO1
MPZ"]SJN=GW=\7BT6[^L:.W.&XBCEDD AL=#A)PG$:>3!),4103A. VSDW;.;
M=FK,T#A9ZW+NK=.];MGT%V?G&KNP7WR6T1/,5SV_ %^UU* 1VV4O;2N<AC^H
MV)UT*H<31X"P.) X=G??8EQM$$E=@[#-\)[[*0M(PC&,6*)L$D)22!DA,$U\
M*GT9$!Y;U6@^-='4N&=3;B"KQ+2MMW4"33."<8'1P)2R%;&I9+HMT."RX%8W
M#LX*;IV89N2"6]W*'A;<.G.]?=N%+^4?MSF[R>^*_%U19H_5AO.C*!]6?!MG
M;MB$P62LJ;WS]3&(LON84)B!NR^?P59V4 MOWI'!",UN0A@"R(&)P01#QW7<
M;5'JU<?!:(+1NCK8J+O;X\'JOI[G0ME25S7.!<_*]X35I:56CX]9Q57OA;@5
MN4Z<(?=B'L9(II*F,!9!"E&J.UD'1"CDI0P181Y"D=69D/G<4^.>S^*_UYD2
M')#E<DT60#;B ]E1N>#B!3 \(QH&UJ'/AW02I*Z[7LD-6L%G8"LZ4+*#K? .
M3X;L$7-U*F0Q\[@G0O:0')P&]1BB'XGIL_.<L/+O6?GP9EV4RK[*#THV,D2)
MB B&?N#[39/MF.N42A*DU/>Y[R5V.90FT]J\8>/D3;92]R]I9P2W&5>YAG!@
MDMI@]UW)"UJ!ARV7:0.1(U8RFG)4.K(!X24/6=UK1T!<9/,O@JUS-5+;1%D'
MV\]]%F/&90S]*& 0(1%#XI&J)4,L&4*$<\_$5#HUP=3LH5;&;6=Q+:49K9P$
ML9M"7$ S].[*#A5C:CBG>L>62=U:,X#Z8?OBGQQPE)?\G#KM"WWVNI[-K'3U
MO5])(?ANI\*;)_WGU9)?+[61DGW31TO+)J=Y'@=^@",LH9!,0,3" *8\3"$5
M/$ D" /U?YNM4 \9)D<!6@58Z;#7\M&R556/Q3 S-0:&>&@JV4&WB:0"5WFN
M7X'ZG'G(0@H70.>J^50/"<9M.M4?HH-F4Q<,U;,>S:H4A1KZPTJ-J NE9-]T
M#ZM/HFRM^8C&-(AB J,P01 EV(>4! BR,/5E2N(X0E8GW&=GG!J[58+J#B^-
MI#.P["@0UQ-E,R)SBMWP9]EDR72T[^<=Z(@L=1CC8K'Z7M4,U]T-&[^/[E\T
MP";*&#-7M5_.SC=NL1=3]0^JNQC?V(]YWCT^+5;/0E3G$#7%M9&: <5AFF(H
M0AY Q /%.(PBZ,F(((H]+L+$AG%.SC0UIJF/9%:5A):.F=-HFC&+$XP&9I16
MQB8+JI9R@#"[LU@X8HK3\XS*$&?5?<D,YV_HTU[ #[R_BL7BD2P_?'C3/+LB
MIK%/TP0&2'IJKQ532-4N"_+0)YQ3@65@GCM[;(:I,8 2$30R B6D3:.!8_AU
MO_M.4!GXG7\!2)\L@*/(6&0#7(K02%D!IH^.91N&#N6[NS <NW'$)@P=<N_W
M8.BZL.^95%%JRZEINE+,,0Y\3)D'A8@5C2$_@B1!ODZK3$/"(H]&GDT]\I<3
M6+'86!7(@6BDLSUA>@$>IY&?"!K!* TD1"(ED.BR[F'D13+P/2*Q48<9)^"-
M4K"J:.J6.@+0]#BN/RR#'[VUB+P[ATB/([;C:CL[3GLQ_,A'9\>5.SPF.W&=
M?76ZC^1']KA^;+ZRF%.&,4NA",(0(APKSJ.I>G>I\%+"91I&1O;;P<A3>VD;
MX<Q+RNWCU/V*7J3]P.]F(Y?#7=A);2\H^K8_WFB%W8ZJL5N\[?@%%_I3ZK:^
MQUW)GU95,++@5U6'\.I#O?M[S02?5N4_1/EYT]%ZGGB>C$/$8)*J5QD%?@ I
M]@3T:8*#A%#/B_Q>_AC7DDZ-%7Y?[O0%9SO"MY_VGCX>YRMLZ2-ZS75[W<.V
M&=CH!RH%=9!B4585Y)]%";8ZS72!N;5+1_;@\+MV:SF7\W7<8D/!?=*M-MB$
M]A%.;QO?Q9VZ=1ZG,DEYD,($ZUH;^F. HQ!!GW@QPIS[B30* G\Y\-1HNY4-
M:.', YGVL.IFU$L0&)@ S92WBE<ZIFFO.*6]@4:+3SHF_FY<TM'?]XQ'8@^"
MKQ?B1GX65?7*6UW#]TY]?@K"JE.A.WT&M\U*8A[#A& &.4&Z43=-($9>Y2J/
M?!Q((3QL%]EL*X+-HSM.E'.K@4XI>"]$H?,>]8DE;YK!?!/+M0#O2+Y4_U2U
M3V@T!96J8%=7RP@FV^4SL[N&7)*AS:F=M3B-,OA:*3!0!%-/]%R%+]E./V[L
M4D]P#@*7^H[3CR=_6ZWX]VRQN&)U+M;;=:Y;T(@\6_$Y5P08,AS 5.J.63R-
M(:4>A1Q'. C]B$8>M^/$KNFFQW^5E$76@[\Z837C*E=0#<Q+K9BZ)'B3SE=+
M"FI1W=&/"2".J*9SJE%IQ43IEQ1B=(]]JKSBG?6"Y!^RHGSQ\37,CS\YP-2V
M+8V@0$LZ Y6LYCGPIV'J?N^=(33P"[\+SB#FAA$0O1+:3X\Z6A;[6<5V4]?/
M7]PS7WVUO+\3^>-;0<N/I-2Y()DH/HNGIKKHC;Q5C,&R)[*XTE&FNM3H^^R;
MF(?<XPCA!'H\4%LCXG.8!E+",.1<QH%$$;6JUM=7D,D1QH/(1160:YFWWG<A
MS$R(,> =F&VT"E#K +02,]"H\=S&/U<5CK7,#A/9+T3-559[7S'&37&_$*R#
M?/=+Q^L?:'0CM>&D3^\;O_&['VRQYLIT>BN><L&RRBVL?EZ()HMDKRF03V(_
MB5,"PR14FR7=K8ER(6 <LL!'TO<9L8ZNN4RDJ;%D=;ZSDJ"H=2EF0+3J +ZC
M3^5=(KT;.CE82YRFQ)>4P@3)JLM? (E4^^"0"+7*:8!%8EWF8,S5'*L(POYZ
MCKY,9E_!<:$?^'O88EZI4[THC4(SL%$)[.HT QNM9M7UPW3K<@>RPWBQ"P4:
M/<+,#8#'8M(<C=R[ +#.4.ON9*"67<Q9['D")0'T48 AHI[:7T0\@G&D3V6D
MH&% [7C7>.[IT:MZI&/KDK^&0)LQYR#@#4R0C<Q&C5&TZ$YK_]JAY:[\K^&\
M8U< MH/C2!%@RP'ZT=/5LLQXMECK=/"F,H;:<NRT(J:^H#PE$11A%$+D5R4J
M8F7C^]+W.!4!]:U*]IV;<&IV^ZZ\8"OPK$\3:&/0S1C*)90#$].%*%K3D2DT
MCECH['2CDH^I\B\YQ_B^'GF959+G=5&L]T]DJNBTXJ/([W4RG4C2@"$"?2()
M1)'G0Q*F!%(>4<8PQ<*L]+CIA%.CFK^N%IP2]@<H*B'!<E6"K-) ?[[E*G\4
M>?V[!W6E$@C\E"V;BW^VR&0T68MN!AH"X8$9J$[VKL7=/Z2=@5KD&:B%=HRD
M18JH8T1'RAC]M-9I!Y4OI'YN]4\5VLW#RVNTRP<!GBJ%P-,Z+]9D6>KG^K'2
MZ\^.$DTM(.S,.S499[PT5 NM]K)2;>ZS3])Z\Y )^>Z'^E+H+\:-E&IKG3>I
M2 @%B4<\":E/%9?',58_20H1"U*)@R FD9%#^,P\4Z/P2E2PD14TPIHG='5A
MVLW)#I$:VHUW'"3'R5\&6%R0"M8U^FB)808J[J:)F5S>;Q?Y-BO88E6L<UVN
M>2>-H(GBJQ)#MXD([39V&QQ":")#PAF,8O4'DBB!- T()"3QD Q0DOK<9I-Y
MH3Q38Y6*QB\NC'CI(IEM2D>$?FB+\5S!Q$'BC!WAYVAC>ZDTH^Y['4'W<EOL
M:MB^C;I8KIV ;T7]W^OE]5+)4CD'M^77YP0)[.MB9[Z71(I!!8,XH!&,F>Y=
M' >)8%;E%<VFG1I1;F3L7YK>$&\S,G2/XL"<UPH,?FI%_AED2[#%]8,!KCWZ
M?MG Y*P+F-&D(_<$LP'BL$.8U=T]@X7JJHWOA;J%+.[(CZ;:QZ]B*616SI&0
M!,E8,T\20L1)!%.4$!@QSM(TIK$R\RRC1[IGG-[992.I943(&5S-",<A5D-O
M FM)02,J4+*V=7G 3XVXIYV:]B$:9L"XBK\X,]NXP15FJA]$3AC>UH]&E*V4
M%3?RBC%=W4![IJHRU/6?VSU'@$(>)[&$@A$?(HQ#B/W(AQ@%/&"^Q*D7V[&)
MV<33(Y5*;NU:O56CMDY=.XHQQ-R,:=SC.##A; #<BCP#3<W[06O?VR'EB($,
M)QV5B.R >,E'EG?WK'[TW^NL?*X;)&X;KGX69*$K8/Q&LJ4N+WZS5'O"IU5!
M%G,<^K$G,((T3!A$$54_2>[!F*0^QSZ.4)Q:%36R%&!J.S M(5@M@1*MRM86
ME3[@L>X#FFTTLBQ99+LL9APV)-@#LUDM>MM?=2O\#+3B@VHI?M(:_*Q7I%7"
M826AGO"Y*A!D._VX=7]Z@G-0SJ?O.#V"--X**72%"V7LU?WF]\//YIAZH9<0
M!B,1>=H:2R$.$A]R&>A-GV2I,.I)9C+9U(BMDF[C5GJV"!(XAVHW5[G&:F!>
M:B6M]G.UK+,Z''4;C>H0.XO@"H<8CA18<1&6=F$3AN!TADR<&V.\< E#;?9"
M)4SOZ;G=71?94A3%3E&-JQ]9,?=B+_53SF'*O00B$DE(44JA(#[G7B0%PK&-
M^7ABGJF1:2LFV)$3?-626D;2GL+5< ][.5I#;UI[ &6_0>V&P=6.],0LXVY!
MNU4]V'.>N;Q/@Y)Z_UK<DF==U4 G&S&6K\6F:G83[*,(( IYBF"4) %$B"60
M!#Z''DFH"$(I V)N:QE..C6::,4&C=QU"E\M^?DB[OVQ-[#(!D!T8"HY //J
M")@.8[#ZP-3="L1PK!&[@]AIM]\PQ/+>2_Q9VV#^]]\^9;J<=+U[U#O'><@3
MSN(DA&DBU*8N0C%,_9BI!9!)D"H#),!694W.3SDUFFE\*<5.6LK[O\%/US.P
MWL@-%DKP/DZK3NQMW%2N$!W',?7E$,RMR%6/1M=^*!-\G'J>.B=\!5^3"0#'
MO4M&=_:P=3XHTTF(FR>1$^VPKW94=:.WN]6['Z58\J8H(/6Q%\<!@PGQ?8A$
MDD*<2@$CX6,B2)AP;-0:P&K6J=%0TXBP7 %123EKLB4L#!QCP TLG"%@')A[
M:I%G8"-TFPC=0'NW N\::,_49[P 6@N7U! 0C^2;<@>UG4%I"UFG16D\V'@F
MI:U^>S:E]<W]C,J[G'#Q2/(_=$F-ZB\Z1[3=/"%&D._+ +* "(CB((4I8@*&
M$0N2F"2")<3&GNR<;6H<7LFG+_BEW(AM9S5V@VMF,#J#;&"^WLI9[>RKOU89
MX2[WH5:@.#(0N^<:U38T4ONE66AVTZ7-"3YD2QU27[5M?T]8$Y^Z#422C'HL
MB!$4B>Y%@!F&%#,*!28,1TD:48QLF,1XYJFQRF[Y^Z;+?2.UX5F:/?9F1#,(
MH@.3SBZ86NI#4#,Q5BL!0]2<]Q X-^\K-0\PA.-TUP#3 7KL96_)L\C?-I]A
M2CPFB&(F%BE20ES1$Y91 D,O$!%+?92$1C;.P<A38YY*-O#68I^TAY/!-K.O
M]@.S1*-XGT;A>PA8[ ;[(C'2CN_<HV"WCSNF;.=>;>^&\?9CQ^3<VW,=O:!O
M:DU1KAY%_D;+M2SS.LLP*_YHGJ4X(!A[/H-$>FIGE2(*24*X(J&021;2. FM
M<OS.S#<U+FK%!7OR BVP;:I--\YFMH]#] ;FL@[@!MAG&>+B+-.F>[:1,VV,
M5#_,M#&[K1^K?!9%F6=,9RJ3XN'3JNYBMBSG3- (>;H!+_%BB"@C$&.>0)F&
M&.,H3N+ JNC"J8FFQB-;.0%3@MIQQTDTS4C#!48#L\4./%K&JE5M(Z4[DCB'
M@R-V.#G-J+1P3MF7?'#V^IY%6IH(QR_*4M3Q!A_4*BVNETQ1SV&Z*0\I#UGD
MP32A2-D:-($IEQ)2&1">)J'O!Y9IO#;3V[P.(W6#U%);UENQP=N,/H;"<&!*
MV00R5W)7OMY*<E"+/G3N;Q_47-5/L9EZW&(I/4 YJ(S29XQ^Y/4WDF?:(_=9
MSZ0C?(E/!0HYAXCK G,1U8T:>0"5W8)P& <)"X6-]?)R@JE9+:U\0 O8*U;Z
M $(SSKD$F(%YQ0H3:]HXI;@C:C@8?M37_Y1R+U_QD]>YJF9T,@YRM]J.A\,T
M)"B&<>CKDZ @AD3]"'T<JY?>#X@7!9=5-S(18VJ4L(GH?=H)CR9-1*^P"H^^
M<'W,F&1XU ?FFQ/5D3K#U$<JF&2#Y& %E(R$>.6"2C9 G2^P9#5:7\HLU3.8
MZ=&KO+3=WC1U.$_CMA14>%Z02$@45T(4^VJWAGT&$X^G$<(1C4*CC!';B2='
MB[6<0J?%MQHTZ9.V9&B(O"G]N<=S<,)[ >!LKX-6$]HW@!/9%BMGE&8X[<@D
M9@?&(6U9WF]'5%QD\R:"_-D/Z%U6+L0\BC$5+/!@$)%8[=&8;@@9$2B]-.(,
M>\Q'1EDEQP:?&N%40NDP$C_XB?[<ICX8AN8<1:^;4"[%9&#2L(7#F!RZ].YH
MB:UNJ]]]]</VE3\ZV"BO=9<:[:O;>4V/Z)5W4@JFJWYOO#-Z0_=9:%&5F5)1
MP2=1;D.'5T5QQ?]K75<;422A#Z;F@DG= "J$8<2)[@!%(/625+M@ LDD$=@S
MSTEU(M+4J.#3S0= -D):!(VX6:!NWG@=V =FFXT^N\[DRA^TK],,**UVTQ56
M.JM^HUB5IL!>8\TL(H1&7[N10HM&6T.[&"6G<'<&-[F9:;RH**?([(53N1VY
M9X3Z6IG*U?9>BS#'(HP(1QPFD4Z0)EZB3-DP@)Q$+*:1\#WBSY?B7A>#O[.(
M1M^;Q>BMQ/5;>3#7@,>>C9 @JZ2TC#;?Q]%LE]P#EI'BQELHKKNAL \'/ZJQ
MJYCO_<''#>P^JMA!]/;QJRZKL_1F]4BS9=W7>=.^89O=@*2?:'<8C%/,(&*Q
MT*V6/2A2J8MYJK<]-,HWMIMV:L;JIKC0CMC:PZ.=!+L%AXJZ=[INHOT]6UC6
M-3=<$3-R<(_SP*1Q#&*P%7F@'C)V,#FN[W1FTE<I]V0&Q*GJ3X9W]PW/K+K(
MW)*\?&ZZ_PH2"9'X#%(62K6Y%AR24/=R"<(P\DB8HCBQ"\Q\.<74F*B1$%0B
M]FRJ? 1(,U*Y#)Z!"60/F1FX4Q,,T"[Y- 3. C$/)A@Y!/.4@H?!ER>O[)G5
ML2!%<2/_3G3KL/(F_YS=/Y1US]0;N:V\\H8L%H+_^OR.L(?]:^<A]N.0$PD]
M(=4&) TDI#%)=!5>$0H_3%-A%:A]L413HX]*(>UQ_EZ+.0/+;4_:C3Z 50H!
M^@R$4JF]V+Z)LKN5-2.H4==K8#[;+%4CH7J50"7C#&S["&]U F\V:Z;5.KC+
M8=J**Y!=);9<+,^XJ2^NX#M(CG$V<#_Z;OOYW<BWV;>,BR4O/F;+E3Z8N5XJ
M<A-%.2>4!SRD HJ$2UWRQ(<D]0+(4LP#)$/&HJ2'A\A@ZHFZC6[50 _:5Z)>
MYN5J"=5#5"H9%MIIFS6BVW&MR3*8L:DK5$?+0ZZDU4C>Y%QM0_)GL!&\3L[9
M ??Z'+C6O&@!ER/F,YEQ5&ZS@. E>]G<VC<\C N9+;-2?,B^"?XRUN/=#[98
MJ\?FOO7>S&,<Q$@B >.8ZK0_W699=PKE',4>419FQ)-Y77GN2ZFL8#.NLA7#
MYA5[*<R [AIQGRV7^D7ZE2QTWT3;@#'+M0@3G-)4A)"A1'TXO#2&:9JDD(<Q
MHA)'C$G1K,6[)9_*2K2B#'@@N.3C+8+99V-(6 ?^AFQ%AY7LAW&1X*>-_!LW
MK\,$K+[8.8OJLYQ^Y.B^?N <1OGU',?NNR,8GU_=WY?O\EPWP_ZT*O\ARK="
M?<L>LZ6V+EN/OH%#PG2LJ?D;E,QY94P#)?EJ*5;KRL&_Z0RNK+(2*%7 5A<S
M#C,&MYNSAL!U8([J :GCPQ-;T#HB#M50#2\QOJ4CXPE&H1];=5NZL;ZOGUG[
MGF3YW\ABK4,_UGFN>*OJ__C[<D4+D7_3R1;7RZ=UN1\9LFG7T_9%JS)3M05^
M(^OSY:H,:J%I\4.FMHQ"!#0A)(!>$&O7*@\@%A)#@>,@\;C4B1,VKM5QQ)X:
M'VJM0:7V;-N92G<B;#  %0BZ OP6!E#A<!#@M=.T< 8V,.C=;Q,:MLHK7LC%
M@P9D&S+V=0L1>+=</XJZC(KE(=)(CYV9R3F]AVG@C\#_R.?(VAH>=UD=V= C
M"3VJY3WN0KRTUT>>O4?20.-'ORZ*M>!OUUK$.EVH$OM+J;[R=75QM;D0.<L*
MP><I\^,0!S[D,4804<^#1! ?^B'V?1(%$4^-/JA]!9C:I[$]L,HJ'0"OE&@:
M.X!O6@U0:#W JE8$B%83BT#T/@O5_0D: _Z!/R8M\K7XH):_S5BL- "5"DW'
M@@*\&PEYBX#_@5=@I/#^ 5;"+I#_ A@[P_;[C#M>D/X%6N^%Y%\R3K_-WR:Z
M_XNXKXY/FCSK*%%?%AHR& >20R12I.N1(>A3Y'E8Q*G/K%I+G)AG:M^0;<)+
M*Z?=IN84G&:[$ <@#<STA_@,D)%^!@9'9O:I64:UB\^H^M*0/7=YSR0<'9&E
M+&+!=]V 5YJ*[BM[]]?G[27-,>O5=Y+SNJ79];(H\W5]]EH^B/SN@2P;EOJT
M6GX312GXWX6.#Q'\ZIM2X%[\IEGNK;*F_S]W[[K<.(ZEB[X*(B9B(BO"F,,+
M2 (SOYRW[IR=F79DNJIC3OU0X.KD+EET4U)6>9[^ "0E43<*H$":?7;,KG;:
M)+#6!_+C6L"Z;"WSF1)4!5%FJ@V9(F.!%)#0C,-$R)03'&28I^YGI5-0;9KG
MK[\VXE<Q>:*8SVFY-,9R'9_G&)XW!9AGE 5A'*L0\I@KB$B6F#Z;# :A2L),
M.TN")*XGO%-0;(JGQO__>WKLOM!3$'5"YD"E*ZR4W3]":B%B DK;US6H@ J6
M&] T,6TA RIHP$ICLW%3JN"K&IX;L $(- B!"B)@, *[;4V/28,36G-?J8I3
M4&G<!,DI:'S&JIN4;+V+3=8IY+NLK5NFQ:)\-0NR. BXY!"'+(&($02IH!0F
M42JCE%-*9>Q84?+<7%-S)ULU%MJ9B!MQ'4_,ND"VC:SR MW@050]4>M3W/$2
M'OXJ.)Z=:>PRC9=4/E&+\>(M[I%-'[4&Q:*J-Z%)Z>7]6IK.J54EU3OU8:$*
M_3153/>TL@UP<AAR:DS1B XVL@.QEJ8_]:96>Z% 2X&J-N#:MH*.*]J7(YX&
M GKH,V^_&#N%._5 K%?4D\L\HP4_]5"^'0/5Y_8>9[ ?U_-'/<K?Y$*N<K[4
MK+=I04@D%B(0,!!A")$TS<""+(!A0'@2A!&3#%L?M)Z;97*$5,L)-H+>F*B-
M_W XKSL+I\5QJ ^0AB:3D_CT:6)X%BB'TTL?@(UT1.GX8+D=/U["H?.,\>S-
MXQTD7I)_[[3PXL5]JE=6+N4NV?,?^>I'82)CJ,CG+YO@4Q,QLW4=/U4^9N5_
MOE_7(5PF0&;SRUFB>$R#((,J2#--GP&&1"GSSP315 F):6I?RM*[?%,CWHV,
MQAS)MU*ZU$KTOX06E/VZ"S,PV3>;E*UD^48]T.@'V@JV=B%!2\<;L%W:.]7Z
MP^LNK4M-S%==XK$*9+[*4CM6RQQL(;I+9_J?=L0ZFH-AME]4<[AI>K8BW.[9
MW*GV]G)3?.==L5PMJ]UEUMI=7CKN*UXWR82(_N1!5>LL:XA-2#_@^>JB=YTP
MX_;5\P+<4:<]/Z.Z-W;XL%AIZGB@?WT2>L1<Y;PNP5L58)FIA 1*Q0G$S!2$
MEPF!+ DXS!+,5!)0RD5BV^6A<Z:IV<.UL-5IP+ZX314C^]X/W0!W,YU7V(:V
M5OLBYM0>P@J-7KTBND<>K7&$E8+M+A)V-_1PRIMCW;RL:N5IJZ+9( ID%G$>
M"Z@4#R"*LQC2E,>0"10%*(NY3.TS0,Y,,C4ZV 2':#G!<RVH@P-U#DD+!]<#
M/@._]S4TE8B@D;'/?N0YC!P\10]8C>3NZ3_]^,\SXGKRUBZ T>ERG;MW/+_I
M@O1[SL^E:_MY,)]-R7)C=LT8C1@)F8(L(A(BQ05DG'%(HC! <2Q41H+9JEC1
M>3??'8WL1'+;\8=[*A_,'*"N@<\+UP)N.\#LO+=>, S,995,-^!=E_+.GM:1
MHIZ<IMVXH_H_1^H<NC+'%UQ9(>+O4CS*5K_-V]4N@#8-0^V>X 2&0H80L91!
MIF@&%19")4F6!K)??8>.2:=FG%2[@76J::&TD6+>7A,;W;,R0A?<=J^V;Q"'
M/E3=[:96 @_3TM<%%-\Y_5U3ODY&O@4(9_/I;>Z]KA;L0U%UQRCE%UK^(5=F
MXW2WN3J+<9(RED:0*A1I@R"BD"&L($\$XD@/G))KJL%V3F[UVKQ>/=BJC.G3
M5NY6<>Y^U6"[%\*.C?SA.G)%V%4!&HG!3N36&9'_&K!6$'FN ML]YZO4@;6"
MX5PE6+N;>^S'?-.C-Y,TOG&8\%1(+"#!@?9,T@!#+&(,I8Q4B)54,HFL=V*.
MAI^:F6,$W!R/.&PL',-FL>UR%1@#\T,;ASX[+<> ..RQ7 7,2+LK5@^*VV[*
M6;4[]U&.[QIO!^6LQ'M[)^>O<B.H9;F:?3/GE;=_Y<M9F@I",AG!F&7&*1,8
M,DD4Q%AAB1GC@50VO+0WZN3HR @&?C>B6;Y]^R!ULU!OU0<F'U.-*E^N<D[G
MX(MV]-?EYHBZ$P?KM^VDWET6A[ZA96WH?^TLC?VQ1GGU3HJ_>>-._[&')7![
M?_OE[U^D,*OPKBB?BSI^8QLX'J<!R0@D0IF:XY)!S%D(:28$$1%7,F765D'G
M5%-[)6_OH9;6X5/8#:2%G> -GH%?VQH9T$@*6J+VL2"Z87.P)KS!-Y)E<0V,
M;@:'%3*=QD?W".,9(E::[!DE=G?T[!];=QSX_D/*U>>B/BIOF@E2)'%*90IQ
M9FK!2(H@"[0W13,21U3RE+IU93P_U=1XLY$45**"C:P]VS1V(&RW7^,'MX$)
MM2]D[JU>+Z+AJ[WK^8G&;>EZ4>&C-JZ7[^C9V;%8+(MY+JH1OZ_9,A<Y+7.Y
MO"NK0^=6#.WN4BFJB!Q]U;W^!7^9)1AE28H(%$B;8BCB')* 13!$"',9JS 6
MZ>RG+%EAW=_1AUPN+U-;NN'>J9;8(%\T!5DV0@.X*=KR1:Y^%*+J6'UPQWV9
M_]2*SE_ W^5<;&]U;/KH9='MJ&[TA1R8%??TN0%MC4P][GI%]S(6VFIM%^P&
MU)J!WYO_':2)ME?P?36%]"+3N(TA?<)XU!S2Z^!]HZ.K3FZ4K_*?\CU=T7?K
MLC1)3"A*4QDQ":E4IL2,,HW6> 0#P5"*(ID$*' +CCX]T=3,Q2;2MR6L*8-%
M02.N:VCT&72[&=0G9@.38E^X>L1%=V-Q15CTF8%'CHKN5N\X*/K"];U3FVC3
MRZC*F?HF?\K%6CZ8@[Z9"D(A,%6:#;B$* E2R 35Y!!'<4(IRG!HM?=F,]G4
M:&%?5A,(T$@+?J_D=?0C.W&V,Z]\H3<P0?0'KD_6UT5$_.5TG9]J[(RMBTJ?
MR,>Z?$\_ MGTY[M='/7PJ^V571<XQ!(J21I SE/M.K(801+*##).D/YU0*((
MN[F.]I-/SS_<R-ZX?I=Z7KK1C<.JV)'/,$@/3$4'$!\@.HY?Y@Z<)\9RF'A4
M_G('Y)#->HQP70#EQZ(T8>#YXK'*7)UQ&L28!@)*G@F(,.&0QAF".#4QDTE(
M$N'4V.',/%,SB:I0>$#U=T3:1RU=PM*.?CP@-##7;.,<55&"1L8J]6* P,8S
M*'@.93R<Y56"%\^H>BY<\=SE??=*_B'G\_^S*/Y<?->C%@LIJK8RY4S&(F&I
M-F62A!*(B(H@YBJ%&4ICD2DL&)-NFR5G9IH:!S3NOY$6_F'$!1MYZWY)SJGD
MYQ"VW3#Q@-LX.R8](.NQ9W(!CBLV3<Z-//*NR04%C[=-+MTP<K^7S_E"?EK)
M)VU%*!1E,N0PS()(<P@R'((%3"35+*+B2'+D8D5<+]+4R*:N),,L6R.PX]8(
MX'>C&ZB4<]RP\;# =J;-N,LV,-==W<S";L7&ZS]Q!/)K=X_8"?2OT?OA"$!O
MG1N.1W8OH-X$_58AS)8%TENW3(TO&]'^T[ZD>5O_;KJZ0O6!.:>1REO0]AE-
M>Y42;X\S6JGP$\*W2X&?^G/?B**GI[P^K[Y=Z-=W8=KJR07/Y?)$>PV<Q(R%
M<0B3(.402>T]:;\I@)%4"<81DTD8NM@[3K-/[55M"5_M3NZ)[Z/1B=O:V)DJ
M@R$^,$/X!+M'8$X/T+P%X+C,/7*@30]8C@-J^@SB;B;<K5?+E7YR].B;#@J?
M%N*K?N1LK8;S(TR-F8Q,]@9$!S*7[0D_H Q,'BTAMUU/3+U]D?_,Q9K.02=@
M3E;'93QZ&2$=PXYFDUQ6K6VB6%S=SV)I#KX_:MD,6QA:,-6%WZV7J^))EH=G
MHT&F:(8D@7$41A!A;;+@1%"(I:09%V&DB%7!T'[33XT9-G$<9DD>%[EQT]QL
M$D?T[8R2X3 =F%@V<)H7!6Q$!W]JV<%&^&&/IOLAY\DT<9Q\5-ND'S"'QDG/
M4:X^JKXO"RZE6)J)OTDZ_Z"I="5--<&%)HD?^?,NS/BK7,U0HK *$@Y9&&"(
M2"(A%:&"*HP2&<L@Q=PJ[O=J2:9&=]J"7)4Y6V_"V$JM 9"5"JVF(CU+ ;FO
MD_-!^7#HCWF4_F:C1L63OY@.$G-0JP):NK3R,&Z 5F>00_=^B/H_EG>4X[4.
M[OO!U7&TWW/ _HD2?)>O:TI%R'>FF6'Y\JX0<H:4R#(1$:C2@$$4F 3;E"50
M,(QH$'.6!H[%Y#OGFQH[;O, 6C+?@$IJDQS52 Z,Z.XI%%VXVP8&>$-SG/"
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M'G"C 6OT[=C!*Z+CD,9&Y$TD=27E#=C(;?(NROJ7H);='Z6XHN6)::RG'96
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M$9Q>]?W/CSI:O?^+BK7K_U^^N-_VT3?YW'1OO%/&@=63(>U!BA1B%F&(LBB
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M ^:0T7J.TM-57[.E?*RHL@I*",*(J3A.82@P-RW%E#:^< P%4IJ]B AEZE8
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MERJ>N6I$6Q.&@:"NP+"L=N#S!5WP7#/\I\5R559.G2/##[#N=HS_NJLY=-#
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M!TF8Q1(F0I@-%99 4B4#IUD4)BKA5#F=WER><FK4820VJ0V5S.#W6DA'RK
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M39,DE)!&*H8HD0%DBE*8BI2Q"*4RC)T:EYZ?:GJ60RTI, M6N?1&UGY=#CH
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MU[N9 )_6FWY+T_9]%7&<$\+5LI\F 419)B!A!,,\"".94)$);-7!^.0H<^.
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MK>FRD"Q"*4<<ZK+'RNI! 21$!)!C%)&(9 EBH=V.:1Z*S6]GUDJO=AJ_%2O
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M<<99&G.)K?Q GN6;'<O5HH-"[^Y:60'IA+4SGWS/I)FI]0OG9V2ZW&H&&M6
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M;]HRJ19(<$%"BJ (4 11F.60Y"2',I))G.%89$%H9S[X%W*&-D<G;5.;FW#
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M';:9IQFD$@N(,X9Y'(5YR(RVBRZ#SXU,/@I>Z/C!Y2[LS(Y3K)!/(Z*L3AG
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M:$W/3.H9K;6UVK#6&_2Q 3UP 'T!_>M:@)KJ*#?M*@)Z((&F;*\N*0%:G&[
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M,N!;K8FE$]O?W)K9Z+]DQD;FN=UD734_UE:N=RP]V:?^Y)K4LO0.YZ%-Z'\
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M)@:='8=3\=X62=_'Y %KD;;R[90C[;T5E07+_?:BZ@(PAF94%@19=J.R>=+
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MX5FL?Z(1S5C$,V'5 R(0GK$MV$H8.%=PO92 5O* >2.0,6=D(Q)0\P685ON
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MSE.C4T,K*>9&=%U1JY -TA'6-&K89E3TZ&UTK$=F.B7_%3@"^UH';(LXY O
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M6<IC&%#"(/(8@FF8IC#$2<@$RB+!(A/G]Q%E-5IN)_"BKU4 M-*G3BNLLG8
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MQBI7U+FV)TL>I:ED-YN4[BOF)=6WI5O>%RJ5\2+Q24BC@,&8)EQYQV%(HE#
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MZ:CH:_^3EX;T?Q</REKZ)IY5SBU5""PKUD_5^O_NM?GC[DC*(ZD?88YA@JF
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MG4L2975<$L<H"RCQ8<;4(2Y..:1^$D'FLR01B* PYI.$J9V3=&[4U\@+BIW
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MN.J\:MWC*HVG[9.\?A&;QX(;S_>>U^<VV?=2OM:RZD_M/HC.SVL'Z(P\J4\
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M8,*\E.$DR P/AT8>@VF.CKY-A;_>4C$RIA,=.565E%KYP9]2 =!JH&[B&QU
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M(*)"73,R#P8DRKB?D33B6EY:)]J>FQE<B0?:PU&#8ZA3N)W?MEZ QMB'3@9
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M+L31F%:TL7'$+N?[FY1DM-4_Y!K]%^USOMXW&265,51GZUA$2*0B"2)(?9%
MA&(,L2<9)V(1(S'W:6+&,Z>[F1NY[/*^\BJIZ4ILU*E$FXCFN=F5J!-.+C*Q
M5B'4V39PFA7:F]$SZ,=^%,8T%)#'0AW^AQXD(6'03Q/J>R)#?J*\US:C8[]U
M5MM,BKP3$'% 0S_"/B0>42 FB;2T(R372QQ$*,&)[V5FEO;E'_$T5K;>9^P$
M9,UKCXN!&_L^XR";<<=7N 'M"]F\K!W[! _#XC#!\8E.)D]QW*_HJ23' T_;
MK7-UL@5Q*ACAFU#K:!NIH'KV%T2$@>_Y"-)0^0]S%D*,.89)DHD$8?E?1*O0
MMEWW<UL7&^FM J ,@=<CE/'@')EH6B3[0I^VTM=/ "6_.\*Q@\T1$1EV/BE!
MV0%S2%R6K5@:[JJAQV+)/ST]KXN?5=QWV3A,D0RGE*<$>@PAB(B'(272G$0T
M\#,J^8L$9M9[?U]SHZJMJ"#OR&IHZPQ JVGPN %L;*MGBU57S!%JAVO X<K:
M&>AI6I/GO,I'=H_&*S9.$8_YFM\I%]?F$\9)%%,D!"2<,^7+$$%"I95#XEBD
M2<*$"+2\RDZV/C<^J.0#=Z8>OH>8Z=SH7X#$V!?Q.Q"L?'0/T3"Y[+X E<G2
M&)__1 SOD7N4'K[^/7QIPEO;'GGW+UO['K*S7]XW!VCWY%?'@W.!0Y8AIL@)
M910BN=F":>#Y,$M]+R99QI%/MH&;JJRFG@5SNC>S,["#/D=TFQ*;W?GBAOP"
MRYW(AH763X.L9\1<@-E$I=1;C*2$73?@X2HAYK73!W%P52S]="?35D<?5/2H
M'/KPTW:L\(?<)7TNRO)VU0E*W!5J00A3'JCJC[[:V 0\@R1,0QAF@J$HQ"&B
M1L<RP]W-S9;YSAX%?UE6>?.5Y. W)?OOH%BUWE55BE$+GC@#NQY?N -S9-XX
MP&X'&OAQ7WF:C>)8H0>/(SHYT]FDM**G^"&]:+YE1S,'IS-?7Y1!<YN]SY<O
M\K=5\KSR]F53;LA*W0(L/"32- DH#'A541O'$(=Q!,,$8X19QD5@E$W&L/^Y
M$='VV)(TQY9E)7%UR50\/<DY5:KB]*#8J0 @X+5V5<K;^@5-;VW;44M2A$*1
M!9"0.("(X12F<2:'CJ<>"7$D$APL-OI&Y)BC-H%9:3-J5:BL_]?IQTYOR1EQ
M1$9>@XY._FO9U6#48H..W%>@T<C=:F2)G*/ER;3W2=<K2V@.%S#;9LQ6-,'X
MXJ/4M%B);X(5LJ_7#[^>Y:=6'9K<9NHLD;!-SIJ0K)U1I[%<63<^MP6K40*T
M6J@;_JT>:LX=:J)';O;@#]/;)+B/?=-I"KGCHI078SA0_$>VW; <XSMRL^]Q
M$GJ[&)"6X"YOR.(6H][@[K9J?\\WC])0^2:(-$U>WPOE[I2OU.[M(\G753[K
MSKZA27S]J2Q?1),%^[ZXDY_Z(RG%->?YI@HR[,1[L@S[/$QAC%3Z2!92F'I^
M 'T6H<Q/440\_>Q%T\H^-^YM2Q]L"O#<2 W(5FSP5!TFEX_Y\S8\M#0W,]_B
M&]&X$YKOR(_,_D?G4:!1'32Z@Z[R0&G?U#OHZ+^MCP!J"-I_@_L"M#" '0Y6
M$:$3?S,&-V?S_78FNI>;Z3=D=A7X-J,X>-$XL4C376.^#=9[EZ1O),*4Y<+^
M3M0SF_+#+[%F>2G*3ZN[JK;O@GIARC#Q( Y$!A%E"<1Q),VG(")Q0!@*]"H'
MC"3?W RC5E @6DE57HRF3K*=!33"H&I8.6\[5"-;,G5-KS-5GK:UOTY4>0+;
M<=ZJ6=4NKQ1]V[&=HKR7DS&>LJ+7]&,]4?VNLR,Q3LFN_F[_!:ITG<7,36&N
M\]W85L5@Q9.X)[^N7Z0=(DV2UZ_R\Z_J@ L1Q31% E(1J"6:A) P&D(>9WZ"
MHRA+D%8YS_-=S6W=K26MG(:VLEX!):U1<74-C/4NL=P@-_(R: ^:1:F,<W@X
MJYK1V]'$!33.*7Q<2^/L&Q9; DE:3R\KE;>//,G=RHUDJB;K6I43M74?#T,>
M4Q5-*S"'* HP3(FJKR&8[]$T(8FO7]1=J\NY$<A6:%!+K3)9B6V"NDIP [M.
M#W4-,]PYEB-3B@:,-M[J>G@:F+[.<9W(FKWD,S4S28T0&K0R]5J:SG TTFS/
M%C1[T[+4JJV]V3HC[,Z4:G^$9CGYI^"+.!6>GU$$44B%M ^S$*88Q1"EB?#B
M(/8BLP)J(\HZM_5AY\K3N>=JG*W(5FI[7ZHQAUW/9)W)8$YQ] //E'W?%O@^
M4?;]JN/5U;EC:!R\=CH[K)8[_L"XJKX[HJ335O,='_*CZL 3=&FQ?_B8\Q>6
MD_6KJD9YO5(]JYN..C5>)X@#^Y@2@F @UQBYO/A4KBPX@"1BB1\*WT]]_1(U
M>GW.;8782@VJPITJH50CN(&AJPFWQL[!/8AC.Y?UXF>4'-,:4X/=@WML)]H^
M6'RC9KL&,V0&MPV:34VW;S#3;6_C8/CJA57AFP(,Y;:024H93R@CD/LH@R@6
M(<29+Z @'O-B+T2,1U;EWP][FALG[^K_BD92RTKO1Y#JV=1.@!J9=W<8M4*"
M'ZV8#D^ ST+ANA+[43]O4W*]3]W>VNJ]+]A>%W&1Y:M\(Y;Y3\$_R35F]9!+
M\KDN2[$IK]G_O.1KN4GDG'"?<VG!"<JE!1?ZJK:G#RG"+$VBC":941BN9K]S
M8XS6BC8D"EV4=6^/G&,W^E52*S'\K$0&.YE!+31HI79YJ60$D[,;)KU>)[YN
M,H+B^.[)['4[*MI5*FX:O%L7DO4VKW?R6]I(LTAYVCVK1Q8"9R3(B+13TA1!
ME/W_U5U;;^0X=G[?7T$@P"()BH$NE$1F@07<=L_"0+=M>)P$P3P8%"]N9<I5
MCE3N&?_[D+K4O50DBY*5ET&/JT1^YV/QB.?P7&*L%!%)H<0LH8))EB9Y5S+$
M3!^93VZTK78KB RLE+IPP3JO\ZW%79_>10?:3EU9K(29QO+,[OCMWUO8H,,]
M S7R6<WRU[,L6^LN>\(\J2^+B4?58/:$["LQAQ'L\S*OE[^*N6!JSW\7M'HO
MQ=7KRC3M\MBS4SO_:.<C7>@(_08I:*&V#9W,<RB/$M6O3'QP-/S]MA,]5BF.
M?1PX93 >'7"T!,4^<;;S#WN_Y^"ZOA-_Z**LWY9TT08($)9RD4L$,T(D1 3K
MWKMI#ED4B) %<9SGYE42#X:?VE96 .M:PT!#M/"7'O)FX&Z^B(V!-^T.$2[A
M)X>,6#B++V)F)+^PV4_%SA5\4NY>K^_A4^,Y>$\BWO'EGOZ6FU74F%C/>4Y9
M&*4,)BFA$+& P)R0 .)$Q F/4LR3P*:P33.LE4X:H5Y-76H1T!J;G<G2TI2@
M1+TK: 89Y=J531)((Z7,,QEF 6%8$$;M.H#8$S5.QX\K=Y+,;#9[P0?6TV<D
MMK:Q=@7T9#^U@XYJ&^T*LF_W['UJ;]/48035]5S]II^6WQ=OQ4U1L=L%U_''
MIK9-WQB3.QBIS\P-F5YVSALTOH@9>N_5,$&-4Z<L/A6O=7?>[W</MT!#5A^H
M(WFE._KRXF?!WY4>[R72RN0Q8<G)].D=>#03R$2\;5/(Z/N7-\WI:KQ^=*Z3
MFW=Q)=46_&]!RU^*G^(9,\P21!B,XCQ6K]N<0!P'&0P$#:@,A4R)5<2HU>Q3
MTQM//T0IJ$;HWB[G/.5F+^_!B!Q8S^PURUE#GVEEDPOP0 L^ S7)0,,'&O\P
MW7*,:1N@6<[YN3^M5XXQ+7VM<LP'<<II6E2K\IUIFWC+)H_2(&:,9##)<0A1
MB)2N2C&!RGX22932+!'FWIWC<TQ-(VVC;+P;_VJ557.41P-OS^7L#.ZGW2?&
M*>OH*#]6:4:7\C1:7M$>7]ZRB/H(.),V=/31,?.$^K#O)0;U?O6"3*#\?$1X
MOA\1WI:<^4]1Z5*E"ZXCBEC=YT+_J<U'U_&'IQJ:Z0;%.O1(G?&;#GY1E$94
M!W5+?2>/\CR#%"4QQ%D4X"A),,JL$LNG(]K4-'I7V4IL1'%())H$M39Y1Y,
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M1TBR"22<3>-LCB:L$_Q'E#^\FEU-E_-OKV8)1CQ0+ZWWA$?&D1V-F!96DHS
M=LEYH[VM (Q'B=@+)[9UG-23<Q.P^>2_GB44WSB/5PFK:TLH.<9+RBCB,& B
MDM-,'+6,L!A5,-$"JV))=BR_%U1<ZU"I(=LF0'*2$JI@<?W;V_$4V,@EGET*
M$D/JE/"H1*DXZQ(QZ#9CE"VUD<<%J#N7WB]E15M'Q[%";109?(0.$T@1,@&+
MYD\JIH@%:HEU+- H=<J1]X(,OA\R&LYFUA%J2\AXA5^>SS_-?I^.(A,>":<$
M!:/P;.2>.(\>%CBF,.;*P&U%BW&W\'ZH:#C#64.@+6&B\YK.Y^_GL]_&TXA.
MDQ(II^R(R#(0F:@F5F4@009FP&LIF*H'C(W5]T-'PSG/:J)M"2+O9XNEG_S7
M^++SJD6B.5-TDZ(2'D5C2^XV1B+ >QTL8]2[>@"YM_9^\&@X_UE)K$/GQ0L/
M<_ =W<DGR;V1Q,:(018-GG@9'-&&>YW BLB/S(6OK;8? !I.=1XLNH%57BHH
M)N^_S*8WR;GHP2OT=TB,B1$9O""^E$1DQR($K3/3["BU;ZZXG^H;SF\>)<*!
MU?\1XM4<H<MX^#1>3F"$I"?)G" QZ$BDH F]'8R-:&94!>E]#,?==6RNN)_Z
M&TYL'B7"@=7_:>Y+E=K';Q=A-D&SI<$)Q8CFZ-]**BP2K@))*G$:N.;>^Z-T
M?V^Y_13?<*;R<.$ULNE/O\8O?OH9NE2\HM9[:BA13I<S2P&>7C:B#RL"9".1
MJUAEXZ^ONA\&&DY!'BW*)L*!_X3)Y#^F&.Q^!+_ <RR=+197>) %&9D#64P7
M EM:=&%LCHHPKRTZKEIS5R,]O6/Y_4JFFL] UA!N$RCYQVQRA0J8=U>Y\\5(
M>"Z]Y90(1M'BZ502[$:0E#S01#T-[KCC8NNR^Z&B^>SC,<)L @W7%3^K@HYR
M#*(2KA:CR!U$$R6A4FET?HPEP5M%A+="9*4E"J8"*+:OOA\VFL]!5A!M$Q Y
MF^*GH3C&O\%KO_37;(V"4\Q+2$1Q@\>C%@;Y $YH2."#XUJ)7.66?-OJ^T&D
M^41D!=$V 9'.^KWR2_@\FW\;@8E1&\-(SKR4D$(@P4E/$@L9Y<42_FVETJK;
M1?<#1/.IQ\,%V00./E[XR>3GJ\5X"HO%2"E@+C-.0($MEDX3YQ*>C:!X,BJQ
MZ&L<(O<6W0\'#6<@CQ5D$S@XO8#Y9SSR_C:?_;[\\FIV<>FGWT9XM,D(3I'L
M2PH]J_*"37)B0&49-8"'&B?&UL7WPT7#Z<E:@AT8'V<QST^NTAA_XF2YA,5*
M!V\F_C/&VYE:*SA*!B*1D2OB#/["&!<>(A7VR(NKW6OOAXZ&LY>5Q-I(Z?Z;
M\?3C\F)Y.I_/YJ]F2$2\Y48:IXWDF62K'9&2&>*E+-6#V1L:O%>V3A'_;AKV
M TO#&<_*8F[BQ/GX!2:3&WL8: #E:2(Z)PRQ@!KB0$6BK/,R*,^CJ5';O[[F
M?J!H. 5ZI!B; ,'[JS 9QS>3F5^.D%U-,Y-(O E$.OS%AN@PI/+6R$AMIC7*
M(-:6W.\]8/.)SD.%V 0"$+H7I=)\%O_Y\0N*;7%^M2S]!LH-SXC&H)G-CG 9
M42XQ>&*MUL2BF\2<"\Z*&C5UC]&P'T::3WM6$W,C#L?B[J$"I)^_?2B4P#3"
M)_BZ_!E_^)\C\#ED$13A(:,79=$J(AN!&'2B!%AEM*95_(XG2=D/0@UG1_L1
M^L!(.D&.4N=4%?=).*VBBX+0\BI.&I&)E2J0+*RS*5N?TG%HN;?<?HAH.!EZ
MN/ :L1]W#Z;?X'<6(\:YEPS#\%(_1J3(: (#!P*&.J5D+ 6EE:*4>POOAX2&
MLZ U!-H4)E;-%59,>!#<><Y(S$P@L)DG'D-QXLMKA9P%M?*XFKR=2^^'BX:S
MHG6$VH:+BFS,_>1LFN#K?\"WD:'2I?(P@='2S2MD])2H,L1$*@77SGI=Y:KU
M_K+[(:+Y?.@QPJR&AK_^]$"(;_$;!_<<ZQ)Y9]/2.:[[L/L$[]=^[,%GU.E$
M]CAI1S8E*UR,-E>X PJ8*#+N[*PS+X^Z4+4"?0,>A8(0+?B[^]Y=4GETA:/<
MOU7N]<UX?G&61FAY%#@;;MZ?!8NGE2WUHPJ\C#9G=5S!U;WEANE*5D]9]SS!
M@^4XM/^_(KPK'!2E)6-TR'QIQ"A!,&)U2"12KZFQC-M\W#F_MM@P#<EZ5?ZS
M9=B&ZM]>-[$<&9<P4F&2)$8Q:O4>?57N'''1&9:Y8=$>5X*[L> P?<AZA<!!
MLFSV/']U_LO'\[=GKT\^G;[^^>3MR2^O3C_^_?3TT\=##O;='U:IU^A^Q!YY
MU%\MR&?O+T?=$\SBV)_G-^.IG\8Q>O>S59.I6S %KYPMS<><Y7@,E%]\,)1P
M%Y(4S#K+'KO.R7X1.HU?+[K:53!9+FZ^<[>]GD/7H3;CP1J??)C B#J=/!,.
M=XM(1)9^C(%21H1BR"CE4JG'.@$<Q65'P3!^1&](N#$K%<0]X %S0_T'F)0T
MZ7L_7W[K^K#Y[K)V4?*F=W]S\G6\&$6CC/9:$Q&UPA@H<>)H8@2_,#2:P!1[
M[)KC$"#M3UTC(#L  [,744AC4'L]N_#CZ2A2G:(H[G<"/,Z-"\0KDTA@PJN<
M9 CVL>;0QT)J1<6PT.E+WX_ Z@#A-P"?7V;3^1H3[Z![3,L,#6B=T7.CZ O*
MQ"5^%0/1,GF7G+5"/>84'X*@K82T Z)#M#NK+>H&\/+A(0?&,2\" U+Z.Q%)
M32!."8K[R3JC9,"_JPV6AU0,$UGWA)0CA=P 3&Z/[E<3OUB<YZ[XH#.WV0NT
MM@"$>8P,94Z>N'(W%*DW- D3M:B-EIW$# N:BNY-'7$W@)MU^J\W$K+-DDF9
M2(ET2Y85\9X'$CUGV<94DA25 ?.0BD8<X>/4.ZLJZP;0\A'F8UB<O+]9OF/E
MVF!F:J,3Y35.4I%(+C.&H0*_ BL"FF;MJI]*CY S+'Z.U?2FM:DD]N<CR*T0
M-(5E1?S\O)412,'ZTJ52V]+NE@I-@J21Q&@8EX&RH!_KQ'0X?K:2,^Q)U0M^
MCA=["Q;HQC*_'4_A#+]<C*R+7J=2]T:%(#)J1JP1AB0FN+2241%KGU</J1CF
MEJ%/S^8P 3< D9/% I:+VZ2H @T&Z2>6@208!KAR2^J) 69L4HA__=B3F$/@
M<9^"1ER9 _4YJR;<9J!Q_8[\E@F4A<RT1(Z>J1(Y K$"-%')Z>RHRAEJI^^V
M$C(L4([1[%:0'"/F@['R&\S#K%9LY!=?3J:I_';Z?Z[&O_E)*<L^6;[R\_FW
M\?3S/_SD"D8L")ZMLD3((B@GD$&5%!&!\YR%L,H_5LQZ4+BT#V$MH.DH"&Q&
M3]6UT8!!>N?G_X1E.;2O>VRAGW;3YH**X#TM[PMC0+=/%%9"<<]$$L))D:A]
MK$SJ$& ]0LZP#G%].-62?!.6ZB3&,CAD\0$BX,Y IGZ!Y0TW,G"3N32E0P9*
M";0HJ6_D"UW\))WQG#_VU.^@X^T1>H;UE.L#J9KL!X_.RX.C"_CDO\(:,R,'
MZ"5FBS2GTAD^,THL.$Y24N@N.I;BHX\U#H'/5D*&&1[8'VZ.EW8#Y]?Y\@O,
M[\A?K$%?4V:\*_=LKC2(5483;T,B+%'O$O?:Y-K'UVYJAIDQV!]X*LF] 02]
MG\.E'Z?3KY<P70 Z>!UK]R0V$C)Z(9 E'D4I="Y7MBD$(KU&;T]3*=UCG7$.
M@=(>9 TSL; _3-761 /@^F6VA 5R\G;FI]L/: I.052.Q%C>UPB&#!G%T-63
MGE%I@HBUG:,GB1IF"&)_P*JKA09@M;$GJ*5>*4F4I Q#3N0@),J)CB)2&4P,
MJI\$XW/@4KW?3H\.]<'2/1P:LZ6?5(3&+[-IW)"(<U3J9#*QNMS3Q7)_DZ4B
M2D>;HW-9Y]I5VKMH:2&4KYAG/%+8303P[^>S2Y@OO[V?>&1CFDJ&Z[)D[?'K
M5;TWO 6_@ _CSU^6Y_E7/)\+[R<9C1H&H%<75UT!TVM %N)XI<MI.KDHK77_
M6+T5X9S3R(-$05./!S9^%81(Q&6.,05D3A^=>W"8$]4W5RTD.8_%WP,WK"DH
M-'#<GJ%*IY_'Z#)<"QR6IU_CY*JTT_G;;)9^'T\F(V4A:LT,4:4C"KJA>/90
MHPA@T(R.:6#"UHX1]J&K!5M;&:#5U=$ Q&[IEL *=9E0:9%NF2-NC5S<42&T
M4)RK5#MK\2RH])P8K0R5@\3: !RVYN;N9#,2Z+,8%C0"NSBE1GKB2M,5*1DO
ME1?@1.T;XR=(:B$[6MW.U%-" YC:'06O\12C IXU(SS)TM++  GE<7<9HQ*D
M\]&%VE'"/G2UD#ZMC*[JZF@ 8L55+ \8EE]FZ6SZ&RR672.Y$82HK#*.<$<M
MD=Q28JT5A(F0M0FI]#^NC*H=I+20,ZT,I!I"'S0&[5H5W%%^-GT_Q[VPA,FW
MO\,DG7:-A#Y]\<O7,T#970]LP7W227-5=2$YCY0'2R"6A\==DL:+3)(,@!O(
M*PSD[P-L1_.9H\AH(6]:"5POK),&;-<'9'4^CABYE@J?-1NL@8?RL)U(,*6B
M56H2@C,D>F!)J<@YJUT7OHN6%C*ME:U7%;$W )_S2YC[,D9J6VYD% SS72T/
M+Q48TO!,0FF<I(Q4FOO2,Z'VF_]'"=H+2-6[H?<*I'H*: %-=S>?:UO")0=(
MOR:>94-DEK+49D@B.'C0W/A4/3>PE9#]DI[5.ZGW"Y^C)=Y$'O\A!P%"%MX1
M8Q'ND@OD!1U"H@(X8S7U5M5.2QX&E^\K27Z4G)NY)AQYRY'3,KI.(JT2DB=E
M*"I17#,)SCIA'FN$?3@Z6L@U5KP"?)8@&U#_V[$/XTE7<WPR73W'^S*;H- 7
MJVCRKE&<X%QIBZ=E\>2E5(F$,FW$9YI*R4U2K/:1LR]MC;SE?UOE65,O"FGB
M1%KC;+-(P^!_V=-,6(92YDX=<5J4V<Q.9D<I9YM1>TUP-?7XJ1_][P;9,:IH
M E8W5>_O_;>2-BTWS#'.KY"2!TR.1(B:BP!X-I=2P910>FB/29):::H-C[1V
M!?DSR&L&>$=A8L>CA-KJ&3 VZU)B;\;I*H[]_-L&@S>\@*7<E>$ZT8(N"?M
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MW.R#E83N1H$%+A.U75M)5I)PY;VG0Q=#JZAC4-G)VG>.NV@9UNGJ&T45Y-^
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M"A8R)9HQ*%,./'$:Y2(A4YIC#$;6?[ZP0<2PD*F@V-U3:PZ0<A.1VDE*XZ(
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M/4?/*::@]XJ'>B"NM0J$^I!N0JT-^ #[%F%8RF7@61/&$KI1!F/,H!5Z50+
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M2O>G0&4/"FS"++[S\W_"LGBF'R%>S;L' ->\8% <4TG9&&/+4S*AB \*B!?
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MJ;>K<#@YZ#56N34H0T:5->T0HZTC@Y(K"#I'$)&<(A>EU\T/LR/([(:\E_9
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MDMI(D?[GZW!]/1L6FP#I0!'F(R@</M1\JEC[CSD[X[()F:S\5,='!J\@.FG
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MM'[!.IGH80RB_M!]7BTV"Q8?/4WAYVH")C&[4YJ6,>MJA BMX<2/"^!8(,>
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M4P<>Y4/3B#Y;7:ROI..Q>CFI4IF;6M:#'%D6VK+&<.L29F-Y@BWTW@P^(SZ
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M[#X]C<@=!5S5S)W0J<2DU1'09DYK.+':6MV#T\$'U":JP)X*:YX:9-J+E_$
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MBA?N;M_Q/?"X__18TP%A?P,NQM/FU.!X_?/'UUNQF60N>BN!^TAB)R=(&T5
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MPQ;*_SP3-T;"<UX%%XQ6J_7R[+P1Q?H++C]]"?-[MX\3[S-GW!C $.@PUBY
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M,=744!RJV_C 2KR<]<W4A*1E"H0]8!9K'K-PX%%R2,BEU[HD+*'IMKN;?,,
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M'SJ.O=5SBZ0W2*^3QYK_AV3#7#M[2E; :QVM+"5SW@V+\XYSZSP@^D]8BP>
M[44?B>>IO%=,V<&%A%X#T\R#,CY!\%% C7))8RXYW9Q'^DAS>Z;LTR]I$1X
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M&YY;48*DG^EA21T#!ILF?F@'CM;ZG!H?URN$MO-ZO5A^6RPW-KE,4-2>F:#
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MAJ1L?09E,QT0V3,HD6L9!09O_* C\,FAID-12X,N1M/NU%BY7N%38J&#W3%
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M!W:U'Y]EDD8?A/=@^%/"B$L;D*&*@HR54EJ"=T//CK<Z4= -HG_C"M;E]->
MJ;T7]^='$OQ].G.+./^1&U'?3;_?+N''$$D"BX_9W50WO@!"5K=F/Z9W4S^[
MB6_^6D:0#_SG[\>+Y2A)&F.N?%B>!XTQ#,XZ4PY"T7S#P$FJBD_-O@QGW7;+
MOT!UK$$@%=M>_]\_GF@7A/;/U8]6/\G_U>>8_G?^Y^^?WSU:WZZNE]_$\!_3
MN+Q;_UY6:PVM<HJS]!8,#8C&3K;*AYO!GK.TD= FY[/=&+ZTX\GB,=N+\<WW
MR;.M70-1\H\'T>P*;4W0DUU024PQPRM ^%K(C+X>+_QDEJE=7+G%ZJ':$?.&
M*9XXBIY(Q!-1R*88\V4K10BSV,?!+ACMH6>(LO!&ZB/*L.'.*B2EC#G2T."C
MK7K(G3',QZC2,#6,_?0T<JND+RJZ5';/4L'I)M+<[<UIO,X=#U\';3;XO"Y5
MW[/&""- @D Q!(\X3@(9HQABDK" ;= 1EP[RNM#5R#V22Z"LETH:\'>/]T3<
M<Z5L,%1G7A++KY@ ?]:8W+QK/%>:4/R01[I(7\M)4!N^@G )J/542VG35MH)
M_'(+CO%_W\):;WYD%Z:'%W=HJ3)N6"=""_E1N]^Z!Y<FREMJ,4HJ/U2FM48N
MY1MI-%J&=>"J>./D(5KZFJ"==>_N/G-EM?>& AGY!9H\[,QIZA&6P1+I.>?%
M;T/NHZ.NOU1$^[NFI;>X&SBU=GG8S(9Q7C''*4.8YC>[?;X_%Y5%0?KHC4^,
MT=(/)AX@I2G@G*'C9T!SCL#;Q,UZ> AEP5F)$](X=]Y3Q9'.X0+C2E#OH@Q\
M:'O3R 2F(JI^'CYGR+T] &VF=0>0#7$.,9'?]1#.((/A7\$5PTP$X@BWPX*G
MA2%-A91\'#IG2+P!V!R:Z^H"D2II C$!<?F=>(>T9A$IPPTU6IF02I<!^@Q>
M'BQD+WY>E1!XH[AY/.'3"..,9!:M7@O@^?5CXZ)&+-+(B2;>%I_J\$)G*)^D
M^I-G*)^BA]JU^-P.<SL=+W^^M3?CR<]7(-;?8AA[._EU/KO]OC:QVDA'//.Y
MBQ"V7PP*&<4)BM3S%$P*=C?"/%!X[_2Y]C#30[^S085=&SY7X8>=^AA>C^WU
M=+98COWJH;/Y=6;J5<R=?&NN5#(^&(\1LY[F]!1&EC")M-+:V""4MAUG$7;]
M9.L#F<^&T3!";^"(^\/.Q_FXS_?R5W9:*2FB,Q%1ID*>M420YH0CKXR,.%I.
M7.G,UBX-=9/*Q9VA7B)N#"+K?>0%X=@'V#@60E!N&46:D(2(P3Q19VARI0?W
M/:6B[IG53ZM'('*&B!L R:I6$L/''W$^'5]_6ZZ[(J;7F:4OLS2__\F[:8A_
M??G3?L\_61M-"1%J8 $CZG&>'0L<.Z\Q&&<0 O,*,U4:3[T(;@=ZYZ!E-\2_
MF.H:P&F>6OG0J',WT3P&HQF0##8\/PM+(C(11&DE R\!8RE,Z2GP3ZFH.P^M
M^)G74\S- 67[D5II>-"4(6M"[F=)#EE///)40@R;$E>[0]X+PZ7V ]^E='P4
M,F<*O'9P]C7.;][/['1M'*-E&JCD^:D>V$+!!F0C!L<@$>"%6.)(MPN?C]=M
M2>_G*FI61FJU%?XY_IA-X'S<(A]31ZDA&GFC!0295B'-C$#.JF ([ 0KNUV9
M>+IVW?BZO.)[2J^!8V+GY'Q_W[S.7+*6*(JDT!)Q&16RS.1G+/)K%E)SQTO7
M%@[14G<<YM#%\/-$W@!T/LUG/L:P> LBRTPL/J970,5X.>*)6:*C1X9  ,FU
MB,@Z"B)*%*+,Q)/DI3W2@\0T5=0\4]>S(03? (+.O-O-% =N@$$5.<W/TAG8
M?&!Q(TA.$>V=-*7KY0->XK]45;0,]BZ@L@: ^<G^7-V#^3I;<[!A.RY^G:_:
MM"G%W"2#J,\>@^?@XDG!D+#@X"5&-+:EZZ;/T=14UKF0H2NIA@9@M6?S/)[+
MLGBW6-S&\'&>_YD=C0^WV:G\F+Y\ RVL?SHRW@F<WX"G IS4;/.1522/4X_1
M>XD)%1<HVI]!>5-)HL'LX= J;0#(7^)T/)M_F"WC8B18XD3D29<Q/Q++@ D7
M(?01$G.:T[D8EQZIL_7YIF*#,I Z5[@-X.)QA+VZL?P%:+'AXW0[Z4]&SLLH
M+$L(\YQM8ZO++3(SQZQ@@EJI2X^WZ4I;W0'X@R!J$+4T +=SIIXP3HG V(+_
MF6?W>R*05DP@2P./P2JA:>FK:$,-MAEL:,B@)^50RJH_GF"U]B+Z_[B>_?A'
M].%N^:L_[3Q\'=\ HP_7_!X3O>]:VB/4;2]Z!S@?'G"V_PLGWE8[F_A25]6R
M.P2F*08 R/<X7:S1/L^C#%=1P"\_'_[..C)8D7='8[YG, V?)G:Z55\J['8,
M06*?Y/UJA,YJ[3RJY/?I>+E8Y]F[I.</_]=UW?0!@? H>?^L],ZV*),2A]MG
M"![F8[^,847HBK[/7W[?I^#>R#[^K;HN]@7@<)+(ZZ!BA=A/<9YF\YO<R;GB
M=A^])QB $Y:KZQ-?RB*<+M^F3,0E3,,)>!C./:UG$EK0?A>HEK,")RA\L+%L
MK1B %K0/KOGHCJN;E4M^'YR='3X<7K$ B;]-OX_SHE\A3/@%?OC/(F0^7;5*
ME?=976S U4DB%1,JC^A;O<Y16%\[:U:IBYZGK?W2:$17G^"SR_G--+R=V.LB
MFGJ\8I62XEEZVBN)1K24=_RKZ2+,RZEI9\DJ ?O9UN^I+!I1U'_._GR@KZP%
M/+!TE=#Z+,4=ETUE!=Z?J>.;&-[.YME-_,-.>F^W8^M6"8E/4ET'J;2P\1:O
M)K-%_#J[)S?7HPKNOF?6KQ+*GKX%NTFI67T.I,8Z<6DA[36BM'?3,/XQ#K=V
MLKK(U4=1.TO5#<J.RWSVG !J;Z7)Y(&NO5G=4S?1O@6K:>B S&?=!-! [\%#
M9NGXICDGY_IX[;K!<J===%0HQ95UZ2;^_5SM=FT-F:.L#_<W-]\GLY\QKO*@
M'[]GW@8I-QS^3MU>^@N6')X5=0-PN*N=?X?/^[N71S[G^_6++U>?OPP"B^>_
M5[?[_8+PZ"SZV@[,OM,#3O3,8?EH8+-P%QB8P0[+L^.!';FTH+K?IV$^^7G]
M,$3^ZF;97V][5^UTNN/Z6CLFDA94]N:ON?\T'_L"^^MAJ3IOUY^NG"?,MZ"1
M7^$$6+ZVRWC_U$-_U>Q9L\YS[J?KZ+ X*BOK\<[^^=L_ERLHO?HVO?[D^YF]
M9Y:N\X;Y2:KK)IQ6^Z_?S%>)[X%ZKY^N7J3O^AFB>_9<9Z7FAP-_Q/G/C^G)
MMYZ X2S<=_I CRV[7G7SF?Y9YKT+5DN0G:*?[<UZ3"R5C6SNIEH_1_EZ,RJS
M'\*>KE=-7T?E/NLDA'_I.L @WDE7I?R[ O#O"L!)NODPFWZ(LQ)*>;Q2O8K9
M,5G/GF&\H7,EPI(WZ^N%V;X6.V">+%S-J)WK&7014VV3=WV]7#/5.]OT>*EJ
MG8SG:FN_*"KK9T/0U$Y^+L:+,DTZ!Q>MUM78T_<^*)[*VONR_.>GN?\X_[J8
MOUDLQS?VKK14KMV[TP>JM3R>J]53Q%99PQ]OEV#CX1R?7A<TI8=7K=8#>:XN
MGQ50.P?@A]GR_\3[DSJ6ZD?N\H%J+9$%#LMGQ599PV]AT=DT;C@M41 ]L&2U
MULASM7A<-&WI[?5M_#I[\U>N]4?@<YIF<[]RK?L:VU.^4ZW874C#7838H-K_
M&,\F*S%_3/\YNXFO9K?3Y?SG>_OG$+H_^K%ZA?.2".@BSP9A !S_]ZV=C-/8
MKZG_:O_Z)4YC&B][-TN<]<%ZI?J2<.@JU[8@ 69L8J=K@M_=?,\/K0,#=X.L
MROANYWVQ7F] (5"<)MEV(K"2+MZ19>LU$!0(PMKT]?806#B.WEVVDQ*;RG4]
M+Z.&J@*SN("X\'-<#9&^KP86,<HG?*:3DIM*?9TNPU:[@#[]&*H#Z/'*1;I_
MCA!;H//GD_WYQV)KTDWIQI\NZ_?8UR"<_KT^]XM4*[B>H(7M';G+?>V"T%_1
MWR['/^(K,!/7L_G/WJTC^U>LIZ9=><\Z,E\[D3R9[)(WCH6:2 XO7*_[ZJ@J
M9J?)I;+J/L59 3T]K%*SI^1Y6<^.,%Z_R0=(^E!$';MKU;O4>Z)2#@CAW[V*
MESQI_MV?^._^Q--T$_[OU]DJ'N^[/1ZO5*V-ZMCNV,ML;05,)O=DE=D:N\O5
M.];WBGO6A??:8\*BS0%6[SVQO4ZU)K5C.V(/H[6=VC6U99)N3U>K=VSWB^-;
MJU^\FGV)DY@G'J\QU+MTL7_%>@?)>?HZ*I?:<0J0$NZ=^H\IC3VL^W9:9J\]
MOWH]$WB>+CO+J[;-C''^ZWQV^WWU2& YC1Y;MUIW[KEV]'D9U;:HW_(0F'!/
M:"DM'ENW6E_NN=;U>1E5WXNSK[.EG92H ^^N5:W=]NP]MU<6]35TY9<0B4]^
M?K+C4$A1^Y:LUEA[OKZ.2*9VH)PC1: P4U7*-!Y:LUJ_[)F*>T8VM=W.36;X
MZL=U,=MX<-%ZK:[G>IG/B*<A[:THV[(0)96X;^UZ?:H%='E$6"V8TGM2BQO4
M@RO7ZS#M8U>?$U3MSHK5*_)Y1M:=*"&\N5G- GT]3D!,!&Y+:??$3]5K.#U3
MW>>)LG;8N&-F_EBL#I'5%-%OLPE(^?.R5"1YVJ?J]:J>G;L[1Y3-Z?]#7+Z;
M^ME-H1QZIP_4:UDMINO#8FM.PT^2S$-I^LB'.FF\J=S1&6*LK/D]YB=SODY^
ME5%ZUV]TTG=+V:<3A=?<)O^X_!;G ^_O_=_HI.J6$E<G"J_VKK;N=F+G[\>+
M9<%2]^%5.ZFSI736LP*JK<"GEJ5O)N3 DIVZ%5I*9AT73?7,_\;XEU?@<VMW
MTF1+J:R.PFK@C9%[Q_W];%'ZA:7':W=28BL)K*/BJ>[M['C>?;??W@4[J:NE
M!-0QL=2^ZIP=JLQ1(87M6Z^3OEI*&!T12@LI_B+C,;<7ZJ2@EK(\^\10W0F9
M]6Z5W*S121\MY6!VF&^CS;NW.D[M5Z4MI4D:;%.=37\%QV5-V.NX\//QJ@Q3
MJ$_U^>4[*;&E!$AWD54_E\(XTV4G'-,?#]R5*C\_MWHGS;:4"^DLL%8':KR;
M+L8@UJ]SNQJFNO74X6/*>T[7./*9(J,VNK)18.[&DT\] <B9]U</+MLG%W:_
MW"]Y.%/_B1M[%ZQXN?,Y73S*?AT11NV<Y3UIO6^U[2Q533='I;U7*PW=<[N:
M3/;8DC(W0 \OW("NCEP&?58@_QXF4&L/_7NPP+\'"YP66R_GDZ]Q?K/XF+[.
M ^"KC(=_9-EJ>^@T'^%YP53W%#)5)8:1/EZIVDW>4WVX/>RWHI*OXV5O]_K1
M4M6NY)ZIE$<"J#TX]'82"7:"9*\FS+XO8W@[L=>]U'-HS6K7;4_3TS,BJ9]8
M'$)G1Y:M=K_V-+4]+Y@F#."*KA+O]>U9KMK=VG,,X3Y!-&0,O\YOILNRMG!K
MR6JW:L\WA4\%TI8E+*2PPZM6NU#;RPXVI[9-P%#NY=+]*]:[0WN.-3P@CR9T
M]?IVOB*L@)+NEZIW*_8<[>Q*H FU?(G^=CY>CN/BZOKZZH<=3WHW\!Y9M]Z]
MUW,4=E0V+Z/*^&DV&7M@X--\Y@>L,C[ZS !5QL-L%*\R;G_J"48*E!OWK]\K
M%[]>/FPO72JD>W[U1BJ21_7V.('?45[5:RS[Z/PP6ZY)+9-&[OZ51K+*/?5\
M1'[#6_3U#_(OSB[B__^__A]02P,$%     @ 589=6.RP]B.V P  )!L  !@
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M6BC?V8[',[O$--Q05'9E9'Z+NY$*UQG=C73!J>AE=H#$QL,E-@S&XV"RF=C
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M."!\]:.N01.%.8$%_YZ\C/%G/X%Z 1]AU*W.4Z0G&JS_"3^)!/0*?;$:(RK
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MDG^ NI4"F_H;*WZ&!YK.^MDSMZ;*C'<OCY<(/CHBL!'H;N;"6J_G/KAD/8W
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MV'F J*[9>_6#/!R7<8X"YKK*"0E:?\(J#E=+)R?HXNV+O 3FCUY+[Y%B0>>
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MH-2\60SVC,MR0TT34(GGMEBI56E6==4N5U$..G"M-R4ZK?!R\_.218%W!A5
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MC&ST]5&;MQ195G&I:]P0*2+$CI^1/8#].EEGO;D?FIE/=YQS"\><85 Q)9J
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M_0$YMSU>R2.K?1PY\QAWTX"?RD5+327P>CUT;,FJSIB"8>=%F7Z5YDRLE-+
M9Y*!X2JDQ51N:FE Y!Z#VPS4P%8"25J$()'.X*%STS$89_9(HI,)I^6F@;G"
M\R(WW/=[D6=M2AW[6 &%F:SRS4YTS*[>[UD2&%"(S_,A;G-9;N4;PM0T(9<
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M0)[S E=)NQ5E6YP9.1E@.\GDWW2$'O)-&B,U;U(&3=T5.@):A$-A#P+,F52
MK#O0U(@C H]^?*^!]D[A^'H4OGN-ANC-=CJ:+U"A"MC8UYP"?WS]QYJ.,&.6
MR'P&REB2;>C\\L\=!1K;(DN YR'P@)Q\ QRN=%1'BZ^BWU'F>4]Z"-HQ 9R
M31&\$[X$CX PHWT JDMXGW)SR!J[\-0F##/4$[(2<">B#+:2I+1!5><1'FN.
MRBP'X0ZP[IC/.Q)$4A'P_4);M#^QI5^^HSYC ]63N49'"=64>:KKS$U Z#A.
M84X(CC>+0.EQ8.:\>&7DRR,X36D1PCL\-FF89*GFH-4@GXN3 H1_NO4IDN5*
MDOF_^8R"SFP[@Y4I=W#7BA4&V/"8*0='MLP5E^NQ7K?@1]?+6^J#I__0LTTE
MJQ#KH,8:S>;0,V8^5)<+G6X1!N(^(3,E?3$I8,19@FH*Z<SFW2\%UI^/.1OJ
ML5_R)C%B4%,:*U'7UHKQL6"?.#@KT!XZL/K\@>K!?VK IJ3J'79[/?7N%S0$
M?WWW"QJ%?WEW_>N[BQN #>@UUK_"QYJ)NM 'R(9_/[C3@ 9]$J4/T;8$6_6G
M[*Y<OS7#R%^/F\%'W](,/FJ:P4??PPP&_%DB@OU(<[(SU K4SO L^4K47K(/
MY'\)SWH;:[0ZCR(]-8+50A:,T1WO?Z@<?I7>1S"TJ'Q["8$(!L.&N) #<P6$
M$,A<W\HUK.X1:/]'X#;A":Q7@-J!K0E_^0JT^QPLGE%>Z?\Q\.VP?R'P"($8
MO!'*;J"CE TN8*U6O:I1!2ZKN>J.JN^A\88YDT3H""5*H?^]21 A-5[&0ESX
M)!D=/E,VK SIV3&E<#91/8M\IG5<.BS^S$<A4'!8R3#BM%4:$=&#6$[PIYEN
M""/X;+BFV.TUH>.IZT]I'T_J^W8 5K@>T?+?DNX"2(;!TFUHH?"J08!J4A-:
M93!2S6Z\ 6L_#_T.**'LULC.U#>VH>X7190M0E9#%H49M  SNB <B++P&Q G
MG)@*95*I*Y1S0*/B>B%IB[1UAP/!%^S7 -9)^P8C.'<">A.LA> -Q7(4#L]:
M'B2=BZD OT5]D"PF!"_>% 8VM(B:9@Z@R?,^CL:?.FIZ,;@9G(]O!N2+:^B7
M.!9*K46.(\,6H:L)%$VV<1')B?6N6*<3'#UR%*#+22WRG/T&]U&ZB>Y2'4["
MIY_V?LU'N=S,T4&ALQGY8-Q,.#B:]\ZA%,M,I(S'&\"JG.C=&N'CF@.QF. X
MR8!$+F C-$DO)&4#(XY8(K>8X^L/Y0E@_F8Z/+T<J*$*'+VGXX^#47\TG2C5
MZ_;4:<W$W:D:U9D,O@WO?Q+5)TU60!2P9V@P\DYXI[5FSB+4S #RP)'@NWC;
M]=16DMOUL#\E._M0HT/32WEV;0>!F$=)2BP$?_1_ R)%DLX):-CD=31#MD]\
MV;,8.J*MY[(DH*BZC\2WF9E8[+*1Z;/EO)-24/!E6[/><#,\)U#-_0=\9"M;
M=:0^+8&[W3]B\QFA5#J]&S;>AY*=J60=(/]:Y9O,VC*>,39'8EQ'6SI^OFQ_
MRLD3<&G>,D24MP-W(->1L0&W*MVQ\V',@'D ,Z](DR!N )L+E"T'E_$,Z/.<
M+8WUD)E;6Y#@\3@ 4@X>2VW+(%-B8@K!CZ,5#%(2ES&1$(/=F.UZGAM(!F0F
M>Z%G+"/)X8*.&_:\DMY$/\ 8/A!$6%_FAOD3'@!#<@&MJ3WVT[,[79N9G+W$
M_OU\!NH1K79#DJ7F=FHN=M=:14ADVKB= (?(I_9I-X[4L$0-'H_7%&1I.>=#
MQY[@+MA1,XU<OO3"$:+LV(!%;O465KSMJ>H )27$R,@K[N$[0UH$DF05LX-6
M2T&[%>M[F )WFTBWU&G:(=UI@7)' .RH13('6E^32 &^L-RN$;P9C05B:+.Z
M$\[H8BA)*8Y$%(6:H+K/4Z#6J$A0O4FRX"/L?+[VQ&H:/9!6;$?L,#=A&C6.
M?\*:<)+FFA_0@4_+7$5;PEXT1PD7S8AID',##4/FFU]A^N)_/]+8/?Z6QNYQ
MT]@]_A[&;GV?G)QK<D;Q8/T'=W^-YT ST<Y25'>0(.($ST866^I#RJN*!(XQ
M^81(11#MT&C<YK#!]L\W!;[DNYNL,H?&549< 15R9URQJ8.CLR4'I-/.8-=I
MA#H2679%PMIIJA<$;4;0H\^17*,5Z<YK>!(9"N@+0MK"*",PBVH1BD!S8GL-
M-%56G";J9G -?X$2.SA3[S^##CN<J-,!Z%?GP]/^%%39_N@,-5NEIC?]T>0<
MU"S2<\?G\-,-#'/[_N^#TZF:CNFIZYOQQ^%D.!Y-U/A<]=63(?GA2)WW/XYO
MZ/'K\>7E6*FKP1E,?JGPX>'HPZ0#3YUV"9+18/II?/,/^\A5?]3_0",!<O&I
MCCKKXUKZ#,#MA]O)U$;QU5X?E,3KS_C3IXOAZ86"U8X!@B$JDR,8 N>XZG]6
M[P=J\,_^U7"$0TT[LC:88'@-LX[/ 3L#'(4P<SJ^N1[?]*>P['U&V&CLT"5/
MM>!;(2(!Z;QZ>6 XF=S";X"7P3]/+_JC#P-K6. CEY<(F_K8OQR>X8N#\W-
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M%H#O[*>2SZMSDO_B15_VA#K!;)AI=/ON(QS+ (Z9XY*<.&(.N>#5,\1@\CD
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MVIE$)'<;VA",C&\N; &PEZ%01,4VU/G1L"[JCAL) @1NHR>E"OIDMEC=-#^
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M_SCV'GJ.7\C32L9]9<9^:2:'I[XK]ZO]]7Y\]AG_OIA>7?[Z_P%02P,$%
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M_#V3420$V^.E<);G+/8]EU#!?\=H<V)C/)"4UD"$R:V7(A$5A/A)(%J6__^
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M4F)=<AFF2Z/"X46ZO0>+( Y<%?#R(X*!D.[X7&NT9&/#TWL*:.:!'+S%B('
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MJV";W8)=8DL((")983%NFO K%&M48!5\ATF!1R$X)1A/-4.D$R_!!PH<KW;
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M[;4:Z-\@7=)7?N@&F8=D/<E2?02*SA>E$;_!#ZDW-[.11>DU*H:J,<GR2G0
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M?0 0.2)78<<T,5 P!' ,@ J>NP7/M_?S'0GGBQ4M8R,*\_N?%!K:Q1K!)JF
M$7$.NB5!*ONN10#E-58<H'LDGRDD!#=!;"1"&]H#T97%_=:51@KV0%.*54@
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M([^W8J0,9&5-Z^3#5?RRR:'7(= 5@30S^9JC!3+'Y).9#H K!R*/[3V71P,
MWS>)\*J![EPPF(]W5AQ%M_\P?1S+/R.JS]B^<6P(_P=!TAA4XT2SXT$4MF J
MERX+GR-S8/U';OV<[5-3CGSC-'CL/<"U<0$%A'2O(F#.95C:P P5EH,Y#O4<
M#2!66)$\$^#?)YBD U%'W;U61_M!=+YOJG O="#+^6W9]=.0]M1PKN:F\PDQ
M3[=)T1EO>Y(XYD#DL[_7\AEB)QY$=8]%=4U+1 8W2I$02^G< ,P]SQCD#@2(
MH>9\D@91#Q)2D$KO^P $=2"2>748DHD8C ?!W#O!O&VF_%!2Y=<'(564?WB0
MJ@>IVA.I^G"?I>J-KIM+6*_?N);PXNHA)+R/LA5&OG@\G$8M">1)'3R(3K#%
M8% !GS?\1\E?MR"-HP9;-97KUU5;ET7.]<"JY89=8)'V%>$QX*]@OK;(6]$0
M,6"WX1B61Z<',M]<ZB9-FG [$8V/N3W^85PA@N.)]Q^S%"3J\K)A,FYDO8#W
M(^OWJJ:*W'5]K9E\P/^2>\@4JY7."\ZW._80S.RBY]PJCF/E-65^B:<(/-]?
MZX;("V3B/O;9ME\+YI#A?M1?1[=N$>!#7W(SM<:C/>(9)LY(['V&/UGAXSD+
MD"(ZP8$1CH)7)(@MQ=LLY^/P9>W*36ZB"& XOAU2,U08Z653]VLFT\7[9*96
M&A8_TTW'3X7?S8JK$0.COQ2%#Q&&!=FR*2:7X_:+WB6EQO*$\>I//F0H2$/R
M*IF:':M#P UO4 /"#-DB=BMFL),8]L1 #PNR9M(,> 8':@Z.47QSGT_8MQ>O
M]N! Y8ER$8F ,\BG4D5M9NE4B2.V;0^'@NVW>[V3'IA8]MQ"NW%:<CL=A<GO
M#TZ9"!O%**V_&+2^NWVB<6,.+X0%INYL08.DLI^Z)1SYE\L )/P ]C5@W\</
M8-]/+W%D49-]A5#TE+G(ZA+)\UKSH62D*.Y='T K=+CR(Y*-U!<UK''79(S!
ME00+1?O1&'7M'R>_8T3R4(0/Y.!5VSKB[?&9ZT$8]^#0-5Q^2:XV(0^]E&B^
MXO::09'F[%-7:1ZA2-1K73&!(,_8[]NW=[1-I[;HOV?IXTT['T\V[7R+C-W)
M&XW\C7>:9CI._,X3*L=%9$1!@+0*5=WI4U:Y*_6A6/4K+])2]888TO5Q#P,2
M6+ @VU&ZXX0U4ZZEQ=,47AW_7^YEV$OX!\*/1L$/0QL"!T;?P?WDQN8RVYK'
M_$'&1EYYXVJE20Y6)'Z6U!J.FWG!<F>")-APFA#1?HAA4&*QD,OQR7"E_K N
MN-4P-9H@1!?%8S#*A@"K4A+*<$L:"KX! :^VS22,AN:.%V/B9S!7-5>_B.78
M5UJRSGF"M>(VH $+,W@+:91TJ6 #(*;D2A4EW6I!+R)#'-:\$1,<13VNZB(W
M;Y'7_1RF%6--=;!Y=FZ9AJ7$;92B#;?C8[.AJ!\QL0QS)8BIT1O?<[(@AX T
MM' K>&N.&C5!2&YRW+]C$"-K_C":%C^9U'\>T/&.2<FW]'NY7U;:I)&VG];9
M]U7R=UWI1I5W?/R]&QT\00/UFQ**8PIUT:.ZY-,(O V?';6K!RD@:B\/^J;L
M) _1Z+5&TXZJU[A)_64/QR\.VA3:8;#99WM6@1@%18M$QRJ9" J59[9<K\ZT
MSJ4M.T(&^<6Q\!=N>%6TI.))$4K3*N9HO\1:.KD$?RS$K>L&H^1V2/@7?*/)
MD0TS4.0+KAO-($8\UKNFUYB/PA1$43+W;%%90M0,/Z'/V&! @[[-]4)AN+W@
M]VY[JM"D\+X$0>D2>:=R$]9=!G.&%PVX[5Q"J*#!K80YUO*J)1P0X3KST7N:
M%PU9Y?GI\LIY81MQT>%#IZ]?9#YQ-(9'KWFB2=2L%!+WTM(:D\-RHW7F.R6$
M:6Y1[1;8O<L"LON:>NS"Z(C6ADP2TX71K\;$Z]$D*9-27;=IT"_1[L^\;V2;
M_PJ.3IL7,LI)[OPT,8T$2+!P0"1$PUNBG=K0>-=J8[HPF@0?S!TMP!%%)*YT
MT\K[\GC!Y\+.D)O4$LYUZ@,3""RY)XK_)'PP>&9Y*<$"SBUB3HV;EAFBVRN,
M0%"(CY\2SI6\K\SYX)5IO\KK\I*W_?S1NJ2$,RD95_MLRP6HY'>*%  F'$<A
M%'MD;T=O++9.I3%IAB^ XN!I@ZZ6>E_6"5.DQZA=M2U8QGH$=(N0*1I&9]U=
M&I;\+-^V!4@%,TOT+@3+<_[O7)?UM<C-U4A.N=:B*$F9PUS#289/)I$JVG6/
M:PCSUKJ4:24%%K9>8B@E)C@5J=>F*NM(2<? 0MURAZ"J9/*&VZJI?4;H ?TQ
MGXU3&V>J='PWP;:9?7LP(G)]Z%[=5"/Z4XV:E&[&HH3ZR=S'<T+=%A[R#>C%
M0G,Z7 6I7@P]XFY4CF?;U-6</L47MI^>@4(QPTG)-\6 9%FL:-=V-14'V2&:
MPR,K54MKV6W6VFD.?] /X7H3KG_R$*[_-X3K.9[B(X Z8JH7]#H10K)HB<D0
MXJB3\!R2WQX->2S(UI"Z%;F;)9$ H>..)_+LD?'F%>==69/+70\F(;9*:;5G
M_5@<B[&!@N,,^PPT-[2#CI-SHK,52]:S9O#("!A%8FV(0*+GA2T,(+Y]PND,
MF@FY=(0A+/$;#X$K\X,T6Q@_IY)XE&O<@K^)MI0-.MYZ?6=DM4D?>A-QI3V/
M)Y:I#'VKLK!32B^2&;!98*."GLOIN+JL:W!C%-YV\MYRJT'LRK"?V"C9@61C
MYO?,SW^M2PP-WWF4)PAS.W7$/LA88/"@S7GH>GJ_V\V%=_7SZ?4";/PQ!,Z0
M5KN4CB=@%HPG8.S8@(QE"J*!CKUK6W8H8:SLGFWO<[L7?)VZ!R$MUWI<XN>X
M\6#/Z))C#*@U/9"Q>XV&E"P&6\3SB1Y<@Z2-:8J3=?'=ZT=9C.Z7$1B3&\<=
M=,"QLTFQ-9L%L)V(MHZY<7T(303.F!A\3X0"B'7?3@\V]:[P6@;B/\BQ143I
MQ-'NI6=<4F&A,8(0-&8R9UEX]<P#E)IJ7]N\!J3D2(;#]H%VPSR,S,'3R<P!
M_Z\E";M;27L70$1@.2CDYA\$CLTL3D%Y R;)T*$V[;!N_22X\"^?/WG^U2!(
ML"T)-=4W,QV?/ZG7EZL+RF;]1DE#B[]R)'FRGY% #KX]>PXO577+%I\$DLR]
MA V=)LY!7W5%&1$<>T9Z%'1#5DUKC9(J&E+9XZ"?F<>/2GJ9'BLW-/B9*L%A
M40WVJVI,*#\L\B7^?+D /U<@8HPWIRC\Z!;'TZ9*Q%*A3#6MA5@K&%'M5"%@
MX;"Q:;%"56MP'J@TN\:&5IO$1#'#$&05;DRS7?-Q2ZP8J> Q)LO'RT2M0%IO
M3,+:%P[('TAJ2B\F?V&#5+ 5LZ:8.T83[0+Z6)'1%!A4M&[=F" 2SJ*#4*//
M=JC1"Q?@?,C!?LH<[$6$%].'UP3G^^ZP83=DXG'7SO(C+\D1U>O8-)E,!^-Z
MM!QS9%X#) 1R$>5* OB<[\"<7)./O!K2>6JBB>#&J=LMW$5<T^8[4/2$&(4J
M&4VSO88>CH_?/4 @'AW#5NA0:=NP.AUH,-V7-6VU*FAE;8+-DSRRD^34@I3Q
M[I4&]51>"]#PCM?*TM:FR77=ESD. /%;'>_,^KIR=7IP;H#?0!&II_\YW#E=
MC6!*AF_!M6$)6)-<87\44SE'NY^#_E(!&*T18]9%BO#;S2UP)S]OP,*I,S[=
ML;,KFOPLM*J#TPLD&D65\Y,Q&'$>=J84&!8EKM$<$@O'+* ,F4KNEL5:VO/X
M<T_^!W(8TR\=1M1?["65K9FFT!B/B.9<6)"]%7%/MU@)[[;'R;>2D*NV;SW\
M^)#5,%F-IP]9C4^O%K?$UU)7?HH;TW," BK<E+V8R+FU@-.ROF;KOH,]SLGU
M1<PO8Z$2CN\=['Y"1QZ:W:1KK6\S&W"#N[[-?GS=89W0^-6F_;OK.0RS6W%8
MD[PRO[G P&;VBB=F[=$1PYQN8]"M58X:X5&I%VPL[[.)5TR;> &.@<)$U++;
M A=$._J'RH3!A)[)0E^;^$]W72<;K1IJ6,&KV2YK\C8'[%3*HE =3U4,P';$
MV;*#7:3B*+G9,F4P<GA@ X, >Z-Y3W)(@BPS#Z^R269G)T?@'/>P HAMN];Z
M_1^\%(>[$C<5F!TKL<#$R^SID8G+X#K8P D*Q\."W&Q!MM&SD4?U'?R\I,*'
MM:Y:4DU6_9M:IEF4H3IY<OID]J_ =CWB0@IB-]&$M5MNN?V.E:%],CL_(I#8
M5(:-\9\V?F9B8&7=]HT> 1$=5 ><=W,KKZ3>EM.?9S3ZTQ>/GQ#(D&$*J1]5
MG?WMB-6^?3>\\VQ'(_K3I[/L:/8XG#4)@W+^ AY6][A5MD\.'?=%2Q-L3PY"
M5-#5D6(>6:_9Z1$,'<N??:<C$AT+Y,T2@QRJI%S=] S!W9C!=OE-FY!D2ZU:
M&,X+>JQZ]//QV^, R9J:5C7D[?(/K9O5#+QKDR7BK)>U*+3SD&%QE\6\<( T
MCCM?M[9J)7PXAHP747[GR8OD89GJ6QV,ZJJH2Q/UGQ*O0;>>PX!B)%NP&*-(
MBX/4V+@=90@+0H>Z0)S94'CZ30;EQM&)+8;D,#0Q8N-I?!F/WL?^UL0!VPUX
M":L)EE,S>G0F<JJA8.9R.5_&+M!$S;5$7>)O1FK^%I[3L*'1%A?J./E>L@97
MG' 3#\I?)D5GR1^S0/@3620/[Y7:>D *_"H67*E^!RDEZBGX<P^ZWP-1IW@X
M^,@J3L#!$=3D-"^;G<^@_K3UE6XJ+@2]9,P[CC1D-J*!-\453C/JC;[ 6)-%
M= U0,Z[N)!W/IZ05AT$B20J9><YDA%R<!S>PBTX;/88R'R0T=P1 &7T L]/B
MB+EB>U$W-Y30,#@@TO!Q^T(D*R*KMQ)0$CS8,SM"[S?H-XC91*8-&4.6X4O&
M2N0]6';Z YA/W<C?M=6[4A-"-'<-6E%@PXWVP]1P665.!%T-UI[J4)K<'6SO
ML SW.'FC0;91/S\7+7UZ_.3L]-'I;'DT.SM*':L:KYA7V0.J#".KL?@G1DR+
MJN<2@ X!,/">)1^''KBKH%S*"E-MN+ZE!D,1Y*#(WO._78V1?(2]!"8SOL)#
M6-2$19\]A$4_O5E#93Q7MXI7D>N1US &5(H"X0!] 2:JN.L$A7: +''-RQI<
M*^NJ>#\7X]C)CU5P-BF!I7=62D&Z+GM%B2,>.)^,6E@L*:5Q&$;G%H#D&*PS
M#01Q2-+)-K+#_K!10\HO"3#EFQ)!=IH7J1?>V"H_3P/[>OCQH[.9M@R3>3);
M'/G%2'% 4X!DFACPIZRMO\N-D$]NA(CO@2&(RR'0@'_]S-8=D: T9"#R'Y34
M=D0-A @#&<80HNV.9A;;',V!')G('-E>IFT)NZF5_ 4=I:B%-^YX1#:UU^QU
M)YS:XMG@'/0E9=#P2?D]FX)7"II#&W83?^2(> K?[=_]+H>!"WV^ ]#TDS^K
M=PII.@PELXWZ:W]!^7Y9%)K=>]-\]C@YGU"/-^Y#[RLAUC4$I=R6,)YOA)5!
MXN[(8DS' D7*L>Q+ LU#WH.9B5MS,MB'549JJI_/YD='9'QQOEEAZ3MYP X
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M>RWO2-:"1TA7U3:95=H:YH-=$!A>,*C#6*;%]#)1I-R%?YUS( 4]]\TCCL_
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M&M<1"&S0<2\;O#&9$\'ASKK3,YJ/!QQ'?F9&#)51DFS,G91XF&EK<GG>B.5
MF8:_B36"<H.FG_".N7J:P;O8F!?=C-P#CXHW5MU,EJFS-L\Y#W?ZXO%C&\+S
MOKXP'HC[W9-D1IDA5[7D6-/_P"*JA^(@ET)Z\J=*(>V-OE_>2WW_%BLN;')K
MD?QD5<2=0XVG(5?6^F6&JPH\W2+G2(>NP(O--*J[E)U6^5J2=]XO^)V=\N;\
M?S1%8!E0_>K8@)5&DO&8".?[4V;>L!%X=U*YG!2Z,EU9#Z6TI+B7$L#!2_2A
M]L# L5V!T5F#W17+FYD6 DR@Y"&^78T4O1*E!%/31$)VZ!B9F/H6@@FW2;^
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M;3L'0;,0\5S"I3EN>3TA.(*V>W5Z6'OUK+17W0V >P8V9D@;;4T39M>&IDC
M#(O-)@*!B((3Y#7LHG@>%?CV(WWNX2UQV>T71_1Q*O]5J"U!V^D&U7HL(M@J
M#S(N4-XLI-X L-(7ES2$+I9U4K>L9WI1]0J.T8+H8 VG:*O36\+@HNW(R-<1
MGFVMA7%BU@)F5!J33-"\_T\!BSPFFVQ*0D XAERJ#3F4$C+'G0!SB&<MA-O+
M9NNN[<2>529V<CHIS2S89J]?8F9;6'QX/BX_W-U<O;T.Q@%:[. JW+R[0?^@
MG0DXK7G%L]<H$CK:*GC<'V&S9+3 FU4*-D:&&H84$IP8.B&78(F@!9"M\)"O
M!*PQ;JNU%#$J)-P+29'SUR5?';*)4<016C_P<9OY.6[4[AU-#UI[L/?PS:SI
M@_.%VI1G"T69%&D&IT-D20PB;:NE&4QJ,$L3.&?I*(A%FB:/8-G!E8L0K4V4
M@VH*VQV0\=%%;S;/"<S.G_\T/CO^KOK?\=&XZ4_Z/7_WPZL&3/X%RD<P2I5_
M$;S0F%I-(9\HW 6D/V=)\NF3E!L\58)'"::S3-% Q,] B0HRM<)YN$%KFG<E
M.D:.'3G;MHLD-!HC'=G)QB6[5.H<M'A"!X8^326J-9P>.$4P$ZE<LL]DW1%<
MTO'Y=Z#*9O ^;)PHP\.=-32_4T<S&C.%/$VTKL'R4+L$O<]:ST;]/1B$2Q">
MVR';O;?SE5P4$:S"+V!@+%+P6LVM!MG0?-NQ35N\+6\35+_P7ADL.*PB#@+N
MG14SLU/RE<B#AEE$.PB\/!!4L42/%/5S:1+1"H*=A/80JGKCG37.7%N]7I7J
MG<FMR4ZY->F?W)HX<FNY#*,0++"N)=>D)+G@:)B !VXB\.,2],%P0\9>N(!V
M*)J5<.5ZAMH0C@,'59((3LWA"2Z4XL;==J)3X%"CBZ%L(FTJ62\V.!F?#&9#
M&QA:@"L$O[!$1R?<3)HS7W_^T^G%=S3A:H)3M.+A>)OY'SRN)/T)/HP3-%WT
MH.1BJ,XO.'-K&(&:]C8#G9N!UGIF;1WBU_T1!-.=@F#:/T$PM8+ B01V+0JF
M)5'@:@NCC6=D)\=Q@?J*AAW(SUKEP@9%F8$N*.C/19C-4TFZ+3U ,P:EP0Q#
MLY(]*CZE<1*_2N5] 6].X9.,984;BYU)^ /&01:%"G(M66D;@X/#U*D*_V$\
MF@\S"@.\$=VF/C:(\D&%R#'F"-[[!NZ7I!R/=^3SE^:'G/3O&#M^R ^T)O/0
M.<:P4I4_AC+K^I277)4D)IVSQAT+YFE&VBY/X=3!OQPDRO +O/O)(H"7&!WF
M<5Y(3/0(E;SRW:_:D*+V*LC60=>,)B#B."J8]1)EG3J/6<FB#HI-HJ,H NY&
MYI'SQ.8#JL9\=GQT@HB/39*1A_!M*B.!TK6" =$7SI(\3];?'MM+Q"Q+HB)O
MON1W2,#N6QH:T[@R&WN +7;6VN%K3@R^9I7:S7HO7\U2*3Z]$DMX]V]%]"BV
MV3<]P^ X%TWIJIX([-UVUVG_!/:T5F ';Y180/WZ(^CTKD5TR1"C7#1F:DS0
M .0/Y^[@B104P7^5^D?1<WC2F7(=7I"#1:XGHBEQ)7-,<.*"J3PGF)A%RB95
M0[R$,O%*\GL*SU/,K1V? SE_9_T^?Q700\].G4$[B'!1#=;ZMK9.E] I39:'
M=_S0.++.6]GAL#$*\H<"WXQRY^&KZ_,2KL]Y_TZRX_I<"7"1NSZ\):\&=ASN
MP*J5OY"(5E*I%3^<B<B8/__I]/5WP4 ,$7:387S]'DZFA)-Q>&<:TS!P9!!7
ML2Q@7D2TE"(C[T:)*_#W4&+11^"=8'H8D45P&A=%3JXJ1B@QLBG4:49'<!UF
M#!4B#;T2Z;H$AUN0IT3'.A>?9*RNRE%>?(J31T(SD%Q!$& :PG*("']?IJ+
MA LCG,+X(8D>,!L&2Q;"-Q9@^8#VSO*M4N#P&:C^39@7"ZG&.A_"*G(H:A$2
M_ _].M@/14I)D$@\,KP*1KJ441+3O1APA4.1ZK%X"WC1(F-C(<S$9I,F&QB'
M1C#I]T4 F)HI^.9@ 0, AV)._MXRA%U()B9,J,$5/DE*]2KCLMO@>-T_,>48
M'%<K$=_3UK_B6'G7(JML;\"YX5\YA8D@SKD9<_(8RS1;A9L2^G1DOG5X FI*
M1H<#-E))C,HK\NDT<X%_\^9#8.84?".P7D D^&#;0&29S,N@W:8\24NLFB ;
M".3%C 7,'0)&"CCF'R@R3%_&K7_^'?]W?(27OIH.PN'@=#AX&(Z"P4/(4$?X
M(1RV1E7U1A3L3KY>]$\4.,G7JTB$:]$]:J2<>_4L%=KT;I0"(>LS&86P,[7N
M)>64P3]AYD4FQ5.$04>;1YOR.F@*KT"N.UGYC(V.L4A!&*/?@-;KWQO!BW2S
M U2LNT_3^+C?QRE9=&[_3ZHALX]'MT<- IU0Z:_/&$?+J-B1=G15E0=NL%SD
MA7Q2JJ.CK4/5'_#*-7K(S5V*(E\E:9A3$B&X+T+.=8 ]CYCJ_(D':%K51IU"
MI7><GQYB&%W+U*N1ZHL]6E?:Q0%73'694Y(I@T@%9!5(F/;;8YA)79%D <B<
M4/.B2@[4QL._).D]6&;_5H4)*/I'-C&'(#CT%.O'B?ZC/TQ\HAXE_%"L28ON
M@AMF9=UDAFW06QJT>9]2V4UE<"!HGC,^BD50,8T(-F 3;-W@]I>GWOH-U:M#
MC'9]5FO477W,E*/8JJP/_@@?S21<N"2_Z0!4VXZ@NQ].J47TCBJNFO;E3H\F
M;</$D]Z<HSUJKM](MUWKU/5YJD#?+!2[@MLPFD*CQ@F.G>6P/0XO!H-Q\V1I
MP]YXH$ WEFN<:^N -?[=!%3)?_N'%.DHV$1%1I'C-U*NX>3=Q."UYE0F>B]"
MCB1'28;8.BN;,"LTHQ^YZA,4+ED3&-7%^R\PHVOR2%3T5E,10,6Q)I+M>M#D
M-!.(INY"LZY[! K:VN(SZ?I5$G&I@9J1!>6]8/QV:C!-GV$*4=V@K="I%B;V
M-#DU[C<PK[+_NA8U)U75'2>J  0DR8-,,R=Z.1,1^6@K&:E41LV./4RQXU32
MA#$<1YB4E+&&2*1@(K95 ?)^D]O\$Z6:,BYD79/WR[&CAQ ,:Y),.N5'15=P
MPP<1%7*O5(=A/=L-[NM)[2$B:]=)U0O=PQ.[VF[0=87-@S!X)CP(7:!L:-[B
M0$^G-9K9"=9V\]G1F)6:+:*M05PAE4AF:%!FNXXH@;-44K[AP)<MAC9G-[CT
MC *GW#E&Y"XGG&?:.(B<A)+*"F6:QJ)F3>$&&Y!5B)<U.(+&[?M\AHF^RI$>
M(LL\.>)7??9,?#S7MPCJS?2>N_#H6-6_H5TF93Q7O BJGW4@*O!SF"Q8[:.
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MEH7,.%^:,;K-K(AZ3A",%MUS@SZR%5YBGK#?V(O-U ^[9BJ,S4P=8 )A3TO
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M^-OES;O;X/V'X.W[V]OK=M)_S#BE_HO_L[Z*_S=L"MW$#^"BDA7V?M,#%="
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M='Q@X*_3;HLH3ILPBA\W#;B&RNJ%F8FE*7<*=&5\KQPM\EF9"!335O>*G\3
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MLLNX=90V_DBKKXOHOM18UECSB(&,."QA*$ZY/Y#:5D1V2D%))>04I8Q7*<<
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M 5[]&-#T40P+3OC^D [O20N)3,L2*L>29G$%F.IPA$Z!EU=+FUHZXD8<#4\
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MB&M!![SY%!2AG'_>B48S@\GDD_2TNZ*FOM"IH:OV'7;FCRV(VQC[ $NF7=;
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M9! 660,S"LUK6\K'"[O?-)./=33L/ JW\PC1:H\8=,-B)J:)6+D\H-DQ_%I
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M_1]?+--\?Z'Q^5^].%K57]^E2;WXZO#9LW_[(KBNUI_J?96E-_E7-%KX=E[
MW.3KN,B*\JLOG]'_OL9O]N=JF6;W7_W[=;K45?1&WT7OBZ7*_WU:J;S:KW29
MSOG"*OV'_NKP$!Y.?][):. ^69IK,SH>TN6G13I+Z^CPV<'IR3=_Q1^8276F
MY@TYAN73Y2.-^>S#]?NS-V?1CY=GKZ]_G$97;\X/PJ&/<-"7/[U[_?:_?[I\
M<PWCO?CY_)+^>?:WL_<7T;O79V]&/X&],S@S"9PZE2?1>UW5= 0OYW,=U^FM
MCK[7L[)1Y7UT]'Q*1V_RV5."(UA^._BKI2IOX'#-BKHNEE\=XN$:R]J<O;^^
M.G]]&5W9??C'C^+KE4H2D(?[F9[#)T<'A\<KE"JPI.]^?O_N[8?+Z#<N[:]-
M5:?S>_XHA3V0UU\=/U_]ZT762>]B7R_2*GJ7J3RZ4U6$&W&6I=4"-J.VFQ&^
M*.;1F^)6+V>ZC Y/:4L>3Z-ZH:,$=BY^K5:KLKA5&?X;/Z=[SN[IW]\5JDP.
MHFOY^"]?OCPZ?/%U%:V:<E54.H(AU$6D\X7*8TV_."^6*Y7?VRO5+,W2^AXO
M4W5=JKBFD[,L8( X %C(]#9-&I55T=T"+BIUI#^M8 (P$_C14GV$BY:KHJP5
MZCQ8ES*=-75:Y/1L[YETX[2NH@_-K$J35)4I+#?,!.>7XJ:(JB9>A(],ZT6D
M_][ $/=GJH)GICF>(5J].YA\A8L(OVABC<I2Y@MG##[$?RY767%/ZIANY0^G
M*"/EQG+OEA&7#7[-<@1N,L,IPYWJ:%X62]A(1?QQ460)/,2^'%CQJL$5@.O?
MJ"I1?X\^X'713ZK\J.OH?9/IZ/3Y\>E>/-D[F>"H5;3"A[G9ZT]Q!L;"K<[N
MHSF,#E_2T;.OO3FXB=)WAU^;1=C#V:4YS6^I58ZWPZWU\$@F!U%TKE9I#:?H
M'SA?72XKL%EHJ=V&P_>>Z#EL<_K\K*S3.--_^?+P^;.O_^L*[N$OGO)D<&ED
M,,RX@L?#Q. ]+'2ITWSJG86.8!Y6EML@8L<C8U\<O#PU(O;R]=4/5]]=O;ZZ
M_N_=D+*7,*AT!AOZRA,:)*/,%WQ^;THXF[ )S_BX-#D>7K.YIR!W9K_"/C0"
M*TN7<!Y8AH'9'H-$@]_RGMWR;3F>?7E\</K"[,NSBY^NWERAP7Q]]?9-=/;F
M(KJX?'WY _^Y&UOUU<'A'[/T?8\/E_[HZ.#HU"Q6HN.BI,W^%1T+_"GLF 1<
MQ+2J^9O'&_@7W[9UBPP,#F-BS"#0Z'!@:ZU9AY-5!);)/2H?7=Z2$ ##0V=@
M3:'B9T-*-?6B*-'XD0_L;= TP)^3-531=]YZP)>^*8::VI@3669,K^HO7YZ^
M^EJ4NTZFT:*XT[>Z1-M.U?0#N#LL;52#!14:=*A@P9#*-5]@#1<5O)-@$-4"
MGYT7-0J[1(.)D(AMXE:)[]WDF:XJMK1X!"PP_:L5S/[78&E O.J5IC,47:0E
MC*PH*W@SO?(41@R#F87WW%.3<)&G8$^F, @>.EP=@UU6IFAXH(%7HA4$3^]]
M\A17>V\VZ1EIV\#M'_FNB)2C+1(I[^ $E)5Y3\&!&H%\"0_X NUS*Q] ?"0:
M#6/XL>S:7L,#=I=&6Y9/Q92M#G-&T!BV;B M 9O:^#F<]B3ELPC+8W[>LDJ\
MB_ WOI'B6>J]TX'!%32G4.[AC=%_PP-H90%Z?^9#,VMY3-ML0K&*5LVJ!,/>
MN0JYV%G1V4VIQ2W##]''3(I5/64'0=R#E0;WB7_HR3=8Q1(<%5S$!@0HOC:^
MR0I]U#36[/C5).Q0*]RF%2PM2!5P$+,&-^8T C^49"(M%?ER4Q&D, H1H2"A
M8ITTH"G8NZMA;]'"X']]+U#G%5QEQ+?GI9)6ROMV!-P\A=67]T>[01PSE/^R
M+^#;EMO;%J=[WI10&11-[;U]6$U817"12UIJ6 "ZO2B:]JUC7:($:[OFP4!I
M&X.W2^.45]D:$MU[08JR@O_@UL*%AHUPFQ9-!:)[ID&KL>L:*&KK>L-_G/--
M CV=^S<POYW2W1<*]DLT*W(5S6$_1"LX[$6"0\R+?-^YR%/>:3@\N^;N3+6G
MP6_.>=6P\V$[I[!.L!08P$%1@&Z^V<B?&5X(YCCI/9IH9X"T1,6$#C;\A_>Y
M6LY2V/IUJDD2K%:H#I=I5=E3"C\I\CC-<)O"ORHTBN!O'8@#,XS6@0P.#Q@:
M8!*@[UU(1 .V P9_Z, :<RL\X&X#]\W*:M^U H3L#A@KQH2J N:1I.!K:3J9
M^ QC1LSA]QE],L.=C"<H9UL+] G>=J%NZ=,RBC,%!P/^C>,CV00B=W ]#GZK
M:S$.9^Z7/\B7>UC[GQP<OC*^W./YEU]\^^'Z[?G_B\Y^.;MZ??8=+-'W;]]S
M\N+#KAA\V^1#OFDHK W2]\,"CGKUR%;>!V=.J01?+ E"%DE!//.7JZLK42/&
M2".C%?1!<-W5+VQ.+-6G=-DLH[PU7U9#*.#)*<O J$&GU0\5]ZLEZQ*=/GLV
MA761^^$<^,:@!AK=4<JL2D@1D.YF.P^#NF@(-;G\BN\Q-?>"X<0+"JT7+"8+
M<)?@7A0L1J.@U HLGWLSB,&3Y.>3P04F4_4K<./(FAO,,,O!>^9^HF:@#)IZ
M^"?=\[E19NX/^)G__XO2W&&E;O3^#);QX[Z:PW[Z2F5WZK[ZXI_-R&\XG.T5
M=MODW=+IB-[K^#Z&#VX>6=9=S<E $F-GI<K0FM>?5BG)@$RM*DUF+@BW>5'.
M-3I*TRC&A&&&_X*C7Z(/5.(?L(=C\C3P"UW7&6>#8@4>+8H*L?5T8OT4%"@H
M=R@!:24CR\TFIS23R*&XN/5C>CQ0- &GE"P# SB-V<.;P0M8DN^A;A0\'B--
MMRK-\%L*Q_5*U0-PS")\J>PTR5.=6-Z#J:.M/Z/('/I*\AV;Q75-B2SX[:3M
M/%'$[)U"U9"N1+!7<&DUYZFXL6,>L8S3B@9O!"\Z7[PX]OV \OG+ER<OOF:?
MS-R+@H;N7K7Z1,N,J4@R?V=PBI4+&<+T5D;?F1L[5](L -C;BK)Z+1>-G6'S
M(B:_[YL@CV&EV'."B5^@>XHA@4O87;<JHY"!V5@<#?VUR;UP*#E830UOA!T"
M>8X+@\9%@UX.CJKB7<@'E/QF+Q$)-_\@<58P8K<ZN?-'N0,/IW9>'IS8U Z;
MY&_?82;G V5VQ$A_]^[]Y?D59WC>7_WPX_63C?X(:NL'G>M29:,+P*(MR\&;
MMRL)C):"8SA;K4H=IRSIWN.-*(C6&Y%=D]A]*&9*T0<7]L5K.P:^I[- ,RYD
MK.0[#(W5.A9KPKF^D.>!.[TQW_A)F)X9'@9-#Q,M=<:3\Q78'N:X2!MRB,5<
MR(%0,Q:2J@/W)R5IXN%6EQCETJSPGMZ<O#G2M!%/Y.6XUBQFI)8DZNV;HK>Q
M;+(Z767WJ!OXWACB<K%1N>_W*BT-+N87E34TEB(WRD(<(H/$<@.^%6UF/V$5
M#HME?OG N$79=C946W%SLF'MK<!P,\-(@IP!+K2_J_Q\(1H6)D;:/7B(YZHT
MAU)!2],;$6UL#2="3X'VGTEPS]R^OBOZ<Z9X8W><T/[AW*@YB*T()>S>7=$'
MV^3&7)H=_0YW].C4 DNM((O6.H.?(2!-!KIU!WJ&I-(I5PXG)8]P4&O$!N_A
M'TAC78B\P$]D&&N4UPYM].,MVN@7S2B@+9?>7EVS26PNQ%>2)KU7TY@H*P,6
M#ZB.=)XZ^&9+KDXM)L5I !3*XG]N.A0\'ZA4"3&:1_=:$1[D35&C"K-^&=X=
M'"U]4W!2QN)//'5-AL8=GK_0!9V:&>A;RKSA:.6<90J<NAD6UM"]E$5_?-Y,
M#":E;8EL\%/0NK".5)7"%L>9L]E>JSORE$.3))B9P%=$EZ)J%('C16-+3(K9
MGWHVH6^I)8TVNMX85^#QIN1NEXK>P:J '][[KO\L4_%'C,YP%K6:L#87O'$&
M4]YO5A9A;'.&='H8KM2#4*)TJ@OT5#IN2DI?=B;OOZ@-E]M&Q%4#DA"^B>%O
M,+H_27X>+, T<\8:[15X1<?/<'/ V9B;!"8&&>2QF;ZA%#V_10H*T<+LNY7!
M,<ERN'58_VX'<5^P9'DA>YFGPUL/9H Y7=G3^KZPB0<^5KQ4>Q+*JQ9@&>O2
MY!S8HK5;8V*Q;6ZW;**!=D4!G6R1 C*6UB,K(.->KS.4*I/$LHX&;GH)CY*8
M#P.BN%DQJ7]V SL"07IW)4+^\ #4QD:3.]&Y4*@CECT^@P (L;Z!+#4SC P$
M3UGD:2R0(*O0RJ*Y(5%4Y#A;K+"HZ=Y+E>8NT(GQ4!H;.$RPD=TA%G?72YVU
M'=Z'CQ/BHFXT><\H&#M!4Q/WA(G/FRQKN;_&"IT79;^+B%_P:C@EY_N \$Y_
MSL5N[>!6K:JU\JN:;J@L/27EM@&!7\&_%RPK:EX>)R-QN[:Y>Y:\RY5*$ZOI
M/0!('TS0VCA^^+8E[EKF#HCCEU^3HO?R%+@WM8TTL\1&=8R;@'(=N*<_(Q_@
MH99,?L2\+8&F8)SB!L9T@]JIZSX8.PPQ9WZ@ 0;)6"2:I+U!N*PR_GC"B0B<
M)+U^>Y6O^>^#E$&8!*'U:X5F2G>HHEE9?-3EOJH(:@1OH@1WY\;BHJPZ(^U)
M(-\>RZB:R'@3,]YN#&$)IP?,$J_V0MZS,R7C3#68N8(W.V4DL$N9P%+P,_#?
M>N*)A7N):O$#.@CI<+,),LGMR8/H#(%**!\J@T-D0YS,"P\V1P<79-T<+C 3
MLVN*FY@.OI< Z0J :2!1V6"(<<YFPUN45A=V0"4ODNV7%^/9C&O4_6.D\/^@
MW$F_ CQZ3+3 GQ)D,(Y4V7C*H'SHW/O+#]?OK\ZO+R5)QE*L_6GT\YNKIV39
M4[*L+UF&C >@/5#SDB$WC<2,9*X14 86=="]5.((/8FT3BU"N\K&WK[4]@$"
M0#'@$PI5B89B>R<M64D9Z]#DG*1@&/Y&T[W)E#&)31JIG:JBYY+=93 L#>=@
MO&=.T%/V<FY=?6\B9]5 Y(S@RF@!,QX#0VPSC19).[#@6:.E+#+: "ZD(&&7
MH12,(PM@:Y]F(8#E$,32GV7IWPK@%:2<*1U\R8&3Y;UQ\,!J$[_S%MA;S:0I
M3;AOT]E/.Y:\1:GX2: '$[,XJ(Y#T'YU#LG9*K?!]:5\06>Y#(%(9PWYYI]3
MGH.L",J4SMND\ZY(\&U*;[5?Z*.*\M]Q Z U]T@; #RPT6R XX.7#V1]!&CV
MV%AT3X-54<L;!RW2D3LV_>/A,%B_PB^Q<H="&XF9'455.F "3QM.!RN3^U7*
M^EP]_])S9\EEQ:<-C8_! '-=ED(3@B(2UH#2#"O)\ABU(VJUO2AM9=@,1;UD
M\)4+?QD@B#<BN"[!7UCR&M3VM(P($;28!T'%@/.MRQH3.?0W98@)5M$WW:G#
M'_;<P[[;ECZIU#+0H!4EOT"U5W,,U3!MCZ>1[4=5\+C>S30 ,H&Q:)GUK@BG
MV9B$T^$#THE?SSF5:&+DZ-%+9JZ]$!3S*;"5;25%D(K4%/_!\X)QN^*N6Q-I
M$@-P&#'LKB<L*6C:L3=M$[R"6YE]ZL);/5NZ%7*/E-QSA27G:)H7I1 :S<#R
M^K@SIM<V 2[Z_9%=D3/;9 1]H,H-YA9]=/$R;&MP_;H=:Z\J8Y^6-&@1QTW)
MQ@/F9URD'NO7BAP<TON>H'V?82%W1?,C,OXFEA%HE7 E']LM4RI#AB'G"8X=
MG&95<<EX5SC:0 FE+LE<2>7'.1>36YX!I$').$UC2A.XW/#DV:NS73DNVZ>6
MA?"/\^&/?&[. KU+^W.A;C$XQ8&XBA.Q/E%AV^837=J""_?'.\2P9O26P=F8
M2%[IE[;"G@X/[.#QVNY*FS'1J)T>O#HT"82WUS]>ON<LP?YW9Q\N+Z3ZG1,)
M%U>_7%U<OKF(+O_SYZM?SEY?OG%IA,?8R3L".WIQ<,@"NOO_CRCDULBSMV0H
MTUG<_XZPAEP^]]A(I(%AF8"TX7 $6>6'3_RP-0,=-*77[TF!.R2&JT9D"A\0
M7+<(OB"I=;= _A%.^E/"8H;.#NAY3<2YQ=3Z[0Q4]>OE^XI(IC;.@MX0QI=C
M3(FTQ.VFC$X/K4P8IIA:G$LG6%'*8SN("PNLF/87;SBX4$BD0)@IM->J=HE)
M7W*BIZ1JB .+,?S]\_8XGKB\.2BDG6*" 1-'A$2]*52V5TU: ++@_;WS+C\O
M4R( FDQMJ"6(P7!-C E,N2&;36AC.9LCE'8%??GBX&B[Q&!?T?&C&W:6L&K
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MF;:11S!<T(@UKUJK[4(?&1A)IPP6)6="<>+&!/7 (L6KBD+Y,6%*9!K'35&
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MQ;9V9![=V*BR&>;$HUCK>=,>X4&G!9"7"#.^>AA^-;FQBIVD7J[*#?@R+,H
M+$G3KXZJ^90+V*Z:&2Q%8).CAVF;HO)/Q6&ALDB2X[ WA&*;[O+SP8<#-'8-
MWQ*^OLM/XER3=4M=8VBUT>^9L'LOR+"-V;*L^>_IA W?"+4.YF8[TM9'>]9W
M?[L<T30$;+.OC'VKO32==+-7PWZ\*XHD__41)DYBXW,F[\W8IWQ#_HZ02V>
M>L=)DTT$QR22:&*7,*O[NSUSICRR*EY%BW)=LYH."8L<]/P%+N%DZIT]CD&9
M+6P2NX&KO-DIG'H,L? C"A0&I"I,#&MN")82-H!:2P_K@1]]$KNA5>;M46YT
MOQ;?[&^8;[07REIGH-$;N]>U(^^9.#^[\&G^!^EM#24/5R)?M;WGRNN25SV@
M)Z8N./09!Y!)!PWW$&DV-^K@@5*-30\X?K:/#(%2@&P0.MSA(-/KFD#]Z9+8
M)T])[!'T7'E,KR7>,J^%4WFCP*\.N"(#\L\3^XZI2;7-7=];)JL^QK8L)?%C
MV/+8TB^][0+'^I%DTV%4Z1#:R[A#')FM9))(/&8\FI&9NBTSUV<@Z3<N1V9J
M?:9)%#"LK#=[-C%T5,B"_QM,&S>@0=-F5PJ:DBV3F^=L_GA6UACCFCU90>D,
MZKI+859/9%]8%N#X&QW0W#=A?6:? $KE<J%%R84 9+[1P[%S<-O8I,I#KA08
M#DD$58V][8N8X]>VOI# SX1%U=31(H2/HS/6\SS?Q.V(#N63D/97"_CYT<H6
M7G.:#342?DYL%/<;QM\F$I06L=3CA6W6GL-3G"WXKA0'D/M"N)G0?2'#W86
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M36E;^AP<,JWW0T@>C\O-9^\.NV PYLB.)D#%T&U@5FM@2QRGZ6]6WU+\4HO
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MX.B317:*.5K).!C6;9&R4*#2LJEW0(O2'MW!X?6E(%S$/!BAR]?UA.B#_*6
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MK^A+]F9-E9 E(0P&QU4R*#:U#KA B3>?4JV9%NKU:$:9!UC[Z^]Y=,_T/"3
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M^.7R_*PE!A=G8O1N:#V_^=,?+Z]^')Z/AF=B\//H\J<!@!:>_-H2YS_2^\6
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M6UN4)IW*! S#6ZWN5+-9U\IG:1[/F'(Z%O"RCE6Z:-&@4^FSFQ8,T30+=;K
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MLUIF\ -ELVNFG.9KI?F7N'0>E)WYMPLE]KZ%$I]2Q[[]]HOM8GZGKA"\@E=
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M/T_U&#$KY1XSNQPXT6EF,FSX<G&G@9KM\V!K =%EE6%<6?D-=Y(;QR J2@3
M5'ZBNX?RDDK.,VGHTWU?!:5-[)AA$7-L!,N3RWS=LGNRKE20]]KGK.0W)N]G
MS3GPF)@!*PZCF?8*YFMUH0=D'5GWC2,); <&2C#5(5]43V6/0 8V;\QV#\SS
MG_)>,-7"Q#$36QI@(Y&\50W(!?AL#TN"*/\KSALIUK=1S8N?XUKK8?K[10L]
MFDQT@!E>B=N0L:'M/+;#BKEFN-S_"*?/TS%N\L"?IL#LDPI6=;>LF]N93"6V
MN[J5:R]..7<2!HN(1\F36^DY8CH[V/1EK'^6V/ C2RM-/*FM&3TUS<\2;EBJ
MDUK/4@[/4HR5*6=ULA^%@"EBE0O.5A$]*GH-V272G4<ZE*&GER[8A'82,<6^
M C:GB!K.9F#WT7],PA3_VA;? G73_1?YZHN@F<TL+S;&%3^DICK!&V?-%1Z!
M13[2PXQ:FW);CE57[N%Q]V-NT<"$)N(; 3Q(<S=)8UVOQUM>N/V8#, J@\L@
MB1X^=&Z>-H\MX"CP*A83QP,.'B^XRU^53]]%\2?BCMHV_^:&@'EZKBY?_&%0
M38J?V]=MU& P(S?-6P^6$J9:[DKS7A/6@N?N?54ER<WJ2S"\0=';QHP^"XL&
M(GMR6M.6M9D:%CT9S[@*;]U<N8&.#765NZ%$;C])4T&8=^;Q(R]C];ZQ>11]
MR?VBZ+L2'34UEL[5+SMPB_][G<UF^=4U<4160@;D9.Y2 JJ_D[%/69?658S^
M(J.K48J "7G*,,P,N_X] Q"HF"[_P0Y5QK]6I D@3R7#!7/XL] .+)YM]/TC
M!7Q \N9B81/N(6ENZJ*3BC ;T%E2U0 7.5%Z1)%@S8*HA+^FB(&=,V[<EF[-
MHBS9.H;:3IN%>W^N^6(G-QNE&9PX21@)OB6J79=;58HR265V4*</B;LBW <L
M58X#G4PY'DUD9']ERK=<BBP:IR8+X/@S>B4G4YJ/^Z2:Q+)</"[9UX/HN-8N
MJ?'FC&*1IA.1XO9==L&:-Y]@TP.9N-?VY=6+](P2Y82Y[ P7@B\WS0B(BK2=
MS_ 8H;=A$NY; #@WO;XL (P[T?X/.[K7\P]Z+SH3V9?]?N?0>]GK'AWU57=\
M.)[XJM_[[7#G[QLT3J-Y3>5K/.VQ]#[=Q"!-_3US\!/Z<_+7E,:O##M<CLY/
MA^+R1S'\]_#J]/R:?KX>79[^2UQ^&)U?7BS!H#7L;143>/C!P]EPW^N<NM&\
MQL4'<IZH8_O#"79O#.3B6(<T*7UT4A[N %9XBV4FG@P, A"L^7&!T^T.XW4*
MJ)7Z=F;SN$V/GJ=^_=E^N_-B^=-.N[OTV:I17_;;A_V'#?N<5LRK!L D(#%^
MV-G?N??PYU@(&MX<]^:?1;=,(8&:U($6S?]Z!MD[@&V.HN^_.S@JT,< 9,OW
M6N,"M-<!.B5"B64N =Y <QXZ=S_EI_V<$/U^KK<^'M?,!]Y+W\9;W@(3#M!F
M*9_M@]BX<9?V^NV#S=OC>7'UJFFG-5N4[WU#/Y%IMRU^LW^X859R[_6/:][?
MRG05VL$&+MHQT(RKSZU9;XE_(//O8CB0.TNV\+4F2MSFTUEQ9?3&'$_+UNI6
M[K. X_@'$HEI4VEO96V5JF YBMMPHPJ=.0R\]/)%:C_J%[1(?UJBUP&RM(4.
MC>A0I'_ __W,5#NQ>?\@I^16\35")BHA$=S+CYMF34SD ?M8,"B$G&$O!MO4
M A\7D8-8)Y_R"K,VOTRE:GQ(FAS.LT6EN2^>*!G-Z'#(@M3TG^58(??:D9]I
MMD#=2,J)U)PW-;:ICF!#JEL\=$ZGS!OU\E?8J]<V1+9#U6INR#JWW5Q7M$ND
MY ++X@U>)NBEP?,TS9#3O(7BT\(2.,ZY7%@@-5Q,4VP<(T434.6CN^1!6L!V
M&@@OC]HO.W^,*L^[M$X=;& 5!=H7]EA7:+EL\VZ.3E^Q")=KMAN&WX^U9.V9
M[*&9<=P[ZK37@;W]3GO_J/\ER-L_:A]T]K_(O%UM^NX?'?[A1G/_L'W8?12E
M59R.7>:HS=1GJ:N#M+6ST@[]VE<;^<#+VC<;9,TV4_DOZ*)/8^P)LHA 56O5
M";Y^!KW:&=1W_AAHE;EFIWUX\!C&N5D 7<8V[]T]JA#;O74W O4LCX#L?L.H
M;QCUI1@5:S0!Y4Q]0Z*_2)LKQ=ZL(7/X<O/LF#,P#!\?7%T=WUI[9+-Y>0^*
M-CX?1_X"_IFFL^#U_P-02P,$%     @ 589=6';P\\O*&   XYX  !X   !E
M>&AI8FET,3 U."UF;W)M;V9R97-T<FEC="YH=&WM76U7V[BV_GY_A2Z]=TZ[
M5D@)T&D+G:Z50EI8IX4N2*=G/IVEV K1X-@9R2;-^?5GOTA^BP.A,],DM/U0
MP)8M:4O:K\_>?C5*Q]'K5R,EP]?_\^I_M[?%<1)D8Q6G(C!*IBH4F=7QE?@<
M*GLMMK==JZ-D,C/Z:I2*W9W=??$Y,=?Z1O+]5*>1>NW?\^HI__WJ*77R:I"$
ML]>O0GTC=/C+E@Z"P?.]%\/!<'>XN__\Y<[@Q7[X?&\P' X'NX%\L??OSA8\
M"LWY&9O.(O7+UEC'VR.%_1\\WYVDAU,=IJ.#SL[._V]5VTES!4T'29HFXX,7
MT#)57])M&>FK^(#&#^V'"<S6/1 D46(.'NW0OT.\LSV48QW-#O[1UV-EQ9F:
MBHMD+.-_M*R,[;951@^YH=7_40<=' [].77C@_=$.E9^O)W=9S#(WI>1'NA4
M=';:SUZ\>HH/^&G.3;8TY  (JLRW'S,1MGO9O^B>=<5)K_N^?](2IV='[>K0
M%U*>>EB7>?0^?'Q__MN'WED?IG#\Z:A'OW8_=R^.Q<?WW;/-FQ,/(U1!8F2J
MD_@@BT-EL-76ZXL>+-OI4;]W+"[[YT?_%.]@$?OB[+Q_>M3[RJG^GME4#V=\
M24-?<7JP]_/D[S],^\T;TZ9&QE*<*!FE(]B8<= 6C].1$C\]>K&[NW/HI_GM
M!W?;RAPEXXF,9ZL;W-9KHD_G\$E+3#)C,PDC2!.A4RMZXTF4S$@0G,9A%BCZ
MM3N5)A0?(QEO 'UQF.M!W)$R:C 35[!+@;1 8:0=G!M]H\-,1B+2%B7M0$7)
M5#Q>;Z)*D^I P\9-UX.VT@K8C;K8HXZ\I8%BX\[S0RN"9 Q-7+MD*%2QR:<Z
M'=%S[E2*Q @I+K.!U:&69M:BFW$V'BB#C]J1-# =^*WT4*6C) :B),$UG"UI
MQ(V,,B7^;Z>]L]-I":M2,4P,=.G6O-@,T0SF$\(;HD@%J;Y1<,&HH3(&=@C,
M#>:[]B?O0@%'U@'NZ4NBTSILE;;H ]WFAB;@/V&SP>] ;:)O%/E5!7$^MFXU
M8'UPEK:T='BJ=4SWX4=:>SDNO>A>&<6[3::I#$9P Y_B95S/M?.::7>5:[8!
MTF7Q6J_#9J==26P0A&!+*-A[N*NG(PV_X([7,4QJ@O-R>Q*V\,!Q&F21;7$D
M)SH%?>\_R'?H)&06A526BCA)1:B&T+O;^MJ*=RC<Q%D"3%?EO=]R(("!PDD;
MR1M%+<=*QF!G6G$%+"_&@V@S&"IW[(X7SN5>%L=$AB&\=#M2P_1@M_/SW5KL
M-K5:D1Y;$5G/7AS^]*CS\T[#__]>].\!TX:WUS%LUQ^DJ9&FG\ Q%6>Y:C(G
MXGY0K$:Q7X%"Z-2Z1(F<1=]@2RUO/+]^-3"O'X9=_F8F+ P+*4UJ;JNLE N)
MHH"LH8$2@P1$*PJ@A7J7T\E8GMVE;)'XJ0FEMJAT/P(-S*@;K:;J+EG5RGMN
M?K.33]H(:*Q!O0-K 5\_DB':)LD$Y&R:Q3J=X6R302J=0)/A#3X.4PM@_E9%
M8F(T&![02GU104:;M%FZ#C.T%$@?L2E<L*2X3DQRHVU!K]J32Q+.2=HJN=B$
M+19-!H&:I*C'#M!XB:]:N%I!E%D0X#Q$'0-?PF&!!N5'98!8L+X3H)*L+*RW
MN_P0X.^Q3E.EQ&/HHZ)M\/B>B&R2X(K,Q!\9'FA\F32:W-5$F,J&J1,Q,7<0
MXVM]F]_^$-(;#TA9"Y;P?YY^^'A^T2^<@,3]5JKM_]VFT#T)U#\YO13==Q<]
M]@Q?GG3?OQ=O>N+7\]/CENB>'8O^24^4':LG7?BK:/CV_.)M[Q3O=#_USS]T
M@<IPY[>6.'U+CQ;O/NE>XBK 0[TS<7GZ[@R>>?.;^-B]@&=./^(B87\7O?ZG
M"[S7/Z<7')U_@'N_B<^G,-8SL;<CCKN_P9C?]GL7U("=O,?=?J^]0CL3EG;)
M0U0+S7PC7_K<F"DV\].CEYU#7(LN$+T':_$.5_3]^_//EW!K[W#Y*2TETLMQ
MK$EB2=P=&!5)=/XLC&RY3G:*1^3 )E&6+G[D'L,K_S\R_@43>:6V!T;)ZVTY
MA/4YD-%4SNS6]QN:6S=)<#O?/T-^<=:[O!2?3WH7O?.WJ^0,K(NP @/$0B\$
M^@)8[U%-6I8:#MDCBDJ'TQH*LW!9<<W[/I6#2!5GR< HMM'E*B=6'?A?#D-M
M)Y&<'>B8QD\/'59?]PPF>Z-03Y*16W9:;KY=[/[V#I^ %(Y:&OJ>W>TVW7J:
MAO/WGNVTW=EIO UW%]Z[[;7[S]O/EWSM4QHR#QLH8T%+^V5K;ZM@"F3Z'>Q.
MOH@.*(3X<[]=/PIH&,[1*9G\Y2>AL]01OS62[>CQ0*9:TB0J,W2K6A-"N\_X
M=-PZ_1V<_-92E*HTO=]&:F*D*Z!JLXKP9E91FI??,VL]JX6>C@5^CS^WJ$WG
MA+GF;8K"O+MIK]TI72+-P5V;I_6W)RPQV3,YOMW']/<(XF4&=UN(XZ[1WMLS
MN %+U4>PVH-=JP?"J/+S-,^*GI*2MH%FUO*(R/VM'Z;9YJ F>_\Z.7USVB_B
MZ9L#*P1N>"[^#OS@ID E<S_=GW,%KVCQ.NU%0N&=BI61T9_T<*\HJK1H4IUV
MY]N*[#^+(#EV,8T^AKM6Z8IIPGH@Q,-.5*"'*/&C61Z!<5B11? -]TPU5),'
M=:K!J"R.E&4X6P"#!$J)(%+20&\84@IDB@@[N&VFVB[MX%D;+UPSL3OM7;%9
M^_0TAPK!#72\T8;%7U:-L%T2TK=,3/E>T*A3WMKJQN%(,0:)3\46@;QQ,!,#
ME4Z5FCL!VM:CRJFG9=Z23Q8>").L/8MNECR[BR4/,H!UG]3]Y,YNN[-A!YJY
M<!-2:+6'&8X5G2$8:,YKFF#<]X!M,Q !+I(8$5=)$M(EA&-3"*#28>N.&$,)
M_.ND6R5 L?Z@U6(JZP!2;556KLB.*.-.ZA@-VJ8MAGXL@=&>5T*J++@,_ Z1
MO^!EBXM/4)J0]9@NC@<VRZ^GIZ=E7OU 5)+=C5-)CBILPHGX-<BG:N9A.+@K
MSW,;-[1'OKDI+ +*@?J!L*:A!*XWS"+:T<"QH"$AJI5!.)FMT:/.$MO(KD8(
MDBH?#H)#E<]&H8> VL/GK3(H>#$G $-OJ*SH./- .,>@\9UN3'60%PX)?I3X
M-+:E#@D>AIH6\W:X;ARUA&:TUU0RL:C[1OP8)K#E[];(+UB[<T^@DN?P;.K+
M!%YO*<<&QZK"%DXHU#: A;EBF!BP&!TC^\=^<BI7A9.03),4MA,)'"*0DC9!
MU5*F-@%MT;3R2>'/) .#1V863"'UA=!T;N5@X^,*%(/+F5%N#1$QQ-0@1"[F
M+4*K5E8\;Y.)I:&ONSK6K&/N+=0Q';JW)8Y5!)(<<[?\@4/IT!*]-%CW.=]/
M!=W;.!74K=%J>?7E_4S$>?0L\V[F6S=P'9D IZW00*6S1&]3&G]Z].SE87Z^
M6V*43)E1Q$FL%LN+%%@*>U_043, &@/;P2% $\E:4X@<:X$&[5F:$U EA;K$
MLZM<; 'KPM3%(,H8 .QS@R(]UH3A25HB5!)SLH^UE0,=(08:7G&A$">-'8(2
MR/1#QJ8H=E&=3LX;@9ICB99UB0GF?+&0GPXTC&.O*8++LLLZ>Q2X5#AI EJC
MX,16.=0Z1UH7HM-M*++A*7=4UQT&XF@DXRM:GR.V])T[ (MN^/34YJ6?:J 6
M4.$J@7T2\]QIV)-)I ,R:JHP\$M%C$^\ #7OKU->UXX%[FX6!RR+I-6R0?&)
M_;"X[S-0Y*(%&X\Y7(-U5?7JEI6BDI<X3@I]T:HHPLQM!/[!OH?'[1!YWB12
M(>M<Q1%7<<"93<V#<CHAD"%6IBVZ>#(S]-XQ)TR!M7U]E_CF^2Y];D&#M@S'
M\B;1[&+@*_! %J6>4D"VH=)I9CA#(I!Q ./*^3#)CKD.V^)33?M>3S[>3"V2
M5"@&L]C+IURJ>A&5IWK>.9?'2+;I*+$L'LB*X6 %YJ-$BIVVY6(6M75*BJR0
M)\6BN75!:5/C_K4M/,P,.9*<)4&DA%E.G!K1O(#-.Z:\Y18YLKGSU4/'UP":
MS\&3.5+\@+!_"PC[BI8;3J915QA3,>R(&R3)-2;9F9GGJ+$<U[7<$O=EG@;,
M5D3J2E&A!HHK<EX=*$H)" 3/SH95?NQCEJ8DJ 5ZFYSL6*BAM<6R62]K[A?<
M:^]MF%G9EU_$9^#)HR0*U\F\]"KX7GO?I\+BUO$B;*&NWR@XR  H](HFO<
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M:W.L.J8>2R$'Z-6I5N*[1(Y&=UUI%\O5JEP1J'+!*HZ64LB3&?#M^$V*R%(
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M7V0$C&KL%LV%P+D#+4:$[X@V.^83&8-5]A\4*K0!_ "F,Q&.'$J'I) KAC
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MT%WF$P^Y=?=)WKJ46S4A[WIF:W*+3U7Y\D5A$TQ^O=S=VOE'S@]X\WIG/Y/
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M/>SS$HI)*")ZTC@HH,*09=4QY?#V4#@">2OP!;L<H7V)PU$&'8^IH4U,A!Z
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M1G(FQER2^,Q^AB5#D:04 EU> T9(0E\%>R<QX4XHC+Q."^0*BGG"W6L*9Q2
MJ+W&V(G 0/>ZJD#$7_6ZXO<&8+\XH]ROH;A./.H&"E_U-0Y+,Q">I$#'*A#R
MZAM^P0,"4WG(,VY6\1P0)-WF0H?Q0#YEF7\6'&W099LN>D"A%3C474>'%/3S
M80=*;#P*\D4G0!1F0)<-AJIS&6<##LX%/93Z6!JM1:\!2:K1727!?Z_=4,]E
M\X^P:C:_-A7Q](F*F-%L_<*GRS>R5?6#UO:Q+LHSIZED.*:T6:ZIN\#^3YY4
M666XV:AMCXQB?;**4D"J:IL^D&?C%H)OI0OV0BOGYE,//Q_8WLG,7; PX(<Q
MY>WU:&MLGA=1Y-UM+'+E.,"5&>O8$;!P@]!ZU:[9PN$2'?2(U1$JJGT9SK60
MA,XB-:H& J,=N>X#VG V]44]M4DZ!]O;]ADM:DC]6T=U0L"[C%]W'+B6V4M_
M4JT&6D99B(Y"882G2[QKLK/C%&6@<=&E,B<5O\J_AUQG,DDM$#O<7<:LPVA4
M@SBMSDI]'M)0CF6(F]"5*;#-><OF)*&LE+WT#.E(X\1S77:/=,PO$%W&.;8T
M80I3+9;U9'#YP:PP\=8]V:9H9YM#>.K8YKX#?QD"K:D9;X,9[6X>]#(OUUUJ
M<U43N,5(J&GRRP1A:ASC#N584$8YP86M1V^I#P6FC0DC1TPWQF@V;NF673HP
M-E#FO*]:H$=5"#]C_52SZ\UL[^$JV!UQ/0T9H]0]NDK8GQ8%X[S9_-V33F3>
M/$I+2L=V9XC%?-.!.UH6IQ4EIAU!Y=1A<'@V1BUD2C<6CL GUIT_*:^OWZE[
MZII2:GR)/FGCCED='!$&4N8AR7AP7OK%-+JKYB32CZWQ+!=0+@;*+]T*+I4B
M>)XG7*IQO4]R=0A%SL8&65D_0XW%S(&(R34H5J!Y9 Q581#7E5^MV^74;/J:
MS6FK>8_/A(V''LHPBMD@B3 C&6$#!&5^TM&5S!,878SD+1L#/4:1A;">UZBL
M;AQ!2+ADC<%NW?D>:MBBA 22:\U9K^J_-5^><9V94--"<#$*$\I3P"8>97*F
M]%XC9DC*J#.%"D<%90]K4UA50M.@Z*,/$XOTZBOL=9. UKA(#2J&ZFWOJ-/&
M!S:VU^3ZVL[ZW?69(RKLK&E0IOO0@+K6]BQHB^N$J[(Y%UZN8[ZV9*WN1^RK
M.@X9FM8RA*L=#J6'R> (BX@P91V$\%<5,<6_&9FN#7K,>R-&.U\[ F]  ]=T
M :+*R%::B6V!1>QSCUR%5-<!OZKHOX)#6UB[8)KI"EOGV(67L#&5I6[ON+AD
MUY3RXB\F][O?3(N7]=!!&:LRJLLD0@RB24M>9491DYHPY+RU^WEG&L,Y'06(
M-@]4XD4JZ+EVU'*MV%2F%CW/B$BC;TB;?;OY:N*PXJS58LVVZ2[R(0"^7S4R
M6#4R^'N-#/)-03/.'92;@AI<3:HDJXJO4>NHO5#&*IA=$.FT0\%IJG0'0?^
M]D$?CBOLLHW%4*T3X36P!:ECOXDPJTHEB5E(W:844QQ:TR[6E?Y9*8>#AO+Y
MI8&G*V.B1_TKEYU2L^PFP@'1H$P_,[2B=%%N9;D8!MDPMD!R6)>J"?T.@390
M;6!#^DF8GDXT$#X8L*D1$^7II%Y7+)LNM>'.MZORT[:@^5:]N4 ,-GS-SJJO
M#K\8]%W%<1PNPV<0_"GP/TGVXJUP$F5$<AN409#'JFF]E$W7V6SHKCO#-I;*
M9^(J7Y"=]+[<O9<[%*;<$:4(<;6=NX><%)/+@/NI9U..OVE5%]8<(6,*<"WO
MBBZEKM2+8>FF0N$OA)>>O*0*,SXH";KL2G=$TR&&.QA+)^,K(]X+@+&Z9JX%
M)M?-"1%+CWA.3)+KRE_II^%5@W[6GZ(4ENH,6='/B9!T'H697-T8&E@>'MN
M+X84E C3KKOE:13+RR8XUC*DZKZ[QFY)7W$,$4P6K3<M+RC(KQ&"\/DT(G6=
M0B D@5BTT_]2-F13(=\G/.;L6RAO^-)K.4_1F:"--:>ZP;;XJ&U9%&FD*;@.
M+DZ&#]!SR!]6<*G; G"FVO$@SV(?:QVCLUM9*T@*X4K4'ID/N2;8"X4H-<8%
MWY%FSM."C72(=&PE.$N^(VL'K-/:$1OAL0\&Z4D%%2::;+"LZF?U/527G$X^
M2T>? 0;4+?;$5-B.=*V5IK;&7) &6!7+'>SN;:#V>7Q._O3$4A^<@8*9DH3
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M5$WV 9^!=1\?P\;5[>TLRWY[=?[^_/1#3H/I9+/2]57G>IP=$Z#]V4W-(YY
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M(ZO9!"3G6K$"WD=."] _>K5>=88HR(!7P[TEO@7'LZF#U8YF;;WI2'S=D#!
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M-Q;?U,+AA0.J6[@.R07^(_L=KC 0$?R3W2<BKU56X+(<,+F50_6@OZ[6O0F
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M^U$Z)0;,'66'^\LXF=_D8[("(9SSR4N,< HP8Z)A.^/XH]@]K!I8*AZS.#)
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M@MK!2..@#+J)M'A,H1DV6,.!L2*P60>X<?4"R'OOZ-'1\?Y.U7^%65.XD3"
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MT.+$>;[(\?B/VE6F&AX<CR/QK4_W#8(H'=]X3X]NY##C2 QTY]TB4\N5N"-
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MJ]CA$*%GTCI"7?8X#2^QV5:KCS8KIM9DDLT->BJB;"^M$ZMZDO[!,AY(#98
M2!)Q(.P=;\AUSGZKC/'(J&$5L+ 3<1\MEMF\&T\'E0.52771P^CRV&FV7KLW
M(Z(!(:4^B"$;^F![;!3 KCUB3'@8,*J#L"$,"L<#2@0,CJ>MOHB'H_#*:U!:
M)6[PF+A<0XNP]Z\&KN-]05V$K-Q#) 41J:S],Y&C"&?,':J)3>8YBU;3;,0=
MCGJZ\N'Q.,*(>C/"W2RR[-DB*MKEBT94 F+41%2LK<]8.W)5U=95RQN_1;(?
ME[[KWM)C-02XOJ6SZO5S.JM>=YU5KU_(6?6:G%4^W+,.*50+$*>.D#AU"XIC
MX_-1TI5L,WL@)58T\0]C#HH$&*/@0'M_/7DPK(F$/4-!KWXW@.9>R&M71@,3
MC^D@[%)6'?E.PT#7N%"1*4B\I;4+S96%HK&\WT('ZO4P!H;*W$6H,\+E7AT:
M\.6BG.:S>X[4!8$=H:8>"A6;%10/B$EG@!YOR_FM>.ZO<_JK0D'3L+-AX Y%
M--&::-0WX:,F[(V9A%D:U3@DQ0&T]VS1,RY,@?N*R"94/]LBKKAGF"<,.!$Q
MW^OOU@B%$%M1%NB7)V NG%HI6!0NHS7-;S-_4HC!91P1"OCL\Y:"C$U(Q<VM
M2-8@ [V<-G[\["UE_TRPU36CK#;J.*EV%1,68D(BG(&/M^H+(&>SA3@#04"J
M>@C'"FX^!=LZBV-4C3@=$MF!).^D1"" :M6^+WS:N[BBT8B++,K&(E6$ELI,
M[FD#$T](6V;DH$+?EA.RMF#&&+2IO1@(^RFF7CFAT!0A2U#(&"\SA]56JO^
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MB1WOTPP/50:I&H5LX^,FGTRP-^Q'8*_<'1YO;7*"T9,#58N*8/\!H.5Q&:J
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M.*XPSNM#E(^NQ(<O/>0+O-8-B2U>NJ"HDO+Z=#\DPYMZ>P^=MV*K*"\?[&S
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M5G(#:;B/GKA,=#5%&JJZ)N(9<4\!#L/C);GBQ84P4C=0P98X':,%UU?TOH,
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M2;$Z\\X-SW";'6[['BB_!Z=':$Z,$QC2W@ %JK=GH_J#0(7W"(:$?__O*?]
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MT"9M4!*NI'-(*63C@Y8"^@'?DVMRT%*OW5F38A#J%5G%LP-;Q\]8@78=>MW
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M:.H#R-3GAZ8^@$Q] 6CJ@\C4EX&FKD6FKC$8_R0J]1%0ZO.C4F-0ZL[VX$^
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MW3JN:Y9Z-+.O'3^P9_:(YI.1/<-)F^9]OT_DV\/YS D<VR=K&)!W18.?SLY
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MX.7T<6%& \])5"KMZ'A(IU^G:J3*8/#SX>#-3WB]G5-W9B*?P.1&NBSU[-4
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M47-IDB+J9J$.;=+7-I1H=LUV*EZ3>ODUX\X(G;H7+CCV=R6PCLPA26&JT):
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MI=Q%P[9?W\=]OO/CWPV=OSNPRLO58)6?1CI>PG^FY2QY^_]02P,$%     @
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M:"TR,#(S,3(S,5]D968N>&UL4$L! A0#%     @ 589=6)PJ'DH]<0  BHL
M !0              ( !S!X% &%S=&@M,C R,S$R,S%?9S$N:G!G4$L! A0#
M%     @ 589=6%<\!OTA8 $ ?1\" !0              ( !.Y % &%S=&@M
M,C R,S$R,S%?9S(N:G!G4$L! A0#%     @ 589=6,Q4""NHZ@$ ]DT4 !4
M             ( !CO & &%S=&@M,C R,S$R,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( %6&75AIUX9QIS,! ![N#0 5              "  6G;" !A<W1H+3(P
M,C,Q,C,Q7W!R92YX;6Q02P$"% ,4    " !5AEU8[+#V([8#   D&P  &
M            @ %##PH 87-T:"TR,#(S,3(S,7AE>'@R,3$N:'1M4$L! A0#
M%     @ 589=6";T1T5!!   0!H  !@              ( !+Q,* &%S=&@M
M,C R,S$R,S%X97AX,C,Q+FAT;5!+ 0(4 Q0    ( %6&75C#=+C1,0@  (XL
M   8              "  :87"@!A<W1H+3(P,C,Q,C,Q>&5X>#,Q,2YH=&U0
M2P$"% ,4    " !5AEU8M56Y@R0(  "'+   &               @ $-( H
M87-T:"TR,#(S,3(S,7AE>'@S,3(N:'1M4$L! A0#%     @ 589=6-]%/\?5
M!   82$  !<              ( !9R@* &%S=&@M,C R,S$R,S%X97AX,S(N
M:'1M4$L! A0#%     @ 589=6,WV<8702P  FU8" !X              ( !
M<2T* &5X:&EB:70Q,#$M,C Q-65Q=6ET>6EN8V5N+FAT;5!+ 0(4 Q0    (
M %6&75@_["<^VRT  -F7   <              "  7UY"@!E>&AI8FET,3 Q
M,2UP:'ES:6-I86YS:&$N:'1M4$L! A0#%     @ 589=6!=!1AS/'   RP !
M !X              ( !DJ<* &5X:&EB:70Q,#(M9F]R;6]F<F5S=')I8W1E
M+FAT;5!+ 0(4 Q0    ( %6&75@\2LAKMA\  #7^   >              "
M 9W$"@!E>&AI8FET,3 S+69O<FUO9G)E<W1R:6-T92YH=&U02P$"% ,4
M" !5AEU8*GHB+ LF  !>'@$ '@              @ &/Y H 97AH:6)I=#$P
M-"UF;W)M;V9I;F-E;G1I=F4N:'1M4$L! A0#%     @ 589=6(\M2\7</@
MT*<! !X              ( !U@H+ &5X:&EB:70Q,#0X+6%S=')A;F%E;7!L
M;WEE+FAT;5!+ 0(4 Q0    ( %6&75C6)"P<#6$  *G6 @ >
M  "  >Y)"P!E>&AI8FET,3 T.2UA<W1R86YA;F]N<75A;"YH=&U02P$"% ,4
M    " !5AEU8C3*HJY E   P' $ '@              @ $WJPL 97AH:6)I
M=#$P-2UF;W)M;V9N;VYQ=6%L:68N:'1M4$L! A0#%     @ 589=6"1?#5ND
M10  ==<! !X              ( ! ]$+ &5X:&EB:70Q,#4T+6%S=')A;F%X
M96UP;&]Y+FAT;5!+ 0(4 Q0    ( %6&75B+(9OEK1X  &7*   >
M      "  >,6# !E>&AI8FET,3 U-RUF;W)M;V9S=&]C:V]P="YH=&U02P$"
M% ,4    " !5AEU8=O#SR\H8  #CG@  '@              @ ',-0P 97AH
M:6)I=#$P-3@M9F]R;6]F<F5S=')I8W0N:'1M4$L! A0#%     @ 589=6*O<
MN</='P  "OX  !X              ( !TDX, &5X:&EB:70Q,#4Y+69O<FUO
M9G)E<W1R:6-T+FAT;5!+ 0(4 Q0    ( %6&75B9;CGJ?$X  ,$6 0 <
M          "  >MN# !E>&AI8FET,3 V,"UK=6UA<F5M<&QO>6TN:'1M4$L!
M A0#%     @ 589=6$X?4SB=20  , D! !P              ( !H;T, &5X
M:&EB:70Q,#8Q+6QO86YA;F1S96-U<BYH=&U02P$"% ,4    " !5AEU8X=U"
M248-  "[(@  '               @ %X!PT 97AH:6)I=#$P-C(M<V5C=7)E
M9'!R;VUI+FAT;5!+ 0(4 Q0    ( %6&75B3:'3AER8  ,01 0 >
M      "  ?@4#0!E>&AI8FET,3DQ+6EN<VED97)T<F%D:6YG<"YH=&U02P$"
M% ,4    " !5AEU8"K>4Z%H0  #H8   '@              @ '+.PT 97AH
M:6)I=#0Q+61E<V-R:7!T:6]N;V9S96,N:'1M4$L! A0#%     @ 589=6'</
M?7G;'   T[0  !X              ( !84P- &5X:&EB:70Y-S$M87-T:'AC
C;VUP96YS871I+FAT;5!+!08     'P ? +L(  !X:0T    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>197
<FILENAME>asth-20231231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:asth="http://www.apollomed.net/20231231"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="asth-20231231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2024-02-22</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2023-12-26</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:PerMemberPerMonthManagedCareContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:CMSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:RiskPoolSettlementsAndIncentivesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">asth:AccountsPayableAndAccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:UniversalCareIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ForYourBenefitIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-01</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ValleyOaksMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-14</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:JadeHealthCareMedicalGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-19</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:OrmaHealthIncAndProviderGrowthSolutionsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-27</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntangibleAssetsAmortizationPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:FiveThreeOneW.CollegeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:OneMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:MediPortalLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:MediPortalLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:AchievaMedInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:AchievaMedInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:AchievaMedInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:ThirdWayHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:ThirdWayHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:SeenHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:Pacific6EnterprisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:Pacific6EnterprisesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-30</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-27</startDate>
            <endDate>2023-07-27</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-27</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcLsmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:LmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RealEstateLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:ConstructionLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:ConstructionLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-16</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-16</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-08</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-03</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-03</startDate>
            <endDate>2023-11-03</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-03</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-03</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-03</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">asth:NewTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AstranaMedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedAndRestatedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">asth:NewTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RealEstateLoanThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:A120HellmanLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-25</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:A120HellmanLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-25</startDate>
            <endDate>2022-01-25</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:A120HellmanLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:A120HellmanLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ConstructionLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ConstructionLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ConstructionLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag8MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:SubordinatedLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:SubordinatedLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SubordinatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ApcBusinessLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:PreferredBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-10</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ApcBusinessLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-10</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-10-01</startDate>
            <endDate>2015-10-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-10-31</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-10-31</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-01</startDate>
            <endDate>2016-03-31</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-31</instant>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:APAMHMedicalCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:APAMHMedicalCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:APAMHMedicalCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:ApolloMedicalHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:ApolloMedicalHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AstranaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AstranaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-14</startDate>
            <endDate>2023-11-14</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CompanyAndAPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CompanyAndAPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-08</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyThirteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-08</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2023-11-15</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-15</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">asth:EquityIncentivePlanTwentyFifteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">asth:ApcStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">asth:ApcStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:LmaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SongPCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:SongPCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:SpinOffTransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AdvanceDiagnosticSurgeryCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MedicalPropertyPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FulgentGeneticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FulgentGeneticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FulgentGeneticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:CallCenterServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RentPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:Tag6MedicalInvestmentGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:Tag2PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:Tag2PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApolloMedOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApolloMedOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:NetworkMedicalManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">asth:ApcShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-23</startDate>
            <endDate>2023-02-23</endDate>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-01</instant>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:ThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">asth:IntersegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:DmgMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:ContingentEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="c-546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:APCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:CollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:DMGAndSunLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-553">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2023MetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-556">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024MetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c-558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:RevolverLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c-559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-31</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="c-561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="c-562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-29</instant>
        </period>
    </context>
    <context id="c-563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-29</startDate>
            <endDate>2024-01-29</endDate>
        </period>
    </context>
    <context id="c-564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-18</instant>
        </period>
    </context>
    <context id="c-565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>asth:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="unit">
        <measure>asth:unit</measure>
    </unit>
    <unit id="loan">
        <measure>asth:loan</measure>
    </unit>
    <unit id="physician">
        <measure>asth:physician</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-33">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-34">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-35">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-36">0001083446</dei:EntityCentralIndexKey>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-95" id="f-642">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <asth:RevenuePaymentTerms contextRef="c-100" id="f-665">P1Y</asth:RevenuePaymentTerms>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-203" id="f-980">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList contextRef="c-1" id="f-1895">http://fasb.org/us-gaap/2023#GeneralAndAdministrativeExpense</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-3">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-37392</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">Astrana Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">95-4472349</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">1668 S. Garfield Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-11">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-12">Alhambra</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-13">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-14">91801</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-15">626</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-16">282-0288</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">ASTH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-20">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-21">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-22">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-23">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-24">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-25">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-26">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-27">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-28">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-29">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-8" id="f-30" unitRef="usd">1300000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-31" unitRef="shares">55423408</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-32">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Portions of the registrant&#x2019;s definitive Proxy Statement for the 2024 annual meeting of the stockholders of the registrant are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. Such Proxy Statement will be filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) within 120 days of the registrant&#x2019;s fiscal year ended December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId contextRef="c-1" id="f-37">42</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-38">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-39">Los Angeles, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">293807000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-41" unitRef="usd">288027000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-4" decimals="-3" id="f-42" unitRef="usd">2498000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-5" decimals="-3" id="f-43" unitRef="usd">5567000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-6" decimals="-3" id="f-44" unitRef="usd">76780000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-7" decimals="-3" id="f-45" unitRef="usd">49631000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-8" decimals="-3" id="f-46" unitRef="usd">58980000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-9" decimals="-3" id="f-47" unitRef="usd">65147000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">10657000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-5" decimals="-3" id="f-49" unitRef="usd">0</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">1335000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-5" decimals="-3" id="f-51" unitRef="usd">1834000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">17450000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-53" unitRef="usd">14798000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-6" decimals="-3" id="f-54" unitRef="usd">0</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-7" decimals="-3" id="f-55" unitRef="usd">996000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-8" decimals="-3" id="f-56" unitRef="usd">0</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-9" decimals="-3" id="f-57" unitRef="usd">2125000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">461507000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-59" unitRef="usd">428125000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">7171000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-61" unitRef="usd">108536000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">71648000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-63" unitRef="usd">76861000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">278831000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-65" unitRef="usd">269053000</us-gaap:Goodwill>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-5" decimals="-3" id="f-67" unitRef="usd">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="c-4" decimals="-3" id="f-68" unitRef="usd">26473000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="c-5" decimals="-3" id="f-69" unitRef="usd">0</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:EquityMethodInvestments contextRef="c-4" decimals="-3" id="f-70" unitRef="usd">25774000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-5" decimals="-3" id="f-71" unitRef="usd">40299000</us-gaap:EquityMethodInvestments>
    <asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue contextRef="c-4" decimals="-3" id="f-72" unitRef="usd">6396000</asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue contextRef="c-5" decimals="-3" id="f-73" unitRef="usd">2396000</asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">345000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-5" decimals="-3" id="f-75" unitRef="usd">0</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-76" unitRef="usd">37396000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-77" unitRef="usd">20444000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">1877000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-79" unitRef="usd">4556000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">471854000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-5" decimals="-3" id="f-81" unitRef="usd">538088000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">933361000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-83" unitRef="usd">966213000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">59949000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-85" unitRef="usd">49562000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <asth:FiduciaryAccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">7737000</asth:FiduciaryAccountsPayableCurrent>
    <asth:FiduciaryAccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-87" unitRef="usd">8065000</asth:FiduciaryAccountsPayableCurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">106657000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-5" decimals="-3" id="f-89" unitRef="usd">81255000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-4" decimals="-3" id="f-90" unitRef="usd">0</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-5" decimals="-3" id="f-91" unitRef="usd">4279000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-4" decimals="-3" id="f-92" unitRef="usd">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-5" decimals="-3" id="f-93" unitRef="usd">664000</us-gaap:DividendsPayableCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-94" unitRef="usd">646000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-95" unitRef="usd">594000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-96" unitRef="usd">4607000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-97" unitRef="usd">3572000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-3" id="f-98" unitRef="usd">19500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-5" decimals="-3" id="f-99" unitRef="usd">619000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-100" unitRef="usd">18940000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-101" unitRef="usd">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-102" unitRef="usd">218674000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-103" unitRef="usd">148610000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-4" decimals="-3" id="f-104" unitRef="usd">4072000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-5" decimals="-3" id="f-105" unitRef="usd">14217000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-106" unitRef="usd">1033000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-107" unitRef="usd">1275000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-108" unitRef="usd">36289000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-109" unitRef="usd">19915000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-110" unitRef="usd">258939000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-5" decimals="-3" id="f-111" unitRef="usd">203389000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-112" unitRef="usd">3586000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-113" unitRef="usd">20260000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-114" unitRef="usd">303919000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-115" unitRef="usd">259056000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-116" unitRef="usd">522593000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-117" unitRef="usd">407666000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-118" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-119" unitRef="usd" xsi:nil="true"/>
    <asth:TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-4" decimals="-3" id="f-120" unitRef="usd">-205883000</asth:TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <asth:TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">14237000</asth:TemporaryEquityDeficitCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-10"
      decimals="INF"
      id="f-122"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-11"
      decimals="INF"
      id="f-123"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-11"
      decimals="INF"
      id="f-124"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-10"
      decimals="INF"
      id="f-125"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-11"
      decimals="INF"
      id="f-126"
      unitRef="shares">1111111</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-10"
      decimals="INF"
      id="f-127"
      unitRef="shares">1111111</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-11"
      decimals="INF"
      id="f-128"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-10"
      decimals="INF"
      id="f-129"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-11" decimals="-3" id="f-130" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-10" decimals="-3" id="f-131" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-12"
      decimals="INF"
      id="f-132"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-13"
      decimals="INF"
      id="f-133"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-12"
      decimals="INF"
      id="f-134"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c-13"
      decimals="INF"
      id="f-135"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-13"
      decimals="INF"
      id="f-136"
      unitRef="shares">555555</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c-12"
      decimals="INF"
      id="f-137"
      unitRef="shares">555555</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-12"
      decimals="INF"
      id="f-138"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c-13"
      decimals="INF"
      id="f-139"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-13" decimals="-3" id="f-140" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-12" decimals="-3" id="f-141" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-142"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-143"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-144" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="INF" id="f-145" unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SharesOutstanding contextRef="c-4" decimals="INF" id="f-146" unitRef="shares">46843743</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="c-5" decimals="INF" id="f-147" unitRef="shares">46575699</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-148" unitRef="shares">10584340</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-5" decimals="INF" id="f-149" unitRef="shares">10299259</us-gaap:TreasuryStockCommonShares>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-150" unitRef="usd">47000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-151" unitRef="usd">47000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-152" unitRef="usd">371037000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-5" decimals="-3" id="f-153" unitRef="usd">360097000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-154" unitRef="usd">243134000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-155" unitRef="usd">182417000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-156" unitRef="usd">614218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-157" unitRef="usd">542561000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-3" id="f-158" unitRef="usd">2433000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-5" decimals="-3" id="f-159" unitRef="usd">1749000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-160" unitRef="usd">616651000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-161" unitRef="usd">544310000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-162" unitRef="usd">933361000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-163" unitRef="usd">966213000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Assets contextRef="c-14" decimals="-5" id="f-164" unitRef="usd">540800000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-15" decimals="-5" id="f-165" unitRef="usd">579800000</us-gaap:Assets>
    <us-gaap:Liabilities contextRef="c-14" decimals="-5" id="f-166" unitRef="usd">146000000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-15" decimals="-5" id="f-167" unitRef="usd">149600000</us-gaap:Liabilities>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-14" decimals="-5" id="f-168" unitRef="usd">273200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OtherLiabilities contextRef="c-14" decimals="-5" id="f-169" unitRef="usd">107300000</us-gaap:OtherLiabilities>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-15" decimals="-5" id="f-170" unitRef="usd">304800000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OtherReceivables contextRef="c-15" decimals="-5" id="f-171" unitRef="usd">11600000</us-gaap:OtherReceivables>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-16" decimals="-3" id="f-172" unitRef="usd">1215614000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-17" decimals="-3" id="f-173" unitRef="usd">930131000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-18" decimals="-3" id="f-174" unitRef="usd">593224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-19" decimals="-3" id="f-175" unitRef="usd">63468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-20" decimals="-3" id="f-176" unitRef="usd">117254000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-21" decimals="-3" id="f-177" unitRef="usd">111627000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-22" decimals="-3" id="f-178" unitRef="usd">38677000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-23" decimals="-3" id="f-179" unitRef="usd">41094000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-24" decimals="-3" id="f-180" unitRef="usd">35959000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-25" decimals="-3" id="f-181" unitRef="usd">59658000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-26" decimals="-3" id="f-182" unitRef="usd">49517000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-27" decimals="-3" id="f-183" unitRef="usd">26564000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-28" decimals="-3" id="f-184" unitRef="usd">9244000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-29" decimals="-3" id="f-185" unitRef="usd">6167000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-30" decimals="-3" id="f-186" unitRef="usd">6541000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-187" unitRef="usd">1386661000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-31" decimals="-3" id="f-188" unitRef="usd">1144163000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-32" decimals="-3" id="f-189" unitRef="usd">773915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-190" unitRef="usd">1171703000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-31" decimals="-3" id="f-191" unitRef="usd">944685000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-32" decimals="-3" id="f-192" unitRef="usd">596142000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-193" unitRef="usd">112597000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-31" decimals="-3" id="f-194" unitRef="usd">77670000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-32" decimals="-3" id="f-195" unitRef="usd">62077000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-196" unitRef="usd">17748000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-31" decimals="-3" id="f-197" unitRef="usd">17543000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-32" decimals="-3" id="f-198" unitRef="usd">17517000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-199" unitRef="usd">1302048000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-31" decimals="-3" id="f-200" unitRef="usd">1039898000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-32" decimals="-3" id="f-201" unitRef="usd">675736000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-202" unitRef="usd">84613000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-31" decimals="-3" id="f-203" unitRef="usd">104265000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-32" decimals="-3" id="f-204" unitRef="usd">98179000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-205" unitRef="usd">5579000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-31" decimals="-3" id="f-206" unitRef="usd">5622000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-32" decimals="-3" id="f-207" unitRef="usd">-4306000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal contextRef="c-1" decimals="-3" id="f-208" unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal contextRef="c-31" decimals="-3" id="f-209" unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal contextRef="c-32" decimals="-3" id="f-210" unitRef="usd">2193000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-3" id="f-211" unitRef="usd">16102000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-31" decimals="-3" id="f-212" unitRef="usd">7920000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-32" decimals="-3" id="f-213" unitRef="usd">5394000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-214" unitRef="usd">14208000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-31" decimals="-3" id="f-215" unitRef="usd">1976000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-32" decimals="-3" id="f-216" unitRef="usd">1571000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-1" decimals="-3" id="f-217" unitRef="usd">-4581000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-31" decimals="-3" id="f-218" unitRef="usd">-21271000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c-32" decimals="-3" id="f-219" unitRef="usd">-10745000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-220" unitRef="usd">6121000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-31" decimals="-3" id="f-221" unitRef="usd">3944000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-32" decimals="-3" id="f-222" unitRef="usd">-3750000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">5225000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-31" decimals="-3" id="f-224" unitRef="usd">-17649000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-32" decimals="-3" id="f-225" unitRef="usd">-20431000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-226" unitRef="usd">89838000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-31" decimals="-3" id="f-227" unitRef="usd">86616000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-32" decimals="-3" id="f-228" unitRef="usd">77748000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-229" unitRef="usd">31989000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-31" decimals="-3" id="f-230" unitRef="usd">40875000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-32" decimals="-3" id="f-231" unitRef="usd">31693000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-232" unitRef="usd">57849000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-31" decimals="-3" id="f-233" unitRef="usd">45741000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-32" decimals="-3" id="f-234" unitRef="usd">46055000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">-2868000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-31" decimals="-3" id="f-236" unitRef="usd">570000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-32" decimals="-3" id="f-237" unitRef="usd">-22868000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-238" unitRef="usd">60717000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-31" decimals="-3" id="f-239" unitRef="usd">45171000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-32" decimals="-3" id="f-240" unitRef="usd">68923000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-241"
      unitRef="usdPerShare">1.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-31"
      decimals="2"
      id="f-242"
      unitRef="usdPerShare">1.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-31"
      decimals="2"
      id="f-243"
      unitRef="usdPerShare">1.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-32"
      decimals="2"
      id="f-244"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-245"
      unitRef="usdPerShare">1.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-31"
      decimals="2"
      id="f-246"
      unitRef="usdPerShare">0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-31"
      decimals="2"
      id="f-247"
      unitRef="usdPerShare">0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-32"
      decimals="2"
      id="f-248"
      unitRef="usdPerShare">1.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-33" decimals="-3" id="f-249" unitRef="usd">113566000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-34"
      decimals="INF"
      id="f-250"
      unitRef="shares">42249137</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-34" decimals="-3" id="f-251" unitRef="usd">42000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-35" decimals="-3" id="f-252" unitRef="usd">261011000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-36" decimals="-3" id="f-253" unitRef="usd">68323000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-37" decimals="-3" id="f-254" unitRef="usd">87000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-3" id="f-255" unitRef="usd">329463000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-39" decimals="-3" id="f-256" unitRef="usd">-25635000</us-gaap:TemporaryEquityNetIncome>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-40" decimals="-3" id="f-257" unitRef="usd">68923000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-41" decimals="-3" id="f-258" unitRef="usd">2767000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-32" decimals="-3" id="f-259" unitRef="usd">71690000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-39" decimals="-3" id="f-260" unitRef="usd">1546000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-41" decimals="-3" id="f-261" unitRef="usd">75000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-32" decimals="-3" id="f-262" unitRef="usd">75000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-39" decimals="-3" id="f-263" unitRef="usd">150000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <asth:StockIssuedDuringPeriodSharesNoncontrollingInterest
      contextRef="c-42"
      decimals="INF"
      id="f-264"
      unitRef="shares">1638045</asth:StockIssuedDuringPeriodSharesNoncontrollingInterest>
    <asth:StockIssuedDuringPeriodValueNoncontrollingInterest contextRef="c-42" decimals="-3" id="f-265" unitRef="usd">2000</asth:StockIssuedDuringPeriodValueNoncontrollingInterest>
    <asth:StockIssuedDuringPeriodValueNoncontrollingInterest contextRef="c-43" decimals="-3" id="f-266" unitRef="usd">40132000</asth:StockIssuedDuringPeriodValueNoncontrollingInterest>
    <asth:StockIssuedDuringPeriodValueNoncontrollingInterest contextRef="c-32" decimals="-3" id="f-267" unitRef="usd">40134000</asth:StockIssuedDuringPeriodValueNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-42"
      decimals="INF"
      id="f-268"
      unitRef="shares">29973</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <asth:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants
      contextRef="c-42"
      decimals="INF"
      id="f-269"
      unitRef="shares">898583</asth:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants>
    <asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-42" decimals="-3" id="f-270" unitRef="usd">1000</asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-43" decimals="-3" id="f-271" unitRef="usd">9060000</asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-32" decimals="-3" id="f-272" unitRef="usd">9061000</asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-42"
      decimals="INF"
      id="f-273"
      unitRef="shares">174158</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-43" decimals="-3" id="f-274" unitRef="usd">5738000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-32" decimals="-3" id="f-275" unitRef="usd">5738000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-43" decimals="-3" id="f-276" unitRef="usd">6745000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-32" decimals="-3" id="f-277" unitRef="usd">6745000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c-41" decimals="-3" id="f-278" unitRef="usd">3769000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c-32" decimals="-3" id="f-279" unitRef="usd">3769000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination contextRef="c-41" decimals="-3" id="f-280" unitRef="usd">500000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination contextRef="c-32" decimals="-3" id="f-281" unitRef="usd">500000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="c-42"
      decimals="INF"
      id="f-282"
      unitRef="shares">10707</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures contextRef="c-43" decimals="-3" id="f-283" unitRef="usd">334000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures contextRef="c-32" decimals="-3" id="f-284" unitRef="usd">334000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <asth:NoncontrollingInterestIncreaseFromCapitalCharge contextRef="c-41" decimals="-3" id="f-285" unitRef="usd">48000</asth:NoncontrollingInterestIncreaseFromCapitalCharge>
    <asth:NoncontrollingInterestIncreaseFromCapitalCharge contextRef="c-32" decimals="-3" id="f-286" unitRef="usd">48000</asth:NoncontrollingInterestIncreaseFromCapitalCharge>
    <us-gaap:TemporaryEquityAccretionOfDividends contextRef="c-39" decimals="-3" id="f-287" unitRef="usd">-30000000</us-gaap:TemporaryEquityAccretionOfDividends>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-41" decimals="-3" id="f-288" unitRef="usd">-1156000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-32" decimals="-3" id="f-289" unitRef="usd">-1156000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-44" decimals="-3" id="f-290" unitRef="usd">56535000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-45"
      decimals="INF"
      id="f-291"
      unitRef="shares">44630873</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-45" decimals="-3" id="f-292" unitRef="usd">45000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-3" id="f-293" unitRef="usd">310876000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-3" id="f-294" unitRef="usd">137246000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-3" id="f-295" unitRef="usd">5940000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-3" id="f-296" unitRef="usd">454107000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-50" decimals="-3" id="f-297" unitRef="usd">-3195000</us-gaap:TemporaryEquityNetIncome>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-51" decimals="-3" id="f-298" unitRef="usd">45171000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-52" decimals="-3" id="f-299" unitRef="usd">3765000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-31" decimals="-3" id="f-300" unitRef="usd">48936000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-52" decimals="-3" id="f-301" unitRef="usd">4338000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-31" decimals="-3" id="f-302" unitRef="usd">4338000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-52" decimals="-3" id="f-303" unitRef="usd">66000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-31" decimals="-3" id="f-304" unitRef="usd">66000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-50" decimals="-3" id="f-305" unitRef="usd">708000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-53"
      decimals="INF"
      id="f-306"
      unitRef="shares">342584</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-54" decimals="-3" id="f-307" unitRef="usd">-321000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-31" decimals="-3" id="f-308" unitRef="usd">-321000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <asth:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants
      contextRef="c-53"
      decimals="INF"
      id="f-309"
      unitRef="shares">860528</asth:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants>
    <asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-53" decimals="-3" id="f-310" unitRef="usd">1000</asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-54" decimals="-3" id="f-311" unitRef="usd">8632000</asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-31" decimals="-3" id="f-312" unitRef="usd">8633000</asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-53"
      decimals="INF"
      id="f-313"
      unitRef="shares">250000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-54" decimals="-3" id="f-314" unitRef="usd">9250000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-31" decimals="-3" id="f-315" unitRef="usd">9250000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-54" decimals="-3" id="f-316" unitRef="usd">16101000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-31" decimals="-3" id="f-317" unitRef="usd">16101000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-53"
      decimals="INF"
      id="f-318"
      unitRef="shares">18756</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-54" decimals="-3" id="f-319" unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-31" decimals="-3" id="f-320" unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c-52" decimals="-3" id="f-321" unitRef="usd">371000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c-31" decimals="-3" id="f-322" unitRef="usd">371000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="c-53"
      decimals="INF"
      id="f-323"
      unitRef="shares">11084</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures contextRef="c-54" decimals="-3" id="f-324" unitRef="usd">457000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures contextRef="c-31" decimals="-3" id="f-325" unitRef="usd">457000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures>
    <asth:TemporaryEquityTaxImpactOnAcquisition contextRef="c-50" decimals="-3" id="f-326" unitRef="usd">448000</asth:TemporaryEquityTaxImpactOnAcquisition>
    <asth:AAMGEquityContingentConsideration contextRef="c-54" decimals="-3" id="f-327" unitRef="usd">5569000</asth:AAMGEquityContingentConsideration>
    <asth:AAMGEquityContingentConsideration contextRef="c-31" decimals="-3" id="f-328" unitRef="usd">5569000</asth:AAMGEquityContingentConsideration>
    <us-gaap:TemporaryEquityAccretionOfDividends contextRef="c-50" decimals="-3" id="f-329" unitRef="usd">-37947000</us-gaap:TemporaryEquityAccretionOfDividends>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares
      contextRef="c-53"
      decimals="INF"
      id="f-330"
      unitRef="shares">984042</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-53" decimals="-3" id="f-331" unitRef="usd">1000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-54" decimals="-3" id="f-332" unitRef="usd">27947000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-52" decimals="-3" id="f-333" unitRef="usd">-4055000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-31" decimals="-3" id="f-334" unitRef="usd">23893000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-55" decimals="-3" id="f-335" unitRef="usd">14237000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-56"
      decimals="INF"
      id="f-336"
      unitRef="shares">46575699</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-3" id="f-337" unitRef="usd">47000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-57" decimals="-3" id="f-338" unitRef="usd">360097000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-58" decimals="-3" id="f-339" unitRef="usd">182417000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-59" decimals="-3" id="f-340" unitRef="usd">1749000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-341" unitRef="usd">544310000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome contextRef="c-60" decimals="-3" id="f-342" unitRef="usd">-7428000</us-gaap:TemporaryEquityNetIncome>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-61" decimals="-3" id="f-343" unitRef="usd">60717000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-62" decimals="-3" id="f-344" unitRef="usd">4560000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">65277000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-62" decimals="-3" id="f-346" unitRef="usd">78000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-1" decimals="-3" id="f-347" unitRef="usd">78000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-62" decimals="-3" id="f-348" unitRef="usd">106000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-1" decimals="-3" id="f-349" unitRef="usd">106000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c-63"
      decimals="INF"
      id="f-350"
      unitRef="shares">390785</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-64" decimals="-3" id="f-351" unitRef="usd">-933000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c-1" decimals="-3" id="f-352" unitRef="usd">-933000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <asth:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants
      contextRef="c-63"
      decimals="INF"
      id="f-353"
      unitRef="shares">140000</asth:StockIssuedDuringThePeriodSharesOfExerciseOfOptionAndWarrants>
    <asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-64" decimals="-3" id="f-354" unitRef="usd">1522000</asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants contextRef="c-1" decimals="-3" id="f-355" unitRef="usd">1522000</asth:StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-60" decimals="-3" id="f-356" unitRef="usd">150000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-63"
      decimals="INF"
      id="f-357"
      unitRef="shares">285081</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-64" decimals="-3" id="f-358" unitRef="usd">10042000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod contextRef="c-1" decimals="-3" id="f-359" unitRef="usd">10042000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-64" decimals="-3" id="f-360" unitRef="usd">22040000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-64" decimals="-3" id="f-361" unitRef="usd">22040000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-63"
      decimals="INF"
      id="f-362"
      unitRef="shares">22340</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-64" decimals="-3" id="f-363" unitRef="usd">800000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="c-1" decimals="-3" id="f-364" unitRef="usd">800000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:TemporaryEquityAccretionOfDividends contextRef="c-60" decimals="-3" id="f-365" unitRef="usd">-210873000</us-gaap:TemporaryEquityAccretionOfDividends>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-62" decimals="-3" id="f-366" unitRef="usd">-3904000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares contextRef="c-1" decimals="-3" id="f-367" unitRef="usd">-3904000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <asth:TemporaryEquityTransferOfCommonControlEntities contextRef="c-60" decimals="-3" id="f-368" unitRef="usd">-1768000</asth:TemporaryEquityTransferOfCommonControlEntities>
    <asth:StockholdersEquityTransferOfCommonControlEntities contextRef="c-64" decimals="-3" id="f-369" unitRef="usd">2447000</asth:StockholdersEquityTransferOfCommonControlEntities>
    <asth:StockholdersEquityTransferOfCommonControlEntities contextRef="c-1" decimals="-3" id="f-370" unitRef="usd">2447000</asth:StockholdersEquityTransferOfCommonControlEntities>
    <asth:TaxImpactFromDividends contextRef="c-60" decimals="-3" id="f-371" unitRef="usd">3076000</asth:TaxImpactFromDividends>
    <asth:TaxImpactFromInvestments contextRef="c-60" decimals="-3" id="f-372" unitRef="usd">361000</asth:TaxImpactFromInvestments>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-65" decimals="-3" id="f-373" unitRef="usd">-205883000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="c-66"
      decimals="INF"
      id="f-374"
      unitRef="shares">46843743</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-66" decimals="-3" id="f-375" unitRef="usd">47000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-67" decimals="-3" id="f-376" unitRef="usd">371037000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-68" decimals="-3" id="f-377" unitRef="usd">243134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-69" decimals="-3" id="f-378" unitRef="usd">2433000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-379" unitRef="usd">616651000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-380" unitRef="usd">57849000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-31" decimals="-3" id="f-381" unitRef="usd">45741000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-32" decimals="-3" id="f-382" unitRef="usd">46055000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-383" unitRef="usd">17748000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-31" decimals="-3" id="f-384" unitRef="usd">17543000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-32" decimals="-3" id="f-385" unitRef="usd">17517000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-386" unitRef="usd">1061000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-31" decimals="-3" id="f-387" unitRef="usd">939000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-32" decimals="-3" id="f-388" unitRef="usd">1078000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-389" unitRef="usd">22040000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-31" decimals="-3" id="f-390" unitRef="usd">16101000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-32" decimals="-3" id="f-391" unitRef="usd">6745000</us-gaap:ShareBasedCompensation>
    <asth:NoncashLeaseExpense contextRef="c-1" decimals="-3" id="f-392" unitRef="usd">7183000</asth:NoncashLeaseExpense>
    <asth:NoncashLeaseExpense contextRef="c-31" decimals="-3" id="f-393" unitRef="usd">3759000</asth:NoncashLeaseExpense>
    <asth:NoncashLeaseExpense contextRef="c-32" decimals="-3" id="f-394" unitRef="usd">3133000</asth:NoncashLeaseExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-395" unitRef="usd">5579000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-31" decimals="-3" id="f-396" unitRef="usd">5622000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-32" decimals="-3" id="f-397" unitRef="usd">-4306000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:UnrealizedGainLossFromInvestmentInEquitySecurities contextRef="c-1" decimals="-3" id="f-398" unitRef="usd">-4782000</asth:UnrealizedGainLossFromInvestmentInEquitySecurities>
    <asth:UnrealizedGainLossFromInvestmentInEquitySecurities contextRef="c-31" decimals="-3" id="f-399" unitRef="usd">-25506000</asth:UnrealizedGainLossFromInvestmentInEquitySecurities>
    <asth:UnrealizedGainLossFromInvestmentInEquitySecurities contextRef="c-32" decimals="-3" id="f-400" unitRef="usd">-10845000</asth:UnrealizedGainLossFromInvestmentInEquitySecurities>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c-1" decimals="-3" id="f-401" unitRef="usd">201000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c-31" decimals="-3" id="f-402" unitRef="usd">4235000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives contextRef="c-32" decimals="-3" id="f-403" unitRef="usd">-1071000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:GainOnSaleOfInvestments contextRef="c-1" decimals="-3" id="f-404" unitRef="usd">1246000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments contextRef="c-31" decimals="-3" id="f-405" unitRef="usd">2272000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments contextRef="c-32" decimals="-3" id="f-406" unitRef="usd">2193000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-1" decimals="-3" id="f-407" unitRef="usd">-12444000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-31" decimals="-3" id="f-408" unitRef="usd">-14278000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-32" decimals="-3" id="f-409" unitRef="usd">7671000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <asth:GainLossOnConsolidationOfEquityMethodInvestment contextRef="c-1" decimals="-3" id="f-410" unitRef="usd">0</asth:GainLossOnConsolidationOfEquityMethodInvestment>
    <asth:GainLossOnConsolidationOfEquityMethodInvestment contextRef="c-31" decimals="-3" id="f-411" unitRef="usd">-901000</asth:GainLossOnConsolidationOfEquityMethodInvestment>
    <asth:GainLossOnConsolidationOfEquityMethodInvestment contextRef="c-32" decimals="-3" id="f-412" unitRef="usd">2752000</asth:GainLossOnConsolidationOfEquityMethodInvestment>
    <asth:GainLossOnEquityReceivable contextRef="c-1" decimals="-3" id="f-413" unitRef="usd">0</asth:GainLossOnEquityReceivable>
    <asth:GainLossOnEquityReceivable contextRef="c-31" decimals="-3" id="f-414" unitRef="usd">0</asth:GainLossOnEquityReceivable>
    <asth:GainLossOnEquityReceivable contextRef="c-32" decimals="-3" id="f-415" unitRef="usd">4270000</asth:GainLossOnEquityReceivable>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-416" unitRef="usd">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-31" decimals="-3" id="f-417" unitRef="usd">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-32" decimals="-3" id="f-418" unitRef="usd">-1145000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:OtherAssetImpairmentCharges contextRef="c-1" decimals="-3" id="f-419" unitRef="usd">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges contextRef="c-31" decimals="-3" id="f-420" unitRef="usd">0</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:OtherAssetImpairmentCharges contextRef="c-32" decimals="-3" id="f-421" unitRef="usd">15723000</us-gaap:OtherAssetImpairmentCharges>
    <us-gaap:ProceedsFromOtherOperatingActivities contextRef="c-1" decimals="-3" id="f-422" unitRef="usd">422000</us-gaap:ProceedsFromOtherOperatingActivities>
    <us-gaap:ProceedsFromOtherOperatingActivities contextRef="c-31" decimals="-3" id="f-423" unitRef="usd">0</us-gaap:ProceedsFromOtherOperatingActivities>
    <us-gaap:ProceedsFromOtherOperatingActivities contextRef="c-32" decimals="-3" id="f-424" unitRef="usd">189000</us-gaap:ProceedsFromOtherOperatingActivities>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-425" unitRef="usd">26735000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-31" decimals="-3" id="f-426" unitRef="usd">38194000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-32" decimals="-3" id="f-427" unitRef="usd">1518000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties contextRef="c-1" decimals="-3" id="f-428" unitRef="usd">-6167000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties contextRef="c-31" decimals="-3" id="f-429" unitRef="usd">-4229000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties contextRef="c-32" decimals="-3" id="f-430" unitRef="usd">20116000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c-1" decimals="-3" id="f-431" unitRef="usd">-311000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c-31" decimals="-3" id="f-432" unitRef="usd">-8196000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c-32" decimals="-3" id="f-433" unitRef="usd">5351000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets contextRef="c-1" decimals="-3" id="f-434" unitRef="usd">2956000</asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets>
    <asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets contextRef="c-31" decimals="-3" id="f-435" unitRef="usd">-818000</asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets>
    <asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets contextRef="c-32" decimals="-3" id="f-436" unitRef="usd">-2708000</asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-437" unitRef="usd">-2864000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-31" decimals="-3" id="f-438" unitRef="usd">243000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-32" decimals="-3" id="f-439" unitRef="usd">1529000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-440" unitRef="usd">-170000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-31" decimals="-3" id="f-441" unitRef="usd">-49000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-32" decimals="-3" id="f-442" unitRef="usd">3217000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c-1" decimals="-3" id="f-443" unitRef="usd">-328000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c-31" decimals="-3" id="f-444" unitRef="usd">-2470000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable contextRef="c-32" decimals="-3" id="f-445" unitRef="usd">892000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <asth:IncreaseDecreaseInMedicalLiabilities contextRef="c-1" decimals="-3" id="f-446" unitRef="usd">18610000</asth:IncreaseDecreaseInMedicalLiabilities>
    <asth:IncreaseDecreaseInMedicalLiabilities contextRef="c-31" decimals="-3" id="f-447" unitRef="usd">22786000</asth:IncreaseDecreaseInMedicalLiabilities>
    <asth:IncreaseDecreaseInMedicalLiabilities contextRef="c-32" decimals="-3" id="f-448" unitRef="usd">5279000</asth:IncreaseDecreaseInMedicalLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-1" decimals="-3" id="f-449" unitRef="usd">-14477000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-31" decimals="-3" id="f-450" unitRef="usd">6917000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable contextRef="c-32" decimals="-3" id="f-451" unitRef="usd">-14005000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-452" unitRef="usd">-6674000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-31" decimals="-3" id="f-453" unitRef="usd">-3945000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-32" decimals="-3" id="f-454" unitRef="usd">-3215000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-455" unitRef="usd">68227000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-31" decimals="-3" id="f-456" unitRef="usd">82128000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-32" decimals="-3" id="f-457" unitRef="usd">70335000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-3" id="f-458" unitRef="usd">6512000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-31" decimals="-3" id="f-459" unitRef="usd">16352000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-32" decimals="-3" id="f-460" unitRef="usd">2585000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties contextRef="c-1" decimals="-3" id="f-461" unitRef="usd">2676000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties contextRef="c-31" decimals="-3" id="f-462" unitRef="usd">4067000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties contextRef="c-32" decimals="-3" id="f-463" unitRef="usd">56000</us-gaap:ProceedsFromCollectionOfLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-3" id="f-464" unitRef="usd">2151000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-31" decimals="-3" id="f-465" unitRef="usd">1854000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-32" decimals="-3" id="f-466" unitRef="usd">28000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-1" decimals="-3" id="f-467" unitRef="usd">491000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-31" decimals="-3" id="f-468" unitRef="usd">31671000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-32" decimals="-3" id="f-469" unitRef="usd">67612000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties contextRef="c-1" decimals="-3" id="f-470" unitRef="usd">26473000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties contextRef="c-31" decimals="-3" id="f-471" unitRef="usd">0</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties contextRef="c-32" decimals="-3" id="f-472" unitRef="usd">0</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment contextRef="c-1" decimals="-3" id="f-473" unitRef="usd">4000000</us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment>
    <us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment contextRef="c-31" decimals="-3" id="f-474" unitRef="usd">0</us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment>
    <us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment contextRef="c-32" decimals="-3" id="f-475" unitRef="usd">0</us-gaap:PaymentsToAcquireTradingSecuritiesHeldforinvestment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-476" unitRef="usd">28529000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-31" decimals="-3" id="f-477" unitRef="usd">22940000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-32" decimals="-3" id="f-478" unitRef="usd">19223000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-479" unitRef="usd">325000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-31" decimals="-3" id="f-480" unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="c-32" decimals="-3" id="f-481" unitRef="usd">13622000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-482" unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments contextRef="c-31" decimals="-3" id="f-483" unitRef="usd">0</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromSaleOfEquityMethodInvestments contextRef="c-32" decimals="-3" id="f-484" unitRef="usd">6375000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital contextRef="c-1" decimals="-3" id="f-485" unitRef="usd">0</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital contextRef="c-31" decimals="-3" id="f-486" unitRef="usd">400000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital contextRef="c-32" decimals="-3" id="f-487" unitRef="usd">0</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <asth:PaymentsToEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-488" unitRef="usd">700000</asth:PaymentsToEquityMethodInvestments>
    <asth:PaymentsToEquityMethodInvestments contextRef="c-31" decimals="-3" id="f-489" unitRef="usd">2105000</asth:PaymentsToEquityMethodInvestments>
    <asth:PaymentsToEquityMethodInvestments contextRef="c-32" decimals="-3" id="f-490" unitRef="usd">0</asth:PaymentsToEquityMethodInvestments>
    <asth:ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity contextRef="c-1" decimals="-3" id="f-491" unitRef="usd">0</asth:ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity>
    <asth:ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity contextRef="c-31" decimals="-3" id="f-492" unitRef="usd">0</asth:ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity>
    <asth:ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity contextRef="c-32" decimals="-3" id="f-493" unitRef="usd">5927000</asth:ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-494" unitRef="usd">-65523000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-31" decimals="-3" id="f-495" unitRef="usd">-7113000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-32" decimals="-3" id="f-496" unitRef="usd">16540000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-1" decimals="-3" id="f-497" unitRef="usd">62074000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-31" decimals="-3" id="f-498" unitRef="usd">14030000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-32" decimals="-3" id="f-499" unitRef="usd">31089000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c-1" decimals="-3" id="f-500" unitRef="usd">204681000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c-31" decimals="-3" id="f-501" unitRef="usd">3865000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt contextRef="c-32" decimals="-3" id="f-502" unitRef="usd">238326000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt contextRef="c-1" decimals="-3" id="f-503" unitRef="usd">284527000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt contextRef="c-31" decimals="-3" id="f-504" unitRef="usd">3598000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt contextRef="c-32" decimals="-3" id="f-505" unitRef="usd">180569000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations contextRef="c-1" decimals="-3" id="f-506" unitRef="usd">675000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations contextRef="c-31" decimals="-3" id="f-507" unitRef="usd">561000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations contextRef="c-32" decimals="-3" id="f-508" unitRef="usd">208000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-1" decimals="-3" id="f-509" unitRef="usd">1522000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-31" decimals="-3" id="f-510" unitRef="usd">8633000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-32" decimals="-3" id="f-511" unitRef="usd">9061000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-512" unitRef="usd">10192000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-31" decimals="-3" id="f-513" unitRef="usd">9250000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-32" decimals="-3" id="f-514" unitRef="usd">5739000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-515" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-31" decimals="-3" id="f-516" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-32" decimals="-3" id="f-517" unitRef="usd">40134000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c-1" decimals="-3" id="f-518" unitRef="usd">78000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c-31" decimals="-3" id="f-519" unitRef="usd">5046000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="c-32" decimals="-3" id="f-520" unitRef="usd">1471000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders contextRef="c-1" decimals="-3" id="f-521" unitRef="usd">0</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders contextRef="c-31" decimals="-3" id="f-522" unitRef="usd">436000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders contextRef="c-32" decimals="-3" id="f-523" unitRef="usd">48000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-524" unitRef="usd">3928000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts contextRef="c-31" decimals="-3" id="f-525" unitRef="usd">0</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentOfFinancingAndStockIssuanceCosts contextRef="c-32" decimals="-3" id="f-526" unitRef="usd">727000</us-gaap:PaymentOfFinancingAndStockIssuanceCosts>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-1" decimals="-3" id="f-527" unitRef="usd">1000000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-31" decimals="-3" id="f-528" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-32" decimals="-3" id="f-529" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-530" unitRef="usd">3421000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-31" decimals="-3" id="f-531" unitRef="usd">-20085000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-32" decimals="-3" id="f-532" unitRef="usd">-47748000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-533" unitRef="usd">6125000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-31" decimals="-3" id="f-534" unitRef="usd">54930000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-32" decimals="-3" id="f-535" unitRef="usd">39127000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-536" unitRef="usd">288027000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-49" decimals="-3" id="f-537" unitRef="usd">233097000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-38" decimals="-3" id="f-538" unitRef="usd">193970000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-539" unitRef="usd">294152000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-540" unitRef="usd">288027000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-49" decimals="-3" id="f-541" unitRef="usd">233097000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-3" id="f-542" unitRef="usd">56567000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-31" decimals="-3" id="f-543" unitRef="usd">47311000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-32" decimals="-3" id="f-544" unitRef="usd">37201000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-545" unitRef="usd">14251000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-31" decimals="-3" id="f-546" unitRef="usd">6672000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-32" decimals="-3" id="f-547" unitRef="usd">4158000</us-gaap:InterestPaidNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-548" unitRef="usd">25124000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-31" decimals="-3" id="f-549" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-32" decimals="-3" id="f-550" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <asth:TemporaryEquityDividendsImpact contextRef="c-1" decimals="-3" id="f-551" unitRef="usd">3076000</asth:TemporaryEquityDividendsImpact>
    <asth:TemporaryEquityDividendsImpact contextRef="c-31" decimals="-3" id="f-552" unitRef="usd">0</asth:TemporaryEquityDividendsImpact>
    <asth:TemporaryEquityDividendsImpact contextRef="c-32" decimals="-3" id="f-553" unitRef="usd">0</asth:TemporaryEquityDividendsImpact>
    <us-gaap:PaymentsForProceedsFromRealEstatePartnershipInvestmentNet contextRef="c-1" decimals="-3" id="f-554" unitRef="usd">152767000</us-gaap:PaymentsForProceedsFromRealEstatePartnershipInvestmentNet>
    <us-gaap:PaymentsForProceedsFromRealEstatePartnershipInvestmentNet contextRef="c-31" decimals="-3" id="f-555" unitRef="usd">0</us-gaap:PaymentsForProceedsFromRealEstatePartnershipInvestmentNet>
    <us-gaap:PaymentsForProceedsFromRealEstatePartnershipInvestmentNet contextRef="c-32" decimals="-3" id="f-556" unitRef="usd">0</us-gaap:PaymentsForProceedsFromRealEstatePartnershipInvestmentNet>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-4" decimals="-3" id="f-557" unitRef="usd">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-5" decimals="-3" id="f-558" unitRef="usd">0</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-49" decimals="-3" id="f-559" unitRef="usd">71000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <asth:IssuanceOfFinancingObligationForBusinessCombination contextRef="c-1" decimals="-3" id="f-560" unitRef="usd">0</asth:IssuanceOfFinancingObligationForBusinessCombination>
    <asth:IssuanceOfFinancingObligationForBusinessCombination contextRef="c-31" decimals="-3" id="f-561" unitRef="usd">0</asth:IssuanceOfFinancingObligationForBusinessCombination>
    <asth:IssuanceOfFinancingObligationForBusinessCombination contextRef="c-32" decimals="-3" id="f-562" unitRef="usd">12706000</asth:IssuanceOfFinancingObligationForBusinessCombination>
    <asth:CashlessExerciseOfStockOptions contextRef="c-1" decimals="-3" id="f-563" unitRef="usd">0</asth:CashlessExerciseOfStockOptions>
    <asth:CashlessExerciseOfStockOptions contextRef="c-31" decimals="-3" id="f-564" unitRef="usd">694000</asth:CashlessExerciseOfStockOptions>
    <asth:CashlessExerciseOfStockOptions contextRef="c-32" decimals="-3" id="f-565" unitRef="usd">0</asth:CashlessExerciseOfStockOptions>
    <asth:FixedAssetObtainedInExchangeForFinanceLeaseLiabilities contextRef="c-1" decimals="-3" id="f-566" unitRef="usd">486000</asth:FixedAssetObtainedInExchangeForFinanceLeaseLiabilities>
    <asth:FixedAssetObtainedInExchangeForFinanceLeaseLiabilities contextRef="c-31" decimals="-3" id="f-567" unitRef="usd">971000</asth:FixedAssetObtainedInExchangeForFinanceLeaseLiabilities>
    <asth:FixedAssetObtainedInExchangeForFinanceLeaseLiabilities contextRef="c-32" decimals="-3" id="f-568" unitRef="usd">0</asth:FixedAssetObtainedInExchangeForFinanceLeaseLiabilities>
    <us-gaap:StockIssued1 contextRef="c-1" decimals="-3" id="f-569" unitRef="usd">800000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-31" decimals="-3" id="f-570" unitRef="usd">1000000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-32" decimals="-3" id="f-571" unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:MortgageLoanRelatedToPropertySales1 contextRef="c-1" decimals="-3" id="f-572" unitRef="usd">0</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:MortgageLoanRelatedToPropertySales1 contextRef="c-31" decimals="-3" id="f-573" unitRef="usd">16275000</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:MortgageLoanRelatedToPropertySales1 contextRef="c-32" decimals="-3" id="f-574" unitRef="usd">0</us-gaap:MortgageLoanRelatedToPropertySales1>
    <asth:CancellationOfRestrictedStockAwards contextRef="c-1" decimals="-3" id="f-575" unitRef="usd">0</asth:CancellationOfRestrictedStockAwards>
    <asth:CancellationOfRestrictedStockAwards contextRef="c-31" decimals="-3" id="f-576" unitRef="usd">0</asth:CancellationOfRestrictedStockAwards>
    <asth:CancellationOfRestrictedStockAwards contextRef="c-32" decimals="-3" id="f-577" unitRef="usd">334000</asth:CancellationOfRestrictedStockAwards>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-578" unitRef="usd">293807000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-579" unitRef="usd">288027000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-49" decimals="-3" id="f-580" unitRef="usd">233097000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent contextRef="c-4" decimals="-3" id="f-581" unitRef="usd">345000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent contextRef="c-5" decimals="-3" id="f-582" unitRef="usd">0</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent contextRef="c-49" decimals="-3" id="f-583" unitRef="usd">0</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-584" unitRef="usd">294152000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-3" id="f-585" unitRef="usd">288027000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-49" decimals="-3" id="f-586" unitRef="usd">233097000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations contextRef="c-1" id="f-587">Description of Business&lt;div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 26, 2024, Apollo Medical Holdings, Inc. rebranded as Astrana Health, Inc (&#x201c;Astrana&#x201d;). Unless the context dictates otherwise, references in these notes to the financial statements, the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; and similar words are references to Astrana and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#x201c;VIEs&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Headquartered in Alhambra, California, Astrana is a leading provider-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. Together with Astrana&#x2019;s affiliated physician groups and consolidated subsidiaries and VIEs, the Company provides value-based care enablement services and care delivery with its consolidated care partners to serve patients in California, Nevada, and Texas, the majority of whom are covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (&#x201c;HMOs&#x201d;), with a small portion of our revenue coming from non-insured patients. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company&#x2019;s physician network consists of primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reportable segments changed from one to three in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#x2019;s chief operating decision maker when reviewing the Company&#x2019;s performance as well as an effort to provide additional transparency to investors and other financial statement users. The three segments identified by the Company are Care Partners, Care Delivery and Care Enablement, which are described as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners aligned on a shared vision for coordinated care delivery. By leveraging the Company&#x2019;s unique care enablement platform and ability to recruit, empower, and incentivize physicians to effectively manage total cost of care, the Company is able to organize partnered providers into successful multi-payer risk-bearing organizations that take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare fee for service (&#x201c;FFS&#x201d;), Medicare Advantage, Medicaid, Commercial, and Exchange. Through the Company&#x2019;s network of &#x201c;independent practice associations&#x201d; (&#x201c;IPAs&#x201d;), &#x201c;accountable care organizations&#x201d; (&#x201c;ACOs&#x201d;), and Restricted Knox-Keene licensed health plan, the Company&#x2019;s healthcare delivery entities are responsible for coordinating and delivering high-quality care to the Company&#x2019;s patients and ensuring continuity of care in Astrana&#x2019;s ecosystem across age, stage of life, or life circumstance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;One of the Company&#x2019;s Accountable Care Organizations (&#x201c;ACO&#x201d;) began participating in the Next Generation Accountable Care Organization (&#x201c;NGACO&#x201d;) Model of CMS in January 2017. The NGACO Model was a Center for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) program that allowed provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participating in this new attribution-based risk-sharing model. With the termination of the NGACO Model on December 31, 2021, the Company&#x2019;s ACO participated as a Direct Contracting Entity (&#x201c;DCE&#x201d;) in the standard track of CMS&#x2019;s Global and Professional Direct Contracting (&#x201c;GPDC&#x201d;) Model for Performance Year 2022 (&#x201c;PY22&#x201d;), beginning January 1, 2022. CMS has since redesigned the GPDC Model in response to the current Administration&#x2019;s health care priorities, including their commitment to advancing health equity, stakeholder feedback, and participant experience, and renamed the GPDC Model to ACO Realizing Equity, Access, and Community Health (&#x201c;ACO REACH&#x201d;) Model. The Company began participation in the ACO REACH Model on January 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Care Delivery&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. The Company&#x2019;s care delivery organization includes primary care, multi-specialty care, and ancillary care services. This segment includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Primary care clinics, including post-acute care services; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Multi-specialty care clinics and medical groups, including hospitalist, intensivist, and physician advisory services, cardiac care and diagnostic testing, and specialized care for women&#x2019;s health; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Ancillary service providers, such as urgent care centers, outpatient imaging centers, ambulatory surgery centers, and full-service labs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Care Enablement segment is an integrated, end-to-end clinical, operational, financial, and administrative platform, powered by the Company&#x2019;s proprietary technology suite, that enhances delivery of high-quality, value-based care to patients and leading to superior clinical and financial outcomes. The Company provides solutions to providers, including independent physicians, provider and medical groups, accountable care organizations, and payers, including health plans and other risk-bearing organizations. The Company&#x2019;s platform meets providers and payers where they are, with a wide spectrum of solutions across the total cost of care risk spectrum, ranging from solutions for fee-for-service entities to full risk-bearing entities, and across patient types, including Medicare, Medicaid, Commercial, and Exchange patients. This segment includes the Company&#x2019;s wholly owned subsidiaries which operate as management services organizations (&#x201c;MSOs&#x201d;), which enter into long-term management and/or administrative services agreements with Independent Practice Associations (&#x201c;IPAs&#x201d;), ACOs, or clinics. By leveraging the Company&#x2019;s care enablement platform, providers and payers can improve their ability to deliver high-quality care to their patients and achieve better patient outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Affiliates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s other affiliates are not included as a reportable segment and primarily consist of the real estate operations and other entities that are individually immaterial. The real estate operations are deemed Excluded Assets that are solely for the benefit of Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (&#x201c;APC&#x201d;) and its shareholders. Excluded Assets means (i) assets received from the sale of shares of APC&#x2019;s Series A Preferred equal to the Series A purchase price, (ii) the assets of APC that are not Healthcare Services Assets (as defined in the Series A Preferred purchase agreement), including APC&#x2019;s equity interests in Astrana Health, Inc., and any entity that is primarily engaged in the business of owning, leasing, developing, or otherwise operating real estate, (iii) any assets acquired with the proceeds of the sale, assignment, or other disposition of any of the assets described in clauses (i) or (ii), and (iv) any proceeds of the assets described in clauses (i), (ii), and (iii). As such, any income pertaining to Excluded Assets have no impact on the Series A Preferred dividend payable by APC to Astrana Health Medical Corporation (&#x201c;Astrana Medical&#x201d;), formerly known as AP-AMH Medical Corporation, and consequently will not affect net income attributable to Astrana. APC and Astrana Medical are consolidated variable interest entities of the Company. See Note 18 &#x2013; &#x201c;Variable Interest Entities (VIEs)&#x201d; to the consolidated financial statements for information on the Company&#x2019;s entities that qualify as consolidated VIEs. &lt;/span&gt;&lt;/div&gt;On December 26, 2023, APC completed a restructuring transaction to spin-off its real estate investments, a component of Excluded Assets (&#x201c;the Spin-Off&#x201d;). To effect the restructuring, APC contributed its real estate investments to a wholly owned subsidiary in exchange for 100% of the subsidiary&#x2019;s membership interest units, which membership interests were then distributed to holders of APC&#x2019;s outstanding common stock as a dividend, with each such stockholder receiving one membership interest unit for each share of outstanding APC common stock held. Dr. Thomas Lam, the Company&#x2019;s Vice Chairman, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder of APC; Dr. Kenneth Sim, the Company&#x2019;s Executive Chairman, is Chairman and a director and stockholder of APC; and Dr. Albert Young, the Company&#x2019;s Chief Administrative Officer, is Senor Executive Vice President and a director and stockholder of APC. The Company leases certain properties that were spun-off and will continue to lease from these properties. After the distribution, the real estate investments became related parties since the chief executive officer of the real estate investments is also a board member of the Company. See Note 15 &#x2013; &#x201c;Related-Party Transactions&#x201d; to the consolidated financial statements for information on related party transactions. The dividend was $190.3&#160;million and recorded at fair value of the investments&#x2019; net assets on the date of distribution, December 26, 2023. The fair value of the dividend was measured using Level 3 inputs by applying market data of similar real estate comparables. The gain, representing the difference between the fair value and the carrying value of the net assets, was $5.3&#160;million and is presented within other income in the accompanying consolidated statement of income. As a result of the distribution, the real estate investments are no longer included within the consolidated financial statements after December 26, 2023.</us-gaap:NatureOfOperations>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-31"
      decimals="INF"
      id="f-588"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-70"
      decimals="INF"
      id="f-589"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-590"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <asth:RestructuringSpinoffTransactionPercentage
      contextRef="c-71"
      decimals="INF"
      id="f-591"
      unitRef="number">1</asth:RestructuringSpinoffTransactionPercentage>
    <asth:RestructuringSpinoffTransactionNumberOfMembershipUnits contextRef="c-71" decimals="INF" id="f-592" unitRef="unit">1</asth:RestructuringSpinoffTransactionNumberOfMembershipUnits>
    <asth:RestructuringSpinoffTransactionDividendRealEstateOperations contextRef="c-71" decimals="-5" id="f-593" unitRef="usd">190300000</asth:RestructuringSpinoffTransactionDividendRealEstateOperations>
    <us-gaap:FairValueNetAssetLiability contextRef="c-4" decimals="-5" id="f-594" unitRef="usd">5300000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c-1" id="f-595">Basis of Presentation and Summary of Significant Accounting Policies&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared by management in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated balance sheets as of December&#160;31, 2023 and 2022 and consolidated statements of income for the years ended December&#160;31, 2023, 2022 and 2021 include Astrana&#x2019;s wholly owned subsidiaries and consolidated variable interest entities (&#x201c;VIEs&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts disclosed in prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications were made between other assets and investments in privately held entities on the accompanying consolidated balance sheet as of December 31, 2022. The reclassification had no effect on net income, earnings per share, retained earnings, cash flows or total assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combinations and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#x201c;IBNR&#x201d;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including constraints, completion factors, and historical margins), income tax valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#x2019;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#x2019;s net assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A legal entity is determined to be a VIE if it has any of the following three characteristics:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity does not have sufficient equity to finance its activities without additional subordinated financial support;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#x2019;s economic performance, as evidenced by:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Substantive participating rights in day-to-day management of the entity&#x2019;s activities; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Substantive kick-out rights over the party responsible for significant decisions;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The obligation to absorb the entity&#x2019;s expected losses; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The right to receive the entity&#x2019;s expected residual returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company determines that any of the three characteristics of a VIE are met, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable interest model&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company &#x2013; that is, the Company has:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The power to direct the activities of a VIE that most significantly influence the VIE&#x2019;s economic performance (power), and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 18 &#x2013; &#x201c;Variable Interest Entities (VIEs)&#x201d; to the consolidated financial statements for information on the Company&#x2019;s consolidated VIEs. If there are variable interests in a VIE but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting, refer to Note 6 &#x2013; &#x201c;Investments in Other Entities&#x201d; for entities that qualify as VIEs but the Company is not the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reportable Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as three reportable segments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Partners;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Delivery; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Enablement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; and Note 20 &#x2014; &#x201c;Segments&#x201d; to the consolidated financial statements for information on the Company&#x2019;s segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company believes it is not exposed to any significant credit risk with respect to its cash, cash equivalents, and restricted cash. As of December&#160;31, 2023 and 2022, the Company&#x2019;s deposit accounts with banks exceeded the FDIC&#x2019;s insured limit by approximately $318.9 million and $324.7 million, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#x2019;s concentration of risk exposure.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash consists of cash held as collateral in the event of default as required by certain health plan contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase and such designation is reevaluated at each balance sheet date. Certificates of deposit in investments in marketable securities are reported at par value, plus accrued interest, with maturity dates greater than ninety days. Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, the Company classifies such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted-average share prices from observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables, Receivables &#x2013; Related Parties, Other Receivables, Loan Receivable, and Loan Receivable - Related Party&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivables are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables &#x2013; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#x2013; related parties are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s loan receivable and loan receivable - related party consists of promissory notes that accrue interest per annum. As of December&#160;31, 2023, promissory notes are expected to be collected by their maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitation receivables relate to each health plan&#x2019;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#x2019;s hospital shared-risk pool receivable that is recorded quarterly based on reports received from the Company&#x2019;s hospital partners and management&#x2019;s estimate of the Company&#x2019;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately 18 months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#x201c;FFS&#x201d;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables, and the Company&#x2019;s expectation is that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#x201c;CECL&#x201d;) model. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts. The consolidated statements of income present disaggregated revenue by service type. The following table presents disaggregated revenue generated by each payer type (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.144%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.528%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.528%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,322&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633,463&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,286&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,093&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,083&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,311&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,198&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,894&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,985&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Less than 10% of total net revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had major payers that contributed to the following percentages of net receivables and receivables - related parties:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.826%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Land, Property, and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land is carried at cost and is not depreciated as it is considered to have an indefinite useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, including leasehold improvements, are carried at cost less accumulated depreciation and amortization. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets ranging from &lt;span style="-sec-ix-hidden:f-642"&gt;three&lt;/span&gt; to thirty-nine years. Leasehold improvements are amortized on a straight-line basis over the shorter of the terms of the respective leases or the expected useful lives of those improvements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maintenance and repairs are charged to expense as incurred. Upon sale or retirement, the asset cost and related accumulated depreciation and amortization are removed from the accounts, and any related gain or loss is included in the determination of consolidated net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, long-term debt, and certain other liabilities. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 820&#x201d;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This hierarchy prioritizes the inputs into three broad levels as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#x2019;s own data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for these assets and liabilities for the years ended December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives include network-payer relationships, management contracts, member relationships, subscriber relationships, and developed technology and are stated at cost, less accumulated amortization, and impairment losses. These intangible assets are amortized using the accelerated method based on the discounted cash flow rate or using the straight-line method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives also include a patient management platform, as well as trade names and trademarks, whose valuations were determined using the cost to recreate method and the relief from royalty method, respectively. These assets are stated at cost, less accumulated amortization, and impairment losses, and are amortized using the straight-line method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finite-lived intangibles and other long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may&#160;not be recoverable. If the expected future cash flows from the use of such assets (undiscounted and without interest charges) are less than the carrying value, a write-down would be recorded to reduce the carrying value of the asset to its estimated fair value. Fair value is determined based on appropriate valuation techniques. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Indefinite-Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles &#x2013; Goodwill and Other,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; goodwill and indefinite-lived intangible assets are reviewed at least annually for impairment under a two step process. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Step 1&#x2014;  Under a qualitative assessment, determine if there are indicators of impairment. If so, proceed to Step 2. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Step 2 &#x2014; Under a quantitative assessment, if the fair value of each reporting unit is less than its carrying value, there is an impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may also elect to skip the qualitative testing and proceed directly to quantitative testing. The Company&#x2019;s four reporting units consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Partners &#x2013; IPA;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Partners &#x2013; ACO;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Delivery; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Enablement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An impairment loss is recognized if the carrying value of a reporting unit exceeds its fair value. If this event arises, the impairment loss recorded is equal to the excess of the carrying value of the reporting unit over its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At least annually, indefinite-lived intangible assets are tested for impairment. Impairment for intangible assets with indefinite lives exists if the carrying value of the intangible asset exceeds its fair value. The fair values of indefinite-lived intangible assets are determined using valuation techniques based on estimates, judgments, and assumptions management believes are appropriate in the circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no impairment of its goodwill or indefinite-lived intangible assets during the years ended December&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Other Entities &#x2013; Equity Method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for certain investments using the equity method of accounting when it is determined that the investment provides the Company with the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee&#x2019;s board of directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize the Company&#x2019;s share of net earnings or losses of the investee and is recognized in the accompanying consolidated statements of income under &#x201c;Income (loss) from equity method investments&#x201d; and also is adjusted by contributions to and distributions from the investee. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Privately Held Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for certain investments using the cost method of accounting when it is determined that the investment provides the Company with little or no influence over the investee. Under the cost method of accounting, the investment is measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. The investments in privately held entities that do not report net asset value are subject to qualitative assessment for indicators of impairments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Care Partners segment is responsible for integrated care that the associated physicians and contracted hospitals provide to their enrollees. The Company&#x2019;s Care Partners segment provides integrated care to HMOs, Medicare, and Medi-Cal enrollees through a network of contracted providers under sub-capitation and direct patient service arrangements. Medical costs for professional and institutional services rendered by contracted providers are recorded as cost of services, excluding depreciation and amortization, in the accompanying consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An estimate of amounts due to contracted physicians, hospitals, and other professional providers is included in medical liabilities in the accompanying consolidated balance sheets. Medical liabilities include claims reported as of the balance sheet date and estimated IBNR claims. Such estimates are developed using actuarial methods and are based on numerous variables, including the utilization of healthcare services, historical payment patterns, cost trends, product mix, seasonality, changes in membership, and other factors. The estimation methods and the resulting reserves are periodically reviewed and updated. Many of the medical contracts are complex in nature and may&#160;be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations may&#160;not come to light until a substantial period of time has passed following the contract implementation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiduciary Cash and Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Care Partner segment collects cash from health plans on behalf of their sub-IPAs and providers and passes the money through to them. The fiduciary cash balance of $7.7 million and $8.1 million as of December&#160;31, 2023 and 2022, respectively, is presented within prepaid expenses and other current assets and the related payable is presented as fiduciary payable in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company receives payments from the following sources for services rendered: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Commercial insurers;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Federal government under the Medicare program administered by CMS;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;State governments under Medicaid and other programs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Other third-party payers (e.g., hospitals and IPAs); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Individual patients and clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue primarily consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Capitation revenue;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Risk pool settlements and incentives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;GPDC/ACO REACH capitation revenue;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management fee income; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;FFS revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Nature of Services and Revenue Streams&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH capitation revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. The following is a summary of the principal forms of the Company&#x2019;s billing arrangements and how revenue is recognized for each.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capitation, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Managed care revenues of the Company consist primarily of capitated fees for medical services provided by the Company under a capitated arrangement directly made with various managed care providers, including HMOs. Capitation revenue is &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;typically prepaid monthly to the Company based on the number of enrollees selecting the Company as their healthcare provider. Capitation revenue is recognized in the month in which the Company is obligated to provide services to plan enrollees under contracts with various health plans. Minor ongoing adjustments to prior months&#x2019; capitation, primarily arising from contracted HMOs finalizing their monthly patient eligibility data for additions or subtractions of enrollees, are recognized in the month they are communicated to the Company. Additionally, Medicare pays capitation using a &#x201c;Risk Adjustment&#x201d; model, which compensates managed care organizations and providers based on the health status (acuity) of each individual enrollee. Health plans and providers with higher acuity enrollees will receive more and those with lower acuity enrollees will receive less. Under Risk Adjustment, capitation is determined based on health severity, measured using patient encounter data. Capitation is paid on a monthly basis based on data submitted for the enrollee for the preceding year and is adjusted in subsequent periods after the final data is compiled. Positive or negative capitation adjustments are made for Medicare enrollees with conditions requiring more or fewer healthcare services than assumed in the interim payments. Since the Company cannot reliably predict these adjustments, periodic changes in capitation amounts earned as a result of Risk Adjustment are recognized when those changes are communicated by the health plans to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Per member per month (&#x201c;PMPM&#x201d;) managed care contracts generally have a term of one year or longer. The Company assesses the profitability of its managed care contracts to identify contracts where current operating results or forecasts indicate probable future losses. If anticipated future variable costs exceed anticipated future revenues, a premium deficiency reserve is recognized. No premium deficiency reserves were recorded as of December&#160;31, 2023. All managed care contracts have a single performance obligation that constitutes a series for the provision of managed healthcare services for a population of enrolled members for the duration of the contract. The transaction price for PMPM contracts is variable as it primarily includes PMPM fees associated with unspecified membership that fluctuates throughout the contract. In certain contracts, PMPM fees also include adjustments for items such as performance incentives, performance guarantees, and risk sharing. The Company generally estimates the transaction price using the most likely amount methodology and amounts are only included in the net transaction price to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The majority of the Company&#x2019;s net PMPM transaction price relates specifically to the Company&#x2019;s efforts to transfer the service for a distinct increment of the series (e.g., day or month) and is recognized as revenue in the month in which members are entitled to service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;GPDC/ACO REACH Capitation Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS contracts with ACOs, which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC/ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, ACOs and providers. By entering into a contract with CMS, an ACO voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each ACO bears the economic costs, and reaps the economic rewards, of fulfilling its responsibilities and managing its risks as an ACO. APAACO has participated in ACO REACH, and its predecessor model, Global and Professional Direct Contracting Model (&#x201c;GPDC Model&#x201d;), since January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the ACO&#x2019;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#x2019;s performance. ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties. ACO REACH capitation revenue is recognized in the accompanying consolidated statements of income under capitation, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Pool Settlements and Incentives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain IPAs enter into hospital shared-risk capitation arrangements with certain health plans and local hospitals, where the hospital is responsible for providing, arranging and paying for institutional risk and the IPA is responsible for providing, arranging, and paying for professional risk. Under a hospital shared-risk pool-sharing agreement, the IPA generally receives a percentage of the net surplus from the affiliated hospital&#x2019;s risk pools with HMOs after deductions for the affiliated hospital&#x2019;s costs. Advance settlement payments are typically made quarterly in arrears if there is a surplus. The Company&#x2019;s risk pool settlements under arrangements with health plans and hospitals are recognized using the most likely amount methodology and amounts are only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The assumptions for historical margin, IBNR completion factors, and constraint percentages were used by management in applying the most likely amount methodology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitated arrangements with certain HMOs, certain IPAs participate in one or more health plan shared-risk arrangements relating to the provision of institutional services to enrollees and thus can earn additional revenue or incur losses based upon the enrollee utilization of institutional services. Health plan shared-risk arrangements are entered into with certain health plans, which are administered by the health plan, where the IPA is responsible for rendering professional services, but the health plan does not enter into a capitation arrangement with a hospital and therefore the health plan retains the institutional risk. Health plan shared-risk deficits, if any, are not payable until and unless (and only to the extent) risk-sharing surpluses are generated. At the termination of the HMO contract, any accumulated deficit will be extinguished.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's risk pool settlements under arrangements with HMOs are recognized, using the most likely methodology, and only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur. Given the lack of access to the health plans&#x2019; data and control over the members assigned to the IPA, the adjustments and/or the withheld amounts are unpredictable and as such, the IPA&#x2019;s risk-share revenues are deemed to be fully constrained until they are notified of the amount by the health plan. Final settlement of risk pools for prior contract years generally occur in the third or fourth quarter of the following year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to risk-sharing revenues, the Company also receives incentives under &#x201c;pay-for-performance&#x201d; programs for quality medical care, based on various criteria. As an incentive to promote quality care, certain HMOs have designed quality incentive programs and commercial generic pharmacy incentive programs to compensate the Company for its efforts to improve the quality of services and efficient and effective use of pharmacy supplemental benefits provided to HMO members. The incentive programs track specific performance measures and calculate payments to the Company based on the performance measures. The Company&#x2019;s incentives under &#x201c;pay-for-performance&#x201d; programs are recognized using the most likely methodology. However, as the Company does not have sufficient insight from the health plans on the amount and timing of the health plan shared-risk pool and incentive payments, these amounts are considered to be fully constrained and only recorded when such payments are known and/or received.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, for the foregoing arrangements, the final settlement is dependent on each distinct day&#x2019;s performance within the annual measurement period but cannot be allocated to specific days until the full measurement period has occurred and performance can be assessed. As such, this is a form of variable consideration estimated at contract inception and updated through the measurement period (i.e., the contract year), to the extent the risk of reversal does not exist and the consideration is not constrained.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;NGACO AIPBP Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the NGACO Model, CMS aligned beneficiaries to the Company to manage direct care and pay providers based on a budgetary benchmark established with CMS. The Company was responsible for managing medical costs for these beneficiaries. The beneficiaries received services from physicians and other medical service providers that were both in-network and out-of-network. The Company received capitation-like All Inclusive Population Based Payment (&#x201c;AIPBP&#x201d;) payments from CMS on a monthly basis to pay claims from in-network providers. The Company recorded such AIPBPs received from CMS as revenue as the Company was primarily responsible and liable for managing the patient care and for satisfying provider obligations, was assuming the credit risk for the services provided by in-network providers through its arrangement with CMS, and had control of the funds, the services provided and the process by which the providers were ultimately paid. Claims from out-of-network providers were processed and paid by CMS, while claims from APAACO&#x2019;s in-network contracted providers were paid by APAACO. The Company&#x2019;s shared savings or losses in managing the services provided by out-of-network providers were generally determined on an annual basis after reconciliation with CMS. Pursuant to the Company&#x2019;s risk share agreement with CMS, the Company was eligible to receive the savings or was liable for the deficit according to the budget established by CMS based on the Company&#x2019;s efficiency in managing how the beneficiaries aligned to the Company by CMS were served by in-network and out-of-network providers. The Company&#x2019;s savings or losses on providing such services were both capped by CMS, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and were subject to significant estimation risk, whereby payments would vary significantly depending upon certain patient characteristics and other variable factors. Accordingly, the Company recognized such surplus or deficit upon substantial completion of reconciliation and determination of the amounts. The Company recorded NGACO AIPBP revenues monthly. Excess AIPBPs over claims paid, plus an estimate for the related IBNR claims were deferred and recorded as a liability until actual claims were paid or incurred. CMS determined if there were any excess AIPBPs for the performance year and the excess was refunded to CMS. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each performance year, CMS paid the Company in accordance with the alternative payment mechanism, if any, for which CMS had approved the Company; the risk arrangement for which the Company has been approved by CMS, and was otherwise provided in an NGACO Participation Agreement between APAACO and CMS (the &#x201c;Participation Agreement&#x201d;). Following the end of each performance year and at such other times as would be required under the Participation Agreement, CMS would issue a settlement report to the Company setting forth the amount of any shared savings or shared losses and the amount of other monies. If CMS owed the Company shared savings or other monies, CMS would pay the Company in full within 30 days after the date on which the relevant settlement report was deemed final, except as provided in the Participation Agreement. If the Company owed CMS shared losses or other monies owed as a result of a final settlement, the Company would pay CMS in full within 30 days after the relevant settlement report was deemed final. If the Company failed to pay the amounts due to CMS in full within 30 days after the date of a demand letter or settlement report, CMS would assess simple interest on the unpaid balance at the rate applicable to other Medicare debts under current provisions of law and applicable regulations. In addition, CMS and the U.S. Department of the Treasury would use any applicable debt collection tools available to collect any amounts owed by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company participated in the AIPBP track of the NGACO Model. Under the AIPBP track, CMS estimated the total annual expenditures for APAACO&#x2019;s assigned patients and paid that projected amount to the Company in monthly installments, and the Company was responsible for all Part A and Part B costs for in-network participating providers and preferred providers contracted by the Company to provide services to the assigned patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As APAACO did not have sufficient insight into the financial performance of the shared risk pool with CMS because of unknown factors related to IBNR claims, risk adjustment factors, and stop-loss provisions, among other factors, an estimate couldn&#x2019;t be developed. Due to these limitations, APAACO could not determine the amount of surplus or deficit that would likely be recognized in the future and therefore this shared risk pool revenue was considered fully constrained. With the ending of the NGACO Model on December 31, 2021, the Company no longer received AIPBPs but remained eligible to recognize any shared savings or loss for performance year 2021 upon issuance of the settlement report from CMS. Pursuant to the Participation Agreement, the Company recognized $48.8 million related to savings from the 2021 performance year as revenue in risk pool settlements and incentives in the accompanying consolidated statements of income for the year ended December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Management Fee Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management fee income encompasses fees paid for management, physician advisory, healthcare staffing, administrative, and other non-medical services provided by the Company to IPAs, hospitals, and other healthcare providers. Such fees may be in the form of billings at agreed-upon hourly rates, percentages of gross revenue or fee collections, or amounts fixed on a monthly, quarterly, or annual basis. The revenue may include variable arrangements measuring factors, such as hours staffed, patient visits, or collections per visit, against benchmarks, and, in certain cases, may be subject to achieving quality metrics or fee collections. The Company recognizes such variable supplemental revenues in the period when such amounts are determined to be fixed and therefore contractually obligated as payable by the customer under the terms of the applicable agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides a significant service of integrating the services selected by the Company&#x2019;s clients into one overall output for which the client has contracted. Therefore, such management contracts generally contain a single performance obligation. The nature of the Company&#x2019;s performance obligation is to stand ready to provide services over the contractual period. Also, the Company&#x2019;s performance obligation forms a series of distinct periods of time over which the Company stands ready to perform. The Company&#x2019;s performance obligation is satisfied as the Company completes each period&#x2019;s obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration from management contracts is variable in nature because the majority of the fees are generally based on revenue or collections, which can vary from period to period. The Company has control over pricing. Contractual fees are invoiced to the Company&#x2019;s clients generally monthly and payment terms are typically due within 30 days. The variable consideration in the Company&#x2019;s management contracts meets the criteria to be allocated to the distinct period of time to which it relates because (i) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;it is due to the activities performed to satisfy the performance obligation during that period and (ii) it represents the consideration to which the Company expects to be entitled.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s management contracts generally have terms ranging from &lt;span style="-sec-ix-hidden:f-665"&gt;one&lt;/span&gt; to thirty years, although they may be terminated earlier under the terms of the applicable contracts. Since the remaining variable consideration will be allocated to a wholly unsatisfied promise that forms part of a single performance obligation recognized under the series guidance, the Company has applied the optional exemption to exclude disclosure of the allocation of the transaction price to remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fee-for-Service Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FFS revenue represents revenue earned under contracts in which the professional component of charges for medical services rendered by the Company&#x2019;s affiliated physician-owned medical groups are billed and collected from third-party payers, hospitals, and patients. FFS revenue related to patient care services is reported net of contractual allowances and policy discounts and is recognized in the period in which the services are rendered to specific patients. All services provided are expected to result in cash flows and are therefore reflected as net revenue in the consolidated financial statements. The recognition of net revenue (gross charges, less contractual allowances) from such services is dependent on such factors as proper completion of medical charts following a patient visit, the forwarding of such charts to the Company&#x2019;s billing center for medical coding and entering into the Company&#x2019;s billing system and the verification of each patient&#x2019;s submission or representation at the time services are rendered as to the payer(s) responsible for payment of such services. Revenue is recorded based on the information known at the time of entering such information into the Company&#x2019;s billing systems, as well as an estimate of the revenue associated with medical services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is responsible for confirming member eligibility, performing program utilization review, potentially directing payment to the provider and accepting the financial risk of loss associated with services rendered, as specified within the Company&#x2019;s client contracts. The Company has the ability to adjust contractual fees with clients and possesses the financial risk of loss in certain contractual obligations. These factors indicate the Company is the principal and, as such, the Company records gross fees contracted with clients in revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration from FFS arrangements is variable in nature because fees are based on patient encounters, credits due to clients, and reimbursement of provider costs, all of which can vary from period to period.&#160;Patient encounters and related episodes of care and procedures qualify as distinct goods and services, provided simultaneously together with other readily available resources, in a single instance of service, and thereby constitute a single performance obligation for each patient encounter and, in most instances, occur at readily determinable transaction prices. As a practical expedient, the Company adopted a portfolio approach for the FFS revenue stream to group together contracts with similar characteristics and analyze historical cash collection trends. The contracts within the portfolio share the characteristics conducive to ensuring that the results do not materially differ under the new standard if it were to be applied to individual patient contracts related to each patient encounter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimating net FFS revenue is a complex process, largely due to the volume of transactions, the number and complexity of contracts with payers, the limited availability at times of certain patient and payer information at the time services are provided, and the length of time it takes for collections to fully mature. These expected collections are based on fees and negotiated payment rates in the case of third-party payers, the specific benefits provided for under each patient&#x2019;s healthcare plans, mandated payment rates in the case of Medicare and Medicaid programs, and historical cash collections (net of recoveries) in combination with expected collections from third-party payers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The relationship between gross charges and the transaction price recognized is significantly influenced by payer mix, as collections on gross charges may vary significantly, depending on whether the patients, to whom services are provided, in the period are insured and the contractual relationships with those payers. Payer mix is subject to change as additional patient and payer information is obtained after the period services are provided. The Company periodically assesses the estimates of unbilled revenue, contractual adjustments and discounts, and payer mix by analyzing actual results, including cash collections, against estimates. Changes in these estimates are charged or credited to the consolidated statements of income in the period that the assessment is made. Significant changes in payer mix, contractual arrangements with payers, specialty mix, acuity, general economic conditions, and healthcare coverage provided by federal or state governments or private insurers may have a significant impact on estimates and significantly affect the results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues and receivables are recognized once the Company has satisfied its performance obligation. Accordingly, contract assets are comprised of receivables and receivables - related parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#211d1e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s billing and accounting systems provide historical trends of cash collections and contractual write-offs, accounts receivable aging, and established fee adjustments from third-party payers. These estimates are recorded and monitored monthly as revenues are recognized.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The principal exposure for uncollectible fees for service visits is from self-pay patients and, to a lesser extent, for co-payments and deductibles from patients with insurance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities (Deferred Revenue)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities are recorded when cash payments are received in advance of the Company&#x2019;s performance. As of December&#160;31, 2023, the Company&#x2019;s contract liability balance was $0.7 million. The Company&#x2019;s contract liability was $0.5&#160;million as of December&#160;31, 2022. Approximately $0.5 million of the Company&#x2019;s contract liability accrued in 2022 has been recognized as revenue during the year ended December&#160;31, 2023. Contract liability is presented within accounts payable and accrued expenses in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period of enactment. The Company records a valuation allowance to reduce deferred tax assets to an amount for which realization is more likely than not. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained upon examination by the tax authorities, based on the merits of the position. The Company&#x2019;s policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. To date, there have been no interest or penalties incurred in relation to the unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a stock-based compensation program for employees, non-employees, directors, and consultants. From time to time, the Company issues shares of its common stock to its employees, directors, and consultants, which shares may be subject to the Company&#x2019;s repurchase right (but not obligation), that vests based on time-based and/or performance-based vesting schedules. The value of share-based awards is recognized as compensation expense and adjusted for forfeitures as they occur. Compensation expenses for time-based awards are recognized on a cumulative straight-line basis over the vesting period of the awards. Share-based awards with performance conditions are recognized to the extent the performance conditions are probable of being achieved. Compensation expenses for performance-based awards are recognized on an accelerated attribution method. The grant date fair value of the restricted stock awards is the grant date&#x2019;s closing market price of the Company&#x2019;s common stock. The fair value of options granted is determined using the Black-Scholes option pricing model and includes several assumptions, including expected term, expected volatility, expected dividends, and risk-free rates. The expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. The expected stock price volatility is determined based on an average of historical volatility. The expected dividend yield is based on the Company&#x2019;s expected dividend payouts. The risk-free interest rate is based on the U.S. Constant Maturity curve over the expected term of the option at the time of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basic and Diluted Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income attributable to holders of the Company&#x2019;s common stock by the weighted-average number of shares of common stock outstanding during the periods presented. Diluted earnings per share is computed using the weighted-average number of shares of common stock outstanding, plus the effect of dilutive securities outstanding during the periods presented, using the treasury stock method. Refer to Note 17 &#x2014; &#x201c;Earnings Per Share&#x201d; for a discussion of shares treated as treasury shares for accounting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-controlling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consolidates entities in which the Company has a controlling financial interest. The Company consolidates subsidiaries in which the Company holds, directly or indirectly, more than 50% of the voting rights, and VIEs in which the Company is the primary beneficiary. Non-controlling interests represent third-party equity ownership interests (including equity ownership interests held by certain VIEs) in the Company&#x2019;s consolidated entities. Net income attributable to non-controlling interests is disclosed in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mezzanine Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to APC&#x2019;s shareholder agreements, in the event of a disqualifying event, as defined in the agreements, APC could be required to repurchase its shares from the respective shareholders based on certain triggers outlined in the shareholder agreements. As the redemption feature of the shares is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as mezzanine or temporary equity. Accordingly, the Company recognizes non-controlling interests in APC as mezzanine equity in the consolidated financial statements. As of December&#160;31, 2023 and 2022, APC&#x2019;s shares were not redeemable nor was it probable the shares would become redeemable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at its inception. The expected term of the lease used for computing the lease liability and right-of-use asset and determining the classification of the lease as operating or financing may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company elected practical expedients for ongoing accounting that is provided by the standard comprised of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The election for classes of underlying assets to not separate non-lease components from lease components, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The election for short-term lease recognition exemption for all leases under twelve-month terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The present value of the lease payments is calculated using a rate implicit in the lease, when readily determinable. However, as most of the Company&#x2019;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to determine the present value of the lease payments for the majority of its leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Beneficial Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, APC received a beneficial interest as a result of selling one of its equity method investments, pursuant to the terms of the stock purchase agreement. The estimated fair value of such interest in April 2020 was&#160;$15.7&#160;million. In 2021, the beneficial interest was determined to not be collectible and the $15.7&#160;million was written off and expensed in other income (expense) in the accompanying consolidated statements of income for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Standards Accounting Board (FASB) issued Accounting Standards Update (ASU) 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for the Company&#x2019;s annual periods beginning January 1, 2024, and for interim periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09 "Income Taxes (Topics 740): Improvements to Income Tax Disclosures" to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#x2019;s annual periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-596">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared by management in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-597">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated balance sheets as of December&#160;31, 2023 and 2022 and consolidated statements of income for the years ended December&#160;31, 2023, 2022 and 2021 include Astrana&#x2019;s wholly owned subsidiaries and consolidated variable interest entities (&#x201c;VIEs&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c-1" id="f-598">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts disclosed in prior period financial statements have been reclassified to conform to the current period presentation. These reclassifications were made between other assets and investments in privately held entities on the accompanying consolidated balance sheet as of December 31, 2022. The reclassification had no effect on net income, earnings per share, retained earnings, cash flows or total assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-599">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.&#160;Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combinations and goodwill valuation and impairment, accrual of medical liabilities (incurred but not reported (&#x201c;IBNR&#x201d;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including constraints, completion factors, and historical margins), income tax valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="c-1" id="f-600">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On an ongoing basis, as circumstances indicate the need for reconsideration, the Company evaluates each legal entity that is not wholly owned by the Company in accordance with the consolidation guidance. The evaluation considers all of the Company&#x2019;s variable interests, including equity ownership, as well as management services agreements. To fall within the scope of the consolidation guidance, an entity must meet both of the following criteria:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity has a legal structure that has been established to conduct business activities and to hold assets; such entity can be in the form of a partnership, limited liability company, or corporation, among others; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The Company has a variable interest in the legal entity; i.e., variable interests that are contractual, such as equity ownership, or other financial interests that change with changes in the fair value of the entity&#x2019;s net assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If an entity does not meet both criteria above, the Company applies other accounting guidance, such as the cost or equity method of accounting. If an entity does meet both criteria above, the Company evaluates such entity for consolidation under either the variable interest model if the legal entity meets any of the following characteristics to qualify as a VIE, or under the voting model for all other legal entities that are not VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A legal entity is determined to be a VIE if it has any of the following three characteristics:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity does not have sufficient equity to finance its activities without additional subordinated financial support;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The entity is established with non-substantive voting rights (i.e., where the entity deprives the majority economic interest holder(s) of voting rights); or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:54pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The equity holders, as a group, lack the characteristics of a controlling financial interest. Equity holders meet this criterion if they lack any of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The power, through voting rights or similar rights, to direct the activities of the entity that most significantly influence the entity&#x2019;s economic performance, as evidenced by:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Substantive participating rights in day-to-day management of the entity&#x2019;s activities; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:135pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt"&gt;Substantive kick-out rights over the party responsible for significant decisions;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The obligation to absorb the entity&#x2019;s expected losses; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:90pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The right to receive the entity&#x2019;s expected residual returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company determines that any of the three characteristics of a VIE are met, the Company will conclude that the entity is a VIE and evaluate it for consolidation under the variable interest model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable interest model&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company consolidates a VIE if both power and benefits belong to the Company &#x2013; that is, the Company has:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The power to direct the activities of a VIE that most significantly influence the VIE&#x2019;s economic performance (power), and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE (economics).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consolidates VIEs whenever it is determined that the Company is the primary beneficiary. Refer to Note 18 &#x2013; &#x201c;Variable Interest Entities (VIEs)&#x201d; to the consolidated financial statements for information on the Company&#x2019;s consolidated VIEs. If there are variable interests in a VIE but the Company is not the primary beneficiary, the Company may account for the investment using the equity method of accounting, refer to Note 6 &#x2013; &#x201c;Investments in Other Entities&#x201d; for entities that qualify as VIEs but the Company is not the primary beneficiary.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:BusinessCombinationsPolicy contextRef="c-1" id="f-601">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-602">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reportable Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as three reportable segments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Partners;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Delivery; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Enablement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; and Note 20 &#x2014; &#x201c;Segments&#x201d; to the consolidated financial statements for information on the Company&#x2019;s segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-603"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-604"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-605">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;The Company maintains its cash in deposit accounts with several banks, which at times may&#160;exceed the insured limits of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company believes it is not exposed to any significant credit risk with respect to its cash, cash equivalents, and restricted cash.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashUninsuredAmount contextRef="c-4" decimals="-5" id="f-606" unitRef="usd">318900000</us-gaap:CashUninsuredAmount>
    <us-gaap:CashUninsuredAmount contextRef="c-5" decimals="-5" id="f-607" unitRef="usd">324700000</us-gaap:CashUninsuredAmount>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-608">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;Restricted cash consists of cash held as collateral in the event of default as required by certain health plan contracts</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c-1" id="f-609">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in marketable securities consist of equity securities and certificates of deposit with various financial institutions. The appropriate classification of investments is determined at the time of purchase and such designation is reevaluated at each balance sheet date. Certificates of deposit in investments in marketable securities are reported at par value, plus accrued interest, with maturity dates greater than ninety days. Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted. Equity securities with low trading volume are determined to not have an active market with buyers and sellers ready to trade. Accordingly, the Company classifies such equity securities as Level 2 in the valuation hierarchy, and their valuation is based on weighted-average share prices from observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, certificates of deposit amounted to approximately $2.2 million and $0, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <asth:MarketableSecuritiesCurrentMaturityPeriod contextRef="c-72" id="f-610">P90D</asth:MarketableSecuritiesCurrentMaturityPeriod>
    <asth:ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock contextRef="c-1" id="f-611">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables, Receivables &#x2013; Related Parties, Other Receivables, Loan Receivable, and Loan Receivable - Related Party&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables are comprised of accounts receivable, capitation and claims receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivables are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables &#x2013; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#x2013; related parties are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s loan receivable and loan receivable - related party consists of promissory notes that accrue interest per annum. As of December&#160;31, 2023, promissory notes are expected to be collected by their maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitation receivables relate to each health plan&#x2019;s capitation and are received by the Company in the month following the month of service. Risk pool settlements and incentive receivables mainly consist of the Company&#x2019;s hospital shared-risk pool receivable that is recorded quarterly based on reports received from the Company&#x2019;s hospital partners and management&#x2019;s estimate of the Company&#x2019;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately 18 months after the risk pool performance year is completed. Other receivables consist of receivables from fee-for-services (&#x201c;FFS&#x201d;) reimbursement for patient care, certain expense reimbursements, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains reserves for potential credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts, customer concentrations, customer credit worthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected and adjustments are recorded when necessary. Reserves are recorded primarily on a specific identification basis.&lt;/span&gt;&lt;/div&gt;Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided and collection is reasonably likely to occur. In regard to the credit loss standard, the Company continuously monitors its collections of receivables, and the Company&#x2019;s expectation is that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#x201c;CECL&#x201d;) model.</asth:ReceivablesAndRelatedPartiesReceivablesPolicyTextBlockPolicyTextBlock>
    <asth:RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear contextRef="c-1" id="f-612">P18M</asth:RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-613">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risks&lt;/span&gt;&lt;/div&gt;The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-614">The following table presents disaggregated revenue generated by each payer type (in thousands):&lt;div style="margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.144%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.528%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.528%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,322&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633,463&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,286&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,093&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,083&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,311&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,198&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,894&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,985&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,144,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-73" decimals="-3" id="f-615" unitRef="usd">167048000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-74" decimals="-3" id="f-616" unitRef="usd">171723000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-75" decimals="-3" id="f-617" unitRef="usd">138333000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-76" decimals="-3" id="f-618" unitRef="usd">901322000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-77" decimals="-3" id="f-619" unitRef="usd">633463000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-78" decimals="-3" id="f-620" unitRef="usd">307286000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-79" decimals="-3" id="f-621" unitRef="usd">266093000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-80" decimals="-3" id="f-622" unitRef="usd">280083000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-81" decimals="-3" id="f-623" unitRef="usd">283311000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-82" decimals="-3" id="f-624" unitRef="usd">52198000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-83" decimals="-3" id="f-625" unitRef="usd">58894000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-84" decimals="-3" id="f-626" unitRef="usd">44985000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-627" unitRef="usd">1386661000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-31" decimals="-3" id="f-628" unitRef="usd">1144163000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-32" decimals="-3" id="f-629" unitRef="usd">773915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock contextRef="c-1" id="f-630">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Less than 10% of total net revenues&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had major payers that contributed to the following percentages of net receivables and receivables - related parties:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.826%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payer E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-85" decimals="3" id="f-631" unitRef="number">0.153</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-86" decimals="3" id="f-632" unitRef="number">0.388</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-87" decimals="3" id="f-633" unitRef="number">0.342</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-88" decimals="3" id="f-634" unitRef="number">0.119</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-89" decimals="3" id="f-635" unitRef="number">0.101</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-90" decimals="3" id="f-636" unitRef="number">0.125</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-91" decimals="3" id="f-637" unitRef="number">0.360</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-92" decimals="3" id="f-638" unitRef="number">0.260</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-93" decimals="3" id="f-639" unitRef="number">0.410</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-94" decimals="3" id="f-640" unitRef="number">0.520</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-641">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Land, Property, and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land is carried at cost and is not depreciated as it is considered to have an indefinite useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, including leasehold improvements, are carried at cost less accumulated depreciation and amortization. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets ranging from &lt;span style="-sec-ix-hidden:f-642"&gt;three&lt;/span&gt; to thirty-nine years. Leasehold improvements are amortized on a straight-line basis over the shorter of the terms of the respective leases or the expected useful lives of those improvements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maintenance and repairs are charged to expense as incurred. Upon sale or retirement, the asset cost and related accumulated depreciation and amortization are removed from the accounts, and any related gain or loss is included in the determination of consolidated net income.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-96" id="f-643">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-644">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments consist of cash and cash equivalents, fiduciary cash, investment in marketable securities, receivables, loans receivable, accounts payable, certain accrued expenses, finance lease obligations, long-term debt, and certain other liabilities. The carrying values of the financial instruments classified as current in the accompanying consolidated balance sheets are considered to be at their fair values, due to the short maturity of these instruments. The carrying amounts of finance lease obligations and long-term debt approximate fair value as they bear interest at rates that approximate current market rates for debt with similar maturities and credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 820&#x201d;), applies to all financial assets and financial liabilities that are measured and reported on a fair value basis and requires disclosure that establishes a framework for measuring fair value and expands disclosure about fair value measurements. ASC&#160;820 establishes a fair value hierarchy for disclosure of the inputs to valuations used to measure fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This hierarchy prioritizes the inputs into three broad levels as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that can be accessed at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates and yield curves), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014;Unobservable inputs that reflect assumptions about what market participants would use in pricing the asset or liability. These inputs would be based on the best information available, including the Company&#x2019;s own data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no changes in Level 1, Level 2, or Level 3 classification and no changes in valuation techniques for these assets and liabilities for the years ended December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-645">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives include network-payer relationships, management contracts, member relationships, subscriber relationships, and developed technology and are stated at cost, less accumulated amortization, and impairment losses. These intangible assets are amortized using the accelerated method based on the discounted cash flow rate or using the straight-line method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite lives also include a patient management platform, as well as trade names and trademarks, whose valuations were determined using the cost to recreate method and the relief from royalty method, respectively. These assets are stated at cost, less accumulated amortization, and impairment losses, and are amortized using the straight-line method.&lt;/span&gt;&lt;/div&gt;Finite-lived intangibles and other long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may&#160;not be recoverable. If the expected future cash flows from the use of such assets (undiscounted and without interest charges) are less than the carrying value, a write-down would be recorded to reduce the carrying value of the asset to its estimated fair value. Fair value is determined based on appropriate valuation techniques.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c-1" id="f-646">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Indefinite-Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under ASC 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles &#x2013; Goodwill and Other,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; goodwill and indefinite-lived intangible assets are reviewed at least annually for impairment under a two step process. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Step 1&#x2014;  Under a qualitative assessment, determine if there are indicators of impairment. If so, proceed to Step 2. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Step 2 &#x2014; Under a quantitative assessment, if the fair value of each reporting unit is less than its carrying value, there is an impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may also elect to skip the qualitative testing and proceed directly to quantitative testing. The Company&#x2019;s four reporting units consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Partners &#x2013; IPA;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Partners &#x2013; ACO;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Delivery; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Care Enablement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An impairment loss is recognized if the carrying value of a reporting unit exceeds its fair value. If this event arises, the impairment loss recorded is equal to the excess of the carrying value of the reporting unit over its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At least annually, indefinite-lived intangible assets are tested for impairment. Impairment for intangible assets with indefinite lives exists if the carrying value of the intangible asset exceeds its fair value. The fair values of indefinite-lived intangible assets are determined using valuation techniques based on estimates, judgments, and assumptions management believes are appropriate in the circumstances.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportingUnits contextRef="c-1" decimals="INF" id="f-647" unitRef="unit">4</us-gaap:NumberOfReportingUnits>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-32" decimals="INF" id="f-648" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="INF" id="f-649" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-31" decimals="INF" id="f-650" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-1" decimals="INF" id="f-651" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-31" decimals="INF" id="f-652" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-32" decimals="INF" id="f-653" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy contextRef="c-1" id="f-654">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Other Entities &#x2013; Equity Method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for certain investments using the equity method of accounting when it is determined that the investment provides the Company with the ability to exercise significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company has an ownership interest in the voting stock of the investee of between 20% and 50%, although other factors, such as representation on the investee&#x2019;s board of directors, are considered in determining whether the equity method of accounting is appropriate. Under the equity method of accounting, the investment, originally recorded at cost, is adjusted to recognize the Company&#x2019;s share of net earnings or losses of the investee and is recognized in the accompanying consolidated statements of income under &#x201c;Income (loss) from equity method investments&#x201d; and also is adjusted by contributions to and distributions from the investee. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Privately Held Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for certain investments using the cost method of accounting when it is determined that the investment provides the Company with little or no influence over the investee. Under the cost method of accounting, the investment is measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. The investments in privately held entities that do not report net asset value are subject to qualitative assessment for indicators of impairments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:HealthCareCostsPolicyPolicyTextBlock contextRef="c-1" id="f-655">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medical Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Care Partners segment is responsible for integrated care that the associated physicians and contracted hospitals provide to their enrollees. The Company&#x2019;s Care Partners segment provides integrated care to HMOs, Medicare, and Medi-Cal enrollees through a network of contracted providers under sub-capitation and direct patient service arrangements. Medical costs for professional and institutional services rendered by contracted providers are recorded as cost of services, excluding depreciation and amortization, in the accompanying consolidated statements of income.&lt;/span&gt;&lt;/div&gt;An estimate of amounts due to contracted physicians, hospitals, and other professional providers is included in medical liabilities in the accompanying consolidated balance sheets. Medical liabilities include claims reported as of the balance sheet date and estimated IBNR claims. Such estimates are developed using actuarial methods and are based on numerous variables, including the utilization of healthcare services, historical payment patterns, cost trends, product mix, seasonality, changes in membership, and other factors. The estimation methods and the resulting reserves are periodically reviewed and updated. Many of the medical contracts are complex in nature and may&#160;be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations may&#160;not come to light until a substantial period of time has passed following the contract implementation.</us-gaap:HealthCareCostsPolicyPolicyTextBlock>
    <asth:FiduciaryCashAndPayablePolicyTextBlock contextRef="c-1" id="f-656">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiduciary Cash and Payable&lt;/span&gt;&lt;/div&gt;The Company&#x2019;s Care Partner segment collects cash from health plans on behalf of their sub-IPAs and providers and passes the money through to them.</asth:FiduciaryCashAndPayablePolicyTextBlock>
    <asth:FiduciaryAccountsPayableCurrent contextRef="c-4" decimals="-5" id="f-657" unitRef="usd">7700000</asth:FiduciaryAccountsPayableCurrent>
    <asth:FiduciaryAccountsPayableCurrent contextRef="c-5" decimals="-5" id="f-658" unitRef="usd">8100000</asth:FiduciaryAccountsPayableCurrent>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-659">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company receives payments from the following sources for services rendered: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Commercial insurers;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Federal government under the Medicare program administered by CMS;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;State governments under Medicaid and other programs;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Other third-party payers (e.g., hospitals and IPAs); and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Individual patients and clients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue primarily consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Capitation revenue;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Risk pool settlements and incentives;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;GPDC/ACO REACH capitation revenue;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management fee income; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;FFS revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Nature of Services and Revenue Streams&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue primarily consists of capitation revenue, risk pool settlements and incentives, GPDC/ACO REACH capitation revenue, management fee income, and FFS revenue. Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related risk of collection for such services may&#160;vary by type of revenue and the customer. The following is a summary of the principal forms of the Company&#x2019;s billing arrangements and how revenue is recognized for each.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Capitation, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Managed care revenues of the Company consist primarily of capitated fees for medical services provided by the Company under a capitated arrangement directly made with various managed care providers, including HMOs. Capitation revenue is &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;typically prepaid monthly to the Company based on the number of enrollees selecting the Company as their healthcare provider. Capitation revenue is recognized in the month in which the Company is obligated to provide services to plan enrollees under contracts with various health plans. Minor ongoing adjustments to prior months&#x2019; capitation, primarily arising from contracted HMOs finalizing their monthly patient eligibility data for additions or subtractions of enrollees, are recognized in the month they are communicated to the Company. Additionally, Medicare pays capitation using a &#x201c;Risk Adjustment&#x201d; model, which compensates managed care organizations and providers based on the health status (acuity) of each individual enrollee. Health plans and providers with higher acuity enrollees will receive more and those with lower acuity enrollees will receive less. Under Risk Adjustment, capitation is determined based on health severity, measured using patient encounter data. Capitation is paid on a monthly basis based on data submitted for the enrollee for the preceding year and is adjusted in subsequent periods after the final data is compiled. Positive or negative capitation adjustments are made for Medicare enrollees with conditions requiring more or fewer healthcare services than assumed in the interim payments. Since the Company cannot reliably predict these adjustments, periodic changes in capitation amounts earned as a result of Risk Adjustment are recognized when those changes are communicated by the health plans to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Per member per month (&#x201c;PMPM&#x201d;) managed care contracts generally have a term of one year or longer. The Company assesses the profitability of its managed care contracts to identify contracts where current operating results or forecasts indicate probable future losses. If anticipated future variable costs exceed anticipated future revenues, a premium deficiency reserve is recognized. No premium deficiency reserves were recorded as of December&#160;31, 2023. All managed care contracts have a single performance obligation that constitutes a series for the provision of managed healthcare services for a population of enrolled members for the duration of the contract. The transaction price for PMPM contracts is variable as it primarily includes PMPM fees associated with unspecified membership that fluctuates throughout the contract. In certain contracts, PMPM fees also include adjustments for items such as performance incentives, performance guarantees, and risk sharing. The Company generally estimates the transaction price using the most likely amount methodology and amounts are only included in the net transaction price to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The majority of the Company&#x2019;s net PMPM transaction price relates specifically to the Company&#x2019;s efforts to transfer the service for a distinct increment of the series (e.g., day or month) and is recognized as revenue in the month in which members are entitled to service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;GPDC/ACO REACH Capitation Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS contracts with ACOs, which are composed of healthcare providers operating under a common legal structure and accept financial accountability for the overall quality and cost of medical care furnished to Medicare FFS beneficiaries aligned to the entity. The combination of the FFS model and the GPDC/ACO REACH model changes the distribution of responsibilities, risks, costs, and rewards among CMS, ACOs and providers. By entering into a contract with CMS, an ACO voluntarily takes on operational, financial, and legal responsibilities and risks that no party has, individually or collectively, under the existing FFS model. Each ACO bears the economic costs, and reaps the economic rewards, of fulfilling its responsibilities and managing its risks as an ACO. APAACO has participated in ACO REACH, and its predecessor model, Global and Professional Direct Contracting Model (&#x201c;GPDC Model&#x201d;), since January 1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each performance year, CMS will pay a total benchmark amount, determined unilaterally by CMS in advance but subject to prospective adjustments throughout the year, for the totality of care provided to the ACO&#x2019;s population of aligned beneficiaries over the course of that year. The benchmark is net of a quality withholding applied by CMS. At the end of each performance year, a portion, or all, of the quality withholding can be earned based on APAACO&#x2019;s performance. ACO REACH capitation revenue is recognized based on the estimated transaction price to transfer the service for a distinct increment of the series (i.e., month) and is recognized net of quality incentives/penalties. ACO REACH capitation revenue is recognized in the accompanying consolidated statements of income under capitation, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Pool Settlements and Incentives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain IPAs enter into hospital shared-risk capitation arrangements with certain health plans and local hospitals, where the hospital is responsible for providing, arranging and paying for institutional risk and the IPA is responsible for providing, arranging, and paying for professional risk. Under a hospital shared-risk pool-sharing agreement, the IPA generally receives a percentage of the net surplus from the affiliated hospital&#x2019;s risk pools with HMOs after deductions for the affiliated hospital&#x2019;s costs. Advance settlement payments are typically made quarterly in arrears if there is a surplus. The Company&#x2019;s risk pool settlements under arrangements with health plans and hospitals are recognized using the most likely amount methodology and amounts are only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur once any uncertainty is resolved. The assumptions for historical margin, IBNR completion factors, and constraint percentages were used by management in applying the most likely amount methodology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitated arrangements with certain HMOs, certain IPAs participate in one or more health plan shared-risk arrangements relating to the provision of institutional services to enrollees and thus can earn additional revenue or incur losses based upon the enrollee utilization of institutional services. Health plan shared-risk arrangements are entered into with certain health plans, which are administered by the health plan, where the IPA is responsible for rendering professional services, but the health plan does not enter into a capitation arrangement with a hospital and therefore the health plan retains the institutional risk. Health plan shared-risk deficits, if any, are not payable until and unless (and only to the extent) risk-sharing surpluses are generated. At the termination of the HMO contract, any accumulated deficit will be extinguished.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's risk pool settlements under arrangements with HMOs are recognized, using the most likely methodology, and only included in revenue to the extent that it is probable that a significant reversal of cumulative revenue will not occur. Given the lack of access to the health plans&#x2019; data and control over the members assigned to the IPA, the adjustments and/or the withheld amounts are unpredictable and as such, the IPA&#x2019;s risk-share revenues are deemed to be fully constrained until they are notified of the amount by the health plan. Final settlement of risk pools for prior contract years generally occur in the third or fourth quarter of the following year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to risk-sharing revenues, the Company also receives incentives under &#x201c;pay-for-performance&#x201d; programs for quality medical care, based on various criteria. As an incentive to promote quality care, certain HMOs have designed quality incentive programs and commercial generic pharmacy incentive programs to compensate the Company for its efforts to improve the quality of services and efficient and effective use of pharmacy supplemental benefits provided to HMO members. The incentive programs track specific performance measures and calculate payments to the Company based on the performance measures. The Company&#x2019;s incentives under &#x201c;pay-for-performance&#x201d; programs are recognized using the most likely methodology. However, as the Company does not have sufficient insight from the health plans on the amount and timing of the health plan shared-risk pool and incentive payments, these amounts are considered to be fully constrained and only recorded when such payments are known and/or received.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, for the foregoing arrangements, the final settlement is dependent on each distinct day&#x2019;s performance within the annual measurement period but cannot be allocated to specific days until the full measurement period has occurred and performance can be assessed. As such, this is a form of variable consideration estimated at contract inception and updated through the measurement period (i.e., the contract year), to the extent the risk of reversal does not exist and the consideration is not constrained.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;NGACO AIPBP Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the NGACO Model, CMS aligned beneficiaries to the Company to manage direct care and pay providers based on a budgetary benchmark established with CMS. The Company was responsible for managing medical costs for these beneficiaries. The beneficiaries received services from physicians and other medical service providers that were both in-network and out-of-network. The Company received capitation-like All Inclusive Population Based Payment (&#x201c;AIPBP&#x201d;) payments from CMS on a monthly basis to pay claims from in-network providers. The Company recorded such AIPBPs received from CMS as revenue as the Company was primarily responsible and liable for managing the patient care and for satisfying provider obligations, was assuming the credit risk for the services provided by in-network providers through its arrangement with CMS, and had control of the funds, the services provided and the process by which the providers were ultimately paid. Claims from out-of-network providers were processed and paid by CMS, while claims from APAACO&#x2019;s in-network contracted providers were paid by APAACO. The Company&#x2019;s shared savings or losses in managing the services provided by out-of-network providers were generally determined on an annual basis after reconciliation with CMS. Pursuant to the Company&#x2019;s risk share agreement with CMS, the Company was eligible to receive the savings or was liable for the deficit according to the budget established by CMS based on the Company&#x2019;s efficiency in managing how the beneficiaries aligned to the Company by CMS were served by in-network and out-of-network providers. The Company&#x2019;s savings or losses on providing such services were both capped by CMS, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and were subject to significant estimation risk, whereby payments would vary significantly depending upon certain patient characteristics and other variable factors. Accordingly, the Company recognized such surplus or deficit upon substantial completion of reconciliation and determination of the amounts. The Company recorded NGACO AIPBP revenues monthly. Excess AIPBPs over claims paid, plus an estimate for the related IBNR claims were deferred and recorded as a liability until actual claims were paid or incurred. CMS determined if there were any excess AIPBPs for the performance year and the excess was refunded to CMS. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each performance year, CMS paid the Company in accordance with the alternative payment mechanism, if any, for which CMS had approved the Company; the risk arrangement for which the Company has been approved by CMS, and was otherwise provided in an NGACO Participation Agreement between APAACO and CMS (the &#x201c;Participation Agreement&#x201d;). Following the end of each performance year and at such other times as would be required under the Participation Agreement, CMS would issue a settlement report to the Company setting forth the amount of any shared savings or shared losses and the amount of other monies. If CMS owed the Company shared savings or other monies, CMS would pay the Company in full within 30 days after the date on which the relevant settlement report was deemed final, except as provided in the Participation Agreement. If the Company owed CMS shared losses or other monies owed as a result of a final settlement, the Company would pay CMS in full within 30 days after the relevant settlement report was deemed final. If the Company failed to pay the amounts due to CMS in full within 30 days after the date of a demand letter or settlement report, CMS would assess simple interest on the unpaid balance at the rate applicable to other Medicare debts under current provisions of law and applicable regulations. In addition, CMS and the U.S. Department of the Treasury would use any applicable debt collection tools available to collect any amounts owed by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company participated in the AIPBP track of the NGACO Model. Under the AIPBP track, CMS estimated the total annual expenditures for APAACO&#x2019;s assigned patients and paid that projected amount to the Company in monthly installments, and the Company was responsible for all Part A and Part B costs for in-network participating providers and preferred providers contracted by the Company to provide services to the assigned patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As APAACO did not have sufficient insight into the financial performance of the shared risk pool with CMS because of unknown factors related to IBNR claims, risk adjustment factors, and stop-loss provisions, among other factors, an estimate couldn&#x2019;t be developed. Due to these limitations, APAACO could not determine the amount of surplus or deficit that would likely be recognized in the future and therefore this shared risk pool revenue was considered fully constrained. With the ending of the NGACO Model on December 31, 2021, the Company no longer received AIPBPs but remained eligible to recognize any shared savings or loss for performance year 2021 upon issuance of the settlement report from CMS. Pursuant to the Participation Agreement, the Company recognized $48.8 million related to savings from the 2021 performance year as revenue in risk pool settlements and incentives in the accompanying consolidated statements of income for the year ended December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Management Fee Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management fee income encompasses fees paid for management, physician advisory, healthcare staffing, administrative, and other non-medical services provided by the Company to IPAs, hospitals, and other healthcare providers. Such fees may be in the form of billings at agreed-upon hourly rates, percentages of gross revenue or fee collections, or amounts fixed on a monthly, quarterly, or annual basis. The revenue may include variable arrangements measuring factors, such as hours staffed, patient visits, or collections per visit, against benchmarks, and, in certain cases, may be subject to achieving quality metrics or fee collections. The Company recognizes such variable supplemental revenues in the period when such amounts are determined to be fixed and therefore contractually obligated as payable by the customer under the terms of the applicable agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides a significant service of integrating the services selected by the Company&#x2019;s clients into one overall output for which the client has contracted. Therefore, such management contracts generally contain a single performance obligation. The nature of the Company&#x2019;s performance obligation is to stand ready to provide services over the contractual period. Also, the Company&#x2019;s performance obligation forms a series of distinct periods of time over which the Company stands ready to perform. The Company&#x2019;s performance obligation is satisfied as the Company completes each period&#x2019;s obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration from management contracts is variable in nature because the majority of the fees are generally based on revenue or collections, which can vary from period to period. The Company has control over pricing. Contractual fees are invoiced to the Company&#x2019;s clients generally monthly and payment terms are typically due within 30 days. The variable consideration in the Company&#x2019;s management contracts meets the criteria to be allocated to the distinct period of time to which it relates because (i) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;it is due to the activities performed to satisfy the performance obligation during that period and (ii) it represents the consideration to which the Company expects to be entitled.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s management contracts generally have terms ranging from &lt;span style="-sec-ix-hidden:f-665"&gt;one&lt;/span&gt; to thirty years, although they may be terminated earlier under the terms of the applicable contracts. Since the remaining variable consideration will be allocated to a wholly unsatisfied promise that forms part of a single performance obligation recognized under the series guidance, the Company has applied the optional exemption to exclude disclosure of the allocation of the transaction price to remaining performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fee-for-Service Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FFS revenue represents revenue earned under contracts in which the professional component of charges for medical services rendered by the Company&#x2019;s affiliated physician-owned medical groups are billed and collected from third-party payers, hospitals, and patients. FFS revenue related to patient care services is reported net of contractual allowances and policy discounts and is recognized in the period in which the services are rendered to specific patients. All services provided are expected to result in cash flows and are therefore reflected as net revenue in the consolidated financial statements. The recognition of net revenue (gross charges, less contractual allowances) from such services is dependent on such factors as proper completion of medical charts following a patient visit, the forwarding of such charts to the Company&#x2019;s billing center for medical coding and entering into the Company&#x2019;s billing system and the verification of each patient&#x2019;s submission or representation at the time services are rendered as to the payer(s) responsible for payment of such services. Revenue is recorded based on the information known at the time of entering such information into the Company&#x2019;s billing systems, as well as an estimate of the revenue associated with medical services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is responsible for confirming member eligibility, performing program utilization review, potentially directing payment to the provider and accepting the financial risk of loss associated with services rendered, as specified within the Company&#x2019;s client contracts. The Company has the ability to adjust contractual fees with clients and possesses the financial risk of loss in certain contractual obligations. These factors indicate the Company is the principal and, as such, the Company records gross fees contracted with clients in revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consideration from FFS arrangements is variable in nature because fees are based on patient encounters, credits due to clients, and reimbursement of provider costs, all of which can vary from period to period.&#160;Patient encounters and related episodes of care and procedures qualify as distinct goods and services, provided simultaneously together with other readily available resources, in a single instance of service, and thereby constitute a single performance obligation for each patient encounter and, in most instances, occur at readily determinable transaction prices. As a practical expedient, the Company adopted a portfolio approach for the FFS revenue stream to group together contracts with similar characteristics and analyze historical cash collection trends. The contracts within the portfolio share the characteristics conducive to ensuring that the results do not materially differ under the new standard if it were to be applied to individual patient contracts related to each patient encounter. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimating net FFS revenue is a complex process, largely due to the volume of transactions, the number and complexity of contracts with payers, the limited availability at times of certain patient and payer information at the time services are provided, and the length of time it takes for collections to fully mature. These expected collections are based on fees and negotiated payment rates in the case of third-party payers, the specific benefits provided for under each patient&#x2019;s healthcare plans, mandated payment rates in the case of Medicare and Medicaid programs, and historical cash collections (net of recoveries) in combination with expected collections from third-party payers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The relationship between gross charges and the transaction price recognized is significantly influenced by payer mix, as collections on gross charges may vary significantly, depending on whether the patients, to whom services are provided, in the period are insured and the contractual relationships with those payers. Payer mix is subject to change as additional patient and payer information is obtained after the period services are provided. The Company periodically assesses the estimates of unbilled revenue, contractual adjustments and discounts, and payer mix by analyzing actual results, including cash collections, against estimates. Changes in these estimates are charged or credited to the consolidated statements of income in the period that the assessment is made. Significant changes in payer mix, contractual arrangements with payers, specialty mix, acuity, general economic conditions, and healthcare coverage provided by federal or state governments or private insurers may have a significant impact on estimates and significantly affect the results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues and receivables are recognized once the Company has satisfied its performance obligation. Accordingly, contract assets are comprised of receivables and receivables - related parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#211d1e;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s billing and accounting systems provide historical trends of cash collections and contractual write-offs, accounts receivable aging, and established fee adjustments from third-party payers. These estimates are recorded and monitored monthly as revenues are recognized.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The principal exposure for uncollectible fees for service visits is from self-pay patients and, to a lesser extent, for co-payments and deductibles from patients with insurance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities (Deferred Revenue)&lt;/span&gt;&lt;/div&gt;Contract liabilities are recorded when cash payments are received in advance of the Company&#x2019;s performance.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming contextRef="c-97" id="f-660">one year</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <asth:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport contextRef="c-98" id="f-661">P30D</asth:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport>
    <asth:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport contextRef="c-98" id="f-662">P30D</asth:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport>
    <asth:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport contextRef="c-98" id="f-663">P30D</asth:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriodOfPaymentUponFinalizationOfSettlementReport>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-99" decimals="-5" id="f-664" unitRef="usd">48800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <asth:RevenuePaymentTerms contextRef="c-101" id="f-666">P30Y</asth:RevenuePaymentTerms>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-5" id="f-667" unitRef="usd">700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-5" id="f-668" unitRef="usd">500000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-102" decimals="-5" id="f-669" unitRef="usd">500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-670">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period of enactment. The Company records a valuation allowance to reduce deferred tax assets to an amount for which realization is more likely than not. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained upon examination by the tax authorities, based on the merits of the position. The Company&#x2019;s policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. To date, there have been no interest or penalties incurred in relation to the unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-671">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a stock-based compensation program for employees, non-employees, directors, and consultants. From time to time, the Company issues shares of its common stock to its employees, directors, and consultants, which shares may be subject to the Company&#x2019;s repurchase right (but not obligation), that vests based on time-based and/or performance-based vesting schedules. The value of share-based awards is recognized as compensation expense and adjusted for forfeitures as they occur. Compensation expenses for time-based awards are recognized on a cumulative straight-line basis over the vesting period of the awards. Share-based awards with performance conditions are recognized to the extent the performance conditions are probable of being achieved. Compensation expenses for performance-based awards are recognized on an accelerated attribution method. The grant date fair value of the restricted stock awards is the grant date&#x2019;s closing market price of the Company&#x2019;s common stock. The fair value of options granted is determined using the Black-Scholes option pricing model and includes several assumptions, including expected term, expected volatility, expected dividends, and risk-free rates. The expected term is presumed to be the midpoint between the vesting date and the end of the contractual term. The expected stock price volatility is determined based on an average of historical volatility. The expected dividend yield is based on the Company&#x2019;s expected dividend payouts. The risk-free interest rate is based on the U.S. Constant Maturity curve over the expected term of the option at the time of grant.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-672">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basic and Diluted Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income attributable to holders of the Company&#x2019;s common stock by the weighted-average number of shares of common stock outstanding during the periods presented. Diluted earnings per share is computed using the weighted-average number of shares of common stock outstanding, plus the effect of dilutive securities outstanding during the periods presented, using the treasury stock method. Refer to Note 17 &#x2014; &#x201c;Earnings Per Share&#x201d; for a discussion of shares treated as treasury shares for accounting purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <asth:MinorityInterestPolicyPolicyTextBlock contextRef="c-1" id="f-673">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-controlling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consolidates entities in which the Company has a controlling financial interest. The Company consolidates subsidiaries in which the Company holds, directly or indirectly, more than 50% of the voting rights, and VIEs in which the Company is the primary beneficiary. Non-controlling interests represent third-party equity ownership interests (including equity ownership interests held by certain VIEs) in the Company&#x2019;s consolidated entities. Net income attributable to non-controlling interests is disclosed in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;</asth:MinorityInterestPolicyPolicyTextBlock>
    <us-gaap:VariableInterestEntityOwnershipPercentage contextRef="c-1" decimals="2" id="f-674" unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <asth:TemporaryEquityPolicyPolicyTextBlock contextRef="c-1" id="f-675">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mezzanine Equity&lt;/span&gt;&lt;/div&gt;Pursuant to APC&#x2019;s shareholder agreements, in the event of a disqualifying event, as defined in the agreements, APC could be required to repurchase its shares from the respective shareholders based on certain triggers outlined in the shareholder agreements. As the redemption feature of the shares is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as mezzanine or temporary equity. Accordingly, the Company recognizes non-controlling interests in APC as mezzanine equity in the consolidated financial statements.</asth:TemporaryEquityPolicyPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-676">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease at its inception. The expected term of the lease used for computing the lease liability and right-of-use asset and determining the classification of the lease as operating or financing may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The Company elected practical expedients for ongoing accounting that is provided by the standard comprised of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The election for classes of underlying assets to not separate non-lease components from lease components, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The election for short-term lease recognition exemption for all leases under twelve-month terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The present value of the lease payments is calculated using a rate implicit in the lease, when readily determinable. However, as most of the Company&#x2019;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate to determine the present value of the lease payments for the majority of its leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <asth:BeneficialInterestPolicyTextBlock contextRef="c-1" id="f-677">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Beneficial Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, APC received a beneficial interest as a result of selling one of its equity method investments, pursuant to the terms of the stock purchase agreement. The estimated fair value of such interest in April 2020 was&#160;$15.7&#160;million. In 2021, the beneficial interest was determined to not be collectible and the $15.7&#160;million was written off and expensed in other income (expense) in the accompanying consolidated statements of income for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;</asth:BeneficialInterestPolicyTextBlock>
    <asth:AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet contextRef="c-103" decimals="-5" id="f-678" unitRef="usd">15700000</asth:AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet>
    <asth:AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet contextRef="c-103" decimals="-5" id="f-679" unitRef="usd">15700000</asth:AdditionalProceedsToBeReceivedFromSaleOfEquityMethodInvestmentsIfCircumstancesMet>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-680">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Standards Accounting Board (FASB) issued Accounting Standards Update (ASU) 2023-07 "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for the Company&#x2019;s annual periods beginning January 1, 2024, and for interim periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09 "Income Taxes (Topics 740): Improvements to Income Tax Disclosures" to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#x2019;s annual periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-681">Business Combinations, Asset Acquisitions, and Goodwill&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Texas Independent Providers, LLC (&#x201c;TIP&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;1, 2023, the Company acquired certain assets relating to TIP. The acquired assets allow the Company to provide high-quality care services to Medicare Advantage patients in Texas. The purchase price consisted of cash funded on September 1, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;For Your Benefit, Inc. (&#x201c;FYB&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;1, 2023, the Company acquired 100% of the equity interest in FYB. FYB is licensed by the California Department of Managed Health Care as a full-service Restricted Knox-Keene licensed health plan to serve Medicare Advantage members only in designated California counties. As a Restricted Knox-Keene licensed health plan, FYB is not permitted to market directly to Medicare beneficiaries, but rather, contracts with &#x201c;upstream&#x201d; Medicare Advantage payer plans on a &#x201c;global capitation&#x201d; basis, which enables FYB to assume full financial responsibility, including both professional and institutional risk, for the medical costs of its Medicare Advantage members under the Knox-Keene Health Care Service Plan Act of 1975.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Chinese Community Health Care Association (&#x201c;CCHCA&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;1, 2023, the Company acquired certain healthcare assets from CCHCA. The acquired assets allow the Company to provide high-quality care to more patients in the San Francisco Community. The purchase price consisted of cash funded on May&#160;1, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;All American Medical Group (&#x201c;AAMG&#x201d;) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2022, Astrana Care Partners Medical Corporation (&#x201c;Astrana Care Partners Medical&#x201d;), formerly known as AP-AMH 2 Medical Corporation, a consolidated VIE of the Company, acquired 100% of the equity interest in AAMG. AAMG is an IPA operating in Northern California. The purchase price consisted of cash funded upon close of the transaction and additional consideration (&#x201c;AAMG contingent consideration&#x201d;) and stock consideration (&#x201c;AAMG stock contingent consideration&#x201d;) contingent on AAMG meeting revenue and capitated member metrics for fiscal year 2023 and 2024. The fair value of the AAMG contingent consideration and AAMG stock contingent consideration on the date of acquisition was $5.9 million and $5.6 million, respectively. Refer to Note 21 - &#x201c;Fair Value Measurements of Financial Instruments&#x201d; for additional information on contingent considerations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valley Oaks Medical Group (&#x201c;VOMG&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 14, 2022, one of the Company&#x2019;s key personnel acquired 100% of the equity interest in VOMG, resulting in the Company consolidating VOMG as a VIE. VOMG owns primary care clinics in Nevada and Texas. The purchase price consists of cash funded upon the close of transaction and additional cash consideration (&#x201c;VOMG contingent consideration&#x201d;) contingent on VOMG meeting financial metrics for fiscal years 2023 and 2024. Refer to Note 21 - &#x201c;Fair Value Measurements of Financial Instruments&#x201d; for additional information on contingent considerations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Jade Health Care Medical Group, Inc. (&#x201c;Jade&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 19, 2022, the Company acquired 100% of the capital stock of Jade. The purchase was paid in cash. Jade is a primary and specialty care physicians&#x2019; group focused on providing high-quality care to its patients in the San Francisco Bay Area in Northern California.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Orma Health, Inc., and Provider Growth Solutions LLC (together, &#x201c;Orma Health&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 27, 2022, the Company acquired 100% of the capital stock of Orma Health, Inc., and Provider Growth Solutions, LLC (together, &#x201c;Orma Health&#x201d;). The purchase was paid in cash and in the Company&#x2019;s capital stock. Orma Health&#x2019;s real-time Clinical AI platform ingests data from multiple sources and utilizes advanced risk-stratification models to identify patients for various clinical programs, including remote patient monitoring (&#x201c;RPM&#x201d;), mental health support, chronic care management, and more. Its clinical platform is also deeply integrated with Orma Health&#x2019;s proprietary RPM ecosystem, which consists of smart health devices and a suite of technology tools to manage patient health.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisitions were accounted for under the acquisition method of accounting. The fair value of the consideration for the acquired companies were allocated to acquired tangible and intangible assets and liabilities based upon their fair values. The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;excess of the purchase consideration over the fair value of the net tangible and identifiable intangible assets acquired was recorded as goodwill. The determination of the fair value of assets and liabilities acquired requires the Company to make estimates and use valuation techniques when market value is not readily available. The results of operations of the acquisitions have been included in the Company&#x2019;s consolidated financial statements from the date of acquisition. Transaction costs associated with business acquisitions are expensed as they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the time of acquisition, the Company estimates the amount of the identifiable intangible assets based on a valuation and the facts and circumstances available at the time. The Company determines the final value of the identifiable intangible assets as soon as information is available, but not more than one year from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the carrying value of goodwill for the years ended December&#160;31, 2023 and 2022 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-104" decimals="2" id="f-682" unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-105" decimals="2" id="f-683" unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-105" decimals="-5" id="f-684" unitRef="usd">5900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <asth:BusinessCombinationStockContingentConsiderationLiability contextRef="c-105" decimals="-5" id="f-685" unitRef="usd">5600000</asth:BusinessCombinationStockContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-106" decimals="2" id="f-686" unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-107" decimals="2" id="f-687" unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-108" decimals="2" id="f-688" unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-689">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the carrying value of goodwill for the years ended December&#160;31, 2023 and 2022 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-49" decimals="-3" id="f-690" unitRef="usd">246416000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-31" decimals="-3" id="f-691" unitRef="usd">21486000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-31" decimals="-3" id="f-692" unitRef="usd">1151000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-693" unitRef="usd">269053000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-3" id="f-694" unitRef="usd">7866000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPurchaseAccountingAdjustments contextRef="c-1" decimals="-3" id="f-695" unitRef="usd">1912000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-696" unitRef="usd">278831000</us-gaap:Goodwill>
    <asth:PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock contextRef="c-1" id="f-697">Land, Property, and Equipment, Net&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land, property, and equipment, net consisted of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.163%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.377%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,876)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, property, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Certain land, property, and equipment, net that were deemed Excluded Assets that are solely for the benefit of APC and its common shareholders were spun-off as part of the Spin-Off. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, the Company had finance leases totaling $1.7 million and $1.8 million, respectively, included in land, property, and equipment, net in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.1 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt; $3.7 million and $2.1 million for the years ended December&#160;31, 2023, 2022 and 2021, respectively, which is included in depreciation and amortization in the accompanying consolidated statements of income.</asth:PropertyPlantAndEquipmentDisclosureAndAssetAcquisitionTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-698">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land, property, and equipment, net consisted of (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.163%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.377%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 39&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,876)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, property, and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Certain land, property, and equipment, net that were deemed Excluded Assets that are solely for the benefit of APC and its common shareholders were spun-off as part of the Spin-Off. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-109" decimals="-3" id="f-699" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-110" decimals="-3" id="f-700" unitRef="usd">32288000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-111" id="f-701">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-112" id="f-702">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-113" decimals="-3" id="f-703" unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-114" decimals="-3" id="f-704" unitRef="usd">58451000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-115" id="f-705">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-116" id="f-706">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-117" decimals="-3" id="f-707" unitRef="usd">4923000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-118" decimals="-3" id="f-708" unitRef="usd">4731000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-119" id="f-709">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-120" id="f-710">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-121" decimals="-3" id="f-711" unitRef="usd">18854000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-122" decimals="-3" id="f-712" unitRef="usd">17161000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-123" decimals="-3" id="f-713" unitRef="usd">340000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-124" decimals="-3" id="f-714" unitRef="usd">12801000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-125" id="f-715">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-126" id="f-716">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-127" decimals="-3" id="f-717" unitRef="usd">5930000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-128" decimals="-3" id="f-718" unitRef="usd">7151000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-719" unitRef="usd">30047000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-720" unitRef="usd">132583000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-721" unitRef="usd">22876000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-722" unitRef="usd">24047000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-4" decimals="-3" id="f-723" unitRef="usd">7171000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-724" unitRef="usd">108536000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-725" unitRef="usd">1700000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-5" decimals="-5" id="f-726" unitRef="usd">1800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-5" id="f-727" unitRef="usd">5100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-31" decimals="-5" id="f-728" unitRef="usd">3700000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-32" decimals="-5" id="f-729" unitRef="usd">2100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-730">Intangible Assets, Net&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023, intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment/&lt;br/&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Network relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(104,859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Management contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Member relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10-14&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient management platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(131,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment/&lt;br/&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite Lived Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Network relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Management contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Member relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient management platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, network relationships, management contracts, member relationships, tradename/trademarks, and developed technology had weighted-average remaining useful lives of 9.4 years, 6.5 years, 11.1 years, 13.9 years, and 4.1 years respectively. Total weighted-average remaining useful lives for all amortized intangible assets as of December&#160;31, 2023 was 9.6 years. Amortization expense was $12.7 million, $13.7 million and $15.4 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively, which is included in depreciation and amortization in the accompanying consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no impairment loss recorded related to intangibles for the years ended December&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-732">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023, intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment/&lt;br/&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Network relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(104,859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Management contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Member relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10-14&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient management platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(131,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment/&lt;br/&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite Lived Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Network relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Management contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Member relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient management platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-731">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2023, intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.648%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.605%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment/&lt;br/&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Network relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(104,859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Management contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Member relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10-14&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient management platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(131,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.514%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.819%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.963%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.401%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment/&lt;br/&gt;Disposal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net&lt;br/&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite Lived Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Network relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11-21&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(95,451)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Management contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(15,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Member relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Patient management platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tradename/trademarks&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;195,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(118,611)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-129" decimals="-3" id="f-733" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-130" decimals="-3" id="f-734" unitRef="usd">0</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-130" decimals="-3" id="f-735" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-131" decimals="-3" id="f-736" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-131" decimals="-3" id="f-737" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-132" id="f-738">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-133" id="f-739">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-134" decimals="-3" id="f-740" unitRef="usd">150679000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-135" decimals="-3" id="f-741" unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-135" decimals="-3" id="f-742" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-136" decimals="-3" id="f-743" unitRef="usd">150679000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-136" decimals="-3" id="f-744" unitRef="usd">104859000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-136" decimals="-3" id="f-745" unitRef="usd">45820000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-137" id="f-746">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-138" decimals="-3" id="f-747" unitRef="usd">22832000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-139" decimals="-3" id="f-748" unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-139" decimals="-3" id="f-749" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-137" decimals="-3" id="f-750" unitRef="usd">22832000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-137" decimals="-3" id="f-751" unitRef="usd">16662000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-137" decimals="-3" id="f-752" unitRef="usd">6170000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-140" id="f-753">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-141" id="f-754">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-142" decimals="-3" id="f-755" unitRef="usd">16633000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-143" decimals="-3" id="f-756" unitRef="usd">7444000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-143" decimals="-3" id="f-757" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-144" decimals="-3" id="f-758" unitRef="usd">24077000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-144" decimals="-3" id="f-759" unitRef="usd">7345000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-144" decimals="-3" id="f-760" unitRef="usd">16732000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-145" id="f-761">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-146" decimals="-3" id="f-762" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-147" decimals="-3" id="f-763" unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-147" decimals="-3" id="f-764" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-145" decimals="-3" id="f-765" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-145" decimals="-3" id="f-766" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-145" decimals="-3" id="f-767" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-148" id="f-768">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-149" decimals="-3" id="f-769" unitRef="usd">1011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-150" decimals="-3" id="f-770" unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-150" decimals="-3" id="f-771" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-148" decimals="-3" id="f-772" unitRef="usd">1011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-148" decimals="-3" id="f-773" unitRef="usd">308000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-148" decimals="-3" id="f-774" unitRef="usd">703000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-151" id="f-775">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-152" decimals="-3" id="f-776" unitRef="usd">107000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-153" decimals="-3" id="f-777" unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-153" decimals="-3" id="f-778" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-151" decimals="-3" id="f-779" unitRef="usd">107000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-151" decimals="-3" id="f-780" unitRef="usd">34000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-151" decimals="-3" id="f-781" unitRef="usd">73000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-5" decimals="-3" id="f-782" unitRef="usd">195472000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <asth:FiniteAndIndefiniteLivedIntangibleAssetsAcquired contextRef="c-1" decimals="-3" id="f-783" unitRef="usd">7444000</asth:FiniteAndIndefiniteLivedIntangibleAssetsAcquired>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-1" decimals="-3" id="f-784" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-4" decimals="-3" id="f-785" unitRef="usd">202916000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-786" unitRef="usd">131268000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-787" unitRef="usd">71648000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-154" decimals="-3" id="f-788" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-155" decimals="-3" id="f-789" unitRef="usd">0</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill contextRef="c-155" decimals="-3" id="f-790" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-129" decimals="-3" id="f-791" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-129" decimals="-3" id="f-792" unitRef="usd">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-156" id="f-793">P11Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-157" id="f-794">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-158" decimals="-3" id="f-795" unitRef="usd">150679000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-159" decimals="-3" id="f-796" unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-159" decimals="-3" id="f-797" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-134" decimals="-3" id="f-798" unitRef="usd">150679000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-134" decimals="-3" id="f-799" unitRef="usd">95451000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-134" decimals="-3" id="f-800" unitRef="usd">55228000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-138" id="f-801">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-160" decimals="-3" id="f-802" unitRef="usd">22832000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-161" decimals="-3" id="f-803" unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-161" decimals="-3" id="f-804" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-138" decimals="-3" id="f-805" unitRef="usd">22832000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-138" decimals="-3" id="f-806" unitRef="usd">15208000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-138" decimals="-3" id="f-807" unitRef="usd">7624000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-142" id="f-808">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-162" decimals="-3" id="f-809" unitRef="usd">8997000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-163" decimals="-3" id="f-810" unitRef="usd">7636000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-163" decimals="-3" id="f-811" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-142" decimals="-3" id="f-812" unitRef="usd">16633000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-142" decimals="-3" id="f-813" unitRef="usd">5619000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-142" decimals="-3" id="f-814" unitRef="usd">11014000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-146" id="f-815">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-164" decimals="-3" id="f-816" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-165" decimals="-3" id="f-817" unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-165" decimals="-3" id="f-818" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-146" decimals="-3" id="f-819" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-146" decimals="-3" id="f-820" unitRef="usd">2060000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-146" decimals="-3" id="f-821" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-149" id="f-822">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-166" decimals="-3" id="f-823" unitRef="usd">1011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-167" decimals="-3" id="f-824" unitRef="usd">0</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-167" decimals="-3" id="f-825" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-149" decimals="-3" id="f-826" unitRef="usd">1011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-149" decimals="-3" id="f-827" unitRef="usd">257000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-149" decimals="-3" id="f-828" unitRef="usd">754000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-152" id="f-829">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-168" decimals="-3" id="f-830" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="c-169" decimals="-3" id="f-831" unitRef="usd">107000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-169" decimals="-3" id="f-832" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-152" decimals="-3" id="f-833" unitRef="usd">107000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-152" decimals="-3" id="f-834" unitRef="usd">16000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-152" decimals="-3" id="f-835" unitRef="usd">91000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-49" decimals="-3" id="f-836" unitRef="usd">187729000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <asth:FiniteAndIndefiniteLivedIntangibleAssetsAcquired contextRef="c-31" decimals="-3" id="f-837" unitRef="usd">7743000</asth:FiniteAndIndefiniteLivedIntangibleAssetsAcquired>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-31" decimals="-3" id="f-838" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c-5" decimals="-3" id="f-839" unitRef="usd">195472000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-840" unitRef="usd">118611000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-841" unitRef="usd">76861000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-135" id="f-842">P9Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-139" id="f-843">P6Y6M</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-143" id="f-844">P11Y1M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-150" id="f-845">P13Y10M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-170" id="f-846">P4Y1M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-171" id="f-847">P9Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-848" unitRef="usd">12700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-31" decimals="-5" id="f-849" unitRef="usd">13700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-32" decimals="-5" id="f-850" unitRef="usd">15400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-851">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-4" decimals="-3" id="f-852" unitRef="usd">12818000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-4" decimals="-3" id="f-853" unitRef="usd">11661000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-4" decimals="-3" id="f-854" unitRef="usd">10232000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-4" decimals="-3" id="f-855" unitRef="usd">8794000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-4" decimals="-3" id="f-856" unitRef="usd">7603000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-4" decimals="-3" id="f-857" unitRef="usd">18390000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-858" unitRef="usd">69498000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="c-1" id="f-859">Investments in Other Entities&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Method&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the twelve months ended December&#160;31, 2023 and 2022, the Company&#x2019;s equity method investment balance consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.379%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Initial Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustment of Fair Value*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Distribution &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(508)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-Off. On the date of distribution, the investments were recorded at fair value. The gain, representing the difference between the fair value and the carrying value of the investment, was $3.4 million and is presented within other income in the accompanying consolidated statement of net income. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;** Other consists of smaller equity method investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.379%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.040%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funding Reclassified to Loan Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Entity Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Distribution &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tag-6 Medical Investment Group, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-off. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity method investments are subject to impairment evaluation. There was no impairment loss recorded related to equity method investments for the years ended December&#160;31, 2023, 2022, and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in privately held entities that do not report net asset value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;MediPortal, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, APC purchased 270,000 membership interests of MediPortal LLC, a New York limited liability company, for $0.4 million or $1.50 per membership interest, which represented approximately 2.8% ownership interest. In connection with &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the initial purchase, APC received a five-year warrant to purchase an additional 270,000 membership interests. A five-year option to purchase an additional 380,000 membership interests and a &lt;span style="-sec-ix-hidden:f-980"&gt;five&lt;/span&gt;-year warrant to purchase 480,000 membership interests were contingent upon the portal completion date. These warrants and options were not exercised and are expired as of December&#160;31, 2023. As APC does not have the ability to exercise significant influence, and lacks control over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the years ended December&#160;31, 2023 and 2022, there were no observable price changes to APC&#x2019;s investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AchievaMed&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2019, Astrana Health Management, Inc. (&#x201c;AHM&#x201d;), formerly known as Network Medical Management Inc., and AchievaMed, Inc., a California corporation (&#x201c;AchievaMed&#x201d;), entered into an agreement in which AHM would purchase 50% of the aggregate shares of capital stock of AchievaMed over a period of time not to exceed five years. As a result of this transaction, AHM invested $0.5 million for a 10% interest. The related investment balance of $0.5&#160;million is included in investments in privately held entities in the accompanying consolidated balance sheets as of December&#160;31, 2023. As AHM does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the years ended December&#160;31, 2023 and 2022, there were no observable price changes to AHM&#x2019;s investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Third Way Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the Company entered into a Simple Agreement for Future Equity (&#x201c;SAFE&#x201d;) with Third Way Health, Inc. (&#x201c;Third Way Health&#x201d;). Based on certain triggering events defined in the SAFE, the Company has rights to Third Way Health&#x2019;s shares. The number of shares to be acquired will be calculated when the triggered event occurs.  As of December&#160;31, 2023 and 2022, the related investment balance of $3.5&#160;million and $1.5&#160;million, respectively, is included in investments in privately held entities in the accompanying consolidated balance sheets. As the Company does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the years ended December&#160;31, 2023 and 2022, there were no observable price changes to the Third Way Health investment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Seen Health, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;1, 2023, the Company entered into a SAFE with Seen Health, Inc. (&#x201c;Seen Health&#x201d;). Based on certain triggering events defined in the SAFE, the Company has rights to Seen Health&#x2019;s shares. The number of shares to be acquired will be calculated when the triggering event occurs. As of December&#160;31, 2023, the related investment balance of $2.0&#160;million is included in investments in privately held entities in the accompanying consolidated balance sheets. As the Company does not have the ability to exercise significant influence, and lacks control, over the investee, this investment is accounted for using a measurement alternative, which allows the investment to be measured at cost, adjusted for observable price changes and impairments, with changes recognized in net income. During the year ended December&#160;31, 2023, there were no observable price changes to the Seen Health investment.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock contextRef="c-1" id="f-860">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the twelve months ended December&#160;31, 2023 and 2022, the Company&#x2019;s equity method investment balance consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.478%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.379%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Initial Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjustment of Fair Value*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Distribution &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(508)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,916)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other **&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-Off. On the date of distribution, the investments were recorded at fair value. The gain, representing the difference between the fair value and the carrying value of the investment, was $3.4 million and is presented within other income in the accompanying consolidated statement of net income. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;** Other consists of smaller equity method investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.379%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.040%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.186%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Ownership&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Allocation of Net Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funding Reclassified to Loan Receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Funding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Entity Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Distribution &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;LaSalle Medical Associates &#x2013; IPA Line of Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531 W. College, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;One MSO, LLC *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tag-6 Medical Investment Group, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(600)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-off. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-172" decimals="2" id="f-861" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-173" decimals="-3" id="f-862" unitRef="usd">5684000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment contextRef="c-174" decimals="-3" id="f-863" unitRef="usd">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-174" decimals="-3" id="f-864" unitRef="usd">4182000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentsContribution contextRef="c-174" decimals="-3" id="f-865" unitRef="usd">0</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentAdjustmentToFairValue contextRef="c-174" decimals="-3" id="f-866" unitRef="usd">0</asth:EquityMethodInvestmentAdjustmentToFairValue>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-174" decimals="-3" id="f-867" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-172" decimals="-3" id="f-868" unitRef="usd">9866000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-175" decimals="2" id="f-869" unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-176" decimals="-3" id="f-870" unitRef="usd">1878000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment contextRef="c-177" decimals="-3" id="f-871" unitRef="usd">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-177" decimals="-3" id="f-872" unitRef="usd">-187000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentsContribution contextRef="c-177" decimals="-3" id="f-873" unitRef="usd">0</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentAdjustmentToFairValue contextRef="c-177" decimals="-3" id="f-874" unitRef="usd">0</asth:EquityMethodInvestmentAdjustmentToFairValue>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-177" decimals="-3" id="f-875" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-175" decimals="-3" id="f-876" unitRef="usd">1691000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-178" decimals="2" id="f-877" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-179" decimals="-3" id="f-878" unitRef="usd">17281000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment contextRef="c-180" decimals="-3" id="f-879" unitRef="usd">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-180" decimals="-3" id="f-880" unitRef="usd">-508000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentsContribution contextRef="c-180" decimals="-3" id="f-881" unitRef="usd">700000</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentAdjustmentToFairValue contextRef="c-180" decimals="-3" id="f-882" unitRef="usd">91000</asth:EquityMethodInvestmentAdjustmentToFairValue>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-180" decimals="-3" id="f-883" unitRef="usd">17564000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-178" decimals="-3" id="f-884" unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-181" decimals="2" id="f-885" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-182" decimals="-3" id="f-886" unitRef="usd">2718000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment contextRef="c-183" decimals="-3" id="f-887" unitRef="usd">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-183" decimals="-3" id="f-888" unitRef="usd">938000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentsContribution contextRef="c-183" decimals="-3" id="f-889" unitRef="usd">0</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentAdjustmentToFairValue contextRef="c-183" decimals="-3" id="f-890" unitRef="usd">3260000</asth:EquityMethodInvestmentAdjustmentToFairValue>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-183" decimals="-3" id="f-891" unitRef="usd">6916000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-181" decimals="-3" id="f-892" unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-184" decimals="2" id="f-893" unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-185" decimals="-3" id="f-894" unitRef="usd">12738000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment contextRef="c-186" decimals="-3" id="f-895" unitRef="usd">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-186" decimals="-3" id="f-896" unitRef="usd">922000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentsContribution contextRef="c-186" decimals="-3" id="f-897" unitRef="usd">0</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentAdjustmentToFairValue contextRef="c-186" decimals="-3" id="f-898" unitRef="usd">0</asth:EquityMethodInvestmentAdjustmentToFairValue>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-186" decimals="-3" id="f-899" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-184" decimals="-3" id="f-900" unitRef="usd">13660000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-187" decimals="2" id="f-901" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-188" decimals="-3" id="f-902" unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment contextRef="c-189" decimals="-3" id="f-903" unitRef="usd">325000</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-189" decimals="-3" id="f-904" unitRef="usd">232000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentsContribution contextRef="c-189" decimals="-3" id="f-905" unitRef="usd">0</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentAdjustmentToFairValue contextRef="c-189" decimals="-3" id="f-906" unitRef="usd">0</asth:EquityMethodInvestmentAdjustmentToFairValue>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-189" decimals="-3" id="f-907" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-187" decimals="-3" id="f-908" unitRef="usd">557000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-5" decimals="-3" id="f-909" unitRef="usd">40299000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment contextRef="c-1" decimals="-3" id="f-910" unitRef="usd">325000</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-911" unitRef="usd">5579000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentsContribution contextRef="c-1" decimals="-3" id="f-912" unitRef="usd">700000</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentAdjustmentToFairValue contextRef="c-1" decimals="-3" id="f-913" unitRef="usd">3351000</asth:EquityMethodInvestmentAdjustmentToFairValue>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-1" decimals="-3" id="f-914" unitRef="usd">24480000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-4" decimals="-3" id="f-915" unitRef="usd">25774000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdjustmentToFairValue contextRef="c-1" decimals="-5" id="f-916" unitRef="usd">3400000</asth:EquityMethodInvestmentAdjustmentToFairValue>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-173" decimals="2" id="f-917" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-190" decimals="-3" id="f-918" unitRef="usd">3034000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-191" decimals="-3" id="f-919" unitRef="usd">4775000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-191" decimals="-3" id="f-920" unitRef="usd">2125000</asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <asth:EquityMethodInvestmentsContribution contextRef="c-191" decimals="-3" id="f-921" unitRef="usd">0</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentsConsolidated contextRef="c-191" decimals="-3" id="f-922" unitRef="usd">0</asth:EquityMethodInvestmentsConsolidated>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-191" decimals="-3" id="f-923" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-173" decimals="-3" id="f-924" unitRef="usd">5684000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-176" decimals="2" id="f-925" unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-192" decimals="-3" id="f-926" unitRef="usd">1719000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-193" decimals="-3" id="f-927" unitRef="usd">159000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-193" decimals="-3" id="f-928" unitRef="usd">0</asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <asth:EquityMethodInvestmentsContribution contextRef="c-193" decimals="-3" id="f-929" unitRef="usd">0</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentsConsolidated contextRef="c-193" decimals="-3" id="f-930" unitRef="usd">0</asth:EquityMethodInvestmentsConsolidated>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-193" decimals="-3" id="f-931" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-176" decimals="-3" id="f-932" unitRef="usd">1878000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-179" decimals="2" id="f-933" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-194" decimals="-3" id="f-934" unitRef="usd">17230000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-195" decimals="-3" id="f-935" unitRef="usd">-619000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-195" decimals="-3" id="f-936" unitRef="usd">0</asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <asth:EquityMethodInvestmentsContribution contextRef="c-195" decimals="-3" id="f-937" unitRef="usd">670000</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentsConsolidated contextRef="c-195" decimals="-3" id="f-938" unitRef="usd">0</asth:EquityMethodInvestmentsConsolidated>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-195" decimals="-3" id="f-939" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-179" decimals="-3" id="f-940" unitRef="usd">17281000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-182" decimals="2" id="f-941" unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-196" decimals="-3" id="f-942" unitRef="usd">2910000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-197" decimals="-3" id="f-943" unitRef="usd">408000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-197" decimals="-3" id="f-944" unitRef="usd">0</asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <asth:EquityMethodInvestmentsContribution contextRef="c-197" decimals="-3" id="f-945" unitRef="usd">0</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentsConsolidated contextRef="c-197" decimals="-3" id="f-946" unitRef="usd">0</asth:EquityMethodInvestmentsConsolidated>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-197" decimals="-3" id="f-947" unitRef="usd">600000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-182" decimals="-3" id="f-948" unitRef="usd">2718000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-198" decimals="2" id="f-949" unitRef="number">1</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-199" decimals="-3" id="f-950" unitRef="usd">4830000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-200" decimals="-3" id="f-951" unitRef="usd">153000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-200" decimals="-3" id="f-952" unitRef="usd">0</asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <asth:EquityMethodInvestmentsContribution contextRef="c-200" decimals="-3" id="f-953" unitRef="usd">1435000</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentsConsolidated contextRef="c-200" decimals="-3" id="f-954" unitRef="usd">6418000</asth:EquityMethodInvestmentsConsolidated>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-200" decimals="-3" id="f-955" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-198" decimals="-3" id="f-956" unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-185" decimals="2" id="f-957" unitRef="number">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="c-201" decimals="-3" id="f-958" unitRef="usd">11992000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-202" decimals="-3" id="f-959" unitRef="usd">746000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-202" decimals="-3" id="f-960" unitRef="usd">0</asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <asth:EquityMethodInvestmentsContribution contextRef="c-202" decimals="-3" id="f-961" unitRef="usd">0</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentsConsolidated contextRef="c-202" decimals="-3" id="f-962" unitRef="usd">0</asth:EquityMethodInvestmentsConsolidated>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-202" decimals="-3" id="f-963" unitRef="usd">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-185" decimals="-3" id="f-964" unitRef="usd">12738000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-49" decimals="-3" id="f-965" unitRef="usd">41715000</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-31" decimals="-3" id="f-966" unitRef="usd">5622000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable contextRef="c-31" decimals="-3" id="f-967" unitRef="usd">2125000</asth:EquityMethodInvestmentFundingReclassifiedToLoanReceivable>
    <asth:EquityMethodInvestmentsContribution contextRef="c-31" decimals="-3" id="f-968" unitRef="usd">2105000</asth:EquityMethodInvestmentsContribution>
    <asth:EquityMethodInvestmentsConsolidated contextRef="c-31" decimals="-3" id="f-969" unitRef="usd">6418000</asth:EquityMethodInvestmentsConsolidated>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount contextRef="c-31" decimals="-3" id="f-970" unitRef="usd">600000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments contextRef="c-5" decimals="-3" id="f-971" unitRef="usd">40299000</us-gaap:EquityMethodInvestments>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares
      contextRef="c-203"
      decimals="INF"
      id="f-972"
      unitRef="shares">270000</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsPurchaseOfShares>
    <asth:PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments contextRef="c-204" decimals="-5" id="f-973" unitRef="usd">400000</asth:PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValueInvestments>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest
      contextRef="c-203"
      decimals="INF"
      id="f-974"
      unitRef="usdPerShare">1.50</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsMembershipInterestAcquiredPerInterest>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage contextRef="c-203" decimals="3" id="f-975" unitRef="number">0.028</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-203" id="f-976">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-203"
      decimals="-3"
      id="f-977"
      unitRef="shares">270000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption contextRef="c-204" id="f-978">P5Y</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentOptionsIssuedTermOfOption>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests
      contextRef="c-204"
      decimals="-3"
      id="f-979"
      unitRef="shares">380000</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsOptionsIssuedOptionToPurchaseAdditionalInterests>
    <asth:EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet contextRef="c-203" decimals="0" id="f-981" unitRef="shares">480000</asth:EquityMethodInvestmentOptionsIssuedOptionToPurchaseAdditionalInterestsIfCircumstancesMet>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears
      contextRef="c-205"
      decimals="INF"
      id="f-982"
      unitRef="number">0.50</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsProportionofOwnershipInterestinVotingCommonStockWithinFiveYears>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment contextRef="c-206" id="f-983">P5Y</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsDurationOfInvestment>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost contextRef="c-205" decimals="-5" id="f-984" unitRef="usd">500000</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage contextRef="c-205" decimals="2" id="f-985" unitRef="number">0.10</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost contextRef="c-207" decimals="-5" id="f-986" unitRef="usd">500000</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost contextRef="c-208" decimals="-5" id="f-987" unitRef="usd">3500000</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost contextRef="c-209" decimals="-5" id="f-988" unitRef="usd">1500000</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost>
    <asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost contextRef="c-210" decimals="-5" id="f-989" unitRef="usd">2000000</asth:EquitySecuritiesWithoutReadilyDeterminableFairValueInvestmentsAggregateCost>
    <asth:LoanReceivableTextBlock contextRef="c-1" id="f-990">Loan Receivable and Loan Receivable &#x2013; Related Parties&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loans receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pacific6&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, AHM received a promissory note from 6 Founder LLC, a California limited liability company doing business as Pacific6 Enterprises totaling $0.5&#160;million as a result of the sale of the Company&#x2019;s interest in MWN. Interest accrues at a rate of 5% per annum and is payable monthly through the maturity date of December 1, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IntraCare &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July&#160;27, 2023, the Company entered into a five-year convertible promissory note with IntraCare as the borrower. The principal on the note is $25.0 million, with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to 8.81%, compounded annually. In the event that the convertible promissory note remains outstanding on or after the maturity date of July&#160;27, 2028, the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into IntraCare preferred shares. As of December&#160;31, 2023, the related note balance of $26.0 million is included in loan receivable, non-current in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the outstanding loan receivable under the CECL model by assessing the party&#x2019;s ability to pay by reviewing their interest payment history quarterly, financial history annually, and reassessing any identified insolvency risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loan receivable &#x2014; related party&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;LaSalle Medical Associates Loan (&#x201c;LMA Loan&#x201d;)&lt;/span&gt;&lt;/div&gt;LaSalle Medical Associates (&#x201c;LMA&#x201d;) issued a promissory note to APC-LSMA for a principal amount of $2.1&#160;million with an August 2023 maturity date. The contractual interest rate on the LMA Loan is 1.0% above the prime rate of interest for commercial customers. In March 2023, LMA paid off the full balance of the promissory note and all interest. APC&#x2019;s investment in LMA is accounted for under the equity method based on the 25% equity ownership interest held by APC-LSMA in LMA&#x2019;s IPA line of business (see Note 6 &#x2014; &#x201c;Investments in Other Entities &#x2014; Equity Method&#x201d;).</asth:LoanReceivableTextBlock>
    <us-gaap:NotesReceivableNet contextRef="c-211" decimals="-5" id="f-991" unitRef="usd">500000</us-gaap:NotesReceivableNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-212" decimals="2" id="f-992" unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="c-213" id="f-993">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-214" decimals="-5" id="f-994" unitRef="usd">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-214" decimals="4" id="f-995" unitRef="number">0.0881</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent contextRef="c-215" decimals="-5" id="f-996" unitRef="usd">26000000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesReceivableNet contextRef="c-216" decimals="-5" id="f-997" unitRef="usd">2100000</us-gaap:NotesReceivableNet>
    <asth:FinanceReceivableInterestRateStatedPercentage contextRef="c-216" decimals="3" id="f-998" unitRef="number">0.010</asth:FinanceReceivableInterestRateStatedPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-217" decimals="2" id="f-999" unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-1000">Accounts Payable and Accrued Expenses&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts payable and accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and other accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitation payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subcontractor IPA payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other provider payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-1001">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts payable and accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and other accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitation payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subcontractor IPA payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other provider payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-1002" unitRef="usd">9075000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-1003" unitRef="usd">10473000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <asth:SpecialtyCapitationPayableCurrent contextRef="c-4" decimals="-3" id="f-1004" unitRef="usd">4503000</asth:SpecialtyCapitationPayableCurrent>
    <asth:SpecialtyCapitationPayableCurrent contextRef="c-5" decimals="-3" id="f-1005" unitRef="usd">4229000</asth:SpecialtyCapitationPayableCurrent>
    <asth:SubcontractorIpaRiskPoolPayable contextRef="c-4" decimals="-3" id="f-1006" unitRef="usd">2529000</asth:SubcontractorIpaRiskPoolPayable>
    <asth:SubcontractorIpaRiskPoolPayable contextRef="c-5" decimals="-3" id="f-1007" unitRef="usd">2415000</asth:SubcontractorIpaRiskPoolPayable>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-1008" unitRef="usd">4407000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-5" decimals="-3" id="f-1009" unitRef="usd">2709000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:RelatedPartyDepositLiabilities contextRef="c-4" decimals="-3" id="f-1010" unitRef="usd">9271000</us-gaap:RelatedPartyDepositLiabilities>
    <us-gaap:RelatedPartyDepositLiabilities contextRef="c-5" decimals="-3" id="f-1011" unitRef="usd">3304000</us-gaap:RelatedPartyDepositLiabilities>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-1012" unitRef="usd">744000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-3" id="f-1013" unitRef="usd">531000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-1014" unitRef="usd">20098000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-1015" unitRef="usd">15301000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-1016" unitRef="usd">9322000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-1017" unitRef="usd">10600000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-1018" unitRef="usd">59949000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-1019" unitRef="usd">49562000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock contextRef="c-1" id="f-1020">Medical Liabilities&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s medical liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical liabilities, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of medical care costs related to claims incurred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for medical care costs related to claims incurred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(759,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(559,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(836,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(626,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical liabilities, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense contextRef="c-1" id="f-1021">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s medical liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical liabilities, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired (see Note 3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of medical care costs related to claims incurred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;866,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total medical care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;852,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for medical care costs related to claims incurred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(759,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(559,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(836,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(626,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical liabilities, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-5" decimals="-3" id="f-1022" unitRef="usd">81255000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-49" decimals="-3" id="f-1023" unitRef="usd">55783000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions contextRef="c-1" decimals="-3" id="f-1024" unitRef="usd">6157000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions contextRef="c-31" decimals="-3" id="f-1025" unitRef="usd">2956000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense contextRef="c-1" decimals="-3" id="f-1026" unitRef="usd">866501000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense contextRef="c-31" decimals="-3" id="f-1027" unitRef="usd">646679000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense contextRef="c-1" decimals="-3" id="f-1028" unitRef="usd">-13566000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense contextRef="c-31" decimals="-3" id="f-1029" unitRef="usd">5152000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 contextRef="c-1" decimals="-3" id="f-1030" unitRef="usd">852935000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 contextRef="c-31" decimals="-3" id="f-1031" unitRef="usd">651831000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 contextRef="c-1" decimals="-3" id="f-1032" unitRef="usd">759354000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 contextRef="c-31" decimals="-3" id="f-1033" unitRef="usd">559751000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 contextRef="c-1" decimals="-3" id="f-1034" unitRef="usd">76696000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 contextRef="c-31" decimals="-3" id="f-1035" unitRef="usd">67149000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense contextRef="c-1" decimals="-3" id="f-1036" unitRef="usd">836050000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense contextRef="c-31" decimals="-3" id="f-1037" unitRef="usd">626900000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease contextRef="c-1" decimals="-3" id="f-1038" unitRef="usd">2360000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease contextRef="c-31" decimals="-3" id="f-1039" unitRef="usd">-2415000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-4" decimals="-3" id="f-1040" unitRef="usd">106657000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-5" decimals="-3" id="f-1041" unitRef="usd">81255000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-1042">Credit Facility, Bank Loans, and Lines of Credit&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s debt balance consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.315%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real Estate Loans*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction Loan *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Promissory Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unamortized financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Long-term debt &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*These loans are a component of Excluded Assets that are solely for the benefit of APC and its common shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s long-term debt was determined using Level 2 inputs primarily related to comparable market prices. As of December&#160;31, 2023 and 2022, the carrying value was not materially different from fair value, as the interest rates on the Company&#x2019;s debt approximated rates currently available to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the future commitments of the Company&#x2019;s debt for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Amended Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 16, 2021, the Company entered into an amended and restated credit agreement (as subsequently amended as described below, the &#x201c;Amended Credit Agreement&#x201d;) with Truist Bank, in its capacity as administrative agent for the lenders, issuing bank, swingline lender and lender, and the banks and other financial institutions from time to time party thereto, to, among other things, amend and restate that certain credit agreement, dated September 11, 2019, by and among the Company, Truist Bank, and certain lenders thereto, in its entirety. The Amended Credit Agreement provides for a five-year revolving credit facility to the Company of $400.0 million (&#x201c;Revolver Loan&#x201d;), which includes a letter of credit sub-facility of up to $25.0 million and a swingline loan sub-facility of $25.0 million. As of December&#160;31, 2023, the Company did not have any outstanding borrowings under the Revolver Loan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 20, 2022, the Company entered into the First Amendment to the Amended Credit Agreement in which all amounts borrowed under the Amended Credit Agreement as of the effective date were automatically converted from LIBOR Loans to SOFR Loans with an initial interest period of one month on and as of the amendment effective date. Amounts borrowed under the Revolver Loan bear interest at an annual rate equal to either, at the Company&#x2019;s option, (a) the Term SOFR Reference Rate (as defined in the Amended Credit Agreement), adjusted for any Term SOFR Adjustment (as defined in the Amended Credit Agreement) plus a spread ranging from  1.25% to 2.50%, as determined on a quarterly basis based on the Company&#x2019;s Consolidated Total Net Leverage Ratio (as defined in the Amended Credit Agreement), or (b) a base rate, plus a spread ranging from 0.25% to 1.50%, as determined on a quarterly basis based on the Company&#x2019;s Consolidated Total Net Leverage Ratio. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 8, 2023, a Second Amendment to the Amended Credit Agreement was entered into which, among other things, (i) increased the letter of credit sub-facility from $25.0 million to $50.0 million; (ii) revised the form of compliance certificate required to be submitted by the Company to the lenders on a quarterly basis; and (iii) waived the Specified Events of Default (as defined in the amendment) that occurred under the Amended Credit Agreement, relating to the Company&#x2019;s calculation of Consolidated Total Net Leverage Ratio  and payment of certain interest and letter of credit fees, in each case, for the periods from the quarter ended September 30, 2021 through the quarter ended March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;3, 2023, the Company entered into a Third Amendment to the Amended Credit Agreement (&#x201c;Third Amendment&#x201d;) with Truist Bank and the other financial institutions party thereto. The Third Amendment provided a new term loan to the Company in an aggregate amount of up to $300.0&#160;million, with $180.0&#160;million funded at the closing of the Third Amendment, and $120.0&#160;million available to be drawn by the Company as delayed draw loans during the six months subsequent to the closing of the Third Amendment (collectively, the &#x201c;Term Loan&#x201d;).  The Term Loan matures on November&#160;3, 2028 (or such earlier date on which it is terminated in accordance with the provisions of the Amended Credit Agreement) and amortizes quarterly at 5% per annum for each of the first two years, 7.5% per annum for years three and four, and 10% per annum for year five. As of December&#160;31, 2023, the Company made total drawdowns under the Term Loan of $280.0&#160;million, of which $180.0&#160;million was used to pay down outstanding amounts borrowed on the Revolver Loan as of the Third Amendment closing date.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will pay a quarterly ticking fee on the delayed draw portion of the Term Loan, during the draw period, in an amount equal to 0.375% per annum multiplied by the average daily unused portion of the delayed draw maximum amount. The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term Loan will be secured by substantially all assets of the Company and subsidiaries of the Company that are not designated as excluded subsidiaries pursuant to the terms of the Amended Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan bears interest at an annual rate equal to either, at the Company&#x2019;s option, (a) the Term SOFR Reference Rate, adjusted for any Term SOFR Adjustment, plus a spread from 1.50% to 2.75%, as determined on a quarterly basis based on the Company&#x2019;s Consolidated Total Net Leverage Ratio, or (b) a base rate, plus a spread of 0.50% to 1.75%, as determined on a quarterly basis based on the Company&#x2019;s Consolidated Total Net Leverage Ratio. As of December&#160;31, 2023, the interest rate on the Term Loan was 7.69%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Amended Credit Agreement, the Company is required to pay an annual agent fee of $50,000 and an annual facility fee of 0.175% to 0.35% on the available commitments under the Amended Credit Agreement, regardless of usage, with the applicable fee determined on a quarterly basis based on the Company&#x2019;s Consolidated Total Net Leverage Ratio. The Company will pay fees for standby letters of credit at an annual rate equal to 1.25% to 2.50%, as determined on a quarterly basis based on the Company&#x2019;s Consolidated Total Net Leverage Ratio, plus fronting fees and standard fees payable to the issuing bank on the respective letter of credit. The Company is also required to pay customary fees between the Company and Truist Bank, the lead arranger of the Amended Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Credit Agreement requires the Company to comply with two key financial ratios, each calculated on a consolidated basis. The Company must maintain a maximum consolidated total net leverage ratio of not greater than 3.75 to 1.00 as of the last day of each fiscal quarter, provided that for any fiscal quarter during which the Company or certain subsidiaries consummate a permitted acquisition or investment, the aggregate purchase price is greater than $75.0&#160;million, the maximum consolidated total net leverage ratio may temporarily increase by 0.25 to 1.00 to 4.00 to 1.00. The Company must maintain a minimum consolidated interest coverage ratio of not less than 3.25 to 1.00 as of the last day of each fiscal quarter. The Third Amendment also revised certain negative covenants in the Credit Agreement, providing the Company with additional baskets and increased flexibility with respect to restrictions on indebtedness, liens, investments, acquisitions and restricted payments. The Third Amendment also updates the definition of Consolidated EBITDA to include additional addbacks and to clarify certain components of the calculation thereof. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Amended Credit Agreement, the terms and conditions of the Guaranty and Security Agreement (the &#x201c;Guaranty and Security Agreement&#x201d;) between the Company, AHM and Truist Bank remain in effect. Pursuant to the Guaranty and Security Agreement, the Company and AHM have granted the lenders under the Amended Credit Agreement a security interest in substantially all of their assets to secure obligations under the Amended Credit Agreement, including, without limitation, all stock and other equity issued by their subsidiaries (including AHM) and all rights with respect to the $545.0&#160;million loan from the Company to Astrana Medical. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, certain of the lenders under the Amended Credit Agreement and their affiliates have provided to the Company and its subsidiaries and the associated practices, and may in the future provide, (i) investment banking, commercial banking, cash management, foreign exchange or other financial services, and (ii) services as a bond trustee and other trust and fiduciary services, for which they have received compensation and may receive compensation in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred Financing Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, unamortized deferred financing costs were $6.1 million and $3.3 million, respectively. During the year ended December 31, 2023, the Company recorded additional deferred financing costs of $3.9 million related to the Third Amendment. As of December&#160;31, 2023, $2.6 million of unamortized deferred financing costs was recognized in prepaid expenses and other current assets in the accompanying consolidated balance sheets and consisted of unamortized deferred financing costs related to unborrowed amounts available on the Term Loan and the unamortized deferred financing costs for the Revolver Loan. As of December&#160;31, 2023, $3.6 million of unamortized deferred financing costs was recorded as a direct reduction against the amounts borrowed on the Term Loan. The remaining unamortized deferred financing costs related to the Revolver Loan are amortized over the life of the Revolver Loan using the straight-line method. The remaining unamortized deferred financing costs related to the Term Loan are amortized over the life of the Term Loan using the effective interest rate method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Real Estate Loans (Excluded Assets for the benefit of APC and its subsidiaries)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Real Estate - East West Bank&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, APC purchased three entities, each of which was included in Excluded Assets and had entered into real estate loan with East West Bank. As of December 31, 2022, the principal on each loan was $5.9 million, $0.6 million and $0.6 million, respectively,  and had a variable interest rate of 0.50%, 0.50% and 0.30% less than the independent index, which is the daily &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wall Street Journal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x201c;Prime Rate&#x201d;, respectively. The maturity date of each loan was August 5, 2030. These loans are a component of Excluded Assets that are solely for the benefit of APC and its shareholders. These loans were spun off on December 26, 2023 as part of the Spin-Off. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Real Estate - MUFG Union Bank N.A.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, a subsidiary of APC, which was included in Excluded Assets, entered into a loan agreement with MUFG Union Bank N.A. with the principal on the loan of $16.3 million and a maturity date of March&#160;1, 2032. The loan was used to purchase property in Monterey Park, California. The variable interest rate was 2.0% in excess of Daily Simple SOFR (as defined in the loan agreement). As of December 31, 2022, the principal on the loan was $16.0 million. On December 14, 2023, APC paid off the outstanding loan balance of $15.6 million. This loan was a component of Excluded Assets that are solely for the benefit of APC and its shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Construction Loan (Excluded Assets for the benefit of APC and its subsidiaries)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021, an entity included in Excluded Assets entered into a construction loan agreement with MUFG Union Bank N.A. (&#x201c;Construction Loan&#x201d;). The Construction Loan has a borrowing capacity of $10.7&#160;million with a maturity date of March&#160;1, 2024 or, upon completion of the construction and certain other requirements defined in the loan agreement, March&#160;1, 2034. The loan balance as of December 31, 2022 was $4.2 million. On December 14, 2023, APC paid off the outstanding loan balance of $8.5 million. This loan was a component of Excluded Assets that are solely for the benefit of APC and its shareholders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Promissory Note Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;FYB Promissory Note Agreement with CCHCA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, FYB entered into a promissory note agreement with CCHCA. The principal on the promissory note is $2.0&#160;million, with a maturity date of May&#160;9, 2024. The interest rate is the prime rate plus 1.0%. The prime rate is updated annually on the effective date of the note and published by the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Wall Street Journal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effective Interest Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s average effective interest rate on its total debt during the years ended December&#160;31, 2023, 2022 and 2021, was 6.19%, 3.22% and 2.06%, respectively. Interest expense in the consolidated statements of income included amortization of deferred debt issuance costs for the years ended December&#160;31, 2023, 2022 and 2021, of $1.1 million, $0.9 million and $1.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lines of Credit &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;APC Business Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, the APC Business Loan Agreement with Preferred Bank (the &#x201c;APC Business Loan Agreement&#x201d;) was amended to, among other things, decrease loan availability to $4.1 million, limit the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and include as a permitted lien, the security interest in all of its assets that APC granted to AHM under a Security Agreement dated on or about September 11, 2019, securing APC&#x2019;s obligations to AHM under their management services agreement dated as of July 1, 1999, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Standby Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company established irrevocable standby letters of credit with Truist Bank under the Amended Credit Agreement for a total of $36.5 million for the benefit of CMS and certain health plans as of December&#160;31, 2023. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional one-year periods from the present, or any future expiration date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of $3.9 million for the benefit of certain health plans as of December&#160;31, 2023. The standby letters of credit are automatically extended without amendment for additional one-year periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="c-1" id="f-1043">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s debt balance consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.315%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real Estate Loans*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction Loan *&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Promissory Note Payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Unamortized financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Long-term debt &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;*These loans are a component of Excluded Assets that are solely for the benefit of APC and its common shareholders.</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-218" decimals="-3" id="f-1044" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-219" decimals="-3" id="f-1045" unitRef="usd">180000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-220" decimals="-3" id="f-1046" unitRef="usd">280000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-221" decimals="-3" id="f-1047" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-222" decimals="-3" id="f-1048" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-223" decimals="-3" id="f-1049" unitRef="usd">23168000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-224" decimals="-3" id="f-1050" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-225" decimals="-3" id="f-1051" unitRef="usd">4159000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-226" decimals="-3" id="f-1052" unitRef="usd">2000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-227" decimals="-3" id="f-1053" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-4" decimals="-3" id="f-1054" unitRef="usd">282000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-5" decimals="-3" id="f-1055" unitRef="usd">207327000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-3" id="f-1056" unitRef="usd">19500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-5" decimals="-3" id="f-1057" unitRef="usd">619000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-4" decimals="-3" id="f-1058" unitRef="usd">3561000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-5" decimals="-3" id="f-1059" unitRef="usd">3319000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-1060" unitRef="usd">258939000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-5" decimals="-3" id="f-1061" unitRef="usd">203389000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-1062">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are the future commitments of the Company&#x2019;s debt for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.181%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1063" unitRef="usd">19500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-4" decimals="-3" id="f-1064" unitRef="usd">15750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-4" decimals="-3" id="f-1065" unitRef="usd">21000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-4" decimals="-3" id="f-1066" unitRef="usd">22750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="c-4" decimals="-3" id="f-1067" unitRef="usd">203000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive contextRef="c-4" decimals="-3" id="f-1068" unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LineOfCredit contextRef="c-4" decimals="-3" id="f-1069" unitRef="usd">282000000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentTerm contextRef="c-228" id="f-1070">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-229" decimals="-5" id="f-1071" unitRef="usd">400000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-230" decimals="INF" id="f-1072" unitRef="usd">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-230" decimals="INF" id="f-1073" unitRef="usd">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-231"
      decimals="INF"
      id="f-1074"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-232"
      decimals="INF"
      id="f-1075"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-233"
      decimals="INF"
      id="f-1076"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-234"
      decimals="INF"
      id="f-1077"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-230" decimals="INF" id="f-1078" unitRef="usd">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-235" decimals="INF" id="f-1079" unitRef="usd">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <asth:LineOfCreditFacilityAmountFundedAtClosing contextRef="c-236" decimals="INF" id="f-1080" unitRef="usd">300000000</asth:LineOfCreditFacilityAmountFundedAtClosing>
    <us-gaap:RepaymentsOfDebt contextRef="c-237" decimals="-5" id="f-1081" unitRef="usd">180000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ProceedsFromRepaymentsOfBankOverdrafts contextRef="c-238" decimals="-5" id="f-1082" unitRef="usd">120000000</us-gaap:ProceedsFromRepaymentsOfBankOverdrafts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-239"
      decimals="INF"
      id="f-1083"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-240"
      decimals="INF"
      id="f-1084"
      unitRef="number">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-241"
      decimals="INF"
      id="f-1085"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-242" decimals="-5" id="f-1086" unitRef="usd">280000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-237" decimals="-5" id="f-1087" unitRef="usd">180000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-243"
      decimals="INF"
      id="f-1088"
      unitRef="number">0.00375</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-244"
      decimals="INF"
      id="f-1089"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-245"
      decimals="INF"
      id="f-1090"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-246"
      decimals="INF"
      id="f-1091"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-247"
      decimals="INF"
      id="f-1092"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="c-248"
      decimals="4"
      id="f-1093"
      unitRef="number">0.0769</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount contextRef="c-249" decimals="-3" id="f-1094" unitRef="usd">50000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-250"
      decimals="INF"
      id="f-1095"
      unitRef="number">0.00175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-251"
      decimals="INF"
      id="f-1096"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-252"
      decimals="INF"
      id="f-1097"
      unitRef="number">0.0125</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="c-253"
      decimals="INF"
      id="f-1098"
      unitRef="number">0.0250</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <asth:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="c-254"
      decimals="INF"
      id="f-1099"
      unitRef="number">3.75</asth:DebtInstrumentCovenantLeverageRatioMaximum>
    <asth:DebtCovenantAggregatePurchasePriceMaximum contextRef="c-254" decimals="-5" id="f-1100" unitRef="usd">75000000</asth:DebtCovenantAggregatePurchasePriceMaximum>
    <asth:DebtInstrumentCovenantLeverageRatioIncrementalChange
      contextRef="c-254"
      decimals="INF"
      id="f-1101"
      unitRef="number">0.25</asth:DebtInstrumentCovenantLeverageRatioIncrementalChange>
    <asth:DebtInstrumentCovenantLeverageRatioAdjustedMaximum
      contextRef="c-254"
      decimals="INF"
      id="f-1102"
      unitRef="number">4.00</asth:DebtInstrumentCovenantLeverageRatioAdjustedMaximum>
    <asth:DebtInstrumentCovenantInterestCoverageRatioMinimum
      contextRef="c-255"
      decimals="INF"
      id="f-1103"
      unitRef="number">3.25</asth:DebtInstrumentCovenantInterestCoverageRatioMinimum>
    <us-gaap:LineOfCredit contextRef="c-256" decimals="-5" id="f-1104" unitRef="usd">545000000</us-gaap:LineOfCredit>
    <asth:UnamortizedDeferredFinancingCosts contextRef="c-4" decimals="-5" id="f-1105" unitRef="usd">6100000</asth:UnamortizedDeferredFinancingCosts>
    <asth:UnamortizedDeferredFinancingCosts contextRef="c-5" decimals="-5" id="f-1106" unitRef="usd">3300000</asth:UnamortizedDeferredFinancingCosts>
    <us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet contextRef="c-257" decimals="-5" id="f-1107" unitRef="usd">3900000</us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-258" decimals="-5" id="f-1108" unitRef="usd">2600000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-4" decimals="-5" id="f-1109" unitRef="usd">3600000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <asth:NumberOfRealEstateLoans contextRef="c-1" decimals="INF" id="f-1110" unitRef="loan">3</asth:NumberOfRealEstateLoans>
    <us-gaap:LongTermDebt contextRef="c-259" decimals="-5" id="f-1111" unitRef="usd">5900000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-260" decimals="-5" id="f-1112" unitRef="usd">600000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-261" decimals="-5" id="f-1113" unitRef="usd">600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-262"
      decimals="INF"
      id="f-1114"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-263"
      decimals="INF"
      id="f-1115"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-264"
      decimals="INF"
      id="f-1116"
      unitRef="number">0.0030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-265" decimals="-5" id="f-1117" unitRef="usd">16300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-266"
      decimals="INF"
      id="f-1118"
      unitRef="number">0.020</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongTermDebt contextRef="c-267" decimals="-5" id="f-1119" unitRef="usd">16000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-268" decimals="-5" id="f-1120" unitRef="usd">15600000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-269" decimals="-5" id="f-1121" unitRef="usd">10700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-270" decimals="-5" id="f-1122" unitRef="usd">4200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-271" decimals="-5" id="f-1123" unitRef="usd">8500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-272" decimals="-5" id="f-1124" unitRef="usd">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-273"
      decimals="3"
      id="f-1125"
      unitRef="number">0.010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c-255"
      decimals="4"
      id="f-1126"
      unitRef="number">0.0619</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c-274"
      decimals="4"
      id="f-1127"
      unitRef="number">0.0322</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c-275"
      decimals="4"
      id="f-1128"
      unitRef="number">0.0206</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestExpense contextRef="c-255" decimals="-5" id="f-1129" unitRef="usd">1100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-274" decimals="-5" id="f-1130" unitRef="usd">900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-275" decimals="-5" id="f-1131" unitRef="usd">1200000</us-gaap:InterestExpense>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-276" decimals="INF" id="f-1132" unitRef="usd">4100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-277" decimals="-5" id="f-1133" unitRef="usd">36500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod contextRef="c-278" id="f-1134">P1Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-279" decimals="-5" id="f-1135" unitRef="usd">3900000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod contextRef="c-280" id="f-1136">P1Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1137">Income Taxes &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provision for income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.184%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes differs from the amount computed by applying the federal income tax rate as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.318%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.369%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.933%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at U.S. federal statutory rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible permanent items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable interest entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on sale of investment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;NOL adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undistributed dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spin-off transaction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rate differs from the Federal statutory rate of 21% due to increases from state taxes, non-deductible permanent items, stock-based compensation, gain on sale of investment, and a one-time gain in connection with the December 26, 2023 Spin-Off transaction. This is offset by variable interest entities, change in valuation allowance, and a benefit related to the reversal on deferred taxes on undistributed dividends. The Company had previously recorded deferred tax liabilities related to undistributed dividends for taxpaying groups that could not consolidate under US federal tax law. As a result of the spinoff transaction that occurred on December 26, 2023, the separate taxpaying groups now have the ability to consolidate under US federal tax law, resulting in tax benefits on the future payment of the dividends. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of the Company&#x2019;s deferred tax assets (liabilities) as of December&#160;31, 2023 and 2022, are shown below (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for bad debts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in other entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(648)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undistributed dividend&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; A valuation allowance of $5.9 million and $8.3 million as of December&#160;31, 2023 and 2022, respectively, has been established against the Company&#x2019;s deferred tax assets related to loss entities the Company cannot consolidate under the federal consolidation rules, as realization of these assets is uncertain. Valuation allowance decreased by $2.4 million in 2023 and increased by $4.3&#160;million in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company had federal and California net operating loss carryforwards of approximately $21.0 million and $44.8 million, respectively. The federal and California net operating loss carryforwards will expire at various dates from 2027 through 2043; however, $5.3 million of the federal net operating loss carryforwards do not expire and can be carried forward indefinitely. The Company has determined certain NOLs are limited pursuant to Internal Revenue Code Sections 382 and 383, but does not anticipate these NOLs will expire before utilization. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, the Company does not have any unrecognized tax benefits related to various federal and state income tax matters. The Company will recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to U.S. federal income tax, as well as income tax in California. The Company&#x2019;s and its subsidiaries&#x2019; state&#160;and federal income tax returns are open to audit under the statute of limitations for the years ended December&#160;31, 2019 through December&#160;31, 2022 and for the years ended December&#160;31, 2020 through December&#160;31, 2022, respectively. The Company is currently under audit for federal and California amended tax years ended December&#160;31, 2019, 2020 and 2021. The Company does not anticipate any significant changes to unrecognized tax benefits over the next 12 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1138">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provision for income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.184%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,806)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1139" unitRef="usd">35434000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-31" decimals="-3" id="f-1140" unitRef="usd">35365000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-32" decimals="-3" id="f-1141" unitRef="usd">15623000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1142" unitRef="usd">8999000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-31" decimals="-3" id="f-1143" unitRef="usd">19788000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-32" decimals="-3" id="f-1144" unitRef="usd">8399000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1145" unitRef="usd">44433000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-31" decimals="-3" id="f-1146" unitRef="usd">55153000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-32" decimals="-3" id="f-1147" unitRef="usd">24022000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1148" unitRef="usd">-3638000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-31" decimals="-3" id="f-1149" unitRef="usd">-11552000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-32" decimals="-3" id="f-1150" unitRef="usd">3878000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1151" unitRef="usd">-8806000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-31" decimals="-3" id="f-1152" unitRef="usd">-2726000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-32" decimals="-3" id="f-1153" unitRef="usd">3793000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1154" unitRef="usd">-12444000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-31" decimals="-3" id="f-1155" unitRef="usd">-14278000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-32" decimals="-3" id="f-1156" unitRef="usd">7671000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1157" unitRef="usd">31989000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-31" decimals="-3" id="f-1158" unitRef="usd">40875000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-32" decimals="-3" id="f-1159" unitRef="usd">31693000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1160">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes differs from the amount computed by applying the federal income tax rate as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.318%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.369%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.933%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax provision at U.S. federal statutory rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible permanent items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable interest entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on sale of investment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;NOL adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undistributed dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spin-off transaction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c-1"
      decimals="INF"
      id="f-1161"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c-31"
      decimals="INF"
      id="f-1162"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c-32"
      decimals="INF"
      id="f-1163"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-1164" unitRef="number">0.116</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-31" decimals="3" id="f-1165" unitRef="number">0.121</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-32" decimals="3" id="f-1166" unitRef="number">0.129</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <asth:EffectiveIncomeTaxRateReconciliationFederalRateAdjustment contextRef="c-1" decimals="3" id="f-1167" unitRef="number">0.025</asth:EffectiveIncomeTaxRateReconciliationFederalRateAdjustment>
    <asth:EffectiveIncomeTaxRateReconciliationFederalRateAdjustment contextRef="c-31" decimals="3" id="f-1168" unitRef="number">0.009</asth:EffectiveIncomeTaxRateReconciliationFederalRateAdjustment>
    <asth:EffectiveIncomeTaxRateReconciliationFederalRateAdjustment contextRef="c-32" decimals="3" id="f-1169" unitRef="number">0.040</asth:EffectiveIncomeTaxRateReconciliationFederalRateAdjustment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary contextRef="c-1" decimals="3" id="f-1170" unitRef="number">-0.021</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary contextRef="c-31" decimals="3" id="f-1171" unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary contextRef="c-32" decimals="3" id="f-1172" unitRef="number">-0.013</us-gaap:EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="3" id="f-1173" unitRef="number">0.028</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-31" decimals="3" id="f-1174" unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-32" decimals="3" id="f-1175" unitRef="number">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="3" id="f-1176" unitRef="number">-0.026</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-31" decimals="3" id="f-1177" unitRef="number">0.044</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-32" decimals="3" id="f-1178" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <asth:EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent contextRef="c-1" decimals="3" id="f-1179" unitRef="number">0.085</asth:EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent>
    <asth:EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent contextRef="c-31" decimals="3" id="f-1180" unitRef="number">0.012</asth:EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent>
    <asth:EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent contextRef="c-32" decimals="3" id="f-1181" unitRef="number">-0.021</asth:EffectiveIncomeTaxRateReconciliationTaxCreditChangeInInvestmentPercent>
    <asth:EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent contextRef="c-1" decimals="3" id="f-1182" unitRef="number">0.002</asth:EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent>
    <asth:EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent contextRef="c-31" decimals="3" id="f-1183" unitRef="number">0.005</asth:EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent>
    <asth:EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent contextRef="c-32" decimals="3" id="f-1184" unitRef="number">-0.001</asth:EffectiveIncomeTaxRateReconciliationNetOperatingLossAdjustmentPercent>
    <asth:EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent contextRef="c-1" decimals="3" id="f-1185" unitRef="number">-0.115</asth:EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent>
    <asth:EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent contextRef="c-31" decimals="3" id="f-1186" unitRef="number">0.072</asth:EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent>
    <asth:EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent contextRef="c-32" decimals="3" id="f-1187" unitRef="number">0.080</asth:EffectiveIncomeTaxRateReconciliationUndistributedDividendPercent>
    <asth:EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent contextRef="c-1" decimals="3" id="f-1188" unitRef="number">0.030</asth:EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent>
    <asth:EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent contextRef="c-31" decimals="3" id="f-1189" unitRef="number">0</asth:EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent>
    <asth:EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent contextRef="c-32" decimals="3" id="f-1190" unitRef="number">0</asth:EffectiveIncomeTaxRateReconciliationSpinOffTransactionPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-1" decimals="3" id="f-1191" unitRef="number">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-31" decimals="3" id="f-1192" unitRef="number">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-32" decimals="3" id="f-1193" unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="c-1" decimals="3" id="f-1194" unitRef="number">0.355</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="c-31" decimals="3" id="f-1195" unitRef="number">0.471</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="c-32" decimals="3" id="f-1196" unitRef="number">0.411</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c-1"
      decimals="INF"
      id="f-1197"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1198">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of the Company&#x2019;s deferred tax assets (liabilities) as of December&#160;31, 2023 and 2022, are shown below (in thousands).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.637%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.639%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax assets &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for bad debts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in other entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets before valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,301)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(648)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Undistributed dividend&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,214)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsStateTaxes contextRef="c-4" decimals="-3" id="f-1199" unitRef="usd">2831000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsStateTaxes contextRef="c-5" decimals="-3" id="f-1200" unitRef="usd">2489000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-4" decimals="-3" id="f-1201" unitRef="usd">1747000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-5" decimals="-3" id="f-1202" unitRef="usd">670000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-4" decimals="-3" id="f-1203" unitRef="usd">1718000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-5" decimals="-3" id="f-1204" unitRef="usd">853000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <asth:DeferredTaxAssetsInvestment contextRef="c-4" decimals="-3" id="f-1205" unitRef="usd">1355000</asth:DeferredTaxAssetsInvestment>
    <asth:DeferredTaxAssetsInvestment contextRef="c-5" decimals="-3" id="f-1206" unitRef="usd">2145000</asth:DeferredTaxAssetsInvestment>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-4" decimals="-3" id="f-1207" unitRef="usd">7551000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-3" id="f-1208" unitRef="usd">9383000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <asth:DeferredTaxAssetsLeaseLiability contextRef="c-4" decimals="-3" id="f-1209" unitRef="usd">10897000</asth:DeferredTaxAssetsLeaseLiability>
    <asth:DeferredTaxAssetsLeaseLiability contextRef="c-5" decimals="-3" id="f-1210" unitRef="usd">6470000</asth:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities contextRef="c-4" decimals="-3" id="f-1211" unitRef="usd">1284000</us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities contextRef="c-5" decimals="-3" id="f-1212" unitRef="usd">8971000</us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-4" decimals="-3" id="f-1213" unitRef="usd">663000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-5" decimals="-3" id="f-1214" unitRef="usd">1011000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-4" decimals="-3" id="f-1215" unitRef="usd">0</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-5" decimals="-3" id="f-1216" unitRef="usd">2000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="-3" id="f-1217" unitRef="usd">28046000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="-3" id="f-1218" unitRef="usd">31994000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-1219" unitRef="usd">5904000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-1220" unitRef="usd">8292000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-4" decimals="-3" id="f-1221" unitRef="usd">22142000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-5" decimals="-3" id="f-1222" unitRef="usd">23702000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-1223" unitRef="usd">329000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-1224" unitRef="usd">1840000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-4" decimals="-3" id="f-1225" unitRef="usd">15301000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="c-5" decimals="-3" id="f-1226" unitRef="usd">21268000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-4" decimals="-3" id="f-1227" unitRef="usd">9936000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-5" decimals="-3" id="f-1228" unitRef="usd">5632000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts contextRef="c-4" decimals="-3" id="f-1229" unitRef="usd">648000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts contextRef="c-5" decimals="-3" id="f-1230" unitRef="usd">725000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts>
    <asth:DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend contextRef="c-4" decimals="-3" id="f-1231" unitRef="usd">0</asth:DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend>
    <asth:DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend contextRef="c-5" decimals="-3" id="f-1232" unitRef="usd">8454000</asth:DeferredTaxLiabilitiesDeferredExpenseUndistributedDividend>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="-3" id="f-1233" unitRef="usd">26214000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-5" decimals="-3" id="f-1234" unitRef="usd">37919000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-4" decimals="-3" id="f-1235" unitRef="usd">4072000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-5" decimals="-3" id="f-1236" unitRef="usd">14217000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-5" id="f-1237" unitRef="usd">5900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-5" id="f-1238" unitRef="usd">8300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-1239" unitRef="usd">-2400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-31" decimals="-5" id="f-1240" unitRef="usd">-4300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards contextRef="c-281" decimals="-5" id="f-1241" unitRef="usd">21000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-282" decimals="-5" id="f-1242" unitRef="usd">44800000</us-gaap:OperatingLossCarryforwards>
    <asth:OperatingLossCarryforwardsNotSubjectToExpiration contextRef="c-281" decimals="-5" id="f-1243" unitRef="usd">5300000</asth:OperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-1244">Mezzanine and Stockholders&#x2019; Equity (Deficit)&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Mezzanine Equity (Deficit)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;APC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the redemption feature (see Note 2 &#x2014; &#x201c;Basis of Presentation and Summary of Significant Accounting Policies&#x201d;) of APC&#x2019;s shares of common stock is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as non-controlling interests in mezzanine or temporary equity. APC&#x2019;s shares were not redeemable, and it was not probable that the shares would become redeemable as of December&#160;31, 2023, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock &#x2013; Series A&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2015, Astrana entered into an agreement with AHM, a wholly owned subsidiary of Astrana, pursuant to which Astrana sold to AHM, and AHM purchased from Astrana, in a private offering of securities, 1,111,111 units, each unit consisting of one share of Astrana&#x2019;s Series A Preferred Stock and a common stock warrant to purchase one share of Astrana&#x2019;s common stock at an exercise price of $9.00 per share. AHM paid Astrana an aggregate of $10.0 million for the units. Holders of the Company&#x2019;s shares of Series A preferred stock are entitled to receive dividends out of legally available assets, on parity with the holders of the Company&#x2019;s shares of common stock. The Series A preferred stock has a liquidation preference in the amount of $9.00 per share plus any declared and unpaid dividends, and is convertible into common stock, at the option of the holder thereof, at any time after issuance, at an initial conversion rate of one-for-one, in each case, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock &#x2013; Series B&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2016, Astrana entered into an agreement with AHM pursuant to which Astrana sold to AHM, and AHM purchased from Astrana, in a private offering of securities, 555,555 units, each unit consisting of one share of Astrana&#x2019;s Series B Preferred Stock and a common stock warrant to purchase one share of Astrana&#x2019;s common stock at an exercise price of $10.00 per share. AHM paid Astrana an aggregate $5.0 million for the units. Holders of the Company&#x2019;s shares of Series B preferred stock are entitled to receive dividends out of legally available assets, on parity with the holders of the Company&#x2019;s shares of common stock. The Series B preferred stock has a liquidation preference in the amount of $9.00 per share plus any declared and unpaid dividends, and is convertible into common stock, at the option of the holder thereof, at any time after issuance, at an initial conversion rate of one-for-one, in each case, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the rights of preferred stockholders, if any, holders of the Company&#x2019;s common stock are entitled to receive such dividends, if any, as may be declared from time to time by the Company&#x2019;s board of directors, at its discretion, from legally available funds. In the event of a liquidation, dissolution or winding up, the holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of the Company&#x2019;s known debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2017 Share Issuances and Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, Astrana completed its business combination with AHM following the satisfaction or waiver of the conditions set forth in the Agreement and Plan of Merger, dated December 21, 2016, as amended, pursuant to which the merger subsidiary of Astrana merged with and into AHM, with AHM surviving as a wholly owned subsidiary of Astrana (&#x201c;2017 Merger&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the 2017 Merger, former AHM shareholders received Astrana common stock subject to a 10% holdback. As of December&#160;31, 2023, 41,048 holdback shares have not been issued to certain former AHM shareholders who were AHM shareholders at the time of closing of the 2017 Merger, as they have yet to submit properly completed letters of transmittal to Astrana in order to receive their pro rata portion of Astrana common stock as contemplated under the Merger Agreement. Pending such receipt, such former AHM shareholders have the right to receive, without interest, their pro rata share of dividends or distributions with a record date after the effectiveness of the 2017 Merger. The consolidated financial statements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered perfunctory and the Company is legally obligated to issue these shares in connection with the 2017 Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, APC declared dividends of $58.0 million, $58.3 million and $57.9 million, respectively, to their Series A Preferred shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, APC declared dividends of $210.9 million, $37.9 million and $29.9 million, respectively, to their common shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, certain consolidated subsidiaries of the Company paid distributions of $3.9 million, $4.1 million and $1.2 million, respectively, to the shareholders who own the non-controlling interests in the entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, APC owned 7,132,698 and 10,299,259 shares of Astrana&#x2019;s common stock, respectively. While such shares of Astrana&#x2019;s common stock are legally issued and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the consolidated financial statements. APC's ownership in Astrana was 13.22% and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.12%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as of December&#160;31, 2023 and 2022, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, Astrana bought back 3,451,642 shares of its common stock, which included 3,166,561 shares of common stock purchased from APC for $100.0 million on November 14, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, the total treasury stock, including the Company&#x2019;s stock held by APC, was 10,584,340 and 10,299,259, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-283"
      decimals="INF"
      id="f-1245"
      unitRef="shares">1111111</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c-284"
      decimals="INF"
      id="f-1246"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c-284"
      decimals="INF"
      id="f-1247"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-284"
      decimals="2"
      id="f-1248"
      unitRef="usdPerShare">9.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-283" decimals="-5" id="f-1249" unitRef="usd">10000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="c-285"
      decimals="INF"
      id="f-1250"
      unitRef="usdPerShare">9.00</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c-284"
      decimals="INF"
      id="f-1251"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-286"
      decimals="INF"
      id="f-1252"
      unitRef="shares">555555</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c-287"
      decimals="INF"
      id="f-1253"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c-287"
      decimals="INF"
      id="f-1254"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-287"
      decimals="2"
      id="f-1255"
      unitRef="usdPerShare">10.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-286" decimals="-5" id="f-1256" unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="c-287"
      decimals="INF"
      id="f-1257"
      unitRef="usdPerShare">9.00</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c-287"
      decimals="INF"
      id="f-1258"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <asth:StockIssuedDuringPeriodSharesMerger
      contextRef="c-1"
      decimals="INF"
      id="f-1259"
      unitRef="shares">41048</asth:StockIssuedDuringPeriodSharesMerger>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-288" decimals="-5" id="f-1260" unitRef="usd">58000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-289" decimals="-5" id="f-1261" unitRef="usd">58300000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-290" decimals="-5" id="f-1262" unitRef="usd">57900000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-291" decimals="-5" id="f-1263" unitRef="usd">210900000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-292" decimals="-5" id="f-1264" unitRef="usd">37900000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-293" decimals="-5" id="f-1265" unitRef="usd">29900000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-294" decimals="-5" id="f-1266" unitRef="usd">3900000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-295" decimals="-5" id="f-1267" unitRef="usd">4100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-296" decimals="-5" id="f-1268" unitRef="usd">1200000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-297"
      decimals="INF"
      id="f-1269"
      unitRef="shares">7132698</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-298"
      decimals="INF"
      id="f-1270"
      unitRef="shares">10299259</us-gaap:TreasuryStockCommonShares>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-299"
      decimals="4"
      id="f-1271"
      unitRef="number">0.1322</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-300"
      decimals="4"
      id="f-1272"
      unitRef="number">0.1812</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-1"
      decimals="INF"
      id="f-1273"
      unitRef="shares">3451642</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-301"
      decimals="INF"
      id="f-1274"
      unitRef="shares">3166561</us-gaap:TreasuryStockCommonShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-302" decimals="-5" id="f-1275" unitRef="usd">100000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-303"
      decimals="INF"
      id="f-1276"
      unitRef="shares">10584340</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-304"
      decimals="INF"
      id="f-1277"
      unitRef="shares">10299259</us-gaap:TreasuryStockCommonShares>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-1278">Stock-Based Compensation&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the 2017 Merger, the Company assumed the 2013 Equity Incentive Plan (the &#x201c;2013 Plan&#x201d;), pursuant to which 500,000 shares of the Company&#x2019;s common stock were reserved for issuance thereunder. The Company issued new shares to satisfy stock options and warrant exercises under the 2013 Plan. As of December&#160;31, 2023, there were no shares available for future grants under the 2013 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the 2017 Merger, the Company assumed the 2015 Equity Incentive Plan (as amended, the &#x201c;2015 Plan&#x201d;), pursuant to which 1,500,000 shares of the Company&#x2019;s common stock were reserved for issuance thereunder. The Company&#x2019;s stockholders approved an amendment to the 2015 Plan at the 2021 annual meeting of stockholders to increase the maximum number of shares authorized for issuance thereunder by 2,000,000 shares, from 1,500,000 shares to 3,500,000 shares. In addition, shares that are subject to outstanding grants under the Company&#x2019;s 2013 Plan, but that ordinarily would have been restored to such plans reserve due to award forfeitures and terminations, were rolled into and became available for awards under the 2015 Plan. The 2015 Plan provides for awards, including incentive stock options, non-qualified options, restricted common stock, and stock appreciation rights. The 2015 Plan was approved by Astrana&#x2019;s stockholders at Astrana&#x2019;s 2016 annual meeting of stockholders that was held in September 2016. As of December&#160;31, 2023, 2022 and 2021, there were approximately 0.4 million, 1.1 million and 1.7 million shares available for future grants under the 2015 Plan, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 15, 2023, the Company adopted the Employment Inducement Award Plan (the &#x201c;Inducement Plan&#x201d;), pursuant to which the Company may from time to time grant equity-based awards to new employees as a material inducement to their employment. Awards granted under the Inducement Plan may be in the form of non-qualified stock options, stock appreciation rights, restricted stock awards, restricted stock units, and other stock-based awards. A total of 500,000 shares of the Company&#x2019;s common stock, par value $0.001 per share, have been reserved for issuance pursuant to awards granted under the Inducement Plan (subject to adjustment as provided in the Inducement Plan). As of December&#160;31, 2023, there were approximately 0.5 million shares available for future grants in the Inducement Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the stock-based compensation expense recognized under all of the Company&#x2019;s stock plans in 2023, 2022 and 2021, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income recognized (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.847%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized compensation expense related to total share-based payments outstanding as of December&#160;31, 2023 was $32.2&#160;million and is expected to be recognized over a weighted-average period of 2.1 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s outstanding stock options consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options canceled, forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215,609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023 and 2022, stock options were exercised for 140,000 and 41,603 shares, respectively, of the Company&#x2019;s common stock, which resulted in proceeds of approximately $1.5 million and $0.7 million, respectively. The exercise prices ranged from $10.00 to $18.11 per share for the exercises during the year ended December&#160;31, 2023 and $15.35 to $23.24 per share for the exercises during the year ended December&#160;31, 2022. The total intrinsic value of stock options exercised was $3.5 million, $1.0 million and $2.8 million during the years ended December&#160;31, 2023, 2022 and 2021, respectively. The intrinsic value of stock options is defined as the difference between the Company&#x2019;s stock price on the exercise date and the grant date exercise price. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, no options were granted. The weighted-average grant-date fair value of options granted during the years ended December&#160;31, 2022 and 2021 was $22.32, and $32.63, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unvested restricted stock award activity for the year ended December&#160;31, 2023 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.502%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.278%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Performance Based Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average &lt;br/&gt;Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average &lt;br/&gt;Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,632&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$72.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,635&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$41.14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,228&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.90&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.61&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260,637)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158,421)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,939)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,267)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713,284&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$60.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,333&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$35.05&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants restricted stock awards to employees and executives, which are earned based on service conditions. The awards will vest over a period of one month to four years in accordance with the terms of those plans. The grant date fair value of the restricted stock awards is the grant date&#x2019;s closing market price of the Company&#x2019;s common stock. During the year ended December&#160;31, 2023, the Company granted 561,386 shares of restricted stock awards with performance based conditions and 480,228 shares of restricted stock without performance conditions. During the year ended December&#160;31, 2023, the weighted average grant date fair value of restricted stock with and without performance based conditions was $33.61 and $33.90, respectively. Shares of restricted stock with performance conditions are recognized to the extent the performance conditions are probable of being achieved. The total fair value of restricted stock awards, as of their respective vesting dates during the years ended December&#160;31, 2023, 2022 and 2021, was $14.3 million, $10.8 million and $1.1 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;All warrants issued by the Company expired as of December 31, 2022. As a result, there were no outstanding warrants as of December&#160;31, 2023 and December&#160;31, 2022. During the twelve months ended December&#160;31, 2022, common stock warrants were exercised for 0.9 million shares of the Company&#x2019;s common stock, which resulted in proceeds of approximately $9.0 million. The exercise price ranged from $10.00 to $11.00 per share for the exercises during the twelve months ended December&#160;31, 2022. Of the 0.9 million warrants exercised during the year ended December&#160;31, 2022, 0.1 million of the common stock warrants were exercised by APC and are treated as treasury shares (see Note 12 &#x2014; &#x201c;Mezzanine and Stockholders&#x2019; Equity&#x201d;).</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-305"
      decimals="INF"
      id="f-1279"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-306"
      decimals="INF"
      id="f-1280"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-307"
      decimals="INF"
      id="f-1281"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c-308"
      decimals="INF"
      id="f-1282"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-307"
      decimals="INF"
      id="f-1283"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-309"
      decimals="INF"
      id="f-1284"
      unitRef="shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-310"
      decimals="-5"
      id="f-1285"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-311"
      decimals="-5"
      id="f-1286"
      unitRef="shares">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-309"
      decimals="-5"
      id="f-1287"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-312"
      decimals="INF"
      id="f-1288"
      unitRef="shares">500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-312"
      decimals="INF"
      id="f-1289"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-313"
      decimals="-5"
      id="f-1290"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-1291">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the stock-based compensation expense recognized under all of the Company&#x2019;s stock plans in 2023, 2022 and 2021, and associated with the issuance of restricted shares of common stock and vesting of stock options that are included in general and administrative expenses in the accompanying consolidated statements of income recognized (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:52.847%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.525%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-314" decimals="-3" id="f-1292" unitRef="usd">1790000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-315" decimals="-3" id="f-1293" unitRef="usd">3792000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-316" decimals="-3" id="f-1294" unitRef="usd">2480000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-317" decimals="-3" id="f-1295" unitRef="usd">20250000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-318" decimals="-3" id="f-1296" unitRef="usd">12309000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-319" decimals="-3" id="f-1297" unitRef="usd">4265000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-1298" unitRef="usd">22040000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-31" decimals="-3" id="f-1299" unitRef="usd">16101000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-32" decimals="-3" id="f-1300" unitRef="usd">6745000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-310" decimals="-5" id="f-1301" unitRef="usd">32200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-320" id="f-1302">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-1303">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s outstanding stock options consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(140,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options canceled, forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215,609)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;504,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-5"
      decimals="INF"
      id="f-1304"
      unitRef="shares">859850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-1305"
      unitRef="usdPerShare">25.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-31" id="f-1306">P2Y2M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-5" decimals="-5" id="f-1307" unitRef="usd">10300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-1308"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1309"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-1"
      decimals="INF"
      id="f-1310"
      unitRef="shares">140000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1311"
      unitRef="usdPerShare">10.87</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-5" id="f-1312" unitRef="usd">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-1313"
      unitRef="shares">215609</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1314"
      unitRef="usdPerShare">16.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-4"
      decimals="INF"
      id="f-1315"
      unitRef="shares">504241</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1316"
      unitRef="usdPerShare">34.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-1317">P2Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-5" id="f-1318" unitRef="usd">4700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-4"
      decimals="INF"
      id="f-1319"
      unitRef="shares">466411</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1320"
      unitRef="usdPerShare">28.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-1321">P1Y10M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="-5" id="f-1322" unitRef="usd">4700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-1"
      decimals="INF"
      id="f-1323"
      unitRef="shares">140000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-31"
      decimals="INF"
      id="f-1324"
      unitRef="shares">41603</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-321" decimals="-5" id="f-1325" unitRef="usd">1500000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-322" decimals="-5" id="f-1326" unitRef="usd">700000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-95"
      decimals="2"
      id="f-1327"
      unitRef="usdPerShare">10.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-96"
      decimals="2"
      id="f-1328"
      unitRef="usdPerShare">18.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-323"
      decimals="2"
      id="f-1329"
      unitRef="usdPerShare">15.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-324"
      decimals="2"
      id="f-1330"
      unitRef="usdPerShare">23.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-5" id="f-1331" unitRef="usd">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-31" decimals="-5" id="f-1332" unitRef="usd">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-32" decimals="-5" id="f-1333" unitRef="usd">2800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-31"
      decimals="2"
      id="f-1334"
      unitRef="usdPerShare">22.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-32"
      decimals="2"
      id="f-1335"
      unitRef="usdPerShare">32.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-1336">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unvested restricted stock award activity for the year ended December&#160;31, 2023 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.502%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.274%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.278%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Performance Based Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average &lt;br/&gt;Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of &lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average &lt;br/&gt;Grant-Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539,632&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$72.58&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,635&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$41.14&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,228&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.90&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.61&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260,637)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158,421)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,939)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,267)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;713,284&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$60.98&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627,333&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$35.05&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-325"
      decimals="INF"
      id="f-1337"
      unitRef="shares">539632</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-325"
      decimals="2"
      id="f-1338"
      unitRef="usdPerShare">72.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-326"
      decimals="INF"
      id="f-1339"
      unitRef="shares">289635</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-326"
      decimals="2"
      id="f-1340"
      unitRef="usdPerShare">41.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-327"
      decimals="INF"
      id="f-1341"
      unitRef="shares">480228</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-327"
      decimals="2"
      id="f-1342"
      unitRef="usdPerShare">33.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-328"
      decimals="INF"
      id="f-1343"
      unitRef="shares">561386</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-328"
      decimals="2"
      id="f-1344"
      unitRef="usdPerShare">33.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-327"
      decimals="INF"
      id="f-1345"
      unitRef="shares">260637</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-327"
      decimals="2"
      id="f-1346"
      unitRef="usdPerShare">39.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-328"
      decimals="INF"
      id="f-1347"
      unitRef="shares">158421</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-328"
      decimals="2"
      id="f-1348"
      unitRef="usdPerShare">37.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-327"
      decimals="INF"
      id="f-1349"
      unitRef="shares">45939</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-327"
      decimals="2"
      id="f-1350"
      unitRef="usdPerShare">36.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-328"
      decimals="INF"
      id="f-1351"
      unitRef="shares">65267</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-328"
      decimals="2"
      id="f-1352"
      unitRef="usdPerShare">42.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-329"
      decimals="INF"
      id="f-1353"
      unitRef="shares">713284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-329"
      decimals="2"
      id="f-1354"
      unitRef="usdPerShare">60.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-330"
      decimals="INF"
      id="f-1355"
      unitRef="shares">627333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-330"
      decimals="2"
      id="f-1356"
      unitRef="usdPerShare">35.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-331" id="f-1357">P1M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-332" id="f-1358">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-333"
      decimals="INF"
      id="f-1359"
      unitRef="shares">561386</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance
      contextRef="c-333"
      decimals="0"
      id="f-1360"
      unitRef="shares">480228</asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-334"
      decimals="2"
      id="f-1361"
      unitRef="usdPerShare">33.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-333"
      decimals="2"
      id="f-1362"
      unitRef="usdPerShare">33.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-333" decimals="-5" id="f-1363" unitRef="usd">14300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-335" decimals="-5" id="f-1364" unitRef="usd">10800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-336" decimals="-5" id="f-1365" unitRef="usd">1100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-5"
      decimals="INF"
      id="f-1366"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-4"
      decimals="INF"
      id="f-1367"
      unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod
      contextRef="c-31"
      decimals="-5"
      id="f-1368"
      unitRef="shares">900000</asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod>
    <asth:WarrantIssuedDuringPeriodValueStockOptionsExercised contextRef="c-31" decimals="-5" id="f-1369" unitRef="usd">9000000</asth:WarrantIssuedDuringPeriodValueStockOptionsExercised>
    <asth:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice
      contextRef="c-337"
      decimals="2"
      id="f-1370"
      unitRef="usdPerShare">10.00</asth:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice>
    <asth:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice
      contextRef="c-338"
      decimals="2"
      id="f-1371"
      unitRef="usdPerShare">11.00</asth:ShareBasedCompensationArrangementBySharebasedPaymentAwardWarrantExercisedExercisePrice>
    <asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod
      contextRef="c-31"
      decimals="-5"
      id="f-1372"
      unitRef="shares">900000</asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod>
    <asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod
      contextRef="c-291"
      decimals="-5"
      id="f-1373"
      unitRef="shares">100000</asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriod>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1374">Commitments and Contingencies&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulatory Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laws and regulations governing the Medicare program and healthcare generally are complex and subject to interpretation. The Company believes it complies with all applicable laws and regulations and is unaware of any pending or threatened investigations involving allegations of potential wrongdoing. While no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medi-Cal programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a risk-bearing organization, the Company is required to follow regulations of the Department of Managed Health Care (&#x201c;DMHC&#x201d;). The Company must comply with a minimum working capital requirement, tangible net equity (&#x201c;TNE&#x201d;) requirement, cash-to-claims ratio, and claims payment requirements prescribed by the DMHC. TNE is defined as net assets less intangibles, less non-allowable assets (which include amounts due from affiliates), plus subordinated obligations.  At December&#160;31, 2023 and 2022, the consolidated IPAs were in compliance with these regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Many of the Company&#x2019;s payer and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services. Such differing interpretations may not come to light until a substantial period of time has passed following contract implementation. Liabilities for claims disputes are recorded when the loss is probable and can be estimated. Any adjustments to reserves are reflected in current operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Standby Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company established irrevocable standby letters of credit with Truist Bank for a total of $36.5 million for the benefit of CMS and certain health plans as of December&#160;31, 2023 (see Note 10 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit &#x2014; Standby Letters of Credit&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank for a total of $3.9 million, for the benefit of certain health plans as of December&#160;31, 2023 (see Note 10 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit &#x2014; Standby Letters of Credit&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of its business. The resolution of any claim or litigation is subject to inherent uncertainty and could have a material adverse effect on the Company&#x2019;s financial condition, cash flows, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liability Insurance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that its insurance coverage is appropriate based upon the Company&#x2019;s claims experience and the nature and risks of the Company&#x2019;s business. In addition to the known incidents that have resulted in the assertion of claims, the Company cannot be certain that its insurance coverage will be adequate to cover liabilities arising out of claims asserted against the Company, the Company&#x2019;s affiliated professional organizations or the Company&#x2019;s affiliated hospitalists in the future where the outcomes of such claims are unfavorable. The Company believes that the ultimate resolution of all pending claims, including liabilities in excess of the Company&#x2019;s insurance coverage, will not have a material adverse effect on the Company&#x2019;s financial position, results of operations, or cash flows; however, there can be no assurance that future claims will not have such a material adverse effect on the Company&#x2019;s business. Contracted physicians are required to obtain their own insurance coverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s contracted physicians are required to carry first-dollar coverage with limits of liability equal to not less than $1.0&#160;million for claims based on occurrence up to an aggregate of $3.0&#160;million per year. The Company&#x2019;s IPAs purchase stop-loss insurance, which will reimburse them for claims from service providers on a per enrollee basis. The specific retention amount per enrollee per policy period is $45,000 to $90,000 for professional coverage.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company currently maintains liability insurance policies on a claims-made basis, which are intended to cover malpractice liability and certain other claims, the coverage must be renewed annually, and may&#160;not continue to be available to the Company in future years at acceptable costs, and on favorable terms.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-277" decimals="-5" id="f-1375" unitRef="usd">36500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-279" decimals="-5" id="f-1376" unitRef="usd">3900000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities contextRef="c-1" decimals="-5" id="f-1377" unitRef="usd">1000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <asth:ClaimsBasedOnOccurrenceAnAggregateAmount contextRef="c-1" decimals="-5" id="f-1378" unitRef="usd">3000000</asth:ClaimsBasedOnOccurrenceAnAggregateAmount>
    <us-gaap:ProfessionalFees contextRef="c-339" decimals="-3" id="f-1379" unitRef="usd">45000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c-340" decimals="-3" id="f-1380" unitRef="usd">90000</us-gaap:ProfessionalFees>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-1381">Related-Party Transactions&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022, and 2021, AHM recognized approximately $16.7 million, $21.2 million, and $18.7 million, respectively, in management fee income, from LMA. On August 31, 2023, the management service agreement between LMA&#x2019;s IPA and AHM was terminated. LMA is accounted for under the equity method based on 25% equity ownership interest held by APC (see Note 6 &#x2014; &#x201c;Investments in Other Entities&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, APC paid approximately $2.7 million, $2.7 million and $2.4 million, respectively, to Pacific Medical Imaging and Oncology Center, Inc. (&#x201c;PMIOC&#x201d;) for provider services. APC and PMIOC have an Ancillary Service Contract together whereby PMIOC provides covered services on behalf of APC to enrollees of the plans of APC. PMIOC is accounted for under the equity method based on 40% equity ownership interest held by APC (see Note 6 &#x2014; &#x201c;Investments in Other Entities&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, the Company paid approximately $1.1 million, to James Song, M.D., a Professional Corporation (&#x201c;Song PC&#x201d;) for provider services. Song PC is accounted for under the equity method accounting based on 25% equity ownership interest held by a subsidiary of the Company (see Note 6 &#x2014; &#x201c;Investments in Other Entities&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Astrana Board Members and Officers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, AHM recognized approximately $2.1 million, $1.8 million and $1.6 million, respectively, in management fee income from Arroyo Vista Family Health Center (&#x201c;Arroyo Vista&#x201d;). Arroyo Vista&#x2019;s chief executive officer is a member of the Company&#x2019;s board of directors. The Company has a managed service agreement with Arroyo Vista. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023 2022 and 2021, the Company paid approximately $0.3 million, $0.3&#160;million and $0.4&#160;million respectively, to Arroyo Vista for services as a provider. The Company has provider contracts with Arroyo Vista. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2023, the Company recognized $14.1 million in operating lease right-of-use assets and $14.5 million in operating lease liabilities from certain lease agreements with properties that were spun-off as part of the Spin-Off. The chief executive officer of the real estate business managing these properties is also a member of the Company&#x2019;s board of directors. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, APC paid approximately $0.3 million, $0.6 million and $0.7 million, respectively, to Advanced Diagnostic Surgery Center for services as a provider. Advanced Diagnostic Surgery Center shares common ownership with certain board members of Astrana. The Company has provider contracts with Advanced Diagnostic Surgery Center.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, APC recognized approximately $0.6 million, $0.6 million and $0.6 million respectively, in rental income from Advanced Diagnostic Surgery Center. Advanced Diagnostic Surgery Center is leasing from a property that is a component of Excluded Assets. The property was spun-off on December 26, 2023, as part of the Spin-Off. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, APC paid approximately $10,000, $0.6 million and $2.0 million respectively, to Fulgent Genetics, Inc. for services as a provider. One of the Company&#x2019;s board members is a board member of Fulgent Genetics, Inc. The Company has provider contracts with Fulgent Genetics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, the Company incurred approximately $1.3 million in expenses payable to Third Way Health for call center services. One of Astrana&#x2019;s officers is a board member of Third Way Health in 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022 and 2021, the Company paid approximately $2.6 million, $1.9 million and $1.3 million, respectively, to Sunny Village Care Center for services as a provider. Sunny Village Care Center shares common ownership with certain Astrana board members and officers. The Company has provider contracts with Sunny Village Care Center. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023 and 2022, APC recognized approximately $1.1 million and $0.3 million, respectively, in rental income from Sunny Village Care Center. Sunny Village Care Center is leasing from a property that is a component of Excluded Assets. The property was spun-off on December 26, 2023 as part of the Spin-Off. Refer to Note 1 &#x2014; &#x201c;Description of Business&#x201d; to the consolidated financial statements for information on the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Company entered into a three-year promissory note with Sunny Village Care Center as the borrower for a principal amount of $0.5 million. The loan balance is presented within long-term debt, net of current portion and deferred financing costs in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, the Company incurred rent expense of approximately $0.1 million from First Commonwealth Property, LLC for office leases. First Commonwealth Property, LLC shares common ownership with certain board members of Astrana. The Company has lease arrangements with First Commonwealth Property, LLC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, Astrana paid approximately $9.8 million, to purchase Astrana&#x2019;s stock from certain board members. During the year ended December&#160;31, 2022, APC paid approximately $9.3 million to purchase Astrana&#x2019;s stock from a board member. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, AHM paid approximately $44,000 to an Astrana board member for consulting services. The Company did not incur any similar expenses for the years ended December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreements with Health Source MSO Inc., a California corporation (&#x201c;HSMSO&#x201d;), Aurion Corporation (&#x201c;Aurion&#x201d;), and AHMC for services provided to the Company. One of the Company&#x2019;s board members is an officer of AHMC, HSMSO, and Aurion. Aurion is also partially owned by one of the Company&#x2019;s board members. Revenue with AHMC and HSMSO consists of capitation, risk pool, and miscellaneous fees and expenses consist of claims expense, management fees, and consulting fees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth fees incurred and income received related to AHMC, HSMSO, and Aurion (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.048%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;AHMC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;HSMSO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;AURION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;AHMC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;HSMSO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;AURION&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. Under this agreement, during the years ended December&#160;31, 2023, 2022 and 2021, the Company has recognized risk pool revenue of $43.8 million, $50.5 million and $60.1 million, respectively, of which $54.0 million and $58.7 million, remained outstanding as of December&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;APC Board Members&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022, and 2021, the Company paid an aggregate of approximately $23.1 million, $34.5 million, and $32.5 million, respectively, to board members for provider services which included approximately $4.2 million, $3.7 million and $3.4 million, respectively, to Astrana board members and officers who are also board members and officers of APC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 6, 2023, the Company entered into a stock repurchase agreement with APC, pursuant to which the Company agreed to repurchase approximately $100.0 million, or 3,166,561 shares, of the Company&#x2019;s common stock from APC. APC is a consolidated affiliate of the Company of which Dr. Thomas Lam, the Company&#x2019;s Co-Chief Executive Officer and President and a director, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder; Dr. Kenneth Sim, the Company&#x2019;s Executive Chairman, is Chairman and a director and stockholder; and Dr. Albert Young, the Company&#x2019;s Chief Administrative Officer, is Senor Executive Vice President and a stockholder. The Company&#x2019;s Board of Directors and the Audit Committee of the Board of Directors approved the proposed repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, affiliates wholly owned by the Company&#x2019;s key personnel, are reported in the accompanying consolidated statements of income on a consolidated basis, together with the Company&#x2019;s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company&#x2019;s subsidiaries as related-party transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intercompany Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of corporate practice of medicine laws, the Company uses designated shareholder professional corporations, of which the sole shareholder is a member of the Company&#x2019;s key personnel, to engage in certain transactions and make intercompany loans from time to time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For equity method investments, loans receivable and line of credits from related parties, see Note 6 &#x2014; &#x201c;Investments in Other Entities,&#x201d; and Note 7 &#x2014; &#x201c;Loans Receivable and Loan Receivable &#x2014; Related Parties,&#x201d; respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-341" decimals="-5" id="f-1382" unitRef="usd">16700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-342" decimals="-5" id="f-1383" unitRef="usd">21200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-343" decimals="-5" id="f-1384" unitRef="usd">18700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-344"
      decimals="INF"
      id="f-1385"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-345" decimals="-5" id="f-1386" unitRef="usd">2700000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-346" decimals="-5" id="f-1387" unitRef="usd">2700000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-347" decimals="-5" id="f-1388" unitRef="usd">2400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-348"
      decimals="2"
      id="f-1389"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-349" decimals="-5" id="f-1390" unitRef="usd">1100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="c-350"
      decimals="INF"
      id="f-1391"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-351" decimals="-5" id="f-1392" unitRef="usd">2100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-352" decimals="-5" id="f-1393" unitRef="usd">1800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-353" decimals="-5" id="f-1394" unitRef="usd">1600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-354" decimals="-5" id="f-1395" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-355" decimals="-5" id="f-1396" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-356" decimals="-5" id="f-1397" unitRef="usd">400000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-357" decimals="-5" id="f-1398" unitRef="usd">14100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability contextRef="c-357" decimals="-5" id="f-1399" unitRef="usd">14500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-358" decimals="-5" id="f-1400" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-359" decimals="-5" id="f-1401" unitRef="usd">600000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-360" decimals="-5" id="f-1402" unitRef="usd">700000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-361" decimals="-5" id="f-1403" unitRef="usd">600000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-362" decimals="-5" id="f-1404" unitRef="usd">600000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-363" decimals="-5" id="f-1405" unitRef="usd">600000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-364" decimals="-3" id="f-1406" unitRef="usd">10000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-365" decimals="-5" id="f-1407" unitRef="usd">600000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-366" decimals="-5" id="f-1408" unitRef="usd">2000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-367" decimals="-5" id="f-1409" unitRef="usd">1300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-368" decimals="-5" id="f-1410" unitRef="usd">2600000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-369" decimals="-5" id="f-1411" unitRef="usd">1900000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-370" decimals="-5" id="f-1412" unitRef="usd">1300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-371" decimals="-5" id="f-1413" unitRef="usd">1100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-372" decimals="-5" id="f-1414" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:DebtInstrumentTerm contextRef="c-373" id="f-1415">P3Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-374" decimals="-5" id="f-1416" unitRef="usd">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-375" decimals="-5" id="f-1417" unitRef="usd">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <asth:PaymentMadeToRelatedParty contextRef="c-376" decimals="-5" id="f-1418" unitRef="usd">9800000</asth:PaymentMadeToRelatedParty>
    <asth:PaymentMadeToRelatedParty contextRef="c-377" decimals="-5" id="f-1419" unitRef="usd">9300000</asth:PaymentMadeToRelatedParty>
    <asth:PaymentMadeToRelatedParty contextRef="c-378" decimals="-3" id="f-1420" unitRef="usd">44000</asth:PaymentMadeToRelatedParty>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c-1" id="f-1421">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth fees incurred and income received related to AHMC, HSMSO, and Aurion (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.042%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.048%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;AHMC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;HSMSO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;AURION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;AHMC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;HSMSO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;AURION&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-379" decimals="-3" id="f-1422" unitRef="usd">49634000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-380" decimals="-3" id="f-1423" unitRef="usd">1242000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-381" decimals="-3" id="f-1424" unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-382" decimals="-3" id="f-1425" unitRef="usd">56397000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-383" decimals="-3" id="f-1426" unitRef="usd">1089000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-384" decimals="-3" id="f-1427" unitRef="usd">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-385" decimals="-3" id="f-1428" unitRef="usd">20000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-386" decimals="-3" id="f-1429" unitRef="usd">822000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-387" decimals="-3" id="f-1430" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-388" decimals="-3" id="f-1431" unitRef="usd">21810000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-389" decimals="-3" id="f-1432" unitRef="usd">1554000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-390" decimals="-3" id="f-1433" unitRef="usd">300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-391" decimals="-3" id="f-1434" unitRef="usd">29634000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-392" decimals="-3" id="f-1435" unitRef="usd">420000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-393" decimals="-3" id="f-1436" unitRef="usd">-300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-394" decimals="-3" id="f-1437" unitRef="usd">34587000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-395" decimals="-3" id="f-1438" unitRef="usd">-465000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction contextRef="c-396" decimals="-3" id="f-1439" unitRef="usd">-300000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:InsuranceServicesRevenue contextRef="c-397" decimals="-5" id="f-1440" unitRef="usd">43800000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue contextRef="c-398" decimals="-5" id="f-1441" unitRef="usd">50500000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:InsuranceServicesRevenue contextRef="c-399" decimals="-5" id="f-1442" unitRef="usd">60100000</us-gaap:InsuranceServicesRevenue>
    <us-gaap:DeferredCreditsAndOtherLiabilities contextRef="c-400" decimals="-5" id="f-1443" unitRef="usd">54000000</us-gaap:DeferredCreditsAndOtherLiabilities>
    <us-gaap:DeferredCreditsAndOtherLiabilities contextRef="c-401" decimals="-5" id="f-1444" unitRef="usd">58700000</us-gaap:DeferredCreditsAndOtherLiabilities>
    <asth:PaymentMadeToRelatedParty contextRef="c-402" decimals="-5" id="f-1445" unitRef="usd">23100000</asth:PaymentMadeToRelatedParty>
    <asth:PaymentMadeToRelatedParty contextRef="c-403" decimals="-5" id="f-1446" unitRef="usd">34500000</asth:PaymentMadeToRelatedParty>
    <asth:PaymentMadeToRelatedParty contextRef="c-404" decimals="-5" id="f-1447" unitRef="usd">32500000</asth:PaymentMadeToRelatedParty>
    <asth:PaymentMadeToRelatedParty contextRef="c-405" decimals="-5" id="f-1448" unitRef="usd">4200000</asth:PaymentMadeToRelatedParty>
    <asth:PaymentMadeToRelatedParty contextRef="c-406" decimals="-5" id="f-1449" unitRef="usd">3700000</asth:PaymentMadeToRelatedParty>
    <asth:PaymentMadeToRelatedParty contextRef="c-407" decimals="-5" id="f-1450" unitRef="usd">3400000</asth:PaymentMadeToRelatedParty>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-302" decimals="-5" id="f-1451" unitRef="usd">100000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-301"
      decimals="INF"
      id="f-1452"
      unitRef="shares">3166561</us-gaap:TreasuryStockCommonShares>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c-1" id="f-1453">Employee Benefit PlanAHM has a qualified 401(k) plan that covers substantially all employees who have completed at least six months of service and meet minimum age requirements. Participants may&#160;contribute a portion of their compensation to the plan, up to the maximum amount permitted under Section 401(k) of the Internal Revenue Code. Participants become fully vested after six years of service. AHM matches a portion of the participants&#x2019; contributions. AHM&#x2019;s matching contributions for the years ended December&#160;31, 2023, 2022, and 2021 were approximately $0.7 million, $0.5 million and $0.4 million, respectively.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <asth:DefinedContributionPlanServicePeriod contextRef="c-1" id="f-1454">P6M</asth:DefinedContributionPlanServicePeriod>
    <asth:DefinedContributionPlanVestingPeriod contextRef="c-1" id="f-1455">P6Y</asth:DefinedContributionPlanVestingPeriod>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-1" decimals="-5" id="f-1456" unitRef="usd">700000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-31" decimals="-5" id="f-1457" unitRef="usd">500000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c-32" decimals="-5" id="f-1458" unitRef="usd">400000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1459">Earnings Per Share&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated using the weighted average number of shares of the Company&#x2019;s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to Astrana by the weighted average number of shares of the Company&#x2019;s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants. The non-controlling interests in APC are allocated their share of Astrana&#x2019;s income from APC&#x2019;s ownership of Astrana common stock and this is included in the net income attributable to non-controlling interests on the consolidated statements of income. Therefore, none of the shares of Astrana held by APC are considered outstanding for the purposes of basic or diluted earnings per share computation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, 2022 and 2021, APC held 7,132,698, 10,299,259 and 10,925,702 shares of Astrana's common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023, 2022 and 2021, restricted stock of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186,290, 133,480&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and 9,137, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2023 and 2022, restricted stock with performance conditions of 782,484 and 245,478, respectively, were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of December&#160;31, 2023 or 2022, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.029%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.457%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.457%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.458%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,553,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,971,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,828,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,943,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,602,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,403,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the shares included in the diluted earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.589%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,553,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,971,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,828,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,943,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,602,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,403,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-291"
      decimals="0"
      id="f-1460"
      unitRef="shares">7132698</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-292"
      decimals="0"
      id="f-1461"
      unitRef="shares">10299259</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-293"
      decimals="0"
      id="f-1462"
      unitRef="shares">10925702</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-408"
      decimals="0"
      id="f-1463"
      unitRef="shares">186290</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-409"
      decimals="0"
      id="f-1464"
      unitRef="shares">133480</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-410"
      decimals="0"
      id="f-1465"
      unitRef="shares">9137</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-411"
      decimals="0"
      id="f-1466"
      unitRef="shares">782484</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-412"
      decimals="0"
      id="f-1467"
      unitRef="shares">245478</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1468">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:65.029%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.457%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.457%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.458%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,553,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,971,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,828,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,943,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,602,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,403,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1469"
      unitRef="usdPerShare">1.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-31"
      decimals="2"
      id="f-1470"
      unitRef="usdPerShare">1.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-32"
      decimals="2"
      id="f-1471"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1472"
      unitRef="usdPerShare">1.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-31"
      decimals="2"
      id="f-1473"
      unitRef="usdPerShare">0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-32"
      decimals="2"
      id="f-1474"
      unitRef="usdPerShare">1.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1475" unitRef="shares">46553256</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-31" decimals="0" id="f-1476" unitRef="shares">44971143</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-32" decimals="0" id="f-1477" unitRef="shares">43828664</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1478" unitRef="shares">46943140</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-31" decimals="0" id="f-1479" unitRef="shares">45602415</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-32" decimals="0" id="f-1480" unitRef="shares">45403085</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c-1" id="f-1481">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the shares included in the diluted earnings per share computations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:64.589%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,553,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,971,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,828,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingently issuable shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,943,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,602,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,403,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1482" unitRef="shares">46553256</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-31" decimals="0" id="f-1483" unitRef="shares">44971143</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-32" decimals="0" id="f-1484" unitRef="shares">43828664</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-413"
      decimals="0"
      id="f-1485"
      unitRef="shares">169577</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-414"
      decimals="0"
      id="f-1486"
      unitRef="shares">439309</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-415"
      decimals="0"
      id="f-1487"
      unitRef="shares">495618</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-416"
      decimals="0"
      id="f-1488"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-417"
      decimals="0"
      id="f-1489"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-418"
      decimals="0"
      id="f-1490"
      unitRef="shares">819151</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-408"
      decimals="0"
      id="f-1491"
      unitRef="shares">51182</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-409"
      decimals="0"
      id="f-1492"
      unitRef="shares">161648</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c-410"
      decimals="0"
      id="f-1493"
      unitRef="shares">259652</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares contextRef="c-1" decimals="0" id="f-1494" unitRef="shares">169125</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares contextRef="c-31" decimals="0" id="f-1495" unitRef="shares">30315</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares contextRef="c-32" decimals="0" id="f-1496" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1497" unitRef="shares">46943140</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-31" decimals="0" id="f-1498" unitRef="shares">45602415</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-32" decimals="0" id="f-1499" unitRef="shares">45403085</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:VariableInterestEntityDisclosureTextBlock contextRef="c-1" id="f-1500">Variable Interest Entities (VIEs)&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s consolidated financial statements include its subsidiaries and consolidated VIEs. A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity&#x2019;s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some states have laws that prohibit business entities with non-physician owners, such as Astrana and its subsidiaries, from practicing medicine, employing physicians to practice medicine, or exercising control over medical decisions by physicians. These laws are generally referred to as corporate practice of medicine laws. States that have corporate practice of medicine laws permit only physicians to practice medicine, exercise control over medical decisions, or engage in certain arrangements, such as fee-splitting, with physicians. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to these laws, the Company operates by maintaining long-term MSAs with its affiliated IPAs and medical groups, each of which is owned and operated by physicians only, and employs or contracts with additional physicians to provide medical services. AHM  is a wholly owned subsidiary of the Company and has entered into MSAs with several affiliated IPAs, including APC. APC contracts with various HMOs or licensed healthcare service plans, each of which pays a fixed payment (&#x201c;capitation&#x201d;). In return, APC arranges for the delivery of healthcare services by contracting with physicians or professional medical corporations for primary care and specialty care services. APC assumes the financial risk of the cost of delivering healthcare services in excess of the fixed amounts received. The risk is subject to stop-loss provisions in contracts with HMOs. Some risk is transferred to the contracted physicians or professional corporations. The physicians in the IPA are exclusively in control of, and responsible for, all aspects of the practice of medicine for enrolled patients. In accordance with relevant accounting guidance, APC has been determined to be a VIE of AHM, as AHM is its primary beneficiary with the ability, through majority representation on the APC Joint Planning Board and otherwise, to direct the activities (excluding clinical decisions) that most significantly affect APC&#x2019;s economic performance. Therefore, APC and its wholly owned subsidiaries and VIEs are consolidated in the accompanying financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain state laws prohibit a professional corporation that has more than one shareholder from being a shareholder in another professional corporation. As a result, the Company cannot directly own shares in other professional corporations. However, an exception to this regulation permits a professional corporation that has only one shareholder to own shares in another professional corporation. In reliance on this exception, the Company designated certain key personnel as the nominee shareholder of professional corporations which hold controlling and non-controlling ownership interests in several medical corporations. Via a Physician Shareholder Agreement with the nominee shareholder. the Company has the ability to designate another person to be the equity holder of the professional corporation. In addition these entities are managed by the Company&#x2019;s wholly owned MSOs via MSA. In accordance with relevant accounting guidance, the professional corporations, and their consolidated medical corporations are consolidated by the Company in the accompanying financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Astrana Medical and Astrana Health Care Partners were formed in May 2019 and July 2021, respectively, as a designated shareholder professional corporation. The Company&#x2019;s Vice Chairman is the sole shareholder of Astrana Medical and Astrana Health Care Partners via a Physician Shareholder Agreement, Astrana makes all the decisions on behalf of Astrana Medical and &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Astrana Health Care Partners. Astrana has the obligation to absorb losses of, or the right to receive benefits from, Astrana Medical and Astrana Health Care Partners. Therefore, Astrana Medical and Astrana Health Care Partners are controlled by and consolidated by Astrana as the primary beneficiary of the VIEs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 23, 2023, Astrana Health Care Partners purchased 100% of certain Care Delivery companies (AMG, a Professional Medical Corporation, 1 World Medicine Urgent Care Corporation, and Eleanor Leung M.D., a Professional Medical Corporation) from APC. As a result, these entities are now consolidated by Astrana Health Care Partners instead of APC. On May 1, 2023, Astrana Health Care Partners sold 25% of Eleanor Leung M.D. to two of its physicians. As a result, Astrana Health Care Partners now owns 75% of Eleanor Leung M.D.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes assets that can only be used to settle the liabilities of the Company&#x2019;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#x2019;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to, or from, affiliates, which are eliminated upon consolidation, are included in the accompanying consolidated balance sheets (in thousands). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net &#x2013; related party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable &#x2014; related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts due from affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable, non-current &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in other entities &#x2013; equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in a privately held entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiduciary accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount due to affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; *&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investment in affiliates represents APC&#x2019;s investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#x2019;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#x2019;s consolidated balance sheets as of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="c-419"
      decimals="INF"
      id="f-1501"
      unitRef="number">1</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="c-420"
      decimals="INF"
      id="f-1502"
      unitRef="number">0.25</us-gaap:VariableInterestEntityOwnershipPercentage>
    <asth:VariableInterestEntityNumberOfPhysicians
      contextRef="c-421"
      decimals="INF"
      id="f-1503"
      unitRef="physician">2</asth:VariableInterestEntityNumberOfPhysicians>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="c-422"
      decimals="INF"
      id="f-1504"
      unitRef="number">0.75</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="c-1" id="f-1505">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table includes assets that can only be used to settle the liabilities of the Company&#x2019;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#x2019;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to, or from, affiliates, which are eliminated upon consolidation, are included in the accompanying consolidated balance sheets (in thousands). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables, net &#x2013; related party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loans receivable &#x2014; related parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts due from affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land, property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes receivable, non-current &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in other entities &#x2013; equity method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in a privately held entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiduciary accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount due to affiliates*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current liabilities &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; *&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investment in affiliates represents APC&#x2019;s investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#x2019;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#x2019;s consolidated balance sheets as of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-423" decimals="-3" id="f-1506" unitRef="usd">184078000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-424" decimals="-3" id="f-1507" unitRef="usd">113080000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-423" decimals="-3" id="f-1508" unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-424" decimals="-3" id="f-1509" unitRef="usd">4543000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-425" decimals="-3" id="f-1510" unitRef="usd">21120000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-426" decimals="-3" id="f-1511" unitRef="usd">14562000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-427" decimals="-3" id="f-1512" unitRef="usd">58707000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-428" decimals="-3" id="f-1513" unitRef="usd">62420000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-423" decimals="-3" id="f-1514" unitRef="usd">1600000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-424" decimals="-3" id="f-1515" unitRef="usd">8702000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-423" decimals="-3" id="f-1516" unitRef="usd">454000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c-424" decimals="-3" id="f-1517" unitRef="usd">1283000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-423" decimals="-3" id="f-1518" unitRef="usd">9991000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-424" decimals="-3" id="f-1519" unitRef="usd">9938000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-425" decimals="-3" id="f-1520" unitRef="usd">0</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-426" decimals="-3" id="f-1521" unitRef="usd">516000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-427" decimals="-3" id="f-1522" unitRef="usd">0</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent contextRef="c-428" decimals="-3" id="f-1523" unitRef="usd">2125000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-423" decimals="-3" id="f-1524" unitRef="usd">0</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-424" decimals="-3" id="f-1525" unitRef="usd">11609000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-423" decimals="-3" id="f-1526" unitRef="usd">275950000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-424" decimals="-3" id="f-1527" unitRef="usd">228778000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-423" decimals="-3" id="f-1528" unitRef="usd">5306000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-424" decimals="-3" id="f-1529" unitRef="usd">106626000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-423" decimals="-3" id="f-1530" unitRef="usd">60906000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-424" decimals="-3" id="f-1531" unitRef="usd">62951000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-423" decimals="-3" id="f-1532" unitRef="usd">140157000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-424" decimals="-3" id="f-1533" unitRef="usd">133448000</us-gaap:Goodwill>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-423" decimals="-3" id="f-1534" unitRef="usd">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent contextRef="c-424" decimals="-3" id="f-1535" unitRef="usd">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:EquityMethodInvestments contextRef="c-423" decimals="-3" id="f-1536" unitRef="usd">12114000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="c-424" decimals="-3" id="f-1537" unitRef="usd">27561000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-423" decimals="-3" id="f-1538" unitRef="usd">405000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue contextRef="c-424" decimals="-3" id="f-1539" unitRef="usd">405000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:OtherLongTermInvestments contextRef="c-423" decimals="-3" id="f-1540" unitRef="usd">273182000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments contextRef="c-424" decimals="-3" id="f-1541" unitRef="usd">304755000</us-gaap:OtherLongTermInvestments>
    <us-gaap:RestrictedCash contextRef="c-423" decimals="-3" id="f-1542" unitRef="usd">40000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-424" decimals="-3" id="f-1543" unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-423" decimals="-3" id="f-1544" unitRef="usd">28796000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-424" decimals="-3" id="f-1545" unitRef="usd">11408000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-423" decimals="-3" id="f-1546" unitRef="usd">1149000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-424" decimals="-3" id="f-1547" unitRef="usd">4320000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-423" decimals="-3" id="f-1548" unitRef="usd">537998000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c-424" decimals="-3" id="f-1549" unitRef="usd">667417000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c-423" decimals="-3" id="f-1550" unitRef="usd">813948000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-424" decimals="-3" id="f-1551" unitRef="usd">896195000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-423" decimals="-3" id="f-1552" unitRef="usd">32707000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="c-424" decimals="-3" id="f-1553" unitRef="usd">27360000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <asth:FiduciaryAccountsPayableCurrent contextRef="c-423" decimals="-3" id="f-1554" unitRef="usd">7737000</asth:FiduciaryAccountsPayableCurrent>
    <asth:FiduciaryAccountsPayableCurrent contextRef="c-424" decimals="-3" id="f-1555" unitRef="usd">8065000</asth:FiduciaryAccountsPayableCurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-423" decimals="-3" id="f-1556" unitRef="usd">55157000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense contextRef="c-424" decimals="-3" id="f-1557" unitRef="usd">55052000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DividendsPayableCurrent contextRef="c-423" decimals="-3" id="f-1558" unitRef="usd">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent contextRef="c-424" decimals="-3" id="f-1559" unitRef="usd">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-423" decimals="-3" id="f-1560" unitRef="usd">646000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-424" decimals="-3" id="f-1561" unitRef="usd">594000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-423" decimals="-3" id="f-1562" unitRef="usd">3305000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-424" decimals="-3" id="f-1563" unitRef="usd">2198000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-423" decimals="-3" id="f-1564" unitRef="usd">8542000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-424" decimals="-3" id="f-1565" unitRef="usd">619000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilities contextRef="c-423" decimals="-3" id="f-1566" unitRef="usd">107340000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="c-424" decimals="-3" id="f-1567" unitRef="usd">0</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesCurrent contextRef="c-423" decimals="-3" id="f-1568" unitRef="usd">216072000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-424" decimals="-3" id="f-1569" unitRef="usd">94526000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-423" decimals="-3" id="f-1570" unitRef="usd">7284000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-424" decimals="-3" id="f-1571" unitRef="usd">6540000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-423" decimals="-3" id="f-1572" unitRef="usd">1033000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-424" decimals="-3" id="f-1573" unitRef="usd">1275000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-423" decimals="-3" id="f-1574" unitRef="usd">28675000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-424" decimals="-3" id="f-1575" unitRef="usd">12035000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-423" decimals="-3" id="f-1576" unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-424" decimals="-3" id="f-1577" unitRef="usd">26645000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-423" decimals="-3" id="f-1578" unitRef="usd">230000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-424" decimals="-3" id="f-1579" unitRef="usd">8542000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-423" decimals="-3" id="f-1580" unitRef="usd">37222000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c-424" decimals="-3" id="f-1581" unitRef="usd">55037000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-423" decimals="-3" id="f-1582" unitRef="usd">253294000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-424" decimals="-3" id="f-1583" unitRef="usd">149563000</us-gaap:Liabilities>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-1585">Leases&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating and finance leases for corporate offices, physicians&#x2019; offices, and certain equipment. This includes leases with properties that were spun-off as part of the Spin-Off. These leases have remaining lease terms ranging from one month to seventeen years, some of which may include options to extend the leases for up to ten years, and some of which may include options to terminate the leases within one year. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as Consumer Price Index.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, assets recorded under finance leases were $1.7 million and $1.8 million, respectively, and accumulated depreciation associated with finance leases was $1.6 million and $1.0 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company has entered into a lease arrangement for seven years with an option to extend an additional five years. The tentative move date is March 2024, once the unit is made available. Base rent during the initial seven-year term of the 2024 lease agreement will total $2.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;Other information related to leases was as follows (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental Cash Flows Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.73 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.66 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.00 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.41 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancellable leases as of December&#160;31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-1584">Leases&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating and finance leases for corporate offices, physicians&#x2019; offices, and certain equipment. This includes leases with properties that were spun-off as part of the Spin-Off. These leases have remaining lease terms ranging from one month to seventeen years, some of which may include options to extend the leases for up to ten years, and some of which may include options to terminate the leases within one year. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as Consumer Price Index.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, assets recorded under finance leases were $1.7 million and $1.8 million, respectively, and accumulated depreciation associated with finance leases was $1.6 million and $1.0 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company rents or subleases certain real estate to third parties, which are accounted for as operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company has entered into a lease arrangement for seven years with an option to extend an additional five years. The tentative move date is March 2024, once the unit is made available. Base rent during the initial seven-year term of the 2024 lease agreement will total $2.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;Other information related to leases was as follows (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental Cash Flows Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.73 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.66 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.00 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.41 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancellable leases as of December&#160;31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-95" id="f-1586">P1M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeFinanceLeaseTermOfContract1 contextRef="c-95" id="f-1587">P1M</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeFinanceLeaseTermOfContract1 contextRef="c-96" id="f-1588">P17Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-96" id="f-1589">P17Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeFinanceLeaseRenewalTerm1 contextRef="c-4" id="f-1590">P10Y</us-gaap:LesseeFinanceLeaseRenewalTerm1>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-4" id="f-1591">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <asth:LesseeFinanceLeaseTerminationPeriodIfApplicable contextRef="c-1" id="f-1592">P1Y</asth:LesseeFinanceLeaseTerminationPeriodIfApplicable>
    <asth:LesseeOperatingLeaseTerminationPeriodIfApplicable contextRef="c-1" id="f-1593">P1Y</asth:LesseeOperatingLeaseTerminationPeriodIfApplicable>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-4" decimals="-5" id="f-1594" unitRef="usd">1700000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="c-5" decimals="-5" id="f-1595" unitRef="usd">1800000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization contextRef="c-4" decimals="-5" id="f-1596" unitRef="usd">1600000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization contextRef="c-5" decimals="-5" id="f-1597" unitRef="usd">1000000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-4" id="f-1598">P7Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <asth:LesseeOperatingLeaseOptionToExtendPeriod contextRef="c-1" id="f-1599">P5Y</asth:LesseeOperatingLeaseOptionToExtendPeriod>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-4" id="f-1600">P7Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:PaymentsForLeasingCosts contextRef="c-1" decimals="-5" id="f-1601" unitRef="usd">2300000</us-gaap:PaymentsForLeasingCosts>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-1602">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;br/&gt;Other information related to leases was as follows (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Supplemental Cash Flows Information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted-Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.73 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.66 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.00 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.41 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted-Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-1603" unitRef="usd">7771000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-31" decimals="-3" id="f-1604" unitRef="usd">6622000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-3" id="f-1605" unitRef="usd">675000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-31" decimals="-3" id="f-1606" unitRef="usd">564000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-1" decimals="-3" id="f-1607" unitRef="usd">103000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-31" decimals="-3" id="f-1608" unitRef="usd">70000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:SubleaseIncome contextRef="c-1" decimals="-3" id="f-1609" unitRef="usd">1025000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-31" decimals="-3" id="f-1610" unitRef="usd">649000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-1611" unitRef="usd">7524000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-31" decimals="-3" id="f-1612" unitRef="usd">6607000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-1613" unitRef="usd">7783000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-31" decimals="-3" id="f-1614" unitRef="usd">6781000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-3" id="f-1615" unitRef="usd">103000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-31" decimals="-3" id="f-1616" unitRef="usd">70000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-3" id="f-1617" unitRef="usd">675000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-31" decimals="-3" id="f-1618" unitRef="usd">564000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-1619" unitRef="usd">25124000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-31" decimals="-3" id="f-1620" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-3" id="f-1621" unitRef="usd">486000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-31" decimals="-3" id="f-1622" unitRef="usd">971000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-1623">P8Y8M23D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-1624">P6Y7M28D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-1625">P3Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-1626">P3Y4M28D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-1627" unitRef="number">0.0602</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="4" id="f-1628" unitRef="number">0.0550</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="4" id="f-1629" unitRef="number">0.0524</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="4" id="f-1630" unitRef="number">0.0492</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-1632">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancellable leases as of December&#160;31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-1631">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancellable leases as of December&#160;31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.223%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.225%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Years ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1633" unitRef="usd">6927000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1634" unitRef="usd">719000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-1635" unitRef="usd">6749000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-1636" unitRef="usd">556000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-1637" unitRef="usd">6342000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-1638" unitRef="usd">302000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-1639" unitRef="usd">6038000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-1640" unitRef="usd">243000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-3" id="f-1641" unitRef="usd">5844000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-3" id="f-1642" unitRef="usd">6000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="-3" id="f-1643" unitRef="usd">21923000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="-3" id="f-1644" unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-1645" unitRef="usd">53823000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-1646" unitRef="usd">1826000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-1647" unitRef="usd">12927000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-1648" unitRef="usd">147000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-1649" unitRef="usd">40896000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-4" decimals="-3" id="f-1650" unitRef="usd">1679000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-1651" unitRef="usd">4607000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-1652" unitRef="usd">646000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-1653" unitRef="usd">36289000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-1654" unitRef="usd">1033000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1655">Segments&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its operating segments in accordance with ASC 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC 280&#x201d;). The Company currently has three reportable segments consisting of: 1) Care Partners; 2) Care Delivery; and 3) Care Enablement (See Note 1 &#x2013; Description of Business). The Company&#x2019;s reportable segments changed from one to three in the first quarter of 2023 as a result of certain changes to the information regularly provided to the Company&#x2019;s chief operating decision maker when reviewing the Company&#x2019;s performance as well as an effort to provide additional transparency to investors and other financial statement users which the Company believes will assist in the evaluation of changes in the operating results of the Company&#x2019;s segments separate from non-operational factors that affect net income, thus providing insight into both operations and other factors impacting reported results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the performance of its operating segments based on segment revenue growth as well as operating income. Management uses revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors. The Company&#x2019;s operations are based in the United States. All revenues of the Company are derived from the United States. The Company&#x2019;s segments are not evaluated using asset information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners with a shared vision for coordinated care delivery. Under relevant accounting guidance, while the Company&#x2019;s Care Partners &#x2013; IPAs and Care Partners &#x2013; ACO are two operating segments, they share similar economic characteristics and meet other criteria, which permits the Company to aggregate them into a single reportable segment, which the Company has done. Revenue for this segment is primarily comprised of capitation and risk pool settlements and incentives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. The care delivery organization includes primary care, multi-specialty care, and ancillary care services. Revenue is primarily earned based on fee-for-service reimbursements, capitation, and performance-based incentives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Care Enablement segment is an integrated, end-to-end clinical and administrative platform powered by the Company&#x2019;s proprietary technology suite, which provides operational, clinical, financial, technology, management, and strategic services to enable success in the delivering of high-quality, value-based care for providers and payers. Revenue for this segment is primarily comprised of management and software fees, charged as a percentage of gross revenue or on a per-member-per-month basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other is not a reportable segment and primarily consists of real estate operations and other entities that are individually immaterial. Revenue is primarily comprised of equipment sales and real estate revenue is presented in other income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company&#x2019;s reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate costs are unallocated and primarily include corporate initiatives, corporate infrastructure costs and corporate shared costs, such as finance, human resources, legal, and executives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,284,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,386,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(170,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(170,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,386,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,182,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(166,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,171,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,208,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(174,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,051,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,144,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,051,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,144,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;944,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;944,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;966,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,039,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.128%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;709,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;709,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;607,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;596,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;637,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(92,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;675,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Balance includes general and administrative expenses and depreciation and amortization. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt; Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1656"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-31"
      decimals="INF"
      id="f-1657"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-70"
      decimals="INF"
      id="f-1658"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <asth:NumberOfOperatingSegmentsThatShareSimilarCharacteristics
      contextRef="c-1"
      decimals="INF"
      id="f-1659"
      unitRef="segment">2</asth:NumberOfOperatingSegmentsThatShareSimilarCharacteristics>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-1660">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information about our segments and prior periods have been recast to conform to the current presentation (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,284,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;61,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,386,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(170,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,300,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;119,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(170,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,386,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,182,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(166,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,171,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(7,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;130,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,208,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;116,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(174,340)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,302,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(33,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;84,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,051,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;42,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,144,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;78,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,051,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(124,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,144,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;944,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;73,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(125,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;944,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;966,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(128,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,039,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.128%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.459%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Partners&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Delivery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Care Enablement&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment Elimination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third Party&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;709,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;71,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;709,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90,543)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;773,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;607,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(89,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;596,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;637,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(92,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;675,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;72,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;98,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Balance includes general and administrative expenses and depreciation and amortization. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt; Income from operations for the intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income which is not presented in the table.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-429" decimals="-3" id="f-1661" unitRef="usd">1284081000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-430" decimals="-3" id="f-1662" unitRef="usd">61600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-431" decimals="-3" id="f-1663" unitRef="usd">40227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-432" decimals="-3" id="f-1664" unitRef="usd">753000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-433" decimals="-3" id="f-1665" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-434" decimals="-3" id="f-1666" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-435" decimals="-3" id="f-1667" unitRef="usd">1386661000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-436" decimals="-3" id="f-1668" unitRef="usd">16031000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-437" decimals="-3" id="f-1669" unitRef="usd">58304000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-438" decimals="-3" id="f-1670" unitRef="usd">95597000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-439" decimals="-3" id="f-1671" unitRef="usd">184000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-440" decimals="-3" id="f-1672" unitRef="usd">-170116000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-441" decimals="-3" id="f-1673" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-442" decimals="-3" id="f-1674" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-443" decimals="-3" id="f-1675" unitRef="usd">1300112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-444" decimals="-3" id="f-1676" unitRef="usd">119904000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-445" decimals="-3" id="f-1677" unitRef="usd">135824000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-446" decimals="-3" id="f-1678" unitRef="usd">937000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-447" decimals="-3" id="f-1679" unitRef="usd">-170116000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-448" decimals="-3" id="f-1680" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-1681" unitRef="usd">1386661000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-443" decimals="-3" id="f-1682" unitRef="usd">1182484000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-444" decimals="-3" id="f-1683" unitRef="usd">96265000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-445" decimals="-3" id="f-1684" unitRef="usd">59075000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-446" decimals="-3" id="f-1685" unitRef="usd">296000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-447" decimals="-3" id="f-1686" unitRef="usd">-166417000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-448" decimals="-3" id="f-1687" unitRef="usd">0</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-1688" unitRef="usd">1171703000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-443" decimals="-3" id="f-1689" unitRef="usd">25907000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-444" decimals="-3" id="f-1690" unitRef="usd">17766000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-445" decimals="-3" id="f-1691" unitRef="usd">57672000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-446" decimals="-3" id="f-1692" unitRef="usd">3752000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-447" decimals="-3" id="f-1693" unitRef="usd">-7923000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-448" decimals="-3" id="f-1694" unitRef="usd">33171000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-1695" unitRef="usd">130345000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-443" decimals="-3" id="f-1696" unitRef="usd">1208391000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-444" decimals="-3" id="f-1697" unitRef="usd">114031000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-445" decimals="-3" id="f-1698" unitRef="usd">116747000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-446" decimals="-3" id="f-1699" unitRef="usd">4048000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-447" decimals="-3" id="f-1700" unitRef="usd">-174340000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-448" decimals="-3" id="f-1701" unitRef="usd">33171000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-1702" unitRef="usd">1302048000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-443" decimals="-3" id="f-1703" unitRef="usd">91721000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-444" decimals="-3" id="f-1704" unitRef="usd">5873000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-445" decimals="-3" id="f-1705" unitRef="usd">19077000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-446" decimals="-3" id="f-1706" unitRef="usd">-3111000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-447" decimals="-3" id="f-1707" unitRef="usd">4224000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-448" decimals="-3" id="f-1708" unitRef="usd">-33171000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-1709" unitRef="usd">84613000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-449" decimals="-3" id="f-1710" unitRef="usd">1051464000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-450" decimals="-3" id="f-1711" unitRef="usd">49806000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-451" decimals="-3" id="f-1712" unitRef="usd">42023000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-452" decimals="-3" id="f-1713" unitRef="usd">870000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-453" decimals="-3" id="f-1714" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-454" decimals="-3" id="f-1715" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-455" decimals="-3" id="f-1716" unitRef="usd">1144163000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-456" decimals="-3" id="f-1717" unitRef="usd">57000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-457" decimals="-3" id="f-1718" unitRef="usd">46326000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-458" decimals="-3" id="f-1719" unitRef="usd">78177000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-459" decimals="-3" id="f-1720" unitRef="usd">115000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-460" decimals="-3" id="f-1721" unitRef="usd">-124675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-461" decimals="-3" id="f-1722" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-462" decimals="-3" id="f-1723" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-463" decimals="-3" id="f-1724" unitRef="usd">1051521000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-464" decimals="-3" id="f-1725" unitRef="usd">96132000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-465" decimals="-3" id="f-1726" unitRef="usd">120200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-466" decimals="-3" id="f-1727" unitRef="usd">985000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-467" decimals="-3" id="f-1728" unitRef="usd">-124675000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-468" decimals="-3" id="f-1729" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-31" decimals="-3" id="f-1730" unitRef="usd">1144163000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-463" decimals="-3" id="f-1731" unitRef="usd">944792000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-464" decimals="-3" id="f-1732" unitRef="usd">73927000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-465" decimals="-3" id="f-1733" unitRef="usd">51531000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-466" decimals="-3" id="f-1734" unitRef="usd">258000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-467" decimals="-3" id="f-1735" unitRef="usd">-125823000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-468" decimals="-3" id="f-1736" unitRef="usd">0</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-31" decimals="-3" id="f-1737" unitRef="usd">944685000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-463" decimals="-3" id="f-1738" unitRef="usd">21507000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-464" decimals="-3" id="f-1739" unitRef="usd">13234000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-465" decimals="-3" id="f-1740" unitRef="usd">41628000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-466" decimals="-3" id="f-1741" unitRef="usd">2681000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-467" decimals="-3" id="f-1742" unitRef="usd">-3150000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-468" decimals="-3" id="f-1743" unitRef="usd">19313000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-31" decimals="-3" id="f-1744" unitRef="usd">95213000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-463" decimals="-3" id="f-1745" unitRef="usd">966299000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-464" decimals="-3" id="f-1746" unitRef="usd">87161000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-465" decimals="-3" id="f-1747" unitRef="usd">93159000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-466" decimals="-3" id="f-1748" unitRef="usd">2939000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-467" decimals="-3" id="f-1749" unitRef="usd">-128973000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-468" decimals="-3" id="f-1750" unitRef="usd">19313000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-31" decimals="-3" id="f-1751" unitRef="usd">1039898000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-463" decimals="-3" id="f-1752" unitRef="usd">85222000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-464" decimals="-3" id="f-1753" unitRef="usd">8971000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-465" decimals="-3" id="f-1754" unitRef="usd">27041000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-466" decimals="-3" id="f-1755" unitRef="usd">-1954000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-467" decimals="-3" id="f-1756" unitRef="usd">4298000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-468" decimals="-3" id="f-1757" unitRef="usd">-19313000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-31" decimals="-3" id="f-1758" unitRef="usd">104265000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-469" decimals="-3" id="f-1759" unitRef="usd">709714000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-470" decimals="-3" id="f-1760" unitRef="usd">28064000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-471" decimals="-3" id="f-1761" unitRef="usd">35851000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-472" decimals="-3" id="f-1762" unitRef="usd">286000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-473" decimals="-3" id="f-1763" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-474" decimals="-3" id="f-1764" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-475" decimals="-3" id="f-1765" unitRef="usd">773915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-476" decimals="-3" id="f-1766" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-477" decimals="-3" id="f-1767" unitRef="usd">18627000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-478" decimals="-3" id="f-1768" unitRef="usd">71842000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-479" decimals="-3" id="f-1769" unitRef="usd">74000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-480" decimals="-3" id="f-1770" unitRef="usd">-90543000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-481" decimals="-3" id="f-1771" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-482" decimals="-3" id="f-1772" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-483" decimals="-3" id="f-1773" unitRef="usd">709714000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-484" decimals="-3" id="f-1774" unitRef="usd">46691000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-485" decimals="-3" id="f-1775" unitRef="usd">107693000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-486" decimals="-3" id="f-1776" unitRef="usd">360000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-487" decimals="-3" id="f-1777" unitRef="usd">-90543000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-488" decimals="-3" id="f-1778" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-32" decimals="-3" id="f-1779" unitRef="usd">773915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-483" decimals="-3" id="f-1780" unitRef="usd">607081000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-484" decimals="-3" id="f-1781" unitRef="usd">37537000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-485" decimals="-3" id="f-1782" unitRef="usd">41557000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-486" decimals="-3" id="f-1783" unitRef="usd">-242000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-487" decimals="-3" id="f-1784" unitRef="usd">-89791000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-488" decimals="-3" id="f-1785" unitRef="usd">0</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization contextRef="c-32" decimals="-3" id="f-1786" unitRef="usd">596142000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-483" decimals="-3" id="f-1787" unitRef="usd">30055000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-484" decimals="-3" id="f-1788" unitRef="usd">9694000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-485" decimals="-3" id="f-1789" unitRef="usd">28637000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-486" decimals="-3" id="f-1790" unitRef="usd">1881000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-487" decimals="-3" id="f-1791" unitRef="usd">-3097000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-488" decimals="-3" id="f-1792" unitRef="usd">12424000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization contextRef="c-32" decimals="-3" id="f-1793" unitRef="usd">79594000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-483" decimals="-3" id="f-1794" unitRef="usd">637136000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-484" decimals="-3" id="f-1795" unitRef="usd">47231000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-485" decimals="-3" id="f-1796" unitRef="usd">70194000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-486" decimals="-3" id="f-1797" unitRef="usd">1639000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-487" decimals="-3" id="f-1798" unitRef="usd">-92888000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-488" decimals="-3" id="f-1799" unitRef="usd">12424000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-32" decimals="-3" id="f-1800" unitRef="usd">675736000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-483" decimals="-3" id="f-1801" unitRef="usd">72578000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-484" decimals="-3" id="f-1802" unitRef="usd">-540000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-485" decimals="-3" id="f-1803" unitRef="usd">37499000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-486" decimals="-3" id="f-1804" unitRef="usd">-1279000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-487" decimals="-3" id="f-1805" unitRef="usd">2345000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-488" decimals="-3" id="f-1806" unitRef="usd">-12424000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-32" decimals="-3" id="f-1807" unitRef="usd">98179000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-1808">Fair Value Measurements of Financial Instruments&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of December&#160;31, 2023 are presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.526%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.526%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.526%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market accounts*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AAMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VOMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DMG remaining equity interest purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sun Labs remaining equity interest purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate collar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Included in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of December&#160;31, 2022 are presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.625%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market accounts*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APCMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AAMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DMG remaining equity interest purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sun Labs remaining equity interest purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Included in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of existing Level 3 liabilities is recognized in &lt;span style="-sec-ix-hidden:f-1895"&gt;unrealized loss on investments and general and administrative expenses&lt;/span&gt; in the accompanying consolidated statements of income. As of December&#160;31, 2023, the reconciliation of our Level 3 liabilities was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of existing Level 3 liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APCMG contingent consideration paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, certificates of deposit amounted to approximately $2.2 million and $0, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, equity securities held by the Company are primarily comprised of common stock of Nutex Health, Inc. (formerly known as Clinigence Holdings, Inc.) (&#x201c;Nutex&#x201d;). In September 2021, Astrana and Nutex entered into a stock purchase agreement in which Astrana purchased shares of common stock, warrants, and potentially additional shares of common stock if certain metrics were not met (such additional shares &#x201c;contingent equity securities&#x201d;) for $3.0 million. The common stock is included in investments in marketable securities in the accompanying consolidated balance sheets. In May 2022, the Company exercised the warrants and subsequently recognized the shares within investments in marketable securities in the accompanying consolidated balance sheet. In March 2023, the contingent equity securities were settled and the Company received additional Nutex common stock. The additional common stock received from the contingent equity securities is included in investments in marketable securities in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, the equity securities were approximately $0.3 million and $5.6 million, respectively, in the accompanying consolidated balance sheets. In December 2023, APC sold all of its common stock in a payer partner. The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total losses recognized on equity securities  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less (loss) gains recognized on equity securities sold  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized losses recognized on equity securities held at end of period  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Rate Swap Agreements and Collar Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to interest rate risk on its floating-rate debt. APC&#x2019;s Excluded Assets entered into interest rate swap agreements to effectively convert its floating-rate debt to a fixed-rate basis. The principal objective of these contracts was to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#x2019;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 10 - &#x201c;Credit Facility, Bank Loans, and Lines of Credit,&#x201d; for further information on the Company&#x2019;s debt. Interest rate swap agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps. The estimated fair value of the interest rate swap agreements was determined using Level 2 inputs. On December 1, 2023, APC&#x2019;s Excluded Assets ended the interest rate swap agreements. As of December&#160;31, 2022, the fair value was $3.2 million and was presented within other long-term assets in the accompanying consolidated balance sheets. For the years ended December&#160;31, 2023 and 2022, APC recognized unrealized gains of $0.2 million and $4.2&#160;million, respectively. The interest rate swaps were deemed Excluded Assets that were solely for the benefit of APC and its common shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s collar agreement is designed to limit the interest rate risk associated with the Company&#x2019;s Revolver Loan. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#x2019;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 10 - &#x201c;Credit Facility, Bank Loans, and Lines of Credit,&#x201d; for further information on the Company&#x2019;s &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;debt. Under the terms of the agreement, the ceiling is 5.0% and the floor is 2.34%. The collar agreement is not designated as a hedging instrument. Changes in the fair value on this contract is recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized loss on investments. The estimated fair value of the collar was determined using Level 2 inputs. As of December&#160;31, 2023 the fair value of the collar was $0.3&#160;million and was presented within other long-term liabilities in the accompanying consolidated balance sheets. For the year ended December&#160;31, 2023, the Company recognized an unrealized loss of $0.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Astrana was entitled to additional common stock if Nutex did not pay AHM management fees exceeding a threshold by the end of December 31, 2022. The contingent equity securities are considered to be derivatives but are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and accompanying consolidated statements of cash flows. The Company determined the fair value of the contingent equity security using a probability-weighted model, which includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of recognizing management fees and assigned probabilities to each such scenario in determining fair value. During the year ended December 31, 2023, the metric was not achieved. Subsequently, the common stock received from the contingent equity securities were accounted for as investments in marketable securities (refer to the subsection above on investments in marketable securities and Note 2 - &#x201c;Basis of Presentation and Summary of Significant Accounting Policies&#x201d; for further information on the Company&#x2019;s investments in marketable securities). As of December&#160;31, 2022, the contingent equity securities were valued at $1.9 million and were presented within prepaid and other current assets in the accompanying consolidated balance sheets. For the year ended December&#160;31, 2022, when the equity securities were still contingent, the Company recognized unrealized losses of $2.4&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining equity interest purchase&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, the Company entered into a financing obligation to purchase the remaining equity interest in Diagnostic Medical Group of Southern California (&#x201c;DMG&#x201d;) and Sun Clinical Laboratories (&#x201c;Sun Labs&#x201d;) within three years from the date the Company consolidated DMG and Sun Labs. The purchase of the remaining DMG equity value is considered a financing obligation with a carrying value of $8.5 million as of both December&#160;31, 2023 and December&#160;31, 2022. Changes in the fair value of the remaining equity purchase are presented in unrealized loss on investments in the accompanying consolidated statements of income. The purchase of the remaining Sun Labs equity value is considered a financing obligation with a carrying value of $7.8 million and $5.8 million as of December&#160;31, 2023 and December&#160;31, 2022, respectively. For the years ended December&#160;31, 2023 and 2022, the change in the fair value of Sun Labs equity value obligation was $2.0&#160;million and $1.7&#160;million, respectively, and is presented in unrealized loss on investments in the accompanying consolidated statements of income. As the financing obligations are embedded in the non-controlling interest, the non-controlling interests are recognized in other liabilities as of December&#160;31, 2023 and other long-term liabilities as of December&#160;31, 2022 in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent considerations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;VOMG&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon consolidating VOMG as a VIE, the purchase price consisted of cash funded upon the close of transaction and additional cash consideration (&#x201c;VOMG contingent consideration&#x201d;) contingent on VOMG meeting financial metrics for fiscal years 2023 and 2024. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). The contingent consideration is included within other long-term liabilities in the accompanying consolidated balance sheets. The contingent consideration was valued at $17,000 as of both December&#160;31, 2023 and December&#160;31, 2022. Changes in the VOMG contingent consideration are presented in general and administrative expenses in the accompanying consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;AAMG &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon acquiring 100% of the equity interest in AAMG, the purchase price consisted of cash funded upon close of the transaction and additional consideration (&#x201c;AAMG contingent consideration&#x201d;) and stock consideration (&#x201c;AAMG stock contingent consideration&#x201d;) contingent on AAMG meeting revenue and capitated member metrics for fiscal years 2023 (&#x201c;2023 metric&#x201d;) and 2024 (&#x201c;2024 metric&#x201d;). If the contingent considerations are met, the settlement will be paid in the Company&#x2019;s common stock. The total amount of stock that can be issued for the 2023 and 2024 metrics is 157,048 and 184,361, respectively. The Company determined the fair value of the contingent considerations using a probability-weighted model that includes significant &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The AAMG contingent consideration for the 2023 metric was valued at $2.6&#160;million and presented within other liabilities in the accompanying consolidated balance sheets as of December&#160;31, 2023. The AAMG contingent consideration for the 2024 metric was valued at $2.9&#160;million and presented within other long-term liabilities in the accompanying consolidated balance sheets as of December&#160;31, 2023. As of December&#160;31, 2022, for capitated member metrics for fiscal years 2023 and 2024, the AAMG contingent consideration was valued at $5.9 million and was presented within other long-term liabilities in the accompanying consolidated balance sheets. Changes in the AAMG contingent consideration are presented in general and administrative expenses in the accompanying consolidated statements of income. The AAMG stock contingent consideration was valued at $5.6&#160;million as of December&#160;31, 2023 and 2022 and is included in additional paid-in capital in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="c-1" id="f-1809">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of December&#160;31, 2023 are presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.526%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.526%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.526%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.545%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market accounts*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AAMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VOMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DMG remaining equity interest purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sun Labs remaining equity interest purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate collar&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Included in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of December&#160;31, 2022 are presented below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.625%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&#160;Measurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market accounts*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 12.25pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APCMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AAMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOMG contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DMG remaining equity interest purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sun Labs remaining equity interest purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Included in cash and cash equivalents&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-489" decimals="-3" id="f-1810" unitRef="usd">4842000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-490" decimals="-3" id="f-1811" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-491" decimals="-3" id="f-1812" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-1813" unitRef="usd">4842000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-489" decimals="-3" id="f-1814" unitRef="usd">2150000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-490" decimals="-3" id="f-1815" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-491" decimals="-3" id="f-1816" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-4" decimals="-3" id="f-1817" unitRef="usd">2150000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-489" decimals="-3" id="f-1818" unitRef="usd">348000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-490" decimals="-3" id="f-1819" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-491" decimals="-3" id="f-1820" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-4" decimals="-3" id="f-1821" unitRef="usd">348000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-489" decimals="-3" id="f-1822" unitRef="usd">7340000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-490" decimals="-3" id="f-1823" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-491" decimals="-3" id="f-1824" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-4" decimals="-3" id="f-1825" unitRef="usd">7340000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-492" decimals="-3" id="f-1826" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-493" decimals="-3" id="f-1827" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-494" decimals="-3" id="f-1828" unitRef="usd">5475000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-495" decimals="-3" id="f-1829" unitRef="usd">5475000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-496" decimals="-3" id="f-1830" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-497" decimals="-3" id="f-1831" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-498" decimals="-3" id="f-1832" unitRef="usd">17000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-499" decimals="-3" id="f-1833" unitRef="usd">17000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-500" decimals="-3" id="f-1834" unitRef="usd">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-501" decimals="-3" id="f-1835" unitRef="usd">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-502" decimals="-3" id="f-1836" unitRef="usd">8542000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-503" decimals="-3" id="f-1837" unitRef="usd">8542000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-504" decimals="-3" id="f-1838" unitRef="usd">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-505" decimals="-3" id="f-1839" unitRef="usd">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-506" decimals="-3" id="f-1840" unitRef="usd">7802000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-507" decimals="-3" id="f-1841" unitRef="usd">7802000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <us-gaap:DerivativeLiabilities contextRef="c-508" decimals="-3" id="f-1842" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-509" decimals="-3" id="f-1843" unitRef="usd">252000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-510" decimals="-3" id="f-1844" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-511" decimals="-3" id="f-1845" unitRef="usd">252000</us-gaap:DerivativeLiabilities>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-489" decimals="-3" id="f-1846" unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-490" decimals="-3" id="f-1847" unitRef="usd">252000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-491" decimals="-3" id="f-1848" unitRef="usd">21836000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-4" decimals="-3" id="f-1849" unitRef="usd">22088000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-512" decimals="-3" id="f-1850" unitRef="usd">135235000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-513" decimals="-3" id="f-1851" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-514" decimals="-3" id="f-1852" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-1853" unitRef="usd">135235000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-512" decimals="-3" id="f-1854" unitRef="usd">5567000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-513" decimals="-3" id="f-1855" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-514" decimals="-3" id="f-1856" unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-5" decimals="-3" id="f-1857" unitRef="usd">5567000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets contextRef="c-515" decimals="-3" id="f-1858" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-516" decimals="-3" id="f-1859" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-517" decimals="-3" id="f-1860" unitRef="usd">1900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-518" decimals="-3" id="f-1861" unitRef="usd">1900000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-519" decimals="-3" id="f-1862" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-520" decimals="-3" id="f-1863" unitRef="usd">3164000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-521" decimals="-3" id="f-1864" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-522" decimals="-3" id="f-1865" unitRef="usd">3164000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-512" decimals="-3" id="f-1866" unitRef="usd">140802000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-513" decimals="-3" id="f-1867" unitRef="usd">3164000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-514" decimals="-3" id="f-1868" unitRef="usd">1900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-5" decimals="-3" id="f-1869" unitRef="usd">145866000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-523" decimals="-3" id="f-1870" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-524" decimals="-3" id="f-1871" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-525" decimals="-3" id="f-1872" unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-526" decimals="-3" id="f-1873" unitRef="usd">1000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-527" decimals="-3" id="f-1874" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-528" decimals="-3" id="f-1875" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-529" decimals="-3" id="f-1876" unitRef="usd">5851000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-530" decimals="-3" id="f-1877" unitRef="usd">5851000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-531" decimals="-3" id="f-1878" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-532" decimals="-3" id="f-1879" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-533" decimals="-3" id="f-1880" unitRef="usd">17000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-534" decimals="-3" id="f-1881" unitRef="usd">17000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-535" decimals="-3" id="f-1882" unitRef="usd">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-536" decimals="-3" id="f-1883" unitRef="usd">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-537" decimals="-3" id="f-1884" unitRef="usd">8542000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <us-gaap:EquityMethodInvestments contextRef="c-538" decimals="-3" id="f-1885" unitRef="usd">8542000</us-gaap:EquityMethodInvestments>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-539" decimals="-3" id="f-1886" unitRef="usd">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-540" decimals="-3" id="f-1887" unitRef="usd">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-541" decimals="-3" id="f-1888" unitRef="usd">5849000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-542" decimals="-3" id="f-1889" unitRef="usd">5849000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-512" decimals="-3" id="f-1890" unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-513" decimals="-3" id="f-1891" unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-514" decimals="-3" id="f-1892" unitRef="usd">21259000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure contextRef="c-5" decimals="-3" id="f-1893" unitRef="usd">21259000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-1894">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of existing Level 3 liabilities is recognized in &lt;span style="-sec-ix-hidden:f-1895"&gt;unrealized loss on investments and general and administrative expenses&lt;/span&gt; in the accompanying consolidated statements of income. As of December&#160;31, 2023, the reconciliation of our Level 3 liabilities was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value of existing Level 3 liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;APCMG contingent consideration paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-5" decimals="-3" id="f-1896" unitRef="usd">21259000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-1" decimals="-3" id="f-1897" unitRef="usd">1577000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <asth:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid contextRef="c-1" decimals="-3" id="f-1898" unitRef="usd">1000000</asth:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationPaid>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-4" decimals="-3" id="f-1899" unitRef="usd">21836000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-543" decimals="-5" id="f-1900" unitRef="usd">2200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-544" decimals="-5" id="f-1901" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeAssets contextRef="c-545" decimals="-5" id="f-1902" unitRef="usd">3000000</us-gaap:DerivativeAssets>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-4" decimals="-5" id="f-1903" unitRef="usd">300000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi contextRef="c-5" decimals="-5" id="f-1904" unitRef="usd">5600000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:GainLossOnInvestmentsTextBlock contextRef="c-1" id="f-1905">The components comprising total gains and losses on equity securities are as follows (in thousands) for the periods listed below:&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total losses recognized on equity securities  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,629)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less (loss) gains recognized on equity securities sold  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized losses recognized on equity securities held at end of period  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,441)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-1" decimals="-3" id="f-1906" unitRef="usd">6629000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss contextRef="c-31" decimals="-3" id="f-1907" unitRef="usd">19169000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-1" decimals="-3" id="f-1908" unitRef="usd">-4052000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss contextRef="c-31" decimals="-3" id="f-1909" unitRef="usd">2272000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="c-1" decimals="-3" id="f-1910" unitRef="usd">2577000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss contextRef="c-31" decimals="-3" id="f-1911" unitRef="usd">21441000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-1912">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interest Rate Swap Agreements and Collar Agreements&lt;/span&gt;&lt;/div&gt;The Company is exposed to interest rate risk on its floating-rate debt. APC&#x2019;s Excluded Assets entered into interest rate swap agreements to effectively convert its floating-rate debt to a fixed-rate basis. The principal objective of these contracts was to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#x2019;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 10 - &#x201c;Credit Facility, Bank Loans, and Lines of Credit,&#x201d; for further information on the Company&#x2019;s debt. Interest rate swap agreements are not designated as hedging instruments. Changes in the fair value on these contracts are recognized as unrealized gain or loss on investments in the accompanying consolidated statements of income and reflected in the accompanying consolidated statements of cash flows as unrealized gain or loss on interest rate swaps. The estimated fair value of the interest rate swap agreements was determined using Level 2 inputs. On December 1, 2023, APC&#x2019;s Excluded Assets ended the interest rate swap agreements. As of December&#160;31, 2022, the fair value was $3.2 million and was presented within other long-term assets in the accompanying consolidated balance sheets.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-546" decimals="-5" id="f-1913" unitRef="usd">3200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-547" decimals="-5" id="f-1914" unitRef="usd">200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-548" decimals="-5" id="f-1915" unitRef="usd">4200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <asth:DerivativeCeilingInterestRate
      contextRef="c-549"
      decimals="3"
      id="f-1916"
      unitRef="number">0.050</asth:DerivativeCeilingInterestRate>
    <us-gaap:DerivativeFloorInterestRate
      contextRef="c-549"
      decimals="4"
      id="f-1917"
      unitRef="number">0.0234</us-gaap:DerivativeFloorInterestRate>
    <us-gaap:FairValueHedgeLiabilitiesAtFairValue contextRef="c-549" decimals="-5" id="f-1918" unitRef="usd">300000</us-gaap:FairValueHedgeLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet contextRef="c-550" decimals="-5" id="f-1919" unitRef="usd">-300000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeAssets contextRef="c-518" decimals="-5" id="f-1920" unitRef="usd">1900000</us-gaap:DerivativeAssets>
    <us-gaap:EquitySecuritiesFvNiUnrealizedLoss contextRef="c-31" decimals="-5" id="f-1921" unitRef="usd">2400000</us-gaap:EquitySecuritiesFvNiUnrealizedLoss>
    <asth:BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase contextRef="c-551" id="f-1922">P3Y</asth:BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase>
    <us-gaap:EquityMethodInvestments contextRef="c-538" decimals="-5" id="f-1923" unitRef="usd">8500000</us-gaap:EquityMethodInvestments>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-507" decimals="-5" id="f-1924" unitRef="usd">7800000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent contextRef="c-552" decimals="-5" id="f-1925" unitRef="usd">5800000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation contextRef="c-553" decimals="-5" id="f-1926" unitRef="usd">-2000000</asth:BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation>
    <asth:BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation contextRef="c-554" decimals="-5" id="f-1927" unitRef="usd">-1700000</asth:BusinessCombinationChangeInFairValueOfEquityInterestPurchaseObligation>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-534" decimals="-3" id="f-1928" unitRef="usd">17000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-495"
      decimals="2"
      id="f-1929"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:CommonStockValue contextRef="c-495" decimals="INF" id="f-1930" unitRef="usd">157048</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-542" decimals="INF" id="f-1931" unitRef="usd">184361</us-gaap:CommonStockValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-555" decimals="-5" id="f-1932" unitRef="usd">2600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-556" decimals="-5" id="f-1933" unitRef="usd">2900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-530" decimals="-5" id="f-1934" unitRef="usd">5900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <asth:BusinessCombinationStockContingentConsiderationLiability contextRef="c-542" decimals="-5" id="f-1935" unitRef="usd">5600000</asth:BusinessCombinationStockContingentConsiderationLiability>
    <asth:BusinessCombinationStockContingentConsiderationLiability contextRef="c-495" decimals="-5" id="f-1936" unitRef="usd">5600000</asth:BusinessCombinationStockContingentConsiderationLiability>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1937">Subsequent Events&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Drawdown on Term Loan and Revolver Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;31, 2023, the Company drew down $20&#160;million on its Term Loan and $90&#160;million on its Revolver Loan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Closing of Acquiring Community Family Care Medical Group IPA, Inc. (&#x201c;CFC&#x201d;) Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Company entered into an Asset and Equity Purchase Agreement (the &#x201c;Purchase Agreement&#x201d;) to acquire the partnership interests of Advanced Health Management Systems, L.P. (&#x201c;AHMS&#x201d;) and certain assets of Community Family Care Medical Group IPA, Inc. (&#x201c;CFC&#x201d;), which acquisitions the Company expected would occur in two separate closings. In November 2023, AHM also entered into a Stock Purchase Agreement (the &#x201c;I Health Purchase Agreement&#x201d;) to purchase 25% of the outstanding shares of common stock of I Health, Inc. (&#x201c;I Health&#x201d;). On January 31, 2024, the first closing under the Purchase Agreement occurred, and the Company completed its acquisition of CFC&#x2019;s assets. The Company expects to complete the second closing under the Purchase Agreement and acquire the outstanding general and limited partnership interests of AHMS during the first quarter of 2024, subject to obtaining required regulatory approvals. It is currently expected that the I Health Purchase Agreement closing will occur during the first quarter of 2024. The purchase price consisted of $93.8&#160;million cash and 631,712 shares of common stock of the Company. In addition, the Purchase Agreement contains earnout payments of up to $15.0&#160;million cash. The Company is in the process of finalizing its purchase price allocation of CFC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Bass Medical Group&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 29, 2024, the Company announced its strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. Together, the two organizations will aim to bring high-quality care via value-based arrangements to patients of all insurance types, including Medicare, Medicaid, ACA Marketplace, and Commercial. Astrana has provided BASS Medical Group with a $20&#160;million senior secured promissory note (&#x201c;BASS secured promissory note&#x201d;),which is intended to be used, in partnership with Astrana, to continue to grow their footprint and invest in high-quality, high-value, and accessible primary and multi-specialty care for communities across California. The BASS secured promissory note matures on January 11, 2031 and has an interest rate per annum equal to 2.9% plus the Secured Overnight Financing Rate as administered by the Federal Reserve Bank of New York (or a successor administrator) compounded annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advanced Diagnostic and Surgical Center, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 18, 2023, the Company acquired 95% of the equity interest of Advanced Diagnostic and Surgical Center, Inc. (&#x201c;ADSC&#x201d;). ADSC is a diagnostic and surgical center that also provides ambulatory surgery services. Certain Astrana board members previously owned ADSC. The transaction was funded with cash. In addition, the arrangement contains earnout payments. The Company is in the process of finalizing its purchase price allocation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2024, the Company&#x2019;s ESPP came into effect. The Company&#x2019;s ESPP allows eligible employees to contribute a portion of their eligible earnings toward the semi-annual purchase of the Company&#x2019;s common stock at a discounted price, subject to an annual maximum dollar amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medicare Shared Savings Program (&#x201c;MSSP&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in 2024, in addition to participating in the ACO REACH Model, one of the Company&#x2019;s ACOs will participate in the Medicare Shared Savings Program (&#x201c;MSSP&#x201d;). The MSSP was created to promote accountability and improve coordination of care for Medicare beneficiaries. The MSSP has multiple risk tracks, and the Company is currently participating in the ENHANCED risk track. Much like the ACO REACH Model, under the MSSP Model, the Company recruits a group of Participant and Preferred (in-network) Providers. Based on the Participant Providers that join the Company&#x2019;s ACO, CMS grants the Company a pool of Traditional Medicare patients (beneficiaries) to manage (the &#x201c;MSSP Aligned Beneficiaries&#x201d;). MSSP Aligned Beneficiaries will receive services from physicians and other medical service providers that are both in-network and out-of-network. Unlike the ACO REACH Program, CMS continues to pay participant and preferred providers on a fee-for-service basis for Medicare covered services provided to MSSP Aligned Beneficiaries. However, the Company continues to bear risk on all Medicare expenditures (both in-network and out-of-network), excluding drug expenditures covered by Medicare Part D, based on a budgetary benchmark established with CMS. The Company&#x2019;s shared savings or losses in managing its beneficiaries are generally determined on an annual basis after reconciliation with CMS.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-557" decimals="-6" id="f-1938" unitRef="usd">20000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-558" decimals="-6" id="f-1939" unitRef="usd">90000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-559"
      decimals="INF"
      id="f-1940"
      unitRef="number">0.25</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-560" decimals="-5" id="f-1941" unitRef="usd">93800000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c-560"
      decimals="INF"
      id="f-1942"
      unitRef="shares">631712</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="c-561" decimals="-5" id="f-1943" unitRef="usd">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:SeniorNotes contextRef="c-562" decimals="-6" id="f-1944" unitRef="usd">20000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-563"
      decimals="INF"
      id="f-1945"
      unitRef="number">0.029</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-564"
      decimals="INF"
      id="f-1946"
      unitRef="number">0.95</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-565" id="f-1947">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-565" id="f-1948">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-565" id="f-1949">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-565" id="f-1950">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc xlink:href="#f-82" xlink:label="f-82" xlink:type="locator"/>
        <link:loc
          xlink:href="#f-117"
          xlink:label="f-117"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-116"
          xlink:label="f-116"
          xlink:type="locator"/>
        <link:loc xlink:href="#f-83" xlink:label="f-83" xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company&#x2019;s consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#x2019;s consolidated VIEs totaling $540.8&#160;million and $579.8&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively, and total liabilities of the Company&#x2019;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of $146.0&#160;million and $149.6&#160;million as of December&#160;31, 2023 and December&#160;31, 2022, respectively. These VIE balances do not include $273.2&#160;million of investment in affiliates and $107.3&#160;million of amounts due to affiliates as of December&#160;31, 2023 and $304.8&#160;million of investment in affiliates and $11.6&#160;million of amounts due from affiliates as of December&#160;31, 2022 as these are eliminated upon consolidation and not presented within the consolidated balance sheets. See Note 18 &#x2013; &#x201c;Variable Interest Entities (VIEs)&#x201d; for further detail.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-82"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-117"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-116"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-83"
          xlink:to="fn-1"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
